P31946	YWHAB	14-3-3 protein beta/alpha	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0051219; F:phosphoprotein binding; IPI:BHF-UCL
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0050815; F:phosphoserine binding; IPI:BHF-UCL
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0000186; P:activation of MAPKK activity; TAS:Reactome
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0006915; P:apoptotic process; TAS:Reactome
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0007411; P:axon guidance; TAS:Reactome
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0051220; P:cytoplasmic sequestering of protein; IDA:BHF-UCL
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0010467; P:gene expression; TAS:Reactome
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0035329; P:hippo signaling; TAS:Reactome
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0045087; P:innate immune response; TAS:Reactome
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0000165; P:MAPK cascade; TAS:Reactome
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0061024; P:membrane organization; TAS:Reactome
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0035308; P:negative regulation of protein dephosphorylation; IDA:BHF-UCL
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0043085; P:positive regulation of catalytic activity; IDA:BHF-UCL
P31946	YWHAB	14-3-3 protein beta/alpha	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0006605; P:protein targeting; IEA:Ensembl
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0016070; P:RNA metabolic process; TAS:Reactome
P31946	YWHAB	14-3-3 protein beta/alpha	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P62258	YWHAE	14-3-3 protein epsilon	GO:0019899; F:enzyme binding; IPI:UniProtKB
P62258	YWHAE	14-3-3 protein epsilon	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
P62258	YWHAE	14-3-3 protein epsilon	GO:0044325; F:ion channel binding; IPI:BHF-UCL
P62258	YWHAE	14-3-3 protein epsilon	GO:0023026; F:MHC class II protein complex binding; IDA:UniProt
P62258	YWHAE	14-3-3 protein epsilon	GO:0051219; F:phosphoprotein binding; IPI:BHF-UCL
P62258	YWHAE	14-3-3 protein epsilon	GO:0050815; F:phosphoserine binding; IPI:BHF-UCL
P62258	YWHAE	14-3-3 protein epsilon	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62258	YWHAE	14-3-3 protein epsilon	GO:0015459; F:potassium channel regulator activity; IDA:BHF-UCL
P62258	YWHAE	14-3-3 protein epsilon	GO:0005515; F:protein binding; IPI:UniProtKB
P62258	YWHAE	14-3-3 protein epsilon	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P62258	YWHAE	14-3-3 protein epsilon	GO:0006915; P:apoptotic process; TAS:Reactome
P62258	YWHAE	14-3-3 protein epsilon	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
P62258	YWHAE	14-3-3 protein epsilon	GO:0021987; P:cerebral cortex development; IEA:Ensembl
P62258	YWHAE	14-3-3 protein epsilon	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P62258	YWHAE	14-3-3 protein epsilon	GO:0035329; P:hippo signaling; TAS:Reactome
P62258	YWHAE	14-3-3 protein epsilon	GO:0021766; P:hippocampus development; IEA:Ensembl
P62258	YWHAE	14-3-3 protein epsilon	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
P62258	YWHAE	14-3-3 protein epsilon	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
P62258	YWHAE	14-3-3 protein epsilon	GO:0061024; P:membrane organization; TAS:Reactome
P62258	YWHAE	14-3-3 protein epsilon	GO:0086013; P:membrane repolarization during cardiac muscle cell action potential; IC:BHF-UCL
P62258	YWHAE	14-3-3 protein epsilon	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P62258	YWHAE	14-3-3 protein epsilon	GO:1902309; P:negative regulation of peptidyl-serine dephosphorylation; IDA:BHF-UCL
P62258	YWHAE	14-3-3 protein epsilon	GO:0001764; P:neuron migration; IEA:Ensembl
P62258	YWHAE	14-3-3 protein epsilon	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P62258	YWHAE	14-3-3 protein epsilon	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
P62258	YWHAE	14-3-3 protein epsilon	GO:0006605; P:protein targeting; IEA:Ensembl
P62258	YWHAE	14-3-3 protein epsilon	GO:0043281; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:Reactome
P62258	YWHAE	14-3-3 protein epsilon	GO:0086091; P:regulation of heart rate by cardiac conduction; IC:BHF-UCL
P62258	YWHAE	14-3-3 protein epsilon	GO:0003064; P:regulation of heart rate by hormone; NAS:BHF-UCL
P62258	YWHAE	14-3-3 protein epsilon	GO:0060306; P:regulation of membrane repolarization; IDA:BHF-UCL
P62258	YWHAE	14-3-3 protein epsilon	GO:1901016; P:regulation of potassium ion transmembrane transporter activity; IDA:BHF-UCL
P62258	YWHAE	14-3-3 protein epsilon	GO:0021762; P:substantia nigra development; IEP:UniProt
P62258	YWHAE	14-3-3 protein epsilon	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q04917	YWHAH	14-3-3 protein eta	GO:0019899; F:enzyme binding; IPI:BHF-UCL
Q04917	YWHAH	14-3-3 protein eta	GO:0035259; F:glucocorticoid receptor binding; IPI:UniProtKB
Q04917	YWHAH	14-3-3 protein eta	GO:0005159; F:insulin-like growth factor receptor binding; ISS:UniProtKB
Q04917	YWHAH	14-3-3 protein eta	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q04917	YWHAH	14-3-3 protein eta	GO:0005515; F:protein binding; IPI:UniProtKB
Q04917	YWHAH	14-3-3 protein eta	GO:0019904; F:protein domain specific binding; ISS:UniProtKB
Q04917	YWHAH	14-3-3 protein eta	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
Q04917	YWHAH	14-3-3 protein eta	GO:0017080; F:sodium channel regulator activity; IDA:BHF-UCL
Q04917	YWHAH	14-3-3 protein eta	GO:0006915; P:apoptotic process; TAS:Reactome
Q04917	YWHAH	14-3-3 protein eta	GO:0006713; P:glucocorticoid catabolic process; IDA:UniProtKB
Q04917	YWHAH	14-3-3 protein eta	GO:0042921; P:glucocorticoid receptor signaling pathway; IDA:UniProtKB
Q04917	YWHAH	14-3-3 protein eta	GO:0006886; P:intracellular protein transport; ISS:UniProtKB
Q04917	YWHAH	14-3-3 protein eta	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
Q04917	YWHAH	14-3-3 protein eta	GO:0086010; P:membrane depolarization during action potential; IDA:BHF-UCL
Q04917	YWHAH	14-3-3 protein eta	GO:0061024; P:membrane organization; TAS:Reactome
Q04917	YWHAH	14-3-3 protein eta	GO:0050774; P:negative regulation of dendrite morphogenesis; ISS:UniProtKB
Q04917	YWHAH	14-3-3 protein eta	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
Q04917	YWHAH	14-3-3 protein eta	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q04917	YWHAH	14-3-3 protein eta	GO:0045664; P:regulation of neuron differentiation; ISS:UniProtKB
Q04917	YWHAH	14-3-3 protein eta	GO:2000649; P:regulation of sodium ion transmembrane transporter activity; IDA:BHF-UCL
Q04917	YWHAH	14-3-3 protein eta	GO:0002028; P:regulation of sodium ion transport; IDA:BHF-UCL
Q04917	YWHAH	14-3-3 protein eta	GO:0048167; P:regulation of synaptic plasticity; ISS:UniProtKB
Q04917	YWHAH	14-3-3 protein eta	GO:0021762; P:substantia nigra development; IEP:UniProt
P61981	YWHAG	14-3-3 protein gamma	GO:0005159; F:insulin-like growth factor receptor binding; IPI:UniProtKB
P61981	YWHAG	14-3-3 protein gamma	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P61981	YWHAG	14-3-3 protein gamma	GO:0005515; F:protein binding; IPI:UniProtKB
P61981	YWHAG	14-3-3 protein gamma	GO:0005080; F:protein kinase C binding; IPI:UniProtKB
P61981	YWHAG	14-3-3 protein gamma	GO:0008426; F:protein kinase C inhibitor activity; NAS:UniProtKB
P61981	YWHAG	14-3-3 protein gamma	GO:0006915; P:apoptotic process; TAS:Reactome
P61981	YWHAG	14-3-3 protein gamma	GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl
P61981	YWHAG	14-3-3 protein gamma	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P61981	YWHAG	14-3-3 protein gamma	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
P61981	YWHAG	14-3-3 protein gamma	GO:0061024; P:membrane organization; TAS:Reactome
P61981	YWHAG	14-3-3 protein gamma	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P61981	YWHAG	14-3-3 protein gamma	GO:0006469; P:negative regulation of protein kinase activity; NAS:UniProtKB
P61981	YWHAG	14-3-3 protein gamma	GO:0071901; P:negative regulation of protein serine/threonine kinase activity; NAS:GOC
P61981	YWHAG	14-3-3 protein gamma	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
P61981	YWHAG	14-3-3 protein gamma	GO:0006605; P:protein targeting; IEA:Ensembl
P61981	YWHAG	14-3-3 protein gamma	GO:0045664; P:regulation of neuron differentiation; IMP:UniProtKB
P61981	YWHAG	14-3-3 protein gamma	GO:0009966; P:regulation of signal transduction; NAS:UniProtKB
P61981	YWHAG	14-3-3 protein gamma	GO:0048167; P:regulation of synaptic plasticity; IMP:UniProtKB
P31947	SFN	14-3-3 protein sigma	GO:0005515; F:protein binding; IPI:UniProtKB
P31947	SFN	14-3-3 protein sigma	GO:0008426; F:protein kinase C inhibitor activity; TAS:ProtInc
P31947	SFN	14-3-3 protein sigma	GO:0006915; P:apoptotic process; TAS:Reactome
P31947	SFN	14-3-3 protein sigma	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
P31947	SFN	14-3-3 protein sigma	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IDA:HGNC
P31947	SFN	14-3-3 protein sigma	GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
P31947	SFN	14-3-3 protein sigma	GO:0043616; P:keratinocyte proliferation; IEA:Ensembl
P31947	SFN	14-3-3 protein sigma	GO:0061024; P:membrane organization; TAS:Reactome
P31947	SFN	14-3-3 protein sigma	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P31947	SFN	14-3-3 protein sigma	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:HGNC
P31947	SFN	14-3-3 protein sigma	GO:0006469; P:negative regulation of protein kinase activity; TAS:ProtInc
P31947	SFN	14-3-3 protein sigma	GO:0071901; P:negative regulation of protein serine/threonine kinase activity; TAS:GOC
P31947	SFN	14-3-3 protein sigma	GO:0030307; P:positive regulation of cell growth; IEA:Ensembl
P31947	SFN	14-3-3 protein sigma	GO:0046827; P:positive regulation of protein export from nucleus; IEA:Ensembl
P31947	SFN	14-3-3 protein sigma	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
P31947	SFN	14-3-3 protein sigma	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:Ensembl
P31947	SFN	14-3-3 protein sigma	GO:0001836; P:release of cytochrome c from mitochondria; IDA:HGNC
P31947	SFN	14-3-3 protein sigma	GO:0007165; P:signal transduction; TAS:ProtInc
P27348	YWHAQ	14-3-3 protein theta	GO:0005515; F:protein binding; IPI:UniProtKB
P27348	YWHAQ	14-3-3 protein theta	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
P27348	YWHAQ	14-3-3 protein theta	GO:0006915; P:apoptotic process; TAS:Reactome
P27348	YWHAQ	14-3-3 protein theta	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
P27348	YWHAQ	14-3-3 protein theta	GO:0061024; P:membrane organization; TAS:Reactome
P27348	YWHAQ	14-3-3 protein theta	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
P27348	YWHAQ	14-3-3 protein theta	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
P27348	YWHAQ	14-3-3 protein theta	GO:0006605; P:protein targeting; IEA:Ensembl
P27348	YWHAQ	14-3-3 protein theta	GO:0007264; P:small GTPase mediated signal transduction; IEA:Ensembl
P27348	YWHAQ	14-3-3 protein theta	GO:0021762; P:substantia nigra development; IEP:UniProt
P63104	YWHAZ	14-3-3 protein zeta/delta	GO:0042802; F:identical protein binding; IPI:IntAct
P63104	YWHAZ	14-3-3 protein zeta/delta	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P63104	YWHAZ	14-3-3 protein zeta/delta	GO:0005515; F:protein binding; IPI:UniProtKB
P63104	YWHAZ	14-3-3 protein zeta/delta	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P63104	YWHAZ	14-3-3 protein zeta/delta	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P63104	YWHAZ	14-3-3 protein zeta/delta	GO:0006915; P:apoptotic process; TAS:Reactome
P63104	YWHAZ	14-3-3 protein zeta/delta	GO:0007596; P:blood coagulation; TAS:Reactome
P63104	YWHAZ	14-3-3 protein zeta/delta	GO:0010467; P:gene expression; TAS:Reactome
P63104	YWHAZ	14-3-3 protein zeta/delta	GO:0002553; P:histamine secretion by mast cell; IEA:Ensembl
P63104	YWHAZ	14-3-3 protein zeta/delta	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
P63104	YWHAZ	14-3-3 protein zeta/delta	GO:0061024; P:membrane organization; TAS:Reactome
P63104	YWHAZ	14-3-3 protein zeta/delta	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P63104	YWHAZ	14-3-3 protein zeta/delta	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
P63104	YWHAZ	14-3-3 protein zeta/delta	GO:0030168; P:platelet activation; TAS:Reactome
P63104	YWHAZ	14-3-3 protein zeta/delta	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
P63104	YWHAZ	14-3-3 protein zeta/delta	GO:0006626; P:protein targeting to mitochondrion; IEA:Ensembl
P63104	YWHAZ	14-3-3 protein zeta/delta	GO:0042493; P:response to drug; IEA:Ensembl
P63104	YWHAZ	14-3-3 protein zeta/delta	GO:0016070; P:RNA metabolic process; TAS:Reactome
P63104	YWHAZ	14-3-3 protein zeta/delta	GO:0007165; P:signal transduction; TAS:ProtInc
P30443	HLA-A	HLA class I histocompatibility antigen, A-1 alpha chain	GO:0042605; F:peptide antigen binding; IBA:RefGenome
P30443	HLA-A	HLA class I histocompatibility antigen, A-1 alpha chain	GO:0005102; F:receptor binding; IBA:RefGenome
P30443	HLA-A	HLA class I histocompatibility antigen, A-1 alpha chain	GO:0046977; F:TAP binding; IDA:UniProt
P30443	HLA-A	HLA class I histocompatibility antigen, A-1 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30443	HLA-A	HLA class I histocompatibility antigen, A-1 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30443	HLA-A	HLA class I histocompatibility antigen, A-1 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30443	HLA-A	HLA class I histocompatibility antigen, A-1 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30443	HLA-A	HLA class I histocompatibility antigen, A-1 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30443	HLA-A	HLA class I histocompatibility antigen, A-1 alpha chain	GO:0016045; P:detection of bacterium; IMP:UniProtKB
P30443	HLA-A	HLA class I histocompatibility antigen, A-1 alpha chain	GO:0006955; P:immune response; IMP:UniProtKB
P30443	HLA-A	HLA class I histocompatibility antigen, A-1 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30443	HLA-A	HLA class I histocompatibility antigen, A-1 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IDA:UniProt
P30443	HLA-A	HLA class I histocompatibility antigen, A-1 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30443	HLA-A	HLA class I histocompatibility antigen, A-1 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30443	HLA-A	HLA class I histocompatibility antigen, A-1 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P01892	HLA-A	HLA class I histocompatibility antigen, A-2 alpha chain	GO:0042605; F:peptide antigen binding; IDA:UniProt
P01892	HLA-A	HLA class I histocompatibility antigen, A-2 alpha chain	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P01892	HLA-A	HLA class I histocompatibility antigen, A-2 alpha chain	GO:0005515; F:protein binding; IPI:UniProtKB
P01892	HLA-A	HLA class I histocompatibility antigen, A-2 alpha chain	GO:0005102; F:receptor binding; IPI:BHF-UCL
P01892	HLA-A	HLA class I histocompatibility antigen, A-2 alpha chain	GO:0046977; F:TAP binding; IDA:UniProt
P01892	HLA-A	HLA class I histocompatibility antigen, A-2 alpha chain	GO:0002486; P:antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent; IDA:UniProt
P01892	HLA-A	HLA class I histocompatibility antigen, A-2 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P01892	HLA-A	HLA class I histocompatibility antigen, A-2 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P01892	HLA-A	HLA class I histocompatibility antigen, A-2 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P01892	HLA-A	HLA class I histocompatibility antigen, A-2 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P01892	HLA-A	HLA class I histocompatibility antigen, A-2 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P01892	HLA-A	HLA class I histocompatibility antigen, A-2 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P01892	HLA-A	HLA class I histocompatibility antigen, A-2 alpha chain	GO:0032729; P:positive regulation of interferon-gamma production; IDA:UniProt
P01892	HLA-A	HLA class I histocompatibility antigen, A-2 alpha chain	GO:2000568; P:positive regulation of memory T cell activation; IDA:UniProt
P01892	HLA-A	HLA class I histocompatibility antigen, A-2 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IDA:UniProt
P01892	HLA-A	HLA class I histocompatibility antigen, A-2 alpha chain	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
P01892	HLA-A	HLA class I histocompatibility antigen, A-2 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P01892	HLA-A	HLA class I histocompatibility antigen, A-2 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P01892	HLA-A	HLA class I histocompatibility antigen, A-2 alpha chain	GO:0016032; P:viral process; TAS:Reactome
P04439	HLA-A	HLA class I histocompatibility antigen, A-3 alpha chain	GO:0042605; F:peptide antigen binding; IBA:RefGenome
P04439	HLA-A	HLA class I histocompatibility antigen, A-3 alpha chain	GO:0005102; F:receptor binding; IBA:RefGenome
P04439	HLA-A	HLA class I histocompatibility antigen, A-3 alpha chain	GO:0046977; F:TAP binding; IDA:UniProt
P04439	HLA-A	HLA class I histocompatibility antigen, A-3 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P04439	HLA-A	HLA class I histocompatibility antigen, A-3 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P04439	HLA-A	HLA class I histocompatibility antigen, A-3 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P04439	HLA-A	HLA class I histocompatibility antigen, A-3 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P04439	HLA-A	HLA class I histocompatibility antigen, A-3 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P04439	HLA-A	HLA class I histocompatibility antigen, A-3 alpha chain	GO:0006955; P:immune response; NAS:UniProtKB
P04439	HLA-A	HLA class I histocompatibility antigen, A-3 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P04439	HLA-A	HLA class I histocompatibility antigen, A-3 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P04439	HLA-A	HLA class I histocompatibility antigen, A-3 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P04439	HLA-A	HLA class I histocompatibility antigen, A-3 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P04439	HLA-A	HLA class I histocompatibility antigen, A-3 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P13746	HLA-A	HLA class I histocompatibility antigen, A-11 alpha chain	GO:0042605; F:peptide antigen binding; IEA:InterPro
P13746	HLA-A	HLA class I histocompatibility antigen, A-11 alpha chain	GO:0046977; F:TAP binding; IDA:UniProt
P13746	HLA-A	HLA class I histocompatibility antigen, A-11 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P13746	HLA-A	HLA class I histocompatibility antigen, A-11 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P13746	HLA-A	HLA class I histocompatibility antigen, A-11 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P13746	HLA-A	HLA class I histocompatibility antigen, A-11 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P13746	HLA-A	HLA class I histocompatibility antigen, A-11 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P13746	HLA-A	HLA class I histocompatibility antigen, A-11 alpha chain	GO:0006955; P:immune response; NAS:UniProtKB
P13746	HLA-A	HLA class I histocompatibility antigen, A-11 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P13746	HLA-A	HLA class I histocompatibility antigen, A-11 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P13746	HLA-A	HLA class I histocompatibility antigen, A-11 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P13746	HLA-A	HLA class I histocompatibility antigen, A-11 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P13746	HLA-A	HLA class I histocompatibility antigen, A-11 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q96QU6	ACCS	1-aminocyclopropane-1-carboxylate synthase-like protein 1	GO:0003824; F:catalytic activity; IEA:InterPro
Q96QU6	ACCS	1-aminocyclopropane-1-carboxylate synthase-like protein 1	GO:0042803; F:protein homodimerization activity; NAS:UniProtKB
Q96QU6	ACCS	1-aminocyclopropane-1-carboxylate synthase-like protein 1	GO:0030170; F:pyridoxal phosphate binding; NAS:UniProtKB
Q96QU6	ACCS	1-aminocyclopropane-1-carboxylate synthase-like protein 1	GO:0009058; P:biosynthetic process; IEA:InterPro
Q4AC99	ACCSL	Probable inactive 1-aminocyclopropane-1-carboxylate synthase-like protein 2	GO:0003824; F:catalytic activity; IEA:InterPro
Q4AC99	ACCSL	Probable inactive 1-aminocyclopropane-1-carboxylate synthase-like protein 2	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q4AC99	ACCSL	Probable inactive 1-aminocyclopropane-1-carboxylate synthase-like protein 2	GO:0009058; P:biosynthetic process; IEA:InterPro
P30447	HLA-A	HLA class I histocompatibility antigen, A-23 alpha chain	GO:0042605; F:peptide antigen binding; IEA:InterPro
P30447	HLA-A	HLA class I histocompatibility antigen, A-23 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30447	HLA-A	HLA class I histocompatibility antigen, A-23 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30447	HLA-A	HLA class I histocompatibility antigen, A-23 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30447	HLA-A	HLA class I histocompatibility antigen, A-23 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30447	HLA-A	HLA class I histocompatibility antigen, A-23 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30447	HLA-A	HLA class I histocompatibility antigen, A-23 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30447	HLA-A	HLA class I histocompatibility antigen, A-23 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30447	HLA-A	HLA class I histocompatibility antigen, A-23 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30447	HLA-A	HLA class I histocompatibility antigen, A-23 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30447	HLA-A	HLA class I histocompatibility antigen, A-23 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P05534	HLA-A	HLA class I histocompatibility antigen, A-24 alpha chain	GO:0042605; F:peptide antigen binding; IEA:InterPro
P05534	HLA-A	HLA class I histocompatibility antigen, A-24 alpha chain	GO:0046977; F:TAP binding; IDA:UniProt
P05534	HLA-A	HLA class I histocompatibility antigen, A-24 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P05534	HLA-A	HLA class I histocompatibility antigen, A-24 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P05534	HLA-A	HLA class I histocompatibility antigen, A-24 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P05534	HLA-A	HLA class I histocompatibility antigen, A-24 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P05534	HLA-A	HLA class I histocompatibility antigen, A-24 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P05534	HLA-A	HLA class I histocompatibility antigen, A-24 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P05534	HLA-A	HLA class I histocompatibility antigen, A-24 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P05534	HLA-A	HLA class I histocompatibility antigen, A-24 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P05534	HLA-A	HLA class I histocompatibility antigen, A-24 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P05534	HLA-A	HLA class I histocompatibility antigen, A-24 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P18462	HLA-A	HLA class I histocompatibility antigen, A-25 alpha chain	GO:0042605; F:peptide antigen binding; IEA:InterPro
P18462	HLA-A	HLA class I histocompatibility antigen, A-25 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P18462	HLA-A	HLA class I histocompatibility antigen, A-25 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P18462	HLA-A	HLA class I histocompatibility antigen, A-25 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P18462	HLA-A	HLA class I histocompatibility antigen, A-25 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P18462	HLA-A	HLA class I histocompatibility antigen, A-25 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P18462	HLA-A	HLA class I histocompatibility antigen, A-25 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P18462	HLA-A	HLA class I histocompatibility antigen, A-25 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P18462	HLA-A	HLA class I histocompatibility antigen, A-25 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P18462	HLA-A	HLA class I histocompatibility antigen, A-25 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P18462	HLA-A	HLA class I histocompatibility antigen, A-25 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30450	HLA-A	HLA class I histocompatibility antigen, A-26 alpha chain	GO:0042605; F:peptide antigen binding; IBA:RefGenome
P30450	HLA-A	HLA class I histocompatibility antigen, A-26 alpha chain	GO:0005102; F:receptor binding; IBA:RefGenome
P30450	HLA-A	HLA class I histocompatibility antigen, A-26 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30450	HLA-A	HLA class I histocompatibility antigen, A-26 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30450	HLA-A	HLA class I histocompatibility antigen, A-26 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30450	HLA-A	HLA class I histocompatibility antigen, A-26 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30450	HLA-A	HLA class I histocompatibility antigen, A-26 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30450	HLA-A	HLA class I histocompatibility antigen, A-26 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30450	HLA-A	HLA class I histocompatibility antigen, A-26 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30450	HLA-A	HLA class I histocompatibility antigen, A-26 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30450	HLA-A	HLA class I histocompatibility antigen, A-26 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30450	HLA-A	HLA class I histocompatibility antigen, A-26 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P16188	HLA-A	HLA class I histocompatibility antigen, A-30 alpha chain	GO:0042605; F:peptide antigen binding; IEA:InterPro
P16188	HLA-A	HLA class I histocompatibility antigen, A-30 alpha chain	GO:0046977; F:TAP binding; IDA:UniProt
P16188	HLA-A	HLA class I histocompatibility antigen, A-30 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P16188	HLA-A	HLA class I histocompatibility antigen, A-30 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P16188	HLA-A	HLA class I histocompatibility antigen, A-30 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P16188	HLA-A	HLA class I histocompatibility antigen, A-30 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P16188	HLA-A	HLA class I histocompatibility antigen, A-30 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P16188	HLA-A	HLA class I histocompatibility antigen, A-30 alpha chain	GO:0006955; P:immune response; NAS:UniProtKB
P16188	HLA-A	HLA class I histocompatibility antigen, A-30 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P16188	HLA-A	HLA class I histocompatibility antigen, A-30 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P16188	HLA-A	HLA class I histocompatibility antigen, A-30 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P16188	HLA-A	HLA class I histocompatibility antigen, A-30 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P16188	HLA-A	HLA class I histocompatibility antigen, A-30 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30512	HLA-A	HLA class I histocompatibility antigen, A-29 alpha chain	GO:0042605; F:peptide antigen binding; IEA:InterPro
P30512	HLA-A	HLA class I histocompatibility antigen, A-29 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30512	HLA-A	HLA class I histocompatibility antigen, A-29 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30512	HLA-A	HLA class I histocompatibility antigen, A-29 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30512	HLA-A	HLA class I histocompatibility antigen, A-29 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30512	HLA-A	HLA class I histocompatibility antigen, A-29 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30512	HLA-A	HLA class I histocompatibility antigen, A-29 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30512	HLA-A	HLA class I histocompatibility antigen, A-29 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30512	HLA-A	HLA class I histocompatibility antigen, A-29 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30512	HLA-A	HLA class I histocompatibility antigen, A-29 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30512	HLA-A	HLA class I histocompatibility antigen, A-29 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P16189	HLA-A	HLA class I histocompatibility antigen, A-31 alpha chain	GO:0042605; F:peptide antigen binding; IEA:InterPro
P16189	HLA-A	HLA class I histocompatibility antigen, A-31 alpha chain	GO:0046977; F:TAP binding; IDA:UniProt
P16189	HLA-A	HLA class I histocompatibility antigen, A-31 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P16189	HLA-A	HLA class I histocompatibility antigen, A-31 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P16189	HLA-A	HLA class I histocompatibility antigen, A-31 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P16189	HLA-A	HLA class I histocompatibility antigen, A-31 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P16189	HLA-A	HLA class I histocompatibility antigen, A-31 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P16189	HLA-A	HLA class I histocompatibility antigen, A-31 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P16189	HLA-A	HLA class I histocompatibility antigen, A-31 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P16189	HLA-A	HLA class I histocompatibility antigen, A-31 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P16189	HLA-A	HLA class I histocompatibility antigen, A-31 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P16189	HLA-A	HLA class I histocompatibility antigen, A-31 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P10314	HLA-A	HLA class I histocompatibility antigen, A-32 alpha chain	GO:0042605; F:peptide antigen binding; IBA:RefGenome
P10314	HLA-A	HLA class I histocompatibility antigen, A-32 alpha chain	GO:0005102; F:receptor binding; IBA:RefGenome
P10314	HLA-A	HLA class I histocompatibility antigen, A-32 alpha chain	GO:0046977; F:TAP binding; IDA:UniProt
P10314	HLA-A	HLA class I histocompatibility antigen, A-32 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P10314	HLA-A	HLA class I histocompatibility antigen, A-32 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P10314	HLA-A	HLA class I histocompatibility antigen, A-32 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P10314	HLA-A	HLA class I histocompatibility antigen, A-32 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P10314	HLA-A	HLA class I histocompatibility antigen, A-32 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P10314	HLA-A	HLA class I histocompatibility antigen, A-32 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P10314	HLA-A	HLA class I histocompatibility antigen, A-32 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P10314	HLA-A	HLA class I histocompatibility antigen, A-32 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P10314	HLA-A	HLA class I histocompatibility antigen, A-32 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P10314	HLA-A	HLA class I histocompatibility antigen, A-32 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P16190	HLA-A	HLA class I histocompatibility antigen, A-33 alpha chain	GO:0042605; F:peptide antigen binding; IEA:InterPro
P16190	HLA-A	HLA class I histocompatibility antigen, A-33 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P16190	HLA-A	HLA class I histocompatibility antigen, A-33 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P16190	HLA-A	HLA class I histocompatibility antigen, A-33 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P16190	HLA-A	HLA class I histocompatibility antigen, A-33 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P16190	HLA-A	HLA class I histocompatibility antigen, A-33 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P16190	HLA-A	HLA class I histocompatibility antigen, A-33 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P16190	HLA-A	HLA class I histocompatibility antigen, A-33 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P16190	HLA-A	HLA class I histocompatibility antigen, A-33 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P16190	HLA-A	HLA class I histocompatibility antigen, A-33 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P16190	HLA-A	HLA class I histocompatibility antigen, A-33 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30453	HLA-A	HLA class I histocompatibility antigen, A-34 alpha chain	GO:0042605; F:peptide antigen binding; IEA:InterPro
P30453	HLA-A	HLA class I histocompatibility antigen, A-34 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30453	HLA-A	HLA class I histocompatibility antigen, A-34 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30453	HLA-A	HLA class I histocompatibility antigen, A-34 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30453	HLA-A	HLA class I histocompatibility antigen, A-34 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30453	HLA-A	HLA class I histocompatibility antigen, A-34 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30453	HLA-A	HLA class I histocompatibility antigen, A-34 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30453	HLA-A	HLA class I histocompatibility antigen, A-34 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30453	HLA-A	HLA class I histocompatibility antigen, A-34 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30453	HLA-A	HLA class I histocompatibility antigen, A-34 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30453	HLA-A	HLA class I histocompatibility antigen, A-34 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30455	HLA-A	HLA class I histocompatibility antigen, A-36 alpha chain	GO:0042605; F:peptide antigen binding; IEA:InterPro
P30455	HLA-A	HLA class I histocompatibility antigen, A-36 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30455	HLA-A	HLA class I histocompatibility antigen, A-36 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30455	HLA-A	HLA class I histocompatibility antigen, A-36 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30455	HLA-A	HLA class I histocompatibility antigen, A-36 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30455	HLA-A	HLA class I histocompatibility antigen, A-36 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30455	HLA-A	HLA class I histocompatibility antigen, A-36 alpha chain	GO:0006955; P:immune response; NAS:UniProtKB
P30455	HLA-A	HLA class I histocompatibility antigen, A-36 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30455	HLA-A	HLA class I histocompatibility antigen, A-36 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30455	HLA-A	HLA class I histocompatibility antigen, A-36 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30455	HLA-A	HLA class I histocompatibility antigen, A-36 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30455	HLA-A	HLA class I histocompatibility antigen, A-36 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30456	HLA-A	HLA class I histocompatibility antigen, A-43 alpha chain	GO:0042605; F:peptide antigen binding; IEA:InterPro
P30456	HLA-A	HLA class I histocompatibility antigen, A-43 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30456	HLA-A	HLA class I histocompatibility antigen, A-43 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30456	HLA-A	HLA class I histocompatibility antigen, A-43 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30456	HLA-A	HLA class I histocompatibility antigen, A-43 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30456	HLA-A	HLA class I histocompatibility antigen, A-43 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30456	HLA-A	HLA class I histocompatibility antigen, A-43 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30456	HLA-A	HLA class I histocompatibility antigen, A-43 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30456	HLA-A	HLA class I histocompatibility antigen, A-43 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30456	HLA-A	HLA class I histocompatibility antigen, A-43 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30456	HLA-A	HLA class I histocompatibility antigen, A-43 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30457	HLA-A	HLA class I histocompatibility antigen, A-66 alpha chain	GO:0042605; F:peptide antigen binding; IEA:InterPro
P30457	HLA-A	HLA class I histocompatibility antigen, A-66 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30457	HLA-A	HLA class I histocompatibility antigen, A-66 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30457	HLA-A	HLA class I histocompatibility antigen, A-66 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30457	HLA-A	HLA class I histocompatibility antigen, A-66 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30457	HLA-A	HLA class I histocompatibility antigen, A-66 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30457	HLA-A	HLA class I histocompatibility antigen, A-66 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30457	HLA-A	HLA class I histocompatibility antigen, A-66 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30457	HLA-A	HLA class I histocompatibility antigen, A-66 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30457	HLA-A	HLA class I histocompatibility antigen, A-66 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30457	HLA-A	HLA class I histocompatibility antigen, A-66 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P01891	HLA-A	HLA class I histocompatibility antigen, A-68 alpha chain	GO:0042605; F:peptide antigen binding; IEA:InterPro
P01891	HLA-A	HLA class I histocompatibility antigen, A-68 alpha chain	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P01891	HLA-A	HLA class I histocompatibility antigen, A-68 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P01891	HLA-A	HLA class I histocompatibility antigen, A-68 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P01891	HLA-A	HLA class I histocompatibility antigen, A-68 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P01891	HLA-A	HLA class I histocompatibility antigen, A-68 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P01891	HLA-A	HLA class I histocompatibility antigen, A-68 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P01891	HLA-A	HLA class I histocompatibility antigen, A-68 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P01891	HLA-A	HLA class I histocompatibility antigen, A-68 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P01891	HLA-A	HLA class I histocompatibility antigen, A-68 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P01891	HLA-A	HLA class I histocompatibility antigen, A-68 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P01891	HLA-A	HLA class I histocompatibility antigen, A-68 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P10316	HLA-A	HLA class I histocompatibility antigen, A-69 alpha chain	GO:0042605; F:peptide antigen binding; IEA:InterPro
P10316	HLA-A	HLA class I histocompatibility antigen, A-69 alpha chain	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P10316	HLA-A	HLA class I histocompatibility antigen, A-69 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P10316	HLA-A	HLA class I histocompatibility antigen, A-69 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P10316	HLA-A	HLA class I histocompatibility antigen, A-69 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P10316	HLA-A	HLA class I histocompatibility antigen, A-69 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P10316	HLA-A	HLA class I histocompatibility antigen, A-69 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P10316	HLA-A	HLA class I histocompatibility antigen, A-69 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P10316	HLA-A	HLA class I histocompatibility antigen, A-69 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P10316	HLA-A	HLA class I histocompatibility antigen, A-69 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P10316	HLA-A	HLA class I histocompatibility antigen, A-69 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P10316	HLA-A	HLA class I histocompatibility antigen, A-69 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30459	HLA-A	HLA class I histocompatibility antigen, A-74 alpha chain	GO:0042605; F:peptide antigen binding; IEA:InterPro
P30459	HLA-A	HLA class I histocompatibility antigen, A-74 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30459	HLA-A	HLA class I histocompatibility antigen, A-74 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30459	HLA-A	HLA class I histocompatibility antigen, A-74 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30459	HLA-A	HLA class I histocompatibility antigen, A-74 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30459	HLA-A	HLA class I histocompatibility antigen, A-74 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30459	HLA-A	HLA class I histocompatibility antigen, A-74 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30459	HLA-A	HLA class I histocompatibility antigen, A-74 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30459	HLA-A	HLA class I histocompatibility antigen, A-74 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30459	HLA-A	HLA class I histocompatibility antigen, A-74 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30459	HLA-A	HLA class I histocompatibility antigen, A-74 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q09160	HLA-A	HLA class I histocompatibility antigen, A-80 alpha chain	GO:0042605; F:peptide antigen binding; IEA:InterPro
Q09160	HLA-A	HLA class I histocompatibility antigen, A-80 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q09160	HLA-A	HLA class I histocompatibility antigen, A-80 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q09160	HLA-A	HLA class I histocompatibility antigen, A-80 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
Q09160	HLA-A	HLA class I histocompatibility antigen, A-80 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q09160	HLA-A	HLA class I histocompatibility antigen, A-80 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q09160	HLA-A	HLA class I histocompatibility antigen, A-80 alpha chain	GO:0006955; P:immune response; NAS:UniProtKB
Q09160	HLA-A	HLA class I histocompatibility antigen, A-80 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q09160	HLA-A	HLA class I histocompatibility antigen, A-80 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
Q09160	HLA-A	HLA class I histocompatibility antigen, A-80 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
Q09160	HLA-A	HLA class I histocompatibility antigen, A-80 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q09160	HLA-A	HLA class I histocompatibility antigen, A-80 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P01889	HLA-B	HLA class I histocompatibility antigen, B-7 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P01889	HLA-B	HLA class I histocompatibility antigen, B-7 alpha chain	GO:0005102; F:receptor binding; IPI:BHF-UCL
P01889	HLA-B	HLA class I histocompatibility antigen, B-7 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P01889	HLA-B	HLA class I histocompatibility antigen, B-7 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P01889	HLA-B	HLA class I histocompatibility antigen, B-7 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P01889	HLA-B	HLA class I histocompatibility antigen, B-7 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P01889	HLA-B	HLA class I histocompatibility antigen, B-7 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P01889	HLA-B	HLA class I histocompatibility antigen, B-7 alpha chain	GO:0006955; P:immune response; NAS:UniProtKB
P01889	HLA-B	HLA class I histocompatibility antigen, B-7 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P01889	HLA-B	HLA class I histocompatibility antigen, B-7 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P01889	HLA-B	HLA class I histocompatibility antigen, B-7 alpha chain	GO:2001198; P:regulation of dendritic cell differentiation; IMP:BHF-UCL
P01889	HLA-B	HLA class I histocompatibility antigen, B-7 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P01889	HLA-B	HLA class I histocompatibility antigen, B-7 alpha chain	GO:0032655; P:regulation of interleukin-12 production; IMP:BHF-UCL
P01889	HLA-B	HLA class I histocompatibility antigen, B-7 alpha chain	GO:0032675; P:regulation of interleukin-6 production; IMP:BHF-UCL
P01889	HLA-B	HLA class I histocompatibility antigen, B-7 alpha chain	GO:0002667; P:regulation of T cell anergy; IMP:BHF-UCL
P01889	HLA-B	HLA class I histocompatibility antigen, B-7 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P01889	HLA-B	HLA class I histocompatibility antigen, B-7 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30460	HLA-B	HLA class I histocompatibility antigen, B-8 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30460	HLA-B	HLA class I histocompatibility antigen, B-8 alpha chain	GO:0005102; F:receptor binding; IBA:RefGenome
P30460	HLA-B	HLA class I histocompatibility antigen, B-8 alpha chain	GO:0046977; F:TAP binding; IDA:UniProt
P30460	HLA-B	HLA class I histocompatibility antigen, B-8 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30460	HLA-B	HLA class I histocompatibility antigen, B-8 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30460	HLA-B	HLA class I histocompatibility antigen, B-8 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30460	HLA-B	HLA class I histocompatibility antigen, B-8 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30460	HLA-B	HLA class I histocompatibility antigen, B-8 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30460	HLA-B	HLA class I histocompatibility antigen, B-8 alpha chain	GO:0006955; P:immune response; NAS:UniProtKB
P30460	HLA-B	HLA class I histocompatibility antigen, B-8 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30460	HLA-B	HLA class I histocompatibility antigen, B-8 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30460	HLA-B	HLA class I histocompatibility antigen, B-8 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30460	HLA-B	HLA class I histocompatibility antigen, B-8 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30460	HLA-B	HLA class I histocompatibility antigen, B-8 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30461	HLA-B	HLA class I histocompatibility antigen, B-13 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30461	HLA-B	HLA class I histocompatibility antigen, B-13 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30461	HLA-B	HLA class I histocompatibility antigen, B-13 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30461	HLA-B	HLA class I histocompatibility antigen, B-13 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30461	HLA-B	HLA class I histocompatibility antigen, B-13 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30461	HLA-B	HLA class I histocompatibility antigen, B-13 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30461	HLA-B	HLA class I histocompatibility antigen, B-13 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30461	HLA-B	HLA class I histocompatibility antigen, B-13 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IDA:UniProt
P30461	HLA-B	HLA class I histocompatibility antigen, B-13 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30461	HLA-B	HLA class I histocompatibility antigen, B-13 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30461	HLA-B	HLA class I histocompatibility antigen, B-13 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30462	HLA-B	HLA class I histocompatibility antigen, B-14 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30462	HLA-B	HLA class I histocompatibility antigen, B-14 alpha chain	GO:0046977; F:TAP binding; IDA:UniProt
P30462	HLA-B	HLA class I histocompatibility antigen, B-14 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30462	HLA-B	HLA class I histocompatibility antigen, B-14 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30462	HLA-B	HLA class I histocompatibility antigen, B-14 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30462	HLA-B	HLA class I histocompatibility antigen, B-14 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30462	HLA-B	HLA class I histocompatibility antigen, B-14 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30462	HLA-B	HLA class I histocompatibility antigen, B-14 alpha chain	GO:0006955; P:immune response; NAS:UniProtKB
P30462	HLA-B	HLA class I histocompatibility antigen, B-14 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30462	HLA-B	HLA class I histocompatibility antigen, B-14 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30462	HLA-B	HLA class I histocompatibility antigen, B-14 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30462	HLA-B	HLA class I histocompatibility antigen, B-14 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30462	HLA-B	HLA class I histocompatibility antigen, B-14 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30464	HLA-B	HLA class I histocompatibility antigen, B-15 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30464	HLA-B	HLA class I histocompatibility antigen, B-15 alpha chain	GO:0005102; F:receptor binding; IBA:RefGenome
P30464	HLA-B	HLA class I histocompatibility antigen, B-15 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30464	HLA-B	HLA class I histocompatibility antigen, B-15 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30464	HLA-B	HLA class I histocompatibility antigen, B-15 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30464	HLA-B	HLA class I histocompatibility antigen, B-15 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30464	HLA-B	HLA class I histocompatibility antigen, B-15 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30464	HLA-B	HLA class I histocompatibility antigen, B-15 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30464	HLA-B	HLA class I histocompatibility antigen, B-15 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30464	HLA-B	HLA class I histocompatibility antigen, B-15 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30464	HLA-B	HLA class I histocompatibility antigen, B-15 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30464	HLA-B	HLA class I histocompatibility antigen, B-15 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30466	HLA-B	HLA class I histocompatibility antigen, B-18 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30466	HLA-B	HLA class I histocompatibility antigen, B-18 alpha chain	GO:0005102; F:receptor binding; IBA:RefGenome
P30466	HLA-B	HLA class I histocompatibility antigen, B-18 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30466	HLA-B	HLA class I histocompatibility antigen, B-18 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30466	HLA-B	HLA class I histocompatibility antigen, B-18 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30466	HLA-B	HLA class I histocompatibility antigen, B-18 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30466	HLA-B	HLA class I histocompatibility antigen, B-18 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30466	HLA-B	HLA class I histocompatibility antigen, B-18 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30466	HLA-B	HLA class I histocompatibility antigen, B-18 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30466	HLA-B	HLA class I histocompatibility antigen, B-18 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30466	HLA-B	HLA class I histocompatibility antigen, B-18 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30466	HLA-B	HLA class I histocompatibility antigen, B-18 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P03989	HLA-B	HLA class I histocompatibility antigen, B-27 alpha chain	GO:0042605; F:peptide antigen binding; IDA:UniProt
P03989	HLA-B	HLA class I histocompatibility antigen, B-27 alpha chain	GO:0002486; P:antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent; IDA:UniProt
P03989	HLA-B	HLA class I histocompatibility antigen, B-27 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P03989	HLA-B	HLA class I histocompatibility antigen, B-27 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P03989	HLA-B	HLA class I histocompatibility antigen, B-27 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P03989	HLA-B	HLA class I histocompatibility antigen, B-27 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P03989	HLA-B	HLA class I histocompatibility antigen, B-27 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P03989	HLA-B	HLA class I histocompatibility antigen, B-27 alpha chain	GO:0006952; P:defense response; TAS:UniProtKB
P03989	HLA-B	HLA class I histocompatibility antigen, B-27 alpha chain	GO:0016045; P:detection of bacterium; IMP:UniProtKB
P03989	HLA-B	HLA class I histocompatibility antigen, B-27 alpha chain	GO:0006955; P:immune response; IMP:UniProtKB
P03989	HLA-B	HLA class I histocompatibility antigen, B-27 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P03989	HLA-B	HLA class I histocompatibility antigen, B-27 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P03989	HLA-B	HLA class I histocompatibility antigen, B-27 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P03989	HLA-B	HLA class I histocompatibility antigen, B-27 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P03989	HLA-B	HLA class I histocompatibility antigen, B-27 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30685	HLA-B	HLA class I histocompatibility antigen, B-35 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30685	HLA-B	HLA class I histocompatibility antigen, B-35 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30685	HLA-B	HLA class I histocompatibility antigen, B-35 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30685	HLA-B	HLA class I histocompatibility antigen, B-35 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30685	HLA-B	HLA class I histocompatibility antigen, B-35 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30685	HLA-B	HLA class I histocompatibility antigen, B-35 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30685	HLA-B	HLA class I histocompatibility antigen, B-35 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30685	HLA-B	HLA class I histocompatibility antigen, B-35 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30685	HLA-B	HLA class I histocompatibility antigen, B-35 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30685	HLA-B	HLA class I histocompatibility antigen, B-35 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30685	HLA-B	HLA class I histocompatibility antigen, B-35 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P18463	HLA-B	HLA class I histocompatibility antigen, B-37 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P18463	HLA-B	HLA class I histocompatibility antigen, B-37 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P18463	HLA-B	HLA class I histocompatibility antigen, B-37 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P18463	HLA-B	HLA class I histocompatibility antigen, B-37 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P18463	HLA-B	HLA class I histocompatibility antigen, B-37 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P18463	HLA-B	HLA class I histocompatibility antigen, B-37 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P18463	HLA-B	HLA class I histocompatibility antigen, B-37 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P18463	HLA-B	HLA class I histocompatibility antigen, B-37 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IDA:UniProt
P18463	HLA-B	HLA class I histocompatibility antigen, B-37 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P18463	HLA-B	HLA class I histocompatibility antigen, B-37 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P18463	HLA-B	HLA class I histocompatibility antigen, B-37 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q95365	HLA-B	HLA class I histocompatibility antigen, B-38 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
Q95365	HLA-B	HLA class I histocompatibility antigen, B-38 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q95365	HLA-B	HLA class I histocompatibility antigen, B-38 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q95365	HLA-B	HLA class I histocompatibility antigen, B-38 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
Q95365	HLA-B	HLA class I histocompatibility antigen, B-38 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q95365	HLA-B	HLA class I histocompatibility antigen, B-38 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q95365	HLA-B	HLA class I histocompatibility antigen, B-38 alpha chain	GO:0045087; P:innate immune response; TAS:Reactome
Q95365	HLA-B	HLA class I histocompatibility antigen, B-38 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q95365	HLA-B	HLA class I histocompatibility antigen, B-38 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
Q95365	HLA-B	HLA class I histocompatibility antigen, B-38 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
Q95365	HLA-B	HLA class I histocompatibility antigen, B-38 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q95365	HLA-B	HLA class I histocompatibility antigen, B-38 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q04826	HLA-B	HLA class I histocompatibility antigen, B-40 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
Q04826	HLA-B	HLA class I histocompatibility antigen, B-40 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q04826	HLA-B	HLA class I histocompatibility antigen, B-40 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q04826	HLA-B	HLA class I histocompatibility antigen, B-40 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
Q04826	HLA-B	HLA class I histocompatibility antigen, B-40 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q04826	HLA-B	HLA class I histocompatibility antigen, B-40 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q04826	HLA-B	HLA class I histocompatibility antigen, B-40 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q04826	HLA-B	HLA class I histocompatibility antigen, B-40 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
Q04826	HLA-B	HLA class I histocompatibility antigen, B-40 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
Q04826	HLA-B	HLA class I histocompatibility antigen, B-40 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q04826	HLA-B	HLA class I histocompatibility antigen, B-40 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30475	HLA-B	HLA class I histocompatibility antigen, B-39 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30475	HLA-B	HLA class I histocompatibility antigen, B-39 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30475	HLA-B	HLA class I histocompatibility antigen, B-39 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30475	HLA-B	HLA class I histocompatibility antigen, B-39 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30475	HLA-B	HLA class I histocompatibility antigen, B-39 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30475	HLA-B	HLA class I histocompatibility antigen, B-39 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30475	HLA-B	HLA class I histocompatibility antigen, B-39 alpha chain	GO:0006955; P:immune response; NAS:UniProtKB
P30475	HLA-B	HLA class I histocompatibility antigen, B-39 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30475	HLA-B	HLA class I histocompatibility antigen, B-39 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30475	HLA-B	HLA class I histocompatibility antigen, B-39 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30475	HLA-B	HLA class I histocompatibility antigen, B-39 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30475	HLA-B	HLA class I histocompatibility antigen, B-39 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30479	HLA-B	HLA class I histocompatibility antigen, B-41 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30479	HLA-B	HLA class I histocompatibility antigen, B-41 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30479	HLA-B	HLA class I histocompatibility antigen, B-41 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30479	HLA-B	HLA class I histocompatibility antigen, B-41 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30479	HLA-B	HLA class I histocompatibility antigen, B-41 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30479	HLA-B	HLA class I histocompatibility antigen, B-41 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30479	HLA-B	HLA class I histocompatibility antigen, B-41 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30479	HLA-B	HLA class I histocompatibility antigen, B-41 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30479	HLA-B	HLA class I histocompatibility antigen, B-41 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30479	HLA-B	HLA class I histocompatibility antigen, B-41 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30479	HLA-B	HLA class I histocompatibility antigen, B-41 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30480	HLA-B	HLA class I histocompatibility antigen, B-42 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30480	HLA-B	HLA class I histocompatibility antigen, B-42 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30480	HLA-B	HLA class I histocompatibility antigen, B-42 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30480	HLA-B	HLA class I histocompatibility antigen, B-42 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30480	HLA-B	HLA class I histocompatibility antigen, B-42 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30480	HLA-B	HLA class I histocompatibility antigen, B-42 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30480	HLA-B	HLA class I histocompatibility antigen, B-42 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30480	HLA-B	HLA class I histocompatibility antigen, B-42 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30480	HLA-B	HLA class I histocompatibility antigen, B-42 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30480	HLA-B	HLA class I histocompatibility antigen, B-42 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30480	HLA-B	HLA class I histocompatibility antigen, B-42 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30481	HLA-B	HLA class I histocompatibility antigen, B-44 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30481	HLA-B	HLA class I histocompatibility antigen, B-44 alpha chain	GO:0005102; F:receptor binding; IBA:RefGenome
P30481	HLA-B	HLA class I histocompatibility antigen, B-44 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30481	HLA-B	HLA class I histocompatibility antigen, B-44 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30481	HLA-B	HLA class I histocompatibility antigen, B-44 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30481	HLA-B	HLA class I histocompatibility antigen, B-44 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30481	HLA-B	HLA class I histocompatibility antigen, B-44 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30481	HLA-B	HLA class I histocompatibility antigen, B-44 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30481	HLA-B	HLA class I histocompatibility antigen, B-44 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30481	HLA-B	HLA class I histocompatibility antigen, B-44 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30481	HLA-B	HLA class I histocompatibility antigen, B-44 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30481	HLA-B	HLA class I histocompatibility antigen, B-44 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30483	HLA-B	HLA class I histocompatibility antigen, B-45 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30483	HLA-B	HLA class I histocompatibility antigen, B-45 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30483	HLA-B	HLA class I histocompatibility antigen, B-45 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30483	HLA-B	HLA class I histocompatibility antigen, B-45 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30483	HLA-B	HLA class I histocompatibility antigen, B-45 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30483	HLA-B	HLA class I histocompatibility antigen, B-45 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30483	HLA-B	HLA class I histocompatibility antigen, B-45 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30483	HLA-B	HLA class I histocompatibility antigen, B-45 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30483	HLA-B	HLA class I histocompatibility antigen, B-45 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30483	HLA-B	HLA class I histocompatibility antigen, B-45 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30483	HLA-B	HLA class I histocompatibility antigen, B-45 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30484	HLA-B	HLA class I histocompatibility antigen, B-46 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30484	HLA-B	HLA class I histocompatibility antigen, B-46 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30484	HLA-B	HLA class I histocompatibility antigen, B-46 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30484	HLA-B	HLA class I histocompatibility antigen, B-46 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30484	HLA-B	HLA class I histocompatibility antigen, B-46 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30484	HLA-B	HLA class I histocompatibility antigen, B-46 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30484	HLA-B	HLA class I histocompatibility antigen, B-46 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30484	HLA-B	HLA class I histocompatibility antigen, B-46 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30484	HLA-B	HLA class I histocompatibility antigen, B-46 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30484	HLA-B	HLA class I histocompatibility antigen, B-46 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30484	HLA-B	HLA class I histocompatibility antigen, B-46 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30485	HLA-B	HLA class I histocompatibility antigen, B-47 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30485	HLA-B	HLA class I histocompatibility antigen, B-47 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30485	HLA-B	HLA class I histocompatibility antigen, B-47 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30485	HLA-B	HLA class I histocompatibility antigen, B-47 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30485	HLA-B	HLA class I histocompatibility antigen, B-47 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30485	HLA-B	HLA class I histocompatibility antigen, B-47 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30485	HLA-B	HLA class I histocompatibility antigen, B-47 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30485	HLA-B	HLA class I histocompatibility antigen, B-47 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30485	HLA-B	HLA class I histocompatibility antigen, B-47 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30485	HLA-B	HLA class I histocompatibility antigen, B-47 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30485	HLA-B	HLA class I histocompatibility antigen, B-47 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30486	HLA-B	HLA class I histocompatibility antigen, B-48 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30486	HLA-B	HLA class I histocompatibility antigen, B-48 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW
P30486	HLA-B	HLA class I histocompatibility antigen, B-48 alpha chain	GO:0006955; P:immune response; IEA:InterPro
P30486	HLA-B	HLA class I histocompatibility antigen, B-48 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30486	HLA-B	HLA class I histocompatibility antigen, B-48 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30487	HLA-B	HLA class I histocompatibility antigen, B-49 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30487	HLA-B	HLA class I histocompatibility antigen, B-49 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30487	HLA-B	HLA class I histocompatibility antigen, B-49 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30487	HLA-B	HLA class I histocompatibility antigen, B-49 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30487	HLA-B	HLA class I histocompatibility antigen, B-49 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30487	HLA-B	HLA class I histocompatibility antigen, B-49 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30487	HLA-B	HLA class I histocompatibility antigen, B-49 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30487	HLA-B	HLA class I histocompatibility antigen, B-49 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30487	HLA-B	HLA class I histocompatibility antigen, B-49 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30487	HLA-B	HLA class I histocompatibility antigen, B-49 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30487	HLA-B	HLA class I histocompatibility antigen, B-49 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30488	HLA-B	HLA class I histocompatibility antigen, B-50 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30488	HLA-B	HLA class I histocompatibility antigen, B-50 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30488	HLA-B	HLA class I histocompatibility antigen, B-50 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30488	HLA-B	HLA class I histocompatibility antigen, B-50 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30488	HLA-B	HLA class I histocompatibility antigen, B-50 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30488	HLA-B	HLA class I histocompatibility antigen, B-50 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30488	HLA-B	HLA class I histocompatibility antigen, B-50 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30488	HLA-B	HLA class I histocompatibility antigen, B-50 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30488	HLA-B	HLA class I histocompatibility antigen, B-50 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30488	HLA-B	HLA class I histocompatibility antigen, B-50 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30488	HLA-B	HLA class I histocompatibility antigen, B-50 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P18464	HLA-B	HLA class I histocompatibility antigen, B-51 alpha chain	GO:0042605; F:peptide antigen binding; IDA:UniProt
P18464	HLA-B	HLA class I histocompatibility antigen, B-51 alpha chain	GO:0002486; P:antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent; IDA:UniProt
P18464	HLA-B	HLA class I histocompatibility antigen, B-51 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P18464	HLA-B	HLA class I histocompatibility antigen, B-51 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P18464	HLA-B	HLA class I histocompatibility antigen, B-51 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P18464	HLA-B	HLA class I histocompatibility antigen, B-51 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P18464	HLA-B	HLA class I histocompatibility antigen, B-51 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P18464	HLA-B	HLA class I histocompatibility antigen, B-51 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P18464	HLA-B	HLA class I histocompatibility antigen, B-51 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P18464	HLA-B	HLA class I histocompatibility antigen, B-51 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P18464	HLA-B	HLA class I histocompatibility antigen, B-51 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P18464	HLA-B	HLA class I histocompatibility antigen, B-51 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30490	HLA-B	HLA class I histocompatibility antigen, B-52 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30490	HLA-B	HLA class I histocompatibility antigen, B-52 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30490	HLA-B	HLA class I histocompatibility antigen, B-52 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30490	HLA-B	HLA class I histocompatibility antigen, B-52 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30490	HLA-B	HLA class I histocompatibility antigen, B-52 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30490	HLA-B	HLA class I histocompatibility antigen, B-52 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30490	HLA-B	HLA class I histocompatibility antigen, B-52 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30490	HLA-B	HLA class I histocompatibility antigen, B-52 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30490	HLA-B	HLA class I histocompatibility antigen, B-52 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30490	HLA-B	HLA class I histocompatibility antigen, B-52 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30490	HLA-B	HLA class I histocompatibility antigen, B-52 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30491	HLA-B	HLA class I histocompatibility antigen, B-53 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30491	HLA-B	HLA class I histocompatibility antigen, B-53 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30491	HLA-B	HLA class I histocompatibility antigen, B-53 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30491	HLA-B	HLA class I histocompatibility antigen, B-53 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30491	HLA-B	HLA class I histocompatibility antigen, B-53 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30491	HLA-B	HLA class I histocompatibility antigen, B-53 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30491	HLA-B	HLA class I histocompatibility antigen, B-53 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30491	HLA-B	HLA class I histocompatibility antigen, B-53 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30491	HLA-B	HLA class I histocompatibility antigen, B-53 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30491	HLA-B	HLA class I histocompatibility antigen, B-53 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30491	HLA-B	HLA class I histocompatibility antigen, B-53 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30493	HLA-B	HLA class I histocompatibility antigen, B-55 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30493	HLA-B	HLA class I histocompatibility antigen, B-55 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30493	HLA-B	HLA class I histocompatibility antigen, B-55 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30493	HLA-B	HLA class I histocompatibility antigen, B-55 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30493	HLA-B	HLA class I histocompatibility antigen, B-55 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30493	HLA-B	HLA class I histocompatibility antigen, B-55 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30493	HLA-B	HLA class I histocompatibility antigen, B-55 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30493	HLA-B	HLA class I histocompatibility antigen, B-55 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30493	HLA-B	HLA class I histocompatibility antigen, B-55 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30493	HLA-B	HLA class I histocompatibility antigen, B-55 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30493	HLA-B	HLA class I histocompatibility antigen, B-55 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30495	HLA-B	HLA class I histocompatibility antigen, B-56 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30495	HLA-B	HLA class I histocompatibility antigen, B-56 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30495	HLA-B	HLA class I histocompatibility antigen, B-56 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30495	HLA-B	HLA class I histocompatibility antigen, B-56 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30495	HLA-B	HLA class I histocompatibility antigen, B-56 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30495	HLA-B	HLA class I histocompatibility antigen, B-56 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30495	HLA-B	HLA class I histocompatibility antigen, B-56 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30495	HLA-B	HLA class I histocompatibility antigen, B-56 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30495	HLA-B	HLA class I histocompatibility antigen, B-56 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30495	HLA-B	HLA class I histocompatibility antigen, B-56 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30495	HLA-B	HLA class I histocompatibility antigen, B-56 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30492	HLA-B	HLA class I histocompatibility antigen, B-54 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30492	HLA-B	HLA class I histocompatibility antigen, B-54 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30492	HLA-B	HLA class I histocompatibility antigen, B-54 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30492	HLA-B	HLA class I histocompatibility antigen, B-54 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30492	HLA-B	HLA class I histocompatibility antigen, B-54 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30492	HLA-B	HLA class I histocompatibility antigen, B-54 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30492	HLA-B	HLA class I histocompatibility antigen, B-54 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30492	HLA-B	HLA class I histocompatibility antigen, B-54 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30492	HLA-B	HLA class I histocompatibility antigen, B-54 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30492	HLA-B	HLA class I histocompatibility antigen, B-54 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30492	HLA-B	HLA class I histocompatibility antigen, B-54 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P18465	HLA-B	HLA class I histocompatibility antigen, B-57 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P18465	HLA-B	HLA class I histocompatibility antigen, B-57 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P18465	HLA-B	HLA class I histocompatibility antigen, B-57 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P18465	HLA-B	HLA class I histocompatibility antigen, B-57 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P18465	HLA-B	HLA class I histocompatibility antigen, B-57 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P18465	HLA-B	HLA class I histocompatibility antigen, B-57 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P18465	HLA-B	HLA class I histocompatibility antigen, B-57 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P18465	HLA-B	HLA class I histocompatibility antigen, B-57 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P18465	HLA-B	HLA class I histocompatibility antigen, B-57 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P18465	HLA-B	HLA class I histocompatibility antigen, B-57 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P18465	HLA-B	HLA class I histocompatibility antigen, B-57 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P10319	HLA-B	HLA class I histocompatibility antigen, B-58 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P10319	HLA-B	HLA class I histocompatibility antigen, B-58 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P10319	HLA-B	HLA class I histocompatibility antigen, B-58 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P10319	HLA-B	HLA class I histocompatibility antigen, B-58 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P10319	HLA-B	HLA class I histocompatibility antigen, B-58 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P10319	HLA-B	HLA class I histocompatibility antigen, B-58 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P10319	HLA-B	HLA class I histocompatibility antigen, B-58 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P10319	HLA-B	HLA class I histocompatibility antigen, B-58 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P10319	HLA-B	HLA class I histocompatibility antigen, B-58 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P10319	HLA-B	HLA class I histocompatibility antigen, B-58 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P10319	HLA-B	HLA class I histocompatibility antigen, B-58 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q29940	HLA-B	HLA class I histocompatibility antigen, B-59 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
Q29940	HLA-B	HLA class I histocompatibility antigen, B-59 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q29940	HLA-B	HLA class I histocompatibility antigen, B-59 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q29940	HLA-B	HLA class I histocompatibility antigen, B-59 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
Q29940	HLA-B	HLA class I histocompatibility antigen, B-59 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q29940	HLA-B	HLA class I histocompatibility antigen, B-59 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q29940	HLA-B	HLA class I histocompatibility antigen, B-59 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q29940	HLA-B	HLA class I histocompatibility antigen, B-59 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
Q29940	HLA-B	HLA class I histocompatibility antigen, B-59 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
Q29940	HLA-B	HLA class I histocompatibility antigen, B-59 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q29940	HLA-B	HLA class I histocompatibility antigen, B-59 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q29836	HLA-B	HLA class I histocompatibility antigen, B-67 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
Q29836	HLA-B	HLA class I histocompatibility antigen, B-67 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q29836	HLA-B	HLA class I histocompatibility antigen, B-67 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q29836	HLA-B	HLA class I histocompatibility antigen, B-67 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
Q29836	HLA-B	HLA class I histocompatibility antigen, B-67 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q29836	HLA-B	HLA class I histocompatibility antigen, B-67 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q29836	HLA-B	HLA class I histocompatibility antigen, B-67 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q29836	HLA-B	HLA class I histocompatibility antigen, B-67 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
Q29836	HLA-B	HLA class I histocompatibility antigen, B-67 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
Q29836	HLA-B	HLA class I histocompatibility antigen, B-67 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q29836	HLA-B	HLA class I histocompatibility antigen, B-67 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q31612	HLA-B	HLA class I histocompatibility antigen, B-73 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
Q31612	HLA-B	HLA class I histocompatibility antigen, B-73 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q31612	HLA-B	HLA class I histocompatibility antigen, B-73 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q31612	HLA-B	HLA class I histocompatibility antigen, B-73 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
Q31612	HLA-B	HLA class I histocompatibility antigen, B-73 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q31612	HLA-B	HLA class I histocompatibility antigen, B-73 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q31612	HLA-B	HLA class I histocompatibility antigen, B-73 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q31612	HLA-B	HLA class I histocompatibility antigen, B-73 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
Q31612	HLA-B	HLA class I histocompatibility antigen, B-73 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
Q31612	HLA-B	HLA class I histocompatibility antigen, B-73 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q31612	HLA-B	HLA class I histocompatibility antigen, B-73 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q31610	HLA-B	HLA class I histocompatibility antigen, B-81 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
Q31610	HLA-B	HLA class I histocompatibility antigen, B-81 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q31610	HLA-B	HLA class I histocompatibility antigen, B-81 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q31610	HLA-B	HLA class I histocompatibility antigen, B-81 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
Q31610	HLA-B	HLA class I histocompatibility antigen, B-81 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q31610	HLA-B	HLA class I histocompatibility antigen, B-81 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q31610	HLA-B	HLA class I histocompatibility antigen, B-81 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q31610	HLA-B	HLA class I histocompatibility antigen, B-81 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
Q31610	HLA-B	HLA class I histocompatibility antigen, B-81 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
Q31610	HLA-B	HLA class I histocompatibility antigen, B-81 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q31610	HLA-B	HLA class I histocompatibility antigen, B-81 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30498	HLA-B	HLA class I histocompatibility antigen, B-78 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30498	HLA-B	HLA class I histocompatibility antigen, B-78 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30498	HLA-B	HLA class I histocompatibility antigen, B-78 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30498	HLA-B	HLA class I histocompatibility antigen, B-78 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30498	HLA-B	HLA class I histocompatibility antigen, B-78 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30498	HLA-B	HLA class I histocompatibility antigen, B-78 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30498	HLA-B	HLA class I histocompatibility antigen, B-78 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30498	HLA-B	HLA class I histocompatibility antigen, B-78 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30498	HLA-B	HLA class I histocompatibility antigen, B-78 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30498	HLA-B	HLA class I histocompatibility antigen, B-78 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30498	HLA-B	HLA class I histocompatibility antigen, B-78 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q29718	HLA-B	HLA class I histocompatibility antigen, B-82 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
Q29718	HLA-B	HLA class I histocompatibility antigen, B-82 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q29718	HLA-B	HLA class I histocompatibility antigen, B-82 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q29718	HLA-B	HLA class I histocompatibility antigen, B-82 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
Q29718	HLA-B	HLA class I histocompatibility antigen, B-82 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q29718	HLA-B	HLA class I histocompatibility antigen, B-82 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q29718	HLA-B	HLA class I histocompatibility antigen, B-82 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q29718	HLA-B	HLA class I histocompatibility antigen, B-82 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
Q29718	HLA-B	HLA class I histocompatibility antigen, B-82 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
Q29718	HLA-B	HLA class I histocompatibility antigen, B-82 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q29718	HLA-B	HLA class I histocompatibility antigen, B-82 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30499	HLA-C	HLA class I histocompatibility antigen, Cw-1 alpha chain	GO:0042605; F:peptide antigen binding; IDA:UniProt
P30499	HLA-C	HLA class I histocompatibility antigen, Cw-1 alpha chain	GO:0046977; F:TAP binding; IDA:UniProt
P30499	HLA-C	HLA class I histocompatibility antigen, Cw-1 alpha chain	GO:0002486; P:antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent; IDA:UniProt
P30499	HLA-C	HLA class I histocompatibility antigen, Cw-1 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30499	HLA-C	HLA class I histocompatibility antigen, Cw-1 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30499	HLA-C	HLA class I histocompatibility antigen, Cw-1 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30499	HLA-C	HLA class I histocompatibility antigen, Cw-1 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30499	HLA-C	HLA class I histocompatibility antigen, Cw-1 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30499	HLA-C	HLA class I histocompatibility antigen, Cw-1 alpha chain	GO:0006955; P:immune response; NAS:UniProtKB
P30499	HLA-C	HLA class I histocompatibility antigen, Cw-1 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30499	HLA-C	HLA class I histocompatibility antigen, Cw-1 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30499	HLA-C	HLA class I histocompatibility antigen, Cw-1 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30499	HLA-C	HLA class I histocompatibility antigen, Cw-1 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30499	HLA-C	HLA class I histocompatibility antigen, Cw-1 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30501	HLA-C	HLA class I histocompatibility antigen, Cw-2 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30501	HLA-C	HLA class I histocompatibility antigen, Cw-2 alpha chain	GO:0046977; F:TAP binding; IDA:UniProt
P30501	HLA-C	HLA class I histocompatibility antigen, Cw-2 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30501	HLA-C	HLA class I histocompatibility antigen, Cw-2 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30501	HLA-C	HLA class I histocompatibility antigen, Cw-2 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30501	HLA-C	HLA class I histocompatibility antigen, Cw-2 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30501	HLA-C	HLA class I histocompatibility antigen, Cw-2 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30501	HLA-C	HLA class I histocompatibility antigen, Cw-2 alpha chain	GO:0006955; P:immune response; NAS:UniProtKB
P30501	HLA-C	HLA class I histocompatibility antigen, Cw-2 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30501	HLA-C	HLA class I histocompatibility antigen, Cw-2 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30501	HLA-C	HLA class I histocompatibility antigen, Cw-2 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30501	HLA-C	HLA class I histocompatibility antigen, Cw-2 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30501	HLA-C	HLA class I histocompatibility antigen, Cw-2 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P04222	HLA-C	HLA class I histocompatibility antigen, Cw-3 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P04222	HLA-C	HLA class I histocompatibility antigen, Cw-3 alpha chain	GO:0005102; F:receptor binding; IBA:RefGenome
P04222	HLA-C	HLA class I histocompatibility antigen, Cw-3 alpha chain	GO:0046977; F:TAP binding; IDA:UniProt
P04222	HLA-C	HLA class I histocompatibility antigen, Cw-3 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P04222	HLA-C	HLA class I histocompatibility antigen, Cw-3 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P04222	HLA-C	HLA class I histocompatibility antigen, Cw-3 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P04222	HLA-C	HLA class I histocompatibility antigen, Cw-3 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P04222	HLA-C	HLA class I histocompatibility antigen, Cw-3 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P04222	HLA-C	HLA class I histocompatibility antigen, Cw-3 alpha chain	GO:0045087; P:innate immune response; TAS:Reactome
P04222	HLA-C	HLA class I histocompatibility antigen, Cw-3 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P04222	HLA-C	HLA class I histocompatibility antigen, Cw-3 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P04222	HLA-C	HLA class I histocompatibility antigen, Cw-3 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P04222	HLA-C	HLA class I histocompatibility antigen, Cw-3 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P04222	HLA-C	HLA class I histocompatibility antigen, Cw-3 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30504	HLA-C	HLA class I histocompatibility antigen, Cw-4 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30504	HLA-C	HLA class I histocompatibility antigen, Cw-4 alpha chain	GO:0046977; F:TAP binding; IDA:UniProt
P30504	HLA-C	HLA class I histocompatibility antigen, Cw-4 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30504	HLA-C	HLA class I histocompatibility antigen, Cw-4 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30504	HLA-C	HLA class I histocompatibility antigen, Cw-4 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30504	HLA-C	HLA class I histocompatibility antigen, Cw-4 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30504	HLA-C	HLA class I histocompatibility antigen, Cw-4 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30504	HLA-C	HLA class I histocompatibility antigen, Cw-4 alpha chain	GO:0045087; P:innate immune response; TAS:Reactome
P30504	HLA-C	HLA class I histocompatibility antigen, Cw-4 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30504	HLA-C	HLA class I histocompatibility antigen, Cw-4 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30504	HLA-C	HLA class I histocompatibility antigen, Cw-4 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30504	HLA-C	HLA class I histocompatibility antigen, Cw-4 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30504	HLA-C	HLA class I histocompatibility antigen, Cw-4 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9TNN7	HLA-C	HLA class I histocompatibility antigen, Cw-5 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
Q9TNN7	HLA-C	HLA class I histocompatibility antigen, Cw-5 alpha chain	GO:0005102; F:receptor binding; IBA:RefGenome
Q9TNN7	HLA-C	HLA class I histocompatibility antigen, Cw-5 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q9TNN7	HLA-C	HLA class I histocompatibility antigen, Cw-5 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q9TNN7	HLA-C	HLA class I histocompatibility antigen, Cw-5 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
Q9TNN7	HLA-C	HLA class I histocompatibility antigen, Cw-5 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q9TNN7	HLA-C	HLA class I histocompatibility antigen, Cw-5 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q9TNN7	HLA-C	HLA class I histocompatibility antigen, Cw-5 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q9TNN7	HLA-C	HLA class I histocompatibility antigen, Cw-5 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
Q9TNN7	HLA-C	HLA class I histocompatibility antigen, Cw-5 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
Q9TNN7	HLA-C	HLA class I histocompatibility antigen, Cw-5 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q9TNN7	HLA-C	HLA class I histocompatibility antigen, Cw-5 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q29963	HLA-C	HLA class I histocompatibility antigen, Cw-6 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
Q29963	HLA-C	HLA class I histocompatibility antigen, Cw-6 alpha chain	GO:0005102; F:receptor binding; IBA:RefGenome
Q29963	HLA-C	HLA class I histocompatibility antigen, Cw-6 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q29963	HLA-C	HLA class I histocompatibility antigen, Cw-6 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q29963	HLA-C	HLA class I histocompatibility antigen, Cw-6 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
Q29963	HLA-C	HLA class I histocompatibility antigen, Cw-6 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q29963	HLA-C	HLA class I histocompatibility antigen, Cw-6 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q29963	HLA-C	HLA class I histocompatibility antigen, Cw-6 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q29963	HLA-C	HLA class I histocompatibility antigen, Cw-6 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
Q29963	HLA-C	HLA class I histocompatibility antigen, Cw-6 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
Q29963	HLA-C	HLA class I histocompatibility antigen, Cw-6 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q29963	HLA-C	HLA class I histocompatibility antigen, Cw-6 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P10321	HLA-C	HLA class I histocompatibility antigen, Cw-7 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P10321	HLA-C	HLA class I histocompatibility antigen, Cw-7 alpha chain	GO:0005102; F:receptor binding; IBA:RefGenome
P10321	HLA-C	HLA class I histocompatibility antigen, Cw-7 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P10321	HLA-C	HLA class I histocompatibility antigen, Cw-7 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P10321	HLA-C	HLA class I histocompatibility antigen, Cw-7 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P10321	HLA-C	HLA class I histocompatibility antigen, Cw-7 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P10321	HLA-C	HLA class I histocompatibility antigen, Cw-7 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P10321	HLA-C	HLA class I histocompatibility antigen, Cw-7 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P10321	HLA-C	HLA class I histocompatibility antigen, Cw-7 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P10321	HLA-C	HLA class I histocompatibility antigen, Cw-7 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P10321	HLA-C	HLA class I histocompatibility antigen, Cw-7 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P10321	HLA-C	HLA class I histocompatibility antigen, Cw-7 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30505	HLA-C	HLA class I histocompatibility antigen, Cw-8 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30505	HLA-C	HLA class I histocompatibility antigen, Cw-8 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30505	HLA-C	HLA class I histocompatibility antigen, Cw-8 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30505	HLA-C	HLA class I histocompatibility antigen, Cw-8 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30505	HLA-C	HLA class I histocompatibility antigen, Cw-8 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30505	HLA-C	HLA class I histocompatibility antigen, Cw-8 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30505	HLA-C	HLA class I histocompatibility antigen, Cw-8 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30505	HLA-C	HLA class I histocompatibility antigen, Cw-8 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30505	HLA-C	HLA class I histocompatibility antigen, Cw-8 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30505	HLA-C	HLA class I histocompatibility antigen, Cw-8 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30505	HLA-C	HLA class I histocompatibility antigen, Cw-8 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30510	HLA-C	HLA class I histocompatibility antigen, Cw-14 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30510	HLA-C	HLA class I histocompatibility antigen, Cw-14 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30510	HLA-C	HLA class I histocompatibility antigen, Cw-14 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30510	HLA-C	HLA class I histocompatibility antigen, Cw-14 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30510	HLA-C	HLA class I histocompatibility antigen, Cw-14 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30510	HLA-C	HLA class I histocompatibility antigen, Cw-14 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30510	HLA-C	HLA class I histocompatibility antigen, Cw-14 alpha chain	GO:0006955; P:immune response; NAS:UniProtKB
P30510	HLA-C	HLA class I histocompatibility antigen, Cw-14 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30510	HLA-C	HLA class I histocompatibility antigen, Cw-14 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30510	HLA-C	HLA class I histocompatibility antigen, Cw-14 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30510	HLA-C	HLA class I histocompatibility antigen, Cw-14 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30510	HLA-C	HLA class I histocompatibility antigen, Cw-14 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
P30508	HLA-C	HLA class I histocompatibility antigen, Cw-12 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
P30508	HLA-C	HLA class I histocompatibility antigen, Cw-12 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30508	HLA-C	HLA class I histocompatibility antigen, Cw-12 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30508	HLA-C	HLA class I histocompatibility antigen, Cw-12 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30508	HLA-C	HLA class I histocompatibility antigen, Cw-12 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30508	HLA-C	HLA class I histocompatibility antigen, Cw-12 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30508	HLA-C	HLA class I histocompatibility antigen, Cw-12 alpha chain	GO:0006955; P:immune response; NAS:UniProtKB
P30508	HLA-C	HLA class I histocompatibility antigen, Cw-12 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30508	HLA-C	HLA class I histocompatibility antigen, Cw-12 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30508	HLA-C	HLA class I histocompatibility antigen, Cw-12 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P30508	HLA-C	HLA class I histocompatibility antigen, Cw-12 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30508	HLA-C	HLA class I histocompatibility antigen, Cw-12 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q07000	HLA-C	HLA class I histocompatibility antigen, Cw-15 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
Q07000	HLA-C	HLA class I histocompatibility antigen, Cw-15 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q07000	HLA-C	HLA class I histocompatibility antigen, Cw-15 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q07000	HLA-C	HLA class I histocompatibility antigen, Cw-15 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
Q07000	HLA-C	HLA class I histocompatibility antigen, Cw-15 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q07000	HLA-C	HLA class I histocompatibility antigen, Cw-15 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q07000	HLA-C	HLA class I histocompatibility antigen, Cw-15 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q07000	HLA-C	HLA class I histocompatibility antigen, Cw-15 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
Q07000	HLA-C	HLA class I histocompatibility antigen, Cw-15 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
Q07000	HLA-C	HLA class I histocompatibility antigen, Cw-15 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q07000	HLA-C	HLA class I histocompatibility antigen, Cw-15 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q95604	HLA-C	HLA class I histocompatibility antigen, Cw-17 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
Q95604	HLA-C	HLA class I histocompatibility antigen, Cw-17 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q95604	HLA-C	HLA class I histocompatibility antigen, Cw-17 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q95604	HLA-C	HLA class I histocompatibility antigen, Cw-17 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
Q95604	HLA-C	HLA class I histocompatibility antigen, Cw-17 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q95604	HLA-C	HLA class I histocompatibility antigen, Cw-17 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q95604	HLA-C	HLA class I histocompatibility antigen, Cw-17 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q95604	HLA-C	HLA class I histocompatibility antigen, Cw-17 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
Q95604	HLA-C	HLA class I histocompatibility antigen, Cw-17 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
Q95604	HLA-C	HLA class I histocompatibility antigen, Cw-17 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q95604	HLA-C	HLA class I histocompatibility antigen, Cw-17 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q29865	HLA-C	HLA class I histocompatibility antigen, Cw-18 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
Q29865	HLA-C	HLA class I histocompatibility antigen, Cw-18 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q29865	HLA-C	HLA class I histocompatibility antigen, Cw-18 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q29865	HLA-C	HLA class I histocompatibility antigen, Cw-18 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
Q29865	HLA-C	HLA class I histocompatibility antigen, Cw-18 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q29865	HLA-C	HLA class I histocompatibility antigen, Cw-18 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q29865	HLA-C	HLA class I histocompatibility antigen, Cw-18 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q29865	HLA-C	HLA class I histocompatibility antigen, Cw-18 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
Q29865	HLA-C	HLA class I histocompatibility antigen, Cw-18 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
Q29865	HLA-C	HLA class I histocompatibility antigen, Cw-18 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q29865	HLA-C	HLA class I histocompatibility antigen, Cw-18 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q29960	HLA-C	HLA class I histocompatibility antigen, Cw-16 alpha chain	GO:0042605; F:peptide antigen binding; ISS:UniProt
Q29960	HLA-C	HLA class I histocompatibility antigen, Cw-16 alpha chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q29960	HLA-C	HLA class I histocompatibility antigen, Cw-16 alpha chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q29960	HLA-C	HLA class I histocompatibility antigen, Cw-16 alpha chain	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
Q29960	HLA-C	HLA class I histocompatibility antigen, Cw-16 alpha chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q29960	HLA-C	HLA class I histocompatibility antigen, Cw-16 alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q29960	HLA-C	HLA class I histocompatibility antigen, Cw-16 alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q29960	HLA-C	HLA class I histocompatibility antigen, Cw-16 alpha chain	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
Q29960	HLA-C	HLA class I histocompatibility antigen, Cw-16 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
Q29960	HLA-C	HLA class I histocompatibility antigen, Cw-16 alpha chain	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q29960	HLA-C	HLA class I histocompatibility antigen, Cw-16 alpha chain	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q15172	PPP2R5A	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform	GO:0019900; F:kinase binding; IPI:BHF-UCL
Q15172	PPP2R5A	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform	GO:0005515; F:protein binding; IPI:UniProtKB
Q15172	PPP2R5A	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform	GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:ProtInc
Q15172	PPP2R5A	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform	GO:0090005; P:negative regulation of establishment of protein localization to plasma membrane; IMP:BHF-UCL
Q15172	PPP2R5A	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform	GO:0090219; P:negative regulation of lipid kinase activity; IMP:BHF-UCL
Q15172	PPP2R5A	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform	GO:0035307; P:positive regulation of protein dephosphorylation; IMP:BHF-UCL
Q15172	PPP2R5A	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform	GO:0007165; P:signal transduction; IEA:InterPro
Q15173	PPP2R5B	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform	GO:0005515; F:protein binding; IPI:IntAct
Q15173	PPP2R5B	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform	GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:ProtInc
Q15173	PPP2R5B	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q15173	PPP2R5B	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q15173	PPP2R5B	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0005515; F:protein binding; IPI:IntAct
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:ProtInc
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0004722; F:protein serine/threonine phosphatase activity; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0016311; P:dephosphorylation; TAS:GOC
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0006006; P:glucose metabolic process; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0006096; P:glycolytic process; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0045087; P:innate immune response; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0007399; P:nervous system development; TAS:ProtInc
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0050790; P:regulation of catalytic activity; TAS:GOC
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q14738	PPP2R5D	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q16537	PPP2R5E	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform	GO:0005515; F:protein binding; IPI:IntAct
Q16537	PPP2R5E	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform	GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:ProtInc
Q16537	PPP2R5E	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform	GO:0050790; P:regulation of catalytic activity; TAS:GOC
Q16537	PPP2R5E	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform	GO:0007165; P:signal transduction; IEA:InterPro
Q13362	PPP2R5C	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform	GO:0005515; F:protein binding; IPI:IntAct
Q13362	PPP2R5C	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform	GO:0008601; F:protein phosphatase type 2A regulator activity; IDA:UniProtKB
Q13362	PPP2R5C	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; IDA:UniProtKB
Q13362	PPP2R5C	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IMP:UniProtKB
Q13362	PPP2R5C	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q13362	PPP2R5C	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:MGI
Q13362	PPP2R5C	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform	GO:0050790; P:regulation of catalytic activity; IDA:GOC
Q13362	PPP2R5C	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform	GO:0007165; P:signal transduction; NAS:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0003823; F:antigen binding; IPI:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0005515; F:protein binding; IPI:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0004722; F:protein serine/threonine phosphatase activity; IEA:Ensembl
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0006915; P:apoptotic process; TAS:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0006672; P:ceramide metabolic process; NAS:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0007059; P:chromosome segregation; IDA:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0010467; P:gene expression; TAS:Reactome
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0000188; P:inactivation of MAPK activity; NAS:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0007084; P:mitotic nuclear envelope reassembly; TAS:Reactome
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0042518; P:negative regulation of tyrosine phosphorylation of Stat3 protein; NAS:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0070262; P:peptidyl-serine dephosphorylation; IEA:Ensembl
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0006461; P:protein complex assembly; TAS:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0006470; P:protein dephosphorylation; TAS:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0030155; P:regulation of cell adhesion; NAS:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0045595; P:regulation of cell differentiation; NAS:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0006275; P:regulation of DNA replication; NAS:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0040008; P:regulation of growth; NAS:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0030111; P:regulation of Wnt signaling pathway; NAS:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0010033; P:response to organic substance; NAS:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0016070; P:RNA metabolic process; TAS:Reactome
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0008380; P:RNA splicing; NAS:UniProtKB
P30153	PPP2R1A	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	GO:0019932; P:second-messenger-mediated signaling; NAS:UniProtKB
P30154	PPP2R1B	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform	GO:0005515; F:protein binding; IPI:IntAct
P30154	PPP2R1B	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform	GO:0060561; P:apoptotic process involved in morphogenesis; IMP:UniProtKB
P30154	PPP2R1B	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform	GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IMP:UniProtKB
P63151	PPP2R2A	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform	GO:0005515; F:protein binding; IPI:UniProtKB
P63151	PPP2R2A	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform	GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:UniProtKB
P63151	PPP2R2A	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform	GO:0004722; F:protein serine/threonine phosphatase activity; IDA:UniProtKB
P63151	PPP2R2A	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P63151	PPP2R2A	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform	GO:0010467; P:gene expression; TAS:Reactome
P63151	PPP2R2A	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P63151	PPP2R2A	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform	GO:0007084; P:mitotic nuclear envelope reassembly; TAS:Reactome
P63151	PPP2R2A	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P63151	PPP2R2A	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P63151	PPP2R2A	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform	GO:0006470; P:protein dephosphorylation; IDA:UniProtKB
P63151	PPP2R2A	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform	GO:0050790; P:regulation of catalytic activity; TAS:GOC
P63151	PPP2R2A	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform	GO:0043278; P:response to morphine; IEA:Ensembl
P63151	PPP2R2A	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform	GO:0016070; P:RNA metabolic process; TAS:Reactome
P63151	PPP2R2A	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform	GO:0007165; P:signal transduction; IEA:InterPro
Q00005	PPP2R2B	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform	GO:0005515; F:protein binding; IPI:IntAct
Q00005	PPP2R2B	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform	GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:ProtInc
Q00005	PPP2R2B	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q00005	PPP2R2B	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform	GO:0050790; P:regulation of catalytic activity; TAS:GOC
Q00005	PPP2R2B	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform	GO:0007165; P:signal transduction; IEA:InterPro
Q66LE6	PPP2R2D	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform	GO:0008601; F:protein phosphatase type 2A regulator activity; ISS:UniProtKB
Q66LE6	PPP2R2D	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform	GO:0010458; P:exit from mitosis; ISS:UniProtKB
Q66LE6	PPP2R2D	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform	GO:0007067; P:mitosis; ISS:UniProtKB
Q66LE6	PPP2R2D	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q66LE6	PPP2R2D	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform	GO:0050790; P:regulation of catalytic activity; ISS:GOC
Q66LE6	PPP2R2D	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform	GO:0007165; P:signal transduction; IEA:InterPro
Q9Y2T4	PPP2R2C	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2T4	PPP2R2C	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform	GO:0008601; F:protein phosphatase type 2A regulator activity; NAS:UniProtKB
Q9Y2T4	PPP2R2C	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform	GO:0050790; P:regulation of catalytic activity; NAS:GOC
Q9Y2T4	PPP2R2C	Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform	GO:0007165; P:signal transduction; IEA:InterPro
P04229	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-1 beta chain	GO:0023026; F:MHC class II protein complex binding; IDA:UniProt
P04229	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-1 beta chain	GO:0042605; F:peptide antigen binding; ISS:UniProtKB
P04229	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-1 beta chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P04229	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-1 beta chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P04229	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-1 beta chain	GO:0016045; P:detection of bacterium; ISS:UniProtKB
P04229	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-1 beta chain	GO:0002455; P:humoral immune response mediated by circulating immunoglobulin; ISS:UniProtKB
P04229	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-1 beta chain	GO:0006955; P:immune response; ISS:UniProtKB
P04229	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-1 beta chain	GO:0002381; P:immunoglobulin production involved in immunoglobulin mediated immune response; ISS:UniProtKB
P04229	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-1 beta chain	GO:0002437; P:inflammatory response to antigenic stimulus; ISS:UniProtKB
P04229	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-1 beta chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P04229	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-1 beta chain	GO:0032689; P:negative regulation of interferon-gamma production; ISS:UniProtKB
P04229	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-1 beta chain	GO:0042130; P:negative regulation of T cell proliferation; ISS:UniProtKB
P04229	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-1 beta chain	GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB
P04229	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-1 beta chain	GO:0051262; P:protein tetramerization; ISS:UniProtKB
P04229	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-1 beta chain	GO:2001179; P:regulation of interleukin-10 secretion; ISS:UniProtKB
P04229	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-1 beta chain	GO:0032673; P:regulation of interleukin-4 production; ISS:UniProtKB
P04229	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-1 beta chain	GO:0031295; P:T cell costimulation; TAS:Reactome
P04229	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-1 beta chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P04229	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-1 beta chain	GO:0042088; P:T-helper 1 type immune response; ISS:UniProtKB
P01912	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-3 chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P01912	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-3 chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P01912	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-3 chain	GO:0002455; P:humoral immune response mediated by circulating immunoglobulin; IDA:UniProtKB
P01912	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-3 chain	GO:0002381; P:immunoglobulin production involved in immunoglobulin mediated immune response; IDA:UniProtKB
P01912	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-3 chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P01912	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-3 chain	GO:0031295; P:T cell costimulation; TAS:Reactome
P01912	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-3 chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0032395; F:MHC class II receptor activity; TAS:UniProtKB
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0042605; F:peptide antigen binding; ISS:UniProtKB
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0005515; F:protein binding; IPI:UniProtKB
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0016045; P:detection of bacterium; ISS:UniProtKB
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0002455; P:humoral immune response mediated by circulating immunoglobulin; ISS:UniProtKB
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0006955; P:immune response; ISS:UniProtKB
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0002381; P:immunoglobulin production involved in immunoglobulin mediated immune response; ISS:UniProtKB
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0002437; P:inflammatory response to antigenic stimulus; IDA:UniProtKB
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0002862; P:negative regulation of inflammatory response to antigenic stimulus; IDA:UniProtKB
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0032689; P:negative regulation of interferon-gamma production; ISS:UniProtKB
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0042130; P:negative regulation of T cell proliferation; ISS:UniProtKB
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0051262; P:protein tetramerization; ISS:UniProtKB
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:2001179; P:regulation of interleukin-10 secretion; ISS:UniProtKB
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0032673; P:regulation of interleukin-4 production; ISS:UniProtKB
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0007165; P:signal transduction; NAS:ProtInc
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0031295; P:T cell costimulation; TAS:Reactome
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P13760	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-4 beta chain	GO:0042088; P:T-helper 1 type immune response; ISS:UniProtKB
P13761	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-7 beta chain	GO:0032395; F:MHC class II receptor activity; TAS:UniProtKB
P13761	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-7 beta chain	GO:0042605; F:peptide antigen binding; IDA:UniProtKB
P13761	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-7 beta chain	GO:0005515; F:protein binding; IPI:UniProtKB
P13761	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-7 beta chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P13761	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-7 beta chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P13761	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-7 beta chain	GO:0016045; P:detection of bacterium; IMP:UniProtKB
P13761	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-7 beta chain	GO:0002455; P:humoral immune response mediated by circulating immunoglobulin; IDA:UniProtKB
P13761	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-7 beta chain	GO:0006955; P:immune response; IDA:UniProtKB
P13761	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-7 beta chain	GO:0002381; P:immunoglobulin production involved in immunoglobulin mediated immune response; IDA:UniProtKB
P13761	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-7 beta chain	GO:0002437; P:inflammatory response to antigenic stimulus; IDA:UniProtKB
P13761	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-7 beta chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P13761	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-7 beta chain	GO:0032689; P:negative regulation of interferon-gamma production; IMP:UniProtKB
P13761	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-7 beta chain	GO:0042130; P:negative regulation of T cell proliferation; IMP:UniProtKB
P13761	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-7 beta chain	GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:UniProtKB
P13761	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-7 beta chain	GO:0051262; P:protein tetramerization; IDA:UniProtKB
P13761	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-7 beta chain	GO:2001179; P:regulation of interleukin-10 secretion; IDA:UniProtKB
P13761	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-7 beta chain	GO:0032673; P:regulation of interleukin-4 production; IDA:UniProtKB
P13761	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-7 beta chain	GO:0031295; P:T cell costimulation; TAS:Reactome
P13761	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-7 beta chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P13761	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-7 beta chain	GO:0042088; P:T-helper 1 type immune response; IMP:UniProtKB
Q30134	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-8 beta chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q30134	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-8 beta chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q30134	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-8 beta chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q30134	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-8 beta chain	GO:0031295; P:T cell costimulation; TAS:Reactome
Q30134	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-8 beta chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q30167	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-10 beta chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q30167	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-10 beta chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q30167	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-10 beta chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q30167	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-10 beta chain	GO:0031295; P:T cell costimulation; TAS:Reactome
Q30167	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-10 beta chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q9TQE0	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-9 beta chain	GO:0042605; F:peptide antigen binding; ISS:UniProtKB
Q9TQE0	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-9 beta chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q9TQE0	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-9 beta chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q9TQE0	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-9 beta chain	GO:0016045; P:detection of bacterium; ISS:UniProtKB
Q9TQE0	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-9 beta chain	GO:0002455; P:humoral immune response mediated by circulating immunoglobulin; ISS:UniProtKB
Q9TQE0	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-9 beta chain	GO:0006955; P:immune response; ISS:UniProtKB
Q9TQE0	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-9 beta chain	GO:0002381; P:immunoglobulin production involved in immunoglobulin mediated immune response; ISS:UniProtKB
Q9TQE0	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-9 beta chain	GO:0002437; P:inflammatory response to antigenic stimulus; ISS:UniProtKB
Q9TQE0	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-9 beta chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q9TQE0	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-9 beta chain	GO:0032689; P:negative regulation of interferon-gamma production; ISS:UniProtKB
Q9TQE0	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-9 beta chain	GO:0042130; P:negative regulation of T cell proliferation; ISS:UniProtKB
Q9TQE0	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-9 beta chain	GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB
Q9TQE0	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-9 beta chain	GO:0051262; P:protein tetramerization; ISS:UniProtKB
Q9TQE0	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-9 beta chain	GO:2001179; P:regulation of interleukin-10 secretion; ISS:UniProtKB
Q9TQE0	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-9 beta chain	GO:0032673; P:regulation of interleukin-4 production; ISS:UniProtKB
Q9TQE0	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-9 beta chain	GO:0031295; P:T cell costimulation; TAS:Reactome
Q9TQE0	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-9 beta chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q9TQE0	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-9 beta chain	GO:0042088; P:T-helper 1 type immune response; ISS:UniProtKB
P20039	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-11 beta chain	GO:0032395; F:MHC class II receptor activity; TAS:UniProtKB
P20039	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-11 beta chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P20039	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-11 beta chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P20039	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-11 beta chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P20039	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-11 beta chain	GO:0031295; P:T cell costimulation; TAS:Reactome
P20039	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-11 beta chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q5Y7A7	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-13 beta chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q5Y7A7	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-13 beta chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q5Y7A7	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-13 beta chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q5Y7A7	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-13 beta chain	GO:0031295; P:T cell costimulation; TAS:Reactome
Q5Y7A7	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-13 beta chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q95IE3	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-12 beta chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q95IE3	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-12 beta chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q95IE3	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-12 beta chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q95IE3	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-12 beta chain	GO:0031295; P:T cell costimulation; TAS:Reactome
Q95IE3	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-12 beta chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q9GIY3	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-14 beta chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q9GIY3	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-14 beta chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q9GIY3	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-14 beta chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q9GIY3	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-14 beta chain	GO:0031295; P:T cell costimulation; TAS:Reactome
Q9GIY3	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-14 beta chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P01911	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-15 beta chain	GO:0023026; F:MHC class II protein complex binding; IDA:UniProt
P01911	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-15 beta chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P01911	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-15 beta chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P01911	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-15 beta chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P01911	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-15 beta chain	GO:0031295; P:T cell costimulation; TAS:Reactome
P01911	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-15 beta chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q29974	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-16 beta chain	GO:0032395; F:MHC class II receptor activity; NAS:UniProtKB
Q29974	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-16 beta chain	GO:0042605; F:peptide antigen binding; ISS:UniProtKB
Q29974	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-16 beta chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q29974	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-16 beta chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q29974	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-16 beta chain	GO:0016045; P:detection of bacterium; ISS:UniProtKB
Q29974	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-16 beta chain	GO:0002455; P:humoral immune response mediated by circulating immunoglobulin; ISS:UniProtKB
Q29974	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-16 beta chain	GO:0006955; P:immune response; ISS:UniProtKB
Q29974	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-16 beta chain	GO:0002381; P:immunoglobulin production involved in immunoglobulin mediated immune response; ISS:UniProtKB
Q29974	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-16 beta chain	GO:0002437; P:inflammatory response to antigenic stimulus; ISS:UniProtKB
Q29974	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-16 beta chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q29974	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-16 beta chain	GO:0032689; P:negative regulation of interferon-gamma production; ISS:UniProtKB
Q29974	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-16 beta chain	GO:0042130; P:negative regulation of T cell proliferation; ISS:UniProtKB
Q29974	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-16 beta chain	GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB
Q29974	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-16 beta chain	GO:0051262; P:protein tetramerization; ISS:UniProtKB
Q29974	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-16 beta chain	GO:2001179; P:regulation of interleukin-10 secretion; ISS:UniProtKB
Q29974	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-16 beta chain	GO:0032673; P:regulation of interleukin-4 production; ISS:UniProtKB
Q29974	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-16 beta chain	GO:0031295; P:T cell costimulation; TAS:Reactome
Q29974	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-16 beta chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q29974	HLA-DRB1	HLA class II histocompatibility antigen, DRB1-16 beta chain	GO:0042088; P:T-helper 1 type immune response; ISS:UniProtKB
P14060	HSD3B1	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1	GO:0003854; F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; ISS:UniProtKB
P14060	HSD3B1	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1	GO:0004769; F:steroid delta-isomerase activity; ISS:UniProtKB
P14060	HSD3B1	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1	GO:0006702; P:androgen biosynthetic process; TAS:UniProtKB
P14060	HSD3B1	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1	GO:0006703; P:estrogen biosynthetic process; TAS:UniProtKB
P14060	HSD3B1	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1	GO:0006704; P:glucocorticoid biosynthetic process; TAS:Reactome
P14060	HSD3B1	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1	GO:0006705; P:mineralocorticoid biosynthetic process; TAS:Reactome
P14060	HSD3B1	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P14060	HSD3B1	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1	GO:0006694; P:steroid biosynthetic process; ISS:UniProtKB
P14060	HSD3B1	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1	GO:0008202; P:steroid metabolic process; TAS:Reactome
P26439	HSD3B2	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2	GO:0003854; F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; IDA:UniProtKB
P26439	HSD3B2	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2	GO:0004769; F:steroid delta-isomerase activity; IDA:UniProtKB
P26439	HSD3B2	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2	GO:0006702; P:androgen biosynthetic process; TAS:Reactome
P26439	HSD3B2	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2	GO:0006704; P:glucocorticoid biosynthetic process; TAS:Reactome
P26439	HSD3B2	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2	GO:0006705; P:mineralocorticoid biosynthetic process; TAS:Reactome
P26439	HSD3B2	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P26439	HSD3B2	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2	GO:0006694; P:steroid biosynthetic process; IDA:UniProtKB
P26439	HSD3B2	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2	GO:0008202; P:steroid metabolic process; TAS:Reactome
Q9H2F3	HSD3B7	3 beta-hydroxysteroid dehydrogenase type 7	GO:0003854; F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; NAS:UniProtKB
Q9H2F3	HSD3B7	3 beta-hydroxysteroid dehydrogenase type 7	GO:0047016; F:cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; IEA:UniProtKB-EC
Q9H2F3	HSD3B7	3 beta-hydroxysteroid dehydrogenase type 7	GO:0006699; P:bile acid biosynthetic process; TAS:UniProtKB
Q9H2F3	HSD3B7	3 beta-hydroxysteroid dehydrogenase type 7	GO:0008206; P:bile acid metabolic process; TAS:Reactome
Q9H2F3	HSD3B7	3 beta-hydroxysteroid dehydrogenase type 7	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y3L3	SH3BP1	SH3 domain-binding protein 1	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q9Y3L3	SH3BP1	SH3 domain-binding protein 1	GO:0007165; P:signal transduction; IEA:InterPro
P78314	SH3BP2	SH3 domain-binding protein 2	GO:0005515; F:protein binding; IPI:IntAct
P78314	SH3BP2	SH3 domain-binding protein 2	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
P78314	SH3BP2	SH3 domain-binding protein 2	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
P78314	SH3BP2	SH3 domain-binding protein 2	GO:0007165; P:signal transduction; TAS:ProtInc
O60239	SH3BP5	SH3 domain-binding protein 5	GO:0005515; F:protein binding; IPI:IntAct
O60239	SH3BP5	SH3 domain-binding protein 5	GO:0004860; F:protein kinase inhibitor activity; IDA:MGI
O60239	SH3BP5	SH3 domain-binding protein 5	GO:0035556; P:intracellular signal transduction; IDA:MGI
O60239	SH3BP5	SH3 domain-binding protein 5	GO:0007165; P:signal transduction; TAS:ProtInc
P46952	HAAO	3-hydroxyanthranilate 3,4-dioxygenase	GO:0000334; F:3-hydroxyanthranilate 3,4-dioxygenase activity; IDA:UniProtKB
P46952	HAAO	3-hydroxyanthranilate 3,4-dioxygenase	GO:0009055; F:electron carrier activity; NAS:UniProtKB
P46952	HAAO	3-hydroxyanthranilate 3,4-dioxygenase	GO:0008198; F:ferrous iron binding; IDA:UniProtKB
P46952	HAAO	3-hydroxyanthranilate 3,4-dioxygenase	GO:0019825; F:oxygen binding; IEA:Ensembl
P46952	HAAO	3-hydroxyanthranilate 3,4-dioxygenase	GO:0034354; P:'de novo' NAD biosynthetic process from tryptophan; IEA:UniProtKB-HAMAP
P46952	HAAO	3-hydroxyanthranilate 3,4-dioxygenase	GO:0043420; P:anthranilate metabolic process; IEA:UniProtKB-HAMAP
P46952	HAAO	3-hydroxyanthranilate 3,4-dioxygenase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P46952	HAAO	3-hydroxyanthranilate 3,4-dioxygenase	GO:0070050; P:neuron cellular homeostasis; IMP:UniProtKB
P46952	HAAO	3-hydroxyanthranilate 3,4-dioxygenase	GO:0019805; P:quinolinate biosynthetic process; NAS:UniProtKB
P46952	HAAO	3-hydroxyanthranilate 3,4-dioxygenase	GO:0046686; P:response to cadmium ion; IDA:UniProtKB
P46952	HAAO	3-hydroxyanthranilate 3,4-dioxygenase	GO:0010043; P:response to zinc ion; IDA:UniProtKB
P46952	HAAO	3-hydroxyanthranilate 3,4-dioxygenase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P46952	HAAO	3-hydroxyanthranilate 3,4-dioxygenase	GO:0006569; P:tryptophan catabolic process; TAS:Reactome
P31937	HIBADH	3-hydroxyisobutyrate dehydrogenase, mitochondrial	GO:0008442; F:3-hydroxyisobutyrate dehydrogenase activity; IDA:UniProtKB
P31937	HIBADH	3-hydroxyisobutyrate dehydrogenase, mitochondrial	GO:0051287; F:NAD binding; IEA:InterPro
P31937	HIBADH	3-hydroxyisobutyrate dehydrogenase, mitochondrial	GO:0004616; F:phosphogluconate dehydrogenase (decarboxylating) activity; IEA:InterPro
P31937	HIBADH	3-hydroxyisobutyrate dehydrogenase, mitochondrial	GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome
P31937	HIBADH	3-hydroxyisobutyrate dehydrogenase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P31937	HIBADH	3-hydroxyisobutyrate dehydrogenase, mitochondrial	GO:0006098; P:pentose-phosphate shunt; IEA:InterPro
P31937	HIBADH	3-hydroxyisobutyrate dehydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P31937	HIBADH	3-hydroxyisobutyrate dehydrogenase, mitochondrial	GO:0006574; P:valine catabolic process; IDA:UniProtKB
P29372	MPG	DNA-3-methyladenine glycosylase	GO:0003684; F:damaged DNA binding; TAS:ProtInc
P29372	MPG	DNA-3-methyladenine glycosylase	GO:0008725; F:DNA-3-methyladenine glycosylase activity; IEA:UniProtKB-EC
P29372	MPG	DNA-3-methyladenine glycosylase	GO:0052822; F:DNA-3-methylguanine glycosylase activity; IEA:UniProtKB-EC
P29372	MPG	DNA-3-methyladenine glycosylase	GO:0052821; F:DNA-7-methyladenine glycosylase activity; IEA:UniProtKB-EC
P29372	MPG	DNA-3-methyladenine glycosylase	GO:0043916; F:DNA-7-methylguanine glycosylase activity; IEA:UniProtKB-EC
P29372	MPG	DNA-3-methyladenine glycosylase	GO:0005515; F:protein binding; IPI:IntAct
P29372	MPG	DNA-3-methyladenine glycosylase	GO:0006284; P:base-excision repair; TAS:Reactome
P29372	MPG	DNA-3-methyladenine glycosylase	GO:0006285; P:base-excision repair, AP site formation; TAS:Reactome
P29372	MPG	DNA-3-methyladenine glycosylase	GO:0045007; P:depurination; TAS:Reactome
P29372	MPG	DNA-3-methyladenine glycosylase	GO:0006307; P:DNA dealkylation involved in DNA repair; TAS:ProtInc
P29372	MPG	DNA-3-methyladenine glycosylase	GO:0006281; P:DNA repair; TAS:Reactome
P11171	EPB41	Protein 4.1	GO:0005545; F:1-phosphatidylinositol binding; IDA:UniProtKB
P11171	EPB41	Protein 4.1	GO:0005515; F:protein binding; IPI:UniProtKB
P11171	EPB41	Protein 4.1	GO:0030507; F:spectrin binding; TAS:BHF-UCL
P11171	EPB41	Protein 4.1	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P11171	EPB41	Protein 4.1	GO:0030036; P:actin cytoskeleton organization; NAS:UniProtKB
P11171	EPB41	Protein 4.1	GO:0008015; P:blood circulation; TAS:ProtInc
P11171	EPB41	Protein 4.1	GO:0030866; P:cortical actin cytoskeleton organization; IEA:InterPro
P11171	EPB41	Protein 4.1	GO:0032092; P:positive regulation of protein binding; IDA:BHF-UCL
Q13541	EIF4EBP1	Eukaryotic translation initiation factor 4E-binding protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13541	EIF4EBP1	Eukaryotic translation initiation factor 4E-binding protein 1	GO:0030371; F:translation repressor activity; IDA:UniProtKB
Q13541	EIF4EBP1	Eukaryotic translation initiation factor 4E-binding protein 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q13541	EIF4EBP1	Eukaryotic translation initiation factor 4E-binding protein 1	GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:UniProtKB
Q13541	EIF4EBP1	Eukaryotic translation initiation factor 4E-binding protein 1	GO:0010467; P:gene expression; TAS:Reactome
Q13541	EIF4EBP1	Eukaryotic translation initiation factor 4E-binding protein 1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q13541	EIF4EBP1	Eukaryotic translation initiation factor 4E-binding protein 1	GO:0030324; P:lung development; IEA:Ensembl
Q13541	EIF4EBP1	Eukaryotic translation initiation factor 4E-binding protein 1	GO:0031333; P:negative regulation of protein complex assembly; IEA:Ensembl
Q13541	EIF4EBP1	Eukaryotic translation initiation factor 4E-binding protein 1	GO:0045947; P:negative regulation of translational initiation; IDA:UniProtKB
Q13541	EIF4EBP1	Eukaryotic translation initiation factor 4E-binding protein 1	GO:0045931; P:positive regulation of mitotic cell cycle; IMP:UniProtKB
Q13541	EIF4EBP1	Eukaryotic translation initiation factor 4E-binding protein 1	GO:0045471; P:response to ethanol; IEA:Ensembl
Q13541	EIF4EBP1	Eukaryotic translation initiation factor 4E-binding protein 1	GO:0002931; P:response to ischemia; IEA:Ensembl
Q13541	EIF4EBP1	Eukaryotic translation initiation factor 4E-binding protein 1	GO:0031929; P:TOR signaling; IDA:UniProtKB
Q13541	EIF4EBP1	Eukaryotic translation initiation factor 4E-binding protein 1	GO:0006412; P:translation; TAS:Reactome
Q13541	EIF4EBP1	Eukaryotic translation initiation factor 4E-binding protein 1	GO:0006413; P:translational initiation; TAS:Reactome
Q13542	EIF4EBP2	Eukaryotic translation initiation factor 4E-binding protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q13542	EIF4EBP2	Eukaryotic translation initiation factor 4E-binding protein 2	GO:0019933; P:cAMP-mediated signaling; IEA:Ensembl
Q13542	EIF4EBP2	Eukaryotic translation initiation factor 4E-binding protein 2	GO:0008286; P:insulin receptor signaling pathway; IEA:Ensembl
Q13542	EIF4EBP2	Eukaryotic translation initiation factor 4E-binding protein 2	GO:0045947; P:negative regulation of translational initiation; IEA:InterPro
Q13542	EIF4EBP2	Eukaryotic translation initiation factor 4E-binding protein 2	GO:0006412; P:translation; TAS:ProtInc
O60516	EIF4EBP3	Eukaryotic translation initiation factor 4E-binding protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
O60516	EIF4EBP3	Eukaryotic translation initiation factor 4E-binding protein 3	GO:0030371; F:translation repressor activity; NAS:UniProtKB
O60516	EIF4EBP3	Eukaryotic translation initiation factor 4E-binding protein 3	GO:0045947; P:negative regulation of translational initiation; NAS:UniProtKB
Q9NRA8	EIF4ENIF1	Eukaryotic translation initiation factor 4E transporter	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NRA8	EIF4ENIF1	Eukaryotic translation initiation factor 4E transporter	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NRA8	EIF4ENIF1	Eukaryotic translation initiation factor 4E transporter	GO:0008565; F:protein transporter activity; TAS:ProtInc
P08195	SLC3A2	4F2 cell-surface antigen heavy chain	GO:0005432; F:calcium:sodium antiporter activity; TAS:UniProtKB
P08195	SLC3A2	4F2 cell-surface antigen heavy chain	GO:0003824; F:catalytic activity; IEA:InterPro
P08195	SLC3A2	4F2 cell-surface antigen heavy chain	GO:0043169; F:cation binding; IEA:InterPro
P08195	SLC3A2	4F2 cell-surface antigen heavy chain	GO:0003725; F:double-stranded RNA binding; IDA:MGI
P08195	SLC3A2	4F2 cell-surface antigen heavy chain	GO:0015175; F:neutral amino acid transmembrane transporter activity; ISS:UniProtKB
P08195	SLC3A2	4F2 cell-surface antigen heavy chain	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P08195	SLC3A2	4F2 cell-surface antigen heavy chain	GO:0005515; F:protein binding; IPI:UniProtKB
P08195	SLC3A2	4F2 cell-surface antigen heavy chain	GO:0006865; P:amino acid transport; TAS:UniProtKB
P08195	SLC3A2	4F2 cell-surface antigen heavy chain	GO:0007596; P:blood coagulation; TAS:Reactome
P08195	SLC3A2	4F2 cell-surface antigen heavy chain	GO:0006816; P:calcium ion transport; NAS:UniProtKB
P08195	SLC3A2	4F2 cell-surface antigen heavy chain	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
P08195	SLC3A2	4F2 cell-surface antigen heavy chain	GO:0016049; P:cell growth; NAS:UniProtKB
P08195	SLC3A2	4F2 cell-surface antigen heavy chain	GO:0006811; P:ion transport; TAS:Reactome
P08195	SLC3A2	4F2 cell-surface antigen heavy chain	GO:0060356; P:leucine import; ISS:UniProtKB
P08195	SLC3A2	4F2 cell-surface antigen heavy chain	GO:0050900; P:leukocyte migration; TAS:Reactome
P08195	SLC3A2	4F2 cell-surface antigen heavy chain	GO:0043330; P:response to exogenous dsRNA; IMP:MGI
P08195	SLC3A2	4F2 cell-surface antigen heavy chain	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
P08195	SLC3A2	4F2 cell-surface antigen heavy chain	GO:0055085; P:transmembrane transport; TAS:Reactome
P08195	SLC3A2	4F2 cell-surface antigen heavy chain	GO:0015827; P:tryptophan transport; ISS:UniProtKB
P08908	HTR1A	5-hydroxytryptamine receptor 1A	GO:0005515; F:protein binding; IPI:IntAct
P08908	HTR1A	5-hydroxytryptamine receptor 1A	GO:0004993; F:serotonin receptor activity; IDA:UniProtKB
P08908	HTR1A	5-hydroxytryptamine receptor 1A	GO:0007198; P:adenylate cyclase-inhibiting serotonin receptor signaling pathway; IDA:UniProtKB
P08908	HTR1A	5-hydroxytryptamine receptor 1A	GO:0001662; P:behavioral fear response; ISS:UniProtKB
P08908	HTR1A	5-hydroxytryptamine receptor 1A	GO:0008283; P:cell proliferation; IEA:InterPro
P08908	HTR1A	5-hydroxytryptamine receptor 1A	GO:0035640; P:exploration behavior; ISS:UniProtKB
P08908	HTR1A	5-hydroxytryptamine receptor 1A	GO:0007186; P:G-protein coupled receptor signaling pathway; IMP:UniProtKB
P08908	HTR1A	5-hydroxytryptamine receptor 1A	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P08908	HTR1A	5-hydroxytryptamine receptor 1A	GO:0050795; P:regulation of behavior; IEA:InterPro
P08908	HTR1A	5-hydroxytryptamine receptor 1A	GO:0042053; P:regulation of dopamine metabolic process; ISS:UniProtKB
P08908	HTR1A	5-hydroxytryptamine receptor 1A	GO:0046883; P:regulation of hormone secretion; IEA:InterPro
P08908	HTR1A	5-hydroxytryptamine receptor 1A	GO:0014062; P:regulation of serotonin secretion; ISS:UniProtKB
P08908	HTR1A	5-hydroxytryptamine receptor 1A	GO:0042428; P:serotonin metabolic process; ISS:UniProtKB
P08908	HTR1A	5-hydroxytryptamine receptor 1A	GO:0007210; P:serotonin receptor signaling pathway; ISS:UniProtKB
P08908	HTR1A	5-hydroxytryptamine receptor 1A	GO:0042310; P:vasoconstriction; IEA:InterPro
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0008144; F:drug binding; IEA:Ensembl
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0051378; F:serotonin binding; IEA:Ensembl
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0004993; F:serotonin receptor activity; IDA:UniProtKB
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0007198; P:adenylate cyclase-inhibiting serotonin receptor signaling pathway; IDA:UniProtKB
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0046849; P:bone remodeling; IEA:Ensembl
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0071312; P:cellular response to alkaloid; IDA:UniProtKB
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0035690; P:cellular response to drug; IDA:UniProtKB
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0071502; P:cellular response to temperature stimulus; IEA:Ensembl
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0042756; P:drinking behavior; IEA:Ensembl
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0002031; P:G-protein coupled receptor internalization; IEA:Ensembl
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0030818; P:negative regulation of cAMP biosynthetic process; IDA:UniProtKB
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0014063; P:negative regulation of serotonin secretion; ISS:UniProtKB
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0032229; P:negative regulation of synaptic transmission, GABAergic; IEA:Ensembl
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0051967; P:negative regulation of synaptic transmission, glutamatergic; IEA:Ensembl
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0050795; P:regulation of behavior; IEA:InterPro
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0014059; P:regulation of dopamine secretion; IEA:Ensembl
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0042220; P:response to cocaine; IEA:Ensembl
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0045471; P:response to ethanol; IEA:Ensembl
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0051385; P:response to mineralocorticoid; IEA:Ensembl
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0007268; P:synaptic transmission; TAS:ProtInc
P28222	HTR1B	5-hydroxytryptamine receptor 1B	GO:0042310; P:vasoconstriction; IEA:InterPro
P28221	HTR1D	5-hydroxytryptamine receptor 1D	GO:0051378; F:serotonin binding; IEA:Ensembl
P28221	HTR1D	5-hydroxytryptamine receptor 1D	GO:0004993; F:serotonin receptor activity; IMP:UniProtKB
P28221	HTR1D	5-hydroxytryptamine receptor 1D	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IMP:UniProtKB
P28221	HTR1D	5-hydroxytryptamine receptor 1D	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P28221	HTR1D	5-hydroxytryptamine receptor 1D	GO:0014827; P:intestine smooth muscle contraction; IMP:UniProtKB
P28221	HTR1D	5-hydroxytryptamine receptor 1D	GO:0050795; P:regulation of behavior; IEA:InterPro
P28221	HTR1D	5-hydroxytryptamine receptor 1D	GO:0040012; P:regulation of locomotion; IEA:InterPro
P28221	HTR1D	5-hydroxytryptamine receptor 1D	GO:0009636; P:response to toxic substance; IEA:Ensembl
P28221	HTR1D	5-hydroxytryptamine receptor 1D	GO:0007268; P:synaptic transmission; TAS:ProtInc
P28221	HTR1D	5-hydroxytryptamine receptor 1D	GO:0042310; P:vasoconstriction; IEA:InterPro
P28566	HTR1E	5-hydroxytryptamine receptor 1E	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P28566	HTR1E	5-hydroxytryptamine receptor 1E	GO:0051378; F:serotonin binding; IDA:MGI
P28566	HTR1E	5-hydroxytryptamine receptor 1E	GO:0004993; F:serotonin receptor activity; IMP:UniProtKB
P28566	HTR1E	5-hydroxytryptamine receptor 1E	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IMP:UniProtKB
P28566	HTR1E	5-hydroxytryptamine receptor 1E	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P28566	HTR1E	5-hydroxytryptamine receptor 1E	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P28566	HTR1E	5-hydroxytryptamine receptor 1E	GO:0030815; P:negative regulation of cAMP metabolic process; IEA:InterPro
P28566	HTR1E	5-hydroxytryptamine receptor 1E	GO:0007210; P:serotonin receptor signaling pathway; IDA:GOC
P28566	HTR1E	5-hydroxytryptamine receptor 1E	GO:0007268; P:synaptic transmission; TAS:ProtInc
P30939	HTR1F	5-hydroxytryptamine receptor 1F	GO:0051378; F:serotonin binding; IDA:MGI
P30939	HTR1F	5-hydroxytryptamine receptor 1F	GO:0004993; F:serotonin receptor activity; IMP:UniProtKB
P30939	HTR1F	5-hydroxytryptamine receptor 1F	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IMP:UniProtKB
P30939	HTR1F	5-hydroxytryptamine receptor 1F	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P30939	HTR1F	5-hydroxytryptamine receptor 1F	GO:0007210; P:serotonin receptor signaling pathway; IDA:GOC
P30939	HTR1F	5-hydroxytryptamine receptor 1F	GO:0007268; P:synaptic transmission; TAS:ProtInc
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0071886; F:1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding; IDA:UniProtKB
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0008144; F:drug binding; IDA:UniProtKB
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0051378; F:serotonin binding; IDA:UniProtKB
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0004993; F:serotonin receptor activity; IDA:UniProtKB
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0007202; P:activation of phospholipase C activity; IDA:UniProtKB
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0007568; P:aging; IEA:Ensembl
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0014824; P:artery smooth muscle contraction; IEA:Ensembl
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0048148; P:behavioral response to cocaine; IEA:Ensembl
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0008219; P:cell death; IEA:Ensembl
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0006874; P:cellular calcium ion homeostasis; IDA:UniProtKB
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; IEA:Ensembl
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; IEA:Ensembl
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0007613; P:memory; IEA:Ensembl
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0043267; P:negative regulation of potassium ion transport; IEA:Ensembl
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0051967; P:negative regulation of synaptic transmission, glutamatergic; IEA:Ensembl
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0014065; P:phosphatidylinositol 3-kinase signaling; IDA:UniProtKB
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0007208; P:phospholipase C-activating serotonin receptor signaling pathway; IEA:Ensembl
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0043406; P:positive regulation of MAP kinase activity; IEA:Ensembl
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0010513; P:positive regulation of phosphatidylinositol biosynthetic process; IDA:UniProtKB
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0050795; P:regulation of behavior; IEA:InterPro
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0014059; P:regulation of dopamine secretion; IEA:Ensembl
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0046883; P:regulation of hormone secretion; IEA:InterPro
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0051209; P:release of sequestered calcium ion into cytosol; IDA:UniProtKB
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0042493; P:response to drug; IDA:UniProtKB
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0007210; P:serotonin receptor signaling pathway; IMP:UniProtKB
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0030431; P:sleep; IEA:Ensembl
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0007268; P:synaptic transmission; TAS:ProtInc
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0001659; P:temperature homeostasis; IEA:Ensembl
P28223	HTR2A	5-hydroxytryptamine receptor 2A	GO:0014832; P:urinary bladder smooth muscle contraction; IEA:Ensembl
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0008144; F:drug binding; IDA:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0001965; F:G-protein alpha-subunit binding; IMP:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0005099; F:Ras GTPase activator activity; ISS:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0051378; F:serotonin binding; IDA:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0004993; F:serotonin receptor activity; IDA:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0007202; P:activation of phospholipase C activity; IDA:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0007610; P:behavior; IEA:UniProtKB-KW
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0019722; P:calcium-mediated signaling; IMP:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0003300; P:cardiac muscle hypertrophy; ISS:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0006874; P:cellular calcium ion homeostasis; IDA:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0071502; P:cellular response to temperature stimulus; ISS:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0006182; P:cGMP biosynthetic process; IDA:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0048598; P:embryonic morphogenesis; ISS:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0070371; P:ERK1 and ERK2 cascade; IMP:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0002031; P:G-protein coupled receptor internalization; IEA:Ensembl
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0007186; P:G-protein coupled receptor signaling pathway; IMP:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0003007; P:heart morphogenesis; ISS:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0014827; P:intestine smooth muscle contraction; IMP:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0010507; P:negative regulation of autophagy; IMP:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0060548; P:negative regulation of cell death; IMP:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0014033; P:neural crest cell differentiation; ISS:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0001755; P:neural crest cell migration; ISS:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0014065; P:phosphatidylinositol 3-kinase signaling; IDA:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0016310; P:phosphorylation; IMP:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0051781; P:positive regulation of cell division; ISS:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0001819; P:positive regulation of cytokine production; IDA:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0050715; P:positive regulation of cytokine secretion; ISS:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0043406; P:positive regulation of MAP kinase activity; IDA:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0051000; P:positive regulation of nitric-oxide synthase activity; IDA:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0010513; P:positive regulation of phosphatidylinositol biosynthetic process; IDA:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0070528; P:protein kinase C signaling; IMP:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; ISS:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0050795; P:regulation of behavior; IMP:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0051209; P:release of sequestered calcium ion into cytosol; IDA:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0042493; P:response to drug; IDA:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0007210; P:serotonin receptor signaling pathway; IMP:UniProtKB
P41595	HTR2B	5-hydroxytryptamine receptor 2B	GO:0042310; P:vasoconstriction; IMP:UniProtKB
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0071886; F:1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding; IDA:UniProtKB
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0008144; F:drug binding; IDA:UniProtKB
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0001587; F:Gq/11-coupled serotonin receptor activity; IDA:UniProtKB
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0051378; F:serotonin binding; IDA:UniProtKB
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0004993; F:serotonin receptor activity; IDA:MGI
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0001662; P:behavioral fear response; ISS:UniProtKB
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0006874; P:cellular calcium ion homeostasis; IDA:UniProtKB
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0006182; P:cGMP biosynthetic process; IDA:UniProtKB
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0007631; P:feeding behavior; ISS:UniProtKB
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0007626; P:locomotory behavior; IEA:InterPro
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; IDA:UniProtKB
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0007208; P:phospholipase C-activating serotonin receptor signaling pathway; ISS:UniProtKB
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0051482; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway; ISS:UniProtKB
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0010513; P:positive regulation of phosphatidylinositol biosynthetic process; IDA:UniProtKB
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0032098; P:regulation of appetite; ISS:UniProtKB
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0043397; P:regulation of corticotropin-releasing hormone secretion; ISS:UniProtKB
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0031644; P:regulation of neurological system process; ISS:UniProtKB
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0051209; P:release of sequestered calcium ion into cytosol; IMP:UniProtKB
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0042493; P:response to drug; IDA:UniProtKB
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0007210; P:serotonin receptor signaling pathway; IMP:UniProtKB
P28335	HTR2C	5-hydroxytryptamine receptor 2C	GO:0007268; P:synaptic transmission; TAS:ProtInc
P46098	HTR3A	5-hydroxytryptamine receptor 3A	GO:0004872; F:receptor activity; TAS:ProtInc
P46098	HTR3A	5-hydroxytryptamine receptor 3A	GO:0051378; F:serotonin binding; IDA:MGI
P46098	HTR3A	5-hydroxytryptamine receptor 3A	GO:0004993; F:serotonin receptor activity; IDA:MGI
P46098	HTR3A	5-hydroxytryptamine receptor 3A	GO:0005232; F:serotonin-activated cation-selective channel activity; TAS:ProtInc
P46098	HTR3A	5-hydroxytryptamine receptor 3A	GO:0005249; F:voltage-gated potassium channel activity; IEA:Ensembl
P46098	HTR3A	5-hydroxytryptamine receptor 3A	GO:0006812; P:cation transport; TAS:GOC
P46098	HTR3A	5-hydroxytryptamine receptor 3A	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P46098	HTR3A	5-hydroxytryptamine receptor 3A	GO:0007586; P:digestion; TAS:ProtInc
P46098	HTR3A	5-hydroxytryptamine receptor 3A	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P46098	HTR3A	5-hydroxytryptamine receptor 3A	GO:0042220; P:response to cocaine; IEA:Ensembl
P46098	HTR3A	5-hydroxytryptamine receptor 3A	GO:0045471; P:response to ethanol; IEA:Ensembl
P46098	HTR3A	5-hydroxytryptamine receptor 3A	GO:0007210; P:serotonin receptor signaling pathway; IDA:GOC
P46098	HTR3A	5-hydroxytryptamine receptor 3A	GO:0007268; P:synaptic transmission; TAS:ProtInc
P46098	HTR3A	5-hydroxytryptamine receptor 3A	GO:0055085; P:transmembrane transport; TAS:Reactome
P46098	HTR3A	5-hydroxytryptamine receptor 3A	GO:0006810; P:transport; TAS:ProtInc
O95264	HTR3B	5-hydroxytryptamine receptor 3B	GO:0005216; F:ion channel activity; TAS:ProtInc
O95264	HTR3B	5-hydroxytryptamine receptor 3B	GO:0004993; F:serotonin receptor activity; TAS:ProtInc
O95264	HTR3B	5-hydroxytryptamine receptor 3B	GO:0005232; F:serotonin-activated cation-selective channel activity; TAS:ProtInc
O95264	HTR3B	5-hydroxytryptamine receptor 3B	GO:0006812; P:cation transport; TAS:GOC
O95264	HTR3B	5-hydroxytryptamine receptor 3B	GO:0034220; P:ion transmembrane transport; TAS:Reactome
O95264	HTR3B	5-hydroxytryptamine receptor 3B	GO:0007268; P:synaptic transmission; TAS:ProtInc
O95264	HTR3B	5-hydroxytryptamine receptor 3B	GO:0055085; P:transmembrane transport; TAS:Reactome
O95264	HTR3B	5-hydroxytryptamine receptor 3B	GO:0006810; P:transport; TAS:ProtInc
Q8WXA8	HTR3C	5-hydroxytryptamine receptor 3C	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
Q8WXA8	HTR3C	5-hydroxytryptamine receptor 3C	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q8WXA8	HTR3C	5-hydroxytryptamine receptor 3C	GO:0055085; P:transmembrane transport; TAS:Reactome
Q70Z44	HTR3D	5-hydroxytryptamine receptor 3D	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
Q70Z44	HTR3D	5-hydroxytryptamine receptor 3D	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q70Z44	HTR3D	5-hydroxytryptamine receptor 3D	GO:0055085; P:transmembrane transport; TAS:Reactome
A5X5Y0	HTR3E	5-hydroxytryptamine receptor 3E	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
A5X5Y0	HTR3E	5-hydroxytryptamine receptor 3E	GO:0034220; P:ion transmembrane transport; TAS:Reactome
A5X5Y0	HTR3E	5-hydroxytryptamine receptor 3E	GO:0055085; P:transmembrane transport; TAS:Reactome
Q13639	HTR4	5-hydroxytryptamine receptor 4	GO:0004993; F:serotonin receptor activity; IDA:MGI
Q13639	HTR4	5-hydroxytryptamine receptor 4	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q13639	HTR4	5-hydroxytryptamine receptor 4	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
Q13639	HTR4	5-hydroxytryptamine receptor 4	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
Q13639	HTR4	5-hydroxytryptamine receptor 4	GO:0032098; P:regulation of appetite; IEA:InterPro
Q13639	HTR4	5-hydroxytryptamine receptor 4	GO:0007210; P:serotonin receptor signaling pathway; IDA:GOC
Q13639	HTR4	5-hydroxytryptamine receptor 4	GO:0007268; P:synaptic transmission; IEA:InterPro
P47898	HTR5A	5-hydroxytryptamine receptor 5A	GO:0004993; F:serotonin receptor activity; IDA:MGI
P47898	HTR5A	5-hydroxytryptamine receptor 5A	GO:0019933; P:cAMP-mediated signaling; IEA:Ensembl
P47898	HTR5A	5-hydroxytryptamine receptor 5A	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P47898	HTR5A	5-hydroxytryptamine receptor 5A	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; IEA:Ensembl
P47898	HTR5A	5-hydroxytryptamine receptor 5A	GO:0021766; P:hippocampus development; IEA:Ensembl
P47898	HTR5A	5-hydroxytryptamine receptor 5A	GO:0032355; P:response to estradiol; IEA:Ensembl
P47898	HTR5A	5-hydroxytryptamine receptor 5A	GO:0007210; P:serotonin receptor signaling pathway; IDA:GOC
P50406	HTR6	5-hydroxytryptamine receptor 6	GO:0004969; F:histamine receptor activity; TAS:ProtInc
P50406	HTR6	5-hydroxytryptamine receptor 6	GO:0005515; F:protein binding; IPI:IntAct
P50406	HTR6	5-hydroxytryptamine receptor 6	GO:0004993; F:serotonin receptor activity; IEA:InterPro
P50406	HTR6	5-hydroxytryptamine receptor 6	GO:0007420; P:brain development; IEA:Ensembl
P50406	HTR6	5-hydroxytryptamine receptor 6	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P50406	HTR6	5-hydroxytryptamine receptor 6	GO:0007612; P:learning; IEA:Ensembl
P50406	HTR6	5-hydroxytryptamine receptor 6	GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl
P50406	HTR6	5-hydroxytryptamine receptor 6	GO:0014058; P:negative regulation of acetylcholine secretion, neurotransmission; IEA:Ensembl
P50406	HTR6	5-hydroxytryptamine receptor 6	GO:0014053; P:negative regulation of gamma-aminobutyric acid secretion; IEA:Ensembl
P50406	HTR6	5-hydroxytryptamine receptor 6	GO:0014050; P:negative regulation of glutamate secretion; IEA:Ensembl
P50406	HTR6	5-hydroxytryptamine receptor 6	GO:0033603; P:positive regulation of dopamine secretion; IEA:Ensembl
P50406	HTR6	5-hydroxytryptamine receptor 6	GO:0014054; P:positive regulation of gamma-aminobutyric acid secretion; IEA:Ensembl
P50406	HTR6	5-hydroxytryptamine receptor 6	GO:0042493; P:response to drug; IEA:Ensembl
P50406	HTR6	5-hydroxytryptamine receptor 6	GO:0032355; P:response to estradiol; IEA:Ensembl
P50406	HTR6	5-hydroxytryptamine receptor 6	GO:0007268; P:synaptic transmission; TAS:ProtInc
P34969	HTR7	5-hydroxytryptamine receptor 7	GO:0004993; F:serotonin receptor activity; TAS:ProtInc
P34969	HTR7	5-hydroxytryptamine receptor 7	GO:0008015; P:blood circulation; TAS:ProtInc
P34969	HTR7	5-hydroxytryptamine receptor 7	GO:0007623; P:circadian rhythm; TAS:ProtInc
P34969	HTR7	5-hydroxytryptamine receptor 7	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P34969	HTR7	5-hydroxytryptamine receptor 7	GO:0007210; P:serotonin receptor signaling pathway; TAS:GOC
P34969	HTR7	5-hydroxytryptamine receptor 7	GO:0006939; P:smooth muscle contraction; IEA:InterPro
P34969	HTR7	5-hydroxytryptamine receptor 7	GO:0007268; P:synaptic transmission; TAS:ProtInc
P34969	HTR7	5-hydroxytryptamine receptor 7	GO:0042310; P:vasoconstriction; IEA:InterPro
Q96P26	NT5C1B	Cytosolic 5'-nucleotidase 1B	GO:0008253; F:5'-nucleotidase activity; IEA:UniProtKB-EC
Q96P26	NT5C1B	Cytosolic 5'-nucleotidase 1B	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q96P26	NT5C1B	Cytosolic 5'-nucleotidase 1B	GO:0000166; F:nucleotide binding; IEA:InterPro
Q96P26	NT5C1B	Cytosolic 5'-nucleotidase 1B	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q96P26	NT5C1B	Cytosolic 5'-nucleotidase 1B	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
Q96P26	NT5C1B	Cytosolic 5'-nucleotidase 1B	GO:0006195; P:purine nucleotide catabolic process; TAS:Reactome
Q96P26	NT5C1B	Cytosolic 5'-nucleotidase 1B	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BXI3	NT5C1A	Cytosolic 5'-nucleotidase 1A	GO:0008253; F:5'-nucleotidase activity; NAS:UniProtKB
Q9BXI3	NT5C1A	Cytosolic 5'-nucleotidase 1A	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q9BXI3	NT5C1A	Cytosolic 5'-nucleotidase 1A	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
Q9BXI3	NT5C1A	Cytosolic 5'-nucleotidase 1A	GO:0046085; P:adenosine metabolic process; IEA:Ensembl
Q9BXI3	NT5C1A	Cytosolic 5'-nucleotidase 1A	GO:0016311; P:dephosphorylation; EXP:GOC
Q9BXI3	NT5C1A	Cytosolic 5'-nucleotidase 1A	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q9BXI3	NT5C1A	Cytosolic 5'-nucleotidase 1A	GO:0009116; P:nucleoside metabolic process; NAS:UniProtKB
Q9BXI3	NT5C1A	Cytosolic 5'-nucleotidase 1A	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
Q9BXI3	NT5C1A	Cytosolic 5'-nucleotidase 1A	GO:0009128; P:purine nucleoside monophosphate catabolic process; IEA:Ensembl
Q9BXI3	NT5C1A	Cytosolic 5'-nucleotidase 1A	GO:0006195; P:purine nucleotide catabolic process; TAS:Reactome
Q9BXI3	NT5C1A	Cytosolic 5'-nucleotidase 1A	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
Q9BXI3	NT5C1A	Cytosolic 5'-nucleotidase 1A	GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome
Q9BXI3	NT5C1A	Cytosolic 5'-nucleotidase 1A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H0P0	NT5C3A	Cytosolic 5'-nucleotidase 3A	GO:0008665; F:2'-phosphotransferase activity; NAS:UniProtKB
Q9H0P0	NT5C3A	Cytosolic 5'-nucleotidase 3A	GO:0008253; F:5'-nucleotidase activity; IDA:UniProtKB
Q9H0P0	NT5C3A	Cytosolic 5'-nucleotidase 3A	GO:0000287; F:magnesium ion binding; NAS:UniProtKB
Q9H0P0	NT5C3A	Cytosolic 5'-nucleotidase 3A	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
Q9H0P0	NT5C3A	Cytosolic 5'-nucleotidase 3A	GO:0046085; P:adenosine metabolic process; IEA:Ensembl
Q9H0P0	NT5C3A	Cytosolic 5'-nucleotidase 3A	GO:0016311; P:dephosphorylation; IDA:GOC
Q9H0P0	NT5C3A	Cytosolic 5'-nucleotidase 3A	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q9H0P0	NT5C3A	Cytosolic 5'-nucleotidase 3A	GO:0009117; P:nucleotide metabolic process; IEA:UniProtKB-KW
Q9H0P0	NT5C3A	Cytosolic 5'-nucleotidase 3A	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
Q9H0P0	NT5C3A	Cytosolic 5'-nucleotidase 3A	GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome
Q9H0P0	NT5C3A	Cytosolic 5'-nucleotidase 3A	GO:0006213; P:pyrimidine nucleoside metabolic process; NAS:UniProtKB
Q9H0P0	NT5C3A	Cytosolic 5'-nucleotidase 3A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q969T7	NT5C3B	7-methylguanosine phosphate-specific 5'-nucleotidase	GO:0008253; F:5'-nucleotidase activity; IEA:UniProtKB-EC
Q969T7	NT5C3B	7-methylguanosine phosphate-specific 5'-nucleotidase	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q969T7	NT5C3B	7-methylguanosine phosphate-specific 5'-nucleotidase	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
Q969T7	NT5C3B	7-methylguanosine phosphate-specific 5'-nucleotidase	GO:0005515; F:protein binding; IPI:IntAct
Q969T7	NT5C3B	7-methylguanosine phosphate-specific 5'-nucleotidase	GO:0009117; P:nucleotide metabolic process; IEA:UniProtKB-KW
P49902	NT5C2	Cytosolic purine 5'-nucleotidase	GO:0008253; F:5'-nucleotidase activity; EXP:Reactome
P49902	NT5C2	Cytosolic purine 5'-nucleotidase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P49902	NT5C2	Cytosolic purine 5'-nucleotidase	GO:0050146; F:nucleoside phosphotransferase activity; TAS:Reactome
P49902	NT5C2	Cytosolic purine 5'-nucleotidase	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
P49902	NT5C2	Cytosolic purine 5'-nucleotidase	GO:0005515; F:protein binding; IPI:IntAct
P49902	NT5C2	Cytosolic purine 5'-nucleotidase	GO:0016311; P:dephosphorylation; EXP:GOC
P49902	NT5C2	Cytosolic purine 5'-nucleotidase	GO:0017144; P:drug metabolic process; TAS:Reactome
P49902	NT5C2	Cytosolic purine 5'-nucleotidase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P49902	NT5C2	Cytosolic purine 5'-nucleotidase	GO:0016310; P:phosphorylation; TAS:GOC
P49902	NT5C2	Cytosolic purine 5'-nucleotidase	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P49902	NT5C2	Cytosolic purine 5'-nucleotidase	GO:0006195; P:purine nucleotide catabolic process; TAS:Reactome
P49902	NT5C2	Cytosolic purine 5'-nucleotidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P21589	NT5E	5'-nucleotidase	GO:0008253; F:5'-nucleotidase activity; EXP:Reactome
P21589	NT5E	5'-nucleotidase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P21589	NT5E	5'-nucleotidase	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
P21589	NT5E	5'-nucleotidase	GO:0046086; P:adenosine biosynthetic process; IEA:Ensembl
P21589	NT5E	5'-nucleotidase	GO:0006196; P:AMP catabolic process; IEA:Ensembl
P21589	NT5E	5'-nucleotidase	GO:0016311; P:dephosphorylation; EXP:GOC
P21589	NT5E	5'-nucleotidase	GO:0006259; P:DNA metabolic process; TAS:ProtInc
P21589	NT5E	5'-nucleotidase	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
P21589	NT5E	5'-nucleotidase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P21589	NT5E	5'-nucleotidase	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P21589	NT5E	5'-nucleotidase	GO:0006195; P:purine nucleotide catabolic process; TAS:Reactome
P21589	NT5E	5'-nucleotidase	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
P21589	NT5E	5'-nucleotidase	GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome
P21589	NT5E	5'-nucleotidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P52209	PGD	6-phosphogluconate dehydrogenase, decarboxylating	GO:0050661; F:NADP binding; IEA:InterPro
P52209	PGD	6-phosphogluconate dehydrogenase, decarboxylating	GO:0004616; F:phosphogluconate dehydrogenase (decarboxylating) activity; ISS:UniProtKB
P52209	PGD	6-phosphogluconate dehydrogenase, decarboxylating	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P52209	PGD	6-phosphogluconate dehydrogenase, decarboxylating	GO:0019521; P:D-gluconate metabolic process; IEA:UniProtKB-KW
P52209	PGD	6-phosphogluconate dehydrogenase, decarboxylating	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
P52209	PGD	6-phosphogluconate dehydrogenase, decarboxylating	GO:0019322; P:pentose biosynthetic process; IEA:Ensembl
P52209	PGD	6-phosphogluconate dehydrogenase, decarboxylating	GO:0006098; P:pentose-phosphate shunt; ISS:UniProtKB
P52209	PGD	6-phosphogluconate dehydrogenase, decarboxylating	GO:0009051; P:pentose-phosphate shunt, oxidative branch; IDA:UniProtKB
P52209	PGD	6-phosphogluconate dehydrogenase, decarboxylating	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95336	PGLS	6-phosphogluconolactonase	GO:0017057; F:6-phosphogluconolactonase activity; IDA:UniProtKB
O95336	PGLS	6-phosphogluconolactonase	GO:0048029; F:monosaccharide binding; IEA:Ensembl
O95336	PGLS	6-phosphogluconolactonase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O95336	PGLS	6-phosphogluconolactonase	GO:0006098; P:pentose-phosphate shunt; IDA:UniProtKB
O95336	PGLS	6-phosphogluconolactonase	GO:0009051; P:pentose-phosphate shunt, oxidative branch; IEA:Ensembl
O95336	PGLS	6-phosphogluconolactonase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P05408	SCG5	Neuroendocrine protein 7B2	GO:0004857; F:enzyme inhibitor activity; ISS:UniProtKB
P05408	SCG5	Neuroendocrine protein 7B2	GO:0005525; F:GTP binding; TAS:ProtInc
P05408	SCG5	Neuroendocrine protein 7B2	GO:0005515; F:protein binding; IPI:UniProtKB
P05408	SCG5	Neuroendocrine protein 7B2	GO:0051082; F:unfolded protein binding; IDA:UniProtKB
P05408	SCG5	Neuroendocrine protein 7B2	GO:0006886; P:intracellular protein transport; ISS:UniProtKB
P05408	SCG5	Neuroendocrine protein 7B2	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
P05408	SCG5	Neuroendocrine protein 7B2	GO:0016486; P:peptide hormone processing; ISS:UniProtKB
P05408	SCG5	Neuroendocrine protein 7B2	GO:0046883; P:regulation of hormone secretion; ISS:UniProtKB
P36639	NUDT1	7,8-dihydro-8-oxoguanine triphosphatase	GO:0035539; F:8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity; IDA:UniProtKB
P36639	NUDT1	7,8-dihydro-8-oxoguanine triphosphatase	GO:0008413; F:8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity; IDA:UniProtKB
P36639	NUDT1	7,8-dihydro-8-oxoguanine triphosphatase	GO:0047693; F:ATP diphosphatase activity; IDA:UniProtKB
P36639	NUDT1	7,8-dihydro-8-oxoguanine triphosphatase	GO:0003924; F:GTPase activity; TAS:ProtInc
P36639	NUDT1	7,8-dihydro-8-oxoguanine triphosphatase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P36639	NUDT1	7,8-dihydro-8-oxoguanine triphosphatase	GO:0030515; F:snoRNA binding; ISS:UniProtKB
P36639	NUDT1	7,8-dihydro-8-oxoguanine triphosphatase	GO:0006200; P:ATP catabolic process; IDA:UniProtKB
P36639	NUDT1	7,8-dihydro-8-oxoguanine triphosphatase	GO:0046061; P:dATP catabolic process; IDA:UniProtKB
P36639	NUDT1	7,8-dihydro-8-oxoguanine triphosphatase	GO:0006203; P:dGTP catabolic process; IDA:UniProtKB
P36639	NUDT1	7,8-dihydro-8-oxoguanine triphosphatase	GO:0042262; P:DNA protection; IDA:UniProtKB
P36639	NUDT1	7,8-dihydro-8-oxoguanine triphosphatase	GO:0006184; P:GTP catabolic process; IDA:UniProtKB
P36639	NUDT1	7,8-dihydro-8-oxoguanine triphosphatase	GO:0006298; P:mismatch repair; IC:UniProtKB
P36639	NUDT1	7,8-dihydro-8-oxoguanine triphosphatase	GO:0034656; P:nucleobase-containing small molecule catabolic process; TAS:Reactome
P36639	NUDT1	7,8-dihydro-8-oxoguanine triphosphatase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P36639	NUDT1	7,8-dihydro-8-oxoguanine triphosphatase	GO:0006195; P:purine nucleotide catabolic process; IDA:UniProtKB
P36639	NUDT1	7,8-dihydro-8-oxoguanine triphosphatase	GO:0006979; P:response to oxidative stress; TAS:ProtInc
P36639	NUDT1	7,8-dihydro-8-oxoguanine triphosphatase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8IZ83	ALDH16A1	Aldehyde dehydrogenase family 16 member A1	GO:0016620; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor; IEA:InterPro
Q676U5	ATG16L1	Autophagy-related protein 16-1	GO:0042802; F:identical protein binding; IPI:IntAct
Q676U5	ATG16L1	Autophagy-related protein 16-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q676U5	ATG16L1	Autophagy-related protein 16-1	GO:0000045; P:autophagic vacuole assembly; NAS:UniProtKB
Q676U5	ATG16L1	Autophagy-related protein 16-1	GO:0051260; P:protein homooligomerization; NAS:UniProtKB
Q676U5	ATG16L1	Autophagy-related protein 16-1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8NAA4	ATG16L2	Autophagy-related protein 16-2	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q8NAA4	ATG16L2	Autophagy-related protein 16-2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P02763	ORM1	Alpha-1-acid glycoprotein 1	GO:0005515; F:protein binding; IPI:IntAct
P02763	ORM1	Alpha-1-acid glycoprotein 1	GO:0006953; P:acute-phase response; TAS:ProtInc
P02763	ORM1	Alpha-1-acid glycoprotein 1	GO:0006954; P:inflammatory response; TAS:ProtInc
P02763	ORM1	Alpha-1-acid glycoprotein 1	GO:0002682; P:regulation of immune system process; IEA:InterPro
P02763	ORM1	Alpha-1-acid glycoprotein 1	GO:0006810; P:transport; IEA:UniProtKB-KW
P19652	ORM2	Alpha-1-acid glycoprotein 2	GO:0006953; P:acute-phase response; TAS:ProtInc
P19652	ORM2	Alpha-1-acid glycoprotein 2	GO:0002682; P:regulation of immune system process; IEA:InterPro
P19652	ORM2	Alpha-1-acid glycoprotein 2	GO:0006810; P:transport; IEA:UniProtKB-KW
P20848	SERPINA2	Putative alpha-1-antitrypsin-related protein	GO:0005515; F:protein binding; IPI:UniProtKB
P20848	SERPINA2	Putative alpha-1-antitrypsin-related protein	GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome
P20848	SERPINA2	Putative alpha-1-antitrypsin-related protein	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P20848	SERPINA2	Putative alpha-1-antitrypsin-related protein	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
P01009	SERPINA1	Alpha-1-antitrypsin	GO:0042802; F:identical protein binding; IPI:IntAct
P01009	SERPINA1	Alpha-1-antitrypsin	GO:0002020; F:protease binding; IPI:UniProtKB
P01009	SERPINA1	Alpha-1-antitrypsin	GO:0005515; F:protein binding; IPI:UniProtKB
P01009	SERPINA1	Alpha-1-antitrypsin	GO:0004867; F:serine-type endopeptidase inhibitor activity; NAS:UniProtKB
P01009	SERPINA1	Alpha-1-antitrypsin	GO:0006953; P:acute-phase response; IEA:UniProtKB-KW
P01009	SERPINA1	Alpha-1-antitrypsin	GO:0007596; P:blood coagulation; TAS:Reactome
P01009	SERPINA1	Alpha-1-antitrypsin	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P01009	SERPINA1	Alpha-1-antitrypsin	GO:0030168; P:platelet activation; TAS:Reactome
P01009	SERPINA1	Alpha-1-antitrypsin	GO:0002576; P:platelet degranulation; TAS:Reactome
P01009	SERPINA1	Alpha-1-antitrypsin	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
P01009	SERPINA1	Alpha-1-antitrypsin	GO:0046687; P:response to chromate; IEA:Ensembl
P01009	SERPINA1	Alpha-1-antitrypsin	GO:0034097; P:response to cytokine; IEA:Ensembl
P01009	SERPINA1	Alpha-1-antitrypsin	GO:0032355; P:response to estradiol; IEA:Ensembl
P01009	SERPINA1	Alpha-1-antitrypsin	GO:0001666; P:response to hypoxia; IEA:Ensembl
P01009	SERPINA1	Alpha-1-antitrypsin	GO:0010288; P:response to lead ion; IEA:Ensembl
P01009	SERPINA1	Alpha-1-antitrypsin	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P01009	SERPINA1	Alpha-1-antitrypsin	GO:0033986; P:response to methanol; IEA:Ensembl
P01009	SERPINA1	Alpha-1-antitrypsin	GO:0034014; P:response to triglyceride; IEA:Ensembl
Q9NQ94	A1CF	APOBEC1 complementation factor	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9NQ94	A1CF	APOBEC1 complementation factor	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NQ94	A1CF	APOBEC1 complementation factor	GO:0003723; F:RNA binding; TAS:ProtInc
Q9NQ94	A1CF	APOBEC1 complementation factor	GO:0003727; F:single-stranded RNA binding; IDA:UniProtKB
Q9NQ94	A1CF	APOBEC1 complementation factor	GO:0016554; P:cytidine to uridine editing; TAS:Reactome
Q9NQ94	A1CF	APOBEC1 complementation factor	GO:0010467; P:gene expression; TAS:Reactome
Q9NQ94	A1CF	APOBEC1 complementation factor	GO:0016556; P:mRNA modification; TAS:Reactome
Q9NQ94	A1CF	APOBEC1 complementation factor	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9NQ94	A1CF	APOBEC1 complementation factor	GO:0050821; P:protein stabilization; IDA:UniProtKB
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0002020; F:protease binding; IPI:UniProtKB
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0005515; F:protein binding; IPI:UniProtKB
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0004867; F:serine-type endopeptidase inhibitor activity; NAS:UniProtKB
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0006953; P:acute-phase response; IEA:UniProtKB-KW
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0007596; P:blood coagulation; TAS:Reactome
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0048514; P:blood vessel morphogenesis; ISS:BHF-UCL
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0030199; P:collagen fibril organization; ISS:BHF-UCL
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0042730; P:fibrinolysis; TAS:Reactome
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0051918; P:negative regulation of fibrinolysis; IDA:BHF-UCL
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0010757; P:negative regulation of plasminogen activation; IDA:BHF-UCL
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0030168; P:platelet activation; TAS:Reactome
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0002576; P:platelet degranulation; TAS:Reactome
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0045597; P:positive regulation of cell differentiation; IDA:BHF-UCL
P08697	SERPINF2	Alpha-2-antiplasmin	GO:2000049; P:positive regulation of cell-cell adhesion mediated by cadherin; TAS:BHF-UCL
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0032967; P:positive regulation of collagen biosynthetic process; IDA:BHF-UCL
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0046330; P:positive regulation of JNK cascade; IDA:BHF-UCL
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0048661; P:positive regulation of smooth muscle cell proliferation; ISS:BHF-UCL
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0051496; P:positive regulation of stress fiber assembly; IDA:BHF-UCL
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0071636; P:positive regulation of transforming growth factor beta production; IDA:BHF-UCL
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0002034; P:regulation of blood vessel size by renin-angiotensin; ISS:BHF-UCL
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
P08697	SERPINF2	Alpha-2-antiplasmin	GO:0010033; P:response to organic substance; IEA:Ensembl
P02750	LRG1	Leucine-rich alpha-2-glycoprotein	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
P01023	A2M	Alpha-2-macroglobulin	GO:0019899; F:enzyme binding; IPI:UniProtKB
P01023	A2M	Alpha-2-macroglobulin	GO:0019838; F:growth factor binding; IDA:UniProtKB
P01023	A2M	Alpha-2-macroglobulin	GO:0019966; F:interleukin-1 binding; IDA:UniProtKB
P01023	A2M	Alpha-2-macroglobulin	GO:0019959; F:interleukin-8 binding; IPI:UniProtKB
P01023	A2M	Alpha-2-macroglobulin	GO:0002020; F:protease binding; IPI:BHF-UCL
P01023	A2M	Alpha-2-macroglobulin	GO:0005515; F:protein binding; IPI:UniProtKB
P01023	A2M	Alpha-2-macroglobulin	GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:UniProtKB
P01023	A2M	Alpha-2-macroglobulin	GO:0043120; F:tumor necrosis factor binding; IDA:UniProtKB
P01023	A2M	Alpha-2-macroglobulin	GO:0007596; P:blood coagulation; TAS:Reactome
P01023	A2M	Alpha-2-macroglobulin	GO:0007597; P:blood coagulation, intrinsic pathway; TAS:Reactome
P01023	A2M	Alpha-2-macroglobulin	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P01023	A2M	Alpha-2-macroglobulin	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P01023	A2M	Alpha-2-macroglobulin	GO:0001869; P:negative regulation of complement activation, lectin pathway; IDA:UniProtKB
P01023	A2M	Alpha-2-macroglobulin	GO:0010951; P:negative regulation of endopeptidase activity; IDA:GOC
P01023	A2M	Alpha-2-macroglobulin	GO:0030168; P:platelet activation; TAS:Reactome
P01023	A2M	Alpha-2-macroglobulin	GO:0002576; P:platelet degranulation; TAS:Reactome
P01023	A2M	Alpha-2-macroglobulin	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P01023	A2M	Alpha-2-macroglobulin	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P01023	A2M	Alpha-2-macroglobulin	GO:0048863; P:stem cell differentiation; IEA:Ensembl
A8K2U0	A2ML1	Alpha-2-macroglobulin-like protein 1	GO:0030414; F:peptidase inhibitor activity; IDA:UniProtKB
A8K2U0	A2ML1	Alpha-2-macroglobulin-like protein 1	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
A8K2U0	A2ML1	Alpha-2-macroglobulin-like protein 1	GO:0052548; P:regulation of endopeptidase activity; IDA:UniProtKB
Q9NPC4	A4GALT	Lactosylceramide 4-alpha-galactosyltransferase	GO:0008378; F:galactosyltransferase activity; IDA:UniProtKB
Q9NPC4	A4GALT	Lactosylceramide 4-alpha-galactosyltransferase	GO:0050512; F:lactosylceramide 4-alpha-galactosyltransferase activity; IEA:UniProtKB-EC
Q9NPC4	A4GALT	Lactosylceramide 4-alpha-galactosyltransferase	GO:0006688; P:glycosphingolipid biosynthetic process; NAS:UniProtKB
Q9NPC4	A4GALT	Lactosylceramide 4-alpha-galactosyltransferase	GO:0007009; P:plasma membrane organization; IDA:MGI
Q9NPC4	A4GALT	Lactosylceramide 4-alpha-galactosyltransferase	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q9UNA3	A4GNT	Alpha-1,4-N-acetylglucosaminyltransferase	GO:0008375; F:acetylglucosaminyltransferase activity; IDA:MGI
Q9UNA3	A4GNT	Alpha-1,4-N-acetylglucosaminyltransferase	GO:0008378; F:galactosyltransferase activity; IEA:InterPro
Q9UNA3	A4GNT	Alpha-1,4-N-acetylglucosaminyltransferase	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
Q9UNA3	A4GNT	Alpha-1,4-N-acetylglucosaminyltransferase	GO:0009101; P:glycoprotein biosynthetic process; IDA:MGI
Q9UNA3	A4GNT	Alpha-1,4-N-acetylglucosaminyltransferase	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
Q9UNA3	A4GNT	Alpha-1,4-N-acetylglucosaminyltransferase	GO:0006493; P:protein O-linked glycosylation; TAS:ProtInc
P05067	APP	Amyloid beta A4 protein	GO:0033130; F:acetylcholine receptor binding; IPI:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0003677; F:DNA binding; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P05067	APP	Amyloid beta A4 protein	GO:0042802; F:identical protein binding; IPI:IntAct
P05067	APP	Amyloid beta A4 protein	GO:0016504; F:peptidase activator activity; IEA:Ensembl
P05067	APP	Amyloid beta A4 protein	GO:0005515; F:protein binding; IPI:IntAct
P05067	APP	Amyloid beta A4 protein	GO:0051425; F:PTB domain binding; IPI:BHF-UCL
P05067	APP	Amyloid beta A4 protein	GO:0005102; F:receptor binding; IPI:BHF-UCL
P05067	APP	Amyloid beta A4 protein	GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0046914; F:transition metal ion binding; IEA:InterPro
P05067	APP	Amyloid beta A4 protein	GO:0008344; P:adult locomotory behavior; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0008088; P:axon cargo transport; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0016199; P:axon midline choice point recognition; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0007409; P:axonogenesis; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0007596; P:blood coagulation; TAS:Reactome
P05067	APP	Amyloid beta A4 protein	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P05067	APP	Amyloid beta A4 protein	GO:0006878; P:cellular copper ion homeostasis; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0008203; P:cholesterol metabolic process; IEA:Ensembl
P05067	APP	Amyloid beta A4 protein	GO:0048669; P:collateral sprouting in absence of injury; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0016358; P:dendrite development; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0006897; P:endocytosis; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0030198; P:extracellular matrix organization; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0030900; P:forebrain development; IEA:Ensembl
P05067	APP	Amyloid beta A4 protein	GO:0045087; P:innate immune response; TAS:Reactome
P05067	APP	Amyloid beta A4 protein	GO:0035235; P:ionotropic glutamate receptor signaling pathway; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0007626; P:locomotory behavior; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0007617; P:mating behavior; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0000085; P:mitotic G2 phase; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0006378; P:mRNA polyadenylation; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0010951; P:negative regulation of endopeptidase activity; IDA:GOC
P05067	APP	Amyloid beta A4 protein	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
P05067	APP	Amyloid beta A4 protein	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
P05067	APP	Amyloid beta A4 protein	GO:0051402; P:neuron apoptotic process; IMP:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0031175; P:neuron projection development; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0016322; P:neuron remodeling; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
P05067	APP	Amyloid beta A4 protein	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
P05067	APP	Amyloid beta A4 protein	GO:0030168; P:platelet activation; TAS:Reactome
P05067	APP	Amyloid beta A4 protein	GO:0002576; P:platelet degranulation; TAS:Reactome
P05067	APP	Amyloid beta A4 protein	GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IEA:Ensembl
P05067	APP	Amyloid beta A4 protein	GO:0045931; P:positive regulation of mitotic cell cycle; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P05067	APP	Amyloid beta A4 protein	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0007176; P:regulation of epidermal growth factor-activated receptor activity; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0040014; P:regulation of multicellular organism growth; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0043393; P:regulation of protein binding; IEA:Ensembl
P05067	APP	Amyloid beta A4 protein	GO:0050803; P:regulation of synapse structure and activity; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0006417; P:regulation of translation; ISS:UniProtKB
P05067	APP	Amyloid beta A4 protein	GO:0006979; P:response to oxidative stress; IEA:Ensembl
P05067	APP	Amyloid beta A4 protein	GO:0051563; P:smooth endoplasmic reticulum calcium ion homeostasis; IEA:Ensembl
P05067	APP	Amyloid beta A4 protein	GO:0001967; P:suckling behavior; IEA:Ensembl
P05067	APP	Amyloid beta A4 protein	GO:0051124; P:synaptic growth at neuromuscular junction; IEA:Ensembl
P05067	APP	Amyloid beta A4 protein	GO:0008542; P:visual learning; ISS:UniProtKB
P30542	ADORA1	Adenosine receptor A1	GO:0001609; F:G-protein coupled adenosine receptor activity; IEA:InterPro
P30542	ADORA1	Adenosine receptor A1	GO:0004629; F:phospholipase C activity; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0005515; F:protein binding; IPI:IntAct
P30542	ADORA1	Adenosine receptor A1	GO:0001883; F:purine nucleoside binding; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0000186; P:activation of MAPKK activity; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0097190; P:apoptotic signaling pathway; TAS:ProtInc
P30542	ADORA1	Adenosine receptor A1	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P30542	ADORA1	Adenosine receptor A1	GO:0050890; P:cognition; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0006954; P:inflammatory response; TAS:ProtInc
P30542	ADORA1	Adenosine receptor A1	GO:0016042; P:lipid catabolic process; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0002674; P:negative regulation of acute inflammatory response; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0055118; P:negative regulation of cardiac muscle contraction; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0042323; P:negative regulation of circadian sleep/wake cycle, non-REM sleep; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0014050; P:negative regulation of glutamate secretion; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0045822; P:negative regulation of heart contraction; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0046888; P:negative regulation of hormone secretion; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0002686; P:negative regulation of leukocyte migration; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0050995; P:negative regulation of lipid catabolic process; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0070256; P:negative regulation of mucus secretion; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0032900; P:negative regulation of neurotrophin production; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0035814; P:negative regulation of renal sodium excretion; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0032229; P:negative regulation of synaptic transmission, GABAergic; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0051967; P:negative regulation of synaptic transmission, glutamatergic; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0045908; P:negative regulation of vasodilation; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0007399; P:nervous system development; TAS:ProtInc
P30542	ADORA1	Adenosine receptor A1	GO:0006909; P:phagocytosis; TAS:ProtInc
P30542	ADORA1	Adenosine receptor A1	GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0045741; P:positive regulation of epidermal growth factor-activated receptor activity; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0032244; P:positive regulation of nucleoside transport; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0002793; P:positive regulation of peptide secretion; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0043268; P:positive regulation of potassium ion transport; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0035307; P:positive regulation of protein dephosphorylation; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0006612; P:protein targeting to membrane; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0003093; P:regulation of glomerular filtration; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0002087; P:regulation of respiratory gaseous exchange by neurological system process; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0060087; P:relaxation of vascular smooth muscle; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0001666; P:response to hypoxia; IEA:Ensembl
P30542	ADORA1	Adenosine receptor A1	GO:0007165; P:signal transduction; TAS:ProtInc
P30542	ADORA1	Adenosine receptor A1	GO:0001659; P:temperature homeostasis; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0019899; F:enzyme binding; IPI:UniProtKB
P29274	ADORA2A	Adenosine receptor A2a	GO:0001609; F:G-protein coupled adenosine receptor activity; IDA:UniProtKB
P29274	ADORA2A	Adenosine receptor A2a	GO:0042802; F:identical protein binding; IPI:IntAct
P29274	ADORA2A	Adenosine receptor A2a	GO:0005515; F:protein binding; IPI:UniProtKB
P29274	ADORA2A	Adenosine receptor A2a	GO:0007190; P:activation of adenylate cyclase activity; TAS:Reactome
P29274	ADORA2A	Adenosine receptor A2a	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; TAS:ProtInc
P29274	ADORA2A	Adenosine receptor A2a	GO:0006915; P:apoptotic process; TAS:ProtInc
P29274	ADORA2A	Adenosine receptor A2a	GO:0048143; P:astrocyte activation; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0008015; P:blood circulation; TAS:ProtInc
P29274	ADORA2A	Adenosine receptor A2a	GO:0007596; P:blood coagulation; TAS:ProtInc
P29274	ADORA2A	Adenosine receptor A2a	GO:0006171; P:cAMP biosynthetic process; TAS:ProtInc
P29274	ADORA2A	Adenosine receptor A2a	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P29274	ADORA2A	Adenosine receptor A2a	GO:0006968; P:cellular defense response; TAS:ProtInc
P29274	ADORA2A	Adenosine receptor A2a	GO:0007417; P:central nervous system development; TAS:ProtInc
P29274	ADORA2A	Adenosine receptor A2a	GO:0042755; P:eating behavior; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0006954; P:inflammatory response; TAS:ProtInc
P29274	ADORA2A	Adenosine receptor A2a	GO:0007626; P:locomotory behavior; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0046636; P:negative regulation of alpha-beta T cell activation; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0040013; P:negative regulation of locomotion; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0043116; P:negative regulation of vascular permeability; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0048812; P:neuron projection morphogenesis; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P29274	ADORA2A	Adenosine receptor A2a	GO:0006909; P:phagocytosis; TAS:ProtInc
P29274	ADORA2A	Adenosine receptor A2a	GO:0014057; P:positive regulation of acetylcholine secretion, neurotransmission; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0010579; P:positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway; IDA:UniProtKB
P29274	ADORA2A	Adenosine receptor A2a	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0045938; P:positive regulation of circadian sleep/wake cycle, sleep; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0014049; P:positive regulation of glutamate secretion; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0050714; P:positive regulation of protein secretion; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0035815; P:positive regulation of renal sodium excretion; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0032230; P:positive regulation of synaptic transmission, GABAergic; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0035810; P:positive regulation of urine volume; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0060134; P:prepulse inhibition; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0051924; P:regulation of calcium ion transport; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0060080; P:regulation of inhibitory postsynaptic membrane potential; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0051881; P:regulation of mitochondrial membrane potential; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0014061; P:regulation of norepinephrine secretion; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0006355; P:regulation of transcription, DNA-templated; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0001975; P:response to amphetamine; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0031000; P:response to caffeine; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0042493; P:response to drug; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0007600; P:sensory perception; TAS:ProtInc
P29274	ADORA2A	Adenosine receptor A2a	GO:0007271; P:synaptic transmission, cholinergic; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0001963; P:synaptic transmission, dopaminergic; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0035249; P:synaptic transmission, glutamatergic; IEA:Ensembl
P29274	ADORA2A	Adenosine receptor A2a	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:Reactome
P29274	ADORA2A	Adenosine receptor A2a	GO:0042311; P:vasodilation; IEA:Ensembl
P29275	ADORA2B	Adenosine receptor A2b	GO:0001609; F:G-protein coupled adenosine receptor activity; IEA:InterPro
P29275	ADORA2B	Adenosine receptor A2b	GO:0007190; P:activation of adenylate cyclase activity; TAS:ProtInc
P29275	ADORA2B	Adenosine receptor A2b	GO:0000187; P:activation of MAPK activity; TAS:ProtInc
P29275	ADORA2B	Adenosine receptor A2b	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P29275	ADORA2B	Adenosine receptor A2b	GO:0006968; P:cellular defense response; TAS:ProtInc
P29275	ADORA2B	Adenosine receptor A2b	GO:0031668; P:cellular response to extracellular stimulus; IEA:Ensembl
P29275	ADORA2B	Adenosine receptor A2b	GO:0007588; P:excretion; TAS:ProtInc
P29275	ADORA2B	Adenosine receptor A2b	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P29275	ADORA2B	Adenosine receptor A2b	GO:0007254; P:JNK cascade; TAS:ProtInc
P29275	ADORA2B	Adenosine receptor A2b	GO:0030828; P:positive regulation of cGMP biosynthetic process; IEA:Ensembl
P29275	ADORA2B	Adenosine receptor A2b	GO:0032722; P:positive regulation of chemokine production; IEA:Ensembl
P29275	ADORA2B	Adenosine receptor A2b	GO:0002882; P:positive regulation of chronic inflammatory response to non-antigenic stimulus; IEA:Ensembl
P29275	ADORA2B	Adenosine receptor A2b	GO:0031284; P:positive regulation of guanylate cyclase activity; IEA:Ensembl
P29275	ADORA2B	Adenosine receptor A2b	GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl
P29275	ADORA2B	Adenosine receptor A2b	GO:0043306; P:positive regulation of mast cell degranulation; IEA:Ensembl
P29275	ADORA2B	Adenosine receptor A2b	GO:0010575; P:positive regulation vascular endothelial growth factor production; IEA:Ensembl
P29275	ADORA2B	Adenosine receptor A2b	GO:0060087; P:relaxation of vascular smooth muscle; IEA:Ensembl
P33765	ADORA3	Adenosine receptor A3	GO:0001609; F:G-protein coupled adenosine receptor activity; IEA:Ensembl
P33765	ADORA3	Adenosine receptor A3	GO:0007190; P:activation of adenylate cyclase activity; TAS:ProtInc
P33765	ADORA3	Adenosine receptor A3	GO:0002553; P:histamine secretion by mast cell; IEA:Ensembl
P33765	ADORA3	Adenosine receptor A3	GO:0006954; P:inflammatory response; TAS:ProtInc
P33765	ADORA3	Adenosine receptor A3	GO:0050850; P:positive regulation of calcium-mediated signaling; IEA:Ensembl
P33765	ADORA3	Adenosine receptor A3	GO:0050729; P:positive regulation of inflammatory response; IEA:Ensembl
P33765	ADORA3	Adenosine receptor A3	GO:0002687; P:positive regulation of leukocyte migration; IEA:Ensembl
P33765	ADORA3	Adenosine receptor A3	GO:0043306; P:positive regulation of mast cell degranulation; IEA:Ensembl
P33765	ADORA3	Adenosine receptor A3	GO:0070257; P:positive regulation of mucus secretion; IEA:Ensembl
P33765	ADORA3	Adenosine receptor A3	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl
P33765	ADORA3	Adenosine receptor A3	GO:0008016; P:regulation of heart contraction; TAS:ProtInc
P33765	ADORA3	Adenosine receptor A3	GO:0009611; P:response to wounding; TAS:ProtInc
P33765	ADORA3	Adenosine receptor A3	GO:0007165; P:signal transduction; TAS:ProtInc
Q9NS82	SLC7A10	Asc-type amino acid transporter 1	GO:0015194; F:L-serine transmembrane transporter activity; TAS:ProtInc
Q9NS82	SLC7A10	Asc-type amino acid transporter 1	GO:0015175; F:neutral amino acid transmembrane transporter activity; IDA:UniProtKB
Q9NS82	SLC7A10	Asc-type amino acid transporter 1	GO:0006865; P:amino acid transport; TAS:Reactome
Q9NS82	SLC7A10	Asc-type amino acid transporter 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q9NS82	SLC7A10	Asc-type amino acid transporter 1	GO:0042941; P:D-alanine transport; IEA:Ensembl
Q9NS82	SLC7A10	Asc-type amino acid transporter 1	GO:0042942; P:D-serine transport; IEA:Ensembl
Q9NS82	SLC7A10	Asc-type amino acid transporter 1	GO:0006811; P:ion transport; TAS:Reactome
Q9NS82	SLC7A10	Asc-type amino acid transporter 1	GO:0015825; P:L-serine transport; TAS:GOC
Q9NS82	SLC7A10	Asc-type amino acid transporter 1	GO:0050900; P:leukocyte migration; TAS:Reactome
Q9NS82	SLC7A10	Asc-type amino acid transporter 1	GO:0015804; P:neutral amino acid transport; IDA:UniProtKB
Q9NS82	SLC7A10	Asc-type amino acid transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P22760	AADAC	Arylacetamide deacetylase	GO:0003824; F:catalytic activity; TAS:ProtInc
P22760	AADAC	Arylacetamide deacetylase	GO:0019213; F:deacetylase activity; IDA:UniProtKB
P22760	AADAC	Arylacetamide deacetylase	GO:0016298; F:lipase activity; TAS:UniProtKB
P22760	AADAC	Arylacetamide deacetylase	GO:0017171; F:serine hydrolase activity; IDA:UniProtKB
P22760	AADAC	Arylacetamide deacetylase	GO:0004806; F:triglyceride lipase activity; ISS:UniProtKB
P22760	AADAC	Arylacetamide deacetylase	GO:0010898; P:positive regulation of triglyceride catabolic process; ISS:UniProtKB
Q9NRG9	AAAS	Aladin	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9NRG9	AAAS	Aladin	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q9NRG9	AAAS	Aladin	GO:0009566; P:fertilization; IEA:Ensembl
Q9NRG9	AAAS	Aladin	GO:0015758; P:glucose transport; TAS:Reactome
Q9NRG9	AAAS	Aladin	GO:0008645; P:hexose transport; TAS:Reactome
Q9NRG9	AAAS	Aladin	GO:0007612; P:learning; IEA:Ensembl
Q9NRG9	AAAS	Aladin	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9NRG9	AAAS	Aladin	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
Q9NRG9	AAAS	Aladin	GO:0006913; P:nucleocytoplasmic transport; IDA:MGI
Q9NRG9	AAAS	Aladin	GO:0010827; P:regulation of glucose transport; TAS:Reactome
Q9NRG9	AAAS	Aladin	GO:0046822; P:regulation of nucleocytoplasmic transport; NAS:UniProtKB
Q9NRG9	AAAS	Aladin	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NRG9	AAAS	Aladin	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9NRG9	AAAS	Aladin	GO:0016032; P:viral process; TAS:Reactome
Q15758	SLC1A5	Neutral amino acid transporter B(0)	GO:0015186; F:L-glutamine transmembrane transporter activity; TAS:BHF-UCL
Q15758	SLC1A5	Neutral amino acid transporter B(0)	GO:0015194; F:L-serine transmembrane transporter activity; IEA:Ensembl
Q15758	SLC1A5	Neutral amino acid transporter B(0)	GO:0015175; F:neutral amino acid transmembrane transporter activity; TAS:ProtInc
Q15758	SLC1A5	Neutral amino acid transporter B(0)	GO:0004872; F:receptor activity; TAS:ProtInc
Q15758	SLC1A5	Neutral amino acid transporter B(0)	GO:0017153; F:sodium:dicarboxylate symporter activity; IEA:InterPro
Q15758	SLC1A5	Neutral amino acid transporter B(0)	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
Q15758	SLC1A5	Neutral amino acid transporter B(0)	GO:0006865; P:amino acid transport; TAS:Reactome
Q15758	SLC1A5	Neutral amino acid transporter B(0)	GO:0006860; P:extracellular amino acid transport; IEA:Ensembl
Q15758	SLC1A5	Neutral amino acid transporter B(0)	GO:0006868; P:glutamine transport; TAS:BHF-UCL
Q15758	SLC1A5	Neutral amino acid transporter B(0)	GO:0006811; P:ion transport; TAS:Reactome
Q15758	SLC1A5	Neutral amino acid transporter B(0)	GO:0015804; P:neutral amino acid transport; TAS:ProtInc
Q15758	SLC1A5	Neutral amino acid transporter B(0)	GO:0055085; P:transmembrane transport; TAS:Reactome
Q86V21	AACS	Acetoacetyl-CoA synthetase	GO:0030729; F:acetoacetate-CoA ligase activity; IEA:UniProtKB-EC
Q86V21	AACS	Acetoacetyl-CoA synthetase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86V21	AACS	Acetoacetyl-CoA synthetase	GO:0047760; F:butyrate-CoA ligase activity; IEA:Ensembl
Q86V21	AACS	Acetoacetyl-CoA synthetase	GO:0060612; P:adipose tissue development; IEA:Ensembl
Q86V21	AACS	Acetoacetyl-CoA synthetase	GO:0071397; P:cellular response to cholesterol; IEA:Ensembl
Q86V21	AACS	Acetoacetyl-CoA synthetase	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
Q86V21	AACS	Acetoacetyl-CoA synthetase	GO:0071394; P:cellular response to testosterone stimulus; IEA:Ensembl
Q86V21	AACS	Acetoacetyl-CoA synthetase	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW
Q86V21	AACS	Acetoacetyl-CoA synthetase	GO:0001889; P:liver development; IEA:Ensembl
Q86V21	AACS	Acetoacetyl-CoA synthetase	GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl
Q86V21	AACS	Acetoacetyl-CoA synthetase	GO:0042493; P:response to drug; IEA:Ensembl
Q86V21	AACS	Acetoacetyl-CoA synthetase	GO:0045471; P:response to ethanol; IEA:Ensembl
Q86V21	AACS	Acetoacetyl-CoA synthetase	GO:0007584; P:response to nutrient; IEA:Ensembl
Q86V21	AACS	Acetoacetyl-CoA synthetase	GO:0034201; P:response to oleic acid; IEA:Ensembl
Q86V21	AACS	Acetoacetyl-CoA synthetase	GO:0014074; P:response to purine-containing compound; IEA:Ensembl
Q86V21	AACS	Acetoacetyl-CoA synthetase	GO:0042594; P:response to starvation; IEA:Ensembl
Q86V21	AACS	Acetoacetyl-CoA synthetase	GO:0050872; P:white fat cell differentiation; IEA:Ensembl
P01011	SERPINA3	Alpha-1-antichymotrypsin	GO:0003677; F:DNA binding; TAS:UniProtKB
P01011	SERPINA3	Alpha-1-antichymotrypsin	GO:0005515; F:protein binding; IPI:UniProtKB
P01011	SERPINA3	Alpha-1-antichymotrypsin	GO:0004867; F:serine-type endopeptidase inhibitor activity; TAS:UniProtKB
P01011	SERPINA3	Alpha-1-antichymotrypsin	GO:0006953; P:acute-phase response; IEA:UniProtKB-KW
P01011	SERPINA3	Alpha-1-antichymotrypsin	GO:0006954; P:inflammatory response; NAS:UniProtKB
P01011	SERPINA3	Alpha-1-antichymotrypsin	GO:0030277; P:maintenance of gastrointestinal epithelium; NAS:UniProtKB
P01011	SERPINA3	Alpha-1-antichymotrypsin	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P01011	SERPINA3	Alpha-1-antichymotrypsin	GO:0019216; P:regulation of lipid metabolic process; NAS:UniProtKB
P01011	SERPINA3	Alpha-1-antichymotrypsin	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
Q8N5Z0	AADAT	Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial	GO:0047536; F:2-aminoadipate transaminase activity; IDA:UniProtKB
Q8N5Z0	AADAT	Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial	GO:0016212; F:kynurenine-oxoglutarate transaminase activity; IDA:UniProtKB
Q8N5Z0	AADAT	Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q8N5Z0	AADAT	Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial	GO:0030170; F:pyridoxal phosphate binding; IEA:Ensembl
Q8N5Z0	AADAT	Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial	GO:0006103; P:2-oxoglutarate metabolic process; IDA:UniProtKB
Q8N5Z0	AADAT	Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial	GO:0009058; P:biosynthetic process; IEA:InterPro
Q8N5Z0	AADAT	Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q8N5Z0	AADAT	Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial	GO:0006536; P:glutamate metabolic process; IDA:UniProtKB
Q8N5Z0	AADAT	Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial	GO:0070189; P:kynurenine metabolic process; IDA:UniProtKB
Q8N5Z0	AADAT	Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial	GO:0097052; P:L-kynurenine metabolic process; IDA:GOC
Q8N5Z0	AADAT	Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial	GO:0033512; P:L-lysine catabolic process to acetyl-CoA via saccharopine; IEA:UniProtKB-UniPathway
Q8N5Z0	AADAT	Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial	GO:0006554; P:lysine catabolic process; TAS:Reactome
Q8N5Z0	AADAT	Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8N5Z0	AADAT	Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial	GO:0006569; P:tryptophan catabolic process; TAS:Reactome
Q8N5Z0	AADAT	Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial	GO:0019441; P:tryptophan catabolic process to kynurenine; IEA:Ensembl
Q6PD74	AAGAB	Alpha- and gamma-adaptin-binding protein p34	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q2M2I8	AAK1	AP2-associated protein kinase 1	GO:0035612; F:AP-2 adaptor complex binding; IDA:UniProtKB
Q2M2I8	AAK1	AP2-associated protein kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q2M2I8	AAK1	AP2-associated protein kinase 1	GO:0005112; F:Notch binding; IDA:UniProtKB
Q2M2I8	AAK1	AP2-associated protein kinase 1	GO:0005515; F:protein binding; IPI:IntAct
Q2M2I8	AAK1	AP2-associated protein kinase 1	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB
Q2M2I8	AAK1	AP2-associated protein kinase 1	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q2M2I8	AAK1	AP2-associated protein kinase 1	GO:0045747; P:positive regulation of Notch signaling pathway; IDA:UniProtKB
Q2M2I8	AAK1	AP2-associated protein kinase 1	GO:0046777; P:protein autophosphorylation; ISS:UniProtKB
Q2M2I8	AAK1	AP2-associated protein kinase 1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q2M2I8	AAK1	AP2-associated protein kinase 1	GO:0050821; P:protein stabilization; IDA:UniProtKB
Q2M2I8	AAK1	AP2-associated protein kinase 1	GO:2000369; P:regulation of clathrin-mediated endocytosis; IDA:UniProtKB
Q2M2I8	AAK1	AP2-associated protein kinase 1	GO:0032880; P:regulation of protein localization; IDA:UniProtKB
Q9Y478	PRKAB1	5'-AMP-activated protein kinase subunit beta-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y478	PRKAB1	5'-AMP-activated protein kinase subunit beta-1	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q9Y478	PRKAB1	5'-AMP-activated protein kinase subunit beta-1	GO:0007050; P:cell cycle arrest; TAS:Reactome
Q9Y478	PRKAB1	5'-AMP-activated protein kinase subunit beta-1	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
Q9Y478	PRKAB1	5'-AMP-activated protein kinase subunit beta-1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q9Y478	PRKAB1	5'-AMP-activated protein kinase subunit beta-1	GO:0061024; P:membrane organization; TAS:Reactome
Q9Y478	PRKAB1	5'-AMP-activated protein kinase subunit beta-1	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
Q9Y478	PRKAB1	5'-AMP-activated protein kinase subunit beta-1	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q9Y478	PRKAB1	5'-AMP-activated protein kinase subunit beta-1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9Y478	PRKAB1	5'-AMP-activated protein kinase subunit beta-1	GO:0050790; P:regulation of catalytic activity; IEA:Ensembl
Q9Y478	PRKAB1	5'-AMP-activated protein kinase subunit beta-1	GO:0007165; P:signal transduction; TAS:ProtInc
O43741	PRKAB2	5'-AMP-activated protein kinase subunit beta-2	GO:0042802; F:identical protein binding; IPI:IntAct
O43741	PRKAB2	5'-AMP-activated protein kinase subunit beta-2	GO:0005515; F:protein binding; IPI:IntAct
O43741	PRKAB2	5'-AMP-activated protein kinase subunit beta-2	GO:0006853; P:carnitine shuttle; TAS:Reactome
O43741	PRKAB2	5'-AMP-activated protein kinase subunit beta-2	GO:0007050; P:cell cycle arrest; TAS:Reactome
O43741	PRKAB2	5'-AMP-activated protein kinase subunit beta-2	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O43741	PRKAB2	5'-AMP-activated protein kinase subunit beta-2	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
O43741	PRKAB2	5'-AMP-activated protein kinase subunit beta-2	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
O43741	PRKAB2	5'-AMP-activated protein kinase subunit beta-2	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
O43741	PRKAB2	5'-AMP-activated protein kinase subunit beta-2	GO:0061024; P:membrane organization; TAS:Reactome
O43741	PRKAB2	5'-AMP-activated protein kinase subunit beta-2	GO:0006468; P:protein phosphorylation; IDA:GOC
O43741	PRKAB2	5'-AMP-activated protein kinase subunit beta-2	GO:0042304; P:regulation of fatty acid biosynthetic process; TAS:Reactome
O43741	PRKAB2	5'-AMP-activated protein kinase subunit beta-2	GO:0007165; P:signal transduction; TAS:ProtInc
O43741	PRKAB2	5'-AMP-activated protein kinase subunit beta-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P54619	PRKAG1	5'-AMP-activated protein kinase subunit gamma-1	GO:0043531; F:ADP binding; ISS:UniProtKB
P54619	PRKAG1	5'-AMP-activated protein kinase subunit gamma-1	GO:0016208; F:AMP binding; ISS:UniProtKB
P54619	PRKAG1	5'-AMP-activated protein kinase subunit gamma-1	GO:0005524; F:ATP binding; ISS:UniProtKB
P54619	PRKAG1	5'-AMP-activated protein kinase subunit gamma-1	GO:0004691; F:cAMP-dependent protein kinase activity; TAS:ProtInc
P54619	PRKAG1	5'-AMP-activated protein kinase subunit gamma-1	GO:0008603; F:cAMP-dependent protein kinase regulator activity; TAS:BHF-UCL
P54619	PRKAG1	5'-AMP-activated protein kinase subunit gamma-1	GO:0005515; F:protein binding; IPI:UniProtKB
P54619	PRKAG1	5'-AMP-activated protein kinase subunit gamma-1	GO:0004672; F:protein kinase activity; IDA:UniProtKB
P54619	PRKAG1	5'-AMP-activated protein kinase subunit gamma-1	GO:0019901; F:protein kinase binding; IDA:BHF-UCL
P54619	PRKAG1	5'-AMP-activated protein kinase subunit gamma-1	GO:0007050; P:cell cycle arrest; TAS:Reactome
P54619	PRKAG1	5'-AMP-activated protein kinase subunit gamma-1	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
P54619	PRKAG1	5'-AMP-activated protein kinase subunit gamma-1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P54619	PRKAG1	5'-AMP-activated protein kinase subunit gamma-1	GO:0061024; P:membrane organization; TAS:Reactome
P54619	PRKAG1	5'-AMP-activated protein kinase subunit gamma-1	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
P54619	PRKAG1	5'-AMP-activated protein kinase subunit gamma-1	GO:0045860; P:positive regulation of protein kinase activity; TAS:BHF-UCL
P54619	PRKAG1	5'-AMP-activated protein kinase subunit gamma-1	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P54619	PRKAG1	5'-AMP-activated protein kinase subunit gamma-1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P54619	PRKAG1	5'-AMP-activated protein kinase subunit gamma-1	GO:0006110; P:regulation of glycolytic process; TAS:BHF-UCL
P54619	PRKAG1	5'-AMP-activated protein kinase subunit gamma-1	GO:0007165; P:signal transduction; TAS:ProtInc
P54619	PRKAG1	5'-AMP-activated protein kinase subunit gamma-1	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0043531; F:ADP binding; IDA:BHF-UCL
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0016208; F:AMP binding; IEA:Ensembl
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0005524; F:ATP binding; IDA:BHF-UCL
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0004862; F:cAMP-dependent protein kinase inhibitor activity; IDA:BHF-UCL
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0008603; F:cAMP-dependent protein kinase regulator activity; IMP:BHF-UCL
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0008607; F:phosphorylase kinase regulator activity; IMP:BHF-UCL
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0030295; F:protein kinase activator activity; IMP:BHF-UCL
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0019901; F:protein kinase binding; IDA:BHF-UCL
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0006754; P:ATP biosynthetic process; TAS:BHF-UCL
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0006853; P:carnitine shuttle; TAS:Reactome
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0007050; P:cell cycle arrest; TAS:Reactome
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0005977; P:glycogen metabolic process; IMP:BHF-UCL
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0035556; P:intracellular signal transduction; IMP:BHF-UCL
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0061024; P:membrane organization; TAS:Reactome
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0006469; P:negative regulation of protein kinase activity; IDA:BHF-UCL
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0071901; P:negative regulation of protein serine/threonine kinase activity; IDA:GOC
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IMP:BHF-UCL
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0045860; P:positive regulation of protein kinase activity; IMP:BHF-UCL
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0042304; P:regulation of fatty acid biosynthetic process; TAS:Reactome
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0019217; P:regulation of fatty acid metabolic process; IMP:BHF-UCL
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0046320; P:regulation of fatty acid oxidation; TAS:BHF-UCL
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0046324; P:regulation of glucose import; TAS:BHF-UCL
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0006110; P:regulation of glycolytic process; IMP:BHF-UCL
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UGJ0	PRKAG2	5'-AMP-activated protein kinase subunit gamma-2	GO:0016126; P:sterol biosynthetic process; TAS:BHF-UCL
Q9UGI9	PRKAG3	5'-AMP-activated protein kinase subunit gamma-3	GO:0004679; F:AMP-activated protein kinase activity; TAS:ProtInc
Q9UGI9	PRKAG3	5'-AMP-activated protein kinase subunit gamma-3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UGI9	PRKAG3	5'-AMP-activated protein kinase subunit gamma-3	GO:0019901; F:protein kinase binding; IDA:BHF-UCL
Q9UGI9	PRKAG3	5'-AMP-activated protein kinase subunit gamma-3	GO:0007050; P:cell cycle arrest; TAS:Reactome
Q9UGI9	PRKAG3	5'-AMP-activated protein kinase subunit gamma-3	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
Q9UGI9	PRKAG3	5'-AMP-activated protein kinase subunit gamma-3	GO:0015758; P:glucose transport; IEA:Ensembl
Q9UGI9	PRKAG3	5'-AMP-activated protein kinase subunit gamma-3	GO:0005978; P:glycogen biosynthetic process; IEA:Ensembl
Q9UGI9	PRKAG3	5'-AMP-activated protein kinase subunit gamma-3	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q9UGI9	PRKAG3	5'-AMP-activated protein kinase subunit gamma-3	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
Q9UGI9	PRKAG3	5'-AMP-activated protein kinase subunit gamma-3	GO:0061024; P:membrane organization; TAS:Reactome
Q9UGI9	PRKAG3	5'-AMP-activated protein kinase subunit gamma-3	GO:0006468; P:protein phosphorylation; TAS:GOC
Q9H7C9	AAMDC	Mth938 domain-containing protein	GO:0043066; P:negative regulation of apoptotic process; IBA:RefGenome
Q9H7C9	AAMDC	Mth938 domain-containing protein	GO:0045600; P:positive regulation of fat cell differentiation; IBA:RefGenome
Q9H7C9	AAMDC	Mth938 domain-containing protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q13685	AAMP	Angio-associated migratory cell protein	GO:0008201; F:heparin binding; TAS:ProtInc
Q13685	AAMP	Angio-associated migratory cell protein	GO:0001525; P:angiogenesis; NAS:UniProtKB
Q13685	AAMP	Angio-associated migratory cell protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q13685	AAMP	Angio-associated migratory cell protein	GO:0010595; P:positive regulation of endothelial cell migration; ISS:UniProtKB
Q13685	AAMP	Angio-associated migratory cell protein	GO:0014909; P:smooth muscle cell migration; IEP:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0050405; F:[acetyl-CoA carboxylase] kinase activity; IEA:UniProtKB-EC
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0047322; F:[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; IEA:UniProtKB-EC
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0004679; F:AMP-activated protein kinase activity; IDA:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0004691; F:cAMP-dependent protein kinase activity; NAS:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0003682; F:chromatin binding; ISS:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0035174; F:histone serine kinase activity; ISS:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0050321; F:tau-protein kinase activity; IEA:UniProtKB-EC
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0000187; P:activation of MAPK activity; NAS:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0007050; P:cell cycle arrest; TAS:Reactome
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0071361; P:cellular response to ethanol; IEA:Ensembl
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0042149; P:cellular response to glucose starvation; ISS:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0031669; P:cellular response to nutrient levels; ISS:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0006695; P:cholesterol biosynthetic process; IEA:UniProtKB-KW
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0009631; P:cold acclimation; IEA:Ensembl
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0055089; P:fatty acid homeostasis; ISS:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0019395; P:fatty acid oxidation; IEA:Ensembl
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0042593; P:glucose homeostasis; ISS:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0006006; P:glucose metabolic process; IEA:Ensembl
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0008610; P:lipid biosynthetic process; ISS:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:2001274; P:negative regulation of glucose import in response to insulin stimulus; IEA:Ensembl
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0046318; P:negative regulation of glucosylceramide biosynthetic process; NAS:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0050995; P:negative regulation of lipid catabolic process; ISS:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0032007; P:negative regulation of TOR signaling; ISS:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0010508; P:positive regulation of autophagy; ISS:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0045542; P:positive regulation of cholesterol biosynthetic process; NAS:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0045821; P:positive regulation of glycolytic process; ISS:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:2000505; P:regulation of energy homeostasis; ISS:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0060627; P:regulation of vesicle-mediated transport; IEA:Ensembl
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0014823; P:response to activity; IEA:Ensembl
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0031000; P:response to caffeine; IEA:Ensembl
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0010332; P:response to gamma radiation; ISS:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0001666; P:response to hypoxia; NAS:UniProtKB
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0048511; P:rhythmic process; IEA:UniProtKB-KW
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0007165; P:signal transduction; TAS:ProtInc
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13131	PRKAA1	5'-AMP-activated protein kinase catalytic subunit alpha-1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0050405; F:[acetyl-CoA carboxylase] kinase activity; IEA:UniProtKB-EC
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0047322; F:[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; IEA:UniProtKB-EC
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0004679; F:AMP-activated protein kinase activity; IDA:UniProtKB
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0003682; F:chromatin binding; ISS:UniProtKB
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0035174; F:histone serine kinase activity; ISS:UniProtKB
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0005515; F:protein binding; IPI:UniProtKB
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0004672; F:protein kinase activity; TAS:ProtInc
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0006914; P:autophagy; IEA:UniProtKB-KW
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0006853; P:carnitine shuttle; TAS:Reactome
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0007050; P:cell cycle arrest; TAS:Reactome
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0042149; P:cellular response to glucose starvation; ISS:UniProtKB
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0031669; P:cellular response to nutrient levels; ISS:UniProtKB
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0006695; P:cholesterol biosynthetic process; IEA:UniProtKB-KW
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0055089; P:fatty acid homeostasis; ISS:UniProtKB
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0042593; P:glucose homeostasis; ISS:UniProtKB
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0008610; P:lipid biosynthetic process; ISS:UniProtKB
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0061024; P:membrane organization; TAS:Reactome
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0032007; P:negative regulation of TOR signaling; ISS:UniProtKB
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0010508; P:positive regulation of autophagy; ISS:UniProtKB
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0045821; P:positive regulation of glycolytic process; ISS:UniProtKB
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:2000505; P:regulation of energy homeostasis; ISS:UniProtKB
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0042304; P:regulation of fatty acid biosynthetic process; TAS:Reactome
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0006950; P:response to stress; ISS:UniProtKB
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0048511; P:rhythmic process; IEA:UniProtKB-KW
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0007165; P:signal transduction; TAS:ProtInc
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P54646	PRKAA2	5'-AMP-activated protein kinase catalytic subunit alpha-2	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q4LEZ3	AARD	Alanine and arginine-rich domain-containing protein	GO:0030324; P:lung development; IEA:Ensembl
Q9BTE6	AARSD1	Alanyl-tRNA editing protein Aarsd1	GO:0004813; F:alanine-tRNA ligase activity; IEA:InterPro
Q9BTE6	AARSD1	Alanyl-tRNA editing protein Aarsd1	GO:0005524; F:ATP binding; IEA:InterPro
Q9BTE6	AARSD1	Alanyl-tRNA editing protein Aarsd1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BTE6	AARSD1	Alanyl-tRNA editing protein Aarsd1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9BTE6	AARSD1	Alanyl-tRNA editing protein Aarsd1	GO:0002196; F:Ser-tRNA(Ala) hydrolase activity; IEA:Ensembl
Q9BTE6	AARSD1	Alanyl-tRNA editing protein Aarsd1	GO:0006419; P:alanyl-tRNA aminoacylation; IEA:InterPro
Q9UDR5	AASS	Alpha-aminoadipic semialdehyde synthase, mitochondrial	GO:0047131; F:saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity; NAS:UniProtKB
Q9UDR5	AASS	Alpha-aminoadipic semialdehyde synthase, mitochondrial	GO:0047130; F:saccharopine dehydrogenase (NADP+, L-lysine-forming) activity; EXP:Reactome
Q9UDR5	AASS	Alpha-aminoadipic semialdehyde synthase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9UDR5	AASS	Alpha-aminoadipic semialdehyde synthase, mitochondrial	GO:0033512; P:L-lysine catabolic process to acetyl-CoA via saccharopine; IEA:UniProtKB-UniPathway
Q9UDR5	AASS	Alpha-aminoadipic semialdehyde synthase, mitochondrial	GO:0006554; P:lysine catabolic process; NAS:UniProtKB
Q9UDR5	AASS	Alpha-aminoadipic semialdehyde synthase, mitochondrial	GO:0051262; P:protein tetramerization; TAS:UniProtKB
Q9UDR5	AASS	Alpha-aminoadipic semialdehyde synthase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8NHS2	GOT1L1	Putative aspartate aminotransferase, cytoplasmic 2	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q8NHS2	GOT1L1	Putative aspartate aminotransferase, cytoplasmic 2	GO:0008483; F:transaminase activity; IEA:UniProtKB-KW
Q8NHS2	GOT1L1	Putative aspartate aminotransferase, cytoplasmic 2	GO:0009058; P:biosynthetic process; IEA:InterPro
Q8NHS2	GOT1L1	Putative aspartate aminotransferase, cytoplasmic 2	GO:0006520; P:cellular amino acid metabolic process; IEA:InterPro
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0031406; F:carboxylic acid binding; IEA:Ensembl
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0004069; F:L-aspartate:2-oxoglutarate aminotransferase activity; IDA:UniProtKB
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0047801; F:L-cysteine:2-oxoglutarate aminotransferase activity; ISS:UniProtKB
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0080130; F:L-phenylalanine:2-oxoglutarate aminotransferase activity; IEA:UniProtKB-EC
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0004609; F:phosphatidylserine decarboxylase activity; IEA:Ensembl
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0008483; F:transaminase activity; TAS:Reactome
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0006103; P:2-oxoglutarate metabolic process; ISS:UniProtKB
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0006532; P:aspartate biosynthetic process; IEA:Ensembl
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0006533; P:aspartate catabolic process; IDA:UniProtKB
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0006531; P:aspartate metabolic process; ISS:UniProtKB
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0032869; P:cellular response to insulin stimulus; IEP:UniProtKB
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0055089; P:fatty acid homeostasis; IEA:Ensembl
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0006094; P:gluconeogenesis; TAS:Reactome
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0006006; P:glucose metabolic process; TAS:Reactome
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0019551; P:glutamate catabolic process to 2-oxoglutarate; IEA:Ensembl
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0019550; P:glutamate catabolic process to aspartate; IEA:Ensembl
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0006536; P:glutamate metabolic process; ISS:UniProtKB
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0006114; P:glycerol biosynthetic process; ISS:UniProtKB
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0019509; P:L-methionine salvage from methylthioadenosine; TAS:Reactome
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0006107; P:oxaloacetate metabolic process; IEA:Ensembl
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0006595; P:polyamine metabolic process; TAS:Reactome
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0051384; P:response to glucocorticoid; IEP:UniProtKB
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
Q9NY61	AATF	Protein AATF	GO:0043522; F:leucine zipper domain binding; IPI:UniProtKB
Q9NY61	AATF	Protein AATF	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NY61	AATF	Protein AATF	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NY61	AATF	Protein AATF	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9NY61	AATF	Protein AATF	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q9NY61	AATF	Protein AATF	GO:0007155; P:cell adhesion; IEA:Ensembl
Q9NY61	AATF	Protein AATF	GO:0006974; P:cellular response to DNA damage stimulus; IEP:UniProtKB
Q9NY61	AATF	Protein AATF	GO:0040016; P:embryonic cleavage; IEA:Ensembl
Q9NY61	AATF	Protein AATF	GO:0042985; P:negative regulation of amyloid precursor protein biosynthetic process; IEA:Ensembl
Q9NY61	AATF	Protein AATF	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q9NY61	AATF	Protein AATF	GO:2000378; P:negative regulation of reactive oxygen species metabolic process; IDA:UniProtKB
Q9NY61	AATF	Protein AATF	GO:0032929; P:negative regulation of superoxide anion generation; IDA:UniProtKB
Q9NY61	AATF	Protein AATF	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9NY61	AATF	Protein AATF	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q9NY61	AATF	Protein AATF	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9NY61	AATF	Protein AATF	GO:0007346; P:regulation of mitotic cell cycle; IEA:Ensembl
Q9NY61	AATF	Protein AATF	GO:0042254; P:ribosome biogenesis; IEA:Ensembl
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0016212; F:kynurenine-oxoglutarate transaminase activity; IEA:UniProtKB-EC
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0004069; F:L-aspartate:2-oxoglutarate aminotransferase activity; IEA:UniProtKB-EC
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0080130; F:L-phenylalanine:2-oxoglutarate aminotransferase activity; IEA:UniProtKB-EC
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0006103; P:2-oxoglutarate metabolic process; ISS:UniProtKB
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0019470; P:4-hydroxyproline catabolic process; TAS:BHF-UCL
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0006532; P:aspartate biosynthetic process; IEA:Ensembl
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0006533; P:aspartate catabolic process; IDA:UniProtKB
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0006531; P:aspartate metabolic process; ISS:UniProtKB
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0009058; P:biosynthetic process; IEA:InterPro
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0006520; P:cellular amino acid metabolic process; IEA:InterPro
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0015908; P:fatty acid transport; IEP:UniProtKB
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0006094; P:gluconeogenesis; TAS:Reactome
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0006006; P:glucose metabolic process; TAS:Reactome
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0019551; P:glutamate catabolic process to 2-oxoglutarate; IEA:Ensembl
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0019550; P:glutamate catabolic process to aspartate; IEA:Ensembl
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0006536; P:glutamate metabolic process; ISS:UniProtKB
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0006107; P:oxaloacetate metabolic process; IEA:Ensembl
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0045471; P:response to ethanol; IDA:UniProtKB
P00505	GOT2	Aspartate aminotransferase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q7Z5M8	ABHD12B	Abhydrolase domain-containing protein 12B	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q96GS6	ABHD17A	Alpha/beta hydrolase domain-containing protein 17A	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q96GS6	ABHD17A	Alpha/beta hydrolase domain-containing protein 17A	GO:0005515; F:protein binding; IPI:IntAct
Q5VST6	ABHD17B	Alpha/beta hydrolase domain-containing protein 17B	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q6PCB6	ABHD17C	Alpha/beta hydrolase domain-containing protein 17C	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q7Z5R6	APBB1IP	Amyloid beta A4 precursor protein-binding family B member 1-interacting protein	GO:0007596; P:blood coagulation; TAS:Reactome
Q7Z5R6	APBB1IP	Amyloid beta A4 precursor protein-binding family B member 1-interacting protein	GO:0030168; P:platelet activation; TAS:Reactome
Q7Z5R6	APBB1IP	Amyloid beta A4 precursor protein-binding family B member 1-interacting protein	GO:0007165; P:signal transduction; IEA:InterPro
P31941	APOBEC3A	DNA dC->dU-editing enzyme APOBEC-3A	GO:0004126; F:cytidine deaminase activity; IDA:UniProtKB
P31941	APOBEC3A	DNA dC->dU-editing enzyme APOBEC-3A	GO:0047844; F:deoxycytidine deaminase activity; IMP:UniProtKB
P31941	APOBEC3A	DNA dC->dU-editing enzyme APOBEC-3A	GO:0005515; F:protein binding; IPI:UniProtKB
P31941	APOBEC3A	DNA dC->dU-editing enzyme APOBEC-3A	GO:0008270; F:zinc ion binding; IEA:InterPro
P31941	APOBEC3A	DNA dC->dU-editing enzyme APOBEC-3A	GO:0071466; P:cellular response to xenobiotic stimulus; IDA:UniProtKB
P31941	APOBEC3A	DNA dC->dU-editing enzyme APOBEC-3A	GO:0044356; P:clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine; IDA:UniProtKB
P31941	APOBEC3A	DNA dC->dU-editing enzyme APOBEC-3A	GO:0009972; P:cytidine deamination; IDA:GOC
P31941	APOBEC3A	DNA dC->dU-editing enzyme APOBEC-3A	GO:0051607; P:defense response to virus; IDA:UniProtKB
P31941	APOBEC3A	DNA dC->dU-editing enzyme APOBEC-3A	GO:0070383; P:DNA cytosine deamination; IDA:UniProtKB
P31941	APOBEC3A	DNA dC->dU-editing enzyme APOBEC-3A	GO:0080111; P:DNA demethylation; IDA:UniProtKB
P31941	APOBEC3A	DNA dC->dU-editing enzyme APOBEC-3A	GO:0045087; P:innate immune response; IDA:UniProtKB
P31941	APOBEC3A	DNA dC->dU-editing enzyme APOBEC-3A	GO:0010529; P:negative regulation of transposition; IDA:UniProtKB
P31941	APOBEC3A	DNA dC->dU-editing enzyme APOBEC-3A	GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB
Q9UH17	APOBEC3B	DNA dC->dU-editing enzyme APOBEC-3B	GO:0047844; F:deoxycytidine deaminase activity; IMP:UniProtKB
Q9UH17	APOBEC3B	DNA dC->dU-editing enzyme APOBEC-3B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UH17	APOBEC3B	DNA dC->dU-editing enzyme APOBEC-3B	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UH17	APOBEC3B	DNA dC->dU-editing enzyme APOBEC-3B	GO:0051607; P:defense response to virus; IDA:UniProtKB
Q9UH17	APOBEC3B	DNA dC->dU-editing enzyme APOBEC-3B	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q9UH17	APOBEC3B	DNA dC->dU-editing enzyme APOBEC-3B	GO:0008152; P:metabolic process; IMP:GOC
Q9UH17	APOBEC3B	DNA dC->dU-editing enzyme APOBEC-3B	GO:0010529; P:negative regulation of transposition; IDA:UniProtKB
Q9NRW3	APOBEC3C	DNA dC->dU-editing enzyme APOBEC-3C	GO:0016814; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines; IEA:InterPro
Q9NRW3	APOBEC3C	DNA dC->dU-editing enzyme APOBEC-3C	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NRW3	APOBEC3C	DNA dC->dU-editing enzyme APOBEC-3C	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NRW3	APOBEC3C	DNA dC->dU-editing enzyme APOBEC-3C	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NRW3	APOBEC3C	DNA dC->dU-editing enzyme APOBEC-3C	GO:0009972; P:cytidine deamination; IDA:UniProtKB
Q9NRW3	APOBEC3C	DNA dC->dU-editing enzyme APOBEC-3C	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q9NRW3	APOBEC3C	DNA dC->dU-editing enzyme APOBEC-3C	GO:0080111; P:DNA demethylation; IDA:UniProtKB
Q9NRW3	APOBEC3C	DNA dC->dU-editing enzyme APOBEC-3C	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q9NRW3	APOBEC3C	DNA dC->dU-editing enzyme APOBEC-3C	GO:0010529; P:negative regulation of transposition; IDA:UniProtKB
Q9NRW3	APOBEC3C	DNA dC->dU-editing enzyme APOBEC-3C	GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB
Q9NRW3	APOBEC3C	DNA dC->dU-editing enzyme APOBEC-3C	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q96AK3	APOBEC3D	DNA dC->dU-editing enzyme APOBEC-3D	GO:0016814; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines; IEA:InterPro
Q96AK3	APOBEC3D	DNA dC->dU-editing enzyme APOBEC-3D	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96AK3	APOBEC3D	DNA dC->dU-editing enzyme APOBEC-3D	GO:0051607; P:defense response to virus; IDA:UniProtKB
Q96AK3	APOBEC3D	DNA dC->dU-editing enzyme APOBEC-3D	GO:0070383; P:DNA cytosine deamination; IDA:UniProtKB
Q96AK3	APOBEC3D	DNA dC->dU-editing enzyme APOBEC-3D	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q96AK3	APOBEC3D	DNA dC->dU-editing enzyme APOBEC-3D	GO:0045869; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; IDA:UniProtKB
Q96AK3	APOBEC3D	DNA dC->dU-editing enzyme APOBEC-3D	GO:0010529; P:negative regulation of transposition; IDA:UniProtKB
Q8IUX4	APOBEC3F	DNA dC->dU-editing enzyme APOBEC-3F	GO:0004126; F:cytidine deaminase activity; IDA:HGNC
Q8IUX4	APOBEC3F	DNA dC->dU-editing enzyme APOBEC-3F	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IUX4	APOBEC3F	DNA dC->dU-editing enzyme APOBEC-3F	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IUX4	APOBEC3F	DNA dC->dU-editing enzyme APOBEC-3F	GO:0003723; F:RNA binding; IDA:HGNC
Q8IUX4	APOBEC3F	DNA dC->dU-editing enzyme APOBEC-3F	GO:0008270; F:zinc ion binding; IDA:HGNC
Q8IUX4	APOBEC3F	DNA dC->dU-editing enzyme APOBEC-3F	GO:0016553; P:base conversion or substitution editing; IDA:HGNC
Q8IUX4	APOBEC3F	DNA dC->dU-editing enzyme APOBEC-3F	GO:0009972; P:cytidine deamination; IDA:GOC
Q8IUX4	APOBEC3F	DNA dC->dU-editing enzyme APOBEC-3F	GO:0051607; P:defense response to virus; IDA:UniProtKB
Q8IUX4	APOBEC3F	DNA dC->dU-editing enzyme APOBEC-3F	GO:0070383; P:DNA cytosine deamination; IDA:UniProtKB
Q8IUX4	APOBEC3F	DNA dC->dU-editing enzyme APOBEC-3F	GO:0080111; P:DNA demethylation; IDA:UniProtKB
Q8IUX4	APOBEC3F	DNA dC->dU-editing enzyme APOBEC-3F	GO:0045087; P:innate immune response; IDA:HGNC
Q8IUX4	APOBEC3F	DNA dC->dU-editing enzyme APOBEC-3F	GO:0045869; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; IDA:UniProtKB
Q8IUX4	APOBEC3F	DNA dC->dU-editing enzyme APOBEC-3F	GO:0010529; P:negative regulation of transposition; IDA:UniProtKB
Q8IUX4	APOBEC3F	DNA dC->dU-editing enzyme APOBEC-3F	GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB
Q8IUX4	APOBEC3F	DNA dC->dU-editing enzyme APOBEC-3F	GO:0048525; P:negative regulation of viral process; IDA:HGNC
Q8IUX4	APOBEC3F	DNA dC->dU-editing enzyme APOBEC-3F	GO:0002230; P:positive regulation of defense response to virus by host; IDA:HGNC
Q9HC16	APOBEC3G	DNA dC->dU-editing enzyme APOBEC-3G	GO:0004126; F:cytidine deaminase activity; TAS:HGNC
Q9HC16	APOBEC3G	DNA dC->dU-editing enzyme APOBEC-3G	GO:0047844; F:deoxycytidine deaminase activity; IDA:UniProtKB
Q9HC16	APOBEC3G	DNA dC->dU-editing enzyme APOBEC-3G	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HC16	APOBEC3G	DNA dC->dU-editing enzyme APOBEC-3G	GO:0042803; F:protein homodimerization activity; NAS:UniProtKB
Q9HC16	APOBEC3G	DNA dC->dU-editing enzyme APOBEC-3G	GO:0003723; F:RNA binding; IDA:UniProtKB
Q9HC16	APOBEC3G	DNA dC->dU-editing enzyme APOBEC-3G	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q9HC16	APOBEC3G	DNA dC->dU-editing enzyme APOBEC-3G	GO:0016553; P:base conversion or substitution editing; TAS:HGNC
Q9HC16	APOBEC3G	DNA dC->dU-editing enzyme APOBEC-3G	GO:0009972; P:cytidine deamination; IDA:UniProtKB
Q9HC16	APOBEC3G	DNA dC->dU-editing enzyme APOBEC-3G	GO:0051607; P:defense response to virus; IDA:UniProtKB
Q9HC16	APOBEC3G	DNA dC->dU-editing enzyme APOBEC-3G	GO:0070383; P:DNA cytosine deamination; IDA:UniProtKB
Q9HC16	APOBEC3G	DNA dC->dU-editing enzyme APOBEC-3G	GO:0045087; P:innate immune response; IDA:HGNC
Q9HC16	APOBEC3G	DNA dC->dU-editing enzyme APOBEC-3G	GO:0045869; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; IDA:UniProtKB
Q9HC16	APOBEC3G	DNA dC->dU-editing enzyme APOBEC-3G	GO:0010529; P:negative regulation of transposition; IDA:UniProtKB
Q9HC16	APOBEC3G	DNA dC->dU-editing enzyme APOBEC-3G	GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB
Q9HC16	APOBEC3G	DNA dC->dU-editing enzyme APOBEC-3G	GO:0048525; P:negative regulation of viral process; IDA:HGNC
Q9HC16	APOBEC3G	DNA dC->dU-editing enzyme APOBEC-3G	GO:0002230; P:positive regulation of defense response to virus by host; IDA:HGNC
Q9HC16	APOBEC3G	DNA dC->dU-editing enzyme APOBEC-3G	GO:0016032; P:viral process; TAS:Reactome
Q6NTF7	APOBEC3H	DNA dC->dU-editing enzyme APOBEC-3H	GO:0004126; F:cytidine deaminase activity; IDA:UniProtKB
Q6NTF7	APOBEC3H	DNA dC->dU-editing enzyme APOBEC-3H	GO:0005515; F:protein binding; IPI:UniProtKB
Q6NTF7	APOBEC3H	DNA dC->dU-editing enzyme APOBEC-3H	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6NTF7	APOBEC3H	DNA dC->dU-editing enzyme APOBEC-3H	GO:0009972; P:cytidine deamination; IDA:GOC
Q6NTF7	APOBEC3H	DNA dC->dU-editing enzyme APOBEC-3H	GO:0051607; P:defense response to virus; IDA:UniProtKB
Q6NTF7	APOBEC3H	DNA dC->dU-editing enzyme APOBEC-3H	GO:0070383; P:DNA cytosine deamination; IDA:UniProtKB
Q6NTF7	APOBEC3H	DNA dC->dU-editing enzyme APOBEC-3H	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q6NTF7	APOBEC3H	DNA dC->dU-editing enzyme APOBEC-3H	GO:0045869; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; IDA:UniProtKB
Q6NTF7	APOBEC3H	DNA dC->dU-editing enzyme APOBEC-3H	GO:0010529; P:negative regulation of transposition; IDA:UniProtKB
Q6NTF7	APOBEC3H	DNA dC->dU-editing enzyme APOBEC-3H	GO:0048525; P:negative regulation of viral process; IMP:UniProtKB
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0008509; F:anion transmembrane transporter activity; ISS:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0034186; F:apolipoprotein A-I binding; IPI:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0034188; F:apolipoprotein A-I receptor activity; IDA:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0034185; F:apolipoprotein binding; IPI:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0005524; F:ATP binding; IDA:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0016887; F:ATPase activity; IEA:InterPro
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0015485; F:cholesterol binding; IC:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0017127; F:cholesterol transporter activity; IDA:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0005543; F:phospholipid binding; IC:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0005548; F:phospholipid transporter activity; IDA:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0005515; F:protein binding; IPI:IntAct
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0031267; F:small GTPase binding; IPI:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0019905; F:syntaxin binding; IPI:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0038027; P:apolipoprotein A-I-mediated signaling pathway; IDA:GOC
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0071397; P:cellular response to cholesterol; IEA:Ensembl
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0033344; P:cholesterol efflux; IDA:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0042632; P:cholesterol homeostasis; IDA:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0008203; P:cholesterol metabolic process; IDA:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0016197; P:endosomal transport; IDA:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0007186; P:G-protein coupled receptor signaling pathway; IMP:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0034380; P:high-density lipoprotein particle assembly; IMP:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0050702; P:interleukin-1 beta secretion; IMP:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0032367; P:intracellular cholesterol transport; IMP:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0007040; P:lysosome organization; IDA:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0010887; P:negative regulation of cholesterol storage; TAS:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; TAS:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0002790; P:peptide secretion; IEA:Ensembl
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0006911; P:phagocytosis, engulfment; IEA:Ensembl
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0033700; P:phospholipid efflux; IDA:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0055091; P:phospholipid homeostasis; IMP:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0045332; P:phospholipid translocation; IEA:Ensembl
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0060155; P:platelet dense granule organization; IMP:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0030819; P:positive regulation of cAMP biosynthetic process; IMP:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0010875; P:positive regulation of cholesterol efflux; IEA:Ensembl
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0006497; P:protein lipidation; IEA:Ensembl
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0032489; P:regulation of Cdc42 protein signal transduction; IMP:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0042493; P:response to drug; IEA:Ensembl
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0034616; P:response to laminar fluid shear stress; IEP:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0055098; P:response to low-density lipoprotein particle; IEP:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0007584; P:response to nutrient; IEA:Ensembl
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0043691; P:reverse cholesterol transport; IMP:BHF-UCL
O95477	ABCA1	ATP-binding cassette sub-family A member 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BZC7	ABCA2	ATP-binding cassette sub-family A member 2	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9BZC7	ABCA2	ATP-binding cassette sub-family A member 2	GO:0016887; F:ATPase activity; IDA:UniProtKB
Q9BZC7	ABCA2	ATP-binding cassette sub-family A member 2	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; NAS:UniProtKB
Q9BZC7	ABCA2	ATP-binding cassette sub-family A member 2	GO:0006200; P:ATP catabolic process; IDA:GOC
Q9BZC7	ABCA2	ATP-binding cassette sub-family A member 2	GO:0042632; P:cholesterol homeostasis; IEP:UniProtKB
Q9BZC7	ABCA2	ATP-binding cassette sub-family A member 2	GO:0006629; P:lipid metabolic process; NAS:UniProtKB
Q9BZC7	ABCA2	ATP-binding cassette sub-family A member 2	GO:0032383; P:regulation of intracellular cholesterol transport; IMP:UniProtKB
Q9BZC7	ABCA2	ATP-binding cassette sub-family A member 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9BZC7	ABCA2	ATP-binding cassette sub-family A member 2	GO:0042493; P:response to drug; TAS:UniProtKB
Q9BZC7	ABCA2	ATP-binding cassette sub-family A member 2	GO:0048545; P:response to steroid hormone; IEP:UniProtKB
Q9BZC7	ABCA2	ATP-binding cassette sub-family A member 2	GO:0055085; P:transmembrane transport; NAS:GOC
Q9BZC7	ABCA2	ATP-binding cassette sub-family A member 2	GO:0006810; P:transport; NAS:UniProtKB
Q99758	ABCA3	ATP-binding cassette sub-family A member 3	GO:0005524; F:ATP binding; TAS:ProtInc
Q99758	ABCA3	ATP-binding cassette sub-family A member 3	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; TAS:ProtInc
Q99758	ABCA3	ATP-binding cassette sub-family A member 3	GO:0005215; F:transporter activity; TAS:ProtInc
Q99758	ABCA3	ATP-binding cassette sub-family A member 3	GO:0042493; P:response to drug; TAS:ProtInc
Q99758	ABCA3	ATP-binding cassette sub-family A member 3	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
Q99758	ABCA3	ATP-binding cassette sub-family A member 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q99758	ABCA3	ATP-binding cassette sub-family A member 3	GO:0006810; P:transport; IDA:MGI
P78363	ABCA4	Retinal-specific ATP-binding cassette transporter	GO:0005524; F:ATP binding; TAS:ProtInc
P78363	ABCA4	Retinal-specific ATP-binding cassette transporter	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; TAS:ProtInc
P78363	ABCA4	Retinal-specific ATP-binding cassette transporter	GO:0004012; F:phospholipid-translocating ATPase activity; IEA:Ensembl
P78363	ABCA4	Retinal-specific ATP-binding cassette transporter	GO:0005215; F:transporter activity; TAS:ProtInc
P78363	ABCA4	Retinal-specific ATP-binding cassette transporter	GO:0006649; P:phospholipid transfer to membrane; IEA:Ensembl
P78363	ABCA4	Retinal-specific ATP-binding cassette transporter	GO:0045494; P:photoreceptor cell maintenance; IEA:Ensembl
P78363	ABCA4	Retinal-specific ATP-binding cassette transporter	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P78363	ABCA4	Retinal-specific ATP-binding cassette transporter	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P78363	ABCA4	Retinal-specific ATP-binding cassette transporter	GO:0055085; P:transmembrane transport; TAS:Reactome
P78363	ABCA4	Retinal-specific ATP-binding cassette transporter	GO:0006810; P:transport; TAS:ProtInc
P78363	ABCA4	Retinal-specific ATP-binding cassette transporter	GO:0007601; P:visual perception; TAS:ProtInc
Q8WWZ7	ABCA5	ATP-binding cassette sub-family A member 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8WWZ7	ABCA5	ATP-binding cassette sub-family A member 5	GO:0016887; F:ATPase activity; IEA:InterPro
Q8WWZ7	ABCA5	ATP-binding cassette sub-family A member 5	GO:0033344; P:cholesterol efflux; ISS:BHF-UCL
Q8WWZ7	ABCA5	ATP-binding cassette sub-family A member 5	GO:0034375; P:high-density lipoprotein particle remodeling; ISS:BHF-UCL
Q8WWZ7	ABCA5	ATP-binding cassette sub-family A member 5	GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; ISS:BHF-UCL
Q8WWZ7	ABCA5	ATP-binding cassette sub-family A member 5	GO:0043691; P:reverse cholesterol transport; IC:BHF-UCL
Q8N139	ABCA6	ATP-binding cassette sub-family A member 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8N139	ABCA6	ATP-binding cassette sub-family A member 6	GO:0016887; F:ATPase activity; IEA:InterPro
Q8N139	ABCA6	ATP-binding cassette sub-family A member 6	GO:0006810; P:transport; IEA:UniProtKB-KW
Q8IZY2	ABCA7	ATP-binding cassette sub-family A member 7	GO:0034188; F:apolipoprotein A-I receptor activity; IDA:Alzheimers_University_of_Toronto
Q8IZY2	ABCA7	ATP-binding cassette sub-family A member 7	GO:0005524; F:ATP binding; TAS:ProtInc
Q8IZY2	ABCA7	ATP-binding cassette sub-family A member 7	GO:0016887; F:ATPase activity; IEA:InterPro
Q8IZY2	ABCA7	ATP-binding cassette sub-family A member 7	GO:0005548; F:phospholipid transporter activity; IEA:Ensembl
Q8IZY2	ABCA7	ATP-binding cassette sub-family A member 7	GO:0005215; F:transporter activity; TAS:ProtInc
Q8IZY2	ABCA7	ATP-binding cassette sub-family A member 7	GO:0038027; P:apolipoprotein A-I-mediated signaling pathway; IDA:Alzheimers_University_of_Toronto
Q8IZY2	ABCA7	ATP-binding cassette sub-family A member 7	GO:0006200; P:ATP catabolic process; IDA:GOC
Q8IZY2	ABCA7	ATP-binding cassette sub-family A member 7	GO:0033344; P:cholesterol efflux; IDA:Alzheimers_University_of_Toronto
Q8IZY2	ABCA7	ATP-binding cassette sub-family A member 7	GO:0034380; P:high-density lipoprotein particle assembly; IDA:Alzheimers_University_of_Toronto
Q8IZY2	ABCA7	ATP-binding cassette sub-family A member 7	GO:0032780; P:negative regulation of ATPase activity; IDA:Alzheimers_University_of_Toronto
Q8IZY2	ABCA7	ATP-binding cassette sub-family A member 7	GO:0006909; P:phagocytosis; IEA:UniProtKB-KW
Q8IZY2	ABCA7	ATP-binding cassette sub-family A member 7	GO:0033700; P:phospholipid efflux; IDA:Alzheimers_University_of_Toronto
Q8IZY2	ABCA7	ATP-binding cassette sub-family A member 7	GO:0017121; P:phospholipid scrambling; IDA:Alzheimers_University_of_Toronto
Q8IZY2	ABCA7	ATP-binding cassette sub-family A member 7	GO:0032781; P:positive regulation of ATPase activity; IDA:Alzheimers_University_of_Toronto
Q8IZY2	ABCA7	ATP-binding cassette sub-family A member 7	GO:0055085; P:transmembrane transport; TAS:Reactome
O94911	ABCA8	ATP-binding cassette sub-family A member 8	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O94911	ABCA8	ATP-binding cassette sub-family A member 8	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IDA:MGI
O94911	ABCA8	ATP-binding cassette sub-family A member 8	GO:0055085; P:transmembrane transport; TAS:Reactome
O94911	ABCA8	ATP-binding cassette sub-family A member 8	GO:0006810; P:transport; IDA:MGI
Q8IUA7	ABCA9	ATP-binding cassette sub-family A member 9	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IUA7	ABCA9	ATP-binding cassette sub-family A member 9	GO:0016887; F:ATPase activity; IEA:InterPro
Q8IUA7	ABCA9	ATP-binding cassette sub-family A member 9	GO:0006810; P:transport; IEA:UniProtKB-KW
Q8WWZ4	ABCA10	ATP-binding cassette sub-family A member 10	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8WWZ4	ABCA10	ATP-binding cassette sub-family A member 10	GO:0016887; F:ATPase activity; IEA:InterPro
Q8WWZ4	ABCA10	ATP-binding cassette sub-family A member 10	GO:0006810; P:transport; IEA:UniProtKB-KW
Q4W5N1	ABCA11P	Putative ATP-binding cassette sub-family A member 11	GO:0005524; F:ATP binding; IEA:InterPro
Q4W5N1	ABCA11P	Putative ATP-binding cassette sub-family A member 11	GO:0016887; F:ATPase activity; IEA:InterPro
Q86UK0	ABCA12	ATP-binding cassette sub-family A member 12	GO:0005524; F:ATP binding; NAS:UniProtKB
Q86UK0	ABCA12	ATP-binding cassette sub-family A member 12	GO:0016887; F:ATPase activity; IEA:InterPro
Q86UK0	ABCA12	ATP-binding cassette sub-family A member 12	GO:0019725; P:cellular homeostasis; NAS:UniProtKB
Q86UK0	ABCA12	ATP-binding cassette sub-family A member 12	GO:0035627; P:ceramide transport; IEA:Ensembl
Q86UK0	ABCA12	ATP-binding cassette sub-family A member 12	GO:0061436; P:establishment of skin barrier; IEA:Ensembl
Q86UK0	ABCA12	ATP-binding cassette sub-family A member 12	GO:0031424; P:keratinization; IEA:Ensembl
Q86UK0	ABCA12	ATP-binding cassette sub-family A member 12	GO:0055088; P:lipid homeostasis; IEA:Ensembl
Q86UK0	ABCA12	ATP-binding cassette sub-family A member 12	GO:0006869; P:lipid transport; NAS:UniProtKB
Q86UK0	ABCA12	ATP-binding cassette sub-family A member 12	GO:0048286; P:lung alveolus development; IEA:Ensembl
Q86UK0	ABCA12	ATP-binding cassette sub-family A member 12	GO:0043129; P:surfactant homeostasis; IEA:Ensembl
Q86UQ4	ABCA13	ATP-binding cassette sub-family A member 13	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86UQ4	ABCA13	ATP-binding cassette sub-family A member 13	GO:0016887; F:ATPase activity; IEA:InterPro
Q86UQ4	ABCA13	ATP-binding cassette sub-family A member 13	GO:0006810; P:transport; IEA:UniProtKB-KW
Q2M3G0	ABCB5	ATP-binding cassette sub-family B member 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q2M3G0	ABCB5	ATP-binding cassette sub-family B member 5	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IBA:RefGenome
Q2M3G0	ABCB5	ATP-binding cassette sub-family B member 5	GO:0015562; F:efflux transmembrane transporter activity; IDA:UniProtKB
Q2M3G0	ABCB5	ATP-binding cassette sub-family B member 5	GO:0042391; P:regulation of membrane potential; IDA:UniProtKB
Q2M3G0	ABCB5	ATP-binding cassette sub-family B member 5	GO:0055085; P:transmembrane transport; IDA:UniProtKB
Q9NP58	ABCB6	ATP-binding cassette sub-family B member 6, mitochondrial	GO:0005524; F:ATP binding; IDA:MGI
Q9NP58	ABCB6	ATP-binding cassette sub-family B member 6, mitochondrial	GO:0015562; F:efflux transmembrane transporter activity; IDA:UniProtKB
Q9NP58	ABCB6	ATP-binding cassette sub-family B member 6, mitochondrial	GO:0020037; F:heme binding; IDA:UniProtKB
Q9NP58	ABCB6	ATP-binding cassette sub-family B member 6, mitochondrial	GO:0015232; F:heme transporter activity; TAS:Reactome
Q9NP58	ABCB6	ATP-binding cassette sub-family B member 6, mitochondrial	GO:0015439; F:heme-transporting ATPase activity; IMP:UniProtKB
Q9NP58	ABCB6	ATP-binding cassette sub-family B member 6, mitochondrial	GO:0007420; P:brain development; IMP:UniProtKB
Q9NP58	ABCB6	ATP-binding cassette sub-family B member 6, mitochondrial	GO:0070574; P:cadmium ion transmembrane transport; IBA:RefGenome
Q9NP58	ABCB6	ATP-binding cassette sub-family B member 6, mitochondrial	GO:0006879; P:cellular iron ion homeostasis; NAS:UniProtKB
Q9NP58	ABCB6	ATP-binding cassette sub-family B member 6, mitochondrial	GO:0071585; P:detoxification of cadmium ion; IBA:RefGenome
Q9NP58	ABCB6	ATP-binding cassette sub-family B member 6, mitochondrial	GO:0015886; P:heme transport; IDA:UniProtKB
Q9NP58	ABCB6	ATP-binding cassette sub-family B member 6, mitochondrial	GO:0006779; P:porphyrin-containing compound biosynthetic process; IDA:UniProtKB
Q9NP58	ABCB6	ATP-binding cassette sub-family B member 6, mitochondrial	GO:0043588; P:skin development; IMP:UniProtKB
Q9NP58	ABCB6	ATP-binding cassette sub-family B member 6, mitochondrial	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9NP58	ABCB6	ATP-binding cassette sub-family B member 6, mitochondrial	GO:0006810; P:transport; IDA:MGI
O75027	ABCB7	ATP-binding cassette sub-family B member 7, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75027	ABCB7	ATP-binding cassette sub-family B member 7, mitochondrial	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IEA:InterPro
O75027	ABCB7	ATP-binding cassette sub-family B member 7, mitochondrial	GO:0015232; F:heme transporter activity; TAS:ProtInc
O75027	ABCB7	ATP-binding cassette sub-family B member 7, mitochondrial	GO:0006879; P:cellular iron ion homeostasis; IBA:RefGenome
O75027	ABCB7	ATP-binding cassette sub-family B member 7, mitochondrial	GO:0015886; P:heme transport; TAS:GOC
O75027	ABCB7	ATP-binding cassette sub-family B member 7, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75027	ABCB7	ATP-binding cassette sub-family B member 7, mitochondrial	GO:0055085; P:transmembrane transport; IBA:RefGenome
O75027	ABCB7	ATP-binding cassette sub-family B member 7, mitochondrial	GO:0006810; P:transport; TAS:ProtInc
Q9NUT2	ABCB8	ATP-binding cassette sub-family B member 8, mitochondrial	GO:0005524; F:ATP binding; TAS:ProtInc
Q9NUT2	ABCB8	ATP-binding cassette sub-family B member 8, mitochondrial	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IBA:RefGenome
Q9NUT2	ABCB8	ATP-binding cassette sub-family B member 8, mitochondrial	GO:0005215; F:transporter activity; TAS:ProtInc
Q9NUT2	ABCB8	ATP-binding cassette sub-family B member 8, mitochondrial	GO:0055085; P:transmembrane transport; IBA:RefGenome
Q9NUT2	ABCB8	ATP-binding cassette sub-family B member 8, mitochondrial	GO:0006810; P:transport; TAS:ProtInc
Q9NP78	ABCB9	ATP-binding cassette sub-family B member 9	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9NP78	ABCB9	ATP-binding cassette sub-family B member 9	GO:0042288; F:MHC class I protein binding; IBA:RefGenome
Q9NP78	ABCB9	ATP-binding cassette sub-family B member 9	GO:0015421; F:oligopeptide-transporting ATPase activity; IBA:RefGenome
Q9NP78	ABCB9	ATP-binding cassette sub-family B member 9	GO:0042605; F:peptide antigen binding; IBA:RefGenome
Q9NP78	ABCB9	ATP-binding cassette sub-family B member 9	GO:0015440; F:peptide-transporting ATPase activity; IDA:UniProtKB
Q9NP78	ABCB9	ATP-binding cassette sub-family B member 9	GO:0005515; F:protein binding; IPI:UniProt
Q9NP78	ABCB9	ATP-binding cassette sub-family B member 9	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q9NP78	ABCB9	ATP-binding cassette sub-family B member 9	GO:0022891; F:substrate-specific transmembrane transporter activity; IDA:UniProtKB
Q9NP78	ABCB9	ATP-binding cassette sub-family B member 9	GO:0046978; F:TAP1 binding; IBA:RefGenome
Q9NP78	ABCB9	ATP-binding cassette sub-family B member 9	GO:0046979; F:TAP2 binding; IBA:RefGenome
Q9NP78	ABCB9	ATP-binding cassette sub-family B member 9	GO:0046980; F:tapasin binding; IBA:RefGenome
Q9NP78	ABCB9	ATP-binding cassette sub-family B member 9	GO:0035672; P:oligopeptide transmembrane transport; IBA:GOC
Q9NP78	ABCB9	ATP-binding cassette sub-family B member 9	GO:0015833; P:peptide transport; IDA:UniProtKB
Q9NP78	ABCB9	ATP-binding cassette sub-family B member 9	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IBA:RefGenome
Q9NP78	ABCB9	ATP-binding cassette sub-family B member 9	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9NP78	ABCB9	ATP-binding cassette sub-family B member 9	GO:0055085; P:transmembrane transport; IBA:RefGenome
Q9NRK6	ABCB10	ATP-binding cassette sub-family B member 10, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NRK6	ABCB10	ATP-binding cassette sub-family B member 10, mitochondrial	GO:0015421; F:oligopeptide-transporting ATPase activity; IBA:RefGenome
Q9NRK6	ABCB10	ATP-binding cassette sub-family B member 10, mitochondrial	GO:0005215; F:transporter activity; NAS:UniProtKB
Q9NRK6	ABCB10	ATP-binding cassette sub-family B member 10, mitochondrial	GO:0035672; P:oligopeptide transmembrane transport; IBA:GOC
Q9NRK6	ABCB10	ATP-binding cassette sub-family B member 10, mitochondrial	GO:0055085; P:transmembrane transport; IBA:RefGenome
Q9NRK6	ABCB10	ATP-binding cassette sub-family B member 10, mitochondrial	GO:0006810; P:transport; NAS:UniProtKB
O95342	ABCB11	Bile salt export pump	GO:0005524; F:ATP binding; TAS:ProtInc
O95342	ABCB11	Bile salt export pump	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IBA:RefGenome
O95342	ABCB11	Bile salt export pump	GO:0015432; F:bile acid-exporting ATPase activity; TAS:ProtInc
O95342	ABCB11	Bile salt export pump	GO:0015126; F:canalicular bile acid transmembrane transporter activity; IBA:RefGenome
O95342	ABCB11	Bile salt export pump	GO:0008554; F:sodium-exporting ATPase activity, phosphorylative mechanism; TAS:ProtInc
O95342	ABCB11	Bile salt export pump	GO:0005215; F:transporter activity; TAS:ProtInc
O95342	ABCB11	Bile salt export pump	GO:0015721; P:bile acid and bile salt transport; TAS:Reactome
O95342	ABCB11	Bile salt export pump	GO:0006699; P:bile acid biosynthetic process; TAS:Reactome
O95342	ABCB11	Bile salt export pump	GO:0008206; P:bile acid metabolic process; TAS:Reactome
O95342	ABCB11	Bile salt export pump	GO:0015722; P:canalicular bile acid transport; IBA:RefGenome
O95342	ABCB11	Bile salt export pump	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95342	ABCB11	Bile salt export pump	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
O95342	ABCB11	Bile salt export pump	GO:0055085; P:transmembrane transport; IBA:RefGenome
O95342	ABCB11	Bile salt export pump	GO:0006810; P:transport; TAS:ProtInc
Q09428	ABCC8	ATP-binding cassette sub-family C member 8	GO:0005524; F:ATP binding; TAS:ProtInc
Q09428	ABCC8	ATP-binding cassette sub-family C member 8	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IEA:InterPro
Q09428	ABCC8	ATP-binding cassette sub-family C member 8	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q09428	ABCC8	ATP-binding cassette sub-family C member 8	GO:0015079; F:potassium ion transmembrane transporter activity; TAS:ProtInc
Q09428	ABCC8	ATP-binding cassette sub-family C member 8	GO:0008281; F:sulfonylurea receptor activity; TAS:ProtInc
Q09428	ABCC8	ATP-binding cassette sub-family C member 8	GO:0005975; P:carbohydrate metabolic process; NAS:ProtInc
Q09428	ABCC8	ATP-binding cassette sub-family C member 8	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q09428	ABCC8	ATP-binding cassette sub-family C member 8	GO:0071805; P:potassium ion transmembrane transport; TAS:GOC
Q09428	ABCC8	ATP-binding cassette sub-family C member 8	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q09428	ABCC8	ATP-binding cassette sub-family C member 8	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
Q09428	ABCC8	ATP-binding cassette sub-family C member 8	GO:0007165; P:signal transduction; TAS:GOC
Q09428	ABCC8	ATP-binding cassette sub-family C member 8	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q09428	ABCC8	ATP-binding cassette sub-family C member 8	GO:0007268; P:synaptic transmission; TAS:Reactome
Q09428	ABCC8	ATP-binding cassette sub-family C member 8	GO:0055085; P:transmembrane transport; TAS:Reactome
O60706	ABCC9	ATP-binding cassette sub-family C member 9	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O60706	ABCC9	ATP-binding cassette sub-family C member 9	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IEA:InterPro
O60706	ABCC9	ATP-binding cassette sub-family C member 9	GO:0044325; F:ion channel binding; IPI:BHF-UCL
O60706	ABCC9	ATP-binding cassette sub-family C member 9	GO:0005267; F:potassium channel activity; IEA:Ensembl
O60706	ABCC9	ATP-binding cassette sub-family C member 9	GO:0015459; F:potassium channel regulator activity; ISS:BHF-UCL
O60706	ABCC9	ATP-binding cassette sub-family C member 9	GO:0008281; F:sulfonylurea receptor activity; ISS:BHF-UCL
O60706	ABCC9	ATP-binding cassette sub-family C member 9	GO:0005215; F:transporter activity; TAS:ProtInc
O60706	ABCC9	ATP-binding cassette sub-family C member 9	GO:0051607; P:defense response to virus; IMP:MGI
O60706	ABCC9	ATP-binding cassette sub-family C member 9	GO:0010107; P:potassium ion import; ISS:BHF-UCL
O60706	ABCC9	ATP-binding cassette sub-family C member 9	GO:0006813; P:potassium ion transport; TAS:ProtInc
O60706	ABCC9	ATP-binding cassette sub-family C member 9	GO:0007165; P:signal transduction; ISS:GOC
O60706	ABCC9	ATP-binding cassette sub-family C member 9	GO:0007268; P:synaptic transmission; TAS:Reactome
O60706	ABCC9	ATP-binding cassette sub-family C member 9	GO:0055085; P:transmembrane transport; TAS:Reactome
Q96J66	ABCC11	ATP-binding cassette sub-family C member 11	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96J66	ABCC11	ATP-binding cassette sub-family C member 11	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IEA:InterPro
Q96J66	ABCC11	ATP-binding cassette sub-family C member 11	GO:0008514; F:organic anion transmembrane transporter activity; IDA:UniProt
Q96J66	ABCC11	ATP-binding cassette sub-family C member 11	GO:0015216; F:purine nucleotide transmembrane transporter activity; IDA:UniProt
Q96J66	ABCC11	ATP-binding cassette sub-family C member 11	GO:0015711; P:organic anion transport; IDA:UniProt
Q96J66	ABCC11	ATP-binding cassette sub-family C member 11	GO:0015865; P:purine nucleotide transport; IDA:UniProt
Q96J66	ABCC11	ATP-binding cassette sub-family C member 11	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9NSE7	ABCC13	Putative ATP-binding cassette sub-family C member 13	GO:0005524; F:ATP binding; IEA:InterPro
Q9NSE7	ABCC13	Putative ATP-binding cassette sub-family C member 13	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IEA:InterPro
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0005524; F:ATP binding; IDA:UniProtKB
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0016887; F:ATPase activity; IDA:UniProtKB
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; NAS:UniProtKB
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0019899; F:enzyme binding; IPI:UniProtKB
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0042802; F:identical protein binding; IPI:IntAct
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0005325; F:peroxisomal fatty-acyl-CoA transporter activity; IGI:UniProtKB
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0005515; F:protein binding; IPI:UniProtKB
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0005215; F:transporter activity; NAS:UniProtKB
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0036109; P:alpha-linolenic acid metabolic process; TAS:Reactome
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0006200; P:ATP catabolic process; IDA:GOC
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0006635; P:fatty acid beta-oxidation; IDA:UniProtKB
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0033540; P:fatty acid beta-oxidation using acyl-CoA oxidase; TAS:Reactome
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0043651; P:linoleic acid metabolic process; TAS:Reactome
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0042758; P:long-chain fatty acid catabolic process; IGI:UniProtKB
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0015910; P:peroxisomal long-chain fatty acid import; IGI:UniProtKB
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0015919; P:peroxisomal membrane transport; NAS:UniProtKB
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0007031; P:peroxisome organization; IDA:UniProtKB
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0033559; P:unsaturated fatty acid metabolic process; TAS:Reactome
P33897	ABCD1	ATP-binding cassette sub-family D member 1	GO:0042760; P:very long-chain fatty acid catabolic process; IDA:UniProtKB
Q9NUQ8	ABCF3	ATP-binding cassette sub-family F member 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NUQ8	ABCF3	ATP-binding cassette sub-family F member 3	GO:0016887; F:ATPase activity; IEA:InterPro
Q9NUQ8	ABCF3	ATP-binding cassette sub-family F member 3	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
O14678	ABCD4	ATP-binding cassette sub-family D member 4	GO:0005524; F:ATP binding; NAS:UniProtKB
O14678	ABCD4	ATP-binding cassette sub-family D member 4	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; NAS:UniProtKB
O14678	ABCD4	ATP-binding cassette sub-family D member 4	GO:0009235; P:cobalamin metabolic process; IMP:UniProtKB
O14678	ABCD4	ATP-binding cassette sub-family D member 4	GO:0055085; P:transmembrane transport; NAS:UniProtKB
Q9UBJ2	ABCD2	ATP-binding cassette sub-family D member 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UBJ2	ABCD2	ATP-binding cassette sub-family D member 2	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IEA:InterPro
Q9UBJ2	ABCD2	ATP-binding cassette sub-family D member 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBJ2	ABCD2	ATP-binding cassette sub-family D member 2	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q9UBJ2	ABCD2	ATP-binding cassette sub-family D member 2	GO:0006635; P:fatty acid beta-oxidation; IGI:UniProtKB
Q9UBJ2	ABCD2	ATP-binding cassette sub-family D member 2	GO:0032000; P:positive regulation of fatty acid beta-oxidation; IDA:UniProtKB
Q9UBJ2	ABCD2	ATP-binding cassette sub-family D member 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UBJ2	ABCD2	ATP-binding cassette sub-family D member 2	GO:0042760; P:very long-chain fatty acid catabolic process; IGI:UniProtKB
Q9UBJ2	ABCD2	ATP-binding cassette sub-family D member 2	GO:0000038; P:very long-chain fatty acid metabolic process; IDA:UniProtKB
P28288	ABCD3	ATP-binding cassette sub-family D member 3	GO:0005524; F:ATP binding; IDA:UniProtKB
P28288	ABCD3	ATP-binding cassette sub-family D member 3	GO:0016887; F:ATPase activity; IDA:UniProtKB
P28288	ABCD3	ATP-binding cassette sub-family D member 3	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IEA:InterPro
P28288	ABCD3	ATP-binding cassette sub-family D member 3	GO:0005515; F:protein binding; IPI:UniProtKB
P28288	ABCD3	ATP-binding cassette sub-family D member 3	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P28288	ABCD3	ATP-binding cassette sub-family D member 3	GO:0006200; P:ATP catabolic process; IDA:GOC
P28288	ABCD3	ATP-binding cassette sub-family D member 3	GO:0006635; P:fatty acid beta-oxidation; IGI:UniProtKB
P28288	ABCD3	ATP-binding cassette sub-family D member 3	GO:0007031; P:peroxisome organization; IDA:UniProtKB
P28288	ABCD3	ATP-binding cassette sub-family D member 3	GO:0055085; P:transmembrane transport; TAS:Reactome
P28288	ABCD3	ATP-binding cassette sub-family D member 3	GO:0042760; P:very long-chain fatty acid catabolic process; IGI:UniProtKB
Q8NE71	ABCF1	ATP-binding cassette sub-family F member 1	GO:0005524; F:ATP binding; IDA:UniProtKB
Q8NE71	ABCF1	ATP-binding cassette sub-family F member 1	GO:0016887; F:ATPase activity; IEA:InterPro
Q8NE71	ABCF1	ATP-binding cassette sub-family F member 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8NE71	ABCF1	ATP-binding cassette sub-family F member 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NE71	ABCF1	ATP-binding cassette sub-family F member 1	GO:0043022; F:ribosome binding; IDA:UniProtKB
Q8NE71	ABCF1	ATP-binding cassette sub-family F member 1	GO:0008494; F:translation activator activity; IDA:UniProtKB
Q8NE71	ABCF1	ATP-binding cassette sub-family F member 1	GO:0008135; F:translation factor activity, nucleic acid binding; TAS:ProtInc
Q8NE71	ABCF1	ATP-binding cassette sub-family F member 1	GO:0006954; P:inflammatory response; TAS:ProtInc
Q8NE71	ABCF1	ATP-binding cassette sub-family F member 1	GO:0045727; P:positive regulation of translation; IDA:UniProtKB
Q8NE71	ABCF1	ATP-binding cassette sub-family F member 1	GO:0006412; P:translation; TAS:ProtInc
Q8NE71	ABCF1	ATP-binding cassette sub-family F member 1	GO:0006413; P:translational initiation; IMP:UniProtKB
P61221	ABCE1	ATP-binding cassette sub-family E member 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P61221	ABCE1	ATP-binding cassette sub-family E member 1	GO:0016887; F:ATPase activity; IEA:InterPro
P61221	ABCE1	ATP-binding cassette sub-family E member 1	GO:0051536; F:iron-sulfur cluster binding; IEA:InterPro
P61221	ABCE1	ATP-binding cassette sub-family E member 1	GO:0008428; F:ribonuclease inhibitor activity; TAS:ProtInc
P61221	ABCE1	ATP-binding cassette sub-family E member 1	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
P61221	ABCE1	ATP-binding cassette sub-family E member 1	GO:0009615; P:response to virus; TAS:ProtInc
P61221	ABCE1	ATP-binding cassette sub-family E member 1	GO:0006401; P:RNA catabolic process; TAS:ProtInc
P61221	ABCE1	ATP-binding cassette sub-family E member 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9UG63	ABCF2	ATP-binding cassette sub-family F member 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UG63	ABCF2	ATP-binding cassette sub-family F member 2	GO:0016887; F:ATPase activity; IEA:InterPro
Q9UG63	ABCF2	ATP-binding cassette sub-family F member 2	GO:0005215; F:transporter activity; TAS:ProtInc
Q9UG63	ABCF2	ATP-binding cassette sub-family F member 2	GO:0006810; P:transport; TAS:ProtInc
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0043531; F:ADP binding; IDA:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0005524; F:ATP binding; IDA:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0015485; F:cholesterol binding; IC:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0017127; F:cholesterol transporter activity; IDA:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0034437; F:glycoprotein transporter activity; IDA:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0005543; F:phospholipid binding; IC:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0005548; F:phospholipid transporter activity; IDA:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0005515; F:protein binding; IPI:IntAct
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0046983; F:protein dimerization activity; NAS:UniProtKB
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0034041; F:sterol-transporting ATPase activity; IDA:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0019534; F:toxin transporter activity; IDA:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0042987; P:amyloid precursor protein catabolic process; IDA:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0033344; P:cholesterol efflux; IDA:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0042632; P:cholesterol homeostasis; IDA:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0008203; P:cholesterol metabolic process; IDA:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0009720; P:detection of hormone stimulus; NAS:UniProtKB
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0034436; P:glycoprotein transport; IDA:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0034375; P:high-density lipoprotein particle remodeling; ISS:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0032367; P:intracellular cholesterol transport; IMP:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0034374; P:low-density lipoprotein particle remodeling; ISS:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0010887; P:negative regulation of cholesterol storage; TAS:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; TAS:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0033700; P:phospholipid efflux; IMP:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0055091; P:phospholipid homeostasis; IMP:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0045542; P:positive regulation of cholesterol biosynthetic process; ISS:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0010875; P:positive regulation of cholesterol efflux; IEA:Ensembl
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0010872; P:regulation of cholesterol esterification; ISS:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0006355; P:regulation of transcription, DNA-templated; ISS:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0055099; P:response to high density lipoprotein particle; IEA:Ensembl
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0033993; P:response to lipid; IDA:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0010033; P:response to organic substance; IDA:UniProtKB
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0043691; P:reverse cholesterol transport; ISS:BHF-UCL
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:1901998; P:toxin transport; IDA:GOC
P45844	ABCG1	ATP-binding cassette sub-family G member 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UNQ0	ABCG2	ATP-binding cassette sub-family G member 2	GO:0005524; F:ATP binding; TAS:ProtInc
Q9UNQ0	ABCG2	ATP-binding cassette sub-family G member 2	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; TAS:ProtInc
Q9UNQ0	ABCG2	ATP-binding cassette sub-family G member 2	GO:0015232; F:heme transporter activity; TAS:Reactome
Q9UNQ0	ABCG2	ATP-binding cassette sub-family G member 2	GO:0005515; F:protein binding; IPI:IntAct
Q9UNQ0	ABCG2	ATP-binding cassette sub-family G member 2	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
Q9UNQ0	ABCG2	ATP-binding cassette sub-family G member 2	GO:0005215; F:transporter activity; TAS:ProtInc
Q9UNQ0	ABCG2	ATP-binding cassette sub-family G member 2	GO:0008559; F:xenobiotic-transporting ATPase activity; TAS:ProtInc
Q9UNQ0	ABCG2	ATP-binding cassette sub-family G member 2	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
Q9UNQ0	ABCG2	ATP-binding cassette sub-family G member 2	GO:0006855; P:drug transmembrane transport; TAS:Reactome
Q9UNQ0	ABCG2	ATP-binding cassette sub-family G member 2	GO:0015886; P:heme transport; TAS:GOC
Q9UNQ0	ABCG2	ATP-binding cassette sub-family G member 2	GO:0042493; P:response to drug; TAS:ProtInc
Q9UNQ0	ABCG2	ATP-binding cassette sub-family G member 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UNQ0	ABCG2	ATP-binding cassette sub-family G member 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UNQ0	ABCG2	ATP-binding cassette sub-family G member 2	GO:0006810; P:transport; TAS:ProtInc
Q9UNQ0	ABCG2	ATP-binding cassette sub-family G member 2	GO:0046415; P:urate metabolic process; IMP:UniProtKB
Q9UNQ0	ABCG2	ATP-binding cassette sub-family G member 2	GO:0042908; P:xenobiotic transport; TAS:GOC
Q9H172	ABCG4	ATP-binding cassette sub-family G member 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H172	ABCG4	ATP-binding cassette sub-family G member 4	GO:0016887; F:ATPase activity; IEA:InterPro
Q9H172	ABCG4	ATP-binding cassette sub-family G member 4	GO:0017127; F:cholesterol transporter activity; TAS:Reactome
Q9H172	ABCG4	ATP-binding cassette sub-family G member 4	GO:0005515; F:protein binding; IPI:IntAct
Q9H172	ABCG4	ATP-binding cassette sub-family G member 4	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
Q9H172	ABCG4	ATP-binding cassette sub-family G member 4	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
Q9H172	ABCG4	ATP-binding cassette sub-family G member 4	GO:0033344; P:cholesterol efflux; TAS:BHF-UCL
Q9H172	ABCG4	ATP-binding cassette sub-family G member 4	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9H222	ABCG5	ATP-binding cassette sub-family G member 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H222	ABCG5	ATP-binding cassette sub-family G member 5	GO:0016887; F:ATPase activity; IEA:InterPro
Q9H222	ABCG5	ATP-binding cassette sub-family G member 5	GO:0017127; F:cholesterol transporter activity; IEA:Ensembl
Q9H222	ABCG5	ATP-binding cassette sub-family G member 5	GO:0005515; F:protein binding; IPI:IntAct
Q9H222	ABCG5	ATP-binding cassette sub-family G member 5	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
Q9H222	ABCG5	ATP-binding cassette sub-family G member 5	GO:0006200; P:ATP catabolic process; IDA:GOC
Q9H222	ABCG5	ATP-binding cassette sub-family G member 5	GO:0033344; P:cholesterol efflux; IGI:BHF-UCL
Q9H222	ABCG5	ATP-binding cassette sub-family G member 5	GO:0042632; P:cholesterol homeostasis; IMP:BHF-UCL
Q9H222	ABCG5	ATP-binding cassette sub-family G member 5	GO:0007588; P:excretion; IGI:BHF-UCL
Q9H222	ABCG5	ATP-binding cassette sub-family G member 5	GO:0030299; P:intestinal cholesterol absorption; IC:BHF-UCL
Q9H222	ABCG5	ATP-binding cassette sub-family G member 5	GO:0045796; P:negative regulation of intestinal cholesterol absorption; IMP:BHF-UCL
Q9H222	ABCG5	ATP-binding cassette sub-family G member 5	GO:0010949; P:negative regulation of intestinal phytosterol absorption; IMP:BHF-UCL
Q9H222	ABCG5	ATP-binding cassette sub-family G member 5	GO:0042493; P:response to drug; IEA:Ensembl
Q9H222	ABCG5	ATP-binding cassette sub-family G member 5	GO:0010212; P:response to ionizing radiation; IEA:Ensembl
Q9H222	ABCG5	ATP-binding cassette sub-family G member 5	GO:0007584; P:response to nutrient; IEA:Ensembl
Q9H222	ABCG5	ATP-binding cassette sub-family G member 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H222	ABCG5	ATP-binding cassette sub-family G member 5	GO:0015918; P:sterol transport; TAS:Reactome
Q9H222	ABCG5	ATP-binding cassette sub-family G member 5	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9H221	ABCG8	ATP-binding cassette sub-family G member 8	GO:0005524; F:ATP binding; IEA:InterPro
Q9H221	ABCG8	ATP-binding cassette sub-family G member 8	GO:0016887; F:ATPase activity; IEA:InterPro
Q9H221	ABCG8	ATP-binding cassette sub-family G member 8	GO:0005515; F:protein binding; IPI:IntAct
Q9H221	ABCG8	ATP-binding cassette sub-family G member 8	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
Q9H221	ABCG8	ATP-binding cassette sub-family G member 8	GO:0015248; F:sterol transporter activity; IEA:Ensembl
Q9H221	ABCG8	ATP-binding cassette sub-family G member 8	GO:0006200; P:ATP catabolic process; IDA:GOC
Q9H221	ABCG8	ATP-binding cassette sub-family G member 8	GO:0033344; P:cholesterol efflux; IGI:BHF-UCL
Q9H221	ABCG8	ATP-binding cassette sub-family G member 8	GO:0042632; P:cholesterol homeostasis; IMP:BHF-UCL
Q9H221	ABCG8	ATP-binding cassette sub-family G member 8	GO:0007588; P:excretion; IGI:BHF-UCL
Q9H221	ABCG8	ATP-binding cassette sub-family G member 8	GO:0030299; P:intestinal cholesterol absorption; IC:BHF-UCL
Q9H221	ABCG8	ATP-binding cassette sub-family G member 8	GO:0045796; P:negative regulation of intestinal cholesterol absorption; IMP:BHF-UCL
Q9H221	ABCG8	ATP-binding cassette sub-family G member 8	GO:0010949; P:negative regulation of intestinal phytosterol absorption; IMP:BHF-UCL
Q9H221	ABCG8	ATP-binding cassette sub-family G member 8	GO:0015914; P:phospholipid transport; IEA:Ensembl
Q9H221	ABCG8	ATP-binding cassette sub-family G member 8	GO:0042493; P:response to drug; IEA:Ensembl
Q9H221	ABCG8	ATP-binding cassette sub-family G member 8	GO:0007584; P:response to nutrient; IEA:Ensembl
Q9H221	ABCG8	ATP-binding cassette sub-family G member 8	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H221	ABCG8	ATP-binding cassette sub-family G member 8	GO:0015918; P:sterol transport; TAS:Reactome
Q9H221	ABCG8	ATP-binding cassette sub-family G member 8	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8N2K0	ABHD12	Monoacylglycerol lipase ABHD12	GO:0047372; F:acylglycerol lipase activity; IEA:UniProtKB-EC
Q8N2K0	ABHD12	Monoacylglycerol lipase ABHD12	GO:0007628; P:adult walking behavior; IEA:Ensembl
Q8N2K0	ABHD12	Monoacylglycerol lipase ABHD12	GO:0006660; P:phosphatidylserine catabolic process; IEA:Ensembl
Q8N2K0	ABHD12	Monoacylglycerol lipase ABHD12	GO:0010996; P:response to auditory stimulus; IEA:Ensembl
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0017091; F:AU-rich element binding; IEA:Ensembl
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0004126; F:cytidine deaminase activity; TAS:ProtInc
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0005515; F:protein binding; IPI:UniProtKB
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0003723; F:RNA binding; TAS:ProtInc
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0008270; F:zinc ion binding; TAS:ProtInc
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0009972; P:cytidine deamination; TAS:GOC
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0016554; P:cytidine to uridine editing; TAS:Reactome
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0051607; P:defense response to virus; IEA:Ensembl
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0080111; P:DNA demethylation; ISS:UniProtKB
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0010467; P:gene expression; TAS:Reactome
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0006629; P:lipid metabolic process; TAS:ProtInc
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0042158; P:lipoprotein biosynthetic process; IEA:Ensembl
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0042953; P:lipoprotein transport; IEA:Ensembl
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0016556; P:mRNA modification; TAS:Reactome
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0048255; P:mRNA stabilization; IEA:Ensembl
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0090310; P:negative regulation of methylation-dependent chromatin silencing; ISS:UniProtKB
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0051592; P:response to calcium ion; IEA:Ensembl
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0042493; P:response to drug; IEA:Ensembl
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0045471; P:response to ethanol; IEA:Ensembl
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0010332; P:response to gamma radiation; IEA:Ensembl
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0006970; P:response to osmotic stress; IEA:Ensembl
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0010043; P:response to zinc ion; IEA:Ensembl
P41238	APOBEC1	C->U-editing enzyme APOBEC-1	GO:0006396; P:RNA processing; TAS:ProtInc
Q9Y235	APOBEC2	Probable C->U-editing enzyme APOBEC-2	GO:0004126; F:cytidine deaminase activity; TAS:ProtInc
Q9Y235	APOBEC2	Probable C->U-editing enzyme APOBEC-2	GO:0003723; F:RNA binding; TAS:ProtInc
Q9Y235	APOBEC2	Probable C->U-editing enzyme APOBEC-2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y235	APOBEC2	Probable C->U-editing enzyme APOBEC-2	GO:0009972; P:cytidine deamination; TAS:GOC
Q9Y235	APOBEC2	Probable C->U-editing enzyme APOBEC-2	GO:0080111; P:DNA demethylation; IDA:UniProtKB
Q9Y235	APOBEC2	Probable C->U-editing enzyme APOBEC-2	GO:0016556; P:mRNA modification; IEA:Ensembl
Q9Y235	APOBEC2	Probable C->U-editing enzyme APOBEC-2	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q8WW27	APOBEC4	Putative C->U-editing enzyme APOBEC-4	GO:0016814; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines; IEA:InterPro
Q8WW27	APOBEC4	Putative C->U-editing enzyme APOBEC-4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WW27	APOBEC4	Putative C->U-editing enzyme APOBEC-4	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q6UXT9	ABHD15	Abhydrolase domain-containing protein 15	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q96SE0	ABHD1	Abhydrolase domain-containing protein 1	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q8WU67	ABHD3	Abhydrolase domain-containing protein 3	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
P08910	ABHD2	Abhydrolase domain-containing protein 2	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
P08910	ABHD2	Abhydrolase domain-containing protein 2	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
P08910	ABHD2	Abhydrolase domain-containing protein 2	GO:0009611; P:response to wounding; IEA:Ensembl
Q8TB40	ABHD4	Abhydrolase domain-containing protein 4	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q8TB40	ABHD4	Abhydrolase domain-containing protein 4	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q8WTS1	ABHD5	1-acylglycerol-3-phosphate O-acyltransferase ABHD5	GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; IEA:UniProtKB-EC
Q8WTS1	ABHD5	1-acylglycerol-3-phosphate O-acyltransferase ABHD5	GO:0042171; F:lysophosphatidic acid acyltransferase activity; IDA:UniProtKB
Q8WTS1	ABHD5	1-acylglycerol-3-phosphate O-acyltransferase ABHD5	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8WTS1	ABHD5	1-acylglycerol-3-phosphate O-acyltransferase ABHD5	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW
Q8WTS1	ABHD5	1-acylglycerol-3-phosphate O-acyltransferase ABHD5	GO:0010891; P:negative regulation of sequestering of triglyceride; IDA:UniProtKB
Q8WTS1	ABHD5	1-acylglycerol-3-phosphate O-acyltransferase ABHD5	GO:0006654; P:phosphatidic acid biosynthetic process; IDA:UniProtKB
Q8WTS1	ABHD5	1-acylglycerol-3-phosphate O-acyltransferase ABHD5	GO:0051006; P:positive regulation of lipoprotein lipase activity; IEA:Ensembl
Q8WTS1	ABHD5	1-acylglycerol-3-phosphate O-acyltransferase ABHD5	GO:0010898; P:positive regulation of triglyceride catabolic process; IDA:UniProtKB
Q8WTS1	ABHD5	1-acylglycerol-3-phosphate O-acyltransferase ABHD5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8WTS1	ABHD5	1-acylglycerol-3-phosphate O-acyltransferase ABHD5	GO:0019433; P:triglyceride catabolic process; TAS:Reactome
Q9BV23	ABHD6	Monoacylglycerol lipase ABHD6	GO:0047372; F:acylglycerol lipase activity; IEA:UniProtKB-EC
Q9BV23	ABHD6	Monoacylglycerol lipase ABHD6	GO:0060292; P:long term synaptic depression; IEA:Ensembl
Q9BV23	ABHD6	Monoacylglycerol lipase ABHD6	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
Q9BV23	ABHD6	Monoacylglycerol lipase ABHD6	GO:2000124; P:regulation of endocannabinoid signaling pathway; IEA:Ensembl
Q96I13	ABHD8	Abhydrolase domain-containing protein 8	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q9NUJ1	ABHD10	Mycophenolic acid acyl-glucuronide esterase, mitochondrial	GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IDA:BHF-UCL
Q9NUJ1	ABHD10	Mycophenolic acid acyl-glucuronide esterase, mitochondrial	GO:0019391; P:glucuronoside catabolic process; IDA:BHF-UCL
Q8NFV4	ABHD11	Alpha/beta hydrolase domain-containing protein 11	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q7L211	ABHD13	Alpha/beta hydrolase domain-containing protein 13	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q9BUJ0	ABHD14A	Alpha/beta hydrolase domain-containing protein 14A	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q96IU4	ABHD14B	Alpha/beta hydrolase domain-containing protein 14B	GO:0016787; F:hydrolase activity; IDA:UniProt
Q96IU4	ABHD14B	Alpha/beta hydrolase domain-containing protein 14B	GO:0005515; F:protein binding; IPI:UniProt
Q96IU4	ABHD14B	Alpha/beta hydrolase domain-containing protein 14B	GO:0008152; P:metabolic process; IDA:GOC
Q96IU4	ABHD14B	Alpha/beta hydrolase domain-containing protein 14B	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProt
O95870	ABHD16A	Abhydrolase domain-containing protein 16A	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q9H3Z7	ABHD16B	Abhydrolase domain-containing protein 16B	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q8IZP0	ABI1	Abl interactor 1	GO:0008092; F:cytoskeletal protein binding; TAS:ProtInc
Q8IZP0	ABI1	Abl interactor 1	GO:0005515; F:protein binding; IPI:IntAct
Q8IZP0	ABI1	Abl interactor 1	GO:0032403; F:protein complex binding; IDA:UniProt
Q8IZP0	ABI1	Abl interactor 1	GO:0030296; F:protein tyrosine kinase activator activity; IEA:Ensembl
Q8IZP0	ABI1	Abl interactor 1	GO:0008154; P:actin polymerization or depolymerization; NAS:UniProtKB
Q8IZP0	ABI1	Abl interactor 1	GO:0006928; P:cellular component movement; IDA:UniProtKB
Q8IZP0	ABI1	Abl interactor 1	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q8IZP0	ABI1	Abl interactor 1	GO:0045087; P:innate immune response; TAS:Reactome
Q8IZP0	ABI1	Abl interactor 1	GO:0072673; P:lamellipodium morphogenesis; IEA:Ensembl
Q8IZP0	ABI1	Abl interactor 1	GO:0035855; P:megakaryocyte development; IEA:Ensembl
Q8IZP0	ABI1	Abl interactor 1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q8IZP0	ABI1	Abl interactor 1	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:MGI
Q8IZP0	ABI1	Abl interactor 1	GO:0001756; P:somitogenesis; IEA:Ensembl
Q8IZP0	ABI1	Abl interactor 1	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc
Q9NYB9	ABI2	Abl interactor 2	GO:0008093; F:cytoskeletal adaptor activity; TAS:UniProtKB
Q9NYB9	ABI2	Abl interactor 2	GO:0003677; F:DNA binding; TAS:ProtInc
Q9NYB9	ABI2	Abl interactor 2	GO:0019900; F:kinase binding; NAS:UniProtKB
Q9NYB9	ABI2	Abl interactor 2	GO:0070064; F:proline-rich region binding; IPI:UniProtKB
Q9NYB9	ABI2	Abl interactor 2	GO:0005515; F:protein binding; IPI:IntAct
Q9NYB9	ABI2	Abl interactor 2	GO:0032403; F:protein complex binding; IDA:UniProt
Q9NYB9	ABI2	Abl interactor 2	GO:0017124; F:SH3 domain binding; IPI:UniProtKB
Q9NYB9	ABI2	Abl interactor 2	GO:0031625; F:ubiquitin protein ligase binding; IPI:BHF-UCL
Q9NYB9	ABI2	Abl interactor 2	GO:0008154; P:actin polymerization or depolymerization; NAS:UniProtKB
Q9NYB9	ABI2	Abl interactor 2	GO:0043010; P:camera-type eye development; IEA:Ensembl
Q9NYB9	ABI2	Abl interactor 2	GO:0016477; P:cell migration; TAS:UniProtKB
Q9NYB9	ABI2	Abl interactor 2	GO:0006928; P:cellular component movement; IDA:UniProtKB
Q9NYB9	ABI2	Abl interactor 2	GO:0007010; P:cytoskeleton organization; TAS:UniProtKB
Q9NYB9	ABI2	Abl interactor 2	GO:0016358; P:dendrite development; IEA:Ensembl
Q9NYB9	ABI2	Abl interactor 2	GO:0007611; P:learning or memory; IEA:Ensembl
Q9NYB9	ABI2	Abl interactor 2	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:MGI
Q9NYB9	ABI2	Abl interactor 2	GO:2000601; P:positive regulation of Arp2/3 complex-mediated actin nucleation; IDA:UniProt
Q9NYB9	ABI2	Abl interactor 2	GO:0016601; P:Rac protein signal transduction; IDA:UniProt
Q9P2A4	ABI3	ABI gene family member 3	GO:0005515; F:protein binding; IPI:IntAct
Q9P2A4	ABI3	ABI gene family member 3	GO:0006928; P:cellular component movement; NAS:UniProtKB
Q9P2A4	ABI3	ABI gene family member 3	GO:0030334; P:regulation of cell migration; IDA:MGI
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0003785; F:actin monomer binding; TAS:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0005524; F:ATP binding; IDA:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0003677; F:DNA binding; NAS:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0030145; F:manganese ion binding; IDA:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0051019; F:mitogen-activated protein kinase binding; IPI:BHF-UCL
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0004515; F:nicotinate-nucleotide adenylyltransferase activity; TAS:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0070064; F:proline-rich region binding; IDA:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0005515; F:protein binding; IPI:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0017124; F:SH3 domain binding; IPI:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0019905; F:syntaxin binding; IPI:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0030036; P:actin cytoskeleton organization; ISS:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0006914; P:autophagy; IEA:UniProtKB-KW
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0007411; P:axon guidance; TAS:Reactome
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0007596; P:blood coagulation; TAS:Reactome
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0006464; P:cellular protein modification process; NAS:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0006975; P:DNA damage induced protein phosphorylation; IDA:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0045087; P:innate immune response; TAS:Reactome
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; TAS:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0006298; P:mismatch repair; TAS:ProtInc
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0042692; P:muscle cell differentiation; TAS:Reactome
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0071901; P:negative regulation of protein serine/threonine kinase activity; IDA:BHF-UCL
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IEA:Ensembl
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0051353; P:positive regulation of oxidoreductase activity; IDA:BHF-UCL
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:2000249; P:regulation of actin cytoskeleton reorganization; TAS:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0010506; P:regulation of autophagy; TAS:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0030155; P:regulation of cell adhesion; TAS:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:2000145; P:regulation of cell motility; TAS:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0030100; P:regulation of endocytosis; TAS:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:2001020; P:regulation of response to DNA damage stimulus; IDA:UniProtKB
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
P00519	ABL1	Tyrosine-protein kinase ABL1	GO:0042770; P:signal transduction in response to DNA damage; IDA:UniProtKB
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0051015; F:actin filament binding; TAS:UniProtKB
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0003785; F:actin monomer binding; TAS:UniProtKB
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0030145; F:manganese ion binding; IDA:UniProtKB
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; TAS:UniProtKB
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0005515; F:protein binding; IPI:IntAct
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0004672; F:protein kinase activity; TAS:ProtInc
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0051017; P:actin filament bundle assembly; IEA:Ensembl
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0007411; P:axon guidance; TAS:Reactome
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0071300; P:cellular response to retinoic acid; IMP:BHF-UCL
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0010976; P:positive regulation of neuron projection development; IMP:BHF-UCL
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0051353; P:positive regulation of oxidoreductase activity; IDA:BHF-UCL
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:2000249; P:regulation of actin cytoskeleton reorganization; TAS:UniProtKB
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0010506; P:regulation of autophagy; TAS:UniProtKB
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0030155; P:regulation of cell adhesion; TAS:UniProtKB
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:2000145; P:regulation of cell motility; TAS:UniProtKB
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0030100; P:regulation of endocytosis; TAS:UniProtKB
P42684	ABL2	Abelson tyrosine-protein kinase 2	GO:0007165; P:signal transduction; TAS:ProtInc
O14639	ABLIM1	Actin-binding LIM protein 1	GO:0003779; F:actin binding; TAS:ProtInc
O14639	ABLIM1	Actin-binding LIM protein 1	GO:0005515; F:protein binding; IPI:IntAct
O14639	ABLIM1	Actin-binding LIM protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
O14639	ABLIM1	Actin-binding LIM protein 1	GO:0007411; P:axon guidance; TAS:Reactome
O14639	ABLIM1	Actin-binding LIM protein 1	GO:0007010; P:cytoskeleton organization; IEA:InterPro
O14639	ABLIM1	Actin-binding LIM protein 1	GO:0009887; P:organ morphogenesis; TAS:ProtInc
O14639	ABLIM1	Actin-binding LIM protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O14639	ABLIM1	Actin-binding LIM protein 1	GO:0007601; P:visual perception; TAS:ProtInc
Q6H8Q1	ABLIM2	Actin-binding LIM protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6H8Q1	ABLIM2	Actin-binding LIM protein 2	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
Q6H8Q1	ABLIM2	Actin-binding LIM protein 2	GO:0007411; P:axon guidance; TAS:Reactome
Q6H8Q1	ABLIM2	Actin-binding LIM protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q6H8Q1	ABLIM2	Actin-binding LIM protein 2	GO:0006351; P:transcription, DNA-templated; IEA:InterPro
O94929	ABLIM3	Actin-binding LIM protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
O94929	ABLIM3	Actin-binding LIM protein 3	GO:0007411; P:axon guidance; TAS:Reactome
O94929	ABLIM3	Actin-binding LIM protein 3	GO:0007010; P:cytoskeleton organization; IEA:InterPro
O94929	ABLIM3	Actin-binding LIM protein 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8N0Z2	ABRA	Actin-binding Rho-activating protein	GO:0003779; F:actin binding; ISS:HGNC
Q8N0Z2	ABRA	Actin-binding Rho-activating protein	GO:0003713; F:transcription coactivator activity; IEA:Ensembl
Q8N0Z2	ABRA	Actin-binding Rho-activating protein	GO:0035025; P:positive regulation of Rho protein signal transduction; ISS:HGNC
Q8N0Z2	ABRA	Actin-binding Rho-activating protein	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; ISS:HGNC
Q8N0Z2	ABRA	Actin-binding Rho-activating protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8N0Z2	ABRA	Actin-binding Rho-activating protein	GO:0000060; P:protein import into nucleus, translocation; IEA:Ensembl
Q8N0Z2	ABRA	Actin-binding Rho-activating protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q12979	ABR	Active breakpoint cluster region-related protein	GO:0005096; F:GTPase activator activity; TAS:ProtInc
Q12979	ABR	Active breakpoint cluster region-related protein	GO:0030675; F:Rac GTPase activator activity; IEA:Ensembl
Q12979	ABR	Active breakpoint cluster region-related protein	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q12979	ABR	Active breakpoint cluster region-related protein	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
Q12979	ABR	Active breakpoint cluster region-related protein	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q12979	ABR	Active breakpoint cluster region-related protein	GO:0007420; P:brain development; IEA:Ensembl
Q12979	ABR	Active breakpoint cluster region-related protein	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q12979	ABR	Active breakpoint cluster region-related protein	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
Q12979	ABR	Active breakpoint cluster region-related protein	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
Q12979	ABR	Active breakpoint cluster region-related protein	GO:0043314; P:negative regulation of neutrophil degranulation; IEA:Ensembl
Q12979	ABR	Active breakpoint cluster region-related protein	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q12979	ABR	Active breakpoint cluster region-related protein	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q12979	ABR	Active breakpoint cluster region-related protein	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q12979	ABR	Active breakpoint cluster region-related protein	GO:0050766; P:positive regulation of phagocytosis; IEA:Ensembl
Q12979	ABR	Active breakpoint cluster region-related protein	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q12979	ABR	Active breakpoint cluster region-related protein	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
Q12979	ABR	Active breakpoint cluster region-related protein	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9ULW3	ABT1	Activator of basal transcription 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9ULW3	ABT1	Activator of basal transcription 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9ULW3	ABT1	Activator of basal transcription 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9ULW3	ABT1	Activator of basal transcription 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9ULW3	ABT1	Activator of basal transcription 1	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q9ULW3	ABT1	Activator of basal transcription 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9ULW3	ABT1	Activator of basal transcription 1	GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl
Q9ULW3	ABT1	Activator of basal transcription 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q969K4	ABTB1	Ankyrin repeat and BTB/POZ domain-containing protein 1	GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-KW
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0003989; F:acetyl-CoA carboxylase activity; ISS:UniProtKB
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0004075; F:biotin carboxylase activity; IEA:UniProtKB-EC
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0006084; P:acetyl-CoA metabolic process; ISS:UniProtKB
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0006768; P:biotin metabolic process; TAS:Reactome
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0006853; P:carnitine shuttle; TAS:Reactome
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0006633; P:fatty acid biosynthetic process; ISS:UniProtKB
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0055088; P:lipid homeostasis; IEA:Ensembl
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:2001295; P:malonyl-CoA biosynthetic process; IEA:UniProtKB-UniPathway
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0044268; P:multicellular organismal protein metabolic process; IEA:Ensembl
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0031325; P:positive regulation of cellular metabolic process; TAS:Reactome
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0051289; P:protein homotetramerization; ISS:UniProtKB
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0001894; P:tissue homeostasis; IEA:Ensembl
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q13085	ACACA	Acetyl-CoA carboxylase 1	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
O00763	ACACB	Acetyl-CoA carboxylase 2	GO:0003989; F:acetyl-CoA carboxylase activity; IDA:UniProtKB
O00763	ACACB	Acetyl-CoA carboxylase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O00763	ACACB	Acetyl-CoA carboxylase 2	GO:0009374; F:biotin binding; IEA:Ensembl
O00763	ACACB	Acetyl-CoA carboxylase 2	GO:0004075; F:biotin carboxylase activity; IEA:UniProtKB-EC
O00763	ACACB	Acetyl-CoA carboxylase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O00763	ACACB	Acetyl-CoA carboxylase 2	GO:0005515; F:protein binding; IPI:UniProtKB
O00763	ACACB	Acetyl-CoA carboxylase 2	GO:0006084; P:acetyl-CoA metabolic process; IDA:UniProtKB
O00763	ACACB	Acetyl-CoA carboxylase 2	GO:0006768; P:biotin metabolic process; TAS:Reactome
O00763	ACACB	Acetyl-CoA carboxylase 2	GO:0006853; P:carnitine shuttle; TAS:Reactome
O00763	ACACB	Acetyl-CoA carboxylase 2	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O00763	ACACB	Acetyl-CoA carboxylase 2	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
O00763	ACACB	Acetyl-CoA carboxylase 2	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
O00763	ACACB	Acetyl-CoA carboxylase 2	GO:2001295; P:malonyl-CoA biosynthetic process; IEA:UniProtKB-UniPathway
O00763	ACACB	Acetyl-CoA carboxylase 2	GO:0031325; P:positive regulation of cellular metabolic process; TAS:Reactome
O00763	ACACB	Acetyl-CoA carboxylase 2	GO:0051289; P:protein homotetramerization; IDA:UniProtKB
O00763	ACACB	Acetyl-CoA carboxylase 2	GO:0042493; P:response to drug; IEA:Ensembl
O00763	ACACB	Acetyl-CoA carboxylase 2	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
O00763	ACACB	Acetyl-CoA carboxylase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00763	ACACB	Acetyl-CoA carboxylase 2	GO:0006766; P:vitamin metabolic process; TAS:Reactome
O00763	ACACB	Acetyl-CoA carboxylase 2	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9UKU7	ACAD8	Isobutyryl-CoA dehydrogenase, mitochondrial	GO:0003995; F:acyl-CoA dehydrogenase activity; EXP:Reactome
Q9UKU7	ACAD8	Isobutyryl-CoA dehydrogenase, mitochondrial	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q9UKU7	ACAD8	Isobutyryl-CoA dehydrogenase, mitochondrial	GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome
Q9UKU7	ACAD8	Isobutyryl-CoA dehydrogenase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9UKU7	ACAD8	Isobutyryl-CoA dehydrogenase, mitochondrial	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q9UKU7	ACAD8	Isobutyryl-CoA dehydrogenase, mitochondrial	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UKU7	ACAD8	Isobutyryl-CoA dehydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UKU7	ACAD8	Isobutyryl-CoA dehydrogenase, mitochondrial	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UKU7	ACAD8	Isobutyryl-CoA dehydrogenase, mitochondrial	GO:0006574; P:valine catabolic process; IEA:UniProtKB-UniPathway
Q9H845	ACAD9	Acyl-CoA dehydrogenase family member 9, mitochondrial	GO:0003995; F:acyl-CoA dehydrogenase activity; IEA:InterPro
Q9H845	ACAD9	Acyl-CoA dehydrogenase family member 9, mitochondrial	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
P28330	ACADL	Long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0003995; F:acyl-CoA dehydrogenase activity; TAS:Reactome
P28330	ACADL	Long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0000062; F:fatty-acyl-CoA binding; IEA:Ensembl
P28330	ACADL	Long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0050660; F:flavin adenine dinucleotide binding; IEA:Ensembl
P28330	ACADL	Long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0004466; F:long-chain-acyl-CoA dehydrogenase activity; ISS:BHF-UCL
P28330	ACADL	Long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0016401; F:palmitoyl-CoA oxidase activity; ISS:BHF-UCL
P28330	ACADL	Long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0042413; P:carnitine catabolic process; ISS:BHF-UCL
P28330	ACADL	Long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0019254; P:carnitine metabolic process, CoA-linked; ISS:BHF-UCL
P28330	ACADL	Long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0044242; P:cellular lipid catabolic process; ISS:BHF-UCL
P28330	ACADL	Long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P28330	ACADL	Long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0006635; P:fatty acid beta-oxidation; TAS:Reactome
P28330	ACADL	Long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0033539; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; ISS:BHF-UCL
P28330	ACADL	Long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0042758; P:long-chain fatty acid catabolic process; IEA:Ensembl
P28330	ACADL	Long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0045717; P:negative regulation of fatty acid biosynthetic process; ISS:BHF-UCL
P28330	ACADL	Long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0046322; P:negative regulation of fatty acid oxidation; ISS:BHF-UCL
P28330	ACADL	Long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0055114; P:oxidation-reduction process; ISS:BHF-UCL
P28330	ACADL	Long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0051289; P:protein homotetramerization; IEA:Ensembl
P28330	ACADL	Long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0090181; P:regulation of cholesterol metabolic process; ISS:BHF-UCL
P28330	ACADL	Long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P28330	ACADL	Long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0001659; P:temperature homeostasis; ISS:BHF-UCL
P11310	ACADM	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0003995; F:acyl-CoA dehydrogenase activity; IMP:UniProtKB
P11310	ACADM	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
P11310	ACADM	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0042802; F:identical protein binding; IDA:BHF-UCL
P11310	ACADM	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0070991; F:medium-chain-acyl-CoA dehydrogenase activity; IDA:BHF-UCL
P11310	ACADM	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0055007; P:cardiac muscle cell differentiation; IEA:Ensembl
P11310	ACADM	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0045329; P:carnitine biosynthetic process; IMP:BHF-UCL
P11310	ACADM	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0019254; P:carnitine metabolic process, CoA-linked; IMP:BHF-UCL
P11310	ACADM	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P11310	ACADM	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0006635; P:fatty acid beta-oxidation; IMP:UniProtKB
P11310	ACADM	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0033539; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; IDA:BHF-UCL
P11310	ACADM	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0005978; P:glycogen biosynthetic process; IEA:Ensembl
P11310	ACADM	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0001889; P:liver development; IEA:Ensembl
P11310	ACADM	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0051793; P:medium-chain fatty acid catabolic process; IDA:BHF-UCL
P11310	ACADM	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0051791; P:medium-chain fatty acid metabolic process; IDA:BHF-UCL
P11310	ACADM	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL
P11310	ACADM	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0009791; P:post-embryonic development; IEA:Ensembl
P11310	ACADM	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0006111; P:regulation of gluconeogenesis; IEA:Ensembl
P11310	ACADM	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0009409; P:response to cold; IEA:Ensembl
P11310	ACADM	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0042594; P:response to starvation; IEA:Ensembl
P11310	ACADM	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P16219	ACADS	Short-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0003995; F:acyl-CoA dehydrogenase activity; TAS:Reactome
P16219	ACADS	Short-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0004085; F:butyryl-CoA dehydrogenase activity; IEA:UniProtKB-EC
P16219	ACADS	Short-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0000062; F:fatty-acyl-CoA binding; IEA:Ensembl
P16219	ACADS	Short-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
P16219	ACADS	Short-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0046359; P:butyrate catabolic process; IEA:Ensembl
P16219	ACADS	Short-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P16219	ACADS	Short-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0006635; P:fatty acid beta-oxidation; TAS:Reactome
P16219	ACADS	Short-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0033539; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; IEA:Ensembl
P16219	ACADS	Short-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0051289; P:protein homotetramerization; IEA:Ensembl
P16219	ACADS	Short-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P16219	ACADS	Short-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0042594; P:response to starvation; IEA:Ensembl
P16219	ACADS	Short-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P49748	ACADVL	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0003995; F:acyl-CoA dehydrogenase activity; TAS:Reactome
P49748	ACADVL	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
P49748	ACADVL	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0004466; F:long-chain-acyl-CoA dehydrogenase activity; TAS:ProtInc
P49748	ACADVL	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P49748	ACADVL	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P49748	ACADVL	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P49748	ACADVL	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P49748	ACADVL	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0015980; P:energy derivation by oxidation of organic compounds; TAS:ProtInc
P49748	ACADVL	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
P49748	ACADVL	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0006635; P:fatty acid beta-oxidation; TAS:Reactome
P49748	ACADVL	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0033539; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; ISS:BHF-UCL
P49748	ACADVL	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0045717; P:negative regulation of fatty acid biosynthetic process; ISS:BHF-UCL
P49748	ACADVL	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0046322; P:negative regulation of fatty acid oxidation; ISS:BHF-UCL
P49748	ACADVL	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0090181; P:regulation of cholesterol metabolic process; ISS:BHF-UCL
P49748	ACADVL	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P49748	ACADVL	Very long-chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0001659; P:temperature homeostasis; ISS:BHF-UCL
Q15027	ACAP1	Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q15027	ACAP1	Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q15027	ACAP1	Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q15027	ACAP1	Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
Q15057	ACAP2	Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q15057	ACAP2	Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q15057	ACAP2	Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2	GO:1990090; P:cellular response to nerve growth factor stimulus; ISS:UniProtKB
Q15057	ACAP2	Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2	GO:0036010; P:protein localization to endosome; ISS:UniProtKB
Q15057	ACAP2	Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
Q96P50	ACAP3	Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q96P50	ACAP3	Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96P50	ACAP3	Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
O00400	SLC33A1	Acetyl-coenzyme A transporter 1	GO:0008521; F:acetyl-CoA transporter activity; TAS:ProtInc
O00400	SLC33A1	Acetyl-coenzyme A transporter 1	GO:0015876; P:acetyl-CoA transport; TAS:GOC
O00400	SLC33A1	Acetyl-coenzyme A transporter 1	GO:0008219; P:cell death; IEA:UniProtKB-KW
O00400	SLC33A1	Acetyl-coenzyme A transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
O00400	SLC33A1	Acetyl-coenzyme A transporter 1	GO:0006810; P:transport; TAS:ProtInc
Q8NC06	ACBD4	Acyl-CoA-binding domain-containing protein 4	GO:0000062; F:fatty-acyl-CoA binding; IEA:InterPro
Q8NC06	ACBD4	Acyl-CoA-binding domain-containing protein 4	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q5T8D3	ACBD5	Acyl-CoA-binding domain-containing protein 5	GO:0000062; F:fatty-acyl-CoA binding; IEA:InterPro
Q5T8D3	ACBD5	Acyl-CoA-binding domain-containing protein 5	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q5T8D3	ACBD5	Acyl-CoA-binding domain-containing protein 5	GO:0006810; P:transport; IEA:UniProtKB-KW
Q8N6N7	ACBD7	Acyl-CoA-binding domain-containing protein 7	GO:0000062; F:fatty-acyl-CoA binding; IEA:InterPro
Q8N6N7	ACBD7	Acyl-CoA-binding domain-containing protein 7	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q9BR61	ACBD6	Acyl-CoA-binding domain-containing protein 6	GO:0000062; F:fatty-acyl-CoA binding; IEA:InterPro
Q9BR61	ACBD6	Acyl-CoA-binding domain-containing protein 6	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q96GR2	ACSBG1	Long-chain-fatty-acid--CoA ligase ACSBG1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96GR2	ACSBG1	Long-chain-fatty-acid--CoA ligase ACSBG1	GO:0004467; F:long-chain fatty acid-CoA ligase activity; IDA:HGNC
Q96GR2	ACSBG1	Long-chain-fatty-acid--CoA ligase ACSBG1	GO:0031957; F:very long-chain fatty acid-CoA ligase activity; IDA:HGNC
Q96GR2	ACSBG1	Long-chain-fatty-acid--CoA ligase ACSBG1	GO:0001676; P:long-chain fatty acid metabolic process; IDA:HGNC
Q96GR2	ACSBG1	Long-chain-fatty-acid--CoA ligase ACSBG1	GO:0042552; P:myelination; NAS:HGNC
Q96GR2	ACSBG1	Long-chain-fatty-acid--CoA ligase ACSBG1	GO:0001552; P:ovarian follicle atresia; IEA:Ensembl
Q96GR2	ACSBG1	Long-chain-fatty-acid--CoA ligase ACSBG1	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
Q96GR2	ACSBG1	Long-chain-fatty-acid--CoA ligase ACSBG1	GO:0000038; P:very long-chain fatty acid metabolic process; IDA:HGNC
Q5FVE4	ACSBG2	Long-chain-fatty-acid--CoA ligase ACSBG2	GO:0047617; F:acyl-CoA hydrolase activity; IDA:MGI
Q5FVE4	ACSBG2	Long-chain-fatty-acid--CoA ligase ACSBG2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5FVE4	ACSBG2	Long-chain-fatty-acid--CoA ligase ACSBG2	GO:0004467; F:long-chain fatty acid-CoA ligase activity; IDA:MGI
Q5FVE4	ACSBG2	Long-chain-fatty-acid--CoA ligase ACSBG2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q5FVE4	ACSBG2	Long-chain-fatty-acid--CoA ligase ACSBG2	GO:0006631; P:fatty acid metabolic process; IDA:MGI
Q5FVE4	ACSBG2	Long-chain-fatty-acid--CoA ligase ACSBG2	GO:0001676; P:long-chain fatty acid metabolic process; IDA:GOC
Q5FVE4	ACSBG2	Long-chain-fatty-acid--CoA ligase ACSBG2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q5FVE4	ACSBG2	Long-chain-fatty-acid--CoA ligase ACSBG2	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
P07108	DBI	Acyl-CoA-binding protein	GO:0030156; F:benzodiazepine receptor binding; TAS:ProtInc
P07108	DBI	Acyl-CoA-binding protein	GO:0000062; F:fatty-acyl-CoA binding; IEA:InterPro
P07108	DBI	Acyl-CoA-binding protein	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
P07108	DBI	Acyl-CoA-binding protein	GO:0001942; P:hair follicle development; IEA:Ensembl
P07108	DBI	Acyl-CoA-binding protein	GO:0006810; P:transport; IEA:UniProtKB-KW
P07108	DBI	Acyl-CoA-binding protein	GO:0006641; P:triglyceride metabolic process; IEA:Ensembl
Q6JQN1	ACAD10	Acyl-CoA dehydrogenase family member 10	GO:0003995; F:acyl-CoA dehydrogenase activity; IEA:InterPro
Q6JQN1	ACAD10	Acyl-CoA dehydrogenase family member 10	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q6JQN1	ACAD10	Acyl-CoA dehydrogenase family member 10	GO:0016787; F:hydrolase activity; IEA:InterPro
Q6JQN1	ACAD10	Acyl-CoA dehydrogenase family member 10	GO:0016772; F:transferase activity, transferring phosphorus-containing groups; IEA:InterPro
Q709F0	ACAD11	Acyl-CoA dehydrogenase family member 11	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q709F0	ACAD11	Acyl-CoA dehydrogenase family member 11	GO:0004466; F:long-chain-acyl-CoA dehydrogenase activity; IDA:UniProtKB
Q709F0	ACAD11	Acyl-CoA dehydrogenase family member 11	GO:0070991; F:medium-chain-acyl-CoA dehydrogenase activity; IDA:UniProtKB
Q709F0	ACAD11	Acyl-CoA dehydrogenase family member 11	GO:0016772; F:transferase activity, transferring phosphorus-containing groups; IEA:InterPro
Q709F0	ACAD11	Acyl-CoA dehydrogenase family member 11	GO:0017099; F:very-long-chain-acyl-CoA dehydrogenase activity; IDA:UniProtKB
Q709F0	ACAD11	Acyl-CoA dehydrogenase family member 11	GO:0033539; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; IDA:UniProtKB
P45954	ACADSB	Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0003995; F:acyl-CoA dehydrogenase activity; EXP:Reactome
P45954	ACADSB	Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
P45954	ACADSB	Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome
P45954	ACADSB	Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P45954	ACADSB	Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0006631; P:fatty acid metabolic process; TAS:ProtInc
P45954	ACADSB	Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96AP0	ACD	Adrenocortical dysplasia protein homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96AP0	ACD	Adrenocortical dysplasia protein homolog	GO:0070182; F:DNA polymerase binding; IPI:BHF-UCL
Q96AP0	ACD	Adrenocortical dysplasia protein homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q96AP0	ACD	Adrenocortical dysplasia protein homolog	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
Q96AP0	ACD	Adrenocortical dysplasia protein homolog	GO:0006886; P:intracellular protein transport; IMP:BHF-UCL
Q96AP0	ACD	Adrenocortical dysplasia protein homolog	GO:0032211; P:negative regulation of telomere maintenance via telomerase; IMP:BHF-UCL
Q96AP0	ACD	Adrenocortical dysplasia protein homolog	GO:0060381; P:positive regulation of single-stranded telomeric DNA binding; IDA:BHF-UCL
Q96AP0	ACD	Adrenocortical dysplasia protein homolog	GO:0051973; P:positive regulation of telomerase activity; IDA:BHF-UCL
Q96AP0	ACD	Adrenocortical dysplasia protein homolog	GO:0031848; P:protection from non-homologous end joining at telomere; ISS:BHF-UCL
Q96AP0	ACD	Adrenocortical dysplasia protein homolog	GO:0070198; P:protein localization to chromosome, telomeric region; IMP:BHF-UCL
Q96AP0	ACD	Adrenocortical dysplasia protein homolog	GO:0035282; P:segmentation; IEA:Ensembl
Q96AP0	ACD	Adrenocortical dysplasia protein homolog	GO:0001501; P:skeletal system development; IEA:Ensembl
Q96AP0	ACD	Adrenocortical dysplasia protein homolog	GO:0032202; P:telomere assembly; IMP:BHF-UCL
Q96AP0	ACD	Adrenocortical dysplasia protein homolog	GO:0016233; P:telomere capping; IGI:BHF-UCL
Q96AP0	ACD	Adrenocortical dysplasia protein homolog	GO:0000723; P:telomere maintenance; IDA:MGI
Q96AP0	ACD	Adrenocortical dysplasia protein homolog	GO:0001655; P:urogenital system development; IEA:Ensembl
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0004180; F:carboxypeptidase activity; IDA:UniProtKB
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0004175; F:endopeptidase activity; IDA:UniProtKB
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0001948; F:glycoprotein binding; IPI:BHF-UCL
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0017046; F:peptide hormone binding; IEA:Ensembl
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0001618; F:virus receptor activity; IMP:UniProtKB
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0008270; F:zinc ion binding; TAS:BHF-UCL
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0002005; P:angiotensin catabolic process in blood; IC:BHF-UCL
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0002003; P:angiotensin maturation; TAS:Reactome
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0003051; P:angiotensin-mediated drinking behavior; IMP:BHF-UCL
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IC:BHF-UCL
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0032800; P:receptor biosynthetic process; IMP:BHF-UCL
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0046813; P:receptor-mediated virion attachment to host cell; IDA:BHF-UCL
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0042127; P:regulation of cell proliferation; TAS:BHF-UCL
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0001817; P:regulation of cytokine production; IC:BHF-UCL
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0050727; P:regulation of inflammatory response; IC:BHF-UCL
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0003081; P:regulation of systemic arterial blood pressure by renin-angiotensin; IMP:BHF-UCL
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0019229; P:regulation of vasoconstriction; IC:BHF-UCL
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0042312; P:regulation of vasodilation; IC:BHF-UCL
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0009615; P:response to virus; IDA:GOC
Q9BYF1	ACE2	Angiotensin-converting enzyme 2	GO:0046718; P:viral entry into host cell; TAS:UniProtKB
Q8TDN7	ACER1	Alkaline ceramidase 1	GO:0017040; F:ceramidase activity; IDA:BHF-UCL
Q8TDN7	ACER1	Alkaline ceramidase 1	GO:0071633; F:dihydroceramidase activity; IDA:BHF-UCL
Q8TDN7	ACER1	Alkaline ceramidase 1	GO:0030154; P:cell differentiation; IMP:BHF-UCL
Q8TDN7	ACER1	Alkaline ceramidase 1	GO:0071277; P:cellular response to calcium ion; IDA:BHF-UCL
Q8TDN7	ACER1	Alkaline ceramidase 1	GO:0046514; P:ceramide catabolic process; ISS:BHF-UCL
Q8TDN7	ACER1	Alkaline ceramidase 1	GO:0008544; P:epidermis development; IEP:BHF-UCL
Q8TDN7	ACER1	Alkaline ceramidase 1	GO:0030216; P:keratinocyte differentiation; IEP:BHF-UCL
Q8TDN7	ACER1	Alkaline ceramidase 1	GO:0019216; P:regulation of lipid metabolic process; IEA:Ensembl
Q8TDN7	ACER1	Alkaline ceramidase 1	GO:0010446; P:response to alkalinity; IDA:BHF-UCL
Q8TDN7	ACER1	Alkaline ceramidase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8TDN7	ACER1	Alkaline ceramidase 1	GO:0030148; P:sphingolipid biosynthetic process; IDA:BHF-UCL
Q8TDN7	ACER1	Alkaline ceramidase 1	GO:0006665; P:sphingolipid metabolic process; ISS:BHF-UCL
Q8TDN7	ACER1	Alkaline ceramidase 1	GO:0046512; P:sphingosine biosynthetic process; IDA:BHF-UCL
Q5QJU3	ACER2	Alkaline ceramidase 2	GO:0017040; F:ceramidase activity; IDA:UniProtKB
Q5QJU3	ACER2	Alkaline ceramidase 2	GO:0071633; F:dihydroceramidase activity; IDA:BHF-UCL
Q5QJU3	ACER2	Alkaline ceramidase 2	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:BHF-UCL
Q5QJU3	ACER2	Alkaline ceramidase 2	GO:0035690; P:cellular response to drug; IEP:BHF-UCL
Q5QJU3	ACER2	Alkaline ceramidase 2	GO:0006672; P:ceramide metabolic process; IEA:InterPro
Q5QJU3	ACER2	Alkaline ceramidase 2	GO:0033629; P:negative regulation of cell adhesion mediated by integrin; IDA:UniProtKB
Q5QJU3	ACER2	Alkaline ceramidase 2	GO:0001953; P:negative regulation of cell-matrix adhesion; IDA:UniProtKB
Q5QJU3	ACER2	Alkaline ceramidase 2	GO:0090285; P:negative regulation of protein glycosylation in Golgi; IMP:UniProtKB
Q5QJU3	ACER2	Alkaline ceramidase 2	GO:0010942; P:positive regulation of cell death; IMP:BHF-UCL
Q5QJU3	ACER2	Alkaline ceramidase 2	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q5QJU3	ACER2	Alkaline ceramidase 2	GO:0032526; P:response to retinoic acid; IDA:UniProtKB
Q5QJU3	ACER2	Alkaline ceramidase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5QJU3	ACER2	Alkaline ceramidase 2	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
Q5QJU3	ACER2	Alkaline ceramidase 2	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q5QJU3	ACER2	Alkaline ceramidase 2	GO:0046512; P:sphingosine biosynthetic process; IDA:UniProtKB
Q9NUN7	ACER3	Alkaline ceramidase 3	GO:0070774; F:phytoceramidase activity; IDA:UniProtKB
Q9NUN7	ACER3	Alkaline ceramidase 3	GO:0006672; P:ceramide metabolic process; IEA:InterPro
Q9NUN7	ACER3	Alkaline ceramidase 3	GO:0071602; P:phytosphingosine biosynthetic process; IDA:UniProtKB
Q9NUN7	ACER3	Alkaline ceramidase 3	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
Q9NUN7	ACER3	Alkaline ceramidase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NUN7	ACER3	Alkaline ceramidase 3	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
Q9NUN7	ACER3	Alkaline ceramidase 3	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q9NUN7	ACER3	Alkaline ceramidase 3	GO:0046512; P:sphingosine biosynthetic process; IDA:UniProtKB
P22303	ACHE	Acetylcholinesterase	GO:0042166; F:acetylcholine binding; NAS:UniProtKB
P22303	ACHE	Acetylcholinesterase	GO:0003990; F:acetylcholinesterase activity; IMP:UniProtKB
P22303	ACHE	Acetylcholinesterase	GO:0001540; F:beta-amyloid binding; TAS:UniProtKB
P22303	ACHE	Acetylcholinesterase	GO:0004104; F:cholinesterase activity; IDA:HGNC
P22303	ACHE	Acetylcholinesterase	GO:0005518; F:collagen binding; IDA:HGNC
P22303	ACHE	Acetylcholinesterase	GO:0016787; F:hydrolase activity; IDA:HGNC
P22303	ACHE	Acetylcholinesterase	GO:0043236; F:laminin binding; IDA:BHF-UCL
P22303	ACHE	Acetylcholinesterase	GO:0005515; F:protein binding; IPI:UniProtKB
P22303	ACHE	Acetylcholinesterase	GO:0042803; F:protein homodimerization activity; NAS:UniProtKB
P22303	ACHE	Acetylcholinesterase	GO:0017171; F:serine hydrolase activity; IDA:HGNC
P22303	ACHE	Acetylcholinesterase	GO:0006581; P:acetylcholine catabolic process; IDA:HGNC
P22303	ACHE	Acetylcholinesterase	GO:0001507; P:acetylcholine catabolic process in synaptic cleft; NAS:UniProtKB
P22303	ACHE	Acetylcholinesterase	GO:0042982; P:amyloid precursor protein metabolic process; TAS:UniProtKB
P22303	ACHE	Acetylcholinesterase	GO:0007155; P:cell adhesion; TAS:UniProtKB
P22303	ACHE	Acetylcholinesterase	GO:0008283; P:cell proliferation; TAS:UniProtKB
P22303	ACHE	Acetylcholinesterase	GO:0019695; P:choline metabolic process; IBA:RefGenome
P22303	ACHE	Acetylcholinesterase	GO:0006260; P:DNA replication; TAS:UniProtKB
P22303	ACHE	Acetylcholinesterase	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
P22303	ACHE	Acetylcholinesterase	GO:0007517; P:muscle organ development; TAS:UniProtKB
P22303	ACHE	Acetylcholinesterase	GO:0032223; P:negative regulation of synaptic transmission, cholinergic; IC:HGNC
P22303	ACHE	Acetylcholinesterase	GO:0007399; P:nervous system development; TAS:UniProtKB
P22303	ACHE	Acetylcholinesterase	GO:0042136; P:neurotransmitter biosynthetic process; TAS:Reactome
P22303	ACHE	Acetylcholinesterase	GO:0045212; P:neurotransmitter receptor biosynthetic process; IEA:Ensembl
P22303	ACHE	Acetylcholinesterase	GO:0002076; P:osteoblast development; IEP:HGNC
P22303	ACHE	Acetylcholinesterase	GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome
P22303	ACHE	Acetylcholinesterase	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P22303	ACHE	Acetylcholinesterase	GO:0050714; P:positive regulation of protein secretion; TAS:UniProtKB
P22303	ACHE	Acetylcholinesterase	GO:0051262; P:protein tetramerization; IEA:Ensembl
P22303	ACHE	Acetylcholinesterase	GO:0031623; P:receptor internalization; IEA:Ensembl
P22303	ACHE	Acetylcholinesterase	GO:0050770; P:regulation of axonogenesis; IBA:RefGenome
P22303	ACHE	Acetylcholinesterase	GO:0048814; P:regulation of dendrite morphogenesis; IBA:RefGenome
P22303	ACHE	Acetylcholinesterase	GO:0001919; P:regulation of receptor recycling; IEA:Ensembl
P22303	ACHE	Acetylcholinesterase	GO:0009611; P:response to wounding; TAS:UniProtKB
P22303	ACHE	Acetylcholinesterase	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
P22303	ACHE	Acetylcholinesterase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P22303	ACHE	Acetylcholinesterase	GO:0007416; P:synapse assembly; TAS:UniProtKB
P22303	ACHE	Acetylcholinesterase	GO:0007268; P:synaptic transmission; TAS:Reactome
P22303	ACHE	Acetylcholinesterase	GO:0007271; P:synaptic transmission, cholinergic; IBA:RefGenome
P12821	ACE	Angiotensin-converting enzyme	GO:0003779; F:actin binding; IDA:UniProtKB
P12821	ACE	Angiotensin-converting enzyme	GO:0031711; F:bradykinin receptor binding; IPI:BHF-UCL
P12821	ACE	Angiotensin-converting enzyme	GO:0004180; F:carboxypeptidase activity; IEA:UniProtKB-KW
P12821	ACE	Angiotensin-converting enzyme	GO:0031404; F:chloride ion binding; IDA:BHF-UCL
P12821	ACE	Angiotensin-converting enzyme	GO:0008144; F:drug binding; IDA:BHF-UCL
P12821	ACE	Angiotensin-converting enzyme	GO:0004175; F:endopeptidase activity; IDA:UniProtKB
P12821	ACE	Angiotensin-converting enzyme	GO:0008237; F:metallopeptidase activity; IDA:UniProtKB
P12821	ACE	Angiotensin-converting enzyme	GO:0008241; F:peptidyl-dipeptidase activity; IDA:UniProtKB
P12821	ACE	Angiotensin-converting enzyme	GO:0005515; F:protein binding; IPI:UniProtKB
P12821	ACE	Angiotensin-converting enzyme	GO:0008270; F:zinc ion binding; IDA:BHF-UCL
P12821	ACE	Angiotensin-converting enzyme	GO:0002005; P:angiotensin catabolic process in blood; IC:UniProtKB
P12821	ACE	Angiotensin-converting enzyme	GO:0002003; P:angiotensin maturation; TAS:Reactome
P12821	ACE	Angiotensin-converting enzyme	GO:0050482; P:arachidonic acid secretion; IDA:BHF-UCL
P12821	ACE	Angiotensin-converting enzyme	GO:0001974; P:blood vessel remodeling; IC:BHF-UCL
P12821	ACE	Angiotensin-converting enzyme	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P12821	ACE	Angiotensin-converting enzyme	GO:0060218; P:hematopoietic stem cell differentiation; IC:BHF-UCL
P12821	ACE	Angiotensin-converting enzyme	GO:0042447; P:hormone catabolic process; IDA:BHF-UCL
P12821	ACE	Angiotensin-converting enzyme	GO:0001822; P:kidney development; IMP:BHF-UCL
P12821	ACE	Angiotensin-converting enzyme	GO:0032943; P:mononuclear cell proliferation; IC:BHF-UCL
P12821	ACE	Angiotensin-converting enzyme	GO:0043171; P:peptide catabolic process; IDA:BHF-UCL
P12821	ACE	Angiotensin-converting enzyme	GO:0008217; P:regulation of blood pressure; ISS:BHF-UCL
P12821	ACE	Angiotensin-converting enzyme	GO:0002019; P:regulation of renal output by angiotensin; IC:BHF-UCL
P12821	ACE	Angiotensin-converting enzyme	GO:0014910; P:regulation of smooth muscle cell migration; ISS:BHF-UCL
P12821	ACE	Angiotensin-converting enzyme	GO:0003081; P:regulation of systemic arterial blood pressure by renin-angiotensin; IC:UniProtKB
P12821	ACE	Angiotensin-converting enzyme	GO:0019229; P:regulation of vasoconstriction; IC:UniProtKB
P12821	ACE	Angiotensin-converting enzyme	GO:0042312; P:regulation of vasodilation; IC:BHF-UCL
Q9GZZ6	CHRNA10	Neuronal acetylcholine receptor subunit alpha-10	GO:0004889; F:acetylcholine-activated cation-selective channel activity; IEA:Ensembl
Q9GZZ6	CHRNA10	Neuronal acetylcholine receptor subunit alpha-10	GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW
Q9GZZ6	CHRNA10	Neuronal acetylcholine receptor subunit alpha-10	GO:0005102; F:receptor binding; TAS:UniProtKB
Q9GZZ6	CHRNA10	Neuronal acetylcholine receptor subunit alpha-10	GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; IEA:Ensembl
Q9GZZ6	CHRNA10	Neuronal acetylcholine receptor subunit alpha-10	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q9GZZ6	CHRNA10	Neuronal acetylcholine receptor subunit alpha-10	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IGI:MGI
Q9GZZ6	CHRNA10	Neuronal acetylcholine receptor subunit alpha-10	GO:0042127; P:regulation of cell proliferation; TAS:UniProtKB
Q9GZZ6	CHRNA10	Neuronal acetylcholine receptor subunit alpha-10	GO:0007271; P:synaptic transmission, cholinergic; TAS:UniProtKB
Q15822	CHRNA2	Neuronal acetylcholine receptor subunit alpha-2	GO:0042166; F:acetylcholine binding; IEA:Ensembl
Q15822	CHRNA2	Neuronal acetylcholine receptor subunit alpha-2	GO:0015464; F:acetylcholine receptor activity; IDA:UniProtKB
Q15822	CHRNA2	Neuronal acetylcholine receptor subunit alpha-2	GO:0004889; F:acetylcholine-activated cation-selective channel activity; IDA:UniProtKB
Q15822	CHRNA2	Neuronal acetylcholine receptor subunit alpha-2	GO:0008144; F:drug binding; IEA:Ensembl
Q15822	CHRNA2	Neuronal acetylcholine receptor subunit alpha-2	GO:0006812; P:cation transport; IDA:GOC
Q15822	CHRNA2	Neuronal acetylcholine receptor subunit alpha-2	GO:0006811; P:ion transport; NAS:UniProtKB
Q15822	CHRNA2	Neuronal acetylcholine receptor subunit alpha-2	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q15822	CHRNA2	Neuronal acetylcholine receptor subunit alpha-2	GO:0007165; P:signal transduction; IDA:UniProtKB
Q15822	CHRNA2	Neuronal acetylcholine receptor subunit alpha-2	GO:0007268; P:synaptic transmission; TAS:Reactome
P32297	CHRNA3	Neuronal acetylcholine receptor subunit alpha-3	GO:0042166; F:acetylcholine binding; IC:UniProtKB
P32297	CHRNA3	Neuronal acetylcholine receptor subunit alpha-3	GO:0015464; F:acetylcholine receptor activity; IDA:UniProtKB
P32297	CHRNA3	Neuronal acetylcholine receptor subunit alpha-3	GO:0004889; F:acetylcholine-activated cation-selective channel activity; IDA:UniProtKB
P32297	CHRNA3	Neuronal acetylcholine receptor subunit alpha-3	GO:0015276; F:ligand-gated ion channel activity; TAS:DFLAT
P32297	CHRNA3	Neuronal acetylcholine receptor subunit alpha-3	GO:0007171; P:activation of transmembrane receptor protein tyrosine kinase activity; ISS:UniProtKB
P32297	CHRNA3	Neuronal acetylcholine receptor subunit alpha-3	GO:0035095; P:behavioral response to nicotine; IMP:UniProtKB
P32297	CHRNA3	Neuronal acetylcholine receptor subunit alpha-3	GO:0006812; P:cation transport; IDA:GOC
P32297	CHRNA3	Neuronal acetylcholine receptor subunit alpha-3	GO:0034220; P:ion transmembrane transport; TAS:GOC
P32297	CHRNA3	Neuronal acetylcholine receptor subunit alpha-3	GO:0006811; P:ion transport; NAS:UniProtKB
P32297	CHRNA3	Neuronal acetylcholine receptor subunit alpha-3	GO:0007626; P:locomotory behavior; ISS:UniProtKB
P32297	CHRNA3	Neuronal acetylcholine receptor subunit alpha-3	GO:0007399; P:nervous system development; IMP:UniProtKB
P32297	CHRNA3	Neuronal acetylcholine receptor subunit alpha-3	GO:0014056; P:regulation of acetylcholine secretion, neurotransmission; ISS:UniProtKB
P32297	CHRNA3	Neuronal acetylcholine receptor subunit alpha-3	GO:0048814; P:regulation of dendrite morphogenesis; ISS:UniProtKB
P32297	CHRNA3	Neuronal acetylcholine receptor subunit alpha-3	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; ISS:UniProtKB
P32297	CHRNA3	Neuronal acetylcholine receptor subunit alpha-3	GO:0042391; P:regulation of membrane potential; ISS:UniProtKB
P32297	CHRNA3	Neuronal acetylcholine receptor subunit alpha-3	GO:0006940; P:regulation of smooth muscle contraction; ISS:UniProtKB
P32297	CHRNA3	Neuronal acetylcholine receptor subunit alpha-3	GO:0007165; P:signal transduction; IDA:UniProtKB
P32297	CHRNA3	Neuronal acetylcholine receptor subunit alpha-3	GO:0007268; P:synaptic transmission; TAS:Reactome
P32297	CHRNA3	Neuronal acetylcholine receptor subunit alpha-3	GO:0060084; P:synaptic transmission involved in micturition; IMP:UniProtKB
P32297	CHRNA3	Neuronal acetylcholine receptor subunit alpha-3	GO:0007271; P:synaptic transmission, cholinergic; ISS:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0042166; F:acetylcholine binding; IC:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0015464; F:acetylcholine receptor activity; IDA:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0004889; F:acetylcholine-activated cation-selective channel activity; IDA:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0015276; F:ligand-gated ion channel activity; TAS:DFLAT
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0001508; P:action potential; ISS:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0042113; P:B cell activation; ISS:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0035095; P:behavioral response to nicotine; IMP:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0006816; P:calcium ion transport; ISS:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0050890; P:cognition; IMP:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0006281; P:DNA repair; IMP:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0035640; P:exploration behavior; IEA:Ensembl
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0034220; P:ion transmembrane transport; TAS:GOC
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0006811; P:ion transport; NAS:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0007626; P:locomotory behavior; IEA:Ensembl
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0051899; P:membrane depolarization; ISS:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0050877; P:neurological system process; IMP:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0014059; P:regulation of dopamine secretion; ISS:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0060080; P:regulation of inhibitory postsynaptic membrane potential; ISS:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0042391; P:regulation of membrane potential; ISS:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0001666; P:response to hypoxia; IDA:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0035094; P:response to nicotine; IDA:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0006979; P:response to oxidative stress; IMP:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0019233; P:sensory perception of pain; ISS:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0007165; P:signal transduction; IDA:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0007268; P:synaptic transmission; NAS:UniProtKB
P43681	CHRNA4	Neuronal acetylcholine receptor subunit alpha-4	GO:0007271; P:synaptic transmission, cholinergic; ISS:UniProtKB
P30532	CHRNA5	Neuronal acetylcholine receptor subunit alpha-5	GO:0015464; F:acetylcholine receptor activity; IDA:UniProtKB
P30532	CHRNA5	Neuronal acetylcholine receptor subunit alpha-5	GO:0004889; F:acetylcholine-activated cation-selective channel activity; NAS:UniProtKB
P30532	CHRNA5	Neuronal acetylcholine receptor subunit alpha-5	GO:0015276; F:ligand-gated ion channel activity; TAS:DFLAT
P30532	CHRNA5	Neuronal acetylcholine receptor subunit alpha-5	GO:0035095; P:behavioral response to nicotine; IMP:UniProtKB
P30532	CHRNA5	Neuronal acetylcholine receptor subunit alpha-5	GO:0006812; P:cation transport; NAS:GOC
P30532	CHRNA5	Neuronal acetylcholine receptor subunit alpha-5	GO:0034220; P:ion transmembrane transport; TAS:GOC
P30532	CHRNA5	Neuronal acetylcholine receptor subunit alpha-5	GO:0007165; P:signal transduction; NAS:UniProtKB
P30532	CHRNA5	Neuronal acetylcholine receptor subunit alpha-5	GO:0007268; P:synaptic transmission; TAS:UniProtKB
P30532	CHRNA5	Neuronal acetylcholine receptor subunit alpha-5	GO:0006810; P:transport; NAS:ProtInc
Q15825	CHRNA6	Neuronal acetylcholine receptor subunit alpha-6	GO:0015464; F:acetylcholine receptor activity; TAS:ProtInc
Q15825	CHRNA6	Neuronal acetylcholine receptor subunit alpha-6	GO:0004889; F:acetylcholine-activated cation-selective channel activity; TAS:ProtInc
Q15825	CHRNA6	Neuronal acetylcholine receptor subunit alpha-6	GO:0006812; P:cation transport; TAS:GOC
Q15825	CHRNA6	Neuronal acetylcholine receptor subunit alpha-6	GO:0051899; P:membrane depolarization; IEA:Ensembl
Q15825	CHRNA6	Neuronal acetylcholine receptor subunit alpha-6	GO:0014059; P:regulation of dopamine secretion; IEA:Ensembl
Q15825	CHRNA6	Neuronal acetylcholine receptor subunit alpha-6	GO:0007165; P:signal transduction; TAS:ProtInc
Q15825	CHRNA6	Neuronal acetylcholine receptor subunit alpha-6	GO:0007268; P:synaptic transmission; TAS:Reactome
Q15825	CHRNA6	Neuronal acetylcholine receptor subunit alpha-6	GO:0006810; P:transport; TAS:ProtInc
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0042166; F:acetylcholine binding; IDA:UniProtKB
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0015464; F:acetylcholine receptor activity; IDA:UniProtKB
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0004889; F:acetylcholine-activated cation-selective channel activity; IDA:UniProtKB
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0001540; F:beta-amyloid binding; IPI:UniProtKB
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0017081; F:chloride channel regulator activity; IDA:UniProtKB
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0008144; F:drug binding; IEA:Ensembl
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0015643; F:toxic substance binding; IDA:UniProtKB
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0000187; P:activation of MAPK activity; IDA:UniProtKB
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0008306; P:associative learning; IEA:Ensembl
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0042113; P:B cell activation; IEA:Ensembl
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0048149; P:behavioral response to ethanol; IEA:Ensembl
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0035095; P:behavioral response to nicotine; IEA:Ensembl
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0006816; P:calcium ion transport; IDA:UniProtKB
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0006874; P:cellular calcium ion homeostasis; IMP:UniProtKB
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0050890; P:cognition; IMP:UniProtKB
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0042416; P:dopamine biosynthetic process; IEA:Ensembl
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0006897; P:endocytosis; IEA:Ensembl
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0060112; P:generation of ovulation cycle rhythm; IEA:Ensembl
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0006811; P:ion transport; NAS:UniProtKB
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0007613; P:memory; NAS:UniProtKB
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0032691; P:negative regulation of interleukin-1 beta production; IEA:Ensembl
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0032715; P:negative regulation of interleukin-6 production; IEA:Ensembl
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0032720; P:negative regulation of tumor necrosis factor production; IMP:UniProtKB
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0019228; P:neuronal action potential; IEA:Ensembl
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0001988; P:positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure; IEA:Ensembl
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0014061; P:regulation of norepinephrine secretion; IEA:Ensembl
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0032225; P:regulation of synaptic transmission, dopaminergic; IEA:Ensembl
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0032094; P:response to food; IEA:Ensembl
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0001666; P:response to hypoxia; IDA:UniProtKB
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0035094; P:response to nicotine; IDA:UniProtKB
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0007165; P:signal transduction; IDA:UniProtKB
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0030317; P:sperm motility; IEA:Ensembl
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0007268; P:synaptic transmission; TAS:Reactome
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0007271; P:synaptic transmission, cholinergic; IEA:Ensembl
P36544	CHRNA7	Neuronal acetylcholine receptor subunit alpha-7	GO:0042110; P:T cell activation; IEA:Ensembl
Q9UGM1	CHRNA9	Neuronal acetylcholine receptor subunit alpha-9	GO:0004889; F:acetylcholine-activated cation-selective channel activity; IEA:Ensembl
Q9UGM1	CHRNA9	Neuronal acetylcholine receptor subunit alpha-9	GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW
Q9UGM1	CHRNA9	Neuronal acetylcholine receptor subunit alpha-9	GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; IEA:Ensembl
Q9UGM1	CHRNA9	Neuronal acetylcholine receptor subunit alpha-9	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q9UGM1	CHRNA9	Neuronal acetylcholine receptor subunit alpha-9	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IGI:MGI
Q9UGM1	CHRNA9	Neuronal acetylcholine receptor subunit alpha-9	GO:0007268; P:synaptic transmission; TAS:Reactome
P02708	CHRNA1	Acetylcholine receptor subunit alpha	GO:0042166; F:acetylcholine binding; IEA:Ensembl
P02708	CHRNA1	Acetylcholine receptor subunit alpha	GO:0015464; F:acetylcholine receptor activity; TAS:ProtInc
P02708	CHRNA1	Acetylcholine receptor subunit alpha	GO:0004889; F:acetylcholine-activated cation-selective channel activity; IMP:MGI
P02708	CHRNA1	Acetylcholine receptor subunit alpha	GO:0005216; F:ion channel activity; TAS:ProtInc
P02708	CHRNA1	Acetylcholine receptor subunit alpha	GO:0006812; P:cation transport; IMP:GOC
P02708	CHRNA1	Acetylcholine receptor subunit alpha	GO:0034220; P:ion transmembrane transport; TAS:GOC
P02708	CHRNA1	Acetylcholine receptor subunit alpha	GO:0046716; P:muscle cell cellular homeostasis; IMP:BHF-UCL
P02708	CHRNA1	Acetylcholine receptor subunit alpha	GO:0050881; P:musculoskeletal movement; IMP:BHF-UCL
P02708	CHRNA1	Acetylcholine receptor subunit alpha	GO:0007528; P:neuromuscular junction development; IMP:MGI
P02708	CHRNA1	Acetylcholine receptor subunit alpha	GO:0050905; P:neuromuscular process; IMP:BHF-UCL
P02708	CHRNA1	Acetylcholine receptor subunit alpha	GO:0007274; P:neuromuscular synaptic transmission; IMP:MGI
P02708	CHRNA1	Acetylcholine receptor subunit alpha	GO:0070050; P:neuron cellular homeostasis; IMP:BHF-UCL
P02708	CHRNA1	Acetylcholine receptor subunit alpha	GO:0019228; P:neuronal action potential; IMP:BHF-UCL
P02708	CHRNA1	Acetylcholine receptor subunit alpha	GO:0042391; P:regulation of membrane potential; IMP:BHF-UCL
P02708	CHRNA1	Acetylcholine receptor subunit alpha	GO:0007165; P:signal transduction; TAS:ProtInc
P02708	CHRNA1	Acetylcholine receptor subunit alpha	GO:0003009; P:skeletal muscle contraction; IMP:BHF-UCL
P02708	CHRNA1	Acetylcholine receptor subunit alpha	GO:0048630; P:skeletal muscle tissue growth; IMP:BHF-UCL
P02708	CHRNA1	Acetylcholine receptor subunit alpha	GO:0007268; P:synaptic transmission; TAS:Reactome
P02708	CHRNA1	Acetylcholine receptor subunit alpha	GO:0006810; P:transport; TAS:ProtInc
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0042166; F:acetylcholine binding; IMP:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0015464; F:acetylcholine receptor activity; IDA:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0004889; F:acetylcholine-activated cation-selective channel activity; IDA:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0008144; F:drug binding; IEA:Ensembl
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0015276; F:ligand-gated ion channel activity; TAS:DFLAT
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0001508; P:action potential; IEA:Ensembl
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0008306; P:associative learning; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0042113; P:B cell activation; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0035095; P:behavioral response to nicotine; IMP:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0006816; P:calcium ion transport; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0021952; P:central nervous system projection neuron axonogenesis; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0050890; P:cognition; IMP:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0001661; P:conditioned taste aversion; IEA:Ensembl
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0034220; P:ion transmembrane transport; TAS:GOC
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0006811; P:ion transport; NAS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0021771; P:lateral geniculate nucleus development; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0007612; P:learning; IMP:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0007626; P:locomotory behavior; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0051899; P:membrane depolarization; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0007613; P:memory; IMP:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0045759; P:negative regulation of action potential; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0050877; P:neurological system process; IMP:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0021631; P:optic nerve morphogenesis; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0030890; P:positive regulation of B cell proliferation; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0033603; P:positive regulation of dopamine secretion; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0032226; P:positive regulation of synaptic transmission, dopaminergic; IEA:Ensembl
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0045188; P:regulation of circadian sleep/wake cycle, non-REM sleep; IEA:Ensembl
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0042320; P:regulation of circadian sleep/wake cycle, REM sleep; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0048814; P:regulation of dendrite morphogenesis; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0042053; P:regulation of dopamine metabolic process; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0014059; P:regulation of dopamine secretion; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0051963; P:regulation of synapse assembly; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0032225; P:regulation of synaptic transmission, dopaminergic; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0042220; P:response to cocaine; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0045471; P:response to ethanol; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0001666; P:response to hypoxia; IDA:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0035094; P:response to nicotine; IDA:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0019233; P:sensory perception of pain; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0007605; P:sensory perception of sound; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0007165; P:signal transduction; IDA:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0006939; P:smooth muscle contraction; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0035176; P:social behavior; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0007268; P:synaptic transmission; TAS:Reactome
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0060084; P:synaptic transmission involved in micturition; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0007271; P:synaptic transmission, cholinergic; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0021562; P:vestibulocochlear nerve development; ISS:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0008542; P:visual learning; IMP:UniProtKB
P17787	CHRNB2	Neuronal acetylcholine receptor subunit beta-2	GO:0007601; P:visual perception; ISS:UniProtKB
Q05901	CHRNB3	Neuronal acetylcholine receptor subunit beta-3	GO:0042166; F:acetylcholine binding; IEA:Ensembl
Q05901	CHRNB3	Neuronal acetylcholine receptor subunit beta-3	GO:0004889; F:acetylcholine-activated cation-selective channel activity; TAS:ProtInc
Q05901	CHRNB3	Neuronal acetylcholine receptor subunit beta-3	GO:0015267; F:channel activity; TAS:ProtInc
Q05901	CHRNB3	Neuronal acetylcholine receptor subunit beta-3	GO:0008144; F:drug binding; IEA:Ensembl
Q05901	CHRNB3	Neuronal acetylcholine receptor subunit beta-3	GO:0006812; P:cation transport; TAS:GOC
Q05901	CHRNB3	Neuronal acetylcholine receptor subunit beta-3	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q05901	CHRNB3	Neuronal acetylcholine receptor subunit beta-3	GO:0007165; P:signal transduction; TAS:ProtInc
Q05901	CHRNB3	Neuronal acetylcholine receptor subunit beta-3	GO:0007268; P:synaptic transmission; TAS:Reactome
Q05901	CHRNB3	Neuronal acetylcholine receptor subunit beta-3	GO:0007271; P:synaptic transmission, cholinergic; TAS:ProtInc
Q05901	CHRNB3	Neuronal acetylcholine receptor subunit beta-3	GO:0055085; P:transmembrane transport; TAS:GOC
Q05901	CHRNB3	Neuronal acetylcholine receptor subunit beta-3	GO:0006810; P:transport; TAS:ProtInc
P30926	CHRNB4	Neuronal acetylcholine receptor subunit beta-4	GO:0015464; F:acetylcholine receptor activity; IDA:UniProtKB
P30926	CHRNB4	Neuronal acetylcholine receptor subunit beta-4	GO:0004889; F:acetylcholine-activated cation-selective channel activity; TAS:UniProtKB
P30926	CHRNB4	Neuronal acetylcholine receptor subunit beta-4	GO:0015276; F:ligand-gated ion channel activity; TAS:DFLAT
P30926	CHRNB4	Neuronal acetylcholine receptor subunit beta-4	GO:0001508; P:action potential; IEA:Ensembl
P30926	CHRNB4	Neuronal acetylcholine receptor subunit beta-4	GO:0035095; P:behavioral response to nicotine; IEA:Ensembl
P30926	CHRNB4	Neuronal acetylcholine receptor subunit beta-4	GO:0006812; P:cation transport; TAS:GOC
P30926	CHRNB4	Neuronal acetylcholine receptor subunit beta-4	GO:0034220; P:ion transmembrane transport; TAS:GOC
P30926	CHRNB4	Neuronal acetylcholine receptor subunit beta-4	GO:0006811; P:ion transport; TAS:UniProtKB
P30926	CHRNB4	Neuronal acetylcholine receptor subunit beta-4	GO:0007626; P:locomotory behavior; IEA:Ensembl
P30926	CHRNB4	Neuronal acetylcholine receptor subunit beta-4	GO:0046928; P:regulation of neurotransmitter secretion; NAS:UniProtKB
P30926	CHRNB4	Neuronal acetylcholine receptor subunit beta-4	GO:0006940; P:regulation of smooth muscle contraction; IEA:Ensembl
P30926	CHRNB4	Neuronal acetylcholine receptor subunit beta-4	GO:0007165; P:signal transduction; IDA:UniProtKB
P30926	CHRNB4	Neuronal acetylcholine receptor subunit beta-4	GO:0006939; P:smooth muscle contraction; IEA:Ensembl
P30926	CHRNB4	Neuronal acetylcholine receptor subunit beta-4	GO:0007268; P:synaptic transmission; TAS:Reactome
P30926	CHRNB4	Neuronal acetylcholine receptor subunit beta-4	GO:0060084; P:synaptic transmission involved in micturition; IMP:UniProtKB
P30926	CHRNB4	Neuronal acetylcholine receptor subunit beta-4	GO:0007271; P:synaptic transmission, cholinergic; TAS:ProtInc
P11230	CHRNB1	Acetylcholine receptor subunit beta	GO:0042166; F:acetylcholine binding; ISS:UniProtKB
P11230	CHRNB1	Acetylcholine receptor subunit beta	GO:0004889; F:acetylcholine-activated cation-selective channel activity; IEA:Ensembl
P11230	CHRNB1	Acetylcholine receptor subunit beta	GO:0015267; F:channel activity; IMP:UniProtKB
P11230	CHRNB1	Acetylcholine receptor subunit beta	GO:0015276; F:ligand-gated ion channel activity; ISS:UniProtKB
P11230	CHRNB1	Acetylcholine receptor subunit beta	GO:0035095; P:behavioral response to nicotine; IMP:UniProtKB
P11230	CHRNB1	Acetylcholine receptor subunit beta	GO:0006812; P:cation transport; IMP:UniProtKB
P11230	CHRNB1	Acetylcholine receptor subunit beta	GO:0034220; P:ion transmembrane transport; ISS:GOC
P11230	CHRNB1	Acetylcholine receptor subunit beta	GO:0006936; P:muscle contraction; IMP:UniProtKB
P11230	CHRNB1	Acetylcholine receptor subunit beta	GO:0048747; P:muscle fiber development; IMP:UniProtKB
P11230	CHRNB1	Acetylcholine receptor subunit beta	GO:0050877; P:neurological system process; IMP:UniProtKB
P11230	CHRNB1	Acetylcholine receptor subunit beta	GO:0007274; P:neuromuscular synaptic transmission; IMP:UniProtKB
P11230	CHRNB1	Acetylcholine receptor subunit beta	GO:0001941; P:postsynaptic membrane organization; IMP:UniProtKB
P11230	CHRNB1	Acetylcholine receptor subunit beta	GO:0042391; P:regulation of membrane potential; ISS:UniProtKB
P11230	CHRNB1	Acetylcholine receptor subunit beta	GO:0007165; P:signal transduction; IMP:UniProtKB
P11230	CHRNB1	Acetylcholine receptor subunit beta	GO:0007271; P:synaptic transmission, cholinergic; IMP:UniProtKB
P11230	CHRNB1	Acetylcholine receptor subunit beta	GO:0055085; P:transmembrane transport; IMP:GOC
Q07001	CHRND	Acetylcholine receptor subunit delta	GO:0042166; F:acetylcholine binding; IEA:Ensembl
Q07001	CHRND	Acetylcholine receptor subunit delta	GO:0004889; F:acetylcholine-activated cation-selective channel activity; TAS:ProtInc
Q07001	CHRND	Acetylcholine receptor subunit delta	GO:0006812; P:cation transport; TAS:GOC
Q07001	CHRND	Acetylcholine receptor subunit delta	GO:0006936; P:muscle contraction; TAS:ProtInc
Q07001	CHRND	Acetylcholine receptor subunit delta	GO:0050881; P:musculoskeletal movement; IMP:BHF-UCL
Q07001	CHRND	Acetylcholine receptor subunit delta	GO:0050905; P:neuromuscular process; NAS:BHF-UCL
Q07001	CHRND	Acetylcholine receptor subunit delta	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
Q07001	CHRND	Acetylcholine receptor subunit delta	GO:0007165; P:signal transduction; TAS:ProtInc
Q07001	CHRND	Acetylcholine receptor subunit delta	GO:0048630; P:skeletal muscle tissue growth; IMP:BHF-UCL
Q07001	CHRND	Acetylcholine receptor subunit delta	GO:0007268; P:synaptic transmission; TAS:Reactome
Q07001	CHRND	Acetylcholine receptor subunit delta	GO:0006810; P:transport; TAS:ProtInc
Q04844	CHRNE	Acetylcholine receptor subunit epsilon	GO:0015464; F:acetylcholine receptor activity; TAS:ProtInc
Q04844	CHRNE	Acetylcholine receptor subunit epsilon	GO:0004889; F:acetylcholine-activated cation-selective channel activity; TAS:ProtInc
Q04844	CHRNE	Acetylcholine receptor subunit epsilon	GO:0008324; F:cation transmembrane transporter activity; TAS:ProtInc
Q04844	CHRNE	Acetylcholine receptor subunit epsilon	GO:0006812; P:cation transport; TAS:GOC
Q04844	CHRNE	Acetylcholine receptor subunit epsilon	GO:0006936; P:muscle contraction; TAS:ProtInc
Q04844	CHRNE	Acetylcholine receptor subunit epsilon	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
Q04844	CHRNE	Acetylcholine receptor subunit epsilon	GO:0007165; P:signal transduction; TAS:ProtInc
Q04844	CHRNE	Acetylcholine receptor subunit epsilon	GO:0007268; P:synaptic transmission; TAS:Reactome
Q04844	CHRNE	Acetylcholine receptor subunit epsilon	GO:0007271; P:synaptic transmission, cholinergic; TAS:ProtInc
Q04844	CHRNE	Acetylcholine receptor subunit epsilon	GO:0006810; P:transport; TAS:ProtInc
P07510	CHRNG	Acetylcholine receptor subunit gamma	GO:0015464; F:acetylcholine receptor activity; TAS:ProtInc
P07510	CHRNG	Acetylcholine receptor subunit gamma	GO:0004889; F:acetylcholine-activated cation-selective channel activity; IEA:Ensembl
P07510	CHRNG	Acetylcholine receptor subunit gamma	GO:0015267; F:channel activity; TAS:ProtInc
P07510	CHRNG	Acetylcholine receptor subunit gamma	GO:0006936; P:muscle contraction; TAS:ProtInc
P07510	CHRNG	Acetylcholine receptor subunit gamma	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
P07510	CHRNG	Acetylcholine receptor subunit gamma	GO:0007165; P:signal transduction; TAS:ProtInc
P07510	CHRNG	Acetylcholine receptor subunit gamma	GO:0007268; P:synaptic transmission; TAS:Reactome
P07510	CHRNG	Acetylcholine receptor subunit gamma	GO:0055085; P:transmembrane transport; TAS:GOC
P07510	CHRNG	Acetylcholine receptor subunit gamma	GO:0006810; P:transport; TAS:ProtInc
Q9UKV3	ACIN1	Apoptotic chromatin condensation inducer in the nucleus	GO:0016887; F:ATPase activity; NAS:UniProtKB
Q9UKV3	ACIN1	Apoptotic chromatin condensation inducer in the nucleus	GO:0019899; F:enzyme binding; NAS:UniProtKB
Q9UKV3	ACIN1	Apoptotic chromatin condensation inducer in the nucleus	GO:0003676; F:nucleic acid binding; NAS:UniProtKB
Q9UKV3	ACIN1	Apoptotic chromatin condensation inducer in the nucleus	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9UKV3	ACIN1	Apoptotic chromatin condensation inducer in the nucleus	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UKV3	ACIN1	Apoptotic chromatin condensation inducer in the nucleus	GO:0005515; F:protein binding; IPI:IntAct
Q9UKV3	ACIN1	Apoptotic chromatin condensation inducer in the nucleus	GO:0030263; P:apoptotic chromosome condensation; IDA:UniProtKB
Q9UKV3	ACIN1	Apoptotic chromatin condensation inducer in the nucleus	GO:0006915; P:apoptotic process; TAS:Reactome
Q9UKV3	ACIN1	Apoptotic chromatin condensation inducer in the nucleus	GO:0006200; P:ATP catabolic process; NAS:GOC
Q9UKV3	ACIN1	Apoptotic chromatin condensation inducer in the nucleus	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q9UKV3	ACIN1	Apoptotic chromatin condensation inducer in the nucleus	GO:0030218; P:erythrocyte differentiation; IEP:UniProtKB
Q9UKV3	ACIN1	Apoptotic chromatin condensation inducer in the nucleus	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9UKV3	ACIN1	Apoptotic chromatin condensation inducer in the nucleus	GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; IDA:UniProtKB
Q9UKV3	ACIN1	Apoptotic chromatin condensation inducer in the nucleus	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q9UKV3	ACIN1	Apoptotic chromatin condensation inducer in the nucleus	GO:0045657; P:positive regulation of monocyte differentiation; IEP:UniProtKB
Q9UKV3	ACIN1	Apoptotic chromatin condensation inducer in the nucleus	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q07912	TNK2	Activated CDC42 kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q07912	TNK2	Activated CDC42 kinase 1	GO:0005154; F:epidermal growth factor receptor binding; IDA:BHF-UCL
Q07912	TNK2	Activated CDC42 kinase 1	GO:0005095; F:GTPase inhibitor activity; TAS:ProtInc
Q07912	TNK2	Activated CDC42 kinase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q07912	TNK2	Activated CDC42 kinase 1	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; TAS:ProtInc
Q07912	TNK2	Activated CDC42 kinase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q07912	TNK2	Activated CDC42 kinase 1	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q07912	TNK2	Activated CDC42 kinase 1	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IDA:UniProtKB
Q07912	TNK2	Activated CDC42 kinase 1	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
Q07912	TNK2	Activated CDC42 kinase 1	GO:0050699; F:WW domain binding; ISS:BHF-UCL
Q07912	TNK2	Activated CDC42 kinase 1	GO:0007166; P:cell surface receptor signaling pathway; TAS:UniProtKB
Q07912	TNK2	Activated CDC42 kinase 1	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q07912	TNK2	Activated CDC42 kinase 1	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
Q07912	TNK2	Activated CDC42 kinase 1	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:GOC
Q07912	TNK2	Activated CDC42 kinase 1	GO:0016310; P:phosphorylation; IDA:UniProtKB
Q07912	TNK2	Activated CDC42 kinase 1	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
Q07912	TNK2	Activated CDC42 kinase 1	GO:2000369; P:regulation of clathrin-mediated endocytosis; IDA:UniProtKB
Q07912	TNK2	Activated CDC42 kinase 1	GO:0007264; P:small GTPase mediated signal transduction; TAS:ProtInc
Q16570	ACKR1	Atypical chemokine receptor 1	GO:0019957; F:C-C chemokine binding; IPI:BHF-UCL
Q16570	ACKR1	Atypical chemokine receptor 1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q16570	ACKR1	Atypical chemokine receptor 1	GO:0004872; F:receptor activity; TAS:ProtInc
Q16570	ACKR1	Atypical chemokine receptor 1	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q16570	ACKR1	Atypical chemokine receptor 1	GO:0070098; P:chemokine-mediated signaling pathway; IEA:InterPro
Q16570	ACKR1	Atypical chemokine receptor 1	GO:0006952; P:defense response; NAS:UniProtKB
Q16570	ACKR1	Atypical chemokine receptor 1	GO:0006954; P:inflammatory response; IEA:Ensembl
Q16570	ACKR1	Atypical chemokine receptor 1	GO:0032642; P:regulation of chemokine production; IEA:Ensembl
O00590	ACKR2	Atypical chemokine receptor 2	GO:0016493; F:C-C chemokine receptor activity; IEA:Ensembl
O00590	ACKR2	Atypical chemokine receptor 2	GO:0016494; F:C-X-C chemokine receptor activity; IEA:InterPro
O00590	ACKR2	Atypical chemokine receptor 2	GO:0004950; F:chemokine receptor activity; TAS:ProtInc
O00590	ACKR2	Atypical chemokine receptor 2	GO:0005044; F:scavenger receptor activity; IMP:UniProtKB
O00590	ACKR2	Atypical chemokine receptor 2	GO:0070098; P:chemokine-mediated signaling pathway; TAS:GOC
O00590	ACKR2	Atypical chemokine receptor 2	GO:0006935; P:chemotaxis; TAS:ProtInc
O00590	ACKR2	Atypical chemokine receptor 2	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
O00590	ACKR2	Atypical chemokine receptor 2	GO:0006955; P:immune response; TAS:ProtInc
O00590	ACKR2	Atypical chemokine receptor 2	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
O00590	ACKR2	Atypical chemokine receptor 2	GO:0007275; P:multicellular organismal development; TAS:ProtInc
O00590	ACKR2	Atypical chemokine receptor 2	GO:0042119; P:neutrophil activation; IEA:InterPro
O00590	ACKR2	Atypical chemokine receptor 2	GO:0006898; P:receptor-mediated endocytosis; IMP:GOC
P25106	ACKR3	Atypical chemokine receptor 3	GO:0019958; F:C-X-C chemokine binding; IMP:UniProtKB
P25106	ACKR3	Atypical chemokine receptor 3	GO:0016494; F:C-X-C chemokine receptor activity; IMP:BHF-UCL
P25106	ACKR3	Atypical chemokine receptor 3	GO:0015026; F:coreceptor activity; IEA:InterPro
P25106	ACKR3	Atypical chemokine receptor 3	GO:0005515; F:protein binding; IPI:UniProtKB
P25106	ACKR3	Atypical chemokine receptor 3	GO:0005044; F:scavenger receptor activity; IMP:UniProtKB
P25106	ACKR3	Atypical chemokine receptor 3	GO:0001525; P:angiogenesis; IEA:InterPro
P25106	ACKR3	Atypical chemokine receptor 3	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P25106	ACKR3	Atypical chemokine receptor 3	GO:0070098; P:chemokine-mediated signaling pathway; IMP:BHF-UCL
P25106	ACKR3	Atypical chemokine receptor 3	GO:0006935; P:chemotaxis; IEA:InterPro
P25106	ACKR3	Atypical chemokine receptor 3	GO:1902230; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; IMP:BHF-UCL
P25106	ACKR3	Atypical chemokine receptor 3	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB
P25106	ACKR3	Atypical chemokine receptor 3	GO:0031623; P:receptor internalization; IMP:UniProtKB
P25106	ACKR3	Atypical chemokine receptor 3	GO:0001570; P:vasculogenesis; IEA:InterPro
P25106	ACKR3	Atypical chemokine receptor 3	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9NPB9	ACKR4	Atypical chemokine receptor 4	GO:0004950; F:chemokine receptor activity; IDA:UniProtKB
Q9NPB9	ACKR4	Atypical chemokine receptor 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NPB9	ACKR4	Atypical chemokine receptor 4	GO:0005044; F:scavenger receptor activity; IEA:InterPro
Q9NPB9	ACKR4	Atypical chemokine receptor 4	GO:0070098; P:chemokine-mediated signaling pathway; IDA:GOC
Q9NPB9	ACKR4	Atypical chemokine receptor 4	GO:0006935; P:chemotaxis; TAS:ProtInc
Q9NPB9	ACKR4	Atypical chemokine receptor 4	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q9NPB9	ACKR4	Atypical chemokine receptor 4	GO:0006955; P:immune response; TAS:ProtInc
O96019	ACTL6A	Actin-like protein 6A	GO:0003682; F:chromatin binding; TAS:ProtInc
O96019	ACTL6A	Actin-like protein 6A	GO:0005515; F:protein binding; IPI:IntAct
O96019	ACTL6A	Actin-like protein 6A	GO:0003713; F:transcription coactivator activity; NAS:BHF-UCL
O96019	ACTL6A	Actin-like protein 6A	GO:0043044; P:ATP-dependent chromatin remodeling; IDA:UniProt
O96019	ACTL6A	Actin-like protein 6A	GO:0006325; P:chromatin organization; TAS:Reactome
O96019	ACTL6A	Actin-like protein 6A	GO:0006338; P:chromatin remodeling; IDA:BHF-UCL
O96019	ACTL6A	Actin-like protein 6A	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
O96019	ACTL6A	Actin-like protein 6A	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
O96019	ACTL6A	Actin-like protein 6A	GO:0043968; P:histone H2A acetylation; IDA:UniProtKB
O96019	ACTL6A	Actin-like protein 6A	GO:0043967; P:histone H4 acetylation; IDA:UniProtKB
O96019	ACTL6A	Actin-like protein 6A	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
O96019	ACTL6A	Actin-like protein 6A	GO:0003407; P:neural retina development; IEP:BHF-UCL
O96019	ACTL6A	Actin-like protein 6A	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
O96019	ACTL6A	Actin-like protein 6A	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; NAS:BHF-UCL
O96019	ACTL6A	Actin-like protein 6A	GO:0007165; P:signal transduction; TAS:ProtInc
O96019	ACTL6A	Actin-like protein 6A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O94805	ACTL6B	Actin-like protein 6B	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
O94805	ACTL6B	Actin-like protein 6B	GO:0003713; F:transcription coactivator activity; NAS:BHF-UCL
O94805	ACTL6B	Actin-like protein 6B	GO:0006325; P:chromatin organization; NAS:UniProtKB
O94805	ACTL6B	Actin-like protein 6B	GO:0006338; P:chromatin remodeling; IDA:BHF-UCL
O94805	ACTL6B	Actin-like protein 6B	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
O94805	ACTL6B	Actin-like protein 6B	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; NAS:BHF-UCL
O94805	ACTL6B	Actin-like protein 6B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y615	ACTL7A	Actin-like protein 7A	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
Q9Y614	ACTL7B	Actin-like protein 7B	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P53396	ACLY	ATP-citrate synthase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P53396	ACLY	ATP-citrate synthase	GO:0003878; F:ATP citrate synthase activity; TAS:UniProtKB
P53396	ACLY	ATP-citrate synthase	GO:0048037; F:cofactor binding; IEA:InterPro
P53396	ACLY	ATP-citrate synthase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P53396	ACLY	ATP-citrate synthase	GO:0005515; F:protein binding; IPI:UniProtKB
P53396	ACLY	ATP-citrate synthase	GO:0004775; F:succinate-CoA ligase (ADP-forming) activity; IEA:InterPro
P53396	ACLY	ATP-citrate synthase	GO:0006200; P:ATP catabolic process; TAS:ProtInc
P53396	ACLY	ATP-citrate synthase	GO:0044262; P:cellular carbohydrate metabolic process; IEA:InterPro
P53396	ACLY	ATP-citrate synthase	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P53396	ACLY	ATP-citrate synthase	GO:0006101; P:citrate metabolic process; TAS:ProtInc
P53396	ACLY	ATP-citrate synthase	GO:0015936; P:coenzyme A metabolic process; TAS:ProtInc
P53396	ACLY	ATP-citrate synthase	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P53396	ACLY	ATP-citrate synthase	GO:0008610; P:lipid biosynthetic process; IDA:UniProtKB
P53396	ACLY	ATP-citrate synthase	GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome
P53396	ACLY	ATP-citrate synthase	GO:0031325; P:positive regulation of cellular metabolic process; TAS:Reactome
P53396	ACLY	ATP-citrate synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P53396	ACLY	ATP-citrate synthase	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
P11229	CHRM1	Muscarinic acetylcholine receptor M1	GO:0008144; F:drug binding; IEA:Ensembl
P11229	CHRM1	Muscarinic acetylcholine receptor M1	GO:0016907; F:G-protein coupled acetylcholine receptor activity; TAS:ProtInc
P11229	CHRM1	Muscarinic acetylcholine receptor M1	GO:0004435; F:phosphatidylinositol phospholipase C activity; TAS:ProtInc
P11229	CHRM1	Muscarinic acetylcholine receptor M1	GO:0008283; P:cell proliferation; TAS:ProtInc
P11229	CHRM1	Muscarinic acetylcholine receptor M1	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P11229	CHRM1	Muscarinic acetylcholine receptor M1	GO:0050890; P:cognition; IEA:InterPro
P11229	CHRM1	Muscarinic acetylcholine receptor M1	GO:0007213; P:G-protein coupled acetylcholine receptor signaling pathway; TAS:ProtInc
P11229	CHRM1	Muscarinic acetylcholine receptor M1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P11229	CHRM1	Muscarinic acetylcholine receptor M1	GO:0007399; P:nervous system development; TAS:ProtInc
P11229	CHRM1	Muscarinic acetylcholine receptor M1	GO:0007274; P:neuromuscular synaptic transmission; IEA:Ensembl
P11229	CHRM1	Muscarinic acetylcholine receptor M1	GO:0007207; P:phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway; TAS:ProtInc
P11229	CHRM1	Muscarinic acetylcholine receptor M1	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P11229	CHRM1	Muscarinic acetylcholine receptor M1	GO:0090316; P:positive regulation of intracellular protein transport; IEA:Ensembl
P11229	CHRM1	Muscarinic acetylcholine receptor M1	GO:0043270; P:positive regulation of ion transport; IGI:MGI
P11229	CHRM1	Muscarinic acetylcholine receptor M1	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; TAS:ProtInc
P11229	CHRM1	Muscarinic acetylcholine receptor M1	GO:0040012; P:regulation of locomotion; IEA:Ensembl
P11229	CHRM1	Muscarinic acetylcholine receptor M1	GO:0046541; P:saliva secretion; IEA:InterPro
P11229	CHRM1	Muscarinic acetylcholine receptor M1	GO:0007165; P:signal transduction; TAS:ProtInc
P08172	CHRM2	Muscarinic acetylcholine receptor M2	GO:0016907; F:G-protein coupled acetylcholine receptor activity; TAS:ProtInc
P08172	CHRM2	Muscarinic acetylcholine receptor M2	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; TAS:ProtInc
P08172	CHRM2	Muscarinic acetylcholine receptor M2	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P08172	CHRM2	Muscarinic acetylcholine receptor M2	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P08172	CHRM2	Muscarinic acetylcholine receptor M2	GO:0007399; P:nervous system development; TAS:ProtInc
P08172	CHRM2	Muscarinic acetylcholine receptor M2	GO:0007207; P:phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway; TAS:ProtInc
P08172	CHRM2	Muscarinic acetylcholine receptor M2	GO:0008016; P:regulation of heart contraction; TAS:ProtInc
P08172	CHRM2	Muscarinic acetylcholine receptor M2	GO:0009615; P:response to virus; IEP:UniProtKB
P20309	CHRM3	Muscarinic acetylcholine receptor M3	GO:0042166; F:acetylcholine binding; IEA:Ensembl
P20309	CHRM3	Muscarinic acetylcholine receptor M3	GO:0008144; F:drug binding; IEA:Ensembl
P20309	CHRM3	Muscarinic acetylcholine receptor M3	GO:0016907; F:G-protein coupled acetylcholine receptor activity; TAS:ProtInc
P20309	CHRM3	Muscarinic acetylcholine receptor M3	GO:0004435; F:phosphatidylinositol phospholipase C activity; TAS:ProtInc
P20309	CHRM3	Muscarinic acetylcholine receptor M3	GO:0005515; F:protein binding; IPI:IntAct
P20309	CHRM3	Muscarinic acetylcholine receptor M3	GO:0004872; F:receptor activity; TAS:ProtInc
P20309	CHRM3	Muscarinic acetylcholine receptor M3	GO:0008283; P:cell proliferation; TAS:ProtInc
P20309	CHRM3	Muscarinic acetylcholine receptor M3	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P20309	CHRM3	Muscarinic acetylcholine receptor M3	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P20309	CHRM3	Muscarinic acetylcholine receptor M3	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P20309	CHRM3	Muscarinic acetylcholine receptor M3	GO:0007399; P:nervous system development; TAS:ProtInc
P20309	CHRM3	Muscarinic acetylcholine receptor M3	GO:0045987; P:positive regulation of smooth muscle contraction; IEA:Ensembl
P20309	CHRM3	Muscarinic acetylcholine receptor M3	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P20309	CHRM3	Muscarinic acetylcholine receptor M3	GO:0003056; P:regulation of vascular smooth muscle contraction; IEA:Ensembl
P20309	CHRM3	Muscarinic acetylcholine receptor M3	GO:0046541; P:saliva secretion; IEA:InterPro
P20309	CHRM3	Muscarinic acetylcholine receptor M3	GO:0007165; P:signal transduction; TAS:ProtInc
P20309	CHRM3	Muscarinic acetylcholine receptor M3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P20309	CHRM3	Muscarinic acetylcholine receptor M3	GO:0006939; P:smooth muscle contraction; IEA:Ensembl
P08173	CHRM4	Muscarinic acetylcholine receptor M4	GO:0016907; F:G-protein coupled acetylcholine receptor activity; TAS:ProtInc
P08173	CHRM4	Muscarinic acetylcholine receptor M4	GO:0007197; P:adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway; IEA:Ensembl
P08173	CHRM4	Muscarinic acetylcholine receptor M4	GO:0008283; P:cell proliferation; TAS:ProtInc
P08173	CHRM4	Muscarinic acetylcholine receptor M4	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P08173	CHRM4	Muscarinic acetylcholine receptor M4	GO:0007213; P:G-protein coupled acetylcholine receptor signaling pathway; TAS:ProtInc
P08173	CHRM4	Muscarinic acetylcholine receptor M4	GO:0040012; P:regulation of locomotion; IEA:InterPro
P08173	CHRM4	Muscarinic acetylcholine receptor M4	GO:0007165; P:signal transduction; TAS:ProtInc
P08912	CHRM5	Muscarinic acetylcholine receptor M5	GO:0016907; F:G-protein coupled acetylcholine receptor activity; TAS:ProtInc
P08912	CHRM5	Muscarinic acetylcholine receptor M5	GO:0004435; F:phosphatidylinositol phospholipase C activity; TAS:ProtInc
P08912	CHRM5	Muscarinic acetylcholine receptor M5	GO:0007197; P:adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway; TAS:ProtInc
P08912	CHRM5	Muscarinic acetylcholine receptor M5	GO:0008283; P:cell proliferation; TAS:ProtInc
P08912	CHRM5	Muscarinic acetylcholine receptor M5	GO:0015872; P:dopamine transport; IEA:Ensembl
P08912	CHRM5	Muscarinic acetylcholine receptor M5	GO:0007213; P:G-protein coupled acetylcholine receptor signaling pathway; TAS:ProtInc
P08912	CHRM5	Muscarinic acetylcholine receptor M5	GO:0001696; P:gastric acid secretion; IEA:InterPro
P08912	CHRM5	Muscarinic acetylcholine receptor M5	GO:0008152; P:metabolic process; TAS:GOC
P08912	CHRM5	Muscarinic acetylcholine receptor M5	GO:0060304; P:regulation of phosphatidylinositol dephosphorylation; IEA:Ensembl
P08912	CHRM5	Muscarinic acetylcholine receptor M5	GO:0019226; P:transmission of nerve impulse; IEA:Ensembl
Q8TDX5	ACMSD	2-amino-3-carboxymuconate-6-semialdehyde decarboxylase	GO:0001760; F:aminocarboxymuconate-semialdehyde decarboxylase activity; IDA:UniProtKB
Q8TDX5	ACMSD	2-amino-3-carboxymuconate-6-semialdehyde decarboxylase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TDX5	ACMSD	2-amino-3-carboxymuconate-6-semialdehyde decarboxylase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q8TDX5	ACMSD	2-amino-3-carboxymuconate-6-semialdehyde decarboxylase	GO:0046874; P:quinolinate metabolic process; IDA:UniProtKB
Q8TDX5	ACMSD	2-amino-3-carboxymuconate-6-semialdehyde decarboxylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8TDX5	ACMSD	2-amino-3-carboxymuconate-6-semialdehyde decarboxylase	GO:0006569; P:tryptophan catabolic process; TAS:Reactome
Q9NRP4	ACN9	Protein ACN9 homolog, mitochondrial	GO:0006111; P:regulation of gluconeogenesis; ISS:UniProtKB
Q8WXI4	ACOT11	Acyl-coenzyme A thioesterase 11	GO:0047617; F:acyl-CoA hydrolase activity; TAS:UniProtKB
Q8WXI4	ACOT11	Acyl-coenzyme A thioesterase 11	GO:0008289; F:lipid binding; IEA:InterPro
Q8WXI4	ACOT11	Acyl-coenzyme A thioesterase 11	GO:0006631; P:fatty acid metabolic process; NAS:UniProtKB
Q8WXI4	ACOT11	Acyl-coenzyme A thioesterase 11	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
Q8WXI4	ACOT11	Acyl-coenzyme A thioesterase 11	GO:0009409; P:response to cold; ISS:BHF-UCL
Q8WXI4	ACOT11	Acyl-coenzyme A thioesterase 11	GO:0009266; P:response to temperature stimulus; ISS:UniProtKB
Q8WYK0	ACOT12	Acyl-coenzyme A thioesterase 12	GO:0003986; F:acetyl-CoA hydrolase activity; ISS:HGNC
Q8WYK0	ACOT12	Acyl-coenzyme A thioesterase 12	GO:0005524; F:ATP binding; IEA:Ensembl
Q8WYK0	ACOT12	Acyl-coenzyme A thioesterase 12	GO:0008289; F:lipid binding; IEA:InterPro
Q8WYK0	ACOT12	Acyl-coenzyme A thioesterase 12	GO:0006084; P:acetyl-CoA metabolic process; IEA:Ensembl
Q8WYK0	ACOT12	Acyl-coenzyme A thioesterase 12	GO:0006637; P:acyl-CoA metabolic process; ISS:HGNC
Q8WYK0	ACOT12	Acyl-coenzyme A thioesterase 12	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW
Q8WYK0	ACOT12	Acyl-coenzyme A thioesterase 12	GO:0006090; P:pyruvate metabolic process; IEA:UniProtKB-UniPathway
Q9NPJ3	ACOT13	Acyl-coenzyme A thioesterase 13	GO:0047617; F:acyl-CoA hydrolase activity; IDA:UniProtKB
Q9NPJ3	ACOT13	Acyl-coenzyme A thioesterase 13	GO:0008152; P:metabolic process; IDA:GOC
Q9NPJ3	ACOT13	Acyl-coenzyme A thioesterase 13	GO:0051289; P:protein homotetramerization; IPI:UniProtKB
Q8N1Q8	THEM5	Acyl-coenzyme A thioesterase THEM5	GO:0016290; F:palmitoyl-CoA hydrolase activity; IDA:UniProtKB
Q8N1Q8	THEM5	Acyl-coenzyme A thioesterase THEM5	GO:0035965; P:cardiolipin acyl-chain remodeling; ISS:UniProtKB
Q8N1Q8	THEM5	Acyl-coenzyme A thioesterase THEM5	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW
Q8N1Q8	THEM5	Acyl-coenzyme A thioesterase THEM5	GO:0035336; P:long-chain fatty-acyl-CoA metabolic process; IDA:UniProtKB
P21399	ACO1	Cytoplasmic aconitate hydratase	GO:0051539; F:4 iron, 4 sulfur cluster binding; IDA:UniProtKB
P21399	ACO1	Cytoplasmic aconitate hydratase	GO:0003994; F:aconitate hydratase activity; IDA:UniProtKB
P21399	ACO1	Cytoplasmic aconitate hydratase	GO:0030350; F:iron-responsive element binding; IDA:UniProtKB
P21399	ACO1	Cytoplasmic aconitate hydratase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P21399	ACO1	Cytoplasmic aconitate hydratase	GO:0005515; F:protein binding; IPI:UniProtKB
P21399	ACO1	Cytoplasmic aconitate hydratase	GO:0003723; F:RNA binding; IDA:UniProtKB
P21399	ACO1	Cytoplasmic aconitate hydratase	GO:0006879; P:cellular iron ion homeostasis; IEA:Ensembl
P21399	ACO1	Cytoplasmic aconitate hydratase	GO:0006101; P:citrate metabolic process; IDA:UniProtKB
P21399	ACO1	Cytoplasmic aconitate hydratase	GO:0050892; P:intestinal absorption; IEA:Ensembl
P21399	ACO1	Cytoplasmic aconitate hydratase	GO:0009791; P:post-embryonic development; IEA:Ensembl
P21399	ACO1	Cytoplasmic aconitate hydratase	GO:0006417; P:regulation of translation; IEA:Ensembl
P21399	ACO1	Cytoplasmic aconitate hydratase	GO:0010040; P:response to iron(II) ion; IDA:UniProtKB
P21399	ACO1	Cytoplasmic aconitate hydratase	GO:0006099; P:tricarboxylic acid cycle; IEA:UniProtKB-KW
O00767	SCD	Acyl-CoA desaturase	GO:0005506; F:iron ion binding; IEA:InterPro
O00767	SCD	Acyl-CoA desaturase	GO:0004768; F:stearoyl-CoA 9-desaturase activity; TAS:ProtInc
O00767	SCD	Acyl-CoA desaturase	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
Q99798	ACO2	Aconitate hydratase, mitochondrial	GO:0051538; F:3 iron, 4 sulfur cluster binding; IEA:Ensembl
Q99798	ACO2	Aconitate hydratase, mitochondrial	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
Q99798	ACO2	Aconitate hydratase, mitochondrial	GO:0003994; F:aconitate hydratase activity; IEA:UniProtKB-EC
Q99798	ACO2	Aconitate hydratase, mitochondrial	GO:0005506; F:iron ion binding; IDA:MGI
Q99798	ACO2	Aconitate hydratase, mitochondrial	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q99798	ACO2	Aconitate hydratase, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q99798	ACO2	Aconitate hydratase, mitochondrial	GO:0006101; P:citrate metabolic process; IDA:MGI
Q99798	ACO2	Aconitate hydratase, mitochondrial	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
Q99798	ACO2	Aconitate hydratase, mitochondrial	GO:0006102; P:isocitrate metabolic process; IEA:Ensembl
Q99798	ACO2	Aconitate hydratase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99798	ACO2	Aconitate hydratase, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; IDA:MGI
Q86TX2	ACOT1	Acyl-coenzyme A thioesterase 1	GO:0047617; F:acyl-CoA hydrolase activity; IDA:HGNC
Q86TX2	ACOT1	Acyl-coenzyme A thioesterase 1	GO:0016290; F:palmitoyl-CoA hydrolase activity; IEA:UniProtKB-EC
Q86TX2	ACOT1	Acyl-coenzyme A thioesterase 1	GO:0006637; P:acyl-CoA metabolic process; IDA:HGNC
Q86TX2	ACOT1	Acyl-coenzyme A thioesterase 1	GO:0001676; P:long-chain fatty acid metabolic process; IDA:HGNC
Q86TX2	ACOT1	Acyl-coenzyme A thioesterase 1	GO:0000038; P:very long-chain fatty acid metabolic process; IDA:HGNC
P49753	ACOT2	Acyl-coenzyme A thioesterase 2, mitochondrial	GO:0047617; F:acyl-CoA hydrolase activity; IDA:HGNC
P49753	ACOT2	Acyl-coenzyme A thioesterase 2, mitochondrial	GO:0016290; F:palmitoyl-CoA hydrolase activity; IEA:UniProtKB-EC
P49753	ACOT2	Acyl-coenzyme A thioesterase 2, mitochondrial	GO:0005102; F:receptor binding; IPI:UniProtKB
P49753	ACOT2	Acyl-coenzyme A thioesterase 2, mitochondrial	GO:0006637; P:acyl-CoA metabolic process; IDA:HGNC
P49753	ACOT2	Acyl-coenzyme A thioesterase 2, mitochondrial	GO:0001676; P:long-chain fatty acid metabolic process; IDA:HGNC
P49753	ACOT2	Acyl-coenzyme A thioesterase 2, mitochondrial	GO:0000038; P:very long-chain fatty acid metabolic process; IDA:HGNC
Q8N9L9	ACOT4	Acyl-coenzyme A thioesterase 4	GO:0047617; F:acyl-CoA hydrolase activity; IDA:UniProtKB
Q8N9L9	ACOT4	Acyl-coenzyme A thioesterase 4	GO:0016290; F:palmitoyl-CoA hydrolase activity; IEA:UniProtKB-EC
Q8N9L9	ACOT4	Acyl-coenzyme A thioesterase 4	GO:0005102; F:receptor binding; IPI:UniProtKB
Q8N9L9	ACOT4	Acyl-coenzyme A thioesterase 4	GO:0004778; F:succinyl-CoA hydrolase activity; IDA:UniProtKB
Q8N9L9	ACOT4	Acyl-coenzyme A thioesterase 4	GO:0006637; P:acyl-CoA metabolic process; IDA:HGNC
Q8N9L9	ACOT4	Acyl-coenzyme A thioesterase 4	GO:0043649; P:dicarboxylic acid catabolic process; IDA:UniProtKB
Q8N9L9	ACOT4	Acyl-coenzyme A thioesterase 4	GO:0043648; P:dicarboxylic acid metabolic process; IDA:HGNC
Q8N9L9	ACOT4	Acyl-coenzyme A thioesterase 4	GO:0001676; P:long-chain fatty acid metabolic process; IDA:HGNC
Q8N9L9	ACOT4	Acyl-coenzyme A thioesterase 4	GO:0032788; P:saturated monocarboxylic acid metabolic process; IDA:HGNC
Q8N9L9	ACOT4	Acyl-coenzyme A thioesterase 4	GO:0046459; P:short-chain fatty acid metabolic process; IDA:HGNC
Q8N9L9	ACOT4	Acyl-coenzyme A thioesterase 4	GO:0006104; P:succinyl-CoA metabolic process; IDA:HGNC
Q8N9L9	ACOT4	Acyl-coenzyme A thioesterase 4	GO:0032789; P:unsaturated monocarboxylic acid metabolic process; IDA:HGNC
Q8N9L9	ACOT4	Acyl-coenzyme A thioesterase 4	GO:0000038; P:very long-chain fatty acid metabolic process; IDA:HGNC
Q3I5F7	ACOT6	Putative acyl-coenzyme A thioesterase 6	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
O14734	ACOT8	Acyl-coenzyme A thioesterase 8	GO:0047617; F:acyl-CoA hydrolase activity; IDA:UniProtKB
O14734	ACOT8	Acyl-coenzyme A thioesterase 8	GO:0033882; F:choloyl-CoA hydrolase activity; IEA:UniProtKB-EC
O14734	ACOT8	Acyl-coenzyme A thioesterase 8	GO:0052815; F:medium-chain acyl-CoA hydrolase activity; IDA:UniProtKB
O14734	ACOT8	Acyl-coenzyme A thioesterase 8	GO:0016290; F:palmitoyl-CoA hydrolase activity; IDA:UniProtKB
O14734	ACOT8	Acyl-coenzyme A thioesterase 8	GO:0005515; F:protein binding; IPI:UniProtKB
O14734	ACOT8	Acyl-coenzyme A thioesterase 8	GO:0005102; F:receptor binding; IPI:UniProtKB
O14734	ACOT8	Acyl-coenzyme A thioesterase 8	GO:0006637; P:acyl-CoA metabolic process; IDA:UniProtKB
O14734	ACOT8	Acyl-coenzyme A thioesterase 8	GO:0036109; P:alpha-linolenic acid metabolic process; TAS:Reactome
O14734	ACOT8	Acyl-coenzyme A thioesterase 8	GO:0006699; P:bile acid biosynthetic process; TAS:Reactome
O14734	ACOT8	Acyl-coenzyme A thioesterase 8	GO:0008206; P:bile acid metabolic process; TAS:Reactome
O14734	ACOT8	Acyl-coenzyme A thioesterase 8	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O14734	ACOT8	Acyl-coenzyme A thioesterase 8	GO:0043649; P:dicarboxylic acid catabolic process; IDA:UniProtKB
O14734	ACOT8	Acyl-coenzyme A thioesterase 8	GO:0033540; P:fatty acid beta-oxidation using acyl-CoA oxidase; TAS:Reactome
O14734	ACOT8	Acyl-coenzyme A thioesterase 8	GO:0016559; P:peroxisome fission; IDA:UniProtKB
O14734	ACOT8	Acyl-coenzyme A thioesterase 8	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O14734	ACOT8	Acyl-coenzyme A thioesterase 8	GO:0033559; P:unsaturated fatty acid metabolic process; TAS:Reactome
O14734	ACOT8	Acyl-coenzyme A thioesterase 8	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9Y305	ACOT9	Acyl-coenzyme A thioesterase 9, mitochondrial	GO:0003986; F:acetyl-CoA hydrolase activity; ISS:HGNC
Q9Y305	ACOT9	Acyl-coenzyme A thioesterase 9, mitochondrial	GO:0006637; P:acyl-CoA metabolic process; ISS:HGNC
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0003995; F:acyl-CoA dehydrogenase activity; IEA:InterPro
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0003997; F:acyl-CoA oxidase activity; IDA:UniProtKB
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0071949; F:FAD binding; IDA:UniProtKB
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0005504; F:fatty acid binding; IEA:Ensembl
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0016401; F:palmitoyl-CoA oxidase activity; IDA:UniProtKB
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0030165; F:PDZ domain binding; IDA:MGI
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0005102; F:receptor binding; IPI:UniProtKB
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0036109; P:alpha-linolenic acid metabolic process; TAS:Reactome
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0033540; P:fatty acid beta-oxidation using acyl-CoA oxidase; IMP:BHF-UCL
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0019395; P:fatty acid oxidation; IGI:UniProtKB
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0006091; P:generation of precursor metabolites and energy; IMP:UniProtKB
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0055088; P:lipid homeostasis; IDA:UniProtKB
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0006629; P:lipid metabolic process; IDA:UniProtKB
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0016559; P:peroxisome fission; IGI:UniProtKB
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:2000189; P:positive regulation of cholesterol homeostasis; IGI:UniProtKB
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0006693; P:prostaglandin metabolic process; IMP:UniProtKB
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0033559; P:unsaturated fatty acid metabolic process; TAS:Reactome
Q15067	ACOX1	Peroxisomal acyl-coenzyme A oxidase 1	GO:0000038; P:very long-chain fatty acid metabolic process; IMP:BHF-UCL
Q99424	ACOX2	Peroxisomal acyl-coenzyme A oxidase 2	GO:0033791; F:3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity; IEA:UniProtKB-EC
Q99424	ACOX2	Peroxisomal acyl-coenzyme A oxidase 2	GO:0003995; F:acyl-CoA dehydrogenase activity; IEA:InterPro
Q99424	ACOX2	Peroxisomal acyl-coenzyme A oxidase 2	GO:0003997; F:acyl-CoA oxidase activity; TAS:Reactome
Q99424	ACOX2	Peroxisomal acyl-coenzyme A oxidase 2	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q99424	ACOX2	Peroxisomal acyl-coenzyme A oxidase 2	GO:0016402; F:pristanoyl-CoA oxidase activity; TAS:Reactome
Q99424	ACOX2	Peroxisomal acyl-coenzyme A oxidase 2	GO:0005102; F:receptor binding; IPI:UniProtKB
Q99424	ACOX2	Peroxisomal acyl-coenzyme A oxidase 2	GO:0006699; P:bile acid biosynthetic process; TAS:Reactome
Q99424	ACOX2	Peroxisomal acyl-coenzyme A oxidase 2	GO:0008206; P:bile acid metabolic process; TAS:Reactome
Q99424	ACOX2	Peroxisomal acyl-coenzyme A oxidase 2	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q99424	ACOX2	Peroxisomal acyl-coenzyme A oxidase 2	GO:0033540; P:fatty acid beta-oxidation using acyl-CoA oxidase; TAS:Reactome
Q99424	ACOX2	Peroxisomal acyl-coenzyme A oxidase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15254	ACOX3	Peroxisomal acyl-coenzyme A oxidase 3	GO:0003995; F:acyl-CoA dehydrogenase activity; IEA:InterPro
O15254	ACOX3	Peroxisomal acyl-coenzyme A oxidase 3	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
O15254	ACOX3	Peroxisomal acyl-coenzyme A oxidase 3	GO:0016402; F:pristanoyl-CoA oxidase activity; TAS:Reactome
O15254	ACOX3	Peroxisomal acyl-coenzyme A oxidase 3	GO:0005102; F:receptor binding; IPI:UniProtKB
O15254	ACOX3	Peroxisomal acyl-coenzyme A oxidase 3	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O15254	ACOX3	Peroxisomal acyl-coenzyme A oxidase 3	GO:0033540; P:fatty acid beta-oxidation using acyl-CoA oxidase; TAS:Reactome
O15254	ACOX3	Peroxisomal acyl-coenzyme A oxidase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NUZ1	ACOXL	Acyl-coenzyme A oxidase-like protein	GO:0003995; F:acyl-CoA dehydrogenase activity; IEA:InterPro
Q9NUZ1	ACOXL	Acyl-coenzyme A oxidase-like protein	GO:0003997; F:acyl-CoA oxidase activity; IEA:InterPro
Q9NUZ1	ACOXL	Acyl-coenzyme A oxidase-like protein	GO:0006635; P:fatty acid beta-oxidation; IEA:InterPro
P13798	APEH	Acylamino-acid-releasing enzyme	GO:0008242; F:omega peptidase activity; IDA:UniProt
P13798	APEH	Acylamino-acid-releasing enzyme	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P13798	APEH	Acylamino-acid-releasing enzyme	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProt
P13798	APEH	Acylamino-acid-releasing enzyme	GO:0050435; P:beta-amyloid metabolic process; IDA:UniProt
P13798	APEH	Acylamino-acid-releasing enzyme	GO:0006508; P:proteolysis; IDA:UniProt
Q8TE99	ACPL2	Acid phosphatase-like protein 2	GO:0003993; F:acid phosphatase activity; IEA:UniProtKB-EC
O14561	NDUFAB1	Acyl carrier protein, mitochondrial	GO:0000036; F:ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process; NAS:UniProtKB
O14561	NDUFAB1	Acyl carrier protein, mitochondrial	GO:0005509; F:calcium ion binding; NAS:UniProtKB
O14561	NDUFAB1	Acyl carrier protein, mitochondrial	GO:0005504; F:fatty acid binding; ISS:UniProtKB
O14561	NDUFAB1	Acyl carrier protein, mitochondrial	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O14561	NDUFAB1	Acyl carrier protein, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
O14561	NDUFAB1	Acyl carrier protein, mitochondrial	GO:0006633; P:fatty acid biosynthetic process; NAS:UniProtKB
O14561	NDUFAB1	Acyl carrier protein, mitochondrial	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O14561	NDUFAB1	Acyl carrier protein, mitochondrial	GO:0009249; P:protein lipoylation; IMP:UniProtKB
O14561	NDUFAB1	Acyl carrier protein, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O14561	NDUFAB1	Acyl carrier protein, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P10323	ACR	Acrosin	GO:0004040; F:amidase activity; ISS:UniProtKB
P10323	ACR	Acrosin	GO:0005507; F:copper ion binding; NAS:UniProtKB
P10323	ACR	Acrosin	GO:0003677; F:DNA binding; NAS:UniProtKB
P10323	ACR	Acrosin	GO:0008144; F:drug binding; ISS:UniProtKB
P10323	ACR	Acrosin	GO:0042806; F:fucose binding; ISS:UniProtKB
P10323	ACR	Acrosin	GO:0005537; F:mannose binding; IDA:UniProtKB
P10323	ACR	Acrosin	GO:0005515; F:protein binding; IPI:UniProtKB
P10323	ACR	Acrosin	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
P10323	ACR	Acrosin	GO:0008270; F:zinc ion binding; NAS:UniProtKB
P10323	ACR	Acrosin	GO:0002077; P:acrosome matrix dispersal; NAS:UniProtKB
P10323	ACR	Acrosin	GO:0007340; P:acrosome reaction; IMP:UniProtKB
P10323	ACR	Acrosin	GO:0007190; P:activation of adenylate cyclase activity; IDA:UniProtKB
P10323	ACR	Acrosin	GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl
P10323	ACR	Acrosin	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
P10323	ACR	Acrosin	GO:0048545; P:response to steroid hormone; IEA:Ensembl
P10323	ACR	Acrosin	GO:0007338; P:single fertilization; ISS:UniProtKB
Q08AH3	ACSM2A	Acyl-coenzyme A synthetase ACSM2A, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q08AH3	ACSM2A	Acyl-coenzyme A synthetase ACSM2A, mitochondrial	GO:0047760; F:butyrate-CoA ligase activity; IDA:BHF-UCL
Q08AH3	ACSM2A	Acyl-coenzyme A synthetase ACSM2A, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q08AH3	ACSM2A	Acyl-coenzyme A synthetase ACSM2A, mitochondrial	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW
Q08AH3	ACSM2A	Acyl-coenzyme A synthetase ACSM2A, mitochondrial	GO:0042593; P:glucose homeostasis; NAS:BHF-UCL
Q08AH3	ACSM2A	Acyl-coenzyme A synthetase ACSM2A, mitochondrial	GO:0036112; P:medium-chain fatty-acyl-CoA metabolic process; IDA:BHF-UCL
Q08AH3	ACSM2A	Acyl-coenzyme A synthetase ACSM2A, mitochondrial	GO:0070328; P:triglyceride homeostasis; NAS:BHF-UCL
Q68CK6	ACSM2B	Acyl-coenzyme A synthetase ACSM2B, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q68CK6	ACSM2B	Acyl-coenzyme A synthetase ACSM2B, mitochondrial	GO:0047760; F:butyrate-CoA ligase activity; IEA:UniProtKB-EC
Q68CK6	ACSM2B	Acyl-coenzyme A synthetase ACSM2B, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q68CK6	ACSM2B	Acyl-coenzyme A synthetase ACSM2B, mitochondrial	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW
Q68CK6	ACSM2B	Acyl-coenzyme A synthetase ACSM2B, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q68CK6	ACSM2B	Acyl-coenzyme A synthetase ACSM2B, mitochondrial	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9NUB1	ACSS1	Acetyl-coenzyme A synthetase 2-like, mitochondrial	GO:0003987; F:acetate-CoA ligase activity; IDA:UniProtKB
Q9NUB1	ACSS1	Acetyl-coenzyme A synthetase 2-like, mitochondrial	GO:0016208; F:AMP binding; IEA:InterPro
Q9NUB1	ACSS1	Acetyl-coenzyme A synthetase 2-like, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NUB1	ACSS1	Acetyl-coenzyme A synthetase 2-like, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NUB1	ACSS1	Acetyl-coenzyme A synthetase 2-like, mitochondrial	GO:0019413; P:acetate biosynthetic process; IEA:Ensembl
Q9NUB1	ACSS1	Acetyl-coenzyme A synthetase 2-like, mitochondrial	GO:0006085; P:acetyl-CoA biosynthetic process; IDA:UniProtKB
Q9NUB1	ACSS1	Acetyl-coenzyme A synthetase 2-like, mitochondrial	GO:0019427; P:acetyl-CoA biosynthetic process from acetate; IEA:InterPro
Q9NUB1	ACSS1	Acetyl-coenzyme A synthetase 2-like, mitochondrial	GO:0006069; P:ethanol oxidation; TAS:Reactome
Q9NUB1	ACSS1	Acetyl-coenzyme A synthetase 2-like, mitochondrial	GO:0019542; P:propionate biosynthetic process; IEA:Ensembl
Q9NUB1	ACSS1	Acetyl-coenzyme A synthetase 2-like, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NUB1	ACSS1	Acetyl-coenzyme A synthetase 2-like, mitochondrial	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9NR19	ACSS2	Acetyl-coenzyme A synthetase, cytoplasmic	GO:0003987; F:acetate-CoA ligase activity; IDA:UniProtKB
Q9NR19	ACSS2	Acetyl-coenzyme A synthetase, cytoplasmic	GO:0016208; F:AMP binding; IC:UniProtKB
Q9NR19	ACSS2	Acetyl-coenzyme A synthetase, cytoplasmic	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NR19	ACSS2	Acetyl-coenzyme A synthetase, cytoplasmic	GO:0019413; P:acetate biosynthetic process; IEA:Ensembl
Q9NR19	ACSS2	Acetyl-coenzyme A synthetase, cytoplasmic	GO:0019427; P:acetyl-CoA biosynthetic process from acetate; IEA:InterPro
Q9NR19	ACSS2	Acetyl-coenzyme A synthetase, cytoplasmic	GO:0006069; P:ethanol oxidation; TAS:Reactome
Q9NR19	ACSS2	Acetyl-coenzyme A synthetase, cytoplasmic	GO:0008610; P:lipid biosynthetic process; IMP:UniProtKB
Q9NR19	ACSS2	Acetyl-coenzyme A synthetase, cytoplasmic	GO:0019542; P:propionate biosynthetic process; IEA:Ensembl
Q9NR19	ACSS2	Acetyl-coenzyme A synthetase, cytoplasmic	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NR19	ACSS2	Acetyl-coenzyme A synthetase, cytoplasmic	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q96CM8	ACSF2	Acyl-CoA synthetase family member 2, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96CM8	ACSF2	Acyl-CoA synthetase family member 2, mitochondrial	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q96CM8	ACSF2	Acyl-CoA synthetase family member 2, mitochondrial	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW
Q4G176	ACSF3	Acyl-CoA synthetase family member 3, mitochondrial	GO:0016878; F:acid-thiol ligase activity; IDA:UniProtKB
Q4G176	ACSF3	Acyl-CoA synthetase family member 3, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q4G176	ACSF3	Acyl-CoA synthetase family member 3, mitochondrial	GO:0090409; F:malonyl-CoA synthetase activity; IDA:UniProtKB
Q4G176	ACSF3	Acyl-CoA synthetase family member 3, mitochondrial	GO:0006633; P:fatty acid biosynthetic process; IDA:UniProtKB
Q4G176	ACSF3	Acyl-CoA synthetase family member 3, mitochondrial	GO:0006631; P:fatty acid metabolic process; IDA:UniProtKB
Q4G176	ACSF3	Acyl-CoA synthetase family member 3, mitochondrial	GO:0090410; P:malonate catabolic process; IDA:UniProtKB
Q4L235	AASDH	Acyl-CoA synthetase family member 4	GO:0016878; F:acid-thiol ligase activity; ISS:UniProtKB
Q4L235	AASDH	Acyl-CoA synthetase family member 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q4L235	AASDH	Acyl-CoA synthetase family member 4	GO:0006631; P:fatty acid metabolic process; ISS:UniProtKB
P33121	ACSL1	Long-chain-fatty-acid--CoA ligase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P33121	ACSL1	Long-chain-fatty-acid--CoA ligase 1	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
P33121	ACSL1	Long-chain-fatty-acid--CoA ligase 1	GO:0004467; F:long-chain fatty acid-CoA ligase activity; IDA:UniProtKB
P33121	ACSL1	Long-chain-fatty-acid--CoA ligase 1	GO:0033211; P:adiponectin-activated signaling pathway; IEA:Ensembl
P33121	ACSL1	Long-chain-fatty-acid--CoA ligase 1	GO:0036109; P:alpha-linolenic acid metabolic process; TAS:Reactome
P33121	ACSL1	Long-chain-fatty-acid--CoA ligase 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P33121	ACSL1	Long-chain-fatty-acid--CoA ligase 1	GO:0043651; P:linoleic acid metabolic process; TAS:Reactome
P33121	ACSL1	Long-chain-fatty-acid--CoA ligase 1	GO:0008610; P:lipid biosynthetic process; IDA:UniProtKB
P33121	ACSL1	Long-chain-fatty-acid--CoA ligase 1	GO:0044539; P:long-chain fatty acid import; IDA:UniProtKB
P33121	ACSL1	Long-chain-fatty-acid--CoA ligase 1	GO:0001676; P:long-chain fatty acid metabolic process; IDA:UniProtKB
P33121	ACSL1	Long-chain-fatty-acid--CoA ligase 1	GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome
P33121	ACSL1	Long-chain-fatty-acid--CoA ligase 1	GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IEA:Ensembl
P33121	ACSL1	Long-chain-fatty-acid--CoA ligase 1	GO:0042493; P:response to drug; IEA:Ensembl
P33121	ACSL1	Long-chain-fatty-acid--CoA ligase 1	GO:0007584; P:response to nutrient; IEA:Ensembl
P33121	ACSL1	Long-chain-fatty-acid--CoA ligase 1	GO:0034201; P:response to oleic acid; IEA:Ensembl
P33121	ACSL1	Long-chain-fatty-acid--CoA ligase 1	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P33121	ACSL1	Long-chain-fatty-acid--CoA ligase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P33121	ACSL1	Long-chain-fatty-acid--CoA ligase 1	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
P33121	ACSL1	Long-chain-fatty-acid--CoA ligase 1	GO:0033559; P:unsaturated fatty acid metabolic process; TAS:Reactome
P33121	ACSL1	Long-chain-fatty-acid--CoA ligase 1	GO:0042178; P:xenobiotic catabolic process; IEA:Ensembl
O60488	ACSL4	Long-chain-fatty-acid--CoA ligase 4	GO:0047676; F:arachidonate-CoA ligase activity; IDA:UniProtKB
O60488	ACSL4	Long-chain-fatty-acid--CoA ligase 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O60488	ACSL4	Long-chain-fatty-acid--CoA ligase 4	GO:0004467; F:long-chain fatty acid-CoA ligase activity; IDA:MGI
O60488	ACSL4	Long-chain-fatty-acid--CoA ligase 4	GO:0031957; F:very long-chain fatty acid-CoA ligase activity; IMP:UniProtKB
O60488	ACSL4	Long-chain-fatty-acid--CoA ligase 4	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O60488	ACSL4	Long-chain-fatty-acid--CoA ligase 4	GO:0060996; P:dendritic spine development; IEA:Ensembl
O60488	ACSL4	Long-chain-fatty-acid--CoA ligase 4	GO:0060136; P:embryonic process involved in female pregnancy; IEA:Ensembl
O60488	ACSL4	Long-chain-fatty-acid--CoA ligase 4	GO:0015908; P:fatty acid transport; IEA:Ensembl
O60488	ACSL4	Long-chain-fatty-acid--CoA ligase 4	GO:0008610; P:lipid biosynthetic process; IDA:UniProtKB
O60488	ACSL4	Long-chain-fatty-acid--CoA ligase 4	GO:0006629; P:lipid metabolic process; IDA:UniProtKB
O60488	ACSL4	Long-chain-fatty-acid--CoA ligase 4	GO:0001676; P:long-chain fatty acid metabolic process; IDA:GOC
O60488	ACSL4	Long-chain-fatty-acid--CoA ligase 4	GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome
O60488	ACSL4	Long-chain-fatty-acid--CoA ligase 4	GO:0032307; P:negative regulation of prostaglandin secretion; IDA:UniProtKB
O60488	ACSL4	Long-chain-fatty-acid--CoA ligase 4	GO:0030307; P:positive regulation of cell growth; IDA:UniProtKB
O60488	ACSL4	Long-chain-fatty-acid--CoA ligase 4	GO:0070672; P:response to interleukin-15; IEA:Ensembl
O60488	ACSL4	Long-chain-fatty-acid--CoA ligase 4	GO:0007584; P:response to nutrient; IEA:Ensembl
O60488	ACSL4	Long-chain-fatty-acid--CoA ligase 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60488	ACSL4	Long-chain-fatty-acid--CoA ligase 4	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
O95573	ACSL3	Long-chain-fatty-acid--CoA ligase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O95573	ACSL3	Long-chain-fatty-acid--CoA ligase 3	GO:0004467; F:long-chain fatty acid-CoA ligase activity; IMP:UniProtKB
O95573	ACSL3	Long-chain-fatty-acid--CoA ligase 3	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
O95573	ACSL3	Long-chain-fatty-acid--CoA ligase 3	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O95573	ACSL3	Long-chain-fatty-acid--CoA ligase 3	GO:0007420; P:brain development; IEA:Ensembl
O95573	ACSL3	Long-chain-fatty-acid--CoA ligase 3	GO:0006633; P:fatty acid biosynthetic process; IEA:Ensembl
O95573	ACSL3	Long-chain-fatty-acid--CoA ligase 3	GO:0044539; P:long-chain fatty acid import; IDA:UniProtKB
O95573	ACSL3	Long-chain-fatty-acid--CoA ligase 3	GO:0042998; P:positive regulation of Golgi to plasma membrane protein transport; IMP:UniProtKB
O95573	ACSL3	Long-chain-fatty-acid--CoA ligase 3	GO:2001247; P:positive regulation of phosphatidylcholine biosynthetic process; IMP:UniProtKB
O95573	ACSL3	Long-chain-fatty-acid--CoA ligase 3	GO:0051047; P:positive regulation of secretion; IMP:UniProtKB
O95573	ACSL3	Long-chain-fatty-acid--CoA ligase 3	GO:0007584; P:response to nutrient; IEA:Ensembl
O95573	ACSL3	Long-chain-fatty-acid--CoA ligase 3	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
O95573	ACSL3	Long-chain-fatty-acid--CoA ligase 3	GO:0034379; P:very-low-density lipoprotein particle assembly; IMP:UniProtKB
Q9ULC5	ACSL5	Long-chain-fatty-acid--CoA ligase 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9ULC5	ACSL5	Long-chain-fatty-acid--CoA ligase 5	GO:0004467; F:long-chain fatty acid-CoA ligase activity; IDA:UniProtKB
Q9ULC5	ACSL5	Long-chain-fatty-acid--CoA ligase 5	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9ULC5	ACSL5	Long-chain-fatty-acid--CoA ligase 5	GO:0001676; P:long-chain fatty acid metabolic process; IDA:UniProtKB
Q9ULC5	ACSL5	Long-chain-fatty-acid--CoA ligase 5	GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome
Q9ULC5	ACSL5	Long-chain-fatty-acid--CoA ligase 5	GO:2001236; P:regulation of extrinsic apoptotic signaling pathway; IDA:UniProtKB
Q9ULC5	ACSL5	Long-chain-fatty-acid--CoA ligase 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9ULC5	ACSL5	Long-chain-fatty-acid--CoA ligase 5	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0004467; F:long-chain fatty acid-CoA ligase activity; IDA:UniProtKB
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0006637; P:acyl-CoA metabolic process; NAS:UniProtKB
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0015908; P:fatty acid transport; IEA:Ensembl
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0001676; P:long-chain fatty acid metabolic process; IDA:UniProtKB
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0007405; P:neuroblast proliferation; IEA:Ensembl
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0048666; P:neuron development; IEA:Ensembl
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0008654; P:phospholipid biosynthetic process; IEA:Ensembl
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0010747; P:positive regulation of plasma membrane long-chain fatty acid transport; IEA:Ensembl
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0010867; P:positive regulation of triglyceride biosynthetic process; IEA:Ensembl
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0009629; P:response to gravity; IEA:Ensembl
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0007584; P:response to nutrient; IEA:Ensembl
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0048545; P:response to steroid hormone; IEA:Ensembl
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UKU0	ACSL6	Long-chain-fatty-acid--CoA ligase 6	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
Q08AH1	ACSM1	Acyl-coenzyme A synthetase ACSM1, mitochondrial	GO:0003996; F:acyl-CoA ligase activity; IDA:UniProtKB
Q08AH1	ACSM1	Acyl-coenzyme A synthetase ACSM1, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q08AH1	ACSM1	Acyl-coenzyme A synthetase ACSM1, mitochondrial	GO:0047760; F:butyrate-CoA ligase activity; IDA:UniProtKB
Q08AH1	ACSM1	Acyl-coenzyme A synthetase ACSM1, mitochondrial	GO:0015645; F:fatty acid ligase activity; IEA:Ensembl
Q08AH1	ACSM1	Acyl-coenzyme A synthetase ACSM1, mitochondrial	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q08AH1	ACSM1	Acyl-coenzyme A synthetase ACSM1, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q08AH1	ACSM1	Acyl-coenzyme A synthetase ACSM1, mitochondrial	GO:0018874; P:benzoate metabolic process; NAS:UniProtKB
Q08AH1	ACSM1	Acyl-coenzyme A synthetase ACSM1, mitochondrial	GO:0019605; P:butyrate metabolic process; NAS:UniProtKB
Q08AH1	ACSM1	Acyl-coenzyme A synthetase ACSM1, mitochondrial	GO:0042632; P:cholesterol homeostasis; NAS:BHF-UCL
Q08AH1	ACSM1	Acyl-coenzyme A synthetase ACSM1, mitochondrial	GO:0015980; P:energy derivation by oxidation of organic compounds; NAS:UniProtKB
Q08AH1	ACSM1	Acyl-coenzyme A synthetase ACSM1, mitochondrial	GO:0006633; P:fatty acid biosynthetic process; IEA:Ensembl
Q08AH1	ACSM1	Acyl-coenzyme A synthetase ACSM1, mitochondrial	GO:0019395; P:fatty acid oxidation; NAS:UniProtKB
Q08AH1	ACSM1	Acyl-coenzyme A synthetase ACSM1, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q08AH1	ACSM1	Acyl-coenzyme A synthetase ACSM1, mitochondrial	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q53FZ2	ACSM3	Acyl-coenzyme A synthetase ACSM3, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q53FZ2	ACSM3	Acyl-coenzyme A synthetase ACSM3, mitochondrial	GO:0047760; F:butyrate-CoA ligase activity; IEA:UniProtKB-EC
Q53FZ2	ACSM3	Acyl-coenzyme A synthetase ACSM3, mitochondrial	GO:0015645; F:fatty acid ligase activity; IEA:Ensembl
Q53FZ2	ACSM3	Acyl-coenzyme A synthetase ACSM3, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q53FZ2	ACSM3	Acyl-coenzyme A synthetase ACSM3, mitochondrial	GO:0042632; P:cholesterol homeostasis; NAS:BHF-UCL
Q53FZ2	ACSM3	Acyl-coenzyme A synthetase ACSM3, mitochondrial	GO:0006633; P:fatty acid biosynthetic process; IEA:Ensembl
Q53FZ2	ACSM3	Acyl-coenzyme A synthetase ACSM3, mitochondrial	GO:0008217; P:regulation of blood pressure; NAS:UniProtKB
Q6NUN0	ACSM5	Acyl-coenzyme A synthetase ACSM5, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6NUN0	ACSM5	Acyl-coenzyme A synthetase ACSM5, mitochondrial	GO:0047760; F:butyrate-CoA ligase activity; IEA:UniProtKB-EC
Q6NUN0	ACSM5	Acyl-coenzyme A synthetase ACSM5, mitochondrial	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q6NUN0	ACSM5	Acyl-coenzyme A synthetase ACSM5, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6NUN0	ACSM5	Acyl-coenzyme A synthetase ACSM5, mitochondrial	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW
P0C7M7	ACSM4	Acyl-coenzyme A synthetase ACSM4, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P0C7M7	ACSM4	Acyl-coenzyme A synthetase ACSM4, mitochondrial	GO:0047760; F:butyrate-CoA ligase activity; IEA:UniProtKB-EC
P0C7M7	ACSM4	Acyl-coenzyme A synthetase ACSM4, mitochondrial	GO:0004321; F:fatty-acyl-CoA synthase activity; IEA:Ensembl
P0C7M7	ACSM4	Acyl-coenzyme A synthetase ACSM4, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P0C7M7	ACSM4	Acyl-coenzyme A synthetase ACSM4, mitochondrial	GO:0006637; P:acyl-CoA metabolic process; IEA:Ensembl
P0C7M7	ACSM4	Acyl-coenzyme A synthetase ACSM4, mitochondrial	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW
Q6P461	ACSM6	Acyl-coenzyme A synthetase ACSM6, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6P461	ACSM6	Acyl-coenzyme A synthetase ACSM6, mitochondrial	GO:0047760; F:butyrate-CoA ligase activity; IEA:UniProtKB-EC
Q6P461	ACSM6	Acyl-coenzyme A synthetase ACSM6, mitochondrial	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q6P461	ACSM6	Acyl-coenzyme A synthetase ACSM6, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6P461	ACSM6	Acyl-coenzyme A synthetase ACSM6, mitochondrial	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW
Q9H6R3	ACSS3	Acyl-CoA synthetase short-chain family member 3, mitochondrial	GO:0003987; F:acetate-CoA ligase activity; IEA:UniProtKB-EC
Q9H6R3	ACSS3	Acyl-CoA synthetase short-chain family member 3, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P62736	ACTA2	Actin, aortic smooth muscle	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P62736	ACTA2	Actin, aortic smooth muscle	GO:0072144; P:glomerular mesangial cell development; IEP:UniProtKB
P62736	ACTA2	Actin, aortic smooth muscle	GO:0006936; P:muscle contraction; TAS:Reactome
P62736	ACTA2	Actin, aortic smooth muscle	GO:0008217; P:regulation of blood pressure; IEA:Ensembl
P62736	ACTA2	Actin, aortic smooth muscle	GO:0009615; P:response to virus; IEP:UniProtKB
P62736	ACTA2	Actin, aortic smooth muscle	GO:0014829; P:vascular smooth muscle contraction; IEA:Ensembl
Q562R1	ACTBL2	Beta-actin-like protein 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BYX7	POTEKP	Putative beta-actin-like protein 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BYX7	POTEKP	Putative beta-actin-like protein 3	GO:0007596; P:blood coagulation; TAS:Reactome
Q9BYX7	POTEKP	Putative beta-actin-like protein 3	GO:0030168; P:platelet activation; TAS:Reactome
Q9BYX7	POTEKP	Putative beta-actin-like protein 3	GO:0002576; P:platelet degranulation; TAS:Reactome
P60709	ACTB	Actin, cytoplasmic 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P60709	ACTB	Actin, cytoplasmic 1	GO:0019894; F:kinesin binding; IPI:UniProtKB
P60709	ACTB	Actin, cytoplasmic 1	GO:0050998; F:nitric-oxide synthase binding; IPI:BHF-UCL
P60709	ACTB	Actin, cytoplasmic 1	GO:0005515; F:protein binding; IPI:UniProtKB
P60709	ACTB	Actin, cytoplasmic 1	GO:0005200; F:structural constituent of cytoskeleton; TAS:UniProtKB
P60709	ACTB	Actin, cytoplasmic 1	GO:0030957; F:Tat protein binding; IPI:BHF-UCL
P60709	ACTB	Actin, cytoplasmic 1	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
P60709	ACTB	Actin, cytoplasmic 1	GO:0034332; P:adherens junction organization; TAS:Reactome
P60709	ACTB	Actin, cytoplasmic 1	GO:0043044; P:ATP-dependent chromatin remodeling; IDA:UniProt
P60709	ACTB	Actin, cytoplasmic 1	GO:0007411; P:axon guidance; TAS:Reactome
P60709	ACTB	Actin, cytoplasmic 1	GO:0007596; P:blood coagulation; TAS:Reactome
P60709	ACTB	Actin, cytoplasmic 1	GO:0034329; P:cell junction assembly; TAS:Reactome
P60709	ACTB	Actin, cytoplasmic 1	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P60709	ACTB	Actin, cytoplasmic 1	GO:0006928; P:cellular component movement; TAS:UniProtKB
P60709	ACTB	Actin, cytoplasmic 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P60709	ACTB	Actin, cytoplasmic 1	GO:0006325; P:chromatin organization; TAS:Reactome
P60709	ACTB	Actin, cytoplasmic 1	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P60709	ACTB	Actin, cytoplasmic 1	GO:0045087; P:innate immune response; TAS:Reactome
P60709	ACTB	Actin, cytoplasmic 1	GO:0061024; P:membrane organization; TAS:Reactome
P60709	ACTB	Actin, cytoplasmic 1	GO:0006457; P:protein folding; TAS:Reactome
P60709	ACTB	Actin, cytoplasmic 1	GO:0001895; P:retina homeostasis; IEP:UniProt
P60709	ACTB	Actin, cytoplasmic 1	GO:0021762; P:substantia nigra development; IEP:UniProt
P68032	ACTC1	Actin, alpha cardiac muscle 1	GO:0005524; F:ATP binding; IDA:UniProtKB
P68032	ACTC1	Actin, alpha cardiac muscle 1	GO:0016887; F:ATPase activity; IDA:UniProtKB
P68032	ACTC1	Actin, alpha cardiac muscle 1	GO:0017022; F:myosin binding; IPI:UniProtKB
P68032	ACTC1	Actin, alpha cardiac muscle 1	GO:0030048; P:actin filament-based movement; IDA:UniProtKB
P68032	ACTC1	Actin, alpha cardiac muscle 1	GO:0033275; P:actin-myosin filament sliding; IMP:BHF-UCL
P68032	ACTC1	Actin, alpha cardiac muscle 1	GO:0031032; P:actomyosin structure organization; ISS:UniProtKB
P68032	ACTC1	Actin, alpha cardiac muscle 1	GO:0006915; P:apoptotic process; ISS:UniProtKB
P68032	ACTC1	Actin, alpha cardiac muscle 1	GO:0006200; P:ATP catabolic process; IDA:GOC
P68032	ACTC1	Actin, alpha cardiac muscle 1	GO:0060048; P:cardiac muscle contraction; IEA:Ensembl
P68032	ACTC1	Actin, alpha cardiac muscle 1	GO:0055008; P:cardiac muscle tissue morphogenesis; ISS:UniProtKB
P68032	ACTC1	Actin, alpha cardiac muscle 1	GO:0055003; P:cardiac myofibril assembly; ISS:UniProtKB
P68032	ACTC1	Actin, alpha cardiac muscle 1	GO:0060047; P:heart contraction; IMP:UniProtKB
P68032	ACTC1	Actin, alpha cardiac muscle 1	GO:0030049; P:muscle filament sliding; TAS:Reactome
P68032	ACTC1	Actin, alpha cardiac muscle 1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P68032	ACTC1	Actin, alpha cardiac muscle 1	GO:0042493; P:response to drug; IEA:Ensembl
P68032	ACTC1	Actin, alpha cardiac muscle 1	GO:0045471; P:response to ethanol; IEA:Ensembl
P68032	ACTC1	Actin, alpha cardiac muscle 1	GO:0030240; P:skeletal muscle thin filament assembly; ISS:UniProtKB
P63261	ACTG1	Actin, cytoplasmic 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P63261	ACTG1	Actin, cytoplasmic 2	GO:0042802; F:identical protein binding; IPI:IntAct
P63261	ACTG1	Actin, cytoplasmic 2	GO:0005515; F:protein binding; IPI:IntAct
P63261	ACTG1	Actin, cytoplasmic 2	GO:0005200; F:structural constituent of cytoskeleton; IC:UniProtKB
P63261	ACTG1	Actin, cytoplasmic 2	GO:0034332; P:adherens junction organization; TAS:Reactome
P63261	ACTG1	Actin, cytoplasmic 2	GO:0007411; P:axon guidance; TAS:Reactome
P63261	ACTG1	Actin, cytoplasmic 2	GO:0034329; P:cell junction assembly; TAS:Reactome
P63261	ACTG1	Actin, cytoplasmic 2	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P63261	ACTG1	Actin, cytoplasmic 2	GO:0006928; P:cellular component movement; TAS:UniProtKB
P63261	ACTG1	Actin, cytoplasmic 2	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P63261	ACTG1	Actin, cytoplasmic 2	GO:0045087; P:innate immune response; TAS:Reactome
P63261	ACTG1	Actin, cytoplasmic 2	GO:0061024; P:membrane organization; TAS:Reactome
P63261	ACTG1	Actin, cytoplasmic 2	GO:0001895; P:retina homeostasis; IEP:UniProt
P63261	ACTG1	Actin, cytoplasmic 2	GO:0045214; P:sarcomere organization; IEA:Ensembl
Q01718	MC2R	Adrenocorticotropic hormone receptor	GO:0004978; F:corticotropin receptor activity; TAS:ProtInc
Q01718	MC2R	Adrenocorticotropic hormone receptor	GO:0004977; F:melanocortin receptor activity; TAS:ProtInc
Q01718	MC2R	Adrenocorticotropic hormone receptor	GO:0005515; F:protein binding; IPI:BHF-UCL
Q01718	MC2R	Adrenocorticotropic hormone receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q01718	MC2R	Adrenocorticotropic hormone receptor	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
Q01718	MC2R	Adrenocorticotropic hormone receptor	GO:0007218; P:neuropeptide signaling pathway; TAS:GOC
Q01718	MC2R	Adrenocorticotropic hormone receptor	GO:0001890; P:placenta development; IEA:Ensembl
Q01718	MC2R	Adrenocorticotropic hormone receptor	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:BHF-UCL
P63267	ACTG2	Actin, gamma-enteric smooth muscle	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P63267	ACTG2	Actin, gamma-enteric smooth muscle	GO:0006936; P:muscle contraction; TAS:Reactome
Q9H568	ACTL8	Actin-like protein 8	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
P12814	ACTN1	Alpha-actinin-1	GO:0005509; F:calcium ion binding; IEA:InterPro
P12814	ACTN1	Alpha-actinin-1	GO:0003725; F:double-stranded RNA binding; IDA:MGI
P12814	ACTN1	Alpha-actinin-1	GO:0005178; F:integrin binding; IDA:UniProtKB
P12814	ACTN1	Alpha-actinin-1	GO:0044325; F:ion channel binding; IPI:BHF-UCL
P12814	ACTN1	Alpha-actinin-1	GO:0005515; F:protein binding; IPI:UniProtKB
P12814	ACTN1	Alpha-actinin-1	GO:0017166; F:vinculin binding; IPI:UniProtKB
P12814	ACTN1	Alpha-actinin-1	GO:0051017; P:actin filament bundle assembly; IEA:Ensembl
P12814	ACTN1	Alpha-actinin-1	GO:0007596; P:blood coagulation; TAS:Reactome
P12814	ACTN1	Alpha-actinin-1	GO:0034329; P:cell junction assembly; TAS:Reactome
P12814	ACTN1	Alpha-actinin-1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P12814	ACTN1	Alpha-actinin-1	GO:0048041; P:focal adhesion assembly; IMP:UniProtKB
P12814	ACTN1	Alpha-actinin-1	GO:0051271; P:negative regulation of cellular component movement; IMP:UniProtKB
P12814	ACTN1	Alpha-actinin-1	GO:0030168; P:platelet activation; TAS:Reactome
P12814	ACTN1	Alpha-actinin-1	GO:0002576; P:platelet degranulation; TAS:Reactome
P12814	ACTN1	Alpha-actinin-1	GO:0042981; P:regulation of apoptotic process; NAS:UniProtKB
P35609	ACTN2	Alpha-actinin-2	GO:0005509; F:calcium ion binding; IEA:InterPro
P35609	ACTN2	Alpha-actinin-2	GO:0008092; F:cytoskeletal protein binding; IDA:UniProtKB
P35609	ACTN2	Alpha-actinin-2	GO:0051373; F:FATZ binding; IDA:UniProtKB
P35609	ACTN2	Alpha-actinin-2	GO:0042802; F:identical protein binding; IPI:IntAct
P35609	ACTN2	Alpha-actinin-2	GO:0005178; F:integrin binding; TAS:UniProtKB
P35609	ACTN2	Alpha-actinin-2	GO:0044325; F:ion channel binding; IPI:BHF-UCL
P35609	ACTN2	Alpha-actinin-2	GO:0005515; F:protein binding; IPI:UniProtKB
P35609	ACTN2	Alpha-actinin-2	GO:0046983; F:protein dimerization activity; IDA:UniProtKB
P35609	ACTN2	Alpha-actinin-2	GO:0008307; F:structural constituent of muscle; TAS:ProtInc
P35609	ACTN2	Alpha-actinin-2	GO:0030375; F:thyroid hormone receptor coactivator activity; IEA:Ensembl
P35609	ACTN2	Alpha-actinin-2	GO:0031432; F:titin binding; IPI:BHF-UCL
P35609	ACTN2	Alpha-actinin-2	GO:0070080; F:titin Z domain binding; IPI:BHF-UCL
P35609	ACTN2	Alpha-actinin-2	GO:0007596; P:blood coagulation; TAS:Reactome
P35609	ACTN2	Alpha-actinin-2	GO:0007155; P:cell adhesion; TAS:UniProtKB
P35609	ACTN2	Alpha-actinin-2	GO:0048041; P:focal adhesion assembly; IMP:UniProtKB
P35609	ACTN2	Alpha-actinin-2	GO:0030035; P:microspike assembly; IDA:UniProtKB
P35609	ACTN2	Alpha-actinin-2	GO:0030049; P:muscle filament sliding; TAS:Reactome
P35609	ACTN2	Alpha-actinin-2	GO:1901017; P:negative regulation of potassium ion transmembrane transporter activity; IMP:BHF-UCL
P35609	ACTN2	Alpha-actinin-2	GO:0043267; P:negative regulation of potassium ion transport; IMP:BHF-UCL
P35609	ACTN2	Alpha-actinin-2	GO:2000009; P:negative regulation of protein localization to cell surface; IMP:BHF-UCL
P35609	ACTN2	Alpha-actinin-2	GO:0030168; P:platelet activation; TAS:Reactome
P35609	ACTN2	Alpha-actinin-2	GO:0002576; P:platelet degranulation; TAS:Reactome
P35609	ACTN2	Alpha-actinin-2	GO:1901018; P:positive regulation of potassium ion transmembrane transporter activity; IDA:BHF-UCL
P35609	ACTN2	Alpha-actinin-2	GO:0043268; P:positive regulation of potassium ion transport; IDA:BHF-UCL
P35609	ACTN2	Alpha-actinin-2	GO:0051289; P:protein homotetramerization; IDA:UniProtKB
P35609	ACTN2	Alpha-actinin-2	GO:0042981; P:regulation of apoptotic process; NAS:UniProtKB
P35609	ACTN2	Alpha-actinin-2	GO:0042391; P:regulation of membrane potential; IMP:BHF-UCL
P35609	ACTN2	Alpha-actinin-2	GO:0007268; P:synaptic transmission; TAS:Reactome
Q08043	ACTN3	Alpha-actinin-3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q08043	ACTN3	Alpha-actinin-3	GO:0005178; F:integrin binding; TAS:UniProtKB
Q08043	ACTN3	Alpha-actinin-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q08043	ACTN3	Alpha-actinin-3	GO:0042803; F:protein homodimerization activity; TAS:UniProtKB
Q08043	ACTN3	Alpha-actinin-3	GO:0008307; F:structural constituent of muscle; TAS:ProtInc
Q08043	ACTN3	Alpha-actinin-3	GO:0048041; P:focal adhesion assembly; IMP:UniProtKB
Q08043	ACTN3	Alpha-actinin-3	GO:0030049; P:muscle filament sliding; TAS:Reactome
Q08043	ACTN3	Alpha-actinin-3	GO:0042981; P:regulation of apoptotic process; NAS:UniProtKB
O43707	ACTN4	Alpha-actinin-4	GO:0003779; F:actin binding; TAS:UniProtKB
O43707	ACTN4	Alpha-actinin-4	GO:0051015; F:actin filament binding; IDA:UniProtKB
O43707	ACTN4	Alpha-actinin-4	GO:0005509; F:calcium ion binding; IEA:InterPro
O43707	ACTN4	Alpha-actinin-4	GO:0005178; F:integrin binding; TAS:UniProtKB
O43707	ACTN4	Alpha-actinin-4	GO:0001882; F:nucleoside binding; IDA:UniProtKB
O43707	ACTN4	Alpha-actinin-4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O43707	ACTN4	Alpha-actinin-4	GO:0005515; F:protein binding; IPI:UniProtKB
O43707	ACTN4	Alpha-actinin-4	GO:0042803; F:protein homodimerization activity; TAS:UniProtKB
O43707	ACTN4	Alpha-actinin-4	GO:0051017; P:actin filament bundle assembly; IEA:Ensembl
O43707	ACTN4	Alpha-actinin-4	GO:0007596; P:blood coagulation; TAS:Reactome
O43707	ACTN4	Alpha-actinin-4	GO:0051271; P:negative regulation of cellular component movement; IEA:Ensembl
O43707	ACTN4	Alpha-actinin-4	GO:0030168; P:platelet activation; TAS:Reactome
O43707	ACTN4	Alpha-actinin-4	GO:0002576; P:platelet degranulation; TAS:Reactome
O43707	ACTN4	Alpha-actinin-4	GO:0051272; P:positive regulation of cellular component movement; IDA:UniProtKB
O43707	ACTN4	Alpha-actinin-4	GO:0048549; P:positive regulation of pinocytosis; IEA:Ensembl
O43707	ACTN4	Alpha-actinin-4	GO:0032417; P:positive regulation of sodium:proton antiporter activity; NAS:UniProtKB
O43707	ACTN4	Alpha-actinin-4	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O43707	ACTN4	Alpha-actinin-4	GO:0042981; P:regulation of apoptotic process; NAS:UniProtKB
O43707	ACTN4	Alpha-actinin-4	GO:0001666; P:response to hypoxia; IEA:Ensembl
O43707	ACTN4	Alpha-actinin-4	GO:0070830; P:tight junction assembly; IEA:Ensembl
P68133	ACTA1	Actin, alpha skeletal muscle	GO:0043531; F:ADP binding; TAS:UniProtKB
P68133	ACTA1	Actin, alpha skeletal muscle	GO:0005524; F:ATP binding; TAS:UniProtKB
P68133	ACTA1	Actin, alpha skeletal muscle	GO:0017022; F:myosin binding; TAS:UniProtKB
P68133	ACTA1	Actin, alpha skeletal muscle	GO:0005515; F:protein binding; IPI:UniProtKB
P68133	ACTA1	Actin, alpha skeletal muscle	GO:0005200; F:structural constituent of cytoskeleton; TAS:UniProtKB
P68133	ACTA1	Actin, alpha skeletal muscle	GO:0016049; P:cell growth; IEA:Ensembl
P68133	ACTA1	Actin, alpha skeletal muscle	GO:0006936; P:muscle contraction; TAS:UniProtKB
P68133	ACTA1	Actin, alpha skeletal muscle	GO:0030049; P:muscle filament sliding; TAS:Reactome
P68133	ACTA1	Actin, alpha skeletal muscle	GO:0009991; P:response to extracellular stimulus; IEA:Ensembl
P68133	ACTA1	Actin, alpha skeletal muscle	GO:0010226; P:response to lithium ion; IEA:Ensembl
P68133	ACTA1	Actin, alpha skeletal muscle	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P68133	ACTA1	Actin, alpha skeletal muscle	GO:0048545; P:response to steroid hormone; IEA:Ensembl
P68133	ACTA1	Actin, alpha skeletal muscle	GO:0043503; P:skeletal muscle fiber adaptation; IEA:Ensembl
P68133	ACTA1	Actin, alpha skeletal muscle	GO:0048741; P:skeletal muscle fiber development; ISS:UniProtKB
P68133	ACTA1	Actin, alpha skeletal muscle	GO:0030240; P:skeletal muscle thin filament assembly; IMP:UniProtKB
P42025	ACTR1B	Beta-centractin	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P42025	ACTR1B	Beta-centractin	GO:0005515; F:protein binding; IPI:IntAct
P42025	ACTR1B	Beta-centractin	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P61163	ACTR1A	Alpha-centractin	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P61163	ACTR1A	Alpha-centractin	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P61163	ACTR1A	Alpha-centractin	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P61163	ACTR1A	Alpha-centractin	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P61163	ACTR1A	Alpha-centractin	GO:0016192; P:vesicle-mediated transport; TAS:ProtInc
P36896	ACVR1B	Activin receptor type-1B	GO:0016361; F:activin receptor activity, type I; IDA:UniProtKB
P36896	ACVR1B	Activin receptor type-1B	GO:0005524; F:ATP binding; IDA:HGNC
P36896	ACVR1B	Activin receptor type-1B	GO:0034711; F:inhibin binding; IPI:BHF-UCL
P36896	ACVR1B	Activin receptor type-1B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P36896	ACVR1B	Activin receptor type-1B	GO:0005515; F:protein binding; IPI:UniProtKB
P36896	ACVR1B	Activin receptor type-1B	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P36896	ACVR1B	Activin receptor type-1B	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IEA:Ensembl
P36896	ACVR1B	Activin receptor type-1B	GO:0046332; F:SMAD binding; IDA:HGNC
P36896	ACVR1B	Activin receptor type-1B	GO:0005024; F:transforming growth factor beta-activated receptor activity; IEA:InterPro
P36896	ACVR1B	Activin receptor type-1B	GO:0004675; F:transmembrane receptor protein serine/threonine kinase activity; NAS:HGNC
P36896	ACVR1B	Activin receptor type-1B	GO:0031625; F:ubiquitin protein ligase binding; NAS:BHF-UCL
P36896	ACVR1B	Activin receptor type-1B	GO:0032924; P:activin receptor signaling pathway; IDA:UniProtKB
P36896	ACVR1B	Activin receptor type-1B	GO:0007417; P:central nervous system development; IEA:Ensembl
P36896	ACVR1B	Activin receptor type-1B	GO:0046545; P:development of primary female sexual characteristics; IEA:Ensembl
P36896	ACVR1B	Activin receptor type-1B	GO:0097191; P:extrinsic apoptotic signaling pathway; IMP:BHF-UCL
P36896	ACVR1B	Activin receptor type-1B	GO:0000082; P:G1/S transition of mitotic cell cycle; IDA:HGNC
P36896	ACVR1B	Activin receptor type-1B	GO:0001942; P:hair follicle development; IEA:Ensembl
P36896	ACVR1B	Activin receptor type-1B	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P36896	ACVR1B	Activin receptor type-1B	GO:0030308; P:negative regulation of cell growth; IDA:HGNC
P36896	ACVR1B	Activin receptor type-1B	GO:0038092; P:nodal signaling pathway; IGI:UniProtKB
P36896	ACVR1B	Activin receptor type-1B	GO:0018107; P:peptidyl-threonine phosphorylation; IDA:UniProtKB
P36896	ACVR1B	Activin receptor type-1B	GO:0032927; P:positive regulation of activin receptor signaling pathway; IDA:BHF-UCL
P36896	ACVR1B	Activin receptor type-1B	GO:0045648; P:positive regulation of erythrocyte differentiation; IDA:HGNC
P36896	ACVR1B	Activin receptor type-1B	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IEA:Ensembl
P36896	ACVR1B	Activin receptor type-1B	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P36896	ACVR1B	Activin receptor type-1B	GO:1901165; P:positive regulation of trophoblast cell migration; IDA:BHF-UCL
P36896	ACVR1B	Activin receptor type-1B	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P36896	ACVR1B	Activin receptor type-1B	GO:0006468; P:protein phosphorylation; IDA:HGNC
P36896	ACVR1B	Activin receptor type-1B	GO:0006355; P:regulation of transcription, DNA-templated; IDA:HGNC
P36896	ACVR1B	Activin receptor type-1B	GO:0007165; P:signal transduction; IDA:HGNC
P36896	ACVR1B	Activin receptor type-1B	GO:0007178; P:transmembrane receptor protein serine/threonine kinase signaling pathway; TAS:ProtInc
Q8NER5	ACVR1C	Activin receptor type-1C	GO:0016361; F:activin receptor activity, type I; IDA:UniProtKB
Q8NER5	ACVR1C	Activin receptor type-1C	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NER5	ACVR1C	Activin receptor type-1C	GO:0019838; F:growth factor binding; IPI:UniProt
Q8NER5	ACVR1C	Activin receptor type-1C	GO:0046872; F:metal ion binding; IC:UniProtKB
Q8NER5	ACVR1C	Activin receptor type-1C	GO:0038100; F:nodal binding; IMP:BHF-UCL
Q8NER5	ACVR1C	Activin receptor type-1C	GO:0005024; F:transforming growth factor beta-activated receptor activity; IEA:InterPro
Q8NER5	ACVR1C	Activin receptor type-1C	GO:0030262; P:apoptotic nuclear changes; IDA:UniProtKB
Q8NER5	ACVR1C	Activin receptor type-1C	GO:0030154; P:cell differentiation; IDA:UniProtKB
Q8NER5	ACVR1C	Activin receptor type-1C	GO:0019915; P:lipid storage; IEA:Ensembl
Q8NER5	ACVR1C	Activin receptor type-1C	GO:1901383; P:negative regulation of chorionic trophoblast cell proliferation; IMP:BHF-UCL
Q8NER5	ACVR1C	Activin receptor type-1C	GO:0046676; P:negative regulation of insulin secretion; IEA:Ensembl
Q8NER5	ACVR1C	Activin receptor type-1C	GO:1901164; P:negative regulation of trophoblast cell migration; IDA:BHF-UCL
Q8NER5	ACVR1C	Activin receptor type-1C	GO:0038092; P:nodal signaling pathway; IMP:BHF-UCL
Q8NER5	ACVR1C	Activin receptor type-1C	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:BHF-UCL
Q8NER5	ACVR1C	Activin receptor type-1C	GO:0006468; P:protein phosphorylation; IC:UniProtKB
Q8NER5	ACVR1C	Activin receptor type-1C	GO:0002021; P:response to dietary excess; IEA:Ensembl
Q8NER5	ACVR1C	Activin receptor type-1C	GO:0009749; P:response to glucose; IEA:Ensembl
Q8NER5	ACVR1C	Activin receptor type-1C	GO:0032868; P:response to insulin; IEA:Ensembl
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0048185; F:activin binding; IDA:UniProtKB
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0016361; F:activin receptor activity, type I; IDA:MGI
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0005524; F:ATP binding; IDA:HGNC
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0005515; F:protein binding; IPI:UniProtKB
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0004674; F:protein serine/threonine kinase activity; IDA:HGNC
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IEA:Ensembl
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0046332; F:SMAD binding; IDA:HGNC
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0050431; F:transforming growth factor beta binding; IPI:UniProtKB
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0005025; F:transforming growth factor beta receptor activity, type I; IEA:Ensembl
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0005024; F:transforming growth factor beta-activated receptor activity; IDA:MGI
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0032924; P:activin receptor signaling pathway; IDA:GOC
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0001525; P:angiogenesis; IMP:HGNC
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0060840; P:artery development; ISS:BHF-UCL
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0008015; P:blood circulation; IMP:HGNC
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0002043; P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis; TAS:DFLAT
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0001955; P:blood vessel maturation; TAS:DFLAT
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0001974; P:blood vessel remodeling; ISS:BHF-UCL
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0030509; P:BMP signaling pathway; IMP:BHF-UCL
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0071773; P:cellular response to BMP stimulus; IMP:BHF-UCL
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IDA:BHF-UCL
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0061154; P:endothelial tube morphogenesis; IMP:BHF-UCL
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0001946; P:lymphangiogenesis; ISS:BHF-UCL
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0060836; P:lymphatic endothelial cell differentiation; IMP:BHF-UCL
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0043537; P:negative regulation of blood vessel endothelial cell migration; IMP:BHF-UCL
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0007162; P:negative regulation of cell adhesion; IMP:HGNC
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0030308; P:negative regulation of cell growth; IDA:BHF-UCL
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0030336; P:negative regulation of cell migration; IMP:HGNC
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0008285; P:negative regulation of cell proliferation; IMP:HGNC
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:2000279; P:negative regulation of DNA biosynthetic process; IMP:BHF-UCL
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0045602; P:negative regulation of endothelial cell differentiation; IEA:Ensembl
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0010596; P:negative regulation of endothelial cell migration; IDA:BHF-UCL
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0001937; P:negative regulation of endothelial cell proliferation; IEA:Ensembl
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0051895; P:negative regulation of focal adhesion assembly; IMP:HGNC
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0030513; P:positive regulation of BMP signaling pathway; IDA:BHF-UCL
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0032332; P:positive regulation of chondrocyte differentiation; TAS:BHF-UCL
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0045603; P:positive regulation of endothelial cell differentiation; IEA:Ensembl
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IMP:BHF-UCL
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:HGNC
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0006468; P:protein phosphorylation; IDA:HGNC
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0008217; P:regulation of blood pressure; IMP:HGNC
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0043535; P:regulation of blood vessel endothelial cell migration; TAS:DFLAT
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0006275; P:regulation of DNA replication; TAS:DFLAT
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0001936; P:regulation of endothelial cell proliferation; TAS:DFLAT
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0006355; P:regulation of transcription, DNA-templated; IMP:HGNC
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0061298; P:retina vasculature development in camera-type eye; ISS:BHF-UCL
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0007165; P:signal transduction; IDA:HGNC
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:HGNC
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0060841; P:venous blood vessel development; ISS:BHF-UCL
P37023	ACVRL1	Serine/threonine-protein kinase receptor R3	GO:0035313; P:wound healing, spreading of epidermal cells; IMP:HGNC
Q04771	ACVR1	Activin receptor type-1	GO:0048185; F:activin binding; IDA:UniProtKB
Q04771	ACVR1	Activin receptor type-1	GO:0016361; F:activin receptor activity, type I; IEA:Ensembl
Q04771	ACVR1	Activin receptor type-1	GO:0005524; F:ATP binding; IDA:HGNC
Q04771	ACVR1	Activin receptor type-1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q04771	ACVR1	Activin receptor type-1	GO:0017046; F:peptide hormone binding; NAS:UniProtKB
Q04771	ACVR1	Activin receptor type-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q04771	ACVR1	Activin receptor type-1	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
Q04771	ACVR1	Activin receptor type-1	GO:0004672; F:protein kinase activity; IDA:BHF-UCL
Q04771	ACVR1	Activin receptor type-1	GO:0004674; F:protein serine/threonine kinase activity; IDA:HGNC
Q04771	ACVR1	Activin receptor type-1	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IEA:Ensembl
Q04771	ACVR1	Activin receptor type-1	GO:0046332; F:SMAD binding; IDA:HGNC
Q04771	ACVR1	Activin receptor type-1	GO:0050431; F:transforming growth factor beta binding; IDA:UniProtKB
Q04771	ACVR1	Activin receptor type-1	GO:0005025; F:transforming growth factor beta receptor activity, type I; IEA:Ensembl
Q04771	ACVR1	Activin receptor type-1	GO:0032924; P:activin receptor signaling pathway; IDA:BHF-UCL
Q04771	ACVR1	Activin receptor type-1	GO:0002526; P:acute inflammatory response; IEA:Ensembl
Q04771	ACVR1	Activin receptor type-1	GO:0003289; P:atrial septum primum morphogenesis; IMP:BHF-UCL
Q04771	ACVR1	Activin receptor type-1	GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL
Q04771	ACVR1	Activin receptor type-1	GO:0060923; P:cardiac muscle cell fate commitment; IMP:BHF-UCL
Q04771	ACVR1	Activin receptor type-1	GO:0071385; P:cellular response to glucocorticoid stimulus; IEA:Ensembl
Q04771	ACVR1	Activin receptor type-1	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
Q04771	ACVR1	Activin receptor type-1	GO:0003143; P:embryonic heart tube morphogenesis; IMP:BHF-UCL
Q04771	ACVR1	Activin receptor type-1	GO:0061445; P:endocardial cushion cell fate commitment; IMP:BHF-UCL
Q04771	ACVR1	Activin receptor type-1	GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:HGNC
Q04771	ACVR1	Activin receptor type-1	GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl
Q04771	ACVR1	Activin receptor type-1	GO:0007281; P:germ cell development; IEA:Ensembl
Q04771	ACVR1	Activin receptor type-1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q04771	ACVR1	Activin receptor type-1	GO:0001707; P:mesoderm formation; IEA:Ensembl
Q04771	ACVR1	Activin receptor type-1	GO:0003183; P:mitral valve morphogenesis; IMP:BHF-UCL
Q04771	ACVR1	Activin receptor type-1	GO:0032926; P:negative regulation of activin receptor signaling pathway; IMP:HGNC
Q04771	ACVR1	Activin receptor type-1	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:BHF-UCL
Q04771	ACVR1	Activin receptor type-1	GO:0009968; P:negative regulation of signal transduction; IMP:HGNC
Q04771	ACVR1	Activin receptor type-1	GO:0001755; P:neural crest cell migration; IEA:Ensembl
Q04771	ACVR1	Activin receptor type-1	GO:0060389; P:pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
Q04771	ACVR1	Activin receptor type-1	GO:0001569; P:patterning of blood vessels; IEA:Ensembl
Q04771	ACVR1	Activin receptor type-1	GO:0018107; P:peptidyl-threonine phosphorylation; IDA:BHF-UCL
Q04771	ACVR1	Activin receptor type-1	GO:0060037; P:pharyngeal system development; IEA:Ensembl
Q04771	ACVR1	Activin receptor type-1	GO:0030501; P:positive regulation of bone mineralization; IMP:BHF-UCL
Q04771	ACVR1	Activin receptor type-1	GO:2000017; P:positive regulation of determination of dorsal identity; IDA:BHF-UCL
Q04771	ACVR1	Activin receptor type-1	GO:0045669; P:positive regulation of osteoblast differentiation; IMP:BHF-UCL
Q04771	ACVR1	Activin receptor type-1	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
Q04771	ACVR1	Activin receptor type-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q04771	ACVR1	Activin receptor type-1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q04771	ACVR1	Activin receptor type-1	GO:0006468; P:protein phosphorylation; IDA:BHF-UCL
Q04771	ACVR1	Activin receptor type-1	GO:0030278; P:regulation of ossification; IMP:UniProtKB
Q04771	ACVR1	Activin receptor type-1	GO:0048641; P:regulation of skeletal muscle tissue development; IEA:Ensembl
Q04771	ACVR1	Activin receptor type-1	GO:0051145; P:smooth muscle cell differentiation; IEA:Ensembl
Q04771	ACVR1	Activin receptor type-1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
Q04771	ACVR1	Activin receptor type-1	GO:0001655; P:urogenital system development; IEA:Ensembl
Q03154	ACY1	Aminoacylase-1	GO:0004046; F:aminoacylase activity; TAS:ProtInc
Q03154	ACY1	Aminoacylase-1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q03154	ACY1	Aminoacylase-1	GO:0008237; F:metallopeptidase activity; IEA:InterPro
Q03154	ACY1	Aminoacylase-1	GO:0006520; P:cellular amino acid metabolic process; IEA:InterPro
P45381	ASPA	Aspartoacylase	GO:0004046; F:aminoacylase activity; TAS:ProtInc
P45381	ASPA	Aspartoacylase	GO:0019807; F:aspartoacylase activity; IEA:UniProtKB-EC
P45381	ASPA	Aspartoacylase	GO:0016788; F:hydrolase activity, acting on ester bonds; IEA:InterPro
P45381	ASPA	Aspartoacylase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P45381	ASPA	Aspartoacylase	GO:0006533; P:aspartate catabolic process; TAS:ProtInc
P45381	ASPA	Aspartoacylase	GO:0022010; P:central nervous system myelination; IEA:Ensembl
P45381	ASPA	Aspartoacylase	GO:0048714; P:positive regulation of oligodendrocyte differentiation; IEA:Ensembl
Q96HD9	ACY3	N-acyl-aromatic-L-amino acid amidohydrolase (carboxylate-forming)	GO:0004046; F:aminoacylase activity; ISS:UniProt
Q96HD9	ACY3	N-acyl-aromatic-L-amino acid amidohydrolase (carboxylate-forming)	GO:0016788; F:hydrolase activity, acting on ester bonds; IEA:InterPro
Q96HD9	ACY3	N-acyl-aromatic-L-amino acid amidohydrolase (carboxylate-forming)	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96HD9	ACY3	N-acyl-aromatic-L-amino acid amidohydrolase (carboxylate-forming)	GO:0016032; P:viral process; IEA:UniProtKB-KW
P07311	ACYP1	Acylphosphatase-1	GO:0003998; F:acylphosphatase activity; IBA:RefGenome
P07311	ACYP1	Acylphosphatase-1	GO:0006796; P:phosphate-containing compound metabolic process; TAS:ProtInc
P14621	ACYP2	Acylphosphatase-2	GO:0003998; F:acylphosphatase activity; IBA:RefGenome
P14621	ACYP2	Acylphosphatase-2	GO:0006796; P:phosphate-containing compound metabolic process; TAS:ProtInc
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0004175; F:endopeptidase activity; ISS:UniProtKB
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0005178; F:integrin binding; NAS:UniProtKB
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0004222; F:metalloendopeptidase activity; IMP:UniProtKB
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0008237; F:metallopeptidase activity; IDA:UniProtKB
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0005515; F:protein binding; IPI:BHF-UCL
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0019901; F:protein kinase binding; ISS:UniProtKB
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0005102; F:receptor binding; NAS:UniProtKB
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0008270; F:zinc ion binding; IEA:InterPro
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0007267; P:cell-cell signaling; NAS:UniProtKB
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0030574; P:collagen catabolic process; TAS:Reactome
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0051089; P:constitutive protein ectodomain proteolysis; IDA:UniProtKB
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0001701; P:in utero embryonic development; ISS:UniProtKB
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0007229; P:integrin-mediated signaling pathway; NAS:UniProtKB
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0006509; P:membrane protein ectodomain proteolysis; IDA:UniProtKB
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0042117; P:monocyte activation; IMP:BHF-UCL
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0007162; P:negative regulation of cell adhesion; IDA:UniProtKB
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0007220; P:Notch receptor processing; TAS:Reactome
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0007219; P:Notch signaling pathway; ISS:UniProtKB
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0051088; P:PMA-inducible membrane protein ectodomain proteolysis; IMP:BHF-UCL
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0030307; P:positive regulation of cell growth; IMP:BHF-UCL
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0030335; P:positive regulation of cell migration; IMP:BHF-UCL
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0008284; P:positive regulation of cell proliferation; IMP:BHF-UCL
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0010820; P:positive regulation of T cell chemotaxis; IMP:BHF-UCL
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
O14672	ADAM10	Disintegrin and metalloproteinase domain-containing protein 10	GO:0034612; P:response to tumor necrosis factor; IDA:BHF-UCL
O75078	ADAM11	Disintegrin and metalloproteinase domain-containing protein 11	GO:0005178; F:integrin binding; TAS:ProtInc
O75078	ADAM11	Disintegrin and metalloproteinase domain-containing protein 11	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
O75078	ADAM11	Disintegrin and metalloproteinase domain-containing protein 11	GO:0008237; F:metallopeptidase activity; TAS:ProtInc
O75078	ADAM11	Disintegrin and metalloproteinase domain-containing protein 11	GO:0008270; F:zinc ion binding; IEA:InterPro
O75078	ADAM11	Disintegrin and metalloproteinase domain-containing protein 11	GO:0007229; P:integrin-mediated signaling pathway; TAS:ProtInc
O43184	ADAM12	Disintegrin and metalloproteinase domain-containing protein 12	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
O43184	ADAM12	Disintegrin and metalloproteinase domain-containing protein 12	GO:0008237; F:metallopeptidase activity; TAS:ProtInc
O43184	ADAM12	Disintegrin and metalloproteinase domain-containing protein 12	GO:0005515; F:protein binding; IPI:UniProtKB
O43184	ADAM12	Disintegrin and metalloproteinase domain-containing protein 12	GO:0017124; F:SH3 domain binding; IPI:BHF-UCL
O43184	ADAM12	Disintegrin and metalloproteinase domain-containing protein 12	GO:0008270; F:zinc ion binding; IEA:InterPro
O43184	ADAM12	Disintegrin and metalloproteinase domain-containing protein 12	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
O43184	ADAM12	Disintegrin and metalloproteinase domain-containing protein 12	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O43184	ADAM12	Disintegrin and metalloproteinase domain-containing protein 12	GO:0007520; P:myoblast fusion; TAS:ProtInc
Q13444	ADAM15	Disintegrin and metalloproteinase domain-containing protein 15	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q13444	ADAM15	Disintegrin and metalloproteinase domain-containing protein 15	GO:0008237; F:metallopeptidase activity; IDA:BHF-UCL
Q13444	ADAM15	Disintegrin and metalloproteinase domain-containing protein 15	GO:0005515; F:protein binding; IPI:IntAct
Q13444	ADAM15	Disintegrin and metalloproteinase domain-containing protein 15	GO:0017124; F:SH3 domain binding; IPI:BHF-UCL
Q13444	ADAM15	Disintegrin and metalloproteinase domain-containing protein 15	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13444	ADAM15	Disintegrin and metalloproteinase domain-containing protein 15	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q13444	ADAM15	Disintegrin and metalloproteinase domain-containing protein 15	GO:0060317; P:cardiac epithelial to mesenchymal transition; IEA:Ensembl
Q13444	ADAM15	Disintegrin and metalloproteinase domain-containing protein 15	GO:0007160; P:cell-matrix adhesion; TAS:ProtInc
Q13444	ADAM15	Disintegrin and metalloproteinase domain-containing protein 15	GO:0030574; P:collagen catabolic process; IEA:UniProtKB-KW
Q13444	ADAM15	Disintegrin and metalloproteinase domain-containing protein 15	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q13444	ADAM15	Disintegrin and metalloproteinase domain-containing protein 15	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q13444	ADAM15	Disintegrin and metalloproteinase domain-containing protein 15	GO:0042246; P:tissue regeneration; IEA:Ensembl
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0005178; F:integrin binding; IPI:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0005138; F:interleukin-6 receptor binding; IPI:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0004222; F:metalloendopeptidase activity; IDA:UniProtKB
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0008237; F:metallopeptidase activity; IDA:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0005112; F:Notch binding; IDA:UniProtKB
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0030165; F:PDZ domain binding; IPI:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0005515; F:protein binding; IPI:IntAct
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0008270; F:zinc ion binding; IEA:InterPro
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0006915; P:apoptotic process; TAS:Reactome
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0030183; P:B cell differentiation; ISS:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0007155; P:cell adhesion; IDA:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0033627; P:cell adhesion mediated by integrin; IDA:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0048870; P:cell motility; ISS:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0030574; P:collagen catabolic process; TAS:Reactome
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0007173; P:epidermal growth factor receptor signaling pathway; IDA:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0035625; P:epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway; IMP:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0002467; P:germinal center formation; ISS:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0006509; P:membrane protein ectodomain proteolysis; IDA:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0031293; P:membrane protein intracellular domain proteolysis; TAS:Reactome
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0032717; P:negative regulation of interleukin-8 production; IMP:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0002446; P:neutrophil mediated immunity; IC:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0007220; P:Notch receptor processing; IDA:UniProtKB
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0051088; P:PMA-inducible membrane protein ectodomain proteolysis; IDA:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0030307; P:positive regulation of cell growth; IMP:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0030335; P:positive regulation of cell migration; IMP:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0008284; P:positive regulation of cell proliferation; IMP:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0051272; P:positive regulation of cellular component movement; ISS:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0032722; P:positive regulation of chemokine production; IMP:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0031659; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle; IDA:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0045741; P:positive regulation of epidermal growth factor-activated receptor activity; IDA:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0002690; P:positive regulation of leukocyte chemotaxis; IC:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0001934; P:positive regulation of protein phosphorylation; IMP:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0010820; P:positive regulation of T cell chemotaxis; IMP:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; ISS:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0006508; P:proteolysis; IDA:UniProtKB
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0033025; P:regulation of mast cell apoptotic process; ISS:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0042493; P:response to drug; ISS:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0055099; P:response to high density lipoprotein particle; IDA:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0001666; P:response to hypoxia; IDA:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0032496; P:response to lipopolysaccharide; IDA:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0048536; P:spleen development; ISS:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0033077; P:T cell differentiation in thymus; ISS:BHF-UCL
P78536	ADAM17	Disintegrin and metalloproteinase domain-containing protein 17	GO:0035313; P:wound healing, spreading of epidermal cells; IEP:BHF-UCL
Q9H013	ADAM19	Disintegrin and metalloproteinase domain-containing protein 19	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q9H013	ADAM19	Disintegrin and metalloproteinase domain-containing protein 19	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H013	ADAM19	Disintegrin and metalloproteinase domain-containing protein 19	GO:0007507; P:heart development; IEA:Ensembl
Q9H013	ADAM19	Disintegrin and metalloproteinase domain-containing protein 19	GO:0006509; P:membrane protein ectodomain proteolysis; IEA:Ensembl
Q9Y3Q7	ADAM18	Disintegrin and metalloproteinase domain-containing protein 18	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q9Y3Q7	ADAM18	Disintegrin and metalloproteinase domain-containing protein 18	GO:0008237; F:metallopeptidase activity; TAS:ProtInc
Q9Y3Q7	ADAM18	Disintegrin and metalloproteinase domain-containing protein 18	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y3Q7	ADAM18	Disintegrin and metalloproteinase domain-containing protein 18	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9Y3Q7	ADAM18	Disintegrin and metalloproteinase domain-containing protein 18	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9Y3Q7	ADAM18	Disintegrin and metalloproteinase domain-containing protein 18	GO:0007283; P:spermatogenesis; TAS:ProtInc
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0004937; F:alpha1-adrenergic receptor activity; NAS:UniProtKB
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0007202; P:activation of phospholipase C activity; ISS:BHF-UCL
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0071875; P:adrenergic receptor signaling pathway; ISS:GOC
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0007512; P:adult heart development; IEA:Ensembl
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0007568; P:aging; ISS:BHF-UCL
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0006915; P:apoptotic process; TAS:ProtInc
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0060402; P:calcium ion transport into cytosol; ISS:BHF-UCL
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0016049; P:cell growth; IEA:Ensembl
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0060073; P:micturition; IEA:Ensembl
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0001985; P:negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure; IEA:Ensembl
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0035024; P:negative regulation of Rho protein signal transduction; ISS:BHF-UCL
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0032229; P:negative regulation of synaptic transmission, GABAergic; ISS:BHF-UCL
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0001994; P:norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure; IEA:Ensembl
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0035265; P:organ growth; IEA:Ensembl
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0097195; P:pilomotor reflex; IEA:Ensembl
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0045760; P:positive regulation of action potential; ISS:BHF-UCL
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0060452; P:positive regulation of cardiac muscle contraction; ISS:BHF-UCL
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISS:BHF-UCL
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:BHF-UCL
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0001996; P:positive regulation of heart rate by epinephrine-norepinephrine; IEA:Ensembl
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0043410; P:positive regulation of MAPK cascade; IDA:UniProtKB
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0090037; P:positive regulation of protein kinase C signaling; ISS:BHF-UCL
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0045987; P:positive regulation of smooth muscle contraction; IEA:Ensembl
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0003084; P:positive regulation of systemic arterial blood pressure; IEA:Ensembl
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0001997; P:positive regulation of the force of heart contraction by epinephrine-norepinephrine; IEA:Ensembl
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0045907; P:positive regulation of vasoconstriction; ISS:BHF-UCL
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0042493; P:response to drug; ISS:BHF-UCL
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0009725; P:response to hormone; ISS:BHF-UCL
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0007165; P:signal transduction; TAS:ProtInc
P35348	ADRA1A	Alpha-1A adrenergic receptor	GO:0006939; P:smooth muscle contraction; TAS:ProtInc
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0004937; F:alpha1-adrenergic receptor activity; TAS:ProtInc
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; TAS:ProtInc
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0071875; P:adrenergic receptor signaling pathway; TAS:GOC
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0007512; P:adult heart development; IEA:Ensembl
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0048148; P:behavioral response to cocaine; IEA:Ensembl
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0016049; P:cell growth; IEA:Ensembl
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0008283; P:cell proliferation; TAS:ProtInc
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0042593; P:glucose homeostasis; IEA:Ensembl
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0007626; P:locomotory behavior; IEA:Ensembl
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0045818; P:negative regulation of glycogen catabolic process; IEA:Ensembl
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0035265; P:organ growth; IEA:Ensembl
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0045819; P:positive regulation of glycogen catabolic process; IEA:Ensembl
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0001996; P:positive regulation of heart rate by epinephrine-norepinephrine; IEA:Ensembl
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0043410; P:positive regulation of MAPK cascade; IDA:UniProtKB
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0001997; P:positive regulation of the force of heart contraction by epinephrine-norepinephrine; IEA:Ensembl
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0055117; P:regulation of cardiac muscle contraction; IEA:InterPro
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0019229; P:regulation of vasoconstriction; IEA:InterPro
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0001975; P:response to amphetamine; IEA:Ensembl
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0043278; P:response to morphine; IEA:Ensembl
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0001987; P:vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure; IEA:Ensembl
P35368	ADRA1B	Alpha-1B adrenergic receptor	GO:0008542; P:visual learning; IEA:Ensembl
P25100	ADRA1D	Alpha-1D adrenergic receptor	GO:0004937; F:alpha1-adrenergic receptor activity; TAS:ProtInc
P25100	ADRA1D	Alpha-1D adrenergic receptor	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; TAS:ProtInc
P25100	ADRA1D	Alpha-1D adrenergic receptor	GO:0071875; P:adrenergic receptor signaling pathway; TAS:GOC
P25100	ADRA1D	Alpha-1D adrenergic receptor	GO:0008283; P:cell proliferation; TAS:ProtInc
P25100	ADRA1D	Alpha-1D adrenergic receptor	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P25100	ADRA1D	Alpha-1D adrenergic receptor	GO:0006259; P:DNA metabolic process; TAS:ProtInc
P25100	ADRA1D	Alpha-1D adrenergic receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P25100	ADRA1D	Alpha-1D adrenergic receptor	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P25100	ADRA1D	Alpha-1D adrenergic receptor	GO:0001986; P:negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure; IEA:Ensembl
P25100	ADRA1D	Alpha-1D adrenergic receptor	GO:0001994; P:norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure; IEA:Ensembl
P25100	ADRA1D	Alpha-1D adrenergic receptor	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
O43506	ADAM20	Disintegrin and metalloproteinase domain-containing protein 20	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
O43506	ADAM20	Disintegrin and metalloproteinase domain-containing protein 20	GO:0008237; F:metallopeptidase activity; TAS:ProtInc
O43506	ADAM20	Disintegrin and metalloproteinase domain-containing protein 20	GO:0008270; F:zinc ion binding; IEA:InterPro
O43506	ADAM20	Disintegrin and metalloproteinase domain-containing protein 20	GO:0007339; P:binding of sperm to zona pellucida; TAS:Reactome
O43506	ADAM20	Disintegrin and metalloproteinase domain-containing protein 20	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
O43506	ADAM20	Disintegrin and metalloproteinase domain-containing protein 20	GO:0007338; P:single fertilization; TAS:Reactome
Q9UKJ8	ADAM21	Disintegrin and metalloproteinase domain-containing protein 21	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q9UKJ8	ADAM21	Disintegrin and metalloproteinase domain-containing protein 21	GO:0008237; F:metallopeptidase activity; TAS:ProtInc
Q9UKJ8	ADAM21	Disintegrin and metalloproteinase domain-containing protein 21	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UKJ8	ADAM21	Disintegrin and metalloproteinase domain-containing protein 21	GO:0007339; P:binding of sperm to zona pellucida; TAS:Reactome
Q9UKJ8	ADAM21	Disintegrin and metalloproteinase domain-containing protein 21	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
Q9UKJ8	ADAM21	Disintegrin and metalloproteinase domain-containing protein 21	GO:0007338; P:single fertilization; TAS:Reactome
Q9P0K1	ADAM22	Disintegrin and metalloproteinase domain-containing protein 22	GO:0005178; F:integrin binding; NAS:UniProtKB
Q9P0K1	ADAM22	Disintegrin and metalloproteinase domain-containing protein 22	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q9P0K1	ADAM22	Disintegrin and metalloproteinase domain-containing protein 22	GO:0005515; F:protein binding; IPI:IntAct
Q9P0K1	ADAM22	Disintegrin and metalloproteinase domain-containing protein 22	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9P0K1	ADAM22	Disintegrin and metalloproteinase domain-containing protein 22	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
Q9P0K1	ADAM22	Disintegrin and metalloproteinase domain-containing protein 22	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9P0K1	ADAM22	Disintegrin and metalloproteinase domain-containing protein 22	GO:0007417; P:central nervous system development; TAS:ProtInc
Q9P0K1	ADAM22	Disintegrin and metalloproteinase domain-containing protein 22	GO:0022011; P:myelination in peripheral nervous system; IEA:Ensembl
Q9P0K1	ADAM22	Disintegrin and metalloproteinase domain-containing protein 22	GO:0007162; P:negative regulation of cell adhesion; NAS:UniProtKB
O75077	ADAM23	Disintegrin and metalloproteinase domain-containing protein 23	GO:0005178; F:integrin binding; TAS:ProtInc
O75077	ADAM23	Disintegrin and metalloproteinase domain-containing protein 23	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
O75077	ADAM23	Disintegrin and metalloproteinase domain-containing protein 23	GO:0008237; F:metallopeptidase activity; TAS:ProtInc
O75077	ADAM23	Disintegrin and metalloproteinase domain-containing protein 23	GO:0005515; F:protein binding; IPI:DFLAT
O75077	ADAM23	Disintegrin and metalloproteinase domain-containing protein 23	GO:0008270; F:zinc ion binding; IEA:InterPro
O75077	ADAM23	Disintegrin and metalloproteinase domain-containing protein 23	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
O75077	ADAM23	Disintegrin and metalloproteinase domain-containing protein 23	GO:0007417; P:central nervous system development; TAS:ProtInc
Q9UKQ2	ADAM28	Disintegrin and metalloproteinase domain-containing protein 28	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q9UKQ2	ADAM28	Disintegrin and metalloproteinase domain-containing protein 28	GO:0008237; F:metallopeptidase activity; IDA:BHF-UCL
Q9UKQ2	ADAM28	Disintegrin and metalloproteinase domain-containing protein 28	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UKQ2	ADAM28	Disintegrin and metalloproteinase domain-containing protein 28	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q9UKF5	ADAM29	Disintegrin and metalloproteinase domain-containing protein 29	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q9UKF5	ADAM29	Disintegrin and metalloproteinase domain-containing protein 29	GO:0008237; F:metallopeptidase activity; TAS:ProtInc
Q9UKF5	ADAM29	Disintegrin and metalloproteinase domain-containing protein 29	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UKF5	ADAM29	Disintegrin and metalloproteinase domain-containing protein 29	GO:0007283; P:spermatogenesis; TAS:ProtInc
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0031692; F:alpha-1B adrenergic receptor binding; ISS:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0031696; F:alpha-2C adrenergic receptor binding; IPI:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0004938; F:alpha2-adrenergic receptor activity; IDA:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0051379; F:epinephrine binding; IDA:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0032795; F:heterotrimeric G-protein binding; IDA:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0051380; F:norepinephrine binding; IDA:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0005515; F:protein binding; IPI:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0031996; F:thioesterase binding; IPI:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0071883; P:activation of MAPK activity by adrenergic receptor signaling pathway; IDA:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0032147; P:activation of protein kinase activity; IDA:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0032148; P:activation of protein kinase B activity; IDA:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0002526; P:acute inflammatory response; IEA:Ensembl
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0071881; P:adenylate cyclase-inhibiting adrenergic receptor signaling pathway; IDA:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0007596; P:blood coagulation; TAS:Reactome
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0006928; P:cellular component movement; TAS:ProtInc
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0032870; P:cellular response to hormone stimulus; IGI:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0006260; P:DNA replication; IEA:Ensembl
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0035625; P:epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway; IDA:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0042596; P:fear response; IEA:Ensembl
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0007565; P:female pregnancy; IEA:Ensembl
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; ISS:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0042593; P:glucose homeostasis; IMP:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0050892; P:intestinal absorption; TAS:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0007194; P:negative regulation of adenylate cyclase activity; ISS:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0071878; P:negative regulation of adrenergic receptor signaling pathway; ISS:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:1901020; P:negative regulation of calcium ion transmembrane transporter activity; ISS:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0051926; P:negative regulation of calcium ion transport; ISS:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0045955; P:negative regulation of calcium ion-dependent exocytosis; IC:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0030818; P:negative regulation of cAMP biosynthetic process; IDA:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0032811; P:negative regulation of epinephrine secretion; NAS:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0046676; P:negative regulation of insulin secretion; IMP:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0061179; P:negative regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0050995; P:negative regulation of lipid catabolic process; IGI:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0010700; P:negative regulation of norepinephrine secretion; NAS:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0070473; P:negative regulation of uterine smooth muscle contraction; IEA:Ensembl
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0071882; P:phospholipase C-activating adrenergic receptor signaling pathway; IDA:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0030168; P:platelet activation; TAS:Reactome
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0030335; P:positive regulation of cell migration; IMP:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0001819; P:positive regulation of cytokine production; IDA:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0045741; P:positive regulation of epidermal growth factor-activated receptor activity; IDA:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0043406; P:positive regulation of MAP kinase activity; IDA:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0051044; P:positive regulation of membrane protein ectodomain proteolysis; IDA:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0043268; P:positive regulation of potassium ion transport; ISS:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0045909; P:positive regulation of vasodilation; IEA:Ensembl
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0090303; P:positive regulation of wound healing; IMP:BHF-UCL
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0007265; P:Ras protein signal transduction; TAS:ProtInc
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0019229; P:regulation of vasoconstriction; IEA:InterPro
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0007266; P:Rho protein signal transduction; TAS:ProtInc
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0007165; P:signal transduction; TAS:ProtInc
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P08913	ADRA2A	Alpha-2A adrenergic receptor	GO:0050955; P:thermoception; IEA:Ensembl
P18089	ADRA2B	Alpha-2B adrenergic receptor	GO:0004938; F:alpha2-adrenergic receptor activity; IDA:BHF-UCL
P18089	ADRA2B	Alpha-2B adrenergic receptor	GO:0051379; F:epinephrine binding; IDA:BHF-UCL
P18089	ADRA2B	Alpha-2B adrenergic receptor	GO:0005515; F:protein binding; IPI:BHF-UCL
P18089	ADRA2B	Alpha-2B adrenergic receptor	GO:0071883; P:activation of MAPK activity by adrenergic receptor signaling pathway; IDA:BHF-UCL
P18089	ADRA2B	Alpha-2B adrenergic receptor	GO:0032148; P:activation of protein kinase B activity; IDA:BHF-UCL
P18089	ADRA2B	Alpha-2B adrenergic receptor	GO:0001525; P:angiogenesis; IEA:Ensembl
P18089	ADRA2B	Alpha-2B adrenergic receptor	GO:0007596; P:blood coagulation; TAS:Reactome
P18089	ADRA2B	Alpha-2B adrenergic receptor	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P18089	ADRA2B	Alpha-2B adrenergic receptor	GO:0035625; P:epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway; IDA:BHF-UCL
P18089	ADRA2B	Alpha-2B adrenergic receptor	GO:0007565; P:female pregnancy; IEA:Ensembl
P18089	ADRA2B	Alpha-2B adrenergic receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P18089	ADRA2B	Alpha-2B adrenergic receptor	GO:0000165; P:MAPK cascade; IEA:Ensembl
P18089	ADRA2B	Alpha-2B adrenergic receptor	GO:0032811; P:negative regulation of epinephrine secretion; NAS:BHF-UCL
P18089	ADRA2B	Alpha-2B adrenergic receptor	GO:0010700; P:negative regulation of norepinephrine secretion; NAS:BHF-UCL
P18089	ADRA2B	Alpha-2B adrenergic receptor	GO:0030168; P:platelet activation; TAS:Reactome
P18089	ADRA2B	Alpha-2B adrenergic receptor	GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl
P18089	ADRA2B	Alpha-2B adrenergic receptor	GO:0045666; P:positive regulation of neuron differentiation; IDA:BHF-UCL
P18089	ADRA2B	Alpha-2B adrenergic receptor	GO:0070474; P:positive regulation of uterine smooth muscle contraction; IEA:Ensembl
P18089	ADRA2B	Alpha-2B adrenergic receptor	GO:0003056; P:regulation of vascular smooth muscle contraction; IEA:Ensembl
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0031694; F:alpha-2A adrenergic receptor binding; IPI:BHF-UCL
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0004938; F:alpha2-adrenergic receptor activity; IDA:BHF-UCL
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0051379; F:epinephrine binding; IDA:BHF-UCL
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0005515; F:protein binding; IPI:BHF-UCL
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0071883; P:activation of MAPK activity by adrenergic receptor signaling pathway; IDA:BHF-UCL
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0032148; P:activation of protein kinase B activity; IDA:BHF-UCL
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0007596; P:blood coagulation; TAS:Reactome
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0035625; P:epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway; IDA:BHF-UCL
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0007565; P:female pregnancy; IEA:Ensembl
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0032811; P:negative regulation of epinephrine secretion; NAS:BHF-UCL
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0010700; P:negative regulation of norepinephrine secretion; NAS:BHF-UCL
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0070473; P:negative regulation of uterine smooth muscle contraction; IEA:Ensembl
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0030168; P:platelet activation; TAS:Reactome
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0045666; P:positive regulation of neuron differentiation; IDA:BHF-UCL
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0051930; P:regulation of sensory perception of pain; IEA:Ensembl
P18825	ADRA2C	Alpha-2C adrenergic receptor	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UKF2	ADAM30	Disintegrin and metalloproteinase domain-containing protein 30	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q9UKF2	ADAM30	Disintegrin and metalloproteinase domain-containing protein 30	GO:0008237; F:metallopeptidase activity; TAS:ProtInc
Q9UKF2	ADAM30	Disintegrin and metalloproteinase domain-containing protein 30	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q9UKF2	ADAM30	Disintegrin and metalloproteinase domain-containing protein 30	GO:0007339; P:binding of sperm to zona pellucida; TAS:Reactome
Q9UKF2	ADAM30	Disintegrin and metalloproteinase domain-containing protein 30	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
Q9UKF2	ADAM30	Disintegrin and metalloproteinase domain-containing protein 30	GO:0007338; P:single fertilization; TAS:Reactome
Q8TC27	ADAM32	Disintegrin and metalloproteinase domain-containing protein 32	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q8TC27	ADAM32	Disintegrin and metalloproteinase domain-containing protein 32	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BZ11	ADAM33	Disintegrin and metalloproteinase domain-containing protein 33	GO:0004222; F:metalloendopeptidase activity; NAS:UniProtKB
Q9BZ11	ADAM33	Disintegrin and metalloproteinase domain-containing protein 33	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9BZ11	ADAM33	Disintegrin and metalloproteinase domain-containing protein 33	GO:0006508; P:proteolysis; NAS:UniProtKB
Q96M93	ADAD1	Adenosine deaminase domain-containing protein 1	GO:0004000; F:adenosine deaminase activity; IEA:InterPro
Q96M93	ADAD1	Adenosine deaminase domain-containing protein 1	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q96M93	ADAD1	Adenosine deaminase domain-containing protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q96M93	ADAD1	Adenosine deaminase domain-containing protein 1	GO:0006396; P:RNA processing; IEA:InterPro
Q96M93	ADAD1	Adenosine deaminase domain-containing protein 1	GO:0007286; P:spermatid development; IEA:Ensembl
Q8NCV1	ADAD2	Adenosine deaminase domain-containing protein 2	GO:0004000; F:adenosine deaminase activity; IEA:InterPro
Q8NCV1	ADAD2	Adenosine deaminase domain-containing protein 2	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q8NCV1	ADAD2	Adenosine deaminase domain-containing protein 2	GO:0006396; P:RNA processing; IEA:InterPro
Q6DHV7	ADAL	Adenosine deaminase-like protein	GO:0004000; F:adenosine deaminase activity; EXP:Reactome
Q6DHV7	ADAL	Adenosine deaminase-like protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6DHV7	ADAL	Adenosine deaminase-like protein	GO:0006154; P:adenosine catabolic process; IBA:RefGenome
Q6DHV7	ADAL	Adenosine deaminase-like protein	GO:0017144; P:drug metabolic process; TAS:Reactome
Q6DHV7	ADAL	Adenosine deaminase-like protein	GO:0046103; P:inosine biosynthetic process; IBA:RefGenome
Q6DHV7	ADAL	Adenosine deaminase-like protein	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q6DHV7	ADAL	Adenosine deaminase-like protein	GO:0009117; P:nucleotide metabolic process; IEA:UniProtKB-KW
Q6DHV7	ADAL	Adenosine deaminase-like protein	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
Q6DHV7	ADAL	Adenosine deaminase-like protein	GO:0043101; P:purine-containing compound salvage; TAS:Reactome
Q6DHV7	ADAL	Adenosine deaminase-like protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99965	ADAM2	Disintegrin and metalloproteinase domain-containing protein 2	GO:0005178; F:integrin binding; TAS:ProtInc
Q99965	ADAM2	Disintegrin and metalloproteinase domain-containing protein 2	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q99965	ADAM2	Disintegrin and metalloproteinase domain-containing protein 2	GO:0008237; F:metallopeptidase activity; TAS:ProtInc
Q99965	ADAM2	Disintegrin and metalloproteinase domain-containing protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q99965	ADAM2	Disintegrin and metalloproteinase domain-containing protein 2	GO:0030534; P:adult behavior; IEA:Ensembl
Q99965	ADAM2	Disintegrin and metalloproteinase domain-containing protein 2	GO:0007339; P:binding of sperm to zona pellucida; TAS:Reactome
Q99965	ADAM2	Disintegrin and metalloproteinase domain-containing protein 2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q99965	ADAM2	Disintegrin and metalloproteinase domain-containing protein 2	GO:0007342; P:fusion of sperm to egg plasma membrane; TAS:ProtInc
Q99965	ADAM2	Disintegrin and metalloproteinase domain-containing protein 2	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
Q99965	ADAM2	Disintegrin and metalloproteinase domain-containing protein 2	GO:0007338; P:single fertilization; TAS:Reactome
Q99965	ADAM2	Disintegrin and metalloproteinase domain-containing protein 2	GO:0008542; P:visual learning; IEA:Ensembl
Q6NVV9	ADAM5	Putative disintegrin and metalloproteinase domain-containing protein 5	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q6NVV9	ADAM5	Putative disintegrin and metalloproteinase domain-containing protein 5	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H2U9	ADAM7	Disintegrin and metalloproteinase domain-containing protein 7	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q9H2U9	ADAM7	Disintegrin and metalloproteinase domain-containing protein 7	GO:0008270; F:zinc ion binding; IEA:InterPro
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0005509; F:calcium ion binding; ISS:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0008237; F:metallopeptidase activity; IDA:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0005515; F:protein binding; IPI:UniProtKB
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0043621; F:protein self-association; TAS:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0008270; F:zinc ion binding; TAS:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0035419; P:activation of MAPK activity involved in innate immune response; ISS:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0001525; P:angiogenesis; ISS:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0000902; P:cell morphogenesis; ISS:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0071456; P:cellular response to hypoxia; IDA:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0006954; P:inflammatory response; IDA:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0002523; P:leukocyte migration involved in inflammatory response; ISS:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0048247; P:lymphocyte chemotaxis; ISS:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0002675; P:positive regulation of acute inflammatory response; ISS:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0045780; P:positive regulation of bone resorption; ISS:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0045785; P:positive regulation of cell adhesion; ISS:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:2000418; P:positive regulation of eosinophil migration; ISS:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:2000415; P:positive regulation of fibronectin-dependent thymocyte migration; ISS:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0051044; P:positive regulation of membrane protein ectodomain proteolysis; IDA:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:2000391; P:positive regulation of neutrophil extravasation; IDA:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0051897; P:positive regulation of protein kinase B signaling; ISS:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0010954; P:positive regulation of protein processing; NAS:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0050714; P:positive regulation of protein secretion; IC:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0033089; P:positive regulation of T cell differentiation in thymus; ISS:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0070245; P:positive regulation of thymocyte apoptotic process; ISS:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:2000309; P:positive regulation of tumor necrosis factor (ligand) superfamily member 11 production; ISS:BHF-UCL
P78325	ADAM8	Disintegrin and metalloproteinase domain-containing protein 8	GO:0022407; P:regulation of cell-cell adhesion; IDA:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0005518; F:collagen binding; IMP:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0005178; F:integrin binding; IDA:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0043236; F:laminin binding; IMP:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0004222; F:metalloendopeptidase activity; IDA:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0008237; F:metallopeptidase activity; IMP:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0005515; F:protein binding; IPI:IntAct
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0005080; F:protein kinase C binding; ISS:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0017124; F:SH3 domain binding; IPI:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0000186; P:activation of MAPKK activity; IDA:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0007155; P:cell adhesion; IMP:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0033627; P:cell adhesion mediated by integrin; IMP:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0033631; P:cell-cell adhesion mediated by integrin; IEP:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0007160; P:cell-matrix adhesion; IMP:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0071222; P:cellular response to lipopolysaccharide; IMP:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0030574; P:collagen catabolic process; TAS:Reactome
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0007229; P:integrin-mediated signaling pathway; IC:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0030216; P:keratinocyte differentiation; IEP:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0006509; P:membrane protein ectodomain proteolysis; IDA:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0042117; P:monocyte activation; IMP:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0051088; P:PMA-inducible membrane protein ectodomain proteolysis; IDA:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0033630; P:positive regulation of cell adhesion mediated by integrin; IMP:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0051549; P:positive regulation of keratinocyte migration; IMP:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0034241; P:positive regulation of macrophage fusion; IMP:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0051044; P:positive regulation of membrane protein ectodomain proteolysis; ISS:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0050714; P:positive regulation of protein secretion; IDA:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0051592; P:response to calcium ion; IMP:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0051384; P:response to glucocorticoid; ISS:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0042542; P:response to hydrogen peroxide; IMP:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0034616; P:response to laminar fluid shear stress; IEA:Ensembl
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0010042; P:response to manganese ion; IMP:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0034612; P:response to tumor necrosis factor; IDA:BHF-UCL
Q13443	ADAM9	Disintegrin and metalloproteinase domain-containing protein 9	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IMP:BHF-UCL
O75689	ADAP1	Arf-GAP with dual PH domain-containing protein 1	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
O75689	ADAP1	Arf-GAP with dual PH domain-containing protein 1	GO:0043533; F:inositol 1,3,4,5 tetrakisphosphate binding; TAS:UniProtKB
O75689	ADAP1	Arf-GAP with dual PH domain-containing protein 1	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IEA:Ensembl
O75689	ADAP1	Arf-GAP with dual PH domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
O75689	ADAP1	Arf-GAP with dual PH domain-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
O75689	ADAP1	Arf-GAP with dual PH domain-containing protein 1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
O75689	ADAP1	Arf-GAP with dual PH domain-containing protein 1	GO:0043547; P:positive regulation of GTPase activity; IDA:GOC
O75689	ADAP1	Arf-GAP with dual PH domain-containing protein 1	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
O75689	ADAP1	Arf-GAP with dual PH domain-containing protein 1	GO:0043087; P:regulation of GTPase activity; IMP:UniProtKB
Q9NPF8	ADAP2	Arf-GAP with dual PH domain-containing protein 2	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q9NPF8	ADAP2	Arf-GAP with dual PH domain-containing protein 2	GO:0043533; F:inositol 1,3,4,5 tetrakisphosphate binding; IDA:UniProtKB
Q9NPF8	ADAP2	Arf-GAP with dual PH domain-containing protein 2	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB
Q9NPF8	ADAP2	Arf-GAP with dual PH domain-containing protein 2	GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; ISS:UniProtKB
Q9NPF8	ADAP2	Arf-GAP with dual PH domain-containing protein 2	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISS:UniProtKB
Q9NPF8	ADAP2	Arf-GAP with dual PH domain-containing protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q9NPF8	ADAP2	Arf-GAP with dual PH domain-containing protein 2	GO:0030674; F:protein binding, bridging; NAS:UniProtKB
Q9NPF8	ADAP2	Arf-GAP with dual PH domain-containing protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NPF8	ADAP2	Arf-GAP with dual PH domain-containing protein 2	GO:0007507; P:heart development; IEP:UniProtKB
Q9NPF8	ADAP2	Arf-GAP with dual PH domain-containing protein 2	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
O00116	AGPS	Alkyldihydroxyacetonephosphate synthase, peroxisomal	GO:0008609; F:alkylglycerone-phosphate synthase activity; IDA:UniProtKB
O00116	AGPS	Alkyldihydroxyacetonephosphate synthase, peroxisomal	GO:0071949; F:FAD binding; ISS:UniProtKB
O00116	AGPS	Alkyldihydroxyacetonephosphate synthase, peroxisomal	GO:0008762; F:UDP-N-acetylmuramate dehydrogenase activity; IEA:InterPro
O00116	AGPS	Alkyldihydroxyacetonephosphate synthase, peroxisomal	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O00116	AGPS	Alkyldihydroxyacetonephosphate synthase, peroxisomal	GO:0008611; P:ether lipid biosynthetic process; ISS:UniProtKB
O00116	AGPS	Alkyldihydroxyacetonephosphate synthase, peroxisomal	GO:0008610; P:lipid biosynthetic process; IDA:MGI
O00116	AGPS	Alkyldihydroxyacetonephosphate synthase, peroxisomal	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BUB4	ADAT1	tRNA-specific adenosine deaminase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BUB4	ADAT1	tRNA-specific adenosine deaminase 1	GO:0003723; F:RNA binding; IMP:UniProtKB
Q9BUB4	ADAT1	tRNA-specific adenosine deaminase 1	GO:0008251; F:tRNA-specific adenosine deaminase activity; IMP:UniProtKB
Q9BUB4	ADAT1	tRNA-specific adenosine deaminase 1	GO:0008033; P:tRNA processing; IMP:UniProtKB
Q7Z6V5	ADAT2	tRNA-specific adenosine deaminase 2	GO:0008251; F:tRNA-specific adenosine deaminase activity; IEA:InterPro
Q7Z6V5	ADAT2	tRNA-specific adenosine deaminase 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q7Z6V5	ADAT2	tRNA-specific adenosine deaminase 2	GO:0002100; P:tRNA wobble adenosine to inosine editing; IEA:InterPro
Q96EY9	ADAT3	Probable inactive tRNA-specific adenosine deaminase-like protein 3	GO:0016787; F:hydrolase activity; IEA:InterPro
Q96EY9	ADAT3	Probable inactive tRNA-specific adenosine deaminase-like protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96EY9	ADAT3	Probable inactive tRNA-specific adenosine deaminase-like protein 3	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
P00813	ADA	Adenosine deaminase	GO:0004000; F:adenosine deaminase activity; IDA:UniProtKB
P00813	ADA	Adenosine deaminase	GO:0005515; F:protein binding; IPI:UniProtKB
P00813	ADA	Adenosine deaminase	GO:0001883; F:purine nucleoside binding; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0008270; F:zinc ion binding; IMP:UniProtKB
P00813	ADA	Adenosine deaminase	GO:0006154; P:adenosine catabolic process; IDA:UniProtKB
P00813	ADA	Adenosine deaminase	GO:0007568; P:aging; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P00813	ADA	Adenosine deaminase	GO:0046061; P:dATP catabolic process; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0006157; P:deoxyadenosine catabolic process; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0048566; P:embryonic digestive tract development; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0002314; P:germinal center B cell differentiation; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0001821; P:histamine secretion; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0043103; P:hypoxanthine salvage; IBA:RefGenome
P00813	ADA	Adenosine deaminase	GO:0046103; P:inosine biosynthetic process; ISS:UniProtKB
P00813	ADA	Adenosine deaminase	GO:0001889; P:liver development; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0048286; P:lung alveolus development; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0060169; P:negative regulation of adenosine receptor signaling pathway; IDA:UniProtKB
P00813	ADA	Adenosine deaminase	GO:0042323; P:negative regulation of circadian sleep/wake cycle, non-REM sleep; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0002686; P:negative regulation of leukocyte migration; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0002906; P:negative regulation of mature B cell apoptotic process; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0070256; P:negative regulation of mucus secretion; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0060407; P:negative regulation of penile erection; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0070244; P:negative regulation of thymocyte apoptotic process; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P00813	ADA	Adenosine deaminase	GO:0048541; P:Peyer's patch development; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0001890; P:placenta development; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0046638; P:positive regulation of alpha-beta T cell differentiation; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0030890; P:positive regulation of B cell proliferation; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0050850; P:positive regulation of calcium-mediated signaling; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0002636; P:positive regulation of germinal center formation; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0010460; P:positive regulation of heart rate; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0045987; P:positive regulation of smooth muscle contraction; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0033089; P:positive regulation of T cell differentiation in thymus; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0050862; P:positive regulation of T cell receptor signaling pathway; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P00813	ADA	Adenosine deaminase	GO:0032261; P:purine nucleotide salvage; IMP:UniProtKB
P00813	ADA	Adenosine deaminase	GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; IEA:InterPro
P00813	ADA	Adenosine deaminase	GO:0043101; P:purine-containing compound salvage; TAS:Reactome
P00813	ADA	Adenosine deaminase	GO:0033632; P:regulation of cell-cell adhesion mediated by integrin; IDA:UniProtKB
P00813	ADA	Adenosine deaminase	GO:0042493; P:response to drug; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0001666; P:response to hypoxia; IDA:UniProtKB
P00813	ADA	Adenosine deaminase	GO:0043278; P:response to morphine; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0033197; P:response to vitamin E; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P00813	ADA	Adenosine deaminase	GO:0042110; P:T cell activation; IDA:UniProtKB
P00813	ADA	Adenosine deaminase	GO:0001829; P:trophectodermal cell differentiation; IEA:Ensembl
P00813	ADA	Adenosine deaminase	GO:0046111; P:xanthine biosynthetic process; IEA:Ensembl
Q86TW2	ADCK1	Uncharacterized aarF domain-containing protein kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86TW2	ADCK1	Uncharacterized aarF domain-containing protein kinase 1	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q7Z695	ADCK2	Uncharacterized aarF domain-containing protein kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q7Z695	ADCK2	Uncharacterized aarF domain-containing protein kinase 2	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q8NI60	ADCK3	Chaperone activity of bc1 complex-like, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NI60	ADCK3	Chaperone activity of bc1 complex-like, mitochondrial	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q8NI60	ADCK3	Chaperone activity of bc1 complex-like, mitochondrial	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q8NI60	ADCK3	Chaperone activity of bc1 complex-like, mitochondrial	GO:0006744; P:ubiquinone biosynthetic process; IEA:UniProtKB-KW
Q3MIX3	ADCK5	Uncharacterized aarF domain-containing protein kinase 5	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q6P093	AADACL2	Arylacetamide deacetylase-like 2	GO:0052689; F:carboxylic ester hydrolase activity; IEA:InterPro
Q96D53	ADCK4	AarF domain-containing protein kinase 4	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q5VUY0	AADACL3	Arylacetamide deacetylase-like 3	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q5VUY2	AADACL4	Arylacetamide deacetylase-like 4	GO:0052689; F:carboxylic ester hydrolase activity; IEA:InterPro
Q08828	ADCY1	Adenylate cyclase type 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q08828	ADCY1	Adenylate cyclase type 1	GO:0008294; F:calcium- and calmodulin-responsive adenylate cyclase activity; NAS:UniProtKB
Q08828	ADCY1	Adenylate cyclase type 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q08828	ADCY1	Adenylate cyclase type 1	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
Q08828	ADCY1	Adenylate cyclase type 1	GO:0034199; P:activation of protein kinase A activity; TAS:Reactome
Q08828	ADCY1	Adenylate cyclase type 1	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; TAS:Reactome
Q08828	ADCY1	Adenylate cyclase type 1	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:Reactome
Q08828	ADCY1	Adenylate cyclase type 1	GO:0007409; P:axonogenesis; IEA:Ensembl
Q08828	ADCY1	Adenylate cyclase type 1	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
Q08828	ADCY1	Adenylate cyclase type 1	GO:0007623; P:circadian rhythm; IEA:Ensembl
Q08828	ADCY1	Adenylate cyclase type 1	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q08828	ADCY1	Adenylate cyclase type 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q08828	ADCY1	Adenylate cyclase type 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q08828	ADCY1	Adenylate cyclase type 1	GO:0045087; P:innate immune response; TAS:Reactome
Q08828	ADCY1	Adenylate cyclase type 1	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q08828	ADCY1	Adenylate cyclase type 1	GO:0007616; P:long-term memory; IEA:Ensembl
Q08828	ADCY1	Adenylate cyclase type 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q08828	ADCY1	Adenylate cyclase type 1	GO:0042493; P:response to drug; IEA:Ensembl
Q08828	ADCY1	Adenylate cyclase type 1	GO:0010226; P:response to lithium ion; IEA:Ensembl
Q08828	ADCY1	Adenylate cyclase type 1	GO:0007165; P:signal transduction; TAS:Reactome
Q08828	ADCY1	Adenylate cyclase type 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q08828	ADCY1	Adenylate cyclase type 1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q08828	ADCY1	Adenylate cyclase type 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q08828	ADCY1	Adenylate cyclase type 1	GO:0006833; P:water transport; TAS:Reactome
Q08462	ADCY2	Adenylate cyclase type 2	GO:0004016; F:adenylate cyclase activity; NAS:UniProtKB
Q08462	ADCY2	Adenylate cyclase type 2	GO:0008179; F:adenylate cyclase binding; ISS:BHF-UCL
Q08462	ADCY2	Adenylate cyclase type 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q08462	ADCY2	Adenylate cyclase type 2	GO:0008294; F:calcium- and calmodulin-responsive adenylate cyclase activity; IEA:Ensembl
Q08462	ADCY2	Adenylate cyclase type 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q08462	ADCY2	Adenylate cyclase type 2	GO:0046982; F:protein heterodimerization activity; ISS:BHF-UCL
Q08462	ADCY2	Adenylate cyclase type 2	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
Q08462	ADCY2	Adenylate cyclase type 2	GO:0034199; P:activation of protein kinase A activity; TAS:Reactome
Q08462	ADCY2	Adenylate cyclase type 2	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; TAS:Reactome
Q08462	ADCY2	Adenylate cyclase type 2	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:Reactome
Q08462	ADCY2	Adenylate cyclase type 2	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; ISS:BHF-UCL
Q08462	ADCY2	Adenylate cyclase type 2	GO:0006171; P:cAMP biosynthetic process; ISS:BHF-UCL
Q08462	ADCY2	Adenylate cyclase type 2	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
Q08462	ADCY2	Adenylate cyclase type 2	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q08462	ADCY2	Adenylate cyclase type 2	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q08462	ADCY2	Adenylate cyclase type 2	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q08462	ADCY2	Adenylate cyclase type 2	GO:0045087; P:innate immune response; TAS:Reactome
Q08462	ADCY2	Adenylate cyclase type 2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q08462	ADCY2	Adenylate cyclase type 2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q08462	ADCY2	Adenylate cyclase type 2	GO:0007165; P:signal transduction; TAS:Reactome
Q08462	ADCY2	Adenylate cyclase type 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q08462	ADCY2	Adenylate cyclase type 2	GO:0007268; P:synaptic transmission; TAS:Reactome
Q08462	ADCY2	Adenylate cyclase type 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q08462	ADCY2	Adenylate cyclase type 2	GO:0006833; P:water transport; TAS:Reactome
O60266	ADCY3	Adenylate cyclase type 3	GO:0004016; F:adenylate cyclase activity; TAS:ProtInc
O60266	ADCY3	Adenylate cyclase type 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O60266	ADCY3	Adenylate cyclase type 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60266	ADCY3	Adenylate cyclase type 3	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
O60266	ADCY3	Adenylate cyclase type 3	GO:0034199; P:activation of protein kinase A activity; TAS:Reactome
O60266	ADCY3	Adenylate cyclase type 3	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; TAS:Reactome
O60266	ADCY3	Adenylate cyclase type 3	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:Reactome
O60266	ADCY3	Adenylate cyclase type 3	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
O60266	ADCY3	Adenylate cyclase type 3	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
O60266	ADCY3	Adenylate cyclase type 3	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O60266	ADCY3	Adenylate cyclase type 3	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
O60266	ADCY3	Adenylate cyclase type 3	GO:0045087; P:innate immune response; TAS:Reactome
O60266	ADCY3	Adenylate cyclase type 3	GO:0035556; P:intracellular signal transduction; IEA:InterPro
O60266	ADCY3	Adenylate cyclase type 3	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O60266	ADCY3	Adenylate cyclase type 3	GO:0007608; P:sensory perception of smell; IEA:UniProtKB-KW
O60266	ADCY3	Adenylate cyclase type 3	GO:0007165; P:signal transduction; TAS:Reactome
O60266	ADCY3	Adenylate cyclase type 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60266	ADCY3	Adenylate cyclase type 3	GO:0007268; P:synaptic transmission; TAS:Reactome
O60266	ADCY3	Adenylate cyclase type 3	GO:0055085; P:transmembrane transport; TAS:Reactome
O60266	ADCY3	Adenylate cyclase type 3	GO:0006833; P:water transport; TAS:Reactome
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0004016; F:adenylate cyclase activity; ISS:BHF-UCL
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0034199; P:activation of protein kinase A activity; TAS:Reactome
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; TAS:Reactome
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:Reactome
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; ISS:UniProtKB
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0006171; P:cAMP biosynthetic process; ISS:BHF-UCL
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0045087; P:innate immune response; TAS:Reactome
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0007165; P:signal transduction; TAS:Reactome
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0007268; P:synaptic transmission; TAS:Reactome
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8NFM4	ADCY4	Adenylate cyclase type 4	GO:0006833; P:water transport; TAS:Reactome
O95622	ADCY5	Adenylate cyclase type 5	GO:0004016; F:adenylate cyclase activity; IEA:UniProtKB-EC
O95622	ADCY5	Adenylate cyclase type 5	GO:0008179; F:adenylate cyclase binding; ISS:BHF-UCL
O95622	ADCY5	Adenylate cyclase type 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O95622	ADCY5	Adenylate cyclase type 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95622	ADCY5	Adenylate cyclase type 5	GO:0046982; F:protein heterodimerization activity; ISS:BHF-UCL
O95622	ADCY5	Adenylate cyclase type 5	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
O95622	ADCY5	Adenylate cyclase type 5	GO:0034199; P:activation of protein kinase A activity; TAS:Reactome
O95622	ADCY5	Adenylate cyclase type 5	GO:0001973; P:adenosine receptor signaling pathway; IEA:Ensembl
O95622	ADCY5	Adenylate cyclase type 5	GO:0007191; P:adenylate cyclase-activating dopamine receptor signaling pathway; IEA:Ensembl
O95622	ADCY5	Adenylate cyclase type 5	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; TAS:Reactome
O95622	ADCY5	Adenylate cyclase type 5	GO:0007195; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; IEA:Ensembl
O95622	ADCY5	Adenylate cyclase type 5	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:Reactome
O95622	ADCY5	Adenylate cyclase type 5	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
O95622	ADCY5	Adenylate cyclase type 5	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
O95622	ADCY5	Adenylate cyclase type 5	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O95622	ADCY5	Adenylate cyclase type 5	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
O95622	ADCY5	Adenylate cyclase type 5	GO:0045087; P:innate immune response; TAS:Reactome
O95622	ADCY5	Adenylate cyclase type 5	GO:0035556; P:intracellular signal transduction; IEA:InterPro
O95622	ADCY5	Adenylate cyclase type 5	GO:0007626; P:locomotory behavior; IEA:Ensembl
O95622	ADCY5	Adenylate cyclase type 5	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
O95622	ADCY5	Adenylate cyclase type 5	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O95622	ADCY5	Adenylate cyclase type 5	GO:0007165; P:signal transduction; TAS:Reactome
O95622	ADCY5	Adenylate cyclase type 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95622	ADCY5	Adenylate cyclase type 5	GO:0007268; P:synaptic transmission; TAS:Reactome
O95622	ADCY5	Adenylate cyclase type 5	GO:0055085; P:transmembrane transport; TAS:Reactome
O95622	ADCY5	Adenylate cyclase type 5	GO:0006833; P:water transport; TAS:Reactome
O43306	ADCY6	Adenylate cyclase type 6	GO:0004016; F:adenylate cyclase activity; IDA:BHF-UCL
O43306	ADCY6	Adenylate cyclase type 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43306	ADCY6	Adenylate cyclase type 6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43306	ADCY6	Adenylate cyclase type 6	GO:0005515; F:protein binding; IPI:UniProtKB
O43306	ADCY6	Adenylate cyclase type 6	GO:0019901; F:protein kinase binding; ISS:BHF-UCL
O43306	ADCY6	Adenylate cyclase type 6	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
O43306	ADCY6	Adenylate cyclase type 6	GO:0034199; P:activation of protein kinase A activity; TAS:Reactome
O43306	ADCY6	Adenylate cyclase type 6	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; TAS:Reactome
O43306	ADCY6	Adenylate cyclase type 6	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:Reactome
O43306	ADCY6	Adenylate cyclase type 6	GO:0006171; P:cAMP biosynthetic process; IDA:BHF-UCL
O43306	ADCY6	Adenylate cyclase type 6	GO:0071870; P:cellular response to catecholamine stimulus; IDA:BHF-UCL
O43306	ADCY6	Adenylate cyclase type 6	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
O43306	ADCY6	Adenylate cyclase type 6	GO:0071380; P:cellular response to prostaglandin E stimulus; IDA:BHF-UCL
O43306	ADCY6	Adenylate cyclase type 6	GO:0007212; P:dopamine receptor signaling pathway; IDA:BHF-UCL
O43306	ADCY6	Adenylate cyclase type 6	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
O43306	ADCY6	Adenylate cyclase type 6	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O43306	ADCY6	Adenylate cyclase type 6	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
O43306	ADCY6	Adenylate cyclase type 6	GO:0045087; P:innate immune response; TAS:Reactome
O43306	ADCY6	Adenylate cyclase type 6	GO:0035556; P:intracellular signal transduction; IEA:InterPro
O43306	ADCY6	Adenylate cyclase type 6	GO:0010977; P:negative regulation of neuron projection development; ISS:ParkinsonsUK-UCL
O43306	ADCY6	Adenylate cyclase type 6	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O43306	ADCY6	Adenylate cyclase type 6	GO:0007165; P:signal transduction; TAS:Reactome
O43306	ADCY6	Adenylate cyclase type 6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43306	ADCY6	Adenylate cyclase type 6	GO:0007268; P:synaptic transmission; TAS:Reactome
O43306	ADCY6	Adenylate cyclase type 6	GO:0055085; P:transmembrane transport; TAS:Reactome
O43306	ADCY6	Adenylate cyclase type 6	GO:0006833; P:water transport; TAS:Reactome
P51828	ADCY7	Adenylate cyclase type 7	GO:0004016; F:adenylate cyclase activity; IDA:UniProtKB
P51828	ADCY7	Adenylate cyclase type 7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P51828	ADCY7	Adenylate cyclase type 7	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P51828	ADCY7	Adenylate cyclase type 7	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
P51828	ADCY7	Adenylate cyclase type 7	GO:0034199; P:activation of protein kinase A activity; TAS:Reactome
P51828	ADCY7	Adenylate cyclase type 7	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; TAS:Reactome
P51828	ADCY7	Adenylate cyclase type 7	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:Reactome
P51828	ADCY7	Adenylate cyclase type 7	GO:0071361; P:cellular response to ethanol; IDA:UniProtKB
P51828	ADCY7	Adenylate cyclase type 7	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
P51828	ADCY7	Adenylate cyclase type 7	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P51828	ADCY7	Adenylate cyclase type 7	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P51828	ADCY7	Adenylate cyclase type 7	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P51828	ADCY7	Adenylate cyclase type 7	GO:0045087; P:innate immune response; TAS:Reactome
P51828	ADCY7	Adenylate cyclase type 7	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P51828	ADCY7	Adenylate cyclase type 7	GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
P51828	ADCY7	Adenylate cyclase type 7	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P51828	ADCY7	Adenylate cyclase type 7	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:UniProtKB
P51828	ADCY7	Adenylate cyclase type 7	GO:0007165; P:signal transduction; TAS:Reactome
P51828	ADCY7	Adenylate cyclase type 7	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P51828	ADCY7	Adenylate cyclase type 7	GO:0007268; P:synaptic transmission; TAS:Reactome
P51828	ADCY7	Adenylate cyclase type 7	GO:0055085; P:transmembrane transport; TAS:Reactome
P51828	ADCY7	Adenylate cyclase type 7	GO:0006833; P:water transport; TAS:Reactome
P40145	ADCY8	Adenylate cyclase type 8	GO:0004016; F:adenylate cyclase activity; TAS:ProtInc
P40145	ADCY8	Adenylate cyclase type 8	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P40145	ADCY8	Adenylate cyclase type 8	GO:0008294; F:calcium- and calmodulin-responsive adenylate cyclase activity; TAS:ProtInc
P40145	ADCY8	Adenylate cyclase type 8	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P40145	ADCY8	Adenylate cyclase type 8	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
P40145	ADCY8	Adenylate cyclase type 8	GO:0034199; P:activation of protein kinase A activity; TAS:Reactome
P40145	ADCY8	Adenylate cyclase type 8	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; TAS:Reactome
P40145	ADCY8	Adenylate cyclase type 8	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:Reactome
P40145	ADCY8	Adenylate cyclase type 8	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
P40145	ADCY8	Adenylate cyclase type 8	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P40145	ADCY8	Adenylate cyclase type 8	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P40145	ADCY8	Adenylate cyclase type 8	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P40145	ADCY8	Adenylate cyclase type 8	GO:0045087; P:innate immune response; TAS:Reactome
P40145	ADCY8	Adenylate cyclase type 8	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P40145	ADCY8	Adenylate cyclase type 8	GO:0007611; P:learning or memory; TAS:ProtInc
P40145	ADCY8	Adenylate cyclase type 8	GO:0007616; P:long-term memory; IEA:Ensembl
P40145	ADCY8	Adenylate cyclase type 8	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P40145	ADCY8	Adenylate cyclase type 8	GO:0007165; P:signal transduction; TAS:Reactome
P40145	ADCY8	Adenylate cyclase type 8	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P40145	ADCY8	Adenylate cyclase type 8	GO:0007268; P:synaptic transmission; TAS:Reactome
P40145	ADCY8	Adenylate cyclase type 8	GO:0055085; P:transmembrane transport; TAS:Reactome
P40145	ADCY8	Adenylate cyclase type 8	GO:0006833; P:water transport; TAS:Reactome
O60503	ADCY9	Adenylate cyclase type 9	GO:0004016; F:adenylate cyclase activity; TAS:ProtInc
O60503	ADCY9	Adenylate cyclase type 9	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O60503	ADCY9	Adenylate cyclase type 9	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60503	ADCY9	Adenylate cyclase type 9	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
O60503	ADCY9	Adenylate cyclase type 9	GO:0016849; F:phosphorus-oxygen lyase activity; IEA:InterPro
O60503	ADCY9	Adenylate cyclase type 9	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
O60503	ADCY9	Adenylate cyclase type 9	GO:0034199; P:activation of protein kinase A activity; TAS:Reactome
O60503	ADCY9	Adenylate cyclase type 9	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; TAS:Reactome
O60503	ADCY9	Adenylate cyclase type 9	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:Reactome
O60503	ADCY9	Adenylate cyclase type 9	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
O60503	ADCY9	Adenylate cyclase type 9	GO:0009190; P:cyclic nucleotide biosynthetic process; IEA:InterPro
O60503	ADCY9	Adenylate cyclase type 9	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
O60503	ADCY9	Adenylate cyclase type 9	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O60503	ADCY9	Adenylate cyclase type 9	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
O60503	ADCY9	Adenylate cyclase type 9	GO:0045087; P:innate immune response; TAS:Reactome
O60503	ADCY9	Adenylate cyclase type 9	GO:0035556; P:intracellular signal transduction; IEA:InterPro
O60503	ADCY9	Adenylate cyclase type 9	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O60503	ADCY9	Adenylate cyclase type 9	GO:0007165; P:signal transduction; TAS:Reactome
O60503	ADCY9	Adenylate cyclase type 9	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60503	ADCY9	Adenylate cyclase type 9	GO:0007268; P:synaptic transmission; TAS:Reactome
O60503	ADCY9	Adenylate cyclase type 9	GO:0055085; P:transmembrane transport; TAS:Reactome
O60503	ADCY9	Adenylate cyclase type 9	GO:0006833; P:water transport; TAS:Reactome
Q96PN6	ADCY10	Adenylate cyclase type 10	GO:0004016; F:adenylate cyclase activity; NAS:UniProtKB
Q96PN6	ADCY10	Adenylate cyclase type 10	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96PN6	ADCY10	Adenylate cyclase type 10	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q96PN6	ADCY10	Adenylate cyclase type 10	GO:0030145; F:manganese ion binding; IEA:Ensembl
Q96PN6	ADCY10	Adenylate cyclase type 10	GO:0006171; P:cAMP biosynthetic process; NAS:UniProtKB
Q96PN6	ADCY10	Adenylate cyclase type 10	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q96PN6	ADCY10	Adenylate cyclase type 10	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q96PN6	ADCY10	Adenylate cyclase type 10	GO:0007283; P:spermatogenesis; IEA:InterPro
Q96A70	ADC	Arginine decarboxylase	GO:0008792; F:arginine decarboxylase activity; IEA:UniProtKB-EC
Q96A70	ADC	Arginine decarboxylase	GO:0042978; F:ornithine decarboxylase activator activity; IEA:Ensembl
Q96A70	ADC	Arginine decarboxylase	GO:0097055; P:agmatine biosynthetic process; TAS:Reactome
Q96A70	ADC	Arginine decarboxylase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q96A70	ADC	Arginine decarboxylase	GO:0006591; P:ornithine metabolic process; IEA:Ensembl
Q96A70	ADC	Arginine decarboxylase	GO:0006596; P:polyamine biosynthetic process; IEA:UniProtKB-KW
Q96A70	ADC	Arginine decarboxylase	GO:0006595; P:polyamine metabolic process; TAS:Reactome
Q96A70	ADC	Arginine decarboxylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96A70	ADC	Arginine decarboxylase	GO:0007283; P:spermatogenesis; NAS:UniProtKB
P35611	ADD1	Alpha-adducin	GO:0003779; F:actin binding; TAS:ProtInc
P35611	ADD1	Alpha-adducin	GO:0051015; F:actin filament binding; IDA:BHF-UCL
P35611	ADD1	Alpha-adducin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P35611	ADD1	Alpha-adducin	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P35611	ADD1	Alpha-adducin	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P35611	ADD1	Alpha-adducin	GO:0030507; F:spectrin binding; IDA:BHF-UCL
P35611	ADD1	Alpha-adducin	GO:0005198; F:structural molecule activity; IEA:Ensembl
P35611	ADD1	Alpha-adducin	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P35611	ADD1	Alpha-adducin	GO:0030036; P:actin cytoskeleton organization; IC:BHF-UCL
P35611	ADD1	Alpha-adducin	GO:0051017; P:actin filament bundle assembly; IDA:BHF-UCL
P35611	ADD1	Alpha-adducin	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P35611	ADD1	Alpha-adducin	GO:0006915; P:apoptotic process; TAS:Reactome
P35611	ADD1	Alpha-adducin	GO:0051016; P:barbed-end actin filament capping; IDA:BHF-UCL
P35611	ADD1	Alpha-adducin	GO:0000902; P:cell morphogenesis; IEA:Ensembl
P35611	ADD1	Alpha-adducin	GO:0006884; P:cell volume homeostasis; IEA:Ensembl
P35611	ADD1	Alpha-adducin	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
P35611	ADD1	Alpha-adducin	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P35611	ADD1	Alpha-adducin	GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl
P35611	ADD1	Alpha-adducin	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P35611	ADD1	Alpha-adducin	GO:0030218; P:erythrocyte differentiation; IEA:Ensembl
P35611	ADD1	Alpha-adducin	GO:0020027; P:hemoglobin metabolic process; IEA:Ensembl
P35611	ADD1	Alpha-adducin	GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl
P35611	ADD1	Alpha-adducin	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P35611	ADD1	Alpha-adducin	GO:0035264; P:multicellular organism growth; IEA:Ensembl
P35611	ADD1	Alpha-adducin	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
P35611	ADD1	Alpha-adducin	GO:0045807; P:positive regulation of endocytosis; IEA:Ensembl
P35611	ADD1	Alpha-adducin	GO:0032092; P:positive regulation of protein binding; IDA:BHF-UCL
P35612	ADD2	Beta-adducin	GO:0003779; F:actin binding; TAS:ProtInc
P35612	ADD2	Beta-adducin	GO:0051015; F:actin filament binding; IDA:BHF-UCL
P35612	ADD2	Beta-adducin	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P35612	ADD2	Beta-adducin	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P35612	ADD2	Beta-adducin	GO:0030507; F:spectrin binding; IDA:BHF-UCL
P35612	ADD2	Beta-adducin	GO:0005198; F:structural molecule activity; IEA:Ensembl
P35612	ADD2	Beta-adducin	GO:0030036; P:actin cytoskeleton organization; IC:BHF-UCL
P35612	ADD2	Beta-adducin	GO:0051017; P:actin filament bundle assembly; IDA:BHF-UCL
P35612	ADD2	Beta-adducin	GO:0051016; P:barbed-end actin filament capping; IDA:BHF-UCL
P35612	ADD2	Beta-adducin	GO:0030097; P:hemopoiesis; IEA:Ensembl
P35612	ADD2	Beta-adducin	GO:0032092; P:positive regulation of protein binding; IDA:BHF-UCL
P35612	ADD2	Beta-adducin	GO:0006461; P:protein complex assembly; IDA:UniProtKB
Q9UEY8	ADD3	Gamma-adducin	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
O15204	ADAMDEC1	ADAM DEC1	GO:0004222; F:metalloendopeptidase activity; NAS:UniProtKB
O15204	ADAMDEC1	ADAM DEC1	GO:0008270; F:zinc ion binding; NAS:UniProtKB
O15204	ADAMDEC1	ADAM DEC1	GO:0006955; P:immune response; NAS:UniProtKB
O15204	ADAMDEC1	ADAM DEC1	GO:0007162; P:negative regulation of cell adhesion; NAS:UniProtKB
Q8N7X0	ADGB	Androglobin	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; IBA:RefGenome
Q8N7X0	ADGB	Androglobin	GO:0020037; F:heme binding; IEA:InterPro
Q8N7X0	ADGB	Androglobin	GO:0005506; F:iron ion binding; IEA:InterPro
Q8N7X0	ADGB	Androglobin	GO:0019825; F:oxygen binding; IEA:InterPro
Q8N7X0	ADGB	Androglobin	GO:0015671; P:oxygen transport; IEA:InterPro
Q8N7X0	ADGB	Androglobin	GO:0006508; P:proteolysis; IBA:RefGenome
P07327	ADH1A	Alcohol dehydrogenase 1A	GO:0004022; F:alcohol dehydrogenase (NAD) activity; TAS:Reactome
P07327	ADH1A	Alcohol dehydrogenase 1A	GO:0004024; F:alcohol dehydrogenase activity, zinc-dependent; IDA:UniProtKB
P07327	ADH1A	Alcohol dehydrogenase 1A	GO:0005515; F:protein binding; IPI:UniProtKB
P07327	ADH1A	Alcohol dehydrogenase 1A	GO:0008270; F:zinc ion binding; IEA:InterPro
P07327	ADH1A	Alcohol dehydrogenase 1A	GO:0006066; P:alcohol metabolic process; NAS:UniProtKB
P07327	ADH1A	Alcohol dehydrogenase 1A	GO:0017144; P:drug metabolic process; TAS:Reactome
P07327	ADH1A	Alcohol dehydrogenase 1A	GO:0006069; P:ethanol oxidation; TAS:Reactome
P07327	ADH1A	Alcohol dehydrogenase 1A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P07327	ADH1A	Alcohol dehydrogenase 1A	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P00325	ADH1B	Alcohol dehydrogenase 1B	GO:0004024; F:alcohol dehydrogenase activity, zinc-dependent; IDA:UniProtKB
P00325	ADH1B	Alcohol dehydrogenase 1B	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
P00325	ADH1B	Alcohol dehydrogenase 1B	GO:0008270; F:zinc ion binding; IEA:InterPro
P00325	ADH1B	Alcohol dehydrogenase 1B	GO:0006069; P:ethanol oxidation; IDA:UniProtKB
P00325	ADH1B	Alcohol dehydrogenase 1B	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P00325	ADH1B	Alcohol dehydrogenase 1B	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P00326	ADH1C	Alcohol dehydrogenase 1C	GO:0004022; F:alcohol dehydrogenase (NAD) activity; IDA:UniProtKB
P00326	ADH1C	Alcohol dehydrogenase 1C	GO:0008270; F:zinc ion binding; IEA:InterPro
P00326	ADH1C	Alcohol dehydrogenase 1C	GO:0006069; P:ethanol oxidation; IDA:UniProtKB
P00326	ADH1C	Alcohol dehydrogenase 1C	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P00326	ADH1C	Alcohol dehydrogenase 1C	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P08319	ADH4	Alcohol dehydrogenase 4	GO:0004022; F:alcohol dehydrogenase (NAD) activity; IDA:UniProtKB
P08319	ADH4	Alcohol dehydrogenase 4	GO:0004024; F:alcohol dehydrogenase activity, zinc-dependent; IDA:UniProtKB
P08319	ADH4	Alcohol dehydrogenase 4	GO:0004032; F:alditol:NADP+ 1-oxidoreductase activity; IEA:Ensembl
P08319	ADH4	Alcohol dehydrogenase 4	GO:0005503; F:all-trans retinal binding; IDA:UniProtKB
P08319	ADH4	Alcohol dehydrogenase 4	GO:0019115; F:benzaldehyde dehydrogenase activity; IDA:UniProtKB
P08319	ADH4	Alcohol dehydrogenase 4	GO:0035276; F:ethanol binding; IEA:InterPro
P08319	ADH4	Alcohol dehydrogenase 4	GO:0051287; F:NAD binding; IDA:UniProtKB
P08319	ADH4	Alcohol dehydrogenase 4	GO:0003960; F:NADPH:quinone reductase activity; ISS:UniProtKB
P08319	ADH4	Alcohol dehydrogenase 4	GO:0016620; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor; IDA:UniProtKB
P08319	ADH4	Alcohol dehydrogenase 4	GO:0019841; F:retinol binding; IDA:UniProtKB
P08319	ADH4	Alcohol dehydrogenase 4	GO:0004745; F:retinol dehydrogenase activity; IDA:UniProtKB
P08319	ADH4	Alcohol dehydrogenase 4	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P08319	ADH4	Alcohol dehydrogenase 4	GO:0046164; P:alcohol catabolic process; ISS:UniProtKB
P08319	ADH4	Alcohol dehydrogenase 4	GO:0006066; P:alcohol metabolic process; IDA:UniProtKB
P08319	ADH4	Alcohol dehydrogenase 4	GO:0006081; P:cellular aldehyde metabolic process; IDA:UniProtKB
P08319	ADH4	Alcohol dehydrogenase 4	GO:0006069; P:ethanol oxidation; IDA:UniProtKB
P08319	ADH4	Alcohol dehydrogenase 4	GO:1901661; P:quinone metabolic process; ISS:UniProtKB
P08319	ADH4	Alcohol dehydrogenase 4	GO:0001523; P:retinoid metabolic process; IDA:UniProtKB
P08319	ADH4	Alcohol dehydrogenase 4	GO:0042572; P:retinol metabolic process; IDA:UniProtKB
P08319	ADH4	Alcohol dehydrogenase 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P08319	ADH4	Alcohol dehydrogenase 4	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P28332	ADH6	Alcohol dehydrogenase 6	GO:0004022; F:alcohol dehydrogenase (NAD) activity; IDA:UniProtKB
P28332	ADH6	Alcohol dehydrogenase 6	GO:0004024; F:alcohol dehydrogenase activity, zinc-dependent; IEA:InterPro
P28332	ADH6	Alcohol dehydrogenase 6	GO:0035276; F:ethanol binding; IEA:InterPro
P28332	ADH6	Alcohol dehydrogenase 6	GO:0008270; F:zinc ion binding; NAS:UniProtKB
P28332	ADH6	Alcohol dehydrogenase 6	GO:0006069; P:ethanol oxidation; IDA:UniProtKB
P28332	ADH6	Alcohol dehydrogenase 6	GO:0045471; P:response to ethanol; IDA:UniProtKB
P28332	ADH6	Alcohol dehydrogenase 6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P28332	ADH6	Alcohol dehydrogenase 6	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P40394	ADH7	Alcohol dehydrogenase class 4 mu/sigma chain	GO:0004022; F:alcohol dehydrogenase (NAD) activity; TAS:UniProtKB
P40394	ADH7	Alcohol dehydrogenase class 4 mu/sigma chain	GO:0004024; F:alcohol dehydrogenase activity, zinc-dependent; IDA:UniProtKB
P40394	ADH7	Alcohol dehydrogenase class 4 mu/sigma chain	GO:0004031; F:aldehyde oxidase activity; IDA:UniProtKB
P40394	ADH7	Alcohol dehydrogenase class 4 mu/sigma chain	GO:0035276; F:ethanol binding; IDA:UniProtKB
P40394	ADH7	Alcohol dehydrogenase class 4 mu/sigma chain	GO:0048019; F:receptor antagonist activity; IDA:UniProtKB
P40394	ADH7	Alcohol dehydrogenase class 4 mu/sigma chain	GO:0019841; F:retinol binding; IDA:UniProtKB
P40394	ADH7	Alcohol dehydrogenase class 4 mu/sigma chain	GO:0004745; F:retinol dehydrogenase activity; IDA:UniProtKB
P40394	ADH7	Alcohol dehydrogenase class 4 mu/sigma chain	GO:0008270; F:zinc ion binding; IEA:InterPro
P40394	ADH7	Alcohol dehydrogenase class 4 mu/sigma chain	GO:0006068; P:ethanol catabolic process; IEA:Ensembl
P40394	ADH7	Alcohol dehydrogenase class 4 mu/sigma chain	GO:0006069; P:ethanol oxidation; IDA:UniProtKB
P40394	ADH7	Alcohol dehydrogenase class 4 mu/sigma chain	GO:1900116; P:extracellular negative regulation of signal transduction; IDA:GOC
P40394	ADH7	Alcohol dehydrogenase class 4 mu/sigma chain	GO:0010430; P:fatty acid omega-oxidation; IDA:UniProtKB
P40394	ADH7	Alcohol dehydrogenase class 4 mu/sigma chain	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
P40394	ADH7	Alcohol dehydrogenase class 4 mu/sigma chain	GO:0009617; P:response to bacterium; IDA:UniProtKB
P40394	ADH7	Alcohol dehydrogenase class 4 mu/sigma chain	GO:0045471; P:response to ethanol; IDA:UniProtKB
P40394	ADH7	Alcohol dehydrogenase class 4 mu/sigma chain	GO:0042573; P:retinoic acid metabolic process; IEA:Ensembl
P40394	ADH7	Alcohol dehydrogenase class 4 mu/sigma chain	GO:0001523; P:retinoid metabolic process; IDA:UniProtKB
P40394	ADH7	Alcohol dehydrogenase class 4 mu/sigma chain	GO:0042572; P:retinol metabolic process; IEA:Ensembl
P40394	ADH7	Alcohol dehydrogenase class 4 mu/sigma chain	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P40394	ADH7	Alcohol dehydrogenase class 4 mu/sigma chain	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P11766	ADH5	Alcohol dehydrogenase class-3	GO:0004022; F:alcohol dehydrogenase (NAD) activity; IEA:UniProtKB-EC
P11766	ADH5	Alcohol dehydrogenase class-3	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P11766	ADH5	Alcohol dehydrogenase class-3	GO:0005504; F:fatty acid binding; IDA:UniProtKB
P11766	ADH5	Alcohol dehydrogenase class-3	GO:0018467; F:formaldehyde dehydrogenase activity; IDA:UniProtKB
P11766	ADH5	Alcohol dehydrogenase class-3	GO:0051903; F:S-(hydroxymethyl)glutathione dehydrogenase activity; TAS:UniProtKB
P11766	ADH5	Alcohol dehydrogenase class-3	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P11766	ADH5	Alcohol dehydrogenase class-3	GO:0007568; P:aging; IEA:Ensembl
P11766	ADH5	Alcohol dehydrogenase class-3	GO:0006068; P:ethanol catabolic process; IEA:Ensembl
P11766	ADH5	Alcohol dehydrogenase class-3	GO:0006069; P:ethanol oxidation; IEA:InterPro
P11766	ADH5	Alcohol dehydrogenase class-3	GO:0046294; P:formaldehyde catabolic process; IEA:Ensembl
P11766	ADH5	Alcohol dehydrogenase class-3	GO:0018119; P:peptidyl-cysteine S-nitrosylation; IEA:Ensembl
P11766	ADH5	Alcohol dehydrogenase class-3	GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl
P11766	ADH5	Alcohol dehydrogenase class-3	GO:0003016; P:respiratory system process; IEA:Ensembl
P11766	ADH5	Alcohol dehydrogenase class-3	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P11766	ADH5	Alcohol dehydrogenase class-3	GO:0051409; P:response to nitrosative stress; IEA:Ensembl
P11766	ADH5	Alcohol dehydrogenase class-3	GO:0051775; P:response to redox state; IDA:UniProtKB
P11766	ADH5	Alcohol dehydrogenase class-3	GO:0001523; P:retinoid metabolic process; IEA:Ensembl
Q0VDE8	ADIG	Adipogenin	GO:0050873; P:brown fat cell differentiation; ISS:HGNC
Q0VDE8	ADIG	Adipogenin	GO:0045600; P:positive regulation of fat cell differentiation; ISS:HGNC
Q0VDE8	ADIG	Adipogenin	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q0VDE8	ADIG	Adipogenin	GO:0050872; P:white fat cell differentiation; ISS:HGNC
Q15848	ADIPOQ	Adiponectin	GO:0005125; F:cytokine activity; NAS:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0005179; F:hormone activity; IDA:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0042802; F:identical protein binding; TAS:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0005515; F:protein binding; IPI:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0005102; F:receptor binding; ISS:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0033691; F:sialic acid binding; IDA:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0033211; P:adiponectin-activated signaling pathway; IEA:Ensembl
Q15848	ADIPOQ	Adiponectin	GO:0050873; P:brown fat cell differentiation; ISS:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0071320; P:cellular response to cAMP; IEA:Ensembl
Q15848	ADIPOQ	Adiponectin	GO:0035690; P:cellular response to drug; ISS:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0071872; P:cellular response to epinephrine stimulus; IEA:Ensembl
Q15848	ADIPOQ	Adiponectin	GO:0032869; P:cellular response to insulin stimulus; ISS:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0007623; P:circadian rhythm; IEA:Ensembl
Q15848	ADIPOQ	Adiponectin	GO:0070994; P:detection of oxidative stress; ISS:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0006635; P:fatty acid beta-oxidation; ISS:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0019395; P:fatty acid oxidation; ISS:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
Q15848	ADIPOQ	Adiponectin	GO:0042593; P:glucose homeostasis; ISS:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0006006; P:glucose metabolic process; ISS:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0034383; P:low-density lipoprotein particle clearance; IDA:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0051899; P:membrane depolarization; IEA:Ensembl
Q15848	ADIPOQ	Adiponectin	GO:0060081; P:membrane hyperpolarization; IEA:Ensembl
Q15848	ADIPOQ	Adiponectin	GO:0045776; P:negative regulation of blood pressure; IDA:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0030336; P:negative regulation of cell migration; ISS:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:2000279; P:negative regulation of DNA biosynthetic process; IDA:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0045599; P:negative regulation of fat cell differentiation; IDA:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0045721; P:negative regulation of gluconeogenesis; ISS:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0030853; P:negative regulation of granulocyte differentiation; IDA:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0034115; P:negative regulation of heterotypic cell-cell adhesion; IDA:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0046888; P:negative regulation of hormone secretion; IEA:Ensembl
Q15848	ADIPOQ	Adiponectin	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0050728; P:negative regulation of inflammatory response; ISS:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0090317; P:negative regulation of intracellular protein transport; IDA:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0045715; P:negative regulation of low-density lipoprotein particle receptor biosynthetic process; IDA:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; IDA:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0045650; P:negative regulation of macrophage differentiation; IDA:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0043407; P:negative regulation of MAP kinase activity; ISS:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:2000590; P:negative regulation of metanephric mesenchymal cell migration; ISS:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0050765; P:negative regulation of phagocytosis; IDA:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0010642; P:negative regulation of platelet-derived growth factor receptor signaling pathway; IDA:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:2000584; P:negative regulation of platelet-derived growth factor receptor-alpha signaling pathway; ISS:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0031953; P:negative regulation of protein autophosphorylation; IDA:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:1900121; P:negative regulation of receptor binding; IDA:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0014912; P:negative regulation of smooth muscle cell migration; IDA:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IDA:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0050805; P:negative regulation of synaptic transmission; IDA:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0032720; P:negative regulation of tumor necrosis factor production; IDA:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; IDA:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl
Q15848	ADIPOQ	Adiponectin	GO:2000481; P:positive regulation of cAMP-dependent protein kinase activity; IDA:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0032270; P:positive regulation of cellular protein metabolic process; IDA:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0010875; P:positive regulation of cholesterol efflux; IDA:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0045923; P:positive regulation of fatty acid metabolic process; ISS:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0046326; P:positive regulation of glucose import; ISS:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:2000467; P:positive regulation of glycogen (starch) synthase activity; ISS:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; ISS:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0032757; P:positive regulation of interleukin-8 production; IDA:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:2000478; P:positive regulation of metanephric glomerular visceral epithelial cell development; ISS:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0071639; P:positive regulation of monocyte chemotactic protein-1 production; IDA:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0033034; P:positive regulation of myeloid cell apoptotic process; IDA:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
Q15848	ADIPOQ	Adiponectin	GO:0010739; P:positive regulation of protein kinase A signaling; IDA:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:2000534; P:positive regulation of renal albumin absorption; IDA:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0009967; P:positive regulation of signal transduction; ISS:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0070208; P:protein heterotrimerization; IEA:Ensembl
Q15848	ADIPOQ	Adiponectin	GO:0051260; P:protein homooligomerization; ISS:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0072659; P:protein localization to plasma membrane; IDA:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0010906; P:regulation of glucose metabolic process; IDA:UniProtKB
Q15848	ADIPOQ	Adiponectin	GO:0014823; P:response to activity; IEA:Ensembl
Q15848	ADIPOQ	Adiponectin	GO:0045471; P:response to ethanol; IEA:Ensembl
Q15848	ADIPOQ	Adiponectin	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
Q15848	ADIPOQ	Adiponectin	GO:0009749; P:response to glucose; ISS:BHF-UCL
Q15848	ADIPOQ	Adiponectin	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q15848	ADIPOQ	Adiponectin	GO:0070543; P:response to linoleic acid; IEA:Ensembl
Q15848	ADIPOQ	Adiponectin	GO:0007584; P:response to nutrient; IEA:Ensembl
Q15848	ADIPOQ	Adiponectin	GO:0009744; P:response to sucrose; IEA:Ensembl
Q15848	ADIPOQ	Adiponectin	GO:0034612; P:response to tumor necrosis factor; IDA:BHF-UCL
Q9Y2D8	SSX2IP	Afadin- and alpha-actinin-binding protein	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2D8	SSX2IP	Afadin- and alpha-actinin-binding protein	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9Y2D8	SSX2IP	Afadin- and alpha-actinin-binding protein	GO:0051297; P:centrosome organization; IMP:UniProtKB
Q9Y2D8	SSX2IP	Afadin- and alpha-actinin-binding protein	GO:2000145; P:regulation of cell motility; IEA:Ensembl
Q9Y2D8	SSX2IP	Afadin- and alpha-actinin-binding protein	GO:0035020; P:regulation of Rac protein signal transduction; IEA:Ensembl
Q15847	ADIRF	Adipogenesis regulatory factor	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q15847	ADIRF	Adipogenesis regulatory factor	GO:0072719; P:cellular response to cisplatin; IDA:UniProtKB
Q15847	ADIRF	Adipogenesis regulatory factor	GO:0071478; P:cellular response to radiation; IDA:UniProtKB
Q15847	ADIRF	Adipogenesis regulatory factor	GO:0045600; P:positive regulation of fat cell differentiation; IDA:UniProtKB
Q15847	ADIRF	Adipogenesis regulatory factor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q15847	ADIRF	Adipogenesis regulatory factor	GO:2001023; P:regulation of response to drug; IDA:UniProtKB
Q15847	ADIRF	Adipogenesis regulatory factor	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P55263	ADK	Adenosine kinase	GO:0004001; F:adenosine kinase activity; EXP:Reactome
P55263	ADK	Adenosine kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P55263	ADK	Adenosine kinase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P55263	ADK	Adenosine kinase	GO:0016773; F:phosphotransferase activity, alcohol group as acceptor; IEA:InterPro
P55263	ADK	Adenosine kinase	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P55263	ADK	Adenosine kinase	GO:0046085; P:adenosine metabolic process; IEA:Ensembl
P55263	ADK	Adenosine kinase	GO:0044209; P:AMP salvage; IEA:UniProtKB-UniPathway
P55263	ADK	Adenosine kinase	GO:0032922; P:circadian regulation of gene expression; IEA:Ensembl
P55263	ADK	Adenosine kinase	GO:0006175; P:dATP biosynthetic process; IEA:Ensembl
P55263	ADK	Adenosine kinase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P55263	ADK	Adenosine kinase	GO:0010613; P:positive regulation of cardiac muscle hypertrophy; IEA:Ensembl
P55263	ADK	Adenosine kinase	GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl
P55263	ADK	Adenosine kinase	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P55263	ADK	Adenosine kinase	GO:0006166; P:purine ribonucleoside salvage; IEA:UniProtKB-KW
P55263	ADK	Adenosine kinase	GO:0043101; P:purine-containing compound salvage; TAS:Reactome
P55263	ADK	Adenosine kinase	GO:0009156; P:ribonucleoside monophosphate biosynthetic process; TAS:ProtInc
P55263	ADK	Adenosine kinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P55263	ADK	Adenosine kinase	GO:0044342; P:type B pancreatic cell proliferation; IEA:Ensembl
Q7Z4H4	ADM2	ADM2	GO:0032403; F:protein complex binding; IDA:UniProtKB
Q7Z4H4	ADM2	ADM2	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
Q7Z4H4	ADM2	ADM2	GO:0001525; P:angiogenesis; IDA:UniProtKB
Q7Z4H4	ADM2	ADM2	GO:0007586; P:digestion; IEA:Ensembl
Q7Z4H4	ADM2	ADM2	GO:0007631; P:feeding behavior; IEA:Ensembl
Q7Z4H4	ADM2	ADM2	GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl
Q7Z4H4	ADM2	ADM2	GO:0045766; P:positive regulation of angiogenesis; IDA:MGI
Q7Z4H4	ADM2	ADM2	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
Q7Z4H4	ADM2	ADM2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P35318	ADM	ADM	GO:0005515; F:protein binding; IPI:UniProtKB
P35318	ADM	ADM	GO:0005102; F:receptor binding; TAS:ProtInc
P35318	ADM	ADM	GO:0007568; P:aging; IEA:Ensembl
P35318	ADM	ADM	GO:0008209; P:androgen metabolic process; IEA:Ensembl
P35318	ADM	ADM	GO:0008015; P:blood circulation; TAS:ProtInc
P35318	ADM	ADM	GO:0060670; P:branching involved in labyrinthine layer morphogenesis; IEA:Ensembl
P35318	ADM	ADM	GO:0006171; P:cAMP biosynthetic process; IDA:UniProtKB
P35318	ADM	ADM	GO:0019933; P:cAMP-mediated signaling; IEA:Ensembl
P35318	ADM	ADM	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P35318	ADM	ADM	GO:0048589; P:developmental growth; IEA:Ensembl
P35318	ADM	ADM	GO:0007565; P:female pregnancy; TAS:ProtInc
P35318	ADM	ADM	GO:0002031; P:G-protein coupled receptor internalization; IDA:UniProtKB
P35318	ADM	ADM	GO:0007507; P:heart development; IEA:Ensembl
P35318	ADM	ADM	GO:0046879; P:hormone secretion; IEA:Ensembl
P35318	ADM	ADM	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P35318	ADM	ADM	GO:0043116; P:negative regulation of vascular permeability; IEA:Ensembl
P35318	ADM	ADM	GO:0045906; P:negative regulation of vasoconstriction; IDA:BHF-UCL
P35318	ADM	ADM	GO:0001843; P:neural tube closure; IEA:Ensembl
P35318	ADM	ADM	GO:0031102; P:neuron projection regeneration; IEA:Ensembl
P35318	ADM	ADM	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
P35318	ADM	ADM	GO:0031100; P:organ regeneration; IEA:Ensembl
P35318	ADM	ADM	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
P35318	ADM	ADM	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P35318	ADM	ADM	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:UniProtKB
P35318	ADM	ADM	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P35318	ADM	ADM	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P35318	ADM	ADM	GO:0010460; P:positive regulation of heart rate; IEA:Ensembl
P35318	ADM	ADM	GO:2001214; P:positive regulation of vasculogenesis; IEA:Ensembl
P35318	ADM	ADM	GO:0045909; P:positive regulation of vasodilation; IEA:Ensembl
P35318	ADM	ADM	GO:0006701; P:progesterone biosynthetic process; TAS:ProtInc
P35318	ADM	ADM	GO:0031623; P:receptor internalization; IDA:UniProtKB
P35318	ADM	ADM	GO:0002026; P:regulation of the force of heart contraction; IEA:Ensembl
P35318	ADM	ADM	GO:0009409; P:response to cold; IEA:Ensembl
P35318	ADM	ADM	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P35318	ADM	ADM	GO:0001666; P:response to hypoxia; IEA:Ensembl
P35318	ADM	ADM	GO:0032868; P:response to insulin; IEA:Ensembl
P35318	ADM	ADM	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P35318	ADM	ADM	GO:0042594; P:response to starvation; IEA:Ensembl
P35318	ADM	ADM	GO:0009611; P:response to wounding; TAS:ProtInc
P35318	ADM	ADM	GO:0007165; P:signal transduction; TAS:ProtInc
P35318	ADM	ADM	GO:0060712; P:spongiotrophoblast layer development; IEA:Ensembl
P35318	ADM	ADM	GO:0097084; P:vascular smooth muscle cell development; IEA:Ensembl
P35318	ADM	ADM	GO:0001570; P:vasculogenesis; IDA:UniProtKB
Q6IQ32	ADNP2	ADNP homeobox protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6IQ32	ADNP2	ADNP homeobox protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q6IQ32	ADNP2	ADNP homeobox protein 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q6IQ32	ADNP2	ADNP homeobox protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q6IQ32	ADNP2	ADNP homeobox protein 2	GO:0034599; P:cellular response to oxidative stress; ISS:UniProtKB
Q6IQ32	ADNP2	ADNP homeobox protein 2	GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB
Q6IQ32	ADNP2	ADNP homeobox protein 2	GO:0060548; P:negative regulation of cell death; ISS:UniProtKB
Q6IQ32	ADNP2	ADNP homeobox protein 2	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q6IQ32	ADNP2	ADNP homeobox protein 2	GO:0030307; P:positive regulation of cell growth; ISS:UniProtKB
Q6IQ32	ADNP2	ADNP homeobox protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H2P0	ADNP	Activity-dependent neuroprotector homeobox protein	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9H2P0	ADNP	Activity-dependent neuroprotector homeobox protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H2P0	ADNP	Activity-dependent neuroprotector homeobox protein	GO:0005515; F:protein binding; IPI:IntAct
Q9H2P0	ADNP	Activity-dependent neuroprotector homeobox protein	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9H2P0	ADNP	Activity-dependent neuroprotector homeobox protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9H2P0	ADNP	Activity-dependent neuroprotector homeobox protein	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q9H2P0	ADNP	Activity-dependent neuroprotector homeobox protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BRR6	ADPGK	ADP-dependent glucokinase	GO:0043843; F:ADP-specific glucokinase activity; IEA:UniProtKB-EC
Q9BRR6	ADPGK	ADP-dependent glucokinase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BRR6	ADPGK	ADP-dependent glucokinase	GO:0006096; P:glycolytic process; IEA:UniProtKB-UniPathway
Q9NRN7	AASDHPPT	L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase	GO:0008897; F:holo-[acyl-carrier-protein] synthase activity; IDA:UniProtKB
Q9NRN7	AASDHPPT	L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q9NRN7	AASDHPPT	L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NRN7	AASDHPPT	L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase	GO:0009059; P:macromolecule biosynthetic process; IEA:InterPro
Q9NRN7	AASDHPPT	L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase	GO:0015939; P:pantothenate metabolic process; TAS:Reactome
Q9NRN7	AASDHPPT	L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NRN7	AASDHPPT	L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9NRN7	AASDHPPT	L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
P54922	ADPRH	[Protein ADP-ribosylarginine] hydrolase	GO:0003875; F:ADP-ribosylarginine hydrolase activity; IMP:UniProtKB
P54922	ADPRH	[Protein ADP-ribosylarginine] hydrolase	GO:0000287; F:magnesium ion binding; IEA:InterPro
P54922	ADPRH	[Protein ADP-ribosylarginine] hydrolase	GO:0006464; P:cellular protein modification process; IMP:UniProtKB
P54922	ADPRH	[Protein ADP-ribosylarginine] hydrolase	GO:0051725; P:protein de-ADP-ribosylation; IEA:InterPro
Q3LIE5	ADPRM	Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase	GO:0047631; F:ADP-ribose diphosphatase activity; IEA:UniProtKB-EC
Q3LIE5	ADPRM	Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase	GO:0047734; F:CDP-glycerol diphosphatase activity; IEA:UniProtKB-EC
Q3LIE5	ADPRM	Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96A54	ADIPOR1	Adiponectin receptor protein 1	GO:0042562; F:hormone binding; IDA:UniProtKB
Q96A54	ADIPOR1	Adiponectin receptor protein 1	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
Q96A54	ADIPOR1	Adiponectin receptor protein 1	GO:0004872; F:receptor activity; IBA:RefGenome
Q96A54	ADIPOR1	Adiponectin receptor protein 1	GO:0033211; P:adiponectin-activated signaling pathway; IBA:RefGenome
Q96A54	ADIPOR1	Adiponectin receptor protein 1	GO:0019395; P:fatty acid oxidation; IDA:UniProtKB
Q96A54	ADIPOR1	Adiponectin receptor protein 1	GO:0009755; P:hormone-mediated signaling pathway; IDA:UniProtKB
Q96A54	ADIPOR1	Adiponectin receptor protein 1	GO:0033210; P:leptin-mediated signaling pathway; IEA:Ensembl
Q96A54	ADIPOR1	Adiponectin receptor protein 1	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
Q96A54	ADIPOR1	Adiponectin receptor protein 1	GO:0046628; P:positive regulation of insulin receptor signaling pathway; IEA:Ensembl
Q96A54	ADIPOR1	Adiponectin receptor protein 1	GO:0046427; P:positive regulation of JAK-STAT cascade; IEA:Ensembl
Q86V24	ADIPOR2	Adiponectin receptor protein 2	GO:0042562; F:hormone binding; ISS:UniProtKB
Q86V24	ADIPOR2	Adiponectin receptor protein 2	GO:0004872; F:receptor activity; IBA:RefGenome
Q86V24	ADIPOR2	Adiponectin receptor protein 2	GO:0033211; P:adiponectin-activated signaling pathway; IBA:RefGenome
Q86V24	ADIPOR2	Adiponectin receptor protein 2	GO:0019395; P:fatty acid oxidation; ISS:UniProtKB
Q86V24	ADIPOR2	Adiponectin receptor protein 2	GO:0007565; P:female pregnancy; IEA:Ensembl
Q86V24	ADIPOR2	Adiponectin receptor protein 2	GO:0007507; P:heart development; IEA:Ensembl
Q86V24	ADIPOR2	Adiponectin receptor protein 2	GO:0009755; P:hormone-mediated signaling pathway; ISS:UniProtKB
Q86V24	ADIPOR2	Adiponectin receptor protein 2	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
Q86V24	ADIPOR2	Adiponectin receptor protein 2	GO:0046326; P:positive regulation of glucose import; IEA:Ensembl
Q86V24	ADIPOR2	Adiponectin receptor protein 2	GO:0007584; P:response to nutrient; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0031694; F:alpha-2A adrenergic receptor binding; IPI:BHF-UCL
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0004939; F:beta-adrenergic receptor activity; TAS:ProtInc
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0004940; F:beta1-adrenergic receptor activity; TAS:ProtInc
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0035240; F:dopamine binding; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0008144; F:drug binding; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0051379; F:epinephrine binding; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0051380; F:norepinephrine binding; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0030165; F:PDZ domain binding; IPI:UniProtKB
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; IDA:UniProtKB
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0005057; F:receptor signaling protein activity; IDA:UniProtKB
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0007190; P:activation of adenylate cyclase activity; TAS:ProtInc
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0071880; P:adenylate cyclase-activating adrenergic receptor signaling pathway; IDA:UniProtKB
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0007568; P:aging; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0006915; P:apoptotic process; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0002024; P:diet induced thermogenesis; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0042596; P:fear response; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0005980; P:glycogen catabolic process; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0031649; P:heat generation; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0055088; P:lipid homeostasis; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0007613; P:memory; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0040015; P:negative regulation of multicellular organism growth; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0045986; P:negative regulation of smooth muscle contraction; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0035811; P:negative regulation of urine volume; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:UniProtKB
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0043950; P:positive regulation of cAMP-mediated signaling; IDA:UniProtKB
P08588	ADRB1	Beta-1 adrenergic receptor	GO:2001259; P:positive regulation of cation channel activity; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0061051; P:positive regulation of cell growth involved in cardiac muscle cell development; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0001996; P:positive regulation of heart rate by epinephrine-norepinephrine; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0032320; P:positive regulation of Ras GTPase activity; IDA:UniProtKB
P08588	ADRB1	Beta-1 adrenergic receptor	GO:1900135; P:positive regulation of renin secretion into blood stream; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0046878; P:positive regulation of saliva secretion; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0003084; P:positive regulation of systemic arterial blood pressure; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0003061; P:positive regulation of the force of heart contraction by norepinephrine; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0033365; P:protein localization to organelle; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0051924; P:regulation of calcium ion transport; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0086004; P:regulation of cardiac muscle cell contraction; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0060080; P:regulation of inhibitory postsynaptic membrane potential; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0009409; P:response to cold; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0007266; P:Rho protein signal transduction; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0002025; P:vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure; IEA:Ensembl
P08588	ADRB1	Beta-1 adrenergic receptor	GO:0042060; P:wound healing; IEA:Ensembl
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0004941; F:beta2-adrenergic receptor activity; IDA:HGNC
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0051380; F:norepinephrine binding; IDA:HGNC
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0015459; F:potassium channel regulator activity; IDA:BHF-UCL
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0042803; F:protein homodimerization activity; IDA:HGNC
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0007190; P:activation of adenylate cyclase activity; IDA:HGNC
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0007171; P:activation of transmembrane receptor protein tyrosine kinase activity; TAS:ProtInc
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; TAS:ProtInc
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0071875; P:adrenergic receptor signaling pathway; IDA:GOC
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0045453; P:bone resorption; IEA:Ensembl
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0002032; P:desensitization of G-protein coupled receptor protein signaling pathway by arrestin; IDA:HGNC
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0002024; P:diet induced thermogenesis; IEA:Ensembl
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0008333; P:endosome to lysosome transport; TAS:ProtInc
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0031649; P:heat generation; IEA:Ensembl
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0040015; P:negative regulation of multicellular organism growth; IEA:Ensembl
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0045986; P:negative regulation of smooth muscle contraction; IEA:Ensembl
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0030501; P:positive regulation of bone mineralization; IEA:Ensembl
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0043410; P:positive regulation of MAPK cascade; IDA:HGNC
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0031398; P:positive regulation of protein ubiquitination; IMP:BHF-UCL
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0006898; P:receptor-mediated endocytosis; IDA:HGNC
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0002028; P:regulation of sodium ion transport; IEA:Ensembl
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0042312; P:regulation of vasodilation; IEA:InterPro
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0009409; P:response to cold; IEA:Ensembl
P07550	ADRB2	Beta-2 adrenergic receptor	GO:0002025; P:vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure; IEA:Ensembl
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0004939; F:beta-adrenergic receptor activity; IDA:HGNC
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0004940; F:beta1-adrenergic receptor activity; IEA:InterPro
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0015052; F:beta3-adrenergic receptor activity; IMP:HGNC
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0051379; F:epinephrine binding; IEA:Ensembl
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0051380; F:norepinephrine binding; IEA:Ensembl
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0042803; F:protein homodimerization activity; IDA:HGNC
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0007190; P:activation of adenylate cyclase activity; IDA:HGNC
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; TAS:ProtInc
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0071875; P:adrenergic receptor signaling pathway; IDA:GOC
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0007568; P:aging; IEA:Ensembl
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0002024; P:diet induced thermogenesis; IEA:Ensembl
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0042755; P:eating behavior; IEA:Ensembl
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0006112; P:energy reserve metabolic process; TAS:ProtInc
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0031649; P:heat generation; IEA:Ensembl
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0040015; P:negative regulation of multicellular organism growth; IEA:Ensembl
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0045823; P:positive regulation of heart contraction; IEA:InterPro
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0043410; P:positive regulation of MAPK cascade; IDA:HGNC
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0046677; P:response to antibiotic; IEA:Ensembl
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0009409; P:response to cold; IEA:Ensembl
P13945	ADRB3	Beta-3 adrenergic receptor	GO:0002025; P:vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure; IEA:Ensembl
Q16186	ADRM1	Proteasomal ubiquitin receptor ADRM1	GO:0061133; F:endopeptidase activator activity; IDA:UniProtKB
Q16186	ADRM1	Proteasomal ubiquitin receptor ADRM1	GO:0002020; F:protease binding; IPI:UniProtKB
Q16186	ADRM1	Proteasomal ubiquitin receptor ADRM1	GO:0070628; F:proteasome binding; IDA:UniProtKB
Q16186	ADRM1	Proteasomal ubiquitin receptor ADRM1	GO:0005515; F:protein binding; IPI:IntAct
Q16186	ADRM1	Proteasomal ubiquitin receptor ADRM1	GO:0010950; P:positive regulation of endopeptidase activity; IDA:GOC
Q16186	ADRM1	Proteasomal ubiquitin receptor ADRM1	GO:0043248; P:proteasome assembly; IDA:UniProtKB
Q16186	ADRM1	Proteasomal ubiquitin receptor ADRM1	GO:0006368; P:transcription elongation from RNA polymerase II promoter; IMP:UniProtKB
P22570	FDXR	NADPH:adrenodoxin oxidoreductase, mitochondrial	GO:0004324; F:ferredoxin-NADP+ reductase activity; TAS:ProtInc
P22570	FDXR	NADPH:adrenodoxin oxidoreductase, mitochondrial	GO:0070402; F:NADPH binding; IEA:Ensembl
P22570	FDXR	NADPH:adrenodoxin oxidoreductase, mitochondrial	GO:0015039; F:NADPH-adrenodoxin reductase activity; IEA:Ensembl
P22570	FDXR	NADPH:adrenodoxin oxidoreductase, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
P22570	FDXR	NADPH:adrenodoxin oxidoreductase, mitochondrial	GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-UniPathway
P22570	FDXR	NADPH:adrenodoxin oxidoreductase, mitochondrial	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P22570	FDXR	NADPH:adrenodoxin oxidoreductase, mitochondrial	GO:0070995; P:NADPH oxidation; IEA:Ensembl
P22570	FDXR	NADPH:adrenodoxin oxidoreductase, mitochondrial	GO:0055114; P:oxidation-reduction process; TAS:ProtInc
P22570	FDXR	NADPH:adrenodoxin oxidoreductase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P22570	FDXR	NADPH:adrenodoxin oxidoreductase, mitochondrial	GO:0006694; P:steroid biosynthetic process; TAS:ProtInc
Q9Y6U3	SCIN	Adseverin	GO:0005545; F:1-phosphatidylinositol binding; TAS:UniProtKB
Q9Y6U3	SCIN	Adseverin	GO:0003779; F:actin binding; ISS:UniProtKB
Q9Y6U3	SCIN	Adseverin	GO:0051015; F:actin filament binding; ISS:UniProtKB
Q9Y6U3	SCIN	Adseverin	GO:0005509; F:calcium ion binding; ISS:UniProtKB
Q9Y6U3	SCIN	Adseverin	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISS:UniProtKB
Q9Y6U3	SCIN	Adseverin	GO:0001786; F:phosphatidylserine binding; ISS:UniProtKB
Q9Y6U3	SCIN	Adseverin	GO:0051693; P:actin filament capping; IEA:UniProtKB-KW
Q9Y6U3	SCIN	Adseverin	GO:0051014; P:actin filament severing; IMP:UniProtKB
Q9Y6U3	SCIN	Adseverin	GO:0045010; P:actin nucleation; ISS:UniProtKB
Q9Y6U3	SCIN	Adseverin	GO:0017156; P:calcium ion-dependent exocytosis; ISS:UniProtKB
Q9Y6U3	SCIN	Adseverin	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q9Y6U3	SCIN	Adseverin	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q9Y6U3	SCIN	Adseverin	GO:0045654; P:positive regulation of megakaryocyte differentiation; IMP:UniProtKB
Q9Y6U3	SCIN	Adseverin	GO:0051047; P:positive regulation of secretion; ISS:UniProtKB
Q9Y6U3	SCIN	Adseverin	GO:0032330; P:regulation of chondrocyte differentiation; ISS:UniProtKB
P12235	SLC25A4	ADP/ATP translocase 1	GO:0015207; F:adenine transmembrane transporter activity; TAS:ProtInc
P12235	SLC25A4	ADP/ATP translocase 1	GO:0005515; F:protein binding; IPI:BHF-UCL
P12235	SLC25A4	ADP/ATP translocase 1	GO:0015853; P:adenine transport; TAS:GOC
P12235	SLC25A4	ADP/ATP translocase 1	GO:0008637; P:apoptotic mitochondrial changes; IEA:Ensembl
P12235	SLC25A4	ADP/ATP translocase 1	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P12235	SLC25A4	ADP/ATP translocase 1	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P12235	SLC25A4	ADP/ATP translocase 1	GO:0000002; P:mitochondrial genome maintenance; TAS:ProtInc
P12235	SLC25A4	ADP/ATP translocase 1	GO:0060546; P:negative regulation of necroptotic process; IMP:BHF-UCL
P12235	SLC25A4	ADP/ATP translocase 1	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P12235	SLC25A4	ADP/ATP translocase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P12235	SLC25A4	ADP/ATP translocase 1	GO:0006810; P:transport; TAS:ProtInc
P12235	SLC25A4	ADP/ATP translocase 1	GO:0016032; P:viral process; TAS:Reactome
P05141	SLC25A5	ADP/ATP translocase 2	GO:0015207; F:adenine transmembrane transporter activity; TAS:ProtInc
P05141	SLC25A5	ADP/ATP translocase 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P05141	SLC25A5	ADP/ATP translocase 2	GO:0005515; F:protein binding; IPI:UniProtKB
P05141	SLC25A5	ADP/ATP translocase 2	GO:0015853; P:adenine transport; TAS:GOC
P05141	SLC25A5	ADP/ATP translocase 2	GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW
P05141	SLC25A5	ADP/ATP translocase 2	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P05141	SLC25A5	ADP/ATP translocase 2	GO:1901029; P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; IMP:UniProtKB
P05141	SLC25A5	ADP/ATP translocase 2	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
P05141	SLC25A5	ADP/ATP translocase 2	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P05141	SLC25A5	ADP/ATP translocase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P05141	SLC25A5	ADP/ATP translocase 2	GO:0006810; P:transport; TAS:ProtInc
P05141	SLC25A5	ADP/ATP translocase 2	GO:0016032; P:viral process; TAS:Reactome
P12236	SLC25A6	ADP/ATP translocase 3	GO:0005471; F:ATP:ADP antiporter activity; NAS:UniProtKB
P12236	SLC25A6	ADP/ATP translocase 3	GO:0046732; P:active induction of host immune response by virus; TAS:Reactome
P12236	SLC25A6	ADP/ATP translocase 3	GO:0015866; P:ADP transport; NAS:GOC
P12236	SLC25A6	ADP/ATP translocase 3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P12236	SLC25A6	ADP/ATP translocase 3	GO:0015867; P:ATP transport; NAS:GOC
P12236	SLC25A6	ADP/ATP translocase 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P12236	SLC25A6	ADP/ATP translocase 3	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P12236	SLC25A6	ADP/ATP translocase 3	GO:0019048; P:modulation by virus of host morphology or physiology; TAS:Reactome
P12236	SLC25A6	ADP/ATP translocase 3	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
P12236	SLC25A6	ADP/ATP translocase 3	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P12236	SLC25A6	ADP/ATP translocase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P12236	SLC25A6	ADP/ATP translocase 3	GO:0019058; P:viral life cycle; TAS:Reactome
P12236	SLC25A6	ADP/ATP translocase 3	GO:0016032; P:viral process; TAS:Reactome
Q9H0C2	SLC25A31	ADP/ATP translocase 4	GO:0005215; F:transporter activity; IEA:InterPro
Q9H0C2	SLC25A31	ADP/ATP translocase 4	GO:0055085; P:transmembrane transport; IEA:InterPro
Q6P4F2	FDX1L	Adrenodoxin-like protein, mitochondrial	GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:UniProtKB-KW
Q6P4F2	FDX1L	Adrenodoxin-like protein, mitochondrial	GO:0009055; F:electron carrier activity; IEA:InterPro
Q6P4F2	FDX1L	Adrenodoxin-like protein, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6P4F2	FDX1L	Adrenodoxin-like protein, mitochondrial	GO:0055114; P:oxidation-reduction process; IEA:UniProtKB-KW
Q6P4F2	FDX1L	Adrenodoxin-like protein, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P10109	FDX1	Adrenodoxin, mitochondrial	GO:0051537; F:2 iron, 2 sulfur cluster binding; IDA:UniProtKB
P10109	FDX1	Adrenodoxin, mitochondrial	GO:0009055; F:electron carrier activity; IDA:UniProtKB
P10109	FDX1	Adrenodoxin, mitochondrial	GO:0005506; F:iron ion binding; TAS:ProtInc
P10109	FDX1	Adrenodoxin, mitochondrial	GO:0008203; P:cholesterol metabolic process; IDA:UniProtKB
P10109	FDX1	Adrenodoxin, mitochondrial	GO:0042446; P:hormone biosynthetic process; IDA:UniProtKB
P10109	FDX1	Adrenodoxin, mitochondrial	GO:0055114; P:oxidation-reduction process; IEA:UniProtKB-KW
P10109	FDX1	Adrenodoxin, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P10109	FDX1	Adrenodoxin, mitochondrial	GO:0006694; P:steroid biosynthetic process; IEA:UniProtKB-KW
Q8IUX7	AEBP1	Adipocyte enhancer-binding protein 1	GO:0004180; F:carboxypeptidase activity; TAS:ProtInc
Q8IUX7	AEBP1	Adipocyte enhancer-binding protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IUX7	AEBP1	Adipocyte enhancer-binding protein 1	GO:0004181; F:metallocarboxypeptidase activity; IEA:InterPro
Q8IUX7	AEBP1	Adipocyte enhancer-binding protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q8IUX7	AEBP1	Adipocyte enhancer-binding protein 1	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
Q8IUX7	AEBP1	Adipocyte enhancer-binding protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IUX7	AEBP1	Adipocyte enhancer-binding protein 1	GO:0007155; P:cell adhesion; IEA:InterPro
Q8IUX7	AEBP1	Adipocyte enhancer-binding protein 1	GO:0007517; P:muscle organ development; TAS:ProtInc
Q8IUX7	AEBP1	Adipocyte enhancer-binding protein 1	GO:0001501; P:skeletal system development; TAS:ProtInc
Q8IUX7	AEBP1	Adipocyte enhancer-binding protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZN18	AEBP2	Zinc finger protein AEBP2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZN18	AEBP2	Zinc finger protein AEBP2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZN18	AEBP2	Zinc finger protein AEBP2	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
Q6ZN18	AEBP2	Zinc finger protein AEBP2	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q6ZN18	AEBP2	Zinc finger protein AEBP2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZN18	AEBP2	Zinc finger protein AEBP2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96SZ5	ADO	2-aminoethanethiol dioxygenase	GO:0047800; F:cysteamine dioxygenase activity; IEA:UniProtKB-EC
Q96SZ5	ADO	2-aminoethanethiol dioxygenase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6UXC1	MAMDC4	Apical endosomal glycoprotein	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8WTP8	AEN	Apoptosis-enhancing nuclease	GO:0004527; F:exonuclease activity; IDA:UniProtKB
Q8WTP8	AEN	Apoptosis-enhancing nuclease	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8WTP8	AEN	Apoptosis-enhancing nuclease	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IDA:UniProtKB
Q8WTP8	AEN	Apoptosis-enhancing nuclease	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:GOC
Q8WTP8	AEN	Apoptosis-enhancing nuclease	GO:0010212; P:response to ionizing radiation; IDA:UniProtKB
Q08117	AES	Amino-terminal enhancer of split	GO:0005515; F:protein binding; IPI:UniProtKB
Q08117	AES	Amino-terminal enhancer of split	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q08117	AES	Amino-terminal enhancer of split	GO:0031668; P:cellular response to extracellular stimulus; IEA:Ensembl
Q08117	AES	Amino-terminal enhancer of split	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q08117	AES	Amino-terminal enhancer of split	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:UniProtKB
Q08117	AES	Amino-terminal enhancer of split	GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB
Q08117	AES	Amino-terminal enhancer of split	GO:0032091; P:negative regulation of protein binding; IDA:BHF-UCL
Q08117	AES	Amino-terminal enhancer of split	GO:0060761; P:negative regulation of response to cytokine stimulus; IMP:BHF-UCL
Q08117	AES	Amino-terminal enhancer of split	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q08117	AES	Amino-terminal enhancer of split	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q08117	AES	Amino-terminal enhancer of split	GO:0009887; P:organ morphogenesis; TAS:ProtInc
Q08117	AES	Amino-terminal enhancer of split	GO:2000210; P:positive regulation of anoikis; IMP:UniProtKB
Q08117	AES	Amino-terminal enhancer of split	GO:0040008; P:regulation of growth; IEA:Ensembl
Q08117	AES	Amino-terminal enhancer of split	GO:0070555; P:response to interleukin-1; IDA:BHF-UCL
Q08117	AES	Amino-terminal enhancer of split	GO:0001501; P:skeletal system development; IEA:Ensembl
Q08117	AES	Amino-terminal enhancer of split	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q08117	AES	Amino-terminal enhancer of split	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P55197	MLLT10	Protein AF-10	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P55197	MLLT10	Protein AF-10	GO:0005515; F:protein binding; IPI:UniProtKB
P55197	MLLT10	Protein AF-10	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
P55197	MLLT10	Protein AF-10	GO:0008270; F:zinc ion binding; IEA:InterPro
P55197	MLLT10	Protein AF-10	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P55197	MLLT10	Protein AF-10	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P55198	MLLT6	Protein AF-17	GO:0005515; F:protein binding; IPI:IntAct
P55198	MLLT6	Protein AF-17	GO:0008270; F:zinc ion binding; IEA:InterPro
P55198	MLLT6	Protein AF-17	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
Q8N4X5	AFAP1L2	Actin filament-associated protein 1-like 2	GO:0030296; F:protein tyrosine kinase activator activity; IDA:HGNC
Q8N4X5	AFAP1L2	Actin filament-associated protein 1-like 2	GO:0042169; F:SH2 domain binding; IPI:HGNC
Q8N4X5	AFAP1L2	Actin filament-associated protein 1-like 2	GO:0017124; F:SH3 domain binding; IPI:HGNC
Q8N4X5	AFAP1L2	Actin filament-associated protein 1-like 2	GO:0006954; P:inflammatory response; IDA:HGNC
Q8N4X5	AFAP1L2	Actin filament-associated protein 1-like 2	GO:0045742; P:positive regulation of epidermal growth factor receptor signaling pathway; IDA:HGNC
Q8N4X5	AFAP1L2	Actin filament-associated protein 1-like 2	GO:0032757; P:positive regulation of interleukin-8 production; IDA:HGNC
Q8N4X5	AFAP1L2	Actin filament-associated protein 1-like 2	GO:0061098; P:positive regulation of protein tyrosine kinase activity; IDA:GOC
Q8N4X5	AFAP1L2	Actin filament-associated protein 1-like 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:HGNC
Q8N4X5	AFAP1L2	Actin filament-associated protein 1-like 2	GO:0032675; P:regulation of interleukin-6 production; IDA:HGNC
Q8N4X5	AFAP1L2	Actin filament-associated protein 1-like 2	GO:0007346; P:regulation of mitotic cell cycle; IDA:HGNC
Q13015	MLLT11	Protein AF1q	GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:UniProtKB
Q13015	MLLT11	Protein AF1q	GO:0097193; P:intrinsic apoptotic signaling pathway; IDA:UniProtKB
Q13015	MLLT11	Protein AF1q	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q13015	MLLT11	Protein AF1q	GO:0051901; P:positive regulation of mitochondrial depolarization; IDA:UniProtKB
Q13015	MLLT11	Protein AF1q	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IDA:UniProtKB
Q13015	MLLT11	Protein AF1q	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P42568	MLLT3	Protein AF-9	GO:0005515; F:protein binding; IPI:IntAct
P42568	MLLT3	Protein AF-9	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P42568	MLLT3	Protein AF-9	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:MGI
P42568	MLLT3	Protein AF-9	GO:2000096; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; IGI:MGI
P42568	MLLT3	Protein AF-9	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P42568	MLLT3	Protein AF-9	GO:0007379; P:segment specification; IEA:Ensembl
P42568	MLLT3	Protein AF-9	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P55196	MLLT4	Afadin	GO:0005515; F:protein binding; IPI:IntAct
P55196	MLLT4	Afadin	GO:0008022; F:protein C-terminus binding; TAS:ProtInc
P55196	MLLT4	Afadin	GO:0034332; P:adherens junction organization; TAS:Reactome
P55196	MLLT4	Afadin	GO:0007155; P:cell adhesion; TAS:ProtInc
P55196	MLLT4	Afadin	GO:0034329; P:cell junction assembly; TAS:Reactome
P55196	MLLT4	Afadin	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P55196	MLLT4	Afadin	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P55196	MLLT4	Afadin	GO:0007165; P:signal transduction; TAS:ProtInc
P43652	AFM	Afamin	GO:0008431; F:vitamin E binding; IDA:UniProtKB
P43652	AFM	Afamin	GO:0051180; P:vitamin transport; IDA:UniProtKB
P51825	AFF1	AF4/FMR2 family member 1	GO:0005515; F:protein binding; IPI:IntAct
P51825	AFF1	AF4/FMR2 family member 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P51825	AFF1	AF4/FMR2 family member 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P51816	AFF2	AF4/FMR2 family member 2	GO:0002151; F:G-quadruplex RNA binding; ISS:UniProtKB
P51816	AFF2	AF4/FMR2 family member 2	GO:0007420; P:brain development; TAS:ProtInc
P51816	AFF2	AF4/FMR2 family member 2	GO:0007611; P:learning or memory; IEA:Ensembl
P51816	AFF2	AF4/FMR2 family member 2	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
P51816	AFF2	AF4/FMR2 family member 2	GO:0043484; P:regulation of RNA splicing; IMP:UniProtKB
P51816	AFF2	AF4/FMR2 family member 2	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
P51826	AFF3	AF4/FMR2 family member 3	GO:0003690; F:double-stranded DNA binding; IDA:BHF-UCL
P51826	AFF3	AF4/FMR2 family member 3	GO:0035116; P:embryonic hindlimb morphogenesis; IMP:BHF-UCL
P51826	AFF3	AF4/FMR2 family member 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P51826	AFF3	AF4/FMR2 family member 3	GO:0034612; P:response to tumor necrosis factor; IMP:BHF-UCL
P51826	AFF3	AF4/FMR2 family member 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UHB7	AFF4	AF4/FMR2 family member 4	GO:0005515; F:protein binding; IPI:IntAct
Q9UHB7	AFF4	AF4/FMR2 family member 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9UHB7	AFF4	AF4/FMR2 family member 4	GO:0007286; P:spermatid development; IEA:Ensembl
Q9UHB7	AFF4	AF4/FMR2 family member 4	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9Y4W6	AFG3L2	AFG3-like protein 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y4W6	AFG3L2	AFG3-like protein 2	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q9Y4W6	AFG3L2	AFG3-like protein 2	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q9Y4W6	AFG3L2	AFG3-like protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y4W6	AFG3L2	AFG3-like protein 2	GO:0051082; F:unfolded protein binding; TAS:ProtInc
Q9Y4W6	AFG3L2	AFG3-like protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y4W6	AFG3L2	AFG3-like protein 2	GO:0007409; P:axonogenesis; IEA:Ensembl
Q9Y4W6	AFG3L2	AFG3-like protein 2	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9Y4W6	AFG3L2	AFG3-like protein 2	GO:0042407; P:cristae formation; IEA:Ensembl
Q9Y4W6	AFG3L2	AFG3-like protein 2	GO:0008053; P:mitochondrial fusion; IEA:Ensembl
Q9Y4W6	AFG3L2	AFG3-like protein 2	GO:0034982; P:mitochondrial protein processing; IEA:Ensembl
Q9Y4W6	AFG3L2	AFG3-like protein 2	GO:0048747; P:muscle fiber development; IEA:Ensembl
Q9Y4W6	AFG3L2	AFG3-like protein 2	GO:0042552; P:myelination; IEA:Ensembl
Q9Y4W6	AFG3L2	AFG3-like protein 2	GO:0021675; P:nerve development; IEA:Ensembl
Q9Y4W6	AFG3L2	AFG3-like protein 2	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
Q9Y4W6	AFG3L2	AFG3-like protein 2	GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl
Q9Y4W6	AFG3L2	AFG3-like protein 2	GO:0060013; P:righting reflex; IEA:Ensembl
Q6ULP2	AFTPH	Aftiphilin	GO:0030276; F:clathrin binding; IDA:UniProtKB
Q6ULP2	AFTPH	Aftiphilin	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q5BKT4	ALG10	Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase	GO:0016758; F:transferase activity, transferring hexosyl groups; IEA:InterPro
Q5BKT4	ALG10	Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q5BKT4	ALG10	Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q5BKT4	ALG10	Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q5BKT4	ALG10	Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q5I7T1	ALG10B	Putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase	GO:0016758; F:transferase activity, transferring hexosyl groups; IEA:InterPro
Q5I7T1	ALG10B	Putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q5I7T1	ALG10B	Putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q5I7T1	ALG10B	Putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q5I7T1	ALG10B	Putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q5T2P9	AGAP10	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 10	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q5T2P9	AGAP10	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 10	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5T2P9	AGAP10	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 10	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
C9J202	ALG1L2	Putative glycosyltransferase ALG1L2	GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW
Q8TF27	AGAP11	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 11	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q8TF27	AGAP11	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 11	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TF27	AGAP11	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 11	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
P06280	GLA	Alpha-galactosidase A	GO:0004557; F:alpha-galactosidase activity; IDA:UniProtKB
P06280	GLA	Alpha-galactosidase A	GO:0003824; F:catalytic activity; IDA:UniProtKB
P06280	GLA	Alpha-galactosidase A	GO:0016936; F:galactoside binding; IEA:Ensembl
P06280	GLA	Alpha-galactosidase A	GO:0016787; F:hydrolase activity; TAS:UniProtKB
P06280	GLA	Alpha-galactosidase A	GO:0005515; F:protein binding; IPI:UniProtKB
P06280	GLA	Alpha-galactosidase A	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P06280	GLA	Alpha-galactosidase A	GO:0052692; F:raffinose alpha-galactosidase activity; IEA:UniProtKB-EC
P06280	GLA	Alpha-galactosidase A	GO:0005102; F:receptor binding; IDA:UniProtKB
P06280	GLA	Alpha-galactosidase A	GO:0016139; P:glycoside catabolic process; IBA:RefGenome
P06280	GLA	Alpha-galactosidase A	GO:0046479; P:glycosphingolipid catabolic process; TAS:UniProtKB
P06280	GLA	Alpha-galactosidase A	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
P06280	GLA	Alpha-galactosidase A	GO:0046477; P:glycosylceramide catabolic process; ISS:UniProtKB
P06280	GLA	Alpha-galactosidase A	GO:0045019; P:negative regulation of nitric oxide biosynthetic process; ISS:UniProtKB
P06280	GLA	Alpha-galactosidase A	GO:0051001; P:negative regulation of nitric-oxide synthase activity; ISS:UniProtKB
P06280	GLA	Alpha-galactosidase A	GO:0009311; P:oligosaccharide metabolic process; IDA:UniProtKB
P06280	GLA	Alpha-galactosidase A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P06280	GLA	Alpha-galactosidase A	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q9UPQ3	AGAP1	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q9UPQ3	AGAP1	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9UPQ3	AGAP1	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1	GO:0005543; F:phospholipid binding; IDA:FlyBase
Q9UPQ3	AGAP1	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UPQ3	AGAP1	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9UPQ3	AGAP1	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
Q9UPQ3	AGAP1	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q99490	AGAP2	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q99490	AGAP2	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q99490	AGAP2	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q99490	AGAP2	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q99490	AGAP2	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2	GO:0007411; P:axon guidance; TAS:Reactome
Q99490	AGAP2	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2	GO:0043524; P:negative regulation of neuron apoptotic process; IGI:MGI
Q99490	AGAP2	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2	GO:0042177; P:negative regulation of protein catabolic process; IDA:MGI
Q99490	AGAP2	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q99490	AGAP2	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
Q99490	AGAP2	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q96P47	AGAP3	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q96P47	AGAP3	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q96P47	AGAP3	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3	GO:0003924; F:GTPase activity; IEA:Ensembl
Q96P47	AGAP3	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96P47	AGAP3	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3	GO:0034614; P:cellular response to reactive oxygen species; IEA:Ensembl
Q96P47	AGAP3	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q96P47	AGAP3	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3	GO:0000060; P:protein import into nucleus, translocation; IEA:Ensembl
Q96P47	AGAP3	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
Q96P47	AGAP3	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q96P64	AGAP4	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 4	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q96P64	AGAP4	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96P64	AGAP4	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 4	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
A6NIR3	AGAP5	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
A6NIR3	AGAP5	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5	GO:0008270; F:zinc ion binding; IEA:InterPro
A6NIR3	AGAP5	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
Q5VUJ5	AGAP7	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 7	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q5VUJ5	AGAP7	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 7	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5VUJ5	AGAP7	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 7	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
Q5VW22	AGAP6	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 6	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q5VW22	AGAP6	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 6	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5VW22	AGAP6	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 6	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
Q5SRD3	AGAP8	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 8	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q5SRD3	AGAP8	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 8	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5SRD3	AGAP8	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 8	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
Q5VTM2	AGAP9	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 9	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q5VTM2	AGAP9	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 9	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5VTM2	AGAP9	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 9	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
P52594	AGFG1	Arf-GAP domain and FG repeat-containing protein 1	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
P52594	AGFG1	Arf-GAP domain and FG repeat-containing protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P52594	AGFG1	Arf-GAP domain and FG repeat-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P52594	AGFG1	Arf-GAP domain and FG repeat-containing protein 1	GO:0003723; F:RNA binding; TAS:ProtInc
P52594	AGFG1	Arf-GAP domain and FG repeat-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
P52594	AGFG1	Arf-GAP domain and FG repeat-containing protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P52594	AGFG1	Arf-GAP domain and FG repeat-containing protein 1	GO:0006406; P:mRNA export from nucleus; TAS:ProtInc
P52594	AGFG1	Arf-GAP domain and FG repeat-containing protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P52594	AGFG1	Arf-GAP domain and FG repeat-containing protein 1	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
P52594	AGFG1	Arf-GAP domain and FG repeat-containing protein 1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
O95081	AGFG2	Arf-GAP domain and FG repeat-containing protein 2	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
O95081	AGFG2	Arf-GAP domain and FG repeat-containing protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
O95081	AGFG2	Arf-GAP domain and FG repeat-containing protein 2	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
Q8N302	AGGF1	Angiogenic factor with G patch and FHA domains 1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8N302	AGGF1	Angiogenic factor with G patch and FHA domains 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N302	AGGF1	Angiogenic factor with G patch and FHA domains 1	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q8N302	AGGF1	Angiogenic factor with G patch and FHA domains 1	GO:0007155; P:cell adhesion; IDA:UniProtKB
Q8N302	AGGF1	Angiogenic factor with G patch and FHA domains 1	GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB
Q8N302	AGGF1	Angiogenic factor with G patch and FHA domains 1	GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:UniProtKB
Q8N302	AGGF1	Angiogenic factor with G patch and FHA domains 1	GO:0006396; P:RNA processing; TAS:UniProtKB
Q8N302	AGGF1	Angiogenic factor with G patch and FHA domains 1	GO:0001570; P:vasculogenesis; TAS:UniProtKB
Q53H12	AGK	Acylglycerol kinase, mitochondrial	GO:0047620; F:acylglycerol kinase activity; IEA:UniProtKB-EC
Q53H12	AGK	Acylglycerol kinase, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q53H12	AGK	Acylglycerol kinase, mitochondrial	GO:0001729; F:ceramide kinase activity; IEA:Ensembl
Q53H12	AGK	Acylglycerol kinase, mitochondrial	GO:0004143; F:diacylglycerol kinase activity; IEA:UniProtKB-EC
Q53H12	AGK	Acylglycerol kinase, mitochondrial	GO:0003951; F:NAD+ kinase activity; IEA:InterPro
Q53H12	AGK	Acylglycerol kinase, mitochondrial	GO:0046513; P:ceramide biosynthetic process; IEA:Ensembl
Q53H12	AGK	Acylglycerol kinase, mitochondrial	GO:0046486; P:glycerolipid metabolic process; IEA:UniProtKB-UniPathway
Q53H12	AGK	Acylglycerol kinase, mitochondrial	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:InterPro
O95394	PGM3	Phosphoacetylglucosamine mutase	GO:0000287; F:magnesium ion binding; IEA:InterPro
O95394	PGM3	Phosphoacetylglucosamine mutase	GO:0004610; F:phosphoacetylglucosamine mutase activity; IDA:UniProtKB
O95394	PGM3	Phosphoacetylglucosamine mutase	GO:0004614; F:phosphoglucomutase activity; IEA:Ensembl
O95394	PGM3	Phosphoacetylglucosamine mutase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O95394	PGM3	Phosphoacetylglucosamine mutase	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
O95394	PGM3	Phosphoacetylglucosamine mutase	GO:0009790; P:embryo development; IEA:Ensembl
O95394	PGM3	Phosphoacetylglucosamine mutase	GO:0006041; P:glucosamine metabolic process; NAS:UniProtKB
O95394	PGM3	Phosphoacetylglucosamine mutase	GO:0019255; P:glucose 1-phosphate metabolic process; IEA:Ensembl
O95394	PGM3	Phosphoacetylglucosamine mutase	GO:0030097; P:hemopoiesis; IBA:RefGenome
O95394	PGM3	Phosphoacetylglucosamine mutase	GO:0043687; P:post-translational protein modification; TAS:Reactome
O95394	PGM3	Phosphoacetylglucosamine mutase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
O95394	PGM3	Phosphoacetylglucosamine mutase	GO:0007283; P:spermatogenesis; IEA:Ensembl
O95394	PGM3	Phosphoacetylglucosamine mutase	GO:0006048; P:UDP-N-acetylglucosamine biosynthetic process; IBA:RefGenome
Q9UL18	AGO1	Protein argonaute-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UL18	AGO1	Protein argonaute-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UL18	AGO1	Protein argonaute-1	GO:0003723; F:RNA binding; IDA:UniProtKB
Q9UL18	AGO1	Protein argonaute-1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q9UL18	AGO1	Protein argonaute-1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9UL18	AGO1	Protein argonaute-1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q9UL18	AGO1	Protein argonaute-1	GO:0010467; P:gene expression; TAS:Reactome
Q9UL18	AGO1	Protein argonaute-1	GO:0045087; P:innate immune response; TAS:Reactome
Q9UL18	AGO1	Protein argonaute-1	GO:0035278; P:negative regulation of translation involved in gene silencing by miRNA; IDA:UniProtKB
Q9UL18	AGO1	Protein argonaute-1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9UL18	AGO1	Protein argonaute-1	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q9UL18	AGO1	Protein argonaute-1	GO:0000956; P:nuclear-transcribed mRNA catabolic process; IDA:UniProtKB
Q9UL18	AGO1	Protein argonaute-1	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q9UL18	AGO1	Protein argonaute-1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UL18	AGO1	Protein argonaute-1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UKV8	AGO2	Protein argonaute-2	GO:0004521; F:endoribonuclease activity; EXP:Reactome
Q9UKV8	AGO2	Protein argonaute-2	GO:0070551; F:endoribonuclease activity, cleaving siRNA-paired mRNA; IDA:UniProtKB
Q9UKV8	AGO2	Protein argonaute-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UKV8	AGO2	Protein argonaute-2	GO:0035198; F:miRNA binding; IEA:UniProtKB-HAMAP
Q9UKV8	AGO2	Protein argonaute-2	GO:0003729; F:mRNA binding; IEA:Ensembl
Q9UKV8	AGO2	Protein argonaute-2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UKV8	AGO2	Protein argonaute-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKV8	AGO2	Protein argonaute-2	GO:0000340; F:RNA 7-methylguanosine cap binding; IDA:UniProtKB
Q9UKV8	AGO2	Protein argonaute-2	GO:0035197; F:siRNA binding; IDA:UniProtKB
Q9UKV8	AGO2	Protein argonaute-2	GO:0003743; F:translation initiation factor activity; NAS:UniProtKB
Q9UKV8	AGO2	Protein argonaute-2	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q9UKV8	AGO2	Protein argonaute-2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9UKV8	AGO2	Protein argonaute-2	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q9UKV8	AGO2	Protein argonaute-2	GO:0010467; P:gene expression; TAS:Reactome
Q9UKV8	AGO2	Protein argonaute-2	GO:0031047; P:gene silencing by RNA; ISS:UniProtKB
Q9UKV8	AGO2	Protein argonaute-2	GO:0045087; P:innate immune response; TAS:Reactome
Q9UKV8	AGO2	Protein argonaute-2	GO:0035279; P:mRNA cleavage involved in gene silencing by miRNA; IDA:UniProtKB
Q9UKV8	AGO2	Protein argonaute-2	GO:0035278; P:negative regulation of translation involved in gene silencing by miRNA; IDA:UniProtKB
Q9UKV8	AGO2	Protein argonaute-2	GO:0045947; P:negative regulation of translational initiation; IDA:UniProtKB
Q9UKV8	AGO2	Protein argonaute-2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9UKV8	AGO2	Protein argonaute-2	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q9UKV8	AGO2	Protein argonaute-2	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q9UKV8	AGO2	Protein argonaute-2	GO:1900153; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; ISS:UniProtKB
Q9UKV8	AGO2	Protein argonaute-2	GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; ISS:UniProtKB
Q9UKV8	AGO2	Protein argonaute-2	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q9UKV8	AGO2	Protein argonaute-2	GO:0031054; P:pre-miRNA processing; IDA:UniProtKB
Q9UKV8	AGO2	Protein argonaute-2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UKV8	AGO2	Protein argonaute-2	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; IDA:GOC
Q9UKV8	AGO2	Protein argonaute-2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UKV8	AGO2	Protein argonaute-2	GO:0006412; P:translation; NAS:UniProtKB
Q9UKV8	AGO2	Protein argonaute-2	GO:0006413; P:translational initiation; NAS:GOC
Q9HCK5	AGO4	Protein argonaute-4	GO:0035198; F:miRNA binding; IEA:UniProtKB-HAMAP
Q9HCK5	AGO4	Protein argonaute-4	GO:0005515; F:protein binding; IPI:IntAct
Q9HCK5	AGO4	Protein argonaute-4	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q9HCK5	AGO4	Protein argonaute-4	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9HCK5	AGO4	Protein argonaute-4	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q9HCK5	AGO4	Protein argonaute-4	GO:0010467; P:gene expression; TAS:Reactome
Q9HCK5	AGO4	Protein argonaute-4	GO:0045087; P:innate immune response; TAS:Reactome
Q9HCK5	AGO4	Protein argonaute-4	GO:0006402; P:mRNA catabolic process; IDA:UniProtKB
Q9HCK5	AGO4	Protein argonaute-4	GO:0035278; P:negative regulation of translation involved in gene silencing by miRNA; IDA:UniProtKB
Q9HCK5	AGO4	Protein argonaute-4	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9HCK5	AGO4	Protein argonaute-4	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q9HCK5	AGO4	Protein argonaute-4	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q9H9G7	AGO3	Protein argonaute-3	GO:0035198; F:miRNA binding; IEA:UniProtKB-HAMAP
Q9H9G7	AGO3	Protein argonaute-3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H9G7	AGO3	Protein argonaute-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H9G7	AGO3	Protein argonaute-3	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q9H9G7	AGO3	Protein argonaute-3	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9H9G7	AGO3	Protein argonaute-3	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q9H9G7	AGO3	Protein argonaute-3	GO:0010467; P:gene expression; TAS:Reactome
Q9H9G7	AGO3	Protein argonaute-3	GO:0045087; P:innate immune response; TAS:Reactome
Q9H9G7	AGO3	Protein argonaute-3	GO:0006402; P:mRNA catabolic process; IDA:UniProtKB
Q9H9G7	AGO3	Protein argonaute-3	GO:0035278; P:negative regulation of translation involved in gene silencing by miRNA; IDA:UniProtKB
Q9H9G7	AGO3	Protein argonaute-3	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9H9G7	AGO3	Protein argonaute-3	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q9H9G7	AGO3	Protein argonaute-3	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q9H9G7	AGO3	Protein argonaute-3	GO:0072091; P:regulation of stem cell proliferation; IMP:UniProtKB
O95994	AGR2	Anterior gradient protein 2 homolog	GO:0002162; F:dystroglycan binding; IDA:UniProtKB
O95994	AGR2	Anterior gradient protein 2 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
O95994	AGR2	Anterior gradient protein 2 homolog	GO:0060480; P:lung goblet cell differentiation; IEA:Ensembl
O95994	AGR2	Anterior gradient protein 2 homolog	GO:0070254; P:mucus secretion; ISS:UniProtKB
Q8TD06	AGR3	Anterior gradient protein 3 homolog	GO:0002162; F:dystroglycan binding; IDA:UniProtKB
Q8TD06	AGR3	Anterior gradient protein 3 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
O00468	AGRN	Agrin	GO:0030548; F:acetylcholine receptor regulator activity; IEA:Ensembl
O00468	AGRN	Agrin	GO:0005509; F:calcium ion binding; ISS:UniProtKB
O00468	AGRN	Agrin	GO:0035374; F:chondroitin sulfate binding; ISS:UniProtKB
O00468	AGRN	Agrin	GO:0002162; F:dystroglycan binding; ISS:UniProtKB
O00468	AGRN	Agrin	GO:0043395; F:heparan sulfate proteoglycan binding; ISS:UniProtKB
O00468	AGRN	Agrin	GO:0043236; F:laminin binding; TAS:UniProtKB
O00468	AGRN	Agrin	GO:0005515; F:protein binding; IPI:UniProtKB
O00468	AGRN	Agrin	GO:0033691; F:sialic acid binding; ISS:UniProtKB
O00468	AGRN	Agrin	GO:0005200; F:structural constituent of cytoskeleton; TAS:UniProtKB
O00468	AGRN	Agrin	GO:0007411; P:axon guidance; TAS:Reactome
O00468	AGRN	Agrin	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O00468	AGRN	Agrin	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
O00468	AGRN	Agrin	GO:0045162; P:clustering of voltage-gated sodium channels; TAS:UniProtKB
O00468	AGRN	Agrin	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O00468	AGRN	Agrin	GO:0007213; P:G-protein coupled acetylcholine receptor signaling pathway; TAS:UniProtKB
O00468	AGRN	Agrin	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
O00468	AGRN	Agrin	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
O00468	AGRN	Agrin	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O00468	AGRN	Agrin	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
O00468	AGRN	Agrin	GO:0045213; P:neurotransmitter receptor metabolic process; IEA:Ensembl
O00468	AGRN	Agrin	GO:0007603; P:phototransduction, visible light; TAS:Reactome
O00468	AGRN	Agrin	GO:0007009; P:plasma membrane organization; IEA:Ensembl
O00468	AGRN	Agrin	GO:0051491; P:positive regulation of filopodium assembly; ISS:UniProtKB
O00468	AGRN	Agrin	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
O00468	AGRN	Agrin	GO:0032321; P:positive regulation of Rho GTPase activity; ISS:UniProtKB
O00468	AGRN	Agrin	GO:0045887; P:positive regulation of synaptic growth at neuromuscular junction; ISS:UniProtKB
O00468	AGRN	Agrin	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
O00468	AGRN	Agrin	GO:0043113; P:receptor clustering; IDA:UniProtKB
O00468	AGRN	Agrin	GO:0001523; P:retinoid metabolic process; TAS:Reactome
O00468	AGRN	Agrin	GO:0007165; P:signal transduction; TAS:UniProtKB
O00468	AGRN	Agrin	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00468	AGRN	Agrin	GO:0050808; P:synapse organization; TAS:UniProtKB
O00253	AGRP	Agouti-related protein	GO:0005184; F:neuropeptide hormone activity; IDA:UniProtKB
O00253	AGRP	Agouti-related protein	GO:0005102; F:receptor binding; TAS:ProtInc
O00253	AGRP	Agouti-related protein	GO:0008343; P:adult feeding behavior; IEA:Ensembl
O00253	AGRP	Agouti-related protein	GO:0042755; P:eating behavior; IEA:Ensembl
O00253	AGRP	Agouti-related protein	GO:0007631; P:feeding behavior; TAS:ProtInc
O00253	AGRP	Agouti-related protein	GO:0009755; P:hormone-mediated signaling pathway; IEA:InterPro
O00253	AGRP	Agouti-related protein	GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
O00253	AGRP	Agouti-related protein	GO:0007218; P:neuropeptide signaling pathway; IDA:UniProtKB
O00253	AGRP	Agouti-related protein	GO:0009648; P:photoperiodism; IEA:Ensembl
O00253	AGRP	Agouti-related protein	GO:2000253; P:positive regulation of feeding behavior; IEA:Ensembl
O00253	AGRP	Agouti-related protein	GO:0060259; P:regulation of feeding behavior; IDA:UniProtKB
O00253	AGRP	Agouti-related protein	GO:0032868; P:response to insulin; IEA:Ensembl
Q9BYV1	AGXT2	Alanine--glyoxylate aminotransferase 2, mitochondrial	GO:0047305; F:(R)-3-amino-2-methylpropionate-pyruvate transaminase activity; IEA:UniProtKB-EC
Q9BYV1	AGXT2	Alanine--glyoxylate aminotransferase 2, mitochondrial	GO:0008453; F:alanine-glyoxylate transaminase activity; IDA:BHF-UCL
Q9BYV1	AGXT2	Alanine--glyoxylate aminotransferase 2, mitochondrial	GO:0016223; F:beta-alanine-pyruvate transaminase activity; IEA:Ensembl
Q9BYV1	AGXT2	Alanine--glyoxylate aminotransferase 2, mitochondrial	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q9BYV1	AGXT2	Alanine--glyoxylate aminotransferase 2, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9BYV1	AGXT2	Alanine--glyoxylate aminotransferase 2, mitochondrial	GO:0019265; P:glycine biosynthetic process, by transamination of glyoxylate; IDA:BHF-UCL
Q9BYV1	AGXT2	Alanine--glyoxylate aminotransferase 2, mitochondrial	GO:0009436; P:glyoxylate catabolic process; IDA:BHF-UCL
Q9BYV1	AGXT2	Alanine--glyoxylate aminotransferase 2, mitochondrial	GO:0046487; P:glyoxylate metabolic process; TAS:Reactome
Q9BYV1	AGXT2	Alanine--glyoxylate aminotransferase 2, mitochondrial	GO:0019481; P:L-alanine catabolic process, by transamination; IDA:BHF-UCL
Q9BYV1	AGXT2	Alanine--glyoxylate aminotransferase 2, mitochondrial	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q9BYV1	AGXT2	Alanine--glyoxylate aminotransferase 2, mitochondrial	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IDA:BHF-UCL
Q9BYV1	AGXT2	Alanine--glyoxylate aminotransferase 2, mitochondrial	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
Q9BYV1	AGXT2	Alanine--glyoxylate aminotransferase 2, mitochondrial	GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome
Q9BYV1	AGXT2	Alanine--glyoxylate aminotransferase 2, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0001596; F:angiotensin type I receptor activity; IDA:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0004945; F:angiotensin type II receptor activity; IDA:UniProtKB
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0031711; F:bradykinin receptor binding; IPI:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0038166; P:angiotensin-activated signaling pathway; IDA:GOC
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0019722; P:calcium-mediated signaling; IDA:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0060326; P:cell chemotaxis; IDA:UniProtKB
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0001822; P:kidney development; IMP:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0034374; P:low-density lipoprotein particle remodeling; NAS:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0086097; P:phospholipase C-activating angiotensin-activated signaling pathway; IDA:GOC
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; NAS:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0032270; P:positive regulation of cellular protein metabolic process; IMP:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0010873; P:positive regulation of cholesterol esterification; IMP:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0051482; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway; IDA:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0050729; P:positive regulation of inflammatory response; TAS:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; IC:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0033864; P:positive regulation of NAD(P)H oxidase activity; TAS:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0032430; P:positive regulation of phospholipase A2 activity; IMP:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; TAS:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0002034; P:regulation of blood vessel size by renin-angiotensin; IC:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0001558; P:regulation of cell growth; NAS:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0042127; P:regulation of cell proliferation; NAS:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0050727; P:regulation of inflammatory response; IC:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0035813; P:regulation of renal sodium excretion; NAS:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0003081; P:regulation of systemic arterial blood pressure by renin-angiotensin; IC:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0019229; P:regulation of vasoconstriction; IDA:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0042312; P:regulation of vasodilation; IC:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0002018; P:renin-angiotensin regulation of aldosterone production; NAS:BHF-UCL
P30556	AGTR1	Type-1 angiotensin II receptor	GO:0007266; P:Rho protein signal transduction; IDA:UniProtKB
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0004945; F:angiotensin type II receptor activity; IPI:BHF-UCL
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0017046; F:peptide hormone binding; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0005515; F:protein binding; IPI:IntAct
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0048019; F:receptor antagonist activity; TAS:BHF-UCL
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0035932; P:aldosterone secretion; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0038166; P:angiotensin-activated signaling pathway; IPI:GOC
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0007610; P:behavior; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0001974; P:blood vessel remodeling; TAS:BHF-UCL
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0007420; P:brain development; NAS:BHF-UCL
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0002035; P:brain renin-angiotensin system; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0061049; P:cell growth involved in cardiac muscle cell development; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0007166; P:cell surface receptor signaling pathway; IDA:BHF-UCL
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0071549; P:cellular response to dexamethasone stimulus; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0006883; P:cellular sodium ion homeostasis; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0021695; P:cerebellar cortex development; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0042416; P:dopamine biosynthetic process; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:1900116; P:extracellular negative regulation of signal transduction; TAS:GOC
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; IC:BHF-UCL
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0007199; P:G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger; ISS:BHF-UCL
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0006954; P:inflammatory response; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0035556; P:intracellular signal transduction; ISS:BHF-UCL
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0043537; P:negative regulation of blood vessel endothelial cell migration; NAS:BHF-UCL
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0030308; P:negative regulation of cell growth; TAS:BHF-UCL
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0048147; P:negative regulation of fibroblast proliferation; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0010459; P:negative regulation of heart rate; ISS:BHF-UCL
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0032304; P:negative regulation of icosanoid secretion; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0051387; P:negative regulation of neurotrophin TRK receptor signaling pathway; IMP:BHF-UCL
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0010700; P:negative regulation of norepinephrine secretion; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0007263; P:nitric oxide mediated signal transduction; TAS:BHF-UCL
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0050715; P:positive regulation of cytokine secretion; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IMP:BHF-UCL
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0072300; P:positive regulation of metanephric glomerulus development; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IC:BHF-UCL
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0051000; P:positive regulation of nitric-oxide synthase activity; ISS:BHF-UCL
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0032516; P:positive regulation of phosphoprotein phosphatase activity; IDA:BHF-UCL
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0035815; P:positive regulation of renal sodium excretion; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0045909; P:positive regulation of vasodilation; IDA:BHF-UCL
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0008217; P:regulation of blood pressure; TAS:ProtInc
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0035566; P:regulation of metanephros size; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0001991; P:regulation of systemic arterial blood pressure by circulatory renin-angiotensin; ISS:BHF-UCL
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0042990; P:regulation of transcription factor import into nucleus; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0002018; P:renin-angiotensin regulation of aldosterone production; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0010243; P:response to organonitrogen compound; IEA:Ensembl
P50052	AGTR2	Type-2 angiotensin II receptor	GO:0002033; P:vasodilation by angiotensin involved in regulation of systemic arterial blood pressure; IEA:Ensembl
Q5TGY3	AHDC1	AT-hook DNA-binding motif-containing protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N157	AHI1	Jouberin	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N157	AHI1	Jouberin	GO:0034613; P:cellular protein localization; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0007417; P:central nervous system development; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0060271; P:cilium morphogenesis; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0035844; P:cloaca development; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0001947; P:heart looping; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0030902; P:hindbrain development; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0070121; P:Kupffer's vesicle development; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0070986; P:left/right axis specification; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0001738; P:morphogenesis of a polarized epithelium; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0071599; P:otic vesicle development; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0035845; P:photoreceptor cell outer segment organization; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0030862; P:positive regulation of polarized epithelial cell differentiation; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0002092; P:positive regulation of receptor internalization; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0039023; P:pronephric duct morphogenesis; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0039008; P:pronephric nephron tubule morphogenesis; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0033365; P:protein localization to organelle; IEA:Ensembl
Q8N157	AHI1	Jouberin	GO:0050795; P:regulation of behavior; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0010842; P:retina layer formation; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0065001; P:specification of axis polarity; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; ISS:UniProtKB
Q8N157	AHI1	Jouberin	GO:0006903; P:vesicle targeting; IEA:Ensembl
Q8N157	AHI1	Jouberin	GO:0016192; P:vesicle-mediated transport; ISS:UniProtKB
Q8IVF2	AHNAK2	Protein AHNAK2	GO:0005515; F:protein binding; IPI:UniProt
Q09666	AHNAK	Neuroblast differentiation-associated protein AHNAK	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q09666	AHNAK	Neuroblast differentiation-associated protein AHNAK	GO:0005515; F:protein binding; IPI:UniProtKB
Q09666	AHNAK	Neuroblast differentiation-associated protein AHNAK	GO:0044548; F:S100 protein binding; IPI:UniProt
Q09666	AHNAK	Neuroblast differentiation-associated protein AHNAK	GO:0097493; F:structural molecule activity conferring elasticity; ISS:UniProt
Q09666	AHNAK	Neuroblast differentiation-associated protein AHNAK	GO:0051259; P:protein oligomerization; ISS:UniProt
Q09666	AHNAK	Neuroblast differentiation-associated protein AHNAK	GO:0043484; P:regulation of RNA splicing; ISS:UniProt
Q09666	AHNAK	Neuroblast differentiation-associated protein AHNAK	GO:1901385; P:regulation of voltage-gated calcium channel activity; IMP:UniProt
A9YTQ3	AHRR	Aryl hydrocarbon receptor repressor	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A9YTQ3	AHRR	Aryl hydrocarbon receptor repressor	GO:0004871; F:signal transducer activity; IEA:InterPro
A9YTQ3	AHRR	Aryl hydrocarbon receptor repressor	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
A9YTQ3	AHRR	Aryl hydrocarbon receptor repressor	GO:0033235; P:positive regulation of protein sumoylation; IEA:Ensembl
A9YTQ3	AHRR	Aryl hydrocarbon receptor repressor	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P35869	AHR	Aryl hydrocarbon receptor	GO:0003677; F:DNA binding; IDA:DFLAT
P35869	AHR	Aryl hydrocarbon receptor	GO:0035326; F:enhancer binding; IDA:MGI
P35869	AHR	Aryl hydrocarbon receptor	GO:0051879; F:Hsp90 protein binding; IDA:BHF-UCL
P35869	AHR	Aryl hydrocarbon receptor	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:UniProtKB
P35869	AHR	Aryl hydrocarbon receptor	GO:0005515; F:protein binding; IPI:IntAct
P35869	AHR	Aryl hydrocarbon receptor	GO:0046983; F:protein dimerization activity; TAS:DFLAT
P35869	AHR	Aryl hydrocarbon receptor	GO:0046982; F:protein heterodimerization activity; TAS:DFLAT
P35869	AHR	Aryl hydrocarbon receptor	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P35869	AHR	Aryl hydrocarbon receptor	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P35869	AHR	Aryl hydrocarbon receptor	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:MGI
P35869	AHR	Aryl hydrocarbon receptor	GO:0004871; F:signal transducer activity; IEA:InterPro
P35869	AHR	Aryl hydrocarbon receptor	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P35869	AHR	Aryl hydrocarbon receptor	GO:0044212; F:transcription regulatory region DNA binding; IDA:DFLAT
P35869	AHR	Aryl hydrocarbon receptor	GO:0006915; P:apoptotic process; TAS:UniProtKB
P35869	AHR	Aryl hydrocarbon receptor	GO:0001568; P:blood vessel development; NAS:DFLAT
P35869	AHR	Aryl hydrocarbon receptor	GO:0007049; P:cell cycle; TAS:UniProtKB
P35869	AHR	Aryl hydrocarbon receptor	GO:0030522; P:intracellular receptor signaling pathway; IDA:GOC
P35869	AHR	Aryl hydrocarbon receptor	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P35869	AHR	Aryl hydrocarbon receptor	GO:0045899; P:positive regulation of RNA polymerase II transcriptional preinitiation complex assembly; IEA:Ensembl
P35869	AHR	Aryl hydrocarbon receptor	GO:0030850; P:prostate gland development; IEA:Ensembl
P35869	AHR	Aryl hydrocarbon receptor	GO:0030888; P:regulation of B cell proliferation; IDA:DFLAT
P35869	AHR	Aryl hydrocarbon receptor	GO:0010468; P:regulation of gene expression; IDA:DFLAT
P35869	AHR	Aryl hydrocarbon receptor	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:DFLAT
P35869	AHR	Aryl hydrocarbon receptor	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
P35869	AHR	Aryl hydrocarbon receptor	GO:0006950; P:response to stress; IDA:UniProtKB
P35869	AHR	Aryl hydrocarbon receptor	GO:0009410; P:response to xenobiotic stimulus; IDA:UniProtKB
P35869	AHR	Aryl hydrocarbon receptor	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
P35869	AHR	Aryl hydrocarbon receptor	GO:0006805; P:xenobiotic metabolic process; TAS:DFLAT
O95433	AHSA1	Activator of 90 kDa heat shock protein ATPase homolog 1	GO:0001671; F:ATPase activator activity; IDA:MGI
O95433	AHSA1	Activator of 90 kDa heat shock protein ATPase homolog 1	GO:0051087; F:chaperone binding; IDA:MGI
O95433	AHSA1	Activator of 90 kDa heat shock protein ATPase homolog 1	GO:0005515; F:protein binding; IPI:UniProtKB
O95433	AHSA1	Activator of 90 kDa heat shock protein ATPase homolog 1	GO:0032781; P:positive regulation of ATPase activity; IDA:GOC
O95433	AHSA1	Activator of 90 kDa heat shock protein ATPase homolog 1	GO:0006950; P:response to stress; IEA:UniProtKB-KW
Q719I0	AHSA2	Activator of 90 kDa heat shock protein ATPase homolog 2	GO:0001671; F:ATPase activator activity; IEA:InterPro
Q719I0	AHSA2	Activator of 90 kDa heat shock protein ATPase homolog 2	GO:0006950; P:response to stress; IEA:UniProtKB-KW
Q9NZD4	AHSP	Alpha-hemoglobin-stabilizing protein	GO:0030492; F:hemoglobin binding; NAS:UniProtKB
Q9NZD4	AHSP	Alpha-hemoglobin-stabilizing protein	GO:0051082; F:unfolded protein binding; NAS:UniProtKB
Q9NZD4	AHSP	Alpha-hemoglobin-stabilizing protein	GO:0020027; P:hemoglobin metabolic process; NAS:UniProtKB
Q9NZD4	AHSP	Alpha-hemoglobin-stabilizing protein	GO:0030097; P:hemopoiesis; NAS:UniProtKB
Q9NZD4	AHSP	Alpha-hemoglobin-stabilizing protein	GO:0006457; P:protein folding; IEA:InterPro
Q9NZD4	AHSP	Alpha-hemoglobin-stabilizing protein	GO:0050821; P:protein stabilization; IEA:InterPro
Q9GZX7	AICDA	Single-stranded DNA cytosine deaminase	GO:0004126; F:cytidine deaminase activity; IDA:UniProtKB
Q9GZX7	AICDA	Single-stranded DNA cytosine deaminase	GO:0005515; F:protein binding; IPI:UniProtKB
Q9GZX7	AICDA	Single-stranded DNA cytosine deaminase	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9GZX7	AICDA	Single-stranded DNA cytosine deaminase	GO:0030183; P:B cell differentiation; NAS:UniProtKB
Q9GZX7	AICDA	Single-stranded DNA cytosine deaminase	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
Q9GZX7	AICDA	Single-stranded DNA cytosine deaminase	GO:0080111; P:DNA demethylation; IDA:UniProtKB
Q9GZX7	AICDA	Single-stranded DNA cytosine deaminase	GO:0045190; P:isotype switching; IEA:Ensembl
Q9GZX7	AICDA	Single-stranded DNA cytosine deaminase	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9GZX7	AICDA	Single-stranded DNA cytosine deaminase	GO:0090310; P:negative regulation of methylation-dependent chromatin silencing; IDA:UniProtKB
Q9GZX7	AICDA	Single-stranded DNA cytosine deaminase	GO:0016445; P:somatic diversification of immunoglobulins; IDA:UniProtKB
Q9GZX7	AICDA	Single-stranded DNA cytosine deaminase	GO:0016446; P:somatic hypermutation of immunoglobulin genes; IMP:UniProtKB
Q96BJ3	AIDA	Axin interactor, dorsalization-associated protein	GO:0009953; P:dorsal/ventral pattern formation; ISS:UniProtKB
Q96BJ3	AIDA	Axin interactor, dorsalization-associated protein	GO:0046329; P:negative regulation of JNK cascade; ISS:UniProtKB
Q96BJ3	AIDA	Axin interactor, dorsalization-associated protein	GO:0043508; P:negative regulation of JUN kinase activity; IDA:MGI
Q96BJ3	AIDA	Axin interactor, dorsalization-associated protein	GO:0043496; P:regulation of protein homodimerization activity; ISS:UniProtKB
Q9BQI0	AIF1L	Allograft inflammatory factor 1-like	GO:0051015; F:actin filament binding; IDA:UniProtKB
Q9BQI0	AIF1L	Allograft inflammatory factor 1-like	GO:0005509; F:calcium ion binding; IEA:InterPro
P55008	AIF1	Allograft inflammatory factor 1	GO:0051015; F:actin filament binding; IDA:UniProtKB
P55008	AIF1	Allograft inflammatory factor 1	GO:0005509; F:calcium ion binding; ISS:UniProtKB
P55008	AIF1	Allograft inflammatory factor 1	GO:0051017; P:actin filament bundle assembly; IDA:UniProtKB
P55008	AIF1	Allograft inflammatory factor 1	GO:0030041; P:actin filament polymerization; IDA:UniProtKB
P55008	AIF1	Allograft inflammatory factor 1	GO:0071346; P:cellular response to interferon-gamma; IEP:UniProtKB
P55008	AIF1	Allograft inflammatory factor 1	GO:0006954; P:inflammatory response; ISS:UniProtKB
P55008	AIF1	Allograft inflammatory factor 1	GO:0001774; P:microglial cell activation; NAS:UniProtKB
P55008	AIF1	Allograft inflammatory factor 1	GO:0071672; P:negative regulation of smooth muscle cell chemotaxis; IDA:UniProtKB
P55008	AIF1	Allograft inflammatory factor 1	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IDA:UniProtKB
P55008	AIF1	Allograft inflammatory factor 1	GO:0006911; P:phagocytosis, engulfment; ISS:UniProtKB
P55008	AIF1	Allograft inflammatory factor 1	GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IDA:UniProtKB
P55008	AIF1	Allograft inflammatory factor 1	GO:0090026; P:positive regulation of monocyte chemotaxis; IDA:UniProtKB
P55008	AIF1	Allograft inflammatory factor 1	GO:0071673; P:positive regulation of smooth muscle cell chemotaxis; IDA:UniProtKB
P55008	AIF1	Allograft inflammatory factor 1	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IDA:UniProtKB
P55008	AIF1	Allograft inflammatory factor 1	GO:2000406; P:positive regulation of T cell migration; IDA:UniProtKB
P55008	AIF1	Allograft inflammatory factor 1	GO:0042102; P:positive regulation of T cell proliferation; IDA:UniProtKB
P55008	AIF1	Allograft inflammatory factor 1	GO:0016601; P:Rac protein signal transduction; ISS:UniProtKB
P55008	AIF1	Allograft inflammatory factor 1	GO:0097178; P:ruffle assembly; ISS:UniProtKB
O95831	AIFM1	Apoptosis-inducing factor 1, mitochondrial	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O95831	AIFM1	Apoptosis-inducing factor 1, mitochondrial	GO:0009055; F:electron carrier activity; TAS:ProtInc
O95831	AIFM1	Apoptosis-inducing factor 1, mitochondrial	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
O95831	AIFM1	Apoptosis-inducing factor 1, mitochondrial	GO:0016174; F:NAD(P)H oxidase activity; TAS:UniProtKB
O95831	AIFM1	Apoptosis-inducing factor 1, mitochondrial	GO:0016651; F:oxidoreductase activity, acting on NAD(P)H; IDA:UniProtKB
O95831	AIFM1	Apoptosis-inducing factor 1, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
O95831	AIFM1	Apoptosis-inducing factor 1, mitochondrial	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
O95831	AIFM1	Apoptosis-inducing factor 1, mitochondrial	GO:0006309; P:apoptotic DNA fragmentation; TAS:ProtInc
O95831	AIFM1	Apoptosis-inducing factor 1, mitochondrial	GO:0006915; P:apoptotic process; IMP:UniProtKB
O95831	AIFM1	Apoptosis-inducing factor 1, mitochondrial	GO:0045454; P:cell redox homeostasis; IEA:InterPro
O95831	AIFM1	Apoptosis-inducing factor 1, mitochondrial	GO:0030261; P:chromosome condensation; TAS:UniProtKB
O95831	AIFM1	Apoptosis-inducing factor 1, mitochondrial	GO:0006308; P:DNA catabolic process; TAS:UniProtKB
O95831	AIFM1	Apoptosis-inducing factor 1, mitochondrial	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISS:UniProtKB
O95831	AIFM1	Apoptosis-inducing factor 1, mitochondrial	GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:UniProtKB
O95831	AIFM1	Apoptosis-inducing factor 1, mitochondrial	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
O95831	AIFM1	Apoptosis-inducing factor 1, mitochondrial	GO:0030182; P:neuron differentiation; IDA:UniProtKB
O95831	AIFM1	Apoptosis-inducing factor 1, mitochondrial	GO:0043065; P:positive regulation of apoptotic process; TAS:UniProtKB
Q9BRQ8	AIFM2	Apoptosis-inducing factor 2	GO:0003677; F:DNA binding; IDA:UniProtKB
Q9BRQ8	AIFM2	Apoptosis-inducing factor 2	GO:0004174; F:electron-transferring-flavoprotein dehydrogenase activity; IDA:UniProtKB
Q9BRQ8	AIFM2	Apoptosis-inducing factor 2	GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB
Q9BRQ8	AIFM2	Apoptosis-inducing factor 2	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; IBA:RefGenome
Q9BRQ8	AIFM2	Apoptosis-inducing factor 2	GO:0008637; P:apoptotic mitochondrial changes; IDA:MGI
Q9BRQ8	AIFM2	Apoptosis-inducing factor 2	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q96NN9	AIFM3	Apoptosis-inducing factor 3	GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:UniProtKB-KW
Q96NN9	AIFM3	Apoptosis-inducing factor 3	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q96NN9	AIFM3	Apoptosis-inducing factor 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96NN9	AIFM3	Apoptosis-inducing factor 3	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q96NN9	AIFM3	Apoptosis-inducing factor 3	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q96NN9	AIFM3	Apoptosis-inducing factor 3	GO:0097194; P:execution phase of apoptosis; IDA:BHF-UCL
Q9NVV5	AIG1	Androgen-induced gene 1 protein	GO:0005515; F:protein binding; IPI:IntAct
O14862	AIM2	Interferon-inducible protein AIM2	GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB
O14862	AIM2	Interferon-inducible protein AIM2	GO:0042802; F:identical protein binding; IPI:IntAct
O14862	AIM2	Interferon-inducible protein AIM2	GO:0005515; F:protein binding; IPI:UniProtKB
O14862	AIM2	Interferon-inducible protein AIM2	GO:0002218; P:activation of innate immune response; IDA:UniProtKB
O14862	AIM2	Interferon-inducible protein AIM2	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O14862	AIM2	Interferon-inducible protein AIM2	GO:0035690; P:cellular response to drug; IDA:MGI
O14862	AIM2	Interferon-inducible protein AIM2	GO:0035458; P:cellular response to interferon-beta; IEA:Ensembl
O14862	AIM2	Interferon-inducible protein AIM2	GO:0006955; P:immune response; TAS:ProtInc
O14862	AIM2	Interferon-inducible protein AIM2	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
O14862	AIM2	Interferon-inducible protein AIM2	GO:0045087; P:innate immune response; TAS:Reactome
O14862	AIM2	Interferon-inducible protein AIM2	GO:0050702; P:interleukin-1 beta secretion; IMP:MGI
O14862	AIM2	Interferon-inducible protein AIM2	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
O14862	AIM2	Interferon-inducible protein AIM2	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
O14862	AIM2	Interferon-inducible protein AIM2	GO:2001056; P:positive regulation of cysteine-type endopeptidase activity; IDA:UniProtKB
O14862	AIM2	Interferon-inducible protein AIM2	GO:0002230; P:positive regulation of defense response to virus by host; ISS:UniProtKB
O14862	AIM2	Interferon-inducible protein AIM2	GO:0032731; P:positive regulation of interleukin-1 beta production; IDA:UniProtKB
O14862	AIM2	Interferon-inducible protein AIM2	GO:0050718; P:positive regulation of interleukin-1 beta secretion; IDA:UniProtKB
O14862	AIM2	Interferon-inducible protein AIM2	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
O14862	AIM2	Interferon-inducible protein AIM2	GO:0032461; P:positive regulation of protein oligomerization; IDA:UniProtKB
O14862	AIM2	Interferon-inducible protein AIM2	GO:0070269; P:pyroptosis; IDA:UniProtKB
O14862	AIM2	Interferon-inducible protein AIM2	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IDA:UniProtKB
Q12904	AIMP1	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1	GO:0005125; F:cytokine activity; ISS:HGNC
Q12904	AIMP1	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q12904	AIMP1	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1	GO:0042803; F:protein homodimerization activity; IDA:HGNC
Q12904	AIMP1	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1	GO:0000049; F:tRNA binding; IDA:HGNC
Q12904	AIMP1	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q12904	AIMP1	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q12904	AIMP1	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q12904	AIMP1	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1	GO:0007267; P:cell-cell signaling; IDA:HGNC
Q12904	AIMP1	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1	GO:0006935; P:chemotaxis; TAS:ProtInc
Q12904	AIMP1	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1	GO:0010467; P:gene expression; TAS:Reactome
Q12904	AIMP1	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1	GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW
Q12904	AIMP1	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1	GO:0006954; P:inflammatory response; TAS:ProtInc
Q12904	AIMP1	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1	GO:0050900; P:leukocyte migration; IDA:HGNC
Q12904	AIMP1	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1	GO:0001937; P:negative regulation of endothelial cell proliferation; IDA:HGNC
Q12904	AIMP1	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1	GO:0009611; P:response to wounding; TAS:ProtInc
Q12904	AIMP1	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1	GO:0007165; P:signal transduction; NAS:ProtInc
Q12904	AIMP1	Aminoacyl tRNA synthase complex-interacting multifunctional protein 1	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q13155	AIMP2	Aminoacyl tRNA synthase complex-interacting multifunctional protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q13155	AIMP2	Aminoacyl tRNA synthase complex-interacting multifunctional protein 2	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q13155	AIMP2	Aminoacyl tRNA synthase complex-interacting multifunctional protein 2	GO:0010467; P:gene expression; TAS:Reactome
Q13155	AIMP2	Aminoacyl tRNA synthase complex-interacting multifunctional protein 2	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q13155	AIMP2	Aminoacyl tRNA synthase complex-interacting multifunctional protein 2	GO:0031398; P:positive regulation of protein ubiquitination; IEA:Ensembl
Q13155	AIMP2	Aminoacyl tRNA synthase complex-interacting multifunctional protein 2	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q13155	AIMP2	Aminoacyl tRNA synthase complex-interacting multifunctional protein 2	GO:0060510; P:Type II pneumocyte differentiation; IEA:Ensembl
Q16352	INA	Alpha-internexin	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
Q16352	INA	Alpha-internexin	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q16352	INA	Alpha-internexin	GO:0060052; P:neurofilament cytoskeleton organization; IEA:Ensembl
Q16352	INA	Alpha-internexin	GO:0021762; P:substantia nigra development; IEP:UniProt
Q9NZN9	AIPL1	Aryl-hydrocarbon-interacting protein-like 1	GO:0001918; F:farnesylated protein binding; IDA:MGI
Q9NZN9	AIPL1	Aryl-hydrocarbon-interacting protein-like 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NZN9	AIPL1	Aryl-hydrocarbon-interacting protein-like 1	GO:0051082; F:unfolded protein binding; TAS:ProtInc
Q9NZN9	AIPL1	Aryl-hydrocarbon-interacting protein-like 1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q9NZN9	AIPL1	Aryl-hydrocarbon-interacting protein-like 1	GO:0007603; P:phototransduction, visible light; IEA:Ensembl
Q9NZN9	AIPL1	Aryl-hydrocarbon-interacting protein-like 1	GO:0018343; P:protein farnesylation; IDA:MGI
Q9NZN9	AIPL1	Aryl-hydrocarbon-interacting protein-like 1	GO:0006457; P:protein folding; IEA:InterPro
Q9NZN9	AIPL1	Aryl-hydrocarbon-interacting protein-like 1	GO:0030823; P:regulation of cGMP metabolic process; IEA:Ensembl
Q9NZN9	AIPL1	Aryl-hydrocarbon-interacting protein-like 1	GO:0001895; P:retina homeostasis; IEA:Ensembl
Q9NZN9	AIPL1	Aryl-hydrocarbon-interacting protein-like 1	GO:0007601; P:visual perception; TAS:ProtInc
O00170	AIP	AH receptor-interacting protein	GO:0036004; F:GAF domain binding; IDA:UniProtKB
O00170	AIP	AH receptor-interacting protein	GO:0005515; F:protein binding; IPI:UniProtKB
O00170	AIP	AH receptor-interacting protein	GO:0004871; F:signal transducer activity; TAS:ProtInc
O00170	AIP	AH receptor-interacting protein	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
O00170	AIP	AH receptor-interacting protein	GO:0008134; F:transcription factor binding; TAS:ProtInc
O00170	AIP	AH receptor-interacting protein	GO:0051082; F:unfolded protein binding; IDA:HGNC
O00170	AIP	AH receptor-interacting protein	GO:0051344; P:negative regulation of cyclic-nucleotide phosphodiesterase activity; IEA:Ensembl
O00170	AIP	AH receptor-interacting protein	GO:0022417; P:protein maturation by protein folding; IDA:HGNC
O00170	AIP	AH receptor-interacting protein	GO:0006626; P:protein targeting to mitochondrion; IDA:HGNC
O00170	AIP	AH receptor-interacting protein	GO:0010738; P:regulation of protein kinase A signaling; IEA:Ensembl
O00170	AIP	AH receptor-interacting protein	GO:2001141; P:regulation of RNA biosynthetic process; TAS:GOC
O00170	AIP	AH receptor-interacting protein	GO:0007165; P:signal transduction; TAS:GOC
O00170	AIP	AH receptor-interacting protein	GO:0006805; P:xenobiotic metabolic process; IEA:Ensembl
O43918	AIRE	Autoimmune regulator	GO:0003682; F:chromatin binding; IDA:UniProtKB
O43918	AIRE	Autoimmune regulator	GO:0042393; F:histone binding; IDA:UniProtKB
O43918	AIRE	Autoimmune regulator	GO:0005515; F:protein binding; IPI:IntAct
O43918	AIRE	Autoimmune regulator	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
O43918	AIRE	Autoimmune regulator	GO:0045182; F:translation regulator activity; IEA:InterPro
O43918	AIRE	Autoimmune regulator	GO:0008270; F:zinc ion binding; IDA:UniProtKB
O43918	AIRE	Autoimmune regulator	GO:0006959; P:humoral immune response; IEA:Ensembl
O43918	AIRE	Autoimmune regulator	GO:0006955; P:immune response; TAS:ProtInc
O43918	AIRE	Autoimmune regulator	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O43918	AIRE	Autoimmune regulator	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O43918	AIRE	Autoimmune regulator	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
O43918	AIRE	Autoimmune regulator	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UKB5	AJAP1	Adherens junction-associated protein 1	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0045294; F:alpha-catenin binding; IDA:MGI
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0003682; F:chromatin binding; IEA:Ensembl
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0005515; F:protein binding; IPI:UniProtKB
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0016339; P:calcium-dependent cell-cell adhesion; IEA:Ensembl
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0034613; P:cellular protein localization; IEA:Ensembl
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0048041; P:focal adhesion assembly; IEA:Ensembl
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0035195; P:gene silencing by miRNA; IMP:MGI
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0046474; P:glycerophospholipid biosynthetic process; IEA:Ensembl
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0030032; P:lamellipodium assembly; IEA:Ensembl
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0035331; P:negative regulation of hippo signaling; IDA:UniProtKB
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0033673; P:negative regulation of kinase activity; IEA:Ensembl
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0031328; P:positive regulation of cellular biosynthetic process; IEA:Ensembl
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:2000637; P:positive regulation of gene silencing by miRNA; IMP:UniProtKB
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0043406; P:positive regulation of MAP kinase activity; IEA:Ensembl
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0031334; P:positive regulation of protein complex assembly; IDA:MGI
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0030334; P:regulation of cell migration; IEA:Ensembl
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:1900037; P:regulation of cellular response to hypoxia; IDA:UniProtKB
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0043087; P:regulation of GTPase activity; IEA:Ensembl
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0001666; P:response to hypoxia; IDA:UniProtKB
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96IF1	AJUBA	LIM domain-containing protein ajuba	GO:0035313; P:wound healing, spreading of epidermal cells; IEA:Ensembl
Q02040	AKAP17A	A-kinase anchor protein 17A	GO:0000166; F:nucleotide binding; IEA:InterPro
Q02040	AKAP17A	A-kinase anchor protein 17A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q02040	AKAP17A	A-kinase anchor protein 17A	GO:0005515; F:protein binding; IPI:IntAct
Q02040	AKAP17A	A-kinase anchor protein 17A	GO:0051018; F:protein kinase A binding; IDA:UniProtKB
Q02040	AKAP17A	A-kinase anchor protein 17A	GO:0042113; P:B cell activation; NAS:UniProtKB
Q02040	AKAP17A	A-kinase anchor protein 17A	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q02040	AKAP17A	A-kinase anchor protein 17A	GO:0043484; P:regulation of RNA splicing; IMP:UniProtKB
Q02040	AKAP17A	A-kinase anchor protein 17A	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q02040	AKAP17A	A-kinase anchor protein 17A	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q02040	AKAP17A	A-kinase anchor protein 17A	GO:0007165; P:signal transduction; NAS:UniProtKB
P14550	AKR1A1	Alcohol dehydrogenase [NADP(+)]	GO:0004032; F:alditol:NADP+ 1-oxidoreductase activity; TAS:ProtInc
P14550	AKR1A1	Alcohol dehydrogenase [NADP(+)]	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P14550	AKR1A1	Alcohol dehydrogenase [NADP(+)]	GO:0047939; F:L-glucuronate reductase activity; IEA:Ensembl
P14550	AKR1A1	Alcohol dehydrogenase [NADP(+)]	GO:0046185; P:aldehyde catabolic process; IEA:Ensembl
P14550	AKR1A1	Alcohol dehydrogenase [NADP(+)]	GO:0006081; P:cellular aldehyde metabolic process; TAS:ProtInc
P14550	AKR1A1	Alcohol dehydrogenase [NADP(+)]	GO:0042840; P:D-glucuronate catabolic process; IEA:Ensembl
P14550	AKR1A1	Alcohol dehydrogenase [NADP(+)]	GO:0006006; P:glucose metabolic process; TAS:ProtInc
P14550	AKR1A1	Alcohol dehydrogenase [NADP(+)]	GO:0019853; P:L-ascorbic acid biosynthetic process; IEA:Ensembl
O60218	AKR1B10	Aldo-keto reductase family 1 member B10	GO:0004033; F:aldo-keto reductase (NADP) activity; TAS:UniProtKB
O60218	AKR1B10	Aldo-keto reductase family 1 member B10	GO:0045550; F:geranylgeranyl reductase activity; IDA:UniProtKB
O60218	AKR1B10	Aldo-keto reductase family 1 member B10	GO:0047718; F:indanol dehydrogenase activity; IDA:UniProtKB
O60218	AKR1B10	Aldo-keto reductase family 1 member B10	GO:0005515; F:protein binding; IPI:IntAct
O60218	AKR1B10	Aldo-keto reductase family 1 member B10	GO:0001758; F:retinal dehydrogenase activity; IDA:UniProtKB
O60218	AKR1B10	Aldo-keto reductase family 1 member B10	GO:0006081; P:cellular aldehyde metabolic process; TAS:ProtInc
O60218	AKR1B10	Aldo-keto reductase family 1 member B10	GO:0044597; P:daunorubicin metabolic process; IMP:UniProtKB
O60218	AKR1B10	Aldo-keto reductase family 1 member B10	GO:0007586; P:digestion; TAS:ProtInc
O60218	AKR1B10	Aldo-keto reductase family 1 member B10	GO:0044598; P:doxorubicin metabolic process; IMP:UniProtKB
O60218	AKR1B10	Aldo-keto reductase family 1 member B10	GO:0016488; P:farnesol catabolic process; IDA:UniProtKB
O60218	AKR1B10	Aldo-keto reductase family 1 member B10	GO:0007603; P:phototransduction, visible light; TAS:Reactome
O60218	AKR1B10	Aldo-keto reductase family 1 member B10	GO:0001523; P:retinoid metabolic process; TAS:Reactome
O60218	AKR1B10	Aldo-keto reductase family 1 member B10	GO:0008202; P:steroid metabolic process; TAS:ProtInc
C9JRZ8	AKR1B15	Aldo-keto reductase family 1 member B15	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0047006; F:17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity; IEA:UniProtKB-EC
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0004032; F:alditol:NADP+ 1-oxidoreductase activity; IDA:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0004033; F:aldo-keto reductase (NADP) activity; TAS:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0047042; F:androsterone dehydrogenase (B-specific) activity; IDA:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0032052; F:bile acid binding; IDA:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0031406; F:carboxylic acid binding; IDA:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0047718; F:indanol dehydrogenase activity; IEA:UniProtKB-EC
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0047086; F:ketosteroid monooxygenase activity; IDA:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0016655; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; IDA:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0018636; F:phenanthrene 9,10-monooxygenase activity; IDA:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0047115; F:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity; IDA:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0015721; P:bile acid and bile salt transport; TAS:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0008206; P:bile acid metabolic process; IDA:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0071395; P:cellular response to jasmonic acid stimulus; IDA:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0042632; P:cholesterol homeostasis; TAS:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0044597; P:daunorubicin metabolic process; IMP:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0007586; P:digestion; IDA:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0044598; P:doxorubicin metabolic process; IMP:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0030855; P:epithelial cell differentiation; IDA:UniProt
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0030299; P:intestinal cholesterol absorption; TAS:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0007603; P:phototransduction, visible light; TAS:Reactome
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0042448; P:progesterone metabolic process; IDA:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0046683; P:response to organophosphorus; IEP:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0042574; P:retinal metabolic process; IDA:UniProtKB
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0001523; P:retinoid metabolic process; TAS:Reactome
Q04828	AKR1C1	Aldo-keto reductase family 1 member C1	GO:0006805; P:xenobiotic metabolic process; NAS:UniProtKB
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0004032; F:alditol:NADP+ 1-oxidoreductase activity; IDA:UniProtKB
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0032052; F:bile acid binding; IDA:UniProtKB
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0031406; F:carboxylic acid binding; IDA:UniProtKB
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0047086; F:ketosteroid monooxygenase activity; IDA:UniProtKB
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0016655; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; IDA:UniProtKB
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0018636; F:phenanthrene 9,10-monooxygenase activity; IDA:UniProtKB
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0004958; F:prostaglandin F receptor activity; IDA:UniProtKB
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0047115; F:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity; IDA:UniProtKB
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0071395; P:cellular response to jasmonic acid stimulus; IDA:UniProtKB
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0044597; P:daunorubicin metabolic process; IMP:UniProtKB
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0007586; P:digestion; IDA:UniProtKB
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0044598; P:doxorubicin metabolic process; IMP:UniProtKB
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:UniProtKB
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:UniProtKB
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0042448; P:progesterone metabolic process; IDA:UniProtKB
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0006693; P:prostaglandin metabolic process; IDA:UniProtKB
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0034694; P:response to prostaglandin; IDA:UniProtKB
P52895	AKR1C2	Aldo-keto reductase family 1 member C2	GO:0008202; P:steroid metabolic process; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0047020; F:15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0004032; F:alditol:NADP+ 1-oxidoreductase activity; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0004033; F:aldo-keto reductase (NADP) activity; TAS:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0047023; F:androsterone dehydrogenase activity; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0047787; F:delta4-3-oxosteroid 5beta-reductase activity; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0035410; F:dihydrotestosterone 17-beta-dehydrogenase activity; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0045550; F:geranylgeranyl reductase activity; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0047718; F:indanol dehydrogenase activity; IEA:UniProtKB-EC
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0045703; F:ketoreductase activity; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0047086; F:ketosteroid monooxygenase activity; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0016655; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0018636; F:phenanthrene 9,10-monooxygenase activity; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0036131; F:prostaglandin D2 11-ketoreductase activity; IEA:UniProtKB-EC
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0004958; F:prostaglandin F receptor activity; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0047017; F:prostaglandin-F synthase activity; IEA:UniProtKB-EC
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0001758; F:retinal dehydrogenase activity; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0004745; F:retinol dehydrogenase activity; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0047045; F:testosterone 17-beta-dehydrogenase (NADP+) activity; IEA:UniProtKB-EC
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0047035; F:testosterone dehydrogenase (NAD+) activity; IEA:UniProtKB-EC
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0047115; F:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity; IEA:UniProtKB-EC
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0071276; P:cellular response to cadmium ion; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0071277; P:cellular response to calcium ion; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0071384; P:cellular response to corticosteroid stimulus; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0071395; P:cellular response to jasmonic acid stimulus; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0071379; P:cellular response to prostaglandin stimulus; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0034614; P:cellular response to reactive oxygen species; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0009267; P:cellular response to starvation; IEP:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0019371; P:cyclooxygenase pathway; TAS:Reactome
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0044597; P:daunorubicin metabolic process; IMP:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0044598; P:doxorubicin metabolic process; IMP:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0016488; P:farnesol catabolic process; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0030216; P:keratinocyte differentiation; IEP:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0008584; P:male gonad development; IEP:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0044259; P:multicellular organismal macromolecule metabolic process; IEP:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:1900053; P:negative regulation of retinoic acid biosynthetic process; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0010942; P:positive regulation of cell death; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:2000353; P:positive regulation of endothelial cell apoptotic process; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0042448; P:progesterone metabolic process; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0006693; P:prostaglandin metabolic process; IEP:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0000060; P:protein import into nucleus, translocation; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0048385; P:regulation of retinoic acid receptor signaling pathway; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:2000224; P:regulation of testosterone biosynthetic process; IMP:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0070293; P:renal absorption; NAS:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0007584; P:response to nutrient; IEP:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0034694; P:response to prostaglandin; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0042574; P:retinal metabolic process; IDA:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0008202; P:steroid metabolic process; IEP:UniProtKB
P42330	AKR1C3	Aldo-keto reductase family 1 member C3	GO:0061370; P:testosterone biosynthetic process; IMP:UniProtKB
P17516	AKR1C4	Aldo-keto reductase family 1 member C4	GO:0004033; F:aldo-keto reductase (NADP) activity; TAS:ProtInc
P17516	AKR1C4	Aldo-keto reductase family 1 member C4	GO:0047023; F:androsterone dehydrogenase activity; IDA:UniProtKB
P17516	AKR1C4	Aldo-keto reductase family 1 member C4	GO:0015125; F:bile acid transmembrane transporter activity; TAS:ProtInc
P17516	AKR1C4	Aldo-keto reductase family 1 member C4	GO:0047743; F:chlordecone reductase activity; IEA:UniProtKB-EC
P17516	AKR1C4	Aldo-keto reductase family 1 member C4	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P17516	AKR1C4	Aldo-keto reductase family 1 member C4	GO:0016655; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; IDA:UniProtKB
P17516	AKR1C4	Aldo-keto reductase family 1 member C4	GO:0001758; F:retinal dehydrogenase activity; IDA:UniProtKB
P17516	AKR1C4	Aldo-keto reductase family 1 member C4	GO:0008209; P:androgen metabolic process; TAS:ProtInc
P17516	AKR1C4	Aldo-keto reductase family 1 member C4	GO:0015721; P:bile acid and bile salt transport; TAS:ProtInc
P17516	AKR1C4	Aldo-keto reductase family 1 member C4	GO:0006699; P:bile acid biosynthetic process; TAS:Reactome
P17516	AKR1C4	Aldo-keto reductase family 1 member C4	GO:0008206; P:bile acid metabolic process; TAS:Reactome
P17516	AKR1C4	Aldo-keto reductase family 1 member C4	GO:0071395; P:cellular response to jasmonic acid stimulus; IDA:UniProtKB
P17516	AKR1C4	Aldo-keto reductase family 1 member C4	GO:0044597; P:daunorubicin metabolic process; IMP:UniProtKB
P17516	AKR1C4	Aldo-keto reductase family 1 member C4	GO:0044598; P:doxorubicin metabolic process; IMP:UniProtKB
P17516	AKR1C4	Aldo-keto reductase family 1 member C4	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P17516	AKR1C4	Aldo-keto reductase family 1 member C4	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P17516	AKR1C4	Aldo-keto reductase family 1 member C4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P17516	AKR1C4	Aldo-keto reductase family 1 member C4	GO:0008202; P:steroid metabolic process; TAS:ProtInc
P51857	AKR1D1	3-oxo-5-beta-steroid 4-dehydrogenase	GO:0047787; F:delta4-3-oxosteroid 5beta-reductase activity; IEA:UniProtKB-EC
P51857	AKR1D1	3-oxo-5-beta-steroid 4-dehydrogenase	GO:0005496; F:steroid binding; TAS:UniProtKB
P51857	AKR1D1	3-oxo-5-beta-steroid 4-dehydrogenase	GO:0008209; P:androgen metabolic process; IDA:UniProtKB
P51857	AKR1D1	3-oxo-5-beta-steroid 4-dehydrogenase	GO:0006699; P:bile acid biosynthetic process; IDA:UniProtKB
P51857	AKR1D1	3-oxo-5-beta-steroid 4-dehydrogenase	GO:0030573; P:bile acid catabolic process; IEA:UniProtKB-KW
P51857	AKR1D1	3-oxo-5-beta-steroid 4-dehydrogenase	GO:0008206; P:bile acid metabolic process; TAS:Reactome
P51857	AKR1D1	3-oxo-5-beta-steroid 4-dehydrogenase	GO:0008207; P:C21-steroid hormone metabolic process; IDA:UniProtKB
P51857	AKR1D1	3-oxo-5-beta-steroid 4-dehydrogenase	GO:0006707; P:cholesterol catabolic process; IDA:UniProtKB
P51857	AKR1D1	3-oxo-5-beta-steroid 4-dehydrogenase	GO:0007586; P:digestion; IDA:UniProtKB
P51857	AKR1D1	3-oxo-5-beta-steroid 4-dehydrogenase	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
P51857	AKR1D1	3-oxo-5-beta-steroid 4-dehydrogenase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43572	AKAP10	A-kinase anchor protein 10, mitochondrial	GO:0007596; P:blood coagulation; TAS:Reactome
O43572	AKAP10	A-kinase anchor protein 10, mitochondrial	GO:0008104; P:protein localization; TAS:ProtInc
O43572	AKAP10	A-kinase anchor protein 10, mitochondrial	GO:0007165; P:signal transduction; TAS:ProtInc
O43572	AKAP10	A-kinase anchor protein 10, mitochondrial	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
Q9UKA4	AKAP11	A-kinase anchor protein 11	GO:0051018; F:protein kinase A binding; TAS:ProtInc
Q9UKA4	AKAP11	A-kinase anchor protein 11	GO:0008157; F:protein phosphatase 1 binding; TAS:ProtInc
Q9UKA4	AKAP11	A-kinase anchor protein 11	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
Q02952	AKAP12	A-kinase anchor protein 12	GO:0008179; F:adenylate cyclase binding; IPI:UniProtKB
Q02952	AKAP12	A-kinase anchor protein 12	GO:0005515; F:protein binding; IPI:IntAct
Q02952	AKAP12	A-kinase anchor protein 12	GO:0051018; F:protein kinase A binding; TAS:ProtInc
Q02952	AKAP12	A-kinase anchor protein 12	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q02952	AKAP12	A-kinase anchor protein 12	GO:0030819; P:positive regulation of cAMP biosynthetic process; IMP:UniProtKB
Q02952	AKAP12	A-kinase anchor protein 12	GO:0010739; P:positive regulation of protein kinase A signaling; IMP:UniProtKB
Q02952	AKAP12	A-kinase anchor protein 12	GO:0006605; P:protein targeting; IEA:InterPro
Q02952	AKAP12	A-kinase anchor protein 12	GO:0090036; P:regulation of protein kinase C signaling; IEA:InterPro
Q86UN6	AKAP14	A-kinase anchor protein 14	GO:0007283; P:spermatogenesis; IEA:Ensembl
O43687	AKAP7	A-kinase anchor protein 7 isoforms alpha and beta	GO:0051018; F:protein kinase A binding; IDA:UniProtKB
O43687	AKAP7	A-kinase anchor protein 7 isoforms alpha and beta	GO:0001508; P:action potential; IC:BHF-UCL
O43687	AKAP7	A-kinase anchor protein 7 isoforms alpha and beta	GO:0071320; P:cellular response to cAMP; IDA:BHF-UCL
O43687	AKAP7	A-kinase anchor protein 7 isoforms alpha and beta	GO:0035556; P:intracellular signal transduction; TAS:UniProtKB
O43687	AKAP7	A-kinase anchor protein 7 isoforms alpha and beta	GO:0006811; P:ion transport; TAS:ProtInc
O43687	AKAP7	A-kinase anchor protein 7 isoforms alpha and beta	GO:1902261; P:positive regulation of delayed rectifier potassium channel activity; IDA:BHF-UCL
O43687	AKAP7	A-kinase anchor protein 7 isoforms alpha and beta	GO:1901381; P:positive regulation of potassium ion transmembrane transport; IDA:BHF-UCL
O43687	AKAP7	A-kinase anchor protein 7 isoforms alpha and beta	GO:0008104; P:protein localization; IC:UniProtKB
O43687	AKAP7	A-kinase anchor protein 7 isoforms alpha and beta	GO:0060306; P:regulation of membrane repolarization; IDA:BHF-UCL
Q9P0M2	AKAP7	A-kinase anchor protein 7 isoform gamma	GO:0003824; F:catalytic activity; IEA:InterPro
Q9P0M2	AKAP7	A-kinase anchor protein 7 isoform gamma	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
Q9P0M2	AKAP7	A-kinase anchor protein 7 isoform gamma	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P0M2	AKAP7	A-kinase anchor protein 7 isoform gamma	GO:0051018; F:protein kinase A binding; IDA:UniProtKB
Q92667	AKAP1	A-kinase anchor protein 1, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q92667	AKAP1	A-kinase anchor protein 1, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q92667	AKAP1	A-kinase anchor protein 1, mitochondrial	GO:0003723; F:RNA binding; TAS:ProtInc
Q92667	AKAP1	A-kinase anchor protein 1, mitochondrial	GO:0007596; P:blood coagulation; TAS:Reactome
O75969	AKAP3	A-kinase anchor protein 3	GO:0005515; F:protein binding; IPI:IntAct
O75969	AKAP3	A-kinase anchor protein 3	GO:0051018; F:protein kinase A binding; TAS:ProtInc
O75969	AKAP3	A-kinase anchor protein 3	GO:0007340; P:acrosome reaction; TAS:ProtInc
O75969	AKAP3	A-kinase anchor protein 3	GO:0006928; P:cellular component movement; TAS:ProtInc
O75969	AKAP3	A-kinase anchor protein 3	GO:0008104; P:protein localization; IEA:Ensembl
O75969	AKAP3	A-kinase anchor protein 3	GO:0007338; P:single fertilization; TAS:ProtInc
O75969	AKAP3	A-kinase anchor protein 3	GO:0007178; P:transmembrane receptor protein serine/threonine kinase signaling pathway; IEA:Ensembl
Q5JQC9	AKAP4	A-kinase anchor protein 4	GO:0051018; F:protein kinase A binding; ISS:UniProtKB
Q5JQC9	AKAP4	A-kinase anchor protein 4	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
Q5JQC9	AKAP4	A-kinase anchor protein 4	GO:0006928; P:cellular component movement; TAS:ProtInc
Q5JQC9	AKAP4	A-kinase anchor protein 4	GO:0008104; P:protein localization; IEA:Ensembl
Q5JQC9	AKAP4	A-kinase anchor protein 4	GO:0007165; P:signal transduction; TAS:ProtInc
Q5JQC9	AKAP4	A-kinase anchor protein 4	GO:0007338; P:single fertilization; TAS:ProtInc
Q5JQC9	AKAP4	A-kinase anchor protein 4	GO:0030317; P:sperm motility; IMP:UniProtKB
Q5JQC9	AKAP4	A-kinase anchor protein 4	GO:0007178; P:transmembrane receptor protein serine/threonine kinase signaling pathway; IEA:Ensembl
P24588	AKAP5	A-kinase anchor protein 5	GO:0008179; F:adenylate cyclase binding; IPI:UniProtKB
P24588	AKAP5	A-kinase anchor protein 5	GO:0005515; F:protein binding; IPI:IntAct
P24588	AKAP5	A-kinase anchor protein 5	GO:0051018; F:protein kinase A binding; TAS:ProtInc
P24588	AKAP5	A-kinase anchor protein 5	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P24588	AKAP5	A-kinase anchor protein 5	GO:0030819; P:positive regulation of cAMP biosynthetic process; IMP:UniProtKB
P24588	AKAP5	A-kinase anchor protein 5	GO:0010739; P:positive regulation of protein kinase A signaling; IMP:UniProtKB
P24588	AKAP5	A-kinase anchor protein 5	GO:0006605; P:protein targeting; IEA:InterPro
P24588	AKAP5	A-kinase anchor protein 5	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P24588	AKAP5	A-kinase anchor protein 5	GO:0007165; P:signal transduction; NAS:ProtInc
P24588	AKAP5	A-kinase anchor protein 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P24588	AKAP5	A-kinase anchor protein 5	GO:0007268; P:synaptic transmission; TAS:Reactome
Q13023	AKAP6	A-kinase anchor protein 6	GO:0008179; F:adenylate cyclase binding; ISS:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:0043495; F:protein anchor; ISS:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q13023	AKAP6	A-kinase anchor protein 6	GO:0032947; F:protein complex scaffold; ISS:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:0051018; F:protein kinase A binding; NAS:UniProtKB
Q13023	AKAP6	A-kinase anchor protein 6	GO:0034237; F:protein kinase A regulatory subunit binding; ISS:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:0001508; P:action potential; IC:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:0019933; P:cAMP-mediated signaling; NAS:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:0071320; P:cellular response to cAMP; IDA:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:0071345; P:cellular response to cytokine stimulus; ISS:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:0030818; P:negative regulation of cAMP biosynthetic process; ISS:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:0070886; P:positive regulation of calcineurin-NFAT signaling cascade; ISS:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:0030307; P:positive regulation of cell growth; ISS:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:0061051; P:positive regulation of cell growth involved in cardiac muscle cell development; ISS:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:1902261; P:positive regulation of delayed rectifier potassium channel activity; IDA:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:0051533; P:positive regulation of NFAT protein import into nucleus; ISS:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:1901381; P:positive regulation of potassium ion transmembrane transport; IDA:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:0032514; P:positive regulation of protein phosphatase type 2B activity; ISS:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; ISS:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:0060316; P:positive regulation of ryanodine-sensitive calcium-release channel activity; ISS:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:0006605; P:protein targeting; NAS:UniProtKB
Q13023	AKAP6	A-kinase anchor protein 6	GO:0060306; P:regulation of membrane repolarization; IDA:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:0010738; P:regulation of protein kinase A signaling; ISS:BHF-UCL
Q13023	AKAP6	A-kinase anchor protein 6	GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; IC:BHF-UCL
O43823	AKAP8	A-kinase anchor protein 8	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
O43823	AKAP8	A-kinase anchor protein 8	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O43823	AKAP8	A-kinase anchor protein 8	GO:0008270; F:zinc ion binding; IEA:Ensembl
O43823	AKAP8	A-kinase anchor protein 8	GO:0007067; P:mitosis; TAS:ProtInc
O43823	AKAP8	A-kinase anchor protein 8	GO:0007076; P:mitotic chromosome condensation; IEA:Ensembl
O43823	AKAP8	A-kinase anchor protein 8	GO:0007165; P:signal transduction; TAS:ProtInc
Q99996	AKAP9	A-kinase anchor protein 9	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q99996	AKAP9	A-kinase anchor protein 9	GO:0005515; F:protein binding; IPI:UniProtKB
Q99996	AKAP9	A-kinase anchor protein 9	GO:0032947; F:protein complex scaffold; IDA:BHF-UCL
Q99996	AKAP9	A-kinase anchor protein 9	GO:0005102; F:receptor binding; TAS:ProtInc
Q99996	AKAP9	A-kinase anchor protein 9	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q99996	AKAP9	A-kinase anchor protein 9	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q99996	AKAP9	A-kinase anchor protein 9	GO:0007165; P:signal transduction; TAS:ProtInc
Q99996	AKAP9	A-kinase anchor protein 9	GO:0007268; P:synaptic transmission; TAS:Reactome
Q99996	AKAP9	A-kinase anchor protein 9	GO:0006810; P:transport; TAS:ProtInc
Q5T2L2	AKR1CL1	Aldo-keto reductase family 1 member C-like protein 1	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q96JD6	AKR1E2	1,5-anhydro-D-fructose reductase	GO:0050571; F:1,5-anhydro-D-fructose reductase activity; IEA:UniProtKB-EC
A6NHY2	ANKDD1B	Ankyrin repeat and death domain-containing protein 1B	GO:0007165; P:signal transduction; IEA:InterPro
Q495B1	ANKDD1A	Ankyrin repeat and death domain-containing protein 1A	GO:0007165; P:signal transduction; IEA:InterPro
Q9P2G1	ANKIB1	Ankyrin repeat and IBR domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9P2G1	ANKIB1	Ankyrin repeat and IBR domain-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NQ31	AKIP1	A-kinase-interacting protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NQ31	AKIP1	A-kinase-interacting protein 1	GO:0034446; P:substrate adhesion-dependent cell spreading; IEA:Ensembl
Q9NWT8	AURKAIP1	Aurora kinase A-interacting protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NWT8	AURKAIP1	Aurora kinase A-interacting protein	GO:0045839; P:negative regulation of mitosis; NAS:UniProtKB
Q9NWT8	AURKAIP1	Aurora kinase A-interacting protein	GO:0045862; P:positive regulation of proteolysis; IDA:MGI
Q53H80	AKIRIN2	Akirin-2	GO:0009790; P:embryo development; IEA:Ensembl
Q53H80	AKIRIN2	Akirin-2	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q53H80	AKIRIN2	Akirin-2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q53H80	AKIRIN2	Akirin-2	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q53H80	AKIRIN2	Akirin-2	GO:0010950; P:positive regulation of endopeptidase activity; IEA:Ensembl
Q53H80	AKIRIN2	Akirin-2	GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl
Q53H80	AKIRIN2	Akirin-2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q53H80	AKIRIN2	Akirin-2	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
Q53H80	AKIRIN2	Akirin-2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z591	AKNA	AT-hook-containing transcription factor	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7Z591	AKNA	AT-hook-containing transcription factor	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z591	AKNA	AT-hook-containing transcription factor	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q12802	AKAP13	A-kinase anchor protein 13	GO:0004691; F:cAMP-dependent protein kinase activity; NAS:UniProtKB
Q12802	AKAP13	A-kinase anchor protein 13	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q12802	AKAP13	A-kinase anchor protein 13	GO:0005515; F:protein binding; IPI:IntAct
Q12802	AKAP13	A-kinase anchor protein 13	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q12802	AKAP13	A-kinase anchor protein 13	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q12802	AKAP13	A-kinase anchor protein 13	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q12802	AKAP13	A-kinase anchor protein 13	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q12802	AKAP13	A-kinase anchor protein 13	GO:0051168; P:nuclear export; IEA:Ensembl
Q12802	AKAP13	A-kinase anchor protein 13	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q12802	AKAP13	A-kinase anchor protein 13	GO:0006468; P:protein phosphorylation; NAS:GOC
Q12802	AKAP13	A-kinase anchor protein 13	GO:0010611; P:regulation of cardiac muscle hypertrophy; IEA:Ensembl
Q12802	AKAP13	A-kinase anchor protein 13	GO:1900169; P:regulation of glucocorticoid mediated signaling pathway; IEA:Ensembl
Q12802	AKAP13	A-kinase anchor protein 13	GO:0045859; P:regulation of protein kinase activity; IEA:Ensembl
Q12802	AKAP13	A-kinase anchor protein 13	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q12802	AKAP13	A-kinase anchor protein 13	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9ULX6	AKAP8L	A-kinase anchor protein 8-like	GO:0017151; F:DEAD/H-box RNA helicase binding; TAS:UniProtKB
Q9ULX6	AKAP8L	A-kinase anchor protein 8-like	GO:0003677; F:DNA binding; IEA:InterPro
Q9ULX6	AKAP8L	A-kinase anchor protein 8-like	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9ULX6	AKAP8L	A-kinase anchor protein 8-like	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9ULX6	AKAP8L	A-kinase anchor protein 8-like	GO:0005515; F:protein binding; IPI:IntAct
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0071889; F:14-3-3 protein binding; IPI:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0005524; F:ATP binding; IDA:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0019899; F:enzyme binding; ISS:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0042802; F:identical protein binding; IPI:IntAct
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0016301; F:kinase activity; IDA:MGI
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0030235; F:nitric-oxide synthase regulator activity; IMP:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; IDA:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0005515; F:protein binding; IPI:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0004672; F:protein kinase activity; TAS:ProtInc
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0006924; P:activation-induced cell death of T cells; IMP:MGI
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0007568; P:aging; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0042640; P:anagen; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0008637; P:apoptotic mitochondrial changes; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0006915; P:apoptotic process; TAS:Reactome
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0007596; P:blood coagulation; TAS:Reactome
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0030154; P:cell differentiation; TAS:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0030030; P:cell projection organization; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0008283; P:cell proliferation; TAS:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0071364; P:cellular response to epidermal growth factor stimulus; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0032869; P:cellular response to insulin stimulus; IMP:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0031018; P:endocrine pancreas development; TAS:Reactome
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0097194; P:execution phase of apoptosis; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0010467; P:gene expression; TAS:Reactome
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0007281; P:germ cell development; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0042593; P:glucose homeostasis; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0015758; P:glucose transport; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0005978; P:glycogen biosynthetic process; IEA:UniProtKB-KW
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0060709; P:glycogen cell differentiation involved in embryonic placenta development; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0030212; P:hyaluronan metabolic process; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0006954; P:inflammatory response; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0045087; P:innate immune response; TAS:Reactome
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0008286; P:insulin receptor signaling pathway; IMP:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0048009; P:insulin-like growth factor receptor signaling pathway; IMP:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0035556; P:intracellular signal transduction; IDA:MGI
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0060644; P:mammary gland epithelial cell differentiation; TAS:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0001893; P:maternal placenta development; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0061024; P:membrane organization; TAS:Reactome
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0010507; P:negative regulation of autophagy; IMP:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0045792; P:negative regulation of cell size; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; ISS:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0010951; P:negative regulation of endopeptidase activity; IMP:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; TAS:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0031999; P:negative regulation of fatty acid beta-oxidation; IMP:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:1902176; P:negative regulation of intrinsic apoptotic signaling pathway in response to oxidative stress; NAS:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0046329; P:negative regulation of JNK cascade; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0010748; P:negative regulation of plasma membrane long-chain fatty acid transport; IMP:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0006469; P:negative regulation of protein kinase activity; IMP:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0045861; P:negative regulation of proteolysis; IMP:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; ISS:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0006809; P:nitric oxide biosynthetic process; TAS:ProtInc
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0046209; P:nitric oxide metabolic process; TAS:Reactome
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0032287; P:peripheral nervous system myelin maintenance; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0016310; P:phosphorylation; IDA:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0030168; P:platelet activation; TAS:Reactome
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IDA:DFLAT
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0030307; P:positive regulation of cell growth; IDA:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0032270; P:positive regulation of cellular protein metabolic process; ISS:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0031659; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle; IDA:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; IMP:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0045600; P:positive regulation of fat cell differentiation; IMP:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0046326; P:positive regulation of glucose import; IMP:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0010907; P:positive regulation of glucose metabolic process; IMP:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0045725; P:positive regulation of glycogen biosynthetic process; IMP:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0046889; P:positive regulation of lipid biosynthetic process; IMP:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IMP:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0051000; P:positive regulation of nitric-oxide synthase activity; IMP:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0001934; P:positive regulation of protein phosphorylation; IDA:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0010765; P:positive regulation of sodium ion transport; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0046777; P:protein autophosphorylation; TAS:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0030163; P:protein catabolic process; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0000060; P:protein import into nucleus, translocation; IMP:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0043491; P:protein kinase B signaling; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0016567; P:protein ubiquitination; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:1901976; P:regulation of cell cycle checkpoint; TAS:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0030334; P:regulation of cell migration; IMP:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0005979; P:regulation of glycogen biosynthetic process; IMP:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0010975; P:regulation of neuron projection development; ISS:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0034405; P:response to fluid shear stress; IMP:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0032094; P:response to food; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0009408; P:response to heat; TAS:ProtInc
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0070141; P:response to UV-A; IDA:BHF-UCL
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0016070; P:RNA metabolic process; TAS:Reactome
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0007165; P:signal transduction; TAS:UniProtKB
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0031295; P:T cell costimulation; TAS:Reactome
P31749	AKT1	RAC-alpha serine/threonine-protein kinase	GO:0006412; P:translation; IEA:Ensembl
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0005524; F:ATP binding; IDA:UniProtKB
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0016301; F:kinase activity; TAS:Reactome
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0005515; F:protein binding; IPI:UniProtKB
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0032859; P:activation of Ral GTPase activity; IEA:Ensembl
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0032869; P:cellular response to insulin stimulus; IMP:BHF-UCL
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0045444; P:fat cell differentiation; TAS:UniProtKB
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0005978; P:glycogen biosynthetic process; IEA:UniProtKB-KW
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0008286; P:insulin receptor signaling pathway; TAS:UniProtKB
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0065002; P:intracellular protein transmembrane transport; ISS:UniProtKB
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0060644; P:mammary gland epithelial cell differentiation; TAS:UniProtKB
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0061024; P:membrane organization; TAS:Reactome
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0010748; P:negative regulation of plasma membrane long-chain fatty acid transport; IMP:BHF-UCL
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0032287; P:peripheral nervous system myelin maintenance; IEA:Ensembl
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:2000147; P:positive regulation of cell motility; IMP:BHF-UCL
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0032000; P:positive regulation of fatty acid beta-oxidation; IMP:BHF-UCL
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0046326; P:positive regulation of glucose import; IMP:BHF-UCL
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:2001275; P:positive regulation of glucose import in response to insulin stimulus; IEA:Ensembl
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0010907; P:positive regulation of glucose metabolic process; IMP:BHF-UCL
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0045725; P:positive regulation of glycogen biosynthetic process; IMP:BHF-UCL
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0090314; P:positive regulation of protein targeting to membrane; ISS:UniProtKB
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0031340; P:positive regulation of vesicle fusion; ISS:UniProtKB
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0072659; P:protein localization to plasma membrane; IEA:Ensembl
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0071156; P:regulation of cell cycle arrest; TAS:UniProtKB
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0030334; P:regulation of cell migration; TAS:UniProtKB
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
P31751	AKT2	RAC-beta serine/threonine-protein kinase	GO:0007165; P:signal transduction; TAS:UniProtKB
Q9Y243	AKT3	RAC-gamma serine/threonine-protein kinase	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9Y243	AKT3	RAC-gamma serine/threonine-protein kinase	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y243	AKT3	RAC-gamma serine/threonine-protein kinase	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q9Y243	AKT3	RAC-gamma serine/threonine-protein kinase	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9Y243	AKT3	RAC-gamma serine/threonine-protein kinase	GO:0000002; P:mitochondrial genome maintenance; IMP:UniProtKB
Q9Y243	AKT3	RAC-gamma serine/threonine-protein kinase	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q9Y243	AKT3	RAC-gamma serine/threonine-protein kinase	GO:0007165; P:signal transduction; IMP:UniProtKB
Q9H8T0	AKTIP	AKT-interacting protein	GO:0016881; F:acid-amino acid ligase activity; IEA:InterPro
Q9H8T0	AKTIP	AKT-interacting protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H8T0	AKTIP	AKT-interacting protein	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9H8T0	AKTIP	AKT-interacting protein	GO:0045022; P:early endosome to late endosome transport; IMP:UniProtKB
Q9H8T0	AKTIP	AKT-interacting protein	GO:0007032; P:endosome organization; IMP:UniProtKB
Q9H8T0	AKTIP	AKT-interacting protein	GO:0008333; P:endosome to lysosome transport; IMP:UniProtKB
Q9H8T0	AKTIP	AKT-interacting protein	GO:0007040; P:lysosome organization; IMP:UniProtKB
Q9H8T0	AKTIP	AKT-interacting protein	GO:0032092; P:positive regulation of protein binding; IDA:MGI
Q9H8T0	AKTIP	AKT-interacting protein	GO:0001934; P:positive regulation of protein phosphorylation; IDA:MGI
Q9H8T0	AKTIP	AKT-interacting protein	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96B36	AKT1S1	Proline-rich AKT1 substrate 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96B36	AKT1S1	Proline-rich AKT1 substrate 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q96B36	AKT1S1	Proline-rich AKT1 substrate 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q96B36	AKT1S1	Proline-rich AKT1 substrate 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q96B36	AKT1S1	Proline-rich AKT1 substrate 1	GO:0045087; P:innate immune response; TAS:Reactome
Q96B36	AKT1S1	Proline-rich AKT1 substrate 1	GO:0045792; P:negative regulation of cell size; IDA:UniProtKB
Q96B36	AKT1S1	Proline-rich AKT1 substrate 1	GO:0006469; P:negative regulation of protein kinase activity; IDA:UniProtKB
Q96B36	AKT1S1	Proline-rich AKT1 substrate 1	GO:0032007; P:negative regulation of TOR signaling; IDA:UniProtKB
Q96B36	AKT1S1	Proline-rich AKT1 substrate 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q96B36	AKT1S1	Proline-rich AKT1 substrate 1	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q96B36	AKT1S1	Proline-rich AKT1 substrate 1	GO:0043523; P:regulation of neuron apoptotic process; ISS:UniProtKB
Q8N8R7	ARL14EP	ARL14 effector protein	GO:0005515; F:protein binding; IPI:IntAct
P00352	ALDH1A1	Retinal dehydrogenase 1	GO:0004029; F:aldehyde dehydrogenase (NAD) activity; EXP:Reactome
P00352	ALDH1A1	Retinal dehydrogenase 1	GO:0005497; F:androgen binding; TAS:ProtInc
P00352	ALDH1A1	Retinal dehydrogenase 1	GO:0005099; F:Ras GTPase activator activity; TAS:UniProtKB
P00352	ALDH1A1	Retinal dehydrogenase 1	GO:0001758; F:retinal dehydrogenase activity; IEA:UniProtKB-EC
P00352	ALDH1A1	Retinal dehydrogenase 1	GO:0006081; P:cellular aldehyde metabolic process; TAS:ProtInc
P00352	ALDH1A1	Retinal dehydrogenase 1	GO:0006069; P:ethanol oxidation; TAS:Reactome
P00352	ALDH1A1	Retinal dehydrogenase 1	GO:0032320; P:positive regulation of Ras GTPase activity; TAS:GOC
P00352	ALDH1A1	Retinal dehydrogenase 1	GO:0042572; P:retinol metabolic process; IEA:UniProtKB-UniPathway
P00352	ALDH1A1	Retinal dehydrogenase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P00352	ALDH1A1	Retinal dehydrogenase 1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0004028; F:3-chloroallyl aldehyde dehydrogenase activity; ISS:UniProtKB
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0016918; F:retinal binding; ISS:UniProtKB
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0001758; F:retinal dehydrogenase activity; ISS:UniProtKB
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0042904; P:9-cis-retinoic acid biosynthetic process; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0001568; P:blood vessel development; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0048738; P:cardiac muscle tissue development; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0009855; P:determination of bilateral symmetry; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0031076; P:embryonic camera-type eye development; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0048566; P:embryonic digestive tract development; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0060324; P:face development; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0003007; P:heart morphogenesis; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0030902; P:hindbrain development; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0001822; P:kidney development; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0001889; P:liver development; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0030324; P:lung development; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0007494; P:midgut development; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0016331; P:morphogenesis of embryonic epithelium; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0014032; P:neural crest cell development; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0021915; P:neural tube development; IMP:UniProtKB
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0030182; P:neuron differentiation; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0031016; P:pancreas development; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0021983; P:pituitary gland development; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0001936; P:regulation of endothelial cell proliferation; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0034097; P:response to cytokine; IDA:UniProtKB
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0032355; P:response to estradiol; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0033189; P:response to vitamin A; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0042574; P:retinal metabolic process; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0042573; P:retinoic acid metabolic process; ISS:UniProtKB
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0048384; P:retinoic acid receptor signaling pathway; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0042572; P:retinol metabolic process; IEA:UniProtKB-UniPathway
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0035799; P:ureter maturation; IEA:Ensembl
O94788	ALDH1A2	Retinal dehydrogenase 2	GO:0006776; P:vitamin A metabolic process; NAS:UniProtKB
P47895	ALDH1A3	Aldehyde dehydrogenase family 1 member A3	GO:0004029; F:aldehyde dehydrogenase (NAD) activity; IEA:Ensembl
P47895	ALDH1A3	Aldehyde dehydrogenase family 1 member A3	GO:0004030; F:aldehyde dehydrogenase [NAD(P)+] activity; IDA:UniProtKB
P47895	ALDH1A3	Aldehyde dehydrogenase family 1 member A3	GO:0070403; F:NAD+ binding; IEA:Ensembl
P47895	ALDH1A3	Aldehyde dehydrogenase family 1 member A3	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P47895	ALDH1A3	Aldehyde dehydrogenase family 1 member A3	GO:0070324; F:thyroid hormone binding; IEA:Ensembl
P47895	ALDH1A3	Aldehyde dehydrogenase family 1 member A3	GO:0048048; P:embryonic eye morphogenesis; ISS:UniProtKB
P47895	ALDH1A3	Aldehyde dehydrogenase family 1 member A3	GO:0060324; P:face development; IEA:Ensembl
P47895	ALDH1A3	Aldehyde dehydrogenase family 1 member A3	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
P47895	ALDH1A3	Aldehyde dehydrogenase family 1 member A3	GO:0007626; P:locomotory behavior; IEA:Ensembl
P47895	ALDH1A3	Aldehyde dehydrogenase family 1 member A3	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
P47895	ALDH1A3	Aldehyde dehydrogenase family 1 member A3	GO:0021768; P:nucleus accumbens development; IEA:Ensembl
P47895	ALDH1A3	Aldehyde dehydrogenase family 1 member A3	GO:0060166; P:olfactory pit development; IEA:Ensembl
P47895	ALDH1A3	Aldehyde dehydrogenase family 1 member A3	GO:0002072; P:optic cup morphogenesis involved in camera-type eye development; IEA:Ensembl
P47895	ALDH1A3	Aldehyde dehydrogenase family 1 member A3	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P47895	ALDH1A3	Aldehyde dehydrogenase family 1 member A3	GO:0042574; P:retinal metabolic process; IDA:UniProtKB
P47895	ALDH1A3	Aldehyde dehydrogenase family 1 member A3	GO:0002138; P:retinoic acid biosynthetic process; IEA:Ensembl
P47895	ALDH1A3	Aldehyde dehydrogenase family 1 member A3	GO:0042573; P:retinoic acid metabolic process; IDA:UniProtKB
P47895	ALDH1A3	Aldehyde dehydrogenase family 1 member A3	GO:0042572; P:retinol metabolic process; IEA:UniProtKB-UniPathway
P47895	ALDH1A3	Aldehyde dehydrogenase family 1 member A3	GO:0060013; P:righting reflex; IEA:Ensembl
P30837	ALDH1B1	Aldehyde dehydrogenase X, mitochondrial	GO:0004029; F:aldehyde dehydrogenase (NAD) activity; IEA:UniProtKB-EC
P30837	ALDH1B1	Aldehyde dehydrogenase X, mitochondrial	GO:0005975; P:carbohydrate metabolic process; NAS:ProtInc
P30837	ALDH1B1	Aldehyde dehydrogenase X, mitochondrial	GO:0006068; P:ethanol catabolic process; IEA:UniProtKB-UniPathway
O75891	ALDH1L1	Cytosolic 10-formyltetrahydrofolate dehydrogenase	GO:0003824; F:catalytic activity; TAS:ProtInc
O75891	ALDH1L1	Cytosolic 10-formyltetrahydrofolate dehydrogenase	GO:0016155; F:formyltetrahydrofolate dehydrogenase activity; IEA:UniProtKB-EC
O75891	ALDH1L1	Cytosolic 10-formyltetrahydrofolate dehydrogenase	GO:0016742; F:hydroxymethyl-, formyl- and related transferase activity; IEA:InterPro
O75891	ALDH1L1	Cytosolic 10-formyltetrahydrofolate dehydrogenase	GO:0008168; F:methyltransferase activity; IEA:InterPro
O75891	ALDH1L1	Cytosolic 10-formyltetrahydrofolate dehydrogenase	GO:0016620; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor; IEA:InterPro
O75891	ALDH1L1	Cytosolic 10-formyltetrahydrofolate dehydrogenase	GO:0009258; P:10-formyltetrahydrofolate catabolic process; TAS:ProtInc
O75891	ALDH1L1	Cytosolic 10-formyltetrahydrofolate dehydrogenase	GO:0009058; P:biosynthetic process; IEA:InterPro
O75891	ALDH1L1	Cytosolic 10-formyltetrahydrofolate dehydrogenase	GO:0006730; P:one-carbon metabolic process; IEA:UniProtKB-KW
Q3SY69	ALDH1L2	Mitochondrial 10-formyltetrahydrofolate dehydrogenase	GO:0016155; F:formyltetrahydrofolate dehydrogenase activity; IEA:UniProtKB-EC
Q3SY69	ALDH1L2	Mitochondrial 10-formyltetrahydrofolate dehydrogenase	GO:0016742; F:hydroxymethyl-, formyl- and related transferase activity; IEA:InterPro
Q3SY69	ALDH1L2	Mitochondrial 10-formyltetrahydrofolate dehydrogenase	GO:0008168; F:methyltransferase activity; IEA:InterPro
Q3SY69	ALDH1L2	Mitochondrial 10-formyltetrahydrofolate dehydrogenase	GO:0016620; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor; IEA:InterPro
Q3SY69	ALDH1L2	Mitochondrial 10-formyltetrahydrofolate dehydrogenase	GO:0009258; P:10-formyltetrahydrofolate catabolic process; IEA:InterPro
Q3SY69	ALDH1L2	Mitochondrial 10-formyltetrahydrofolate dehydrogenase	GO:0009058; P:biosynthetic process; IEA:InterPro
Q3SY69	ALDH1L2	Mitochondrial 10-formyltetrahydrofolate dehydrogenase	GO:0006730; P:one-carbon metabolic process; IEA:UniProtKB-KW
Q60I27	ALS2CL	ALS2 C-terminal-like protein	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q60I27	ALS2CL	ALS2 C-terminal-like protein	GO:0042802; F:identical protein binding; IPI:MGI
Q60I27	ALS2CL	ALS2 C-terminal-like protein	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q60I27	ALS2CL	ALS2 C-terminal-like protein	GO:0007032; P:endosome organization; IGI:MGI
Q60I27	ALS2CL	ALS2 C-terminal-like protein	GO:0008104; P:protein localization; IEA:Ensembl
Q96Q35	ALS2CR12	Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein	GO:0005515; F:protein binding; IPI:IntAct
Q96Q35	ALS2CR12	Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein	GO:0043087; P:regulation of GTPase activity; NAS:UniProtKB
P30838	ALDH3A1	Aldehyde dehydrogenase, dimeric NADP-preferring	GO:0004028; F:3-chloroallyl aldehyde dehydrogenase activity; IEA:Ensembl
P30838	ALDH3A1	Aldehyde dehydrogenase, dimeric NADP-preferring	GO:0008106; F:alcohol dehydrogenase (NADP+) activity; IDA:UniProtKB
P30838	ALDH3A1	Aldehyde dehydrogenase, dimeric NADP-preferring	GO:0004029; F:aldehyde dehydrogenase (NAD) activity; IDA:UniProtKB
P30838	ALDH3A1	Aldehyde dehydrogenase, dimeric NADP-preferring	GO:0004030; F:aldehyde dehydrogenase [NAD(P)+] activity; IEA:UniProtKB-EC
P30838	ALDH3A1	Aldehyde dehydrogenase, dimeric NADP-preferring	GO:0007568; P:aging; IEA:Ensembl
P30838	ALDH3A1	Aldehyde dehydrogenase, dimeric NADP-preferring	GO:0006081; P:cellular aldehyde metabolic process; IDA:UniProtKB
P30838	ALDH3A1	Aldehyde dehydrogenase, dimeric NADP-preferring	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
P30838	ALDH3A1	Aldehyde dehydrogenase, dimeric NADP-preferring	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P30838	ALDH3A1	Aldehyde dehydrogenase, dimeric NADP-preferring	GO:0051591; P:response to cAMP; IEA:Ensembl
P30838	ALDH3A1	Aldehyde dehydrogenase, dimeric NADP-preferring	GO:0042493; P:response to drug; IEA:Ensembl
P30838	ALDH3A1	Aldehyde dehydrogenase, dimeric NADP-preferring	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P30838	ALDH3A1	Aldehyde dehydrogenase, dimeric NADP-preferring	GO:0001666; P:response to hypoxia; IEA:Ensembl
P30838	ALDH3A1	Aldehyde dehydrogenase, dimeric NADP-preferring	GO:0007584; P:response to nutrient; IEA:Ensembl
P51648	ALDH3A2	Fatty aldehyde dehydrogenase	GO:0004029; F:aldehyde dehydrogenase (NAD) activity; IDA:UniProtKB
P51648	ALDH3A2	Fatty aldehyde dehydrogenase	GO:0004030; F:aldehyde dehydrogenase [NAD(P)+] activity; IEA:InterPro
P51648	ALDH3A2	Fatty aldehyde dehydrogenase	GO:0046577; F:long-chain-alcohol oxidase activity; IDA:UniProtKB
P51648	ALDH3A2	Fatty aldehyde dehydrogenase	GO:0050061; F:long-chain-aldehyde dehydrogenase activity; IDA:UniProtKB
P51648	ALDH3A2	Fatty aldehyde dehydrogenase	GO:0052814; F:medium-chain-aldehyde dehydrogenase activity; IDA:UniProtKB
P51648	ALDH3A2	Fatty aldehyde dehydrogenase	GO:0006081; P:cellular aldehyde metabolic process; IDA:UniProtKB
P51648	ALDH3A2	Fatty aldehyde dehydrogenase	GO:0007417; P:central nervous system development; IMP:UniProtKB
P51648	ALDH3A2	Fatty aldehyde dehydrogenase	GO:0008544; P:epidermis development; IMP:UniProtKB
P51648	ALDH3A2	Fatty aldehyde dehydrogenase	GO:0055114; P:oxidation-reduction process; IDA:GOC
P51648	ALDH3A2	Fatty aldehyde dehydrogenase	GO:0007422; P:peripheral nervous system development; IMP:UniProtKB
P51648	ALDH3A2	Fatty aldehyde dehydrogenase	GO:0033306; P:phytol metabolic process; IMP:UniProtKB
P51648	ALDH3A2	Fatty aldehyde dehydrogenase	GO:0006714; P:sesquiterpenoid metabolic process; IDA:UniProtKB
P43353	ALDH3B1	Aldehyde dehydrogenase family 3 member B1	GO:0004028; F:3-chloroallyl aldehyde dehydrogenase activity; TAS:ProtInc
P43353	ALDH3B1	Aldehyde dehydrogenase family 3 member B1	GO:0004030; F:aldehyde dehydrogenase [NAD(P)+] activity; IDA:MGI
P43353	ALDH3B1	Aldehyde dehydrogenase family 3 member B1	GO:0006066; P:alcohol metabolic process; TAS:ProtInc
P43353	ALDH3B1	Aldehyde dehydrogenase family 3 member B1	GO:0046185; P:aldehyde catabolic process; IDA:MGI
P43353	ALDH3B1	Aldehyde dehydrogenase family 3 member B1	GO:0034599; P:cellular response to oxidative stress; IDA:MGI
P43353	ALDH3B1	Aldehyde dehydrogenase family 3 member B1	GO:0006068; P:ethanol catabolic process; IEA:UniProtKB-UniPathway
P43353	ALDH3B1	Aldehyde dehydrogenase family 3 member B1	GO:0006629; P:lipid metabolic process; TAS:ProtInc
P43353	ALDH3B1	Aldehyde dehydrogenase family 3 member B1	GO:0055114; P:oxidation-reduction process; IDA:MGI
P48448	ALDH3B2	Aldehyde dehydrogenase family 3 member B2	GO:0004028; F:3-chloroallyl aldehyde dehydrogenase activity; TAS:ProtInc
P48448	ALDH3B2	Aldehyde dehydrogenase family 3 member B2	GO:0004030; F:aldehyde dehydrogenase [NAD(P)+] activity; IEA:UniProtKB-EC
P48448	ALDH3B2	Aldehyde dehydrogenase family 3 member B2	GO:0006066; P:alcohol metabolic process; TAS:ProtInc
P48448	ALDH3B2	Aldehyde dehydrogenase family 3 member B2	GO:0006068; P:ethanol catabolic process; IEA:UniProtKB-UniPathway
P48448	ALDH3B2	Aldehyde dehydrogenase family 3 member B2	GO:0006629; P:lipid metabolic process; TAS:ProtInc
P30038	ALDH4A1	Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial	GO:0003842; F:1-pyrroline-5-carboxylate dehydrogenase activity; EXP:Reactome
P30038	ALDH4A1	Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial	GO:0004029; F:aldehyde dehydrogenase (NAD) activity; TAS:ProtInc
P30038	ALDH4A1	Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P30038	ALDH4A1	Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial	GO:0042802; F:identical protein binding; IPI:IntAct
P30038	ALDH4A1	Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial	GO:0019470; P:4-hydroxyproline catabolic process; TAS:BHF-UCL
P30038	ALDH4A1	Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P30038	ALDH4A1	Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial	GO:0006561; P:proline biosynthetic process; IEA:InterPro
P30038	ALDH4A1	Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial	GO:0006562; P:proline catabolic process; TAS:Reactome
P30038	ALDH4A1	Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial	GO:0010133; P:proline catabolic process to glutamate; IEA:UniProtKB-UniPathway
P30038	ALDH4A1	Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial	GO:0006560; P:proline metabolic process; TAS:ProtInc
P30038	ALDH4A1	Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P20292	ALOX5AP	Arachidonate 5-lipoxygenase-activating protein	GO:0050544; F:arachidonic acid binding; IDA:UniProtKB
P20292	ALOX5AP	Arachidonate 5-lipoxygenase-activating protein	GO:0008047; F:enzyme activator activity; IEA:InterPro
P20292	ALOX5AP	Arachidonate 5-lipoxygenase-activating protein	GO:0005515; F:protein binding; IPI:UniProtKB
P20292	ALOX5AP	Arachidonate 5-lipoxygenase-activating protein	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
P20292	ALOX5AP	Arachidonate 5-lipoxygenase-activating protein	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P20292	ALOX5AP	Arachidonate 5-lipoxygenase-activating protein	GO:0071277; P:cellular response to calcium ion; IDA:UniProtKB
P20292	ALOX5AP	Arachidonate 5-lipoxygenase-activating protein	GO:0019370; P:leukotriene biosynthetic process; IDA:UniProtKB
P20292	ALOX5AP	Arachidonate 5-lipoxygenase-activating protein	GO:0006691; P:leukotriene metabolic process; TAS:Reactome
P20292	ALOX5AP	Arachidonate 5-lipoxygenase-activating protein	GO:0002540; P:leukotriene production involved in inflammatory response; IEA:Ensembl
P20292	ALOX5AP	Arachidonate 5-lipoxygenase-activating protein	GO:2001300; P:lipoxin metabolic process; TAS:Reactome
P20292	ALOX5AP	Arachidonate 5-lipoxygenase-activating protein	GO:0019372; P:lipoxygenase pathway; TAS:Reactome
P20292	ALOX5AP	Arachidonate 5-lipoxygenase-activating protein	GO:0002675; P:positive regulation of acute inflammatory response; IEA:Ensembl
P20292	ALOX5AP	Arachidonate 5-lipoxygenase-activating protein	GO:0070207; P:protein homotrimerization; IPI:UniProtKB
P20292	ALOX5AP	Arachidonate 5-lipoxygenase-activating protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P49419	ALDH7A1	Alpha-aminoadipic semialdehyde dehydrogenase	GO:0004029; F:aldehyde dehydrogenase (NAD) activity; ISS:UniProtKB
P49419	ALDH7A1	Alpha-aminoadipic semialdehyde dehydrogenase	GO:0008802; F:betaine-aldehyde dehydrogenase activity; IEA:UniProtKB-EC
P49419	ALDH7A1	Alpha-aminoadipic semialdehyde dehydrogenase	GO:0004043; F:L-aminoadipate-semialdehyde dehydrogenase activity; EXP:Reactome
P49419	ALDH7A1	Alpha-aminoadipic semialdehyde dehydrogenase	GO:0005515; F:protein binding; IPI:IntAct
P49419	ALDH7A1	Alpha-aminoadipic semialdehyde dehydrogenase	GO:0006081; P:cellular aldehyde metabolic process; ISS:UniProtKB
P49419	ALDH7A1	Alpha-aminoadipic semialdehyde dehydrogenase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P49419	ALDH7A1	Alpha-aminoadipic semialdehyde dehydrogenase	GO:0019285; P:glycine betaine biosynthetic process from choline; IEA:UniProtKB-UniPathway
P49419	ALDH7A1	Alpha-aminoadipic semialdehyde dehydrogenase	GO:0006554; P:lysine catabolic process; TAS:Reactome
P49419	ALDH7A1	Alpha-aminoadipic semialdehyde dehydrogenase	GO:0007605; P:sensory perception of sound; TAS:ProtInc
P49419	ALDH7A1	Alpha-aminoadipic semialdehyde dehydrogenase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H2A2	ALDH8A1	Aldehyde dehydrogenase family 8 member A1	GO:0001758; F:retinal dehydrogenase activity; IDA:UniProtKB
Q9H2A2	ALDH8A1	Aldehyde dehydrogenase family 8 member A1	GO:0042904; P:9-cis-retinoic acid biosynthetic process; IEA:Ensembl
Q9H2A2	ALDH8A1	Aldehyde dehydrogenase family 8 member A1	GO:0042574; P:retinal metabolic process; IDA:UniProtKB
Q9H2A2	ALDH8A1	Aldehyde dehydrogenase family 8 member A1	GO:0042573; P:retinoic acid metabolic process; IDA:UniProtKB
P49189	ALDH9A1	4-trimethylaminobutyraldehyde dehydrogenase	GO:0033737; F:1-pyrroline dehydrogenase activity; IEA:UniProtKB-EC
P49189	ALDH9A1	4-trimethylaminobutyraldehyde dehydrogenase	GO:0004028; F:3-chloroallyl aldehyde dehydrogenase activity; TAS:Reactome
P49189	ALDH9A1	4-trimethylaminobutyraldehyde dehydrogenase	GO:0047105; F:4-trimethylammoniobutyraldehyde dehydrogenase activity; IEA:UniProtKB-EC
P49189	ALDH9A1	4-trimethylaminobutyraldehyde dehydrogenase	GO:0004029; F:aldehyde dehydrogenase (NAD) activity; IDA:UniProtKB
P49189	ALDH9A1	4-trimethylaminobutyraldehyde dehydrogenase	GO:0043176; F:amine binding; IEA:Ensembl
P49189	ALDH9A1	4-trimethylaminobutyraldehyde dehydrogenase	GO:0019145; F:aminobutyraldehyde dehydrogenase activity; IDA:UniProtKB
P49189	ALDH9A1	4-trimethylaminobutyraldehyde dehydrogenase	GO:0051287; F:NAD binding; IEA:Ensembl
P49189	ALDH9A1	4-trimethylaminobutyraldehyde dehydrogenase	GO:0045329; P:carnitine biosynthetic process; TAS:Reactome
P49189	ALDH9A1	4-trimethylaminobutyraldehyde dehydrogenase	GO:0006081; P:cellular aldehyde metabolic process; IDA:UniProtKB
P49189	ALDH9A1	4-trimethylaminobutyraldehyde dehydrogenase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P49189	ALDH9A1	4-trimethylaminobutyraldehyde dehydrogenase	GO:0042445; P:hormone metabolic process; TAS:UniProtKB
P49189	ALDH9A1	4-trimethylaminobutyraldehyde dehydrogenase	GO:0001822; P:kidney development; IEA:Ensembl
P49189	ALDH9A1	4-trimethylaminobutyraldehyde dehydrogenase	GO:0001889; P:liver development; IEA:Ensembl
P49189	ALDH9A1	4-trimethylaminobutyraldehyde dehydrogenase	GO:0042136; P:neurotransmitter biosynthetic process; IDA:UniProtKB
P49189	ALDH9A1	4-trimethylaminobutyraldehyde dehydrogenase	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
P49189	ALDH9A1	4-trimethylaminobutyraldehyde dehydrogenase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P24298	GPT	Alanine aminotransferase 1	GO:0004021; F:L-alanine:2-oxoglutarate aminotransferase activity; NAS:UniProtKB
P24298	GPT	Alanine aminotransferase 1	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
P24298	GPT	Alanine aminotransferase 1	GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome
P24298	GPT	Alanine aminotransferase 1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P24298	GPT	Alanine aminotransferase 1	GO:0042853; P:L-alanine catabolic process; IEA:UniProtKB-UniPathway
P24298	GPT	Alanine aminotransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8TD30	GPT2	Alanine aminotransferase 2	GO:0004021; F:L-alanine:2-oxoglutarate aminotransferase activity; IDA:UniProtKB
Q8TD30	GPT2	Alanine aminotransferase 2	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q8TD30	GPT2	Alanine aminotransferase 2	GO:0006103; P:2-oxoglutarate metabolic process; IDA:UniProtKB
Q8TD30	GPT2	Alanine aminotransferase 2	GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome
Q8TD30	GPT2	Alanine aminotransferase 2	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q8TD30	GPT2	Alanine aminotransferase 2	GO:0042853; P:L-alanine catabolic process; IEA:UniProtKB-UniPathway
Q8TD30	GPT2	Alanine aminotransferase 2	GO:0042851; P:L-alanine metabolic process; IDA:UniProtKB
Q8TD30	GPT2	Alanine aminotransferase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P02768	ALB	Serum albumin	GO:0016209; F:antioxidant activity; NAS:UniProtKB
P02768	ALB	Serum albumin	GO:0051087; F:chaperone binding; IPI:BHF-UCL
P02768	ALB	Serum albumin	GO:0005507; F:copper ion binding; NAS:UniProtKB
P02768	ALB	Serum albumin	GO:0003677; F:DNA binding; IDA:UniProtKB
P02768	ALB	Serum albumin	GO:0008144; F:drug binding; IDA:UniProtKB
P02768	ALB	Serum albumin	GO:0005504; F:fatty acid binding; IDA:UniProtKB
P02768	ALB	Serum albumin	GO:0005515; F:protein binding; IPI:UniProtKB
P02768	ALB	Serum albumin	GO:0030170; F:pyridoxal phosphate binding; IDA:UniProtKB
P02768	ALB	Serum albumin	GO:0015643; F:toxic substance binding; IDA:UniProtKB
P02768	ALB	Serum albumin	GO:0008270; F:zinc ion binding; IEA:Ensembl
P02768	ALB	Serum albumin	GO:0015721; P:bile acid and bile salt transport; TAS:Reactome
P02768	ALB	Serum albumin	GO:0008206; P:bile acid metabolic process; TAS:Reactome
P02768	ALB	Serum albumin	GO:0007596; P:blood coagulation; TAS:Reactome
P02768	ALB	Serum albumin	GO:0009267; P:cellular response to starvation; IDA:UniProtKB
P02768	ALB	Serum albumin	GO:0019836; P:hemolysis by symbiont of host erythrocytes; IDA:UniProtKB
P02768	ALB	Serum albumin	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
P02768	ALB	Serum albumin	GO:0051659; P:maintenance of mitochondrion location; IDA:UniProtKB
P02768	ALB	Serum albumin	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P02768	ALB	Serum albumin	GO:0043069; P:negative regulation of programmed cell death; NAS:UniProtKB
P02768	ALB	Serum albumin	GO:0030168; P:platelet activation; TAS:Reactome
P02768	ALB	Serum albumin	GO:0002576; P:platelet degranulation; TAS:Reactome
P02768	ALB	Serum albumin	GO:0046010; P:positive regulation of circadian sleep/wake cycle, non-REM sleep; IEA:Ensembl
P02768	ALB	Serum albumin	GO:0046689; P:response to mercury ion; IEA:Ensembl
P02768	ALB	Serum albumin	GO:0007584; P:response to nutrient; IEA:Ensembl
P02768	ALB	Serum albumin	GO:0010033; P:response to organic substance; IEA:Ensembl
P02768	ALB	Serum albumin	GO:0070541; P:response to platinum ion; IEA:Ensembl
P02768	ALB	Serum albumin	GO:0001895; P:retina homeostasis; IEP:UniProt
P02768	ALB	Serum albumin	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P02768	ALB	Serum albumin	GO:0043252; P:sodium-independent organic anion transport; TAS:Reactome
P02768	ALB	Serum albumin	GO:0055085; P:transmembrane transport; TAS:Reactome
P02768	ALB	Serum albumin	GO:0006810; P:transport; TAS:UniProtKB
P05091	ALDH2	Aldehyde dehydrogenase, mitochondrial	GO:0004029; F:aldehyde dehydrogenase (NAD) activity; EXP:Reactome
P05091	ALDH2	Aldehyde dehydrogenase, mitochondrial	GO:0004030; F:aldehyde dehydrogenase [NAD(P)+] activity; TAS:ProtInc
P05091	ALDH2	Aldehyde dehydrogenase, mitochondrial	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P05091	ALDH2	Aldehyde dehydrogenase, mitochondrial	GO:0006066; P:alcohol metabolic process; TAS:ProtInc
P05091	ALDH2	Aldehyde dehydrogenase, mitochondrial	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
P05091	ALDH2	Aldehyde dehydrogenase, mitochondrial	GO:0006068; P:ethanol catabolic process; IEA:UniProtKB-UniPathway
P05091	ALDH2	Aldehyde dehydrogenase, mitochondrial	GO:0006069; P:ethanol oxidation; TAS:Reactome
P05091	ALDH2	Aldehyde dehydrogenase, mitochondrial	GO:0042136; P:neurotransmitter biosynthetic process; TAS:Reactome
P05091	ALDH2	Aldehyde dehydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P05091	ALDH2	Aldehyde dehydrogenase, mitochondrial	GO:0007268; P:synaptic transmission; TAS:Reactome
P05091	ALDH2	Aldehyde dehydrogenase, mitochondrial	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0003779; F:actin binding; TAS:BHF-UCL
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0008092; F:cytoskeletal protein binding; IDA:BHF-UCL
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0070061; F:fructose binding; IDA:BHF-UCL
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0004332; F:fructose-bisphosphate aldolase activity; IDA:BHF-UCL
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0042802; F:identical protein binding; TAS:BHF-UCL
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0005515; F:protein binding; IPI:IntAct
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0015631; F:tubulin binding; TAS:BHF-UCL
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0007015; P:actin filament organization; TAS:BHF-UCL
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0006754; P:ATP biosynthetic process; IMP:BHF-UCL
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0007596; P:blood coagulation; TAS:Reactome
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0030388; P:fructose 1,6-bisphosphate metabolic process; IDA:BHF-UCL
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0006000; P:fructose metabolic process; IMP:BHF-UCL
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0006094; P:gluconeogenesis; TAS:Reactome
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0006006; P:glucose metabolic process; TAS:Reactome
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0006096; P:glycolytic process; IMP:BHF-UCL
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0046716; P:muscle cell cellular homeostasis; IMP:BHF-UCL
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0030168; P:platelet activation; TAS:Reactome
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0002576; P:platelet degranulation; TAS:Reactome
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0051289; P:protein homotetramerization; ISS:UniProtKB
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0008360; P:regulation of cell shape; IDA:BHF-UCL
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P04075	ALDOA	Fructose-bisphosphate aldolase A	GO:0006941; P:striated muscle contraction; IMP:BHF-UCL
P05062	ALDOB	Fructose-bisphosphate aldolase B	GO:0051117; F:ATPase binding; IDA:BHF-UCL
P05062	ALDOB	Fructose-bisphosphate aldolase B	GO:0008092; F:cytoskeletal protein binding; IDA:BHF-UCL
P05062	ALDOB	Fructose-bisphosphate aldolase B	GO:0070061; F:fructose binding; IMP:BHF-UCL
P05062	ALDOB	Fructose-bisphosphate aldolase B	GO:0004332; F:fructose-bisphosphate aldolase activity; IDA:BHF-UCL
P05062	ALDOB	Fructose-bisphosphate aldolase B	GO:0042802; F:identical protein binding; IPI:BHF-UCL
P05062	ALDOB	Fructose-bisphosphate aldolase B	GO:0005515; F:protein binding; IPI:IntAct
P05062	ALDOB	Fructose-bisphosphate aldolase B	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P05062	ALDOB	Fructose-bisphosphate aldolase B	GO:0030388; P:fructose 1,6-bisphosphate metabolic process; IDA:BHF-UCL
P05062	ALDOB	Fructose-bisphosphate aldolase B	GO:0006001; P:fructose catabolic process; TAS:Reactome
P05062	ALDOB	Fructose-bisphosphate aldolase B	GO:0006000; P:fructose metabolic process; IMP:BHF-UCL
P05062	ALDOB	Fructose-bisphosphate aldolase B	GO:0006094; P:gluconeogenesis; TAS:Reactome
P05062	ALDOB	Fructose-bisphosphate aldolase B	GO:0006006; P:glucose metabolic process; TAS:Reactome
P05062	ALDOB	Fructose-bisphosphate aldolase B	GO:0006096; P:glycolytic process; IDA:BHF-UCL
P05062	ALDOB	Fructose-bisphosphate aldolase B	GO:0006116; P:NADH oxidation; IDA:BHF-UCL
P05062	ALDOB	Fructose-bisphosphate aldolase B	GO:0032781; P:positive regulation of ATPase activity; IGI:BHF-UCL
P05062	ALDOB	Fructose-bisphosphate aldolase B	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P05062	ALDOB	Fructose-bisphosphate aldolase B	GO:0070072; P:vacuolar proton-transporting V-type ATPase complex assembly; IGI:BHF-UCL
P09972	ALDOC	Fructose-bisphosphate aldolase C	GO:0008092; F:cytoskeletal protein binding; IDA:BHF-UCL
P09972	ALDOC	Fructose-bisphosphate aldolase C	GO:0004332; F:fructose-bisphosphate aldolase activity; IDA:UniProtKB
P09972	ALDOC	Fructose-bisphosphate aldolase C	GO:0005515; F:protein binding; IPI:UniProtKB
P09972	ALDOC	Fructose-bisphosphate aldolase C	GO:0007568; P:aging; IEA:Ensembl
P09972	ALDOC	Fructose-bisphosphate aldolase C	GO:0006915; P:apoptotic process; IEA:Ensembl
P09972	ALDOC	Fructose-bisphosphate aldolase C	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P09972	ALDOC	Fructose-bisphosphate aldolase C	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
P09972	ALDOC	Fructose-bisphosphate aldolase C	GO:0030388; P:fructose 1,6-bisphosphate metabolic process; IDA:UniProtKB
P09972	ALDOC	Fructose-bisphosphate aldolase C	GO:0006000; P:fructose metabolic process; TAS:ProtInc
P09972	ALDOC	Fructose-bisphosphate aldolase C	GO:0006094; P:gluconeogenesis; TAS:Reactome
P09972	ALDOC	Fructose-bisphosphate aldolase C	GO:0006006; P:glucose metabolic process; TAS:Reactome
P09972	ALDOC	Fructose-bisphosphate aldolase C	GO:0006096; P:glycolytic process; TAS:Reactome
P09972	ALDOC	Fructose-bisphosphate aldolase C	GO:0031100; P:organ regeneration; IEA:Ensembl
P09972	ALDOC	Fructose-bisphosphate aldolase C	GO:0051290; P:protein heterotetramerization; IEA:Ensembl
P09972	ALDOC	Fructose-bisphosphate aldolase C	GO:0051289; P:protein homotetramerization; IEA:Ensembl
P09972	ALDOC	Fructose-bisphosphate aldolase C	GO:0001666; P:response to hypoxia; IEA:Ensembl
P09972	ALDOC	Fructose-bisphosphate aldolase C	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P09972	ALDOC	Fructose-bisphosphate aldolase C	GO:0010243; P:response to organonitrogen compound; IEA:Ensembl
P09972	ALDOC	Fructose-bisphosphate aldolase C	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P15121	AKR1B1	Aldose reductase	GO:0004032; F:alditol:NADP+ 1-oxidoreductase activity; TAS:ProtInc
P15121	AKR1B1	Aldose reductase	GO:0004033; F:aldo-keto reductase (NADP) activity; TAS:UniProtKB
P15121	AKR1B1	Aldose reductase	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P15121	AKR1B1	Aldose reductase	GO:0043795; F:glyceraldehyde oxidoreductase activity; IDA:UniProtKB
P15121	AKR1B1	Aldose reductase	GO:0006700; P:C21-steroid hormone biosynthetic process; TAS:Reactome
P15121	AKR1B1	Aldose reductase	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
P15121	AKR1B1	Aldose reductase	GO:0044597; P:daunorubicin metabolic process; IMP:UniProtKB
P15121	AKR1B1	Aldose reductase	GO:0044598; P:doxorubicin metabolic process; IMP:UniProtKB
P15121	AKR1B1	Aldose reductase	GO:0006950; P:response to stress; TAS:UniProtKB
P15121	AKR1B1	Aldose reductase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P15121	AKR1B1	Aldose reductase	GO:0008202; P:steroid metabolic process; TAS:Reactome
P84996	GNAS	Protein ALEX	GO:0005515; F:protein binding; IPI:UniProt
P84996	GNAS	Protein ALEX	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IMP:UniProt
P84996	GNAS	Protein ALEX	GO:0060348; P:bone development; IMP:UniProt
P84996	GNAS	Protein ALEX	GO:0050890; P:cognition; IMP:UniProt
P84996	GNAS	Protein ALEX	GO:0048589; P:developmental growth; IMP:UniProt
P84996	GNAS	Protein ALEX	GO:0060789; P:hair follicle placode formation; IMP:UniProt
P84996	GNAS	Protein ALEX	GO:0070527; P:platelet aggregation; IMP:UniProt
Q2TAA5	ALG11	GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase	GO:0004377; F:GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity; IEA:UniProtKB-EC
Q2TAA5	ALG11	GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q2TAA5	ALG11	GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q2TAA5	ALG11	GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q2TAA5	ALG11	GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9BV10	ALG12	Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase	GO:0000009; F:alpha-1,6-mannosyltransferase activity; IC:UniProtKB
Q9BV10	ALG12	Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase	GO:0052917; F:dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity; IEA:UniProtKB-EC
Q9BV10	ALG12	Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9BV10	ALG12	Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; IDA:MGI
Q9BV10	ALG12	Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase	GO:0097502; P:mannosylation; IC:GOC
Q9BV10	ALG12	Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9BV10	ALG12	Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase	GO:0006457; P:protein folding; NAS:UniProtKB
Q9BV10	ALG12	Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase	GO:0006487; P:protein N-linked glycosylation; IGI:UniProtKB
Q9BV10	ALG12	Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9NP73	ALG13	Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q9NP73	ALG13	Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
Q9NP73	ALG13	Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13	GO:0004577; F:N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; IEA:UniProtKB-EC
Q9NP73	ALG13	Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NP73	ALG13	Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9NP73	ALG13	Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q9NP73	ALG13	Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13	GO:0030259; P:lipid glycosylation; IEA:InterPro
Q9NP73	ALG13	Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9NP73	ALG13	Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q96F25	ALG14	UDP-N-acetylglucosamine transferase subunit ALG14 homolog	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q96F25	ALG14	UDP-N-acetylglucosamine transferase subunit ALG14 homolog	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q96F25	ALG14	UDP-N-acetylglucosamine transferase subunit ALG14 homolog	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q96F25	ALG14	UDP-N-acetylglucosamine transferase subunit ALG14 homolog	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q6GMV1	ALG1L	Putative glycosyltransferase ALG1-like	GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW
Q9BT22	ALG1	Chitobiosyldiphosphodolichol beta-mannosyltransferase	GO:0004578; F:chitobiosyldiphosphodolichol beta-mannosyltransferase activity; IEA:UniProtKB-EC
Q9BT22	ALG1	Chitobiosyldiphosphodolichol beta-mannosyltransferase	GO:0000030; F:mannosyltransferase activity; TAS:ProtInc
Q9BT22	ALG1	Chitobiosyldiphosphodolichol beta-mannosyltransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9BT22	ALG1	Chitobiosyldiphosphodolichol beta-mannosyltransferase	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q9BT22	ALG1	Chitobiosyldiphosphodolichol beta-mannosyltransferase	GO:0009103; P:lipopolysaccharide biosynthetic process; TAS:ProtInc
Q9BT22	ALG1	Chitobiosyldiphosphodolichol beta-mannosyltransferase	GO:0097502; P:mannosylation; TAS:GOC
Q9BT22	ALG1	Chitobiosyldiphosphodolichol beta-mannosyltransferase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9BT22	ALG1	Chitobiosyldiphosphodolichol beta-mannosyltransferase	GO:0006486; P:protein glycosylation; TAS:ProtInc
Q9BT22	ALG1	Chitobiosyldiphosphodolichol beta-mannosyltransferase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9H553	ALG2	Alpha-1,3/1,6-mannosyltransferase ALG2	GO:0000033; F:alpha-1,3-mannosyltransferase activity; IDA:UniProtKB
Q9H553	ALG2	Alpha-1,3/1,6-mannosyltransferase ALG2	GO:0048306; F:calcium-dependent protein binding; IMP:UniProtKB
Q9H553	ALG2	Alpha-1,3/1,6-mannosyltransferase ALG2	GO:0004378; F:GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity; IEA:UniProtKB-EC
Q9H553	ALG2	Alpha-1,3/1,6-mannosyltransferase ALG2	GO:0043495; F:protein anchor; IMP:UniProtKB
Q9H553	ALG2	Alpha-1,3/1,6-mannosyltransferase ALG2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H553	ALG2	Alpha-1,3/1,6-mannosyltransferase ALG2	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q9H553	ALG2	Alpha-1,3/1,6-mannosyltransferase ALG2	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q9H553	ALG2	Alpha-1,3/1,6-mannosyltransferase ALG2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9H553	ALG2	Alpha-1,3/1,6-mannosyltransferase ALG2	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; IGI:UniProtKB
Q9H553	ALG2	Alpha-1,3/1,6-mannosyltransferase ALG2	GO:0097502; P:mannosylation; IDA:GOC
Q9H553	ALG2	Alpha-1,3/1,6-mannosyltransferase ALG2	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9H553	ALG2	Alpha-1,3/1,6-mannosyltransferase ALG2	GO:0033577; P:protein glycosylation in endoplasmic reticulum; IGI:UniProtKB
Q9H553	ALG2	Alpha-1,3/1,6-mannosyltransferase ALG2	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9H553	ALG2	Alpha-1,3/1,6-mannosyltransferase ALG2	GO:0051592; P:response to calcium ion; IDA:UniProtKB
Q92685	ALG3	Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase	GO:0000033; F:alpha-1,3-mannosyltransferase activity; IDA:UniProtKB
Q92685	ALG3	Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase	GO:0052925; F:dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity; IEA:UniProtKB-EC
Q92685	ALG3	Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q92685	ALG3	Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q92685	ALG3	Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase	GO:0097502; P:mannosylation; IDA:GOC
Q92685	ALG3	Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q92685	ALG3	Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase	GO:0006486; P:protein glycosylation; NAS:UniProtKB
Q92685	ALG3	Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9Y673	ALG5	Dolichyl-phosphate beta-glucosyltransferase	GO:0004581; F:dolichyl-phosphate beta-glucosyltransferase activity; IEA:UniProtKB-EC
Q9Y673	ALG5	Dolichyl-phosphate beta-glucosyltransferase	GO:0004576; F:oligosaccharyl transferase activity; TAS:ProtInc
Q9Y673	ALG5	Dolichyl-phosphate beta-glucosyltransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9Y673	ALG5	Dolichyl-phosphate beta-glucosyltransferase	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
Q9Y673	ALG5	Dolichyl-phosphate beta-glucosyltransferase	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q9Y673	ALG5	Dolichyl-phosphate beta-glucosyltransferase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9Y673	ALG5	Dolichyl-phosphate beta-glucosyltransferase	GO:0006486; P:protein glycosylation; TAS:ProtInc
Q9Y673	ALG5	Dolichyl-phosphate beta-glucosyltransferase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9Y672	ALG6	Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase	GO:0046527; F:glucosyltransferase activity; IDA:MGI
Q9Y672	ALG6	Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9Y672	ALG6	Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q9Y672	ALG6	Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9Y672	ALG6	Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase	GO:0006487; P:protein N-linked glycosylation; IGI:UniProtKB
Q9Y672	ALG6	Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9BVK2	ALG8	Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase	GO:0000033; F:alpha-1,3-mannosyltransferase activity; IMP:UniProtKB
Q9BVK2	ALG8	Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9BVK2	ALG8	Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q9BVK2	ALG8	Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase	GO:0097502; P:mannosylation; IMP:GOC
Q9BVK2	ALG8	Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9BVK2	ALG8	Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase	GO:0006487; P:protein N-linked glycosylation; IMP:UniProtKB
Q9BVK2	ALG8	Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9H6U8	ALG9	Alpha-1,2-mannosyltransferase ALG9	GO:0052926; F:dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity; IEA:UniProtKB-EC
Q9H6U8	ALG9	Alpha-1,2-mannosyltransferase ALG9	GO:0052918; F:dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity; IEA:UniProtKB-EC
Q9H6U8	ALG9	Alpha-1,2-mannosyltransferase ALG9	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9H6U8	ALG9	Alpha-1,2-mannosyltransferase ALG9	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q9H6U8	ALG9	Alpha-1,2-mannosyltransferase ALG9	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9H6U8	ALG9	Alpha-1,2-mannosyltransferase ALG9	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q13686	ALKBH1	Alkylated DNA repair protein alkB homolog 1	GO:0042056; F:chemoattractant activity; IEA:Ensembl
Q13686	ALKBH1	Alkylated DNA repair protein alkB homolog 1	GO:0003906; F:DNA-(apurinic or apyrimidinic site) lyase activity; IDA:UniProtKB
Q13686	ALKBH1	Alkylated DNA repair protein alkB homolog 1	GO:0008198; F:ferrous iron binding; IDA:UniProtKB
Q13686	ALKBH1	Alkylated DNA repair protein alkB homolog 1	GO:0070579; F:methylcytosine dioxygenase activity; IDA:UniProtKB
Q13686	ALKBH1	Alkylated DNA repair protein alkB homolog 1	GO:0048589; P:developmental growth; IEA:Ensembl
Q13686	ALKBH1	Alkylated DNA repair protein alkB homolog 1	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
Q13686	ALKBH1	Alkylated DNA repair protein alkB homolog 1	GO:0006307; P:DNA dealkylation involved in DNA repair; IDA:UniProtKB
Q13686	ALKBH1	Alkylated DNA repair protein alkB homolog 1	GO:0080111; P:DNA demethylation; IDA:UniProtKB
Q13686	ALKBH1	Alkylated DNA repair protein alkB homolog 1	GO:0006281; P:DNA repair; IDA:UniProtKB
Q13686	ALKBH1	Alkylated DNA repair protein alkB homolog 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q13686	ALKBH1	Alkylated DNA repair protein alkB homolog 1	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q13686	ALKBH1	Alkylated DNA repair protein alkB homolog 1	GO:0001764; P:neuron migration; IEA:Ensembl
Q13686	ALKBH1	Alkylated DNA repair protein alkB homolog 1	GO:0031175; P:neuron projection development; IEA:Ensembl
Q13686	ALKBH1	Alkylated DNA repair protein alkB homolog 1	GO:0070989; P:oxidative demethylation; IDA:UniProtKB
Q13686	ALKBH1	Alkylated DNA repair protein alkB homolog 1	GO:0001890; P:placenta development; IEA:Ensembl
Q13686	ALKBH1	Alkylated DNA repair protein alkB homolog 1	GO:0042245; P:RNA repair; IDA:UniProtKB
Q6NS38	ALKBH2	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2	GO:0051747; F:cytosine C-5 DNA demethylase activity; IDA:UniProtKB
Q6NS38	ALKBH2	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2	GO:0043734; F:DNA-N1-methyladenine dioxygenase activity; IDA:UniProtKB
Q6NS38	ALKBH2	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2	GO:0008198; F:ferrous iron binding; IDA:UniProtKB
Q6NS38	ALKBH2	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2	GO:0006307; P:DNA dealkylation involved in DNA repair; IDA:UniProtKB
Q6NS38	ALKBH2	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2	GO:0080111; P:DNA demethylation; TAS:BHF-UCL
Q6NS38	ALKBH2	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2	GO:0006281; P:DNA repair; TAS:Reactome
Q6NS38	ALKBH2	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2	GO:0070989; P:oxidative demethylation; TAS:BHF-UCL
Q6NS38	ALKBH2	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2	GO:0035511; P:oxidative DNA demethylation; IDA:UniProtKB
Q96Q83	ALKBH3	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3	GO:0051747; F:cytosine C-5 DNA demethylase activity; IEA:Ensembl
Q96Q83	ALKBH3	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3	GO:0043734; F:DNA-N1-methyladenine dioxygenase activity; IDA:UniProtKB
Q96Q83	ALKBH3	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3	GO:0008198; F:ferrous iron binding; IDA:UniProtKB
Q96Q83	ALKBH3	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3	GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW
Q96Q83	ALKBH3	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q96Q83	ALKBH3	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3	GO:0008283; P:cell proliferation; IMP:UniProtKB
Q96Q83	ALKBH3	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3	GO:0006307; P:DNA dealkylation involved in DNA repair; IDA:UniProtKB
Q96Q83	ALKBH3	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3	GO:0006281; P:DNA repair; IDA:UniProtKB
Q96Q83	ALKBH3	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3	GO:0035552; P:oxidative single-stranded DNA demethylation; IDA:UniProtKB
Q9NXW9	ALKBH4	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4	GO:0003779; F:actin binding; IDA:UniProtKB
Q9NXW9	ALKBH4	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4	GO:0032451; F:demethylase activity; TAS:UniProtKB
Q9NXW9	ALKBH4	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NXW9	ALKBH4	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4	GO:0016706; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; IDA:UniProtKB
Q9NXW9	ALKBH4	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4	GO:0031032; P:actomyosin structure organization; IMP:UniProtKB
Q9NXW9	ALKBH4	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4	GO:0036090; P:cleavage furrow ingression; IMP:UniProtKB
Q9NXW9	ALKBH4	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4	GO:0006482; P:protein demethylation; IDA:UniProtKB
Q9NXW9	ALKBH4	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NXW9	ALKBH4	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6P6C2	ALKBH5	RNA demethylase ALKBH5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6P6C2	ALKBH5	RNA demethylase ALKBH5	GO:0035515; F:oxidative RNA demethylase activity; IDA:UniProtKB
Q6P6C2	ALKBH5	RNA demethylase ALKBH5	GO:0016706; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; IDA:UniProtKB
Q6P6C2	ALKBH5	RNA demethylase ALKBH5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6P6C2	ALKBH5	RNA demethylase ALKBH5	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q6P6C2	ALKBH5	RNA demethylase ALKBH5	GO:0006406; P:mRNA export from nucleus; IMP:UniProtKB
Q6P6C2	ALKBH5	RNA demethylase ALKBH5	GO:0006397; P:mRNA processing; IMP:UniProtKB
Q6P6C2	ALKBH5	RNA demethylase ALKBH5	GO:0035553; P:oxidative single-stranded RNA demethylation; IDA:UniProtKB
Q6P6C2	ALKBH5	RNA demethylase ALKBH5	GO:0001666; P:response to hypoxia; IDA:UniProtKB
Q6P6C2	ALKBH5	RNA demethylase ALKBH5	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q3KRA9	ALKBH6	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q3KRA9	ALKBH6	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6	GO:0016706; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; IEA:InterPro
Q3KRA9	ALKBH6	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BT30	ALKBH7	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial	GO:0051213; F:dioxygenase activity; IEA:UniProtKB-KW
Q9BT30	ALKBH7	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BT30	ALKBH7	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q9BT30	ALKBH7	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial	GO:0006631; P:fatty acid metabolic process; ISS:UniProtKB
Q9BT30	ALKBH7	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial	GO:0010883; P:regulation of lipid storage; ISS:UniProtKB
Q9BT30	ALKBH7	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial	GO:1902445; P:regulation of mitochondrial membrane permeability involved in programmed necrotic cell death; IMP:UniProtKB
Q96BT7	ALKBH8	Alkylated DNA repair protein alkB homolog 8	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96BT7	ALKBH8	Alkylated DNA repair protein alkB homolog 8	GO:0016706; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; IEA:InterPro
Q96BT7	ALKBH8	Alkylated DNA repair protein alkB homolog 8	GO:0005515; F:protein binding; IPI:UniProtKB
Q96BT7	ALKBH8	Alkylated DNA repair protein alkB homolog 8	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q96BT7	ALKBH8	Alkylated DNA repair protein alkB homolog 8	GO:0016300; F:tRNA (uracil) methyltransferase activity; IDA:UniProtKB
Q96BT7	ALKBH8	Alkylated DNA repair protein alkB homolog 8	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q96BT7	ALKBH8	Alkylated DNA repair protein alkB homolog 8	GO:0030488; P:tRNA methylation; IDA:UniProtKB
Q6ZNB7	AGMO	Alkylglycerol monooxygenase	GO:0050479; F:glyceryl-ether monooxygenase activity; IDA:UniProtKB
Q6ZNB7	AGMO	Alkylglycerol monooxygenase	GO:0005506; F:iron ion binding; IMP:UniProtKB
Q6ZNB7	AGMO	Alkylglycerol monooxygenase	GO:0046485; P:ether lipid metabolic process; IDA:UniProtKB
Q6ZNB7	AGMO	Alkylglycerol monooxygenase	GO:0006633; P:fatty acid biosynthetic process; IEA:InterPro
Q6ZNB7	AGMO	Alkylglycerol monooxygenase	GO:0006643; P:membrane lipid metabolic process; IDA:UniProtKB
Q9UM73	ALK	ALK tyrosine kinase receptor	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UM73	ALK	ALK tyrosine kinase receptor	GO:0004704; F:NF-kappaB-inducing kinase activity; TAS:UniProtKB
Q9UM73	ALK	ALK tyrosine kinase receptor	GO:0005515; F:protein binding; IPI:IntAct
Q9UM73	ALK	ALK tyrosine kinase receptor	GO:0004713; F:protein tyrosine kinase activity; IDA:MGI
Q9UM73	ALK	ALK tyrosine kinase receptor	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IDA:UniProtKB
Q9UM73	ALK	ALK tyrosine kinase receptor	GO:0000187; P:activation of MAPK activity; TAS:UniProtKB
Q9UM73	ALK	ALK tyrosine kinase receptor	GO:0008283; P:cell proliferation; TAS:UniProtKB
Q9UM73	ALK	ALK tyrosine kinase receptor	GO:0048666; P:neuron development; TAS:UniProtKB
Q9UM73	ALK	ALK tyrosine kinase receptor	GO:0038061; P:NIK/NF-kappaB signaling; TAS:GOC
Q9UM73	ALK	ALK tyrosine kinase receptor	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:GOC
Q9UM73	ALK	ALK tyrosine kinase receptor	GO:0016310; P:phosphorylation; IDA:UniProtKB
Q9UM73	ALK	ALK tyrosine kinase receptor	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:UniProtKB
Q9UM73	ALK	ALK tyrosine kinase receptor	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q9UM73	ALK	ALK tyrosine kinase receptor	GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB
Q9UM73	ALK	ALK tyrosine kinase receptor	GO:0007165; P:signal transduction; TAS:UniProtKB
Q9UM73	ALK	ALK tyrosine kinase receptor	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:InterPro
Q8N6M5	ALLC	Probable allantoicase	GO:0004037; F:allantoicase activity; IEA:UniProtKB-EC
Q8N6M5	ALLC	Probable allantoicase	GO:0000256; P:allantoin catabolic process; IEA:InterPro
Q8TCU4	ALMS1	Alstrom syndrome protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q8TCU4	ALMS1	Alstrom syndrome protein 1	GO:0016197; P:endosomal transport; IMP:MGI
Q8TCU4	ALMS1	Alstrom syndrome protein 1	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q8TCU4	ALMS1	Alstrom syndrome protein 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8TCU4	ALMS1	Alstrom syndrome protein 1	GO:0051492; P:regulation of stress fiber assembly; IMP:MGI
Q96QP1	ALPK1	Alpha-protein kinase 1	GO:0005524; F:ATP binding; IEA:InterPro
Q96QP1	ALPK1	Alpha-protein kinase 1	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q86TB3	ALPK2	Alpha-protein kinase 2	GO:0005524; F:ATP binding; IEA:InterPro
Q86TB3	ALPK2	Alpha-protein kinase 2	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q96L96	ALPK3	Alpha-protein kinase 3	GO:0005524; F:ATP binding; IEA:InterPro
Q96L96	ALPK3	Alpha-protein kinase 3	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q96L96	ALPK3	Alpha-protein kinase 3	GO:0007507; P:heart development; ISS:HGNC
P55789	GFER	FAD-linked sulfhydryl oxidase ALR	GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB
P55789	GFER	FAD-linked sulfhydryl oxidase ALR	GO:0005515; F:protein binding; IPI:UniProtKB
P55789	GFER	FAD-linked sulfhydryl oxidase ALR	GO:0015035; F:protein disulfide oxidoreductase activity; IDA:UniProtKB
P55789	GFER	FAD-linked sulfhydryl oxidase ALR	GO:0016972; F:thiol oxidase activity; IEA:UniProtKB-EC
P55789	GFER	FAD-linked sulfhydryl oxidase ALR	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P55789	GFER	FAD-linked sulfhydryl oxidase ALR	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
Q96Q42	ALS2	Alsin	GO:0005515; F:protein binding; IPI:IntAct
Q96Q42	ALS2	Alsin	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q96Q42	ALS2	Alsin	GO:0043539; F:protein serine/threonine kinase activator activity; IDA:UniProtKB
Q96Q42	ALS2	Alsin	GO:0017137; F:Rab GTPase binding; IDA:UniProtKB
Q96Q42	ALS2	Alsin	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q96Q42	ALS2	Alsin	GO:0030676; F:Rac guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q96Q42	ALS2	Alsin	GO:0005087; F:Ran guanyl-nucleotide exchange factor activity; NAS:UniProtKB
Q96Q42	ALS2	Alsin	GO:0001662; P:behavioral fear response; IEA:Ensembl
Q96Q42	ALS2	Alsin	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q96Q42	ALS2	Alsin	GO:0016197; P:endosomal transport; IEA:Ensembl
Q96Q42	ALS2	Alsin	GO:0007032; P:endosome organization; NAS:UniProtKB
Q96Q42	ALS2	Alsin	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q96Q42	ALS2	Alsin	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
Q96Q42	ALS2	Alsin	GO:0048812; P:neuron projection morphogenesis; IDA:UniProtKB
Q96Q42	ALS2	Alsin	GO:0045860; P:positive regulation of protein kinase activity; IDA:UniProtKB
Q96Q42	ALS2	Alsin	GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IDA:GOC
Q96Q42	ALS2	Alsin	GO:0032855; P:positive regulation of Rac GTPase activity; IDA:UniProtKB
Q96Q42	ALS2	Alsin	GO:0035022; P:positive regulation of Rac protein signal transduction; IC:UniProtKB
Q96Q42	ALS2	Alsin	GO:0008104; P:protein localization; IEA:Ensembl
Q96Q42	ALS2	Alsin	GO:0001881; P:receptor recycling; IEA:Ensembl
Q96Q42	ALS2	Alsin	GO:0051036; P:regulation of endosome size; IEP:UniProtKB
Q96Q42	ALS2	Alsin	GO:0032314; P:regulation of Rac GTPase activity; IDA:GOC
Q96Q42	ALS2	Alsin	GO:0032316; P:regulation of Ran GTPase activity; NAS:GOC
Q96Q42	ALS2	Alsin	GO:0006979; P:response to oxidative stress; IEA:Ensembl
Q96Q42	ALS2	Alsin	GO:0035249; P:synaptic transmission, glutamatergic; IEA:Ensembl
Q96Q42	ALS2	Alsin	GO:0016050; P:vesicle organization; IEA:Ensembl
P35858	IGFALS	Insulin-like growth factor-binding protein complex acid labile subunit	GO:0005520; F:insulin-like growth factor binding; TAS:ProtInc
P35858	IGFALS	Insulin-like growth factor-binding protein complex acid labile subunit	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P35858	IGFALS	Insulin-like growth factor-binding protein complex acid labile subunit	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P35858	IGFALS	Insulin-like growth factor-binding protein complex acid labile subunit	GO:0007165; P:signal transduction; TAS:ProtInc
Q15699	ALX1	ALX homeobox protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q15699	ALX1	ALX homeobox protein 1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q15699	ALX1	ALX homeobox protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q15699	ALX1	ALX homeobox protein 1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q15699	ALX1	ALX homeobox protein 1	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q15699	ALX1	ALX homeobox protein 1	GO:0007420; P:brain development; TAS:ProtInc
Q15699	ALX1	ALX homeobox protein 1	GO:0001502; P:cartilage condensation; TAS:ProtInc
Q15699	ALX1	ALX homeobox protein 1	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
Q15699	ALX1	ALX homeobox protein 1	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
Q15699	ALX1	ALX homeobox protein 1	GO:0014031; P:mesenchymal cell development; IEA:Ensembl
Q15699	ALX1	ALX homeobox protein 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q15699	ALX1	ALX homeobox protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q15699	ALX1	ALX homeobox protein 1	GO:0001843; P:neural tube closure; IEA:Ensembl
Q15699	ALX1	ALX homeobox protein 1	GO:0060021; P:palate development; IEA:Ensembl
Q15699	ALX1	ALX homeobox protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q15699	ALX1	ALX homeobox protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q15699	ALX1	ALX homeobox protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
O95076	ALX3	Homeobox protein aristaless-like 3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O95076	ALX3	Homeobox protein aristaless-like 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O95076	ALX3	Homeobox protein aristaless-like 3	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
O95076	ALX3	Homeobox protein aristaless-like 3	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
O95076	ALX3	Homeobox protein aristaless-like 3	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
O95076	ALX3	Homeobox protein aristaless-like 3	GO:0007389; P:pattern specification process; IEA:Ensembl
O95076	ALX3	Homeobox protein aristaless-like 3	GO:0042981; P:regulation of apoptotic process; IEA:Ensembl
O95076	ALX3	Homeobox protein aristaless-like 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H161	ALX4	Homeobox protein aristaless-like 4	GO:0003677; F:DNA binding; NAS:UniProtKB
Q9H161	ALX4	Homeobox protein aristaless-like 4	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q9H161	ALX4	Homeobox protein aristaless-like 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q9H161	ALX4	Homeobox protein aristaless-like 4	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q9H161	ALX4	Homeobox protein aristaless-like 4	GO:0048565; P:digestive tract development; IEA:Ensembl
Q9H161	ALX4	Homeobox protein aristaless-like 4	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
Q9H161	ALX4	Homeobox protein aristaless-like 4	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
Q9H161	ALX4	Homeobox protein aristaless-like 4	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
Q9H161	ALX4	Homeobox protein aristaless-like 4	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
Q9H161	ALX4	Homeobox protein aristaless-like 4	GO:0001942; P:hair follicle development; IMP:UniProtKB
Q9H161	ALX4	Homeobox protein aristaless-like 4	GO:0007517; P:muscle organ development; IEA:Ensembl
Q9H161	ALX4	Homeobox protein aristaless-like 4	GO:0060021; P:palate development; IEA:Ensembl
Q9H161	ALX4	Homeobox protein aristaless-like 4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9H161	ALX4	Homeobox protein aristaless-like 4	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q9H161	ALX4	Homeobox protein aristaless-like 4	GO:0042981; P:regulation of apoptotic process; IEA:Ensembl
Q9H161	ALX4	Homeobox protein aristaless-like 4	GO:0001501; P:skeletal system development; NAS:UniProtKB
Q9H161	ALX4	Homeobox protein aristaless-like 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UHK6	AMACR	Alpha-methylacyl-CoA racemase	GO:0008111; F:alpha-methylacyl-CoA racemase activity; IDA:UniProtKB
Q9UHK6	AMACR	Alpha-methylacyl-CoA racemase	GO:0005102; F:receptor binding; IPI:UniProtKB
Q9UHK6	AMACR	Alpha-methylacyl-CoA racemase	GO:0006699; P:bile acid biosynthetic process; TAS:Reactome
Q9UHK6	AMACR	Alpha-methylacyl-CoA racemase	GO:0008206; P:bile acid metabolic process; IDA:UniProtKB
Q9UHK6	AMACR	Alpha-methylacyl-CoA racemase	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9UHK6	AMACR	Alpha-methylacyl-CoA racemase	GO:0033540; P:fatty acid beta-oxidation using acyl-CoA oxidase; TAS:Reactome
Q9UHK6	AMACR	Alpha-methylacyl-CoA racemase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NP70	AMBN	Ameloblastin	GO:0008083; F:growth factor activity; ISS:BHF-UCL
Q9NP70	AMBN	Ameloblastin	GO:0030345; F:structural constituent of tooth enamel; IEA:InterPro
Q9NP70	AMBN	Ameloblastin	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
Q9NP70	AMBN	Ameloblastin	GO:0007155; P:cell adhesion; ISS:BHF-UCL
Q9NP70	AMBN	Ameloblastin	GO:0008283; P:cell proliferation; ISS:BHF-UCL
Q9NP70	AMBN	Ameloblastin	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:InterPro
P02760	AMBP	Protein AMBP	GO:0019855; F:calcium channel inhibitor activity; NAS:UniProtKB
P02760	AMBP	Protein AMBP	GO:0046904; F:calcium oxalate binding; NAS:UniProtKB
P02760	AMBP	Protein AMBP	GO:0020037; F:heme binding; IDA:UniProtKB
P02760	AMBP	Protein AMBP	GO:0019862; F:IgA binding; IDA:UniProtKB
P02760	AMBP	Protein AMBP	GO:0005515; F:protein binding; IPI:IntAct
P02760	AMBP	Protein AMBP	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P02760	AMBP	Protein AMBP	GO:0004867; F:serine-type endopeptidase inhibitor activity; TAS:UniProtKB
P02760	AMBP	Protein AMBP	GO:0036094; F:small molecule binding; IEA:InterPro
P02760	AMBP	Protein AMBP	GO:0007155; P:cell adhesion; NAS:UniProtKB
P02760	AMBP	Protein AMBP	GO:0007565; P:female pregnancy; NAS:UniProtKB
P02760	AMBP	Protein AMBP	GO:0042167; P:heme catabolic process; NAS:UniProtKB
P02760	AMBP	Protein AMBP	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
P02760	AMBP	Protein AMBP	GO:0050777; P:negative regulation of immune response; NAS:UniProtKB
P02760	AMBP	Protein AMBP	GO:0046329; P:negative regulation of JNK cascade; TAS:UniProtKB
P02760	AMBP	Protein AMBP	GO:0030163; P:protein catabolic process; IEA:Ensembl
P02760	AMBP	Protein AMBP	GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW
P02760	AMBP	Protein AMBP	GO:0016032; P:viral process; IEA:UniProtKB-KW
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0005509; F:calcium ion binding; IEA:Ensembl
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0005507; F:copper ion binding; IEA:InterPro
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0004598; F:peptidylamidoglycolate lyase activity; IDA:UniProt
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0004504; F:peptidylglycine monooxygenase activity; IDA:UniProt
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0005515; F:protein binding; IPI:UniProtKB
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0008270; F:zinc ion binding; IDA:UniProt
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0007417; P:central nervous system development; IEA:Ensembl
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0007507; P:heart development; IEA:Ensembl
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0007595; P:lactation; IEA:Ensembl
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0060173; P:limb development; IEA:Ensembl
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0001676; P:long-chain fatty acid metabolic process; IEA:Ensembl
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0042476; P:odontogenesis; IEA:Ensembl
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0022602; P:ovulation cycle process; IEA:Ensembl
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0001519; P:peptide amidation; IDA:UniProt
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0018032; P:protein amidation; IEA:Ensembl
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0051260; P:protein homooligomerization; IEA:Ensembl
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0032956; P:regulation of actin cytoskeleton organization; IEA:Ensembl
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0050708; P:regulation of protein secretion; IEA:Ensembl
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0046688; P:response to copper ion; IEA:Ensembl
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0042493; P:response to drug; IEA:Ensembl
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0032355; P:response to estradiol; IEA:Ensembl
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0001666; P:response to hypoxia; IEA:Ensembl
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0009268; P:response to pH; IEA:Ensembl
P19021	PAM	Peptidyl-glycine alpha-amidating monooxygenase	GO:0009404; P:toxin metabolic process; IEA:Ensembl
Q99218	AMELY	Amelogenin, Y isoform	GO:0030345; F:structural constituent of tooth enamel; IDA:BHF-UCL
Q99218	AMELY	Amelogenin, Y isoform	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
Q99217	AMELX	Amelogenin, X isoform	GO:0008083; F:growth factor activity; ISS:BHF-UCL
Q99217	AMELX	Amelogenin, X isoform	GO:0046848; F:hydroxyapatite binding; ISS:BHF-UCL
Q99217	AMELX	Amelogenin, X isoform	GO:0042802; F:identical protein binding; ISS:BHF-UCL
Q99217	AMELX	Amelogenin, X isoform	GO:0005515; F:protein binding; IPI:BHF-UCL
Q99217	AMELX	Amelogenin, X isoform	GO:0030345; F:structural constituent of tooth enamel; IDA:BHF-UCL
Q99217	AMELX	Amelogenin, X isoform	GO:0031214; P:biomineral tissue development; TAS:BHF-UCL
Q99217	AMELX	Amelogenin, X isoform	GO:0007155; P:cell adhesion; ISS:BHF-UCL
Q99217	AMELX	Amelogenin, X isoform	GO:0008283; P:cell proliferation; ISS:BHF-UCL
Q99217	AMELX	Amelogenin, X isoform	GO:0002062; P:chondrocyte differentiation; ISS:BHF-UCL
Q99217	AMELX	Amelogenin, X isoform	GO:0070166; P:enamel mineralization; IMP:BHF-UCL
Q99217	AMELX	Amelogenin, X isoform	GO:0001837; P:epithelial to mesenchymal transition; ISS:BHF-UCL
Q99217	AMELX	Amelogenin, X isoform	GO:0050801; P:ion homeostasis; TAS:BHF-UCL
Q99217	AMELX	Amelogenin, X isoform	GO:0042475; P:odontogenesis of dentin-containing tooth; ISS:BHF-UCL
Q99217	AMELX	Amelogenin, X isoform	GO:0001649; P:osteoblast differentiation; ISS:BHF-UCL
Q99217	AMELX	Amelogenin, X isoform	GO:0032967; P:positive regulation of collagen biosynthetic process; ISS:BHF-UCL
Q99217	AMELX	Amelogenin, X isoform	GO:0070172; P:positive regulation of tooth mineralization; TAS:BHF-UCL
Q99217	AMELX	Amelogenin, X isoform	GO:0007165; P:signal transduction; TAS:BHF-UCL
Q99217	AMELX	Amelogenin, X isoform	GO:0034505; P:tooth mineralization; IMP:BHF-UCL
Q5JTC6	AMER1	APC membrane recruitment protein 1	GO:0008013; F:beta-catenin binding; IDA:UniProtKB
Q5JTC6	AMER1	APC membrane recruitment protein 1	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProtKB
Q5JTC6	AMER1	APC membrane recruitment protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q5JTC6	AMER1	APC membrane recruitment protein 1	GO:0060612; P:adipose tissue development; IEA:Ensembl
Q5JTC6	AMER1	APC membrane recruitment protein 1	GO:0060348; P:bone development; IEA:Ensembl
Q5JTC6	AMER1	APC membrane recruitment protein 1	GO:0072161; P:mesenchymal cell differentiation involved in kidney development; IEA:Ensembl
Q5JTC6	AMER1	APC membrane recruitment protein 1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:UniProtKB
Q5JTC6	AMER1	APC membrane recruitment protein 1	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:UniProtKB
Q5JTC6	AMER1	APC membrane recruitment protein 1	GO:0060828; P:regulation of canonical Wnt signaling pathway; IMP:UniProtKB
Q5JTC6	AMER1	APC membrane recruitment protein 1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q8N7J2	AMER2	APC membrane recruitment protein 2	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProtKB
Q8N7J2	AMER2	APC membrane recruitment protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N7J2	AMER2	APC membrane recruitment protein 2	GO:0007398; P:ectoderm development; ISS:UniProtKB
Q8N7J2	AMER2	APC membrane recruitment protein 2	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:UniProtKB
Q8N7J2	AMER2	APC membrane recruitment protein 2	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q8N944	AMER3	APC membrane recruitment protein 3	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q8N944	AMER3	APC membrane recruitment protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q8N944	AMER3	APC membrane recruitment protein 3	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9UKV5	AMFR	E3 ubiquitin-protein ligase AMFR	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKV5	AMFR	E3 ubiquitin-protein ligase AMFR	GO:0004872; F:receptor activity; IPI:UniProtKB
Q9UKV5	AMFR	E3 ubiquitin-protein ligase AMFR	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9UKV5	AMFR	E3 ubiquitin-protein ligase AMFR	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UKV5	AMFR	E3 ubiquitin-protein ligase AMFR	GO:0007568; P:aging; IEA:Ensembl
Q9UKV5	AMFR	E3 ubiquitin-protein ligase AMFR	GO:0006928; P:cellular component movement; TAS:ProtInc
Q9UKV5	AMFR	E3 ubiquitin-protein ligase AMFR	GO:0030968; P:endoplasmic reticulum unfolded protein response; IMP:UniProtKB
Q9UKV5	AMFR	E3 ubiquitin-protein ligase AMFR	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9UKV5	AMFR	E3 ubiquitin-protein ligase AMFR	GO:0007611; P:learning or memory; IEA:Ensembl
Q9UKV5	AMFR	E3 ubiquitin-protein ligase AMFR	GO:0051259; P:protein oligomerization; IDA:UniProtKB
Q9UKV5	AMFR	E3 ubiquitin-protein ligase AMFR	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q9UKV5	AMFR	E3 ubiquitin-protein ligase AMFR	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UKV5	AMFR	E3 ubiquitin-protein ligase AMFR	GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q86WK6	AMIGO1	Amphoterin-induced protein 1	GO:0007413; P:axonal fasciculation; ISS:UniProtKB
Q86WK6	AMIGO1	Amphoterin-induced protein 1	GO:0007409; P:axonogenesis; IEA:Ensembl
Q86WK6	AMIGO1	Amphoterin-induced protein 1	GO:0007157; P:heterophilic cell-cell adhesion; ISS:UniProtKB
Q86WK6	AMIGO1	Amphoterin-induced protein 1	GO:0007156; P:homophilic cell adhesion; ISS:UniProtKB
Q86WK6	AMIGO1	Amphoterin-induced protein 1	GO:0042552; P:myelination; ISS:UniProtKB
Q86WK6	AMIGO1	Amphoterin-induced protein 1	GO:0050772; P:positive regulation of axonogenesis; ISS:UniProtKB
Q86SJ2	AMIGO2	Amphoterin-induced protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q86SJ2	AMIGO2	Amphoterin-induced protein 2	GO:0007157; P:heterophilic cell-cell adhesion; ISS:UniProtKB
Q86SJ2	AMIGO2	Amphoterin-induced protein 2	GO:0007156; P:homophilic cell adhesion; ISS:UniProtKB
Q86SJ2	AMIGO2	Amphoterin-induced protein 2	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q86SJ2	AMIGO2	Amphoterin-induced protein 2	GO:0043069; P:negative regulation of programmed cell death; ISS:UniProtKB
Q86WK7	AMIGO3	Amphoterin-induced protein 3	GO:0007157; P:heterophilic cell-cell adhesion; ISS:UniProtKB
Q16671	AMHR2	Anti-Muellerian hormone type-2 receptor	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q16671	AMHR2	Anti-Muellerian hormone type-2 receptor	GO:0042562; F:hormone binding; IPI:UniProtKB
Q16671	AMHR2	Anti-Muellerian hormone type-2 receptor	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q16671	AMHR2	Anti-Muellerian hormone type-2 receptor	GO:0005515; F:protein binding; IPI:IntAct
Q16671	AMHR2	Anti-Muellerian hormone type-2 receptor	GO:0004872; F:receptor activity; IMP:UniProtKB
Q16671	AMHR2	Anti-Muellerian hormone type-2 receptor	GO:0005026; F:transforming growth factor beta receptor activity, type II; IEA:Ensembl
Q16671	AMHR2	Anti-Muellerian hormone type-2 receptor	GO:0001880; P:Mullerian duct regression; NAS:UniProtKB
Q16671	AMHR2	Anti-Muellerian hormone type-2 receptor	GO:0007548; P:sex differentiation; ISS:UniProtKB
Q16671	AMHR2	Anti-Muellerian hormone type-2 receptor	GO:0007165; P:signal transduction; IMP:UniProtKB
Q16671	AMHR2	Anti-Muellerian hormone type-2 receptor	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl
Q9Y4X0	AMMECR1	AMME syndrome candidate gene 1 protein	GO:0005515; F:protein binding; IPI:IntAct
Q9BXJ7	AMN	Protein amnionless	GO:0005102; F:receptor binding; IPI:UniProt
Q9BXJ7	AMN	Protein amnionless	GO:0009235; P:cobalamin metabolic process; TAS:Reactome
Q9BXJ7	AMN	Protein amnionless	GO:0015889; P:cobalamin transport; IDA:UniProt
Q9BXJ7	AMN	Protein amnionless	GO:0007588; P:excretion; IEA:Ensembl
Q9BXJ7	AMN	Protein amnionless	GO:0043001; P:Golgi to plasma membrane protein transport; IDA:UniProt
Q9BXJ7	AMN	Protein amnionless	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
Q9BXJ7	AMN	Protein amnionless	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9BXJ7	AMN	Protein amnionless	GO:0006898; P:receptor-mediated endocytosis; IDA:UniProt
Q9BXJ7	AMN	Protein amnionless	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BXJ7	AMN	Protein amnionless	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9BXJ7	AMN	Protein amnionless	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q8IY63	AMOTL1	Angiomotin-like protein 1	GO:0042802; F:identical protein binding; IDA:MGI
Q8IY63	AMOTL1	Angiomotin-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IY63	AMOTL1	Angiomotin-like protein 1	GO:0003365; P:establishment of cell polarity involved in ameboidal cell migration; IEA:Ensembl
Q8IY63	AMOTL1	Angiomotin-like protein 1	GO:0035329; P:hippo signaling; TAS:Reactome
Q8IY63	AMOTL1	Angiomotin-like protein 1	GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IEA:Ensembl
Q8IY63	AMOTL1	Angiomotin-like protein 1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9Y2J4	AMOTL2	Angiomotin-like protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y2J4	AMOTL2	Angiomotin-like protein 2	GO:0035329; P:hippo signaling; TAS:Reactome
Q9Y2J4	AMOTL2	Angiomotin-like protein 2	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q4VCS5	AMOT	Angiomotin	GO:0043532; F:angiostatin binding; IDA:UniProtKB
Q4VCS5	AMOT	Angiomotin	GO:0005515; F:protein binding; IPI:IntAct
Q4VCS5	AMOT	Angiomotin	GO:0004872; F:receptor activity; IDA:MGI
Q4VCS5	AMOT	Angiomotin	GO:0030036; P:actin cytoskeleton organization; TAS:UniProtKB
Q4VCS5	AMOT	Angiomotin	GO:0043534; P:blood vessel endothelial cell migration; IEA:Ensembl
Q4VCS5	AMOT	Angiomotin	GO:0042074; P:cell migration involved in gastrulation; IEA:Ensembl
Q4VCS5	AMOT	Angiomotin	GO:0007043; P:cell-cell junction assembly; TAS:UniProtKB
Q4VCS5	AMOT	Angiomotin	GO:0034613; P:cellular protein localization; IDA:MGI
Q4VCS5	AMOT	Angiomotin	GO:0006935; P:chemotaxis; IEA:Ensembl
Q4VCS5	AMOT	Angiomotin	GO:0003365; P:establishment of cell polarity involved in ameboidal cell migration; IEA:Ensembl
Q4VCS5	AMOT	Angiomotin	GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl
Q4VCS5	AMOT	Angiomotin	GO:0035329; P:hippo signaling; IGI:MGI
Q4VCS5	AMOT	Angiomotin	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q4VCS5	AMOT	Angiomotin	GO:0016525; P:negative regulation of angiogenesis; IDA:MGI
Q4VCS5	AMOT	Angiomotin	GO:0034260; P:negative regulation of GTPase activity; IEA:Ensembl
Q4VCS5	AMOT	Angiomotin	GO:0043116; P:negative regulation of vascular permeability; IDA:UniProtKB
Q4VCS5	AMOT	Angiomotin	GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IDA:UniProtKB
Q4VCS5	AMOT	Angiomotin	GO:0045793; P:positive regulation of cell size; TAS:UniProtKB
Q4VCS5	AMOT	Angiomotin	GO:0040019; P:positive regulation of embryonic development; IEA:Ensembl
Q4VCS5	AMOT	Angiomotin	GO:0051496; P:positive regulation of stress fiber assembly; TAS:UniProtKB
Q4VCS5	AMOT	Angiomotin	GO:0030334; P:regulation of cell migration; IDA:MGI
Q4VCS5	AMOT	Angiomotin	GO:0051056; P:regulation of small GTPase mediated signal transduction; IEA:Ensembl
Q4VCS5	AMOT	Angiomotin	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q9H4A4	RNPEP	Aminopeptidase B	GO:0004177; F:aminopeptidase activity; ISS:UniProtKB
Q9H4A4	RNPEP	Aminopeptidase B	GO:0004301; F:epoxide hydrolase activity; NAS:UniProtKB
Q9H4A4	RNPEP	Aminopeptidase B	GO:0008235; F:metalloexopeptidase activity; NAS:UniProtKB
Q9H4A4	RNPEP	Aminopeptidase B	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9H4A4	RNPEP	Aminopeptidase B	GO:0019370; P:leukotriene biosynthetic process; IEA:InterPro
Q9H4A4	RNPEP	Aminopeptidase B	GO:0006508; P:proteolysis; IC:UniProtKB
P23109	AMPD1	AMP deaminase 1	GO:0003876; F:AMP deaminase activity; TAS:ProtInc
P23109	AMPD1	AMP deaminase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P23109	AMPD1	AMP deaminase 1	GO:0032264; P:IMP salvage; IEA:UniProtKB-UniPathway
P23109	AMPD1	AMP deaminase 1	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P23109	AMPD1	AMP deaminase 1	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P23109	AMPD1	AMP deaminase 1	GO:0043101; P:purine-containing compound salvage; TAS:Reactome
P23109	AMPD1	AMP deaminase 1	GO:0010033; P:response to organic substance; IEA:Ensembl
P23109	AMPD1	AMP deaminase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q01433	AMPD2	AMP deaminase 2	GO:0003876; F:AMP deaminase activity; NAS:UniProtKB
Q01433	AMPD2	AMP deaminase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q01433	AMPD2	AMP deaminase 2	GO:0097009; P:energy homeostasis; IGI:MGI
Q01433	AMPD2	AMP deaminase 2	GO:0006188; P:IMP biosynthetic process; IGI:MGI
Q01433	AMPD2	AMP deaminase 2	GO:0032264; P:IMP salvage; IEA:UniProtKB-UniPathway
Q01433	AMPD2	AMP deaminase 2	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q01433	AMPD2	AMP deaminase 2	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
Q01433	AMPD2	AMP deaminase 2	GO:0043101; P:purine-containing compound salvage; TAS:Reactome
Q01433	AMPD2	AMP deaminase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q01432	AMPD3	AMP deaminase 3	GO:0003876; F:AMP deaminase activity; TAS:ProtInc
Q01432	AMPD3	AMP deaminase 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q01432	AMPD3	AMP deaminase 3	GO:0006196; P:AMP catabolic process; TAS:ProtInc
Q01432	AMPD3	AMP deaminase 3	GO:0032264; P:IMP salvage; IEA:UniProtKB-UniPathway
Q01432	AMPD3	AMP deaminase 3	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q01432	AMPD3	AMP deaminase 3	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
Q01432	AMPD3	AMP deaminase 3	GO:0043101; P:purine-containing compound salvage; TAS:Reactome
Q01432	AMPD3	AMP deaminase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q07075	ENPEP	Glutamyl aminopeptidase	GO:0004177; F:aminopeptidase activity; IDA:UniProtKB
Q07075	ENPEP	Glutamyl aminopeptidase	GO:0070006; F:metalloaminopeptidase activity; IDA:UniProtKB
Q07075	ENPEP	Glutamyl aminopeptidase	GO:0008237; F:metallopeptidase activity; EXP:Reactome
Q07075	ENPEP	Glutamyl aminopeptidase	GO:0008270; F:zinc ion binding; IEA:InterPro
Q07075	ENPEP	Glutamyl aminopeptidase	GO:0001525; P:angiogenesis; ISS:UniProtKB
Q07075	ENPEP	Glutamyl aminopeptidase	GO:0002005; P:angiotensin catabolic process in blood; NAS:UniProtKB
Q07075	ENPEP	Glutamyl aminopeptidase	GO:0002003; P:angiotensin maturation; TAS:Reactome
Q07075	ENPEP	Glutamyl aminopeptidase	GO:0016477; P:cell migration; IDA:MGI
Q07075	ENPEP	Glutamyl aminopeptidase	GO:0008283; P:cell proliferation; NAS:UniProtKB
Q07075	ENPEP	Glutamyl aminopeptidase	GO:0007267; P:cell-cell signaling; NAS:UniProtKB
Q07075	ENPEP	Glutamyl aminopeptidase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q07075	ENPEP	Glutamyl aminopeptidase	GO:0032835; P:glomerulus development; ISS:UniProtKB
Q07075	ENPEP	Glutamyl aminopeptidase	GO:0003081; P:regulation of systemic arterial blood pressure by renin-angiotensin; IDA:UniProtKB
P49418	AMPH	Amphiphysin	GO:0005543; F:phospholipid binding; IDA:FlyBase
P49418	AMPH	Amphiphysin	GO:0005515; F:protein binding; IPI:UniProtKB
P49418	AMPH	Amphiphysin	GO:0006897; P:endocytosis; TAS:ProtInc
P49418	AMPH	Amphiphysin	GO:0007612; P:learning; IEA:Ensembl
P49418	AMPH	Amphiphysin	GO:0007268; P:synaptic transmission; TAS:ProtInc
P49418	AMPH	Amphiphysin	GO:0048488; P:synaptic vesicle endocytosis; IEA:Ensembl
P28838	LAP3	Cytosol aminopeptidase	GO:0004177; F:aminopeptidase activity; NAS:UniProtKB
P28838	LAP3	Cytosol aminopeptidase	GO:0030145; F:manganese ion binding; IEA:InterPro
P28838	LAP3	Cytosol aminopeptidase	GO:0008235; F:metalloexopeptidase activity; NAS:UniProtKB
P28838	LAP3	Cytosol aminopeptidase	GO:0006508; P:proteolysis; NAS:UniProtKB
P15144	ANPEP	Aminopeptidase N	GO:0004177; F:aminopeptidase activity; TAS:ProtInc
P15144	ANPEP	Aminopeptidase N	GO:0008237; F:metallopeptidase activity; TAS:ProtInc
P15144	ANPEP	Aminopeptidase N	GO:0004872; F:receptor activity; TAS:ProtInc
P15144	ANPEP	Aminopeptidase N	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
P15144	ANPEP	Aminopeptidase N	GO:0008270; F:zinc ion binding; IEA:InterPro
P15144	ANPEP	Aminopeptidase N	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P15144	ANPEP	Aminopeptidase N	GO:0002003; P:angiotensin maturation; TAS:Reactome
P15144	ANPEP	Aminopeptidase N	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P15144	ANPEP	Aminopeptidase N	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P15144	ANPEP	Aminopeptidase N	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q8N6M6	AOPEP	Aminopeptidase O	GO:0004177; F:aminopeptidase activity; IDA:UniProtKB
Q8N6M6	AOPEP	Aminopeptidase O	GO:0008237; F:metallopeptidase activity; IDA:UniProtKB
Q8N6M6	AOPEP	Aminopeptidase O	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N6M6	AOPEP	Aminopeptidase O	GO:0019370; P:leukotriene biosynthetic process; IEA:InterPro
Q8N6M6	AOPEP	Aminopeptidase O	GO:0006508; P:proteolysis; IDA:UniProtKB
Q6Q4G3	AQPEP	Aminopeptidase Q	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
Q6Q4G3	AQPEP	Aminopeptidase Q	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9C0C7	AMBRA1	Activating molecule in BECN1-regulated autophagy protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9C0C7	AMBRA1	Activating molecule in BECN1-regulated autophagy protein 1	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q9C0C7	AMBRA1	Activating molecule in BECN1-regulated autophagy protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9C0C7	AMBRA1	Activating molecule in BECN1-regulated autophagy protein 1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q9C0C7	AMBRA1	Activating molecule in BECN1-regulated autophagy protein 1	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q9C0C7	AMBRA1	Activating molecule in BECN1-regulated autophagy protein 1	GO:0021915; P:neural tube development; IEA:Ensembl
P30533	LRPAP1	Alpha-2-macroglobulin receptor-associated protein	GO:0004873; F:asialoglycoprotein receptor activity; TAS:ProtInc
P30533	LRPAP1	Alpha-2-macroglobulin receptor-associated protein	GO:0008201; F:heparin binding; TAS:ProtInc
P30533	LRPAP1	Alpha-2-macroglobulin receptor-associated protein	GO:0050750; F:low-density lipoprotein particle receptor binding; IDA:MGI
P30533	LRPAP1	Alpha-2-macroglobulin receptor-associated protein	GO:0005515; F:protein binding; IPI:IntAct
P30533	LRPAP1	Alpha-2-macroglobulin receptor-associated protein	GO:0048019; F:receptor antagonist activity; IDA:BHF-UCL
P30533	LRPAP1	Alpha-2-macroglobulin receptor-associated protein	GO:0051082; F:unfolded protein binding; TAS:ProtInc
P30533	LRPAP1	Alpha-2-macroglobulin receptor-associated protein	GO:0070326; F:very-low-density lipoprotein particle receptor binding; IPI:BHF-UCL
P30533	LRPAP1	Alpha-2-macroglobulin receptor-associated protein	GO:1900116; P:extracellular negative regulation of signal transduction; IDA:GOC
P30533	LRPAP1	Alpha-2-macroglobulin receptor-associated protein	GO:1900222; P:negative regulation of beta-amyloid clearance; IGI:BHF-UCL
P30533	LRPAP1	Alpha-2-macroglobulin receptor-associated protein	GO:0032091; P:negative regulation of protein binding; IDA:BHF-UCL
P30533	LRPAP1	Alpha-2-macroglobulin receptor-associated protein	GO:0010916; P:negative regulation of very-low-density lipoprotein particle clearance; IDA:BHF-UCL
P30533	LRPAP1	Alpha-2-macroglobulin receptor-associated protein	GO:0006457; P:protein folding; TAS:ProtInc
P30533	LRPAP1	Alpha-2-macroglobulin receptor-associated protein	GO:0006898; P:receptor-mediated endocytosis; TAS:GOC
P30533	LRPAP1	Alpha-2-macroglobulin receptor-associated protein	GO:0016192; P:vesicle-mediated transport; TAS:ProtInc
Q6UX39	AMTN	Amelotin	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
Q6UX39	AMTN	Amelotin	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q6UX39	AMTN	Amelotin	GO:0042475; P:odontogenesis of dentin-containing tooth; ISS:HGNC
P04745	AMY1A	Alpha-amylase 1	GO:0004556; F:alpha-amylase activity; TAS:ProtInc
P04745	AMY1A	Alpha-amylase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P04745	AMY1A	Alpha-amylase 1	GO:0005515; F:protein binding; IPI:IntAct
P04745	AMY1A	Alpha-amylase 1	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
P04745	AMY1A	Alpha-amylase 1	GO:0007586; P:digestion; TAS:ProtInc
P19961	AMY2B	Alpha-amylase 2B	GO:0004556; F:alpha-amylase activity; TAS:ProtInc
P19961	AMY2B	Alpha-amylase 2B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P19961	AMY2B	Alpha-amylase 2B	GO:0005975; P:carbohydrate metabolic process; NAS:ProtInc
P19961	AMY2B	Alpha-amylase 2B	GO:0007586; P:digestion; TAS:ProtInc
P04746	AMY2A	Pancreatic alpha-amylase	GO:0004556; F:alpha-amylase activity; IDA:UniProtKB
P04746	AMY2A	Pancreatic alpha-amylase	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P04746	AMY2A	Pancreatic alpha-amylase	GO:0031404; F:chloride ion binding; IDA:UniProtKB
P04746	AMY2A	Pancreatic alpha-amylase	GO:0016052; P:carbohydrate catabolic process; IDA:UniProtKB
P04746	AMY2A	Pancreatic alpha-amylase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P04746	AMY2A	Pancreatic alpha-amylase	GO:0044245; P:polysaccharide digestion; TAS:Reactome
P04746	AMY2A	Pancreatic alpha-amylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q400G9	AMZ1	Archaemetzincin-1	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
Q400G9	AMZ1	Archaemetzincin-1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86W34	AMZ2	Archaemetzincin-2	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
Q86W34	AMZ2	Archaemetzincin-2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N6S4	ANKRD13C	Ankyrin repeat domain-containing protein 13C	GO:0005102; F:receptor binding; IPI:BHF-UCL
Q8N6S4	ANKRD13C	Ankyrin repeat domain-containing protein 13C	GO:0006621; P:protein retention in ER lumen; IMP:BHF-UCL
Q8N6S4	ANKRD13C	Ankyrin repeat domain-containing protein 13C	GO:2000209; P:regulation of anoikis; IDA:BHF-UCL
Q8N6S4	ANKRD13C	Ankyrin repeat domain-containing protein 13C	GO:0010869; P:regulation of receptor biosynthetic process; IDA:BHF-UCL
Q9BXX3	ANKRD30A	Ankyrin repeat domain-containing protein 30A	GO:0003677; F:DNA binding; NAS:UniProtKB
Q9BXX3	ANKRD30A	Ankyrin repeat domain-containing protein 30A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9BXX3	ANKRD30A	Ankyrin repeat domain-containing protein 30A	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P39687	ANP32A	Acidic leucine-rich nuclear phosphoprotein 32 family member A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P39687	ANP32A	Acidic leucine-rich nuclear phosphoprotein 32 family member A	GO:0005515; F:protein binding; IPI:IntAct
P39687	ANP32A	Acidic leucine-rich nuclear phosphoprotein 32 family member A	GO:0010467; P:gene expression; TAS:Reactome
P39687	ANP32A	Acidic leucine-rich nuclear phosphoprotein 32 family member A	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
P39687	ANP32A	Acidic leucine-rich nuclear phosphoprotein 32 family member A	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P39687	ANP32A	Acidic leucine-rich nuclear phosphoprotein 32 family member A	GO:0006913; P:nucleocytoplasmic transport; IDA:UniProtKB
P39687	ANP32A	Acidic leucine-rich nuclear phosphoprotein 32 family member A	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P39687	ANP32A	Acidic leucine-rich nuclear phosphoprotein 32 family member A	GO:0016070; P:RNA metabolic process; TAS:Reactome
P39687	ANP32A	Acidic leucine-rich nuclear phosphoprotein 32 family member A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q92688	ANP32B	Acidic leucine-rich nuclear phosphoprotein 32 family member B	GO:0042393; F:histone binding; IDA:UniProt
Q92688	ANP32B	Acidic leucine-rich nuclear phosphoprotein 32 family member B	GO:0070063; F:RNA polymerase binding; IDA:UniProt
Q92688	ANP32B	Acidic leucine-rich nuclear phosphoprotein 32 family member B	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProt
Q92688	ANP32B	Acidic leucine-rich nuclear phosphoprotein 32 family member B	GO:0045596; P:negative regulation of cell differentiation; IDA:UniProt
Q92688	ANP32B	Acidic leucine-rich nuclear phosphoprotein 32 family member B	GO:0006334; P:nucleosome assembly; IDA:UniProt
Q92688	ANP32B	Acidic leucine-rich nuclear phosphoprotein 32 family member B	GO:0046827; P:positive regulation of protein export from nucleus; IMP:UniProt
Q9BTT0	ANP32E	Acidic leucine-rich nuclear phosphoprotein 32 family member E	GO:0042393; F:histone binding; IDA:UniProtKB
Q9BTT0	ANP32E	Acidic leucine-rich nuclear phosphoprotein 32 family member E	GO:0019212; F:phosphatase inhibitor activity; ISS:UniProtKB
Q9BTT0	ANP32E	Acidic leucine-rich nuclear phosphoprotein 32 family member E	GO:0043486; P:histone exchange; IDA:UniProtKB
Q9BTT0	ANP32E	Acidic leucine-rich nuclear phosphoprotein 32 family member E	GO:0043086; P:negative regulation of catalytic activity; ISS:GOC
P54802	NAGLU	Alpha-N-acetylglucosaminidase	GO:0004561; F:alpha-N-acetylglucosaminidase activity; TAS:ProtInc
P54802	NAGLU	Alpha-N-acetylglucosaminidase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P54802	NAGLU	Alpha-N-acetylglucosaminidase	GO:0021680; P:cerebellar Purkinje cell layer development; IEA:Ensembl
P54802	NAGLU	Alpha-N-acetylglucosaminidase	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
P54802	NAGLU	Alpha-N-acetylglucosaminidase	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P54802	NAGLU	Alpha-N-acetylglucosaminidase	GO:0060119; P:inner ear receptor cell development; IEA:Ensembl
P54802	NAGLU	Alpha-N-acetylglucosaminidase	GO:0045475; P:locomotor rhythm; IEA:Ensembl
P54802	NAGLU	Alpha-N-acetylglucosaminidase	GO:0007040; P:lysosome organization; IEA:Ensembl
P54802	NAGLU	Alpha-N-acetylglucosaminidase	GO:0042474; P:middle ear morphogenesis; IEA:Ensembl
P54802	NAGLU	Alpha-N-acetylglucosaminidase	GO:0007399; P:nervous system development; TAS:ProtInc
P54802	NAGLU	Alpha-N-acetylglucosaminidase	GO:0046548; P:retinal rod cell development; IEA:Ensembl
P54802	NAGLU	Alpha-N-acetylglucosaminidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5JPF3	ANKRD36C	Ankyrin repeat domain-containing protein 36C	GO:0008200; F:ion channel inhibitor activity; NAS:UniProtKB
Q9UJX6	ANAPC2	Anaphase-promoting complex subunit 2	GO:0004842; F:ubiquitin-protein ligase activity; TAS:ProtInc
Q9UJX6	ANAPC2	Anaphase-promoting complex subunit 2	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q9UJX6	ANAPC2	Anaphase-promoting complex subunit 2	GO:0008054; P:cyclin catabolic process; TAS:ProtInc
Q9UJX6	ANAPC2	Anaphase-promoting complex subunit 2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9UJX6	ANAPC2	Anaphase-promoting complex subunit 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9UJX6	ANAPC2	Anaphase-promoting complex subunit 2	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:Reactome
Q9UJX6	ANAPC2	Anaphase-promoting complex subunit 2	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UJX6	ANAPC2	Anaphase-promoting complex subunit 2	GO:0045773; P:positive regulation of axon extension; IEA:Ensembl
Q9UJX6	ANAPC2	Anaphase-promoting complex subunit 2	GO:0050775; P:positive regulation of dendrite morphogenesis; IEA:Ensembl
Q9UJX6	ANAPC2	Anaphase-promoting complex subunit 2	GO:0090129; P:positive regulation of synapse maturation; ISS:UniProtKB
Q9UJX6	ANAPC2	Anaphase-promoting complex subunit 2	GO:0031915; P:positive regulation of synaptic plasticity; ISS:UniProtKB
Q9UJX6	ANAPC2	Anaphase-promoting complex subunit 2	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UJX6	ANAPC2	Anaphase-promoting complex subunit 2	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
Q9UJX6	ANAPC2	Anaphase-promoting complex subunit 2	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
Q9UJX6	ANAPC2	Anaphase-promoting complex subunit 2	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UJX6	ANAPC2	Anaphase-promoting complex subunit 2	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
P10275	AR	Androgen receptor	GO:0005497; F:androgen binding; NAS:UniProtKB
P10275	AR	Androgen receptor	GO:0004882; F:androgen receptor activity; IDA:UniProtKB
P10275	AR	Androgen receptor	GO:0008013; F:beta-catenin binding; IDA:BHF-UCL
P10275	AR	Androgen receptor	GO:0003682; F:chromatin binding; IDA:UniProtKB
P10275	AR	Androgen receptor	GO:0003677; F:DNA binding; NAS:UniProtKB
P10275	AR	Androgen receptor	GO:0019899; F:enzyme binding; IPI:UniProtKB
P10275	AR	Androgen receptor	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:BHF-UCL
P10275	AR	Androgen receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P10275	AR	Androgen receptor	GO:0046983; F:protein dimerization activity; NAS:UniProtKB
P10275	AR	Androgen receptor	GO:0005102; F:receptor binding; IPI:UniProtKB
P10275	AR	Androgen receptor	GO:0001085; F:RNA polymerase II transcription factor binding; IPI:BHF-UCL
P10275	AR	Androgen receptor	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P10275	AR	Androgen receptor	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P10275	AR	Androgen receptor	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P10275	AR	Androgen receptor	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P10275	AR	Androgen receptor	GO:0008270; F:zinc ion binding; IEA:InterPro
P10275	AR	Androgen receptor	GO:0030521; P:androgen receptor signaling pathway; IDA:UniProtKB
P10275	AR	Androgen receptor	GO:0008219; P:cell death; IEA:UniProtKB-KW
P10275	AR	Androgen receptor	GO:0016049; P:cell growth; NAS:UniProtKB
P10275	AR	Androgen receptor	GO:0008283; P:cell proliferation; NAS:UniProtKB
P10275	AR	Androgen receptor	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P10275	AR	Androgen receptor	GO:0010467; P:gene expression; TAS:Reactome
P10275	AR	Androgen receptor	GO:0030522; P:intracellular receptor signaling pathway; IDA:BHF-UCL
P10275	AR	Androgen receptor	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IDA:BHF-UCL
P10275	AR	Androgen receptor	GO:0045720; P:negative regulation of integrin biosynthetic process; IDA:BHF-UCL
P10275	AR	Androgen receptor	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P10275	AR	Androgen receptor	GO:0045726; P:positive regulation of integrin biosynthetic process; IDA:BHF-UCL
P10275	AR	Androgen receptor	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:BHF-UCL
P10275	AR	Androgen receptor	GO:0042327; P:positive regulation of phosphorylation; IMP:BHF-UCL
P10275	AR	Androgen receptor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P10275	AR	Androgen receptor	GO:0045945; P:positive regulation of transcription from RNA polymerase III promoter; IDA:BHF-UCL
P10275	AR	Androgen receptor	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P10275	AR	Androgen receptor	GO:0030850; P:prostate gland development; NAS:UniProtKB
P10275	AR	Androgen receptor	GO:0051259; P:protein oligomerization; IDA:MGI
P10275	AR	Androgen receptor	GO:0090003; P:regulation of establishment of protein localization to plasma membrane; IDA:BHF-UCL
P10275	AR	Androgen receptor	GO:0007548; P:sex differentiation; NAS:UniProtKB
P10275	AR	Androgen receptor	GO:0007165; P:signal transduction; TAS:ProtInc
P10275	AR	Androgen receptor	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P10275	AR	Androgen receptor	GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB
P10275	AR	Androgen receptor	GO:0006810; P:transport; TAS:ProtInc
P16860	NPPB	Natriuretic peptides B	GO:0008613; F:diuretic hormone activity; TAS:UniProtKB
P16860	NPPB	Natriuretic peptides B	GO:0005179; F:hormone activity; NAS:UniProtKB
P16860	NPPB	Natriuretic peptides B	GO:0005102; F:receptor binding; IDA:UniProtKB
P16860	NPPB	Natriuretic peptides B	GO:0007589; P:body fluid secretion; TAS:UniProtKB
P16860	NPPB	Natriuretic peptides B	GO:0007166; P:cell surface receptor signaling pathway; NAS:UniProtKB
P16860	NPPB	Natriuretic peptides B	GO:0006182; P:cGMP biosynthetic process; IDA:UniProtKB
P16860	NPPB	Natriuretic peptides B	GO:0016525; P:negative regulation of angiogenesis; TAS:UniProtKB
P16860	NPPB	Natriuretic peptides B	GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB
P16860	NPPB	Natriuretic peptides B	GO:0035815; P:positive regulation of renal sodium excretion; TAS:UniProtKB
P16860	NPPB	Natriuretic peptides B	GO:0035810; P:positive regulation of urine volume; TAS:UniProtKB
P16860	NPPB	Natriuretic peptides B	GO:0007168; P:receptor guanylyl cyclase signaling pathway; IDA:UniProtKB
P16860	NPPB	Natriuretic peptides B	GO:0008217; P:regulation of blood pressure; NAS:UniProtKB
P16860	NPPB	Natriuretic peptides B	GO:0050880; P:regulation of blood vessel size; IEA:UniProtKB-KW
P16860	NPPB	Natriuretic peptides B	GO:0043114; P:regulation of vascular permeability; TAS:UniProtKB
P16860	NPPB	Natriuretic peptides B	GO:0042312; P:regulation of vasodilation; NAS:UniProtKB
P23582	NPPC	C-type natriuretic peptide	GO:0005102; F:receptor binding; IPI:UniProtKB
P23582	NPPC	C-type natriuretic peptide	GO:0006182; P:cGMP biosynthetic process; IDA:UniProtKB
P23582	NPPC	C-type natriuretic peptide	GO:0003418; P:growth plate cartilage chondrocyte differentiation; ISS:UniProtKB
P23582	NPPC	C-type natriuretic peptide	GO:0003419; P:growth plate cartilage chondrocyte proliferation; ISS:UniProtKB
P23582	NPPC	C-type natriuretic peptide	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P23582	NPPC	C-type natriuretic peptide	GO:0051053; P:negative regulation of DNA metabolic process; IEA:Ensembl
P23582	NPPC	C-type natriuretic peptide	GO:0051447; P:negative regulation of meiotic cell cycle; IDA:MGI
P23582	NPPC	C-type natriuretic peptide	GO:1900194; P:negative regulation of oocyte maturation; IDA:MGI
P23582	NPPC	C-type natriuretic peptide	GO:0001503; P:ossification; IEA:UniProtKB-KW
P23582	NPPC	C-type natriuretic peptide	GO:0030828; P:positive regulation of cGMP biosynthetic process; IEA:Ensembl
P23582	NPPC	C-type natriuretic peptide	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
P23582	NPPC	C-type natriuretic peptide	GO:0045909; P:positive regulation of vasodilation; IEA:Ensembl
P23582	NPPC	C-type natriuretic peptide	GO:0009791; P:post-embryonic development; IEA:Ensembl
P23582	NPPC	C-type natriuretic peptide	GO:0007168; P:receptor guanylyl cyclase signaling pathway; IDA:UniProtKB
P23582	NPPC	C-type natriuretic peptide	GO:0050880; P:regulation of blood vessel size; IEA:UniProtKB-KW
P23582	NPPC	C-type natriuretic peptide	GO:0030814; P:regulation of cAMP metabolic process; IDA:MGI
P23582	NPPC	C-type natriuretic peptide	GO:0030823; P:regulation of cGMP metabolic process; IDA:MGI
P23582	NPPC	C-type natriuretic peptide	GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl
P23582	NPPC	C-type natriuretic peptide	GO:0048660; P:regulation of smooth muscle cell proliferation; IEA:Ensembl
P23582	NPPC	C-type natriuretic peptide	GO:0042493; P:response to drug; IEA:Ensembl
P23582	NPPC	C-type natriuretic peptide	GO:0045471; P:response to ethanol; IEA:Ensembl
P23582	NPPC	C-type natriuretic peptide	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q9P2R3	ANKFY1	Ankyrin repeat and FYVE domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9P2R3	ANKFY1	Ankyrin repeat and FYVE domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
P01160	NPPA	Natriuretic peptides A	GO:0005102; F:receptor binding; IDA:UniProtKB
P01160	NPPA	Natriuretic peptides A	GO:0014898; P:cardiac muscle hypertrophy in response to stress; IEA:Ensembl
P01160	NPPA	Natriuretic peptides A	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P01160	NPPA	Natriuretic peptides A	GO:0006182; P:cGMP biosynthetic process; IDA:UniProtKB
P01160	NPPA	Natriuretic peptides A	GO:0007565; P:female pregnancy; ISS:UniProtKB
P01160	NPPA	Natriuretic peptides A	GO:0010467; P:gene expression; TAS:Reactome
P01160	NPPA	Natriuretic peptides A	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
P01160	NPPA	Natriuretic peptides A	GO:0003085; P:negative regulation of systemic arterial blood pressure; IEA:Ensembl
P01160	NPPA	Natriuretic peptides A	GO:0007168; P:receptor guanylyl cyclase signaling pathway; IDA:UniProtKB
P01160	NPPA	Natriuretic peptides A	GO:0008217; P:regulation of blood pressure; IDA:UniProtKB
P01160	NPPA	Natriuretic peptides A	GO:0050880; P:regulation of blood vessel size; IEA:UniProtKB-KW
P01160	NPPA	Natriuretic peptides A	GO:0001666; P:response to hypoxia; IEA:Ensembl
P01160	NPPA	Natriuretic peptides A	GO:0032868; P:response to insulin; IEA:Ensembl
P01160	NPPA	Natriuretic peptides A	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P03950	ANG	Angiogenin	GO:0003779; F:actin binding; IDA:UniProtKB
P03950	ANG	Angiogenin	GO:0005507; F:copper ion binding; IDA:UniProtKB
P03950	ANG	Angiogenin	GO:0003677; F:DNA binding; IC:UniProtKB
P03950	ANG	Angiogenin	GO:0004519; F:endonuclease activity; TAS:UniProtKB
P03950	ANG	Angiogenin	GO:0016892; F:endoribonuclease activity, producing 3'-phosphomonoesters; IEA:InterPro
P03950	ANG	Angiogenin	GO:0008201; F:heparin binding; IDA:UniProtKB
P03950	ANG	Angiogenin	GO:0042277; F:peptide binding; IDA:UniProtKB
P03950	ANG	Angiogenin	GO:0005515; F:protein binding; IPI:UniProtKB
P03950	ANG	Angiogenin	GO:0005102; F:receptor binding; IDA:UniProtKB
P03950	ANG	Angiogenin	GO:0004540; F:ribonuclease activity; IDA:UniProtKB
P03950	ANG	Angiogenin	GO:0019843; F:rRNA binding; TAS:UniProtKB
P03950	ANG	Angiogenin	GO:0030041; P:actin filament polymerization; ISS:UniProtKB
P03950	ANG	Angiogenin	GO:0032431; P:activation of phospholipase A2 activity; IMP:UniProtKB
P03950	ANG	Angiogenin	GO:0007202; P:activation of phospholipase C activity; IMP:UniProtKB
P03950	ANG	Angiogenin	GO:0032148; P:activation of protein kinase B activity; IMP:UniProtKB
P03950	ANG	Angiogenin	GO:0001525; P:angiogenesis; IMP:UniProtKB
P03950	ANG	Angiogenin	GO:0007154; P:cell communication; NAS:UniProtKB
P03950	ANG	Angiogenin	GO:0008219; P:cell death; IEA:UniProtKB-KW
P03950	ANG	Angiogenin	GO:0016477; P:cell migration; IMP:UniProtKB
P03950	ANG	Angiogenin	GO:0006651; P:diacylglycerol biosynthetic process; IDA:UniProtKB
P03950	ANG	Angiogenin	GO:0042592; P:homeostatic process; NAS:UniProtKB
P03950	ANG	Angiogenin	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IDA:UniProtKB
P03950	ANG	Angiogenin	GO:0017148; P:negative regulation of translation; IEA:UniProtKB-KW
P03950	ANG	Angiogenin	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; TAS:GOC
P03950	ANG	Angiogenin	GO:0001556; P:oocyte maturation; NAS:UniProtKB
P03950	ANG	Angiogenin	GO:0001541; P:ovarian follicle development; NAS:UniProtKB
P03950	ANG	Angiogenin	GO:0001890; P:placenta development; NAS:UniProtKB
P03950	ANG	Angiogenin	GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:UniProtKB
P03950	ANG	Angiogenin	GO:0042327; P:positive regulation of phosphorylation; IDA:UniProtKB
P03950	ANG	Angiogenin	GO:0050714; P:positive regulation of protein secretion; IDA:UniProtKB
P03950	ANG	Angiogenin	GO:0009725; P:response to hormone; IDA:UniProtKB
P03950	ANG	Angiogenin	GO:0001666; P:response to hypoxia; IDA:UniProtKB
P03950	ANG	Angiogenin	GO:0090501; P:RNA phosphodiester bond hydrolysis; IDA:GOC
P03950	ANG	Angiogenin	GO:0009303; P:rRNA transcription; IMP:UniProtKB
O95841	ANGPTL1	Angiopoietin-related protein 1	GO:0005102; F:receptor binding; TAS:ProtInc
O95841	ANGPTL1	Angiopoietin-related protein 1	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:Ensembl
Q9UKU9	ANGPTL2	Angiopoietin-related protein 2	GO:0005102; F:receptor binding; TAS:ProtInc
Q9UKU9	ANGPTL2	Angiopoietin-related protein 2	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q9BY76	ANGPTL4	Angiopoietin-related protein 4	GO:0004857; F:enzyme inhibitor activity; ISS:UniProtKB
Q9BY76	ANGPTL4	Angiopoietin-related protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q9BY76	ANGPTL4	Angiopoietin-related protein 4	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q9BY76	ANGPTL4	Angiopoietin-related protein 4	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9BY76	ANGPTL4	Angiopoietin-related protein 4	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9BY76	ANGPTL4	Angiopoietin-related protein 4	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q9BY76	ANGPTL4	Angiopoietin-related protein 4	GO:2000352; P:negative regulation of endothelial cell apoptotic process; IEA:Ensembl
Q9BY76	ANGPTL4	Angiopoietin-related protein 4	GO:0051005; P:negative regulation of lipoprotein lipase activity; IDA:BHF-UCL
Q9BY76	ANGPTL4	Angiopoietin-related protein 4	GO:0045766; P:positive regulation of angiogenesis; TAS:UniProtKB
Q9BY76	ANGPTL4	Angiopoietin-related protein 4	GO:0051260; P:protein homooligomerization; IEA:Ensembl
Q9BY76	ANGPTL4	Angiopoietin-related protein 4	GO:0001666; P:response to hypoxia; NAS:UniProtKB
Q9BY76	ANGPTL4	Angiopoietin-related protein 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BY76	ANGPTL4	Angiopoietin-related protein 4	GO:0070328; P:triglyceride homeostasis; ISS:BHF-UCL
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0004857; F:enzyme inhibitor activity; ISS:UniProtKB
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0008083; F:growth factor activity; IDA:BHF-UCL
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0005178; F:integrin binding; IPI:UniProtKB
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0004859; F:phospholipase inhibitor activity; IDA:BHF-UCL
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0055090; P:acylglycerol homeostasis; IDA:BHF-UCL
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0048844; P:artery morphogenesis; ISS:BHF-UCL
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0007160; P:cell-matrix adhesion; IPI:UniProtKB
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0042632; P:cholesterol homeostasis; IDA:BHF-UCL
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0008203; P:cholesterol metabolic process; IDA:BHF-UCL
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0006631; P:fatty acid metabolic process; IDA:BHF-UCL
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0006071; P:glycerol metabolic process; IDA:BHF-UCL
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0007229; P:integrin-mediated signaling pathway; NAS:UniProtKB
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0055088; P:lipid homeostasis; IDA:BHF-UCL
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0019915; P:lipid storage; IDA:BHF-UCL
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0051005; P:negative regulation of lipoprotein lipase activity; IDA:BHF-UCL
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0010519; P:negative regulation of phospholipase activity; IDA:BHF-UCL
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0009395; P:phospholipid catabolic process; IDA:BHF-UCL
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0055091; P:phospholipid homeostasis; IDA:BHF-UCL
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0006644; P:phospholipid metabolic process; IDA:BHF-UCL
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0050996; P:positive regulation of lipid catabolic process; IDA:BHF-UCL
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0009725; P:response to hormone; IEA:Ensembl
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0007165; P:signal transduction; IDA:BHF-UCL
Q9Y5C1	ANGPTL3	Angiopoietin-related protein 3	GO:0070328; P:triglyceride homeostasis; ISS:BHF-UCL
Q8NI99	ANGPTL6	Angiopoietin-related protein 6	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q8NI99	ANGPTL6	Angiopoietin-related protein 6	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O43827	ANGPTL7	Angiopoietin-related protein 7	GO:0006979; P:response to oxidative stress; TAS:ProtInc
Q15389	ANGPT1	Angiopoietin-1	GO:0030971; F:receptor tyrosine kinase binding; IPI:UniProtKB
Q15389	ANGPT1	Angiopoietin-1	GO:0007171; P:activation of transmembrane receptor protein tyrosine kinase activity; IDA:UniProtKB
Q15389	ANGPT1	Angiopoietin-1	GO:0007596; P:blood coagulation; TAS:Reactome
Q15389	ANGPT1	Angiopoietin-1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q15389	ANGPT1	Angiopoietin-1	GO:0031589; P:cell-substrate adhesion; IEA:Ensembl
Q15389	ANGPT1	Angiopoietin-1	GO:0072012; P:glomerulus vasculature development; ISS:UniProtKB
Q15389	ANGPT1	Angiopoietin-1	GO:0030097; P:hemopoiesis; IEA:Ensembl
Q15389	ANGPT1	Angiopoietin-1	GO:0030210; P:heparin biosynthetic process; IDA:UniProtKB
Q15389	ANGPT1	Angiopoietin-1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q15389	ANGPT1	Angiopoietin-1	GO:0050900; P:leukocyte migration; TAS:Reactome
Q15389	ANGPT1	Angiopoietin-1	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q15389	ANGPT1	Angiopoietin-1	GO:0007162; P:negative regulation of cell adhesion; IDA:UniProtKB
Q15389	ANGPT1	Angiopoietin-1	GO:2000352; P:negative regulation of endothelial cell apoptotic process; IDA:UniProtKB
Q15389	ANGPT1	Angiopoietin-1	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q15389	ANGPT1	Angiopoietin-1	GO:0043116; P:negative regulation of vascular permeability; IDA:UniProtKB
Q15389	ANGPT1	Angiopoietin-1	GO:0050918; P:positive chemotaxis; IDA:UniProtKB
Q15389	ANGPT1	Angiopoietin-1	GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IDA:UniProtKB
Q15389	ANGPT1	Angiopoietin-1	GO:0045785; P:positive regulation of cell adhesion; IEA:Ensembl
Q15389	ANGPT1	Angiopoietin-1	GO:0010595; P:positive regulation of endothelial cell migration; IDA:UniProtKB
Q15389	ANGPT1	Angiopoietin-1	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
Q15389	ANGPT1	Angiopoietin-1	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IEA:Ensembl
Q15389	ANGPT1	Angiopoietin-1	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
Q15389	ANGPT1	Angiopoietin-1	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl
Q15389	ANGPT1	Angiopoietin-1	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:UniProtKB
Q15389	ANGPT1	Angiopoietin-1	GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB
Q15389	ANGPT1	Angiopoietin-1	GO:0002092; P:positive regulation of receptor internalization; IDA:UniProtKB
Q15389	ANGPT1	Angiopoietin-1	GO:0034394; P:protein localization to cell surface; IDA:UniProtKB
Q15389	ANGPT1	Angiopoietin-1	GO:0014842; P:regulation of satellite cell proliferation; IDA:UniProtKB
Q15389	ANGPT1	Angiopoietin-1	GO:0002040; P:sprouting angiogenesis; IDA:UniProtKB
Q15389	ANGPT1	Angiopoietin-1	GO:0048014; P:Tie signaling pathway; IDA:UniProtKB
O15123	ANGPT2	Angiopoietin-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15123	ANGPT2	Angiopoietin-2	GO:0005515; F:protein binding; IPI:IntAct
O15123	ANGPT2	Angiopoietin-2	GO:0005102; F:receptor binding; TAS:ProtInc
O15123	ANGPT2	Angiopoietin-2	GO:0030971; F:receptor tyrosine kinase binding; IPI:UniProtKB
O15123	ANGPT2	Angiopoietin-2	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
O15123	ANGPT2	Angiopoietin-2	GO:0007596; P:blood coagulation; TAS:Reactome
O15123	ANGPT2	Angiopoietin-2	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
O15123	ANGPT2	Angiopoietin-2	GO:0007281; P:germ cell development; IEA:Ensembl
O15123	ANGPT2	Angiopoietin-2	GO:0072012; P:glomerulus vasculature development; ISS:UniProtKB
O15123	ANGPT2	Angiopoietin-2	GO:0050900; P:leukocyte migration; TAS:Reactome
O15123	ANGPT2	Angiopoietin-2	GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
O15123	ANGPT2	Angiopoietin-2	GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl
O15123	ANGPT2	Angiopoietin-2	GO:0043537; P:negative regulation of blood vessel endothelial cell migration; IDA:UniProtKB
O15123	ANGPT2	Angiopoietin-2	GO:0010812; P:negative regulation of cell-substrate adhesion; IEA:Ensembl
O15123	ANGPT2	Angiopoietin-2	GO:0050928; P:negative regulation of positive chemotaxis; IDA:UniProtKB
O15123	ANGPT2	Angiopoietin-2	GO:0031100; P:organ regeneration; IEA:Ensembl
O15123	ANGPT2	Angiopoietin-2	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
O15123	ANGPT2	Angiopoietin-2	GO:0014823; P:response to activity; IEA:Ensembl
O15123	ANGPT2	Angiopoietin-2	GO:0009749; P:response to glucose; IEA:Ensembl
O15123	ANGPT2	Angiopoietin-2	GO:0001666; P:response to hypoxia; IEA:Ensembl
O15123	ANGPT2	Angiopoietin-2	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
O15123	ANGPT2	Angiopoietin-2	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
O15123	ANGPT2	Angiopoietin-2	GO:0009314; P:response to radiation; IEA:Ensembl
O15123	ANGPT2	Angiopoietin-2	GO:0007165; P:signal transduction; TAS:ProtInc
O15123	ANGPT2	Angiopoietin-2	GO:0048014; P:Tie signaling pathway; IDA:UniProtKB
Q9Y264	ANGPT4	Angiopoietin-4	GO:0030971; F:receptor tyrosine kinase binding; IDA:UniProtKB
Q9Y264	ANGPT4	Angiopoietin-4	GO:0030297; F:transmembrane receptor protein tyrosine kinase activator activity; IDA:UniProtKB
Q9Y264	ANGPT4	Angiopoietin-4	GO:0007171; P:activation of transmembrane receptor protein tyrosine kinase activity; IDA:GOC
Q9Y264	ANGPT4	Angiopoietin-4	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q9Y264	ANGPT4	Angiopoietin-4	GO:0007596; P:blood coagulation; TAS:Reactome
Q9Y264	ANGPT4	Angiopoietin-4	GO:0071456; P:cellular response to hypoxia; IEP:UniProtKB
Q9Y264	ANGPT4	Angiopoietin-4	GO:0050900; P:leukocyte migration; TAS:Reactome
Q9Y264	ANGPT4	Angiopoietin-4	GO:0016525; P:negative regulation of angiogenesis; IDA:UniProtKB
Q9Y264	ANGPT4	Angiopoietin-4	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q9Y264	ANGPT4	Angiopoietin-4	GO:0043537; P:negative regulation of blood vessel endothelial cell migration; IDA:UniProtKB
Q9Y264	ANGPT4	Angiopoietin-4	GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB
Q9Y264	ANGPT4	Angiopoietin-4	GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IDA:UniProtKB
Q9Y264	ANGPT4	Angiopoietin-4	GO:0010595; P:positive regulation of endothelial cell migration; IDA:UniProtKB
Q9Y264	ANGPT4	Angiopoietin-4	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P01019	AGT	Angiotensinogen	GO:0008083; F:growth factor activity; TAS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0005179; F:hormone activity; ISS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0005515; F:protein binding; IPI:IntAct
P01019	AGT	Angiotensinogen	GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome
P01019	AGT	Angiotensinogen	GO:0031702; F:type 1 angiotensin receptor binding; IPI:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0031703; F:type 2 angiotensin receptor binding; IPI:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0007250; P:activation of NF-kappaB-inducing kinase activity; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0007202; P:activation of phospholipase C activity; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0007568; P:aging; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0002003; P:angiotensin maturation; TAS:Reactome
P01019	AGT	Angiotensinogen	GO:0001998; P:angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0003051; P:angiotensin-mediated drinking behavior; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0014824; P:artery smooth muscle contraction; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0048143; P:astrocyte activation; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0001568; P:blood vessel development; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0001974; P:blood vessel remodeling; TAS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0035411; P:catenin import into nucleus; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0061049; P:cell growth involved in cardiac muscle cell development; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P01019	AGT	Angiotensinogen	GO:0007160; P:cell-matrix adhesion; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P01019	AGT	Angiotensinogen	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P01019	AGT	Angiotensinogen	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0006883; P:cellular sodium ion homeostasis; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0050663; P:cytokine secretion; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0070371; P:ERK1 and ERK2 cascade; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0008065; P:establishment of blood-nerve barrier; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0007588; P:excretion; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0048144; P:fibroblast proliferation; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0007199; P:G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger; TAS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0001822; P:kidney development; IMP:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0034374; P:low-density lipoprotein particle remodeling; NAS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P01019	AGT	Angiotensinogen	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0051387; P:negative regulation of neurotrophin TRK receptor signaling pathway; IDA:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0034104; P:negative regulation of tissue remodeling; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0007263; P:nitric oxide mediated signal transduction; TAS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0001543; P:ovarian follicle rupture; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0030432; P:peristalsis; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; NAS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0010535; P:positive regulation of activation of JAK2 kinase activity; IMP:UniProtKB
P01019	AGT	Angiotensinogen	GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; IDA:UniProtKB
P01019	AGT	Angiotensinogen	GO:0010613; P:positive regulation of cardiac muscle hypertrophy; ISS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0032270; P:positive regulation of cellular protein metabolic process; IDA:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0010873; P:positive regulation of cholesterol esterification; IDA:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0001819; P:positive regulation of cytokine production; TAS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0010595; P:positive regulation of endothelial cell migration; IDA:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0045742; P:positive regulation of epidermal growth factor receptor signaling pathway; IDA:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0003331; P:positive regulation of extracellular matrix constituent secretion; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IDA:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0045723; P:positive regulation of fatty acid biosynthetic process; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0048146; P:positive regulation of fibroblast proliferation; ISS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0050729; P:positive regulation of inflammatory response; TAS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; IC:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0033864; P:positive regulation of NAD(P)H oxidase activity; TAS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0046622; P:positive regulation of organ growth; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IDA:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0061098; P:positive regulation of protein tyrosine kinase activity; IMP:UniProtKB
P01019	AGT	Angiotensinogen	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; TAS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0035815; P:positive regulation of renal sodium excretion; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0032930; P:positive regulation of superoxide anion generation; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P01019	AGT	Angiotensinogen	GO:0002034; P:regulation of blood vessel size by renin-angiotensin; TAS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0002016; P:regulation of blood volume by renin-angiotensin; NAS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0051924; P:regulation of calcium ion transport; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0001558; P:regulation of cell growth; NAS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0042127; P:regulation of cell proliferation; NAS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0014061; P:regulation of norepinephrine secretion; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
P01019	AGT	Angiotensinogen	GO:0002019; P:regulation of renal output by angiotensin; NAS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0035813; P:regulation of renal sodium excretion; NAS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0019229; P:regulation of vasoconstriction; NAS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0001999; P:renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0003014; P:renal system process; IDA:UniProt
P01019	AGT	Angiotensinogen	GO:0002018; P:renin-angiotensin regulation of aldosterone production; NAS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0009409; P:response to cold; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0014873; P:response to muscle activity involved in regulation of muscle adaptation; ISS:BHF-UCL
P01019	AGT	Angiotensinogen	GO:0009651; P:response to salt stress; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P01019	AGT	Angiotensinogen	GO:0051145; P:smooth muscle cell differentiation; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0048659; P:smooth muscle cell proliferation; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0051403; P:stress-activated MAPK cascade; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0070471; P:uterine smooth muscle contraction; IEA:Ensembl
P01019	AGT	Angiotensinogen	GO:0042311; P:vasodilation; IEA:Ensembl
E9PGG2	ANHX	Anomalous homeobox protein	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
E9PGG2	ANHX	Anomalous homeobox protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P16157	ANK1	Ankyrin-1	GO:0051117; F:ATPase binding; IPI:BHF-UCL
P16157	ANK1	Ankyrin-1	GO:0008093; F:cytoskeletal adaptor activity; TAS:UniProtKB
P16157	ANK1	Ankyrin-1	GO:0019899; F:enzyme binding; IPI:UniProtKB
P16157	ANK1	Ankyrin-1	GO:0005515; F:protein binding; IPI:UniProtKB
P16157	ANK1	Ankyrin-1	GO:0030507; F:spectrin binding; NAS:UniProtKB
P16157	ANK1	Ankyrin-1	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P16157	ANK1	Ankyrin-1	GO:0005198; F:structural molecule activity; NAS:UniProtKB
P16157	ANK1	Ankyrin-1	GO:0007411; P:axon guidance; TAS:Reactome
P16157	ANK1	Ankyrin-1	GO:0007010; P:cytoskeleton organization; NAS:UniProtKB
P16157	ANK1	Ankyrin-1	GO:0006888; P:ER to Golgi vesicle-mediated transport; IDA:BHF-UCL
P16157	ANK1	Ankyrin-1	GO:0048821; P:erythrocyte development; IEA:Ensembl
P16157	ANK1	Ankyrin-1	GO:0006887; P:exocytosis; NAS:UniProtKB
P16157	ANK1	Ankyrin-1	GO:0045199; P:maintenance of epithelial cell apical/basal polarity; TAS:UniProtKB
P16157	ANK1	Ankyrin-1	GO:0015672; P:monovalent inorganic cation transport; IEA:Ensembl
P16157	ANK1	Ankyrin-1	GO:0006779; P:porphyrin-containing compound biosynthetic process; IEA:Ensembl
P16157	ANK1	Ankyrin-1	GO:0010638; P:positive regulation of organelle organization; IEA:Ensembl
P16157	ANK1	Ankyrin-1	GO:0072661; P:protein targeting to plasma membrane; IMP:BHF-UCL
P16157	ANK1	Ankyrin-1	GO:0007165; P:signal transduction; IEA:InterPro
Q01484	ANK2	Ankyrin-2	GO:0051117; F:ATPase binding; ISS:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q01484	ANK2	Ankyrin-2	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0015459; F:potassium channel regulator activity; IEA:Ensembl
Q01484	ANK2	Ankyrin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q01484	ANK2	Ankyrin-2	GO:0030674; F:protein binding, bridging; ISS:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0030507; F:spectrin binding; IPI:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0005200; F:structural constituent of cytoskeleton; IEA:Ensembl
Q01484	ANK2	Ankyrin-2	GO:0086014; P:atrial cardiac muscle cell action potential; IMP:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0086066; P:atrial cardiac muscle cell to AV node cell communication; ISS:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0003283; P:atrial septum development; IMP:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0007411; P:axon guidance; TAS:Reactome
Q01484	ANK2	Ankyrin-2	GO:0060048; P:cardiac muscle contraction; IEA:Ensembl
Q01484	ANK2	Ankyrin-2	GO:0006874; P:cellular calcium ion homeostasis; ISS:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0034613; P:cellular protein localization; IGI:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0086046; P:membrane depolarization during SA node cell action potential; TAS:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0030913; P:paranodal junction assembly; IEA:Ensembl
Q01484	ANK2	Ankyrin-2	GO:1901021; P:positive regulation of calcium ion transmembrane transporter activity; ISS:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0051928; P:positive regulation of calcium ion transport; ISS:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:2001259; P:positive regulation of cation channel activity; ISS:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0010628; P:positive regulation of gene expression; IGI:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:1901018; P:positive regulation of potassium ion transmembrane transporter activity; ISS:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0043268; P:positive regulation of potassium ion transport; ISS:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0034394; P:protein localization to cell surface; ISS:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0070972; P:protein localization to endoplasmic reticulum; IGI:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0036309; P:protein localization to M-band; ISS:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0033365; P:protein localization to organelle; IGI:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0072659; P:protein localization to plasma membrane; IGI:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0036371; P:protein localization to T-tubule; ISS:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0050821; P:protein stabilization; ISS:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0072661; P:protein targeting to plasma membrane; IEA:Ensembl
Q01484	ANK2	Ankyrin-2	GO:1901019; P:regulation of calcium ion transmembrane transporter activity; ISS:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0051924; P:regulation of calcium ion transport; IGI:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0086004; P:regulation of cardiac muscle cell contraction; IGI:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0086036; P:regulation of cardiac muscle cell membrane potential; IEA:Ensembl
Q01484	ANK2	Ankyrin-2	GO:0055117; P:regulation of cardiac muscle contraction; IMP:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0010882; P:regulation of cardiac muscle contraction by calcium ion signaling; IMP:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; IGI:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0002027; P:regulation of heart rate; IMP:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0031647; P:regulation of protein stability; IC:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0051279; P:regulation of release of sequestered calcium ion into cytosol; IGI:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0051597; P:response to methylmercury; IEA:Ensembl
Q01484	ANK2	Ankyrin-2	GO:0086015; P:SA node cell action potential; ISS:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0086070; P:SA node cell to atrial cardiac muscle cell communication; IMP:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0070296; P:sarcoplasmic reticulum calcium ion transport; TAS:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0033292; P:T-tubule organization; ISS:BHF-UCL
Q01484	ANK2	Ankyrin-2	GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0045296; F:cadherin binding; ISS:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0008092; F:cytoskeletal protein binding; ISS:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0044325; F:ion channel binding; ISS:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q12955	ANK3	Ankyrin-3	GO:0030674; F:protein binding, bridging; ISS:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0030507; F:spectrin binding; ISS:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0005200; F:structural constituent of cytoskeleton; IMP:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0007411; P:axon guidance; IEA:Ensembl
Q12955	ANK3	Ankyrin-3	GO:0007409; P:axonogenesis; ISS:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0007016; P:cytoskeletal anchoring at plasma membrane; TAS:ProtInc
Q12955	ANK3	Ankyrin-3	GO:0045184; P:establishment of protein localization; IMP:UniProtKB
Q12955	ANK3	Ankyrin-3	GO:0043001; P:Golgi to plasma membrane protein transport; IMP:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0072660; P:maintenance of protein location in plasma membrane; IGI:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0071709; P:membrane assembly; IMP:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0000281; P:mitotic cytokinesis; IMP:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
Q12955	ANK3	Ankyrin-3	GO:0019228; P:neuronal action potential; ISS:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0007009; P:plasma membrane organization; IMP:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0010650; P:positive regulation of cell communication by electrical coupling; IEA:Ensembl
Q12955	ANK3	Ankyrin-3	GO:0010628; P:positive regulation of gene expression; ISS:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0034112; P:positive regulation of homotypic cell-cell adhesion; IEA:Ensembl
Q12955	ANK3	Ankyrin-3	GO:1900827; P:positive regulation of membrane depolarization during cardiac muscle cell action potential; ISS:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0045838; P:positive regulation of membrane potential; ISS:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0090314; P:positive regulation of protein targeting to membrane; IEA:Ensembl
Q12955	ANK3	Ankyrin-3	GO:2000651; P:positive regulation of sodium ion transmembrane transporter activity; ISS:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0010765; P:positive regulation of sodium ion transport; ISS:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0072659; P:protein localization to plasma membrane; IMP:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0072661; P:protein targeting to plasma membrane; IMP:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0043266; P:regulation of potassium ion transport; ISS:BHF-UCL
Q12955	ANK3	Ankyrin-3	GO:0007165; P:signal transduction; IEA:InterPro
Q9NU02	ANKEF1	Ankyrin repeat and EF-hand domain-containing protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8IWZ3	ANKHD1	Ankyrin repeat and KH domain-containing protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IWZ3	ANKHD1	Ankyrin repeat and KH domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9HCJ1	ANKH	Progressive ankylosis protein homolog	GO:0030504; F:inorganic diphosphate transmembrane transporter activity; IDA:UniProtKB
Q9HCJ1	ANKH	Progressive ankylosis protein homolog	GO:0005315; F:inorganic phosphate transmembrane transporter activity; IDA:UniProtKB
Q9HCJ1	ANKH	Progressive ankylosis protein homolog	GO:0015114; F:phosphate ion transmembrane transporter activity; IEA:InterPro
Q9HCJ1	ANKH	Progressive ankylosis protein homolog	GO:0030505; P:inorganic diphosphate transport; IDA:GOC
Q9HCJ1	ANKH	Progressive ankylosis protein homolog	GO:0007626; P:locomotory behavior; NAS:UniProtKB
Q9HCJ1	ANKH	Progressive ankylosis protein homolog	GO:0030500; P:regulation of bone mineralization; ISS:UniProtKB
Q9HCJ1	ANKH	Progressive ankylosis protein homolog	GO:0001501; P:skeletal system development; NAS:UniProtKB
Q8NFD2	ANKK1	Ankyrin repeat and protein kinase domain-containing protein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NFD2	ANKK1	Ankyrin repeat and protein kinase domain-containing protein 1	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q86XL3	ANKLE2	Ankyrin repeat and LEM domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q86XL3	ANKLE2	Ankyrin repeat and LEM domain-containing protein 2	GO:0051721; F:protein phosphatase 2A binding; IDA:UniProtKB
Q86XL3	ANKLE2	Ankyrin repeat and LEM domain-containing protein 2	GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:UniProtKB
Q86XL3	ANKLE2	Ankyrin repeat and LEM domain-containing protein 2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q86XL3	ANKLE2	Ankyrin repeat and LEM domain-containing protein 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q86XL3	ANKLE2	Ankyrin repeat and LEM domain-containing protein 2	GO:0007084; P:mitotic nuclear envelope reassembly; IMP:UniProtKB
Q86XL3	ANKLE2	Ankyrin repeat and LEM domain-containing protein 2	GO:0042326; P:negative regulation of phosphorylation; IDA:UniProtKB
Q86XL3	ANKLE2	Ankyrin repeat and LEM domain-containing protein 2	GO:0035307; P:positive regulation of protein dephosphorylation; IDA:UniProtKB
Q86XL3	ANKLE2	Ankyrin repeat and LEM domain-containing protein 2	GO:0050790; P:regulation of catalytic activity; TAS:UniProtKB
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0003677; F:DNA binding; IDA:BHF-UCL
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0002039; F:p53 binding; IPI:BHF-UCL
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0005515; F:protein binding; IPI:BHF-UCL
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0070412; F:R-SMAD binding; IPI:BHF-UCL
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0001105; F:RNA polymerase II transcription coactivator activity; IDA:BHF-UCL
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0001085; F:RNA polymerase II transcription factor binding; IPI:BHF-UCL
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0031432; F:titin binding; IPI:BHF-UCL
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0003714; F:transcription corepressor activity; TAS:BHF-UCL
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0055008; P:cardiac muscle tissue morphogenesis; IMP:BHF-UCL
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0035690; P:cellular response to drug; IEA:Ensembl
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0071347; P:cellular response to interleukin-1; IDA:BHF-UCL
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0071222; P:cellular response to lipopolysaccharide; IDA:BHF-UCL
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0071260; P:cellular response to mechanical stimulus; IDA:UniProtKB
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IDA:BHF-UCL
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0071356; P:cellular response to tumor necrosis factor; IDA:BHF-UCL
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:2000279; P:negative regulation of DNA biosynthetic process; IMP:BHF-UCL
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0043065; P:positive regulation of apoptotic process; IMP:BHF-UCL
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0043517; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; IDA:BHF-UCL
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0050714; P:positive regulation of protein secretion; IMP:UniProtKB
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:GOC
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0035994; P:response to muscle stretch; IMP:BHF-UCL
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0045214; P:sarcomere organization; NAS:BHF-UCL
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q15327	ANKRD1	Ankyrin repeat domain-containing protein 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9GZV1	ANKRD2	Ankyrin repeat domain-containing protein 2	GO:0043422; F:protein kinase B binding; IPI:UniProtKB
Q9GZV1	ANKRD2	Ankyrin repeat domain-containing protein 2	GO:0008307; F:structural constituent of muscle; NAS:UniProtKB
Q9GZV1	ANKRD2	Ankyrin repeat domain-containing protein 2	GO:0006936; P:muscle contraction; NAS:UniProtKB
Q9GZV1	ANKRD2	Ankyrin repeat domain-containing protein 2	GO:0007517; P:muscle organ development; NAS:UniProtKB
Q9GZV1	ANKRD2	Ankyrin repeat domain-containing protein 2	GO:0045662; P:negative regulation of myoblast differentiation; IMP:UniProtKB
Q9GZV1	ANKRD2	Ankyrin repeat domain-containing protein 2	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q9Y2G4	ANKRD6	Ankyrin repeat domain-containing protein 6	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IBA:RefGenome
Q9Y2G4	ANKRD6	Ankyrin repeat domain-containing protein 6	GO:0046330; P:positive regulation of JNK cascade; IBA:RefGenome
Q9Y2G4	ANKRD6	Ankyrin repeat domain-containing protein 6	GO:2000096; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; IEA:Ensembl
Q92527	ANKRD7	Ankyrin repeat domain-containing protein 7	GO:0008584; P:male gonad development; TAS:ProtInc
Q9P2S6	ANKMY1	Ankyrin repeat and MYND domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IV38	ANKMY2	Ankyrin repeat and MYND domain-containing protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H8Y5	ANKZF1	Ankyrin repeat and zinc finger domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H8Y5	ANKZF1	Ankyrin repeat and zinc finger domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NQW6	ANLN	Actin-binding protein anillin	GO:0003779; F:actin binding; IDA:MGI
Q9NQW6	ANLN	Actin-binding protein anillin	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9NQW6	ANLN	Actin-binding protein anillin	GO:0000281; P:mitotic cytokinesis; IDA:MGI
Q9NQW6	ANLN	Actin-binding protein anillin	GO:0007096; P:regulation of exit from mitosis; TAS:ProtInc
Q9NQW6	ANLN	Actin-binding protein anillin	GO:0000921; P:septin ring assembly; TAS:ProtInc
Q99873	PRMT1	Protein arginine N-methyltransferase 1	GO:0042054; F:histone methyltransferase activity; IDA:UniProtKB
Q99873	PRMT1	Protein arginine N-methyltransferase 1	GO:0044020; F:histone methyltransferase activity (H4-R3 specific); IDA:UniProtKB
Q99873	PRMT1	Protein arginine N-methyltransferase 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q99873	PRMT1	Protein arginine N-methyltransferase 1	GO:0008168; F:methyltransferase activity; TAS:ProtInc
Q99873	PRMT1	Protein arginine N-methyltransferase 1	GO:0008170; F:N-methyltransferase activity; IDA:UniProtKB
Q99873	PRMT1	Protein arginine N-methyltransferase 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q99873	PRMT1	Protein arginine N-methyltransferase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q99873	PRMT1	Protein arginine N-methyltransferase 1	GO:0035242; F:protein-arginine omega-N asymmetric methyltransferase activity; IBA:RefGenome
Q99873	PRMT1	Protein arginine N-methyltransferase 1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q99873	PRMT1	Protein arginine N-methyltransferase 1	GO:0043985; P:histone H4-R3 methylation; IDA:UniProtKB
Q99873	PRMT1	Protein arginine N-methyltransferase 1	GO:0016571; P:histone methylation; IDA:UniProtKB
Q99873	PRMT1	Protein arginine N-methyltransferase 1	GO:0045653; P:negative regulation of megakaryocyte differentiation; IDA:UniProtKB
Q99873	PRMT1	Protein arginine N-methyltransferase 1	GO:0031175; P:neuron projection development; IMP:UniProtKB
Q99873	PRMT1	Protein arginine N-methyltransferase 1	GO:0018216; P:peptidyl-arginine methylation; IDA:UniProtKB
Q99873	PRMT1	Protein arginine N-methyltransferase 1	GO:0019919; P:peptidyl-arginine methylation, to asymmetrical-dimethyl arginine; IBA:RefGenome
Q99873	PRMT1	Protein arginine N-methyltransferase 1	GO:0006479; P:protein methylation; TAS:ProtInc
Q99873	PRMT1	Protein arginine N-methyltransferase 1	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0050681; F:androgen receptor binding; IPI:UniProtKB
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0030331; F:estrogen receptor binding; IDA:UniProtKB
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0042054; F:histone methyltransferase activity; IDA:UniProtKB
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0008469; F:histone-arginine N-methyltransferase activity; ISS:UniProtKB
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0042975; F:peroxisome proliferator activated receptor binding; IPI:UniProtKB
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0033142; F:progesterone receptor binding; IPI:UniProtKB
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0005515; F:protein binding; IPI:UniProtKB
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0016274; F:protein-arginine N-methyltransferase activity; ISS:UniProtKB
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0035242; F:protein-arginine omega-N asymmetric methyltransferase activity; IBA:RefGenome
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0042974; F:retinoic acid receptor binding; IPI:UniProtKB
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0004871; F:signal transducer activity; TAS:ProtInc
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0046966; F:thyroid hormone receptor binding; IPI:UniProtKB
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0048588; P:developmental cell growth; ISS:UniProtKB
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0034969; P:histone arginine methylation; IBA:RefGenome
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0016571; P:histone methylation; IDA:UniProtKB
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; ISS:UniProtKB
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0019919; P:peptidyl-arginine methylation, to asymmetrical-dimethyl arginine; IBA:RefGenome
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0043065; P:positive regulation of apoptotic process; IGI:UniProtKB
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0006479; P:protein methylation; TAS:ProtInc
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0060765; P:regulation of androgen receptor signaling pathway; IDA:UniProtKB
P55345	PRMT2	Protein arginine N-methyltransferase 2	GO:0007165; P:signal transduction; TAS:ProtInc
O60678	PRMT3	Protein arginine N-methyltransferase 3	GO:0008469; F:histone-arginine N-methyltransferase activity; IBA:RefGenome
O60678	PRMT3	Protein arginine N-methyltransferase 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60678	PRMT3	Protein arginine N-methyltransferase 3	GO:0008168; F:methyltransferase activity; IDA:UniProtKB
O60678	PRMT3	Protein arginine N-methyltransferase 3	GO:0072341; F:modified amino acid binding; IEA:Ensembl
O60678	PRMT3	Protein arginine N-methyltransferase 3	GO:0005515; F:protein binding; IPI:UniProtKB
O60678	PRMT3	Protein arginine N-methyltransferase 3	GO:0016274; F:protein-arginine N-methyltransferase activity; NAS:UniProtKB
O60678	PRMT3	Protein arginine N-methyltransferase 3	GO:0035242; F:protein-arginine omega-N asymmetric methyltransferase activity; IBA:RefGenome
O60678	PRMT3	Protein arginine N-methyltransferase 3	GO:0034969; P:histone arginine methylation; IBA:RefGenome
O60678	PRMT3	Protein arginine N-methyltransferase 3	GO:0031397; P:negative regulation of protein ubiquitination; IDA:UniProtKB
O60678	PRMT3	Protein arginine N-methyltransferase 3	GO:0019919; P:peptidyl-arginine methylation, to asymmetrical-dimethyl arginine; IBA:RefGenome
O60678	PRMT3	Protein arginine N-methyltransferase 3	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0003682; F:chromatin binding; IEA:Ensembl
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0008469; F:histone-arginine N-methyltransferase activity; IBA:RefGenome
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0005515; F:protein binding; IPI:UniProtKB
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0035243; F:protein-arginine omega-N symmetric methyltransferase activity; IMP:UniProtKB
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0043021; F:ribonucleoprotein complex binding; IPI:UniProtKB
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0008283; P:cell proliferation; TAS:ProtInc
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0042118; P:endothelial cell activation; IMP:UniProtKB
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0010467; P:gene expression; TAS:Reactome
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0043985; P:histone H4-R3 methylation; NAS:UniProtKB
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0018216; P:peptidyl-arginine methylation; IMP:UniProtKB
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0019918; P:peptidyl-arginine methylation, to symmetrical-dimethyl arginine; IMP:GOC
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0035246; P:peptidyl-arginine N-methylation; IDA:MGI
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0006479; P:protein methylation; IEA:InterPro
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0007088; P:regulation of mitosis; TAS:ProtInc
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0016070; P:RNA metabolic process; TAS:Reactome
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0000387; P:spliceosomal snRNP assembly; IMP:UniProtKB
O14744	PRMT5	Protein arginine N-methyltransferase 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96LA8	PRMT6	Protein arginine N-methyltransferase 6	GO:0042393; F:histone binding; IDA:UniProtKB
Q96LA8	PRMT6	Protein arginine N-methyltransferase 6	GO:0042054; F:histone methyltransferase activity; IDA:UniProtKB
Q96LA8	PRMT6	Protein arginine N-methyltransferase 6	GO:0070612; F:histone methyltransferase activity (H2A-R3 specific); IDA:UniProtKB
Q96LA8	PRMT6	Protein arginine N-methyltransferase 6	GO:0070611; F:histone methyltransferase activity (H3-R2 specific); IDA:UniProtKB
Q96LA8	PRMT6	Protein arginine N-methyltransferase 6	GO:0044020; F:histone methyltransferase activity (H4-R3 specific); IDA:UniProtKB
Q96LA8	PRMT6	Protein arginine N-methyltransferase 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q96LA8	PRMT6	Protein arginine N-methyltransferase 6	GO:0035242; F:protein-arginine omega-N asymmetric methyltransferase activity; IDA:UniProtKB
Q96LA8	PRMT6	Protein arginine N-methyltransferase 6	GO:0035241; F:protein-arginine omega-N monomethyltransferase activity; IDA:UniProtKB
Q96LA8	PRMT6	Protein arginine N-methyltransferase 6	GO:0006284; P:base-excision repair; TAS:UniProtKB
Q96LA8	PRMT6	Protein arginine N-methyltransferase 6	GO:0034970; P:histone H3-R2 methylation; IDA:UniProtKB
Q96LA8	PRMT6	Protein arginine N-methyltransferase 6	GO:0043985; P:histone H4-R3 methylation; IDA:GOC
Q96LA8	PRMT6	Protein arginine N-methyltransferase 6	GO:0016571; P:histone methylation; IDA:UniProtKB
Q96LA8	PRMT6	Protein arginine N-methyltransferase 6	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q96LA8	PRMT6	Protein arginine N-methyltransferase 6	GO:0019919; P:peptidyl-arginine methylation, to asymmetrical-dimethyl arginine; IDA:UniProtKB
Q96LA8	PRMT6	Protein arginine N-methyltransferase 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96LA8	PRMT6	Protein arginine N-methyltransferase 6	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0016277; F:[myelin basic protein]-arginine N-methyltransferase activity; IDA:HGNC
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0042393; F:histone binding; IC:HGNC
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0044020; F:histone methyltransferase activity (H4-R3 specific); ISS:UniProtKB
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0008469; F:histone-arginine N-methyltransferase activity; IDA:HGNC
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0035242; F:protein-arginine omega-N asymmetric methyltransferase activity; IBA:RefGenome
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0035241; F:protein-arginine omega-N monomethyltransferase activity; IDA:UniProtKB
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0035243; F:protein-arginine omega-N symmetric methyltransferase activity; IDA:UniProtKB
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0043021; F:ribonucleoprotein complex binding; IPI:UniProtKB
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0008757; F:S-adenosylmethionine-dependent methyltransferase activity; IDA:HGNC
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0043046; P:DNA methylation involved in gamete generation; ISS:UniProtKB
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0034969; P:histone arginine methylation; ISS:UniProtKB
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0016571; P:histone methylation; IDA:HGNC
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0018216; P:peptidyl-arginine methylation; IMP:UniProtKB
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0019919; P:peptidyl-arginine methylation, to asymmetrical-dimethyl arginine; IBA:RefGenome
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0019918; P:peptidyl-arginine methylation, to symmetrical-dimethyl arginine; IDA:GOC
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0006349; P:regulation of gene expression by genetic imprinting; ISS:UniProtKB
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0043393; P:regulation of protein binding; IC:HGNC
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0000387; P:spliceosomal snRNP assembly; IMP:UniProtKB
Q9NVM4	PRMT7	Protein arginine N-methyltransferase 7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NR22	PRMT8	Protein arginine N-methyltransferase 8	GO:0044020; F:histone methyltransferase activity (H4-R3 specific); IBA:RefGenome
Q9NR22	PRMT8	Protein arginine N-methyltransferase 8	GO:0008469; F:histone-arginine N-methyltransferase activity; IDA:HGNC
Q9NR22	PRMT8	Protein arginine N-methyltransferase 8	GO:0042802; F:identical protein binding; IPI:IntAct
Q9NR22	PRMT8	Protein arginine N-methyltransferase 8	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NR22	PRMT8	Protein arginine N-methyltransferase 8	GO:0046982; F:protein heterodimerization activity; IDA:HGNC
Q9NR22	PRMT8	Protein arginine N-methyltransferase 8	GO:0042803; F:protein homodimerization activity; IDA:HGNC
Q9NR22	PRMT8	Protein arginine N-methyltransferase 8	GO:0035242; F:protein-arginine omega-N asymmetric methyltransferase activity; IDA:UniProtKB
Q9NR22	PRMT8	Protein arginine N-methyltransferase 8	GO:0035241; F:protein-arginine omega-N monomethyltransferase activity; IDA:UniProtKB
Q9NR22	PRMT8	Protein arginine N-methyltransferase 8	GO:0008757; F:S-adenosylmethionine-dependent methyltransferase activity; IDA:HGNC
Q9NR22	PRMT8	Protein arginine N-methyltransferase 8	GO:0034969; P:histone arginine methylation; IDA:GOC
Q9NR22	PRMT8	Protein arginine N-methyltransferase 8	GO:0043985; P:histone H4-R3 methylation; IBA:GOC
Q9NR22	PRMT8	Protein arginine N-methyltransferase 8	GO:0016571; P:histone methylation; IDA:HGNC
Q9NR22	PRMT8	Protein arginine N-methyltransferase 8	GO:0018216; P:peptidyl-arginine methylation; IDA:UniProtKB
Q9NR22	PRMT8	Protein arginine N-methyltransferase 8	GO:0019919; P:peptidyl-arginine methylation, to asymmetrical-dimethyl arginine; IDA:HGNC
Q9NR22	PRMT8	Protein arginine N-methyltransferase 8	GO:0043393; P:regulation of protein binding; TAS:HGNC
Q9NR22	PRMT8	Protein arginine N-methyltransferase 8	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q6P2P2	PRMT9	Putative protein arginine N-methyltransferase 9	GO:0008276; F:protein methyltransferase activity; IEA:InterPro
Q9NW15	ANO10	Anoctamin-10	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9NW15	ANO10	Anoctamin-10	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9NW15	ANO10	Anoctamin-10	GO:0055085; P:transmembrane transport; TAS:Reactome
Q5XXA6	ANO1	Anoctamin-1	GO:0005229; F:intracellular calcium activated chloride channel activity; IDA:UniProtKB
Q5XXA6	ANO1	Anoctamin-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q5XXA6	ANO1	Anoctamin-1	GO:1902476; P:chloride transmembrane transport; IDA:GOC
Q5XXA6	ANO1	Anoctamin-1	GO:0006821; P:chloride transport; ISS:UniProtKB
Q5XXA6	ANO1	Anoctamin-1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q5XXA6	ANO1	Anoctamin-1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q5XXA6	ANO1	Anoctamin-1	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
Q5XXA6	ANO1	Anoctamin-1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9NQ90	ANO2	Anoctamin-2	GO:0005229; F:intracellular calcium activated chloride channel activity; IDA:UniProtKB
Q9NQ90	ANO2	Anoctamin-2	GO:1902476; P:chloride transmembrane transport; IDA:GOC
Q9NQ90	ANO2	Anoctamin-2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9NQ90	ANO2	Anoctamin-2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9BYT9	ANO3	Anoctamin-3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9BYT9	ANO3	Anoctamin-3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q32M45	ANO4	Anoctamin-4	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q32M45	ANO4	Anoctamin-4	GO:0055085; P:transmembrane transport; TAS:Reactome
Q75V66	ANO5	Anoctamin-5	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q75V66	ANO5	Anoctamin-5	GO:0055085; P:transmembrane transport; TAS:Reactome
Q4KMQ2	ANO6	Anoctamin-6	GO:0005227; F:calcium activated cation channel activity; ISS:UniProtKB
Q4KMQ2	ANO6	Anoctamin-6	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
Q4KMQ2	ANO6	Anoctamin-6	GO:0005244; F:voltage-gated ion channel activity; ISS:UniProtKB
Q4KMQ2	ANO6	Anoctamin-6	GO:0002543; P:activation of blood coagulation via clotting cascade; IMP:UniProtKB
Q4KMQ2	ANO6	Anoctamin-6	GO:0007596; P:blood coagulation; ISS:UniProtKB
Q4KMQ2	ANO6	Anoctamin-6	GO:0006812; P:cation transport; ISS:GOC
Q4KMQ2	ANO6	Anoctamin-6	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q4KMQ2	ANO6	Anoctamin-6	GO:0097045; P:phosphatidylserine exposure on blood platelet; IMP:UniProtKB
Q4KMQ2	ANO6	Anoctamin-6	GO:0017121; P:phospholipid scrambling; ISS:UniProtKB
Q4KMQ2	ANO6	Anoctamin-6	GO:0055085; P:transmembrane transport; TAS:Reactome
Q6IWH7	ANO7	Anoctamin-7	GO:0005254; F:chloride channel activity; IEA:Ensembl
Q6IWH7	ANO7	Anoctamin-7	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q6IWH7	ANO7	Anoctamin-7	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9HCE9	ANO8	Anoctamin-8	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9HCE9	ANO8	Anoctamin-8	GO:0055085; P:transmembrane transport; TAS:Reactome
A1A5B4	ANO9	Anoctamin-9	GO:0034220; P:ion transmembrane transport; TAS:Reactome
A1A5B4	ANO9	Anoctamin-9	GO:0055085; P:transmembrane transport; TAS:Reactome
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0005524; F:ATP binding; IEA:InterPro
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0008528; F:G-protein coupled peptide receptor activity; NAS:UniProtKB
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0004383; F:guanylate cyclase activity; IDA:UniProtKB
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0042562; F:hormone binding; IPI:UniProtKB
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0016941; F:natriuretic peptide receptor activity; IDA:UniProtKB
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0017046; F:peptide hormone binding; IEA:Ensembl
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0004672; F:protein kinase activity; IEA:InterPro
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0007589; P:body fluid secretion; TAS:UniProtKB
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0007166; P:cell surface receptor signaling pathway; NAS:UniProtKB
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0006182; P:cGMP biosynthetic process; IDA:UniProtKB
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0042417; P:dopamine metabolic process; IEA:Ensembl
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:GOC
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0035556; P:intracellular signal transduction; IEA:Ensembl
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0016525; P:negative regulation of angiogenesis; TAS:UniProtKB
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IEA:Ensembl
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0030828; P:positive regulation of cGMP biosynthetic process; IEA:Ensembl
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0035815; P:positive regulation of renal sodium excretion; TAS:UniProtKB
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0035810; P:positive regulation of urine volume; TAS:UniProtKB
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0007168; P:receptor guanylyl cyclase signaling pathway; IDA:UniProtKB
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0008217; P:regulation of blood pressure; NAS:UniProtKB
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0050880; P:regulation of blood vessel size; IEA:UniProtKB-KW
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0043114; P:regulation of vascular permeability; TAS:UniProtKB
P16066	NPR1	Atrial natriuretic peptide receptor 1	GO:0042312; P:regulation of vasodilation; NAS:UniProtKB
P20594	NPR2	Atrial natriuretic peptide receptor 2	GO:0005524; F:ATP binding; IEA:Ensembl
P20594	NPR2	Atrial natriuretic peptide receptor 2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P20594	NPR2	Atrial natriuretic peptide receptor 2	GO:0004383; F:guanylate cyclase activity; IDA:UniProtKB
P20594	NPR2	Atrial natriuretic peptide receptor 2	GO:0042562; F:hormone binding; IPI:UniProtKB
P20594	NPR2	Atrial natriuretic peptide receptor 2	GO:0016941; F:natriuretic peptide receptor activity; IDA:UniProtKB
P20594	NPR2	Atrial natriuretic peptide receptor 2	GO:0017046; F:peptide hormone binding; IEA:Ensembl
P20594	NPR2	Atrial natriuretic peptide receptor 2	GO:0004672; F:protein kinase activity; IEA:InterPro
P20594	NPR2	Atrial natriuretic peptide receptor 2	GO:0004872; F:receptor activity; TAS:ProtInc
P20594	NPR2	Atrial natriuretic peptide receptor 2	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
P20594	NPR2	Atrial natriuretic peptide receptor 2	GO:0060348; P:bone development; IEA:Ensembl
P20594	NPR2	Atrial natriuretic peptide receptor 2	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P20594	NPR2	Atrial natriuretic peptide receptor 2	GO:0097011; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; IEP:UniProtKB
P20594	NPR2	Atrial natriuretic peptide receptor 2	GO:0006182; P:cGMP biosynthetic process; IDA:UniProtKB
P20594	NPR2	Atrial natriuretic peptide receptor 2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P20594	NPR2	Atrial natriuretic peptide receptor 2	GO:0001503; P:ossification; IEA:UniProtKB-KW
P20594	NPR2	Atrial natriuretic peptide receptor 2	GO:0007168; P:receptor guanylyl cyclase signaling pathway; IDA:UniProtKB
P20594	NPR2	Atrial natriuretic peptide receptor 2	GO:0008217; P:regulation of blood pressure; TAS:ProtInc
P20594	NPR2	Atrial natriuretic peptide receptor 2	GO:0007165; P:signal transduction; NAS:ProtInc
P17342	NPR3	Atrial natriuretic peptide receptor 3	GO:0008528; F:G-protein coupled peptide receptor activity; ISS:BHF-UCL
P17342	NPR3	Atrial natriuretic peptide receptor 3	GO:0042562; F:hormone binding; IPI:UniProtKB
P17342	NPR3	Atrial natriuretic peptide receptor 3	GO:0016941; F:natriuretic peptide receptor activity; IDA:UniProtKB
P17342	NPR3	Atrial natriuretic peptide receptor 3	GO:0017046; F:peptide hormone binding; ISS:BHF-UCL
P17342	NPR3	Atrial natriuretic peptide receptor 3	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IEA:Ensembl
P17342	NPR3	Atrial natriuretic peptide receptor 3	GO:0007194; P:negative regulation of adenylate cyclase activity; IEA:Ensembl
P17342	NPR3	Atrial natriuretic peptide receptor 3	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IEA:Ensembl
P17342	NPR3	Atrial natriuretic peptide receptor 3	GO:0002158; P:osteoclast proliferation; ISS:UniProtKB
P17342	NPR3	Atrial natriuretic peptide receptor 3	GO:0030157; P:pancreatic juice secretion; IEA:Ensembl
P17342	NPR3	Atrial natriuretic peptide receptor 3	GO:0048015; P:phosphatidylinositol-mediated signaling; IEA:Ensembl
P17342	NPR3	Atrial natriuretic peptide receptor 3	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P17342	NPR3	Atrial natriuretic peptide receptor 3	GO:0051000; P:positive regulation of nitric-oxide synthase activity; ISS:BHF-UCL
P17342	NPR3	Atrial natriuretic peptide receptor 3	GO:0035810; P:positive regulation of urine volume; ISS:UniProtKB
P17342	NPR3	Atrial natriuretic peptide receptor 3	GO:0008217; P:regulation of blood pressure; ISS:UniProtKB
P17342	NPR3	Atrial natriuretic peptide receptor 3	GO:0033688; P:regulation of osteoblast proliferation; ISS:UniProtKB
P17342	NPR3	Atrial natriuretic peptide receptor 3	GO:0001501; P:skeletal system development; ISS:UniProtKB
Q6UB99	ANKRD11	Ankyrin repeat domain-containing protein 11	GO:0060348; P:bone development; IEA:Ensembl
Q6UB99	ANKRD11	Ankyrin repeat domain-containing protein 11	GO:0060325; P:face morphogenesis; IMP:MGI
Q6UB99	ANKRD11	Ankyrin repeat domain-containing protein 11	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q6UB99	ANKRD11	Ankyrin repeat domain-containing protein 11	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q6UB99	ANKRD11	Ankyrin repeat domain-containing protein 11	GO:0042475; P:odontogenesis of dentin-containing tooth; IMP:MGI
Q6UB99	ANKRD11	Ankyrin repeat domain-containing protein 11	GO:0048705; P:skeletal system morphogenesis; IMP:MGI
Q6UB99	ANKRD11	Ankyrin repeat domain-containing protein 11	GO:0001894; P:tissue homeostasis; IEA:Ensembl
O75179	ANKRD17	Ankyrin repeat domain-containing protein 17	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75179	ANKRD17	Ankyrin repeat domain-containing protein 17	GO:0003723; F:RNA binding; IEA:InterPro
O75179	ANKRD17	Ankyrin repeat domain-containing protein 17	GO:0001955; P:blood vessel maturation; IEA:Ensembl
O75179	ANKRD17	Ankyrin repeat domain-containing protein 17	GO:0051151; P:negative regulation of smooth muscle cell differentiation; IEA:Ensembl
O75179	ANKRD17	Ankyrin repeat domain-containing protein 17	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q86SG2	ANKRD23	Ankyrin repeat domain-containing protein 23	GO:0031432; F:titin binding; IPI:BHF-UCL
Q86SG2	ANKRD23	Ankyrin repeat domain-containing protein 23	GO:0006631; P:fatty acid metabolic process; IEA:Ensembl
Q86SG2	ANKRD23	Ankyrin repeat domain-containing protein 23	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
Q9UPS8	ANKRD26	Ankyrin repeat domain-containing protein 26	GO:0042593; P:glucose homeostasis; IEA:Ensembl
Q9UPS8	ANKRD26	Ankyrin repeat domain-containing protein 26	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IEA:Ensembl
Q9UPS8	ANKRD26	Ankyrin repeat domain-containing protein 26	GO:0045599; P:negative regulation of fat cell differentiation; IEA:Ensembl
Q9UPS8	ANKRD26	Ankyrin repeat domain-containing protein 26	GO:0046627; P:negative regulation of insulin receptor signaling pathway; IEA:Ensembl
Q9UPS8	ANKRD26	Ankyrin repeat domain-containing protein 26	GO:0040015; P:negative regulation of multicellular organism growth; IEA:Ensembl
Q9UPS8	ANKRD26	Ankyrin repeat domain-containing protein 26	GO:0046621; P:negative regulation of organ growth; IEA:Ensembl
Q9UPS8	ANKRD26	Ankyrin repeat domain-containing protein 26	GO:0019217; P:regulation of fatty acid metabolic process; IEA:Ensembl
Q9UPS8	ANKRD26	Ankyrin repeat domain-containing protein 26	GO:0060259; P:regulation of feeding behavior; IEA:Ensembl
Q96NW4	ANKRD27	Ankyrin repeat domain-containing protein 27	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q96NW4	ANKRD27	Ankyrin repeat domain-containing protein 27	GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:MGI
Q96NW4	ANKRD27	Ankyrin repeat domain-containing protein 27	GO:0005515; F:protein binding; IPI:IntAct
Q96NW4	ANKRD27	Ankyrin repeat domain-containing protein 27	GO:0045022; P:early endosome to late endosome transport; IDA:MGI
Q96NW4	ANKRD27	Ankyrin repeat domain-containing protein 27	GO:0043087; P:regulation of GTPase activity; IDA:GOC
O15084	ANKRD28	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A	GO:0005515; F:protein binding; IPI:IntAct
Q7Z3H0	ANKRD33	Ankyrin repeat domain-containing protein 33	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q8N9B4	ANKRD42	Ankyrin repeat domain-containing protein 42	GO:1900017; P:positive regulation of cytokine production involved in inflammatory response; IEA:Ensembl
Q8N9B4	ANKRD42	Ankyrin repeat domain-containing protein 42	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:Ensembl
Q8N8A2	ANKRD44	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B	GO:0005515; F:protein binding; IPI:IntAct
Q8WVL7	ANKRD49	Ankyrin repeat domain-containing protein 49	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9ULJ7	ANKRD50	Ankyrin repeat domain-containing protein 50	GO:0005515; F:protein binding; IPI:IntAct
Q8NB46	ANKRD52	Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C	GO:0005515; F:protein binding; IPI:IntAct
Q6NXT1	ANKRD54	Ankyrin repeat domain-containing protein 54	GO:0019887; F:protein kinase regulator activity; IEA:Ensembl
Q6NXT1	ANKRD54	Ankyrin repeat domain-containing protein 54	GO:0006913; P:nucleocytoplasmic transport; IEA:Ensembl
Q6NXT1	ANKRD54	Ankyrin repeat domain-containing protein 54	GO:0045648; P:positive regulation of erythrocyte differentiation; ISS:UniProtKB
Q6NXT1	ANKRD54	Ankyrin repeat domain-containing protein 54	GO:1902531; P:regulation of intracellular signal transduction; ISS:UniProtKB
Q9H9E1	ANKRA2	Ankyrin repeat family A protein 2	GO:0030169; F:low-density lipoprotein particle binding; IDA:UniProtKB
Q92625	ANKS1A	Ankyrin repeat and SAM domain-containing protein 1A	GO:0005515; F:protein binding; IPI:IntAct
Q92625	ANKS1A	Ankyrin repeat and SAM domain-containing protein 1A	GO:0048013; P:ephrin receptor signaling pathway; ISS:UniProtKB
Q92625	ANKS1A	Ankyrin repeat and SAM domain-containing protein 1A	GO:0016322; P:neuron remodeling; ISS:UniProtKB
Q92625	ANKS1A	Ankyrin repeat and SAM domain-containing protein 1A	GO:0006929; P:substrate-dependent cell migration; ISS:UniProtKB
Q7Z6G8	ANKS1B	Ankyrin repeat and sterile alpha motif domain-containing protein 1B	GO:0046875; F:ephrin receptor binding; IPI:UniProtKB
P01008	SERPINC1	Antithrombin-III	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P01008	SERPINC1	Antithrombin-III	GO:0002020; F:protease binding; IPI:UniProtKB
P01008	SERPINC1	Antithrombin-III	GO:0005515; F:protein binding; IPI:UniProtKB
P01008	SERPINC1	Antithrombin-III	GO:0004867; F:serine-type endopeptidase inhibitor activity; NAS:UniProtKB
P01008	SERPINC1	Antithrombin-III	GO:0007596; P:blood coagulation; TAS:Reactome
P01008	SERPINC1	Antithrombin-III	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P01008	SERPINC1	Antithrombin-III	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
P01008	SERPINC1	Antithrombin-III	GO:2000266; P:regulation of blood coagulation, intrinsic pathway; IEA:InterPro
P01008	SERPINC1	Antithrombin-III	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
P01008	SERPINC1	Antithrombin-III	GO:0007584; P:response to nutrient; IEA:Ensembl
Q9H6X2	ANTXR1	Anthrax toxin receptor 1	GO:0051015; F:actin filament binding; IDA:UniProtKB
Q9H6X2	ANTXR1	Anthrax toxin receptor 1	GO:0005518; F:collagen binding; IDA:UniProtKB
Q9H6X2	ANTXR1	Anthrax toxin receptor 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H6X2	ANTXR1	Anthrax toxin receptor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H6X2	ANTXR1	Anthrax toxin receptor 1	GO:0004888; F:transmembrane signaling receptor activity; IDA:UniProtKB
Q9H6X2	ANTXR1	Anthrax toxin receptor 1	GO:0031532; P:actin cytoskeleton reorganization; IDA:UniProtKB
Q9H6X2	ANTXR1	Anthrax toxin receptor 1	GO:0022414; P:reproductive process; IEA:Ensembl
Q9H6X2	ANTXR1	Anthrax toxin receptor 1	GO:0007165; P:signal transduction; IDA:GOC
Q9H6X2	ANTXR1	Anthrax toxin receptor 1	GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:UniProtKB
P58335	ANTXR2	Anthrax toxin receptor 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P58335	ANTXR2	Anthrax toxin receptor 2	GO:0005515; F:protein binding; IPI:IntAct
P58335	ANTXR2	Anthrax toxin receptor 2	GO:0004872; F:receptor activity; IEA:InterPro
P58335	ANTXR2	Anthrax toxin receptor 2	GO:0022414; P:reproductive process; IEA:Ensembl
A6NF34	ANTXRL	Anthrax toxin receptor-like	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A6NF34	ANTXRL	Anthrax toxin receptor-like	GO:0004872; F:receptor activity; IEA:InterPro
Q9UJ72	ANXA10	Annexin A10	GO:0005509; F:calcium ion binding; TAS:ProtInc
Q9UJ72	ANXA10	Annexin A10	GO:0005544; F:calcium-dependent phospholipid binding; IEA:InterPro
P50995	ANXA11	Annexin A11	GO:0005509; F:calcium ion binding; IEA:Ensembl
P50995	ANXA11	Annexin A11	GO:0005544; F:calcium-dependent phospholipid binding; IEA:UniProtKB-KW
P50995	ANXA11	Annexin A11	GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB
P50995	ANXA11	Annexin A11	GO:0023026; F:MHC class II protein complex binding; IDA:UniProt
P50995	ANXA11	Annexin A11	GO:0008429; F:phosphatidylethanolamine binding; IEA:Ensembl
P50995	ANXA11	Annexin A11	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P50995	ANXA11	Annexin A11	GO:0005515; F:protein binding; IPI:UniProtKB
P50995	ANXA11	Annexin A11	GO:0044548; F:S100 protein binding; IPI:UniProtKB
P50995	ANXA11	Annexin A11	GO:0007109; P:cytokinesis, completion of separation; IMP:UniProtKB
P50995	ANXA11	Annexin A11	GO:0006909; P:phagocytosis; IEP:UniProtKB
P50995	ANXA11	Annexin A11	GO:0051592; P:response to calcium ion; IDA:UniProtKB
P27216	ANXA13	Annexin A13	GO:0005509; F:calcium ion binding; IEA:InterPro
P27216	ANXA13	Annexin A13	GO:0005544; F:calcium-dependent phospholipid binding; IEA:UniProtKB-KW
P27216	ANXA13	Annexin A13	GO:1901611; F:phosphatidylglycerol binding; IDA:UniProt
P27216	ANXA13	Annexin A13	GO:0001786; F:phosphatidylserine binding; IDA:UniProt
P27216	ANXA13	Annexin A13	GO:0030154; P:cell differentiation; NAS:UniProtKB
P27216	ANXA13	Annexin A13	GO:0042997; P:negative regulation of Golgi to plasma membrane protein transport; ISS:UniProt
P27216	ANXA13	Annexin A13	GO:0042998; P:positive regulation of Golgi to plasma membrane protein transport; ISS:UniProt
P04083	ANXA1	Annexin A1	GO:0005509; F:calcium ion binding; TAS:ProtInc
P04083	ANXA1	Annexin A1	GO:0005544; F:calcium-dependent phospholipid binding; IDA:UniProtKB
P04083	ANXA1	Annexin A1	GO:0019834; F:phospholipase A2 inhibitor activity; IDA:UniProtKB
P04083	ANXA1	Annexin A1	GO:0005543; F:phospholipid binding; TAS:ProtInc
P04083	ANXA1	Annexin A1	GO:0005515; F:protein binding; IPI:IntAct
P04083	ANXA1	Annexin A1	GO:0030674; F:protein binding, bridging; IDA:UniProtKB
P04083	ANXA1	Annexin A1	GO:0005102; F:receptor binding; TAS:ProtInc
P04083	ANXA1	Annexin A1	GO:0005198; F:structural molecule activity; IDA:UniProtKB
P04083	ANXA1	Annexin A1	GO:0046632; P:alpha-beta T cell differentiation; ISS:BHF-UCL
P04083	ANXA1	Annexin A1	GO:0050482; P:arachidonic acid secretion; IEA:Ensembl
P04083	ANXA1	Annexin A1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P04083	ANXA1	Annexin A1	GO:0006928; P:cellular component movement; TAS:ProtInc
P04083	ANXA1	Annexin A1	GO:0071385; P:cellular response to glucocorticoid stimulus; IDA:BHF-UCL
P04083	ANXA1	Annexin A1	GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl
P04083	ANXA1	Annexin A1	GO:0031018; P:endocrine pancreas development; IEA:Ensembl
P04083	ANXA1	Annexin A1	GO:0060206; P:estrous cycle phase; IEA:Ensembl
P04083	ANXA1	Annexin A1	GO:0042063; P:gliogenesis; IEA:Ensembl
P04083	ANXA1	Annexin A1	GO:0070365; P:hepatocyte differentiation; IEA:Ensembl
P04083	ANXA1	Annexin A1	GO:0006954; P:inflammatory response; TAS:ProtInc
P04083	ANXA1	Annexin A1	GO:0030073; P:insulin secretion; IEA:Ensembl
P04083	ANXA1	Annexin A1	GO:0030216; P:keratinocyte differentiation; IDA:UniProtKB
P04083	ANXA1	Annexin A1	GO:0002674; P:negative regulation of acute inflammatory response; IEA:Ensembl
P04083	ANXA1	Annexin A1	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
P04083	ANXA1	Annexin A1	GO:0043086; P:negative regulation of catalytic activity; IDA:GOC
P04083	ANXA1	Annexin A1	GO:0050709; P:negative regulation of protein secretion; IEA:Ensembl
P04083	ANXA1	Annexin A1	GO:0097350; P:neutrophil clearance; IMP:BHF-UCL
P04083	ANXA1	Annexin A1	GO:0001780; P:neutrophil homeostasis; IMP:BHF-UCL
P04083	ANXA1	Annexin A1	GO:0018149; P:peptide cross-linking; IDA:UniProtKB
P04083	ANXA1	Annexin A1	GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl
P04083	ANXA1	Annexin A1	GO:0033031; P:positive regulation of neutrophil apoptotic process; IEA:Ensembl
P04083	ANXA1	Annexin A1	GO:0031394; P:positive regulation of prostaglandin biosynthetic process; IEA:Ensembl
P04083	ANXA1	Annexin A1	GO:0031340; P:positive regulation of vesicle fusion; IDA:UniProtKB
P04083	ANXA1	Annexin A1	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P04083	ANXA1	Annexin A1	GO:0042493; P:response to drug; IEA:Ensembl
P04083	ANXA1	Annexin A1	GO:0032355; P:response to estradiol; IEA:Ensembl
P04083	ANXA1	Annexin A1	GO:0070555; P:response to interleukin-1; IEA:Ensembl
P04083	ANXA1	Annexin A1	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P04083	ANXA1	Annexin A1	GO:0010165; P:response to X-ray; IEA:Ensembl
P04083	ANXA1	Annexin A1	GO:0007165; P:signal transduction; TAS:UniProtKB
P07355	ANXA2	Annexin A2	GO:0005509; F:calcium ion binding; IEA:InterPro
P07355	ANXA2	Annexin A2	GO:0005544; F:calcium-dependent phospholipid binding; IDA:UniProtKB
P07355	ANXA2	Annexin A2	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IMP:UniProt
P07355	ANXA2	Annexin A2	GO:0019834; F:phospholipase A2 inhibitor activity; IDA:UniProt
P07355	ANXA2	Annexin A2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P07355	ANXA2	Annexin A2	GO:0005515; F:protein binding; IPI:UniProtKB
P07355	ANXA2	Annexin A2	GO:0044548; F:S100 protein binding; IPI:UniProt
P07355	ANXA2	Annexin A2	GO:0001525; P:angiogenesis; IEP:UniProtKB
P07355	ANXA2	Annexin A2	GO:0007589; P:body fluid secretion; IEA:Ensembl
P07355	ANXA2	Annexin A2	GO:0071229; P:cellular response to acid; IEA:Ensembl
P07355	ANXA2	Annexin A2	GO:0030199; P:collagen fibril organization; IEA:Ensembl
P07355	ANXA2	Annexin A2	GO:0042730; P:fibrinolysis; IEA:Ensembl
P07355	ANXA2	Annexin A2	GO:0006900; P:membrane budding; IMP:UniProt
P07355	ANXA2	Annexin A2	GO:0001765; P:membrane raft assembly; IMP:UniProt
P07355	ANXA2	Annexin A2	GO:0043086; P:negative regulation of catalytic activity; IDA:GOC
P07355	ANXA2	Annexin A2	GO:0036035; P:osteoclast development; IDA:UniProt
P07355	ANXA2	Annexin A2	GO:0051099; P:positive regulation of binding; IEA:Ensembl
P07355	ANXA2	Annexin A2	GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl
P07355	ANXA2	Annexin A2	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
P07355	ANXA2	Annexin A2	GO:0031340; P:positive regulation of vesicle fusion; IDA:UniProtKB
P07355	ANXA2	Annexin A2	GO:0051290; P:protein heterotetramerization; IDA:UniProt
P07355	ANXA2	Annexin A2	GO:0072661; P:protein targeting to plasma membrane; IEA:Ensembl
P12429	ANXA3	Annexin A3	GO:0005509; F:calcium ion binding; IEA:InterPro
P12429	ANXA3	Annexin A3	GO:0005544; F:calcium-dependent phospholipid binding; IDA:UniProtKB
P12429	ANXA3	Annexin A3	GO:0019834; F:phospholipase A2 inhibitor activity; IEA:UniProtKB-KW
P12429	ANXA3	Annexin A3	GO:0042742; P:defense response to bacterium; IDA:UniProtKB
P12429	ANXA3	Annexin A3	GO:0043312; P:neutrophil degranulation; IDA:UniProtKB
P12429	ANXA3	Annexin A3	GO:0006909; P:phagocytosis; IDA:UniProtKB
P12429	ANXA3	Annexin A3	GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB
P12429	ANXA3	Annexin A3	GO:0010595; P:positive regulation of endothelial cell migration; IDA:UniProtKB
P12429	ANXA3	Annexin A3	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P09525	ANXA4	Annexin A4	GO:0005509; F:calcium ion binding; IEA:InterPro
P09525	ANXA4	Annexin A4	GO:0005544; F:calcium-dependent phospholipid binding; IDA:UniProtKB
P09525	ANXA4	Annexin A4	GO:0004859; F:phospholipase inhibitor activity; NAS:UniProtKB
P09525	ANXA4	Annexin A4	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
P09525	ANXA4	Annexin A4	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
P09525	ANXA4	Annexin A4	GO:0043086; P:negative regulation of catalytic activity; NAS:GOC
P09525	ANXA4	Annexin A4	GO:0007165; P:signal transduction; TAS:UniProtKB
P08758	ANXA5	Annexin A5	GO:0005509; F:calcium ion binding; IEA:InterPro
P08758	ANXA5	Annexin A5	GO:0005544; F:calcium-dependent phospholipid binding; IDA:UniProtKB
P08758	ANXA5	Annexin A5	GO:0004859; F:phospholipase inhibitor activity; TAS:ProtInc
P08758	ANXA5	Annexin A5	GO:0005543; F:phospholipid binding; TAS:ProtInc
P08758	ANXA5	Annexin A5	GO:0007596; P:blood coagulation; IEA:UniProtKB-KW
P08758	ANXA5	Annexin A5	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
P08758	ANXA5	Annexin A5	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
P08758	ANXA5	Annexin A5	GO:0050819; P:negative regulation of coagulation; IEA:InterPro
P08758	ANXA5	Annexin A5	GO:0010033; P:response to organic substance; IEA:Ensembl
P08758	ANXA5	Annexin A5	GO:0007165; P:signal transduction; TAS:UniProtKB
P08133	ANXA6	Annexin A6	GO:0005509; F:calcium ion binding; IEA:InterPro
P08133	ANXA6	Annexin A6	GO:0005544; F:calcium-dependent phospholipid binding; IDA:UniProtKB
P08133	ANXA6	Annexin A6	GO:0005515; F:protein binding; IPI:UniProtKB
P08133	ANXA6	Annexin A6	GO:0006816; P:calcium ion transport; IEA:Ensembl
P08133	ANXA6	Annexin A6	GO:0006937; P:regulation of muscle contraction; IEA:Ensembl
P20073	ANXA7	Annexin A7	GO:0005509; F:calcium ion binding; IEA:InterPro
P20073	ANXA7	Annexin A7	GO:0005544; F:calcium-dependent phospholipid binding; IEA:UniProtKB-KW
P20073	ANXA7	Annexin A7	GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB
P20073	ANXA7	Annexin A7	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P20073	ANXA7	Annexin A7	GO:0005515; F:protein binding; IPI:UniProtKB
P20073	ANXA7	Annexin A7	GO:0008283; P:cell proliferation; IEA:Ensembl
P20073	ANXA7	Annexin A7	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
P20073	ANXA7	Annexin A7	GO:0009992; P:cellular water homeostasis; IEA:Ensembl
P20073	ANXA7	Annexin A7	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
P20073	ANXA7	Annexin A7	GO:0007599; P:hemostasis; IEA:Ensembl
P20073	ANXA7	Annexin A7	GO:0061025; P:membrane fusion; IEA:Ensembl
P20073	ANXA7	Annexin A7	GO:0008360; P:regulation of cell shape; IEA:Ensembl
P20073	ANXA7	Annexin A7	GO:0051592; P:response to calcium ion; IEA:Ensembl
P20073	ANXA7	Annexin A7	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P20073	ANXA7	Annexin A7	GO:0009651; P:response to salt stress; IEA:Ensembl
P20073	ANXA7	Annexin A7	GO:0035176; P:social behavior; IEP:UniProtKB
P13928	ANXA8	Annexin A8	GO:0051015; F:actin filament binding; IDA:UniProt
P13928	ANXA8	Annexin A8	GO:0005509; F:calcium ion binding; IDA:UniProt
P13928	ANXA8	Annexin A8	GO:0005544; F:calcium-dependent phospholipid binding; IDA:UniProt
P13928	ANXA8	Annexin A8	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProt
P13928	ANXA8	Annexin A8	GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; IDA:UniProt
P13928	ANXA8	Annexin A8	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProt
P13928	ANXA8	Annexin A8	GO:0007596; P:blood coagulation; IEA:UniProtKB-KW
P13928	ANXA8	Annexin A8	GO:0016197; P:endosomal transport; IMP:UniProt
P13928	ANXA8	Annexin A8	GO:0007032; P:endosome organization; IMP:UniProt
P13928	ANXA8	Annexin A8	GO:1900138; P:negative regulation of phospholipase A2 activity; IDA:UniProt
P13928	ANXA8	Annexin A8	GO:1900004; P:negative regulation of serine-type endopeptidase activity; IDA:UniProt
O76027	ANXA9	Annexin A9	GO:0015464; F:acetylcholine receptor activity; IDA:UniProtKB
O76027	ANXA9	Annexin A9	GO:0005509; F:calcium ion binding; IEA:InterPro
O76027	ANXA9	Annexin A9	GO:0005544; F:calcium-dependent phospholipid binding; IEA:InterPro
O76027	ANXA9	Annexin A9	GO:0001786; F:phosphatidylserine binding; IDA:UniProtKB
O76027	ANXA9	Annexin A9	GO:0005543; F:phospholipid binding; IDA:UniProtKB
O76027	ANXA9	Annexin A9	GO:0005515; F:protein binding; IPI:IntAct
O76027	ANXA9	Annexin A9	GO:0042803; F:protein homodimerization activity; TAS:UniProtKB
O76027	ANXA9	Annexin A9	GO:0016337; P:single organismal cell-cell adhesion; IDA:UniProtKB
O76027	ANXA9	Annexin A9	GO:0007268; P:synaptic transmission; IDA:GOC
P28039	AOAH	Acyloxyacyl hydrolase	GO:0050528; F:acyloxyacyl hydrolase activity; IEA:UniProtKB-EC
P28039	AOAH	Acyloxyacyl hydrolase	GO:0003824; F:catalytic activity; TAS:ProtInc
P28039	AOAH	Acyloxyacyl hydrolase	GO:0004465; F:lipoprotein lipase activity; TAS:ProtInc
P28039	AOAH	Acyloxyacyl hydrolase	GO:0006954; P:inflammatory response; TAS:ProtInc
P28039	AOAH	Acyloxyacyl hydrolase	GO:0006629; P:lipid metabolic process; TAS:ProtInc
P28039	AOAH	Acyloxyacyl hydrolase	GO:0008653; P:lipopolysaccharide metabolic process; IEA:Ensembl
P28039	AOAH	Acyloxyacyl hydrolase	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0005261; F:cation channel activity; IDA:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0005507; F:copper ion binding; IDA:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0052597; F:diamine oxidase activity; IDA:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0008144; F:drug binding; IDA:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0008201; F:heparin binding; IDA:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0052598; F:histamine oxidase activity; IEA:UniProtKB-EC
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0052599; F:methylputrescine oxidase activity; IEA:UniProtKB-EC
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0008131; F:primary amine oxidase activity; IDA:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0052600; F:propane-1,3-diamine oxidase activity; IEA:UniProtKB-EC
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0032403; F:protein complex binding; IDA:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0048038; F:quinone binding; IDA:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0004872; F:receptor activity; IDA:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0005272; F:sodium channel activity; TAS:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0009308; P:amine metabolic process; IEA:InterPro
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0097185; P:cellular response to azide; IDA:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0071280; P:cellular response to copper ion; IDA:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0035874; P:cellular response to copper ion starvation; IDA:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0071504; P:cellular response to heparin; TAS:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0071420; P:cellular response to histamine; IDA:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0046677; P:response to antibiotic; IDA:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0042493; P:response to drug; IDA:UniProtKB
P19801	AOC1	Amiloride-sensitive amine oxidase [copper-containing]	GO:0035725; P:sodium ion transmembrane transport; TAS:UniProtKB
O75106	AOC2	Retina-specific copper amine oxidase	GO:0052595; F:aliphatic-amine oxidase activity; IEA:UniProtKB-EC
O75106	AOC2	Retina-specific copper amine oxidase	GO:0052594; F:aminoacetone:oxygen oxidoreductase(deaminating) activity; IEA:UniProtKB-EC
O75106	AOC2	Retina-specific copper amine oxidase	GO:0005507; F:copper ion binding; IEA:InterPro
O75106	AOC2	Retina-specific copper amine oxidase	GO:0009055; F:electron carrier activity; TAS:UniProtKB
O75106	AOC2	Retina-specific copper amine oxidase	GO:0052596; F:phenethylamine:oxygen oxidoreductase (deaminating) activity; IEA:UniProtKB-EC
O75106	AOC2	Retina-specific copper amine oxidase	GO:0008131; F:primary amine oxidase activity; IEA:UniProtKB-EC
O75106	AOC2	Retina-specific copper amine oxidase	GO:0048038; F:quinone binding; IEA:InterPro
O75106	AOC2	Retina-specific copper amine oxidase	GO:0052593; F:tryptamine:oxygen oxidoreductase (deaminating) activity; IEA:UniProtKB-EC
O75106	AOC2	Retina-specific copper amine oxidase	GO:0009308; P:amine metabolic process; IEA:InterPro
O75106	AOC2	Retina-specific copper amine oxidase	GO:0006584; P:catecholamine metabolic process; IEA:UniProtKB-KW
O75106	AOC2	Retina-specific copper amine oxidase	GO:0007601; P:visual perception; TAS:ProtInc
Q16853	AOC3	Membrane primary amine oxidase	GO:0052595; F:aliphatic-amine oxidase activity; IEA:UniProtKB-EC
Q16853	AOC3	Membrane primary amine oxidase	GO:0052594; F:aminoacetone:oxygen oxidoreductase(deaminating) activity; IEA:UniProtKB-EC
Q16853	AOC3	Membrane primary amine oxidase	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q16853	AOC3	Membrane primary amine oxidase	GO:0005261; F:cation channel activity; IDA:UniProtKB
Q16853	AOC3	Membrane primary amine oxidase	GO:0005507; F:copper ion binding; IDA:UniProtKB
Q16853	AOC3	Membrane primary amine oxidase	GO:0052596; F:phenethylamine:oxygen oxidoreductase (deaminating) activity; IEA:UniProtKB-EC
Q16853	AOC3	Membrane primary amine oxidase	GO:0008131; F:primary amine oxidase activity; IDA:UniProtKB
Q16853	AOC3	Membrane primary amine oxidase	GO:0005515; F:protein binding; IPI:UniProtKB
Q16853	AOC3	Membrane primary amine oxidase	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q16853	AOC3	Membrane primary amine oxidase	GO:0042803; F:protein homodimerization activity; TAS:UniProtKB
Q16853	AOC3	Membrane primary amine oxidase	GO:0048038; F:quinone binding; IDA:UniProtKB
Q16853	AOC3	Membrane primary amine oxidase	GO:0052593; F:tryptamine:oxygen oxidoreductase (deaminating) activity; IEA:UniProtKB-EC
Q16853	AOC3	Membrane primary amine oxidase	GO:0009308; P:amine metabolic process; IDA:UniProtKB
Q16853	AOC3	Membrane primary amine oxidase	GO:0006812; P:cation transport; IDA:GOC
Q16853	AOC3	Membrane primary amine oxidase	GO:0007155; P:cell adhesion; IDA:UniProtKB
Q16853	AOC3	Membrane primary amine oxidase	GO:0006954; P:inflammatory response; TAS:UniProtKB
Q16853	AOC3	Membrane primary amine oxidase	GO:0046677; P:response to antibiotic; IDA:UniProtKB
P21397	MAOA	Amine oxidase [flavin-containing] A	GO:0008131; F:primary amine oxidase activity; TAS:Reactome
P21397	MAOA	Amine oxidase [flavin-containing] A	GO:0006576; P:cellular biogenic amine metabolic process; TAS:ProtInc
P21397	MAOA	Amine oxidase [flavin-containing] A	GO:0042420; P:dopamine catabolic process; IEA:Ensembl
P21397	MAOA	Amine oxidase [flavin-containing] A	GO:0042136; P:neurotransmitter biosynthetic process; TAS:Reactome
P21397	MAOA	Amine oxidase [flavin-containing] A	GO:0042135; P:neurotransmitter catabolic process; IEA:UniProtKB-KW
P21397	MAOA	Amine oxidase [flavin-containing] A	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
P21397	MAOA	Amine oxidase [flavin-containing] A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P21397	MAOA	Amine oxidase [flavin-containing] A	GO:0007268; P:synaptic transmission; TAS:Reactome
P21397	MAOA	Amine oxidase [flavin-containing] A	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P27338	MAOB	Amine oxidase [flavin-containing] B	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P27338	MAOB	Amine oxidase [flavin-containing] B	GO:0050660; F:flavin adenine dinucleotide binding; IEA:Ensembl
P27338	MAOB	Amine oxidase [flavin-containing] B	GO:0008131; F:primary amine oxidase activity; TAS:Reactome
P27338	MAOB	Amine oxidase [flavin-containing] B	GO:0014063; P:negative regulation of serotonin secretion; IEA:Ensembl
P27338	MAOB	Amine oxidase [flavin-containing] B	GO:0045964; P:positive regulation of dopamine metabolic process; IEA:Ensembl
P27338	MAOB	Amine oxidase [flavin-containing] B	GO:0010044; P:response to aluminum ion; IEA:Ensembl
P27338	MAOB	Amine oxidase [flavin-containing] B	GO:0051412; P:response to corticosterone; IEA:Ensembl
P27338	MAOB	Amine oxidase [flavin-containing] B	GO:0042493; P:response to drug; IEA:Ensembl
P27338	MAOB	Amine oxidase [flavin-containing] B	GO:0045471; P:response to ethanol; IEA:Ensembl
P27338	MAOB	Amine oxidase [flavin-containing] B	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P27338	MAOB	Amine oxidase [flavin-containing] B	GO:0010269; P:response to selenium ion; IEA:Ensembl
P27338	MAOB	Amine oxidase [flavin-containing] B	GO:0009636; P:response to toxic substance; IEA:Ensembl
P27338	MAOB	Amine oxidase [flavin-containing] B	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P27338	MAOB	Amine oxidase [flavin-containing] B	GO:0021762; P:substantia nigra development; IEP:UniProt
P27338	MAOB	Amine oxidase [flavin-containing] B	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q06278	AOX1	Aldehyde oxidase	GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:UniProtKB-KW
Q06278	AOX1	Aldehyde oxidase	GO:0004031; F:aldehyde oxidase activity; TAS:Reactome
Q06278	AOX1	Aldehyde oxidase	GO:0009055; F:electron carrier activity; IEA:InterPro
Q06278	AOX1	Aldehyde oxidase	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q06278	AOX1	Aldehyde oxidase	GO:0005506; F:iron ion binding; IEA:InterPro
Q06278	AOX1	Aldehyde oxidase	GO:0043546; F:molybdopterin cofactor binding; IEA:InterPro
Q06278	AOX1	Aldehyde oxidase	GO:0051287; F:NAD binding; IEA:InterPro
Q06278	AOX1	Aldehyde oxidase	GO:0008762; F:UDP-N-acetylmuramate dehydrogenase activity; IEA:InterPro
Q06278	AOX1	Aldehyde oxidase	GO:0004854; F:xanthine dehydrogenase activity; TAS:ProtInc
Q06278	AOX1	Aldehyde oxidase	GO:0006954; P:inflammatory response; TAS:ProtInc
Q06278	AOX1	Aldehyde oxidase	GO:0072593; P:reactive oxygen species metabolic process; TAS:ProtInc
Q06278	AOX1	Aldehyde oxidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q06278	AOX1	Aldehyde oxidase	GO:0042816; P:vitamin B6 metabolic process; TAS:Reactome
Q06278	AOX1	Aldehyde oxidase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q06278	AOX1	Aldehyde oxidase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
O60641	SNAP91	Clathrin coat assembly protein AP180	GO:0005545; F:1-phosphatidylinositol binding; IEA:InterPro
O60641	SNAP91	Clathrin coat assembly protein AP180	GO:0005515; F:protein binding; IPI:IntAct
O60641	SNAP91	Clathrin coat assembly protein AP180	GO:0048268; P:clathrin coat assembly; IEA:InterPro
O60641	SNAP91	Clathrin coat assembly protein AP180	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q63HQ0	AP1AR	AP-1 complex-associated regulatory protein	GO:0035650; F:AP-1 adaptor complex binding; IDA:UniProtKB
Q63HQ0	AP1AR	AP-1 complex-associated regulatory protein	GO:0019894; F:kinesin binding; IDA:UniProtKB
Q63HQ0	AP1AR	AP-1 complex-associated regulatory protein	GO:0034613; P:cellular protein localization; IEA:Ensembl
Q63HQ0	AP1AR	AP-1 complex-associated regulatory protein	GO:2000146; P:negative regulation of cell motility; IEA:Ensembl
Q63HQ0	AP1AR	AP-1 complex-associated regulatory protein	GO:0001920; P:negative regulation of receptor recycling; IMP:UniProtKB
Q63HQ0	AP1AR	AP-1 complex-associated regulatory protein	GO:1900025; P:negative regulation of substrate adhesion-dependent cell spreading; IMP:MGI
Q63HQ0	AP1AR	AP-1 complex-associated regulatory protein	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q63HQ0	AP1AR	AP-1 complex-associated regulatory protein	GO:0034315; P:regulation of Arp2/3 complex-mediated actin nucleation; IEA:Ensembl
Q63HQ0	AP1AR	AP-1 complex-associated regulatory protein	GO:0048203; P:vesicle targeting, trans-Golgi to endosome; IDA:UniProtKB
Q10567	AP1B1	AP-1 complex subunit beta-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q10567	AP1B1	AP-1 complex subunit beta-1	GO:0008565; F:protein transporter activity; IEA:InterPro
Q10567	AP1B1	AP-1 complex subunit beta-1	GO:0005215; F:transporter activity; TAS:ProtInc
Q10567	AP1B1	AP-1 complex subunit beta-1	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q10567	AP1B1	AP-1 complex subunit beta-1	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q10567	AP1B1	AP-1 complex subunit beta-1	GO:0061024; P:membrane organization; TAS:Reactome
Q10567	AP1B1	AP-1 complex subunit beta-1	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
Q10567	AP1B1	AP-1 complex subunit beta-1	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
Q10567	AP1B1	AP-1 complex subunit beta-1	GO:0016032; P:viral process; TAS:Reactome
O43747	AP1G1	AP-1 complex subunit gamma-1	GO:0019894; F:kinesin binding; IPI:UniProtKB
O43747	AP1G1	AP-1 complex subunit gamma-1	GO:0005515; F:protein binding; IPI:UniProtKB
O43747	AP1G1	AP-1 complex subunit gamma-1	GO:0008565; F:protein transporter activity; IEA:InterPro
O43747	AP1G1	AP-1 complex subunit gamma-1	GO:0005215; F:transporter activity; TAS:ProtInc
O43747	AP1G1	AP-1 complex subunit gamma-1	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
O43747	AP1G1	AP-1 complex subunit gamma-1	GO:0090160; P:Golgi to lysosome transport; IMP:UniProt
O43747	AP1G1	AP-1 complex subunit gamma-1	GO:0006886; P:intracellular protein transport; TAS:ProtInc
O43747	AP1G1	AP-1 complex subunit gamma-1	GO:0061024; P:membrane organization; TAS:Reactome
O43747	AP1G1	AP-1 complex subunit gamma-1	GO:0043323; P:positive regulation of natural killer cell degranulation; IMP:UniProt
O43747	AP1G1	AP-1 complex subunit gamma-1	GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; IMP:UniProt
O43747	AP1G1	AP-1 complex subunit gamma-1	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
O43747	AP1G1	AP-1 complex subunit gamma-1	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
O43747	AP1G1	AP-1 complex subunit gamma-1	GO:0016032; P:viral process; TAS:Reactome
O75843	AP1G2	AP-1 complex subunit gamma-like 2	GO:0005515; F:protein binding; IPI:IntAct
O75843	AP1G2	AP-1 complex subunit gamma-like 2	GO:0008565; F:protein transporter activity; IEA:InterPro
O75843	AP1G2	AP-1 complex subunit gamma-like 2	GO:0006886; P:intracellular protein transport; IEA:InterPro
O75843	AP1G2	AP-1 complex subunit gamma-like 2	GO:0016192; P:vesicle-mediated transport; NAS:UniProtKB
O75843	AP1G2	AP-1 complex subunit gamma-like 2	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9BXS5	AP1M1	AP-1 complex subunit mu-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BXS5	AP1M1	AP-1 complex subunit mu-1	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q9BXS5	AP1M1	AP-1 complex subunit mu-1	GO:0035646; P:endosome to melanosome transport; IMP:UniProtKB
Q9BXS5	AP1M1	AP-1 complex subunit mu-1	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9BXS5	AP1M1	AP-1 complex subunit mu-1	GO:0032438; P:melanosome organization; IMP:UniProtKB
Q9BXS5	AP1M1	AP-1 complex subunit mu-1	GO:0061024; P:membrane organization; TAS:Reactome
Q9BXS5	AP1M1	AP-1 complex subunit mu-1	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
Q9BXS5	AP1M1	AP-1 complex subunit mu-1	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
Q9BXS5	AP1M1	AP-1 complex subunit mu-1	GO:0016032; P:viral process; TAS:Reactome
Q9Y6Q5	AP1M2	AP-1 complex subunit mu-2	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q9Y6Q5	AP1M2	AP-1 complex subunit mu-2	GO:0061024; P:membrane organization; TAS:Reactome
Q9Y6Q5	AP1M2	AP-1 complex subunit mu-2	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
Q9Y6Q5	AP1M2	AP-1 complex subunit mu-2	GO:0006605; P:protein targeting; TAS:ProtInc
Q9Y6Q5	AP1M2	AP-1 complex subunit mu-2	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
Q9Y6Q5	AP1M2	AP-1 complex subunit mu-2	GO:0006903; P:vesicle targeting; TAS:ProtInc
Q9Y6Q5	AP1M2	AP-1 complex subunit mu-2	GO:0016032; P:viral process; TAS:Reactome
P61966	AP1S1	AP-1 complex subunit sigma-1A	GO:0008565; F:protein transporter activity; IEA:InterPro
P61966	AP1S1	AP-1 complex subunit sigma-1A	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P61966	AP1S1	AP-1 complex subunit sigma-1A	GO:0006886; P:intracellular protein transport; IEA:InterPro
P61966	AP1S1	AP-1 complex subunit sigma-1A	GO:0061024; P:membrane organization; TAS:Reactome
P61966	AP1S1	AP-1 complex subunit sigma-1A	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
P61966	AP1S1	AP-1 complex subunit sigma-1A	GO:0006898; P:receptor-mediated endocytosis; TAS:UniProtKB
P61966	AP1S1	AP-1 complex subunit sigma-1A	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
P61966	AP1S1	AP-1 complex subunit sigma-1A	GO:0009615; P:response to virus; IEP:UniProtKB
P61966	AP1S1	AP-1 complex subunit sigma-1A	GO:0016032; P:viral process; TAS:Reactome
P56377	AP1S2	AP-1 complex subunit sigma-2	GO:0008565; F:protein transporter activity; IEA:InterPro
P56377	AP1S2	AP-1 complex subunit sigma-2	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P56377	AP1S2	AP-1 complex subunit sigma-2	GO:0006886; P:intracellular protein transport; IEA:InterPro
P56377	AP1S2	AP-1 complex subunit sigma-2	GO:0061024; P:membrane organization; TAS:Reactome
P56377	AP1S2	AP-1 complex subunit sigma-2	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
P56377	AP1S2	AP-1 complex subunit sigma-2	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
P56377	AP1S2	AP-1 complex subunit sigma-2	GO:0016032; P:viral process; TAS:Reactome
Q96PC3	AP1S3	AP-1 complex subunit sigma-3	GO:0008565; F:protein transporter activity; IEA:InterPro
Q96PC3	AP1S3	AP-1 complex subunit sigma-3	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q96PC3	AP1S3	AP-1 complex subunit sigma-3	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q96PC3	AP1S3	AP-1 complex subunit sigma-3	GO:0061024; P:membrane organization; TAS:Reactome
Q96PC3	AP1S3	AP-1 complex subunit sigma-3	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
Q96PC3	AP1S3	AP-1 complex subunit sigma-3	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
Q96PC3	AP1S3	AP-1 complex subunit sigma-3	GO:0016032; P:viral process; TAS:Reactome
O95782	AP2A1	AP-2 complex subunit alpha-1	GO:0005515; F:protein binding; IPI:UniProtKB
O95782	AP2A1	AP-2 complex subunit alpha-1	GO:0008565; F:protein transporter activity; IEA:InterPro
O95782	AP2A1	AP-2 complex subunit alpha-1	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
O95782	AP2A1	AP-2 complex subunit alpha-1	GO:0007411; P:axon guidance; TAS:Reactome
O95782	AP2A1	AP-2 complex subunit alpha-1	GO:0006897; P:endocytosis; NAS:UniProtKB
O95782	AP2A1	AP-2 complex subunit alpha-1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O95782	AP2A1	AP-2 complex subunit alpha-1	GO:0006895; P:Golgi to endosome transport; NAS:UniProtKB
O95782	AP2A1	AP-2 complex subunit alpha-1	GO:0006886; P:intracellular protein transport; NAS:UniProtKB
O95782	AP2A1	AP-2 complex subunit alpha-1	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
O95782	AP2A1	AP-2 complex subunit alpha-1	GO:1900126; P:negative regulation of hyaluronan biosynthetic process; IDA:UniProtKB
O95782	AP2A1	AP-2 complex subunit alpha-1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O95782	AP2A1	AP-2 complex subunit alpha-1	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
O95782	AP2A1	AP-2 complex subunit alpha-1	GO:0007268; P:synaptic transmission; TAS:Reactome
O95782	AP2A1	AP-2 complex subunit alpha-1	GO:0016032; P:viral process; TAS:Reactome
O94973	AP2A2	AP-2 complex subunit alpha-2	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
O94973	AP2A2	AP-2 complex subunit alpha-2	GO:0005515; F:protein binding; IPI:IntAct
O94973	AP2A2	AP-2 complex subunit alpha-2	GO:0008565; F:protein transporter activity; IEA:InterPro
O94973	AP2A2	AP-2 complex subunit alpha-2	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
O94973	AP2A2	AP-2 complex subunit alpha-2	GO:0007411; P:axon guidance; TAS:Reactome
O94973	AP2A2	AP-2 complex subunit alpha-2	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
O94973	AP2A2	AP-2 complex subunit alpha-2	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O94973	AP2A2	AP-2 complex subunit alpha-2	GO:0006886; P:intracellular protein transport; IEA:InterPro
O94973	AP2A2	AP-2 complex subunit alpha-2	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
O94973	AP2A2	AP-2 complex subunit alpha-2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O94973	AP2A2	AP-2 complex subunit alpha-2	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
O94973	AP2A2	AP-2 complex subunit alpha-2	GO:0007268; P:synaptic transmission; TAS:Reactome
O94973	AP2A2	AP-2 complex subunit alpha-2	GO:0016032; P:viral process; TAS:Reactome
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0003682; F:chromatin binding; ISS:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0000987; F:core promoter proximal region sequence-specific DNA binding; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0046983; F:protein dimerization activity; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0042803; F:protein homodimerization activity; TAS:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0000982; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0001105; F:RNA polymerase II transcription coactivator activity; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0001106; F:RNA polymerase II transcription corepressor activity; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0021506; P:anterior neuropore closure; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0071711; P:basement membrane organization; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0060349; P:bone morphogenesis; ISS:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0071281; P:cellular response to iron ion; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0061303; P:cornea development in camera-type eye; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0010172; P:embryonic body morphogenesis; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0048701; P:embryonic cranial skeleton morphogenesis; ISS:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0035115; P:embryonic forelimb morphogenesis; ISS:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0009880; P:embryonic pattern specification; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0048730; P:epidermis morphogenesis; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0061029; P:eyelid development in camera-type eye; ISS:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0060325; P:face morphogenesis; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0021884; P:forebrain neuron development; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0042472; P:inner ear morphogenesis; IMP:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0003334; P:keratinocyte development; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0001822; P:kidney development; IMP:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0060235; P:lens induction in camera-type eye; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0072210; P:metanephric nephron development; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:2000378; P:negative regulation of reactive oxygen species metabolic process; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0010944; P:negative regulation of transcription by competitive promoter binding; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0014032; P:neural crest cell development; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0021623; P:oculomotor nerve formation; ISS:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0003409; P:optic cup structural organization; ISS:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0003404; P:optic vesicle morphogenesis; ISS:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0003151; P:outflow tract morphogenesis; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0060021; P:palate development; IMP:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0030501; P:positive regulation of bone mineralization; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0043525; P:positive regulation of neuron apoptotic process; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0070172; P:positive regulation of tooth mineralization; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0045595; P:regulation of cell differentiation; IDA:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0045664; P:regulation of neuron differentiation; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0010842; P:retina layer formation; IEP:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0007605; P:sensory perception of sound; IMP:UniProtKB
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0048485; P:sympathetic nervous system development; IEA:Ensembl
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:GOC
P05549	TFAP2A	Transcription factor AP-2-alpha	GO:0021559; P:trigeminal nerve development; ISS:UniProtKB
P63010	AP2B1	AP-2 complex subunit beta	GO:0030276; F:clathrin binding; IPI:UniProtKB
P63010	AP2B1	AP-2 complex subunit beta	GO:0005515; F:protein binding; IPI:IntAct
P63010	AP2B1	AP-2 complex subunit beta	GO:0008565; F:protein transporter activity; IEA:InterPro
P63010	AP2B1	AP-2 complex subunit beta	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P63010	AP2B1	AP-2 complex subunit beta	GO:0007411; P:axon guidance; TAS:Reactome
P63010	AP2B1	AP-2 complex subunit beta	GO:0048268; P:clathrin coat assembly; IEA:Ensembl
P63010	AP2B1	AP-2 complex subunit beta	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
P63010	AP2B1	AP-2 complex subunit beta	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P63010	AP2B1	AP-2 complex subunit beta	GO:0006886; P:intracellular protein transport; IEA:InterPro
P63010	AP2B1	AP-2 complex subunit beta	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
P63010	AP2B1	AP-2 complex subunit beta	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P63010	AP2B1	AP-2 complex subunit beta	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
P63010	AP2B1	AP-2 complex subunit beta	GO:0007268; P:synaptic transmission; TAS:Reactome
P63010	AP2B1	AP-2 complex subunit beta	GO:0016032; P:viral process; TAS:Reactome
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0003677; F:DNA binding; IDA:UniProtKB
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0005515; F:protein binding; IPI:UniProtKB
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0046983; F:protein dimerization activity; IDA:UniProtKB
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IDA:UniProtKB
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:UniProtKB
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IEA:Ensembl
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0021987; P:cerebral cortex development; IEA:Ensembl
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0060598; P:dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis; IEA:Ensembl
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0060750; P:epithelial cell proliferation involved in mammary gland duct elongation; IEA:Ensembl
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0021877; P:forebrain neuron fate commitment; IEA:Ensembl
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0030718; P:germ-line stem cell maintenance; IEA:Ensembl
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0001942; P:hair follicle development; IEA:Ensembl
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0003334; P:keratinocyte development; IEA:Ensembl
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0008584; P:male gonad development; IEP:UniProtKB
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:GOC
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0045682; P:regulation of epidermis development; IEA:Ensembl
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0048733; P:sebaceous gland development; IEA:Ensembl
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
Q92754	TFAP2C	Transcription factor AP-2 gamma	GO:0001829; P:trophectodermal cell differentiation; IEA:Ensembl
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0003682; F:chromatin binding; IEA:Ensembl
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0003677; F:DNA binding; TAS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0001158; F:enhancer sequence-specific DNA binding; IDA:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0005515; F:protein binding; IPI:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0046983; F:protein dimerization activity; IDA:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IDA:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0000983; F:RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0001105; F:RNA polymerase II transcription coactivator activity; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0001106; F:RNA polymerase II transcription corepressor activity; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0035909; P:aorta morphogenesis; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0055074; P:calcium ion homeostasis; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0097275; P:cellular ammonia homeostasis; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0097276; P:cellular creatinine homeostasis; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0097277; P:cellular urea homeostasis; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0072044; P:collecting duct development; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0072017; P:distal tubule development; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0097070; P:ductus arteriosus closure; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0045444; P:fat cell differentiation; IEP:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0035136; P:forelimb morphogenesis; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0042593; P:glucose homeostasis; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0006006; P:glucose metabolic process; IMP:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0035137; P:hindlimb morphogenesis; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0001822; P:kidney development; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0010960; P:magnesium ion homeostasis; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0072210; P:metanephric nephron development; IEA:Ensembl
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0055062; P:phosphate ion homeostasis; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0043525; P:positive regulation of neuron apoptotic process; IDA:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0035810; P:positive regulation of urine volume; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0055075; P:potassium ion homeostasis; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0030510; P:regulation of BMP signaling pathway; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0045595; P:regulation of cell differentiation; IDA:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0050796; P:regulation of insulin secretion; IMP:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0006355; P:regulation of transcription, DNA-templated; IDA:HGNC
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0003091; P:renal water homeostasis; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0042493; P:response to drug; IEA:Ensembl
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0010226; P:response to lithium ion; IEA:Ensembl
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0010842; P:retina layer formation; IEP:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0043588; P:skin development; IEA:Ensembl
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0055078; P:sodium ion homeostasis; ISS:UniProtKB
Q92481	TFAP2B	Transcription factor AP-2-beta	GO:0048485; P:sympathetic nervous system development; ISS:UniProtKB
Q7Z6R9	TFAP2D	Transcription factor AP-2-delta	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl
Q7Z6R9	TFAP2D	Transcription factor AP-2-delta	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IEA:Ensembl
Q7Z6R9	TFAP2D	Transcription factor AP-2-delta	GO:0061379; P:inferior colliculus development; IEA:Ensembl
Q7Z6R9	TFAP2D	Transcription factor AP-2-delta	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q7Z6R9	TFAP2D	Transcription factor AP-2-delta	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q6VUC0	TFAP2E	Transcription factor AP-2-epsilon	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6VUC0	TFAP2E	Transcription factor AP-2-epsilon	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q6VUC0	TFAP2E	Transcription factor AP-2-epsilon	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q6VUC0	TFAP2E	Transcription factor AP-2-epsilon	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96CW1	AP2M1	AP-2 complex subunit mu	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q96CW1	AP2M1	AP-2 complex subunit mu	GO:0005515; F:protein binding; IPI:UniProtKB
Q96CW1	AP2M1	AP-2 complex subunit mu	GO:0005215; F:transporter activity; TAS:ProtInc
Q96CW1	AP2M1	AP-2 complex subunit mu	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q96CW1	AP2M1	AP-2 complex subunit mu	GO:0007411; P:axon guidance; TAS:Reactome
Q96CW1	AP2M1	AP-2 complex subunit mu	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q96CW1	AP2M1	AP-2 complex subunit mu	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q96CW1	AP2M1	AP-2 complex subunit mu	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q96CW1	AP2M1	AP-2 complex subunit mu	GO:0061024; P:membrane organization; TAS:Reactome
Q96CW1	AP2M1	AP-2 complex subunit mu	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
Q96CW1	AP2M1	AP-2 complex subunit mu	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q96CW1	AP2M1	AP-2 complex subunit mu	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
Q96CW1	AP2M1	AP-2 complex subunit mu	GO:0007268; P:synaptic transmission; TAS:Reactome
Q96CW1	AP2M1	AP-2 complex subunit mu	GO:0016032; P:viral process; TAS:Reactome
P53680	AP2S1	AP-2 complex subunit sigma	GO:0008565; F:protein transporter activity; NAS:UniProtKB
P53680	AP2S1	AP-2 complex subunit sigma	GO:0005215; F:transporter activity; NAS:ProtInc
P53680	AP2S1	AP-2 complex subunit sigma	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P53680	AP2S1	AP-2 complex subunit sigma	GO:0007411; P:axon guidance; TAS:Reactome
P53680	AP2S1	AP-2 complex subunit sigma	GO:0048268; P:clathrin coat assembly; TAS:UniProtKB
P53680	AP2S1	AP-2 complex subunit sigma	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
P53680	AP2S1	AP-2 complex subunit sigma	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P53680	AP2S1	AP-2 complex subunit sigma	GO:0006886; P:intracellular protein transport; IEA:InterPro
P53680	AP2S1	AP-2 complex subunit sigma	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
P53680	AP2S1	AP-2 complex subunit sigma	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P53680	AP2S1	AP-2 complex subunit sigma	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
P53680	AP2S1	AP-2 complex subunit sigma	GO:0030100; P:regulation of endocytosis; TAS:UniProtKB
P53680	AP2S1	AP-2 complex subunit sigma	GO:0007268; P:synaptic transmission; TAS:Reactome
P53680	AP2S1	AP-2 complex subunit sigma	GO:0016032; P:viral process; TAS:Reactome
O00203	AP3B1	AP-3 complex subunit beta-1	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
O00203	AP3B1	AP-3 complex subunit beta-1	GO:0008089; P:anterograde axon cargo transport; IEA:Ensembl
O00203	AP3B1	AP-3 complex subunit beta-1	GO:0048490; P:anterograde synaptic vesicle transport; IEA:Ensembl
O00203	AP3B1	AP-3 complex subunit beta-1	GO:0048007; P:antigen processing and presentation, exogenous lipid antigen via MHC class Ib; IEA:Ensembl
O00203	AP3B1	AP-3 complex subunit beta-1	GO:0007596; P:blood coagulation; IEA:Ensembl
O00203	AP3B1	AP-3 complex subunit beta-1	GO:0006886; P:intracellular protein transport; TAS:ProtInc
O00203	AP3B1	AP-3 complex subunit beta-1	GO:0032438; P:melanosome organization; IMP:UniProtKB
O00203	AP3B1	AP-3 complex subunit beta-1	GO:0051138; P:positive regulation of NK T cell differentiation; IEA:Ensembl
O00203	AP3B1	AP-3 complex subunit beta-1	GO:0006622; P:protein targeting to lysosome; IEA:Ensembl
Q13367	AP3B2	AP-3 complex subunit beta-2	GO:0005215; F:transporter activity; TAS:ProtInc
Q13367	AP3B2	AP-3 complex subunit beta-2	GO:0008089; P:anterograde axon cargo transport; ISS:UniProtKB
Q13367	AP3B2	AP-3 complex subunit beta-2	GO:0048490; P:anterograde synaptic vesicle transport; ISS:UniProtKB
Q13367	AP3B2	AP-3 complex subunit beta-2	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q13367	AP3B2	AP-3 complex subunit beta-2	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:ProtInc
O14617	AP3D1	AP-3 complex subunit delta-1	GO:0008565; F:protein transporter activity; IEA:InterPro
O14617	AP3D1	AP-3 complex subunit delta-1	GO:0005215; F:transporter activity; TAS:ProtInc
O14617	AP3D1	AP-3 complex subunit delta-1	GO:0008089; P:anterograde axon cargo transport; ISS:UniProtKB
O14617	AP3D1	AP-3 complex subunit delta-1	GO:0048490; P:anterograde synaptic vesicle transport; ISS:UniProtKB
O14617	AP3D1	AP-3 complex subunit delta-1	GO:0048007; P:antigen processing and presentation, exogenous lipid antigen via MHC class Ib; IEA:Ensembl
O14617	AP3D1	AP-3 complex subunit delta-1	GO:0006726; P:eye pigment biosynthetic process; TAS:ProtInc
O14617	AP3D1	AP-3 complex subunit delta-1	GO:0006886; P:intracellular protein transport; TAS:ProtInc
O14617	AP3D1	AP-3 complex subunit delta-1	GO:0051138; P:positive regulation of NK T cell differentiation; IEA:Ensembl
O14617	AP3D1	AP-3 complex subunit delta-1	GO:0033365; P:protein localization to organelle; IEA:Ensembl
O14617	AP3D1	AP-3 complex subunit delta-1	GO:0061088; P:regulation of sequestering of zinc ion; IMP:BHF-UCL
O14617	AP3D1	AP-3 complex subunit delta-1	GO:0048499; P:synaptic vesicle membrane organization; IEA:Ensembl
Q9Y2T2	AP3M1	AP-3 complex subunit mu-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y2T2	AP3M1	AP-3 complex subunit mu-1	GO:0008089; P:anterograde axon cargo transport; ISS:UniProtKB
Q9Y2T2	AP3M1	AP-3 complex subunit mu-1	GO:0048490; P:anterograde synaptic vesicle transport; ISS:UniProtKB
Q9Y2T2	AP3M1	AP-3 complex subunit mu-1	GO:0006622; P:protein targeting to lysosome; TAS:ProtInc
P53677	AP3M2	AP-3 complex subunit mu-2	GO:0008089; P:anterograde axon cargo transport; ISS:UniProtKB
P53677	AP3M2	AP-3 complex subunit mu-2	GO:0048490; P:anterograde synaptic vesicle transport; ISS:UniProtKB
P53677	AP3M2	AP-3 complex subunit mu-2	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q92572	AP3S1	AP-3 complex subunit sigma-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q92572	AP3S1	AP-3 complex subunit sigma-1	GO:0008565; F:protein transporter activity; IEA:InterPro
Q92572	AP3S1	AP-3 complex subunit sigma-1	GO:0005215; F:transporter activity; NAS:ProtInc
Q92572	AP3S1	AP-3 complex subunit sigma-1	GO:0008089; P:anterograde axon cargo transport; ISS:UniProtKB
Q92572	AP3S1	AP-3 complex subunit sigma-1	GO:0048490; P:anterograde synaptic vesicle transport; ISS:UniProtKB
Q92572	AP3S1	AP-3 complex subunit sigma-1	GO:0008286; P:insulin receptor signaling pathway; TAS:ProtInc
Q92572	AP3S1	AP-3 complex subunit sigma-1	GO:0006886; P:intracellular protein transport; IEA:InterPro
P59780	AP3S2	AP-3 complex subunit sigma-2	GO:0008565; F:protein transporter activity; IEA:InterPro
P59780	AP3S2	AP-3 complex subunit sigma-2	GO:0008089; P:anterograde axon cargo transport; ISS:UniProtKB
P59780	AP3S2	AP-3 complex subunit sigma-2	GO:0048490; P:anterograde synaptic vesicle transport; ISS:UniProtKB
P59780	AP3S2	AP-3 complex subunit sigma-2	GO:0006886; P:intracellular protein transport; TAS:ProtInc
P50583	NUDT2	Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]	GO:0004081; F:bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity; ISS:UniProtKB
P50583	NUDT2	Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]	GO:0008803; F:bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity; TAS:ProtInc
P50583	NUDT2	Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P50583	NUDT2	Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]	GO:0006915; P:apoptotic process; ISS:UniProtKB
P50583	NUDT2	Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
Q9Y6B7	AP4B1	AP-4 complex subunit beta-1	GO:0008565; F:protein transporter activity; IEA:InterPro
Q9Y6B7	AP4B1	AP-4 complex subunit beta-1	GO:0005215; F:transporter activity; TAS:ProtInc
Q9Y6B7	AP4B1	AP-4 complex subunit beta-1	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9Y6B7	AP4B1	AP-4 complex subunit beta-1	GO:0016192; P:vesicle-mediated transport; IEA:InterPro
O00189	AP4M1	AP-4 complex subunit mu-1	GO:0005215; F:transporter activity; TAS:ProtInc
O00189	AP4M1	AP-4 complex subunit mu-1	GO:0006895; P:Golgi to endosome transport; IMP:UniProtKB
O00189	AP4M1	AP-4 complex subunit mu-1	GO:0006886; P:intracellular protein transport; IMP:UniProtKB
O00189	AP4M1	AP-4 complex subunit mu-1	GO:0016192; P:vesicle-mediated transport; TAS:ProtInc
Q9UPM8	AP4E1	AP-4 complex subunit epsilon-1	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9UPM8	AP4E1	AP-4 complex subunit epsilon-1	GO:0016192; P:vesicle-mediated transport; IEA:InterPro
Q9Y587	AP4S1	AP-4 complex subunit sigma-1	GO:0008565; F:protein transporter activity; IEA:InterPro
Q9Y587	AP4S1	AP-4 complex subunit sigma-1	GO:0005215; F:transporter activity; TAS:ProtInc
Q9H0R1	AP5M1	AP-5 complex subunit mu-1	GO:0016197; P:endosomal transport; IMP:UniProtKB
Q9H0R1	AP5M1	AP-5 complex subunit mu-1	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9H0R1	AP5M1	AP-5 complex subunit mu-1	GO:0016192; P:vesicle-mediated transport; IEA:InterPro
Q2VPB7	AP5B1	AP-5 complex subunit beta-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q2VPB7	AP5B1	AP-5 complex subunit beta-1	GO:0016197; P:endosomal transport; IMP:UniProtKB
Q2VPB7	AP5B1	AP-5 complex subunit beta-1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9NUS5	AP5S1	AP-5 complex subunit sigma-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NUS5	AP5S1	AP-5 complex subunit sigma-1	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
Q9NUS5	AP5S1	AP-5 complex subunit sigma-1	GO:0016197; P:endosomal transport; IMP:UniProtKB
Q9NUS5	AP5S1	AP-5 complex subunit sigma-1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O43299	AP5Z1	AP-5 complex subunit zeta-1	GO:0005515; F:protein binding; IPI:UniProtKB
O43299	AP5Z1	AP-5 complex subunit zeta-1	GO:0008219; P:cell death; IEA:UniProtKB-KW
O43299	AP5Z1	AP-5 complex subunit zeta-1	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
O43299	AP5Z1	AP-5 complex subunit zeta-1	GO:0016197; P:endosomal transport; IMP:UniProtKB
O43299	AP5Z1	AP-5 complex subunit zeta-1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O14727	APAF1	Apoptotic protease-activating factor 1	GO:0043531; F:ADP binding; IEA:InterPro
O14727	APAF1	Apoptotic protease-activating factor 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O14727	APAF1	Apoptotic protease-activating factor 1	GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; NAS:UniProtKB
O14727	APAF1	Apoptotic protease-activating factor 1	GO:0000166; F:nucleotide binding; TAS:UniProtKB
O14727	APAF1	Apoptotic protease-activating factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
O14727	APAF1	Apoptotic protease-activating factor 1	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
O14727	APAF1	Apoptotic protease-activating factor 1	GO:0008635; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; IDA:UniProtKB
O14727	APAF1	Apoptotic protease-activating factor 1	GO:0006309; P:apoptotic DNA fragmentation; IEA:Ensembl
O14727	APAF1	Apoptotic protease-activating factor 1	GO:0006915; P:apoptotic process; TAS:Reactome
O14727	APAF1	Apoptotic protease-activating factor 1	GO:0006952; P:defense response; IEA:InterPro
O14727	APAF1	Apoptotic protease-activating factor 1	GO:0030900; P:forebrain development; IEA:Ensembl
O14727	APAF1	Apoptotic protease-activating factor 1	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:UniProtKB
O14727	APAF1	Apoptotic protease-activating factor 1	GO:0007399; P:nervous system development; TAS:ProtInc
O14727	APAF1	Apoptotic protease-activating factor 1	GO:0001843; P:neural tube closure; IEA:Ensembl
O14727	APAF1	Apoptotic protease-activating factor 1	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
O14727	APAF1	Apoptotic protease-activating factor 1	GO:0043065; P:positive regulation of apoptotic process; TAS:UniProtKB
O14727	APAF1	Apoptotic protease-activating factor 1	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
O14727	APAF1	Apoptotic protease-activating factor 1	GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB
O14727	APAF1	Apoptotic protease-activating factor 1	GO:0072432; P:response to G1 DNA damage checkpoint signaling; TAS:UniProtKB
Q02410	APBA1	Amyloid beta A4 precursor protein-binding family A member 1	GO:0001540; F:beta-amyloid binding; IEA:Ensembl
Q02410	APBA1	Amyloid beta A4 precursor protein-binding family A member 1	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IEA:Ensembl
Q02410	APBA1	Amyloid beta A4 precursor protein-binding family A member 1	GO:0005515; F:protein binding; IPI:IntAct
Q02410	APBA1	Amyloid beta A4 precursor protein-binding family A member 1	GO:0008088; P:axon cargo transport; TAS:ProtInc
Q02410	APBA1	Amyloid beta A4 precursor protein-binding family A member 1	GO:0007155; P:cell adhesion; TAS:ProtInc
Q02410	APBA1	Amyloid beta A4 precursor protein-binding family A member 1	GO:0014051; P:gamma-aminobutyric acid secretion; IEA:Ensembl
Q02410	APBA1	Amyloid beta A4 precursor protein-binding family A member 1	GO:0014047; P:glutamate secretion; IEA:Ensembl
Q02410	APBA1	Amyloid beta A4 precursor protein-binding family A member 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q02410	APBA1	Amyloid beta A4 precursor protein-binding family A member 1	GO:0006886; P:intracellular protein transport; TAS:ProtInc
Q02410	APBA1	Amyloid beta A4 precursor protein-binding family A member 1	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q02410	APBA1	Amyloid beta A4 precursor protein-binding family A member 1	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q02410	APBA1	Amyloid beta A4 precursor protein-binding family A member 1	GO:0007399; P:nervous system development; TAS:ProtInc
Q02410	APBA1	Amyloid beta A4 precursor protein-binding family A member 1	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q02410	APBA1	Amyloid beta A4 precursor protein-binding family A member 1	GO:0010468; P:regulation of gene expression; IEA:Ensembl
Q02410	APBA1	Amyloid beta A4 precursor protein-binding family A member 1	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q99767	APBA2	Amyloid beta A4 precursor protein-binding family A member 2	GO:0001540; F:beta-amyloid binding; IEA:Ensembl
Q99767	APBA2	Amyloid beta A4 precursor protein-binding family A member 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q99767	APBA2	Amyloid beta A4 precursor protein-binding family A member 2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q99767	APBA2	Amyloid beta A4 precursor protein-binding family A member 2	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q99767	APBA2	Amyloid beta A4 precursor protein-binding family A member 2	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q99767	APBA2	Amyloid beta A4 precursor protein-binding family A member 2	GO:0007399; P:nervous system development; TAS:ProtInc
Q99767	APBA2	Amyloid beta A4 precursor protein-binding family A member 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q99767	APBA2	Amyloid beta A4 precursor protein-binding family A member 2	GO:0010468; P:regulation of gene expression; IEA:Ensembl
Q99767	APBA2	Amyloid beta A4 precursor protein-binding family A member 2	GO:0007268; P:synaptic transmission; IEA:Ensembl
O96018	APBA3	Amyloid beta A4 precursor protein-binding family A member 3	GO:0001540; F:beta-amyloid binding; IEA:Ensembl
O96018	APBA3	Amyloid beta A4 precursor protein-binding family A member 3	GO:0019899; F:enzyme binding; IPI:UniProtKB
O96018	APBA3	Amyloid beta A4 precursor protein-binding family A member 3	GO:0004857; F:enzyme inhibitor activity; IDA:UniProtKB
O96018	APBA3	Amyloid beta A4 precursor protein-binding family A member 3	GO:0005515; F:protein binding; IPI:UniProtKB
O96018	APBA3	Amyloid beta A4 precursor protein-binding family A member 3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O96018	APBA3	Amyloid beta A4 precursor protein-binding family A member 3	GO:0043086; P:negative regulation of catalytic activity; IDA:UniProtKB
O96018	APBA3	Amyloid beta A4 precursor protein-binding family A member 3	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O96018	APBA3	Amyloid beta A4 precursor protein-binding family A member 3	GO:0010468; P:regulation of gene expression; IEA:Ensembl
O96018	APBA3	Amyloid beta A4 precursor protein-binding family A member 3	GO:0007268; P:synaptic transmission; IEA:Ensembl
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0001540; F:beta-amyloid binding; ISS:UniProtKB
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0003682; F:chromatin binding; IDA:UniProtKB
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0042393; F:histone binding; IPI:UniProtKB
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0070064; F:proline-rich region binding; IPI:UniProtKB
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0005515; F:protein binding; IPI:UniProtKB
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0008134; F:transcription factor binding; ISS:UniProtKB
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0007411; P:axon guidance; IEA:Ensembl
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0007409; P:axonogenesis; NAS:UniProtKB
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0007050; P:cell cycle arrest; ISS:UniProtKB
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0006302; P:double-strand break repair; IEA:Ensembl
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0043967; P:histone H4 acetylation; ISS:UniProtKB
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0030308; P:negative regulation of cell growth; ISS:UniProtKB
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0050760; P:negative regulation of thymidylate synthase biosynthetic process; ISS:UniProtKB
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0001764; P:neuron migration; IEA:Ensembl
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0045739; P:positive regulation of DNA repair; IEA:Ensembl
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0007165; P:signal transduction; NAS:UniProtKB
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O00213	APBB1	Amyloid beta A4 precursor protein-binding family B member 1	GO:0008542; P:visual learning; IEA:Ensembl
Q92870	APBB2	Amyloid beta A4 precursor protein-binding family B member 2	GO:0001540; F:beta-amyloid binding; ISS:UniProtKB
Q92870	APBB2	Amyloid beta A4 precursor protein-binding family B member 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q92870	APBB2	Amyloid beta A4 precursor protein-binding family B member 2	GO:0008134; F:transcription factor binding; ISS:UniProtKB
Q92870	APBB2	Amyloid beta A4 precursor protein-binding family B member 2	GO:0007411; P:axon guidance; IEA:Ensembl
Q92870	APBB2	Amyloid beta A4 precursor protein-binding family B member 2	GO:0007050; P:cell cycle arrest; ISS:UniProtKB
Q92870	APBB2	Amyloid beta A4 precursor protein-binding family B member 2	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q92870	APBB2	Amyloid beta A4 precursor protein-binding family B member 2	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
Q92870	APBB2	Amyloid beta A4 precursor protein-binding family B member 2	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q92870	APBB2	Amyloid beta A4 precursor protein-binding family B member 2	GO:0030308; P:negative regulation of cell growth; ISS:UniProtKB
Q92870	APBB2	Amyloid beta A4 precursor protein-binding family B member 2	GO:0001764; P:neuron migration; IEA:Ensembl
Q92870	APBB2	Amyloid beta A4 precursor protein-binding family B member 2	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q92870	APBB2	Amyloid beta A4 precursor protein-binding family B member 2	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
O95704	APBB3	Amyloid beta A4 precursor protein-binding family B member 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q92624	APPBP2	Amyloid protein-binding protein 2	GO:0003777; F:microtubule motor activity; TAS:ProtInc
Q92624	APPBP2	Amyloid protein-binding protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q92624	APPBP2	Amyloid protein-binding protein 2	GO:0006886; P:intracellular protein transport; TAS:ProtInc
Q92624	APPBP2	Amyloid protein-binding protein 2	GO:0046907; P:intracellular transport; IDA:MGI
Q92624	APPBP2	Amyloid protein-binding protein 2	GO:0008152; P:metabolic process; TAS:GOC
Q9UM13	ANAPC10	Anaphase-promoting complex subunit 10	GO:0004842; F:ubiquitin-protein ligase activity; TAS:ProtInc
Q9UM13	ANAPC10	Anaphase-promoting complex subunit 10	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q9UM13	ANAPC10	Anaphase-promoting complex subunit 10	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:ProtInc
Q9UM13	ANAPC10	Anaphase-promoting complex subunit 10	GO:0007067; P:mitosis; NAS:UniProtKB
Q9UM13	ANAPC10	Anaphase-promoting complex subunit 10	GO:0000090; P:mitotic anaphase; TAS:ProtInc
Q9UM13	ANAPC10	Anaphase-promoting complex subunit 10	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9UM13	ANAPC10	Anaphase-promoting complex subunit 10	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:Reactome
Q9UM13	ANAPC10	Anaphase-promoting complex subunit 10	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UM13	ANAPC10	Anaphase-promoting complex subunit 10	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UM13	ANAPC10	Anaphase-promoting complex subunit 10	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
Q9UM13	ANAPC10	Anaphase-promoting complex subunit 10	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UM13	ANAPC10	Anaphase-promoting complex subunit 10	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
Q9NYG5	ANAPC11	Anaphase-promoting complex subunit 11	GO:0004842; F:ubiquitin-protein ligase activity; IEA:InterPro
Q9NYG5	ANAPC11	Anaphase-promoting complex subunit 11	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NYG5	ANAPC11	Anaphase-promoting complex subunit 11	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q9NYG5	ANAPC11	Anaphase-promoting complex subunit 11	GO:0007067; P:mitosis; TAS:UniProtKB
Q9NYG5	ANAPC11	Anaphase-promoting complex subunit 11	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9NYG5	ANAPC11	Anaphase-promoting complex subunit 11	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:Reactome
Q9NYG5	ANAPC11	Anaphase-promoting complex subunit 11	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9NYG5	ANAPC11	Anaphase-promoting complex subunit 11	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9NYG5	ANAPC11	Anaphase-promoting complex subunit 11	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
Q9NYG5	ANAPC11	Anaphase-promoting complex subunit 11	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q9NYG5	ANAPC11	Anaphase-promoting complex subunit 11	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9BS18	ANAPC13	Anaphase-promoting complex subunit 13	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9BS18	ANAPC13	Anaphase-promoting complex subunit 13	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
P60006	ANAPC15	Anaphase-promoting complex subunit 15	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P60006	ANAPC15	Anaphase-promoting complex subunit 15	GO:0090266; P:regulation of mitotic cell cycle spindle assembly checkpoint; IMP:UniProtKB
Q96DE5	ANAPC16	Anaphase-promoting complex subunit 16	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q96DE5	ANAPC16	Anaphase-promoting complex subunit 16	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q9H1A4	ANAPC1	Anaphase-promoting complex subunit 1	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q9H1A4	ANAPC1	Anaphase-promoting complex subunit 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9H1A4	ANAPC1	Anaphase-promoting complex subunit 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9H1A4	ANAPC1	Anaphase-promoting complex subunit 1	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:Reactome
Q9H1A4	ANAPC1	Anaphase-promoting complex subunit 1	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9H1A4	ANAPC1	Anaphase-promoting complex subunit 1	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9H1A4	ANAPC1	Anaphase-promoting complex subunit 1	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
Q9H1A4	ANAPC1	Anaphase-promoting complex subunit 1	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O95996	APC2	Adenomatous polyposis coli protein 2	GO:0008013; F:beta-catenin binding; IDA:MGI
O95996	APC2	Adenomatous polyposis coli protein 2	GO:0005515; F:protein binding; IPI:IntAct
O95996	APC2	Adenomatous polyposis coli protein 2	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:BHF-UCL
O95996	APC2	Adenomatous polyposis coli protein 2	GO:0035414; P:negative regulation of catenin import into nucleus; IDA:BHF-UCL
O95996	APC2	Adenomatous polyposis coli protein 2	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9UJX5	ANAPC4	Anaphase-promoting complex subunit 4	GO:0005515; F:protein binding; IPI:IntAct
Q9UJX5	ANAPC4	Anaphase-promoting complex subunit 4	GO:0019903; F:protein phosphatase binding; IPI:BHF-UCL
Q9UJX5	ANAPC4	Anaphase-promoting complex subunit 4	GO:0004842; F:ubiquitin-protein ligase activity; TAS:ProtInc
Q9UJX5	ANAPC4	Anaphase-promoting complex subunit 4	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q9UJX5	ANAPC4	Anaphase-promoting complex subunit 4	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:ProtInc
Q9UJX5	ANAPC4	Anaphase-promoting complex subunit 4	GO:0007067; P:mitosis; TAS:ProtInc
Q9UJX5	ANAPC4	Anaphase-promoting complex subunit 4	GO:0000090; P:mitotic anaphase; TAS:ProtInc
Q9UJX5	ANAPC4	Anaphase-promoting complex subunit 4	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9UJX5	ANAPC4	Anaphase-promoting complex subunit 4	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:Reactome
Q9UJX5	ANAPC4	Anaphase-promoting complex subunit 4	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UJX5	ANAPC4	Anaphase-promoting complex subunit 4	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UJX5	ANAPC4	Anaphase-promoting complex subunit 4	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
Q9UJX5	ANAPC4	Anaphase-promoting complex subunit 4	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UJX5	ANAPC4	Anaphase-promoting complex subunit 4	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
Q9UJX4	ANAPC5	Anaphase-promoting complex subunit 5	GO:0019903; F:protein phosphatase binding; IPI:BHF-UCL
Q9UJX4	ANAPC5	Anaphase-promoting complex subunit 5	GO:0004842; F:ubiquitin-protein ligase activity; TAS:ProtInc
Q9UJX4	ANAPC5	Anaphase-promoting complex subunit 5	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q9UJX4	ANAPC5	Anaphase-promoting complex subunit 5	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:ProtInc
Q9UJX4	ANAPC5	Anaphase-promoting complex subunit 5	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9UJX4	ANAPC5	Anaphase-promoting complex subunit 5	GO:0000090; P:mitotic anaphase; TAS:ProtInc
Q9UJX4	ANAPC5	Anaphase-promoting complex subunit 5	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9UJX4	ANAPC5	Anaphase-promoting complex subunit 5	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:Reactome
Q9UJX4	ANAPC5	Anaphase-promoting complex subunit 5	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UJX4	ANAPC5	Anaphase-promoting complex subunit 5	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UJX4	ANAPC5	Anaphase-promoting complex subunit 5	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
Q9UJX4	ANAPC5	Anaphase-promoting complex subunit 5	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UJX4	ANAPC5	Anaphase-promoting complex subunit 5	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
Q9UJX3	ANAPC7	Anaphase-promoting complex subunit 7	GO:0019903; F:protein phosphatase binding; IPI:BHF-UCL
Q9UJX3	ANAPC7	Anaphase-promoting complex subunit 7	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q9UJX3	ANAPC7	Anaphase-promoting complex subunit 7	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9UJX3	ANAPC7	Anaphase-promoting complex subunit 7	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9UJX3	ANAPC7	Anaphase-promoting complex subunit 7	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:Reactome
Q9UJX3	ANAPC7	Anaphase-promoting complex subunit 7	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UJX3	ANAPC7	Anaphase-promoting complex subunit 7	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UJX3	ANAPC7	Anaphase-promoting complex subunit 7	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
Q9UJX3	ANAPC7	Anaphase-promoting complex subunit 7	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q8J025	APCDD1	Protein APCDD1	GO:0017147; F:Wnt-protein binding; IDA:UniProtKB
Q8J025	APCDD1	Protein APCDD1	GO:0043615; P:astrocyte cell migration; IEA:Ensembl
Q8J025	APCDD1	Protein APCDD1	GO:0001942; P:hair follicle development; IMP:UniProtKB
Q8J025	APCDD1	Protein APCDD1	GO:0030178; P:negative regulation of Wnt signaling pathway; IDA:UniProtKB
Q8J025	APCDD1	Protein APCDD1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P25054	APC	Adenomatous polyposis coli protein	GO:0008013; F:beta-catenin binding; IPI:UniProtKB
P25054	APC	Adenomatous polyposis coli protein	GO:0045295; F:gamma-catenin binding; IPI:BHF-UCL
P25054	APC	Adenomatous polyposis coli protein	GO:0008017; F:microtubule binding; IDA:UniProtKB
P25054	APC	Adenomatous polyposis coli protein	GO:0051010; F:microtubule plus-end binding; IDA:UniProtKB
P25054	APC	Adenomatous polyposis coli protein	GO:0005515; F:protein binding; IPI:UniProtKB
P25054	APC	Adenomatous polyposis coli protein	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P25054	APC	Adenomatous polyposis coli protein	GO:0019887; F:protein kinase regulator activity; IDA:UniProtKB
P25054	APC	Adenomatous polyposis coli protein	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0006915; P:apoptotic process; TAS:Reactome
P25054	APC	Adenomatous polyposis coli protein	GO:0009798; P:axis specification; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0007409; P:axonogenesis; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0060070; P:canonical Wnt signaling pathway; NAS:UniProtKB
P25054	APC	Adenomatous polyposis coli protein	GO:0044336; P:canonical Wnt signaling pathway involved in negative regulation of apoptotic process; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0044337; P:canonical Wnt signaling pathway involved in positive regulation of apoptotic process; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0007155; P:cell adhesion; NAS:UniProtKB
P25054	APC	Adenomatous polyposis coli protein	GO:0007050; P:cell cycle arrest; IDA:UniProtKB
P25054	APC	Adenomatous polyposis coli protein	GO:0016477; P:cell migration; IMP:UniProtKB
P25054	APC	Adenomatous polyposis coli protein	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
P25054	APC	Adenomatous polyposis coli protein	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
P25054	APC	Adenomatous polyposis coli protein	GO:0051276; P:chromosome organization; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0031122; P:cytoplasmic microtubule organization; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0001942; P:hair follicle development; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0001822; P:kidney development; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0007091; P:metaphase/anaphase transition of mitotic cell cycle; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0000281; P:mitotic cytokinesis; IMP:MGI
P25054	APC	Adenomatous polyposis coli protein	GO:0007094; P:mitotic spindle assembly checkpoint; IMP:MGI
P25054	APC	Adenomatous polyposis coli protein	GO:0046716; P:muscle cell cellular homeostasis; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IGI:MGI
P25054	APC	Adenomatous polyposis coli protein	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
P25054	APC	Adenomatous polyposis coli protein	GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:UniProtKB
P25054	APC	Adenomatous polyposis coli protein	GO:0060770; P:negative regulation of epithelial cell proliferation involved in prostate gland development; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0043409; P:negative regulation of MAPK cascade; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0007026; P:negative regulation of microtubule depolymerization; IDA:UniProtKB
P25054	APC	Adenomatous polyposis coli protein	GO:0042483; P:negative regulation of odontogenesis; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0043065; P:positive regulation of apoptotic process; IMP:MGI
P25054	APC	Adenomatous polyposis coli protein	GO:0045785; P:positive regulation of cell adhesion; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0051781; P:positive regulation of cell division; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0030335; P:positive regulation of cell migration; IMP:MGI
P25054	APC	Adenomatous polyposis coli protein	GO:0030858; P:positive regulation of epithelial cell differentiation; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0031116; P:positive regulation of microtubule polymerization; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0045732; P:positive regulation of protein catabolic process; IC:BHF-UCL
P25054	APC	Adenomatous polyposis coli protein	GO:0031274; P:positive regulation of pseudopodium assembly; IMP:MGI
P25054	APC	Adenomatous polyposis coli protein	GO:0006461; P:protein complex assembly; IDA:UniProtKB
P25054	APC	Adenomatous polyposis coli protein	GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0051988; P:regulation of attachment of spindle microtubules to kinetochore; NAS:UniProtKB
P25054	APC	Adenomatous polyposis coli protein	GO:0032886; P:regulation of microtubule-based process; IMP:UniProtKB
P25054	APC	Adenomatous polyposis coli protein	GO:0051171; P:regulation of nitrogen compound metabolic process; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0045667; P:regulation of osteoblast differentiation; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0045670; P:regulation of osteoclast differentiation; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0048538; P:thymus development; IEA:Ensembl
P25054	APC	Adenomatous polyposis coli protein	GO:0070830; P:tight junction assembly; NAS:UniProtKB
Q9ULZ1	APLN	Apelin	GO:0005102; F:receptor binding; TAS:ProtInc
Q9ULZ1	APLN	Apelin	GO:0042756; P:drinking behavior; IEA:Ensembl
Q9ULZ1	APLN	Apelin	GO:0006955; P:immune response; TAS:ProtInc
Q9ULZ1	APLN	Apelin	GO:0007595; P:lactation; TAS:ProtInc
Q9ULZ1	APLN	Apelin	GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl
Q9ULZ1	APLN	Apelin	GO:0045906; P:negative regulation of vasoconstriction; IEA:Ensembl
Q9ULZ1	APLN	Apelin	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q9ULZ1	APLN	Apelin	GO:0051461; P:positive regulation of corticotropin secretion; IEA:Ensembl
Q9ULZ1	APLN	Apelin	GO:0051466; P:positive regulation of corticotropin-releasing hormone secretion; IEA:Ensembl
Q9ULZ1	APLN	Apelin	GO:0031652; P:positive regulation of heat generation; IEA:Ensembl
Q9ULZ1	APLN	Apelin	GO:0042327; P:positive regulation of phosphorylation; IEA:Ensembl
Q9ULZ1	APLN	Apelin	GO:0045909; P:positive regulation of vasodilation; IEA:Ensembl
Q9ULZ1	APLN	Apelin	GO:0043576; P:regulation of respiratory gaseous exchange; IEA:Ensembl
Q9ULZ1	APLN	Apelin	GO:0002026; P:regulation of the force of heart contraction; IEA:Ensembl
Q9ULZ1	APLN	Apelin	GO:0007165; P:signal transduction; TAS:ProtInc
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0008408; F:3'-5' exonuclease activity; IDA:UniProtKB
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0031490; F:chromatin DNA binding; IDA:UniProtKB
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0003684; F:damaged DNA binding; IDA:UniProtKB
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0003677; F:DNA binding; IDA:UniProtKB
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0003906; F:DNA-(apurinic or apyrimidinic site) lyase activity; IDA:UniProtKB
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0004520; F:endodeoxyribonuclease activity; TAS:ProtInc
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0004519; F:endonuclease activity; IDA:MGI
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0046872; F:metal ion binding; IDA:UniProtKB
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0016491; F:oxidoreductase activity; IDA:UniProtKB
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0004528; F:phosphodiesterase I activity; TAS:UniProtKB
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0008081; F:phosphoric diester hydrolase activity; IDA:MGI
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0005515; F:protein binding; IPI:UniProtKB
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0004523; F:RNA-DNA hybrid ribonuclease activity; TAS:UniProtKB
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0016890; F:site-specific endodeoxyribonuclease activity, specific for altered base; IDA:UniProtKB
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0004844; F:uracil DNA N-glycosylase activity; TAS:ProtInc
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0007568; P:aging; IEA:Ensembl
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0006284; P:base-excision repair; TAS:Reactome
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0045454; P:cell redox homeostasis; IEA:Ensembl
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0071320; P:cellular response to cAMP; IEA:Ensembl
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0071375; P:cellular response to peptide hormone stimulus; IEA:Ensembl
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0080111; P:DNA demethylation; IDA:UniProtKB
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0006281; P:DNA repair; IDA:UniProtKB
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0014912; P:negative regulation of smooth muscle cell migration; IEA:Ensembl
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:GOC
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0055114; P:oxidation-reduction process; IDA:GOC
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0045739; P:positive regulation of DNA repair; IDA:UniProtKB
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0043488; P:regulation of mRNA stability; IMP:UniProtKB
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0042493; P:response to drug; IEA:Ensembl
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; TAS:GOC
P27695	APEX1	DNA-(apurinic or apyrimidinic site) lyase	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UBZ4	APEX2	DNA-(apurinic or apyrimidinic site) lyase 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UBZ4	APEX2	DNA-(apurinic or apyrimidinic site) lyase 2	GO:0003906; F:DNA-(apurinic or apyrimidinic site) lyase activity; IEA:UniProtKB-EC
Q9UBZ4	APEX2	DNA-(apurinic or apyrimidinic site) lyase 2	GO:0004527; F:exonuclease activity; IEA:UniProtKB-KW
Q9UBZ4	APEX2	DNA-(apurinic or apyrimidinic site) lyase 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UBZ4	APEX2	DNA-(apurinic or apyrimidinic site) lyase 2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9UBZ4	APEX2	DNA-(apurinic or apyrimidinic site) lyase 2	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q9UBZ4	APEX2	DNA-(apurinic or apyrimidinic site) lyase 2	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q96BI3	APH1A	Gamma-secretase subunit APH-1A	GO:0004175; F:endopeptidase activity; IEA:Ensembl
Q96BI3	APH1A	Gamma-secretase subunit APH-1A	GO:0005515; F:protein binding; IPI:UniProtKB
Q96BI3	APH1A	Gamma-secretase subunit APH-1A	GO:0042987; P:amyloid precursor protein catabolic process; IMP:UniProtKB
Q96BI3	APH1A	Gamma-secretase subunit APH-1A	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q96BI3	APH1A	Gamma-secretase subunit APH-1A	GO:0006509; P:membrane protein ectodomain proteolysis; IDA:HGNC
Q96BI3	APH1A	Gamma-secretase subunit APH-1A	GO:0031293; P:membrane protein intracellular domain proteolysis; IMP:UniProtKB
Q96BI3	APH1A	Gamma-secretase subunit APH-1A	GO:0001656; P:metanephros development; IEA:Ensembl
Q96BI3	APH1A	Gamma-secretase subunit APH-1A	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q96BI3	APH1A	Gamma-secretase subunit APH-1A	GO:0007220; P:Notch receptor processing; IMP:UniProtKB
Q96BI3	APH1A	Gamma-secretase subunit APH-1A	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q96BI3	APH1A	Gamma-secretase subunit APH-1A	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q96BI3	APH1A	Gamma-secretase subunit APH-1A	GO:0043085; P:positive regulation of catalytic activity; IDA:HGNC
Q96BI3	APH1A	Gamma-secretase subunit APH-1A	GO:0016485; P:protein processing; IDA:HGNC
Q8WW43	APH1B	Gamma-secretase subunit APH-1B	GO:0008233; F:peptidase activity; IDA:MGI
Q8WW43	APH1B	Gamma-secretase subunit APH-1B	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WW43	APH1B	Gamma-secretase subunit APH-1B	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q8WW43	APH1B	Gamma-secretase subunit APH-1B	GO:0031293; P:membrane protein intracellular domain proteolysis; TAS:Reactome
Q8WW43	APH1B	Gamma-secretase subunit APH-1B	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q8WW43	APH1B	Gamma-secretase subunit APH-1B	GO:0007220; P:Notch receptor processing; TAS:Reactome
Q8WW43	APH1B	Gamma-secretase subunit APH-1B	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q8WW43	APH1B	Gamma-secretase subunit APH-1B	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q8WW43	APH1B	Gamma-secretase subunit APH-1B	GO:0043085; P:positive regulation of catalytic activity; IEA:InterPro
Q8WW43	APH1B	Gamma-secretase subunit APH-1B	GO:0016485; P:protein processing; IDA:MGI
Q9BZZ5	API5	Apoptosis inhibitor 5	GO:0017134; F:fibroblast growth factor binding; IPI:UniProtKB
Q9BZZ5	API5	Apoptosis inhibitor 5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BZZ5	API5	Apoptosis inhibitor 5	GO:0005515; F:protein binding; IPI:IntAct
Q9BZZ5	API5	Apoptosis inhibitor 5	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9BZZ5	API5	Apoptosis inhibitor 5	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q9BZZ5	API5	Apoptosis inhibitor 5	GO:2000270; P:negative regulation of fibroblast apoptotic process; IEA:Ensembl
P35414	APLNR	Apelin receptor	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P35414	APLNR	Apelin receptor	GO:0004872; F:receptor activity; TAS:ProtInc
P35414	APLNR	Apelin receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P35414	APLNR	Apelin receptor	GO:0007369; P:gastrulation; IEA:UniProtKB-KW
P35414	APLNR	Apelin receptor	GO:0007507; P:heart development; ISS:UniProtKB
P35414	APLNR	Apelin receptor	GO:0050878; P:regulation of body fluid levels; IEA:Ensembl
Q96LR9	APOLD1	Apolipoprotein L domain-containing protein 1	GO:0008289; F:lipid binding; IEA:InterPro
Q96LR9	APOLD1	Apolipoprotein L domain-containing protein 1	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q96LR9	APOLD1	Apolipoprotein L domain-containing protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96LR9	APOLD1	Apolipoprotein L domain-containing protein 1	GO:0042118; P:endothelial cell activation; IEA:Ensembl
Q96LR9	APOLD1	Apolipoprotein L domain-containing protein 1	GO:0006869; P:lipid transport; IEA:InterPro
Q96LR9	APOLD1	Apolipoprotein L domain-containing protein 1	GO:0042157; P:lipoprotein metabolic process; IEA:InterPro
Q96LR9	APOLD1	Apolipoprotein L domain-containing protein 1	GO:0045601; P:regulation of endothelial cell differentiation; IEA:Ensembl
Q96LR9	APOLD1	Apolipoprotein L domain-containing protein 1	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q8IW19	APLF	Aprataxin and PNK-like factor	GO:0008408; F:3'-5' exonuclease activity; IDA:UniProtKB
Q8IW19	APLF	Aprataxin and PNK-like factor	GO:0003906; F:DNA-(apurinic or apyrimidinic site) lyase activity; IDA:UniProtKB
Q8IW19	APLF	Aprataxin and PNK-like factor	GO:0004520; F:endodeoxyribonuclease activity; IDA:UniProtKB
Q8IW19	APLF	Aprataxin and PNK-like factor	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IW19	APLF	Aprataxin and PNK-like factor	GO:0000166; F:nucleotide binding; IDA:UniProtKB
Q8IW19	APLF	Aprataxin and PNK-like factor	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IW19	APLF	Aprataxin and PNK-like factor	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q8IW19	APLF	Aprataxin and PNK-like factor	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
Q8IW19	APLF	Aprataxin and PNK-like factor	GO:0006302; P:double-strand break repair; IMP:UniProtKB
Q8IW19	APLF	Aprataxin and PNK-like factor	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:GOC
Q8IW19	APLF	Aprataxin and PNK-like factor	GO:0051106; P:positive regulation of DNA ligation; IGI:MGI
Q8IW19	APLF	Aprataxin and PNK-like factor	GO:0000012; P:single strand break repair; IMP:UniProtKB
P51693	APLP1	Amyloid-like protein 1	GO:0031694; F:alpha-2A adrenergic receptor binding; IPI:BHF-UCL
P51693	APLP1	Amyloid-like protein 1	GO:0031695; F:alpha-2B adrenergic receptor binding; IPI:BHF-UCL
P51693	APLP1	Amyloid-like protein 1	GO:0031696; F:alpha-2C adrenergic receptor binding; IPI:BHF-UCL
P51693	APLP1	Amyloid-like protein 1	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P51693	APLP1	Amyloid-like protein 1	GO:0042802; F:identical protein binding; IPI:IntAct
P51693	APLP1	Amyloid-like protein 1	GO:0005515; F:protein binding; IPI:IntAct
P51693	APLP1	Amyloid-like protein 1	GO:0046914; F:transition metal ion binding; IEA:InterPro
P51693	APLP1	Amyloid-like protein 1	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IC:BHF-UCL
P51693	APLP1	Amyloid-like protein 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P51693	APLP1	Amyloid-like protein 1	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P51693	APLP1	Amyloid-like protein 1	GO:0071874; P:cellular response to norepinephrine stimulus; IDA:BHF-UCL
P51693	APLP1	Amyloid-like protein 1	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
P51693	APLP1	Amyloid-like protein 1	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
P51693	APLP1	Amyloid-like protein 1	GO:0030900; P:forebrain development; IEA:Ensembl
P51693	APLP1	Amyloid-like protein 1	GO:0006378; P:mRNA polyadenylation; IEA:Ensembl
P51693	APLP1	Amyloid-like protein 1	GO:0030818; P:negative regulation of cAMP biosynthetic process; IDA:BHF-UCL
P51693	APLP1	Amyloid-like protein 1	GO:0007399; P:nervous system development; TAS:ProtInc
P51693	APLP1	Amyloid-like protein 1	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P51693	APLP1	Amyloid-like protein 1	GO:0006417; P:regulation of translation; IEA:Ensembl
Q06481	APLP2	Amyloid-like protein 2	GO:0003677; F:DNA binding; NAS:UniProtKB
Q06481	APLP2	Amyloid-like protein 2	GO:0008201; F:heparin binding; IEA:InterPro
Q06481	APLP2	Amyloid-like protein 2	GO:0042802; F:identical protein binding; IPI:IntAct
Q06481	APLP2	Amyloid-like protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q06481	APLP2	Amyloid-like protein 2	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q06481	APLP2	Amyloid-like protein 2	GO:0046914; F:transition metal ion binding; IEA:InterPro
Q06481	APLP2	Amyloid-like protein 2	GO:0006878; P:cellular copper ion homeostasis; IEA:Ensembl
Q06481	APLP2	Amyloid-like protein 2	GO:0008203; P:cholesterol metabolic process; IEA:Ensembl
Q06481	APLP2	Amyloid-like protein 2	GO:0009790; P:embryo development; IEA:Ensembl
Q06481	APLP2	Amyloid-like protein 2	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q06481	APLP2	Amyloid-like protein 2	GO:0030900; P:forebrain development; IEA:Ensembl
Q06481	APLP2	Amyloid-like protein 2	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
Q06481	APLP2	Amyloid-like protein 2	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q06481	APLP2	Amyloid-like protein 2	GO:0007617; P:mating behavior; IEA:Ensembl
Q06481	APLP2	Amyloid-like protein 2	GO:0030901; P:midbrain development; IEA:Ensembl
Q06481	APLP2	Amyloid-like protein 2	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q06481	APLP2	Amyloid-like protein 2	GO:0007176; P:regulation of epidermal growth factor-activated receptor activity; IEA:Ensembl
Q06481	APLP2	Amyloid-like protein 2	GO:0043393; P:regulation of protein binding; IEA:Ensembl
Q06481	APLP2	Amyloid-like protein 2	GO:0001967; P:suckling behavior; IEA:Ensembl
Q9HDC9	APMAP	Adipocyte plasma membrane-associated protein	GO:0004064; F:arylesterase activity; IDA:UniProtKB
Q9HDC9	APMAP	Adipocyte plasma membrane-associated protein	GO:0016844; F:strictosidine synthase activity; IEA:InterPro
Q9HDC9	APMAP	Adipocyte plasma membrane-associated protein	GO:0009058; P:biosynthetic process; IEA:InterPro
P02647	APOA1	Apolipoprotein A-I	GO:0034191; F:apolipoprotein A-I receptor binding; IPI:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0034190; F:apolipoprotein receptor binding; IPI:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0001540; F:beta-amyloid binding; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0015485; F:cholesterol binding; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0017127; F:cholesterol transporter activity; IMP:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0008035; F:high-density lipoprotein particle binding; IEA:Ensembl
P02647	APOA1	Apolipoprotein A-I	GO:0070653; F:high-density lipoprotein particle receptor binding; IPI:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0042802; F:identical protein binding; IPI:IntAct
P02647	APOA1	Apolipoprotein A-I	GO:0055102; F:lipase inhibitor activity; IEA:Ensembl
P02647	APOA1	Apolipoprotein A-I	GO:0060228; F:phosphatidylcholine-sterol O-acyltransferase activator activity; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0005543; F:phospholipid binding; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0005548; F:phospholipid transporter activity; IEA:Ensembl
P02647	APOA1	Apolipoprotein A-I	GO:0005515; F:protein binding; IPI:UniProtKB
P02647	APOA1	Apolipoprotein A-I	GO:0030325; P:adrenal gland development; IEA:Ensembl
P02647	APOA1	Apolipoprotein A-I	GO:0007596; P:blood coagulation; TAS:Reactome
P02647	APOA1	Apolipoprotein A-I	GO:0043534; P:blood vessel endothelial cell migration; IEA:Ensembl
P02647	APOA1	Apolipoprotein A-I	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P02647	APOA1	Apolipoprotein A-I	GO:0006695; P:cholesterol biosynthetic process; IEA:Ensembl
P02647	APOA1	Apolipoprotein A-I	GO:0033344; P:cholesterol efflux; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0042632; P:cholesterol homeostasis; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0070508; P:cholesterol import; IMP:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0008203; P:cholesterol metabolic process; IMP:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0030301; P:cholesterol transport; IDA:MGI
P02647	APOA1	Apolipoprotein A-I	GO:0001935; P:endothelial cell proliferation; IEA:Ensembl
P02647	APOA1	Apolipoprotein A-I	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0008211; P:glucocorticoid metabolic process; IEA:Ensembl
P02647	APOA1	Apolipoprotein A-I	GO:0034380; P:high-density lipoprotein particle assembly; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0034384; P:high-density lipoprotein particle clearance; IC:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0034375; P:high-density lipoprotein particle remodeling; IC:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0019915; P:lipid storage; IEA:Ensembl
P02647	APOA1	Apolipoprotein A-I	GO:0042158; P:lipoprotein biosynthetic process; IEA:Ensembl
P02647	APOA1	Apolipoprotein A-I	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
P02647	APOA1	Apolipoprotein A-I	GO:0060354; P:negative regulation of cell adhesion molecule production; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0002740; P:negative regulation of cytokine secretion involved in immune response; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0034115; P:negative regulation of heterotypic cell-cell adhesion; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0050728; P:negative regulation of inflammatory response; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0050713; P:negative regulation of interleukin-1 beta secretion; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0060192; P:negative regulation of lipase activity; IEA:Ensembl
P02647	APOA1	Apolipoprotein A-I	GO:0060761; P:negative regulation of response to cytokine stimulus; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0010903; P:negative regulation of very-low-density lipoprotein particle remodeling; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0031100; P:organ regeneration; IEA:Ensembl
P02647	APOA1	Apolipoprotein A-I	GO:0018206; P:peptidyl-methionine modification; IDA:UniProtKB
P02647	APOA1	Apolipoprotein A-I	GO:0014012; P:peripheral nervous system axon regeneration; IEA:Ensembl
P02647	APOA1	Apolipoprotein A-I	GO:0006656; P:phosphatidylcholine biosynthetic process; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0033700; P:phospholipid efflux; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0055091; P:phospholipid homeostasis; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P02647	APOA1	Apolipoprotein A-I	GO:0030168; P:platelet activation; TAS:Reactome
P02647	APOA1	Apolipoprotein A-I	GO:0002576; P:platelet degranulation; TAS:Reactome
P02647	APOA1	Apolipoprotein A-I	GO:0010873; P:positive regulation of cholesterol esterification; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0051345; P:positive regulation of hydrolase activity; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0051347; P:positive regulation of transferase activity; IEA:Ensembl
P02647	APOA1	Apolipoprotein A-I	GO:0018158; P:protein oxidation; IDA:UniProtKB
P02647	APOA1	Apolipoprotein A-I	GO:0050821; P:protein stabilization; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0032489; P:regulation of Cdc42 protein signal transduction; IDA:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0030300; P:regulation of intestinal cholesterol absorption; IEA:Ensembl
P02647	APOA1	Apolipoprotein A-I	GO:0001932; P:regulation of protein phosphorylation; IEA:Ensembl
P02647	APOA1	Apolipoprotein A-I	GO:0042493; P:response to drug; IEA:Ensembl
P02647	APOA1	Apolipoprotein A-I	GO:0043627; P:response to estrogen; IEA:Ensembl
P02647	APOA1	Apolipoprotein A-I	GO:0007584; P:response to nutrient; IEA:Ensembl
P02647	APOA1	Apolipoprotein A-I	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P02647	APOA1	Apolipoprotein A-I	GO:0043691; P:reverse cholesterol transport; IMP:BHF-UCL
P02647	APOA1	Apolipoprotein A-I	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P02647	APOA1	Apolipoprotein A-I	GO:0055085; P:transmembrane transport; TAS:Reactome
P02647	APOA1	Apolipoprotein A-I	GO:0070328; P:triglyceride homeostasis; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0034190; F:apolipoprotein receptor binding; IPI:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0015485; F:cholesterol binding; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0017127; F:cholesterol transporter activity; IEA:Ensembl
P02652	APOA2	Apolipoprotein A-II	GO:0008035; F:high-density lipoprotein particle binding; IEA:Ensembl
P02652	APOA2	Apolipoprotein A-II	GO:0070653; F:high-density lipoprotein particle receptor binding; IPI:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0055102; F:lipase inhibitor activity; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0008289; F:lipid binding; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0005319; F:lipid transporter activity; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0031210; F:phosphatidylcholine binding; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0060228; F:phosphatidylcholine-sterol O-acyltransferase activator activity; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0005543; F:phospholipid binding; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0005515; F:protein binding; IPI:UniProtKB
P02652	APOA2	Apolipoprotein A-II	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
P02652	APOA2	Apolipoprotein A-II	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0002526; P:acute inflammatory response; IEA:Ensembl
P02652	APOA2	Apolipoprotein A-II	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P02652	APOA2	Apolipoprotein A-II	GO:0033344; P:cholesterol efflux; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0042632; P:cholesterol homeostasis; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0008203; P:cholesterol metabolic process; IEA:Ensembl
P02652	APOA2	Apolipoprotein A-II	GO:0046340; P:diacylglycerol catabolic process; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0034380; P:high-density lipoprotein particle assembly; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0034384; P:high-density lipoprotein particle clearance; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0034375; P:high-density lipoprotein particle remodeling; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
P02652	APOA2	Apolipoprotein A-II	GO:0034374; P:low-density lipoprotein particle remodeling; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0060621; P:negative regulation of cholesterol import; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0032375; P:negative regulation of cholesterol transport; IMP:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0060695; P:negative regulation of cholesterol transporter activity; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0002740; P:negative regulation of cytokine secretion involved in immune response; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0060192; P:negative regulation of lipase activity; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0050995; P:negative regulation of lipid catabolic process; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0010903; P:negative regulation of very-low-density lipoprotein particle remodeling; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0031100; P:organ regeneration; IEA:Ensembl
P02652	APOA2	Apolipoprotein A-II	GO:0018206; P:peptidyl-methionine modification; IDA:UniProtKB
P02652	APOA2	Apolipoprotein A-II	GO:0006656; P:phosphatidylcholine biosynthetic process; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0009395; P:phospholipid catabolic process; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0033700; P:phospholipid efflux; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P02652	APOA2	Apolipoprotein A-II	GO:0043085; P:positive regulation of catalytic activity; IDA:GOC
P02652	APOA2	Apolipoprotein A-II	GO:0010873; P:positive regulation of cholesterol esterification; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0045416; P:positive regulation of interleukin-8 biosynthetic process; IDA:UniProtKB
P02652	APOA2	Apolipoprotein A-II	GO:0050996; P:positive regulation of lipid catabolic process; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0006457; P:protein folding; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0018158; P:protein oxidation; IDA:UniProtKB
P02652	APOA2	Apolipoprotein A-II	GO:0030300; P:regulation of intestinal cholesterol absorption; IEA:Ensembl
P02652	APOA2	Apolipoprotein A-II	GO:0031647; P:regulation of protein stability; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0042493; P:response to drug; IEA:Ensembl
P02652	APOA2	Apolipoprotein A-II	GO:0043627; P:response to estrogen; IEA:Ensembl
P02652	APOA2	Apolipoprotein A-II	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P02652	APOA2	Apolipoprotein A-II	GO:0009749; P:response to glucose; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P02652	APOA2	Apolipoprotein A-II	GO:0043691; P:reverse cholesterol transport; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P02652	APOA2	Apolipoprotein A-II	GO:0006641; P:triglyceride metabolic process; TAS:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0034370; P:triglyceride-rich lipoprotein particle remodeling; IDA:BHF-UCL
P02652	APOA2	Apolipoprotein A-II	GO:0016032; P:viral process; IEA:UniProtKB-KW
P08519	LPA	Apolipoprotein(a)	GO:0034185; F:apolipoprotein binding; IPI:BHF-UCL
P08519	LPA	Apolipoprotein(a)	GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc
P08519	LPA	Apolipoprotein(a)	GO:0001968; F:fibronectin binding; IPI:BHF-UCL
P08519	LPA	Apolipoprotein(a)	GO:0008201; F:heparin binding; NAS:BHF-UCL
P08519	LPA	Apolipoprotein(a)	GO:0005515; F:protein binding; IPI:IntAct
P08519	LPA	Apolipoprotein(a)	GO:0004252; F:serine-type endopeptidase activity; IDA:BHF-UCL
P08519	LPA	Apolipoprotein(a)	GO:0008015; P:blood circulation; TAS:ProtInc
P08519	LPA	Apolipoprotein(a)	GO:0006629; P:lipid metabolic process; NAS:ProtInc
P08519	LPA	Apolipoprotein(a)	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
P08519	LPA	Apolipoprotein(a)	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
P08519	LPA	Apolipoprotein(a)	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
P08519	LPA	Apolipoprotein(a)	GO:0006898; P:receptor-mediated endocytosis; TAS:Reactome
P08519	LPA	Apolipoprotein(a)	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6Q788	APOA5	Apolipoprotein A-V	GO:0008047; F:enzyme activator activity; IDA:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0019899; F:enzyme binding; IDA:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0008201; F:heparin binding; IDA:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0060229; F:lipase activator activity; IMP:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0035473; F:lipase binding; IPI:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0008289; F:lipid binding; IDA:UniProtKB
Q6Q788	APOA5	Apolipoprotein A-V	GO:0060230; F:lipoprotein lipase activator activity; IDA:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0070325; F:lipoprotein particle receptor binding; IPI:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0050750; F:low-density lipoprotein particle receptor binding; IPI:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0031210; F:phosphatidylcholine binding; IDA:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0005543; F:phospholipid binding; IDA:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0055090; P:acylglycerol homeostasis; IDA:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q6Q788	APOA5	Apolipoprotein A-V	GO:0042632; P:cholesterol homeostasis; IDA:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0006869; P:lipid transport; IDA:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0042157; P:lipoprotein metabolic process; IEA:InterPro
Q6Q788	APOA5	Apolipoprotein A-V	GO:0031100; P:organ regeneration; IEA:Ensembl
Q6Q788	APOA5	Apolipoprotein A-V	GO:0045723; P:positive regulation of fatty acid biosynthetic process; IDA:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0050996; P:positive regulation of lipid catabolic process; IDA:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0051006; P:positive regulation of lipoprotein lipase activity; IDA:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0048260; P:positive regulation of receptor-mediated endocytosis; TAS:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0010898; P:positive regulation of triglyceride catabolic process; IDA:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0010902; P:positive regulation of very-low-density lipoprotein particle remodeling; IDA:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0009725; P:response to hormone; IEA:Ensembl
Q6Q788	APOA5	Apolipoprotein A-V	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6Q788	APOA5	Apolipoprotein A-V	GO:0042246; P:tissue regeneration; IEP:UniProtKB
Q6Q788	APOA5	Apolipoprotein A-V	GO:0019433; P:triglyceride catabolic process; IMP:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0070328; P:triglyceride homeostasis; IDA:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0006641; P:triglyceride metabolic process; IDA:BHF-UCL
Q6Q788	APOA5	Apolipoprotein A-V	GO:0034370; P:triglyceride-rich lipoprotein particle remodeling; IEA:Ensembl
P06727	APOA4	Apolipoprotein A-IV	GO:0016209; F:antioxidant activity; IDA:HGNC
P06727	APOA4	Apolipoprotein A-IV	GO:0017127; F:cholesterol transporter activity; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0005507; F:copper ion binding; IDA:HGNC
P06727	APOA4	Apolipoprotein A-IV	GO:0008289; F:lipid binding; IMP:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0005319; F:lipid transporter activity; TAS:ProtInc
P06727	APOA4	Apolipoprotein A-IV	GO:0031210; F:phosphatidylcholine binding; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0060228; F:phosphatidylcholine-sterol O-acyltransferase activator activity; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0033344; P:cholesterol efflux; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0042632; P:cholesterol homeostasis; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0008203; P:cholesterol metabolic process; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0034378; P:chylomicron assembly; TAS:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0034371; P:chylomicron remodeling; IC:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0034375; P:high-density lipoprotein particle remodeling; IC:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0042744; P:hydrogen peroxide catabolic process; IDA:HGNC
P06727	APOA4	Apolipoprotein A-IV	GO:0002227; P:innate immune response in mucosa; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0007159; P:leukocyte cell-cell adhesion; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0055088; P:lipid homeostasis; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0006869; P:lipid transport; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
P06727	APOA4	Apolipoprotein A-IV	GO:0044240; P:multicellular organismal lipid catabolic process; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0034445; P:negative regulation of plasma lipoprotein particle oxidation; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0046470; P:phosphatidylcholine metabolic process; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0033700; P:phospholipid efflux; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P06727	APOA4	Apolipoprotein A-IV	GO:0010873; P:positive regulation of cholesterol esterification; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0045723; P:positive regulation of fatty acid biosynthetic process; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0051006; P:positive regulation of lipoprotein lipase activity; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0010898; P:positive regulation of triglyceride catabolic process; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0065005; P:protein-lipid complex assembly; IMP:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0032374; P:regulation of cholesterol transport; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0030300; P:regulation of intestinal cholesterol absorption; IEA:Ensembl
P06727	APOA4	Apolipoprotein A-IV	GO:0019430; P:removal of superoxide radicals; IDA:HGNC
P06727	APOA4	Apolipoprotein A-IV	GO:0006982; P:response to lipid hydroperoxide; IDA:HGNC
P06727	APOA4	Apolipoprotein A-IV	GO:0035634; P:response to stilbenoid; IEA:Ensembl
P06727	APOA4	Apolipoprotein A-IV	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P06727	APOA4	Apolipoprotein A-IV	GO:0043691; P:reverse cholesterol transport; IDA:BHF-UCL
P06727	APOA4	Apolipoprotein A-IV	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P06727	APOA4	Apolipoprotein A-IV	GO:0034372; P:very-low-density lipoprotein particle remodeling; IDA:BHF-UCL
Q0VD83	APOBR	Apolipoprotein B receptor	GO:0030229; F:very-low-density lipoprotein particle receptor activity; IEA:Ensembl
Q0VD83	APOBR	Apolipoprotein B receptor	GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW
Q0VD83	APOBR	Apolipoprotein B receptor	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q0VD83	APOBR	Apolipoprotein B receptor	GO:0006641; P:triglyceride metabolic process; IEA:Ensembl
P04114	APOB	Apolipoprotein B-100	GO:0017127; F:cholesterol transporter activity; IMP:BHF-UCL
P04114	APOB	Apolipoprotein B-100	GO:0008201; F:heparin binding; IDA:BHF-UCL
P04114	APOB	Apolipoprotein B-100	GO:0035473; F:lipase binding; IPI:BHF-UCL
P04114	APOB	Apolipoprotein B-100	GO:0050750; F:low-density lipoprotein particle receptor binding; IMP:BHF-UCL
P04114	APOB	Apolipoprotein B-100	GO:0005543; F:phospholipid binding; IDA:BHF-UCL
P04114	APOB	Apolipoprotein B-100	GO:0005515; F:protein binding; IPI:UniProtKB
P04114	APOB	Apolipoprotein B-100	GO:0048844; P:artery morphogenesis; IEA:Ensembl
P04114	APOB	Apolipoprotein B-100	GO:0007596; P:blood coagulation; TAS:Reactome
P04114	APOB	Apolipoprotein B-100	GO:0071379; P:cellular response to prostaglandin stimulus; IEA:Ensembl
P04114	APOB	Apolipoprotein B-100	GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl
P04114	APOB	Apolipoprotein B-100	GO:0033344; P:cholesterol efflux; IEA:Ensembl
P04114	APOB	Apolipoprotein B-100	GO:0042632; P:cholesterol homeostasis; IMP:BHF-UCL
P04114	APOB	Apolipoprotein B-100	GO:0008203; P:cholesterol metabolic process; IMP:BHF-UCL
P04114	APOB	Apolipoprotein B-100	GO:0030301; P:cholesterol transport; IMP:BHF-UCL
P04114	APOB	Apolipoprotein B-100	GO:0009566; P:fertilization; IEA:Ensembl
P04114	APOB	Apolipoprotein B-100	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P04114	APOB	Apolipoprotein B-100	GO:0050900; P:leukocyte migration; TAS:Reactome
P04114	APOB	Apolipoprotein B-100	GO:0042158; P:lipoprotein biosynthetic process; IEA:Ensembl
P04114	APOB	Apolipoprotein B-100	GO:0042159; P:lipoprotein catabolic process; IEA:Ensembl
P04114	APOB	Apolipoprotein B-100	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
P04114	APOB	Apolipoprotein B-100	GO:0042953; P:lipoprotein transport; IEA:Ensembl
P04114	APOB	Apolipoprotein B-100	GO:0034383; P:low-density lipoprotein particle clearance; IMP:BHF-UCL
P04114	APOB	Apolipoprotein B-100	GO:0034374; P:low-density lipoprotein particle remodeling; IMP:BHF-UCL
P04114	APOB	Apolipoprotein B-100	GO:0007399; P:nervous system development; IEA:Ensembl
P04114	APOB	Apolipoprotein B-100	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P04114	APOB	Apolipoprotein B-100	GO:0010886; P:positive regulation of cholesterol storage; IDA:BHF-UCL
P04114	APOB	Apolipoprotein B-100	GO:0010884; P:positive regulation of lipid storage; IDA:BHF-UCL
P04114	APOB	Apolipoprotein B-100	GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; IDA:BHF-UCL
P04114	APOB	Apolipoprotein B-100	GO:0009791; P:post-embryonic development; IEA:Ensembl
P04114	APOB	Apolipoprotein B-100	GO:0006898; P:receptor-mediated endocytosis; TAS:Reactome
P04114	APOB	Apolipoprotein B-100	GO:0045540; P:regulation of cholesterol biosynthetic process; IEA:Ensembl
P04114	APOB	Apolipoprotein B-100	GO:0009743; P:response to carbohydrate; IEA:Ensembl
P04114	APOB	Apolipoprotein B-100	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P04114	APOB	Apolipoprotein B-100	GO:0010269; P:response to selenium ion; IEA:Ensembl
P04114	APOB	Apolipoprotein B-100	GO:0009615; P:response to virus; IEP:UniProtKB
P04114	APOB	Apolipoprotein B-100	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P04114	APOB	Apolipoprotein B-100	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P04114	APOB	Apolipoprotein B-100	GO:0030317; P:sperm motility; IEA:Ensembl
P04114	APOB	Apolipoprotein B-100	GO:0007283; P:spermatogenesis; IEA:Ensembl
P04114	APOB	Apolipoprotein B-100	GO:0019433; P:triglyceride catabolic process; IEA:Ensembl
P04114	APOB	Apolipoprotein B-100	GO:0006642; P:triglyceride mobilization; IEA:Ensembl
P04114	APOB	Apolipoprotein B-100	GO:0034379; P:very-low-density lipoprotein particle assembly; IC:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0005504; F:fatty acid binding; IDA:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0055102; F:lipase inhibitor activity; IDA:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0031210; F:phosphatidylcholine binding; TAS:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0060228; F:phosphatidylcholine-sterol O-acyltransferase activator activity; TAS:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0004859; F:phospholipase inhibitor activity; IDA:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0033344; P:cholesterol efflux; IDA:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0008203; P:cholesterol metabolic process; IEA:Ensembl
P02654	APOC1	Apolipoprotein C-I	GO:0034382; P:chylomicron remnant clearance; IDA:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0034375; P:high-density lipoprotein particle remodeling; TAS:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0006629; P:lipid metabolic process; TAS:ProtInc
P02654	APOC1	Apolipoprotein C-I	GO:0042157; P:lipoprotein metabolic process; IEA:InterPro
P02654	APOC1	Apolipoprotein C-I	GO:0032375; P:negative regulation of cholesterol transport; IDA:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0045717; P:negative regulation of fatty acid biosynthetic process; IDA:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0050995; P:negative regulation of lipid catabolic process; IDA:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0045833; P:negative regulation of lipid metabolic process; IDA:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0051005; P:negative regulation of lipoprotein lipase activity; IDA:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0010900; P:negative regulation of phosphatidylcholine catabolic process; IDA:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0048261; P:negative regulation of receptor-mediated endocytosis; IDA:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0010916; P:negative regulation of very-low-density lipoprotein particle clearance; IDA:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0033700; P:phospholipid efflux; IDA:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0034369; P:plasma lipoprotein particle remodeling; IDA:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
P02654	APOC1	Apolipoprotein C-I	GO:0010873; P:positive regulation of cholesterol esterification; TAS:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0032374; P:regulation of cholesterol transport; IC:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0006641; P:triglyceride metabolic process; IEA:Ensembl
P02654	APOC1	Apolipoprotein C-I	GO:0034379; P:very-low-density lipoprotein particle assembly; TAS:BHF-UCL
P02654	APOC1	Apolipoprotein C-I	GO:0034447; P:very-low-density lipoprotein particle clearance; IGI:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0055102; F:lipase inhibitor activity; IDA:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0008289; F:lipid binding; IDA:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0060230; F:lipoprotein lipase activator activity; IDA:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0016004; F:phospholipase activator activity; IDA:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0043274; F:phospholipase binding; IPI:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0042803; F:protein homodimerization activity; IMP:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0033344; P:cholesterol efflux; IDA:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0042632; P:cholesterol homeostasis; IC:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0034382; P:chylomicron remnant clearance; IDA:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0034371; P:chylomicron remodeling; IC:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0034384; P:high-density lipoprotein particle clearance; IMP:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
P02655	APOC2	Apolipoprotein C-II	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
P02655	APOC2	Apolipoprotein C-II	GO:0042953; P:lipoprotein transport; IEA:Ensembl
P02655	APOC2	Apolipoprotein C-II	GO:0043086; P:negative regulation of catalytic activity; IDA:GOC
P02655	APOC2	Apolipoprotein C-II	GO:0032375; P:negative regulation of cholesterol transport; IMP:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0045833; P:negative regulation of lipid metabolic process; IDA:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0048261; P:negative regulation of receptor-mediated endocytosis; IDA:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0010916; P:negative regulation of very-low-density lipoprotein particle clearance; IDA:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0033700; P:phospholipid efflux; IDA:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P02655	APOC2	Apolipoprotein C-II	GO:0045723; P:positive regulation of fatty acid biosynthetic process; IDA:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0051006; P:positive regulation of lipoprotein lipase activity; IDA:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0010518; P:positive regulation of phospholipase activity; IDA:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0060697; P:positive regulation of phospholipid catabolic process; IDA:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0010898; P:positive regulation of triglyceride catabolic process; IDA:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0010902; P:positive regulation of very-low-density lipoprotein particle remodeling; IC:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0042493; P:response to drug; IEA:Ensembl
P02655	APOC2	Apolipoprotein C-II	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P02655	APOC2	Apolipoprotein C-II	GO:0043691; P:reverse cholesterol transport; IC:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P02655	APOC2	Apolipoprotein C-II	GO:0070328; P:triglyceride homeostasis; IMP:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0034370; P:triglyceride-rich lipoprotein particle remodeling; TAS:BHF-UCL
P02655	APOC2	Apolipoprotein C-II	GO:0034372; P:very-low-density lipoprotein particle remodeling; TAS:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0015485; F:cholesterol binding; IC:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0030234; F:enzyme regulator activity; IDA:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0070653; F:high-density lipoprotein particle receptor binding; IPI:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0055102; F:lipase inhibitor activity; IDA:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0005543; F:phospholipid binding; IDA:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
P02656	APOC3	Apolipoprotein C-III	GO:0033344; P:cholesterol efflux; IDA:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0042632; P:cholesterol homeostasis; IMP:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0008203; P:cholesterol metabolic process; IEA:Ensembl
P02656	APOC3	Apolipoprotein C-III	GO:0034382; P:chylomicron remnant clearance; IDA:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0034375; P:high-density lipoprotein particle remodeling; IMP:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0006954; P:inflammatory response; IEA:Ensembl
P02656	APOC3	Apolipoprotein C-III	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
P02656	APOC3	Apolipoprotein C-III	GO:0042953; P:lipoprotein transport; IEA:Ensembl
P02656	APOC3	Apolipoprotein C-III	GO:0060621; P:negative regulation of cholesterol import; IMP:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0045717; P:negative regulation of fatty acid biosynthetic process; IDA:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0010987; P:negative regulation of high-density lipoprotein particle clearance; IMP:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0050995; P:negative regulation of lipid catabolic process; IDA:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0045833; P:negative regulation of lipid metabolic process; IDA:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0051005; P:negative regulation of lipoprotein lipase activity; IDA:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0010989; P:negative regulation of low-density lipoprotein particle clearance; IMP:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0048261; P:negative regulation of receptor-mediated endocytosis; IDA:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0010897; P:negative regulation of triglyceride catabolic process; IDA:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0010916; P:negative regulation of very-low-density lipoprotein particle clearance; IDA:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0010903; P:negative regulation of very-low-density lipoprotein particle remodeling; IDA:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0033700; P:phospholipid efflux; IDA:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P02656	APOC3	Apolipoprotein C-III	GO:0032489; P:regulation of Cdc42 protein signal transduction; IDA:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0042493; P:response to drug; IEA:Ensembl
P02656	APOC3	Apolipoprotein C-III	GO:0007584; P:response to nutrient; IEA:Ensembl
P02656	APOC3	Apolipoprotein C-III	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P02656	APOC3	Apolipoprotein C-III	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P02656	APOC3	Apolipoprotein C-III	GO:0043691; P:reverse cholesterol transport; IC:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P02656	APOC3	Apolipoprotein C-III	GO:0019433; P:triglyceride catabolic process; IDA:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0070328; P:triglyceride homeostasis; IMP:BHF-UCL
P02656	APOC3	Apolipoprotein C-III	GO:0006641; P:triglyceride metabolic process; IMP:HGNC
P02656	APOC3	Apolipoprotein C-III	GO:0006642; P:triglyceride mobilization; IEA:Ensembl
P02656	APOC3	Apolipoprotein C-III	GO:0034379; P:very-low-density lipoprotein particle assembly; TAS:BHF-UCL
P55056	APOC4	Apolipoprotein C-IV	GO:0005319; F:lipid transporter activity; TAS:ProtInc
P55056	APOC4	Apolipoprotein C-IV	GO:0006629; P:lipid metabolic process; TAS:ProtInc
P55056	APOC4	Apolipoprotein C-IV	GO:0010890; P:positive regulation of sequestering of triglyceride; IMP:BHF-UCL
P55056	APOC4	Apolipoprotein C-IV	GO:0070328; P:triglyceride homeostasis; IMP:BHF-UCL
P05090	APOD	Apolipoprotein D	GO:0015485; F:cholesterol binding; IDA:UniProtKB
P05090	APOD	Apolipoprotein D	GO:0005319; F:lipid transporter activity; NAS:UniProtKB
P05090	APOD	Apolipoprotein D	GO:0005515; F:protein binding; IPI:UniProtKB
P05090	APOD	Apolipoprotein D	GO:0007568; P:aging; NAS:UniProtKB
P05090	APOD	Apolipoprotein D	GO:0001525; P:angiogenesis; NAS:UniProtKB
P05090	APOD	Apolipoprotein D	GO:0007420; P:brain development; ISS:UniProtKB
P05090	APOD	Apolipoprotein D	GO:0006006; P:glucose metabolic process; IDA:UniProtKB
P05090	APOD	Apolipoprotein D	GO:0006629; P:lipid metabolic process; IDA:UniProtKB
P05090	APOD	Apolipoprotein D	GO:0006869; P:lipid transport; NAS:GOC
P05090	APOD	Apolipoprotein D	GO:1900016; P:negative regulation of cytokine production involved in inflammatory response; IDA:UniProtKB
P05090	APOD	Apolipoprotein D	GO:0051895; P:negative regulation of focal adhesion assembly; IMP:UniProtKB
P05090	APOD	Apolipoprotein D	GO:0060588; P:negative regulation of lipoprotein lipid oxidation; IDA:UniProtKB
P05090	APOD	Apolipoprotein D	GO:0071638; P:negative regulation of monocyte chemotactic protein-1 production; IDA:UniProtKB
P05090	APOD	Apolipoprotein D	GO:0010642; P:negative regulation of platelet-derived growth factor receptor signaling pathway; IDA:UniProtKB
P05090	APOD	Apolipoprotein D	GO:0042308; P:negative regulation of protein import into nucleus; IDA:UniProtKB
P05090	APOD	Apolipoprotein D	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IDA:UniProtKB
P05090	APOD	Apolipoprotein D	GO:2000098; P:negative regulation of smooth muscle cell-matrix adhesion; IMP:UniProtKB
P05090	APOD	Apolipoprotein D	GO:2000405; P:negative regulation of T cell migration; IDA:UniProtKB
P05090	APOD	Apolipoprotein D	GO:0014012; P:peripheral nervous system axon regeneration; ISS:UniProtKB
P05090	APOD	Apolipoprotein D	GO:0048678; P:response to axon injury; ISS:UniProtKB
P05090	APOD	Apolipoprotein D	GO:0042493; P:response to drug; ISS:UniProtKB
P05090	APOD	Apolipoprotein D	GO:0000302; P:response to reactive oxygen species; IDA:UniProtKB
P05090	APOD	Apolipoprotein D	GO:0042246; P:tissue regeneration; ISS:UniProtKB
P02649	APOE	Apolipoprotein E	GO:0016209; F:antioxidant activity; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0001540; F:beta-amyloid binding; IDA:UniProtKB
P02649	APOE	Apolipoprotein E	GO:0017127; F:cholesterol transporter activity; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0008201; F:heparin binding; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0046848; F:hydroxyapatite binding; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0042802; F:identical protein binding; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0008289; F:lipid binding; IDA:UniProtKB
P02649	APOE	Apolipoprotein E	GO:0005319; F:lipid transporter activity; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0071813; F:lipoprotein particle binding; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0005324; F:long-chain fatty acid transporter activity; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:0050750; F:low-density lipoprotein particle receptor binding; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0046911; F:metal chelating activity; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0060228; F:phosphatidylcholine-sterol O-acyltransferase activator activity; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0005543; F:phospholipid binding; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0005515; F:protein binding; IPI:IntAct
P02649	APOE	Apolipoprotein E	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0048156; F:tau protein binding; IPI:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0070326; F:very-low-density lipoprotein particle receptor binding; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0007568; P:aging; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0097113; P:alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:0048844; P:artery morphogenesis; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0008219; P:cell death; IEA:UniProtKB-KW
P02649	APOE	Apolipoprotein E	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0071397; P:cellular response to cholesterol; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0071347; P:cellular response to interleukin-1; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0019934; P:cGMP-mediated signaling; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0006707; P:cholesterol catabolic process; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0033344; P:cholesterol efflux; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0042632; P:cholesterol homeostasis; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0008203; P:cholesterol metabolic process; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0034382; P:chylomicron remnant clearance; IMP:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0007010; P:cytoskeleton organization; TAS:UniProtKB
P02649	APOE	Apolipoprotein E	GO:0097062; P:dendritic spine maintenance; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:0055089; P:fatty acid homeostasis; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:0097435; P:fibril organization; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0034380; P:high-density lipoprotein particle assembly; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0034384; P:high-density lipoprotein particle clearance; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0034375; P:high-density lipoprotein particle remodeling; IGI:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0046907; P:intracellular transport; TAS:UniProtKB
P02649	APOE	Apolipoprotein E	GO:0042158; P:lipoprotein biosynthetic process; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0042159; P:lipoprotein catabolic process; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
P02649	APOE	Apolipoprotein E	GO:0015909; P:long-chain fatty acid transport; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:0034374; P:low-density lipoprotein particle remodeling; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0051651; P:maintenance of location in cell; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0097114; P:N-methyl-D-aspartate receptor clustering; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:1902430; P:negative regulation of beta-amyloid formation; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:0030195; P:negative regulation of blood coagulation; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0043537; P:negative regulation of blood vessel endothelial cell migration; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0045541; P:negative regulation of cholesterol biosynthetic process; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0061000; P:negative regulation of dendritic spine development; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:0001937; P:negative regulation of endothelial cell proliferation; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0050728; P:negative regulation of inflammatory response; IC:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0043407; P:negative regulation of MAP kinase activity; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0010544; P:negative regulation of platelet activation; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:1901627; P:negative regulation of postsynaptic membrane organization; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:1901630; P:negative regulation of presynaptic membrane organization; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:0007263; P:nitric oxide mediated signal transduction; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0048709; P:oligodendrocyte differentiation; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0014012; P:peripheral nervous system axon regeneration; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0033700; P:phospholipid efflux; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P02649	APOE	Apolipoprotein E	GO:0045773; P:positive regulation of axon extension; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:1902004; P:positive regulation of beta-amyloid formation; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:0030828; P:positive regulation of cGMP biosynthetic process; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0010875; P:positive regulation of cholesterol efflux; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:0010873; P:positive regulation of cholesterol esterification; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0060999; P:positive regulation of dendritic spine development; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:0046889; P:positive regulation of lipid biosynthetic process; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:0032805; P:positive regulation of low-density lipoprotein particle receptor catabolic process; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0051044; P:positive regulation of membrane protein ectodomain proteolysis; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:1901216; P:positive regulation of neuron death; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:0051000; P:positive regulation of nitric-oxide synthase activity; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0017038; P:protein import; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:0006898; P:receptor-mediated endocytosis; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0030516; P:regulation of axon extension; TAS:UniProtKB
P02649	APOE	Apolipoprotein E	GO:1900221; P:regulation of beta-amyloid clearance; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:0032489; P:regulation of Cdc42 protein signal transduction; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:1901214; P:regulation of neuron death; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:0048168; P:regulation of neuronal synaptic plasticity; TAS:UniProtKB
P02649	APOE	Apolipoprotein E	GO:0045859; P:regulation of protein kinase activity; IDA:Alzheimers_University_of_Toronto
P02649	APOE	Apolipoprotein E	GO:0002021; P:response to dietary excess; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0045471; P:response to ethanol; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0032868; P:response to insulin; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0000302; P:response to reactive oxygen species; NAS:UniProtKB
P02649	APOE	Apolipoprotein E	GO:0032526; P:response to retinoic acid; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P02649	APOE	Apolipoprotein E	GO:0043691; P:reverse cholesterol transport; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P02649	APOE	Apolipoprotein E	GO:0007271; P:synaptic transmission, cholinergic; TAS:UniProtKB
P02649	APOE	Apolipoprotein E	GO:0006641; P:triglyceride metabolic process; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0042311; P:vasodilation; IEA:Ensembl
P02649	APOE	Apolipoprotein E	GO:0034447; P:very-low-density lipoprotein particle clearance; IDA:BHF-UCL
P02649	APOE	Apolipoprotein E	GO:0034372; P:very-low-density lipoprotein particle remodeling; IDA:BHF-UCL
Q13790	APOF	Apolipoprotein F	GO:0015485; F:cholesterol binding; TAS:ProtInc
Q13790	APOF	Apolipoprotein F	GO:0005319; F:lipid transporter activity; TAS:ProtInc
Q13790	APOF	Apolipoprotein F	GO:0005102; F:receptor binding; TAS:ProtInc
Q13790	APOF	Apolipoprotein F	GO:0033344; P:cholesterol efflux; IEA:Ensembl
Q13790	APOF	Apolipoprotein F	GO:0008203; P:cholesterol metabolic process; TAS:ProtInc
Q13790	APOF	Apolipoprotein F	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q13790	APOF	Apolipoprotein F	GO:0006869; P:lipid transport; TAS:ProtInc
Q13790	APOF	Apolipoprotein F	GO:0006641; P:triglyceride metabolic process; IEA:Ensembl
P02749	APOH	Beta-2-glycoprotein 1	GO:0001948; F:glycoprotein binding; IPI:BHF-UCL
P02749	APOH	Beta-2-glycoprotein 1	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P02749	APOH	Beta-2-glycoprotein 1	GO:0042802; F:identical protein binding; IPI:IntAct
P02749	APOH	Beta-2-glycoprotein 1	GO:0008289; F:lipid binding; IDA:BHF-UCL
P02749	APOH	Beta-2-glycoprotein 1	GO:0060230; F:lipoprotein lipase activator activity; IDA:BHF-UCL
P02749	APOH	Beta-2-glycoprotein 1	GO:0005543; F:phospholipid binding; IDA:BHF-UCL
P02749	APOH	Beta-2-glycoprotein 1	GO:0005515; F:protein binding; IPI:IntAct
P02749	APOH	Beta-2-glycoprotein 1	GO:0007597; P:blood coagulation, intrinsic pathway; IDA:BHF-UCL
P02749	APOH	Beta-2-glycoprotein 1	GO:0016525; P:negative regulation of angiogenesis; IDA:BHF-UCL
P02749	APOH	Beta-2-glycoprotein 1	GO:0030195; P:negative regulation of blood coagulation; IDA:BHF-UCL
P02749	APOH	Beta-2-glycoprotein 1	GO:0010596; P:negative regulation of endothelial cell migration; IDA:BHF-UCL
P02749	APOH	Beta-2-glycoprotein 1	GO:0001937; P:negative regulation of endothelial cell proliferation; IDA:BHF-UCL
P02749	APOH	Beta-2-glycoprotein 1	GO:0051918; P:negative regulation of fibrinolysis; IDA:BHF-UCL
P02749	APOH	Beta-2-glycoprotein 1	GO:0033033; P:negative regulation of myeloid cell apoptotic process; IDA:BHF-UCL
P02749	APOH	Beta-2-glycoprotein 1	GO:0034392; P:negative regulation of smooth muscle cell apoptotic process; IDA:BHF-UCL
P02749	APOH	Beta-2-glycoprotein 1	GO:0031639; P:plasminogen activation; IDA:BHF-UCL
P02749	APOH	Beta-2-glycoprotein 1	GO:0030194; P:positive regulation of blood coagulation; TAS:BHF-UCL
P02749	APOH	Beta-2-glycoprotein 1	GO:0051006; P:positive regulation of lipoprotein lipase activity; IDA:BHF-UCL
P02749	APOH	Beta-2-glycoprotein 1	GO:0051917; P:regulation of fibrinolysis; IDA:BHF-UCL
P02749	APOH	Beta-2-glycoprotein 1	GO:0006641; P:triglyceride metabolic process; IDA:BHF-UCL
P02749	APOH	Beta-2-glycoprotein 1	GO:0034197; P:triglyceride transport; ISS:BHF-UCL
O14791	APOL1	Apolipoprotein L1	GO:0005254; F:chloride channel activity; IDA:BHF-UCL
O14791	APOL1	Apolipoprotein L1	GO:0008289; F:lipid binding; IDA:BHF-UCL
O14791	APOL1	Apolipoprotein L1	GO:0005515; F:protein binding; IPI:BHF-UCL
O14791	APOL1	Apolipoprotein L1	GO:1902476; P:chloride transmembrane transport; IDA:GOC
O14791	APOL1	Apolipoprotein L1	GO:0006821; P:chloride transport; IDA:BHF-UCL
O14791	APOL1	Apolipoprotein L1	GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW
O14791	APOL1	Apolipoprotein L1	GO:0019835; P:cytolysis; IDA:BHF-UCL
O14791	APOL1	Apolipoprotein L1	GO:0045087; P:innate immune response; IDA:BHF-UCL
O14791	APOL1	Apolipoprotein L1	GO:0031640; P:killing of cells of other organism; IDA:BHF-UCL
O14791	APOL1	Apolipoprotein L1	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
O14791	APOL1	Apolipoprotein L1	GO:0042157; P:lipoprotein metabolic process; IEA:InterPro
Q9BQE5	APOL2	Apolipoprotein L2	GO:0008035; F:high-density lipoprotein particle binding; NAS:UniProtKB
Q9BQE5	APOL2	Apolipoprotein L2	GO:0008289; F:lipid binding; NAS:UniProtKB
Q9BQE5	APOL2	Apolipoprotein L2	GO:0005102; F:receptor binding; NAS:UniProtKB
Q9BQE5	APOL2	Apolipoprotein L2	GO:0006953; P:acute-phase response; NAS:UniProtKB
Q9BQE5	APOL2	Apolipoprotein L2	GO:0008203; P:cholesterol metabolic process; NAS:UniProtKB
Q9BQE5	APOL2	Apolipoprotein L2	GO:0006629; P:lipid metabolic process; NAS:UniProtKB
Q9BQE5	APOL2	Apolipoprotein L2	GO:0006869; P:lipid transport; NAS:UniProtKB
Q9BQE5	APOL2	Apolipoprotein L2	GO:0042157; P:lipoprotein metabolic process; IEA:InterPro
Q9BQE5	APOL2	Apolipoprotein L2	GO:0060135; P:maternal process involved in female pregnancy; NAS:UniProtKB
Q9BQE5	APOL2	Apolipoprotein L2	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
O95236	APOL3	Apolipoprotein L3	GO:0008289; F:lipid binding; IEA:InterPro
O95236	APOL3	Apolipoprotein L3	GO:0005319; F:lipid transporter activity; TAS:ProtInc
O95236	APOL3	Apolipoprotein L3	GO:0004871; F:signal transducer activity; IMP:UniProtKB
O95236	APOL3	Apolipoprotein L3	GO:0006954; P:inflammatory response; TAS:ProtInc
O95236	APOL3	Apolipoprotein L3	GO:0042157; P:lipoprotein metabolic process; IEA:InterPro
O95236	APOL3	Apolipoprotein L3	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
O95236	APOL3	Apolipoprotein L3	GO:0007165; P:signal transduction; IMP:GOC
Q9BPW4	APOL4	Apolipoprotein L4	GO:0008289; F:lipid binding; IEA:InterPro
Q9BPW4	APOL4	Apolipoprotein L4	GO:0006629; P:lipid metabolic process; NAS:UniProtKB
Q9BPW4	APOL4	Apolipoprotein L4	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q9BPW4	APOL4	Apolipoprotein L4	GO:0042157; P:lipoprotein metabolic process; IEA:InterPro
Q9BWW9	APOL5	Apolipoprotein L5	GO:0008035; F:high-density lipoprotein particle binding; NAS:UniProtKB
Q9BWW9	APOL5	Apolipoprotein L5	GO:0008289; F:lipid binding; IEA:InterPro
Q9BWW9	APOL5	Apolipoprotein L5	GO:0006629; P:lipid metabolic process; NAS:UniProtKB
Q9BWW9	APOL5	Apolipoprotein L5	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q9BWW9	APOL5	Apolipoprotein L5	GO:0042157; P:lipoprotein metabolic process; IEA:InterPro
Q9BWW8	APOL6	Apolipoprotein L6	GO:0008289; F:lipid binding; IEA:InterPro
Q9BWW8	APOL6	Apolipoprotein L6	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q9BWW8	APOL6	Apolipoprotein L6	GO:0042157; P:lipoprotein metabolic process; IEA:InterPro
O95445	APOM	Apolipoprotein M	GO:0016209; F:antioxidant activity; IDA:BHF-UCL
O95445	APOM	Apolipoprotein M	GO:0005319; F:lipid transporter activity; IDA:BHF-UCL
O95445	APOM	Apolipoprotein M	GO:0005543; F:phospholipid binding; IDA:BHF-UCL
O95445	APOM	Apolipoprotein M	GO:0033344; P:cholesterol efflux; IDA:BHF-UCL
O95445	APOM	Apolipoprotein M	GO:0042632; P:cholesterol homeostasis; IC:BHF-UCL
O95445	APOM	Apolipoprotein M	GO:0034380; P:high-density lipoprotein particle assembly; ISS:BHF-UCL
O95445	APOM	Apolipoprotein M	GO:0034384; P:high-density lipoprotein particle clearance; ISS:BHF-UCL
O95445	APOM	Apolipoprotein M	GO:0034375; P:high-density lipoprotein particle remodeling; IMP:BHF-UCL
O95445	APOM	Apolipoprotein M	GO:0042157; P:lipoprotein metabolic process; IEA:Ensembl
O95445	APOM	Apolipoprotein M	GO:0034445; P:negative regulation of plasma lipoprotein particle oxidation; IDA:BHF-UCL
O95445	APOM	Apolipoprotein M	GO:0009749; P:response to glucose; IEA:Ensembl
O95445	APOM	Apolipoprotein M	GO:0043691; P:reverse cholesterol transport; ISS:BHF-UCL
Q9BUR5	APOO	Apolipoprotein O	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q96IL0	APOPT1	Apoptogenic protein 1, mitochondrial	GO:0097193; P:intrinsic apoptotic signaling pathway; IEA:Ensembl
Q96IL0	APOPT1	Apoptogenic protein 1, mitochondrial	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
Q96IL0	APOPT1	Apoptogenic protein 1, mitochondrial	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IEA:Ensembl
Q96IL0	APOPT1	Apoptogenic protein 1, mitochondrial	GO:0034393; P:positive regulation of smooth muscle cell apoptotic process; IEA:Ensembl
Q53RT3	ASPRV1	Retroviral-like aspartic protease 1	GO:0004190; F:aspartic-type endopeptidase activity; IDA:UniProtKB
Q53RT3	ASPRV1	Retroviral-like aspartic protease 1	GO:0016485; P:protein processing; IDA:UniProtKB
Q53RT3	ASPRV1	Retroviral-like aspartic protease 1	GO:0043588; P:skin development; ISS:UniProtKB
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0006915; P:apoptotic process; IMP:MGI
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0042149; P:cellular response to glucose starvation; IMP:UniProtKB
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0071456; P:cellular response to hypoxia; IEP:UniProtKB
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0051607; P:defense response to virus; IDA:BHF-UCL
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0097193; P:intrinsic apoptotic signaling pathway; IDA:UniProtKB
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IMP:UniProtKB
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IEA:Ensembl
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0048147; P:negative regulation of fibroblast proliferation; IEA:Ensembl
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0010917; P:negative regulation of mitochondrial membrane potential; ISS:UniProtKB
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0043517; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; IMP:UniProtKB
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; IDA:BHF-UCL
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0010907; P:positive regulation of glucose metabolic process; IDA:UniProtKB
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IDA:UniProtKB
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0032461; P:positive regulation of protein oligomerization; IDA:UniProtKB
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IDA:UniProtKB
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0010498; P:proteasomal protein catabolic process; IDA:UniProtKB
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0072593; P:reactive oxygen species metabolic process; IDA:UniProtKB
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0046902; P:regulation of mitochondrial membrane permeability; IDA:UniProtKB
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0001836; P:release of cytochrome c from mitochondria; IEA:Ensembl
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0043331; P:response to dsRNA; IDA:HGNC
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0009411; P:response to UV; IEA:Ensembl
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0010165; P:response to X-ray; IEA:Ensembl
Q13794	PMAIP1	Phorbol-12-myristate-13-acetate-induced protein 1	GO:0043029; P:T cell homeostasis; ISS:UniProtKB
Q7Z2E3	APTX	Aprataxin	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q7Z2E3	APTX	Aprataxin	GO:0003684; F:damaged DNA binding; IDA:UniProtKB
Q7Z2E3	APTX	Aprataxin	GO:0033699; F:DNA 5'-adenosine monophosphate hydrolase activity; IDA:UniProtKB
Q7Z2E3	APTX	Aprataxin	GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB
Q7Z2E3	APTX	Aprataxin	GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB
Q7Z2E3	APTX	Aprataxin	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z2E3	APTX	Aprataxin	GO:0008967; F:phosphoglycolate phosphatase activity; IDA:UniProtKB
Q7Z2E3	APTX	Aprataxin	GO:0051219; F:phosphoprotein binding; IPI:UniProtKB
Q7Z2E3	APTX	Aprataxin	GO:0046403; F:polynucleotide 3'-phosphatase activity; IDA:UniProtKB
Q7Z2E3	APTX	Aprataxin	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z2E3	APTX	Aprataxin	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q7Z2E3	APTX	Aprataxin	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q7Z2E3	APTX	Aprataxin	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
Q7Z2E3	APTX	Aprataxin	GO:0016311; P:dephosphorylation; IDA:GOC
Q7Z2E3	APTX	Aprataxin	GO:0000738; P:DNA catabolic process, exonucleolytic; IDA:GOC
Q7Z2E3	APTX	Aprataxin	GO:0006266; P:DNA ligation; IEA:Ensembl
Q7Z2E3	APTX	Aprataxin	GO:0006302; P:double-strand break repair; IDA:UniProtKB
Q7Z2E3	APTX	Aprataxin	GO:0098506; P:polynucleotide 3' dephosphorylation; IDA:GOC
Q7Z2E3	APTX	Aprataxin	GO:0031647; P:regulation of protein stability; IMP:UniProtKB
Q7Z2E3	APTX	Aprataxin	GO:0042542; P:response to hydrogen peroxide; IDA:UniProtKB
Q7Z2E3	APTX	Aprataxin	GO:0000012; P:single strand break repair; IDA:UniProtKB
P07741	APRT	Adenine phosphoribosyltransferase	GO:0002055; F:adenine binding; IEA:Ensembl
P07741	APRT	Adenine phosphoribosyltransferase	GO:0003999; F:adenine phosphoribosyltransferase activity; TAS:Reactome
P07741	APRT	Adenine phosphoribosyltransferase	GO:0016208; F:AMP binding; IDA:MGI
P07741	APRT	Adenine phosphoribosyltransferase	GO:0006168; P:adenine salvage; IEA:Ensembl
P07741	APRT	Adenine phosphoribosyltransferase	GO:0044209; P:AMP salvage; IEA:UniProtKB-UniPathway
P07741	APRT	Adenine phosphoribosyltransferase	GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl
P07741	APRT	Adenine phosphoribosyltransferase	GO:0007625; P:grooming behavior; IEA:Ensembl
P07741	APRT	Adenine phosphoribosyltransferase	GO:0007595; P:lactation; IEA:Ensembl
P07741	APRT	Adenine phosphoribosyltransferase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P07741	APRT	Adenine phosphoribosyltransferase	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P07741	APRT	Adenine phosphoribosyltransferase	GO:0006166; P:purine ribonucleoside salvage; IEA:UniProtKB-KW
P07741	APRT	Adenine phosphoribosyltransferase	GO:0043101; P:purine-containing compound salvage; TAS:Reactome
P07741	APRT	Adenine phosphoribosyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8IXF9	AQP12A	Aquaporin-12A	GO:0005215; F:transporter activity; IEA:InterPro
A6NM10	AQP12B	Aquaporin-12B	GO:0005215; F:transporter activity; IEA:InterPro
Q96PS8	AQP10	Aquaporin-10	GO:0005215; F:transporter activity; IEA:InterPro
Q96PS8	AQP10	Aquaporin-10	GO:0009636; P:response to toxic substance; IDA:UniProtKB
Q96PS8	AQP10	Aquaporin-10	GO:0055085; P:transmembrane transport; TAS:Reactome
Q96PS8	AQP10	Aquaporin-10	GO:0006833; P:water transport; TAS:Reactome
Q8NBQ7	AQP11	Aquaporin-11	GO:0005215; F:transporter activity; IEA:InterPro
Q8NBQ7	AQP11	Aquaporin-11	GO:0048388; P:endosomal lumen acidification; IEA:Ensembl
Q8NBQ7	AQP11	Aquaporin-11	GO:0051260; P:protein homooligomerization; IEA:Ensembl
Q8NBQ7	AQP11	Aquaporin-11	GO:0072014; P:proximal tubule development; IEA:Ensembl
Q8NBQ7	AQP11	Aquaporin-11	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8NBQ7	AQP11	Aquaporin-11	GO:0006833; P:water transport; TAS:Reactome
P29972	AQP1	Aquaporin-1	GO:0008519; F:ammonium transmembrane transporter activity; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0035379; F:carbon dioxide transmembrane transporter activity; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0015168; F:glycerol transmembrane transporter activity; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0005223; F:intracellular cGMP activated cation channel activity; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0030184; F:nitric oxide transmembrane transporter activity; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0005267; F:potassium channel activity; IMP:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0015079; F:potassium ion transmembrane transporter activity; ISS:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0005515; F:protein binding; IPI:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0022857; F:transmembrane transporter activity; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0015250; F:water channel activity; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0005372; F:water transmembrane transporter activity; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0072488; P:ammonium transmembrane transport; IDA:GOC
P29972	AQP1	Aquaporin-1	GO:0015696; P:ammonium transport; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0015701; P:bicarbonate transport; TAS:Reactome
P29972	AQP1	Aquaporin-1	GO:0035378; P:carbon dioxide transmembrane transport; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0015670; P:carbon dioxide transport; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0006884; P:cell volume homeostasis; IMP:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0019725; P:cellular homeostasis; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0071474; P:cellular hyperosmotic response; IMP:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0071320; P:cellular response to cAMP; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0071280; P:cellular response to copper ion; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0071549; P:cellular response to dexamethasone stimulus; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0070301; P:cellular response to hydrogen peroxide; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0071456; P:cellular response to hypoxia; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0071241; P:cellular response to inorganic substance; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0071260; P:cellular response to mechanical stimulus; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0071288; P:cellular response to mercury ion; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0071732; P:cellular response to nitric oxide; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0071300; P:cellular response to retinoic acid; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0071472; P:cellular response to salt stress; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0033554; P:cellular response to stress; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0034644; P:cellular response to UV; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0033326; P:cerebrospinal fluid secretion; IEP:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0006182; P:cGMP biosynthetic process; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0030950; P:establishment or maintenance of actin cytoskeleton polarity; IMP:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0015793; P:glycerol transport; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0021670; P:lateral ventricle development; IEP:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0085018; P:maintenance of symbiont-containing vacuole by host; IMP:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0050891; P:multicellular organismal water homeostasis; IEP:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0030185; P:nitric oxide transport; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0042476; P:odontogenesis; IEP:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0030157; P:pancreatic juice secretion; IEP:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0048146; P:positive regulation of fibroblast proliferation; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0046878; P:positive regulation of saliva secretion; IMP:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0071805; P:potassium ion transmembrane transport; IMP:GOC
P29972	AQP1	Aquaporin-1	GO:0006813; P:potassium ion transport; ISS:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0003097; P:renal water transport; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0042493; P:response to drug; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P29972	AQP1	Aquaporin-1	GO:0035377; P:transepithelial water transport; IDA:UniProtKB
P29972	AQP1	Aquaporin-1	GO:0055085; P:transmembrane transport; TAS:Reactome
P29972	AQP1	Aquaporin-1	GO:0006833; P:water transport; IDA:UniProtKB
P41181	AQP2	Aquaporin-2	GO:0015168; F:glycerol transmembrane transporter activity; IDA:UniProtKB
P41181	AQP2	Aquaporin-2	GO:0015250; F:water channel activity; EXP:Reactome
P41181	AQP2	Aquaporin-2	GO:0005372; F:water transmembrane transporter activity; IDA:UniProtKB
P41181	AQP2	Aquaporin-2	GO:0030042; P:actin filament depolymerization; IEA:Ensembl
P41181	AQP2	Aquaporin-2	GO:0007568; P:aging; IEA:Ensembl
P41181	AQP2	Aquaporin-2	GO:0006915; P:apoptotic process; IEA:Ensembl
P41181	AQP2	Aquaporin-2	GO:0006884; P:cell volume homeostasis; IEA:Ensembl
P41181	AQP2	Aquaporin-2	GO:0071280; P:cellular response to copper ion; IDA:UniProtKB
P41181	AQP2	Aquaporin-2	GO:0071288; P:cellular response to mercury ion; IDA:UniProtKB
P41181	AQP2	Aquaporin-2	GO:0042631; P:cellular response to water deprivation; IEA:Ensembl
P41181	AQP2	Aquaporin-2	GO:0007588; P:excretion; TAS:ProtInc
P41181	AQP2	Aquaporin-2	GO:0007565; P:female pregnancy; IEA:Ensembl
P41181	AQP2	Aquaporin-2	GO:0015793; P:glycerol transport; IDA:UniProtKB
P41181	AQP2	Aquaporin-2	GO:0006972; P:hyperosmotic response; IEA:Ensembl
P41181	AQP2	Aquaporin-2	GO:0072205; P:metanephric collecting duct development; IEA:Ensembl
P41181	AQP2	Aquaporin-2	GO:0051928; P:positive regulation of calcium ion transport; IEA:Ensembl
P41181	AQP2	Aquaporin-2	GO:0003097; P:renal water transport; IEA:Ensembl
P41181	AQP2	Aquaporin-2	GO:0051592; P:response to calcium ion; IEA:Ensembl
P41181	AQP2	Aquaporin-2	GO:0033762; P:response to glucagon; IEA:Ensembl
P41181	AQP2	Aquaporin-2	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P41181	AQP2	Aquaporin-2	GO:0010226; P:response to lithium ion; IEA:Ensembl
P41181	AQP2	Aquaporin-2	GO:0009651; P:response to salt stress; IEA:Ensembl
P41181	AQP2	Aquaporin-2	GO:0042594; P:response to starvation; IEA:Ensembl
P41181	AQP2	Aquaporin-2	GO:0055085; P:transmembrane transport; TAS:Reactome
P41181	AQP2	Aquaporin-2	GO:0006833; P:water transport; IDA:UniProtKB
Q92482	AQP3	Aquaporin-3	GO:0015254; F:glycerol channel activity; IDA:BHF-UCL
Q92482	AQP3	Aquaporin-3	GO:0005215; F:transporter activity; NAS:ProtInc
Q92482	AQP3	Aquaporin-3	GO:0015250; F:water channel activity; TAS:BHF-UCL
Q92482	AQP3	Aquaporin-3	GO:0007588; P:excretion; TAS:ProtInc
Q92482	AQP3	Aquaporin-3	GO:0042476; P:odontogenesis; IEP:UniProtKB
Q92482	AQP3	Aquaporin-3	GO:0002684; P:positive regulation of immune system process; IDA:BHF-UCL
Q92482	AQP3	Aquaporin-3	GO:0045616; P:regulation of keratinocyte differentiation; TAS:BHF-UCL
Q92482	AQP3	Aquaporin-3	GO:0070295; P:renal water absorption; IEA:Ensembl
Q92482	AQP3	Aquaporin-3	GO:0051592; P:response to calcium ion; TAS:BHF-UCL
Q92482	AQP3	Aquaporin-3	GO:0032526; P:response to retinoic acid; IDA:BHF-UCL
Q92482	AQP3	Aquaporin-3	GO:0033280; P:response to vitamin D; TAS:BHF-UCL
Q92482	AQP3	Aquaporin-3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q92482	AQP3	Aquaporin-3	GO:0006810; P:transport; NAS:ProtInc
Q92482	AQP3	Aquaporin-3	GO:0015840; P:urea transport; IEA:Ensembl
Q92482	AQP3	Aquaporin-3	GO:0006833; P:water transport; TAS:BHF-UCL
P55087	AQP4	Aquaporin-4	GO:0015288; F:porin activity; IEA:Ensembl
P55087	AQP4	Aquaporin-4	GO:0015250; F:water channel activity; EXP:Reactome
P55087	AQP4	Aquaporin-4	GO:0005372; F:water transmembrane transporter activity; TAS:ProtInc
P55087	AQP4	Aquaporin-4	GO:0015670; P:carbon dioxide transport; IEA:Ensembl
P55087	AQP4	Aquaporin-4	GO:0071392; P:cellular response to estradiol stimulus; IEA:Ensembl
P55087	AQP4	Aquaporin-4	GO:0071346; P:cellular response to interferon-gamma; IDA:UniProtKB
P55087	AQP4	Aquaporin-4	GO:0007588; P:excretion; TAS:ProtInc
P55087	AQP4	Aquaporin-4	GO:0007565; P:female pregnancy; IEA:Ensembl
P55087	AQP4	Aquaporin-4	GO:0042538; P:hyperosmotic salinity response; IEA:Ensembl
P55087	AQP4	Aquaporin-4	GO:0050891; P:multicellular organismal water homeostasis; IEP:UniProtKB
P55087	AQP4	Aquaporin-4	GO:0007399; P:nervous system development; TAS:ProtInc
P55087	AQP4	Aquaporin-4	GO:0051260; P:protein homooligomerization; IEA:Ensembl
P55087	AQP4	Aquaporin-4	GO:0070295; P:renal water absorption; IEA:Ensembl
P55087	AQP4	Aquaporin-4	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P55087	AQP4	Aquaporin-4	GO:0009314; P:response to radiation; IEA:Ensembl
P55087	AQP4	Aquaporin-4	GO:0007605; P:sensory perception of sound; IEA:Ensembl
P55087	AQP4	Aquaporin-4	GO:0055085; P:transmembrane transport; TAS:Reactome
P55087	AQP4	Aquaporin-4	GO:0006810; P:transport; TAS:ProtInc
P55087	AQP4	Aquaporin-4	GO:0006833; P:water transport; TAS:Reactome
P55064	AQP5	Aquaporin-5	GO:0005515; F:protein binding; IPI:IntAct
P55064	AQP5	Aquaporin-5	GO:0015250; F:water channel activity; IDA:UniProtKB
P55064	AQP5	Aquaporin-5	GO:0048593; P:camera-type eye morphogenesis; IEA:Ensembl
P55064	AQP5	Aquaporin-5	GO:0015670; P:carbon dioxide transport; IDA:UniProtKB
P55064	AQP5	Aquaporin-5	GO:0007588; P:excretion; TAS:ProtInc
P55064	AQP5	Aquaporin-5	GO:0042476; P:odontogenesis; IEP:UniProtKB
P55064	AQP5	Aquaporin-5	GO:0030157; P:pancreatic juice secretion; IEP:UniProtKB
P55064	AQP5	Aquaporin-5	GO:0046541; P:saliva secretion; IEA:Ensembl
P55064	AQP5	Aquaporin-5	GO:0055085; P:transmembrane transport; TAS:Reactome
P55064	AQP5	Aquaporin-5	GO:0006833; P:water transport; TAS:Reactome
Q13520	AQP6	Aquaporin-6	GO:0005253; F:anion channel activity; EXP:Reactome
Q13520	AQP6	Aquaporin-6	GO:0015112; F:nitrate transmembrane transporter activity; IEA:Ensembl
Q13520	AQP6	Aquaporin-6	GO:0015250; F:water channel activity; TAS:ProtInc
Q13520	AQP6	Aquaporin-6	GO:0007588; P:excretion; TAS:ProtInc
Q13520	AQP6	Aquaporin-6	GO:0042476; P:odontogenesis; IEP:UniProtKB
Q13520	AQP6	Aquaporin-6	GO:0055085; P:transmembrane transport; TAS:Reactome
Q13520	AQP6	Aquaporin-6	GO:0006810; P:transport; TAS:ProtInc
Q13520	AQP6	Aquaporin-6	GO:0006833; P:water transport; TAS:Reactome
A6NL99	AQP7P3	Putative aquaporin-7-like protein 3	GO:0005215; F:transporter activity; IEA:InterPro
O14520	AQP7	Aquaporin-7	GO:0015254; F:glycerol channel activity; EXP:Reactome
O14520	AQP7	Aquaporin-7	GO:0015265; F:urea channel activity; IEA:Ensembl
O14520	AQP7	Aquaporin-7	GO:0015250; F:water channel activity; TAS:ProtInc
O14520	AQP7	Aquaporin-7	GO:0007588; P:excretion; TAS:ProtInc
O14520	AQP7	Aquaporin-7	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
O14520	AQP7	Aquaporin-7	GO:0015793; P:glycerol transport; TAS:Reactome
O14520	AQP7	Aquaporin-7	GO:0070295; P:renal water absorption; IEA:Ensembl
O14520	AQP7	Aquaporin-7	GO:0042493; P:response to drug; IEA:Ensembl
O14520	AQP7	Aquaporin-7	GO:0007283; P:spermatogenesis; IEA:Ensembl
O14520	AQP7	Aquaporin-7	GO:0055085; P:transmembrane transport; TAS:Reactome
O14520	AQP7	Aquaporin-7	GO:0006833; P:water transport; TAS:Reactome
O94778	AQP8	Aquaporin-8	GO:0015250; F:water channel activity; TAS:ProtInc
O94778	AQP8	Aquaporin-8	GO:0015722; P:canalicular bile acid transport; IEA:Ensembl
O94778	AQP8	Aquaporin-8	GO:0071320; P:cellular response to cAMP; IEP:UniProtKB
O94778	AQP8	Aquaporin-8	GO:0055085; P:transmembrane transport; TAS:Reactome
O94778	AQP8	Aquaporin-8	GO:0006810; P:transport; TAS:ProtInc
O94778	AQP8	Aquaporin-8	GO:0006833; P:water transport; TAS:Reactome
O43315	AQP9	Aquaporin-9	GO:0005275; F:amine transmembrane transporter activity; TAS:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0046943; F:carboxylic acid transmembrane transporter activity; TAS:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0015254; F:glycerol channel activity; EXP:Reactome
O43315	AQP9	Aquaporin-9	GO:0015166; F:polyol transmembrane transporter activity; TAS:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0015288; F:porin activity; NAS:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0005345; F:purine nucleobase transmembrane transporter activity; IDA:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0005350; F:pyrimidine nucleobase transmembrane transporter activity; IDA:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0015250; F:water channel activity; IDA:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0005372; F:water transmembrane transporter activity; TAS:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0015837; P:amine transport; IDA:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0015722; P:canalicular bile acid transport; IEA:Ensembl
O43315	AQP9	Aquaporin-9	GO:0046942; P:carboxylic acid transport; TAS:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0071320; P:cellular response to cAMP; IEP:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0007588; P:excretion; TAS:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0015793; P:glycerol transport; TAS:Reactome
O43315	AQP9	Aquaporin-9	GO:0006955; P:immune response; TAS:ProtInc
O43315	AQP9	Aquaporin-9	GO:0008152; P:metabolic process; TAS:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0015791; P:polyol transport; IDA:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0006863; P:purine nucleobase transport; IDA:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0015855; P:pyrimidine nucleobase transport; IDA:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0072531; P:pyrimidine-containing compound transmembrane transport; IDA:GOC
O43315	AQP9	Aquaporin-9	GO:0046689; P:response to mercury ion; IDA:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0010033; P:response to organic substance; IDA:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0006970; P:response to osmotic stress; TAS:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0055085; P:transmembrane transport; TAS:Reactome
O43315	AQP9	Aquaporin-9	GO:0006810; P:transport; TAS:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0030104; P:water homeostasis; NAS:UniProtKB
O43315	AQP9	Aquaporin-9	GO:0006833; P:water transport; IDA:UniProtKB
O60306	AQR	Intron-binding protein aquarius	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O60306	AQR	Intron-binding protein aquarius	GO:0097157; F:pre-mRNA intronic binding; IEA:InterPro
O60306	AQR	Intron-binding protein aquarius	GO:0005515; F:protein binding; IPI:IntAct
O60306	AQR	Intron-binding protein aquarius	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q5H913	ARL13A	ADP-ribosylation factor-like protein 13A	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q5H913	ARL13A	ADP-ribosylation factor-like protein 13A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q3SXY8	ARL13B	ADP-ribosylation factor-like protein 13B	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q3SXY8	ARL13B	ADP-ribosylation factor-like protein 13B	GO:0005515; F:protein binding; IPI:UniProtKB
Q3SXY8	ARL13B	ADP-ribosylation factor-like protein 13B	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q3SXY8	ARL13B	ADP-ribosylation factor-like protein 13B	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
Q3SXY8	ARL13B	ADP-ribosylation factor-like protein 13B	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
Q3SXY8	ARL13B	ADP-ribosylation factor-like protein 13B	GO:0021943; P:formation of radial glial scaffolds; ISS:UniProtKB
Q3SXY8	ARL13B	ADP-ribosylation factor-like protein 13B	GO:0021830; P:interneuron migration from the subpallium to the cortex; ISS:UniProtKB
Q3SXY8	ARL13B	ADP-ribosylation factor-like protein 13B	GO:0021532; P:neural tube patterning; ISS:UniProtKB
Q3SXY8	ARL13B	ADP-ribosylation factor-like protein 13B	GO:0035058; P:nonmotile primary cilium assembly; ISS:UniProtKB
Q3SXY8	ARL13B	ADP-ribosylation factor-like protein 13B	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q3SXY8	ARL13B	ADP-ribosylation factor-like protein 13B	GO:0007224; P:smoothened signaling pathway; ISS:UniProtKB
Q9Y2Y0	ARL2BP	ADP-ribosylation factor-like protein 2-binding protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y2Y0	ARL2BP	ADP-ribosylation factor-like protein 2-binding protein	GO:0005083; F:small GTPase regulator activity; TAS:ProtInc
Q9Y2Y0	ARL2BP	ADP-ribosylation factor-like protein 2-binding protein	GO:0003713; F:transcription coactivator activity; IMP:UniProtKB
Q9Y2Y0	ARL2BP	ADP-ribosylation factor-like protein 2-binding protein	GO:0051457; P:maintenance of protein location in nucleus; IMP:UniProtKB
Q9Y2Y0	ARL2BP	ADP-ribosylation factor-like protein 2-binding protein	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IMP:UniProtKB
Q9Y2Y0	ARL2BP	ADP-ribosylation factor-like protein 2-binding protein	GO:0050790; P:regulation of catalytic activity; TAS:GOC
Q9Y2Y0	ARL2BP	ADP-ribosylation factor-like protein 2-binding protein	GO:2001141; P:regulation of RNA biosynthetic process; IMP:GOC
Q9Y2Y0	ARL2BP	ADP-ribosylation factor-like protein 2-binding protein	GO:0007165; P:signal transduction; TAS:ProtInc
Q15041	ARL6IP1	ADP-ribosylation factor-like protein 6-interacting protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q15041	ARL6IP1	ADP-ribosylation factor-like protein 6-interacting protein 1	GO:0006613; P:cotranslational protein targeting to membrane; IEA:Ensembl
Q66PJ3	ARL6IP4	ADP-ribosylation factor-like protein 6-interacting protein 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q66PJ3	ARL6IP4	ADP-ribosylation factor-like protein 6-interacting protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q66PJ3	ARL6IP4	ADP-ribosylation factor-like protein 6-interacting protein 4	GO:0008380; P:RNA splicing; TAS:ProtInc
P10398	ARAF	Serine/threonine-protein kinase A-Raf	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P10398	ARAF	Serine/threonine-protein kinase A-Raf	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P10398	ARAF	Serine/threonine-protein kinase A-Raf	GO:0005515; F:protein binding; IPI:IntAct
P10398	ARAF	Serine/threonine-protein kinase A-Raf	GO:0004672; F:protein kinase activity; TAS:ProtInc
P10398	ARAF	Serine/threonine-protein kinase A-Raf	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P10398	ARAF	Serine/threonine-protein kinase A-Raf	GO:0005057; F:receptor signaling protein activity; IEA:InterPro
P10398	ARAF	Serine/threonine-protein kinase A-Raf	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P10398	ARAF	Serine/threonine-protein kinase A-Raf	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P10398	ARAF	Serine/threonine-protein kinase A-Raf	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:UniProtKB
P10398	ARAF	Serine/threonine-protein kinase A-Raf	GO:0032434; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB
P10398	ARAF	Serine/threonine-protein kinase A-Raf	GO:0032006; P:regulation of TOR signaling; IMP:UniProtKB
Q6UW56	ATRAID	All-trans retinoic acid-induced differentiation factor	GO:0005515; F:protein binding; IPI:UniProtKB
Q6UW56	ATRAID	All-trans retinoic acid-induced differentiation factor	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q6UW56	ATRAID	All-trans retinoic acid-induced differentiation factor	GO:2000599; P:negative regulation of cyclin catabolic process; IDA:UniProtKB
Q6UW56	ATRAID	All-trans retinoic acid-induced differentiation factor	GO:0033689; P:negative regulation of osteoblast proliferation; IDA:UniProtKB
Q6UW56	ATRAID	All-trans retinoic acid-induced differentiation factor	GO:0030501; P:positive regulation of bone mineralization; IDA:UniProtKB
Q6UW56	ATRAID	All-trans retinoic acid-induced differentiation factor	GO:0045669; P:positive regulation of osteoblast differentiation; IDA:UniProtKB
Q6UW56	ATRAID	All-trans retinoic acid-induced differentiation factor	GO:0010468; P:regulation of gene expression; IDA:UniProtKB
Q96P48	ARAP1	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1	GO:0008060; F:ARF GTPase activator activity; IDA:UniProtKB
Q96P48	ARAP1	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB
Q96P48	ARAP1	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q96P48	ARAP1	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1	GO:0005100; F:Rho GTPase activator activity; IDA:UniProtKB
Q96P48	ARAP1	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96P48	ARAP1	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1	GO:0030037; P:actin filament reorganization involved in cell cycle; TAS:UniProtKB
Q96P48	ARAP1	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1	GO:0051497; P:negative regulation of stress fiber assembly; IMP:UniProtKB
Q96P48	ARAP1	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1	GO:0043089; P:positive regulation of Cdc42 GTPase activity; IDA:UniProtKB
Q96P48	ARAP1	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1	GO:0051491; P:positive regulation of filopodium assembly; IMP:UniProtKB
Q96P48	ARAP1	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1	GO:0001921; P:positive regulation of receptor recycling; IEA:Ensembl
Q96P48	ARAP1	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
Q96P48	ARAP1	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
Q96P48	ARAP1	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1	GO:0051270; P:regulation of cellular component movement; IMP:UniProtKB
Q96P48	ARAP1	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q96P48	ARAP1	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q8WZ64	ARAP2	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q8WZ64	ARAP2	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB
Q8WZ64	ARAP2	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WZ64	ARAP2	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
Q8WZ64	ARAP2	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q8WZ64	ARAP2	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q8WWN8	ARAP3	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3	GO:0008060; F:ARF GTPase activator activity; ISS:UniProtKB
Q8WWN8	ARAP3	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB
Q8WWN8	ARAP3	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3	GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; IDA:UniProtKB
Q8WWN8	ARAP3	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q8WWN8	ARAP3	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3	GO:0005100; F:Rho GTPase activator activity; ISS:UniProtKB
Q8WWN8	ARAP3	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WWN8	ARAP3	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3	GO:0007010; P:cytoskeleton organization; TAS:UniProtKB
Q8WWN8	ARAP3	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3	GO:0030336; P:negative regulation of cell migration; ISS:UniProtKB
Q8WWN8	ARAP3	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3	GO:0035021; P:negative regulation of Rac protein signal transduction; IEA:Ensembl
Q8WWN8	ARAP3	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3	GO:0035024; P:negative regulation of Rho protein signal transduction; ISS:UniProtKB
Q8WWN8	ARAP3	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
Q8WWN8	ARAP3	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3	GO:0008360; P:regulation of cell shape; ISS:UniProtKB
Q8WWN8	ARAP3	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q8WWN8	ARAP3	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q8WWN8	ARAP3	Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3	GO:0016192; P:vesicle-mediated transport; TAS:UniProtKB
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0031694; F:alpha-2A adrenergic receptor binding; ISS:BHF-UCL
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0047696; F:beta-adrenergic receptor kinase activity; IEA:UniProtKB-EC
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0031755; F:Edg-2 lysophosphatidic acid receptor binding; IDA:UniProtKB
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0004703; F:G-protein coupled receptor kinase activity; ISS:BHF-UCL
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0005515; F:protein binding; IPI:UniProtKB
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0004672; F:protein kinase activity; ISS:BHF-UCL
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0002029; P:desensitization of G-protein coupled receptor protein signaling pathway; ISS:BHF-UCL
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0007213; P:G-protein coupled acetylcholine receptor signaling pathway; ISS:BHF-UCL
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0007507; P:heart development; IEA:Ensembl
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0045087; P:innate immune response; TAS:Reactome
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0045988; P:negative regulation of striated muscle contraction; IMP:BHF-UCL
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0003108; P:negative regulation of the force of heart contraction by chemical signal; IMP:BHF-UCL
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0018105; P:peptidyl-serine phosphorylation; ISS:BHF-UCL
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0018107; P:peptidyl-threonine phosphorylation; IEA:Ensembl
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0033605; P:positive regulation of catecholamine secretion; ISS:BHF-UCL
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0031623; P:receptor internalization; IDA:UniProtKB
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0007165; P:signal transduction; TAS:Reactome
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0007217; P:tachykinin receptor signaling pathway; IDA:BHF-UCL
P25098	ADRBK1	Beta-adrenergic receptor kinase 1	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
P35626	ADRBK2	Beta-adrenergic receptor kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P35626	ADRBK2	Beta-adrenergic receptor kinase 2	GO:0047696; F:beta-adrenergic receptor kinase activity; IEA:UniProtKB-EC
P35626	ADRBK2	Beta-adrenergic receptor kinase 2	GO:0004703; F:G-protein coupled receptor kinase activity; IEA:Ensembl
P35626	ADRBK2	Beta-adrenergic receptor kinase 2	GO:0004672; F:protein kinase activity; TAS:ProtInc
P35626	ADRBK2	Beta-adrenergic receptor kinase 2	GO:0031623; P:receptor internalization; IDA:UniProtKB
P35626	ADRBK2	Beta-adrenergic receptor kinase 2	GO:0007165; P:signal transduction; TAS:ProtInc
P35626	ADRBK2	Beta-adrenergic receptor kinase 2	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
Q92747	ARPC1A	Actin-related protein 2/3 complex subunit 1A	GO:0003779; F:actin binding; TAS:ProtInc
Q92747	ARPC1A	Actin-related protein 2/3 complex subunit 1A	GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc
Q92747	ARPC1A	Actin-related protein 2/3 complex subunit 1A	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q92747	ARPC1A	Actin-related protein 2/3 complex subunit 1A	GO:0045087; P:innate immune response; TAS:Reactome
Q92747	ARPC1A	Actin-related protein 2/3 complex subunit 1A	GO:0030833; P:regulation of actin filament polymerization; IEA:InterPro
O15143	ARPC1B	Actin-related protein 2/3 complex subunit 1B	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
O15143	ARPC1B	Actin-related protein 2/3 complex subunit 1B	GO:0006928; P:cellular component movement; TAS:ProtInc
O15143	ARPC1B	Actin-related protein 2/3 complex subunit 1B	GO:0030833; P:regulation of actin filament polymerization; IEA:InterPro
Q7LC44	ARC	Activity-regulated cytoskeleton-associated protein	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q7LC44	ARC	Activity-regulated cytoskeleton-associated protein	GO:0016477; P:cell migration; IMP:UniProtKB
Q7LC44	ARC	Activity-regulated cytoskeleton-associated protein	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q7LC44	ARC	Activity-regulated cytoskeleton-associated protein	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q7LC44	ARC	Activity-regulated cytoskeleton-associated protein	GO:0007492; P:endoderm development; IEA:Ensembl
Q7LC44	ARC	Activity-regulated cytoskeleton-associated protein	GO:0007612; P:learning; IEA:Ensembl
Q7LC44	ARC	Activity-regulated cytoskeleton-associated protein	GO:0022604; P:regulation of cell morphogenesis; IMP:UniProtKB
Q7LC44	ARC	Activity-regulated cytoskeleton-associated protein	GO:0048168; P:regulation of neuronal synaptic plasticity; IEA:Ensembl
P15514	AREG	Amphiregulin	GO:0008083; F:growth factor activity; TAS:ProtInc
P15514	AREG	Amphiregulin	GO:0005515; F:protein binding; IPI:IntAct
P15514	AREG	Amphiregulin	GO:0008283; P:cell proliferation; TAS:ProtInc
P15514	AREG	Amphiregulin	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P15514	AREG	Amphiregulin	GO:0007173; P:epidermal growth factor receptor signaling pathway; IDA:BHF-UCL
P15514	AREG	Amphiregulin	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:BHF-UCL
P15514	AREG	Amphiregulin	GO:0045740; P:positive regulation of DNA replication; IMP:BHF-UCL
O15033	AREL1	Apoptosis-resistant E3 ubiquitin protein ligase 1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
O15033	AREL1	Apoptosis-resistant E3 ubiquitin protein ligase 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O15033	AREL1	Apoptosis-resistant E3 ubiquitin protein ligase 1	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
O15033	AREL1	Apoptosis-resistant E3 ubiquitin protein ligase 1	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB
P84077	ARF1	ADP-ribosylation factor 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P84077	ARF1	ADP-ribosylation factor 1	GO:0003924; F:GTPase activity; TAS:ProtInc
P84077	ARF1	ADP-ribosylation factor 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P84077	ARF1	ADP-ribosylation factor 1	GO:0005515; F:protein binding; IPI:IntAct
P84077	ARF1	ADP-ribosylation factor 1	GO:0005057; F:receptor signaling protein activity; TAS:ProtInc
P84077	ARF1	ADP-ribosylation factor 1	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P84077	ARF1	ADP-ribosylation factor 1	GO:0006878; P:cellular copper ion homeostasis; IMP:UniProtKB
P84077	ARF1	ADP-ribosylation factor 1	GO:0048205; P:COPI coating of Golgi vesicle; TAS:Reactome
P84077	ARF1	ADP-ribosylation factor 1	GO:0097061; P:dendritic spine organization; ISS:UniProtKB
P84077	ARF1	ADP-ribosylation factor 1	GO:0006184; P:GTP catabolic process; TAS:GOC
P84077	ARF1	ADP-ribosylation factor 1	GO:0060292; P:long term synaptic depression; ISS:UniProtKB
P84077	ARF1	ADP-ribosylation factor 1	GO:0061024; P:membrane organization; TAS:Reactome
P84077	ARF1	ADP-ribosylation factor 1	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
P84077	ARF1	ADP-ribosylation factor 1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P84077	ARF1	ADP-ribosylation factor 1	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
P84077	ARF1	ADP-ribosylation factor 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P84077	ARF1	ADP-ribosylation factor 1	GO:0034315; P:regulation of Arp2/3 complex-mediated actin nucleation; ISS:UniProtKB
P84077	ARF1	ADP-ribosylation factor 1	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
P84077	ARF1	ADP-ribosylation factor 1	GO:0002090; P:regulation of receptor internalization; ISS:UniProtKB
P84077	ARF1	ADP-ribosylation factor 1	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; TAS:Reactome
P84077	ARF1	ADP-ribosylation factor 1	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P84077	ARF1	ADP-ribosylation factor 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P84077	ARF1	ADP-ribosylation factor 1	GO:0016032; P:viral process; TAS:Reactome
P61204	ARF3	ADP-ribosylation factor 3	GO:0005525; F:GTP binding; TAS:ProtInc
P61204	ARF3	ADP-ribosylation factor 3	GO:0003924; F:GTPase activity; TAS:ProtInc
P61204	ARF3	ADP-ribosylation factor 3	GO:0006184; P:GTP catabolic process; TAS:GOC
P61204	ARF3	ADP-ribosylation factor 3	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
P61204	ARF3	ADP-ribosylation factor 3	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P61204	ARF3	ADP-ribosylation factor 3	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P61204	ARF3	ADP-ribosylation factor 3	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P61204	ARF3	ADP-ribosylation factor 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P61204	ARF3	ADP-ribosylation factor 3	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
P18085	ARF4	ADP-ribosylation factor 4	GO:0005154; F:epidermal growth factor receptor binding; IDA:UniProt
P18085	ARF4	ADP-ribosylation factor 4	GO:0005525; F:GTP binding; IDA:UniProt
P18085	ARF4	ADP-ribosylation factor 4	GO:0005515; F:protein binding; IPI:IntAct
P18085	ARF4	ADP-ribosylation factor 4	GO:0031584; P:activation of phospholipase D activity; IDA:UniProt
P18085	ARF4	ADP-ribosylation factor 4	GO:0007420; P:brain development; IEA:Ensembl
P18085	ARF4	ADP-ribosylation factor 4	GO:0016477; P:cell migration; IDA:UniProt
P18085	ARF4	ADP-ribosylation factor 4	GO:0007173; P:epidermal growth factor receptor signaling pathway; IEA:Ensembl
P18085	ARF4	ADP-ribosylation factor 4	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProt
P18085	ARF4	ADP-ribosylation factor 4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProt
P18085	ARF4	ADP-ribosylation factor 4	GO:0006471; P:protein ADP-ribosylation; IDA:UniProt
P18085	ARF4	ADP-ribosylation factor 4	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P18085	ARF4	ADP-ribosylation factor 4	GO:2000377; P:regulation of reactive oxygen species metabolic process; IDA:UniProt
P18085	ARF4	ADP-ribosylation factor 4	GO:0048678; P:response to axon injury; IEA:Ensembl
P18085	ARF4	ADP-ribosylation factor 4	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P18085	ARF4	ADP-ribosylation factor 4	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
P84085	ARF5	ADP-ribosylation factor 5	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P84085	ARF5	ADP-ribosylation factor 5	GO:0003924; F:GTPase activity; TAS:ProtInc
P84085	ARF5	ADP-ribosylation factor 5	GO:0005515; F:protein binding; IPI:UniProtKB
P84085	ARF5	ADP-ribosylation factor 5	GO:0006184; P:GTP catabolic process; TAS:GOC
P84085	ARF5	ADP-ribosylation factor 5	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P84085	ARF5	ADP-ribosylation factor 5	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P84085	ARF5	ADP-ribosylation factor 5	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
P62330	ARF6	ADP-ribosylation factor 6	GO:0005525; F:GTP binding; TAS:UniProtKB
P62330	ARF6	ADP-ribosylation factor 6	GO:0003924; F:GTPase activity; TAS:ProtInc
P62330	ARF6	ADP-ribosylation factor 6	GO:0005515; F:protein binding; IPI:UniProtKB
P62330	ARF6	ADP-ribosylation factor 6	GO:0031996; F:thioesterase binding; IPI:UniProtKB
P62330	ARF6	ADP-ribosylation factor 6	GO:0007155; P:cell adhesion; TAS:UniProtKB
P62330	ARF6	ADP-ribosylation factor 6	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P62330	ARF6	ADP-ribosylation factor 6	GO:0051301; P:cell division; IEA:UniProtKB-KW
P62330	ARF6	ADP-ribosylation factor 6	GO:0006928; P:cellular component movement; TAS:UniProtKB
P62330	ARF6	ADP-ribosylation factor 6	GO:0030866; P:cortical actin cytoskeleton organization; IMP:UniProtKB
P62330	ARF6	ADP-ribosylation factor 6	GO:0090162; P:establishment of epithelial cell polarity; IEA:Ensembl
P62330	ARF6	ADP-ribosylation factor 6	GO:0006184; P:GTP catabolic process; TAS:GOC
P62330	ARF6	ADP-ribosylation factor 6	GO:0097284; P:hepatocyte apoptotic process; IEA:Ensembl
P62330	ARF6	ADP-ribosylation factor 6	GO:0001889; P:liver development; IEA:Ensembl
P62330	ARF6	ADP-ribosylation factor 6	GO:0033028; P:myeloid cell apoptotic process; IEA:Ensembl
P62330	ARF6	ADP-ribosylation factor 6	GO:0048261; P:negative regulation of receptor-mediated endocytosis; TAS:UniProtKB
P62330	ARF6	ADP-ribosylation factor 6	GO:0030838; P:positive regulation of actin filament polymerization; IMP:UniProtKB
P62330	ARF6	ADP-ribosylation factor 6	GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; ISS:BHF-UCL
P62330	ARF6	ADP-ribosylation factor 6	GO:0034394; P:protein localization to cell surface; ISS:BHF-UCL
P62330	ARF6	ADP-ribosylation factor 6	GO:0036010; P:protein localization to endosome; IMP:UniProtKB
P62330	ARF6	ADP-ribosylation factor 6	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P62330	ARF6	ADP-ribosylation factor 6	GO:0060998; P:regulation of dendritic spine development; ISS:UniProtKB
P62330	ARF6	ADP-ribosylation factor 6	GO:0051489; P:regulation of filopodium assembly; IDA:UniProtKB
P62330	ARF6	ADP-ribosylation factor 6	GO:0035020; P:regulation of Rac protein signal transduction; IDA:UniProtKB
P62330	ARF6	ADP-ribosylation factor 6	GO:0031529; P:ruffle organization; IDA:UniProtKB
P62330	ARF6	ADP-ribosylation factor 6	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P62330	ARF6	ADP-ribosylation factor 6	GO:0016192; P:vesicle-mediated transport; TAS:UniProtKB
Q8N6T3	ARFGAP1	ADP-ribosylation factor GTPase-activating protein 1	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q8N6T3	ARFGAP1	ADP-ribosylation factor GTPase-activating protein 1	GO:0005096; F:GTPase activator activity; IDA:MGI
Q8N6T3	ARFGAP1	ADP-ribosylation factor GTPase-activating protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q8N6T3	ARFGAP1	ADP-ribosylation factor GTPase-activating protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N6T3	ARFGAP1	ADP-ribosylation factor GTPase-activating protein 1	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q8N6T3	ARFGAP1	ADP-ribosylation factor GTPase-activating protein 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8N6T3	ARFGAP1	ADP-ribosylation factor GTPase-activating protein 1	GO:0048205; P:COPI coating of Golgi vesicle; TAS:Reactome
Q8N6T3	ARFGAP1	ADP-ribosylation factor GTPase-activating protein 1	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q8N6T3	ARFGAP1	ADP-ribosylation factor GTPase-activating protein 1	GO:0061024; P:membrane organization; TAS:Reactome
Q8N6T3	ARFGAP1	ADP-ribosylation factor GTPase-activating protein 1	GO:0043547; P:positive regulation of GTPase activity; IDA:GOC
Q8N6T3	ARFGAP1	ADP-ribosylation factor GTPase-activating protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8N6T3	ARFGAP1	ADP-ribosylation factor GTPase-activating protein 1	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
Q8N6T3	ARFGAP1	ADP-ribosylation factor GTPase-activating protein 1	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; TAS:Reactome
Q8N6H7	ARFGAP2	ADP-ribosylation factor GTPase-activating protein 2	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q8N6H7	ARFGAP2	ADP-ribosylation factor GTPase-activating protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N6H7	ARFGAP2	ADP-ribosylation factor GTPase-activating protein 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8N6H7	ARFGAP2	ADP-ribosylation factor GTPase-activating protein 2	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
Q8N6H7	ARFGAP2	ADP-ribosylation factor GTPase-activating protein 2	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q9NP61	ARFGAP3	ADP-ribosylation factor GTPase-activating protein 3	GO:0008060; F:ARF GTPase activator activity; IDA:UniProtKB
Q9NP61	ARFGAP3	ADP-ribosylation factor GTPase-activating protein 3	GO:0008565; F:protein transporter activity; NAS:UniProtKB
Q9NP61	ARFGAP3	ADP-ribosylation factor GTPase-activating protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NP61	ARFGAP3	ADP-ribosylation factor GTPase-activating protein 3	GO:0006886; P:intracellular protein transport; NAS:UniProtKB
Q9NP61	ARFGAP3	ADP-ribosylation factor GTPase-activating protein 3	GO:0043547; P:positive regulation of GTPase activity; IDA:GOC
Q9NP61	ARFGAP3	ADP-ribosylation factor GTPase-activating protein 3	GO:0009306; P:protein secretion; IEP:UniProtKB
Q9NP61	ARFGAP3	ADP-ribosylation factor GTPase-activating protein 3	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
Q9NP61	ARFGAP3	ADP-ribosylation factor GTPase-activating protein 3	GO:0016192; P:vesicle-mediated transport; NAS:UniProtKB
P53367	ARFIP1	Arfaptin-1	GO:0006886; P:intracellular protein transport; IDA:MGI
P53367	ARFIP1	Arfaptin-1	GO:0050708; P:regulation of protein secretion; IDA:MGI
P53365	ARFIP2	Arfaptin-2	GO:0005525; F:GTP binding; TAS:ProtInc
P53365	ARFIP2	Arfaptin-2	GO:0030742; F:GTP-dependent protein binding; IPI:UniProtKB
P53365	ARFIP2	Arfaptin-2	GO:0005515; F:protein binding; IPI:IntAct
P53365	ARFIP2	Arfaptin-2	GO:0048365; F:Rac GTPase binding; TAS:UniProtKB
P53365	ARFIP2	Arfaptin-2	GO:0030036; P:actin cytoskeleton organization; IMP:UniProtKB
P53365	ARFIP2	Arfaptin-2	GO:0006928; P:cellular component movement; TAS:ProtInc
P53365	ARFIP2	Arfaptin-2	GO:0030032; P:lamellipodium assembly; TAS:UniProtKB
P53365	ARFIP2	Arfaptin-2	GO:0031529; P:ruffle organization; TAS:UniProtKB
P53365	ARFIP2	Arfaptin-2	GO:0007264; P:small GTPase mediated signal transduction; TAS:ProtInc
Q13795	ARFRP1	ADP-ribosylation factor-related protein 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q13795	ARFRP1	ADP-ribosylation factor-related protein 1	GO:0003924; F:GTPase activity; TAS:ProtInc
Q13795	ARFRP1	ADP-ribosylation factor-related protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13795	ARFRP1	ADP-ribosylation factor-related protein 1	GO:0007369; P:gastrulation; IEA:Ensembl
Q13795	ARFRP1	ADP-ribosylation factor-related protein 1	GO:0043001; P:Golgi to plasma membrane protein transport; IMP:UniProtKB
Q13795	ARFRP1	ADP-ribosylation factor-related protein 1	GO:0006184; P:GTP catabolic process; TAS:GOC
Q13795	ARFRP1	ADP-ribosylation factor-related protein 1	GO:0034067; P:protein localization to Golgi apparatus; IMP:UniProtKB
Q13795	ARFRP1	ADP-ribosylation factor-related protein 1	GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB
Q13795	ARFRP1	ADP-ribosylation factor-related protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q13795	ARFRP1	ADP-ribosylation factor-related protein 1	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q8N1W1	ARHGEF28	Rho guanine nucleotide exchange factor 28	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N1W1	ARHGEF28	Rho guanine nucleotide exchange factor 28	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q8N1W1	ARHGEF28	Rho guanine nucleotide exchange factor 28	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q8N1W1	ARHGEF28	Rho guanine nucleotide exchange factor 28	GO:0021955; P:central nervous system neuron axonogenesis; IEA:Ensembl
Q8N1W1	ARHGEF28	Rho guanine nucleotide exchange factor 28	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8N1W1	ARHGEF28	Rho guanine nucleotide exchange factor 28	GO:0060052; P:neurofilament cytoskeleton organization; IEA:Ensembl
A8MVX0	ARHGEF33	Rho guanine nucleotide exchange factor 33	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q8N4T4	ARHGEF39	Rho guanine nucleotide exchange factor 39	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q8N4T4	ARHGEF39	Rho guanine nucleotide exchange factor 39	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
Q9HCE6	ARHGEF10L	Rho guanine nucleotide exchange factor 10-like protein	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
A6NJG6	ARGFX	Arginine-fifty homeobox	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
A6NJG6	ARGFX	Arginine-fifty homeobox	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
A6NJG6	ARGFX	Arginine-fifty homeobox	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P05089	ARG1	Arginase-1	GO:0004053; F:arginase activity; EXP:Reactome
P05089	ARG1	Arginase-1	GO:0030145; F:manganese ion binding; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0006527; P:arginine catabolic process; TAS:ProtInc
P05089	ARG1	Arginase-1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P05089	ARG1	Arginase-1	GO:0071549; P:cellular response to dexamethasone stimulus; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0071377; P:cellular response to glucagon stimulus; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0032964; P:collagen biosynthetic process; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0001889; P:liver development; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0030324; P:lung development; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0060056; P:mammary gland involution; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0070207; P:protein homotrimerization; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0010963; P:regulation of L-arginine import; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0014075; P:response to amine; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0043200; P:response to amino acid; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0048678; P:response to axon injury; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0046686; P:response to cadmium ion; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0042493; P:response to drug; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0009635; P:response to herbicide; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0010042; P:response to manganese ion; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0051597; P:response to methylmercury; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0010269; P:response to selenium ion; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0033189; P:response to vitamin A; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0033197; P:response to vitamin E; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0010043; P:response to zinc ion; IEA:Ensembl
P05089	ARG1	Arginase-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P05089	ARG1	Arginase-1	GO:0000050; P:urea cycle; TAS:Reactome
P78540	ARG2	Arginase-2, mitochondrial	GO:0004053; F:arginase activity; EXP:Reactome
P78540	ARG2	Arginase-2, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P78540	ARG2	Arginase-2, mitochondrial	GO:0006525; P:arginine metabolic process; IEA:UniProtKB-KW
P78540	ARG2	Arginase-2, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P78540	ARG2	Arginase-2, mitochondrial	GO:0006809; P:nitric oxide biosynthetic process; TAS:ProtInc
P78540	ARG2	Arginase-2, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P78540	ARG2	Arginase-2, mitochondrial	GO:0006941; P:striated muscle contraction; IEA:Ensembl
P78540	ARG2	Arginase-2, mitochondrial	GO:0000050; P:urea cycle; TAS:Reactome
P78540	ARG2	Arginase-2, mitochondrial	GO:0001657; P:ureteric bud development; IEA:Ensembl
Q9NWB6	ARGLU1	Arginine and glutamate-rich protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NWB6	ARGLU1	Arginine and glutamate-rich protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NWB6	ARGLU1	Arginine and glutamate-rich protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A1IGU5	ARHGEF37	Rho guanine nucleotide exchange factor 37	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q9NXL2	ARHGEF38	Rho guanine nucleotide exchange factor 38	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q8TER5	ARHGEF40	Rho guanine nucleotide exchange factor 40	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q92888	ARHGEF1	Rho guanine nucleotide exchange factor 1	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q92888	ARHGEF1	Rho guanine nucleotide exchange factor 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q92888	ARHGEF1	Rho guanine nucleotide exchange factor 1	GO:0005515; F:protein binding; IPI:IntAct
Q92888	ARHGEF1	Rho guanine nucleotide exchange factor 1	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; TAS:ProtInc
Q92888	ARHGEF1	Rho guanine nucleotide exchange factor 1	GO:0008283; P:cell proliferation; TAS:ProtInc
Q92888	ARHGEF1	Rho guanine nucleotide exchange factor 1	GO:0050771; P:negative regulation of axonogenesis; TAS:Reactome
Q92888	ARHGEF1	Rho guanine nucleotide exchange factor 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q92888	ARHGEF1	Rho guanine nucleotide exchange factor 1	GO:0050770; P:regulation of axonogenesis; TAS:Reactome
Q92888	ARHGEF1	Rho guanine nucleotide exchange factor 1	GO:0032319; P:regulation of Rho GTPase activity; TAS:GOC
Q92888	ARHGEF1	Rho guanine nucleotide exchange factor 1	GO:0007266; P:Rho protein signal transduction; TAS:ProtInc
Q92888	ARHGEF1	Rho guanine nucleotide exchange factor 1	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0048365; F:Rac GTPase binding; IDA:UniProtKB
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0030676; F:Rac guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0017048; F:Rho GTPase binding; IDA:UniProtKB
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0008134; F:transcription factor binding; ISS:BHF-UCL
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0007015; P:actin filament organization; IMP:UniProtKB
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0000902; P:cell morphogenesis; IMP:UniProtKB
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0071474; P:cellular hyperosmotic response; ISS:BHF-UCL
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0071225; P:cellular response to muramyl dipeptide; IDA:UniProtKB
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0071356; P:cellular response to tumor necrosis factor; ISS:BHF-UCL
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0000132; P:establishment of mitotic spindle orientation; IEA:Ensembl
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0006886; P:intracellular protein transport; NAS:UniProtKB
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; ISS:BHF-UCL
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:1902219; P:negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress; ISS:BHF-UCL
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0007026; P:negative regulation of microtubule depolymerization; IMP:UniProtKB
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0060546; P:negative regulation of necroptotic process; ISS:BHF-UCL
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0050768; P:negative regulation of neurogenesis; IEA:Ensembl
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0032755; P:positive regulation of interleukin-6 production; IDA:UniProtKB
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0032760; P:positive regulation of tumor necrosis factor production; IDA:UniProtKB
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0042127; P:regulation of cell proliferation; TAS:UniProtKB
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0032314; P:regulation of Rac GTPase activity; IDA:GOC
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0032319; P:regulation of Rho GTPase activity; IDA:GOC
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0035023; P:regulation of Rho protein signal transduction; NAS:UniProtKB
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q92974	ARHGEF2	Rho guanine nucleotide exchange factor 2	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9NR81	ARHGEF3	Rho guanine nucleotide exchange factor 3	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; TAS:ProtInc
Q9NR81	ARHGEF3	Rho guanine nucleotide exchange factor 3	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q9NR81	ARHGEF3	Rho guanine nucleotide exchange factor 3	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9NR81	ARHGEF3	Rho guanine nucleotide exchange factor 3	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q9NR81	ARHGEF3	Rho guanine nucleotide exchange factor 3	GO:0032319; P:regulation of Rho GTPase activity; TAS:GOC
Q9NR81	ARHGEF3	Rho guanine nucleotide exchange factor 3	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q9NR81	ARHGEF3	Rho guanine nucleotide exchange factor 3	GO:0007266; P:Rho protein signal transduction; TAS:ProtInc
Q9NR81	ARHGEF3	Rho guanine nucleotide exchange factor 3	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9NR80	ARHGEF4	Rho guanine nucleotide exchange factor 4	GO:0005085; F:guanyl-nucleotide exchange factor activity; IMP:UniProtKB
Q9NR80	ARHGEF4	Rho guanine nucleotide exchange factor 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NR80	ARHGEF4	Rho guanine nucleotide exchange factor 4	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q9NR80	ARHGEF4	Rho guanine nucleotide exchange factor 4	GO:0030676; F:Rac guanyl-nucleotide exchange factor activity; IMP:UniProtKB
Q9NR80	ARHGEF4	Rho guanine nucleotide exchange factor 4	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q9NR80	ARHGEF4	Rho guanine nucleotide exchange factor 4	GO:0046847; P:filopodium assembly; IMP:UniProtKB
Q9NR80	ARHGEF4	Rho guanine nucleotide exchange factor 4	GO:0030032; P:lamellipodium assembly; IMP:UniProtKB
Q9NR80	ARHGEF4	Rho guanine nucleotide exchange factor 4	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9NR80	ARHGEF4	Rho guanine nucleotide exchange factor 4	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q9NR80	ARHGEF4	Rho guanine nucleotide exchange factor 4	GO:0043087; P:regulation of GTPase activity; IMP:GOC
Q9NR80	ARHGEF4	Rho guanine nucleotide exchange factor 4	GO:0032314; P:regulation of Rac GTPase activity; IMP:GOC
Q9NR80	ARHGEF4	Rho guanine nucleotide exchange factor 4	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q9NR80	ARHGEF4	Rho guanine nucleotide exchange factor 4	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q12774	ARHGEF5	Rho guanine nucleotide exchange factor 5	GO:0005525; F:GTP binding; TAS:ProtInc
Q12774	ARHGEF5	Rho guanine nucleotide exchange factor 5	GO:0005515; F:protein binding; IPI:IntAct
Q12774	ARHGEF5	Rho guanine nucleotide exchange factor 5	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q12774	ARHGEF5	Rho guanine nucleotide exchange factor 5	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
Q12774	ARHGEF5	Rho guanine nucleotide exchange factor 5	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q12774	ARHGEF5	Rho guanine nucleotide exchange factor 5	GO:0002408; P:myeloid dendritic cell chemotaxis; IEA:Ensembl
Q12774	ARHGEF5	Rho guanine nucleotide exchange factor 5	GO:0071803; P:positive regulation of podosome assembly; IEA:Ensembl
Q12774	ARHGEF5	Rho guanine nucleotide exchange factor 5	GO:0032321; P:positive regulation of Rho GTPase activity; IEA:Ensembl
Q12774	ARHGEF5	Rho guanine nucleotide exchange factor 5	GO:0032319; P:regulation of Rho GTPase activity; IDA:MGI
Q15052	ARHGEF6	Rho guanine nucleotide exchange factor 6	GO:0005096; F:GTPase activator activity; NAS:UniProtKB
Q15052	ARHGEF6	Rho guanine nucleotide exchange factor 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q15052	ARHGEF6	Rho guanine nucleotide exchange factor 6	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; NAS:UniProtKB
Q15052	ARHGEF6	Rho guanine nucleotide exchange factor 6	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q15052	ARHGEF6	Rho guanine nucleotide exchange factor 6	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q15052	ARHGEF6	Rho guanine nucleotide exchange factor 6	GO:0034329; P:cell junction assembly; TAS:Reactome
Q15052	ARHGEF6	Rho guanine nucleotide exchange factor 6	GO:0007254; P:JNK cascade; NAS:UniProtKB
Q15052	ARHGEF6	Rho guanine nucleotide exchange factor 6	GO:0030032; P:lamellipodium assembly; ISS:UniProtKB
Q15052	ARHGEF6	Rho guanine nucleotide exchange factor 6	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q15052	ARHGEF6	Rho guanine nucleotide exchange factor 6	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q15052	ARHGEF6	Rho guanine nucleotide exchange factor 6	GO:0043547; P:positive regulation of GTPase activity; NAS:GOC
Q15052	ARHGEF6	Rho guanine nucleotide exchange factor 6	GO:0032319; P:regulation of Rho GTPase activity; NAS:GOC
Q15052	ARHGEF6	Rho guanine nucleotide exchange factor 6	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q15052	ARHGEF6	Rho guanine nucleotide exchange factor 6	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q14155	ARHGEF7	Rho guanine nucleotide exchange factor 7	GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:BHF-UCL
Q14155	ARHGEF7	Rho guanine nucleotide exchange factor 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q14155	ARHGEF7	Rho guanine nucleotide exchange factor 7	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
Q14155	ARHGEF7	Rho guanine nucleotide exchange factor 7	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q14155	ARHGEF7	Rho guanine nucleotide exchange factor 7	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q14155	ARHGEF7	Rho guanine nucleotide exchange factor 7	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q14155	ARHGEF7	Rho guanine nucleotide exchange factor 7	GO:0030032; P:lamellipodium assembly; ISS:UniProtKB
Q14155	ARHGEF7	Rho guanine nucleotide exchange factor 7	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
Q14155	ARHGEF7	Rho guanine nucleotide exchange factor 7	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q14155	ARHGEF7	Rho guanine nucleotide exchange factor 7	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q14155	ARHGEF7	Rho guanine nucleotide exchange factor 7	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q14155	ARHGEF7	Rho guanine nucleotide exchange factor 7	GO:0043547; P:positive regulation of GTPase activity; IDA:BHF-UCL
Q14155	ARHGEF7	Rho guanine nucleotide exchange factor 7	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q14155	ARHGEF7	Rho guanine nucleotide exchange factor 7	GO:0007165; P:signal transduction; TAS:ProtInc
Q14155	ARHGEF7	Rho guanine nucleotide exchange factor 7	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q7Z628	NET1	Neuroepithelial cell-transforming gene 1 protein	GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:ProtInc
Q7Z628	NET1	Neuroepithelial cell-transforming gene 1 protein	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q7Z628	NET1	Neuroepithelial cell-transforming gene 1 protein	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q7Z628	NET1	Neuroepithelial cell-transforming gene 1 protein	GO:0070301; P:cellular response to hydrogen peroxide; IDA:UniProtKB
Q7Z628	NET1	Neuroepithelial cell-transforming gene 1 protein	GO:0071479; P:cellular response to ionizing radiation; IDA:UniProtKB
Q7Z628	NET1	Neuroepithelial cell-transforming gene 1 protein	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q7Z628	NET1	Neuroepithelial cell-transforming gene 1 protein	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q7Z628	NET1	Neuroepithelial cell-transforming gene 1 protein	GO:0032321; P:positive regulation of Rho GTPase activity; IMP:UniProtKB
Q7Z628	NET1	Neuroepithelial cell-transforming gene 1 protein	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
Q7Z628	NET1	Neuroepithelial cell-transforming gene 1 protein	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q7Z628	NET1	Neuroepithelial cell-transforming gene 1 protein	GO:0007165; P:signal transduction; TAS:ProtInc
Q7Z628	NET1	Neuroepithelial cell-transforming gene 1 protein	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
O43307	ARHGEF9	Rho guanine nucleotide exchange factor 9	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
O43307	ARHGEF9	Rho guanine nucleotide exchange factor 9	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
O43307	ARHGEF9	Rho guanine nucleotide exchange factor 9	GO:0034220; P:ion transmembrane transport; TAS:Reactome
O43307	ARHGEF9	Rho guanine nucleotide exchange factor 9	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O43307	ARHGEF9	Rho guanine nucleotide exchange factor 9	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
O43307	ARHGEF9	Rho guanine nucleotide exchange factor 9	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
O43307	ARHGEF9	Rho guanine nucleotide exchange factor 9	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
O43307	ARHGEF9	Rho guanine nucleotide exchange factor 9	GO:0007268; P:synaptic transmission; TAS:Reactome
O43307	ARHGEF9	Rho guanine nucleotide exchange factor 9	GO:0055085; P:transmembrane transport; TAS:Reactome
O15013	ARHGEF10	Rho guanine nucleotide exchange factor 10	GO:0019894; F:kinesin binding; IPI:BHF-UCL
O15013	ARHGEF10	Rho guanine nucleotide exchange factor 10	GO:0005515; F:protein binding; IPI:IntAct
O15013	ARHGEF10	Rho guanine nucleotide exchange factor 10	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IDA:BHF-UCL
O15013	ARHGEF10	Rho guanine nucleotide exchange factor 10	GO:0051298; P:centrosome duplication; IMP:BHF-UCL
O15013	ARHGEF10	Rho guanine nucleotide exchange factor 10	GO:0022011; P:myelination in peripheral nervous system; IMP:BHF-UCL
O15013	ARHGEF10	Rho guanine nucleotide exchange factor 10	GO:0033126; P:positive regulation of GTP catabolic process; IDA:BHF-UCL
O15013	ARHGEF10	Rho guanine nucleotide exchange factor 10	GO:0051496; P:positive regulation of stress fiber assembly; IMP:BHF-UCL
O15013	ARHGEF10	Rho guanine nucleotide exchange factor 10	GO:0032319; P:regulation of Rho GTPase activity; IDA:GOC
O15013	ARHGEF10	Rho guanine nucleotide exchange factor 10	GO:0090307; P:spindle assembly involved in mitosis; IMP:BHF-UCL
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0001664; F:G-protein coupled receptor binding; IDA:MGI
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0005515; F:protein binding; IPI:IntAct
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; TAS:UniProtKB
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0030036; P:actin cytoskeleton organization; NAS:UniProtKB
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0007411; P:axon guidance; TAS:Reactome
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0006928; P:cellular component movement; NAS:UniProtKB
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0000910; P:cytokinesis; NAS:UniProtKB
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0030010; P:establishment of cell polarity; NAS:UniProtKB
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:UniProtKB
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0032319; P:regulation of Rho GTPase activity; TAS:GOC
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0007266; P:Rho protein signal transduction; IDA:UniProtKB
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0006941; P:striated muscle contraction; NAS:UniProtKB
O15085	ARHGEF11	Rho guanine nucleotide exchange factor 11	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
Q9NZN5	ARHGEF12	Rho guanine nucleotide exchange factor 12	GO:0001664; F:G-protein coupled receptor binding; IDA:MGI
Q9NZN5	ARHGEF12	Rho guanine nucleotide exchange factor 12	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q9NZN5	ARHGEF12	Rho guanine nucleotide exchange factor 12	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NZN5	ARHGEF12	Rho guanine nucleotide exchange factor 12	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q9NZN5	ARHGEF12	Rho guanine nucleotide exchange factor 12	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q9NZN5	ARHGEF12	Rho guanine nucleotide exchange factor 12	GO:0007411; P:axon guidance; TAS:Reactome
Q9NZN5	ARHGEF12	Rho guanine nucleotide exchange factor 12	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:MGI
Q9NZN5	ARHGEF12	Rho guanine nucleotide exchange factor 12	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9NZN5	ARHGEF12	Rho guanine nucleotide exchange factor 12	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q9NZN5	ARHGEF12	Rho guanine nucleotide exchange factor 12	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q9NZN5	ARHGEF12	Rho guanine nucleotide exchange factor 12	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9NZN5	ARHGEF12	Rho guanine nucleotide exchange factor 12	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
O94989	ARHGEF15	Rho guanine nucleotide exchange factor 15	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
O94989	ARHGEF15	Rho guanine nucleotide exchange factor 15	GO:0005515; F:protein binding; IPI:UniProtKB
O94989	ARHGEF15	Rho guanine nucleotide exchange factor 15	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IDA:UniProtKB
O94989	ARHGEF15	Rho guanine nucleotide exchange factor 15	GO:2000297; P:negative regulation of synapse maturation; ISS:UniProtKB
O94989	ARHGEF15	Rho guanine nucleotide exchange factor 15	GO:0051496; P:positive regulation of stress fiber assembly; ISS:UniProtKB
O94989	ARHGEF15	Rho guanine nucleotide exchange factor 15	GO:0050790; P:regulation of catalytic activity; IDA:UniProtKB
O94989	ARHGEF15	Rho guanine nucleotide exchange factor 15	GO:0032319; P:regulation of Rho GTPase activity; IDA:GOC
O94989	ARHGEF15	Rho guanine nucleotide exchange factor 15	GO:0061299; P:retina vasculature morphogenesis in camera-type eye; IEA:Ensembl
Q5VV41	ARHGEF16	Rho guanine nucleotide exchange factor 16	GO:0030165; F:PDZ domain binding; IPI:BHF-UCL
Q5VV41	ARHGEF16	Rho guanine nucleotide exchange factor 16	GO:0005515; F:protein binding; IPI:UniProtKB
Q5VV41	ARHGEF16	Rho guanine nucleotide exchange factor 16	GO:0030971; F:receptor tyrosine kinase binding; IPI:UniProtKB
Q5VV41	ARHGEF16	Rho guanine nucleotide exchange factor 16	GO:0017048; F:Rho GTPase binding; IPI:UniProtKB
Q5VV41	ARHGEF16	Rho guanine nucleotide exchange factor 16	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q5VV41	ARHGEF16	Rho guanine nucleotide exchange factor 16	GO:0032864; P:activation of Cdc42 GTPase activity; IDA:BHF-UCL
Q5VV41	ARHGEF16	Rho guanine nucleotide exchange factor 16	GO:0032863; P:activation of Rac GTPase activity; IMP:UniProtKB
Q5VV41	ARHGEF16	Rho guanine nucleotide exchange factor 16	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q5VV41	ARHGEF16	Rho guanine nucleotide exchange factor 16	GO:0060326; P:cell chemotaxis; IMP:UniProtKB
Q5VV41	ARHGEF16	Rho guanine nucleotide exchange factor 16	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q5VV41	ARHGEF16	Rho guanine nucleotide exchange factor 16	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q5VV41	ARHGEF16	Rho guanine nucleotide exchange factor 16	GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; IMP:UniProtKB
Q5VV41	ARHGEF16	Rho guanine nucleotide exchange factor 16	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q5VV41	ARHGEF16	Rho guanine nucleotide exchange factor 16	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q96PE2	ARHGEF17	Rho guanine nucleotide exchange factor 17	GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:MGI
Q96PE2	ARHGEF17	Rho guanine nucleotide exchange factor 17	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q96PE2	ARHGEF17	Rho guanine nucleotide exchange factor 17	GO:0030036; P:actin cytoskeleton organization; IDA:MGI
Q96PE2	ARHGEF17	Rho guanine nucleotide exchange factor 17	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q96PE2	ARHGEF17	Rho guanine nucleotide exchange factor 17	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q96PE2	ARHGEF17	Rho guanine nucleotide exchange factor 17	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q96PE2	ARHGEF17	Rho guanine nucleotide exchange factor 17	GO:0043087; P:regulation of GTPase activity; IDA:GOC
Q96PE2	ARHGEF17	Rho guanine nucleotide exchange factor 17	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q96PE2	ARHGEF17	Rho guanine nucleotide exchange factor 17	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q6ZSZ5	ARHGEF18	Rho guanine nucleotide exchange factor 18	GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:MGI
Q6ZSZ5	ARHGEF18	Rho guanine nucleotide exchange factor 18	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q6ZSZ5	ARHGEF18	Rho guanine nucleotide exchange factor 18	GO:0030036; P:actin cytoskeleton organization; IDA:MGI
Q6ZSZ5	ARHGEF18	Rho guanine nucleotide exchange factor 18	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q6ZSZ5	ARHGEF18	Rho guanine nucleotide exchange factor 18	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q6ZSZ5	ARHGEF18	Rho guanine nucleotide exchange factor 18	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q6ZSZ5	ARHGEF18	Rho guanine nucleotide exchange factor 18	GO:0008360; P:regulation of cell shape; IDA:MGI
Q6ZSZ5	ARHGEF18	Rho guanine nucleotide exchange factor 18	GO:0043087; P:regulation of GTPase activity; IDA:GOC
Q6ZSZ5	ARHGEF18	Rho guanine nucleotide exchange factor 18	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q6ZSZ5	ARHGEF18	Rho guanine nucleotide exchange factor 18	GO:0007264; P:small GTPase mediated signal transduction; IDA:MGI
Q6ZSZ5	ARHGEF18	Rho guanine nucleotide exchange factor 18	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q8IW93	ARHGEF19	Rho guanine nucleotide exchange factor 19	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q8IW93	ARHGEF19	Rho guanine nucleotide exchange factor 19	GO:0005515; F:protein binding; IPI:IntAct
Q8IW93	ARHGEF19	Rho guanine nucleotide exchange factor 19	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q8IW93	ARHGEF19	Rho guanine nucleotide exchange factor 19	GO:0032321; P:positive regulation of Rho GTPase activity; IEA:Ensembl
Q8IW93	ARHGEF19	Rho guanine nucleotide exchange factor 19	GO:0032956; P:regulation of actin cytoskeleton organization; IGI:MGI
Q8IW93	ARHGEF19	Rho guanine nucleotide exchange factor 19	GO:0042060; P:wound healing; IEA:Ensembl
Q86VW2	ARHGEF25	Rho guanine nucleotide exchange factor 25	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q96DR7	ARHGEF26	Rho guanine nucleotide exchange factor 26	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0035612; F:AP-2 adaptor complex binding; IDA:BHF-UCL
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0001540; F:beta-amyloid binding; IPI:BHF-UCL
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0035615; F:clathrin adaptor activity; IDA:BHF-UCL
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0030276; F:clathrin binding; IDA:UniProtKB
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0050750; F:low-density lipoprotein particle receptor binding; IPI:BHF-UCL
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:BHF-UCL
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0001784; F:phosphotyrosine binding; IDA:UniProtKB
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0030159; F:receptor signaling complex scaffold activity; IMP:UniProtKB
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0035591; F:signaling adaptor activity; IDA:BHF-UCL
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0042982; P:amyloid precursor protein metabolic process; IMP:BHF-UCL
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0042632; P:cholesterol homeostasis; IMP:BHF-UCL
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0008203; P:cholesterol metabolic process; NAS:UniProtKB
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0090205; P:positive regulation of cholesterol metabolic process; IC:BHF-UCL
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0048260; P:positive regulation of receptor-mediated endocytosis; IMP:UniProtKB
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0009967; P:positive regulation of signal transduction; IDA:GOC
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0031623; P:receptor internalization; IMP:BHF-UCL
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0006898; P:receptor-mediated endocytosis; IDA:BHF-UCL
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0090118; P:receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; IMP:BHF-UCL
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0090003; P:regulation of establishment of protein localization to plasma membrane; IMP:BHF-UCL
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0043393; P:regulation of protein binding; IMP:UniProtKB
Q5SW96	LDLRAP1	Low density lipoprotein receptor adapter protein 1	GO:0006810; P:transport; NAS:UniProtKB
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0003677; F:DNA binding; NAS:UniProtKB
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0016922; F:ligand-dependent nuclear receptor binding; IPI:BHF-UCL
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0005515; F:protein binding; IPI:IntAct
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0003713; F:transcription coactivator activity; NAS:BHF-UCL
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0030521; P:androgen receptor signaling pathway; IDA:UniProtKB
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0043044; P:ATP-dependent chromatin remodeling; IEA:Ensembl
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0003205; P:cardiac chamber development; IEA:Ensembl
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0006338; P:chromatin remodeling; IDA:BHF-UCL
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0048096; P:chromatin-mediated maintenance of transcription; TAS:UniProtKB
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0030900; P:forebrain development; IEA:Ensembl
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0042921; P:glucocorticoid receptor signaling pathway; IDA:UniProtKB
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0030520; P:intracellular estrogen receptor signaling pathway; IDA:UniProtKB
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0001843; P:neural tube closure; IEA:Ensembl
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0006337; P:nucleosome disassembly; IDA:BHF-UCL
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0042766; P:nucleosome mobilization; TAS:UniProtKB
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0003408; P:optic cup formation involved in camera-type eye development; IEA:Ensembl
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0060674; P:placenta blood vessel development; IEA:Ensembl
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; NAS:BHF-UCL
O14497	ARID1A	AT-rich interactive domain-containing protein 1A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NDY3	ADPRHL1	[Protein ADP-ribosylarginine] hydrolase-like protein 1	GO:0003875; F:ADP-ribosylarginine hydrolase activity; IEA:InterPro
Q8NDY3	ADPRHL1	[Protein ADP-ribosylarginine] hydrolase-like protein 1	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q8NDY3	ADPRHL1	[Protein ADP-ribosylarginine] hydrolase-like protein 1	GO:0051725; P:protein de-ADP-ribosylation; IEA:InterPro
Q8NFD5	ARID1B	AT-rich interactive domain-containing protein 1B	GO:0003677; F:DNA binding; IDA:GDB
Q8NFD5	ARID1B	AT-rich interactive domain-containing protein 1B	GO:0005515; F:protein binding; IPI:IntAct
Q8NFD5	ARID1B	AT-rich interactive domain-containing protein 1B	GO:0003713; F:transcription coactivator activity; NAS:UniProtKB
Q8NFD5	ARID1B	AT-rich interactive domain-containing protein 1B	GO:0048096; P:chromatin-mediated maintenance of transcription; NAS:UniProtKB
Q8NFD5	ARID1B	AT-rich interactive domain-containing protein 1B	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q8NFD5	ARID1B	AT-rich interactive domain-containing protein 1B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NX46	ADPRHL2	Poly(ADP-ribose) glycohydrolase ARH3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NX46	ADPRHL2	Poly(ADP-ribose) glycohydrolase ARH3	GO:0004649; F:poly(ADP-ribose) glycohydrolase activity; IEA:UniProtKB-EC
Q9Y4X5	ARIH1	E3 ubiquitin-protein ligase ARIH1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y4X5	ARIH1	E3 ubiquitin-protein ligase ARIH1	GO:0019787; F:small conjugating protein ligase activity; TAS:UniProtKB
Q9Y4X5	ARIH1	E3 ubiquitin-protein ligase ARIH1	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q9Y4X5	ARIH1	E3 ubiquitin-protein ligase ARIH1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9Y4X5	ARIH1	E3 ubiquitin-protein ligase ARIH1	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q9Y4X5	ARIH1	E3 ubiquitin-protein ligase ARIH1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q9Y4X5	ARIH1	E3 ubiquitin-protein ligase ARIH1	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q9Y4X5	ARIH1	E3 ubiquitin-protein ligase ARIH1	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:UniProtKB
O95376	ARIH2	E3 ubiquitin-protein ligase ARIH2	GO:0003676; F:nucleic acid binding; IEA:InterPro
O95376	ARIH2	E3 ubiquitin-protein ligase ARIH2	GO:0005515; F:protein binding; IPI:UniProtKB
O95376	ARIH2	E3 ubiquitin-protein ligase ARIH2	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
O95376	ARIH2	E3 ubiquitin-protein ligase ARIH2	GO:0008270; F:zinc ion binding; TAS:ProtInc
O95376	ARIH2	E3 ubiquitin-protein ligase ARIH2	GO:0048588; P:developmental cell growth; IDA:UniProtKB
O95376	ARIH2	E3 ubiquitin-protein ligase ARIH2	GO:0071425; P:hematopoietic stem cell proliferation; IDA:UniProtKB
O95376	ARIH2	E3 ubiquitin-protein ligase ARIH2	GO:0007275; P:multicellular organismal development; TAS:ProtInc
O95376	ARIH2	E3 ubiquitin-protein ligase ARIH2	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
O95376	ARIH2	E3 ubiquitin-protein ligase ARIH2	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
O95376	ARIH2	E3 ubiquitin-protein ligase ARIH2	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
O95376	ARIH2	E3 ubiquitin-protein ligase ARIH2	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q99856	ARID3A	AT-rich interactive domain-containing protein 3A	GO:0003682; F:chromatin binding; IEA:Ensembl
Q99856	ARID3A	AT-rich interactive domain-containing protein 3A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q99856	ARID3A	AT-rich interactive domain-containing protein 3A	GO:0005515; F:protein binding; IPI:IntAct
Q99856	ARID3A	AT-rich interactive domain-containing protein 3A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q99856	ARID3A	AT-rich interactive domain-containing protein 3A	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q99856	ARID3A	AT-rich interactive domain-containing protein 3A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IVW6	ARID3B	AT-rich interactive domain-containing protein 3B	GO:0003677; F:DNA binding; NAS:UniProtKB
Q8IVW6	ARID3B	AT-rich interactive domain-containing protein 3B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8IVW6	ARID3B	AT-rich interactive domain-containing protein 3B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A6NKF2	ARID3C	AT-rich interactive domain-containing protein 3C	GO:0003682; F:chromatin binding; IEA:Ensembl
A6NKF2	ARID3C	AT-rich interactive domain-containing protein 3C	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A6NKF2	ARID3C	AT-rich interactive domain-containing protein 3C	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
A6NKF2	ARID3C	AT-rich interactive domain-containing protein 3C	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P29374	ARID4A	AT-rich interactive domain-containing protein 4A	GO:0003677; F:DNA binding; IDA:GDB
P29374	ARID4A	AT-rich interactive domain-containing protein 4A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P29374	ARID4A	AT-rich interactive domain-containing protein 4A	GO:0048821; P:erythrocyte development; IEA:Ensembl
P29374	ARID4A	AT-rich interactive domain-containing protein 4A	GO:0080182; P:histone H3-K4 trimethylation; IEA:Ensembl
P29374	ARID4A	AT-rich interactive domain-containing protein 4A	GO:0036124; P:histone H3-K9 trimethylation; IEA:Ensembl
P29374	ARID4A	AT-rich interactive domain-containing protein 4A	GO:0034773; P:histone H4-K20 trimethylation; IEA:Ensembl
P29374	ARID4A	AT-rich interactive domain-containing protein 4A	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:GDB
P29374	ARID4A	AT-rich interactive domain-containing protein 4A	GO:0006349; P:regulation of gene expression by genetic imprinting; IEA:Ensembl
P29374	ARID4A	AT-rich interactive domain-containing protein 4A	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q4LE39	ARID4B	AT-rich interactive domain-containing protein 4B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q4LE39	ARID4B	AT-rich interactive domain-containing protein 4B	GO:0005515; F:protein binding; IPI:IntAct
Q4LE39	ARID4B	AT-rich interactive domain-containing protein 4B	GO:0036124; P:histone H3-K9 trimethylation; IEA:Ensembl
Q4LE39	ARID4B	AT-rich interactive domain-containing protein 4B	GO:0034773; P:histone H4-K20 trimethylation; IEA:Ensembl
Q4LE39	ARID4B	AT-rich interactive domain-containing protein 4B	GO:0006349; P:regulation of gene expression by genetic imprinting; IEA:Ensembl
Q4LE39	ARID4B	AT-rich interactive domain-containing protein 4B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q4LE39	ARID4B	AT-rich interactive domain-containing protein 4B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q03989	ARID5A	AT-rich interactive domain-containing protein 5A	GO:0003682; F:chromatin binding; IEA:Ensembl
Q03989	ARID5A	AT-rich interactive domain-containing protein 5A	GO:0003677; F:DNA binding; TAS:GDB
Q03989	ARID5A	AT-rich interactive domain-containing protein 5A	GO:0005515; F:protein binding; IPI:IntAct
Q03989	ARID5A	AT-rich interactive domain-containing protein 5A	GO:0002062; P:chondrocyte differentiation; IEA:Ensembl
Q03989	ARID5A	AT-rich interactive domain-containing protein 5A	GO:0045892; P:negative regulation of transcription, DNA-templated; TAS:GDB
Q03989	ARID5A	AT-rich interactive domain-containing protein 5A	GO:0035066; P:positive regulation of histone acetylation; IEA:Ensembl
Q03989	ARID5A	AT-rich interactive domain-containing protein 5A	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q03989	ARID5A	AT-rich interactive domain-containing protein 5A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0003677; F:DNA binding; IDA:GDB
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0005515; F:protein binding; IPI:UniProtKB
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0060612; P:adipose tissue development; ISS:UniProtKB
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0030325; P:adrenal gland development; IEA:Ensembl
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0048468; P:cell development; IEA:Ensembl
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0060325; P:face morphogenesis; IEA:Ensembl
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0045444; P:fat cell differentiation; IEA:Ensembl
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0060613; P:fat pad development; IEA:Ensembl
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0008585; P:female gonad development; IEA:Ensembl
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0010761; P:fibroblast migration; IEA:Ensembl
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0001822; P:kidney development; IEA:Ensembl
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0001889; P:liver development; TAS:UniProtKB
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0008584; P:male gonad development; IEA:Ensembl
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0048644; P:muscle organ morphogenesis; IEA:Ensembl
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0045892; P:negative regulation of transcription, DNA-templated; TAS:GDB
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0060021; P:palate development; IEA:Ensembl
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IEA:Ensembl
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl
Q14865	ARID5B	AT-rich interactive domain-containing protein 5B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q68CP9	ARID2	AT-rich interactive domain-containing protein 2	GO:0003677; F:DNA binding; IDA:GDB
Q68CP9	ARID2	AT-rich interactive domain-containing protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q68CP9	ARID2	AT-rich interactive domain-containing protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q68CP9	ARID2	AT-rich interactive domain-containing protein 2	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q68CP9	ARID2	AT-rich interactive domain-containing protein 2	GO:0006337; P:nucleosome disassembly; IDA:BHF-UCL
Q68CP9	ARID2	AT-rich interactive domain-containing protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q68CP9	ARID2	AT-rich interactive domain-containing protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y4B4	RAD54L2	Helicase ARIP4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y4B4	RAD54L2	Helicase ARIP4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y4B4	RAD54L2	Helicase ARIP4	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q9Y4B4	RAD54L2	Helicase ARIP4	GO:0003712; F:transcription cofactor activity; IEA:Ensembl
O43488	AKR7A2	Aflatoxin B1 aldehyde reductase member 2	GO:0004032; F:alditol:NADP+ 1-oxidoreductase activity; TAS:ProtInc
O43488	AKR7A2	Aflatoxin B1 aldehyde reductase member 2	GO:0009055; F:electron carrier activity; TAS:UniProtKB
O43488	AKR7A2	Aflatoxin B1 aldehyde reductase member 2	GO:0019119; F:phenanthrene-9,10-epoxide hydrolase activity; IDA:UniProtKB
O43488	AKR7A2	Aflatoxin B1 aldehyde reductase member 2	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
O43488	AKR7A2	Aflatoxin B1 aldehyde reductase member 2	GO:0006081; P:cellular aldehyde metabolic process; TAS:ProtInc
O43488	AKR7A2	Aflatoxin B1 aldehyde reductase member 2	GO:0044597; P:daunorubicin metabolic process; IMP:UniProtKB
O43488	AKR7A2	Aflatoxin B1 aldehyde reductase member 2	GO:0044598; P:doxorubicin metabolic process; IMP:UniProtKB
O95154	AKR7A3	Aflatoxin B1 aldehyde reductase member 3	GO:0004032; F:alditol:NADP+ 1-oxidoreductase activity; IEA:Ensembl
O95154	AKR7A3	Aflatoxin B1 aldehyde reductase member 3	GO:0004033; F:aldo-keto reductase (NADP) activity; TAS:ProtInc
O95154	AKR7A3	Aflatoxin B1 aldehyde reductase member 3	GO:0009055; F:electron carrier activity; TAS:UniProtKB
O95154	AKR7A3	Aflatoxin B1 aldehyde reductase member 3	GO:0046223; P:aflatoxin catabolic process; IEA:Ensembl
O95154	AKR7A3	Aflatoxin B1 aldehyde reductase member 3	GO:0006081; P:cellular aldehyde metabolic process; TAS:ProtInc
Q8NHP1	AKR7L	Aflatoxin B1 aldehyde reductase member 4	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q8N8L6	ARL10	ADP-ribosylation factor-like protein 10	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q8N8L6	ARL10	ADP-ribosylation factor-like protein 10	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q969Q4	ARL11	ADP-ribosylation factor-like protein 11	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q969Q4	ARL11	ADP-ribosylation factor-like protein 11	GO:0005515; F:protein binding; IPI:IntAct
Q969Q4	ARL11	ADP-ribosylation factor-like protein 11	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q8N4G2	ARL14	ADP-ribosylation factor-like protein 14	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q8N4G2	ARL14	ADP-ribosylation factor-like protein 14	GO:0005515; F:protein binding; IPI:IntAct
Q8N4G2	ARL14	ADP-ribosylation factor-like protein 14	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9NXU5	ARL15	ADP-ribosylation factor-like protein 15	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9NXU5	ARL15	ADP-ribosylation factor-like protein 15	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q0P5N6	ARL16	ADP-ribosylation factor-like protein 16	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q0P5N6	ARL16	ADP-ribosylation factor-like protein 16	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q8IVW1	ARL17A	ADP-ribosylation factor-like protein 17	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q8IVW1	ARL17A	ADP-ribosylation factor-like protein 17	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8IVW1	ARL17A	ADP-ribosylation factor-like protein 17	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q8IVW1	ARL17A	ADP-ribosylation factor-like protein 17	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
P40616	ARL1	ADP-ribosylation factor-like protein 1	GO:0008047; F:enzyme activator activity; IDA:UniProtKB
P40616	ARL1	ADP-ribosylation factor-like protein 1	GO:0005525; F:GTP binding; IDA:UniProtKB
P40616	ARL1	ADP-ribosylation factor-like protein 1	GO:0003924; F:GTPase activity; IDA:UniProtKB
P40616	ARL1	ADP-ribosylation factor-like protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P40616	ARL1	ADP-ribosylation factor-like protein 1	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P40616	ARL1	ADP-ribosylation factor-like protein 1	GO:0031584; P:activation of phospholipase D activity; IDA:UniProtKB
P40616	ARL1	ADP-ribosylation factor-like protein 1	GO:0007030; P:Golgi organization; ISS:UniProtKB
P40616	ARL1	ADP-ribosylation factor-like protein 1	GO:0048193; P:Golgi vesicle transport; IEA:Ensembl
P40616	ARL1	ADP-ribosylation factor-like protein 1	GO:0006184; P:GTP catabolic process; IDA:UniProtKB
P40616	ARL1	ADP-ribosylation factor-like protein 1	GO:0034067; P:protein localization to Golgi apparatus; IMP:UniProtKB
P40616	ARL1	ADP-ribosylation factor-like protein 1	GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB
P40616	ARL1	ADP-ribosylation factor-like protein 1	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P40616	ARL1	ADP-ribosylation factor-like protein 1	GO:0009404; P:toxin metabolic process; IDA:UniProtKB
P36404	ARL2	ADP-ribosylation factor-like protein 2	GO:0005525; F:GTP binding; IMP:UniProtKB
P36404	ARL2	ADP-ribosylation factor-like protein 2	GO:0003924; F:GTPase activity; IMP:UniProtKB
P36404	ARL2	ADP-ribosylation factor-like protein 2	GO:0005095; F:GTPase inhibitor activity; TAS:ProtInc
P36404	ARL2	ADP-ribosylation factor-like protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
P36404	ARL2	ADP-ribosylation factor-like protein 2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P36404	ARL2	ADP-ribosylation factor-like protein 2	GO:0051297; P:centrosome organization; IMP:UniProtKB
P36404	ARL2	ADP-ribosylation factor-like protein 2	GO:0006184; P:GTP catabolic process; IMP:GOC
P36404	ARL2	ADP-ribosylation factor-like protein 2	GO:0051457; P:maintenance of protein location in nucleus; IDA:UniProtKB
P36404	ARL2	ADP-ribosylation factor-like protein 2	GO:0034260; P:negative regulation of GTPase activity; IDA:UniProtKB
P36404	ARL2	ADP-ribosylation factor-like protein 2	GO:0010811; P:positive regulation of cell-substrate adhesion; ISS:UniProtKB
P36404	ARL2	ADP-ribosylation factor-like protein 2	GO:0031116; P:positive regulation of microtubule polymerization; IDA:UniProtKB
P36404	ARL2	ADP-ribosylation factor-like protein 2	GO:0031113; P:regulation of microtubule polymerization; IMP:UniProtKB
P36404	ARL2	ADP-ribosylation factor-like protein 2	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P36404	ARL2	ADP-ribosylation factor-like protein 2	GO:0070830; P:tight junction assembly; ISS:UniProtKB
P36404	ARL2	ADP-ribosylation factor-like protein 2	GO:0007021; P:tubulin complex assembly; TAS:ProtInc
P36405	ARL3	ADP-ribosylation factor-like protein 3	GO:0019003; F:GDP binding; IDA:UniProtKB
P36405	ARL3	ADP-ribosylation factor-like protein 3	GO:0005525; F:GTP binding; IDA:UniProtKB
P36405	ARL3	ADP-ribosylation factor-like protein 3	GO:0003924; F:GTPase activity; IEA:Ensembl
P36405	ARL3	ADP-ribosylation factor-like protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P36405	ARL3	ADP-ribosylation factor-like protein 3	GO:0008017; F:microtubule binding; IDA:UniProtKB
P36405	ARL3	ADP-ribosylation factor-like protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
P36405	ARL3	ADP-ribosylation factor-like protein 3	GO:0060271; P:cilium morphogenesis; IMP:UniProtKB
P36405	ARL3	ADP-ribosylation factor-like protein 3	GO:0000910; P:cytokinesis; IMP:UniProtKB
P36405	ARL3	ADP-ribosylation factor-like protein 3	GO:0042073; P:intraciliary transport; IEA:Ensembl
P36405	ARL3	ADP-ribosylation factor-like protein 3	GO:0001822; P:kidney development; ISS:UniProtKB
P36405	ARL3	ADP-ribosylation factor-like protein 3	GO:0042461; P:photoreceptor cell development; ISS:UniProtKB
P36405	ARL3	ADP-ribosylation factor-like protein 3	GO:0006892; P:post-Golgi vesicle-mediated transport; IMP:MGI
P36405	ARL3	ADP-ribosylation factor-like protein 3	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P36405	ARL3	ADP-ribosylation factor-like protein 3	GO:0007264; P:small GTPase mediated signal transduction; IDA:UniProtKB
P40617	ARL4A	ADP-ribosylation factor-like protein 4A	GO:0005525; F:GTP binding; IDA:UniProtKB
P40617	ARL4A	ADP-ribosylation factor-like protein 4A	GO:0005515; F:protein binding; IPI:UniProtKB
P40617	ARL4A	ADP-ribosylation factor-like protein 4A	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
P40617	ARL4A	ADP-ribosylation factor-like protein 4A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P56559	ARL4C	ADP-ribosylation factor-like protein 4C	GO:0043014; F:alpha-tubulin binding; IDA:UniProtKB
P56559	ARL4C	ADP-ribosylation factor-like protein 4C	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P56559	ARL4C	ADP-ribosylation factor-like protein 4C	GO:0003924; F:GTPase activity; TAS:ProtInc
P56559	ARL4C	ADP-ribosylation factor-like protein 4C	GO:0005515; F:protein binding; IPI:UniProtKB
P56559	ARL4C	ADP-ribosylation factor-like protein 4C	GO:0032456; P:endocytic recycling; IDA:UniProtKB
P56559	ARL4C	ADP-ribosylation factor-like protein 4C	GO:0006184; P:GTP catabolic process; TAS:GOC
P56559	ARL4C	ADP-ribosylation factor-like protein 4C	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P49703	ARL4D	ADP-ribosylation factor-like protein 4D	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P49703	ARL4D	ADP-ribosylation factor-like protein 4D	GO:0003924; F:GTPase activity; TAS:ProtInc
P49703	ARL4D	ADP-ribosylation factor-like protein 4D	GO:0005515; F:protein binding; IPI:UniProtKB
P49703	ARL4D	ADP-ribosylation factor-like protein 4D	GO:0006184; P:GTP catabolic process; TAS:GOC
P49703	ARL4D	ADP-ribosylation factor-like protein 4D	GO:0009306; P:protein secretion; TAS:ProtInc
P49703	ARL4D	ADP-ribosylation factor-like protein 4D	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9Y689	ARL5A	ADP-ribosylation factor-like protein 5A	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9Y689	ARL5A	ADP-ribosylation factor-like protein 5A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q96KC2	ARL5B	ADP-ribosylation factor-like protein 5B	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q96KC2	ARL5B	ADP-ribosylation factor-like protein 5B	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
A6NH57	ARL5C	Putative ADP-ribosylation factor-like protein 5C	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
A6NH57	ARL5C	Putative ADP-ribosylation factor-like protein 5C	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9H0F7	ARL6	ADP-ribosylation factor-like protein 6	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9H0F7	ARL6	ADP-ribosylation factor-like protein 6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H0F7	ARL6	ADP-ribosylation factor-like protein 6	GO:0005543; F:phospholipid binding; ISS:UniProtKB
Q9H0F7	ARL6	ADP-ribosylation factor-like protein 6	GO:0005515; F:protein binding; IPI:IntAct
Q9H0F7	ARL6	ADP-ribosylation factor-like protein 6	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q9H0F7	ARL6	ADP-ribosylation factor-like protein 6	GO:0007368; P:determination of left/right symmetry; ISS:BHF-UCL
Q9H0F7	ARL6	ADP-ribosylation factor-like protein 6	GO:0045444; P:fat cell differentiation; IEA:Ensembl
Q9H0F7	ARL6	ADP-ribosylation factor-like protein 6	GO:0032402; P:melanosome transport; ISS:BHF-UCL
Q9H0F7	ARL6	ADP-ribosylation factor-like protein 6	GO:0051258; P:protein polymerization; ISS:UniProtKB
Q9H0F7	ARL6	ADP-ribosylation factor-like protein 6	GO:0006612; P:protein targeting to membrane; ISS:UniProtKB
Q9H0F7	ARL6	ADP-ribosylation factor-like protein 6	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9H0F7	ARL6	ADP-ribosylation factor-like protein 6	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q9H0F7	ARL6	ADP-ribosylation factor-like protein 6	GO:0016055; P:Wnt signaling pathway; IMP:UniProtKB
Q96BM9	ARL8A	ADP-ribosylation factor-like protein 8A	GO:0043014; F:alpha-tubulin binding; ISS:UniProtKB
Q96BM9	ARL8A	ADP-ribosylation factor-like protein 8A	GO:0048487; F:beta-tubulin binding; ISS:UniProtKB
Q96BM9	ARL8A	ADP-ribosylation factor-like protein 8A	GO:0005525; F:GTP binding; IDA:UniProtKB
Q96BM9	ARL8A	ADP-ribosylation factor-like protein 8A	GO:0003924; F:GTPase activity; NAS:UniProtKB
Q96BM9	ARL8A	ADP-ribosylation factor-like protein 8A	GO:0007059; P:chromosome segregation; ISS:UniProtKB
Q96BM9	ARL8A	ADP-ribosylation factor-like protein 8A	GO:0006184; P:GTP catabolic process; NAS:GOC
Q96BM9	ARL8A	ADP-ribosylation factor-like protein 8A	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q96BM9	ARL8A	ADP-ribosylation factor-like protein 8A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9NVJ2	ARL8B	ADP-ribosylation factor-like protein 8B	GO:0043014; F:alpha-tubulin binding; IDA:UniProtKB
Q9NVJ2	ARL8B	ADP-ribosylation factor-like protein 8B	GO:0048487; F:beta-tubulin binding; IDA:UniProtKB
Q9NVJ2	ARL8B	ADP-ribosylation factor-like protein 8B	GO:0019003; F:GDP binding; IDA:UniProtKB
Q9NVJ2	ARL8B	ADP-ribosylation factor-like protein 8B	GO:0005525; F:GTP binding; IDA:UniProtKB
Q9NVJ2	ARL8B	ADP-ribosylation factor-like protein 8B	GO:0003924; F:GTPase activity; NAS:UniProtKB
Q9NVJ2	ARL8B	ADP-ribosylation factor-like protein 8B	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9NVJ2	ARL8B	ADP-ribosylation factor-like protein 8B	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q9NVJ2	ARL8B	ADP-ribosylation factor-like protein 8B	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q9NVJ2	ARL8B	ADP-ribosylation factor-like protein 8B	GO:0006184; P:GTP catabolic process; NAS:GOC
Q9NVJ2	ARL8B	ADP-ribosylation factor-like protein 8B	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q6T311	ARL9	ADP-ribosylation factor-like protein 9	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q6T311	ARL9	ADP-ribosylation factor-like protein 9	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P04424	ASL	Argininosuccinate lyase	GO:0004056; F:argininosuccinate lyase activity; EXP:Reactome
P04424	ASL	Argininosuccinate lyase	GO:0042450; P:arginine biosynthetic process via ornithine; IEA:InterPro
P04424	ASL	Argininosuccinate lyase	GO:0006527; P:arginine catabolic process; TAS:ProtInc
P04424	ASL	Argininosuccinate lyase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P04424	ASL	Argininosuccinate lyase	GO:0006475; P:internal protein amino acid acetylation; IDA:UniProtKB
P04424	ASL	Argininosuccinate lyase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P04424	ASL	Argininosuccinate lyase	GO:0000050; P:urea cycle; TAS:Reactome
Q8N2F6	ARMC10	Armadillo repeat-containing protein 10	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q9NVT9	ARMC1	Armadillo repeat-containing protein 1	GO:0046872; F:metal ion binding; IEA:InterPro
Q9NVT9	ARMC1	Armadillo repeat-containing protein 1	GO:0030001; P:metal ion transport; IEA:InterPro
Q5T2S8	ARMC4	Armadillo repeat-containing protein 4	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
P0C7Q2	ARMS2	Age-related maculopathy susceptibility protein 2	GO:0001895; P:retina homeostasis; IMP:BHF-UCL
Q9UH62	ARMCX3	Armadillo repeat-containing X-linked protein 3	GO:0034613; P:cellular protein localization; IEA:Ensembl
Q9UH62	ARMCX3	Armadillo repeat-containing X-linked protein 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9HBZ2	ARNT2	Aryl hydrocarbon receptor nuclear translocator 2	GO:0017162; F:aryl hydrocarbon receptor binding; ISS:UniProtKB
Q9HBZ2	ARNT2	Aryl hydrocarbon receptor nuclear translocator 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9HBZ2	ARNT2	Aryl hydrocarbon receptor nuclear translocator 2	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q9HBZ2	ARNT2	Aryl hydrocarbon receptor nuclear translocator 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q9HBZ2	ARNT2	Aryl hydrocarbon receptor nuclear translocator 2	GO:0004871; F:signal transducer activity; IEA:InterPro
Q9HBZ2	ARNT2	Aryl hydrocarbon receptor nuclear translocator 2	GO:0007417; P:central nervous system development; ISS:UniProtKB
Q9HBZ2	ARNT2	Aryl hydrocarbon receptor nuclear translocator 2	GO:0001701; P:in utero embryonic development; ISS:UniProtKB
Q9HBZ2	ARNT2	Aryl hydrocarbon receptor nuclear translocator 2	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q9HBZ2	ARNT2	Aryl hydrocarbon receptor nuclear translocator 2	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q9HBZ2	ARNT2	Aryl hydrocarbon receptor nuclear translocator 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9HBZ2	ARNT2	Aryl hydrocarbon receptor nuclear translocator 2	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q9HBZ2	ARNT2	Aryl hydrocarbon receptor nuclear translocator 2	GO:0006355; P:regulation of transcription, DNA-templated; IDA:MGI
Q9HBZ2	ARNT2	Aryl hydrocarbon receptor nuclear translocator 2	GO:0032355; P:response to estradiol; IEA:Ensembl
Q9HBZ2	ARNT2	Aryl hydrocarbon receptor nuclear translocator 2	GO:0001666; P:response to hypoxia; IDA:UniProtKB
Q9HBZ2	ARNT2	Aryl hydrocarbon receptor nuclear translocator 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0004874; F:aryl hydrocarbon receptor activity; IEA:Ensembl
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0017162; F:aryl hydrocarbon receptor binding; IPI:BHF-UCL
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0035326; F:enhancer binding; IDA:MGI
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0005515; F:protein binding; IPI:IntAct
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0030154; P:cell differentiation; IEA:Ensembl
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0001892; P:embryonic placenta development; IEA:Ensembl
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0042789; P:mRNA transcription from RNA polymerase II promoter; IC:BHF-UCL
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0001938; P:positive regulation of endothelial cell proliferation; IC:BHF-UCL
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0045648; P:positive regulation of erythrocyte differentiation; IC:BHF-UCL
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0045821; P:positive regulation of glycolytic process; IC:BHF-UCL
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0046886; P:positive regulation of hormone biosynthetic process; IDA:BHF-UCL
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0033235; P:positive regulation of protein sumoylation; IEA:Ensembl
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; IC:BHF-UCL
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0010575; P:positive regulation vascular endothelial growth factor production; IDA:BHF-UCL
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0043619; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; IDA:BHF-UCL
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0001666; P:response to hypoxia; IDA:BHF-UCL
P27540	ARNT	Aryl hydrocarbon receptor nuclear translocator	GO:0006351; P:transcription, DNA-templated; TAS:ProtInc
Q86WX3	RPS19BP1	Active regulator of SIRT1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q86WX3	RPS19BP1	Active regulator of SIRT1	GO:0005515; F:protein binding; IPI:IntAct
Q9NZ32	ACTR10	Actin-related protein 10	GO:0007018; P:microtubule-based movement; IEA:Ensembl
P56211	ARPP19	cAMP-regulated phosphoprotein 19	GO:0019212; F:phosphatase inhibitor activity; ISS:UniProtKB
P56211	ARPP19	cAMP-regulated phosphoprotein 19	GO:0015459; F:potassium channel regulator activity; IDA:UniProtKB
P56211	ARPP19	cAMP-regulated phosphoprotein 19	GO:0051721; F:protein phosphatase 2A binding; ISS:UniProtKB
P56211	ARPP19	cAMP-regulated phosphoprotein 19	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
P56211	ARPP19	cAMP-regulated phosphoprotein 19	GO:0008601; F:protein phosphatase type 2A regulator activity; ISS:UniProtKB
P56211	ARPP19	cAMP-regulated phosphoprotein 19	GO:0005102; F:receptor binding; IDA:UniProtKB
P56211	ARPP19	cAMP-regulated phosphoprotein 19	GO:0000086; P:G2/M transition of mitotic cell cycle; IMP:UniProtKB
P56211	ARPP19	cAMP-regulated phosphoprotein 19	GO:0007067; P:mitosis; IMP:UniProtKB
P56211	ARPP19	cAMP-regulated phosphoprotein 19	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P56211	ARPP19	cAMP-regulated phosphoprotein 19	GO:0043086; P:negative regulation of catalytic activity; ISS:GOC
P56211	ARPP19	cAMP-regulated phosphoprotein 19	GO:0045722; P:positive regulation of gluconeogenesis; IDA:UniProtKB
P56211	ARPP19	cAMP-regulated phosphoprotein 19	GO:0046326; P:positive regulation of glucose import; NAS:UniProtKB
P56211	ARPP19	cAMP-regulated phosphoprotein 19	GO:0050790; P:regulation of catalytic activity; ISS:GOC
Q9UBL0	ARPP21	cAMP-regulated phosphoprotein 21	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9UBL0	ARPP21	cAMP-regulated phosphoprotein 21	GO:0034605; P:cellular response to heat; IEA:Ensembl
P61160	ACTR2	Actin-related protein 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P61160	ACTR2	Actin-related protein 2	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
P61160	ACTR2	Actin-related protein 2	GO:0008356; P:asymmetric cell division; IEA:Ensembl
P61160	ACTR2	Actin-related protein 2	GO:0006928; P:cellular component movement; TAS:UniProtKB
P61160	ACTR2	Actin-related protein 2	GO:0016482; P:cytoplasmic transport; IEA:Ensembl
P61160	ACTR2	Actin-related protein 2	GO:0007163; P:establishment or maintenance of cell polarity; IEA:Ensembl
P61160	ACTR2	Actin-related protein 2	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P61160	ACTR2	Actin-related protein 2	GO:0045087; P:innate immune response; TAS:Reactome
P61160	ACTR2	Actin-related protein 2	GO:0033206; P:meiotic cytokinesis; IEA:Ensembl
P61160	ACTR2	Actin-related protein 2	GO:0051653; P:spindle localization; IEA:Ensembl
Q9P1U1	ACTR3B	Actin-related protein 3B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9C0K3	ACTR3C	Actin-related protein 3C	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P61158	ACTR3	Actin-related protein 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P61158	ACTR3	Actin-related protein 3	GO:0005515; F:protein binding; IPI:IntAct
P61158	ACTR3	Actin-related protein 3	GO:0008356; P:asymmetric cell division; IEA:Ensembl
P61158	ACTR3	Actin-related protein 3	GO:0006928; P:cellular component movement; TAS:UniProtKB
P61158	ACTR3	Actin-related protein 3	GO:0060271; P:cilium morphogenesis; IMP:UniProtKB
P61158	ACTR3	Actin-related protein 3	GO:0007163; P:establishment or maintenance of cell polarity; IEA:Ensembl
P61158	ACTR3	Actin-related protein 3	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P61158	ACTR3	Actin-related protein 3	GO:0045087; P:innate immune response; TAS:Reactome
P61158	ACTR3	Actin-related protein 3	GO:0033206; P:meiotic cytokinesis; IEA:Ensembl
P61158	ACTR3	Actin-related protein 3	GO:0030838; P:positive regulation of actin filament polymerization; IEA:Ensembl
P61158	ACTR3	Actin-related protein 3	GO:0050775; P:positive regulation of dendrite morphogenesis; IEA:Ensembl
P61158	ACTR3	Actin-related protein 3	GO:0051491; P:positive regulation of filopodium assembly; IEA:Ensembl
P61158	ACTR3	Actin-related protein 3	GO:0010592; P:positive regulation of lamellipodium assembly; IEA:Ensembl
P61158	ACTR3	Actin-related protein 3	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P61158	ACTR3	Actin-related protein 3	GO:0043519; P:regulation of myosin II filament organization; IEA:Ensembl
P61158	ACTR3	Actin-related protein 3	GO:0046677; P:response to antibiotic; IEA:Ensembl
P61158	ACTR3	Actin-related protein 3	GO:0009743; P:response to carbohydrate; IEA:Ensembl
P61158	ACTR3	Actin-related protein 3	GO:0051653; P:spindle localization; IEA:Ensembl
Q9BPX5	ARPC5L	Actin-related protein 2/3 complex subunit 5-like protein	GO:0030833; P:regulation of actin filament polymerization; IEA:InterPro
Q9H9F9	ACTR5	Actin-related protein 5	GO:0005515; F:protein binding; IPI:IntAct
Q9H9F9	ACTR5	Actin-related protein 5	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q9H9F9	ACTR5	Actin-related protein 5	GO:0006302; P:double-strand break repair; IMP:UniProtKB
Q9H9F9	ACTR5	Actin-related protein 5	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H9F9	ACTR5	Actin-related protein 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H9F9	ACTR5	Actin-related protein 5	GO:0070914; P:UV-damage excision repair; IMP:UniProtKB
Q9GZN1	ACTR6	Actin-related protein 6	GO:0005515; F:protein binding; IPI:IntAct
Q9H981	ACTR8	Actin-related protein 8	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H981	ACTR8	Actin-related protein 8	GO:0005515; F:protein binding; IPI:IntAct
Q9H981	ACTR8	Actin-related protein 8	GO:0006338; P:chromatin remodeling; IEA:InterPro
Q9H981	ACTR8	Actin-related protein 8	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q9H981	ACTR8	Actin-related protein 8	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q9H981	ACTR8	Actin-related protein 8	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9H981	ACTR8	Actin-related protein 8	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H981	ACTR8	Actin-related protein 8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15144	ARPC2	Actin-related protein 2/3 complex subunit 2	GO:0005515; F:protein binding; IPI:UniProtKB
O15144	ARPC2	Actin-related protein 2/3 complex subunit 2	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
O15144	ARPC2	Actin-related protein 2/3 complex subunit 2	GO:0006928; P:cellular component movement; TAS:ProtInc
O15144	ARPC2	Actin-related protein 2/3 complex subunit 2	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
O15144	ARPC2	Actin-related protein 2/3 complex subunit 2	GO:0045087; P:innate immune response; TAS:Reactome
O15144	ARPC2	Actin-related protein 2/3 complex subunit 2	GO:0030838; P:positive regulation of actin filament polymerization; IEA:Ensembl
O15144	ARPC2	Actin-related protein 2/3 complex subunit 2	GO:0010592; P:positive regulation of lamellipodium assembly; IMP:UniProt
O15144	ARPC2	Actin-related protein 2/3 complex subunit 2	GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IEA:Ensembl
O15145	ARPC3	Actin-related protein 2/3 complex subunit 3	GO:0005515; F:protein binding; IPI:UniProtKB
O15145	ARPC3	Actin-related protein 2/3 complex subunit 3	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
O15145	ARPC3	Actin-related protein 2/3 complex subunit 3	GO:0034314; P:Arp2/3 complex-mediated actin nucleation; IEA:InterPro
O15145	ARPC3	Actin-related protein 2/3 complex subunit 3	GO:0006928; P:cellular component movement; TAS:ProtInc
O15145	ARPC3	Actin-related protein 2/3 complex subunit 3	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
O15145	ARPC3	Actin-related protein 2/3 complex subunit 3	GO:0045087; P:innate immune response; TAS:Reactome
P59998	ARPC4	Actin-related protein 2/3 complex subunit 4	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P59998	ARPC4	Actin-related protein 2/3 complex subunit 4	GO:0005515; F:protein binding; IPI:UniProtKB
P59998	ARPC4	Actin-related protein 2/3 complex subunit 4	GO:0030041; P:actin filament polymerization; IEA:InterPro
P59998	ARPC4	Actin-related protein 2/3 complex subunit 4	GO:0045010; P:actin nucleation; NAS:UniProtKB
P59998	ARPC4	Actin-related protein 2/3 complex subunit 4	GO:0034314; P:Arp2/3 complex-mediated actin nucleation; IEA:InterPro
P59998	ARPC4	Actin-related protein 2/3 complex subunit 4	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P59998	ARPC4	Actin-related protein 2/3 complex subunit 4	GO:0045087; P:innate immune response; TAS:Reactome
O15511	ARPC5	Actin-related protein 2/3 complex subunit 5	GO:0005515; F:protein binding; IPI:UniProtKB
O15511	ARPC5	Actin-related protein 2/3 complex subunit 5	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
O15511	ARPC5	Actin-related protein 2/3 complex subunit 5	GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc
O15511	ARPC5	Actin-related protein 2/3 complex subunit 5	GO:0006928; P:cellular component movement; TAS:ProtInc
O15511	ARPC5	Actin-related protein 2/3 complex subunit 5	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
O15511	ARPC5	Actin-related protein 2/3 complex subunit 5	GO:0045087; P:innate immune response; TAS:Reactome
O15511	ARPC5	Actin-related protein 2/3 complex subunit 5	GO:0030833; P:regulation of actin filament polymerization; IEA:InterPro
Q7Z6K5	ARPIN	Arpin	GO:0033058; P:directional locomotion; IMP:UniProtKB
Q7Z6K5	ARPIN	Arpin	GO:0051126; P:negative regulation of actin nucleation; IDA:UniProtKB
Q7Z6K5	ARPIN	Arpin	GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB
Q7Z6K5	ARPIN	Arpin	GO:2000393; P:negative regulation of lamellipodium morphogenesis; IMP:UniProtKB
P49407	ARRB1	Beta-arrestin-1	GO:0031701; F:angiotensin receptor binding; IPI:UniProtKB
P49407	ARRB1	Beta-arrestin-1	GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IEA:Ensembl
P49407	ARRB1	Beta-arrestin-1	GO:0004857; F:enzyme inhibitor activity; TAS:ProtInc
P49407	ARRB1	Beta-arrestin-1	GO:0005096; F:GTPase activator activity; IMP:UniProtKB
P49407	ARRB1	Beta-arrestin-1	GO:0005159; F:insulin-like growth factor receptor binding; IPI:UniProtKB
P49407	ARRB1	Beta-arrestin-1	GO:0005515; F:protein binding; IPI:UniProtKB
P49407	ARRB1	Beta-arrestin-1	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P49407	ARRB1	Beta-arrestin-1	GO:0044212; F:transcription regulatory region DNA binding; IMP:BHF-UCL
P49407	ARRB1	Beta-arrestin-1	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P49407	ARRB1	Beta-arrestin-1	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
P49407	ARRB1	Beta-arrestin-1	GO:0006309; P:apoptotic DNA fragmentation; IEA:Ensembl
P49407	ARRB1	Beta-arrestin-1	GO:0007596; P:blood coagulation; TAS:Reactome
P49407	ARRB1	Beta-arrestin-1	GO:0042699; P:follicle-stimulating hormone signaling pathway; IEA:Ensembl
P49407	ARRB1	Beta-arrestin-1	GO:0002031; P:G-protein coupled receptor internalization; IMP:UniProtKB
P49407	ARRB1	Beta-arrestin-1	GO:0061024; P:membrane organization; TAS:Reactome
P49407	ARRB1	Beta-arrestin-1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P49407	ARRB1	Beta-arrestin-1	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IEA:Ensembl
P49407	ARRB1	Beta-arrestin-1	GO:0034260; P:negative regulation of GTPase activity; IEA:Ensembl
P49407	ARRB1	Beta-arrestin-1	GO:0032715; P:negative regulation of interleukin-6 production; IDA:UniProtKB
P49407	ARRB1	Beta-arrestin-1	GO:0032717; P:negative regulation of interleukin-8 production; IDA:UniProtKB
P49407	ARRB1	Beta-arrestin-1	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
P49407	ARRB1	Beta-arrestin-1	GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl
P49407	ARRB1	Beta-arrestin-1	GO:0031397; P:negative regulation of protein ubiquitination; IDA:UniProtKB
P49407	ARRB1	Beta-arrestin-1	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P49407	ARRB1	Beta-arrestin-1	GO:0007602; P:phototransduction; IEA:Ensembl
P49407	ARRB1	Beta-arrestin-1	GO:0030168; P:platelet activation; TAS:Reactome
P49407	ARRB1	Beta-arrestin-1	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P49407	ARRB1	Beta-arrestin-1	GO:0043547; P:positive regulation of GTPase activity; IMP:GOC
P49407	ARRB1	Beta-arrestin-1	GO:0035066; P:positive regulation of histone acetylation; IMP:BHF-UCL
P49407	ARRB1	Beta-arrestin-1	GO:0090240; P:positive regulation of histone H4 acetylation; IMP:UniProtKB
P49407	ARRB1	Beta-arrestin-1	GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl
P49407	ARRB1	Beta-arrestin-1	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IEA:Ensembl
P49407	ARRB1	Beta-arrestin-1	GO:0032092; P:positive regulation of protein binding; IEA:Ensembl
P49407	ARRB1	Beta-arrestin-1	GO:0001934; P:positive regulation of protein phosphorylation; IMP:UniProtKB
P49407	ARRB1	Beta-arrestin-1	GO:0031398; P:positive regulation of protein ubiquitination; IEA:Ensembl
P49407	ARRB1	Beta-arrestin-1	GO:0002092; P:positive regulation of receptor internalization; IMP:UniProtKB
P49407	ARRB1	Beta-arrestin-1	GO:0035025; P:positive regulation of Rho protein signal transduction; IMP:UniProtKB
P49407	ARRB1	Beta-arrestin-1	GO:0034393; P:positive regulation of smooth muscle cell apoptotic process; IEA:Ensembl
P49407	ARRB1	Beta-arrestin-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P49407	ARRB1	Beta-arrestin-1	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
P49407	ARRB1	Beta-arrestin-1	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
P49407	ARRB1	Beta-arrestin-1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P49407	ARRB1	Beta-arrestin-1	GO:0016567; P:protein ubiquitination; IMP:UniProtKB
P49407	ARRB1	Beta-arrestin-1	GO:0043149; P:stress fiber assembly; IMP:UniProtKB
P49407	ARRB1	Beta-arrestin-1	GO:0006366; P:transcription from RNA polymerase II promoter; IMP:UniProtKB
P32121	ARRB2	Beta-arrestin-2	GO:0031701; F:angiotensin receptor binding; IPI:UniProtKB
P32121	ARRB2	Beta-arrestin-2	GO:0001664; F:G-protein coupled receptor binding; IPI:UniProtKB
P32121	ARRB2	Beta-arrestin-2	GO:0005515; F:protein binding; IPI:UniProtKB
P32121	ARRB2	Beta-arrestin-2	GO:0032947; F:protein complex scaffold; IDA:BHF-UCL
P32121	ARRB2	Beta-arrestin-2	GO:0005102; F:receptor binding; IPI:UniProtKB
P32121	ARRB2	Beta-arrestin-2	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P32121	ARRB2	Beta-arrestin-2	GO:0007628; P:adult walking behavior; IEA:Ensembl
P32121	ARRB2	Beta-arrestin-2	GO:0006309; P:apoptotic DNA fragmentation; IEA:Ensembl
P32121	ARRB2	Beta-arrestin-2	GO:0007596; P:blood coagulation; TAS:Reactome
P32121	ARRB2	Beta-arrestin-2	GO:0007420; P:brain development; IEA:Ensembl
P32121	ARRB2	Beta-arrestin-2	GO:0060326; P:cell chemotaxis; IMP:UniProtKB
P32121	ARRB2	Beta-arrestin-2	GO:0002032; P:desensitization of G-protein coupled receptor protein signaling pathway by arrestin; IMP:UniProtKB
P32121	ARRB2	Beta-arrestin-2	GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; IEA:Ensembl
P32121	ARRB2	Beta-arrestin-2	GO:0042699; P:follicle-stimulating hormone signaling pathway; IEA:Ensembl
P32121	ARRB2	Beta-arrestin-2	GO:0002031; P:G-protein coupled receptor internalization; IDA:UniProtKB
P32121	ARRB2	Beta-arrestin-2	GO:0034260; P:negative regulation of GTPase activity; IEA:Ensembl
P32121	ARRB2	Beta-arrestin-2	GO:0032691; P:negative regulation of interleukin-1 beta production; IEA:Ensembl
P32121	ARRB2	Beta-arrestin-2	GO:0032695; P:negative regulation of interleukin-12 production; IEA:Ensembl
P32121	ARRB2	Beta-arrestin-2	GO:0032715; P:negative regulation of interleukin-6 production; IEA:Ensembl
P32121	ARRB2	Beta-arrestin-2	GO:0045953; P:negative regulation of natural killer cell mediated cytotoxicity; IMP:UniProtKB
P32121	ARRB2	Beta-arrestin-2	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
P32121	ARRB2	Beta-arrestin-2	GO:0031397; P:negative regulation of protein ubiquitination; IDA:UniProtKB
P32121	ARRB2	Beta-arrestin-2	GO:0034392; P:negative regulation of smooth muscle cell apoptotic process; IEA:Ensembl
P32121	ARRB2	Beta-arrestin-2	GO:0034122; P:negative regulation of toll-like receptor signaling pathway; IEA:Ensembl
P32121	ARRB2	Beta-arrestin-2	GO:0032720; P:negative regulation of tumor necrosis factor production; IEA:Ensembl
P32121	ARRB2	Beta-arrestin-2	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P32121	ARRB2	Beta-arrestin-2	GO:0030168; P:platelet activation; TAS:Reactome
P32121	ARRB2	Beta-arrestin-2	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P32121	ARRB2	Beta-arrestin-2	GO:0051928; P:positive regulation of calcium ion transport; IEA:Ensembl
P32121	ARRB2	Beta-arrestin-2	GO:2000573; P:positive regulation of DNA biosynthetic process; IEA:Ensembl
P32121	ARRB2	Beta-arrestin-2	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P32121	ARRB2	Beta-arrestin-2	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
P32121	ARRB2	Beta-arrestin-2	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
P32121	ARRB2	Beta-arrestin-2	GO:0031398; P:positive regulation of protein ubiquitination; IGI:BHF-UCL
P32121	ARRB2	Beta-arrestin-2	GO:0002092; P:positive regulation of receptor internalization; IMP:UniProtKB
P32121	ARRB2	Beta-arrestin-2	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IEA:Ensembl
P32121	ARRB2	Beta-arrestin-2	GO:0032226; P:positive regulation of synaptic transmission, dopaminergic; IEA:Ensembl
P32121	ARRB2	Beta-arrestin-2	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
P32121	ARRB2	Beta-arrestin-2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P32121	ARRB2	Beta-arrestin-2	GO:0016567; P:protein ubiquitination; IMP:UniProtKB
P32121	ARRB2	Beta-arrestin-2	GO:0031623; P:receptor internalization; IDA:BHF-UCL
P32121	ARRB2	Beta-arrestin-2	GO:0060765; P:regulation of androgen receptor signaling pathway; IDA:BHF-UCL
P32121	ARRB2	Beta-arrestin-2	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
P32121	ARRB2	Beta-arrestin-2	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
P36575	ARR3	Arrestin-C	GO:0005515; F:protein binding; IPI:IntAct
P36575	ARR3	Arrestin-C	GO:0006897; P:endocytosis; IEA:Ensembl
P36575	ARR3	Arrestin-C	GO:0001932; P:regulation of protein phosphorylation; IEA:Ensembl
P36575	ARR3	Arrestin-C	GO:0007165; P:signal transduction; TAS:ProtInc
P36575	ARR3	Arrestin-C	GO:0007601; P:visual perception; TAS:ProtInc
Q8TBH0	ARRDC2	Arrestin domain-containing protein 2	GO:0007165; P:signal transduction; IEA:InterPro
Q96B67	ARRDC3	Arrestin domain-containing protein 3	GO:0031699; F:beta-3 adrenergic receptor binding; IDA:MGI
Q96B67	ARRDC3	Arrestin domain-containing protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q96B67	ARRDC3	Arrestin domain-containing protein 3	GO:0060613; P:fat pad development; IEA:Ensembl
Q96B67	ARRDC3	Arrestin domain-containing protein 3	GO:0031651; P:negative regulation of heat generation; IEA:Ensembl
Q96B67	ARRDC3	Arrestin domain-containing protein 3	GO:0090327; P:negative regulation of locomotion involved in locomotory behavior; IEA:Ensembl
Q96B67	ARRDC3	Arrestin domain-containing protein 3	GO:0044252; P:negative regulation of multicellular organismal metabolic process; IEA:Ensembl
Q96B67	ARRDC3	Arrestin domain-containing protein 3	GO:0071879; P:positive regulation of adrenergic receptor signaling pathway; IEA:Ensembl
Q96B67	ARRDC3	Arrestin domain-containing protein 3	GO:0051443; P:positive regulation of ubiquitin-protein ligase activity; IPI:MGI
Q96B67	ARRDC3	Arrestin domain-containing protein 3	GO:0001659; P:temperature homeostasis; IEA:Ensembl
Q8NCT1	ARRDC4	Arrestin domain-containing protein 4	GO:0051443; P:positive regulation of ubiquitin-protein ligase activity; IPI:MGI
P10523	SAG	S-arrestin	GO:0004864; F:protein phosphatase inhibitor activity; TAS:ProtInc
P10523	SAG	S-arrestin	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P10523	SAG	S-arrestin	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
P10523	SAG	S-arrestin	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P10523	SAG	S-arrestin	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
P10523	SAG	S-arrestin	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
P10523	SAG	S-arrestin	GO:0007601; P:visual perception; IEA:UniProtKB-KW
P15289	ARSA	Arylsulfatase A	GO:0004065; F:arylsulfatase activity; TAS:ProtInc
P15289	ARSA	Arylsulfatase A	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P15289	ARSA	Arylsulfatase A	GO:0004098; F:cerebroside-sulfatase activity; TAS:Reactome
P15289	ARSA	Arylsulfatase A	GO:0008484; F:sulfuric ester hydrolase activity; IDA:MGI
P15289	ARSA	Arylsulfatase A	GO:0006914; P:autophagy; IEA:Ensembl
P15289	ARSA	Arylsulfatase A	GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl
P15289	ARSA	Arylsulfatase A	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P15289	ARSA	Arylsulfatase A	GO:0007417; P:central nervous system development; IEA:Ensembl
P15289	ARSA	Arylsulfatase A	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
P15289	ARSA	Arylsulfatase A	GO:0043687; P:post-translational protein modification; TAS:Reactome
P15289	ARSA	Arylsulfatase A	GO:0043627; P:response to estrogen; IEA:Ensembl
P15289	ARSA	Arylsulfatase A	GO:0045471; P:response to ethanol; IEA:Ensembl
P15289	ARSA	Arylsulfatase A	GO:0051597; P:response to methylmercury; IEA:Ensembl
P15289	ARSA	Arylsulfatase A	GO:0007584; P:response to nutrient; IEA:Ensembl
P15289	ARSA	Arylsulfatase A	GO:0009268; P:response to pH; IEA:Ensembl
P15289	ARSA	Arylsulfatase A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P15289	ARSA	Arylsulfatase A	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
P15848	ARSB	Arylsulfatase B	GO:0004065; F:arylsulfatase activity; TAS:ProtInc
P15848	ARSB	Arylsulfatase B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P15848	ARSB	Arylsulfatase B	GO:0003943; F:N-acetylgalactosamine-4-sulfatase activity; TAS:Reactome
P15848	ARSB	Arylsulfatase B	GO:0006914; P:autophagy; IEA:Ensembl
P15848	ARSB	Arylsulfatase B	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P15848	ARSB	Arylsulfatase B	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P15848	ARSB	Arylsulfatase B	GO:0007417; P:central nervous system development; IEA:Ensembl
P15848	ARSB	Arylsulfatase B	GO:0030207; P:chondroitin sulfate catabolic process; TAS:Reactome
P15848	ARSB	Arylsulfatase B	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
P15848	ARSB	Arylsulfatase B	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P15848	ARSB	Arylsulfatase B	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
P15848	ARSB	Arylsulfatase B	GO:0007041; P:lysosomal transport; TAS:ProtInc
P15848	ARSB	Arylsulfatase B	GO:0007040; P:lysosome organization; TAS:ProtInc
P15848	ARSB	Arylsulfatase B	GO:0043687; P:post-translational protein modification; TAS:Reactome
P15848	ARSB	Arylsulfatase B	GO:0043627; P:response to estrogen; IEA:Ensembl
P15848	ARSB	Arylsulfatase B	GO:0051597; P:response to methylmercury; IEA:Ensembl
P15848	ARSB	Arylsulfatase B	GO:0007584; P:response to nutrient; IEA:Ensembl
P15848	ARSB	Arylsulfatase B	GO:0009268; P:response to pH; IEA:Ensembl
P15848	ARSB	Arylsulfatase B	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P15848	ARSB	Arylsulfatase B	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
P51689	ARSD	Arylsulfatase D	GO:0004065; F:arylsulfatase activity; TAS:ProtInc
P51689	ARSD	Arylsulfatase D	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P51689	ARSD	Arylsulfatase D	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P51689	ARSD	Arylsulfatase D	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
P51689	ARSD	Arylsulfatase D	GO:0043687; P:post-translational protein modification; TAS:Reactome
P51689	ARSD	Arylsulfatase D	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P51689	ARSD	Arylsulfatase D	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
P51690	ARSE	Arylsulfatase E	GO:0004065; F:arylsulfatase activity; TAS:ProtInc
P51690	ARSE	Arylsulfatase E	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P51690	ARSE	Arylsulfatase E	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P51690	ARSE	Arylsulfatase E	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
P51690	ARSE	Arylsulfatase E	GO:0043687; P:post-translational protein modification; TAS:Reactome
P51690	ARSE	Arylsulfatase E	GO:0001501; P:skeletal system development; TAS:ProtInc
P51690	ARSE	Arylsulfatase E	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P51690	ARSE	Arylsulfatase E	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
P54793	ARSF	Arylsulfatase F	GO:0004065; F:arylsulfatase activity; TAS:ProtInc
P54793	ARSF	Arylsulfatase F	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P54793	ARSF	Arylsulfatase F	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P54793	ARSF	Arylsulfatase F	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
P54793	ARSF	Arylsulfatase F	GO:0043687; P:post-translational protein modification; TAS:Reactome
P54793	ARSF	Arylsulfatase F	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P54793	ARSF	Arylsulfatase F	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q96EG1	ARSG	Arylsulfatase G	GO:0004065; F:arylsulfatase activity; IDA:UniProtKB
Q96EG1	ARSG	Arylsulfatase G	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96EG1	ARSG	Arylsulfatase G	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q96EG1	ARSG	Arylsulfatase G	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
Q96EG1	ARSG	Arylsulfatase G	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q96EG1	ARSG	Arylsulfatase G	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96EG1	ARSG	Arylsulfatase G	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q96EG1	ARSG	Arylsulfatase G	GO:0006790; P:sulfur compound metabolic process; IDA:UniProtKB
Q5FYA8	ARSH	Arylsulfatase H	GO:0004065; F:arylsulfatase activity; TAS:HGNC
Q5FYA8	ARSH	Arylsulfatase H	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5FYA8	ARSH	Arylsulfatase H	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q5FYA8	ARSH	Arylsulfatase H	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
Q5FYA8	ARSH	Arylsulfatase H	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q5FYA8	ARSH	Arylsulfatase H	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5FYA8	ARSH	Arylsulfatase H	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q5FYB1	ARSI	Arylsulfatase I	GO:0004065; F:arylsulfatase activity; TAS:HGNC
Q5FYB1	ARSI	Arylsulfatase I	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5FYB1	ARSI	Arylsulfatase I	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q5FYB1	ARSI	Arylsulfatase I	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
Q5FYB1	ARSI	Arylsulfatase I	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q5FYB1	ARSI	Arylsulfatase I	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5FYB1	ARSI	Arylsulfatase I	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q5FYB0	ARSJ	Arylsulfatase J	GO:0004065; F:arylsulfatase activity; TAS:HGNC
Q5FYB0	ARSJ	Arylsulfatase J	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5FYB0	ARSJ	Arylsulfatase J	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q5FYB0	ARSJ	Arylsulfatase J	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
Q5FYB0	ARSJ	Arylsulfatase J	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q5FYB0	ARSJ	Arylsulfatase J	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5FYB0	ARSJ	Arylsulfatase J	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q6UWY0	ARSK	Arylsulfatase K	GO:0004065; F:arylsulfatase activity; TAS:HGNC
Q6UWY0	ARSK	Arylsulfatase K	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6UWY0	ARSK	Arylsulfatase K	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q6UWY0	ARSK	Arylsulfatase K	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
Q6UWY0	ARSK	Arylsulfatase K	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q6UWY0	ARSK	Arylsulfatase K	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6UWY0	ARSK	Arylsulfatase K	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q5T4W7	ARTN	Artemin	GO:0005102; F:receptor binding; TAS:ProtInc
Q5T4W7	ARTN	Artemin	GO:0007411; P:axon guidance; TAS:Reactome
Q5T4W7	ARTN	Artemin	GO:0050930; P:induction of positive chemotaxis; IEA:Ensembl
Q5T4W7	ARTN	Artemin	GO:0097021; P:lymphocyte migration into lymphoid organs; IEA:Ensembl
Q5T4W7	ARTN	Artemin	GO:0007405; P:neuroblast proliferation; TAS:ProtInc
Q5T4W7	ARTN	Artemin	GO:0007422; P:peripheral nervous system development; IEA:Ensembl
Q5T4W7	ARTN	Artemin	GO:0061146; P:Peyer's patch morphogenesis; IEA:Ensembl
Q5T4W7	ARTN	Artemin	GO:0007165; P:signal transduction; TAS:ProtInc
Q9H2C2	ARV1	Protein ARV1	GO:0008206; P:bile acid metabolic process; IEA:Ensembl
Q9H2C2	ARV1	Protein ARV1	GO:0030301; P:cholesterol transport; IEA:Ensembl
Q9H2C2	ARV1	Protein ARV1	GO:0090181; P:regulation of cholesterol metabolic process; IEA:Ensembl
Q9H2C2	ARV1	Protein ARV1	GO:0006665; P:sphingolipid metabolic process; IEA:UniProtKB-KW
O00192	ARVCF	Armadillo repeat protein deleted in velo-cardio-facial syndrome	GO:0005515; F:protein binding; IPI:UniProtKB
O00192	ARVCF	Armadillo repeat protein deleted in velo-cardio-facial syndrome	GO:0016339; P:calcium-dependent cell-cell adhesion; IEA:InterPro
O00192	ARVCF	Armadillo repeat protein deleted in velo-cardio-facial syndrome	GO:0007155; P:cell adhesion; TAS:ProtInc
O00192	ARVCF	Armadillo repeat protein deleted in velo-cardio-facial syndrome	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q96QS3	ARX	Homeobox protein ARX	GO:0003682; F:chromatin binding; IEA:Ensembl
Q96QS3	ARX	Homeobox protein ARX	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q96QS3	ARX	Homeobox protein ARX	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q96QS3	ARX	Homeobox protein ARX	GO:0007411; P:axon guidance; IEA:Ensembl
Q96QS3	ARX	Homeobox protein ARX	GO:0021846; P:cell proliferation in forebrain; IEA:Ensembl
Q96QS3	ARX	Homeobox protein ARX	GO:0021853; P:cerebral cortex GABAergic interneuron migration; IEA:Ensembl
Q96QS3	ARX	Homeobox protein ARX	GO:0021800; P:cerebral cortex tangential migration; IEA:Ensembl
Q96QS3	ARX	Homeobox protein ARX	GO:0021831; P:embryonic olfactory bulb interneuron precursor migration; IEA:Ensembl
Q96QS3	ARX	Homeobox protein ARX	GO:0072148; P:epithelial cell fate commitment; IEA:Ensembl
Q96QS3	ARX	Homeobox protein ARX	GO:0021759; P:globus pallidus development; IEA:Ensembl
Q96QS3	ARX	Homeobox protein ARX	GO:0044241; P:lipid digestion; IEA:Ensembl
Q96QS3	ARX	Homeobox protein ARX	GO:0001764; P:neuron migration; IEA:Ensembl
Q96QS3	ARX	Homeobox protein ARX	GO:0046622; P:positive regulation of organ growth; IEA:Ensembl
Q96QS3	ARX	Homeobox protein ARX	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q96QS3	ARX	Homeobox protein ARX	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P18440	NAT1	Arylamine N-acetyltransferase 1	GO:0004060; F:arylamine N-acetyltransferase activity; TAS:ProtInc
P18440	NAT1	Arylamine N-acetyltransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P18440	NAT1	Arylamine N-acetyltransferase 1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P11245	NAT2	Arylamine N-acetyltransferase 2	GO:0004060; F:arylamine N-acetyltransferase activity; TAS:ProtInc
P11245	NAT2	Arylamine N-acetyltransferase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P11245	NAT2	Arylamine N-acetyltransferase 2	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9HBK9	AS3MT	Arsenite methyltransferase	GO:0030791; F:arsenite methyltransferase activity; ISS:UniProtKB
Q9HBK9	AS3MT	Arsenite methyltransferase	GO:0030792; F:methylarsonite methyltransferase activity; ISS:UniProtKB
Q9HBK9	AS3MT	Arsenite methyltransferase	GO:0018872; P:arsonoacetate metabolic process; ISS:UniProtKB
Q9HBK9	AS3MT	Arsenite methyltransferase	GO:0009404; P:toxin metabolic process; ISS:UniProtKB
P0C7U2	ASAH2C	Putative neutral ceramidase C	GO:0017040; F:ceramidase activity; IEA:UniProtKB-EC
P0C7U2	ASAH2C	Putative neutral ceramidase C	GO:0006665; P:sphingolipid metabolic process; IEA:UniProtKB-KW
Q13510	ASAH1	Acid ceramidase	GO:0003824; F:catalytic activity; TAS:ProtInc
Q13510	ASAH1	Acid ceramidase	GO:0017040; F:ceramidase activity; TAS:Reactome
Q13510	ASAH1	Acid ceramidase	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q13510	ASAH1	Acid ceramidase	GO:0006672; P:ceramide metabolic process; TAS:ProtInc
Q13510	ASAH1	Acid ceramidase	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
Q13510	ASAH1	Acid ceramidase	GO:0030324; P:lung development; IEA:Ensembl
Q13510	ASAH1	Acid ceramidase	GO:0010033; P:response to organic substance; IEA:Ensembl
Q13510	ASAH1	Acid ceramidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q13510	ASAH1	Acid ceramidase	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q9NR71	ASAH2	Neutral ceramidase	GO:0017040; F:ceramidase activity; IEA:UniProtKB-EC
Q9NR71	ASAH2	Neutral ceramidase	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9NR71	ASAH2	Neutral ceramidase	GO:0006672; P:ceramide metabolic process; TAS:ProtInc
Q9NR71	ASAH2	Neutral ceramidase	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
Q9NR71	ASAH2	Neutral ceramidase	GO:0007165; P:signal transduction; TAS:ProtInc
Q9NR71	ASAH2	Neutral ceramidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NR71	ASAH2	Neutral ceramidase	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q9ULH1	ASAP1	Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q9ULH1	ASAP1	Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9ULH1	ASAP1	Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9ULH1	ASAP1	Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1	GO:0060271; P:cilium morphogenesis; IMP:UniProtKB
Q9ULH1	ASAP1	Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
O43150	ASAP2	Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
O43150	ASAP2	Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2	GO:0008047; F:enzyme activator activity; TAS:ProtInc
O43150	ASAP2	Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
O43150	ASAP2	Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
O43150	ASAP2	Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
O43150	ASAP2	Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
Q8TDY4	ASAP3	Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3	GO:0008060; F:ARF GTPase activator activity; IDA:UniProtKB
Q8TDY4	ASAP3	Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TDY4	ASAP3	Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3	GO:0016477; P:cell migration; IMP:UniProtKB
Q8TDY4	ASAP3	Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3	GO:0032850; P:positive regulation of ARF GTPase activity; IDA:UniProtKB
Q8TDY4	ASAP3	Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3	GO:0051492; P:regulation of stress fiber assembly; IMP:UniProtKB
Q8WXI3	ASB10	Ankyrin repeat and SOCS box protein 10	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8WXI3	ASB10	Ankyrin repeat and SOCS box protein 10	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8WXH4	ASB11	Ankyrin repeat and SOCS box protein 11	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8WXH4	ASB11	Ankyrin repeat and SOCS box protein 11	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8WXK4	ASB12	Ankyrin repeat and SOCS box protein 12	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8WXK4	ASB12	Ankyrin repeat and SOCS box protein 12	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
A6NK59	ASB14	Ankyrin repeat and SOCS box protein 14	GO:0035556; P:intracellular signal transduction; IEA:InterPro
A6NK59	ASB14	Ankyrin repeat and SOCS box protein 14	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8WXK3	ASB13	Ankyrin repeat and SOCS box protein 13	GO:0005515; F:protein binding; IPI:IntAct
Q8WXK3	ASB13	Ankyrin repeat and SOCS box protein 13	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8WXK3	ASB13	Ankyrin repeat and SOCS box protein 13	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8WXK1	ASB15	Ankyrin repeat and SOCS box protein 15	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8WXK1	ASB15	Ankyrin repeat and SOCS box protein 15	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q96NS5	ASB16	Ankyrin repeat and SOCS box protein 16	GO:0005515; F:protein binding; IPI:IntAct
Q96NS5	ASB16	Ankyrin repeat and SOCS box protein 16	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q96NS5	ASB16	Ankyrin repeat and SOCS box protein 16	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8WXJ9	ASB17	Ankyrin repeat and SOCS box protein 17	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8WXJ9	ASB17	Ankyrin repeat and SOCS box protein 17	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q6ZVZ8	ASB18	Ankyrin repeat and SOCS box protein 18	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q6ZVZ8	ASB18	Ankyrin repeat and SOCS box protein 18	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9Y576	ASB1	Ankyrin repeat and SOCS box protein 1	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9Y576	ASB1	Ankyrin repeat and SOCS box protein 1	GO:0030539; P:male genitalia development; IEA:Ensembl
Q9Y576	ASB1	Ankyrin repeat and SOCS box protein 1	GO:0042036; P:negative regulation of cytokine biosynthetic process; NAS:UniProtKB
Q9Y576	ASB1	Ankyrin repeat and SOCS box protein 1	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q96Q27	ASB2	Ankyrin repeat and SOCS box protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q96Q27	ASB2	Ankyrin repeat and SOCS box protein 2	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q96Q27	ASB2	Ankyrin repeat and SOCS box protein 2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q96Q27	ASB2	Ankyrin repeat and SOCS box protein 2	GO:0045445; P:myoblast differentiation; IEA:Ensembl
Q96Q27	ASB2	Ankyrin repeat and SOCS box protein 2	GO:0000209; P:protein polyubiquitination; IEA:Ensembl
Q96Q27	ASB2	Ankyrin repeat and SOCS box protein 2	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q96Q27	ASB2	Ankyrin repeat and SOCS box protein 2	GO:0007165; P:signal transduction; TAS:ProtInc
Q96Q27	ASB2	Ankyrin repeat and SOCS box protein 2	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q9Y575	ASB3	Ankyrin repeat and SOCS box protein 3	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9Y575	ASB3	Ankyrin repeat and SOCS box protein 3	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9Y574	ASB4	Ankyrin repeat and SOCS box protein 4	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q9Y574	ASB4	Ankyrin repeat and SOCS box protein 4	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9Y574	ASB4	Ankyrin repeat and SOCS box protein 4	GO:2001214; P:positive regulation of vasculogenesis; ISS:UniProtKB
Q9Y574	ASB4	Ankyrin repeat and SOCS box protein 4	GO:0051865; P:protein autoubiquitination; IEA:Ensembl
Q8WWX0	ASB5	Ankyrin repeat and SOCS box protein 5	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8WWX0	ASB5	Ankyrin repeat and SOCS box protein 5	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9NWX5	ASB6	Ankyrin repeat and SOCS box protein 6	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9NWX5	ASB6	Ankyrin repeat and SOCS box protein 6	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9H672	ASB7	Ankyrin repeat and SOCS box protein 7	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9H672	ASB7	Ankyrin repeat and SOCS box protein 7	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9H765	ASB8	Ankyrin repeat and SOCS box protein 8	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9H765	ASB8	Ankyrin repeat and SOCS box protein 8	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q96DX5	ASB9	Ankyrin repeat and SOCS box protein 9	GO:0005515; F:protein binding; IPI:IntAct
Q96DX5	ASB9	Ankyrin repeat and SOCS box protein 9	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q96DX5	ASB9	Ankyrin repeat and SOCS box protein 9	GO:0045732; P:positive regulation of protein catabolic process; IDA:MGI
Q96DX5	ASB9	Ankyrin repeat and SOCS box protein 9	GO:0016567; P:protein ubiquitination; IDA:MGI
Q8N9N2	ASCC1	Activating signal cointegrator 1 complex subunit 1	GO:0003824; F:catalytic activity; IEA:InterPro
Q8N9N2	ASCC1	Activating signal cointegrator 1 complex subunit 1	GO:0003723; F:RNA binding; IEA:InterPro
Q8N9N2	ASCC1	Activating signal cointegrator 1 complex subunit 1	GO:0006355; P:regulation of transcription, DNA-templated; IDA:MGI
Q8N9N2	ASCC1	Activating signal cointegrator 1 complex subunit 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H1I8	ASCC2	Activating signal cointegrator 1 complex subunit 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H1I8	ASCC2	Activating signal cointegrator 1 complex subunit 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N3C0	ASCC3	Activating signal cointegrator 1 complex subunit 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8N3C0	ASCC3	Activating signal cointegrator 1 complex subunit 3	GO:0043140; F:ATP-dependent 3'-5' DNA helicase activity; IDA:UniProtKB
Q8N3C0	ASCC3	Activating signal cointegrator 1 complex subunit 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8N3C0	ASCC3	Activating signal cointegrator 1 complex subunit 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N3C0	ASCC3	Activating signal cointegrator 1 complex subunit 3	GO:0008283; P:cell proliferation; IMP:UniProtKB
Q8N3C0	ASCC3	Activating signal cointegrator 1 complex subunit 3	GO:0006307; P:DNA dealkylation involved in DNA repair; IDA:UniProtKB
Q8N3C0	ASCC3	Activating signal cointegrator 1 complex subunit 3	GO:0032508; P:DNA duplex unwinding; IDA:UniProtKB
Q8N3C0	ASCC3	Activating signal cointegrator 1 complex subunit 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N3C0	ASCC3	Activating signal cointegrator 1 complex subunit 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P50553	ASCL1	Achaete-scute homolog 1	GO:0043425; F:bHLH transcription factor binding; IPI:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0003677; F:DNA binding; ISS:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0070888; F:E-box binding; IDA:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0005515; F:protein binding; IPI:IntAct
P50553	ASCL1	Achaete-scute homolog 1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0000989; F:transcription factor binding transcription factor activity; ISS:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0061104; P:adrenal chromaffin cell differentiation; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0061103; P:carotid body glomus cell differentiation; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0071259; P:cellular response to magnetism; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0021954; P:central nervous system neuron development; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0021987; P:cerebral cortex development; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0021892; P:cerebral cortex GABAergic interneuron differentiation; IEP:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0021879; P:forebrain neuron differentiation; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0060487; P:lung epithelial cell differentiation; NAS:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0061100; P:lung neuroendocrine cell differentiation; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0050883; P:musculoskeletal movement, spinal reflex action; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0045665; P:negative regulation of neuron differentiation; IDA:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0007400; P:neuroblast fate determination; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0007405; P:neuroblast proliferation; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0022008; P:neurogenesis; IDA:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0048665; P:neuron fate specification; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0001764; P:neuron migration; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0003358; P:noradrenergic neuron development; ISS:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0003359; P:noradrenergic neuron fate commitment; IMP:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0007219; P:Notch signaling pathway; IDA:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0060166; P:olfactory pit development; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0014003; P:oligodendrocyte development; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0045787; P:positive regulation of cell cycle; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:2000179; P:positive regulation of neural precursor cell proliferation; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0050769; P:positive regulation of neurogenesis; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0045747; P:positive regulation of Notch signaling pathway; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0010468; P:regulation of gene expression; ISS:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0060165; P:regulation of timing of subpallium neuron differentiation; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0070849; P:response to epidermal growth factor; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0051593; P:response to folic acid; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0010226; P:response to lithium ion; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0032526; P:response to retinoic acid; IEP:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0021527; P:spinal cord association neuron differentiation; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0021530; P:spinal cord oligodendrocyte cell fate specification; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0061102; P:stomach neuroendocrine cell differentiation; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0060163; P:subpallium neuron fate commitment; IEA:Ensembl
P50553	ASCL1	Achaete-scute homolog 1	GO:0061549; P:sympathetic ganglion development; ISS:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0048485; P:sympathetic nervous system development; NAS:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P50553	ASCL1	Achaete-scute homolog 1	GO:0060579; P:ventral spinal cord interneuron fate commitment; ISS:UniProtKB
P50553	ASCL1	Achaete-scute homolog 1	GO:0021750; P:vestibular nucleus development; IEA:Ensembl
Q99929	ASCL2	Achaete-scute homolog 2	GO:0070888; F:E-box binding; IDA:UniProtKB
Q99929	ASCL2	Achaete-scute homolog 2	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q99929	ASCL2	Achaete-scute homolog 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q99929	ASCL2	Achaete-scute homolog 2	GO:0010626; P:negative regulation of Schwann cell proliferation; IEA:Ensembl
Q99929	ASCL2	Achaete-scute homolog 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q99929	ASCL2	Achaete-scute homolog 2	GO:0001890; P:placenta development; NAS:UniProtKB
Q99929	ASCL2	Achaete-scute homolog 2	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q99929	ASCL2	Achaete-scute homolog 2	GO:0001666; P:response to hypoxia; IEP:UniProtKB
Q99929	ASCL2	Achaete-scute homolog 2	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
Q99929	ASCL2	Achaete-scute homolog 2	GO:0060708; P:spongiotrophoblast differentiation; IEA:Ensembl
Q99929	ASCL2	Achaete-scute homolog 2	GO:0060712; P:spongiotrophoblast layer development; IEP:UniProtKB
Q99929	ASCL2	Achaete-scute homolog 2	GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB
Q9NQ33	ASCL3	Achaete-scute homolog 3	GO:0003677; F:DNA binding; ISS:UniProtKB
Q9NQ33	ASCL3	Achaete-scute homolog 3	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q9NQ33	ASCL3	Achaete-scute homolog 3	GO:0006351; P:transcription, DNA-templated; ISS:UniProtKB
Q7RTU5	ASCL5	Achaete-scute homolog 5	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7RTU5	ASCL5	Achaete-scute homolog 5	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7RTU5	ASCL5	Achaete-scute homolog 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6XD76	ASCL4	Achaete-scute homolog 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6XD76	ASCL4	Achaete-scute homolog 4	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; NAS:UniProtKB
Q6XD76	ASCL4	Achaete-scute homolog 4	GO:0043588; P:skin development; NAS:UniProtKB
Q6XD76	ASCL4	Achaete-scute homolog 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; NAS:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0005515; F:protein binding; IPI:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0042803; F:protein homodimerization activity; IDA:HGNC
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0032090; F:Pyrin domain binding; IPI:HGNC
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; NAS:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0002218; P:activation of innate immune response; IDA:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0006915; P:apoptotic process; TAS:ProtInc
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0071347; P:cellular response to interleukin-1; IDA:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0071222; P:cellular response to lipopolysaccharide; IDA:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0071356; P:cellular response to tumor necrosis factor; IDA:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0050829; P:defense response to Gram-negative bacterium; IMP:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0051607; P:defense response to virus; IDA:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0045087; P:innate immune response; TAS:Reactome
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0032611; P:interleukin-1 beta production; IEA:Ensembl
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IMP:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IMP:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0044351; P:macropinocytosis; ISS:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0001773; P:myeloid dendritic cell activation; IMP:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0002277; P:myeloid dendritic cell activation involved in immune response; ISS:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0032688; P:negative regulation of interferon-beta production; IMP:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0071901; P:negative regulation of protein serine/threonine kinase activity; IDA:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0030838; P:positive regulation of actin filament polymerization; ISS:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0042104; P:positive regulation of activated T cell proliferation; ISS:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0002821; P:positive regulation of adaptive immune response; IMP:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0002588; P:positive regulation of antigen processing and presentation of peptide antigen via MHC class II; ISS:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0090197; P:positive regulation of chemokine secretion; IMP:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:2001056; P:positive regulation of cysteine-type endopeptidase activity; IDA:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:HGNC
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0002230; P:positive regulation of defense response to virus by host; IEA:Ensembl
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IDA:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0032729; P:positive regulation of interferon-gamma production; ISS:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0050718; P:positive regulation of interleukin-1 beta secretion; IDA:HGNC
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:2001181; P:positive regulation of interleukin-10 secretion; IMP:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0032755; P:positive regulation of interleukin-6 production; ISS:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:2000778; P:positive regulation of interleukin-6 secretion; IMP:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:2000484; P:positive regulation of interleukin-8 secretion; IMP:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0046330; P:positive regulation of JNK cascade; IMP:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0050766; P:positive regulation of phagocytosis; ISS:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IDA:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0050870; P:positive regulation of T cell activation; IMP:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:2000406; P:positive regulation of T cell migration; ISS:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0032760; P:positive regulation of tumor necrosis factor production; IMP:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0050727; P:regulation of inflammatory response; IEA:Ensembl
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:2001242; P:regulation of intrinsic apoptotic signaling pathway; IDA:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0031647; P:regulation of protein stability; ISS:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0032314; P:regulation of Rac GTPase activity; IEA:Ensembl
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0010803; P:regulation of tumor necrosis factor-mediated signaling pathway; IMP:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0007165; P:signal transduction; NAS:UniProtKB
Q9ULZ3	PYCARD	Apoptosis-associated speck-like protein containing a CARD	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IDA:HGNC
Q9Y294	ASF1A	Histone chaperone ASF1A	GO:0003682; F:chromatin binding; NAS:UniProtKB
Q9Y294	ASF1A	Histone chaperone ASF1A	GO:0042393; F:histone binding; IDA:MGI
Q9Y294	ASF1A	Histone chaperone ASF1A	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y294	ASF1A	Histone chaperone ASF1A	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q9Y294	ASF1A	Histone chaperone ASF1A	GO:0006281; P:DNA repair; IDA:MGI
Q9Y294	ASF1A	Histone chaperone ASF1A	GO:0006335; P:DNA replication-dependent nucleosome assembly; IDA:UniProt
Q9Y294	ASF1A	Histone chaperone ASF1A	GO:0006336; P:DNA replication-independent nucleosome assembly; IDA:UniProt
Q9Y294	ASF1A	Histone chaperone ASF1A	GO:0042692; P:muscle cell differentiation; IEA:Ensembl
Q9Y294	ASF1A	Histone chaperone ASF1A	GO:0031936; P:negative regulation of chromatin silencing; NAS:UniProtKB
Q9Y294	ASF1A	Histone chaperone ASF1A	GO:0006334; P:nucleosome assembly; IDA:MGI
Q9Y294	ASF1A	Histone chaperone ASF1A	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
Q9Y294	ASF1A	Histone chaperone ASF1A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NVP2	ASF1B	Histone chaperone ASF1B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NVP2	ASF1B	Histone chaperone ASF1B	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9NVP2	ASF1B	Histone chaperone ASF1B	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q9NVP2	ASF1B	Histone chaperone ASF1B	GO:0006335; P:DNA replication-dependent nucleosome assembly; IDA:UniProt
Q9NVP2	ASF1B	Histone chaperone ASF1B	GO:0006336; P:DNA replication-independent nucleosome assembly; IDA:UniProt
Q9NVP2	ASF1B	Histone chaperone ASF1B	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9NVP2	ASF1B	Histone chaperone ASF1B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NVP2	ASF1B	Histone chaperone ASF1B	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q9NVP2	ASF1B	Histone chaperone ASF1B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7L266	ASRGL1	Isoaspartyl peptidase/L-asparaginase	GO:0004067; F:asparaginase activity; IDA:UniProtKB
Q7L266	ASRGL1	Isoaspartyl peptidase/L-asparaginase	GO:0008798; F:beta-aspartyl-peptidase activity; IDA:UniProtKB
Q7L266	ASRGL1	Isoaspartyl peptidase/L-asparaginase	GO:0033345; P:asparagine catabolic process via L-aspartate; IDA:UniProtKB
P07306	ASGR1	Asialoglycoprotein receptor 1	GO:0004873; F:asialoglycoprotein receptor activity; TAS:ProtInc
P07306	ASGR1	Asialoglycoprotein receptor 1	GO:0030246; F:carbohydrate binding; IEA:InterPro
P07306	ASGR1	Asialoglycoprotein receptor 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P07306	ASGR1	Asialoglycoprotein receptor 1	GO:0005515; F:protein binding; IPI:IntAct
P07306	ASGR1	Asialoglycoprotein receptor 1	GO:0031668; P:cellular response to extracellular stimulus; IEA:Ensembl
P07306	ASGR1	Asialoglycoprotein receptor 1	GO:0006898; P:receptor-mediated endocytosis; TAS:ProtInc
P07307	ASGR2	Asialoglycoprotein receptor 2	GO:0004873; F:asialoglycoprotein receptor activity; TAS:UniProtKB
P07307	ASGR2	Asialoglycoprotein receptor 2	GO:0030246; F:carbohydrate binding; IEA:InterPro
P07307	ASGR2	Asialoglycoprotein receptor 2	GO:0005515; F:protein binding; IPI:IntAct
P07307	ASGR2	Asialoglycoprotein receptor 2	GO:0030282; P:bone mineralization; IEA:Ensembl
P07307	ASGR2	Asialoglycoprotein receptor 2	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P07307	ASGR2	Asialoglycoprotein receptor 2	GO:0009100; P:glycoprotein metabolic process; IEA:Ensembl
P07307	ASGR2	Asialoglycoprotein receptor 2	GO:0055088; P:lipid homeostasis; IEA:Ensembl
P07307	ASGR2	Asialoglycoprotein receptor 2	GO:0006898; P:receptor-mediated endocytosis; TAS:GOC
P07307	ASGR2	Asialoglycoprotein receptor 2	GO:0031647; P:regulation of protein stability; IEA:Ensembl
Q9NR48	ASH1L	Histone-lysine N-methyltransferase ASH1L	GO:0003682; F:chromatin binding; IEA:InterPro
Q9NR48	ASH1L	Histone-lysine N-methyltransferase ASH1L	GO:0003677; F:DNA binding; IEA:InterPro
Q9NR48	ASH1L	Histone-lysine N-methyltransferase ASH1L	GO:0018024; F:histone-lysine N-methyltransferase activity; IEA:UniProtKB-EC
Q9NR48	ASH1L	Histone-lysine N-methyltransferase ASH1L	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NR48	ASH1L	Histone-lysine N-methyltransferase ASH1L	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9NR48	ASH1L	Histone-lysine N-methyltransferase ASH1L	GO:0006323; P:DNA packaging; TAS:ProtInc
Q9NR48	ASH1L	Histone-lysine N-methyltransferase ASH1L	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NR48	ASH1L	Histone-lysine N-methyltransferase ASH1L	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9UBL3	ASH2L	Set1/Ash2 histone methyltransferase complex subunit ASH2	GO:0003677; F:DNA binding; IC:UniProtKB
Q9UBL3	ASH2L	Set1/Ash2 histone methyltransferase complex subunit ASH2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UBL3	ASH2L	Set1/Ash2 histone methyltransferase complex subunit ASH2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBL3	ASH2L	Set1/Ash2 histone methyltransferase complex subunit ASH2	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q9UBL3	ASH2L	Set1/Ash2 histone methyltransferase complex subunit ASH2	GO:0006974; P:cellular response to DNA damage stimulus; IDA:MGI
Q9UBL3	ASH2L	Set1/Ash2 histone methyltransferase complex subunit ASH2	GO:0030097; P:hemopoiesis; NAS:UniProtKB
Q9UBL3	ASH2L	Set1/Ash2 histone methyltransferase complex subunit ASH2	GO:0051568; P:histone H3-K4 methylation; IDA:UniProtKB
Q9UBL3	ASH2L	Set1/Ash2 histone methyltransferase complex subunit ASH2	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
Q9UBL3	ASH2L	Set1/Ash2 histone methyltransferase complex subunit ASH2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UBL3	ASH2L	Set1/Ash2 histone methyltransferase complex subunit ASH2	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9UBL3	ASH2L	Set1/Ash2 histone methyltransferase complex subunit ASH2	GO:0043627; P:response to estrogen; IDA:UniProtKB
Q9UBL3	ASH2L	Set1/Ash2 histone methyltransferase complex subunit ASH2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9UBL3	ASH2L	Set1/Ash2 histone methyltransferase complex subunit ASH2	GO:0006351; P:transcription, DNA-templated; NAS:UniProtKB
Q9BVC5	C2orf49	Ashwin	GO:0048598; P:embryonic morphogenesis; IEA:InterPro
P78348	ASIC1	Acid-sensing ion channel 1	GO:0044736; F:acid-sensing ion channel activity; IDA:UniProtKB
P78348	ASIC1	Acid-sensing ion channel 1	GO:0022839; F:ion gated channel activity; IEA:Ensembl
P78348	ASIC1	Acid-sensing ion channel 1	GO:0015280; F:ligand-gated sodium channel activity; TAS:ProtInc
P78348	ASIC1	Acid-sensing ion channel 1	GO:0005515; F:protein binding; IPI:IntAct
P78348	ASIC1	Acid-sensing ion channel 1	GO:0008306; P:associative learning; IEA:Ensembl
P78348	ASIC1	Acid-sensing ion channel 1	GO:0070588; P:calcium ion transmembrane transport; IEA:Ensembl
P78348	ASIC1	Acid-sensing ion channel 1	GO:0071467; P:cellular response to pH; IDA:UniProtKB
P78348	ASIC1	Acid-sensing ion channel 1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P78348	ASIC1	Acid-sensing ion channel 1	GO:0007613; P:memory; IEA:Ensembl
P78348	ASIC1	Acid-sensing ion channel 1	GO:0046929; P:negative regulation of neurotransmitter secretion; IEA:Ensembl
P78348	ASIC1	Acid-sensing ion channel 1	GO:0070207; P:protein homotrimerization; ISS:UniProtKB
P78348	ASIC1	Acid-sensing ion channel 1	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
P78348	ASIC1	Acid-sensing ion channel 1	GO:0001101; P:response to acid; IEA:Ensembl
P78348	ASIC1	Acid-sensing ion channel 1	GO:0009268; P:response to pH; TAS:ProtInc
P78348	ASIC1	Acid-sensing ion channel 1	GO:0050915; P:sensory perception of sour taste; IMP:UniProt
P78348	ASIC1	Acid-sensing ion channel 1	GO:0007165; P:signal transduction; TAS:ProtInc
P78348	ASIC1	Acid-sensing ion channel 1	GO:0035725; P:sodium ion transmembrane transport; IDA:UniProtKB
P78348	ASIC1	Acid-sensing ion channel 1	GO:0006814; P:sodium ion transport; NAS:UniProtKB
P78348	ASIC1	Acid-sensing ion channel 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P78348	ASIC1	Acid-sensing ion channel 1	GO:0006810; P:transport; TAS:ProtInc
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0022839; F:ion gated channel activity; IEA:Ensembl
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0015280; F:ligand-gated sodium channel activity; TAS:ProtInc
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0005515; F:protein binding; IPI:IntAct
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0005248; F:voltage-gated sodium channel activity; IEA:Ensembl
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0007417; P:central nervous system development; TAS:ProtInc
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0050974; P:detection of mechanical stimulus involved in sensory perception; IEA:Ensembl
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0015672; P:monovalent inorganic cation transport; TAS:ProtInc
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0007422; P:peripheral nervous system development; TAS:ProtInc
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0007602; P:phototransduction; IEA:Ensembl
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0051965; P:positive regulation of synapse assembly; IEA:Ensembl
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0035418; P:protein localization to synapse; IEA:Ensembl
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0003026; P:regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback; IEA:Ensembl
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0019229; P:regulation of vasoconstriction; IEA:Ensembl
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0001101; P:response to acid; IEA:Ensembl
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0007605; P:sensory perception of sound; IEA:Ensembl
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0050915; P:sensory perception of sour taste; IMP:UniProt
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q16515	ASIC2	Acid-sensing ion channel 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UHC3	ASIC3	Acid-sensing ion channel 3	GO:0005261; F:cation channel activity; TAS:ProtInc
Q9UHC3	ASIC3	Acid-sensing ion channel 3	GO:0042931; F:enterobactin transporter activity; IEA:Ensembl
Q9UHC3	ASIC3	Acid-sensing ion channel 3	GO:0015280; F:ligand-gated sodium channel activity; IEA:Ensembl
Q9UHC3	ASIC3	Acid-sensing ion channel 3	GO:0005272; F:sodium channel activity; TAS:ProtInc
Q9UHC3	ASIC3	Acid-sensing ion channel 3	GO:0050968; P:detection of chemical stimulus involved in sensory perception of pain; IEA:Ensembl
Q9UHC3	ASIC3	Acid-sensing ion channel 3	GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; IEA:Ensembl
Q9UHC3	ASIC3	Acid-sensing ion channel 3	GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; IEA:Ensembl
Q9UHC3	ASIC3	Acid-sensing ion channel 3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9UHC3	ASIC3	Acid-sensing ion channel 3	GO:0001101; P:response to acid; IEA:Ensembl
Q9UHC3	ASIC3	Acid-sensing ion channel 3	GO:0009408; P:response to heat; IEA:Ensembl
Q9UHC3	ASIC3	Acid-sensing ion channel 3	GO:0007600; P:sensory perception; TAS:ProtInc
Q9UHC3	ASIC3	Acid-sensing ion channel 3	GO:0050915; P:sensory perception of sour taste; IMP:UniProt
Q9UHC3	ASIC3	Acid-sensing ion channel 3	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UHC3	ASIC3	Acid-sensing ion channel 3	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
Q9UHC3	ASIC3	Acid-sensing ion channel 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UHC3	ASIC3	Acid-sensing ion channel 3	GO:0006810; P:transport; TAS:ProtInc
Q96FT7	ASIC4	Acid-sensing ion channel 4	GO:0005216; F:ion channel activity; TAS:ProtInc
Q96FT7	ASIC4	Acid-sensing ion channel 4	GO:0005272; F:sodium channel activity; IEA:UniProtKB-KW
Q96FT7	ASIC4	Acid-sensing ion channel 4	GO:0015081; F:sodium ion transmembrane transporter activity; TAS:ProtInc
Q96FT7	ASIC4	Acid-sensing ion channel 4	GO:0034220; P:ion transmembrane transport; TAS:GOC
Q96FT7	ASIC4	Acid-sensing ion channel 4	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
Q96FT7	ASIC4	Acid-sensing ion channel 4	GO:0006810; P:transport; TAS:ProtInc
Q9NY37	ASIC5	Acid-sensing ion channel 5	GO:0015252; F:hydrogen ion channel activity; IEA:Ensembl
Q9NY37	ASIC5	Acid-sensing ion channel 5	GO:0015280; F:ligand-gated sodium channel activity; IEA:Ensembl
Q9NY37	ASIC5	Acid-sensing ion channel 5	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9NY37	ASIC5	Acid-sensing ion channel 5	GO:0055085; P:transmembrane transport; TAS:Reactome
P42127	ASIP	Agouti-signaling protein	GO:0005102; F:receptor binding; TAS:ProtInc
P42127	ASIP	Agouti-signaling protein	GO:0008343; P:adult feeding behavior; IEA:Ensembl
P42127	ASIP	Agouti-signaling protein	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P42127	ASIP	Agouti-signaling protein	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P42127	ASIP	Agouti-signaling protein	GO:0071514; P:genetic imprinting; IEA:Ensembl
P42127	ASIP	Agouti-signaling protein	GO:0009755; P:hormone-mediated signaling pathway; IEA:InterPro
P42127	ASIP	Agouti-signaling protein	GO:0042438; P:melanin biosynthetic process; IEA:Ensembl
P42127	ASIP	Agouti-signaling protein	GO:0032438; P:melanosome organization; IEA:Ensembl
P42127	ASIP	Agouti-signaling protein	GO:0032402; P:melanosome transport; IEA:Ensembl
P42127	ASIP	Agouti-signaling protein	GO:0040030; P:regulation of molecular function, epigenetic; IEA:Ensembl
P42127	ASIP	Agouti-signaling protein	GO:0007165; P:signal transduction; TAS:ProtInc
Q92484	SMPDL3A	Acid sphingomyelinase-like phosphodiesterase 3a	GO:0016787; F:hydrolase activity; IEA:InterPro
Q92484	SMPDL3A	Acid sphingomyelinase-like phosphodiesterase 3a	GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:UniProtKB-KW
Q92484	SMPDL3A	Acid sphingomyelinase-like phosphodiesterase 3a	GO:0005515; F:protein binding; IPI:UniProtKB
Q92484	SMPDL3A	Acid sphingomyelinase-like phosphodiesterase 3a	GO:0004767; F:sphingomyelin phosphodiesterase activity; IEA:InterPro
Q92484	SMPDL3A	Acid sphingomyelinase-like phosphodiesterase 3a	GO:0006685; P:sphingomyelin catabolic process; IEA:InterPro
Q92485	SMPDL3B	Acid sphingomyelinase-like phosphodiesterase 3b	GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:UniProtKB-KW
Q92485	SMPDL3B	Acid sphingomyelinase-like phosphodiesterase 3b	GO:0004767; F:sphingomyelin phosphodiesterase activity; IEA:InterPro
Q92485	SMPDL3B	Acid sphingomyelinase-like phosphodiesterase 3b	GO:0006685; P:sphingomyelin catabolic process; IEA:InterPro
O95671	ASMTL	N-acetylserotonin O-methyltransferase-like protein	GO:0008171; F:O-methyltransferase activity; IEA:InterPro
P46597	ASMT	Acetylserotonin O-methyltransferase	GO:0017096; F:acetylserotonin O-methyltransferase activity; IDA:UniProtKB
P46597	ASMT	Acetylserotonin O-methyltransferase	GO:0042802; F:identical protein binding; IPI:IntAct
P46597	ASMT	Acetylserotonin O-methyltransferase	GO:0008171; F:O-methyltransferase activity; TAS:ProtInc
P46597	ASMT	Acetylserotonin O-methyltransferase	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P46597	ASMT	Acetylserotonin O-methyltransferase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P46597	ASMT	Acetylserotonin O-methyltransferase	GO:0046219; P:indolalkylamine biosynthetic process; TAS:Reactome
P46597	ASMT	Acetylserotonin O-methyltransferase	GO:0030187; P:melatonin biosynthetic process; IDA:UniProtKB
P46597	ASMT	Acetylserotonin O-methyltransferase	GO:2000019; P:negative regulation of male gonad development; IEA:Ensembl
P46597	ASMT	Acetylserotonin O-methyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P46597	ASMT	Acetylserotonin O-methyltransferase	GO:0006412; P:translation; TAS:ProtInc
P17405	SMPD1	Sphingomyelin phosphodiesterase	GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:UniProtKB-KW
P17405	SMPD1	Sphingomyelin phosphodiesterase	GO:0005515; F:protein binding; IPI:IntAct
P17405	SMPD1	Sphingomyelin phosphodiesterase	GO:0004767; F:sphingomyelin phosphodiesterase activity; TAS:ProtInc
P17405	SMPD1	Sphingomyelin phosphodiesterase	GO:0008219; P:cell death; IEA:UniProtKB-KW
P17405	SMPD1	Sphingomyelin phosphodiesterase	GO:0046513; P:ceramide biosynthetic process; IMP:BHF-UCL
P17405	SMPD1	Sphingomyelin phosphodiesterase	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
P17405	SMPD1	Sphingomyelin phosphodiesterase	GO:0043407; P:negative regulation of MAP kinase activity; IMP:BHF-UCL
P17405	SMPD1	Sphingomyelin phosphodiesterase	GO:0007399; P:nervous system development; TAS:ProtInc
P17405	SMPD1	Sphingomyelin phosphodiesterase	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P17405	SMPD1	Sphingomyelin phosphodiesterase	GO:0035307; P:positive regulation of protein dephosphorylation; IMP:BHF-UCL
P17405	SMPD1	Sphingomyelin phosphodiesterase	GO:0042220; P:response to cocaine; IEA:Ensembl
P17405	SMPD1	Sphingomyelin phosphodiesterase	GO:0042493; P:response to drug; IEA:Ensembl
P17405	SMPD1	Sphingomyelin phosphodiesterase	GO:0007165; P:signal transduction; TAS:ProtInc
P17405	SMPD1	Sphingomyelin phosphodiesterase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P17405	SMPD1	Sphingomyelin phosphodiesterase	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
P17405	SMPD1	Sphingomyelin phosphodiesterase	GO:0006685; P:sphingomyelin catabolic process; IEA:InterPro
P17405	SMPD1	Sphingomyelin phosphodiesterase	GO:0006684; P:sphingomyelin metabolic process; TAS:ProtInc
P17405	SMPD1	Sphingomyelin phosphodiesterase	GO:0023021; P:termination of signal transduction; IMP:BHF-UCL
O43681	ASNA1	ATPase ASNA1	GO:0015105; F:arsenite transmembrane transporter activity; TAS:ProtInc
O43681	ASNA1	ATPase ASNA1	GO:0005524; F:ATP binding; IEA:UniProtKB-HAMAP
O43681	ASNA1	ATPase ASNA1	GO:0016887; F:ATPase activity; IEA:InterPro
O43681	ASNA1	ATPase ASNA1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43681	ASNA1	ATPase ASNA1	GO:0005215; F:transporter activity; TAS:ProtInc
O43681	ASNA1	ATPase ASNA1	GO:0015698; P:inorganic anion transport; TAS:GOC
O43681	ASNA1	ATPase ASNA1	GO:0045048; P:protein insertion into ER membrane; IEA:UniProtKB-HAMAP
O43681	ASNA1	ATPase ASNA1	GO:0006810; P:transport; TAS:ProtInc
Q9NWL6	ASNSD1	Asparagine synthetase domain-containing protein 1	GO:0004066; F:asparagine synthase (glutamine-hydrolyzing) activity; IEA:InterPro
Q9NWL6	ASNSD1	Asparagine synthetase domain-containing protein 1	GO:0006529; P:asparagine biosynthetic process; IEA:UniProtKB-KW
Q9NWL6	ASNSD1	Asparagine synthetase domain-containing protein 1	GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0004066; F:asparagine synthase (glutamine-hydrolyzing) activity; IDA:UniProtKB
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0048037; F:cofactor binding; IEA:Ensembl
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0006529; P:asparagine biosynthetic process; IC:UniProtKB
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0042149; P:cellular response to glucose starvation; IDA:UniProtKB
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0032870; P:cellular response to hormone stimulus; IEA:Ensembl
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0070981; P:L-asparagine biosynthetic process; IEA:UniProtKB-UniPathway
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0001889; P:liver development; IEA:Ensembl
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0045931; P:positive regulation of mitotic cell cycle; IDA:UniProtKB
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0043200; P:response to amino acid; IEA:Ensembl
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0032354; P:response to follicle-stimulating hormone; IEA:Ensembl
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0009416; P:response to light stimulus; IEA:Ensembl
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0031427; P:response to methotrexate; IEA:Ensembl
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0009636; P:response to toxic substance; IEA:Ensembl
P08243	ASNS	Asparagine synthetase [glutamine-hydrolyzing]	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BZE9	ASPSCR1	Tether containing UBX domain for GLUT4	GO:0005515; F:protein binding; IPI:IntAct
Q9BZE9	ASPSCR1	Tether containing UBX domain for GLUT4	GO:0042593; P:glucose homeostasis; IEA:Ensembl
Q9BZE9	ASPSCR1	Tether containing UBX domain for GLUT4	GO:0006886; P:intracellular protein transport; IEA:Ensembl
Q9BZE9	ASPSCR1	Tether containing UBX domain for GLUT4	GO:0061024; P:membrane organization; TAS:Reactome
Q9BZE9	ASPSCR1	Tether containing UBX domain for GLUT4	GO:0046324; P:regulation of glucose import; IEA:Ensembl
A6ND91	ASPDH	Putative L-aspartate dehydrogenase	GO:0033735; F:aspartate dehydrogenase activity; IEA:UniProtKB-EC
A6ND91	ASPDH	Putative L-aspartate dehydrogenase	GO:0050661; F:NADP binding; IEA:InterPro
A6ND91	ASPDH	Putative L-aspartate dehydrogenase	GO:0009435; P:NAD biosynthetic process; IEA:UniProtKB-UniPathway
A6ND91	ASPDH	Putative L-aspartate dehydrogenase	GO:0006742; P:NADP catabolic process; IEA:InterPro
P20933	AGA	N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase	GO:0003948; F:N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; IDA:UniProtKB
P20933	AGA	N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase	GO:0008233; F:peptidase activity; IEA:UniProtKB-KW
P20933	AGA	N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase	GO:0006517; P:protein deglycosylation; IDA:UniProtKB
Q5U4P2	ASPHD1	Aspartate beta-hydroxylase domain-containing protein 1	GO:0051213; F:dioxygenase activity; IEA:UniProtKB-KW
Q5U4P2	ASPHD1	Aspartate beta-hydroxylase domain-containing protein 1	GO:0018193; P:peptidyl-amino acid modification; IEA:InterPro
Q6ICH7	ASPHD2	Aspartate beta-hydroxylase domain-containing protein 2	GO:0051213; F:dioxygenase activity; IEA:UniProtKB-KW
Q6ICH7	ASPHD2	Aspartate beta-hydroxylase domain-containing protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ICH7	ASPHD2	Aspartate beta-hydroxylase domain-containing protein 2	GO:0018193; P:peptidyl-amino acid modification; IEA:InterPro
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0009055; F:electron carrier activity; TAS:UniProtKB
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0044325; F:ion channel binding; TAS:BHF-UCL
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0004597; F:peptide-aspartate beta-dioxygenase activity; TAS:ProtInc
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0005515; F:protein binding; IPI:UniProtKB
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0008307; F:structural constituent of muscle; TAS:ProtInc
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0005198; F:structural molecule activity; TAS:ProtInc
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0097202; P:activation of cysteine-type endopeptidase activity; IDA:BHF-UCL
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0032237; P:activation of store-operated calcium channel activity; IDA:UniProtKB
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0071277; P:cellular response to calcium ion; IDA:UniProtKB
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0005513; P:detection of calcium ion; TAS:BHF-UCL
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0060325; P:face morphogenesis; IEA:Ensembl
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0035108; P:limb morphogenesis; IEA:Ensembl
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0006936; P:muscle contraction; TAS:ProtInc
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0060021; P:palate development; IEA:Ensembl
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0007389; P:pattern specification process; IEA:Ensembl
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0042264; P:peptidyl-aspartic acid hydroxylation; IEA:Ensembl
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0010524; P:positive regulation of calcium ion transport into cytosol; IDA:UniProtKB
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0090316; P:positive regulation of intracellular protein transport; IDA:UniProtKB
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0045862; P:positive regulation of proteolysis; IDA:BHF-UCL
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0060316; P:positive regulation of ryanodine-sensitive calcium-release channel activity; TAS:BHF-UCL
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; ISS:BHF-UCL
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0010649; P:regulation of cell communication by electrical coupling; TAS:BHF-UCL
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0031585; P:regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; IDA:UniProtKB
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:1901879; P:regulation of protein depolymerization; IEA:Ensembl
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0031647; P:regulation of protein stability; IEA:Ensembl
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; TAS:BHF-UCL
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0060314; P:regulation of ryanodine-sensitive calcium-release channel activity; TAS:BHF-UCL
Q12797	ASPH	Aspartyl/asparaginyl beta-hydroxylase	GO:0033198; P:response to ATP; IDA:UniProtKB
Q8IZT6	ASPM	Abnormal spindle-like microcephaly-associated protein	GO:0048589; P:developmental growth; IEA:Ensembl
Q8IZT6	ASPM	Abnormal spindle-like microcephaly-associated protein	GO:0021873; P:forebrain neuroblast division; IEA:Ensembl
Q8IZT6	ASPM	Abnormal spindle-like microcephaly-associated protein	GO:0051661; P:maintenance of centrosome location; IEA:Ensembl
Q8IZT6	ASPM	Abnormal spindle-like microcephaly-associated protein	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q8IZT6	ASPM	Abnormal spindle-like microcephaly-associated protein	GO:0045769; P:negative regulation of asymmetric cell division; IEA:Ensembl
Q8IZT6	ASPM	Abnormal spindle-like microcephaly-associated protein	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
Q8IZT6	ASPM	Abnormal spindle-like microcephaly-associated protein	GO:0001764; P:neuron migration; IEA:Ensembl
Q8IZT6	ASPM	Abnormal spindle-like microcephaly-associated protein	GO:0048477; P:oogenesis; IEA:Ensembl
Q8IZT6	ASPM	Abnormal spindle-like microcephaly-associated protein	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl
Q8IZT6	ASPM	Abnormal spindle-like microcephaly-associated protein	GO:0002052; P:positive regulation of neuroblast proliferation; IEA:Ensembl
Q8IZT6	ASPM	Abnormal spindle-like microcephaly-associated protein	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q9BXN1	ASPN	Asporin	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q9BXN1	ASPN	Asporin	GO:0030282; P:bone mineralization; IDA:UniProtKB
Q9BXN1	ASPN	Asporin	GO:0070171; P:negative regulation of tooth mineralization; ISS:UniProtKB
Q9BXN1	ASPN	Asporin	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
Q96KQ4	PPP1R13B	Apoptosis-stimulating of p53 protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96KQ4	PPP1R13B	Apoptosis-stimulating of p53 protein 1	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IDA:UniProtKB
Q96KQ4	PPP1R13B	Apoptosis-stimulating of p53 protein 1	GO:0045786; P:negative regulation of cell cycle; TAS:UniProtKB
Q13625	TP53BP2	Apoptosis-stimulating of p53 protein 2	GO:0042802; F:identical protein binding; IPI:IntAct
Q13625	TP53BP2	Apoptosis-stimulating of p53 protein 2	GO:0051059; F:NF-kappaB binding; IPI:UniProtKB
Q13625	TP53BP2	Apoptosis-stimulating of p53 protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q13625	TP53BP2	Apoptosis-stimulating of p53 protein 2	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
Q13625	TP53BP2	Apoptosis-stimulating of p53 protein 2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q13625	TP53BP2	Apoptosis-stimulating of p53 protein 2	GO:0007417; P:central nervous system development; IEA:Ensembl
Q13625	TP53BP2	Apoptosis-stimulating of p53 protein 2	GO:0009792; P:embryo development ending in birth or egg hatching; IEA:Ensembl
Q13625	TP53BP2	Apoptosis-stimulating of p53 protein 2	GO:0007507; P:heart development; IEA:Ensembl
Q13625	TP53BP2	Apoptosis-stimulating of p53 protein 2	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IDA:UniProtKB
Q13625	TP53BP2	Apoptosis-stimulating of p53 protein 2	GO:0045786; P:negative regulation of cell cycle; TAS:UniProtKB
Q13625	TP53BP2	Apoptosis-stimulating of p53 protein 2	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
Q13625	TP53BP2	Apoptosis-stimulating of p53 protein 2	GO:0010212; P:response to ionizing radiation; IEA:Ensembl
Q13625	TP53BP2	Apoptosis-stimulating of p53 protein 2	GO:0007165; P:signal transduction; TAS:ProtInc
P26436	ACRV1	Acrosomal protein SP-10	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P00966	ASS1	Argininosuccinate synthase	GO:0004055; F:argininosuccinate synthase activity; EXP:Reactome
P00966	ASS1	Argininosuccinate synthase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P00966	ASS1	Argininosuccinate synthase	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P00966	ASS1	Argininosuccinate synthase	GO:0005515; F:protein binding; IPI:IntAct
P00966	ASS1	Argininosuccinate synthase	GO:0006526; P:arginine biosynthetic process; IEA:UniProtKB-UniPathway
P00966	ASS1	Argininosuccinate synthase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P00966	ASS1	Argininosuccinate synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P00966	ASS1	Argininosuccinate synthase	GO:0000050; P:urea cycle; TAS:Reactome
Q2TB18	ASTE1	Protein asteroid homolog 1	GO:0004518; F:nuclease activity; IEA:InterPro
Q2TB18	ASTE1	Protein asteroid homolog 1	GO:0006281; P:DNA repair; IEA:InterPro
Q6HA08	ASTL	Astacin-like metalloendopeptidase	GO:0070001; F:aspartic-type peptidase activity; ISS:UniProtKB
Q6HA08	ASTL	Astacin-like metalloendopeptidase	GO:0070002; F:glutamic-type peptidase activity; ISS:UniProtKB
Q6HA08	ASTL	Astacin-like metalloendopeptidase	GO:0004222; F:metalloendopeptidase activity; IDA:UniProtKB
Q6HA08	ASTL	Astacin-like metalloendopeptidase	GO:0008233; F:peptidase activity; IDA:MGI
Q6HA08	ASTL	Astacin-like metalloendopeptidase	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6HA08	ASTL	Astacin-like metalloendopeptidase	GO:0007155; P:cell adhesion; ISS:UniProtKB
Q6HA08	ASTL	Astacin-like metalloendopeptidase	GO:0009566; P:fertilization; ISS:UniProtKB
Q6HA08	ASTL	Astacin-like metalloendopeptidase	GO:2000360; P:negative regulation of binding of sperm to zona pellucida; ISS:UniProtKB
Q6HA08	ASTL	Astacin-like metalloendopeptidase	GO:0010954; P:positive regulation of protein processing; ISS:UniProtKB
Q6HA08	ASTL	Astacin-like metalloendopeptidase	GO:0060468; P:prevention of polyspermy; ISS:UniProtKB
Q6HA08	ASTL	Astacin-like metalloendopeptidase	GO:0006508; P:proteolysis; IDA:MGI
O14525	ASTN1	Astrotactin-1	GO:0007626; P:locomotory behavior; IEA:Ensembl
O14525	ASTN1	Astrotactin-1	GO:0007158; P:neuron cell-cell adhesion; IEA:Ensembl
O14525	ASTN1	Astrotactin-1	GO:0001764; P:neuron migration; IEA:Ensembl
O75129	ASTN2	Astrotactin-2	GO:2000009; P:negative regulation of protein localization to cell surface; IEA:Ensembl
Q9NVM9	ASUN	Protein asunder homolog	GO:0005515; F:protein binding; IPI:IntAct
Q9NVM9	ASUN	Protein asunder homolog	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9NVM9	ASUN	Protein asunder homolog	GO:0080154; P:regulation of fertilization; ISS:UniProtKB
Q9NVM9	ASUN	Protein asunder homolog	GO:0007346; P:regulation of mitotic cell cycle; IMP:UniProtKB
Q9NVM9	ASUN	Protein asunder homolog	GO:0030317; P:sperm motility; ISS:UniProtKB
Q8IXJ9	ASXL1	Putative Polycomb group protein ASXL1	GO:0003677; F:DNA binding; IEA:InterPro
Q8IXJ9	ASXL1	Putative Polycomb group protein ASXL1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IXJ9	ASXL1	Putative Polycomb group protein ASXL1	GO:0042975; F:peroxisome proliferator activated receptor binding; ISS:UniProtKB
Q8IXJ9	ASXL1	Putative Polycomb group protein ASXL1	GO:0005515; F:protein binding; IPI:IntAct
Q8IXJ9	ASXL1	Putative Polycomb group protein ASXL1	GO:0042974; F:retinoic acid receptor binding; ISS:UniProtKB
Q8IXJ9	ASXL1	Putative Polycomb group protein ASXL1	GO:0003713; F:transcription coactivator activity; ISS:UniProtKB
Q8IXJ9	ASXL1	Putative Polycomb group protein ASXL1	GO:0003714; F:transcription corepressor activity; ISS:UniProtKB
Q8IXJ9	ASXL1	Putative Polycomb group protein ASXL1	GO:0060348; P:bone development; IEA:Ensembl
Q8IXJ9	ASXL1	Putative Polycomb group protein ASXL1	GO:0035522; P:monoubiquitinated histone H2A deubiquitination; IDA:UniProtKB
Q8IXJ9	ASXL1	Putative Polycomb group protein ASXL1	GO:0045599; P:negative regulation of fat cell differentiation; ISS:UniProtKB
Q8IXJ9	ASXL1	Putative Polycomb group protein ASXL1	GO:0035359; P:negative regulation of peroxisome proliferator activated receptor signaling pathway; ISS:UniProtKB
Q8IXJ9	ASXL1	Putative Polycomb group protein ASXL1	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; ISS:UniProtKB
Q8IXJ9	ASXL1	Putative Polycomb group protein ASXL1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q8IXJ9	ASXL1	Putative Polycomb group protein ASXL1	GO:0048386; P:positive regulation of retinoic acid receptor signaling pathway; ISS:UniProtKB
Q8IXJ9	ASXL1	Putative Polycomb group protein ASXL1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q8IXJ9	ASXL1	Putative Polycomb group protein ASXL1	GO:0032526; P:response to retinoic acid; ISS:UniProtKB
Q8IXJ9	ASXL1	Putative Polycomb group protein ASXL1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q76L83	ASXL2	Putative Polycomb group protein ASXL2	GO:0003677; F:DNA binding; IEA:InterPro
Q76L83	ASXL2	Putative Polycomb group protein ASXL2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q76L83	ASXL2	Putative Polycomb group protein ASXL2	GO:0042975; F:peroxisome proliferator activated receptor binding; IDA:UniProtKB
Q76L83	ASXL2	Putative Polycomb group protein ASXL2	GO:0045600; P:positive regulation of fat cell differentiation; IDA:UniProtKB
Q76L83	ASXL2	Putative Polycomb group protein ASXL2	GO:0035360; P:positive regulation of peroxisome proliferator activated receptor signaling pathway; IDA:UniProtKB
Q76L83	ASXL2	Putative Polycomb group protein ASXL2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q76L83	ASXL2	Putative Polycomb group protein ASXL2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9C0F0	ASXL3	Putative Polycomb group protein ASXL3	GO:0003677; F:DNA binding; IEA:InterPro
Q9C0F0	ASXL3	Putative Polycomb group protein ASXL3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9C0F0	ASXL3	Putative Polycomb group protein ASXL3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9C0F0	ASXL3	Putative Polycomb group protein ASXL3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WWH4	ASZ1	Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1	GO:0004871; F:signal transducer activity; NAS:UniProtKB
Q8WWH4	ASZ1	Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8WWH4	ASZ1	Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1	GO:0043046; P:DNA methylation involved in gamete generation; ISS:UniProtKB
Q8WWH4	ASZ1	Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1	GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW
Q8WWH4	ASZ1	Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1	GO:0007140; P:male meiosis; ISS:UniProtKB
Q8WWH4	ASZ1	Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8WWH4	ASZ1	Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1	GO:0034587; P:piRNA metabolic process; ISS:UniProtKB
Q8WWH4	ASZ1	Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1	GO:0007165; P:signal transduction; NAS:GOC
Q8WWH4	ASZ1	Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1	GO:0007283; P:spermatogenesis; ISS:UniProtKB
O60312	ATP10A	Probable phospholipid-transporting ATPase VA	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O60312	ATP10A	Probable phospholipid-transporting ATPase VA	GO:0019829; F:cation-transporting ATPase activity; IEA:InterPro
O60312	ATP10A	Probable phospholipid-transporting ATPase VA	GO:0000287; F:magnesium ion binding; IEA:InterPro
O60312	ATP10A	Probable phospholipid-transporting ATPase VA	GO:0004012; F:phospholipid-translocating ATPase activity; NAS:UniProtKB
O60312	ATP10A	Probable phospholipid-transporting ATPase VA	GO:0005515; F:protein binding; IPI:UniProtKB
O60312	ATP10A	Probable phospholipid-transporting ATPase VA	GO:0034220; P:ion transmembrane transport; TAS:Reactome
O60312	ATP10A	Probable phospholipid-transporting ATPase VA	GO:0045332; P:phospholipid translocation; NAS:UniProtKB
O60312	ATP10A	Probable phospholipid-transporting ATPase VA	GO:0008360; P:regulation of cell shape; NAS:UniProtKB
O60312	ATP10A	Probable phospholipid-transporting ATPase VA	GO:0055085; P:transmembrane transport; TAS:Reactome
O94823	ATP10B	Probable phospholipid-transporting ATPase VB	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O94823	ATP10B	Probable phospholipid-transporting ATPase VB	GO:0019829; F:cation-transporting ATPase activity; IEA:InterPro
O94823	ATP10B	Probable phospholipid-transporting ATPase VB	GO:0000287; F:magnesium ion binding; IEA:InterPro
O94823	ATP10B	Probable phospholipid-transporting ATPase VB	GO:0004012; F:phospholipid-translocating ATPase activity; IEA:UniProtKB-EC
O94823	ATP10B	Probable phospholipid-transporting ATPase VB	GO:0005515; F:protein binding; IPI:UniProtKB
O94823	ATP10B	Probable phospholipid-transporting ATPase VB	GO:0045332; P:phospholipid translocation; NAS:UniProtKB
Q9P241	ATP10D	Probable phospholipid-transporting ATPase VD	GO:0005524; F:ATP binding; NAS:UniProtKB
Q9P241	ATP10D	Probable phospholipid-transporting ATPase VD	GO:0019829; F:cation-transporting ATPase activity; IEA:InterPro
Q9P241	ATP10D	Probable phospholipid-transporting ATPase VD	GO:0000287; F:magnesium ion binding; NAS:UniProtKB
Q9P241	ATP10D	Probable phospholipid-transporting ATPase VD	GO:0004012; F:phospholipid-translocating ATPase activity; NAS:UniProtKB
Q9P241	ATP10D	Probable phospholipid-transporting ATPase VD	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P241	ATP10D	Probable phospholipid-transporting ATPase VD	GO:0006812; P:cation transport; NAS:UniProtKB
Q9P241	ATP10D	Probable phospholipid-transporting ATPase VD	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9P241	ATP10D	Probable phospholipid-transporting ATPase VD	GO:0045332; P:phospholipid translocation; NAS:UniProtKB
Q9P241	ATP10D	Probable phospholipid-transporting ATPase VD	GO:0055085; P:transmembrane transport; TAS:Reactome
P98196	ATP11A	Probable phospholipid-transporting ATPase IH	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P98196	ATP11A	Probable phospholipid-transporting ATPase IH	GO:0019829; F:cation-transporting ATPase activity; IEA:InterPro
P98196	ATP11A	Probable phospholipid-transporting ATPase IH	GO:0000287; F:magnesium ion binding; IEA:InterPro
P98196	ATP11A	Probable phospholipid-transporting ATPase IH	GO:0004012; F:phospholipid-translocating ATPase activity; IEA:UniProtKB-EC
P98196	ATP11A	Probable phospholipid-transporting ATPase IH	GO:0005515; F:protein binding; IPI:UniProtKB
P98196	ATP11A	Probable phospholipid-transporting ATPase IH	GO:0045332; P:phospholipid translocation; NAS:UniProtKB
Q9Y2G3	ATP11B	Probable phospholipid-transporting ATPase IF	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y2G3	ATP11B	Probable phospholipid-transporting ATPase IF	GO:0019829; F:cation-transporting ATPase activity; IEA:InterPro
Q9Y2G3	ATP11B	Probable phospholipid-transporting ATPase IF	GO:0015075; F:ion transmembrane transporter activity; NAS:UniProtKB
Q9Y2G3	ATP11B	Probable phospholipid-transporting ATPase IF	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q9Y2G3	ATP11B	Probable phospholipid-transporting ATPase IF	GO:0004012; F:phospholipid-translocating ATPase activity; TAS:UniProtKB
Q9Y2G3	ATP11B	Probable phospholipid-transporting ATPase IF	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y2G3	ATP11B	Probable phospholipid-transporting ATPase IF	GO:0015917; P:aminophospholipid transport; TAS:UniProtKB
Q9Y2G3	ATP11B	Probable phospholipid-transporting ATPase IF	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9Y2G3	ATP11B	Probable phospholipid-transporting ATPase IF	GO:0006811; P:ion transport; NAS:UniProtKB
Q9Y2G3	ATP11B	Probable phospholipid-transporting ATPase IF	GO:0045332; P:phospholipid translocation; NAS:UniProtKB
Q9Y2G3	ATP11B	Probable phospholipid-transporting ATPase IF	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8NB49	ATP11C	Probable phospholipid-transporting ATPase IG	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NB49	ATP11C	Probable phospholipid-transporting ATPase IG	GO:0019829; F:cation-transporting ATPase activity; IEA:InterPro
Q8NB49	ATP11C	Probable phospholipid-transporting ATPase IG	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q8NB49	ATP11C	Probable phospholipid-transporting ATPase IG	GO:0004012; F:phospholipid-translocating ATPase activity; IEA:UniProtKB-EC
Q8NB49	ATP11C	Probable phospholipid-transporting ATPase IG	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NB49	ATP11C	Probable phospholipid-transporting ATPase IG	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q8NB49	ATP11C	Probable phospholipid-transporting ATPase IG	GO:0045332; P:phospholipid translocation; NAS:UniProtKB
Q8NB49	ATP11C	Probable phospholipid-transporting ATPase IG	GO:0055085; P:transmembrane transport; TAS:Reactome
P54707	ATP12A	Potassium-transporting ATPase alpha chain 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P54707	ATP12A	Potassium-transporting ATPase alpha chain 2	GO:0008900; F:hydrogen:potassium-exchanging ATPase activity; IEA:UniProtKB-EC
P54707	ATP12A	Potassium-transporting ATPase alpha chain 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P54707	ATP12A	Potassium-transporting ATPase alpha chain 2	GO:0006754; P:ATP biosynthetic process; IEA:InterPro
P54707	ATP12A	Potassium-transporting ATPase alpha chain 2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P54707	ATP12A	Potassium-transporting ATPase alpha chain 2	GO:0055075; P:potassium ion homeostasis; IEA:Ensembl
P54707	ATP12A	Potassium-transporting ATPase alpha chain 2	GO:0006885; P:regulation of pH; IEA:Ensembl
P54707	ATP12A	Potassium-transporting ATPase alpha chain 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9HD20	ATP13A1	Probable cation-transporting ATPase 13A1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9HD20	ATP13A1	Probable cation-transporting ATPase 13A1	GO:0019829; F:cation-transporting ATPase activity; IEA:InterPro
Q9HD20	ATP13A1	Probable cation-transporting ATPase 13A1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NQ11	ATP13A2	Probable cation-transporting ATPase 13A2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NQ11	ATP13A2	Probable cation-transporting ATPase 13A2	GO:0019829; F:cation-transporting ATPase activity; IEA:InterPro
Q9NQ11	ATP13A2	Probable cation-transporting ATPase 13A2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NQ11	ATP13A2	Probable cation-transporting ATPase 13A2	GO:0005515; F:protein binding; IPI:IntAct
Q9NQ11	ATP13A2	Probable cation-transporting ATPase 13A2	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9H7F0	ATP13A3	Probable cation-transporting ATPase 13A3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H7F0	ATP13A3	Probable cation-transporting ATPase 13A3	GO:0019829; F:cation-transporting ATPase activity; IEA:InterPro
Q9H7F0	ATP13A3	Probable cation-transporting ATPase 13A3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q4VNC1	ATP13A4	Probable cation-transporting ATPase 13A4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q4VNC1	ATP13A4	Probable cation-transporting ATPase 13A4	GO:0019829; F:cation-transporting ATPase activity; IEA:InterPro
Q4VNC1	ATP13A4	Probable cation-transporting ATPase 13A4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q4VNC0	ATP13A5	Probable cation-transporting ATPase 13A5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q4VNC0	ATP13A5	Probable cation-transporting ATPase 13A5	GO:0019829; F:cation-transporting ATPase activity; IEA:InterPro
Q4VNC0	ATP13A5	Probable cation-transporting ATPase 13A5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0043531; F:ADP binding; IEA:Ensembl
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0051087; F:chaperone binding; ISS:BHF-UCL
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0030955; F:potassium ion binding; IEA:Ensembl
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0005515; F:protein binding; IPI:UniProtKB
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0031402; F:sodium ion binding; IEA:Ensembl
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0005391; F:sodium:potassium-exchanging ATPase activity; ISS:UniProtKB
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0006754; P:ATP biosynthetic process; IEA:InterPro
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0060081; P:membrane hyperpolarization; IEA:Ensembl
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0031947; P:negative regulation of glucocorticoid biosynthetic process; IEA:Ensembl
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0045822; P:negative regulation of heart contraction; IEA:Ensembl
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0045823; P:positive regulation of heart contraction; IEA:Ensembl
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0045989; P:positive regulation of striated muscle contraction; IEA:Ensembl
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0010107; P:potassium ion import; IEA:Ensembl
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0008217; P:regulation of blood pressure; IEA:Ensembl
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0086004; P:regulation of cardiac muscle cell contraction; IEA:Ensembl
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0002028; P:regulation of sodium ion transport; ISS:UniProtKB
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0002026; P:regulation of the force of heart contraction; IEA:Ensembl
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0042493; P:response to drug; IEA:Ensembl
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0035725; P:sodium ion transmembrane transport; ISS:GOC
P05023	ATP1A1	Sodium/potassium-transporting ATPase subunit alpha-1	GO:0055085; P:transmembrane transport; TAS:Reactome
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0005391; F:sodium:potassium-exchanging ATPase activity; IMP:UniProtKB
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0006754; P:ATP biosynthetic process; IEA:InterPro
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:Ensembl
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0040011; P:locomotion; IEA:Ensembl
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0051481; P:negative regulation of cytosolic calcium ion concentration; IEA:Ensembl
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0045822; P:negative regulation of heart contraction; IEA:Ensembl
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0045988; P:negative regulation of striated muscle contraction; IEA:Ensembl
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0001504; P:neurotransmitter uptake; IEA:Ensembl
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0006813; P:potassium ion transport; NAS:UniProtKB
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0008217; P:regulation of blood pressure; IEA:Ensembl
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0086004; P:regulation of cardiac muscle cell contraction; IEA:Ensembl
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0002087; P:regulation of respiratory gaseous exchange by neurological system process; IEA:Ensembl
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0006940; P:regulation of smooth muscle contraction; IEA:Ensembl
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0006942; P:regulation of striated muscle contraction; NAS:UniProtKB
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0002026; P:regulation of the force of heart contraction; IEA:Ensembl
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0019229; P:regulation of vasoconstriction; IEA:Ensembl
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0035094; P:response to nicotine; IEA:Ensembl
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0035725; P:sodium ion transmembrane transport; IMP:GOC
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0006814; P:sodium ion transport; NAS:UniProtKB
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0055085; P:transmembrane transport; TAS:Reactome
P50993	ATP1A2	Sodium/potassium-transporting ATPase subunit alpha-2	GO:0008542; P:visual learning; IEA:Ensembl
P13637	ATP1A3	Sodium/potassium-transporting ATPase subunit alpha-3	GO:0005524; F:ATP binding; NAS:UniProtKB
P13637	ATP1A3	Sodium/potassium-transporting ATPase subunit alpha-3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P13637	ATP1A3	Sodium/potassium-transporting ATPase subunit alpha-3	GO:0005391; F:sodium:potassium-exchanging ATPase activity; IMP:UniProtKB
P13637	ATP1A3	Sodium/potassium-transporting ATPase subunit alpha-3	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P13637	ATP1A3	Sodium/potassium-transporting ATPase subunit alpha-3	GO:0006754; P:ATP biosynthetic process; IEA:InterPro
P13637	ATP1A3	Sodium/potassium-transporting ATPase subunit alpha-3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P13637	ATP1A3	Sodium/potassium-transporting ATPase subunit alpha-3	GO:0035235; P:ionotropic glutamate receptor signaling pathway; IEA:Ensembl
P13637	ATP1A3	Sodium/potassium-transporting ATPase subunit alpha-3	GO:0007613; P:memory; IEA:Ensembl
P13637	ATP1A3	Sodium/potassium-transporting ATPase subunit alpha-3	GO:0042493; P:response to drug; IEA:Ensembl
P13637	ATP1A3	Sodium/potassium-transporting ATPase subunit alpha-3	GO:0035725; P:sodium ion transmembrane transport; IMP:GOC
P13637	ATP1A3	Sodium/potassium-transporting ATPase subunit alpha-3	GO:0055085; P:transmembrane transport; TAS:Reactome
P13637	ATP1A3	Sodium/potassium-transporting ATPase subunit alpha-3	GO:0008542; P:visual learning; IEA:Ensembl
Q13733	ATP1A4	Sodium/potassium-transporting ATPase subunit alpha-4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13733	ATP1A4	Sodium/potassium-transporting ATPase subunit alpha-4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13733	ATP1A4	Sodium/potassium-transporting ATPase subunit alpha-4	GO:0005391; F:sodium:potassium-exchanging ATPase activity; TAS:UniProtKB
Q13733	ATP1A4	Sodium/potassium-transporting ATPase subunit alpha-4	GO:0006754; P:ATP biosynthetic process; IEA:InterPro
Q13733	ATP1A4	Sodium/potassium-transporting ATPase subunit alpha-4	GO:0015991; P:ATP hydrolysis coupled proton transport; TAS:UniProtKB
Q13733	ATP1A4	Sodium/potassium-transporting ATPase subunit alpha-4	GO:0009566; P:fertilization; IEA:Ensembl
Q13733	ATP1A4	Sodium/potassium-transporting ATPase subunit alpha-4	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q13733	ATP1A4	Sodium/potassium-transporting ATPase subunit alpha-4	GO:0006813; P:potassium ion transport; TAS:UniProtKB
Q13733	ATP1A4	Sodium/potassium-transporting ATPase subunit alpha-4	GO:0030641; P:regulation of cellular pH; IDA:UniProtKB
Q13733	ATP1A4	Sodium/potassium-transporting ATPase subunit alpha-4	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
Q13733	ATP1A4	Sodium/potassium-transporting ATPase subunit alpha-4	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
Q13733	ATP1A4	Sodium/potassium-transporting ATPase subunit alpha-4	GO:0006814; P:sodium ion transport; TAS:UniProtKB
Q13733	ATP1A4	Sodium/potassium-transporting ATPase subunit alpha-4	GO:0030317; P:sperm motility; IDA:UniProtKB
Q13733	ATP1A4	Sodium/potassium-transporting ATPase subunit alpha-4	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q13733	ATP1A4	Sodium/potassium-transporting ATPase subunit alpha-4	GO:0055085; P:transmembrane transport; TAS:Reactome
P14415	ATP1B2	Sodium/potassium-transporting ATPase subunit beta-2	GO:0005515; F:protein binding; IPI:UniProtKB
P14415	ATP1B2	Sodium/potassium-transporting ATPase subunit beta-2	GO:0005391; F:sodium:potassium-exchanging ATPase activity; TAS:ProtInc
P14415	ATP1B2	Sodium/potassium-transporting ATPase subunit beta-2	GO:0007596; P:blood coagulation; TAS:Reactome
P14415	ATP1B2	Sodium/potassium-transporting ATPase subunit beta-2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P14415	ATP1B2	Sodium/potassium-transporting ATPase subunit beta-2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P14415	ATP1B2	Sodium/potassium-transporting ATPase subunit beta-2	GO:0050900; P:leukocyte migration; TAS:Reactome
P14415	ATP1B2	Sodium/potassium-transporting ATPase subunit beta-2	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
P14415	ATP1B2	Sodium/potassium-transporting ATPase subunit beta-2	GO:0055085; P:transmembrane transport; TAS:Reactome
P14415	ATP1B2	Sodium/potassium-transporting ATPase subunit beta-2	GO:0006810; P:transport; TAS:ProtInc
P05026	ATP1B1	Sodium/potassium-transporting ATPase subunit beta-1	GO:0023026; F:MHC class II protein complex binding; IDA:UniProt
P05026	ATP1B1	Sodium/potassium-transporting ATPase subunit beta-1	GO:0005515; F:protein binding; IPI:UniProtKB
P05026	ATP1B1	Sodium/potassium-transporting ATPase subunit beta-1	GO:0005391; F:sodium:potassium-exchanging ATPase activity; TAS:ProtInc
P05026	ATP1B1	Sodium/potassium-transporting ATPase subunit beta-1	GO:0007596; P:blood coagulation; TAS:Reactome
P05026	ATP1B1	Sodium/potassium-transporting ATPase subunit beta-1	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P05026	ATP1B1	Sodium/potassium-transporting ATPase subunit beta-1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P05026	ATP1B1	Sodium/potassium-transporting ATPase subunit beta-1	GO:0050900; P:leukocyte migration; TAS:Reactome
P05026	ATP1B1	Sodium/potassium-transporting ATPase subunit beta-1	GO:0001666; P:response to hypoxia; IEA:Ensembl
P05026	ATP1B1	Sodium/potassium-transporting ATPase subunit beta-1	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
P05026	ATP1B1	Sodium/potassium-transporting ATPase subunit beta-1	GO:0055085; P:transmembrane transport; TAS:Reactome
P05026	ATP1B1	Sodium/potassium-transporting ATPase subunit beta-1	GO:0006810; P:transport; TAS:ProtInc
Q9UN42	ATP1B4	Protein ATP1B4	GO:0015077; F:monovalent inorganic cation transmembrane transporter activity; TAS:ProtInc
Q9UN42	ATP1B4	Protein ATP1B4	GO:0015672; P:monovalent inorganic cation transport; TAS:GOC
Q9UN42	ATP1B4	Protein ATP1B4	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UN42	ATP1B4	Protein ATP1B4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UN42	ATP1B4	Protein ATP1B4	GO:0006810; P:transport; TAS:ProtInc
P54709	ATP1B3	Sodium/potassium-transporting ATPase subunit beta-3	GO:0005391; F:sodium:potassium-exchanging ATPase activity; TAS:ProtInc
P54709	ATP1B3	Sodium/potassium-transporting ATPase subunit beta-3	GO:0007596; P:blood coagulation; TAS:Reactome
P54709	ATP1B3	Sodium/potassium-transporting ATPase subunit beta-3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P54709	ATP1B3	Sodium/potassium-transporting ATPase subunit beta-3	GO:0050900; P:leukocyte migration; TAS:Reactome
P54709	ATP1B3	Sodium/potassium-transporting ATPase subunit beta-3	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
P54709	ATP1B3	Sodium/potassium-transporting ATPase subunit beta-3	GO:0055085; P:transmembrane transport; TAS:Reactome
P54709	ATP1B3	Sodium/potassium-transporting ATPase subunit beta-3	GO:0006810; P:transport; TAS:ProtInc
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0005509; F:calcium ion binding; IMP:UniProtKB
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0005388; F:calcium-transporting ATPase activity; IEA:InterPro
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0046872; F:metal ion binding; IEA:InterPro
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0005515; F:protein binding; IPI:UniProtKB
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0008637; P:apoptotic mitochondrial changes; IMP:BHF-UCL
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0006200; P:ATP catabolic process; ISS:UniProtKB
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0007596; P:blood coagulation; TAS:Reactome
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0070509; P:calcium ion import; IMP:BHF-UCL
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0070588; P:calcium ion transmembrane transport; IDA:GOC
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0006816; P:calcium ion transport; IDA:UniProtKB
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IMP:BHF-UCL
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0051659; P:maintenance of mitochondrion location; IMP:BHF-UCL
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0032471; P:negative regulation of endoplasmic reticulum calcium ion concentration; IMP:BHF-UCL
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0045988; P:negative regulation of striated muscle contraction; IMP:UniProtKB
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0032470; P:positive regulation of endoplasmic reticulum calcium ion concentration; IMP:BHF-UCL
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0031448; P:positive regulation of fast-twitch skeletal muscle fiber contraction; IDA:UniProtKB
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0051561; P:positive regulation of mitochondrial calcium ion concentration; IMP:BHF-UCL
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0006942; P:regulation of striated muscle contraction; IMP:UniProtKB
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0090076; P:relaxation of skeletal muscle; IDA:BHF-UCL
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0034976; P:response to endoplasmic reticulum stress; IMP:BHF-UCL
O14983	ATP2A1	Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0005388; F:calcium-transporting ATPase activity; TAS:ProtInc
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0086039; F:calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential; TAS:BHF-UCL
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0005515; F:protein binding; IPI:IntAct
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0044548; F:S100 protein binding; IPI:UniProtKB
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0007596; P:blood coagulation; TAS:Reactome
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0070588; P:calcium ion transmembrane transport; TAS:GOC
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0007155; P:cell adhesion; TAS:ProtInc
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0006874; P:cellular calcium ion homeostasis; TAS:BHF-UCL
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0008544; P:epidermis development; TAS:ProtInc
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0006984; P:ER-nucleus signaling pathway; IEA:Ensembl
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0045822; P:negative regulation of heart contraction; IEA:Ensembl
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0010460; P:positive regulation of heart rate; TAS:BHF-UCL
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0086036; P:regulation of cardiac muscle cell membrane potential; TAS:BHF-UCL
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0002026; P:regulation of the force of heart contraction; IEA:Ensembl
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0055119; P:relaxation of cardiac muscle; TAS:BHF-UCL
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0070296; P:sarcoplasmic reticulum calcium ion transport; TAS:BHF-UCL
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0055085; P:transmembrane transport; TAS:Reactome
P16615	ATP2A2	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	GO:0006810; P:transport; TAS:ProtInc
Q93084	ATP2A3	Sarcoplasmic/endoplasmic reticulum calcium ATPase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q93084	ATP2A3	Sarcoplasmic/endoplasmic reticulum calcium ATPase 3	GO:0005388; F:calcium-transporting ATPase activity; TAS:ProtInc
Q93084	ATP2A3	Sarcoplasmic/endoplasmic reticulum calcium ATPase 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q93084	ATP2A3	Sarcoplasmic/endoplasmic reticulum calcium ATPase 3	GO:0007596; P:blood coagulation; TAS:Reactome
Q93084	ATP2A3	Sarcoplasmic/endoplasmic reticulum calcium ATPase 3	GO:0070588; P:calcium ion transmembrane transport; TAS:GOC
Q93084	ATP2A3	Sarcoplasmic/endoplasmic reticulum calcium ATPase 3	GO:0006816; P:calcium ion transport; TAS:UniProtKB
Q93084	ATP2A3	Sarcoplasmic/endoplasmic reticulum calcium ATPase 3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q93084	ATP2A3	Sarcoplasmic/endoplasmic reticulum calcium ATPase 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q93084	ATP2A3	Sarcoplasmic/endoplasmic reticulum calcium ATPase 3	GO:0006810; P:transport; TAS:ProtInc
P20020	ATP2B1	Plasma membrane calcium-transporting ATPase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P20020	ATP2B1	Plasma membrane calcium-transporting ATPase 1	GO:0005388; F:calcium-transporting ATPase activity; TAS:ProtInc
P20020	ATP2B1	Plasma membrane calcium-transporting ATPase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P20020	ATP2B1	Plasma membrane calcium-transporting ATPase 1	GO:0005515; F:protein binding; IPI:UniProtKB
P20020	ATP2B1	Plasma membrane calcium-transporting ATPase 1	GO:0007596; P:blood coagulation; TAS:Reactome
P20020	ATP2B1	Plasma membrane calcium-transporting ATPase 1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P20020	ATP2B1	Plasma membrane calcium-transporting ATPase 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P20020	ATP2B1	Plasma membrane calcium-transporting ATPase 1	GO:0006810; P:transport; TAS:ProtInc
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0005524; F:ATP binding; IDA:UniProtKB
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0030899; F:calcium-dependent ATPase activity; IEA:Ensembl
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0005388; F:calcium-transporting ATPase activity; IDA:UniProtKB
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0005516; F:calmodulin binding; IDA:UniProtKB
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0030165; F:PDZ domain binding; IDA:UniProtKB
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0005515; F:protein binding; IPI:IntAct
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0060088; P:auditory receptor cell stereocilium organization; IEA:Ensembl
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0007596; P:blood coagulation; TAS:Reactome
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0070588; P:calcium ion transmembrane transport; IDA:GOC
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0006816; P:calcium ion transport; IMP:DFLAT
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0021707; P:cerebellar granule cell differentiation; IEA:Ensembl
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0021702; P:cerebellar Purkinje cell differentiation; IEA:Ensembl
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0046068; P:cGMP metabolic process; IEA:Ensembl
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0090102; P:cochlea development; IEA:Ensembl
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0051480; P:cytosolic calcium ion homeostasis; IMP:DFLAT
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; IEA:Ensembl
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0007595; P:lactation; IEA:Ensembl
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0040011; P:locomotion; IEA:Ensembl
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0030182; P:neuron differentiation; IDA:UniProtKB
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0006996; P:organelle organization; IEA:Ensembl
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0045299; P:otolith mineralization; IEA:Ensembl
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0051928; P:positive regulation of calcium ion transport; IEA:Ensembl
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0008361; P:regulation of cell size; IEA:Ensembl
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0007605; P:sensory perception of sound; IMP:UniProtKB
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0042428; P:serotonin metabolic process; IEA:Ensembl
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0050808; P:synapse organization; IEA:Ensembl
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q01814	ATP2B2	Plasma membrane calcium-transporting ATPase 2	GO:0006810; P:transport; NAS:UniProtKB
Q16720	ATP2B3	Plasma membrane calcium-transporting ATPase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q16720	ATP2B3	Plasma membrane calcium-transporting ATPase 3	GO:0005388; F:calcium-transporting ATPase activity; TAS:ProtInc
Q16720	ATP2B3	Plasma membrane calcium-transporting ATPase 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q16720	ATP2B3	Plasma membrane calcium-transporting ATPase 3	GO:0007596; P:blood coagulation; TAS:Reactome
Q16720	ATP2B3	Plasma membrane calcium-transporting ATPase 3	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q16720	ATP2B3	Plasma membrane calcium-transporting ATPase 3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q16720	ATP2B3	Plasma membrane calcium-transporting ATPase 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q16720	ATP2B3	Plasma membrane calcium-transporting ATPase 3	GO:0006810; P:transport; TAS:ProtInc
P23634	ATP2B4	Plasma membrane calcium-transporting ATPase 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P23634	ATP2B4	Plasma membrane calcium-transporting ATPase 4	GO:0005388; F:calcium-transporting ATPase activity; TAS:ProtInc
P23634	ATP2B4	Plasma membrane calcium-transporting ATPase 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P23634	ATP2B4	Plasma membrane calcium-transporting ATPase 4	GO:0005515; F:protein binding; IPI:IntAct
P23634	ATP2B4	Plasma membrane calcium-transporting ATPase 4	GO:0097110; F:scaffold protein binding; ISS:BHF-UCL
P23634	ATP2B4	Plasma membrane calcium-transporting ATPase 4	GO:0007596; P:blood coagulation; TAS:Reactome
P23634	ATP2B4	Plasma membrane calcium-transporting ATPase 4	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P23634	ATP2B4	Plasma membrane calcium-transporting ATPase 4	GO:1902083; P:negative regulation of peptidyl-cysteine S-nitrosylation; NAS:BHF-UCL
P23634	ATP2B4	Plasma membrane calcium-transporting ATPase 4	GO:1902305; P:regulation of sodium ion transmembrane transport; IC:BHF-UCL
P23634	ATP2B4	Plasma membrane calcium-transporting ATPase 4	GO:0055085; P:transmembrane transport; TAS:Reactome
P23634	ATP2B4	Plasma membrane calcium-transporting ATPase 4	GO:0006810; P:transport; TAS:ProtInc
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0005524; F:ATP binding; IDA:UniProtKB
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0005388; F:calcium-transporting ATPase activity; IDA:UniProtKB
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0030145; F:manganese ion binding; IDA:UniProtKB
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0015410; F:manganese-transporting ATPase activity; IDA:UniProtKB
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0004871; F:signal transducer activity; IMP:UniProtKB
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0031532; P:actin cytoskeleton reorganization; IMP:UniProtKB
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0070588; P:calcium ion transmembrane transport; IDA:GOC
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0006816; P:calcium ion transport; IDA:UniProtKB
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0016339; P:calcium-dependent cell-cell adhesion; IMP:UniProtKB
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0006874; P:cellular calcium ion homeostasis; IDA:UniProtKB
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0030026; P:cellular manganese ion homeostasis; IDA:UniProtKB
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0008544; P:epidermis development; IMP:UniProtKB
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0032468; P:Golgi calcium ion homeostasis; IMP:UniProtKB
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0032472; P:Golgi calcium ion transport; IMP:UniProtKB
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0071421; P:manganese ion transmembrane transport; IDA:GOC
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0006828; P:manganese ion transport; IDA:UniProtKB
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0007165; P:signal transduction; IMP:GOC
P98194	ATP2C1	Calcium-transporting ATPase type 2C member 1	GO:0055085; P:transmembrane transport; TAS:Reactome
O75185	ATP2C2	Calcium-transporting ATPase type 2C member 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75185	ATP2C2	Calcium-transporting ATPase type 2C member 2	GO:0005388; F:calcium-transporting ATPase activity; IEA:InterPro
O75185	ATP2C2	Calcium-transporting ATPase type 2C member 2	GO:0046872; F:metal ion binding; IEA:InterPro
O75185	ATP2C2	Calcium-transporting ATPase type 2C member 2	GO:0005515; F:protein binding; IPI:IntAct
O75185	ATP2C2	Calcium-transporting ATPase type 2C member 2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
O75185	ATP2C2	Calcium-transporting ATPase type 2C member 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8TBG4	ETNPPL	Ethanolamine-phosphate phospho-lyase	GO:0050459; F:ethanolamine-phosphate phospho-lyase activity; IEA:UniProtKB-EC
Q8TBG4	ETNPPL	Ethanolamine-phosphate phospho-lyase	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q8TBG4	ETNPPL	Ethanolamine-phosphate phospho-lyase	GO:0008483; F:transaminase activity; IEA:UniProtKB-KW
Q8IUZ5	PHYKPL	5-phosphohydroxy-L-lysine phospho-lyase	GO:0016829; F:lyase activity; IEA:UniProtKB-KW
Q8IUZ5	PHYKPL	5-phosphohydroxy-L-lysine phospho-lyase	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q8IUZ5	PHYKPL	5-phosphohydroxy-L-lysine phospho-lyase	GO:0008483; F:transaminase activity; IEA:UniProtKB-KW
Q06055	ATP5G2	ATP synthase F(0) complex subunit C2, mitochondrial	GO:0015078; F:hydrogen ion transmembrane transporter activity; IEA:InterPro
Q06055	ATP5G2	ATP synthase F(0) complex subunit C2, mitochondrial	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q06055	ATP5G2	ATP synthase F(0) complex subunit C2, mitochondrial	GO:0005215; F:transporter activity; NAS:ProtInc
Q06055	ATP5G2	ATP synthase F(0) complex subunit C2, mitochondrial	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
Q06055	ATP5G2	ATP synthase F(0) complex subunit C2, mitochondrial	GO:0015986; P:ATP synthesis coupled proton transport; IEA:InterPro
Q06055	ATP5G2	ATP synthase F(0) complex subunit C2, mitochondrial	GO:0045471; P:response to ethanol; IEA:Ensembl
P05496	ATP5G1	ATP synthase F(0) complex subunit C1, mitochondrial	GO:0015078; F:hydrogen ion transmembrane transporter activity; IEA:InterPro
P05496	ATP5G1	ATP synthase F(0) complex subunit C1, mitochondrial	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
P05496	ATP5G1	ATP synthase F(0) complex subunit C1, mitochondrial	GO:0005215; F:transporter activity; NAS:ProtInc
P05496	ATP5G1	ATP synthase F(0) complex subunit C1, mitochondrial	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
P05496	ATP5G1	ATP synthase F(0) complex subunit C1, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P05496	ATP5G1	ATP synthase F(0) complex subunit C1, mitochondrial	GO:0042776; P:mitochondrial ATP synthesis coupled proton transport; TAS:Reactome
P05496	ATP5G1	ATP synthase F(0) complex subunit C1, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P05496	ATP5G1	ATP synthase F(0) complex subunit C1, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5VTU8	ATP5EP2	ATP synthase subunit epsilon-like protein, mitochondrial	GO:0046933; F:proton-transporting ATP synthase activity, rotational mechanism; IEA:InterPro
Q5VTU8	ATP5EP2	ATP synthase subunit epsilon-like protein, mitochondrial	GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; IEA:InterPro
Q5VTU8	ATP5EP2	ATP synthase subunit epsilon-like protein, mitochondrial	GO:0015986; P:ATP synthesis coupled proton transport; IEA:InterPro
P48201	ATP5G3	ATP synthase F(0) complex subunit C3, mitochondrial	GO:0015078; F:hydrogen ion transmembrane transporter activity; IEA:InterPro
P48201	ATP5G3	ATP synthase F(0) complex subunit C3, mitochondrial	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
P48201	ATP5G3	ATP synthase F(0) complex subunit C3, mitochondrial	GO:0005215; F:transporter activity; NAS:ProtInc
P48201	ATP5G3	ATP synthase F(0) complex subunit C3, mitochondrial	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
P48201	ATP5G3	ATP synthase F(0) complex subunit C3, mitochondrial	GO:0015986; P:ATP synthesis coupled proton transport; IEA:InterPro
Q7Z4Y8	ATP5L2	ATP synthase subunit g 2, mitochondrial	GO:0015078; F:hydrogen ion transmembrane transporter activity; IEA:InterPro
Q7Z4Y8	ATP5L2	ATP synthase subunit g 2, mitochondrial	GO:0015986; P:ATP synthesis coupled proton transport; IEA:InterPro
P24539	ATP5F1	ATP synthase F(0) complex subunit B1, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
P24539	ATP5F1	ATP synthase F(0) complex subunit B1, mitochondrial	GO:0046933; F:proton-transporting ATP synthase activity, rotational mechanism; IBA:RefGenome
P24539	ATP5F1	ATP synthase F(0) complex subunit B1, mitochondrial	GO:0022857; F:transmembrane transporter activity; IC:UniProtKB
P24539	ATP5F1	ATP synthase F(0) complex subunit B1, mitochondrial	GO:0006200; P:ATP catabolic process; IDA:GOC
P24539	ATP5F1	ATP synthase F(0) complex subunit B1, mitochondrial	GO:0015986; P:ATP synthesis coupled proton transport; IBA:RefGenome
P24539	ATP5F1	ATP synthase F(0) complex subunit B1, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P24539	ATP5F1	ATP synthase F(0) complex subunit B1, mitochondrial	GO:0042776; P:mitochondrial ATP synthesis coupled proton transport; IC:UniProtKB
P24539	ATP5F1	ATP synthase F(0) complex subunit B1, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P24539	ATP5F1	ATP synthase F(0) complex subunit B1, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P24539	ATP5F1	ATP synthase F(0) complex subunit B1, mitochondrial	GO:0021762; P:substantia nigra development; IEP:UniProt
Q14CW9	ATXN7L3	Ataxin-7-like protein 3	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IDA:UniProtKB
Q14CW9	ATXN7L3	Ataxin-7-like protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q14CW9	ATXN7L3	Ataxin-7-like protein 3	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q14CW9	ATXN7L3	Ataxin-7-like protein 3	GO:0008270; F:zinc ion binding; IEA:UniProtKB-HAMAP
Q14CW9	ATXN7L3	Ataxin-7-like protein 3	GO:0006325; P:chromatin organization; TAS:Reactome
Q14CW9	ATXN7L3	Ataxin-7-like protein 3	GO:0016578; P:histone deubiquitination; IDA:UniProtKB
Q14CW9	ATXN7L3	Ataxin-7-like protein 3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q14CW9	ATXN7L3	Ataxin-7-like protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2Q0	ATP8A1	Probable phospholipid-transporting ATPase IA	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y2Q0	ATP8A1	Probable phospholipid-transporting ATPase IA	GO:0019829; F:cation-transporting ATPase activity; NAS:UniProtKB
Q9Y2Q0	ATP8A1	Probable phospholipid-transporting ATPase IA	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q9Y2Q0	ATP8A1	Probable phospholipid-transporting ATPase IA	GO:0004012; F:phospholipid-translocating ATPase activity; IEA:UniProtKB-EC
Q9Y2Q0	ATP8A1	Probable phospholipid-transporting ATPase IA	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y2Q0	ATP8A1	Probable phospholipid-transporting ATPase IA	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9Y2Q0	ATP8A1	Probable phospholipid-transporting ATPase IA	GO:0045332; P:phospholipid translocation; NAS:UniProtKB
Q9Y2Q0	ATP8A1	Probable phospholipid-transporting ATPase IA	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9NTI2	ATP8A2	Probable phospholipid-transporting ATPase IB	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NTI2	ATP8A2	Probable phospholipid-transporting ATPase IB	GO:0019829; F:cation-transporting ATPase activity; IEA:InterPro
Q9NTI2	ATP8A2	Probable phospholipid-transporting ATPase IB	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q9NTI2	ATP8A2	Probable phospholipid-transporting ATPase IB	GO:0004012; F:phospholipid-translocating ATPase activity; IEA:UniProtKB-EC
Q9NTI2	ATP8A2	Probable phospholipid-transporting ATPase IB	GO:0007568; P:aging; IEA:Ensembl
Q9NTI2	ATP8A2	Probable phospholipid-transporting ATPase IB	GO:0007409; P:axonogenesis; IEA:Ensembl
Q9NTI2	ATP8A2	Probable phospholipid-transporting ATPase IB	GO:0042755; P:eating behavior; IEA:Ensembl
Q9NTI2	ATP8A2	Probable phospholipid-transporting ATPase IB	GO:0003011; P:involuntary skeletal muscle contraction; IEA:Ensembl
Q9NTI2	ATP8A2	Probable phospholipid-transporting ATPase IB	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q9NTI2	ATP8A2	Probable phospholipid-transporting ATPase IB	GO:0050884; P:neuromuscular process controlling posture; IEA:Ensembl
Q9NTI2	ATP8A2	Probable phospholipid-transporting ATPase IB	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
Q9NTI2	ATP8A2	Probable phospholipid-transporting ATPase IB	GO:0043588; P:skin development; IEA:Ensembl
O43520	ATP8B1	Probable phospholipid-transporting ATPase IC	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43520	ATP8B1	Probable phospholipid-transporting ATPase IC	GO:0019829; F:cation-transporting ATPase activity; IEA:InterPro
O43520	ATP8B1	Probable phospholipid-transporting ATPase IC	GO:0000287; F:magnesium ion binding; IEA:InterPro
O43520	ATP8B1	Probable phospholipid-transporting ATPase IC	GO:0004012; F:phospholipid-translocating ATPase activity; TAS:UniProtKB
O43520	ATP8B1	Probable phospholipid-transporting ATPase IC	GO:0005515; F:protein binding; IPI:UniProtKB
O43520	ATP8B1	Probable phospholipid-transporting ATPase IC	GO:0015721; P:bile acid and bile salt transport; NAS:UniProtKB
O43520	ATP8B1	Probable phospholipid-transporting ATPase IC	GO:0008206; P:bile acid metabolic process; IEA:Ensembl
O43520	ATP8B1	Probable phospholipid-transporting ATPase IC	GO:0034220; P:ion transmembrane transport; TAS:Reactome
O43520	ATP8B1	Probable phospholipid-transporting ATPase IC	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
O43520	ATP8B1	Probable phospholipid-transporting ATPase IC	GO:0045332; P:phospholipid translocation; NAS:UniProtKB
O43520	ATP8B1	Probable phospholipid-transporting ATPase IC	GO:0055085; P:transmembrane transport; TAS:Reactome
O60423	ATP8B3	Probable phospholipid-transporting ATPase IK	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O60423	ATP8B3	Probable phospholipid-transporting ATPase IK	GO:0019829; F:cation-transporting ATPase activity; IEA:InterPro
O60423	ATP8B3	Probable phospholipid-transporting ATPase IK	GO:0000287; F:magnesium ion binding; IEA:InterPro
O60423	ATP8B3	Probable phospholipid-transporting ATPase IK	GO:0004012; F:phospholipid-translocating ATPase activity; IEA:UniProtKB-EC
O60423	ATP8B3	Probable phospholipid-transporting ATPase IK	GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl
P98198	ATP8B2	Probable phospholipid-transporting ATPase ID	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P98198	ATP8B2	Probable phospholipid-transporting ATPase ID	GO:0019829; F:cation-transporting ATPase activity; IEA:InterPro
P98198	ATP8B2	Probable phospholipid-transporting ATPase ID	GO:0000287; F:magnesium ion binding; IEA:InterPro
P98198	ATP8B2	Probable phospholipid-transporting ATPase ID	GO:0004012; F:phospholipid-translocating ATPase activity; IEA:UniProtKB-EC
P98198	ATP8B2	Probable phospholipid-transporting ATPase ID	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P98198	ATP8B2	Probable phospholipid-transporting ATPase ID	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8TF62	ATP8B4	Probable phospholipid-transporting ATPase IM	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8TF62	ATP8B4	Probable phospholipid-transporting ATPase IM	GO:0019829; F:cation-transporting ATPase activity; IEA:InterPro
Q8TF62	ATP8B4	Probable phospholipid-transporting ATPase IM	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q8TF62	ATP8B4	Probable phospholipid-transporting ATPase IM	GO:0004012; F:phospholipid-translocating ATPase activity; IEA:UniProtKB-EC
Q8NBU5	ATAD1	ATPase family AAA domain-containing protein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NBU5	ATAD1	ATPase family AAA domain-containing protein 1	GO:0016887; F:ATPase activity; ISS:UniProtKB
Q8NBU5	ATAD1	ATPase family AAA domain-containing protein 1	GO:0007612; P:learning; ISS:UniProtKB
Q8NBU5	ATAD1	ATPase family AAA domain-containing protein 1	GO:0007613; P:memory; ISS:UniProtKB
Q8NBU5	ATAD1	ATPase family AAA domain-containing protein 1	GO:0051967; P:negative regulation of synaptic transmission, glutamatergic; ISS:UniProtKB
Q8NBU5	ATAD1	ATPase family AAA domain-containing protein 1	GO:0002092; P:positive regulation of receptor internalization; ISS:UniProtKB
Q6PL18	ATAD2	ATPase family AAA domain-containing protein 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6PL18	ATAD2	ATPase family AAA domain-containing protein 2	GO:0016887; F:ATPase activity; IDA:UniProt
Q6PL18	ATAD2	ATPase family AAA domain-containing protein 2	GO:0006200; P:ATP catabolic process; IDA:UniProt
Q6PL18	ATAD2	ATPase family AAA domain-containing protein 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProt
Q6PL18	ATAD2	ATPase family AAA domain-containing protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96QE3	ATAD5	ATPase family AAA domain-containing protein 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96QE3	ATAD5	ATPase family AAA domain-containing protein 5	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q96QE3	ATAD5	ATPase family AAA domain-containing protein 5	GO:0006974; P:cellular response to DNA damage stimulus; IEA:UniProtKB-KW
Q5SQI0	ATAT1	Alpha-tubulin N-acetyltransferase 1	GO:0019799; F:tubulin N-acetyltransferase activity; IMP:UniProtKB
Q5SQI0	ATAT1	Alpha-tubulin N-acetyltransferase 1	GO:0071929; P:alpha-tubulin acetylation; IEA:UniProtKB-HAMAP
Q5SQI0	ATAT1	Alpha-tubulin N-acetyltransferase 1	GO:0048666; P:neuron development; IEA:UniProtKB-HAMAP
Q5SQI0	ATAT1	Alpha-tubulin N-acetyltransferase 1	GO:0070507; P:regulation of microtubule cytoskeleton organization; IEA:UniProtKB-HAMAP
Q86WG3	ATCAY	Caytaxin	GO:0019894; F:kinesin binding; IPI:UniProtKB
Q86WG3	ATCAY	Caytaxin	GO:0005515; F:protein binding; IPI:UniProtKB
Q86WG3	ATCAY	Caytaxin	GO:0006915; P:apoptotic process; IBA:RefGenome
Q86WG3	ATCAY	Caytaxin	GO:0048311; P:mitochondrion distribution; ISS:UniProtKB
Q86WG3	ATCAY	Caytaxin	GO:2000212; P:negative regulation of glutamate metabolic process; IDA:UniProtKB
Q86WG3	ATCAY	Caytaxin	GO:0031175; P:neuron projection development; ISS:UniProtKB
Q86WG3	ATCAY	Caytaxin	GO:0032880; P:regulation of protein localization; IDA:UniProtKB
Q86WG3	ATCAY	Caytaxin	GO:0006810; P:transport; IEA:UniProtKB-KW
Q9ULI0	ATAD2B	ATPase family AAA domain-containing protein 2B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9ULI0	ATAD2B	ATPase family AAA domain-containing protein 2B	GO:0070577; F:lysine-acetylated histone binding; IDA:UniProtKB
Q9ULI0	ATAD2B	ATPase family AAA domain-containing protein 2B	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q9NVI7	ATAD3A	ATPase family AAA domain-containing protein 3A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NVI7	ATAD3A	ATPase family AAA domain-containing protein 3A	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q9NVI7	ATAD3A	ATPase family AAA domain-containing protein 3A	GO:0016049; P:cell growth; IMP:UniProtKB
Q9NVI7	ATAD3A	ATPase family AAA domain-containing protein 3A	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q5T9A4	ATAD3B	ATPase family AAA domain-containing protein 3B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5T9A4	ATAD3B	ATPase family AAA domain-containing protein 3B	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q5T2N8	ATAD3C	ATPase family AAA domain-containing protein 3C	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5T2N8	ATAD3C	ATPase family AAA domain-containing protein 3C	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
O95260	ATE1	Arginyl-tRNA--protein transferase 1	GO:0004057; F:arginyltransferase activity; TAS:UniProtKB
O95260	ATE1	Arginyl-tRNA--protein transferase 1	GO:0005515; F:protein binding; IPI:IntAct
O95260	ATE1	Arginyl-tRNA--protein transferase 1	GO:0016598; P:protein arginylation; NAS:UniProtKB
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0005515; F:protein binding; IPI:IntAct
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0043623; P:cellular protein complex assembly; IEA:Ensembl
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0045087; P:innate immune response; TAS:Reactome
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0045740; P:positive regulation of DNA replication; IEA:Ensembl
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0032025; P:response to cobalt ion; IEA:Ensembl
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P18846	ATF1	Cyclic AMP-dependent transcription factor ATF-1	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0035497; F:cAMP response element binding; IDA:BHF-UCL
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0008140; F:cAMP response element binding protein binding; IDA:BHF-UCL
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0003682; F:chromatin binding; IEA:Ensembl
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0004402; F:histone acetyltransferase activity; IDA:UniProtKB
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0005515; F:protein binding; IPI:UniProtKB
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IDA:BHF-UCL
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IC:BHF-UCL
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0001076; F:RNA polymerase II transcription factor binding transcription factor activity; IC:BHF-UCL
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:MGI
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0060612; P:adipose tissue development; IEA:Ensembl
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0006325; P:chromatin organization; TAS:Reactome
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0045444; P:fat cell differentiation; IEA:Ensembl
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0016573; P:histone acetylation; IDA:GOC
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0045087; P:innate immune response; TAS:Reactome
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0031573; P:intra-S DNA damage checkpoint; IMP:UniProtKB
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0003151; P:outflow tract morphogenesis; IEA:Ensembl
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:1902110; P:positive regulation of mitochondrial membrane permeability involved in apoptotic process; IMP:UniProtKB
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:UniProtKB
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0032915; P:positive regulation of transforming growth factor beta2 production; IEA:Ensembl
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; TAS:Reactome
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IC:BHF-UCL
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0006970; P:response to osmotic stress; IDA:UniProtKB
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0006366; P:transcription from RNA polymerase II promoter; IC:GOC
P15336	ATF2	Cyclic AMP-dependent transcription factor ATF-2	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P18848	ATF4	Cyclic AMP-dependent transcription factor ATF-4	GO:0003677; F:DNA binding; IDA:UniProtKB
P18848	ATF4	Cyclic AMP-dependent transcription factor ATF-4	GO:0005515; F:protein binding; IPI:UniProtKB
P18848	ATF4	Cyclic AMP-dependent transcription factor ATF-4	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P18848	ATF4	Cyclic AMP-dependent transcription factor ATF-4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
P18848	ATF4	Cyclic AMP-dependent transcription factor ATF-4	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P18848	ATF4	Cyclic AMP-dependent transcription factor ATF-4	GO:0006520; P:cellular amino acid metabolic process; TAS:UniProtKB
P18848	ATF4	Cyclic AMP-dependent transcription factor ATF-4	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P18848	ATF4	Cyclic AMP-dependent transcription factor ATF-4	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P18848	ATF4	Cyclic AMP-dependent transcription factor ATF-4	GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:Ensembl
P18848	ATF4	Cyclic AMP-dependent transcription factor ATF-4	GO:0006094; P:gluconeogenesis; ISS:UniProtKB
P18848	ATF4	Cyclic AMP-dependent transcription factor ATF-4	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISS:UniProtKB
P18848	ATF4	Cyclic AMP-dependent transcription factor ATF-4	GO:0043267; P:negative regulation of potassium ion transport; IEA:Ensembl
P18848	ATF4	Cyclic AMP-dependent transcription factor ATF-4	GO:0043525; P:positive regulation of neuron apoptotic process; ISS:UniProtKB
P18848	ATF4	Cyclic AMP-dependent transcription factor ATF-4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
P18848	ATF4	Cyclic AMP-dependent transcription factor ATF-4	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P18848	ATF4	Cyclic AMP-dependent transcription factor ATF-4	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
P18848	ATF4	Cyclic AMP-dependent transcription factor ATF-4	GO:0034976; P:response to endoplasmic reticulum stress; IDA:BHF-UCL
P18848	ATF4	Cyclic AMP-dependent transcription factor ATF-4	GO:0006366; P:transcription from RNA polymerase II promoter; ISS:UniProtKB
P18847	ATF3	Cyclic AMP-dependent transcription factor ATF-3	GO:0042802; F:identical protein binding; IPI:IntAct
P18847	ATF3	Cyclic AMP-dependent transcription factor ATF-3	GO:0005515; F:protein binding; IPI:IntAct
P18847	ATF3	Cyclic AMP-dependent transcription factor ATF-3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P18847	ATF3	Cyclic AMP-dependent transcription factor ATF-3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P18847	ATF3	Cyclic AMP-dependent transcription factor ATF-3	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
P18847	ATF3	Cyclic AMP-dependent transcription factor ATF-3	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P18847	ATF3	Cyclic AMP-dependent transcription factor ATF-3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P18847	ATF3	Cyclic AMP-dependent transcription factor ATF-3	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P18847	ATF3	Cyclic AMP-dependent transcription factor ATF-3	GO:0006094; P:gluconeogenesis; IEA:Ensembl
P18847	ATF3	Cyclic AMP-dependent transcription factor ATF-3	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
P18847	ATF3	Cyclic AMP-dependent transcription factor ATF-3	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P18847	ATF3	Cyclic AMP-dependent transcription factor ATF-3	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
P18847	ATF3	Cyclic AMP-dependent transcription factor ATF-3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2D1	ATF5	Cyclic AMP-dependent transcription factor ATF-5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y2D1	ATF5	Cyclic AMP-dependent transcription factor ATF-5	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9Y2D1	ATF5	Cyclic AMP-dependent transcription factor ATF-5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9Y2D1	ATF5	Cyclic AMP-dependent transcription factor ATF-5	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q9Y2D1	ATF5	Cyclic AMP-dependent transcription factor ATF-5	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q9Y2D1	ATF5	Cyclic AMP-dependent transcription factor ATF-5	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q9Y2D1	ATF5	Cyclic AMP-dependent transcription factor ATF-5	GO:0048712; P:negative regulation of astrocyte differentiation; IEA:Ensembl
Q9Y2D1	ATF5	Cyclic AMP-dependent transcription factor ATF-5	GO:0021891; P:olfactory bulb interneuron development; IEA:Ensembl
Q9Y2D1	ATF5	Cyclic AMP-dependent transcription factor ATF-5	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q9Y2D1	ATF5	Cyclic AMP-dependent transcription factor ATF-5	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9Y2D1	ATF5	Cyclic AMP-dependent transcription factor ATF-5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P18850	ATF6	Cyclic AMP-dependent transcription factor ATF-6 alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P18850	ATF6	Cyclic AMP-dependent transcription factor ATF-6 alpha	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P18850	ATF6	Cyclic AMP-dependent transcription factor ATF-6 alpha	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P18850	ATF6	Cyclic AMP-dependent transcription factor ATF-6 alpha	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P18850	ATF6	Cyclic AMP-dependent transcription factor ATF-6 alpha	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P18850	ATF6	Cyclic AMP-dependent transcription factor ATF-6 alpha	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P18850	ATF6	Cyclic AMP-dependent transcription factor ATF-6 alpha	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:BHF-UCL
P18850	ATF6	Cyclic AMP-dependent transcription factor ATF-6 alpha	GO:0006990; P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response; TAS:ProtInc
P18850	ATF6	Cyclic AMP-dependent transcription factor ATF-6 alpha	GO:0006457; P:protein folding; TAS:ProtInc
P18850	ATF6	Cyclic AMP-dependent transcription factor ATF-6 alpha	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P18850	ATF6	Cyclic AMP-dependent transcription factor ATF-6 alpha	GO:0006950; P:response to stress; TAS:ProtInc
P18850	ATF6	Cyclic AMP-dependent transcription factor ATF-6 alpha	GO:0007165; P:signal transduction; TAS:ProtInc
P18850	ATF6	Cyclic AMP-dependent transcription factor ATF-6 alpha	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q99941	ATF6B	Cyclic AMP-dependent transcription factor ATF-6 beta	GO:0005515; F:protein binding; IPI:IntAct
Q99941	ATF6B	Cyclic AMP-dependent transcription factor ATF-6 beta	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q99941	ATF6B	Cyclic AMP-dependent transcription factor ATF-6 beta	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q99941	ATF6B	Cyclic AMP-dependent transcription factor ATF-6 beta	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
Q99941	ATF6B	Cyclic AMP-dependent transcription factor ATF-6 beta	GO:0007165; P:signal transduction; TAS:ProtInc
Q99941	ATF6B	Cyclic AMP-dependent transcription factor ATF-6 beta	GO:0006351; P:transcription, DNA-templated; TAS:ProtInc
P17544	ATF7	Cyclic AMP-dependent transcription factor ATF-7	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17544	ATF7	Cyclic AMP-dependent transcription factor ATF-7	GO:0051019; F:mitogen-activated protein kinase binding; IDA:UniProtKB
P17544	ATF7	Cyclic AMP-dependent transcription factor ATF-7	GO:0005515; F:protein binding; IPI:UniProtKB
P17544	ATF7	Cyclic AMP-dependent transcription factor ATF-7	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P17544	ATF7	Cyclic AMP-dependent transcription factor ATF-7	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
P17544	ATF7	Cyclic AMP-dependent transcription factor ATF-7	GO:0008134; F:transcription factor binding; IDA:UniProtKB
P17544	ATF7	Cyclic AMP-dependent transcription factor ATF-7	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
P17544	ATF7	Cyclic AMP-dependent transcription factor ATF-7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17544	ATF7	Cyclic AMP-dependent transcription factor ATF-7	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9H0Y0	ATG10	Ubiquitin-like-conjugating enzyme ATG10	GO:0019777; F:Atg12 ligase activity; ISS:UniProtKB
Q9H0Y0	ATG10	Ubiquitin-like-conjugating enzyme ATG10	GO:0006914; P:autophagy; IMP:UniProtKB
Q9H0Y0	ATG10	Ubiquitin-like-conjugating enzyme ATG10	GO:0034263; P:autophagy in response to ER overload; IMP:UniProtKB
Q9H0Y0	ATG10	Ubiquitin-like-conjugating enzyme ATG10	GO:0031401; P:positive regulation of protein modification process; ISS:UniProtKB
Q9H0Y0	ATG10	Ubiquitin-like-conjugating enzyme ATG10	GO:0006497; P:protein lipidation; ISS:UniProtKB
Q9H0Y0	ATG10	Ubiquitin-like-conjugating enzyme ATG10	GO:0032446; P:protein modification by small protein conjugation; IDA:UniProtKB
Q9H0Y0	ATG10	Ubiquitin-like-conjugating enzyme ATG10	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O94817	ATG12	Ubiquitin-like protein ATG12	GO:0005515; F:protein binding; IPI:UniProtKB
O94817	ATG12	Ubiquitin-like protein ATG12	GO:0000045; P:autophagic vacuole assembly; ISS:UniProtKB
O94817	ATG12	Ubiquitin-like protein ATG12	GO:0045087; P:innate immune response; TAS:Reactome
O94817	ATG12	Ubiquitin-like protein ATG12	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
O75143	ATG13	Autophagy-related protein 13	GO:0005515; F:protein binding; IPI:UniProtKB
O75143	ATG13	Autophagy-related protein 13	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O75143	ATG13	Autophagy-related protein 13	GO:0000045; P:autophagic vacuole assembly; IMP:UniProtKB
Q2TAZ0	ATG2A	Autophagy-related protein 2 homolog A	GO:0005515; F:protein binding; IPI:IntAct
Q2TAZ0	ATG2A	Autophagy-related protein 2 homolog A	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q96BY7	ATG2B	Autophagy-related protein 2 homolog B	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q9NT62	ATG3	Ubiquitin-like-conjugating enzyme ATG3	GO:0019777; F:Atg12 ligase activity; ISS:UniProtKB
Q9NT62	ATG3	Ubiquitin-like-conjugating enzyme ATG3	GO:0019776; F:Atg8 ligase activity; ISS:UniProtKB
Q9NT62	ATG3	Ubiquitin-like-conjugating enzyme ATG3	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9NT62	ATG3	Ubiquitin-like-conjugating enzyme ATG3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NT62	ATG3	Ubiquitin-like-conjugating enzyme ATG3	GO:0019787; F:small conjugating protein ligase activity; IDA:MGI
Q9NT62	ATG3	Ubiquitin-like-conjugating enzyme ATG3	GO:0000045; P:autophagic vacuole assembly; ISS:UniProtKB
Q9NT62	ATG3	Ubiquitin-like-conjugating enzyme ATG3	GO:0006464; P:cellular protein modification process; IDA:MGI
Q9NT62	ATG3	Ubiquitin-like-conjugating enzyme ATG3	GO:0043653; P:mitochondrial fragmentation involved in apoptotic process; ISS:UniProtKB
Q9NT62	ATG3	Ubiquitin-like-conjugating enzyme ATG3	GO:0006612; P:protein targeting to membrane; ISS:UniProtKB
Q9NT62	ATG3	Ubiquitin-like-conjugating enzyme ATG3	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q9NT62	ATG3	Ubiquitin-like-conjugating enzyme ATG3	GO:1902017; P:regulation of cilium assembly; ISS:UniProtKB
Q8WYN0	ATG4A	Cysteine protease ATG4A	GO:0008234; F:cysteine-type peptidase activity; IDA:UniProtKB
Q8WYN0	ATG4A	Cysteine protease ATG4A	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q8WYN0	ATG4A	Cysteine protease ATG4A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8WYN0	ATG4A	Cysteine protease ATG4A	GO:0006508; P:proteolysis; IDA:UniProtKB
Q9Y4P1	ATG4B	Cysteine protease ATG4B	GO:0008234; F:cysteine-type peptidase activity; IDA:UniProtKB
Q9Y4P1	ATG4B	Cysteine protease ATG4B	GO:0004175; F:endopeptidase activity; IDA:BHF-UCL
Q9Y4P1	ATG4B	Cysteine protease ATG4B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y4P1	ATG4B	Cysteine protease ATG4B	GO:0000045; P:autophagic vacuole assembly; IGI:UniProtKB
Q9Y4P1	ATG4B	Cysteine protease ATG4B	GO:0006914; P:autophagy; IGI:UniProtKB
Q9Y4P1	ATG4B	Cysteine protease ATG4B	GO:0010508; P:positive regulation of autophagy; IDA:BHF-UCL
Q9Y4P1	ATG4B	Cysteine protease ATG4B	GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl
Q9Y4P1	ATG4B	Cysteine protease ATG4B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9Y4P1	ATG4B	Cysteine protease ATG4B	GO:0006508; P:proteolysis; IDA:UniProtKB
Q96DT6	ATG4C	Cysteine protease ATG4C	GO:0004197; F:cysteine-type endopeptidase activity; IMP:UniProtKB
Q96DT6	ATG4C	Cysteine protease ATG4C	GO:0008233; F:peptidase activity; IDA:UniProtKB
Q96DT6	ATG4C	Cysteine protease ATG4C	GO:0000045; P:autophagic vacuole assembly; IGI:UniProtKB
Q96DT6	ATG4C	Cysteine protease ATG4C	GO:0006914; P:autophagy; IGI:UniProtKB
Q96DT6	ATG4C	Cysteine protease ATG4C	GO:0006612; P:protein targeting to membrane; ISS:UniProtKB
Q96DT6	ATG4C	Cysteine protease ATG4C	GO:0006508; P:proteolysis; IDA:UniProtKB
Q86TL0	ATG4D	Cysteine protease ATG4D	GO:0004197; F:cysteine-type endopeptidase activity; ISS:UniProtKB
Q86TL0	ATG4D	Cysteine protease ATG4D	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q86TL0	ATG4D	Cysteine protease ATG4D	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q86TL0	ATG4D	Cysteine protease ATG4D	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9H1Y0	ATG5	Autophagy protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H1Y0	ATG5	Autophagy protein 5	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9H1Y0	ATG5	Autophagy protein 5	GO:0000045; P:autophagic vacuole assembly; ISS:UniProtKB
Q9H1Y0	ATG5	Autophagy protein 5	GO:0006914; P:autophagy; ISS:UniProtKB
Q9H1Y0	ATG5	Autophagy protein 5	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
Q9H1Y0	ATG5	Autophagy protein 5	GO:0060047; P:heart contraction; IEA:Ensembl
Q9H1Y0	ATG5	Autophagy protein 5	GO:0045087; P:innate immune response; TAS:Reactome
Q9H1Y0	ATG5	Autophagy protein 5	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q9H1Y0	ATG5	Autophagy protein 5	GO:0031397; P:negative regulation of protein ubiquitination; IEA:Ensembl
Q9H1Y0	ATG5	Autophagy protein 5	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
Q9H1Y0	ATG5	Autophagy protein 5	GO:0048840; P:otolith development; IEA:Ensembl
Q9H1Y0	ATG5	Autophagy protein 5	GO:0043687; P:post-translational protein modification; ISS:UniProtKB
Q9H1Y0	ATG5	Autophagy protein 5	GO:1902017; P:regulation of cilium assembly; ISS:UniProtKB
Q9H1Y0	ATG5	Autophagy protein 5	GO:0002739; P:regulation of cytokine secretion involved in immune response; IEA:Ensembl
Q9H1Y0	ATG5	Autophagy protein 5	GO:0042493; P:response to drug; IEA:Ensembl
Q9H1Y0	ATG5	Autophagy protein 5	GO:0009620; P:response to fungus; IEA:Ensembl
Q9H1Y0	ATG5	Autophagy protein 5	GO:0042311; P:vasodilation; IEA:Ensembl
Q9H1Y0	ATG5	Autophagy protein 5	GO:0055015; P:ventricular cardiac muscle cell development; IEA:Ensembl
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0019778; F:APG12 activating enzyme activity; ISS:UniProtKB
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0005515; F:protein binding; IPI:UniProtKB
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0004839; F:ubiquitin activating enzyme activity; TAS:ProtInc
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0007628; P:adult walking behavior; IEA:Ensembl
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0006914; P:autophagy; IEA:UniProtKB-KW
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0055013; P:cardiac muscle cell development; IEA:Ensembl
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0006520; P:cellular amino acid metabolic process; IEA:Ensembl
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0006464; P:cellular protein modification process; TAS:ProtInc
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0021955; P:central nervous system neuron axonogenesis; IEA:Ensembl
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0021680; P:cerebellar Purkinje cell layer development; IEA:Ensembl
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0021987; P:cerebral cortex development; IEA:Ensembl
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0001889; P:liver development; IEA:Ensembl
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0061025; P:membrane fusion; TAS:ProtInc
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0050877; P:neurological system process; IEA:Ensembl
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0006996; P:organelle organization; IEA:Ensembl
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0016239; P:positive regulation of macroautophagy; IMP:BHF-UCL
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0031401; P:positive regulation of protein modification process; IDA:MGI
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0009791; P:post-embryonic development; IEA:Ensembl
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0030163; P:protein catabolic process; IEA:Ensembl
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0006497; P:protein lipidation; IDA:MGI
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0032446; P:protein modification by small protein conjugation; IEA:Ensembl
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0021860; P:pyramidal neuron development; IEA:Ensembl
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0031396; P:regulation of protein ubiquitination; IEA:Ensembl
O95352	ATG7	Ubiquitin-like modifier-activating enzyme ATG7	GO:0042594; P:response to starvation; IEA:Ensembl
Q7Z3C6	ATG9A	Autophagy-related protein 9A	GO:0005515; F:protein binding; IPI:IntAct
Q7Z3C6	ATG9A	Autophagy-related protein 9A	GO:0000045; P:autophagic vacuole assembly; IMP:MGI
Q7Z3C6	ATG9A	Autophagy-related protein 9A	GO:0045087; P:innate immune response; IEA:Ensembl
Q7Z3C6	ATG9A	Autophagy-related protein 9A	GO:0034067; P:protein localization to Golgi apparatus; IEA:Ensembl
Q7Z3C6	ATG9A	Autophagy-related protein 9A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q674R7	ATG9B	Autophagy-related protein 9B	GO:0000045; P:autophagic vacuole assembly; IDA:MGI
Q9BSB4	ATG101	Autophagy-related protein 101	GO:0042802; F:identical protein binding; IPI:IntAct
Q9BSB4	ATG101	Autophagy-related protein 101	GO:0005515; F:protein binding; IPI:IntAct
Q9BSB4	ATG101	Autophagy-related protein 101	GO:0032403; F:protein complex binding; IPI:UniProtKB
Q9BSB4	ATG101	Autophagy-related protein 101	GO:0000045; P:autophagic vacuole assembly; IMP:UniProtKB
Q32M88	ATHL1	Acid trehalase-like protein 1	GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:UniProtKB-KW
Q32M88	ATHL1	Acid trehalase-like protein 1	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q9UII2	ATPIF1	ATPase inhibitor, mitochondrial	GO:0043532; F:angiostatin binding; IDA:UniProtKB
Q9UII2	ATPIF1	ATPase inhibitor, mitochondrial	GO:0051117; F:ATPase binding; IDA:UniProtKB
Q9UII2	ATPIF1	ATPase inhibitor, mitochondrial	GO:0042030; F:ATPase inhibitor activity; IDA:UniProtKB
Q9UII2	ATPIF1	ATPase inhibitor, mitochondrial	GO:0005516; F:calmodulin binding; ISS:UniProtKB
Q9UII2	ATPIF1	ATPase inhibitor, mitochondrial	GO:0004857; F:enzyme inhibitor activity; TAS:ProtInc
Q9UII2	ATPIF1	ATPase inhibitor, mitochondrial	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q9UII2	ATPIF1	ATPase inhibitor, mitochondrial	GO:0001525; P:angiogenesis; TAS:UniProtKB
Q9UII2	ATPIF1	ATPase inhibitor, mitochondrial	GO:0030218; P:erythrocyte differentiation; IMP:UniProtKB
Q9UII2	ATPIF1	ATPase inhibitor, mitochondrial	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
Q9UII2	ATPIF1	ATPase inhibitor, mitochondrial	GO:0006783; P:heme biosynthetic process; IMP:UniProtKB
Q9UII2	ATPIF1	ATPase inhibitor, mitochondrial	GO:0001937; P:negative regulation of endothelial cell proliferation; IDA:UniProtKB
Q9UII2	ATPIF1	ATPase inhibitor, mitochondrial	GO:0051346; P:negative regulation of hydrolase activity; IDA:UniProtKB
Q9UII2	ATPIF1	ATPase inhibitor, mitochondrial	GO:0045980; P:negative regulation of nucleotide metabolic process; IEA:InterPro
Q9UII2	ATPIF1	ATPase inhibitor, mitochondrial	GO:1901030; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; IEA:Ensembl
Q9UII2	ATPIF1	ATPase inhibitor, mitochondrial	GO:0051260; P:protein homooligomerization; ISS:UniProtKB
Q9UII2	ATPIF1	ATPase inhibitor, mitochondrial	GO:0051289; P:protein homotetramerization; ISS:UniProtKB
Q9UII2	ATPIF1	ATPase inhibitor, mitochondrial	GO:0072593; P:reactive oxygen species metabolic process; IEA:Ensembl
Q8N6G6	ADAMTSL1	ADAMTS-like protein 1	GO:0008237; F:metallopeptidase activity; IEA:InterPro
Q8N6G6	ADAMTSL1	ADAMTS-like protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86TH1	ADAMTSL2	ADAMTS-like protein 2	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q86TH1	ADAMTSL2	ADAMTS-like protein 2	GO:0005515; F:protein binding; IPI:BHF-UCL
Q86TH1	ADAMTSL2	ADAMTS-like protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86TH1	ADAMTSL2	ADAMTS-like protein 2	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IMP:BHF-UCL
P82987	ADAMTSL3	ADAMTS-like protein 3	GO:0008237; F:metallopeptidase activity; IEA:InterPro
P82987	ADAMTSL3	ADAMTS-like protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6UY14	ADAMTSL4	ADAMTS-like protein 4	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q6UY14	ADAMTSL4	ADAMTS-like protein 4	GO:0002020; F:protease binding; IPI:UniProtKB
Q6UY14	ADAMTSL4	ADAMTS-like protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q6UY14	ADAMTSL4	ADAMTS-like protein 4	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q6UY14	ADAMTSL4	ADAMTS-like protein 4	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q6UY14	ADAMTSL4	ADAMTS-like protein 4	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q6ZMM2	ADAMTSL5	ADAMTS-like protein 5	GO:0008201; F:heparin binding; IDA:UniProtKB
Q6ZMM2	ADAMTSL5	ADAMTS-like protein 5	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q6ZMM2	ADAMTSL5	ADAMTS-like protein 5	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WXF7	ATL1	Atlastin-1	GO:0005525; F:GTP binding; ISS:UniProtKB
Q8WXF7	ATL1	Atlastin-1	GO:0003924; F:GTPase activity; IDA:UniProtKB
Q8WXF7	ATL1	Atlastin-1	GO:0042802; F:identical protein binding; IDA:UniProtKB
Q8WXF7	ATL1	Atlastin-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WXF7	ATL1	Atlastin-1	GO:0007409; P:axonogenesis; ISS:UniProtKB
Q8WXF7	ATL1	Atlastin-1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q8WXF7	ATL1	Atlastin-1	GO:0007029; P:endoplasmic reticulum organization; IDA:UniProtKB
Q8WXF7	ATL1	Atlastin-1	GO:0006184; P:GTP catabolic process; IDA:GOC
Q8WXF7	ATL1	Atlastin-1	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
Q8NHH9	ATL2	Atlastin-2	GO:0005525; F:GTP binding; IEA:InterPro
Q8NHH9	ATL2	Atlastin-2	GO:0003924; F:GTPase activity; IEA:InterPro
Q8NHH9	ATL2	Atlastin-2	GO:0042802; F:identical protein binding; IDA:UniProtKB
Q8NHH9	ATL2	Atlastin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NHH9	ATL2	Atlastin-2	GO:0007029; P:endoplasmic reticulum organization; IMP:UniProtKB
Q8NHH9	ATL2	Atlastin-2	GO:0007030; P:Golgi organization; IMP:UniProtKB
Q8NHH9	ATL2	Atlastin-2	GO:0006184; P:GTP catabolic process; NAS:GOC
Q8NHH9	ATL2	Atlastin-2	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
Q6DD88	ATL3	Atlastin-3	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q6DD88	ATL3	Atlastin-3	GO:0003924; F:GTPase activity; NAS:UniProtKB
Q6DD88	ATL3	Atlastin-3	GO:0042802; F:identical protein binding; IDA:UniProtKB
Q6DD88	ATL3	Atlastin-3	GO:0007029; P:endoplasmic reticulum organization; IMP:UniProtKB
Q6DD88	ATL3	Atlastin-3	GO:0007030; P:Golgi organization; IMP:UniProtKB
Q6DD88	ATL3	Atlastin-3	GO:0006184; P:GTP catabolic process; NAS:GOC
Q6DD88	ATL3	Atlastin-3	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
O43313	ATMIN	ATM interactor	GO:0045502; F:dynein binding; IPI:UniProtKB
O43313	ATMIN	ATM interactor	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43313	ATMIN	ATM interactor	GO:0005515; F:protein binding; IPI:IntAct
O43313	ATMIN	ATM interactor	GO:0044212; F:transcription regulatory region DNA binding; IEA:Ensembl
O43313	ATMIN	ATM interactor	GO:0006974; P:cellular response to DNA damage stimulus; IEA:UniProtKB-KW
O43313	ATMIN	ATM interactor	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O43313	ATMIN	ATM interactor	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13315	ATM	Serine-protein kinase ATM	GO:0016303; F:1-phosphatidylinositol-3-kinase activity; IMP:UniProtKB
Q13315	ATM	Serine-protein kinase ATM	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13315	ATM	Serine-protein kinase ATM	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q13315	ATM	Serine-protein kinase ATM	GO:0004677; F:DNA-dependent protein kinase activity; IDA:BHF-UCL
Q13315	ATM	Serine-protein kinase ATM	GO:0035174; F:histone serine kinase activity; IEA:Ensembl
Q13315	ATM	Serine-protein kinase ATM	GO:0005515; F:protein binding; IPI:UniProtKB
Q13315	ATM	Serine-protein kinase ATM	GO:0032403; F:protein complex binding; IDA:BHF-UCL
Q13315	ATM	Serine-protein kinase ATM	GO:0046983; F:protein dimerization activity; IDA:BHF-UCL
Q13315	ATM	Serine-protein kinase ATM	GO:0047485; F:protein N-terminus binding; IDA:UniProtKB
Q13315	ATM	Serine-protein kinase ATM	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q13315	ATM	Serine-protein kinase ATM	GO:0007420; P:brain development; IEA:Ensembl
Q13315	ATM	Serine-protein kinase ATM	GO:0007050; P:cell cycle arrest; IMP:BHF-UCL
Q13315	ATM	Serine-protein kinase ATM	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
Q13315	ATM	Serine-protein kinase ATM	GO:0071480; P:cellular response to gamma radiation; IDA:BHF-UCL
Q13315	ATM	Serine-protein kinase ATM	GO:0006975; P:DNA damage induced protein phosphorylation; IDA:BHF-UCL
Q13315	ATM	Serine-protein kinase ATM	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
Q13315	ATM	Serine-protein kinase ATM	GO:0006281; P:DNA repair; TAS:Reactome
Q13315	ATM	Serine-protein kinase ATM	GO:0006302; P:double-strand break repair; TAS:Reactome
Q13315	ATM	Serine-protein kinase ATM	GO:0000724; P:double-strand break repair via homologous recombination; TAS:Reactome
Q13315	ATM	Serine-protein kinase ATM	GO:0007507; P:heart development; IEA:Ensembl
Q13315	ATM	Serine-protein kinase ATM	GO:0071044; P:histone mRNA catabolic process; IDA:UniProtKB
Q13315	ATM	Serine-protein kinase ATM	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
Q13315	ATM	Serine-protein kinase ATM	GO:0042159; P:lipoprotein catabolic process; IEA:Ensembl
Q13315	ATM	Serine-protein kinase ATM	GO:0007094; P:mitotic spindle assembly checkpoint; IMP:UniProtKB
Q13315	ATM	Serine-protein kinase ATM	GO:0030889; P:negative regulation of B cell proliferation; IMP:UniProtKB
Q13315	ATM	Serine-protein kinase ATM	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
Q13315	ATM	Serine-protein kinase ATM	GO:0048599; P:oocyte development; IEA:Ensembl
Q13315	ATM	Serine-protein kinase ATM	GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL
Q13315	ATM	Serine-protein kinase ATM	GO:0036092; P:phosphatidylinositol-3-phosphate biosynthetic process; IMP:GOC
Q13315	ATM	Serine-protein kinase ATM	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q13315	ATM	Serine-protein kinase ATM	GO:0043517; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; IMP:BHF-UCL
Q13315	ATM	Serine-protein kinase ATM	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
Q13315	ATM	Serine-protein kinase ATM	GO:0002331; P:pre-B cell allelic exclusion; ISS:UniProtKB
Q13315	ATM	Serine-protein kinase ATM	GO:0046777; P:protein autophosphorylation; IDA:BHF-UCL
Q13315	ATM	Serine-protein kinase ATM	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q13315	ATM	Serine-protein kinase ATM	GO:0007131; P:reciprocal meiotic recombination; TAS:ProtInc
Q13315	ATM	Serine-protein kinase ATM	GO:0090399; P:replicative senescence; IMP:BHF-UCL
Q13315	ATM	Serine-protein kinase ATM	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q13315	ATM	Serine-protein kinase ATM	GO:0010212; P:response to ionizing radiation; IDA:UniProtKB
Q13315	ATM	Serine-protein kinase ATM	GO:0007165; P:signal transduction; TAS:ProtInc
Q13315	ATM	Serine-protein kinase ATM	GO:0072434; P:signal transduction involved in mitotic G2 DNA damage checkpoint; IMP:BHF-UCL
Q13315	ATM	Serine-protein kinase ATM	GO:0001756; P:somitogenesis; IEA:Ensembl
P54259	ATN1	Atrophin-1	GO:0005515; F:protein binding; IPI:UniProtKB
P54259	ATN1	Atrophin-1	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P54259	ATN1	Atrophin-1	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
P54259	ATN1	Atrophin-1	GO:0016477; P:cell migration; IEA:Ensembl
P54259	ATN1	Atrophin-1	GO:0007417; P:central nervous system development; TAS:ProtInc
P54259	ATN1	Atrophin-1	GO:0030011; P:maintenance of cell polarity; IEA:Ensembl
P54259	ATN1	Atrophin-1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P54259	ATN1	Atrophin-1	GO:0051402; P:neuron apoptotic process; IDA:UniProtKB
P54259	ATN1	Atrophin-1	GO:0009404; P:toxin metabolic process; IEA:Ensembl
P54259	ATN1	Atrophin-1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P54710	FXYD2	Sodium/potassium-transporting ATPase subunit gamma	GO:0005216; F:ion channel activity; IEA:InterPro
P54710	FXYD2	Sodium/potassium-transporting ATPase subunit gamma	GO:0005391; F:sodium:potassium-exchanging ATPase activity; TAS:ProtInc
P54710	FXYD2	Sodium/potassium-transporting ATPase subunit gamma	GO:0005215; F:transporter activity; TAS:ProtInc
P54710	FXYD2	Sodium/potassium-transporting ATPase subunit gamma	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P54710	FXYD2	Sodium/potassium-transporting ATPase subunit gamma	GO:0001558; P:regulation of cell growth; IEA:Ensembl
P54710	FXYD2	Sodium/potassium-transporting ATPase subunit gamma	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P54710	FXYD2	Sodium/potassium-transporting ATPase subunit gamma	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
P54710	FXYD2	Sodium/potassium-transporting ATPase subunit gamma	GO:0055085; P:transmembrane transport; TAS:Reactome
P54710	FXYD2	Sodium/potassium-transporting ATPase subunit gamma	GO:0006810; P:transport; TAS:ProtInc
Q92858	ATOH1	Protein atonal homolog 1	GO:0031490; F:chromatin DNA binding; IEA:Ensembl
Q92858	ATOH1	Protein atonal homolog 1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q92858	ATOH1	Protein atonal homolog 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q92858	ATOH1	Protein atonal homolog 1	GO:0042668; P:auditory receptor cell fate determination; IEA:Ensembl
Q92858	ATOH1	Protein atonal homolog 1	GO:0042667; P:auditory receptor cell fate specification; IEA:Ensembl
Q92858	ATOH1	Protein atonal homolog 1	GO:0007411; P:axon guidance; IEA:Ensembl
Q92858	ATOH1	Protein atonal homolog 1	GO:0007417; P:central nervous system development; TAS:ProtInc
Q92858	ATOH1	Protein atonal homolog 1	GO:0021987; P:cerebral cortex development; IEA:Ensembl
Q92858	ATOH1	Protein atonal homolog 1	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q92858	ATOH1	Protein atonal homolog 1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q92858	ATOH1	Protein atonal homolog 1	GO:0001764; P:neuron migration; IEA:Ensembl
Q92858	ATOH1	Protein atonal homolog 1	GO:0045609; P:positive regulation of auditory receptor cell differentiation; IEA:Ensembl
Q92858	ATOH1	Protein atonal homolog 1	GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB
Q92858	ATOH1	Protein atonal homolog 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q92858	ATOH1	Protein atonal homolog 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q8N100	ATOH7	Protein atonal homolog 7	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N100	ATOH7	Protein atonal homolog 7	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8N100	ATOH7	Protein atonal homolog 7	GO:0007623; P:circadian rhythm; IEA:Ensembl
Q8N100	ATOH7	Protein atonal homolog 7	GO:0009649; P:entrainment of circadian clock; IEA:Ensembl
Q8N100	ATOH7	Protein atonal homolog 7	GO:0003407; P:neural retina development; IMP:MGI
Q8N100	ATOH7	Protein atonal homolog 7	GO:0021554; P:optic nerve development; IMP:MGI
Q8N100	ATOH7	Protein atonal homolog 7	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N100	ATOH7	Protein atonal homolog 7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96SQ7	ATOH8	Protein atonal homolog 8	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96SQ7	ATOH8	Protein atonal homolog 8	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96SQ7	ATOH8	Protein atonal homolog 8	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q96SQ7	ATOH8	Protein atonal homolog 8	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96SQ7	ATOH8	Protein atonal homolog 8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O00244	ATOX1	Copper transport protein ATOX1	GO:0016531; F:copper chaperone activity; IDA:UniProtKB
O00244	ATOX1	Copper transport protein ATOX1	GO:0005507; F:copper ion binding; IDA:UniProtKB
O00244	ATOX1	Copper transport protein ATOX1	GO:0032767; F:copper-dependent protein binding; IPI:UniProtKB
O00244	ATOX1	Copper transport protein ATOX1	GO:0016530; F:metallochaperone activity; TAS:UniProtKB
O00244	ATOX1	Copper transport protein ATOX1	GO:0006878; P:cellular copper ion homeostasis; TAS:ProtInc
O00244	ATOX1	Copper transport protein ATOX1	GO:0006825; P:copper ion transport; TAS:UniProtKB
O00244	ATOX1	Copper transport protein ATOX1	GO:0006979; P:response to oxidative stress; TAS:ProtInc
Q9Y6H3	XRCC6BP1	Mitochondrial inner membrane protease ATP23 homolog	GO:0004677; F:DNA-dependent protein kinase activity; TAS:UniProtKB
Q9Y6H3	XRCC6BP1	Mitochondrial inner membrane protease ATP23 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y6H3	XRCC6BP1	Mitochondrial inner membrane protease ATP23 homolog	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q9Y6H3	XRCC6BP1	Mitochondrial inner membrane protease ATP23 homolog	GO:0006303; P:double-strand break repair via nonhomologous end joining; TAS:UniProtKB
Q9Y6H3	XRCC6BP1	Mitochondrial inner membrane protease ATP23 homolog	GO:0006468; P:protein phosphorylation; TAS:GOC
P20648	ATP4A	Potassium-transporting ATPase alpha chain 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P20648	ATP4A	Potassium-transporting ATPase alpha chain 1	GO:0008900; F:hydrogen:potassium-exchanging ATPase activity; TAS:ProtInc
P20648	ATP4A	Potassium-transporting ATPase alpha chain 1	GO:0000287; F:magnesium ion binding; IEA:InterPro
P20648	ATP4A	Potassium-transporting ATPase alpha chain 1	GO:0006754; P:ATP biosynthetic process; IEA:InterPro
P20648	ATP4A	Potassium-transporting ATPase alpha chain 1	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
P20648	ATP4A	Potassium-transporting ATPase alpha chain 1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P20648	ATP4A	Potassium-transporting ATPase alpha chain 1	GO:0045851; P:pH reduction; IEA:Ensembl
P20648	ATP4A	Potassium-transporting ATPase alpha chain 1	GO:0010155; P:regulation of proton transport; IEA:Ensembl
P20648	ATP4A	Potassium-transporting ATPase alpha chain 1	GO:0042493; P:response to drug; IEA:Ensembl
P20648	ATP4A	Potassium-transporting ATPase alpha chain 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P20648	ATP4A	Potassium-transporting ATPase alpha chain 1	GO:0006810; P:transport; TAS:ProtInc
P51164	ATP4B	Potassium-transporting ATPase subunit beta	GO:0008900; F:hydrogen:potassium-exchanging ATPase activity; TAS:ProtInc
P51164	ATP4B	Potassium-transporting ATPase subunit beta	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P51164	ATP4B	Potassium-transporting ATPase subunit beta	GO:1902600; P:hydrogen ion transmembrane transport; TAS:GOC
P51164	ATP4B	Potassium-transporting ATPase subunit beta	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P51164	ATP4B	Potassium-transporting ATPase subunit beta	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P51164	ATP4B	Potassium-transporting ATPase subunit beta	GO:0010243; P:response to organonitrogen compound; IEA:Ensembl
P51164	ATP4B	Potassium-transporting ATPase subunit beta	GO:0006814; P:sodium ion transport; IEA:InterPro
P51164	ATP4B	Potassium-transporting ATPase subunit beta	GO:0055085; P:transmembrane transport; TAS:Reactome
O75947	ATP5H	ATP synthase subunit d, mitochondrial	GO:0015078; F:hydrogen ion transmembrane transporter activity; IEA:InterPro
O75947	ATP5H	ATP synthase subunit d, mitochondrial	GO:0022857; F:transmembrane transporter activity; IC:UniProtKB
O75947	ATP5H	ATP synthase subunit d, mitochondrial	GO:0006200; P:ATP catabolic process; IDA:GOC
O75947	ATP5H	ATP synthase subunit d, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
O75947	ATP5H	ATP synthase subunit d, mitochondrial	GO:0042776; P:mitochondrial ATP synthesis coupled proton transport; IC:UniProtKB
O75947	ATP5H	ATP synthase subunit d, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O75947	ATP5H	ATP synthase subunit d, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P56381	ATP5E	ATP synthase subunit epsilon, mitochondrial	GO:0046933; F:proton-transporting ATP synthase activity, rotational mechanism; IEA:InterPro
P56381	ATP5E	ATP synthase subunit epsilon, mitochondrial	GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; IEA:InterPro
P56381	ATP5E	ATP synthase subunit epsilon, mitochondrial	GO:0022857; F:transmembrane transporter activity; IC:UniProtKB
P56381	ATP5E	ATP synthase subunit epsilon, mitochondrial	GO:0006200; P:ATP catabolic process; IDA:GOC
P56381	ATP5E	ATP synthase subunit epsilon, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P56381	ATP5E	ATP synthase subunit epsilon, mitochondrial	GO:0042776; P:mitochondrial ATP synthesis coupled proton transport; IC:UniProtKB
P56381	ATP5E	ATP synthase subunit epsilon, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P56381	ATP5E	ATP synthase subunit epsilon, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P56385	ATP5I	ATP synthase subunit e, mitochondrial	GO:0015078; F:hydrogen ion transmembrane transporter activity; IEA:InterPro
P56385	ATP5I	ATP synthase subunit e, mitochondrial	GO:0022857; F:transmembrane transporter activity; IC:UniProtKB
P56385	ATP5I	ATP synthase subunit e, mitochondrial	GO:0006200; P:ATP catabolic process; IDA:GOC
P56385	ATP5I	ATP synthase subunit e, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P56385	ATP5I	ATP synthase subunit e, mitochondrial	GO:0042776; P:mitochondrial ATP synthesis coupled proton transport; IC:UniProtKB
P56385	ATP5I	ATP synthase subunit e, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P56385	ATP5I	ATP synthase subunit e, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99766	ATP5S	ATP synthase subunit s, mitochondrial	GO:0015078; F:hydrogen ion transmembrane transporter activity; NAS:UniProtKB
Q99766	ATP5S	ATP synthase subunit s, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q99766	ATP5S	ATP synthase subunit s, mitochondrial	GO:0006754; P:ATP biosynthetic process; IEA:UniProtKB-KW
Q99766	ATP5S	ATP synthase subunit s, mitochondrial	GO:1902600; P:hydrogen ion transmembrane transport; NAS:GOC
Q99766	ATP5S	ATP synthase subunit s, mitochondrial	GO:0015992; P:proton transport; NAS:UniProtKB
O75964	ATP5L	ATP synthase subunit g, mitochondrial	GO:0015078; F:hydrogen ion transmembrane transporter activity; IEA:InterPro
O75964	ATP5L	ATP synthase subunit g, mitochondrial	GO:0022857; F:transmembrane transporter activity; IC:UniProtKB
O75964	ATP5L	ATP synthase subunit g, mitochondrial	GO:0006200; P:ATP catabolic process; IDA:GOC
O75964	ATP5L	ATP synthase subunit g, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
O75964	ATP5L	ATP synthase subunit g, mitochondrial	GO:0042776; P:mitochondrial ATP synthesis coupled proton transport; IC:UniProtKB
O75964	ATP5L	ATP synthase subunit g, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O75964	ATP5L	ATP synthase subunit g, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P18859	ATP5J	ATP synthase-coupling factor 6, mitochondrial	GO:0015078; F:hydrogen ion transmembrane transporter activity; IEA:InterPro
P18859	ATP5J	ATP synthase-coupling factor 6, mitochondrial	GO:0022857; F:transmembrane transporter activity; IC:UniProtKB
P18859	ATP5J	ATP synthase-coupling factor 6, mitochondrial	GO:0005215; F:transporter activity; NAS:ProtInc
P18859	ATP5J	ATP synthase-coupling factor 6, mitochondrial	GO:0006200; P:ATP catabolic process; IDA:GOC
P18859	ATP5J	ATP synthase-coupling factor 6, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P18859	ATP5J	ATP synthase-coupling factor 6, mitochondrial	GO:0042776; P:mitochondrial ATP synthesis coupled proton transport; IC:UniProtKB
P18859	ATP5J	ATP synthase-coupling factor 6, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P18859	ATP5J	ATP synthase-coupling factor 6, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P18859	ATP5J	ATP synthase-coupling factor 6, mitochondrial	GO:0021762; P:substantia nigra development; IEP:UniProt
P00846	MT-ATP6	ATP synthase subunit a	GO:0015078; F:hydrogen ion transmembrane transporter activity; IEA:InterPro
P00846	MT-ATP6	ATP synthase subunit a	GO:0022857; F:transmembrane transporter activity; IC:UniProtKB
P00846	MT-ATP6	ATP synthase subunit a	GO:0006200; P:ATP catabolic process; IDA:GOC
P00846	MT-ATP6	ATP synthase subunit a	GO:0044237; P:cellular metabolic process; TAS:Reactome
P00846	MT-ATP6	ATP synthase subunit a	GO:0042776; P:mitochondrial ATP synthesis coupled proton transport; IC:UniProtKB
P00846	MT-ATP6	ATP synthase subunit a	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P00846	MT-ATP6	ATP synthase subunit a	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0005524; F:ATP binding; TAS:HGNC
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0005507; F:copper ion binding; IDA:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0005375; F:copper ion transmembrane transporter activity; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0032767; F:copper-dependent protein binding; IPI:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0004008; F:copper-exporting ATPase activity; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0016532; F:superoxide dismutase copper chaperone activity; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0001568; P:blood vessel development; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0001974; P:blood vessel remodeling; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0051216; P:cartilage development; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0006584; P:catecholamine metabolic process; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0006878; P:cellular copper ion homeostasis; IMP:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0021954; P:central nervous system neuron development; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0021702; P:cerebellar Purkinje cell differentiation; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0030199; P:collagen fibril organization; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0060003; P:copper ion export; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0015677; P:copper ion import; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0006825; P:copper ion transport; IMP:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0048813; P:dendrite morphogenesis; IEA:Ensembl
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0010273; P:detoxification of copper ion; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0042417; P:dopamine metabolic process; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0048251; P:elastic fiber assembly; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0051542; P:elastin biosynthetic process; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0042414; P:epinephrine metabolic process; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0030198; P:extracellular matrix organization; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0031069; P:hair follicle morphogenesis; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0007595; P:lactation; IEA:Ensembl
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0007626; P:locomotory behavior; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0048286; P:lung alveolus development; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0007005; P:mitochondrion organization; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0048553; P:negative regulation of metalloenzyme activity; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0048812; P:neuron projection morphogenesis; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0042421; P:norepinephrine biosynthetic process; IEA:Ensembl
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0042415; P:norepinephrine metabolic process; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0018205; P:peptidyl-lysine modification; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0043473; P:pigmentation; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0043085; P:positive regulation of catalytic activity; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0048554; P:positive regulation of metalloenzyme activity; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0051353; P:positive regulation of oxidoreductase activity; IDA:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0021860; P:pyramidal neuron development; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0010468; P:regulation of gene expression; IEA:Ensembl
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0002082; P:regulation of oxidative phosphorylation; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0001836; P:release of cytochrome c from mitochondria; IEA:Ensembl
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0019430; P:removal of superoxide radicals; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0010041; P:response to iron(III) ion; IEA:Ensembl
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0010043; P:response to zinc ion; IEA:Ensembl
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0042428; P:serotonin metabolic process; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0043588; P:skin development; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0042093; P:T-helper cell differentiation; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0006568; P:tryptophan metabolic process; ISS:UniProtKB
Q04656	ATP7A	Copper-transporting ATPase 1	GO:0006570; P:tyrosine metabolic process; IEA:Ensembl
P35670	ATP7B	Copper-transporting ATPase 2	GO:0005524; F:ATP binding; IDA:UniProtKB
P35670	ATP7B	Copper-transporting ATPase 2	GO:0005507; F:copper ion binding; IDA:UniProtKB
P35670	ATP7B	Copper-transporting ATPase 2	GO:0004008; F:copper-exporting ATPase activity; NAS:UniProtKB
P35670	ATP7B	Copper-transporting ATPase 2	GO:0005515; F:protein binding; IPI:UniProtKB
P35670	ATP7B	Copper-transporting ATPase 2	GO:0006878; P:cellular copper ion homeostasis; TAS:UniProtKB
P35670	ATP7B	Copper-transporting ATPase 2	GO:0006882; P:cellular zinc ion homeostasis; IEA:Ensembl
P35670	ATP7B	Copper-transporting ATPase 2	GO:0015677; P:copper ion import; IDA:UniProtKB
P35670	ATP7B	Copper-transporting ATPase 2	GO:0006825; P:copper ion transport; IGI:UniProtKB
P35670	ATP7B	Copper-transporting ATPase 2	GO:0015680; P:intracellular copper ion transport; IEA:Ensembl
P35670	ATP7B	Copper-transporting ATPase 2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P35670	ATP7B	Copper-transporting ATPase 2	GO:0007595; P:lactation; IEA:Ensembl
P35670	ATP7B	Copper-transporting ATPase 2	GO:0046688; P:response to copper ion; IDA:UniProtKB
P35670	ATP7B	Copper-transporting ATPase 2	GO:0051208; P:sequestering of calcium ion; IDA:UniProtKB
P35670	ATP7B	Copper-transporting ATPase 2	GO:0055085; P:transmembrane transport; TAS:Reactome
P03928	MT-ATP8	ATP synthase protein 8	GO:0015078; F:hydrogen ion transmembrane transporter activity; IEA:InterPro
P03928	MT-ATP8	ATP synthase protein 8	GO:0022857; F:transmembrane transporter activity; IC:UniProtKB
P03928	MT-ATP8	ATP synthase protein 8	GO:0006200; P:ATP catabolic process; IDA:GOC
P03928	MT-ATP8	ATP synthase protein 8	GO:0044237; P:cellular metabolic process; TAS:Reactome
P03928	MT-ATP8	ATP synthase protein 8	GO:0042776; P:mitochondrial ATP synthesis coupled proton transport; IC:UniProtKB
P03928	MT-ATP8	ATP synthase protein 8	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P03928	MT-ATP8	ATP synthase protein 8	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75110	ATP9A	Probable phospholipid-transporting ATPase IIA	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75110	ATP9A	Probable phospholipid-transporting ATPase IIA	GO:0019829; F:cation-transporting ATPase activity; IEA:InterPro
O75110	ATP9A	Probable phospholipid-transporting ATPase IIA	GO:0000287; F:magnesium ion binding; IEA:InterPro
O75110	ATP9A	Probable phospholipid-transporting ATPase IIA	GO:0004012; F:phospholipid-translocating ATPase activity; IEA:UniProtKB-EC
O75110	ATP9A	Probable phospholipid-transporting ATPase IIA	GO:0045332; P:phospholipid translocation; NAS:UniProtKB
O43861	ATP9B	Probable phospholipid-transporting ATPase IIB	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43861	ATP9B	Probable phospholipid-transporting ATPase IIB	GO:0019829; F:cation-transporting ATPase activity; IEA:InterPro
O43861	ATP9B	Probable phospholipid-transporting ATPase IIB	GO:0000287; F:magnesium ion binding; IEA:InterPro
O43861	ATP9B	Probable phospholipid-transporting ATPase IIB	GO:0004012; F:phospholipid-translocating ATPase activity; IEA:UniProtKB-EC
O43861	ATP9B	Probable phospholipid-transporting ATPase IIB	GO:0072600; P:establishment of protein localization to Golgi; IMP:UniProtKB
O43861	ATP9B	Probable phospholipid-transporting ATPase IIB	GO:0045332; P:phospholipid translocation; NAS:UniProtKB
P25705	ATP5A1	ATP synthase subunit alpha, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P25705	ATP5A1	ATP synthase subunit alpha, mitochondrial	GO:0042288; F:MHC class I protein binding; IDA:UniProtKB
P25705	ATP5A1	ATP synthase subunit alpha, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P25705	ATP5A1	ATP synthase subunit alpha, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
P25705	ATP5A1	ATP synthase subunit alpha, mitochondrial	GO:0046933; F:proton-transporting ATP synthase activity, rotational mechanism; IEA:InterPro
P25705	ATP5A1	ATP synthase subunit alpha, mitochondrial	GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; IEA:InterPro
P25705	ATP5A1	ATP synthase subunit alpha, mitochondrial	GO:0022857; F:transmembrane transporter activity; IC:UniProtKB
P25705	ATP5A1	ATP synthase subunit alpha, mitochondrial	GO:0006754; P:ATP biosynthetic process; NAS:UniProtKB
P25705	ATP5A1	ATP synthase subunit alpha, mitochondrial	GO:0006200; P:ATP catabolic process; IDA:GOC
P25705	ATP5A1	ATP synthase subunit alpha, mitochondrial	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
P25705	ATP5A1	ATP synthase subunit alpha, mitochondrial	GO:0015986; P:ATP synthesis coupled proton transport; IEA:InterPro
P25705	ATP5A1	ATP synthase subunit alpha, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P25705	ATP5A1	ATP synthase subunit alpha, mitochondrial	GO:0009790; P:embryo development; ISS:UniProtKB
P25705	ATP5A1	ATP synthase subunit alpha, mitochondrial	GO:0006629; P:lipid metabolic process; ISS:UniProtKB
P25705	ATP5A1	ATP synthase subunit alpha, mitochondrial	GO:0042776; P:mitochondrial ATP synthesis coupled proton transport; IC:UniProtKB
P25705	ATP5A1	ATP synthase subunit alpha, mitochondrial	GO:0001937; P:negative regulation of endothelial cell proliferation; IMP:UniProtKB
P25705	ATP5A1	ATP synthase subunit alpha, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P25705	ATP5A1	ATP synthase subunit alpha, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P06576	ATP5B	ATP synthase subunit beta, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P06576	ATP5B	ATP synthase subunit beta, mitochondrial	GO:0042288; F:MHC class I protein binding; IDA:UniProtKB
P06576	ATP5B	ATP synthase subunit beta, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
P06576	ATP5B	ATP synthase subunit beta, mitochondrial	GO:0046933; F:proton-transporting ATP synthase activity, rotational mechanism; IEA:InterPro
P06576	ATP5B	ATP synthase subunit beta, mitochondrial	GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; IMP:UniProtKB
P06576	ATP5B	ATP synthase subunit beta, mitochondrial	GO:0022857; F:transmembrane transporter activity; IC:UniProtKB
P06576	ATP5B	ATP synthase subunit beta, mitochondrial	GO:0005215; F:transporter activity; NAS:UniProtKB
P06576	ATP5B	ATP synthase subunit beta, mitochondrial	GO:0001525; P:angiogenesis; IMP:UniProtKB
P06576	ATP5B	ATP synthase subunit beta, mitochondrial	GO:0006754; P:ATP biosynthetic process; IMP:UniProtKB
P06576	ATP5B	ATP synthase subunit beta, mitochondrial	GO:0006200; P:ATP catabolic process; IDA:GOC
P06576	ATP5B	ATP synthase subunit beta, mitochondrial	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
P06576	ATP5B	ATP synthase subunit beta, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P06576	ATP5B	ATP synthase subunit beta, mitochondrial	GO:0006091; P:generation of precursor metabolites and energy; NAS:UniProtKB
P06576	ATP5B	ATP synthase subunit beta, mitochondrial	GO:0006629; P:lipid metabolic process; IEA:Ensembl
P06576	ATP5B	ATP synthase subunit beta, mitochondrial	GO:0042776; P:mitochondrial ATP synthesis coupled proton transport; IC:UniProtKB
P06576	ATP5B	ATP synthase subunit beta, mitochondrial	GO:0006933; P:negative regulation of cell adhesion involved in substrate-bound cell migration; IEA:Ensembl
P06576	ATP5B	ATP synthase subunit beta, mitochondrial	GO:0015992; P:proton transport; IMP:UniProtKB
P06576	ATP5B	ATP synthase subunit beta, mitochondrial	GO:0051453; P:regulation of intracellular pH; IMP:UniProtKB
P06576	ATP5B	ATP synthase subunit beta, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P06576	ATP5B	ATP synthase subunit beta, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P30049	ATP5D	ATP synthase subunit delta, mitochondrial	GO:0046933; F:proton-transporting ATP synthase activity, rotational mechanism; IEA:InterPro
P30049	ATP5D	ATP synthase subunit delta, mitochondrial	GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; IEA:InterPro
P30049	ATP5D	ATP synthase subunit delta, mitochondrial	GO:0022857; F:transmembrane transporter activity; IC:UniProtKB
P30049	ATP5D	ATP synthase subunit delta, mitochondrial	GO:0005215; F:transporter activity; NAS:UniProtKB
P30049	ATP5D	ATP synthase subunit delta, mitochondrial	GO:0006754; P:ATP biosynthetic process; NAS:UniProtKB
P30049	ATP5D	ATP synthase subunit delta, mitochondrial	GO:0006200; P:ATP catabolic process; NAS:UniProtKB
P30049	ATP5D	ATP synthase subunit delta, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P30049	ATP5D	ATP synthase subunit delta, mitochondrial	GO:0042776; P:mitochondrial ATP synthesis coupled proton transport; NAS:UniProtKB
P30049	ATP5D	ATP synthase subunit delta, mitochondrial	GO:0006119; P:oxidative phosphorylation; NAS:UniProtKB
P30049	ATP5D	ATP synthase subunit delta, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P30049	ATP5D	ATP synthase subunit delta, mitochondrial	GO:0046688; P:response to copper ion; NAS:UniProtKB
P30049	ATP5D	ATP synthase subunit delta, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5TC12	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q5TC12	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	GO:0006461; P:protein complex assembly; IEA:InterPro
Q8N5M1	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N5M1	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	GO:0043461; P:proton-transporting ATP synthase complex assembly; NAS:UniProtKB
P36542	ATP5C1	ATP synthase subunit gamma, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P36542	ATP5C1	ATP synthase subunit gamma, mitochondrial	GO:0046933; F:proton-transporting ATP synthase activity, rotational mechanism; IEA:InterPro
P36542	ATP5C1	ATP synthase subunit gamma, mitochondrial	GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; IEA:InterPro
P36542	ATP5C1	ATP synthase subunit gamma, mitochondrial	GO:0022857; F:transmembrane transporter activity; IC:UniProtKB
P36542	ATP5C1	ATP synthase subunit gamma, mitochondrial	GO:0006754; P:ATP biosynthetic process; NAS:UniProtKB
P36542	ATP5C1	ATP synthase subunit gamma, mitochondrial	GO:0006200; P:ATP catabolic process; IDA:GOC
P36542	ATP5C1	ATP synthase subunit gamma, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P36542	ATP5C1	ATP synthase subunit gamma, mitochondrial	GO:0042776; P:mitochondrial ATP synthesis coupled proton transport; IC:UniProtKB
P36542	ATP5C1	ATP synthase subunit gamma, mitochondrial	GO:0006119; P:oxidative phosphorylation; NAS:UniProtKB
P36542	ATP5C1	ATP synthase subunit gamma, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P36542	ATP5C1	ATP synthase subunit gamma, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P56134	ATP5J2	ATP synthase subunit f, mitochondrial	GO:0022857; F:transmembrane transporter activity; IC:UniProtKB
P56134	ATP5J2	ATP synthase subunit f, mitochondrial	GO:0006200; P:ATP catabolic process; IDA:GOC
P56134	ATP5J2	ATP synthase subunit f, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P56134	ATP5J2	ATP synthase subunit f, mitochondrial	GO:0042776; P:mitochondrial ATP synthesis coupled proton transport; IC:UniProtKB
P56134	ATP5J2	ATP synthase subunit f, mitochondrial	GO:0015992; P:proton transport; NAS:UniProtKB
P56134	ATP5J2	ATP synthase subunit f, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P56134	ATP5J2	ATP synthase subunit f, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P48047	ATP5O	ATP synthase subunit O, mitochondrial	GO:0008144; F:drug binding; IDA:UniProtKB
P48047	ATP5O	ATP synthase subunit O, mitochondrial	GO:0046933; F:proton-transporting ATP synthase activity, rotational mechanism; IEA:InterPro
P48047	ATP5O	ATP synthase subunit O, mitochondrial	GO:0022857; F:transmembrane transporter activity; IC:UniProtKB
P48047	ATP5O	ATP synthase subunit O, mitochondrial	GO:0005215; F:transporter activity; NAS:ProtInc
P48047	ATP5O	ATP synthase subunit O, mitochondrial	GO:0006754; P:ATP biosynthetic process; NAS:UniProtKB
P48047	ATP5O	ATP synthase subunit O, mitochondrial	GO:0006200; P:ATP catabolic process; IDA:UniProtKB
P48047	ATP5O	ATP synthase subunit O, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P48047	ATP5O	ATP synthase subunit O, mitochondrial	GO:0042776; P:mitochondrial ATP synthesis coupled proton transport; IMP:UniProtKB
P48047	ATP5O	ATP synthase subunit O, mitochondrial	GO:0015992; P:proton transport; NAS:UniProtKB
P48047	ATP5O	ATP synthase subunit O, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P48047	ATP5O	ATP synthase subunit O, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6RW13	AGTRAP	Type-1 angiotensin II receptor-associated protein	GO:0004945; F:angiotensin type II receptor activity; IEA:Ensembl
Q6RW13	AGTRAP	Type-1 angiotensin II receptor-associated protein	GO:0005515; F:protein binding; IPI:IntAct
Q6RW13	AGTRAP	Type-1 angiotensin II receptor-associated protein	GO:0008217; P:regulation of blood pressure; IEA:Ensembl
Q6RW13	AGTRAP	Type-1 angiotensin II receptor-associated protein	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q8WXE1	ATRIP	ATR-interacting protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WXE1	ATRIP	ATR-interacting protein	GO:0000077; P:DNA damage checkpoint; TAS:UniProtKB
Q8WXE1	ATRIP	ATR-interacting protein	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q8WXE1	ATRIP	ATR-interacting protein	GO:0006260; P:DNA replication; TAS:Reactome
Q5VV63	ATRNL1	Attractin-like protein 1	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q5VV63	ATRNL1	Attractin-like protein 1	GO:0004872; F:receptor activity; IEA:InterPro
Q5VV63	ATRNL1	Attractin-like protein 1	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:Ensembl
Q5VV63	ATRNL1	Attractin-like protein 1	GO:0007275; P:multicellular organismal development; IEA:InterPro
O75882	ATRN	Attractin	GO:0030246; F:carbohydrate binding; IEA:InterPro
O75882	ATRN	Attractin	GO:0004872; F:receptor activity; TAS:ProtInc
O75882	ATRN	Attractin	GO:0021549; P:cerebellum development; IEA:Ensembl
O75882	ATRN	Attractin	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
O75882	ATRN	Attractin	GO:0042552; P:myelination; IEA:Ensembl
O75882	ATRN	Attractin	GO:0043473; P:pigmentation; IEA:Ensembl
O75882	ATRN	Attractin	GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl
O75882	ATRN	Attractin	GO:0006979; P:response to oxidative stress; IEA:Ensembl
P46100	ATRX	Transcriptional regulator ATRX	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P46100	ATRX	Transcriptional regulator ATRX	GO:0003682; F:chromatin binding; IEA:Ensembl
P46100	ATRX	Transcriptional regulator ATRX	GO:0070087; F:chromo shadow domain binding; IPI:BHF-UCL
P46100	ATRX	Transcriptional regulator ATRX	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P46100	ATRX	Transcriptional regulator ATRX	GO:0003678; F:DNA helicase activity; TAS:ProtInc
P46100	ATRX	Transcriptional regulator ATRX	GO:0004386; F:helicase activity; TAS:ProtInc
P46100	ATRX	Transcriptional regulator ATRX	GO:0005515; F:protein binding; IPI:IntAct
P46100	ATRX	Transcriptional regulator ATRX	GO:0008270; F:zinc ion binding; IEA:InterPro
P46100	ATRX	Transcriptional regulator ATRX	GO:0032508; P:DNA duplex unwinding; TAS:GOC
P46100	ATRX	Transcriptional regulator ATRX	GO:0006306; P:DNA methylation; TAS:ProtInc
P46100	ATRX	Transcriptional regulator ATRX	GO:0006310; P:DNA recombination; TAS:ProtInc
P46100	ATRX	Transcriptional regulator ATRX	GO:0006281; P:DNA repair; TAS:ProtInc
P46100	ATRX	Transcriptional regulator ATRX	GO:0030900; P:forebrain development; IEA:Ensembl
P46100	ATRX	Transcriptional regulator ATRX	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0032405; F:MutLalpha complex binding; IDA:MGI
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0032407; F:MutSalpha complex binding; IDA:MGI
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0005515; F:protein binding; IPI:UniProtKB
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0004674; F:protein serine/threonine kinase activity; IDA:BHF-UCL
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0007049; P:cell cycle; TAS:ProtInc
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0006974; P:cellular response to DNA damage stimulus; TAS:UniProtKB
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0071480; P:cellular response to gamma radiation; IDA:BHF-UCL
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0034644; P:cellular response to UV; IMP:BHF-UCL
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0000077; P:DNA damage checkpoint; IDA:UniProtKB
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0006281; P:DNA repair; TAS:Reactome
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0006260; P:DNA replication; TAS:Reactome
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0008156; P:negative regulation of DNA replication; IMP:UniProtKB
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0043517; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; IMP:BHF-UCL
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0046777; P:protein autophosphorylation; IDA:BHF-UCL
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0043393; P:regulation of protein binding; IEA:Ensembl
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0090399; P:replicative senescence; IMP:BHF-UCL
Q13535	ATR	Serine/threonine-protein kinase ATR	GO:0042493; P:response to drug; IEA:Ensembl
Q9H324	ADAMTS10	A disintegrin and metalloproteinase with thrombospondin motifs 10	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q9H324	ADAMTS10	A disintegrin and metalloproteinase with thrombospondin motifs 10	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H324	ADAMTS10	A disintegrin and metalloproteinase with thrombospondin motifs 10	GO:0008270; F:zinc ion binding; IEA:InterPro
P58397	ADAMTS12	A disintegrin and metalloproteinase with thrombospondin motifs 12	GO:0004222; F:metalloendopeptidase activity; IDA:BHF-UCL
P58397	ADAMTS12	A disintegrin and metalloproteinase with thrombospondin motifs 12	GO:0005515; F:protein binding; IPI:IntAct
P58397	ADAMTS12	A disintegrin and metalloproteinase with thrombospondin motifs 12	GO:0008270; F:zinc ion binding; IEA:InterPro
P58397	ADAMTS12	A disintegrin and metalloproteinase with thrombospondin motifs 12	GO:0016477; P:cell migration; IMP:BHF-UCL
P58397	ADAMTS12	A disintegrin and metalloproteinase with thrombospondin motifs 12	GO:0007160; P:cell-matrix adhesion; IMP:BHF-UCL
P58397	ADAMTS12	A disintegrin and metalloproteinase with thrombospondin motifs 12	GO:0071773; P:cellular response to BMP stimulus; IDA:BHF-UCL
P58397	ADAMTS12	A disintegrin and metalloproteinase with thrombospondin motifs 12	GO:0071347; P:cellular response to interleukin-1; IMP:BHF-UCL
P58397	ADAMTS12	A disintegrin and metalloproteinase with thrombospondin motifs 12	GO:0071356; P:cellular response to tumor necrosis factor; IMP:BHF-UCL
P58397	ADAMTS12	A disintegrin and metalloproteinase with thrombospondin motifs 12	GO:2001113; P:negative regulation of cellular response to hepatocyte growth factor stimulus; IDA:BHF-UCL
P58397	ADAMTS12	A disintegrin and metalloproteinase with thrombospondin motifs 12	GO:1902548; P:negative regulation of cellular response to vascular endothelial growth factor stimulus; IDA:BHF-UCL
P58397	ADAMTS12	A disintegrin and metalloproteinase with thrombospondin motifs 12	GO:0032331; P:negative regulation of chondrocyte differentiation; IDA:BHF-UCL
P58397	ADAMTS12	A disintegrin and metalloproteinase with thrombospondin motifs 12	GO:1902203; P:negative regulation of hepatocyte growth factor receptor signaling pathway; IDA:BHF-UCL
P58397	ADAMTS12	A disintegrin and metalloproteinase with thrombospondin motifs 12	GO:0030167; P:proteoglycan catabolic process; IDA:BHF-UCL
P58397	ADAMTS12	A disintegrin and metalloproteinase with thrombospondin motifs 12	GO:0051603; P:proteolysis involved in cellular protein catabolic process; IDA:BHF-UCL
P58397	ADAMTS12	A disintegrin and metalloproteinase with thrombospondin motifs 12	GO:1901509; P:regulation of endothelial tube morphogenesis; IDA:BHF-UCL
P58397	ADAMTS12	A disintegrin and metalloproteinase with thrombospondin motifs 12	GO:0050727; P:regulation of inflammatory response; IDA:BHF-UCL
Q76LX8	ADAMTS13	A disintegrin and metalloproteinase with thrombospondin motifs 13	GO:0005509; F:calcium ion binding; TAS:UniProtKB
Q76LX8	ADAMTS13	A disintegrin and metalloproteinase with thrombospondin motifs 13	GO:0005178; F:integrin binding; TAS:UniProtKB
Q76LX8	ADAMTS13	A disintegrin and metalloproteinase with thrombospondin motifs 13	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q76LX8	ADAMTS13	A disintegrin and metalloproteinase with thrombospondin motifs 13	GO:0008237; F:metallopeptidase activity; TAS:UniProtKB
Q76LX8	ADAMTS13	A disintegrin and metalloproteinase with thrombospondin motifs 13	GO:0005515; F:protein binding; IPI:UniProtKB
Q76LX8	ADAMTS13	A disintegrin and metalloproteinase with thrombospondin motifs 13	GO:0008270; F:zinc ion binding; TAS:UniProtKB
Q76LX8	ADAMTS13	A disintegrin and metalloproteinase with thrombospondin motifs 13	GO:0007160; P:cell-matrix adhesion; NAS:UniProtKB
Q76LX8	ADAMTS13	A disintegrin and metalloproteinase with thrombospondin motifs 13	GO:0009100; P:glycoprotein metabolic process; NAS:UniProtKB
Q76LX8	ADAMTS13	A disintegrin and metalloproteinase with thrombospondin motifs 13	GO:0007229; P:integrin-mediated signaling pathway; NAS:UniProtKB
Q76LX8	ADAMTS13	A disintegrin and metalloproteinase with thrombospondin motifs 13	GO:0043171; P:peptide catabolic process; IDA:UniProtKB
Q76LX8	ADAMTS13	A disintegrin and metalloproteinase with thrombospondin motifs 13	GO:0030168; P:platelet activation; NAS:UniProtKB
Q76LX8	ADAMTS13	A disintegrin and metalloproteinase with thrombospondin motifs 13	GO:0016485; P:protein processing; TAS:UniProtKB
Q76LX8	ADAMTS13	A disintegrin and metalloproteinase with thrombospondin motifs 13	GO:0006508; P:proteolysis; IDA:UniProtKB
Q76LX8	ADAMTS13	A disintegrin and metalloproteinase with thrombospondin motifs 13	GO:0034341; P:response to interferon-gamma; IEA:Ensembl
Q76LX8	ADAMTS13	A disintegrin and metalloproteinase with thrombospondin motifs 13	GO:0070670; P:response to interleukin-4; IEA:Ensembl
Q76LX8	ADAMTS13	A disintegrin and metalloproteinase with thrombospondin motifs 13	GO:0034612; P:response to tumor necrosis factor; IEA:Ensembl
Q8WXS8	ADAMTS14	A disintegrin and metalloproteinase with thrombospondin motifs 14	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q8WXS8	ADAMTS14	A disintegrin and metalloproteinase with thrombospondin motifs 14	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WXS8	ADAMTS14	A disintegrin and metalloproteinase with thrombospondin motifs 14	GO:0030574; P:collagen catabolic process; IEA:UniProtKB-KW
Q8WXS8	ADAMTS14	A disintegrin and metalloproteinase with thrombospondin motifs 14	GO:0030199; P:collagen fibril organization; IEA:Ensembl
Q8WXS8	ADAMTS14	A disintegrin and metalloproteinase with thrombospondin motifs 14	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q8TE58	ADAMTS15	A disintegrin and metalloproteinase with thrombospondin motifs 15	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q8TE58	ADAMTS15	A disintegrin and metalloproteinase with thrombospondin motifs 15	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TE57	ADAMTS16	A disintegrin and metalloproteinase with thrombospondin motifs 16	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q8TE57	ADAMTS16	A disintegrin and metalloproteinase with thrombospondin motifs 16	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TE56	ADAMTS17	A disintegrin and metalloproteinase with thrombospondin motifs 17	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q8TE56	ADAMTS17	A disintegrin and metalloproteinase with thrombospondin motifs 17	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TE60	ADAMTS18	A disintegrin and metalloproteinase with thrombospondin motifs 18	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q8TE60	ADAMTS18	A disintegrin and metalloproteinase with thrombospondin motifs 18	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TE60	ADAMTS18	A disintegrin and metalloproteinase with thrombospondin motifs 18	GO:0001654; P:eye development; IMP:UniProtKB
Q8TE59	ADAMTS19	A disintegrin and metalloproteinase with thrombospondin motifs 19	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q8TE59	ADAMTS19	A disintegrin and metalloproteinase with thrombospondin motifs 19	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UHI8	ADAMTS1	A disintegrin and metalloproteinase with thrombospondin motifs 1	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
Q9UHI8	ADAMTS1	A disintegrin and metalloproteinase with thrombospondin motifs 1	GO:0004222; F:metalloendopeptidase activity; IEA:Ensembl
Q9UHI8	ADAMTS1	A disintegrin and metalloproteinase with thrombospondin motifs 1	GO:0008237; F:metallopeptidase activity; TAS:ProtInc
Q9UHI8	ADAMTS1	A disintegrin and metalloproteinase with thrombospondin motifs 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UHI8	ADAMTS1	A disintegrin and metalloproteinase with thrombospondin motifs 1	GO:0060347; P:heart trabecula formation; IEA:Ensembl
Q9UHI8	ADAMTS1	A disintegrin and metalloproteinase with thrombospondin motifs 1	GO:0007229; P:integrin-mediated signaling pathway; TAS:ProtInc
Q9UHI8	ADAMTS1	A disintegrin and metalloproteinase with thrombospondin motifs 1	GO:0001822; P:kidney development; IEA:Ensembl
Q9UHI8	ADAMTS1	A disintegrin and metalloproteinase with thrombospondin motifs 1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q9UHI8	ADAMTS1	A disintegrin and metalloproteinase with thrombospondin motifs 1	GO:0001542; P:ovulation from ovarian follicle; IEA:Ensembl
P59510	ADAMTS20	A disintegrin and metalloproteinase with thrombospondin motifs 20	GO:0004222; F:metalloendopeptidase activity; IEA:Ensembl
P59510	ADAMTS20	A disintegrin and metalloproteinase with thrombospondin motifs 20	GO:0008270; F:zinc ion binding; IEA:InterPro
P59510	ADAMTS20	A disintegrin and metalloproteinase with thrombospondin motifs 20	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
P59510	ADAMTS20	A disintegrin and metalloproteinase with thrombospondin motifs 20	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P59510	ADAMTS20	A disintegrin and metalloproteinase with thrombospondin motifs 20	GO:0045636; P:positive regulation of melanocyte differentiation; IEA:Ensembl
P59510	ADAMTS20	A disintegrin and metalloproteinase with thrombospondin motifs 20	GO:0009967; P:positive regulation of signal transduction; IEA:Ensembl
O95450	ADAMTS2	A disintegrin and metalloproteinase with thrombospondin motifs 2	GO:0004222; F:metalloendopeptidase activity; TAS:ProtInc
O95450	ADAMTS2	A disintegrin and metalloproteinase with thrombospondin motifs 2	GO:0008237; F:metallopeptidase activity; TAS:ProtInc
O95450	ADAMTS2	A disintegrin and metalloproteinase with thrombospondin motifs 2	GO:0008270; F:zinc ion binding; IEA:InterPro
O95450	ADAMTS2	A disintegrin and metalloproteinase with thrombospondin motifs 2	GO:0030574; P:collagen catabolic process; IEA:UniProtKB-KW
O95450	ADAMTS2	A disintegrin and metalloproteinase with thrombospondin motifs 2	GO:0030199; P:collagen fibril organization; IEA:Ensembl
O95450	ADAMTS2	A disintegrin and metalloproteinase with thrombospondin motifs 2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O95450	ADAMTS2	A disintegrin and metalloproteinase with thrombospondin motifs 2	GO:0030324; P:lung development; IEA:Ensembl
O95450	ADAMTS2	A disintegrin and metalloproteinase with thrombospondin motifs 2	GO:0043588; P:skin development; IEA:Ensembl
O95450	ADAMTS2	A disintegrin and metalloproteinase with thrombospondin motifs 2	GO:0007283; P:spermatogenesis; IEA:Ensembl
O15072	ADAMTS3	A disintegrin and metalloproteinase with thrombospondin motifs 3	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
O15072	ADAMTS3	A disintegrin and metalloproteinase with thrombospondin motifs 3	GO:0004222; F:metalloendopeptidase activity; NAS:UniProtKB
O15072	ADAMTS3	A disintegrin and metalloproteinase with thrombospondin motifs 3	GO:0008270; F:zinc ion binding; NAS:UniProtKB
O15072	ADAMTS3	A disintegrin and metalloproteinase with thrombospondin motifs 3	GO:0030574; P:collagen catabolic process; NAS:UniProtKB
O15072	ADAMTS3	A disintegrin and metalloproteinase with thrombospondin motifs 3	GO:0030199; P:collagen fibril organization; NAS:UniProtKB
O15072	ADAMTS3	A disintegrin and metalloproteinase with thrombospondin motifs 3	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O75173	ADAMTS4	A disintegrin and metalloproteinase with thrombospondin motifs 4	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
O75173	ADAMTS4	A disintegrin and metalloproteinase with thrombospondin motifs 4	GO:0008237; F:metallopeptidase activity; TAS:ProtInc
O75173	ADAMTS4	A disintegrin and metalloproteinase with thrombospondin motifs 4	GO:0008233; F:peptidase activity; TAS:ProtInc
O75173	ADAMTS4	A disintegrin and metalloproteinase with thrombospondin motifs 4	GO:0002020; F:protease binding; IPI:BHF-UCL
O75173	ADAMTS4	A disintegrin and metalloproteinase with thrombospondin motifs 4	GO:0005515; F:protein binding; IPI:UniProtKB
O75173	ADAMTS4	A disintegrin and metalloproteinase with thrombospondin motifs 4	GO:0008270; F:zinc ion binding; IEA:InterPro
O75173	ADAMTS4	A disintegrin and metalloproteinase with thrombospondin motifs 4	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
O75173	ADAMTS4	A disintegrin and metalloproteinase with thrombospondin motifs 4	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O75173	ADAMTS4	A disintegrin and metalloproteinase with thrombospondin motifs 4	GO:0006508; P:proteolysis; TAS:ProtInc
O75173	ADAMTS4	A disintegrin and metalloproteinase with thrombospondin motifs 4	GO:0001501; P:skeletal system development; TAS:ProtInc
Q9UNA0	ADAMTS5	A disintegrin and metalloproteinase with thrombospondin motifs 5	GO:0005178; F:integrin binding; TAS:ProtInc
Q9UNA0	ADAMTS5	A disintegrin and metalloproteinase with thrombospondin motifs 5	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q9UNA0	ADAMTS5	A disintegrin and metalloproteinase with thrombospondin motifs 5	GO:0008237; F:metallopeptidase activity; TAS:ProtInc
Q9UNA0	ADAMTS5	A disintegrin and metalloproteinase with thrombospondin motifs 5	GO:0005515; F:protein binding; IPI:IntAct
Q9UNA0	ADAMTS5	A disintegrin and metalloproteinase with thrombospondin motifs 5	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UNA0	ADAMTS5	A disintegrin and metalloproteinase with thrombospondin motifs 5	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q9UNA0	ADAMTS5	A disintegrin and metalloproteinase with thrombospondin motifs 5	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q9UNA0	ADAMTS5	A disintegrin and metalloproteinase with thrombospondin motifs 5	GO:0006508; P:proteolysis; TAS:ProtInc
Q9UKP5	ADAMTS6	A disintegrin and metalloproteinase with thrombospondin motifs 6	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q9UKP5	ADAMTS6	A disintegrin and metalloproteinase with thrombospondin motifs 6	GO:0008237; F:metallopeptidase activity; TAS:ProtInc
Q9UKP5	ADAMTS6	A disintegrin and metalloproteinase with thrombospondin motifs 6	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UKP4	ADAMTS7	A disintegrin and metalloproteinase with thrombospondin motifs 7	GO:0004222; F:metalloendopeptidase activity; IDA:BHF-UCL
Q9UKP4	ADAMTS7	A disintegrin and metalloproteinase with thrombospondin motifs 7	GO:0008237; F:metallopeptidase activity; TAS:ProtInc
Q9UKP4	ADAMTS7	A disintegrin and metalloproteinase with thrombospondin motifs 7	GO:0005515; F:protein binding; IPI:BHF-UCL
Q9UKP4	ADAMTS7	A disintegrin and metalloproteinase with thrombospondin motifs 7	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UKP4	ADAMTS7	A disintegrin and metalloproteinase with thrombospondin motifs 7	GO:0071773; P:cellular response to BMP stimulus; IDA:BHF-UCL
Q9UKP4	ADAMTS7	A disintegrin and metalloproteinase with thrombospondin motifs 7	GO:0071347; P:cellular response to interleukin-1; IMP:BHF-UCL
Q9UKP4	ADAMTS7	A disintegrin and metalloproteinase with thrombospondin motifs 7	GO:0071356; P:cellular response to tumor necrosis factor; IMP:BHF-UCL
Q9UKP4	ADAMTS7	A disintegrin and metalloproteinase with thrombospondin motifs 7	GO:0032331; P:negative regulation of chondrocyte differentiation; IDA:BHF-UCL
Q9UKP4	ADAMTS7	A disintegrin and metalloproteinase with thrombospondin motifs 7	GO:0051603; P:proteolysis involved in cellular protein catabolic process; IMP:BHF-UCL
Q9UP79	ADAMTS8	A disintegrin and metalloproteinase with thrombospondin motifs 8	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
Q9UP79	ADAMTS8	A disintegrin and metalloproteinase with thrombospondin motifs 8	GO:0005178; F:integrin binding; TAS:ProtInc
Q9UP79	ADAMTS8	A disintegrin and metalloproteinase with thrombospondin motifs 8	GO:0009673; F:low affinity phosphate transmembrane transporter activity; TAS:ProtInc
Q9UP79	ADAMTS8	A disintegrin and metalloproteinase with thrombospondin motifs 8	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q9UP79	ADAMTS8	A disintegrin and metalloproteinase with thrombospondin motifs 8	GO:0008237; F:metallopeptidase activity; TAS:ProtInc
Q9UP79	ADAMTS8	A disintegrin and metalloproteinase with thrombospondin motifs 8	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UP79	ADAMTS8	A disintegrin and metalloproteinase with thrombospondin motifs 8	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q9UP79	ADAMTS8	A disintegrin and metalloproteinase with thrombospondin motifs 8	GO:0035435; P:phosphate ion transmembrane transport; TAS:GOC
Q9P2N4	ADAMTS9	A disintegrin and metalloproteinase with thrombospondin motifs 9	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q9P2N4	ADAMTS9	A disintegrin and metalloproteinase with thrombospondin motifs 9	GO:0008237; F:metallopeptidase activity; IDA:MGI
Q9P2N4	ADAMTS9	A disintegrin and metalloproteinase with thrombospondin motifs 9	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9P2N4	ADAMTS9	A disintegrin and metalloproteinase with thrombospondin motifs 9	GO:0006516; P:glycoprotein catabolic process; TAS:ProtInc
Q9P2N4	ADAMTS9	A disintegrin and metalloproteinase with thrombospondin motifs 9	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q9P2N4	ADAMTS9	A disintegrin and metalloproteinase with thrombospondin motifs 9	GO:0045636; P:positive regulation of melanocyte differentiation; IEA:Ensembl
Q9P2N4	ADAMTS9	A disintegrin and metalloproteinase with thrombospondin motifs 9	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9P2N4	ADAMTS9	A disintegrin and metalloproteinase with thrombospondin motifs 9	GO:0006508; P:proteolysis; IDA:MGI
Q9P2N4	ADAMTS9	A disintegrin and metalloproteinase with thrombospondin motifs 9	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
P17735	TAT	Tyrosine aminotransferase	GO:0016597; F:amino acid binding; IEA:Ensembl
P17735	TAT	Tyrosine aminotransferase	GO:0080130; F:L-phenylalanine:2-oxoglutarate aminotransferase activity; IEA:UniProtKB-EC
P17735	TAT	Tyrosine aminotransferase	GO:0004838; F:L-tyrosine:2-oxoglutarate aminotransferase activity; IDA:UniProtKB
P17735	TAT	Tyrosine aminotransferase	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
P17735	TAT	Tyrosine aminotransferase	GO:0006103; P:2-oxoglutarate metabolic process; IDA:UniProtKB
P17735	TAT	Tyrosine aminotransferase	GO:0009058; P:biosynthetic process; IEA:InterPro
P17735	TAT	Tyrosine aminotransferase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P17735	TAT	Tyrosine aminotransferase	GO:0006536; P:glutamate metabolic process; IDA:UniProtKB
P17735	TAT	Tyrosine aminotransferase	GO:0006559; P:L-phenylalanine catabolic process; TAS:Reactome
P17735	TAT	Tyrosine aminotransferase	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P17735	TAT	Tyrosine aminotransferase	GO:0046689; P:response to mercury ion; IEA:Ensembl
P17735	TAT	Tyrosine aminotransferase	GO:0006979; P:response to oxidative stress; IEA:Ensembl
P17735	TAT	Tyrosine aminotransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P17735	TAT	Tyrosine aminotransferase	GO:0006572; P:tyrosine catabolic process; IDA:UniProtKB
Q9UBB4	ATXN10	Ataxin-10	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBB4	ATXN10	Ataxin-10	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9UBB4	ATXN10	Ataxin-10	GO:0007399; P:nervous system development; IMP:UniProtKB
Q9UBB4	ATXN10	Ataxin-10	GO:0031175; P:neuron projection development; IDA:UniProtKB
P0C7T5	ATXN1L	Ataxin-1-like	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P0C7T5	ATXN1L	Ataxin-1-like	GO:0005515; F:protein binding; IPI:IntAct
P0C7T5	ATXN1L	Ataxin-1-like	GO:0003723; F:RNA binding; IEA:InterPro
P0C7T5	ATXN1L	Ataxin-1-like	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P0C7T5	ATXN1L	Ataxin-1-like	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P54253	ATXN1	Ataxin-1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P54253	ATXN1	Ataxin-1	GO:0042802; F:identical protein binding; IPI:IntAct
P54253	ATXN1	Ataxin-1	GO:0034046; F:poly(G) binding; IDA:UniProtKB
P54253	ATXN1	Ataxin-1	GO:0008266; F:poly(U) RNA binding; IDA:UniProtKB
P54253	ATXN1	Ataxin-1	GO:0005515; F:protein binding; IPI:UniProtKB
P54253	ATXN1	Ataxin-1	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P54253	ATXN1	Ataxin-1	GO:0043621; F:protein self-association; IDA:UniProtKB
P54253	ATXN1	Ataxin-1	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P54253	ATXN1	Ataxin-1	GO:0008219; P:cell death; IEA:UniProtKB-KW
P54253	ATXN1	Ataxin-1	GO:0043569; P:negative regulation of insulin-like growth factor receptor signaling pathway; IEA:Ensembl
P54253	ATXN1	Ataxin-1	GO:0042326; P:negative regulation of phosphorylation; IEA:Ensembl
P54253	ATXN1	Ataxin-1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P54253	ATXN1	Ataxin-1	GO:0051168; P:nuclear export; IDA:UniProtKB
P54253	ATXN1	Ataxin-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P54253	ATXN1	Ataxin-1	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
P54253	ATXN1	Ataxin-1	GO:0006396; P:RNA processing; NAS:UniProtKB
P54253	ATXN1	Ataxin-1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P54253	ATXN1	Ataxin-1	GO:0008542; P:visual learning; IEA:Ensembl
Q8WWM7	ATXN2L	Ataxin-2-like protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8WWM7	ATXN2L	Ataxin-2-like protein	GO:0005515; F:protein binding; IPI:IntAct
Q8WWM7	ATXN2L	Ataxin-2-like protein	GO:0010603; P:regulation of cytoplasmic mRNA processing body assembly; IDA:UniProtKB
Q8WWM7	ATXN2L	Ataxin-2-like protein	GO:0034063; P:stress granule assembly; IMP:UniProtKB
Q99700	ATXN2	Ataxin-2	GO:0005154; F:epidermal growth factor receptor binding; IPI:UniProtKB
Q99700	ATXN2	Ataxin-2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q99700	ATXN2	Ataxin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q99700	ATXN2	Ataxin-2	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q99700	ATXN2	Ataxin-2	GO:0003723; F:RNA binding; NAS:UniProtKB
Q99700	ATXN2	Ataxin-2	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q99700	ATXN2	Ataxin-2	GO:0021702; P:cerebellar Purkinje cell differentiation; IEA:Ensembl
Q99700	ATXN2	Ataxin-2	GO:0033962; P:cytoplasmic mRNA processing body assembly; IMP:UniProtKB
Q99700	ATXN2	Ataxin-2	GO:0048872; P:homeostasis of number of cells; IEA:Ensembl
Q99700	ATXN2	Ataxin-2	GO:0040015; P:negative regulation of multicellular organism growth; IEA:Ensembl
Q99700	ATXN2	Ataxin-2	GO:0002091; P:negative regulation of receptor internalization; IMP:UniProtKB
Q99700	ATXN2	Ataxin-2	GO:0050905; P:neuromuscular process; IEA:Ensembl
Q99700	ATXN2	Ataxin-2	GO:0048812; P:neuron projection morphogenesis; IEA:Ensembl
Q99700	ATXN2	Ataxin-2	GO:0006417; P:regulation of translation; NAS:UniProtKB
Q99700	ATXN2	Ataxin-2	GO:0016070; P:RNA metabolic process; NAS:UniProtKB
Q99700	ATXN2	Ataxin-2	GO:0050658; P:RNA transport; NAS:UniProtKB
Q99700	ATXN2	Ataxin-2	GO:0034063; P:stress granule assembly; IMP:UniProtKB
Q9H3M9	ATXN3L	Putative ataxin-3-like protein	GO:0008242; F:omega peptidase activity; IEA:InterPro
Q9H3M9	ATXN3L	Putative ataxin-3-like protein	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q9H3M9	ATXN3L	Putative ataxin-3-like protein	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
Q9H3M9	ATXN3L	Putative ataxin-3-like protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H3M9	ATXN3L	Putative ataxin-3-like protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P54252	ATXN3	Ataxin-3	GO:0042802; F:identical protein binding; IPI:IntAct
P54252	ATXN3	Ataxin-3	GO:0008242; F:omega peptidase activity; IEA:InterPro
P54252	ATXN3	Ataxin-3	GO:0005515; F:protein binding; IPI:IntAct
P54252	ATXN3	Ataxin-3	GO:0031625; F:ubiquitin protein ligase binding; ISS:UniProtKB
P54252	ATXN3	Ataxin-3	GO:0004221; F:ubiquitin thiolesterase activity; ISS:UniProtKB
P54252	ATXN3	Ataxin-3	GO:0004843; F:ubiquitin-specific protease activity; ISS:UniProtKB
P54252	ATXN3	Ataxin-3	GO:0030036; P:actin cytoskeleton organization; IMP:MGI
P54252	ATXN3	Ataxin-3	GO:0008219; P:cell death; IEA:UniProtKB-KW
P54252	ATXN3	Ataxin-3	GO:0071218; P:cellular response to misfolded protein; ISS:UniProtKB
P54252	ATXN3	Ataxin-3	GO:0045104; P:intermediate filament cytoskeleton organization; IMP:MGI
P54252	ATXN3	Ataxin-3	GO:0000226; P:microtubule cytoskeleton organization; IMP:MGI
P54252	ATXN3	Ataxin-3	GO:0006515; P:misfolded or incompletely synthesized protein catabolic process; ISS:UniProtKB
P54252	ATXN3	Ataxin-3	GO:0035520; P:monoubiquitinated protein deubiquitination; ISS:UniProtKB
P54252	ATXN3	Ataxin-3	GO:0007399; P:nervous system development; TAS:ProtInc
P54252	ATXN3	Ataxin-3	GO:0006289; P:nucleotide-excision repair; TAS:ProtInc
P54252	ATXN3	Ataxin-3	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB
P54252	ATXN3	Ataxin-3	GO:0010810; P:regulation of cell-substrate adhesion; IMP:MGI
P54252	ATXN3	Ataxin-3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P54252	ATXN3	Ataxin-3	GO:0007268; P:synaptic transmission; TAS:ProtInc
P54252	ATXN3	Ataxin-3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15265	ATXN7	Ataxin-7	GO:0003682; F:chromatin binding; IEA:Ensembl
O15265	ATXN7	Ataxin-7	GO:0005515; F:protein binding; IPI:UniProtKB
O15265	ATXN7	Ataxin-7	GO:0008219; P:cell death; IEA:UniProtKB-KW
O15265	ATXN7	Ataxin-7	GO:0006325; P:chromatin organization; TAS:Reactome
O15265	ATXN7	Ataxin-7	GO:0016578; P:histone deubiquitination; IDA:UniProtKB
O15265	ATXN7	Ataxin-7	GO:0000226; P:microtubule cytoskeleton organization; IMP:UniProtKB
O15265	ATXN7	Ataxin-7	GO:0043569; P:negative regulation of insulin-like growth factor receptor signaling pathway; IEA:Ensembl
O15265	ATXN7	Ataxin-7	GO:0042326; P:negative regulation of phosphorylation; IEA:Ensembl
O15265	ATXN7	Ataxin-7	GO:0006997; P:nucleus organization; TAS:ProtInc
O15265	ATXN7	Ataxin-7	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O15265	ATXN7	Ataxin-7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15265	ATXN7	Ataxin-7	GO:0007601; P:visual perception; TAS:ProtInc
Q156A1	ATXN8	Ataxin-8	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9H1Z8	C2orf40	Augurin	GO:0090398; P:cellular senescence; IEA:Ensembl
Q9H1Z8	C2orf40	Augurin	GO:0008054; P:cyclin catabolic process; IEA:Ensembl
Q9H1Z8	C2orf40	Augurin	GO:0070314; P:G1 to G0 transition; IEA:Ensembl
Q13825	AUH	Methylglutaconyl-CoA hydratase, mitochondrial	GO:0004300; F:enoyl-CoA hydratase activity; IDA:UniProtKB
Q13825	AUH	Methylglutaconyl-CoA hydratase, mitochondrial	GO:0004490; F:methylglutaconyl-CoA hydratase activity; EXP:Reactome
Q13825	AUH	Methylglutaconyl-CoA hydratase, mitochondrial	GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB
Q13825	AUH	Methylglutaconyl-CoA hydratase, mitochondrial	GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome
Q13825	AUH	Methylglutaconyl-CoA hydratase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q13825	AUH	Methylglutaconyl-CoA hydratase, mitochondrial	GO:0006552; P:leucine catabolic process; IEA:UniProtKB-UniPathway
Q13825	AUH	Methylglutaconyl-CoA hydratase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H7T9	AUNIP	Aurora kinase A and ninein-interacting protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H7T9	AUNIP	Aurora kinase A and ninein-interacting protein	GO:0007051; P:spindle organization; IMP:UniProtKB
Q9Y679	AUP1	Ancient ubiquitous protein 1	GO:0005515; F:protein binding; IPI:IntAct
O14965	AURKA	Aurora kinase A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O14965	AURKA	Aurora kinase A	GO:0005515; F:protein binding; IPI:UniProtKB
O14965	AURKA	Aurora kinase A	GO:0004672; F:protein kinase activity; IDA:UniProtKB
O14965	AURKA	Aurora kinase A	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O14965	AURKA	Aurora kinase A	GO:0004674; F:protein serine/threonine kinase activity; EXP:Reactome
O14965	AURKA	Aurora kinase A	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; TAS:UniProtKB
O14965	AURKA	Aurora kinase A	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
O14965	AURKA	Aurora kinase A	GO:0007049; P:cell cycle; NAS:UniProtKB
O14965	AURKA	Aurora kinase A	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
O14965	AURKA	Aurora kinase A	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
O14965	AURKA	Aurora kinase A	GO:0007067; P:mitosis; TAS:ProtInc
O14965	AURKA	Aurora kinase A	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O14965	AURKA	Aurora kinase A	GO:0032091; P:negative regulation of protein binding; IDA:UniProtKB
O14965	AURKA	Aurora kinase A	GO:0048015; P:phosphatidylinositol-mediated signaling; NAS:UniProtKB
O14965	AURKA	Aurora kinase A	GO:0045840; P:positive regulation of mitosis; TAS:UniProtKB
O14965	AURKA	Aurora kinase A	GO:0046777; P:protein autophosphorylation; TAS:UniProtKB
O14965	AURKA	Aurora kinase A	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
O14965	AURKA	Aurora kinase A	GO:0046605; P:regulation of centrosome cycle; TAS:UniProtKB
O14965	AURKA	Aurora kinase A	GO:0031647; P:regulation of protein stability; IMP:UniProtKB
O14965	AURKA	Aurora kinase A	GO:0007051; P:spindle organization; NAS:UniProtKB
O14965	AURKA	Aurora kinase A	GO:0043146; P:spindle stabilization; IMP:UniProtKB
Q96GD4	AURKB	Aurora kinase B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96GD4	AURKB	Aurora kinase B	GO:0035174; F:histone serine kinase activity; ISS:UniProtKB
Q96GD4	AURKB	Aurora kinase B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96GD4	AURKB	Aurora kinase B	GO:0005515; F:protein binding; IPI:UniProtKB
Q96GD4	AURKB	Aurora kinase B	GO:0004674; F:protein serine/threonine kinase activity; IDA:FlyBase
Q96GD4	AURKB	Aurora kinase B	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; TAS:UniProtKB
Q96GD4	AURKB	Aurora kinase B	GO:0007568; P:aging; IEA:Ensembl
Q96GD4	AURKB	Aurora kinase B	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q96GD4	AURKB	Aurora kinase B	GO:0008608; P:attachment of spindle microtubules to kinetochore; TAS:UniProtKB
Q96GD4	AURKB	Aurora kinase B	GO:0008283; P:cell proliferation; IEA:Ensembl
Q96GD4	AURKB	Aurora kinase B	GO:0034644; P:cellular response to UV; IDA:UniProtKB
Q96GD4	AURKB	Aurora kinase B	GO:0036089; P:cleavage furrow formation; IDA:UniProtKB
Q96GD4	AURKB	Aurora kinase B	GO:0043988; P:histone H3-S28 phosphorylation; ISS:UniProtKB
Q96GD4	AURKB	Aurora kinase B	GO:0016570; P:histone modification; TAS:UniProtKB
Q96GD4	AURKB	Aurora kinase B	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q96GD4	AURKB	Aurora kinase B	GO:0002903; P:negative regulation of B cell apoptotic process; IDA:UniProtKB
Q96GD4	AURKB	Aurora kinase B	GO:0032091; P:negative regulation of protein binding; IDA:UniProtKB
Q96GD4	AURKB	Aurora kinase B	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q96GD4	AURKB	Aurora kinase B	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB
Q96GD4	AURKB	Aurora kinase B	GO:0046777; P:protein autophosphorylation; TAS:UniProtKB
Q96GD4	AURKB	Aurora kinase B	GO:0034501; P:protein localization to kinetochore; IMP:UniProtKB
Q96GD4	AURKB	Aurora kinase B	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q96GD4	AURKB	Aurora kinase B	GO:0051983; P:regulation of chromosome segregation; TAS:UniProtKB
Q96GD4	AURKB	Aurora kinase B	GO:0031577; P:spindle checkpoint; IEA:InterPro
Q96GD4	AURKB	Aurora kinase B	GO:0051256; P:spindle midzone assembly involved in mitosis; IMP:UniProtKB
Q96GD4	AURKB	Aurora kinase B	GO:0043146; P:spindle stabilization; IMP:UniProtKB
Q9UQB9	AURKC	Aurora kinase C	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UQB9	AURKC	Aurora kinase C	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q9UQB9	AURKC	Aurora kinase C	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q9UQB9	AURKC	Aurora kinase C	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; TAS:UniProtKB
Q9UQB9	AURKC	Aurora kinase C	GO:0008608; P:attachment of spindle microtubules to kinetochore; TAS:UniProtKB
Q9UQB9	AURKC	Aurora kinase C	GO:0000910; P:cytokinesis; TAS:ProtInc
Q9UQB9	AURKC	Aurora kinase C	GO:0016570; P:histone modification; TAS:UniProtKB
Q9UQB9	AURKC	Aurora kinase C	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q9UQB9	AURKC	Aurora kinase C	GO:0032467; P:positive regulation of cytokinesis; TAS:UniProtKB
Q9UQB9	AURKC	Aurora kinase C	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9UQB9	AURKC	Aurora kinase C	GO:0051256; P:spindle midzone assembly involved in mitosis; TAS:UniProtKB
O75061	DNAJC6	Putative tyrosine-protein phosphatase auxilin	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
O75061	DNAJC6	Putative tyrosine-protein phosphatase auxilin	GO:0061024; P:membrane organization; TAS:Reactome
O75061	DNAJC6	Putative tyrosine-protein phosphatase auxilin	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
Q9NQS1	AVEN	Cell death regulator Aven	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NQS1	AVEN	Cell death regulator Aven	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9NQS1	AVEN	Cell death regulator Aven	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
O75366	AVIL	Advillin	GO:0003779; F:actin binding; ISS:UniProtKB
O75366	AVIL	Advillin	GO:0051693; P:actin filament capping; IEA:UniProtKB-KW
O75366	AVIL	Advillin	GO:0060271; P:cilium morphogenesis; IMP:UniProtKB
O75366	AVIL	Advillin	GO:0007010; P:cytoskeleton organization; IEA:InterPro
O75366	AVIL	Advillin	GO:0007399; P:nervous system development; TAS:ProtInc
O75366	AVIL	Advillin	GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB
Q8NBF6	AVL9	Late secretory pathway protein AVL9 homolog	GO:0016477; P:cell migration; IDA:UniProtKB
Q5T686	AVPI1	Arginine vasopressin-induced protein 1	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
Q5T686	AVPI1	Arginine vasopressin-induced protein 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P27037	ACVR2A	Activin receptor type-2A	GO:0005524; F:ATP binding; IEA:InterPro
P27037	ACVR2A	Activin receptor type-2A	GO:0015026; F:coreceptor activity; IDA:BHF-UCL
P27037	ACVR2A	Activin receptor type-2A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P27037	ACVR2A	Activin receptor type-2A	GO:0005515; F:protein binding; IPI:UniProtKB
P27037	ACVR2A	Activin receptor type-2A	GO:0004674; F:protein serine/threonine kinase activity; EXP:Reactome
P27037	ACVR2A	Activin receptor type-2A	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IEA:InterPro
P27037	ACVR2A	Activin receptor type-2A	GO:0005024; F:transforming growth factor beta-activated receptor activity; IEA:InterPro
P27037	ACVR2A	Activin receptor type-2A	GO:0004675; F:transmembrane receptor protein serine/threonine kinase activity; TAS:ProtInc
P27037	ACVR2A	Activin receptor type-2A	GO:0032924; P:activin receptor signaling pathway; IDA:GOC
P27037	ACVR2A	Activin receptor type-2A	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P27037	ACVR2A	Activin receptor type-2A	GO:0030509; P:BMP signaling pathway; IEA:Ensembl
P27037	ACVR2A	Activin receptor type-2A	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
P27037	ACVR2A	Activin receptor type-2A	GO:0048706; P:embryonic skeletal system development; IEA:Ensembl
P27037	ACVR2A	Activin receptor type-2A	GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl
P27037	ACVR2A	Activin receptor type-2A	GO:0007498; P:mesoderm development; IEA:Ensembl
P27037	ACVR2A	Activin receptor type-2A	GO:0043084; P:penile erection; IEA:Ensembl
P27037	ACVR2A	Activin receptor type-2A	GO:0032927; P:positive regulation of activin receptor signaling pathway; IDA:HGNC
P27037	ACVR2A	Activin receptor type-2A	GO:0030501; P:positive regulation of bone mineralization; IMP:BHF-UCL
P27037	ACVR2A	Activin receptor type-2A	GO:0045648; P:positive regulation of erythrocyte differentiation; IDA:HGNC
P27037	ACVR2A	Activin receptor type-2A	GO:0045669; P:positive regulation of osteoblast differentiation; IMP:BHF-UCL
P27037	ACVR2A	Activin receptor type-2A	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IMP:BHF-UCL
P27037	ACVR2A	Activin receptor type-2A	GO:0001934; P:positive regulation of protein phosphorylation; IMP:MGI
P27037	ACVR2A	Activin receptor type-2A	GO:0030510; P:regulation of BMP signaling pathway; IEA:Ensembl
P27037	ACVR2A	Activin receptor type-2A	GO:0050999; P:regulation of nitric-oxide synthase activity; IEA:Ensembl
P27037	ACVR2A	Activin receptor type-2A	GO:0060011; P:Sertoli cell proliferation; IEA:Ensembl
P27037	ACVR2A	Activin receptor type-2A	GO:0042713; P:sperm ejaculation; IEA:Ensembl
P27037	ACVR2A	Activin receptor type-2A	GO:0007283; P:spermatogenesis; IEA:Ensembl
P27037	ACVR2A	Activin receptor type-2A	GO:0007178; P:transmembrane receptor protein serine/threonine kinase signaling pathway; TAS:ProtInc
Q13705	ACVR2B	Activin receptor type-2B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13705	ACVR2B	Activin receptor type-2B	GO:0019838; F:growth factor binding; IPI:HGNC
Q13705	ACVR2B	Activin receptor type-2B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13705	ACVR2B	Activin receptor type-2B	GO:0005515; F:protein binding; IPI:UniProtKB
Q13705	ACVR2B	Activin receptor type-2B	GO:0004674; F:protein serine/threonine kinase activity; IMP:HGNC
Q13705	ACVR2B	Activin receptor type-2B	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:Ensembl
Q13705	ACVR2B	Activin receptor type-2B	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IEA:InterPro
Q13705	ACVR2B	Activin receptor type-2B	GO:0005024; F:transforming growth factor beta-activated receptor activity; IEA:InterPro
Q13705	ACVR2B	Activin receptor type-2B	GO:0032147; P:activation of protein kinase activity; IEA:Ensembl
Q13705	ACVR2B	Activin receptor type-2B	GO:0032924; P:activin receptor signaling pathway; TAS:GOC
Q13705	ACVR2B	Activin receptor type-2B	GO:0009952; P:anterior/posterior pattern specification; IMP:HGNC
Q13705	ACVR2B	Activin receptor type-2B	GO:0060840; P:artery development; ISS:BHF-UCL
Q13705	ACVR2B	Activin receptor type-2B	GO:0001974; P:blood vessel remodeling; ISS:BHF-UCL
Q13705	ACVR2B	Activin receptor type-2B	GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL
Q13705	ACVR2B	Activin receptor type-2B	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
Q13705	ACVR2B	Activin receptor type-2B	GO:0048617; P:embryonic foregut morphogenesis; IEA:Ensembl
Q13705	ACVR2B	Activin receptor type-2B	GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl
Q13705	ACVR2B	Activin receptor type-2B	GO:0007507; P:heart development; IEA:Ensembl
Q13705	ACVR2B	Activin receptor type-2B	GO:0030073; P:insulin secretion; IEA:Ensembl
Q13705	ACVR2B	Activin receptor type-2B	GO:0001822; P:kidney development; IEA:Ensembl
Q13705	ACVR2B	Activin receptor type-2B	GO:0030324; P:lung development; IEA:Ensembl
Q13705	ACVR2B	Activin receptor type-2B	GO:0001946; P:lymphangiogenesis; ISS:BHF-UCL
Q13705	ACVR2B	Activin receptor type-2B	GO:0060836; P:lymphatic endothelial cell differentiation; ISS:BHF-UCL
Q13705	ACVR2B	Activin receptor type-2B	GO:0007498; P:mesoderm development; IEA:Ensembl
Q13705	ACVR2B	Activin receptor type-2B	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
Q13705	ACVR2B	Activin receptor type-2B	GO:0035265; P:organ growth; IEA:Ensembl
Q13705	ACVR2B	Activin receptor type-2B	GO:0060021; P:palate development; IEA:Ensembl
Q13705	ACVR2B	Activin receptor type-2B	GO:0031016; P:pancreas development; IEA:Ensembl
Q13705	ACVR2B	Activin receptor type-2B	GO:0032927; P:positive regulation of activin receptor signaling pathway; IDA:HGNC
Q13705	ACVR2B	Activin receptor type-2B	GO:0030501; P:positive regulation of bone mineralization; IMP:BHF-UCL
Q13705	ACVR2B	Activin receptor type-2B	GO:0045669; P:positive regulation of osteoblast differentiation; IMP:BHF-UCL
Q13705	ACVR2B	Activin receptor type-2B	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q13705	ACVR2B	Activin receptor type-2B	GO:0006355; P:regulation of transcription, DNA-templated; IDA:HGNC
Q13705	ACVR2B	Activin receptor type-2B	GO:0009749; P:response to glucose; IEA:Ensembl
Q13705	ACVR2B	Activin receptor type-2B	GO:0061298; P:retina vasculature development in camera-type eye; ISS:BHF-UCL
Q13705	ACVR2B	Activin receptor type-2B	GO:0007165; P:signal transduction; IDA:HGNC
Q13705	ACVR2B	Activin receptor type-2B	GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl
Q13705	ACVR2B	Activin receptor type-2B	GO:0007178; P:transmembrane receptor protein serine/threonine kinase signaling pathway; TAS:ProtInc
Q13705	ACVR2B	Activin receptor type-2B	GO:0060841; P:venous blood vessel development; ISS:BHF-UCL
Q6E213	AWAT2	Acyl-CoA wax alcohol acyltransferase 2	GO:0047196; F:long-chain-alcohol O-fatty-acyltransferase activity; IEA:UniProtKB-EC
Q6E213	AWAT2	Acyl-CoA wax alcohol acyltransferase 2	GO:0050252; F:retinol O-fatty-acyltransferase activity; IEA:UniProtKB-EC
Q6E213	AWAT2	Acyl-CoA wax alcohol acyltransferase 2	GO:0010025; P:wax biosynthetic process; IEA:Ensembl
Q58HT5	AWAT1	Acyl-CoA wax alcohol acyltransferase 1	GO:0047196; F:long-chain-alcohol O-fatty-acyltransferase activity; IEA:UniProtKB-EC
Q58HT5	AWAT1	Acyl-CoA wax alcohol acyltransferase 1	GO:0006629; P:lipid metabolic process; IEA:UniProtKB-KW
A6NMY6	ANXA2P2	Putative annexin A2-like protein	GO:0005509; F:calcium ion binding; IEA:InterPro
A6NMY6	ANXA2P2	Putative annexin A2-like protein	GO:0005544; F:calcium-dependent phospholipid binding; IEA:UniProtKB-KW
A6NMY6	ANXA2P2	Putative annexin A2-like protein	GO:0004859; F:phospholipase inhibitor activity; IEA:InterPro
Q5T2P8	ANXA8L1	Annexin A8-like protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q5T2P8	ANXA8L1	Annexin A8-like protein 1	GO:0005544; F:calcium-dependent phospholipid binding; IEA:UniProtKB-KW
Q5VT79	ANXA8L2	Annexin A8-like protein 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q5VT79	ANXA8L2	Annexin A8-like protein 2	GO:0005544; F:calcium-dependent phospholipid binding; IEA:UniProtKB-KW
O15169	AXIN1	Axin-1	GO:0070016; F:armadillo repeat domain binding; ISS:BHF-UCL
O15169	AXIN1	Axin-1	GO:0008013; F:beta-catenin binding; IDA:BHF-UCL
O15169	AXIN1	Axin-1	GO:0019899; F:enzyme binding; IPI:UniProtKB
O15169	AXIN1	Axin-1	GO:0005096; F:GTPase activator activity; IBA:RefGenome
O15169	AXIN1	Axin-1	GO:0070411; F:I-SMAD binding; IPI:BHF-UCL
O15169	AXIN1	Axin-1	GO:0042802; F:identical protein binding; ISS:BHF-UCL
O15169	AXIN1	Axin-1	GO:0005515; F:protein binding; IPI:UniProtKB
O15169	AXIN1	Axin-1	GO:0032947; F:protein complex scaffold; IDA:BHF-UCL
O15169	AXIN1	Axin-1	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
O15169	AXIN1	Axin-1	GO:0019901; F:protein kinase binding; ISS:BHF-UCL
O15169	AXIN1	Axin-1	GO:0004871; F:signal transducer activity; IDA:BHF-UCL
O15169	AXIN1	Axin-1	GO:0046332; F:SMAD binding; IPI:BHF-UCL
O15169	AXIN1	Axin-1	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
O15169	AXIN1	Axin-1	GO:0007257; P:activation of JUN kinase activity; IBA:RefGenome
O15169	AXIN1	Axin-1	GO:0032147; P:activation of protein kinase activity; IDA:BHF-UCL
O15169	AXIN1	Axin-1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O15169	AXIN1	Axin-1	GO:0048320; P:axial mesoderm formation; IBA:RefGenome
O15169	AXIN1	Axin-1	GO:0060070; P:canonical Wnt signaling pathway; IC:UniProtKB
O15169	AXIN1	Axin-1	GO:0060823; P:canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation; IBA:RefGenome
O15169	AXIN1	Axin-1	GO:0008219; P:cell death; IBA:RefGenome
O15169	AXIN1	Axin-1	GO:0043623; P:cellular protein complex assembly; IDA:BHF-UCL
O15169	AXIN1	Axin-1	GO:0071407; P:cellular response to organic cyclic compound; IBA:RefGenome
O15169	AXIN1	Axin-1	GO:0031122; P:cytoplasmic microtubule organization; IBA:RefGenome
O15169	AXIN1	Axin-1	GO:0007368; P:determination of left/right symmetry; IBA:RefGenome
O15169	AXIN1	Axin-1	GO:0009950; P:dorsal/ventral axis specification; IBA:RefGenome
O15169	AXIN1	Axin-1	GO:0048048; P:embryonic eye morphogenesis; IBA:RefGenome
O15169	AXIN1	Axin-1	GO:0060272; P:embryonic skeletal joint morphogenesis; IBA:RefGenome
O15169	AXIN1	Axin-1	GO:0021797; P:forebrain anterior/posterior pattern specification; IBA:RefGenome
O15169	AXIN1	Axin-1	GO:0071514; P:genetic imprinting; IEA:Ensembl
O15169	AXIN1	Axin-1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O15169	AXIN1	Axin-1	GO:0055001; P:muscle cell development; IBA:RefGenome
O15169	AXIN1	Axin-1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IBA:RefGenome
O15169	AXIN1	Axin-1	GO:0045599; P:negative regulation of fat cell differentiation; IBA:RefGenome
O15169	AXIN1	Axin-1	GO:0051248; P:negative regulation of protein metabolic process; IEA:Ensembl
O15169	AXIN1	Axin-1	GO:0034244; P:negative regulation of transcription elongation from RNA polymerase II promoter; IEA:Ensembl
O15169	AXIN1	Axin-1	GO:0030178; P:negative regulation of Wnt signaling pathway; IDA:BHF-UCL
O15169	AXIN1	Axin-1	GO:0006913; P:nucleocytoplasmic transport; IEA:Ensembl
O15169	AXIN1	Axin-1	GO:0030910; P:olfactory placode formation; IBA:RefGenome
O15169	AXIN1	Axin-1	GO:0001743; P:optic placode formation; IBA:RefGenome
O15169	AXIN1	Axin-1	GO:0043547; P:positive regulation of GTPase activity; IBA:GOC
O15169	AXIN1	Axin-1	GO:0046330; P:positive regulation of JNK cascade; ISS:UniProtKB
O15169	AXIN1	Axin-1	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; NAS:BHF-UCL
O15169	AXIN1	Axin-1	GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; NAS:BHF-UCL
O15169	AXIN1	Axin-1	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IEA:Ensembl
O15169	AXIN1	Axin-1	GO:0045732; P:positive regulation of protein catabolic process; IDA:BHF-UCL
O15169	AXIN1	Axin-1	GO:0001934; P:positive regulation of protein phosphorylation; IDA:BHF-UCL
O15169	AXIN1	Axin-1	GO:0031398; P:positive regulation of protein ubiquitination; NAS:BHF-UCL
O15169	AXIN1	Axin-1	GO:2000060; P:positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ISS:BHF-UCL
O15169	AXIN1	Axin-1	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:BHF-UCL
O15169	AXIN1	Axin-1	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl
O15169	AXIN1	Axin-1	GO:0051443; P:positive regulation of ubiquitin-protein ligase activity; IMP:BHF-UCL
O15169	AXIN1	Axin-1	GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl
O15169	AXIN1	Axin-1	GO:0030163; P:protein catabolic process; IEA:Ensembl
O15169	AXIN1	Axin-1	GO:0051260; P:protein homooligomerization; IEA:Ensembl
O15169	AXIN1	Axin-1	GO:0000209; P:protein polyubiquitination; IEA:Ensembl
O15169	AXIN1	Axin-1	GO:0035412; P:regulation of catenin import into nucleus; IBA:RefGenome
O15169	AXIN1	Axin-1	GO:0007605; P:sensory perception of sound; IEA:Ensembl
O15169	AXIN1	Axin-1	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
O15169	AXIN1	Axin-1	GO:0090244; P:Wnt signaling pathway involved in somitogenesis; IBA:RefGenome
O15169	AXIN1	Axin-1	GO:0021881; P:Wnt-activated signaling pathway involved in forebrain neuron fate commitment; IBA:RefGenome
Q9Y2T1	AXIN2	Axin-2	GO:0070016; F:armadillo repeat domain binding; IBA:RefGenome
Q9Y2T1	AXIN2	Axin-2	GO:0008013; F:beta-catenin binding; NAS:BHF-UCL
Q9Y2T1	AXIN2	Axin-2	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9Y2T1	AXIN2	Axin-2	GO:0005096; F:GTPase activator activity; IBA:RefGenome
Q9Y2T1	AXIN2	Axin-2	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2T1	AXIN2	Axin-2	GO:0019901; F:protein kinase binding; IBA:RefGenome
Q9Y2T1	AXIN2	Axin-2	GO:0004871; F:signal transducer activity; IEA:InterPro
Q9Y2T1	AXIN2	Axin-2	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q9Y2T1	AXIN2	Axin-2	GO:0030282; P:bone mineralization; IEA:Ensembl
Q9Y2T1	AXIN2	Axin-2	GO:0008283; P:cell proliferation; IEA:Ensembl
Q9Y2T1	AXIN2	Axin-2	GO:0034613; P:cellular protein localization; IDA:BHF-UCL
Q9Y2T1	AXIN2	Axin-2	GO:0071407; P:cellular response to organic cyclic compound; IBA:RefGenome
Q9Y2T1	AXIN2	Axin-2	GO:0003413; P:chondrocyte differentiation involved in endochondral bone morphogenesis; IEA:Ensembl
Q9Y2T1	AXIN2	Axin-2	GO:0009950; P:dorsal/ventral axis specification; IBA:RefGenome
Q9Y2T1	AXIN2	Axin-2	GO:0001957; P:intramembranous ossification; IBA:RefGenome
Q9Y2T1	AXIN2	Axin-2	GO:0043570; P:maintenance of DNA repeat elements; IMP:BHF-UCL
Q9Y2T1	AXIN2	Axin-2	GO:0048255; P:mRNA stabilization; IMP:BHF-UCL
Q9Y2T1	AXIN2	Axin-2	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:BHF-UCL
Q9Y2T1	AXIN2	Axin-2	GO:0035414; P:negative regulation of catenin import into nucleus; IMP:BHF-UCL
Q9Y2T1	AXIN2	Axin-2	GO:0008285; P:negative regulation of cell proliferation; IMP:BHF-UCL
Q9Y2T1	AXIN2	Axin-2	GO:0045668; P:negative regulation of osteoblast differentiation; IBA:RefGenome
Q9Y2T1	AXIN2	Axin-2	GO:0042476; P:odontogenesis; IMP:BHF-UCL
Q9Y2T1	AXIN2	Axin-2	GO:0010942; P:positive regulation of cell death; IMP:BHF-UCL
Q9Y2T1	AXIN2	Axin-2	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IMP:BHF-UCL
Q9Y2T1	AXIN2	Axin-2	GO:0043547; P:positive regulation of GTPase activity; IBA:GOC
Q9Y2T1	AXIN2	Axin-2	GO:0001934; P:positive regulation of protein phosphorylation; IMP:BHF-UCL
Q9Y2T1	AXIN2	Axin-2	GO:0070602; P:regulation of centromeric sister chromatid cohesion; IMP:BHF-UCL
Q9Y2T1	AXIN2	Axin-2	GO:0061181; P:regulation of chondrocyte development; IEA:Ensembl
Q9Y2T1	AXIN2	Axin-2	GO:0032423; P:regulation of mismatch repair; IMP:BHF-UCL
Q9Y2T1	AXIN2	Axin-2	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
Q9Y2T1	AXIN2	Axin-2	GO:0090244; P:Wnt signaling pathway involved in somitogenesis; IBA:RefGenome
Q9H6S1	AZI2	5-azacytidine-induced protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q9H6S1	AZI2	5-azacytidine-induced protein 2	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
O14977	AZIN1	Antizyme inhibitor 1	GO:0003824; F:catalytic activity; IEA:InterPro
O14977	AZIN1	Antizyme inhibitor 1	GO:0004857; F:enzyme inhibitor activity; TAS:ProtInc
O14977	AZIN1	Antizyme inhibitor 1	GO:0042978; F:ornithine decarboxylase activator activity; IEA:Ensembl
O14977	AZIN1	Antizyme inhibitor 1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
O14977	AZIN1	Antizyme inhibitor 1	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
O14977	AZIN1	Antizyme inhibitor 1	GO:0006596; P:polyamine biosynthetic process; IEA:UniProtKB-KW
O14977	AZIN1	Antizyme inhibitor 1	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
O14977	AZIN1	Antizyme inhibitor 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0051434; F:BH3 domain binding; IPI:UniProt
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0046982; F:protein heterodimerization activity; IBA:RefGenome
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0042803; F:protein homodimerization activity; IBA:RefGenome
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0008637; P:apoptotic mitochondrial changes; TAS:ProtInc
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0006915; P:apoptotic process; TAS:Reactome
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0071839; P:apoptotic process in bone marrow; IEA:Ensembl
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0008283; P:cell proliferation; IEA:Ensembl
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0060154; P:cellular process regulating host cell cycle in response to virus; IEA:Ensembl
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0071312; P:cellular response to alkaloid; IEA:Ensembl
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0071480; P:cellular response to gamma radiation; IEA:Ensembl
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0000910; P:cytokinesis; IMP:UniProtKB
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IBA:RefGenome
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0009566; P:fertilization; IEA:Ensembl
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0007281; P:germ cell development; IEA:Ensembl
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0040007; P:growth; IEA:Ensembl
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0097284; P:hepatocyte apoptotic process; IEA:Ensembl
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0045087; P:innate immune response; TAS:Reactome
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0008584; P:male gonad development; IEA:Ensembl
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0007093; P:mitotic cell cycle checkpoint; IMP:UniProtKB
Q07817	BCL2L1	Bcl-2-like protein 1	GO:2000811; P:negative regulation of anoikis; IMP:UniProtKB
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0010507; P:negative regulation of autophagy; TAS:UniProtKB
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0090005; P:negative regulation of establishment of protein localization to plasma membrane; IDA:BHF-UCL
Q07817	BCL2L1	Bcl-2-like protein 1	GO:1900118; P:negative regulation of execution phase of apoptosis; IDA:UniProtKB
Q07817	BCL2L1	Bcl-2-like protein 1	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; TAS:BHF-UCL
Q07817	BCL2L1	Bcl-2-like protein 1	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IDA:BHF-UCL
Q07817	BCL2L1	Bcl-2-like protein 1	GO:1902230; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; IDA:BHF-UCL
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; IC:BHF-UCL
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0001541; P:ovarian follicle development; IEA:Ensembl
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q07817	BCL2L1	Bcl-2-like protein 1	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; TAS:Reactome
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0046902; P:regulation of mitochondrial membrane permeability; IDA:HGNC
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0051881; P:regulation of mitochondrial membrane potential; IDA:HGNC
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0001836; P:release of cytochrome c from mitochondria; IDA:HGNC
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0046898; P:response to cycloheximide; IEA:Ensembl
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0034097; P:response to cytokine; IDA:MGI
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q07817	BCL2L1	Bcl-2-like protein 1	GO:0019050; P:suppression by virus of host apoptotic process; IDA:MGI
Q92843	BCL2L2	Bcl-2-like protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q92843	BCL2L2	Bcl-2-like protein 2	GO:0046982; F:protein heterodimerization activity; IBA:RefGenome
Q92843	BCL2L2	Bcl-2-like protein 2	GO:0042803; F:protein homodimerization activity; IBA:RefGenome
Q92843	BCL2L2	Bcl-2-like protein 2	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IBA:RefGenome
Q92843	BCL2L2	Bcl-2-like protein 2	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IBA:RefGenome
Q92843	BCL2L2	Bcl-2-like protein 2	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q92843	BCL2L2	Bcl-2-like protein 2	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IBA:RefGenome
Q92843	BCL2L2	Bcl-2-like protein 2	GO:0060011; P:Sertoli cell proliferation; IEA:Ensembl
Q92843	BCL2L2	Bcl-2-like protein 2	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q9HD36	BCL2L10	Bcl-2-like protein 10	GO:0005515; F:protein binding; IPI:HGNC
Q9HD36	BCL2L10	Bcl-2-like protein 10	GO:0046982; F:protein heterodimerization activity; IBA:RefGenome
Q9HD36	BCL2L10	Bcl-2-like protein 10	GO:0042803; F:protein homodimerization activity; IBA:RefGenome
Q9HD36	BCL2L10	Bcl-2-like protein 10	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:ProtInc
Q9HD36	BCL2L10	Bcl-2-like protein 10	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IBA:RefGenome
Q9HD36	BCL2L10	Bcl-2-like protein 10	GO:0007292; P:female gamete generation; TAS:ProtInc
Q9HD36	BCL2L10	Bcl-2-like protein 10	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IBA:RefGenome
Q9HD36	BCL2L10	Bcl-2-like protein 10	GO:0043066; P:negative regulation of apoptotic process; IDA:HGNC
Q9HD36	BCL2L10	Bcl-2-like protein 10	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
Q9HD36	BCL2L10	Bcl-2-like protein 10	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IBA:RefGenome
Q9HD36	BCL2L10	Bcl-2-like protein 10	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q9HD36	BCL2L10	Bcl-2-like protein 10	GO:0007283; P:spermatogenesis; TAS:ProtInc
O43521	BCL2L11	Bcl-2-like protein 11	GO:0005515; F:protein binding; IPI:IntAct
O43521	BCL2L11	Bcl-2-like protein 11	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
O43521	BCL2L11	Bcl-2-like protein 11	GO:0006915; P:apoptotic process; TAS:UniProtKB
O43521	BCL2L11	Bcl-2-like protein 11	GO:1902263; P:apoptotic process involved in embryonic digit morphogenesis; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
O43521	BCL2L11	Bcl-2-like protein 11	GO:0001783; P:B cell apoptotic process; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0001782; P:B cell homeostasis; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0007420; P:brain development; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0007160; P:cell-matrix adhesion; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0060154; P:cellular process regulating host cell cycle in response to virus; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0048066; P:developmental pigmentation; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0043583; P:ear development; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
O43521	BCL2L11	Bcl-2-like protein 11	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IDA:MGI
O43521	BCL2L11	Bcl-2-like protein 11	GO:0001822; P:kidney development; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0008584; P:male gonad development; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0030879; P:mammary gland development; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0002262; P:myeloid cell homeostasis; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O43521	BCL2L11	Bcl-2-like protein 11	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
O43521	BCL2L11	Bcl-2-like protein 11	GO:0060139; P:positive regulation of apoptotic process by virus; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0045787; P:positive regulation of cell cycle; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:2000271; P:positive regulation of fibroblast apoptotic process; IDA:UniProtKB
O43521	BCL2L11	Bcl-2-like protein 11	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
O43521	BCL2L11	Bcl-2-like protein 11	GO:1902110; P:positive regulation of mitochondrial membrane permeability involved in apoptotic process; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0032464; P:positive regulation of protein homooligomerization; IDA:BHF-UCL
O43521	BCL2L11	Bcl-2-like protein 11	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
O43521	BCL2L11	Bcl-2-like protein 11	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IMP:UniProtKB
O43521	BCL2L11	Bcl-2-like protein 11	GO:0048563; P:post-embryonic organ morphogenesis; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0048070; P:regulation of developmental pigmentation; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0046620; P:regulation of organ growth; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB
O43521	BCL2L11	Bcl-2-like protein 11	GO:0007283; P:spermatogenesis; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0048536; P:spleen development; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0043029; P:T cell homeostasis; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0070242; P:thymocyte apoptotic process; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0048538; P:thymus development; IEA:Ensembl
O43521	BCL2L11	Bcl-2-like protein 11	GO:0035148; P:tube formation; IEA:Ensembl
Q9HB09	BCL2L12	Bcl-2-like protein 12	GO:0005515; F:protein binding; IPI:IntAct
Q9HB09	BCL2L12	Bcl-2-like protein 12	GO:1990001; P:inhibition of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProt
Q9HB09	BCL2L12	Bcl-2-like protein 12	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProt
Q9BXK5	BCL2L13	Bcl-2-like protein 13	GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; NAS:UniProtKB
Q9BXK5	BCL2L13	Bcl-2-like protein 13	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; NAS:UniProtKB
Q9BXK5	BCL2L13	Bcl-2-like protein 13	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q9BZR8	BCL2L14	Apoptosis facilitator Bcl-2-like protein 14	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BZR8	BCL2L14	Apoptosis facilitator Bcl-2-like protein 14	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q9BZR8	BCL2L14	Apoptosis facilitator Bcl-2-like protein 14	GO:0006915; P:apoptotic process; IDA:UniProtKB
Q9BZR8	BCL2L14	Apoptosis facilitator Bcl-2-like protein 14	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IDA:UniProtKB
Q9BZR8	BCL2L14	Apoptosis facilitator Bcl-2-like protein 14	GO:0042981; P:regulation of apoptotic process; IEA:InterPro
Q5TBC7	BCL2L15	Bcl-2-like protein 15	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q16548	BCL2A1	Bcl-2-related protein A1	GO:0005515; F:protein binding; IPI:HGNC
Q16548	BCL2A1	Bcl-2-related protein A1	GO:0046982; F:protein heterodimerization activity; IBA:RefGenome
Q16548	BCL2A1	Bcl-2-related protein A1	GO:0042803; F:protein homodimerization activity; IBA:RefGenome
Q16548	BCL2A1	Bcl-2-related protein A1	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IBA:RefGenome
Q16548	BCL2A1	Bcl-2-related protein A1	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IBA:RefGenome
Q16548	BCL2A1	Bcl-2-related protein A1	GO:0043066; P:negative regulation of apoptotic process; IBA:RefGenome
Q16548	BCL2A1	Bcl-2-related protein A1	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IBA:RefGenome
P61769	B2M	Beta-2-microglobulin	GO:0042802; F:identical protein binding; IPI:IntAct
P61769	B2M	Beta-2-microglobulin	GO:0005515; F:protein binding; IPI:IntAct
P61769	B2M	Beta-2-microglobulin	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P61769	B2M	Beta-2-microglobulin	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P61769	B2M	Beta-2-microglobulin	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P61769	B2M	Beta-2-microglobulin	GO:0002481; P:antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent; IEA:Ensembl
P61769	B2M	Beta-2-microglobulin	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P61769	B2M	Beta-2-microglobulin	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P61769	B2M	Beta-2-microglobulin	GO:0045087; P:innate immune response; TAS:Reactome
P61769	B2M	Beta-2-microglobulin	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P61769	B2M	Beta-2-microglobulin	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:Ensembl
P61769	B2M	Beta-2-microglobulin	GO:0042026; P:protein refolding; IEA:Ensembl
P61769	B2M	Beta-2-microglobulin	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
P61769	B2M	Beta-2-microglobulin	GO:0050776; P:regulation of immune response; TAS:Reactome
P61769	B2M	Beta-2-microglobulin	GO:0046686; P:response to cadmium ion; IEA:Ensembl
P61769	B2M	Beta-2-microglobulin	GO:0042493; P:response to drug; IEA:Ensembl
P61769	B2M	Beta-2-microglobulin	GO:0002237; P:response to molecule of bacterial origin; IEA:Ensembl
P61769	B2M	Beta-2-microglobulin	GO:0001895; P:retina homeostasis; IEP:UniProt
P61769	B2M	Beta-2-microglobulin	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
P61769	B2M	Beta-2-microglobulin	GO:0016032; P:viral process; TAS:Reactome
P04920	SLC4A2	Anion exchange protein 2	GO:0008509; F:anion transmembrane transporter activity; TAS:ProtInc
P04920	SLC4A2	Anion exchange protein 2	GO:0015108; F:chloride transmembrane transporter activity; IEA:Ensembl
P04920	SLC4A2	Anion exchange protein 2	GO:0005452; F:inorganic anion exchanger activity; IEA:InterPro
P04920	SLC4A2	Anion exchange protein 2	GO:0006820; P:anion transport; TAS:ProtInc
P04920	SLC4A2	Anion exchange protein 2	GO:0015701; P:bicarbonate transport; TAS:Reactome
P04920	SLC4A2	Anion exchange protein 2	GO:0006811; P:ion transport; TAS:Reactome
P04920	SLC4A2	Anion exchange protein 2	GO:0055085; P:transmembrane transport; TAS:Reactome
P48751	SLC4A3	Anion exchange protein 3	GO:0005452; F:inorganic anion exchanger activity; TAS:ProtInc
P48751	SLC4A3	Anion exchange protein 3	GO:0015701; P:bicarbonate transport; TAS:Reactome
P48751	SLC4A3	Anion exchange protein 3	GO:0006811; P:ion transport; TAS:Reactome
P48751	SLC4A3	Anion exchange protein 3	GO:0051453; P:regulation of intracellular pH; IEA:Ensembl
P48751	SLC4A3	Anion exchange protein 3	GO:0055085; P:transmembrane transport; TAS:Reactome
P48751	SLC4A3	Anion exchange protein 3	GO:0006810; P:transport; TAS:ProtInc
Q96Q91	SLC4A9	Anion exchange protein 4	GO:0005452; F:inorganic anion exchanger activity; IEA:InterPro
Q96Q91	SLC4A9	Anion exchange protein 4	GO:0015701; P:bicarbonate transport; TAS:Reactome
Q96Q91	SLC4A9	Anion exchange protein 4	GO:0006811; P:ion transport; TAS:Reactome
Q96Q91	SLC4A9	Anion exchange protein 4	GO:0055085; P:transmembrane transport; TAS:Reactome
P02730	SLC4A1	Band 3 anion transport protein	GO:0008509; F:anion transmembrane transporter activity; TAS:ProtInc
P02730	SLC4A1	Band 3 anion transport protein	GO:0015301; F:anion:anion antiporter activity; IDA:UniProtKB
P02730	SLC4A1	Band 3 anion transport protein	GO:0030506; F:ankyrin binding; IPI:BHF-UCL
P02730	SLC4A1	Band 3 anion transport protein	GO:0015106; F:bicarbonate transmembrane transporter activity; IDA:UniProtKB
P02730	SLC4A1	Band 3 anion transport protein	GO:0015108; F:chloride transmembrane transporter activity; ISS:UniProtKB
P02730	SLC4A1	Band 3 anion transport protein	GO:0005452; F:inorganic anion exchanger activity; IDA:UniProtKB
P02730	SLC4A1	Band 3 anion transport protein	GO:0043495; F:protein anchor; TAS:BHF-UCL
P02730	SLC4A1	Band 3 anion transport protein	GO:0005515; F:protein binding; IPI:UniProtKB
P02730	SLC4A1	Band 3 anion transport protein	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P02730	SLC4A1	Band 3 anion transport protein	GO:0006820; P:anion transport; IDA:UniProtKB
P02730	SLC4A1	Band 3 anion transport protein	GO:0015701; P:bicarbonate transport; IDA:UniProtKB
P02730	SLC4A1	Band 3 anion transport protein	GO:0006873; P:cellular ion homeostasis; TAS:ProtInc
P02730	SLC4A1	Band 3 anion transport protein	GO:1902476; P:chloride transmembrane transport; ISS:GOC
P02730	SLC4A1	Band 3 anion transport protein	GO:0006821; P:chloride transport; ISS:UniProtKB
P02730	SLC4A1	Band 3 anion transport protein	GO:0006811; P:ion transport; TAS:Reactome
P02730	SLC4A1	Band 3 anion transport protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P02730	SLC4A1	Band 3 anion transport protein	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9P2W7	B3GAT1	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1	GO:0015018; F:galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; IEA:UniProtKB-EC
Q9P2W7	B3GAT1	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9P2W7	B3GAT1	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1	GO:0008499; F:UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; IEA:Ensembl
Q9P2W7	B3GAT1	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9P2W7	B3GAT1	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q9P2W7	B3GAT1	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9P2W7	B3GAT1	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q9P2W7	B3GAT1	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NPZ5	B3GAT2	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 2	GO:0015018; F:galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; ISS:UniProtKB
Q9NPZ5	B3GAT2	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NPZ5	B3GAT2	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9NPZ5	B3GAT2	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 2	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q9NPZ5	B3GAT2	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 2	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9NPZ5	B3GAT2	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 2	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q9NPZ5	B3GAT2	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O94766	B3GAT3	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3	GO:0015018; F:galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; NAS:UniProtKB
O94766	B3GAT3	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3	GO:0015020; F:glucuronosyltransferase activity; IMP:MGI
O94766	B3GAT3	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O94766	B3GAT3	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O94766	B3GAT3	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
O94766	B3GAT3	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3	GO:0050650; P:chondroitin sulfate proteoglycan biosynthetic process; IDA:MGI
O94766	B3GAT3	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3	GO:0050651; P:dermatan sulfate proteoglycan biosynthetic process; IDA:MGI
O94766	B3GAT3	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3	GO:0006024; P:glycosaminoglycan biosynthetic process; NAS:UniProtKB
O94766	B3GAT3	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O94766	B3GAT3	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3	GO:0015012; P:heparan sulfate proteoglycan biosynthetic process; IDA:MGI
O94766	B3GAT3	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
O94766	B3GAT3	Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75752	B3GALNT1	UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1	GO:0047273; F:galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity; IEA:UniProtKB-EC
O75752	B3GALNT1	UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1	GO:0008499; F:UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; TAS:ProtInc
O75752	B3GALNT1	UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1	GO:0009312; P:oligosaccharide biosynthetic process; IEA:Ensembl
O75752	B3GALNT1	UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1	GO:0006486; P:protein glycosylation; TAS:ProtInc
Q8NCR0	B3GALNT2	UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2	GO:0008376; F:acetylgalactosaminyltransferase activity; IDA:UniProtKB
Q8NCR0	B3GALNT2	UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2	GO:0008375; F:acetylglucosaminyltransferase activity; IDA:UniProtKB
Q8NCR0	B3GALNT2	UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2	GO:0008378; F:galactosyltransferase activity; IEA:InterPro
Q8NCR0	B3GALNT2	UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2	GO:0006486; P:protein glycosylation; IMP:UniProtKB
Q8NCR0	B3GALNT2	UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2	GO:0006493; P:protein O-linked glycosylation; IDA:UniProtKB
Q6Y288	B3GALTL	Beta-1,3-glucosyltransferase	GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW
Q6Y288	B3GALTL	Beta-1,3-glucosyltransferase	GO:0006004; P:fucose metabolic process; IEA:UniProtKB-KW
Q6Y288	B3GALTL	Beta-1,3-glucosyltransferase	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
O43505	B3GNT1	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase	GO:0008532; F:N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity; IDA:UniProtKB
O43505	B3GNT1	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase	GO:0007411; P:axon guidance; IEA:Ensembl
O43505	B3GNT1	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O43505	B3GNT1	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O43505	B3GNT1	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
O43505	B3GNT1	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
O43505	B3GNT1	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase	GO:0030311; P:poly-N-acetyllactosamine biosynthetic process; IDA:UniProtKB
O43505	B3GNT1	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
O43505	B3GNT1	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NY97	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	GO:0008378; F:galactosyltransferase activity; IEA:InterPro
Q9NY97	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	GO:0007411; P:axon guidance; IEA:Ensembl
Q9NY97	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9NY97	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9NY97	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9NY97	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
Q9NY97	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
Q9NY97	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	GO:0016266; P:O-glycan processing; TAS:Reactome
Q9NY97	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9NY97	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	GO:0007608; P:sensory perception of smell; IEA:Ensembl
Q9NY97	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y2A9	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	GO:0047223; F:beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity; IEA:UniProtKB-EC
Q9Y2A9	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	GO:0008378; F:galactosyltransferase activity; IEA:InterPro
Q9Y2A9	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9Y2A9	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9Y2A9	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9Y2A9	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
Q9Y2A9	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
Q9Y2A9	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	GO:0016266; P:O-glycan processing; TAS:Reactome
Q9Y2A9	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9Y2A9	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9C0J1	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	GO:0008378; F:galactosyltransferase activity; IEA:InterPro
Q9C0J1	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9C0J1	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9C0J1	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9C0J1	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
Q9C0J1	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
Q9C0J1	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	GO:0016266; P:O-glycan processing; TAS:Reactome
Q9C0J1	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9C0J1	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BYG0	B3GNT5	Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase	GO:0008457; F:beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity; IDA:UniProtKB
Q9BYG0	B3GNT5	Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase	GO:0008378; F:galactosyltransferase activity; IEA:InterPro
Q9BYG0	B3GNT5	Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase	GO:0047256; F:lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity; IEA:UniProtKB-EC
Q9BYG0	B3GNT5	Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase	GO:0008917; F:lipopolysaccharide N-acetylglucosaminyltransferase activity; IEA:Ensembl
Q9BYG0	B3GNT5	Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9BYG0	B3GNT5	Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase	GO:0007417; P:central nervous system development; IDA:UniProtKB
Q9BYG0	B3GNT5	Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase	GO:0009247; P:glycolipid biosynthetic process; TAS:UniProtKB
Q9BYG0	B3GNT5	Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase	GO:0016266; P:O-glycan processing; TAS:Reactome
Q9BYG0	B3GNT5	Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9BYG0	B3GNT5	Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase	GO:0006486; P:protein glycosylation; TAS:UniProtKB
Q6ZMB0	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6	GO:0047223; F:beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity; NAS:UniProtKB
Q6ZMB0	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6	GO:0008378; F:galactosyltransferase activity; IDA:UniProtKB
Q6ZMB0	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q6ZMB0	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6	GO:0009101; P:glycoprotein biosynthetic process; NAS:UniProtKB
Q6ZMB0	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6	GO:0016266; P:O-glycan processing; TAS:Reactome
Q6ZMB0	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6	GO:0016269; P:O-glycan processing, core 3; NAS:UniProtKB
Q6ZMB0	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q8NFL0	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	GO:0008378; F:galactosyltransferase activity; IEA:InterPro
Q8NFL0	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q8NFL0	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8NFL0	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q8NFL0	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
Q8NFL0	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
Q8NFL0	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	GO:0016266; P:O-glycan processing; TAS:Reactome
Q8NFL0	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q8NFL0	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q7Z7M8	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	GO:0008378; F:galactosyltransferase activity; IEA:InterPro
Q7Z7M8	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	GO:0016262; F:protein N-acetylglucosaminyltransferase activity; IDA:HGNC
Q7Z7M8	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q7Z7M8	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	GO:0016266; P:O-glycan processing; TAS:Reactome
Q7Z7M8	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	GO:0030311; P:poly-N-acetyllactosamine biosynthetic process; IDA:HGNC
Q7Z7M8	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q67FW5	B3GNTL1	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1	GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW
Q6UX72	B3GNT9	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9	GO:0008378; F:galactosyltransferase activity; IEA:InterPro
Q6UX72	B3GNT9	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9	GO:0006486; P:protein glycosylation; IEA:InterPro
Q9Y5Z6	B3GALT1	Beta-1,3-galactosyltransferase 1	GO:0008499; F:UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; IDA:UniProtKB
Q9Y5Z6	B3GALT1	Beta-1,3-galactosyltransferase 1	GO:0009312; P:oligosaccharide biosynthetic process; IEA:Ensembl
Q9Y5Z6	B3GALT1	Beta-1,3-galactosyltransferase 1	GO:0006486; P:protein glycosylation; IDA:UniProtKB
O43825	B3GALT2	Beta-1,3-galactosyltransferase 2	GO:0008499; F:UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; TAS:ProtInc
O43825	B3GALT2	Beta-1,3-galactosyltransferase 2	GO:0009312; P:oligosaccharide biosynthetic process; IEA:Ensembl
O43825	B3GALT2	Beta-1,3-galactosyltransferase 2	GO:0006486; P:protein glycosylation; TAS:ProtInc
Q9Y2C3	B3GALT5	Beta-1,3-galactosyltransferase 5	GO:0008499; F:UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; TAS:ProtInc
Q9Y2C3	B3GALT5	Beta-1,3-galactosyltransferase 5	GO:0006486; P:protein glycosylation; TAS:ProtInc
O96024	B3GALT4	Beta-1,3-galactosyltransferase 4	GO:0047915; F:ganglioside galactosyltransferase activity; IEA:UniProtKB-EC
O96024	B3GALT4	Beta-1,3-galactosyltransferase 4	GO:0008499; F:UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; TAS:ProtInc
O96024	B3GALT4	Beta-1,3-galactosyltransferase 4	GO:0006486; P:protein glycosylation; TAS:ProtInc
Q96L58	B3GALT6	Beta-1,3-galactosyltransferase 6	GO:0047220; F:galactosylxylosylprotein 3-beta-galactosyltransferase activity; IEA:UniProtKB-EC
Q96L58	B3GALT6	Beta-1,3-galactosyltransferase 6	GO:0008499; F:UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity; IEA:Ensembl
Q96L58	B3GALT6	Beta-1,3-galactosyltransferase 6	GO:0035250; F:UDP-galactosyltransferase activity; IDA:UniProtKB
Q96L58	B3GALT6	Beta-1,3-galactosyltransferase 6	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q96L58	B3GALT6	Beta-1,3-galactosyltransferase 6	GO:0030206; P:chondroitin sulfate biosynthetic process; IEA:UniProtKB-UniPathway
Q96L58	B3GALT6	Beta-1,3-galactosyltransferase 6	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q96L58	B3GALT6	Beta-1,3-galactosyltransferase 6	GO:0006024; P:glycosaminoglycan biosynthetic process; IMP:UniProtKB
Q96L58	B3GALT6	Beta-1,3-galactosyltransferase 6	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q96L58	B3GALT6	Beta-1,3-galactosyltransferase 6	GO:0015012; P:heparan sulfate proteoglycan biosynthetic process; IEA:UniProtKB-UniPathway
Q96L58	B3GALT6	Beta-1,3-galactosyltransferase 6	GO:0006486; P:protein glycosylation; IEA:InterPro
Q96L58	B3GALT6	Beta-1,3-galactosyltransferase 6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q00973	B4GALNT1	Beta-1,4 N-acetylgalactosaminyltransferase 1	GO:0003947; F:(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity; TAS:ProtInc
Q00973	B4GALNT1	Beta-1,4 N-acetylgalactosaminyltransferase 1	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
Q00973	B4GALNT1	Beta-1,4 N-acetylgalactosaminyltransferase 1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q00973	B4GALNT1	Beta-1,4 N-acetylgalactosaminyltransferase 1	GO:0001574; P:ganglioside biosynthetic process; IEA:Ensembl
Q00973	B4GALNT1	Beta-1,4 N-acetylgalactosaminyltransferase 1	GO:0006687; P:glycosphingolipid metabolic process; TAS:ProtInc
Q00973	B4GALNT1	Beta-1,4 N-acetylgalactosaminyltransferase 1	GO:0030259; P:lipid glycosylation; IEA:InterPro
Q00973	B4GALNT1	Beta-1,4 N-acetylgalactosaminyltransferase 1	GO:0019915; P:lipid storage; IEA:Ensembl
Q00973	B4GALNT1	Beta-1,4 N-acetylgalactosaminyltransferase 1	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q00973	B4GALNT1	Beta-1,4 N-acetylgalactosaminyltransferase 1	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q8NHY0	B4GALNT2	Beta-1,4 N-acetylgalactosaminyltransferase 2	GO:0008376; F:acetylgalactosaminyltransferase activity; IDA:UniProtKB
Q8NHY0	B4GALNT2	Beta-1,4 N-acetylgalactosaminyltransferase 2	GO:0030259; P:lipid glycosylation; IEA:InterPro
Q8NHY0	B4GALNT2	Beta-1,4 N-acetylgalactosaminyltransferase 2	GO:0022408; P:negative regulation of cell-cell adhesion; IDA:UniProtKB
Q8NHY0	B4GALNT2	Beta-1,4 N-acetylgalactosaminyltransferase 2	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q8NHY0	B4GALNT2	Beta-1,4 N-acetylgalactosaminyltransferase 2	GO:0019276; P:UDP-N-acetylgalactosamine metabolic process; IDA:UniProtKB
Q8NHY0	B4GALNT2	Beta-1,4 N-acetylgalactosaminyltransferase 2	GO:0006047; P:UDP-N-acetylglucosamine metabolic process; IEA:Ensembl
Q6L9W6	B4GALNT3	Beta-1,4-N-acetylgalactosaminyltransferase 3	GO:0008376; F:acetylgalactosaminyltransferase activity; IDA:HGNC
Q6L9W6	B4GALNT3	Beta-1,4-N-acetylgalactosaminyltransferase 3	GO:0033842; F:N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity; IEA:UniProtKB-EC
Q6L9W6	B4GALNT3	Beta-1,4-N-acetylgalactosaminyltransferase 3	GO:0008152; P:metabolic process; IDA:GOC
Q76KP1	B4GALNT4	N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1	GO:0008376; F:acetylgalactosaminyltransferase activity; IDA:HGNC
Q76KP1	B4GALNT4	N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1	GO:0033842; F:N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity; IEA:UniProtKB-EC
Q76KP1	B4GALNT4	N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1	GO:0008152; P:metabolic process; IDA:GOC
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0043014; F:alpha-tubulin binding; IDA:UniProtKB
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0003831; F:beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; IDA:UniProtKB
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0048487; F:beta-tubulin binding; IPI:UniProtKB
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0008378; F:galactosyltransferase activity; NAS:UniProtKB
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0004461; F:lactose synthase activity; IDA:UniProtKB
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0030145; F:manganese ion binding; IDA:UniProtKB
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0003945; F:N-acetyllactosamine synthase activity; IDA:UniProtKB
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0035250; F:UDP-galactosyltransferase activity; IDA:UniProtKB
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0002526; P:acute inflammatory response; IEA:Ensembl
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0060055; P:angiogenesis involved in wound healing; IEA:Ensembl
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0007339; P:binding of sperm to zona pellucida; TAS:Reactome
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0007155; P:cell adhesion; IEA:Ensembl
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0045136; P:development of secondary sexual characteristics; IEA:Ensembl
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0002064; P:epithelial cell development; IEA:Ensembl
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0006012; P:galactose metabolic process; IEA:Ensembl
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0005989; P:lactose biosynthetic process; IEA:Ensembl
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0050900; P:leukocyte migration; IEA:Ensembl
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0030879; P:mammary gland development; IEA:Ensembl
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0009312; P:oligosaccharide biosynthetic process; IDA:UniProtKB
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0007341; P:penetration of zona pellucida; IEA:Ensembl
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0060058; P:positive regulation of apoptotic process involved in mammary gland involution; IEA:Ensembl
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0060054; P:positive regulation of epithelial cell proliferation involved in wound healing; IEA:Ensembl
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0006487; P:protein N-linked glycosylation; IDA:UniProtKB
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0060046; P:regulation of acrosome reaction; IEA:Ensembl
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0051270; P:regulation of cellular component movement; IEA:Ensembl
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0007338; P:single fertilization; TAS:Reactome
P15291	B4GALT1	Beta-1,4-galactosyltransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60909	B4GALT2	Beta-1,4-galactosyltransferase 2	GO:0003831; F:beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; IEA:UniProtKB-EC
O60909	B4GALT2	Beta-1,4-galactosyltransferase 2	GO:0008378; F:galactosyltransferase activity; TAS:ProtInc
O60909	B4GALT2	Beta-1,4-galactosyltransferase 2	GO:0004461; F:lactose synthase activity; IEA:UniProtKB-EC
O60909	B4GALT2	Beta-1,4-galactosyltransferase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60909	B4GALT2	Beta-1,4-galactosyltransferase 2	GO:0003945; F:N-acetyllactosamine synthase activity; IEA:UniProtKB-EC
O60909	B4GALT2	Beta-1,4-galactosyltransferase 2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O60909	B4GALT2	Beta-1,4-galactosyltransferase 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O60909	B4GALT2	Beta-1,4-galactosyltransferase 2	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O60909	B4GALT2	Beta-1,4-galactosyltransferase 2	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
O60909	B4GALT2	Beta-1,4-galactosyltransferase 2	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
O60909	B4GALT2	Beta-1,4-galactosyltransferase 2	GO:0043687; P:post-translational protein modification; TAS:Reactome
O60909	B4GALT2	Beta-1,4-galactosyltransferase 2	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
O60909	B4GALT2	Beta-1,4-galactosyltransferase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60512	B4GALT3	Beta-1,4-galactosyltransferase 3	GO:0003831; F:beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; IEA:UniProtKB-EC
O60512	B4GALT3	Beta-1,4-galactosyltransferase 3	GO:0008378; F:galactosyltransferase activity; TAS:ProtInc
O60512	B4GALT3	Beta-1,4-galactosyltransferase 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60512	B4GALT3	Beta-1,4-galactosyltransferase 3	GO:0003945; F:N-acetyllactosamine synthase activity; IEA:UniProtKB-EC
O60512	B4GALT3	Beta-1,4-galactosyltransferase 3	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O60512	B4GALT3	Beta-1,4-galactosyltransferase 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O60512	B4GALT3	Beta-1,4-galactosyltransferase 3	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O60512	B4GALT3	Beta-1,4-galactosyltransferase 3	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
O60512	B4GALT3	Beta-1,4-galactosyltransferase 3	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
O60512	B4GALT3	Beta-1,4-galactosyltransferase 3	GO:0043687; P:post-translational protein modification; TAS:Reactome
O60512	B4GALT3	Beta-1,4-galactosyltransferase 3	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
O60512	B4GALT3	Beta-1,4-galactosyltransferase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60513	B4GALT4	Beta-1,4-galactosyltransferase 4	GO:0008378; F:galactosyltransferase activity; TAS:ProtInc
O60513	B4GALT4	Beta-1,4-galactosyltransferase 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60513	B4GALT4	Beta-1,4-galactosyltransferase 4	GO:0003945; F:N-acetyllactosamine synthase activity; IEA:UniProtKB-EC
O60513	B4GALT4	Beta-1,4-galactosyltransferase 4	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O60513	B4GALT4	Beta-1,4-galactosyltransferase 4	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O60513	B4GALT4	Beta-1,4-galactosyltransferase 4	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O60513	B4GALT4	Beta-1,4-galactosyltransferase 4	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
O60513	B4GALT4	Beta-1,4-galactosyltransferase 4	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
O60513	B4GALT4	Beta-1,4-galactosyltransferase 4	GO:0006643; P:membrane lipid metabolic process; TAS:ProtInc
O60513	B4GALT4	Beta-1,4-galactosyltransferase 4	GO:0043687; P:post-translational protein modification; TAS:Reactome
O60513	B4GALT4	Beta-1,4-galactosyltransferase 4	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
O60513	B4GALT4	Beta-1,4-galactosyltransferase 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UBX8	B4GALT6	Beta-1,4-galactosyltransferase 6	GO:0008378; F:galactosyltransferase activity; TAS:ProtInc
Q9UBX8	B4GALT6	Beta-1,4-galactosyltransferase 6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UBX8	B4GALT6	Beta-1,4-galactosyltransferase 6	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9UBX8	B4GALT6	Beta-1,4-galactosyltransferase 6	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UBX8	B4GALT6	Beta-1,4-galactosyltransferase 6	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9UBX8	B4GALT6	Beta-1,4-galactosyltransferase 6	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
Q9UBX8	B4GALT6	Beta-1,4-galactosyltransferase 6	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
Q9UBX8	B4GALT6	Beta-1,4-galactosyltransferase 6	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9UBX8	B4GALT6	Beta-1,4-galactosyltransferase 6	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9UBX8	B4GALT6	Beta-1,4-galactosyltransferase 6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43286	B4GALT5	Beta-1,4-galactosyltransferase 5	GO:0008378; F:galactosyltransferase activity; TAS:ProtInc
O43286	B4GALT5	Beta-1,4-galactosyltransferase 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43286	B4GALT5	Beta-1,4-galactosyltransferase 5	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O43286	B4GALT5	Beta-1,4-galactosyltransferase 5	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O43286	B4GALT5	Beta-1,4-galactosyltransferase 5	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O43286	B4GALT5	Beta-1,4-galactosyltransferase 5	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
O43286	B4GALT5	Beta-1,4-galactosyltransferase 5	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
O43286	B4GALT5	Beta-1,4-galactosyltransferase 5	GO:0016266; P:O-glycan processing; TAS:Reactome
O43286	B4GALT5	Beta-1,4-galactosyltransferase 5	GO:0043687; P:post-translational protein modification; TAS:Reactome
O43286	B4GALT5	Beta-1,4-galactosyltransferase 5	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
O43286	B4GALT5	Beta-1,4-galactosyltransferase 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UBV7	B4GALT7	Beta-1,4-galactosyltransferase 7	GO:0003831; F:beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; IDA:UniProtKB
Q9UBV7	B4GALT7	Beta-1,4-galactosyltransferase 7	GO:0008378; F:galactosyltransferase activity; IDA:UniProtKB
Q9UBV7	B4GALT7	Beta-1,4-galactosyltransferase 7	GO:0030145; F:manganese ion binding; IDA:UniProtKB
Q9UBV7	B4GALT7	Beta-1,4-galactosyltransferase 7	GO:0046525; F:xylosylprotein 4-beta-galactosyltransferase activity; IDA:UniProtKB
Q9UBV7	B4GALT7	Beta-1,4-galactosyltransferase 7	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9UBV7	B4GALT7	Beta-1,4-galactosyltransferase 7	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q9UBV7	B4GALT7	Beta-1,4-galactosyltransferase 7	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q9UBV7	B4GALT7	Beta-1,4-galactosyltransferase 7	GO:0043206; P:extracellular fibril organization; IMP:UniProtKB
Q9UBV7	B4GALT7	Beta-1,4-galactosyltransferase 7	GO:0006024; P:glycosaminoglycan biosynthetic process; IDA:UniProtKB
Q9UBV7	B4GALT7	Beta-1,4-galactosyltransferase 7	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9UBV7	B4GALT7	Beta-1,4-galactosyltransferase 7	GO:0048147; P:negative regulation of fibroblast proliferation; IMP:UniProtKB
Q9UBV7	B4GALT7	Beta-1,4-galactosyltransferase 7	GO:0006487; P:protein N-linked glycosylation; IDA:UniProtKB
Q9UBV7	B4GALT7	Beta-1,4-galactosyltransferase 7	GO:0006029; P:proteoglycan metabolic process; IMP:UniProtKB
Q9UBV7	B4GALT7	Beta-1,4-galactosyltransferase 7	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UPM9	B9D1	B9 domain-containing protein 1	GO:0008158; F:hedgehog receptor activity; ISS:UniProtKB
Q9UPM9	B9D1	B9 domain-containing protein 1	GO:0043010; P:camera-type eye development; IEA:Ensembl
Q9UPM9	B9D1	B9 domain-containing protein 1	GO:0035051; P:cardiocyte differentiation; IEA:Ensembl
Q9UPM9	B9D1	B9 domain-containing protein 1	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q9UPM9	B9D1	B9 domain-containing protein 1	GO:0060271; P:cilium morphogenesis; ISS:UniProtKB
Q9UPM9	B9D1	B9 domain-containing protein 1	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
Q9UPM9	B9D1	B9 domain-containing protein 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9UPM9	B9D1	B9 domain-containing protein 1	GO:0060563; P:neuroepithelial cell differentiation; IEA:Ensembl
Q9UPM9	B9D1	B9 domain-containing protein 1	GO:0032880; P:regulation of protein localization; IEA:Ensembl
Q9UPM9	B9D1	B9 domain-containing protein 1	GO:0007224; P:smoothened signaling pathway; ISS:UniProtKB
Q9BPU9	B9D2	B9 domain-containing protein 2	GO:0043015; F:gamma-tubulin binding; ISS:UniProtKB
Q9BPU9	B9D2	B9 domain-containing protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q9BPU9	B9D2	B9 domain-containing protein 2	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q9BPU9	B9D2	B9 domain-containing protein 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q14032	BAAT	Bile acid-CoA:amino acid N-acyltransferase	GO:0047963; F:glycine N-choloyltransferase activity; IDA:UniProtKB
Q14032	BAAT	Bile acid-CoA:amino acid N-acyltransferase	GO:0052816; F:long-chain acyl-CoA hydrolase activity; IDA:UniProtKB
Q14032	BAAT	Bile acid-CoA:amino acid N-acyltransferase	GO:0052815; F:medium-chain acyl-CoA hydrolase activity; IDA:UniProtKB
Q14032	BAAT	Bile acid-CoA:amino acid N-acyltransferase	GO:0016410; F:N-acyltransferase activity; IDA:MGI
Q14032	BAAT	Bile acid-CoA:amino acid N-acyltransferase	GO:0016290; F:palmitoyl-CoA hydrolase activity; IEA:UniProtKB-EC
Q14032	BAAT	Bile acid-CoA:amino acid N-acyltransferase	GO:0005102; F:receptor binding; IPI:UniProtKB
Q14032	BAAT	Bile acid-CoA:amino acid N-acyltransferase	GO:0052817; F:very long chain acyl-CoA hydrolase activity; IDA:UniProtKB
Q14032	BAAT	Bile acid-CoA:amino acid N-acyltransferase	GO:0006637; P:acyl-CoA metabolic process; IDA:UniProtKB
Q14032	BAAT	Bile acid-CoA:amino acid N-acyltransferase	GO:0015721; P:bile acid and bile salt transport; TAS:Reactome
Q14032	BAAT	Bile acid-CoA:amino acid N-acyltransferase	GO:0006699; P:bile acid biosynthetic process; IDA:UniProtKB
Q14032	BAAT	Bile acid-CoA:amino acid N-acyltransferase	GO:0002152; P:bile acid conjugation; IDA:UniProtKB
Q14032	BAAT	Bile acid-CoA:amino acid N-acyltransferase	GO:0008206; P:bile acid metabolic process; TAS:Reactome
Q14032	BAAT	Bile acid-CoA:amino acid N-acyltransferase	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW
Q14032	BAAT	Bile acid-CoA:amino acid N-acyltransferase	GO:0006544; P:glycine metabolic process; IDA:UniProtKB
Q14032	BAAT	Bile acid-CoA:amino acid N-acyltransferase	GO:0001889; P:liver development; IEA:Ensembl
Q14032	BAAT	Bile acid-CoA:amino acid N-acyltransferase	GO:0031100; P:organ regeneration; IEA:Ensembl
Q14032	BAAT	Bile acid-CoA:amino acid N-acyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14032	BAAT	Bile acid-CoA:amino acid N-acyltransferase	GO:0019530; P:taurine metabolic process; IDA:UniProtKB
Q9NWV8	BABAM1	BRISC and BRCA1-A complex member 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NWV8	BABAM1	BRISC and BRCA1-A complex member 1	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q9NWV8	BABAM1	BRISC and BRCA1-A complex member 1	GO:0006302; P:double-strand break repair; IMP:UniProtKB
Q9NWV8	BABAM1	BRISC and BRCA1-A complex member 1	GO:0031572; P:G2 DNA damage checkpoint; IMP:UniProtKB
Q9NWV8	BABAM1	BRISC and BRCA1-A complex member 1	GO:0045739; P:positive regulation of DNA repair; IMP:UniProtKB
Q9NWV8	BABAM1	BRISC and BRCA1-A complex member 1	GO:0070536; P:protein K63-linked deubiquitination; IMP:UniProtKB
Q9NWV8	BABAM1	BRISC and BRCA1-A complex member 1	GO:0010212; P:response to ionizing radiation; IMP:UniProtKB
Q8WZ19	KCTD13	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 1	GO:0017049; F:GTP-Rho binding; IDA:UniProtKB
Q8WZ19	KCTD13	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 1	GO:0016477; P:cell migration; IMP:UniProtKB
Q8WZ19	KCTD13	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 1	GO:0006260; P:DNA replication; ISS:UniProtKB
Q8WZ19	KCTD13	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 1	GO:0035024; P:negative regulation of Rho protein signal transduction; IMP:UniProtKB
Q8WZ19	KCTD13	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 1	GO:0045740; P:positive regulation of DNA replication; IEA:Ensembl
Q8WZ19	KCTD13	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 1	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q8WZ19	KCTD13	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 1	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q8WZ19	KCTD13	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 1	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q8WZ19	KCTD13	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 1	GO:0043149; P:stress fiber assembly; IMP:UniProtKB
Q13829	TNFAIP1	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2	GO:0017049; F:GTP-Rho binding; IDA:UniProtKB
Q13829	TNFAIP1	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q13829	TNFAIP1	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2	GO:0006915; P:apoptotic process; TAS:UniProtKB
Q13829	TNFAIP1	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2	GO:0016477; P:cell migration; IMP:UniProtKB
Q13829	TNFAIP1	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2	GO:0006260; P:DNA replication; ISS:UniProtKB
Q13829	TNFAIP1	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2	GO:0009790; P:embryo development; ISS:UniProtKB
Q13829	TNFAIP1	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2	GO:0006955; P:immune response; IEP:UniProtKB
Q13829	TNFAIP1	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2	GO:0035024; P:negative regulation of Rho protein signal transduction; IMP:UniProtKB
Q13829	TNFAIP1	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2	GO:0045740; P:positive regulation of DNA replication; IEA:Ensembl
Q13829	TNFAIP1	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q13829	TNFAIP1	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q13829	TNFAIP1	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q13829	TNFAIP1	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2	GO:0043149; P:stress fiber assembly; IMP:UniProtKB
Q9H3F6	KCTD10	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB
Q9H3F6	KCTD10	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q9H3F6	KCTD10	BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3	GO:0016567; P:protein ubiquitination; ISS:UniProtKB
P56817	BACE1	Beta-secretase 1	GO:0004190; F:aspartic-type endopeptidase activity; IDA:UniProtKB
P56817	BACE1	Beta-secretase 1	GO:0001540; F:beta-amyloid binding; IPI:Alzheimers_University_of_Toronto
P56817	BACE1	Beta-secretase 1	GO:0008798; F:beta-aspartyl-peptidase activity; TAS:ProtInc
P56817	BACE1	Beta-secretase 1	GO:0019899; F:enzyme binding; IPI:UniProtKB
P56817	BACE1	Beta-secretase 1	GO:0005515; F:protein binding; IPI:IntAct
P56817	BACE1	Beta-secretase 1	GO:0050435; P:beta-amyloid metabolic process; IDA:UniProtKB
P56817	BACE1	Beta-secretase 1	GO:0006509; P:membrane protein ectodomain proteolysis; TAS:UniProtKB
P56817	BACE1	Beta-secretase 1	GO:0006508; P:proteolysis; IDA:UniProtKB
Q9Y5Z0	BACE2	Beta-secretase 2	GO:0004190; F:aspartic-type endopeptidase activity; IDA:UniProtKB
Q9Y5Z0	BACE2	Beta-secretase 2	GO:0006509; P:membrane protein ectodomain proteolysis; IDA:UniProtKB
Q9Y5Z0	BACE2	Beta-secretase 2	GO:0042985; P:negative regulation of amyloid precursor protein biosynthetic process; IMP:UniProtKB
Q9Y5Z0	BACE2	Beta-secretase 2	GO:0016486; P:peptide hormone processing; NAS:UniProtKB
Q9Y5Z0	BACE2	Beta-secretase 2	GO:0006508; P:proteolysis; NAS:UniProtKB
Q9BYV9	BACH2	Transcription regulator protein BACH2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9BYV9	BACH2	Transcription regulator protein BACH2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q9BYV9	BACH2	Transcription regulator protein BACH2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O14867	BACH1	Transcription regulator protein BACH1	GO:0020037; F:heme binding; NAS:UniProtKB
O14867	BACH1	Transcription regulator protein BACH1	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IDA:UniProtKB
O14867	BACH1	Transcription regulator protein BACH1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O14867	BACH1	Transcription regulator protein BACH1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
O14867	BACH1	Transcription regulator protein BACH1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
O14867	BACH1	Transcription regulator protein BACH1	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; IDA:UniProtKB
O14867	BACH1	Transcription regulator protein BACH1	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; IMP:UniProtKB
O14867	BACH1	Transcription regulator protein BACH1	GO:0000117; P:regulation of transcription involved in G2/M transition of mitotic cell cycle; IMP:UniProtKB
O14867	BACH1	Transcription regulator protein BACH1	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
Q6ZUV0	ACOT7L	Cytosolic acyl coenzyme A thioester hydrolase-like	GO:0016290; F:palmitoyl-CoA hydrolase activity; IEA:UniProtKB-EC
O00154	ACOT7	Cytosolic acyl coenzyme A thioester hydrolase	GO:0000062; F:fatty-acyl-CoA binding; IDA:BHF-UCL
O00154	ACOT7	Cytosolic acyl coenzyme A thioester hydrolase	GO:0036042; F:long-chain fatty acyl-CoA binding; IDA:BHF-UCL
O00154	ACOT7	Cytosolic acyl coenzyme A thioester hydrolase	GO:0016290; F:palmitoyl-CoA hydrolase activity; IDA:BHF-UCL
O00154	ACOT7	Cytosolic acyl coenzyme A thioester hydrolase	GO:0005515; F:protein binding; IPI:BHF-UCL
O00154	ACOT7	Cytosolic acyl coenzyme A thioester hydrolase	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
O00154	ACOT7	Cytosolic acyl coenzyme A thioester hydrolase	GO:0015937; P:coenzyme A biosynthetic process; IDA:BHF-UCL
O00154	ACOT7	Cytosolic acyl coenzyme A thioester hydrolase	GO:0009062; P:fatty acid catabolic process; IEA:Ensembl
O00154	ACOT7	Cytosolic acyl coenzyme A thioester hydrolase	GO:0036116; P:long-chain fatty-acyl-CoA catabolic process; IDA:BHF-UCL
O00154	ACOT7	Cytosolic acyl coenzyme A thioester hydrolase	GO:0051792; P:medium-chain fatty acid biosynthetic process; IDA:BHF-UCL
O00154	ACOT7	Cytosolic acyl coenzyme A thioester hydrolase	GO:0036114; P:medium-chain fatty-acyl-CoA catabolic process; IDA:BHF-UCL
O00154	ACOT7	Cytosolic acyl coenzyme A thioester hydrolase	GO:1900535; P:palmitic acid biosynthetic process; IDA:BHF-UCL
Q92934	BAD	Bcl2 antagonist of cell death	GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; IDA:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0008289; F:lipid binding; IDA:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0005543; F:phospholipid binding; IMP:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0005515; F:protein binding; IPI:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0097202; P:activation of cysteine-type endopeptidase activity; IDA:BHF-UCL
Q92934	BAD	Bcl2 antagonist of cell death	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; ISS:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0046031; P:ADP metabolic process; ISS:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0006915; P:apoptotic process; IDA:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q92934	BAD	Bcl2 antagonist of cell death	GO:0046034; P:ATP metabolic process; ISS:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0060154; P:cellular process regulating host cell cycle in response to virus; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0071247; P:cellular response to chromate; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0071456; P:cellular response to hypoxia; IEP:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0071396; P:cellular response to lipid; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0071316; P:cellular response to nicotine; IDA:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0019221; P:cytokine-mediated signaling pathway; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q92934	BAD	Bcl2 antagonist of cell death	GO:0097191; P:extrinsic apoptotic signaling pathway; IMP:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q92934	BAD	Bcl2 antagonist of cell death	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q92934	BAD	Bcl2 antagonist of cell death	GO:0006007; P:glucose catabolic process; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0042593; P:glucose homeostasis; ISS:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0045087; P:innate immune response; TAS:Reactome
Q92934	BAD	Bcl2 antagonist of cell death	GO:0097193; P:intrinsic apoptotic signaling pathway; IMP:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q92934	BAD	Bcl2 antagonist of cell death	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q92934	BAD	Bcl2 antagonist of cell death	GO:0046931; P:pore complex assembly; IDA:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0060139; P:positive regulation of apoptotic process by virus; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0010508; P:positive regulation of autophagy; TAS:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0045579; P:positive regulation of B cell differentiation; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0050679; P:positive regulation of epithelial cell proliferation; IMP:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0033133; P:positive regulation of glucokinase activity; ISS:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0032024; P:positive regulation of insulin secretion; ISS:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; TAS:Reactome
Q92934	BAD	Bcl2 antagonist of cell death	GO:0010918; P:positive regulation of mitochondrial membrane potential; ISS:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:1901216; P:positive regulation of neuron death; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
Q92934	BAD	Bcl2 antagonist of cell death	GO:0045862; P:positive regulation of proteolysis; IDA:BHF-UCL
Q92934	BAD	Bcl2 antagonist of cell death	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IMP:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0045582; P:positive regulation of T cell differentiation; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:2000078; P:positive regulation of type B pancreatic cell development; ISS:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0046902; P:regulation of mitochondrial membrane permeability; IMP:UniProtKB
Q92934	BAD	Bcl2 antagonist of cell death	GO:0001836; P:release of cytochrome c from mitochondria; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0043200; P:response to amino acid; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0051592; P:response to calcium ion; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0042493; P:response to drug; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0032355; P:response to estradiol; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0045471; P:response to ethanol; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0009749; P:response to glucose; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0034201; P:response to oleic acid; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0032570; P:response to progesterone; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0033574; P:response to testosterone; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0019050; P:suppression by virus of host apoptotic process; IEA:Ensembl
Q92934	BAD	Bcl2 antagonist of cell death	GO:0044342; P:type B pancreatic cell proliferation; ISS:UniProtKB
Q9H503	BANF2	Barrier-to-autointegration factor-like protein	GO:0003677; F:DNA binding; IEA:InterPro
O75531	BANF1	Barrier-to-autointegration factor	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O75531	BANF1	Barrier-to-autointegration factor	GO:0005515; F:protein binding; IPI:UniProtKB
O75531	BANF1	Barrier-to-autointegration factor	GO:0015074; P:DNA integration; IEA:Ensembl
O75531	BANF1	Barrier-to-autointegration factor	GO:0075713; P:establishment of integrated proviral latency; TAS:Reactome
O75531	BANF1	Barrier-to-autointegration factor	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O75531	BANF1	Barrier-to-autointegration factor	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
O75531	BANF1	Barrier-to-autointegration factor	GO:0007084; P:mitotic nuclear envelope reassembly; TAS:Reactome
O75531	BANF1	Barrier-to-autointegration factor	GO:0009615; P:response to virus; TAS:ProtInc
O75531	BANF1	Barrier-to-autointegration factor	GO:0016032; P:viral process; TAS:Reactome
Q99933	BAG1	BAG family molecular chaperone regulator 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q99933	BAG1	BAG family molecular chaperone regulator 1	GO:0005057; F:receptor signaling protein activity; TAS:ProtInc
Q99933	BAG1	BAG family molecular chaperone regulator 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q99933	BAG1	BAG family molecular chaperone regulator 1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q99933	BAG1	BAG family molecular chaperone regulator 1	GO:0070389; P:chaperone cofactor-dependent protein refolding; IDA:UniProtKB
Q99933	BAG1	BAG family molecular chaperone regulator 1	GO:0035556; P:intracellular signal transduction; TAS:GOC
Q99933	BAG1	BAG family molecular chaperone regulator 1	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
O95816	BAG2	BAG family molecular chaperone regulator 2	GO:0005515; F:protein binding; IPI:IntAct
O95816	BAG2	BAG family molecular chaperone regulator 2	GO:0006457; P:protein folding; TAS:ProtInc
O95816	BAG2	BAG family molecular chaperone regulator 2	GO:0019538; P:protein metabolic process; IDA:MGI
O95817	BAG3	BAG family molecular chaperone regulator 3	GO:0005515; F:protein binding; IPI:UniProtKB
O95817	BAG3	BAG family molecular chaperone regulator 3	GO:0007420; P:brain development; IEA:Ensembl
O95817	BAG3	BAG family molecular chaperone regulator 3	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
O95817	BAG3	BAG family molecular chaperone regulator 3	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
O95817	BAG3	BAG family molecular chaperone regulator 3	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IDA:MGI
O95817	BAG3	BAG family molecular chaperone regulator 3	GO:0043066; P:negative regulation of apoptotic process; NAS:UniProtKB
O95817	BAG3	BAG family molecular chaperone regulator 3	GO:0010664; P:negative regulation of striated muscle cell apoptotic process; IEA:Ensembl
O95817	BAG3	BAG family molecular chaperone regulator 3	GO:0006457; P:protein folding; NAS:UniProtKB
O95817	BAG3	BAG family molecular chaperone regulator 3	GO:0050821; P:protein stabilization; IEA:Ensembl
O95817	BAG3	BAG family molecular chaperone regulator 3	GO:0021510; P:spinal cord development; IEA:Ensembl
O95429	BAG4	BAG family molecular chaperone regulator 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O95429	BAG4	BAG family molecular chaperone regulator 4	GO:0005057; F:receptor signaling protein activity; TAS:ProtInc
O95429	BAG4	BAG family molecular chaperone regulator 4	GO:0071364; P:cellular response to epidermal growth factor stimulus; IEA:Ensembl
O95429	BAG4	BAG family molecular chaperone regulator 4	GO:0071356; P:cellular response to tumor necrosis factor; IDA:UniProtKB
O95429	BAG4	BAG family molecular chaperone regulator 4	GO:0035556; P:intracellular signal transduction; TAS:GOC
O95429	BAG4	BAG family molecular chaperone regulator 4	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
O95429	BAG4	BAG family molecular chaperone regulator 4	GO:0090367; P:negative regulation of mRNA modification; IEA:Ensembl
O95429	BAG4	BAG family molecular chaperone regulator 4	GO:2001145; P:negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; IEA:Ensembl
O95429	BAG4	BAG family molecular chaperone regulator 4	GO:0030838; P:positive regulation of actin filament polymerization; IEA:Ensembl
O95429	BAG4	BAG family molecular chaperone regulator 4	GO:0045785; P:positive regulation of cell adhesion; IEA:Ensembl
O95429	BAG4	BAG family molecular chaperone regulator 4	GO:0010763; P:positive regulation of fibroblast migration; IEA:Ensembl
O95429	BAG4	BAG family molecular chaperone regulator 4	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IEA:Ensembl
O95429	BAG4	BAG family molecular chaperone regulator 4	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
O95429	BAG4	BAG family molecular chaperone regulator 4	GO:0051496; P:positive regulation of stress fiber assembly; IEA:Ensembl
O95429	BAG4	BAG family molecular chaperone regulator 4	GO:0006457; P:protein folding; TAS:ProtInc
O95429	BAG4	BAG family molecular chaperone regulator 4	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
O95429	BAG4	BAG family molecular chaperone regulator 4	GO:0072659; P:protein localization to plasma membrane; IEA:Ensembl
O95429	BAG4	BAG family molecular chaperone regulator 4	GO:0097178; P:ruffle assembly; IEA:Ensembl
Q9UL15	BAG5	BAG family molecular chaperone regulator 5	GO:0051087; F:chaperone binding; IPI:BHF-UCL
Q9UL15	BAG5	BAG family molecular chaperone regulator 5	GO:0031625; F:ubiquitin protein ligase binding; ISS:BHF-UCL
Q9UL15	BAG5	BAG family molecular chaperone regulator 5	GO:0061084; P:negative regulation of protein refolding; ISS:BHF-UCL
Q9UL15	BAG5	BAG family molecular chaperone regulator 5	GO:0031397; P:negative regulation of protein ubiquitination; ISS:BHF-UCL
Q9UL15	BAG5	BAG family molecular chaperone regulator 5	GO:0051444; P:negative regulation of ubiquitin-protein ligase activity; ISS:BHF-UCL
Q9UL15	BAG5	BAG family molecular chaperone regulator 5	GO:0070997; P:neuron death; ISS:BHF-UCL
Q9UL15	BAG5	BAG family molecular chaperone regulator 5	GO:0006457; P:protein folding; TAS:ProtInc
Q9UL15	BAG5	BAG family molecular chaperone regulator 5	GO:0090083; P:regulation of inclusion body assembly; IMP:BHF-UCL
P46379	BAG6	Large proline-rich protein BAG6	GO:0031593; F:polyubiquitin binding; ISS:UniProtKB
P46379	BAG6	Large proline-rich protein BAG6	GO:0070628; F:proteasome binding; ISS:UniProtKB
P46379	BAG6	Large proline-rich protein BAG6	GO:0005515; F:protein binding; IPI:UniProtKB
P46379	BAG6	Large proline-rich protein BAG6	GO:0043022; F:ribosome binding; IDA:UniProtKB
P46379	BAG6	Large proline-rich protein BAG6	GO:0007420; P:brain development; ISS:UniProtKB
P46379	BAG6	Large proline-rich protein BAG6	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P46379	BAG6	Large proline-rich protein BAG6	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
P46379	BAG6	Large proline-rich protein BAG6	GO:0009790; P:embryo development; ISS:UniProtKB
P46379	BAG6	Large proline-rich protein BAG6	GO:0002376; P:immune system process; IEA:UniProtKB-KW
P46379	BAG6	Large proline-rich protein BAG6	GO:0018393; P:internal peptidyl-lysine acetylation; IDA:UniProtKB
P46379	BAG6	Large proline-rich protein BAG6	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IMP:UniProtKB
P46379	BAG6	Large proline-rich protein BAG6	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISS:UniProtKB
P46379	BAG6	Large proline-rich protein BAG6	GO:0001822; P:kidney development; ISS:UniProtKB
P46379	BAG6	Large proline-rich protein BAG6	GO:0030324; P:lung development; ISS:UniProtKB
P46379	BAG6	Large proline-rich protein BAG6	GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; ISS:UniProtKB
P46379	BAG6	Large proline-rich protein BAG6	GO:0045861; P:negative regulation of proteolysis; ISS:UniProtKB
P46379	BAG6	Large proline-rich protein BAG6	GO:0050821; P:protein stabilization; ISS:UniProtKB
P46379	BAG6	Large proline-rich protein BAG6	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P46379	BAG6	Large proline-rich protein BAG6	GO:0007283; P:spermatogenesis; ISS:UniProtKB
P46379	BAG6	Large proline-rich protein BAG6	GO:0007130; P:synaptonemal complex assembly; ISS:UniProtKB
P46379	BAG6	Large proline-rich protein BAG6	GO:0071816; P:tail-anchored membrane protein insertion into ER membrane; IDA:UniProtKB
P46379	BAG6	Large proline-rich protein BAG6	GO:0006810; P:transport; IEA:UniProtKB-KW
P46379	BAG6	Large proline-rich protein BAG6	GO:0006511; P:ubiquitin-dependent protein catabolic process; ISS:UniProtKB
Q9P281	BAHCC1	BAH and coiled-coil domain-containing protein 1	GO:0003682; F:chromatin binding; IEA:InterPro
Q8TBE0	BAHD1	Bromo adjacent homology domain-containing 1 protein	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q8TBE0	BAHD1	Bromo adjacent homology domain-containing 1 protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TBE0	BAHD1	Bromo adjacent homology domain-containing 1 protein	GO:0031507; P:heterochromatin assembly; IMP:UniProtKB
Q8TBE0	BAHD1	Bromo adjacent homology domain-containing 1 protein	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q8TBE0	BAHD1	Bromo adjacent homology domain-containing 1 protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O14514	BAI1	Brain-specific angiogenesis inhibitor 1	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
O14514	BAI1	Brain-specific angiogenesis inhibitor 1	GO:0007409; P:axonogenesis; TAS:ProtInc
O14514	BAI1	Brain-specific angiogenesis inhibitor 1	GO:0007155; P:cell adhesion; TAS:ProtInc
O14514	BAI1	Brain-specific angiogenesis inhibitor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
O14514	BAI1	Brain-specific angiogenesis inhibitor 1	GO:0016525; P:negative regulation of angiogenesis; IEA:InterPro
O14514	BAI1	Brain-specific angiogenesis inhibitor 1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
O14514	BAI1	Brain-specific angiogenesis inhibitor 1	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
O14514	BAI1	Brain-specific angiogenesis inhibitor 1	GO:0007422; P:peripheral nervous system development; TAS:ProtInc
O14514	BAI1	Brain-specific angiogenesis inhibitor 1	GO:0007165; P:signal transduction; TAS:ProtInc
O60241	BAI2	Brain-specific angiogenesis inhibitor 2	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
O60241	BAI2	Brain-specific angiogenesis inhibitor 2	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
O60241	BAI2	Brain-specific angiogenesis inhibitor 2	GO:0016525; P:negative regulation of angiogenesis; IEA:InterPro
O60241	BAI2	Brain-specific angiogenesis inhibitor 2	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
O60241	BAI2	Brain-specific angiogenesis inhibitor 2	GO:0007422; P:peripheral nervous system development; IEA:Ensembl
O60242	BAI3	Brain-specific angiogenesis inhibitor 3	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
O60242	BAI3	Brain-specific angiogenesis inhibitor 3	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
O60242	BAI3	Brain-specific angiogenesis inhibitor 3	GO:0016525; P:negative regulation of angiogenesis; IEA:InterPro
O60242	BAI3	Brain-specific angiogenesis inhibitor 3	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q9UQB8	BAIAP2	Brain-specific angiogenesis inhibitor 1-associated protein 2	GO:0008093; F:cytoskeletal adaptor activity; TAS:ProtInc
Q9UQB8	BAIAP2	Brain-specific angiogenesis inhibitor 1-associated protein 2	GO:0042802; F:identical protein binding; IPI:IntAct
Q9UQB8	BAIAP2	Brain-specific angiogenesis inhibitor 1-associated protein 2	GO:0070064; F:proline-rich region binding; IDA:UniProtKB
Q9UQB8	BAIAP2	Brain-specific angiogenesis inhibitor 1-associated protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q9UQB8	BAIAP2	Brain-specific angiogenesis inhibitor 1-associated protein 2	GO:0008022; F:protein C-terminus binding; TAS:ProtInc
Q9UQB8	BAIAP2	Brain-specific angiogenesis inhibitor 1-associated protein 2	GO:0051764; P:actin crosslink formation; ISS:UniProtKB
Q9UQB8	BAIAP2	Brain-specific angiogenesis inhibitor 1-associated protein 2	GO:0051017; P:actin filament bundle assembly; ISS:UniProtKB
Q9UQB8	BAIAP2	Brain-specific angiogenesis inhibitor 1-associated protein 2	GO:0007409; P:axonogenesis; TAS:ProtInc
Q9UQB8	BAIAP2	Brain-specific angiogenesis inhibitor 1-associated protein 2	GO:0016358; P:dendrite development; IEA:Ensembl
Q9UQB8	BAIAP2	Brain-specific angiogenesis inhibitor 1-associated protein 2	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q9UQB8	BAIAP2	Brain-specific angiogenesis inhibitor 1-associated protein 2	GO:0046847; P:filopodium assembly; IEA:InterPro
Q9UQB8	BAIAP2	Brain-specific angiogenesis inhibitor 1-associated protein 2	GO:0045087; P:innate immune response; TAS:Reactome
Q9UQB8	BAIAP2	Brain-specific angiogenesis inhibitor 1-associated protein 2	GO:0008286; P:insulin receptor signaling pathway; TAS:ProtInc
Q9UQB8	BAIAP2	Brain-specific angiogenesis inhibitor 1-associated protein 2	GO:0032956; P:regulation of actin cytoskeleton organization; IMP:UniProtKB
Q9UQB8	BAIAP2	Brain-specific angiogenesis inhibitor 1-associated protein 2	GO:0008360; P:regulation of cell shape; ISS:UniProtKB
Q9UQB8	BAIAP2	Brain-specific angiogenesis inhibitor 1-associated protein 2	GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl
Q9UQB8	BAIAP2	Brain-specific angiogenesis inhibitor 1-associated protein 2	GO:0009617; P:response to bacterium; IMP:UniProtKB
O94812	BAIAP3	BAI1-associated protein 3	GO:0008022; F:protein C-terminus binding; TAS:ProtInc
O94812	BAIAP3	BAI1-associated protein 3	GO:0007186; P:G-protein coupled receptor signaling pathway; IPI:MGI
O94812	BAIAP3	BAI1-associated protein 3	GO:0007269; P:neurotransmitter secretion; TAS:ProtInc
Q6ZNE5	ATG14	Beclin 1-associated autophagy-related key regulator	GO:0005515; F:protein binding; IPI:UniProtKB
Q6ZNE5	ATG14	Beclin 1-associated autophagy-related key regulator	GO:0000045; P:autophagic vacuole assembly; IMP:UniProtKB
Q6ZNE5	ATG14	Beclin 1-associated autophagy-related key regulator	GO:0010508; P:positive regulation of autophagy; IEA:InterPro
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0042802; F:identical protein binding; IPI:IntAct
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0005515; F:protein binding; IPI:UniProtKB
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0042803; F:protein homodimerization activity; IBA:RefGenome
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0097202; P:activation of cysteine-type endopeptidase activity; IDA:BHF-UCL
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0008635; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0007568; P:aging; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0006915; P:apoptotic process; TAS:Reactome
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:1902262; P:apoptotic process involved in patterning of blood vessels; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0097190; P:apoptotic signaling pathway; IMP:UniProtKB
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0001783; P:B cell apoptotic process; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0001782; P:B cell homeostasis; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0002352; P:B cell negative selection; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0007420; P:brain development; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0008283; P:cell proliferation; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0034644; P:cellular response to UV; IMP:UniProtKB
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0031018; P:endocrine pancreas development; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; TAS:UniProtKB
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0010248; P:establishment or maintenance of transmembrane electrochemical gradient; IDA:HGNC
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IBA:RefGenome
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0044346; P:fibroblast apoptotic process; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IBA:RefGenome
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0035108; P:limb morphogenesis; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0008053; P:mitochondrial fusion; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0002262; P:myeloid cell homeostasis; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0032471; P:negative regulation of endoplasmic reticulum calcium ion concentration; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0031100; P:organ regeneration; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0010524; P:positive regulation of calcium ion transport into cytosol; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:1900103; P:positive regulation of endoplasmic reticulum unfolded protein response; IMP:UniProtKB
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:1901030; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; TAS:Reactome
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0045862; P:positive regulation of proteolysis; IDA:BHF-UCL
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0048597; P:post-embryonic camera-type eye morphogenesis; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0046902; P:regulation of mitochondrial membrane permeability; IDA:BHF-UCL
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0051881; P:regulation of mitochondrial membrane potential; IDA:HGNC
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0043497; P:regulation of protein heterodimerization activity; IDA:HGNC
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0043496; P:regulation of protein homodimerization activity; IDA:HGNC
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0001836; P:release of cytochrome c from mitochondria; IDA:BHF-UCL
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0042493; P:response to drug; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0045471; P:response to ethanol; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0009620; P:response to fungus; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0010332; P:response to gamma radiation; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0010046; P:response to mycotoxin; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0010225; P:response to UV-C; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0070242; P:thymocyte apoptotic process; IEA:Ensembl
Q16611	BAK1	Bcl-2 homologous antagonist/killer	GO:0060068; P:vagina development; IEA:Ensembl
Q13145	BAMBI	BMP and activin membrane-bound inhibitor homolog	GO:0005109; F:frizzled binding; IPI:BHF-UCL
Q13145	BAMBI	BMP and activin membrane-bound inhibitor homolog	GO:0005114; F:type II transforming growth factor beta receptor binding; TAS:BHF-UCL
Q13145	BAMBI	BMP and activin membrane-bound inhibitor homolog	GO:0016477; P:cell migration; IDA:BHF-UCL
Q13145	BAMBI	BMP and activin membrane-bound inhibitor homolog	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
Q13145	BAMBI	BMP and activin membrane-bound inhibitor homolog	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:BHF-UCL
Q13145	BAMBI	BMP and activin membrane-bound inhibitor homolog	GO:0035413; P:positive regulation of catenin import into nucleus; IMP:BHF-UCL
Q13145	BAMBI	BMP and activin membrane-bound inhibitor homolog	GO:0008284; P:positive regulation of cell proliferation; IMP:BHF-UCL
Q13145	BAMBI	BMP and activin membrane-bound inhibitor homolog	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IMP:BHF-UCL
Q13145	BAMBI	BMP and activin membrane-bound inhibitor homolog	GO:0032092; P:positive regulation of protein binding; IMP:BHF-UCL
Q13145	BAMBI	BMP and activin membrane-bound inhibitor homolog	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
Q13145	BAMBI	BMP and activin membrane-bound inhibitor homolog	GO:0008360; P:regulation of cell shape; IMP:BHF-UCL
Q13145	BAMBI	BMP and activin membrane-bound inhibitor homolog	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q8NDB2	BANK1	B-cell scaffold protein with ankyrin repeats	GO:0042113; P:B cell activation; IEA:UniProtKB-KW
Q8N9N5	BANP	Protein BANP	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N9N5	BANP	Protein BANP	GO:0005515; F:protein binding; IPI:IntAct
Q8N9N5	BANP	Protein BANP	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8N9N5	BANP	Protein BANP	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q8N9N5	BANP	Protein BANP	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8N9N5	BANP	Protein BANP	GO:0042177; P:negative regulation of protein catabolic process; IEA:Ensembl
Q8N9N5	BANP	Protein BANP	GO:0034504; P:protein localization to nucleus; IEA:Ensembl
Q8N9N5	BANP	Protein BANP	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N9N5	BANP	Protein BANP	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IXM2	BAP18	Chromatin complexes subunit BAP18	GO:0003682; F:chromatin binding; IEA:InterPro
Q8IXM2	BAP18	Chromatin complexes subunit BAP18	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IXM2	BAP18	Chromatin complexes subunit BAP18	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q92560	BAP1	Ubiquitin carboxyl-terminal hydrolase BAP1	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q92560	BAP1	Ubiquitin carboxyl-terminal hydrolase BAP1	GO:0008233; F:peptidase activity; NAS:UniProtKB
Q92560	BAP1	Ubiquitin carboxyl-terminal hydrolase BAP1	GO:0005515; F:protein binding; IPI:UniProtKB
Q92560	BAP1	Ubiquitin carboxyl-terminal hydrolase BAP1	GO:0004221; F:ubiquitin thiolesterase activity; IMP:UniProtKB
Q92560	BAP1	Ubiquitin carboxyl-terminal hydrolase BAP1	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q92560	BAP1	Ubiquitin carboxyl-terminal hydrolase BAP1	GO:0006464; P:cellular protein modification process; NAS:UniProtKB
Q92560	BAP1	Ubiquitin carboxyl-terminal hydrolase BAP1	GO:0035522; P:monoubiquitinated histone H2A deubiquitination; IDA:UniProtKB
Q92560	BAP1	Ubiquitin carboxyl-terminal hydrolase BAP1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q92560	BAP1	Ubiquitin carboxyl-terminal hydrolase BAP1	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
Q92560	BAP1	Ubiquitin carboxyl-terminal hydrolase BAP1	GO:0071108; P:protein K48-linked deubiquitination; IMP:UniProtKB
Q92560	BAP1	Ubiquitin carboxyl-terminal hydrolase BAP1	GO:0051726; P:regulation of cell cycle; IMP:UniProtKB
Q92560	BAP1	Ubiquitin carboxyl-terminal hydrolase BAP1	GO:0001558; P:regulation of cell growth; IMP:UniProtKB
Q92560	BAP1	Ubiquitin carboxyl-terminal hydrolase BAP1	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q9UHQ4	BCAP29	B-cell receptor-associated protein 29	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9UHQ4	BCAP29	B-cell receptor-associated protein 29	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9UHQ4	BCAP29	B-cell receptor-associated protein 29	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
P51572	BCAP31	B-cell receptor-associated protein 31	GO:0005515; F:protein binding; IPI:UniProtKB
P51572	BCAP31	B-cell receptor-associated protein 31	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P51572	BCAP31	B-cell receptor-associated protein 31	GO:0006915; P:apoptotic process; TAS:Reactome
P51572	BCAP31	B-cell receptor-associated protein 31	GO:0035584; P:calcium-mediated signaling using intracellular calcium source; IMP:UniProtKB
P51572	BCAP31	B-cell receptor-associated protein 31	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
P51572	BCAP31	B-cell receptor-associated protein 31	GO:0006955; P:immune response; IEA:Ensembl
P51572	BCAP31	B-cell receptor-associated protein 31	GO:0006886; P:intracellular protein transport; IEA:InterPro
P51572	BCAP31	B-cell receptor-associated protein 31	GO:0032471; P:negative regulation of endoplasmic reticulum calcium ion concentration; IMP:UniProtKB
P51572	BCAP31	B-cell receptor-associated protein 31	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
P51572	BCAP31	B-cell receptor-associated protein 31	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IMP:UniProtKB
P51572	BCAP31	B-cell receptor-associated protein 31	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
P51572	BCAP31	B-cell receptor-associated protein 31	GO:0051561; P:positive regulation of mitochondrial calcium ion concentration; IMP:UniProtKB
P51572	BCAP31	B-cell receptor-associated protein 31	GO:0007283; P:spermatogenesis; IEA:Ensembl
P51572	BCAP31	B-cell receptor-associated protein 31	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q99728	BARD1	BRCA1-associated RING domain protein 1	GO:0019900; F:kinase binding; NAS:UniProtKB
Q99728	BARD1	BRCA1-associated RING domain protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q99728	BARD1	BRCA1-associated RING domain protein 1	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q99728	BARD1	BRCA1-associated RING domain protein 1	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q99728	BARD1	BRCA1-associated RING domain protein 1	GO:0003723; F:RNA binding; IDA:MGI
Q99728	BARD1	BRCA1-associated RING domain protein 1	GO:0004842; F:ubiquitin-protein ligase activity; NAS:UniProtKB
Q99728	BARD1	BRCA1-associated RING domain protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q99728	BARD1	BRCA1-associated RING domain protein 1	GO:0007050; P:cell cycle arrest; NAS:UniProtKB
Q99728	BARD1	BRCA1-associated RING domain protein 1	GO:0006974; P:cellular response to DNA damage stimulus; NAS:UniProtKB
Q99728	BARD1	BRCA1-associated RING domain protein 1	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q99728	BARD1	BRCA1-associated RING domain protein 1	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q99728	BARD1	BRCA1-associated RING domain protein 1	GO:0031441; P:negative regulation of mRNA 3'-end processing; NAS:UniProtKB
Q99728	BARD1	BRCA1-associated RING domain protein 1	GO:0046826; P:negative regulation of protein export from nucleus; IDA:UniProtKB
Q99728	BARD1	BRCA1-associated RING domain protein 1	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q99728	BARD1	BRCA1-associated RING domain protein 1	GO:0045732; P:positive regulation of protein catabolic process; NAS:UniProtKB
Q99728	BARD1	BRCA1-associated RING domain protein 1	GO:0085020; P:protein K6-linked ubiquitination; IDA:UniProtKB
Q99728	BARD1	BRCA1-associated RING domain protein 1	GO:0016567; P:protein ubiquitination; NAS:UniProtKB
Q99728	BARD1	BRCA1-associated RING domain protein 1	GO:0042325; P:regulation of phosphorylation; IMP:UniProtKB
Q99728	BARD1	BRCA1-associated RING domain protein 1	GO:0001894; P:tissue homeostasis; TAS:UniProtKB
Q9BZE3	BARHL1	BarH-like 1 homeobox protein	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q9BZE3	BARHL1	BarH-like 1 homeobox protein	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9BZE3	BARHL1	BarH-like 1 homeobox protein	GO:0030901; P:midbrain development; IEA:Ensembl
Q9BZE3	BARHL1	BarH-like 1 homeobox protein	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q9BZE3	BARHL1	BarH-like 1 homeobox protein	GO:0001764; P:neuron migration; IEA:Ensembl
Q9BZE3	BARHL1	BarH-like 1 homeobox protein	GO:0007605; P:sensory perception of sound; IEA:Ensembl
Q9NY43	BARHL2	BarH-like 2 homeobox protein	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q9NY43	BARHL2	BarH-like 2 homeobox protein	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9NY43	BARHL2	BarH-like 2 homeobox protein	GO:0001709; P:cell fate determination; IEA:Ensembl
Q9NY43	BARHL2	BarH-like 2 homeobox protein	GO:0030182; P:neuron differentiation; IEA:Ensembl
Q9NY43	BARHL2	BarH-like 2 homeobox protein	GO:0001764; P:neuron migration; IEA:Ensembl
Q9NY43	BARHL2	BarH-like 2 homeobox protein	GO:0045727; P:positive regulation of translation; IEA:Ensembl
Q9NY43	BARHL2	BarH-like 2 homeobox protein	GO:0030516; P:regulation of axon extension; IEA:Ensembl
Q9HBU1	BARX1	Homeobox protein BarH-like 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9HBU1	BARX1	Homeobox protein BarH-like 1	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
Q9HBU1	BARX1	Homeobox protein BarH-like 1	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q9HBU1	BARX1	Homeobox protein BarH-like 1	GO:0007267; P:cell-cell signaling; IEA:Ensembl
Q9HBU1	BARX1	Homeobox protein BarH-like 1	GO:0055123; P:digestive system development; IEA:Ensembl
Q9HBU1	BARX1	Homeobox protein BarH-like 1	GO:0030855; P:epithelial cell differentiation; IEA:Ensembl
Q9HBU1	BARX1	Homeobox protein BarH-like 1	GO:0030178; P:negative regulation of Wnt signaling pathway; IEA:Ensembl
Q9HBU1	BARX1	Homeobox protein BarH-like 1	GO:0048536; P:spleen development; IEA:Ensembl
Q9HBU1	BARX1	Homeobox protein BarH-like 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UMQ3	BARX2	Homeobox protein BarH-like 2	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9UMQ3	BARX2	Homeobox protein BarH-like 2	GO:0003677; F:DNA binding; IDA:MGI
Q9UMQ3	BARX2	Homeobox protein BarH-like 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q9UMQ3	BARX2	Homeobox protein BarH-like 2	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
Q9UMQ3	BARX2	Homeobox protein BarH-like 2	GO:0001502; P:cartilage condensation; IEA:Ensembl
Q9UMQ3	BARX2	Homeobox protein BarH-like 2	GO:0042637; P:catagen; IEA:Ensembl
Q9UMQ3	BARX2	Homeobox protein BarH-like 2	GO:0014902; P:myotube differentiation; IEA:Ensembl
Q9UMQ3	BARX2	Homeobox protein BarH-like 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UMQ3	BARX2	Homeobox protein BarH-like 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UMQ3	BARX2	Homeobox protein BarH-like 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P35613	BSG	Basigin	GO:0005537; F:mannose binding; IEA:UniProtKB-KW
P35613	BSG	Basigin	GO:0005515; F:protein binding; IPI:UniProtKB
P35613	BSG	Basigin	GO:0007596; P:blood coagulation; TAS:Reactome
P35613	BSG	Basigin	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P35613	BSG	Basigin	GO:0044237; P:cellular metabolic process; TAS:Reactome
P35613	BSG	Basigin	GO:0046697; P:decidualization; IEA:Ensembl
P35613	BSG	Basigin	GO:0007566; P:embryo implantation; IEA:Ensembl
P35613	BSG	Basigin	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P35613	BSG	Basigin	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P35613	BSG	Basigin	GO:0050900; P:leukocyte migration; TAS:Reactome
P35613	BSG	Basigin	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
P35613	BSG	Basigin	GO:0072661; P:protein targeting to plasma membrane; ISS:UniProtKB
P35613	BSG	Basigin	GO:0006090; P:pyruvate metabolic process; TAS:Reactome
P35613	BSG	Basigin	GO:0051591; P:response to cAMP; IEA:Ensembl
P35613	BSG	Basigin	GO:0046689; P:response to mercury ion; IEA:Ensembl
P35613	BSG	Basigin	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P35613	BSG	Basigin	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P80723	BASP1	Brain acid soluble protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P80723	BASP1	Brain acid soluble protein 1	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P80723	BASP1	Brain acid soluble protein 1	GO:0003714; F:transcription corepressor activity; IMP:UniProtKB
P80723	BASP1	Brain acid soluble protein 1	GO:0044212; F:transcription regulatory region DNA binding; ISS:UniProtKB
P80723	BASP1	Brain acid soluble protein 1	GO:0060539; P:diaphragm development; ISS:UniProtKB
P80723	BASP1	Brain acid soluble protein 1	GO:0072112; P:glomerular visceral epithelial cell differentiation; ISS:UniProtKB
P80723	BASP1	Brain acid soluble protein 1	GO:0008406; P:gonad development; ISS:UniProtKB
P80723	BASP1	Brain acid soluble protein 1	GO:0060231; P:mesenchymal to epithelial transition; ISS:UniProtKB
P80723	BASP1	Brain acid soluble protein 1	GO:0072075; P:metanephric mesenchyme development; ISS:UniProtKB
P80723	BASP1	Brain acid soluble protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P80723	BASP1	Brain acid soluble protein 1	GO:0060421; P:positive regulation of heart growth; ISS:UniProtKB
P80723	BASP1	Brain acid soluble protein 1	GO:2001076; P:positive regulation of metanephric ureteric bud development; ISS:UniProtKB
P80723	BASP1	Brain acid soluble protein 1	GO:0021762; P:substantia nigra development; IEP:UniProt
P80723	BASP1	Brain acid soluble protein 1	GO:0007356; P:thorax and anterior abdomen determination; ISS:UniProtKB
P82251	SLC7A9	b(0,+)-type amino acid transporter 1	GO:0015171; F:amino acid transmembrane transporter activity; TAS:ProtInc
P82251	SLC7A9	b(0,+)-type amino acid transporter 1	GO:0015184; F:L-cystine transmembrane transporter activity; TAS:ProtInc
P82251	SLC7A9	b(0,+)-type amino acid transporter 1	GO:0015175; F:neutral amino acid transmembrane transporter activity; ISS:UniProtKB
P82251	SLC7A9	b(0,+)-type amino acid transporter 1	GO:0042605; F:peptide antigen binding; ISS:UniProtKB
P82251	SLC7A9	b(0,+)-type amino acid transporter 1	GO:0005515; F:protein binding; IPI:UniProtKB
P82251	SLC7A9	b(0,+)-type amino acid transporter 1	GO:0006865; P:amino acid transport; TAS:Reactome
P82251	SLC7A9	b(0,+)-type amino acid transporter 1	GO:0007596; P:blood coagulation; TAS:Reactome
P82251	SLC7A9	b(0,+)-type amino acid transporter 1	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
P82251	SLC7A9	b(0,+)-type amino acid transporter 1	GO:0006811; P:ion transport; TAS:Reactome
P82251	SLC7A9	b(0,+)-type amino acid transporter 1	GO:0015811; P:L-cystine transport; TAS:GOC
P82251	SLC7A9	b(0,+)-type amino acid transporter 1	GO:0050900; P:leukocyte migration; TAS:Reactome
P82251	SLC7A9	b(0,+)-type amino acid transporter 1	GO:0015804; P:neutral amino acid transport; ISS:UniProtKB
P82251	SLC7A9	b(0,+)-type amino acid transporter 1	GO:0006461; P:protein complex assembly; TAS:ProtInc
P82251	SLC7A9	b(0,+)-type amino acid transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P82251	SLC7A9	b(0,+)-type amino acid transporter 1	GO:0006810; P:transport; TAS:ProtInc
Q8N1L9	BATF2	Basic leucine zipper transcriptional factor ATF-like 2	GO:0005515; F:protein binding; IPI:IntAct
Q8N1L9	BATF2	Basic leucine zipper transcriptional factor ATF-like 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q8N1L9	BATF2	Basic leucine zipper transcriptional factor ATF-like 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8N1L9	BATF2	Basic leucine zipper transcriptional factor ATF-like 2	GO:0042832; P:defense response to protozoan; ISS:UniProtKB
Q8N1L9	BATF2	Basic leucine zipper transcriptional factor ATF-like 2	GO:0043011; P:myeloid dendritic cell differentiation; ISS:UniProtKB
Q8N1L9	BATF2	Basic leucine zipper transcriptional factor ATF-like 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NR55	BATF3	Basic leucine zipper transcriptional factor ATF-like 3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9NR55	BATF3	Basic leucine zipper transcriptional factor ATF-like 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9NR55	BATF3	Basic leucine zipper transcriptional factor ATF-like 3	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q9NR55	BATF3	Basic leucine zipper transcriptional factor ATF-like 3	GO:0097028; P:dendritic cell differentiation; ISS:UniProtKB
Q9NR55	BATF3	Basic leucine zipper transcriptional factor ATF-like 3	GO:0043011; P:myeloid dendritic cell differentiation; ISS:UniProtKB
Q9NR55	BATF3	Basic leucine zipper transcriptional factor ATF-like 3	GO:0009615; P:response to virus; ISS:UniProtKB
Q9NR55	BATF3	Basic leucine zipper transcriptional factor ATF-like 3	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q16520	BATF	Basic leucine zipper transcriptional factor ATF-like	GO:0005515; F:protein binding; IPI:UniProtKB
Q16520	BATF	Basic leucine zipper transcriptional factor ATF-like	GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB
Q16520	BATF	Basic leucine zipper transcriptional factor ATF-like	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q16520	BATF	Basic leucine zipper transcriptional factor ATF-like	GO:0006974; P:cellular response to DNA damage stimulus; ISS:UniProtKB
Q16520	BATF	Basic leucine zipper transcriptional factor ATF-like	GO:0001816; P:cytokine production; ISS:UniProtKB
Q16520	BATF	Basic leucine zipper transcriptional factor ATF-like	GO:0042832; P:defense response to protozoan; ISS:UniProtKB
Q16520	BATF	Basic leucine zipper transcriptional factor ATF-like	GO:0030330; P:DNA damage response, signal transduction by p53 class mediator; ISS:UniProtKB
Q16520	BATF	Basic leucine zipper transcriptional factor ATF-like	GO:0060218; P:hematopoietic stem cell differentiation; ISS:UniProtKB
Q16520	BATF	Basic leucine zipper transcriptional factor ATF-like	GO:0045190; P:isotype switching; ISS:UniProtKB
Q16520	BATF	Basic leucine zipper transcriptional factor ATF-like	GO:0002320; P:lymphoid progenitor cell differentiation; ISS:UniProtKB
Q16520	BATF	Basic leucine zipper transcriptional factor ATF-like	GO:0043011; P:myeloid dendritic cell differentiation; ISS:UniProtKB
Q16520	BATF	Basic leucine zipper transcriptional factor ATF-like	GO:0072539; P:T-helper 17 cell differentiation; ISS:UniProtKB
Q16520	BATF	Basic leucine zipper transcriptional factor ATF-like	GO:0072540; P:T-helper 17 cell lineage commitment; ISS:UniProtKB
Q16520	BATF	Basic leucine zipper transcriptional factor ATF-like	GO:0045064; P:T-helper 2 cell differentiation; ISS:UniProtKB
Q16520	BATF	Basic leucine zipper transcriptional factor ATF-like	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NRL2	BAZ1A	Bromodomain adjacent to zinc finger domain protein 1A	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NRL2	BAZ1A	Bromodomain adjacent to zinc finger domain protein 1A	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NRL2	BAZ1A	Bromodomain adjacent to zinc finger domain protein 1A	GO:0006338; P:chromatin remodeling; TAS:BHF-UCL
Q9NRL2	BAZ1A	Bromodomain adjacent to zinc finger domain protein 1A	GO:0006261; P:DNA-dependent DNA replication; IDA:UniProtKB
Q9NRL2	BAZ1A	Bromodomain adjacent to zinc finger domain protein 1A	GO:0006355; P:regulation of transcription, DNA-templated; NAS:BHF-UCL
Q9NRL2	BAZ1A	Bromodomain adjacent to zinc finger domain protein 1A	GO:0006351; P:transcription, DNA-templated; NAS:BHF-UCL
Q07812	BAX	Apoptosis regulator BAX	GO:0051434; F:BH3 domain binding; IDA:UniProtKB
Q07812	BAX	Apoptosis regulator BAX	GO:0015267; F:channel activity; IDA:BHF-UCL
Q07812	BAX	Apoptosis regulator BAX	GO:0042802; F:identical protein binding; IPI:IntAct
Q07812	BAX	Apoptosis regulator BAX	GO:0008289; F:lipid binding; IDA:HGNC
Q07812	BAX	Apoptosis regulator BAX	GO:0005515; F:protein binding; IPI:UniProtKB
Q07812	BAX	Apoptosis regulator BAX	GO:0046982; F:protein heterodimerization activity; IPI:HGNC
Q07812	BAX	Apoptosis regulator BAX	GO:0042803; F:protein homodimerization activity; IDA:HGNC
Q07812	BAX	Apoptosis regulator BAX	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:HGNC
Q07812	BAX	Apoptosis regulator BAX	GO:0008635; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; IDA:HGNC
Q07812	BAX	Apoptosis regulator BAX	GO:0097296; P:activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0008637; P:apoptotic mitochondrial changes; IDA:HGNC
Q07812	BAX	Apoptosis regulator BAX	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q07812	BAX	Apoptosis regulator BAX	GO:1902263; P:apoptotic process involved in embryonic digit morphogenesis; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:1902262; P:apoptotic process involved in patterning of blood vessels; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0097190; P:apoptotic signaling pathway; IDA:HGNC
Q07812	BAX	Apoptosis regulator BAX	GO:0001783; P:B cell apoptotic process; IDA:HGNC
Q07812	BAX	Apoptosis regulator BAX	GO:0001782; P:B cell homeostasis; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0002358; P:B cell homeostatic proliferation; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0002352; P:B cell negative selection; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:1990117; P:B cell receptor apoptotic signaling pathway; IDA:BHF-UCL
Q07812	BAX	Apoptosis regulator BAX	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0071310; P:cellular response to organic substance; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0034644; P:cellular response to UV; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0021987; P:cerebral cortex development; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0045136; P:development of secondary sexual characteristics; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0035234; P:ectopic germ cell programmed cell death; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; TAS:UniProtKB
Q07812	BAX	Apoptosis regulator BAX	GO:0010248; P:establishment or maintenance of transmembrane electrochemical gradient; IDA:HGNC
Q07812	BAX	Apoptosis regulator BAX	GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:BHF-UCL
Q07812	BAX	Apoptosis regulator BAX	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IBA:RefGenome
Q07812	BAX	Apoptosis regulator BAX	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IC:BHF-UCL
Q07812	BAX	Apoptosis regulator BAX	GO:0009566; P:fertilization; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0007281; P:germ cell development; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0006687; P:glycosphingolipid metabolic process; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0021854; P:hypothalamus development; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0097193; P:intrinsic apoptotic signaling pathway; IDA:BHF-UCL
Q07812	BAX	Apoptosis regulator BAX	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IBA:RefGenome
Q07812	BAX	Apoptosis regulator BAX	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IMP:UniProtKB
Q07812	BAX	Apoptosis regulator BAX	GO:0001822; P:kidney development; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0043653; P:mitochondrial fragmentation involved in apoptotic process; IDA:HGNC
Q07812	BAX	Apoptosis regulator BAX	GO:0008053; P:mitochondrial fusion; IDA:HGNC
Q07812	BAX	Apoptosis regulator BAX	GO:0002262; P:myeloid cell homeostasis; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0032471; P:negative regulation of endoplasmic reticulum calcium ion concentration; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0048147; P:negative regulation of fibroblast proliferation; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0032091; P:negative regulation of protein binding; IDA:UniProtKB
Q07812	BAX	Apoptosis regulator BAX	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0001764; P:neuron migration; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0030264; P:nuclear fragmentation involved in apoptotic nuclear change; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0001541; P:ovarian follicle development; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:1902512; P:positive regulation of apoptotic DNA fragmentation; IMP:BHF-UCL
Q07812	BAX	Apoptosis regulator BAX	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q07812	BAX	Apoptosis regulator BAX	GO:0060058; P:positive regulation of apoptotic process involved in mammary gland involution; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0002904; P:positive regulation of B cell apoptotic process; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0048087; P:positive regulation of developmental pigmentation; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:1900103; P:positive regulation of endoplasmic reticulum unfolded protein response; IMP:UniProtKB
Q07812	BAX	Apoptosis regulator BAX	GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
Q07812	BAX	Apoptosis regulator BAX	GO:1901030; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; TAS:Reactome
Q07812	BAX	Apoptosis regulator BAX	GO:0043525; P:positive regulation of neuron apoptotic process; IDA:HGNC
Q07812	BAX	Apoptosis regulator BAX	GO:0032461; P:positive regulation of protein oligomerization; IDA:UniProtKB
Q07812	BAX	Apoptosis regulator BAX	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IDA:UniProtKB
Q07812	BAX	Apoptosis regulator BAX	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0048597; P:post-embryonic camera-type eye morphogenesis; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
Q07812	BAX	Apoptosis regulator BAX	GO:0001844; P:protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0051259; P:protein oligomerization; IDA:UniProtKB
Q07812	BAX	Apoptosis regulator BAX	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0033599; P:regulation of mammary gland epithelial cell proliferation; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0051881; P:regulation of mitochondrial membrane potential; IDA:HGNC
Q07812	BAX	Apoptosis regulator BAX	GO:0006808; P:regulation of nitrogen utilization; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0043497; P:regulation of protein heterodimerization activity; IPI:HGNC
Q07812	BAX	Apoptosis regulator BAX	GO:0043496; P:regulation of protein homodimerization activity; IDA:HGNC
Q07812	BAX	Apoptosis regulator BAX	GO:0001836; P:release of cytochrome c from mitochondria; IDA:BHF-UCL
Q07812	BAX	Apoptosis regulator BAX	GO:0032976; P:release of matrix enzymes from mitochondria; IDA:HGNC
Q07812	BAX	Apoptosis regulator BAX	GO:0001101; P:response to acid; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0048678; P:response to axon injury; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0010332; P:response to gamma radiation; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0009651; P:response to salt stress; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0009636; P:response to toxic substance; IDA:HGNC
Q07812	BAX	Apoptosis regulator BAX	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:1990009; P:retinal cell apoptotic process; IMP:HGNC
Q07812	BAX	Apoptosis regulator BAX	GO:0046666; P:retinal cell programmed cell death; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0060011; P:Sertoli cell proliferation; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0048515; P:spermatid differentiation; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0001777; P:T cell homeostatic proliferation; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0070242; P:thymocyte apoptotic process; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0006927; P:transformed cell apoptotic process; IMP:HGNC
Q07812	BAX	Apoptosis regulator BAX	GO:0060068; P:vagina development; IEA:Ensembl
Q07812	BAX	Apoptosis regulator BAX	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0070577; F:lysine-acetylated histone binding; IDA:UniProtKB
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0035173; F:histone kinase activity; IDA:UniProtKB
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0032947; F:protein complex scaffold; IDA:BHF-UCL
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0071884; F:vitamin D receptor activator activity; IMP:BHF-UCL
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0042809; F:vitamin D receptor binding; IPI:BHF-UCL
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0043044; P:ATP-dependent chromatin remodeling; IDA:BHF-UCL
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0048096; P:chromatin-mediated maintenance of transcription; ISS:BHF-UCL
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0034725; P:DNA replication-dependent nucleosome disassembly; IMP:BHF-UCL
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0006302; P:double-strand break repair; ISS:BHF-UCL
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0003007; P:heart morphogenesis; ISS:BHF-UCL
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0016572; P:histone phosphorylation; IDA:UniProtKB
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0006337; P:nucleosome disassembly; IDA:BHF-UCL
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:GOC
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:2000273; P:positive regulation of receptor activity; IMP:GOC
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0006355; P:regulation of transcription, DNA-templated; ISS:BHF-UCL
Q9UIG0	BAZ1B	Tyrosine-protein kinase BAZ1B	GO:0006351; P:transcription, DNA-templated; NAS:BHF-UCL
Q9UIF9	BAZ2A	Bromodomain adjacent to zinc finger domain protein 2A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UIF9	BAZ2A	Bromodomain adjacent to zinc finger domain protein 2A	GO:0070577; F:lysine-acetylated histone binding; ISS:UniProtKB
Q9UIF9	BAZ2A	Bromodomain adjacent to zinc finger domain protein 2A	GO:0016922; F:ligand-dependent nuclear receptor binding; NAS:BHF-UCL
Q9UIF9	BAZ2A	Bromodomain adjacent to zinc finger domain protein 2A	GO:0005515; F:protein binding; IPI:IntAct
Q9UIF9	BAZ2A	Bromodomain adjacent to zinc finger domain protein 2A	GO:0003723; F:RNA binding; ISS:UniProtKB
Q9UIF9	BAZ2A	Bromodomain adjacent to zinc finger domain protein 2A	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UIF9	BAZ2A	Bromodomain adjacent to zinc finger domain protein 2A	GO:0006338; P:chromatin remodeling; NAS:UniProtKB
Q9UIF9	BAZ2A	Bromodomain adjacent to zinc finger domain protein 2A	GO:0000183; P:chromatin silencing at rDNA; ISS:UniProtKB
Q9UIF9	BAZ2A	Bromodomain adjacent to zinc finger domain protein 2A	GO:0006306; P:DNA methylation; ISS:UniProtKB
Q9UIF9	BAZ2A	Bromodomain adjacent to zinc finger domain protein 2A	GO:0070869; P:heterochromatin assembly involved in chromatin silencing; IEA:Ensembl
Q9UIF9	BAZ2A	Bromodomain adjacent to zinc finger domain protein 2A	GO:0016575; P:histone deacetylation; ISS:UniProtKB
Q9UIF9	BAZ2A	Bromodomain adjacent to zinc finger domain protein 2A	GO:0051567; P:histone H3-K9 methylation; IEA:Ensembl
Q9UIF9	BAZ2A	Bromodomain adjacent to zinc finger domain protein 2A	GO:0070933; P:histone H4 deacetylation; IEA:Ensembl
Q9UIF9	BAZ2A	Bromodomain adjacent to zinc finger domain protein 2A	GO:0034770; P:histone H4-K20 methylation; IEA:Ensembl
Q9UIF9	BAZ2A	Bromodomain adjacent to zinc finger domain protein 2A	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9UIF9	BAZ2A	Bromodomain adjacent to zinc finger domain protein 2A	GO:0006351; P:transcription, DNA-templated; NAS:UniProtKB
Q9UIF8	BAZ2B	Bromodomain adjacent to zinc finger domain protein 2B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UIF8	BAZ2B	Bromodomain adjacent to zinc finger domain protein 2B	GO:0005515; F:protein binding; IPI:BHF-UCL
Q9UIF8	BAZ2B	Bromodomain adjacent to zinc finger domain protein 2B	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UIF8	BAZ2B	Bromodomain adjacent to zinc finger domain protein 2B	GO:0006355; P:regulation of transcription, DNA-templated; NAS:BHF-UCL
Q9UIF8	BAZ2B	Bromodomain adjacent to zinc finger domain protein 2B	GO:0006351; P:transcription, DNA-templated; NAS:BHF-UCL
Q96PG8	BBC3	Bcl-2-binding component 3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:0006915; P:apoptotic process; TAS:Reactome
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:0097190; P:apoptotic signaling pathway; IDA:UniProtKB
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:0006974; P:cellular response to DNA damage stimulus; ISS:BHF-UCL
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:0071456; P:cellular response to hypoxia; IEP:UniProtKB
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:0008340; P:determination of adult lifespan; ISS:BHF-UCL
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:0097194; P:execution phase of apoptosis; IDA:UniProtKB
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISS:UniProtKB
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:0032471; P:negative regulation of endoplasmic reticulum calcium ion concentration; IDA:UniProtKB
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:0045926; P:negative regulation of growth; IMP:UniProtKB
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:2001056; P:positive regulation of cysteine-type endopeptidase activity; ISS:UniProtKB
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:0043525; P:positive regulation of neuron apoptotic process; ISS:UniProtKB
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:0032464; P:positive regulation of protein homooligomerization; IDA:UniProtKB
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; IDA:UniProtKB
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IDA:UniProtKB
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:0070245; P:positive regulation of thymocyte apoptotic process; ISS:BHF-UCL
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:0001836; P:release of cytochrome c from mitochondria; IDA:UniProtKB
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:0051209; P:release of sequestered calcium ion into cytosol; IDA:UniProtKB
Q9BXH1	BBC3	Bcl-2-binding component 3	GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB
A8MTZ0	BBIP1	BBSome-interacting protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
A8MTZ0	BBIP1	BBSome-interacting protein 1	GO:0042384; P:cilium assembly; IMP:UniProtKB
A8MTZ0	BBIP1	BBSome-interacting protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8ND07	CCDC176	Basal body-orientation factor 1	GO:0044458; P:motile cilium assembly; ISS:UniProtKB
Q8TAM1	BBS10	Bardet-Biedl syndrome 10 protein	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8TAM1	BBS10	Bardet-Biedl syndrome 10 protein	GO:0005515; F:protein binding; IPI:IntAct
Q8TAM1	BBS10	Bardet-Biedl syndrome 10 protein	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:MGI
Q8TAM1	BBS10	Bardet-Biedl syndrome 10 protein	GO:0044267; P:cellular protein metabolic process; IEA:InterPro
Q8TAM1	BBS10	Bardet-Biedl syndrome 10 protein	GO:0051131; P:chaperone-mediated protein complex assembly; IMP:MGI
Q8TAM1	BBS10	Bardet-Biedl syndrome 10 protein	GO:0035058; P:nonmotile primary cilium assembly; IMP:BHF-UCL
Q8TAM1	BBS10	Bardet-Biedl syndrome 10 protein	GO:0045494; P:photoreceptor cell maintenance; IMP:BHF-UCL
Q8TAM1	BBS10	Bardet-Biedl syndrome 10 protein	GO:0043254; P:regulation of protein complex assembly; IMP:MGI
Q8TAM1	BBS10	Bardet-Biedl syndrome 10 protein	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q8TAM1	BBS10	Bardet-Biedl syndrome 10 protein	GO:0001895; P:retina homeostasis; IMP:BHF-UCL
Q8TAM1	BBS10	Bardet-Biedl syndrome 10 protein	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q6ZW61	BBS12	Bardet-Biedl syndrome 12 protein	GO:0005524; F:ATP binding; IEA:InterPro
Q6ZW61	BBS12	Bardet-Biedl syndrome 12 protein	GO:0005515; F:protein binding; IPI:IntAct
Q6ZW61	BBS12	Bardet-Biedl syndrome 12 protein	GO:0044267; P:cellular protein metabolic process; IEA:InterPro
Q6ZW61	BBS12	Bardet-Biedl syndrome 12 protein	GO:0051131; P:chaperone-mediated protein complex assembly; IMP:MGI
Q6ZW61	BBS12	Bardet-Biedl syndrome 12 protein	GO:0045599; P:negative regulation of fat cell differentiation; IMP:MGI
Q8NFJ9	BBS1	Bardet-Biedl syndrome 1 protein	GO:0005113; F:patched binding; IPI:MGI
Q8NFJ9	BBS1	Bardet-Biedl syndrome 1 protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NFJ9	BBS1	Bardet-Biedl syndrome 1 protein	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:MGI
Q8NFJ9	BBS1	Bardet-Biedl syndrome 1 protein	GO:0005119; F:smoothened binding; IPI:MGI
Q8NFJ9	BBS1	Bardet-Biedl syndrome 1 protein	GO:0042384; P:cilium assembly; IMP:BHF-UCL
Q8NFJ9	BBS1	Bardet-Biedl syndrome 1 protein	GO:0043001; P:Golgi to plasma membrane protein transport; IMP:MGI
Q8NFJ9	BBS1	Bardet-Biedl syndrome 1 protein	GO:0035058; P:nonmotile primary cilium assembly; IMP:BHF-UCL
Q8NFJ9	BBS1	Bardet-Biedl syndrome 1 protein	GO:0045494; P:photoreceptor cell maintenance; IMP:BHF-UCL
Q8NFJ9	BBS1	Bardet-Biedl syndrome 1 protein	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q8NFJ9	BBS1	Bardet-Biedl syndrome 1 protein	GO:0001895; P:retina homeostasis; IMP:BHF-UCL
Q8NFJ9	BBS1	Bardet-Biedl syndrome 1 protein	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:MGI
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0030534; P:adult behavior; ISS:BHF-UCL
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0014824; P:artery smooth muscle contraction; IEA:Ensembl
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0048854; P:brain morphogenesis; ISS:BHF-UCL
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0051216; P:cartilage development; IEA:Ensembl
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0021987; P:cerebral cortex development; ISS:BHF-UCL
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0060271; P:cilium morphogenesis; ISS:BHF-UCL
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0045444; P:fat cell differentiation; ISS:BHF-UCL
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0043001; P:Golgi to plasma membrane protein transport; IMP:MGI
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0021766; P:hippocampus development; ISS:BHF-UCL
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0032402; P:melanosome transport; ISS:BHF-UCL
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0038108; P:negative regulation of appetite by leptin-mediated signaling pathway; ISS:BHF-UCL
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0040015; P:negative regulation of multicellular organism growth; ISS:BHF-UCL
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0035058; P:nonmotile primary cilium assembly; IEA:InterPro
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0045494; P:photoreceptor cell maintenance; ISS:BHF-UCL
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0008104; P:protein localization; ISS:BHF-UCL
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0033365; P:protein localization to organelle; ISS:BHF-UCL
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0060296; P:regulation of cilium beat frequency involved in ciliary motility; ISS:BHF-UCL
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0007288; P:sperm axoneme assembly; ISS:BHF-UCL
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0021756; P:striatum development; ISS:BHF-UCL
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0042311; P:vasodilation; IEA:Ensembl
Q9BXC9	BBS2	Bardet-Biedl syndrome 2 protein	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q8N3I7	BBS5	Bardet-Biedl syndrome 5 protein	GO:0032266; F:phosphatidylinositol-3-phosphate binding; IDA:BHF-UCL
Q8N3I7	BBS5	Bardet-Biedl syndrome 5 protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N3I7	BBS5	Bardet-Biedl syndrome 5 protein	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:MGI
Q8N3I7	BBS5	Bardet-Biedl syndrome 5 protein	GO:0042384; P:cilium assembly; IMP:BHF-UCL
Q8N3I7	BBS5	Bardet-Biedl syndrome 5 protein	GO:0001947; P:heart looping; ISS:BHF-UCL
Q8N3I7	BBS5	Bardet-Biedl syndrome 5 protein	GO:0032402; P:melanosome transport; ISS:BHF-UCL
Q8N3I7	BBS5	Bardet-Biedl syndrome 5 protein	GO:0044458; P:motile cilium assembly; ISS:BHF-UCL
Q8N3I7	BBS5	Bardet-Biedl syndrome 5 protein	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8N3I7	BBS5	Bardet-Biedl syndrome 5 protein	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q8N3I7	BBS5	Bardet-Biedl syndrome 5 protein	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q8IWZ6	BBS7	Bardet-Biedl syndrome 7 protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IWZ6	BBS7	Bardet-Biedl syndrome 7 protein	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:MGI
Q8IWZ6	BBS7	Bardet-Biedl syndrome 7 protein	GO:0007420; P:brain development; IEA:Ensembl
Q8IWZ6	BBS7	Bardet-Biedl syndrome 7 protein	GO:0060271; P:cilium morphogenesis; ISS:BHF-UCL
Q8IWZ6	BBS7	Bardet-Biedl syndrome 7 protein	GO:0007368; P:determination of left/right symmetry; ISS:BHF-UCL
Q8IWZ6	BBS7	Bardet-Biedl syndrome 7 protein	GO:0048546; P:digestive tract morphogenesis; ISS:BHF-UCL
Q8IWZ6	BBS7	Bardet-Biedl syndrome 7 protein	GO:0001654; P:eye development; IEA:Ensembl
Q8IWZ6	BBS7	Bardet-Biedl syndrome 7 protein	GO:0045444; P:fat cell differentiation; ISS:BHF-UCL
Q8IWZ6	BBS7	Bardet-Biedl syndrome 7 protein	GO:0001947; P:heart looping; ISS:BHF-UCL
Q8IWZ6	BBS7	Bardet-Biedl syndrome 7 protein	GO:0060173; P:limb development; IEA:Ensembl
Q8IWZ6	BBS7	Bardet-Biedl syndrome 7 protein	GO:0032402; P:melanosome transport; ISS:BHF-UCL
Q8IWZ6	BBS7	Bardet-Biedl syndrome 7 protein	GO:0035058; P:nonmotile primary cilium assembly; IEA:InterPro
Q8IWZ6	BBS7	Bardet-Biedl syndrome 7 protein	GO:0060021; P:palate development; IEA:Ensembl
Q8IWZ6	BBS7	Bardet-Biedl syndrome 7 protein	GO:0051877; P:pigment granule aggregation in cell center; ISS:BHF-UCL
Q8IWZ6	BBS7	Bardet-Biedl syndrome 7 protein	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IPI:MGI
Q8IWZ6	BBS7	Bardet-Biedl syndrome 7 protein	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8IWZ6	BBS7	Bardet-Biedl syndrome 7 protein	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IPI:MGI
Q8IWZ6	BBS7	Bardet-Biedl syndrome 7 protein	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
Q8IWZ6	BBS7	Bardet-Biedl syndrome 7 protein	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0043014; F:alpha-tubulin binding; IDA:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0048487; F:beta-tubulin binding; IDA:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0034452; F:dynactin binding; IDA:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0003777; F:microtubule motor activity; IMP:UniProtKB
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:MGI
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0030534; P:adult behavior; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0048854; P:brain morphogenesis; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0051297; P:centrosome organization; IMP:UniProtKB
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0021987; P:cerebral cortex development; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0042384; P:cilium assembly; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0060271; P:cilium morphogenesis; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0060027; P:convergent extension involved in gastrulation; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0016358; P:dendrite development; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0045444; P:fat cell differentiation; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0001947; P:heart looping; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0021766; P:hippocampus development; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0046907; P:intracellular transport; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0051457; P:maintenance of protein location in nucleus; IGI:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0032402; P:melanosome transport; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0008152; P:metabolic process; IMP:GOC
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0034454; P:microtubule anchoring at centrosome; IMP:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0000226; P:microtubule cytoskeleton organization; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0000281; P:mitotic cytokinesis; IMP:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0038108; P:negative regulation of appetite by leptin-mediated signaling pathway; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0003085; P:negative regulation of systemic arterial blood pressure; IEA:Ensembl
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0001843; P:neural tube closure; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0035058; P:nonmotile primary cilium assembly; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0045494; P:photoreceptor cell maintenance; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0051877; P:pigment granule aggregation in cell center; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0045724; P:positive regulation of cilium assembly; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0071539; P:protein localization to centrosome; IMP:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0033365; P:protein localization to organelle; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0060296; P:regulation of cilium beat frequency involved in ciliary motility; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0032465; P:regulation of cytokinesis; IMP:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0019216; P:regulation of lipid metabolic process; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0001895; P:retina homeostasis; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0046548; P:retinal rod cell development; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0007608; P:sensory perception of smell; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0050893; P:sensory processing; TAS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0007286; P:spermatid development; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0021756; P:striatum development; ISS:BHF-UCL
Q96RK4	BBS4	Bardet-Biedl syndrome 4 protein	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q8WY36	BBX	HMG box transcription factor BBX	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8WY36	BBX	HMG box transcription factor BBX	GO:0060348; P:bone development; IEA:Ensembl
Q8WY36	BBX	HMG box transcription factor BBX	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8WY36	BBX	HMG box transcription factor BBX	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H165	BCL11A	B-cell lymphoma/leukemia 11A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H165	BCL11A	B-cell lymphoma/leukemia 11A	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9H165	BCL11A	B-cell lymphoma/leukemia 11A	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
Q9H165	BCL11A	B-cell lymphoma/leukemia 11A	GO:0042803; F:protein homodimerization activity; TAS:BHF-UCL
Q9H165	BCL11A	B-cell lymphoma/leukemia 11A	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
Q9H165	BCL11A	B-cell lymphoma/leukemia 11A	GO:0030183; P:B cell differentiation; IEA:Ensembl
Q9H165	BCL11A	B-cell lymphoma/leukemia 11A	GO:0030517; P:negative regulation of axon extension; ISS:BHF-UCL
Q9H165	BCL11A	B-cell lymphoma/leukemia 11A	GO:0048671; P:negative regulation of collateral sprouting; IMP:BHF-UCL
Q9H165	BCL11A	B-cell lymphoma/leukemia 11A	GO:2000171; P:negative regulation of dendrite development; IMP:BHF-UCL
Q9H165	BCL11A	B-cell lymphoma/leukemia 11A	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
Q9H165	BCL11A	B-cell lymphoma/leukemia 11A	GO:0010977; P:negative regulation of neuron projection development; IDA:BHF-UCL
Q9H165	BCL11A	B-cell lymphoma/leukemia 11A	GO:0032463; P:negative regulation of protein homooligomerization; IC:BHF-UCL
Q9H165	BCL11A	B-cell lymphoma/leukemia 11A	GO:0048672; P:positive regulation of collateral sprouting; IMP:BHF-UCL
Q9H165	BCL11A	B-cell lymphoma/leukemia 11A	GO:0010976; P:positive regulation of neuron projection development; IDA:BHF-UCL
Q9H165	BCL11A	B-cell lymphoma/leukemia 11A	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q9H165	BCL11A	B-cell lymphoma/leukemia 11A	GO:0016925; P:protein sumoylation; ISS:UniProtKB
Q9H165	BCL11A	B-cell lymphoma/leukemia 11A	GO:0050773; P:regulation of dendrite development; IMP:BHF-UCL
Q9H165	BCL11A	B-cell lymphoma/leukemia 11A	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H165	BCL11A	B-cell lymphoma/leukemia 11A	GO:0030217; P:T cell differentiation; IEA:Ensembl
Q9H165	BCL11A	B-cell lymphoma/leukemia 11A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0005515; F:protein binding; IPI:IntAct
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0046632; P:alpha-beta T cell differentiation; IEA:Ensembl
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0003382; P:epithelial cell morphogenesis; IEA:Ensembl
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0003334; P:keratinocyte development; IEA:Ensembl
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0071678; P:olfactory bulb axon guidance; IEA:Ensembl
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:MGI
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0043368; P:positive T cell selection; IEA:Ensembl
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0031077; P:post-embryonic camera-type eye development; IEA:Ensembl
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0010837; P:regulation of keratinocyte proliferation; IEA:Ensembl
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0019216; P:regulation of lipid metabolic process; IEA:Ensembl
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0045664; P:regulation of neuron differentiation; IEA:Ensembl
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0021773; P:striatal medium spiny neuron differentiation; IEA:Ensembl
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0033153; P:T cell receptor V(D)J recombination; IEA:Ensembl
Q9C0K0	BCL11B	B-cell lymphoma/leukemia 11B	GO:0048538; P:thymus development; IEA:Ensembl
P50895	BCAM	Basal cell adhesion molecule	GO:0043236; F:laminin binding; IMP:BHF-UCL
P50895	BCAM	Basal cell adhesion molecule	GO:0005055; F:laminin receptor activity; IMP:BHF-UCL
P50895	BCAM	Basal cell adhesion molecule	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
P50895	BCAM	Basal cell adhesion molecule	GO:0007155; P:cell adhesion; TAS:ProtInc
P50895	BCAM	Basal cell adhesion molecule	GO:0007160; P:cell-matrix adhesion; IMP:BHF-UCL
P50895	BCAM	Basal cell adhesion molecule	GO:0007165; P:signal transduction; TAS:ProtInc
Q6ZUJ8	PIK3AP1	Phosphoinositide 3-kinase adapter protein 1	GO:0036312; F:phosphatidylinositol 3-kinase regulatory subunit binding; ISS:UniProtKB
Q6ZUJ8	PIK3AP1	Phosphoinositide 3-kinase adapter protein 1	GO:0034122; P:negative regulation of toll-like receptor signaling pathway; IEA:Ensembl
Q6ZUJ8	PIK3AP1	Phosphoinositide 3-kinase adapter protein 1	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; ISS:UniProtKB
Q6ZUJ8	PIK3AP1	Phosphoinositide 3-kinase adapter protein 1	GO:0034123; P:positive regulation of toll-like receptor signaling pathway; IEA:Ensembl
Q6ZUJ8	PIK3AP1	Phosphoinositide 3-kinase adapter protein 1	GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB
Q6ZUJ8	PIK3AP1	Phosphoinositide 3-kinase adapter protein 1	GO:0034134; P:toll-like receptor 2 signaling pathway; ISS:UniProtKB
Q6ZUJ8	PIK3AP1	Phosphoinositide 3-kinase adapter protein 1	GO:0034142; P:toll-like receptor 4 signaling pathway; ISS:UniProtKB
Q6ZUJ8	PIK3AP1	Phosphoinositide 3-kinase adapter protein 1	GO:0034154; P:toll-like receptor 7 signaling pathway; ISS:UniProtKB
Q6ZUJ8	PIK3AP1	Phosphoinositide 3-kinase adapter protein 1	GO:0034162; P:toll-like receptor 9 signaling pathway; ISS:UniProtKB
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0004871; F:signal transducer activity; TAS:ProtInc
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0007015; P:actin filament organization; IDA:UniProtKB
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0050851; P:antigen receptor-mediated signaling pathway; IDA:UniProtKB
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0050853; P:B cell receptor signaling pathway; IDA:UniProtKB
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0007596; P:blood coagulation; TAS:Reactome
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0060326; P:cell chemotaxis; IMP:BHF-UCL
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0051301; P:cell division; NAS:UniProtKB
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0016477; P:cell migration; IDA:UniProtKB
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0008283; P:cell proliferation; TAS:ProtInc
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0035729; P:cellular response to hepatocyte growth factor stimulus; IMP:BHF-UCL
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; ISS:UniProtKB
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0007186; P:G-protein coupled receptor signaling pathway; ISS:UniProtKB
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0048012; P:hepatocyte growth factor receptor signaling pathway; IMP:BHF-UCL
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0008286; P:insulin receptor signaling pathway; ISS:UniProtKB
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0007229; P:integrin-mediated signaling pathway; IDA:UniProtKB
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; ISS:UniProtKB
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0030168; P:platelet activation; TAS:Reactome
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; ISS:UniProtKB
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0010595; P:positive regulation of endothelial cell migration; IDA:BHF-UCL
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0001558; P:regulation of cell growth; TAS:UniProtKB
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0050852; P:T cell receptor signaling pathway; NAS:UniProtKB
P56945	BCAR1	Breast cancer anti-estrogen resistance protein 1	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IMP:BHF-UCL
O75815	BCAR3	Breast cancer anti-estrogen resistance protein 3	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW
O75815	BCAR3	Breast cancer anti-estrogen resistance protein 3	GO:0005515; F:protein binding; IPI:IntAct
O75815	BCAR3	Breast cancer anti-estrogen resistance protein 3	GO:0042493; P:response to drug; TAS:ProtInc
O75815	BCAR3	Breast cancer anti-estrogen resistance protein 3	GO:0007165; P:signal transduction; TAS:ProtInc
O75815	BCAR3	Breast cancer anti-estrogen resistance protein 3	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9H6U6	BCAS3	Breast carcinoma-amplified sequence 3	GO:0005515; F:protein binding; IPI:IntAct
P54687	BCAT1	Branched-chain-amino-acid aminotransferase, cytosolic	GO:0004084; F:branched-chain-amino-acid transaminase activity; EXP:Reactome
P54687	BCAT1	Branched-chain-amino-acid aminotransferase, cytosolic	GO:0052656; F:L-isoleucine transaminase activity; IEA:UniProtKB-EC
P54687	BCAT1	Branched-chain-amino-acid aminotransferase, cytosolic	GO:0052654; F:L-leucine transaminase activity; IEA:UniProtKB-EC
P54687	BCAT1	Branched-chain-amino-acid aminotransferase, cytosolic	GO:0052655; F:L-valine transaminase activity; IEA:UniProtKB-EC
P54687	BCAT1	Branched-chain-amino-acid aminotransferase, cytosolic	GO:0009082; P:branched-chain amino acid biosynthetic process; TAS:ProtInc
P54687	BCAT1	Branched-chain-amino-acid aminotransferase, cytosolic	GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome
P54687	BCAT1	Branched-chain-amino-acid aminotransferase, cytosolic	GO:0008283; P:cell proliferation; TAS:ProtInc
P54687	BCAT1	Branched-chain-amino-acid aminotransferase, cytosolic	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P54687	BCAT1	Branched-chain-amino-acid aminotransferase, cytosolic	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:ProtInc
P54687	BCAT1	Branched-chain-amino-acid aminotransferase, cytosolic	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15382	BCAT2	Branched-chain-amino-acid aminotransferase, mitochondrial	GO:0004084; F:branched-chain-amino-acid transaminase activity; EXP:Reactome
O15382	BCAT2	Branched-chain-amino-acid aminotransferase, mitochondrial	GO:0052656; F:L-isoleucine transaminase activity; IEA:UniProtKB-EC
O15382	BCAT2	Branched-chain-amino-acid aminotransferase, mitochondrial	GO:0052654; F:L-leucine transaminase activity; IEA:UniProtKB-EC
O15382	BCAT2	Branched-chain-amino-acid aminotransferase, mitochondrial	GO:0052655; F:L-valine transaminase activity; IEA:UniProtKB-EC
O15382	BCAT2	Branched-chain-amino-acid aminotransferase, mitochondrial	GO:0009082; P:branched-chain amino acid biosynthetic process; TAS:ProtInc
O15382	BCAT2	Branched-chain-amino-acid aminotransferase, mitochondrial	GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome
O15382	BCAT2	Branched-chain-amino-acid aminotransferase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
O15382	BCAT2	Branched-chain-amino-acid aminotransferase, mitochondrial	GO:0006550; P:isoleucine catabolic process; IEA:Ensembl
O15382	BCAT2	Branched-chain-amino-acid aminotransferase, mitochondrial	GO:0006551; P:leucine metabolic process; IEA:Ensembl
O15382	BCAT2	Branched-chain-amino-acid aminotransferase, mitochondrial	GO:0010817; P:regulation of hormone levels; IEA:Ensembl
O15382	BCAT2	Branched-chain-amino-acid aminotransferase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15382	BCAT2	Branched-chain-amino-acid aminotransferase, mitochondrial	GO:0006573; P:valine metabolic process; IEA:Ensembl
Q9P287	BCCIP	BRCA2 and CDKN1A-interacting protein	GO:0019207; F:kinase regulator activity; IDA:MGI
Q9P287	BCCIP	BRCA2 and CDKN1A-interacting protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9P287	BCCIP	BRCA2 and CDKN1A-interacting protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P287	BCCIP	BRCA2 and CDKN1A-interacting protein	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9P287	BCCIP	BRCA2 and CDKN1A-interacting protein	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q9P287	BCCIP	BRCA2 and CDKN1A-interacting protein	GO:0061101; P:neuroendocrine cell differentiation; IDA:UniProtKB
Q9P287	BCCIP	BRCA2 and CDKN1A-interacting protein	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:MGI
Q9NWK9	ZNHIT6	Box C/D snoRNA protein 1	GO:0042802; F:identical protein binding; IPI:BHF-UCL
Q9NWK9	ZNHIT6	Box C/D snoRNA protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NWK9	ZNHIT6	Box C/D snoRNA protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NWK9	ZNHIT6	Box C/D snoRNA protein 1	GO:0000492; P:box C/D snoRNP assembly; IMP:BHF-UCL
Q9NWK9	ZNHIT6	Box C/D snoRNA protein 1	GO:0042254; P:ribosome biogenesis; IEA:UniProtKB-KW
Q9HAY6	BCMO1	Beta,beta-carotene 15,15'-monooxygenase	GO:0003834; F:beta-carotene 15,15'-monooxygenase activity; IDA:UniProtKB
Q9HAY6	BCMO1	Beta,beta-carotene 15,15'-monooxygenase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HAY6	BCMO1	Beta,beta-carotene 15,15'-monooxygenase	GO:0004497; F:monooxygenase activity; IEA:UniProtKB-KW
Q9HAY6	BCMO1	Beta,beta-carotene 15,15'-monooxygenase	GO:0007603; P:phototransduction, visible light; TAS:Reactome
Q9HAY6	BCMO1	Beta,beta-carotene 15,15'-monooxygenase	GO:0042574; P:retinal metabolic process; NAS:BHF-UCL
Q9HAY6	BCMO1	Beta,beta-carotene 15,15'-monooxygenase	GO:0001523; P:retinoid metabolic process; IDA:UniProtKB
Q9HAY6	BCMO1	Beta,beta-carotene 15,15'-monooxygenase	GO:0042572; P:retinol metabolic process; IEA:UniProtKB-UniPathway
Q9HAY6	BCMO1	Beta,beta-carotene 15,15'-monooxygenase	GO:0035238; P:vitamin A biosynthetic process; NAS:BHF-UCL
Q9BYV7	BCO2	Beta,beta-carotene 9',10'-oxygenase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BYV7	BCO2	Beta,beta-carotene 9',10'-oxygenase	GO:0016702; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; IDA:UniProtKB
Q9BYV7	BCO2	Beta,beta-carotene 9',10'-oxygenase	GO:0016121; P:carotene catabolic process; IDA:BHF-UCL
Q9BYV7	BCO2	Beta,beta-carotene 9',10'-oxygenase	GO:0016119; P:carotene metabolic process; IDA:UniProtKB
Q9BYV7	BCO2	Beta,beta-carotene 9',10'-oxygenase	GO:0016116; P:carotenoid metabolic process; ISS:BHF-UCL
Q9BYV7	BCO2	Beta,beta-carotene 9',10'-oxygenase	GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL
Q9BYV7	BCO2	Beta,beta-carotene 9',10'-oxygenase	GO:0051881; P:regulation of mitochondrial membrane potential; ISS:BHF-UCL
Q9BYV7	BCO2	Beta,beta-carotene 9',10'-oxygenase	GO:2000377; P:regulation of reactive oxygen species metabolic process; ISS:BHF-UCL
Q9BYV7	BCO2	Beta,beta-carotene 9',10'-oxygenase	GO:0042574; P:retinal metabolic process; NAS:UniProtKB
Q9BYV7	BCO2	Beta,beta-carotene 9',10'-oxygenase	GO:0042573; P:retinoic acid metabolic process; NAS:UniProtKB
O14874	BCKDK	[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial	GO:0047323; F:[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity; IEA:UniProtKB-EC
O14874	BCKDK	[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial	GO:0005524; F:ATP binding; IEA:InterPro
O14874	BCKDK	[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial	GO:0016301; F:kinase activity; IEA:UniProtKB-KW
O14874	BCKDK	[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
O14874	BCKDK	[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial	GO:0004674; F:protein serine/threonine kinase activity; IEA:Ensembl
O14874	BCKDK	[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial	GO:0009083; P:branched-chain amino acid catabolic process; ISS:HGNC
O14874	BCKDK	[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial	GO:0009063; P:cellular amino acid catabolic process; NAS:UniProtKB
O14874	BCKDK	[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial	GO:0016310; P:phosphorylation; ISS:HGNC
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0019899; F:enzyme binding; IPI:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0019900; F:kinase binding; IPI:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0051059; F:NF-kappaB binding; IDA:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0002020; F:protease binding; IPI:BHF-UCL
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0005515; F:protein binding; IPI:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0043422; F:protein kinase B binding; IPI:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0019901; F:protein kinase binding; IDA:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0043621; F:protein self-association; IPI:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0008134; F:transcription factor binding; IPI:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0002250; P:adaptive immune response; TAS:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0001783; P:B cell apoptotic process; IEA:Ensembl
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0008219; P:cell death; IDA:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0006968; P:cellular defense response; IEA:Ensembl
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0016064; P:immunoglobulin mediated immune response; IEA:Ensembl
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0045087; P:innate immune response; IEP:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0042226; P:interleukin-6 biosynthetic process; NAS:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0042109; P:lymphotoxin A biosynthetic process; NAS:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0002906; P:negative regulation of mature B cell apoptotic process; IDA:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0001843; P:neural tube closure; ISS:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IDA:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0045416; P:positive regulation of interleukin-8 biosynthetic process; IMP:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0032765; P:positive regulation of mast cell cytokine production; NAS:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0042327; P:positive regulation of phosphorylation; IDA:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0050870; P:positive regulation of T cell activation; IEA:Ensembl
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0051260; P:protein homooligomerization; ISS:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0051259; P:protein oligomerization; IPI:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0050856; P:regulation of T cell receptor signaling pathway; IEA:Ensembl
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0032094; P:response to food; IDA:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0009620; P:response to fungus; IEA:Ensembl
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0002237; P:response to molecule of bacterial origin; IEP:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0070231; P:T cell apoptotic process; IEA:Ensembl
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0050852; P:T cell receptor signaling pathway; IDA:UniProtKB
O95999	BCL10	B-cell lymphoma/leukemia 10	GO:0002224; P:toll-like receptor signaling pathway; IC:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0051434; F:BH3 domain binding; IPI:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0015267; F:channel activity; IDA:BHF-UCL
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0016248; F:channel inhibitor activity; IDA:BHF-UCL
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0042802; F:identical protein binding; IPI:IntAct
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0002020; F:protease binding; IDA:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0005515; F:protein binding; IPI:IntAct
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0043565; F:sequence-specific DNA binding; IDA:MGI
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0007015; P:actin filament organization; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0006915; P:apoptotic process; TAS:Reactome
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0031103; P:axon regeneration; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0007409; P:axonogenesis; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0001782; P:B cell homeostasis; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0002326; P:B cell lineage commitment; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0042100; P:B cell proliferation; IDA:MGI
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0050853; P:B cell receptor signaling pathway; IMP:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0001662; P:behavioral fear response; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0043375; P:CD8-positive, alpha-beta T cell lineage commitment; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0007569; P:cell aging; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0008219; P:cell death; IDA:MGI
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0016049; P:cell growth; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0042149; P:cellular response to glucose starvation; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0071310; P:cellular response to organic substance; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0021747; P:cochlear nucleus development; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0051607; P:defense response to virus; IDA:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0048589; P:developmental growth; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0048546; P:digestive tract morphogenesis; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0043583; P:ear development; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; TAS:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IDA:MGI
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0007565; P:female pregnancy; NAS:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0048041; P:focal adhesion assembly; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0022612; P:gland morphogenesis; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0032835; P:glomerulus development; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0006959; P:humoral immune response; TAS:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0045087; P:innate immune response; TAS:Reactome
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IBA:RefGenome
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IDA:MGI
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0002320; P:lymphoid progenitor cell differentiation; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0008584; P:male gonad development; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0006582; P:melanin metabolic process; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0030318; P:melanocyte differentiation; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0014031; P:mesenchymal cell development; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0001656; P:metanephros development; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:2000811; P:negative regulation of anoikis; IMP:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
P10415	BCL2	Apoptosis regulator Bcl-2	GO:2001234; P:negative regulation of apoptotic signaling pathway; IMP:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0010507; P:negative regulation of autophagy; TAS:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0010523; P:negative regulation of calcium ion transport into cytosol; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0032848; P:negative regulation of cellular pH reduction; IDA:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IGI:MGI
P10415	BCL2	Apoptosis regulator Bcl-2	GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IDA:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0051902; P:negative regulation of mitochondrial depolarization; TAS:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0045930; P:negative regulation of mitotic cell cycle; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0033033; P:negative regulation of myeloid cell apoptotic process; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0043524; P:negative regulation of neuron apoptotic process; IDA:MGI
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0030279; P:negative regulation of ossification; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0033689; P:negative regulation of osteoblast proliferation; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0046671; P:negative regulation of retinal cell programmed cell death; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0051402; P:neuron apoptotic process; TAS:HGNC
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0048599; P:oocyte development; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0035265; P:organ growth; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0001503; P:ossification; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0001541; P:ovarian follicle development; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0018107; P:peptidyl-threonine phosphorylation; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0048753; P:pigment granule organization; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0030890; P:positive regulation of B cell proliferation; IMP:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0043085; P:positive regulation of catalytic activity; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0030307; P:positive regulation of cell growth; IDA:MGI
P10415	BCL2	Apoptosis regulator Bcl-2	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; TAS:Reactome
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0045636; P:positive regulation of melanocyte differentiation; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0014042; P:positive regulation of neuron maturation; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0048743; P:positive regulation of skeletal muscle fiber development; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0014911; P:positive regulation of smooth muscle cell migration; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0009791; P:post-embryonic development; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0006470; P:protein dephosphorylation; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0000209; P:protein polyubiquitination; IDA:MGI
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0072593; P:reactive oxygen species metabolic process; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0051924; P:regulation of calcium ion transport; IDA:MGI
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0001952; P:regulation of cell-matrix adhesion; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0010559; P:regulation of glycoprotein biosynthetic process; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0046902; P:regulation of mitochondrial membrane permeability; ISS:HGNC
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0051881; P:regulation of mitochondrial membrane potential; ISS:HGNC
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0006808; P:regulation of nitrogen utilization; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0043497; P:regulation of protein heterodimerization activity; IDA:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0043496; P:regulation of protein homodimerization activity; IDA:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0031647; P:regulation of protein stability; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0022898; P:regulation of transmembrane transporter activity; IDA:BHF-UCL
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0045069; P:regulation of viral genome replication; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0001836; P:release of cytochrome c from mitochondria; NAS:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0003014; P:renal system process; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0001101; P:response to acid; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0034097; P:response to cytokine; IDA:MGI
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0042493; P:response to drug; IMP:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0010332; P:response to gamma radiation; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0010039; P:response to iron ion; IDA:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0002931; P:response to ischemia; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0035094; P:response to nicotine; IDA:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0009314; P:response to radiation; NAS:UniProtKB
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0009636; P:response to toxic substance; IDA:HGNC
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0010224; P:response to UV-B; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0048536; P:spleen development; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0043029; P:T cell homeostasis; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0048538; P:thymus development; IEA:Ensembl
P10415	BCL2	Apoptosis regulator Bcl-2	GO:0055085; P:transmembrane transport; IDA:GOC
Q8N143	BCL6B	B-cell CLL/lymphoma 6 member B protein	GO:0003677; F:DNA binding; IEA:Ensembl
Q8N143	BCL6B	B-cell CLL/lymphoma 6 member B protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N143	BCL6B	B-cell CLL/lymphoma 6 member B protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P20749	BCL3	B-cell lymphoma 3 protein	GO:0003677; F:DNA binding; IEA:Ensembl
P20749	BCL3	B-cell lymphoma 3 protein	GO:0005515; F:protein binding; IPI:UniProtKB
P20749	BCL3	B-cell lymphoma 3 protein	GO:0030674; F:protein binding, bridging; TAS:UniProtKB
P20749	BCL3	B-cell lymphoma 3 protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P20749	BCL3	B-cell lymphoma 3 protein	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P20749	BCL3	B-cell lymphoma 3 protein	GO:0019730; P:antimicrobial humoral response; IEA:Ensembl
P20749	BCL3	B-cell lymphoma 3 protein	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
P20749	BCL3	B-cell lymphoma 3 protein	GO:0042742; P:defense response to bacterium; IEA:Ensembl
P20749	BCL3	B-cell lymphoma 3 protein	GO:0042832; P:defense response to protozoan; IEA:Ensembl
P20749	BCL3	B-cell lymphoma 3 protein	GO:0030330; P:DNA damage response, signal transduction by p53 class mediator; IMP:UniProtKB
P20749	BCL3	B-cell lymphoma 3 protein	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
P20749	BCL3	B-cell lymphoma 3 protein	GO:0002268; P:follicular dendritic cell differentiation; IEA:Ensembl
P20749	BCL3	B-cell lymphoma 3 protein	GO:0002467; P:germinal center formation; IEA:Ensembl
P20749	BCL3	B-cell lymphoma 3 protein	GO:0002455; P:humoral immune response mediated by circulating immunoglobulin; IEA:Ensembl
P20749	BCL3	B-cell lymphoma 3 protein	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
P20749	BCL3	B-cell lymphoma 3 protein	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IMP:MGI
P20749	BCL3	B-cell lymphoma 3 protein	GO:0051457; P:maintenance of protein location in nucleus; NAS:UniProtKB
P20749	BCL3	B-cell lymphoma 3 protein	GO:0002315; P:marginal zone B cell differentiation; IEA:Ensembl
P20749	BCL3	B-cell lymphoma 3 protein	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P20749	BCL3	B-cell lymphoma 3 protein	GO:0045415; P:negative regulation of interleukin-8 biosynthetic process; IMP:UniProtKB
P20749	BCL3	B-cell lymphoma 3 protein	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P20749	BCL3	B-cell lymphoma 3 protein	GO:0042536; P:negative regulation of tumor necrosis factor biosynthetic process; IEA:Ensembl
P20749	BCL3	B-cell lymphoma 3 protein	GO:0032729; P:positive regulation of interferon-gamma production; IEA:Ensembl
P20749	BCL3	B-cell lymphoma 3 protein	GO:0045082; P:positive regulation of interleukin-10 biosynthetic process; IEA:Ensembl
P20749	BCL3	B-cell lymphoma 3 protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P20749	BCL3	B-cell lymphoma 3 protein	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P20749	BCL3	B-cell lymphoma 3 protein	GO:0045727; P:positive regulation of translation; IMP:UniProtKB
P20749	BCL3	B-cell lymphoma 3 protein	GO:0000060; P:protein import into nucleus, translocation; IMP:UniProtKB
P20749	BCL3	B-cell lymphoma 3 protein	GO:0042981; P:regulation of apoptotic process; IDA:UniProtKB
P20749	BCL3	B-cell lymphoma 3 protein	GO:0051101; P:regulation of DNA binding; IEP:UniProtKB
P20749	BCL3	B-cell lymphoma 3 protein	GO:0042345; P:regulation of NF-kappaB import into nucleus; IEP:UniProtKB
P20749	BCL3	B-cell lymphoma 3 protein	GO:0010225; P:response to UV-C; IDA:UniProtKB
P20749	BCL3	B-cell lymphoma 3 protein	GO:0009615; P:response to virus; IDA:UniProtKB
P20749	BCL3	B-cell lymphoma 3 protein	GO:0048536; P:spleen development; IEA:Ensembl
P20749	BCL3	B-cell lymphoma 3 protein	GO:0042088; P:T-helper 1 type immune response; IEA:Ensembl
P20749	BCL3	B-cell lymphoma 3 protein	GO:0045064; P:T-helper 2 cell differentiation; IEA:Ensembl
P20749	BCL3	B-cell lymphoma 3 protein	GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB
P41182	BCL6	B-cell lymphoma 6 protein	GO:0003682; F:chromatin binding; IDA:MGI
P41182	BCL6	B-cell lymphoma 6 protein	GO:0031490; F:chromatin DNA binding; IEA:Ensembl
P41182	BCL6	B-cell lymphoma 6 protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P41182	BCL6	B-cell lymphoma 6 protein	GO:0005515; F:protein binding; IPI:UniProtKB
P41182	BCL6	B-cell lymphoma 6 protein	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
P41182	BCL6	B-cell lymphoma 6 protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IMP:UniProtKB
P41182	BCL6	B-cell lymphoma 6 protein	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
P41182	BCL6	B-cell lymphoma 6 protein	GO:0030183; P:B cell differentiation; IEA:Ensembl
P41182	BCL6	B-cell lymphoma 6 protein	GO:0000902; P:cell morphogenesis; IEA:Ensembl
P41182	BCL6	B-cell lymphoma 6 protein	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
P41182	BCL6	B-cell lymphoma 6 protein	GO:0048821; P:erythrocyte development; IEA:Ensembl
P41182	BCL6	B-cell lymphoma 6 protein	GO:0002467; P:germinal center formation; IEA:Ensembl
P41182	BCL6	B-cell lymphoma 6 protein	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
P41182	BCL6	B-cell lymphoma 6 protein	GO:0002903; P:negative regulation of B cell apoptotic process; NAS:UniProtKB
P41182	BCL6	B-cell lymphoma 6 protein	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
P41182	BCL6	B-cell lymphoma 6 protein	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P41182	BCL6	B-cell lymphoma 6 protein	GO:0001953; P:negative regulation of cell-matrix adhesion; IEA:Ensembl
P41182	BCL6	B-cell lymphoma 6 protein	GO:0048294; P:negative regulation of isotype switching to IgE isotypes; IEA:Ensembl
P41182	BCL6	B-cell lymphoma 6 protein	GO:0032764; P:negative regulation of mast cell cytokine production; IEA:Ensembl
P41182	BCL6	B-cell lymphoma 6 protein	GO:0035024; P:negative regulation of Rho protein signal transduction; IEA:Ensembl
P41182	BCL6	B-cell lymphoma 6 protein	GO:0045629; P:negative regulation of T-helper 2 cell differentiation; IEA:Ensembl
P41182	BCL6	B-cell lymphoma 6 protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P41182	BCL6	B-cell lymphoma 6 protein	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
P41182	BCL6	B-cell lymphoma 6 protein	GO:0002829; P:negative regulation of type 2 immune response; IEA:Ensembl
P41182	BCL6	B-cell lymphoma 6 protein	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P41182	BCL6	B-cell lymphoma 6 protein	GO:0030890; P:positive regulation of B cell proliferation; IEA:Ensembl
P41182	BCL6	B-cell lymphoma 6 protein	GO:0051272; P:positive regulation of cellular component movement; IEA:Ensembl
P41182	BCL6	B-cell lymphoma 6 protein	GO:0000060; P:protein import into nucleus, translocation; IGI:UniProtKB
P41182	BCL6	B-cell lymphoma 6 protein	GO:0002634; P:regulation of germinal center formation; NAS:UniProtKB
P41182	BCL6	B-cell lymphoma 6 protein	GO:0050776; P:regulation of immune response; NAS:UniProtKB
P41182	BCL6	B-cell lymphoma 6 protein	GO:0050727; P:regulation of inflammatory response; IEA:Ensembl
P41182	BCL6	B-cell lymphoma 6 protein	GO:0043380; P:regulation of memory T cell differentiation; IEA:Ensembl
P41182	BCL6	B-cell lymphoma 6 protein	GO:0032319; P:regulation of Rho GTPase activity; IEA:Ensembl
P41182	BCL6	B-cell lymphoma 6 protein	GO:0007266; P:Rho protein signal transduction; IEA:Ensembl
P41182	BCL6	B-cell lymphoma 6 protein	GO:0007283; P:spermatogenesis; IEA:Ensembl
P41182	BCL6	B-cell lymphoma 6 protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P41182	BCL6	B-cell lymphoma 6 protein	GO:0042092; P:type 2 immune response; IEA:Ensembl
Q4VC05	BCL7A	B-cell CLL/lymphoma 7 protein family member A	GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB
Q9BQE9	BCL7B	B-cell CLL/lymphoma 7 protein family member B	GO:0003779; F:actin binding; NAS:UniProtKB
Q8WUZ0	BCL7C	B-cell CLL/lymphoma 7 protein family member C	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q86UU0	BCL9L	B-cell CLL/lymphoma 9-like protein	GO:0008013; F:beta-catenin binding; IDA:MGI
Q86UU0	BCL9L	B-cell CLL/lymphoma 9-like protein	GO:0003713; F:transcription coactivator activity; NAS:BHF-UCL
Q86UU0	BCL9L	B-cell CLL/lymphoma 9-like protein	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
Q86UU0	BCL9L	B-cell CLL/lymphoma 9-like protein	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IMP:BHF-UCL
Q86UU0	BCL9L	B-cell CLL/lymphoma 9-like protein	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IMP:BHF-UCL
Q86UU0	BCL9L	B-cell CLL/lymphoma 9-like protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q86UU0	BCL9L	B-cell CLL/lymphoma 9-like protein	GO:0022604; P:regulation of cell morphogenesis; IMP:BHF-UCL
Q86UU0	BCL9L	B-cell CLL/lymphoma 9-like protein	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q86UU0	BCL9L	B-cell CLL/lymphoma 9-like protein	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
Q86UU0	BCL9L	B-cell CLL/lymphoma 9-like protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O00512	BCL9	B-cell CLL/lymphoma 9 protein	GO:0005515; F:protein binding; IPI:IntAct
O00512	BCL9	B-cell CLL/lymphoma 9 protein	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
O00512	BCL9	B-cell CLL/lymphoma 9 protein	GO:0014908; P:myotube differentiation involved in skeletal muscle regeneration; IEA:Ensembl
O00512	BCL9	B-cell CLL/lymphoma 9 protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O00512	BCL9	B-cell CLL/lymphoma 9 protein	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
O00512	BCL9	B-cell CLL/lymphoma 9 protein	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
Q9NYF8	BCLAF1	Bcl-2-associated transcription factor 1	GO:0003677; F:DNA binding; IDA:MGI
Q9NYF8	BCLAF1	Bcl-2-associated transcription factor 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NYF8	BCLAF1	Bcl-2-associated transcription factor 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NYF8	BCLAF1	Bcl-2-associated transcription factor 1	GO:0006915; P:apoptotic process; TAS:UniProtKB
Q9NYF8	BCLAF1	Bcl-2-associated transcription factor 1	GO:0045892; P:negative regulation of transcription, DNA-templated; TAS:UniProtKB
Q9NYF8	BCLAF1	Bcl-2-associated transcription factor 1	GO:0043065; P:positive regulation of apoptotic process; IDA:MGI
Q9NYF8	BCLAF1	Bcl-2-associated transcription factor 1	GO:2000144; P:positive regulation of DNA-templated transcription, initiation; IMP:UniProtKB
Q9NYF8	BCLAF1	Bcl-2-associated transcription factor 1	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
Q9NYF8	BCLAF1	Bcl-2-associated transcription factor 1	GO:2001022; P:positive regulation of response to DNA damage stimulus; IMP:UniProtKB
Q9NYF8	BCLAF1	Bcl-2-associated transcription factor 1	GO:0043620; P:regulation of DNA-templated transcription in response to stress; IMP:UniProtKB
Q9NYF8	BCLAF1	Bcl-2-associated transcription factor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5H9F3	BCORL1	BCL-6 corepressor-like protein 1	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q5H9F3	BCORL1	BCL-6 corepressor-like protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5H9F3	BCORL1	BCL-6 corepressor-like protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6W2J9	BCOR	BCL-6 corepressor	GO:0031072; F:heat shock protein binding; IDA:UniProtKB
Q6W2J9	BCOR	BCL-6 corepressor	GO:0042826; F:histone deacetylase binding; IPI:UniProtKB
Q6W2J9	BCOR	BCL-6 corepressor	GO:0005515; F:protein binding; IPI:UniProtKB
Q6W2J9	BCOR	BCL-6 corepressor	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q6W2J9	BCOR	BCL-6 corepressor	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q6W2J9	BCOR	BCL-6 corepressor	GO:0044212; F:transcription regulatory region DNA binding; IMP:UniProtKB
Q6W2J9	BCOR	BCL-6 corepressor	GO:0007507; P:heart development; IMP:UniProtKB
Q6W2J9	BCOR	BCL-6 corepressor	GO:0035518; P:histone H2A monoubiquitination; IDA:UniProtKB
Q6W2J9	BCOR	BCL-6 corepressor	GO:0030502; P:negative regulation of bone mineralization; IMP:UniProtKB
Q6W2J9	BCOR	BCL-6 corepressor	GO:0000415; P:negative regulation of histone H3-K36 methylation; IMP:UniProtKB
Q6W2J9	BCOR	BCL-6 corepressor	GO:0051572; P:negative regulation of histone H3-K4 methylation; IMP:UniProtKB
Q6W2J9	BCOR	BCL-6 corepressor	GO:0070171; P:negative regulation of tooth mineralization; IMP:UniProtKB
Q6W2J9	BCOR	BCL-6 corepressor	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q6W2J9	BCOR	BCL-6 corepressor	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q6W2J9	BCOR	BCL-6 corepressor	GO:0042476; P:odontogenesis; IMP:UniProtKB
Q6W2J9	BCOR	BCL-6 corepressor	GO:0060021; P:palate development; IMP:UniProtKB
Q6W2J9	BCOR	BCL-6 corepressor	GO:0065001; P:specification of axis polarity; IMP:UniProtKB
Q6W2J9	BCOR	BCL-6 corepressor	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P11274	BCR	Breakpoint cluster region protein	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P11274	BCR	Breakpoint cluster region protein	GO:0005096; F:GTPase activator activity; TAS:ProtInc
P11274	BCR	Breakpoint cluster region protein	GO:0016301; F:kinase activity; TAS:Reactome
P11274	BCR	Breakpoint cluster region protein	GO:0005515; F:protein binding; IPI:IntAct
P11274	BCR	Breakpoint cluster region protein	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
P11274	BCR	Breakpoint cluster region protein	GO:0004713; F:protein tyrosine kinase activity; TAS:Reactome
P11274	BCR	Breakpoint cluster region protein	GO:0030675; F:Rac GTPase activator activity; IEA:Ensembl
P11274	BCR	Breakpoint cluster region protein	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
P11274	BCR	Breakpoint cluster region protein	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
P11274	BCR	Breakpoint cluster region protein	GO:0007420; P:brain development; IEA:Ensembl
P11274	BCR	Breakpoint cluster region protein	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
P11274	BCR	Breakpoint cluster region protein	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
P11274	BCR	Breakpoint cluster region protein	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
P11274	BCR	Breakpoint cluster region protein	GO:0043314; P:negative regulation of neutrophil degranulation; IEA:Ensembl
P11274	BCR	Breakpoint cluster region protein	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
P11274	BCR	Breakpoint cluster region protein	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:GOC
P11274	BCR	Breakpoint cluster region protein	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IEA:Ensembl
P11274	BCR	Breakpoint cluster region protein	GO:0050766; P:positive regulation of phagocytosis; IEA:Ensembl
P11274	BCR	Breakpoint cluster region protein	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
P11274	BCR	Breakpoint cluster region protein	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P11274	BCR	Breakpoint cluster region protein	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
P11274	BCR	Breakpoint cluster region protein	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P11274	BCR	Breakpoint cluster region protein	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P11274	BCR	Breakpoint cluster region protein	GO:0007165; P:signal transduction; TAS:ProtInc
P11274	BCR	Breakpoint cluster region protein	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9Y276	BCS1L	Mitochondrial chaperone BCS1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y276	BCS1L	Mitochondrial chaperone BCS1	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q9Y276	BCS1L	Mitochondrial chaperone BCS1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y276	BCS1L	Mitochondrial chaperone BCS1	GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:UniProtKB
Q9Y276	BCS1L	Mitochondrial chaperone BCS1	GO:0034551; P:mitochondrial respiratory chain complex III assembly; IMP:UniProtKB
Q9Y276	BCS1L	Mitochondrial chaperone BCS1	GO:0033617; P:mitochondrial respiratory chain complex IV assembly; IMP:UniProtKB
Q9Y276	BCS1L	Mitochondrial chaperone BCS1	GO:0007005; P:mitochondrion organization; IMP:UniProtKB
Q8NFC6	BOD1L1	Biorientation of chromosomes in cell division protein 1-like 1	GO:0003677; F:DNA binding; IEA:InterPro
Q9BUT1	BDH2	3-hydroxybutyrate dehydrogenase type 2	GO:0003858; F:3-hydroxybutyrate dehydrogenase activity; IDA:HGNC
Q9BUT1	BDH2	3-hydroxybutyrate dehydrogenase type 2	GO:0051287; F:NAD binding; IDA:HGNC
Q9BUT1	BDH2	3-hydroxybutyrate dehydrogenase type 2	GO:0016628; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; ISS:UniProtKB
Q9BUT1	BDH2	3-hydroxybutyrate dehydrogenase type 2	GO:0030855; P:epithelial cell differentiation; IDA:UniProt
Q9BUT1	BDH2	3-hydroxybutyrate dehydrogenase type 2	GO:0006635; P:fatty acid beta-oxidation; IDA:HGNC
Q9BUT1	BDH2	3-hydroxybutyrate dehydrogenase type 2	GO:0042168; P:heme metabolic process; ISS:UniProtKB
Q9BUT1	BDH2	3-hydroxybutyrate dehydrogenase type 2	GO:0055072; P:iron ion homeostasis; ISS:UniProtKB
Q9BUT1	BDH2	3-hydroxybutyrate dehydrogenase type 2	GO:0019290; P:siderophore biosynthetic process; ISS:UniProtKB
Q02338	BDH1	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	GO:0003858; F:3-hydroxybutyrate dehydrogenase activity; IDA:UniProtKB
Q02338	BDH1	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	GO:0005543; F:phospholipid binding; IEA:Ensembl
Q02338	BDH1	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	GO:0060612; P:adipose tissue development; IEA:Ensembl
Q02338	BDH1	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	GO:0007420; P:brain development; IEA:Ensembl
Q02338	BDH1	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	GO:0046950; P:cellular ketone body metabolic process; TAS:Reactome
Q02338	BDH1	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q02338	BDH1	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	GO:0046951; P:ketone body biosynthetic process; TAS:Reactome
Q02338	BDH1	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	GO:0046952; P:ketone body catabolic process; TAS:Reactome
Q02338	BDH1	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	GO:0001889; P:liver development; IEA:Ensembl
Q02338	BDH1	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	GO:0046686; P:response to cadmium ion; IEA:Ensembl
Q02338	BDH1	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	GO:0051412; P:response to corticosterone; IEA:Ensembl
Q02338	BDH1	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	GO:0042493; P:response to drug; IEA:Ensembl
Q02338	BDH1	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	GO:0032355; P:response to estradiol; IEA:Ensembl
Q02338	BDH1	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	GO:0045471; P:response to ethanol; IEA:Ensembl
Q02338	BDH1	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	GO:0060416; P:response to growth hormone; IEA:Ensembl
Q02338	BDH1	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	GO:0032868; P:response to insulin; IEA:Ensembl
Q02338	BDH1	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	GO:0007584; P:response to nutrient; IEA:Ensembl
Q02338	BDH1	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	GO:0042594; P:response to starvation; IEA:Ensembl
Q02338	BDH1	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	GO:0009636; P:response to toxic substance; IEA:Ensembl
Q02338	BDH1	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P23560	BDNF	Brain-derived neurotrophic factor	GO:0008083; F:growth factor activity; TAS:ProtInc
P23560	BDNF	Brain-derived neurotrophic factor	GO:0007411; P:axon guidance; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0007412; P:axon target recognition; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0001662; P:behavioral fear response; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0002544; P:chronic inflammatory response; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0016358; P:dendrite development; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0007631; P:feeding behavior; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0014047; P:glutamate secretion; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0048839; P:inner ear development; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0007611; P:learning or memory; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0042490; P:mechanoreceptor differentiation; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0007406; P:negative regulation of neuroblast proliferation; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0045843; P:negative regulation of striated muscle tissue development; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0021675; P:nerve development; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0007399; P:nervous system development; TAS:ProtInc
P23560	BDNF	Brain-derived neurotrophic factor	GO:0008038; P:neuron recognition; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0048170; P:positive regulation of long-term neuronal synaptic plasticity; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0051965; P:positive regulation of synapse assembly; IDA:BHF-UCL
P23560	BDNF	Brain-derived neurotrophic factor	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0019222; P:regulation of metabolic process; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0046668; P:regulation of retinal cell programmed cell death; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0048172; P:regulation of short-term neuronal synaptic plasticity; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0072347; P:response to anesthetic; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0014076; P:response to fluoxetine; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0009725; P:response to hormone; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0055093; P:response to hyperoxia; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0001666; P:response to hypoxia; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0033189; P:response to vitamin A; IEA:Ensembl
P23560	BDNF	Brain-derived neurotrophic factor	GO:0001657; P:ureteric bud development; IEA:Ensembl
A6H8Y1	BDP1	Transcription factor TFIIIB component B'' homolog	GO:0003682; F:chromatin binding; IEA:InterPro
A6H8Y1	BDP1	Transcription factor TFIIIB component B'' homolog	GO:0003677; F:DNA binding; IEA:InterPro
A6H8Y1	BDP1	Transcription factor TFIIIB component B'' homolog	GO:0010467; P:gene expression; TAS:Reactome
A6H8Y1	BDP1	Transcription factor TFIIIB component B'' homolog	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A6H8Y1	BDP1	Transcription factor TFIIIB component B'' homolog	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
Q3B7T3	BEAN1	Protein BEAN1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q14457	BECN1	Beclin-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q14457	BECN1	Beclin-1	GO:0000045; P:autophagic vacuole assembly; IEA:Ensembl
Q14457	BECN1	Beclin-1	GO:0050435; P:beta-amyloid metabolic process; IEA:Ensembl
Q14457	BECN1	Beclin-1	GO:0006968; P:cellular defense response; TAS:ProtInc
Q14457	BECN1	Beclin-1	GO:0071275; P:cellular response to aluminum ion; IEA:Ensembl
Q14457	BECN1	Beclin-1	GO:0071364; P:cellular response to epidermal growth factor stimulus; IEA:Ensembl
Q14457	BECN1	Beclin-1	GO:0000910; P:cytokinesis; IMP:UniProtKB
Q14457	BECN1	Beclin-1	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q14457	BECN1	Beclin-1	GO:0007040; P:lysosome organization; IEA:Ensembl
Q14457	BECN1	Beclin-1	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
Q14457	BECN1	Beclin-1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q14457	BECN1	Beclin-1	GO:0048666; P:neuron development; IEA:Ensembl
Q14457	BECN1	Beclin-1	GO:0016239; P:positive regulation of macroautophagy; IEA:Ensembl
Q14457	BECN1	Beclin-1	GO:0042493; P:response to drug; IEA:Ensembl
Q14457	BECN1	Beclin-1	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q14457	BECN1	Beclin-1	GO:0033197; P:response to vitamin E; IEA:Ensembl
Q14457	BECN1	Beclin-1	GO:0016032; P:viral process; IEA:UniProtKB-KW
A8MW95	BECN1P1	Beclin-2	GO:0005515; F:protein binding; IPI:UniProtKB
A8MW95	BECN1P1	Beclin-2	GO:0006914; P:autophagy; IMP:UniProtKB
A8MW95	BECN1P1	Beclin-2	GO:0008333; P:endosome to lysosome transport; IMP:UniProtKB
A8MW95	BECN1P1	Beclin-2	GO:1990172; P:G-protein coupled receptor catabolic process; IMP:UniProtKB
Q9BUH8	BEGAIN	Brain-enriched guanylate kinase-associated protein	GO:0005515; F:protein binding; IPI:IntAct
Q8N7W2	BEND7	BEN domain-containing protein 7	GO:0005515; F:protein binding; IPI:IntAct
O76090	BEST1	Bestrophin-1	GO:0005254; F:chloride channel activity; IDA:MGI
O76090	BEST1	Bestrophin-1	GO:1902476; P:chloride transmembrane transport; IDA:GOC
O76090	BEST1	Bestrophin-1	GO:0006821; P:chloride transport; IDA:MGI
O76090	BEST1	Bestrophin-1	GO:0050908; P:detection of light stimulus involved in visual perception; IEA:Ensembl
O76090	BEST1	Bestrophin-1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
O76090	BEST1	Bestrophin-1	GO:0051924; P:regulation of calcium ion transport; IEA:Ensembl
O76090	BEST1	Bestrophin-1	GO:0030321; P:transepithelial chloride transport; IDA:HGNC
O76090	BEST1	Bestrophin-1	GO:0055085; P:transmembrane transport; TAS:Reactome
O76090	BEST1	Bestrophin-1	GO:0007601; P:visual perception; TAS:ProtInc
Q8NFU1	BEST2	Bestrophin-2	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
Q8NFU1	BEST2	Bestrophin-2	GO:1902476; P:chloride transmembrane transport; ISS:GOC
Q8NFU1	BEST2	Bestrophin-2	GO:0051899; P:membrane depolarization; ISS:HGNC
Q8NFU1	BEST2	Bestrophin-2	GO:0007608; P:sensory perception of smell; ISS:HGNC
Q8N1M1	BEST3	Bestrophin-3	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
Q8N1M1	BEST3	Bestrophin-3	GO:0043271; P:negative regulation of ion transport; IEA:Ensembl
Q8NFU0	BEST4	Bestrophin-4	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
Q9NYM9	BET1L	BET1-like protein	GO:0005484; F:SNAP receptor activity; IDA:HGNC
Q9NYM9	BET1L	BET1-like protein	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9NYM9	BET1L	BET1-like protein	GO:0042147; P:retrograde transport, endosome to Golgi; IDA:HGNC
O15155	BET1	BET1 homolog	GO:0005515; F:protein binding; IPI:IntAct
O15155	BET1	BET1 homolog	GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:ProtInc
O15155	BET1	BET1 homolog	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O15155	BET1	BET1 homolog	GO:0048280; P:vesicle fusion with Golgi apparatus; IEA:Ensembl
Q6UXH0	C19orf80	Betatrophin	GO:0005179; F:hormone activity; ISS:UniProtKB
Q6UXH0	C19orf80	Betatrophin	GO:0005515; F:protein binding; IPI:IntAct
Q6UXH0	C19orf80	Betatrophin	GO:0048469; P:cell maturation; IEA:Ensembl
Q6UXH0	C19orf80	Betatrophin	GO:0044255; P:cellular lipid metabolic process; ISS:UniProtKB
Q6UXH0	C19orf80	Betatrophin	GO:0045444; P:fat cell differentiation; IEA:Ensembl
Q6UXH0	C19orf80	Betatrophin	GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW
Q6UXH0	C19orf80	Betatrophin	GO:0010954; P:positive regulation of protein processing; IDA:MGI
Q6UXH0	C19orf80	Betatrophin	GO:0019216; P:regulation of lipid metabolic process; IEA:Ensembl
Q6UXH0	C19orf80	Betatrophin	GO:0050746; P:regulation of lipoprotein metabolic process; IMP:MGI
Q6UXH0	C19orf80	Betatrophin	GO:0070328; P:triglyceride homeostasis; IGI:MGI
Q6UXH0	C19orf80	Betatrophin	GO:0044342; P:type B pancreatic cell proliferation; ISS:UniProtKB
Q9HBH7	BEX1	Protein BEX1	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
Q9HBH7	BEX1	Protein BEX1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9HBH7	BEX1	Protein BEX1	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q9HBH7	BEX1	Protein BEX1	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q9HBH7	BEX1	Protein BEX1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9BXY8	BEX2	Protein BEX2	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9BXY8	BEX2	Protein BEX2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9BXY8	BEX2	Protein BEX2	GO:0042981; P:regulation of apoptotic process; IDA:UniProtKB
Q9BXY8	BEX2	Protein BEX2	GO:0051726; P:regulation of cell cycle; IDA:UniProtKB
Q00994	NGFRAP1	Protein BEX3	GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; TAS:Reactome
Q00994	NGFRAP1	Protein BEX3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q00994	NGFRAP1	Protein BEX3	GO:0005515; F:protein binding; IPI:IntAct
Q00994	NGFRAP1	Protein BEX3	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:GOC
Q00994	NGFRAP1	Protein BEX3	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q00994	NGFRAP1	Protein BEX3	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
Q00994	NGFRAP1	Protein BEX3	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q00994	NGFRAP1	Protein BEX3	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q00994	NGFRAP1	Protein BEX3	GO:0043281; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:Reactome
Q9NZS9	BFAR	Bifunctional apoptosis regulator	GO:0005198; F:structural molecule activity; TAS:ProtInc
Q9NZS9	BFAR	Bifunctional apoptosis regulator	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NZS9	BFAR	Bifunctional apoptosis regulator	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9NZS9	BFAR	Bifunctional apoptosis regulator	GO:0043066; P:negative regulation of apoptotic process; IDA:MGI
Q12934	BFSP1	Filensin	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
Q12934	BFSP1	Filensin	GO:0005212; F:structural constituent of eye lens; IEA:UniProtKB-KW
Q12934	BFSP1	Filensin	GO:0048469; P:cell maturation; IEA:Ensembl
Q12934	BFSP1	Filensin	GO:0070307; P:lens fiber cell development; IEA:Ensembl
Q13515	BFSP2	Phakinin	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
Q13515	BFSP2	Phakinin	GO:0005212; F:structural constituent of eye lens; IEA:UniProtKB-KW
Q13515	BFSP2	Phakinin	GO:0048469; P:cell maturation; IEA:Ensembl
Q13515	BFSP2	Phakinin	GO:0045104; P:intermediate filament cytoskeleton organization; IEA:Ensembl
Q13515	BFSP2	Phakinin	GO:0070307; P:lens fiber cell development; IEA:Ensembl
Q13515	BFSP2	Phakinin	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q13515	BFSP2	Phakinin	GO:0007601; P:visual perception; IEA:UniProtKB-KW
P16278	GLB1	Beta-galactosidase	GO:0004565; F:beta-galactosidase activity; TAS:UniProtKB
P16278	GLB1	Beta-galactosidase	GO:0016936; F:galactoside binding; IEA:Ensembl
P16278	GLB1	Beta-galactosidase	GO:0005515; F:protein binding; IPI:UniProtKB
P16278	GLB1	Beta-galactosidase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P16278	GLB1	Beta-galactosidase	GO:0019388; P:galactose catabolic process; IEA:Ensembl
P16278	GLB1	Beta-galactosidase	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
P16278	GLB1	Beta-galactosidase	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P16278	GLB1	Beta-galactosidase	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
P16278	GLB1	Beta-galactosidase	GO:0042340; P:keratan sulfate catabolic process; TAS:Reactome
P16278	GLB1	Beta-galactosidase	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
P16278	GLB1	Beta-galactosidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P16278	GLB1	Beta-galactosidase	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
P16442	ABO	Histo-blood group ABO system transferase	GO:0004381; F:fucosylgalactoside 3-alpha-galactosyltransferase activity; IEA:UniProtKB-EC
P16442	ABO	Histo-blood group ABO system transferase	GO:0004380; F:glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity; IEA:UniProtKB-EC
P16442	ABO	Histo-blood group ABO system transferase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P16442	ABO	Histo-blood group ABO system transferase	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q15582	TGFBI	Transforming growth factor-beta-induced protein ig-h3	GO:0050840; F:extracellular matrix binding; IEA:Ensembl
Q15582	TGFBI	Transforming growth factor-beta-induced protein ig-h3	GO:0005178; F:integrin binding; TAS:ProtInc
Q15582	TGFBI	Transforming growth factor-beta-induced protein ig-h3	GO:0001525; P:angiogenesis; IEP:UniProtKB
Q15582	TGFBI	Transforming growth factor-beta-induced protein ig-h3	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q15582	TGFBI	Transforming growth factor-beta-induced protein ig-h3	GO:0008283; P:cell proliferation; TAS:ProtInc
Q15582	TGFBI	Transforming growth factor-beta-induced protein ig-h3	GO:0002062; P:chondrocyte differentiation; IEA:Ensembl
Q15582	TGFBI	Transforming growth factor-beta-induced protein ig-h3	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q15582	TGFBI	Transforming growth factor-beta-induced protein ig-h3	GO:0007162; P:negative regulation of cell adhesion; TAS:ProtInc
Q15582	TGFBI	Transforming growth factor-beta-induced protein ig-h3	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q15582	TGFBI	Transforming growth factor-beta-induced protein ig-h3	GO:0007601; P:visual perception; TAS:ProtInc
P08236	GUSB	Beta-glucuronidase	GO:0004566; F:beta-glucuronidase activity; TAS:Reactome
P08236	GUSB	Beta-glucuronidase	GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro
P08236	GUSB	Beta-glucuronidase	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
P08236	GUSB	Beta-glucuronidase	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
P08236	GUSB	Beta-glucuronidase	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P08236	GUSB	Beta-glucuronidase	GO:0030214; P:hyaluronan catabolic process; TAS:Reactome
P08236	GUSB	Beta-glucuronidase	GO:0030212; P:hyaluronan metabolic process; TAS:Reactome
P08236	GUSB	Beta-glucuronidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6P575	GUSBP11	Putative inactive beta-glucuronidase protein GUSBP11	GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro
Q6P575	GUSBP11	Putative inactive beta-glucuronidase protein GUSBP11	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q7RTU4	BHLHA9	Class A basic helix-loop-helix protein 9	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7RTU4	BHLHA9	Class A basic helix-loop-helix protein 9	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q7RTU4	BHLHA9	Class A basic helix-loop-helix protein 9	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7RTU4	BHLHA9	Class A basic helix-loop-helix protein 9	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7RTS1	BHLHA15	Class A basic helix-loop-helix protein 15	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7RTS1	BHLHA15	Class A basic helix-loop-helix protein 15	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7RTS1	BHLHA15	Class A basic helix-loop-helix protein 15	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NDY6	BHLHE23	Class E basic helix-loop-helix protein 23	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NDY6	BHLHE23	Class E basic helix-loop-helix protein 23	GO:0046671; P:negative regulation of retinal cell programmed cell death; IEA:Ensembl
Q8NDY6	BHLHE23	Class E basic helix-loop-helix protein 23	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8NDY6	BHLHE23	Class E basic helix-loop-helix protein 23	GO:0048050; P:post-embryonic eye morphogenesis; IEA:Ensembl
Q8NDY6	BHLHE23	Class E basic helix-loop-helix protein 23	GO:0046548; P:retinal rod cell development; IEA:Ensembl
Q8NDY6	BHLHE23	Class E basic helix-loop-helix protein 23	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NFJ8	BHLHE22	Class E basic helix-loop-helix protein 22	GO:0003682; F:chromatin binding; IEA:Ensembl
Q8NFJ8	BHLHE22	Class E basic helix-loop-helix protein 22	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IEA:Ensembl
Q8NFJ8	BHLHE22	Class E basic helix-loop-helix protein 22	GO:0021960; P:anterior commissure morphogenesis; IEA:Ensembl
Q8NFJ8	BHLHE22	Class E basic helix-loop-helix protein 22	GO:0021796; P:cerebral cortex regionalization; IEA:Ensembl
Q8NFJ8	BHLHE22	Class E basic helix-loop-helix protein 22	GO:0021540; P:corpus callosum morphogenesis; IEA:Ensembl
Q8NFJ8	BHLHE22	Class E basic helix-loop-helix protein 22	GO:0021957; P:corticospinal tract morphogenesis; IEA:Ensembl
Q8NFJ8	BHLHE22	Class E basic helix-loop-helix protein 22	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q8NFJ8	BHLHE22	Class E basic helix-loop-helix protein 22	GO:0060040; P:retinal bipolar neuron differentiation; IEA:Ensembl
O14503	BHLHE40	Class E basic helix-loop-helix protein 40	GO:0043425; F:bHLH transcription factor binding; IPI:BHF-UCL
O14503	BHLHE40	Class E basic helix-loop-helix protein 40	GO:0070888; F:E-box binding; IDA:BHF-UCL
O14503	BHLHE40	Class E basic helix-loop-helix protein 40	GO:0043426; F:MRF binding; ISS:BHF-UCL
O14503	BHLHE40	Class E basic helix-loop-helix protein 40	GO:0005515; F:protein binding; IPI:IntAct
O14503	BHLHE40	Class E basic helix-loop-helix protein 40	GO:0019904; F:protein domain specific binding; IPI:BHF-UCL
O14503	BHLHE40	Class E basic helix-loop-helix protein 40	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
O14503	BHLHE40	Class E basic helix-loop-helix protein 40	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
O14503	BHLHE40	Class E basic helix-loop-helix protein 40	GO:0001102; F:RNA polymerase II activating transcription factor binding; ISS:BHF-UCL
O14503	BHLHE40	Class E basic helix-loop-helix protein 40	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IDA:BHF-UCL
O14503	BHLHE40	Class E basic helix-loop-helix protein 40	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
O14503	BHLHE40	Class E basic helix-loop-helix protein 40	GO:0001191; F:RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription; IDA:BHF-UCL
O14503	BHLHE40	Class E basic helix-loop-helix protein 40	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:BHF-UCL
O14503	BHLHE40	Class E basic helix-loop-helix protein 40	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
O14503	BHLHE40	Class E basic helix-loop-helix protein 40	GO:0032922; P:circadian regulation of gene expression; IDA:BHF-UCL
O14503	BHLHE40	Class E basic helix-loop-helix protein 40	GO:0043153; P:entrainment of circadian clock by photoperiod; ISS:BHF-UCL
O14503	BHLHE40	Class E basic helix-loop-helix protein 40	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
O14503	BHLHE40	Class E basic helix-loop-helix protein 40	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
O14503	BHLHE40	Class E basic helix-loop-helix protein 40	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
O14503	BHLHE40	Class E basic helix-loop-helix protein 40	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:GOC
Q9C0J9	BHLHE41	Class E basic helix-loop-helix protein 41	GO:0043425; F:bHLH transcription factor binding; IPI:BHF-UCL
Q9C0J9	BHLHE41	Class E basic helix-loop-helix protein 41	GO:0070888; F:E-box binding; IDA:BHF-UCL
Q9C0J9	BHLHE41	Class E basic helix-loop-helix protein 41	GO:0042826; F:histone deacetylase binding; ISS:BHF-UCL
Q9C0J9	BHLHE41	Class E basic helix-loop-helix protein 41	GO:0043426; F:MRF binding; ISS:BHF-UCL
Q9C0J9	BHLHE41	Class E basic helix-loop-helix protein 41	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
Q9C0J9	BHLHE41	Class E basic helix-loop-helix protein 41	GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
Q9C0J9	BHLHE41	Class E basic helix-loop-helix protein 41	GO:0001102; F:RNA polymerase II activating transcription factor binding; ISS:BHF-UCL
Q9C0J9	BHLHE41	Class E basic helix-loop-helix protein 41	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; ISS:BHF-UCL
Q9C0J9	BHLHE41	Class E basic helix-loop-helix protein 41	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; ISS:BHF-UCL
Q9C0J9	BHLHE41	Class E basic helix-loop-helix protein 41	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
Q9C0J9	BHLHE41	Class E basic helix-loop-helix protein 41	GO:0001191; F:RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription; ISS:BHF-UCL
Q9C0J9	BHLHE41	Class E basic helix-loop-helix protein 41	GO:0030154; P:cell differentiation; NAS:UniProtKB
Q9C0J9	BHLHE41	Class E basic helix-loop-helix protein 41	GO:0008283; P:cell proliferation; NAS:UniProtKB
Q9C0J9	BHLHE41	Class E basic helix-loop-helix protein 41	GO:0032922; P:circadian regulation of gene expression; IEA:Ensembl
Q9C0J9	BHLHE41	Class E basic helix-loop-helix protein 41	GO:0010832; P:negative regulation of myotube differentiation; ISS:BHF-UCL
Q9C0J9	BHLHE41	Class E basic helix-loop-helix protein 41	GO:0010944; P:negative regulation of transcription by competitive promoter binding; ISS:BHF-UCL
Q9C0J9	BHLHE41	Class E basic helix-loop-helix protein 41	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9C0J9	BHLHE41	Class E basic helix-loop-helix protein 41	GO:0009887; P:organ morphogenesis; NAS:UniProtKB
Q6PI77	BHLHB9	Protein BHLHb9	GO:0042803; F:protein homodimerization activity; ISS:UniProt
Q6PI77	BHLHB9	Protein BHLHb9	GO:0007611; P:learning or memory; ISS:UniProt
Q6PI77	BHLHB9	Protein BHLHb9	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProt
Q6PI77	BHLHB9	Protein BHLHb9	GO:0061003; P:positive regulation of dendritic spine morphogenesis; ISS:UniProt
Q6PI77	BHLHB9	Protein BHLHb9	GO:0050769; P:positive regulation of neurogenesis; ISS:UniProt
Q6PI77	BHLHB9	Protein BHLHb9	GO:0051965; P:positive regulation of synapse assembly; ISS:UniProt
Q93088	BHMT	Betaine--homocysteine S-methyltransferase 1	GO:0047150; F:betaine-homocysteine S-methyltransferase activity; NAS:UniProtKB
Q93088	BHMT	Betaine--homocysteine S-methyltransferase 1	GO:0008898; F:S-adenosylmethionine-homocysteine S-methyltransferase activity; TAS:ProtInc
Q93088	BHMT	Betaine--homocysteine S-methyltransferase 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q93088	BHMT	Betaine--homocysteine S-methyltransferase 1	GO:0006579; P:amino-acid betaine catabolic process; IEA:UniProtKB-UniPathway
Q93088	BHMT	Betaine--homocysteine S-methyltransferase 1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q93088	BHMT	Betaine--homocysteine S-methyltransferase 1	GO:0009086; P:methionine biosynthetic process; IEA:Ensembl
Q93088	BHMT	Betaine--homocysteine S-methyltransferase 1	GO:0006479; P:protein methylation; NAS:UniProtKB
Q93088	BHMT	Betaine--homocysteine S-methyltransferase 1	GO:0050666; P:regulation of homocysteine metabolic process; NAS:UniProtKB
Q93088	BHMT	Betaine--homocysteine S-methyltransferase 1	GO:0010243; P:response to organonitrogen compound; IEA:Ensembl
Q93088	BHMT	Betaine--homocysteine S-methyltransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q93088	BHMT	Betaine--homocysteine S-methyltransferase 1	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
Q9H2M3	BHMT2	S-methylmethionine--homocysteine S-methyltransferase BHMT2	GO:0047150; F:betaine-homocysteine S-methyltransferase activity; IEA:InterPro
Q9H2M3	BHMT2	S-methylmethionine--homocysteine S-methyltransferase BHMT2	GO:0008898; F:S-adenosylmethionine-homocysteine S-methyltransferase activity; IEA:UniProtKB-EC
Q9H2M3	BHMT2	S-methylmethionine--homocysteine S-methyltransferase BHMT2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H2M3	BHMT2	S-methylmethionine--homocysteine S-methyltransferase BHMT2	GO:0009086; P:methionine biosynthetic process; IEA:InterPro
P55061	TMBIM6	Bax inhibitor 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P55061	TMBIM6	Bax inhibitor 1	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
P55061	TMBIM6	Bax inhibitor 1	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
Q9UHR4	BAIAP2L1	Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1	GO:0070064; F:proline-rich region binding; IDA:UniProtKB
Q9UHR4	BAIAP2L1	Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1	GO:0046847; P:filopodium assembly; IEA:InterPro
Q9UHR4	BAIAP2L1	Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1	GO:2000251; P:positive regulation of actin cytoskeleton reorganization; IMP:UniProtKB
Q9UHR4	BAIAP2L1	Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1	GO:0030838; P:positive regulation of actin filament polymerization; IDA:UniProtKB
Q9UHR4	BAIAP2L1	Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1	GO:0009617; P:response to bacterium; IDA:UniProtKB
Q9UHR4	BAIAP2L1	Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1	GO:0007165; P:signal transduction; IEA:InterPro
Q6UXY1	BAIAP2L2	Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 2	GO:0005543; F:phospholipid binding; ISS:UniProtKB
Q6UXY1	BAIAP2L2	Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 2	GO:0046847; P:filopodium assembly; IEA:InterPro
Q6UXY1	BAIAP2L2	Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 2	GO:0061024; P:membrane organization; ISS:UniProtKB
Q6UXY1	BAIAP2L2	Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 2	GO:0032956; P:regulation of actin cytoskeleton organization; IEA:InterPro
Q6UXY1	BAIAP2L2	Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 2	GO:0007165; P:signal transduction; IEA:InterPro
Q9H694	BICC1	Protein bicaudal C homolog 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H694	BICC1	Protein bicaudal C homolog 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9H694	BICC1	Protein bicaudal C homolog 1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:UniProtKB
Q96G01	BICD1	Protein bicaudal D homolog 1	GO:0008093; F:cytoskeletal adaptor activity; IDA:BHF-UCL
Q96G01	BICD1	Protein bicaudal D homolog 1	GO:0034452; F:dynactin binding; IDA:BHF-UCL
Q96G01	BICD1	Protein bicaudal D homolog 1	GO:0045502; F:dynein binding; IDA:BHF-UCL
Q96G01	BICD1	Protein bicaudal D homolog 1	GO:0005515; F:protein binding; IPI:IntAct
Q96G01	BICD1	Protein bicaudal D homolog 1	GO:0031871; F:proteinase activated receptor binding; ISS:BHF-UCL
Q96G01	BICD1	Protein bicaudal D homolog 1	GO:0017137; F:Rab GTPase binding; IPI:BHF-UCL
Q96G01	BICD1	Protein bicaudal D homolog 1	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
Q96G01	BICD1	Protein bicaudal D homolog 1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q96G01	BICD1	Protein bicaudal D homolog 1	GO:0008298; P:intracellular mRNA localization; NAS:UniProtKB
Q96G01	BICD1	Protein bicaudal D homolog 1	GO:0072393; P:microtubule anchoring at microtubule organizing center; ISS:BHF-UCL
Q96G01	BICD1	Protein bicaudal D homolog 1	GO:0072385; P:minus-end-directed organelle transport along microtubule; IMP:BHF-UCL
Q96G01	BICD1	Protein bicaudal D homolog 1	GO:1900275; P:negative regulation of phospholipase C activity; ISS:BHF-UCL
Q96G01	BICD1	Protein bicaudal D homolog 1	GO:1900737; P:negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway; ISS:BHF-UCL
Q96G01	BICD1	Protein bicaudal D homolog 1	GO:0048260; P:positive regulation of receptor-mediated endocytosis; IMP:BHF-UCL
Q96G01	BICD1	Protein bicaudal D homolog 1	GO:0033365; P:protein localization to organelle; IDA:BHF-UCL
Q96G01	BICD1	Protein bicaudal D homolog 1	GO:1900276; P:regulation of proteinase activated receptor activity; ISS:BHF-UCL
Q96G01	BICD1	Protein bicaudal D homolog 1	GO:0006396; P:RNA processing; TAS:ProtInc
Q96G01	BICD1	Protein bicaudal D homolog 1	GO:0034063; P:stress granule assembly; ISS:BHF-UCL
Q96G01	BICD1	Protein bicaudal D homolog 1	GO:0016032; P:viral process; IMP:BHF-UCL
Q8TD16	BICD2	Protein bicaudal D homolog 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TD16	BICD2	Protein bicaudal D homolog 2	GO:0017137; F:Rab GTPase binding; ISS:BHF-UCL
Q8TD16	BICD2	Protein bicaudal D homolog 2	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q8TD16	BICD2	Protein bicaudal D homolog 2	GO:0072393; P:microtubule anchoring at microtubule organizing center; ISS:BHF-UCL
Q8TD16	BICD2	Protein bicaudal D homolog 2	GO:0072385; P:minus-end-directed organelle transport along microtubule; ISS:BHF-UCL
Q6ZP65	CCDC64	Bicaudal D-related protein 1	GO:0034452; F:dynactin binding; ISS:UniProtKB
Q6ZP65	CCDC64	Bicaudal D-related protein 1	GO:0017137; F:Rab GTPase binding; ISS:UniProtKB
Q6ZP65	CCDC64	Bicaudal D-related protein 1	GO:0055107; P:Golgi to secretory granule transport; ISS:UniProtKB
Q6ZP65	CCDC64	Bicaudal D-related protein 1	GO:0031175; P:neuron projection development; ISS:UniProtKB
P55957	BID	BH3-interacting domain death agonist	GO:0005123; F:death receptor binding; TAS:ProtInc
P55957	BID	BH3-interacting domain death agonist	GO:0005515; F:protein binding; IPI:IntAct
P55957	BID	BH3-interacting domain death agonist	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
P55957	BID	BH3-interacting domain death agonist	GO:0008637; P:apoptotic mitochondrial changes; TAS:ProtInc
P55957	BID	BH3-interacting domain death agonist	GO:0006915; P:apoptotic process; TAS:Reactome
P55957	BID	BH3-interacting domain death agonist	GO:0007420; P:brain development; IEA:Ensembl
P55957	BID	BH3-interacting domain death agonist	GO:0090150; P:establishment of protein localization to membrane; IDA:BHF-UCL
P55957	BID	BH3-interacting domain death agonist	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; TAS:ProtInc
P55957	BID	BH3-interacting domain death agonist	GO:0034349; P:glial cell apoptotic process; IEA:Ensembl
P55957	BID	BH3-interacting domain death agonist	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
P55957	BID	BH3-interacting domain death agonist	GO:0051402; P:neuron apoptotic process; TAS:HGNC
P55957	BID	BH3-interacting domain death agonist	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
P55957	BID	BH3-interacting domain death agonist	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB
P55957	BID	BH3-interacting domain death agonist	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; TAS:Reactome
P55957	BID	BH3-interacting domain death agonist	GO:1901030; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; TAS:Reactome
P55957	BID	BH3-interacting domain death agonist	GO:0032464; P:positive regulation of protein homooligomerization; IDA:BHF-UCL
P55957	BID	BH3-interacting domain death agonist	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
P55957	BID	BH3-interacting domain death agonist	GO:0032461; P:positive regulation of protein oligomerization; IDA:UniProtKB
P55957	BID	BH3-interacting domain death agonist	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IMP:UniProtKB
P55957	BID	BH3-interacting domain death agonist	GO:0051260; P:protein homooligomerization; IEA:Ensembl
P55957	BID	BH3-interacting domain death agonist	GO:0006626; P:protein targeting to mitochondrion; IEA:Ensembl
P55957	BID	BH3-interacting domain death agonist	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P55957	BID	BH3-interacting domain death agonist	GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl
P55957	BID	BH3-interacting domain death agonist	GO:1902108; P:regulation of mitochondrial membrane permeability involved in apoptotic process; IEA:Ensembl
P55957	BID	BH3-interacting domain death agonist	GO:0001836; P:release of cytochrome c from mitochondria; IDA:HGNC
P55957	BID	BH3-interacting domain death agonist	GO:0032355; P:response to estradiol; IEA:Ensembl
P55957	BID	BH3-interacting domain death agonist	GO:0042770; P:signal transduction in response to DNA damage; TAS:UniProtKB
P53004	BLVRA	Biliverdin reductase A	GO:0004074; F:biliverdin reductase activity; IDA:UniProtKB
P53004	BLVRA	Biliverdin reductase A	GO:0008270; F:zinc ion binding; IEA:InterPro
P53004	BLVRA	Biliverdin reductase A	GO:0042167; P:heme catabolic process; TAS:UniProtKB
P53004	BLVRA	Biliverdin reductase A	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
P53004	BLVRA	Biliverdin reductase A	GO:0006778; P:porphyrin-containing compound metabolic process; TAS:Reactome
P53004	BLVRA	Biliverdin reductase A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y6D6	ARFGEF1	Brefeldin A-inhibited guanine nucleotide-exchange protein 1	GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; IBA:RefGenome
Q9Y6D6	ARFGEF1	Brefeldin A-inhibited guanine nucleotide-exchange protein 1	GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q9Y6D6	ARFGEF1	Brefeldin A-inhibited guanine nucleotide-exchange protein 1	GO:0017022; F:myosin binding; IPI:UniProtKB
Q9Y6D6	ARFGEF1	Brefeldin A-inhibited guanine nucleotide-exchange protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6D6	ARFGEF1	Brefeldin A-inhibited guanine nucleotide-exchange protein 1	GO:0034237; F:protein kinase A regulatory subunit binding; IDA:UniProtKB
Q9Y6D6	ARFGEF1	Brefeldin A-inhibited guanine nucleotide-exchange protein 1	GO:0010256; P:endomembrane system organization; IMP:UniProtKB
Q9Y6D6	ARFGEF1	Brefeldin A-inhibited guanine nucleotide-exchange protein 1	GO:0006887; P:exocytosis; TAS:ProtInc
Q9Y6D6	ARFGEF1	Brefeldin A-inhibited guanine nucleotide-exchange protein 1	GO:0007030; P:Golgi organization; IMP:UniProtKB
Q9Y6D6	ARFGEF1	Brefeldin A-inhibited guanine nucleotide-exchange protein 1	GO:0030837; P:negative regulation of actin filament polymerization; IMP:UniProtKB
Q9Y6D6	ARFGEF1	Brefeldin A-inhibited guanine nucleotide-exchange protein 1	GO:0034259; P:negative regulation of Rho GTPase activity; IDA:UniProtKB
Q9Y6D6	ARFGEF1	Brefeldin A-inhibited guanine nucleotide-exchange protein 1	GO:0090284; P:positive regulation of protein glycosylation in Golgi; IMP:UniProtKB
Q9Y6D6	ARFGEF1	Brefeldin A-inhibited guanine nucleotide-exchange protein 1	GO:0090303; P:positive regulation of wound healing; IMP:UniProtKB
Q9Y6D6	ARFGEF1	Brefeldin A-inhibited guanine nucleotide-exchange protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9Y6D6	ARFGEF1	Brefeldin A-inhibited guanine nucleotide-exchange protein 1	GO:0032012; P:regulation of ARF protein signal transduction; IEA:InterPro
Q9Y6D6	ARFGEF1	Brefeldin A-inhibited guanine nucleotide-exchange protein 1	GO:2000114; P:regulation of establishment of cell polarity; IMP:UniProtKB
Q9Y6D6	ARFGEF1	Brefeldin A-inhibited guanine nucleotide-exchange protein 1	GO:0016192; P:vesicle-mediated transport; IBA:RefGenome
Q9Y6D5	ARFGEF2	Brefeldin A-inhibited guanine nucleotide-exchange protein 2	GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q9Y6D5	ARFGEF2	Brefeldin A-inhibited guanine nucleotide-exchange protein 2	GO:0050811; F:GABA receptor binding; ISS:UniProtKB
Q9Y6D5	ARFGEF2	Brefeldin A-inhibited guanine nucleotide-exchange protein 2	GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:MGI
Q9Y6D5	ARFGEF2	Brefeldin A-inhibited guanine nucleotide-exchange protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q9Y6D5	ARFGEF2	Brefeldin A-inhibited guanine nucleotide-exchange protein 2	GO:0034237; F:protein kinase A regulatory subunit binding; IDA:UniProtKB
Q9Y6D5	ARFGEF2	Brefeldin A-inhibited guanine nucleotide-exchange protein 2	GO:0010256; P:endomembrane system organization; IMP:UniProtKB
Q9Y6D5	ARFGEF2	Brefeldin A-inhibited guanine nucleotide-exchange protein 2	GO:0007032; P:endosome organization; IMP:UniProtKB
Q9Y6D5	ARFGEF2	Brefeldin A-inhibited guanine nucleotide-exchange protein 2	GO:0006887; P:exocytosis; TAS:ProtInc
Q9Y6D5	ARFGEF2	Brefeldin A-inhibited guanine nucleotide-exchange protein 2	GO:0006893; P:Golgi to plasma membrane transport; IMP:UniProtKB
Q9Y6D5	ARFGEF2	Brefeldin A-inhibited guanine nucleotide-exchange protein 2	GO:0035556; P:intracellular signal transduction; IDA:MGI
Q9Y6D5	ARFGEF2	Brefeldin A-inhibited guanine nucleotide-exchange protein 2	GO:0032760; P:positive regulation of tumor necrosis factor production; IMP:UniProtKB
Q9Y6D5	ARFGEF2	Brefeldin A-inhibited guanine nucleotide-exchange protein 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9Y6D5	ARFGEF2	Brefeldin A-inhibited guanine nucleotide-exchange protein 2	GO:0001881; P:receptor recycling; IDA:UniProtKB
Q9Y6D5	ARFGEF2	Brefeldin A-inhibited guanine nucleotide-exchange protein 2	GO:0032012; P:regulation of ARF protein signal transduction; IEA:InterPro
Q9Y6D5	ARFGEF2	Brefeldin A-inhibited guanine nucleotide-exchange protein 2	GO:0043087; P:regulation of GTPase activity; IDA:GOC
Q9Y6D5	ARFGEF2	Brefeldin A-inhibited guanine nucleotide-exchange protein 2	GO:0016192; P:vesicle-mediated transport; IBA:RefGenome
Q5TH69	ARFGEF3	Brefeldin A-inhibited guanine nucleotide-exchange protein 3	GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; IBA:RefGenome
Q5TH69	ARFGEF3	Brefeldin A-inhibited guanine nucleotide-exchange protein 3	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q5TH69	ARFGEF3	Brefeldin A-inhibited guanine nucleotide-exchange protein 3	GO:0032012; P:regulation of ARF protein signal transduction; IEA:InterPro
Q5TH69	ARFGEF3	Brefeldin A-inhibited guanine nucleotide-exchange protein 3	GO:0043087; P:regulation of GTPase activity; IBA:GOC
Q5TH69	ARFGEF3	Brefeldin A-inhibited guanine nucleotide-exchange protein 3	GO:0016192; P:vesicle-mediated transport; IBA:RefGenome
Q13323	BIK	Bcl-2-interacting killer	GO:0005515; F:protein binding; IPI:UniProtKB
Q13323	BIK	Bcl-2-interacting killer	GO:0008637; P:apoptotic mitochondrial changes; IEA:Ensembl
Q13323	BIK	Bcl-2-interacting killer	GO:0006915; P:apoptotic process; TAS:UniProtKB
Q13323	BIK	Bcl-2-interacting killer	GO:0008584; P:male gonad development; IEA:Ensembl
Q13323	BIK	Bcl-2-interacting killer	GO:0032464; P:positive regulation of protein homooligomerization; IDA:BHF-UCL
Q13323	BIK	Bcl-2-interacting killer	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IDA:BHF-UCL
Q13323	BIK	Bcl-2-interacting killer	GO:0007283; P:spermatogenesis; IEA:Ensembl
O00499	BIN1	Myc box-dependent-interacting protein 1	GO:0042802; F:identical protein binding; IPI:IntAct
O00499	BIN1	Myc box-dependent-interacting protein 1	GO:0005515; F:protein binding; IPI:IntAct
O00499	BIN1	Myc box-dependent-interacting protein 1	GO:0048156; F:tau protein binding; IPI:Alzheimers_University_of_Toronto
O00499	BIN1	Myc box-dependent-interacting protein 1	GO:0008283; P:cell proliferation; TAS:ProtInc
O00499	BIN1	Myc box-dependent-interacting protein 1	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
O00499	BIN1	Myc box-dependent-interacting protein 1	GO:0060988; P:lipid tube assembly; IMP:Alzheimers_University_of_Toronto
O00499	BIN1	Myc box-dependent-interacting protein 1	GO:0042692; P:muscle cell differentiation; IEA:Ensembl
O00499	BIN1	Myc box-dependent-interacting protein 1	GO:0043065; P:positive regulation of apoptotic process; IMP:Alzheimers_University_of_Toronto
O00499	BIN1	Myc box-dependent-interacting protein 1	GO:0048711; P:positive regulation of astrocyte differentiation; IMP:Alzheimers_University_of_Toronto
O00499	BIN1	Myc box-dependent-interacting protein 1	GO:0045807; P:positive regulation of endocytosis; IEA:Ensembl
O00499	BIN1	Myc box-dependent-interacting protein 1	GO:0043547; P:positive regulation of GTPase activity; IEA:Ensembl
O00499	BIN1	Myc box-dependent-interacting protein 1	GO:0071156; P:regulation of cell cycle arrest; IDA:Alzheimers_University_of_Toronto
O00499	BIN1	Myc box-dependent-interacting protein 1	GO:0045664; P:regulation of neuron differentiation; IMP:Alzheimers_University_of_Toronto
O00499	BIN1	Myc box-dependent-interacting protein 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9UBW5	BIN2	Bridging integrator 2	GO:0005543; F:phospholipid binding; IDA:UniProtKB
Q9UBW5	BIN2	Bridging integrator 2	GO:0005515; F:protein binding; IPI:IntAct
Q9UBW5	BIN2	Bridging integrator 2	GO:0060326; P:cell chemotaxis; IMP:UniProtKB
Q9UBW5	BIN2	Bridging integrator 2	GO:0097320; P:membrane tubulation; IDA:UniProtKB
Q9UBW5	BIN2	Bridging integrator 2	GO:0006911; P:phagocytosis, engulfment; IMP:UniProtKB
Q9UBW5	BIN2	Bridging integrator 2	GO:0071800; P:podosome assembly; IMP:UniProtKB
Q9NQY0	BIN3	Bridging integrator 3	GO:0008093; F:cytoskeletal adaptor activity; NAS:UniProtKB
Q9NQY0	BIN3	Bridging integrator 3	GO:0005515; F:protein binding; IPI:IntAct
Q9NQY0	BIN3	Bridging integrator 3	GO:0007015; P:actin filament organization; NAS:UniProtKB
Q9NQY0	BIN3	Bridging integrator 3	GO:0000917; P:barrier septum assembly; IEA:UniProtKB-KW
Q9NQY0	BIN3	Bridging integrator 3	GO:0000910; P:cytokinesis; NAS:UniProtKB
Q9NQY0	BIN3	Bridging integrator 3	GO:0008104; P:protein localization; IMP:UniProtKB
Q9NQY0	BIN3	Bridging integrator 3	GO:0009826; P:unidimensional cell growth; IMP:UniProtKB
Q96LW7	C9orf89	Bcl10-interacting CARD protein	GO:0050700; F:CARD domain binding; NAS:UniProtKB
Q96LW7	C9orf89	Bcl10-interacting CARD protein	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; NAS:UniProtKB
Q13075	NAIP	Baculoviral IAP repeat-containing protein 1	GO:0005524; F:ATP binding; IMP:UniProtKB
Q13075	NAIP	Baculoviral IAP repeat-containing protein 1	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q13075	NAIP	Baculoviral IAP repeat-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13075	NAIP	Baculoviral IAP repeat-containing protein 1	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q13075	NAIP	Baculoviral IAP repeat-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13075	NAIP	Baculoviral IAP repeat-containing protein 1	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q13075	NAIP	Baculoviral IAP repeat-containing protein 1	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q13075	NAIP	Baculoviral IAP repeat-containing protein 1	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB
Q13075	NAIP	Baculoviral IAP repeat-containing protein 1	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
Q13075	NAIP	Baculoviral IAP repeat-containing protein 1	GO:0043524; P:negative regulation of neuron apoptotic process; TAS:UniProtKB
Q13075	NAIP	Baculoviral IAP repeat-containing protein 1	GO:0007399; P:nervous system development; TAS:ProtInc
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0045087; P:innate immune response; TAS:Reactome
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0070266; P:necroptotic process; IEA:Ensembl
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0060546; P:negative regulation of necroptotic process; IEA:Ensembl
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0042326; P:negative regulation of phosphorylation; IEA:Ensembl
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:2000378; P:negative regulation of reactive oxygen species metabolic process; IEA:Ensembl
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0038061; P:NIK/NF-kappaB signaling; TAS:UniProtKB
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; TAS:UniProtKB
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0016567; P:protein ubiquitination; IDA:GOC
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0042981; P:regulation of apoptotic process; IMP:UniProtKB
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:2000116; P:regulation of cysteine-type endopeptidase activity; TAS:UniProtKB
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0050727; P:regulation of inflammatory response; TAS:UniProtKB
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0045088; P:regulation of innate immune response; TAS:UniProtKB
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0060544; P:regulation of necroptotic process; IMP:UniProtKB
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0070424; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway; TAS:UniProtKB
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0039535; P:regulation of RIG-I signaling pathway; TAS:UniProtKB
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0034121; P:regulation of toll-like receptor signaling pathway; TAS:UniProtKB
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q13489	BIRC3	Baculoviral IAP repeat-containing protein 3	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0003713; F:transcription coactivator activity; IMP:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0006915; P:apoptotic process; TAS:Reactome
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0045087; P:innate immune response; TAS:Reactome
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0070266; P:necroptotic process; IEA:Ensembl
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0038061; P:NIK/NF-kappaB signaling; TAS:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0001890; P:placenta development; IEA:Ensembl
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:1902524; P:positive regulation of protein K48-linked ubiquitination; IDA:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:1902523; P:positive regulation of protein K63-linked ubiquitination; IDA:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:1902527; P:positive regulation of protein monoubiquitination; IDA:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0042981; P:regulation of apoptotic process; IMP:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0051726; P:regulation of cell cycle; IDA:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0045595; P:regulation of cell differentiation; TAS:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0042127; P:regulation of cell proliferation; TAS:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:2000116; P:regulation of cysteine-type endopeptidase activity; TAS:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0050727; P:regulation of inflammatory response; TAS:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0045088; P:regulation of innate immune response; TAS:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0060544; P:regulation of necroptotic process; IMP:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0070424; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway; TAS:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0039535; P:regulation of RIG-I signaling pathway; TAS:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0034121; P:regulation of toll-like receptor signaling pathway; TAS:UniProtKB
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0051591; P:response to cAMP; IEA:Ensembl
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0045471; P:response to ethanol; IEA:Ensembl
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13490	BIRC2	Baculoviral IAP repeat-containing protein 2	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0051087; F:chaperone binding; IPI:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0050897; F:cobalt ion binding; NAS:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0048037; F:cofactor binding; IDA:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IMP:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0019899; F:enzyme binding; IPI:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0042802; F:identical protein binding; IPI:IntAct
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0008017; F:microtubule binding; IDA:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0008536; F:Ran GTPase binding; IPI:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0015631; F:tubulin binding; IDA:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0008270; F:zinc ion binding; IDA:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0051301; P:cell division; IMP:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0000910; P:cytokinesis; IMP:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0051303; P:establishment of chromosome localization; IMP:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0000086; P:G2/M transition of mitotic cell cycle; IDA:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0007067; P:mitosis; IEA:UniProtKB-KW
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0008284; P:positive regulation of cell proliferation; TAS:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0031536; P:positive regulation of exit from mitosis; IMP:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0045931; P:positive regulation of mitotic cell cycle; IMP:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0031503; P:protein complex localization; IMP:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0031577; P:spindle checkpoint; IMP:UniProtKB
O15392	BIRC5	Baculoviral IAP repeat-containing protein 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NR09	BIRC6	Baculoviral IAP repeat-containing protein 6	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IMP:UniProtKB
Q9NR09	BIRC6	Baculoviral IAP repeat-containing protein 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NR09	BIRC6	Baculoviral IAP repeat-containing protein 6	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9NR09	BIRC6	Baculoviral IAP repeat-containing protein 6	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9NR09	BIRC6	Baculoviral IAP repeat-containing protein 6	GO:0060711; P:labyrinthine layer development; IEA:Ensembl
Q9NR09	BIRC6	Baculoviral IAP repeat-containing protein 6	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9NR09	BIRC6	Baculoviral IAP repeat-containing protein 6	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q9NR09	BIRC6	Baculoviral IAP repeat-containing protein 6	GO:0010951; P:negative regulation of endopeptidase activity; IMP:GOC
Q9NR09	BIRC6	Baculoviral IAP repeat-containing protein 6	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB
Q9NR09	BIRC6	Baculoviral IAP repeat-containing protein 6	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q9NR09	BIRC6	Baculoviral IAP repeat-containing protein 6	GO:0006468; P:protein phosphorylation; TAS:UniProtKB
Q9NR09	BIRC6	Baculoviral IAP repeat-containing protein 6	GO:0016567; P:protein ubiquitination; TAS:UniProtKB
Q9NR09	BIRC6	Baculoviral IAP repeat-containing protein 6	GO:0042127; P:regulation of cell proliferation; TAS:UniProtKB
Q9NR09	BIRC6	Baculoviral IAP repeat-containing protein 6	GO:0032465; P:regulation of cytokinesis; IMP:UniProtKB
Q9NR09	BIRC6	Baculoviral IAP repeat-containing protein 6	GO:0060712; P:spongiotrophoblast layer development; IEA:Ensembl
Q96CA5	BIRC7	Baculoviral IAP repeat-containing protein 7	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; TAS:UniProtKB
Q96CA5	BIRC7	Baculoviral IAP repeat-containing protein 7	GO:0019899; F:enzyme binding; NAS:UniProtKB
Q96CA5	BIRC7	Baculoviral IAP repeat-containing protein 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q96CA5	BIRC7	Baculoviral IAP repeat-containing protein 7	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q96CA5	BIRC7	Baculoviral IAP repeat-containing protein 7	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96CA5	BIRC7	Baculoviral IAP repeat-containing protein 7	GO:0007257; P:activation of JUN kinase activity; NAS:UniProtKB
Q96CA5	BIRC7	Baculoviral IAP repeat-containing protein 7	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q96CA5	BIRC7	Baculoviral IAP repeat-containing protein 7	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q96CA5	BIRC7	Baculoviral IAP repeat-containing protein 7	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
Q96CA5	BIRC7	Baculoviral IAP repeat-containing protein 7	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q96CA5	BIRC7	Baculoviral IAP repeat-containing protein 7	GO:0042127; P:regulation of cell proliferation; IDA:UniProtKB
Q96CA5	BIRC7	Baculoviral IAP repeat-containing protein 7	GO:0070247; P:regulation of natural killer cell apoptotic process; IDA:UniProtKB
Q96P09	BIRC8	Baculoviral IAP repeat-containing protein 8	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96P09	BIRC8	Baculoviral IAP repeat-containing protein 8	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P46663	BDKRB1	B1 bradykinin receptor	GO:0004947; F:bradykinin receptor activity; TAS:ProtInc
P46663	BDKRB1	B1 bradykinin receptor	GO:0042277; F:peptide binding; IEA:Ensembl
P46663	BDKRB1	B1 bradykinin receptor	GO:0005515; F:protein binding; IPI:IntAct
P46663	BDKRB1	B1 bradykinin receptor	GO:0016477; P:cell migration; IEA:Ensembl
P46663	BDKRB1	B1 bradykinin receptor	GO:0006954; P:inflammatory response; IEA:Ensembl
P46663	BDKRB1	B1 bradykinin receptor	GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl
P46663	BDKRB1	B1 bradykinin receptor	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
P46663	BDKRB1	B1 bradykinin receptor	GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl
P46663	BDKRB1	B1 bradykinin receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
P46663	BDKRB1	B1 bradykinin receptor	GO:0002687; P:positive regulation of leukocyte migration; IEA:Ensembl
P46663	BDKRB1	B1 bradykinin receptor	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IEA:Ensembl
P46663	BDKRB1	B1 bradykinin receptor	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P46663	BDKRB1	B1 bradykinin receptor	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P46663	BDKRB1	B1 bradykinin receptor	GO:0009612; P:response to mechanical stimulus; IEA:InterPro
P46663	BDKRB1	B1 bradykinin receptor	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P30411	BDKRB2	B2 bradykinin receptor	GO:0004947; F:bradykinin receptor activity; IDA:BHF-UCL
P30411	BDKRB2	B2 bradykinin receptor	GO:0004435; F:phosphatidylinositol phospholipase C activity; TAS:ProtInc
P30411	BDKRB2	B2 bradykinin receptor	GO:0002020; F:protease binding; IPI:BHF-UCL
P30411	BDKRB2	B2 bradykinin receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P30411	BDKRB2	B2 bradykinin receptor	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P30411	BDKRB2	B2 bradykinin receptor	GO:0031702; F:type 1 angiotensin receptor binding; IPI:BHF-UCL
P30411	BDKRB2	B2 bradykinin receptor	GO:0050482; P:arachidonic acid secretion; IDA:BHF-UCL
P30411	BDKRB2	B2 bradykinin receptor	GO:0008015; P:blood circulation; NAS:ProtInc
P30411	BDKRB2	B2 bradykinin receptor	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P30411	BDKRB2	B2 bradykinin receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P30411	BDKRB2	B2 bradykinin receptor	GO:0006954; P:inflammatory response; IC:BHF-UCL
P30411	BDKRB2	B2 bradykinin receptor	GO:0008152; P:metabolic process; TAS:GOC
P30411	BDKRB2	B2 bradykinin receptor	GO:1902239; P:negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator; IEA:Ensembl
P30411	BDKRB2	B2 bradykinin receptor	GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; IEA:Ensembl
P30411	BDKRB2	B2 bradykinin receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
P30411	BDKRB2	B2 bradykinin receptor	GO:0043114; P:regulation of vascular permeability; IC:BHF-UCL
P30411	BDKRB2	B2 bradykinin receptor	GO:0019229; P:regulation of vasoconstriction; IC:BHF-UCL
P30411	BDKRB2	B2 bradykinin receptor	GO:0009651; P:response to salt stress; IEA:Ensembl
P30411	BDKRB2	B2 bradykinin receptor	GO:0006939; P:smooth muscle contraction; IC:BHF-UCL
P30411	BDKRB2	B2 bradykinin receptor	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc
P30411	BDKRB2	B2 bradykinin receptor	GO:0042310; P:vasoconstriction; IEA:InterPro
P30411	BDKRB2	B2 bradykinin receptor	GO:0042311; P:vasodilation; IEA:Ensembl
P78537	BLOC1S1	Biogenesis of lysosome-related organelles complex 1 subunit 1	GO:0005515; F:protein binding; IPI:IntAct
P78537	BLOC1S1	Biogenesis of lysosome-related organelles complex 1 subunit 1	GO:0009060; P:aerobic respiration; IMP:UniProtKB
P78537	BLOC1S1	Biogenesis of lysosome-related organelles complex 1 subunit 1	GO:0008089; P:anterograde axon cargo transport; ISS:UniProtKB
P78537	BLOC1S1	Biogenesis of lysosome-related organelles complex 1 subunit 1	GO:0048490; P:anterograde synaptic vesicle transport; ISS:UniProtKB
P78537	BLOC1S1	Biogenesis of lysosome-related organelles complex 1 subunit 1	GO:0032438; P:melanosome organization; NAS:UniProtKB
P78537	BLOC1S1	Biogenesis of lysosome-related organelles complex 1 subunit 1	GO:0061024; P:membrane organization; TAS:Reactome
P78537	BLOC1S1	Biogenesis of lysosome-related organelles complex 1 subunit 1	GO:0031175; P:neuron projection development; ISS:UniProtKB
P78537	BLOC1S1	Biogenesis of lysosome-related organelles complex 1 subunit 1	GO:0018394; P:peptidyl-lysine acetylation; IMP:UniProtKB
P78537	BLOC1S1	Biogenesis of lysosome-related organelles complex 1 subunit 1	GO:0060155; P:platelet dense granule organization; NAS:UniProtKB
P78537	BLOC1S1	Biogenesis of lysosome-related organelles complex 1 subunit 1	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
Q6QNY1	BLOC1S2	Biogenesis of lysosome-related organelles complex 1 subunit 2	GO:0043015; F:gamma-tubulin binding; IDA:UniProtKB
Q6QNY1	BLOC1S2	Biogenesis of lysosome-related organelles complex 1 subunit 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q6QNY1	BLOC1S2	Biogenesis of lysosome-related organelles complex 1 subunit 2	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q6QNY1	BLOC1S2	Biogenesis of lysosome-related organelles complex 1 subunit 2	GO:0008089; P:anterograde axon cargo transport; ISS:UniProtKB
Q6QNY1	BLOC1S2	Biogenesis of lysosome-related organelles complex 1 subunit 2	GO:0048490; P:anterograde synaptic vesicle transport; ISS:UniProtKB
Q6QNY1	BLOC1S2	Biogenesis of lysosome-related organelles complex 1 subunit 2	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IDA:UniProtKB
Q6QNY1	BLOC1S2	Biogenesis of lysosome-related organelles complex 1 subunit 2	GO:0032438; P:melanosome organization; NAS:UniProtKB
Q6QNY1	BLOC1S2	Biogenesis of lysosome-related organelles complex 1 subunit 2	GO:0007020; P:microtubule nucleation; NAS:UniProtKB
Q6QNY1	BLOC1S2	Biogenesis of lysosome-related organelles complex 1 subunit 2	GO:0097345; P:mitochondrial outer membrane permeabilization; IDA:UniProtKB
Q6QNY1	BLOC1S2	Biogenesis of lysosome-related organelles complex 1 subunit 2	GO:0031175; P:neuron projection development; ISS:UniProtKB
Q6QNY1	BLOC1S2	Biogenesis of lysosome-related organelles complex 1 subunit 2	GO:0060155; P:platelet dense granule organization; NAS:UniProtKB
Q6QNY1	BLOC1S2	Biogenesis of lysosome-related organelles complex 1 subunit 2	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q6QNY1	BLOC1S2	Biogenesis of lysosome-related organelles complex 1 subunit 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q6QNY1	BLOC1S2	Biogenesis of lysosome-related organelles complex 1 subunit 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q6QNY0	BLOC1S3	Biogenesis of lysosome-related organelles complex 1 subunit 3	GO:0005515; F:protein binding; IPI:IntAct
Q6QNY0	BLOC1S3	Biogenesis of lysosome-related organelles complex 1 subunit 3	GO:0008089; P:anterograde axon cargo transport; ISS:UniProtKB
Q6QNY0	BLOC1S3	Biogenesis of lysosome-related organelles complex 1 subunit 3	GO:0048490; P:anterograde synaptic vesicle transport; ISS:UniProtKB
Q6QNY0	BLOC1S3	Biogenesis of lysosome-related organelles complex 1 subunit 3	GO:0035646; P:endosome to melanosome transport; IDA:UniProtKB
Q6QNY0	BLOC1S3	Biogenesis of lysosome-related organelles complex 1 subunit 3	GO:0001654; P:eye development; IMP:UniProtKB
Q6QNY0	BLOC1S3	Biogenesis of lysosome-related organelles complex 1 subunit 3	GO:0032438; P:melanosome organization; NAS:UniProtKB
Q6QNY0	BLOC1S3	Biogenesis of lysosome-related organelles complex 1 subunit 3	GO:0032402; P:melanosome transport; IDA:UniProtKB
Q6QNY0	BLOC1S3	Biogenesis of lysosome-related organelles complex 1 subunit 3	GO:0061024; P:membrane organization; TAS:Reactome
Q6QNY0	BLOC1S3	Biogenesis of lysosome-related organelles complex 1 subunit 3	GO:0031175; P:neuron projection development; ISS:UniProtKB
Q6QNY0	BLOC1S3	Biogenesis of lysosome-related organelles complex 1 subunit 3	GO:0043473; P:pigmentation; IMP:UniProtKB
Q6QNY0	BLOC1S3	Biogenesis of lysosome-related organelles complex 1 subunit 3	GO:0030168; P:platelet activation; IMP:UniProtKB
Q6QNY0	BLOC1S3	Biogenesis of lysosome-related organelles complex 1 subunit 3	GO:0060155; P:platelet dense granule organization; NAS:UniProtKB
Q6QNY0	BLOC1S3	Biogenesis of lysosome-related organelles complex 1 subunit 3	GO:0032816; P:positive regulation of natural killer cell activation; IEA:Ensembl
Q6QNY0	BLOC1S3	Biogenesis of lysosome-related organelles complex 1 subunit 3	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
Q6QNY0	BLOC1S3	Biogenesis of lysosome-related organelles complex 1 subunit 3	GO:0042493; P:response to drug; IEA:Ensembl
Q6QNY0	BLOC1S3	Biogenesis of lysosome-related organelles complex 1 subunit 3	GO:0033299; P:secretion of lysosomal enzymes; IEA:Ensembl
Q9NUP1	BLOC1S4	Biogenesis of lysosome-related organelles complex 1 subunit 4	GO:0005515; F:protein binding; IPI:IntAct
Q9NUP1	BLOC1S4	Biogenesis of lysosome-related organelles complex 1 subunit 4	GO:0008089; P:anterograde axon cargo transport; ISS:UniProtKB
Q9NUP1	BLOC1S4	Biogenesis of lysosome-related organelles complex 1 subunit 4	GO:0048490; P:anterograde synaptic vesicle transport; ISS:UniProtKB
Q9NUP1	BLOC1S4	Biogenesis of lysosome-related organelles complex 1 subunit 4	GO:0032438; P:melanosome organization; NAS:UniProtKB
Q9NUP1	BLOC1S4	Biogenesis of lysosome-related organelles complex 1 subunit 4	GO:0061024; P:membrane organization; TAS:Reactome
Q9NUP1	BLOC1S4	Biogenesis of lysosome-related organelles complex 1 subunit 4	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q9NUP1	BLOC1S4	Biogenesis of lysosome-related organelles complex 1 subunit 4	GO:0031175; P:neuron projection development; ISS:UniProtKB
Q9NUP1	BLOC1S4	Biogenesis of lysosome-related organelles complex 1 subunit 4	GO:0070527; P:platelet aggregation; IEA:Ensembl
Q9NUP1	BLOC1S4	Biogenesis of lysosome-related organelles complex 1 subunit 4	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
Q8TDH9	BLOC1S5	Biogenesis of lysosome-related organelles complex 1 subunit 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TDH9	BLOC1S5	Biogenesis of lysosome-related organelles complex 1 subunit 5	GO:0008089; P:anterograde axon cargo transport; ISS:UniProtKB
Q8TDH9	BLOC1S5	Biogenesis of lysosome-related organelles complex 1 subunit 5	GO:0048490; P:anterograde synaptic vesicle transport; ISS:UniProtKB
Q8TDH9	BLOC1S5	Biogenesis of lysosome-related organelles complex 1 subunit 5	GO:0035646; P:endosome to melanosome transport; IDA:UniProtKB
Q8TDH9	BLOC1S5	Biogenesis of lysosome-related organelles complex 1 subunit 5	GO:0032438; P:melanosome organization; NAS:UniProtKB
Q8TDH9	BLOC1S5	Biogenesis of lysosome-related organelles complex 1 subunit 5	GO:0032402; P:melanosome transport; IDA:UniProtKB
Q8TDH9	BLOC1S5	Biogenesis of lysosome-related organelles complex 1 subunit 5	GO:0031175; P:neuron projection development; ISS:UniProtKB
Q8TDH9	BLOC1S5	Biogenesis of lysosome-related organelles complex 1 subunit 5	GO:0050942; P:positive regulation of pigment cell differentiation; IDA:UniProtKB
Q9UL45	BLOC1S6	Biogenesis of lysosome-related organelles complex 1 subunit 6	GO:0051015; F:actin filament binding; IDA:UniProtKB
Q9UL45	BLOC1S6	Biogenesis of lysosome-related organelles complex 1 subunit 6	GO:0042802; F:identical protein binding; IPI:IntAct
Q9UL45	BLOC1S6	Biogenesis of lysosome-related organelles complex 1 subunit 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UL45	BLOC1S6	Biogenesis of lysosome-related organelles complex 1 subunit 6	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q9UL45	BLOC1S6	Biogenesis of lysosome-related organelles complex 1 subunit 6	GO:0019905; F:syntaxin binding; TAS:UniProtKB
Q9UL45	BLOC1S6	Biogenesis of lysosome-related organelles complex 1 subunit 6	GO:0008089; P:anterograde axon cargo transport; ISS:UniProtKB
Q9UL45	BLOC1S6	Biogenesis of lysosome-related organelles complex 1 subunit 6	GO:0048490; P:anterograde synaptic vesicle transport; ISS:UniProtKB
Q9UL45	BLOC1S6	Biogenesis of lysosome-related organelles complex 1 subunit 6	GO:0007596; P:blood coagulation; IEA:Ensembl
Q9UL45	BLOC1S6	Biogenesis of lysosome-related organelles complex 1 subunit 6	GO:0035646; P:endosome to melanosome transport; IDA:UniProtKB
Q9UL45	BLOC1S6	Biogenesis of lysosome-related organelles complex 1 subunit 6	GO:0030318; P:melanocyte differentiation; IEA:Ensembl
Q9UL45	BLOC1S6	Biogenesis of lysosome-related organelles complex 1 subunit 6	GO:0032438; P:melanosome organization; NAS:UniProtKB
Q9UL45	BLOC1S6	Biogenesis of lysosome-related organelles complex 1 subunit 6	GO:0032402; P:melanosome transport; IDA:UniProtKB
Q9UL45	BLOC1S6	Biogenesis of lysosome-related organelles complex 1 subunit 6	GO:0061024; P:membrane organization; TAS:Reactome
Q9UL45	BLOC1S6	Biogenesis of lysosome-related organelles complex 1 subunit 6	GO:0031175; P:neuron projection development; ISS:UniProtKB
Q9UL45	BLOC1S6	Biogenesis of lysosome-related organelles complex 1 subunit 6	GO:0032816; P:positive regulation of natural killer cell activation; IEA:Ensembl
Q9UL45	BLOC1S6	Biogenesis of lysosome-related organelles complex 1 subunit 6	GO:0050942; P:positive regulation of pigment cell differentiation; IDA:UniProtKB
Q9UL45	BLOC1S6	Biogenesis of lysosome-related organelles complex 1 subunit 6	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
Q9UL45	BLOC1S6	Biogenesis of lysosome-related organelles complex 1 subunit 6	GO:0033299; P:secretion of lysosomal enzymes; IEA:Ensembl
Q9UL45	BLOC1S6	Biogenesis of lysosome-related organelles complex 1 subunit 6	GO:0016081; P:synaptic vesicle docking involved in exocytosis; NAS:UniProtKB
P62952	BLCAP	Bladder cancer-associated protein	GO:0005515; F:protein binding; IPI:IntAct
P62952	BLCAP	Bladder cancer-associated protein	GO:0030262; P:apoptotic nuclear changes; IDA:UniProtKB
P62952	BLCAP	Bladder cancer-associated protein	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8IZY5	BLID	BH3-like motif-containing cell death inducer	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P51451	BLK	Tyrosine-protein kinase Blk	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P51451	BLK	Tyrosine-protein kinase Blk	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB
P51451	BLK	Tyrosine-protein kinase Blk	GO:0004713; F:protein tyrosine kinase activity; TAS:ProtInc
P51451	BLK	Tyrosine-protein kinase Blk	GO:0050853; P:B cell receptor signaling pathway; IDA:UniProtKB
P51451	BLK	Tyrosine-protein kinase Blk	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
P51451	BLK	Tyrosine-protein kinase Blk	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:GOC
P51451	BLK	Tyrosine-protein kinase Blk	GO:0032024; P:positive regulation of insulin secretion; IMP:UniProtKB
Q13867	BLMH	Bleomycin hydrolase	GO:0004177; F:aminopeptidase activity; TAS:ProtInc
Q13867	BLMH	Bleomycin hydrolase	GO:0004180; F:carboxypeptidase activity; TAS:ProtInc
Q13867	BLMH	Bleomycin hydrolase	GO:0004197; F:cysteine-type endopeptidase activity; TAS:ProtInc
Q13867	BLMH	Bleomycin hydrolase	GO:0008234; F:cysteine-type peptidase activity; TAS:ProtInc
Q13867	BLMH	Bleomycin hydrolase	GO:0005515; F:protein binding; IPI:IntAct
Q13867	BLMH	Bleomycin hydrolase	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q13867	BLMH	Bleomycin hydrolase	GO:0000209; P:protein polyubiquitination; TAS:Reactome
Q13867	BLMH	Bleomycin hydrolase	GO:0006508; P:proteolysis; TAS:ProtInc
Q13867	BLMH	Bleomycin hydrolase	GO:0042493; P:response to drug; IEA:Ensembl
Q13867	BLMH	Bleomycin hydrolase	GO:0009636; P:response to toxic substance; IEA:Ensembl
P54132	BLM	Bloom syndrome protein	GO:0036310; F:annealing helicase activity; IDA:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0005524; F:ATP binding; IDA:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0043140; F:ATP-dependent 3'-5' DNA helicase activity; IEA:Ensembl
P54132	BLM	Bloom syndrome protein	GO:0004003; F:ATP-dependent DNA helicase activity; IDA:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0008026; F:ATP-dependent helicase activity; IDA:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0016887; F:ATPase activity; IDA:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0000405; F:bubble DNA binding; IDA:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0009378; F:four-way junction helicase activity; IDA:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0051880; F:G-quadruplex DNA binding; IDA:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0004386; F:helicase activity; IDA:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0002039; F:p53 binding; IPI:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0005515; F:protein binding; IPI:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0046632; P:alpha-beta T cell differentiation; IEA:Ensembl
P54132	BLM	Bloom syndrome protein	GO:0006200; P:ATP catabolic process; IDA:GOC
P54132	BLM	Bloom syndrome protein	GO:0072757; P:cellular response to camptothecin; IDA:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0072711; P:cellular response to hydroxyurea; IDA:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0071479; P:cellular response to ionizing radiation; IDA:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0000729; P:DNA double-strand break processing; IDA:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0032508; P:DNA duplex unwinding; IDA:GOC
P54132	BLM	Bloom syndrome protein	GO:0006310; P:DNA recombination; NAS:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0006281; P:DNA repair; NAS:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0000733; P:DNA strand renaturation; IDA:GOC
P54132	BLM	Bloom syndrome protein	GO:0000724; P:double-strand break repair via homologous recombination; NAS:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0031572; P:G2 DNA damage checkpoint; NAS:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0000085; P:mitotic G2 phase; NAS:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0051782; P:negative regulation of cell division; IMP:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0045910; P:negative regulation of DNA recombination; IMP:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0045950; P:negative regulation of mitotic recombination; IEA:Ensembl
P54132	BLM	Bloom syndrome protein	GO:0070244; P:negative regulation of thymocyte apoptotic process; IEA:Ensembl
P54132	BLM	Bloom syndrome protein	GO:0046641; P:positive regulation of alpha-beta T cell proliferation; IEA:Ensembl
P54132	BLM	Bloom syndrome protein	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0051259; P:protein oligomerization; IDA:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0051098; P:regulation of binding; IEA:Ensembl
P54132	BLM	Bloom syndrome protein	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IMP:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0031297; P:replication fork processing; IDA:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0048478; P:replication fork protection; NAS:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0010165; P:response to X-ray; IDA:UniProtKB
P54132	BLM	Bloom syndrome protein	GO:0000723; P:telomere maintenance; IEA:Ensembl
Q8WV28	BLNK	B-cell linker protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WV28	BLNK	B-cell linker protein	GO:0005070; F:SH3/SH2 adaptor activity; IDA:UniProtKB
Q8WV28	BLNK	B-cell linker protein	GO:0005068; F:transmembrane receptor protein tyrosine kinase adaptor activity; TAS:ProtInc
Q8WV28	BLNK	B-cell linker protein	GO:0030183; P:B cell differentiation; NAS:UniProtKB
Q8WV28	BLNK	B-cell linker protein	GO:0006959; P:humoral immune response; TAS:ProtInc
Q8WV28	BLNK	B-cell linker protein	GO:0006954; P:inflammatory response; TAS:ProtInc
Q8WV28	BLNK	B-cell linker protein	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q8WV28	BLNK	B-cell linker protein	GO:0009967; P:positive regulation of signal transduction; IDA:GOC
Q8WV28	BLNK	B-cell linker protein	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:GOC
P30043	BLVRB	Flavin reductase (NADPH)	GO:0004074; F:biliverdin reductase activity; IDA:UniProtKB
P30043	BLVRB	Flavin reductase (NADPH)	GO:0042602; F:riboflavin reductase (NADPH) activity; IDA:UniProtKB
P30043	BLVRB	Flavin reductase (NADPH)	GO:0042167; P:heme catabolic process; IDA:UniProtKB
P30043	BLVRB	Flavin reductase (NADPH)	GO:0006778; P:porphyrin-containing compound metabolic process; TAS:Reactome
P30043	BLVRB	Flavin reductase (NADPH)	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0017162; F:aryl hydrocarbon receptor binding; IPI:BHF-UCL
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0001047; F:core promoter binding; ISS:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0003677; F:DNA binding; IDA:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0070888; F:E-box binding; IDA:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0051879; F:Hsp90 protein binding; IDA:BHF-UCL
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0000982; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0001190; F:RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0004871; F:signal transducer activity; IEA:InterPro
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0032922; P:circadian regulation of gene expression; IDA:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0007623; P:circadian rhythm; TAS:ProtInc
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0045599; P:negative regulation of fat cell differentiation; ISS:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0032007; P:negative regulation of TOR signaling; ISS:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0090403; P:oxidative stress-induced premature senescence; ISS:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; ISS:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0042753; P:positive regulation of circadian rhythm; ISS:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:2001016; P:positive regulation of skeletal muscle cell differentiation; ISS:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0000060; P:protein import into nucleus, translocation; IEA:Ensembl
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0051726; P:regulation of cell cycle; ISS:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:2000772; P:regulation of cellular senescence; ISS:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0042634; P:regulation of hair cycle; IMP:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0050796; P:regulation of insulin secretion; ISS:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0050767; P:regulation of neurogenesis; ISS:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0042176; P:regulation of protein catabolic process; IEA:Ensembl
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:2000074; P:regulation of type B pancreatic cell development; ISS:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0051775; P:response to redox state; IDA:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0007283; P:spermatogenesis; ISS:UniProtKB
O00327	ARNTL	Aryl hydrocarbon receptor nuclear translocator-like protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; ISS:GOC
Q8WYA1	ARNTL2	Aryl hydrocarbon receptor nuclear translocator-like protein 2	GO:0070888; F:E-box binding; IDA:UniProtKB
Q8WYA1	ARNTL2	Aryl hydrocarbon receptor nuclear translocator-like protein 2	GO:0000982; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q8WYA1	ARNTL2	Aryl hydrocarbon receptor nuclear translocator-like protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q8WYA1	ARNTL2	Aryl hydrocarbon receptor nuclear translocator-like protein 2	GO:0004871; F:signal transducer activity; IEA:InterPro
Q8WYA1	ARNTL2	Aryl hydrocarbon receptor nuclear translocator-like protein 2	GO:0007623; P:circadian rhythm; IDA:MGI
Q8WYA1	ARNTL2	Aryl hydrocarbon receptor nuclear translocator-like protein 2	GO:0009649; P:entrainment of circadian clock; NAS:UniProtKB
Q8WYA1	ARNTL2	Aryl hydrocarbon receptor nuclear translocator-like protein 2	GO:0042753; P:positive regulation of circadian rhythm; ISS:UniProtKB
Q8WYA1	ARNTL2	Aryl hydrocarbon receptor nuclear translocator-like protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q8WYA1	ARNTL2	Aryl hydrocarbon receptor nuclear translocator-like protein 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q8WYA1	ARNTL2	Aryl hydrocarbon receptor nuclear translocator-like protein 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q8WYA1	ARNTL2	Aryl hydrocarbon receptor nuclear translocator-like protein 2	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q8WYA1	ARNTL2	Aryl hydrocarbon receptor nuclear translocator-like protein 2	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:GOC
Q96LC9	BMF	Bcl-2-modifying factor	GO:0005515; F:protein binding; IPI:UniProtKB
Q96LC9	BMF	Bcl-2-modifying factor	GO:0043276; P:anoikis; IDA:MGI
Q96LC9	BMF	Bcl-2-modifying factor	GO:0006915; P:apoptotic process; TAS:Reactome
Q96LC9	BMF	Bcl-2-modifying factor	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
Q96LC9	BMF	Bcl-2-modifying factor	GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl
Q96LC9	BMF	Bcl-2-modifying factor	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; TAS:Reactome
Q96LC9	BMF	Bcl-2-modifying factor	GO:0032464; P:positive regulation of protein homooligomerization; ISS:BHF-UCL
Q96LC9	BMF	Bcl-2-modifying factor	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
Q96LC9	BMF	Bcl-2-modifying factor	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; ISS:BHF-UCL
P35226	BMI1	Polycomb complex protein BMI-1	GO:0005515; F:protein binding; IPI:IntAct
P35226	BMI1	Polycomb complex protein BMI-1	GO:0071535; F:RING-like zinc finger domain binding; IPI:UniProtKB
P35226	BMI1	Polycomb complex protein BMI-1	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P35226	BMI1	Polycomb complex protein BMI-1	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
P35226	BMI1	Polycomb complex protein BMI-1	GO:0030097; P:hemopoiesis; IEP:UniProtKB
P35226	BMI1	Polycomb complex protein BMI-1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
P35226	BMI1	Polycomb complex protein BMI-1	GO:0048146; P:positive regulation of fibroblast proliferation; IMP:BHF-UCL
P35226	BMI1	Polycomb complex protein BMI-1	GO:0051443; P:positive regulation of ubiquitin-protein ligase activity; IDA:UniProtKB
P35226	BMI1	Polycomb complex protein BMI-1	GO:0010468; P:regulation of gene expression; IMP:BHF-UCL
P35226	BMI1	Polycomb complex protein BMI-1	GO:0007379; P:segment specification; TAS:ProtInc
P35226	BMI1	Polycomb complex protein BMI-1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95393	BMP10	Bone morphogenetic protein 10	GO:0005179; F:hormone activity; IDA:BHF-UCL
O95393	BMP10	Bone morphogenetic protein 10	GO:0005515; F:protein binding; IPI:BHF-UCL
O95393	BMP10	Bone morphogenetic protein 10	GO:0033612; F:receptor serine/threonine kinase binding; IDA:UniProtKB
O95393	BMP10	Bone morphogenetic protein 10	GO:0032924; P:activin receptor signaling pathway; IDA:BHF-UCL
O95393	BMP10	Bone morphogenetic protein 10	GO:0007512; P:adult heart development; ISS:BHF-UCL
O95393	BMP10	Bone morphogenetic protein 10	GO:0055009; P:atrial cardiac muscle tissue morphogenesis; ISS:BHF-UCL
O95393	BMP10	Bone morphogenetic protein 10	GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL
O95393	BMP10	Bone morphogenetic protein 10	GO:0060038; P:cardiac muscle cell proliferation; ISS:UniProtKB
O95393	BMP10	Bone morphogenetic protein 10	GO:0014898; P:cardiac muscle hypertrophy in response to stress; IC:BHF-UCL
O95393	BMP10	Bone morphogenetic protein 10	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
O95393	BMP10	Bone morphogenetic protein 10	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O95393	BMP10	Bone morphogenetic protein 10	GO:0060347; P:heart trabecula formation; ISS:BHF-UCL
O95393	BMP10	Bone morphogenetic protein 10	GO:0010614; P:negative regulation of cardiac muscle hypertrophy; ISS:BHF-UCL
O95393	BMP10	Bone morphogenetic protein 10	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
O95393	BMP10	Bone morphogenetic protein 10	GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB
O95393	BMP10	Bone morphogenetic protein 10	GO:0010596; P:negative regulation of endothelial cell migration; IDA:BHF-UCL
O95393	BMP10	Bone morphogenetic protein 10	GO:0060389; P:pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
O95393	BMP10	Bone morphogenetic protein 10	GO:0060045; P:positive regulation of cardiac muscle cell proliferation; ISS:BHF-UCL
O95393	BMP10	Bone morphogenetic protein 10	GO:0010613; P:positive regulation of cardiac muscle hypertrophy; IMP:BHF-UCL
O95393	BMP10	Bone morphogenetic protein 10	GO:2000138; P:positive regulation of cell proliferation involved in heart morphogenesis; ISS:BHF-UCL
O95393	BMP10	Bone morphogenetic protein 10	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
O95393	BMP10	Bone morphogenetic protein 10	GO:0060298; P:positive regulation of sarcomere organization; IDA:BHF-UCL
O95393	BMP10	Bone morphogenetic protein 10	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
O95393	BMP10	Bone morphogenetic protein 10	GO:0055117; P:regulation of cardiac muscle contraction; IMP:BHF-UCL
O95393	BMP10	Bone morphogenetic protein 10	GO:0045214; P:sarcomere organization; ISS:BHF-UCL
O95393	BMP10	Bone morphogenetic protein 10	GO:0055015; P:ventricular cardiac muscle cell development; ISS:BHF-UCL
O95393	BMP10	Bone morphogenetic protein 10	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; ISS:BHF-UCL
O95972	BMP15	Bone morphogenetic protein 15	GO:0007292; P:female gamete generation; TAS:ProtInc
O95972	BMP15	Bone morphogenetic protein 15	GO:0060016; P:granulosa cell development; IEA:InterPro
O95972	BMP15	Bone morphogenetic protein 15	GO:0001541; P:ovarian follicle development; IEA:InterPro
O95972	BMP15	Bone morphogenetic protein 15	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P13497	BMP1	Bone morphogenetic protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
P13497	BMP1	Bone morphogenetic protein 1	GO:0004222; F:metalloendopeptidase activity; TAS:Reactome
P13497	BMP1	Bone morphogenetic protein 1	GO:0008237; F:metallopeptidase activity; NAS:UniProtKB
P13497	BMP1	Bone morphogenetic protein 1	GO:0008233; F:peptidase activity; IDA:UniProtKB
P13497	BMP1	Bone morphogenetic protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
P13497	BMP1	Bone morphogenetic protein 1	GO:0001502; P:cartilage condensation; TAS:ProtInc
P13497	BMP1	Bone morphogenetic protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P13497	BMP1	Bone morphogenetic protein 1	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P13497	BMP1	Bone morphogenetic protein 1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P13497	BMP1	Bone morphogenetic protein 1	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
P13497	BMP1	Bone morphogenetic protein 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P13497	BMP1	Bone morphogenetic protein 1	GO:0001503; P:ossification; IEA:UniProtKB-KW
P13497	BMP1	Bone morphogenetic protein 1	GO:0061036; P:positive regulation of cartilage development; IDA:MGI
P13497	BMP1	Bone morphogenetic protein 1	GO:0006508; P:proteolysis; IDA:UniProtKB
P13497	BMP1	Bone morphogenetic protein 1	GO:0001501; P:skeletal system development; NAS:UniProtKB
P13497	BMP1	Bone morphogenetic protein 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NSY1	BMP2K	BMP-2-inducible protein kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NSY1	BMP2K	BMP-2-inducible protein kinase	GO:0019208; F:phosphatase regulator activity; IEA:Ensembl
Q9NSY1	BMP2K	BMP-2-inducible protein kinase	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q9NSY1	BMP2K	BMP-2-inducible protein kinase	GO:0030500; P:regulation of bone mineralization; IEA:Ensembl
P12643	BMP2	Bone morphogenetic protein 2	GO:0070700; F:BMP receptor binding; IDA:MGI
P12643	BMP2	Bone morphogenetic protein 2	GO:0019211; F:phosphatase activator activity; IDA:MGI
P12643	BMP2	Bone morphogenetic protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0046982; F:protein heterodimerization activity; IDA:MGI
P12643	BMP2	Bone morphogenetic protein 2	GO:0005102; F:receptor binding; TAS:ProtInc
P12643	BMP2	Bone morphogenetic protein 2	GO:0004745; F:retinol dehydrogenase activity; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0046332; F:SMAD binding; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0000187; P:activation of MAPK activity; IDA:AgBase
P12643	BMP2	Bone morphogenetic protein 2	GO:0003181; P:atrioventricular valve morphogenesis; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0003130; P:BMP signaling pathway involved in heart induction; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0030282; P:bone mineralization; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0035630; P:bone mineralization involved in bone maturation; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0001658; P:branching involved in ureteric bud morphogenesis; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0060317; P:cardiac epithelial to mesenchymal transition; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0055007; P:cardiac muscle cell differentiation; IMP:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0055008; P:cardiac muscle tissue morphogenesis; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0035051; P:cardiocyte differentiation; IMP:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0045165; P:cell fate commitment; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P12643	BMP2	Bone morphogenetic protein 2	GO:0071773; P:cellular response to BMP stimulus; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
P12643	BMP2	Bone morphogenetic protein 2	GO:0002062; P:chondrocyte differentiation; IDA:AgBase
P12643	BMP2	Bone morphogenetic protein 2	GO:0060128; P:corticotropin hormone secreting cell differentiation; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0009790; P:embryo development; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0035054; P:embryonic heart tube anterior/posterior pattern specification; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0003203; P:endocardial cushion morphogenesis; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0001837; P:epithelial to mesenchymal transition; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P12643	BMP2	Bone morphogenetic protein 2	GO:0040007; P:growth; IEA:InterPro
P12643	BMP2	Bone morphogenetic protein 2	GO:0007507; P:heart development; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0001701; P:in utero embryonic development; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0006954; P:inflammatory response; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0048839; P:inner ear development; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0048762; P:mesenchymal cell differentiation; IDA:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0072138; P:mesenchymal cell proliferation involved in ureteric bud development; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0060485; P:mesenchyme development; IMP:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0032348; P:negative regulation of aldosterone biosynthetic process; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0051042; P:negative regulation of calcium-independent cell-cell adhesion; IDA:AgBase
P12643	BMP2	Bone morphogenetic protein 2	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEP:AgBase
P12643	BMP2	Bone morphogenetic protein 2	GO:2000726; P:negative regulation of cardiac muscle cell differentiation; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0045786; P:negative regulation of cell cycle; IDA:HGNC
P12643	BMP2	Bone morphogenetic protein 2	GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:2000065; P:negative regulation of cortisol biosynthetic process; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0043569; P:negative regulation of insulin-like growth factor receptor signaling pathway; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0010894; P:negative regulation of steroid biosynthetic process; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0003308; P:negative regulation of Wnt signaling pathway involved in heart development; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0007219; P:Notch signaling pathway; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0042475; P:odontogenesis of dentin-containing tooth; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0009887; P:organ morphogenesis; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0001649; P:osteoblast differentiation; IDA:MGI
P12643	BMP2	Bone morphogenetic protein 2	GO:0055114; P:oxidation-reduction process; ISS:GOC
P12643	BMP2	Bone morphogenetic protein 2	GO:0060389; P:pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0060039; P:pericardium development; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0043065; P:positive regulation of apoptotic process; IDA:MGI
P12643	BMP2	Bone morphogenetic protein 2	GO:0048711; P:positive regulation of astrocyte differentiation; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0030501; P:positive regulation of bone mineralization; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0061036; P:positive regulation of cartilage development; IDA:MGI
P12643	BMP2	Bone morphogenetic protein 2	GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:DFLAT
P12643	BMP2	Bone morphogenetic protein 2	GO:0045600; P:positive regulation of fat cell differentiation; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0043410; P:positive regulation of MAPK cascade; IDA:DFLAT
P12643	BMP2	Bone morphogenetic protein 2	GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0042482; P:positive regulation of odontogenesis; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0045778; P:positive regulation of ossification; IDA:MGI
P12643	BMP2	Bone morphogenetic protein 2	GO:0045669; P:positive regulation of osteoblast differentiation; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0033690; P:positive regulation of osteoblast proliferation; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:1900745; P:positive regulation of p38MAPK cascade; IDA:DFLAT
P12643	BMP2	Bone morphogenetic protein 2	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0010922; P:positive regulation of phosphatase activity; IDA:MGI
P12643	BMP2	Bone morphogenetic protein 2	GO:0001934; P:positive regulation of protein phosphorylation; IDA:MGI
P12643	BMP2	Bone morphogenetic protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:1901522; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; IDA:BHF-UCL
P12643	BMP2	Bone morphogenetic protein 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0030177; P:positive regulation of Wnt signaling pathway; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0060804; P:positive regulation of Wnt signaling pathway by BMP signaling pathway; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0031648; P:protein destabilization; IEA:Ensembl
P12643	BMP2	Bone morphogenetic protein 2	GO:0006468; P:protein phosphorylation; IDA:DFLAT
P12643	BMP2	Bone morphogenetic protein 2	GO:0006029; P:proteoglycan metabolic process; IEA:Ensembl
P12643	BMP2	Bone morphogenetic protein 2	GO:0042487; P:regulation of odontogenesis of dentin-containing tooth; IEA:Ensembl
P12643	BMP2	Bone morphogenetic protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IDA:HGNC
P12643	BMP2	Bone morphogenetic protein 2	GO:0001666; P:response to hypoxia; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0001501; P:skeletal system development; TAS:ProtInc
P12643	BMP2	Bone morphogenetic protein 2	GO:0060395; P:SMAD protein signal transduction; IDA:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0021537; P:telencephalon development; IDA:MGI
P12643	BMP2	Bone morphogenetic protein 2	GO:0021978; P:telencephalon regionalization; ISS:UniProtKB
P12643	BMP2	Bone morphogenetic protein 2	GO:0060129; P:thyroid-stimulating hormone-secreting cell differentiation; ISS:UniProtKB
P55107	GDF10	Bone morphogenetic protein 3B	GO:0008083; F:growth factor activity; TAS:ProtInc
P55107	GDF10	Bone morphogenetic protein 3B	GO:0040007; P:growth; IEA:InterPro
P55107	GDF10	Bone morphogenetic protein 3B	GO:0001501; P:skeletal system development; TAS:ProtInc
P55107	GDF10	Bone morphogenetic protein 3B	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:ProtInc
P12645	BMP3	Bone morphogenetic protein 3	GO:0070700; F:BMP receptor binding; IPI:MGI
P12645	BMP3	Bone morphogenetic protein 3	GO:0005102; F:receptor binding; TAS:ProtInc
P12645	BMP3	Bone morphogenetic protein 3	GO:0051216; P:cartilage development; IEA:UniProtKB-KW
P12645	BMP3	Bone morphogenetic protein 3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P12645	BMP3	Bone morphogenetic protein 3	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P12645	BMP3	Bone morphogenetic protein 3	GO:0040007; P:growth; IEA:InterPro
P12645	BMP3	Bone morphogenetic protein 3	GO:0001503; P:ossification; IEA:UniProtKB-KW
P12645	BMP3	Bone morphogenetic protein 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P12645	BMP3	Bone morphogenetic protein 3	GO:0001501; P:skeletal system development; TAS:ProtInc
P12644	BMP4	Bone morphogenetic protein 4	GO:0070700; F:BMP receptor binding; IDA:MGI
P12644	BMP4	Bone morphogenetic protein 4	GO:0042056; F:chemoattractant activity; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0005125; F:cytokine activity; IDA:MGI
P12644	BMP4	Bone morphogenetic protein 4	GO:0008201; F:heparin binding; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0000186; P:activation of MAPKK activity; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0009948; P:anterior/posterior axis specification; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0002043; P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis; IDA:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:0003130; P:BMP signaling pathway involved in heart induction; IMP:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:0071893; P:BMP signaling pathway involved in nephric duct formation; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0061151; P:BMP signaling pathway involved in renal system segmentation; ISS:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0061149; P:BMP signaling pathway involved in ureter morphogenesis; ISS:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0060442; P:branching involved in prostate gland morphogenesis; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0001658; P:branching involved in ureteric bud morphogenesis; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0048754; P:branching morphogenesis of an epithelial tube; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0060433; P:bronchus development; IDA:MGI
P12644	BMP4	Bone morphogenetic protein 4	GO:0060503; P:bud dilation involved in lung branching; IDA:MGI
P12644	BMP4	Bone morphogenetic protein 4	GO:0060449; P:bud elongation involved in lung branching; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0003279; P:cardiac septum development; TAS:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0002062; P:chondrocyte differentiation; ISS:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0060197; P:cloacal septation; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0007182; P:common-partner SMAD protein phosphorylation; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0060363; P:cranial suture morphogenesis; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0035993; P:deltoid tuberosity development; ISS:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0060272; P:embryonic skeletal joint morphogenesis; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0003197; P:endocardial cushion development; TAS:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:0001958; P:endochondral ossification; ISS:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0060502; P:epithelial cell proliferation involved in lung morphogenesis; IDA:MGI
P12644	BMP4	Bone morphogenetic protein 4	GO:0060441; P:epithelial tube branching involved in lung morphogenesis; IDA:MGI
P12644	BMP4	Bone morphogenetic protein 4	GO:0060684; P:epithelial-mesenchymal cell signaling; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0030218; P:erythrocyte differentiation; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P12644	BMP4	Bone morphogenetic protein 4	GO:0007281; P:germ cell development; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0072104; P:glomerular capillary formation; ISS:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0072015; P:glomerular visceral epithelial cell development; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0002244; P:hematopoietic progenitor cell differentiation; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0060113; P:inner ear receptor cell differentiation; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0048392; P:intermediate mesodermal cell differentiation; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0001822; P:kidney development; IMP:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0060235; P:lens induction in camera-type eye; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0048286; P:lung alveolus development; IDA:MGI
P12644	BMP4	Bone morphogenetic protein 4	GO:0060425; P:lung morphogenesis; IDA:MGI
P12644	BMP4	Bone morphogenetic protein 4	GO:0002320; P:lymphoid progenitor cell differentiation; IMP:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:0030225; P:macrophage differentiation; IDA:DFLAT
P12644	BMP4	Bone morphogenetic protein 4	GO:0060592; P:mammary gland formation; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0072161; P:mesenchymal cell differentiation involved in kidney development; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0072198; P:mesenchymal cell proliferation involved in ureter development; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0072138; P:mesenchymal cell proliferation involved in ureteric bud development; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0003337; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0007500; P:mesodermal cell fate determination; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0001823; P:mesonephros development; IEP:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0072205; P:metanephric collecting duct development; ISS:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0030224; P:monocyte differentiation; IDA:DFLAT
P12644	BMP4	Bone morphogenetic protein 4	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0072097; P:negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0090191; P:negative regulation of branching involved in ureteric bud morphogenesis; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0045786; P:negative regulation of cell cycle; IDA:HGNC
P12644	BMP4	Bone morphogenetic protein 4	GO:0060548; P:negative regulation of cell death; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0008285; P:negative regulation of cell proliferation; IDA:MGI
P12644	BMP4	Bone morphogenetic protein 4	GO:2000137; P:negative regulation of cell proliferation involved in heart morphogenesis; IMP:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:0032331; P:negative regulation of chondrocyte differentiation; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0072125; P:negative regulation of glomerular mesangial cell proliferation; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0090194; P:negative regulation of glomerulus development; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0033088; P:negative regulation of immature T cell proliferation in thymus; IMP:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:0043407; P:negative regulation of MAP kinase activity; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0072200; P:negative regulation of mesenchymal cell proliferation involved in ureter development; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:2000007; P:negative regulation of metanephric comma-shaped body morphogenesis; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:2000005; P:negative regulation of metanephric S-shaped body morphogenesis; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0045839; P:negative regulation of mitosis; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0045662; P:negative regulation of myoblast differentiation; IDA:MGI
P12644	BMP4	Bone morphogenetic protein 4	GO:0042326; P:negative regulation of phosphorylation; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0060686; P:negative regulation of prostatic bud formation; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0045843; P:negative regulation of striated muscle tissue development; IDA:MGI
P12644	BMP4	Bone morphogenetic protein 4	GO:0033085; P:negative regulation of T cell differentiation in thymus; IMP:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:0070244; P:negative regulation of thymocyte apoptotic process; IMP:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:MGI
P12644	BMP4	Bone morphogenetic protein 4	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0001843; P:neural tube closure; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0048663; P:neuron fate commitment; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0042476; P:odontogenesis; IGI:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0001649; P:osteoblast differentiation; IDA:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:0021983; P:pituitary gland development; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0050918; P:positive chemotaxis; IDA:GOC
P12644	BMP4	Bone morphogenetic protein 4	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0030513; P:positive regulation of BMP signaling pathway; ISS:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0030501; P:positive regulation of bone mineralization; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0061047; P:positive regulation of branching involved in lung morphogenesis; ISS:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0055020; P:positive regulation of cardiac muscle fiber development; IMP:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:0061036; P:positive regulation of cartilage development; IDA:MGI
P12644	BMP4	Bone morphogenetic protein 4	GO:0010942; P:positive regulation of cell death; IDA:MGI
P12644	BMP4	Bone morphogenetic protein 4	GO:0032967; P:positive regulation of collagen biosynthetic process; IDA:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:2000105; P:positive regulation of DNA-dependent DNA replication; IDA:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:0045603; P:positive regulation of endothelial cell differentiation; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0010595; P:positive regulation of endothelial cell migration; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0045606; P:positive regulation of epidermal cell differentiation; IDA:UniProt
P12644	BMP4	Bone morphogenetic protein 4	GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0090184; P:positive regulation of kidney development; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0045778; P:positive regulation of ossification; IDA:MGI
P12644	BMP4	Bone morphogenetic protein 4	GO:0045669; P:positive regulation of osteoblast differentiation; IDA:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0032092; P:positive regulation of protein binding; IDA:MGI
P12644	BMP4	Bone morphogenetic protein 4	GO:0001934; P:positive regulation of protein phosphorylation; IDA:MGI
P12644	BMP4	Bone morphogenetic protein 4	GO:0060391; P:positive regulation of SMAD protein import into nucleus; IDA:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0009791; P:post-embryonic development; IDA:MGI
P12644	BMP4	Bone morphogenetic protein 4	GO:0034504; P:protein localization to nucleus; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0061155; P:pulmonary artery endothelial tube morphogenesis; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0060687; P:regulation of branching involved in prostate gland morphogenesis; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0010453; P:regulation of cell fate commitment; IDA:UniProt
P12644	BMP4	Bone morphogenetic protein 4	GO:0042487; P:regulation of odontogenesis of dentin-containing tooth; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0060393; P:regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:0051150; P:regulation of smooth muscle cell differentiation; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0072001; P:renal system development; IEP:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0003014; P:renal system process; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0003139; P:secondary heart field specification; IMP:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:0060395; P:SMAD protein signal transduction; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0048745; P:smooth muscle tissue development; ISS:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0007224; P:smoothened signaling pathway; IEP:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0010159; P:specification of organ position; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0072101; P:specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway; IDA:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0043401; P:steroid hormone mediated signaling pathway; IMP:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0021537; P:telencephalon development; IDA:MGI
P12644	BMP4	Bone morphogenetic protein 4	GO:0021978; P:telencephalon regionalization; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0035990; P:tendon cell differentiation; ISS:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0060438; P:trachea development; IDA:MGI
P12644	BMP4	Bone morphogenetic protein 4	GO:0060440; P:trachea formation; IEA:Ensembl
P12644	BMP4	Bone morphogenetic protein 4	GO:0003323; P:type B pancreatic cell development; IDA:BHF-UCL
P12644	BMP4	Bone morphogenetic protein 4	GO:0072192; P:ureter epithelial cell differentiation; ISS:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0072193; P:ureter smooth muscle cell differentiation; ISS:UniProtKB
P12644	BMP4	Bone morphogenetic protein 4	GO:0001657; P:ureteric bud development; IDA:MGI
P22003	BMP5	Bone morphogenetic protein 5	GO:0070700; F:BMP receptor binding; IPI:MGI
P22003	BMP5	Bone morphogenetic protein 5	GO:0051216; P:cartilage development; IEA:UniProtKB-KW
P22003	BMP5	Bone morphogenetic protein 5	GO:0040007; P:growth; IEA:InterPro
P22003	BMP5	Bone morphogenetic protein 5	GO:0030539; P:male genitalia development; IEA:Ensembl
P22003	BMP5	Bone morphogenetic protein 5	GO:0032348; P:negative regulation of aldosterone biosynthetic process; IDA:BHF-UCL
P22003	BMP5	Bone morphogenetic protein 5	GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL
P22003	BMP5	Bone morphogenetic protein 5	GO:2000065; P:negative regulation of cortisol biosynthetic process; IDA:BHF-UCL
P22003	BMP5	Bone morphogenetic protein 5	GO:0010719; P:negative regulation of epithelial to mesenchymal transition; NAS:BHF-UCL
P22003	BMP5	Bone morphogenetic protein 5	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; NAS:BHF-UCL
P22003	BMP5	Bone morphogenetic protein 5	GO:0043569; P:negative regulation of insulin-like growth factor receptor signaling pathway; IDA:BHF-UCL
P22003	BMP5	Bone morphogenetic protein 5	GO:0071676; P:negative regulation of mononuclear cell migration; NAS:BHF-UCL
P22003	BMP5	Bone morphogenetic protein 5	GO:0010894; P:negative regulation of steroid biosynthetic process; IDA:BHF-UCL
P22003	BMP5	Bone morphogenetic protein 5	GO:0001503; P:ossification; IEA:UniProtKB-KW
P22003	BMP5	Bone morphogenetic protein 5	GO:0007389; P:pattern specification process; IEA:Ensembl
P22003	BMP5	Bone morphogenetic protein 5	GO:1900006; P:positive regulation of dendrite development; IDA:BHF-UCL
P22003	BMP5	Bone morphogenetic protein 5	GO:2000105; P:positive regulation of DNA-dependent DNA replication; IDA:BHF-UCL
P22003	BMP5	Bone morphogenetic protein 5	GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:BHF-UCL
P22003	BMP5	Bone morphogenetic protein 5	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
P22003	BMP5	Bone morphogenetic protein 5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P22003	BMP5	Bone morphogenetic protein 5	GO:0001501; P:skeletal system development; NAS:UniProtKB
P22003	BMP5	Bone morphogenetic protein 5	GO:0003323; P:type B pancreatic cell development; IDA:BHF-UCL
P22004	BMP6	Bone morphogenetic protein 6	GO:0070700; F:BMP receptor binding; IPI:MGI
P22004	BMP6	Bone morphogenetic protein 6	GO:0046982; F:protein heterodimerization activity; IDA:MGI
P22004	BMP6	Bone morphogenetic protein 6	GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL
P22004	BMP6	Bone morphogenetic protein 6	GO:0051216; P:cartilage development; IEA:UniProtKB-KW
P22004	BMP6	Bone morphogenetic protein 6	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P22004	BMP6	Bone morphogenetic protein 6	GO:0001958; P:endochondral ossification; IEA:Ensembl
P22004	BMP6	Bone morphogenetic protein 6	GO:0001654; P:eye development; IEA:Ensembl
P22004	BMP6	Bone morphogenetic protein 6	GO:0040007; P:growth; IEA:InterPro
P22004	BMP6	Bone morphogenetic protein 6	GO:0006955; P:immune response; IMP:BHF-UCL
P22004	BMP6	Bone morphogenetic protein 6	GO:0006954; P:inflammatory response; IEA:Ensembl
P22004	BMP6	Bone morphogenetic protein 6	GO:0001822; P:kidney development; IEA:Ensembl
P22004	BMP6	Bone morphogenetic protein 6	GO:0030539; P:male genitalia development; IEA:Ensembl
P22004	BMP6	Bone morphogenetic protein 6	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
P22004	BMP6	Bone morphogenetic protein 6	GO:0032349; P:positive regulation of aldosterone biosynthetic process; IDA:UniProtKB
P22004	BMP6	Bone morphogenetic protein 6	GO:2000860; P:positive regulation of aldosterone secretion; IEA:Ensembl
P22004	BMP6	Bone morphogenetic protein 6	GO:0030501; P:positive regulation of bone mineralization; IDA:BHF-UCL
P22004	BMP6	Bone morphogenetic protein 6	GO:0032332; P:positive regulation of chondrocyte differentiation; IEA:Ensembl
P22004	BMP6	Bone morphogenetic protein 6	GO:2000105; P:positive regulation of DNA-dependent DNA replication; NAS:BHF-UCL
P22004	BMP6	Bone morphogenetic protein 6	GO:0045603; P:positive regulation of endothelial cell differentiation; IEA:Ensembl
P22004	BMP6	Bone morphogenetic protein 6	GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl
P22004	BMP6	Bone morphogenetic protein 6	GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:BHF-UCL
P22004	BMP6	Bone morphogenetic protein 6	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P22004	BMP6	Bone morphogenetic protein 6	GO:0045669; P:positive regulation of osteoblast differentiation; IDA:BHF-UCL
P22004	BMP6	Bone morphogenetic protein 6	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:UniProtKB
P22004	BMP6	Bone morphogenetic protein 6	GO:0050714; P:positive regulation of protein secretion; NAS:BHF-UCL
P22004	BMP6	Bone morphogenetic protein 6	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P22004	BMP6	Bone morphogenetic protein 6	GO:0014823; P:response to activity; IEA:Ensembl
P22004	BMP6	Bone morphogenetic protein 6	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P22004	BMP6	Bone morphogenetic protein 6	GO:0010039; P:response to iron ion; IEA:Ensembl
P22004	BMP6	Bone morphogenetic protein 6	GO:0032026; P:response to magnesium ion; IEA:Ensembl
P22004	BMP6	Bone morphogenetic protein 6	GO:0032526; P:response to retinoic acid; IEA:Ensembl
P22004	BMP6	Bone morphogenetic protein 6	GO:0001501; P:skeletal system development; TAS:ProtInc
P22004	BMP6	Bone morphogenetic protein 6	GO:0060395; P:SMAD protein signal transduction; IDA:UniProtKB
P22004	BMP6	Bone morphogenetic protein 6	GO:0003323; P:type B pancreatic cell development; IDA:BHF-UCL
P18075	BMP7	Bone morphogenetic protein 7	GO:0008201; F:heparin binding; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0005515; F:protein binding; IPI:BHF-UCL
P18075	BMP7	Bone morphogenetic protein 7	GO:0007411; P:axon guidance; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL
P18075	BMP7	Bone morphogenetic protein 7	GO:0060445; P:branching involved in salivary gland morphogenesis; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0051216; P:cartilage development; IEA:UniProtKB-KW
P18075	BMP7	Bone morphogenetic protein 7	GO:0071456; P:cellular response to hypoxia; ISS:BHF-UCL
P18075	BMP7	Bone morphogenetic protein 7	GO:0016358; P:dendrite development; TAS:BHF-UCL
P18075	BMP7	Bone morphogenetic protein 7	GO:0048596; P:embryonic camera-type eye morphogenesis; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0009880; P:embryonic pattern specification; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0060272; P:embryonic skeletal joint morphogenesis; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0030855; P:epithelial cell differentiation; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0001837; P:epithelial to mesenchymal transition; TAS:HGNC
P18075	BMP7	Bone morphogenetic protein 7	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P18075	BMP7	Bone morphogenetic protein 7	GO:0040007; P:growth; IEA:InterPro
P18075	BMP7	Bone morphogenetic protein 7	GO:0048762; P:mesenchymal cell differentiation; IDA:UniProtKB
P18075	BMP7	Bone morphogenetic protein 7	GO:0060485; P:mesenchyme development; ISS:UniProtKB
P18075	BMP7	Bone morphogenetic protein 7	GO:0001707; P:mesoderm formation; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0001823; P:mesonephros development; IEP:UniProtKB
P18075	BMP7	Bone morphogenetic protein 7	GO:0072136; P:metanephric mesenchymal cell proliferation involved in metanephros development; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0072133; P:metanephric mesenchyme morphogenesis; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0001656; P:metanephros development; IEP:UniProtKB
P18075	BMP7	Bone morphogenetic protein 7	GO:0070487; P:monocyte aggregation; IDA:UniProtKB
P18075	BMP7	Bone morphogenetic protein 7	GO:0045786; P:negative regulation of cell cycle; IDA:HGNC
P18075	BMP7	Bone morphogenetic protein 7	GO:0060548; P:negative regulation of cell death; IDA:UniProtKB
P18075	BMP7	Bone morphogenetic protein 7	GO:0072125; P:negative regulation of glomerular mesangial cell proliferation; IDA:UniProtKB
P18075	BMP7	Bone morphogenetic protein 7	GO:0043407; P:negative regulation of MAP kinase activity; IDA:UniProtKB
P18075	BMP7	Bone morphogenetic protein 7	GO:0072040; P:negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0045839; P:negative regulation of mitosis; IDA:UniProtKB
P18075	BMP7	Bone morphogenetic protein 7	GO:0050768; P:negative regulation of neurogenesis; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0045665; P:negative regulation of neuron differentiation; IDA:MGI
P18075	BMP7	Bone morphogenetic protein 7	GO:0042347; P:negative regulation of NF-kappaB import into nucleus; ISS:BHF-UCL
P18075	BMP7	Bone morphogenetic protein 7	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; ISS:BHF-UCL
P18075	BMP7	Bone morphogenetic protein 7	GO:0045746; P:negative regulation of Notch signaling pathway; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0042326; P:negative regulation of phosphorylation; IDA:UniProtKB
P18075	BMP7	Bone morphogenetic protein 7	GO:0060686; P:negative regulation of prostatic bud formation; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0010664; P:negative regulation of striated muscle cell apoptotic process; ISS:BHF-UCL
P18075	BMP7	Bone morphogenetic protein 7	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P18075	BMP7	Bone morphogenetic protein 7	GO:0072134; P:nephrogenic mesenchyme morphogenesis; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0048812; P:neuron projection morphogenesis; IDA:MGI
P18075	BMP7	Bone morphogenetic protein 7	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0001503; P:ossification; IEA:UniProtKB-KW
P18075	BMP7	Bone morphogenetic protein 7	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0030501; P:positive regulation of bone mineralization; IDA:BHF-UCL
P18075	BMP7	Bone morphogenetic protein 7	GO:1900006; P:positive regulation of dendrite development; IDA:BHF-UCL
P18075	BMP7	Bone morphogenetic protein 7	GO:0034116; P:positive regulation of heterotypic cell-cell adhesion; IDA:UniProtKB
P18075	BMP7	Bone morphogenetic protein 7	GO:1900106; P:positive regulation of hyaluranon cable assembly; IDA:UniProtKB
P18075	BMP7	Bone morphogenetic protein 7	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0045669; P:positive regulation of osteoblast differentiation; IDA:BHF-UCL
P18075	BMP7	Bone morphogenetic protein 7	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:UniProtKB
P18075	BMP7	Bone morphogenetic protein 7	GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IDA:BHF-UCL
P18075	BMP7	Bone morphogenetic protein 7	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P18075	BMP7	Bone morphogenetic protein 7	GO:0034504; P:protein localization to nucleus; IDA:UniProtKB
P18075	BMP7	Bone morphogenetic protein 7	GO:0060687; P:regulation of branching involved in prostate gland morphogenesis; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0060393; P:regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
P18075	BMP7	Bone morphogenetic protein 7	GO:2000121; P:regulation of removal of superoxide radicals; ISS:BHF-UCL
P18075	BMP7	Bone morphogenetic protein 7	GO:0032355; P:response to estradiol; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0033280; P:response to vitamin D; IEA:Ensembl
P18075	BMP7	Bone morphogenetic protein 7	GO:0001501; P:skeletal system development; TAS:ProtInc
P18075	BMP7	Bone morphogenetic protein 7	GO:0060395; P:SMAD protein signal transduction; IDA:UniProtKB
P18075	BMP7	Bone morphogenetic protein 7	GO:0043401; P:steroid hormone mediated signaling pathway; IMP:UniProtKB
P18075	BMP7	Bone morphogenetic protein 7	GO:0001657; P:ureteric bud development; ISS:UniProtKB
Q7Z5Y6	BMP8A	Bone morphogenetic protein 8A	GO:0051216; P:cartilage development; IEA:UniProtKB-KW
Q7Z5Y6	BMP8A	Bone morphogenetic protein 8A	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q7Z5Y6	BMP8A	Bone morphogenetic protein 8A	GO:0002024; P:diet induced thermogenesis; IDA:UniProtKB
Q7Z5Y6	BMP8A	Bone morphogenetic protein 8A	GO:0040007; P:growth; IEA:InterPro
Q7Z5Y6	BMP8A	Bone morphogenetic protein 8A	GO:0046676; P:negative regulation of insulin secretion; IDA:UniProtKB
Q7Z5Y6	BMP8A	Bone morphogenetic protein 8A	GO:0001503; P:ossification; IEA:UniProtKB-KW
Q7Z5Y6	BMP8A	Bone morphogenetic protein 8A	GO:2000505; P:regulation of energy homeostasis; IDA:UniProtKB
P34820	BMP8B	Bone morphogenetic protein 8B	GO:0051216; P:cartilage development; IEA:UniProtKB-KW
P34820	BMP8B	Bone morphogenetic protein 8B	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P34820	BMP8B	Bone morphogenetic protein 8B	GO:0040007; P:growth; IEA:InterPro
P34820	BMP8B	Bone morphogenetic protein 8B	GO:0001503; P:ossification; IEA:UniProtKB-KW
P34820	BMP8B	Bone morphogenetic protein 8B	GO:0001501; P:skeletal system development; TAS:ProtInc
Q8N8U9	BMPER	BMP-binding endothelial regulator protein	GO:0002043; P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis; IDA:BHF-UCL
Q8N8U9	BMPER	BMP-binding endothelial regulator protein	GO:0042118; P:endothelial cell activation; IDA:BHF-UCL
Q8N8U9	BMPER	BMP-binding endothelial regulator protein	GO:0048839; P:inner ear development; IEA:Ensembl
Q8N8U9	BMPER	BMP-binding endothelial regulator protein	GO:0030514; P:negative regulation of BMP signaling pathway; TAS:BHF-UCL
Q8N8U9	BMPER	BMP-binding endothelial regulator protein	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL
Q8N8U9	BMPER	BMP-binding endothelial regulator protein	GO:0010594; P:regulation of endothelial cell migration; IDA:BHF-UCL
Q8N8U9	BMPER	BMP-binding endothelial regulator protein	GO:0060393; P:regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
Q8N8U9	BMPER	BMP-binding endothelial regulator protein	GO:0001657; P:ureteric bud development; IEA:Ensembl
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0016362; F:activin receptor activity, type II; TAS:Reactome
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0005515; F:protein binding; IPI:IntAct
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0005024; F:transforming growth factor beta-activated receptor activity; IEA:InterPro
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0032924; P:activin receptor signaling pathway; TAS:GOC
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0009952; P:anterior/posterior pattern specification; ISS:BHF-UCL
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0060840; P:artery development; ISS:BHF-UCL
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0001974; P:blood vessel remodeling; ISS:BHF-UCL
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0007420; P:brain development; IEA:Ensembl
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0009267; P:cellular response to starvation; IEP:BHF-UCL
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0048286; P:lung alveolus development; ISS:BHF-UCL
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0001946; P:lymphangiogenesis; ISS:BHF-UCL
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0060836; P:lymphatic endothelial cell differentiation; ISS:BHF-UCL
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0001707; P:mesoderm formation; ISS:BHF-UCL
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:2000279; P:negative regulation of DNA biosynthetic process; IMP:BHF-UCL
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0003085; P:negative regulation of systemic arterial blood pressure; IMP:BHF-UCL
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0045906; P:negative regulation of vasoconstriction; ISS:BHF-UCL
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0030513; P:positive regulation of BMP signaling pathway; IMP:UniProtKB
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0030501; P:positive regulation of bone mineralization; IMP:BHF-UCL
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0010595; P:positive regulation of endothelial cell migration; IMP:UniProtKB
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:UniProtKB
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0010634; P:positive regulation of epithelial cell migration; IDA:UniProtKB
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0045669; P:positive regulation of osteoblast differentiation; IMP:BHF-UCL
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IMP:UniProtKB
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0001934; P:positive regulation of protein phosphorylation; IMP:MGI
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0042127; P:regulation of cell proliferation; IMP:HGNC
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0014916; P:regulation of lung blood pressure; IMP:BHF-UCL
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0061298; P:retina vasculature development in camera-type eye; ISS:BHF-UCL
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0006366; P:transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0007178; P:transmembrane receptor protein serine/threonine kinase signaling pathway; IDA:BHF-UCL
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; ISS:BHF-UCL
Q13873	BMPR2	Bone morphogenetic protein receptor type-2	GO:0060841; P:venous blood vessel development; ISS:BHF-UCL
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0005524; F:ATP binding; IDA:HGNC
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0005515; F:protein binding; IPI:UniProtKB
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0004674; F:protein serine/threonine kinase activity; IDA:HGNC
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0046332; F:SMAD binding; IDA:HGNC
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0005024; F:transforming growth factor beta-activated receptor activity; IEA:InterPro
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0004675; F:transmembrane receptor protein serine/threonine kinase activity; TAS:Reactome
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0051216; P:cartilage development; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0048589; P:developmental growth; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0009950; P:dorsal/ventral axis specification; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0007398; P:ectoderm development; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0048568; P:embryonic organ development; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0003272; P:endocardial cushion formation; ISS:BHF-UCL
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0060914; P:heart formation; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0035137; P:hindlimb morphogenesis; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0006955; P:immune response; IMP:BHF-UCL
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0048368; P:lateral mesoderm development; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0030324; P:lung development; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0048382; P:mesendoderm development; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0001707; P:mesoderm formation; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0001880; P:Mullerian duct regression; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0050768; P:negative regulation of neurogenesis; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0014032; P:neural crest cell development; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0021998; P:neural plate mediolateral regionalization; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0060021; P:palate development; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0048352; P:paraxial mesoderm structural organization; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0021983; P:pituitary gland development; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0030501; P:positive regulation of bone mineralization; IMP:BHF-UCL
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0045669; P:positive regulation of osteoblast differentiation; IMP:BHF-UCL
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0060391; P:positive regulation of SMAD protein import into nucleus; IDA:BHF-UCL
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0006468; P:protein phosphorylation; IDA:HGNC
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0048378; P:regulation of lateral mesodermal cell fate specification; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0001756; P:somitogenesis; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0019827; P:stem cell maintenance; IEA:Ensembl
P36894	BMPR1A	Bone morphogenetic protein receptor type-1A	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:ProtInc
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0005524; F:ATP binding; IDA:HGNC
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0005515; F:protein binding; IPI:UniProtKB
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0004674; F:protein serine/threonine kinase activity; IDA:HGNC
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IEA:InterPro
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0046332; F:SMAD binding; IDA:HGNC
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0005025; F:transforming growth factor beta receptor activity, type I; IEA:Ensembl
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0004675; F:transmembrane receptor protein serine/threonine kinase activity; IMP:UniProtKB
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0030509; P:BMP signaling pathway; NAS:UniProtKB
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0001502; P:cartilage condensation; NAS:UniProtKB
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0002062; P:chondrocyte differentiation; IEA:Ensembl
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0001654; P:eye development; ISS:UniProtKB
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0006954; P:inflammatory response; IEA:Ensembl
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0035108; P:limb morphogenesis; IMP:UniProtKB
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0001550; P:ovarian cumulus expansion; ISS:UniProtKB
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0042698; P:ovulation cycle; ISS:UniProtKB
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0030501; P:positive regulation of bone mineralization; IMP:BHF-UCL
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0045597; P:positive regulation of cell differentiation; IMP:UniProtKB
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0045669; P:positive regulation of osteoblast differentiation; IMP:BHF-UCL
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0006468; P:protein phosphorylation; IDA:HGNC
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0031290; P:retinal ganglion cell axon guidance; IEA:Ensembl
O00238	BMPR1B	Bone morphogenetic protein receptor type-1B	GO:0001501; P:skeletal system development; IMP:UniProtKB
Q14692	BMS1	Ribosome biogenesis protein BMS1 homolog	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q14692	BMS1	Ribosome biogenesis protein BMS1 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14692	BMS1	Ribosome biogenesis protein BMS1 homolog	GO:0042255; P:ribosome assembly; ISS:UniProtKB
Q1RMZ1	C7orf60	Probable methyltransferase BTM2 homolog	GO:0016433; F:rRNA (adenine) methyltransferase activity; IEA:InterPro
P51813	BMX	Cytoplasmic tyrosine-protein kinase BMX	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P51813	BMX	Cytoplasmic tyrosine-protein kinase BMX	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P51813	BMX	Cytoplasmic tyrosine-protein kinase BMX	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB
P51813	BMX	Cytoplasmic tyrosine-protein kinase BMX	GO:0005515; F:protein binding; IPI:UniProtKB
P51813	BMX	Cytoplasmic tyrosine-protein kinase BMX	GO:0004713; F:protein tyrosine kinase activity; TAS:ProtInc
P51813	BMX	Cytoplasmic tyrosine-protein kinase BMX	GO:0004871; F:signal transducer activity; TAS:ProtInc
P51813	BMX	Cytoplasmic tyrosine-protein kinase BMX	GO:0006915; P:apoptotic process; TAS:Reactome
P51813	BMX	Cytoplasmic tyrosine-protein kinase BMX	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P51813	BMX	Cytoplasmic tyrosine-protein kinase BMX	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
P51813	BMX	Cytoplasmic tyrosine-protein kinase BMX	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P51813	BMX	Cytoplasmic tyrosine-protein kinase BMX	GO:0007498; P:mesoderm development; TAS:ProtInc
P51813	BMX	Cytoplasmic tyrosine-protein kinase BMX	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:GOC
P51813	BMX	Cytoplasmic tyrosine-protein kinase BMX	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P51813	BMX	Cytoplasmic tyrosine-protein kinase BMX	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P51813	BMX	Cytoplasmic tyrosine-protein kinase BMX	GO:0006950; P:response to stress; IEA:UniProtKB-KW
P51813	BMX	Cytoplasmic tyrosine-protein kinase BMX	GO:0007165; P:signal transduction; IDA:UniProtKB
Q7Z5W3	BCDIN3D	Pre-miRNA 5'-monophosphate methyltransferase	GO:0008171; F:O-methyltransferase activity; IDA:UniProtKB
Q7Z5W3	BCDIN3D	Pre-miRNA 5'-monophosphate methyltransferase	GO:0008173; F:RNA methyltransferase activity; IDA:UniProtKB
Q7Z5W3	BCDIN3D	Pre-miRNA 5'-monophosphate methyltransferase	GO:0010586; P:miRNA metabolic process; IDA:UniProtKB
Q7Z5W3	BCDIN3D	Pre-miRNA 5'-monophosphate methyltransferase	GO:2000632; P:negative regulation of pre-miRNA processing; IDA:UniProtKB
Q7Z5W3	BCDIN3D	Pre-miRNA 5'-monophosphate methyltransferase	GO:0001510; P:RNA methylation; IDA:UniProtKB
Q01954	BNC1	Zinc finger protein basonuclin-1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q01954	BNC1	Zinc finger protein basonuclin-1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q01954	BNC1	Zinc finger protein basonuclin-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q01954	BNC1	Zinc finger protein basonuclin-1	GO:0051276; P:chromosome organization; IEA:Ensembl
Q01954	BNC1	Zinc finger protein basonuclin-1	GO:0008544; P:epidermis development; TAS:ProtInc
Q01954	BNC1	Zinc finger protein basonuclin-1	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q01954	BNC1	Zinc finger protein basonuclin-1	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
Q01954	BNC1	Zinc finger protein basonuclin-1	GO:0006356; P:regulation of transcription from RNA polymerase I promoter; IEA:Ensembl
Q01954	BNC1	Zinc finger protein basonuclin-1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q01954	BNC1	Zinc finger protein basonuclin-1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q01954	BNC1	Zinc finger protein basonuclin-1	GO:0042060; P:wound healing; IEA:Ensembl
Q6ZN30	BNC2	Zinc finger protein basonuclin-2	GO:0003677; F:DNA binding; IEA:Ensembl
Q6ZN30	BNC2	Zinc finger protein basonuclin-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZN30	BNC2	Zinc finger protein basonuclin-2	GO:0003416; P:endochondral bone growth; IEA:Ensembl
Q6ZN30	BNC2	Zinc finger protein basonuclin-2	GO:0060485; P:mesenchyme development; IEA:Ensembl
Q6ZN30	BNC2	Zinc finger protein basonuclin-2	GO:0060021; P:palate development; IEA:Ensembl
Q6ZN30	BNC2	Zinc finger protein basonuclin-2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZN30	BNC2	Zinc finger protein basonuclin-2	GO:0043586; P:tongue development; IEA:Ensembl
Q6ZN30	BNC2	Zinc finger protein basonuclin-2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60238	BNIP3L	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like	GO:0042802; F:identical protein binding; IPI:IntAct
O60238	BNIP3L	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like	GO:0005521; F:lamin binding; IDA:UniProtKB
O60238	BNIP3L	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like	GO:0005515; F:protein binding; IPI:UniProtKB
O60238	BNIP3L	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
O60238	BNIP3L	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O60238	BNIP3L	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like	GO:0051607; P:defense response to virus; IDA:UniProtKB
O60238	BNIP3L	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like	GO:0097345; P:mitochondrial outer membrane permeabilization; IBA:RefGenome
O60238	BNIP3L	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like	GO:0035694; P:mitochondrial protein catabolic process; IMP:UniProtKB
O60238	BNIP3L	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
O60238	BNIP3L	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
O60238	BNIP3L	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q12982	BNIP2	BCL2/adenovirus E1B 19 kDa protein-interacting protein 2	GO:0005509; F:calcium ion binding; TAS:UniProtKB
Q12982	BNIP2	BCL2/adenovirus E1B 19 kDa protein-interacting protein 2	GO:0005096; F:GTPase activator activity; TAS:ProtInc
Q12982	BNIP2	BCL2/adenovirus E1B 19 kDa protein-interacting protein 2	GO:0042802; F:identical protein binding; IBA:RefGenome
Q12982	BNIP2	BCL2/adenovirus E1B 19 kDa protein-interacting protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q12982	BNIP2	BCL2/adenovirus E1B 19 kDa protein-interacting protein 2	GO:0006915; P:apoptotic process; IPI:MGI
Q12982	BNIP2	BCL2/adenovirus E1B 19 kDa protein-interacting protein 2	GO:0042692; P:muscle cell differentiation; TAS:Reactome
Q12982	BNIP2	BCL2/adenovirus E1B 19 kDa protein-interacting protein 2	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
Q12982	BNIP2	BCL2/adenovirus E1B 19 kDa protein-interacting protein 2	GO:0043547; P:positive regulation of GTPase activity; TAS:GOC
Q12982	BNIP2	BCL2/adenovirus E1B 19 kDa protein-interacting protein 2	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0051020; F:GTPase binding; IPI:BHF-UCL
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0042802; F:identical protein binding; IPI:IntAct
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0006915; P:apoptotic process; IPI:MGI
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0048102; P:autophagic cell death; IEA:Ensembl
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0008219; P:cell death; ISS:UniProtKB
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0071279; P:cellular response to cobalt ion; IMP:BHF-UCL
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0071456; P:cellular response to hypoxia; IMP:BHF-UCL
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0051607; P:defense response to virus; IDA:UniProtKB
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0008626; P:granzyme-mediated apoptotic signaling pathway; IDA:UniProtKB
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:1990144; P:intrinsic apoptotic signaling pathway in response to hypoxia; IMP:BHF-UCL
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0043653; P:mitochondrial fragmentation involved in apoptotic process; IDA:BHF-UCL
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0097345; P:mitochondrial outer membrane permeabilization; IDA:UniProtKB
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0035694; P:mitochondrial protein catabolic process; IMP:UniProtKB
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0045837; P:negative regulation of membrane potential; IDA:UniProtKB
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0010637; P:negative regulation of mitochondrial fusion; IDA:BHF-UCL
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0051402; P:neuron apoptotic process; ISS:UniProtKB
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0010508; P:positive regulation of autophagy; TAS:UniProtKB
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0090141; P:positive regulation of mitochondrial fission; IDA:BHF-UCL
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0043068; P:positive regulation of programmed cell death; IDA:UniProtKB
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0043243; P:positive regulation of protein complex disassembly; IDA:BHF-UCL
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IDA:BHF-UCL
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0072593; P:reactive oxygen species metabolic process; IDA:UniProtKB
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0046902; P:regulation of mitochondrial membrane permeability; IDA:UniProtKB
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0055093; P:response to hyperoxia; IEA:Ensembl
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0001666; P:response to hypoxia; ISS:UniProtKB
Q12983	BNIP3	BCL2/adenovirus E1B 19 kDa protein-interacting protein 3	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q7Z465	BNIPL	Bcl-2/adenovirus E1B 19 kDa-interacting protein 2-like protein	GO:0042802; F:identical protein binding; IPI:UniProtKB
Q7Z465	BNIPL	Bcl-2/adenovirus E1B 19 kDa-interacting protein 2-like protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z465	BNIPL	Bcl-2/adenovirus E1B 19 kDa-interacting protein 2-like protein	GO:0006915; P:apoptotic process; IDA:MGI
Q7Z465	BNIPL	Bcl-2/adenovirus E1B 19 kDa-interacting protein 2-like protein	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q7Z465	BNIPL	Bcl-2/adenovirus E1B 19 kDa-interacting protein 2-like protein	GO:0040009; P:regulation of growth rate; IDA:UniProtKB
Q9BWV1	BOC	Brother of CDO	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BWV1	BOC	Brother of CDO	GO:0007411; P:axon guidance; IEA:Ensembl
Q9BWV1	BOC	Brother of CDO	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9BWV1	BOC	Brother of CDO	GO:0042692; P:muscle cell differentiation; TAS:Reactome
Q9BWV1	BOC	Brother of CDO	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
Q9BWV1	BOC	Brother of CDO	GO:0045663; P:positive regulation of myoblast differentiation; ISS:HGNC
Q9BWV1	BOC	Brother of CDO	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
Q96IK1	BOD1	Biorientation of chromosomes in cell division protein 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
O75936	BBOX1	Gamma-butyrobetaine dioxygenase	GO:0008336; F:gamma-butyrobetaine dioxygenase activity; IDA:UniProtKB
O75936	BBOX1	Gamma-butyrobetaine dioxygenase	GO:0005506; F:iron ion binding; IEA:InterPro
O75936	BBOX1	Gamma-butyrobetaine dioxygenase	GO:0008270; F:zinc ion binding; IDA:UniProtKB
O75936	BBOX1	Gamma-butyrobetaine dioxygenase	GO:0045329; P:carnitine biosynthetic process; IDA:UniProtKB
O75936	BBOX1	Gamma-butyrobetaine dioxygenase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
O75936	BBOX1	Gamma-butyrobetaine dioxygenase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UMX3	BOK	Bcl-2-related ovarian killer protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UMX3	BOK	Bcl-2-related ovarian killer protein	GO:0046982; F:protein heterodimerization activity; IBA:RefGenome
Q9UMX3	BOK	Bcl-2-related ovarian killer protein	GO:0042803; F:protein homodimerization activity; IBA:RefGenome
Q9UMX3	BOK	Bcl-2-related ovarian killer protein	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
Q9UMX3	BOK	Bcl-2-related ovarian killer protein	GO:0006915; P:apoptotic process; IDA:UniProtKB
Q9UMX3	BOK	Bcl-2-related ovarian killer protein	GO:0007420; P:brain development; IEA:Ensembl
Q9UMX3	BOK	Bcl-2-related ovarian killer protein	GO:0008283; P:cell proliferation; IEP:UniProtKB
Q9UMX3	BOK	Bcl-2-related ovarian killer protein	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IBA:RefGenome
Q9UMX3	BOK	Bcl-2-related ovarian killer protein	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IMP:UniProtKB
Q9UMX3	BOK	Bcl-2-related ovarian killer protein	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IBA:RefGenome
Q9UMX3	BOK	Bcl-2-related ovarian killer protein	GO:0008584; P:male gonad development; IEA:Ensembl
Q9UMX3	BOK	Bcl-2-related ovarian killer protein	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
Q9UMX3	BOK	Bcl-2-related ovarian killer protein	GO:0048709; P:oligodendrocyte differentiation; IEA:Ensembl
Q9UMX3	BOK	Bcl-2-related ovarian killer protein	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q9UMX3	BOK	Bcl-2-related ovarian killer protein	GO:1900119; P:positive regulation of execution phase of apoptosis; IMP:UniProtKB
Q8N9W6	BOLL	Protein boule-like	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8N9W6	BOLL	Protein boule-like	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N9W6	BOLL	Protein boule-like	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q8N9W6	BOLL	Protein boule-like	GO:0008494; F:translation activator activity; IDA:UniProtKB
Q8N9W6	BOLL	Protein boule-like	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8N9W6	BOLL	Protein boule-like	GO:0007126; P:meiotic nuclear division; IDA:MGI
Q8N9W6	BOLL	Protein boule-like	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8N9W6	BOLL	Protein boule-like	GO:0045948; P:positive regulation of translational initiation; IDA:UniProtKB
Q8N9W6	BOLL	Protein boule-like	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q14137	BOP1	Ribosome biogenesis protein BOP1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14137	BOP1	Ribosome biogenesis protein BOP1	GO:0005515; F:protein binding; IPI:UniProtKB
Q14137	BOP1	Ribosome biogenesis protein BOP1	GO:0043021; F:ribonucleoprotein complex binding; IEA:UniProtKB-HAMAP
Q14137	BOP1	Ribosome biogenesis protein BOP1	GO:0008283; P:cell proliferation; NAS:UniProtKB
Q14137	BOP1	Ribosome biogenesis protein BOP1	GO:0000466; P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IEA:UniProtKB-HAMAP
Q14137	BOP1	Ribosome biogenesis protein BOP1	GO:0000463; P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IMP:UniProtKB
Q14137	BOP1	Ribosome biogenesis protein BOP1	GO:0051726; P:regulation of cell cycle; IMP:UniProtKB
Q14137	BOP1	Ribosome biogenesis protein BOP1	GO:0042254; P:ribosome biogenesis; NAS:UniProtKB
Q7L3V2	BOP	Protein Bop	GO:0005515; F:protein binding; IPI:UniProtKB
Q7L3V2	BOP	Protein Bop	GO:0097345; P:mitochondrial outer membrane permeabilization; IMP:UniProtKB
Q7L3V2	BOP	Protein Bop	GO:0051881; P:regulation of mitochondrial membrane potential; IMP:UniProtKB
Q6PGQ7	BORA	Protein aurora borealis	GO:0005515; F:protein binding; IPI:UniProtKB
Q6PGQ7	BORA	Protein aurora borealis	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q6PGQ7	BORA	Protein aurora borealis	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q6PGQ7	BORA	Protein aurora borealis	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q6PGQ7	BORA	Protein aurora borealis	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q6PGQ7	BORA	Protein aurora borealis	GO:0007088; P:regulation of mitosis; IMP:UniProtKB
Q6PGQ7	BORA	Protein aurora borealis	GO:0060236; P:regulation of mitotic spindle organization; IMP:UniProtKB
Q6PGQ7	BORA	Protein aurora borealis	GO:0032880; P:regulation of protein localization; IMP:UniProtKB
Q53HL2	CDCA8	Borealin	GO:0005515; F:protein binding; IPI:UniProtKB
Q53HL2	CDCA8	Borealin	GO:0051276; P:chromosome organization; IMP:UniProtKB
Q53HL2	CDCA8	Borealin	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q53HL2	CDCA8	Borealin	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q53HL2	CDCA8	Borealin	GO:0000089; P:mitotic metaphase; IMP:UniProtKB
O14613	CDC42EP2	Cdc42 effector protein 2	GO:0017049; F:GTP-Rho binding; IPI:UniProtKB
O14613	CDC42EP2	Cdc42 effector protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
O14613	CDC42EP2	Cdc42 effector protein 2	GO:0005100; F:Rho GTPase activator activity; IMP:UniProtKB
O14613	CDC42EP2	Cdc42 effector protein 2	GO:0030036; P:actin cytoskeleton organization; IDA:UniProtKB
O14613	CDC42EP2	Cdc42 effector protein 2	GO:0007015; P:actin filament organization; NAS:UniProtKB
O14613	CDC42EP2	Cdc42 effector protein 2	GO:0030838; P:positive regulation of actin filament polymerization; IDA:UniProtKB
O14613	CDC42EP2	Cdc42 effector protein 2	GO:0031334; P:positive regulation of protein complex assembly; TAS:UniProtKB
O14613	CDC42EP2	Cdc42 effector protein 2	GO:0031274; P:positive regulation of pseudopodium assembly; IDA:UniProtKB
O14613	CDC42EP2	Cdc42 effector protein 2	GO:0032321; P:positive regulation of Rho GTPase activity; IMP:GOC
O14613	CDC42EP2	Cdc42 effector protein 2	GO:0008360; P:regulation of cell shape; IDA:UniProtKB
Q9UKI2	CDC42EP3	Cdc42 effector protein 3	GO:0005519; F:cytoskeletal regulatory protein binding; TAS:ProtInc
Q9UKI2	CDC42EP3	Cdc42 effector protein 3	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
Q9UKI2	CDC42EP3	Cdc42 effector protein 3	GO:0007165; P:signal transduction; TAS:ProtInc
Q9H3Q1	CDC42EP4	Cdc42 effector protein 4	GO:0017049; F:GTP-Rho binding; NAS:UniProtKB
Q9H3Q1	CDC42EP4	Cdc42 effector protein 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H3Q1	CDC42EP4	Cdc42 effector protein 4	GO:0031274; P:positive regulation of pseudopodium assembly; IDA:UniProtKB
Q9H3Q1	CDC42EP4	Cdc42 effector protein 4	GO:0008360; P:regulation of cell shape; IDA:UniProtKB
Q9H3Q1	CDC42EP4	Cdc42 effector protein 4	GO:0007266; P:Rho protein signal transduction; IEA:Ensembl
Q6NZY7	CDC42EP5	Cdc42 effector protein 5	GO:0017049; F:GTP-Rho binding; IPI:UniProtKB
Q6NZY7	CDC42EP5	Cdc42 effector protein 5	GO:0007254; P:JNK cascade; IEA:Ensembl
Q6NZY7	CDC42EP5	Cdc42 effector protein 5	GO:0030838; P:positive regulation of actin filament polymerization; IDA:UniProtKB
Q6NZY7	CDC42EP5	Cdc42 effector protein 5	GO:0031274; P:positive regulation of pseudopodium assembly; IDA:UniProtKB
Q6NZY7	CDC42EP5	Cdc42 effector protein 5	GO:0008360; P:regulation of cell shape; IDA:UniProtKB
Q6NZY7	CDC42EP5	Cdc42 effector protein 5	GO:0007266; P:Rho protein signal transduction; IEA:Ensembl
Q00587	CDC42EP1	Cdc42 effector protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q00587	CDC42EP1	Cdc42 effector protein 1	GO:0031274; P:positive regulation of pseudopodium assembly; IDA:UniProtKB
Q00587	CDC42EP1	Cdc42 effector protein 1	GO:0008360; P:regulation of cell shape; IDA:UniProtKB
Q00587	CDC42EP1	Cdc42 effector protein 1	GO:0007266; P:Rho protein signal transduction; IEA:Ensembl
Q86WA6	BPHL	Valacyclovir hydrolase	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q86WA6	BPHL	Valacyclovir hydrolase	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
Q86WA6	BPHL	Valacyclovir hydrolase	GO:0009636; P:response to toxic substance; TAS:ProtInc
Q96DR5	BPIFA2	BPI fold-containing family A member 2	GO:0001530; F:lipopolysaccharide binding; IDA:UniProt
Q9BQP9	BPIFA3	BPI fold-containing family A member 3	GO:0008289; F:lipid binding; IEA:InterPro
Q9NP55	BPIFA1	BPI fold-containing family A member 1	GO:0008289; F:lipid binding; IEA:InterPro
Q9NP55	BPIFA1	BPI fold-containing family A member 1	GO:0019731; P:antibacterial humoral response; IDA:UniProtKB
Q9NP55	BPIFA1	BPI fold-containing family A member 1	GO:0045087; P:innate immune response; IDA:UniProtKB
Q9NP55	BPIFA1	BPI fold-containing family A member 1	GO:0050891; P:multicellular organismal water homeostasis; IDA:UniProtKB
Q9NP55	BPIFA1	BPI fold-containing family A member 1	GO:1900229; P:negative regulation of single-species biofilm formation in or on host organism; IMP:UniProtKB
Q9NP55	BPIFA1	BPI fold-containing family A member 1	GO:0050828; P:regulation of liquid surface tension; IDA:UniProtKB
Q9NP55	BPIFA1	BPI fold-containing family A member 1	GO:1902305; P:regulation of sodium ion transmembrane transport; IDA:UniProtKB
Q8TDL5	BPIFB1	BPI fold-containing family B member 1	GO:0008289; F:lipid binding; IEA:InterPro
Q8TDL5	BPIFB1	BPI fold-containing family B member 1	GO:0002227; P:innate immune response in mucosa; IDA:UniProt
Q8TDL5	BPIFB1	BPI fold-containing family B member 1	GO:0034144; P:negative regulation of toll-like receptor 4 signaling pathway; IDA:UniProt
Q8N4F0	BPIFB2	BPI fold-containing family B member 2	GO:0008289; F:lipid binding; IEA:InterPro
P59826	BPIFB3	BPI fold-containing family B member 3	GO:0008289; F:lipid binding; IEA:InterPro
P59826	BPIFB3	BPI fold-containing family B member 3	GO:0045087; P:innate immune response; NAS:UniProtKB
P59827	BPIFB4	BPI fold-containing family B member 4	GO:0008289; F:lipid binding; IEA:InterPro
Q8NFQ5	BPIFB6	BPI fold-containing family B member 6	GO:0008289; F:lipid binding; IEA:InterPro
Q8NFQ6	BPIFC	BPI fold-containing family C protein	GO:0001530; F:lipopolysaccharide binding; NAS:UniProtKB
Q8NFQ6	BPIFC	BPI fold-containing family C protein	GO:0005543; F:phospholipid binding; NAS:UniProtKB
P17213	BPI	Bactericidal permeability-increasing protein	GO:0001530; F:lipopolysaccharide binding; IDA:BHF-UCL
P17213	BPI	Bactericidal permeability-increasing protein	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
P17213	BPI	Bactericidal permeability-increasing protein	GO:0006955; P:immune response; IEA:Ensembl
P17213	BPI	Bactericidal permeability-increasing protein	GO:0032715; P:negative regulation of interleukin-6 production; IDA:BHF-UCL
P17213	BPI	Bactericidal permeability-increasing protein	GO:0032717; P:negative regulation of interleukin-8 production; IDA:BHF-UCL
P17213	BPI	Bactericidal permeability-increasing protein	GO:0043031; P:negative regulation of macrophage activation; IDA:BHF-UCL
P17213	BPI	Bactericidal permeability-increasing protein	GO:0032720; P:negative regulation of tumor necrosis factor production; IDA:BHF-UCL
P50747	HLCS	Biotin--protein ligase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P50747	HLCS	Biotin--protein ligase	GO:0009374; F:biotin binding; IDA:UniProtKB
P50747	HLCS	Biotin--protein ligase	GO:0004077; F:biotin-[acetyl-CoA-carboxylase] ligase activity; IEA:UniProtKB-EC
P50747	HLCS	Biotin--protein ligase	GO:0004078; F:biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity; IEA:UniProtKB-EC
P50747	HLCS	Biotin--protein ligase	GO:0004079; F:biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity; IEA:UniProtKB-EC
P50747	HLCS	Biotin--protein ligase	GO:0004080; F:biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity; IDA:UniProtKB
P50747	HLCS	Biotin--protein ligase	GO:0018271; F:biotin-protein ligase activity; IDA:UniProtKB
P50747	HLCS	Biotin--protein ligase	GO:0019899; F:enzyme binding; IPI:UniProtKB
P50747	HLCS	Biotin--protein ligase	GO:0005515; F:protein binding; IPI:IntAct
P50747	HLCS	Biotin--protein ligase	GO:0006768; P:biotin metabolic process; TAS:Reactome
P50747	HLCS	Biotin--protein ligase	GO:0008283; P:cell proliferation; IMP:UniProtKB
P50747	HLCS	Biotin--protein ligase	GO:0071110; P:histone biotinylation; IDA:UniProtKB
P50747	HLCS	Biotin--protein ligase	GO:0016570; P:histone modification; IDA:UniProtKB
P50747	HLCS	Biotin--protein ligase	GO:0009305; P:protein biotinylation; IDA:UniProtKB
P50747	HLCS	Biotin--protein ligase	GO:0070781; P:response to biotin; IDA:UniProtKB
P50747	HLCS	Biotin--protein ligase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P50747	HLCS	Biotin--protein ligase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P50747	HLCS	Biotin--protein ligase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
O95861	BPNT1	3'(2'),5'-bisphosphate nucleotidase 1	GO:0008441; F:3'(2'),5'-bisphosphate nucleotidase activity; IEA:Ensembl
O95861	BPNT1	3'(2'),5'-bisphosphate nucleotidase 1	GO:0004441; F:inositol-1,4-bisphosphate 1-phosphatase activity; IEA:Ensembl
O95861	BPNT1	3'(2'),5'-bisphosphate nucleotidase 1	GO:0000287; F:magnesium ion binding; IEA:Ensembl
O95861	BPNT1	3'(2'),5'-bisphosphate nucleotidase 1	GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; TAS:Reactome
O95861	BPNT1	3'(2'),5'-bisphosphate nucleotidase 1	GO:0016311; P:dephosphorylation; TAS:GOC
O95861	BPNT1	3'(2'),5'-bisphosphate nucleotidase 1	GO:0007399; P:nervous system development; TAS:ProtInc
O95861	BPNT1	3'(2'),5'-bisphosphate nucleotidase 1	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
O95861	BPNT1	3'(2'),5'-bisphosphate nucleotidase 1	GO:0046854; P:phosphatidylinositol phosphorylation; IEA:InterPro
O95861	BPNT1	3'(2'),5'-bisphosphate nucleotidase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95861	BPNT1	3'(2'),5'-bisphosphate nucleotidase 1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q12830	BPTF	Nucleosome-remodeling factor subunit BPTF	GO:0005515; F:protein binding; IPI:IntAct
Q12830	BPTF	Nucleosome-remodeling factor subunit BPTF	GO:0043565; F:sequence-specific DNA binding; IDA:HGNC
Q12830	BPTF	Nucleosome-remodeling factor subunit BPTF	GO:0008134; F:transcription factor binding; IDA:MGI
Q12830	BPTF	Nucleosome-remodeling factor subunit BPTF	GO:0008270; F:zinc ion binding; IEA:InterPro
Q12830	BPTF	Nucleosome-remodeling factor subunit BPTF	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q12830	BPTF	Nucleosome-remodeling factor subunit BPTF	GO:0006200; P:ATP catabolic process; IDA:GOC
Q12830	BPTF	Nucleosome-remodeling factor subunit BPTF	GO:0007420; P:brain development; IMP:HGNC
Q12830	BPTF	Nucleosome-remodeling factor subunit BPTF	GO:0006338; P:chromatin remodeling; IDA:HGNC
Q12830	BPTF	Nucleosome-remodeling factor subunit BPTF	GO:0001892; P:embryonic placenta development; IEA:Ensembl
Q12830	BPTF	Nucleosome-remodeling factor subunit BPTF	GO:0007492; P:endoderm development; IEA:Ensembl
Q12830	BPTF	Nucleosome-remodeling factor subunit BPTF	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q12830	BPTF	Nucleosome-remodeling factor subunit BPTF	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:HGNC
Q12830	BPTF	Nucleosome-remodeling factor subunit BPTF	GO:0006355; P:regulation of transcription, DNA-templated; IMP:HGNC
Q12830	BPTF	Nucleosome-remodeling factor subunit BPTF	GO:0006351; P:transcription, DNA-templated; IMP:HGNC
O15178	T	Brachyury protein	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
O15178	T	Brachyury protein	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; ISS:BHF-UCL
O15178	T	Brachyury protein	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IDA:BHF-UCL
O15178	T	Brachyury protein	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
O15178	T	Brachyury protein	GO:0001085; F:RNA polymerase II transcription factor binding; ISS:BHF-UCL
O15178	T	Brachyury protein	GO:0001191; F:RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription; ISS:BHF-UCL
O15178	T	Brachyury protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
O15178	T	Brachyury protein	GO:0008595; P:anterior/posterior axis specification, embryo; TAS:ProtInc
O15178	T	Brachyury protein	GO:0030509; P:BMP signaling pathway; IEA:Ensembl
O15178	T	Brachyury protein	GO:0060349; P:bone morphogenesis; IEA:Ensembl
O15178	T	Brachyury protein	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
O15178	T	Brachyury protein	GO:0061371; P:determination of heart left/right asymmetry; IEA:Ensembl
O15178	T	Brachyury protein	GO:0048706; P:embryonic skeletal system development; IEA:Ensembl
O15178	T	Brachyury protein	GO:0003007; P:heart morphogenesis; IDA:BHF-UCL
O15178	T	Brachyury protein	GO:0007498; P:mesoderm development; TAS:ProtInc
O15178	T	Brachyury protein	GO:0007509; P:mesoderm migration involved in gastrulation; IEA:Ensembl
O15178	T	Brachyury protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
O15178	T	Brachyury protein	GO:0001839; P:neural plate morphogenesis; IEA:Ensembl
O15178	T	Brachyury protein	GO:0001843; P:neural tube closure; IEA:Ensembl
O15178	T	Brachyury protein	GO:0014028; P:notochord formation; IEA:Ensembl
O15178	T	Brachyury protein	GO:0007341; P:penetration of zona pellucida; IEA:Ensembl
O15178	T	Brachyury protein	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
O15178	T	Brachyury protein	GO:0003257; P:positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; IDA:BHF-UCL
O15178	T	Brachyury protein	GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl
O15178	T	Brachyury protein	GO:0090009; P:primitive streak formation; NAS:BHF-UCL
O15178	T	Brachyury protein	GO:0007165; P:signal transduction; NAS:ProtInc
O15178	T	Brachyury protein	GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl
O15178	T	Brachyury protein	GO:0060395; P:SMAD protein signal transduction; IEA:Ensembl
O15178	T	Brachyury protein	GO:0001756; P:somitogenesis; IEA:Ensembl
O15178	T	Brachyury protein	GO:0001570; P:vasculogenesis; IEA:Ensembl
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0005509; F:calcium ion binding; IDA:BHF-UCL
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0042802; F:identical protein binding; IPI:IntAct
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0004709; F:MAP kinase kinase kinase activity; IEA:Ensembl
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0005515; F:protein binding; IPI:IntAct
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0004672; F:protein kinase activity; IDA:BHF-UCL
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0000186; P:activation of MAPKK activity; TAS:Reactome
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0071277; P:cellular response to calcium ion; IDA:BHF-UCL
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:UniProtKB
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0006468; P:protein phosphorylation; IDA:BHF-UCL
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0051591; P:response to cAMP; IEA:Ensembl
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0070849; P:response to epidermal growth factor; IDA:BHF-UCL
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P15056	BRAF	Serine/threonine-protein kinase B-raf	GO:0007268; P:synaptic transmission; TAS:Reactome
Q7Z569	BRAP	BRCA1-associated protein	GO:0008139; F:nuclear localization sequence binding; IDA:MGI
Q7Z569	BRAP	BRCA1-associated protein	GO:0000166; F:nucleotide binding; IEA:InterPro
Q7Z569	BRAP	BRCA1-associated protein	GO:0005515; F:protein binding; IPI:IntAct
Q7Z569	BRAP	BRCA1-associated protein	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q7Z569	BRAP	BRCA1-associated protein	GO:0008270; F:zinc ion binding; IEA:InterPro
Q7Z569	BRAP	BRCA1-associated protein	GO:0000165; P:MAPK cascade; IDA:MGI
Q7Z569	BRAP	BRCA1-associated protein	GO:0009968; P:negative regulation of signal transduction; IDA:UniProtKB
Q7Z569	BRAP	BRCA1-associated protein	GO:0016567; P:protein ubiquitination; IDA:FlyBase
Q7Z569	BRAP	BRCA1-associated protein	GO:0007265; P:Ras protein signal transduction; IDA:MGI
Q6PJG6	BRAT1	BRCA1-associated ATM activator 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q6PJG6	BRAT1	BRCA1-associated ATM activator 1	GO:0010212; P:response to ionizing radiation; IMP:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0050681; F:androgen receptor binding; NAS:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0003677; F:DNA binding; TAS:ProtInc
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0019899; F:enzyme binding; IPI:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0005515; F:protein binding; IPI:IntAct
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0003723; F:RNA binding; IDA:MGI
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0003713; F:transcription coactivator activity; NAS:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0015631; F:tubulin binding; NAS:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0008270; F:zinc ion binding; TAS:ProtInc
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0006915; P:apoptotic process; TAS:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0006974; P:cellular response to DNA damage stimulus; TAS:ProtInc
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0071681; P:cellular response to indole-3-methanol; IDA:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0007059; P:chromosome segregation; IMP:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; TAS:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0006281; P:DNA repair; TAS:Reactome
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0006302; P:double-strand break repair; IMP:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0000724; P:double-strand break repair via homologous recombination; IDA:HGNC
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0031572; P:G2 DNA damage checkpoint; IMP:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IDA:MGI
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0046600; P:negative regulation of centriole replication; NAS:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0045717; P:negative regulation of fatty acid biosynthetic process; IMP:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0051573; P:negative regulation of histone H3-K9 methylation; IDA:BHF-UCL
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0071158; P:positive regulation of cell cycle arrest; IDA:BHF-UCL
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0045739; P:positive regulation of DNA repair; IMP:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0035066; P:positive regulation of histone acetylation; IDA:BHF-UCL
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0051571; P:positive regulation of histone H3-K4 methylation; IDA:BHF-UCL
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:2000617; P:positive regulation of histone H3-K9 acetylation; IDA:BHF-UCL
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:2000620; P:positive regulation of histone H4-K16 acetylation; IDA:BHF-UCL
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0070512; P:positive regulation of histone H4-K20 methylation; IDA:BHF-UCL
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0006301; P:postreplication repair; IDA:HGNC
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0085020; P:protein K6-linked ubiquitination; IDA:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0016567; P:protein ubiquitination; IDA:HGNC
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:2000145; P:regulation of cell motility; IDA:BHF-UCL
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0042127; P:regulation of cell proliferation; TAS:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0006359; P:regulation of transcription from RNA polymerase III promoter; TAS:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0043627; P:response to estrogen; IDA:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0010212; P:response to ionizing radiation; IMP:UniProtKB
P38398	BRCA1	Breast cancer type 1 susceptibility protein	GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:BHF-UCL
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0043015; F:gamma-tubulin binding; IPI:UniProtKB
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0010484; F:H3 histone acetyltransferase activity; IDA:UniProtKB
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0010485; F:H4 histone acetyltransferase activity; IDA:UniProtKB
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0002020; F:protease binding; IPI:UniProtKB
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0005515; F:protein binding; IPI:UniProtKB
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0007420; P:brain development; IEA:Ensembl
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0007569; P:cell aging; IEA:Ensembl
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0051298; P:centrosome duplication; IMP:UniProtKB
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0000910; P:cytokinesis; IDA:UniProtKB
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IEA:Ensembl
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0006281; P:DNA repair; TAS:Reactome
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0006302; P:double-strand break repair; IMP:UniProtKB
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0000724; P:double-strand break repair via homologous recombination; IDA:UniProtKB
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0008585; P:female gonad development; IEA:Ensembl
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0030097; P:hemopoiesis; IEA:Ensembl
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0043967; P:histone H4 acetylation; IDA:UniProtKB
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0001833; P:inner cell mass cell proliferation; IEA:Ensembl
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IEA:Ensembl
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0007141; P:male meiosis I; IEA:Ensembl
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0033600; P:negative regulation of mammary gland epithelial cell proliferation; IDA:UniProtKB
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0006289; P:nucleotide-excision repair; IMP:UniProtKB
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0001556; P:oocyte maturation; IEA:Ensembl
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0045931; P:positive regulation of mitotic cell cycle; IEA:Ensembl
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0032465; P:regulation of cytokinesis; IEA:Ensembl
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0048478; P:replication fork protection; IEA:Ensembl
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0010332; P:response to gamma radiation; IEA:Ensembl
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0010225; P:response to UV-C; IEA:Ensembl
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0010165; P:response to X-ray; IEA:Ensembl
P51587	BRCA2	Breast cancer type 2 susceptibility protein	GO:0007283; P:spermatogenesis; IEA:Ensembl
P46736	BRCC3	Lys-63-specific deubiquitinase BRCC36	GO:0030234; F:enzyme regulator activity; IDA:MGI
P46736	BRCC3	Lys-63-specific deubiquitinase BRCC36	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P46736	BRCC3	Lys-63-specific deubiquitinase BRCC36	GO:0008237; F:metallopeptidase activity; IMP:UniProtKB
P46736	BRCC3	Lys-63-specific deubiquitinase BRCC36	GO:0031593; F:polyubiquitin binding; IDA:UniProtKB
P46736	BRCC3	Lys-63-specific deubiquitinase BRCC36	GO:0005515; F:protein binding; IPI:UniProtKB
P46736	BRCC3	Lys-63-specific deubiquitinase BRCC36	GO:0004221; F:ubiquitin thiolesterase activity; IMP:UniProtKB
P46736	BRCC3	Lys-63-specific deubiquitinase BRCC36	GO:0004843; F:ubiquitin-specific protease activity; IMP:UniProtKB
P46736	BRCC3	Lys-63-specific deubiquitinase BRCC36	GO:0006302; P:double-strand break repair; IMP:UniProtKB
P46736	BRCC3	Lys-63-specific deubiquitinase BRCC36	GO:0031572; P:G2 DNA damage checkpoint; IMP:UniProtKB
P46736	BRCC3	Lys-63-specific deubiquitinase BRCC36	GO:0070537; P:histone H2A K63-linked deubiquitination; IDA:UniProtKB
P46736	BRCC3	Lys-63-specific deubiquitinase BRCC36	GO:0045739; P:positive regulation of DNA repair; IMP:UniProtKB
P46736	BRCC3	Lys-63-specific deubiquitinase BRCC36	GO:0070536; P:protein K63-linked deubiquitination; IDA:UniProtKB
P46736	BRCC3	Lys-63-specific deubiquitinase BRCC36	GO:0050790; P:regulation of catalytic activity; IDA:GOC
P46736	BRCC3	Lys-63-specific deubiquitinase BRCC36	GO:0010212; P:response to ionizing radiation; IMP:UniProtKB
P46736	BRCC3	Lys-63-specific deubiquitinase BRCC36	GO:0010165; P:response to X-ray; IDA:MGI
O95696	BRD1	Bromodomain-containing protein 1	GO:0042393; F:histone binding; IDA:UniProtKB
O95696	BRD1	Bromodomain-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
O95696	BRD1	Bromodomain-containing protein 1	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
P25440	BRD2	Bromodomain-containing protein 2	GO:0003682; F:chromatin binding; IDA:UniProtKB
P25440	BRD2	Bromodomain-containing protein 2	GO:0070577; F:lysine-acetylated histone binding; IDA:UniProtKB
P25440	BRD2	Bromodomain-containing protein 2	GO:0005515; F:protein binding; IPI:IntAct
P25440	BRD2	Bromodomain-containing protein 2	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
P25440	BRD2	Bromodomain-containing protein 2	GO:0006334; P:nucleosome assembly; IMP:UniProtKB
P25440	BRD2	Bromodomain-containing protein 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P25440	BRD2	Bromodomain-containing protein 2	GO:0007283; P:spermatogenesis; TAS:ProtInc
P25440	BRD2	Bromodomain-containing protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15059	BRD3	Bromodomain-containing protein 3	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q15059	BRD3	Bromodomain-containing protein 3	GO:0070577; F:lysine-acetylated histone binding; IDA:UniProtKB
Q15059	BRD3	Bromodomain-containing protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q15059	BRD3	Bromodomain-containing protein 3	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q15059	BRD3	Bromodomain-containing protein 3	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q15059	BRD3	Bromodomain-containing protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60885	BRD4	Bromodomain-containing protein 4	GO:0003682; F:chromatin binding; IDA:UniProtKB
O60885	BRD4	Bromodomain-containing protein 4	GO:0003677; F:DNA binding; IEA:Ensembl
O60885	BRD4	Bromodomain-containing protein 4	GO:0070577; F:lysine-acetylated histone binding; IDA:UniProtKB
O60885	BRD4	Bromodomain-containing protein 4	GO:0002039; F:p53 binding; IDA:UniProtKB
O60885	BRD4	Bromodomain-containing protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
O60885	BRD4	Bromodomain-containing protein 4	GO:0006974; P:cellular response to DNA damage stimulus; IEA:UniProtKB-KW
O60885	BRD4	Bromodomain-containing protein 4	GO:0006338; P:chromatin remodeling; IDA:UniProtKB
O60885	BRD4	Bromodomain-containing protein 4	GO:0007059; P:chromosome segregation; IEA:Ensembl
O60885	BRD4	Bromodomain-containing protein 4	GO:0044154; P:histone H3-K14 acetylation; IEA:Ensembl
O60885	BRD4	Bromodomain-containing protein 4	GO:0043983; P:histone H4-K12 acetylation; IEA:Ensembl
O60885	BRD4	Bromodomain-containing protein 4	GO:0001833; P:inner cell mass cell proliferation; IEA:Ensembl
O60885	BRD4	Bromodomain-containing protein 4	GO:2000002; P:negative regulation of DNA damage checkpoint; IMP:UniProtKB
O60885	BRD4	Bromodomain-containing protein 4	GO:0043388; P:positive regulation of DNA binding; IEA:Ensembl
O60885	BRD4	Bromodomain-containing protein 4	GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IMP:MGI
O60885	BRD4	Bromodomain-containing protein 4	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
O60885	BRD4	Bromodomain-containing protein 4	GO:0032968; P:positive regulation of transcription elongation from RNA polymerase II promoter; IDA:UniProtKB
O60885	BRD4	Bromodomain-containing protein 4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O60885	BRD4	Bromodomain-containing protein 4	GO:0006468; P:protein phosphorylation; IEA:Ensembl
O60885	BRD4	Bromodomain-containing protein 4	GO:0050727; P:regulation of inflammatory response; IDA:UniProtKB
O60885	BRD4	Bromodomain-containing protein 4	GO:1901407; P:regulation of phosphorylation of RNA polymerase II C-terminal domain; IDA:UniProtKB
O60885	BRD4	Bromodomain-containing protein 4	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; IMP:MGI
O60885	BRD4	Bromodomain-containing protein 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60885	BRD4	Bromodomain-containing protein 4	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9NPI1	BRD7	Bromodomain-containing protein 7	GO:0070577; F:lysine-acetylated histone binding; IDA:UniProtKB
Q9NPI1	BRD7	Bromodomain-containing protein 7	GO:0042393; F:histone binding; IDA:MGI
Q9NPI1	BRD7	Bromodomain-containing protein 7	GO:0002039; F:p53 binding; IPI:UniProtKB
Q9NPI1	BRD7	Bromodomain-containing protein 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NPI1	BRD7	Bromodomain-containing protein 7	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q9NPI1	BRD7	Bromodomain-containing protein 7	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q9NPI1	BRD7	Bromodomain-containing protein 7	GO:0008134; F:transcription factor binding; IDA:MGI
Q9NPI1	BRD7	Bromodomain-containing protein 7	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q9NPI1	BRD7	Bromodomain-containing protein 7	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9NPI1	BRD7	Bromodomain-containing protein 7	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q9NPI1	BRD7	Bromodomain-containing protein 7	GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IDA:UniProtKB
Q9NPI1	BRD7	Bromodomain-containing protein 7	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9NPI1	BRD7	Bromodomain-containing protein 7	GO:0035066; P:positive regulation of histone acetylation; IDA:UniProtKB
Q9NPI1	BRD7	Bromodomain-containing protein 7	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9NPI1	BRD7	Bromodomain-containing protein 7	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q9NPI1	BRD7	Bromodomain-containing protein 7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NPI1	BRD7	Bromodomain-containing protein 7	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9H0E9	BRD8	Bromodomain-containing protein 8	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9H0E9	BRD8	Bromodomain-containing protein 8	GO:0004887; F:thyroid hormone receptor activity; TAS:ProtInc
Q9H0E9	BRD8	Bromodomain-containing protein 8	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q9H0E9	BRD8	Bromodomain-containing protein 8	GO:0006325; P:chromatin organization; TAS:Reactome
Q9H0E9	BRD8	Bromodomain-containing protein 8	GO:0043968; P:histone H2A acetylation; IDA:UniProtKB
Q9H0E9	BRD8	Bromodomain-containing protein 8	GO:0043967; P:histone H4 acetylation; IDA:UniProtKB
Q9H0E9	BRD8	Bromodomain-containing protein 8	GO:0030522; P:intracellular receptor signaling pathway; TAS:GOC
Q9H0E9	BRD8	Bromodomain-containing protein 8	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q9H0E9	BRD8	Bromodomain-containing protein 8	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9H0E9	BRD8	Bromodomain-containing protein 8	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9H0E9	BRD8	Bromodomain-containing protein 8	GO:0007165; P:signal transduction; TAS:ProtInc
Q9H8M2	BRD9	Bromodomain-containing protein 9	GO:0070577; F:lysine-acetylated histone binding; IDA:UniProtKB
Q9H8M2	BRD9	Bromodomain-containing protein 9	GO:0003676; F:nucleic acid binding; NAS:UniProtKB
Q9H8M2	BRD9	Bromodomain-containing protein 9	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q9H8M2	BRD9	Bromodomain-containing protein 9	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H8M2	BRD9	Bromodomain-containing protein 9	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q58F21	BRDT	Bromodomain testis-specific protein	GO:0070577; F:lysine-acetylated histone binding; ISS:UniProtKB
Q58F21	BRDT	Bromodomain testis-specific protein	GO:0042393; F:histone binding; IDA:UniProtKB
Q58F21	BRDT	Bromodomain testis-specific protein	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q58F21	BRDT	Bromodomain testis-specific protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q58F21	BRDT	Bromodomain testis-specific protein	GO:0006338; P:chromatin remodeling; ISS:UniProtKB
Q58F21	BRDT	Bromodomain testis-specific protein	GO:0001207; P:histone displacement; ISS:UniProtKB
Q58F21	BRDT	Bromodomain testis-specific protein	GO:0007140; P:male meiosis; ISS:UniProtKB
Q58F21	BRDT	Bromodomain testis-specific protein	GO:0007141; P:male meiosis I; ISS:UniProtKB
Q58F21	BRDT	Bromodomain testis-specific protein	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q58F21	BRDT	Bromodomain testis-specific protein	GO:0051039; P:positive regulation of transcription during meiosis; ISS:UniProtKB
Q58F21	BRDT	Bromodomain testis-specific protein	GO:0043484; P:regulation of RNA splicing; ISS:UniProtKB
Q58F21	BRDT	Bromodomain testis-specific protein	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q58F21	BRDT	Bromodomain testis-specific protein	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q58F21	BRDT	Bromodomain testis-specific protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5VTR2	RNF20	E3 ubiquitin-protein ligase BRE1A	GO:0003682; F:chromatin binding; IEA:Ensembl
Q5VTR2	RNF20	E3 ubiquitin-protein ligase BRE1A	GO:0042393; F:histone binding; IDA:UniProtKB
Q5VTR2	RNF20	E3 ubiquitin-protein ligase BRE1A	GO:0002039; F:p53 binding; IDA:UniProtKB
Q5VTR2	RNF20	E3 ubiquitin-protein ligase BRE1A	GO:0005515; F:protein binding; IPI:UniProtKB
Q5VTR2	RNF20	E3 ubiquitin-protein ligase BRE1A	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q5VTR2	RNF20	E3 ubiquitin-protein ligase BRE1A	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q5VTR2	RNF20	E3 ubiquitin-protein ligase BRE1A	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q5VTR2	RNF20	E3 ubiquitin-protein ligase BRE1A	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5VTR2	RNF20	E3 ubiquitin-protein ligase BRE1A	GO:0033523; P:histone H2B ubiquitination; IDA:UniProtKB
Q5VTR2	RNF20	E3 ubiquitin-protein ligase BRE1A	GO:0010390; P:histone monoubiquitination; IDA:UniProtKB
Q5VTR2	RNF20	E3 ubiquitin-protein ligase BRE1A	GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB
Q5VTR2	RNF20	E3 ubiquitin-protein ligase BRE1A	GO:0031062; P:positive regulation of histone methylation; IEA:Ensembl
Q5VTR2	RNF20	E3 ubiquitin-protein ligase BRE1A	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q5VTR2	RNF20	E3 ubiquitin-protein ligase BRE1A	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q5VTR2	RNF20	E3 ubiquitin-protein ligase BRE1A	GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB
Q5VTR2	RNF20	E3 ubiquitin-protein ligase BRE1A	GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB
O75150	RNF40	E3 ubiquitin-protein ligase BRE1B	GO:0005515; F:protein binding; IPI:UniProtKB
O75150	RNF40	E3 ubiquitin-protein ligase BRE1B	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
O75150	RNF40	E3 ubiquitin-protein ligase BRE1B	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
O75150	RNF40	E3 ubiquitin-protein ligase BRE1B	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
O75150	RNF40	E3 ubiquitin-protein ligase BRE1B	GO:0008270; F:zinc ion binding; IEA:InterPro
O75150	RNF40	E3 ubiquitin-protein ligase BRE1B	GO:0033523; P:histone H2B ubiquitination; IDA:UniProtKB
O75150	RNF40	E3 ubiquitin-protein ligase BRE1B	GO:0010390; P:histone monoubiquitination; IDA:UniProtKB
O75150	RNF40	E3 ubiquitin-protein ligase BRE1B	GO:0006511; P:ubiquitin-dependent protein catabolic process; ISS:UniProtKB
Q9NXR7	BRE	BRCA1-A complex subunit BRE	GO:0000268; F:peroxisome targeting sequence binding; TAS:UniProtKB
Q9NXR7	BRE	BRCA1-A complex subunit BRE	GO:0031593; F:polyubiquitin binding; IDA:UniProtKB
Q9NXR7	BRE	BRCA1-A complex subunit BRE	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NXR7	BRE	BRCA1-A complex subunit BRE	GO:0005164; F:tumor necrosis factor receptor binding; IDA:UniProtKB
Q9NXR7	BRE	BRCA1-A complex subunit BRE	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9NXR7	BRE	BRCA1-A complex subunit BRE	GO:0006974; P:cellular response to DNA damage stimulus; IEP:UniProtKB
Q9NXR7	BRE	BRCA1-A complex subunit BRE	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q9NXR7	BRE	BRCA1-A complex subunit BRE	GO:0006302; P:double-strand break repair; IMP:UniProtKB
Q9NXR7	BRE	BRCA1-A complex subunit BRE	GO:0031572; P:G2 DNA damage checkpoint; IMP:UniProtKB
Q9NXR7	BRE	BRCA1-A complex subunit BRE	GO:0045739; P:positive regulation of DNA repair; IMP:UniProtKB
Q9NXR7	BRE	BRCA1-A complex subunit BRE	GO:0010212; P:response to ionizing radiation; IMP:UniProtKB
Q9NXR7	BRE	BRCA1-A complex subunit BRE	GO:0007165; P:signal transduction; TAS:ProtInc
Q9HAW0	BRF2	Transcription factor IIIB 50 kDa subunit	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9HAW0	BRF2	Transcription factor IIIB 50 kDa subunit	GO:0006352; P:DNA-templated transcription, initiation; IEA:InterPro
Q9HAW0	BRF2	Transcription factor IIIB 50 kDa subunit	GO:0010467; P:gene expression; TAS:Reactome
Q9HAW0	BRF2	Transcription factor IIIB 50 kDa subunit	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9HAW0	BRF2	Transcription factor IIIB 50 kDa subunit	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
O95415	BRI3	Brain protein I3	GO:0042802; F:identical protein binding; IPI:MGI
Q8WUW1	BRK1	Protein BRICK1	GO:0032403; F:protein complex binding; IDA:UniProt
Q8WUW1	BRK1	Protein BRICK1	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
Q8WUW1	BRK1	Protein BRICK1	GO:0048870; P:cell motility; IEA:Ensembl
Q8WUW1	BRK1	Protein BRICK1	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q8WUW1	BRK1	Protein BRICK1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q8WUW1	BRK1	Protein BRICK1	GO:0045087; P:innate immune response; TAS:Reactome
Q8WUW1	BRK1	Protein BRICK1	GO:2000601; P:positive regulation of Arp2/3 complex-mediated actin nucleation; IDA:UniProt
Q8WUW1	BRK1	Protein BRICK1	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q8WUW1	BRK1	Protein BRICK1	GO:0010592; P:positive regulation of lamellipodium assembly; IMP:UniProt
Q8WUW1	BRK1	Protein BRICK1	GO:0070207; P:protein homotrimerization; IDA:UniProt
Q8WUW1	BRK1	Protein BRICK1	GO:0016601; P:Rac protein signal transduction; IDA:UniProt
Q5PSV4	BRMS1L	Breast cancer metastasis-suppressor 1-like protein	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q5PSV4	BRMS1L	Breast cancer metastasis-suppressor 1-like protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5PSV4	BRMS1L	Breast cancer metastasis-suppressor 1-like protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HCU9	BRMS1	Breast cancer metastasis-suppressor 1	GO:0051059; F:NF-kappaB binding; IDA:UniProtKB
Q9HCU9	BRMS1	Breast cancer metastasis-suppressor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HCU9	BRMS1	Breast cancer metastasis-suppressor 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9HCU9	BRMS1	Breast cancer metastasis-suppressor 1	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q9HCU9	BRMS1	Breast cancer metastasis-suppressor 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9HCU9	BRMS1	Breast cancer metastasis-suppressor 1	GO:2000210; P:positive regulation of anoikis; IMP:UniProtKB
Q9HCU9	BRMS1	Breast cancer metastasis-suppressor 1	GO:0090312; P:positive regulation of protein deacetylation; IDA:UniProtKB
Q9HCU9	BRMS1	Breast cancer metastasis-suppressor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60477	BRINP1	BMP/retinoic acid-inducible neural-specific protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
O60477	BRINP1	BMP/retinoic acid-inducible neural-specific protein 1	GO:0007050; P:cell cycle arrest; IEA:UniProtKB-KW
O60477	BRINP1	BMP/retinoic acid-inducible neural-specific protein 1	GO:0008219; P:cell death; IDA:UniProtKB
O60477	BRINP1	BMP/retinoic acid-inducible neural-specific protein 1	GO:0045786; P:negative regulation of cell cycle; IDA:UniProtKB
Q9C0B6	BRINP2	BMP/retinoic acid-inducible neural-specific protein 2	GO:0007050; P:cell cycle arrest; IEA:UniProtKB-KW
Q76B58	BRINP3	BMP/retinoic acid-inducible neural-specific protein 3	GO:0007050; P:cell cycle arrest; IEA:UniProtKB-KW
Q76B58	BRINP3	BMP/retinoic acid-inducible neural-specific protein 3	GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB
Q76B58	BRINP3	BMP/retinoic acid-inducible neural-specific protein 3	GO:0045930; P:negative regulation of mitotic cell cycle; ISS:UniProtKB
Q76B58	BRINP3	BMP/retinoic acid-inducible neural-specific protein 3	GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB
Q96NH3	TBC1D32	Protein broad-minded	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q96NH3	TBC1D32	Protein broad-minded	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P55201	BRPF1	Peregrin	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P55201	BRPF1	Peregrin	GO:0008270; F:zinc ion binding; IEA:InterPro
P55201	BRPF1	Peregrin	GO:0006325; P:chromatin organization; TAS:Reactome
P55201	BRPF1	Peregrin	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
P55201	BRPF1	Peregrin	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P55201	BRPF1	Peregrin	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9ULD4	BRPF3	Bromodomain and PHD finger-containing protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q9ULD4	BRPF3	Bromodomain and PHD finger-containing protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9ULD4	BRPF3	Bromodomain and PHD finger-containing protein 3	GO:0007596; P:blood coagulation; TAS:Reactome
Q9ULD4	BRPF3	Bromodomain and PHD finger-containing protein 3	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
Q9ULD4	BRPF3	Bromodomain and PHD finger-containing protein 3	GO:0030168; P:platelet activation; TAS:Reactome
Q9ULD4	BRPF3	Bromodomain and PHD finger-containing protein 3	GO:0002576; P:platelet degranulation; TAS:Reactome
P32247	BRS3	Bombesin receptor subtype-3	GO:0004946; F:bombesin receptor activity; TAS:ProtInc
P32247	BRS3	Bombesin receptor subtype-3	GO:0008343; P:adult feeding behavior; TAS:ProtInc
P32247	BRS3	Bombesin receptor subtype-3	GO:0006006; P:glucose metabolic process; TAS:ProtInc
P32247	BRS3	Bombesin receptor subtype-3	GO:0008217; P:regulation of blood pressure; TAS:ProtInc
Q8TDC3	BRSK1	Serine/threonine-protein kinase BRSK1	GO:0005524; F:ATP binding; IC:UniProtKB
Q8TDC3	BRSK1	Serine/threonine-protein kinase BRSK1	GO:0043015; F:gamma-tubulin binding; ISS:UniProtKB
Q8TDC3	BRSK1	Serine/threonine-protein kinase BRSK1	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q8TDC3	BRSK1	Serine/threonine-protein kinase BRSK1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q8TDC3	BRSK1	Serine/threonine-protein kinase BRSK1	GO:0050321; F:tau-protein kinase activity; IDA:UniProtKB
Q8TDC3	BRSK1	Serine/threonine-protein kinase BRSK1	GO:0007409; P:axonogenesis; ISS:UniProtKB
Q8TDC3	BRSK1	Serine/threonine-protein kinase BRSK1	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q8TDC3	BRSK1	Serine/threonine-protein kinase BRSK1	GO:0051298; P:centrosome duplication; ISS:UniProtKB
Q8TDC3	BRSK1	Serine/threonine-protein kinase BRSK1	GO:0030010; P:establishment of cell polarity; ISS:UniProtKB
Q8TDC3	BRSK1	Serine/threonine-protein kinase BRSK1	GO:0031572; P:G2 DNA damage checkpoint; IDA:UniProtKB
Q8TDC3	BRSK1	Serine/threonine-protein kinase BRSK1	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q8TDC3	BRSK1	Serine/threonine-protein kinase BRSK1	GO:0007269; P:neurotransmitter secretion; ISS:UniProtKB
Q8TDC3	BRSK1	Serine/threonine-protein kinase BRSK1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q8TDC3	BRSK1	Serine/threonine-protein kinase BRSK1	GO:0009411; P:response to UV; IDA:UniProtKB
Q8IWQ3	BRSK2	Serine/threonine-protein kinase BRSK2	GO:0005524; F:ATP binding; IDA:UniProtKB
Q8IWQ3	BRSK2	Serine/threonine-protein kinase BRSK2	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q8IWQ3	BRSK2	Serine/threonine-protein kinase BRSK2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q8IWQ3	BRSK2	Serine/threonine-protein kinase BRSK2	GO:0050321; F:tau-protein kinase activity; IDA:UniProtKB
Q8IWQ3	BRSK2	Serine/threonine-protein kinase BRSK2	GO:0031532; P:actin cytoskeleton reorganization; IMP:UniProtKB
Q8IWQ3	BRSK2	Serine/threonine-protein kinase BRSK2	GO:0007409; P:axonogenesis; ISS:UniProtKB
Q8IWQ3	BRSK2	Serine/threonine-protein kinase BRSK2	GO:0030010; P:establishment of cell polarity; ISS:UniProtKB
Q8IWQ3	BRSK2	Serine/threonine-protein kinase BRSK2	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q8IWQ3	BRSK2	Serine/threonine-protein kinase BRSK2	GO:0000086; P:G2/M transition of mitotic cell cycle; IMP:UniProtKB
Q8IWQ3	BRSK2	Serine/threonine-protein kinase BRSK2	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IMP:UniProtKB
Q8IWQ3	BRSK2	Serine/threonine-protein kinase BRSK2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q8IWQ3	BRSK2	Serine/threonine-protein kinase BRSK2	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q8IWQ3	BRSK2	Serine/threonine-protein kinase BRSK2	GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl
Q8IWQ3	BRSK2	Serine/threonine-protein kinase BRSK2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q8IWQ3	BRSK2	Serine/threonine-protein kinase BRSK2	GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:UniProtKB
Q9NSI6	BRWD1	Bromodomain and WD repeat-containing protein 1	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q9NSI6	BRWD1	Bromodomain and WD repeat-containing protein 1	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
Q9NSI6	BRWD1	Bromodomain and WD repeat-containing protein 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9NSI6	BRWD1	Bromodomain and WD repeat-containing protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6RI45	BRWD3	Bromodomain and WD repeat-containing protein 3	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q6RI45	BRWD3	Bromodomain and WD repeat-containing protein 3	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
Q8TDN6	BRIX1	Ribosome biogenesis protein BRX1 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8TDN6	BRIX1	Ribosome biogenesis protein BRX1 homolog	GO:0042254; P:ribosome biogenesis; IEA:UniProtKB-KW
Q96G97	BSCL2	Seipin	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q96G97	BSCL2	Seipin	GO:0045444; P:fat cell differentiation; ISS:UniProtKB
Q96G97	BSCL2	Seipin	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q96G97	BSCL2	Seipin	GO:0034389; P:lipid particle organization; IMP:UniProtKB
Q96G97	BSCL2	Seipin	GO:0019915; P:lipid storage; IMP:UniProtKB
Q96G97	BSCL2	Seipin	GO:0050995; P:negative regulation of lipid catabolic process; ISS:UniProtKB
Q3C1V8	BSX	Brain-specific homeobox protein homolog	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q3C1V8	BSX	Brain-specific homeobox protein homolog	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q3C1V8	BSX	Brain-specific homeobox protein homolog	GO:0042755; P:eating behavior; IEA:Ensembl
Q3C1V8	BSX	Brain-specific homeobox protein homolog	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q3C1V8	BSX	Brain-specific homeobox protein homolog	GO:0060056; P:mammary gland involution; IEA:Ensembl
Q3C1V8	BSX	Brain-specific homeobox protein homolog	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q3C1V8	BSX	Brain-specific homeobox protein homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WZ55	BSND	Barttin	GO:0005254; F:chloride channel activity; IEA:Ensembl
Q8WZ55	BSND	Barttin	GO:0017081; F:chloride channel regulator activity; IEA:Ensembl
Q8WZ55	BSND	Barttin	GO:1902476; P:chloride transmembrane transport; ISS:GOC
Q8WZ55	BSND	Barttin	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q8WZ55	BSND	Barttin	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UPA5	BSN	Protein bassoon	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UPA5	BSN	Protein bassoon	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q075Z2	BSPH1	Binder of sperm protein homolog 1	GO:0007338; P:single fertilization; IEA:UniProtKB-KW
Q5W0U4	BSPRY	B box and SPRY domain-containing protein	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5W0U4	BSPRY	B box and SPRY domain-containing protein	GO:0006816; P:calcium ion transport; IEA:UniProtKB-KW
Q9GZN4	PRSS22	Brain-specific serine protease 4	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q10588	BST1	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2	GO:0050135; F:NAD(P)+ nucleosidase activity; IEA:UniProtKB-EC
Q10588	BST1	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2	GO:0003953; F:NAD+ nucleosidase activity; IEA:InterPro
Q10588	BST1	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2	GO:0006959; P:humoral immune response; TAS:ProtInc
Q10588	BST1	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q10589	BST2	Bone marrow stromal antigen 2	GO:0008191; F:metalloendopeptidase inhibitor activity; IDA:UniProtKB
Q10589	BST2	Bone marrow stromal antigen 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q10589	BST2	Bone marrow stromal antigen 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q10589	BST2	Bone marrow stromal antigen 2	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q10589	BST2	Bone marrow stromal antigen 2	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q10589	BST2	Bone marrow stromal antigen 2	GO:0042113; P:B cell activation; IEA:UniProtKB-KW
Q10589	BST2	Bone marrow stromal antigen 2	GO:0008283; P:cell proliferation; TAS:ProtInc
Q10589	BST2	Bone marrow stromal antigen 2	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q10589	BST2	Bone marrow stromal antigen 2	GO:0051607; P:defense response to virus; IDA:UniProtKB
Q10589	BST2	Bone marrow stromal antigen 2	GO:0006959; P:humoral immune response; TAS:ProtInc
Q10589	BST2	Bone marrow stromal antigen 2	GO:0045087; P:innate immune response; IDA:UniProtKB
Q10589	BST2	Bone marrow stromal antigen 2	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q10589	BST2	Bone marrow stromal antigen 2	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q10589	BST2	Bone marrow stromal antigen 2	GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB
Q10589	BST2	Bone marrow stromal antigen 2	GO:0010951; P:negative regulation of endopeptidase activity; IDA:GOC
Q10589	BST2	Bone marrow stromal antigen 2	GO:1901253; P:negative regulation of intracellular transport of viral material; IDA:UniProtKB
Q10589	BST2	Bone marrow stromal antigen 2	GO:0002737; P:negative regulation of plasmacytoid dendritic cell cytokine production; IDA:UniProtKB
Q10589	BST2	Bone marrow stromal antigen 2	GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB
Q10589	BST2	Bone marrow stromal antigen 2	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q10589	BST2	Bone marrow stromal antigen 2	GO:0032956; P:regulation of actin cytoskeleton organization; ISS:UniProtKB
Q10589	BST2	Bone marrow stromal antigen 2	GO:0035455; P:response to interferon-alpha; ISS:UniProtKB
Q10589	BST2	Bone marrow stromal antigen 2	GO:0035456; P:response to interferon-beta; ISS:UniProtKB
Q10589	BST2	Bone marrow stromal antigen 2	GO:0034341; P:response to interferon-gamma; ISS:UniProtKB
Q10589	BST2	Bone marrow stromal antigen 2	GO:0009615; P:response to virus; IDA:UniProtKB
Q10589	BST2	Bone marrow stromal antigen 2	GO:0007165; P:signal transduction; IMP:GOC
Q13410	BTN1A1	Butyrophilin subfamily 1 member A1	GO:0004872; F:receptor activity; TAS:ProtInc
Q7KYR7	BTN2A1	Butyrophilin subfamily 2 member A1	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q8WVV5	BTN2A2	Butyrophilin subfamily 2 member A2	GO:0046007; P:negative regulation of activated T cell proliferation; ISS:UniProtKB
Q8WVV5	BTN2A2	Butyrophilin subfamily 2 member A2	GO:0031324; P:negative regulation of cellular metabolic process; ISS:UniProtKB
Q8WVV5	BTN2A2	Butyrophilin subfamily 2 member A2	GO:0050710; P:negative regulation of cytokine secretion; ISS:UniProtKB
O00481	BTN3A1	Butyrophilin subfamily 3 member A1	GO:0005515; F:protein binding; IPI:IntAct
O00481	BTN3A1	Butyrophilin subfamily 3 member A1	GO:0050798; P:activated T cell proliferation; IMP:UniProtKB
O00481	BTN3A1	Butyrophilin subfamily 3 member A1	GO:0050663; P:cytokine secretion; IDA:UniProtKB
O00481	BTN3A1	Butyrophilin subfamily 3 member A1	GO:0072643; P:interferon-gamma secretion; IMP:UniProtKB
O00481	BTN3A1	Butyrophilin subfamily 3 member A1	GO:0050852; P:T cell receptor signaling pathway; IDA:UniProtKB
P78410	BTN3A2	Butyrophilin subfamily 3 member A2	GO:0072643; P:interferon-gamma secretion; IMP:UniProtKB
P78410	BTN3A2	Butyrophilin subfamily 3 member A2	GO:0002456; P:T cell mediated immunity; IMP:UniProtKB
O00478	BTN3A3	Butyrophilin subfamily 3 member A3	GO:0002456; P:T cell mediated immunity; IMP:UniProtKB
O14981	BTAF1	TATA-binding protein-associated factor 172	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O14981	BTAF1	TATA-binding protein-associated factor 172	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O14981	BTAF1	TATA-binding protein-associated factor 172	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
O14981	BTAF1	TATA-binding protein-associated factor 172	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
O14981	BTAF1	TATA-binding protein-associated factor 172	GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB
Q9H0C5	BTBD1	BTB/POZ domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H0C5	BTBD1	BTB/POZ domain-containing protein 1	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9H0C5	BTBD1	BTB/POZ domain-containing protein 1	GO:0043393; P:regulation of protein binding; NAS:UniProtKB
Q9BX70	BTBD2	BTB/POZ domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y2F9	BTBD3	BTB/POZ domain-containing protein 3	GO:0021987; P:cerebral cortex development; ISS:UniProtKB
Q9Y2F9	BTBD3	BTB/POZ domain-containing protein 3	GO:0048813; P:dendrite morphogenesis; ISS:UniProtKB
Q9P203	BTBD7	BTB/POZ domain-containing protein 7	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9P203	BTBD7	BTB/POZ domain-containing protein 7	GO:0060693; P:regulation of branching involved in salivary gland morphogenesis; IEA:Ensembl
Q96Q07	BTBD9	BTB/POZ domain-containing protein 9	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
Q96Q07	BTBD9	BTB/POZ domain-containing protein 9	GO:0007155; P:cell adhesion; IEA:InterPro
Q96Q07	BTBD9	BTB/POZ domain-containing protein 9	GO:0042748; P:circadian sleep/wake cycle, non-REM sleep; IEA:Ensembl
Q96Q07	BTBD9	BTB/POZ domain-containing protein 9	GO:0007616; P:long-term memory; IEA:Ensembl
Q96Q07	BTBD9	BTB/POZ domain-containing protein 9	GO:0060586; P:multicellular organismal iron ion homeostasis; IEA:Ensembl
Q96Q07	BTBD9	BTB/POZ domain-containing protein 9	GO:1900242; P:regulation of synaptic vesicle endocytosis; IEA:Ensembl
Q96Q07	BTBD9	BTB/POZ domain-containing protein 9	GO:0050951; P:sensory perception of temperature stimulus; IEA:Ensembl
Q96Q07	BTBD9	BTB/POZ domain-containing protein 9	GO:0042428; P:serotonin metabolic process; IEA:Ensembl
A6NE02	BTBD17	BTB/POZ domain-containing protein 17	GO:0045071; P:negative regulation of viral genome replication; ISS:UniProtKB
A6NE02	BTBD17	BTB/POZ domain-containing protein 17	GO:0009615; P:response to virus; ISS:UniProtKB
P35070	BTC	Probetacellulin	GO:0005154; F:epidermal growth factor receptor binding; TAS:ProtInc
P35070	BTC	Probetacellulin	GO:0008083; F:growth factor activity; TAS:ProtInc
P35070	BTC	Probetacellulin	GO:0005515; F:protein binding; IPI:IntAct
P35070	BTC	Probetacellulin	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P35070	BTC	Probetacellulin	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P35070	BTC	Probetacellulin	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P35070	BTC	Probetacellulin	GO:0045087; P:innate immune response; TAS:Reactome
P35070	BTC	Probetacellulin	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P35070	BTC	Probetacellulin	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P35070	BTC	Probetacellulin	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P35070	BTC	Probetacellulin	GO:0045597; P:positive regulation of cell differentiation; IEA:Ensembl
P35070	BTC	Probetacellulin	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P35070	BTC	Probetacellulin	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P35070	BTC	Probetacellulin	GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl
P35070	BTC	Probetacellulin	GO:0045840; P:positive regulation of mitosis; IEA:Ensembl
P35070	BTC	Probetacellulin	GO:0035810; P:positive regulation of urine volume; IEA:Ensembl
P43251	BTD	Biotinidase	GO:0004075; F:biotin carboxylase activity; TAS:ProtInc
P43251	BTD	Biotinidase	GO:0047708; F:biotinidase activity; IEA:UniProtKB-EC
P43251	BTD	Biotinidase	GO:0006768; P:biotin metabolic process; TAS:Reactome
P43251	BTD	Biotinidase	GO:0007417; P:central nervous system development; TAS:ProtInc
P43251	BTD	Biotinidase	GO:0008544; P:epidermis development; TAS:ProtInc
P43251	BTD	Biotinidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P43251	BTD	Biotinidase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P43251	BTD	Biotinidase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
P20290	BTF3	Transcription factor BTF3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P20290	BTF3	Transcription factor BTF3	GO:0005515; F:protein binding; IPI:IntAct
P20290	BTF3	Transcription factor BTF3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P20290	BTF3	Transcription factor BTF3	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P20290	BTF3	Transcription factor BTF3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P20290	BTF3	Transcription factor BTF3	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P62324	BTG1	Protein BTG1	GO:0019899; F:enzyme binding; IPI:UniProtKB
P62324	BTG1	Protein BTG1	GO:0019900; F:kinase binding; NAS:UniProtKB
P62324	BTG1	Protein BTG1	GO:0005515; F:protein binding; IPI:UniProtKB
P62324	BTG1	Protein BTG1	GO:0003712; F:transcription cofactor activity; NAS:UniProtKB
P62324	BTG1	Protein BTG1	GO:0016477; P:cell migration; NAS:UniProtKB
P62324	BTG1	Protein BTG1	GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB
P62324	BTG1	Protein BTG1	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
P62324	BTG1	Protein BTG1	GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB
P62324	BTG1	Protein BTG1	GO:0045603; P:positive regulation of endothelial cell differentiation; IMP:UniProtKB
P62324	BTG1	Protein BTG1	GO:2000271; P:positive regulation of fibroblast apoptotic process; IMP:UniProtKB
P62324	BTG1	Protein BTG1	GO:0045663; P:positive regulation of myoblast differentiation; NAS:UniProtKB
P62324	BTG1	Protein BTG1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P78543	BTG2	Protein BTG2	GO:0005515; F:protein binding; IPI:IntAct
P78543	BTG2	Protein BTG2	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P78543	BTG2	Protein BTG2	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P78543	BTG2	Protein BTG2	GO:0008306; P:associative learning; IEA:Ensembl
P78543	BTG2	Protein BTG2	GO:0006974; P:cellular response to DNA damage stimulus; IDA:MGI
P78543	BTG2	Protein BTG2	GO:0021954; P:central nervous system neuron development; IEA:Ensembl
P78543	BTG2	Protein BTG2	GO:0021542; P:dentate gyrus development; IEA:Ensembl
P78543	BTG2	Protein BTG2	GO:0006281; P:DNA repair; TAS:ProtInc
P78543	BTG2	Protein BTG2	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
P78543	BTG2	Protein BTG2	GO:2000178; P:negative regulation of neural precursor cell proliferation; IEA:Ensembl
P78543	BTG2	Protein BTG2	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P78543	BTG2	Protein BTG2	GO:0017148; P:negative regulation of translation; IDA:UniProtKB
P78543	BTG2	Protein BTG2	GO:0031175; P:neuron projection development; IMP:UniProtKB
P78543	BTG2	Protein BTG2	GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; IDA:MGI
P78543	BTG2	Protein BTG2	GO:0006479; P:protein methylation; IEA:Ensembl
P78543	BTG2	Protein BTG2	GO:0051602; P:response to electrical stimulus; IEA:Ensembl
P78543	BTG2	Protein BTG2	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P78543	BTG2	Protein BTG2	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P78543	BTG2	Protein BTG2	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P78543	BTG2	Protein BTG2	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q14201	BTG3	Protein BTG3	GO:0005515; F:protein binding; IPI:IntAct
Q14201	BTG3	Protein BTG3	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q14201	BTG3	Protein BTG3	GO:0045930; P:negative regulation of mitotic cell cycle; IDA:MGI
Q9NY30	BTG4	Protein BTG4	GO:0007050; P:cell cycle arrest; TAS:UniProtKB
Q9NY30	BTG4	Protein BTG4	GO:0008285; P:negative regulation of cell proliferation; TAS:UniProtKB
Q9NY30	BTG4	Protein BTG4	GO:0045930; P:negative regulation of mitotic cell cycle; IEA:Ensembl
Q9NY30	BTG4	Protein BTG4	GO:0030182; P:neuron differentiation; TAS:UniProtKB
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0005524; F:ATP binding; TAS:HGNC
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0042802; F:identical protein binding; IPI:IntAct
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; TAS:UniProtKB
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0005515; F:protein binding; IPI:UniProtKB
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0004713; F:protein tyrosine kinase activity; TAS:HGNC
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0002250; P:adaptive immune response; TAS:UniProtKB
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0097190; P:apoptotic signaling pathway; TAS:ProtInc
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0042113; P:B cell activation; TAS:UniProtKB
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0050853; P:B cell receptor signaling pathway; TAS:UniProtKB
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0019722; P:calcium-mediated signaling; TAS:HGNC
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0048469; P:cell maturation; IEA:Ensembl
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0002553; P:histamine secretion by mast cell; IEA:Ensembl
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0045087; P:innate immune response; TAS:UniProtKB
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0035556; P:intracellular signal transduction; TAS:HGNC
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0007498; P:mesoderm development; TAS:ProtInc
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0045579; P:positive regulation of B cell differentiation; TAS:UniProtKB
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:UniProtKB
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0006468; P:protein phosphorylation; TAS:HGNC
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0002902; P:regulation of B cell apoptotic process; TAS:UniProtKB
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0002721; P:regulation of B cell cytokine production; TAS:UniProtKB
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0010033; P:response to organic substance; IEA:Ensembl
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0000302; P:response to reactive oxygen species; IEA:Ensembl
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q06187	BTK	Tyrosine-protein kinase BTK	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z6A9	BTLA	B- and T-lymphocyte attenuator	GO:0004872; F:receptor activity; IEA:Ensembl
Q7Z6A9	BTLA	B- and T-lymphocyte attenuator	GO:0002768; P:immune response-regulating cell surface receptor signaling pathway; IEA:Ensembl
Q7Z6A9	BTLA	B- and T-lymphocyte attenuator	GO:0046642; P:negative regulation of alpha-beta T cell proliferation; IEA:Ensembl
Q7Z6A9	BTLA	B- and T-lymphocyte attenuator	GO:0030889; P:negative regulation of B cell proliferation; IEA:Ensembl
Q7Z6A9	BTLA	B- and T-lymphocyte attenuator	GO:0031295; P:T cell costimulation; TAS:Reactome
Q6UX41	BTNL8	Butyrophilin-like protein 8	GO:0005515; F:protein binding; IPI:IntAct
O60566	BUB1B	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O60566	BUB1B	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	GO:0005515; F:protein binding; IPI:UniProtKB
O60566	BUB1B	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	GO:0004672; F:protein kinase activity; NAS:UniProtKB
O60566	BUB1B	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
O60566	BUB1B	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
O60566	BUB1B	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O60566	BUB1B	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	GO:0007049; P:cell cycle; NAS:UniProtKB
O60566	BUB1B	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	GO:0008283; P:cell proliferation; TAS:ProtInc
O60566	BUB1B	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	GO:0007091; P:metaphase/anaphase transition of mitotic cell cycle; IEA:Ensembl
O60566	BUB1B	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	GO:0007067; P:mitosis; NAS:UniProtKB
O60566	BUB1B	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O60566	BUB1B	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	GO:0007093; P:mitotic cell cycle checkpoint; TAS:ProtInc
O60566	BUB1B	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:Reactome
O60566	BUB1B	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O60566	BUB1B	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	GO:0048015; P:phosphatidylinositol-mediated signaling; NAS:UniProtKB
O60566	BUB1B	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	GO:0071459; P:protein localization to chromosome, centromeric region; IEA:Ensembl
O60566	BUB1B	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	GO:0034501; P:protein localization to kinetochore; IPI:UniProtKB
O60566	BUB1B	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O60566	BUB1B	Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	GO:0007051; P:spindle organization; NAS:UniProtKB
O43683	BUB1	Mitotic checkpoint serine/threonine-protein kinase BUB1	GO:0005524; F:ATP binding; IEA:InterPro
O43683	BUB1	Mitotic checkpoint serine/threonine-protein kinase BUB1	GO:0005515; F:protein binding; IPI:UniProtKB
O43683	BUB1	Mitotic checkpoint serine/threonine-protein kinase BUB1	GO:0004672; F:protein kinase activity; TAS:ProtInc
O43683	BUB1	Mitotic checkpoint serine/threonine-protein kinase BUB1	GO:0004674; F:protein serine/threonine kinase activity; IEA:InterPro
O43683	BUB1	Mitotic checkpoint serine/threonine-protein kinase BUB1	GO:0016772; F:transferase activity, transferring phosphorus-containing groups; IEA:InterPro
O43683	BUB1	Mitotic checkpoint serine/threonine-protein kinase BUB1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O43683	BUB1	Mitotic checkpoint serine/threonine-protein kinase BUB1	GO:0008283; P:cell proliferation; IEA:Ensembl
O43683	BUB1	Mitotic checkpoint serine/threonine-protein kinase BUB1	GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW
O43683	BUB1	Mitotic checkpoint serine/threonine-protein kinase BUB1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
O43683	BUB1	Mitotic checkpoint serine/threonine-protein kinase BUB1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O43683	BUB1	Mitotic checkpoint serine/threonine-protein kinase BUB1	GO:0007093; P:mitotic cell cycle checkpoint; TAS:ProtInc
O43683	BUB1	Mitotic checkpoint serine/threonine-protein kinase BUB1	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:ProtInc
O43683	BUB1	Mitotic checkpoint serine/threonine-protein kinase BUB1	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl
O43683	BUB1	Mitotic checkpoint serine/threonine-protein kinase BUB1	GO:0051983; P:regulation of chromosome segregation; IMP:UniProtKB
O43683	BUB1	Mitotic checkpoint serine/threonine-protein kinase BUB1	GO:0007063; P:regulation of sister chromatid cohesion; IDA:UniProtKB
O43683	BUB1	Mitotic checkpoint serine/threonine-protein kinase BUB1	GO:0071173; P:spindle assembly checkpoint; IDA:UniProtKB
O43683	BUB1	Mitotic checkpoint serine/threonine-protein kinase BUB1	GO:0016032; P:viral process; IEA:UniProtKB-KW
O43684	BUB3	Mitotic checkpoint protein BUB3	GO:0005515; F:protein binding; IPI:UniProtKB
O43684	BUB3	Mitotic checkpoint protein BUB3	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
O43684	BUB3	Mitotic checkpoint protein BUB3	GO:0008608; P:attachment of spindle microtubules to kinetochore; IDA:UniProtKB
O43684	BUB3	Mitotic checkpoint protein BUB3	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
O43684	BUB3	Mitotic checkpoint protein BUB3	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O43684	BUB3	Mitotic checkpoint protein BUB3	GO:0000070; P:mitotic sister chromatid segregation; IEA:Ensembl
O43684	BUB3	Mitotic checkpoint protein BUB3	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:Reactome
O43684	BUB3	Mitotic checkpoint protein BUB3	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O43684	BUB3	Mitotic checkpoint protein BUB3	GO:0051983; P:regulation of chromosome segregation; IEA:Ensembl
O43684	BUB3	Mitotic checkpoint protein BUB3	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O43684	BUB3	Mitotic checkpoint protein BUB3	GO:0071173; P:spindle assembly checkpoint; IDA:UniProtKB
Q9BRD0	BUD13	BUD13 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BRD0	BUD13	BUD13 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q9BRD0	BUD13	BUD13 homolog	GO:0006406; P:mRNA export from nucleus; ISS:BHF-UCL
Q9BRD0	BUD13	BUD13 homolog	GO:0000398; P:mRNA splicing, via spliceosome; ISS:BHF-UCL
P41223	BUD31	Protein BUD31 homolog	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P41223	BUD31	Protein BUD31 homolog	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9UBR1	UPB1	Beta-ureidopropionase	GO:0003837; F:beta-ureidopropionase activity; EXP:Reactome
Q9UBR1	UPB1	Beta-ureidopropionase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UBR1	UPB1	Beta-ureidopropionase	GO:0019483; P:beta-alanine biosynthetic process; IEA:UniProtKB-UniPathway
Q9UBR1	UPB1	Beta-ureidopropionase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q9UBR1	UPB1	Beta-ureidopropionase	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
Q9UBR1	UPB1	Beta-ureidopropionase	GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome
Q9UBR1	UPB1	Beta-ureidopropionase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95971	CD160	CD160 antigen	GO:0032393; F:MHC class I receptor activity; IDA:HGNC
O95971	CD160	CD160 antigen	GO:0004872; F:receptor activity; TAS:ProtInc
O95971	CD160	CD160 antigen	GO:0005102; F:receptor binding; IDA:HGNC
O95971	CD160	CD160 antigen	GO:0008283; P:cell proliferation; TAS:ProtInc
O95971	CD160	CD160 antigen	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
O95971	CD160	CD160 antigen	GO:0006968; P:cellular defense response; TAS:ProtInc
O95971	CD160	CD160 antigen	GO:0050829; P:defense response to Gram-negative bacterium; IEA:Ensembl
O95971	CD160	CD160 antigen	GO:0050776; P:regulation of immune response; TAS:Reactome
Q13895	BYSL	Bystin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13895	BYSL	Bystin	GO:0005515; F:protein binding; IPI:IntAct
Q13895	BYSL	Bystin	GO:0007155; P:cell adhesion; TAS:ProtInc
Q13895	BYSL	Bystin	GO:0008283; P:cell proliferation; IEA:Ensembl
Q13895	BYSL	Bystin	GO:0007565; P:female pregnancy; TAS:ProtInc
Q13895	BYSL	Bystin	GO:0000462; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IEA:Ensembl
Q13895	BYSL	Bystin	GO:0001829; P:trophectodermal cell differentiation; IEA:Ensembl
Q7L1Q6	BZW1	Basic leucine zipper and W2 domain-containing protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7L1Q6	BZW1	Basic leucine zipper and W2 domain-containing protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7L1Q6	BZW1	Basic leucine zipper and W2 domain-containing protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y6E2	BZW2	Basic leucine zipper and W2 domain-containing protein 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9Y6E2	BZW2	Basic leucine zipper and W2 domain-containing protein 2	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
P15538	CYP11B1	Cytochrome P450 11B1, mitochondrial	GO:0020037; F:heme binding; IC:BHF-UCL
P15538	CYP11B1	Cytochrome P450 11B1, mitochondrial	GO:0005506; F:iron ion binding; IEA:InterPro
P15538	CYP11B1	Cytochrome P450 11B1, mitochondrial	GO:0004507; F:steroid 11-beta-monooxygenase activity; IDA:BHF-UCL
P15538	CYP11B1	Cytochrome P450 11B1, mitochondrial	GO:0032342; P:aldosterone biosynthetic process; IMP:UniProtKB
P15538	CYP11B1	Cytochrome P450 11B1, mitochondrial	GO:0006700; P:C21-steroid hormone biosynthetic process; IDA:BHF-UCL
P15538	CYP11B1	Cytochrome P450 11B1, mitochondrial	GO:0032870; P:cellular response to hormone stimulus; IEP:UniProtKB
P15538	CYP11B1	Cytochrome P450 11B1, mitochondrial	GO:0035865; P:cellular response to potassium ion; IEP:UniProtKB
P15538	CYP11B1	Cytochrome P450 11B1, mitochondrial	GO:0034651; P:cortisol biosynthetic process; IMP:UniProtKB
P15538	CYP11B1	Cytochrome P450 11B1, mitochondrial	GO:0006704; P:glucocorticoid biosynthetic process; TAS:Reactome
P15538	CYP11B1	Cytochrome P450 11B1, mitochondrial	GO:0042593; P:glucose homeostasis; TAS:BHF-UCL
P15538	CYP11B1	Cytochrome P450 11B1, mitochondrial	GO:0006955; P:immune response; TAS:BHF-UCL
P15538	CYP11B1	Cytochrome P450 11B1, mitochondrial	GO:0006705; P:mineralocorticoid biosynthetic process; TAS:Reactome
P15538	CYP11B1	Cytochrome P450 11B1, mitochondrial	GO:0008217; P:regulation of blood pressure; IMP:BHF-UCL
P15538	CYP11B1	Cytochrome P450 11B1, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P15538	CYP11B1	Cytochrome P450 11B1, mitochondrial	GO:0008202; P:steroid metabolic process; TAS:Reactome
P15538	CYP11B1	Cytochrome P450 11B1, mitochondrial	GO:0016125; P:sterol metabolic process; TAS:Reactome
P15538	CYP11B1	Cytochrome P450 11B1, mitochondrial	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P19099	CYP11B2	Cytochrome P450 11B2, mitochondrial	GO:0047783; F:corticosterone 18-monooxygenase activity; IEA:UniProtKB-EC
P19099	CYP11B2	Cytochrome P450 11B2, mitochondrial	GO:0020037; F:heme binding; IDA:UniProtKB
P19099	CYP11B2	Cytochrome P450 11B2, mitochondrial	GO:0005506; F:iron ion binding; IEA:InterPro
P19099	CYP11B2	Cytochrome P450 11B2, mitochondrial	GO:0004507; F:steroid 11-beta-monooxygenase activity; IDA:UniProtKB
P19099	CYP11B2	Cytochrome P450 11B2, mitochondrial	GO:0032342; P:aldosterone biosynthetic process; IDA:UniProtKB
P19099	CYP11B2	Cytochrome P450 11B2, mitochondrial	GO:0006700; P:C21-steroid hormone biosynthetic process; IDA:BHF-UCL
P19099	CYP11B2	Cytochrome P450 11B2, mitochondrial	GO:0032870; P:cellular response to hormone stimulus; IEP:UniProtKB
P19099	CYP11B2	Cytochrome P450 11B2, mitochondrial	GO:0035865; P:cellular response to potassium ion; IEP:UniProtKB
P19099	CYP11B2	Cytochrome P450 11B2, mitochondrial	GO:0034651; P:cortisol biosynthetic process; IMP:UniProtKB
P19099	CYP11B2	Cytochrome P450 11B2, mitochondrial	GO:0006705; P:mineralocorticoid biosynthetic process; TAS:Reactome
P19099	CYP11B2	Cytochrome P450 11B2, mitochondrial	GO:0055075; P:potassium ion homeostasis; IMP:BHF-UCL
P19099	CYP11B2	Cytochrome P450 11B2, mitochondrial	GO:0002017; P:regulation of blood volume by renal aldosterone; IMP:BHF-UCL
P19099	CYP11B2	Cytochrome P450 11B2, mitochondrial	GO:0003091; P:renal water homeostasis; IC:BHF-UCL
P19099	CYP11B2	Cytochrome P450 11B2, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P19099	CYP11B2	Cytochrome P450 11B2, mitochondrial	GO:0055078; P:sodium ion homeostasis; IMP:BHF-UCL
P19099	CYP11B2	Cytochrome P450 11B2, mitochondrial	GO:0008202; P:steroid metabolic process; TAS:Reactome
P19099	CYP11B2	Cytochrome P450 11B2, mitochondrial	GO:0016125; P:sterol metabolic process; TAS:Reactome
P19099	CYP11B2	Cytochrome P450 11B2, mitochondrial	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q86VB7	CD163	Scavenger receptor cysteine-rich type 1 protein M130	GO:0005515; F:protein binding; IPI:UniProtKB
Q86VB7	CD163	Scavenger receptor cysteine-rich type 1 protein M130	GO:0005044; F:scavenger receptor activity; NAS:UniProtKB
Q86VB7	CD163	Scavenger receptor cysteine-rich type 1 protein M130	GO:0006953; P:acute-phase response; IEA:UniProtKB-KW
Q86VB7	CD163	Scavenger receptor cysteine-rich type 1 protein M130	GO:0006898; P:receptor-mediated endocytosis; NAS:GOC
Q9NR16	CD163L1	Scavenger receptor cysteine-rich type 1 protein M160	GO:0005044; F:scavenger receptor activity; IEA:InterPro
Q96L14	CEP170P1	Cep170-like protein	GO:0042802; F:identical protein binding; IPI:IntAct
Q69YN2	CWF19L1	CWF19-like protein 1	GO:0003824; F:catalytic activity; IEA:InterPro
Q2TBE0	CWF19L2	CWF19-like protein 2	GO:0003824; F:catalytic activity; IEA:InterPro
Q13901	C1D	Nuclear nucleic acid-binding protein C1D	GO:0003677; F:DNA binding; TAS:ProtInc
Q13901	C1D	Nuclear nucleic acid-binding protein C1D	GO:0005515; F:protein binding; IPI:IntAct
Q13901	C1D	Nuclear nucleic acid-binding protein C1D	GO:0003723; F:RNA binding; IDA:UniProtKB
Q13901	C1D	Nuclear nucleic acid-binding protein C1D	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
Q13901	C1D	Nuclear nucleic acid-binding protein C1D	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q13901	C1D	Nuclear nucleic acid-binding protein C1D	GO:0000460; P:maturation of 5.8S rRNA; IMP:UniProtKB
Q13901	C1D	Nuclear nucleic acid-binding protein C1D	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q13901	C1D	Nuclear nucleic acid-binding protein C1D	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96EU7	C1GALT1C1	C1GALT1-specific chaperone 1	GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; TAS:Reactome
Q96EU7	C1GALT1C1	C1GALT1-specific chaperone 1	GO:0005515; F:protein binding; IPI:IntAct
Q96EU7	C1GALT1C1	C1GALT1-specific chaperone 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q96EU7	C1GALT1C1	C1GALT1-specific chaperone 1	GO:0016266; P:O-glycan processing; TAS:Reactome
Q96EU7	C1GALT1C1	C1GALT1-specific chaperone 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9NS00	C1GALT1	Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1	GO:0016263; F:glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity; IDA:UniProtKB
Q9NS00	C1GALT1	Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NS00	C1GALT1	Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NS00	C1GALT1	Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1	GO:0001525; P:angiogenesis; IMP:UniProtKB
Q9NS00	C1GALT1	Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9NS00	C1GALT1	Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9NS00	C1GALT1	Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1	GO:0001822; P:kidney development; IMP:UniProtKB
Q9NS00	C1GALT1	Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1	GO:0016266; P:O-glycan processing; TAS:Reactome
Q9NS00	C1GALT1	Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
P02745	C1QA	Complement C1q subcomponent subunit A	GO:0005515; F:protein binding; IPI:IntAct
P02745	C1QA	Complement C1q subcomponent subunit A	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P02745	C1QA	Complement C1q subcomponent subunit A	GO:0006956; P:complement activation; TAS:Reactome
P02745	C1QA	Complement C1q subcomponent subunit A	GO:0006958; P:complement activation, classical pathway; TAS:Reactome
P02745	C1QA	Complement C1q subcomponent subunit A	GO:0045087; P:innate immune response; TAS:Reactome
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0031690; F:adrenergic receptor binding; ISS:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0001849; F:complement component C1q binding; IDA:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0005540; F:hyaluronic acid binding; IDA:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0030984; F:kininogen binding; IDA:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0097177; F:mitochondrial ribosome binding; ISS:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0003729; F:mRNA binding; ISS:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0008134; F:transcription factor binding; IDA:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0007596; P:blood coagulation; TAS:Reactome
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0007597; P:blood coagulation, intrinsic pathway; TAS:Reactome
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0006955; P:immune response; TAS:ProtInc
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0042256; P:mature ribosome assembly; IMP:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0050687; P:negative regulation of defense response to virus; IMP:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0032689; P:negative regulation of interferon-gamma production; IDA:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0032695; P:negative regulation of interleukin-12 production; IDA:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0039534; P:negative regulation of MDA-5 signaling pathway; IDA:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; IDA:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0039536; P:negative regulation of RIG-I signaling pathway; IDA:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0014065; P:phosphatidylinositol 3-kinase signaling; IMP:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0045785; P:positive regulation of cell adhesion; IMP:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:2000510; P:positive regulation of dendritic cell chemotaxis; IMP:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0070131; P:positive regulation of mitochondrial translation; ISS:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0090023; P:positive regulation of neutrophil chemotaxis; IDA:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0051897; P:positive regulation of protein kinase B signaling; IMP:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IMP:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:1901165; P:positive regulation of trophoblast cell migration; IMP:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0030449; P:regulation of complement activation; IDA:UniProtKB
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q07021	C1QBP	Complement component 1 Q subcomponent-binding protein, mitochondrial	GO:0016032; P:viral process; IEA:UniProtKB-KW
P02746	C1QB	Complement C1q subcomponent subunit B	GO:0005515; F:protein binding; IPI:IntAct
P02746	C1QB	Complement C1q subcomponent subunit B	GO:0006956; P:complement activation; TAS:Reactome
P02746	C1QB	Complement C1q subcomponent subunit B	GO:0006958; P:complement activation, classical pathway; TAS:Reactome
P02746	C1QB	Complement C1q subcomponent subunit B	GO:0045087; P:innate immune response; TAS:Reactome
P02746	C1QB	Complement C1q subcomponent subunit B	GO:0048839; P:inner ear development; IEA:Ensembl
P02747	C1QC	Complement C1q subcomponent subunit C	GO:0006956; P:complement activation; TAS:Reactome
P02747	C1QC	Complement C1q subcomponent subunit C	GO:0006958; P:complement activation, classical pathway; TAS:Reactome
P02747	C1QC	Complement C1q subcomponent subunit C	GO:0006955; P:immune response; NAS:UniProtKB
P02747	C1QC	Complement C1q subcomponent subunit C	GO:0045087; P:innate immune response; TAS:Reactome
P02747	C1QC	Complement C1q subcomponent subunit C	GO:0030853; P:negative regulation of granulocyte differentiation; IDA:BHF-UCL
P02747	C1QC	Complement C1q subcomponent subunit C	GO:0045650; P:negative regulation of macrophage differentiation; IDA:BHF-UCL
Q7Z5L3	C1QL2	Complement C1q-like protein 2	GO:0051259; P:protein oligomerization; IEA:Ensembl
Q5VWW1	C1QL3	Complement C1q-like protein 3	GO:0050807; P:regulation of synapse organization; IEA:Ensembl
Q9NPY3	CD93	Complement component C1q receptor	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NPY3	CD93	Complement component C1q receptor	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q9NPY3	CD93	Complement component C1q receptor	GO:0001849; F:complement component C1q binding; IDA:UniProtKB
Q9NPY3	CD93	Complement component C1q receptor	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NPY3	CD93	Complement component C1q receptor	GO:0004872; F:receptor activity; NAS:UniProtKB
Q9NPY3	CD93	Complement component C1q receptor	GO:0016337; P:single organismal cell-cell adhesion; IDA:UniProtKB
Q9NPY3	CD93	Complement component C1q receptor	GO:0042116; P:macrophage activation; NAS:UniProtKB
Q9NPY3	CD93	Complement component C1q receptor	GO:0006909; P:phagocytosis; NAS:UniProtKB
Q9NPY3	CD93	Complement component C1q receptor	GO:0016032; P:viral process; IEA:UniProtKB-KW
O75973	C1QL1	C1q-related factor	GO:0007626; P:locomotory behavior; NAS:UniProtKB
Q9BXJ1	C1QTNF1	Complement C1q tumor necrosis factor-related protein 1	GO:0005518; F:collagen binding; IDA:UniProt
Q9BXJ1	C1QTNF1	Complement C1q tumor necrosis factor-related protein 1	GO:0005515; F:protein binding; IPI:UniProt
Q9BXJ1	C1QTNF1	Complement C1q tumor necrosis factor-related protein 1	GO:0010544; P:negative regulation of platelet activation; IDA:UniProt
Q9BXJ1	C1QTNF1	Complement C1q tumor necrosis factor-related protein 1	GO:0090331; P:negative regulation of platelet aggregation; IDA:UniProt
Q9BXJ1	C1QTNF1	Complement C1q tumor necrosis factor-related protein 1	GO:2000860; P:positive regulation of aldosterone secretion; IDA:UniProt
Q9BXJ1	C1QTNF1	Complement C1q tumor necrosis factor-related protein 1	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProt
Q9BXJ1	C1QTNF1	Complement C1q tumor necrosis factor-related protein 1	GO:0010628; P:positive regulation of gene expression; IDA:UniProt
Q9BXJ1	C1QTNF1	Complement C1q tumor necrosis factor-related protein 1	GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl
Q9BXJ1	C1QTNF1	Complement C1q tumor necrosis factor-related protein 1	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
Q9BXJ1	C1QTNF1	Complement C1q tumor necrosis factor-related protein 1	GO:0070208; P:protein heterotrimerization; IEA:Ensembl
Q9BXJ1	C1QTNF1	Complement C1q tumor necrosis factor-related protein 1	GO:0051260; P:protein homooligomerization; IEA:Ensembl
Q9BXJ1	C1QTNF1	Complement C1q tumor necrosis factor-related protein 1	GO:0010906; P:regulation of glucose metabolic process; IEA:Ensembl
Q9BXJ5	C1QTNF2	Complement C1q tumor necrosis factor-related protein 2	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
Q9BXJ5	C1QTNF2	Complement C1q tumor necrosis factor-related protein 2	GO:0046321; P:positive regulation of fatty acid oxidation; IEA:Ensembl
Q9BXJ5	C1QTNF2	Complement C1q tumor necrosis factor-related protein 2	GO:0046326; P:positive regulation of glucose import; IEA:Ensembl
Q9BXJ5	C1QTNF2	Complement C1q tumor necrosis factor-related protein 2	GO:0045725; P:positive regulation of glycogen biosynthetic process; IEA:Ensembl
Q9BXJ5	C1QTNF2	Complement C1q tumor necrosis factor-related protein 2	GO:0070208; P:protein heterotrimerization; IEA:Ensembl
Q9BXJ5	C1QTNF2	Complement C1q tumor necrosis factor-related protein 2	GO:0051260; P:protein homooligomerization; IEA:Ensembl
Q9BXJ4	C1QTNF3	Complement C1q tumor necrosis factor-related protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BXJ4	C1QTNF3	Complement C1q tumor necrosis factor-related protein 3	GO:0035356; P:cellular triglyceride homeostasis; IDA:UniProtKB
Q9BXJ4	C1QTNF3	Complement C1q tumor necrosis factor-related protein 3	GO:0045444; P:fat cell differentiation; IEP:UniProtKB
Q9BXJ4	C1QTNF3	Complement C1q tumor necrosis factor-related protein 3	GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB
Q9BXJ4	C1QTNF3	Complement C1q tumor necrosis factor-related protein 3	GO:0045721; P:negative regulation of gluconeogenesis; IDA:MGI
Q9BXJ4	C1QTNF3	Complement C1q tumor necrosis factor-related protein 3	GO:0050728; P:negative regulation of inflammatory response; IDA:UniProtKB
Q9BXJ4	C1QTNF3	Complement C1q tumor necrosis factor-related protein 3	GO:1900165; P:negative regulation of interleukin-6 secretion; IDA:UniProtKB
Q9BXJ4	C1QTNF3	Complement C1q tumor necrosis factor-related protein 3	GO:0071638; P:negative regulation of monocyte chemotactic protein-1 production; IDA:UniProtKB
Q9BXJ4	C1QTNF3	Complement C1q tumor necrosis factor-related protein 3	GO:0042347; P:negative regulation of NF-kappaB import into nucleus; IDA:UniProtKB
Q9BXJ4	C1QTNF3	Complement C1q tumor necrosis factor-related protein 3	GO:0070165; P:positive regulation of adiponectin secretion; IDA:UniProtKB
Q9BXJ4	C1QTNF3	Complement C1q tumor necrosis factor-related protein 3	GO:0050715; P:positive regulation of cytokine secretion; IDA:UniProtKB
Q9BXJ4	C1QTNF3	Complement C1q tumor necrosis factor-related protein 3	GO:0070206; P:protein trimerization; IDA:UniProtKB
Q9BXI9	C1QTNF6	Complement C1q tumor necrosis factor-related protein 6	GO:0070208; P:protein heterotrimerization; IEA:Ensembl
Q9BXJ2	C1QTNF7	Complement C1q tumor necrosis factor-related protein 7	GO:0051260; P:protein homooligomerization; IEA:Ensembl
Q9NZP8	C1RL	Complement C1r subcomponent-like protein	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q9NZP8	C1RL	Complement C1r subcomponent-like protein	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
Q9NZP8	C1RL	Complement C1r subcomponent-like protein	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
P00736	C1R	Complement C1r subcomponent	GO:0005509; F:calcium ion binding; IEA:InterPro
P00736	C1R	Complement C1r subcomponent	GO:0005515; F:protein binding; IPI:IntAct
P00736	C1R	Complement C1r subcomponent	GO:0004252; F:serine-type endopeptidase activity; EXP:Reactome
P00736	C1R	Complement C1r subcomponent	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
P00736	C1R	Complement C1r subcomponent	GO:0006956; P:complement activation; TAS:Reactome
P00736	C1R	Complement C1r subcomponent	GO:0006958; P:complement activation, classical pathway; TAS:Reactome
P00736	C1R	Complement C1r subcomponent	GO:0006955; P:immune response; TAS:ProtInc
P00736	C1R	Complement C1r subcomponent	GO:0045087; P:innate immune response; TAS:Reactome
P09871	C1S	Complement C1s subcomponent	GO:0005509; F:calcium ion binding; IEA:InterPro
P09871	C1S	Complement C1s subcomponent	GO:0042802; F:identical protein binding; IPI:IntAct
P09871	C1S	Complement C1s subcomponent	GO:0005515; F:protein binding; IPI:IntAct
P09871	C1S	Complement C1s subcomponent	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
P09871	C1S	Complement C1s subcomponent	GO:0006956; P:complement activation; TAS:Reactome
P09871	C1S	Complement C1s subcomponent	GO:0006958; P:complement activation, classical pathway; TAS:Reactome
P09871	C1S	Complement C1s subcomponent	GO:0045087; P:innate immune response; TAS:Reactome
P11586	MTHFD1	C-1-tetrahydrofolate synthase, cytoplasmic	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P11586	MTHFD1	C-1-tetrahydrofolate synthase, cytoplasmic	GO:0004329; F:formate-tetrahydrofolate ligase activity; IBA:RefGenome
P11586	MTHFD1	C-1-tetrahydrofolate synthase, cytoplasmic	GO:0004477; F:methenyltetrahydrofolate cyclohydrolase activity; IBA:RefGenome
P11586	MTHFD1	C-1-tetrahydrofolate synthase, cytoplasmic	GO:0004488; F:methylenetetrahydrofolate dehydrogenase (NADP+) activity; IBA:RefGenome
P11586	MTHFD1	C-1-tetrahydrofolate synthase, cytoplasmic	GO:0004486; F:methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; TAS:Reactome
P11586	MTHFD1	C-1-tetrahydrofolate synthase, cytoplasmic	GO:0046655; P:folic acid metabolic process; TAS:Reactome
P11586	MTHFD1	C-1-tetrahydrofolate synthase, cytoplasmic	GO:0009396; P:folic acid-containing compound biosynthetic process; IEA:InterPro
P11586	MTHFD1	C-1-tetrahydrofolate synthase, cytoplasmic	GO:0000105; P:histidine biosynthetic process; IEA:UniProtKB-KW
P11586	MTHFD1	C-1-tetrahydrofolate synthase, cytoplasmic	GO:0009086; P:methionine biosynthetic process; IEA:UniProtKB-KW
P11586	MTHFD1	C-1-tetrahydrofolate synthase, cytoplasmic	GO:0006730; P:one-carbon metabolic process; IBA:RefGenome
P11586	MTHFD1	C-1-tetrahydrofolate synthase, cytoplasmic	GO:0006164; P:purine nucleotide biosynthetic process; IEA:UniProtKB-KW
P11586	MTHFD1	C-1-tetrahydrofolate synthase, cytoplasmic	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P11586	MTHFD1	C-1-tetrahydrofolate synthase, cytoplasmic	GO:0035999; P:tetrahydrofolate interconversion; IEA:UniProtKB-UniPathway
P11586	MTHFD1	C-1-tetrahydrofolate synthase, cytoplasmic	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P11586	MTHFD1	C-1-tetrahydrofolate synthase, cytoplasmic	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q6UB35	MTHFD1L	Monofunctional C1-tetrahydrofolate synthase, mitochondrial	GO:0005524; F:ATP binding; IDA:BHF-UCL
Q6UB35	MTHFD1L	Monofunctional C1-tetrahydrofolate synthase, mitochondrial	GO:0004329; F:formate-tetrahydrofolate ligase activity; IDA:BHF-UCL
Q6UB35	MTHFD1L	Monofunctional C1-tetrahydrofolate synthase, mitochondrial	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
Q6UB35	MTHFD1L	Monofunctional C1-tetrahydrofolate synthase, mitochondrial	GO:0009396; P:folic acid-containing compound biosynthetic process; IEA:InterPro
Q6UB35	MTHFD1L	Monofunctional C1-tetrahydrofolate synthase, mitochondrial	GO:0006760; P:folic acid-containing compound metabolic process; IDA:BHF-UCL
Q6UB35	MTHFD1L	Monofunctional C1-tetrahydrofolate synthase, mitochondrial	GO:0015942; P:formate metabolic process; IDA:BHF-UCL
Q6UB35	MTHFD1L	Monofunctional C1-tetrahydrofolate synthase, mitochondrial	GO:0006730; P:one-carbon metabolic process; IBA:RefGenome
Q6UB35	MTHFD1L	Monofunctional C1-tetrahydrofolate synthase, mitochondrial	GO:0055114; P:oxidation-reduction process; IEA:InterPro
Q6UB35	MTHFD1L	Monofunctional C1-tetrahydrofolate synthase, mitochondrial	GO:0035999; P:tetrahydrofolate interconversion; IEA:UniProtKB-UniPathway
Q6UB35	MTHFD1L	Monofunctional C1-tetrahydrofolate synthase, mitochondrial	GO:0046653; P:tetrahydrofolate metabolic process; IDA:BHF-UCL
Q4G0S4	CYP27C1	Cytochrome P450 27C1	GO:0020037; F:heme binding; IEA:InterPro
Q4G0S4	CYP27C1	Cytochrome P450 27C1	GO:0005506; F:iron ion binding; IEA:InterPro
Q4G0S4	CYP27C1	Cytochrome P450 27C1	GO:0004497; F:monooxygenase activity; IEA:UniProtKB-KW
Q4G0S4	CYP27C1	Cytochrome P450 27C1	GO:0016705; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; IEA:InterPro
Q4AC94	C2CD3	C2 domain-containing protein 3	GO:0007420; P:brain development; IEA:Ensembl
Q4AC94	C2CD3	C2 domain-containing protein 3	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
Q4AC94	C2CD3	C2 domain-containing protein 3	GO:0001947; P:heart looping; IEA:Ensembl
Q4AC94	C2CD3	C2 domain-containing protein 3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q4AC94	C2CD3	C2 domain-containing protein 3	GO:0021997; P:neural plate axis specification; IEA:Ensembl
Q4AC94	C2CD3	C2 domain-containing protein 3	GO:0021915; P:neural tube development; IEA:Ensembl
Q4AC94	C2CD3	C2 domain-containing protein 3	GO:0035058; P:nonmotile primary cilium assembly; IMP:UniProtKB
Q4AC94	C2CD3	C2 domain-containing protein 3	GO:0016485; P:protein processing; IEA:Ensembl
Q4AC94	C2CD3	C2 domain-containing protein 3	GO:0030162; P:regulation of proteolysis; IEA:Ensembl
Q4AC94	C2CD3	C2 domain-containing protein 3	GO:0008589; P:regulation of smoothened signaling pathway; IEA:Ensembl
Q86YS7	C2CD5	C2 domain-containing protein 5	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q86YS7	C2CD5	C2 domain-containing protein 5	GO:0005544; F:calcium-dependent phospholipid binding; IDA:UniProtKB
Q86YS7	C2CD5	C2 domain-containing protein 5	GO:0032869; P:cellular response to insulin stimulus; IDA:UniProtKB
Q86YS7	C2CD5	C2 domain-containing protein 5	GO:0038028; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; ISS:UniProtKB
Q86YS7	C2CD5	C2 domain-containing protein 5	GO:0065002; P:intracellular protein transmembrane transport; IMP:UniProtKB
Q86YS7	C2CD5	C2 domain-containing protein 5	GO:2001275; P:positive regulation of glucose import in response to insulin stimulus; IEA:Ensembl
Q86YS7	C2CD5	C2 domain-containing protein 5	GO:0010828; P:positive regulation of glucose transport; ISS:UniProtKB
Q86YS7	C2CD5	C2 domain-containing protein 5	GO:0090314; P:positive regulation of protein targeting to membrane; IMP:UniProtKB
Q86YS7	C2CD5	C2 domain-containing protein 5	GO:0031340; P:positive regulation of vesicle fusion; IMP:UniProtKB
Q86YS7	C2CD5	C2 domain-containing protein 5	GO:0072659; P:protein localization to plasma membrane; IEA:Ensembl
Q86YS7	C2CD5	C2 domain-containing protein 5	GO:0006906; P:vesicle fusion; IEA:Ensembl
Q6P1N0	CC2D1A	Coiled-coil and C2 domain-containing protein 1A	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl
Q6P1N0	CC2D1A	Coiled-coil and C2 domain-containing protein 1A	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IEA:Ensembl
Q6P1N0	CC2D1A	Coiled-coil and C2 domain-containing protein 1A	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q6P1N0	CC2D1A	Coiled-coil and C2 domain-containing protein 1A	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q6P1N0	CC2D1A	Coiled-coil and C2 domain-containing protein 1A	GO:0007165; P:signal transduction; IMP:GOC
Q5T0F9	CC2D1B	Coiled-coil and C2 domain-containing protein 1B	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl
Q5T0F9	CC2D1B	Coiled-coil and C2 domain-containing protein 1B	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IEA:Ensembl
Q9P2K1	CC2D2A	Coiled-coil and C2 domain-containing protein 2A	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q9P2K1	CC2D2A	Coiled-coil and C2 domain-containing protein 2A	GO:0060271; P:cilium morphogenesis; ISS:UniProtKB
Q9P2K1	CC2D2A	Coiled-coil and C2 domain-containing protein 2A	GO:0007224; P:smoothened signaling pathway; ISS:UniProtKB
Q6ZSU1	CYP2G1P	Putative inactive cytochrome P450 2G1	GO:0020037; F:heme binding; IEA:InterPro
Q6ZSU1	CYP2G1P	Putative inactive cytochrome P450 2G1	GO:0005506; F:iron ion binding; IEA:InterPro
Q6ZSU1	CYP2G1P	Putative inactive cytochrome P450 2G1	GO:0016705; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; IEA:InterPro
P33076	CIITA	MHC class II transactivator	GO:0033613; F:activating transcription factor binding; IPI:BHF-UCL
P33076	CIITA	MHC class II transactivator	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P33076	CIITA	MHC class II transactivator	GO:0005515; F:protein binding; IPI:UniProtKB
P33076	CIITA	MHC class II transactivator	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P33076	CIITA	MHC class II transactivator	GO:0032403; F:protein complex binding; IDA:UniProtKB
P33076	CIITA	MHC class II transactivator	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P33076	CIITA	MHC class II transactivator	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
P33076	CIITA	MHC class II transactivator	GO:0007568; P:aging; IEA:Ensembl
P33076	CIITA	MHC class II transactivator	GO:0071257; P:cellular response to electrical stimulus; IEA:Ensembl
P33076	CIITA	MHC class II transactivator	GO:0071360; P:cellular response to exogenous dsRNA; IEA:Ensembl
P33076	CIITA	MHC class II transactivator	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P33076	CIITA	MHC class II transactivator	GO:0006955; P:immune response; TAS:ProtInc
P33076	CIITA	MHC class II transactivator	GO:0006954; P:inflammatory response; IEA:Ensembl
P33076	CIITA	MHC class II transactivator	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P33076	CIITA	MHC class II transactivator	GO:0032966; P:negative regulation of collagen biosynthetic process; IC:BHF-UCL
P33076	CIITA	MHC class II transactivator	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P33076	CIITA	MHC class II transactivator	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
P33076	CIITA	MHC class II transactivator	GO:0045345; P:positive regulation of MHC class I biosynthetic process; IDA:BHF-UCL
P33076	CIITA	MHC class II transactivator	GO:0045348; P:positive regulation of MHC class II biosynthetic process; IC:BHF-UCL
P33076	CIITA	MHC class II transactivator	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P33076	CIITA	MHC class II transactivator	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
P33076	CIITA	MHC class II transactivator	GO:0046677; P:response to antibiotic; IDA:MGI
P33076	CIITA	MHC class II transactivator	GO:0034341; P:response to interferon-gamma; IDA:BHF-UCL
P33076	CIITA	MHC class II transactivator	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q16581	C3AR1	C3a anaphylatoxin chemotactic receptor	GO:0004943; F:C3a anaphylatoxin receptor activity; TAS:ProtInc
Q16581	C3AR1	C3a anaphylatoxin chemotactic receptor	GO:0004876; F:complement component C3a receptor activity; TAS:ProtInc
Q16581	C3AR1	C3a anaphylatoxin chemotactic receptor	GO:0004930; F:G-protein coupled receptor activity; IGI:UniProtKB
Q16581	C3AR1	C3a anaphylatoxin chemotactic receptor	GO:0004982; F:N-formyl peptide receptor activity; IEA:InterPro
Q16581	C3AR1	C3a anaphylatoxin chemotactic receptor	GO:0004435; F:phosphatidylinositol phospholipase C activity; TAS:ProtInc
Q16581	C3AR1	C3a anaphylatoxin chemotactic receptor	GO:0008015; P:blood circulation; TAS:ProtInc
Q16581	C3AR1	C3a anaphylatoxin chemotactic receptor	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
Q16581	C3AR1	C3a anaphylatoxin chemotactic receptor	GO:0002430; P:complement receptor mediated signaling pathway; TAS:GOC
Q16581	C3AR1	C3a anaphylatoxin chemotactic receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q16581	C3AR1	C3a anaphylatoxin chemotactic receptor	GO:0006954; P:inflammatory response; TAS:ProtInc
Q16581	C3AR1	C3a anaphylatoxin chemotactic receptor	GO:0008152; P:metabolic process; TAS:GOC
Q16581	C3AR1	C3a anaphylatoxin chemotactic receptor	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
Q16581	C3AR1	C3a anaphylatoxin chemotactic receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IGI:UniProtKB
Q16581	C3AR1	C3a anaphylatoxin chemotactic receptor	GO:0010759; P:positive regulation of macrophage chemotaxis; IEA:Ensembl
Q16581	C3AR1	C3a anaphylatoxin chemotactic receptor	GO:0090023; P:positive regulation of neutrophil chemotaxis; IEA:Ensembl
Q16581	C3AR1	C3a anaphylatoxin chemotactic receptor	GO:0010575; P:positive regulation vascular endothelial growth factor production; IEA:Ensembl
Q6ZMU1	C3P1	Putative protein C3P1	GO:0004866; F:endopeptidase inhibitor activity; IEA:InterPro
Q9NRR8	CDC42SE1	CDC42 small effector protein 1	GO:0005095; F:GTPase inhibitor activity; TAS:ProtInc
Q9NRR8	CDC42SE1	CDC42 small effector protein 1	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
Q9NRR8	CDC42SE1	CDC42 small effector protein 1	GO:0006909; P:phagocytosis; IEA:UniProtKB-KW
Q9NRR8	CDC42SE1	CDC42 small effector protein 1	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
Q9NRR8	CDC42SE1	CDC42 small effector protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q9NRR3	CDC42SE2	CDC42 small effector protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NRR3	CDC42SE2	CDC42 small effector protein 2	GO:0005198; F:structural molecule activity; IDA:UniProtKB
Q9NRR3	CDC42SE2	CDC42 small effector protein 2	GO:0006909; P:phagocytosis; IEA:UniProtKB-KW
Q9NRR3	CDC42SE2	CDC42 small effector protein 2	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
Q9NRR3	CDC42SE2	CDC42 small effector protein 2	GO:0009966; P:regulation of signal transduction; IDA:UniProtKB
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0097001; F:ceramide binding; IDA:UniProtKB
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0035620; F:ceramide transporter activity; IDA:UniProtKB
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0070273; F:phosphatidylinositol-4-phosphate binding; IDA:UniProtKB
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0000902; P:cell morphogenesis; IEA:Ensembl
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0008283; P:cell proliferation; IEA:Ensembl
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0006672; P:ceramide metabolic process; IEA:Ensembl
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0007029; P:endoplasmic reticulum organization; IEA:Ensembl
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0035621; P:ER to Golgi ceramide transport; IMP:UniProtKB
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0003007; P:heart morphogenesis; IEA:Ensembl
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0006955; P:immune response; NAS:UniProtKB
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0055088; P:lipid homeostasis; IEA:Ensembl
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0070584; P:mitochondrion morphogenesis; IEA:Ensembl
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0006936; P:muscle contraction; IEA:Ensembl
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0034976; P:response to endoplasmic reticulum stress; IEA:Ensembl
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0007165; P:signal transduction; IEA:Ensembl
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
Q9Y5P4	COL4A3BP	Collagen type IV alpha-3-binding protein	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
P04003	C4BPA	C4b-binding protein alpha chain	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P04003	C4BPA	C4b-binding protein alpha chain	GO:0005515; F:protein binding; IPI:IntAct
P04003	C4BPA	C4b-binding protein alpha chain	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
P04003	C4BPA	C4b-binding protein alpha chain	GO:0045087; P:innate immune response; TAS:Reactome
P04003	C4BPA	C4b-binding protein alpha chain	GO:0030449; P:regulation of complement activation; TAS:Reactome
P20851	C4BPB	C4b-binding protein beta chain	GO:0007596; P:blood coagulation; TAS:ProtInc
P20851	C4BPB	C4b-binding protein beta chain	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
P20851	C4BPB	C4b-binding protein beta chain	GO:0045087; P:innate immune response; TAS:Reactome
P20851	C4BPB	C4b-binding protein beta chain	GO:0030449; P:regulation of complement activation; TAS:Reactome
Q99643	SDHC	Succinate dehydrogenase cytochrome b560 subunit, mitochondrial	GO:0009055; F:electron carrier activity; IEA:InterPro
Q99643	SDHC	Succinate dehydrogenase cytochrome b560 subunit, mitochondrial	GO:0020037; F:heme binding; ISS:UniProtKB
Q99643	SDHC	Succinate dehydrogenase cytochrome b560 subunit, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q99643	SDHC	Succinate dehydrogenase cytochrome b560 subunit, mitochondrial	GO:0000104; F:succinate dehydrogenase activity; IEA:InterPro
Q99643	SDHC	Succinate dehydrogenase cytochrome b560 subunit, mitochondrial	GO:0009060; P:aerobic respiration; TAS:UniProtKB
Q99643	SDHC	Succinate dehydrogenase cytochrome b560 subunit, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q99643	SDHC	Succinate dehydrogenase cytochrome b560 subunit, mitochondrial	GO:0055114; P:oxidation-reduction process; TAS:UniProtKB
Q99643	SDHC	Succinate dehydrogenase cytochrome b560 subunit, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
Q99643	SDHC	Succinate dehydrogenase cytochrome b560 subunit, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99643	SDHC	Succinate dehydrogenase cytochrome b560 subunit, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; TAS:UniProtKB
Q8N8Q1	CYB561D1	Cytochrome b561 domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N8Q1	CYB561D1	Cytochrome b561 domain-containing protein 1	GO:0055114; P:oxidation-reduction process; IEA:UniProtKB-KW
O14569	CYB561D2	Cytochrome b561 domain-containing protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14569	CYB561D2	Cytochrome b561 domain-containing protein 2	GO:0055114; P:oxidation-reduction process; IEA:UniProtKB-KW
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0004944; F:C5a anaphylatoxin receptor activity; IDA:UniProtKB
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0004878; F:complement component C5a receptor activity; IDA:UniProtKB
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0004982; F:N-formyl peptide receptor activity; IEA:InterPro
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0000187; P:activation of MAPK activity; TAS:ProtInc
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0007202; P:activation of phospholipase C activity; TAS:ProtInc
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0006915; P:apoptotic process; IEA:Ensembl
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0021534; P:cell proliferation in hindbrain; IEA:Ensembl
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0006968; P:cellular defense response; TAS:ProtInc
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0006935; P:chemotaxis; TAS:ProtInc
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0038178; P:complement component C5a signaling pathway; IDA:GOC
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0050830; P:defense response to Gram-positive bacterium; IEA:Ensembl
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0006955; P:immune response; TAS:ProtInc
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0006954; P:inflammatory response; IEA:Ensembl
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0042789; P:mRNA transcription from RNA polymerase II promoter; IDA:UniProtKB
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0030593; P:neutrophil chemotaxis; IEA:Ensembl
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0031100; P:organ regeneration; IEA:Ensembl
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:UniProtKB
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0032494; P:response to peptidoglycan; IEA:Ensembl
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0007606; P:sensory perception of chemical stimulus; TAS:ProtInc
P21730	C5AR1	C5a anaphylatoxin chemotactic receptor 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q9P296	C5AR2	C5a anaphylatoxin chemotactic receptor 2	GO:0004944; F:C5a anaphylatoxin receptor activity; IEA:InterPro
Q9P296	C5AR2	C5a anaphylatoxin chemotactic receptor 2	GO:0004982; F:N-formyl peptide receptor activity; IEA:InterPro
Q9P296	C5AR2	C5a anaphylatoxin chemotactic receptor 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P296	C5AR2	C5a anaphylatoxin chemotactic receptor 2	GO:0006935; P:chemotaxis; IEA:InterPro
Q9P296	C5AR2	C5a anaphylatoxin chemotactic receptor 2	GO:1900165; P:negative regulation of interleukin-6 secretion; IMP:UniProtKB
Q9P296	C5AR2	C5a anaphylatoxin chemotactic receptor 2	GO:0090024; P:negative regulation of neutrophil chemotaxis; IMP:UniProtKB
Q9P296	C5AR2	C5a anaphylatoxin chemotactic receptor 2	GO:0032720; P:negative regulation of tumor necrosis factor production; IMP:UniProtKB
Q9P296	C5AR2	C5a anaphylatoxin chemotactic receptor 2	GO:2000482; P:regulation of interleukin-8 secretion; IMP:UniProtKB
Q9UKL3	CASP8AP2	CASP8-associated protein 2	GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; ISS:UniProtKB
Q9UKL3	CASP8AP2	CASP8-associated protein 2	GO:0005123; F:death receptor binding; TAS:ProtInc
Q9UKL3	CASP8AP2	CASP8-associated protein 2	GO:0003677; F:DNA binding; IEA:InterPro
Q9UKL3	CASP8AP2	CASP8-associated protein 2	GO:0016505; F:peptidase activator activity involved in apoptotic process; ISS:UniProtKB
Q9UKL3	CASP8AP2	CASP8-associated protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKL3	CASP8AP2	CASP8-associated protein 2	GO:0032184; F:SUMO polymer binding; IDA:UniProtKB
Q9UKL3	CASP8AP2	CASP8-associated protein 2	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q9UKL3	CASP8AP2	CASP8-associated protein 2	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
Q9UKL3	CASP8AP2	CASP8-associated protein 2	GO:0097190; P:apoptotic signaling pathway; TAS:ProtInc
Q9UKL3	CASP8AP2	CASP8-associated protein 2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9UKL3	CASP8AP2	CASP8-associated protein 2	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
Q9UKL3	CASP8AP2	CASP8-associated protein 2	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IMP:UniProtKB
Q9UKL3	CASP8AP2	CASP8-associated protein 2	GO:0036337; P:Fas signaling pathway; IMP:UniProtKB
Q9UKL3	CASP8AP2	CASP8-associated protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UKL3	CASP8AP2	CASP8-associated protein 2	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UKL3	CASP8AP2	CASP8-associated protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BWL3	C1orf43	Uncharacterized protein C1orf43	GO:0050662; F:coenzyme binding; IEA:InterPro
Q9BWL3	C1orf43	Uncharacterized protein C1orf43	GO:0016616; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; IEA:InterPro
Q8TCZ2	CD99L2	CD99 antigen-like protein 2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q8N6N3	C1orf52	UPF0690 protein C1orf52	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8N0U7	C1orf87	Uncharacterized protein C1orf87	GO:0005509; F:calcium ion binding; IEA:InterPro
Q6P1W5	C1orf94	Uncharacterized protein C1orf94	GO:0005515; F:protein binding; IPI:IntAct
Q8NDD1	C1orf131	Uncharacterized protein C1orf131	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P54289	CACNA2D1	Voltage-dependent calcium channel subunit alpha-2/delta-1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P54289	CACNA2D1	Voltage-dependent calcium channel subunit alpha-2/delta-1	GO:0005245; F:voltage-gated calcium channel activity; IDA:BHF-UCL
P54289	CACNA2D1	Voltage-dependent calcium channel subunit alpha-2/delta-1	GO:0006816; P:calcium ion transport; IDA:UniProtKB
P54289	CACNA2D1	Voltage-dependent calcium channel subunit alpha-2/delta-1	GO:0051924; P:regulation of calcium ion transport; IDA:BHF-UCL
Q9NY47	CACNA2D2	Voltage-dependent calcium channel subunit alpha-2/delta-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NY47	CACNA2D2	Voltage-dependent calcium channel subunit alpha-2/delta-2	GO:0005245; F:voltage-gated calcium channel activity; IEA:Ensembl
Q9NY47	CACNA2D2	Voltage-dependent calcium channel subunit alpha-2/delta-2	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q9NY47	CACNA2D2	Voltage-dependent calcium channel subunit alpha-2/delta-2	GO:0048747; P:muscle fiber development; IEA:Ensembl
Q9NY47	CACNA2D2	Voltage-dependent calcium channel subunit alpha-2/delta-2	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
Q9NY47	CACNA2D2	Voltage-dependent calcium channel subunit alpha-2/delta-2	GO:0046622; P:positive regulation of organ growth; IEA:Ensembl
Q9NY47	CACNA2D2	Voltage-dependent calcium channel subunit alpha-2/delta-2	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
Q9NY47	CACNA2D2	Voltage-dependent calcium channel subunit alpha-2/delta-2	GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl
Q9NY47	CACNA2D2	Voltage-dependent calcium channel subunit alpha-2/delta-2	GO:0060024; P:rhythmic synaptic transmission; IEA:Ensembl
Q9NY47	CACNA2D2	Voltage-dependent calcium channel subunit alpha-2/delta-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8IZS8	CACNA2D3	Voltage-dependent calcium channel subunit alpha-2/delta-3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IZS8	CACNA2D3	Voltage-dependent calcium channel subunit alpha-2/delta-3	GO:0005245; F:voltage-gated calcium channel activity; IEA:Ensembl
Q7Z3S7	CACNA2D4	Voltage-dependent calcium channel subunit alpha-2/delta-4	GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW
Q7Z3S7	CACNA2D4	Voltage-dependent calcium channel subunit alpha-2/delta-4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z3S7	CACNA2D4	Voltage-dependent calcium channel subunit alpha-2/delta-4	GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW
Q8WTZ4	CA5BP1	Putative inactive carbonic anhydrase 5B-like protein	GO:0004089; F:carbonate dehydratase activity; IEA:InterPro
Q8WTZ4	CA5BP1	Putative inactive carbonic anhydrase 5B-like protein	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H8G2	CAAP1	Caspase activity and apoptosis inhibitor 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9Y376	CAB39	Calcium-binding protein 39	GO:0019900; F:kinase binding; IPI:BHF-UCL
Q9Y376	CAB39	Calcium-binding protein 39	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y376	CAB39	Calcium-binding protein 39	GO:0030295; F:protein kinase activator activity; IDA:UniProtKB
Q9Y376	CAB39	Calcium-binding protein 39	GO:0032147; P:activation of protein kinase activity; IEA:Ensembl
Q9Y376	CAB39	Calcium-binding protein 39	GO:0007050; P:cell cycle arrest; TAS:Reactome
Q9Y376	CAB39	Calcium-binding protein 39	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q9Y376	CAB39	Calcium-binding protein 39	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q9Y376	CAB39	Calcium-binding protein 39	GO:0006468; P:protein phosphorylation; IDA:GOC
Q9BRK5	SDF4	45 kDa calcium-binding protein	GO:0005509; F:calcium ion binding; IDA:BHF-UCL
Q9BRK5	SDF4	45 kDa calcium-binding protein	GO:0042802; F:identical protein binding; ISS:BHF-UCL
Q9BRK5	SDF4	45 kDa calcium-binding protein	GO:0005515; F:protein binding; IPI:BHF-UCL
Q9BRK5	SDF4	45 kDa calcium-binding protein	GO:0017156; P:calcium ion-dependent exocytosis; ISS:BHF-UCL
Q9BRK5	SDF4	45 kDa calcium-binding protein	GO:0021549; P:cerebellum development; ISS:BHF-UCL
Q9BRK5	SDF4	45 kDa calcium-binding protein	GO:0045444; P:fat cell differentiation; ISS:BHF-UCL
Q9BRK5	SDF4	45 kDa calcium-binding protein	GO:0045471; P:response to ethanol; ISS:BHF-UCL
Q9BRK5	SDF4	45 kDa calcium-binding protein	GO:0009650; P:UV protection; ISS:BHF-UCL
Q9BRK5	SDF4	45 kDa calcium-binding protein	GO:0070625; P:zymogen granule exocytosis; ISS:BHF-UCL
Q9Y6J0	CABIN1	Calcineurin-binding protein cabin-1	GO:0004864; F:protein phosphatase inhibitor activity; NAS:UniProtKB
Q9Y6J0	CABIN1	Calcineurin-binding protein cabin-1	GO:0007166; P:cell surface receptor signaling pathway; NAS:UniProtKB
Q9Y6J0	CABIN1	Calcineurin-binding protein cabin-1	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q9Y6J0	CABIN1	Calcineurin-binding protein cabin-1	GO:0006336; P:DNA replication-independent nucleosome assembly; IDA:UniProt
Q9Y6J0	CABIN1	Calcineurin-binding protein cabin-1	GO:0043086; P:negative regulation of catalytic activity; NAS:GOC
Q8TDN4	CABLES1	CDK5 and ABL1 enzyme substrate 1	GO:0016538; F:cyclin-dependent protein serine/threonine kinase regulator activity; IEA:InterPro
Q8TDN4	CABLES1	CDK5 and ABL1 enzyme substrate 1	GO:0005515; F:protein binding; IPI:IntAct
Q8TDN4	CABLES1	CDK5 and ABL1 enzyme substrate 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q8TDN4	CABLES1	CDK5 and ABL1 enzyme substrate 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8TDN4	CABLES1	CDK5 and ABL1 enzyme substrate 1	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q8TDN4	CABLES1	CDK5 and ABL1 enzyme substrate 1	GO:0007399; P:nervous system development; IEA:Ensembl
Q8TDN4	CABLES1	CDK5 and ABL1 enzyme substrate 1	GO:0051726; P:regulation of cell cycle; IEA:InterPro
Q8TDN4	CABLES1	CDK5 and ABL1 enzyme substrate 1	GO:0051302; P:regulation of cell division; IEA:InterPro
Q9BTV7	CABLES2	CDK5 and ABL1 enzyme substrate 2	GO:0016538; F:cyclin-dependent protein serine/threonine kinase regulator activity; IEA:InterPro
Q9BTV7	CABLES2	CDK5 and ABL1 enzyme substrate 2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9BTV7	CABLES2	CDK5 and ABL1 enzyme substrate 2	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q9BTV7	CABLES2	CDK5 and ABL1 enzyme substrate 2	GO:0051726; P:regulation of cell cycle; IEA:InterPro
Q9BTV7	CABLES2	CDK5 and ABL1 enzyme substrate 2	GO:0051302; P:regulation of cell division; IEA:InterPro
Q9NZU7	CABP1	Calcium-binding protein 1	GO:0005509; F:calcium ion binding; TAS:ProtInc
Q9NZU7	CABP1	Calcium-binding protein 1	GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB
Q9NZU7	CABP1	Calcium-binding protein 1	GO:0004857; F:enzyme inhibitor activity; TAS:ProtInc
Q9NZU7	CABP1	Calcium-binding protein 1	GO:0008139; F:nuclear localization sequence binding; ISS:UniProtKB
Q9NZU7	CABP1	Calcium-binding protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NZU7	CABP1	Calcium-binding protein 1	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
Q9NZU7	CABP1	Calcium-binding protein 1	GO:0010651; P:negative regulation of cell communication by electrical coupling; IEA:Ensembl
Q9NZU7	CABP1	Calcium-binding protein 1	GO:0042308; P:negative regulation of protein import into nucleus; ISS:UniProtKB
Q9NZU7	CABP1	Calcium-binding protein 1	GO:1901386; P:negative regulation of voltage-gated calcium channel activity; IEA:Ensembl
Q9NPB3	CABP2	Calcium-binding protein 2	GO:0005509; F:calcium ion binding; TAS:ProtInc
Q9NPB3	CABP2	Calcium-binding protein 2	GO:0007165; P:signal transduction; TAS:ProtInc
P57796	CABP4	Calcium-binding protein 4	GO:0005509; F:calcium ion binding; NAS:UniProtKB
P57796	CABP4	Calcium-binding protein 4	GO:0008594; P:photoreceptor cell morphogenesis; IEA:Ensembl
P57796	CABP4	Calcium-binding protein 4	GO:0007602; P:phototransduction; IEA:Ensembl
P57796	CABP4	Calcium-binding protein 4	GO:0060040; P:retinal bipolar neuron differentiation; IEA:Ensembl
P57796	CABP4	Calcium-binding protein 4	GO:0046549; P:retinal cone cell development; IEA:Ensembl
P57796	CABP4	Calcium-binding protein 4	GO:0007165; P:signal transduction; NAS:UniProtKB
P57796	CABP4	Calcium-binding protein 4	GO:0007601; P:visual perception; IMP:UniProtKB
Q86V35	CABP7	Calcium-binding protein 7	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NP86	CABP5	Calcium-binding protein 5	GO:0005509; F:calcium ion binding; NAS:UniProtKB
Q9NP86	CABP5	Calcium-binding protein 5	GO:0007165; P:signal transduction; NAS:UniProtKB
Q9BXU9	CALN1	Calcium-binding protein 8	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96KC9	CABS1	Calcium-binding and spermatid-specific protein 1	GO:0005509; F:calcium ion binding; ISS:UniProtKB
Q96KC9	CABS1	Calcium-binding and spermatid-specific protein 1	GO:0007283; P:spermatogenesis; IEA:Ensembl
O75952	CABYR	Calcium-binding tyrosine phosphorylation-regulated protein	GO:0005509; F:calcium ion binding; IDA:BHF-UCL
O75952	CABYR	Calcium-binding tyrosine phosphorylation-regulated protein	GO:0019899; F:enzyme binding; IPI:BHF-UCL
O75952	CABYR	Calcium-binding tyrosine phosphorylation-regulated protein	GO:0046982; F:protein heterodimerization activity; ISS:BHF-UCL
O75952	CABYR	Calcium-binding tyrosine phosphorylation-regulated protein	GO:0017124; F:SH3 domain binding; NAS:BHF-UCL
O75952	CABYR	Calcium-binding tyrosine phosphorylation-regulated protein	GO:0003351; P:epithelial cilium movement; NAS:BHF-UCL
O75952	CABYR	Calcium-binding tyrosine phosphorylation-regulated protein	GO:0048240; P:sperm capacitation; NAS:BHF-UCL
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0008331; F:high voltage-gated calcium channel activity; IBA:RefGenome
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0005515; F:protein binding; IPI:UniProtKB
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0019905; F:syntaxin binding; IDA:UniProtKB
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0005245; F:voltage-gated calcium channel activity; IDA:UniProtKB
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0007628; P:adult walking behavior; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0048266; P:behavioral response to pain; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0070509; P:calcium ion import; IBA:RefGenome
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0017156; P:calcium ion-dependent exocytosis; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0048791; P:calcium ion-dependent exocytosis of neurotransmitter; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0008219; P:cell death; IDA:UniProtKB
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0016049; P:cell growth; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0030644; P:cellular chloride ion homeostasis; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0021679; P:cerebellar molecular layer development; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0021702; P:cerebellar Purkinje cell differentiation; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0021590; P:cerebellum maturation; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0048813; P:dendrite morphogenesis; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0014051; P:gamma-aminobutyric acid secretion; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0006006; P:glucose metabolic process; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0042445; P:hormone metabolic process; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0051899; P:membrane depolarization; TAS:Reactome
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0050883; P:musculoskeletal movement, spinal reflex action; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0032353; P:negative regulation of hormone biosynthetic process; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0007274; P:neuromuscular synaptic transmission; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0042133; P:neurotransmitter metabolic process; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0043113; P:receptor clustering; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0014056; P:regulation of acetylcholine secretion, neurotransmission; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0050770; P:regulation of axonogenesis; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0017158; P:regulation of calcium ion-dependent exocytosis; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0060024; P:rhythmic synaptic transmission; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0000096; P:sulfur amino acid metabolic process; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0007416; P:synapse assembly; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0007268; P:synaptic transmission; IBA:RefGenome
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0035249; P:synaptic transmission, glutamatergic; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0019226; P:transmission of nerve impulse; IEA:Ensembl
O00555	CACNA1A	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	GO:0021750; P:vestibular nucleus development; IEA:Ensembl
Q00975	CACNA1B	Voltage-dependent N-type calcium channel subunit alpha-1B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q00975	CACNA1B	Voltage-dependent N-type calcium channel subunit alpha-1B	GO:0005509; F:calcium ion binding; IEA:InterPro
Q00975	CACNA1B	Voltage-dependent N-type calcium channel subunit alpha-1B	GO:0008331; F:high voltage-gated calcium channel activity; IBA:RefGenome
Q00975	CACNA1B	Voltage-dependent N-type calcium channel subunit alpha-1B	GO:0005515; F:protein binding; IPI:UniProtKB
Q00975	CACNA1B	Voltage-dependent N-type calcium channel subunit alpha-1B	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q00975	CACNA1B	Voltage-dependent N-type calcium channel subunit alpha-1B	GO:0005245; F:voltage-gated calcium channel activity; TAS:ProtInc
Q00975	CACNA1B	Voltage-dependent N-type calcium channel subunit alpha-1B	GO:0070509; P:calcium ion import; IBA:RefGenome
Q00975	CACNA1B	Voltage-dependent N-type calcium channel subunit alpha-1B	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q00975	CACNA1B	Voltage-dependent N-type calcium channel subunit alpha-1B	GO:0051899; P:membrane depolarization; TAS:Reactome
Q00975	CACNA1B	Voltage-dependent N-type calcium channel subunit alpha-1B	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q00975	CACNA1B	Voltage-dependent N-type calcium channel subunit alpha-1B	GO:0007269; P:neurotransmitter secretion; IEA:Ensembl
Q00975	CACNA1B	Voltage-dependent N-type calcium channel subunit alpha-1B	GO:0008217; P:regulation of blood pressure; IEA:Ensembl
Q00975	CACNA1B	Voltage-dependent N-type calcium channel subunit alpha-1B	GO:0051924; P:regulation of calcium ion transport; IEA:Ensembl
Q00975	CACNA1B	Voltage-dependent N-type calcium channel subunit alpha-1B	GO:0008016; P:regulation of heart contraction; IEA:Ensembl
Q00975	CACNA1B	Voltage-dependent N-type calcium channel subunit alpha-1B	GO:0048265; P:response to pain; IEA:Ensembl
Q00975	CACNA1B	Voltage-dependent N-type calcium channel subunit alpha-1B	GO:0007268; P:synaptic transmission; IBA:RefGenome
Q00975	CACNA1B	Voltage-dependent N-type calcium channel subunit alpha-1B	GO:0006810; P:transport; TAS:ProtInc
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0051393; F:alpha-actinin binding; IPI:BHF-UCL
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0005516; F:calmodulin binding; IPI:UniProtKB
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0008331; F:high voltage-gated calcium channel activity; IBA:RefGenome
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0005515; F:protein binding; IPI:UniProtKB
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0005245; F:voltage-gated calcium channel activity; IDA:UniProtKB
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0007628; P:adult walking behavior; IEA:Ensembl
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0007411; P:axon guidance; TAS:Reactome
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0070509; P:calcium ion import; IBA:RefGenome
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0060402; P:calcium ion transport into cytosol; TAS:BHF-UCL
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0017156; P:calcium ion-dependent exocytosis; IEA:Ensembl
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0035585; P:calcium-mediated signaling using extracellular calcium source; TAS:BHF-UCL
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0086064; P:cell communication by electrical coupling involved in cardiac conduction; TAS:BHF-UCL
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0042593; P:glucose homeostasis; IEA:Ensembl
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0030252; P:growth hormone secretion; IEA:Ensembl
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0030073; P:insulin secretion; IEA:Ensembl
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0008217; P:regulation of blood pressure; IEA:Ensembl
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; TAS:BHF-UCL
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0046620; P:regulation of organ growth; IEA:Ensembl
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0019229; P:regulation of vasoconstriction; IEA:Ensembl
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0060083; P:smooth muscle contraction involved in micturition; IEA:Ensembl
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0007268; P:synaptic transmission; IEA:Ensembl
Q13936	CACNA1C	Voltage-dependent L-type calcium channel subunit alpha-1C	GO:0008542; P:visual learning; IEA:Ensembl
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0051393; F:alpha-actinin binding; IPI:BHF-UCL
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0030506; F:ankyrin binding; ISS:BHF-UCL
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0008331; F:high voltage-gated calcium channel activity; IEA:Ensembl
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0005245; F:voltage-gated calcium channel activity; IDA:UniProtKB
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0086007; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential; IC:BHF-UCL
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0086059; F:voltage-gated calcium channel activity involved SA node cell action potential; IMP:BHF-UCL
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; ISS:BHF-UCL
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0007411; P:axon guidance; TAS:Reactome
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0070509; P:calcium ion import; IDA:BHF-UCL
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0070588; P:calcium ion transmembrane transport; ISS:BHF-UCL
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0006816; P:calcium ion transport; IDA:UniProtKB
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0086012; P:membrane depolarization during cardiac muscle cell action potential; IC:BHF-UCL
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0086052; P:membrane repolarization during SA node cell action potential; IMP:BHF-UCL
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0051928; P:positive regulation of calcium ion transport; IDA:BHF-UCL
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0060372; P:regulation of atrial cardiac muscle cell membrane repolarization; ISS:BHF-UCL
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:1901379; P:regulation of potassium ion transmembrane transport; ISS:BHF-UCL
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:1901016; P:regulation of potassium ion transmembrane transporter activity; ISS:BHF-UCL
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0007605; P:sensory perception of sound; IMP:BHF-UCL
Q01668	CACNA1D	Voltage-dependent L-type calcium channel subunit alpha-1D	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0005509; F:calcium ion binding; IEA:InterPro
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0008331; F:high voltage-gated calcium channel activity; IBA:RefGenome
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0005245; F:voltage-gated calcium channel activity; IDA:MGI
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0001662; P:behavioral fear response; IEA:Ensembl
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0048266; P:behavioral response to pain; IEA:Ensembl
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0070509; P:calcium ion import; IBA:RefGenome
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0042593; P:glucose homeostasis; IEA:Ensembl
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0051899; P:membrane depolarization; TAS:Reactome
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0002027; P:regulation of heart rate; IEA:Ensembl
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0090273; P:regulation of somatostatin secretion; IEA:Ensembl
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0019233; P:sensory perception of pain; IEA:Ensembl
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0030317; P:sperm motility; IEA:Ensembl
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0007268; P:synaptic transmission; IBA:RefGenome
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0019226; P:transmission of nerve impulse; IEA:Ensembl
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0006810; P:transport; TAS:ProtInc
Q15878	CACNA1E	Voltage-dependent R-type calcium channel subunit alpha-1E	GO:0008542; P:visual learning; IEA:Ensembl
O43497	CACNA1G	Voltage-dependent T-type calcium channel subunit alpha-1G	GO:0008332; F:low voltage-gated calcium channel activity; IDA:BHF-UCL
O43497	CACNA1G	Voltage-dependent T-type calcium channel subunit alpha-1G	GO:0097110; F:scaffold protein binding; IPI:BHF-UCL
O43497	CACNA1G	Voltage-dependent T-type calcium channel subunit alpha-1G	GO:0007411; P:axon guidance; TAS:Reactome
O43497	CACNA1G	Voltage-dependent T-type calcium channel subunit alpha-1G	GO:0070509; P:calcium ion import; IDA:BHF-UCL
O43497	CACNA1G	Voltage-dependent T-type calcium channel subunit alpha-1G	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
O43497	CACNA1G	Voltage-dependent T-type calcium channel subunit alpha-1G	GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; IBA:RefGenome
O43497	CACNA1G	Voltage-dependent T-type calcium channel subunit alpha-1G	GO:0060371; P:regulation of atrial cardiac muscle cell membrane depolarization; IEA:Ensembl
O43497	CACNA1G	Voltage-dependent T-type calcium channel subunit alpha-1G	GO:0002027; P:regulation of heart rate; IEA:Ensembl
O43497	CACNA1G	Voltage-dependent T-type calcium channel subunit alpha-1G	GO:0042391; P:regulation of membrane potential; IDA:BHF-UCL
O43497	CACNA1G	Voltage-dependent T-type calcium channel subunit alpha-1G	GO:0010045; P:response to nickel cation; IEA:Ensembl
O43497	CACNA1G	Voltage-dependent T-type calcium channel subunit alpha-1G	GO:0007268; P:synaptic transmission; IEA:Ensembl
O43497	CACNA1G	Voltage-dependent T-type calcium channel subunit alpha-1G	GO:0006810; P:transport; TAS:ProtInc
O60840	CACNA1F	Voltage-dependent L-type calcium channel subunit alpha-1F	GO:0008331; F:high voltage-gated calcium channel activity; IBA:RefGenome
O60840	CACNA1F	Voltage-dependent L-type calcium channel subunit alpha-1F	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60840	CACNA1F	Voltage-dependent L-type calcium channel subunit alpha-1F	GO:0005245; F:voltage-gated calcium channel activity; IDA:UniProtKB
O60840	CACNA1F	Voltage-dependent L-type calcium channel subunit alpha-1F	GO:0007409; P:axonogenesis; IEA:Ensembl
O60840	CACNA1F	Voltage-dependent L-type calcium channel subunit alpha-1F	GO:0070509; P:calcium ion import; IBA:RefGenome
O60840	CACNA1F	Voltage-dependent L-type calcium channel subunit alpha-1F	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
O60840	CACNA1F	Voltage-dependent L-type calcium channel subunit alpha-1F	GO:0048813; P:dendrite morphogenesis; IEA:Ensembl
O60840	CACNA1F	Voltage-dependent L-type calcium channel subunit alpha-1F	GO:0050908; P:detection of light stimulus involved in visual perception; IMP:UniProtKB
O60840	CACNA1F	Voltage-dependent L-type calcium channel subunit alpha-1F	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
O60840	CACNA1F	Voltage-dependent L-type calcium channel subunit alpha-1F	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
O60840	CACNA1F	Voltage-dependent L-type calcium channel subunit alpha-1F	GO:0007601; P:visual perception; IMP:UniProtKB
O95180	CACNA1H	Voltage-dependent T-type calcium channel subunit alpha-1H	GO:0008332; F:low voltage-gated calcium channel activity; IDA:BHF-UCL
O95180	CACNA1H	Voltage-dependent T-type calcium channel subunit alpha-1H	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95180	CACNA1H	Voltage-dependent T-type calcium channel subunit alpha-1H	GO:0097110; F:scaffold protein binding; IPI:BHF-UCL
O95180	CACNA1H	Voltage-dependent T-type calcium channel subunit alpha-1H	GO:0032342; P:aldosterone biosynthetic process; IMP:UniProtKB
O95180	CACNA1H	Voltage-dependent T-type calcium channel subunit alpha-1H	GO:0007411; P:axon guidance; TAS:Reactome
O95180	CACNA1H	Voltage-dependent T-type calcium channel subunit alpha-1H	GO:0070509; P:calcium ion import; IDA:BHF-UCL
O95180	CACNA1H	Voltage-dependent T-type calcium channel subunit alpha-1H	GO:0032870; P:cellular response to hormone stimulus; IEP:UniProtKB
O95180	CACNA1H	Voltage-dependent T-type calcium channel subunit alpha-1H	GO:0035865; P:cellular response to potassium ion; IEP:UniProtKB
O95180	CACNA1H	Voltage-dependent T-type calcium channel subunit alpha-1H	GO:0034651; P:cortisol biosynthetic process; IMP:UniProtKB
O95180	CACNA1H	Voltage-dependent T-type calcium channel subunit alpha-1H	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
O95180	CACNA1H	Voltage-dependent T-type calcium channel subunit alpha-1H	GO:0006936; P:muscle contraction; TAS:ProtInc
O95180	CACNA1H	Voltage-dependent T-type calcium channel subunit alpha-1H	GO:0007517; P:muscle organ development; NAS:ProtInc
O95180	CACNA1H	Voltage-dependent T-type calcium channel subunit alpha-1H	GO:0007520; P:myoblast fusion; TAS:ProtInc
O95180	CACNA1H	Voltage-dependent T-type calcium channel subunit alpha-1H	GO:2000344; P:positive regulation of acrosome reaction; IMP:UniProtKB
O95180	CACNA1H	Voltage-dependent T-type calcium channel subunit alpha-1H	GO:0008016; P:regulation of heart contraction; TAS:ProtInc
O95180	CACNA1H	Voltage-dependent T-type calcium channel subunit alpha-1H	GO:0042391; P:regulation of membrane potential; IDA:BHF-UCL
O95180	CACNA1H	Voltage-dependent T-type calcium channel subunit alpha-1H	GO:0006810; P:transport; TAS:ProtInc
Q9P0X4	CACNA1I	Voltage-dependent T-type calcium channel subunit alpha-1I	GO:0005515; F:protein binding; IPI:IntAct
Q9P0X4	CACNA1I	Voltage-dependent T-type calcium channel subunit alpha-1I	GO:0005245; F:voltage-gated calcium channel activity; IBA:RefGenome
Q9P0X4	CACNA1I	Voltage-dependent T-type calcium channel subunit alpha-1I	GO:0007411; P:axon guidance; TAS:Reactome
Q9P0X4	CACNA1I	Voltage-dependent T-type calcium channel subunit alpha-1I	GO:0070509; P:calcium ion import; IBA:RefGenome
Q9P0X4	CACNA1I	Voltage-dependent T-type calcium channel subunit alpha-1I	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q9P0X4	CACNA1I	Voltage-dependent T-type calcium channel subunit alpha-1I	GO:0019228; P:neuronal action potential; IEA:Ensembl
Q9P0X4	CACNA1I	Voltage-dependent T-type calcium channel subunit alpha-1I	GO:0007165; P:signal transduction; TAS:ProtInc
Q9P0X4	CACNA1I	Voltage-dependent T-type calcium channel subunit alpha-1I	GO:0030431; P:sleep; IEA:Ensembl
Q9P0X4	CACNA1I	Voltage-dependent T-type calcium channel subunit alpha-1I	GO:0006810; P:transport; TAS:ProtInc
Q13698	CACNA1S	Voltage-dependent L-type calcium channel subunit alpha-1S	GO:0008331; F:high voltage-gated calcium channel activity; IDA:UniProtKB
Q13698	CACNA1S	Voltage-dependent L-type calcium channel subunit alpha-1S	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13698	CACNA1S	Voltage-dependent L-type calcium channel subunit alpha-1S	GO:0005245; F:voltage-gated calcium channel activity; IDA:UniProtKB
Q13698	CACNA1S	Voltage-dependent L-type calcium channel subunit alpha-1S	GO:0007411; P:axon guidance; TAS:Reactome
Q13698	CACNA1S	Voltage-dependent L-type calcium channel subunit alpha-1S	GO:0070509; P:calcium ion import; IBA:RefGenome
Q13698	CACNA1S	Voltage-dependent L-type calcium channel subunit alpha-1S	GO:0006816; P:calcium ion transport; IDA:UniProtKB
Q13698	CACNA1S	Voltage-dependent L-type calcium channel subunit alpha-1S	GO:0007029; P:endoplasmic reticulum organization; IEA:Ensembl
Q13698	CACNA1S	Voltage-dependent L-type calcium channel subunit alpha-1S	GO:0002074; P:extraocular skeletal muscle development; IEA:Ensembl
Q13698	CACNA1S	Voltage-dependent L-type calcium channel subunit alpha-1S	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q13698	CACNA1S	Voltage-dependent L-type calcium channel subunit alpha-1S	GO:0006936; P:muscle contraction; IMP:UniProtKB
Q13698	CACNA1S	Voltage-dependent L-type calcium channel subunit alpha-1S	GO:0007520; P:myoblast fusion; IEA:Ensembl
Q13698	CACNA1S	Voltage-dependent L-type calcium channel subunit alpha-1S	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
Q13698	CACNA1S	Voltage-dependent L-type calcium channel subunit alpha-1S	GO:0043501; P:skeletal muscle adaptation; IEA:Ensembl
Q13698	CACNA1S	Voltage-dependent L-type calcium channel subunit alpha-1S	GO:0048741; P:skeletal muscle fiber development; IEA:Ensembl
Q13698	CACNA1S	Voltage-dependent L-type calcium channel subunit alpha-1S	GO:0001501; P:skeletal system development; IEA:Ensembl
Q13698	CACNA1S	Voltage-dependent L-type calcium channel subunit alpha-1S	GO:0006941; P:striated muscle contraction; IEA:Ensembl
Q02641	CACNB1	Voltage-dependent L-type calcium channel subunit beta-1	GO:0008331; F:high voltage-gated calcium channel activity; IEA:Ensembl
Q02641	CACNB1	Voltage-dependent L-type calcium channel subunit beta-1	GO:0005245; F:voltage-gated calcium channel activity; TAS:ProtInc
Q02641	CACNB1	Voltage-dependent L-type calcium channel subunit beta-1	GO:0007411; P:axon guidance; TAS:Reactome
Q02641	CACNB1	Voltage-dependent L-type calcium channel subunit beta-1	GO:0006612; P:protein targeting to membrane; IEA:Ensembl
Q02641	CACNB1	Voltage-dependent L-type calcium channel subunit beta-1	GO:0006810; P:transport; TAS:ProtInc
Q08289	CACNB2	Voltage-dependent L-type calcium channel subunit beta-2	GO:0005262; F:calcium channel activity; NAS:UniProtKB
Q08289	CACNB2	Voltage-dependent L-type calcium channel subunit beta-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q08289	CACNB2	Voltage-dependent L-type calcium channel subunit beta-2	GO:0005245; F:voltage-gated calcium channel activity; IDA:BHF-UCL
Q08289	CACNB2	Voltage-dependent L-type calcium channel subunit beta-2	GO:0007411; P:axon guidance; TAS:Reactome
Q08289	CACNB2	Voltage-dependent L-type calcium channel subunit beta-2	GO:0070509; P:calcium ion import; IDA:BHF-UCL
Q08289	CACNB2	Voltage-dependent L-type calcium channel subunit beta-2	GO:0007528; P:neuromuscular junction development; TAS:ProtInc
Q08289	CACNB2	Voltage-dependent L-type calcium channel subunit beta-2	GO:0051928; P:positive regulation of calcium ion transport; IDA:BHF-UCL
Q08289	CACNB2	Voltage-dependent L-type calcium channel subunit beta-2	GO:0007268; P:synaptic transmission; IEA:Ensembl
Q08289	CACNB2	Voltage-dependent L-type calcium channel subunit beta-2	GO:0006810; P:transport; TAS:ProtInc
Q08289	CACNB2	Voltage-dependent L-type calcium channel subunit beta-2	GO:0007601; P:visual perception; IEA:Ensembl
P54284	CACNB3	Voltage-dependent L-type calcium channel subunit beta-3	GO:0005245; F:voltage-gated calcium channel activity; TAS:ProtInc
P54284	CACNB3	Voltage-dependent L-type calcium channel subunit beta-3	GO:0007411; P:axon guidance; TAS:Reactome
P54284	CACNB3	Voltage-dependent L-type calcium channel subunit beta-3	GO:0006816; P:calcium ion transport; IDA:UniProtKB
P54284	CACNB3	Voltage-dependent L-type calcium channel subunit beta-3	GO:0051899; P:membrane depolarization; TAS:Reactome
P54284	CACNB3	Voltage-dependent L-type calcium channel subunit beta-3	GO:0007268; P:synaptic transmission; TAS:Reactome
P54284	CACNB3	Voltage-dependent L-type calcium channel subunit beta-3	GO:0050852; P:T cell receptor signaling pathway; IEA:Ensembl
P54284	CACNB3	Voltage-dependent L-type calcium channel subunit beta-3	GO:0006810; P:transport; TAS:ProtInc
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0005515; F:protein binding; IPI:IntAct
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0005245; F:voltage-gated calcium channel activity; IEA:Ensembl
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0007628; P:adult walking behavior; IEA:Ensembl
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0007411; P:axon guidance; TAS:Reactome
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0070588; P:calcium ion transmembrane transport; IDA:GOC
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0046058; P:cAMP metabolic process; IEA:Ensembl
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0050908; P:detection of light stimulus involved in visual perception; IEA:Ensembl
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0014051; P:gamma-aminobutyric acid secretion; IEA:Ensembl
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:Ensembl
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0051899; P:membrane depolarization; TAS:Reactome
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0048747; P:muscle fiber development; IEA:Ensembl
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0019227; P:neuronal action potential propagation; IEA:Ensembl
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0048541; P:Peyer's patch development; IEA:Ensembl
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:1901385; P:regulation of voltage-gated calcium channel activity; IMP:UniProtKB
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0048536; P:spleen development; IEA:Ensembl
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0007268; P:synaptic transmission; TAS:Reactome
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0035249; P:synaptic transmission, glutamatergic; IEA:Ensembl
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0050852; P:T cell receptor signaling pathway; IEA:Ensembl
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0048538; P:thymus development; IEA:Ensembl
O00305	CACNB4	Voltage-dependent L-type calcium channel subunit beta-4	GO:0006810; P:transport; TAS:ProtInc
Q86Y37	CACUL1	CDK2-associated and cullin domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q86Y37	CACUL1	CDK2-associated and cullin domain-containing protein 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q86Y37	CACUL1	CDK2-associated and cullin domain-containing protein 1	GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:UniProtKB
Q86Y37	CACUL1	CDK2-associated and cullin domain-containing protein 1	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
Q86Y37	CACUL1	CDK2-associated and cullin domain-containing protein 1	GO:0045860; P:positive regulation of protein kinase activity; IMP:UniProtKB
Q86Y37	CACUL1	CDK2-associated and cullin domain-containing protein 1	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q9P1Z2	CALCOCO1	Calcium-binding and coiled-coil domain-containing protein 1	GO:0070016; F:armadillo repeat domain binding; IPI:UniProtKB
Q9P1Z2	CALCOCO1	Calcium-binding and coiled-coil domain-containing protein 1	GO:0008013; F:beta-catenin binding; IPI:AgBase
Q9P1Z2	CALCOCO1	Calcium-binding and coiled-coil domain-containing protein 1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9P1Z2	CALCOCO1	Calcium-binding and coiled-coil domain-containing protein 1	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IDA:AgBase
Q9P1Z2	CALCOCO1	Calcium-binding and coiled-coil domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P1Z2	CALCOCO1	Calcium-binding and coiled-coil domain-containing protein 1	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q9P1Z2	CALCOCO1	Calcium-binding and coiled-coil domain-containing protein 1	GO:0043565; F:sequence-specific DNA binding; IDA:AgBase
Q9P1Z2	CALCOCO1	Calcium-binding and coiled-coil domain-containing protein 1	GO:0003713; F:transcription coactivator activity; IMP:UniProtKB
Q9P1Z2	CALCOCO1	Calcium-binding and coiled-coil domain-containing protein 1	GO:0003712; F:transcription cofactor activity; IDA:UniProtKB
Q9P1Z2	CALCOCO1	Calcium-binding and coiled-coil domain-containing protein 1	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q9P1Z2	CALCOCO1	Calcium-binding and coiled-coil domain-containing protein 1	GO:0030518; P:intracellular steroid hormone receptor signaling pathway; ISS:HGNC
Q9P1Z2	CALCOCO1	Calcium-binding and coiled-coil domain-containing protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9P1Z2	CALCOCO1	Calcium-binding and coiled-coil domain-containing protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q9P1Z2	CALCOCO1	Calcium-binding and coiled-coil domain-containing protein 1	GO:0007165; P:signal transduction; ISS:HGNC
Q9P1Z2	CALCOCO1	Calcium-binding and coiled-coil domain-containing protein 1	GO:0006351; P:transcription, DNA-templated; ISS:HGNC
Q9P1Z2	CALCOCO1	Calcium-binding and coiled-coil domain-containing protein 1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q13137	CALCOCO2	Calcium-binding and coiled-coil domain-containing protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q13137	CALCOCO2	Calcium-binding and coiled-coil domain-containing protein 2	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q13137	CALCOCO2	Calcium-binding and coiled-coil domain-containing protein 2	GO:0034341; P:response to interferon-gamma; IDA:BHF-UCL
Q13137	CALCOCO2	Calcium-binding and coiled-coil domain-containing protein 2	GO:0016032; P:viral process; TAS:ProtInc
P43155	CRAT	Carnitine O-acetyltransferase	GO:0004092; F:carnitine O-acetyltransferase activity; IDA:UniProtKB
P43155	CRAT	Carnitine O-acetyltransferase	GO:0005102; F:receptor binding; IPI:UniProtKB
P43155	CRAT	Carnitine O-acetyltransferase	GO:0019254; P:carnitine metabolic process, CoA-linked; IDA:UniProtKB
P43155	CRAT	Carnitine O-acetyltransferase	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P43155	CRAT	Carnitine O-acetyltransferase	GO:0033540; P:fatty acid beta-oxidation using acyl-CoA oxidase; TAS:Reactome
P43155	CRAT	Carnitine O-acetyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P43155	CRAT	Carnitine O-acetyltransferase	GO:0006810; P:transport; IEA:UniProtKB-KW
Q9Y6N8	CDH10	Cadherin-10	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y6N8	CDH10	Cadherin-10	GO:0034332; P:adherens junction organization; TAS:Reactome
Q9Y6N8	CDH10	Cadherin-10	GO:0034329; P:cell junction assembly; TAS:Reactome
Q9Y6N8	CDH10	Cadherin-10	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
Q9Y6N8	CDH10	Cadherin-10	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q9Y6N8	CDH10	Cadherin-10	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
P55287	CDH11	Cadherin-11	GO:0005509; F:calcium ion binding; IEA:InterPro
P55287	CDH11	Cadherin-11	GO:0034332; P:adherens junction organization; TAS:Reactome
P55287	CDH11	Cadherin-11	GO:0007155; P:cell adhesion; TAS:ProtInc
P55287	CDH11	Cadherin-11	GO:0034329; P:cell junction assembly; TAS:Reactome
P55287	CDH11	Cadherin-11	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P55287	CDH11	Cadherin-11	GO:0021957; P:corticospinal tract morphogenesis; IEA:Ensembl
P55287	CDH11	Cadherin-11	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
P55287	CDH11	Cadherin-11	GO:0001503; P:ossification; NAS:UniProtKB
P55287	CDH11	Cadherin-11	GO:0001501; P:skeletal system development; TAS:ProtInc
P55289	CDH12	Cadherin-12	GO:0005509; F:calcium ion binding; IEA:InterPro
P55289	CDH12	Cadherin-12	GO:0034332; P:adherens junction organization; TAS:Reactome
P55289	CDH12	Cadherin-12	GO:0034329; P:cell junction assembly; TAS:Reactome
P55289	CDH12	Cadherin-12	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P55289	CDH12	Cadherin-12	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
P55290	CDH13	Cadherin-13	GO:0055100; F:adiponectin binding; ISS:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0045296; F:cadherin binding; IDA:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0005509; F:calcium ion binding; IEA:InterPro
P55290	CDH13	Cadherin-13	GO:0071813; F:lipoprotein particle binding; IDA:UniProtKB
P55290	CDH13	Cadherin-13	GO:0030169; F:low-density lipoprotein particle binding; IDA:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0034332; P:adherens junction organization; TAS:Reactome
P55290	CDH13	Cadherin-13	GO:0016339; P:calcium-dependent cell-cell adhesion; IDA:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0034329; P:cell junction assembly; TAS:Reactome
P55290	CDH13	Cadherin-13	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P55290	CDH13	Cadherin-13	GO:0043542; P:endothelial cell migration; IDA:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0007156; P:homophilic cell adhesion; IDA:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0043616; P:keratinocyte proliferation; IDA:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0030032; P:lamellipodium assembly; IDA:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0051668; P:localization within membrane; IMP:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0055096; P:low-density lipoprotein particle mediated signaling; IDA:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0000278; P:mitotic cell cycle; IEA:Ensembl
P55290	CDH13	Cadherin-13	GO:0007162; P:negative regulation of cell adhesion; IDA:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0050850; P:positive regulation of calcium-mediated signaling; IDA:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0030335; P:positive regulation of cell migration; IDA:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0001954; P:positive regulation of cell-matrix adhesion; IMP:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0050927; P:positive regulation of positive chemotaxis; IDA:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IMP:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0016601; P:Rac protein signal transduction; IMP:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0001558; P:regulation of cell growth; IEA:Ensembl
P55290	CDH13	Cadherin-13	GO:0030100; P:regulation of endocytosis; IMP:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0042058; P:regulation of epidermal growth factor receptor signaling pathway; IMP:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0007266; P:Rho protein signal transduction; IMP:BHF-UCL
P55290	CDH13	Cadherin-13	GO:0002040; P:sprouting angiogenesis; IDA:BHF-UCL
P55291	CDH15	Cadherin-15	GO:0005509; F:calcium ion binding; IEA:InterPro
P55291	CDH15	Cadherin-15	GO:0034332; P:adherens junction organization; TAS:Reactome
P55291	CDH15	Cadherin-15	GO:0007155; P:cell adhesion; TAS:ProtInc
P55291	CDH15	Cadherin-15	GO:0034329; P:cell junction assembly; TAS:Reactome
P55291	CDH15	Cadherin-15	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P55291	CDH15	Cadherin-15	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
P55291	CDH15	Cadherin-15	GO:0042692; P:muscle cell differentiation; TAS:Reactome
P55291	CDH15	Cadherin-15	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
Q12864	CDH17	Cadherin-17	GO:0005509; F:calcium ion binding; IEA:InterPro
Q12864	CDH17	Cadherin-17	GO:0005427; F:proton-dependent oligopeptide secondary active transmembrane transporter activity; IEA:Ensembl
Q12864	CDH17	Cadherin-17	GO:0005215; F:transporter activity; TAS:ProtInc
Q12864	CDH17	Cadherin-17	GO:0016339; P:calcium-dependent cell-cell adhesion; IEA:Ensembl
Q12864	CDH17	Cadherin-17	GO:0007155; P:cell adhesion; TAS:ProtInc
Q12864	CDH17	Cadherin-17	GO:0007156; P:homophilic cell adhesion; IEA:Ensembl
Q12864	CDH17	Cadherin-17	GO:0006810; P:transport; NAS:ProtInc
O75309	CDH16	Cadherin-16	GO:0005509; F:calcium ion binding; IEA:InterPro
O75309	CDH16	Cadherin-16	GO:0007155; P:cell adhesion; TAS:ProtInc
O75309	CDH16	Cadherin-16	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q13634	CDH18	Cadherin-18	GO:0005509; F:calcium ion binding; IEA:InterPro
Q13634	CDH18	Cadherin-18	GO:0034332; P:adherens junction organization; TAS:Reactome
Q13634	CDH18	Cadherin-18	GO:0034329; P:cell junction assembly; TAS:Reactome
Q13634	CDH18	Cadherin-18	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q13634	CDH18	Cadherin-18	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9H159	CDH19	Cadherin-19	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9H159	CDH19	Cadherin-19	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9HBT6	CDH20	Cadherin-20	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9HBT6	CDH20	Cadherin-20	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9UJ99	CDH22	Cadherin-22	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UJ99	CDH22	Cadherin-22	GO:0007420; P:brain development; IEA:Ensembl
Q9UJ99	CDH22	Cadherin-22	GO:0016339; P:calcium-dependent cell-cell adhesion; IEA:Ensembl
Q9UJ99	CDH22	Cadherin-22	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9H251	CDH23	Cadherin-23	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9H251	CDH23	Cadherin-23	GO:0005515; F:protein binding; IPI:HGNC
Q9H251	CDH23	Cadherin-23	GO:0006816; P:calcium ion transport; IMP:DFLAT
Q9H251	CDH23	Cadherin-23	GO:0016339; P:calcium-dependent cell-cell adhesion; NAS:UniProtKB
Q9H251	CDH23	Cadherin-23	GO:0051480; P:cytosolic calcium ion homeostasis; IMP:DFLAT
Q9H251	CDH23	Cadherin-23	GO:0050957; P:equilibrioception; IMP:HGNC
Q9H251	CDH23	Cadherin-23	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9H251	CDH23	Cadherin-23	GO:0045494; P:photoreceptor cell maintenance; IMP:HGNC
Q9H251	CDH23	Cadherin-23	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q9H251	CDH23	Cadherin-23	GO:0050953; P:sensory perception of light stimulus; IMP:HGNC
Q9H251	CDH23	Cadherin-23	GO:0007605; P:sensory perception of sound; IMP:DFLAT
Q9H251	CDH23	Cadherin-23	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q86UP0	CDH24	Cadherin-24	GO:0045294; F:alpha-catenin binding; IPI:UniProtKB
Q86UP0	CDH24	Cadherin-24	GO:0008013; F:beta-catenin binding; IPI:UniProtKB
Q86UP0	CDH24	Cadherin-24	GO:0005509; F:calcium ion binding; IDA:MGI
Q86UP0	CDH24	Cadherin-24	GO:0070097; F:delta-catenin binding; IPI:UniProtKB
Q86UP0	CDH24	Cadherin-24	GO:0034332; P:adherens junction organization; TAS:Reactome
Q86UP0	CDH24	Cadherin-24	GO:0034329; P:cell junction assembly; TAS:Reactome
Q86UP0	CDH24	Cadherin-24	GO:0016337; P:single organismal cell-cell adhesion; IDA:MGI
Q86UP0	CDH24	Cadherin-24	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q86UP0	CDH24	Cadherin-24	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q8IXH8	CDH26	Cadherin-like protein 26	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8IXH8	CDH26	Cadherin-like protein 26	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
P12830	CDH1	Cadherin-1	GO:0030506; F:ankyrin binding; IPI:BHF-UCL
P12830	CDH1	Cadherin-1	GO:0008013; F:beta-catenin binding; IDA:BHF-UCL
P12830	CDH1	Cadherin-1	GO:0005509; F:calcium ion binding; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0050839; F:cell adhesion molecule binding; NAS:BHF-UCL
P12830	CDH1	Cadherin-1	GO:0045295; F:gamma-catenin binding; IPI:BHF-UCL
P12830	CDH1	Cadherin-1	GO:0001948; F:glycoprotein binding; IPI:UniProt
P12830	CDH1	Cadherin-1	GO:0032794; F:GTPase activating protein binding; IPI:UniProtKB
P12830	CDH1	Cadherin-1	GO:0005515; F:protein binding; IPI:UniProtKB
P12830	CDH1	Cadherin-1	GO:0034332; P:adherens junction organization; TAS:Reactome
P12830	CDH1	Cadherin-1	GO:0006915; P:apoptotic process; TAS:Reactome
P12830	CDH1	Cadherin-1	GO:0034329; P:cell junction assembly; TAS:Reactome
P12830	CDH1	Cadherin-1	GO:0016337; P:single organismal cell-cell adhesion; IDA:BHF-UCL
P12830	CDH1	Cadherin-1	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P12830	CDH1	Cadherin-1	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
P12830	CDH1	Cadherin-1	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0071681; P:cellular response to indole-3-methanol; IDA:UniProtKB
P12830	CDH1	Cadherin-1	GO:0071285; P:cellular response to lithium ion; IDA:UniProtKB
P12830	CDH1	Cadherin-1	GO:0090102; P:cochlea development; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0003382; P:epithelial cell morphogenesis; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0090002; P:establishment of protein localization to plasma membrane; IMP:UniProt
P12830	CDH1	Cadherin-1	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P12830	CDH1	Cadherin-1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P12830	CDH1	Cadherin-1	GO:0007156; P:homophilic cell adhesion; NAS:UniProtKB
P12830	CDH1	Cadherin-1	GO:0060576; P:intestinal epithelial cell development; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0022408; P:negative regulation of cell-cell adhesion; IMP:UniProtKB
P12830	CDH1	Cadherin-1	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0031175; P:neuron projection development; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0021983; P:pituitary gland development; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0042993; P:positive regulation of transcription factor import into nucleus; IDA:BHF-UCL
P12830	CDH1	Cadherin-1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
P12830	CDH1	Cadherin-1	GO:0051260; P:protein homooligomerization; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0072659; P:protein localization to plasma membrane; IDA:BHF-UCL
P12830	CDH1	Cadherin-1	GO:0019538; P:protein metabolic process; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0060693; P:regulation of branching involved in salivary gland morphogenesis; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0043281; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0050776; P:regulation of immune response; TAS:Reactome
P12830	CDH1	Cadherin-1	GO:2000008; P:regulation of protein localization to cell surface; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0033561; P:regulation of water loss via skin; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0042493; P:response to drug; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0009636; P:response to toxic substance; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0060662; P:salivary gland cavitation; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0007605; P:sensory perception of sound; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0007416; P:synapse assembly; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0070830; P:tight junction assembly; IEA:Ensembl
P12830	CDH1	Cadherin-1	GO:0001829; P:trophectodermal cell differentiation; IEA:Ensembl
P19022	CDH2	Cadherin-2	GO:0045294; F:alpha-catenin binding; IPI:BHF-UCL
P19022	CDH2	Cadherin-2	GO:0008013; F:beta-catenin binding; TAS:AgBase
P19022	CDH2	Cadherin-2	GO:0005509; F:calcium ion binding; IEA:InterPro
P19022	CDH2	Cadherin-2	GO:0045295; F:gamma-catenin binding; IPI:BHF-UCL
P19022	CDH2	Cadherin-2	GO:0005515; F:protein binding; IPI:IntAct
P19022	CDH2	Cadherin-2	GO:0034332; P:adherens junction organization; TAS:Reactome
P19022	CDH2	Cadherin-2	GO:0048514; P:blood vessel morphogenesis; IEA:Ensembl
P19022	CDH2	Cadherin-2	GO:0016339; P:calcium-dependent cell-cell adhesion; IEA:Ensembl
P19022	CDH2	Cadherin-2	GO:0007155; P:cell adhesion; TAS:ProtInc
P19022	CDH2	Cadherin-2	GO:0034329; P:cell junction assembly; TAS:Reactome
P19022	CDH2	Cadherin-2	GO:0016477; P:cell migration; IEA:Ensembl
P19022	CDH2	Cadherin-2	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P19022	CDH2	Cadherin-2	GO:0007157; P:heterophilic cell-cell adhesion; IEA:Ensembl
P19022	CDH2	Cadherin-2	GO:0007156; P:homophilic cell adhesion; IEA:Ensembl
P19022	CDH2	Cadherin-2	GO:0042692; P:muscle cell differentiation; TAS:Reactome
P19022	CDH2	Cadherin-2	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEA:Ensembl
P19022	CDH2	Cadherin-2	GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl
P19022	CDH2	Cadherin-2	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
P19022	CDH2	Cadherin-2	GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl
P22223	CDH3	Cadherin-3	GO:0005509; F:calcium ion binding; IEA:InterPro
P22223	CDH3	Cadherin-3	GO:0034332; P:adherens junction organization; TAS:Reactome
P22223	CDH3	Cadherin-3	GO:0060070; P:canonical Wnt signaling pathway; IMP:UniProt
P22223	CDH3	Cadherin-3	GO:0007155; P:cell adhesion; TAS:ProtInc
P22223	CDH3	Cadherin-3	GO:0034329; P:cell junction assembly; TAS:Reactome
P22223	CDH3	Cadherin-3	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P22223	CDH3	Cadherin-3	GO:0022405; P:hair cycle process; IMP:UniProt
P22223	CDH3	Cadherin-3	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
P22223	CDH3	Cadherin-3	GO:0031424; P:keratinization; IMP:UniProt
P22223	CDH3	Cadherin-3	GO:0051796; P:negative regulation of catagen; IMP:UniProt
P22223	CDH3	Cadherin-3	GO:0032912; P:negative regulation of transforming growth factor beta2 production; IMP:UniProt
P22223	CDH3	Cadherin-3	GO:0010628; P:positive regulation of gene expression; IMP:UniProt
P22223	CDH3	Cadherin-3	GO:0043568; P:positive regulation of insulin-like growth factor receptor signaling pathway; IMP:UniProt
P22223	CDH3	Cadherin-3	GO:0010838; P:positive regulation of keratinocyte proliferation; IMP:UniProt
P22223	CDH3	Cadherin-3	GO:0048023; P:positive regulation of melanin biosynthetic process; IMP:UniProt
P22223	CDH3	Cadherin-3	GO:0032773; P:positive regulation of monophenol monooxygenase activity; IMP:UniProt
P22223	CDH3	Cadherin-3	GO:0060901; P:regulation of hair cycle by canonical Wnt signaling pathway; IMP:UniProt
P22223	CDH3	Cadherin-3	GO:0042493; P:response to drug; IEA:Ensembl
P22223	CDH3	Cadherin-3	GO:0001895; P:retina homeostasis; IMP:UniProt
P22223	CDH3	Cadherin-3	GO:0007601; P:visual perception; IEA:UniProtKB-KW
P22223	CDH3	Cadherin-3	GO:0042060; P:wound healing; IEA:Ensembl
P55283	CDH4	Cadherin-4	GO:0005509; F:calcium ion binding; IEA:InterPro
P55283	CDH4	Cadherin-4	GO:0034332; P:adherens junction organization; TAS:Reactome
P55283	CDH4	Cadherin-4	GO:0007411; P:axon guidance; IEA:Ensembl
P55283	CDH4	Cadherin-4	GO:0007155; P:cell adhesion; TAS:ProtInc
P55283	CDH4	Cadherin-4	GO:0034329; P:cell junction assembly; TAS:Reactome
P55283	CDH4	Cadherin-4	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P55283	CDH4	Cadherin-4	GO:0007157; P:heterophilic cell-cell adhesion; IEA:Ensembl
P55283	CDH4	Cadherin-4	GO:0007156; P:homophilic cell adhesion; IEA:Ensembl
P55283	CDH4	Cadherin-4	GO:0045773; P:positive regulation of axon extension; IEA:Ensembl
P33151	CDH5	Cadherin-5	GO:0008013; F:beta-catenin binding; IPI:BHF-UCL
P33151	CDH5	Cadherin-5	GO:0005509; F:calcium ion binding; IEA:InterPro
P33151	CDH5	Cadherin-5	GO:0044325; F:ion channel binding; IPI:BHF-UCL
P33151	CDH5	Cadherin-5	GO:0005515; F:protein binding; IPI:UniProtKB
P33151	CDH5	Cadherin-5	GO:0005102; F:receptor binding; IPI:BHF-UCL
P33151	CDH5	Cadherin-5	GO:0034332; P:adherens junction organization; TAS:Reactome
P33151	CDH5	Cadherin-5	GO:0001955; P:blood vessel maturation; IEA:Ensembl
P33151	CDH5	Cadherin-5	GO:0034329; P:cell junction assembly; TAS:Reactome
P33151	CDH5	Cadherin-5	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P33151	CDH5	Cadherin-5	GO:0007156; P:homophilic cell adhesion; TAS:ProtInc
P33151	CDH5	Cadherin-5	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P33151	CDH5	Cadherin-5	GO:2000114; P:regulation of establishment of cell polarity; IMP:UniProtKB
P55285	CDH6	Cadherin-6	GO:0005509; F:calcium ion binding; IEA:InterPro
P55285	CDH6	Cadherin-6	GO:0034332; P:adherens junction organization; TAS:Reactome
P55285	CDH6	Cadherin-6	GO:0007155; P:cell adhesion; TAS:ProtInc
P55285	CDH6	Cadherin-6	GO:0034329; P:cell junction assembly; TAS:Reactome
P55285	CDH6	Cadherin-6	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P55285	CDH6	Cadherin-6	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9ULB5	CDH7	Cadherin-7	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9ULB5	CDH7	Cadherin-7	GO:0034332; P:adherens junction organization; TAS:Reactome
Q9ULB5	CDH7	Cadherin-7	GO:0034329; P:cell junction assembly; TAS:Reactome
Q9ULB5	CDH7	Cadherin-7	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
Q9ULB5	CDH7	Cadherin-7	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q9ULB5	CDH7	Cadherin-7	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
P55286	CDH8	Cadherin-8	GO:0005509; F:calcium ion binding; IEA:InterPro
P55286	CDH8	Cadherin-8	GO:0034332; P:adherens junction organization; TAS:Reactome
P55286	CDH8	Cadherin-8	GO:0007155; P:cell adhesion; TAS:ProtInc
P55286	CDH8	Cadherin-8	GO:0034329; P:cell junction assembly; TAS:Reactome
P55286	CDH8	Cadherin-8	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P55286	CDH8	Cadherin-8	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
P55286	CDH8	Cadherin-8	GO:0009409; P:response to cold; IEA:Ensembl
P55286	CDH8	Cadherin-8	GO:0035249; P:synaptic transmission, glutamatergic; IEA:Ensembl
Q9ULB4	CDH9	Cadherin-9	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9ULB4	CDH9	Cadherin-9	GO:0034332; P:adherens junction organization; TAS:Reactome
Q9ULB4	CDH9	Cadherin-9	GO:0034329; P:cell junction assembly; TAS:Reactome
Q9ULB4	CDH9	Cadherin-9	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
Q9ULB4	CDH9	Cadherin-9	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q9ULB4	CDH9	Cadherin-9	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0030165; F:PDZ domain binding; ISS:UniProtKB
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0008022; F:protein C-terminus binding; ISS:UniProtKB
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0005102; F:receptor binding; IPI:UniProtKB
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0034332; P:adherens junction organization; TAS:Reactome
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0060348; P:bone development; IEA:Ensembl
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0007420; P:brain development; IEA:Ensembl
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0016338; P:calcium-independent cell-cell adhesion; IEA:Ensembl
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0034329; P:cell junction assembly; TAS:Reactome
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0008037; P:cell recognition; IDA:UniProtKB
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0051606; P:detection of stimulus; IDA:UniProtKB
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0007157; P:heterophilic cell-cell adhesion; ISS:UniProtKB
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0007156; P:homophilic cell adhesion; ISS:UniProtKB
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0001889; P:liver development; IEA:Ensembl
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0050715; P:positive regulation of cytokine secretion; IDA:UniProtKB
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; IDA:UniProtKB
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0042271; P:susceptibility to natural killer cell mediated cytotoxicity; IDA:UniProtKB
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0007416; P:synapse assembly; IEA:Ensembl
Q9BY67	CADM1	Cell adhesion molecule 1	GO:0009826; P:unidimensional cell growth; IEA:Ensembl
Q8N3J6	CADM2	Cell adhesion molecule 2	GO:0034332; P:adherens junction organization; TAS:Reactome
Q8N3J6	CADM2	Cell adhesion molecule 2	GO:0007420; P:brain development; IEA:Ensembl
Q8N3J6	CADM2	Cell adhesion molecule 2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q8N3J6	CADM2	Cell adhesion molecule 2	GO:0034329; P:cell junction assembly; TAS:Reactome
Q8N3J6	CADM2	Cell adhesion molecule 2	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q8N126	CADM3	Cell adhesion molecule 3	GO:0042803; F:protein homodimerization activity; ISS:HGNC
Q8N126	CADM3	Cell adhesion molecule 3	GO:0034332; P:adherens junction organization; TAS:Reactome
Q8N126	CADM3	Cell adhesion molecule 3	GO:0034329; P:cell junction assembly; TAS:Reactome
Q8N126	CADM3	Cell adhesion molecule 3	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q8N126	CADM3	Cell adhesion molecule 3	GO:0007157; P:heterophilic cell-cell adhesion; ISS:HGNC
Q8N126	CADM3	Cell adhesion molecule 3	GO:0007156; P:homophilic cell adhesion; ISS:HGNC
Q8N126	CADM3	Cell adhesion molecule 3	GO:0008104; P:protein localization; IEA:Ensembl
Q8NFZ8	CADM4	Cell adhesion molecule 4	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q5T440	IBA57	Putative transferase CAF17, mitochondrial	GO:0004047; F:aminomethyltransferase activity; IEA:InterPro
Q5T440	IBA57	Putative transferase CAF17, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q5T440	IBA57	Putative transferase CAF17, mitochondrial	GO:0006546; P:glycine catabolic process; IEA:InterPro
Q5T440	IBA57	Putative transferase CAF17, mitochondrial	GO:0006783; P:heme biosynthetic process; IEA:UniProtKB-KW
Q13111	CHAF1A	Chromatin assembly factor 1 subunit A	GO:0003682; F:chromatin binding; TAS:ProtInc
Q13111	CHAF1A	Chromatin assembly factor 1 subunit A	GO:0070087; F:chromo shadow domain binding; IPI:BHF-UCL
Q13111	CHAF1A	Chromatin assembly factor 1 subunit A	GO:0042802; F:identical protein binding; IPI:IntAct
Q13111	CHAF1A	Chromatin assembly factor 1 subunit A	GO:0005515; F:protein binding; IPI:IntAct
Q13111	CHAF1A	Chromatin assembly factor 1 subunit A	GO:0051082; F:unfolded protein binding; TAS:ProtInc
Q13111	CHAF1A	Chromatin assembly factor 1 subunit A	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q13111	CHAF1A	Chromatin assembly factor 1 subunit A	GO:0031497; P:chromatin assembly; IDA:UniProtKB
Q13111	CHAF1A	Chromatin assembly factor 1 subunit A	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q13111	CHAF1A	Chromatin assembly factor 1 subunit A	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q13111	CHAF1A	Chromatin assembly factor 1 subunit A	GO:0006335; P:DNA replication-dependent nucleosome assembly; IDA:UniProt
Q13111	CHAF1A	Chromatin assembly factor 1 subunit A	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q13111	CHAF1A	Chromatin assembly factor 1 subunit A	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q13111	CHAF1A	Chromatin assembly factor 1 subunit A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13112	CHAF1B	Chromatin assembly factor 1 subunit B	GO:0003682; F:chromatin binding; TAS:ProtInc
Q13112	CHAF1B	Chromatin assembly factor 1 subunit B	GO:0042393; F:histone binding; NAS:UniProtKB
Q13112	CHAF1B	Chromatin assembly factor 1 subunit B	GO:0051082; F:unfolded protein binding; TAS:ProtInc
Q13112	CHAF1B	Chromatin assembly factor 1 subunit B	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q13112	CHAF1B	Chromatin assembly factor 1 subunit B	GO:0031497; P:chromatin assembly; IDA:UniProtKB
Q13112	CHAF1B	Chromatin assembly factor 1 subunit B	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q13112	CHAF1B	Chromatin assembly factor 1 subunit B	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q13112	CHAF1B	Chromatin assembly factor 1 subunit B	GO:0006335; P:DNA replication-dependent nucleosome assembly; IDA:UniProt
Q13112	CHAF1B	Chromatin assembly factor 1 subunit B	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q13112	CHAF1B	Chromatin assembly factor 1 subunit B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q13112	CHAF1B	Chromatin assembly factor 1 subunit B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NS85	CA10	Carbonic anhydrase-related protein 10	GO:0007420; P:brain development; NAS:UniProtKB
O43570	CA12	Carbonic anhydrase 12	GO:0004089; F:carbonate dehydratase activity; TAS:ProtInc
O43570	CA12	Carbonic anhydrase 12	GO:0008270; F:zinc ion binding; TAS:ProtInc
O43570	CA12	Carbonic anhydrase 12	GO:0015701; P:bicarbonate transport; TAS:Reactome
O43570	CA12	Carbonic anhydrase 12	GO:0006730; P:one-carbon metabolic process; IEA:InterPro
O43570	CA12	Carbonic anhydrase 12	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8N1Q1	CA13	Carbonic anhydrase 13	GO:0004089; F:carbonate dehydratase activity; IEA:UniProtKB-EC
Q8N1Q1	CA13	Carbonic anhydrase 13	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N1Q1	CA13	Carbonic anhydrase 13	GO:0015701; P:bicarbonate transport; TAS:Reactome
Q8N1Q1	CA13	Carbonic anhydrase 13	GO:0006730; P:one-carbon metabolic process; IEA:InterPro
Q8N1Q1	CA13	Carbonic anhydrase 13	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9ULX7	CA14	Carbonic anhydrase 14	GO:0004089; F:carbonate dehydratase activity; TAS:ProtInc
Q9ULX7	CA14	Carbonic anhydrase 14	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9ULX7	CA14	Carbonic anhydrase 14	GO:0015701; P:bicarbonate transport; TAS:Reactome
Q9ULX7	CA14	Carbonic anhydrase 14	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P00915	CA1	Carbonic anhydrase 1	GO:0004089; F:carbonate dehydratase activity; TAS:ProtInc
P00915	CA1	Carbonic anhydrase 1	GO:0008270; F:zinc ion binding; IEA:InterPro
P00915	CA1	Carbonic anhydrase 1	GO:0015701; P:bicarbonate transport; TAS:Reactome
P00915	CA1	Carbonic anhydrase 1	GO:0006730; P:one-carbon metabolic process; IEA:InterPro
P00915	CA1	Carbonic anhydrase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P00918	CA2	Carbonic anhydrase 2	GO:0004089; F:carbonate dehydratase activity; TAS:ProtInc
P00918	CA2	Carbonic anhydrase 2	GO:0005515; F:protein binding; IPI:UniProtKB
P00918	CA2	Carbonic anhydrase 2	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P00918	CA2	Carbonic anhydrase 2	GO:0038166; P:angiotensin-activated signaling pathway; IDA:UniProtKB
P00918	CA2	Carbonic anhydrase 2	GO:0015701; P:bicarbonate transport; TAS:Reactome
P00918	CA2	Carbonic anhydrase 2	GO:0015670; P:carbon dioxide transport; IEA:Ensembl
P00918	CA2	Carbonic anhydrase 2	GO:0001822; P:kidney development; IEA:Ensembl
P00918	CA2	Carbonic anhydrase 2	GO:0002009; P:morphogenesis of an epithelium; IEA:Ensembl
P00918	CA2	Carbonic anhydrase 2	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
P00918	CA2	Carbonic anhydrase 2	GO:0006730; P:one-carbon metabolic process; IEA:InterPro
P00918	CA2	Carbonic anhydrase 2	GO:0045780; P:positive regulation of bone resorption; IEA:Ensembl
P00918	CA2	Carbonic anhydrase 2	GO:0032849; P:positive regulation of cellular pH reduction; IEA:Ensembl
P00918	CA2	Carbonic anhydrase 2	GO:2001150; P:positive regulation of dipeptide transmembrane transport; ISS:UniProtKB
P00918	CA2	Carbonic anhydrase 2	GO:0045672; P:positive regulation of osteoclast differentiation; IEA:Ensembl
P00918	CA2	Carbonic anhydrase 2	GO:0044070; P:regulation of anion transport; IDA:UniProtKB
P00918	CA2	Carbonic anhydrase 2	GO:0051453; P:regulation of intracellular pH; ISS:UniProtKB
P00918	CA2	Carbonic anhydrase 2	GO:0043627; P:response to estrogen; IEA:Ensembl
P00918	CA2	Carbonic anhydrase 2	GO:0009268; P:response to pH; IEA:Ensembl
P00918	CA2	Carbonic anhydrase 2	GO:0010043; P:response to zinc ion; IEA:Ensembl
P00918	CA2	Carbonic anhydrase 2	GO:0046903; P:secretion; IEA:Ensembl
P00918	CA2	Carbonic anhydrase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P07451	CA3	Carbonic anhydrase 3	GO:0004089; F:carbonate dehydratase activity; TAS:ProtInc
P07451	CA3	Carbonic anhydrase 3	GO:0016151; F:nickel cation binding; IEA:Ensembl
P07451	CA3	Carbonic anhydrase 3	GO:0008270; F:zinc ion binding; IEA:InterPro
P07451	CA3	Carbonic anhydrase 3	GO:0015701; P:bicarbonate transport; TAS:Reactome
P07451	CA3	Carbonic anhydrase 3	GO:0006730; P:one-carbon metabolic process; IEA:InterPro
P07451	CA3	Carbonic anhydrase 3	GO:0045471; P:response to ethanol; IEA:Ensembl
P07451	CA3	Carbonic anhydrase 3	GO:0006979; P:response to oxidative stress; IEA:Ensembl
P07451	CA3	Carbonic anhydrase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P22748	CA4	Carbonic anhydrase 4	GO:0004089; F:carbonate dehydratase activity; TAS:Reactome
P22748	CA4	Carbonic anhydrase 4	GO:0005515; F:protein binding; IPI:DFLAT
P22748	CA4	Carbonic anhydrase 4	GO:0008270; F:zinc ion binding; IEA:InterPro
P22748	CA4	Carbonic anhydrase 4	GO:0015701; P:bicarbonate transport; IMP:DFLAT
P22748	CA4	Carbonic anhydrase 4	GO:0006730; P:one-carbon metabolic process; IEA:InterPro
P22748	CA4	Carbonic anhydrase 4	GO:0048513; P:organ development; IEA:Ensembl
P22748	CA4	Carbonic anhydrase 4	GO:0042493; P:response to drug; IEA:Ensembl
P22748	CA4	Carbonic anhydrase 4	GO:0048545; P:response to steroid hormone; IEA:Ensembl
P22748	CA4	Carbonic anhydrase 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P35218	CA5A	Carbonic anhydrase 5A, mitochondrial	GO:0004089; F:carbonate dehydratase activity; TAS:ProtInc
P35218	CA5A	Carbonic anhydrase 5A, mitochondrial	GO:0008270; F:zinc ion binding; IEA:InterPro
P35218	CA5A	Carbonic anhydrase 5A, mitochondrial	GO:0015701; P:bicarbonate transport; TAS:Reactome
P35218	CA5A	Carbonic anhydrase 5A, mitochondrial	GO:0006730; P:one-carbon metabolic process; IEA:InterPro
P35218	CA5A	Carbonic anhydrase 5A, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y2D0	CA5B	Carbonic anhydrase 5B, mitochondrial	GO:0004089; F:carbonate dehydratase activity; TAS:ProtInc
Q9Y2D0	CA5B	Carbonic anhydrase 5B, mitochondrial	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y2D0	CA5B	Carbonic anhydrase 5B, mitochondrial	GO:0015701; P:bicarbonate transport; TAS:Reactome
Q9Y2D0	CA5B	Carbonic anhydrase 5B, mitochondrial	GO:0006730; P:one-carbon metabolic process; IEA:InterPro
Q9Y2D0	CA5B	Carbonic anhydrase 5B, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P23280	CA6	Carbonic anhydrase 6	GO:0004089; F:carbonate dehydratase activity; TAS:Reactome
P23280	CA6	Carbonic anhydrase 6	GO:0008270; F:zinc ion binding; IEA:InterPro
P23280	CA6	Carbonic anhydrase 6	GO:0015701; P:bicarbonate transport; TAS:Reactome
P23280	CA6	Carbonic anhydrase 6	GO:0001580; P:detection of chemical stimulus involved in sensory perception of bitter taste; IDA:UniProt
P23280	CA6	Carbonic anhydrase 6	GO:0006730; P:one-carbon metabolic process; IEA:InterPro
P23280	CA6	Carbonic anhydrase 6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P43166	CA7	Carbonic anhydrase 7	GO:0004089; F:carbonate dehydratase activity; TAS:ProtInc
P43166	CA7	Carbonic anhydrase 7	GO:0008270; F:zinc ion binding; IEA:InterPro
P43166	CA7	Carbonic anhydrase 7	GO:0015701; P:bicarbonate transport; TAS:Reactome
P43166	CA7	Carbonic anhydrase 7	GO:0006730; P:one-carbon metabolic process; IEA:InterPro
P43166	CA7	Carbonic anhydrase 7	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P35219	CA8	Carbonic anhydrase-related protein	GO:0004089; F:carbonate dehydratase activity; TAS:ProtInc
P35219	CA8	Carbonic anhydrase-related protein	GO:0008270; F:zinc ion binding; IEA:InterPro
P35219	CA8	Carbonic anhydrase-related protein	GO:0006730; P:one-carbon metabolic process; IEA:InterPro
P35219	CA8	Carbonic anhydrase-related protein	GO:0048015; P:phosphatidylinositol-mediated signaling; IEA:Ensembl
Q16790	CA9	Carbonic anhydrase 9	GO:0004089; F:carbonate dehydratase activity; TAS:ProtInc
Q16790	CA9	Carbonic anhydrase 9	GO:0008270; F:zinc ion binding; IEA:InterPro
Q16790	CA9	Carbonic anhydrase 9	GO:0015701; P:bicarbonate transport; TAS:Reactome
Q16790	CA9	Carbonic anhydrase 9	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
Q16790	CA9	Carbonic anhydrase 9	GO:0002009; P:morphogenesis of an epithelium; IEA:Ensembl
Q16790	CA9	Carbonic anhydrase 9	GO:0006730; P:one-carbon metabolic process; IEA:InterPro
Q16790	CA9	Carbonic anhydrase 9	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
Q16790	CA9	Carbonic anhydrase 9	GO:0042493; P:response to drug; IEA:Ensembl
Q16790	CA9	Carbonic anhydrase 9	GO:0033574; P:response to testosterone; IEA:Ensembl
Q16790	CA9	Carbonic anhydrase 9	GO:0046903; P:secretion; IEA:Ensembl
Q16790	CA9	Carbonic anhydrase 9	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5VU97	CACHD1	VWFA and cache domain-containing protein 1	GO:0006816; P:calcium ion transport; IEA:UniProtKB-KW
Q8IU99	CALHM1	Calcium homeostasis modulator protein 1	GO:0005227; F:calcium activated cation channel activity; IDA:UniProtKB
Q8IU99	CALHM1	Calcium homeostasis modulator protein 1	GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW
Q8IU99	CALHM1	Calcium homeostasis modulator protein 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q8IU99	CALHM1	Calcium homeostasis modulator protein 1	GO:0005244; F:voltage-gated ion channel activity; IDA:UniProtKB
Q8IU99	CALHM1	Calcium homeostasis modulator protein 1	GO:0015867; P:ATP transport; ISS:UniProtKB
Q8IU99	CALHM1	Calcium homeostasis modulator protein 1	GO:0006812; P:cation transport; IDA:UniProtKB
Q8IU99	CALHM1	Calcium homeostasis modulator protein 1	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
Q8IU99	CALHM1	Calcium homeostasis modulator protein 1	GO:0034765; P:regulation of ion transmembrane transport; IDA:UniProtKB
Q8IU99	CALHM1	Calcium homeostasis modulator protein 1	GO:0050913; P:sensory perception of bitter taste; ISS:UniProtKB
Q8IU99	CALHM1	Calcium homeostasis modulator protein 1	GO:0050916; P:sensory perception of sweet taste; ISS:UniProtKB
Q8IU99	CALHM1	Calcium homeostasis modulator protein 1	GO:0050917; P:sensory perception of umami taste; ISS:UniProtKB
Q9HA72	CALHM2	Calcium homeostasis modulator protein 2	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q86XJ0	CALHM3	Calcium homeostasis modulator protein 3	GO:0006811; P:ion transport; IEA:UniProtKB-KW
P05937	CALB1	Calbindin	GO:0005509; F:calcium ion binding; IMP:UniProt
P05937	CALB1	Calbindin	GO:0005515; F:protein binding; IPI:IntAct
P05937	CALB1	Calbindin	GO:0005499; F:vitamin D binding; IEA:UniProtKB-KW
P05937	CALB1	Calbindin	GO:0008270; F:zinc ion binding; IMP:UniProt
P05937	CALB1	Calbindin	GO:0071310; P:cellular response to organic substance; IEA:Ensembl
P05937	CALB1	Calbindin	GO:0051480; P:cytosolic calcium ion homeostasis; IEA:Ensembl
P05937	CALB1	Calbindin	GO:0007626; P:locomotory behavior; IEA:Ensembl
P05937	CALB1	Calbindin	GO:0007616; P:long-term memory; IMP:UniProt
P05937	CALB1	Calbindin	GO:0072205; P:metanephric collecting duct development; IEA:Ensembl
P05937	CALB1	Calbindin	GO:0072286; P:metanephric connecting tubule development; IEA:Ensembl
P05937	CALB1	Calbindin	GO:0072221; P:metanephric distal convoluted tubule development; IEA:Ensembl
P05937	CALB1	Calbindin	GO:0035502; P:metanephric part of ureteric bud development; IEA:Ensembl
P05937	CALB1	Calbindin	GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl
P05937	CALB1	Calbindin	GO:0010842; P:retina layer formation; IEA:Ensembl
P05937	CALB1	Calbindin	GO:0007614; P:short-term memory; IMP:UniProt
P22676	CALB2	Calretinin	GO:0005509; F:calcium ion binding; IEA:Ensembl
P22676	CALB2	Calretinin	GO:0051480; P:cytosolic calcium ion homeostasis; IEA:Ensembl
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0005515; F:protein binding; IPI:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0032403; F:protein complex binding; IDA:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0005102; F:receptor binding; IDA:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0007190; P:activation of adenylate cyclase activity; IDA:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0051480; P:cytosolic calcium ion homeostasis; IDA:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0043542; P:endothelial cell migration; IDA:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0001935; P:endothelial cell proliferation; IDA:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0002031; P:G-protein coupled receptor internalization; IDA:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0007159; P:leukocyte cell-cell adhesion; IDA:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0045776; P:negative regulation of blood pressure; IDA:MGI
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0045779; P:negative regulation of bone resorption; IDA:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0010523; P:negative regulation of calcium ion transport into cytosol; IDA:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0045671; P:negative regulation of osteoclast differentiation; IDA:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0001976; P:neurological system process involved in regulation of systemic arterial blood pressure; IDA:MGI
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0051482; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway; IDA:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0032730; P:positive regulation of interleukin-1 alpha production; IDA:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0032757; P:positive regulation of interleukin-8 production; IDA:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0045651; P:positive regulation of macrophage differentiation; IDA:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0045909; P:positive regulation of vasodilation; IDA:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0031623; P:receptor internalization; IDA:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0008217; P:regulation of blood pressure; NAS:UniProtKB
P06881	CALCA	Calcitonin gene-related peptide 1	GO:0001944; P:vasculature development; IDA:UniProtKB
P10092	CALCB	Calcitonin gene-related peptide 2	GO:0005184; F:neuropeptide hormone activity; TAS:ProtInc
P10092	CALCB	Calcitonin gene-related peptide 2	GO:0006874; P:cellular calcium ion homeostasis; TAS:ProtInc
P10092	CALCB	Calcitonin gene-related peptide 2	GO:0007165; P:signal transduction; TAS:ProtInc
P30988	CALCR	Calcitonin receptor	GO:0032841; F:calcitonin binding; IDA:UniProtKB
P30988	CALCR	Calcitonin receptor	GO:0004948; F:calcitonin receptor activity; IDA:UniProtKB
P30988	CALCR	Calcitonin receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P30988	CALCR	Calcitonin receptor	GO:0008565; F:protein transporter activity; IDA:UniProtKB
P30988	CALCR	Calcitonin receptor	GO:0004872; F:receptor activity; IDA:UniProtKB
P30988	CALCR	Calcitonin receptor	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IDA:UniProtKB
P30988	CALCR	Calcitonin receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:GOC
P30988	CALCR	Calcitonin receptor	GO:0045762; P:positive regulation of adenylate cyclase activity; IDA:UniProtKB
P30988	CALCR	Calcitonin receptor	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:UniProtKB
P30988	CALCR	Calcitonin receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB
P30988	CALCR	Calcitonin receptor	GO:0072659; P:protein localization to plasma membrane; IDA:UniProtKB
P30988	CALCR	Calcitonin receptor	GO:0015031; P:protein transport; IDA:UniProtKB
P30988	CALCR	Calcitonin receptor	GO:0031623; P:receptor internalization; IDA:UniProtKB
P30988	CALCR	Calcitonin receptor	GO:0051384; P:response to glucocorticoid; IDA:UniProtKB
P01258	CALCA	Calcitonin	GO:0031716; F:calcitonin receptor binding; IPI:UniProtKB
P01258	CALCA	Calcitonin	GO:0042802; F:identical protein binding; IPI:IntAct
P01258	CALCA	Calcitonin	GO:0005515; F:protein binding; IPI:IntAct
P01258	CALCA	Calcitonin	GO:0032147; P:activation of protein kinase activity; IDA:UniProtKB
P01258	CALCA	Calcitonin	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P01258	CALCA	Calcitonin	GO:0007568; P:aging; IEA:Ensembl
P01258	CALCA	Calcitonin	GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; IEA:Ensembl
P01258	CALCA	Calcitonin	GO:0007566; P:embryo implantation; IDA:UniProtKB
P01258	CALCA	Calcitonin	GO:0007631; P:feeding behavior; IEA:Ensembl
P01258	CALCA	Calcitonin	GO:0006954; P:inflammatory response; IEA:Ensembl
P01258	CALCA	Calcitonin	GO:0002548; P:monocyte chemotaxis; IDA:BHF-UCL
P01258	CALCA	Calcitonin	GO:0045779; P:negative regulation of bone resorption; IDA:UniProtKB
P01258	CALCA	Calcitonin	GO:0031645; P:negative regulation of neurological system process; IEA:Ensembl
P01258	CALCA	Calcitonin	GO:0030279; P:negative regulation of ossification; IEA:Ensembl
P01258	CALCA	Calcitonin	GO:0045986; P:negative regulation of smooth muscle contraction; IEA:Ensembl
P01258	CALCA	Calcitonin	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P01258	CALCA	Calcitonin	GO:0007218; P:neuropeptide signaling pathway; IEA:Ensembl
P01258	CALCA	Calcitonin	GO:0045762; P:positive regulation of adenylate cyclase activity; IDA:UniProtKB
P01258	CALCA	Calcitonin	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB
P01258	CALCA	Calcitonin	GO:0051482; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway; IDA:UniProtKB
P01258	CALCA	Calcitonin	GO:0045778; P:positive regulation of ossification; IEA:Ensembl
P01258	CALCA	Calcitonin	GO:0002027; P:regulation of heart rate; IEA:Ensembl
P01258	CALCA	Calcitonin	GO:0050727; P:regulation of inflammatory response; IEA:Ensembl
P01258	CALCA	Calcitonin	GO:0009408; P:response to heat; IEA:Ensembl
P01258	CALCA	Calcitonin	GO:0048265; P:response to pain; IEA:Ensembl
P01258	CALCA	Calcitonin	GO:0001984; P:vasodilation of artery involved in baroreceptor response to increased systemic arterial blood pressure; IEA:Ensembl
Q05682	CALD1	Caldesmon	GO:0003779; F:actin binding; TAS:ProtInc
Q05682	CALD1	Caldesmon	GO:0005516; F:calmodulin binding; TAS:ProtInc
Q05682	CALD1	Caldesmon	GO:0005523; F:tropomyosin binding; TAS:ProtInc
Q05682	CALD1	Caldesmon	GO:0006928; P:cellular component movement; TAS:UniProtKB
Q05682	CALD1	Caldesmon	GO:0006936; P:muscle contraction; TAS:Reactome
Q13939	CCIN	Calicin	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q13939	CCIN	Calicin	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q13939	CCIN	Calicin	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
P27482	CALML3	Calmodulin-like protein 3	GO:0005509; F:calcium ion binding; TAS:ProtInc
P27482	CALML3	Calmodulin-like protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q96GE6	CALML4	Calmodulin-like protein 4	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NZT1	CALML5	Calmodulin-like protein 5	GO:0005509; F:calcium ion binding; TAS:ProtInc
Q9NZT1	CALML5	Calmodulin-like protein 5	GO:0008544; P:epidermis development; TAS:ProtInc
Q9NZT1	CALML5	Calmodulin-like protein 5	GO:0007165; P:signal transduction; TAS:ProtInc
Q8TD86	CALML6	Calmodulin-like protein 6	GO:0005509; F:calcium ion binding; IEA:InterPro
P62158	CALM1	Calmodulin	GO:0005509; F:calcium ion binding; IDA:BHF-UCL
P62158	CALM1	Calmodulin	GO:0044325; F:ion channel binding; IPI:BHF-UCL
P62158	CALM1	Calmodulin	GO:0031997; F:N-terminal myristoylation domain binding; IPI:UniProtKB
P62158	CALM1	Calmodulin	GO:0030235; F:nitric-oxide synthase regulator activity; IEA:Ensembl
P62158	CALM1	Calmodulin	GO:0043274; F:phospholipase binding; IPI:BHF-UCL
P62158	CALM1	Calmodulin	GO:0005515; F:protein binding; IPI:UniProtKB
P62158	CALM1	Calmodulin	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P62158	CALM1	Calmodulin	GO:0072542; F:protein phosphatase activator activity; IDA:BHF-UCL
P62158	CALM1	Calmodulin	GO:0031996; F:thioesterase binding; IPI:UniProtKB
P62158	CALM1	Calmodulin	GO:0031432; F:titin binding; IPI:BHF-UCL
P62158	CALM1	Calmodulin	GO:0007190; P:activation of adenylate cyclase activity; IEA:Ensembl
P62158	CALM1	Calmodulin	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0007596; P:blood coagulation; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0005513; P:detection of calcium ion; IMP:BHF-UCL
P62158	CALM1	Calmodulin	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:UniProtKB
P62158	CALM1	Calmodulin	GO:0006006; P:glucose metabolic process; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0005980; P:glycogen catabolic process; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0045087; P:innate immune response; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0061024; P:membrane organization; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0006936; P:muscle contraction; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0060315; P:negative regulation of ryanodine-sensitive calcium-release channel activity; ISS:BHF-UCL
P62158	CALM1	Calmodulin	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0046209; P:nitric oxide metabolic process; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0030168; P:platelet activation; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0002576; P:platelet degranulation; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0030801; P:positive regulation of cyclic nucleotide metabolic process; IDA:BHF-UCL
P62158	CALM1	Calmodulin	GO:0051343; P:positive regulation of cyclic-nucleotide phosphodiesterase activity; IDA:BHF-UCL
P62158	CALM1	Calmodulin	GO:0051000; P:positive regulation of nitric-oxide synthase activity; IEA:Ensembl
P62158	CALM1	Calmodulin	GO:0032516; P:positive regulation of phosphoprotein phosphatase activity; IDA:BHF-UCL
P62158	CALM1	Calmodulin	GO:0035307; P:positive regulation of protein dephosphorylation; IDA:BHF-UCL
P62158	CALM1	Calmodulin	GO:0060316; P:positive regulation of ryanodine-sensitive calcium-release channel activity; IDA:BHF-UCL
P62158	CALM1	Calmodulin	GO:0055117; P:regulation of cardiac muscle contraction; IMP:BHF-UCL
P62158	CALM1	Calmodulin	GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; IC:BHF-UCL
P62158	CALM1	Calmodulin	GO:1901844; P:regulation of cell communication by electrical coupling involved in cardiac conduction; IC:BHF-UCL
P62158	CALM1	Calmodulin	GO:0032465; P:regulation of cytokinesis; IMP:UniProtKB
P62158	CALM1	Calmodulin	GO:0002027; P:regulation of heart rate; IMP:BHF-UCL
P62158	CALM1	Calmodulin	GO:1901841; P:regulation of high voltage-gated calcium channel activity; IEA:Ensembl
P62158	CALM1	Calmodulin	GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; IDA:BHF-UCL
P62158	CALM1	Calmodulin	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0001975; P:response to amphetamine; IEA:Ensembl
P62158	CALM1	Calmodulin	GO:0051592; P:response to calcium ion; IDA:BHF-UCL
P62158	CALM1	Calmodulin	GO:0051412; P:response to corticosterone; IEA:Ensembl
P62158	CALM1	Calmodulin	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0007165; P:signal transduction; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P62158	CALM1	Calmodulin	GO:0021762; P:substantia nigra development; IEP:UniProt
P62158	CALM1	Calmodulin	GO:0007268; P:synaptic transmission; TAS:Reactome
Q96L12	CALR3	Calreticulin-3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96L12	CALR3	Calreticulin-3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96L12	CALR3	Calreticulin-3	GO:0006457; P:protein folding; IEA:InterPro
Q96L12	CALR3	Calreticulin-3	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q16602	CALCRL	Calcitonin gene-related peptide type 1 receptor	GO:0001605; F:adrenomedullin receptor activity; IDA:UniProtKB
Q16602	CALCRL	Calcitonin gene-related peptide type 1 receptor	GO:0001635; F:calcitonin gene-related polypeptide receptor activity; IEA:Ensembl
Q16602	CALCRL	Calcitonin gene-related peptide type 1 receptor	GO:0004948; F:calcitonin receptor activity; IEA:Ensembl
Q16602	CALCRL	Calcitonin gene-related peptide type 1 receptor	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q16602	CALCRL	Calcitonin gene-related peptide type 1 receptor	GO:0005515; F:protein binding; IPI:UniProtKB
Q16602	CALCRL	Calcitonin gene-related peptide type 1 receptor	GO:0008565; F:protein transporter activity; IDA:UniProtKB
Q16602	CALCRL	Calcitonin gene-related peptide type 1 receptor	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
Q16602	CALCRL	Calcitonin gene-related peptide type 1 receptor	GO:0001525; P:angiogenesis; IDA:UniProtKB
Q16602	CALCRL	Calcitonin gene-related peptide type 1 receptor	GO:0006816; P:calcium ion transport; IDA:UniProtKB
Q16602	CALCRL	Calcitonin gene-related peptide type 1 receptor	GO:0006171; P:cAMP biosynthetic process; IDA:UniProtKB
Q16602	CALCRL	Calcitonin gene-related peptide type 1 receptor	GO:0071329; P:cellular response to sucrose stimulus; IDA:UniProtKB
Q16602	CALCRL	Calcitonin gene-related peptide type 1 receptor	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
Q16602	CALCRL	Calcitonin gene-related peptide type 1 receptor	GO:0007507; P:heart development; IEA:Ensembl
Q16602	CALCRL	Calcitonin gene-related peptide type 1 receptor	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
Q16602	CALCRL	Calcitonin gene-related peptide type 1 receptor	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:UniProtKB
Q16602	CALCRL	Calcitonin gene-related peptide type 1 receptor	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
Q16602	CALCRL	Calcitonin gene-related peptide type 1 receptor	GO:0015031; P:protein transport; IDA:UniProtKB
Q16602	CALCRL	Calcitonin gene-related peptide type 1 receptor	GO:0031623; P:receptor internalization; IDA:UniProtKB
Q16602	CALCRL	Calcitonin gene-related peptide type 1 receptor	GO:0006937; P:regulation of muscle contraction; IEA:Ensembl
P27797	CALR	Calreticulin	GO:0050681; F:androgen receptor binding; IDA:BHF-UCL
P27797	CALR	Calreticulin	GO:0005509; F:calcium ion binding; ISS:UniProtKB
P27797	CALR	Calreticulin	GO:0030246; F:carbohydrate binding; TAS:BHF-UCL
P27797	CALR	Calreticulin	GO:0051087; F:chaperone binding; TAS:BHF-UCL
P27797	CALR	Calreticulin	GO:0001849; F:complement component C1q binding; TAS:BHF-UCL
P27797	CALR	Calreticulin	GO:0003677; F:DNA binding; NAS:UniProtKB
P27797	CALR	Calreticulin	GO:0042562; F:hormone binding; IEA:Ensembl
P27797	CALR	Calreticulin	GO:0005178; F:integrin binding; IPI:BHF-UCL
P27797	CALR	Calreticulin	GO:0005506; F:iron ion binding; IEA:Ensembl
P27797	CALR	Calreticulin	GO:0003729; F:mRNA binding; IDA:BHF-UCL
P27797	CALR	Calreticulin	GO:0042277; F:peptide binding; IEA:Ensembl
P27797	CALR	Calreticulin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P27797	CALR	Calreticulin	GO:0005515; F:protein binding; IPI:IntAct
P27797	CALR	Calreticulin	GO:0044183; F:protein binding involved in protein folding; TAS:BHF-UCL
P27797	CALR	Calreticulin	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P27797	CALR	Calreticulin	GO:0051082; F:unfolded protein binding; TAS:BHF-UCL
P27797	CALR	Calreticulin	GO:0008270; F:zinc ion binding; TAS:BHF-UCL
P27797	CALR	Calreticulin	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P27797	CALR	Calreticulin	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P27797	CALR	Calreticulin	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P27797	CALR	Calreticulin	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P27797	CALR	Calreticulin	GO:0055007; P:cardiac muscle cell differentiation; IEA:Ensembl
P27797	CALR	Calreticulin	GO:0007050; P:cell cycle arrest; IGI:BHF-UCL
P27797	CALR	Calreticulin	GO:0006874; P:cellular calcium ion homeostasis; TAS:UniProtKB
P27797	CALR	Calreticulin	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P27797	CALR	Calreticulin	GO:0071285; P:cellular response to lithium ion; IEA:Ensembl
P27797	CALR	Calreticulin	GO:0090398; P:cellular senescence; IGI:BHF-UCL
P27797	CALR	Calreticulin	GO:0061077; P:chaperone-mediated protein folding; IEA:Ensembl
P27797	CALR	Calreticulin	GO:0030866; P:cortical actin cytoskeleton organization; IEA:Ensembl
P27797	CALR	Calreticulin	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P27797	CALR	Calreticulin	GO:0042921; P:glucocorticoid receptor signaling pathway; TAS:BHF-UCL
P27797	CALR	Calreticulin	GO:0033144; P:negative regulation of intracellular steroid hormone receptor signaling pathway; IDA:BHF-UCL
P27797	CALR	Calreticulin	GO:0045665; P:negative regulation of neuron differentiation; IDA:BHF-UCL
P27797	CALR	Calreticulin	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IDA:BHF-UCL
P27797	CALR	Calreticulin	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P27797	CALR	Calreticulin	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
P27797	CALR	Calreticulin	GO:0017148; P:negative regulation of translation; ISS:BHF-UCL
P27797	CALR	Calreticulin	GO:0002502; P:peptide antigen assembly with MHC class I protein complex; ISS:BHF-UCL
P27797	CALR	Calreticulin	GO:0045787; P:positive regulation of cell cycle; IGI:BHF-UCL
P27797	CALR	Calreticulin	GO:0008284; P:positive regulation of cell proliferation; IGI:BHF-UCL
P27797	CALR	Calreticulin	GO:2000510; P:positive regulation of dendritic cell chemotaxis; IMP:UniProtKB
P27797	CALR	Calreticulin	GO:0045740; P:positive regulation of DNA replication; IGI:BHF-UCL
P27797	CALR	Calreticulin	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P27797	CALR	Calreticulin	GO:0050766; P:positive regulation of phagocytosis; ISS:BHF-UCL
P27797	CALR	Calreticulin	GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IMP:UniProtKB
P27797	CALR	Calreticulin	GO:0043687; P:post-translational protein modification; TAS:Reactome
P27797	CALR	Calreticulin	GO:0006611; P:protein export from nucleus; IDA:UniProtKB
P27797	CALR	Calreticulin	GO:0006457; P:protein folding; TAS:BHF-UCL
P27797	CALR	Calreticulin	GO:0034504; P:protein localization to nucleus; IDA:UniProtKB
P27797	CALR	Calreticulin	GO:0022417; P:protein maturation by protein folding; TAS:BHF-UCL
P27797	CALR	Calreticulin	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
P27797	CALR	Calreticulin	GO:0050821; P:protein stabilization; ISS:UniProtKB
P27797	CALR	Calreticulin	GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB
P27797	CALR	Calreticulin	GO:0040020; P:regulation of meiosis; IEA:Ensembl
P27797	CALR	Calreticulin	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
P27797	CALR	Calreticulin	GO:0042493; P:response to drug; IEA:Ensembl
P27797	CALR	Calreticulin	GO:0032355; P:response to estradiol; IEA:Ensembl
P27797	CALR	Calreticulin	GO:0033574; P:response to testosterone; IEA:Ensembl
P27797	CALR	Calreticulin	GO:0051208; P:sequestering of calcium ion; TAS:BHF-UCL
P27797	CALR	Calreticulin	GO:0007283; P:spermatogenesis; IEA:Ensembl
O43852	CALU	Calumenin	GO:0005509; F:calcium ion binding; IDA:UniProtKB
O43852	CALU	Calumenin	GO:0005515; F:protein binding; IPI:UniProtKB
O43852	CALU	Calumenin	GO:0007596; P:blood coagulation; TAS:Reactome
O43852	CALU	Calumenin	GO:0030168; P:platelet activation; TAS:Reactome
O43852	CALU	Calumenin	GO:0002576; P:platelet degranulation; TAS:Reactome
P27824	CANX	Calnexin	GO:0005509; F:calcium ion binding; TAS:ProtInc
P27824	CANX	Calnexin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P27824	CANX	Calnexin	GO:0005515; F:protein binding; IPI:UniProtKB
P27824	CANX	Calnexin	GO:0007568; P:aging; IEA:Ensembl
P27824	CANX	Calnexin	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P27824	CANX	Calnexin	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P27824	CANX	Calnexin	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P27824	CANX	Calnexin	GO:0061077; P:chaperone-mediated protein folding; IEA:Ensembl
P27824	CANX	Calnexin	GO:0072583; P:clathrin-mediated endocytosis; ISS:UniProtKB
P27824	CANX	Calnexin	GO:0043687; P:post-translational protein modification; TAS:Reactome
P27824	CANX	Calnexin	GO:0006457; P:protein folding; TAS:Reactome
P27824	CANX	Calnexin	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
P27824	CANX	Calnexin	GO:0009306; P:protein secretion; TAS:ProtInc
P27824	CANX	Calnexin	GO:0048488; P:synaptic vesicle endocytosis; ISS:UniProtKB
Q9NYX4	CALY	Neuron-specific vesicular protein calcyon	GO:0032051; F:clathrin light chain binding; IDA:UniProtKB
Q9NYX4	CALY	Neuron-specific vesicular protein calcyon	GO:0048268; P:clathrin coat assembly; IDA:UniProtKB
Q9NYX4	CALY	Neuron-specific vesicular protein calcyon	GO:0007212; P:dopamine receptor signaling pathway; IEA:InterPro
Q9NYX4	CALY	Neuron-specific vesicular protein calcyon	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q9NYX4	CALY	Neuron-specific vesicular protein calcyon	GO:0045807; P:positive regulation of endocytosis; IMP:UniProtKB
Q8NCB2	CAMKV	CaM kinase-like vesicle-associated protein	GO:0005524; F:ATP binding; IEA:InterPro
Q8NCB2	CAMKV	CaM kinase-like vesicle-associated protein	GO:0004672; F:protein kinase activity; IEA:InterPro
P49069	CAMLG	Calcium signal-modulating cyclophilin ligand	GO:0005515; F:protein binding; IPI:UniProtKB
P49069	CAMLG	Calcium signal-modulating cyclophilin ligand	GO:0006952; P:defense response; TAS:ProtInc
P49069	CAMLG	Calcium signal-modulating cyclophilin ligand	GO:0007173; P:epidermal growth factor receptor signaling pathway; IEA:Ensembl
P49069	CAMLG	Calcium signal-modulating cyclophilin ligand	GO:0001881; P:receptor recycling; IEA:Ensembl
P49069	CAMLG	Calcium signal-modulating cyclophilin ligand	GO:0007165; P:signal transduction; TAS:ProtInc
P49069	CAMLG	Calcium signal-modulating cyclophilin ligand	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q5T5Y3	CAMSAP1	Calmodulin-regulated spectrin-associated protein 1	GO:0005516; F:calmodulin binding; ISS:UniProtKB
Q5T5Y3	CAMSAP1	Calmodulin-regulated spectrin-associated protein 1	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q5T5Y3	CAMSAP1	Calmodulin-regulated spectrin-associated protein 1	GO:0030507; F:spectrin binding; IDA:UniProtKB
Q5T5Y3	CAMSAP1	Calmodulin-regulated spectrin-associated protein 1	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q5T5Y3	CAMSAP1	Calmodulin-regulated spectrin-associated protein 1	GO:0031175; P:neuron projection development; IMP:UniProtKB
Q5T5Y3	CAMSAP1	Calmodulin-regulated spectrin-associated protein 1	GO:0022604; P:regulation of cell morphogenesis; IMP:UniProtKB
Q08AD1	CAMSAP2	Calmodulin-regulated spectrin-associated protein 2	GO:0051011; F:microtubule minus-end binding; IDA:UniProtKB
Q08AD1	CAMSAP2	Calmodulin-regulated spectrin-associated protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q08AD1	CAMSAP2	Calmodulin-regulated spectrin-associated protein 2	GO:0000226; P:microtubule cytoskeleton organization; IMP:UniProtKB
Q08AD1	CAMSAP2	Calmodulin-regulated spectrin-associated protein 2	GO:0033043; P:regulation of organelle organization; IMP:UniProtKB
Q9P1Y5	CAMSAP3	Calmodulin-regulated spectrin-associated protein 3	GO:0051011; F:microtubule minus-end binding; IDA:UniProtKB
Q9P1Y5	CAMSAP3	Calmodulin-regulated spectrin-associated protein 3	GO:0090136; P:epithelial cell-cell adhesion; IMP:UniProtKB
Q9P1Y5	CAMSAP3	Calmodulin-regulated spectrin-associated protein 3	GO:0034453; P:microtubule anchoring; IMP:UniProtKB
Q9P1Y5	CAMSAP3	Calmodulin-regulated spectrin-associated protein 3	GO:0000226; P:microtubule cytoskeleton organization; IMP:UniProtKB
Q9P1Y5	CAMSAP3	Calmodulin-regulated spectrin-associated protein 3	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q9P1Y5	CAMSAP3	Calmodulin-regulated spectrin-associated protein 3	GO:0070507; P:regulation of microtubule cytoskeleton organization; IMP:UniProtKB
Q9P1Y5	CAMSAP3	Calmodulin-regulated spectrin-associated protein 3	GO:0033043; P:regulation of organelle organization; IMP:UniProtKB
Q9P1Y5	CAMSAP3	Calmodulin-regulated spectrin-associated protein 3	GO:0045218; P:zonula adherens maintenance; IMP:UniProtKB
P49913	CAMP	Cathelicidin antimicrobial peptide	GO:0005515; F:protein binding; IPI:IntAct
P49913	CAMP	Cathelicidin antimicrobial peptide	GO:0019731; P:antibacterial humoral response; IDA:UniProt
P49913	CAMP	Cathelicidin antimicrobial peptide	GO:0042742; P:defense response to bacterium; TAS:ProtInc
P49913	CAMP	Cathelicidin antimicrobial peptide	GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProt
P49913	CAMP	Cathelicidin antimicrobial peptide	GO:0002227; P:innate immune response in mucosa; IDA:UniProt
P49913	CAMP	Cathelicidin antimicrobial peptide	GO:0051701; P:interaction with host; TAS:Reactome
P49913	CAMP	Cathelicidin antimicrobial peptide	GO:0051873; P:killing by host of symbiont cells; IDA:MGI
P49913	CAMP	Cathelicidin antimicrobial peptide	GO:0044140; P:negative regulation of growth of symbiont on or near host surface; IDA:MGI
P49913	CAMP	Cathelicidin antimicrobial peptide	GO:0090382; P:phagosome maturation; TAS:Reactome
Q9HC96	CAPN10	Calpain-10	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; IMP:BHF-UCL
Q9HC96	CAPN10	Calpain-10	GO:0008092; F:cytoskeletal protein binding; ISS:BHF-UCL
Q9HC96	CAPN10	Calpain-10	GO:0000149; F:SNARE binding; ISS:BHF-UCL
Q9HC96	CAPN10	Calpain-10	GO:0031532; P:actin cytoskeleton reorganization; ISS:BHF-UCL
Q9HC96	CAPN10	Calpain-10	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; IC:BHF-UCL
Q9HC96	CAPN10	Calpain-10	GO:0032869; P:cellular response to insulin stimulus; IMP:BHF-UCL
Q9HC96	CAPN10	Calpain-10	GO:0046326; P:positive regulation of glucose import; IMP:BHF-UCL
Q9HC96	CAPN10	Calpain-10	GO:0032024; P:positive regulation of insulin secretion; IMP:BHF-UCL
Q9HC96	CAPN10	Calpain-10	GO:0032388; P:positive regulation of intracellular transport; ISS:BHF-UCL
Q9HC96	CAPN10	Calpain-10	GO:2000676; P:positive regulation of type B pancreatic cell apoptotic process; IEA:Ensembl
Q9HC96	CAPN10	Calpain-10	GO:0006508; P:proteolysis; IMP:BHF-UCL
Q9HC96	CAPN10	Calpain-10	GO:0097050; P:type B pancreatic cell apoptotic process; IDA:BHF-UCL
Q9UMQ6	CAPN11	Calpain-11	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UMQ6	CAPN11	Calpain-11	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; IBA:RefGenome
Q9UMQ6	CAPN11	Calpain-11	GO:0008233; F:peptidase activity; TAS:ProtInc
Q9UMQ6	CAPN11	Calpain-11	GO:0006508; P:proteolysis; IBA:RefGenome
Q6ZSI9	CAPN12	Calpain-12	GO:0005509; F:calcium ion binding; IEA:InterPro
Q6ZSI9	CAPN12	Calpain-12	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; IBA:RefGenome
Q6ZSI9	CAPN12	Calpain-12	GO:0006508; P:proteolysis; IBA:RefGenome
Q6MZZ7	CAPN13	Calpain-13	GO:0005509; F:calcium ion binding; IEA:InterPro
Q6MZZ7	CAPN13	Calpain-13	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; IBA:RefGenome
Q6MZZ7	CAPN13	Calpain-13	GO:0006508; P:proteolysis; IBA:RefGenome
A8MX76	CAPN14	Calpain-14	GO:0005509; F:calcium ion binding; IEA:InterPro
A8MX76	CAPN14	Calpain-14	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; IBA:RefGenome
A8MX76	CAPN14	Calpain-14	GO:0006508; P:proteolysis; IBA:RefGenome
O75808	CAPN15	Calpain-15	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; IBA:RefGenome
O75808	CAPN15	Calpain-15	GO:0008234; F:cysteine-type peptidase activity; TAS:ProtInc
O75808	CAPN15	Calpain-15	GO:0008233; F:peptidase activity; TAS:ProtInc
O75808	CAPN15	Calpain-15	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O75808	CAPN15	Calpain-15	GO:0008270; F:zinc ion binding; IEA:InterPro
O75808	CAPN15	Calpain-15	GO:0006508; P:proteolysis; IBA:RefGenome
O75808	CAPN15	Calpain-15	GO:0006355; P:regulation of transcription, DNA-templated; TAS:GOC
P07384	CAPN1	Calpain-1 catalytic subunit	GO:0005509; F:calcium ion binding; IEA:InterPro
P07384	CAPN1	Calpain-1 catalytic subunit	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; ISS:UniProtKB
P07384	CAPN1	Calpain-1 catalytic subunit	GO:0005515; F:protein binding; IPI:IntAct
P07384	CAPN1	Calpain-1 catalytic subunit	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P07384	CAPN1	Calpain-1 catalytic subunit	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P07384	CAPN1	Calpain-1 catalytic subunit	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P07384	CAPN1	Calpain-1 catalytic subunit	GO:0006508; P:proteolysis; ISS:UniProtKB
P07384	CAPN1	Calpain-1 catalytic subunit	GO:0032801; P:receptor catabolic process; IEA:Ensembl
P17655	CAPN2	Calpain-2 catalytic subunit	GO:0005509; F:calcium ion binding; IEA:Ensembl
P17655	CAPN2	Calpain-2 catalytic subunit	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; ISS:UniProtKB
P17655	CAPN2	Calpain-2 catalytic subunit	GO:0008234; F:cysteine-type peptidase activity; TAS:ProtInc
P17655	CAPN2	Calpain-2 catalytic subunit	GO:0008092; F:cytoskeletal protein binding; NAS:BHF-UCL
P17655	CAPN2	Calpain-2 catalytic subunit	GO:0005515; F:protein binding; IPI:IntAct
P17655	CAPN2	Calpain-2 catalytic subunit	GO:0001824; P:blastocyst development; IEA:Ensembl
P17655	CAPN2	Calpain-2 catalytic subunit	GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB
P17655	CAPN2	Calpain-2 catalytic subunit	GO:0007520; P:myoblast fusion; IEA:Ensembl
P17655	CAPN2	Calpain-2 catalytic subunit	GO:0016540; P:protein autoprocessing; IEA:Ensembl
P17655	CAPN2	Calpain-2 catalytic subunit	GO:0006508; P:proteolysis; ISS:UniProtKB
P17655	CAPN2	Calpain-2 catalytic subunit	GO:0051603; P:proteolysis involved in cellular protein catabolic process; IC:BHF-UCL
P17655	CAPN2	Calpain-2 catalytic subunit	GO:0051493; P:regulation of cytoskeleton organization; TAS:BHF-UCL
P17655	CAPN2	Calpain-2 catalytic subunit	GO:0001666; P:response to hypoxia; IEA:Ensembl
P20807	CAPN3	Calpain-3	GO:0005509; F:calcium ion binding; ISS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; ISS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0003824; F:catalytic activity; IDA:UniProtKB
P20807	CAPN3	Calpain-3	GO:0008234; F:cysteine-type peptidase activity; TAS:ProtInc
P20807	CAPN3	Calpain-3	GO:0055103; F:ligase regulator activity; IDA:UniProtKB
P20807	CAPN3	Calpain-3	GO:0008233; F:peptidase activity; IDA:UniProtKB
P20807	CAPN3	Calpain-3	GO:0005515; F:protein binding; IPI:IntAct
P20807	CAPN3	Calpain-3	GO:0032947; F:protein complex scaffold; ISS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0004871; F:signal transducer activity; TAS:ProtInc
P20807	CAPN3	Calpain-3	GO:0031402; F:sodium ion binding; ISS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0008307; F:structural constituent of muscle; ISS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0031432; F:titin binding; IPI:UniProtKB
P20807	CAPN3	Calpain-3	GO:0006915; P:apoptotic process; TAS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0001896; P:autolysis; IEA:Ensembl
P20807	CAPN3	Calpain-3	GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0071472; P:cellular response to salt stress; ISS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0070315; P:G1 to G0 transition involved in cell differentiation; IEA:Ensembl
P20807	CAPN3	Calpain-3	GO:0046716; P:muscle cell cellular homeostasis; TAS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0007517; P:muscle organ development; TAS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0061061; P:muscle structure development; ISS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0030239; P:myofibril assembly; ISS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P20807	CAPN3	Calpain-3	GO:0033234; P:negative regulation of protein sumoylation; IDA:UniProtKB
P20807	CAPN3	Calpain-3	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
P20807	CAPN3	Calpain-3	GO:0045862; P:positive regulation of proteolysis; ISS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; ISS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0014718; P:positive regulation of satellite cell activation involved in skeletal muscle regeneration; ISS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
P20807	CAPN3	Calpain-3	GO:0006461; P:protein complex assembly; ISS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0072657; P:protein localization to membrane; ISS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0006508; P:proteolysis; IDA:UniProtKB
P20807	CAPN3	Calpain-3	GO:0050790; P:regulation of catalytic activity; IDA:UniProtKB
P20807	CAPN3	Calpain-3	GO:0043122; P:regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
P20807	CAPN3	Calpain-3	GO:0045661; P:regulation of myoblast differentiation; IEA:Ensembl
P20807	CAPN3	Calpain-3	GO:0051592; P:response to calcium ion; ISS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0014850; P:response to muscle activity; ISS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0045214; P:sarcomere organization; ISS:UniProtKB
P20807	CAPN3	Calpain-3	GO:0097264; P:self proteolysis; IDA:UniProtKB
P20807	CAPN3	Calpain-3	GO:0007165; P:signal transduction; TAS:GOC
O15484	CAPN5	Calpain-5	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; IBA:RefGenome
O15484	CAPN5	Calpain-5	GO:0006508; P:proteolysis; IBA:RefGenome
O15484	CAPN5	Calpain-5	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y6Q1	CAPN6	Calpain-6	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; IBA:RefGenome
Q9Y6Q1	CAPN6	Calpain-6	GO:0008017; F:microtubule binding; ISS:UniProtKB
Q9Y6Q1	CAPN6	Calpain-6	GO:0001578; P:microtubule bundle formation; ISS:UniProtKB
Q9Y6Q1	CAPN6	Calpain-6	GO:0006508; P:proteolysis; IBA:RefGenome
Q9Y6Q1	CAPN6	Calpain-6	GO:0051493; P:regulation of cytoskeleton organization; ISS:UniProtKB
Q9Y6W3	CAPN7	Calpain-7	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; IBA:RefGenome
Q9Y6W3	CAPN7	Calpain-7	GO:0004175; F:endopeptidase activity; IDA:UniProt
Q9Y6W3	CAPN7	Calpain-7	GO:0090541; F:MIT domain binding; IPI:UniProtKB
Q9Y6W3	CAPN7	Calpain-7	GO:0005515; F:protein binding; IPI:IntAct
Q9Y6W3	CAPN7	Calpain-7	GO:0010634; P:positive regulation of epithelial cell migration; IDA:UniProt
Q9Y6W3	CAPN7	Calpain-7	GO:0097264; P:self proteolysis; IDA:UniProtKB
A6NHC0	CAPN8	Calpain-8	GO:0005509; F:calcium ion binding; IEA:InterPro
A6NHC0	CAPN8	Calpain-8	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; IBA:RefGenome
A6NHC0	CAPN8	Calpain-8	GO:0006508; P:proteolysis; IBA:RefGenome
O14815	CAPN9	Calpain-9	GO:0005509; F:calcium ion binding; TAS:ProtInc
O14815	CAPN9	Calpain-9	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; IBA:RefGenome
O14815	CAPN9	Calpain-9	GO:0007586; P:digestion; TAS:ProtInc
O14815	CAPN9	Calpain-9	GO:0006508; P:proteolysis; IBA:RefGenome
P63098	PPP3R1	Calcineurin subunit B type 1	GO:0005509; F:calcium ion binding; NAS:UniProtKB
P63098	PPP3R1	Calcineurin subunit B type 1	GO:0004723; F:calcium-dependent protein serine/threonine phosphatase activity; NAS:UniProtKB
P63098	PPP3R1	Calcineurin subunit B type 1	GO:0005516; F:calmodulin binding; NAS:UniProtKB
P63098	PPP3R1	Calcineurin subunit B type 1	GO:0005515; F:protein binding; IPI:IntAct
P63098	PPP3R1	Calcineurin subunit B type 1	GO:0019904; F:protein domain specific binding; IPI:BHF-UCL
P63098	PPP3R1	Calcineurin subunit B type 1	GO:0006915; P:apoptotic process; TAS:Reactome
P63098	PPP3R1	Calcineurin subunit B type 1	GO:0016311; P:dephosphorylation; NAS:GOC
P63098	PPP3R1	Calcineurin subunit B type 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P63098	PPP3R1	Calcineurin subunit B type 1	GO:0045087; P:innate immune response; TAS:Reactome
P63098	PPP3R1	Calcineurin subunit B type 1	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
P63098	PPP3R1	Calcineurin subunit B type 1	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
Q96LZ3	PPP3R2	Calcineurin subunit B type 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q86VP6	CAND1	Cullin-associated NEDD8-dissociated protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q86VP6	CAND1	Cullin-associated NEDD8-dissociated protein 1	GO:0030154; P:cell differentiation; IDA:UniProtKB
Q86VP6	CAND1	Cullin-associated NEDD8-dissociated protein 1	GO:0043086; P:negative regulation of catalytic activity; IDA:UniProtKB
Q86VP6	CAND1	Cullin-associated NEDD8-dissociated protein 1	GO:0045899; P:positive regulation of RNA polymerase II transcriptional preinitiation complex assembly; IEA:Ensembl
Q86VP6	CAND1	Cullin-associated NEDD8-dissociated protein 1	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q86VP6	CAND1	Cullin-associated NEDD8-dissociated protein 1	GO:0010265; P:SCF complex assembly; IDA:UniProtKB
O75155	CAND2	Cullin-associated NEDD8-dissociated protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
O75155	CAND2	Cullin-associated NEDD8-dissociated protein 2	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
O75155	CAND2	Cullin-associated NEDD8-dissociated protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WVQ1	CANT1	Soluble calcium-activated nucleotidase 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8WVQ1	CANT1	Soluble calcium-activated nucleotidase 1	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q8WVQ1	CANT1	Soluble calcium-activated nucleotidase 1	GO:0045134; F:uridine-diphosphatase activity; IEA:UniProtKB-EC
Q8WVQ1	CANT1	Soluble calcium-activated nucleotidase 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q8WVQ1	CANT1	Soluble calcium-activated nucleotidase 1	GO:0030166; P:proteoglycan biosynthetic process; IMP:UniProtKB
Q8WVQ1	CANT1	Soluble calcium-activated nucleotidase 1	GO:0007165; P:signal transduction; IMP:GOC
Q01518	CAP1	Adenylyl cyclase-associated protein 1	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
Q01518	CAP1	Adenylyl cyclase-associated protein 1	GO:0007190; P:activation of adenylate cyclase activity; TAS:ProtInc
Q01518	CAP1	Adenylyl cyclase-associated protein 1	GO:0001667; P:ameboidal cell migration; IEA:Ensembl
Q01518	CAP1	Adenylyl cyclase-associated protein 1	GO:0007411; P:axon guidance; TAS:Reactome
Q01518	CAP1	Adenylyl cyclase-associated protein 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q01518	CAP1	Adenylyl cyclase-associated protein 1	GO:0007163; P:establishment or maintenance of cell polarity; TAS:ProtInc
Q01518	CAP1	Adenylyl cyclase-associated protein 1	GO:0030168; P:platelet activation; TAS:Reactome
Q01518	CAP1	Adenylyl cyclase-associated protein 1	GO:0002576; P:platelet degranulation; TAS:Reactome
Q01518	CAP1	Adenylyl cyclase-associated protein 1	GO:0006898; P:receptor-mediated endocytosis; IEA:Ensembl
Q01518	CAP1	Adenylyl cyclase-associated protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
P40123	CAP2	Adenylyl cyclase-associated protein 2	GO:0007190; P:activation of adenylate cyclase activity; TAS:ProtInc
P40123	CAP2	Adenylyl cyclase-associated protein 2	GO:0007411; P:axon guidance; TAS:Reactome
P40123	CAP2	Adenylyl cyclase-associated protein 2	GO:0007010; P:cytoskeleton organization; IEA:InterPro
P40123	CAP2	Adenylyl cyclase-associated protein 2	GO:0007163; P:establishment or maintenance of cell polarity; TAS:ProtInc
P40123	CAP2	Adenylyl cyclase-associated protein 2	GO:0007165; P:signal transduction; TAS:ProtInc
P20160	AZU1	Azurocidin	GO:0003824; F:catalytic activity; IEA:InterPro
P20160	AZU1	Azurocidin	GO:0008201; F:heparin binding; NAS:UniProtKB
P20160	AZU1	Azurocidin	GO:0015643; F:toxic substance binding; NAS:UniProtKB
P20160	AZU1	Azurocidin	GO:0045123; P:cellular extravasation; NAS:UniProtKB
P20160	AZU1	Azurocidin	GO:0050829; P:defense response to Gram-negative bacterium; TAS:UniProtKB
P20160	AZU1	Azurocidin	GO:0008347; P:glial cell migration; IDA:UniProtKB
P20160	AZU1	Azurocidin	GO:0050930; P:induction of positive chemotaxis; NAS:UniProtKB
P20160	AZU1	Azurocidin	GO:0006954; P:inflammatory response; NAS:UniProtKB
P20160	AZU1	Azurocidin	GO:0048246; P:macrophage chemotaxis; NAS:UniProtKB
P20160	AZU1	Azurocidin	GO:0001774; P:microglial cell activation; IEP:UniProtKB
P20160	AZU1	Azurocidin	GO:0042117; P:monocyte activation; TAS:UniProtKB
P20160	AZU1	Azurocidin	GO:0043066; P:negative regulation of apoptotic process; NAS:UniProtKB
P20160	AZU1	Azurocidin	GO:0045785; P:positive regulation of cell adhesion; IDA:UniProtKB
P20160	AZU1	Azurocidin	GO:0050754; P:positive regulation of fractalkine biosynthetic process; IDA:UniProtKB
P20160	AZU1	Azurocidin	GO:0050725; P:positive regulation of interleukin-1 beta biosynthetic process; IDA:UniProtKB
P20160	AZU1	Azurocidin	GO:0045348; P:positive regulation of MHC class II biosynthetic process; IEP:UniProtKB
P20160	AZU1	Azurocidin	GO:0050766; P:positive regulation of phagocytosis; IDA:UniProtKB
P20160	AZU1	Azurocidin	GO:0042535; P:positive regulation of tumor necrosis factor biosynthetic process; IDA:UniProtKB
P20160	AZU1	Azurocidin	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; TAS:UniProtKB
P20160	AZU1	Azurocidin	GO:0006508; P:proteolysis; IBA:RefGenome
P20160	AZU1	Azurocidin	GO:0043114; P:regulation of vascular permeability; NAS:UniProtKB
P40121	CAPG	Macrophage-capping protein	GO:0051016; P:barbed-end actin filament capping; TAS:ProtInc
P40121	CAPG	Macrophage-capping protein	GO:0030031; P:cell projection assembly; IEA:Ensembl
P40121	CAPG	Macrophage-capping protein	GO:0006461; P:protein complex assembly; NAS:ProtInc
O75052	NOS1AP	Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein	GO:0050998; F:nitric-oxide synthase binding; ISS:UniProtKB
O75052	NOS1AP	Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein	GO:0030165; F:PDZ domain binding; ISS:UniProtKB
O75052	NOS1AP	Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein	GO:0042981; P:regulation of apoptotic process; NAS:DFLAT
O75052	NOS1AP	Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein	GO:0045428; P:regulation of nitric oxide biosynthetic process; NAS:DFLAT
O75052	NOS1AP	Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein	GO:0050999; P:regulation of nitric-oxide synthase activity; NAS:DFLAT
Q14444	CAPRIN1	Caprin-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14444	CAPRIN1	Caprin-1	GO:0003723; F:RNA binding; ISS:UniProtKB
Q14444	CAPRIN1	Caprin-1	GO:0017148; P:negative regulation of translation; ISS:UniProtKB
Q14444	CAPRIN1	Caprin-1	GO:0050775; P:positive regulation of dendrite morphogenesis; ISS:UniProtKB
Q14444	CAPRIN1	Caprin-1	GO:0061003; P:positive regulation of dendritic spine morphogenesis; ISS:UniProtKB
Q6IMN6	CAPRIN2	Caprin-2	GO:0005515; F:protein binding; IPI:IntAct
Q6IMN6	CAPRIN2	Caprin-2	GO:0005102; F:receptor binding; IPI:BHF-UCL
Q6IMN6	CAPRIN2	Caprin-2	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q6IMN6	CAPRIN2	Caprin-2	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q6IMN6	CAPRIN2	Caprin-2	GO:0017148; P:negative regulation of translation; IEA:UniProtKB-KW
Q6IMN6	CAPRIN2	Caprin-2	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:BHF-UCL
Q6IMN6	CAPRIN2	Caprin-2	GO:0050775; P:positive regulation of dendrite morphogenesis; ISS:UniProtKB
Q6IMN6	CAPRIN2	Caprin-2	GO:0061003; P:positive regulation of dendritic spine morphogenesis; ISS:UniProtKB
Q6IMN6	CAPRIN2	Caprin-2	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:BHF-UCL
Q6IMN6	CAPRIN2	Caprin-2	GO:0032092; P:positive regulation of protein binding; IDA:BHF-UCL
Q6IMN6	CAPRIN2	Caprin-2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9ULU8	CADPS	Calcium-dependent secretion activator 1	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q9ULU8	CADPS	Calcium-dependent secretion activator 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9ULU8	CADPS	Calcium-dependent secretion activator 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9ULU8	CADPS	Calcium-dependent secretion activator 1	GO:0050432; P:catecholamine secretion; IEA:Ensembl
Q9ULU8	CADPS	Calcium-dependent secretion activator 1	GO:0006887; P:exocytosis; TAS:ProtInc
Q9ULU8	CADPS	Calcium-dependent secretion activator 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9ULU8	CADPS	Calcium-dependent secretion activator 1	GO:0016082; P:synaptic vesicle priming; IEA:Ensembl
Q9ULU8	CADPS	Calcium-dependent secretion activator 1	GO:0016050; P:vesicle organization; IEA:Ensembl
Q86UW7	CADPS2	Calcium-dependent secretion activator 2	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q86UW7	CADPS2	Calcium-dependent secretion activator 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86UW7	CADPS2	Calcium-dependent secretion activator 2	GO:0045921; P:positive regulation of exocytosis; IEA:Ensembl
Q86UW7	CADPS2	Calcium-dependent secretion activator 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q86UW7	CADPS2	Calcium-dependent secretion activator 2	GO:0016082; P:synaptic vesicle priming; IEA:Ensembl
Q8WWF8	CAPSL	Calcyphosin-like protein	GO:0005509; F:calcium ion binding; IEA:InterPro
P47756	CAPZB	F-actin-capping protein subunit beta	GO:0003779; F:actin binding; TAS:ProtInc
P47756	CAPZB	F-actin-capping protein subunit beta	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
P47756	CAPZB	F-actin-capping protein subunit beta	GO:0051016; P:barbed-end actin filament capping; IEA:Ensembl
P47756	CAPZB	F-actin-capping protein subunit beta	GO:0007596; P:blood coagulation; TAS:Reactome
P47756	CAPZB	F-actin-capping protein subunit beta	GO:0006928; P:cellular component movement; TAS:UniProtKB
P47756	CAPZB	F-actin-capping protein subunit beta	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
P47756	CAPZB	F-actin-capping protein subunit beta	GO:0030032; P:lamellipodium assembly; IEA:Ensembl
P47756	CAPZB	F-actin-capping protein subunit beta	GO:0048747; P:muscle fiber development; IEA:Ensembl
P47756	CAPZB	F-actin-capping protein subunit beta	GO:0031115; P:negative regulation of microtubule polymerization; IEA:Ensembl
P47756	CAPZB	F-actin-capping protein subunit beta	GO:0031175; P:neuron projection development; IEA:Ensembl
P47756	CAPZB	F-actin-capping protein subunit beta	GO:0022604; P:regulation of cell morphogenesis; IMP:UniProtKB
P47756	CAPZB	F-actin-capping protein subunit beta	GO:0090036; P:regulation of protein kinase C signaling; IEA:Ensembl
Q9BWT7	CARD10	Caspase recruitment domain-containing protein 10	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BWT7	CARD10	Caspase recruitment domain-containing protein 10	GO:0030159; F:receptor signaling complex scaffold activity; NAS:UniProtKB
Q9BWT7	CARD10	Caspase recruitment domain-containing protein 10	GO:0007250; P:activation of NF-kappaB-inducing kinase activity; IDA:UniProtKB
Q9BWT7	CARD10	Caspase recruitment domain-containing protein 10	GO:0006461; P:protein complex assembly; NAS:UniProtKB
Q9BWT7	CARD10	Caspase recruitment domain-containing protein 10	GO:0042981; P:regulation of apoptotic process; IEA:InterPro
Q9BXL7	CARD11	Caspase recruitment domain-containing protein 11	GO:0050700; F:CARD domain binding; IPI:UniProtKB
Q9BXL7	CARD11	Caspase recruitment domain-containing protein 11	GO:0004385; F:guanylate kinase activity; NAS:UniProtKB
Q9BXL7	CARD11	Caspase recruitment domain-containing protein 11	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BXL7	CARD11	Caspase recruitment domain-containing protein 11	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9BXL7	CARD11	Caspase recruitment domain-containing protein 11	GO:0045087; P:innate immune response; TAS:Reactome
Q9BXL7	CARD11	Caspase recruitment domain-containing protein 11	GO:0046939; P:nucleotide phosphorylation; NAS:GOC
Q9BXL7	CARD11	Caspase recruitment domain-containing protein 11	GO:0030890; P:positive regulation of B cell proliferation; IEA:Ensembl
Q9BXL7	CARD11	Caspase recruitment domain-containing protein 11	GO:0001819; P:positive regulation of cytokine production; IMP:UniProtKB
Q9BXL7	CARD11	Caspase recruitment domain-containing protein 11	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
Q9BXL7	CARD11	Caspase recruitment domain-containing protein 11	GO:0045086; P:positive regulation of interleukin-2 biosynthetic process; IEA:Ensembl
Q9BXL7	CARD11	Caspase recruitment domain-containing protein 11	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
Q9BXL7	CARD11	Caspase recruitment domain-containing protein 11	GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl
Q9BXL7	CARD11	Caspase recruitment domain-containing protein 11	GO:0042981; P:regulation of apoptotic process; IEA:InterPro
Q9BXL7	CARD11	Caspase recruitment domain-containing protein 11	GO:0045577; P:regulation of B cell differentiation; IEA:Ensembl
Q9BXL7	CARD11	Caspase recruitment domain-containing protein 11	GO:0045580; P:regulation of T cell differentiation; IEA:Ensembl
Q9BXL7	CARD11	Caspase recruitment domain-containing protein 11	GO:0031295; P:T cell costimulation; IDA:UniProtKB
Q9BXL7	CARD11	Caspase recruitment domain-containing protein 11	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q9BXL7	CARD11	Caspase recruitment domain-containing protein 11	GO:0045061; P:thymic T cell selection; IEA:Ensembl
Q9BXL6	CARD14	Caspase recruitment domain-containing protein 14	GO:0050700; F:CARD domain binding; IPI:UniProtKB
Q9BXL6	CARD14	Caspase recruitment domain-containing protein 14	GO:0007250; P:activation of NF-kappaB-inducing kinase activity; NAS:UniProtKB
Q9BXL6	CARD14	Caspase recruitment domain-containing protein 14	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9BXL6	CARD14	Caspase recruitment domain-containing protein 14	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q9BXL6	CARD14	Caspase recruitment domain-containing protein 14	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
Q9BXL6	CARD14	Caspase recruitment domain-containing protein 14	GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB
Q9BXL6	CARD14	Caspase recruitment domain-containing protein 14	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IMP:UniProtKB
Q5XLA6	CARD17	Caspase recruitment domain-containing protein 17	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q5XLA6	CARD17	Caspase recruitment domain-containing protein 17	GO:0042981; P:regulation of apoptotic process; IEA:InterPro
Q5EG05	CARD16	Caspase recruitment domain-containing protein 16	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q5EG05	CARD16	Caspase recruitment domain-containing protein 16	GO:0042981; P:regulation of apoptotic process; IEA:InterPro
P57730	CARD18	Caspase recruitment domain-containing protein 18	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
P57730	CARD18	Caspase recruitment domain-containing protein 18	GO:0006954; P:inflammatory response; NAS:UniProtKB
P57730	CARD18	Caspase recruitment domain-containing protein 18	GO:0042981; P:regulation of apoptotic process; IEA:InterPro
Q9BX69	CARD6	Caspase recruitment domain-containing protein 6	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9BX69	CARD6	Caspase recruitment domain-containing protein 6	GO:0042981; P:regulation of apoptotic process; IEA:InterPro
Q9Y2G2	CARD8	Caspase recruitment domain-containing protein 8	GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; IDA:HGNC
Q9Y2G2	CARD8	Caspase recruitment domain-containing protein 8	GO:0032089; F:NACHT domain binding; IPI:HGNC
Q9Y2G2	CARD8	Caspase recruitment domain-containing protein 8	GO:0005515; F:protein binding; IPI:HGNC
Q9Y2G2	CARD8	Caspase recruitment domain-containing protein 8	GO:0042803; F:protein homodimerization activity; IDA:HGNC
Q9Y2G2	CARD8	Caspase recruitment domain-containing protein 8	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:GOC
Q9Y2G2	CARD8	Caspase recruitment domain-containing protein 8	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:HGNC
Q9Y2G2	CARD8	Caspase recruitment domain-containing protein 8	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:HGNC
Q9Y2G2	CARD8	Caspase recruitment domain-containing protein 8	GO:0050718; P:positive regulation of interleukin-1 beta secretion; IDA:HGNC
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0050700; F:CARD domain binding; IPI:UniProtKB
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0050830; P:defense response to Gram-positive bacterium; IEA:Ensembl
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0051607; P:defense response to virus; IEA:Ensembl
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0045087; P:innate immune response; TAS:Reactome
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0046330; P:positive regulation of JNK cascade; IDA:MGI
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0032874; P:positive regulation of stress-activated MAPK cascade; IDA:MGI
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0032760; P:positive regulation of tumor necrosis factor production; IEA:Ensembl
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0042981; P:regulation of apoptotic process; IEA:InterPro
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0045076; P:regulation of interleukin-2 biosynthetic process; IEA:Ensembl
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0045408; P:regulation of interleukin-6 biosynthetic process; IEA:Ensembl
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0042534; P:regulation of tumor necrosis factor biosynthetic process; IEA:Ensembl
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0042493; P:response to drug; IEA:Ensembl
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0043330; P:response to exogenous dsRNA; IEA:Ensembl
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0009620; P:response to fungus; IEA:Ensembl
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0032495; P:response to muramyl dipeptide; IEA:Ensembl
Q9H257	CARD9	Caspase recruitment domain-containing protein 9	GO:0032494; P:response to peptidoglycan; IEA:Ensembl
Q9NXV6	CDKN2AIP	CDKN2A-interacting protein	GO:0002039; F:p53 binding; IDA:BHF-UCL
Q9NXV6	CDKN2AIP	CDKN2A-interacting protein	GO:0005515; F:protein binding; IPI:BHF-UCL
Q9NXV6	CDKN2AIP	CDKN2A-interacting protein	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9NXV6	CDKN2AIP	CDKN2A-interacting protein	GO:0030308; P:negative regulation of cell growth; IMP:BHF-UCL
Q9NXV6	CDKN2AIP	CDKN2A-interacting protein	GO:0009967; P:positive regulation of signal transduction; IMP:BHF-UCL
Q9NXV6	CDKN2AIP	CDKN2A-interacting protein	GO:0031647; P:regulation of protein stability; IMP:BHF-UCL
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0008013; F:beta-catenin binding; TAS:AgBase
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0070577; F:lysine-acetylated histone binding; ISS:UniProtKB
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0042054; F:histone methyltransferase activity; IDA:UniProtKB
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0035642; F:histone methyltransferase activity (H3-R17 specific); ISS:UniProtKB
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0008469; F:histone-arginine N-methyltransferase activity; IBA:RefGenome
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; ISS:UniProtKB
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0005515; F:protein binding; IPI:IntAct
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0008276; F:protein methyltransferase activity; ISS:UniProtKB
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0016274; F:protein-arginine N-methyltransferase activity; ISS:UniProtKB
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0035242; F:protein-arginine omega-N asymmetric methyltransferase activity; ISS:UniProtKB
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0003713; F:transcription coactivator activity; ISS:UniProtKB
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0044212; F:transcription regulatory region DNA binding; ISS:UniProtKB
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0060350; P:endochondral bone morphogenesis; IEA:Ensembl
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0034971; P:histone H3-R17 methylation; ISS:UniProtKB
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0034970; P:histone H3-R2 methylation; IMP:UniProtKB
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0016571; P:histone methylation; IDA:UniProtKB
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0030520; P:intracellular estrogen receptor signaling pathway; IEA:Ensembl
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0032091; P:negative regulation of protein binding; IEA:Ensembl
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0009405; P:pathogenesis; IEA:InterPro
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0019919; P:peptidyl-arginine methylation, to asymmetrical-dimethyl arginine; IBA:RefGenome
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0045600; P:positive regulation of fat cell differentiation; ISS:UniProtKB
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0003420; P:regulation of growth plate cartilage chondrocyte proliferation; IEA:Ensembl
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0033146; P:regulation of intracellular estrogen receptor signaling pathway; ISS:UniProtKB
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0051591; P:response to cAMP; IEA:Ensembl
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86X55	CARM1	Histone-arginine methyltransferase CARM1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q8N187	CARF	Calcium-responsive transcription factor	GO:0003677; F:DNA binding; IDA:UniProtKB
Q8N187	CARF	Calcium-responsive transcription factor	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q8N187	CARF	Calcium-responsive transcription factor	GO:0071277; P:cellular response to calcium ion; IDA:UniProtKB
Q8N187	CARF	Calcium-responsive transcription factor	GO:0035865; P:cellular response to potassium ion; IDA:UniProtKB
Q8N187	CARF	Calcium-responsive transcription factor	GO:0061400; P:positive regulation of transcription from RNA polymerase II promoter in response to calcium ion; IDA:UniProtKB
Q8N187	CARF	Calcium-responsive transcription factor	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q16568	CARTPT	Cocaine- and amphetamine-regulated transcript protein	GO:0005515; F:protein binding; IPI:IntAct
Q16568	CARTPT	Cocaine- and amphetamine-regulated transcript protein	GO:0000186; P:activation of MAPKK activity; ISS:HGNC
Q16568	CARTPT	Cocaine- and amphetamine-regulated transcript protein	GO:0008343; P:adult feeding behavior; ISS:HGNC
Q16568	CARTPT	Cocaine- and amphetamine-regulated transcript protein	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q16568	CARTPT	Cocaine- and amphetamine-regulated transcript protein	GO:0001678; P:cellular glucose homeostasis; IDA:HGNC
Q16568	CARTPT	Cocaine- and amphetamine-regulated transcript protein	GO:0009267; P:cellular response to starvation; ISS:HGNC
Q16568	CARTPT	Cocaine- and amphetamine-regulated transcript protein	GO:0032922; P:circadian regulation of gene expression; ISS:HGNC
Q16568	CARTPT	Cocaine- and amphetamine-regulated transcript protein	GO:0007186; P:G-protein coupled receptor signaling pathway; ISS:HGNC
Q16568	CARTPT	Cocaine- and amphetamine-regulated transcript protein	GO:0032099; P:negative regulation of appetite; ISS:HGNC
Q16568	CARTPT	Cocaine- and amphetamine-regulated transcript protein	GO:0045779; P:negative regulation of bone resorption; IMP:HGNC
Q16568	CARTPT	Cocaine- and amphetamine-regulated transcript protein	GO:0070093; P:negative regulation of glucagon secretion; IEA:Ensembl
Q16568	CARTPT	Cocaine- and amphetamine-regulated transcript protein	GO:0045671; P:negative regulation of osteoclast differentiation; TAS:HGNC
Q16568	CARTPT	Cocaine- and amphetamine-regulated transcript protein	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
Q16568	CARTPT	Cocaine- and amphetamine-regulated transcript protein	GO:0045777; P:positive regulation of blood pressure; IDA:HGNC
Q16568	CARTPT	Cocaine- and amphetamine-regulated transcript protein	GO:0032812; P:positive regulation of epinephrine secretion; IDA:HGNC
Q16568	CARTPT	Cocaine- and amphetamine-regulated transcript protein	GO:0051971; P:positive regulation of transmission of nerve impulse; IDA:HGNC
Q16568	CARTPT	Cocaine- and amphetamine-regulated transcript protein	GO:0050796; P:regulation of insulin secretion; IEA:Ensembl
Q16568	CARTPT	Cocaine- and amphetamine-regulated transcript protein	GO:0007165; P:signal transduction; TAS:ProtInc
Q16568	CARTPT	Cocaine- and amphetamine-regulated transcript protein	GO:0070253; P:somatostatin secretion; IEA:Ensembl
Q16568	CARTPT	Cocaine- and amphetamine-regulated transcript protein	GO:0007268; P:synaptic transmission; IEA:UniProtKB-KW
P47710	CSN1S1	Alpha-S1-casein	GO:0005215; F:transporter activity; IEA:InterPro
P05814	CSN2	Beta-casein	GO:0005509; F:calcium ion binding; TAS:ProtInc
P05814	CSN2	Beta-casein	GO:0004857; F:enzyme inhibitor activity; TAS:ProtInc
P05814	CSN2	Beta-casein	GO:0005215; F:transporter activity; IEA:InterPro
P05814	CSN2	Beta-casein	GO:0006816; P:calcium ion transport; TAS:ProtInc
P05814	CSN2	Beta-casein	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
O15234	CASC3	Protein CASC3	GO:0019899; F:enzyme binding; IPI:UniProtKB
O15234	CASC3	Protein CASC3	GO:0042802; F:identical protein binding; IDA:MGI
O15234	CASC3	Protein CASC3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O15234	CASC3	Protein CASC3	GO:0005515; F:protein binding; IPI:IntAct
O15234	CASC3	Protein CASC3	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
O15234	CASC3	Protein CASC3	GO:0010467; P:gene expression; TAS:Reactome
O15234	CASC3	Protein CASC3	GO:0008298; P:intracellular mRNA localization; IEA:Ensembl
O15234	CASC3	Protein CASC3	GO:0016071; P:mRNA metabolic process; TAS:Reactome
O15234	CASC3	Protein CASC3	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
O15234	CASC3	Protein CASC3	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
O15234	CASC3	Protein CASC3	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
O15234	CASC3	Protein CASC3	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
O15234	CASC3	Protein CASC3	GO:0006950; P:response to stress; IEA:UniProtKB-KW
O15234	CASC3	Protein CASC3	GO:0016070; P:RNA metabolic process; TAS:Reactome
O15234	CASC3	Protein CASC3	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q8NG31	CASC5	Protein CASC5	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NG31	CASC5	Protein CASC5	GO:0001675; P:acrosome assembly; NAS:UniProtKB
Q8NG31	CASC5	Protein CASC5	GO:0008608; P:attachment of spindle microtubules to kinetochore; IDA:UniProtKB
Q8NG31	CASC5	Protein CASC5	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
Q8NG31	CASC5	Protein CASC5	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q8NG31	CASC5	Protein CASC5	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8NG31	CASC5	Protein CASC5	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q8NG31	CASC5	Protein CASC5	GO:0006334; P:nucleosome assembly; TAS:Reactome
Q8NG31	CASC5	Protein CASC5	GO:0034501; P:protein localization to kinetochore; IDA:MGI
Q8NG31	CASC5	Protein CASC5	GO:0071173; P:spindle assembly checkpoint; IDA:UniProtKB
P07498	CSN3	Kappa-casein	GO:0007595; P:lactation; IEA:Ensembl
Q14511	NEDD9	Enhancer of filamentation 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q14511	NEDD9	Enhancer of filamentation 1	GO:0051017; P:actin filament bundle assembly; NAS:UniProtKB
Q14511	NEDD9	Enhancer of filamentation 1	GO:0007155; P:cell adhesion; NAS:ProtInc
Q14511	NEDD9	Enhancer of filamentation 1	GO:0007010; P:cytoskeleton organization; NAS:UniProtKB
Q14511	NEDD9	Enhancer of filamentation 1	GO:0007229; P:integrin-mediated signaling pathway; NAS:UniProtKB
Q14511	NEDD9	Enhancer of filamentation 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q14511	NEDD9	Enhancer of filamentation 1	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q14511	NEDD9	Enhancer of filamentation 1	GO:0007165; P:signal transduction; TAS:ProtInc
P29466	CASP1	Caspase-1	GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; TAS:ProtInc
P29466	CASP1	Caspase-1	GO:0004197; F:cysteine-type endopeptidase activity; IBA:RefGenome
P29466	CASP1	Caspase-1	GO:0005515; F:protein binding; IPI:IntAct
P29466	CASP1	Caspase-1	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:GOC
P29466	CASP1	Caspase-1	GO:0006915; P:apoptotic process; TAS:ProtInc
P29466	CASP1	Caspase-1	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
P29466	CASP1	Caspase-1	GO:0071310; P:cellular response to organic substance; IDA:MGI
P29466	CASP1	Caspase-1	GO:0097194; P:execution phase of apoptosis; IBA:RefGenome
P29466	CASP1	Caspase-1	GO:0045087; P:innate immune response; TAS:Reactome
P29466	CASP1	Caspase-1	GO:0032611; P:interleukin-1 beta production; IEA:Ensembl
P29466	CASP1	Caspase-1	GO:0060081; P:membrane hyperpolarization; IEA:Ensembl
P29466	CASP1	Caspase-1	GO:0051882; P:mitochondrial depolarization; IEA:Ensembl
P29466	CASP1	Caspase-1	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
P29466	CASP1	Caspase-1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
P29466	CASP1	Caspase-1	GO:0050717; P:positive regulation of interleukin-1 alpha secretion; IEA:Ensembl
P29466	CASP1	Caspase-1	GO:0050718; P:positive regulation of interleukin-1 beta secretion; IEA:Ensembl
P29466	CASP1	Caspase-1	GO:0006508; P:proteolysis; IDA:UniProtKB
P29466	CASP1	Caspase-1	GO:0070269; P:pyroptosis; IEA:Ensembl
P29466	CASP1	Caspase-1	GO:0050727; P:regulation of inflammatory response; IBA:RefGenome
P29466	CASP1	Caspase-1	GO:0033198; P:response to ATP; IEA:Ensembl
P29466	CASP1	Caspase-1	GO:0001666; P:response to hypoxia; IEA:Ensembl
P29466	CASP1	Caspase-1	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P29466	CASP1	Caspase-1	GO:0007165; P:signal transduction; TAS:ProtInc
P42575	CASP2	Caspase-2	GO:0004197; F:cysteine-type endopeptidase activity; IDA:UniProtKB
P42575	CASP2	Caspase-2	GO:0097153; F:cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
P42575	CASP2	Caspase-2	GO:0019899; F:enzyme binding; ISS:UniProtKB
P42575	CASP2	Caspase-2	GO:0005515; F:protein binding; IPI:IntAct
P42575	CASP2	Caspase-2	GO:0019904; F:protein domain specific binding; IPI:BHF-UCL
P42575	CASP2	Caspase-2	GO:0007568; P:aging; IEA:Ensembl
P42575	CASP2	Caspase-2	GO:0006915; P:apoptotic process; NAS:UniProtKB
P42575	CASP2	Caspase-2	GO:0097190; P:apoptotic signaling pathway; TAS:UniProtKB
P42575	CASP2	Caspase-2	GO:0007420; P:brain development; IEA:Ensembl
P42575	CASP2	Caspase-2	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
P42575	CASP2	Caspase-2	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; IMP:UniProtKB
P42575	CASP2	Caspase-2	GO:0035234; P:ectopic germ cell programmed cell death; IEA:Ensembl
P42575	CASP2	Caspase-2	GO:0097194; P:execution phase of apoptosis; TAS:UniProtKB
P42575	CASP2	Caspase-2	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IBA:RefGenome
P42575	CASP2	Caspase-2	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; TAS:UniProtKB
P42575	CASP2	Caspase-2	GO:0001554; P:luteolysis; IEA:Ensembl
P42575	CASP2	Caspase-2	GO:0003407; P:neural retina development; IEA:Ensembl
P42575	CASP2	Caspase-2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P42575	CASP2	Caspase-2	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P42575	CASP2	Caspase-2	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
P42575	CASP2	Caspase-2	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
P42575	CASP2	Caspase-2	GO:0016485; P:protein processing; IDA:BHF-UCL
P42575	CASP2	Caspase-2	GO:0043281; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:Reactome
P42574	CASP3	Caspase-3	GO:0004190; F:aspartic-type endopeptidase activity; EXP:Reactome
P42574	CASP3	Caspase-3	GO:0004861; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; IEA:Ensembl
P42574	CASP3	Caspase-3	GO:0004197; F:cysteine-type endopeptidase activity; IDA:UniProtKB
P42574	CASP3	Caspase-3	GO:0097153; F:cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
P42574	CASP3	Caspase-3	GO:0097200; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; IMP:UniProtKB
P42574	CASP3	Caspase-3	GO:0008233; F:peptidase activity; IDA:UniProtKB
P42574	CASP3	Caspase-3	GO:0005515; F:protein binding; IPI:UniProtKB
P42574	CASP3	Caspase-3	GO:0008635; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; TAS:Reactome
P42574	CASP3	Caspase-3	GO:0006309; P:apoptotic DNA fragmentation; TAS:Reactome
P42574	CASP3	Caspase-3	GO:0006915; P:apoptotic process; TAS:Reactome
P42574	CASP3	Caspase-3	GO:0097190; P:apoptotic signaling pathway; TAS:BHF-UCL
P42574	CASP3	Caspase-3	GO:0001782; P:B cell homeostasis; IEA:Ensembl
P42574	CASP3	Caspase-3	GO:0045165; P:cell fate commitment; IEA:Ensembl
P42574	CASP3	Caspase-3	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
P42574	CASP3	Caspase-3	GO:0006974; P:cellular response to DNA damage stimulus; IEA:Ensembl
P42574	CASP3	Caspase-3	GO:0030218; P:erythrocyte differentiation; IDA:UniProtKB
P42574	CASP3	Caspase-3	GO:0097194; P:execution phase of apoptosis; IDA:UniProtKB
P42574	CASP3	Caspase-3	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P42574	CASP3	Caspase-3	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P42574	CASP3	Caspase-3	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P42574	CASP3	Caspase-3	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
P42574	CASP3	Caspase-3	GO:0034349; P:glial cell apoptotic process; IEA:Ensembl
P42574	CASP3	Caspase-3	GO:0007507; P:heart development; IEA:Ensembl
P42574	CASP3	Caspase-3	GO:0035329; P:hippo signaling; TAS:Reactome
P42574	CASP3	Caspase-3	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
P42574	CASP3	Caspase-3	GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IEA:Ensembl
P42574	CASP3	Caspase-3	GO:0030216; P:keratinocyte differentiation; IBA:RefGenome
P42574	CASP3	Caspase-3	GO:0046007; P:negative regulation of activated T cell proliferation; IEA:Ensembl
P42574	CASP3	Caspase-3	GO:0043066; P:negative regulation of apoptotic process; IGI:MGI
P42574	CASP3	Caspase-3	GO:0030889; P:negative regulation of B cell proliferation; IEA:Ensembl
P42574	CASP3	Caspase-3	GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:Ensembl
P42574	CASP3	Caspase-3	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
P42574	CASP3	Caspase-3	GO:0030182; P:neuron differentiation; IBA:RefGenome
P42574	CASP3	Caspase-3	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P42574	CASP3	Caspase-3	GO:0030220; P:platelet formation; TAS:UniProtKB
P42574	CASP3	Caspase-3	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
P42574	CASP3	Caspase-3	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
P42574	CASP3	Caspase-3	GO:0006508; P:proteolysis; IDA:UniProtKB
P42574	CASP3	Caspase-3	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P42574	CASP3	Caspase-3	GO:0043281; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:Reactome
P42574	CASP3	Caspase-3	GO:0001836; P:release of cytochrome c from mitochondria; IEA:Ensembl
P42574	CASP3	Caspase-3	GO:0034612; P:response to tumor necrosis factor; TAS:BHF-UCL
P42574	CASP3	Caspase-3	GO:0009411; P:response to UV; IEA:Ensembl
P42574	CASP3	Caspase-3	GO:0009611; P:response to wounding; IEA:Ensembl
P42574	CASP3	Caspase-3	GO:0007605; P:sensory perception of sound; IEA:Ensembl
P42574	CASP3	Caspase-3	GO:0043029; P:T cell homeostasis; IEA:Ensembl
P49662	CASP4	Caspase-4	GO:0004197; F:cysteine-type endopeptidase activity; IBA:RefGenome
P49662	CASP4	Caspase-4	GO:0006915; P:apoptotic process; TAS:ProtInc
P49662	CASP4	Caspase-4	GO:0097194; P:execution phase of apoptosis; IBA:RefGenome
P49662	CASP4	Caspase-4	GO:0006508; P:proteolysis; TAS:ProtInc
P49662	CASP4	Caspase-4	GO:0042981; P:regulation of apoptotic process; IEA:InterPro
P49662	CASP4	Caspase-4	GO:0050727; P:regulation of inflammatory response; IBA:RefGenome
P51878	CASP5	Caspase-5	GO:0004197; F:cysteine-type endopeptidase activity; IBA:RefGenome
P51878	CASP5	Caspase-5	GO:0008234; F:cysteine-type peptidase activity; TAS:ProtInc
P51878	CASP5	Caspase-5	GO:0006915; P:apoptotic process; TAS:ProtInc
P51878	CASP5	Caspase-5	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
P51878	CASP5	Caspase-5	GO:0097194; P:execution phase of apoptosis; IBA:RefGenome
P51878	CASP5	Caspase-5	GO:0006508; P:proteolysis; TAS:ProtInc
P51878	CASP5	Caspase-5	GO:0042981; P:regulation of apoptotic process; IEA:InterPro
P51878	CASP5	Caspase-5	GO:0050727; P:regulation of inflammatory response; IBA:RefGenome
P51878	CASP5	Caspase-5	GO:0021762; P:substantia nigra development; IEP:UniProt
P55212	CASP6	Caspase-6	GO:0004197; F:cysteine-type endopeptidase activity; IBA:RefGenome
P55212	CASP6	Caspase-6	GO:0008234; F:cysteine-type peptidase activity; TAS:ProtInc
P55212	CASP6	Caspase-6	GO:0042802; F:identical protein binding; IPI:IntAct
P55212	CASP6	Caspase-6	GO:0005515; F:protein binding; IPI:UniProtKB
P55212	CASP6	Caspase-6	GO:0006915; P:apoptotic process; IBA:RefGenome
P55212	CASP6	Caspase-6	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
P55212	CASP6	Caspase-6	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
P55212	CASP6	Caspase-6	GO:0006508; P:proteolysis; IDA:UniProtKB
P55210	CASP7	Caspase-7	GO:0004190; F:aspartic-type endopeptidase activity; IEA:Ensembl
P55210	CASP7	Caspase-7	GO:0004197; F:cysteine-type endopeptidase activity; IBA:RefGenome
P55210	CASP7	Caspase-7	GO:0097153; F:cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
P55210	CASP7	Caspase-7	GO:0008234; F:cysteine-type peptidase activity; TAS:ProtInc
P55210	CASP7	Caspase-7	GO:0005515; F:protein binding; IPI:UniProtKB
P55210	CASP7	Caspase-7	GO:0008635; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; TAS:Reactome
P55210	CASP7	Caspase-7	GO:0007568; P:aging; IEA:Ensembl
P55210	CASP7	Caspase-7	GO:0006915; P:apoptotic process; TAS:Reactome
P55210	CASP7	Caspase-7	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
P55210	CASP7	Caspase-7	GO:0097194; P:execution phase of apoptosis; IBA:RefGenome
P55210	CASP7	Caspase-7	GO:0007507; P:heart development; IEA:Ensembl
P55210	CASP7	Caspase-7	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
P55210	CASP7	Caspase-7	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
P55210	CASP7	Caspase-7	GO:0006508; P:proteolysis; IDA:UniProtKB
P55210	CASP7	Caspase-7	GO:0001836; P:release of cytochrome c from mitochondria; IEA:Ensembl
P55210	CASP7	Caspase-7	GO:0009411; P:response to UV; IEA:Ensembl
Q14790	CASP8	Caspase-8	GO:0004197; F:cysteine-type endopeptidase activity; IDA:UniProtKB
Q14790	CASP8	Caspase-8	GO:0097153; F:cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
Q14790	CASP8	Caspase-8	GO:0097199; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; IMP:UniProtKB
Q14790	CASP8	Caspase-8	GO:0008234; F:cysteine-type peptidase activity; TAS:ProtInc
Q14790	CASP8	Caspase-8	GO:0035877; F:death effector domain binding; IPI:UniProtKB
Q14790	CASP8	Caspase-8	GO:0008233; F:peptidase activity; IMP:UniProtKB
Q14790	CASP8	Caspase-8	GO:0002020; F:protease binding; IPI:UniProtKB
Q14790	CASP8	Caspase-8	GO:0005515; F:protein binding; IPI:IntAct
Q14790	CASP8	Caspase-8	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q14790	CASP8	Caspase-8	GO:0097202; P:activation of cysteine-type endopeptidase activity; IDA:BHF-UCL
Q14790	CASP8	Caspase-8	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:Reactome
Q14790	CASP8	Caspase-8	GO:0001525; P:angiogenesis; IEA:Ensembl
Q14790	CASP8	Caspase-8	GO:0006915; P:apoptotic process; IMP:UniProtKB
Q14790	CASP8	Caspase-8	GO:0097190; P:apoptotic signaling pathway; IMP:BHF-UCL
Q14790	CASP8	Caspase-8	GO:0042113; P:B cell activation; TAS:UniProtKB
Q14790	CASP8	Caspase-8	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q14790	CASP8	Caspase-8	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
Q14790	CASP8	Caspase-8	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
Q14790	CASP8	Caspase-8	GO:0097194; P:execution phase of apoptosis; IMP:UniProtKB
Q14790	CASP8	Caspase-8	GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:UniProtKB
Q14790	CASP8	Caspase-8	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IBA:RefGenome
Q14790	CASP8	Caspase-8	GO:0007507; P:heart development; IEA:Ensembl
Q14790	CASP8	Caspase-8	GO:0097284; P:hepatocyte apoptotic process; IEA:Ensembl
Q14790	CASP8	Caspase-8	GO:0045087; P:innate immune response; TAS:Reactome
Q14790	CASP8	Caspase-8	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
Q14790	CASP8	Caspase-8	GO:0030225; P:macrophage differentiation; TAS:UniProtKB
Q14790	CASP8	Caspase-8	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q14790	CASP8	Caspase-8	GO:0030101; P:natural killer cell activation; TAS:UniProtKB
Q14790	CASP8	Caspase-8	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q14790	CASP8	Caspase-8	GO:0001841; P:neural tube formation; IEA:Ensembl
Q14790	CASP8	Caspase-8	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q14790	CASP8	Caspase-8	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
Q14790	CASP8	Caspase-8	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl
Q14790	CASP8	Caspase-8	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q14790	CASP8	Caspase-8	GO:0045651; P:positive regulation of macrophage differentiation; IMP:UniProtKB
Q14790	CASP8	Caspase-8	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
Q14790	CASP8	Caspase-8	GO:0045862; P:positive regulation of proteolysis; IDA:BHF-UCL
Q14790	CASP8	Caspase-8	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q14790	CASP8	Caspase-8	GO:0006508; P:proteolysis; IDA:UniProtKB
Q14790	CASP8	Caspase-8	GO:0051603; P:proteolysis involved in cellular protein catabolic process; IMP:BHF-UCL
Q14790	CASP8	Caspase-8	GO:2001239; P:regulation of extrinsic apoptotic signaling pathway in absence of ligand; TAS:Reactome
Q14790	CASP8	Caspase-8	GO:0070243; P:regulation of thymocyte apoptotic process; IEA:Ensembl
Q14790	CASP8	Caspase-8	GO:0046677; P:response to antibiotic; IEA:Ensembl
Q14790	CASP8	Caspase-8	GO:0032025; P:response to cobalt ion; IEA:Ensembl
Q14790	CASP8	Caspase-8	GO:0009409; P:response to cold; IEA:Ensembl
Q14790	CASP8	Caspase-8	GO:0032355; P:response to estradiol; IEA:Ensembl
Q14790	CASP8	Caspase-8	GO:0045471; P:response to ethanol; IEA:Ensembl
Q14790	CASP8	Caspase-8	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
Q14790	CASP8	Caspase-8	GO:0034612; P:response to tumor necrosis factor; IMP:BHF-UCL
Q14790	CASP8	Caspase-8	GO:0060715; P:syncytiotrophoblast cell differentiation involved in labyrinthine layer development; TAS:UniProtKB
Q14790	CASP8	Caspase-8	GO:0042110; P:T cell activation; TAS:UniProtKB
Q14790	CASP8	Caspase-8	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q14790	CASP8	Caspase-8	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q14790	CASP8	Caspase-8	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q14790	CASP8	Caspase-8	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q14790	CASP8	Caspase-8	GO:0016032; P:viral process; IEA:UniProtKB-KW
P55211	CASP9	Caspase-9	GO:0004197; F:cysteine-type endopeptidase activity; IBA:RefGenome
P55211	CASP9	Caspase-9	GO:0008047; F:enzyme activator activity; TAS:ProtInc
P55211	CASP9	Caspase-9	GO:0008233; F:peptidase activity; IDA:MGI
P55211	CASP9	Caspase-9	GO:0005515; F:protein binding; IPI:UniProtKB
P55211	CASP9	Caspase-9	GO:0019901; F:protein kinase binding; IDA:UniProtKB
P55211	CASP9	Caspase-9	GO:0017124; F:SH3 domain binding; IDA:UniProtKB
P55211	CASP9	Caspase-9	GO:0008635; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; TAS:Reactome
P55211	CASP9	Caspase-9	GO:0007568; P:aging; IEA:Ensembl
P55211	CASP9	Caspase-9	GO:0006915; P:apoptotic process; TAS:UniProtKB
P55211	CASP9	Caspase-9	GO:0071549; P:cellular response to dexamethasone stimulus; IEA:Ensembl
P55211	CASP9	Caspase-9	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
P55211	CASP9	Caspase-9	GO:0034644; P:cellular response to UV; IDA:UniProtKB
P55211	CASP9	Caspase-9	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P55211	CASP9	Caspase-9	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P55211	CASP9	Caspase-9	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P55211	CASP9	Caspase-9	GO:0034349; P:glial cell apoptotic process; IEA:Ensembl
P55211	CASP9	Caspase-9	GO:0045087; P:innate immune response; TAS:Reactome
P55211	CASP9	Caspase-9	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
P55211	CASP9	Caspase-9	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IMP:UniProtKB
P55211	CASP9	Caspase-9	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P55211	CASP9	Caspase-9	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P55211	CASP9	Caspase-9	GO:0030220; P:platelet formation; TAS:UniProtKB
P55211	CASP9	Caspase-9	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
P55211	CASP9	Caspase-9	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
P55211	CASP9	Caspase-9	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P55211	CASP9	Caspase-9	GO:2001020; P:regulation of response to DNA damage stimulus; IMP:UniProtKB
P55211	CASP9	Caspase-9	GO:0046677; P:response to antibiotic; IEA:Ensembl
P55211	CASP9	Caspase-9	GO:0032025; P:response to cobalt ion; IEA:Ensembl
P55211	CASP9	Caspase-9	GO:0032355; P:response to estradiol; IEA:Ensembl
P55211	CASP9	Caspase-9	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P55211	CASP9	Caspase-9	GO:0042770; P:signal transduction in response to DNA damage; IDA:UniProtKB
Q92851	CASP10	Caspase-10	GO:0004197; F:cysteine-type endopeptidase activity; TAS:ProtInc
Q92851	CASP10	Caspase-10	GO:0097199; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; IMP:UniProtKB
Q92851	CASP10	Caspase-10	GO:0035877; F:death effector domain binding; IPI:UniProtKB
Q92851	CASP10	Caspase-10	GO:0005515; F:protein binding; IPI:IntAct
Q92851	CASP10	Caspase-10	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q92851	CASP10	Caspase-10	GO:0006915; P:apoptotic process; IBA:RefGenome
Q92851	CASP10	Caspase-10	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q92851	CASP10	Caspase-10	GO:0045087; P:innate immune response; TAS:Reactome
Q92851	CASP10	Caspase-10	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q92851	CASP10	Caspase-10	GO:0042981; P:regulation of apoptotic process; IEA:InterPro
Q6UXS9	CASP12	Inactive caspase-12	GO:0004197; F:cysteine-type endopeptidase activity; IBA:RefGenome
Q6UXS9	CASP12	Inactive caspase-12	GO:0030968; P:endoplasmic reticulum unfolded protein response; IEA:Ensembl
Q6UXS9	CASP12	Inactive caspase-12	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IBA:RefGenome
Q6UXS9	CASP12	Inactive caspase-12	GO:0042981; P:regulation of apoptotic process; IEA:InterPro
P31944	CASP14	Caspase-14	GO:0004197; F:cysteine-type endopeptidase activity; IBA:RefGenome
P31944	CASP14	Caspase-14	GO:0070268; P:cornification; TAS:UniProtKB
P31944	CASP14	Caspase-14	GO:0008544; P:epidermis development; TAS:ProtInc
P31944	CASP14	Caspase-14	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IBA:RefGenome
P31944	CASP14	Caspase-14	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IBA:RefGenome
P31944	CASP14	Caspase-14	GO:0031424; P:keratinization; TAS:UniProtKB
P0CB46	CASP16	Putative caspase-16	GO:0004197; F:cysteine-type endopeptidase activity; IBA:RefGenome
P0CB46	CASP16	Putative caspase-16	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IBA:RefGenome
P0CB46	CASP16	Putative caspase-16	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IBA:RefGenome
Q13948	CUX1	Protein CASP	GO:0006891; P:intra-Golgi vesicle-mediated transport; IEA:InterPro
P31415	CASQ1	Calsequestrin-1	GO:0005509; F:calcium ion binding; IEA:Ensembl
P31415	CASQ1	Calsequestrin-1	GO:0007029; P:endoplasmic reticulum organization; IEA:Ensembl
P31415	CASQ1	Calsequestrin-1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P31415	CASQ1	Calsequestrin-1	GO:0051282; P:regulation of sequestering of calcium ion; IEA:Ensembl
P31415	CASQ1	Calsequestrin-1	GO:0014809; P:regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; IEA:Ensembl
P31415	CASQ1	Calsequestrin-1	GO:0014894; P:response to denervation involved in regulation of muscle adaptation; IEA:Ensembl
P31415	CASQ1	Calsequestrin-1	GO:0009408; P:response to heat; IEA:Ensembl
P31415	CASQ1	Calsequestrin-1	GO:0010033; P:response to organic substance; IEA:Ensembl
P31415	CASQ1	Calsequestrin-1	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
P31415	CASQ1	Calsequestrin-1	GO:0055085; P:transmembrane transport; TAS:Reactome
O14958	CASQ2	Calsequestrin-2	GO:0005509; F:calcium ion binding; IDA:BHF-UCL
O14958	CASQ2	Calsequestrin-2	GO:0005515; F:protein binding; IPI:BHF-UCL
O14958	CASQ2	Calsequestrin-2	GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
O14958	CASQ2	Calsequestrin-2	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
O14958	CASQ2	Calsequestrin-2	GO:0071313; P:cellular response to caffeine; IMP:BHF-UCL
O14958	CASQ2	Calsequestrin-2	GO:0005513; P:detection of calcium ion; TAS:BHF-UCL
O14958	CASQ2	Calsequestrin-2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
O14958	CASQ2	Calsequestrin-2	GO:1901017; P:negative regulation of potassium ion transmembrane transporter activity; ISS:BHF-UCL
O14958	CASQ2	Calsequestrin-2	GO:0043267; P:negative regulation of potassium ion transport; ISS:BHF-UCL
O14958	CASQ2	Calsequestrin-2	GO:0060315; P:negative regulation of ryanodine-sensitive calcium-release channel activity; IDA:BHF-UCL
O14958	CASQ2	Calsequestrin-2	GO:0051258; P:protein polymerization; IDA:BHF-UCL
O14958	CASQ2	Calsequestrin-2	GO:0086029; P:Purkinje myocyte to ventricular cardiac muscle cell signaling; NAS:BHF-UCL
O14958	CASQ2	Calsequestrin-2	GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; IMP:BHF-UCL
O14958	CASQ2	Calsequestrin-2	GO:0010649; P:regulation of cell communication by electrical coupling; IMP:BHF-UCL
O14958	CASQ2	Calsequestrin-2	GO:0002027; P:regulation of heart rate; IMP:BHF-UCL
O14958	CASQ2	Calsequestrin-2	GO:0060306; P:regulation of membrane repolarization; ISS:BHF-UCL
O14958	CASQ2	Calsequestrin-2	GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; ISS:BHF-UCL
O14958	CASQ2	Calsequestrin-2	GO:0051208; P:sequestering of calcium ion; IDA:BHF-UCL
O14958	CASQ2	Calsequestrin-2	GO:0006941; P:striated muscle contraction; TAS:ProtInc
O14958	CASQ2	Calsequestrin-2	GO:0055085; P:transmembrane transport; TAS:Reactome
P41180	CASR	Extracellular calcium-sensing receptor	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P41180	CASR	Extracellular calcium-sensing receptor	GO:0004435; F:phosphatidylinositol phospholipase C activity; TAS:ProtInc
P41180	CASR	Extracellular calcium-sensing receptor	GO:0005515; F:protein binding; IPI:IntAct
P41180	CASR	Extracellular calcium-sensing receptor	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P41180	CASR	Extracellular calcium-sensing receptor	GO:0070509; P:calcium ion import; IDA:UniProtKB
P41180	CASR	Extracellular calcium-sensing receptor	GO:0006874; P:cellular calcium ion homeostasis; TAS:ProtInc
P41180	CASR	Extracellular calcium-sensing receptor	GO:0007635; P:chemosensory behavior; TAS:ProtInc
P41180	CASR	Extracellular calcium-sensing receptor	GO:0005513; P:detection of calcium ion; TAS:ProtInc
P41180	CASR	Extracellular calcium-sensing receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P41180	CASR	Extracellular calcium-sensing receptor	GO:0008152; P:metabolic process; TAS:GOC
P41180	CASR	Extracellular calcium-sensing receptor	GO:0001503; P:ossification; TAS:ProtInc
Q9NQ75	CASS4	Cas scaffolding protein family member 4	GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro
Q9NQ75	CASS4	Cas scaffolding protein family member 4	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q86V15	CASZ1	Zinc finger protein castor homolog 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86V15	CASZ1	Zinc finger protein castor homolog 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86V15	CASZ1	Zinc finger protein castor homolog 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q86V15	CASZ1	Zinc finger protein castor homolog 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P04040	CAT	Catalase	GO:0004046; F:aminoacylase activity; IEA:Ensembl
P04040	CAT	Catalase	GO:0016209; F:antioxidant activity; IDA:UniProtKB
P04040	CAT	Catalase	GO:0004096; F:catalase activity; IDA:UniProtKB
P04040	CAT	Catalase	GO:0019899; F:enzyme binding; IPI:UniProtKB
P04040	CAT	Catalase	GO:0020037; F:heme binding; IDA:UniProtKB
P04040	CAT	Catalase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P04040	CAT	Catalase	GO:0050661; F:NADP binding; IDA:UniProtKB
P04040	CAT	Catalase	GO:0016684; F:oxidoreductase activity, acting on peroxide as acceptor; ISS:UniProtKB
P04040	CAT	Catalase	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P04040	CAT	Catalase	GO:0005102; F:receptor binding; IPI:UniProtKB
P04040	CAT	Catalase	GO:0009060; P:aerobic respiration; IEA:Ensembl
P04040	CAT	Catalase	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P04040	CAT	Catalase	GO:0008203; P:cholesterol metabolic process; IEA:Ensembl
P04040	CAT	Catalase	GO:0020027; P:hemoglobin metabolic process; IEA:Ensembl
P04040	CAT	Catalase	GO:0042744; P:hydrogen peroxide catabolic process; IDA:UniProtKB
P04040	CAT	Catalase	GO:0001822; P:kidney development; IEA:Ensembl
P04040	CAT	Catalase	GO:0042697; P:menopause; IEA:Ensembl
P04040	CAT	Catalase	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P04040	CAT	Catalase	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IEA:Ensembl
P04040	CAT	Catalase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P04040	CAT	Catalase	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P04040	CAT	Catalase	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:Ensembl
P04040	CAT	Catalase	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl
P04040	CAT	Catalase	GO:0051289; P:protein homotetramerization; IDA:UniProtKB
P04040	CAT	Catalase	GO:0051262; P:protein tetramerization; IDA:UniProtKB
P04040	CAT	Catalase	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P04040	CAT	Catalase	GO:0006195; P:purine nucleotide catabolic process; TAS:Reactome
P04040	CAT	Catalase	GO:0055093; P:response to hyperoxia; IEA:Ensembl
P04040	CAT	Catalase	GO:0001666; P:response to hypoxia; IEA:Ensembl
P04040	CAT	Catalase	GO:0000302; P:response to reactive oxygen species; IMP:UniProtKB
P04040	CAT	Catalase	GO:0033197; P:response to vitamin E; IEA:Ensembl
P04040	CAT	Catalase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P04040	CAT	Catalase	GO:0006641; P:triglyceride metabolic process; IEA:Ensembl
P04040	CAT	Catalase	GO:0001657; P:ureteric bud development; IEA:Ensembl
P04040	CAT	Catalase	GO:0009650; P:UV protection; IMP:UniProtKB
P07858	CTSB	Cathepsin B	GO:0005518; F:collagen binding; IDA:BHF-UCL
P07858	CTSB	Cathepsin B	GO:0004197; F:cysteine-type endopeptidase activity; IDA:BHF-UCL
P07858	CTSB	Cathepsin B	GO:0008234; F:cysteine-type peptidase activity; IDA:UniProtKB
P07858	CTSB	Cathepsin B	GO:0008233; F:peptidase activity; IDA:BHF-UCL
P07858	CTSB	Cathepsin B	GO:0005515; F:protein binding; IPI:UniProtKB
P07858	CTSB	Cathepsin B	GO:0043394; F:proteoglycan binding; IPI:BHF-UCL
P07858	CTSB	Cathepsin B	GO:0097067; P:cellular response to thyroid hormone stimulus; IEP:UniProtKB
P07858	CTSB	Cathepsin B	GO:0030574; P:collagen catabolic process; IDA:BHF-UCL
P07858	CTSB	Cathepsin B	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
P07858	CTSB	Cathepsin B	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P07858	CTSB	Cathepsin B	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P07858	CTSB	Cathepsin B	GO:0045087; P:innate immune response; TAS:Reactome
P07858	CTSB	Cathepsin B	GO:0006508; P:proteolysis; IDA:UniProtKB
P07858	CTSB	Cathepsin B	GO:0051603; P:proteolysis involved in cellular protein catabolic process; IDA:BHF-UCL
P07858	CTSB	Cathepsin B	GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB
P07858	CTSB	Cathepsin B	GO:0050790; P:regulation of catalytic activity; IEA:InterPro
P07858	CTSB	Cathepsin B	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P53634	CTSC	Dipeptidyl peptidase 1	GO:0031404; F:chloride ion binding; IEA:Ensembl
P53634	CTSC	Dipeptidyl peptidase 1	GO:0008234; F:cysteine-type peptidase activity; IDA:UniProtKB
P53634	CTSC	Dipeptidyl peptidase 1	GO:0016505; F:peptidase activator activity involved in apoptotic process; IEA:Ensembl
P53634	CTSC	Dipeptidyl peptidase 1	GO:0005515; F:protein binding; IPI:IntAct
P53634	CTSC	Dipeptidyl peptidase 1	GO:0004252; F:serine-type endopeptidase activity; IEA:Ensembl
P53634	CTSC	Dipeptidyl peptidase 1	GO:0007568; P:aging; IEA:Ensembl
P53634	CTSC	Dipeptidyl peptidase 1	GO:0006955; P:immune response; TAS:ProtInc
P53634	CTSC	Dipeptidyl peptidase 1	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
P53634	CTSC	Dipeptidyl peptidase 1	GO:0006508; P:proteolysis; IDA:UniProtKB
P53634	CTSC	Dipeptidyl peptidase 1	GO:0010033; P:response to organic substance; IEA:Ensembl
P53634	CTSC	Dipeptidyl peptidase 1	GO:0001913; P:T cell mediated cytotoxicity; IEA:Ensembl
P07339	CTSD	Cathepsin D	GO:0004190; F:aspartic-type endopeptidase activity; TAS:ProtInc
P07339	CTSD	Cathepsin D	GO:0005515; F:protein binding; IPI:IntAct
P07339	CTSD	Cathepsin D	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P07339	CTSD	Cathepsin D	GO:0000045; P:autophagic vacuole assembly; IEA:Ensembl
P07339	CTSD	Cathepsin D	GO:0008219; P:cell death; IEA:UniProtKB-KW
P07339	CTSD	Cathepsin D	GO:0030574; P:collagen catabolic process; TAS:Reactome
P07339	CTSD	Cathepsin D	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P07339	CTSD	Cathepsin D	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P14091	CTSE	Cathepsin E	GO:0004190; F:aspartic-type endopeptidase activity; IDA:UniProtKB
P14091	CTSE	Cathepsin E	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; IDA:UniProtKB
P14091	CTSE	Cathepsin E	GO:0007586; P:digestion; TAS:ProtInc
P14091	CTSE	Cathepsin E	GO:0016540; P:protein autoprocessing; IEA:Ensembl
Q9UBX1	CTSF	Cathepsin F	GO:0004197; F:cysteine-type endopeptidase activity; TAS:ProtInc
Q9UBX1	CTSF	Cathepsin F	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q9UBX1	CTSF	Cathepsin F	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9UBX1	CTSF	Cathepsin F	GO:0006508; P:proteolysis; TAS:ProtInc
P08311	CTSG	Cathepsin G	GO:0008201; F:heparin binding; IDA:MGI
P08311	CTSG	Cathepsin G	GO:0008233; F:peptidase activity; IDA:MGI
P08311	CTSG	Cathepsin G	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
P08311	CTSG	Cathepsin G	GO:0002003; P:angiotensin maturation; TAS:Reactome
P08311	CTSG	Cathepsin G	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P08311	CTSG	Cathepsin G	GO:0050832; P:defense response to fungus; IBA:RefGenome
P08311	CTSG	Cathepsin G	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P08311	CTSG	Cathepsin G	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P08311	CTSG	Cathepsin G	GO:0006955; P:immune response; TAS:ProtInc
P08311	CTSG	Cathepsin G	GO:0044130; P:negative regulation of growth of symbiont in host; IEA:Ensembl
P08311	CTSG	Cathepsin G	GO:0070946; P:neutrophil mediated killing of gram-positive bacterium; IBA:RefGenome
P08311	CTSG	Cathepsin G	GO:0050778; P:positive regulation of immune response; IEA:Ensembl
P08311	CTSG	Cathepsin G	GO:0006508; P:proteolysis; IDA:UniProtKB
P08311	CTSG	Cathepsin G	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P09668	CTSH	Pro-cathepsin H	GO:0004177; F:aminopeptidase activity; IDA:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; IDA:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0004197; F:cysteine-type endopeptidase activity; TAS:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0008234; F:cysteine-type peptidase activity; IDA:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0004175; F:endopeptidase activity; IDA:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0030108; F:HLA-A specific activating MHC class I receptor activity; IDA:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0008233; F:peptidase activity; IDA:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0005515; F:protein binding; IPI:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0004252; F:serine-type endopeptidase activity; ISS:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0070324; F:thyroid hormone binding; IDA:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0002250; P:adaptive immune response; IEP:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0019882; P:antigen processing and presentation; TAS:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0010815; P:bradykinin catabolic process; IDA:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0097067; P:cellular response to thyroid hormone stimulus; IEP:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0060448; P:dichotomous subdivision of terminal units involved in lung branching; ISS:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0070371; P:ERK1 and ERK2 cascade; IDA:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0002764; P:immune response-regulating signaling pathway; IDA:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0033619; P:membrane protein proteolysis; IDA:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0001656; P:metanephros development; ISS:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0010813; P:neuropeptide catabolic process; IDA:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0045766; P:positive regulation of angiogenesis; ISS:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
P09668	CTSH	Pro-cathepsin H	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0010634; P:positive regulation of epithelial cell migration; ISS:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0010952; P:positive regulation of peptidase activity; IDA:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0031648; P:protein destabilization; IMP:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0006508; P:proteolysis; IDA:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0032526; P:response to retinoic acid; ISS:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0007283; P:spermatogenesis; IEA:Ensembl
P09668	CTSH	Pro-cathepsin H	GO:0043129; P:surfactant homeostasis; IDA:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0001913; P:T cell mediated cytotoxicity; ISS:UniProtKB
P09668	CTSH	Pro-cathepsin H	GO:0031638; P:zymogen activation; IDA:UniProtKB
Q8WUQ7	CACTIN	Cactin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8WUQ7	CACTIN	Cactin	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WUQ7	CACTIN	Cactin	GO:0071347; P:cellular response to interleukin-1; IDA:UniProtKB
Q8WUQ7	CACTIN	Cactin	GO:0071222; P:cellular response to lipopolysaccharide; IDA:UniProtKB
Q8WUQ7	CACTIN	Cactin	GO:0071356; P:cellular response to tumor necrosis factor; IDA:UniProtKB
Q8WUQ7	CACTIN	Cactin	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q8WUQ7	CACTIN	Cactin	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q8WUQ7	CACTIN	Cactin	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8WUQ7	CACTIN	Cactin	GO:0032688; P:negative regulation of interferon-beta production; IMP:UniProtKB
Q8WUQ7	CACTIN	Cactin	GO:0032717; P:negative regulation of interleukin-8 production; IDA:UniProtKB
Q8WUQ7	CACTIN	Cactin	GO:0031665; P:negative regulation of lipopolysaccharide-mediated signaling pathway; IMP:UniProtKB
Q8WUQ7	CACTIN	Cactin	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q8WUQ7	CACTIN	Cactin	GO:0001933; P:negative regulation of protein phosphorylation; IMP:UniProtKB
Q8WUQ7	CACTIN	Cactin	GO:0034122; P:negative regulation of toll-like receptor signaling pathway; IDA:UniProtKB
Q8WUQ7	CACTIN	Cactin	GO:0032720; P:negative regulation of tumor necrosis factor production; IDA:UniProtKB
Q8WUQ7	CACTIN	Cactin	GO:0060339; P:negative regulation of type I interferon-mediated signaling pathway; IMP:UniProtKB
Q7Z7H3	CATIP	Ciliogenesis-associated TTC17-interacting protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z7H3	CATIP	Ciliogenesis-associated TTC17-interacting protein	GO:0030041; P:actin filament polymerization; IMP:UniProtKB
Q7Z7H3	CATIP	Ciliogenesis-associated TTC17-interacting protein	GO:0044782; P:cilium organization; IMP:UniProtKB
P43235	CTSK	Cathepsin K	GO:0005518; F:collagen binding; IDA:BHF-UCL
P43235	CTSK	Cathepsin K	GO:0004197; F:cysteine-type endopeptidase activity; IDA:BHF-UCL
P43235	CTSK	Cathepsin K	GO:0008234; F:cysteine-type peptidase activity; TAS:ProtInc
P43235	CTSK	Cathepsin K	GO:0001968; F:fibronectin binding; IPI:BHF-UCL
P43235	CTSK	Cathepsin K	GO:0043394; F:proteoglycan binding; IPI:BHF-UCL
P43235	CTSK	Cathepsin K	GO:0045453; P:bone resorption; IEA:Ensembl
P43235	CTSK	Cathepsin K	GO:0030574; P:collagen catabolic process; IDA:BHF-UCL
P43235	CTSK	Cathepsin K	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P43235	CTSK	Cathepsin K	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P43235	CTSK	Cathepsin K	GO:0045087; P:innate immune response; TAS:Reactome
P43235	CTSK	Cathepsin K	GO:0001957; P:intramembranous ossification; IEA:Ensembl
P43235	CTSK	Cathepsin K	GO:0006508; P:proteolysis; TAS:ProtInc
P43235	CTSK	Cathepsin K	GO:0051603; P:proteolysis involved in cellular protein catabolic process; IDA:BHF-UCL
P43235	CTSK	Cathepsin K	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P07711	CTSL	Cathepsin L1	GO:0005518; F:collagen binding; IDA:BHF-UCL
P07711	CTSL	Cathepsin L1	GO:0004197; F:cysteine-type endopeptidase activity; IDA:UniProtKB
P07711	CTSL	Cathepsin L1	GO:0008234; F:cysteine-type peptidase activity; IDA:UniProtKB
P07711	CTSL	Cathepsin L1	GO:0001968; F:fibronectin binding; IPI:BHF-UCL
P07711	CTSL	Cathepsin L1	GO:0042393; F:histone binding; IDA:BHF-UCL
P07711	CTSL	Cathepsin L1	GO:0005515; F:protein binding; IPI:IntAct
P07711	CTSL	Cathepsin L1	GO:0043394; F:proteoglycan binding; IPI:BHF-UCL
P07711	CTSL	Cathepsin L1	GO:0002250; P:adaptive immune response; IEP:UniProtKB
P07711	CTSL	Cathepsin L1	GO:0019882; P:antigen processing and presentation; TAS:UniProtKB
P07711	CTSL	Cathepsin L1	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P07711	CTSL	Cathepsin L1	GO:0097067; P:cellular response to thyroid hormone stimulus; IEP:UniProtKB
P07711	CTSL	Cathepsin L1	GO:0030574; P:collagen catabolic process; IDA:BHF-UCL
P07711	CTSL	Cathepsin L1	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P07711	CTSL	Cathepsin L1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P07711	CTSL	Cathepsin L1	GO:0045087; P:innate immune response; TAS:Reactome
P07711	CTSL	Cathepsin L1	GO:0071888; P:macrophage apoptotic process; NAS:BHF-UCL
P07711	CTSL	Cathepsin L1	GO:0006508; P:proteolysis; IDA:UniProtKB
P07711	CTSL	Cathepsin L1	GO:0051603; P:proteolysis involved in cellular protein catabolic process; IDA:BHF-UCL
P07711	CTSL	Cathepsin L1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
O60911	CTSV	Cathepsin L2	GO:0004177; F:aminopeptidase activity; IEA:Ensembl
O60911	CTSV	Cathepsin L2	GO:0004197; F:cysteine-type endopeptidase activity; TAS:ProtInc
O60911	CTSV	Cathepsin L2	GO:0008234; F:cysteine-type peptidase activity; TAS:ProtInc
O60911	CTSV	Cathepsin L2	GO:0042277; F:peptide binding; IEA:Ensembl
O60911	CTSV	Cathepsin L2	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
O60911	CTSV	Cathepsin L2	GO:0048102; P:autophagic cell death; IEA:Ensembl
O60911	CTSV	Cathepsin L2	GO:0009267; P:cellular response to starvation; IEA:Ensembl
O60911	CTSV	Cathepsin L2	GO:0046697; P:decidualization; IEA:Ensembl
O60911	CTSV	Cathepsin L2	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
O60911	CTSV	Cathepsin L2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O60911	CTSV	Cathepsin L2	GO:0010259; P:multicellular organismal aging; IEA:Ensembl
O60911	CTSV	Cathepsin L2	GO:0021675; P:nerve development; IEA:Ensembl
O60911	CTSV	Cathepsin L2	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
O60911	CTSV	Cathepsin L2	GO:0009749; P:response to glucose; IEA:Ensembl
O60911	CTSV	Cathepsin L2	GO:0034698; P:response to gonadotropin; IEA:Ensembl
O60911	CTSV	Cathepsin L2	GO:0060008; P:Sertoli cell differentiation; IEA:Ensembl
O60911	CTSV	Cathepsin L2	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q5NE16	CTSL3P	Putative inactive cathepsin L-like protein CTSL3P	GO:0008234; F:cysteine-type peptidase activity; IEA:InterPro
P43234	CTSO	Cathepsin O	GO:0004197; F:cysteine-type endopeptidase activity; TAS:ProtInc
P43234	CTSO	Cathepsin O	GO:0006508; P:proteolysis; TAS:ProtInc
P25774	CTSS	Cathepsin S	GO:0005518; F:collagen binding; IDA:BHF-UCL
P25774	CTSS	Cathepsin S	GO:0004197; F:cysteine-type endopeptidase activity; IDA:BHF-UCL
P25774	CTSS	Cathepsin S	GO:0001968; F:fibronectin binding; IPI:BHF-UCL
P25774	CTSS	Cathepsin S	GO:0043236; F:laminin binding; IDA:BHF-UCL
P25774	CTSS	Cathepsin S	GO:0043394; F:proteoglycan binding; IPI:BHF-UCL
P25774	CTSS	Cathepsin S	GO:0002250; P:adaptive immune response; IEP:UniProtKB
P25774	CTSS	Cathepsin S	GO:0019882; P:antigen processing and presentation; TAS:UniProtKB
P25774	CTSS	Cathepsin S	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P25774	CTSS	Cathepsin S	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P25774	CTSS	Cathepsin S	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P25774	CTSS	Cathepsin S	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P25774	CTSS	Cathepsin S	GO:0034769; P:basement membrane disassembly; IDA:BHF-UCL
P25774	CTSS	Cathepsin S	GO:0097067; P:cellular response to thyroid hormone stimulus; IEP:UniProtKB
P25774	CTSS	Cathepsin S	GO:0030574; P:collagen catabolic process; IDA:BHF-UCL
P25774	CTSS	Cathepsin S	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P25774	CTSS	Cathepsin S	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P25774	CTSS	Cathepsin S	GO:0006955; P:immune response; TAS:ProtInc
P25774	CTSS	Cathepsin S	GO:0045087; P:innate immune response; TAS:Reactome
P25774	CTSS	Cathepsin S	GO:0006508; P:proteolysis; TAS:ProtInc
P25774	CTSS	Cathepsin S	GO:0051603; P:proteolysis involved in cellular protein catabolic process; IDA:BHF-UCL
P25774	CTSS	Cathepsin S	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P56202	CTSW	Cathepsin W	GO:0008234; F:cysteine-type peptidase activity; TAS:ProtInc
P56202	CTSW	Cathepsin W	GO:0006955; P:immune response; TAS:ProtInc
Q9UBR2	CTSZ	Cathepsin Z	GO:0008234; F:cysteine-type peptidase activity; TAS:ProtInc
Q9UBR2	CTSZ	Cathepsin Z	GO:0002003; P:angiotensin maturation; TAS:Reactome
Q9UBR2	CTSZ	Cathepsin Z	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UBR2	CTSZ	Cathepsin Z	GO:0060441; P:epithelial tube branching involved in lung morphogenesis; IEA:Ensembl
Q9UBR2	CTSZ	Cathepsin Z	GO:0006508; P:proteolysis; TAS:ProtInc
Q03135	CAV1	Caveolin-1	GO:0015485; F:cholesterol binding; TAS:HGNC
Q03135	CAV1	Caveolin-1	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q03135	CAV1	Caveolin-1	GO:0050998; F:nitric-oxide synthase binding; IPI:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0005113; F:patched binding; NAS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0016504; F:peptidase activator activity; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0005515; F:protein binding; IPI:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0032947; F:protein complex scaffold; TAS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0005102; F:receptor binding; IPI:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0005198; F:structural molecule activity; IDA:UniProtKB
Q03135	CAV1	Caveolin-1	GO:0001525; P:angiogenesis; IEA:Ensembl
Q03135	CAV1	Caveolin-1	GO:0097190; P:apoptotic signaling pathway; IMP:UniProtKB
Q03135	CAV1	Caveolin-1	GO:0007596; P:blood coagulation; TAS:Reactome
Q03135	CAV1	Caveolin-1	GO:0055074; P:calcium ion homeostasis; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0006816; P:calcium ion transport; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0070836; P:caveola assembly; IMP:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0072584; P:caveolin-mediated endocytosis; IDA:UniProtKB
Q03135	CAV1	Caveolin-1	GO:0006874; P:cellular calcium ion homeostasis; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0071455; P:cellular response to hyperoxia; IMP:UniProtKB
Q03135	CAV1	Caveolin-1	GO:0009267; P:cellular response to starvation; IEP:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0042632; P:cholesterol homeostasis; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0030301; P:cholesterol transport; TAS:HGNC
Q03135	CAV1	Caveolin-1	GO:0051480; P:cytosolic calcium ion homeostasis; IDA:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0000188; P:inactivation of MAPK activity; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0007595; P:lactation; IEA:Ensembl
Q03135	CAV1	Caveolin-1	GO:0050900; P:leukocyte migration; TAS:Reactome
Q03135	CAV1	Caveolin-1	GO:0019915; P:lipid storage; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0032507; P:maintenance of protein location in cell; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0030879; P:mammary gland development; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0060056; P:mammary gland involution; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0000165; P:MAPK cascade; IEA:Ensembl
Q03135	CAV1	Caveolin-1	GO:0051899; P:membrane depolarization; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:2000811; P:negative regulation of anoikis; IMP:UniProtKB
Q03135	CAV1	Caveolin-1	GO:0030514; P:negative regulation of BMP signaling pathway; IDA:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISS:UniProtKB
Q03135	CAV1	Caveolin-1	GO:0001960; P:negative regulation of cytokine-mediated signaling pathway; IEA:Ensembl
Q03135	CAV1	Caveolin-1	GO:0001937; P:negative regulation of endothelial cell proliferation; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0030857; P:negative regulation of epithelial cell differentiation; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0046426; P:negative regulation of JAK-STAT cascade; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0043409; P:negative regulation of MAPK cascade; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0045019; P:negative regulation of nitric oxide biosynthetic process; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0051001; P:negative regulation of nitric-oxide synthase activity; IEA:Ensembl
Q03135	CAV1	Caveolin-1	GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; IDA:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0048550; P:negative regulation of pinocytosis; IMP:UniProt
Q03135	CAV1	Caveolin-1	GO:0032091; P:negative regulation of protein binding; IDA:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0031397; P:negative regulation of protein ubiquitination; IMP:UniProtKB
Q03135	CAV1	Caveolin-1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q03135	CAV1	Caveolin-1	GO:0042524; P:negative regulation of tyrosine phosphorylation of Stat5 protein; IEA:Ensembl
Q03135	CAV1	Caveolin-1	GO:0033484; P:nitric oxide homeostasis; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0046209; P:nitric oxide metabolic process; TAS:Reactome
Q03135	CAV1	Caveolin-1	GO:0010524; P:positive regulation of calcium ion transport into cytosol; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB
Q03135	CAV1	Caveolin-1	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
Q03135	CAV1	Caveolin-1	GO:0048554; P:positive regulation of metalloenzyme activity; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0045907; P:positive regulation of vasoconstriction; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0051260; P:protein homooligomerization; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0008104; P:protein localization; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:2000286; P:receptor internalization involved in canonical Wnt signaling pathway; IMP:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0030193; P:regulation of blood coagulation; IMP:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0019217; P:regulation of fatty acid metabolic process; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome
Q03135	CAV1	Caveolin-1	GO:0052547; P:regulation of peptidase activity; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0006940; P:regulation of smooth muscle contraction; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0003057; P:regulation of the force of heart contraction by chemical signal; IEA:Ensembl
Q03135	CAV1	Caveolin-1	GO:0051592; P:response to calcium ion; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0043627; P:response to estrogen; IDA:MGI
Q03135	CAV1	Caveolin-1	GO:0001666; P:response to hypoxia; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0002931; P:response to ischemia; IEA:Ensembl
Q03135	CAV1	Caveolin-1	GO:0032570; P:response to progesterone; IDA:MGI
Q03135	CAV1	Caveolin-1	GO:0007519; P:skeletal muscle tissue development; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q03135	CAV1	Caveolin-1	GO:0031295; P:T cell costimulation; IDA:UniProtKB
Q03135	CAV1	Caveolin-1	GO:0006641; P:triglyceride metabolic process; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0001570; P:vasculogenesis; ISS:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0042310; P:vasoconstriction; IEA:Ensembl
Q03135	CAV1	Caveolin-1	GO:0016050; P:vesicle organization; IDA:BHF-UCL
Q03135	CAV1	Caveolin-1	GO:0016032; P:viral process; IEA:UniProtKB-KW
P51636	CAV2	Caveolin-2	GO:0031748; F:D1 dopamine receptor binding; IPI:BHF-UCL
P51636	CAV2	Caveolin-2	GO:0005515; F:protein binding; IPI:UniProtKB
P51636	CAV2	Caveolin-2	GO:0042803; F:protein homodimerization activity; IDA:MGI
P51636	CAV2	Caveolin-2	GO:0070836; P:caveola assembly; IMP:BHF-UCL
P51636	CAV2	Caveolin-2	GO:0007029; P:endoplasmic reticulum organization; ISS:UniProtKB
P51636	CAV2	Caveolin-2	GO:0007005; P:mitochondrion organization; ISS:UniProtKB
P51636	CAV2	Caveolin-2	GO:0001937; P:negative regulation of endothelial cell proliferation; ISS:UniProtKB
P51636	CAV2	Caveolin-2	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl
P51636	CAV2	Caveolin-2	GO:0060161; P:positive regulation of dopamine receptor signaling pathway; IMP:BHF-UCL
P51636	CAV2	Caveolin-2	GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl
P51636	CAV2	Caveolin-2	GO:0051259; P:protein oligomerization; IEA:Ensembl
P51636	CAV2	Caveolin-2	GO:0007088; P:regulation of mitosis; IEP:BHF-UCL
P51636	CAV2	Caveolin-2	GO:0048741; P:skeletal muscle fiber development; ISS:UniProtKB
P51636	CAV2	Caveolin-2	GO:0007268; P:synaptic transmission; IEA:Ensembl
P51636	CAV2	Caveolin-2	GO:0048278; P:vesicle docking; IDA:BHF-UCL
P51636	CAV2	Caveolin-2	GO:0006906; P:vesicle fusion; IDA:BHF-UCL
P51636	CAV2	Caveolin-2	GO:0016050; P:vesicle organization; IDA:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0005246; F:calcium channel regulator activity; IDA:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0071253; F:connexin binding; IDA:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0044325; F:ion channel binding; IPI:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0019870; F:potassium channel inhibitor activity; ISS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0005515; F:protein binding; IPI:UniProtKB
P56539	CAV3	Caveolin-3	GO:0008022; F:protein C-terminus binding; IDA:UniProtKB
P56539	CAV3	Caveolin-3	GO:0032403; F:protein complex binding; IDA:UniProtKB
P56539	CAV3	Caveolin-3	GO:0032947; F:protein complex scaffold; IPI:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0017080; F:sodium channel regulator activity; IDA:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0007015; P:actin filament organization; IEA:Ensembl
P56539	CAV3	Caveolin-3	GO:0055013; P:cardiac muscle cell development; IEA:Ensembl
P56539	CAV3	Caveolin-3	GO:0070836; P:caveola assembly; IDA:MGI
P56539	CAV3	Caveolin-3	GO:0030154; P:cell differentiation; ISS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0016049; P:cell growth; ISS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0042632; P:cholesterol homeostasis; ISS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0031122; P:cytoplasmic microtubule organization; IEA:Ensembl
P56539	CAV3	Caveolin-3	GO:0006897; P:endocytosis; ISS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0090002; P:establishment of protein localization to plasma membrane; IEA:Ensembl
P56539	CAV3	Caveolin-3	GO:0042593; P:glucose homeostasis; ISS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0060347; P:heart trabecula formation; IEA:Ensembl
P56539	CAV3	Caveolin-3	GO:0031579; P:membrane raft organization; ISS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0046716; P:muscle cell cellular homeostasis; ISS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0007517; P:muscle organ development; TAS:UniProtKB
P56539	CAV3	Caveolin-3	GO:0007520; P:myoblast fusion; IEA:Ensembl
P56539	CAV3	Caveolin-3	GO:0051926; P:negative regulation of calcium ion transport; IDA:MGI
P56539	CAV3	Caveolin-3	GO:0010614; P:negative regulation of cardiac muscle hypertrophy; IMP:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0061052; P:negative regulation of cell growth involved in cardiac muscle cell development; IEA:Ensembl
P56539	CAV3	Caveolin-3	GO:0045792; P:negative regulation of cell size; IMP:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0043407; P:negative regulation of MAP kinase activity; IMP:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0043409; P:negative regulation of MAPK cascade; ISS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0051001; P:negative regulation of nitric-oxide synthase activity; ISS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:1901380; P:negative regulation of potassium ion transmembrane transport; ISS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:1901017; P:negative regulation of potassium ion transmembrane transporter activity; ISS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0006469; P:negative regulation of protein kinase activity; ISS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:2000009; P:negative regulation of protein localization to cell surface; NAS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0060299; P:negative regulation of sarcomere organization; IMP:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0051647; P:nucleus localization; IEA:Ensembl
P56539	CAV3	Caveolin-3	GO:0007009; P:plasma membrane organization; ISS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0001778; P:plasma membrane repair; IEA:Ensembl
P56539	CAV3	Caveolin-3	GO:2001288; P:positive regulation of caveolin-mediated endocytosis; IEA:Ensembl
P56539	CAV3	Caveolin-3	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P56539	CAV3	Caveolin-3	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0031116; P:positive regulation of microtubule polymerization; ISS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0010831; P:positive regulation of myotube differentiation; IEA:Ensembl
P56539	CAV3	Caveolin-3	GO:2000060; P:positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; NAS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0008104; P:protein localization; ISS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0072659; P:protein localization to plasma membrane; ISS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0060762; P:regulation of branching involved in mammary gland duct morphogenesis; IEA:Ensembl
P56539	CAV3	Caveolin-3	GO:0090279; P:regulation of calcium ion import; IDA:BHF-UCL
P56539	CAV3	Caveolin-3	GO:1901019; P:regulation of calcium ion transmembrane transporter activity; IDA:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0055117; P:regulation of cardiac muscle contraction; IMP:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0008016; P:regulation of heart contraction; ISS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0002027; P:regulation of heart rate; IMP:BHF-UCL
P56539	CAV3	Caveolin-3	GO:1900825; P:regulation of membrane depolarization during cardiac muscle cell action potential; IMP:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0042391; P:regulation of membrane potential; IDA:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0051394; P:regulation of nerve growth factor receptor activity; IMP:MGI
P56539	CAV3	Caveolin-3	GO:1900744; P:regulation of p38MAPK cascade; IEA:Ensembl
P56539	CAV3	Caveolin-3	GO:0051896; P:regulation of protein kinase B signaling; IEA:Ensembl
P56539	CAV3	Caveolin-3	GO:0038009; P:regulation of signal transduction by receptor internalization; IMP:MGI
P56539	CAV3	Caveolin-3	GO:0014819; P:regulation of skeletal muscle contraction; IMP:BHF-UCL
P56539	CAV3	Caveolin-3	GO:2000649; P:regulation of sodium ion transmembrane transporter activity; IDA:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl
P56539	CAV3	Caveolin-3	GO:0060373; P:regulation of ventricular cardiac muscle cell membrane depolarization; IDA:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0033292; P:T-tubule organization; TAS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0006641; P:triglyceride metabolic process; ISS:BHF-UCL
P56539	CAV3	Caveolin-3	GO:0086005; P:ventricular cardiac muscle cell action potential; ISS:BHF-UCL
Q13938	CAPS	Calcyphosin	GO:0005509; F:calcium ion binding; TAS:ProtInc
Q13938	CAPS	Calcyphosin	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
Q9BXY5	CAPS2	Calcyphosin-2	GO:0005509; F:calcium ion binding; IEA:InterPro
P52907	CAPZA1	F-actin-capping protein subunit alpha-1	GO:0003779; F:actin binding; TAS:ProtInc
P52907	CAPZA1	F-actin-capping protein subunit alpha-1	GO:0005515; F:protein binding; IPI:IntAct
P52907	CAPZA1	F-actin-capping protein subunit alpha-1	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
P52907	CAPZA1	F-actin-capping protein subunit alpha-1	GO:0051693; P:actin filament capping; IEA:UniProtKB-KW
P52907	CAPZA1	F-actin-capping protein subunit alpha-1	GO:0007596; P:blood coagulation; TAS:Reactome
P52907	CAPZA1	F-actin-capping protein subunit alpha-1	GO:0006928; P:cellular component movement; TAS:UniProtKB
P52907	CAPZA1	F-actin-capping protein subunit alpha-1	GO:0045087; P:innate immune response; TAS:Reactome
P52907	CAPZA1	F-actin-capping protein subunit alpha-1	GO:0006461; P:protein complex assembly; TAS:ProtInc
P47755	CAPZA2	F-actin-capping protein subunit alpha-2	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
P47755	CAPZA2	F-actin-capping protein subunit alpha-2	GO:0051693; P:actin filament capping; IEA:UniProtKB-KW
P47755	CAPZA2	F-actin-capping protein subunit alpha-2	GO:0007596; P:blood coagulation; TAS:Reactome
P47755	CAPZA2	F-actin-capping protein subunit alpha-2	GO:0006928; P:cellular component movement; TAS:ProtInc
P47755	CAPZA2	F-actin-capping protein subunit alpha-2	GO:0045087; P:innate immune response; TAS:Reactome
P47755	CAPZA2	F-actin-capping protein subunit alpha-2	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q96KX2	CAPZA3	F-actin-capping protein subunit alpha-3	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
Q96KX2	CAPZA3	F-actin-capping protein subunit alpha-3	GO:0051693; P:actin filament capping; IEA:UniProtKB-KW
Q96KX2	CAPZA3	F-actin-capping protein subunit alpha-3	GO:0007286; P:spermatid development; IEA:Ensembl
Q8WU43	C2orf15	Uncharacterized protein C2orf15	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
A6NGG8	C2orf71	Uncharacterized protein C2orf71	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
A6NGG8	C2orf71	Uncharacterized protein C2orf71	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q53S99	C2orf83	Folate transporter-like protein C2orf83	GO:0006810; P:transport; IEA:InterPro
Q9H9S4	CAB39L	Calcium-binding protein 39-like	GO:0007050; P:cell cycle arrest; TAS:Reactome
Q9H9S4	CAB39L	Calcium-binding protein 39-like	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q6P9G0	CYB5D1	Cytochrome b5 domain-containing protein 1	GO:0020037; F:heme binding; IEA:InterPro
Q6P9G0	CYB5D1	Cytochrome b5 domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P08185	SERPINA6	Corticosteroid-binding globulin	GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome
P08185	SERPINA6	Corticosteroid-binding globulin	GO:0005496; F:steroid binding; IDA:UniProtKB
P08185	SERPINA6	Corticosteroid-binding globulin	GO:0008211; P:glucocorticoid metabolic process; IEA:Ensembl
P08185	SERPINA6	Corticosteroid-binding globulin	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P08185	SERPINA6	Corticosteroid-binding globulin	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
P08185	SERPINA6	Corticosteroid-binding globulin	GO:0006810; P:transport; IEA:UniProtKB-KW
Q13191	CBLB	E3 ubiquitin-protein ligase CBL-B	GO:0005509; F:calcium ion binding; IEA:InterPro
Q13191	CBLB	E3 ubiquitin-protein ligase CBL-B	GO:0005515; F:protein binding; IPI:IntAct
Q13191	CBLB	E3 ubiquitin-protein ligase CBL-B	GO:0004871; F:signal transducer activity; IEA:InterPro
Q13191	CBLB	E3 ubiquitin-protein ligase CBL-B	GO:0004842; F:ubiquitin-protein ligase activity; IEA:InterPro
Q13191	CBLB	E3 ubiquitin-protein ligase CBL-B	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q13191	CBLB	E3 ubiquitin-protein ligase CBL-B	GO:0007166; P:cell surface receptor signaling pathway; IEA:InterPro
Q13191	CBLB	E3 ubiquitin-protein ligase CBL-B	GO:0006955; P:immune response; IEA:Ensembl
Q13191	CBLB	E3 ubiquitin-protein ligase CBL-B	GO:0035556; P:intracellular signal transduction; IEA:Ensembl
Q13191	CBLB	E3 ubiquitin-protein ligase CBL-B	GO:0046642; P:negative regulation of alpha-beta T cell proliferation; IEA:Ensembl
Q13191	CBLB	E3 ubiquitin-protein ligase CBL-B	GO:0050860; P:negative regulation of T cell receptor signaling pathway; IEA:Ensembl
Q13191	CBLB	E3 ubiquitin-protein ligase CBL-B	GO:0006607; P:NLS-bearing protein import into nucleus; TAS:ProtInc
Q13191	CBLB	E3 ubiquitin-protein ligase CBL-B	GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl
Q13191	CBLB	E3 ubiquitin-protein ligase CBL-B	GO:0002669; P:positive regulation of T cell anergy; IEA:Ensembl
Q13191	CBLB	E3 ubiquitin-protein ligase CBL-B	GO:0007165; P:signal transduction; TAS:ProtInc
Q13191	CBLB	E3 ubiquitin-protein ligase CBL-B	GO:0042110; P:T cell activation; IEA:Ensembl
Q9ULV8	CBLC	E3 ubiquitin-protein ligase CBL-C	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9ULV8	CBLC	E3 ubiquitin-protein ligase CBL-C	GO:0005154; F:epidermal growth factor receptor binding; IDA:BHF-UCL
Q9ULV8	CBLC	E3 ubiquitin-protein ligase CBL-C	GO:0001784; F:phosphotyrosine binding; IDA:BHF-UCL
Q9ULV8	CBLC	E3 ubiquitin-protein ligase CBL-C	GO:0017124; F:SH3 domain binding; IDA:BHF-UCL
Q9ULV8	CBLC	E3 ubiquitin-protein ligase CBL-C	GO:0004871; F:signal transducer activity; IEA:InterPro
Q9ULV8	CBLC	E3 ubiquitin-protein ligase CBL-C	GO:0004842; F:ubiquitin-protein ligase activity; IDA:BHF-UCL
Q9ULV8	CBLC	E3 ubiquitin-protein ligase CBL-C	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q9ULV8	CBLC	E3 ubiquitin-protein ligase CBL-C	GO:0007166; P:cell surface receptor signaling pathway; IEA:InterPro
Q9ULV8	CBLC	E3 ubiquitin-protein ligase CBL-C	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; IDA:BHF-UCL
Q9ULV8	CBLC	E3 ubiquitin-protein ligase CBL-C	GO:0007175; P:negative regulation of epidermal growth factor-activated receptor activity; IDA:BHF-UCL
Q9ULV8	CBLC	E3 ubiquitin-protein ligase CBL-C	GO:0043407; P:negative regulation of MAP kinase activity; IDA:BHF-UCL
Q9ULV8	CBLC	E3 ubiquitin-protein ligase CBL-C	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:BHF-UCL
P23435	CBLN1	Cerebellin-1	GO:0021707; P:cerebellar granule cell differentiation; ISS:BHF-UCL
P23435	CBLN1	Cerebellin-1	GO:0007157; P:heterophilic cell-cell adhesion; ISS:BHF-UCL
P23435	CBLN1	Cerebellin-1	GO:0007399; P:nervous system development; TAS:ProtInc
P23435	CBLN1	Cerebellin-1	GO:0051965; P:positive regulation of synapse assembly; IEA:Ensembl
P23435	CBLN1	Cerebellin-1	GO:0009306; P:protein secretion; IEA:Ensembl
P23435	CBLN1	Cerebellin-1	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q8IUK8	CBLN2	Cerebellin-2	GO:0051965; P:positive regulation of synapse assembly; IEA:Ensembl
Q9NTU7	CBLN4	Cerebellin-4	GO:0009306; P:protein secretion; IEA:Ensembl
P22681	CBL	E3 ubiquitin-protein ligase CBL	GO:0005509; F:calcium ion binding; IEA:InterPro
P22681	CBL	E3 ubiquitin-protein ligase CBL	GO:0046875; F:ephrin receptor binding; IPI:UniProtKB
P22681	CBL	E3 ubiquitin-protein ligase CBL	GO:0005515; F:protein binding; IPI:UniProtKB
P22681	CBL	E3 ubiquitin-protein ligase CBL	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P22681	CBL	E3 ubiquitin-protein ligase CBL	GO:0017124; F:SH3 domain binding; IPI:BHF-UCL
P22681	CBL	E3 ubiquitin-protein ligase CBL	GO:0004871; F:signal transducer activity; IEA:InterPro
P22681	CBL	E3 ubiquitin-protein ligase CBL	GO:0004842; F:ubiquitin-protein ligase activity; TAS:HGNC
P22681	CBL	E3 ubiquitin-protein ligase CBL	GO:0008270; F:zinc ion binding; IEA:InterPro
P22681	CBL	E3 ubiquitin-protein ligase CBL	GO:0007166; P:cell surface receptor signaling pathway; TAS:HGNC
P22681	CBL	E3 ubiquitin-protein ligase CBL	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:HGNC
P22681	CBL	E3 ubiquitin-protein ligase CBL	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P22681	CBL	E3 ubiquitin-protein ligase CBL	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P22681	CBL	E3 ubiquitin-protein ligase CBL	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
P22681	CBL	E3 ubiquitin-protein ligase CBL	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IMP:BHF-UCL
P22681	CBL	E3 ubiquitin-protein ligase CBL	GO:0048260; P:positive regulation of receptor-mediated endocytosis; TAS:HGNC
P22681	CBL	E3 ubiquitin-protein ligase CBL	GO:0016567; P:protein ubiquitination; TAS:HGNC
P22681	CBL	E3 ubiquitin-protein ligase CBL	GO:0006355; P:regulation of transcription, DNA-templated; TAS:GOC
P22681	CBL	E3 ubiquitin-protein ligase CBL	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P15085	CPA1	Carboxypeptidase A1	GO:0004181; F:metallocarboxypeptidase activity; TAS:ProtInc
P15085	CPA1	Carboxypeptidase A1	GO:0008270; F:zinc ion binding; IEA:InterPro
P15085	CPA1	Carboxypeptidase A1	GO:0006508; P:proteolysis; TAS:ProtInc
P48052	CPA2	Carboxypeptidase A2	GO:0004180; F:carboxypeptidase activity; IDA:UniProtKB
P48052	CPA2	Carboxypeptidase A2	GO:0004181; F:metallocarboxypeptidase activity; IDA:UniProtKB
P48052	CPA2	Carboxypeptidase A2	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P48052	CPA2	Carboxypeptidase A2	GO:0007039; P:vacuolar protein catabolic process; TAS:ProtInc
P15088	CPA3	Mast cell carboxypeptidase A	GO:0004181; F:metallocarboxypeptidase activity; NAS:UniProtKB
P15088	CPA3	Mast cell carboxypeptidase A	GO:0008270; F:zinc ion binding; IEA:InterPro
P15088	CPA3	Mast cell carboxypeptidase A	GO:0002003; P:angiotensin maturation; TAS:Reactome
P15088	CPA3	Mast cell carboxypeptidase A	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P15088	CPA3	Mast cell carboxypeptidase A	GO:0006508; P:proteolysis; TAS:UniProtKB
Q9UI42	CPA4	Carboxypeptidase A4	GO:0004181; F:metallocarboxypeptidase activity; NAS:UniProtKB
Q9UI42	CPA4	Carboxypeptidase A4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UI42	CPA4	Carboxypeptidase A4	GO:0016573; P:histone acetylation; NAS:UniProtKB
Q8WXQ8	CPA5	Carboxypeptidase A5	GO:0004181; F:metallocarboxypeptidase activity; IEA:InterPro
Q8WXQ8	CPA5	Carboxypeptidase A5	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N4T0	CPA6	Carboxypeptidase A6	GO:0004181; F:metallocarboxypeptidase activity; NAS:UniProtKB
Q8N4T0	CPA6	Carboxypeptidase A6	GO:0008270; F:zinc ion binding; IEA:InterPro
P15086	CPB1	Carboxypeptidase B	GO:0004180; F:carboxypeptidase activity; TAS:ProtInc
P15086	CPB1	Carboxypeptidase B	GO:0004181; F:metallocarboxypeptidase activity; IEA:InterPro
P15086	CPB1	Carboxypeptidase B	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96IY4	CPB2	Carboxypeptidase B2	GO:0004181; F:metallocarboxypeptidase activity; TAS:ProtInc
Q96IY4	CPB2	Carboxypeptidase B2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96IY4	CPB2	Carboxypeptidase B2	GO:0007596; P:blood coagulation; IEA:UniProtKB-KW
Q96IY4	CPB2	Carboxypeptidase B2	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
Q96IY4	CPB2	Carboxypeptidase B2	GO:0042730; P:fibrinolysis; IEA:UniProtKB-KW
Q96IY4	CPB2	Carboxypeptidase B2	GO:0097421; P:liver regeneration; IEA:Ensembl
Q96IY4	CPB2	Carboxypeptidase B2	GO:0051918; P:negative regulation of fibrinolysis; IEA:Ensembl
Q96IY4	CPB2	Carboxypeptidase B2	GO:2000346; P:negative regulation of hepatocyte proliferation; IEA:Ensembl
Q96IY4	CPB2	Carboxypeptidase B2	GO:0010757; P:negative regulation of plasminogen activation; IEA:Ensembl
Q96IY4	CPB2	Carboxypeptidase B2	GO:0003331; P:positive regulation of extracellular matrix constituent secretion; IEA:Ensembl
Q96IY4	CPB2	Carboxypeptidase B2	GO:0006508; P:proteolysis; TAS:ProtInc
Q96IY4	CPB2	Carboxypeptidase B2	GO:0042493; P:response to drug; IEA:Ensembl
Q96IY4	CPB2	Carboxypeptidase B2	GO:0009408; P:response to heat; IEA:Ensembl
Q9UPW5	AGTPBP1	Cytosolic carboxypeptidase 1	GO:0004181; F:metallocarboxypeptidase activity; ISS:UniProtKB
Q9UPW5	AGTPBP1	Cytosolic carboxypeptidase 1	GO:0015631; F:tubulin binding; ISS:UniProtKB
Q9UPW5	AGTPBP1	Cytosolic carboxypeptidase 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UPW5	AGTPBP1	Cytosolic carboxypeptidase 1	GO:0007628; P:adult walking behavior; IEA:Ensembl
Q9UPW5	AGTPBP1	Cytosolic carboxypeptidase 1	GO:0035609; P:C-terminal protein deglutamylation; ISS:UniProtKB
Q9UPW5	AGTPBP1	Cytosolic carboxypeptidase 1	GO:0021702; P:cerebellar Purkinje cell differentiation; ISS:UniProtKB
Q9UPW5	AGTPBP1	Cytosolic carboxypeptidase 1	GO:0001754; P:eye photoreceptor cell differentiation; ISS:UniProtKB
Q9UPW5	AGTPBP1	Cytosolic carboxypeptidase 1	GO:0007005; P:mitochondrion organization; ISS:UniProtKB
Q9UPW5	AGTPBP1	Cytosolic carboxypeptidase 1	GO:0050905; P:neuromuscular process; ISS:UniProtKB
Q9UPW5	AGTPBP1	Cytosolic carboxypeptidase 1	GO:0042133; P:neurotransmitter metabolic process; IEA:Ensembl
Q9UPW5	AGTPBP1	Cytosolic carboxypeptidase 1	GO:0021772; P:olfactory bulb development; ISS:UniProtKB
Q9UPW5	AGTPBP1	Cytosolic carboxypeptidase 1	GO:0035610; P:protein side chain deglutamylation; ISS:UniProtKB
Q9UPW5	AGTPBP1	Cytosolic carboxypeptidase 1	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
Q5U5Z8	AGBL2	Cytosolic carboxypeptidase 2	GO:0004181; F:metallocarboxypeptidase activity; IEA:InterPro
Q5U5Z8	AGBL2	Cytosolic carboxypeptidase 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8NEM8	AGBL3	Cytosolic carboxypeptidase 3	GO:0004181; F:metallocarboxypeptidase activity; IDA:UniProtKB
Q8NEM8	AGBL3	Cytosolic carboxypeptidase 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96MI9	AGBL1	Cytosolic carboxypeptidase 4	GO:0004181; F:metallocarboxypeptidase activity; ISS:UniProtKB
Q96MI9	AGBL1	Cytosolic carboxypeptidase 4	GO:0015631; F:tubulin binding; ISS:UniProtKB
Q96MI9	AGBL1	Cytosolic carboxypeptidase 4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96MI9	AGBL1	Cytosolic carboxypeptidase 4	GO:0035609; P:C-terminal protein deglutamylation; ISS:UniProtKB
Q96MI9	AGBL1	Cytosolic carboxypeptidase 4	GO:0035610; P:protein side chain deglutamylation; ISS:UniProtKB
Q8NDL9	AGBL5	Cytosolic carboxypeptidase-like protein 5	GO:0004181; F:metallocarboxypeptidase activity; ISS:UniProtKB
Q8NDL9	AGBL5	Cytosolic carboxypeptidase-like protein 5	GO:0015631; F:tubulin binding; ISS:UniProtKB
Q8NDL9	AGBL5	Cytosolic carboxypeptidase-like protein 5	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8NDL9	AGBL5	Cytosolic carboxypeptidase-like protein 5	GO:0035611; P:protein branching point deglutamylation; ISS:UniProtKB
Q8NDL9	AGBL5	Cytosolic carboxypeptidase-like protein 5	GO:0035608; P:protein deglutamylation; ISS:UniProtKB
Q5VU57	AGBL4	Cytosolic carboxypeptidase 6	GO:0004181; F:metallocarboxypeptidase activity; ISS:UniProtKB
Q5VU57	AGBL4	Cytosolic carboxypeptidase 6	GO:0015631; F:tubulin binding; ISS:UniProtKB
Q5VU57	AGBL4	Cytosolic carboxypeptidase 6	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5VU57	AGBL4	Cytosolic carboxypeptidase 6	GO:0035609; P:C-terminal protein deglutamylation; ISS:UniProtKB
Q5VU57	AGBL4	Cytosolic carboxypeptidase 6	GO:0035610; P:protein side chain deglutamylation; ISS:UniProtKB
O75976	CPD	Carboxypeptidase D	GO:0004181; F:metallocarboxypeptidase activity; IEA:InterPro
O75976	CPD	Carboxypeptidase D	GO:0004185; F:serine-type carboxypeptidase activity; TAS:ProtInc
O75976	CPD	Carboxypeptidase D	GO:0008270; F:zinc ion binding; IEA:InterPro
P16870	CPE	Carboxypeptidase E	GO:0004180; F:carboxypeptidase activity; TAS:ProtInc
P16870	CPE	Carboxypeptidase E	GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL
P16870	CPE	Carboxypeptidase E	GO:0004181; F:metallocarboxypeptidase activity; IEA:InterPro
P16870	CPE	Carboxypeptidase E	GO:0042043; F:neurexin family protein binding; IPI:BHF-UCL
P16870	CPE	Carboxypeptidase E	GO:0008270; F:zinc ion binding; IEA:InterPro
P16870	CPE	Carboxypeptidase E	GO:0003214; P:cardiac left ventricle morphogenesis; IMP:BHF-UCL
P16870	CPE	Carboxypeptidase E	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P16870	CPE	Carboxypeptidase E	GO:0006464; P:cellular protein modification process; NAS:UniProtKB
P16870	CPE	Carboxypeptidase E	GO:0030070; P:insulin processing; IEA:Ensembl
P16870	CPE	Carboxypeptidase E	GO:0008152; P:metabolic process; TAS:ProtInc
P16870	CPE	Carboxypeptidase E	GO:0007218; P:neuropeptide signaling pathway; NAS:UniProtKB
P16870	CPE	Carboxypeptidase E	GO:0072657; P:protein localization to membrane; IDA:BHF-UCL
P14384	CPM	Carboxypeptidase M	GO:0004180; F:carboxypeptidase activity; TAS:ProtInc
P14384	CPM	Carboxypeptidase M	GO:0004181; F:metallocarboxypeptidase activity; TAS:ProtInc
P14384	CPM	Carboxypeptidase M	GO:0008270; F:zinc ion binding; IEA:InterPro
P14384	CPM	Carboxypeptidase M	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P15169	CPN1	Carboxypeptidase N catalytic chain	GO:0004181; F:metallocarboxypeptidase activity; TAS:ProtInc
P15169	CPN1	Carboxypeptidase N catalytic chain	GO:0008270; F:zinc ion binding; IEA:InterPro
P15169	CPN1	Carboxypeptidase N catalytic chain	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
Q8IVL8	CPO	Carboxypeptidase O	GO:0004181; F:metallocarboxypeptidase activity; IEA:InterPro
Q8IVL8	CPO	Carboxypeptidase O	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y646	CPQ	Carboxypeptidase Q	GO:0004180; F:carboxypeptidase activity; IEA:UniProtKB-KW
Q9Y646	CPQ	Carboxypeptidase Q	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y646	CPQ	Carboxypeptidase Q	GO:0070573; F:metallodipeptidase activity; IDA:UniProtKB
Q9Y646	CPQ	Carboxypeptidase Q	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q9Y646	CPQ	Carboxypeptidase Q	GO:0043171; P:peptide catabolic process; IDA:UniProtKB
Q9Y646	CPQ	Carboxypeptidase Q	GO:0006508; P:proteolysis; IDA:UniProtKB
Q9Y646	CPQ	Carboxypeptidase Q	GO:0006590; P:thyroid hormone generation; ISS:UniProtKB
Q9Y646	CPQ	Carboxypeptidase Q	GO:0042246; P:tissue regeneration; ISS:UniProtKB
Q66K79	CPZ	Carboxypeptidase Z	GO:0004181; F:metallocarboxypeptidase activity; TAS:ProtInc
Q66K79	CPZ	Carboxypeptidase Z	GO:0008270; F:zinc ion binding; IEA:InterPro
Q66K79	CPZ	Carboxypeptidase Z	GO:0006508; P:proteolysis; TAS:ProtInc
Q66K79	CPZ	Carboxypeptidase Z	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q92793	CREBBP	CREB-binding protein	GO:0016407; F:acetyltransferase activity; IDA:UniProtKB
Q92793	CREBBP	CREB-binding protein	GO:0003682; F:chromatin binding; IEA:Ensembl
Q92793	CREBBP	CREB-binding protein	GO:0000987; F:core promoter proximal region sequence-specific DNA binding; IDA:BHF-UCL
Q92793	CREBBP	CREB-binding protein	GO:0004402; F:histone acetyltransferase activity; IDA:UniProtKB
Q92793	CREBBP	CREB-binding protein	GO:0043426; F:MRF binding; IDA:UniProtKB
Q92793	CREBBP	CREB-binding protein	GO:0002039; F:p53 binding; IPI:UniProtKB
Q92793	CREBBP	CREB-binding protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q92793	CREBBP	CREB-binding protein	GO:0001102; F:RNA polymerase II activating transcription factor binding; TAS:BHF-UCL
Q92793	CREBBP	CREB-binding protein	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IDA:BHF-UCL
Q92793	CREBBP	CREB-binding protein	GO:0001105; F:RNA polymerase II transcription coactivator activity; TAS:BHF-UCL
Q92793	CREBBP	CREB-binding protein	GO:0001085; F:RNA polymerase II transcription factor binding; IPI:BHF-UCL
Q92793	CREBBP	CREB-binding protein	GO:0001191; F:RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription; IDA:BHF-UCL
Q92793	CREBBP	CREB-binding protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q92793	CREBBP	CREB-binding protein	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q92793	CREBBP	CREB-binding protein	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q92793	CREBBP	CREB-binding protein	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q92793	CREBBP	CREB-binding protein	GO:0008270; F:zinc ion binding; IEA:InterPro
Q92793	CREBBP	CREB-binding protein	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q92793	CREBBP	CREB-binding protein	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
Q92793	CREBBP	CREB-binding protein	GO:0006325; P:chromatin organization; TAS:Reactome
Q92793	CREBBP	CREB-binding protein	GO:0042733; P:embryonic digit morphogenesis; TAS:BHF-UCL
Q92793	CREBBP	CREB-binding protein	GO:0010467; P:gene expression; TAS:Reactome
Q92793	CREBBP	CREB-binding protein	GO:0030718; P:germ-line stem cell maintenance; IEA:Ensembl
Q92793	CREBBP	CREB-binding protein	GO:0016573; P:histone acetylation; IDA:UniProtKB
Q92793	CREBBP	CREB-binding protein	GO:0042592; P:homeostatic process; NAS:UniProtKB
Q92793	CREBBP	CREB-binding protein	GO:0045087; P:innate immune response; TAS:Reactome
Q92793	CREBBP	CREB-binding protein	GO:0018076; P:N-terminal peptidyl-lysine acetylation; IDA:UniProtKB
Q92793	CREBBP	CREB-binding protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q92793	CREBBP	CREB-binding protein	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q92793	CREBBP	CREB-binding protein	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q92793	CREBBP	CREB-binding protein	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q92793	CREBBP	CREB-binding protein	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q92793	CREBBP	CREB-binding protein	GO:0008589; P:regulation of smoothened signaling pathway; TAS:BHF-UCL
Q92793	CREBBP	CREB-binding protein	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
Q92793	CREBBP	CREB-binding protein	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q92793	CREBBP	CREB-binding protein	GO:0001666; P:response to hypoxia; TAS:UniProtKB
Q92793	CREBBP	CREB-binding protein	GO:0007165; P:signal transduction; NAS:UniProtKB
Q92793	CREBBP	CREB-binding protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q92793	CREBBP	CREB-binding protein	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q92793	CREBBP	CREB-binding protein	GO:0016032; P:viral process; IEA:UniProtKB-KW
P16152	CBR1	Carbonyl reductase [NADPH] 1	GO:0047021; F:15-hydroxyprostaglandin dehydrogenase (NADP+) activity; IEA:UniProtKB-EC
P16152	CBR1	Carbonyl reductase [NADPH] 1	GO:0004090; F:carbonyl reductase (NADPH) activity; IDA:UniProtKB
P16152	CBR1	Carbonyl reductase [NADPH] 1	GO:0016491; F:oxidoreductase activity; IEA:InterPro
P16152	CBR1	Carbonyl reductase [NADPH] 1	GO:0016655; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; IDA:UniProtKB
P16152	CBR1	Carbonyl reductase [NADPH] 1	GO:0050221; F:prostaglandin-E2 9-reductase activity; IEA:UniProtKB-EC
P16152	CBR1	Carbonyl reductase [NADPH] 1	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P16152	CBR1	Carbonyl reductase [NADPH] 1	GO:0019371; P:cyclooxygenase pathway; TAS:Reactome
P16152	CBR1	Carbonyl reductase [NADPH] 1	GO:0017144; P:drug metabolic process; IDA:UniProtKB
P16152	CBR1	Carbonyl reductase [NADPH] 1	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
P16152	CBR1	Carbonyl reductase [NADPH] 1	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
P16152	CBR1	Carbonyl reductase [NADPH] 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P16152	CBR1	Carbonyl reductase [NADPH] 1	GO:0042373; P:vitamin K metabolic process; IDA:UniProtKB
O75828	CBR3	Carbonyl reductase [NADPH] 3	GO:0000253; F:3-keto sterol reductase activity; IEA:Ensembl
O75828	CBR3	Carbonyl reductase [NADPH] 3	GO:0004090; F:carbonyl reductase (NADPH) activity; IDA:UniProtKB
O75828	CBR3	Carbonyl reductase [NADPH] 3	GO:0070402; F:NADPH binding; IDA:UniProtKB
O75828	CBR3	Carbonyl reductase [NADPH] 3	GO:0042376; P:phylloquinone catabolic process; IEA:Ensembl
Q8N4T8	CBR4	Carbonyl reductase family member 4	GO:0003955; F:NAD(P)H dehydrogenase (quinone) activity; IDA:UniProtKB
Q8N4T8	CBR4	Carbonyl reductase family member 4	GO:0070402; F:NADPH binding; IDA:UniProtKB
Q8N4T8	CBR4	Carbonyl reductase family member 4	GO:0008753; F:NADPH dehydrogenase (quinone) activity; IDA:UniProtKB
Q8N4T8	CBR4	Carbonyl reductase family member 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N4T8	CBR4	Carbonyl reductase family member 4	GO:0048038; F:quinone binding; IDA:UniProtKB
Q8N4T8	CBR4	Carbonyl reductase family member 4	GO:0044597; P:daunorubicin metabolic process; IMP:UniProtKB
Q8N4T8	CBR4	Carbonyl reductase family member 4	GO:0044598; P:doxorubicin metabolic process; IMP:UniProtKB
Q8N4T8	CBR4	Carbonyl reductase family member 4	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-UniPathway
Q8N4T8	CBR4	Carbonyl reductase family member 4	GO:0051289; P:protein homotetramerization; IPI:UniProtKB
P35520	CBS	Cystathionine beta-synthase	GO:0030554; F:adenyl nucleotide binding; IEA:InterPro
P35520	CBS	Cystathionine beta-synthase	GO:0004122; F:cystathionine beta-synthase activity; IDA:UniProtKB
P35520	CBS	Cystathionine beta-synthase	GO:0019899; F:enzyme binding; IPI:UniProtKB
P35520	CBS	Cystathionine beta-synthase	GO:0020037; F:heme binding; IDA:UniProtKB
P35520	CBS	Cystathionine beta-synthase	GO:0042802; F:identical protein binding; IPI:IntAct
P35520	CBS	Cystathionine beta-synthase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P35520	CBS	Cystathionine beta-synthase	GO:0072341; F:modified amino acid binding; IDA:UniProtKB
P35520	CBS	Cystathionine beta-synthase	GO:0005515; F:protein binding; IPI:UniProtKB
P35520	CBS	Cystathionine beta-synthase	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P35520	CBS	Cystathionine beta-synthase	GO:0030170; F:pyridoxal phosphate binding; IDA:UniProtKB
P35520	CBS	Cystathionine beta-synthase	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P35520	CBS	Cystathionine beta-synthase	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
P35520	CBS	Cystathionine beta-synthase	GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; IEA:Ensembl
P35520	CBS	Cystathionine beta-synthase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P35520	CBS	Cystathionine beta-synthase	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
P35520	CBS	Cystathionine beta-synthase	GO:0021587; P:cerebellum morphogenesis; IEA:Ensembl
P35520	CBS	Cystathionine beta-synthase	GO:0006535; P:cysteine biosynthetic process from serine; IEA:InterPro
P35520	CBS	Cystathionine beta-synthase	GO:0019343; P:cysteine biosynthetic process via cystathionine; IEA:InterPro
P35520	CBS	Cystathionine beta-synthase	GO:0001958; P:endochondral ossification; IEA:Ensembl
P35520	CBS	Cystathionine beta-synthase	GO:0043418; P:homocysteine catabolic process; IDA:UniProtKB
P35520	CBS	Cystathionine beta-synthase	GO:0050667; P:homocysteine metabolic process; IDA:UniProtKB
P35520	CBS	Cystathionine beta-synthase	GO:0070814; P:hydrogen sulfide biosynthetic process; IDA:UniProtKB
P35520	CBS	Cystathionine beta-synthase	GO:0019448; P:L-cysteine catabolic process; IDA:UniProtKB
P35520	CBS	Cystathionine beta-synthase	GO:0006565; P:L-serine catabolic process; IDA:UniProtKB
P35520	CBS	Cystathionine beta-synthase	GO:0006563; P:L-serine metabolic process; IDA:UniProtKB
P35520	CBS	Cystathionine beta-synthase	GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
P35520	CBS	Cystathionine beta-synthase	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P35520	CBS	Cystathionine beta-synthase	GO:0050880; P:regulation of blood vessel size; IEA:Ensembl
P35520	CBS	Cystathionine beta-synthase	GO:0030823; P:regulation of cGMP metabolic process; IEA:Ensembl
P35520	CBS	Cystathionine beta-synthase	GO:0043506; P:regulation of JUN kinase activity; IEA:Ensembl
P35520	CBS	Cystathionine beta-synthase	GO:0051593; P:response to folic acid; IEA:Ensembl
P35520	CBS	Cystathionine beta-synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P35520	CBS	Cystathionine beta-synthase	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
P35520	CBS	Cystathionine beta-synthase	GO:0006801; P:superoxide metabolic process; IEA:Ensembl
P35520	CBS	Cystathionine beta-synthase	GO:0019346; P:transsulfuration; TAS:Reactome
Q9BRT8	CBWD1	COBW domain-containing protein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5JTY5	CBWD3	COBW domain-containing protein 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IUF1	CBWD2	COBW domain-containing protein 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5RIA9	CBWD5	COBW domain-containing protein 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q4V339	CBWD6	COBW domain-containing protein 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
A6NM15	CBWD7	Putative COBW domain-containing protein 7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P83916	CBX1	Chromobox protein homolog 1	GO:0003682; F:chromatin binding; TAS:ProtInc
P83916	CBX1	Chromobox protein homolog 1	GO:0019899; F:enzyme binding; IPI:UniProtKB
P83916	CBX1	Chromobox protein homolog 1	GO:1990226; F:histone methyltransferase binding; IPI:BHF-UCL
P83916	CBX1	Chromobox protein homolog 1	GO:0005515; F:protein binding; IPI:UniProtKB
P83916	CBX1	Chromobox protein homolog 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q14781	CBX2	Chromobox protein homolog 2	GO:0003682; F:chromatin binding; IEA:Ensembl
Q14781	CBX2	Chromobox protein homolog 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q14781	CBX2	Chromobox protein homolog 2	GO:0005515; F:protein binding; IPI:IntAct
Q14781	CBX2	Chromobox protein homolog 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q14781	CBX2	Chromobox protein homolog 2	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q14781	CBX2	Chromobox protein homolog 2	GO:0045137; P:development of primary sexual characteristics; IMP:UniProtKB
Q14781	CBX2	Chromobox protein homolog 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q14781	CBX2	Chromobox protein homolog 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13185	CBX3	Chromobox protein homolog 3	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q13185	CBX3	Chromobox protein homolog 3	GO:1990226; F:histone methyltransferase binding; IPI:BHF-UCL
Q13185	CBX3	Chromobox protein homolog 3	GO:0042802; F:identical protein binding; IPI:IntAct
Q13185	CBX3	Chromobox protein homolog 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q13185	CBX3	Chromobox protein homolog 3	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q13185	CBX3	Chromobox protein homolog 3	GO:0006338; P:chromatin remodeling; NAS:UniProtKB
Q13185	CBX3	Chromobox protein homolog 3	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q13185	CBX3	Chromobox protein homolog 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O00257	CBX4	E3 SUMO-protein ligase CBX4	GO:0003682; F:chromatin binding; IEA:Ensembl
O00257	CBX4	E3 SUMO-protein ligase CBX4	GO:0019899; F:enzyme binding; IPI:UniProtKB
O00257	CBX4	E3 SUMO-protein ligase CBX4	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
O00257	CBX4	E3 SUMO-protein ligase CBX4	GO:0005515; F:protein binding; IPI:IntAct
O00257	CBX4	E3 SUMO-protein ligase CBX4	GO:0003727; F:single-stranded RNA binding; IEA:Ensembl
O00257	CBX4	E3 SUMO-protein ligase CBX4	GO:0032183; F:SUMO binding; IDA:MGI
O00257	CBX4	E3 SUMO-protein ligase CBX4	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
O00257	CBX4	E3 SUMO-protein ligase CBX4	GO:0044212; F:transcription regulatory region DNA binding; IEA:Ensembl
O00257	CBX4	E3 SUMO-protein ligase CBX4	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
O00257	CBX4	E3 SUMO-protein ligase CBX4	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
O00257	CBX4	E3 SUMO-protein ligase CBX4	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
O00257	CBX4	E3 SUMO-protein ligase CBX4	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
O00257	CBX4	E3 SUMO-protein ligase CBX4	GO:0016925; P:protein sumoylation; IEA:UniProtKB-UniPathway
O00257	CBX4	E3 SUMO-protein ligase CBX4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P45973	CBX5	Chromobox protein homolog 5	GO:0003682; F:chromatin binding; IEA:Ensembl
P45973	CBX5	Chromobox protein homolog 5	GO:0019899; F:enzyme binding; IPI:UniProtKB
P45973	CBX5	Chromobox protein homolog 5	GO:1990226; F:histone methyltransferase binding; IPI:BHF-UCL
P45973	CBX5	Chromobox protein homolog 5	GO:0035064; F:methylated histone binding; IDA:UniProtKB
P45973	CBX5	Chromobox protein homolog 5	GO:0005515; F:protein binding; IPI:UniProtKB
P45973	CBX5	Chromobox protein homolog 5	GO:0030674; F:protein binding, bridging; ISS:BHF-UCL
P45973	CBX5	Chromobox protein homolog 5	GO:0070491; F:repressing transcription factor binding; ISS:BHF-UCL
P45973	CBX5	Chromobox protein homolog 5	GO:0007596; P:blood coagulation; TAS:Reactome
P45973	CBX5	Chromobox protein homolog 5	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P45973	CBX5	Chromobox protein homolog 5	GO:0016032; P:viral process; IEA:UniProtKB-KW
O95503	CBX6	Chromobox protein homolog 6	GO:0005515; F:protein binding; IPI:IntAct
O95503	CBX6	Chromobox protein homolog 6	GO:0003727; F:single-stranded RNA binding; IEA:Ensembl
O95503	CBX6	Chromobox protein homolog 6	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
O95503	CBX6	Chromobox protein homolog 6	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
O95503	CBX6	Chromobox protein homolog 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95931	CBX7	Chromobox protein homolog 7	GO:0003682; F:chromatin binding; IEA:Ensembl
O95931	CBX7	Chromobox protein homolog 7	GO:0005515; F:protein binding; IPI:UniProtKB
O95931	CBX7	Chromobox protein homolog 7	GO:0003727; F:single-stranded RNA binding; IEA:Ensembl
O95931	CBX7	Chromobox protein homolog 7	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
O95931	CBX7	Chromobox protein homolog 7	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
O95931	CBX7	Chromobox protein homolog 7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HC52	CBX8	Chromobox protein homolog 8	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q9HC52	CBX8	Chromobox protein homolog 8	GO:0005515; F:protein binding; IPI:IntAct
Q9HC52	CBX8	Chromobox protein homolog 8	GO:0003727; F:single-stranded RNA binding; IEA:Ensembl
Q9HC52	CBX8	Chromobox protein homolog 8	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q9HC52	CBX8	Chromobox protein homolog 8	GO:0016574; P:histone ubiquitination; IEA:Ensembl
Q9HC52	CBX8	Chromobox protein homolog 8	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q9HC52	CBX8	Chromobox protein homolog 8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y3M2	CBY1	Protein chibby homolog 1	GO:0008013; F:beta-catenin binding; IDA:UniProtKB
Q9Y3M2	CBY1	Protein chibby homolog 1	GO:0042802; F:identical protein binding; IPI:UniProtKB
Q9Y3M2	CBY1	Protein chibby homolog 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y3M2	CBY1	Protein chibby homolog 1	GO:0055007; P:cardiac muscle cell differentiation; ISS:UniProtKB
Q9Y3M2	CBY1	Protein chibby homolog 1	GO:0042384; P:cilium assembly; IEA:Ensembl
Q9Y3M2	CBY1	Protein chibby homolog 1	GO:0045444; P:fat cell differentiation; ISS:UniProtKB
Q9Y3M2	CBY1	Protein chibby homolog 1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEA:Ensembl
Q9Y3M2	CBY1	Protein chibby homolog 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9Y3M2	CBY1	Protein chibby homolog 1	GO:0030178; P:negative regulation of Wnt signaling pathway; IDA:UniProtKB
Q9Y3M2	CBY1	Protein chibby homolog 1	GO:0008104; P:protein localization; IMP:UniProtKB
Q6P1S2	C3orf33	Protein C3orf33	GO:0016788; F:hydrolase activity, acting on ester bonds; IEA:InterPro
Q6P1S2	C3orf33	Protein C3orf33	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q6P1S2	C3orf33	Protein C3orf33	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
Q6P1S2	C3orf33	Protein C3orf33	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q5JPI3	C3orf38	Uncharacterized protein C3orf38	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8IW40	CCDC103	Coiled-coil domain-containing protein 103	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
Q8IW40	CCDC103	Coiled-coil domain-containing protein 103	GO:0070286; P:axonemal dynein complex assembly; IMP:BHF-UCL
Q8IW40	CCDC103	Coiled-coil domain-containing protein 103	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
Q8IW40	CCDC103	Coiled-coil domain-containing protein 103	GO:0003341; P:cilium movement; IGI:BHF-UCL
Q8IW40	CCDC103	Coiled-coil domain-containing protein 103	GO:0071907; P:determination of digestive tract left/right asymmetry; IMP:BHF-UCL
Q8IW40	CCDC103	Coiled-coil domain-containing protein 103	GO:0060287; P:epithelial cilium movement involved in determination of left/right asymmetry; IC:BHF-UCL
Q8IW40	CCDC103	Coiled-coil domain-containing protein 103	GO:0001947; P:heart looping; IMP:BHF-UCL
Q8IW40	CCDC103	Coiled-coil domain-containing protein 103	GO:0036159; P:inner dynein arm assembly; IGI:BHF-UCL
Q8IW40	CCDC103	Coiled-coil domain-containing protein 103	GO:0036158; P:outer dynein arm assembly; IGI:BHF-UCL
Q8IYK2	CCDC105	Coiled-coil domain-containing protein 105	GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro
Q9BWC9	CCDC106	Coiled-coil domain-containing protein 106	GO:0005515; F:protein binding; IPI:IntAct
Q6ZU64	CCDC108	Coiled-coil domain-containing protein 108	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6ZU64	CCDC108	Coiled-coil domain-containing protein 108	GO:0005198; F:structural molecule activity; IEA:InterPro
Q96M63	CCDC114	Coiled-coil domain-containing protein 114	GO:0036158; P:outer dynein arm assembly; IMP:UniProtKB
Q96CT7	CCDC124	Coiled-coil domain-containing protein 124	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96CT7	CCDC124	Coiled-coil domain-containing protein 124	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q96CT7	CCDC124	Coiled-coil domain-containing protein 124	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q96EE4	CCDC126	Coiled-coil domain-containing protein 126	GO:0030144; F:alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity; IEA:InterPro
Q96EE4	CCDC126	Coiled-coil domain-containing protein 126	GO:0006487; P:protein N-linked glycosylation; IEA:InterPro
P13994	CCDC130	Coiled-coil domain-containing protein 130	GO:0005515; F:protein binding; IPI:IntAct
P13994	CCDC130	Coiled-coil domain-containing protein 130	GO:0009615; P:response to virus; IEP:UniProtKB
Q8IY82	CCDC135	Coiled-coil domain-containing protein lobo homolog	GO:0097588; P:archaeal or bacterial-type flagellum-dependent cell motility; IEA:UniProtKB-KW
Q8IY82	CCDC135	Coiled-coil domain-containing protein lobo homolog	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8IY82	CCDC135	Coiled-coil domain-containing protein lobo homolog	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q6PK04	CCDC137	Coiled-coil domain-containing protein 137	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6ZP82	CCDC141	Coiled-coil domain-containing protein 141	GO:0005515; F:protein binding; IPI:IntAct
Q9UNH5	CDC14A	Dual specificity protein phosphatase CDC14A	GO:0004721; F:phosphoprotein phosphatase activity; TAS:ProtInc
Q9UNH5	CDC14A	Dual specificity protein phosphatase CDC14A	GO:0005515; F:protein binding; IPI:HGNC
Q9UNH5	CDC14A	Dual specificity protein phosphatase CDC14A	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q9UNH5	CDC14A	Dual specificity protein phosphatase CDC14A	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro
Q9UNH5	CDC14A	Dual specificity protein phosphatase CDC14A	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9UNH5	CDC14A	Dual specificity protein phosphatase CDC14A	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q9UNH5	CDC14A	Dual specificity protein phosphatase CDC14A	GO:0008283; P:cell proliferation; TAS:ProtInc
O60729	CDC14B	Dual specificity protein phosphatase CDC14B	GO:0005515; F:protein binding; IPI:IntAct
O60729	CDC14B	Dual specificity protein phosphatase CDC14B	GO:0004722; F:protein serine/threonine phosphatase activity; IDA:UniProtKB
O60729	CDC14B	Dual specificity protein phosphatase CDC14B	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
O60729	CDC14B	Dual specificity protein phosphatase CDC14B	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro
O60729	CDC14B	Dual specificity protein phosphatase CDC14B	GO:0051488; P:activation of anaphase-promoting complex activity; IMP:UniProtKB
O60729	CDC14B	Dual specificity protein phosphatase CDC14B	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
O60729	CDC14B	Dual specificity protein phosphatase CDC14B	GO:0031572; P:G2 DNA damage checkpoint; IDA:UniProtKB
O60729	CDC14B	Dual specificity protein phosphatase CDC14B	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:GOC
O60729	CDC14B	Dual specificity protein phosphatase CDC14B	GO:0006470; P:protein dephosphorylation; IMP:UniProtKB
A4D256	CDC14C	Dual specificity protein phosphatase CDC14C	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
A4D256	CDC14C	Dual specificity protein phosphatase CDC14C	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro
A5D8V7	CCDC151	Coiled-coil domain-containing protein 151	GO:0005515; F:protein binding; IPI:IntAct
A6NF36	CCDC182	Coiled-coil domain-containing protein 182	GO:0008585; P:female gonad development; ISS:UniProtKB
Q9BUN5	CCDC28B	Coiled-coil domain-containing protein 28B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BUN5	CCDC28B	Coiled-coil domain-containing protein 28B	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q8NHW4	CCL4L1	C-C motif chemokine 4-like	GO:0060326; P:cell chemotaxis; IEA:GOC
Q8NHW4	CCL4L1	C-C motif chemokine 4-like	GO:0006955; P:immune response; IEA:InterPro
Q8NHW4	CCL4L1	C-C motif chemokine 4-like	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q9NV96	TMEM30A	Cell cycle control protein 50A	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NV96	TMEM30A	Cell cycle control protein 50A	GO:0045332; P:phospholipid translocation; IEA:Ensembl
Q9NV96	TMEM30A	Cell cycle control protein 50A	GO:0070863; P:positive regulation of protein exit from endoplasmic reticulum; IDA:UniProtKB
Q9NV96	TMEM30A	Cell cycle control protein 50A	GO:0036010; P:protein localization to endosome; IMP:UniProtKB
Q3MIR4	TMEM30B	Cell cycle control protein 50B	GO:0005515; F:protein binding; IPI:UniProtKB
Q3MIR4	TMEM30B	Cell cycle control protein 50B	GO:0070863; P:positive regulation of protein exit from endoplasmic reticulum; IDA:UniProtKB
Q15834	CCDC85B	Coiled-coil domain-containing protein 85B	GO:0005515; F:protein binding; IPI:UniProtKB
Q15834	CCDC85B	Coiled-coil domain-containing protein 85B	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q15834	CCDC85B	Coiled-coil domain-containing protein 85B	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q15834	CCDC85B	Coiled-coil domain-containing protein 85B	GO:0045599; P:negative regulation of fat cell differentiation; ISS:UniProtKB
Q15834	CCDC85B	Coiled-coil domain-containing protein 85B	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q15834	CCDC85B	Coiled-coil domain-containing protein 85B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A6NKD9	CCDC85C	Coiled-coil domain-containing protein 85C	GO:0021987; P:cerebral cortex development; ISS:UniProtKB
Q8IX12	CCAR1	Cell division cycle and apoptosis regulator protein 1	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IGI:MGI
Q8IX12	CCAR1	Cell division cycle and apoptosis regulator protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IX12	CCAR1	Cell division cycle and apoptosis regulator protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q8IX12	CCAR1	Cell division cycle and apoptosis regulator protein 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8IX12	CCAR1	Cell division cycle and apoptosis regulator protein 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8IX12	CCAR1	Cell division cycle and apoptosis regulator protein 1	GO:0010467; P:gene expression; TAS:Reactome
Q8IX12	CCAR1	Cell division cycle and apoptosis regulator protein 1	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q8IX12	CCAR1	Cell division cycle and apoptosis regulator protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8IX12	CCAR1	Cell division cycle and apoptosis regulator protein 1	GO:0008380; P:RNA splicing; TAS:Reactome
Q8IX12	CCAR1	Cell division cycle and apoptosis regulator protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N163	CCAR2	Cell cycle and apoptosis regulator protein 2	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q8N163	CCAR2	Cell cycle and apoptosis regulator protein 2	GO:0004857; F:enzyme inhibitor activity; IDA:UniProtKB
Q8N163	CCAR2	Cell cycle and apoptosis regulator protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8N163	CCAR2	Cell cycle and apoptosis regulator protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N163	CCAR2	Cell cycle and apoptosis regulator protein 2	GO:0000993; F:RNA polymerase II core binding; IDA:UniProtKB
Q8N163	CCAR2	Cell cycle and apoptosis regulator protein 2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8N163	CCAR2	Cell cycle and apoptosis regulator protein 2	GO:0006974; P:cellular response to DNA damage stimulus; IEA:UniProtKB-KW
Q8N163	CCAR2	Cell cycle and apoptosis regulator protein 2	GO:0043653; P:mitochondrial fragmentation involved in apoptotic process; IDA:UniProtKB
Q8N163	CCAR2	Cell cycle and apoptosis regulator protein 2	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q8N163	CCAR2	Cell cycle and apoptosis regulator protein 2	GO:0043086; P:negative regulation of catalytic activity; IDA:GOC
Q8N163	CCAR2	Cell cycle and apoptosis regulator protein 2	GO:1902230; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; IMP:UniProtKB
Q8N163	CCAR2	Cell cycle and apoptosis regulator protein 2	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q8N163	CCAR2	Cell cycle and apoptosis regulator protein 2	GO:2000003; P:positive regulation of DNA damage checkpoint; IMP:UniProtKB
Q8N163	CCAR2	Cell cycle and apoptosis regulator protein 2	GO:0032784; P:regulation of DNA-templated transcription, elongation; IMP:UniProtKB
Q8N163	CCAR2	Cell cycle and apoptosis regulator protein 2	GO:0009411; P:response to UV; IMP:UniProtKB
Q8N163	CCAR2	Cell cycle and apoptosis regulator protein 2	GO:0008380; P:RNA splicing; IMP:UniProtKB
Q6UXH8	CCBE1	Collagen and calcium-binding EGF domain-containing protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q6UXH8	CCBE1	Collagen and calcium-binding EGF domain-containing protein 1	GO:0005518; F:collagen binding; IDA:MGI
Q6UXH8	CCBE1	Collagen and calcium-binding EGF domain-containing protein 1	GO:0001946; P:lymphangiogenesis; IMP:UniProtKB
Q6UXH8	CCBE1	Collagen and calcium-binding EGF domain-containing protein 1	GO:0010595; P:positive regulation of endothelial cell migration; IEA:Ensembl
Q6UXH8	CCBE1	Collagen and calcium-binding EGF domain-containing protein 1	GO:0002040; P:sprouting angiogenesis; ISS:UniProtKB
Q6UXH8	CCBE1	Collagen and calcium-binding EGF domain-containing protein 1	GO:0048845; P:venous blood vessel morphogenesis; ISS:UniProtKB
Q8WUD4	CCDC12	Coiled-coil domain-containing protein 12	GO:0005515; F:protein binding; IPI:IntAct
Q49A88	CCDC14	Coiled-coil domain-containing protein 14	GO:0021762; P:substantia nigra development; IEP:UniProt
Q8N300	CCDC23	Coiled-coil domain-containing protein 23	GO:0010596; P:negative regulation of endothelial cell migration; IGI:MGI
Q8N300	CCDC23	Coiled-coil domain-containing protein 23	GO:0031397; P:negative regulation of protein ubiquitination; IDA:MGI
Q8N300	CCDC23	Coiled-coil domain-containing protein 23	GO:0009306; P:protein secretion; IDA:MGI
Q8N5R6	CCDC33	Coiled-coil domain-containing protein 33	GO:0005515; F:protein binding; IPI:IntAct
Q9UFE4	CCDC39	Coiled-coil domain-containing protein 39	GO:0070286; P:axonemal dynein complex assembly; IMP:UniProtKB
Q9UFE4	CCDC39	Coiled-coil domain-containing protein 39	GO:0060285; P:cilium-dependent cell motility; IMP:UniProtKB
Q9UFE4	CCDC39	Coiled-coil domain-containing protein 39	GO:0071907; P:determination of digestive tract left/right asymmetry; IMP:BHF-UCL
Q9UFE4	CCDC39	Coiled-coil domain-containing protein 39	GO:0071910; P:determination of liver left/right asymmetry; IMP:BHF-UCL
Q9UFE4	CCDC39	Coiled-coil domain-containing protein 39	GO:0035469; P:determination of pancreatic left/right asymmetry; IMP:BHF-UCL
Q9UFE4	CCDC39	Coiled-coil domain-containing protein 39	GO:0060287; P:epithelial cilium movement involved in determination of left/right asymmetry; IMP:UniProtKB
Q9UFE4	CCDC39	Coiled-coil domain-containing protein 39	GO:0001947; P:heart looping; IMP:BHF-UCL
Q9UFE4	CCDC39	Coiled-coil domain-containing protein 39	GO:0030324; P:lung development; IMP:BHF-UCL
Q4G0X9	CCDC40	Coiled-coil domain-containing protein 40	GO:0070286; P:axonemal dynein complex assembly; IMP:UniProtKB
Q4G0X9	CCDC40	Coiled-coil domain-containing protein 40	GO:0071907; P:determination of digestive tract left/right asymmetry; IMP:BHF-UCL
Q4G0X9	CCDC40	Coiled-coil domain-containing protein 40	GO:0071910; P:determination of liver left/right asymmetry; IMP:BHF-UCL
Q4G0X9	CCDC40	Coiled-coil domain-containing protein 40	GO:0035469; P:determination of pancreatic left/right asymmetry; IMP:BHF-UCL
Q4G0X9	CCDC40	Coiled-coil domain-containing protein 40	GO:0003351; P:epithelial cilium movement; IMP:BHF-UCL
Q4G0X9	CCDC40	Coiled-coil domain-containing protein 40	GO:0060287; P:epithelial cilium movement involved in determination of left/right asymmetry; IMP:UniProtKB
Q4G0X9	CCDC40	Coiled-coil domain-containing protein 40	GO:0001947; P:heart looping; IMP:BHF-UCL
Q4G0X9	CCDC40	Coiled-coil domain-containing protein 40	GO:0030324; P:lung development; IMP:BHF-UCL
Q4G0X9	CCDC40	Coiled-coil domain-containing protein 40	GO:0003356; P:regulation of cilium beat frequency; IMP:BHF-UCL
Q96A33	CCDC47	Coiled-coil domain-containing protein 47	GO:0005509; F:calcium ion binding; IEA:Ensembl
Q96A33	CCDC47	Coiled-coil domain-containing protein 47	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96A33	CCDC47	Coiled-coil domain-containing protein 47	GO:0005515; F:protein binding; IPI:IntAct
Q96A33	CCDC47	Coiled-coil domain-containing protein 47	GO:0055074; P:calcium ion homeostasis; IEA:Ensembl
Q96A33	CCDC47	Coiled-coil domain-containing protein 47	GO:0009790; P:embryo development; IEA:Ensembl
Q96A33	CCDC47	Coiled-coil domain-containing protein 47	GO:0006983; P:ER overload response; IEA:Ensembl
Q96A33	CCDC47	Coiled-coil domain-containing protein 47	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q8IVM0	CCDC50	Coiled-coil domain-containing protein 50	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3C0	CCDC53	WASH complex subunit CCDC53	GO:0005515; F:protein binding; IPI:IntAct
A2RUB6	CCDC66	Coiled-coil domain-containing protein 66	GO:0060060; P:post-embryonic retina morphogenesis in camera-type eye; IEA:Ensembl
A2RUB6	CCDC66	Coiled-coil domain-containing protein 66	GO:0046548; P:retinal rod cell development; IEA:Ensembl
A2IDD5	CCDC78	Coiled-coil domain-containing protein 78	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
A2IDD5	CCDC78	Coiled-coil domain-containing protein 78	GO:0098535; P:de novo centriole assembly; IDA:UniProtKB
A2IDD5	CCDC78	Coiled-coil domain-containing protein 78	GO:0003009; P:skeletal muscle contraction; IMP:UniProtKB
Q76M96	CCDC80	Coiled-coil domain-containing protein 80	GO:0008201; F:heparin binding; IEA:Ensembl
Q76M96	CCDC80	Coiled-coil domain-containing protein 80	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q76M96	CCDC80	Coiled-coil domain-containing protein 80	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
Q9H6F5	CCDC86	Coiled-coil domain-containing protein 86	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H6F5	CCDC86	Coiled-coil domain-containing protein 86	GO:0005515; F:protein binding; IPI:IntAct
Q9H6F5	CCDC86	Coiled-coil domain-containing protein 86	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9NVE4	CCDC87	Coiled-coil domain-containing protein 87	GO:0000910; P:cytokinesis; IEA:InterPro
Q9NVE4	CCDC87	Coiled-coil domain-containing protein 87	GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro
Q7Z6B0	CCDC91	Coiled-coil domain-containing protein 91	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q53HC0	CCDC92	Coiled-coil domain-containing protein 92	GO:0005515; F:protein binding; IPI:UniProtKB
O95273	CCNDBP1	Cyclin-D1-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
O95273	CCNDBP1	Cyclin-D1-binding protein 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q16204	CCDC6	Coiled-coil domain-containing protein 6	GO:0005515; F:protein binding; IPI:IntAct
Q16204	CCDC6	Coiled-coil domain-containing protein 6	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
Q9H0W5	CCDC8	Coiled-coil domain-containing protein 8	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q9Y3X0	CCDC9	Coiled-coil domain-containing protein 9	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q06432	CACNG1	Voltage-dependent calcium channel gamma-1 subunit	GO:0005245; F:voltage-gated calcium channel activity; TAS:ProtInc
Q06432	CACNG1	Voltage-dependent calcium channel gamma-1 subunit	GO:0006936; P:muscle contraction; TAS:ProtInc
Q06432	CACNG1	Voltage-dependent calcium channel gamma-1 subunit	GO:0070296; P:sarcoplasmic reticulum calcium ion transport; IEA:Ensembl
Q06432	CACNG1	Voltage-dependent calcium channel gamma-1 subunit	GO:0006810; P:transport; TAS:ProtInc
Q9Y698	CACNG2	Voltage-dependent calcium channel gamma-2 subunit	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y698	CACNG2	Voltage-dependent calcium channel gamma-2 subunit	GO:0005245; F:voltage-gated calcium channel activity; TAS:ProtInc
Q9Y698	CACNG2	Voltage-dependent calcium channel gamma-2 subunit	GO:0051899; P:membrane depolarization; TAS:Reactome
Q9Y698	CACNG2	Voltage-dependent calcium channel gamma-2 subunit	GO:0060081; P:membrane hyperpolarization; IEA:Ensembl
Q9Y698	CACNG2	Voltage-dependent calcium channel gamma-2 subunit	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
Q9Y698	CACNG2	Voltage-dependent calcium channel gamma-2 subunit	GO:2000311; P:regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; ISS:UniProtKB
Q9Y698	CACNG2	Voltage-dependent calcium channel gamma-2 subunit	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9Y698	CACNG2	Voltage-dependent calcium channel gamma-2 subunit	GO:0019226; P:transmission of nerve impulse; IEA:Ensembl
Q9Y698	CACNG2	Voltage-dependent calcium channel gamma-2 subunit	GO:0006810; P:transport; TAS:ProtInc
O60359	CACNG3	Voltage-dependent calcium channel gamma-3 subunit	GO:0005245; F:voltage-gated calcium channel activity; NAS:UniProtKB
O60359	CACNG3	Voltage-dependent calcium channel gamma-3 subunit	GO:0006816; P:calcium ion transport; NAS:UniProtKB
O60359	CACNG3	Voltage-dependent calcium channel gamma-3 subunit	GO:2000311; P:regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; ISS:UniProtKB
O60359	CACNG3	Voltage-dependent calcium channel gamma-3 subunit	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9UBN1	CACNG4	Voltage-dependent calcium channel gamma-4 subunit	GO:0005245; F:voltage-gated calcium channel activity; TAS:ProtInc
Q9UBN1	CACNG4	Voltage-dependent calcium channel gamma-4 subunit	GO:0051899; P:membrane depolarization; TAS:Reactome
Q9UBN1	CACNG4	Voltage-dependent calcium channel gamma-4 subunit	GO:2000311; P:regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; IDA:UniProtKB
Q9UBN1	CACNG4	Voltage-dependent calcium channel gamma-4 subunit	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9UBN1	CACNG4	Voltage-dependent calcium channel gamma-4 subunit	GO:0019226; P:transmission of nerve impulse; IEA:Ensembl
Q9UBN1	CACNG4	Voltage-dependent calcium channel gamma-4 subunit	GO:0006810; P:transport; TAS:ProtInc
Q9UF02	CACNG5	Voltage-dependent calcium channel gamma-5 subunit	GO:0015075; F:ion transmembrane transporter activity; TAS:ProtInc
Q9UF02	CACNG5	Voltage-dependent calcium channel gamma-5 subunit	GO:0005245; F:voltage-gated calcium channel activity; TAS:ProtInc
Q9UF02	CACNG5	Voltage-dependent calcium channel gamma-5 subunit	GO:2000311; P:regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; ISS:UniProtKB
Q9UF02	CACNG5	Voltage-dependent calcium channel gamma-5 subunit	GO:0006810; P:transport; TAS:ProtInc
Q9BXT2	CACNG6	Voltage-dependent calcium channel gamma-6 subunit	GO:0005245; F:voltage-gated calcium channel activity; NAS:UniProtKB
Q9BXT2	CACNG6	Voltage-dependent calcium channel gamma-6 subunit	GO:0006816; P:calcium ion transport; NAS:UniProtKB
P62955	CACNG7	Voltage-dependent calcium channel gamma-7 subunit	GO:0005245; F:voltage-gated calcium channel activity; NAS:UniProtKB
P62955	CACNG7	Voltage-dependent calcium channel gamma-7 subunit	GO:0006816; P:calcium ion transport; NAS:UniProtKB
P62955	CACNG7	Voltage-dependent calcium channel gamma-7 subunit	GO:2000311; P:regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; IDA:UniProtKB
Q8WXS5	CACNG8	Voltage-dependent calcium channel gamma-8 subunit	GO:0005245; F:voltage-gated calcium channel activity; NAS:UniProtKB
Q8WXS5	CACNG8	Voltage-dependent calcium channel gamma-8 subunit	GO:0006816; P:calcium ion transport; NAS:UniProtKB
Q8WXS5	CACNG8	Voltage-dependent calcium channel gamma-8 subunit	GO:2000311; P:regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; IDA:UniProtKB
Q8WXS5	CACNG8	Voltage-dependent calcium channel gamma-8 subunit	GO:0007268; P:synaptic transmission; TAS:Reactome
Q8WXS4	TMEM37	Voltage-dependent calcium channel gamma-like subunit	GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW
Q8WXS4	TMEM37	Voltage-dependent calcium channel gamma-like subunit	GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW
Q8TD31	CCHCR1	Coiled-coil alpha-helical rod protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8TD31	CCHCR1	Coiled-coil alpha-helical rod protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8TD31	CCHCR1	Coiled-coil alpha-helical rod protein 1	GO:0006611; P:protein export from nucleus; IEA:Ensembl
P53701	HCCS	Cytochrome c-type heme lyase	GO:0004408; F:holocytochrome-c synthase activity; TAS:ProtInc
P53701	HCCS	Cytochrome c-type heme lyase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P53701	HCCS	Cytochrome c-type heme lyase	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P53701	HCCS	Cytochrome c-type heme lyase	GO:0055114; P:oxidation-reduction process; TAS:ProtInc
P32238	CCKAR	Cholecystokinin receptor type A	GO:0004951; F:cholecystokinin receptor activity; TAS:ProtInc
P32238	CCKAR	Cholecystokinin receptor type A	GO:0007409; P:axonogenesis; IEA:Ensembl
P32238	CCKAR	Cholecystokinin receptor type A	GO:0038188; P:cholecystokinin signaling pathway; TAS:GOC
P32238	CCKAR	Cholecystokinin receptor type A	GO:0007586; P:digestion; TAS:ProtInc
P32238	CCKAR	Cholecystokinin receptor type A	GO:0007631; P:feeding behavior; TAS:ProtInc
P32238	CCKAR	Cholecystokinin receptor type A	GO:0030900; P:forebrain development; IEA:Ensembl
P32238	CCKAR	Cholecystokinin receptor type A	GO:0001764; P:neuron migration; IEA:Ensembl
P32238	CCKAR	Cholecystokinin receptor type A	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; TAS:ProtInc
P32238	CCKAR	Cholecystokinin receptor type A	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
P32238	CCKAR	Cholecystokinin receptor type A	GO:0007584; P:response to nutrient; TAS:ProtInc
P06307	CCK	Cholecystokinin	GO:0005179; F:hormone activity; TAS:ProtInc
P06307	CCK	Cholecystokinin	GO:0005184; F:neuropeptide hormone activity; ISS:UniProtKB
P06307	CCK	Cholecystokinin	GO:0005515; F:protein binding; IPI:IntAct
P06307	CCK	Cholecystokinin	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
P06307	CCK	Cholecystokinin	GO:0007409; P:axonogenesis; ISS:UniProtKB
P06307	CCK	Cholecystokinin	GO:0001662; P:behavioral fear response; IEA:Ensembl
P06307	CCK	Cholecystokinin	GO:0042755; P:eating behavior; ISS:UniProtKB
P06307	CCK	Cholecystokinin	GO:0032099; P:negative regulation of appetite; IEA:Ensembl
P06307	CCK	Cholecystokinin	GO:0001764; P:neuron migration; ISS:UniProtKB
P06307	CCK	Cholecystokinin	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P06307	CCK	Cholecystokinin	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P06307	CCK	Cholecystokinin	GO:0051901; P:positive regulation of mitochondrial depolarization; IEA:Ensembl
P06307	CCK	Cholecystokinin	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
P06307	CCK	Cholecystokinin	GO:0032461; P:positive regulation of protein oligomerization; IEA:Ensembl
P06307	CCK	Cholecystokinin	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P06307	CCK	Cholecystokinin	GO:0051930; P:regulation of sensory perception of pain; IEA:Ensembl
P06307	CCK	Cholecystokinin	GO:0001836; P:release of cytochrome c from mitochondria; IEA:Ensembl
P06307	CCK	Cholecystokinin	GO:0007165; P:signal transduction; TAS:ProtInc
P51671	CCL11	Eotaxin	GO:0008009; F:chemokine activity; IDA:UniProtKB
P51671	CCL11	Eotaxin	GO:0005515; F:protein binding; IPI:IntAct
P51671	CCL11	Eotaxin	GO:0007015; P:actin filament organization; IEA:Ensembl
P51671	CCL11	Eotaxin	GO:0060444; P:branching involved in mammary gland duct morphogenesis; IEA:Ensembl
P51671	CCL11	Eotaxin	GO:0007155; P:cell adhesion; TAS:ProtInc
P51671	CCL11	Eotaxin	GO:0006874; P:cellular calcium ion homeostasis; TAS:ProtInc
P51671	CCL11	Eotaxin	GO:0006935; P:chemotaxis; TAS:ProtInc
P51671	CCL11	Eotaxin	GO:0002544; P:chronic inflammatory response; IEA:Ensembl
P51671	CCL11	Eotaxin	GO:0007010; P:cytoskeleton organization; IDA:UniProtKB
P51671	CCL11	Eotaxin	GO:0048245; P:eosinophil chemotaxis; IDA:UniProtKB
P51671	CCL11	Eotaxin	GO:0070371; P:ERK1 and ERK2 cascade; IEA:Ensembl
P51671	CCL11	Eotaxin	GO:0006955; P:immune response; IEA:InterPro
P51671	CCL11	Eotaxin	GO:0006954; P:inflammatory response; TAS:ProtInc
P51671	CCL11	Eotaxin	GO:0060763; P:mammary duct terminal end bud growth; IEA:Ensembl
P51671	CCL11	Eotaxin	GO:0002551; P:mast cell chemotaxis; IEA:Ensembl
P51671	CCL11	Eotaxin	GO:0030838; P:positive regulation of actin filament polymerization; IDA:BHF-UCL
P51671	CCL11	Eotaxin	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
P51671	CCL11	Eotaxin	GO:0030335; P:positive regulation of cell migration; IDA:BHF-UCL
P51671	CCL11	Eotaxin	GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:BHF-UCL
P51671	CCL11	Eotaxin	GO:0032855; P:positive regulation of Rac GTPase activity; IDA:BHF-UCL
P51671	CCL11	Eotaxin	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P51671	CCL11	Eotaxin	GO:0008360; P:regulation of cell shape; IDA:UniProtKB
P51671	CCL11	Eotaxin	GO:0070670; P:response to interleukin-4; IEA:Ensembl
P51671	CCL11	Eotaxin	GO:0009314; P:response to radiation; TAS:ProtInc
P51671	CCL11	Eotaxin	GO:0009615; P:response to virus; TAS:ProtInc
P51671	CCL11	Eotaxin	GO:0007165; P:signal transduction; TAS:ProtInc
Q99616	CCL13	C-C motif chemokine 13	GO:0008009; F:chemokine activity; IDA:UniProtKB
Q99616	CCL13	C-C motif chemokine 13	GO:0005102; F:receptor binding; TAS:ProtInc
Q99616	CCL13	C-C motif chemokine 13	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q99616	CCL13	C-C motif chemokine 13	GO:0006874; P:cellular calcium ion homeostasis; TAS:ProtInc
Q99616	CCL13	C-C motif chemokine 13	GO:0006935; P:chemotaxis; TAS:ProtInc
Q99616	CCL13	C-C motif chemokine 13	GO:0007010; P:cytoskeleton organization; IDA:UniProtKB
Q99616	CCL13	C-C motif chemokine 13	GO:0048245; P:eosinophil chemotaxis; IDA:UniProtKB
Q99616	CCL13	C-C motif chemokine 13	GO:0006955; P:immune response; IEA:InterPro
Q99616	CCL13	C-C motif chemokine 13	GO:0006954; P:inflammatory response; TAS:ProtInc
Q99616	CCL13	C-C motif chemokine 13	GO:0008360; P:regulation of cell shape; IDA:UniProtKB
Q99616	CCL13	C-C motif chemokine 13	GO:0007165; P:signal transduction; TAS:ProtInc
Q16627	CCL14	C-C motif chemokine 14	GO:0060326; P:cell chemotaxis; IEA:GOC
Q16627	CCL14	C-C motif chemokine 14	GO:0006874; P:cellular calcium ion homeostasis; TAS:ProtInc
Q16627	CCL14	C-C motif chemokine 14	GO:0006955; P:immune response; IEA:InterPro
Q16627	CCL14	C-C motif chemokine 14	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
O15467	CCL16	C-C motif chemokine 16	GO:0042056; F:chemoattractant activity; IDA:UniProtKB
O15467	CCL16	C-C motif chemokine 16	GO:0008009; F:chemokine activity; TAS:ProtInc
O15467	CCL16	C-C motif chemokine 16	GO:0060326; P:cell chemotaxis; TAS:GOC
O15467	CCL16	C-C motif chemokine 16	GO:0007154; P:cell communication; TAS:ProtInc
O15467	CCL16	C-C motif chemokine 16	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O15467	CCL16	C-C motif chemokine 16	GO:0006935; P:chemotaxis; TAS:ProtInc
O15467	CCL16	C-C motif chemokine 16	GO:0006955; P:immune response; IEA:InterPro
O15467	CCL16	C-C motif chemokine 16	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
O15467	CCL16	C-C motif chemokine 16	GO:0050918; P:positive chemotaxis; IDA:GOC
Q16663	CCL15	C-C motif chemokine 15	GO:0042056; F:chemoattractant activity; IDA:UniProtKB
Q16663	CCL15	C-C motif chemokine 15	GO:0008009; F:chemokine activity; TAS:ProtInc
Q16663	CCL15	C-C motif chemokine 15	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
Q16663	CCL15	C-C motif chemokine 15	GO:0005102; F:receptor binding; TAS:ProtInc
Q16663	CCL15	C-C motif chemokine 15	GO:0060326; P:cell chemotaxis; TAS:GOC
Q16663	CCL15	C-C motif chemokine 15	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q16663	CCL15	C-C motif chemokine 15	GO:0006874; P:cellular calcium ion homeostasis; TAS:ProtInc
Q16663	CCL15	C-C motif chemokine 15	GO:0006935; P:chemotaxis; TAS:ProtInc
Q16663	CCL15	C-C motif chemokine 15	GO:0006955; P:immune response; IEA:InterPro
Q16663	CCL15	C-C motif chemokine 15	GO:0050918; P:positive chemotaxis; IDA:GOC
Q16663	CCL15	C-C motif chemokine 15	GO:0007165; P:signal transduction; TAS:ProtInc
Q92583	CCL17	C-C motif chemokine 17	GO:0008009; F:chemokine activity; TAS:ProtInc
Q92583	CCL17	C-C motif chemokine 17	GO:0005102; F:receptor binding; TAS:ProtInc
Q92583	CCL17	C-C motif chemokine 17	GO:0060326; P:cell chemotaxis; TAS:GOC
Q92583	CCL17	C-C motif chemokine 17	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q92583	CCL17	C-C motif chemokine 17	GO:0006935; P:chemotaxis; TAS:ProtInc
Q92583	CCL17	C-C motif chemokine 17	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q92583	CCL17	C-C motif chemokine 17	GO:0006955; P:immune response; IEA:InterPro
Q92583	CCL17	C-C motif chemokine 17	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q92583	CCL17	C-C motif chemokine 17	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P55774	CCL18	C-C motif chemokine 18	GO:0008009; F:chemokine activity; TAS:ProtInc
P55774	CCL18	C-C motif chemokine 18	GO:0005515; F:protein binding; IPI:IntAct
P55774	CCL18	C-C motif chemokine 18	GO:0060326; P:cell chemotaxis; TAS:GOC
P55774	CCL18	C-C motif chemokine 18	GO:0007154; P:cell communication; TAS:ProtInc
P55774	CCL18	C-C motif chemokine 18	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P55774	CCL18	C-C motif chemokine 18	GO:0006935; P:chemotaxis; TAS:ProtInc
P55774	CCL18	C-C motif chemokine 18	GO:0006955; P:immune response; TAS:ProtInc
P55774	CCL18	C-C motif chemokine 18	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
P55774	CCL18	C-C motif chemokine 18	GO:0009607; P:response to biotic stimulus; TAS:ProtInc
P55774	CCL18	C-C motif chemokine 18	GO:0007165; P:signal transduction; TAS:ProtInc
P22362	CCL1	C-C motif chemokine 1	GO:0008009; F:chemokine activity; TAS:ProtInc
P22362	CCL1	C-C motif chemokine 1	GO:0060326; P:cell chemotaxis; TAS:GOC
P22362	CCL1	C-C motif chemokine 1	GO:0006874; P:cellular calcium ion homeostasis; TAS:ProtInc
P22362	CCL1	C-C motif chemokine 1	GO:0006935; P:chemotaxis; TAS:ProtInc
P22362	CCL1	C-C motif chemokine 1	GO:0006955; P:immune response; IEA:InterPro
P22362	CCL1	C-C motif chemokine 1	GO:0007165; P:signal transduction; TAS:ProtInc
P22362	CCL1	C-C motif chemokine 1	GO:0016032; P:viral process; TAS:ProtInc
Q99731	CCL19	C-C motif chemokine 19	GO:0048020; F:CCR chemokine receptor binding; IPI:UniProtKB
Q99731	CCL19	C-C motif chemokine 19	GO:0031735; F:CCR10 chemokine receptor binding; IDA:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0031732; F:CCR7 chemokine receptor binding; ISS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0008009; F:chemokine activity; IDA:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0042379; F:chemokine receptor binding; IDA:UniProtKB
Q99731	CCL19	C-C motif chemokine 19	GO:0007257; P:activation of JUN kinase activity; ISS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0007154; P:cell communication; TAS:ProtInc
Q99731	CCL19	C-C motif chemokine 19	GO:0048469; P:cell maturation; ISS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0006874; P:cellular calcium ion homeostasis; TAS:ProtInc
Q99731	CCL19	C-C motif chemokine 19	GO:0002407; P:dendritic cell chemotaxis; IDA:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0001768; P:establishment of T cell polarity; IDA:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0006955; P:immune response; TAS:ProtInc
Q99731	CCL19	C-C motif chemokine 19	GO:0001771; P:immunological synapse formation; ISS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0006954; P:inflammatory response; NAS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0072610; P:interleukin-12 secretion; ISS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0097029; P:mature dendritic cell differentiation; ISS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0002408; P:myeloid dendritic cell chemotaxis; IDA:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:2000107; P:negative regulation of leukocyte apoptotic process; IDA:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0043089; P:positive regulation of Cdc42 GTPase activity; ISS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:2000147; P:positive regulation of cell motility; IDA:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0050921; P:positive regulation of chemotaxis; ISS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0002606; P:positive regulation of dendritic cell antigen processing and presentation; ISS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:2000549; P:positive regulation of dendritic cell dendrite assembly; ISS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0045807; P:positive regulation of endocytosis; ISS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0010560; P:positive regulation of glycoprotein biosynthetic process; ISS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0050718; P:positive regulation of interleukin-1 beta secretion; ISS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0032735; P:positive regulation of interleukin-12 production; ISS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0046330; P:positive regulation of JNK cascade; IDA:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0090023; P:positive regulation of neutrophil chemotaxis; IDA:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0042346; P:positive regulation of NF-kappaB import into nucleus; IDA:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IDA:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0045860; P:positive regulation of protein kinase activity; IDA:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0032320; P:positive regulation of Ras GTPase activity; ISS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0048260; P:positive regulation of receptor-mediated endocytosis; ISS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0042102; P:positive regulation of T cell proliferation; ISS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0045627; P:positive regulation of T-helper 1 cell differentiation; ISS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0032760; P:positive regulation of tumor necrosis factor production; ISS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0060491; P:regulation of cell projection assembly; ISS:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0051209; P:release of sequestered calcium ion into cytosol; IDA:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0071731; P:response to nitric oxide; IDA:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
Q99731	CCL19	C-C motif chemokine 19	GO:0034695; P:response to prostaglandin E; IDA:BHF-UCL
Q99731	CCL19	C-C motif chemokine 19	GO:0009615; P:response to virus; TAS:ProtInc
Q99731	CCL19	C-C motif chemokine 19	GO:0031295; P:T cell costimulation; ISS:BHF-UCL
P78556	CCL20	C-C motif chemokine 20	GO:0008009; F:chemokine activity; TAS:ProtInc
P78556	CCL20	C-C motif chemokine 20	GO:0005515; F:protein binding; IPI:IntAct
P78556	CCL20	C-C motif chemokine 20	GO:0060326; P:cell chemotaxis; TAS:GOC
P78556	CCL20	C-C motif chemokine 20	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P78556	CCL20	C-C motif chemokine 20	GO:0042466; P:chemokinesis; IEA:Ensembl
P78556	CCL20	C-C motif chemokine 20	GO:0006935; P:chemotaxis; TAS:ProtInc
P78556	CCL20	C-C motif chemokine 20	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
P78556	CCL20	C-C motif chemokine 20	GO:0006955; P:immune response; TAS:ProtInc
P78556	CCL20	C-C motif chemokine 20	GO:0006954; P:inflammatory response; TAS:ProtInc
P78556	CCL20	C-C motif chemokine 20	GO:0007165; P:signal transduction; TAS:ProtInc
O00585	CCL21	C-C motif chemokine 21	GO:0031732; F:CCR7 chemokine receptor binding; ISS:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0008009; F:chemokine activity; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0042379; F:chemokine receptor binding; IDA:UniProtKB
O00585	CCL21	C-C motif chemokine 21	GO:0032862; P:activation of Rho GTPase activity; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0048469; P:cell maturation; ISS:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O00585	CCL21	C-C motif chemokine 21	GO:0002407; P:dendritic cell chemotaxis; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0097026; P:dendritic cell dendrite assembly; ISS:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0001768; P:establishment of T cell polarity; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0006955; P:immune response; TAS:ProtInc
O00585	CCL21	C-C motif chemokine 21	GO:0001771; P:immunological synapse formation; ISS:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0006954; P:inflammatory response; NAS:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0035759; P:mesangial cell-matrix adhesion; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:2000548; P:negative regulation of dendritic cell dendrite assembly; ISS:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:2000107; P:negative regulation of leukocyte apoptotic process; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0030838; P:positive regulation of actin filament polymerization; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0033630; P:positive regulation of cell adhesion mediated by integrin; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:2000147; P:positive regulation of cell motility; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0001954; P:positive regulation of cell-matrix adhesion; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0050921; P:positive regulation of chemotaxis; ISS:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0002606; P:positive regulation of dendritic cell antigen processing and presentation; ISS:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0051491; P:positive regulation of filopodium assembly; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0010560; P:positive regulation of glycoprotein biosynthetic process; ISS:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0046330; P:positive regulation of JNK cascade; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:2000529; P:positive regulation of myeloid dendritic cell chemotaxis; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0090023; P:positive regulation of neutrophil chemotaxis; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0045860; P:positive regulation of protein kinase activity; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0031274; P:positive regulation of pseudopodium assembly; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0048260; P:positive regulation of receptor-mediated endocytosis; ISS:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0051209; P:release of sequestered calcium ion into cytosol; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0034695; P:response to prostaglandin E; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0031529; P:ruffle organization; IDA:BHF-UCL
O00585	CCL21	C-C motif chemokine 21	GO:0031295; P:T cell costimulation; ISS:BHF-UCL
O00626	CCL22	C-C motif chemokine 22	GO:0008009; F:chemokine activity; TAS:ProtInc
O00626	CCL22	C-C motif chemokine 22	GO:0060326; P:cell chemotaxis; TAS:GOC
O00626	CCL22	C-C motif chemokine 22	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O00626	CCL22	C-C motif chemokine 22	GO:0006935; P:chemotaxis; TAS:ProtInc
O00626	CCL22	C-C motif chemokine 22	GO:0006955; P:immune response; TAS:ProtInc
O00626	CCL22	C-C motif chemokine 22	GO:0006954; P:inflammatory response; TAS:ProtInc
O00626	CCL22	C-C motif chemokine 22	GO:0009615; P:response to virus; TAS:ProtInc
O00626	CCL22	C-C motif chemokine 22	GO:0007165; P:signal transduction; TAS:ProtInc
P55773	CCL23	C-C motif chemokine 23	GO:0031726; F:CCR1 chemokine receptor binding; IPI:UniProtKB
P55773	CCL23	C-C motif chemokine 23	GO:0008009; F:chemokine activity; IDA:UniProtKB
P55773	CCL23	C-C motif chemokine 23	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P55773	CCL23	C-C motif chemokine 23	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P55773	CCL23	C-C motif chemokine 23	GO:0006874; P:cellular calcium ion homeostasis; TAS:ProtInc
P55773	CCL23	C-C motif chemokine 23	GO:0006935; P:chemotaxis; TAS:ProtInc
P55773	CCL23	C-C motif chemokine 23	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P55773	CCL23	C-C motif chemokine 23	GO:0006955; P:immune response; TAS:ProtInc
P55773	CCL23	C-C motif chemokine 23	GO:0006954; P:inflammatory response; TAS:ProtInc
P55773	CCL23	C-C motif chemokine 23	GO:0002548; P:monocyte chemotaxis; IC:UniProtKB
P55773	CCL23	C-C motif chemokine 23	GO:2001264; P:negative regulation of C-C chemokine binding; IDA:UniProtKB
P55773	CCL23	C-C motif chemokine 23	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P55773	CCL23	C-C motif chemokine 23	GO:0007165; P:signal transduction; NAS:ProtInc
O00175	CCL24	C-C motif chemokine 24	GO:0008009; F:chemokine activity; IDA:UniProtKB
O00175	CCL24	C-C motif chemokine 24	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O00175	CCL24	C-C motif chemokine 24	GO:0006935; P:chemotaxis; TAS:ProtInc
O00175	CCL24	C-C motif chemokine 24	GO:0007010; P:cytoskeleton organization; IDA:UniProtKB
O00175	CCL24	C-C motif chemokine 24	GO:0048245; P:eosinophil chemotaxis; IDA:UniProtKB
O00175	CCL24	C-C motif chemokine 24	GO:0006955; P:immune response; TAS:ProtInc
O00175	CCL24	C-C motif chemokine 24	GO:0006954; P:inflammatory response; TAS:ProtInc
O00175	CCL24	C-C motif chemokine 24	GO:0030838; P:positive regulation of actin filament polymerization; IDA:BHF-UCL
O00175	CCL24	C-C motif chemokine 24	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
O00175	CCL24	C-C motif chemokine 24	GO:0030335; P:positive regulation of cell migration; IDA:BHF-UCL
O00175	CCL24	C-C motif chemokine 24	GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:BHF-UCL
O00175	CCL24	C-C motif chemokine 24	GO:2000418; P:positive regulation of eosinophil migration; IEA:Ensembl
O00175	CCL24	C-C motif chemokine 24	GO:0050729; P:positive regulation of inflammatory response; IEA:Ensembl
O00175	CCL24	C-C motif chemokine 24	GO:0032855; P:positive regulation of Rac GTPase activity; IDA:BHF-UCL
O00175	CCL24	C-C motif chemokine 24	GO:0008360; P:regulation of cell shape; IDA:UniProtKB
O00175	CCL24	C-C motif chemokine 24	GO:0007165; P:signal transduction; TAS:ProtInc
O15444	CCL25	C-C motif chemokine 25	GO:0031735; F:CCR10 chemokine receptor binding; IDA:BHF-UCL
O15444	CCL25	C-C motif chemokine 25	GO:0008009; F:chemokine activity; TAS:ProtInc
O15444	CCL25	C-C motif chemokine 25	GO:0042379; F:chemokine receptor binding; IDA:UniProtKB
O15444	CCL25	C-C motif chemokine 25	GO:0005179; F:hormone activity; TAS:ProtInc
O15444	CCL25	C-C motif chemokine 25	GO:0060326; P:cell chemotaxis; TAS:GOC
O15444	CCL25	C-C motif chemokine 25	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
O15444	CCL25	C-C motif chemokine 25	GO:0006935; P:chemotaxis; TAS:ProtInc
O15444	CCL25	C-C motif chemokine 25	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
O15444	CCL25	C-C motif chemokine 25	GO:0006955; P:immune response; TAS:ProtInc
O15444	CCL25	C-C motif chemokine 25	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
O15444	CCL25	C-C motif chemokine 25	GO:0050900; P:leukocyte migration; IEA:Ensembl
Q9Y258	CCL26	C-C motif chemokine 26	GO:0008009; F:chemokine activity; TAS:ProtInc
Q9Y258	CCL26	C-C motif chemokine 26	GO:0060326; P:cell chemotaxis; TAS:GOC
Q9Y258	CCL26	C-C motif chemokine 26	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9Y258	CCL26	C-C motif chemokine 26	GO:0006935; P:chemotaxis; TAS:ProtInc
Q9Y258	CCL26	C-C motif chemokine 26	GO:0006955; P:immune response; TAS:ProtInc
Q9Y258	CCL26	C-C motif chemokine 26	GO:0006954; P:inflammatory response; TAS:ProtInc
Q9Y258	CCL26	C-C motif chemokine 26	GO:0030838; P:positive regulation of actin filament polymerization; IDA:BHF-UCL
Q9Y258	CCL26	C-C motif chemokine 26	GO:0030335; P:positive regulation of cell migration; IDA:BHF-UCL
Q9Y258	CCL26	C-C motif chemokine 26	GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:BHF-UCL
Q9Y258	CCL26	C-C motif chemokine 26	GO:0032855; P:positive regulation of Rac GTPase activity; IDA:BHF-UCL
Q9Y258	CCL26	C-C motif chemokine 26	GO:0007165; P:signal transduction; NAS:ProtInc
Q9Y4X3	CCL27	C-C motif chemokine 27	GO:0008009; F:chemokine activity; TAS:ProtInc
Q9Y4X3	CCL27	C-C motif chemokine 27	GO:0060326; P:cell chemotaxis; TAS:GOC
Q9Y4X3	CCL27	C-C motif chemokine 27	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9Y4X3	CCL27	C-C motif chemokine 27	GO:0006935; P:chemotaxis; TAS:ProtInc
Q9Y4X3	CCL27	C-C motif chemokine 27	GO:0006955; P:immune response; TAS:ProtInc
Q9NRJ3	CCL28	C-C motif chemokine 28	GO:0008009; F:chemokine activity; TAS:UniProtKB
Q9NRJ3	CCL28	C-C motif chemokine 28	GO:0060326; P:cell chemotaxis; TAS:GOC
Q9NRJ3	CCL28	C-C motif chemokine 28	GO:0006935; P:chemotaxis; TAS:UniProtKB
Q9NRJ3	CCL28	C-C motif chemokine 28	GO:0006955; P:immune response; IEA:InterPro
Q9NRJ3	CCL28	C-C motif chemokine 28	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
Q9NRJ3	CCL28	C-C motif chemokine 28	GO:0007584; P:response to nutrient; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0031727; F:CCR2 chemokine receptor binding; ISS:BHF-UCL
P13500	CCL2	C-C motif chemokine 2	GO:0008009; F:chemokine activity; TAS:ProtInc
P13500	CCL2	C-C motif chemokine 2	GO:0008201; F:heparin binding; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0004672; F:protein kinase activity; TAS:ProtInc
P13500	CCL2	C-C motif chemokine 2	GO:0005102; F:receptor binding; TAS:ProtInc
P13500	CCL2	C-C motif chemokine 2	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P13500	CCL2	C-C motif chemokine 2	GO:0007568; P:aging; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0001525; P:angiogenesis; TAS:BHF-UCL
P13500	CCL2	C-C motif chemokine 2	GO:0043615; P:astrocyte cell migration; IDA:BHF-UCL
P13500	CCL2	C-C motif chemokine 2	GO:0007155; P:cell adhesion; TAS:ProtInc
P13500	CCL2	C-C motif chemokine 2	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P13500	CCL2	C-C motif chemokine 2	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0019725; P:cellular homeostasis; TAS:BHF-UCL
P13500	CCL2	C-C motif chemokine 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P13500	CCL2	C-C motif chemokine 2	GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEP:UniProtKB
P13500	CCL2	C-C motif chemokine 2	GO:0071346; P:cellular response to interferon-gamma; IEP:UniProtKB
P13500	CCL2	C-C motif chemokine 2	GO:0071347; P:cellular response to interleukin-1; IEP:UniProtKB
P13500	CCL2	C-C motif chemokine 2	GO:0071222; P:cellular response to lipopolysaccharide; ISS:BHF-UCL
P13500	CCL2	C-C motif chemokine 2	GO:0071407; P:cellular response to organic cyclic compound; IDA:UniProtKB
P13500	CCL2	C-C motif chemokine 2	GO:0071356; P:cellular response to tumor necrosis factor; IEP:UniProtKB
P13500	CCL2	C-C motif chemokine 2	GO:0070098; P:chemokine-mediated signaling pathway; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0006935; P:chemotaxis; TAS:ProtInc
P13500	CCL2	C-C motif chemokine 2	GO:0019221; P:cytokine-mediated signaling pathway; IDA:BHF-UCL
P13500	CCL2	C-C motif chemokine 2	GO:0007010; P:cytoskeleton organization; IDA:UniProtKB
P13500	CCL2	C-C motif chemokine 2	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P13500	CCL2	C-C motif chemokine 2	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P13500	CCL2	C-C motif chemokine 2	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P13500	CCL2	C-C motif chemokine 2	GO:0035684; P:helper T cell extravasation; ISS:BHF-UCL
P13500	CCL2	C-C motif chemokine 2	GO:0006959; P:humoral immune response; TAS:ProtInc
P13500	CCL2	C-C motif chemokine 2	GO:0006954; P:inflammatory response; IDA:UniProtKB
P13500	CCL2	C-C motif chemokine 2	GO:0007259; P:JAK-STAT cascade; TAS:ProtInc
P13500	CCL2	C-C motif chemokine 2	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IDA:UniProtKB
P13500	CCL2	C-C motif chemokine 2	GO:0048247; P:lymphocyte chemotaxis; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0048246; P:macrophage chemotaxis; IDA:BHF-UCL
P13500	CCL2	C-C motif chemokine 2	GO:0000165; P:MAPK cascade; IMP:UniProtKB
P13500	CCL2	C-C motif chemokine 2	GO:0060137; P:maternal process involved in parturition; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0002548; P:monocyte chemotaxis; IDA:BHF-UCL
P13500	CCL2	C-C motif chemokine 2	GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0034351; P:negative regulation of glial cell apoptotic process; IDA:UniProtKB
P13500	CCL2	C-C motif chemokine 2	GO:2000502; P:negative regulation of natural killer cell chemotaxis; IDA:UniProtKB
P13500	CCL2	C-C motif chemokine 2	GO:0043524; P:negative regulation of neuron apoptotic process; IDA:UniProtKB
P13500	CCL2	C-C motif chemokine 2	GO:0030593; P:neutrophil chemotaxis; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P13500	CCL2	C-C motif chemokine 2	GO:0031100; P:organ regeneration; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:2000427; P:positive regulation of apoptotic cell clearance; ISS:BHF-UCL
P13500	CCL2	C-C motif chemokine 2	GO:0090280; P:positive regulation of calcium ion import; IDA:BHF-UCL
P13500	CCL2	C-C motif chemokine 2	GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0090265; P:positive regulation of immune complex clearance by monocytes and macrophages; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0010759; P:positive regulation of macrophage chemotaxis; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; ISS:BHF-UCL
P13500	CCL2	C-C motif chemokine 2	GO:0050806; P:positive regulation of synaptic transmission; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0050870; P:positive regulation of T cell activation; ISS:BHF-UCL
P13500	CCL2	C-C motif chemokine 2	GO:0043491; P:protein kinase B signaling; IMP:UniProtKB
P13500	CCL2	C-C motif chemokine 2	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P13500	CCL2	C-C motif chemokine 2	GO:0008360; P:regulation of cell shape; IDA:UniProtKB
P13500	CCL2	C-C motif chemokine 2	GO:0010574; P:regulation of vascular endothelial growth factor production; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0014823; P:response to activity; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0043200; P:response to amino acid; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0046677; P:response to antibiotic; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0009617; P:response to bacterium; IEP:BHF-UCL
P13500	CCL2	C-C motif chemokine 2	GO:0042493; P:response to drug; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0045471; P:response to ethanol; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0010332; P:response to gamma radiation; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0009408; P:response to heat; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0001666; P:response to hypoxia; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0032570; P:response to progesterone; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0033552; P:response to vitamin B3; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0007165; P:signal transduction; NAS:ProtInc
P13500	CCL2	C-C motif chemokine 2	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IEA:Ensembl
P13500	CCL2	C-C motif chemokine 2	GO:0019079; P:viral genome replication; TAS:ProtInc
P10147	CCL3	C-C motif chemokine 3	GO:0004698; F:calcium-dependent protein kinase C activity; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0031726; F:CCR1 chemokine receptor binding; IPI:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0031730; F:CCR5 chemokine receptor binding; IPI:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0042056; F:chemoattractant activity; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0008009; F:chemokine activity; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0042802; F:identical protein binding; IPI:IntAct
P10147	CCL3	C-C motif chemokine 3	GO:0016301; F:kinase activity; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0016004; F:phospholipase activator activity; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0005515; F:protein binding; IPI:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0004672; F:protein kinase activity; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0043615; P:astrocyte cell migration; ISS:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0007610; P:behavior; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0006816; P:calcium ion transport; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0019722; P:calcium-mediated signaling; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0001775; P:cell activation; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0007267; P:cell-cell signaling; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0006874; P:cellular calcium ion homeostasis; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0071346; P:cellular response to interferon-gamma; IEP:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0071347; P:cellular response to interleukin-1; IEP:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0071407; P:cellular response to organic cyclic compound; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0071356; P:cellular response to tumor necrosis factor; IEP:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0006935; P:chemotaxis; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0007010; P:cytoskeleton organization; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0048245; P:eosinophil chemotaxis; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0043308; P:eosinophil degranulation; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0006887; P:exocytosis; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0071621; P:granulocyte chemotaxis; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0006954; P:inflammatory response; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0048247; P:lymphocyte chemotaxis; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0048246; P:macrophage chemotaxis; ISS:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0000165; P:MAPK cascade; IMP:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0002548; P:monocyte chemotaxis; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0043922; P:negative regulation by host of viral transcription; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0030502; P:negative regulation of bone mineralization; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0045671; P:negative regulation of osteoclast differentiation; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0030593; P:neutrophil chemotaxis; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0001649; P:osteoblast differentiation; IEP:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0050918; P:positive chemotaxis; IDA:GOC
P10147	CCL3	C-C motif chemokine 3	GO:0090280; P:positive regulation of calcium ion import; TAS:BHF-UCL
P10147	CCL3	C-C motif chemokine 3	GO:0051928; P:positive regulation of calcium ion transport; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0050850; P:positive regulation of calcium-mediated signaling; IMP:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0043085; P:positive regulation of catalytic activity; IDA:GOC
P10147	CCL3	C-C motif chemokine 3	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0050729; P:positive regulation of inflammatory response; ISS:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0050718; P:positive regulation of interleukin-1 beta secretion; ISS:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:2000503; P:positive regulation of natural killer cell chemotaxis; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0043525; P:positive regulation of neuron apoptotic process; ISS:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0051897; P:positive regulation of protein kinase B signaling; IEP:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0032760; P:positive regulation of tumor necrosis factor production; ISS:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0043491; P:protein kinase B signaling; IMP:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0006468; P:protein phosphorylation; IDA:GOC
P10147	CCL3	C-C motif chemokine 3	GO:0008360; P:regulation of cell shape; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0051930; P:regulation of sensory perception of pain; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0014808; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0070723; P:response to cholesterol; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0009636; P:response to toxic substance; IDA:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0023052; P:signaling; IEP:UniProtKB
P10147	CCL3	C-C motif chemokine 3	GO:0010818; P:T cell chemotaxis; IDA:UniProtKB
P13236	CCL4	C-C motif chemokine 4	GO:0031726; F:CCR1 chemokine receptor binding; IPI:UniProtKB
P13236	CCL4	C-C motif chemokine 4	GO:0031730; F:CCR5 chemokine receptor binding; IPI:UniProtKB
P13236	CCL4	C-C motif chemokine 4	GO:0008009; F:chemokine activity; TAS:ProtInc
P13236	CCL4	C-C motif chemokine 4	GO:0005125; F:cytokine activity; TAS:ProtInc
P13236	CCL4	C-C motif chemokine 4	GO:0042802; F:identical protein binding; IPI:IntAct
P13236	CCL4	C-C motif chemokine 4	GO:0005515; F:protein binding; IPI:IntAct
P13236	CCL4	C-C motif chemokine 4	GO:0007155; P:cell adhesion; TAS:ProtInc
P13236	CCL4	C-C motif chemokine 4	GO:0060326; P:cell chemotaxis; TAS:GOC
P13236	CCL4	C-C motif chemokine 4	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P13236	CCL4	C-C motif chemokine 4	GO:0006928; P:cellular component movement; TAS:ProtInc
P13236	CCL4	C-C motif chemokine 4	GO:0007163; P:establishment or maintenance of cell polarity; TAS:ProtInc
P13236	CCL4	C-C motif chemokine 4	GO:0006955; P:immune response; TAS:ProtInc
P13236	CCL4	C-C motif chemokine 4	GO:0006954; P:inflammatory response; TAS:ProtInc
P13236	CCL4	C-C motif chemokine 4	GO:0043922; P:negative regulation by host of viral transcription; IDA:UniProtKB
P13236	CCL4	C-C motif chemokine 4	GO:0051928; P:positive regulation of calcium ion transport; IDA:UniProtKB
P13236	CCL4	C-C motif chemokine 4	GO:0050850; P:positive regulation of calcium-mediated signaling; IMP:UniProtKB
P13236	CCL4	C-C motif chemokine 4	GO:2000503; P:positive regulation of natural killer cell chemotaxis; IDA:UniProtKB
P13236	CCL4	C-C motif chemokine 4	GO:0009636; P:response to toxic substance; IDA:UniProtKB
P13236	CCL4	C-C motif chemokine 4	GO:0009615; P:response to virus; TAS:ProtInc
P13236	CCL4	C-C motif chemokine 4	GO:0007165; P:signal transduction; TAS:ProtInc
P13501	CCL5	C-C motif chemokine 5	GO:0031726; F:CCR1 chemokine receptor binding; IPI:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0031729; F:CCR4 chemokine receptor binding; TAS:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0031730; F:CCR5 chemokine receptor binding; IPI:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0042056; F:chemoattractant activity; IDA:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0008009; F:chemokine activity; NAS:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0046817; F:chemokine receptor antagonist activity; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0042379; F:chemokine receptor binding; IPI:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0004435; F:phosphatidylinositol phospholipase C activity; IDA:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0016004; F:phospholipase activator activity; IDA:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0005515; F:protein binding; IPI:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0004672; F:protein kinase activity; IDA:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0043621; F:protein self-association; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0030298; F:receptor signaling protein tyrosine kinase activator activity; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0031584; P:activation of phospholipase D activity; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0006816; P:calcium ion transport; IDA:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0007267; P:cell-cell signaling; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0006874; P:cellular calcium ion homeostasis; IDA:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0043623; P:cellular protein complex assembly; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEP:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0071346; P:cellular response to interferon-gamma; IEP:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0071347; P:cellular response to interleukin-1; IEP:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0071407; P:cellular response to organic cyclic compound; IDA:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0071356; P:cellular response to tumor necrosis factor; IEP:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0070098; P:chemokine-mediated signaling pathway; TAS:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0006935; P:chemotaxis; NAS:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0002407; P:dendritic cell chemotaxis; TAS:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0048245; P:eosinophil chemotaxis; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0006887; P:exocytosis; IDA:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0006954; P:inflammatory response; IDA:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0007159; P:leukocyte cell-cell adhesion; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IDA:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0048246; P:macrophage chemotaxis; TAS:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0000165; P:MAPK cascade; IMP:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0002548; P:monocyte chemotaxis; IC:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0043922; P:negative regulation by host of viral transcription; IDA:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0070100; P:negative regulation of chemokine-mediated signaling pathway; IDA:GOC
P13501	CCL5	C-C motif chemokine 5	GO:0045744; P:negative regulation of G-protein coupled receptor protein signaling pathway; IDA:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:2000110; P:negative regulation of macrophage apoptotic process; IEA:Ensembl
P13501	CCL5	C-C motif chemokine 5	GO:0070233; P:negative regulation of T cell apoptotic process; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0045071; P:negative regulation of viral genome replication; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0042119; P:neutrophil activation; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0050918; P:positive chemotaxis; IDA:GOC
P13501	CCL5	C-C motif chemokine 5	GO:0010535; P:positive regulation of activation of JAK2 kinase activity; TAS:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0051928; P:positive regulation of calcium ion transport; IDA:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0045785; P:positive regulation of cell adhesion; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0033634; P:positive regulation of cell-cell adhesion mediated by integrin; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0031328; P:positive regulation of cellular biosynthetic process; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
P13501	CCL5	C-C motif chemokine 5	GO:0034112; P:positive regulation of homotypic cell-cell adhesion; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0045089; P:positive regulation of innate immune response; TAS:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0046427; P:positive regulation of JAK-STAT cascade; TAS:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0010759; P:positive regulation of macrophage chemotaxis; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0090026; P:positive regulation of monocyte chemotaxis; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:2000503; P:positive regulation of natural killer cell chemotaxis; IDA:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0042327; P:positive regulation of phosphorylation; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0061098; P:positive regulation of protein tyrosine kinase activity; IDA:GOC
P13501	CCL5	C-C motif chemokine 5	GO:0014911; P:positive regulation of smooth muscle cell migration; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0070234; P:positive regulation of T cell apoptotic process; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0010820; P:positive regulation of T cell chemotaxis; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0042102; P:positive regulation of T cell proliferation; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0045948; P:positive regulation of translational initiation; NAS:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0045070; P:positive regulation of viral genome replication; TAS:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0043491; P:protein kinase B signaling; IMP:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0006468; P:protein phosphorylation; IDA:GOC
P13501	CCL5	C-C motif chemokine 5	GO:0051262; P:protein tetramerization; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0002676; P:regulation of chronic inflammatory response; TAS:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0050863; P:regulation of T cell activation; IDA:BHF-UCL
P13501	CCL5	C-C motif chemokine 5	GO:0009636; P:response to toxic substance; IDA:UniProtKB
P13501	CCL5	C-C motif chemokine 5	GO:0009615; P:response to virus; TAS:BHF-UCL
P80098	CCL7	C-C motif chemokine 7	GO:0031726; F:CCR1 chemokine receptor binding; IPI:UniProtKB
P80098	CCL7	C-C motif chemokine 7	GO:0008009; F:chemokine activity; IDA:UniProtKB
P80098	CCL7	C-C motif chemokine 7	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P80098	CCL7	C-C motif chemokine 7	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P80098	CCL7	C-C motif chemokine 7	GO:0006874; P:cellular calcium ion homeostasis; TAS:ProtInc
P80098	CCL7	C-C motif chemokine 7	GO:0071361; P:cellular response to ethanol; IEA:Ensembl
P80098	CCL7	C-C motif chemokine 7	GO:0006935; P:chemotaxis; TAS:ProtInc
P80098	CCL7	C-C motif chemokine 7	GO:0007010; P:cytoskeleton organization; IDA:UniProtKB
P80098	CCL7	C-C motif chemokine 7	GO:0048245; P:eosinophil chemotaxis; IDA:UniProtKB
P80098	CCL7	C-C motif chemokine 7	GO:0006955; P:immune response; IEA:InterPro
P80098	CCL7	C-C motif chemokine 7	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
P80098	CCL7	C-C motif chemokine 7	GO:0002548; P:monocyte chemotaxis; IC:UniProtKB
P80098	CCL7	C-C motif chemokine 7	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
P80098	CCL7	C-C motif chemokine 7	GO:2000503; P:positive regulation of natural killer cell chemotaxis; IDA:UniProtKB
P80098	CCL7	C-C motif chemokine 7	GO:0008360; P:regulation of cell shape; IDA:UniProtKB
P80098	CCL7	C-C motif chemokine 7	GO:0010332; P:response to gamma radiation; IEA:Ensembl
P80098	CCL7	C-C motif chemokine 7	GO:0007165; P:signal transduction; TAS:ProtInc
P80075	CCL8	C-C motif chemokine 8	GO:0008009; F:chemokine activity; TAS:ProtInc
P80075	CCL8	C-C motif chemokine 8	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P80075	CCL8	C-C motif chemokine 8	GO:0016004; F:phospholipase activator activity; IDA:UniProtKB
P80075	CCL8	C-C motif chemokine 8	GO:0004672; F:protein kinase activity; IDA:UniProtKB
P80075	CCL8	C-C motif chemokine 8	GO:0006816; P:calcium ion transport; IDA:UniProtKB
P80075	CCL8	C-C motif chemokine 8	GO:0060326; P:cell chemotaxis; TAS:GOC
P80075	CCL8	C-C motif chemokine 8	GO:0007267; P:cell-cell signaling; IDA:UniProtKB
P80075	CCL8	C-C motif chemokine 8	GO:0006874; P:cellular calcium ion homeostasis; IDA:UniProtKB
P80075	CCL8	C-C motif chemokine 8	GO:0006935; P:chemotaxis; TAS:ProtInc
P80075	CCL8	C-C motif chemokine 8	GO:0006887; P:exocytosis; IDA:UniProtKB
P80075	CCL8	C-C motif chemokine 8	GO:0006955; P:immune response; IEA:InterPro
P80075	CCL8	C-C motif chemokine 8	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
P80075	CCL8	C-C motif chemokine 8	GO:0043085; P:positive regulation of catalytic activity; IDA:GOC
P80075	CCL8	C-C motif chemokine 8	GO:0006468; P:protein phosphorylation; IDA:GOC
P80075	CCL8	C-C motif chemokine 8	GO:0009615; P:response to virus; TAS:ProtInc
P80075	CCL8	C-C motif chemokine 8	GO:0007165; P:signal transduction; TAS:ProtInc
Q9BSQ5	CCM2	Malcavernin	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BSQ5	CCM2	Malcavernin	GO:0060837; P:blood vessel endothelial cell differentiation; IEA:Ensembl
Q9BSQ5	CCM2	Malcavernin	GO:0045216; P:cell-cell junction organization; IEA:Ensembl
Q9BSQ5	CCM2	Malcavernin	GO:0001885; P:endothelial cell development; IEA:Ensembl
Q9BSQ5	CCM2	Malcavernin	GO:0061154; P:endothelial tube morphogenesis; IMP:MGI
Q9BSQ5	CCM2	Malcavernin	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9BSQ5	CCM2	Malcavernin	GO:0048839; P:inner ear development; IEA:Ensembl
Q9BSQ5	CCM2	Malcavernin	GO:0007229; P:integrin-mediated signaling pathway; TAS:UniProtKB
Q9BSQ5	CCM2	Malcavernin	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q9BSQ5	CCM2	Malcavernin	GO:0060039; P:pericardium development; IEA:Ensembl
Q9BSQ5	CCM2	Malcavernin	GO:0051403; P:stress-activated MAPK cascade; TAS:UniProtKB
Q9BSQ5	CCM2	Malcavernin	GO:0001570; P:vasculogenesis; IMP:UniProtKB
Q9BSQ5	CCM2	Malcavernin	GO:0048845; P:venous blood vessel morphogenesis; IEA:Ensembl
P78396	CCNA1	Cyclin-A1	GO:0005515; F:protein binding; IPI:IntAct
P78396	CCNA1	Cyclin-A1	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P78396	CCNA1	Cyclin-A1	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P78396	CCNA1	Cyclin-A1	GO:0007141; P:male meiosis I; TAS:ProtInc
P78396	CCNA1	Cyclin-A1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P78396	CCNA1	Cyclin-A1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P78396	CCNA1	Cyclin-A1	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:InterPro
P78396	CCNA1	Cyclin-A1	GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; IEA:InterPro
P78396	CCNA1	Cyclin-A1	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; TAS:Reactome
P78396	CCNA1	Cyclin-A1	GO:0007283; P:spermatogenesis; TAS:ProtInc
P20248	CCNA2	Cyclin-A2	GO:0005515; F:protein binding; IPI:IntAct
P20248	CCNA2	Cyclin-A2	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P20248	CCNA2	Cyclin-A2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P20248	CCNA2	Cyclin-A2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P20248	CCNA2	Cyclin-A2	GO:0007095; P:mitotic G2 DNA damage checkpoint; TAS:ProtInc
P20248	CCNA2	Cyclin-A2	GO:0031100; P:organ regeneration; IEA:Ensembl
P20248	CCNA2	Cyclin-A2	GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl
P20248	CCNA2	Cyclin-A2	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P20248	CCNA2	Cyclin-A2	GO:0007265; P:Ras protein signal transduction; IEP:BHF-UCL
P20248	CCNA2	Cyclin-A2	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:InterPro
P20248	CCNA2	Cyclin-A2	GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; IEA:InterPro
P20248	CCNA2	Cyclin-A2	GO:0032355; P:response to estradiol; IEA:Ensembl
P20248	CCNA2	Cyclin-A2	GO:0033762; P:response to glucagon; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0016301; F:kinase activity; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0005113; F:patched binding; IPI:BHF-UCL
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0005515; F:protein binding; IPI:IntAct
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0071398; P:cellular response to fatty acid; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0071283; P:cellular response to iron(III) ion; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0048565; P:digestive tract development; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0007080; P:mitotic metaphase plate congression; IMP:BHF-UCL
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0071174; P:mitotic spindle checkpoint; IMP:BHF-UCL
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0043148; P:mitotic spindle stabilization; IMP:BHF-UCL
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0001556; P:oocyte maturation; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0051987; P:positive regulation of attachment of spindle microtubules to kinetochore; IMP:BHF-UCL
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0060045; P:positive regulation of cardiac muscle cell proliferation; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0033129; P:positive regulation of histone phosphorylation; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0045931; P:positive regulation of mitotic cell cycle; IMP:BHF-UCL
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0031442; P:positive regulation of mRNA 3'-end processing; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0006461; P:protein complex assembly; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0006468; P:protein phosphorylation; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0051726; P:regulation of cell cycle; TAS:Reactome
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0060623; P:regulation of chromosome condensation; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:InterPro
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0046680; P:response to DDT; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0042493; P:response to drug; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0007283; P:spermatogenesis; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0042246; P:tissue regeneration; IEA:Ensembl
P14635	CCNB1	G2/mitotic-specific cyclin-B1	GO:0055015; P:ventricular cardiac muscle cell development; IEA:Ensembl
O95067	CCNB2	G2/mitotic-specific cyclin-B2	GO:0005515; F:protein binding; IPI:IntAct
O95067	CCNB2	G2/mitotic-specific cyclin-B2	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
O95067	CCNB2	G2/mitotic-specific cyclin-B2	GO:0040007; P:growth; IEA:Ensembl
O95067	CCNB2	G2/mitotic-specific cyclin-B2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O95067	CCNB2	G2/mitotic-specific cyclin-B2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
O95067	CCNB2	G2/mitotic-specific cyclin-B2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O95067	CCNB2	G2/mitotic-specific cyclin-B2	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
O95067	CCNB2	G2/mitotic-specific cyclin-B2	GO:0051726; P:regulation of cell cycle; TAS:Reactome
O95067	CCNB2	G2/mitotic-specific cyclin-B2	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:InterPro
O95067	CCNB2	G2/mitotic-specific cyclin-B2	GO:0043029; P:T cell homeostasis; IEA:Ensembl
O95067	CCNB2	G2/mitotic-specific cyclin-B2	GO:0048538; P:thymus development; IEA:Ensembl
Q8WWL7	CCNB3	G2/mitotic-specific cyclin-B3	GO:0005515; F:protein binding; IPI:IntAct
Q8WWL7	CCNB3	G2/mitotic-specific cyclin-B3	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q8WWL7	CCNB3	G2/mitotic-specific cyclin-B3	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:InterPro
Q8WWL7	CCNB3	G2/mitotic-specific cyclin-B3	GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; IEA:InterPro
P24863	CCNC	Cyclin-C	GO:0005515; F:protein binding; IPI:IntAct
P24863	CCNC	Cyclin-C	GO:0010467; P:gene expression; TAS:Reactome
P24863	CCNC	Cyclin-C	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P24863	CCNC	Cyclin-C	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
P24863	CCNC	Cyclin-C	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:InterPro
P24863	CCNC	Cyclin-C	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P24863	CCNC	Cyclin-C	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
P24863	CCNC	Cyclin-C	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P30279	CCND2	G1/S-specific cyclin-D2	GO:0005515; F:protein binding; IPI:IntAct
P30279	CCND2	G1/S-specific cyclin-D2	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
P30279	CCND2	G1/S-specific cyclin-D2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P30279	CCND2	G1/S-specific cyclin-D2	GO:0051301; P:cell division; IEA:UniProtKB-KW
P30279	CCND2	G1/S-specific cyclin-D2	GO:0045737; P:positive regulation of cyclin-dependent protein kinase activity; IDA:BHF-UCL
P30279	CCND2	G1/S-specific cyclin-D2	GO:0001934; P:positive regulation of protein phosphorylation; IDA:BHF-UCL
P30281	CCND3	G1/S-specific cyclin-D3	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:Ensembl
P30281	CCND3	G1/S-specific cyclin-D3	GO:0005515; F:protein binding; IPI:IntAct
P30281	CCND3	G1/S-specific cyclin-D3	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
P30281	CCND3	G1/S-specific cyclin-D3	GO:0051301; P:cell division; IEA:UniProtKB-KW
P30281	CCND3	G1/S-specific cyclin-D3	GO:0045737; P:positive regulation of cyclin-dependent protein kinase activity; IDA:BHF-UCL
P30281	CCND3	G1/S-specific cyclin-D3	GO:0001934; P:positive regulation of protein phosphorylation; IDA:BHF-UCL
P30281	CCND3	G1/S-specific cyclin-D3	GO:0007165; P:signal transduction; IEA:Ensembl
P30281	CCND3	G1/S-specific cyclin-D3	GO:0042098; P:T cell proliferation; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0016538; F:cyclin-dependent protein serine/threonine kinase regulator activity; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0019899; F:enzyme binding; IPI:UniProtKB
P24385	CCND1	G1/S-specific cyclin-D1	GO:0042826; F:histone deacetylase binding; IPI:UniProtKB
P24385	CCND1	G1/S-specific cyclin-D1	GO:0070064; F:proline-rich region binding; IDA:UniProtKB
P24385	CCND1	G1/S-specific cyclin-D1	GO:0005515; F:protein binding; IPI:UniProtKB
P24385	CCND1	G1/S-specific cyclin-D1	GO:0004672; F:protein kinase activity; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P24385	CCND1	G1/S-specific cyclin-D1	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
P24385	CCND1	G1/S-specific cyclin-D1	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P24385	CCND1	G1/S-specific cyclin-D1	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0051301; P:cell division; IEA:UniProtKB-KW
P24385	CCND1	G1/S-specific cyclin-D1	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
P24385	CCND1	G1/S-specific cyclin-D1	GO:0030968; P:endoplasmic reticulum unfolded protein response; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0045444; P:fat cell differentiation; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0000082; P:G1/S transition of mitotic cell cycle; IDA:UniProtKB
P24385	CCND1	G1/S-specific cyclin-D1	GO:0007595; P:lactation; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0033327; P:Leydig cell differentiation; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0001889; P:liver development; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0060749; P:mammary gland alveolus development; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0033598; P:mammary gland epithelial cell proliferation; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P24385	CCND1	G1/S-specific cyclin-D1	GO:0031571; P:mitotic G1 DNA damage checkpoint; IDA:UniProtKB
P24385	CCND1	G1/S-specific cyclin-D1	GO:0071157; P:negative regulation of cell cycle arrest; IDA:UniProtKB
P24385	CCND1	G1/S-specific cyclin-D1	GO:0030857; P:negative regulation of epithelial cell differentiation; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P24385	CCND1	G1/S-specific cyclin-D1	GO:0030178; P:negative regulation of Wnt signaling pathway; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P24385	CCND1	G1/S-specific cyclin-D1	GO:0031100; P:organ regeneration; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0045737; P:positive regulation of cyclin-dependent protein kinase activity; IDA:BHF-UCL
P24385	CCND1	G1/S-specific cyclin-D1	GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IDA:UniProtKB
P24385	CCND1	G1/S-specific cyclin-D1	GO:0033601; P:positive regulation of mammary gland epithelial cell proliferation; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0001934; P:positive regulation of protein phosphorylation; IDA:BHF-UCL
P24385	CCND1	G1/S-specific cyclin-D1	GO:0000320; P:re-entry into mitotic cell cycle; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0051592; P:response to calcium ion; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0051412; P:response to corticosterone; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0042493; P:response to drug; IEP:UniProtKB
P24385	CCND1	G1/S-specific cyclin-D1	GO:0043627; P:response to estrogen; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0045471; P:response to ethanol; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0010039; P:response to iron ion; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0032026; P:response to magnesium ion; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0010243; P:response to organonitrogen compound; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0070141; P:response to UV-A; IDA:BHF-UCL
P24385	CCND1	G1/S-specific cyclin-D1	GO:0033197; P:response to vitamin E; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0010165; P:response to X-ray; IEA:Ensembl
P24385	CCND1	G1/S-specific cyclin-D1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P24864	CCNE1	G1/S-specific cyclin-E1	GO:0050681; F:androgen receptor binding; NAS:UniProtKB
P24864	CCNE1	G1/S-specific cyclin-E1	GO:0016538; F:cyclin-dependent protein serine/threonine kinase regulator activity; IEA:Ensembl
P24864	CCNE1	G1/S-specific cyclin-E1	GO:0016301; F:kinase activity; IEA:Ensembl
P24864	CCNE1	G1/S-specific cyclin-E1	GO:0005515; F:protein binding; IPI:UniProtKB
P24864	CCNE1	G1/S-specific cyclin-E1	GO:0003713; F:transcription coactivator activity; NAS:UniProtKB
P24864	CCNE1	G1/S-specific cyclin-E1	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
P24864	CCNE1	G1/S-specific cyclin-E1	GO:0051301; P:cell division; IEA:UniProtKB-KW
P24864	CCNE1	G1/S-specific cyclin-E1	GO:0006270; P:DNA replication initiation; IEA:Ensembl
P24864	CCNE1	G1/S-specific cyclin-E1	GO:0000082; P:G1/S transition of mitotic cell cycle; NAS:UniProtKB
P24864	CCNE1	G1/S-specific cyclin-E1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P24864	CCNE1	G1/S-specific cyclin-E1	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
P24864	CCNE1	G1/S-specific cyclin-E1	GO:0006468; P:protein phosphorylation; IMP:MGI
P24864	CCNE1	G1/S-specific cyclin-E1	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:InterPro
P24864	CCNE1	G1/S-specific cyclin-E1	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; TAS:Reactome
P24864	CCNE1	G1/S-specific cyclin-E1	GO:0016055; P:Wnt signaling pathway; IEA:Ensembl
O96020	CCNE2	G1/S-specific cyclin-E2	GO:0016538; F:cyclin-dependent protein serine/threonine kinase regulator activity; IEA:Ensembl
O96020	CCNE2	G1/S-specific cyclin-E2	GO:0005515; F:protein binding; IPI:IntAct
O96020	CCNE2	G1/S-specific cyclin-E2	GO:0000075; P:cell cycle checkpoint; TAS:ProtInc
O96020	CCNE2	G1/S-specific cyclin-E2	GO:0051301; P:cell division; IEA:UniProtKB-KW
O96020	CCNE2	G1/S-specific cyclin-E2	GO:0006270; P:DNA replication initiation; IEA:Ensembl
O96020	CCNE2	G1/S-specific cyclin-E2	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
O96020	CCNE2	G1/S-specific cyclin-E2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O96020	CCNE2	G1/S-specific cyclin-E2	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
P41002	CCNF	Cyclin-F	GO:0005515; F:protein binding; IPI:UniProtKB
P41002	CCNF	Cyclin-F	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P41002	CCNF	Cyclin-F	GO:0010826; P:negative regulation of centrosome duplication; IDA:UniProtKB
P41002	CCNF	Cyclin-F	GO:0001890; P:placenta development; IEA:Ensembl
P41002	CCNF	Cyclin-F	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
P41002	CCNF	Cyclin-F	GO:0000320; P:re-entry into mitotic cell cycle; IEA:Ensembl
P41002	CCNF	Cyclin-F	GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
P51959	CCNG1	Cyclin-G1	GO:0005515; F:protein binding; IPI:IntAct
P51959	CCNG1	Cyclin-G1	GO:0007420; P:brain development; IEA:Ensembl
P51959	CCNG1	Cyclin-G1	GO:0016049; P:cell growth; IEA:Ensembl
P51959	CCNG1	Cyclin-G1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P51959	CCNG1	Cyclin-G1	GO:0007095; P:mitotic G2 DNA damage checkpoint; IEA:Ensembl
P51959	CCNG1	Cyclin-G1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P51959	CCNG1	Cyclin-G1	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
P51959	CCNG1	Cyclin-G1	GO:0010243; P:response to organonitrogen compound; IEA:Ensembl
P51959	CCNG1	Cyclin-G1	GO:0006949; P:syncytium formation; IEA:Ensembl
Q16589	CCNG2	Cyclin-G2	GO:0000075; P:cell cycle checkpoint; TAS:ProtInc
Q16589	CCNG2	Cyclin-G2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q16589	CCNG2	Cyclin-G2	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
P51946	CCNH	Cyclin-H	GO:0016538; F:cyclin-dependent protein serine/threonine kinase regulator activity; IEA:InterPro
P51946	CCNH	Cyclin-H	GO:0016301; F:kinase activity; IEA:Ensembl
P51946	CCNH	Cyclin-H	GO:0005515; F:protein binding; IPI:IntAct
P51946	CCNH	Cyclin-H	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
P51946	CCNH	Cyclin-H	GO:0006200; P:ATP catabolic process; IDA:GOC
P51946	CCNH	Cyclin-H	GO:0006281; P:DNA repair; TAS:Reactome
P51946	CCNH	Cyclin-H	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P51946	CCNH	Cyclin-H	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P51946	CCNH	Cyclin-H	GO:0010467; P:gene expression; TAS:Reactome
P51946	CCNH	Cyclin-H	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P51946	CCNH	Cyclin-H	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P51946	CCNH	Cyclin-H	GO:0000718; P:nucleotide-excision repair, DNA damage removal; TAS:Reactome
P51946	CCNH	Cyclin-H	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P51946	CCNH	Cyclin-H	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P51946	CCNH	Cyclin-H	GO:0006468; P:protein phosphorylation; IDA:GOC
P51946	CCNH	Cyclin-H	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:InterPro
P51946	CCNH	Cyclin-H	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
P51946	CCNH	Cyclin-H	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
P51946	CCNH	Cyclin-H	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P51946	CCNH	Cyclin-H	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
P51946	CCNH	Cyclin-H	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
P51946	CCNH	Cyclin-H	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
P51946	CCNH	Cyclin-H	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P51946	CCNH	Cyclin-H	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P51946	CCNH	Cyclin-H	GO:0016032; P:viral process; TAS:Reactome
Q6ZMN8	CCNI2	Cyclin-I2	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:InterPro
Q14094	CCNI	Cyclin-I	GO:0007283; P:spermatogenesis; NAS:UniProtKB
O75909	CCNK	Cyclin-K	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IDA:MGI
O75909	CCNK	Cyclin-K	GO:0005515; F:protein binding; IPI:IntAct
O75909	CCNK	Cyclin-K	GO:0019901; F:protein kinase binding; IPI:MGI
O75909	CCNK	Cyclin-K	GO:0008353; F:RNA polymerase II carboxy-terminal domain kinase activity; IDA:MGI
O75909	CCNK	Cyclin-K	GO:0006974; P:cellular response to DNA damage stimulus; IMP:MGI
O75909	CCNK	Cyclin-K	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O75909	CCNK	Cyclin-K	GO:0007067; P:mitosis; IEA:UniProtKB-KW
O75909	CCNK	Cyclin-K	GO:0071157; P:negative regulation of cell cycle arrest; IGI:MGI
O75909	CCNK	Cyclin-K	GO:0006468; P:protein phosphorylation; IDA:GOC
O75909	CCNK	Cyclin-K	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
O75909	CCNK	Cyclin-K	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O75909	CCNK	Cyclin-K	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9UK58	CCNL1	Cyclin-L1	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:InterPro
Q9UK58	CCNL1	Cyclin-L1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UK58	CCNL1	Cyclin-L1	GO:0006396; P:RNA processing; IEA:InterPro
Q9UK58	CCNL1	Cyclin-L1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96S94	CCNL2	Cyclin-L2	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:InterPro
Q96S94	CCNL2	Cyclin-L2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96S94	CCNL2	Cyclin-L2	GO:0006396; P:RNA processing; IEA:InterPro
Q96S94	CCNL2	Cyclin-L2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P22674	CCNO	Cyclin-O	GO:0004844; F:uracil DNA N-glycosylase activity; IDA:HGNC
P22674	CCNO	Cyclin-O	GO:0006284; P:base-excision repair; IDA:HGNC
P22674	CCNO	Cyclin-O	GO:0006285; P:base-excision repair, AP site formation; TAS:Reactome
P22674	CCNO	Cyclin-O	GO:0007049; P:cell cycle; IDA:UniProtKB
P22674	CCNO	Cyclin-O	GO:0051301; P:cell division; IDA:UniProtKB
P22674	CCNO	Cyclin-O	GO:0045008; P:depyrimidination; TAS:Reactome
P22674	CCNO	Cyclin-O	GO:0006281; P:DNA repair; TAS:Reactome
P22674	CCNO	Cyclin-O	GO:0009790; P:embryo development; IEA:Ensembl
P22674	CCNO	Cyclin-O	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:InterPro
P22674	CCNO	Cyclin-O	GO:0042493; P:response to drug; IEA:Ensembl
O60563	CCNT1	Cyclin-T1	GO:0003682; F:chromatin binding; IEA:Ensembl
O60563	CCNT1	Cyclin-T1	GO:0003677; F:DNA binding; IDA:MGI
O60563	CCNT1	Cyclin-T1	GO:0005515; F:protein binding; IPI:UniProtKB
O60563	CCNT1	Cyclin-T1	GO:0017069; F:snRNA binding; IEA:Ensembl
O60563	CCNT1	Cyclin-T1	GO:0044212; F:transcription regulatory region DNA binding; IEA:Ensembl
O60563	CCNT1	Cyclin-T1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
O60563	CCNT1	Cyclin-T1	GO:0051301; P:cell division; IEA:UniProtKB-KW
O60563	CCNT1	Cyclin-T1	GO:0010467; P:gene expression; TAS:Reactome
O60563	CCNT1	Cyclin-T1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
O60563	CCNT1	Cyclin-T1	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
O60563	CCNT1	Cyclin-T1	GO:0006468; P:protein phosphorylation; IPI:MGI
O60563	CCNT1	Cyclin-T1	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:InterPro
O60563	CCNT1	Cyclin-T1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
O60563	CCNT1	Cyclin-T1	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
O60563	CCNT1	Cyclin-T1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
O60563	CCNT1	Cyclin-T1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
O60563	CCNT1	Cyclin-T1	GO:0006351; P:transcription, DNA-templated; IEA:InterPro
O60563	CCNT1	Cyclin-T1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
O60563	CCNT1	Cyclin-T1	GO:0016032; P:viral process; TAS:Reactome
O60583	CCNT2	Cyclin-T2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
O60583	CCNT2	Cyclin-T2	GO:0051301; P:cell division; IEA:UniProtKB-KW
O60583	CCNT2	Cyclin-T2	GO:0010467; P:gene expression; TAS:Reactome
O60583	CCNT2	Cyclin-T2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
O60583	CCNT2	Cyclin-T2	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
O60583	CCNT2	Cyclin-T2	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
O60583	CCNT2	Cyclin-T2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
O60583	CCNT2	Cyclin-T2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
O60583	CCNT2	Cyclin-T2	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
O60583	CCNT2	Cyclin-T2	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
O60583	CCNT2	Cyclin-T2	GO:0016032; P:viral process; TAS:Reactome
Q8ND76	CCNY	Cyclin-Y	GO:0016538; F:cyclin-dependent protein serine/threonine kinase regulator activity; IDA:UniProtKB
Q8ND76	CCNY	Cyclin-Y	GO:0005515; F:protein binding; IPI:UniProtKB
Q8ND76	CCNY	Cyclin-Y	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q8ND76	CCNY	Cyclin-Y	GO:0000086; P:G2/M transition of mitotic cell cycle; IDA:UniProtKB
Q8ND76	CCNY	Cyclin-Y	GO:0045737; P:positive regulation of cyclin-dependent protein kinase activity; IDA:UniProtKB
Q8ND76	CCNY	Cyclin-Y	GO:0060828; P:regulation of canonical Wnt signaling pathway; IDA:UniProtKB
Q8ND76	CCNY	Cyclin-Y	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9ULG6	CCPG1	Cell cycle progression protein 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9ULG6	CCPG1	Cell cycle progression protein 1	GO:0045787; P:positive regulation of cell cycle; IMP:UniProt
Q9ULG6	CCPG1	Cell cycle progression protein 1	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProt
Q9ULG6	CCPG1	Cell cycle progression protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9ULG6	CCPG1	Cell cycle progression protein 1	GO:2001106; P:regulation of Rho guanyl-nucleotide exchange factor activity; IEA:Ensembl
P46092	CCR10	C-C chemokine receptor type 10	GO:0016493; F:C-C chemokine receptor activity; IEA:Ensembl
P46092	CCR10	C-C chemokine receptor type 10	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P46092	CCR10	C-C chemokine receptor type 10	GO:0006935; P:chemotaxis; IEA:Ensembl
P46092	CCR10	C-C chemokine receptor type 10	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P46092	CCR10	C-C chemokine receptor type 10	GO:0006955; P:immune response; IEA:InterPro
P46092	CCR10	C-C chemokine receptor type 10	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P32246	CCR1	C-C chemokine receptor type 1	GO:0019957; F:C-C chemokine binding; IPI:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0016493; F:C-C chemokine receptor activity; IDA:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0071791; F:chemokine (C-C motif) ligand 5 binding; IPI:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0035717; F:chemokine (C-C motif) ligand 7 binding; IPI:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0004950; F:chemokine receptor activity; IDA:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0004435; F:phosphatidylinositol phospholipase C activity; IDA:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0005515; F:protein binding; IPI:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0006816; P:calcium ion transport; IDA:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0007155; P:cell adhesion; TAS:ProtInc
P32246	CCR1	C-C chemokine receptor type 1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P32246	CCR1	C-C chemokine receptor type 1	GO:0007267; P:cell-cell signaling; IDA:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0006874; P:cellular calcium ion homeostasis; IDA:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0070098; P:chemokine-mediated signaling pathway; IDA:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0006935; P:chemotaxis; NAS:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0019221; P:cytokine-mediated signaling pathway; NAS:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0002407; P:dendritic cell chemotaxis; TAS:BHF-UCL
P32246	CCR1	C-C chemokine receptor type 1	GO:0006887; P:exocytosis; IDA:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P32246	CCR1	C-C chemokine receptor type 1	GO:0006955; P:immune response; IDA:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0006954; P:inflammatory response; TAS:ProtInc
P32246	CCR1	C-C chemokine receptor type 1	GO:0008152; P:metabolic process; IDA:GOC
P32246	CCR1	C-C chemokine receptor type 1	GO:0030502; P:negative regulation of bone mineralization; IMP:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0051928; P:positive regulation of calcium ion transport; IDA:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0090026; P:positive regulation of monocyte chemotaxis; IDA:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0045672; P:positive regulation of osteoclast differentiation; IMP:UniProtKB
P32246	CCR1	C-C chemokine receptor type 1	GO:0009611; P:response to wounding; TAS:ProtInc
P41597	CCR2	C-C chemokine receptor type 2	GO:0016493; F:C-C chemokine receptor activity; IEA:InterPro
P41597	CCR2	C-C chemokine receptor type 2	GO:0031727; F:CCR2 chemokine receptor binding; IDA:MGI
P41597	CCR2	C-C chemokine receptor type 2	GO:0004950; F:chemokine receptor activity; TAS:ProtInc
P41597	CCR2	C-C chemokine receptor type 2	GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0001974; P:blood vessel remodeling; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0006874; P:cellular calcium ion homeostasis; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0006968; P:cellular defense response; TAS:ProtInc
P41597	CCR2	C-C chemokine receptor type 2	GO:0019725; P:cellular homeostasis; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0070098; P:chemokine-mediated signaling pathway; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0006935; P:chemotaxis; TAS:ProtInc
P41597	CCR2	C-C chemokine receptor type 2	GO:0019221; P:cytokine-mediated signaling pathway; IDA:MGI
P41597	CCR2	C-C chemokine receptor type 2	GO:0002407; P:dendritic cell chemotaxis; TAS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0006955; P:immune response; TAS:ProtInc
P41597	CCR2	C-C chemokine receptor type 2	GO:0006954; P:inflammatory response; TAS:ProtInc
P41597	CCR2	C-C chemokine receptor type 2	GO:0045087; P:innate immune response; TAS:Reactome
P41597	CCR2	C-C chemokine receptor type 2	GO:0007259; P:JAK-STAT cascade; TAS:ProtInc
P41597	CCR2	C-C chemokine receptor type 2	GO:0007194; P:negative regulation of adenylate cyclase activity; TAS:ProtInc
P41597	CCR2	C-C chemokine receptor type 2	GO:0016525; P:negative regulation of angiogenesis; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0043310; P:negative regulation of eosinophil degranulation; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0002829; P:negative regulation of type 2 immune response; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0046641; P:positive regulation of alpha-beta T cell proliferation; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:2000464; P:positive regulation of astrocyte chemotaxis; IDA:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:2000451; P:positive regulation of CD8-positive, alpha-beta T cell extravasation; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
P41597	CCR2	C-C chemokine receptor type 2	GO:2000473; P:positive regulation of hematopoietic stem cell migration; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0090265; P:positive regulation of immune complex clearance by monocytes and macrophages; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0050729; P:positive regulation of inflammatory response; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0032729; P:positive regulation of interferon-gamma production; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0032743; P:positive regulation of interleukin-2 production; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0090026; P:positive regulation of monocyte chemotaxis; IDA:UniProtKB
P41597	CCR2	C-C chemokine receptor type 2	GO:2000439; P:positive regulation of monocyte extravasation; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0050870; P:positive regulation of T cell activation; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0010820; P:positive regulation of T cell chemotaxis; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0002827; P:positive regulation of T-helper 1 type immune response; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0042535; P:positive regulation of tumor necrosis factor biosynthetic process; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0010574; P:regulation of vascular endothelial growth factor production; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0009611; P:response to wounding; TAS:ProtInc
P41597	CCR2	C-C chemokine receptor type 2	GO:0035705; P:T-helper 17 cell chemotaxis; ISS:BHF-UCL
P41597	CCR2	C-C chemokine receptor type 2	GO:0016032; P:viral process; IEA:UniProtKB-KW
P51677	CCR3	C-C chemokine receptor type 3	GO:0016493; F:C-C chemokine receptor activity; IEA:Ensembl
P51677	CCR3	C-C chemokine receptor type 3	GO:0004950; F:chemokine receptor activity; TAS:ProtInc
P51677	CCR3	C-C chemokine receptor type 3	GO:0005515; F:protein binding; IPI:IntAct
P51677	CCR3	C-C chemokine receptor type 3	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; TAS:ProtInc
P51677	CCR3	C-C chemokine receptor type 3	GO:0007155; P:cell adhesion; TAS:ProtInc
P51677	CCR3	C-C chemokine receptor type 3	GO:0006968; P:cellular defense response; TAS:ProtInc
P51677	CCR3	C-C chemokine receptor type 3	GO:0070098; P:chemokine-mediated signaling pathway; TAS:GOC
P51677	CCR3	C-C chemokine receptor type 3	GO:0006935; P:chemotaxis; TAS:ProtInc
P51677	CCR3	C-C chemokine receptor type 3	GO:0006954; P:inflammatory response; TAS:ProtInc
P51677	CCR3	C-C chemokine receptor type 3	GO:0045766; P:positive regulation of angiogenesis; IMP:BHF-UCL
P51677	CCR3	C-C chemokine receptor type 3	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
P51677	CCR3	C-C chemokine receptor type 3	GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl
P51677	CCR3	C-C chemokine receptor type 3	GO:0016032; P:viral process; IEA:UniProtKB-KW
P51679	CCR4	C-C chemokine receptor type 4	GO:0016493; F:C-C chemokine receptor activity; IEA:Ensembl
P51679	CCR4	C-C chemokine receptor type 4	GO:0004950; F:chemokine receptor activity; TAS:ProtInc
P51679	CCR4	C-C chemokine receptor type 4	GO:0070098; P:chemokine-mediated signaling pathway; TAS:GOC
P51679	CCR4	C-C chemokine receptor type 4	GO:0006935; P:chemotaxis; TAS:ProtInc
P51679	CCR4	C-C chemokine receptor type 4	GO:0006955; P:immune response; TAS:ProtInc
P51679	CCR4	C-C chemokine receptor type 4	GO:0006954; P:inflammatory response; TAS:ProtInc
P51679	CCR4	C-C chemokine receptor type 4	GO:0001764; P:neuron migration; IEA:Ensembl
P51679	CCR4	C-C chemokine receptor type 4	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
P51679	CCR4	C-C chemokine receptor type 4	GO:0050927; P:positive regulation of positive chemotaxis; IEA:Ensembl
P51679	CCR4	C-C chemokine receptor type 4	GO:0046677; P:response to antibiotic; IEA:Ensembl
P51679	CCR4	C-C chemokine receptor type 4	GO:0009617; P:response to bacterium; IEA:Ensembl
P51679	CCR4	C-C chemokine receptor type 4	GO:0009314; P:response to radiation; IEA:Ensembl
P51679	CCR4	C-C chemokine receptor type 4	GO:0002507; P:tolerance induction; IEA:Ensembl
P51681	CCR5	C-C chemokine receptor type 5	GO:0003779; F:actin binding; IDA:UniProtKB
P51681	CCR5	C-C chemokine receptor type 5	GO:0019957; F:C-C chemokine binding; IPI:UniProtKB
P51681	CCR5	C-C chemokine receptor type 5	GO:0016493; F:C-C chemokine receptor activity; NAS:UniProtKB
P51681	CCR5	C-C chemokine receptor type 5	GO:0071791; F:chemokine (C-C motif) ligand 5 binding; IPI:UniProtKB
P51681	CCR5	C-C chemokine receptor type 5	GO:0004950; F:chemokine receptor activity; TAS:ProtInc
P51681	CCR5	C-C chemokine receptor type 5	GO:0015026; F:coreceptor activity; TAS:ProtInc
P51681	CCR5	C-C chemokine receptor type 5	GO:0004435; F:phosphatidylinositol phospholipase C activity; TAS:ProtInc
P51681	CCR5	C-C chemokine receptor type 5	GO:0005515; F:protein binding; IPI:UniProtKB
P51681	CCR5	C-C chemokine receptor type 5	GO:0001974; P:blood vessel remodeling; IEA:InterPro
P51681	CCR5	C-C chemokine receptor type 5	GO:0006816; P:calcium ion transport; IDA:UniProtKB
P51681	CCR5	C-C chemokine receptor type 5	GO:0019722; P:calcium-mediated signaling; IDA:UniProtKB
P51681	CCR5	C-C chemokine receptor type 5	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P51681	CCR5	C-C chemokine receptor type 5	GO:0007267; P:cell-cell signaling; IDA:UniProtKB
P51681	CCR5	C-C chemokine receptor type 5	GO:0006968; P:cellular defense response; TAS:ProtInc
P51681	CCR5	C-C chemokine receptor type 5	GO:0071222; P:cellular response to lipopolysaccharide; IEP:UniProtKB
P51681	CCR5	C-C chemokine receptor type 5	GO:0070098; P:chemokine-mediated signaling pathway; IDA:GOC
P51681	CCR5	C-C chemokine receptor type 5	GO:0006935; P:chemotaxis; TAS:ProtInc
P51681	CCR5	C-C chemokine receptor type 5	GO:0002407; P:dendritic cell chemotaxis; TAS:BHF-UCL
P51681	CCR5	C-C chemokine receptor type 5	GO:0030260; P:entry into host cell; TAS:Reactome
P51681	CCR5	C-C chemokine receptor type 5	GO:0007186; P:G-protein coupled receptor signaling pathway; IMP:UniProtKB
P51681	CCR5	C-C chemokine receptor type 5	GO:0006955; P:immune response; TAS:ProtInc
P51681	CCR5	C-C chemokine receptor type 5	GO:0006954; P:inflammatory response; TAS:ProtInc
P51681	CCR5	C-C chemokine receptor type 5	GO:0000165; P:MAPK cascade; IEP:UniProtKB
P51681	CCR5	C-C chemokine receptor type 5	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
P51681	CCR5	C-C chemokine receptor type 5	GO:0090026; P:positive regulation of monocyte chemotaxis; IEA:InterPro
P51681	CCR5	C-C chemokine receptor type 5	GO:0014808; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; IDA:UniProtKB
P51681	CCR5	C-C chemokine receptor type 5	GO:0070723; P:response to cholesterol; IMP:UniProtKB
P51681	CCR5	C-C chemokine receptor type 5	GO:0023052; P:signaling; IEP:UniProtKB
P51681	CCR5	C-C chemokine receptor type 5	GO:0016032; P:viral process; TAS:Reactome
P51684	CCR6	C-C chemokine receptor type 6	GO:0016493; F:C-C chemokine receptor activity; IEA:InterPro
P51684	CCR6	C-C chemokine receptor type 6	GO:0004950; F:chemokine receptor activity; TAS:ProtInc
P51684	CCR6	C-C chemokine receptor type 6	GO:0004872; F:receptor activity; TAS:ProtInc
P51684	CCR6	C-C chemokine receptor type 6	GO:0006928; P:cellular component movement; TAS:ProtInc
P51684	CCR6	C-C chemokine receptor type 6	GO:0006968; P:cellular defense response; TAS:ProtInc
P51684	CCR6	C-C chemokine receptor type 6	GO:0070098; P:chemokine-mediated signaling pathway; TAS:GOC
P51684	CCR6	C-C chemokine receptor type 6	GO:0006935; P:chemotaxis; TAS:ProtInc
P51684	CCR6	C-C chemokine receptor type 6	GO:0002407; P:dendritic cell chemotaxis; TAS:BHF-UCL
P51684	CCR6	C-C chemokine receptor type 6	GO:0006959; P:humoral immune response; TAS:ProtInc
P51684	CCR6	C-C chemokine receptor type 6	GO:0006955; P:immune response; TAS:ProtInc
P51684	CCR6	C-C chemokine receptor type 6	GO:0045087; P:innate immune response; TAS:Reactome
P51684	CCR6	C-C chemokine receptor type 6	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
P51684	CCR6	C-C chemokine receptor type 6	GO:0007165; P:signal transduction; TAS:ProtInc
P32248	CCR7	C-C chemokine receptor type 7	GO:0016493; F:C-C chemokine receptor activity; ISS:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0038117; F:C-C motif chemokine 19 receptor activity; IDA:UniProtKB
P32248	CCR7	C-C chemokine receptor type 7	GO:0038121; F:C-C motif chemokine 21 receptor activity; IDA:UniProtKB
P32248	CCR7	C-C chemokine receptor type 7	GO:0035757; F:chemokine (C-C motif) ligand 19 binding; IPI:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0035758; F:chemokine (C-C motif) ligand 21 binding; IPI:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0004930; F:G-protein coupled receptor activity; TAS:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0032862; P:activation of Rho GTPase activity; IC:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0038115; P:chemokine (C-C motif) ligand 19 signaling pathway; IDA:GOC
P32248	CCR7	C-C chemokine receptor type 7	GO:0038116; P:chemokine (C-C motif) ligand 21 signaling pathway; IDA:GOC
P32248	CCR7	C-C chemokine receptor type 7	GO:0070098; P:chemokine-mediated signaling pathway; ISS:GOC
P32248	CCR7	C-C chemokine receptor type 7	GO:0002407; P:dendritic cell chemotaxis; IC:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0001768; P:establishment of T cell polarity; IC:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0006955; P:immune response; IEA:Ensembl
P32248	CCR7	C-C chemokine receptor type 7	GO:0006954; P:inflammatory response; NAS:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0072610; P:interleukin-12 secretion; ISS:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0097022; P:lymphocyte migration into lymph node; TAS:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0097029; P:mature dendritic cell differentiation; ISS:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0002408; P:myeloid dendritic cell chemotaxis; IC:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:2000107; P:negative regulation of leukocyte apoptotic process; IC:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0045060; P:negative thymic T cell selection; IEA:Ensembl
P32248	CCR7	C-C chemokine receptor type 7	GO:0030838; P:positive regulation of actin filament polymerization; IC:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0045785; P:positive regulation of cell adhesion; IC:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:2000147; P:positive regulation of cell motility; IC:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0001954; P:positive regulation of cell-matrix adhesion; IC:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
P32248	CCR7	C-C chemokine receptor type 7	GO:0002606; P:positive regulation of dendritic cell antigen processing and presentation; ISS:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:2000510; P:positive regulation of dendritic cell chemotaxis; ISS:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IC:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0051491; P:positive regulation of filopodium assembly; IC:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:2000526; P:positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation; ISS:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0002922; P:positive regulation of humoral immune response; ISS:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0002885; P:positive regulation of hypersensitivity; ISS:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IC:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:2000522; P:positive regulation of immunological synapse formation; ISS:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0032735; P:positive regulation of interleukin-12 production; ISS:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0046330; P:positive regulation of JNK cascade; IC:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0090023; P:positive regulation of neutrophil chemotaxis; IDA:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IC:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0045860; P:positive regulation of protein kinase activity; IC:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0051897; P:positive regulation of protein kinase B signaling; IC:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0031274; P:positive regulation of pseudopodium assembly; IC:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:2000525; P:positive regulation of T cell costimulation; ISS:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0050862; P:positive regulation of T cell receptor signaling pathway; IEA:Ensembl
P32248	CCR7	C-C chemokine receptor type 7	GO:2000547; P:regulation of dendritic cell dendrite assembly; ISS:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0032649; P:regulation of interferon-gamma production; ISS:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0050706; P:regulation of interleukin-1 beta secretion; ISS:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0051209; P:release of sequestered calcium ion into cytosol; IC:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P32248	CCR7	C-C chemokine receptor type 7	GO:0071731; P:response to nitric oxide; IC:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0034695; P:response to prostaglandin E; IC:BHF-UCL
P32248	CCR7	C-C chemokine receptor type 7	GO:0031529; P:ruffle organization; IC:BHF-UCL
P51685	CCR8	C-C chemokine receptor type 8	GO:0016493; F:C-C chemokine receptor activity; IEA:Ensembl
P51685	CCR8	C-C chemokine receptor type 8	GO:0004950; F:chemokine receptor activity; TAS:ProtInc
P51685	CCR8	C-C chemokine receptor type 8	GO:0015026; F:coreceptor activity; TAS:ProtInc
P51685	CCR8	C-C chemokine receptor type 8	GO:0007155; P:cell adhesion; TAS:ProtInc
P51685	CCR8	C-C chemokine receptor type 8	GO:0070098; P:chemokine-mediated signaling pathway; TAS:GOC
P51685	CCR8	C-C chemokine receptor type 8	GO:0006935; P:chemotaxis; TAS:ProtInc
P51685	CCR8	C-C chemokine receptor type 8	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P51685	CCR8	C-C chemokine receptor type 8	GO:0006955; P:immune response; TAS:ProtInc
P51685	CCR8	C-C chemokine receptor type 8	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
P51686	CCR9	C-C chemokine receptor type 9	GO:0016493; F:C-C chemokine receptor activity; IEA:Ensembl
P51686	CCR9	C-C chemokine receptor type 9	GO:0004950; F:chemokine receptor activity; TAS:ProtInc
P51686	CCR9	C-C chemokine receptor type 9	GO:0006968; P:cellular defense response; TAS:ProtInc
P51686	CCR9	C-C chemokine receptor type 9	GO:0070098; P:chemokine-mediated signaling pathway; TAS:GOC
P51686	CCR9	C-C chemokine receptor type 9	GO:0006935; P:chemotaxis; TAS:ProtInc
P51686	CCR9	C-C chemokine receptor type 9	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P51686	CCR9	C-C chemokine receptor type 9	GO:0006955; P:immune response; TAS:ProtInc
P51686	CCR9	C-C chemokine receptor type 9	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
O00421	CCRL2	C-C chemokine receptor-like 2	GO:0048020; F:CCR chemokine receptor binding; IPI:UniProtKB
O00421	CCRL2	C-C chemokine receptor-like 2	GO:0004950; F:chemokine receptor activity; TAS:ProtInc
O00421	CCRL2	C-C chemokine receptor-like 2	GO:0042379; F:chemokine receptor binding; IPI:UniProtKB
O00421	CCRL2	C-C chemokine receptor-like 2	GO:0070098; P:chemokine-mediated signaling pathway; TAS:GOC
O00421	CCRL2	C-C chemokine receptor-like 2	GO:0006935; P:chemotaxis; TAS:ProtInc
O00421	CCRL2	C-C chemokine receptor-like 2	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
O00421	CCRL2	C-C chemokine receptor-like 2	GO:0006954; P:inflammatory response; ISS:UniProtKB
Q6IQ19	CCSAP	Centriole, cilia and spindle-associated protein	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q6IQ19	CCSAP	Centriole, cilia and spindle-associated protein	GO:0060296; P:regulation of cilium beat frequency involved in ciliary motility; ISS:UniProtKB
Q6IQ19	CCSAP	Centriole, cilia and spindle-associated protein	GO:0045995; P:regulation of embryonic development; ISS:UniProtKB
Q9H7U1	CCSER2	Serine-rich coiled-coil domain-containing protein 2	GO:0001578; P:microtubule bundle formation; IEA:Ensembl
O14618	CCS	Copper chaperone for superoxide dismutase	GO:0005507; F:copper ion binding; TAS:ProtInc
O14618	CCS	Copper chaperone for superoxide dismutase	GO:0005375; F:copper ion transmembrane transporter activity; TAS:ProtInc
O14618	CCS	Copper chaperone for superoxide dismutase	GO:0005515; F:protein binding; IPI:UniProtKB
O14618	CCS	Copper chaperone for superoxide dismutase	GO:0015035; F:protein disulfide oxidoreductase activity; TAS:Reactome
O14618	CCS	Copper chaperone for superoxide dismutase	GO:0004784; F:superoxide dismutase activity; IBA:RefGenome
O14618	CCS	Copper chaperone for superoxide dismutase	GO:0016532; F:superoxide dismutase copper chaperone activity; IBA:RefGenome
O14618	CCS	Copper chaperone for superoxide dismutase	GO:0008270; F:zinc ion binding; IBA:RefGenome
O14618	CCS	Copper chaperone for superoxide dismutase	GO:0035434; P:copper ion transmembrane transport; TAS:GOC
O14618	CCS	Copper chaperone for superoxide dismutase	GO:0015680; P:intracellular copper ion transport; IBA:RefGenome
O14618	CCS	Copper chaperone for superoxide dismutase	GO:0051353; P:positive regulation of oxidoreductase activity; IEA:Ensembl
O14618	CCS	Copper chaperone for superoxide dismutase	GO:0019430; P:removal of superoxide radicals; IBA:RefGenome
O14618	CCS	Copper chaperone for superoxide dismutase	GO:0006801; P:superoxide metabolic process; TAS:ProtInc
Q8N7R7	CCNYL1	Cyclin-Y-like protein 1	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:InterPro
Q5T2Q4	CCNYL2	Cyclin-Y-like protein 2	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:InterPro
Q99440	C4orf6	Uncharacterized protein C4orf6	GO:0007399; P:nervous system development; TAS:ProtInc
Q6YHK3	CD109	CD109 antigen	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q6YHK3	CD109	CD109 antigen	GO:0050431; F:transforming growth factor beta binding; IPI:UniProt
Q6YHK3	CD109	CD109 antigen	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProt
Q6YHK3	CD109	CD109 antigen	GO:0061045; P:negative regulation of wound healing; IDA:UniProt
Q9UQ88	CDK11A	Cyclin-dependent kinase 11A	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9UQ88	CDK11A	Cyclin-dependent kinase 11A	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC
Q9UQ88	CDK11A	Cyclin-dependent kinase 11A	GO:0004672; F:protein kinase activity; NAS:UniProtKB
Q9UQ88	CDK11A	Cyclin-dependent kinase 11A	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9UQ88	CDK11A	Cyclin-dependent kinase 11A	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q9UQ88	CDK11A	Cyclin-dependent kinase 11A	GO:0007067; P:mitosis; NAS:UniProtKB
Q9UQ88	CDK11A	Cyclin-dependent kinase 11A	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9UQ88	CDK11A	Cyclin-dependent kinase 11A	GO:0001558; P:regulation of cell growth; IEP:UniProtKB
Q9UQ88	CDK11A	Cyclin-dependent kinase 11A	GO:0050684; P:regulation of mRNA processing; IDA:UniProtKB
Q9UQ88	CDK11A	Cyclin-dependent kinase 11A	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P21127	CDK11B	Cyclin-dependent kinase 11B	GO:0005524; F:ATP binding; IDA:UniProtKB
P21127	CDK11B	Cyclin-dependent kinase 11B	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC
P21127	CDK11B	Cyclin-dependent kinase 11B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P21127	CDK11B	Cyclin-dependent kinase 11B	GO:0005515; F:protein binding; IPI:IntAct
P21127	CDK11B	Cyclin-dependent kinase 11B	GO:0004672; F:protein kinase activity; TAS:ProtInc
P21127	CDK11B	Cyclin-dependent kinase 11B	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P21127	CDK11B	Cyclin-dependent kinase 11B	GO:0006915; P:apoptotic process; NAS:UniProtKB
P21127	CDK11B	Cyclin-dependent kinase 11B	GO:0008283; P:cell proliferation; TAS:ProtInc
P21127	CDK11B	Cyclin-dependent kinase 11B	GO:0007067; P:mitosis; NAS:UniProtKB
P21127	CDK11B	Cyclin-dependent kinase 11B	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P21127	CDK11B	Cyclin-dependent kinase 11B	GO:0001558; P:regulation of cell growth; IEP:UniProtKB
P21127	CDK11B	Cyclin-dependent kinase 11B	GO:0050684; P:regulation of mRNA processing; IDA:UniProtKB
P21127	CDK11B	Cyclin-dependent kinase 11B	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
O75794	CDC123	Cell division cycle protein 123 homolog	GO:0007050; P:cell cycle arrest; TAS:ProtInc
O75794	CDC123	Cell division cycle protein 123 homolog	GO:0051301; P:cell division; IEA:UniProtKB-KW
O75794	CDC123	Cell division cycle protein 123 homolog	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
O75794	CDC123	Cell division cycle protein 123 homolog	GO:0007346; P:regulation of mitotic cell cycle; ISS:HGNC
P08571	CD14	Monocyte differentiation antigen CD14	GO:0001530; F:lipopolysaccharide binding; IDA:MGI
P08571	CD14	Monocyte differentiation antigen CD14	GO:0070891; F:lipoteichoic acid binding; IDA:MGI
P08571	CD14	Monocyte differentiation antigen CD14	GO:0001847; F:opsonin receptor activity; TAS:BHF-UCL
P08571	CD14	Monocyte differentiation antigen CD14	GO:0016019; F:peptidoglycan receptor activity; TAS:ProtInc
P08571	CD14	Monocyte differentiation antigen CD14	GO:0005515; F:protein binding; IPI:IntAct
P08571	CD14	Monocyte differentiation antigen CD14	GO:0006915; P:apoptotic process; TAS:ProtInc
P08571	CD14	Monocyte differentiation antigen CD14	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P08571	CD14	Monocyte differentiation antigen CD14	GO:0071222; P:cellular response to lipopolysaccharide; IDA:MGI
P08571	CD14	Monocyte differentiation antigen CD14	GO:0071223; P:cellular response to lipoteichoic acid; IDA:MGI
P08571	CD14	Monocyte differentiation antigen CD14	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
P08571	CD14	Monocyte differentiation antigen CD14	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
P08571	CD14	Monocyte differentiation antigen CD14	GO:0045087; P:innate immune response; TAS:Reactome
P08571	CD14	Monocyte differentiation antigen CD14	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P08571	CD14	Monocyte differentiation antigen CD14	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P08571	CD14	Monocyte differentiation antigen CD14	GO:0006909; P:phagocytosis; TAS:ProtInc
P08571	CD14	Monocyte differentiation antigen CD14	GO:0050715; P:positive regulation of cytokine secretion; IEA:Ensembl
P08571	CD14	Monocyte differentiation antigen CD14	GO:0045807; P:positive regulation of endocytosis; IEA:Ensembl
P08571	CD14	Monocyte differentiation antigen CD14	GO:0032760; P:positive regulation of tumor necrosis factor production; IDA:MGI
P08571	CD14	Monocyte differentiation antigen CD14	GO:0045471; P:response to ethanol; IEA:Ensembl
P08571	CD14	Monocyte differentiation antigen CD14	GO:0009408; P:response to heat; IEA:Ensembl
P08571	CD14	Monocyte differentiation antigen CD14	GO:0032026; P:response to magnesium ion; IEA:Ensembl
P08571	CD14	Monocyte differentiation antigen CD14	GO:0034612; P:response to tumor necrosis factor; IEA:Ensembl
P08571	CD14	Monocyte differentiation antigen CD14	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P08571	CD14	Monocyte differentiation antigen CD14	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P08571	CD14	Monocyte differentiation antigen CD14	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P08571	CD14	Monocyte differentiation antigen CD14	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P08571	CD14	Monocyte differentiation antigen CD14	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P08571	CD14	Monocyte differentiation antigen CD14	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P08571	CD14	Monocyte differentiation antigen CD14	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P48509	CD151	CD151 antigen	GO:0005515; F:protein binding; IPI:UniProtKB
P48509	CD151	CD151 antigen	GO:0007155; P:cell adhesion; NAS:ProtInc
P48509	CD151	CD151 antigen	GO:0034329; P:cell junction assembly; TAS:Reactome
P48509	CD151	CD151 antigen	GO:0016477; P:cell migration; IEA:Ensembl
P48509	CD151	CD151 antigen	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P48509	CD151	CD151 antigen	GO:0031581; P:hemidesmosome assembly; TAS:Reactome
P48509	CD151	CD151 antigen	GO:0042098; P:T cell proliferation; IEA:Ensembl
Q13740	ALCAM	CD166 antigen	GO:0005102; F:receptor binding; TAS:ProtInc
Q13740	ALCAM	CD166 antigen	GO:0007411; P:axon guidance; TAS:Reactome
Q13740	ALCAM	CD166 antigen	GO:0007155; P:cell adhesion; TAS:ProtInc
Q13740	ALCAM	CD166 antigen	GO:0008045; P:motor neuron axon guidance; IEA:Ensembl
Q13740	ALCAM	CD166 antigen	GO:0007165; P:signal transduction; TAS:ProtInc
Q8N6Q3	CD177	CD177 antigen	GO:0007596; P:blood coagulation; TAS:Reactome
Q8N6Q3	CD177	CD177 antigen	GO:0050900; P:leukocyte migration; TAS:Reactome
Q99467	CD180	CD180 antigen	GO:0002322; P:B cell proliferation involved in immune response; IEA:Ensembl
Q99467	CD180	CD180 antigen	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
Q99467	CD180	CD180 antigen	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q99467	CD180	CD180 antigen	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q99467	CD180	CD180 antigen	GO:0031666; P:positive regulation of lipopolysaccharide-mediated signaling pathway; IGI:MGI
P15391	CD19	B-lymphocyte antigen CD19	GO:0005057; F:receptor signaling protein activity; TAS:ProtInc
P15391	CD19	B-lymphocyte antigen CD19	GO:0050853; P:B cell receptor signaling pathway; IEA:Ensembl
P15391	CD19	B-lymphocyte antigen CD19	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P15391	CD19	B-lymphocyte antigen CD19	GO:0006968; P:cellular defense response; TAS:ProtInc
P15391	CD19	B-lymphocyte antigen CD19	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P15391	CD19	B-lymphocyte antigen CD19	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P15391	CD19	B-lymphocyte antigen CD19	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P15391	CD19	B-lymphocyte antigen CD19	GO:0045087; P:innate immune response; TAS:Reactome
P15391	CD19	B-lymphocyte antigen CD19	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P15391	CD19	B-lymphocyte antigen CD19	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P15391	CD19	B-lymphocyte antigen CD19	GO:0050776; P:regulation of immune response; TAS:Reactome
P06126	CD1A	T-cell surface glycoprotein CD1a	GO:0030881; F:beta-2-microglobulin binding; IBA:RefGenome
P06126	CD1A	T-cell surface glycoprotein CD1a	GO:0030883; F:endogenous lipid antigen binding; IBA:RefGenome
P06126	CD1A	T-cell surface glycoprotein CD1a	GO:0030884; F:exogenous lipid antigen binding; IBA:RefGenome
P06126	CD1A	T-cell surface glycoprotein CD1a	GO:0071723; F:lipopeptide binding; IBA:RefGenome
P06126	CD1A	T-cell surface glycoprotein CD1a	GO:0005515; F:protein binding; IPI:IntAct
P06126	CD1A	T-cell surface glycoprotein CD1a	GO:0048007; P:antigen processing and presentation, exogenous lipid antigen via MHC class Ib; IBA:RefGenome
P06126	CD1A	T-cell surface glycoprotein CD1a	GO:0006955; P:immune response; NAS:UniProtKB
P29016	CD1B	T-cell surface glycoprotein CD1b	GO:0030881; F:beta-2-microglobulin binding; IBA:RefGenome
P29016	CD1B	T-cell surface glycoprotein CD1b	GO:0030883; F:endogenous lipid antigen binding; IBA:RefGenome
P29016	CD1B	T-cell surface glycoprotein CD1b	GO:0030884; F:exogenous lipid antigen binding; IBA:RefGenome
P29016	CD1B	T-cell surface glycoprotein CD1b	GO:0071723; F:lipopeptide binding; IBA:RefGenome
P29016	CD1B	T-cell surface glycoprotein CD1b	GO:0005515; F:protein binding; IPI:IntAct
P29016	CD1B	T-cell surface glycoprotein CD1b	GO:0048007; P:antigen processing and presentation, exogenous lipid antigen via MHC class Ib; IBA:RefGenome
P29016	CD1B	T-cell surface glycoprotein CD1b	GO:0006955; P:immune response; IEA:InterPro
P29017	CD1C	T-cell surface glycoprotein CD1c	GO:0030881; F:beta-2-microglobulin binding; IBA:RefGenome
P29017	CD1C	T-cell surface glycoprotein CD1c	GO:0030883; F:endogenous lipid antigen binding; IDA:UniProtKB
P29017	CD1C	T-cell surface glycoprotein CD1c	GO:0030884; F:exogenous lipid antigen binding; IDA:UniProtKB
P29017	CD1C	T-cell surface glycoprotein CD1c	GO:0051861; F:glycolipid binding; IDA:UniProtKB
P29017	CD1C	T-cell surface glycoprotein CD1c	GO:0071723; F:lipopeptide binding; IDA:UniProtKB
P29017	CD1C	T-cell surface glycoprotein CD1c	GO:0048007; P:antigen processing and presentation, exogenous lipid antigen via MHC class Ib; IBA:RefGenome
P29017	CD1C	T-cell surface glycoprotein CD1c	GO:0002286; P:T cell activation involved in immune response; IDA:UniProtKB
P15813	CD1D	Antigen-presenting glycoprotein CD1d	GO:0030881; F:beta-2-microglobulin binding; TAS:UniProtKB
P15813	CD1D	Antigen-presenting glycoprotein CD1d	GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL
P15813	CD1D	Antigen-presenting glycoprotein CD1d	GO:0030883; F:endogenous lipid antigen binding; IBA:RefGenome
P15813	CD1D	Antigen-presenting glycoprotein CD1d	GO:0030884; F:exogenous lipid antigen binding; IDA:UniProtKB
P15813	CD1D	Antigen-presenting glycoprotein CD1d	GO:0042393; F:histone binding; IPI:UniProtKB
P15813	CD1D	Antigen-presenting glycoprotein CD1d	GO:0030882; F:lipid antigen binding; IDA:BHF-UCL
P15813	CD1D	Antigen-presenting glycoprotein CD1d	GO:0071723; F:lipopeptide binding; IBA:RefGenome
P15813	CD1D	Antigen-presenting glycoprotein CD1d	GO:0004872; F:receptor activity; IC:UniProtKB
P15813	CD1D	Antigen-presenting glycoprotein CD1d	GO:0048006; P:antigen processing and presentation, endogenous lipid antigen via MHC class Ib; IDA:UniProtKB
P15813	CD1D	Antigen-presenting glycoprotein CD1d	GO:0048007; P:antigen processing and presentation, exogenous lipid antigen via MHC class Ib; IBA:RefGenome
P15813	CD1D	Antigen-presenting glycoprotein CD1d	GO:0016045; P:detection of bacterium; TAS:UniProtKB
P15813	CD1D	Antigen-presenting glycoprotein CD1d	GO:0034113; P:heterotypic cell-cell adhesion; TAS:BHF-UCL
P15813	CD1D	Antigen-presenting glycoprotein CD1d	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
P15813	CD1D	Antigen-presenting glycoprotein CD1d	GO:0045089; P:positive regulation of innate immune response; TAS:UniProtKB
P15813	CD1D	Antigen-presenting glycoprotein CD1d	GO:0042102; P:positive regulation of T cell proliferation; IDA:BHF-UCL
P15813	CD1D	Antigen-presenting glycoprotein CD1d	GO:0045058; P:T cell selection; TAS:UniProtKB
P15813	CD1D	Antigen-presenting glycoprotein CD1d	GO:0016032; P:viral process; IEA:UniProtKB-KW
P15812	CD1E	T-cell surface glycoprotein CD1e, membrane-associated	GO:0030881; F:beta-2-microglobulin binding; IBA:RefGenome
P15812	CD1E	T-cell surface glycoprotein CD1e, membrane-associated	GO:0030883; F:endogenous lipid antigen binding; IBA:RefGenome
P15812	CD1E	T-cell surface glycoprotein CD1e, membrane-associated	GO:0030884; F:exogenous lipid antigen binding; IBA:RefGenome
P15812	CD1E	T-cell surface glycoprotein CD1e, membrane-associated	GO:0071723; F:lipopeptide binding; IBA:RefGenome
P15812	CD1E	T-cell surface glycoprotein CD1e, membrane-associated	GO:0048007; P:antigen processing and presentation, exogenous lipid antigen via MHC class Ib; IBA:RefGenome
P15812	CD1E	T-cell surface glycoprotein CD1e, membrane-associated	GO:0006955; P:immune response; NAS:UniProtKB
Q9NNX6	CD209	CD209 antigen	GO:0030246; F:carbohydrate binding; NAS:UniProtKB
Q9NNX6	CD209	CD209 antigen	GO:0005537; F:mannose binding; TAS:UniProtKB
Q9NNX6	CD209	CD209 antigen	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NNX6	CD209	CD209 antigen	GO:0042605; F:peptide antigen binding; NAS:UniProtKB
Q9NNX6	CD209	CD209 antigen	GO:0046790; F:virion binding; TAS:UniProtKB
Q9NNX6	CD209	CD209 antigen	GO:0019882; P:antigen processing and presentation; NAS:UniProtKB
Q9NNX6	CD209	CD209 antigen	GO:0009988; P:cell-cell recognition; TAS:UniProtKB
Q9NNX6	CD209	CD209 antigen	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q9NNX6	CD209	CD209 antigen	GO:0007157; P:heterophilic cell-cell adhesion; TAS:UniProtKB
Q9NNX6	CD209	CD209 antigen	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q9NNX6	CD209	CD209 antigen	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
Q9NNX6	CD209	CD209 antigen	GO:0075733; P:intracellular transport of virus; TAS:UniProtKB
Q9NNX6	CD209	CD209 antigen	GO:0007159; P:leukocyte cell-cell adhesion; NAS:UniProtKB
Q9NNX6	CD209	CD209 antigen	GO:0019048; P:modulation by virus of host morphology or physiology; TAS:UniProtKB
Q9NNX6	CD209	CD209 antigen	GO:0046968; P:peptide antigen transport; NAS:UniProtKB
Q9NNX6	CD209	CD209 antigen	GO:0042129; P:regulation of T cell proliferation; IDA:MGI
Q9NNX6	CD209	CD209 antigen	GO:0019079; P:viral genome replication; NAS:UniProtKB
Q9NNX6	CD209	CD209 antigen	GO:0019062; P:virion attachment to host cell; TAS:UniProtKB
P11836	MS4A1	B-lymphocyte antigen CD20	GO:0023026; F:MHC class II protein complex binding; IDA:UniProt
P11836	MS4A1	B-lymphocyte antigen CD20	GO:0042100; P:B cell proliferation; NAS:UniProt
P11836	MS4A1	B-lymphocyte antigen CD20	GO:0006959; P:humoral immune response; NAS:UniProt
Q15762	CD226	CD226 antigen	GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL
Q15762	CD226	CD226 antigen	GO:0005178; F:integrin binding; IPI:BHF-UCL
Q15762	CD226	CD226 antigen	GO:0005515; F:protein binding; IPI:IntAct
Q15762	CD226	CD226 antigen	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
Q15762	CD226	CD226 antigen	GO:0007155; P:cell adhesion; TAS:ProtInc
Q15762	CD226	CD226 antigen	GO:0008037; P:cell recognition; TAS:BHF-UCL
Q15762	CD226	CD226 antigen	GO:0001816; P:cytokine production; IEA:Ensembl
Q15762	CD226	CD226 antigen	GO:0060369; P:positive regulation of Fc receptor mediated stimulatory signaling pathway; IDA:BHF-UCL
Q15762	CD226	CD226 antigen	GO:0002891; P:positive regulation of immunoglobulin mediated immune response; IDA:BHF-UCL
Q15762	CD226	CD226 antigen	GO:0033005; P:positive regulation of mast cell activation; IDA:BHF-UCL
Q15762	CD226	CD226 antigen	GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; IMP:BHF-UCL
Q15762	CD226	CD226 antigen	GO:0002860; P:positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; IMP:BHF-UCL
Q15762	CD226	CD226 antigen	GO:0050776; P:regulation of immune response; TAS:Reactome
Q15762	CD226	CD226 antigen	GO:0007165; P:signal transduction; TAS:ProtInc
P20273	CD22	B-cell receptor CD22	GO:0005515; F:protein binding; IPI:IntAct
P20273	CD22	B-cell receptor CD22	GO:0007155; P:cell adhesion; NAS:ProtInc
Q9BZW8	CD244	Natural killer cell receptor 2B4	GO:0005515; F:protein binding; IPI:IntAct
Q9BZW8	CD244	Natural killer cell receptor 2B4	GO:0004872; F:receptor activity; TAS:ProtInc
Q9BZW8	CD244	Natural killer cell receptor 2B4	GO:0007596; P:blood coagulation; TAS:Reactome
Q9BZW8	CD244	Natural killer cell receptor 2B4	GO:0050900; P:leukocyte migration; TAS:Reactome
Q9BZW8	CD244	Natural killer cell receptor 2B4	GO:0007165; P:signal transduction; TAS:ProtInc
Q9HCU0	CD248	Endosialin	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9HCU0	CD248	Endosialin	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q9HCU0	CD248	Endosialin	GO:0050840; F:extracellular matrix binding; IEA:Ensembl
Q9HCU0	CD248	Endosialin	GO:0060033; P:anatomical structure regression; IEA:Ensembl
Q9HCU0	CD248	Endosialin	GO:0016477; P:cell migration; IEA:Ensembl
Q9HCU0	CD248	Endosialin	GO:0048535; P:lymph node development; IEA:Ensembl
Q9HCU0	CD248	Endosialin	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q9HCU0	CD248	Endosialin	GO:2000353; P:positive regulation of endothelial cell apoptotic process; IEA:Ensembl
Q5ZPR3	CD276	CD276 antigen	GO:0005515; F:protein binding; IPI:UniProtKB
Q5ZPR3	CD276	CD276 antigen	GO:0005102; F:receptor binding; NAS:HGNC
Q5ZPR3	CD276	CD276 antigen	GO:0008283; P:cell proliferation; NAS:UniProtKB
Q5ZPR3	CD276	CD276 antigen	GO:0006955; P:immune response; NAS:UniProtKB
Q5ZPR3	CD276	CD276 antigen	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
Q5ZPR3	CD276	CD276 antigen	GO:0045077; P:negative regulation of interferon-gamma biosynthetic process; IEA:Ensembl
Q5ZPR3	CD276	CD276 antigen	GO:0045085; P:negative regulation of interleukin-2 biosynthetic process; IEA:Ensembl
Q5ZPR3	CD276	CD276 antigen	GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl
Q5ZPR3	CD276	CD276 antigen	GO:0030501; P:positive regulation of bone mineralization; IEA:Ensembl
Q5ZPR3	CD276	CD276 antigen	GO:0045078; P:positive regulation of interferon-gamma biosynthetic process; IDA:HGNC
Q5ZPR3	CD276	CD276 antigen	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
Q5ZPR3	CD276	CD276 antigen	GO:0042102; P:positive regulation of T cell proliferation; IDA:HGNC
Q5ZPR3	CD276	CD276 antigen	GO:0050776; P:regulation of immune response; NAS:HGNC
Q5ZPR3	CD276	CD276 antigen	GO:0042110; P:T cell activation; IDA:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0005515; F:protein binding; IPI:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0030296; F:protein tyrosine kinase activator activity; IDA:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0004871; F:signal transducer activity; NAS:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0007411; P:axon guidance; TAS:Reactome
P25063	CD24	Signal transducer CD24	GO:0032597; P:B cell receptor transport into membrane raft; IDA:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0001775; P:cell activation; IDA:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0016477; P:cell migration; ISS:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0032600; P:chemokine receptor transport out of membrane raft; ISS:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0042632; P:cholesterol homeostasis; ISS:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0072139; P:glomerular parietal epithelial cell differentiation; IMP:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0072112; P:glomerular visceral epithelial cell differentiation; IMP:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0002768; P:immune response-regulating cell surface receptor signaling pathway; IC:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0097193; P:intrinsic apoptotic signaling pathway; NAS:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0032913; P:negative regulation of transforming growth factor beta3 production; IMP:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0042104; P:positive regulation of activated T cell proliferation; IDA:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0043406; P:positive regulation of MAP kinase activity; IDA:UniProtKB
P25063	CD24	Signal transducer CD24	GO:2000768; P:positive regulation of nephron tubule epithelial cell differentiation; IMP:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0061098; P:positive regulation of protein tyrosine kinase activity; IDA:GOC
P25063	CD24	Signal transducer CD24	GO:0001959; P:regulation of cytokine-mediated signaling pathway; ISS:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0030856; P:regulation of epithelial cell differentiation; NAS:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0043408; P:regulation of MAPK cascade; IDA:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0042325; P:regulation of phosphorylation; IDA:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0045730; P:respiratory burst; IDA:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0043627; P:response to estrogen; IEP:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0001666; P:response to hypoxia; IEP:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0002237; P:response to molecule of bacterial origin; ISS:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0031295; P:T cell costimulation; IDA:UniProtKB
P25063	CD24	Signal transducer CD24	GO:0016055; P:Wnt signaling pathway; NAS:UniProtKB
P26842	CD27	CD27 antigen	GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IDA:UniProtKB
P26842	CD27	CD27 antigen	GO:0005515; F:protein binding; IPI:UniProtKB
P26842	CD27	CD27 antigen	GO:0004888; F:transmembrane signaling receptor activity; NAS:UniProtKB
P26842	CD27	CD27 antigen	GO:0007166; P:cell surface receptor signaling pathway; NAS:UniProtKB
P26842	CD27	CD27 antigen	GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:BHF-UCL
P26842	CD27	CD27 antigen	GO:0016064; P:immunoglobulin mediated immune response; NAS:UniProtKB
P26842	CD27	CD27 antigen	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P26842	CD27	CD27 antigen	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:GOC
P26842	CD27	CD27 antigen	GO:0070233; P:negative regulation of T cell apoptotic process; IEA:Ensembl
P26842	CD27	CD27 antigen	GO:0045579; P:positive regulation of B cell differentiation; NAS:UniProtKB
P26842	CD27	CD27 antigen	GO:0046330; P:positive regulation of JNK cascade; ISS:UniProtKB
P26842	CD27	CD27 antigen	GO:0008588; P:release of cytoplasmic sequestered NF-kappaB; NAS:UniProtKB
P26842	CD27	CD27 antigen	GO:0045471; P:response to ethanol; IEA:Ensembl
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0015026; F:coreceptor activity; TAS:UniProtKB
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0042802; F:identical protein binding; NAS:UniProtKB
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0002020; F:protease binding; IPI:BHF-UCL
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0005515; F:protein binding; IPI:UniProtKB
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0005070; F:SH3/SH2 adaptor activity; IDA:UniProtKB
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0097190; P:apoptotic signaling pathway; IEA:Ensembl
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0007166; P:cell surface receptor signaling pathway; TAS:UniProtKB
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0042089; P:cytokine biosynthetic process; TAS:UniProtKB
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0006959; P:humoral immune response; TAS:UniProtKB
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0045087; P:innate immune response; TAS:Reactome
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0045060; P:negative thymic T cell selection; IEA:Ensembl
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0046641; P:positive regulation of alpha-beta T cell proliferation; IEA:Ensembl
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0002863; P:positive regulation of inflammatory response to antigenic stimulus; IEA:Ensembl
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0045086; P:positive regulation of interleukin-2 biosynthetic process; IDA:UniProtKB
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0048304; P:positive regulation of isotype switching to IgG isotypes; IEA:Ensembl
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0045840; P:positive regulation of mitosis; IDA:UniProtKB
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0009967; P:positive regulation of signal transduction; IDA:GOC
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0042102; P:positive regulation of T cell proliferation; IDA:UniProtKB
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0045727; P:positive regulation of translation; NAS:UniProtKB
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0045070; P:positive regulation of viral genome replication; NAS:UniProtKB
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0045066; P:regulatory T cell differentiation; IDA:BHF-UCL
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0031295; P:T cell costimulation; TAS:Reactome
P10747	CD28	T-cell-specific surface glycoprotein CD28	GO:0016032; P:viral process; TAS:Reactome
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:0004861; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; IDA:BHF-UCL
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:0051059; F:NF-kappaB binding; IDA:BHF-UCL
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:0005515; F:protein binding; IPI:BHF-UCL
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:0007050; P:cell cycle arrest; IDA:BHF-UCL
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:0000075; P:cell cycle checkpoint; IMP:HGNC
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:0000082; P:G1/S transition of mitotic cell cycle; IDA:BHF-UCL
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:0030308; P:negative regulation of cell growth; IDA:BHF-UCL
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:0001953; P:negative regulation of cell-matrix adhesion; IMP:BHF-UCL
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:BHF-UCL
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:BHF-UCL
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:0042326; P:negative regulation of phosphorylation; IDA:BHF-UCL
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:2000774; P:positive regulation of cellular senescence; IMP:UniProtKB
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:2000111; P:positive regulation of macrophage apoptotic process; ISS:BHF-UCL
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:0034393; P:positive regulation of smooth muscle cell apoptotic process; ISS:BHF-UCL
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:0007265; P:Ras protein signal transduction; IEP:BHF-UCL
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:0090399; P:replicative senescence; IMP:BHF-UCL
P42771	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3	GO:0035986; P:senescence-associated heterochromatin focus assembly; IMP:UniProtKB
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0097371; F:MDM2/MDM4 family protein binding; IPI:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0002039; F:p53 binding; IPI:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0055105; F:ubiquitin-protein ligase inhibitor activity; ISS:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0008637; P:apoptotic mitochondrial changes; IMP:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0007050; P:cell cycle arrest; IMP:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0090398; P:cellular senescence; IMP:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0030889; P:negative regulation of B cell proliferation; ISS:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0033088; P:negative regulation of immature T cell proliferation in thymus; ISS:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0006469; P:negative regulation of protein kinase activity; IMP:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0051444; P:negative regulation of ubiquitin-protein ligase activity; ISS:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0071158; P:positive regulation of cell cycle arrest; IDA:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0043517; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; IDA:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0033235; P:positive regulation of protein sumoylation; IMP:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0031648; P:protein destabilization; IDA:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0050821; P:protein stabilization; IDA:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:1902510; P:regulation of apoptotic DNA fragmentation; IMP:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; IMP:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0046825; P:regulation of protein export from nucleus; IMP:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0031647; P:regulation of protein stability; ISS:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0048103; P:somatic stem cell division; ISS:BHF-UCL
Q8N726	CDKN2A	Cyclin-dependent kinase inhibitor 2A, isoform 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y5K6	CD2AP	CD2-associated protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y5K6	CD2AP	CD2-associated protein	GO:0017124; F:SH3 domain binding; IPI:UniProtKB
Q9Y5K6	CD2AP	CD2-associated protein	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
Q9Y5K6	CD2AP	CD2-associated protein	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
Q9Y5K6	CD2AP	CD2-associated protein	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9Y5K6	CD2AP	CD2-associated protein	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q9Y5K6	CD2AP	CD2-associated protein	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q9Y5K6	CD2AP	CD2-associated protein	GO:0048259; P:regulation of receptor-mediated endocytosis; IEA:Ensembl
Q9Y5K6	CD2AP	CD2-associated protein	GO:0007165; P:signal transduction; NAS:ProtInc
Q9Y5K6	CD2AP	CD2-associated protein	GO:0006930; P:substrate-dependent cell migration, cell extension; TAS:ProtInc
Q9Y5K6	CD2AP	CD2-associated protein	GO:0016050; P:vesicle organization; IEA:Ensembl
O95400	CD2BP2	CD2 antigen cytoplasmic tail-binding protein 2	GO:0005515; F:protein binding; IPI:IntAct
O95400	CD2BP2	CD2 antigen cytoplasmic tail-binding protein 2	GO:0043021; F:ribonucleoprotein complex binding; IDA:BHF-UCL
O95400	CD2BP2	CD2 antigen cytoplasmic tail-binding protein 2	GO:0010467; P:gene expression; TAS:Reactome
O95400	CD2BP2	CD2 antigen cytoplasmic tail-binding protein 2	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
O95400	CD2BP2	CD2 antigen cytoplasmic tail-binding protein 2	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
O95400	CD2BP2	CD2 antigen cytoplasmic tail-binding protein 2	GO:0008380; P:RNA splicing; TAS:Reactome
O95400	CD2BP2	CD2 antigen cytoplasmic tail-binding protein 2	GO:0000244; P:spliceosomal tri-snRNP complex assembly; NAS:BHF-UCL
P06729	CD2	T-cell surface antigen CD2	GO:0005515; F:protein binding; IPI:UniProtKB
P06729	CD2	T-cell surface antigen CD2	GO:0004872; F:receptor activity; NAS:UniProtKB
P06729	CD2	T-cell surface antigen CD2	GO:0005102; F:receptor binding; IPI:UniProt
P06729	CD2	T-cell surface antigen CD2	GO:0006915; P:apoptotic process; TAS:UniProtKB
P06729	CD2	T-cell surface antigen CD2	GO:0007596; P:blood coagulation; TAS:Reactome
P06729	CD2	T-cell surface antigen CD2	GO:0007166; P:cell surface receptor signaling pathway; TAS:UniProtKB
P06729	CD2	T-cell surface antigen CD2	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
P06729	CD2	T-cell surface antigen CD2	GO:0034113; P:heterotypic cell-cell adhesion; IDA:UniProt
P06729	CD2	T-cell surface antigen CD2	GO:0050900; P:leukocyte migration; TAS:Reactome
P06729	CD2	T-cell surface antigen CD2	GO:0001766; P:membrane raft polarization; TAS:UniProtKB
P06729	CD2	T-cell surface antigen CD2	GO:0030101; P:natural killer cell activation; NAS:UniProtKB
P06729	CD2	T-cell surface antigen CD2	GO:1902715; P:positive regulation of interferon-gamma secretion; IDA:UniProt
P06729	CD2	T-cell surface antigen CD2	GO:2000484; P:positive regulation of interleukin-8 secretion; IMP:UniProt
P06729	CD2	T-cell surface antigen CD2	GO:0030887; P:positive regulation of myeloid dendritic cell activation; NAS:UniProtKB
P06729	CD2	T-cell surface antigen CD2	GO:0032760; P:positive regulation of tumor necrosis factor production; IDA:UniProt
P06729	CD2	T-cell surface antigen CD2	GO:0045580; P:regulation of T cell differentiation; NAS:UniProtKB
P06729	CD2	T-cell surface antigen CD2	GO:0042110; P:T cell activation; TAS:UniProtKB
Q8IX05	CD302	CD302 antigen	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q8IX05	CD302	CD302 antigen	GO:0006909; P:phagocytosis; IDA:MGI
Q9NPF0	CD320	CD320 antigen	GO:0031419; F:cobalamin binding; IDA:MGI
Q9NPF0	CD320	CD320 antigen	GO:0009235; P:cobalamin metabolic process; TAS:Reactome
Q9NPF0	CD320	CD320 antigen	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
Q9NPF0	CD320	CD320 antigen	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NPF0	CD320	CD320 antigen	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9NPF0	CD320	CD320 antigen	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
P20138	CD33	Myeloid cell surface antigen CD33	GO:0005515; F:protein binding; IPI:IntAct
P20138	CD33	Myeloid cell surface antigen CD33	GO:0004872; F:receptor activity; TAS:ProtInc
P20138	CD33	Myeloid cell surface antigen CD33	GO:0007155; P:cell adhesion; NAS:ProtInc
P20138	CD33	Myeloid cell surface antigen CD33	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P20138	CD33	Myeloid cell surface antigen CD33	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P20138	CD33	Myeloid cell surface antigen CD33	GO:0007165; P:signal transduction; TAS:ProtInc
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0030246; F:carbohydrate binding; IDA:HGNC
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0043199; F:sulfate binding; IEA:Ensembl
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0048870; P:cell motility; IEP:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0008283; P:cell proliferation; ISS:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0016337; P:single organismal cell-cell adhesion; IDA:HGNC
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0001935; P:endothelial cell proliferation; IDA:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0003158; P:endothelium development; IEP:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0071971; P:extracellular vesicular exosome assembly; IDA:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0072011; P:glomerular endothelium development; IEP:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0003094; P:glomerular filtration; IEP:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0006536; P:glutamate metabolic process; IDA:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0071425; P:hematopoietic stem cell proliferation; IMP:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0030097; P:hemopoiesis; IMP:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0050900; P:leukocyte migration; ISS:HGNC
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0035759; P:mesangial cell-matrix adhesion; ISS:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0072254; P:metanephric glomerular mesangial cell differentiation; IEP:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0030195; P:negative regulation of blood coagulation; IDA:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:1900035; P:negative regulation of cellular response to heat; IDA:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:1900038; P:negative regulation of cellular response to hypoxia; IDA:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:1900041; P:negative regulation of interleukin-2 secretion; IMP:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:1901215; P:negative regulation of neuron death; IDA:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0045019; P:negative regulation of nitric oxide biosynthetic process; IDA:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0032720; P:negative regulation of tumor necrosis factor production; IDA:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0038001; P:paracrine signaling; IDA:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0010628; P:positive regulation of gene expression; IEP:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:1900168; P:positive regulation of glial cell line-derived neurotrophic factor secretion; IDA:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0071657; P:positive regulation of granulocyte colony-stimulating factor production; IDA:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0032733; P:positive regulation of interleukin-10 production; IDA:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0042482; P:positive regulation of odontogenesis; IDA:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0071636; P:positive regulation of transforming growth factor beta production; IDA:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:2001214; P:positive regulation of vasculogenesis; IDA:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0008217; P:regulation of blood pressure; IDA:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0050776; P:regulation of immune response; TAS:Reactome
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0007165; P:signal transduction; IEP:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0072089; P:stem cell proliferation; IEP:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0001894; P:tissue homeostasis; IDA:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0060290; P:transdifferentiation; IEP:UniProtKB
P28906	CD34	Hematopoietic progenitor cell antigen CD34	GO:0061042; P:vascular wound healing; IEP:UniProtKB
P16671	CD36	Platelet glycoprotein 4	GO:0008035; F:high-density lipoprotein particle binding; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0008289; F:lipid binding; IDA:BHF-UCL
P16671	CD36	Platelet glycoprotein 4	GO:0071813; F:lipoprotein particle binding; IDA:UniProtKB
P16671	CD36	Platelet glycoprotein 4	GO:0070892; F:lipoteichoic acid receptor activity; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0030169; F:low-density lipoprotein particle binding; IDA:BHF-UCL
P16671	CD36	Platelet glycoprotein 4	GO:0005041; F:low-density lipoprotein receptor activity; IMP:BHF-UCL
P16671	CD36	Platelet glycoprotein 4	GO:0070053; F:thrombospondin receptor activity; ISS:BHF-UCL
P16671	CD36	Platelet glycoprotein 4	GO:0050431; F:transforming growth factor beta binding; ISS:BHF-UCL
P16671	CD36	Platelet glycoprotein 4	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P16671	CD36	Platelet glycoprotein 4	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P16671	CD36	Platelet glycoprotein 4	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P16671	CD36	Platelet glycoprotein 4	GO:0043277; P:apoptotic cell clearance; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0007596; P:blood coagulation; TAS:Reactome
P16671	CD36	Platelet glycoprotein 4	GO:0007155; P:cell adhesion; TAS:ProtInc
P16671	CD36	Platelet glycoprotein 4	GO:0007166; P:cell surface receptor signaling pathway; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P16671	CD36	Platelet glycoprotein 4	GO:0071221; P:cellular response to bacterial lipopeptide; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0071447; P:cellular response to hydroperoxide; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0071223; P:cellular response to lipoteichoic acid; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0019934; P:cGMP-mediated signaling; IDA:BHF-UCL
P16671	CD36	Platelet glycoprotein 4	GO:0030301; P:cholesterol transport; ISS:BHF-UCL
P16671	CD36	Platelet glycoprotein 4	GO:0050830; P:defense response to Gram-positive bacterium; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0045087; P:innate immune response; TAS:Reactome
P16671	CD36	Platelet glycoprotein 4	GO:0006629; P:lipid metabolic process; NAS:ProtInc
P16671	CD36	Platelet glycoprotein 4	GO:0019915; P:lipid storage; IMP:BHF-UCL
P16671	CD36	Platelet glycoprotein 4	GO:0042953; P:lipoprotein transport; IMP:BHF-UCL
P16671	CD36	Platelet glycoprotein 4	GO:0044539; P:long-chain fatty acid import; IDA:UniProtKB
P16671	CD36	Platelet glycoprotein 4	GO:0034383; P:low-density lipoprotein particle clearance; IMP:BHF-UCL
P16671	CD36	Platelet glycoprotein 4	GO:0055096; P:low-density lipoprotein particle mediated signaling; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P16671	CD36	Platelet glycoprotein 4	GO:0044130; P:negative regulation of growth of symbiont in host; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0042992; P:negative regulation of transcription factor import into nucleus; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0007263; P:nitric oxide mediated signal transduction; IDA:BHF-UCL
P16671	CD36	Platelet glycoprotein 4	GO:0006910; P:phagocytosis, recognition; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0034381; P:plasma lipoprotein particle clearance; ISS:BHF-UCL
P16671	CD36	Platelet glycoprotein 4	GO:0015911; P:plasma membrane long-chain fatty acid transport; IDA:BHF-UCL
P16671	CD36	Platelet glycoprotein 4	GO:0030168; P:platelet activation; TAS:Reactome
P16671	CD36	Platelet glycoprotein 4	GO:0002576; P:platelet degranulation; TAS:Reactome
P16671	CD36	Platelet glycoprotein 4	GO:0030194; P:positive regulation of blood coagulation; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:2000334; P:positive regulation of blood microparticle formation; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0001954; P:positive regulation of cell-matrix adhesion; IDA:BHF-UCL
P16671	CD36	Platelet glycoprotein 4	GO:0010886; P:positive regulation of cholesterol storage; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0032735; P:positive regulation of interleukin-12 production; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0060907; P:positive regulation of macrophage cytokine production; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; IMP:BHF-UCL
P16671	CD36	Platelet glycoprotein 4	GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0060100; P:positive regulation of phagocytosis, engulfment; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0032760; P:positive regulation of tumor necrosis factor production; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0006898; P:receptor-mediated endocytosis; IMP:GOC
P16671	CD36	Platelet glycoprotein 4	GO:2000121; P:regulation of removal of superoxide radicals; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0035634; P:response to stilbenoid; IEA:Ensembl
P16671	CD36	Platelet glycoprotein 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P16671	CD36	Platelet glycoprotein 4	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P16671	CD36	Platelet glycoprotein 4	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P16671	CD36	Platelet glycoprotein 4	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P16671	CD36	Platelet glycoprotein 4	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P16671	CD36	Platelet glycoprotein 4	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P11049	CD37	Leukocyte antigen CD37	GO:0005515; F:protein binding; IPI:UniProtKB
P11049	CD37	Leukocyte antigen CD37	GO:0042832; P:defense response to protozoan; IEA:Ensembl
P11049	CD37	Leukocyte antigen CD37	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P11049	CD37	Leukocyte antigen CD37	GO:0030886; P:negative regulation of myeloid dendritic cell activation; IEA:Ensembl
P11049	CD37	Leukocyte antigen CD37	GO:0002639; P:positive regulation of immunoglobulin production; IEA:Ensembl
P11049	CD37	Leukocyte antigen CD37	GO:0050688; P:regulation of defense response to virus; IEA:Ensembl
P11049	CD37	Leukocyte antigen CD37	GO:0002920; P:regulation of humoral immune response; IEA:Ensembl
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0050135; F:NAD(P)+ nucleosidase activity; IEA:UniProtKB-EC
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0003953; F:NAD+ nucleosidase activity; IEA:Ensembl
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0016849; F:phosphorus-oxygen lyase activity; IEA:Ensembl
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0097190; P:apoptotic signaling pathway; TAS:ProtInc
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0050853; P:B cell receptor signaling pathway; IMP:UniProtKB
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0007565; P:female pregnancy; IEA:Ensembl
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0060292; P:long term synaptic depression; IEA:Ensembl
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0045779; P:negative regulation of bone resorption; IEA:Ensembl
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0030890; P:positive regulation of B cell proliferation; IMP:UniProtKB
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0030307; P:positive regulation of cell growth; IEA:Ensembl
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0042493; P:response to drug; IMP:UniProtKB
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0032355; P:response to estradiol; IEA:Ensembl
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0033194; P:response to hydroperoxide; IEA:Ensembl
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0001666; P:response to hypoxia; IEA:Ensembl
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0070555; P:response to interleukin-1; IEA:Ensembl
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0032570; P:response to progesterone; IEA:Ensembl
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0032526; P:response to retinoic acid; IEA:Ensembl
P28907	CD38	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	GO:0007165; P:signal transduction; NAS:ProtInc
P04234	CD3D	T-cell surface glycoprotein CD3 delta chain	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
P04234	CD3D	T-cell surface glycoprotein CD3 delta chain	GO:0003713; F:transcription coactivator activity; IDA:MGI
P04234	CD3D	T-cell surface glycoprotein CD3 delta chain	GO:0004888; F:transmembrane signaling receptor activity; IC:UniProtKB
P04234	CD3D	T-cell surface glycoprotein CD3 delta chain	GO:0007166; P:cell surface receptor signaling pathway; IC:UniProtKB
P04234	CD3D	T-cell surface glycoprotein CD3 delta chain	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
P04234	CD3D	T-cell surface glycoprotein CD3 delta chain	GO:0045059; P:positive thymic T cell selection; ISS:UniProtKB
P04234	CD3D	T-cell surface glycoprotein CD3 delta chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P04234	CD3D	T-cell surface glycoprotein CD3 delta chain	GO:0031295; P:T cell costimulation; TAS:Reactome
P04234	CD3D	T-cell surface glycoprotein CD3 delta chain	GO:0030217; P:T cell differentiation; IDA:MGI
P04234	CD3D	T-cell surface glycoprotein CD3 delta chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0005515; F:protein binding; IPI:IntAct
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0019901; F:protein kinase binding; NAS:UniProtKB
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0030159; F:receptor signaling complex scaffold activity; NAS:UniProtKB
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0005057; F:receptor signaling protein activity; TAS:ProtInc
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0017124; F:SH3 domain binding; IPI:UniProtKB
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0042608; F:T cell receptor binding; NAS:UniProtKB
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0004888; F:transmembrane signaling receptor activity; NAS:UniProtKB
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0097190; P:apoptotic signaling pathway; IEA:Ensembl
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0007166; P:cell surface receptor signaling pathway; NAS:UniProtKB
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0035556; P:intracellular signal transduction; TAS:GOC
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0045879; P:negative regulation of smoothened signaling pathway; IEA:Ensembl
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0045060; P:negative thymic T cell selection; IEA:Ensembl
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0046641; P:positive regulation of alpha-beta T cell proliferation; IEA:Ensembl
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0050850; P:positive regulation of calcium-mediated signaling; IEA:Ensembl
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0032729; P:positive regulation of interferon-gamma production; IEA:Ensembl
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0045086; P:positive regulation of interleukin-2 biosynthetic process; IEA:Ensembl
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0032753; P:positive regulation of interleukin-4 production; IEA:Ensembl
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0002669; P:positive regulation of T cell anergy; IEA:Ensembl
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0042102; P:positive regulation of T cell proliferation; IMP:UniProtKB
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0006461; P:protein complex assembly; NAS:UniProtKB
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0042981; P:regulation of apoptotic process; NAS:UniProtKB
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0007584; P:response to nutrient; IEA:Ensembl
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0007172; P:signal complex assembly; TAS:ProtInc
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0042110; P:T cell activation; NAS:UniProtKB
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0031295; P:T cell costimulation; TAS:Reactome
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P07766	CD3E	T-cell surface glycoprotein CD3 epsilon chain	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc
P09693	CD3G	T-cell surface glycoprotein CD3 gamma chain	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
P09693	CD3G	T-cell surface glycoprotein CD3 gamma chain	GO:0030159; F:receptor signaling complex scaffold activity; NAS:UniProtKB
P09693	CD3G	T-cell surface glycoprotein CD3 gamma chain	GO:0042608; F:T cell receptor binding; NAS:UniProtKB
P09693	CD3G	T-cell surface glycoprotein CD3 gamma chain	GO:0004888; F:transmembrane signaling receptor activity; IMP:UniProtKB
P09693	CD3G	T-cell surface glycoprotein CD3 gamma chain	GO:0007166; P:cell surface receptor signaling pathway; IMP:UniProtKB
P09693	CD3G	T-cell surface glycoprotein CD3 gamma chain	GO:0007163; P:establishment or maintenance of cell polarity; IMP:UniProtKB
P09693	CD3G	T-cell surface glycoprotein CD3 gamma chain	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P09693	CD3G	T-cell surface glycoprotein CD3 gamma chain	GO:0045087; P:innate immune response; TAS:Reactome
P09693	CD3G	T-cell surface glycoprotein CD3 gamma chain	GO:0006461; P:protein complex assembly; NAS:UniProtKB
P09693	CD3G	T-cell surface glycoprotein CD3 gamma chain	GO:0015031; P:protein transport; IMP:UniProtKB
P09693	CD3G	T-cell surface glycoprotein CD3 gamma chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P09693	CD3G	T-cell surface glycoprotein CD3 gamma chain	GO:0070228; P:regulation of lymphocyte apoptotic process; IMP:UniProtKB
P09693	CD3G	T-cell surface glycoprotein CD3 gamma chain	GO:0042110; P:T cell activation; NAS:UniProtKB
P09693	CD3G	T-cell surface glycoprotein CD3 gamma chain	GO:0031295; P:T cell costimulation; TAS:Reactome
P09693	CD3G	T-cell surface glycoprotein CD3 gamma chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P20963	CD247	T-cell surface glycoprotein CD3 zeta chain	GO:0042802; F:identical protein binding; IPI:IntAct
P20963	CD247	T-cell surface glycoprotein CD3 zeta chain	GO:0005515; F:protein binding; IPI:UniProtKB
P20963	CD247	T-cell surface glycoprotein CD3 zeta chain	GO:0042803; F:protein homodimerization activity; NAS:UniProtKB
P20963	CD247	T-cell surface glycoprotein CD3 zeta chain	GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro
P20963	CD247	T-cell surface glycoprotein CD3 zeta chain	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P20963	CD247	T-cell surface glycoprotein CD3 zeta chain	GO:0045087; P:innate immune response; TAS:Reactome
P20963	CD247	T-cell surface glycoprotein CD3 zeta chain	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
P20963	CD247	T-cell surface glycoprotein CD3 zeta chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P20963	CD247	T-cell surface glycoprotein CD3 zeta chain	GO:0031295; P:T cell costimulation; TAS:Reactome
P20963	CD247	T-cell surface glycoprotein CD3 zeta chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P20963	CD247	T-cell surface glycoprotein CD3 zeta chain	GO:0016032; P:viral process; TAS:Reactome
P29965	CD40LG	CD40 ligand	GO:0005174; F:CD40 receptor binding; IPI:UniProtKB
P29965	CD40LG	CD40 ligand	GO:0030183; P:B cell differentiation; IEA:Ensembl
P29965	CD40LG	CD40 ligand	GO:0042100; P:B cell proliferation; IDA:UniProtKB
P29965	CD40LG	CD40 ligand	GO:0048305; P:immunoglobulin secretion; IEA:Ensembl
P29965	CD40LG	CD40 ligand	GO:0006954; P:inflammatory response; IDA:UniProtKB
P29965	CD40LG	CD40 ligand	GO:0045190; P:isotype switching; ISS:UniProtKB
P29965	CD40LG	CD40 ligand	GO:0007159; P:leukocyte cell-cell adhesion; NAS:UniProtKB
P29965	CD40LG	CD40 ligand	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P29965	CD40LG	CD40 ligand	GO:0030168; P:platelet activation; IDA:UniProtKB
P29965	CD40LG	CD40 ligand	GO:2000353; P:positive regulation of endothelial cell apoptotic process; IDA:BHF-UCL
P29965	CD40LG	CD40 ligand	GO:0032735; P:positive regulation of interleukin-12 production; IDA:UniProtKB
P29965	CD40LG	CD40 ligand	GO:0050776; P:regulation of immune response; TAS:Reactome
P29965	CD40LG	CD40 ligand	GO:0051023; P:regulation of immunoglobulin secretion; IEA:Ensembl
P16070	CD44	CD44 antigen	GO:0005518; F:collagen binding; NAS:UniProtKB
P16070	CD44	CD44 antigen	GO:0005540; F:hyaluronic acid binding; IDA:UniProtKB
P16070	CD44	CD44 antigen	GO:0004415; F:hyalurononglucosaminidase activity; IDA:UniProtKB
P16070	CD44	CD44 antigen	GO:0005515; F:protein binding; IPI:IntAct
P16070	CD44	CD44 antigen	GO:0007596; P:blood coagulation; TAS:Reactome
P16070	CD44	CD44 antigen	GO:0060442; P:branching involved in prostate gland morphogenesis; IEA:Ensembl
P16070	CD44	CD44 antigen	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
P16070	CD44	CD44 antigen	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P16070	CD44	CD44 antigen	GO:0051216; P:cartilage development; IEP:UniProtKB
P16070	CD44	CD44 antigen	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
P16070	CD44	CD44 antigen	GO:0007160; P:cell-matrix adhesion; NAS:UniProtKB
P16070	CD44	CD44 antigen	GO:0044344; P:cellular response to fibroblast growth factor stimulus; IDA:UniProtKB
P16070	CD44	CD44 antigen	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P16070	CD44	CD44 antigen	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P16070	CD44	CD44 antigen	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P16070	CD44	CD44 antigen	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P16070	CD44	CD44 antigen	GO:0030214; P:hyaluronan catabolic process; IDA:UniProtKB
P16070	CD44	CD44 antigen	GO:0030212; P:hyaluronan metabolic process; TAS:Reactome
P16070	CD44	CD44 antigen	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P16070	CD44	CD44 antigen	GO:0050900; P:leukocyte migration; TAS:Reactome
P16070	CD44	CD44 antigen	GO:0070487; P:monocyte aggregation; IMP:UniProtKB
P16070	CD44	CD44 antigen	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P16070	CD44	CD44 antigen	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
P16070	CD44	CD44 antigen	GO:0043518; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; IDA:BHF-UCL
P16070	CD44	CD44 antigen	GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IDA:BHF-UCL
P16070	CD44	CD44 antigen	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL
P16070	CD44	CD44 antigen	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P16070	CD44	CD44 antigen	GO:0034116; P:positive regulation of heterotypic cell-cell adhesion; IMP:UniProtKB
P16070	CD44	CD44 antigen	GO:1900625; P:positive regulation of monocyte aggregation; IMP:BHF-UCL
P16070	CD44	CD44 antigen	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:BHF-UCL
P16070	CD44	CD44 antigen	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL
P16070	CD44	CD44 antigen	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P16070	CD44	CD44 antigen	GO:0016055; P:Wnt signaling pathway; IEA:Ensembl
P16070	CD44	CD44 antigen	GO:0002246; P:wound healing involved in inflammatory response; IEA:Ensembl
Q08722	CD47	Leukocyte surface antigen CD47	GO:0005515; F:protein binding; IPI:UniProtKB
Q08722	CD47	Leukocyte surface antigen CD47	GO:0070053; F:thrombospondin receptor activity; IPI:BHF-UCL
Q08722	CD47	Leukocyte surface antigen CD47	GO:0007596; P:blood coagulation; TAS:Reactome
Q08722	CD47	Leukocyte surface antigen CD47	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q08722	CD47	Leukocyte surface antigen CD47	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q08722	CD47	Leukocyte surface antigen CD47	GO:0007229; P:integrin-mediated signaling pathway; TAS:ProtInc
Q08722	CD47	Leukocyte surface antigen CD47	GO:0050900; P:leukocyte migration; TAS:Reactome
Q08722	CD47	Leukocyte surface antigen CD47	GO:0008228; P:opsonization; IEA:Ensembl
Q08722	CD47	Leukocyte surface antigen CD47	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q08722	CD47	Leukocyte surface antigen CD47	GO:0022409; P:positive regulation of cell-cell adhesion; IDA:UniProtKB
Q08722	CD47	Leukocyte surface antigen CD47	GO:0050729; P:positive regulation of inflammatory response; IEA:Ensembl
Q08722	CD47	Leukocyte surface antigen CD47	GO:0050766; P:positive regulation of phagocytosis; IEA:Ensembl
Q08722	CD47	Leukocyte surface antigen CD47	GO:0050870; P:positive regulation of T cell activation; IDA:UniProtKB
Q08722	CD47	Leukocyte surface antigen CD47	GO:0009617; P:response to bacterium; IEA:Ensembl
P09326	CD48	CD48 antigen	GO:0003823; F:antigen binding; IEA:Ensembl
P09326	CD48	CD48 antigen	GO:0005515; F:protein binding; IPI:UniProtKB
P09326	CD48	CD48 antigen	GO:0004872; F:receptor activity; IEA:InterPro
P09326	CD48	CD48 antigen	GO:0007596; P:blood coagulation; TAS:Reactome
P09326	CD48	CD48 antigen	GO:0006952; P:defense response; TAS:ProtInc
P09326	CD48	CD48 antigen	GO:0050900; P:leukocyte migration; TAS:Reactome
P09326	CD48	CD48 antigen	GO:0045576; P:mast cell activation; IEA:Ensembl
P09326	CD48	CD48 antigen	GO:0007165; P:signal transduction; IEA:Ensembl
P09326	CD48	CD48 antigen	GO:0042110; P:T cell activation; IEA:Ensembl
P01730	CD4	T-cell surface glycoprotein CD4	GO:0015026; F:coreceptor activity; NAS:UniProtKB
P01730	CD4	T-cell surface glycoprotein CD4	GO:0019899; F:enzyme binding; IPI:UniProtKB
P01730	CD4	T-cell surface glycoprotein CD4	GO:0005201; F:extracellular matrix structural constituent; NAS:UniProtKB
P01730	CD4	T-cell surface glycoprotein CD4	GO:0001948; F:glycoprotein binding; IPI:UniProtKB
P01730	CD4	T-cell surface glycoprotein CD4	GO:0042289; F:MHC class II protein binding; NAS:UniProtKB
P01730	CD4	T-cell surface glycoprotein CD4	GO:0005515; F:protein binding; IPI:UniProtKB
P01730	CD4	T-cell surface glycoprotein CD4	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P01730	CD4	T-cell surface glycoprotein CD4	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P01730	CD4	T-cell surface glycoprotein CD4	GO:0004872; F:receptor activity; TAS:ProtInc
P01730	CD4	T-cell surface glycoprotein CD4	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
P01730	CD4	T-cell surface glycoprotein CD4	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P01730	CD4	T-cell surface glycoprotein CD4	GO:0007155; P:cell adhesion; IEA:InterPro
P01730	CD4	T-cell surface glycoprotein CD4	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P01730	CD4	T-cell surface glycoprotein CD4	GO:0001816; P:cytokine production; IEA:Ensembl
P01730	CD4	T-cell surface glycoprotein CD4	GO:0050829; P:defense response to Gram-negative bacterium; IEA:Ensembl
P01730	CD4	T-cell surface glycoprotein CD4	GO:0030260; P:entry into host cell; TAS:Reactome
P01730	CD4	T-cell surface glycoprotein CD4	GO:0007167; P:enzyme linked receptor protein signaling pathway; TAS:ProtInc
P01730	CD4	T-cell surface glycoprotein CD4	GO:0006955; P:immune response; NAS:UniProtKB
P01730	CD4	T-cell surface glycoprotein CD4	GO:0006948; P:induction by virus of host cell-cell fusion; IDA:UniProtKB
P01730	CD4	T-cell surface glycoprotein CD4	GO:0045087; P:innate immune response; TAS:Reactome
P01730	CD4	T-cell surface glycoprotein CD4	GO:0032507; P:maintenance of protein location in cell; IDA:MGI
P01730	CD4	T-cell surface glycoprotein CD4	GO:0050850; P:positive regulation of calcium-mediated signaling; IEA:Ensembl
P01730	CD4	T-cell surface glycoprotein CD4	GO:0045086; P:positive regulation of interleukin-2 biosynthetic process; NAS:UniProtKB
P01730	CD4	T-cell surface glycoprotein CD4	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
P01730	CD4	T-cell surface glycoprotein CD4	GO:0045860; P:positive regulation of protein kinase activity; IDA:UniProtKB
P01730	CD4	T-cell surface glycoprotein CD4	GO:0045234; P:protein palmitoleylation; IDA:MGI
P01730	CD4	T-cell surface glycoprotein CD4	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
P01730	CD4	T-cell surface glycoprotein CD4	GO:0050863; P:regulation of T cell activation; IDA:UniProtKB
P01730	CD4	T-cell surface glycoprotein CD4	GO:0007165; P:signal transduction; TAS:ProtInc
P01730	CD4	T-cell surface glycoprotein CD4	GO:0031295; P:T cell costimulation; TAS:Reactome
P01730	CD4	T-cell surface glycoprotein CD4	GO:0030217; P:T cell differentiation; IDA:UniProtKB
P01730	CD4	T-cell surface glycoprotein CD4	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P01730	CD4	T-cell surface glycoprotein CD4	GO:0045058; P:T cell selection; IDA:UniProtKB
P01730	CD4	T-cell surface glycoprotein CD4	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; NAS:UniProtKB
P01730	CD4	T-cell surface glycoprotein CD4	GO:0016032; P:viral process; TAS:Reactome
P31358	CD52	CAMPATH-1 antigen	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB
P31358	CD52	CAMPATH-1 antigen	GO:0045730; P:respiratory burst; NAS:UniProtKB
P19397	CD53	Leukocyte surface antigen CD53	GO:0005515; F:protein binding; IPI:UniProtKB
P19397	CD53	Leukocyte surface antigen CD53	GO:1901741; P:positive regulation of myoblast fusion; ISS:UniProtKB
P19397	CD53	Leukocyte surface antigen CD53	GO:0007165; P:signal transduction; NAS:ProtInc
P13987	CD59	CD59 glycoprotein	GO:0001848; F:complement binding; IBA:RefGenome
P13987	CD59	CD59 glycoprotein	GO:0005515; F:protein binding; IPI:IntAct
P13987	CD59	CD59 glycoprotein	GO:0007596; P:blood coagulation; TAS:ProtInc
P13987	CD59	CD59 glycoprotein	GO:0001775; P:cell activation; IBA:RefGenome
P13987	CD59	CD59 glycoprotein	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P13987	CD59	CD59 glycoprotein	GO:0045087; P:innate immune response; TAS:Reactome
P13987	CD59	CD59 glycoprotein	GO:0001971; P:negative regulation of activation of membrane attack complex; IEA:Ensembl
P13987	CD59	CD59 glycoprotein	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P13987	CD59	CD59 glycoprotein	GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl
P13987	CD59	CD59 glycoprotein	GO:0030449; P:regulation of complement activation; TAS:Reactome
O43866	CD5L	CD5 antigen-like	GO:0005044; F:scavenger receptor activity; IEA:InterPro
O43866	CD5L	CD5 antigen-like	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O43866	CD5L	CD5 antigen-like	GO:0006968; P:cellular defense response; TAS:ProtInc
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0045296; F:cadherin binding; ISS:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0005509; F:calcium ion binding; ISS:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0016534; F:cyclin-dependent protein kinase 5 activator activity; IEA:Ensembl
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:Ensembl
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0016301; F:kinase activity; ISS:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0043539; F:protein serine/threonine kinase activator activity; IDA:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0007411; P:axon guidance; ISS:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0007413; P:axonal fasciculation; ISS:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0007420; P:brain development; ISS:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0008283; P:cell proliferation; TAS:ProtInc
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0021549; P:cerebellum development; IEA:Ensembl
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0009790; P:embryo development; ISS:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0048013; P:ephrin receptor signaling pathway; ISS:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0007213; P:G-protein coupled acetylcholine receptor signaling pathway; ISS:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0021766; P:hippocampus development; IEA:Ensembl
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0035235; P:ionotropic glutamate receptor signaling pathway; ISS:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0021819; P:layer formation in cerebral cortex; IEA:Ensembl
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0030517; P:negative regulation of axon extension; IEA:Ensembl
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:DFLAT
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0007158; P:neuron cell-cell adhesion; ISS:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0001764; P:neuron migration; ISS:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0031175; P:neuron projection development; ISS:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0018107; P:peptidyl-threonine phosphorylation; IDA:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0043525; P:positive regulation of neuron apoptotic process; ISS:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0090314; P:positive regulation of protein targeting to membrane; IEA:Ensembl
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0032956; P:regulation of actin cytoskeleton organization; IEA:Ensembl
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0061001; P:regulation of dendritic spine morphogenesis; ISS:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0070507; P:regulation of microtubule cytoskeleton organization; IEA:Ensembl
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0045664; P:regulation of neuron differentiation; NAS:UniProtKB
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0033136; P:serine phosphorylation of STAT3 protein; IEA:Ensembl
Q15078	CDK5R1	Cyclin-dependent kinase 5 activator 1	GO:0021722; P:superior olivary nucleus maturation; IEA:Ensembl
Q13319	CDK5R2	Cyclin-dependent kinase 5 activator 2	GO:0016534; F:cyclin-dependent protein kinase 5 activator activity; IEA:Ensembl
Q13319	CDK5R2	Cyclin-dependent kinase 5 activator 2	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q13319	CDK5R2	Cyclin-dependent kinase 5 activator 2	GO:0021549; P:cerebellum development; IEA:Ensembl
Q13319	CDK5R2	Cyclin-dependent kinase 5 activator 2	GO:0021766; P:hippocampus development; IEA:Ensembl
Q13319	CDK5R2	Cyclin-dependent kinase 5 activator 2	GO:0021819; P:layer formation in cerebral cortex; IEA:Ensembl
Q13319	CDK5R2	Cyclin-dependent kinase 5 activator 2	GO:0001764; P:neuron migration; IEA:Ensembl
Q13319	CDK5R2	Cyclin-dependent kinase 5 activator 2	GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; IEA:Ensembl
Q13319	CDK5R2	Cyclin-dependent kinase 5 activator 2	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
Q13319	CDK5R2	Cyclin-dependent kinase 5 activator 2	GO:0021722; P:superior olivary nucleus maturation; IEA:Ensembl
P06127	CD5	T-cell surface glycoprotein CD5	GO:0005515; F:protein binding; IPI:UniProtKB
P06127	CD5	T-cell surface glycoprotein CD5	GO:0004872; F:receptor activity; NAS:UniProtKB
P06127	CD5	T-cell surface glycoprotein CD5	GO:0005044; F:scavenger receptor activity; IEA:InterPro
P06127	CD5	T-cell surface glycoprotein CD5	GO:0004888; F:transmembrane signaling receptor activity; NAS:UniProtKB
P06127	CD5	T-cell surface glycoprotein CD5	GO:0097190; P:apoptotic signaling pathway; IEA:Ensembl
P06127	CD5	T-cell surface glycoprotein CD5	GO:0008283; P:cell proliferation; NAS:UniProtKB
P06127	CD5	T-cell surface glycoprotein CD5	GO:0008037; P:cell recognition; NAS:UniProtKB
P06127	CD5	T-cell surface glycoprotein CD5	GO:0031295; P:T cell costimulation; IEA:Ensembl
P08962	CD63	CD63 antigen	GO:0005515; F:protein binding; IPI:IntAct
P08962	CD63	CD63 antigen	GO:0007596; P:blood coagulation; TAS:Reactome
P08962	CD63	CD63 antigen	GO:0034613; P:cellular protein localization; IDA:MGI
P08962	CD63	CD63 antigen	GO:0030168; P:platelet activation; TAS:Reactome
P08962	CD63	CD63 antigen	GO:0002576; P:platelet degranulation; TAS:Reactome
P08962	CD63	CD63 antigen	GO:2000680; P:regulation of rubidium ion transport; IDA:MGI
P34810	CD68	Macrosialin	GO:0071310; P:cellular response to organic substance; IEA:Ensembl
Q07108	CD69	Early activation antigen CD69	GO:0005509; F:calcium ion binding; IEA:Ensembl
Q07108	CD69	Early activation antigen CD69	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q07108	CD69	Early activation antigen CD69	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q07108	CD69	Early activation antigen CD69	GO:0035690; P:cellular response to drug; IEA:Ensembl
Q07108	CD69	Early activation antigen CD69	GO:0007165; P:signal transduction; TAS:GOC
P30203	CD6	T-cell differentiation antigen CD6	GO:0005044; F:scavenger receptor activity; IEA:InterPro
P30203	CD6	T-cell differentiation antigen CD6	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P32970	CD70	CD70 antigen	GO:0002020; F:protease binding; IPI:BHF-UCL
P32970	CD70	CD70 antigen	GO:0005515; F:protein binding; IPI:UniProtKB
P32970	CD70	CD70 antigen	GO:0005102; F:receptor binding; TAS:ProtInc
P32970	CD70	CD70 antigen	GO:0008283; P:cell proliferation; TAS:ProtInc
P32970	CD70	CD70 antigen	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P32970	CD70	CD70 antigen	GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:BHF-UCL
P32970	CD70	CD70 antigen	GO:0006955; P:immune response; IEA:InterPro
P32970	CD70	CD70 antigen	GO:0007165; P:signal transduction; TAS:ProtInc
P21854	CD72	B-cell differentiation antigen CD72	GO:0030246; F:carbohydrate binding; IEA:InterPro
P21854	CD72	B-cell differentiation antigen CD72	GO:0005515; F:protein binding; IPI:UniProtKB
P21854	CD72	B-cell differentiation antigen CD72	GO:0005102; F:receptor binding; TAS:ProtInc
P21854	CD72	B-cell differentiation antigen CD72	GO:0004888; F:transmembrane signaling receptor activity; NAS:UniProtKB
P21854	CD72	B-cell differentiation antigen CD72	GO:0007411; P:axon guidance; TAS:Reactome
P21854	CD72	B-cell differentiation antigen CD72	GO:0007155; P:cell adhesion; TAS:ProtInc
P21854	CD72	B-cell differentiation antigen CD72	GO:0007165; P:signal transduction; NAS:GOC
P11912	CD79A	B-cell antigen receptor complex-associated protein alpha chain	GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro
P11912	CD79A	B-cell antigen receptor complex-associated protein alpha chain	GO:0042113; P:B cell activation; ISS:UniProtKB
P11912	CD79A	B-cell antigen receptor complex-associated protein alpha chain	GO:0030183; P:B cell differentiation; ISS:UniProtKB
P11912	CD79A	B-cell antigen receptor complex-associated protein alpha chain	GO:0042100; P:B cell proliferation; ISS:UniProtKB
P11912	CD79A	B-cell antigen receptor complex-associated protein alpha chain	GO:0050853; P:B cell receptor signaling pathway; ISS:UniProtKB
P40259	CD79B	B-cell antigen receptor complex-associated protein beta chain	GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro
P40259	CD79B	B-cell antigen receptor complex-associated protein beta chain	GO:0050853; P:B cell receptor signaling pathway; IEA:Ensembl
P40259	CD79B	B-cell antigen receptor complex-associated protein beta chain	GO:0006955; P:immune response; TAS:ProtInc
P40259	CD79B	B-cell antigen receptor complex-associated protein beta chain	GO:0007165; P:signal transduction; TAS:ProtInc
P09564	CD7	T-cell antigen CD7	GO:0004872; F:receptor activity; TAS:UniProtKB
P09564	CD7	T-cell antigen CD7	GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl
P09564	CD7	T-cell antigen CD7	GO:0006955; P:immune response; TAS:UniProtKB
P09564	CD7	T-cell antigen CD7	GO:0042110; P:T cell activation; TAS:UniProtKB
P09564	CD7	T-cell antigen CD7	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; NAS:UniProtKB
P33681	CD80	T-lymphocyte activation antigen CD80	GO:0015026; F:coreceptor activity; NAS:UniProtKB
P33681	CD80	T-lymphocyte activation antigen CD80	GO:0005515; F:protein binding; IPI:UniProtKB
P33681	CD80	T-lymphocyte activation antigen CD80	GO:0007267; P:cell-cell signaling; IC:UniProtKB
P33681	CD80	T-lymphocyte activation antigen CD80	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P33681	CD80	T-lymphocyte activation antigen CD80	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P33681	CD80	T-lymphocyte activation antigen CD80	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P33681	CD80	T-lymphocyte activation antigen CD80	GO:0045087; P:innate immune response; TAS:Reactome
P33681	CD80	T-lymphocyte activation antigen CD80	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
P33681	CD80	T-lymphocyte activation antigen CD80	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P33681	CD80	T-lymphocyte activation antigen CD80	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P33681	CD80	T-lymphocyte activation antigen CD80	GO:0046641; P:positive regulation of alpha-beta T cell proliferation; IEA:Ensembl
P33681	CD80	T-lymphocyte activation antigen CD80	GO:0045425; P:positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process; NAS:UniProtKB
P33681	CD80	T-lymphocyte activation antigen CD80	GO:0045086; P:positive regulation of interleukin-2 biosynthetic process; NAS:UniProtKB
P33681	CD80	T-lymphocyte activation antigen CD80	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P33681	CD80	T-lymphocyte activation antigen CD80	GO:0009967; P:positive regulation of signal transduction; NAS:UniProtKB
P33681	CD80	T-lymphocyte activation antigen CD80	GO:0045627; P:positive regulation of T-helper 1 cell differentiation; NAS:UniProtKB
P33681	CD80	T-lymphocyte activation antigen CD80	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
P33681	CD80	T-lymphocyte activation antigen CD80	GO:0042110; P:T cell activation; IC:UniProtKB
P33681	CD80	T-lymphocyte activation antigen CD80	GO:0031295; P:T cell costimulation; TAS:Reactome
P33681	CD80	T-lymphocyte activation antigen CD80	GO:0016032; P:viral process; IEA:UniProtKB-KW
P60033	CD81	CD81 antigen	GO:0023026; F:MHC class II protein complex binding; IDA:UniProtKB
P60033	CD81	CD81 antigen	GO:0005515; F:protein binding; IPI:UniProtKB
P60033	CD81	CD81 antigen	GO:0000187; P:activation of MAPK activity; IDA:UniProtKB
P60033	CD81	CD81 antigen	GO:0008283; P:cell proliferation; TAS:ProtInc
P60033	CD81	CD81 antigen	GO:0006661; P:phosphatidylinositol biosynthetic process; IDA:UniProtKB
P60033	CD81	CD81 antigen	GO:0046488; P:phosphatidylinositol metabolic process; IDA:UniProtKB
P60033	CD81	CD81 antigen	GO:0043128; P:positive regulation of 1-phosphatidylinositol 4-kinase activity; IDA:UniProtKB
P60033	CD81	CD81 antigen	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P60033	CD81	CD81 antigen	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P60033	CD81	CD81 antigen	GO:0008104; P:protein localization; IDA:UniProtKB
P60033	CD81	CD81 antigen	GO:0046813; P:receptor-mediated virion attachment to host cell; TAS:UniProtKB
P60033	CD81	CD81 antigen	GO:0050776; P:regulation of immune response; TAS:Reactome
P60033	CD81	CD81 antigen	GO:0046718; P:viral entry into host cell; TAS:UniProtKB
Q01151	CD83	CD83 antigen	GO:0006952; P:defense response; TAS:ProtInc
Q01151	CD83	CD83 antigen	GO:0006959; P:humoral immune response; TAS:ProtInc
Q01151	CD83	CD83 antigen	GO:0032713; P:negative regulation of interleukin-4 production; IEA:Ensembl
Q01151	CD83	CD83 antigen	GO:0043372; P:positive regulation of CD4-positive, alpha-beta T cell differentiation; IEA:Ensembl
Q01151	CD83	CD83 antigen	GO:0032733; P:positive regulation of interleukin-10 production; IEA:Ensembl
Q01151	CD83	CD83 antigen	GO:0032743; P:positive regulation of interleukin-2 production; IEA:Ensembl
Q01151	CD83	CD83 antigen	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
Q01151	CD83	CD83 antigen	GO:0007165; P:signal transduction; TAS:ProtInc
P27701	CD82	CD82 antigen	GO:0005515; F:protein binding; IPI:IntAct
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0015026; F:coreceptor activity; NAS:UniProtKB
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0005515; F:protein binding; IPI:UniProtKB
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0004872; F:receptor activity; TAS:ProtInc
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0007568; P:aging; IEA:Ensembl
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0042113; P:B cell activation; IEA:Ensembl
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0007267; P:cell-cell signaling; IC:UniProtKB
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0071345; P:cellular response to cytokine stimulus; IEA:Ensembl
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0071248; P:cellular response to metal ion; IEA:Ensembl
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0051607; P:defense response to virus; IEA:Ensembl
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0006955; P:immune response; TAS:ProtInc
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0045087; P:innate immune response; TAS:Reactome
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0043011; P:myeloid dendritic cell differentiation; IEA:Ensembl
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0002668; P:negative regulation of T cell anergy; IEA:Ensembl
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0042104; P:positive regulation of activated T cell proliferation; IEA:Ensembl
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0045086; P:positive regulation of interleukin-2 biosynthetic process; NAS:UniProtKB
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0045404; P:positive regulation of interleukin-4 biosynthetic process; NAS:UniProtKB
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0043017; P:positive regulation of lymphotoxin A biosynthetic process; NAS:UniProtKB
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0045630; P:positive regulation of T-helper 2 cell differentiation; NAS:UniProtKB
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0042493; P:response to drug; IEA:Ensembl
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0034341; P:response to interferon-gamma; IEA:Ensembl
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0001878; P:response to yeast; IEA:Ensembl
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0042110; P:T cell activation; IC:UniProtKB
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0031295; P:T cell costimulation; TAS:Reactome
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0002309; P:T cell proliferation involved in immune response; IEA:Ensembl
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0002224; P:toll-like receptor signaling pathway; IEA:Ensembl
P42081	CD86	T-lymphocyte activation antigen CD86	GO:0016032; P:viral process; IEA:UniProtKB-KW
P01732	CD8A	T-cell surface glycoprotein CD8 alpha chain	GO:0015026; F:coreceptor activity; NAS:UniProtKB
P01732	CD8A	T-cell surface glycoprotein CD8 alpha chain	GO:0042288; F:MHC class I protein binding; NAS:UniProtKB
P01732	CD8A	T-cell surface glycoprotein CD8 alpha chain	GO:0005515; F:protein binding; IPI:UniProtKB
P01732	CD8A	T-cell surface glycoprotein CD8 alpha chain	GO:0019882; P:antigen processing and presentation; NAS:UniProtKB
P01732	CD8A	T-cell surface glycoprotein CD8 alpha chain	GO:0045065; P:cytotoxic T cell differentiation; IEA:Ensembl
P01732	CD8A	T-cell surface glycoprotein CD8 alpha chain	GO:0051607; P:defense response to virus; IEA:Ensembl
P01732	CD8A	T-cell surface glycoprotein CD8 alpha chain	GO:0006955; P:immune response; NAS:UniProtKB
P01732	CD8A	T-cell surface glycoprotein CD8 alpha chain	GO:0050850; P:positive regulation of calcium-mediated signaling; IEA:Ensembl
P01732	CD8A	T-cell surface glycoprotein CD8 alpha chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P01732	CD8A	T-cell surface glycoprotein CD8 alpha chain	GO:0042110; P:T cell activation; NAS:UniProtKB
P01732	CD8A	T-cell surface glycoprotein CD8 alpha chain	GO:0002456; P:T cell mediated immunity; IEA:Ensembl
P01732	CD8A	T-cell surface glycoprotein CD8 alpha chain	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; NAS:UniProtKB
A6NJW9	CD8BP	Putative T-cell surface glycoprotein CD8 beta-2 chain	GO:0002376; P:immune system process; IEA:UniProtKB-KW
P10966	CD8B	T-cell surface glycoprotein CD8 beta chain	GO:0015026; F:coreceptor activity; NAS:UniProtKB
P10966	CD8B	T-cell surface glycoprotein CD8 beta chain	GO:0042288; F:MHC class I protein binding; NAS:UniProtKB
P10966	CD8B	T-cell surface glycoprotein CD8 beta chain	GO:0005515; F:protein binding; IPI:UniProtKB
P10966	CD8B	T-cell surface glycoprotein CD8 beta chain	GO:0006955; P:immune response; NAS:UniProtKB
P10966	CD8B	T-cell surface glycoprotein CD8 beta chain	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
P10966	CD8B	T-cell surface glycoprotein CD8 beta chain	GO:0050776; P:regulation of immune response; TAS:Reactome
P10966	CD8B	T-cell surface glycoprotein CD8 beta chain	GO:0042110; P:T cell activation; NAS:UniProtKB
P10966	CD8B	T-cell surface glycoprotein CD8 beta chain	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; NAS:UniProtKB
P10966	CD8B	T-cell surface glycoprotein CD8 beta chain	GO:0016032; P:viral process; TAS:Reactome
P48960	CD97	CD97 antigen	GO:0005509; F:calcium ion binding; IEA:InterPro
P48960	CD97	CD97 antigen	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P48960	CD97	CD97 antigen	GO:0005515; F:protein binding; IPI:UniProt
P48960	CD97	CD97 antigen	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
P48960	CD97	CD97 antigen	GO:0007155; P:cell adhesion; TAS:ProtInc
P48960	CD97	CD97 antigen	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P48960	CD97	CD97 antigen	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P48960	CD97	CD97 antigen	GO:0006928; P:cellular component movement; TAS:ProtInc
P48960	CD97	CD97 antigen	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P48960	CD97	CD97 antigen	GO:0006955; P:immune response; TAS:ProtInc
P48960	CD97	CD97 antigen	GO:0006954; P:inflammatory response; TAS:ProtInc
P48960	CD97	CD97 antigen	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
P14209	CD99	CD99 antigen	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P21926	CD9	CD9 antigen	GO:0005515; F:protein binding; IPI:UniProtKB
P21926	CD9	CD9 antigen	GO:0007596; P:blood coagulation; TAS:Reactome
P21926	CD9	CD9 antigen	GO:0007420; P:brain development; IEA:Ensembl
P21926	CD9	CD9 antigen	GO:0007155; P:cell adhesion; IDA:UniProtKB
P21926	CD9	CD9 antigen	GO:0006928; P:cellular component movement; IDA:UniProtKB
P21926	CD9	CD9 antigen	GO:0007342; P:fusion of sperm to egg plasma membrane; IDA:UniProtKB
P21926	CD9	CD9 antigen	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
P21926	CD9	CD9 antigen	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P21926	CD9	CD9 antigen	GO:0014003; P:oligodendrocyte development; IEA:Ensembl
P21926	CD9	CD9 antigen	GO:0030913; P:paranodal junction assembly; ISS:UniProtKB
P21926	CD9	CD9 antigen	GO:0030168; P:platelet activation; NAS:UniProtKB
P21926	CD9	CD9 antigen	GO:0002576; P:platelet degranulation; TAS:Reactome
P21926	CD9	CD9 antigen	GO:0009414; P:response to water deprivation; IEA:Ensembl
P21926	CD9	CD9 antigen	GO:0007338; P:single fertilization; TAS:Reactome
Q96GN5	CDCA7L	Cell division cycle-associated 7-like protein	GO:0008284; P:positive regulation of cell proliferation; IDA:MGI
Q96GN5	CDCA7L	Cell division cycle-associated 7-like protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96GN5	CDCA7L	Cell division cycle-associated 7-like protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BWV3	CDADC1	Cytidine and dCMP deaminase domain-containing protein 1	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q9BWV3	CDADC1	Cytidine and dCMP deaminase domain-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IWY9	CDAN1	Codanin-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IWY9	CDAN1	Codanin-1	GO:0031497; P:chromatin assembly; IMP:UniProtKB
Q8IWY9	CDAN1	Codanin-1	GO:0008156; P:negative regulation of DNA replication; IMP:UniProtKB
Q13042	CDC16	Cell division cycle protein 16 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q13042	CDC16	Cell division cycle protein 16 homolog	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q13042	CDC16	Cell division cycle protein 16 homolog	GO:0008283; P:cell proliferation; TAS:ProtInc
Q13042	CDC16	Cell division cycle protein 16 homolog	GO:0007067; P:mitosis; TAS:ProtInc
Q13042	CDC16	Cell division cycle protein 16 homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q13042	CDC16	Cell division cycle protein 16 homolog	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:Reactome
Q13042	CDC16	Cell division cycle protein 16 homolog	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q13042	CDC16	Cell division cycle protein 16 homolog	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q13042	CDC16	Cell division cycle protein 16 homolog	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
Q13042	CDC16	Cell division cycle protein 16 homolog	GO:0007088; P:regulation of mitosis; TAS:ProtInc
Q13042	CDC16	Cell division cycle protein 16 homolog	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q12834	CDC20	Cell division cycle protein 20 homolog	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q12834	CDC20	Cell division cycle protein 20 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q12834	CDC20	Cell division cycle protein 20 homolog	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q12834	CDC20	Cell division cycle protein 20 homolog	GO:0051488; P:activation of anaphase-promoting complex activity; IDA:UniProtKB
Q12834	CDC20	Cell division cycle protein 20 homolog	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q12834	CDC20	Cell division cycle protein 20 homolog	GO:0007049; P:cell cycle; TAS:ProtInc
Q12834	CDC20	Cell division cycle protein 20 homolog	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q12834	CDC20	Cell division cycle protein 20 homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q12834	CDC20	Cell division cycle protein 20 homolog	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:Reactome
Q12834	CDC20	Cell division cycle protein 20 homolog	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q12834	CDC20	Cell division cycle protein 20 homolog	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q12834	CDC20	Cell division cycle protein 20 homolog	GO:0090129; P:positive regulation of synapse maturation; ISS:UniProtKB
Q12834	CDC20	Cell division cycle protein 20 homolog	GO:0031915; P:positive regulation of synaptic plasticity; ISS:UniProtKB
Q12834	CDC20	Cell division cycle protein 20 homolog	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q12834	CDC20	Cell division cycle protein 20 homolog	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q12834	CDC20	Cell division cycle protein 20 homolog	GO:0050773; P:regulation of dendrite development; IEA:Ensembl
Q12834	CDC20	Cell division cycle protein 20 homolog	GO:0040020; P:regulation of meiosis; IEA:Ensembl
Q12834	CDC20	Cell division cycle protein 20 homolog	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UJX2	CDC23	Cell division cycle protein 23 homolog	GO:0004842; F:ubiquitin-protein ligase activity; TAS:UniProtKB
Q9UJX2	CDC23	Cell division cycle protein 23 homolog	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q9UJX2	CDC23	Cell division cycle protein 23 homolog	GO:0007049; P:cell cycle; TAS:UniProtKB
Q9UJX2	CDC23	Cell division cycle protein 23 homolog	GO:0007091; P:metaphase/anaphase transition of mitotic cell cycle; TAS:ProtInc
Q9UJX2	CDC23	Cell division cycle protein 23 homolog	GO:0007067; P:mitosis; IDA:UniProtKB
Q9UJX2	CDC23	Cell division cycle protein 23 homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9UJX2	CDC23	Cell division cycle protein 23 homolog	GO:0000080; P:mitotic G1 phase; IDA:UniProtKB
Q9UJX2	CDC23	Cell division cycle protein 23 homolog	GO:0007080; P:mitotic metaphase plate congression; IDA:UniProtKB
Q9UJX2	CDC23	Cell division cycle protein 23 homolog	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:Reactome
Q9UJX2	CDC23	Cell division cycle protein 23 homolog	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UJX2	CDC23	Cell division cycle protein 23 homolog	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UJX2	CDC23	Cell division cycle protein 23 homolog	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
Q9UJX2	CDC23	Cell division cycle protein 23 homolog	GO:0007096; P:regulation of exit from mitosis; TAS:ProtInc
Q9UJX2	CDC23	Cell division cycle protein 23 homolog	GO:0030071; P:regulation of mitotic metaphase/anaphase transition; IDA:UniProtKB
Q9UJX2	CDC23	Cell division cycle protein 23 homolog	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UJX2	CDC23	Cell division cycle protein 23 homolog	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
Q8NHZ8	CDC26	Anaphase-promoting complex subunit CDC26	GO:0005515; F:protein binding; IPI:IntAct
Q8NHZ8	CDC26	Anaphase-promoting complex subunit CDC26	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q8NHZ8	CDC26	Anaphase-promoting complex subunit CDC26	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q8NHZ8	CDC26	Anaphase-promoting complex subunit CDC26	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8NHZ8	CDC26	Anaphase-promoting complex subunit CDC26	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:Reactome
Q8NHZ8	CDC26	Anaphase-promoting complex subunit CDC26	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q8NHZ8	CDC26	Anaphase-promoting complex subunit CDC26	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q8NHZ8	CDC26	Anaphase-promoting complex subunit CDC26	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
Q8NHZ8	CDC26	Anaphase-promoting complex subunit CDC26	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P30260	CDC27	Cell division cycle protein 27 homolog	GO:0005515; F:protein binding; IPI:IntAct
P30260	CDC27	Cell division cycle protein 27 homolog	GO:0019903; F:protein phosphatase binding; IPI:BHF-UCL
P30260	CDC27	Cell division cycle protein 27 homolog	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P30260	CDC27	Cell division cycle protein 27 homolog	GO:0008283; P:cell proliferation; TAS:ProtInc
P30260	CDC27	Cell division cycle protein 27 homolog	GO:0007091; P:metaphase/anaphase transition of mitotic cell cycle; IMP:MGI
P30260	CDC27	Cell division cycle protein 27 homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P30260	CDC27	Cell division cycle protein 27 homolog	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:Reactome
P30260	CDC27	Cell division cycle protein 27 homolog	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P30260	CDC27	Cell division cycle protein 27 homolog	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P30260	CDC27	Cell division cycle protein 27 homolog	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
P30260	CDC27	Cell division cycle protein 27 homolog	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q16543	CDC37	Hsp90 co-chaperone Cdc37	GO:0031072; F:heat shock protein binding; IPI:UniProtKB
Q16543	CDC37	Hsp90 co-chaperone Cdc37	GO:0005515; F:protein binding; IPI:IntAct
Q16543	CDC37	Hsp90 co-chaperone Cdc37	GO:0051082; F:unfolded protein binding; TAS:ProtInc
Q16543	CDC37	Hsp90 co-chaperone Cdc37	GO:0006605; P:protein targeting; TAS:ProtInc
Q16543	CDC37	Hsp90 co-chaperone Cdc37	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
Q16543	CDC37	Hsp90 co-chaperone Cdc37	GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; IMP:MGI
Q16543	CDC37	Hsp90 co-chaperone Cdc37	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; IMP:MGI
P60953	CDC42	Cell division control protein 42 homolog	GO:0034191; F:apolipoprotein A-I receptor binding; IPI:BHF-UCL
P60953	CDC42	Cell division control protein 42 homolog	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P60953	CDC42	Cell division control protein 42 homolog	GO:0003924; F:GTPase activity; TAS:UniProtKB
P60953	CDC42	Cell division control protein 42 homolog	GO:0042802; F:identical protein binding; IPI:IntAct
P60953	CDC42	Cell division control protein 42 homolog	GO:0005515; F:protein binding; IPI:IntAct
P60953	CDC42	Cell division control protein 42 homolog	GO:0019901; F:protein kinase binding; IDA:BHF-UCL
P60953	CDC42	Cell division control protein 42 homolog	GO:0031996; F:thioesterase binding; IPI:UniProtKB
P60953	CDC42	Cell division control protein 42 homolog	GO:0030036; P:actin cytoskeleton organization; IDA:UniProtKB
P60953	CDC42	Cell division control protein 42 homolog	GO:0090135; P:actin filament branching; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0051017; P:actin filament bundle assembly; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0034332; P:adherens junction organization; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0007411; P:axon guidance; TAS:Reactome
P60953	CDC42	Cell division control protein 42 homolog	GO:0007596; P:blood coagulation; TAS:Reactome
P60953	CDC42	Cell division control protein 42 homolog	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0003161; P:cardiac conduction system development; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0034613; P:cellular protein localization; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P60953	CDC42	Cell division control protein 42 homolog	GO:0090136; P:epithelial cell-cell adhesion; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0060684; P:epithelial-mesenchymal cell signaling; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0051683; P:establishment of Golgi localization; ISS:BHF-UCL
P60953	CDC42	Cell division control protein 42 homolog	GO:0035088; P:establishment or maintenance of apical/basal cell polarity; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0007163; P:establishment or maintenance of cell polarity; TAS:UniProtKB
P60953	CDC42	Cell division control protein 42 homolog	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P60953	CDC42	Cell division control protein 42 homolog	GO:0046847; P:filopodium assembly; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0007030; P:Golgi organization; ISS:BHF-UCL
P60953	CDC42	Cell division control protein 42 homolog	GO:0006184; P:GTP catabolic process; TAS:GOC
P60953	CDC42	Cell division control protein 42 homolog	GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0060789; P:hair follicle placode formation; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0060047; P:heart contraction; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0045087; P:innate immune response; TAS:Reactome
P60953	CDC42	Cell division control protein 42 homolog	GO:0031424; P:keratinization; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0003334; P:keratinocyte development; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0030225; P:macrophage differentiation; TAS:UniProtKB
P60953	CDC42	Cell division control protein 42 homolog	GO:0035264; P:multicellular organism growth; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0042692; P:muscle cell differentiation; TAS:Reactome
P60953	CDC42	Cell division control protein 42 homolog	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
P60953	CDC42	Cell division control protein 42 homolog	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0031333; P:negative regulation of protein complex assembly; IPI:UniProtKB
P60953	CDC42	Cell division control protein 42 homolog	GO:0048664; P:neuron fate determination; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0007097; P:nuclear migration; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0072384; P:organelle transport along microtubule; ISS:BHF-UCL
P60953	CDC42	Cell division control protein 42 homolog	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB
P60953	CDC42	Cell division control protein 42 homolog	GO:0045740; P:positive regulation of DNA replication; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0071338; P:positive regulation of hair follicle cell proliferation; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0090316; P:positive regulation of intracellular protein transport; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0046330; P:positive regulation of JNK cascade; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0048554; P:positive regulation of metalloenzyme activity; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
P60953	CDC42	Cell division control protein 42 homolog	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0031274; P:positive regulation of pseudopodium assembly; IDA:UniProtKB
P60953	CDC42	Cell division control protein 42 homolog	GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IDA:UniProtKB
P60953	CDC42	Cell division control protein 42 homolog	GO:0051835; P:positive regulation of synapse structural plasticity; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0051988; P:regulation of attachment of spindle microtubules to kinetochore; IMP:UniProtKB
P60953	CDC42	Cell division control protein 42 homolog	GO:0051489; P:regulation of filopodium assembly; IDA:UniProtKB
P60953	CDC42	Cell division control protein 42 homolog	GO:0007088; P:regulation of mitosis; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0042176; P:regulation of protein catabolic process; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0043497; P:regulation of protein heterodimerization activity; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0045859; P:regulation of protein kinase activity; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0031647; P:regulation of protein stability; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P60953	CDC42	Cell division control protein 42 homolog	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P60953	CDC42	Cell division control protein 42 homolog	GO:0002040; P:sprouting angiogenesis; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0060661; P:submandibular salivary gland formation; IEA:Ensembl
P60953	CDC42	Cell division control protein 42 homolog	GO:0021762; P:substantia nigra development; IEP:UniProt
P60953	CDC42	Cell division control protein 42 homolog	GO:0031295; P:T cell costimulation; TAS:Reactome
O75419	CDC45	Cell division control protein 45 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
O75419	CDC45	Cell division control protein 45 homolog	GO:0006260; P:DNA replication; TAS:Reactome
O75419	CDC45	Cell division control protein 45 homolog	GO:0000076; P:DNA replication checkpoint; TAS:ProtInc
O75419	CDC45	Cell division control protein 45 homolog	GO:0006270; P:DNA replication initiation; TAS:ProtInc
O75419	CDC45	Cell division control protein 45 homolog	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
O75419	CDC45	Cell division control protein 45 homolog	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
O75419	CDC45	Cell division control protein 45 homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O75419	CDC45	Cell division control protein 45 homolog	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; TAS:Reactome
Q99459	CDC5L	Cell division cycle 5-like protein	GO:0003682; F:chromatin binding; IEA:InterPro
Q99459	CDC5L	Cell division cycle 5-like protein	GO:0003677; F:DNA binding; NAS:UniProtKB
Q99459	CDC5L	Cell division cycle 5-like protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q99459	CDC5L	Cell division cycle 5-like protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q99459	CDC5L	Cell division cycle 5-like protein	GO:0071987; F:WD40-repeat domain binding; IDA:UniProtKB
Q99459	CDC5L	Cell division cycle 5-like protein	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q99459	CDC5L	Cell division cycle 5-like protein	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q99459	CDC5L	Cell division cycle 5-like protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q99459	CDC5L	Cell division cycle 5-like protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q99741	CDC6	Cell division control protein 6 homolog	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q99741	CDC6	Cell division control protein 6 homolog	GO:0003682; F:chromatin binding; IEA:Ensembl
Q99741	CDC6	Cell division control protein 6 homolog	GO:0019900; F:kinase binding; IPI:BHF-UCL
Q99741	CDC6	Cell division control protein 6 homolog	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q99741	CDC6	Cell division control protein 6 homolog	GO:0000166; F:nucleotide binding; TAS:ProtInc
Q99741	CDC6	Cell division control protein 6 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q99741	CDC6	Cell division control protein 6 homolog	GO:0006260; P:DNA replication; TAS:Reactome
Q99741	CDC6	Cell division control protein 6 homolog	GO:0000076; P:DNA replication checkpoint; TAS:ProtInc
Q99741	CDC6	Cell division control protein 6 homolog	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q99741	CDC6	Cell division control protein 6 homolog	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q99741	CDC6	Cell division control protein 6 homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q99741	CDC6	Cell division control protein 6 homolog	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q99741	CDC6	Cell division control protein 6 homolog	GO:0008156; P:negative regulation of DNA replication; TAS:ProtInc
Q99741	CDC6	Cell division control protein 6 homolog	GO:0051984; P:positive regulation of chromosome segregation; IDA:BHF-UCL
Q99741	CDC6	Cell division control protein 6 homolog	GO:0032467; P:positive regulation of cytokinesis; IMP:BHF-UCL
Q99741	CDC6	Cell division control protein 6 homolog	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
Q99741	CDC6	Cell division control protein 6 homolog	GO:0030071; P:regulation of mitotic metaphase/anaphase transition; IMP:BHF-UCL
Q99741	CDC6	Cell division control protein 6 homolog	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; TAS:Reactome
Q99741	CDC6	Cell division control protein 6 homolog	GO:0007089; P:traversing start control point of mitotic cell cycle; TAS:ProtInc
Q6P1J9	CDC73	Parafibromin	GO:0005515; F:protein binding; IPI:IntAct
Q6P1J9	CDC73	Parafibromin	GO:0000993; F:RNA polymerase II core binding; IDA:UniProtKB
Q6P1J9	CDC73	Parafibromin	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q6P1J9	CDC73	Parafibromin	GO:0071222; P:cellular response to lipopolysaccharide; ISS:UniProtKB
Q6P1J9	CDC73	Parafibromin	GO:0001711; P:endodermal cell fate commitment; ISS:UniProtKB
Q6P1J9	CDC73	Parafibromin	GO:0033523; P:histone H2B ubiquitination; IDA:UniProtKB
Q6P1J9	CDC73	Parafibromin	GO:0010390; P:histone monoubiquitination; IDA:UniProtKB
Q6P1J9	CDC73	Parafibromin	GO:0006378; P:mRNA polyadenylation; IMP:UniProtKB
Q6P1J9	CDC73	Parafibromin	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q6P1J9	CDC73	Parafibromin	GO:0050680; P:negative regulation of epithelial cell proliferation; IMP:UniProtKB
Q6P1J9	CDC73	Parafibromin	GO:0048147; P:negative regulation of fibroblast proliferation; IMP:UniProtKB
Q6P1J9	CDC73	Parafibromin	GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IDA:UniProtKB
Q6P1J9	CDC73	Parafibromin	GO:0045638; P:negative regulation of myeloid cell differentiation; IDA:UniProtKB
Q6P1J9	CDC73	Parafibromin	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q6P1J9	CDC73	Parafibromin	GO:0031442; P:positive regulation of mRNA 3'-end processing; IMP:UniProtKB
Q6P1J9	CDC73	Parafibromin	GO:0032968; P:positive regulation of transcription elongation from RNA polymerase II promoter; IDA:UniProtKB
Q6P1J9	CDC73	Parafibromin	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q6P1J9	CDC73	Parafibromin	GO:0030177; P:positive regulation of Wnt signaling pathway; IDA:UniProtKB
Q6P1J9	CDC73	Parafibromin	GO:0031648; P:protein destabilization; IMP:UniProtKB
Q6P1J9	CDC73	Parafibromin	GO:0019827; P:stem cell maintenance; ISS:UniProtKB
Q6P1J9	CDC73	Parafibromin	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6P1J9	CDC73	Parafibromin	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
O00311	CDC7	Cell division cycle 7-related protein kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O00311	CDC7	Cell division cycle 7-related protein kinase	GO:0016301; F:kinase activity; IDA:HGNC
O00311	CDC7	Cell division cycle 7-related protein kinase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O00311	CDC7	Cell division cycle 7-related protein kinase	GO:0005515; F:protein binding; IPI:IntAct
O00311	CDC7	Cell division cycle 7-related protein kinase	GO:0004672; F:protein kinase activity; IMP:UniProt
O00311	CDC7	Cell division cycle 7-related protein kinase	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
O00311	CDC7	Cell division cycle 7-related protein kinase	GO:0044770; P:cell cycle phase transition; IMP:BHF-UCL
O00311	CDC7	Cell division cycle 7-related protein kinase	GO:0051301; P:cell division; IEA:UniProtKB-KW
O00311	CDC7	Cell division cycle 7-related protein kinase	GO:0006260; P:DNA replication; TAS:Reactome
O00311	CDC7	Cell division cycle 7-related protein kinase	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
O00311	CDC7	Cell division cycle 7-related protein kinase	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O00311	CDC7	Cell division cycle 7-related protein kinase	GO:0008284; P:positive regulation of cell proliferation; IMP:HGNC
Q99618	CDCA3	Cell division cycle-associated protein 3	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q99618	CDCA3	Cell division cycle-associated protein 3	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q69YH5	CDCA2	Cell division cycle-associated protein 2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9BXL8	CDCA4	Cell division cycle-associated protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q96FF9	CDCA5	Sororin	GO:0003682; F:chromatin binding; TAS:UniProtKB
Q96FF9	CDCA5	Sororin	GO:0005515; F:protein binding; IPI:UniProtKB
Q96FF9	CDCA5	Sororin	GO:0006302; P:double-strand break repair; IMP:UniProtKB
Q96FF9	CDCA5	Sororin	GO:0000082; P:G1/S transition of mitotic cell cycle; IDA:UniProtKB
Q96FF9	CDCA5	Sororin	GO:0007067; P:mitosis; IDA:UniProtKB
Q96FF9	CDCA5	Sororin	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q96FF9	CDCA5	Sororin	GO:0007076; P:mitotic chromosome condensation; IMP:UniProtKB
Q96FF9	CDCA5	Sororin	GO:0051329; P:mitotic interphase; ISS:UniProtKB
Q96FF9	CDCA5	Sororin	GO:0007080; P:mitotic metaphase plate congression; IMP:UniProtKB
Q96FF9	CDCA5	Sororin	GO:0007064; P:mitotic sister chromatid cohesion; IMP:UniProtKB
Q96FF9	CDCA5	Sororin	GO:0071922; P:regulation of cohesin localization to chromatin; IMP:UniProtKB
Q9BWT1	CDCA7	Cell division cycle-associated protein 7	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9BWT1	CDCA7	Cell division cycle-associated protein 7	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q9BWT1	CDCA7	Cell division cycle-associated protein 7	GO:0042127; P:regulation of cell proliferation; IDA:MGI
Q9BWT1	CDCA7	Cell division cycle-associated protein 7	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9BWT1	CDCA7	Cell division cycle-associated protein 7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P32320	CDA	Cytidine deaminase	GO:0004126; F:cytidine deaminase activity; IDA:UniProtKB
P32320	CDA	Cytidine deaminase	GO:0001882; F:nucleoside binding; IDA:UniProtKB
P32320	CDA	Cytidine deaminase	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P32320	CDA	Cytidine deaminase	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P32320	CDA	Cytidine deaminase	GO:0007166; P:cell surface receptor signaling pathway; NAS:UniProtKB
P32320	CDA	Cytidine deaminase	GO:0009972; P:cytidine deamination; IDA:UniProtKB
P32320	CDA	Cytidine deaminase	GO:0019858; P:cytosine metabolic process; TAS:UniProtKB
P32320	CDA	Cytidine deaminase	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
P32320	CDA	Cytidine deaminase	GO:0045980; P:negative regulation of nucleotide metabolic process; IDA:UniProtKB
P32320	CDA	Cytidine deaminase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P32320	CDA	Cytidine deaminase	GO:0051289; P:protein homotetramerization; IDA:UniProtKB
P32320	CDA	Cytidine deaminase	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
P32320	CDA	Cytidine deaminase	GO:0043097; P:pyrimidine nucleoside salvage; TAS:Reactome
P32320	CDA	Cytidine deaminase	GO:0008655; P:pyrimidine-containing compound salvage; NAS:UniProtKB
P32320	CDA	Cytidine deaminase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96JP9	CDHR1	Cadherin-related family member 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96JP9	CDHR1	Cadherin-related family member 1	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q96JP9	CDHR1	Cadherin-related family member 1	GO:0045494; P:photoreceptor cell maintenance; IEA:Ensembl
Q9BYE9	CDHR2	Cadherin-related family member 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9BYE9	CDHR2	Cadherin-related family member 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BYE9	CDHR2	Cadherin-related family member 2	GO:0007155; P:cell adhesion; IDA:UniProtKB
Q9BYE9	CDHR2	Cadherin-related family member 2	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9BYE9	CDHR2	Cadherin-related family member 2	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
A6H8M9	CDHR4	Cadherin-related family member 4	GO:0005509; F:calcium ion binding; IEA:InterPro
A6H8M9	CDHR4	Cadherin-related family member 4	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9HBB8	CDHR5	Cadherin-related family member 5	GO:0008013; F:beta-catenin binding; IPI:UniProt
Q9HBB8	CDHR5	Cadherin-related family member 5	GO:0005509; F:calcium ion binding; ISS:UniProtKB
Q9HBB8	CDHR5	Cadherin-related family member 5	GO:0007155; P:cell adhesion; ISS:UniProtKB
Q9HBB8	CDHR5	Cadherin-related family member 5	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q6ZTQ4	CDHR3	Cadherin-related family member 3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q6ZTQ4	CDHR3	Cadherin-related family member 3	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9H305	CDIP1	Cell death-inducing p53-target protein 1	GO:0006915; P:apoptotic process; IGI:MGI
Q9H305	CDIP1	Cell death-inducing p53-target protein 1	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IMP:MGI
Q9H305	CDIP1	Cell death-inducing p53-target protein 1	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IGI:MGI
O14735	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	GO:0043178; F:alcohol binding; IEA:Ensembl
O14735	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	GO:0030246; F:carbohydrate binding; IEA:Ensembl
O14735	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	GO:0003881; F:CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity; IDA:UniProtKB
O14735	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	GO:0019992; F:diacylglycerol binding; IEA:Ensembl
O14735	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	GO:0030145; F:manganese ion binding; IEA:Ensembl
O14735	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	GO:0016740; F:transferase activity; IEA:UniProtKB-KW
O14735	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	GO:0046341; P:CDP-diacylglycerol metabolic process; IEA:Ensembl
O14735	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
O14735	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	GO:0006661; P:phosphatidylinositol biosynthetic process; IDA:UniProtKB
O14735	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
O14735	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15131	CDK10	Cyclin-dependent kinase 10	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q15131	CDK10	Cyclin-dependent kinase 10	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
Q15131	CDK10	Cyclin-dependent kinase 10	GO:0005515; F:protein binding; IPI:IntAct
Q15131	CDK10	Cyclin-dependent kinase 10	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q15131	CDK10	Cyclin-dependent kinase 10	GO:0007089; P:traversing start control point of mitotic cell cycle; TAS:ProtInc
Q9NYV4	CDK12	Cyclin-dependent kinase 12	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NYV4	CDK12	Cyclin-dependent kinase 12	GO:0030332; F:cyclin binding; IPI:MGI
Q9NYV4	CDK12	Cyclin-dependent kinase 12	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC
Q9NYV4	CDK12	Cyclin-dependent kinase 12	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NYV4	CDK12	Cyclin-dependent kinase 12	GO:0004672; F:protein kinase activity; IDA:HGNC
Q9NYV4	CDK12	Cyclin-dependent kinase 12	GO:0008353; F:RNA polymerase II carboxy-terminal domain kinase activity; IMP:UniProtKB
Q9NYV4	CDK12	Cyclin-dependent kinase 12	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9NYV4	CDK12	Cyclin-dependent kinase 12	GO:0070816; P:phosphorylation of RNA polymerase II C-terminal domain; IMP:UniProtKB
Q9NYV4	CDK12	Cyclin-dependent kinase 12	GO:0046777; P:protein autophosphorylation; IDA:HGNC
Q9NYV4	CDK12	Cyclin-dependent kinase 12	GO:0043405; P:regulation of MAP kinase activity; IMP:UniProtKB
Q9NYV4	CDK12	Cyclin-dependent kinase 12	GO:0008380; P:RNA splicing; ISS:UniProtKB
Q14004	CDK13	Cyclin-dependent kinase 13	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q14004	CDK13	Cyclin-dependent kinase 13	GO:0030332; F:cyclin binding; IPI:MGI
Q14004	CDK13	Cyclin-dependent kinase 13	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC
Q14004	CDK13	Cyclin-dependent kinase 13	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14004	CDK13	Cyclin-dependent kinase 13	GO:0005515; F:protein binding; IPI:IntAct
Q14004	CDK13	Cyclin-dependent kinase 13	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q14004	CDK13	Cyclin-dependent kinase 13	GO:0008353; F:RNA polymerase II carboxy-terminal domain kinase activity; IDA:UniProtKB
Q14004	CDK13	Cyclin-dependent kinase 13	GO:0000380; P:alternative mRNA splicing, via spliceosome; ISS:UniProtKB
Q14004	CDK13	Cyclin-dependent kinase 13	GO:0030097; P:hemopoiesis; IMP:UniProtKB
Q14004	CDK13	Cyclin-dependent kinase 13	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q14004	CDK13	Cyclin-dependent kinase 13	GO:0070816; P:phosphorylation of RNA polymerase II C-terminal domain; IDA:UniProtKB
Q14004	CDK13	Cyclin-dependent kinase 13	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q14004	CDK13	Cyclin-dependent kinase 13	GO:0007088; P:regulation of mitosis; TAS:ProtInc
Q14004	CDK13	Cyclin-dependent kinase 13	GO:0016032; P:viral process; IEA:UniProtKB-KW
O94921	CDK14	Cyclin-dependent kinase 14	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O94921	CDK14	Cyclin-dependent kinase 14	GO:0030332; F:cyclin binding; IPI:UniProtKB
O94921	CDK14	Cyclin-dependent kinase 14	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IMP:UniProtKB
O94921	CDK14	Cyclin-dependent kinase 14	GO:0005515; F:protein binding; IPI:IntAct
O94921	CDK14	Cyclin-dependent kinase 14	GO:0051301; P:cell division; IEA:UniProtKB-KW
O94921	CDK14	Cyclin-dependent kinase 14	GO:0000086; P:G2/M transition of mitotic cell cycle; IDA:UniProtKB
O94921	CDK14	Cyclin-dependent kinase 14	GO:0060828; P:regulation of canonical Wnt signaling pathway; IDA:UniProtKB
O94921	CDK14	Cyclin-dependent kinase 14	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q96Q40	CDK15	Cyclin-dependent kinase 15	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96Q40	CDK15	Cyclin-dependent kinase 15	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC
Q96Q40	CDK15	Cyclin-dependent kinase 15	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96Q40	CDK15	Cyclin-dependent kinase 15	GO:0005515; F:protein binding; IPI:IntAct
Q00536	CDK16	Cyclin-dependent kinase 16	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q00536	CDK16	Cyclin-dependent kinase 16	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC
Q00536	CDK16	Cyclin-dependent kinase 16	GO:0005515; F:protein binding; IPI:IntAct
Q00536	CDK16	Cyclin-dependent kinase 16	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q00536	CDK16	Cyclin-dependent kinase 16	GO:0006887; P:exocytosis; ISS:UniProtKB
Q00536	CDK16	Cyclin-dependent kinase 16	GO:0030252; P:growth hormone secretion; ISS:UniProtKB
Q00536	CDK16	Cyclin-dependent kinase 16	GO:0031175; P:neuron projection development; ISS:UniProtKB
Q00536	CDK16	Cyclin-dependent kinase 16	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q00536	CDK16	Cyclin-dependent kinase 16	GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:UniProtKB
Q00536	CDK16	Cyclin-dependent kinase 16	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q07002	CDK18	Cyclin-dependent kinase 18	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q07002	CDK18	Cyclin-dependent kinase 18	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC
Q07002	CDK18	Cyclin-dependent kinase 18	GO:0005515; F:protein binding; IPI:IntAct
Q00537	CDK17	Cyclin-dependent kinase 17	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q00537	CDK17	Cyclin-dependent kinase 17	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC
Q00537	CDK17	Cyclin-dependent kinase 17	GO:0005515; F:protein binding; IPI:IntAct
Q00537	CDK17	Cyclin-dependent kinase 17	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q00537	CDK17	Cyclin-dependent kinase 17	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q9BWU1	CDK19	Cyclin-dependent kinase 19	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BWU1	CDK19	Cyclin-dependent kinase 19	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC
P06493	CDK1	Cyclin-dependent kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P06493	CDK1	Cyclin-dependent kinase 1	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IDA:UniProtKB
P06493	CDK1	Cyclin-dependent kinase 1	GO:0035173; F:histone kinase activity; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0005515; F:protein binding; IPI:UniProtKB
P06493	CDK1	Cyclin-dependent kinase 1	GO:0004672; F:protein kinase activity; NAS:ProtInc
P06493	CDK1	Cyclin-dependent kinase 1	GO:0004674; F:protein serine/threonine kinase activity; IDA:WormBase
P06493	CDK1	Cyclin-dependent kinase 1	GO:0008353; F:RNA polymerase II carboxy-terminal domain kinase activity; IDA:UniProtKB
P06493	CDK1	Cyclin-dependent kinase 1	GO:0000187; P:activation of MAPK activity; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0000186; P:activation of MAPKK activity; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P06493	CDK1	Cyclin-dependent kinase 1	GO:0007411; P:axon guidance; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0007569; P:cell aging; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0016477; P:cell migration; TAS:UniProtKB
P06493	CDK1	Cyclin-dependent kinase 1	GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0007098; P:centrosome cycle; TAS:UniProtKB
P06493	CDK1	Cyclin-dependent kinase 1	GO:0030261; P:chromosome condensation; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0006281; P:DNA repair; TAS:UniProtKB
P06493	CDK1	Cyclin-dependent kinase 1	GO:0006260; P:DNA replication; TAS:UniProtKB
P06493	CDK1	Cyclin-dependent kinase 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
P06493	CDK1	Cyclin-dependent kinase 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0045087; P:innate immune response; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0000165; P:MAPK cascade; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0000226; P:microtubule cytoskeleton organization; TAS:UniProtKB
P06493	CDK1	Cyclin-dependent kinase 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P06493	CDK1	Cyclin-dependent kinase 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0007095; P:mitotic G2 DNA damage checkpoint; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P06493	CDK1	Cyclin-dependent kinase 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0031100; P:organ regeneration; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0018105; P:peptidyl-serine phosphorylation; IDA:WormBase
P06493	CDK1	Cyclin-dependent kinase 1	GO:0060045; P:positive regulation of cardiac muscle cell proliferation; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0045740; P:positive regulation of DNA replication; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0045931; P:positive regulation of mitotic cell cycle; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0033160; P:positive regulation of protein import into nucleus, translocation; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0007344; P:pronuclear fusion; TAS:UniProtKB
P06493	CDK1	Cyclin-dependent kinase 1	GO:0006461; P:protein complex assembly; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0034501; P:protein localization to kinetochore; IDA:BHF-UCL
P06493	CDK1	Cyclin-dependent kinase 1	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0045995; P:regulation of embryonic development; TAS:UniProtKB
P06493	CDK1	Cyclin-dependent kinase 1	GO:0014038; P:regulation of Schwann cell differentiation; TAS:UniProtKB
P06493	CDK1	Cyclin-dependent kinase 1	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0014823; P:response to activity; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0014075; P:response to amine; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0048678; P:response to axon injury; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0046686; P:response to cadmium ion; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0046688; P:response to copper ion; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0042493; P:response to drug; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0045471; P:response to ethanol; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0009636; P:response to toxic substance; IEA:Ensembl
P06493	CDK1	Cyclin-dependent kinase 1	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P06493	CDK1	Cyclin-dependent kinase 1	GO:0055015; P:ventricular cardiac muscle cell development; IEA:Ensembl
Q8IZL9	CDK20	Cyclin-dependent kinase 20	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IZL9	CDK20	Cyclin-dependent kinase 20	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC
Q8IZL9	CDK20	Cyclin-dependent kinase 20	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IZL9	CDK20	Cyclin-dependent kinase 20	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q8IZL9	CDK20	Cyclin-dependent kinase 20	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P24941	CDK2	Cyclin-dependent kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P24941	CDK2	Cyclin-dependent kinase 2	GO:0030332; F:cyclin binding; IDA:UniProtKB
P24941	CDK2	Cyclin-dependent kinase 2	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IDA:UniProtKB
P24941	CDK2	Cyclin-dependent kinase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P24941	CDK2	Cyclin-dependent kinase 2	GO:0005515; F:protein binding; IPI:UniProtKB
P24941	CDK2	Cyclin-dependent kinase 2	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P24941	CDK2	Cyclin-dependent kinase 2	GO:0007596; P:blood coagulation; TAS:Reactome
P24941	CDK2	Cyclin-dependent kinase 2	GO:0071732; P:cellular response to nitric oxide; TAS:UniProtKB
P24941	CDK2	Cyclin-dependent kinase 2	GO:0051298; P:centrosome duplication; TAS:UniProtKB
P24941	CDK2	Cyclin-dependent kinase 2	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P24941	CDK2	Cyclin-dependent kinase 2	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
P24941	CDK2	Cyclin-dependent kinase 2	GO:0006260; P:DNA replication; TAS:UniProtKB
P24941	CDK2	Cyclin-dependent kinase 2	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P24941	CDK2	Cyclin-dependent kinase 2	GO:0000086; P:G2/M transition of mitotic cell cycle; NAS:UniProtKB
P24941	CDK2	Cyclin-dependent kinase 2	GO:0016572; P:histone phosphorylation; IDA:GOC
P24941	CDK2	Cyclin-dependent kinase 2	GO:0007126; P:meiotic nuclear division; TAS:UniProtKB
P24941	CDK2	Cyclin-dependent kinase 2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P24941	CDK2	Cyclin-dependent kinase 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P24941	CDK2	Cyclin-dependent kinase 2	GO:0031571; P:mitotic G1 DNA damage checkpoint; TAS:UniProtKB
P24941	CDK2	Cyclin-dependent kinase 2	GO:0000085; P:mitotic G2 phase; TAS:Reactome
P24941	CDK2	Cyclin-dependent kinase 2	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P24941	CDK2	Cyclin-dependent kinase 2	GO:0032298; P:positive regulation of DNA-dependent DNA replication initiation; IEA:Ensembl
P24941	CDK2	Cyclin-dependent kinase 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P24941	CDK2	Cyclin-dependent kinase 2	GO:0006813; P:potassium ion transport; IEA:Ensembl
P24941	CDK2	Cyclin-dependent kinase 2	GO:0007265; P:Ras protein signal transduction; IEP:BHF-UCL
P24941	CDK2	Cyclin-dependent kinase 2	GO:0060968; P:regulation of gene silencing; IDA:UniProtKB
P24941	CDK2	Cyclin-dependent kinase 2	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q00526	CDK3	Cyclin-dependent kinase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q00526	CDK3	Cyclin-dependent kinase 3	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
Q00526	CDK3	Cyclin-dependent kinase 3	GO:0008283; P:cell proliferation; TAS:UniProtKB
Q00526	CDK3	Cyclin-dependent kinase 3	GO:0045023; P:G0 to G1 transition; TAS:UniProtKB
Q00526	CDK3	Cyclin-dependent kinase 3	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:UniProtKB
Q00526	CDK3	Cyclin-dependent kinase 3	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P11802	CDK4	Cyclin-dependent kinase 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P11802	CDK4	Cyclin-dependent kinase 4	GO:0030332; F:cyclin binding; IPI:UniProtKB
P11802	CDK4	Cyclin-dependent kinase 4	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IDA:BHF-UCL
P11802	CDK4	Cyclin-dependent kinase 4	GO:0005515; F:protein binding; IPI:UniProtKB
P11802	CDK4	Cyclin-dependent kinase 4	GO:0051301; P:cell division; IEA:UniProtKB-KW
P11802	CDK4	Cyclin-dependent kinase 4	GO:0007623; P:circadian rhythm; IEA:Ensembl
P11802	CDK4	Cyclin-dependent kinase 4	GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:BHF-UCL
P11802	CDK4	Cyclin-dependent kinase 4	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P11802	CDK4	Cyclin-dependent kinase 4	GO:0071157; P:negative regulation of cell cycle arrest; IDA:UniProtKB
P11802	CDK4	Cyclin-dependent kinase 4	GO:0031100; P:organ regeneration; IEA:Ensembl
P11802	CDK4	Cyclin-dependent kinase 4	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P11802	CDK4	Cyclin-dependent kinase 4	GO:0008284; P:positive regulation of cell proliferation; IMP:BHF-UCL
P11802	CDK4	Cyclin-dependent kinase 4	GO:0045793; P:positive regulation of cell size; IEA:Ensembl
P11802	CDK4	Cyclin-dependent kinase 4	GO:0048146; P:positive regulation of fibroblast proliferation; IMP:BHF-UCL
P11802	CDK4	Cyclin-dependent kinase 4	GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IDA:UniProtKB
P11802	CDK4	Cyclin-dependent kinase 4	GO:0045727; P:positive regulation of translation; IEA:Ensembl
P11802	CDK4	Cyclin-dependent kinase 4	GO:0006468; P:protein phosphorylation; IDA:BHF-UCL
P11802	CDK4	Cyclin-dependent kinase 4	GO:0010468; P:regulation of gene expression; IMP:BHF-UCL
P11802	CDK4	Cyclin-dependent kinase 4	GO:0042493; P:response to drug; IGI:UniProtKB
P11802	CDK4	Cyclin-dependent kinase 4	GO:0055093; P:response to hyperoxia; IEA:Ensembl
P11802	CDK4	Cyclin-dependent kinase 4	GO:0010288; P:response to lead ion; IEA:Ensembl
P11802	CDK4	Cyclin-dependent kinase 4	GO:0033574; P:response to testosterone; IEA:Ensembl
P11802	CDK4	Cyclin-dependent kinase 4	GO:0009636; P:response to toxic substance; IEA:Ensembl
P11802	CDK4	Cyclin-dependent kinase 4	GO:0007165; P:signal transduction; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0030549; F:acetylcholine receptor activator activity; ISS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; ISS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0005176; F:ErbB-2 class receptor binding; ISS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0043125; F:ErbB-3 class receptor binding; ISS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0016301; F:kinase activity; ISS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0050321; F:tau-protein kinase activity; ISS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0048675; P:axon extension; TAS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0007411; P:axon guidance; TAS:Reactome
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0048148; P:behavioral response to cocaine; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0007596; P:blood coagulation; TAS:Reactome
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0070509; P:calcium ion import; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0008283; P:cell proliferation; TAS:ProtInc
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0007160; P:cell-matrix adhesion; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0021954; P:central nervous system neuron development; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0021697; P:cerebellar cortex formation; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0022038; P:corpus callosum development; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0030866; P:cortical actin cytoskeleton organization; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0048813; P:dendrite morphogenesis; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0009790; P:embryo development; ISS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0021766; P:hippocampus development; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0006886; P:intracellular protein transport; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0021819; P:layer formation in cerebral cortex; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0008045; P:motor neuron axon guidance; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0030517; P:negative regulation of axon extension; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0045786; P:negative regulation of cell cycle; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0046826; P:negative regulation of protein export from nucleus; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0031397; P:negative regulation of protein ubiquitination; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0031914; P:negative regulation of synaptic plasticity; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:DFLAT
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0051402; P:neuron apoptotic process; TAS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0001764; P:neuron migration; TAS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0031175; P:neuron projection development; ISS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0006913; P:nucleocytoplasmic transport; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0048709; P:oligodendrocyte differentiation; IDA:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0018107; P:peptidyl-threonine phosphorylation; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0016310; P:phosphorylation; IDA:DFLAT
Q00535	CDK5	Cyclin-dependent kinase 5	GO:2000251; P:positive regulation of actin cytoskeleton reorganization; TAS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0043525; P:positive regulation of neuron apoptotic process; ISS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0032092; P:positive regulation of protein binding; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0045860; P:positive regulation of protein kinase activity; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0090314; P:positive regulation of protein targeting to membrane; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:2000273; P:positive regulation of receptor activity; ISS:GOC
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0035418; P:protein localization to synapse; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0032801; P:receptor catabolic process; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0043113; P:receptor clustering; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0045055; P:regulated secretory pathway; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0071156; P:regulation of cell cycle arrest; TAS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0030334; P:regulation of cell migration; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0061001; P:regulation of dendritic spine morphogenesis; ISS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0048167; P:regulation of synaptic plasticity; ISS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0014044; P:Schwann cell development; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0019233; P:sensory perception of pain; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0033136; P:serine phosphorylation of STAT3 protein; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0007416; P:synapse assembly; TAS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0007268; P:synaptic transmission; TAS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0001963; P:synaptic transmission, dopaminergic; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0035249; P:synaptic transmission, glutamatergic; IEA:Ensembl
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0048488; P:synaptic vesicle endocytosis; TAS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0016079; P:synaptic vesicle exocytosis; TAS:UniProtKB
Q00535	CDK5	Cyclin-dependent kinase 5	GO:0008542; P:visual learning; IEA:Ensembl
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0005524; F:ATP binding; IDA:BHF-UCL
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0030332; F:cyclin binding; IPI:BHF-UCL
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IDA:BHF-UCL
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0005515; F:protein binding; IPI:IntAct
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0014002; P:astrocyte development; ISS:UniProtKB
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0007050; P:cell cycle arrest; TAS:UniProtKB
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0043697; P:cell dedifferentiation; IMP:BHF-UCL
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0021542; P:dentate gyrus development; ISS:UniProtKB
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:UniProtKB
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0048699; P:generation of neurons; ISS:UniProtKB
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0042063; P:gliogenesis; IMP:BHF-UCL
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0021670; P:lateral ventricle development; ISS:UniProtKB
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0045786; P:negative regulation of cell cycle; IDA:UniProtKB
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0045596; P:negative regulation of cell differentiation; TAS:UniProtKB
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0008285; P:negative regulation of cell proliferation; TAS:UniProtKB
Q00534	CDK6	Cyclin-dependent kinase 6	GO:2000773; P:negative regulation of cellular senescence; IDA:UniProtKB
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0050680; P:negative regulation of epithelial cell proliferation; IMP:BHF-UCL
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0045638; P:negative regulation of myeloid cell differentiation; IDA:UniProtKB
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0045668; P:negative regulation of osteoblast differentiation; IDA:BHF-UCL
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0001954; P:positive regulation of cell-matrix adhesion; IDA:BHF-UCL
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0048146; P:positive regulation of fibroblast proliferation; IMP:BHF-UCL
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0006468; P:protein phosphorylation; IDA:BHF-UCL
Q00534	CDK6	Cyclin-dependent kinase 6	GO:2000145; P:regulation of cell motility; ISS:UniProtKB
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0045646; P:regulation of erythrocyte differentiation; IMP:BHF-UCL
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0010468; P:regulation of gene expression; IDA:BHF-UCL
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0009615; P:response to virus; IEP:UniProtKB
Q00534	CDK6	Cyclin-dependent kinase 6	GO:0003323; P:type B pancreatic cell development; IDA:UniProtKB
P50613	CDK7	Cyclin-dependent kinase 7	GO:0050681; F:androgen receptor binding; NAS:UniProtKB
P50613	CDK7	Cyclin-dependent kinase 7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P50613	CDK7	Cyclin-dependent kinase 7	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
P50613	CDK7	Cyclin-dependent kinase 7	GO:0008094; F:DNA-dependent ATPase activity; IDA:UniProtKB
P50613	CDK7	Cyclin-dependent kinase 7	GO:0005515; F:protein binding; IPI:IntAct
P50613	CDK7	Cyclin-dependent kinase 7	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P50613	CDK7	Cyclin-dependent kinase 7	GO:0004672; F:protein kinase activity; TAS:ProtInc
P50613	CDK7	Cyclin-dependent kinase 7	GO:0008353; F:RNA polymerase II carboxy-terminal domain kinase activity; IDA:UniProtKB
P50613	CDK7	Cyclin-dependent kinase 7	GO:0003713; F:transcription coactivator activity; NAS:UniProtKB
P50613	CDK7	Cyclin-dependent kinase 7	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
P50613	CDK7	Cyclin-dependent kinase 7	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
P50613	CDK7	Cyclin-dependent kinase 7	GO:0006200; P:ATP catabolic process; IDA:GOC
P50613	CDK7	Cyclin-dependent kinase 7	GO:0007050; P:cell cycle arrest; TAS:UniProtKB
P50613	CDK7	Cyclin-dependent kinase 7	GO:0051301; P:cell division; IEA:UniProtKB-KW
P50613	CDK7	Cyclin-dependent kinase 7	GO:0008283; P:cell proliferation; TAS:ProtInc
P50613	CDK7	Cyclin-dependent kinase 7	GO:0006281; P:DNA repair; TAS:Reactome
P50613	CDK7	Cyclin-dependent kinase 7	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P50613	CDK7	Cyclin-dependent kinase 7	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P50613	CDK7	Cyclin-dependent kinase 7	GO:0010467; P:gene expression; TAS:Reactome
P50613	CDK7	Cyclin-dependent kinase 7	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P50613	CDK7	Cyclin-dependent kinase 7	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P50613	CDK7	Cyclin-dependent kinase 7	GO:0000718; P:nucleotide-excision repair, DNA damage removal; TAS:Reactome
P50613	CDK7	Cyclin-dependent kinase 7	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P50613	CDK7	Cyclin-dependent kinase 7	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
P50613	CDK7	Cyclin-dependent kinase 7	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P50613	CDK7	Cyclin-dependent kinase 7	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
P50613	CDK7	Cyclin-dependent kinase 7	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
P50613	CDK7	Cyclin-dependent kinase 7	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
P50613	CDK7	Cyclin-dependent kinase 7	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P50613	CDK7	Cyclin-dependent kinase 7	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
P50613	CDK7	Cyclin-dependent kinase 7	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
P50613	CDK7	Cyclin-dependent kinase 7	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
P50613	CDK7	Cyclin-dependent kinase 7	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P50613	CDK7	Cyclin-dependent kinase 7	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P50613	CDK7	Cyclin-dependent kinase 7	GO:0016032; P:viral process; TAS:Reactome
P49336	CDK8	Cyclin-dependent kinase 8	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49336	CDK8	Cyclin-dependent kinase 8	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC
P49336	CDK8	Cyclin-dependent kinase 8	GO:0005515; F:protein binding; IPI:UniProtKB
P49336	CDK8	Cyclin-dependent kinase 8	GO:0004672; F:protein kinase activity; TAS:ProtInc
P49336	CDK8	Cyclin-dependent kinase 8	GO:0008353; F:RNA polymerase II carboxy-terminal domain kinase activity; IEA:UniProtKB-EC
P49336	CDK8	Cyclin-dependent kinase 8	GO:0010467; P:gene expression; TAS:Reactome
P49336	CDK8	Cyclin-dependent kinase 8	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P49336	CDK8	Cyclin-dependent kinase 8	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
P49336	CDK8	Cyclin-dependent kinase 8	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P49336	CDK8	Cyclin-dependent kinase 8	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
P49336	CDK8	Cyclin-dependent kinase 8	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P50750	CDK9	Cyclin-dependent kinase 9	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P50750	CDK9	Cyclin-dependent kinase 9	GO:0003682; F:chromatin binding; IEA:Ensembl
P50750	CDK9	Cyclin-dependent kinase 9	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
P50750	CDK9	Cyclin-dependent kinase 9	GO:0003677; F:DNA binding; IDA:MGI
P50750	CDK9	Cyclin-dependent kinase 9	GO:0005515; F:protein binding; IPI:UniProtKB
P50750	CDK9	Cyclin-dependent kinase 9	GO:0004672; F:protein kinase activity; TAS:ProtInc
P50750	CDK9	Cyclin-dependent kinase 9	GO:0008353; F:RNA polymerase II carboxy-terminal domain kinase activity; IDA:UniProtKB
P50750	CDK9	Cyclin-dependent kinase 9	GO:0017069; F:snRNA binding; IEA:Ensembl
P50750	CDK9	Cyclin-dependent kinase 9	GO:0044212; F:transcription regulatory region DNA binding; IEA:Ensembl
P50750	CDK9	Cyclin-dependent kinase 9	GO:0008283; P:cell proliferation; TAS:ProtInc
P50750	CDK9	Cyclin-dependent kinase 9	GO:0071345; P:cellular response to cytokine stimulus; IDA:UniProtKB
P50750	CDK9	Cyclin-dependent kinase 9	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
P50750	CDK9	Cyclin-dependent kinase 9	GO:0010467; P:gene expression; TAS:Reactome
P50750	CDK9	Cyclin-dependent kinase 9	GO:0071157; P:negative regulation of cell cycle arrest; IDA:UniProtKB
P50750	CDK9	Cyclin-dependent kinase 9	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
P50750	CDK9	Cyclin-dependent kinase 9	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P50750	CDK9	Cyclin-dependent kinase 9	GO:0006468; P:protein phosphorylation; IDA:MGI
P50750	CDK9	Cyclin-dependent kinase 9	GO:0006282; P:regulation of DNA repair; IDA:UniProtKB
P50750	CDK9	Cyclin-dependent kinase 9	GO:0031056; P:regulation of histone modification; IDA:UniProtKB
P50750	CDK9	Cyclin-dependent kinase 9	GO:0043111; P:replication fork arrest; IDA:UniProtKB
P50750	CDK9	Cyclin-dependent kinase 9	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P50750	CDK9	Cyclin-dependent kinase 9	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
P50750	CDK9	Cyclin-dependent kinase 9	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P50750	CDK9	Cyclin-dependent kinase 9	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
P50750	CDK9	Cyclin-dependent kinase 9	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P50750	CDK9	Cyclin-dependent kinase 9	GO:0016032; P:viral process; TAS:Reactome
O14519	CDK2AP1	Cyclin-dependent kinase 2-associated protein 1	GO:0003677; F:DNA binding; TAS:ProtInc
O14519	CDK2AP1	Cyclin-dependent kinase 2-associated protein 1	GO:0006261; P:DNA-dependent DNA replication; TAS:ProtInc
O14519	CDK2AP1	Cyclin-dependent kinase 2-associated protein 1	GO:0000084; P:mitotic S phase; TAS:ProtInc
O14519	CDK2AP1	Cyclin-dependent kinase 2-associated protein 1	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q5VV42	CDKAL1	Threonylcarbamoyladenosine tRNA methylthiotransferase	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
Q5VV42	CDKAL1	Threonylcarbamoyladenosine tRNA methylthiotransferase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5VV42	CDKAL1	Threonylcarbamoyladenosine tRNA methylthiotransferase	GO:0035598; F:N6-threonylcarbomyladenosine methylthiotransferase activity; IEA:Ensembl
Q5VV42	CDKAL1	Threonylcarbamoyladenosine tRNA methylthiotransferase	GO:1990145; P:maintenance of translational fidelity; IEA:Ensembl
Q00532	CDKL1	Cyclin-dependent kinase-like 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q00532	CDKL1	Cyclin-dependent kinase-like 1	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
Q00532	CDKL1	Cyclin-dependent kinase-like 1	GO:0007507; P:heart development; IEA:Ensembl
Q00532	CDKL1	Cyclin-dependent kinase-like 1	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q92772	CDKL2	Cyclin-dependent kinase-like 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q92772	CDKL2	Cyclin-dependent kinase-like 2	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC
Q92772	CDKL2	Cyclin-dependent kinase-like 2	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q92772	CDKL2	Cyclin-dependent kinase-like 2	GO:0007548; P:sex differentiation; TAS:ProtInc
Q92772	CDKL2	Cyclin-dependent kinase-like 2	GO:0007165; P:signal transduction; TAS:ProtInc
Q8IVW4	CDKL3	Cyclin-dependent kinase-like 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IVW4	CDKL3	Cyclin-dependent kinase-like 3	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC
Q8IVW4	CDKL3	Cyclin-dependent kinase-like 3	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q8IVW4	CDKL3	Cyclin-dependent kinase-like 3	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q5MAI5	CDKL4	Cyclin-dependent kinase-like 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5MAI5	CDKL4	Cyclin-dependent kinase-like 4	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC
O76039	CDKL5	Cyclin-dependent kinase-like 5	GO:0005524; F:ATP binding; IDA:HGNC
O76039	CDKL5	Cyclin-dependent kinase-like 5	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC
O76039	CDKL5	Cyclin-dependent kinase-like 5	GO:0016301; F:kinase activity; IDA:MGI
O76039	CDKL5	Cyclin-dependent kinase-like 5	GO:0004672; F:protein kinase activity; IDA:HGNC
O76039	CDKL5	Cyclin-dependent kinase-like 5	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
O76039	CDKL5	Cyclin-dependent kinase-like 5	GO:0048365; F:Rac GTPase binding; ISS:BHF-UCL
O76039	CDKL5	Cyclin-dependent kinase-like 5	GO:0001764; P:neuron migration; ISS:BHF-UCL
O76039	CDKL5	Cyclin-dependent kinase-like 5	GO:0045773; P:positive regulation of axon extension; ISS:BHF-UCL
O76039	CDKL5	Cyclin-dependent kinase-like 5	GO:0050775; P:positive regulation of dendrite morphogenesis; ISS:BHF-UCL
O76039	CDKL5	Cyclin-dependent kinase-like 5	GO:0032855; P:positive regulation of Rac GTPase activity; ISS:BHF-UCL
O76039	CDKL5	Cyclin-dependent kinase-like 5	GO:0046777; P:protein autophosphorylation; IDA:HGNC
O76039	CDKL5	Cyclin-dependent kinase-like 5	GO:0006468; P:protein phosphorylation; TAS:ProtInc
O76039	CDKL5	Cyclin-dependent kinase-like 5	GO:0050773; P:regulation of dendrite development; ISS:BHF-UCL
Q16667	CDKN3	Cyclin-dependent kinase inhibitor 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q16667	CDKN3	Cyclin-dependent kinase inhibitor 3	GO:0004722; F:protein serine/threonine phosphatase activity; IDA:MGI
Q16667	CDKN3	Cyclin-dependent kinase inhibitor 3	GO:0004725; F:protein tyrosine phosphatase activity; IDA:MGI
Q16667	CDKN3	Cyclin-dependent kinase inhibitor 3	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; TAS:ProtInc
Q16667	CDKN3	Cyclin-dependent kinase inhibitor 3	GO:0007050; P:cell cycle arrest; IDA:MGI
Q16667	CDKN3	Cyclin-dependent kinase inhibitor 3	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:ProtInc
Q16667	CDKN3	Cyclin-dependent kinase inhibitor 3	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q16667	CDKN3	Cyclin-dependent kinase inhibitor 3	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:GOC
Q16667	CDKN3	Cyclin-dependent kinase inhibitor 3	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0019912; F:cyclin-dependent protein kinase activating kinase activity; IDA:UniProtKB
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0004861; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; TAS:BHF-UCL
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0005515; F:protein binding; IPI:UniProtKB
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0007050; P:cell cycle arrest; IDA:BHF-UCL
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0006974; P:cellular response to DNA damage stimulus; IMP:BHF-UCL
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0031668; P:cellular response to extracellular stimulus; IMP:BHF-UCL
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0071479; P:cellular response to ionizing radiation; IMP:BHF-UCL
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0090398; P:cellular senescence; IMP:BHF-UCL
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; IDA:BHF-UCL
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0000082; P:G1/S transition of mitotic cell cycle; IDA:BHF-UCL
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0000086; P:G2/M transition of mitotic cell cycle; IMP:BHF-UCL
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0045087; P:innate immune response; TAS:Reactome
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:ProtInc
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IEA:Ensembl
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0071850; P:mitotic cell cycle arrest; IEA:Ensembl
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0030308; P:negative regulation of cell growth; IDA:BHF-UCL
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:Ensembl
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0042326; P:negative regulation of phosphorylation; IDA:BHF-UCL
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0031100; P:organ regeneration; IEA:Ensembl
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0030890; P:positive regulation of B cell proliferation; IEA:Ensembl
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0048146; P:positive regulation of fibroblast proliferation; IMP:BHF-UCL
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0043068; P:positive regulation of programmed cell death; IEA:Ensembl
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0045860; P:positive regulation of protein kinase activity; IDA:GOC
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IMP:BHF-UCL
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0006468; P:protein phosphorylation; IDA:GOC
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0007265; P:Ras protein signal transduction; IEP:BHF-UCL
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:2000278; P:regulation of DNA biosynthetic process; IEA:Ensembl
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0033158; P:regulation of protein import into nucleus, translocation; IEA:Ensembl
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0046685; P:response to arsenic-containing substance; IEA:Ensembl
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0051412; P:response to corticosterone; IEA:Ensembl
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0042493; P:response to drug; IEA:Ensembl
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0055093; P:response to hyperoxia; IEA:Ensembl
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0010243; P:response to organonitrogen compound; IEA:Ensembl
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0009636; P:response to toxic substance; IEA:Ensembl
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0009411; P:response to UV; IEA:Ensembl
P38936	CDKN1A	Cyclin-dependent kinase inhibitor 1	GO:0090400; P:stress-induced premature senescence; TAS:BHF-UCL
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0004861; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; TAS:ProtInc
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0005515; F:protein binding; IPI:UniProtKB
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0019903; F:protein phosphatase binding; IPI:BHF-UCL
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0005072; F:transforming growth factor beta receptor, cytoplasmic mediator activity; TAS:ProtInc
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0048102; P:autophagic cell death; IDA:BHF-UCL
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0007050; P:cell cycle arrest; IMP:HGNC
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0071236; P:cellular response to antibiotic; IEA:Ensembl
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0071285; P:cellular response to lithium ion; IDA:MGI
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0000082; P:G1/S transition of mitotic cell cycle; IDA:BHF-UCL
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0045087; P:innate immune response; TAS:Reactome
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0048839; P:inner ear development; IEA:Ensembl
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0071850; P:mitotic cell cycle arrest; IDA:UniProtKB
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0030308; P:negative regulation of cell growth; IDA:BHF-UCL
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0051271; P:negative regulation of cellular component movement; IEA:Ensembl
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:Ensembl
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0060770; P:negative regulation of epithelial cell proliferation involved in prostate gland development; IEA:Ensembl
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0033673; P:negative regulation of kinase activity; IDA:UniProtKB
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0045930; P:negative regulation of mitotic cell cycle; IDA:UniProtKB
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0042326; P:negative regulation of phosphorylation; IDA:BHF-UCL
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0010942; P:positive regulation of cell death; IDA:UniProtKB
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0031116; P:positive regulation of microtubule polymerization; IEA:Ensembl
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0045732; P:positive regulation of protein catabolic process; IDA:MGI
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0006813; P:potassium ion transport; IEA:Ensembl
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0043200; P:response to amino acid; IEA:Ensembl
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0046686; P:response to cadmium ion; IEA:Ensembl
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0042493; P:response to drug; IEA:Ensembl
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0032355; P:response to estradiol; IEA:Ensembl
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0009749; P:response to glucose; IEA:Ensembl
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0001666; P:response to hypoxia; IEA:Ensembl
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P46527	CDKN1B	Cyclin-dependent kinase inhibitor 1B	GO:0007605; P:sensory perception of sound; IEA:Ensembl
P49918	CDKN1C	Cyclin-dependent kinase inhibitor 1C	GO:0004861; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; TAS:ProtInc
P49918	CDKN1C	Cyclin-dependent kinase inhibitor 1C	GO:0005515; F:protein binding; IPI:UniProtKB
P49918	CDKN1C	Cyclin-dependent kinase inhibitor 1C	GO:0007050; P:cell cycle arrest; TAS:ProtInc
P49918	CDKN1C	Cyclin-dependent kinase inhibitor 1C	GO:0000080; P:mitotic G1 phase; TAS:ProtInc
P49918	CDKN1C	Cyclin-dependent kinase inhibitor 1C	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P49918	CDKN1C	Cyclin-dependent kinase inhibitor 1C	GO:0050680; P:negative regulation of epithelial cell proliferation; IMP:BHF-UCL
P49918	CDKN1C	Cyclin-dependent kinase inhibitor 1C	GO:0033673; P:negative regulation of kinase activity; IDA:UniProtKB
P49918	CDKN1C	Cyclin-dependent kinase inhibitor 1C	GO:0042326; P:negative regulation of phosphorylation; IDA:UniProtKB
P49918	CDKN1C	Cyclin-dependent kinase inhibitor 1C	GO:0071901; P:negative regulation of protein serine/threonine kinase activity; TAS:GOC
P49918	CDKN1C	Cyclin-dependent kinase inhibitor 1C	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P49918	CDKN1C	Cyclin-dependent kinase inhibitor 1C	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P49918	CDKN1C	Cyclin-dependent kinase inhibitor 1C	GO:0042551; P:neuron maturation; IEA:Ensembl
P49918	CDKN1C	Cyclin-dependent kinase inhibitor 1C	GO:0001890; P:placenta development; IEA:Ensembl
P49918	CDKN1C	Cyclin-dependent kinase inhibitor 1C	GO:0045893; P:positive regulation of transcription, DNA-templated; IGI:UniProtKB
P49918	CDKN1C	Cyclin-dependent kinase inhibitor 1C	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IMP:BHF-UCL
P49918	CDKN1C	Cyclin-dependent kinase inhibitor 1C	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0004861; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; NAS:UniProtKB
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0005515; F:protein binding; IPI:IntAct
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0007568; P:aging; IEA:Ensembl
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0007050; P:cell cycle arrest; IMP:BHF-UCL
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0031668; P:cellular response to extracellular stimulus; IMP:BHF-UCL
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0031670; P:cellular response to nutrient; IMP:BHF-UCL
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0000086; P:G2/M transition of mitotic cell cycle; IMP:BHF-UCL
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0010467; P:gene expression; TAS:Reactome
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0001889; P:liver development; IEA:Ensembl
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0030219; P:megakaryocyte differentiation; IEP:UniProtKB
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0007093; P:mitotic cell cycle checkpoint; IMP:BHF-UCL
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0008285; P:negative regulation of cell proliferation; IMP:BHF-UCL
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0050680; P:negative regulation of epithelial cell proliferation; IMP:BHF-UCL
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0042326; P:negative regulation of phosphorylation; IDA:BHF-UCL
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0071901; P:negative regulation of protein serine/threonine kinase activity; IDA:GOC
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0030858; P:positive regulation of epithelial cell differentiation; IEA:Ensembl
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IMP:BHF-UCL
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:BHF-UCL
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0034097; P:response to cytokine; IEA:Ensembl
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0048536; P:spleen development; IEA:Ensembl
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
P42772	CDKN2B	Cyclin-dependent kinase 4 inhibitor B	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P42773	CDKN2C	Cyclin-dependent kinase 4 inhibitor C	GO:0004861; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; IDA:BHF-UCL
P42773	CDKN2C	Cyclin-dependent kinase 4 inhibitor C	GO:0005515; F:protein binding; IPI:IntAct
P42773	CDKN2C	Cyclin-dependent kinase 4 inhibitor C	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
P42773	CDKN2C	Cyclin-dependent kinase 4 inhibitor C	GO:0007050; P:cell cycle arrest; IDA:BHF-UCL
P42773	CDKN2C	Cyclin-dependent kinase 4 inhibitor C	GO:0000082; P:G1/S transition of mitotic cell cycle; IDA:BHF-UCL
P42773	CDKN2C	Cyclin-dependent kinase 4 inhibitor C	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P42773	CDKN2C	Cyclin-dependent kinase 4 inhibitor C	GO:0030308; P:negative regulation of cell growth; IDA:BHF-UCL
P42773	CDKN2C	Cyclin-dependent kinase 4 inhibitor C	GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL
P42773	CDKN2C	Cyclin-dependent kinase 4 inhibitor C	GO:0042326; P:negative regulation of phosphorylation; IDA:BHF-UCL
P42773	CDKN2C	Cyclin-dependent kinase 4 inhibitor C	GO:0071901; P:negative regulation of protein serine/threonine kinase activity; IDA:GOC
P42773	CDKN2C	Cyclin-dependent kinase 4 inhibitor C	GO:0048709; P:oligodendrocyte differentiation; IEA:Ensembl
P42773	CDKN2C	Cyclin-dependent kinase 4 inhibitor C	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:BHF-UCL
P55273	CDKN2D	Cyclin-dependent kinase 4 inhibitor D	GO:0004861; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; IDA:BHF-UCL
P55273	CDKN2D	Cyclin-dependent kinase 4 inhibitor D	GO:0005515; F:protein binding; IPI:IntAct
P55273	CDKN2D	Cyclin-dependent kinase 4 inhibitor D	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
P55273	CDKN2D	Cyclin-dependent kinase 4 inhibitor D	GO:0048102; P:autophagic cell death; IMP:BHF-UCL
P55273	CDKN2D	Cyclin-dependent kinase 4 inhibitor D	GO:0007050; P:cell cycle arrest; IDA:BHF-UCL
P55273	CDKN2D	Cyclin-dependent kinase 4 inhibitor D	GO:0000731; P:DNA synthesis involved in DNA repair; IMP:BHF-UCL
P55273	CDKN2D	Cyclin-dependent kinase 4 inhibitor D	GO:0000082; P:G1/S transition of mitotic cell cycle; IDA:BHF-UCL
P55273	CDKN2D	Cyclin-dependent kinase 4 inhibitor D	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P55273	CDKN2D	Cyclin-dependent kinase 4 inhibitor D	GO:0030308; P:negative regulation of cell growth; IDA:BHF-UCL
P55273	CDKN2D	Cyclin-dependent kinase 4 inhibitor D	GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL
P55273	CDKN2D	Cyclin-dependent kinase 4 inhibitor D	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:BHF-UCL
P55273	CDKN2D	Cyclin-dependent kinase 4 inhibitor D	GO:1902230; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; IMP:BHF-UCL
P55273	CDKN2D	Cyclin-dependent kinase 4 inhibitor D	GO:0042326; P:negative regulation of phosphorylation; IDA:BHF-UCL
P55273	CDKN2D	Cyclin-dependent kinase 4 inhibitor D	GO:0071901; P:negative regulation of protein serine/threonine kinase activity; IDA:GOC
P55273	CDKN2D	Cyclin-dependent kinase 4 inhibitor D	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:BHF-UCL
P55273	CDKN2D	Cyclin-dependent kinase 4 inhibitor D	GO:0032526; P:response to retinoic acid; IMP:BHF-UCL
P55273	CDKN2D	Cyclin-dependent kinase 4 inhibitor D	GO:0009411; P:response to UV; IMP:BHF-UCL
P55273	CDKN2D	Cyclin-dependent kinase 4 inhibitor D	GO:0033280; P:response to vitamin D; IMP:BHF-UCL
P55273	CDKN2D	Cyclin-dependent kinase 4 inhibitor D	GO:0007605; P:sensory perception of sound; IEA:Ensembl
Q16878	CDO1	Cysteine dioxygenase type 1	GO:0017172; F:cysteine dioxygenase activity; ISS:UniProtKB
Q16878	CDO1	Cysteine dioxygenase type 1	GO:0008198; F:ferrous iron binding; IEA:Ensembl
Q16878	CDO1	Cysteine dioxygenase type 1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q16878	CDO1	Cysteine dioxygenase type 1	GO:0006534; P:cysteine metabolic process; TAS:UniProtKB
Q16878	CDO1	Cysteine dioxygenase type 1	GO:0006954; P:inflammatory response; TAS:UniProtKB
Q16878	CDO1	Cysteine dioxygenase type 1	GO:0019448; P:L-cysteine catabolic process; IEA:Ensembl
Q16878	CDO1	Cysteine dioxygenase type 1	GO:0007595; P:lactation; IEA:Ensembl
Q16878	CDO1	Cysteine dioxygenase type 1	GO:0055114; P:oxidation-reduction process; TAS:UniProtKB
Q16878	CDO1	Cysteine dioxygenase type 1	GO:0043200; P:response to amino acid; IEA:Ensembl
Q16878	CDO1	Cysteine dioxygenase type 1	GO:0051591; P:response to cAMP; IEA:Ensembl
Q16878	CDO1	Cysteine dioxygenase type 1	GO:0045471; P:response to ethanol; IEA:Ensembl
Q16878	CDO1	Cysteine dioxygenase type 1	GO:0033762; P:response to glucagon; IEA:Ensembl
Q16878	CDO1	Cysteine dioxygenase type 1	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
Q16878	CDO1	Cysteine dioxygenase type 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16878	CDO1	Cysteine dioxygenase type 1	GO:0000097; P:sulfur amino acid biosynthetic process; TAS:UniProtKB
Q16878	CDO1	Cysteine dioxygenase type 1	GO:0000098; P:sulfur amino acid catabolic process; TAS:Reactome
Q16878	CDO1	Cysteine dioxygenase type 1	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
Q16878	CDO1	Cysteine dioxygenase type 1	GO:0042412; P:taurine biosynthetic process; TAS:UniProtKB
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0005515; F:protein binding; IPI:UniProtKB
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0007155; P:cell adhesion; TAS:UniProtKB
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0001708; P:cell fate specification; IEA:Ensembl
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0021987; P:cerebral cortex development; IEA:Ensembl
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0010172; P:embryonic body morphogenesis; IEA:Ensembl
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0060059; P:embryonic retina morphogenesis in camera-type eye; IEA:Ensembl
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0002088; P:lens development in camera-type eye; IEA:Ensembl
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0042692; P:muscle cell differentiation; TAS:Reactome
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0007520; P:myoblast fusion; IEA:Ensembl
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:2000179; P:positive regulation of neural precursor cell proliferation; IEA:Ensembl
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0048643; P:positive regulation of skeletal muscle tissue development; IEA:Ensembl
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0051057; P:positive regulation of small GTPase mediated signal transduction; IEA:Ensembl
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0043497; P:regulation of protein heterodimerization activity; IEA:Ensembl
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0014816; P:satellite cell differentiation; IEA:Ensembl
Q4KMG0	CDON	Cell adhesion molecule-related/down-regulated by oncogenes	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
Q01850	CDR2	Cerebellar degeneration-related protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q92903	CDS1	Phosphatidate cytidylyltransferase 1	GO:0004142; F:diacylglycerol cholinephosphotransferase activity; NAS:UniProtKB
Q92903	CDS1	Phosphatidate cytidylyltransferase 1	GO:0004605; F:phosphatidate cytidylyltransferase activity; IDA:UniProtKB
Q92903	CDS1	Phosphatidate cytidylyltransferase 1	GO:0006657; P:CDP-choline pathway; NAS:GOC
Q92903	CDS1	Phosphatidate cytidylyltransferase 1	GO:0016024; P:CDP-diacylglycerol biosynthetic process; IDA:UniProtKB
Q92903	CDS1	Phosphatidate cytidylyltransferase 1	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q92903	CDS1	Phosphatidate cytidylyltransferase 1	GO:0006661; P:phosphatidylinositol biosynthetic process; IDA:UniProtKB
Q92903	CDS1	Phosphatidate cytidylyltransferase 1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q92903	CDS1	Phosphatidate cytidylyltransferase 1	GO:0007602; P:phototransduction; NAS:UniProtKB
Q92903	CDS1	Phosphatidate cytidylyltransferase 1	GO:0007165; P:signal transduction; NAS:UniProtKB
Q92903	CDS1	Phosphatidate cytidylyltransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95674	CDS2	Phosphatidate cytidylyltransferase 2	GO:0004605; F:phosphatidate cytidylyltransferase activity; NAS:UniProtKB
O95674	CDS2	Phosphatidate cytidylyltransferase 2	GO:0016024; P:CDP-diacylglycerol biosynthetic process; IEA:UniProtKB-UniPathway
O95674	CDS2	Phosphatidate cytidylyltransferase 2	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
O95674	CDS2	Phosphatidate cytidylyltransferase 2	GO:0006655; P:phosphatidylglycerol biosynthetic process; TAS:Reactome
O95674	CDS2	Phosphatidate cytidylyltransferase 2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
O95674	CDS2	Phosphatidate cytidylyltransferase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15517	CDSN	Corneodesmosin	GO:0042803; F:protein homodimerization activity; IDA:MGI
Q15517	CDSN	Corneodesmosin	GO:0007155; P:cell adhesion; TAS:ProtInc
Q15517	CDSN	Corneodesmosin	GO:0016337; P:single organismal cell-cell adhesion; IDA:MGI
Q15517	CDSN	Corneodesmosin	GO:0008544; P:epidermis development; TAS:ProtInc
Q15517	CDSN	Corneodesmosin	GO:0030216; P:keratinocyte differentiation; NAS:UniProtKB
Q15517	CDSN	Corneodesmosin	GO:0043589; P:skin morphogenesis; IMP:UniProtKB
Q9H211	CDT1	DNA replication factor Cdt1	GO:0003677; F:DNA binding; ISS:UniProtKB
Q9H211	CDT1	DNA replication factor Cdt1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H211	CDT1	DNA replication factor Cdt1	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q9H211	CDT1	DNA replication factor Cdt1	GO:0000076; P:DNA replication checkpoint; IDA:UniProtKB
Q9H211	CDT1	DNA replication factor Cdt1	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q9H211	CDT1	DNA replication factor Cdt1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9H211	CDT1	DNA replication factor Cdt1	GO:0030174; P:regulation of DNA-dependent DNA replication initiation; IDA:UniProtKB
Q9H211	CDT1	DNA replication factor Cdt1	GO:0033262; P:regulation of nuclear cell cycle DNA replication; IEA:Ensembl
Q9H211	CDT1	DNA replication factor Cdt1	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; TAS:Reactome
Q9UKY7	CDV3	Protein CDV3 homolog	GO:0008283; P:cell proliferation; NAS:UniProtKB
P47902	CDX1	Homeobox protein CDX-1	GO:0005515; F:protein binding; IPI:IntAct
P47902	CDX1	Homeobox protein CDX-1	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IDA:NTNU_SB
P47902	CDX1	Homeobox protein CDX-1	GO:0001205; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:NTNU_SB
P47902	CDX1	Homeobox protein CDX-1	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P47902	CDX1	Homeobox protein CDX-1	GO:0060349; P:bone morphogenesis; IEA:Ensembl
P47902	CDX1	Homeobox protein CDX-1	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P47902	CDX1	Homeobox protein CDX-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB
Q99626	CDX2	Homeobox protein CDX-2	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
Q99626	CDX2	Homeobox protein CDX-2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q99626	CDX2	Homeobox protein CDX-2	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
Q99626	CDX2	Homeobox protein CDX-2	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
Q99626	CDX2	Homeobox protein CDX-2	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q99626	CDX2	Homeobox protein CDX-2	GO:0001568; P:blood vessel development; IEA:Ensembl
Q99626	CDX2	Homeobox protein CDX-2	GO:0008333; P:endosome to lysosome transport; IEA:Ensembl
Q99626	CDX2	Homeobox protein CDX-2	GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; IEA:Ensembl
Q99626	CDX2	Homeobox protein CDX-2	GO:0060711; P:labyrinthine layer development; IEA:Ensembl
Q99626	CDX2	Homeobox protein CDX-2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB
Q99626	CDX2	Homeobox protein CDX-2	GO:0009887; P:organ morphogenesis; TAS:ProtInc
Q99626	CDX2	Homeobox protein CDX-2	GO:0045597; P:positive regulation of cell differentiation; IEA:Ensembl
Q99626	CDX2	Homeobox protein CDX-2	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q99626	CDX2	Homeobox protein CDX-2	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q99626	CDX2	Homeobox protein CDX-2	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
Q99626	CDX2	Homeobox protein CDX-2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q99626	CDX2	Homeobox protein CDX-2	GO:0001829; P:trophectodermal cell differentiation; IEA:Ensembl
O14627	CDX4	Homeobox protein CDX-4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O14627	CDX4	Homeobox protein CDX-4	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
O14627	CDX4	Homeobox protein CDX-4	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
O14627	CDX4	Homeobox protein CDX-4	GO:0001568; P:blood vessel development; IEA:Ensembl
O14627	CDX4	Homeobox protein CDX-4	GO:0060711; P:labyrinthine layer development; IEA:Ensembl
O14627	CDX4	Homeobox protein CDX-4	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O14627	CDX4	Homeobox protein CDX-4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y6F8	CDY1	Testis-specific chromodomain protein Y 1	GO:0004402; F:histone acetyltransferase activity; IEA:UniProtKB-EC
Q9Y6F8	CDY1	Testis-specific chromodomain protein Y 1	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q9Y6F8	CDY1	Testis-specific chromodomain protein Y 1	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q9Y6F7	CDY2A	Testis-specific chromodomain protein Y 2	GO:0004402; F:histone acetyltransferase activity; IEA:UniProtKB-EC
Q9Y6F7	CDY2A	Testis-specific chromodomain protein Y 2	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q9Y232	CDYL	Chromodomain Y-like protein	GO:0004402; F:histone acetyltransferase activity; IEA:UniProtKB-EC
Q9Y232	CDYL	Chromodomain Y-like protein	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q9Y232	CDYL	Chromodomain Y-like protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y232	CDYL	Chromodomain Y-like protein	GO:0003714; F:transcription corepressor activity; IMP:UniProtKB
Q9Y232	CDYL	Chromodomain Y-like protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y232	CDYL	Chromodomain Y-like protein	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q9Y232	CDYL	Chromodomain Y-like protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N8U2	CDYL2	Chromodomain Y-like protein 2	GO:0003824; F:catalytic activity; IEA:InterPro
Q8N8U2	CDYL2	Chromodomain Y-like protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q96GV9	C5orf30	UNC119-binding protein C5orf30	GO:0005515; F:protein binding; IPI:UniProtKB
Q96GV9	C5orf30	UNC119-binding protein C5orf30	GO:0060271; P:cilium morphogenesis; ISS:UniProtKB
Q96GV9	C5orf30	UNC119-binding protein C5orf30	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O60308	CEP104	Centrosomal protein of 104 kDa	GO:0016595; F:glutamate binding; IEA:Ensembl
O60308	CEP104	Centrosomal protein of 104 kDa	GO:0016594; F:glycine binding; IEA:Ensembl
O60308	CEP104	Centrosomal protein of 104 kDa	GO:0016596; F:thienylcyclohexylpiperidine binding; IEA:Ensembl
Q8N8E3	CEP112	Centrosomal protein of 112 kDa	GO:0097120; P:receptor localization to synapse; IEA:Ensembl
Q8N960	CEP120	Centrosomal protein of 120 kDa	GO:0030953; P:astral microtubule organization; IEA:Ensembl
Q8N960	CEP120	Centrosomal protein of 120 kDa	GO:0021987; P:cerebral cortex development; IEA:Ensembl
Q8N960	CEP120	Centrosomal protein of 120 kDa	GO:0022027; P:interkinetic nuclear migration; IEA:Ensembl
Q8N960	CEP120	Centrosomal protein of 120 kDa	GO:0022008; P:neurogenesis; IEA:Ensembl
Q8N960	CEP120	Centrosomal protein of 120 kDa	GO:0032886; P:regulation of microtubule-based process; IEA:Ensembl
Q8N960	CEP120	Centrosomal protein of 120 kDa	GO:0032880; P:regulation of protein localization; IEA:Ensembl
O94986	CEP152	Centrosomal protein of 152 kDa	GO:0005515; F:protein binding; IPI:UniProtKB
O94986	CEP152	Centrosomal protein of 152 kDa	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O94986	CEP152	Centrosomal protein of 152 kDa	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
O94986	CEP152	Centrosomal protein of 152 kDa	GO:0007099; P:centriole replication; ISS:UniProtKB
O94986	CEP152	Centrosomal protein of 152 kDa	GO:0051298; P:centrosome duplication; IMP:UniProtKB
O94986	CEP152	Centrosomal protein of 152 kDa	GO:0098535; P:de novo centriole assembly; ISS:UniProtKB
O94986	CEP152	Centrosomal protein of 152 kDa	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
O94986	CEP152	Centrosomal protein of 152 kDa	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q5TB80	CEP162	Centrosomal protein of 162 kDa	GO:0005515; F:protein binding; IPI:UniProtKB
Q5TB80	CEP162	Centrosomal protein of 162 kDa	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q5SW79	CEP170	Centrosomal protein of 170 kDa	GO:0005515; F:protein binding; IPI:IntAct
Q9UPV0	CEP164	Centrosomal protein of 164 kDa	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UPV0	CEP164	Centrosomal protein of 164 kDa	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q9UPV0	CEP164	Centrosomal protein of 164 kDa	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q9UPV0	CEP164	Centrosomal protein of 164 kDa	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q9UPV0	CEP164	Centrosomal protein of 164 kDa	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9UPV0	CEP164	Centrosomal protein of 164 kDa	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8TEP8	CEP192	Centrosomal protein of 192 kDa	GO:0019902; F:phosphatase binding; IDA:UniProtKB
Q8TEP8	CEP192	Centrosomal protein of 192 kDa	GO:0005515; F:protein binding; IPI:IntAct
Q8TEP8	CEP192	Centrosomal protein of 192 kDa	GO:0051298; P:centrosome duplication; IMP:UniProtKB
Q8TEP8	CEP192	Centrosomal protein of 192 kDa	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q8TEP8	CEP192	Centrosomal protein of 192 kDa	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8TEP8	CEP192	Centrosomal protein of 192 kDa	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q8TEP8	CEP192	Centrosomal protein of 192 kDa	GO:0051225; P:spindle assembly; IMP:UniProtKB
O15078	CEP290	Centrosomal protein of 290 kDa	GO:0005515; F:protein binding; IPI:UniProtKB
O15078	CEP290	Centrosomal protein of 290 kDa	GO:0042384; P:cilium assembly; ISS:UniProtKB
O15078	CEP290	Centrosomal protein of 290 kDa	GO:0060271; P:cilium morphogenesis; ISS:UniProtKB
O15078	CEP290	Centrosomal protein of 290 kDa	GO:0007163; P:establishment or maintenance of cell polarity; IEA:Ensembl
O15078	CEP290	Centrosomal protein of 290 kDa	GO:0042462; P:eye photoreceptor cell development; ISS:HGNC
O15078	CEP290	Centrosomal protein of 290 kDa	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
O15078	CEP290	Centrosomal protein of 290 kDa	GO:0030902; P:hindbrain development; ISS:HGNC
O15078	CEP290	Centrosomal protein of 290 kDa	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O15078	CEP290	Centrosomal protein of 290 kDa	GO:0030916; P:otic vesicle formation; ISS:HGNC
O15078	CEP290	Centrosomal protein of 290 kDa	GO:0090316; P:positive regulation of intracellular protein transport; IMP:UniProtKB
O15078	CEP290	Centrosomal protein of 290 kDa	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:HGNC
O15078	CEP290	Centrosomal protein of 290 kDa	GO:0048793; P:pronephros development; ISS:HGNC
O15078	CEP290	Centrosomal protein of 290 kDa	GO:0015031; P:protein transport; ISS:UniProtKB
O15078	CEP290	Centrosomal protein of 290 kDa	GO:0030814; P:regulation of cAMP metabolic process; IEA:Ensembl
O15078	CEP290	Centrosomal protein of 290 kDa	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
Q8IYX8	CEP57L1	Centrosomal protein CEP57L1	GO:0034453; P:microtubule anchoring; IEA:InterPro
Q2WEN9	CEACAM16	Carcinoembryonic antigen-related cell adhesion molecule 16	GO:0007605; P:sensory perception of sound; IMP:MGI
P13688	CEACAM1	Carcinoembryonic antigen-related cell adhesion molecule 1	GO:0005515; F:protein binding; IPI:IntAct
P13688	CEACAM1	Carcinoembryonic antigen-related cell adhesion molecule 1	GO:0001525; P:angiogenesis; NAS:UniProtKB
P13688	CEACAM1	Carcinoembryonic antigen-related cell adhesion molecule 1	GO:0016477; P:cell migration; NAS:UniProtKB
P13688	CEACAM1	Carcinoembryonic antigen-related cell adhesion molecule 1	GO:0007156; P:homophilic cell adhesion; NAS:UniProtKB
P13688	CEACAM1	Carcinoembryonic antigen-related cell adhesion molecule 1	GO:0007229; P:integrin-mediated signaling pathway; NAS:UniProtKB
P06731	CEACAM5	Carcinoembryonic antigen-related cell adhesion molecule 5	GO:0034235; F:GPI anchor binding; IMP:UniProt
P06731	CEACAM5	Carcinoembryonic antigen-related cell adhesion molecule 5	GO:0042802; F:identical protein binding; IPI:IntAct
P06731	CEACAM5	Carcinoembryonic antigen-related cell adhesion molecule 5	GO:0042803; F:protein homodimerization activity; IDA:UniProt
P06731	CEACAM5	Carcinoembryonic antigen-related cell adhesion molecule 5	GO:0034109; P:homotypic cell-cell adhesion; IDA:UniProt
P06731	CEACAM5	Carcinoembryonic antigen-related cell adhesion molecule 5	GO:2000811; P:negative regulation of anoikis; IDA:UniProt
P06731	CEACAM5	Carcinoembryonic antigen-related cell adhesion molecule 5	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProt
P06731	CEACAM5	Carcinoembryonic antigen-related cell adhesion molecule 5	GO:0010832; P:negative regulation of myotube differentiation; IDA:UniProt
P40199	CEACAM6	Carcinoembryonic antigen-related cell adhesion molecule 6	GO:0005515; F:protein binding; IPI:IntAct
P40199	CEACAM6	Carcinoembryonic antigen-related cell adhesion molecule 6	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P40199	CEACAM6	Carcinoembryonic antigen-related cell adhesion molecule 6	GO:0007165; P:signal transduction; TAS:ProtInc
P31997	CEACAM8	Carcinoembryonic antigen-related cell adhesion molecule 8	GO:0006955; P:immune response; TAS:ProtInc
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0003677; F:DNA binding; TAS:ProtInc
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0005515; F:protein binding; IPI:IntAct
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0006953; P:acute-phase response; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0048469; P:cell maturation; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0071285; P:cellular response to lithium ion; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0008203; P:cholesterol metabolic process; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0019221; P:cytokine-mediated signaling pathway; NAS:UniProtKB
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0001892; P:embryonic placenta development; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0048839; P:inner ear development; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0001889; P:liver development; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0030324; P:lung development; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0030225; P:macrophage differentiation; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0007005; P:mitochondrion organization; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0030099; P:myeloid cell differentiation; NAS:UniProtKB
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0031100; P:organ regeneration; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0045600; P:positive regulation of fat cell differentiation; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0045945; P:positive regulation of transcription from RNA polymerase III promoter; IDA:UniProtKB
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0033274; P:response to vitamin B2; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0000050; P:urea cycle; IEA:Ensembl
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0016032; P:viral process; IEA:UniProtKB-KW
P49715	CEBPA	CCAAT/enhancer-binding protein alpha	GO:0050872; P:white fat cell differentiation; IEA:Ensembl
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0003677; F:DNA binding; TAS:ProtInc
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0005515; F:protein binding; IPI:UniProtKB
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0006953; P:acute-phase response; TAS:ProtInc
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0001892; P:embryonic placenta development; IEA:Ensembl
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0006955; P:immune response; TAS:ProtInc
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0006954; P:inflammatory response; TAS:ProtInc
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0060644; P:mammary gland epithelial cell differentiation; IEA:Ensembl
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0033598; P:mammary gland epithelial cell proliferation; IEA:Ensembl
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0030182; P:neuron differentiation; IEA:Ensembl
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0045600; P:positive regulation of fat cell differentiation; ISS:UniProtKB
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0045408; P:regulation of interleukin-6 biosynthetic process; IEA:Ensembl
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0060850; P:regulation of transcription involved in cell fate commitment; ISS:UniProtKB
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P17676	CEBPB	CCAAT/enhancer-binding protein beta	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P49716	CEBPD	CCAAT/enhancer-binding protein delta	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P49716	CEBPD	CCAAT/enhancer-binding protein delta	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P49716	CEBPD	CCAAT/enhancer-binding protein delta	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q15744	CEBPE	CCAAT/enhancer-binding protein epsilon	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q15744	CEBPE	CCAAT/enhancer-binding protein epsilon	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q15744	CEBPE	CCAAT/enhancer-binding protein epsilon	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
Q15744	CEBPE	CCAAT/enhancer-binding protein epsilon	GO:0042089; P:cytokine biosynthetic process; IEA:Ensembl
Q15744	CEBPE	CCAAT/enhancer-binding protein epsilon	GO:0006952; P:defense response; TAS:ProtInc
Q15744	CEBPE	CCAAT/enhancer-binding protein epsilon	GO:0042742; P:defense response to bacterium; IEA:Ensembl
Q15744	CEBPE	CCAAT/enhancer-binding protein epsilon	GO:0030225; P:macrophage differentiation; IEA:Ensembl
Q15744	CEBPE	CCAAT/enhancer-binding protein epsilon	GO:0006909; P:phagocytosis; IEA:Ensembl
Q15744	CEBPE	CCAAT/enhancer-binding protein epsilon	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
Q15744	CEBPE	CCAAT/enhancer-binding protein epsilon	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P53567	CEBPG	CCAAT/enhancer-binding protein gamma	GO:0003677; F:DNA binding; IDA:UniProtKB
P53567	CEBPG	CCAAT/enhancer-binding protein gamma	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
P53567	CEBPG	CCAAT/enhancer-binding protein gamma	GO:0005515; F:protein binding; IPI:UniProtKB
P53567	CEBPG	CCAAT/enhancer-binding protein gamma	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
P53567	CEBPG	CCAAT/enhancer-binding protein gamma	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
P53567	CEBPG	CCAAT/enhancer-binding protein gamma	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P53567	CEBPG	CCAAT/enhancer-binding protein gamma	GO:0008134; F:transcription factor binding; IDA:UniProtKB
P53567	CEBPG	CCAAT/enhancer-binding protein gamma	GO:0030183; P:B cell differentiation; ISS:UniProtKB
P53567	CEBPG	CCAAT/enhancer-binding protein gamma	GO:0043353; P:enucleate erythrocyte differentiation; ISS:UniProtKB
P53567	CEBPG	CCAAT/enhancer-binding protein gamma	GO:0006955; P:immune response; ISS:UniProtKB
P53567	CEBPG	CCAAT/enhancer-binding protein gamma	GO:0001889; P:liver development; ISS:UniProtKB
P53567	CEBPG	CCAAT/enhancer-binding protein gamma	GO:0016071; P:mRNA metabolic process; IEA:Ensembl
P53567	CEBPG	CCAAT/enhancer-binding protein gamma	GO:0042267; P:natural killer cell mediated cytotoxicity; ISS:UniProtKB
P53567	CEBPG	CCAAT/enhancer-binding protein gamma	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
P53567	CEBPG	CCAAT/enhancer-binding protein gamma	GO:0043388; P:positive regulation of DNA binding; TAS:UniProtKB
P53567	CEBPG	CCAAT/enhancer-binding protein gamma	GO:0045739; P:positive regulation of DNA repair; IEP:UniProtKB
P53567	CEBPG	CCAAT/enhancer-binding protein gamma	GO:0045078; P:positive regulation of interferon-gamma biosynthetic process; ISS:UniProtKB
P53567	CEBPG	CCAAT/enhancer-binding protein gamma	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; TAS:UniProtKB
P53567	CEBPG	CCAAT/enhancer-binding protein gamma	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:MGI
P53567	CEBPG	CCAAT/enhancer-binding protein gamma	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q03701	CEBPZ	CCAAT/enhancer-binding protein zeta	GO:0003677; F:DNA binding; TAS:ProtInc
Q03701	CEBPZ	CCAAT/enhancer-binding protein zeta	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q03701	CEBPZ	CCAAT/enhancer-binding protein zeta	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q03701	CEBPZ	CCAAT/enhancer-binding protein zeta	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9NZK5	CECR1	Adenosine deaminase CECR1	GO:0004000; F:adenosine deaminase activity; IDA:UniProtKB
Q9NZK5	CECR1	Adenosine deaminase CECR1	GO:0031685; F:adenosine receptor binding; IDA:UniProtKB
Q9NZK5	CECR1	Adenosine deaminase CECR1	GO:0008083; F:growth factor activity; NAS:UniProtKB
Q9NZK5	CECR1	Adenosine deaminase CECR1	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
Q9NZK5	CECR1	Adenosine deaminase CECR1	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q9NZK5	CECR1	Adenosine deaminase CECR1	GO:0043394; F:proteoglycan binding; IDA:UniProtKB
Q9NZK5	CECR1	Adenosine deaminase CECR1	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q9NZK5	CECR1	Adenosine deaminase CECR1	GO:0006154; P:adenosine catabolic process; IDA:UniProtKB
Q9NZK5	CECR1	Adenosine deaminase CECR1	GO:0043103; P:hypoxanthine salvage; IBA:RefGenome
Q9NZK5	CECR1	Adenosine deaminase CECR1	GO:0046103; P:inosine biosynthetic process; IBA:RefGenome
Q9NZK5	CECR1	Adenosine deaminase CECR1	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
Q9BXF3	CECR2	Cat eye syndrome critical region protein 2	GO:0005515; F:protein binding; IPI:HGNC
Q9BXF3	CECR2	Cat eye syndrome critical region protein 2	GO:0006309; P:apoptotic DNA fragmentation; TAS:HGNC
Q9BXF3	CECR2	Cat eye syndrome critical region protein 2	GO:0043044; P:ATP-dependent chromatin remodeling; IDA:MGI
Q9BXF3	CECR2	Cat eye syndrome critical region protein 2	GO:0090102; P:cochlea development; IEA:Ensembl
Q9BXF3	CECR2	Cat eye syndrome critical region protein 2	GO:0000910; P:cytokinesis; NAS:UniProtKB
Q9BXF3	CECR2	Cat eye syndrome critical region protein 2	GO:0007010; P:cytoskeleton organization; NAS:UniProtKB
Q9BXF3	CECR2	Cat eye syndrome critical region protein 2	GO:0097194; P:execution phase of apoptosis; IDA:BHF-UCL
Q9BXF3	CECR2	Cat eye syndrome critical region protein 2	GO:0060122; P:inner ear receptor stereocilium organization; IEA:Ensembl
Q9BXF3	CECR2	Cat eye syndrome critical region protein 2	GO:0001842; P:neural fold formation; IEA:Ensembl
Q9BXF3	CECR2	Cat eye syndrome critical region protein 2	GO:0001843; P:neural tube closure; IEA:Ensembl
Q9BXF3	CECR2	Cat eye syndrome critical region protein 2	GO:0007338; P:single fertilization; IEA:Ensembl
Q9BXF3	CECR2	Cat eye syndrome critical region protein 2	GO:0016192; P:vesicle-mediated transport; NAS:UniProtKB
Q16739	UGCG	Ceramide glucosyltransferase	GO:0008120; F:ceramide glucosyltransferase activity; TAS:ProtInc
Q16739	UGCG	Ceramide glucosyltransferase	GO:0008544; P:epidermis development; TAS:ProtInc
Q16739	UGCG	Ceramide glucosyltransferase	GO:0006679; P:glucosylceramide biosynthetic process; TAS:ProtInc
Q16739	UGCG	Ceramide glucosyltransferase	GO:0006688; P:glycosphingolipid biosynthetic process; TAS:ProtInc
Q16739	UGCG	Ceramide glucosyltransferase	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
Q16739	UGCG	Ceramide glucosyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16739	UGCG	Ceramide glucosyltransferase	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
P08217	CELA2A	Chymotrypsin-like elastase family member 2A	GO:0017171; F:serine hydrolase activity; IDA:MGI
P08217	CELA2A	Chymotrypsin-like elastase family member 2A	GO:0004252; F:serine-type endopeptidase activity; TAS:ProtInc
P09093	CELA3A	Chymotrypsin-like elastase family member 3A	GO:0004252; F:serine-type endopeptidase activity; TAS:ProtInc
P09093	CELA3A	Chymotrypsin-like elastase family member 3A	GO:0008203; P:cholesterol metabolic process; TAS:ProtInc
P09093	CELA3A	Chymotrypsin-like elastase family member 3A	GO:0007586; P:digestion; TAS:ProtInc
P09093	CELA3A	Chymotrypsin-like elastase family member 3A	GO:0006508; P:proteolysis; TAS:ProtInc
P08218	CELA2B	Chymotrypsin-like elastase family member 2B	GO:0004252; F:serine-type endopeptidase activity; TAS:ProtInc
P08861	CELA3B	Chymotrypsin-like elastase family member 3B	GO:0008233; F:peptidase activity; TAS:ProtInc
P08861	CELA3B	Chymotrypsin-like elastase family member 3B	GO:0004252; F:serine-type endopeptidase activity; NAS:UniProtKB
P08861	CELA3B	Chymotrypsin-like elastase family member 3B	GO:0008203; P:cholesterol metabolic process; TAS:ProtInc
P08861	CELA3B	Chymotrypsin-like elastase family member 3B	GO:0006508; P:proteolysis; TAS:ProtInc
Q9UNI1	CELA1	Chymotrypsin-like elastase family member 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UNI1	CELA1	Chymotrypsin-like elastase family member 1	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q9UNI1	CELA1	Chymotrypsin-like elastase family member 1	GO:0031017; P:exocrine pancreas development; IEA:Ensembl
Q9UNI1	CELA1	Chymotrypsin-like elastase family member 1	GO:0006954; P:inflammatory response; IEA:Ensembl
Q9UNI1	CELA1	Chymotrypsin-like elastase family member 1	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q9UNI1	CELA1	Chymotrypsin-like elastase family member 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UNI1	CELA1	Chymotrypsin-like elastase family member 1	GO:0061113; P:pancreas morphogenesis; IEA:Ensembl
Q9UNI1	CELA1	Chymotrypsin-like elastase family member 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UNI1	CELA1	Chymotrypsin-like elastase family member 1	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q9UNI1	CELA1	Chymotrypsin-like elastase family member 1	GO:0045595; P:regulation of cell differentiation; IEA:Ensembl
Q9UNI1	CELA1	Chymotrypsin-like elastase family member 1	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q9UNI1	CELA1	Chymotrypsin-like elastase family member 1	GO:0016055; P:Wnt signaling pathway; IEA:Ensembl
Q92879	CELF1	CUGBP Elav-like family member 1	GO:0042835; F:BRE binding; IDA:UniProtKB
Q92879	CELF1	CUGBP Elav-like family member 1	GO:0003729; F:mRNA binding; IDA:BHF-UCL
Q92879	CELF1	CUGBP Elav-like family member 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q92879	CELF1	CUGBP Elav-like family member 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q92879	CELF1	CUGBP Elav-like family member 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q92879	CELF1	CUGBP Elav-like family member 1	GO:0003723; F:RNA binding; IDA:UniProtKB
Q92879	CELF1	CUGBP Elav-like family member 1	GO:0000900; F:translation repressor activity, nucleic acid binding; NAS:UniProtKB
Q92879	CELF1	CUGBP Elav-like family member 1	GO:0009790; P:embryo development; NAS:UniProtKB
Q92879	CELF1	CUGBP Elav-like family member 1	GO:0007281; P:germ cell development; NAS:UniProtKB
Q92879	CELF1	CUGBP Elav-like family member 1	GO:0006397; P:mRNA processing; TAS:ProtInc
Q92879	CELF1	CUGBP Elav-like family member 1	GO:0006376; P:mRNA splice site selection; ISS:UniProtKB
Q92879	CELF1	CUGBP Elav-like family member 1	GO:0017148; P:negative regulation of translation; NAS:GOC
Q92879	CELF1	CUGBP Elav-like family member 1	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
Q92879	CELF1	CUGBP Elav-like family member 1	GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB
Q92879	CELF1	CUGBP Elav-like family member 1	GO:0016246; P:RNA interference; NAS:UniProtKB
Q92879	CELF1	CUGBP Elav-like family member 1	GO:0007286; P:spermatid development; IEA:Ensembl
O95319	CELF2	CUGBP Elav-like family member 2	GO:0000166; F:nucleotide binding; IEA:InterPro
O95319	CELF2	CUGBP Elav-like family member 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O95319	CELF2	CUGBP Elav-like family member 2	GO:0003723; F:RNA binding; TAS:ProtInc
O95319	CELF2	CUGBP Elav-like family member 2	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
O95319	CELF2	CUGBP Elav-like family member 2	GO:0008016; P:regulation of heart contraction; TAS:ProtInc
O95319	CELF2	CUGBP Elav-like family member 2	GO:0006396; P:RNA processing; TAS:ProtInc
Q5SZQ8	CELF3	CUGBP Elav-like family member 3	GO:0003729; F:mRNA binding; NAS:UniProtKB
Q5SZQ8	CELF3	CUGBP Elav-like family member 3	GO:0000166; F:nucleotide binding; IEA:InterPro
Q5SZQ8	CELF3	CUGBP Elav-like family member 3	GO:0003723; F:RNA binding; IMP:UniProtKB
Q5SZQ8	CELF3	CUGBP Elav-like family member 3	GO:0000398; P:mRNA splicing, via spliceosome; NAS:UniProtKB
Q5SZQ8	CELF3	CUGBP Elav-like family member 3	GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; IDA:UniProtKB
Q5SZQ8	CELF3	CUGBP Elav-like family member 3	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB
Q5SZQ8	CELF3	CUGBP Elav-like family member 3	GO:0008380; P:RNA splicing; IMP:UniProtKB
Q5SZQ8	CELF3	CUGBP Elav-like family member 3	GO:0030317; P:sperm motility; IEA:Ensembl
Q5SZQ8	CELF3	CUGBP Elav-like family member 3	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q9BZC1	CELF4	CUGBP Elav-like family member 4	GO:0042835; F:BRE binding; ISS:UniProtKB
Q9BZC1	CELF4	CUGBP Elav-like family member 4	GO:0003729; F:mRNA binding; IEA:Ensembl
Q9BZC1	CELF4	CUGBP Elav-like family member 4	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9BZC1	CELF4	CUGBP Elav-like family member 4	GO:0000900; F:translation repressor activity, nucleic acid binding; NAS:UniProtKB
Q9BZC1	CELF4	CUGBP Elav-like family member 4	GO:0000380; P:alternative mRNA splicing, via spliceosome; IDA:MGI
Q9BZC1	CELF4	CUGBP Elav-like family member 4	GO:0009790; P:embryo development; NAS:UniProtKB
Q9BZC1	CELF4	CUGBP Elav-like family member 4	GO:0007281; P:germ cell development; NAS:UniProtKB
Q9BZC1	CELF4	CUGBP Elav-like family member 4	GO:0006376; P:mRNA splice site selection; IEA:Ensembl
Q9BZC1	CELF4	CUGBP Elav-like family member 4	GO:0090394; P:negative regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
Q9BZC1	CELF4	CUGBP Elav-like family member 4	GO:0017148; P:negative regulation of translation; NAS:GOC
Q9BZC1	CELF4	CUGBP Elav-like family member 4	GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; IDA:UniProtKB
Q9BZC1	CELF4	CUGBP Elav-like family member 4	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB
Q8N6W0	CELF5	CUGBP Elav-like family member 5	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8N6W0	CELF5	CUGBP Elav-like family member 5	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q8N6W0	CELF5	CUGBP Elav-like family member 5	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q96J87	CELF6	CUGBP Elav-like family member 6	GO:0000166; F:nucleotide binding; IEA:InterPro
Q96J87	CELF6	CUGBP Elav-like family member 6	GO:0003723; F:RNA binding; NAS:UniProtKB
Q96J87	CELF6	CUGBP Elav-like family member 6	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q96J87	CELF6	CUGBP Elav-like family member 6	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0004930; F:G-protein coupled receptor activity; NAS:UniProtKB
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0046983; F:protein dimerization activity; NAS:UniProtKB
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0004888; F:transmembrane signaling receptor activity; NAS:UniProtKB
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0045176; P:apical protein localization; IEA:Ensembl
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0007417; P:central nervous system development; NAS:UniProtKB
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0048105; P:establishment of body hair planar orientation; IEA:Ensembl
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0001736; P:establishment of planar polarity; ISS:UniProtKB
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0042249; P:establishment of planar polarity of embryonic epithelium; IEA:Ensembl
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0001942; P:hair follicle development; IEA:Ensembl
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0060490; P:lateral sprouting involved in lung morphogenesis; IEA:Ensembl
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0001843; P:neural tube closure; ISS:UniProtKB
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0001764; P:neuron migration; IEA:Ensembl
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0060488; P:orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis; IEA:Ensembl
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0090179; P:planar cell polarity pathway involved in neural tube closure; IEA:Ensembl
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0060489; P:planar dichotomous subdivision of terminal units involved in lung branching morphogenesis; IEA:Ensembl
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0090251; P:protein localization involved in establishment of planar polarity; IEA:Ensembl
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0032956; P:regulation of actin cytoskeleton organization; IEA:Ensembl
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0007266; P:Rho protein signal transduction; IEA:Ensembl
Q9NYQ6	CELSR1	Cadherin EGF LAG seven-pass G-type receptor 1	GO:0042060; P:wound healing; IEA:Ensembl
Q9HCU4	CELSR2	Cadherin EGF LAG seven-pass G-type receptor 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9HCU4	CELSR2	Cadherin EGF LAG seven-pass G-type receptor 2	GO:0004930; F:G-protein coupled receptor activity; NAS:UniProtKB
Q9HCU4	CELSR2	Cadherin EGF LAG seven-pass G-type receptor 2	GO:0033326; P:cerebrospinal fluid secretion; IEA:Ensembl
Q9HCU4	CELSR2	Cadherin EGF LAG seven-pass G-type receptor 2	GO:0042384; P:cilium assembly; IEA:Ensembl
Q9HCU4	CELSR2	Cadherin EGF LAG seven-pass G-type receptor 2	GO:0003341; P:cilium movement; IEA:Ensembl
Q9HCU4	CELSR2	Cadherin EGF LAG seven-pass G-type receptor 2	GO:0048813; P:dendrite morphogenesis; ISS:BHF-UCL
Q9HCU4	CELSR2	Cadherin EGF LAG seven-pass G-type receptor 2	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
Q9HCU4	CELSR2	Cadherin EGF LAG seven-pass G-type receptor 2	GO:0007156; P:homophilic cell adhesion; ISS:BHF-UCL
Q9HCU4	CELSR2	Cadherin EGF LAG seven-pass G-type receptor 2	GO:0021999; P:neural plate anterior/posterior regionalization; ISS:BHF-UCL
Q9HCU4	CELSR2	Cadherin EGF LAG seven-pass G-type receptor 2	GO:0001764; P:neuron migration; IEA:Ensembl
Q9HCU4	CELSR2	Cadherin EGF LAG seven-pass G-type receptor 2	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q9HCU4	CELSR2	Cadherin EGF LAG seven-pass G-type receptor 2	GO:0022407; P:regulation of cell-cell adhesion; ISS:BHF-UCL
Q9HCU4	CELSR2	Cadherin EGF LAG seven-pass G-type receptor 2	GO:0032880; P:regulation of protein localization; IEA:Ensembl
Q9HCU4	CELSR2	Cadherin EGF LAG seven-pass G-type receptor 2	GO:0006355; P:regulation of transcription, DNA-templated; ISS:BHF-UCL
Q9HCU4	CELSR2	Cadherin EGF LAG seven-pass G-type receptor 2	GO:0021591; P:ventricular system development; IEA:Ensembl
Q9HCU4	CELSR2	Cadherin EGF LAG seven-pass G-type receptor 2	GO:0016055; P:Wnt signaling pathway; ISS:BHF-UCL
Q9NYQ7	CELSR3	Cadherin EGF LAG seven-pass G-type receptor 3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NYQ7	CELSR3	Cadherin EGF LAG seven-pass G-type receptor 3	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q9NYQ7	CELSR3	Cadherin EGF LAG seven-pass G-type receptor 3	GO:0005515; F:protein binding; IPI:IntAct
Q9NYQ7	CELSR3	Cadherin EGF LAG seven-pass G-type receptor 3	GO:0007413; P:axonal fasciculation; IEA:Ensembl
Q9NYQ7	CELSR3	Cadherin EGF LAG seven-pass G-type receptor 3	GO:0042384; P:cilium assembly; IEA:Ensembl
Q9NYQ7	CELSR3	Cadherin EGF LAG seven-pass G-type receptor 3	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q9NYQ7	CELSR3	Cadherin EGF LAG seven-pass G-type receptor 3	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9NYQ7	CELSR3	Cadherin EGF LAG seven-pass G-type receptor 3	GO:0001764; P:neuron migration; IEA:Ensembl
Q9NYQ7	CELSR3	Cadherin EGF LAG seven-pass G-type receptor 3	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q9NYQ7	CELSR3	Cadherin EGF LAG seven-pass G-type receptor 3	GO:0032880; P:regulation of protein localization; IEA:Ensembl
P19835	CEL	Bile salt-activated lipase	GO:0047372; F:acylglycerol lipase activity; TAS:Reactome
P19835	CEL	Bile salt-activated lipase	GO:0003824; F:catalytic activity; TAS:UniProtKB
P19835	CEL	Bile salt-activated lipase	GO:0008201; F:heparin binding; NAS:UniProtKB
P19835	CEL	Bile salt-activated lipase	GO:0016787; F:hydrolase activity; TAS:UniProtKB
P19835	CEL	Bile salt-activated lipase	GO:0005515; F:protein binding; IPI:UniProtKB
P19835	CEL	Bile salt-activated lipase	GO:0004771; F:sterol esterase activity; NAS:UniProtKB
P19835	CEL	Bile salt-activated lipase	GO:0004806; F:triglyceride lipase activity; NAS:UniProtKB
P19835	CEL	Bile salt-activated lipase	GO:0006707; P:cholesterol catabolic process; IDA:UniProtKB
P19835	CEL	Bile salt-activated lipase	GO:0009062; P:fatty acid catabolic process; NAS:UniProtKB
P19835	CEL	Bile salt-activated lipase	GO:0030299; P:intestinal cholesterol absorption; NAS:UniProtKB
P19835	CEL	Bile salt-activated lipase	GO:0044258; P:intestinal lipid catabolic process; NAS:UniProtKB
P19835	CEL	Bile salt-activated lipase	GO:0044241; P:lipid digestion; TAS:Reactome
P19835	CEL	Bile salt-activated lipase	GO:0006629; P:lipid metabolic process; NAS:UniProtKB
P19835	CEL	Bile salt-activated lipase	GO:0030157; P:pancreatic juice secretion; IDA:UniProtKB
P19835	CEL	Bile salt-activated lipase	GO:0018350; P:protein esterification; NAS:UniProtKB
P19835	CEL	Bile salt-activated lipase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P19835	CEL	Bile salt-activated lipase	GO:0006641; P:triglyceride metabolic process; IC:UniProtKB
Q8WUJ3	CEMIP	Cell migration-inducing and hyaluronan-binding protein	GO:0046923; F:ER retention sequence binding; IDA:UniProtKB
Q8WUJ3	CEMIP	Cell migration-inducing and hyaluronan-binding protein	GO:0005540; F:hyaluronic acid binding; IEA:UniProtKB-KW
Q8WUJ3	CEMIP	Cell migration-inducing and hyaluronan-binding protein	GO:0004415; F:hyalurononglucosaminidase activity; IDA:UniProtKB
Q8WUJ3	CEMIP	Cell migration-inducing and hyaluronan-binding protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WUJ3	CEMIP	Cell migration-inducing and hyaluronan-binding protein	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
Q8WUJ3	CEMIP	Cell migration-inducing and hyaluronan-binding protein	GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IDA:UniProtKB
Q8WUJ3	CEMIP	Cell migration-inducing and hyaluronan-binding protein	GO:1900020; P:positive regulation of protein kinase C activity; IDA:UniProtKB
Q8WUJ3	CEMIP	Cell migration-inducing and hyaluronan-binding protein	GO:0090314; P:positive regulation of protein targeting to membrane; IDA:UniProtKB
Q8WUJ3	CEMIP	Cell migration-inducing and hyaluronan-binding protein	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IDA:UniProtKB
Q8N111	CEND1	Cell cycle exit and neuronal differentiation protein 1	GO:0007628; P:adult walking behavior; IEA:Ensembl
Q8N111	CEND1	Cell cycle exit and neuronal differentiation protein 1	GO:0021686; P:cerebellar granular layer maturation; IEA:Ensembl
Q8N111	CEND1	Cell cycle exit and neuronal differentiation protein 1	GO:0021702; P:cerebellar Purkinje cell differentiation; IEA:Ensembl
Q8N111	CEND1	Cell cycle exit and neuronal differentiation protein 1	GO:0021941; P:negative regulation of cerebellar granule cell precursor proliferation; IEA:Ensembl
Q8N111	CEND1	Cell cycle exit and neuronal differentiation protein 1	GO:0021933; P:radial glia guided migration of cerebellar granule cell; IEA:Ensembl
B2RD01	CENPBD1	CENPB DNA-binding domain-containing protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P49450	CENPA	Histone H3-like centromeric protein A	GO:0003682; F:chromatin binding; TAS:ProtInc
P49450	CENPA	Histone H3-like centromeric protein A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P49450	CENPA	Histone H3-like centromeric protein A	GO:0005515; F:protein binding; IPI:UniProtKB
P49450	CENPA	Histone H3-like centromeric protein A	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
P49450	CENPA	Histone H3-like centromeric protein A	GO:0000132; P:establishment of mitotic spindle orientation; IMP:UniProtKB
P49450	CENPA	Histone H3-like centromeric protein A	GO:0051382; P:kinetochore assembly; IDA:BHF-UCL
P49450	CENPA	Histone H3-like centromeric protein A	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P49450	CENPA	Histone H3-like centromeric protein A	GO:0006334; P:nucleosome assembly; TAS:Reactome
P49450	CENPA	Histone H3-like centromeric protein A	GO:0071459; P:protein localization to chromosome, centromeric region; IDA:BHF-UCL
P49450	CENPA	Histone H3-like centromeric protein A	GO:0016032; P:viral process; IEA:UniProtKB-KW
P07199	CENPB	Major centromere autoantigen B	GO:0019237; F:centromeric DNA binding; IC:BHF-UCL
P07199	CENPB	Major centromere autoantigen B	GO:0003682; F:chromatin binding; NAS:UniProtKB
P07199	CENPB	Major centromere autoantigen B	GO:0003696; F:satellite DNA binding; NAS:UniProtKB
P07199	CENPB	Major centromere autoantigen B	GO:0043565; F:sequence-specific DNA binding; TAS:BHF-UCL
P07199	CENPB	Major centromere autoantigen B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q03188	CENPC	Centromere protein C	GO:0019237; F:centromeric DNA binding; IEA:InterPro
Q03188	CENPC	Centromere protein C	GO:0003677; F:DNA binding; TAS:ProtInc
Q03188	CENPC	Centromere protein C	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q03188	CENPC	Centromere protein C	GO:0051382; P:kinetochore assembly; IEA:InterPro
Q03188	CENPC	Centromere protein C	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q03188	CENPC	Centromere protein C	GO:0000278; P:mitotic cell cycle; IMP:UniProtKB
Q02224	CENPE	Centromere-associated protein E	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q02224	CENPE	Centromere-associated protein E	GO:0043515; F:kinetochore binding; IDA:UniProtKB
Q02224	CENPE	Centromere-associated protein E	GO:0003777; F:microtubule motor activity; IMP:UniProtKB
Q02224	CENPE	Centromere-associated protein E	GO:0005515; F:protein binding; IPI:UniProtKB
Q02224	CENPE	Centromere-associated protein E	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q02224	CENPE	Centromere-associated protein E	GO:0007596; P:blood coagulation; TAS:Reactome
Q02224	CENPE	Centromere-associated protein E	GO:0051382; P:kinetochore assembly; NAS:UniProtKB
Q02224	CENPE	Centromere-associated protein E	GO:0008152; P:metabolic process; IMP:GOC
Q02224	CENPE	Centromere-associated protein E	GO:0007018; P:microtubule-based movement; TAS:Reactome
Q02224	CENPE	Centromere-associated protein E	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q02224	CENPE	Centromere-associated protein E	GO:0007079; P:mitotic chromosome movement towards spindle pole; TAS:ProtInc
Q02224	CENPE	Centromere-associated protein E	GO:0000089; P:mitotic metaphase; TAS:ProtInc
Q02224	CENPE	Centromere-associated protein E	GO:0007080; P:mitotic metaphase plate congression; TAS:ProtInc
Q02224	CENPE	Centromere-associated protein E	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q02224	CENPE	Centromere-associated protein E	GO:0045860; P:positive regulation of protein kinase activity; IMP:UniProtKB
P49454	CENPF	Centromere protein F	GO:0003682; F:chromatin binding; NAS:UniProtKB
P49454	CENPF	Centromere protein F	GO:0045502; F:dynein binding; IDA:UniProtKB
P49454	CENPF	Centromere protein F	GO:0005515; F:protein binding; IPI:UniProtKB
P49454	CENPF	Centromere protein F	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P49454	CENPF	Centromere protein F	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P49454	CENPF	Centromere protein F	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P49454	CENPF	Centromere protein F	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P49454	CENPF	Centromere protein F	GO:0008283; P:cell proliferation; NAS:UniProtKB
P49454	CENPF	Centromere protein F	GO:0007059; P:chromosome segregation; IMP:UniProtKB
P49454	CENPF	Centromere protein F	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
P49454	CENPF	Centromere protein F	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P49454	CENPF	Centromere protein F	GO:0051382; P:kinetochore assembly; NAS:UniProtKB
P49454	CENPF	Centromere protein F	GO:0051310; P:metaphase plate congression; IDA:UniProtKB
P49454	CENPF	Centromere protein F	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P49454	CENPF	Centromere protein F	GO:0000278; P:mitotic cell cycle; IMP:UniProtKB
P49454	CENPF	Centromere protein F	GO:0000085; P:mitotic G2 phase; IMP:UniProtKB
P49454	CENPF	Centromere protein F	GO:0000087; P:mitotic M phase; IDA:UniProtKB
P49454	CENPF	Centromere protein F	GO:0007094; P:mitotic spindle assembly checkpoint; NAS:UniProtKB
P49454	CENPF	Centromere protein F	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
P49454	CENPF	Centromere protein F	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P49454	CENPF	Centromere protein F	GO:0015031; P:protein transport; IDA:UniProtKB
P49454	CENPF	Centromere protein F	GO:0051726; P:regulation of cell cycle; TAS:Reactome
P49454	CENPF	Centromere protein F	GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; IMP:UniProtKB
P49454	CENPF	Centromere protein F	GO:0016202; P:regulation of striated muscle tissue development; ISS:UniProtKB
P49454	CENPF	Centromere protein F	GO:0042493; P:response to drug; NAS:UniProtKB
Q9H3R5	CENPH	Centromere protein H	GO:0043515; F:kinetochore binding; IDA:UniProtKB
Q9H3R5	CENPH	Centromere protein H	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H3R5	CENPH	Centromere protein H	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
Q9H3R5	CENPH	Centromere protein H	GO:0051382; P:kinetochore assembly; IEA:InterPro
Q9H3R5	CENPH	Centromere protein H	GO:0051383; P:kinetochore organization; TAS:UniProtKB
Q9H3R5	CENPH	Centromere protein H	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9H3R5	CENPH	Centromere protein H	GO:0006334; P:nucleosome assembly; TAS:Reactome
Q9HC77	CENPJ	Centromere protein J	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HC77	CENPJ	Centromere protein J	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q9HC77	CENPJ	Centromere protein J	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q9HC77	CENPJ	Centromere protein J	GO:0015631; F:tubulin binding; IDA:UniProtKB
Q9HC77	CENPJ	Centromere protein J	GO:0051301; P:cell division; NAS:UniProtKB
Q9HC77	CENPJ	Centromere protein J	GO:0007099; P:centriole replication; IMP:UniProtKB
Q9HC77	CENPJ	Centromere protein J	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q9HC77	CENPJ	Centromere protein J	GO:0007020; P:microtubule nucleation; TAS:UniProtKB
Q9HC77	CENPJ	Centromere protein J	GO:0046785; P:microtubule polymerization; IMP:UniProtKB
Q9HC77	CENPJ	Centromere protein J	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9HC77	CENPJ	Centromere protein J	GO:0046599; P:regulation of centriole replication; IMP:UniProtKB
Q92674	CENPI	Centromere protein I	GO:0005515; F:protein binding; IPI:UniProtKB
Q92674	CENPI	Centromere protein I	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
Q92674	CENPI	Centromere protein I	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q92674	CENPI	Centromere protein I	GO:0006334; P:nucleosome assembly; TAS:Reactome
Q92674	CENPI	Centromere protein I	GO:0007548; P:sex differentiation; TAS:ProtInc
Q9BS16	CENPK	Centromere protein K	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
Q9BS16	CENPK	Centromere protein K	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9BS16	CENPK	Centromere protein K	GO:0006334; P:nucleosome assembly; TAS:Reactome
Q9BS16	CENPK	Centromere protein K	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8N0S6	CENPL	Centromere protein L	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9NSP4	CENPM	Centromere protein M	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q96H22	CENPN	Centromere protein N	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
Q96H22	CENPN	Centromere protein N	GO:0007059; P:chromosome segregation; IEA:InterPro
Q96H22	CENPN	Centromere protein N	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q96H22	CENPN	Centromere protein N	GO:0006334; P:nucleosome assembly; TAS:Reactome
Q9BU64	CENPO	Centromere protein O	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
Q9BU64	CENPO	Centromere protein O	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9BU64	CENPO	Centromere protein O	GO:0006334; P:nucleosome assembly; TAS:Reactome
Q6IPU0	CENPP	Centromere protein P	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
Q6IPU0	CENPP	Centromere protein P	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q6IPU0	CENPP	Centromere protein P	GO:0006334; P:nucleosome assembly; TAS:Reactome
Q7L2Z9	CENPQ	Centromere protein Q	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
Q7L2Z9	CENPQ	Centromere protein Q	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q7L2Z9	CENPQ	Centromere protein Q	GO:0006334; P:nucleosome assembly; TAS:Reactome
Q13352	ITGB3BP	Centromere protein R	GO:0008022; F:protein C-terminus binding; TAS:ProtInc
Q13352	ITGB3BP	Centromere protein R	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q13352	ITGB3BP	Centromere protein R	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q13352	ITGB3BP	Centromere protein R	GO:0007155; P:cell adhesion; TAS:ProtInc
Q13352	ITGB3BP	Centromere protein R	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
Q13352	ITGB3BP	Centromere protein R	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q13352	ITGB3BP	Centromere protein R	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q13352	ITGB3BP	Centromere protein R	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q13352	ITGB3BP	Centromere protein R	GO:0006334; P:nucleosome assembly; TAS:Reactome
Q13352	ITGB3BP	Centromere protein R	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q13352	ITGB3BP	Centromere protein R	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q13352	ITGB3BP	Centromere protein R	GO:0007165; P:signal transduction; TAS:ProtInc
Q13352	ITGB3BP	Centromere protein R	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N2Z9	APITD1	Centromere protein S	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q8N2Z9	APITD1	Centromere protein S	GO:0003677; F:DNA binding; IDA:UniProtKB
Q8N2Z9	APITD1	Centromere protein S	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N2Z9	APITD1	Centromere protein S	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q8N2Z9	APITD1	Centromere protein S	GO:0006281; P:DNA repair; IDA:UniProtKB
Q8N2Z9	APITD1	Centromere protein S	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q8N2Z9	APITD1	Centromere protein S	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8N2Z9	APITD1	Centromere protein S	GO:0031398; P:positive regulation of protein ubiquitination; TAS:UniProtKB
Q8N2Z9	APITD1	Centromere protein S	GO:0031297; P:replication fork processing; IMP:UniProtKB
Q8N2Z9	APITD1	Centromere protein S	GO:0000712; P:resolution of meiotic recombination intermediates; IMP:UniProtKB
Q96BT3	CENPT	Centromere protein T	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96BT3	CENPT	Centromere protein T	GO:0005515; F:protein binding; IPI:UniProtKB
Q96BT3	CENPT	Centromere protein T	GO:0051276; P:chromosome organization; IMP:UniProtKB
Q96BT3	CENPT	Centromere protein T	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q96BT3	CENPT	Centromere protein T	GO:0051382; P:kinetochore assembly; IMP:UniProtKB
Q96BT3	CENPT	Centromere protein T	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q96BT3	CENPT	Centromere protein T	GO:0000278; P:mitotic cell cycle; IMP:UniProtKB
Q71F23	CENPU	Centromere protein U	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
Q71F23	CENPU	Centromere protein U	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q71F23	CENPU	Centromere protein U	GO:0006334; P:nucleosome assembly; TAS:Reactome
Q71F23	CENPU	Centromere protein U	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q71F23	CENPU	Centromere protein U	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q71F23	CENPU	Centromere protein U	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q7Z7K6	CENPV	Centromere protein V	GO:0016846; F:carbon-sulfur lyase activity; IEA:InterPro
Q7Z7K6	CENPV	Centromere protein V	GO:0001667; P:ameboidal cell migration; IDA:MGI
Q7Z7K6	CENPV	Centromere protein V	GO:0034508; P:centromere complex assembly; IMP:UniProtKB
Q7Z7K6	CENPV	Centromere protein V	GO:0031508; P:centromeric heterochromatin assembly; IMP:UniProtKB
Q7Z7K6	CENPV	Centromere protein V	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q7Z7K6	CENPV	Centromere protein V	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB
Q7Z7K6	CENPV	Centromere protein V	GO:0033044; P:regulation of chromosome organization; IMP:UniProtKB
Q5EE01	CENPW	Centromere protein W	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5EE01	CENPW	Centromere protein W	GO:0005515; F:protein binding; IPI:UniProtKB
Q5EE01	CENPW	Centromere protein W	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:UniProtKB
Q5EE01	CENPW	Centromere protein W	GO:0051276; P:chromosome organization; IMP:UniProtKB
Q5EE01	CENPW	Centromere protein W	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q5EE01	CENPW	Centromere protein W	GO:0051382; P:kinetochore assembly; IMP:UniProtKB
Q5EE01	CENPW	Centromere protein W	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q5EE01	CENPW	Centromere protein W	GO:0000278; P:mitotic cell cycle; IMP:UniProtKB
A8MT69	STRA13	Centromere protein X	GO:0003677; F:DNA binding; IDA:UniProtKB
A8MT69	STRA13	Centromere protein X	GO:0005515; F:protein binding; IPI:UniProtKB
A8MT69	STRA13	Centromere protein X	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
A8MT69	STRA13	Centromere protein X	GO:0051382; P:kinetochore assembly; IEA:InterPro
A8MT69	STRA13	Centromere protein X	GO:0007067; P:mitosis; IEA:UniProtKB-KW
A8MT69	STRA13	Centromere protein X	GO:0031398; P:positive regulation of protein ubiquitination; TAS:UniProtKB
A8MT69	STRA13	Centromere protein X	GO:0031297; P:replication fork processing; IMP:UniProtKB
A8MT69	STRA13	Centromere protein X	GO:0000712; P:resolution of meiotic recombination intermediates; IMP:UniProtKB
Q9BYV8	CEP41	Centrosomal protein of 41 kDa	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BYV8	CEP41	Centrosomal protein of 41 kDa	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q9BYV8	CEP41	Centrosomal protein of 41 kDa	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q9BYV8	CEP41	Centrosomal protein of 41 kDa	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9BYV8	CEP41	Centrosomal protein of 41 kDa	GO:0018095; P:protein polyglutamylation; ISS:UniProtKB
Q9BYV8	CEP41	Centrosomal protein of 41 kDa	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q53EZ4	CEP55	Centrosomal protein of 55 kDa	GO:0005515; F:protein binding; IPI:IntAct
Q53EZ4	CEP55	Centrosomal protein of 55 kDa	GO:0045184; P:establishment of protein localization; IMP:UniProt
Q53EZ4	CEP55	Centrosomal protein of 55 kDa	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q53EZ4	CEP55	Centrosomal protein of 55 kDa	GO:0000281; P:mitotic cytokinesis; IGI:MGI
Q86XR8	CEP57	Centrosomal protein of 57 kDa	GO:0017134; F:fibroblast growth factor binding; IPI:UniProtKB
Q86XR8	CEP57	Centrosomal protein of 57 kDa	GO:0005515; F:protein binding; IPI:IntAct
Q86XR8	CEP57	Centrosomal protein of 57 kDa	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q86XR8	CEP57	Centrosomal protein of 57 kDa	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IPI:UniProtKB
Q86XR8	CEP57	Centrosomal protein of 57 kDa	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q86XR8	CEP57	Centrosomal protein of 57 kDa	GO:0034453; P:microtubule anchoring; IEA:InterPro
Q86XR8	CEP57	Centrosomal protein of 57 kDa	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q86XR8	CEP57	Centrosomal protein of 57 kDa	GO:0051260; P:protein homooligomerization; IEA:Ensembl
Q86XR8	CEP57	Centrosomal protein of 57 kDa	GO:0000060; P:protein import into nucleus, translocation; ISS:UniProtKB
Q86XR8	CEP57	Centrosomal protein of 57 kDa	GO:0007286; P:spermatid development; ISS:HGNC
Q96MT8	CEP63	Centrosomal protein of 63 kDa	GO:0005515; F:protein binding; IPI:IntAct
Q96MT8	CEP63	Centrosomal protein of 63 kDa	GO:0007099; P:centriole replication; ISS:UniProtKB
Q96MT8	CEP63	Centrosomal protein of 63 kDa	GO:0000077; P:DNA damage checkpoint; ISS:UniProtKB
Q96MT8	CEP63	Centrosomal protein of 63 kDa	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q96MT8	CEP63	Centrosomal protein of 63 kDa	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q96MT8	CEP63	Centrosomal protein of 63 kDa	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q96MT8	CEP63	Centrosomal protein of 63 kDa	GO:0042770; P:signal transduction in response to DNA damage; ISS:UniProtKB
Q96MT8	CEP63	Centrosomal protein of 63 kDa	GO:0051225; P:spindle assembly; ISS:UniProtKB
Q76N32	CEP68	Centrosomal protein of 68 kDa	GO:0051297; P:centrosome organization; IMP:UniProtKB
Q8NHQ1	CEP70	Centrosomal protein of 70 kDa	GO:0005515; F:protein binding; IPI:IntAct
Q8NHQ1	CEP70	Centrosomal protein of 70 kDa	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q8NHQ1	CEP70	Centrosomal protein of 70 kDa	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9P209	CEP72	Centrosomal protein of 72 kDa	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P209	CEP72	Centrosomal protein of 72 kDa	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q9P209	CEP72	Centrosomal protein of 72 kDa	GO:0033566; P:gamma-tubulin complex localization; IMP:UniProtKB
Q9P209	CEP72	Centrosomal protein of 72 kDa	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9P209	CEP72	Centrosomal protein of 72 kDa	GO:0007051; P:spindle organization; IMP:UniProtKB
Q8TAP6	CEP76	Centrosomal protein of 76 kDa	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TAP6	CEP76	Centrosomal protein of 76 kDa	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q8TAP6	CEP76	Centrosomal protein of 76 kDa	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8TAP6	CEP76	Centrosomal protein of 76 kDa	GO:0046599; P:regulation of centriole replication; IMP:UniProtKB
Q5JTW2	CEP78	Centrosomal protein of 78 kDa	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q5JTW2	CEP78	Centrosomal protein of 78 kDa	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9Y592	CEP83	Centrosomal protein of 83 kDa	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y592	CEP83	Centrosomal protein of 83 kDa	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q9Y592	CEP83	Centrosomal protein of 83 kDa	GO:0071539; P:protein localization to centrosome; IMP:MGI
Q9Y592	CEP83	Centrosomal protein of 83 kDa	GO:0048278; P:vesicle docking; IMP:UniProtKB
Q6P2H3	CEP85	Centrosomal protein of 85 kDa	GO:0005515; F:protein binding; IPI:IntAct
Q96ST8	CEP89	Centrosomal protein of 89 kDa	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q8IW35	CEP97	Centrosomal protein of 97 kDa	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IW35	CEP97	Centrosomal protein of 97 kDa	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
Q9Y6K0	CEPT1	Choline/ethanolaminephosphotransferase 1	GO:0004142; F:diacylglycerol cholinephosphotransferase activity; TAS:Reactome
Q9Y6K0	CEPT1	Choline/ethanolaminephosphotransferase 1	GO:0004307; F:ethanolaminephosphotransferase activity; TAS:ProtInc
Q9Y6K0	CEPT1	Choline/ethanolaminephosphotransferase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y6K0	CEPT1	Choline/ethanolaminephosphotransferase 1	GO:0006657; P:CDP-choline pathway; TAS:GOC
Q9Y6K0	CEPT1	Choline/ethanolaminephosphotransferase 1	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9Y6K0	CEPT1	Choline/ethanolaminephosphotransferase 1	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q9Y6K0	CEPT1	Choline/ethanolaminephosphotransferase 1	GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome
Q9Y6K0	CEPT1	Choline/ethanolaminephosphotransferase 1	GO:0006646; P:phosphatidylethanolamine biosynthetic process; TAS:Reactome
Q9Y6K0	CEPT1	Choline/ethanolaminephosphotransferase 1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9Y6K0	CEPT1	Choline/ethanolaminephosphotransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95813	CER1	Cerberus	GO:0036122; F:BMP binding; IDA:BHF-UCL
O95813	CER1	Cerberus	GO:0016015; F:morphogen activity; IDA:BHF-UCL
O95813	CER1	Cerberus	GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
O95813	CER1	Cerberus	GO:0009948; P:anterior/posterior axis specification; ISS:BHF-UCL
O95813	CER1	Cerberus	GO:0009952; P:anterior/posterior pattern specification; ISS:BHF-UCL
O95813	CER1	Cerberus	GO:0030509; P:BMP signaling pathway; TAS:Reactome
O95813	CER1	Cerberus	GO:0030282; P:bone mineralization; IMP:BHF-UCL
O95813	CER1	Cerberus	GO:0042074; P:cell migration involved in gastrulation; ISS:BHF-UCL
O95813	CER1	Cerberus	GO:0071773; P:cellular response to BMP stimulus; ISS:BHF-UCL
O95813	CER1	Cerberus	GO:0048263; P:determination of dorsal identity; IMP:BHF-UCL
O95813	CER1	Cerberus	GO:0007369; P:gastrulation; ISS:BHF-UCL
O95813	CER1	Cerberus	GO:0003419; P:growth plate cartilage chondrocyte proliferation; ISS:BHF-UCL
O95813	CER1	Cerberus	GO:0032926; P:negative regulation of activin receptor signaling pathway; IDA:BHF-UCL
O95813	CER1	Cerberus	GO:0030514; P:negative regulation of BMP signaling pathway; ISS:BHF-UCL
O95813	CER1	Cerberus	GO:0008285; P:negative regulation of cell proliferation; ISS:BHF-UCL
O95813	CER1	Cerberus	GO:2000381; P:negative regulation of mesoderm development; IMP:BHF-UCL
O95813	CER1	Cerberus	GO:0007399; P:nervous system development; IMP:BHF-UCL
O95813	CER1	Cerberus	GO:0035582; P:sequestering of BMP in extracellular matrix; IDA:BHF-UCL
O95813	CER1	Cerberus	GO:0023019; P:signal transduction involved in regulation of gene expression; ISS:BHF-UCL
O95813	CER1	Cerberus	GO:0001657; P:ureteric bud development; ISS:UniProtKB
Q8TCT0	CERK	Ceramide kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8TCT0	CERK	Ceramide kinase	GO:0001729; F:ceramide kinase activity; IDA:UniProtKB
Q8TCT0	CERK	Ceramide kinase	GO:0004143; F:diacylglycerol kinase activity; IEA:InterPro
Q8TCT0	CERK	Ceramide kinase	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q8TCT0	CERK	Ceramide kinase	GO:0003951; F:NAD+ kinase activity; IEA:InterPro
Q8TCT0	CERK	Ceramide kinase	GO:0006672; P:ceramide metabolic process; IDA:UniProtKB
Q8TCT0	CERK	Ceramide kinase	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
Q8TCT0	CERK	Ceramide kinase	GO:0046834; P:lipid phosphorylation; IDA:GOC
Q8TCT0	CERK	Ceramide kinase	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:InterPro
Q8TCT0	CERK	Ceramide kinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8TCT0	CERK	Ceramide kinase	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q49MI3	CERKL	Ceramide kinase-like protein	GO:0004143; F:diacylglycerol kinase activity; IEA:InterPro
Q49MI3	CERKL	Ceramide kinase-like protein	GO:0003951; F:NAD+ kinase activity; IEA:InterPro
Q49MI3	CERKL	Ceramide kinase-like protein	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q49MI3	CERKL	Ceramide kinase-like protein	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:InterPro
P27544	CERS1	Ceramide synthase 1	GO:0050291; F:sphingosine N-acyltransferase activity; ISS:HGNC
P27544	CERS1	Ceramide synthase 1	GO:0072721; P:cellular response to dithiothreitol; IDA:UniProt
P27544	CERS1	Ceramide synthase 1	GO:0035690; P:cellular response to drug; IDA:UniProt
P27544	CERS1	Ceramide synthase 1	GO:0036146; P:cellular response to mycotoxin; IDA:UniProt
P27544	CERS1	Ceramide synthase 1	GO:0071492; P:cellular response to UV-A; IDA:UniProt
P27544	CERS1	Ceramide synthase 1	GO:0046513; P:ceramide biosynthetic process; IDA:UniProt
P27544	CERS1	Ceramide synthase 1	GO:0051974; P:negative regulation of telomerase activity; IDA:UniProt
P27544	CERS1	Ceramide synthase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P27544	CERS1	Ceramide synthase 1	GO:0030148; P:sphingolipid biosynthetic process; IDA:UniProt
P27544	CERS1	Ceramide synthase 1	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q96G23	CERS2	Ceramide synthase 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q96G23	CERS2	Ceramide synthase 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q96G23	CERS2	Ceramide synthase 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q96G23	CERS2	Ceramide synthase 2	GO:0050291; F:sphingosine N-acyltransferase activity; IEA:Ensembl
Q96G23	CERS2	Ceramide synthase 2	GO:0046513; P:ceramide biosynthetic process; IEA:Ensembl
Q96G23	CERS2	Ceramide synthase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96G23	CERS2	Ceramide synthase 2	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
Q96G23	CERS2	Ceramide synthase 2	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q8IU89	CERS3	Ceramide synthase 3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q8IU89	CERS3	Ceramide synthase 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8IU89	CERS3	Ceramide synthase 3	GO:0050291; F:sphingosine N-acyltransferase activity; IEA:UniProtKB-EC
Q8IU89	CERS3	Ceramide synthase 3	GO:0046513; P:ceramide biosynthetic process; IMP:UniProtKB
Q8IU89	CERS3	Ceramide synthase 3	GO:0030216; P:keratinocyte differentiation; IMP:UniProtKB
Q8IU89	CERS3	Ceramide synthase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8IU89	CERS3	Ceramide synthase 3	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
Q8IU89	CERS3	Ceramide synthase 3	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q9HA82	CERS4	Ceramide synthase 4	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9HA82	CERS4	Ceramide synthase 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9HA82	CERS4	Ceramide synthase 4	GO:0050291; F:sphingosine N-acyltransferase activity; IEA:Ensembl
Q9HA82	CERS4	Ceramide synthase 4	GO:0046513; P:ceramide biosynthetic process; IEA:Ensembl
Q9HA82	CERS4	Ceramide synthase 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9HA82	CERS4	Ceramide synthase 4	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
Q9HA82	CERS4	Ceramide synthase 4	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q8N5B7	CERS5	Ceramide synthase 5	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q8N5B7	CERS5	Ceramide synthase 5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8N5B7	CERS5	Ceramide synthase 5	GO:0050291; F:sphingosine N-acyltransferase activity; IDA:HGNC
Q8N5B7	CERS5	Ceramide synthase 5	GO:0046513; P:ceramide biosynthetic process; IDA:HGNC
Q8N5B7	CERS5	Ceramide synthase 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8N5B7	CERS5	Ceramide synthase 5	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
Q8N5B7	CERS5	Ceramide synthase 5	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q6ZMG9	CERS6	Ceramide synthase 6	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q6ZMG9	CERS6	Ceramide synthase 6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q6ZMG9	CERS6	Ceramide synthase 6	GO:0050291; F:sphingosine N-acyltransferase activity; IEA:Ensembl
Q6ZMG9	CERS6	Ceramide synthase 6	GO:0046513; P:ceramide biosynthetic process; IEA:Ensembl
Q6ZMG9	CERS6	Ceramide synthase 6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6ZMG9	CERS6	Ceramide synthase 6	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
Q6ZMG9	CERS6	Ceramide synthase 6	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
P00450	CP	Ceruloplasmin	GO:0051087; F:chaperone binding; IPI:BHF-UCL
P00450	CP	Ceruloplasmin	GO:0005507; F:copper ion binding; IEA:Ensembl
P00450	CP	Ceruloplasmin	GO:0004322; F:ferroxidase activity; TAS:ProtInc
P00450	CP	Ceruloplasmin	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
P00450	CP	Ceruloplasmin	GO:0006825; P:copper ion transport; IEA:UniProtKB-KW
P00450	CP	Ceruloplasmin	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UKY3	CES1P1	Putative inactive carboxylesterase 4	GO:0052689; F:carboxylic ester hydrolase activity; TAS:ProtInc
Q9UKY3	CES1P1	Putative inactive carboxylesterase 4	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q9UKY3	CES1P1	Putative inactive carboxylesterase 4	GO:0008152; P:metabolic process; TAS:GOC
Q12798	CETN1	Centrin-1	GO:0005524; F:ATP binding; IEA:InterPro
Q12798	CETN1	Centrin-1	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q12798	CETN1	Centrin-1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q12798	CETN1	Centrin-1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q12798	CETN1	Centrin-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q12798	CETN1	Centrin-1	GO:0034605; P:cellular response to heat; IEA:Ensembl
Q12798	CETN1	Centrin-1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P41208	CETN2	Centrin-2	GO:0005524; F:ATP binding; IEA:InterPro
P41208	CETN2	Centrin-2	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
P41208	CETN2	Centrin-2	GO:0005509; F:calcium ion binding; NAS:UniProtKB
P41208	CETN2	Centrin-2	GO:0003676; F:nucleic acid binding; IEA:InterPro
P41208	CETN2	Centrin-2	GO:0005515; F:protein binding; IPI:UniProtKB
P41208	CETN2	Centrin-2	GO:0007099; P:centriole replication; IMP:UniProtKB
P41208	CETN2	Centrin-2	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P41208	CETN2	Centrin-2	GO:0007067; P:mitosis; NAS:UniProtKB
P41208	CETN2	Centrin-2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P41208	CETN2	Centrin-2	GO:0006289; P:nucleotide-excision repair; IDA:UniProtKB
P41208	CETN2	Centrin-2	GO:0032465; P:regulation of cytokinesis; IMP:UniProtKB
P41208	CETN2	Centrin-2	GO:0007283; P:spermatogenesis; IEA:Ensembl
O15182	CETN3	Centrin-3	GO:0005509; F:calcium ion binding; IEA:InterPro
O15182	CETN3	Centrin-3	GO:0007098; P:centrosome cycle; TAS:ProtInc
O15182	CETN3	Centrin-3	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P11597	CETP	Cholesteryl ester transfer protein	GO:0015485; F:cholesterol binding; IDA:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0017127; F:cholesterol transporter activity; IDA:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0008289; F:lipid binding; IDA:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0005319; F:lipid transporter activity; IDA:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0031210; F:phosphatidylcholine binding; IDA:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0005548; F:phospholipid transporter activity; IDA:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0017129; F:triglyceride binding; IDA:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0042632; P:cholesterol homeostasis; IMP:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0008203; P:cholesterol metabolic process; IDA:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0030301; P:cholesterol transport; IDA:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0034375; P:high-density lipoprotein particle remodeling; IMP:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0055088; P:lipid homeostasis; IDA:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0006869; P:lipid transport; IDA:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
P11597	CETP	Cholesteryl ester transfer protein	GO:0034374; P:low-density lipoprotein particle remodeling; IDA:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; IC:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0046470; P:phosphatidylcholine metabolic process; IDA:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0055091; P:phospholipid homeostasis; IDA:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0015914; P:phospholipid transport; IDA:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0006898; P:receptor-mediated endocytosis; TAS:Reactome
P11597	CETP	Cholesteryl ester transfer protein	GO:0010874; P:regulation of cholesterol efflux; IMP:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0043691; P:reverse cholesterol transport; IC:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P11597	CETP	Cholesteryl ester transfer protein	GO:0070328; P:triglyceride homeostasis; IDA:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0006641; P:triglyceride metabolic process; IDA:BHF-UCL
P11597	CETP	Cholesteryl ester transfer protein	GO:0034372; P:very-low-density lipoprotein particle remodeling; IDA:BHF-UCL
Q6UXA7	C6orf15	Uncharacterized protein C6orf15	GO:0008201; F:heparin binding; IEA:Ensembl
Q6UXA7	C6orf15	Uncharacterized protein C6orf15	GO:0005540; F:hyaluronic acid binding; IEA:Ensembl
Q6UXA7	C6orf15	Uncharacterized protein C6orf15	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q6UWU4	C6orf89	Bombesin receptor-activated protein C6orf89	GO:0050673; P:epithelial cell proliferation; IDA:UniProtKB
Q6UWU4	C6orf89	Bombesin receptor-activated protein C6orf89	GO:0045787; P:positive regulation of cell cycle; IDA:UniProtKB
Q6UWU4	C6orf89	Bombesin receptor-activated protein C6orf89	GO:0042060; P:wound healing; IDA:UniProtKB
Q7Z4R8	C6orf120	UPF0669 protein C6orf120	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
A8K010	LINC00473	Putative transcriptional regulator encoded by LINC00473	GO:0006351; P:transcription, DNA-templated; IMP:UniProtKB
P00751	CFB	Complement factor B	GO:0001848; F:complement binding; TAS:UniProtKB
P00751	CFB	Complement factor B	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
P00751	CFB	Complement factor B	GO:0006956; P:complement activation; IEA:InterPro
P00751	CFB	Complement factor B	GO:0006957; P:complement activation, alternative pathway; NAS:UniProtKB
P00751	CFB	Complement factor B	GO:0045087; P:innate immune response; TAS:Reactome
P00751	CFB	Complement factor B	GO:0030449; P:regulation of complement activation; TAS:Reactome
P00746	CFD	Complement factor D	GO:0004252; F:serine-type endopeptidase activity; TAS:ProtInc
P00746	CFD	Complement factor D	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
P00746	CFD	Complement factor D	GO:0007596; P:blood coagulation; TAS:Reactome
P00746	CFD	Complement factor D	GO:0006956; P:complement activation; TAS:Reactome
P00746	CFD	Complement factor D	GO:0006957; P:complement activation, alternative pathway; TAS:Reactome
P00746	CFD	Complement factor D	GO:0045087; P:innate immune response; TAS:Reactome
P00746	CFD	Complement factor D	GO:0030168; P:platelet activation; TAS:Reactome
P00746	CFD	Complement factor D	GO:0002576; P:platelet degranulation; TAS:Reactome
P00746	CFD	Complement factor D	GO:0006508; P:proteolysis; TAS:ProtInc
P08603	CFH	Complement factor H	GO:0043395; F:heparan sulfate proteoglycan binding; IDA:BHF-UCL
P08603	CFH	Complement factor H	GO:0008201; F:heparin binding; IDA:BHF-UCL
P08603	CFH	Complement factor H	GO:0005515; F:protein binding; IPI:IntAct
P08603	CFH	Complement factor H	GO:0006956; P:complement activation; TAS:ProtInc
P08603	CFH	Complement factor H	GO:0006957; P:complement activation, alternative pathway; IEA:UniProtKB-KW
P08603	CFH	Complement factor H	GO:0045087; P:innate immune response; TAS:Reactome
P08603	CFH	Complement factor H	GO:0030449; P:regulation of complement activation; TAS:Reactome
P05156	CFI	Complement factor I	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P05156	CFI	Complement factor I	GO:0005044; F:scavenger receptor activity; IEA:InterPro
P05156	CFI	Complement factor I	GO:0004252; F:serine-type endopeptidase activity; TAS:ProtInc
P05156	CFI	Complement factor I	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
P05156	CFI	Complement factor I	GO:0045087; P:innate immune response; TAS:Reactome
P05156	CFI	Complement factor I	GO:0030449; P:regulation of complement activation; TAS:Reactome
P0CG36	CFC1B	Cryptic family protein 1B	GO:0007369; P:gastrulation; IEA:UniProtKB-KW
P0CG37	CFC1	Cryptic protein	GO:0038100; F:nodal binding; IPI:UniProtKB
P0CG37	CFC1	Cryptic protein	GO:0007368; P:determination of left/right symmetry; NAS:UniProtKB
P0CG37	CFC1	Cryptic protein	GO:0007369; P:gastrulation; IEA:UniProtKB-KW
P0CG37	CFC1	Cryptic protein	GO:0038092; P:nodal signaling pathway; IMP:UniProtKB
Q9UEE9	CFDP1	Craniofacial development protein 1	GO:0007155; P:cell adhesion; IEA:Ensembl
Q9UEE9	CFDP1	Craniofacial development protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9UEE9	CFDP1	Craniofacial development protein 1	GO:2000270; P:negative regulation of fibroblast apoptotic process; IEA:Ensembl
Q9UEE9	CFDP1	Craniofacial development protein 1	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q9UEE9	CFDP1	Craniofacial development protein 1	GO:0008360; P:regulation of cell shape; IEA:Ensembl
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:0008234; F:cysteine-type peptidase activity; IEA:InterPro
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:0035877; F:death effector domain binding; IBA:RefGenome
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:0008047; F:enzyme activator activity; IDA:UniProtKB
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:0002020; F:protease binding; IPI:UniProtKB
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:0005515; F:protein binding; IPI:IntAct
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:0006915; P:apoptotic process; IMP:UniProtKB
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IDA:UniProtKB
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IMP:BHF-UCL
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:1901740; P:negative regulation of myoblast fusion; ISS:BHF-UCL
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:0043085; P:positive regulation of catalytic activity; IDA:GOC
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:BHF-UCL
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:2001239; P:regulation of extrinsic apoptotic signaling pathway in absence of ligand; TAS:Reactome
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:0060544; P:regulation of necroptotic process; IDA:UniProtKB
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:0014842; P:regulation of satellite cell proliferation; ISS:BHF-UCL
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:0014732; P:skeletal muscle atrophy; ISS:BHF-UCL
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:0007519; P:skeletal muscle tissue development; ISS:BHF-UCL
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:0043403; P:skeletal muscle tissue regeneration; ISS:BHF-UCL
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:0014866; P:skeletal myofibril assembly; ISS:BHF-UCL
O15519	CFLAR	CASP8 and FADD-like apoptosis regulator	GO:0016032; P:viral process; IEA:UniProtKB-KW
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0005524; F:ATP binding; TAS:ProtInc
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0005224; F:ATP-binding and phosphorylation-dependent chloride channel activity; TAS:ProtInc
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0015106; F:bicarbonate transmembrane transporter activity; ISS:UniProtKB
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0005260; F:channel-conductance-controlling ATPase activity; NAS:UniProtKB
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0005254; F:chloride channel activity; IDA:UniProtKB
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0019869; F:chloride channel inhibitor activity; IDA:UniProtKB
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0015108; F:chloride transmembrane transporter activity; ISS:UniProtKB
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0019899; F:enzyme binding; IPI:UniProtKB
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0030165; F:PDZ domain binding; IDA:UniProtKB
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0005515; F:protein binding; IPI:UniProtKB
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0071320; P:cellular response to cAMP; ISS:UniProtKB
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0032870; P:cellular response to hormone stimulus; IEA:Ensembl
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:1902476; P:chloride transmembrane transport; IDA:GOC
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0006695; P:cholesterol biosynthetic process; IEA:Ensembl
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0030301; P:cholesterol transport; IEA:Ensembl
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0051454; P:intracellular pH elevation; ISS:UniProtKB
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0015705; P:iodide transport; IEA:Ensembl
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0030324; P:lung development; IEA:Ensembl
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0060081; P:membrane hyperpolarization; ISS:UniProtKB
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0045909; P:positive regulation of vasodilation; IEA:Ensembl
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0007585; P:respiratory gaseous exchange; TAS:ProtInc
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0034097; P:response to cytokine; IEA:Ensembl
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0042493; P:response to drug; IEA:Ensembl
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0043627; P:response to estrogen; IEA:Ensembl
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0048240; P:sperm capacitation; ISS:UniProtKB
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0030321; P:transepithelial chloride transport; IEA:Ensembl
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0055085; P:transmembrane transport; TAS:Reactome
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0006810; P:transport; TAS:ProtInc
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0042311; P:vasodilation; IEA:Ensembl
P13569	CFTR	Cystic fibrosis transmembrane conductance regulator	GO:0006833; P:water transport; IEA:Ensembl
Q9BRJ6	C7orf50	Uncharacterized protein C7orf50	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8N884	MB21D1	Cyclic GMP-AMP synthase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8N884	MB21D1	Cyclic GMP-AMP synthase	GO:0061501; F:cyclic-GMP-AMP synthase activity; IDA:UniProtKB
Q8N884	MB21D1	Cyclic GMP-AMP synthase	GO:0003677; F:DNA binding; IDA:UniProtKB
Q8N884	MB21D1	Cyclic GMP-AMP synthase	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q8N884	MB21D1	Cyclic GMP-AMP synthase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N884	MB21D1	Cyclic GMP-AMP synthase	GO:0002218; P:activation of innate immune response; IMP:UniProtKB
Q8N884	MB21D1	Cyclic GMP-AMP synthase	GO:0071360; P:cellular response to exogenous dsRNA; IDA:UniProtKB
Q8N884	MB21D1	Cyclic GMP-AMP synthase	GO:0009190; P:cyclic nucleotide biosynthetic process; IDA:UniProtKB
Q8N884	MB21D1	Cyclic GMP-AMP synthase	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q8N884	MB21D1	Cyclic GMP-AMP synthase	GO:0045087; P:innate immune response; TAS:Reactome
Q8N884	MB21D1	Cyclic GMP-AMP synthase	GO:0002230; P:positive regulation of defense response to virus by host; IMP:UniProtKB
Q8N884	MB21D1	Cyclic GMP-AMP synthase	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0008376; F:acetylgalactosaminyltransferase activity; IDA:UniProtKB
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0047238; F:glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; IDA:UniProtKB
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0015020; F:glucuronosyltransferase activity; IDA:UniProtKB
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0047237; F:glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; IDA:UniProtKB
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0046872; F:metal ion binding; NAS:UniProtKB
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0008955; F:peptidoglycan glycosyltransferase activity; IDA:UniProtKB
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0009653; P:anatomical structure morphogenesis; NAS:UniProtKB
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0051216; P:cartilage development; IEA:Ensembl
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0008283; P:cell proliferation; NAS:UniProtKB
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0008037; P:cell recognition; NAS:UniProtKB
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0030206; P:chondroitin sulfate biosynthetic process; IDA:UniProtKB
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0050650; P:chondroitin sulfate proteoglycan biosynthetic process; ISS:UniProtKB
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0050653; P:chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; IDA:UniProtKB
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0050651; P:dermatan sulfate proteoglycan biosynthetic process; ISS:UniProtKB
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0001958; P:endochondral ossification; IEA:Ensembl
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0030198; P:extracellular matrix organization; NAS:UniProtKB
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0015014; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; NAS:UniProtKB
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0030210; P:heparin biosynthetic process; NAS:UniProtKB
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0007399; P:nervous system development; NAS:UniProtKB
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0030166; P:proteoglycan biosynthetic process; ISS:UniProtKB
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0046398; P:UDP-glucuronate metabolic process; IDA:UniProtKB
Q8TDX6	CSGALNACT1	Chondroitin sulfate N-acetylgalactosaminyltransferase 1	GO:0019276; P:UDP-N-acetylgalactosamine metabolic process; IDA:UniProtKB
Q8N6G5	CSGALNACT2	Chondroitin sulfate N-acetylgalactosaminyltransferase 2	GO:0008376; F:acetylgalactosaminyltransferase activity; IDA:UniProtKB
Q8N6G5	CSGALNACT2	Chondroitin sulfate N-acetylgalactosaminyltransferase 2	GO:0047237; F:glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; IEA:UniProtKB-EC
Q8N6G5	CSGALNACT2	Chondroitin sulfate N-acetylgalactosaminyltransferase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N6G5	CSGALNACT2	Chondroitin sulfate N-acetylgalactosaminyltransferase 2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q8N6G5	CSGALNACT2	Chondroitin sulfate N-acetylgalactosaminyltransferase 2	GO:0030206; P:chondroitin sulfate biosynthetic process; TAS:Reactome
Q8N6G5	CSGALNACT2	Chondroitin sulfate N-acetylgalactosaminyltransferase 2	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q8N6G5	CSGALNACT2	Chondroitin sulfate N-acetylgalactosaminyltransferase 2	GO:0050650; P:chondroitin sulfate proteoglycan biosynthetic process; IDA:UniProtKB
Q8N6G5	CSGALNACT2	Chondroitin sulfate N-acetylgalactosaminyltransferase 2	GO:0050653; P:chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; TAS:UniProtKB
Q8N6G5	CSGALNACT2	Chondroitin sulfate N-acetylgalactosaminyltransferase 2	GO:0050651; P:dermatan sulfate proteoglycan biosynthetic process; IDA:UniProtKB
Q8N6G5	CSGALNACT2	Chondroitin sulfate N-acetylgalactosaminyltransferase 2	GO:0050652; P:dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; TAS:UniProtKB
Q8N6G5	CSGALNACT2	Chondroitin sulfate N-acetylgalactosaminyltransferase 2	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q8N6G5	CSGALNACT2	Chondroitin sulfate N-acetylgalactosaminyltransferase 2	GO:0030166; P:proteoglycan biosynthetic process; IDA:UniProtKB
Q8N6G5	CSGALNACT2	Chondroitin sulfate N-acetylgalactosaminyltransferase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UFW8	CGGBP1	CGG triplet repeat-binding protein 1	GO:0003690; F:double-stranded DNA binding; TAS:ProtInc
Q9UFW8	CGGBP1	CGG triplet repeat-binding protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UFW8	CGGBP1	CGG triplet repeat-binding protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P01233	CGB	Choriogonadotropin subunit beta	GO:0005179; F:hormone activity; TAS:ProtInc
P01233	CGB	Choriogonadotropin subunit beta	GO:0006915; P:apoptotic process; TAS:ProtInc
P01233	CGB	Choriogonadotropin subunit beta	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P01233	CGB	Choriogonadotropin subunit beta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P01233	CGB	Choriogonadotropin subunit beta	GO:0007292; P:female gamete generation; TAS:ProtInc
P01233	CGB	Choriogonadotropin subunit beta	GO:0016486; P:peptide hormone processing; TAS:Reactome
P01233	CGB	Choriogonadotropin subunit beta	GO:0007165; P:signal transduction; TAS:ProtInc
P32929	CTH	Cystathionine gamma-lyase	GO:0016846; F:carbon-sulfur lyase activity; TAS:Reactome
P32929	CTH	Cystathionine gamma-lyase	GO:0004123; F:cystathionine gamma-lyase activity; IDA:UniProtKB
P32929	CTH	Cystathionine gamma-lyase	GO:0047982; F:homocysteine desulfhydrase activity; TAS:Reactome
P32929	CTH	Cystathionine gamma-lyase	GO:0080146; F:L-cysteine desulfhydrase activity; TAS:Reactome
P32929	CTH	Cystathionine gamma-lyase	GO:0044540; F:L-cystine L-cysteine-lyase (deaminating); IMP:UniProtKB
P32929	CTH	Cystathionine gamma-lyase	GO:0005515; F:protein binding; IPI:UniProtKB
P32929	CTH	Cystathionine gamma-lyase	GO:0030170; F:pyridoxal phosphate binding; IDA:UniProtKB
P32929	CTH	Cystathionine gamma-lyase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P32929	CTH	Cystathionine gamma-lyase	GO:0019344; P:cysteine biosynthetic process; IDA:UniProtKB
P32929	CTH	Cystathionine gamma-lyase	GO:0006534; P:cysteine metabolic process; TAS:ProtInc
P32929	CTH	Cystathionine gamma-lyase	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:UniProtKB
P32929	CTH	Cystathionine gamma-lyase	GO:0070814; P:hydrogen sulfide biosynthetic process; IDA:UniProtKB
P32929	CTH	Cystathionine gamma-lyase	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P32929	CTH	Cystathionine gamma-lyase	GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl
P32929	CTH	Cystathionine gamma-lyase	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
P32929	CTH	Cystathionine gamma-lyase	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:Ensembl
P32929	CTH	Cystathionine gamma-lyase	GO:0051289; P:protein homotetramerization; IPI:UniProtKB
P32929	CTH	Cystathionine gamma-lyase	GO:0044524; P:protein sulfhydration; IMP:UniProtKB
P32929	CTH	Cystathionine gamma-lyase	GO:0018272; P:protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine; IDA:UniProtKB
P32929	CTH	Cystathionine gamma-lyase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P32929	CTH	Cystathionine gamma-lyase	GO:0000098; P:sulfur amino acid catabolic process; TAS:Reactome
P32929	CTH	Cystathionine gamma-lyase	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
P32929	CTH	Cystathionine gamma-lyase	GO:0019346; P:transsulfuration; TAS:Reactome
Q0VF96	CGNL1	Cingulin-like protein 1	GO:0003774; F:motor activity; IEA:InterPro
Q99674	CGREF1	Cell growth regulator with EF hand domain protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q99674	CGREF1	Cell growth regulator with EF hand domain protein 1	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q99674	CGREF1	Cell growth regulator with EF hand domain protein 1	GO:0007050; P:cell cycle arrest; IEA:UniProtKB-KW
Q99674	CGREF1	Cell growth regulator with EF hand domain protein 1	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
Q99674	CGREF1	Cell growth regulator with EF hand domain protein 1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q99674	CGREF1	Cell growth regulator with EF hand domain protein 1	GO:0006950; P:response to stress; TAS:ProtInc
Q99675	CGRRF1	Cell growth regulator with RING finger domain protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q99675	CGRRF1	Cell growth regulator with RING finger domain protein 1	GO:0007050; P:cell cycle arrest; IEA:UniProtKB-KW
Q99675	CGRRF1	Cell growth regulator with RING finger domain protein 1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q99675	CGRRF1	Cell growth regulator with RING finger domain protein 1	GO:0006950; P:response to stress; TAS:ProtInc
Q16880	UGT8	2-hydroxyacylsphingosine 1-beta-galactosyltransferase	GO:0003851; F:2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity; IEA:UniProtKB-EC
Q16880	UGT8	2-hydroxyacylsphingosine 1-beta-galactosyltransferase	GO:0008489; F:UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity; TAS:ProtInc
Q16880	UGT8	2-hydroxyacylsphingosine 1-beta-galactosyltransferase	GO:0008088; P:axon cargo transport; IEA:Ensembl
Q16880	UGT8	2-hydroxyacylsphingosine 1-beta-galactosyltransferase	GO:0007417; P:central nervous system development; TAS:ProtInc
Q16880	UGT8	2-hydroxyacylsphingosine 1-beta-galactosyltransferase	GO:0007010; P:cytoskeleton organization; IEA:Ensembl
Q16880	UGT8	2-hydroxyacylsphingosine 1-beta-galactosyltransferase	GO:0006682; P:galactosylceramide biosynthetic process; IEA:UniProtKB-UniPathway
Q16880	UGT8	2-hydroxyacylsphingosine 1-beta-galactosyltransferase	GO:0048812; P:neuron projection morphogenesis; IEA:Ensembl
Q16880	UGT8	2-hydroxyacylsphingosine 1-beta-galactosyltransferase	GO:0030913; P:paranodal junction assembly; IEA:Ensembl
Q16880	UGT8	2-hydroxyacylsphingosine 1-beta-galactosyltransferase	GO:0007422; P:peripheral nervous system development; TAS:ProtInc
Q16880	UGT8	2-hydroxyacylsphingosine 1-beta-galactosyltransferase	GO:0002175; P:protein localization to paranode region of axon; IEA:Ensembl
Q9NR00	C8orf4	Uncharacterized protein C8orf4	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q96LL4	C8orf48	Uncharacterized protein C8orf48	GO:0005515; F:protein binding; IPI:IntAct
Q6P047	C8orf74	Uncharacterized protein C8orf74	GO:0005515; F:protein binding; IPI:IntAct
P0DMB2	C8orf88	Uncharacterized protein C8orf88	GO:0045947; P:negative regulation of translational initiation; IEA:InterPro
P61604	HSPE1	10 kDa heat shock protein, mitochondrial	GO:0005524; F:ATP binding; IEA:InterPro
P61604	HSPE1	10 kDa heat shock protein, mitochondrial	GO:0051087; F:chaperone binding; IPI:UniProtKB
P61604	HSPE1	10 kDa heat shock protein, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P61604	HSPE1	10 kDa heat shock protein, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
P61604	HSPE1	10 kDa heat shock protein, mitochondrial	GO:0051082; F:unfolded protein binding; NAS:UniProtKB
P61604	HSPE1	10 kDa heat shock protein, mitochondrial	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; NAS:UniProtKB
P61604	HSPE1	10 kDa heat shock protein, mitochondrial	GO:0006457; P:protein folding; TAS:ProtInc
P61604	HSPE1	10 kDa heat shock protein, mitochondrial	GO:0006986; P:response to unfolded protein; TAS:ProtInc
O95992	CH25H	Cholesterol 25-hydroxylase	GO:0001567; F:cholesterol 25-hydroxylase activity; IEA:UniProtKB-EC
O95992	CH25H	Cholesterol 25-hydroxylase	GO:0005506; F:iron ion binding; IEA:InterPro
O95992	CH25H	Cholesterol 25-hydroxylase	GO:0008395; F:steroid hydroxylase activity; TAS:Reactome
O95992	CH25H	Cholesterol 25-hydroxylase	GO:0006699; P:bile acid biosynthetic process; TAS:Reactome
O95992	CH25H	Cholesterol 25-hydroxylase	GO:0008206; P:bile acid metabolic process; TAS:Reactome
O95992	CH25H	Cholesterol 25-hydroxylase	GO:0008203; P:cholesterol metabolic process; IEA:Ensembl
O95992	CH25H	Cholesterol 25-hydroxylase	GO:0006633; P:fatty acid biosynthetic process; IEA:InterPro
O95992	CH25H	Cholesterol 25-hydroxylase	GO:0006629; P:lipid metabolic process; TAS:ProtInc
O95992	CH25H	Cholesterol 25-hydroxylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95992	CH25H	Cholesterol 25-hydroxylase	GO:0016126; P:sterol biosynthetic process; IEA:UniProtKB-KW
P36222	CHI3L1	Chitinase-3-like protein 1	GO:0008061; F:chitin binding; IDA:UniProtKB
P36222	CHI3L1	Chitinase-3-like protein 1	GO:0005201; F:extracellular matrix structural constituent; NAS:UniProtKB
P36222	CHI3L1	Chitinase-3-like protein 1	GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro
P36222	CHI3L1	Chitinase-3-like protein 1	GO:0007250; P:activation of NF-kappaB-inducing kinase activity; ISS:UniProtKB
P36222	CHI3L1	Chitinase-3-like protein 1	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
P36222	CHI3L1	Chitinase-3-like protein 1	GO:0051216; P:cartilage development; NAS:UniProtKB
P36222	CHI3L1	Chitinase-3-like protein 1	GO:0071356; P:cellular response to tumor necrosis factor; ISS:UniProtKB
P36222	CHI3L1	Chitinase-3-like protein 1	GO:0006032; P:chitin catabolic process; IEA:InterPro
P36222	CHI3L1	Chitinase-3-like protein 1	GO:0006954; P:inflammatory response; IEP:UniProtKB
P36222	CHI3L1	Chitinase-3-like protein 1	GO:0072606; P:interleukin-8 secretion; ISS:UniProtKB
P36222	CHI3L1	Chitinase-3-like protein 1	GO:0030324; P:lung development; IMP:UniProtKB
P36222	CHI3L1	Chitinase-3-like protein 1	GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB
P36222	CHI3L1	Chitinase-3-like protein 1	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB
P36222	CHI3L1	Chitinase-3-like protein 1	GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; ISS:UniProtKB
P36222	CHI3L1	Chitinase-3-like protein 1	GO:0051897; P:positive regulation of protein kinase B signaling; IMP:UniProtKB
P36222	CHI3L1	Chitinase-3-like protein 1	GO:0070555; P:response to interleukin-1; IEP:UniProtKB
P36222	CHI3L1	Chitinase-3-like protein 1	GO:0070741; P:response to interleukin-6; IEP:UniProtKB
P36222	CHI3L1	Chitinase-3-like protein 1	GO:0009612; P:response to mechanical stimulus; IEP:UniProtKB
P36222	CHI3L1	Chitinase-3-like protein 1	GO:0034612; P:response to tumor necrosis factor; IEP:UniProtKB
Q15782	CHI3L2	Chitinase-3-like protein 2	GO:0008061; F:chitin binding; IDA:UniProtKB
Q15782	CHI3L2	Chitinase-3-like protein 2	GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro
Q15782	CHI3L2	Chitinase-3-like protein 2	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q15782	CHI3L2	Chitinase-3-like protein 2	GO:0006032; P:chitin catabolic process; IEA:InterPro
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0016887; F:ATPase activity; ISS:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0051087; F:chaperone binding; IPI:UniProtKB
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0003688; F:DNA replication origin binding; ISS:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0003725; F:double-stranded RNA binding; IDA:MGI
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0001530; F:lipopolysaccharide binding; IDA:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0002039; F:p53 binding; IPI:UniProtKB
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0003697; F:single-stranded DNA binding; ISS:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0051082; F:unfolded protein binding; IC:UniProtKB
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0006458; P:'de novo' protein folding; ISS:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0006200; P:ATP catabolic process; ISS:GOC
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0042113; P:B cell activation; IDA:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0002368; P:B cell cytokine production; IDA:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0042100; P:B cell proliferation; IDA:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0051131; P:chaperone-mediated protein complex assembly; ISS:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0048291; P:isotype switching to IgG isotypes; IDA:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; IDA:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0043065; P:positive regulation of apoptotic process; IMP:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0032727; P:positive regulation of interferon-alpha production; IDA:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0032729; P:positive regulation of interferon-gamma production; IDA:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0032733; P:positive regulation of interleukin-10 production; IDA:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0032735; P:positive regulation of interleukin-12 production; IDA:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0032755; P:positive regulation of interleukin-6 production; IDA:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0043032; P:positive regulation of macrophage activation; IDA:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0050870; P:positive regulation of T cell activation; IDA:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0002842; P:positive regulation of T cell mediated immune response to tumor cell; IDA:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0051604; P:protein maturation; ISS:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0042026; P:protein refolding; IDA:UniProtKB
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0050821; P:protein stabilization; IMP:UniProtKB
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0006986; P:response to unfolded protein; IDA:BHF-UCL
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0042110; P:T cell activation; IDA:MGI
P10809	HSPD1	60 kDa heat shock protein, mitochondrial	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9BUX1	CHAC1	Cation transport regulator-like protein 1	GO:0005112; F:Notch binding; ISS:UniProtKB
Q9BUX1	CHAC1	Cation transport regulator-like protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9BUX1	CHAC1	Cation transport regulator-like protein 1	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IMP:UniProtKB
Q9BUX1	CHAC1	Cation transport regulator-like protein 1	GO:0045746; P:negative regulation of Notch signaling pathway; IMP:UniProtKB
Q9BUX1	CHAC1	Cation transport regulator-like protein 1	GO:0010955; P:negative regulation of protein processing; IMP:UniProtKB
Q9BUX1	CHAC1	Cation transport regulator-like protein 1	GO:0022008; P:neurogenesis; ISS:UniProtKB
Q9BUX1	CHAC1	Cation transport regulator-like protein 1	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
Q9BUX1	CHAC1	Cation transport regulator-like protein 1	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
O15335	CHAD	Chondroadherin	GO:0001502; P:cartilage condensation; IEA:Ensembl
Q96JM3	CHAMP1	Chromosome alignment-maintaining phosphoprotein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96JM3	CHAMP1	Chromosome alignment-maintaining phosphoprotein 1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q96JM3	CHAMP1	Chromosome alignment-maintaining phosphoprotein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96JM3	CHAMP1	Chromosome alignment-maintaining phosphoprotein 1	GO:0051315; P:attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; IMP:UniProtKB
Q96JM3	CHAMP1	Chromosome alignment-maintaining phosphoprotein 1	GO:0034501; P:protein localization to kinetochore; IMP:UniProtKB
Q96JM3	CHAMP1	Chromosome alignment-maintaining phosphoprotein 1	GO:0035372; P:protein localization to microtubule; IMP:UniProtKB
Q96JM3	CHAMP1	Chromosome alignment-maintaining phosphoprotein 1	GO:0031134; P:sister chromatid biorientation; IMP:UniProtKB
Q8WYQ3	CHCHD10	Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial	GO:0006754; P:ATP biosynthetic process; IMP:BHF-UCL
Q8WYQ3	CHCHD10	Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial	GO:2000984; P:negative regulation of ATP citrate synthase activity; IMP:BHF-UCL
Q8WYQ3	CHCHD10	Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial	GO:0006119; P:oxidative phosphorylation; IMP:BHF-UCL
Q96BP2	CHCHD1	Coiled-coil-helix-coiled-coil-helix domain-containing protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96BP2	CHCHD1	Coiled-coil-helix-coiled-coil-helix domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NX63	CHCHD3	Coiled-coil-helix-coiled-coil-helix domain-containing protein 3, mitochondrial	GO:0019902; F:phosphatase binding; IDA:UniProtKB
Q9NX63	CHCHD3	Coiled-coil-helix-coiled-coil-helix domain-containing protein 3, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NX63	CHCHD3	Coiled-coil-helix-coiled-coil-helix domain-containing protein 3, mitochondrial	GO:0032947; F:protein complex scaffold; ISS:UniProtKB
Q9NX63	CHCHD3	Coiled-coil-helix-coiled-coil-helix domain-containing protein 3, mitochondrial	GO:0001227; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IDA:UniProtKB
Q9NX63	CHCHD3	Coiled-coil-helix-coiled-coil-helix domain-containing protein 3, mitochondrial	GO:0007007; P:inner mitochondrial membrane organization; IMP:UniProtKB
Q9NX63	CHCHD3	Coiled-coil-helix-coiled-coil-helix domain-containing protein 3, mitochondrial	GO:0008053; P:mitochondrial fusion; IMP:UniProtKB
Q9NX63	CHCHD3	Coiled-coil-helix-coiled-coil-helix domain-containing protein 3, mitochondrial	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9BRQ6	CHCHD6	Coiled-coil-helix-coiled-coil-helix domain-containing protein 6, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BRQ6	CHCHD6	Coiled-coil-helix-coiled-coil-helix domain-containing protein 6, mitochondrial	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q9BRQ6	CHCHD6	Coiled-coil-helix-coiled-coil-helix domain-containing protein 6, mitochondrial	GO:0042407; P:cristae formation; IMP:UniProtKB
Q86WJ1	CHD1L	Chromodomain-helicase-DNA-binding protein 1-like	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86WJ1	CHD1L	Chromodomain-helicase-DNA-binding protein 1-like	GO:0004003; F:ATP-dependent DNA helicase activity; TAS:UniProtKB
Q86WJ1	CHD1L	Chromodomain-helicase-DNA-binding protein 1-like	GO:0016887; F:ATPase activity; IMP:UniProtKB
Q86WJ1	CHD1L	Chromodomain-helicase-DNA-binding protein 1-like	GO:0003677; F:DNA binding; IEA:InterPro
Q86WJ1	CHD1L	Chromodomain-helicase-DNA-binding protein 1-like	GO:0000166; F:nucleotide binding; IDA:UniProtKB
Q86WJ1	CHD1L	Chromodomain-helicase-DNA-binding protein 1-like	GO:0005515; F:protein binding; IPI:UniProtKB
Q86WJ1	CHD1L	Chromodomain-helicase-DNA-binding protein 1-like	GO:0006200; P:ATP catabolic process; IMP:GOC
Q86WJ1	CHD1L	Chromodomain-helicase-DNA-binding protein 1-like	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q86WJ1	CHD1L	Chromodomain-helicase-DNA-binding protein 1-like	GO:0006338; P:chromatin remodeling; IDA:UniProtKB
Q86WJ1	CHD1L	Chromodomain-helicase-DNA-binding protein 1-like	GO:0032508; P:DNA duplex unwinding; TAS:GOC
Q86WJ1	CHD1L	Chromodomain-helicase-DNA-binding protein 1-like	GO:0006281; P:DNA repair; TAS:UniProtKB
O14646	CHD1	Chromodomain-helicase-DNA-binding protein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O14646	CHD1	Chromodomain-helicase-DNA-binding protein 1	GO:0004003; F:ATP-dependent DNA helicase activity; TAS:ProtInc
O14646	CHD1	Chromodomain-helicase-DNA-binding protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O14646	CHD1	Chromodomain-helicase-DNA-binding protein 1	GO:0035064; F:methylated histone binding; IDA:UniProtKB
O14646	CHD1	Chromodomain-helicase-DNA-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
O14646	CHD1	Chromodomain-helicase-DNA-binding protein 1	GO:0006338; P:chromatin remodeling; IEA:Ensembl
O14646	CHD1	Chromodomain-helicase-DNA-binding protein 1	GO:0032508; P:DNA duplex unwinding; TAS:GOC
O14646	CHD1	Chromodomain-helicase-DNA-binding protein 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O14646	CHD1	Chromodomain-helicase-DNA-binding protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O14647	CHD2	Chromodomain-helicase-DNA-binding protein 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O14647	CHD2	Chromodomain-helicase-DNA-binding protein 2	GO:0004003; F:ATP-dependent DNA helicase activity; TAS:ProtInc
O14647	CHD2	Chromodomain-helicase-DNA-binding protein 2	GO:0001046; F:core promoter sequence-specific DNA binding; ISS:UniProtKB
O14647	CHD2	Chromodomain-helicase-DNA-binding protein 2	GO:0003677; F:DNA binding; TAS:ProtInc
O14647	CHD2	Chromodomain-helicase-DNA-binding protein 2	GO:0042393; F:histone binding; ISS:UniProtKB
O14647	CHD2	Chromodomain-helicase-DNA-binding protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O14647	CHD2	Chromodomain-helicase-DNA-binding protein 2	GO:0006974; P:cellular response to DNA damage stimulus; IEA:Ensembl
O14647	CHD2	Chromodomain-helicase-DNA-binding protein 2	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
O14647	CHD2	Chromodomain-helicase-DNA-binding protein 2	GO:0032508; P:DNA duplex unwinding; TAS:GOC
O14647	CHD2	Chromodomain-helicase-DNA-binding protein 2	GO:0060218; P:hematopoietic stem cell differentiation; IEA:Ensembl
O14647	CHD2	Chromodomain-helicase-DNA-binding protein 2	GO:0007517; P:muscle organ development; ISS:UniProtKB
O14647	CHD2	Chromodomain-helicase-DNA-binding protein 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O14647	CHD2	Chromodomain-helicase-DNA-binding protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q12873	CHD3	Chromodomain-helicase-DNA-binding protein 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q12873	CHD3	Chromodomain-helicase-DNA-binding protein 3	GO:0004003; F:ATP-dependent DNA helicase activity; TAS:ProtInc
Q12873	CHD3	Chromodomain-helicase-DNA-binding protein 3	GO:0003677; F:DNA binding; TAS:ProtInc
Q12873	CHD3	Chromodomain-helicase-DNA-binding protein 3	GO:0004386; F:helicase activity; NAS:UniProtKB
Q12873	CHD3	Chromodomain-helicase-DNA-binding protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q12873	CHD3	Chromodomain-helicase-DNA-binding protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q12873	CHD3	Chromodomain-helicase-DNA-binding protein 3	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q12873	CHD3	Chromodomain-helicase-DNA-binding protein 3	GO:0051297; P:centrosome organization; IDA:UniProtKB
Q12873	CHD3	Chromodomain-helicase-DNA-binding protein 3	GO:0006333; P:chromatin assembly or disassembly; IEA:Ensembl
Q12873	CHD3	Chromodomain-helicase-DNA-binding protein 3	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q12873	CHD3	Chromodomain-helicase-DNA-binding protein 3	GO:0032508; P:DNA duplex unwinding; TAS:GOC
Q12873	CHD3	Chromodomain-helicase-DNA-binding protein 3	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q12873	CHD3	Chromodomain-helicase-DNA-binding protein 3	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q12873	CHD3	Chromodomain-helicase-DNA-binding protein 3	GO:0007051; P:spindle organization; IDA:UniProtKB
Q12873	CHD3	Chromodomain-helicase-DNA-binding protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14839	CHD4	Chromodomain-helicase-DNA-binding protein 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q14839	CHD4	Chromodomain-helicase-DNA-binding protein 4	GO:0004003; F:ATP-dependent DNA helicase activity; TAS:ProtInc
Q14839	CHD4	Chromodomain-helicase-DNA-binding protein 4	GO:0003677; F:DNA binding; TAS:ProtInc
Q14839	CHD4	Chromodomain-helicase-DNA-binding protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q14839	CHD4	Chromodomain-helicase-DNA-binding protein 4	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:BHF-UCL
Q14839	CHD4	Chromodomain-helicase-DNA-binding protein 4	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q14839	CHD4	Chromodomain-helicase-DNA-binding protein 4	GO:0043044; P:ATP-dependent chromatin remodeling; IDA:UniProt
Q14839	CHD4	Chromodomain-helicase-DNA-binding protein 4	GO:0032508; P:DNA duplex unwinding; TAS:GOC
Q14839	CHD4	Chromodomain-helicase-DNA-binding protein 4	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q14839	CHD4	Chromodomain-helicase-DNA-binding protein 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TDI0	CHD5	Chromodomain-helicase-DNA-binding protein 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8TDI0	CHD5	Chromodomain-helicase-DNA-binding protein 5	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q8TDI0	CHD5	Chromodomain-helicase-DNA-binding protein 5	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TDI0	CHD5	Chromodomain-helicase-DNA-binding protein 5	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q8TDI0	CHD5	Chromodomain-helicase-DNA-binding protein 5	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TDI0	CHD5	Chromodomain-helicase-DNA-binding protein 5	GO:0021895; P:cerebral cortex neuron differentiation; ISS:UniProtKB
Q8TDI0	CHD5	Chromodomain-helicase-DNA-binding protein 5	GO:0098532; P:histone H3-K27 trimethylation; IMP:UniProtKB
Q8TDI0	CHD5	Chromodomain-helicase-DNA-binding protein 5	GO:0043967; P:histone H4 acetylation; ISS:UniProtKB
Q8TDI0	CHD5	Chromodomain-helicase-DNA-binding protein 5	GO:0008285; P:negative regulation of cell proliferation; ISS:UniProtKB
Q8TDI0	CHD5	Chromodomain-helicase-DNA-binding protein 5	GO:1901798; P:positive regulation of signal transduction by p53 class mediator; ISS:UniProtKB
Q8TDI0	CHD5	Chromodomain-helicase-DNA-binding protein 5	GO:0060850; P:regulation of transcription involved in cell fate commitment; IMP:UniProtKB
Q8TDI0	CHD5	Chromodomain-helicase-DNA-binding protein 5	GO:0035093; P:spermatogenesis, exchange of chromosomal proteins; ISS:UniProtKB
Q8TDI0	CHD5	Chromodomain-helicase-DNA-binding protein 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TD26	CHD6	Chromodomain-helicase-DNA-binding protein 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8TD26	CHD6	Chromodomain-helicase-DNA-binding protein 6	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q8TD26	CHD6	Chromodomain-helicase-DNA-binding protein 6	GO:0003682; F:chromatin binding; IEA:InterPro
Q8TD26	CHD6	Chromodomain-helicase-DNA-binding protein 6	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TD26	CHD6	Chromodomain-helicase-DNA-binding protein 6	GO:0008094; F:DNA-dependent ATPase activity; IDA:UniProtKB
Q8TD26	CHD6	Chromodomain-helicase-DNA-binding protein 6	GO:0001221; F:transcription cofactor binding; IPI:UniProtKB
Q8TD26	CHD6	Chromodomain-helicase-DNA-binding protein 6	GO:0006200; P:ATP catabolic process; IDA:GOC
Q8TD26	CHD6	Chromodomain-helicase-DNA-binding protein 6	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q8TD26	CHD6	Chromodomain-helicase-DNA-binding protein 6	GO:0036091; P:positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress; IMP:UniProtKB
Q8TD26	CHD6	Chromodomain-helicase-DNA-binding protein 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0003682; F:chromatin binding; TAS:BHF-UCL
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0007512; P:adult heart development; IEA:Ensembl
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0007628; P:adult walking behavior; IEA:Ensembl
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0048844; P:artery morphogenesis; IEA:Ensembl
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0008015; P:blood circulation; IEA:Ensembl
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0007417; P:central nervous system development; IMP:BHF-UCL
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0050890; P:cognition; IMP:BHF-UCL
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0021545; P:cranial nerve development; IMP:BHF-UCL
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0060324; P:face development; IMP:BHF-UCL
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0030540; P:female genitalia development; IEA:Ensembl
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0048806; P:genitalia development; IMP:BHF-UCL
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0003007; P:heart morphogenesis; IMP:BHF-UCL
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0001701; P:in utero embryonic development; IMP:BHF-UCL
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0042472; P:inner ear morphogenesis; IMP:BHF-UCL
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0060173; P:limb development; IMP:BHF-UCL
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0043584; P:nose development; IMP:BHF-UCL
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0060021; P:palate development; IMP:BHF-UCL
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0060123; P:regulation of growth hormone secretion; IMP:BHF-UCL
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0006355; P:regulation of transcription, DNA-templated; NAS:BHF-UCL
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0060041; P:retina development in camera-type eye; IMP:BHF-UCL
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0048752; P:semicircular canal morphogenesis; IEA:Ensembl
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0007605; P:sensory perception of sound; IEA:Ensembl
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0001501; P:skeletal system development; IMP:BHF-UCL
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0030217; P:T cell differentiation; IMP:BHF-UCL
Q9P2D1	CHD7	Chromodomain-helicase-DNA-binding protein 7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:0008013; F:beta-catenin binding; IDA:UniProtKB
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:0003677; F:DNA binding; IMP:UniProtKB
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:0003678; F:DNA helicase activity; IMP:UniProtKB
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:0008094; F:DNA-dependent ATPase activity; IDA:UniProtKB
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:0042393; F:histone binding; ISS:UniProtKB
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:0002039; F:p53 binding; ISS:UniProtKB
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:0005515; F:protein binding; IPI:IntAct
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:0006200; P:ATP catabolic process; IDA:GOC
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:0043044; P:ATP-dependent chromatin remodeling; IMP:UniProtKB
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:0060070; P:canonical Wnt signaling pathway; IDA:UniProtKB
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:0032508; P:DNA duplex unwinding; IMP:GOC
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:2000270; P:negative regulation of fibroblast apoptotic process; IEA:Ensembl
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:0030178; P:negative regulation of Wnt signaling pathway; IDA:UniProtKB
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:0045945; P:positive regulation of transcription from RNA polymerase III promoter; IMP:UniProtKB
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9HCK8	CHD8	Chromodomain-helicase-DNA-binding protein 8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q3L8U1	CHD9	Chromodomain-helicase-DNA-binding protein 9	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q3L8U1	CHD9	Chromodomain-helicase-DNA-binding protein 9	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q3L8U1	CHD9	Chromodomain-helicase-DNA-binding protein 9	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q3L8U1	CHD9	Chromodomain-helicase-DNA-binding protein 9	GO:0005515; F:protein binding; IPI:IntAct
Q3L8U1	CHD9	Chromodomain-helicase-DNA-binding protein 9	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q3L8U1	CHD9	Chromodomain-helicase-DNA-binding protein 9	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q3L8U1	CHD9	Chromodomain-helicase-DNA-binding protein 9	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q3L8U1	CHD9	Chromodomain-helicase-DNA-binding protein 9	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q3L8U1	CHD9	Chromodomain-helicase-DNA-binding protein 9	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NE62	CHDH	Choline dehydrogenase, mitochondrial	GO:0008812; F:choline dehydrogenase activity; IEA:UniProtKB-EC
Q8NE62	CHDH	Choline dehydrogenase, mitochondrial	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q8NE62	CHDH	Choline dehydrogenase, mitochondrial	GO:0019285; P:glycine betaine biosynthetic process from choline; IEA:UniProtKB-UniPathway
Q8IWX8	CHERP	Calcium homeostasis endoplasmic reticulum protein	GO:0044325; F:ion channel binding; IPI:UniProtKB
Q8IWX8	CHERP	Calcium homeostasis endoplasmic reticulum protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IWX8	CHERP	Calcium homeostasis endoplasmic reticulum protein	GO:0005515; F:protein binding; IPI:IntAct
Q8IWX8	CHERP	Calcium homeostasis endoplasmic reticulum protein	GO:0006874; P:cellular calcium ion homeostasis; IDA:MGI
Q8IWX8	CHERP	Calcium homeostasis endoplasmic reticulum protein	GO:0008285; P:negative regulation of cell proliferation; IDA:MGI
Q8IWX8	CHERP	Calcium homeostasis endoplasmic reticulum protein	GO:0007399; P:nervous system development; TAS:ProtInc
Q8IWX8	CHERP	Calcium homeostasis endoplasmic reticulum protein	GO:0051533; P:positive regulation of NFAT protein import into nucleus; IMP:UniProtKB
Q8IWX8	CHERP	Calcium homeostasis endoplasmic reticulum protein	GO:0051209; P:release of sequestered calcium ion into cytosol; IMP:UniProtKB
Q8IWX8	CHERP	Calcium homeostasis endoplasmic reticulum protein	GO:0006396; P:RNA processing; IEA:InterPro
Q96EP1	CHFR	E3 ubiquitin-protein ligase CHFR	GO:0000166; F:nucleotide binding; IDA:UniProtKB
Q96EP1	CHFR	E3 ubiquitin-protein ligase CHFR	GO:0005515; F:protein binding; IPI:UniProtKB
Q96EP1	CHFR	E3 ubiquitin-protein ligase CHFR	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q96EP1	CHFR	E3 ubiquitin-protein ligase CHFR	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96EP1	CHFR	E3 ubiquitin-protein ligase CHFR	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q96EP1	CHFR	E3 ubiquitin-protein ligase CHFR	GO:0007093; P:mitotic cell cycle checkpoint; IMP:UniProtKB
Q96EP1	CHFR	E3 ubiquitin-protein ligase CHFR	GO:0019941; P:modification-dependent protein catabolic process; IDA:UniProtKB
Q96EP1	CHFR	E3 ubiquitin-protein ligase CHFR	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q96EP1	CHFR	E3 ubiquitin-protein ligase CHFR	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q9BZP6	CHIA	Acidic mammalian chitinase	GO:0030246; F:carbohydrate binding; NAS:UniProtKB
Q9BZP6	CHIA	Acidic mammalian chitinase	GO:0008061; F:chitin binding; TAS:UniProtKB
Q9BZP6	CHIA	Acidic mammalian chitinase	GO:0004568; F:chitinase activity; IDA:UniProtKB
Q9BZP6	CHIA	Acidic mammalian chitinase	GO:0019900; F:kinase binding; IPI:UniProtKB
Q9BZP6	CHIA	Acidic mammalian chitinase	GO:0003796; F:lysozyme activity; NAS:UniProtKB
Q9BZP6	CHIA	Acidic mammalian chitinase	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9BZP6	CHIA	Acidic mammalian chitinase	GO:0006037; P:cell wall chitin metabolic process; TAS:UniProtKB
Q9BZP6	CHIA	Acidic mammalian chitinase	GO:0006032; P:chitin catabolic process; IDA:UniProtKB
Q9BZP6	CHIA	Acidic mammalian chitinase	GO:0006030; P:chitin metabolic process; NAS:UniProtKB
Q9BZP6	CHIA	Acidic mammalian chitinase	GO:0007586; P:digestion; NAS:UniProtKB
Q9BZP6	CHIA	Acidic mammalian chitinase	GO:0006955; P:immune response; NAS:UniProtKB
Q9BZP6	CHIA	Acidic mammalian chitinase	GO:0000272; P:polysaccharide catabolic process; IEA:UniProtKB-KW
Q9BZP6	CHIA	Acidic mammalian chitinase	GO:0090197; P:positive regulation of chemokine secretion; IDA:UniProtKB
Q9BZP6	CHIA	Acidic mammalian chitinase	GO:0002532; P:production of molecular mediator involved in inflammatory response; IDA:UniProtKB
Q9BZP6	CHIA	Acidic mammalian chitinase	GO:0001101; P:response to acid; TAS:UniProtKB
Q9BZP6	CHIA	Acidic mammalian chitinase	GO:0009620; P:response to fungus; TAS:UniProtKB
Q9UKJ5	CHIC2	Cysteine-rich hydrophobic domain 2 protein	GO:0005515; F:protein binding; IPI:IntAct
Q9BWS9	CHID1	Chitinase domain-containing protein 1	GO:0004568; F:chitinase activity; IEA:InterPro
Q9BWS9	CHID1	Chitinase domain-containing protein 1	GO:0070492; F:oligosaccharide binding; IPI:UniProt
Q9BWS9	CHID1	Chitinase domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProt
Q9BWS9	CHID1	Chitinase domain-containing protein 1	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q9BWS9	CHID1	Chitinase domain-containing protein 1	GO:0006032; P:chitin catabolic process; IEA:InterPro
Q9BWS9	CHID1	Chitinase domain-containing protein 1	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q9BWS9	CHID1	Chitinase domain-containing protein 1	GO:1900016; P:negative regulation of cytokine production involved in inflammatory response; IDA:UniProt
P15882	CHN1	N-chimaerin	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
P15882	CHN1	N-chimaerin	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P15882	CHN1	N-chimaerin	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
P15882	CHN1	N-chimaerin	GO:0048013; P:ephrin receptor signaling pathway; ISS:UniProtKB
P15882	CHN1	N-chimaerin	GO:0008045; P:motor neuron axon guidance; ISS:UniProtKB
P15882	CHN1	N-chimaerin	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
P15882	CHN1	N-chimaerin	GO:0050770; P:regulation of axonogenesis; ISS:UniProtKB
P15882	CHN1	N-chimaerin	GO:0032314; P:regulation of Rac GTPase activity; IEA:Ensembl
P15882	CHN1	N-chimaerin	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P15882	CHN1	N-chimaerin	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P52757	CHN2	Beta-chimaerin	GO:0005096; F:GTPase activator activity; TAS:ProtInc
P52757	CHN2	Beta-chimaerin	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P52757	CHN2	Beta-chimaerin	GO:0005515; F:protein binding; IPI:IntAct
P52757	CHN2	Beta-chimaerin	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
P52757	CHN2	Beta-chimaerin	GO:0043547; P:positive regulation of GTPase activity; TAS:GOC
P52757	CHN2	Beta-chimaerin	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
P52757	CHN2	Beta-chimaerin	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P52757	CHN2	Beta-chimaerin	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0030544; F:Hsp70 protein binding; IDA:HGNC
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0051879; F:Hsp90 protein binding; IDA:BHF-UCL
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0019900; F:kinase binding; IPI:BHF-UCL
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0051787; F:misfolded protein binding; IDA:BHF-UCL
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0030674; F:protein binding, bridging; TAS:HGNC
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0046332; F:SMAD binding; IDA:HGNC
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0030911; F:TPR domain binding; IDA:HGNC
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0034450; F:ubiquitin-ubiquitin ligase activity; ISS:UniProtKB
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0071218; P:cellular response to misfolded protein; IDA:BHF-UCL
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0006515; P:misfolded or incompletely synthesized protein catabolic process; IDA:BHF-UCL
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0090035; P:positive regulation of chaperone-mediated protein complex assembly; IDA:BHF-UCL
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:HGNC
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0031398; P:positive regulation of protein ubiquitination; IDA:BHF-UCL
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:HGNC
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0051604; P:protein maturation; TAS:HGNC
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0000209; P:protein polyubiquitination; IMP:UniProtKB
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0031943; P:regulation of glucocorticoid metabolic process; IDA:HGNC
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q9UNE7	STUB1	E3 ubiquitin-protein ligase CHIP	GO:0030579; P:ubiquitin-dependent SMAD protein catabolic process; IDA:HGNC
Q13231	CHIT1	Chitotriosidase-1	GO:0008061; F:chitin binding; TAS:UniProtKB
Q13231	CHIT1	Chitotriosidase-1	GO:0004568; F:chitinase activity; TAS:UniProtKB
Q13231	CHIT1	Chitotriosidase-1	GO:0008843; F:endochitinase activity; IDA:UniProtKB
Q13231	CHIT1	Chitotriosidase-1	GO:0006032; P:chitin catabolic process; IDA:UniProtKB
Q13231	CHIT1	Chitotriosidase-1	GO:0006955; P:immune response; NAS:UniProtKB
Q13231	CHIT1	Chitotriosidase-1	GO:0000272; P:polysaccharide catabolic process; IEA:UniProtKB-KW
Q13231	CHIT1	Chitotriosidase-1	GO:0009617; P:response to bacterium; TAS:ProtInc
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0035402; F:histone kinase activity (H3-T11 specific); IDA:UniProtKB
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0005515; F:protein binding; IPI:UniProtKB
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0071313; P:cellular response to caffeine; IEA:Ensembl
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0048096; P:chromatin-mediated maintenance of transcription; ISS:UniProtKB
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0000077; P:DNA damage checkpoint; IDA:UniProtKB
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0006975; P:DNA damage induced protein phosphorylation; IDA:UniProtKB
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0006281; P:DNA repair; IMP:UniProtKB
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0006260; P:DNA replication; TAS:Reactome
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0031572; P:G2 DNA damage checkpoint; IMP:UniProtKB
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0000086; P:G2/M transition of mitotic cell cycle; IEA:Ensembl
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0035407; P:histone H3-T11 phosphorylation; IDA:GOC
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0045839; P:negative regulation of mitosis; IDA:UniProtKB
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0018107; P:peptidyl-threonine phosphorylation; IDA:UniProtKB
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0010569; P:regulation of double-strand break repair via homologous recombination; IDA:UniProtKB
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:2000615; P:regulation of histone H3-K9 acetylation; ISS:UniProtKB
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0046602; P:regulation of mitotic centrosome separation; IDA:UniProtKB
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0010767; P:regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage; ISS:UniProtKB
O14757	CHEK1	Serine/threonine-protein kinase Chk1	GO:0090399; P:replicative senescence; NAS:BHF-UCL
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0042802; F:identical protein binding; IPI:IntAct
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0005515; F:protein binding; IPI:UniProtKB
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0044257; P:cellular protein catabolic process; IMP:UniProtKB
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0000077; P:DNA damage checkpoint; TAS:UniProtKB
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0006975; P:DNA damage induced protein phosphorylation; IMP:UniProtKB
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0006302; P:double-strand break repair; IMP:UniProtKB
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0000086; P:G2/M transition of mitotic cell cycle; IMP:UniProtKB
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IDA:UniProtKB
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0050821; P:protein stabilization; IDA:UniProtKB
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0042176; P:regulation of protein catabolic process; IMP:UniProtKB
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0090399; P:replicative senescence; NAS:BHF-UCL
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0010332; P:response to gamma radiation; IEA:Ensembl
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0042770; P:signal transduction in response to DNA damage; IDA:MGI
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0072428; P:signal transduction involved in intra-S DNA damage checkpoint; IMP:UniProtKB
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0090307; P:spindle assembly involved in mitosis; IMP:UniProtKB
O96017	CHEK2	Serine/threonine-protein kinase Chk2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P35790	CHKA	Choline kinase alpha	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P35790	CHKA	Choline kinase alpha	GO:0033265; F:choline binding; IEA:Ensembl
P35790	CHKA	Choline kinase alpha	GO:0004103; F:choline kinase activity; IDA:UniProtKB
P35790	CHKA	Choline kinase alpha	GO:0004104; F:cholinesterase activity; IEA:Ensembl
P35790	CHKA	Choline kinase alpha	GO:0008144; F:drug binding; IDA:UniProtKB
P35790	CHKA	Choline kinase alpha	GO:0004305; F:ethanolamine kinase activity; IDA:UniProtKB
P35790	CHKA	Choline kinase alpha	GO:0004871; F:signal transducer activity; TAS:ProtInc
P35790	CHKA	Choline kinase alpha	GO:0006657; P:CDP-choline pathway; IDA:GOC
P35790	CHKA	Choline kinase alpha	GO:0019695; P:choline metabolic process; IEA:Ensembl
P35790	CHKA	Choline kinase alpha	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
P35790	CHKA	Choline kinase alpha	GO:0006629; P:lipid metabolic process; TAS:ProtInc
P35790	CHKA	Choline kinase alpha	GO:0006869; P:lipid transport; TAS:ProtInc
P35790	CHKA	Choline kinase alpha	GO:0006656; P:phosphatidylcholine biosynthetic process; IDA:UniProtKB
P35790	CHKA	Choline kinase alpha	GO:0006646; P:phosphatidylethanolamine biosynthetic process; IDA:UniProtKB
P35790	CHKA	Choline kinase alpha	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P35790	CHKA	Choline kinase alpha	GO:0007165; P:signal transduction; TAS:GOC
P35790	CHKA	Choline kinase alpha	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y259	CHKB	Choline/ethanolamine kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y259	CHKB	Choline/ethanolamine kinase	GO:0004103; F:choline kinase activity; IDA:UniProtKB
Q9Y259	CHKB	Choline/ethanolamine kinase	GO:0004305; F:ethanolamine kinase activity; IDA:UniProtKB
Q9Y259	CHKB	Choline/ethanolamine kinase	GO:0006657; P:CDP-choline pathway; IDA:GOC
Q9Y259	CHKB	Choline/ethanolamine kinase	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9Y259	CHKB	Choline/ethanolamine kinase	GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome
Q9Y259	CHKB	Choline/ethanolamine kinase	GO:0006646; P:phosphatidylethanolamine biosynthetic process; IDA:UniProtKB
Q9Y259	CHKB	Choline/ethanolamine kinase	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9Y259	CHKB	Choline/ethanolamine kinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00533	CHL1	Neural cell adhesion molecule L1-like protein	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
O00533	CHL1	Neural cell adhesion molecule L1-like protein	GO:0007411; P:axon guidance; TAS:Reactome
O00533	CHL1	Neural cell adhesion molecule L1-like protein	GO:0007155; P:cell adhesion; TAS:ProtInc
O00533	CHL1	Neural cell adhesion molecule L1-like protein	GO:0050890; P:cognition; IEA:Ensembl
O00533	CHL1	Neural cell adhesion molecule L1-like protein	GO:0035640; P:exploration behavior; IEA:Ensembl
O00533	CHL1	Neural cell adhesion molecule L1-like protein	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
O00533	CHL1	Neural cell adhesion molecule L1-like protein	GO:0001764; P:neuron migration; IEA:Ensembl
O00533	CHL1	Neural cell adhesion molecule L1-like protein	GO:0007165; P:signal transduction; TAS:ProtInc
P06276	BCHE	Cholinesterase	GO:0003990; F:acetylcholinesterase activity; ISS:UniProtKB
P06276	BCHE	Cholinesterase	GO:0001540; F:beta-amyloid binding; NAS:UniProtKB
P06276	BCHE	Cholinesterase	GO:0003824; F:catalytic activity; NAS:UniProtKB
P06276	BCHE	Cholinesterase	GO:0033265; F:choline binding; IEA:Ensembl
P06276	BCHE	Cholinesterase	GO:0004104; F:cholinesterase activity; IDA:UniProtKB
P06276	BCHE	Cholinesterase	GO:0019899; F:enzyme binding; NAS:UniProtKB
P06276	BCHE	Cholinesterase	GO:0042802; F:identical protein binding; IPI:IntAct
P06276	BCHE	Cholinesterase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P06276	BCHE	Cholinesterase	GO:0019695; P:choline metabolic process; IBA:RefGenome
P06276	BCHE	Cholinesterase	GO:0050783; P:cocaine metabolic process; TAS:UniProtKB
P06276	BCHE	Cholinesterase	GO:0007612; P:learning; IEA:Ensembl
P06276	BCHE	Cholinesterase	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P06276	BCHE	Cholinesterase	GO:0050805; P:negative regulation of synaptic transmission; IEA:Ensembl
P06276	BCHE	Cholinesterase	GO:0014016; P:neuroblast differentiation; IEA:Ensembl
P06276	BCHE	Cholinesterase	GO:0043279; P:response to alkaloid; IEA:Ensembl
P06276	BCHE	Cholinesterase	GO:0042493; P:response to drug; IEA:Ensembl
P06276	BCHE	Cholinesterase	GO:0051593; P:response to folic acid; IEA:Ensembl
P06276	BCHE	Cholinesterase	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P06276	BCHE	Cholinesterase	GO:0007271; P:synaptic transmission, cholinergic; IBA:RefGenome
Q7LBR1	CHMP1B	Charged multivesicular body protein 1b	GO:0005515; F:protein binding; IPI:UniProtKB
Q7LBR1	CHMP1B	Charged multivesicular body protein 1b	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q7LBR1	CHMP1B	Charged multivesicular body protein 1b	GO:0000910; P:cytokinesis; IMP:UniProtKB
Q7LBR1	CHMP1B	Charged multivesicular body protein 1b	GO:0045184; P:establishment of protein localization; IMP:UniProt
Q7LBR1	CHMP1B	Charged multivesicular body protein 1b	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9HD42	CHMP1A	Charged multivesicular body protein 1a	GO:0008237; F:metallopeptidase activity; TAS:ProtInc
Q9HD42	CHMP1A	Charged multivesicular body protein 1a	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HD42	CHMP1A	Charged multivesicular body protein 1a	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q9HD42	CHMP1A	Charged multivesicular body protein 1a	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q9HD42	CHMP1A	Charged multivesicular body protein 1a	GO:0000910; P:cytokinesis; IMP:UniProtKB
Q9HD42	CHMP1A	Charged multivesicular body protein 1a	GO:0016458; P:gene silencing; IDA:UniProtKB
Q9HD42	CHMP1A	Charged multivesicular body protein 1a	GO:0007076; P:mitotic chromosome condensation; IDA:UniProtKB
Q9HD42	CHMP1A	Charged multivesicular body protein 1a	GO:0045014; P:negative regulation of transcription by glucose; IDA:UniProtKB
Q9HD42	CHMP1A	Charged multivesicular body protein 1a	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9HD42	CHMP1A	Charged multivesicular body protein 1a	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9HD42	CHMP1A	Charged multivesicular body protein 1a	GO:0006508; P:proteolysis; TAS:GOC
Q9HD42	CHMP1A	Charged multivesicular body protein 1a	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HD42	CHMP1A	Charged multivesicular body protein 1a	GO:0016192; P:vesicle-mediated transport; IDA:UniProtKB
O43633	CHMP2A	Charged multivesicular body protein 2a	GO:0005515; F:protein binding; IPI:UniProtKB
O43633	CHMP2A	Charged multivesicular body protein 2a	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
O43633	CHMP2A	Charged multivesicular body protein 2a	GO:0016197; P:endosomal transport; TAS:Reactome
O43633	CHMP2A	Charged multivesicular body protein 2a	GO:0045184; P:establishment of protein localization; IMP:UniProt
O43633	CHMP2A	Charged multivesicular body protein 2a	GO:0061024; P:membrane organization; TAS:Reactome
O43633	CHMP2A	Charged multivesicular body protein 2a	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O43633	CHMP2A	Charged multivesicular body protein 2a	GO:0019058; P:viral life cycle; TAS:Reactome
O43633	CHMP2A	Charged multivesicular body protein 2a	GO:0016032; P:viral process; TAS:Reactome
Q9UQN3	CHMP2B	Charged multivesicular body protein 2b	GO:0005515; F:protein binding; IPI:UniProt
Q9UQN3	CHMP2B	Charged multivesicular body protein 2b	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q9UQN3	CHMP2B	Charged multivesicular body protein 2b	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9UQN3	CHMP2B	Charged multivesicular body protein 2b	GO:0016197; P:endosomal transport; TAS:Reactome
Q9UQN3	CHMP2B	Charged multivesicular body protein 2b	GO:0061024; P:membrane organization; TAS:Reactome
Q9UQN3	CHMP2B	Charged multivesicular body protein 2b	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9UQN3	CHMP2B	Charged multivesicular body protein 2b	GO:0019058; P:viral life cycle; TAS:Reactome
Q9UQN3	CHMP2B	Charged multivesicular body protein 2b	GO:0016032; P:viral process; TAS:Reactome
Q9BY43	CHMP4A	Charged multivesicular body protein 4a	GO:0051117; F:ATPase binding; IPI:UniProt
Q9BY43	CHMP4A	Charged multivesicular body protein 4a	GO:0042802; F:identical protein binding; IMP:UniProt
Q9BY43	CHMP4A	Charged multivesicular body protein 4a	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q9BY43	CHMP4A	Charged multivesicular body protein 4a	GO:0005515; F:protein binding; IPI:UniProt
Q9BY43	CHMP4A	Charged multivesicular body protein 4a	GO:0016197; P:endosomal transport; TAS:Reactome
Q9BY43	CHMP4A	Charged multivesicular body protein 4a	GO:0006900; P:membrane budding; IMP:UniProt
Q9BY43	CHMP4A	Charged multivesicular body protein 4a	GO:0061024; P:membrane organization; TAS:Reactome
Q9BY43	CHMP4A	Charged multivesicular body protein 4a	GO:0097320; P:membrane tubulation; IMP:UniProt
Q9BY43	CHMP4A	Charged multivesicular body protein 4a	GO:1902902; P:negative regulation of autophagic vacuole assembly; IMP:UniProt
Q9BY43	CHMP4A	Charged multivesicular body protein 4a	GO:1901215; P:negative regulation of neuron death; IMP:UniProt
Q9BY43	CHMP4A	Charged multivesicular body protein 4a	GO:0006620; P:posttranslational protein targeting to membrane; IMP:UniProt
Q9BY43	CHMP4A	Charged multivesicular body protein 4a	GO:0051260; P:protein homooligomerization; IMP:UniProt
Q9BY43	CHMP4A	Charged multivesicular body protein 4a	GO:0019058; P:viral life cycle; TAS:Reactome
Q9BY43	CHMP4A	Charged multivesicular body protein 4a	GO:0016032; P:viral process; TAS:Reactome
Q9H444	CHMP4B	Charged multivesicular body protein 4b	GO:0042802; F:identical protein binding; IDA:UniProt
Q9H444	CHMP4B	Charged multivesicular body protein 4b	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H444	CHMP4B	Charged multivesicular body protein 4b	GO:0016197; P:endosomal transport; TAS:Reactome
Q9H444	CHMP4B	Charged multivesicular body protein 4b	GO:0061024; P:membrane organization; TAS:Reactome
Q9H444	CHMP4B	Charged multivesicular body protein 4b	GO:1902902; P:negative regulation of autophagic vacuole assembly; IMP:UniProt
Q9H444	CHMP4B	Charged multivesicular body protein 4b	GO:1901215; P:negative regulation of neuron death; IMP:UniProt
Q9H444	CHMP4B	Charged multivesicular body protein 4b	GO:0006620; P:posttranslational protein targeting to membrane; IMP:UniProt
Q9H444	CHMP4B	Charged multivesicular body protein 4b	GO:0051260; P:protein homooligomerization; IDA:UniProt
Q9H444	CHMP4B	Charged multivesicular body protein 4b	GO:0019058; P:viral life cycle; TAS:Reactome
Q9H444	CHMP4B	Charged multivesicular body protein 4b	GO:0016032; P:viral process; TAS:Reactome
Q96CF2	CHMP4C	Charged multivesicular body protein 4c	GO:0005515; F:protein binding; IPI:IntAct
Q96CF2	CHMP4C	Charged multivesicular body protein 4c	GO:0016197; P:endosomal transport; TAS:Reactome
Q96CF2	CHMP4C	Charged multivesicular body protein 4c	GO:0061024; P:membrane organization; TAS:Reactome
Q96CF2	CHMP4C	Charged multivesicular body protein 4c	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96CF2	CHMP4C	Charged multivesicular body protein 4c	GO:0019058; P:viral life cycle; TAS:Reactome
Q96CF2	CHMP4C	Charged multivesicular body protein 4c	GO:0016032; P:viral process; TAS:Reactome
P59074	CHMP4BP1	Putative charged multivesicular body protein 4B-like protein CHMP4BP1	GO:0015031; P:protein transport; IEA:InterPro
Q9Y3E7	CHMP3	Charged multivesicular body protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y3E7	CHMP3	Charged multivesicular body protein 3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9Y3E7	CHMP3	Charged multivesicular body protein 3	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9Y3E7	CHMP3	Charged multivesicular body protein 3	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q9Y3E7	CHMP3	Charged multivesicular body protein 3	GO:0016197; P:endosomal transport; TAS:Reactome
Q9Y3E7	CHMP3	Charged multivesicular body protein 3	GO:0061024; P:membrane organization; TAS:Reactome
Q9Y3E7	CHMP3	Charged multivesicular body protein 3	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9Y3E7	CHMP3	Charged multivesicular body protein 3	GO:0019058; P:viral life cycle; TAS:Reactome
Q9Y3E7	CHMP3	Charged multivesicular body protein 3	GO:0016032; P:viral process; TAS:Reactome
Q9NZZ3	CHMP5	Charged multivesicular body protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NZZ3	CHMP5	Charged multivesicular body protein 5	GO:0016197; P:endosomal transport; TAS:Reactome
Q9NZZ3	CHMP5	Charged multivesicular body protein 5	GO:0008333; P:endosome to lysosome transport; IEA:Ensembl
Q9NZZ3	CHMP5	Charged multivesicular body protein 5	GO:0007040; P:lysosome organization; IEA:Ensembl
Q9NZZ3	CHMP5	Charged multivesicular body protein 5	GO:0061024; P:membrane organization; TAS:Reactome
Q9NZZ3	CHMP5	Charged multivesicular body protein 5	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9NZZ3	CHMP5	Charged multivesicular body protein 5	GO:0001919; P:regulation of receptor recycling; IEA:Ensembl
Q9NZZ3	CHMP5	Charged multivesicular body protein 5	GO:0019058; P:viral life cycle; TAS:Reactome
Q9NZZ3	CHMP5	Charged multivesicular body protein 5	GO:0016032; P:viral process; TAS:Reactome
Q96FZ7	CHMP6	Charged multivesicular body protein 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q96FZ7	CHMP6	Charged multivesicular body protein 6	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q96FZ7	CHMP6	Charged multivesicular body protein 6	GO:0016197; P:endosomal transport; TAS:Reactome
Q96FZ7	CHMP6	Charged multivesicular body protein 6	GO:0061024; P:membrane organization; TAS:Reactome
Q96FZ7	CHMP6	Charged multivesicular body protein 6	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96FZ7	CHMP6	Charged multivesicular body protein 6	GO:0019058; P:viral life cycle; TAS:Reactome
Q96FZ7	CHMP6	Charged multivesicular body protein 6	GO:0016032; P:viral process; TAS:Reactome
Q8WUX9	CHMP7	Charged multivesicular body protein 7	GO:0008565; F:protein transporter activity; IMP:UniProtKB
Q8WUX9	CHMP7	Charged multivesicular body protein 7	GO:0016197; P:endosomal transport; TAS:Reactome
Q8WUX9	CHMP7	Charged multivesicular body protein 7	GO:0045324; P:late endosome to vacuole transport; IMP:UniProtKB
Q8WUX9	CHMP7	Charged multivesicular body protein 7	GO:0061024; P:membrane organization; TAS:Reactome
Q8WUX9	CHMP7	Charged multivesicular body protein 7	GO:0019058; P:viral life cycle; TAS:Reactome
Q8WUX9	CHMP7	Charged multivesicular body protein 7	GO:0016032; P:viral process; TAS:Reactome
Q9H9P2	CHODL	Chondrolectin	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q9H9P2	CHODL	Chondrolectin	GO:0007517; P:muscle organ development; NAS:HGNC
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0048306; F:calcium-dependent protein binding; IDA:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0019900; F:kinase binding; ISS:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0008017; F:microtubule binding; ISS:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0015459; F:potassium channel regulator activity; TAS:ProtInc
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0004860; F:protein kinase inhibitor activity; IEA:UniProtKB-KW
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0005215; F:transporter activity; ISS:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0017156; P:calcium ion-dependent exocytosis; IEA:Ensembl
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0071468; P:cellular response to acidity; ISS:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0031122; P:cytoplasmic microtubule organization; ISS:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0022406; P:membrane docking; ISS:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0061025; P:membrane fusion; ISS:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0061024; P:membrane organization; ISS:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0001578; P:microtubule bundle formation; ISS:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0070885; P:negative regulation of calcineurin-NFAT signaling cascade; IDA:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0031953; P:negative regulation of protein autophosphorylation; ISS:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0042308; P:negative regulation of protein import into nucleus; IDA:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0006469; P:negative regulation of protein kinase activity; ISS:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0001933; P:negative regulation of protein phosphorylation; ISS:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0031397; P:negative regulation of protein ubiquitination; ISS:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0060050; P:positive regulation of protein glycosylation; ISS:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0090314; P:positive regulation of protein targeting to membrane; ISS:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0051222; P:positive regulation of protein transport; ISS:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0032417; P:positive regulation of sodium:proton antiporter activity; IDA:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0006611; P:protein export from nucleus; ISS:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0051259; P:protein oligomerization; IEA:Ensembl
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0050821; P:protein stabilization; ISS:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0051453; P:regulation of intracellular pH; IDA:UniProtKB
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0007264; P:small GTPase mediated signal transduction; TAS:ProtInc
Q99653	CHP1	Calcineurin B homologous protein 1	GO:0045056; P:transcytosis; IEA:Ensembl
O43745	CHP2	Calcineurin B homologous protein 2	GO:0005509; F:calcium ion binding; IDA:UniProtKB
O43745	CHP2	Calcineurin B homologous protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
O43745	CHP2	Calcineurin B homologous protein 2	GO:0071277; P:cellular response to calcium ion; IDA:UniProtKB
O43745	CHP2	Calcineurin B homologous protein 2	GO:0070886; P:positive regulation of calcineurin-NFAT signaling cascade; IDA:UniProtKB
O43745	CHP2	Calcineurin B homologous protein 2	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
O43745	CHP2	Calcineurin B homologous protein 2	GO:0010922; P:positive regulation of phosphatase activity; IDA:UniProtKB
O43745	CHP2	Calcineurin B homologous protein 2	GO:0042307; P:positive regulation of protein import into nucleus; IDA:UniProtKB
O43745	CHP2	Calcineurin B homologous protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O43745	CHP2	Calcineurin B homologous protein 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96BS2	TESC	Calcineurin B homologous protein 3	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q96BS2	TESC	Calcineurin B homologous protein 3	GO:0000287; F:magnesium ion binding; ISS:UniProtKB
Q96BS2	TESC	Calcineurin B homologous protein 3	GO:0019212; F:phosphatase inhibitor activity; ISS:UniProtKB
Q96BS2	TESC	Calcineurin B homologous protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q96BS2	TESC	Calcineurin B homologous protein 3	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q96BS2	TESC	Calcineurin B homologous protein 3	GO:0004860; F:protein kinase inhibitor activity; IEA:UniProtKB-KW
Q96BS2	TESC	Calcineurin B homologous protein 3	GO:0071300; P:cellular response to retinoic acid; IDA:UniProtKB
Q96BS2	TESC	Calcineurin B homologous protein 3	GO:0008584; P:male gonad development; IEA:Ensembl
Q96BS2	TESC	Calcineurin B homologous protein 3	GO:0030219; P:megakaryocyte differentiation; IEA:Ensembl
Q96BS2	TESC	Calcineurin B homologous protein 3	GO:0043086; P:negative regulation of catalytic activity; ISS:GOC
Q96BS2	TESC	Calcineurin B homologous protein 3	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q96BS2	TESC	Calcineurin B homologous protein 3	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
Q96BS2	TESC	Calcineurin B homologous protein 3	GO:0030854; P:positive regulation of granulocyte differentiation; IDA:UniProtKB
Q96BS2	TESC	Calcineurin B homologous protein 3	GO:0045654; P:positive regulation of megakaryocyte differentiation; IMP:UniProtKB
Q96BS2	TESC	Calcineurin B homologous protein 3	GO:0032417; P:positive regulation of sodium:proton antiporter activity; IDA:UniProtKB
Q96BS2	TESC	Calcineurin B homologous protein 3	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q96BS2	TESC	Calcineurin B homologous protein 3	GO:0051604; P:protein maturation; IDA:UniProtKB
Q96BS2	TESC	Calcineurin B homologous protein 3	GO:0050821; P:protein stabilization; IDA:UniProtKB
Q96BS2	TESC	Calcineurin B homologous protein 3	GO:0072661; P:protein targeting to plasma membrane; IDA:UniProtKB
Q96BS2	TESC	Calcineurin B homologous protein 3	GO:0033628; P:regulation of cell adhesion mediated by integrin; IMP:UniProtKB
Q9P2E5	CHPF2	Chondroitin sulfate glucuronyltransferase	GO:0050510; F:N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; IEA:UniProtKB-EC
Q9P2E5	CHPF2	Chondroitin sulfate glucuronyltransferase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9P2E5	CHPF2	Chondroitin sulfate glucuronyltransferase	GO:0030206; P:chondroitin sulfate biosynthetic process; TAS:Reactome
Q9P2E5	CHPF2	Chondroitin sulfate glucuronyltransferase	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q9P2E5	CHPF2	Chondroitin sulfate glucuronyltransferase	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9P2E5	CHPF2	Chondroitin sulfate glucuronyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8WUD6	CHPT1	Cholinephosphotransferase 1	GO:0019992; F:diacylglycerol binding; NAS:UniProtKB
Q8WUD6	CHPT1	Cholinephosphotransferase 1	GO:0004142; F:diacylglycerol cholinephosphotransferase activity; IDA:UniProtKB
Q8WUD6	CHPT1	Cholinephosphotransferase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8WUD6	CHPT1	Cholinephosphotransferase 1	GO:0006657; P:CDP-choline pathway; NAS:UniProtKB
Q8WUD6	CHPT1	Cholinephosphotransferase 1	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q8WUD6	CHPT1	Cholinephosphotransferase 1	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q8WUD6	CHPT1	Cholinephosphotransferase 1	GO:0006656; P:phosphatidylcholine biosynthetic process; IDA:UniProtKB
Q8WUD6	CHPT1	Cholinephosphotransferase 1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q8WUD6	CHPT1	Cholinephosphotransferase 1	GO:0006663; P:platelet activating factor biosynthetic process; IDA:UniProtKB
Q8WUD6	CHPT1	Cholinephosphotransferase 1	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
Q8WUD6	CHPT1	Cholinephosphotransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NRG0	CHRAC1	Chromatin accessibility complex protein 1	GO:0003677; F:DNA binding; NAS:UniProtKB
Q9NRG0	CHRAC1	Chromatin accessibility complex protein 1	GO:0003887; F:DNA-directed DNA polymerase activity; NAS:UniProtKB
Q9NRG0	CHRAC1	Chromatin accessibility complex protein 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9NRG0	CHRAC1	Chromatin accessibility complex protein 1	GO:0006338; P:chromatin remodeling; NAS:UniProtKB
Q9NRG0	CHRAC1	Chromatin accessibility complex protein 1	GO:0006261; P:DNA-dependent DNA replication; NAS:GOC
Q9UHD1	CHORDC1	Cysteine and histidine-rich domain-containing protein 1	GO:0051879; F:Hsp90 protein binding; IPI:UniProtKB
Q9UHD1	CHORDC1	Cysteine and histidine-rich domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UHD1	CHORDC1	Cysteine and histidine-rich domain-containing protein 1	GO:0008270; F:zinc ion binding; IEA:Ensembl
Q9UHD1	CHORDC1	Cysteine and histidine-rich domain-containing protein 1	GO:0061077; P:chaperone-mediated protein folding; ISS:UniProtKB
Q9UHD1	CHORDC1	Cysteine and histidine-rich domain-containing protein 1	GO:2000299; P:negative regulation of Rho-dependent protein serine/threonine kinase activity; IEA:Ensembl
Q9UHD1	CHORDC1	Cysteine and histidine-rich domain-containing protein 1	GO:1900034; P:regulation of cellular response to heat; ISS:UniProtKB
Q9UHD1	CHORDC1	Cysteine and histidine-rich domain-containing protein 1	GO:0010824; P:regulation of centrosome duplication; IEA:Ensembl
Q9UHD1	CHORDC1	Cysteine and histidine-rich domain-containing protein 1	GO:0006950; P:response to stress; IEA:UniProtKB-KW
Q9H2X0	CHRD	Chordin	GO:0019955; F:cytokine binding; NAS:BHF-UCL
Q9H2X0	CHRD	Chordin	GO:0008201; F:heparin binding; IEA:Ensembl
Q9H2X0	CHRD	Chordin	GO:0005515; F:protein binding; IPI:IntAct
Q9H2X0	CHRD	Chordin	GO:0021919; P:BMP signaling pathway involved in spinal cord dorsal/ventral patterning; IMP:BHF-UCL
Q9H2X0	CHRD	Chordin	GO:0033504; P:floor plate development; TAS:BHF-UCL
Q9H2X0	CHRD	Chordin	GO:0030900; P:forebrain development; IEA:Ensembl
Q9H2X0	CHRD	Chordin	GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl
Q9H2X0	CHRD	Chordin	GO:0001707; P:mesoderm formation; IEA:Ensembl
Q9H2X0	CHRD	Chordin	GO:0030514; P:negative regulation of BMP signaling pathway; IMP:BHF-UCL
Q9H2X0	CHRD	Chordin	GO:0030336; P:negative regulation of cell migration; IDA:BHF-UCL
Q9H2X0	CHRD	Chordin	GO:0045668; P:negative regulation of osteoblast differentiation; IMP:BHF-UCL
Q9H2X0	CHRD	Chordin	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
Q9H2X0	CHRD	Chordin	GO:0045785; P:positive regulation of cell adhesion; IDA:BHF-UCL
Q9H2X0	CHRD	Chordin	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IMP:BHF-UCL
Q9H2X0	CHRD	Chordin	GO:0001501; P:skeletal system development; TAS:UniProtKB
Q9Y2V2	CARHSP1	Calcium-regulated heat stable protein 1	GO:0003677; F:DNA binding; IEA:InterPro
Q9Y2V2	CARHSP1	Calcium-regulated heat stable protein 1	GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB
Q9Y2V2	CARHSP1	Calcium-regulated heat stable protein 1	GO:0019902; F:phosphatase binding; NAS:UniProtKB
Q9Y2V2	CARHSP1	Calcium-regulated heat stable protein 1	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
Q9Y2V2	CARHSP1	Calcium-regulated heat stable protein 1	GO:0043488; P:regulation of mRNA stability; ISS:UniProtKB
Q9Y2V2	CARHSP1	Calcium-regulated heat stable protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q86X52	CHSY1	Chondroitin sulfate synthase 1	GO:0047238; F:glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; IDA:MGI
Q86X52	CHSY1	Chondroitin sulfate synthase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86X52	CHSY1	Chondroitin sulfate synthase 1	GO:0050510; F:N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; IEA:UniProtKB-EC
Q86X52	CHSY1	Chondroitin sulfate synthase 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q86X52	CHSY1	Chondroitin sulfate synthase 1	GO:0030206; P:chondroitin sulfate biosynthetic process; IDA:MGI
Q86X52	CHSY1	Chondroitin sulfate synthase 1	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q86X52	CHSY1	Chondroitin sulfate synthase 1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q86X52	CHSY1	Chondroitin sulfate synthase 1	GO:0030279; P:negative regulation of ossification; IMP:UniProtKB
Q86X52	CHSY1	Chondroitin sulfate synthase 1	GO:0031667; P:response to nutrient levels; IEA:Ensembl
Q86X52	CHSY1	Chondroitin sulfate synthase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8IZ52	CHPF	Chondroitin sulfate synthase 2	GO:0047238; F:glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; IEA:UniProtKB-EC
Q8IZ52	CHPF	Chondroitin sulfate synthase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IZ52	CHPF	Chondroitin sulfate synthase 2	GO:0050510; F:N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; IEA:UniProtKB-EC
Q8IZ52	CHPF	Chondroitin sulfate synthase 2	GO:0005515; F:protein binding; IPI:IntAct
Q8IZ52	CHPF	Chondroitin sulfate synthase 2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q8IZ52	CHPF	Chondroitin sulfate synthase 2	GO:0030206; P:chondroitin sulfate biosynthetic process; TAS:Reactome
Q8IZ52	CHPF	Chondroitin sulfate synthase 2	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q8IZ52	CHPF	Chondroitin sulfate synthase 2	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q8IZ52	CHPF	Chondroitin sulfate synthase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q70JA7	CHSY3	Chondroitin sulfate synthase 3	GO:0047238; F:glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; IEA:UniProtKB-EC
Q70JA7	CHSY3	Chondroitin sulfate synthase 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q70JA7	CHSY3	Chondroitin sulfate synthase 3	GO:0050510; F:N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; IEA:UniProtKB-EC
Q70JA7	CHSY3	Chondroitin sulfate synthase 3	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q70JA7	CHSY3	Chondroitin sulfate synthase 3	GO:0030206; P:chondroitin sulfate biosynthetic process; TAS:Reactome
Q70JA7	CHSY3	Chondroitin sulfate synthase 3	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q70JA7	CHSY3	Chondroitin sulfate synthase 3	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q70JA7	CHSY3	Chondroitin sulfate synthase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43916	CHST1	Carbohydrate sulfotransferase 1	GO:0045130; F:keratan sulfotransferase activity; IDA:UniProtKB
O43916	CHST1	Carbohydrate sulfotransferase 1	GO:0008146; F:sulfotransferase activity; IDA:UniProtKB
O43916	CHST1	Carbohydrate sulfotransferase 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O43916	CHST1	Carbohydrate sulfotransferase 1	GO:0006012; P:galactose metabolic process; IDA:UniProtKB
O43916	CHST1	Carbohydrate sulfotransferase 1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O43916	CHST1	Carbohydrate sulfotransferase 1	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
O43916	CHST1	Carbohydrate sulfotransferase 1	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
O43916	CHST1	Carbohydrate sulfotransferase 1	GO:0042339; P:keratan sulfate metabolic process; IDA:UniProtKB
O43916	CHST1	Carbohydrate sulfotransferase 1	GO:0005976; P:polysaccharide metabolic process; TAS:ProtInc
O43916	CHST1	Carbohydrate sulfotransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43916	CHST1	Carbohydrate sulfotransferase 1	GO:0006790; P:sulfur compound metabolic process; IDA:UniProtKB
Q9Y4C5	CHST2	Carbohydrate sulfotransferase 2	GO:0001517; F:N-acetylglucosamine 6-O-sulfotransferase activity; IDA:UniProtKB
Q9Y4C5	CHST2	Carbohydrate sulfotransferase 2	GO:0008146; F:sulfotransferase activity; TAS:ProtInc
Q9Y4C5	CHST2	Carbohydrate sulfotransferase 2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9Y4C5	CHST2	Carbohydrate sulfotransferase 2	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9Y4C5	CHST2	Carbohydrate sulfotransferase 2	GO:0006954; P:inflammatory response; TAS:ProtInc
Q9Y4C5	CHST2	Carbohydrate sulfotransferase 2	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
Q9Y4C5	CHST2	Carbohydrate sulfotransferase 2	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
Q9Y4C5	CHST2	Carbohydrate sulfotransferase 2	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q9Y4C5	CHST2	Carbohydrate sulfotransferase 2	GO:0006044; P:N-acetylglucosamine metabolic process; IDA:UniProtKB
Q9Y4C5	CHST2	Carbohydrate sulfotransferase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y4C5	CHST2	Carbohydrate sulfotransferase 2	GO:0006790; P:sulfur compound metabolic process; IDA:UniProtKB
Q7LGC8	CHST3	Carbohydrate sulfotransferase 3	GO:0008459; F:chondroitin 6-sulfotransferase activity; IDA:UniProtKB
Q7LGC8	CHST3	Carbohydrate sulfotransferase 3	GO:0050698; F:proteoglycan sulfotransferase activity; IEA:Ensembl
Q7LGC8	CHST3	Carbohydrate sulfotransferase 3	GO:0008146; F:sulfotransferase activity; TAS:ProtInc
Q7LGC8	CHST3	Carbohydrate sulfotransferase 3	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q7LGC8	CHST3	Carbohydrate sulfotransferase 3	GO:0030206; P:chondroitin sulfate biosynthetic process; IDA:UniProtKB
Q7LGC8	CHST3	Carbohydrate sulfotransferase 3	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q7LGC8	CHST3	Carbohydrate sulfotransferase 3	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q7LGC8	CHST3	Carbohydrate sulfotransferase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q7LGC8	CHST3	Carbohydrate sulfotransferase 3	GO:0006790; P:sulfur compound metabolic process; IDA:UniProtKB
Q7LGC8	CHST3	Carbohydrate sulfotransferase 3	GO:0043029; P:T cell homeostasis; IEA:Ensembl
Q8NCG5	CHST4	Carbohydrate sulfotransferase 4	GO:0001517; F:N-acetylglucosamine 6-O-sulfotransferase activity; IDA:UniProtKB
Q8NCG5	CHST4	Carbohydrate sulfotransferase 4	GO:0008146; F:sulfotransferase activity; TAS:ProtInc
Q8NCG5	CHST4	Carbohydrate sulfotransferase 4	GO:0005975; P:carbohydrate metabolic process; IEA:UniProtKB-KW
Q8NCG5	CHST4	Carbohydrate sulfotransferase 4	GO:0007155; P:cell adhesion; TAS:ProtInc
Q8NCG5	CHST4	Carbohydrate sulfotransferase 4	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q8NCG5	CHST4	Carbohydrate sulfotransferase 4	GO:0006928; P:cellular component movement; TAS:ProtInc
Q8NCG5	CHST4	Carbohydrate sulfotransferase 4	GO:0006955; P:immune response; TAS:ProtInc
Q8NCG5	CHST4	Carbohydrate sulfotransferase 4	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q8NCG5	CHST4	Carbohydrate sulfotransferase 4	GO:0050901; P:leukocyte tethering or rolling; IEA:Ensembl
Q8NCG5	CHST4	Carbohydrate sulfotransferase 4	GO:0006044; P:N-acetylglucosamine metabolic process; IDA:UniProtKB
Q8NCG5	CHST4	Carbohydrate sulfotransferase 4	GO:0006477; P:protein sulfation; TAS:ProtInc
Q8NCG5	CHST4	Carbohydrate sulfotransferase 4	GO:0006790; P:sulfur compound metabolic process; IDA:UniProtKB
Q9GZS9	CHST5	Carbohydrate sulfotransferase 5	GO:0001517; F:N-acetylglucosamine 6-O-sulfotransferase activity; IDA:UniProtKB
Q9GZS9	CHST5	Carbohydrate sulfotransferase 5	GO:0008146; F:sulfotransferase activity; TAS:ProtInc
Q9GZS9	CHST5	Carbohydrate sulfotransferase 5	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9GZS9	CHST5	Carbohydrate sulfotransferase 5	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9GZS9	CHST5	Carbohydrate sulfotransferase 5	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
Q9GZS9	CHST5	Carbohydrate sulfotransferase 5	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
Q9GZS9	CHST5	Carbohydrate sulfotransferase 5	GO:0006044; P:N-acetylglucosamine metabolic process; IDA:UniProtKB
Q9GZS9	CHST5	Carbohydrate sulfotransferase 5	GO:0006477; P:protein sulfation; TAS:ProtInc
Q9GZS9	CHST5	Carbohydrate sulfotransferase 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9GZS9	CHST5	Carbohydrate sulfotransferase 5	GO:0006790; P:sulfur compound metabolic process; IDA:UniProtKB
Q9GZX3	CHST6	Carbohydrate sulfotransferase 6	GO:0001517; F:N-acetylglucosamine 6-O-sulfotransferase activity; IDA:UniProtKB
Q9GZX3	CHST6	Carbohydrate sulfotransferase 6	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9GZX3	CHST6	Carbohydrate sulfotransferase 6	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9GZX3	CHST6	Carbohydrate sulfotransferase 6	GO:0018146; P:keratan sulfate biosynthetic process; IDA:UniProtKB
Q9GZX3	CHST6	Carbohydrate sulfotransferase 6	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
Q9GZX3	CHST6	Carbohydrate sulfotransferase 6	GO:0006044; P:N-acetylglucosamine metabolic process; IDA:UniProtKB
Q9GZX3	CHST6	Carbohydrate sulfotransferase 6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9GZX3	CHST6	Carbohydrate sulfotransferase 6	GO:0006790; P:sulfur compound metabolic process; IDA:UniProtKB
Q9NS84	CHST7	Carbohydrate sulfotransferase 7	GO:0008459; F:chondroitin 6-sulfotransferase activity; IDA:UniProtKB
Q9NS84	CHST7	Carbohydrate sulfotransferase 7	GO:0001517; F:N-acetylglucosamine 6-O-sulfotransferase activity; IDA:UniProtKB
Q9NS84	CHST7	Carbohydrate sulfotransferase 7	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9NS84	CHST7	Carbohydrate sulfotransferase 7	GO:0030206; P:chondroitin sulfate biosynthetic process; IDA:UniProtKB
Q9NS84	CHST7	Carbohydrate sulfotransferase 7	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q9NS84	CHST7	Carbohydrate sulfotransferase 7	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9NS84	CHST7	Carbohydrate sulfotransferase 7	GO:0006044; P:N-acetylglucosamine metabolic process; IDA:UniProtKB
Q9NS84	CHST7	Carbohydrate sulfotransferase 7	GO:0005976; P:polysaccharide metabolic process; TAS:UniProtKB
Q9NS84	CHST7	Carbohydrate sulfotransferase 7	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NS84	CHST7	Carbohydrate sulfotransferase 7	GO:0006790; P:sulfur compound metabolic process; IDA:UniProtKB
Q9H2A9	CHST8	Carbohydrate sulfotransferase 8	GO:0001537; F:N-acetylgalactosamine 4-O-sulfotransferase activity; IDA:UniProtKB
Q9H2A9	CHST8	Carbohydrate sulfotransferase 8	GO:0016051; P:carbohydrate biosynthetic process; IEA:InterPro
Q9H2A9	CHST8	Carbohydrate sulfotransferase 8	GO:0007417; P:central nervous system development; NAS:UniProtKB
Q9H2A9	CHST8	Carbohydrate sulfotransferase 8	GO:0042446; P:hormone biosynthetic process; IEP:UniProtKB
Q9H2A9	CHST8	Carbohydrate sulfotransferase 8	GO:0030166; P:proteoglycan biosynthetic process; IDA:UniProtKB
Q9H2A9	CHST8	Carbohydrate sulfotransferase 8	GO:0006790; P:sulfur compound metabolic process; IDA:UniProtKB
Q7L1S5	CHST9	Carbohydrate sulfotransferase 9	GO:0001537; F:N-acetylgalactosamine 4-O-sulfotransferase activity; IDA:UniProtKB
Q7L1S5	CHST9	Carbohydrate sulfotransferase 9	GO:0016051; P:carbohydrate biosynthetic process; IEA:InterPro
Q7L1S5	CHST9	Carbohydrate sulfotransferase 9	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q7L1S5	CHST9	Carbohydrate sulfotransferase 9	GO:0030206; P:chondroitin sulfate biosynthetic process; TAS:Reactome
Q7L1S5	CHST9	Carbohydrate sulfotransferase 9	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q7L1S5	CHST9	Carbohydrate sulfotransferase 9	GO:0030203; P:glycosaminoglycan metabolic process; NAS:UniProtKB
Q7L1S5	CHST9	Carbohydrate sulfotransferase 9	GO:0042446; P:hormone biosynthetic process; ISS:UniProtKB
Q7L1S5	CHST9	Carbohydrate sulfotransferase 9	GO:0030166; P:proteoglycan biosynthetic process; ISS:UniProtKB
Q7L1S5	CHST9	Carbohydrate sulfotransferase 9	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q7L1S5	CHST9	Carbohydrate sulfotransferase 9	GO:0006790; P:sulfur compound metabolic process; IDA:UniProtKB
O43529	CHST10	Carbohydrate sulfotransferase 10	GO:0016232; F:HNK-1 sulfotransferase activity; IEA:Ensembl
O43529	CHST10	Carbohydrate sulfotransferase 10	GO:0008146; F:sulfotransferase activity; TAS:ProtInc
O43529	CHST10	Carbohydrate sulfotransferase 10	GO:0016051; P:carbohydrate biosynthetic process; IEA:InterPro
O43529	CHST10	Carbohydrate sulfotransferase 10	GO:0007155; P:cell adhesion; TAS:ProtInc
O43529	CHST10	Carbohydrate sulfotransferase 10	GO:0007612; P:learning; IEA:Ensembl
O43529	CHST10	Carbohydrate sulfotransferase 10	GO:0007616; P:long-term memory; IEA:Ensembl
Q9NRB3	CHST12	Carbohydrate sulfotransferase 12	GO:0050656; F:3'-phosphoadenosine 5'-phosphosulfate binding; NAS:UniProtKB
Q9NRB3	CHST12	Carbohydrate sulfotransferase 12	GO:0047756; F:chondroitin 4-sulfotransferase activity; IDA:UniProtKB
Q9NRB3	CHST12	Carbohydrate sulfotransferase 12	GO:0016051; P:carbohydrate biosynthetic process; IEA:InterPro
Q9NRB3	CHST12	Carbohydrate sulfotransferase 12	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9NRB3	CHST12	Carbohydrate sulfotransferase 12	GO:0030206; P:chondroitin sulfate biosynthetic process; IDA:UniProtKB
Q9NRB3	CHST12	Carbohydrate sulfotransferase 12	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q9NRB3	CHST12	Carbohydrate sulfotransferase 12	GO:0030208; P:dermatan sulfate biosynthetic process; IDA:UniProtKB
Q9NRB3	CHST12	Carbohydrate sulfotransferase 12	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9NRB3	CHST12	Carbohydrate sulfotransferase 12	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NPF2	CHST11	Carbohydrate sulfotransferase 11	GO:0047756; F:chondroitin 4-sulfotransferase activity; IDA:UniProtKB
Q9NPF2	CHST11	Carbohydrate sulfotransferase 11	GO:0001537; F:N-acetylgalactosamine 4-O-sulfotransferase activity; IDA:UniProtKB
Q9NPF2	CHST11	Carbohydrate sulfotransferase 11	GO:0050659; F:N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity; IEA:Ensembl
Q9NPF2	CHST11	Carbohydrate sulfotransferase 11	GO:0016051; P:carbohydrate biosynthetic process; IEA:InterPro
Q9NPF2	CHST11	Carbohydrate sulfotransferase 11	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9NPF2	CHST11	Carbohydrate sulfotransferase 11	GO:0002063; P:chondrocyte development; IEA:Ensembl
Q9NPF2	CHST11	Carbohydrate sulfotransferase 11	GO:0030206; P:chondroitin sulfate biosynthetic process; IDA:UniProtKB
Q9NPF2	CHST11	Carbohydrate sulfotransferase 11	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q9NPF2	CHST11	Carbohydrate sulfotransferase 11	GO:0048589; P:developmental growth; IEA:Ensembl
Q9NPF2	CHST11	Carbohydrate sulfotransferase 11	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
Q9NPF2	CHST11	Carbohydrate sulfotransferase 11	GO:0048703; P:embryonic viscerocranium morphogenesis; IEA:Ensembl
Q9NPF2	CHST11	Carbohydrate sulfotransferase 11	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9NPF2	CHST11	Carbohydrate sulfotransferase 11	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q9NPF2	CHST11	Carbohydrate sulfotransferase 11	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl
Q9NPF2	CHST11	Carbohydrate sulfotransferase 11	GO:0033037; P:polysaccharide localization; IEA:Ensembl
Q9NPF2	CHST11	Carbohydrate sulfotransferase 11	GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl
Q9NPF2	CHST11	Carbohydrate sulfotransferase 11	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q9NPF2	CHST11	Carbohydrate sulfotransferase 11	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q9NPF2	CHST11	Carbohydrate sulfotransferase 11	GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl
Q9NPF2	CHST11	Carbohydrate sulfotransferase 11	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8NET6	CHST13	Carbohydrate sulfotransferase 13	GO:0047756; F:chondroitin 4-sulfotransferase activity; IDA:UniProtKB
Q8NET6	CHST13	Carbohydrate sulfotransferase 13	GO:0001537; F:N-acetylgalactosamine 4-O-sulfotransferase activity; IDA:UniProtKB
Q8NET6	CHST13	Carbohydrate sulfotransferase 13	GO:0016051; P:carbohydrate biosynthetic process; IEA:InterPro
Q8NET6	CHST13	Carbohydrate sulfotransferase 13	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q8NET6	CHST13	Carbohydrate sulfotransferase 13	GO:0030206; P:chondroitin sulfate biosynthetic process; IDA:UniProtKB
Q8NET6	CHST13	Carbohydrate sulfotransferase 13	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q8NET6	CHST13	Carbohydrate sulfotransferase 13	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q8NET6	CHST13	Carbohydrate sulfotransferase 13	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8NCH0	CHST14	Carbohydrate sulfotransferase 14	GO:0001537; F:N-acetylgalactosamine 4-O-sulfotransferase activity; IDA:UniProtKB
Q8NCH0	CHST14	Carbohydrate sulfotransferase 14	GO:0042301; F:phosphate ion binding; NAS:UniProtKB
Q8NCH0	CHST14	Carbohydrate sulfotransferase 14	GO:0016051; P:carbohydrate biosynthetic process; IEA:InterPro
Q8NCH0	CHST14	Carbohydrate sulfotransferase 14	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q8NCH0	CHST14	Carbohydrate sulfotransferase 14	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q8NCH0	CHST14	Carbohydrate sulfotransferase 14	GO:0030208; P:dermatan sulfate biosynthetic process; TAS:Reactome
Q8NCH0	CHST14	Carbohydrate sulfotransferase 14	GO:0050655; P:dermatan sulfate proteoglycan metabolic process; IDA:UniProtKB
Q8NCH0	CHST14	Carbohydrate sulfotransferase 14	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q8NCH0	CHST14	Carbohydrate sulfotransferase 14	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q7LFX5	CHST15	Carbohydrate sulfotransferase 15	GO:0050656; F:3'-phosphoadenosine 5'-phosphosulfate binding; IDA:UniProtKB
Q7LFX5	CHST15	Carbohydrate sulfotransferase 15	GO:0050659; F:N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity; IDA:UniProtKB
Q7LFX5	CHST15	Carbohydrate sulfotransferase 15	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q7LFX5	CHST15	Carbohydrate sulfotransferase 15	GO:0030206; P:chondroitin sulfate biosynthetic process; TAS:Reactome
Q7LFX5	CHST15	Carbohydrate sulfotransferase 15	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q7LFX5	CHST15	Carbohydrate sulfotransferase 15	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q7LFX5	CHST15	Carbohydrate sulfotransferase 15	GO:0019319; P:hexose biosynthetic process; IDA:UniProtKB
Q7LFX5	CHST15	Carbohydrate sulfotransferase 15	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y3Y2	CHTOP	Chromatin target of PRMT1 protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y3Y2	CHTOP	Chromatin target of PRMT1 protein	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3Y2	CHTOP	Chromatin target of PRMT1 protein	GO:0006406; P:mRNA export from nucleus; IDA:UniProtKB
Q9Y3Y2	CHTOP	Chromatin target of PRMT1 protein	GO:0032781; P:positive regulation of ATPase activity; IDA:UniProtKB
Q9Y3Y2	CHTOP	Chromatin target of PRMT1 protein	GO:0051096; P:positive regulation of helicase activity; IDA:UniProtKB
Q9Y3Y2	CHTOP	Chromatin target of PRMT1 protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y3Y2	CHTOP	Chromatin target of PRMT1 protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WUH1	CHURC1	Protein Churchill	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WUH1	CHURC1	Protein Churchill	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8WUH1	CHURC1	Protein Churchill	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:InterPro
Q8WUH1	CHURC1	Protein Churchill	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
H0YL14	C9orf69	Protein C9orf69	GO:0005525; F:GTP binding; IEA:InterPro
H0YL14	C9orf69	Protein C9orf69	GO:0005515; F:protein binding; IPI:UniProtKB
H0YL14	C9orf69	Protein C9orf69	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
H0YL14	C9orf69	Protein C9orf69	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
H0YL14	C9orf69	Protein C9orf69	GO:0048524; P:positive regulation of viral process; IDA:UniProtKB
H0YL14	C9orf69	Protein C9orf69	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q96LT7	C9orf72	Protein C9orf72	GO:0005515; F:protein binding; IPI:UniProtKB
Q96LT7	C9orf72	Protein C9orf72	GO:0017137; F:Rab GTPase binding; IDA:UniProtKB
Q96LT7	C9orf72	Protein C9orf72	GO:0006914; P:autophagy; IMP:UniProtKB
Q96LT7	C9orf72	Protein C9orf72	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q96LT7	C9orf72	Protein C9orf72	GO:0006897; P:endocytosis; IMP:UniProtKB
Q5T280	C9orf114	Uncharacterized protein C9orf114	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y375	NDUFAF1	Complex I intermediate-associated protein 30, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y375	NDUFAF1	Complex I intermediate-associated protein 30, mitochondrial	GO:0051082; F:unfolded protein binding; NAS:UniProtKB
Q9Y375	NDUFAF1	Complex I intermediate-associated protein 30, mitochondrial	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
Q9Y375	NDUFAF1	Complex I intermediate-associated protein 30, mitochondrial	GO:0006461; P:protein complex assembly; NAS:UniProtKB
O76071	CIAO1	Probable cytosolic iron-sulfur protein assembly protein CIAO1	GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW
O76071	CIAO1	Probable cytosolic iron-sulfur protein assembly protein CIAO1	GO:0016226; P:iron-sulfur cluster assembly; IGI:UniProtKB
O76071	CIAO1	Probable cytosolic iron-sulfur protein assembly protein CIAO1	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
O76071	CIAO1	Probable cytosolic iron-sulfur protein assembly protein CIAO1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O76071	CIAO1	Probable cytosolic iron-sulfur protein assembly protein CIAO1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8N365	CIART	Circadian-associated transcriptional repressor	GO:0001046; F:core promoter sequence-specific DNA binding; IDA:UniProtKB
Q8N365	CIART	Circadian-associated transcriptional repressor	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N365	CIART	Circadian-associated transcriptional repressor	GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB
Q8N365	CIART	Circadian-associated transcriptional repressor	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q8N365	CIART	Circadian-associated transcriptional repressor	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96Q77	CIB3	Calcium and integrin-binding family member 3	GO:0005509; F:calcium ion binding; IEA:InterPro
A0PJX0	CIB4	Calcium and integrin-binding family member 4	GO:0005509; F:calcium ion binding; IEA:InterPro
O75838	CIB2	Calcium and integrin-binding family member 2	GO:0005509; F:calcium ion binding; IEA:InterPro
O75838	CIB2	Calcium and integrin-binding family member 2	GO:0005515; F:protein binding; IPI:UniProtKB
O75838	CIB2	Calcium and integrin-binding family member 2	GO:0055074; P:calcium ion homeostasis; ISS:UniProtKB
O75838	CIB2	Calcium and integrin-binding family member 2	GO:0045494; P:photoreceptor cell maintenance; ISS:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0005509; F:calcium ion binding; IMP:HGNC
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0043495; F:protein anchor; IGI:BHF-UCL
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0017016; F:Ras GTPase binding; IPI:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0006915; P:apoptotic process; IMP:HGNC
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0007155; P:cell adhesion; TAS:ProtInc
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0006974; P:cellular response to DNA damage stimulus; IDA:HGNC
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0071363; P:cellular response to growth factor stimulus; ISS:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:1990090; P:cellular response to nerve growth factor stimulus; IDA:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0071356; P:cellular response to tumor necrosis factor; IMP:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0031122; P:cytoplasmic microtubule organization; IMP:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0006302; P:double-strand break repair; TAS:ProtInc
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0007113; P:endomitotic cell cycle; IDA:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0097191; P:extrinsic apoptotic signaling pathway; TAS:BHF-UCL
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0045653; P:negative regulation of megakaryocyte differentiation; ISS:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0007026; P:negative regulation of microtubule depolymerization; IDA:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0010977; P:negative regulation of neuron projection development; IDA:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0051898; P:negative regulation of protein kinase B signaling; ISS:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0001933; P:negative regulation of protein phosphorylation; ISS:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0030220; P:platelet formation; ISS:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0070886; P:positive regulation of calcineurin-NFAT signaling cascade; IDA:BHF-UCL
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0033630; P:positive regulation of cell adhesion mediated by integrin; IDA:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0030307; P:positive regulation of cell growth; ISS:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; ISS:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0001954; P:positive regulation of cell-matrix adhesion; ISS:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; IGI:BHF-UCL
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:1901313; P:positive regulation of gene expression involved in extracellular matrix organization; ISS:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:2000256; P:positive regulation of male germ cell proliferation; ISS:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0048554; P:positive regulation of metalloenzyme activity; ISS:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0071902; P:positive regulation of protein serine/threonine kinase activity; ISS:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0090314; P:positive regulation of protein targeting to membrane; IMP:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IDA:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0051302; P:regulation of cell division; IMP:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0042127; P:regulation of cell proliferation; IMP:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0002931; P:response to ischemia; ISS:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0007286; P:spermatid development; ISS:UniProtKB
Q99828	CIB1	Calcium and integrin-binding protein 1	GO:0038163; P:thrombopoietin-mediated signaling pathway; ISS:UniProtKB
Q96RK0	CIC	Protein capicua homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96RK0	CIC	Protein capicua homolog	GO:0005515; F:protein binding; IPI:IntAct
Q96RK0	CIC	Protein capicua homolog	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96RK0	CIC	Protein capicua homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60543	CIDEA	Cell death activator CIDE-A	GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
O60543	CIDEA	Cell death activator CIDE-A	GO:0006309; P:apoptotic DNA fragmentation; IEA:Ensembl
O60543	CIDEA	Cell death activator CIDE-A	GO:0008219; P:cell death; ISS:BHF-UCL
O60543	CIDEA	Cell death activator CIDE-A	GO:0006629; P:lipid metabolic process; ISS:BHF-UCL
O60543	CIDEA	Cell death activator CIDE-A	GO:0019915; P:lipid storage; ISS:BHF-UCL
O60543	CIDEA	Cell death activator CIDE-A	GO:0050710; P:negative regulation of cytokine secretion; IMP:BHF-UCL
O60543	CIDEA	Cell death activator CIDE-A	GO:1900118; P:negative regulation of execution phase of apoptosis; ISS:BHF-UCL
O60543	CIDEA	Cell death activator CIDE-A	GO:0050995; P:negative regulation of lipid catabolic process; IMP:BHF-UCL
O60543	CIDEA	Cell death activator CIDE-A	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; ISS:BHF-UCL
O60543	CIDEA	Cell death activator CIDE-A	GO:0032720; P:negative regulation of tumor necrosis factor production; IMP:BHF-UCL
O60543	CIDEA	Cell death activator CIDE-A	GO:0010890; P:positive regulation of sequestering of triglyceride; ISS:BHF-UCL
O60543	CIDEA	Cell death activator CIDE-A	GO:1902510; P:regulation of apoptotic DNA fragmentation; ISS:BHF-UCL
O60543	CIDEA	Cell death activator CIDE-A	GO:0042981; P:regulation of apoptotic process; IBA:RefGenome
O60543	CIDEA	Cell death activator CIDE-A	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O60543	CIDEA	Cell death activator CIDE-A	GO:0035634; P:response to stilbenoid; IEA:Ensembl
O60543	CIDEA	Cell death activator CIDE-A	GO:0001659; P:temperature homeostasis; ISS:BHF-UCL
O60543	CIDEA	Cell death activator CIDE-A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UHD4	CIDEB	Cell death activator CIDE-B	GO:0042802; F:identical protein binding; IPI:IntAct
Q9UHD4	CIDEB	Cell death activator CIDE-B	GO:0005515; F:protein binding; IPI:IntAct
Q9UHD4	CIDEB	Cell death activator CIDE-B	GO:0006915; P:apoptotic process; IDA:MGI
Q9UHD4	CIDEB	Cell death activator CIDE-B	GO:0097194; P:execution phase of apoptosis; ISS:BHF-UCL
Q9UHD4	CIDEB	Cell death activator CIDE-B	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; TAS:ProtInc
Q9UHD4	CIDEB	Cell death activator CIDE-B	GO:0042981; P:regulation of apoptotic process; IBA:RefGenome
Q96AQ7	CIDEC	Cell death activator CIDE-3	GO:0006915; P:apoptotic process; IDA:MGI
Q96AQ7	CIDEC	Cell death activator CIDE-3	GO:0097194; P:execution phase of apoptosis; IDA:UniProtKB
Q96AQ7	CIDEC	Cell death activator CIDE-3	GO:0034389; P:lipid particle organization; IMP:UniProtKB
Q96AQ7	CIDEC	Cell death activator CIDE-3	GO:0042981; P:regulation of apoptotic process; IBA:RefGenome
Q96AQ7	CIDEC	Cell death activator CIDE-3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96AQ7	CIDEC	Cell death activator CIDE-3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43734	TRAF3IP2	Adapter protein CIKS	GO:0005515; F:protein binding; IPI:UniProtKB
O43734	TRAF3IP2	Adapter protein CIKS	GO:0001783; P:B cell apoptotic process; IEA:Ensembl
O43734	TRAF3IP2	Adapter protein CIKS	GO:0006959; P:humoral immune response; IEA:Ensembl
O43734	TRAF3IP2	Adapter protein CIKS	GO:0048305; P:immunoglobulin secretion; IEA:Ensembl
O43734	TRAF3IP2	Adapter protein CIKS	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
O43734	TRAF3IP2	Adapter protein CIKS	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
O75339	CILP	Cartilage intermediate layer protein 1	GO:0043569; P:negative regulation of insulin-like growth factor receptor signaling pathway; IDA:BHF-UCL
Q9P2M7	CGN	Cingulin	GO:0003779; F:actin binding; ISS:UniProtKB
Q9P2M7	CGN	Cingulin	GO:0003774; F:motor activity; IEA:InterPro
Q9P2M7	CGN	Cingulin	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P2M7	CGN	Cingulin	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q9BW66	CINP	Cyclin-dependent kinase 2-interacting protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BW66	CINP	Cyclin-dependent kinase 2-interacting protein	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9BW66	CINP	Cyclin-dependent kinase 2-interacting protein	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q9BW66	CINP	Cyclin-dependent kinase 2-interacting protein	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q9BW66	CINP	Cyclin-dependent kinase 2-interacting protein	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q9NPC3	CCNB1IP1	E3 ubiquitin-protein ligase CCNB1IP1	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9NPC3	CCNB1IP1	E3 ubiquitin-protein ligase CCNB1IP1	GO:0005515; F:protein binding; IPI:IntAct
Q9NPC3	CCNB1IP1	E3 ubiquitin-protein ligase CCNB1IP1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NPC3	CCNB1IP1	E3 ubiquitin-protein ligase CCNB1IP1	GO:0001825; P:blastocyst formation; IEA:Ensembl
Q9NPC3	CCNB1IP1	E3 ubiquitin-protein ligase CCNB1IP1	GO:0051026; P:chiasma assembly; ISS:UniProtKB
Q9NPC3	CCNB1IP1	E3 ubiquitin-protein ligase CCNB1IP1	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9NPC3	CCNB1IP1	E3 ubiquitin-protein ligase CCNB1IP1	GO:0007131; P:reciprocal meiotic recombination; ISS:UniProtKB
Q9NPC3	CCNB1IP1	E3 ubiquitin-protein ligase CCNB1IP1	GO:0007286; P:spermatid development; IEA:Ensembl
Q8TCG1	KIAA1524	Protein CIP2A	GO:0005515; F:protein binding; IPI:IntAct
Q15642	TRIP10	Cdc42-interacting protein 4	GO:0042802; F:identical protein binding; IPI:IntAct
Q15642	TRIP10	Cdc42-interacting protein 4	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q15642	TRIP10	Cdc42-interacting protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q15642	TRIP10	Cdc42-interacting protein 4	GO:0030036; P:actin cytoskeleton organization; NAS:UniProtKB
Q15642	TRIP10	Cdc42-interacting protein 4	GO:0007154; P:cell communication; NAS:UniProtKB
Q15642	TRIP10	Cdc42-interacting protein 4	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q15642	TRIP10	Cdc42-interacting protein 4	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q15642	TRIP10	Cdc42-interacting protein 4	GO:0007165; P:signal transduction; TAS:ProtInc
Q15642	TRIP10	Cdc42-interacting protein 4	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9C0C6	CIPC	CLOCK-interacting pacemaker	GO:0042754; P:negative regulation of circadian rhythm; ISS:UniProtKB
Q9C0C6	CIPC	CLOCK-interacting pacemaker	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q9C0C6	CIPC	CLOCK-interacting pacemaker	GO:0048511; P:rhythmic process; IEA:UniProtKB-KW
Q9C0C6	CIPC	CLOCK-interacting pacemaker	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q969X6	CIRH1A	Cirhin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q969X6	CIRH1A	Cirhin	GO:0005515; F:protein binding; IPI:UniProtKB
Q969X6	CIRH1A	Cirhin	GO:0030490; P:maturation of SSU-rRNA; IMP:UniProtKB
Q969X6	CIRH1A	Cirhin	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q969X6	CIRH1A	Cirhin	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86X95	CIR1	Corepressor interacting with RBPJ 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q86X95	CIR1	Corepressor interacting with RBPJ 1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; TAS:BHF-UCL
Q86X95	CIR1	Corepressor interacting with RBPJ 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q86X95	CIR1	Corepressor interacting with RBPJ 1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q86X95	CIR1	Corepressor interacting with RBPJ 1	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q86X95	CIR1	Corepressor interacting with RBPJ 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q86X95	CIR1	Corepressor interacting with RBPJ 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:GOC
Q86X95	CIR1	Corepressor interacting with RBPJ 1	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q86X95	CIR1	Corepressor interacting with RBPJ 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:GOC
Q14011	CIRBP	Cold-inducible RNA-binding protein	GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB
Q14011	CIRBP	Cold-inducible RNA-binding protein	GO:0000166; F:nucleotide binding; IEA:InterPro
Q14011	CIRBP	Cold-inducible RNA-binding protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14011	CIRBP	Cold-inducible RNA-binding protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q14011	CIRBP	Cold-inducible RNA-binding protein	GO:0070181; F:SSU rRNA binding; IDA:UniProtKB
Q14011	CIRBP	Cold-inducible RNA-binding protein	GO:0030371; F:translation repressor activity; ISS:UniProtKB
Q14011	CIRBP	Cold-inducible RNA-binding protein	GO:0048255; P:mRNA stabilization; IDA:UniProtKB
Q14011	CIRBP	Cold-inducible RNA-binding protein	GO:0045727; P:positive regulation of translation; IDA:UniProtKB
Q14011	CIRBP	Cold-inducible RNA-binding protein	GO:0009409; P:response to cold; TAS:ProtInc
Q14011	CIRBP	Cold-inducible RNA-binding protein	GO:0009411; P:response to UV; IDA:UniProtKB
Q14011	CIRBP	Cold-inducible RNA-binding protein	GO:0034063; P:stress granule assembly; ISS:UniProtKB
Q9NZ45	CISD1	CDGSH iron-sulfur domain-containing protein 1	GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:UniProtKB-KW
Q9NZ45	CISD1	CDGSH iron-sulfur domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NZ45	CISD1	CDGSH iron-sulfur domain-containing protein 1	GO:0043457; P:regulation of cellular respiration; IEA:Ensembl
Q8N5K1	CISD2	CDGSH iron-sulfur domain-containing protein 2	GO:0051537; F:2 iron, 2 sulfur cluster binding; IDA:UniProtKB
Q8N5K1	CISD2	CDGSH iron-sulfur domain-containing protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N5K1	CISD2	CDGSH iron-sulfur domain-containing protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8N5K1	CISD2	CDGSH iron-sulfur domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N5K1	CISD2	CDGSH iron-sulfur domain-containing protein 2	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q8N5K1	CISD2	CDGSH iron-sulfur domain-containing protein 2	GO:0000422; P:mitochondrion degradation; IEA:Ensembl
Q8N5K1	CISD2	CDGSH iron-sulfur domain-containing protein 2	GO:0010259; P:multicellular organismal aging; ISS:UniProtKB
Q8N5K1	CISD2	CDGSH iron-sulfur domain-containing protein 2	GO:0010506; P:regulation of autophagy; IMP:UniProtKB
P0C7P0	CISD3	CDGSH iron-sulfur domain-containing protein 3, mitochondrial	GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:UniProtKB-KW
P0C7P0	CISD3	CDGSH iron-sulfur domain-containing protein 3, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NSE2	CISH	Cytokine-inducible SH2-containing protein	GO:0005515; F:protein binding; IPI:IntAct
Q9NSE2	CISH	Cytokine-inducible SH2-containing protein	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
Q9NSE2	CISH	Cytokine-inducible SH2-containing protein	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome
Q9NSE2	CISH	Cytokine-inducible SH2-containing protein	GO:0009968; P:negative regulation of signal transduction; IEA:UniProtKB-KW
Q9NSE2	CISH	Cytokine-inducible SH2-containing protein	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
Q9NSE2	CISH	Cytokine-inducible SH2-containing protein	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9NSE2	CISH	Cytokine-inducible SH2-containing protein	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
O75390	CS	Citrate synthase, mitochondrial	GO:0004108; F:citrate (Si)-synthase activity; IDA:UniProtKB
O75390	CS	Citrate synthase, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75390	CS	Citrate synthase, mitochondrial	GO:0005975; P:carbohydrate metabolic process; IDA:UniProtKB
O75390	CS	Citrate synthase, mitochondrial	GO:0044262; P:cellular carbohydrate metabolic process; IEA:InterPro
O75390	CS	Citrate synthase, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
O75390	CS	Citrate synthase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75390	CS	Citrate synthase, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; TAS:Reactome
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0003682; F:chromatin binding; ISS:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0070410; F:co-SMAD binding; IPI:BHF-UCL
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0050693; F:LBD domain binding; IDA:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0007420; P:brain development; IEA:Ensembl
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0001658; P:branching involved in ureteric bud morphogenesis; ISS:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0008283; P:cell proliferation; TAS:BHF-UCL
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0000578; P:embryonic axis specification; IEA:Ensembl
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0060711; P:labyrinthine layer development; IEA:Ensembl
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0042438; P:melanin biosynthetic process; ISS:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0030318; P:melanocyte differentiation; IMP:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0060231; P:mesenchymal to epithelial transition; TAS:BHF-UCL
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0001656; P:metanephros development; TAS:BHF-UCL
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0003340; P:negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; IEA:Ensembl
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0043524; P:negative regulation of neuron apoptotic process; IDA:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0045668; P:negative regulation of osteoblast differentiation; ISS:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0030178; P:negative regulation of Wnt signaling pathway; TAS:BHF-UCL
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0006913; P:nucleocytoplasmic transport; IDA:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0043473; P:pigmentation; IMP:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0001890; P:placenta development; ISS:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; TAS:BHF-UCL
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0051591; P:response to cAMP; ISS:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0034097; P:response to cytokine; ISS:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0043627; P:response to estrogen; IDA:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0032868; P:response to insulin; ISS:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0034341; P:response to interferon-gamma; ISS:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0070555; P:response to interleukin-1; ISS:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0071105; P:response to interleukin-11; ISS:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0070669; P:response to interleukin-2; ISS:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0070670; P:response to interleukin-4; ISS:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0070741; P:response to interleukin-6; ISS:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0071104; P:response to interleukin-9; ISS:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0032496; P:response to lipopolysaccharide; ISS:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0071107; P:response to parathyroid hormone; ISS:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0071559; P:response to transforming growth factor beta; IDA:UniProtKB
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0060395; P:SMAD protein signal transduction; IDA:BHF-UCL
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0060712; P:spongiotrophoblast layer development; IEA:Ensembl
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
Q99966	CITED1	Cbp/p300-interacting transactivator 1	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q96RK1	CITED4	Cbp/p300-interacting transactivator 4	GO:0003713; F:transcription coactivator activity; ISS:UniProtKB
Q96RK1	CITED4	Cbp/p300-interacting transactivator 4	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q96RK1	CITED4	Cbp/p300-interacting transactivator 4	GO:0043627; P:response to estrogen; ISS:UniProtKB
Q96RK1	CITED4	Cbp/p300-interacting transactivator 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0003682; F:chromatin binding; ISS:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0035035; F:histone acetyltransferase binding; IDA:BHF-UCL
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0050693; F:LBD domain binding; IPI:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0001105; F:RNA polymerase II transcription coactivator activity; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0001106; F:RNA polymerase II transcription corepressor activity; IDA:BHF-UCL
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0035802; P:adrenal cortex formation; ISS:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0060349; P:bone morphogenesis; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0061308; P:cardiac neural crest cell development involved in heart development; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0007569; P:cell aging; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0008283; P:cell proliferation; IDA:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0007417; P:central nervous system development; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0021602; P:cranial nerve morphogenesis; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0046697; P:decidualization; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0007368; P:determination of left/right symmetry; ISS:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0048596; P:embryonic camera-type eye morphogenesis; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0060971; P:embryonic heart tube left/right pattern formation; ISS:BHF-UCL
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0001892; P:embryonic placenta development; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0060136; P:embryonic process involved in female pregnancy; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0003197; P:endocardial cushion development; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0048821; P:erythrocyte development; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0030851; P:granulocyte differentiation; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0007507; P:heart development; IMP:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0001947; P:heart looping; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0002244; P:hematopoietic progenitor cell differentiation; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0070986; P:left/right axis specification; ISS:BHF-UCL
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0002089; P:lens morphogenesis in camera-type eye; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0001889; P:liver development; ISS:BHF-UCL
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0008584; P:male gonad development; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0043066; P:negative regulation of apoptotic process; ISS:BHF-UCL
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0030336; P:negative regulation of cell migration; IMP:BHF-UCL
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0061428; P:negative regulation of transcription from RNA polymerase II promoter in response to hypoxia; IDA:BHF-UCL
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0001843; P:neural tube closure; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:1900164; P:nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry; ISS:BHF-UCL
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0003151; P:outflow tract morphogenesis; ISS:BHF-UCL
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0007422; P:peripheral nervous system development; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0045787; P:positive regulation of cell cycle; ISS:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0022409; P:positive regulation of cell-cell adhesion; ISS:BHF-UCL
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:2000020; P:positive regulation of male gonad development; ISS:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0035360; P:positive regulation of peroxisome proliferator activated receptor signaling pathway; IDA:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; ISS:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0061156; P:pulmonary artery morphogenesis; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0003156; P:regulation of organ formation; ISS:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:2001141; P:regulation of RNA biosynthetic process; IDA:GOC
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0043627; P:response to estrogen; IDA:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0034405; P:response to fluid shear stress; IMP:BHF-UCL
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0001666; P:response to hypoxia; IDA:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0007530; P:sex determination; ISS:UniProtKB
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0048536; P:spleen development; ISS:BHF-UCL
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0048538; P:thymus development; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0001829; P:trophectodermal cell differentiation; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q99967	CITED2	Cbp/p300-interacting transactivator 2	GO:0060412; P:ventricular septum morphogenesis; ISS:BHF-UCL
Q9ULV3	CIZ1	Cip1-interacting zinc finger protein	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9ULV3	CIZ1	Cip1-interacting zinc finger protein	GO:0005515; F:protein binding; IPI:IntAct
Q9ULV3	CIZ1	Cip1-interacting zinc finger protein	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q9ULV3	CIZ1	Cip1-interacting zinc finger protein	GO:0051457; P:maintenance of protein location in nucleus; IEA:Ensembl
Q9ULV3	CIZ1	Cip1-interacting zinc finger protein	GO:0032298; P:positive regulation of DNA-dependent DNA replication initiation; IEA:Ensembl
Q9H2I8	C10orf11	Leucine-rich repeat-containing protein C10orf11	GO:0030318; P:melanocyte differentiation; IMP:UniProtKB
P0C842	LINC00614	Putative uncharacterized protein encoded by LINC00614	GO:0003824; F:catalytic activity; IEA:InterPro
Q5T681	C10orf62	Uncharacterized protein C10orf62	GO:0005515; F:protein binding; IPI:IntAct
Q96M02	C10orf90	Centrosomal protein C10orf90	GO:0007095; P:mitotic G2 DNA damage checkpoint; IEA:Ensembl
Q96M02	C10orf90	Centrosomal protein C10orf90	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
Q96M02	C10orf90	Centrosomal protein C10orf90	GO:0050821; P:protein stabilization; IEA:Ensembl
Q96M02	C10orf90	Centrosomal protein C10orf90	GO:0010212; P:response to ionizing radiation; IEA:Ensembl
Q96M02	C10orf90	Centrosomal protein C10orf90	GO:0009411; P:response to UV; IEA:Ensembl
Q9H7T3	C10orf95	Uncharacterized protein C10orf95	GO:0005515; F:protein binding; IPI:IntAct
Q9H0W9	C11orf54	Ester hydrolase C11orf54	GO:0016788; F:hydrolase activity, acting on ester bonds; IDA:FlyBase
Q9H0W9	C11orf54	Ester hydrolase C11orf54	GO:0005515; F:protein binding; IPI:IntAct
Q9H0W9	C11orf54	Ester hydrolase C11orf54	GO:0008270; F:zinc ion binding; IDA:FlyBase
Q9H0W9	C11orf54	Ester hydrolase C11orf54	GO:0008152; P:metabolic process; IDA:GOC
Q9H3H3	C11orf68	UPF0696 protein C11orf68	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7Z7J9	CAMK2N1	Calcium/calmodulin-dependent protein kinase II inhibitor 1	GO:0008427; F:calcium-dependent protein kinase inhibitor activity; IEA:Ensembl
Q96S95	CAMK2N2	Calcium/calmodulin-dependent protein kinase II inhibitor 2	GO:0008427; F:calcium-dependent protein kinase inhibitor activity; IEA:Ensembl
Q96SZ6	CDK5RAP1	CDK5 regulatory subunit-associated protein 1	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
Q96SZ6	CDK5RAP1	CDK5 regulatory subunit-associated protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96SZ6	CDK5RAP1	CDK5 regulatory subunit-associated protein 1	GO:0019901; F:protein kinase binding; NAS:UniProtKB
Q96SZ6	CDK5RAP1	CDK5 regulatory subunit-associated protein 1	GO:0016740; F:transferase activity; IEA:InterPro
Q96SZ6	CDK5RAP1	CDK5 regulatory subunit-associated protein 1	GO:0007420; P:brain development; NAS:UniProtKB
Q96SZ6	CDK5RAP1	CDK5 regulatory subunit-associated protein 1	GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:UniProtKB
Q96SZ6	CDK5RAP1	CDK5 regulatory subunit-associated protein 1	GO:0045664; P:regulation of neuron differentiation; NAS:UniProtKB
Q96SZ6	CDK5RAP1	CDK5 regulatory subunit-associated protein 1	GO:0006400; P:tRNA modification; IEA:InterPro
Q96SN8	CDK5RAP2	CDK5 regulatory subunit-associated protein 2	GO:0005516; F:calmodulin binding; IPI:UniProtKB
Q96SN8	CDK5RAP2	CDK5 regulatory subunit-associated protein 2	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q96SN8	CDK5RAP2	CDK5 regulatory subunit-associated protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q96SN8	CDK5RAP2	CDK5 regulatory subunit-associated protein 2	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q96SN8	CDK5RAP2	CDK5 regulatory subunit-associated protein 2	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q96SN8	CDK5RAP2	CDK5 regulatory subunit-associated protein 2	GO:0015631; F:tubulin binding; IPI:UniProtKB
Q96SN8	CDK5RAP2	CDK5 regulatory subunit-associated protein 2	GO:0007420; P:brain development; ISS:UniProtKB
Q96SN8	CDK5RAP2	CDK5 regulatory subunit-associated protein 2	GO:0051297; P:centrosome organization; IMP:UniProtKB
Q96SN8	CDK5RAP2	CDK5 regulatory subunit-associated protein 2	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q96SN8	CDK5RAP2	CDK5 regulatory subunit-associated protein 2	GO:0000132; P:establishment of mitotic spindle orientation; ISS:UniProtKB
Q96SN8	CDK5RAP2	CDK5 regulatory subunit-associated protein 2	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q96SN8	CDK5RAP2	CDK5 regulatory subunit-associated protein 2	GO:0001578; P:microtubule bundle formation; IDA:UniProtKB
Q96SN8	CDK5RAP2	CDK5 regulatory subunit-associated protein 2	GO:0000226; P:microtubule cytoskeleton organization; IDA:UniProtKB
Q96SN8	CDK5RAP2	CDK5 regulatory subunit-associated protein 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q96SN8	CDK5RAP2	CDK5 regulatory subunit-associated protein 2	GO:0046600; P:negative regulation of centriole replication; ISS:UniProtKB
Q96SN8	CDK5RAP2	CDK5 regulatory subunit-associated protein 2	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
Q96SN8	CDK5RAP2	CDK5 regulatory subunit-associated protein 2	GO:0022008; P:neurogenesis; ISS:UniProtKB
Q96SN8	CDK5RAP2	CDK5 regulatory subunit-associated protein 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q96SN8	CDK5RAP2	CDK5 regulatory subunit-associated protein 2	GO:0045664; P:regulation of neuron differentiation; NAS:UniProtKB
Q96SN8	CDK5RAP2	CDK5 regulatory subunit-associated protein 2	GO:0090231; P:regulation of spindle checkpoint; IDA:UniProtKB
Q96JB5	CDK5RAP3	CDK5 regulatory subunit-associated protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q96JB5	CDK5RAP3	CDK5 regulatory subunit-associated protein 3	GO:0019901; F:protein kinase binding; NAS:UniProtKB
Q96JB5	CDK5RAP3	CDK5 regulatory subunit-associated protein 3	GO:0007420; P:brain development; NAS:UniProtKB
Q96JB5	CDK5RAP3	CDK5 regulatory subunit-associated protein 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q96JB5	CDK5RAP3	CDK5 regulatory subunit-associated protein 3	GO:0071569; P:protein ufmylation; IDA:MGI
Q96JB5	CDK5RAP3	CDK5 regulatory subunit-associated protein 3	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; ISS:UniProtKB
Q96JB5	CDK5RAP3	CDK5 regulatory subunit-associated protein 3	GO:0045664; P:regulation of neuron differentiation; NAS:UniProtKB
Q8WWK9	CKAP2	Cytoskeleton-associated protein 2	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8WWK9	CKAP2	Cytoskeleton-associated protein 2	GO:0000281; P:mitotic cytokinesis; IGI:MGI
Q8WWK9	CKAP2	Cytoskeleton-associated protein 2	GO:0007026; P:negative regulation of microtubule depolymerization; IEA:Ensembl
Q8WWK9	CKAP2	Cytoskeleton-associated protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IGI:MGI
Q07065	CKAP4	Cytoskeleton-associated protein 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14008	CKAP5	Cytoskeleton-associated protein 5	GO:0005515; F:protein binding; IPI:HGNC
Q14008	CKAP5	Cytoskeleton-associated protein 5	GO:0051297; P:centrosome organization; IMP:HGNC
Q14008	CKAP5	Cytoskeleton-associated protein 5	GO:0030951; P:establishment or maintenance of microtubule cytoskeleton polarity; IMP:HGNC
Q14008	CKAP5	Cytoskeleton-associated protein 5	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q14008	CKAP5	Cytoskeleton-associated protein 5	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q14008	CKAP5	Cytoskeleton-associated protein 5	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q14008	CKAP5	Cytoskeleton-associated protein 5	GO:0050658; P:RNA transport; ISS:HGNC
Q14008	CKAP5	Cytoskeleton-associated protein 5	GO:0007051; P:spindle organization; IMP:UniProtKB
Q8TAZ6	CMTM2	CKLF-like MARVEL transmembrane domain-containing protein 2	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
Q8IZ96	CMTM1	CKLF-like MARVEL transmembrane domain-containing protein 1	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
Q96MX0	CMTM3	CKLF-like MARVEL transmembrane domain-containing protein 3	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
Q8IZR5	CMTM4	CKLF-like MARVEL transmembrane domain-containing protein 4	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
Q96DZ9	CMTM5	CKLF-like MARVEL transmembrane domain-containing protein 5	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
Q9NX76	CMTM6	CKLF-like MARVEL transmembrane domain-containing protein 6	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
Q96FZ5	CMTM7	CKLF-like MARVEL transmembrane domain-containing protein 7	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
Q8IZV2	CMTM8	CKLF-like MARVEL transmembrane domain-containing protein 8	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
Q9UBR5	CKLF	Chemokine-like factor	GO:0008009; F:chemokine activity; IDA:UniProtKB
Q9UBR5	CKLF	Chemokine-like factor	GO:0008283; P:cell proliferation; IDA:UniProtKB
Q9UBR5	CKLF	Chemokine-like factor	GO:0048247; P:lymphocyte chemotaxis; IDA:UniProtKB
Q9UBR5	CKLF	Chemokine-like factor	GO:0048246; P:macrophage chemotaxis; IDA:UniProtKB
Q9UBR5	CKLF	Chemokine-like factor	GO:0030593; P:neutrophil chemotaxis; IDA:UniProtKB
Q9UBR5	CKLF	Chemokine-like factor	GO:0032940; P:secretion by cell; IDA:UniProtKB
P61024	CKS1B	Cyclin-dependent kinases regulatory subunit 1	GO:0016538; F:cyclin-dependent protein serine/threonine kinase regulator activity; IEA:InterPro
P61024	CKS1B	Cyclin-dependent kinases regulatory subunit 1	GO:0005515; F:protein binding; IPI:IntAct
P61024	CKS1B	Cyclin-dependent kinases regulatory subunit 1	GO:0051301; P:cell division; IEA:UniProtKB-KW
P61024	CKS1B	Cyclin-dependent kinases regulatory subunit 1	GO:0008283; P:cell proliferation; TAS:ProtInc
P61024	CKS1B	Cyclin-dependent kinases regulatory subunit 1	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P61024	CKS1B	Cyclin-dependent kinases regulatory subunit 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P61024	CKS1B	Cyclin-dependent kinases regulatory subunit 1	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
P33552	CKS2	Cyclin-dependent kinases regulatory subunit 2	GO:0016538; F:cyclin-dependent protein serine/threonine kinase regulator activity; IEA:InterPro
P33552	CKS2	Cyclin-dependent kinases regulatory subunit 2	GO:0007049; P:cell cycle; NAS:UniProtKB
P33552	CKS2	Cyclin-dependent kinases regulatory subunit 2	GO:0008283; P:cell proliferation; TAS:ProtInc
P33552	CKS2	Cyclin-dependent kinases regulatory subunit 2	GO:0007127; P:meiosis I; IEA:Ensembl
P33552	CKS2	Cyclin-dependent kinases regulatory subunit 2	GO:0048015; P:phosphatidylinositol-mediated signaling; NAS:UniProtKB
P33552	CKS2	Cyclin-dependent kinases regulatory subunit 2	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
P33552	CKS2	Cyclin-dependent kinases regulatory subunit 2	GO:0007051; P:spindle organization; NAS:UniProtKB
Q9H3J6	C12orf65	Probable peptide chain release factor C12orf65, mitochondrial	GO:0003747; F:translation release factor activity; IEA:InterPro
Q9H3J6	C12orf65	Probable peptide chain release factor C12orf65, mitochondrial	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q5QGZ9	CLEC12A	C-type lectin domain family 12 member A	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q2HXU8	CLEC12B	C-type lectin domain family 12 member B	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q6ZS10	CLEC17A	C-type lectin domain family 17, member A	GO:0042806; F:fucose binding; IDA:UniProtKB
Q6ZS10	CLEC17A	C-type lectin domain family 17, member A	GO:0005537; F:mannose binding; IDA:UniProtKB
Q6ZS10	CLEC17A	C-type lectin domain family 17, member A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A5D8T8	CLEC18A	C-type lectin domain family 18 member A	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q6UXF7	CLEC18B	C-type lectin domain family 18 member B	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q8NCF0	CLEC18C	C-type lectin domain family 18 member C	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q6UXS0	CLEC19A	C-type lectin domain family 19 member A	GO:0030246; F:carbohydrate binding; IEA:InterPro
P16619	CCL3L1	C-C motif chemokine 3-like 1	GO:0060326; P:cell chemotaxis; IEA:GOC
P16619	CCL3L1	C-C motif chemokine 3-like 1	GO:0006955; P:immune response; IEA:InterPro
P16619	CCL3L1	C-C motif chemokine 3-like 1	GO:0006954; P:inflammatory response; TAS:UniProtKB
P16619	CCL3L1	C-C motif chemokine 3-like 1	GO:0008285; P:negative regulation of cell proliferation; TAS:UniProtKB
Q7Z460	CLASP1	CLIP-associating protein 1	GO:0043515; F:kinetochore binding; IMP:UniProtKB
Q7Z460	CLASP1	CLIP-associating protein 1	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q7Z460	CLASP1	CLIP-associating protein 1	GO:0051010; F:microtubule plus-end binding; IDA:UniProtKB
Q7Z460	CLASP1	CLIP-associating protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z460	CLASP1	CLIP-associating protein 1	GO:0007411; P:axon guidance; TAS:Reactome
Q7Z460	CLASP1	CLIP-associating protein 1	GO:0051301; P:cell division; IDA:MGI
Q7Z460	CLASP1	CLIP-associating protein 1	GO:0051294; P:establishment of spindle orientation; IDA:MGI
Q7Z460	CLASP1	CLIP-associating protein 1	GO:0007163; P:establishment or maintenance of cell polarity; NAS:UniProtKB
Q7Z460	CLASP1	CLIP-associating protein 1	GO:0010458; P:exit from mitosis; IMP:UniProtKB
Q7Z460	CLASP1	CLIP-associating protein 1	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q7Z460	CLASP1	CLIP-associating protein 1	GO:0034453; P:microtubule anchoring; IMP:UniProtKB
Q7Z460	CLASP1	CLIP-associating protein 1	GO:0001578; P:microtubule bundle formation; IMP:UniProtKB
Q7Z460	CLASP1	CLIP-associating protein 1	GO:0000226; P:microtubule cytoskeleton organization; IGI:UniProtKB
Q7Z460	CLASP1	CLIP-associating protein 1	GO:0007020; P:microtubule nucleation; IMP:UniProtKB
Q7Z460	CLASP1	CLIP-associating protein 1	GO:0031023; P:microtubule organizing center organization; IMP:UniProtKB
Q7Z460	CLASP1	CLIP-associating protein 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q7Z460	CLASP1	CLIP-associating protein 1	GO:0007026; P:negative regulation of microtubule depolymerization; IMP:UniProtKB
Q7Z460	CLASP1	CLIP-associating protein 1	GO:0031111; P:negative regulation of microtubule polymerization or depolymerization; IMP:UniProtKB
O75122	CLASP2	CLIP-associating protein 2	GO:0008107; F:galactoside 2-alpha-L-fucosyltransferase activity; NAS:UniProtKB
O75122	CLASP2	CLIP-associating protein 2	GO:0051010; F:microtubule plus-end binding; IDA:UniProtKB
O75122	CLASP2	CLIP-associating protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
O75122	CLASP2	CLIP-associating protein 2	GO:0007411; P:axon guidance; TAS:Reactome
O75122	CLASP2	CLIP-associating protein 2	GO:0007163; P:establishment or maintenance of cell polarity; TAS:UniProtKB
O75122	CLASP2	CLIP-associating protein 2	GO:0036065; P:fucosylation; NAS:GOC
O75122	CLASP2	CLIP-associating protein 2	GO:0034453; P:microtubule anchoring; IMP:UniProtKB
O75122	CLASP2	CLIP-associating protein 2	GO:0007020; P:microtubule nucleation; IMP:UniProtKB
O75122	CLASP2	CLIP-associating protein 2	GO:0031023; P:microtubule organizing center organization; IMP:UniProtKB
O75122	CLASP2	CLIP-associating protein 2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
O75122	CLASP2	CLIP-associating protein 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O75122	CLASP2	CLIP-associating protein 2	GO:0007026; P:negative regulation of microtubule depolymerization; NAS:UniProtKB
O75122	CLASP2	CLIP-associating protein 2	GO:0031110; P:regulation of microtubule polymerization or depolymerization; IMP:UniProtKB
O75122	CLASP2	CLIP-associating protein 2	GO:0032886; P:regulation of microtubule-based process; IMP:UniProtKB
Q8N2M8	CLASRP	CLK4-associating serine/arginine rich protein	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q8N2M8	CLASRP	CLK4-associating serine/arginine rich protein	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
P28329	CHAT	Choline O-acetyltransferase	GO:0004102; F:choline O-acetyltransferase activity; IEA:UniProtKB-EC
P28329	CHAT	Choline O-acetyltransferase	GO:0007628; P:adult walking behavior; IEA:Ensembl
P28329	CHAT	Choline O-acetyltransferase	GO:0016358; P:dendrite development; IEA:Ensembl
P28329	CHAT	Choline O-acetyltransferase	GO:0007529; P:establishment of synaptic specificity at neuromuscular junction; IEA:Ensembl
P28329	CHAT	Choline O-acetyltransferase	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
P28329	CHAT	Choline O-acetyltransferase	GO:0007517; P:muscle organ development; IEA:Ensembl
P28329	CHAT	Choline O-acetyltransferase	GO:0007274; P:neuromuscular synaptic transmission; IEA:Ensembl
P28329	CHAT	Choline O-acetyltransferase	GO:0042136; P:neurotransmitter biosynthetic process; IEA:UniProtKB-KW
P28329	CHAT	Choline O-acetyltransferase	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
P28329	CHAT	Choline O-acetyltransferase	GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome
P28329	CHAT	Choline O-acetyltransferase	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P28329	CHAT	Choline O-acetyltransferase	GO:0007622; P:rhythmic behavior; IEA:Ensembl
P28329	CHAT	Choline O-acetyltransferase	GO:0043179; P:rhythmic excitation; IEA:Ensembl
P28329	CHAT	Choline O-acetyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P28329	CHAT	Choline O-acetyltransferase	GO:0007268; P:synaptic transmission; TAS:Reactome
Q8IUN9	CLEC10A	C-type lectin domain family 10 member A	GO:0030246; F:carbohydrate binding; TAS:ProtInc
Q8IUN9	CLEC10A	C-type lectin domain family 10 member A	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q8IUN9	CLEC10A	C-type lectin domain family 10 member A	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q9Y240	CLEC11A	C-type lectin domain family 11 member A	GO:0030246; F:carbohydrate binding; NAS:UniProtKB
Q9Y240	CLEC11A	C-type lectin domain family 11 member A	GO:0008083; F:growth factor activity; IDA:UniProtKB
Q9Y240	CLEC11A	C-type lectin domain family 11 member A	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q86T13	CLEC14A	C-type lectin domain family 14 member A	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q8NC01	CLEC1A	C-type lectin domain family 1 member A	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q8NC01	CLEC1A	C-type lectin domain family 1 member A	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q8NC01	CLEC1A	C-type lectin domain family 1 member A	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q8NC01	CLEC1A	C-type lectin domain family 1 member A	GO:0006952; P:defense response; TAS:ProtInc
Q9P126	CLEC1B	C-type lectin domain family 1 member B	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q9P126	CLEC1B	C-type lectin domain family 1 member B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P126	CLEC1B	C-type lectin domain family 1 member B	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q9P126	CLEC1B	C-type lectin domain family 1 member B	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q9P126	CLEC1B	C-type lectin domain family 1 member B	GO:0006952; P:defense response; TAS:ProtInc
Q92478	CLEC2B	C-type lectin domain family 2 member B	GO:0030246; F:carbohydrate binding; TAS:ProtInc
Q6UVW9	CLEC2A	C-type lectin domain family 2 member A	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q6UVW9	CLEC2A	C-type lectin domain family 2 member A	GO:0005515; F:protein binding; IPI:UniProtKB
Q6UVW9	CLEC2A	C-type lectin domain family 2 member A	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q6UVW9	CLEC2A	C-type lectin domain family 2 member A	GO:0042267; P:natural killer cell mediated cytotoxicity; TAS:UniProtKB
Q9UHP7	CLEC2D	C-type lectin domain family 2 member D	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q9UHP7	CLEC2D	C-type lectin domain family 2 member D	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q9UHP7	CLEC2D	C-type lectin domain family 2 member D	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P0C7M8	CLEC2L	C-type lectin domain family 2 member L	GO:0030246; F:carbohydrate binding; IEA:InterPro
O75596	CLEC3A	C-type lectin domain family 3 member A	GO:0030246; F:carbohydrate binding; TAS:ProtInc
O75596	CLEC3A	C-type lectin domain family 3 member A	GO:0001501; P:skeletal system development; TAS:ProtInc
Q9UMR7	CLEC4A	C-type lectin domain family 4 member A	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q9UMR7	CLEC4A	C-type lectin domain family 4 member A	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q9UMR7	CLEC4A	C-type lectin domain family 4 member A	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9UMR7	CLEC4A	C-type lectin domain family 4 member A	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q9UMR7	CLEC4A	C-type lectin domain family 4 member A	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q8WTT0	CLEC4C	C-type lectin domain family 4 member C	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q8WTT0	CLEC4C	C-type lectin domain family 4 member C	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q9ULY5	CLEC4E	C-type lectin domain family 4 member E	GO:0030246; F:carbohydrate binding; TAS:ProtInc
Q9ULY5	CLEC4E	C-type lectin domain family 4 member E	GO:0004872; F:receptor activity; IEA:Ensembl
Q9ULY5	CLEC4E	C-type lectin domain family 4 member E	GO:0006955; P:immune response; IEA:Ensembl
Q9ULY5	CLEC4E	C-type lectin domain family 4 member E	GO:0050715; P:positive regulation of cytokine secretion; IEA:Ensembl
Q8WXI8	CLEC4D	C-type lectin domain family 4 member D	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q8WXI8	CLEC4D	C-type lectin domain family 4 member D	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q8N1N0	CLEC4F	C-type lectin domain family 4 member F	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q8N1N0	CLEC4F	C-type lectin domain family 4 member F	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q6UXB4	CLEC4G	C-type lectin domain family 4 member G	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q6UXB4	CLEC4G	C-type lectin domain family 4 member G	GO:0005515; F:protein binding; IPI:IntAct
Q9UJ71	CD207	C-type lectin domain family 4 member K	GO:0030246; F:carbohydrate binding; IDA:UniProtKB
Q9UJ71	CD207	C-type lectin domain family 4 member K	GO:0005537; F:mannose binding; TAS:ProtInc
Q9UJ71	CD207	C-type lectin domain family 4 member K	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q9UJ71	CD207	C-type lectin domain family 4 member K	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q9UJ71	CD207	C-type lectin domain family 4 member K	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q9UJ71	CD207	C-type lectin domain family 4 member K	GO:0051607; P:defense response to virus; IDA:UniProtKB
Q9H2X3	CLEC4M	C-type lectin domain family 4 member M	GO:0030246; F:carbohydrate binding; NAS:UniProtKB
Q9H2X3	CLEC4M	C-type lectin domain family 4 member M	GO:0030369; F:ICAM-3 receptor activity; NAS:UniProtKB
Q9H2X3	CLEC4M	C-type lectin domain family 4 member M	GO:0005537; F:mannose binding; IEA:UniProtKB-KW
Q9H2X3	CLEC4M	C-type lectin domain family 4 member M	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H2X3	CLEC4M	C-type lectin domain family 4 member M	GO:0042605; F:peptide antigen binding; NAS:UniProtKB
Q9H2X3	CLEC4M	C-type lectin domain family 4 member M	GO:0004872; F:receptor activity; NAS:UniProtKB
Q9H2X3	CLEC4M	C-type lectin domain family 4 member M	GO:0046790; F:virion binding; TAS:UniProtKB
Q9H2X3	CLEC4M	C-type lectin domain family 4 member M	GO:0019882; P:antigen processing and presentation; NAS:UniProtKB
Q9H2X3	CLEC4M	C-type lectin domain family 4 member M	GO:0009988; P:cell-cell recognition; TAS:UniProtKB
Q9H2X3	CLEC4M	C-type lectin domain family 4 member M	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q9H2X3	CLEC4M	C-type lectin domain family 4 member M	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q9H2X3	CLEC4M	C-type lectin domain family 4 member M	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
Q9H2X3	CLEC4M	C-type lectin domain family 4 member M	GO:0075733; P:intracellular transport of virus; TAS:UniProtKB
Q9H2X3	CLEC4M	C-type lectin domain family 4 member M	GO:0007159; P:leukocyte cell-cell adhesion; NAS:UniProtKB
Q9H2X3	CLEC4M	C-type lectin domain family 4 member M	GO:0019048; P:modulation by virus of host morphology or physiology; TAS:UniProtKB
Q9H2X3	CLEC4M	C-type lectin domain family 4 member M	GO:0046968; P:peptide antigen transport; NAS:UniProtKB
Q9H2X3	CLEC4M	C-type lectin domain family 4 member M	GO:0019079; P:viral genome replication; NAS:UniProtKB
Q9H2X3	CLEC4M	C-type lectin domain family 4 member M	GO:0019062; P:virion attachment to host cell; TAS:UniProtKB
Q9NY25	CLEC5A	C-type lectin domain family 5 member A	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q9NY25	CLEC5A	C-type lectin domain family 5 member A	GO:0001618; F:virus receptor activity; IDA:UniProtKB
Q9NY25	CLEC5A	C-type lectin domain family 5 member A	GO:0006968; P:cellular defense response; TAS:ProtInc
Q9NY25	CLEC5A	C-type lectin domain family 5 member A	GO:0045087; P:innate immune response; IDA:UniProtKB
Q9NY25	CLEC5A	C-type lectin domain family 5 member A	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB
Q9NY25	CLEC5A	C-type lectin domain family 5 member A	GO:0033033; P:negative regulation of myeloid cell apoptotic process; IEA:Ensembl
Q9NY25	CLEC5A	C-type lectin domain family 5 member A	GO:0002076; P:osteoblast development; ISS:UniProtKB
Q9NY25	CLEC5A	C-type lectin domain family 5 member A	GO:0050715; P:positive regulation of cytokine secretion; IEA:Ensembl
Q9NY25	CLEC5A	C-type lectin domain family 5 member A	GO:0009615; P:response to virus; IDA:GOC
Q9NY25	CLEC5A	C-type lectin domain family 5 member A	GO:0007165; P:signal transduction; TAS:ProtInc
Q9NY25	CLEC5A	C-type lectin domain family 5 member A	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q6EIG7	CLEC6A	C-type lectin domain family 6 member A	GO:0030246; F:carbohydrate binding; ISS:UniProtKB
Q6EIG7	CLEC6A	C-type lectin domain family 6 member A	GO:0050832; P:defense response to fungus; ISS:UniProtKB
Q6EIG7	CLEC6A	C-type lectin domain family 6 member A	GO:0045087; P:innate immune response; ISS:UniProtKB
Q6EIG7	CLEC6A	C-type lectin domain family 6 member A	GO:0050715; P:positive regulation of cytokine secretion; ISS:UniProtKB
Q6EIG7	CLEC6A	C-type lectin domain family 6 member A	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; ISS:UniProtKB
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0001872; F:(1->3)-beta-D-glucan binding; IEA:Ensembl
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0001874; F:(1->3)-beta-D-glucan receptor activity; IEA:Ensembl
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0030246; F:carbohydrate binding; IDA:UniProtKB
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0042287; F:MHC protein binding; NAS:UniProtKB
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0008329; F:signaling pattern recognition receptor activity; IDA:UniProtKB
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0009756; P:carbohydrate mediated signaling; TAS:UniProtKB
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0008037; P:cell recognition; IDA:UniProtKB
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0002752; P:cell surface pattern recognition receptor signaling pathway; IEA:Ensembl
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0071226; P:cellular response to molecule of fungal origin; IEA:Ensembl
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0042832; P:defense response to protozoan; NAS:UniProtKB
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0001879; P:detection of yeast; IEA:Ensembl
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0002366; P:leukocyte activation involved in immune response; IEA:Ensembl
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0006911; P:phagocytosis, engulfment; IEA:Ensembl
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0006910; P:phagocytosis, recognition; IDA:UniProtKB
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0050766; P:positive regulation of phagocytosis; IEA:Ensembl
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0032760; P:positive regulation of tumor necrosis factor production; IEA:Ensembl
Q9BXN2	CLEC7A	C-type lectin domain family 7 member A	GO:0042110; P:T cell activation; TAS:UniProtKB
Q6UXN8	CLEC9A	C-type lectin domain family 9 member A	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q6UXN8	CLEC9A	C-type lectin domain family 9 member A	GO:0050715; P:positive regulation of cytokine secretion; IDA:UniProtKB
Q6UXN8	CLEC9A	C-type lectin domain family 9 member A	GO:0006898; P:receptor-mediated endocytosis; IDA:UniProtKB
A8K7I4	CLCA1	Calcium-activated chloride channel regulator 1	GO:0005254; F:chloride channel activity; TAS:ProtInc
A8K7I4	CLCA1	Calcium-activated chloride channel regulator 1	GO:0006816; P:calcium ion transport; IEA:UniProtKB-KW
A8K7I4	CLCA1	Calcium-activated chloride channel regulator 1	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
A8K7I4	CLCA1	Calcium-activated chloride channel regulator 1	GO:1902476; P:chloride transmembrane transport; TAS:GOC
A8K7I4	CLCA1	Calcium-activated chloride channel regulator 1	GO:0006821; P:chloride transport; TAS:GOC
A8K7I4	CLCA1	Calcium-activated chloride channel regulator 1	GO:0006810; P:transport; TAS:ProtInc
Q9UQC9	CLCA2	Calcium-activated chloride channel regulator 2	GO:0005254; F:chloride channel activity; TAS:ProtInc
Q9UQC9	CLCA2	Calcium-activated chloride channel regulator 2	GO:0015276; F:ligand-gated ion channel activity; IEA:Ensembl
Q9UQC9	CLCA2	Calcium-activated chloride channel regulator 2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9UQC9	CLCA2	Calcium-activated chloride channel regulator 2	GO:1902476; P:chloride transmembrane transport; TAS:GOC
Q9UQC9	CLCA2	Calcium-activated chloride channel regulator 2	GO:0006810; P:transport; TAS:ProtInc
Q9Y6N3	CLCA3P	Calcium-activated chloride channel regulator family member 3	GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW
Q9Y6N3	CLCA3P	Calcium-activated chloride channel regulator family member 3	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
Q9Y6N3	CLCA3P	Calcium-activated chloride channel regulator family member 3	GO:0005215; F:transporter activity; TAS:ProtInc
Q9Y6N3	CLCA3P	Calcium-activated chloride channel regulator family member 3	GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW
Q9Y6N3	CLCA3P	Calcium-activated chloride channel regulator family member 3	GO:0006810; P:transport; TAS:ProtInc
Q14CN2	CLCA4	Calcium-activated chloride channel regulator 4	GO:0005254; F:chloride channel activity; TAS:ProtInc
Q14CN2	CLCA4	Calcium-activated chloride channel regulator 4	GO:1902476; P:chloride transmembrane transport; TAS:GOC
Q14CN2	CLCA4	Calcium-activated chloride channel regulator 4	GO:0006821; P:chloride transport; TAS:GOC
Q14CN2	CLCA4	Calcium-activated chloride channel regulator 4	GO:0006810; P:transport; TAS:ProtInc
P09496	CLTA	Clathrin light chain A	GO:0032050; F:clathrin heavy chain binding; IPI:FlyBase
P09496	CLTA	Clathrin light chain A	GO:0042277; F:peptide binding; IEA:Ensembl
P09496	CLTA	Clathrin light chain A	GO:0005515; F:protein binding; IPI:IntAct
P09496	CLTA	Clathrin light chain A	GO:0005198; F:structural molecule activity; IEA:InterPro
P09496	CLTA	Clathrin light chain A	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P09496	CLTA	Clathrin light chain A	GO:0007411; P:axon guidance; TAS:Reactome
P09496	CLTA	Clathrin light chain A	GO:0006897; P:endocytosis; IEA:Ensembl
P09496	CLTA	Clathrin light chain A	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P09496	CLTA	Clathrin light chain A	GO:0006886; P:intracellular protein transport; IEA:InterPro
P09496	CLTA	Clathrin light chain A	GO:0061024; P:membrane organization; TAS:Reactome
P09496	CLTA	Clathrin light chain A	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
P09496	CLTA	Clathrin light chain A	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P09496	CLTA	Clathrin light chain A	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
P09497	CLTB	Clathrin light chain B	GO:0042277; F:peptide binding; IEA:Ensembl
P09497	CLTB	Clathrin light chain B	GO:0005515; F:protein binding; IPI:UniProtKB
P09497	CLTB	Clathrin light chain B	GO:0005198; F:structural molecule activity; IEA:InterPro
P09497	CLTB	Clathrin light chain B	GO:0006886; P:intracellular protein transport; IEA:InterPro
P09497	CLTB	Clathrin light chain B	GO:0016192; P:vesicle-mediated transport; IEA:InterPro
Q96S66	CLCC1	Chloride channel CLIC-like protein 1	GO:0005254; F:chloride channel activity; IEA:Ensembl
Q9UBD9	CLCF1	Cardiotrophin-like cytokine factor 1	GO:0005127; F:ciliary neurotrophic factor receptor binding; IDA:BHF-UCL
Q9UBD9	CLCF1	Cardiotrophin-like cytokine factor 1	GO:0005125; F:cytokine activity; NAS:UniProtKB
Q9UBD9	CLCF1	Cardiotrophin-like cytokine factor 1	GO:0008083; F:growth factor activity; TAS:HGNC
Q9UBD9	CLCF1	Cardiotrophin-like cytokine factor 1	GO:0005515; F:protein binding; IPI:BHF-UCL
Q9UBD9	CLCF1	Cardiotrophin-like cytokine factor 1	GO:0046982; F:protein heterodimerization activity; IDA:BHF-UCL
Q9UBD9	CLCF1	Cardiotrophin-like cytokine factor 1	GO:0005102; F:receptor binding; IPI:HGNC
Q9UBD9	CLCF1	Cardiotrophin-like cytokine factor 1	GO:0030183; P:B cell differentiation; ISS:BHF-UCL
Q9UBD9	CLCF1	Cardiotrophin-like cytokine factor 1	GO:0007166; P:cell surface receptor signaling pathway; ISS:BHF-UCL
Q9UBD9	CLCF1	Cardiotrophin-like cytokine factor 1	GO:0019221; P:cytokine-mediated signaling pathway; NAS:UniProtKB
Q9UBD9	CLCF1	Cardiotrophin-like cytokine factor 1	GO:0007259; P:JAK-STAT cascade; ISS:BHF-UCL
Q9UBD9	CLCF1	Cardiotrophin-like cytokine factor 1	GO:0043524; P:negative regulation of neuron apoptotic process; IDA:BHF-UCL
Q9UBD9	CLCF1	Cardiotrophin-like cytokine factor 1	GO:0048711; P:positive regulation of astrocyte differentiation; ISS:BHF-UCL
Q9UBD9	CLCF1	Cardiotrophin-like cytokine factor 1	GO:0030890; P:positive regulation of B cell proliferation; ISS:BHF-UCL
Q9UBD9	CLCF1	Cardiotrophin-like cytokine factor 1	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
Q9UBD9	CLCF1	Cardiotrophin-like cytokine factor 1	GO:0002639; P:positive regulation of immunoglobulin production; ISS:BHF-UCL
Q9UBD9	CLCF1	Cardiotrophin-like cytokine factor 1	GO:0048295; P:positive regulation of isotype switching to IgE isotypes; ISS:BHF-UCL
Q9UBD9	CLCF1	Cardiotrophin-like cytokine factor 1	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IDA:BHF-UCL
P51800	CLCNKA	Chloride channel protein ClC-Ka	GO:0030554; F:adenyl nucleotide binding; IEA:InterPro
P51800	CLCNKA	Chloride channel protein ClC-Ka	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P51800	CLCNKA	Chloride channel protein ClC-Ka	GO:0005247; F:voltage-gated chloride channel activity; TAS:ProtInc
P51800	CLCNKA	Chloride channel protein ClC-Ka	GO:0007588; P:excretion; TAS:ProtInc
P51800	CLCNKA	Chloride channel protein ClC-Ka	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P51800	CLCNKA	Chloride channel protein ClC-Ka	GO:0044070; P:regulation of anion transport; TAS:GOC
P51800	CLCNKA	Chloride channel protein ClC-Ka	GO:0055085; P:transmembrane transport; TAS:Reactome
P51800	CLCNKA	Chloride channel protein ClC-Ka	GO:0006810; P:transport; TAS:ProtInc
P51801	CLCNKB	Chloride channel protein ClC-Kb	GO:0030554; F:adenyl nucleotide binding; IEA:InterPro
P51801	CLCNKB	Chloride channel protein ClC-Kb	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P51801	CLCNKB	Chloride channel protein ClC-Kb	GO:0005247; F:voltage-gated chloride channel activity; TAS:ProtInc
P51801	CLCNKB	Chloride channel protein ClC-Kb	GO:0007588; P:excretion; TAS:ProtInc
P51801	CLCNKB	Chloride channel protein ClC-Kb	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P51801	CLCNKB	Chloride channel protein ClC-Kb	GO:0044070; P:regulation of anion transport; TAS:GOC
P51801	CLCNKB	Chloride channel protein ClC-Kb	GO:0055085; P:transmembrane transport; TAS:Reactome
P51801	CLCNKB	Chloride channel protein ClC-Kb	GO:0006810; P:transport; TAS:ProtInc
P35523	CLCN1	Chloride channel protein 1	GO:0030554; F:adenyl nucleotide binding; IEA:InterPro
P35523	CLCN1	Chloride channel protein 1	GO:0005254; F:chloride channel activity; TAS:ProtInc
P35523	CLCN1	Chloride channel protein 1	GO:0005247; F:voltage-gated chloride channel activity; TAS:ProtInc
P35523	CLCN1	Chloride channel protein 1	GO:1902476; P:chloride transmembrane transport; TAS:GOC
P35523	CLCN1	Chloride channel protein 1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P35523	CLCN1	Chloride channel protein 1	GO:0006936; P:muscle contraction; TAS:ProtInc
P35523	CLCN1	Chloride channel protein 1	GO:0019227; P:neuronal action potential propagation; IEA:Ensembl
P35523	CLCN1	Chloride channel protein 1	GO:0044070; P:regulation of anion transport; TAS:GOC
P35523	CLCN1	Chloride channel protein 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P35523	CLCN1	Chloride channel protein 1	GO:0006810; P:transport; TAS:ProtInc
P51788	CLCN2	Chloride channel protein 2	GO:0030554; F:adenyl nucleotide binding; IEA:InterPro
P51788	CLCN2	Chloride channel protein 2	GO:0005247; F:voltage-gated chloride channel activity; TAS:ProtInc
P51788	CLCN2	Chloride channel protein 2	GO:0060689; P:cell differentiation involved in salivary gland development; IEA:Ensembl
P51788	CLCN2	Chloride channel protein 2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P51788	CLCN2	Chloride channel protein 2	GO:0044070; P:regulation of anion transport; TAS:GOC
P51788	CLCN2	Chloride channel protein 2	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
P51788	CLCN2	Chloride channel protein 2	GO:0055085; P:transmembrane transport; TAS:Reactome
P51788	CLCN2	Chloride channel protein 2	GO:0006810; P:transport; TAS:ProtInc
P51790	CLCN3	H(+)/Cl(-) exchange transporter 3	GO:0030554; F:adenyl nucleotide binding; IEA:InterPro
P51790	CLCN3	H(+)/Cl(-) exchange transporter 3	GO:0015297; F:antiporter activity; IEA:UniProtKB-KW
P51790	CLCN3	H(+)/Cl(-) exchange transporter 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P51790	CLCN3	H(+)/Cl(-) exchange transporter 3	GO:0005254; F:chloride channel activity; TAS:UniProtKB
P51790	CLCN3	H(+)/Cl(-) exchange transporter 3	GO:0030165; F:PDZ domain binding; IDA:UniProtKB
P51790	CLCN3	H(+)/Cl(-) exchange transporter 3	GO:0005515; F:protein binding; IPI:UniProtKB
P51790	CLCN3	H(+)/Cl(-) exchange transporter 3	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
P51790	CLCN3	H(+)/Cl(-) exchange transporter 3	GO:0042803; F:protein homodimerization activity; NAS:UniProtKB
P51790	CLCN3	H(+)/Cl(-) exchange transporter 3	GO:0005247; F:voltage-gated chloride channel activity; IEA:InterPro
P51790	CLCN3	H(+)/Cl(-) exchange transporter 3	GO:1902476; P:chloride transmembrane transport; TAS:GOC
P51790	CLCN3	H(+)/Cl(-) exchange transporter 3	GO:0048388; P:endosomal lumen acidification; TAS:UniProtKB
P51790	CLCN3	H(+)/Cl(-) exchange transporter 3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P51790	CLCN3	H(+)/Cl(-) exchange transporter 3	GO:0044070; P:regulation of anion transport; TAS:GOC
P51790	CLCN3	H(+)/Cl(-) exchange transporter 3	GO:0006885; P:regulation of pH; TAS:UniProtKB
P51790	CLCN3	H(+)/Cl(-) exchange transporter 3	GO:0055085; P:transmembrane transport; TAS:Reactome
P51790	CLCN3	H(+)/Cl(-) exchange transporter 3	GO:0006810; P:transport; TAS:ProtInc
P51793	CLCN4	H(+)/Cl(-) exchange transporter 4	GO:0030554; F:adenyl nucleotide binding; IEA:InterPro
P51793	CLCN4	H(+)/Cl(-) exchange transporter 4	GO:0015297; F:antiporter activity; IEA:UniProtKB-KW
P51793	CLCN4	H(+)/Cl(-) exchange transporter 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P51793	CLCN4	H(+)/Cl(-) exchange transporter 4	GO:0005254; F:chloride channel activity; IDA:MGI
P51793	CLCN4	H(+)/Cl(-) exchange transporter 4	GO:0005247; F:voltage-gated chloride channel activity; IEA:InterPro
P51793	CLCN4	H(+)/Cl(-) exchange transporter 4	GO:1902476; P:chloride transmembrane transport; IDA:GOC
P51793	CLCN4	H(+)/Cl(-) exchange transporter 4	GO:0006821; P:chloride transport; IDA:MGI
P51793	CLCN4	H(+)/Cl(-) exchange transporter 4	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P51793	CLCN4	H(+)/Cl(-) exchange transporter 4	GO:0044070; P:regulation of anion transport; TAS:GOC
P51793	CLCN4	H(+)/Cl(-) exchange transporter 4	GO:0055085; P:transmembrane transport; TAS:Reactome
P51793	CLCN4	H(+)/Cl(-) exchange transporter 4	GO:0006810; P:transport; TAS:ProtInc
P51795	CLCN5	H(+)/Cl(-) exchange transporter 5	GO:0015297; F:antiporter activity; IEA:UniProtKB-KW
P51795	CLCN5	H(+)/Cl(-) exchange transporter 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P51795	CLCN5	H(+)/Cl(-) exchange transporter 5	GO:0005254; F:chloride channel activity; TAS:ProtInc
P51795	CLCN5	H(+)/Cl(-) exchange transporter 5	GO:0005247; F:voltage-gated chloride channel activity; IEA:Ensembl
P51795	CLCN5	H(+)/Cl(-) exchange transporter 5	GO:1902476; P:chloride transmembrane transport; TAS:GOC
P51795	CLCN5	H(+)/Cl(-) exchange transporter 5	GO:0006897; P:endocytosis; IEA:Ensembl
P51795	CLCN5	H(+)/Cl(-) exchange transporter 5	GO:0007588; P:excretion; TAS:ProtInc
P51795	CLCN5	H(+)/Cl(-) exchange transporter 5	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P51795	CLCN5	H(+)/Cl(-) exchange transporter 5	GO:0055085; P:transmembrane transport; TAS:Reactome
P51795	CLCN5	H(+)/Cl(-) exchange transporter 5	GO:0006810; P:transport; TAS:ProtInc
P51797	CLCN6	Chloride transport protein 6	GO:0015297; F:antiporter activity; IEA:UniProtKB-KW
P51797	CLCN6	Chloride transport protein 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P51797	CLCN6	Chloride transport protein 6	GO:0005247; F:voltage-gated chloride channel activity; NAS:UniProtKB
P51797	CLCN6	Chloride transport protein 6	GO:0006884; P:cell volume homeostasis; NAS:UniProtKB
P51797	CLCN6	Chloride transport protein 6	GO:0006821; P:chloride transport; NAS:UniProtKB
P51797	CLCN6	Chloride transport protein 6	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P51797	CLCN6	Chloride transport protein 6	GO:0044070; P:regulation of anion transport; NAS:GOC
P51797	CLCN6	Chloride transport protein 6	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P51797	CLCN6	Chloride transport protein 6	GO:0007165; P:signal transduction; NAS:UniProtKB
P51797	CLCN6	Chloride transport protein 6	GO:0055085; P:transmembrane transport; TAS:Reactome
P51798	CLCN7	H(+)/Cl(-) exchange transporter 7	GO:0015297; F:antiporter activity; IEA:UniProtKB-KW
P51798	CLCN7	H(+)/Cl(-) exchange transporter 7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P51798	CLCN7	H(+)/Cl(-) exchange transporter 7	GO:0005254; F:chloride channel activity; TAS:ProtInc
P51798	CLCN7	H(+)/Cl(-) exchange transporter 7	GO:0005247; F:voltage-gated chloride channel activity; IEA:InterPro
P51798	CLCN7	H(+)/Cl(-) exchange transporter 7	GO:1902476; P:chloride transmembrane transport; TAS:GOC
P51798	CLCN7	H(+)/Cl(-) exchange transporter 7	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P51798	CLCN7	H(+)/Cl(-) exchange transporter 7	GO:0009268; P:response to pH; IEA:Ensembl
P51798	CLCN7	H(+)/Cl(-) exchange transporter 7	GO:0055085; P:transmembrane transport; TAS:Reactome
P51798	CLCN7	H(+)/Cl(-) exchange transporter 7	GO:0006810; P:transport; TAS:ProtInc
P78369	CLDN10	Claudin-10	GO:0042802; F:identical protein binding; ISS:UniProtKB
P78369	CLDN10	Claudin-10	GO:0005198; F:structural molecule activity; IEA:InterPro
P78369	CLDN10	Claudin-10	GO:0016338; P:calcium-independent cell-cell adhesion; ISS:UniProtKB
P78369	CLDN10	Claudin-10	GO:0007155; P:cell adhesion; TAS:ProtInc
P78369	CLDN10	Claudin-10	GO:0006811; P:ion transport; IEA:UniProtKB-KW
O75508	CLDN11	Claudin-11	GO:0042802; F:identical protein binding; ISS:UniProtKB
O75508	CLDN11	Claudin-11	GO:0005198; F:structural molecule activity; IEA:InterPro
O75508	CLDN11	Claudin-11	GO:0008366; P:axon ensheathment; IEA:Ensembl
O75508	CLDN11	Claudin-11	GO:0016338; P:calcium-independent cell-cell adhesion; ISS:UniProtKB
O75508	CLDN11	Claudin-11	GO:0007283; P:spermatogenesis; IEA:Ensembl
P56749	CLDN12	Claudin-12	GO:0042802; F:identical protein binding; ISS:UniProtKB
P56749	CLDN12	Claudin-12	GO:0005198; F:structural molecule activity; IEA:InterPro
P56749	CLDN12	Claudin-12	GO:0016338; P:calcium-independent cell-cell adhesion; ISS:UniProtKB
P56749	CLDN12	Claudin-12	GO:0034329; P:cell junction assembly; TAS:Reactome
P56749	CLDN12	Claudin-12	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P56749	CLDN12	Claudin-12	GO:0070830; P:tight junction assembly; TAS:Reactome
O95500	CLDN14	Claudin-14	GO:0042802; F:identical protein binding; ISS:UniProtKB
O95500	CLDN14	Claudin-14	GO:0005198; F:structural molecule activity; IEA:InterPro
O95500	CLDN14	Claudin-14	GO:0016338; P:calcium-independent cell-cell adhesion; ISS:UniProtKB
O95500	CLDN14	Claudin-14	GO:0034329; P:cell junction assembly; TAS:Reactome
O95500	CLDN14	Claudin-14	GO:0045216; P:cell-cell junction organization; TAS:Reactome
O95500	CLDN14	Claudin-14	GO:0006461; P:protein complex assembly; TAS:ProtInc
O95500	CLDN14	Claudin-14	GO:0070830; P:tight junction assembly; TAS:Reactome
P56746	CLDN15	Claudin-15	GO:0042802; F:identical protein binding; ISS:UniProtKB
P56746	CLDN15	Claudin-15	GO:0005198; F:structural molecule activity; IEA:InterPro
P56746	CLDN15	Claudin-15	GO:0016338; P:calcium-independent cell-cell adhesion; ISS:UniProtKB
P56746	CLDN15	Claudin-15	GO:0034329; P:cell junction assembly; TAS:Reactome
P56746	CLDN15	Claudin-15	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P56746	CLDN15	Claudin-15	GO:0070830; P:tight junction assembly; TAS:Reactome
Q9Y5I7	CLDN16	Claudin-16	GO:0042802; F:identical protein binding; ISS:UniProtKB
Q9Y5I7	CLDN16	Claudin-16	GO:0015095; F:magnesium ion transmembrane transporter activity; TAS:ProtInc
Q9Y5I7	CLDN16	Claudin-16	GO:0005515; F:protein binding; IPI:IntAct
Q9Y5I7	CLDN16	Claudin-16	GO:0005198; F:structural molecule activity; IEA:InterPro
Q9Y5I7	CLDN16	Claudin-16	GO:0016338; P:calcium-independent cell-cell adhesion; ISS:UniProtKB
Q9Y5I7	CLDN16	Claudin-16	GO:0006875; P:cellular metal ion homeostasis; TAS:ProtInc
Q9Y5I7	CLDN16	Claudin-16	GO:0007588; P:excretion; TAS:ProtInc
Q9Y5I7	CLDN16	Claudin-16	GO:0015693; P:magnesium ion transport; TAS:GOC
P56750	CLDN17	Claudin-17	GO:0042802; F:identical protein binding; ISS:UniProtKB
P56750	CLDN17	Claudin-17	GO:0005198; F:structural molecule activity; IEA:InterPro
P56750	CLDN17	Claudin-17	GO:0016338; P:calcium-independent cell-cell adhesion; ISS:UniProtKB
P56750	CLDN17	Claudin-17	GO:0034329; P:cell junction assembly; TAS:Reactome
P56750	CLDN17	Claudin-17	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P56750	CLDN17	Claudin-17	GO:0070830; P:tight junction assembly; TAS:Reactome
P56856	CLDN18	Claudin-18	GO:0042802; F:identical protein binding; ISS:UniProtKB
P56856	CLDN18	Claudin-18	GO:0005198; F:structural molecule activity; IEA:InterPro
P56856	CLDN18	Claudin-18	GO:0016338; P:calcium-independent cell-cell adhesion; ISS:UniProtKB
P56856	CLDN18	Claudin-18	GO:0034329; P:cell junction assembly; TAS:Reactome
P56856	CLDN18	Claudin-18	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P56856	CLDN18	Claudin-18	GO:0070830; P:tight junction assembly; TAS:Reactome
Q8N6F1	CLDN19	Claudin-19	GO:0042802; F:identical protein binding; ISS:UniProtKB
Q8N6F1	CLDN19	Claudin-19	GO:0005198; F:structural molecule activity; IEA:Ensembl
Q8N6F1	CLDN19	Claudin-19	GO:0043297; P:apical junction assembly; IEA:Ensembl
Q8N6F1	CLDN19	Claudin-19	GO:0016338; P:calcium-independent cell-cell adhesion; ISS:UniProtKB
Q8N6F1	CLDN19	Claudin-19	GO:0019227; P:neuronal action potential propagation; IEA:Ensembl
Q8N6F1	CLDN19	Claudin-19	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q8N6F1	CLDN19	Claudin-19	GO:0007601; P:visual perception; IEA:UniProtKB-KW
O95832	CLDN1	Claudin-1	GO:0042802; F:identical protein binding; ISS:UniProtKB
O95832	CLDN1	Claudin-1	GO:0005198; F:structural molecule activity; IEA:InterPro
O95832	CLDN1	Claudin-1	GO:0016338; P:calcium-independent cell-cell adhesion; ISS:UniProtKB
O95832	CLDN1	Claudin-1	GO:0007155; P:cell adhesion; TAS:ProtInc
O95832	CLDN1	Claudin-1	GO:0045216; P:cell-cell junction organization; IMP:MGI
O95832	CLDN1	Claudin-1	GO:0016032; P:viral process; IEA:UniProtKB-KW
P56880	CLDN20	Claudin-20	GO:0042802; F:identical protein binding; ISS:UniProtKB
P56880	CLDN20	Claudin-20	GO:0005198; F:structural molecule activity; IEA:InterPro
P56880	CLDN20	Claudin-20	GO:0016338; P:calcium-independent cell-cell adhesion; ISS:UniProtKB
P56880	CLDN20	Claudin-20	GO:0034329; P:cell junction assembly; TAS:Reactome
P56880	CLDN20	Claudin-20	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P56880	CLDN20	Claudin-20	GO:0070830; P:tight junction assembly; TAS:Reactome
Q8N7P3	CLDN22	Claudin-22	GO:0042802; F:identical protein binding; ISS:UniProtKB
Q8N7P3	CLDN22	Claudin-22	GO:0005198; F:structural molecule activity; IEA:InterPro
Q8N7P3	CLDN22	Claudin-22	GO:0016338; P:calcium-independent cell-cell adhesion; ISS:UniProtKB
Q8N7P3	CLDN22	Claudin-22	GO:0034329; P:cell junction assembly; TAS:Reactome
Q8N7P3	CLDN22	Claudin-22	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q8N7P3	CLDN22	Claudin-22	GO:0070830; P:tight junction assembly; TAS:Reactome
Q96B33	CLDN23	Claudin-23	GO:0042802; F:identical protein binding; ISS:UniProtKB
Q96B33	CLDN23	Claudin-23	GO:0005198; F:structural molecule activity; IEA:InterPro
Q96B33	CLDN23	Claudin-23	GO:0016338; P:calcium-independent cell-cell adhesion; ISS:UniProtKB
Q96B33	CLDN23	Claudin-23	GO:0034329; P:cell junction assembly; TAS:Reactome
Q96B33	CLDN23	Claudin-23	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q96B33	CLDN23	Claudin-23	GO:0070830; P:tight junction assembly; TAS:Reactome
A6NM45	CLDN24	Putative claudin-24	GO:0005198; F:structural molecule activity; IEA:InterPro
C9JDP6	CLDN25	Putative claudin-25	GO:0005198; F:structural molecule activity; IEA:InterPro
P57739	CLDN2	Claudin-2	GO:0042802; F:identical protein binding; ISS:UniProtKB
P57739	CLDN2	Claudin-2	GO:0005198; F:structural molecule activity; IEA:InterPro
P57739	CLDN2	Claudin-2	GO:0016338; P:calcium-independent cell-cell adhesion; ISS:UniProtKB
O15551	CLDN3	Claudin-3	GO:0005198; F:structural molecule activity; IEA:InterPro
O15551	CLDN3	Claudin-3	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
O15551	CLDN3	Claudin-3	GO:0016338; P:calcium-independent cell-cell adhesion; IEA:Ensembl
O15551	CLDN3	Claudin-3	GO:0001666; P:response to hypoxia; IEP:UniProtKB
O15551	CLDN3	Claudin-3	GO:0007165; P:signal transduction; TAS:GOC
O14493	CLDN4	Claudin-4	GO:0042802; F:identical protein binding; ISS:UniProtKB
O14493	CLDN4	Claudin-4	GO:0005198; F:structural molecule activity; IEA:InterPro
O14493	CLDN4	Claudin-4	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
O14493	CLDN4	Claudin-4	GO:0016338; P:calcium-independent cell-cell adhesion; ISS:UniProtKB
O14493	CLDN4	Claudin-4	GO:0007565; P:female pregnancy; IEA:Ensembl
O14493	CLDN4	Claudin-4	GO:0032570; P:response to progesterone; IEA:Ensembl
O14493	CLDN4	Claudin-4	GO:0007165; P:signal transduction; TAS:GOC
O00501	CLDN5	Claudin-5	GO:0042802; F:identical protein binding; ISS:UniProtKB
O00501	CLDN5	Claudin-5	GO:0005198; F:structural molecule activity; IEA:InterPro
O00501	CLDN5	Claudin-5	GO:0016338; P:calcium-independent cell-cell adhesion; ISS:UniProtKB
O00501	CLDN5	Claudin-5	GO:0042552; P:myelination; IEA:Ensembl
P56747	CLDN6	Claudin-6	GO:0042802; F:identical protein binding; ISS:UniProtKB
P56747	CLDN6	Claudin-6	GO:0005198; F:structural molecule activity; IEA:InterPro
P56747	CLDN6	Claudin-6	GO:0016338; P:calcium-independent cell-cell adhesion; ISS:UniProtKB
O95471	CLDN7	Claudin-7	GO:0042802; F:identical protein binding; ISS:UniProtKB
O95471	CLDN7	Claudin-7	GO:0005515; F:protein binding; IPI:UniProtKB
O95471	CLDN7	Claudin-7	GO:0005198; F:structural molecule activity; IEA:InterPro
O95471	CLDN7	Claudin-7	GO:0016338; P:calcium-independent cell-cell adhesion; ISS:UniProtKB
P56748	CLDN8	Claudin-8	GO:0042802; F:identical protein binding; ISS:UniProtKB
P56748	CLDN8	Claudin-8	GO:0005198; F:structural molecule activity; IEA:InterPro
P56748	CLDN8	Claudin-8	GO:0016338; P:calcium-independent cell-cell adhesion; ISS:UniProtKB
O95484	CLDN9	Claudin-9	GO:0042802; F:identical protein binding; ISS:UniProtKB
O95484	CLDN9	Claudin-9	GO:0005198; F:structural molecule activity; IEA:InterPro
O95484	CLDN9	Claudin-9	GO:0016338; P:calcium-independent cell-cell adhesion; ISS:UniProtKB
O95484	CLDN9	Claudin-9	GO:0034329; P:cell junction assembly; TAS:Reactome
O95484	CLDN9	Claudin-9	GO:0045216; P:cell-cell junction organization; TAS:Reactome
O95484	CLDN9	Claudin-9	GO:0070830; P:tight junction assembly; TAS:Reactome
O14967	CLGN	Calmegin	GO:0005509; F:calcium ion binding; IEA:InterPro
O14967	CLGN	Calmegin	GO:0051082; F:unfolded protein binding; TAS:ProtInc
O14967	CLGN	Calmegin	GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl
O14967	CLGN	Calmegin	GO:0006461; P:protein complex assembly; IEA:Ensembl
O14967	CLGN	Calmegin	GO:0006457; P:protein folding; IEA:InterPro
O14967	CLGN	Calmegin	GO:0007338; P:single fertilization; TAS:ProtInc
Q00610	CLTC	Clathrin heavy chain 1	GO:0032051; F:clathrin light chain binding; IPI:FlyBase
Q00610	CLTC	Clathrin heavy chain 1	GO:0003725; F:double-stranded RNA binding; IDA:MGI
Q00610	CLTC	Clathrin heavy chain 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q00610	CLTC	Clathrin heavy chain 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q00610	CLTC	Clathrin heavy chain 1	GO:0005198; F:structural molecule activity; NAS:UniProtKB
Q00610	CLTC	Clathrin heavy chain 1	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q00610	CLTC	Clathrin heavy chain 1	GO:0006886; P:intracellular protein transport; NAS:UniProtKB
Q00610	CLTC	Clathrin heavy chain 1	GO:0061024; P:membrane organization; TAS:Reactome
Q00610	CLTC	Clathrin heavy chain 1	GO:0007067; P:mitosis; IMP:UniProtKB
Q00610	CLTC	Clathrin heavy chain 1	GO:1900126; P:negative regulation of hyaluronan biosynthetic process; IDA:UniProtKB
Q00610	CLTC	Clathrin heavy chain 1	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
Q00610	CLTC	Clathrin heavy chain 1	GO:0031623; P:receptor internalization; IMP:BHF-UCL
Q00610	CLTC	Clathrin heavy chain 1	GO:0006898; P:receptor-mediated endocytosis; IMP:UniProtKB
Q00610	CLTC	Clathrin heavy chain 1	GO:0033572; P:transferrin transport; IMP:BHF-UCL
P53675	CLTCL1	Clathrin heavy chain 2	GO:0005515; F:protein binding; IPI:UniProtKB
P53675	CLTCL1	Clathrin heavy chain 2	GO:0004871; F:signal transducer activity; TAS:ProtInc
P53675	CLTCL1	Clathrin heavy chain 2	GO:0005198; F:structural molecule activity; IEA:InterPro
P53675	CLTCL1	Clathrin heavy chain 2	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P53675	CLTCL1	Clathrin heavy chain 2	GO:0006886; P:intracellular protein transport; IEA:InterPro
P53675	CLTCL1	Clathrin heavy chain 2	GO:0007067; P:mitosis; IDA:UniProtKB
P53675	CLTCL1	Clathrin heavy chain 2	GO:0046326; P:positive regulation of glucose import; IMP:UniProtKB
P53675	CLTCL1	Clathrin heavy chain 2	GO:0006898; P:receptor-mediated endocytosis; IDA:UniProtKB
P53675	CLTCL1	Clathrin heavy chain 2	GO:0007165; P:signal transduction; TAS:GOC
O00299	CLIC1	Chloride intracellular channel protein 1	GO:0005254; F:chloride channel activity; IDA:MGI
O00299	CLIC1	Chloride intracellular channel protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
O00299	CLIC1	Chloride intracellular channel protein 1	GO:0005247; F:voltage-gated chloride channel activity; IEA:InterPro
O00299	CLIC1	Chloride intracellular channel protein 1	GO:1902476; P:chloride transmembrane transport; IDA:GOC
O00299	CLIC1	Chloride intracellular channel protein 1	GO:0006821; P:chloride transport; IDA:MGI
O00299	CLIC1	Chloride intracellular channel protein 1	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
O00299	CLIC1	Chloride intracellular channel protein 1	GO:0051881; P:regulation of mitochondrial membrane potential; IEA:Ensembl
O00299	CLIC1	Chloride intracellular channel protein 1	GO:0007165; P:signal transduction; TAS:UniProtKB
O15247	CLIC2	Chloride intracellular channel protein 2	GO:0005254; F:chloride channel activity; TAS:ProtInc
O15247	CLIC2	Chloride intracellular channel protein 2	GO:0004602; F:glutathione peroxidase activity; IDA:BHF-UCL
O15247	CLIC2	Chloride intracellular channel protein 2	GO:0005515; F:protein binding; IPI:BHF-UCL
O15247	CLIC2	Chloride intracellular channel protein 2	GO:0005247; F:voltage-gated chloride channel activity; IEA:InterPro
O15247	CLIC2	Chloride intracellular channel protein 2	GO:1902476; P:chloride transmembrane transport; TAS:GOC
O15247	CLIC2	Chloride intracellular channel protein 2	GO:0060315; P:negative regulation of ryanodine-sensitive calcium-release channel activity; IDA:BHF-UCL
O15247	CLIC2	Chloride intracellular channel protein 2	GO:0055114; P:oxidation-reduction process; IDA:GOC
O15247	CLIC2	Chloride intracellular channel protein 2	GO:0051099; P:positive regulation of binding; IDA:BHF-UCL
O15247	CLIC2	Chloride intracellular channel protein 2	GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; IC:BHF-UCL
O15247	CLIC2	Chloride intracellular channel protein 2	GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; IDA:BHF-UCL
O15247	CLIC2	Chloride intracellular channel protein 2	GO:0007165; P:signal transduction; TAS:UniProtKB
O15247	CLIC2	Chloride intracellular channel protein 2	GO:0006810; P:transport; TAS:ProtInc
O95833	CLIC3	Chloride intracellular channel protein 3	GO:0005254; F:chloride channel activity; IMP:UniProtKB
O95833	CLIC3	Chloride intracellular channel protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
O95833	CLIC3	Chloride intracellular channel protein 3	GO:0005247; F:voltage-gated chloride channel activity; IEA:InterPro
O95833	CLIC3	Chloride intracellular channel protein 3	GO:1902476; P:chloride transmembrane transport; IMP:GOC
O95833	CLIC3	Chloride intracellular channel protein 3	GO:0006821; P:chloride transport; IMP:UniProtKB
O95833	CLIC3	Chloride intracellular channel protein 3	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y696	CLIC4	Chloride intracellular channel protein 4	GO:0005254; F:chloride channel activity; TAS:ProtInc
Q9Y696	CLIC4	Chloride intracellular channel protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y696	CLIC4	Chloride intracellular channel protein 4	GO:0005247; F:voltage-gated chloride channel activity; IEA:InterPro
Q9Y696	CLIC4	Chloride intracellular channel protein 4	GO:0001525; P:angiogenesis; IEA:Ensembl
Q9Y696	CLIC4	Chloride intracellular channel protein 4	GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl
Q9Y696	CLIC4	Chloride intracellular channel protein 4	GO:0030154; P:cell differentiation; TAS:UniProtKB
Q9Y696	CLIC4	Chloride intracellular channel protein 4	GO:0071277; P:cellular response to calcium ion; IMP:UniProtKB
Q9Y696	CLIC4	Chloride intracellular channel protein 4	GO:1902476; P:chloride transmembrane transport; TAS:GOC
Q9Y696	CLIC4	Chloride intracellular channel protein 4	GO:0006821; P:chloride transport; NAS:UniProtKB
Q9Y696	CLIC4	Chloride intracellular channel protein 4	GO:0001886; P:endothelial cell morphogenesis; IEA:Ensembl
Q9Y696	CLIC4	Chloride intracellular channel protein 4	GO:0035088; P:establishment or maintenance of apical/basal cell polarity; NAS:UniProtKB
Q9Y696	CLIC4	Chloride intracellular channel protein 4	GO:0009566; P:fertilization; IEA:Ensembl
Q9Y696	CLIC4	Chloride intracellular channel protein 4	GO:0030216; P:keratinocyte differentiation; IMP:UniProtKB
Q9Y696	CLIC4	Chloride intracellular channel protein 4	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q9Y696	CLIC4	Chloride intracellular channel protein 4	GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB
Q9Y696	CLIC4	Chloride intracellular channel protein 4	GO:0051493; P:regulation of cytoskeleton organization; NAS:UniProtKB
Q9Y696	CLIC4	Chloride intracellular channel protein 4	GO:0061299; P:retina vasculature morphogenesis in camera-type eye; IEA:Ensembl
Q9Y696	CLIC4	Chloride intracellular channel protein 4	GO:0007035; P:vacuolar acidification; IEA:Ensembl
Q9NZA1	CLIC5	Chloride intracellular channel protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NZA1	CLIC5	Chloride intracellular channel protein 5	GO:0005247; F:voltage-gated chloride channel activity; IEA:InterPro
Q9NZA1	CLIC5	Chloride intracellular channel protein 5	GO:0060088; P:auditory receptor cell stereocilium organization; IEA:Ensembl
Q9NZA1	CLIC5	Chloride intracellular channel protein 5	GO:0006821; P:chloride transport; IDA:UniProtKB
Q9NZA1	CLIC5	Chloride intracellular channel protein 5	GO:0002024; P:diet induced thermogenesis; IEA:Ensembl
Q9NZA1	CLIC5	Chloride intracellular channel protein 5	GO:0007565; P:female pregnancy; TAS:ProtInc
Q9NZA1	CLIC5	Chloride intracellular channel protein 5	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q9NZA1	CLIC5	Chloride intracellular channel protein 5	GO:0008104; P:protein localization; IEA:Ensembl
Q9NZA1	CLIC5	Chloride intracellular channel protein 5	GO:0007605; P:sensory perception of sound; IEA:Ensembl
Q9NZA1	CLIC5	Chloride intracellular channel protein 5	GO:0006810; P:transport; NAS:ProtInc
Q96NY7	CLIC6	Chloride intracellular channel protein 6	GO:0005247; F:voltage-gated chloride channel activity; IEA:InterPro
P30622	CLIP1	CAP-Gly domain-containing linker protein 1	GO:0046872; F:metal ion binding; NAS:UniProtKB
P30622	CLIP1	CAP-Gly domain-containing linker protein 1	GO:0008017; F:microtubule binding; IDA:UniProtKB
P30622	CLIP1	CAP-Gly domain-containing linker protein 1	GO:0051010; F:microtubule plus-end binding; IDA:UniProtKB
P30622	CLIP1	CAP-Gly domain-containing linker protein 1	GO:0003676; F:nucleic acid binding; IEA:InterPro
P30622	CLIP1	CAP-Gly domain-containing linker protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P30622	CLIP1	CAP-Gly domain-containing linker protein 1	GO:0042803; F:protein homodimerization activity; TAS:UniProtKB
P30622	CLIP1	CAP-Gly domain-containing linker protein 1	GO:0015631; F:tubulin binding; IDA:UniProtKB
P30622	CLIP1	CAP-Gly domain-containing linker protein 1	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P30622	CLIP1	CAP-Gly domain-containing linker protein 1	GO:0001578; P:microtubule bundle formation; IMP:UniProtKB
P30622	CLIP1	CAP-Gly domain-containing linker protein 1	GO:0007067; P:mitosis; TAS:UniProtKB
P30622	CLIP1	CAP-Gly domain-containing linker protein 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P30622	CLIP1	CAP-Gly domain-containing linker protein 1	GO:0031116; P:positive regulation of microtubule polymerization; IMP:UniProtKB
P30622	CLIP1	CAP-Gly domain-containing linker protein 1	GO:0006810; P:transport; IEA:UniProtKB-KW
Q96DZ5	CLIP3	CAP-Gly domain-containing linker protein 3	GO:0035594; F:ganglioside binding; IDA:UniProtKB
Q96DZ5	CLIP3	CAP-Gly domain-containing linker protein 3	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q96DZ5	CLIP3	CAP-Gly domain-containing linker protein 3	GO:0072321; P:chaperone-mediated protein transport; IMP:UniProtKB
Q96DZ5	CLIP3	CAP-Gly domain-containing linker protein 3	GO:0045444; P:fat cell differentiation; ISS:UniProtKB
Q96DZ5	CLIP3	CAP-Gly domain-containing linker protein 3	GO:0044091; P:membrane biogenesis; IMP:UniProtKB
Q96DZ5	CLIP3	CAP-Gly domain-containing linker protein 3	GO:0031115; P:negative regulation of microtubule polymerization; IMP:UniProtKB
Q96DZ5	CLIP3	CAP-Gly domain-containing linker protein 3	GO:0018230; P:peptidyl-L-cysteine S-palmitoylation; IMP:UniProtKB
Q96DZ5	CLIP3	CAP-Gly domain-containing linker protein 3	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q96DZ5	CLIP3	CAP-Gly domain-containing linker protein 3	GO:0045807; P:positive regulation of endocytosis; IMP:UniProtKB
Q96DZ5	CLIP3	CAP-Gly domain-containing linker protein 3	GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; ISS:UniProtKB
Q96DZ5	CLIP3	CAP-Gly domain-containing linker protein 3	GO:0010828; P:positive regulation of glucose transport; ISS:UniProtKB
Q96DZ5	CLIP3	CAP-Gly domain-containing linker protein 3	GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB
P49759	CLK1	Dual specificity protein kinase CLK1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49759	CLK1	Dual specificity protein kinase CLK1	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; TAS:ProtInc
P49759	CLK1	Dual specificity protein kinase CLK1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P49759	CLK1	Dual specificity protein kinase CLK1	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC
P49759	CLK1	Dual specificity protein kinase CLK1	GO:0008283; P:cell proliferation; TAS:ProtInc
P49759	CLK1	Dual specificity protein kinase CLK1	GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl
P49759	CLK1	Dual specificity protein kinase CLK1	GO:0018107; P:peptidyl-threonine phosphorylation; IEA:Ensembl
P49759	CLK1	Dual specificity protein kinase CLK1	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
P49759	CLK1	Dual specificity protein kinase CLK1	GO:0043484; P:regulation of RNA splicing; IMP:UniProtKB
P49760	CLK2	Dual specificity protein kinase CLK2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49760	CLK2	Dual specificity protein kinase CLK2	GO:0005515; F:protein binding; IPI:UniProtKB
P49760	CLK2	Dual specificity protein kinase CLK2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P49760	CLK2	Dual specificity protein kinase CLK2	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC
P49760	CLK2	Dual specificity protein kinase CLK2	GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW
P49760	CLK2	Dual specificity protein kinase CLK2	GO:0045721; P:negative regulation of gluconeogenesis; ISS:UniProtKB
P49760	CLK2	Dual specificity protein kinase CLK2	GO:0046777; P:protein autophosphorylation; ISS:UniProtKB
P49760	CLK2	Dual specificity protein kinase CLK2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P49760	CLK2	Dual specificity protein kinase CLK2	GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB
P49760	CLK2	Dual specificity protein kinase CLK2	GO:0010212; P:response to ionizing radiation; IMP:UniProtKB
P49760	CLK2	Dual specificity protein kinase CLK2	GO:0032526; P:response to retinoic acid; IEA:Ensembl
P49761	CLK3	Dual specificity protein kinase CLK3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49761	CLK3	Dual specificity protein kinase CLK3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P49761	CLK3	Dual specificity protein kinase CLK3	GO:0005515; F:protein binding; IPI:IntAct
P49761	CLK3	Dual specificity protein kinase CLK3	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB
P49761	CLK3	Dual specificity protein kinase CLK3	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC
P49761	CLK3	Dual specificity protein kinase CLK3	GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW
P49761	CLK3	Dual specificity protein kinase CLK3	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
P49761	CLK3	Dual specificity protein kinase CLK3	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P49761	CLK3	Dual specificity protein kinase CLK3	GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB
Q9HAZ1	CLK4	Dual specificity protein kinase CLK4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9HAZ1	CLK4	Dual specificity protein kinase CLK4	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB
Q9HAZ1	CLK4	Dual specificity protein kinase CLK4	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC
Q9HAZ1	CLK4	Dual specificity protein kinase CLK4	GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW
Q9HAZ1	CLK4	Dual specificity protein kinase CLK4	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
Q9HAZ1	CLK4	Dual specificity protein kinase CLK4	GO:0043484; P:regulation of RNA splicing; IMP:UniProtKB
Q8TDQ1	CD300LF	CMRF35-like molecule 1	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q496F6	CD300E	CMRF35-like molecule 2	GO:0045087; P:innate immune response; TAS:Reactome
Q6UXZ3	CD300LD	CMRF35-like molecule 4	GO:0005515; F:protein binding; IPI:IntAct
Q6UXZ3	CD300LD	CMRF35-like molecule 4	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q08708	CD300C	CMRF35-like molecule 6	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q08708	CD300C	CMRF35-like molecule 6	GO:0006968; P:cellular defense response; TAS:ProtInc
Q08708	CD300C	CMRF35-like molecule 6	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q08708	CD300C	CMRF35-like molecule 6	GO:0007165; P:signal transduction; TAS:GOC
A8K4G0	CD300LB	CMRF35-like molecule 7	GO:0045087; P:innate immune response; TAS:Reactome
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:0008429; F:phosphatidylethanolamine binding; IDA:UniProt
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:0001786; F:phosphatidylserine binding; IDA:UniProt
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:0005515; F:protein binding; IPI:UniProt
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:0038023; F:signaling receptor activity; IDA:UniProt
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:1902569; P:negative regulation of activation of JAK2 kinase activity; IDA:UniProt
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:0030889; P:negative regulation of B cell proliferation; IMP:UniProt
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:0050859; P:negative regulation of B cell receptor signaling pathway; IDA:UniProt
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:1902567; P:negative regulation of eosinophil activation; IDA:UniProt
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:2000417; P:negative regulation of eosinophil migration; IDA:UniProt
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:0048147; P:negative regulation of fibroblast proliferation; IDA:UniProt
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:0043407; P:negative regulation of MAP kinase activity; IDA:UniProt
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:0033007; P:negative regulation of mast cell activation involved in immune response; IDA:UniProt
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:0043305; P:negative regulation of mast cell degranulation; IDA:UniProt
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:1902564; P:negative regulation of neutrophil activation; IDA:UniProt
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:0051134; P:negative regulation of NK T cell activation; IDA:UniProt
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:0060101; P:negative regulation of phagocytosis, engulfment; IMP:UniProt
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:0032516; P:positive regulation of phosphoprotein phosphatase activity; IDA:UniProt
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:0050856; P:regulation of T cell receptor signaling pathway; IDA:UniProt
Q9UGN4	CD300A	CMRF35-like molecule 8	GO:0007165; P:signal transduction; IDA:GOC
Q6UXG3	CD300LG	CMRF35-like molecule 9	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q96JQ2	CLMN	Calmin	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q96JQ2	CLMN	Calmin	GO:0031175; P:neuron projection development; IEA:Ensembl
Q9H6B4	CLMP	CXADR-like membrane protein	GO:0048565; P:digestive tract development; IMP:UniProtKB
Q13286	CLN3	Battenin	GO:0005515; F:protein binding; IPI:UniProtKB
Q13286	CLN3	Battenin	GO:0051082; F:unfolded protein binding; TAS:ProtInc
Q13286	CLN3	Battenin	GO:0001508; P:action potential; ISS:UniProtKB
Q13286	CLN3	Battenin	GO:0042987; P:amyloid precursor protein catabolic process; IDA:UniProtKB
Q13286	CLN3	Battenin	GO:0015809; P:arginine transport; IDA:UniProtKB
Q13286	CLN3	Battenin	GO:0008306; P:associative learning; ISS:UniProtKB
Q13286	CLN3	Battenin	GO:0000046; P:autophagic vacuole fusion; ISS:UniProtKB
Q13286	CLN3	Battenin	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q13286	CLN3	Battenin	GO:0006520; P:cellular amino acid metabolic process; ISS:UniProtKB
Q13286	CLN3	Battenin	GO:0006672; P:ceramide metabolic process; IDA:UniProtKB
Q13286	CLN3	Battenin	GO:0051480; P:cytosolic calcium ion homeostasis; ISS:UniProtKB
Q13286	CLN3	Battenin	GO:0006681; P:galactosylceramide metabolic process; IMP:UniProtKB
Q13286	CLN3	Battenin	GO:0001575; P:globoside metabolic process; IMP:UniProtKB
Q13286	CLN3	Battenin	GO:0006678; P:glucosylceramide metabolic process; IMP:UniProtKB
Q13286	CLN3	Battenin	GO:0035235; P:ionotropic glutamate receptor signaling pathway; ISS:UniProtKB
Q13286	CLN3	Battenin	GO:0007042; P:lysosomal lumen acidification; IMP:UniProtKB
Q13286	CLN3	Battenin	GO:0035752; P:lysosomal lumen pH elevation; IDA:UniProtKB
Q13286	CLN3	Battenin	GO:0007040; P:lysosome organization; ISS:UniProtKB
Q13286	CLN3	Battenin	GO:0016236; P:macroautophagy; NAS:UniProtKB
Q13286	CLN3	Battenin	GO:0061024; P:membrane organization; ISS:UniProtKB
Q13286	CLN3	Battenin	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q13286	CLN3	Battenin	GO:0043086; P:negative regulation of catalytic activity; ISS:UniProtKB
Q13286	CLN3	Battenin	GO:0016242; P:negative regulation of macroautophagy; ISS:UniProtKB
Q13286	CLN3	Battenin	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB
Q13286	CLN3	Battenin	GO:0045861; P:negative regulation of proteolysis; ISS:UniProtKB
Q13286	CLN3	Battenin	GO:0050885; P:neuromuscular process controlling balance; ISS:UniProtKB
Q13286	CLN3	Battenin	GO:0042133; P:neurotransmitter metabolic process; ISS:UniProtKB
Q13286	CLN3	Battenin	GO:0030163; P:protein catabolic process; NAS:UniProtKB
Q13286	CLN3	Battenin	GO:0016485; P:protein processing; ISS:UniProtKB
Q13286	CLN3	Battenin	GO:0006898; P:receptor-mediated endocytosis; IMP:UniProtKB
Q13286	CLN3	Battenin	GO:0006684; P:sphingomyelin metabolic process; IMP:UniProtKB
Q13286	CLN3	Battenin	GO:0007034; P:vacuolar transport; IBA:RefGenome
Q13286	CLN3	Battenin	GO:0047496; P:vesicle transport along microtubule; IMP:UniProtKB
O75503	CLN5	Ceroid-lipofuscinosis neuronal protein 5	GO:0005537; F:mannose binding; IDA:UniProtKB
O75503	CLN5	Ceroid-lipofuscinosis neuronal protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
O75503	CLN5	Ceroid-lipofuscinosis neuronal protein 5	GO:0007420; P:brain development; IEP:UniProtKB
O75503	CLN5	Ceroid-lipofuscinosis neuronal protein 5	GO:0008219; P:cell death; IEA:UniProtKB-KW
O75503	CLN5	Ceroid-lipofuscinosis neuronal protein 5	GO:0070085; P:glycosylation; IDA:UniProtKB
O75503	CLN5	Ceroid-lipofuscinosis neuronal protein 5	GO:0007042; P:lysosomal lumen acidification; IMP:UniProtKB
O75503	CLN5	Ceroid-lipofuscinosis neuronal protein 5	GO:0022008; P:neurogenesis; IEP:UniProtKB
O75503	CLN5	Ceroid-lipofuscinosis neuronal protein 5	GO:0042551; P:neuron maturation; NAS:UniProtKB
O75503	CLN5	Ceroid-lipofuscinosis neuronal protein 5	GO:0030163; P:protein catabolic process; NAS:UniProtKB
O75503	CLN5	Ceroid-lipofuscinosis neuronal protein 5	GO:0006465; P:signal peptide processing; IDA:UniProtKB
O75503	CLN5	Ceroid-lipofuscinosis neuronal protein 5	GO:0007601; P:visual perception; IEA:Ensembl
Q9NWW5	CLN6	Ceroid-lipofuscinosis neuronal protein 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NWW5	CLN6	Ceroid-lipofuscinosis neuronal protein 6	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q9NWW5	CLN6	Ceroid-lipofuscinosis neuronal protein 6	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9NWW5	CLN6	Ceroid-lipofuscinosis neuronal protein 6	GO:0044265; P:cellular macromolecule catabolic process; IEA:Ensembl
Q9NWW5	CLN6	Ceroid-lipofuscinosis neuronal protein 6	GO:0008203; P:cholesterol metabolic process; IMP:UniProtKB
Q9NWW5	CLN6	Ceroid-lipofuscinosis neuronal protein 6	GO:0001573; P:ganglioside metabolic process; IMP:UniProtKB
Q9NWW5	CLN6	Ceroid-lipofuscinosis neuronal protein 6	GO:0030203; P:glycosaminoglycan metabolic process; IMP:UniProtKB
Q9NWW5	CLN6	Ceroid-lipofuscinosis neuronal protein 6	GO:0031987; P:locomotion involved in locomotory behavior; IEA:Ensembl
Q9NWW5	CLN6	Ceroid-lipofuscinosis neuronal protein 6	GO:0007042; P:lysosomal lumen acidification; IMP:UniProtKB
Q9NWW5	CLN6	Ceroid-lipofuscinosis neuronal protein 6	GO:0045862; P:positive regulation of proteolysis; IMP:UniProtKB
Q9NWW5	CLN6	Ceroid-lipofuscinosis neuronal protein 6	GO:0030163; P:protein catabolic process; NAS:UniProtKB
Q9NWW5	CLN6	Ceroid-lipofuscinosis neuronal protein 6	GO:0007601; P:visual perception; IEA:Ensembl
Q9UBY8	CLN8	Protein CLN8	GO:0007628; P:adult walking behavior; IEA:Ensembl
Q9UBY8	CLN8	Protein CLN8	GO:0001306; P:age-dependent response to oxidative stress; IEA:Ensembl
Q9UBY8	CLN8	Protein CLN8	GO:0008306; P:associative learning; IEA:Ensembl
Q9UBY8	CLN8	Protein CLN8	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9UBY8	CLN8	Protein CLN8	GO:0044257; P:cellular protein catabolic process; IEA:Ensembl
Q9UBY8	CLN8	Protein CLN8	GO:0046513; P:ceramide biosynthetic process; NAS:UniProtKB
Q9UBY8	CLN8	Protein CLN8	GO:0006672; P:ceramide metabolic process; IMP:UniProtKB
Q9UBY8	CLN8	Protein CLN8	GO:0008203; P:cholesterol metabolic process; IMP:UniProtKB
Q9UBY8	CLN8	Protein CLN8	GO:0051935; P:L-glutamate uptake involved in synaptic transmission; IEA:Ensembl
Q9UBY8	CLN8	Protein CLN8	GO:0008610; P:lipid biosynthetic process; NAS:UniProtKB
Q9UBY8	CLN8	Protein CLN8	GO:0006869; P:lipid transport; NAS:UniProtKB
Q9UBY8	CLN8	Protein CLN8	GO:0007040; P:lysosome organization; IEA:Ensembl
Q9UBY8	CLN8	Protein CLN8	GO:0007006; P:mitochondrial membrane organization; IEA:Ensembl
Q9UBY8	CLN8	Protein CLN8	GO:0050881; P:musculoskeletal movement; IEA:Ensembl
Q9UBY8	CLN8	Protein CLN8	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q9UBY8	CLN8	Protein CLN8	GO:0045861; P:negative regulation of proteolysis; NAS:UniProtKB
Q9UBY8	CLN8	Protein CLN8	GO:0051348; P:negative regulation of transferase activity; IEA:Ensembl
Q9UBY8	CLN8	Protein CLN8	GO:0007399; P:nervous system development; IMP:UniProtKB
Q9UBY8	CLN8	Protein CLN8	GO:0060052; P:neurofilament cytoskeleton organization; IEA:Ensembl
Q9UBY8	CLN8	Protein CLN8	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q9UBY8	CLN8	Protein CLN8	GO:0050884; P:neuromuscular process controlling posture; IEA:Ensembl
Q9UBY8	CLN8	Protein CLN8	GO:0006644; P:phospholipid metabolic process; IMP:UniProtKB
Q9UBY8	CLN8	Protein CLN8	GO:0045494; P:photoreceptor cell maintenance; IEA:Ensembl
Q9UBY8	CLN8	Protein CLN8	GO:0030163; P:protein catabolic process; NAS:UniProtKB
Q9UBY8	CLN8	Protein CLN8	GO:0008361; P:regulation of cell size; IEA:Ensembl
Q9UBY8	CLN8	Protein CLN8	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
Q9UBY8	CLN8	Protein CLN8	GO:0035176; P:social behavior; IEA:Ensembl
Q9UBY8	CLN8	Protein CLN8	GO:0021523; P:somatic motor neuron differentiation; IEA:Ensembl
Q9UBY8	CLN8	Protein CLN8	GO:0007601; P:visual perception; IEA:Ensembl
Q7Z7G1	CLNK	Cytokine-dependent hematopoietic cell linker	GO:0005515; F:protein binding; IPI:IntAct
Q7Z7G1	CLNK	Cytokine-dependent hematopoietic cell linker	GO:0005070; F:SH3/SH2 adaptor activity; NAS:UniProtKB
Q7Z7G1	CLNK	Cytokine-dependent hematopoietic cell linker	GO:0006955; P:immune response; NAS:UniProtKB
Q7Z7G1	CLNK	Cytokine-dependent hematopoietic cell linker	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q7Z7G1	CLNK	Cytokine-dependent hematopoietic cell linker	GO:0009967; P:positive regulation of signal transduction; NAS:GOC
Q7Z7G1	CLNK	Cytokine-dependent hematopoietic cell linker	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:Ensembl
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0001047; F:core promoter binding; ISS:UniProtKB
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0070888; F:E-box binding; IDA:BHF-UCL
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0004402; F:histone acetyltransferase activity; IMP:UniProtKB
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0005515; F:protein binding; IPI:UniProtKB
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:BHF-UCL
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0000982; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0001190; F:RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription; ISS:BHF-UCL
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0004871; F:signal transducer activity; IEA:InterPro
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0071479; P:cellular response to ionizing radiation; IDA:UniProtKB
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0006325; P:chromatin organization; TAS:Reactome
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0032922; P:circadian regulation of gene expression; IDA:UniProtKB
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0007623; P:circadian rhythm; TAS:ProtInc
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0000077; P:DNA damage checkpoint; IMP:UniProtKB
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0016573; P:histone acetylation; IMP:GOC
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0009648; P:photoperiodism; TAS:ProtInc
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IGI:MGI
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0042634; P:regulation of hair cycle; IMP:UniProtKB
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0050796; P:regulation of insulin secretion; ISS:UniProtKB
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:2000074; P:regulation of type B pancreatic cell development; ISS:UniProtKB
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0007165; P:signal transduction; TAS:ProtInc
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0007283; P:spermatogenesis; ISS:UniProtKB
O15516	CLOCK	Circadian locomoter output cycles protein kaput	GO:0006366; P:transcription from RNA polymerase II promoter; ISS:GOC
Q96KA5	CLPTM1L	Cleft lip and palate transmembrane protein 1-like protein	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q92989	CLP1	Polyribonucleotide 5'-hydroxyl-kinase Clp1	GO:0005524; F:ATP binding; TAS:UniProtKB
Q92989	CLP1	Polyribonucleotide 5'-hydroxyl-kinase Clp1	GO:0046404; F:ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity; IEA:UniProtKB-EC
Q92989	CLP1	Polyribonucleotide 5'-hydroxyl-kinase Clp1	GO:0051736; F:ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity; IDA:UniProtKB
Q92989	CLP1	Polyribonucleotide 5'-hydroxyl-kinase Clp1	GO:0051733; F:polydeoxyribonucleotide kinase activity; IDA:UniProtKB
Q92989	CLP1	Polyribonucleotide 5'-hydroxyl-kinase Clp1	GO:0010467; P:gene expression; TAS:Reactome
Q92989	CLP1	Polyribonucleotide 5'-hydroxyl-kinase Clp1	GO:0031124; P:mRNA 3'-end processing; TAS:UniProtKB
Q92989	CLP1	Polyribonucleotide 5'-hydroxyl-kinase Clp1	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q92989	CLP1	Polyribonucleotide 5'-hydroxyl-kinase Clp1	GO:0008380; P:RNA splicing; TAS:Reactome
Q92989	CLP1	Polyribonucleotide 5'-hydroxyl-kinase Clp1	GO:0035087; P:siRNA loading onto RISC involved in RNA interference; IDA:UniProtKB
Q92989	CLP1	Polyribonucleotide 5'-hydroxyl-kinase Clp1	GO:0030423; P:targeting of mRNA for destruction involved in RNA interference; IMP:UniProtKB
Q92989	CLP1	Polyribonucleotide 5'-hydroxyl-kinase Clp1	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q92989	CLP1	Polyribonucleotide 5'-hydroxyl-kinase Clp1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q92989	CLP1	Polyribonucleotide 5'-hydroxyl-kinase Clp1	GO:0006388; P:tRNA splicing, via endonucleolytic cleavage and ligation; IDA:UniProtKB
Q9H078	CLPB	Caseinolytic peptidase B protein homolog	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H078	CLPB	Caseinolytic peptidase B protein homolog	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q9H078	CLPB	Caseinolytic peptidase B protein homolog	GO:0034605; P:cellular response to heat; IDA:UniProtKB
Q16740	CLPP	ATP-dependent Clp protease proteolytic subunit, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q16740	CLPP	ATP-dependent Clp protease proteolytic subunit, mitochondrial	GO:0008233; F:peptidase activity; TAS:ProtInc
Q16740	CLPP	ATP-dependent Clp protease proteolytic subunit, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q16740	CLPP	ATP-dependent Clp protease proteolytic subunit, mitochondrial	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
Q16740	CLPP	ATP-dependent Clp protease proteolytic subunit, mitochondrial	GO:0051260; P:protein homooligomerization; IEA:Ensembl
Q16740	CLPP	ATP-dependent Clp protease proteolytic subunit, mitochondrial	GO:0051603; P:proteolysis involved in cellular protein catabolic process; IDA:UniProtKB
O96005	CLPTM1	Cleft lip and palate transmembrane protein 1	GO:0005515; F:protein binding; IPI:IntAct
O96005	CLPTM1	Cleft lip and palate transmembrane protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O96005	CLPTM1	Cleft lip and palate transmembrane protein 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
O96005	CLPTM1	Cleft lip and palate transmembrane protein 1	GO:0033081; P:regulation of T cell differentiation in thymus; ISS:BHF-UCL
O76031	CLPX	ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial	GO:0005524; F:ATP binding; ISS:UniProtKB
O76031	CLPX	ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial	GO:0016887; F:ATPase activity; IDA:UniProtKB
O76031	CLPX	ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O76031	CLPX	ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial	GO:0016504; F:peptidase activator activity; IDA:UniProtKB
O76031	CLPX	ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
O76031	CLPX	ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial	GO:0006200; P:ATP catabolic process; IDA:UniProtKB
O76031	CLPX	ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial	GO:0010952; P:positive regulation of peptidase activity; IDA:GOC
O76031	CLPX	ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial	GO:0006457; P:protein folding; IEA:InterPro
O76031	CLPX	ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial	GO:0051603; P:proteolysis involved in cellular protein catabolic process; IDA:UniProtKB
P58418	CLRN1	Clarin-1	GO:0007015; P:actin filament organization; IDA:MGI
P58418	CLRN1	Clarin-1	GO:0048870; P:cell motility; IDA:MGI
P58418	CLRN1	Clarin-1	GO:0050957; P:equilibrioception; IMP:HGNC
P58418	CLRN1	Clarin-1	GO:0045494; P:photoreceptor cell maintenance; IMP:HGNC
P58418	CLRN1	Clarin-1	GO:0010592; P:positive regulation of lamellipodium assembly; IDA:MGI
P58418	CLRN1	Clarin-1	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
P58418	CLRN1	Clarin-1	GO:0050953; P:sensory perception of light stimulus; IMP:HGNC
P58418	CLRN1	Clarin-1	GO:0007605; P:sensory perception of sound; IMP:HGNC
P58418	CLRN1	Clarin-1	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q9HAW4	CLSPN	Claspin	GO:0010997; F:anaphase-promoting complex binding; IPI:UniProtKB
Q9HAW4	CLSPN	Claspin	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9HAW4	CLSPN	Claspin	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HAW4	CLSPN	Claspin	GO:0032147; P:activation of protein kinase activity; IDA:UniProtKB
Q9HAW4	CLSPN	Claspin	GO:0006915; P:apoptotic process; TAS:Reactome
Q9HAW4	CLSPN	Claspin	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q9HAW4	CLSPN	Claspin	GO:0000077; P:DNA damage checkpoint; IMP:UniProtKB
Q9HAW4	CLSPN	Claspin	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q9HAW4	CLSPN	Claspin	GO:0006260; P:DNA replication; TAS:Reactome
Q9HAW4	CLSPN	Claspin	GO:0031572; P:G2 DNA damage checkpoint; IDA:UniProtKB
Q9HAW4	CLSPN	Claspin	GO:0033314; P:mitotic DNA replication checkpoint; IMP:UniProtKB
Q9HAW4	CLSPN	Claspin	GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB
Q9Y271	CYSLTR1	Cysteinyl leukotriene receptor 1	GO:0004974; F:leukotriene receptor activity; TAS:ProtInc
Q9Y271	CYSLTR1	Cysteinyl leukotriene receptor 1	GO:0006816; P:calcium ion transport; IEA:Ensembl
Q9Y271	CYSLTR1	Cysteinyl leukotriene receptor 1	GO:0006935; P:chemotaxis; IEA:Ensembl
Q9Y271	CYSLTR1	Cysteinyl leukotriene receptor 1	GO:0006952; P:defense response; TAS:ProtInc
Q9Y271	CYSLTR1	Cysteinyl leukotriene receptor 1	GO:0006954; P:inflammatory response; IEA:Ensembl
Q9Y271	CYSLTR1	Cysteinyl leukotriene receptor 1	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
Q9Y271	CYSLTR1	Cysteinyl leukotriene receptor 1	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
Q9Y271	CYSLTR1	Cysteinyl leukotriene receptor 1	GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl
Q9Y271	CYSLTR1	Cysteinyl leukotriene receptor 1	GO:0007585; P:respiratory gaseous exchange; TAS:ProtInc
Q9NS75	CYSLTR2	Cysteinyl leukotriene receptor 2	GO:0001631; F:cysteinyl leukotriene receptor activity; IEA:Ensembl
Q9NS75	CYSLTR2	Cysteinyl leukotriene receptor 2	GO:0004974; F:leukotriene receptor activity; NAS:UniProtKB
Q9NS75	CYSLTR2	Cysteinyl leukotriene receptor 2	GO:0006955; P:immune response; NAS:UniProtKB
Q9NS75	CYSLTR2	Cysteinyl leukotriene receptor 2	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
Q9NS75	CYSLTR2	Cysteinyl leukotriene receptor 2	GO:0010942; P:positive regulation of cell death; IEA:Ensembl
Q9NS75	CYSLTR2	Cysteinyl leukotriene receptor 2	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl
Q96AJ1	CLUAP1	Clusterin-associated protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q96AJ1	CLUAP1	Clusterin-associated protein 1	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
Q15846	CLUL1	Clusterin-like protein 1	GO:0008219; P:cell death; IEA:InterPro
P10909	CLU	Clusterin	GO:0051787; F:misfolded protein binding; IDA:UniProtKB
P10909	CLU	Clusterin	GO:0005515; F:protein binding; IPI:IntAct
P10909	CLU	Clusterin	GO:0031625; F:ubiquitin protein ligase binding; IDA:UniProtKB
P10909	CLU	Clusterin	GO:0007596; P:blood coagulation; TAS:Reactome
P10909	CLU	Clusterin	GO:0000902; P:cell morphogenesis; IDA:Alzheimers_University_of_Toronto
P10909	CLU	Clusterin	GO:0032286; P:central nervous system myelin maintenance; IMP:Alzheimers_University_of_Toronto
P10909	CLU	Clusterin	GO:0051131; P:chaperone-mediated protein complex assembly; IDA:Alzheimers_University_of_Toronto
P10909	CLU	Clusterin	GO:0061077; P:chaperone-mediated protein folding; IDA:UniProtKB
P10909	CLU	Clusterin	GO:0006956; P:complement activation; TAS:ProtInc
P10909	CLU	Clusterin	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
P10909	CLU	Clusterin	GO:0097435; P:fibril organization; IDA:Alzheimers_University_of_Toronto
P10909	CLU	Clusterin	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
P10909	CLU	Clusterin	GO:0097193; P:intrinsic apoptotic signaling pathway; IDA:UniProtKB
P10909	CLU	Clusterin	GO:0006629; P:lipid metabolic process; NAS:ProtInc
P10909	CLU	Clusterin	GO:0001774; P:microglial cell activation; IDA:Alzheimers_University_of_Toronto
P10909	CLU	Clusterin	GO:0061518; P:microglial cell proliferation; IDA:Alzheimers_University_of_Toronto
P10909	CLU	Clusterin	GO:1902430; P:negative regulation of beta-amyloid formation; IDA:Alzheimers_University_of_Toronto
P10909	CLU	Clusterin	GO:1902230; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; IMP:BHF-UCL
P10909	CLU	Clusterin	GO:0032463; P:negative regulation of protein homooligomerization; IMP:BHF-UCL
P10909	CLU	Clusterin	GO:0030168; P:platelet activation; TAS:Reactome
P10909	CLU	Clusterin	GO:0002576; P:platelet degranulation; TAS:Reactome
P10909	CLU	Clusterin	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
P10909	CLU	Clusterin	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
P10909	CLU	Clusterin	GO:1901216; P:positive regulation of neuron death; IDA:Alzheimers_University_of_Toronto
P10909	CLU	Clusterin	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
P10909	CLU	Clusterin	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IDA:Alzheimers_University_of_Toronto
P10909	CLU	Clusterin	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB
P10909	CLU	Clusterin	GO:0045860; P:positive regulation of protein kinase activity; IMP:Alzheimers_University_of_Toronto
P10909	CLU	Clusterin	GO:2000060; P:positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IMP:UniProtKB
P10909	CLU	Clusterin	GO:0032760; P:positive regulation of tumor necrosis factor production; IDA:Alzheimers_University_of_Toronto
P10909	CLU	Clusterin	GO:0017038; P:protein import; IDA:Alzheimers_University_of_Toronto
P10909	CLU	Clusterin	GO:0050821; P:protein stabilization; IDA:UniProtKB
P10909	CLU	Clusterin	GO:1900221; P:regulation of beta-amyloid clearance; IDA:Alzheimers_University_of_Toronto
P10909	CLU	Clusterin	GO:1901214; P:regulation of neuron death; IDA:Alzheimers_University_of_Toronto
P10909	CLU	Clusterin	GO:0009966; P:regulation of signal transduction; IMP:Alzheimers_University_of_Toronto
P10909	CLU	Clusterin	GO:0001836; P:release of cytochrome c from mitochondria; IC:BHF-UCL
P10909	CLU	Clusterin	GO:0051788; P:response to misfolded protein; IDA:BHF-UCL
P10909	CLU	Clusterin	GO:0009615; P:response to virus; IEP:UniProtKB
P10909	CLU	Clusterin	GO:0043691; P:reverse cholesterol transport; TAS:BHF-UCL
O75153	CLUH	Clustered mitochondria protein homolog	GO:0048312; P:intracellular distribution of mitochondria; IEA:InterPro
Q8IUQ0	CLVS1	Clavesin-1	GO:0080025; F:phosphatidylinositol-3,5-bisphosphate binding; IDA:UniProtKB
Q8IUQ0	CLVS1	Clavesin-1	GO:0005215; F:transporter activity; IEA:InterPro
Q8IUQ0	CLVS1	Clavesin-1	GO:0007040; P:lysosome organization; ISS:UniProtKB
Q5SYC1	CLVS2	Clavesin-2	GO:0080025; F:phosphatidylinositol-3,5-bisphosphate binding; IDA:UniProtKB
Q5SYC1	CLVS2	Clavesin-2	GO:0005215; F:transporter activity; IEA:InterPro
Q5SYC1	CLVS2	Clavesin-2	GO:0007040; P:lysosome organization; ISS:UniProtKB
Q8N0X4	CLYBL	Citrate lyase subunit beta-like protein, mitochondrial	GO:0008815; F:citrate (pro-3S)-lyase activity; IEA:InterPro
Q8N0X4	CLYBL	Citrate lyase subunit beta-like protein, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N0X4	CLYBL	Citrate lyase subunit beta-like protein, mitochondrial	GO:0006725; P:cellular aromatic compound metabolic process; IEA:InterPro
P23946	CMA1	Chymase	GO:0042277; F:peptide binding; IEA:Ensembl
P23946	CMA1	Chymase	GO:0004252; F:serine-type endopeptidase activity; NAS:UniProtKB
P23946	CMA1	Chymase	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
P23946	CMA1	Chymase	GO:0002003; P:angiotensin maturation; TAS:Reactome
P23946	CMA1	Chymase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P23946	CMA1	Chymase	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
P23946	CMA1	Chymase	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P23946	CMA1	Chymase	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P23946	CMA1	Chymase	GO:0050720; P:interleukin-1 beta biosynthetic process; IDA:BHF-UCL
P23946	CMA1	Chymase	GO:0030901; P:midbrain development; IEA:Ensembl
P23946	CMA1	Chymase	GO:0006518; P:peptide metabolic process; IEA:Ensembl
P23946	CMA1	Chymase	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
P23946	CMA1	Chymase	GO:0006508; P:proteolysis; IBA:RefGenome
P23946	CMA1	Chymase	GO:0050727; P:regulation of inflammatory response; IC:BHF-UCL
Q9Y471	CMAHP	Putative cytidine monophosphate-N-acetylneuraminic acid hydroxylase-like protein	GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:InterPro
Q9Y471	CMAHP	Putative cytidine monophosphate-N-acetylneuraminic acid hydroxylase-like protein	GO:0016491; F:oxidoreductase activity; IEA:InterPro
Q96DG6	CMBL	Carboxymethylenebutenolidase homolog	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
O75746	SLC25A12	Calcium-binding mitochondrial carrier protein Aralar1	GO:0005509; F:calcium ion binding; IEA:InterPro
O75746	SLC25A12	Calcium-binding mitochondrial carrier protein Aralar1	GO:0015183; F:L-aspartate transmembrane transporter activity; IDA:UniProtKB
O75746	SLC25A12	Calcium-binding mitochondrial carrier protein Aralar1	GO:0005313; F:L-glutamate transmembrane transporter activity; IDA:UniProtKB
O75746	SLC25A12	Calcium-binding mitochondrial carrier protein Aralar1	GO:0015810; P:aspartate transport; IDA:UniProtKB
O75746	SLC25A12	Calcium-binding mitochondrial carrier protein Aralar1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O75746	SLC25A12	Calcium-binding mitochondrial carrier protein Aralar1	GO:0006094; P:gluconeogenesis; TAS:Reactome
O75746	SLC25A12	Calcium-binding mitochondrial carrier protein Aralar1	GO:0006006; P:glucose metabolic process; TAS:Reactome
O75746	SLC25A12	Calcium-binding mitochondrial carrier protein Aralar1	GO:0015813; P:L-glutamate transport; IDA:UniProtKB
O75746	SLC25A12	Calcium-binding mitochondrial carrier protein Aralar1	GO:0043490; P:malate-aspartate shuttle; IDA:UniProtKB
O75746	SLC25A12	Calcium-binding mitochondrial carrier protein Aralar1	GO:0051592; P:response to calcium ion; IDA:UniProtKB
O75746	SLC25A12	Calcium-binding mitochondrial carrier protein Aralar1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75746	SLC25A12	Calcium-binding mitochondrial carrier protein Aralar1	GO:0055085; P:transmembrane transport; IEA:InterPro
Q9UJS0	SLC25A13	Calcium-binding mitochondrial carrier protein Aralar2	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q9UJS0	SLC25A13	Calcium-binding mitochondrial carrier protein Aralar2	GO:0015183; F:L-aspartate transmembrane transporter activity; IDA:UniProtKB
Q9UJS0	SLC25A13	Calcium-binding mitochondrial carrier protein Aralar2	GO:0005313; F:L-glutamate transmembrane transporter activity; IDA:UniProtKB
Q9UJS0	SLC25A13	Calcium-binding mitochondrial carrier protein Aralar2	GO:0005215; F:transporter activity; NAS:UniProtKB
Q9UJS0	SLC25A13	Calcium-binding mitochondrial carrier protein Aralar2	GO:0015810; P:aspartate transport; IDA:UniProtKB
Q9UJS0	SLC25A13	Calcium-binding mitochondrial carrier protein Aralar2	GO:0006754; P:ATP biosynthetic process; IDA:UniProtKB
Q9UJS0	SLC25A13	Calcium-binding mitochondrial carrier protein Aralar2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9UJS0	SLC25A13	Calcium-binding mitochondrial carrier protein Aralar2	GO:0045333; P:cellular respiration; IDA:UniProtKB
Q9UJS0	SLC25A13	Calcium-binding mitochondrial carrier protein Aralar2	GO:0006094; P:gluconeogenesis; TAS:Reactome
Q9UJS0	SLC25A13	Calcium-binding mitochondrial carrier protein Aralar2	GO:0006006; P:glucose metabolic process; TAS:Reactome
Q9UJS0	SLC25A13	Calcium-binding mitochondrial carrier protein Aralar2	GO:0015813; P:L-glutamate transport; IDA:UniProtKB
Q9UJS0	SLC25A13	Calcium-binding mitochondrial carrier protein Aralar2	GO:0043490; P:malate-aspartate shuttle; IDA:UniProtKB
Q9UJS0	SLC25A13	Calcium-binding mitochondrial carrier protein Aralar2	GO:0051592; P:response to calcium ion; IDA:UniProtKB
Q9UJS0	SLC25A13	Calcium-binding mitochondrial carrier protein Aralar2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UJS0	SLC25A13	Calcium-binding mitochondrial carrier protein Aralar2	GO:0006810; P:transport; NAS:UniProtKB
P56277	CMC4	Cx9C motif-containing protein 4	GO:0008283; P:cell proliferation; TAS:ProtInc
P10645	CHGA	Chromogranin-A	GO:0008217; P:regulation of blood pressure; TAS:ProtInc
Q8IY22	CMIP	C-Maf-inducing protein	GO:0005515; F:protein binding; IPI:IntAct
Q7Z624	CAMKMT	Calmodulin-lysine N-methyltransferase	GO:0018025; F:calmodulin-lysine N-methyltransferase activity; IEA:UniProtKB-EC
Q99788	CMKLR1	Chemokine-like receptor 1	GO:0004950; F:chemokine receptor activity; TAS:ProtInc
Q99788	CMKLR1	Chemokine-like receptor 1	GO:0004930; F:G-protein coupled receptor activity; NAS:UniProtKB
Q99788	CMKLR1	Chemokine-like receptor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q99788	CMKLR1	Chemokine-like receptor 1	GO:0004872; F:receptor activity; TAS:ProtInc
Q99788	CMKLR1	Chemokine-like receptor 1	GO:0070098; P:chemokine-mediated signaling pathway; TAS:GOC
Q99788	CMKLR1	Chemokine-like receptor 1	GO:0006935; P:chemotaxis; IDA:UniProtKB
Q99788	CMKLR1	Chemokine-like receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:UniProtKB
Q99788	CMKLR1	Chemokine-like receptor 1	GO:0006955; P:immune response; TAS:ProtInc
Q99788	CMKLR1	Chemokine-like receptor 1	GO:0032695; P:negative regulation of interleukin-12 production; ISS:UniProtKB
Q99788	CMKLR1	Chemokine-like receptor 1	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q99788	CMKLR1	Chemokine-like receptor 1	GO:0045600; P:positive regulation of fat cell differentiation; ISS:UniProtKB
Q99788	CMKLR1	Chemokine-like receptor 1	GO:0010759; P:positive regulation of macrophage chemotaxis; IMP:DFLAT
Q99788	CMKLR1	Chemokine-like receptor 1	GO:0050848; P:regulation of calcium-mediated signaling; IDA:UniProtKB
Q99788	CMKLR1	Chemokine-like receptor 1	GO:0001501; P:skeletal system development; TAS:ProtInc
Q5EBM0	CMPK2	UMP-CMP kinase 2, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5EBM0	CMPK2	UMP-CMP kinase 2, mitochondrial	GO:0004127; F:cytidylate kinase activity; IDA:MGI
Q5EBM0	CMPK2	UMP-CMP kinase 2, mitochondrial	GO:0004550; F:nucleoside diphosphate kinase activity; IDA:UniProtKB
Q5EBM0	CMPK2	UMP-CMP kinase 2, mitochondrial	GO:0004798; F:thymidylate kinase activity; IEA:Ensembl
Q5EBM0	CMPK2	UMP-CMP kinase 2, mitochondrial	GO:0033862; F:UMP kinase activity; IDA:MGI
Q5EBM0	CMPK2	UMP-CMP kinase 2, mitochondrial	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
Q5EBM0	CMPK2	UMP-CMP kinase 2, mitochondrial	GO:0006233; P:dTDP biosynthetic process; IEA:Ensembl
Q5EBM0	CMPK2	UMP-CMP kinase 2, mitochondrial	GO:0006227; P:dUDP biosynthetic process; IEA:Ensembl
Q5EBM0	CMPK2	UMP-CMP kinase 2, mitochondrial	GO:0006165; P:nucleoside diphosphate phosphorylation; IDA:UniProtKB
Q5EBM0	CMPK2	UMP-CMP kinase 2, mitochondrial	GO:0009142; P:nucleoside triphosphate biosynthetic process; IDA:UniProtKB
Q9BQ75	CMSS1	Protein CMSS1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y6Y1	CAMTA1	Calmodulin-binding transcription activator 1	GO:0003677; F:DNA binding; IEA:InterPro
Q9Y6Y1	CAMTA1	Calmodulin-binding transcription activator 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y6Y1	CAMTA1	Calmodulin-binding transcription activator 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O94983	CAMTA2	Calmodulin-binding transcription activator 2	GO:0003682; F:chromatin binding; IDA:MGI
O94983	CAMTA2	Calmodulin-binding transcription activator 2	GO:0003677; F:DNA binding; IEA:InterPro
O94983	CAMTA2	Calmodulin-binding transcription activator 2	GO:0042826; F:histone deacetylase binding; IDA:MGI
O94983	CAMTA2	Calmodulin-binding transcription activator 2	GO:0005515; F:protein binding; IPI:IntAct
O94983	CAMTA2	Calmodulin-binding transcription activator 2	GO:0008134; F:transcription factor binding; IGI:MGI
O94983	CAMTA2	Calmodulin-binding transcription activator 2	GO:0014898; P:cardiac muscle hypertrophy in response to stress; IDA:MGI
O94983	CAMTA2	Calmodulin-binding transcription activator 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IGI:MGI
O94983	CAMTA2	Calmodulin-binding transcription activator 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:MGI
O94983	CAMTA2	Calmodulin-binding transcription activator 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86VU5	COMTD1	Catechol O-methyltransferase domain-containing protein 1	GO:0008171; F:O-methyltransferase activity; IEA:InterPro
Q8N1G2	CMTR1	Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1	GO:0004483; F:mRNA (nucleoside-2'-O-)-methyltransferase activity; IDA:UniProtKB
Q8N1G2	CMTR1	Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8N1G2	CMTR1	Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1	GO:0006370; P:7-methylguanosine mRNA capping; IDA:UniProtKB
Q8N1G2	CMTR1	Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1	GO:0097309; P:cap1 mRNA methylation; IDA:UniProtKB
Q8N1G2	CMTR1	Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1	GO:0080009; P:mRNA methylation; IDA:UniProtKB
Q8IYT2	CMTR2	Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2	GO:0004483; F:mRNA (nucleoside-2'-O-)-methyltransferase activity; IDA:UniProtKB
Q8IYT2	CMTR2	Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2	GO:0006370; P:7-methylguanosine mRNA capping; IDA:UniProtKB
Q8IYT2	CMTR2	Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2	GO:0097310; P:cap2 mRNA methylation; IDA:UniProtKB
Q8N3K9	CMYA5	Cardiomyopathy-associated protein 5	GO:0005515; F:protein binding; IPI:IntAct
Q8N3K9	CMYA5	Cardiomyopathy-associated protein 5	GO:0070885; P:negative regulation of calcineurin-NFAT signaling cascade; IEA:Ensembl
Q8N3K9	CMYA5	Cardiomyopathy-associated protein 5	GO:0032513; P:negative regulation of protein phosphatase type 2B activity; IEA:Ensembl
Q8N3K9	CMYA5	Cardiomyopathy-associated protein 5	GO:0014733; P:regulation of skeletal muscle adaptation; IEA:Ensembl
Q9H972	C14orf93	Uncharacterized protein C14orf93	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
A8MTL3	C14orf164	RING finger protein C14orf164	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y224	C14orf166	UPF0568 protein C14orf166	GO:0042802; F:identical protein binding; IPI:IntAct
Q9Y224	C14orf166	UPF0568 protein C14orf166	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y224	C14orf166	UPF0568 protein C14orf166	GO:0005515; F:protein binding; IPI:IntAct
Q9Y224	C14orf166	UPF0568 protein C14orf166	GO:0000993; F:RNA polymerase II core binding; IDA:UniProtKB
Q9Y224	C14orf166	UPF0568 protein C14orf166	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q9Y224	C14orf166	UPF0568 protein C14orf166	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y224	C14orf166	UPF0568 protein C14orf166	GO:0016032; P:viral process; IEA:UniProtKB-KW
P09543	CNP	2',3'-cyclic-nucleotide 3'-phosphodiesterase	GO:0004113; F:2',3'-cyclic-nucleotide 3'-phosphodiesterase activity; TAS:ProtInc
P09543	CNP	2',3'-cyclic-nucleotide 3'-phosphodiesterase	GO:0030551; F:cyclic nucleotide binding; IEA:Ensembl
P09543	CNP	2',3'-cyclic-nucleotide 3'-phosphodiesterase	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
P09543	CNP	2',3'-cyclic-nucleotide 3'-phosphodiesterase	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P09543	CNP	2',3'-cyclic-nucleotide 3'-phosphodiesterase	GO:0007568; P:aging; IEA:Ensembl
P09543	CNP	2',3'-cyclic-nucleotide 3'-phosphodiesterase	GO:0007409; P:axonogenesis; IEA:Ensembl
P09543	CNP	2',3'-cyclic-nucleotide 3'-phosphodiesterase	GO:0009214; P:cyclic nucleotide catabolic process; IEA:InterPro
P09543	CNP	2',3'-cyclic-nucleotide 3'-phosphodiesterase	GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl
P09543	CNP	2',3'-cyclic-nucleotide 3'-phosphodiesterase	GO:0046902; P:regulation of mitochondrial membrane permeability; IEA:Ensembl
P09543	CNP	2',3'-cyclic-nucleotide 3'-phosphodiesterase	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P09543	CNP	2',3'-cyclic-nucleotide 3'-phosphodiesterase	GO:0009636; P:response to toxic substance; IEA:Ensembl
P09543	CNP	2',3'-cyclic-nucleotide 3'-phosphodiesterase	GO:0021762; P:substantia nigra development; IEP:UniProt
P09543	CNP	2',3'-cyclic-nucleotide 3'-phosphodiesterase	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q9NSA3	CTNNBIP1	Beta-catenin-interacting protein 1	GO:0070016; F:armadillo repeat domain binding; IPI:BHF-UCL
Q9NSA3	CTNNBIP1	Beta-catenin-interacting protein 1	GO:0008013; F:beta-catenin binding; IPI:BHF-UCL
Q9NSA3	CTNNBIP1	Beta-catenin-interacting protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NSA3	CTNNBIP1	Beta-catenin-interacting protein 1	GO:0009952; P:anterior/posterior pattern specification; IBA:RefGenome
Q9NSA3	CTNNBIP1	Beta-catenin-interacting protein 1	GO:0001658; P:branching involved in ureteric bud morphogenesis; IBA:RefGenome
Q9NSA3	CTNNBIP1	Beta-catenin-interacting protein 1	GO:0043392; P:negative regulation of DNA binding; IEA:Ensembl
Q9NSA3	CTNNBIP1	Beta-catenin-interacting protein 1	GO:0072201; P:negative regulation of mesenchymal cell proliferation; IMP:BHF-UCL
Q9NSA3	CTNNBIP1	Beta-catenin-interacting protein 1	GO:0032091; P:negative regulation of protein binding; IDA:BHF-UCL
Q9NSA3	CTNNBIP1	Beta-catenin-interacting protein 1	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL
Q9NSA3	CTNNBIP1	Beta-catenin-interacting protein 1	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IEA:Ensembl
Q9NSA3	CTNNBIP1	Beta-catenin-interacting protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9NSA3	CTNNBIP1	Beta-catenin-interacting protein 1	GO:0060633; P:negative regulation of transcription initiation from RNA polymerase II promoter; IEA:Ensembl
Q9NSA3	CTNNBIP1	Beta-catenin-interacting protein 1	GO:0030178; P:negative regulation of Wnt signaling pathway; IBA:RefGenome
Q9NSA3	CTNNBIP1	Beta-catenin-interacting protein 1	GO:0045657; P:positive regulation of monocyte differentiation; IMP:BHF-UCL
Q9NSA3	CTNNBIP1	Beta-catenin-interacting protein 1	GO:0045669; P:positive regulation of osteoblast differentiation; IMP:BHF-UCL
Q9NSA3	CTNNBIP1	Beta-catenin-interacting protein 1	GO:0002528; P:regulation of vascular permeability involved in acute inflammatory response; IMP:BHF-UCL
Q9NSA3	CTNNBIP1	Beta-catenin-interacting protein 1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P62633	CNBP	Cellular nucleic acid-binding protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62633	CNBP	Cellular nucleic acid-binding protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P62633	CNBP	Cellular nucleic acid-binding protein	GO:0003697; F:single-stranded DNA binding; IEA:Ensembl
P62633	CNBP	Cellular nucleic acid-binding protein	GO:0003727; F:single-stranded RNA binding; IEA:Ensembl
P62633	CNBP	Cellular nucleic acid-binding protein	GO:0008270; F:zinc ion binding; IEA:InterPro
P62633	CNBP	Cellular nucleic acid-binding protein	GO:0006695; P:cholesterol biosynthetic process; TAS:ProtInc
P62633	CNBP	Cellular nucleic acid-binding protein	GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB
P62633	CNBP	Cellular nucleic acid-binding protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
P62633	CNBP	Cellular nucleic acid-binding protein	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
P62633	CNBP	Cellular nucleic acid-binding protein	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
P62633	CNBP	Cellular nucleic acid-binding protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13956	PDE6H	Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; IEA:UniProtKB-EC
Q13956	PDE6H	Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0030553; F:cGMP binding; IEA:InterPro
Q13956	PDE6H	Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0004857; F:enzyme inhibitor activity; TAS:ProtInc
Q13956	PDE6H	Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
Q13956	PDE6H	Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
Q13956	PDE6H	Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0045742; P:positive regulation of epidermal growth factor receptor signaling pathway; IEA:Ensembl
Q13956	PDE6H	Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0045745; P:positive regulation of G-protein coupled receptor protein signaling pathway; IEA:Ensembl
Q13956	PDE6H	Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q13956	PDE6H	Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0007601; P:visual perception; TAS:ProtInc
Q15021	NCAPD2	Condensin complex subunit 1	GO:0042393; F:histone binding; IDA:UniProtKB
Q15021	NCAPD2	Condensin complex subunit 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15021	NCAPD2	Condensin complex subunit 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q15021	NCAPD2	Condensin complex subunit 1	GO:0007076; P:mitotic chromosome condensation; IDA:UniProtKB
Q15003	NCAPH	Condensin complex subunit 2	GO:0005515; F:protein binding; IPI:IntAct
Q15003	NCAPH	Condensin complex subunit 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q15003	NCAPH	Condensin complex subunit 2	GO:0007076; P:mitotic chromosome condensation; IDA:UniProtKB
Q9BPX3	NCAPG	Condensin complex subunit 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BPX3	NCAPG	Condensin complex subunit 3	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9BPX3	NCAPG	Condensin complex subunit 3	GO:0007076; P:mitotic chromosome condensation; IDA:UniProtKB
P42695	NCAPD3	Condensin-2 complex subunit D3	GO:0035064; F:methylated histone binding; IDA:UniProtKB
P42695	NCAPD3	Condensin-2 complex subunit D3	GO:0005515; F:protein binding; IPI:UniProtKB
P42695	NCAPD3	Condensin-2 complex subunit D3	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P42695	NCAPD3	Condensin-2 complex subunit D3	GO:0007076; P:mitotic chromosome condensation; IDA:UniProtKB
Q86XI2	NCAPG2	Condensin-2 complex subunit G2	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q86XI2	NCAPG2	Condensin-2 complex subunit G2	GO:0005515; F:protein binding; IPI:IntAct
Q86XI2	NCAPG2	Condensin-2 complex subunit G2	GO:0030261; P:chromosome condensation; IEA:UniProtKB-KW
Q86XI2	NCAPG2	Condensin-2 complex subunit G2	GO:0001833; P:inner cell mass cell proliferation; IEA:Ensembl
Q86XI2	NCAPG2	Condensin-2 complex subunit G2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q86XI2	NCAPG2	Condensin-2 complex subunit G2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q6IBW4	NCAPH2	Condensin-2 complex subunit H2	GO:0005515; F:protein binding; IPI:IntAct
Q6IBW4	NCAPH2	Condensin-2 complex subunit H2	GO:0030261; P:chromosome condensation; IEA:UniProtKB-KW
Q6IBW4	NCAPH2	Condensin-2 complex subunit H2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q96KN2	CNDP1	Beta-Ala-His dipeptidase	GO:0004180; F:carboxypeptidase activity; IEA:UniProtKB-KW
Q96KN2	CNDP1	Beta-Ala-His dipeptidase	GO:0016805; F:dipeptidase activity; IEA:InterPro
Q96KN2	CNDP1	Beta-Ala-His dipeptidase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96KN2	CNDP1	Beta-Ala-His dipeptidase	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
Q96KN2	CNDP1	Beta-Ala-His dipeptidase	GO:0034701; F:tripeptidase activity; IEA:InterPro
Q96KP4	CNDP2	Cytosolic non-specific dipeptidase	GO:0004180; F:carboxypeptidase activity; TAS:Reactome
Q96KP4	CNDP2	Cytosolic non-specific dipeptidase	GO:0016805; F:dipeptidase activity; IEA:InterPro
Q96KP4	CNDP2	Cytosolic non-specific dipeptidase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96KP4	CNDP2	Cytosolic non-specific dipeptidase	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
Q96KP4	CNDP2	Cytosolic non-specific dipeptidase	GO:0034701; F:tripeptidase activity; IEA:InterPro
Q96KP4	CNDP2	Cytosolic non-specific dipeptidase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q96KP4	CNDP2	Cytosolic non-specific dipeptidase	GO:0006750; P:glutathione biosynthetic process; TAS:Reactome
Q96KP4	CNDP2	Cytosolic non-specific dipeptidase	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
Q96KP4	CNDP2	Cytosolic non-specific dipeptidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96KP4	CNDP2	Cytosolic non-specific dipeptidase	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
Q96KP4	CNDP2	Cytosolic non-specific dipeptidase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
O95476	CTDNEP1	CTD nuclear envelope phosphatase 1	GO:0005515; F:protein binding; IPI:IntAct
O95476	CTDNEP1	CTD nuclear envelope phosphatase 1	GO:0004722; F:protein serine/threonine phosphatase activity; IMP:UniProtKB
O95476	CTDNEP1	CTD nuclear envelope phosphatase 1	GO:0006998; P:nuclear envelope organization; IDA:UniProtKB
O95476	CTDNEP1	CTD nuclear envelope phosphatase 1	GO:0010867; P:positive regulation of triglyceride biosynthetic process; IGI:UniProtKB
O95476	CTDNEP1	CTD nuclear envelope phosphatase 1	GO:0006470; P:protein dephosphorylation; IDA:UniProtKB
O95476	CTDNEP1	CTD nuclear envelope phosphatase 1	GO:0034504; P:protein localization to nucleus; IDA:UniProtKB
Q9BYD5	CNFN	Cornifelin	GO:0031424; P:keratinization; IEA:UniProtKB-KW
P29973	CNGA1	cGMP-gated cation channel alpha-1	GO:0030553; F:cGMP binding; IBA:RefGenome
P29973	CNGA1	cGMP-gated cation channel alpha-1	GO:0005222; F:intracellular cAMP activated cation channel activity; IBA:RefGenome
P29973	CNGA1	cGMP-gated cation channel alpha-1	GO:0005223; F:intracellular cGMP activated cation channel activity; IBA:RefGenome
P29973	CNGA1	cGMP-gated cation channel alpha-1	GO:0005515; F:protein binding; IPI:IntAct
P29973	CNGA1	cGMP-gated cation channel alpha-1	GO:0005249; F:voltage-gated potassium channel activity; IBA:RefGenome
P29973	CNGA1	cGMP-gated cation channel alpha-1	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P29973	CNGA1	cGMP-gated cation channel alpha-1	GO:0071805; P:potassium ion transmembrane transport; IBA:RefGenome
P29973	CNGA1	cGMP-gated cation channel alpha-1	GO:0042391; P:regulation of membrane potential; IBA:RefGenome
P29973	CNGA1	cGMP-gated cation channel alpha-1	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
P29973	CNGA1	cGMP-gated cation channel alpha-1	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
P29973	CNGA1	cGMP-gated cation channel alpha-1	GO:0006810; P:transport; TAS:ProtInc
P29973	CNGA1	cGMP-gated cation channel alpha-1	GO:0007601; P:visual perception; TAS:ProtInc
Q16280	CNGA2	Cyclic nucleotide-gated olfactory channel	GO:0030552; F:cAMP binding; IEA:UniProtKB-KW
Q16280	CNGA2	Cyclic nucleotide-gated olfactory channel	GO:0030553; F:cGMP binding; IBA:RefGenome
Q16280	CNGA2	Cyclic nucleotide-gated olfactory channel	GO:0005223; F:intracellular cGMP activated cation channel activity; IBA:RefGenome
Q16280	CNGA2	Cyclic nucleotide-gated olfactory channel	GO:0005249; F:voltage-gated potassium channel activity; IBA:RefGenome
Q16280	CNGA2	Cyclic nucleotide-gated olfactory channel	GO:0007603; P:phototransduction, visible light; IBA:RefGenome
Q16280	CNGA2	Cyclic nucleotide-gated olfactory channel	GO:0071805; P:potassium ion transmembrane transport; IBA:RefGenome
Q16280	CNGA2	Cyclic nucleotide-gated olfactory channel	GO:0042391; P:regulation of membrane potential; IBA:RefGenome
Q16280	CNGA2	Cyclic nucleotide-gated olfactory channel	GO:0007608; P:sensory perception of smell; IEA:UniProtKB-KW
Q16281	CNGA3	Cyclic nucleotide-gated cation channel alpha-3	GO:0030553; F:cGMP binding; IMP:UniProt
Q16281	CNGA3	Cyclic nucleotide-gated cation channel alpha-3	GO:0005222; F:intracellular cAMP activated cation channel activity; IBA:RefGenome
Q16281	CNGA3	Cyclic nucleotide-gated cation channel alpha-3	GO:0005223; F:intracellular cGMP activated cation channel activity; IMP:UniProt
Q16281	CNGA3	Cyclic nucleotide-gated cation channel alpha-3	GO:0015276; F:ligand-gated ion channel activity; TAS:ProtInc
Q16281	CNGA3	Cyclic nucleotide-gated cation channel alpha-3	GO:0005249; F:voltage-gated potassium channel activity; IBA:RefGenome
Q16281	CNGA3	Cyclic nucleotide-gated cation channel alpha-3	GO:0006812; P:cation transport; IMP:UniProt
Q16281	CNGA3	Cyclic nucleotide-gated cation channel alpha-3	GO:0007603; P:phototransduction, visible light; IBA:RefGenome
Q16281	CNGA3	Cyclic nucleotide-gated cation channel alpha-3	GO:0071805; P:potassium ion transmembrane transport; IBA:RefGenome
Q16281	CNGA3	Cyclic nucleotide-gated cation channel alpha-3	GO:0042391; P:regulation of membrane potential; IBA:RefGenome
Q16281	CNGA3	Cyclic nucleotide-gated cation channel alpha-3	GO:0051591; P:response to cAMP; IEA:Ensembl
Q16281	CNGA3	Cyclic nucleotide-gated cation channel alpha-3	GO:0031960; P:response to corticosteroid; IEA:Ensembl
Q16281	CNGA3	Cyclic nucleotide-gated cation channel alpha-3	GO:0032026; P:response to magnesium ion; IEA:Ensembl
Q16281	CNGA3	Cyclic nucleotide-gated cation channel alpha-3	GO:0046549; P:retinal cone cell development; IEA:Ensembl
Q16281	CNGA3	Cyclic nucleotide-gated cation channel alpha-3	GO:0007165; P:signal transduction; TAS:ProtInc
Q16281	CNGA3	Cyclic nucleotide-gated cation channel alpha-3	GO:0006810; P:transport; TAS:ProtInc
Q16281	CNGA3	Cyclic nucleotide-gated cation channel alpha-3	GO:0007601; P:visual perception; TAS:ProtInc
Q8IV77	CNGA4	Cyclic nucleotide-gated cation channel alpha-4	GO:0030552; F:cAMP binding; IEA:UniProtKB-KW
Q8IV77	CNGA4	Cyclic nucleotide-gated cation channel alpha-4	GO:0030553; F:cGMP binding; IBA:RefGenome
Q8IV77	CNGA4	Cyclic nucleotide-gated cation channel alpha-4	GO:0005222; F:intracellular cAMP activated cation channel activity; IBA:RefGenome
Q8IV77	CNGA4	Cyclic nucleotide-gated cation channel alpha-4	GO:0005223; F:intracellular cGMP activated cation channel activity; IBA:RefGenome
Q8IV77	CNGA4	Cyclic nucleotide-gated cation channel alpha-4	GO:0005249; F:voltage-gated potassium channel activity; IBA:RefGenome
Q8IV77	CNGA4	Cyclic nucleotide-gated cation channel alpha-4	GO:0007603; P:phototransduction, visible light; IBA:RefGenome
Q8IV77	CNGA4	Cyclic nucleotide-gated cation channel alpha-4	GO:0071805; P:potassium ion transmembrane transport; IBA:RefGenome
Q8IV77	CNGA4	Cyclic nucleotide-gated cation channel alpha-4	GO:0042391; P:regulation of membrane potential; IBA:RefGenome
Q8IV77	CNGA4	Cyclic nucleotide-gated cation channel alpha-4	GO:0007608; P:sensory perception of smell; IEA:UniProtKB-KW
Q14028	CNGB1	Cyclic nucleotide-gated cation channel beta-1	GO:0030552; F:cAMP binding; IEA:UniProtKB-KW
Q14028	CNGB1	Cyclic nucleotide-gated cation channel beta-1	GO:0030553; F:cGMP binding; IDA:UniProt
Q14028	CNGB1	Cyclic nucleotide-gated cation channel beta-1	GO:0005222; F:intracellular cAMP activated cation channel activity; IEA:Ensembl
Q14028	CNGB1	Cyclic nucleotide-gated cation channel beta-1	GO:0005223; F:intracellular cGMP activated cation channel activity; IDA:UniProt
Q14028	CNGB1	Cyclic nucleotide-gated cation channel beta-1	GO:0015276; F:ligand-gated ion channel activity; TAS:ProtInc
Q14028	CNGB1	Cyclic nucleotide-gated cation channel beta-1	GO:0005515; F:protein binding; IPI:IntAct
Q14028	CNGB1	Cyclic nucleotide-gated cation channel beta-1	GO:0005249; F:voltage-gated potassium channel activity; IBA:RefGenome
Q14028	CNGB1	Cyclic nucleotide-gated cation channel beta-1	GO:0006812; P:cation transport; IDA:UniProt
Q14028	CNGB1	Cyclic nucleotide-gated cation channel beta-1	GO:0051480; P:cytosolic calcium ion homeostasis; IEA:Ensembl
Q14028	CNGB1	Cyclic nucleotide-gated cation channel beta-1	GO:0050908; P:detection of light stimulus involved in visual perception; IMP:UniProt
Q14028	CNGB1	Cyclic nucleotide-gated cation channel beta-1	GO:0007603; P:phototransduction, visible light; TAS:Reactome
Q14028	CNGB1	Cyclic nucleotide-gated cation channel beta-1	GO:0071805; P:potassium ion transmembrane transport; IBA:RefGenome
Q14028	CNGB1	Cyclic nucleotide-gated cation channel beta-1	GO:0051290; P:protein heterotetramerization; IEA:Ensembl
Q14028	CNGB1	Cyclic nucleotide-gated cation channel beta-1	GO:0042391; P:regulation of membrane potential; IBA:RefGenome
Q14028	CNGB1	Cyclic nucleotide-gated cation channel beta-1	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
Q14028	CNGB1	Cyclic nucleotide-gated cation channel beta-1	GO:0001895; P:retina homeostasis; IMP:UniProt
Q14028	CNGB1	Cyclic nucleotide-gated cation channel beta-1	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
Q14028	CNGB1	Cyclic nucleotide-gated cation channel beta-1	GO:0007608; P:sensory perception of smell; IEA:UniProtKB-KW
Q14028	CNGB1	Cyclic nucleotide-gated cation channel beta-1	GO:0006810; P:transport; TAS:ProtInc
Q14028	CNGB1	Cyclic nucleotide-gated cation channel beta-1	GO:0007601; P:visual perception; TAS:ProtInc
Q9NQW8	CNGB3	Cyclic nucleotide-gated cation channel beta-3	GO:0030553; F:cGMP binding; IDA:UniProt
Q9NQW8	CNGB3	Cyclic nucleotide-gated cation channel beta-3	GO:0005222; F:intracellular cAMP activated cation channel activity; IBA:RefGenome
Q9NQW8	CNGB3	Cyclic nucleotide-gated cation channel beta-3	GO:0005223; F:intracellular cGMP activated cation channel activity; IDA:UniProt
Q9NQW8	CNGB3	Cyclic nucleotide-gated cation channel beta-3	GO:0005249; F:voltage-gated potassium channel activity; IBA:RefGenome
Q9NQW8	CNGB3	Cyclic nucleotide-gated cation channel beta-3	GO:0006812; P:cation transport; IDA:UniProt
Q9NQW8	CNGB3	Cyclic nucleotide-gated cation channel beta-3	GO:0007603; P:phototransduction, visible light; IBA:RefGenome
Q9NQW8	CNGB3	Cyclic nucleotide-gated cation channel beta-3	GO:0071805; P:potassium ion transmembrane transport; IBA:RefGenome
Q9NQW8	CNGB3	Cyclic nucleotide-gated cation channel beta-3	GO:0042391; P:regulation of membrane potential; IBA:RefGenome
Q9NQW8	CNGB3	Cyclic nucleotide-gated cation channel beta-3	GO:0007165; P:signal transduction; NAS:ProtInc
Q9NQW8	CNGB3	Cyclic nucleotide-gated cation channel beta-3	GO:0006810; P:transport; NAS:ProtInc
Q9NQW8	CNGB3	Cyclic nucleotide-gated cation channel beta-3	GO:0007601; P:visual perception; TAS:ProtInc
O95406	CNIH1	Protein cornichon homolog 1	GO:0006955; P:immune response; TAS:ProtInc
O95406	CNIH1	Protein cornichon homolog 1	GO:0035556; P:intracellular signal transduction; IEA:InterPro
O95406	CNIH1	Protein cornichon homolog 1	GO:0007165; P:signal transduction; TAS:ProtInc
O95406	CNIH1	Protein cornichon homolog 1	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q6PI25	CNIH2	Protein cornichon homolog 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q6PI25	CNIH2	Protein cornichon homolog 2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q6PI25	CNIH2	Protein cornichon homolog 2	GO:0051668; P:localization within membrane; IEA:Ensembl
Q6PI25	CNIH2	Protein cornichon homolog 2	GO:2000311; P:regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; IDA:UniProtKB
Q6PI25	CNIH2	Protein cornichon homolog 2	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
Q6PI25	CNIH2	Protein cornichon homolog 2	GO:0035249; P:synaptic transmission, glutamatergic; IEA:Ensembl
Q8TBE1	CNIH3	Protein cornichon homolog 3	GO:0016247; F:channel regulator activity; IEA:Ensembl
Q8TBE1	CNIH3	Protein cornichon homolog 3	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8TBE1	CNIH3	Protein cornichon homolog 3	GO:2000311; P:regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; IDA:UniProtKB
Q8TBE1	CNIH3	Protein cornichon homolog 3	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
Q8TBE1	CNIH3	Protein cornichon homolog 3	GO:0035249; P:synaptic transmission, glutamatergic; IEA:Ensembl
Q9P003	CNIH4	Protein cornichon homolog 4	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q969H4	CNKSR1	Connector enhancer of kinase suppressor of ras 1	GO:0030674; F:protein binding, bridging; IDA:MGI
Q969H4	CNKSR1	Connector enhancer of kinase suppressor of ras 1	GO:0007265; P:Ras protein signal transduction; IPI:MGI
Q969H4	CNKSR1	Connector enhancer of kinase suppressor of ras 1	GO:0007266; P:Rho protein signal transduction; IPI:MGI
Q969H4	CNKSR1	Connector enhancer of kinase suppressor of ras 1	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc
Q8WXI2	CNKSR2	Connector enhancer of kinase suppressor of ras 2	GO:0009966; P:regulation of signal transduction; IEA:InterPro
Q6P9H4	CNKSR3	Connector enhancer of kinase suppressor of ras 3	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
Q6P9H4	CNKSR3	Connector enhancer of kinase suppressor of ras 3	GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; ISS:UniProtKB
Q6P9H4	CNKSR3	Connector enhancer of kinase suppressor of ras 3	GO:0010765; P:positive regulation of sodium ion transport; ISS:UniProtKB
P51911	CNN1	Calponin-1	GO:0031032; P:actomyosin structure organization; IEA:InterPro
P51911	CNN1	Calponin-1	GO:0006940; P:regulation of smooth muscle contraction; TAS:UniProtKB
Q99439	CNN2	Calponin-2	GO:0003779; F:actin binding; TAS:ProtInc
Q99439	CNN2	Calponin-2	GO:0031032; P:actomyosin structure organization; IEA:InterPro
Q99439	CNN2	Calponin-2	GO:0071260; P:cellular response to mechanical stimulus; IDA:MGI
Q99439	CNN2	Calponin-2	GO:0007010; P:cytoskeleton organization; TAS:ProtInc
Q99439	CNN2	Calponin-2	GO:0030097; P:hemopoiesis; IEA:Ensembl
Q99439	CNN2	Calponin-2	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
Q99439	CNN2	Calponin-2	GO:0050765; P:negative regulation of phagocytosis; IEA:Ensembl
Q99439	CNN2	Calponin-2	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
Q99439	CNN2	Calponin-2	GO:0032970; P:regulation of actin filament-based process; IDA:MGI
Q99439	CNN2	Calponin-2	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q99439	CNN2	Calponin-2	GO:0042060; P:wound healing; IEA:Ensembl
Q15417	CNN3	Calponin-3	GO:0031032; P:actomyosin structure organization; IEA:InterPro
Q15417	CNN3	Calponin-3	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
Q9NRU3	CNNM1	Metal transporter CNNM1	GO:0030554; F:adenyl nucleotide binding; IEA:InterPro
Q9NRU3	CNNM1	Metal transporter CNNM1	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q9H8M5	CNNM2	Metal transporter CNNM2	GO:0030554; F:adenyl nucleotide binding; IEA:InterPro
Q9H8M5	CNNM2	Metal transporter CNNM2	GO:0010960; P:magnesium ion homeostasis; IMP:MGI
Q9H8M5	CNNM2	Metal transporter CNNM2	GO:0015693; P:magnesium ion transport; IEA:Ensembl
Q8NE01	CNNM3	Metal transporter CNNM3	GO:0030554; F:adenyl nucleotide binding; IEA:InterPro
Q8NE01	CNNM3	Metal transporter CNNM3	GO:0005515; F:protein binding; IPI:IntAct
Q8NE01	CNNM3	Metal transporter CNNM3	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q6P4Q7	CNNM4	Metal transporter CNNM4	GO:0030554; F:adenyl nucleotide binding; IEA:InterPro
Q6P4Q7	CNNM4	Metal transporter CNNM4	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
Q6P4Q7	CNNM4	Metal transporter CNNM4	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q6P4Q7	CNNM4	Metal transporter CNNM4	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q6P4Q7	CNNM4	Metal transporter CNNM4	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q9H9A5	CNOT10	CCR4-NOT transcription complex subunit 10	GO:0005515; F:protein binding; IPI:IntAct
Q9H9A5	CNOT10	CCR4-NOT transcription complex subunit 10	GO:0010467; P:gene expression; TAS:Reactome
Q9H9A5	CNOT10	CCR4-NOT transcription complex subunit 10	GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW
Q9H9A5	CNOT10	CCR4-NOT transcription complex subunit 10	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9H9A5	CNOT10	CCR4-NOT transcription complex subunit 10	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q9H9A5	CNOT10	CCR4-NOT transcription complex subunit 10	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
Q9H9A5	CNOT10	CCR4-NOT transcription complex subunit 10	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H9A5	CNOT10	CCR4-NOT transcription complex subunit 10	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q9H9A5	CNOT10	CCR4-NOT transcription complex subunit 10	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9H9A5	CNOT10	CCR4-NOT transcription complex subunit 10	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UKZ1	CNOT11	CCR4-NOT transcription complex subunit 11	GO:0005515; F:protein binding; IPI:IntAct
Q9UKZ1	CNOT11	CCR4-NOT transcription complex subunit 11	GO:0008283; P:cell proliferation; NAS:UniProtKB
Q9UKZ1	CNOT11	CCR4-NOT transcription complex subunit 11	GO:0010467; P:gene expression; TAS:Reactome
Q9UKZ1	CNOT11	CCR4-NOT transcription complex subunit 11	GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW
Q9UKZ1	CNOT11	CCR4-NOT transcription complex subunit 11	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9UKZ1	CNOT11	CCR4-NOT transcription complex subunit 11	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q9UKZ1	CNOT11	CCR4-NOT transcription complex subunit 11	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
Q9UKZ1	CNOT11	CCR4-NOT transcription complex subunit 11	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UKZ1	CNOT11	CCR4-NOT transcription complex subunit 11	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q9UKZ1	CNOT11	CCR4-NOT transcription complex subunit 11	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9UKZ1	CNOT11	CCR4-NOT transcription complex subunit 11	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96LI5	CNOT6L	CCR4-NOT transcription complex subunit 6-like	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96LI5	CNOT6L	CCR4-NOT transcription complex subunit 6-like	GO:0004535; F:poly(A)-specific ribonuclease activity; TAS:Reactome
Q96LI5	CNOT6L	CCR4-NOT transcription complex subunit 6-like	GO:0005515; F:protein binding; IPI:IntAct
Q96LI5	CNOT6L	CCR4-NOT transcription complex subunit 6-like	GO:0010467; P:gene expression; TAS:Reactome
Q96LI5	CNOT6L	CCR4-NOT transcription complex subunit 6-like	GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW
Q96LI5	CNOT6L	CCR4-NOT transcription complex subunit 6-like	GO:0061157; P:mRNA destabilization; IEA:Ensembl
Q96LI5	CNOT6L	CCR4-NOT transcription complex subunit 6-like	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q96LI5	CNOT6L	CCR4-NOT transcription complex subunit 6-like	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q96LI5	CNOT6L	CCR4-NOT transcription complex subunit 6-like	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
Q96LI5	CNOT6L	CCR4-NOT transcription complex subunit 6-like	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
Q96LI5	CNOT6L	CCR4-NOT transcription complex subunit 6-like	GO:0010606; P:positive regulation of cytoplasmic mRNA processing body assembly; IMP:UniProtKB
Q96LI5	CNOT6L	CCR4-NOT transcription complex subunit 6-like	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96LI5	CNOT6L	CCR4-NOT transcription complex subunit 6-like	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q96LI5	CNOT6L	CCR4-NOT transcription complex subunit 6-like	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q96LI5	CNOT6L	CCR4-NOT transcription complex subunit 6-like	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; TAS:GOC
Q96LI5	CNOT6L	CCR4-NOT transcription complex subunit 6-like	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:0030331; F:estrogen receptor binding; IDA:UniProtKB
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:0005515; F:protein binding; IPI:IntAct
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:0042974; F:retinoic acid receptor binding; IDA:UniProtKB
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:0010467; P:gene expression; TAS:Reactome
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:0033147; P:negative regulation of intracellular estrogen receptor signaling pathway; IDA:UniProtKB
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IDA:UniProtKB
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:0010606; P:positive regulation of cytoplasmic mRNA processing body assembly; IDA:UniProtKB
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:1900153; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; IMP:UniProtKB
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; IMP:UniProtKB
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:2000036; P:regulation of stem cell maintenance; IMP:UniProtKB
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:0016070; P:RNA metabolic process; TAS:Reactome
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; IDA:GOC
A5YKK6	CNOT1	CCR4-NOT transcription complex subunit 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NZN8	CNOT2	CCR4-NOT transcription complex subunit 2	GO:0005515; F:protein binding; IPI:IntAct
Q9NZN8	CNOT2	CCR4-NOT transcription complex subunit 2	GO:0001104; F:RNA polymerase II transcription cofactor activity; TAS:UniProtKB
Q9NZN8	CNOT2	CCR4-NOT transcription complex subunit 2	GO:0001226; F:RNA polymerase II transcription corepressor binding; IDA:UniProtKB
Q9NZN8	CNOT2	CCR4-NOT transcription complex subunit 2	GO:0010467; P:gene expression; TAS:Reactome
Q9NZN8	CNOT2	CCR4-NOT transcription complex subunit 2	GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW
Q9NZN8	CNOT2	CCR4-NOT transcription complex subunit 2	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9NZN8	CNOT2	CCR4-NOT transcription complex subunit 2	GO:0033147; P:negative regulation of intracellular estrogen receptor signaling pathway; IMP:UniProtKB
Q9NZN8	CNOT2	CCR4-NOT transcription complex subunit 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9NZN8	CNOT2	CCR4-NOT transcription complex subunit 2	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q9NZN8	CNOT2	CCR4-NOT transcription complex subunit 2	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
Q9NZN8	CNOT2	CCR4-NOT transcription complex subunit 2	GO:0010606; P:positive regulation of cytoplasmic mRNA processing body assembly; IMP:UniProtKB
Q9NZN8	CNOT2	CCR4-NOT transcription complex subunit 2	GO:2000036; P:regulation of stem cell maintenance; IMP:UniProtKB
Q9NZN8	CNOT2	CCR4-NOT transcription complex subunit 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; NAS:UniProtKB
Q9NZN8	CNOT2	CCR4-NOT transcription complex subunit 2	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q9NZN8	CNOT2	CCR4-NOT transcription complex subunit 2	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9NZN8	CNOT2	CCR4-NOT transcription complex subunit 2	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; IMP:GOC
Q9NZN8	CNOT2	CCR4-NOT transcription complex subunit 2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:GOC
Q9NZN8	CNOT2	CCR4-NOT transcription complex subunit 2	GO:0001829; P:trophectodermal cell differentiation; IEA:Ensembl
O75175	CNOT3	CCR4-NOT transcription complex subunit 3	GO:0005515; F:protein binding; IPI:IntAct
O75175	CNOT3	CCR4-NOT transcription complex subunit 3	GO:0010467; P:gene expression; TAS:Reactome
O75175	CNOT3	CCR4-NOT transcription complex subunit 3	GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW
O75175	CNOT3	CCR4-NOT transcription complex subunit 3	GO:0016071; P:mRNA metabolic process; TAS:Reactome
O75175	CNOT3	CCR4-NOT transcription complex subunit 3	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
O75175	CNOT3	CCR4-NOT transcription complex subunit 3	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
O75175	CNOT3	CCR4-NOT transcription complex subunit 3	GO:2000036; P:regulation of stem cell maintenance; IMP:UniProtKB
O75175	CNOT3	CCR4-NOT transcription complex subunit 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O75175	CNOT3	CCR4-NOT transcription complex subunit 3	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
O75175	CNOT3	CCR4-NOT transcription complex subunit 3	GO:0016070; P:RNA metabolic process; TAS:Reactome
O75175	CNOT3	CCR4-NOT transcription complex subunit 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75175	CNOT3	CCR4-NOT transcription complex subunit 3	GO:0001829; P:trophectodermal cell differentiation; IEA:Ensembl
O95628	CNOT4	CCR4-NOT transcription complex subunit 4	GO:0000166; F:nucleotide binding; IEA:InterPro
O95628	CNOT4	CCR4-NOT transcription complex subunit 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O95628	CNOT4	CCR4-NOT transcription complex subunit 4	GO:0005515; F:protein binding; IPI:UniProtKB
O95628	CNOT4	CCR4-NOT transcription complex subunit 4	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
O95628	CNOT4	CCR4-NOT transcription complex subunit 4	GO:0008270; F:zinc ion binding; IEA:InterPro
O95628	CNOT4	CCR4-NOT transcription complex subunit 4	GO:0010467; P:gene expression; TAS:Reactome
O95628	CNOT4	CCR4-NOT transcription complex subunit 4	GO:0016071; P:mRNA metabolic process; TAS:Reactome
O95628	CNOT4	CCR4-NOT transcription complex subunit 4	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
O95628	CNOT4	CCR4-NOT transcription complex subunit 4	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
O95628	CNOT4	CCR4-NOT transcription complex subunit 4	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
O95628	CNOT4	CCR4-NOT transcription complex subunit 4	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9ULM6	CNOT6	CCR4-NOT transcription complex subunit 6	GO:0004532; F:exoribonuclease activity; IDA:UniProtKB
Q9ULM6	CNOT6	CCR4-NOT transcription complex subunit 6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9ULM6	CNOT6	CCR4-NOT transcription complex subunit 6	GO:0004535; F:poly(A)-specific ribonuclease activity; IDA:UniProtKB
Q9ULM6	CNOT6	CCR4-NOT transcription complex subunit 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q9ULM6	CNOT6	CCR4-NOT transcription complex subunit 6	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9ULM6	CNOT6	CCR4-NOT transcription complex subunit 6	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; IDA:UniProtKB
Q9ULM6	CNOT6	CCR4-NOT transcription complex subunit 6	GO:0010467; P:gene expression; TAS:Reactome
Q9ULM6	CNOT6	CCR4-NOT transcription complex subunit 6	GO:0035195; P:gene silencing by miRNA; TAS:UniProtKB
Q9ULM6	CNOT6	CCR4-NOT transcription complex subunit 6	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9ULM6	CNOT6	CCR4-NOT transcription complex subunit 6	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q9ULM6	CNOT6	CCR4-NOT transcription complex subunit 6	GO:0070966; P:nuclear-transcribed mRNA catabolic process, no-go decay; IMP:UniProtKB
Q9ULM6	CNOT6	CCR4-NOT transcription complex subunit 6	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
Q9ULM6	CNOT6	CCR4-NOT transcription complex subunit 6	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
Q9ULM6	CNOT6	CCR4-NOT transcription complex subunit 6	GO:0010606; P:positive regulation of cytoplasmic mRNA processing body assembly; IMP:UniProtKB
Q9ULM6	CNOT6	CCR4-NOT transcription complex subunit 6	GO:2000327; P:positive regulation of ligand-dependent nuclear receptor transcription coactivator activity; IDA:UniProtKB
Q9ULM6	CNOT6	CCR4-NOT transcription complex subunit 6	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9ULM6	CNOT6	CCR4-NOT transcription complex subunit 6	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q9ULM6	CNOT6	CCR4-NOT transcription complex subunit 6	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9ULM6	CNOT6	CCR4-NOT transcription complex subunit 6	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; IDA:GOC
Q9ULM6	CNOT6	CCR4-NOT transcription complex subunit 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0000175; F:3'-5'-exoribonuclease activity; IDA:UniProtKB
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0004532; F:exoribonuclease activity; IDA:UniProtKB
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0004535; F:poly(A)-specific ribonuclease activity; IDA:UniProtKB
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0033962; P:cytoplasmic mRNA processing body assembly; IEA:Ensembl
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0000290; P:deadenylation-dependent decapping of nuclear-transcribed mRNA; IEA:Ensembl
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; IDA:UniProtKB
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0010467; P:gene expression; TAS:Reactome
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0035195; P:gene silencing by miRNA; TAS:UniProtKB
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0031047; P:gene silencing by RNA; ISS:UniProtKB
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:1900153; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; IMP:UniProtKB
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; IMP:UniProtKB
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; IDA:GOC
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UIV1	CNOT7	CCR4-NOT transcription complex subunit 7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UFF9	CNOT8	CCR4-NOT transcription complex subunit 8	GO:0000175; F:3'-5'-exoribonuclease activity; IDA:UniProtKB
Q9UFF9	CNOT8	CCR4-NOT transcription complex subunit 8	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UFF9	CNOT8	CCR4-NOT transcription complex subunit 8	GO:0004535; F:poly(A)-specific ribonuclease activity; IDA:UniProtKB
Q9UFF9	CNOT8	CCR4-NOT transcription complex subunit 8	GO:0005515; F:protein binding; IPI:IntAct
Q9UFF9	CNOT8	CCR4-NOT transcription complex subunit 8	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9UFF9	CNOT8	CCR4-NOT transcription complex subunit 8	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9UFF9	CNOT8	CCR4-NOT transcription complex subunit 8	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; IDA:UniProtKB
Q9UFF9	CNOT8	CCR4-NOT transcription complex subunit 8	GO:0010467; P:gene expression; TAS:Reactome
Q9UFF9	CNOT8	CCR4-NOT transcription complex subunit 8	GO:0035195; P:gene silencing by miRNA; TAS:UniProtKB
Q9UFF9	CNOT8	CCR4-NOT transcription complex subunit 8	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9UFF9	CNOT8	CCR4-NOT transcription complex subunit 8	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q9UFF9	CNOT8	CCR4-NOT transcription complex subunit 8	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q9UFF9	CNOT8	CCR4-NOT transcription complex subunit 8	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
Q9UFF9	CNOT8	CCR4-NOT transcription complex subunit 8	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
Q9UFF9	CNOT8	CCR4-NOT transcription complex subunit 8	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9UFF9	CNOT8	CCR4-NOT transcription complex subunit 8	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q9UFF9	CNOT8	CCR4-NOT transcription complex subunit 8	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9UFF9	CNOT8	CCR4-NOT transcription complex subunit 8	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; IDA:GOC
Q9UFF9	CNOT8	CCR4-NOT transcription complex subunit 8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BV87	CNPPD1	Protein CNPPD1	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:InterPro
Q9Y2B0	CNPY2	Protein canopy homolog 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y2B0	CNPY2	Protein canopy homolog 2	GO:0010629; P:negative regulation of gene expression; ISS:BHF-UCL
Q9Y2B0	CNPY2	Protein canopy homolog 2	GO:0045716; P:positive regulation of low-density lipoprotein particle receptor biosynthetic process; ISS:BHF-UCL
Q9Y2B0	CNPY2	Protein canopy homolog 2	GO:0010988; P:regulation of low-density lipoprotein particle clearance; ISS:BHF-UCL
Q9BT09	CNPY3	Protein canopy homolog 3	GO:0045087; P:innate immune response; TAS:Reactome
Q9BT09	CNPY3	Protein canopy homolog 3	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P21554	CNR1	Cannabinoid receptor 1	GO:0004949; F:cannabinoid receptor activity; IDA:UniProtKB
P21554	CNR1	Cannabinoid receptor 1	GO:0008144; F:drug binding; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IDA:UniProtKB
P21554	CNR1	Cannabinoid receptor 1	GO:0007568; P:aging; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P21554	CNR1	Cannabinoid receptor 1	GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0007613; P:memory; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0045759; P:negative regulation of action potential; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0033602; P:negative regulation of dopamine secretion; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0031999; P:negative regulation of fatty acid beta-oxidation; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0033004; P:negative regulation of mast cell activation; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0051001; P:negative regulation of nitric-oxide synthase activity; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0002866; P:positive regulation of acute inflammatory response to antigenic stimulus; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0031622; P:positive regulation of fever generation; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0060259; P:regulation of feeding behavior; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0050796; P:regulation of insulin secretion; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0060405; P:regulation of penile erection; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0032228; P:regulation of synaptic transmission, GABAergic; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0051966; P:regulation of synaptic transmission, glutamatergic; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0042220; P:response to cocaine; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0045471; P:response to ethanol; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0043278; P:response to morphine; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0035094; P:response to nicotine; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0007584; P:response to nutrient; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P21554	CNR1	Cannabinoid receptor 1	GO:0007283; P:spermatogenesis; IEA:Ensembl
P34972	CNR2	Cannabinoid receptor 2	GO:0004949; F:cannabinoid receptor activity; TAS:ProtInc
P34972	CNR2	Cannabinoid receptor 2	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P34972	CNR2	Cannabinoid receptor 2	GO:0006955; P:immune response; TAS:ProtInc
P34972	CNR2	Cannabinoid receptor 2	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
P34972	CNR2	Cannabinoid receptor 2	GO:0045759; P:negative regulation of action potential; IEA:Ensembl
P34972	CNR2	Cannabinoid receptor 2	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
P34972	CNR2	Cannabinoid receptor 2	GO:0033004; P:negative regulation of mast cell activation; IEA:Ensembl
P34972	CNR2	Cannabinoid receptor 2	GO:0051001; P:negative regulation of nitric-oxide synthase activity; IEA:Ensembl
P34972	CNR2	Cannabinoid receptor 2	GO:0032229; P:negative regulation of synaptic transmission, GABAergic; IEA:Ensembl
P34972	CNR2	Cannabinoid receptor 2	GO:0001975; P:response to amphetamine; IEA:Ensembl
P34972	CNR2	Cannabinoid receptor 2	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P34972	CNR2	Cannabinoid receptor 2	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P18545	PDE6G	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; IEA:UniProtKB-EC
P18545	PDE6G	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0030553; F:cGMP binding; IEA:InterPro
P18545	PDE6G	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0004857; F:enzyme inhibitor activity; TAS:ProtInc
P18545	PDE6G	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0005515; F:protein binding; IPI:IntAct
P18545	PDE6G	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
P18545	PDE6G	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
P18545	PDE6G	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P18545	PDE6G	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0045742; P:positive regulation of epidermal growth factor receptor signaling pathway; IEA:Ensembl
P18545	PDE6G	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0045745; P:positive regulation of G-protein coupled receptor protein signaling pathway; IEA:Ensembl
P18545	PDE6G	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
P18545	PDE6G	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
P18545	PDE6G	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	GO:0007601; P:visual perception; TAS:ProtInc
Q6PJW8	CNST	Consortin	GO:0071253; F:connexin binding; ISS:UniProtKB
Q6PJW8	CNST	Consortin	GO:0019902; F:phosphatase binding; IDA:UniProtKB
Q6PJW8	CNST	Consortin	GO:0005515; F:protein binding; IPI:IntAct
Q6PJW8	CNST	Consortin	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q6PJW8	CNST	Consortin	GO:0042998; P:positive regulation of Golgi to plasma membrane protein transport; IMP:UniProtKB
Q96NU0	CNTNAP3B	Contactin-associated protein-like 3B	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9H8S5	CNTD2	Cyclin N-terminal domain-containing protein 2	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:InterPro
P26992	CNTFR	Ciliary neurotrophic factor receptor subunit alpha	GO:0004897; F:ciliary neurotrophic factor receptor activity; TAS:ProtInc
P26992	CNTFR	Ciliary neurotrophic factor receptor subunit alpha	GO:0019955; F:cytokine binding; IPI:HGNC
P26992	CNTFR	Ciliary neurotrophic factor receptor subunit alpha	GO:0005102; F:receptor binding; IPI:BHF-UCL
P26992	CNTFR	Ciliary neurotrophic factor receptor subunit alpha	GO:0003360; P:brainstem development; IEA:Ensembl
P26992	CNTFR	Ciliary neurotrophic factor receptor subunit alpha	GO:0070120; P:ciliary neurotrophic factor-mediated signaling pathway; IDA:BHF-UCL
P26992	CNTFR	Ciliary neurotrophic factor receptor subunit alpha	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P26992	CNTFR	Ciliary neurotrophic factor receptor subunit alpha	GO:0007399; P:nervous system development; TAS:ProtInc
P26992	CNTFR	Ciliary neurotrophic factor receptor subunit alpha	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P26992	CNTFR	Ciliary neurotrophic factor receptor subunit alpha	GO:0007548; P:sex differentiation; IEA:Ensembl
P26992	CNTFR	Ciliary neurotrophic factor receptor subunit alpha	GO:0007165; P:signal transduction; NAS:ProtInc
P26992	CNTFR	Ciliary neurotrophic factor receptor subunit alpha	GO:0060538; P:skeletal muscle organ development; IEA:Ensembl
P26992	CNTFR	Ciliary neurotrophic factor receptor subunit alpha	GO:0001967; P:suckling behavior; IEA:Ensembl
P26441	CNTF	Ciliary neurotrophic factor	GO:0005127; F:ciliary neurotrophic factor receptor binding; TAS:ProtInc
P26441	CNTF	Ciliary neurotrophic factor	GO:0008083; F:growth factor activity; IDA:BHF-UCL
P26441	CNTF	Ciliary neurotrophic factor	GO:0005138; F:interleukin-6 receptor binding; IPI:BHF-UCL
P26441	CNTF	Ciliary neurotrophic factor	GO:0070120; P:ciliary neurotrophic factor-mediated signaling pathway; IDA:BHF-UCL
P26441	CNTF	Ciliary neurotrophic factor	GO:0040007; P:growth; IEA:InterPro
P26441	CNTF	Ciliary neurotrophic factor	GO:0048644; P:muscle organ morphogenesis; IEA:Ensembl
P26441	CNTF	Ciliary neurotrophic factor	GO:0043524; P:negative regulation of neuron apoptotic process; IDA:BHF-UCL
P26441	CNTF	Ciliary neurotrophic factor	GO:0046533; P:negative regulation of photoreceptor cell differentiation; IEA:Ensembl
P26441	CNTF	Ciliary neurotrophic factor	GO:0048666; P:neuron development; IEA:Ensembl
P26441	CNTF	Ciliary neurotrophic factor	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P26441	CNTF	Ciliary neurotrophic factor	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IDA:BHF-UCL
P26441	CNTF	Ciliary neurotrophic factor	GO:0046668; P:regulation of retinal cell programmed cell death; IEA:Ensembl
P26441	CNTF	Ciliary neurotrophic factor	GO:0007165; P:signal transduction; NAS:ProtInc
Q9NXG0	CNTLN	Centlein	GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro
Q12860	CNTN1	Contactin-1	GO:0030246; F:carbohydrate binding; IEA:Ensembl
Q12860	CNTN1	Contactin-1	GO:0007411; P:axon guidance; TAS:Reactome
Q12860	CNTN1	Contactin-1	GO:0007155; P:cell adhesion; NAS:ProtInc
Q12860	CNTN1	Contactin-1	GO:0021549; P:cerebellum development; IEA:Ensembl
Q12860	CNTN1	Contactin-1	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q12860	CNTN1	Contactin-1	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
Q12860	CNTN1	Contactin-1	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
Q12860	CNTN1	Contactin-1	GO:0010765; P:positive regulation of sodium ion transport; IEA:Ensembl
Q02246	CNTN2	Contactin-2	GO:0030246; F:carbohydrate binding; IEA:Ensembl
Q02246	CNTN2	Contactin-2	GO:0042802; F:identical protein binding; TAS:BHF-UCL
Q02246	CNTN2	Contactin-2	GO:0007628; P:adult walking behavior; IEA:Ensembl
Q02246	CNTN2	Contactin-2	GO:0007411; P:axon guidance; TAS:Reactome
Q02246	CNTN2	Contactin-2	GO:0007413; P:axonal fasciculation; IEA:Ensembl
Q02246	CNTN2	Contactin-2	GO:0007155; P:cell adhesion; NAS:ProtInc
Q02246	CNTN2	Contactin-2	GO:0034613; P:cellular protein localization; ISS:BHF-UCL
Q02246	CNTN2	Contactin-2	GO:0022010; P:central nervous system myelination; IEA:Ensembl
Q02246	CNTN2	Contactin-2	GO:0021853; P:cerebral cortex GABAergic interneuron migration; IEA:Ensembl
Q02246	CNTN2	Contactin-2	GO:0045163; P:clustering of voltage-gated potassium channels; ISS:BHF-UCL
Q02246	CNTN2	Contactin-2	GO:0071206; P:establishment of protein localization to juxtaparanode region of axon; IEA:Ensembl
Q02246	CNTN2	Contactin-2	GO:0007612; P:learning; IEA:Ensembl
Q02246	CNTN2	Contactin-2	GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl
Q02246	CNTN2	Contactin-2	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
Q02246	CNTN2	Contactin-2	GO:0001764; P:neuron migration; IEA:Ensembl
Q02246	CNTN2	Contactin-2	GO:0060168; P:positive regulation of adenosine receptor signaling pathway; IEA:Ensembl
Q02246	CNTN2	Contactin-2	GO:0010954; P:positive regulation of protein processing; IEA:Ensembl
Q02246	CNTN2	Contactin-2	GO:0097090; P:presynaptic membrane organization; IMP:UniProtKB
Q02246	CNTN2	Contactin-2	GO:0031623; P:receptor internalization; IEA:Ensembl
Q02246	CNTN2	Contactin-2	GO:0048710; P:regulation of astrocyte differentiation; IEA:Ensembl
Q02246	CNTN2	Contactin-2	GO:0031133; P:regulation of axon diameter; IEA:Ensembl
Q02246	CNTN2	Contactin-2	GO:0048168; P:regulation of neuronal synaptic plasticity; IEA:Ensembl
Q9P232	CNTN3	Contactin-3	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9P232	CNTN3	Contactin-3	GO:0007399; P:nervous system development; IEA:Ensembl
Q8IWV2	CNTN4	Contactin-4	GO:0007411; P:axon guidance; TAS:UniProtKB
Q8IWV2	CNTN4	Contactin-4	GO:0007413; P:axonal fasciculation; TAS:UniProtKB
Q8IWV2	CNTN4	Contactin-4	GO:0007409; P:axonogenesis; TAS:UniProtKB
Q8IWV2	CNTN4	Contactin-4	GO:0007420; P:brain development; ISS:UniProtKB
Q8IWV2	CNTN4	Contactin-4	GO:0045665; P:negative regulation of neuron differentiation; IMP:UniProtKB
Q8IWV2	CNTN4	Contactin-4	GO:0007399; P:nervous system development; IMP:UniProtKB
Q8IWV2	CNTN4	Contactin-4	GO:0007158; P:neuron cell-cell adhesion; TAS:UniProtKB
Q8IWV2	CNTN4	Contactin-4	GO:0031175; P:neuron projection development; ISS:UniProtKB
Q8IWV2	CNTN4	Contactin-4	GO:0048167; P:regulation of synaptic plasticity; TAS:UniProtKB
O94779	CNTN5	Contactin-5	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
O94779	CNTN5	Contactin-5	GO:0007605; P:sensory perception of sound; IEA:Ensembl
Q9UQ52	CNTN6	Contactin-6	GO:0007411; P:axon guidance; TAS:Reactome
Q9UQ52	CNTN6	Contactin-6	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9UQ52	CNTN6	Contactin-6	GO:0007417; P:central nervous system development; TAS:ProtInc
Q9UQ52	CNTN6	Contactin-6	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
P78357	CNTNAP1	Contactin-associated protein 1	GO:0005515; F:protein binding; IPI:IntAct
P78357	CNTNAP1	Contactin-associated protein 1	GO:0004872; F:receptor activity; TAS:ProtInc
P78357	CNTNAP1	Contactin-associated protein 1	GO:0017124; F:SH3 domain binding; ISS:BHF-UCL
P78357	CNTNAP1	Contactin-associated protein 1	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
P78357	CNTNAP1	Contactin-associated protein 1	GO:0008088; P:axon cargo transport; ISS:BHF-UCL
P78357	CNTNAP1	Contactin-associated protein 1	GO:0007411; P:axon guidance; TAS:Reactome
P78357	CNTNAP1	Contactin-associated protein 1	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P78357	CNTNAP1	Contactin-associated protein 1	GO:0007010; P:cytoskeleton organization; ISS:BHF-UCL
P78357	CNTNAP1	Contactin-associated protein 1	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
P78357	CNTNAP1	Contactin-associated protein 1	GO:0050884; P:neuromuscular process controlling posture; IEA:Ensembl
P78357	CNTNAP1	Contactin-associated protein 1	GO:0048812; P:neuron projection morphogenesis; ISS:BHF-UCL
P78357	CNTNAP1	Contactin-associated protein 1	GO:0019227; P:neuronal action potential propagation; ISS:BHF-UCL
P78357	CNTNAP1	Contactin-associated protein 1	GO:0030913; P:paranodal junction assembly; ISS:BHF-UCL
P78357	CNTNAP1	Contactin-associated protein 1	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
P78357	CNTNAP1	Contactin-associated protein 1	GO:0002175; P:protein localization to paranode region of axon; ISS:BHF-UCL
P78357	CNTNAP1	Contactin-associated protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UHC6	CNTNAP2	Contactin-associated protein-like 2	GO:0019899; F:enzyme binding; IPI:BHF-UCL
Q9UHC6	CNTNAP2	Contactin-associated protein-like 2	GO:0030534; P:adult behavior; IMP:BHF-UCL
Q9UHC6	CNTNAP2	Contactin-associated protein-like 2	GO:0007420; P:brain development; TAS:BHF-UCL
Q9UHC6	CNTNAP2	Contactin-associated protein-like 2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9UHC6	CNTNAP2	Contactin-associated protein-like 2	GO:0034613; P:cellular protein localization; ISS:BHF-UCL
Q9UHC6	CNTNAP2	Contactin-associated protein-like 2	GO:0021987; P:cerebral cortex development; IEP:BHF-UCL
Q9UHC6	CNTNAP2	Contactin-associated protein-like 2	GO:0045163; P:clustering of voltage-gated potassium channels; ISS:BHF-UCL
Q9UHC6	CNTNAP2	Contactin-associated protein-like 2	GO:0007612; P:learning; IMP:BHF-UCL
Q9UHC6	CNTNAP2	Contactin-associated protein-like 2	GO:0021761; P:limbic system development; IEP:BHF-UCL
Q9UHC6	CNTNAP2	Contactin-associated protein-like 2	GO:0031175; P:neuron projection development; ISS:BHF-UCL
Q9UHC6	CNTNAP2	Contactin-associated protein-like 2	GO:0008038; P:neuron recognition; NAS:UniProtKB
Q9UHC6	CNTNAP2	Contactin-associated protein-like 2	GO:0071205; P:protein localization to juxtaparanode region of axon; ISS:BHF-UCL
Q9UHC6	CNTNAP2	Contactin-associated protein-like 2	GO:0035176; P:social behavior; IMP:BHF-UCL
Q9UHC6	CNTNAP2	Contactin-associated protein-like 2	GO:0021756; P:striatum development; IEP:BHF-UCL
Q9UHC6	CNTNAP2	Contactin-associated protein-like 2	GO:0071109; P:superior temporal gyrus development; IEP:BHF-UCL
Q9UHC6	CNTNAP2	Contactin-associated protein-like 2	GO:0021794; P:thalamus development; IEP:BHF-UCL
Q9UHC6	CNTNAP2	Contactin-associated protein-like 2	GO:0019226; P:transmission of nerve impulse; NAS:UniProtKB
Q9UHC6	CNTNAP2	Contactin-associated protein-like 2	GO:0071625; P:vocalization behavior; IMP:BHF-UCL
Q9BZ76	CNTNAP3	Contactin-associated protein-like 3	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9BZ76	CNTNAP3	Contactin-associated protein-like 3	GO:0008037; P:cell recognition; NAS:UniProtKB
Q9C0A0	CNTNAP4	Contactin-associated protein-like 4	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q8WYK1	CNTNAP5	Contactin-associated protein-like 5	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q8N137	CNTROB	Centrobin	GO:0005515; F:protein binding; IPI:HGNC
Q8N137	CNTROB	Centrobin	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q8N137	CNTROB	Centrobin	GO:0007099; P:centriole replication; IMP:HGNC
Q8N137	CNTROB	Centrobin	GO:0051299; P:centrosome separation; IMP:HGNC
Q8N137	CNTROB	Centrobin	GO:0000910; P:cytokinesis; IMP:HGNC
Q7Z7A1	CNTRL	Centriolin	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z7A1	CNTRL	Centriolin	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q7Z7A1	CNTRL	Centriolin	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q7Z7A1	CNTRL	Centriolin	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q2M3C6	C15orf27	Transmembrane protein C15orf27	GO:0005245; F:voltage-gated calcium channel activity; IBA:RefGenome
Q2M3C6	C15orf27	Transmembrane protein C15orf27	GO:0070509; P:calcium ion import; IBA:RefGenome
Q2M3C6	C15orf27	Transmembrane protein C15orf27	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q6ZUT6	C15orf52	Uncharacterized protein C15orf52	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0005201; F:extracellular matrix structural constituent; IEA:Ensembl
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0042802; F:identical protein binding; IDA:UniProtKB
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0048407; F:platelet-derived growth factor binding; IDA:MGI
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0005515; F:protein binding; IPI:UniProtKB
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0007596; P:blood coagulation; TAS:Reactome
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0001568; P:blood vessel development; IMP:UniProtKB
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0060346; P:bone trabecula formation; IEA:Ensembl
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; IEA:Ensembl
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEA:Ensembl
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0032964; P:collagen biosynthetic process; IMP:UniProtKB
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0030199; P:collagen fibril organization; IMP:UniProtKB
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0048706; P:embryonic skeletal system development; IMP:UniProtKB
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0001958; P:endochondral ossification; IEA:Ensembl
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0060325; P:face morphogenesis; IEA:Ensembl
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0001957; P:intramembranous ossification; IEA:Ensembl
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0050900; P:leukocyte migration; TAS:Reactome
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0010812; P:negative regulation of cell-substrate adhesion; IEA:Ensembl
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0030168; P:platelet activation; TAS:Reactome
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:UniProtKB
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IDA:UniProtKB
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0070208; P:protein heterotrimerization; IEA:Ensembl
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0034504; P:protein localization to nucleus; IDA:UniProtKB
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0015031; P:protein transport; IEA:Ensembl
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0051591; P:response to cAMP; IEA:Ensembl
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0031960; P:response to corticosteroid; IEA:Ensembl
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0032355; P:response to estradiol; IEA:Ensembl
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0007584; P:response to nutrient; IEA:Ensembl
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0007605; P:sensory perception of sound; IMP:UniProtKB
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0001501; P:skeletal system development; IMP:UniProtKB
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0043589; P:skin morphogenesis; IMP:UniProtKB
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0034505; P:tooth mineralization; IMP:UniProtKB
P02452	COL1A1	Collagen alpha-1(I) chain	GO:0007601; P:visual perception; IMP:UniProtKB
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0005201; F:extracellular matrix structural constituent; NAS:UniProtKB
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0042802; F:identical protein binding; IDA:UniProtKB
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0048407; F:platelet-derived growth factor binding; IDA:MGI
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0005515; F:protein binding; IPI:UniProtKB
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0030674; F:protein binding, bridging; IMP:UniProtKB
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0007596; P:blood coagulation; TAS:Reactome
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0001568; P:blood vessel development; IMP:UniProtKB
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0030199; P:collagen fibril organization; IMP:UniProtKB
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0050900; P:leukocyte migration; TAS:Reactome
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0042476; P:odontogenesis; NAS:UniProtKB
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0030168; P:platelet activation; TAS:Reactome
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0070208; P:protein heterotrimerization; IEA:Ensembl
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0008217; P:regulation of blood pressure; IMP:UniProtKB
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0007266; P:Rho protein signal transduction; IDA:UniProtKB
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0001501; P:skeletal system development; IMP:UniProtKB
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0043589; P:skin morphogenesis; IMP:UniProtKB
P08123	COL1A2	Collagen alpha-2(I) chain	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0030020; F:extracellular matrix structural constituent conferring tensile strength; IC:BHF-UCL
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0042802; F:identical protein binding; NAS:BHF-UCL
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0048407; F:platelet-derived growth factor binding; IDA:MGI
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0007411; P:axon guidance; TAS:Reactome
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0001502; P:cartilage condensation; IEA:Ensembl
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0051216; P:cartilage development; TAS:BHF-UCL
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; IEA:Ensembl
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0071773; P:cellular response to BMP stimulus; IEA:Ensembl
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0007417; P:central nervous system development; IEA:Ensembl
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0002062; P:chondrocyte differentiation; IEA:Ensembl
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0030199; P:collagen fibril organization; IMP:BHF-UCL
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0060272; P:embryonic skeletal joint morphogenesis; IMP:BHF-UCL
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0001958; P:endochondral ossification; IEA:Ensembl
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0003007; P:heart morphogenesis; IEA:Ensembl
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0060174; P:limb bud formation; IEA:Ensembl
P02458	COL2A1	Collagen alpha-1(II) chain	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0030903; P:notochord development; IEA:Ensembl
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0071599; P:otic vesicle development; IEA:Ensembl
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0060021; P:palate development; IEA:Ensembl
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0006029; P:proteoglycan metabolic process; IEA:Ensembl
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0010468; P:regulation of gene expression; IEA:Ensembl
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0007605; P:sensory perception of sound; IMP:BHF-UCL
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0001501; P:skeletal system development; IMP:BHF-UCL
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0001894; P:tissue homeostasis; IEA:Ensembl
P02458	COL2A1	Collagen alpha-1(II) chain	GO:0007601; P:visual perception; IMP:UniProtKB
P06681	C2	Complement C2	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
P06681	C2	Complement C2	GO:0006956; P:complement activation; TAS:Reactome
P06681	C2	Complement C2	GO:0006958; P:complement activation, classical pathway; TAS:ProtInc
P06681	C2	Complement C2	GO:0045087; P:innate immune response; TAS:Reactome
P06681	C2	Complement C2	GO:0030449; P:regulation of complement activation; TAS:Reactome
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0005201; F:extracellular matrix structural constituent; IMP:UniProtKB
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0005178; F:integrin binding; IMP:UniProtKB
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0048407; F:platelet-derived growth factor binding; IDA:MGI
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0005515; F:protein binding; IPI:UniProtKB
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0007568; P:aging; IEA:Ensembl
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0007411; P:axon guidance; TAS:Reactome
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0001568; P:blood vessel development; IEA:Ensembl
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0007160; P:cell-matrix adhesion; IDA:UniProtKB
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0021987; P:cerebral cortex development; ISS:UniProtKB
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0030199; P:collagen fibril organization; IMP:UniProtKB
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0048565; P:digestive tract development; IEA:Ensembl
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0043206; P:extracellular fibril organization; IMP:UniProtKB
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0007507; P:heart development; IMP:UniProtKB
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0007229; P:integrin-mediated signaling pathway; IMP:UniProtKB
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0050777; P:negative regulation of immune response; IMP:UniProtKB
P02461	COL3A1	Collagen alpha-1(III) chain	GO:2001223; P:negative regulation of neuron migration; ISS:UniProtKB
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0018149; P:peptide cross-linking; IDA:UniProtKB
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0030168; P:platelet activation; NAS:UniProtKB
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0035025; P:positive regulation of Rho protein signal transduction; ISS:UniProtKB
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0034097; P:response to cytokine; IDA:UniProtKB
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0009314; P:response to radiation; IDA:UniProtKB
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0001501; P:skeletal system development; IEA:Ensembl
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0043588; P:skin development; IMP:UniProtKB
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
P02461	COL3A1	Collagen alpha-1(III) chain	GO:0042060; P:wound healing; IDA:UniProtKB
P01024	C3	Complement C3	GO:0031715; F:C5L2 anaphylatoxin chemotactic receptor binding; IDA:UniProtKB
P01024	C3	Complement C3	GO:0004866; F:endopeptidase inhibitor activity; IEA:InterPro
P01024	C3	Complement C3	GO:0005515; F:protein binding; IPI:IntAct
P01024	C3	Complement C3	GO:0005102; F:receptor binding; TAS:ProtInc
P01024	C3	Complement C3	GO:0006956; P:complement activation; TAS:Reactome
P01024	C3	Complement C3	GO:0006957; P:complement activation, alternative pathway; TAS:Reactome
P01024	C3	Complement C3	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
P01024	C3	Complement C3	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW
P01024	C3	Complement C3	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P01024	C3	Complement C3	GO:0006955; P:immune response; TAS:ProtInc
P01024	C3	Complement C3	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
P01024	C3	Complement C3	GO:0045087; P:innate immune response; TAS:Reactome
P01024	C3	Complement C3	GO:0001970; P:positive regulation of activation of membrane attack complex; IEA:Ensembl
P01024	C3	Complement C3	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
P01024	C3	Complement C3	GO:0045745; P:positive regulation of G-protein coupled receptor protein signaling pathway; IDA:UniProtKB
P01024	C3	Complement C3	GO:0010828; P:positive regulation of glucose transport; IDA:UniProtKB
P01024	C3	Complement C3	GO:0010884; P:positive regulation of lipid storage; IDA:UniProtKB
P01024	C3	Complement C3	GO:0050766; P:positive regulation of phagocytosis; IEA:Ensembl
P01024	C3	Complement C3	GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB
P01024	C3	Complement C3	GO:0001798; P:positive regulation of type IIa hypersensitivity; IEA:Ensembl
P01024	C3	Complement C3	GO:0010575; P:positive regulation vascular endothelial growth factor production; IDA:BHF-UCL
P01024	C3	Complement C3	GO:0030449; P:regulation of complement activation; TAS:Reactome
P01024	C3	Complement C3	GO:0050776; P:regulation of immune response; TAS:Reactome
P01024	C3	Complement C3	GO:0010866; P:regulation of triglyceride biosynthetic process; IDA:UniProtKB
P01024	C3	Complement C3	GO:0007165; P:signal transduction; TAS:ProtInc
P02462	COL4A1	Collagen alpha-1(IV) chain	GO:0030023; F:extracellular matrix constituent conferring elasticity; IC:BHF-UCL
P02462	COL4A1	Collagen alpha-1(IV) chain	GO:0005201; F:extracellular matrix structural constituent; IMP:BHF-UCL
P02462	COL4A1	Collagen alpha-1(IV) chain	GO:0048407; F:platelet-derived growth factor binding; IDA:MGI
P02462	COL4A1	Collagen alpha-1(IV) chain	GO:0005515; F:protein binding; IPI:IntAct
P02462	COL4A1	Collagen alpha-1(IV) chain	GO:0007411; P:axon guidance; TAS:Reactome
P02462	COL4A1	Collagen alpha-1(IV) chain	GO:0071711; P:basement membrane organization; IMP:BHF-UCL
P02462	COL4A1	Collagen alpha-1(IV) chain	GO:0048514; P:blood vessel morphogenesis; IMP:BHF-UCL
P02462	COL4A1	Collagen alpha-1(IV) chain	GO:0007420; P:brain development; IMP:BHF-UCL
P02462	COL4A1	Collagen alpha-1(IV) chain	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
P02462	COL4A1	Collagen alpha-1(IV) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P02462	COL4A1	Collagen alpha-1(IV) chain	GO:0030855; P:epithelial cell differentiation; IEA:Ensembl
P02462	COL4A1	Collagen alpha-1(IV) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P02462	COL4A1	Collagen alpha-1(IV) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P02462	COL4A1	Collagen alpha-1(IV) chain	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
P02462	COL4A1	Collagen alpha-1(IV) chain	GO:0001569; P:patterning of blood vessels; IMP:BHF-UCL
P02462	COL4A1	Collagen alpha-1(IV) chain	GO:0061333; P:renal tubule morphogenesis; IMP:BHF-UCL
P02462	COL4A1	Collagen alpha-1(IV) chain	GO:0061304; P:retinal blood vessel morphogenesis; IMP:BHF-UCL
P08572	COL4A2	Collagen alpha-2(IV) chain	GO:0005201; F:extracellular matrix structural constituent; TAS:UniProtKB
P08572	COL4A2	Collagen alpha-2(IV) chain	GO:0005515; F:protein binding; IPI:IntAct
P08572	COL4A2	Collagen alpha-2(IV) chain	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P08572	COL4A2	Collagen alpha-2(IV) chain	GO:0007411; P:axon guidance; TAS:Reactome
P08572	COL4A2	Collagen alpha-2(IV) chain	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEA:Ensembl
P08572	COL4A2	Collagen alpha-2(IV) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P08572	COL4A2	Collagen alpha-2(IV) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P08572	COL4A2	Collagen alpha-2(IV) chain	GO:0030198; P:extracellular matrix organization; NAS:UniProtKB
P08572	COL4A2	Collagen alpha-2(IV) chain	GO:0016525; P:negative regulation of angiogenesis; IDA:UniProtKB
P08572	COL4A2	Collagen alpha-2(IV) chain	GO:0006351; P:transcription, DNA-templated; IEA:Ensembl
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0005178; F:integrin binding; IDA:UniProtKB
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0008191; F:metalloendopeptidase inhibitor activity; NAS:UniProtKB
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0005515; F:protein binding; IPI:UniProtKB
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0005198; F:structural molecule activity; NAS:ProtInc
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0007411; P:axon guidance; TAS:Reactome
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0008015; P:blood circulation; TAS:ProtInc
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0008283; P:cell proliferation; IDA:UniProtKB
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0007166; P:cell surface receptor signaling pathway; NAS:UniProtKB
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0072577; P:endothelial cell apoptotic process; IDA:UniProtKB
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0032836; P:glomerular basement membrane development; ISS:UniProtKB
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0016525; P:negative regulation of angiogenesis; IDA:UniProtKB
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0010951; P:negative regulation of endopeptidase activity; NAS:GOC
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0009749; P:response to glucose; IEA:Ensembl
Q01955	COL4A3	Collagen alpha-3(IV) chain	GO:0007605; P:sensory perception of sound; TAS:ProtInc
P53420	COL4A4	Collagen alpha-4(IV) chain	GO:0005201; F:extracellular matrix structural constituent; IMP:UniProtKB
P53420	COL4A4	Collagen alpha-4(IV) chain	GO:0007411; P:axon guidance; TAS:Reactome
P53420	COL4A4	Collagen alpha-4(IV) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P53420	COL4A4	Collagen alpha-4(IV) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P53420	COL4A4	Collagen alpha-4(IV) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P53420	COL4A4	Collagen alpha-4(IV) chain	GO:0032836; P:glomerular basement membrane development; IMP:UniProtKB
P29400	COL4A5	Collagen alpha-5(IV) chain	GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro
P29400	COL4A5	Collagen alpha-5(IV) chain	GO:0007411; P:axon guidance; TAS:Reactome
P29400	COL4A5	Collagen alpha-5(IV) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P29400	COL4A5	Collagen alpha-5(IV) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P29400	COL4A5	Collagen alpha-5(IV) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P29400	COL4A5	Collagen alpha-5(IV) chain	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
Q14031	COL4A6	Collagen alpha-6(IV) chain	GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro
Q14031	COL4A6	Collagen alpha-6(IV) chain	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q14031	COL4A6	Collagen alpha-6(IV) chain	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
Q14031	COL4A6	Collagen alpha-6(IV) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
Q14031	COL4A6	Collagen alpha-6(IV) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q14031	COL4A6	Collagen alpha-6(IV) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P0C0L4	C4A	Complement C4-A	GO:0004866; F:endopeptidase inhibitor activity; IEA:InterPro
P0C0L4	C4A	Complement C4-A	GO:0006956; P:complement activation; TAS:Reactome
P0C0L4	C4A	Complement C4-A	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
P0C0L4	C4A	Complement C4-A	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
P0C0L4	C4A	Complement C4-A	GO:0045087; P:innate immune response; TAS:Reactome
P0C0L4	C4A	Complement C4-A	GO:0030449; P:regulation of complement activation; TAS:Reactome
P0C0L5	C4B	Complement C4-B	GO:0004866; F:endopeptidase inhibitor activity; IEA:InterPro
P0C0L5	C4B	Complement C4-B	GO:0006956; P:complement activation; TAS:Reactome
P0C0L5	C4B	Complement C4-B	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
P0C0L5	C4B	Complement C4-B	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
P0C0L5	C4B	Complement C4-B	GO:0045087; P:innate immune response; TAS:Reactome
P0C0L5	C4B	Complement C4-B	GO:0030449; P:regulation of complement activation; TAS:Reactome
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0005201; F:extracellular matrix structural constituent; IEA:Ensembl
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0008201; F:heparin binding; IDA:UniProtKB
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0005178; F:integrin binding; NAS:UniProtKB
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0048407; F:platelet-derived growth factor binding; IDA:MGI
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0043394; F:proteoglycan binding; IPI:UniProtKB
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0007411; P:axon guidance; TAS:Reactome
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0001568; P:blood vessel development; IEA:Ensembl
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0007155; P:cell adhesion; IMP:UniProtKB
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0016477; P:cell migration; IMP:UniProtKB
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0032964; P:collagen biosynthetic process; IMP:UniProtKB
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0030199; P:collagen fibril organization; IMP:UniProtKB
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0043206; P:extracellular fibril organization; IMP:UniProtKB
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0048592; P:eye morphogenesis; IMP:UniProtKB
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0003007; P:heart morphogenesis; IEA:Ensembl
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0045112; P:integrin biosynthetic process; IMP:UniProtKB
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0051128; P:regulation of cellular component organization; IEA:Ensembl
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0043588; P:skin development; IMP:UniProtKB
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0035989; P:tendon development; IEA:Ensembl
P20908	COL5A1	Collagen alpha-1(V) chain	GO:0035313; P:wound healing, spreading of epidermal cells; IMP:UniProtKB
P05997	COL5A2	Collagen alpha-2(V) chain	GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro
P05997	COL5A2	Collagen alpha-2(V) chain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P05997	COL5A2	Collagen alpha-2(V) chain	GO:0007411; P:axon guidance; TAS:Reactome
P05997	COL5A2	Collagen alpha-2(V) chain	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
P05997	COL5A2	Collagen alpha-2(V) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P05997	COL5A2	Collagen alpha-2(V) chain	GO:0030199; P:collagen fibril organization; IMP:UniProtKB
P05997	COL5A2	Collagen alpha-2(V) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P05997	COL5A2	Collagen alpha-2(V) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P05997	COL5A2	Collagen alpha-2(V) chain	GO:0048592; P:eye morphogenesis; IMP:UniProtKB
P05997	COL5A2	Collagen alpha-2(V) chain	GO:0001501; P:skeletal system development; IEA:Ensembl
P05997	COL5A2	Collagen alpha-2(V) chain	GO:0043588; P:skin development; IMP:UniProtKB
P25940	COL5A3	Collagen alpha-3(V) chain	GO:0005518; F:collagen binding; NAS:UniProtKB
P25940	COL5A3	Collagen alpha-3(V) chain	GO:0005201; F:extracellular matrix structural constituent; NAS:UniProtKB
P25940	COL5A3	Collagen alpha-3(V) chain	GO:0008201; F:heparin binding; IEA:Ensembl
P25940	COL5A3	Collagen alpha-3(V) chain	GO:0007411; P:axon guidance; TAS:Reactome
P25940	COL5A3	Collagen alpha-3(V) chain	GO:0007160; P:cell-matrix adhesion; IEA:Ensembl
P25940	COL5A3	Collagen alpha-3(V) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P25940	COL5A3	Collagen alpha-3(V) chain	GO:0030199; P:collagen fibril organization; NAS:UniProtKB
P25940	COL5A3	Collagen alpha-3(V) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P25940	COL5A3	Collagen alpha-3(V) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P25940	COL5A3	Collagen alpha-3(V) chain	GO:0043588; P:skin development; NAS:UniProtKB
P01031	C5	Complement C5	GO:0008009; F:chemokine activity; TAS:ProtInc
P01031	C5	Complement C5	GO:0004866; F:endopeptidase inhibitor activity; IEA:InterPro
P01031	C5	Complement C5	GO:0005515; F:protein binding; IPI:IntAct
P01031	C5	Complement C5	GO:0005102; F:receptor binding; TAS:ProtInc
P01031	C5	Complement C5	GO:0000187; P:activation of MAPK activity; TAS:ProtInc
P01031	C5	Complement C5	GO:0060326; P:cell chemotaxis; TAS:GOC
P01031	C5	Complement C5	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P01031	C5	Complement C5	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
P01031	C5	Complement C5	GO:0006935; P:chemotaxis; TAS:ProtInc
P01031	C5	Complement C5	GO:0006956; P:complement activation; TAS:Reactome
P01031	C5	Complement C5	GO:0006957; P:complement activation, alternative pathway; IEA:UniProtKB-KW
P01031	C5	Complement C5	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
P01031	C5	Complement C5	GO:0019835; P:cytolysis; IEA:UniProtKB-KW
P01031	C5	Complement C5	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P01031	C5	Complement C5	GO:0042593; P:glucose homeostasis; IEA:Ensembl
P01031	C5	Complement C5	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P01031	C5	Complement C5	GO:0006954; P:inflammatory response; TAS:ProtInc
P01031	C5	Complement C5	GO:0045087; P:innate immune response; TAS:Reactome
P01031	C5	Complement C5	GO:0002523; P:leukocyte migration involved in inflammatory response; IEA:Ensembl
P01031	C5	Complement C5	GO:0033602; P:negative regulation of dopamine secretion; IEA:Ensembl
P01031	C5	Complement C5	GO:0010760; P:negative regulation of macrophage chemotaxis; IDA:BHF-UCL
P01031	C5	Complement C5	GO:0010700; P:negative regulation of norepinephrine secretion; IEA:Ensembl
P01031	C5	Complement C5	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
P01031	C5	Complement C5	GO:0090197; P:positive regulation of chemokine secretion; IDA:BHF-UCL
P01031	C5	Complement C5	GO:0050921; P:positive regulation of chemotaxis; IEA:Ensembl
P01031	C5	Complement C5	GO:0010575; P:positive regulation vascular endothelial growth factor production; IDA:BHF-UCL
P01031	C5	Complement C5	GO:0030449; P:regulation of complement activation; TAS:Reactome
P01031	C5	Complement C5	GO:0006950; P:response to stress; TAS:ProtInc
P12109	COL6A1	Collagen alpha-1(VI) chain	GO:0048407; F:platelet-derived growth factor binding; IDA:MGI
P12109	COL6A1	Collagen alpha-1(VI) chain	GO:0007411; P:axon guidance; TAS:Reactome
P12109	COL6A1	Collagen alpha-1(VI) chain	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P12109	COL6A1	Collagen alpha-1(VI) chain	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
P12109	COL6A1	Collagen alpha-1(VI) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P12109	COL6A1	Collagen alpha-1(VI) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P12109	COL6A1	Collagen alpha-1(VI) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P12109	COL6A1	Collagen alpha-1(VI) chain	GO:0070208; P:protein heterotrimerization; IPI:MGI
P12110	COL6A2	Collagen alpha-2(VI) chain	GO:0005515; F:protein binding; IPI:IntAct
P12110	COL6A2	Collagen alpha-2(VI) chain	GO:0007411; P:axon guidance; TAS:Reactome
P12110	COL6A2	Collagen alpha-2(VI) chain	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P12110	COL6A2	Collagen alpha-2(VI) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P12110	COL6A2	Collagen alpha-2(VI) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P12110	COL6A2	Collagen alpha-2(VI) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P12110	COL6A2	Collagen alpha-2(VI) chain	GO:0070208; P:protein heterotrimerization; IPI:MGI
P12110	COL6A2	Collagen alpha-2(VI) chain	GO:0009749; P:response to glucose; IEA:Ensembl
P12111	COL6A3	Collagen alpha-3(VI) chain	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
P12111	COL6A3	Collagen alpha-3(VI) chain	GO:0007411; P:axon guidance; TAS:Reactome
P12111	COL6A3	Collagen alpha-3(VI) chain	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P12111	COL6A3	Collagen alpha-3(VI) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P12111	COL6A3	Collagen alpha-3(VI) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P12111	COL6A3	Collagen alpha-3(VI) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P12111	COL6A3	Collagen alpha-3(VI) chain	GO:0007517; P:muscle organ development; TAS:ProtInc
A8TX70	COL6A5	Collagen alpha-5(VI) chain	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
A8TX70	COL6A5	Collagen alpha-5(VI) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
A8TX70	COL6A5	Collagen alpha-5(VI) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
A8TX70	COL6A5	Collagen alpha-5(VI) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
A6NMZ7	COL6A6	Collagen alpha-6(VI) chain	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
A6NMZ7	COL6A6	Collagen alpha-6(VI) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
A6NMZ7	COL6A6	Collagen alpha-6(VI) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
A6NMZ7	COL6A6	Collagen alpha-6(VI) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P13671	C6	Complement component C6	GO:0005515; F:protein binding; IPI:IntAct
P13671	C6	Complement component C6	GO:0006956; P:complement activation; TAS:ProtInc
P13671	C6	Complement component C6	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
P13671	C6	Complement component C6	GO:0019835; P:cytolysis; IEA:UniProtKB-KW
P13671	C6	Complement component C6	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P13671	C6	Complement component C6	GO:0045087; P:innate immune response; TAS:Reactome
P13671	C6	Complement component C6	GO:0001970; P:positive regulation of activation of membrane attack complex; IEA:Ensembl
P13671	C6	Complement component C6	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
P13671	C6	Complement component C6	GO:0030449; P:regulation of complement activation; TAS:Reactome
Q02388	COL7A1	Collagen alpha-1(VII) chain	GO:0005515; F:protein binding; IPI:UniProtKB
Q02388	COL7A1	Collagen alpha-1(VII) chain	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q02388	COL7A1	Collagen alpha-1(VII) chain	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q02388	COL7A1	Collagen alpha-1(VII) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
Q02388	COL7A1	Collagen alpha-1(VII) chain	GO:0008544; P:epidermis development; TAS:ProtInc
Q02388	COL7A1	Collagen alpha-1(VII) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q02388	COL7A1	Collagen alpha-1(VII) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P10643	C7	Complement component C7	GO:0006883; P:cellular sodium ion homeostasis; IEA:Ensembl
P10643	C7	Complement component C7	GO:0006956; P:complement activation; TAS:ProtInc
P10643	C7	Complement component C7	GO:0006957; P:complement activation, alternative pathway; IEA:UniProtKB-KW
P10643	C7	Complement component C7	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
P10643	C7	Complement component C7	GO:0019835; P:cytolysis; IEA:UniProtKB-KW
P10643	C7	Complement component C7	GO:0045087; P:innate immune response; TAS:Reactome
P10643	C7	Complement component C7	GO:0030449; P:regulation of complement activation; TAS:Reactome
P27658	COL8A1	Collagen alpha-1(VIII) chain	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P27658	COL8A1	Collagen alpha-1(VIII) chain	GO:0048593; P:camera-type eye morphogenesis; IEA:Ensembl
P27658	COL8A1	Collagen alpha-1(VIII) chain	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P27658	COL8A1	Collagen alpha-1(VIII) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P27658	COL8A1	Collagen alpha-1(VIII) chain	GO:0050673; P:epithelial cell proliferation; IEA:Ensembl
P27658	COL8A1	Collagen alpha-1(VIII) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P27658	COL8A1	Collagen alpha-1(VIII) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P27658	COL8A1	Collagen alpha-1(VIII) chain	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
P25067	COL8A2	Collagen alpha-2(VIII) chain	GO:0005201; F:extracellular matrix structural constituent; NAS:UniProtKB
P25067	COL8A2	Collagen alpha-2(VIII) chain	GO:0030674; F:protein binding, bridging; NAS:UniProtKB
P25067	COL8A2	Collagen alpha-2(VIII) chain	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P25067	COL8A2	Collagen alpha-2(VIII) chain	GO:0048593; P:camera-type eye morphogenesis; IEA:Ensembl
P25067	COL8A2	Collagen alpha-2(VIII) chain	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
P25067	COL8A2	Collagen alpha-2(VIII) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P25067	COL8A2	Collagen alpha-2(VIII) chain	GO:0050673; P:epithelial cell proliferation; IEA:Ensembl
P25067	COL8A2	Collagen alpha-2(VIII) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P25067	COL8A2	Collagen alpha-2(VIII) chain	GO:0030198; P:extracellular matrix organization; NAS:UniProtKB
P07357	C8A	Complement component C8 alpha chain	GO:0006956; P:complement activation; IDA:MGI
P07357	C8A	Complement component C8 alpha chain	GO:0006957; P:complement activation, alternative pathway; IEA:UniProtKB-KW
P07357	C8A	Complement component C8 alpha chain	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
P07357	C8A	Complement component C8 alpha chain	GO:0019835; P:cytolysis; IEA:UniProtKB-KW
P07357	C8A	Complement component C8 alpha chain	GO:0006955; P:immune response; TAS:ProtInc
P07357	C8A	Complement component C8 alpha chain	GO:0045087; P:innate immune response; TAS:Reactome
P07357	C8A	Complement component C8 alpha chain	GO:0030449; P:regulation of complement activation; TAS:Reactome
P07358	C8B	Complement component C8 beta chain	GO:0006956; P:complement activation; TAS:ProtInc
P07358	C8B	Complement component C8 beta chain	GO:0006957; P:complement activation, alternative pathway; IEA:UniProtKB-KW
P07358	C8B	Complement component C8 beta chain	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
P07358	C8B	Complement component C8 beta chain	GO:0019835; P:cytolysis; IEA:UniProtKB-KW
P07358	C8B	Complement component C8 beta chain	GO:0006955; P:immune response; TAS:ProtInc
P07358	C8B	Complement component C8 beta chain	GO:0045087; P:innate immune response; TAS:Reactome
P07358	C8B	Complement component C8 beta chain	GO:0030449; P:regulation of complement activation; TAS:Reactome
P07360	C8G	Complement component C8 gamma chain	GO:0019841; F:retinol binding; IEA:UniProtKB-KW
P07360	C8G	Complement component C8 gamma chain	GO:0006957; P:complement activation, alternative pathway; IEA:UniProtKB-KW
P07360	C8G	Complement component C8 gamma chain	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
P07360	C8G	Complement component C8 gamma chain	GO:0019835; P:cytolysis; IEA:UniProtKB-KW
P07360	C8G	Complement component C8 gamma chain	GO:0045087; P:innate immune response; TAS:Reactome
P07360	C8G	Complement component C8 gamma chain	GO:0030449; P:regulation of complement activation; TAS:Reactome
P20849	COL9A1	Collagen alpha-1(IX) chain	GO:0030020; F:extracellular matrix structural constituent conferring tensile strength; IC:BHF-UCL
P20849	COL9A1	Collagen alpha-1(IX) chain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P20849	COL9A1	Collagen alpha-1(IX) chain	GO:0007411; P:axon guidance; TAS:Reactome
P20849	COL9A1	Collagen alpha-1(IX) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P20849	COL9A1	Collagen alpha-1(IX) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P20849	COL9A1	Collagen alpha-1(IX) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P20849	COL9A1	Collagen alpha-1(IX) chain	GO:0003417; P:growth plate cartilage development; IEA:Ensembl
P20849	COL9A1	Collagen alpha-1(IX) chain	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P20849	COL9A1	Collagen alpha-1(IX) chain	GO:0001894; P:tissue homeostasis; IEA:Ensembl
Q14055	COL9A2	Collagen alpha-2(IX) chain	GO:0030020; F:extracellular matrix structural constituent conferring tensile strength; IC:BHF-UCL
Q14055	COL9A2	Collagen alpha-2(IX) chain	GO:0007411; P:axon guidance; TAS:Reactome
Q14055	COL9A2	Collagen alpha-2(IX) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
Q14055	COL9A2	Collagen alpha-2(IX) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q14055	COL9A2	Collagen alpha-2(IX) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q14055	COL9A2	Collagen alpha-2(IX) chain	GO:0001501; P:skeletal system development; TAS:ProtInc
Q14050	COL9A3	Collagen alpha-3(IX) chain	GO:0030020; F:extracellular matrix structural constituent conferring tensile strength; IC:BHF-UCL
Q14050	COL9A3	Collagen alpha-3(IX) chain	GO:0007411; P:axon guidance; TAS:Reactome
Q14050	COL9A3	Collagen alpha-3(IX) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
Q14050	COL9A3	Collagen alpha-3(IX) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q14050	COL9A3	Collagen alpha-3(IX) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q14050	COL9A3	Collagen alpha-3(IX) chain	GO:0008585; P:female gonad development; IEA:Ensembl
Q14050	COL9A3	Collagen alpha-3(IX) chain	GO:0008584; P:male gonad development; IEA:Ensembl
P02748	C9	Complement component C9	GO:0006957; P:complement activation, alternative pathway; IEA:UniProtKB-KW
P02748	C9	Complement component C9	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
P02748	C9	Complement component C9	GO:0019836; P:hemolysis by symbiont of host erythrocytes; TAS:ProtInc
P02748	C9	Complement component C9	GO:0045087; P:innate immune response; TAS:Reactome
P02748	C9	Complement component C9	GO:0030449; P:regulation of complement activation; TAS:Reactome
Q9GZY4	COA1	Cytochrome c oxidase assembly factor 1 homolog	GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:UniProtKB
Q9GZY4	COA1	Cytochrome c oxidase assembly factor 1 homolog	GO:0033617; P:mitochondrial respiratory chain complex IV assembly; IMP:UniProtKB
Q9Y2R0	COA3	Cytochrome c oxidase assembly factor 3 homolog, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2R0	COA3	Cytochrome c oxidase assembly factor 3 homolog, mitochondrial	GO:0033617; P:mitochondrial respiratory chain complex IV assembly; IMP:UniProtKB
Q9Y2R0	COA3	Cytochrome c oxidase assembly factor 3 homolog, mitochondrial	GO:0070131; P:positive regulation of mitochondrial translation; IMP:UniProtKB
Q5JTJ3	COA6	Cytochrome c oxidase assembly factor 6 homolog	GO:0004129; F:cytochrome-c oxidase activity; IEA:InterPro
Q5JTJ3	COA6	Cytochrome c oxidase assembly factor 6 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q03692	COL10A1	Collagen alpha-1(X) chain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q03692	COL10A1	Collagen alpha-1(X) chain	GO:0051216; P:cartilage development; IEA:Ensembl
Q03692	COL10A1	Collagen alpha-1(X) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
Q03692	COL10A1	Collagen alpha-1(X) chain	GO:0001958; P:endochondral ossification; IEA:Ensembl
Q03692	COL10A1	Collagen alpha-1(X) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q03692	COL10A1	Collagen alpha-1(X) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q03692	COL10A1	Collagen alpha-1(X) chain	GO:0001501; P:skeletal system development; TAS:ProtInc
Q96CD2	PPCDC	Phosphopantothenoylcysteine decarboxylase	GO:0004633; F:phosphopantothenoylcysteine decarboxylase activity; IDA:UniProtKB
Q96CD2	PPCDC	Phosphopantothenoylcysteine decarboxylase	GO:0015937; P:coenzyme A biosynthetic process; IDA:UniProtKB
Q96CD2	PPCDC	Phosphopantothenoylcysteine decarboxylase	GO:0009108; P:coenzyme biosynthetic process; TAS:Reactome
Q96CD2	PPCDC	Phosphopantothenoylcysteine decarboxylase	GO:0015939; P:pantothenate metabolic process; TAS:Reactome
Q96CD2	PPCDC	Phosphopantothenoylcysteine decarboxylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96CD2	PPCDC	Phosphopantothenoylcysteine decarboxylase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q96CD2	PPCDC	Phosphopantothenoylcysteine decarboxylase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q13057	COASY	Bifunctional coenzyme A synthase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13057	COASY	Bifunctional coenzyme A synthase	GO:0004140; F:dephospho-CoA kinase activity; IDA:UniProtKB
Q13057	COASY	Bifunctional coenzyme A synthase	GO:0004595; F:pantetheine-phosphate adenylyltransferase activity; IDA:UniProtKB
Q13057	COASY	Bifunctional coenzyme A synthase	GO:0005515; F:protein binding; IPI:IntAct
Q13057	COASY	Bifunctional coenzyme A synthase	GO:0015937; P:coenzyme A biosynthetic process; IDA:UniProtKB
Q13057	COASY	Bifunctional coenzyme A synthase	GO:0009108; P:coenzyme biosynthetic process; TAS:Reactome
Q13057	COASY	Bifunctional coenzyme A synthase	GO:0015939; P:pantothenate metabolic process; TAS:Reactome
Q13057	COASY	Bifunctional coenzyme A synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q13057	COASY	Bifunctional coenzyme A synthase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q13057	COASY	Bifunctional coenzyme A synthase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
P12107	COL11A1	Collagen alpha-1(XI) chain	GO:0050840; F:extracellular matrix binding; NAS:UniProtKB
P12107	COL11A1	Collagen alpha-1(XI) chain	GO:0005201; F:extracellular matrix structural constituent; NAS:UniProtKB
P12107	COL11A1	Collagen alpha-1(XI) chain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P12107	COL11A1	Collagen alpha-1(XI) chain	GO:0030674; F:protein binding, bridging; NAS:UniProtKB
P12107	COL11A1	Collagen alpha-1(XI) chain	GO:0001502; P:cartilage condensation; IEA:Ensembl
P12107	COL11A1	Collagen alpha-1(XI) chain	GO:0002063; P:chondrocyte development; IEA:Ensembl
P12107	COL11A1	Collagen alpha-1(XI) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P12107	COL11A1	Collagen alpha-1(XI) chain	GO:0030199; P:collagen fibril organization; NAS:UniProtKB
P12107	COL11A1	Collagen alpha-1(XI) chain	GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; IMP:UniProtKB
P12107	COL11A1	Collagen alpha-1(XI) chain	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P12107	COL11A1	Collagen alpha-1(XI) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P12107	COL11A1	Collagen alpha-1(XI) chain	GO:0030198; P:extracellular matrix organization; NAS:UniProtKB
P12107	COL11A1	Collagen alpha-1(XI) chain	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
P12107	COL11A1	Collagen alpha-1(XI) chain	GO:0006029; P:proteoglycan metabolic process; IEA:Ensembl
P12107	COL11A1	Collagen alpha-1(XI) chain	GO:0007605; P:sensory perception of sound; IMP:UniProtKB
P12107	COL11A1	Collagen alpha-1(XI) chain	GO:0035989; P:tendon development; IEA:Ensembl
P12107	COL11A1	Collagen alpha-1(XI) chain	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IEA:Ensembl
P12107	COL11A1	Collagen alpha-1(XI) chain	GO:0007601; P:visual perception; IMP:UniProtKB
P13942	COL11A2	Collagen alpha-2(XI) chain	GO:0030020; F:extracellular matrix structural constituent conferring tensile strength; NAS:UniProtKB
P13942	COL11A2	Collagen alpha-2(XI) chain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P13942	COL11A2	Collagen alpha-2(XI) chain	GO:0005515; F:protein binding; IPI:IntAct
P13942	COL11A2	Collagen alpha-2(XI) chain	GO:0030674; F:protein binding, bridging; NAS:UniProtKB
P13942	COL11A2	Collagen alpha-2(XI) chain	GO:0051216; P:cartilage development; IMP:UniProtKB
P13942	COL11A2	Collagen alpha-2(XI) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P13942	COL11A2	Collagen alpha-2(XI) chain	GO:0030199; P:collagen fibril organization; IDA:UniProtKB
P13942	COL11A2	Collagen alpha-2(XI) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P13942	COL11A2	Collagen alpha-2(XI) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P13942	COL11A2	Collagen alpha-2(XI) chain	GO:0060021; P:palate development; IMP:UniProtKB
P13942	COL11A2	Collagen alpha-2(XI) chain	GO:0007605; P:sensory perception of sound; IMP:UniProtKB
P13942	COL11A2	Collagen alpha-2(XI) chain	GO:0001501; P:skeletal system development; IMP:UniProtKB
P13942	COL11A2	Collagen alpha-2(XI) chain	GO:0060023; P:soft palate development; IMP:UniProtKB
O75128	COBL	Protein cordon-bleu	GO:0003785; F:actin monomer binding; ISS:BHF-UCL
O75128	COBL	Protein cordon-bleu	GO:0051639; P:actin filament network formation; ISS:BHF-UCL
O75128	COBL	Protein cordon-bleu	GO:0030041; P:actin filament polymerization; ISS:BHF-UCL
O75128	COBL	Protein cordon-bleu	GO:0048669; P:collateral sprouting in absence of injury; ISS:BHF-UCL
O75128	COBL	Protein cordon-bleu	GO:0048565; P:digestive tract development; ISS:BHF-UCL
O75128	COBL	Protein cordon-bleu	GO:0000578; P:embryonic axis specification; ISS:BHF-UCL
O75128	COBL	Protein cordon-bleu	GO:0033504; P:floor plate development; ISS:BHF-UCL
O75128	COBL	Protein cordon-bleu	GO:0001889; P:liver development; ISS:BHF-UCL
O75128	COBL	Protein cordon-bleu	GO:0001843; P:neural tube closure; ISS:BHF-UCL
O75128	COBL	Protein cordon-bleu	GO:0030903; P:notochord development; ISS:BHF-UCL
O75128	COBL	Protein cordon-bleu	GO:1900006; P:positive regulation of dendrite development; ISS:BHF-UCL
O75128	COBL	Protein cordon-bleu	GO:0001757; P:somite specification; ISS:BHF-UCL
Q99715	COL12A1	Collagen alpha-1(XII) chain	GO:0030020; F:extracellular matrix structural constituent conferring tensile strength; NAS:UniProtKB
Q99715	COL12A1	Collagen alpha-1(XII) chain	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q99715	COL12A1	Collagen alpha-1(XII) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
Q99715	COL12A1	Collagen alpha-1(XII) chain	GO:0030199; P:collagen fibril organization; NAS:UniProtKB
Q99715	COL12A1	Collagen alpha-1(XII) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q99715	COL12A1	Collagen alpha-1(XII) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q99715	COL12A1	Collagen alpha-1(XII) chain	GO:0001501; P:skeletal system development; TAS:ProtInc
O43405	COCH	Cochlin	GO:0005515; F:protein binding; IPI:UniProtKB
O43405	COCH	Cochlin	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
O43405	COCH	Cochlin	GO:0007605; P:sensory perception of sound; TAS:ProtInc
Q5TAT6	COL13A1	Collagen alpha-1(XIII) chain	GO:0008201; F:heparin binding; IDA:UniProtKB
Q5TAT6	COL13A1	Collagen alpha-1(XIII) chain	GO:0005515; F:protein binding; IPI:UniProtKB
Q5TAT6	COL13A1	Collagen alpha-1(XIII) chain	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q5TAT6	COL13A1	Collagen alpha-1(XIII) chain	GO:0016337; P:single organismal cell-cell adhesion; IEP:UniProtKB
Q5TAT6	COL13A1	Collagen alpha-1(XIII) chain	GO:0007160; P:cell-matrix adhesion; IPI:UniProtKB
Q5TAT6	COL13A1	Collagen alpha-1(XIII) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
Q5TAT6	COL13A1	Collagen alpha-1(XIII) chain	GO:0001958; P:endochondral ossification; ISS:UniProtKB
Q5TAT6	COL13A1	Collagen alpha-1(XIII) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q5TAT6	COL13A1	Collagen alpha-1(XIII) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q5TAT6	COL13A1	Collagen alpha-1(XIII) chain	GO:0001763; P:morphogenesis of a branching structure; ISS:UniProtKB
Q9UH73	EBF1	Transcription factor COE1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UH73	EBF1	Transcription factor COE1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UH73	EBF1	Transcription factor COE1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q9UH73	EBF1	Transcription factor COE1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9UH73	EBF1	Transcription factor COE1	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q9UH73	EBF1	Transcription factor COE1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HAK2	EBF2	Transcription factor COE2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9HAK2	EBF2	Transcription factor COE2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HAK2	EBF2	Transcription factor COE2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9HAK2	EBF2	Transcription factor COE2	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q9HAK2	EBF2	Transcription factor COE2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H4W6	EBF3	Transcription factor COE3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H4W6	EBF3	Transcription factor COE3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H4W6	EBF3	Transcription factor COE3	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9H4W6	EBF3	Transcription factor COE3	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q9H4W6	EBF3	Transcription factor COE3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BQW3	EBF4	Transcription factor COE4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BQW3	EBF4	Transcription factor COE4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BQW3	EBF4	Transcription factor COE4	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9BQW3	EBF4	Transcription factor COE4	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9BQW3	EBF4	Transcription factor COE4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q05707	COL14A1	Collagen alpha-1(XIV) chain	GO:0005518; F:collagen binding; NAS:UniProtKB
Q05707	COL14A1	Collagen alpha-1(XIV) chain	GO:0005201; F:extracellular matrix structural constituent; NAS:UniProtKB
Q05707	COL14A1	Collagen alpha-1(XIV) chain	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q05707	COL14A1	Collagen alpha-1(XIV) chain	GO:0030674; F:protein binding, bridging; NAS:UniProtKB
Q05707	COL14A1	Collagen alpha-1(XIV) chain	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
Q05707	COL14A1	Collagen alpha-1(XIV) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
Q05707	COL14A1	Collagen alpha-1(XIV) chain	GO:0030199; P:collagen fibril organization; NAS:UniProtKB
Q05707	COL14A1	Collagen alpha-1(XIV) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q05707	COL14A1	Collagen alpha-1(XIV) chain	GO:0030198; P:extracellular matrix organization; NAS:UniProtKB
Q05707	COL14A1	Collagen alpha-1(XIV) chain	GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl
Q05707	COL14A1	Collagen alpha-1(XIV) chain	GO:0061050; P:regulation of cell growth involved in cardiac muscle cell development; IEA:Ensembl
Q05707	COL14A1	Collagen alpha-1(XIV) chain	GO:0003229; P:ventricular cardiac muscle tissue development; IEA:Ensembl
P23528	CFL1	Cofilin-1	GO:0005515; F:protein binding; IPI:IntAct
P23528	CFL1	Cofilin-1	GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc
P23528	CFL1	Cofilin-1	GO:0030042; P:actin filament depolymerization; IEA:InterPro
P23528	CFL1	Cofilin-1	GO:0007411; P:axon guidance; TAS:Reactome
P23528	CFL1	Cofilin-1	GO:0007596; P:blood coagulation; TAS:Reactome
P23528	CFL1	Cofilin-1	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
P23528	CFL1	Cofilin-1	GO:0030010; P:establishment of cell polarity; IEA:Ensembl
P23528	CFL1	Cofilin-1	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P23528	CFL1	Cofilin-1	GO:0045087; P:innate immune response; TAS:Reactome
P23528	CFL1	Cofilin-1	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
P23528	CFL1	Cofilin-1	GO:0045792; P:negative regulation of cell size; IEA:Ensembl
P23528	CFL1	Cofilin-1	GO:0001755; P:neural crest cell migration; IEA:Ensembl
P23528	CFL1	Cofilin-1	GO:0001842; P:neural fold formation; IEA:Ensembl
P23528	CFL1	Cofilin-1	GO:0030168; P:platelet activation; TAS:Reactome
P23528	CFL1	Cofilin-1	GO:0002576; P:platelet degranulation; TAS:Reactome
P23528	CFL1	Cofilin-1	GO:0030836; P:positive regulation of actin filament depolymerization; IEA:Ensembl
P23528	CFL1	Cofilin-1	GO:0006606; P:protein import into nucleus; IEA:Ensembl
P23528	CFL1	Cofilin-1	GO:0006468; P:protein phosphorylation; IEA:Ensembl
P23528	CFL1	Cofilin-1	GO:0022604; P:regulation of cell morphogenesis; IMP:UniProtKB
P23528	CFL1	Cofilin-1	GO:0043200; P:response to amino acid; IEA:Ensembl
P23528	CFL1	Cofilin-1	GO:0009615; P:response to virus; IEP:UniProtKB
P23528	CFL1	Cofilin-1	GO:0007266; P:Rho protein signal transduction; TAS:ProtInc
Q9Y281	CFL2	Cofilin-2	GO:0005515; F:protein binding; IPI:IntAct
Q9Y281	CFL2	Cofilin-2	GO:0030042; P:actin filament depolymerization; IEA:InterPro
Q9Y281	CFL2	Cofilin-2	GO:0030836; P:positive regulation of actin filament depolymerization; IMP:UniProt
P39059	COL15A1	Collagen alpha-1(XV) chain	GO:0005201; F:extracellular matrix structural constituent; IC:UniProtKB
P39059	COL15A1	Collagen alpha-1(XV) chain	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P39059	COL15A1	Collagen alpha-1(XV) chain	GO:0007155; P:cell adhesion; IC:UniProtKB
P39059	COL15A1	Collagen alpha-1(XV) chain	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P39059	COL15A1	Collagen alpha-1(XV) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P39059	COL15A1	Collagen alpha-1(XV) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P39059	COL15A1	Collagen alpha-1(XV) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P39059	COL15A1	Collagen alpha-1(XV) chain	GO:0007165; P:signal transduction; NAS:UniProtKB
Q8WTW3	COG1	Conserved oligomeric Golgi complex subunit 1	GO:0005515; F:protein binding; IPI:IntAct
Q8WTW3	COG1	Conserved oligomeric Golgi complex subunit 1	GO:0007030; P:Golgi organization; NAS:UniProtKB
Q8WTW3	COG1	Conserved oligomeric Golgi complex subunit 1	GO:0006891; P:intra-Golgi vesicle-mediated transport; NAS:UniProtKB
Q8WTW3	COG1	Conserved oligomeric Golgi complex subunit 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q14746	COG2	Conserved oligomeric Golgi complex subunit 2	GO:0005515; F:protein binding; IPI:IntAct
Q14746	COG2	Conserved oligomeric Golgi complex subunit 2	GO:0008565; F:protein transporter activity; IMP:UniProtKB
Q14746	COG2	Conserved oligomeric Golgi complex subunit 2	GO:0007030; P:Golgi organization; IMP:UniProtKB
Q14746	COG2	Conserved oligomeric Golgi complex subunit 2	GO:0006891; P:intra-Golgi vesicle-mediated transport; IMP:UniProtKB
Q14746	COG2	Conserved oligomeric Golgi complex subunit 2	GO:0006886; P:intracellular protein transport; TAS:ProtInc
Q14746	COG2	Conserved oligomeric Golgi complex subunit 2	GO:0009312; P:oligosaccharide biosynthetic process; TAS:ProtInc
Q14746	COG2	Conserved oligomeric Golgi complex subunit 2	GO:0006486; P:protein glycosylation; TAS:ProtInc
Q96JB2	COG3	Conserved oligomeric Golgi complex subunit 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q96JB2	COG3	Conserved oligomeric Golgi complex subunit 3	GO:0008565; F:protein transporter activity; IDA:UniProtKB
Q96JB2	COG3	Conserved oligomeric Golgi complex subunit 3	GO:0006888; P:ER to Golgi vesicle-mediated transport; IDA:UniProtKB
Q96JB2	COG3	Conserved oligomeric Golgi complex subunit 3	GO:0006891; P:intra-Golgi vesicle-mediated transport; IDA:UniProtKB
Q96JB2	COG3	Conserved oligomeric Golgi complex subunit 3	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q96JB2	COG3	Conserved oligomeric Golgi complex subunit 3	GO:0006486; P:protein glycosylation; IMP:UniProtKB
Q96JB2	COG3	Conserved oligomeric Golgi complex subunit 3	GO:0033365; P:protein localization to organelle; IMP:UniProtKB
Q96JB2	COG3	Conserved oligomeric Golgi complex subunit 3	GO:0050821; P:protein stabilization; IMP:UniProtKB
Q96JB2	COG3	Conserved oligomeric Golgi complex subunit 3	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; IMP:UniProtKB
Q9UP83	COG5	Conserved oligomeric Golgi complex subunit 5	GO:0005515; F:protein binding; IPI:IntAct
Q9UP83	COG5	Conserved oligomeric Golgi complex subunit 5	GO:0006891; P:intra-Golgi vesicle-mediated transport; NAS:UniProtKB
Q9UP83	COG5	Conserved oligomeric Golgi complex subunit 5	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9H9E3	COG4	Conserved oligomeric Golgi complex subunit 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H9E3	COG4	Conserved oligomeric Golgi complex subunit 4	GO:0007030; P:Golgi organization; IMP:UniProtKB
Q9H9E3	COG4	Conserved oligomeric Golgi complex subunit 4	GO:0048213; P:Golgi vesicle prefusion complex stabilization; IMP:UniProtKB
Q9H9E3	COG4	Conserved oligomeric Golgi complex subunit 4	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9H9E3	COG4	Conserved oligomeric Golgi complex subunit 4	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; IMP:UniProtKB
Q9Y2V7	COG6	Conserved oligomeric Golgi complex subunit 6	GO:0070085; P:glycosylation; IMP:UniProtKB
Q9Y2V7	COG6	Conserved oligomeric Golgi complex subunit 6	GO:0006891; P:intra-Golgi vesicle-mediated transport; IEA:InterPro
Q9Y2V7	COG6	Conserved oligomeric Golgi complex subunit 6	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P83436	COG7	Conserved oligomeric Golgi complex subunit 7	GO:0005515; F:protein binding; IPI:UniProtKB
P83436	COG7	Conserved oligomeric Golgi complex subunit 7	GO:0006886; P:intracellular protein transport; IMP:UniProtKB
P83436	COG7	Conserved oligomeric Golgi complex subunit 7	GO:0006486; P:protein glycosylation; IMP:UniProtKB
P83436	COG7	Conserved oligomeric Golgi complex subunit 7	GO:0034067; P:protein localization to Golgi apparatus; IMP:UniProtKB
P83436	COG7	Conserved oligomeric Golgi complex subunit 7	GO:0033365; P:protein localization to organelle; IMP:UniProtKB
P83436	COG7	Conserved oligomeric Golgi complex subunit 7	GO:0050821; P:protein stabilization; IMP:UniProtKB
P83436	COG7	Conserved oligomeric Golgi complex subunit 7	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; IMP:UniProtKB
Q96MW5	COG8	Conserved oligomeric Golgi complex subunit 8	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q07092	COL16A1	Collagen alpha-1(XVI) chain	GO:0005178; F:integrin binding; IDA:UniProtKB
Q07092	COL16A1	Collagen alpha-1(XVI) chain	GO:0005515; F:protein binding; IPI:UniProtKB
Q07092	COL16A1	Collagen alpha-1(XVI) chain	GO:0007155; P:cell adhesion; IDA:UniProtKB
Q07092	COL16A1	Collagen alpha-1(XVI) chain	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
Q07092	COL16A1	Collagen alpha-1(XVI) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
Q07092	COL16A1	Collagen alpha-1(XVI) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q07092	COL16A1	Collagen alpha-1(XVI) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q07092	COL16A1	Collagen alpha-1(XVI) chain	GO:0007565; P:female pregnancy; TAS:ProtInc
Q07092	COL16A1	Collagen alpha-1(XVI) chain	GO:0007229; P:integrin-mediated signaling pathway; TAS:UniProtKB
Q9UMD9	COL17A1	Collagen alpha-1(XVII) chain	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UMD9	COL17A1	Collagen alpha-1(XVII) chain	GO:0034329; P:cell junction assembly; TAS:Reactome
Q9UMD9	COL17A1	Collagen alpha-1(XVII) chain	GO:0007160; P:cell-matrix adhesion; TAS:ProtInc
Q9UMD9	COL17A1	Collagen alpha-1(XVII) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
Q9UMD9	COL17A1	Collagen alpha-1(XVII) chain	GO:0008544; P:epidermis development; TAS:ProtInc
Q9UMD9	COL17A1	Collagen alpha-1(XVII) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q9UMD9	COL17A1	Collagen alpha-1(XVII) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q9UMD9	COL17A1	Collagen alpha-1(XVII) chain	GO:0031581; P:hemidesmosome assembly; IDA:UniProtKB
P39060	COL18A1	Collagen alpha-1(XVIII) chain	GO:0042802; F:identical protein binding; IPI:IntAct
P39060	COL18A1	Collagen alpha-1(XVIII) chain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P39060	COL18A1	Collagen alpha-1(XVIII) chain	GO:0005515; F:protein binding; IPI:IntAct
P39060	COL18A1	Collagen alpha-1(XVIII) chain	GO:0005198; F:structural molecule activity; IEA:InterPro
P39060	COL18A1	Collagen alpha-1(XVIII) chain	GO:0001525; P:angiogenesis; IEA:Ensembl
P39060	COL18A1	Collagen alpha-1(XVIII) chain	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P39060	COL18A1	Collagen alpha-1(XVIII) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
P39060	COL18A1	Collagen alpha-1(XVIII) chain	GO:0001886; P:endothelial cell morphogenesis; IEA:Ensembl
P39060	COL18A1	Collagen alpha-1(XVIII) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P39060	COL18A1	Collagen alpha-1(XVIII) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P39060	COL18A1	Collagen alpha-1(XVIII) chain	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P39060	COL18A1	Collagen alpha-1(XVIII) chain	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P39060	COL18A1	Collagen alpha-1(XVIII) chain	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
P39060	COL18A1	Collagen alpha-1(XVIII) chain	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P39060	COL18A1	Collagen alpha-1(XVIII) chain	GO:2000353; P:positive regulation of endothelial cell apoptotic process; IEA:Ensembl
P39060	COL18A1	Collagen alpha-1(XVIII) chain	GO:0042493; P:response to drug; IEA:Ensembl
P39060	COL18A1	Collagen alpha-1(XVIII) chain	GO:0051599; P:response to hydrostatic pressure; IEA:Ensembl
P39060	COL18A1	Collagen alpha-1(XVIII) chain	GO:0007601; P:visual perception; TAS:ProtInc
P38432	COIL	Coilin	GO:0015036; F:disulfide oxidoreductase activity; IEA:Ensembl
P38432	COIL	Coilin	GO:0042802; F:identical protein binding; IPI:IntAct
P38432	COIL	Coilin	GO:0005515; F:protein binding; IPI:IntAct
P38432	COIL	Coilin	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q14993	COL19A1	Collagen alpha-1(XIX) chain	GO:0005201; F:extracellular matrix structural constituent; NAS:UniProtKB
Q14993	COL19A1	Collagen alpha-1(XIX) chain	GO:0030674; F:protein binding, bridging; NAS:UniProtKB
Q14993	COL19A1	Collagen alpha-1(XIX) chain	GO:0007155; P:cell adhesion; NAS:UniProtKB
Q14993	COL19A1	Collagen alpha-1(XIX) chain	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q14993	COL19A1	Collagen alpha-1(XIX) chain	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
Q14993	COL19A1	Collagen alpha-1(XIX) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
Q14993	COL19A1	Collagen alpha-1(XIX) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q14993	COL19A1	Collagen alpha-1(XIX) chain	GO:0030198; P:extracellular matrix organization; NAS:UniProtKB
Q14993	COL19A1	Collagen alpha-1(XIX) chain	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
Q14993	COL19A1	Collagen alpha-1(XIX) chain	GO:0001501; P:skeletal system development; TAS:ProtInc
Q9P218	COL20A1	Collagen alpha-1(XX) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q9Y6Z7	COLEC10	Collectin-10	GO:0005537; F:mannose binding; TAS:ProtInc
Q9BWP8	COLEC11	Collectin-11	GO:0005537; F:mannose binding; IEA:UniProtKB-KW
Q9BWP8	COLEC11	Collectin-11	GO:0032502; P:developmental process; ISS:UniProtKB
Q9BWP8	COLEC11	Collectin-11	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q5KU26	COLEC12	Collectin-12	GO:0005534; F:galactose binding; NAS:UniProtKB
Q5KU26	COLEC12	Collectin-12	GO:0030169; F:low-density lipoprotein particle binding; IDA:UniProtKB
Q5KU26	COLEC12	Collectin-12	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5KU26	COLEC12	Collectin-12	GO:0005044; F:scavenger receptor activity; TAS:UniProtKB
Q5KU26	COLEC12	Collectin-12	GO:0008329; F:signaling pattern recognition receptor activity; IDA:UniProtKB
Q5KU26	COLEC12	Collectin-12	GO:0009756; P:carbohydrate mediated signaling; NAS:UniProtKB
Q5KU26	COLEC12	Collectin-12	GO:0006952; P:defense response; TAS:UniProtKB
Q5KU26	COLEC12	Collectin-12	GO:0045087; P:innate immune response; TAS:UniProtKB
Q5KU26	COLEC12	Collectin-12	GO:0002221; P:pattern recognition receptor signaling pathway; IDA:GOC
Q5KU26	COLEC12	Collectin-12	GO:0006910; P:phagocytosis, recognition; IDA:UniProtKB
Q5KU26	COLEC12	Collectin-12	GO:0051260; P:protein homooligomerization; NAS:UniProtKB
Q5KU26	COLEC12	Collectin-12	GO:0006898; P:receptor-mediated endocytosis; TAS:GOC
Q96P44	COL21A1	Collagen alpha-1(XXI) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P01189	POMC	Pro-opiomelanocortin	GO:0001664; F:G-protein coupled receptor binding; IDA:BHF-UCL
P01189	POMC	Pro-opiomelanocortin	GO:0005179; F:hormone activity; IMP:UniProtKB
P01189	POMC	Pro-opiomelanocortin	GO:0005102; F:receptor binding; IMP:UniProtKB
P01189	POMC	Pro-opiomelanocortin	GO:0070996; F:type 1 melanocortin receptor binding; IDA:BHF-UCL
P01189	POMC	Pro-opiomelanocortin	GO:0031781; F:type 3 melanocortin receptor binding; IPI:BHF-UCL
P01189	POMC	Pro-opiomelanocortin	GO:0031782; F:type 4 melanocortin receptor binding; IPI:BHF-UCL
P01189	POMC	Pro-opiomelanocortin	GO:0007267; P:cell-cell signaling; IMP:UniProtKB
P01189	POMC	Pro-opiomelanocortin	GO:0033059; P:cellular pigmentation; IMP:UniProtKB
P01189	POMC	Pro-opiomelanocortin	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P01189	POMC	Pro-opiomelanocortin	GO:0006091; P:generation of precursor metabolites and energy; IMP:UniProtKB
P01189	POMC	Pro-opiomelanocortin	GO:0032720; P:negative regulation of tumor necrosis factor production; IDA:BHF-UCL
P01189	POMC	Pro-opiomelanocortin	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
P01189	POMC	Pro-opiomelanocortin	GO:0016486; P:peptide hormone processing; TAS:Reactome
P01189	POMC	Pro-opiomelanocortin	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P01189	POMC	Pro-opiomelanocortin	GO:0032098; P:regulation of appetite; IMP:UniProtKB
P01189	POMC	Pro-opiomelanocortin	GO:0008217; P:regulation of blood pressure; ISS:UniProtKB
P01189	POMC	Pro-opiomelanocortin	GO:0007165; P:signal transduction; IMP:UniProtKB
A2RUU4	CLPSL1	Colipase-like protein 1	GO:0008047; F:enzyme activator activity; IEA:InterPro
A2RUU4	CLPSL1	Colipase-like protein 1	GO:0007586; P:digestion; IEA:InterPro
A2RUU4	CLPSL1	Colipase-like protein 1	GO:0016042; P:lipid catabolic process; IEA:InterPro
Q6UWE3	CLPSL2	Colipase-like protein 2	GO:0008047; F:enzyme activator activity; IEA:InterPro
Q6UWE3	CLPSL2	Colipase-like protein 2	GO:0007586; P:digestion; IEA:InterPro
Q6UWE3	CLPSL2	Colipase-like protein 2	GO:0016042; P:lipid catabolic process; IEA:InterPro
Q9Y215	COLQ	Acetylcholinesterase collagenic tail peptide	GO:0005515; F:protein binding; IPI:IntAct
Q9Y215	COLQ	Acetylcholinesterase collagenic tail peptide	GO:0001507; P:acetylcholine catabolic process in synaptic cleft; TAS:ProtInc
Q9Y215	COLQ	Acetylcholinesterase collagenic tail peptide	GO:0008105; P:asymmetric protein localization; TAS:ProtInc
P04118	CLPS	Colipase	GO:0008047; F:enzyme activator activity; IEA:InterPro
P04118	CLPS	Colipase	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
P04118	CLPS	Colipase	GO:0044241; P:lipid digestion; TAS:Reactome
P04118	CLPS	Colipase	GO:0006629; P:lipid metabolic process; NAS:ProtInc
P04118	CLPS	Colipase	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P04118	CLPS	Colipase	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P04118	CLPS	Colipase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99708	RBBP8	DNA endonuclease RBBP8	GO:0003684; F:damaged DNA binding; IDA:UniProtKB
Q99708	RBBP8	DNA endonuclease RBBP8	GO:0005515; F:protein binding; IPI:UniProtKB
Q99708	RBBP8	DNA endonuclease RBBP8	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:BHF-UCL
Q99708	RBBP8	DNA endonuclease RBBP8	GO:0001106; F:RNA polymerase II transcription corepressor activity; IDA:BHF-UCL
Q99708	RBBP8	DNA endonuclease RBBP8	GO:0000014; F:single-stranded DNA endodeoxyribonuclease activity; IMP:UniProtKB
Q99708	RBBP8	DNA endonuclease RBBP8	GO:0001835; P:blastocyst hatching; IEA:Ensembl
Q99708	RBBP8	DNA endonuclease RBBP8	GO:0000075; P:cell cycle checkpoint; TAS:ProtInc
Q99708	RBBP8	DNA endonuclease RBBP8	GO:0000737; P:DNA catabolic process, endonucleolytic; IMP:GOC
Q99708	RBBP8	DNA endonuclease RBBP8	GO:0010792; P:DNA double-strand break processing involved in repair via single-strand annealing; IMP:UniProtKB
Q99708	RBBP8	DNA endonuclease RBBP8	GO:0006281; P:DNA repair; TAS:ProtInc
Q99708	RBBP8	DNA endonuclease RBBP8	GO:0000724; P:double-strand break repair via homologous recombination; IDA:UniProtKB
Q99708	RBBP8	DNA endonuclease RBBP8	GO:0000082; P:G1/S transition of mitotic cell cycle; IEA:Ensembl
Q99708	RBBP8	DNA endonuclease RBBP8	GO:0031572; P:G2 DNA damage checkpoint; IDA:UniProtKB
Q99708	RBBP8	DNA endonuclease RBBP8	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q99708	RBBP8	DNA endonuclease RBBP8	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q99708	RBBP8	DNA endonuclease RBBP8	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:GOC
Q99708	RBBP8	DNA endonuclease RBBP8	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q8NFW1	COL22A1	Collagen alpha-1(XXII) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q86X83	COMMD2	COMM domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBI1	COMMD3	COMM domain-containing protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N668	COMMD1	COMM domain-containing protein 1	GO:0005507; F:copper ion binding; IDA:UniProtKB
Q8N668	COMMD1	COMM domain-containing protein 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q8N668	COMMD1	COMM domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N668	COMMD1	COMM domain-containing protein 1	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q8N668	COMMD1	COMM domain-containing protein 1	GO:0055070; P:copper ion homeostasis; IDA:UniProtKB
Q8N668	COMMD1	COMM domain-containing protein 1	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q8N668	COMMD1	COMM domain-containing protein 1	GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB
Q8N668	COMMD1	COMM domain-containing protein 1	GO:0032434; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q9H0A8	COMMD4	COMM domain-containing protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9GZQ3	COMMD5	COMM domain-containing protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z4G1	COMMD6	COMM domain-containing protein 6	GO:0051059; F:NF-kappaB binding; IPI:MGI
Q7Z4G1	COMMD6	COMM domain-containing protein 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z4G1	COMMD6	COMM domain-containing protein 6	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:MGI
Q86VX2	COMMD7	COMM domain-containing protein 7	GO:0051059; F:NF-kappaB binding; IDA:UniProtKB
Q86VX2	COMMD7	COMM domain-containing protein 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q86VX2	COMMD7	COMM domain-containing protein 7	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q86VX2	COMMD7	COMM domain-containing protein 7	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q86VX2	COMMD7	COMM domain-containing protein 7	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IDA:UniProtKB
Q9NX08	COMMD8	COMM domain-containing protein 8	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6G5	COMMD10	COMM domain-containing protein 10	GO:0005515; F:protein binding; IPI:UniProtKB
P49747	COMP	Cartilage oligomeric matrix protein	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P49747	COMP	Cartilage oligomeric matrix protein	GO:0005518; F:collagen binding; IDA:UniProtKB
P49747	COMP	Cartilage oligomeric matrix protein	GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc
P49747	COMP	Cartilage oligomeric matrix protein	GO:0043395; F:heparan sulfate proteoglycan binding; IDA:UniProtKB
P49747	COMP	Cartilage oligomeric matrix protein	GO:0008201; F:heparin binding; IDA:UniProtKB
P49747	COMP	Cartilage oligomeric matrix protein	GO:0002020; F:protease binding; IPI:BHF-UCL
P49747	COMP	Cartilage oligomeric matrix protein	GO:0005515; F:protein binding; IPI:UniProtKB
P49747	COMP	Cartilage oligomeric matrix protein	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P49747	COMP	Cartilage oligomeric matrix protein	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P49747	COMP	Cartilage oligomeric matrix protein	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P49747	COMP	Cartilage oligomeric matrix protein	GO:0003417; P:growth plate cartilage development; IEA:Ensembl
P49747	COMP	Cartilage oligomeric matrix protein	GO:0060173; P:limb development; IDA:UniProtKB
P49747	COMP	Cartilage oligomeric matrix protein	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P49747	COMP	Cartilage oligomeric matrix protein	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P49747	COMP	Cartilage oligomeric matrix protein	GO:0001501; P:skeletal system development; TAS:ProtInc
P21964	COMT	Catechol O-methyltransferase	GO:0016206; F:catechol O-methyltransferase activity; IEA:UniProtKB-EC
P21964	COMT	Catechol O-methyltransferase	GO:0000287; F:magnesium ion binding; IEA:InterPro
P21964	COMT	Catechol O-methyltransferase	GO:0008171; F:O-methyltransferase activity; TAS:ProtInc
P21964	COMT	Catechol O-methyltransferase	GO:0042420; P:dopamine catabolic process; IEA:Ensembl
P21964	COMT	Catechol O-methyltransferase	GO:0008210; P:estrogen metabolic process; IEA:Ensembl
P21964	COMT	Catechol O-methyltransferase	GO:0007565; P:female pregnancy; IEA:Ensembl
P21964	COMT	Catechol O-methyltransferase	GO:0007612; P:learning; IEA:Ensembl
P21964	COMT	Catechol O-methyltransferase	GO:0032259; P:methylation; TAS:Reactome
P21964	COMT	Catechol O-methyltransferase	GO:0048609; P:multicellular organismal reproductive process; IEA:Ensembl
P21964	COMT	Catechol O-methyltransferase	GO:0045963; P:negative regulation of dopamine metabolic process; IEA:Ensembl
P21964	COMT	Catechol O-methyltransferase	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IEA:Ensembl
P21964	COMT	Catechol O-methyltransferase	GO:0042136; P:neurotransmitter biosynthetic process; TAS:Reactome
P21964	COMT	Catechol O-methyltransferase	GO:0042135; P:neurotransmitter catabolic process; IEA:UniProtKB-KW
P21964	COMT	Catechol O-methyltransferase	GO:0050668; P:positive regulation of homocysteine metabolic process; IEA:Ensembl
P21964	COMT	Catechol O-methyltransferase	GO:0042493; P:response to drug; IEA:Ensembl
P21964	COMT	Catechol O-methyltransferase	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P21964	COMT	Catechol O-methyltransferase	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P21964	COMT	Catechol O-methyltransferase	GO:0048265; P:response to pain; IEA:Ensembl
P21964	COMT	Catechol O-methyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P21964	COMT	Catechol O-methyltransferase	GO:0007268; P:synaptic transmission; TAS:Reactome
P21964	COMT	Catechol O-methyltransferase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q86Y22	COL23A1	Collagen alpha-1(XXIII) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
Q86Y22	COL23A1	Collagen alpha-1(XXIII) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q86Y22	COL23A1	Collagen alpha-1(XXIII) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q17RW2	COL24A1	Collagen alpha-1(XXIV) chain	GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro
Q17RW2	COL24A1	Collagen alpha-1(XXIV) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q9BXS0	COL25A1	Collagen alpha-1(XXV) chain	GO:0001540; F:beta-amyloid binding; IDA:UniProtKB
Q9BXS0	COL25A1	Collagen alpha-1(XXV) chain	GO:0008201; F:heparin binding; IDA:UniProtKB
Q9BXS0	COL25A1	Collagen alpha-1(XXV) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
Q9BXS0	COL25A1	Collagen alpha-1(XXV) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q9BXS0	COL25A1	Collagen alpha-1(XXV) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P53621	COPA	Coatomer subunit alpha	GO:0005198; F:structural molecule activity; IEA:InterPro
P53621	COPA	Coatomer subunit alpha	GO:0048205; P:COPI coating of Golgi vesicle; TAS:Reactome
P53621	COPA	Coatomer subunit alpha	GO:0006886; P:intracellular protein transport; IEA:InterPro
P53621	COPA	Coatomer subunit alpha	GO:0061024; P:membrane organization; TAS:Reactome
P53621	COPA	Coatomer subunit alpha	GO:0030157; P:pancreatic juice secretion; IDA:MGI
P53621	COPA	Coatomer subunit alpha	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; TAS:Reactome
P35606	COPB2	Coatomer subunit beta'	GO:0005198; F:structural molecule activity; IEA:InterPro
P35606	COPB2	Coatomer subunit beta'	GO:0048205; P:COPI coating of Golgi vesicle; TAS:Reactome
P35606	COPB2	Coatomer subunit beta'	GO:0006891; P:intra-Golgi vesicle-mediated transport; IDA:UniProtKB
P35606	COPB2	Coatomer subunit beta'	GO:0006886; P:intracellular protein transport; IEA:InterPro
P35606	COPB2	Coatomer subunit beta'	GO:0061024; P:membrane organization; TAS:Reactome
P35606	COPB2	Coatomer subunit beta'	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; TAS:UniProtKB
P53618	COPB1	Coatomer subunit beta	GO:0005515; F:protein binding; IPI:UniProtKB
P53618	COPB1	Coatomer subunit beta	GO:0005198; F:structural molecule activity; IEA:InterPro
P53618	COPB1	Coatomer subunit beta	GO:0048205; P:COPI coating of Golgi vesicle; TAS:Reactome
P53618	COPB1	Coatomer subunit beta	GO:0006891; P:intra-Golgi vesicle-mediated transport; ISS:UniProtKB
P53618	COPB1	Coatomer subunit beta	GO:0006886; P:intracellular protein transport; IEA:InterPro
P53618	COPB1	Coatomer subunit beta	GO:0061024; P:membrane organization; TAS:Reactome
P53618	COPB1	Coatomer subunit beta	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; TAS:Reactome
P53618	COPB1	Coatomer subunit beta	GO:0016032; P:viral process; IEA:UniProtKB-KW
P48444	ARCN1	Coatomer subunit delta	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P48444	ARCN1	Coatomer subunit delta	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P48444	ARCN1	Coatomer subunit delta	GO:0021691; P:cerebellar Purkinje cell layer maturation; IEA:Ensembl
P48444	ARCN1	Coatomer subunit delta	GO:0048205; P:COPI coating of Golgi vesicle; TAS:Reactome
P48444	ARCN1	Coatomer subunit delta	GO:0006886; P:intracellular protein transport; TAS:ProtInc
P48444	ARCN1	Coatomer subunit delta	GO:0061024; P:membrane organization; TAS:Reactome
P48444	ARCN1	Coatomer subunit delta	GO:0043473; P:pigmentation; IEA:Ensembl
P48444	ARCN1	Coatomer subunit delta	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; TAS:Reactome
O14579	COPE	Coatomer subunit epsilon	GO:0005198; F:structural molecule activity; IEA:InterPro
O14579	COPE	Coatomer subunit epsilon	GO:0048205; P:COPI coating of Golgi vesicle; TAS:Reactome
O14579	COPE	Coatomer subunit epsilon	GO:0006891; P:intra-Golgi vesicle-mediated transport; ISS:UniProtKB
O14579	COPE	Coatomer subunit epsilon	GO:0061024; P:membrane organization; TAS:Reactome
O14579	COPE	Coatomer subunit epsilon	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O14579	COPE	Coatomer subunit epsilon	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; TAS:Reactome
Q9Y678	COPG1	Coatomer subunit gamma-1	GO:0005515; F:protein binding; IPI:IntAct
Q9Y678	COPG1	Coatomer subunit gamma-1	GO:0005198; F:structural molecule activity; IEA:InterPro
Q9Y678	COPG1	Coatomer subunit gamma-1	GO:0048205; P:COPI coating of Golgi vesicle; TAS:Reactome
Q9Y678	COPG1	Coatomer subunit gamma-1	GO:0051683; P:establishment of Golgi localization; ISS:BHF-UCL
Q9Y678	COPG1	Coatomer subunit gamma-1	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9Y678	COPG1	Coatomer subunit gamma-1	GO:0061024; P:membrane organization; TAS:Reactome
Q9Y678	COPG1	Coatomer subunit gamma-1	GO:0072384; P:organelle transport along microtubule; ISS:BHF-UCL
Q9Y678	COPG1	Coatomer subunit gamma-1	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; TAS:Reactome
Q9UBF2	COPG2	Coatomer subunit gamma-2	GO:0005198; F:structural molecule activity; IEA:InterPro
Q9UBF2	COPG2	Coatomer subunit gamma-2	GO:0006891; P:intra-Golgi vesicle-mediated transport; IDA:UniProtKB
Q9UBF2	COPG2	Coatomer subunit gamma-2	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9UBF2	COPG2	Coatomer subunit gamma-2	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; TAS:UniProtKB
Q9NQ92	COPRS	Coordinator of PRMT5 and differentiation stimulator	GO:0042393; F:histone binding; IDA:UniProtKB
Q9NQ92	COPRS	Coordinator of PRMT5 and differentiation stimulator	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NQ92	COPRS	Coordinator of PRMT5 and differentiation stimulator	GO:0043985; P:histone H4-R3 methylation; IDA:UniProtKB
Q9NQ92	COPRS	Coordinator of PRMT5 and differentiation stimulator	GO:0007517; P:muscle organ development; ISS:UniProtKB
Q9NQ92	COPRS	Coordinator of PRMT5 and differentiation stimulator	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NQ92	COPRS	Coordinator of PRMT5 and differentiation stimulator	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15431	SLC31A1	High affinity copper uptake protein 1	GO:0005375; F:copper ion transmembrane transporter activity; TAS:ProtInc
O15431	SLC31A1	High affinity copper uptake protein 1	GO:0006825; P:copper ion transport; TAS:ProtInc
O15431	SLC31A1	High affinity copper uptake protein 1	GO:0055085; P:transmembrane transport; TAS:Reactome
O15432	SLC31A2	Probable low affinity copper uptake protein 2	GO:0005375; F:copper ion transmembrane transporter activity; TAS:ProtInc
O15432	SLC31A2	Probable low affinity copper uptake protein 2	GO:0006825; P:copper ion transport; TAS:ProtInc
P61923	COPZ1	Coatomer subunit zeta-1	GO:0048205; P:COPI coating of Golgi vesicle; TAS:Reactome
P61923	COPZ1	Coatomer subunit zeta-1	GO:0006891; P:intra-Golgi vesicle-mediated transport; IDA:UniProtKB
P61923	COPZ1	Coatomer subunit zeta-1	GO:0006886; P:intracellular protein transport; IEA:InterPro
P61923	COPZ1	Coatomer subunit zeta-1	GO:0061024; P:membrane organization; TAS:Reactome
P61923	COPZ1	Coatomer subunit zeta-1	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; TAS:UniProtKB
Q9P299	COPZ2	Coatomer subunit zeta-2	GO:0006886; P:intracellular protein transport; NAS:UniProtKB
Q9P299	COPZ2	Coatomer subunit zeta-2	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q96H96	COQ2	4-hydroxybenzoate polyprenyltransferase, mitochondrial	GO:0002083; F:4-hydroxybenzoate decaprenyltransferase activity; IEA:UniProtKB-EC
Q96H96	COQ2	4-hydroxybenzoate polyprenyltransferase, mitochondrial	GO:0047293; F:4-hydroxybenzoate nonaprenyltransferase activity; IEA:UniProtKB-EC
Q96H96	COQ2	4-hydroxybenzoate polyprenyltransferase, mitochondrial	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q96H96	COQ2	4-hydroxybenzoate polyprenyltransferase, mitochondrial	GO:0006071; P:glycerol metabolic process; IGI:UniProtKB
Q96H96	COQ2	4-hydroxybenzoate polyprenyltransferase, mitochondrial	GO:0008299; P:isoprenoid biosynthetic process; IEA:UniProtKB-KW
Q96H96	COQ2	4-hydroxybenzoate polyprenyltransferase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96H96	COQ2	4-hydroxybenzoate polyprenyltransferase, mitochondrial	GO:0006744; P:ubiquinone biosynthetic process; IDA:UniProtKB
Q9NZJ6	COQ3	Hexaprenyldihydroxybenzoate methyltransferase, mitochondrial	GO:0008425; F:2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity; IEA:InterPro
Q9NZJ6	COQ3	Hexaprenyldihydroxybenzoate methyltransferase, mitochondrial	GO:0008689; F:3-demethylubiquinone-9 3-O-methyltransferase activity; IEA:UniProtKB-EC
Q9NZJ6	COQ3	Hexaprenyldihydroxybenzoate methyltransferase, mitochondrial	GO:0004395; F:hexaprenyldihydroxybenzoate methyltransferase activity; IEA:UniProtKB-EC
Q9NZJ6	COQ3	Hexaprenyldihydroxybenzoate methyltransferase, mitochondrial	GO:0008171; F:O-methyltransferase activity; TAS:ProtInc
Q9NZJ6	COQ3	Hexaprenyldihydroxybenzoate methyltransferase, mitochondrial	GO:0006071; P:glycerol metabolic process; IGI:UniProtKB
Q9NZJ6	COQ3	Hexaprenyldihydroxybenzoate methyltransferase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NZJ6	COQ3	Hexaprenyldihydroxybenzoate methyltransferase, mitochondrial	GO:0006744; P:ubiquinone biosynthetic process; IGI:UniProtKB
Q9Y3A0	COQ4	Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial	GO:0006744; P:ubiquinone biosynthetic process; IEA:UniProtKB-UniPathway
Q5HYK3	COQ5	2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q5HYK3	COQ5	2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5HYK3	COQ5	2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial	GO:0006744; P:ubiquinone biosynthetic process; TAS:Reactome
Q9Y2Z9	COQ6	Ubiquinone biosynthesis monooxygenase COQ6	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q9Y2Z9	COQ6	Ubiquinone biosynthesis monooxygenase COQ6	GO:0016709; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; IEA:InterPro
Q9Y2Z9	COQ6	Ubiquinone biosynthesis monooxygenase COQ6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y2Z9	COQ6	Ubiquinone biosynthesis monooxygenase COQ6	GO:0006744; P:ubiquinone biosynthetic process; TAS:Reactome
Q99807	COQ7	Ubiquinone biosynthesis protein COQ7 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q99807	COQ7	Ubiquinone biosynthesis protein COQ7 homolog	GO:0001306; P:age-dependent response to oxidative stress; IEA:Ensembl
Q99807	COQ7	Ubiquinone biosynthesis protein COQ7 homolog	GO:0034599; P:cellular response to oxidative stress; IEA:Ensembl
Q99807	COQ7	Ubiquinone biosynthesis protein COQ7 homolog	GO:0008340; P:determination of adult lifespan; IEA:Ensembl
Q99807	COQ7	Ubiquinone biosynthesis protein COQ7 homolog	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q99807	COQ7	Ubiquinone biosynthesis protein COQ7 homolog	GO:0042775; P:mitochondrial ATP synthesis coupled electron transport; IEA:Ensembl
Q99807	COQ7	Ubiquinone biosynthesis protein COQ7 homolog	GO:0070584; P:mitochondrion morphogenesis; IEA:Ensembl
Q99807	COQ7	Ubiquinone biosynthesis protein COQ7 homolog	GO:0001841; P:neural tube formation; IEA:Ensembl
Q99807	COQ7	Ubiquinone biosynthesis protein COQ7 homolog	GO:0022008; P:neurogenesis; IEA:Ensembl
Q99807	COQ7	Ubiquinone biosynthesis protein COQ7 homolog	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99807	COQ7	Ubiquinone biosynthesis protein COQ7 homolog	GO:0006744; P:ubiquinone biosynthetic process; TAS:Reactome
O75208	COQ9	Ubiquinone biosynthesis protein COQ9, mitochondrial	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; IEA:Ensembl
O75208	COQ9	Ubiquinone biosynthesis protein COQ9, mitochondrial	GO:0006744; P:ubiquinone biosynthetic process; IEA:UniProtKB-UniPathway
Q96A83	COL26A1	Collagen alpha-1(XXVI) chain	GO:0030574; P:collagen catabolic process; TAS:Reactome
Q96A83	COL26A1	Collagen alpha-1(XXVI) chain	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q96A83	COL26A1	Collagen alpha-1(XXVI) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P31146	CORO1A	Coronin-1A	GO:0051015; F:actin filament binding; IDA:UniProtKB
P31146	CORO1A	Coronin-1A	GO:0008092; F:cytoskeletal protein binding; ISS:UniProtKB
P31146	CORO1A	Coronin-1A	GO:0043548; F:phosphatidylinositol 3-kinase binding; IDA:UniProtKB
P31146	CORO1A	Coronin-1A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P31146	CORO1A	Coronin-1A	GO:0005515; F:protein binding; IPI:UniProtKB
P31146	CORO1A	Coronin-1A	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P31146	CORO1A	Coronin-1A	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P31146	CORO1A	Coronin-1A	GO:0030036; P:actin cytoskeleton organization; IMP:UniProtKB
P31146	CORO1A	Coronin-1A	GO:0007015; P:actin filament organization; IEA:Ensembl
P31146	CORO1A	Coronin-1A	GO:0006816; P:calcium ion transport; IEA:Ensembl
P31146	CORO1A	Coronin-1A	GO:0031589; P:cell-substrate adhesion; IMP:UniProtKB
P31146	CORO1A	Coronin-1A	GO:0006928; P:cellular component movement; NAS:UniProtKB
P31146	CORO1A	Coronin-1A	GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl
P31146	CORO1A	Coronin-1A	GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl
P31146	CORO1A	Coronin-1A	GO:0045087; P:innate immune response; NAS:UniProtKB
P31146	CORO1A	Coronin-1A	GO:0030595; P:leukocyte chemotaxis; IBA:RefGenome
P31146	CORO1A	Coronin-1A	GO:0051126; P:negative regulation of actin nucleation; IDA:UniProtKB
P31146	CORO1A	Coronin-1A	GO:0006909; P:phagocytosis; IMP:UniProtKB
P31146	CORO1A	Coronin-1A	GO:0001845; P:phagolysosome assembly; IMP:UniProtKB
P31146	CORO1A	Coronin-1A	GO:0050918; P:positive chemotaxis; IDA:UniProtKB
P31146	CORO1A	Coronin-1A	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
P31146	CORO1A	Coronin-1A	GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl
P31146	CORO1A	Coronin-1A	GO:0030833; P:regulation of actin filament polymerization; IEA:Ensembl
P31146	CORO1A	Coronin-1A	GO:0008360; P:regulation of cell shape; IBA:RefGenome
P31146	CORO1A	Coronin-1A	GO:0043029; P:T cell homeostasis; IEA:Ensembl
P31146	CORO1A	Coronin-1A	GO:0032796; P:uropod organization; IBA:RefGenome
Q9BR76	CORO1B	Coronin-1B	GO:0051015; F:actin filament binding; IDA:UniProt
Q9BR76	CORO1B	Coronin-1B	GO:0071933; F:Arp2/3 complex binding; IDA:UniProt
Q9BR76	CORO1B	Coronin-1B	GO:0042802; F:identical protein binding; IDA:UniProt
Q9BR76	CORO1B	Coronin-1B	GO:0005515; F:protein binding; IPI:IntAct
Q9BR76	CORO1B	Coronin-1B	GO:0030036; P:actin cytoskeleton organization; IBA:RefGenome
Q9BR76	CORO1B	Coronin-1B	GO:0090135; P:actin filament branching; IDA:UniProt
Q9BR76	CORO1B	Coronin-1B	GO:0051017; P:actin filament bundle assembly; IDA:UniProt
Q9BR76	CORO1B	Coronin-1B	GO:0016477; P:cell migration; IDA:UniProt
Q9BR76	CORO1B	Coronin-1B	GO:0035767; P:endothelial cell chemotaxis; IDA:UniProt
Q9BR76	CORO1B	Coronin-1B	GO:0034316; P:negative regulation of Arp2/3 complex-mediated actin nucleation; IDA:UniProt
Q9BR76	CORO1B	Coronin-1B	GO:2000394; P:positive regulation of lamellipodium morphogenesis; IDA:UniProt
Q9BR76	CORO1B	Coronin-1B	GO:1902463; P:protein localization to cell leading edge; IDA:UniProt
Q9BR76	CORO1B	Coronin-1B	GO:0031529; P:ruffle organization; IDA:UniProt
Q9BR76	CORO1B	Coronin-1B	GO:0042060; P:wound healing; IDA:UniProt
Q9ULV4	CORO1C	Coronin-1C	GO:0051015; F:actin filament binding; IBA:RefGenome
Q9ULV4	CORO1C	Coronin-1C	GO:0030036; P:actin cytoskeleton organization; IBA:RefGenome
Q9ULV4	CORO1C	Coronin-1C	GO:0006909; P:phagocytosis; TAS:ProtInc
Q9ULV4	CORO1C	Coronin-1C	GO:0007165; P:signal transduction; TAS:ProtInc
Q92828	CORO2A	Coronin-2A	GO:0051015; F:actin filament binding; IBA:RefGenome
Q92828	CORO2A	Coronin-2A	GO:0030036; P:actin cytoskeleton organization; IBA:RefGenome
Q92828	CORO2A	Coronin-2A	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
Q9UQ03	CORO2B	Coronin-2B	GO:0003779; F:actin binding; NAS:UniProtKB
Q9UQ03	CORO2B	Coronin-2B	GO:0051015; F:actin filament binding; IBA:RefGenome
Q9UQ03	CORO2B	Coronin-2B	GO:0030036; P:actin cytoskeleton organization; NAS:UniProtKB
Q8IZC6	COL27A1	Collagen alpha-1(XXVII) chain	GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro
Q8IZC6	COL27A1	Collagen alpha-1(XXVII) chain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IZC6	COL27A1	Collagen alpha-1(XXVII) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q9Y5Q5	CORIN	Atrial natriuretic peptide-converting enzyme	GO:0005044; F:scavenger receptor activity; IEA:InterPro
Q9Y5Q5	CORIN	Atrial natriuretic peptide-converting enzyme	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
Q9Y5Q5	CORIN	Atrial natriuretic peptide-converting enzyme	GO:0070008; F:serine-type exopeptidase activity; IEA:InterPro
Q9Y5Q5	CORIN	Atrial natriuretic peptide-converting enzyme	GO:0007565; P:female pregnancy; IMP:UniProtKB
Q9Y5Q5	CORIN	Atrial natriuretic peptide-converting enzyme	GO:0016486; P:peptide hormone processing; IDA:UniProtKB
Q9Y5Q5	CORIN	Atrial natriuretic peptide-converting enzyme	GO:0006508; P:proteolysis; IDA:GOC
Q9Y5Q5	CORIN	Atrial natriuretic peptide-converting enzyme	GO:0008217; P:regulation of blood pressure; ISS:UniProtKB
Q9Y5Q5	CORIN	Atrial natriuretic peptide-converting enzyme	GO:0035813; P:regulation of renal sodium excretion; ISS:UniProtKB
Q9Y5Q5	CORIN	Atrial natriuretic peptide-converting enzyme	GO:0003050; P:regulation of systemic arterial blood pressure by atrial natriuretic peptide; IMP:UniProtKB
Q6QEF8	CORO6	Coronin-6	GO:0051015; F:actin filament binding; IBA:RefGenome
Q6QEF8	CORO6	Coronin-6	GO:0030036; P:actin cytoskeleton organization; IBA:RefGenome
P57737	CORO7	Coronin-7	GO:0005515; F:protein binding; IPI:IntAct
O00230	CORT	Cortistatin	GO:0001664; F:G-protein coupled receptor binding; IPI:UniProtKB
O00230	CORT	Cortistatin	GO:0005184; F:neuropeptide hormone activity; IDA:UniProtKB
O00230	CORT	Cortistatin	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IDA:UniProtKB
O00230	CORT	Cortistatin	GO:0007268; P:synaptic transmission; NAS:UniProtKB
Q2UY09	COL28A1	Collagen alpha-1(XXVIII) chain	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q2UY09	COL28A1	Collagen alpha-1(XXVIII) chain	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q2UY09	COL28A1	Collagen alpha-1(XXVIII) chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P10589	NR2F1	COUP transcription factor 1	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; TAS:ProtInc
P10589	NR2F1	COUP transcription factor 1	GO:0005515; F:protein binding; IPI:BHF-UCL
P10589	NR2F1	COUP transcription factor 1	GO:0044323; F:retinoic acid-responsive element binding; IEA:Ensembl
P10589	NR2F1	COUP transcription factor 1	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
P10589	NR2F1	COUP transcription factor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P10589	NR2F1	COUP transcription factor 1	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P10589	NR2F1	COUP transcription factor 1	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P10589	NR2F1	COUP transcription factor 1	GO:0008270; F:zinc ion binding; IEA:InterPro
P10589	NR2F1	COUP transcription factor 1	GO:0021796; P:cerebral cortex regionalization; IEA:Ensembl
P10589	NR2F1	COUP transcription factor 1	GO:0010467; P:gene expression; TAS:Reactome
P10589	NR2F1	COUP transcription factor 1	GO:0030522; P:intracellular receptor signaling pathway; TAS:GOC
P10589	NR2F1	COUP transcription factor 1	GO:0010977; P:negative regulation of neuron projection development; IEA:Ensembl
P10589	NR2F1	COUP transcription factor 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P10589	NR2F1	COUP transcription factor 1	GO:0001764; P:neuron migration; IEA:Ensembl
P10589	NR2F1	COUP transcription factor 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P10589	NR2F1	COUP transcription factor 1	GO:0007165; P:signal transduction; TAS:ProtInc
P10589	NR2F1	COUP transcription factor 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P24468	NR2F2	COUP transcription factor 2	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:UniProtKB
P24468	NR2F2	COUP transcription factor 2	GO:0005515; F:protein binding; IPI:UniProtKB
P24468	NR2F2	COUP transcription factor 2	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P24468	NR2F2	COUP transcription factor 2	GO:0001972; F:retinoic acid binding; IDA:UniProtKB
P24468	NR2F2	COUP transcription factor 2	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
P24468	NR2F2	COUP transcription factor 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P24468	NR2F2	COUP transcription factor 2	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P24468	NR2F2	COUP transcription factor 2	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
P24468	NR2F2	COUP transcription factor 2	GO:0008270; F:zinc ion binding; IEA:InterPro
P24468	NR2F2	COUP transcription factor 2	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P24468	NR2F2	COUP transcription factor 2	GO:0048514; P:blood vessel morphogenesis; IEA:Ensembl
P24468	NR2F2	COUP transcription factor 2	GO:0009566; P:fertilization; IEA:Ensembl
P24468	NR2F2	COUP transcription factor 2	GO:0030900; P:forebrain development; IEA:Ensembl
P24468	NR2F2	COUP transcription factor 2	GO:0030522; P:intracellular receptor signaling pathway; IDA:GOC
P24468	NR2F2	COUP transcription factor 2	GO:0060173; P:limb development; IEA:Ensembl
P24468	NR2F2	COUP transcription factor 2	GO:0006629; P:lipid metabolic process; TAS:ProtInc
P24468	NR2F2	COUP transcription factor 2	GO:0001893; P:maternal placenta development; IEA:Ensembl
P24468	NR2F2	COUP transcription factor 2	GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:BHF-UCL
P24468	NR2F2	COUP transcription factor 2	GO:0010596; P:negative regulation of endothelial cell migration; IMP:BHF-UCL
P24468	NR2F2	COUP transcription factor 2	GO:0001937; P:negative regulation of endothelial cell proliferation; IMP:BHF-UCL
P24468	NR2F2	COUP transcription factor 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P24468	NR2F2	COUP transcription factor 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
P24468	NR2F2	COUP transcription factor 2	GO:0001764; P:neuron migration; IEA:Ensembl
P24468	NR2F2	COUP transcription factor 2	GO:0060674; P:placenta blood vessel development; IEA:Ensembl
P24468	NR2F2	COUP transcription factor 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P24468	NR2F2	COUP transcription factor 2	GO:0009956; P:radial pattern formation; IEA:Ensembl
P24468	NR2F2	COUP transcription factor 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P24468	NR2F2	COUP transcription factor 2	GO:0060849; P:regulation of transcription involved in lymphatic endothelial cell fate commitment; IMP:BHF-UCL
P24468	NR2F2	COUP transcription factor 2	GO:0032355; P:response to estradiol; IEA:Ensembl
P24468	NR2F2	COUP transcription factor 2	GO:0007165; P:signal transduction; TAS:ProtInc
P24468	NR2F2	COUP transcription factor 2	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
P24468	NR2F2	COUP transcription factor 2	GO:0060707; P:trophoblast giant cell differentiation; IEA:Ensembl
Q14019	COTL1	Coactosin-like protein	GO:0003779; F:actin binding; IDA:UniProtKB
Q14019	COTL1	Coactosin-like protein	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q14019	COTL1	Coactosin-like protein	GO:0005515; F:protein binding; IPI:IntAct
Q14019	COTL1	Coactosin-like protein	GO:0050832; P:defense response to fungus; IEA:Ensembl
Q12887	COX10	Protoheme IX farnesyltransferase, mitochondrial	GO:0004311; F:farnesyltranstransferase activity; TAS:ProtInc
Q12887	COX10	Protoheme IX farnesyltransferase, mitochondrial	GO:0008495; F:protoheme IX farnesyltransferase activity; IEA:InterPro
Q12887	COX10	Protoheme IX farnesyltransferase, mitochondrial	GO:0009060; P:aerobic respiration; IEA:Ensembl
Q12887	COX10	Protoheme IX farnesyltransferase, mitochondrial	GO:0045333; P:cellular respiration; IGI:HGNC
Q12887	COX10	Protoheme IX farnesyltransferase, mitochondrial	GO:0006784; P:heme a biosynthetic process; IMP:HGNC
Q12887	COX10	Protoheme IX farnesyltransferase, mitochondrial	GO:0006783; P:heme biosynthetic process; TAS:Reactome
Q12887	COX10	Protoheme IX farnesyltransferase, mitochondrial	GO:0048034; P:heme O biosynthetic process; IEA:InterPro
Q12887	COX10	Protoheme IX farnesyltransferase, mitochondrial	GO:1902600; P:hydrogen ion transmembrane transport; IMP:GOC
Q12887	COX10	Protoheme IX farnesyltransferase, mitochondrial	GO:0006123; P:mitochondrial electron transport, cytochrome c to oxygen; IC:HGNC
Q12887	COX10	Protoheme IX farnesyltransferase, mitochondrial	GO:0000266; P:mitochondrial fission; IEA:Ensembl
Q12887	COX10	Protoheme IX farnesyltransferase, mitochondrial	GO:0006778; P:porphyrin-containing compound metabolic process; TAS:Reactome
Q12887	COX10	Protoheme IX farnesyltransferase, mitochondrial	GO:0008535; P:respiratory chain complex IV assembly; IMP:HGNC
Q12887	COX10	Protoheme IX farnesyltransferase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y6N1	COX11	Cytochrome c oxidase assembly protein COX11, mitochondrial	GO:0005507; F:copper ion binding; IEA:InterPro
Q9Y6N1	COX11	Cytochrome c oxidase assembly protein COX11, mitochondrial	GO:0004129; F:cytochrome-c oxidase activity; TAS:ProtInc
Q9Y6N1	COX11	Cytochrome c oxidase assembly protein COX11, mitochondrial	GO:0009055; F:electron carrier activity; TAS:UniProtKB
Q9Y6N1	COX11	Cytochrome c oxidase assembly protein COX11, mitochondrial	GO:1902600; P:hydrogen ion transmembrane transport; TAS:GOC
Q9Y6N1	COX11	Cytochrome c oxidase assembly protein COX11, mitochondrial	GO:0033132; P:negative regulation of glucokinase activity; IEA:Ensembl
Q9Y6N1	COX11	Cytochrome c oxidase assembly protein COX11, mitochondrial	GO:0008535; P:respiratory chain complex IV assembly; TAS:ProtInc
Q9Y6N1	COX11	Cytochrome c oxidase assembly protein COX11, mitochondrial	GO:0007585; P:respiratory gaseous exchange; TAS:ProtInc
Q96I36	COX14	Cytochrome c oxidase assembly protein COX14	GO:0033617; P:mitochondrial respiratory chain complex IV assembly; IMP:UniProtKB
Q7KZN9	COX15	Cytochrome c oxidase assembly protein COX15 homolog	GO:0004129; F:cytochrome-c oxidase activity; TAS:UniProtKB
Q7KZN9	COX15	Cytochrome c oxidase assembly protein COX15 homolog	GO:0016627; F:oxidoreductase activity, acting on the CH-CH group of donors; IEA:InterPro
Q7KZN9	COX15	Cytochrome c oxidase assembly protein COX15 homolog	GO:0045333; P:cellular respiration; IC:HGNC
Q7KZN9	COX15	Cytochrome c oxidase assembly protein COX15 homolog	GO:0006784; P:heme a biosynthetic process; IGI:HGNC
Q7KZN9	COX15	Cytochrome c oxidase assembly protein COX15 homolog	GO:0006783; P:heme biosynthetic process; TAS:Reactome
Q7KZN9	COX15	Cytochrome c oxidase assembly protein COX15 homolog	GO:1902600; P:hydrogen ion transmembrane transport; IGI:GOC
Q7KZN9	COX15	Cytochrome c oxidase assembly protein COX15 homolog	GO:0006123; P:mitochondrial electron transport, cytochrome c to oxygen; IC:HGNC
Q7KZN9	COX15	Cytochrome c oxidase assembly protein COX15 homolog	GO:0055114; P:oxidation-reduction process; TAS:UniProtKB
Q7KZN9	COX15	Cytochrome c oxidase assembly protein COX15 homolog	GO:0006778; P:porphyrin-containing compound metabolic process; TAS:Reactome
Q7KZN9	COX15	Cytochrome c oxidase assembly protein COX15 homolog	GO:0008535; P:respiratory chain complex IV assembly; IMP:HGNC
Q7KZN9	COX15	Cytochrome c oxidase assembly protein COX15 homolog	GO:0007585; P:respiratory gaseous exchange; TAS:UniProtKB
Q7KZN9	COX15	Cytochrome c oxidase assembly protein COX15 homolog	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14061	COX17	Cytochrome c oxidase copper chaperone	GO:0016531; F:copper chaperone activity; IEA:InterPro
Q14061	COX17	Cytochrome c oxidase copper chaperone	GO:0005507; F:copper ion binding; TAS:ProtInc
Q14061	COX17	Cytochrome c oxidase copper chaperone	GO:0007420; P:brain development; IEA:Ensembl
Q14061	COX17	Cytochrome c oxidase copper chaperone	GO:0006825; P:copper ion transport; TAS:ProtInc
Q14061	COX17	Cytochrome c oxidase copper chaperone	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
Q14061	COX17	Cytochrome c oxidase copper chaperone	GO:0007507; P:heart development; IEA:Ensembl
Q8N8Q8	COX18	Mitochondrial inner membrane protein COX18	GO:0008565; F:protein transporter activity; IGI:UniProtKB
Q8N8Q8	COX18	Mitochondrial inner membrane protein COX18	GO:0051204; P:protein insertion into mitochondrial membrane; IGI:UniProtKB
Q8N8Q8	COX18	Mitochondrial inner membrane protein COX18	GO:0015031; P:protein transport; IGI:GOC
Q8N8Q8	COX18	Mitochondrial inner membrane protein COX18	GO:0008535; P:respiratory chain complex IV assembly; IGI:UniProtKB
P00395	MT-CO1	Cytochrome c oxidase subunit 1	GO:0004129; F:cytochrome-c oxidase activity; IEA:UniProtKB-EC
P00395	MT-CO1	Cytochrome c oxidase subunit 1	GO:0020037; F:heme binding; IEA:InterPro
P00395	MT-CO1	Cytochrome c oxidase subunit 1	GO:0005506; F:iron ion binding; IEA:InterPro
P00395	MT-CO1	Cytochrome c oxidase subunit 1	GO:0005515; F:protein binding; IPI:IntAct
P00395	MT-CO1	Cytochrome c oxidase subunit 1	GO:0009060; P:aerobic respiration; IEA:InterPro
P00395	MT-CO1	Cytochrome c oxidase subunit 1	GO:0044237; P:cellular metabolic process; TAS:Reactome
P00395	MT-CO1	Cytochrome c oxidase subunit 1	GO:1902600; P:hydrogen ion transmembrane transport; IMP:GOC
P00395	MT-CO1	Cytochrome c oxidase subunit 1	GO:0006119; P:oxidative phosphorylation; IEA:UniProtKB-UniPathway
P00395	MT-CO1	Cytochrome c oxidase subunit 1	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P00395	MT-CO1	Cytochrome c oxidase subunit 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P00403	MT-CO2	Cytochrome c oxidase subunit 2	GO:0005507; F:copper ion binding; IEA:InterPro
P00403	MT-CO2	Cytochrome c oxidase subunit 2	GO:0004129; F:cytochrome-c oxidase activity; NAS:UniProtKB
P00403	MT-CO2	Cytochrome c oxidase subunit 2	GO:0044237; P:cellular metabolic process; TAS:Reactome
P00403	MT-CO2	Cytochrome c oxidase subunit 2	GO:1902600; P:hydrogen ion transmembrane transport; IMP:GOC
P00403	MT-CO2	Cytochrome c oxidase subunit 2	GO:0006123; P:mitochondrial electron transport, cytochrome c to oxygen; NAS:UniProtKB
P00403	MT-CO2	Cytochrome c oxidase subunit 2	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P00403	MT-CO2	Cytochrome c oxidase subunit 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P00414	MT-CO3	Cytochrome c oxidase subunit 3	GO:0004129; F:cytochrome-c oxidase activity; IEA:InterPro
P00414	MT-CO3	Cytochrome c oxidase subunit 3	GO:0005515; F:protein binding; IPI:IntAct
P00414	MT-CO3	Cytochrome c oxidase subunit 3	GO:0019646; P:aerobic electron transport chain; IEA:InterPro
P00414	MT-CO3	Cytochrome c oxidase subunit 3	GO:0044237; P:cellular metabolic process; TAS:Reactome
P00414	MT-CO3	Cytochrome c oxidase subunit 3	GO:0008535; P:respiratory chain complex IV assembly; IMP:UniProtKB
P00414	MT-CO3	Cytochrome c oxidase subunit 3	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P00414	MT-CO3	Cytochrome c oxidase subunit 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P13073	COX4I1	Cytochrome c oxidase subunit 4 isoform 1, mitochondrial	GO:0004129; F:cytochrome-c oxidase activity; TAS:ProtInc
P13073	COX4I1	Cytochrome c oxidase subunit 4 isoform 1, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
P13073	COX4I1	Cytochrome c oxidase subunit 4 isoform 1, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P13073	COX4I1	Cytochrome c oxidase subunit 4 isoform 1, mitochondrial	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P13073	COX4I1	Cytochrome c oxidase subunit 4 isoform 1, mitochondrial	GO:1902600; P:hydrogen ion transmembrane transport; TAS:GOC
P13073	COX4I1	Cytochrome c oxidase subunit 4 isoform 1, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P13073	COX4I1	Cytochrome c oxidase subunit 4 isoform 1, mitochondrial	GO:0007584; P:response to nutrient; IEA:Ensembl
P13073	COX4I1	Cytochrome c oxidase subunit 4 isoform 1, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96KJ9	COX4I2	Cytochrome c oxidase subunit 4 isoform 2, mitochondrial	GO:0004129; F:cytochrome-c oxidase activity; IDA:UniProtKB
Q96KJ9	COX4I2	Cytochrome c oxidase subunit 4 isoform 2, mitochondrial	GO:0045333; P:cellular respiration; NAS:UniProtKB
Q96KJ9	COX4I2	Cytochrome c oxidase subunit 4 isoform 2, mitochondrial	GO:0006091; P:generation of precursor metabolites and energy; NAS:UniProtKB
Q96KJ9	COX4I2	Cytochrome c oxidase subunit 4 isoform 2, mitochondrial	GO:1902600; P:hydrogen ion transmembrane transport; IDA:GOC
Q96KJ9	COX4I2	Cytochrome c oxidase subunit 4 isoform 2, mitochondrial	GO:0055114; P:oxidation-reduction process; NAS:UniProtKB
P20674	COX5A	Cytochrome c oxidase subunit 5A, mitochondrial	GO:0004129; F:cytochrome-c oxidase activity; TAS:ProtInc
P20674	COX5A	Cytochrome c oxidase subunit 5A, mitochondrial	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P20674	COX5A	Cytochrome c oxidase subunit 5A, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P20674	COX5A	Cytochrome c oxidase subunit 5A, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P20674	COX5A	Cytochrome c oxidase subunit 5A, mitochondrial	GO:1902600; P:hydrogen ion transmembrane transport; TAS:GOC
P20674	COX5A	Cytochrome c oxidase subunit 5A, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P20674	COX5A	Cytochrome c oxidase subunit 5A, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P10606	COX5B	Cytochrome c oxidase subunit 5B, mitochondrial	GO:0004129; F:cytochrome-c oxidase activity; TAS:ProtInc
P10606	COX5B	Cytochrome c oxidase subunit 5B, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P10606	COX5B	Cytochrome c oxidase subunit 5B, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P10606	COX5B	Cytochrome c oxidase subunit 5B, mitochondrial	GO:1902600; P:hydrogen ion transmembrane transport; TAS:GOC
P10606	COX5B	Cytochrome c oxidase subunit 5B, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P10606	COX5B	Cytochrome c oxidase subunit 5B, mitochondrial	GO:0007585; P:respiratory gaseous exchange; TAS:ProtInc
P10606	COX5B	Cytochrome c oxidase subunit 5B, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P09669	COX6C	Cytochrome c oxidase subunit 6C	GO:0004129; F:cytochrome-c oxidase activity; IEA:InterPro
P09669	COX6C	Cytochrome c oxidase subunit 6C	GO:0044237; P:cellular metabolic process; TAS:Reactome
P09669	COX6C	Cytochrome c oxidase subunit 6C	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P09669	COX6C	Cytochrome c oxidase subunit 6C	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P09669	COX6C	Cytochrome c oxidase subunit 6C	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P24311	COX7B	Cytochrome c oxidase subunit 7B, mitochondrial	GO:0004129; F:cytochrome-c oxidase activity; TAS:ProtInc
P24311	COX7B	Cytochrome c oxidase subunit 7B, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P24311	COX7B	Cytochrome c oxidase subunit 7B, mitochondrial	GO:0007417; P:central nervous system development; IMP:UniProtKB
P24311	COX7B	Cytochrome c oxidase subunit 7B, mitochondrial	GO:1902600; P:hydrogen ion transmembrane transport; TAS:GOC
P24311	COX7B	Cytochrome c oxidase subunit 7B, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P24311	COX7B	Cytochrome c oxidase subunit 7B, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P15954	COX7C	Cytochrome c oxidase subunit 7C, mitochondrial	GO:0004129; F:cytochrome-c oxidase activity; IEA:InterPro
P15954	COX7C	Cytochrome c oxidase subunit 7C, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P15954	COX7C	Cytochrome c oxidase subunit 7C, mitochondrial	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P15954	COX7C	Cytochrome c oxidase subunit 7C, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P15954	COX7C	Cytochrome c oxidase subunit 7C, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O14548	COX7A2L	Cytochrome c oxidase subunit 7A-related protein, mitochondrial	GO:0004129; F:cytochrome-c oxidase activity; TAS:ProtInc
O14548	COX7A2L	Cytochrome c oxidase subunit 7A-related protein, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
O14548	COX7A2L	Cytochrome c oxidase subunit 7A-related protein, mitochondrial	GO:1902600; P:hydrogen ion transmembrane transport; TAS:GOC
O14548	COX7A2L	Cytochrome c oxidase subunit 7A-related protein, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O14548	COX7A2L	Cytochrome c oxidase subunit 7A-related protein, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60397	COX7A2P2	Putative cytochrome c oxidase subunit 7A3, mitochondrial	GO:0004129; F:cytochrome-c oxidase activity; IEA:InterPro
P10176	COX8A	Cytochrome c oxidase subunit 8A, mitochondrial	GO:0004129; F:cytochrome-c oxidase activity; TAS:ProtInc
P10176	COX8A	Cytochrome c oxidase subunit 8A, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P10176	COX8A	Cytochrome c oxidase subunit 8A, mitochondrial	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P10176	COX8A	Cytochrome c oxidase subunit 8A, mitochondrial	GO:1902600; P:hydrogen ion transmembrane transport; TAS:GOC
P10176	COX8A	Cytochrome c oxidase subunit 8A, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P10176	COX8A	Cytochrome c oxidase subunit 8A, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q7Z4L0	COX8C	Cytochrome c oxidase subunit 8C, mitochondrial	GO:0004129; F:cytochrome-c oxidase activity; IEA:InterPro
Q7Z7K0	CMC1	COX assembly mitochondrial protein homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BSU1	C16orf70	UPF0183 protein C16orf70	GO:0005515; F:protein binding; IPI:IntAct
Q9Y6A4	C16orf80	UPF0468 protein C16orf80	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y6A4	C16orf80	UPF0468 protein C16orf80	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q6PH81	C16orf87	UPF0547 protein C16orf87	GO:0005515; F:protein binding; IPI:IntAct
O43303	CCP110	Centriolar coiled-coil protein of 110 kDa	GO:0005515; F:protein binding; IPI:UniProtKB
O43303	CCP110	Centriolar coiled-coil protein of 110 kDa	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
O43303	CCP110	Centriolar coiled-coil protein of 110 kDa	GO:0007099; P:centriole replication; IMP:UniProtKB
O43303	CCP110	Centriolar coiled-coil protein of 110 kDa	GO:0051298; P:centrosome duplication; IDA:UniProtKB
O43303	CCP110	Centriolar coiled-coil protein of 110 kDa	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
O43303	CCP110	Centriolar coiled-coil protein of 110 kDa	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O43303	CCP110	Centriolar coiled-coil protein of 110 kDa	GO:0032465; P:regulation of cytokinesis; IMP:UniProtKB
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0015485; F:cholesterol binding; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0008386; F:cholesterol monooxygenase (side-chain-cleaving) activity; IDA:UniProtKB
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0020037; F:heme binding; IDA:UniProtKB
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0005506; F:iron ion binding; IEA:InterPro
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0018879; P:biphenyl metabolic process; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0006700; P:C21-steroid hormone biosynthetic process; IDA:UniProtKB
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0071236; P:cellular response to antibiotic; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0071276; P:cellular response to cadmium ion; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0071320; P:cellular response to cAMP; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0071347; P:cellular response to interleukin-1; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0071375; P:cellular response to peptide hormone stimulus; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0021549; P:cerebellum development; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0008203; P:cholesterol metabolic process; IDA:UniProtKB
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0018894; P:dibenzo-p-dioxin metabolic process; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0006703; P:estrogen biosynthetic process; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0050756; P:fractalkine metabolic process; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0060014; P:granulosa cell differentiation; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0021766; P:hippocampus development; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0033327; P:Leydig cell differentiation; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0007617; P:mating behavior; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0018958; P:phenol-containing compound metabolic process; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0018963; P:phthalate metabolic process; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0006701; P:progesterone biosynthetic process; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0043279; P:response to alkaloid; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0051412; P:response to corticosterone; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0042493; P:response to drug; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0060992; P:response to fungicide; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0010332; P:response to gamma radiation; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0033595; P:response to genistein; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0017085; P:response to insecticide; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0033591; P:response to L-ascorbic acid; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0009651; P:response to salt stress; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0033197; P:response to vitamin E; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0014037; P:Schwann cell differentiation; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0008202; P:steroid metabolic process; TAS:Reactome
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0016125; P:sterol metabolic process; TAS:Reactome
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0061370; P:testosterone biosynthetic process; IEA:Ensembl
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0042359; P:vitamin D metabolic process; ISS:UniProtKB
P05108	CYP11A1	Cholesterol side-chain cleavage enzyme, mitochondrial	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9UPN4	CEP131	Centrosomal protein of 131 kDa	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UPN4	CEP131	Centrosomal protein of 131 kDa	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q9UPN4	CEP131	Centrosomal protein of 131 kDa	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9UPN4	CEP131	Centrosomal protein of 131 kDa	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q9UPN4	CEP131	Centrosomal protein of 131 kDa	GO:0035735; P:intraciliary transport involved in cilium morphogenesis; IMP:UniProtKB
Q9UPN4	CEP131	Centrosomal protein of 131 kDa	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9UPN4	CEP131	Centrosomal protein of 131 kDa	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9UPN4	CEP131	Centrosomal protein of 131 kDa	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
Q9UPN4	CEP131	Centrosomal protein of 131 kDa	GO:0090316; P:positive regulation of intracellular protein transport; IMP:UniProtKB
Q9UPN4	CEP131	Centrosomal protein of 131 kDa	GO:0010824; P:regulation of centrosome duplication; IMP:UniProtKB
Q9UPN4	CEP131	Centrosomal protein of 131 kDa	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q66GS9	CEP135	Centrosomal protein of 135 kDa	GO:0005515; F:protein binding; IPI:IntAct
Q66GS9	CEP135	Centrosomal protein of 135 kDa	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q66GS9	CEP135	Centrosomal protein of 135 kDa	GO:0007099; P:centriole replication; IMP:UniProtKB
Q66GS9	CEP135	Centrosomal protein of 135 kDa	GO:0010457; P:centriole-centriole cohesion; IMP:UniProtKB
Q66GS9	CEP135	Centrosomal protein of 135 kDa	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q66GS9	CEP135	Centrosomal protein of 135 kDa	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0047442; F:17-alpha-hydroxyprogesterone aldolase activity; IEA:UniProtKB-EC
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0020037; F:heme binding; IDA:UniProtKB
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0005506; F:iron ion binding; IEA:InterPro
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0019825; F:oxygen binding; TAS:ProtInc
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0004508; F:steroid 17-alpha-monooxygenase activity; IDA:UniProtKB
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0030325; P:adrenal gland development; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0006702; P:androgen biosynthetic process; TAS:Reactome
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0018879; P:biphenyl metabolic process; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0071236; P:cellular response to antibiotic; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0071371; P:cellular response to gonadotropin stimulus; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0018894; P:dibenzo-p-dioxin metabolic process; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0006704; P:glucocorticoid biosynthetic process; TAS:Reactome
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0021766; P:hippocampus development; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0042446; P:hormone biosynthetic process; IDA:UniProtKB
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0033327; P:Leydig cell differentiation; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0030728; P:ovulation; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0018958; P:phenol-containing compound metabolic process; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0018963; P:phthalate metabolic process; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0090031; P:positive regulation of steroid hormone biosynthetic process; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0042448; P:progesterone metabolic process; IDA:UniProtKB
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0010034; P:response to acetate; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0051591; P:response to cAMP; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0034097; P:response to cytokine; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0042493; P:response to drug; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0060992; P:response to fungicide; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0009635; P:response to herbicide; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0017085; P:response to insecticide; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0010212; P:response to ionizing radiation; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0051597; P:response to methylmercury; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0031667; P:response to nutrient levels; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0032526; P:response to retinoic acid; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0048545; P:response to steroid hormone; IEA:Ensembl
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0007548; P:sex differentiation; TAS:ProtInc
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0006694; P:steroid biosynthetic process; TAS:ProtInc
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0008202; P:steroid metabolic process; IDA:UniProtKB
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0016125; P:sterol metabolic process; TAS:Reactome
P05093	CYP17A1	Steroid 17-alpha-hydroxylase/17,20 lyase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P11511	CYP19A1	Aromatase	GO:0070330; F:aromatase activity; IDA:UniProtKB
P11511	CYP19A1	Aromatase	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P11511	CYP19A1	Aromatase	GO:0020037; F:heme binding; IDA:UniProtKB
P11511	CYP19A1	Aromatase	GO:0005506; F:iron ion binding; IEA:InterPro
P11511	CYP19A1	Aromatase	GO:0016712; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; TAS:UniProtKB
P11511	CYP19A1	Aromatase	GO:0019825; F:oxygen binding; TAS:ProtInc
P11511	CYP19A1	Aromatase	GO:0008209; P:androgen metabolic process; IEA:Ensembl
P11511	CYP19A1	Aromatase	GO:0006703; P:estrogen biosynthetic process; TAS:Reactome
P11511	CYP19A1	Aromatase	GO:0060736; P:prostate gland growth; IEA:Ensembl
P11511	CYP19A1	Aromatase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P11511	CYP19A1	Aromatase	GO:0006694; P:steroid biosynthetic process; TAS:ProtInc
P11511	CYP19A1	Aromatase	GO:0008202; P:steroid metabolic process; TAS:Reactome
P11511	CYP19A1	Aromatase	GO:0016125; P:sterol metabolic process; TAS:Reactome
P11511	CYP19A1	Aromatase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P04798	CYP1A1	Cytochrome P450 1A1	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
P04798	CYP1A1	Cytochrome P450 1A1	GO:0032451; F:demethylase activity; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0016711; F:flavonoid 3'-monooxygenase activity; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0020037; F:heme binding; IEA:InterPro
P04798	CYP1A1	Cytochrome P450 1A1	GO:0005506; F:iron ion binding; IEA:InterPro
P04798	CYP1A1	Cytochrome P450 1A1	GO:0016491; F:oxidoreductase activity; IDA:BHF-UCL
P04798	CYP1A1	Cytochrome P450 1A1	GO:0016679; F:oxidoreductase activity, acting on diphenols and related substances as donors; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0019825; F:oxygen binding; TAS:ProtInc
P04798	CYP1A1	Cytochrome P450 1A1	GO:0008395; F:steroid hydroxylase activity; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0070576; F:vitamin D 24-hydroxylase activity; IDA:BHF-UCL
P04798	CYP1A1	Cytochrome P450 1A1	GO:0042904; P:9-cis-retinoic acid biosynthetic process; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0007568; P:aging; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0009308; P:amine metabolic process; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P04798	CYP1A1	Cytochrome P450 1A1	GO:0043010; P:camera-type eye development; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0008283; P:cell proliferation; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P04798	CYP1A1	Cytochrome P450 1A1	GO:0071407; P:cellular response to organic cyclic compound; IDA:MGI
P04798	CYP1A1	Cytochrome P450 1A1	GO:0009804; P:coumarin metabolic process; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0019341; P:dibenzo-p-dioxin catabolic process; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0048565; P:digestive tract development; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0017144; P:drug metabolic process; IDA:BHF-UCL
P04798	CYP1A1	Cytochrome P450 1A1	GO:0009792; P:embryo development ending in birth or egg hatching; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0019373; P:epoxygenase P450 pathway; TAS:Reactome
P04798	CYP1A1	Cytochrome P450 1A1	GO:0009812; P:flavonoid metabolic process; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0070365; P:hepatocyte differentiation; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0050665; P:hydrogen peroxide biosynthetic process; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0017143; P:insecticide metabolic process; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0060137; P:maternal process involved in parturition; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0097267; P:omega-hydroxylase P450 pathway; TAS:Reactome
P04798	CYP1A1	Cytochrome P450 1A1	GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL
P04798	CYP1A1	Cytochrome P450 1A1	GO:0006778; P:porphyrin-containing compound metabolic process; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0046677; P:response to antibiotic; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0046685; P:response to arsenic-containing substance; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0042493; P:response to drug; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0032094; P:response to food; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0009635; P:response to herbicide; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0055093; P:response to hyperoxia; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0001666; P:response to hypoxia; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0010041; P:response to iron(III) ion; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0009624; P:response to nematode; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0009615; P:response to virus; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0033189; P:response to vitamin A; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0009611; P:response to wounding; IEA:Ensembl
P04798	CYP1A1	Cytochrome P450 1A1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P04798	CYP1A1	Cytochrome P450 1A1	GO:0042359; P:vitamin D metabolic process; IC:BHF-UCL
P04798	CYP1A1	Cytochrome P450 1A1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P05177	CYP1A2	Cytochrome P450 1A2	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
P05177	CYP1A2	Cytochrome P450 1A2	GO:0034875; F:caffeine oxidase activity; IDA:BHF-UCL
P05177	CYP1A2	Cytochrome P450 1A2	GO:0032451; F:demethylase activity; IDA:UniProtKB
P05177	CYP1A2	Cytochrome P450 1A2	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P05177	CYP1A2	Cytochrome P450 1A2	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P05177	CYP1A2	Cytochrome P450 1A2	GO:0020037; F:heme binding; IDA:UniProtKB
P05177	CYP1A2	Cytochrome P450 1A2	GO:0005506; F:iron ion binding; IEA:InterPro
P05177	CYP1A2	Cytochrome P450 1A2	GO:0004497; F:monooxygenase activity; IDA:BHF-UCL
P05177	CYP1A2	Cytochrome P450 1A2	GO:0016491; F:oxidoreductase activity; IDA:BHF-UCL
P05177	CYP1A2	Cytochrome P450 1A2	GO:0016712; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; IMP:UniProtKB
P05177	CYP1A2	Cytochrome P450 1A2	GO:0009820; P:alkaloid metabolic process; IDA:BHF-UCL
P05177	CYP1A2	Cytochrome P450 1A2	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P05177	CYP1A2	Cytochrome P450 1A2	GO:0045333; P:cellular respiration; IEA:Ensembl
P05177	CYP1A2	Cytochrome P450 1A2	GO:0071276; P:cellular response to cadmium ion; IEA:Ensembl
P05177	CYP1A2	Cytochrome P450 1A2	GO:0018894; P:dibenzo-p-dioxin metabolic process; IEA:Ensembl
P05177	CYP1A2	Cytochrome P450 1A2	GO:0042737; P:drug catabolic process; IMP:BHF-UCL
P05177	CYP1A2	Cytochrome P450 1A2	GO:0017144; P:drug metabolic process; IDA:BHF-UCL
P05177	CYP1A2	Cytochrome P450 1A2	GO:0019373; P:epoxygenase P450 pathway; TAS:Reactome
P05177	CYP1A2	Cytochrome P450 1A2	GO:0042738; P:exogenous drug catabolic process; IDA:BHF-UCL
P05177	CYP1A2	Cytochrome P450 1A2	GO:0046483; P:heterocycle metabolic process; IDA:BHF-UCL
P05177	CYP1A2	Cytochrome P450 1A2	GO:0050665; P:hydrogen peroxide biosynthetic process; IEA:Ensembl
P05177	CYP1A2	Cytochrome P450 1A2	GO:0030324; P:lung development; IEA:Ensembl
P05177	CYP1A2	Cytochrome P450 1A2	GO:0032259; P:methylation; TAS:Reactome
P05177	CYP1A2	Cytochrome P450 1A2	GO:0032787; P:monocarboxylic acid metabolic process; IDA:BHF-UCL
P05177	CYP1A2	Cytochrome P450 1A2	GO:0016098; P:monoterpenoid metabolic process; IDA:BHF-UCL
P05177	CYP1A2	Cytochrome P450 1A2	GO:0097267; P:omega-hydroxylase P450 pathway; TAS:Reactome
P05177	CYP1A2	Cytochrome P450 1A2	GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL
P05177	CYP1A2	Cytochrome P450 1A2	GO:0071615; P:oxidative deethylation; IDA:BHF-UCL
P05177	CYP1A2	Cytochrome P450 1A2	GO:0070989; P:oxidative demethylation; IDA:BHF-UCL
P05177	CYP1A2	Cytochrome P450 1A2	GO:0006778; P:porphyrin-containing compound metabolic process; IEA:Ensembl
P05177	CYP1A2	Cytochrome P450 1A2	GO:0009791; P:post-embryonic development; IEA:Ensembl
P05177	CYP1A2	Cytochrome P450 1A2	GO:0010468; P:regulation of gene expression; IEA:Ensembl
P05177	CYP1A2	Cytochrome P450 1A2	GO:0032355; P:response to estradiol; IEA:Ensembl
P05177	CYP1A2	Cytochrome P450 1A2	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P05177	CYP1A2	Cytochrome P450 1A2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P05177	CYP1A2	Cytochrome P450 1A2	GO:0006706; P:steroid catabolic process; IMP:BHF-UCL
P05177	CYP1A2	Cytochrome P450 1A2	GO:0009403; P:toxin biosynthetic process; IDA:BHF-UCL
P05177	CYP1A2	Cytochrome P450 1A2	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0020037; F:heme binding; IDA:UniProtKB
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0005506; F:iron ion binding; IEA:InterPro
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0004497; F:monooxygenase activity; TAS:UniProtKB
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0016712; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; IDA:MGI
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0019825; F:oxygen binding; TAS:UniProtKB
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0001525; P:angiogenesis; IEA:Ensembl
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0006725; P:cellular aromatic compound metabolic process; IEA:Ensembl
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0071407; P:cellular response to organic cyclic compound; IDA:MGI
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0043542; P:endothelial cell migration; IEA:Ensembl
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0071603; P:endothelial cell-cell adhesion; IEA:Ensembl
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0019373; P:epoxygenase P450 pathway; TAS:Reactome
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0097267; P:omega-hydroxylase P450 pathway; TAS:Reactome
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0055114; P:oxidation-reduction process; TAS:UniProtKB
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0009636; P:response to toxic substance; IEA:Ensembl
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0061298; P:retina vasculature development in camera-type eye; IEA:Ensembl
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0008202; P:steroid metabolic process; IDA:UniProtKB
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0016125; P:sterol metabolic process; TAS:Reactome
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0009404; P:toxin metabolic process; IEA:Ensembl
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0007601; P:visual perception; TAS:UniProtKB
Q16678	CYP1B1	Cytochrome P450 1B1	GO:0006805; P:xenobiotic metabolic process; IDA:UniProtKB
Q6UW02	CYP20A1	Cytochrome P450 20A1	GO:0020037; F:heme binding; IEA:InterPro
Q6UW02	CYP20A1	Cytochrome P450 20A1	GO:0005506; F:iron ion binding; IEA:InterPro
Q6UW02	CYP20A1	Cytochrome P450 20A1	GO:0004497; F:monooxygenase activity; IEA:UniProtKB-KW
Q6UW02	CYP20A1	Cytochrome P450 20A1	GO:0016705; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; IEA:InterPro
P08686	CYP21A2	Steroid 21-hydroxylase	GO:0020037; F:heme binding; IEA:InterPro
P08686	CYP21A2	Steroid 21-hydroxylase	GO:0005506; F:iron ion binding; IEA:InterPro
P08686	CYP21A2	Steroid 21-hydroxylase	GO:0004509; F:steroid 21-monooxygenase activity; IEA:UniProtKB-EC
P08686	CYP21A2	Steroid 21-hydroxylase	GO:0005496; F:steroid binding; IEA:UniProtKB-KW
P08686	CYP21A2	Steroid 21-hydroxylase	GO:0008395; F:steroid hydroxylase activity; TAS:ProtInc
P08686	CYP21A2	Steroid 21-hydroxylase	GO:0006704; P:glucocorticoid biosynthetic process; TAS:Reactome
P08686	CYP21A2	Steroid 21-hydroxylase	GO:0006705; P:mineralocorticoid biosynthetic process; TAS:Reactome
P08686	CYP21A2	Steroid 21-hydroxylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P08686	CYP21A2	Steroid 21-hydroxylase	GO:0008202; P:steroid metabolic process; TAS:Reactome
P08686	CYP21A2	Steroid 21-hydroxylase	GO:0016125; P:sterol metabolic process; TAS:Reactome
P08686	CYP21A2	Steroid 21-hydroxylase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q07973	CYP24A1	1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	GO:0030342; F:1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity; IDA:UniProtKB
Q07973	CYP24A1	1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	GO:0008403; F:25-hydroxycholecalciferol-24-hydroxylase activity; IEA:Ensembl
Q07973	CYP24A1	1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	GO:0020037; F:heme binding; TAS:UniProtKB
Q07973	CYP24A1	1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	GO:0005506; F:iron ion binding; IEA:InterPro
Q07973	CYP24A1	1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	GO:0016491; F:oxidoreductase activity; NAS:UniProtKB
Q07973	CYP24A1	1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	GO:0001649; P:osteoblast differentiation; IEP:BHF-UCL
Q07973	CYP24A1	1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q07973	CYP24A1	1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	GO:0033280; P:response to vitamin D; IDA:BHF-UCL
Q07973	CYP24A1	1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q07973	CYP24A1	1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	GO:0008202; P:steroid metabolic process; TAS:Reactome
Q07973	CYP24A1	1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	GO:0042369; P:vitamin D catabolic process; NAS:BHF-UCL
Q07973	CYP24A1	1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	GO:0042359; P:vitamin D metabolic process; TAS:Reactome
Q07973	CYP24A1	1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	GO:0070561; P:vitamin D receptor signaling pathway; NAS:BHF-UCL
Q07973	CYP24A1	1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q07973	CYP24A1	1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9BV73	CEP250	Centrosome-associated protein CEP250	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BV73	CEP250	Centrosome-associated protein CEP250	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q9BV73	CEP250	Centrosome-associated protein CEP250	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q9BV73	CEP250	Centrosome-associated protein CEP250	GO:0010457; P:centriole-centriole cohesion; IMP:UniProtKB
Q9BV73	CEP250	Centrosome-associated protein CEP250	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q9BV73	CEP250	Centrosome-associated protein CEP250	GO:0000278; P:mitotic cell cycle; IDA:UniProtKB
Q9BV73	CEP250	Centrosome-associated protein CEP250	GO:0008104; P:protein localization; IMP:UniProtKB
Q9BV73	CEP250	Centrosome-associated protein CEP250	GO:0030997; P:regulation of centriole-centriole cohesion; IDA:UniProtKB
O43174	CYP26A1	Cytochrome P450 26A1	GO:0020037; F:heme binding; NAS:BHF-UCL
O43174	CYP26A1	Cytochrome P450 26A1	GO:0005506; F:iron ion binding; IEA:InterPro
O43174	CYP26A1	Cytochrome P450 26A1	GO:0019825; F:oxygen binding; TAS:ProtInc
O43174	CYP26A1	Cytochrome P450 26A1	GO:0008401; F:retinoic acid 4-hydroxylase activity; IDA:BHF-UCL
O43174	CYP26A1	Cytochrome P450 26A1	GO:0001972; F:retinoic acid binding; IDA:BHF-UCL
O43174	CYP26A1	Cytochrome P450 26A1	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
O43174	CYP26A1	Cytochrome P450 26A1	GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl
O43174	CYP26A1	Cytochrome P450 26A1	GO:0007417; P:central nervous system development; IEA:Ensembl
O43174	CYP26A1	Cytochrome P450 26A1	GO:0008152; P:metabolic process; TAS:ProtInc
O43174	CYP26A1	Cytochrome P450 26A1	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; TAS:BHF-UCL
O43174	CYP26A1	Cytochrome P450 26A1	GO:0014032; P:neural crest cell development; IEA:Ensembl
O43174	CYP26A1	Cytochrome P450 26A1	GO:0034653; P:retinoic acid catabolic process; IDA:BHF-UCL
O43174	CYP26A1	Cytochrome P450 26A1	GO:0048384; P:retinoic acid receptor signaling pathway; IEA:Ensembl
O43174	CYP26A1	Cytochrome P450 26A1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43174	CYP26A1	Cytochrome P450 26A1	GO:0006766; P:vitamin metabolic process; TAS:Reactome
O43174	CYP26A1	Cytochrome P450 26A1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:0020037; F:heme binding; NAS:BHF-UCL
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:0005506; F:iron ion binding; IEA:InterPro
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:0008401; F:retinoic acid 4-hydroxylase activity; IDA:BHF-UCL
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:0001972; F:retinoic acid binding; IDA:BHF-UCL
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:0060349; P:bone morphogenesis; IMP:UniProtKB
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:0001709; P:cell fate determination; ISS:BHF-UCL
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:0030326; P:embryonic limb morphogenesis; ISS:BHF-UCL
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:0007140; P:male meiosis; ISS:BHF-UCL
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; TAS:BHF-UCL
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:2001037; P:positive regulation of tongue muscle cell differentiation; IEA:Ensembl
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:0009954; P:proximal/distal pattern formation; ISS:BHF-UCL
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:0034653; P:retinoic acid catabolic process; IDA:BHF-UCL
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:0048384; P:retinoic acid receptor signaling pathway; IEA:Ensembl
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:0007283; P:spermatogenesis; ISS:BHF-UCL
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:0043587; P:tongue morphogenesis; IEA:Ensembl
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9NR63	CYP26B1	Cytochrome P450 26B1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q6V0L0	CYP26C1	Cytochrome P450 26C1	GO:0020037; F:heme binding; IEA:InterPro
Q6V0L0	CYP26C1	Cytochrome P450 26C1	GO:0005506; F:iron ion binding; IEA:InterPro
Q6V0L0	CYP26C1	Cytochrome P450 26C1	GO:0008401; F:retinoic acid 4-hydroxylase activity; IDA:BHF-UCL
Q6V0L0	CYP26C1	Cytochrome P450 26C1	GO:0001972; F:retinoic acid binding; IDA:BHF-UCL
Q6V0L0	CYP26C1	Cytochrome P450 26C1	GO:0009952; P:anterior/posterior pattern specification; ISS:BHF-UCL
Q6V0L0	CYP26C1	Cytochrome P450 26C1	GO:0007417; P:central nervous system development; ISS:BHF-UCL
Q6V0L0	CYP26C1	Cytochrome P450 26C1	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; NAS:BHF-UCL
Q6V0L0	CYP26C1	Cytochrome P450 26C1	GO:0014032; P:neural crest cell development; ISS:BHF-UCL
Q6V0L0	CYP26C1	Cytochrome P450 26C1	GO:0048284; P:organelle fusion; ISS:BHF-UCL
Q6V0L0	CYP26C1	Cytochrome P450 26C1	GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL
Q6V0L0	CYP26C1	Cytochrome P450 26C1	GO:0034653; P:retinoic acid catabolic process; IDA:BHF-UCL
Q6V0L0	CYP26C1	Cytochrome P450 26C1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6V0L0	CYP26C1	Cytochrome P450 26C1	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q6V0L0	CYP26C1	Cytochrome P450 26C1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q02318	CYP27A1	Sterol 26-hydroxylase, mitochondrial	GO:0047749; F:cholestanetriol 26-monooxygenase activity; IEA:UniProtKB-EC
Q02318	CYP27A1	Sterol 26-hydroxylase, mitochondrial	GO:0031073; F:cholesterol 26-hydroxylase activity; IEA:Ensembl
Q02318	CYP27A1	Sterol 26-hydroxylase, mitochondrial	GO:0020037; F:heme binding; IEA:InterPro
Q02318	CYP27A1	Sterol 26-hydroxylase, mitochondrial	GO:0005506; F:iron ion binding; IEA:InterPro
Q02318	CYP27A1	Sterol 26-hydroxylase, mitochondrial	GO:0008395; F:steroid hydroxylase activity; TAS:ProtInc
Q02318	CYP27A1	Sterol 26-hydroxylase, mitochondrial	GO:0030343; F:vitamin D3 25-hydroxylase activity; IEA:Ensembl
Q02318	CYP27A1	Sterol 26-hydroxylase, mitochondrial	GO:0006699; P:bile acid biosynthetic process; TAS:Reactome
Q02318	CYP27A1	Sterol 26-hydroxylase, mitochondrial	GO:0008206; P:bile acid metabolic process; TAS:Reactome
Q02318	CYP27A1	Sterol 26-hydroxylase, mitochondrial	GO:0008203; P:cholesterol metabolic process; IEA:Ensembl
Q02318	CYP27A1	Sterol 26-hydroxylase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q02318	CYP27A1	Sterol 26-hydroxylase, mitochondrial	GO:0016125; P:sterol metabolic process; TAS:Reactome
Q02318	CYP27A1	Sterol 26-hydroxylase, mitochondrial	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0004498; F:calcidiol 1-monooxygenase activity; IDA:BHF-UCL
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0020037; F:heme binding; IEA:InterPro
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0005506; F:iron ion binding; IEA:InterPro
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0030282; P:bone mineralization; IEP:BHF-UCL
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0036378; P:calcitriol biosynthetic process from calciol; IDA:BHF-UCL
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0055074; P:calcium ion homeostasis; IMP:BHF-UCL
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0006816; P:calcium ion transport; ISS:BHF-UCL
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0046697; P:decidualization; IEP:BHF-UCL
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0070314; P:G1 to G0 transition; IMP:BHF-UCL
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0010956; P:negative regulation of calcidiol 1-monooxygenase activity; IDA:BHF-UCL
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0030308; P:negative regulation of cell growth; IMP:BHF-UCL
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0045618; P:positive regulation of keratinocyte differentiation; IMP:BHF-UCL
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0010980; P:positive regulation of vitamin D 24-hydroxylase activity; IDA:BHF-UCL
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0070564; P:positive regulation of vitamin D receptor signaling pathway; IDA:BHF-UCL
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0030500; P:regulation of bone mineralization; IMP:BHF-UCL
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0043627; P:response to estrogen; IEP:BHF-UCL
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0034341; P:response to interferon-gamma; IDA:BHF-UCL
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0032496; P:response to lipopolysaccharide; IDA:BHF-UCL
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0033280; P:response to vitamin D; IDA:BHF-UCL
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0008202; P:steroid metabolic process; TAS:Reactome
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0042369; P:vitamin D catabolic process; IEA:Ensembl
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0042359; P:vitamin D metabolic process; IDA:BHF-UCL
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0006766; P:vitamin metabolic process; TAS:Reactome
O15528	CYP27B1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P11509	CYP2A6	Cytochrome P450 2A6	GO:0008389; F:coumarin 7-hydroxylase activity; IDA:UniProtKB
P11509	CYP2A6	Cytochrome P450 2A6	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P11509	CYP2A6	Cytochrome P450 2A6	GO:0020037; F:heme binding; IDA:UniProtKB
P11509	CYP2A6	Cytochrome P450 2A6	GO:0005506; F:iron ion binding; IEA:InterPro
P11509	CYP2A6	Cytochrome P450 2A6	GO:0016712; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; IEA:InterPro
P11509	CYP2A6	Cytochrome P450 2A6	GO:0046226; P:coumarin catabolic process; IDA:BHF-UCL
P11509	CYP2A6	Cytochrome P450 2A6	GO:0009804; P:coumarin metabolic process; IDA:BHF-UCL
P11509	CYP2A6	Cytochrome P450 2A6	GO:0017144; P:drug metabolic process; IDA:BHF-UCL
P11509	CYP2A6	Cytochrome P450 2A6	GO:0042738; P:exogenous drug catabolic process; IDA:BHF-UCL
P11509	CYP2A6	Cytochrome P450 2A6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P11509	CYP2A6	Cytochrome P450 2A6	GO:0008202; P:steroid metabolic process; IMP:BHF-UCL
P11509	CYP2A6	Cytochrome P450 2A6	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P20853	CYP2A7	Cytochrome P450 2A7	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
P20853	CYP2A7	Cytochrome P450 2A7	GO:0020037; F:heme binding; IEA:InterPro
P20853	CYP2A7	Cytochrome P450 2A7	GO:0005506; F:iron ion binding; IEA:InterPro
P20853	CYP2A7	Cytochrome P450 2A7	GO:0019825; F:oxygen binding; TAS:ProtInc
Q16696	CYP2A13	Cytochrome P450 2A13	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
Q16696	CYP2A13	Cytochrome P450 2A13	GO:0020037; F:heme binding; IDA:UniProtKB
Q16696	CYP2A13	Cytochrome P450 2A13	GO:0005506; F:iron ion binding; IEA:InterPro
Q16696	CYP2A13	Cytochrome P450 2A13	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16696	CYP2A13	Cytochrome P450 2A13	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P20813	CYP2B6	Cytochrome P450 2B6	GO:0020037; F:heme binding; IDA:UniProtKB
P20813	CYP2B6	Cytochrome P450 2B6	GO:0005506; F:iron ion binding; IEA:InterPro
P20813	CYP2B6	Cytochrome P450 2B6	GO:0004497; F:monooxygenase activity; IDA:BHF-UCL
P20813	CYP2B6	Cytochrome P450 2B6	GO:0016712; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; IEA:InterPro
P20813	CYP2B6	Cytochrome P450 2B6	GO:0042180; P:cellular ketone metabolic process; IDA:BHF-UCL
P20813	CYP2B6	Cytochrome P450 2B6	GO:0017144; P:drug metabolic process; IDA:BHF-UCL
P20813	CYP2B6	Cytochrome P450 2B6	GO:0042738; P:exogenous drug catabolic process; IDA:BHF-UCL
P20813	CYP2B6	Cytochrome P450 2B6	GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL
P20813	CYP2B6	Cytochrome P450 2B6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P20813	CYP2B6	Cytochrome P450 2B6	GO:0008202; P:steroid metabolic process; IMP:BHF-UCL
P20813	CYP2B6	Cytochrome P450 2B6	GO:0006805; P:xenobiotic metabolic process; IDA:UniProtKB
P10632	CYP2C8	Cytochrome P450 2C8	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
P10632	CYP2C8	Cytochrome P450 2C8	GO:0034875; F:caffeine oxidase activity; IDA:BHF-UCL
P10632	CYP2C8	Cytochrome P450 2C8	GO:0020037; F:heme binding; IEA:InterPro
P10632	CYP2C8	Cytochrome P450 2C8	GO:0005506; F:iron ion binding; IEA:InterPro
P10632	CYP2C8	Cytochrome P450 2C8	GO:0004497; F:monooxygenase activity; IDA:BHF-UCL
P10632	CYP2C8	Cytochrome P450 2C8	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P10632	CYP2C8	Cytochrome P450 2C8	GO:0017144; P:drug metabolic process; IDA:BHF-UCL
P10632	CYP2C8	Cytochrome P450 2C8	GO:0019373; P:epoxygenase P450 pathway; TAS:Reactome
P10632	CYP2C8	Cytochrome P450 2C8	GO:0042738; P:exogenous drug catabolic process; IDA:BHF-UCL
P10632	CYP2C8	Cytochrome P450 2C8	GO:0097267; P:omega-hydroxylase P450 pathway; TAS:Reactome
P10632	CYP2C8	Cytochrome P450 2C8	GO:0006082; P:organic acid metabolic process; IDA:BHF-UCL
P10632	CYP2C8	Cytochrome P450 2C8	GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL
P10632	CYP2C8	Cytochrome P450 2C8	GO:0070989; P:oxidative demethylation; IDA:BHF-UCL
P10632	CYP2C8	Cytochrome P450 2C8	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P10632	CYP2C8	Cytochrome P450 2C8	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P11712	CYP2C9	Cytochrome P450 2C9	GO:0052741; F:(R)-limonene 6-monooxygenase activity; IEA:UniProtKB-EC
P11712	CYP2C9	Cytochrome P450 2C9	GO:0018675; F:(S)-limonene 6-monooxygenase activity; IEA:UniProtKB-EC
P11712	CYP2C9	Cytochrome P450 2C9	GO:0018676; F:(S)-limonene 7-monooxygenase activity; IEA:UniProtKB-EC
P11712	CYP2C9	Cytochrome P450 2C9	GO:0034875; F:caffeine oxidase activity; IDA:BHF-UCL
P11712	CYP2C9	Cytochrome P450 2C9	GO:0008144; F:drug binding; IDA:BHF-UCL
P11712	CYP2C9	Cytochrome P450 2C9	GO:0020037; F:heme binding; IEA:InterPro
P11712	CYP2C9	Cytochrome P450 2C9	GO:0005506; F:iron ion binding; IEA:InterPro
P11712	CYP2C9	Cytochrome P450 2C9	GO:0004497; F:monooxygenase activity; NAS:UniProtKB
P11712	CYP2C9	Cytochrome P450 2C9	GO:0016491; F:oxidoreductase activity; IDA:BHF-UCL
P11712	CYP2C9	Cytochrome P450 2C9	GO:0008395; F:steroid hydroxylase activity; IMP:BHF-UCL
P11712	CYP2C9	Cytochrome P450 2C9	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P11712	CYP2C9	Cytochrome P450 2C9	GO:0043603; P:cellular amide metabolic process; IDA:BHF-UCL
P11712	CYP2C9	Cytochrome P450 2C9	GO:0042737; P:drug catabolic process; IMP:BHF-UCL
P11712	CYP2C9	Cytochrome P450 2C9	GO:0017144; P:drug metabolic process; IMP:UniProtKB
P11712	CYP2C9	Cytochrome P450 2C9	GO:0019373; P:epoxygenase P450 pathway; TAS:Reactome
P11712	CYP2C9	Cytochrome P450 2C9	GO:0042738; P:exogenous drug catabolic process; IDA:BHF-UCL
P11712	CYP2C9	Cytochrome P450 2C9	GO:0032787; P:monocarboxylic acid metabolic process; IDA:BHF-UCL
P11712	CYP2C9	Cytochrome P450 2C9	GO:0016098; P:monoterpenoid metabolic process; IDA:BHF-UCL
P11712	CYP2C9	Cytochrome P450 2C9	GO:0097267; P:omega-hydroxylase P450 pathway; TAS:Reactome
P11712	CYP2C9	Cytochrome P450 2C9	GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL
P11712	CYP2C9	Cytochrome P450 2C9	GO:0070989; P:oxidative demethylation; IDA:BHF-UCL
P11712	CYP2C9	Cytochrome P450 2C9	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P11712	CYP2C9	Cytochrome P450 2C9	GO:0008202; P:steroid metabolic process; IMP:BHF-UCL
P11712	CYP2C9	Cytochrome P450 2C9	GO:0019627; P:urea metabolic process; IDA:BHF-UCL
P11712	CYP2C9	Cytochrome P450 2C9	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P33260	CYP2C18	Cytochrome P450 2C18	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
P33260	CYP2C18	Cytochrome P450 2C18	GO:0020037; F:heme binding; IEA:InterPro
P33260	CYP2C18	Cytochrome P450 2C18	GO:0005506; F:iron ion binding; IEA:InterPro
P33260	CYP2C18	Cytochrome P450 2C18	GO:0004497; F:monooxygenase activity; TAS:ProtInc
P33260	CYP2C18	Cytochrome P450 2C18	GO:0019825; F:oxygen binding; TAS:ProtInc
P33260	CYP2C18	Cytochrome P450 2C18	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P33260	CYP2C18	Cytochrome P450 2C18	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P33261	CYP2C19	Cytochrome P450 2C19	GO:0052741; F:(R)-limonene 6-monooxygenase activity; IEA:UniProtKB-EC
P33261	CYP2C19	Cytochrome P450 2C19	GO:0018675; F:(S)-limonene 6-monooxygenase activity; IEA:UniProtKB-EC
P33261	CYP2C19	Cytochrome P450 2C19	GO:0018676; F:(S)-limonene 7-monooxygenase activity; IEA:UniProtKB-EC
P33261	CYP2C19	Cytochrome P450 2C19	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P33261	CYP2C19	Cytochrome P450 2C19	GO:0020037; F:heme binding; IDA:UniProtKB
P33261	CYP2C19	Cytochrome P450 2C19	GO:0005506; F:iron ion binding; IEA:InterPro
P33261	CYP2C19	Cytochrome P450 2C19	GO:0004497; F:monooxygenase activity; IDA:BHF-UCL
P33261	CYP2C19	Cytochrome P450 2C19	GO:0016491; F:oxidoreductase activity; IDA:BHF-UCL
P33261	CYP2C19	Cytochrome P450 2C19	GO:0019825; F:oxygen binding; TAS:ProtInc
P33261	CYP2C19	Cytochrome P450 2C19	GO:0008395; F:steroid hydroxylase activity; IMP:BHF-UCL
P33261	CYP2C19	Cytochrome P450 2C19	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P33261	CYP2C19	Cytochrome P450 2C19	GO:0017144; P:drug metabolic process; IDA:BHF-UCL
P33261	CYP2C19	Cytochrome P450 2C19	GO:0019373; P:epoxygenase P450 pathway; TAS:Reactome
P33261	CYP2C19	Cytochrome P450 2C19	GO:0042738; P:exogenous drug catabolic process; IDA:BHF-UCL
P33261	CYP2C19	Cytochrome P450 2C19	GO:0046483; P:heterocycle metabolic process; IDA:BHF-UCL
P33261	CYP2C19	Cytochrome P450 2C19	GO:0016098; P:monoterpenoid metabolic process; IDA:BHF-UCL
P33261	CYP2C19	Cytochrome P450 2C19	GO:0097267; P:omega-hydroxylase P450 pathway; TAS:Reactome
P33261	CYP2C19	Cytochrome P450 2C19	GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL
P33261	CYP2C19	Cytochrome P450 2C19	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P33261	CYP2C19	Cytochrome P450 2C19	GO:0008202; P:steroid metabolic process; IMP:BHF-UCL
P33261	CYP2C19	Cytochrome P450 2C19	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P10635	CYP2D6	Cytochrome P450 2D6	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
P10635	CYP2D6	Cytochrome P450 2D6	GO:0008144; F:drug binding; IDA:BHF-UCL
P10635	CYP2D6	Cytochrome P450 2D6	GO:0020037; F:heme binding; IDA:UniProtKB
P10635	CYP2D6	Cytochrome P450 2D6	GO:0005506; F:iron ion binding; IEA:InterPro
P10635	CYP2D6	Cytochrome P450 2D6	GO:0004497; F:monooxygenase activity; IDA:BHF-UCL
P10635	CYP2D6	Cytochrome P450 2D6	GO:0016491; F:oxidoreductase activity; IDA:BHF-UCL
P10635	CYP2D6	Cytochrome P450 2D6	GO:0009822; P:alkaloid catabolic process; IDA:BHF-UCL
P10635	CYP2D6	Cytochrome P450 2D6	GO:0009820; P:alkaloid metabolic process; IDA:BHF-UCL
P10635	CYP2D6	Cytochrome P450 2D6	GO:0009804; P:coumarin metabolic process; IDA:BHF-UCL
P10635	CYP2D6	Cytochrome P450 2D6	GO:0042737; P:drug catabolic process; IDA:BHF-UCL
P10635	CYP2D6	Cytochrome P450 2D6	GO:0017144; P:drug metabolic process; IDA:BHF-UCL
P10635	CYP2D6	Cytochrome P450 2D6	GO:0046483; P:heterocycle metabolic process; IDA:BHF-UCL
P10635	CYP2D6	Cytochrome P450 2D6	GO:0033076; P:isoquinoline alkaloid metabolic process; IDA:BHF-UCL
P10635	CYP2D6	Cytochrome P450 2D6	GO:0016098; P:monoterpenoid metabolic process; IDA:BHF-UCL
P10635	CYP2D6	Cytochrome P450 2D6	GO:0051100; P:negative regulation of binding; IDA:BHF-UCL
P10635	CYP2D6	Cytochrome P450 2D6	GO:0090350; P:negative regulation of cellular organofluorine metabolic process; IDA:BHF-UCL
P10635	CYP2D6	Cytochrome P450 2D6	GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL
P10635	CYP2D6	Cytochrome P450 2D6	GO:0070989; P:oxidative demethylation; IDA:BHF-UCL
P10635	CYP2D6	Cytochrome P450 2D6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P10635	CYP2D6	Cytochrome P450 2D6	GO:0008202; P:steroid metabolic process; IMP:BHF-UCL
P10635	CYP2D6	Cytochrome P450 2D6	GO:0006805; P:xenobiotic metabolic process; TAS:BHF-UCL
P05181	CYP2E1	Cytochrome P450 2E1	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P05181	CYP2E1	Cytochrome P450 2E1	GO:0020037; F:heme binding; IDA:UniProtKB
P05181	CYP2E1	Cytochrome P450 2E1	GO:0005506; F:iron ion binding; IEA:InterPro
P05181	CYP2E1	Cytochrome P450 2E1	GO:0004497; F:monooxygenase activity; IDA:BHF-UCL
P05181	CYP2E1	Cytochrome P450 2E1	GO:0016491; F:oxidoreductase activity; IDA:BHF-UCL
P05181	CYP2E1	Cytochrome P450 2E1	GO:0016709; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; TAS:UniProtKB
P05181	CYP2E1	Cytochrome P450 2E1	GO:0016712; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; IEA:Ensembl
P05181	CYP2E1	Cytochrome P450 2E1	GO:0019825; F:oxygen binding; TAS:ProtInc
P05181	CYP2E1	Cytochrome P450 2E1	GO:0017144; P:drug metabolic process; IDA:BHF-UCL
P05181	CYP2E1	Cytochrome P450 2E1	GO:0046483; P:heterocycle metabolic process; IDA:BHF-UCL
P05181	CYP2E1	Cytochrome P450 2E1	GO:0016098; P:monoterpenoid metabolic process; IDA:BHF-UCL
P05181	CYP2E1	Cytochrome P450 2E1	GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL
P05181	CYP2E1	Cytochrome P450 2E1	GO:0042493; P:response to drug; IEA:Ensembl
P05181	CYP2E1	Cytochrome P450 2E1	GO:0045471; P:response to ethanol; IEA:Ensembl
P05181	CYP2E1	Cytochrome P450 2E1	GO:0010243; P:response to organonitrogen compound; IEA:Ensembl
P05181	CYP2E1	Cytochrome P450 2E1	GO:0010193; P:response to ozone; IEA:Ensembl
P05181	CYP2E1	Cytochrome P450 2E1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P05181	CYP2E1	Cytochrome P450 2E1	GO:0008202; P:steroid metabolic process; IMP:BHF-UCL
P05181	CYP2E1	Cytochrome P450 2E1	GO:0006641; P:triglyceride metabolic process; IEA:Ensembl
P05181	CYP2E1	Cytochrome P450 2E1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P24903	CYP2F1	Cytochrome P450 2F1	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
P24903	CYP2F1	Cytochrome P450 2F1	GO:0020037; F:heme binding; IEA:InterPro
P24903	CYP2F1	Cytochrome P450 2F1	GO:0005506; F:iron ion binding; IEA:InterPro
P24903	CYP2F1	Cytochrome P450 2F1	GO:0004497; F:monooxygenase activity; TAS:ProtInc
P24903	CYP2F1	Cytochrome P450 2F1	GO:0016712; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; IDA:UniProtKB
P24903	CYP2F1	Cytochrome P450 2F1	GO:0019825; F:oxygen binding; TAS:ProtInc
P24903	CYP2F1	Cytochrome P450 2F1	GO:0018931; P:naphthalene metabolic process; IDA:UniProtKB
P24903	CYP2F1	Cytochrome P450 2F1	GO:0009636; P:response to toxic substance; IEA:Ensembl
P24903	CYP2F1	Cytochrome P450 2F1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P24903	CYP2F1	Cytochrome P450 2F1	GO:0018979; P:trichloroethylene metabolic process; IEA:Ensembl
P24903	CYP2F1	Cytochrome P450 2F1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P51589	CYP2J2	Cytochrome P450 2J2	GO:0008405; F:arachidonic acid 11,12-epoxygenase activity; IDA:BHF-UCL
P51589	CYP2J2	Cytochrome P450 2J2	GO:0008404; F:arachidonic acid 14,15-epoxygenase activity; IDA:BHF-UCL
P51589	CYP2J2	Cytochrome P450 2J2	GO:0008392; F:arachidonic acid epoxygenase activity; IDA:BHF-UCL
P51589	CYP2J2	Cytochrome P450 2J2	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
P51589	CYP2J2	Cytochrome P450 2J2	GO:0020037; F:heme binding; IEA:InterPro
P51589	CYP2J2	Cytochrome P450 2J2	GO:0005506; F:iron ion binding; IEA:InterPro
P51589	CYP2J2	Cytochrome P450 2J2	GO:0071614; F:linoleic acid epoxygenase activity; IDA:BHF-UCL
P51589	CYP2J2	Cytochrome P450 2J2	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P51589	CYP2J2	Cytochrome P450 2J2	GO:0019373; P:epoxygenase P450 pathway; IDA:BHF-UCL
P51589	CYP2J2	Cytochrome P450 2J2	GO:0006690; P:icosanoid metabolic process; TAS:ProtInc
P51589	CYP2J2	Cytochrome P450 2J2	GO:0043651; P:linoleic acid metabolic process; IDA:BHF-UCL
P51589	CYP2J2	Cytochrome P450 2J2	GO:0008016; P:regulation of heart contraction; TAS:ProtInc
P51589	CYP2J2	Cytochrome P450 2J2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P51589	CYP2J2	Cytochrome P450 2J2	GO:0006805; P:xenobiotic metabolic process; TAS:BHF-UCL
Q6VVX0	CYP2R1	Vitamin D 25-hydroxylase	GO:0020037; F:heme binding; IEA:InterPro
Q6VVX0	CYP2R1	Vitamin D 25-hydroxylase	GO:0005506; F:iron ion binding; IEA:InterPro
Q6VVX0	CYP2R1	Vitamin D 25-hydroxylase	GO:0004497; F:monooxygenase activity; IEA:UniProtKB-KW
Q6VVX0	CYP2R1	Vitamin D 25-hydroxylase	GO:0016705; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; IEA:InterPro
Q6VVX0	CYP2R1	Vitamin D 25-hydroxylase	GO:0030343; F:vitamin D3 25-hydroxylase activity; IEA:Ensembl
Q6VVX0	CYP2R1	Vitamin D 25-hydroxylase	GO:0010164; P:response to cesium ion; IEA:Ensembl
Q6VVX0	CYP2R1	Vitamin D 25-hydroxylase	GO:0010212; P:response to ionizing radiation; IEA:Ensembl
Q6VVX0	CYP2R1	Vitamin D 25-hydroxylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6VVX0	CYP2R1	Vitamin D 25-hydroxylase	GO:0008202; P:steroid metabolic process; TAS:Reactome
Q6VVX0	CYP2R1	Vitamin D 25-hydroxylase	GO:0042359; P:vitamin D metabolic process; TAS:Reactome
Q6VVX0	CYP2R1	Vitamin D 25-hydroxylase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q6VVX0	CYP2R1	Vitamin D 25-hydroxylase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q96SQ9	CYP2S1	Cytochrome P450 2S1	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
Q96SQ9	CYP2S1	Cytochrome P450 2S1	GO:0020037; F:heme binding; IEA:InterPro
Q96SQ9	CYP2S1	Cytochrome P450 2S1	GO:0005506; F:iron ion binding; IEA:InterPro
Q96SQ9	CYP2S1	Cytochrome P450 2S1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96SQ9	CYP2S1	Cytochrome P450 2S1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q7Z449	CYP2U1	Cytochrome P450 2U1	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
Q7Z449	CYP2U1	Cytochrome P450 2U1	GO:0020037; F:heme binding; IEA:InterPro
Q7Z449	CYP2U1	Cytochrome P450 2U1	GO:0005506; F:iron ion binding; IEA:InterPro
Q7Z449	CYP2U1	Cytochrome P450 2U1	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
Q7Z449	CYP2U1	Cytochrome P450 2U1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q7Z449	CYP2U1	Cytochrome P450 2U1	GO:0097267; P:omega-hydroxylase P450 pathway; TAS:Reactome
Q7Z449	CYP2U1	Cytochrome P450 2U1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q7Z449	CYP2U1	Cytochrome P450 2U1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q8TAV3	CYP2W1	Cytochrome P450 2W1	GO:0020037; F:heme binding; IEA:InterPro
Q8TAV3	CYP2W1	Cytochrome P450 2W1	GO:0005506; F:iron ion binding; IEA:InterPro
Q8TAV3	CYP2W1	Cytochrome P450 2W1	GO:0004497; F:monooxygenase activity; IEA:UniProtKB-KW
Q8TAV3	CYP2W1	Cytochrome P450 2W1	GO:0016705; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; IEA:InterPro
Q8TAV3	CYP2W1	Cytochrome P450 2W1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8TAV3	CYP2W1	Cytochrome P450 2W1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9HB55	CYP3A43	Cytochrome P450 3A43	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
Q9HB55	CYP3A43	Cytochrome P450 3A43	GO:0020037; F:heme binding; IEA:InterPro
Q9HB55	CYP3A43	Cytochrome P450 3A43	GO:0005506; F:iron ion binding; IEA:InterPro
Q9HB55	CYP3A43	Cytochrome P450 3A43	GO:0004497; F:monooxygenase activity; ISS:UniProtKB
Q9HB55	CYP3A43	Cytochrome P450 3A43	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9HB55	CYP3A43	Cytochrome P450 3A43	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9NYL5	CYP39A1	24-hydroxycholesterol 7-alpha-hydroxylase	GO:0033782; F:24-hydroxycholesterol 7alpha-hydroxylase activity; IEA:UniProtKB-EC
Q9NYL5	CYP39A1	24-hydroxycholesterol 7-alpha-hydroxylase	GO:0020037; F:heme binding; IEA:InterPro
Q9NYL5	CYP39A1	24-hydroxycholesterol 7-alpha-hydroxylase	GO:0005506; F:iron ion binding; IEA:InterPro
Q9NYL5	CYP39A1	24-hydroxycholesterol 7-alpha-hydroxylase	GO:0008396; F:oxysterol 7-alpha-hydroxylase activity; IDA:UniProtKB
Q9NYL5	CYP39A1	24-hydroxycholesterol 7-alpha-hydroxylase	GO:0008387; F:steroid 7-alpha-hydroxylase activity; IEA:Ensembl
Q9NYL5	CYP39A1	24-hydroxycholesterol 7-alpha-hydroxylase	GO:0006699; P:bile acid biosynthetic process; IDA:UniProtKB
Q9NYL5	CYP39A1	24-hydroxycholesterol 7-alpha-hydroxylase	GO:0030573; P:bile acid catabolic process; IEA:UniProtKB-KW
Q9NYL5	CYP39A1	24-hydroxycholesterol 7-alpha-hydroxylase	GO:0008206; P:bile acid metabolic process; TAS:Reactome
Q9NYL5	CYP39A1	24-hydroxycholesterol 7-alpha-hydroxylase	GO:0006707; P:cholesterol catabolic process; IEA:Ensembl
Q9NYL5	CYP39A1	24-hydroxycholesterol 7-alpha-hydroxylase	GO:0007586; P:digestion; TAS:UniProtKB
Q9NYL5	CYP39A1	24-hydroxycholesterol 7-alpha-hydroxylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NYL5	CYP39A1	24-hydroxycholesterol 7-alpha-hydroxylase	GO:0016125; P:sterol metabolic process; TAS:Reactome
Q9NYL5	CYP39A1	24-hydroxycholesterol 7-alpha-hydroxylase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P08684	CYP3A4	Cytochrome P450 3A4	GO:0047638; F:albendazole monooxygenase activity; IEA:UniProtKB-EC
P08684	CYP3A4	Cytochrome P450 3A4	GO:0034875; F:caffeine oxidase activity; IDA:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0020037; F:heme binding; IEA:InterPro
P08684	CYP3A4	Cytochrome P450 3A4	GO:0005506; F:iron ion binding; IDA:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0004497; F:monooxygenase activity; ISS:UniProtKB
P08684	CYP3A4	Cytochrome P450 3A4	GO:0016491; F:oxidoreductase activity; IDA:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0016712; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; IEA:InterPro
P08684	CYP3A4	Cytochrome P450 3A4	GO:0019825; F:oxygen binding; TAS:ProtInc
P08684	CYP3A4	Cytochrome P450 3A4	GO:0050591; F:quinine 3-monooxygenase activity; IEA:UniProtKB-EC
P08684	CYP3A4	Cytochrome P450 3A4	GO:0005496; F:steroid binding; IDA:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0008395; F:steroid hydroxylase activity; IMP:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0033780; F:taurochenodeoxycholate 6alpha-hydroxylase activity; IEA:UniProtKB-EC
P08684	CYP3A4	Cytochrome P450 3A4	GO:0050649; F:testosterone 6-beta-hydroxylase activity; IMP:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0070576; F:vitamin D 24-hydroxylase activity; IDA:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0030343; F:vitamin D3 25-hydroxylase activity; IDA:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0009822; P:alkaloid catabolic process; IDA:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0008209; P:androgen metabolic process; TAS:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0036378; P:calcitriol biosynthetic process from calciol; IDA:GOC
P08684	CYP3A4	Cytochrome P450 3A4	GO:0042737; P:drug catabolic process; IDA:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0017144; P:drug metabolic process; IDA:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0042738; P:exogenous drug catabolic process; IDA:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0046483; P:heterocycle metabolic process; IDA:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0006629; P:lipid metabolic process; TAS:ProtInc
P08684	CYP3A4	Cytochrome P450 3A4	GO:0016098; P:monoterpenoid metabolic process; IDA:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0070989; P:oxidative demethylation; IDA:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P08684	CYP3A4	Cytochrome P450 3A4	GO:0006706; P:steroid catabolic process; IMP:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0008202; P:steroid metabolic process; IMP:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0042359; P:vitamin D metabolic process; IC:BHF-UCL
P08684	CYP3A4	Cytochrome P450 3A4	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P20815	CYP3A5	Cytochrome P450 3A5	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
P20815	CYP3A5	Cytochrome P450 3A5	GO:0020037; F:heme binding; IEA:InterPro
P20815	CYP3A5	Cytochrome P450 3A5	GO:0005506; F:iron ion binding; IEA:InterPro
P20815	CYP3A5	Cytochrome P450 3A5	GO:0004497; F:monooxygenase activity; ISS:UniProtKB
P20815	CYP3A5	Cytochrome P450 3A5	GO:0016491; F:oxidoreductase activity; IDA:BHF-UCL
P20815	CYP3A5	Cytochrome P450 3A5	GO:0019825; F:oxygen binding; TAS:ProtInc
P20815	CYP3A5	Cytochrome P450 3A5	GO:0009822; P:alkaloid catabolic process; IDA:BHF-UCL
P20815	CYP3A5	Cytochrome P450 3A5	GO:0042737; P:drug catabolic process; IDA:BHF-UCL
P20815	CYP3A5	Cytochrome P450 3A5	GO:0070989; P:oxidative demethylation; IDA:BHF-UCL
P20815	CYP3A5	Cytochrome P450 3A5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P20815	CYP3A5	Cytochrome P450 3A5	GO:0008202; P:steroid metabolic process; TAS:ProtInc
P20815	CYP3A5	Cytochrome P450 3A5	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P24462	CYP3A7	Cytochrome P450 3A7	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
P24462	CYP3A7	Cytochrome P450 3A7	GO:0020037; F:heme binding; IEA:InterPro
P24462	CYP3A7	Cytochrome P450 3A7	GO:0005506; F:iron ion binding; IEA:InterPro
P24462	CYP3A7	Cytochrome P450 3A7	GO:0004497; F:monooxygenase activity; ISS:UniProtKB
P24462	CYP3A7	Cytochrome P450 3A7	GO:0019825; F:oxygen binding; TAS:ProtInc
P24462	CYP3A7	Cytochrome P450 3A7	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P24462	CYP3A7	Cytochrome P450 3A7	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9Y6A2	CYP46A1	Cholesterol 24-hydroxylase	GO:0033781; F:cholesterol 24-hydroxylase activity; IDA:UniProtKB
Q9Y6A2	CYP46A1	Cholesterol 24-hydroxylase	GO:0020037; F:heme binding; IDA:UniProtKB
Q9Y6A2	CYP46A1	Cholesterol 24-hydroxylase	GO:0005506; F:iron ion binding; IEA:InterPro
Q9Y6A2	CYP46A1	Cholesterol 24-hydroxylase	GO:0008395; F:steroid hydroxylase activity; TAS:ProtInc
Q9Y6A2	CYP46A1	Cholesterol 24-hydroxylase	GO:0006699; P:bile acid biosynthetic process; TAS:Reactome
Q9Y6A2	CYP46A1	Cholesterol 24-hydroxylase	GO:0008206; P:bile acid metabolic process; TAS:Reactome
Q9Y6A2	CYP46A1	Cholesterol 24-hydroxylase	GO:0006707; P:cholesterol catabolic process; IDA:UniProtKB
Q9Y6A2	CYP46A1	Cholesterol 24-hydroxylase	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y6A2	CYP46A1	Cholesterol 24-hydroxylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y6A2	CYP46A1	Cholesterol 24-hydroxylase	GO:0016125; P:sterol metabolic process; TAS:Reactome
Q9Y6A2	CYP46A1	Cholesterol 24-hydroxylase	GO:0006805; P:xenobiotic metabolic process; IDA:UniProtKB
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0018685; F:alkane 1-monooxygenase activity; IDA:BHF-UCL
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0008392; F:arachidonic acid epoxygenase activity; IDA:UniProtKB
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0052869; F:arachidonic acid omega-hydroxylase activity; IEA:UniProtKB-EC
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0020037; F:heme binding; IEA:InterPro
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0005506; F:iron ion binding; IEA:InterPro
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0050051; F:leukotriene-B4 20-monooxygenase activity; IDA:UniProtKB
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0019369; P:arachidonic acid metabolic process; IDA:UniProtKB
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0019373; P:epoxygenase P450 pathway; IDA:UniProtKB
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0006631; P:fatty acid metabolic process; TAS:ProtInc
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0036101; P:leukotriene B4 catabolic process; IDA:GOC
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0006691; P:leukotriene metabolic process; IDA:UniProtKB
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0001676; P:long-chain fatty acid metabolic process; IDA:BHF-UCL
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0097267; P:omega-hydroxylase P450 pathway; TAS:Reactome
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0032305; P:positive regulation of icosanoid secretion; IMP:UniProtKB
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0003095; P:pressure natriuresis; IEP:UniProtKB
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0003091; P:renal water homeostasis; IEP:UniProtKB
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0055078; P:sodium ion homeostasis; IEP:UniProtKB
Q02928	CYP4A11	Cytochrome P450 4A11	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q5TCH4	CYP4A22	Cytochrome P450 4A22	GO:0018685; F:alkane 1-monooxygenase activity; IEA:UniProtKB-EC
Q5TCH4	CYP4A22	Cytochrome P450 4A22	GO:0052869; F:arachidonic acid omega-hydroxylase activity; IEA:UniProtKB-EC
Q5TCH4	CYP4A22	Cytochrome P450 4A22	GO:0020037; F:heme binding; IEA:InterPro
Q5TCH4	CYP4A22	Cytochrome P450 4A22	GO:0005506; F:iron ion binding; IEA:InterPro
P13584	CYP4B1	Cytochrome P450 4B1	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
P13584	CYP4B1	Cytochrome P450 4B1	GO:0008144; F:drug binding; IEA:Ensembl
P13584	CYP4B1	Cytochrome P450 4B1	GO:0018585; F:fluorene oxygenase activity; IEA:Ensembl
P13584	CYP4B1	Cytochrome P450 4B1	GO:0020037; F:heme binding; IEA:InterPro
P13584	CYP4B1	Cytochrome P450 4B1	GO:0005506; F:iron ion binding; IEA:InterPro
P13584	CYP4B1	Cytochrome P450 4B1	GO:0019825; F:oxygen binding; TAS:ProtInc
P13584	CYP4B1	Cytochrome P450 4B1	GO:0018879; P:biphenyl metabolic process; IEA:Ensembl
P13584	CYP4B1	Cytochrome P450 4B1	GO:0042738; P:exogenous drug catabolic process; IEA:Ensembl
P13584	CYP4B1	Cytochrome P450 4B1	GO:0018917; P:fluorene metabolic process; IEA:Ensembl
P13584	CYP4B1	Cytochrome P450 4B1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P13584	CYP4B1	Cytochrome P450 4B1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0018685; F:alkane 1-monooxygenase activity; IDA:BHF-UCL
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0052871; F:alpha-tocopherol omega-hydroxylase activity; IDA:UniProtKB
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0008392; F:arachidonic acid epoxygenase activity; IDA:UniProtKB
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0052869; F:arachidonic acid omega-hydroxylase activity; IDA:UniProtKB
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0020037; F:heme binding; IEA:InterPro
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0005506; F:iron ion binding; IEA:InterPro
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0050051; F:leukotriene-B4 20-monooxygenase activity; IDA:UniProtKB
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0005515; F:protein binding; IPI:IntAct
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0052872; F:tocotrienol omega-hydroxylase activity; IDA:UniProtKB
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0047057; F:vitamin-K-epoxide reductase (warfarin-sensitive) activity; IMP:UniProtKB
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0019369; P:arachidonic acid metabolic process; IDA:UniProtKB
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0017144; P:drug metabolic process; IMP:UniProtKB
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0019373; P:epoxygenase P450 pathway; IDA:UniProtKB
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0006690; P:icosanoid metabolic process; TAS:Reactome
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0036101; P:leukotriene B4 catabolic process; IDA:UniProtKB
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0006691; P:leukotriene metabolic process; TAS:Reactome
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0001676; P:long-chain fatty acid metabolic process; IDA:BHF-UCL
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0030195; P:negative regulation of blood coagulation; IMP:UniProtKB
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0032304; P:negative regulation of icosanoid secretion; IMP:UniProtKB
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0097267; P:omega-hydroxylase P450 pathway; TAS:Reactome
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0032305; P:positive regulation of icosanoid secretion; IMP:UniProtKB
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0003095; P:pressure natriuresis; IEP:UniProtKB
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0008217; P:regulation of blood pressure; IMP:UniProtKB
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0003091; P:renal water homeostasis; IEP:UniProtKB
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0055078; P:sodium ion homeostasis; IEP:UniProtKB
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0000038; P:very long-chain fatty acid metabolic process; IDA:BHF-UCL
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0042360; P:vitamin E metabolic process; IDA:UniProtKB
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0042371; P:vitamin K biosynthetic process; IMP:UniProtKB
P78329	CYP4F2	Leukotriene-B(4) omega-hydroxylase 1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q08477	CYP4F3	Leukotriene-B(4) omega-hydroxylase 2	GO:0052871; F:alpha-tocopherol omega-hydroxylase activity; IEA:UniProtKB-EC
Q08477	CYP4F3	Leukotriene-B(4) omega-hydroxylase 2	GO:0020037; F:heme binding; IEA:InterPro
Q08477	CYP4F3	Leukotriene-B(4) omega-hydroxylase 2	GO:0005506; F:iron ion binding; IEA:InterPro
Q08477	CYP4F3	Leukotriene-B(4) omega-hydroxylase 2	GO:0050051; F:leukotriene-B4 20-monooxygenase activity; IEA:UniProtKB-EC
Q08477	CYP4F3	Leukotriene-B(4) omega-hydroxylase 2	GO:0004497; F:monooxygenase activity; TAS:ProtInc
Q08477	CYP4F3	Leukotriene-B(4) omega-hydroxylase 2	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
Q08477	CYP4F3	Leukotriene-B(4) omega-hydroxylase 2	GO:0006690; P:icosanoid metabolic process; TAS:Reactome
Q08477	CYP4F3	Leukotriene-B(4) omega-hydroxylase 2	GO:0006691; P:leukotriene metabolic process; TAS:Reactome
Q08477	CYP4F3	Leukotriene-B(4) omega-hydroxylase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q08477	CYP4F3	Leukotriene-B(4) omega-hydroxylase 2	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9HBI6	CYP4F11	Cytochrome P450 4F11	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
Q9HBI6	CYP4F11	Cytochrome P450 4F11	GO:0020037; F:heme binding; TAS:UniProtKB
Q9HBI6	CYP4F11	Cytochrome P450 4F11	GO:0005506; F:iron ion binding; IEA:InterPro
Q9HBI6	CYP4F11	Cytochrome P450 4F11	GO:0006954; P:inflammatory response; TAS:UniProtKB
Q9HBI6	CYP4F11	Cytochrome P450 4F11	GO:0055114; P:oxidation-reduction process; TAS:UniProtKB
Q9HBI6	CYP4F11	Cytochrome P450 4F11	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9HBI6	CYP4F11	Cytochrome P450 4F11	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P98187	CYP4F8	Cytochrome P450 4F8	GO:0018685; F:alkane 1-monooxygenase activity; TAS:ProtInc
P98187	CYP4F8	Cytochrome P450 4F8	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
P98187	CYP4F8	Cytochrome P450 4F8	GO:0020037; F:heme binding; IEA:InterPro
P98187	CYP4F8	Cytochrome P450 4F8	GO:0005506; F:iron ion binding; IEA:InterPro
P98187	CYP4F8	Cytochrome P450 4F8	GO:0006690; P:icosanoid metabolic process; TAS:Reactome
P98187	CYP4F8	Cytochrome P450 4F8	GO:0006693; P:prostaglandin metabolic process; TAS:ProtInc
P98187	CYP4F8	Cytochrome P450 4F8	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P98187	CYP4F8	Cytochrome P450 4F8	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0018685; F:alkane 1-monooxygenase activity; ISS:UniProtKB
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0008392; F:arachidonic acid epoxygenase activity; ISS:UniProtKB
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0020037; F:heme binding; IEA:InterPro
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0005506; F:iron ion binding; IEA:InterPro
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0050051; F:leukotriene-B4 20-monooxygenase activity; ISS:UniProtKB
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0047057; F:vitamin-K-epoxide reductase (warfarin-sensitive) activity; ISS:UniProtKB
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0019369; P:arachidonic acid metabolic process; ISS:UniProtKB
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0017144; P:drug metabolic process; ISS:UniProtKB
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0019373; P:epoxygenase P450 pathway; ISS:UniProtKB
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0036101; P:leukotriene B4 catabolic process; ISS:UniProtKB
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0001676; P:long-chain fatty acid metabolic process; ISS:UniProtKB
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0030195; P:negative regulation of blood coagulation; ISS:UniProtKB
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0055114; P:oxidation-reduction process; ISS:UniProtKB
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0003095; P:pressure natriuresis; ISS:UniProtKB
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0003091; P:renal water homeostasis; ISS:UniProtKB
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0055078; P:sodium ion homeostasis; ISS:UniProtKB
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0000038; P:very long-chain fatty acid metabolic process; ISS:UniProtKB
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0042360; P:vitamin E metabolic process; ISS:UniProtKB
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0042371; P:vitamin K biosynthetic process; ISS:UniProtKB
Q9HCS2	CYP4F12	Cytochrome P450 4F12	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q6NT55	CYP4F22	Cytochrome P450 4F22	GO:0020037; F:heme binding; IEA:InterPro
Q6NT55	CYP4F22	Cytochrome P450 4F22	GO:0005506; F:iron ion binding; IEA:InterPro
Q6NT55	CYP4F22	Cytochrome P450 4F22	GO:0004497; F:monooxygenase activity; IEA:UniProtKB-KW
Q6NT55	CYP4F22	Cytochrome P450 4F22	GO:0016705; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; IEA:InterPro
Q6ZWL3	CYP4V2	Cytochrome P450 4V2	GO:0020037; F:heme binding; IEA:InterPro
Q6ZWL3	CYP4V2	Cytochrome P450 4V2	GO:0005506; F:iron ion binding; IEA:InterPro
Q6ZWL3	CYP4V2	Cytochrome P450 4V2	GO:0004497; F:monooxygenase activity; IEA:UniProtKB-KW
Q6ZWL3	CYP4V2	Cytochrome P450 4V2	GO:0016705; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; IEA:InterPro
Q6ZWL3	CYP4V2	Cytochrome P450 4V2	GO:0010430; P:fatty acid omega-oxidation; IDA:UniProtKB
Q6ZWL3	CYP4V2	Cytochrome P450 4V2	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q6ZWL3	CYP4V2	Cytochrome P450 4V2	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q8N118	CYP4X1	Cytochrome P450 4X1	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
Q8N118	CYP4X1	Cytochrome P450 4X1	GO:0020037; F:heme binding; IEA:InterPro
Q8N118	CYP4X1	Cytochrome P450 4X1	GO:0005506; F:iron ion binding; IEA:InterPro
Q86W10	CYP4Z1	Cytochrome P450 4Z1	GO:0070330; F:aromatase activity; IEA:UniProtKB-EC
Q86W10	CYP4Z1	Cytochrome P450 4Z1	GO:0020037; F:heme binding; IEA:InterPro
Q86W10	CYP4Z1	Cytochrome P450 4Z1	GO:0005506; F:iron ion binding; IEA:InterPro
Q8N1L4	CYP4Z2P	Putative inactive cytochrome P450 family member 4Z2	GO:0020037; F:heme binding; IEA:InterPro
Q8N1L4	CYP4Z2P	Putative inactive cytochrome P450 family member 4Z2	GO:0005506; F:iron ion binding; IEA:InterPro
Q8N1L4	CYP4Z2P	Putative inactive cytochrome P450 family member 4Z2	GO:0016705; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; IEA:InterPro
Q16850	CYP51A1	Lanosterol 14-alpha demethylase	GO:0020037; F:heme binding; IDA:UniProtKB
Q16850	CYP51A1	Lanosterol 14-alpha demethylase	GO:0005506; F:iron ion binding; IEA:InterPro
Q16850	CYP51A1	Lanosterol 14-alpha demethylase	GO:0008398; F:sterol 14-demethylase activity; IDA:UniProtKB
Q16850	CYP51A1	Lanosterol 14-alpha demethylase	GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome
Q16850	CYP51A1	Lanosterol 14-alpha demethylase	GO:0033488; P:cholesterol biosynthetic process via 24,25-dihydrolanosterol; IEA:Ensembl
Q16850	CYP51A1	Lanosterol 14-alpha demethylase	GO:0070988; P:demethylation; IDA:GOC
Q16850	CYP51A1	Lanosterol 14-alpha demethylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16850	CYP51A1	Lanosterol 14-alpha demethylase	GO:0006694; P:steroid biosynthetic process; IDA:UniProtKB
Q16850	CYP51A1	Lanosterol 14-alpha demethylase	GO:0016125; P:sterol metabolic process; TAS:Reactome
Q16850	CYP51A1	Lanosterol 14-alpha demethylase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P22680	CYP7A1	Cholesterol 7-alpha-monooxygenase	GO:0008123; F:cholesterol 7-alpha-monooxygenase activity; ISS:UniProtKB
P22680	CYP7A1	Cholesterol 7-alpha-monooxygenase	GO:0020037; F:heme binding; IEA:InterPro
P22680	CYP7A1	Cholesterol 7-alpha-monooxygenase	GO:0005506; F:iron ion binding; IEA:InterPro
P22680	CYP7A1	Cholesterol 7-alpha-monooxygenase	GO:0006699; P:bile acid biosynthetic process; IDA:UniProtKB
P22680	CYP7A1	Cholesterol 7-alpha-monooxygenase	GO:0008206; P:bile acid metabolic process; TAS:Reactome
P22680	CYP7A1	Cholesterol 7-alpha-monooxygenase	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P22680	CYP7A1	Cholesterol 7-alpha-monooxygenase	GO:0071397; P:cellular response to cholesterol; ISS:UniProtKB
P22680	CYP7A1	Cholesterol 7-alpha-monooxygenase	GO:0071333; P:cellular response to glucose stimulus; IDA:UniProtKB
P22680	CYP7A1	Cholesterol 7-alpha-monooxygenase	GO:0006707; P:cholesterol catabolic process; ISS:UniProtKB
P22680	CYP7A1	Cholesterol 7-alpha-monooxygenase	GO:0042632; P:cholesterol homeostasis; ISS:UniProtKB
P22680	CYP7A1	Cholesterol 7-alpha-monooxygenase	GO:0070857; P:regulation of bile acid biosynthetic process; IDA:UniProtKB
P22680	CYP7A1	Cholesterol 7-alpha-monooxygenase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P22680	CYP7A1	Cholesterol 7-alpha-monooxygenase	GO:0016125; P:sterol metabolic process; TAS:Reactome
P22680	CYP7A1	Cholesterol 7-alpha-monooxygenase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
O75881	CYP7B1	25-hydroxycholesterol 7-alpha-hydroxylase	GO:0033783; F:25-hydroxycholesterol 7alpha-hydroxylase activity; IEA:UniProtKB-EC
O75881	CYP7B1	25-hydroxycholesterol 7-alpha-hydroxylase	GO:0020037; F:heme binding; IEA:InterPro
O75881	CYP7B1	25-hydroxycholesterol 7-alpha-hydroxylase	GO:0005506; F:iron ion binding; IEA:InterPro
O75881	CYP7B1	25-hydroxycholesterol 7-alpha-hydroxylase	GO:0008396; F:oxysterol 7-alpha-hydroxylase activity; TAS:ProtInc
O75881	CYP7B1	25-hydroxycholesterol 7-alpha-hydroxylase	GO:0006699; P:bile acid biosynthetic process; TAS:Reactome
O75881	CYP7B1	25-hydroxycholesterol 7-alpha-hydroxylase	GO:0008206; P:bile acid metabolic process; TAS:Reactome
O75881	CYP7B1	25-hydroxycholesterol 7-alpha-hydroxylase	GO:0008219; P:cell death; IEA:UniProtKB-KW
O75881	CYP7B1	25-hydroxycholesterol 7-alpha-hydroxylase	GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW
O75881	CYP7B1	25-hydroxycholesterol 7-alpha-hydroxylase	GO:0033147; P:negative regulation of intracellular estrogen receptor signaling pathway; IEA:Ensembl
O75881	CYP7B1	25-hydroxycholesterol 7-alpha-hydroxylase	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
O75881	CYP7B1	25-hydroxycholesterol 7-alpha-hydroxylase	GO:0060740; P:prostate gland epithelium morphogenesis; IEA:Ensembl
O75881	CYP7B1	25-hydroxycholesterol 7-alpha-hydroxylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75881	CYP7B1	25-hydroxycholesterol 7-alpha-hydroxylase	GO:0016125; P:sterol metabolic process; TAS:Reactome
O75881	CYP7B1	25-hydroxycholesterol 7-alpha-hydroxylase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9UNU6	CYP8B1	7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase	GO:0033778; F:7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity; IEA:UniProtKB-EC
Q9UNU6	CYP8B1	7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase	GO:0020037; F:heme binding; IBA:RefGenome
Q9UNU6	CYP8B1	7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase	GO:0005506; F:iron ion binding; IEA:InterPro
Q9UNU6	CYP8B1	7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase	GO:0019825; F:oxygen binding; TAS:ProtInc
Q9UNU6	CYP8B1	7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase	GO:0008397; F:sterol 12-alpha-hydroxylase activity; IBA:RefGenome
Q9UNU6	CYP8B1	7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase	GO:0006699; P:bile acid biosynthetic process; TAS:Reactome
Q9UNU6	CYP8B1	7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase	GO:0008206; P:bile acid metabolic process; TAS:Reactome
Q9UNU6	CYP8B1	7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase	GO:0006629; P:lipid metabolic process; IBA:RefGenome
Q9UNU6	CYP8B1	7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UNU6	CYP8B1	7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase	GO:0016125; P:sterol metabolic process; TAS:Reactome
Q9UNU6	CYP8B1	7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9BZB8	CPEB1	Cytoplasmic polyadenylation element-binding protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BZB8	CPEB1	Cytoplasmic polyadenylation element-binding protein 1	GO:0035925; F:mRNA 3'-UTR AU-rich region binding; ISS:UniProtKB
Q9BZB8	CPEB1	Cytoplasmic polyadenylation element-binding protein 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9BZB8	CPEB1	Cytoplasmic polyadenylation element-binding protein 1	GO:0000900; F:translation repressor activity, nucleic acid binding; ISS:UniProtKB
Q9BZB8	CPEB1	Cytoplasmic polyadenylation element-binding protein 1	GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB
Q9BZB8	CPEB1	Cytoplasmic polyadenylation element-binding protein 1	GO:0071456; P:cellular response to hypoxia; IDA:UniProtKB
Q9BZB8	CPEB1	Cytoplasmic polyadenylation element-binding protein 1	GO:0032869; P:cellular response to insulin stimulus; IDA:UniProtKB
Q9BZB8	CPEB1	Cytoplasmic polyadenylation element-binding protein 1	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9BZB8	CPEB1	Cytoplasmic polyadenylation element-binding protein 1	GO:2000766; P:negative regulation of cytoplasmic translation; IMP:UniProtKB
Q7Z5Q1	CPEB2	Cytoplasmic polyadenylation element-binding protein 2	GO:0005095; F:GTPase inhibitor activity; ISS:UniProtKB
Q7Z5Q1	CPEB2	Cytoplasmic polyadenylation element-binding protein 2	GO:0035925; F:mRNA 3'-UTR AU-rich region binding; ISS:UniProtKB
Q7Z5Q1	CPEB2	Cytoplasmic polyadenylation element-binding protein 2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q7Z5Q1	CPEB2	Cytoplasmic polyadenylation element-binding protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7Z5Q1	CPEB2	Cytoplasmic polyadenylation element-binding protein 2	GO:0043023; F:ribosomal large subunit binding; ISS:UniProtKB
Q7Z5Q1	CPEB2	Cytoplasmic polyadenylation element-binding protein 2	GO:0043024; F:ribosomal small subunit binding; ISS:UniProtKB
Q7Z5Q1	CPEB2	Cytoplasmic polyadenylation element-binding protein 2	GO:0043022; F:ribosome binding; ISS:UniProtKB
Q7Z5Q1	CPEB2	Cytoplasmic polyadenylation element-binding protein 2	GO:0000900; F:translation repressor activity, nucleic acid binding; ISS:UniProtKB
Q7Z5Q1	CPEB2	Cytoplasmic polyadenylation element-binding protein 2	GO:0071243; P:cellular response to arsenic-containing substance; ISS:UniProtKB
Q7Z5Q1	CPEB2	Cytoplasmic polyadenylation element-binding protein 2	GO:0071456; P:cellular response to hypoxia; IDA:UniProtKB
Q7Z5Q1	CPEB2	Cytoplasmic polyadenylation element-binding protein 2	GO:0032869; P:cellular response to insulin stimulus; IDA:UniProtKB
Q7Z5Q1	CPEB2	Cytoplasmic polyadenylation element-binding protein 2	GO:0034599; P:cellular response to oxidative stress; ISS:UniProtKB
Q7Z5Q1	CPEB2	Cytoplasmic polyadenylation element-binding protein 2	GO:2000766; P:negative regulation of cytoplasmic translation; IMP:UniProtKB
Q7Z5Q1	CPEB2	Cytoplasmic polyadenylation element-binding protein 2	GO:1900248; P:negative regulation of cytoplasmic translational elongation; ISS:UniProtKB
Q7Z5Q1	CPEB2	Cytoplasmic polyadenylation element-binding protein 2	GO:0034260; P:negative regulation of GTPase activity; ISS:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:0035925; F:mRNA 3'-UTR AU-rich region binding; ISS:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:0003723; F:RNA binding; IDA:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:0035613; F:RNA stem-loop binding; ISS:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:0008135; F:translation factor activity, nucleic acid binding; IDA:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:0000900; F:translation repressor activity, nucleic acid binding; ISS:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:0061158; P:3'-UTR-mediated mRNA destabilization; IDA:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:0071230; P:cellular response to amino acid stimulus; IDA:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:0007616; P:long-term memory; ISS:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:1900248; P:negative regulation of cytoplasmic translational elongation; ISS:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:0017148; P:negative regulation of translation; IDA:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:0060999; P:positive regulation of dendritic spine development; ISS:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:1900365; P:positive regulation of mRNA polyadenylation; ISS:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:1900153; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; IDA:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; IDA:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:0045727; P:positive regulation of translation; ISS:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:0060998; P:regulation of dendritic spine development; ISS:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:0048167; P:regulation of synaptic plasticity; ISS:UniProtKB
Q8NE35	CPEB3	Cytoplasmic polyadenylation element-binding protein 3	GO:0006412; P:translation; IDA:GOC
Q17RY0	CPEB4	Cytoplasmic polyadenylation element-binding protein 4	GO:0000166; F:nucleotide binding; IEA:InterPro
Q17RY0	CPEB4	Cytoplasmic polyadenylation element-binding protein 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q17RY0	CPEB4	Cytoplasmic polyadenylation element-binding protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q17RY0	CPEB4	Cytoplasmic polyadenylation element-binding protein 4	GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB
Q17RY0	CPEB4	Cytoplasmic polyadenylation element-binding protein 4	GO:0036294; P:cellular response to decreased oxygen levels; ISS:UniProtKB
Q17RY0	CPEB4	Cytoplasmic polyadenylation element-binding protein 4	GO:0042149; P:cellular response to glucose starvation; ISS:UniProtKB
Q17RY0	CPEB4	Cytoplasmic polyadenylation element-binding protein 4	GO:0035235; P:ionotropic glutamate receptor signaling pathway; ISS:UniProtKB
Q17RY0	CPEB4	Cytoplasmic polyadenylation element-binding protein 4	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB
Q17RY0	CPEB4	Cytoplasmic polyadenylation element-binding protein 4	GO:0002931; P:response to ischemia; ISS:UniProtKB
Q6FI81	CIAPIN1	Anamorsin	GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:UniProtKB-HAMAP
Q6FI81	CIAPIN1	Anamorsin	GO:0009055; F:electron carrier activity; IEA:UniProtKB-HAMAP
Q6FI81	CIAPIN1	Anamorsin	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6FI81	CIAPIN1	Anamorsin	GO:0005515; F:protein binding; IPI:IntAct
Q6FI81	CIAPIN1	Anamorsin	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q6FI81	CIAPIN1	Anamorsin	GO:0030097; P:hemopoiesis; IEA:UniProtKB-HAMAP
Q6FI81	CIAPIN1	Anamorsin	GO:0016226; P:iron-sulfur cluster assembly; IEA:UniProtKB-HAMAP
Q6FI81	CIAPIN1	Anamorsin	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB
Q6FI81	CIAPIN1	Anamorsin	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O14810	CPLX1	Complexin-1	GO:0005326; F:neurotransmitter transporter activity; IEA:Ensembl
O14810	CPLX1	Complexin-1	GO:0006887; P:exocytosis; TAS:ProtInc
O14810	CPLX1	Complexin-1	GO:0014047; P:glutamate secretion; TAS:Reactome
O14810	CPLX1	Complexin-1	GO:0030073; P:insulin secretion; IEA:Ensembl
O14810	CPLX1	Complexin-1	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
O14810	CPLX1	Complexin-1	GO:0007268; P:synaptic transmission; TAS:Reactome
O14810	CPLX1	Complexin-1	GO:0016079; P:synaptic vesicle exocytosis; IEA:Ensembl
Q6PUV4	CPLX2	Complexin-2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q6PUV4	CPLX2	Complexin-2	GO:0043303; P:mast cell degranulation; IEA:UniProtKB-KW
Q6PUV4	CPLX2	Complexin-2	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q6PUV4	CPLX2	Complexin-2	GO:0031915; P:positive regulation of synaptic plasticity; ISS:UniProtKB
Q6PUV4	CPLX2	Complexin-2	GO:0016079; P:synaptic vesicle exocytosis; IEA:Ensembl
Q6PUV4	CPLX2	Complexin-2	GO:0006904; P:vesicle docking involved in exocytosis; TAS:ProtInc
Q7Z7G2	CPLX4	Complexin-4	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q7Z7G2	CPLX4	Complexin-4	GO:0006836; P:neurotransmitter transport; IEA:UniProtKB-KW
Q7Z7G2	CPLX4	Complexin-4	GO:0046928; P:regulation of neurotransmitter secretion; IEA:Ensembl
Q8WVH0	CPLX3	Complexin-3	GO:0005326; F:neurotransmitter transporter activity; IEA:Ensembl
Q8WVH0	CPLX3	Complexin-3	GO:0030073; P:insulin secretion; IEA:Ensembl
Q8WVH0	CPLX3	Complexin-3	GO:0046928; P:regulation of neurotransmitter secretion; IEA:Ensembl
Q8WVH0	CPLX3	Complexin-3	GO:0016079; P:synaptic vesicle exocytosis; IEA:Ensembl
Q8IZJ3	CPAMD8	C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
P22792	CPN2	Carboxypeptidase N subunit 2	GO:0030234; F:enzyme regulator activity; NAS:UniProtKB
P22792	CPN2	Carboxypeptidase N subunit 2	GO:0050821; P:protein stabilization; NAS:UniProtKB
P22792	CPN2	Carboxypeptidase N subunit 2	GO:0050790; P:regulation of catalytic activity; NAS:GOC
Q99829	CPNE1	Copine-1	GO:0005544; F:calcium-dependent phospholipid binding; TAS:ProtInc
Q99829	CPNE1	Copine-1	GO:0001786; F:phosphatidylserine binding; IDA:MGI
Q99829	CPNE1	Copine-1	GO:0005215; F:transporter activity; TAS:ProtInc
Q99829	CPNE1	Copine-1	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q99829	CPNE1	Copine-1	GO:0016192; P:vesicle-mediated transport; TAS:ProtInc
O75131	CPNE3	Copine-3	GO:0005544; F:calcium-dependent phospholipid binding; TAS:UniProtKB
O75131	CPNE3	Copine-3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75131	CPNE3	Copine-3	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
O75131	CPNE3	Copine-3	GO:0005215; F:transporter activity; TAS:ProtInc
O75131	CPNE3	Copine-3	GO:0006629; P:lipid metabolic process; TAS:ProtInc
O75131	CPNE3	Copine-3	GO:0006468; P:protein phosphorylation; IDA:GOC
O75131	CPNE3	Copine-3	GO:0016192; P:vesicle-mediated transport; TAS:ProtInc
O95741	CPNE6	Copine-6	GO:0005509; F:calcium ion binding; TAS:ProtInc
O95741	CPNE6	Copine-6	GO:0001786; F:phosphatidylserine binding; IEA:Ensembl
O95741	CPNE6	Copine-6	GO:0005215; F:transporter activity; TAS:ProtInc
O95741	CPNE6	Copine-6	GO:0006629; P:lipid metabolic process; TAS:ProtInc
O95741	CPNE6	Copine-6	GO:0007399; P:nervous system development; TAS:ProtInc
O95741	CPNE6	Copine-6	GO:0007268; P:synaptic transmission; TAS:ProtInc
O95741	CPNE6	Copine-6	GO:0016192; P:vesicle-mediated transport; TAS:ProtInc
Q9UBL6	CPNE7	Copine-7	GO:0005215; F:transporter activity; TAS:ProtInc
Q9UBL6	CPNE7	Copine-7	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q9UBL6	CPNE7	Copine-7	GO:0006810; P:transport; TAS:GOC
P04632	CAPNS1	Calpain small subunit 1	GO:0005509; F:calcium ion binding; IEA:InterPro
P04632	CAPNS1	Calpain small subunit 1	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; IBA:RefGenome
P04632	CAPNS1	Calpain small subunit 1	GO:0005515; F:protein binding; IPI:IntAct
P04632	CAPNS1	Calpain small subunit 1	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P04632	CAPNS1	Calpain small subunit 1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P04632	CAPNS1	Calpain small subunit 1	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P04632	CAPNS1	Calpain small subunit 1	GO:0006508; P:proteolysis; IBA:RefGenome
Q96L46	CAPNS2	Calpain small subunit 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96L46	CAPNS2	Calpain small subunit 2	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; IBA:RefGenome
Q96L46	CAPNS2	Calpain small subunit 2	GO:0006508; P:proteolysis; IBA:RefGenome
Q9BRF8	CPPED1	Calcineurin-like phosphoesterase domain-containing protein 1	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q9BRF8	CPPED1	Calcineurin-like phosphoesterase domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A6NMK7	CPSF4L	Putative cleavage and polyadenylation specificity factor subunit 4-like protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A6NMK7	CPSF4L	Putative cleavage and polyadenylation specificity factor subunit 4-like protein	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q10570	CPSF1	Cleavage and polyadenylation specificity factor subunit 1	GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB
Q10570	CPSF1	Cleavage and polyadenylation specificity factor subunit 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q10570	CPSF1	Cleavage and polyadenylation specificity factor subunit 1	GO:0010467; P:gene expression; TAS:Reactome
Q10570	CPSF1	Cleavage and polyadenylation specificity factor subunit 1	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q10570	CPSF1	Cleavage and polyadenylation specificity factor subunit 1	GO:0006379; P:mRNA cleavage; IDA:UniProtKB
Q10570	CPSF1	Cleavage and polyadenylation specificity factor subunit 1	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
Q10570	CPSF1	Cleavage and polyadenylation specificity factor subunit 1	GO:0006378; P:mRNA polyadenylation; IDA:UniProtKB
Q10570	CPSF1	Cleavage and polyadenylation specificity factor subunit 1	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q10570	CPSF1	Cleavage and polyadenylation specificity factor subunit 1	GO:0008380; P:RNA splicing; TAS:Reactome
Q10570	CPSF1	Cleavage and polyadenylation specificity factor subunit 1	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q10570	CPSF1	Cleavage and polyadenylation specificity factor subunit 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q9P2I0	CPSF2	Cleavage and polyadenylation specificity factor subunit 2	GO:0016787; F:hydrolase activity; IEA:InterPro
Q9P2I0	CPSF2	Cleavage and polyadenylation specificity factor subunit 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P2I0	CPSF2	Cleavage and polyadenylation specificity factor subunit 2	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9P2I0	CPSF2	Cleavage and polyadenylation specificity factor subunit 2	GO:0010467; P:gene expression; TAS:Reactome
Q9P2I0	CPSF2	Cleavage and polyadenylation specificity factor subunit 2	GO:0006398; P:histone mRNA 3'-end processing; IDA:UniProtKB
Q9P2I0	CPSF2	Cleavage and polyadenylation specificity factor subunit 2	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q9P2I0	CPSF2	Cleavage and polyadenylation specificity factor subunit 2	GO:0006379; P:mRNA cleavage; IEA:InterPro
Q9P2I0	CPSF2	Cleavage and polyadenylation specificity factor subunit 2	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
Q9P2I0	CPSF2	Cleavage and polyadenylation specificity factor subunit 2	GO:0006378; P:mRNA polyadenylation; IEA:InterPro
Q9P2I0	CPSF2	Cleavage and polyadenylation specificity factor subunit 2	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q9P2I0	CPSF2	Cleavage and polyadenylation specificity factor subunit 2	GO:0008380; P:RNA splicing; TAS:Reactome
Q9P2I0	CPSF2	Cleavage and polyadenylation specificity factor subunit 2	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q9P2I0	CPSF2	Cleavage and polyadenylation specificity factor subunit 2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q9UKF6	CPSF3	Cleavage and polyadenylation specificity factor subunit 3	GO:0008409; F:5'-3' exonuclease activity; ISS:UniProtKB
Q9UKF6	CPSF3	Cleavage and polyadenylation specificity factor subunit 3	GO:0004521; F:endoribonuclease activity; ISS:UniProtKB
Q9UKF6	CPSF3	Cleavage and polyadenylation specificity factor subunit 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UKF6	CPSF3	Cleavage and polyadenylation specificity factor subunit 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKF6	CPSF3	Cleavage and polyadenylation specificity factor subunit 3	GO:0003723; F:RNA binding; ISS:UniProtKB
Q9UKF6	CPSF3	Cleavage and polyadenylation specificity factor subunit 3	GO:0010467; P:gene expression; TAS:Reactome
Q9UKF6	CPSF3	Cleavage and polyadenylation specificity factor subunit 3	GO:0006398; P:histone mRNA 3'-end processing; IDA:UniProtKB
Q9UKF6	CPSF3	Cleavage and polyadenylation specificity factor subunit 3	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q9UKF6	CPSF3	Cleavage and polyadenylation specificity factor subunit 3	GO:0006379; P:mRNA cleavage; TAS:ProtInc
Q9UKF6	CPSF3	Cleavage and polyadenylation specificity factor subunit 3	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
Q9UKF6	CPSF3	Cleavage and polyadenylation specificity factor subunit 3	GO:0006378; P:mRNA polyadenylation; TAS:ProtInc
Q9UKF6	CPSF3	Cleavage and polyadenylation specificity factor subunit 3	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q9UKF6	CPSF3	Cleavage and polyadenylation specificity factor subunit 3	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; ISS:GOC
Q9UKF6	CPSF3	Cleavage and polyadenylation specificity factor subunit 3	GO:0008380; P:RNA splicing; TAS:Reactome
Q9UKF6	CPSF3	Cleavage and polyadenylation specificity factor subunit 3	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q9UKF6	CPSF3	Cleavage and polyadenylation specificity factor subunit 3	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
O95639	CPSF4	Cleavage and polyadenylation specificity factor subunit 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O95639	CPSF4	Cleavage and polyadenylation specificity factor subunit 4	GO:0008270; F:zinc ion binding; IEA:InterPro
O95639	CPSF4	Cleavage and polyadenylation specificity factor subunit 4	GO:0046778; P:modification by virus of host mRNA processing; TAS:Reactome
O95639	CPSF4	Cleavage and polyadenylation specificity factor subunit 4	GO:0019048; P:modulation by virus of host morphology or physiology; TAS:Reactome
O95639	CPSF4	Cleavage and polyadenylation specificity factor subunit 4	GO:0019054; P:modulation by virus of host process; TAS:Reactome
O95639	CPSF4	Cleavage and polyadenylation specificity factor subunit 4	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
O95639	CPSF4	Cleavage and polyadenylation specificity factor subunit 4	GO:0019058; P:viral life cycle; TAS:Reactome
O43809	NUDT21	Cleavage and polyadenylation specificity factor subunit 5	GO:0017091; F:AU-rich element binding; IDA:UniProtKB
O43809	NUDT21	Cleavage and polyadenylation specificity factor subunit 5	GO:0042826; F:histone deacetylase binding; IPI:UniProtKB
O43809	NUDT21	Cleavage and polyadenylation specificity factor subunit 5	GO:0016787; F:hydrolase activity; IEA:InterPro
O43809	NUDT21	Cleavage and polyadenylation specificity factor subunit 5	GO:0003729; F:mRNA binding; IDA:UniProtKB
O43809	NUDT21	Cleavage and polyadenylation specificity factor subunit 5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O43809	NUDT21	Cleavage and polyadenylation specificity factor subunit 5	GO:0005515; F:protein binding; IPI:UniProtKB
O43809	NUDT21	Cleavage and polyadenylation specificity factor subunit 5	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
O43809	NUDT21	Cleavage and polyadenylation specificity factor subunit 5	GO:0010467; P:gene expression; TAS:Reactome
O43809	NUDT21	Cleavage and polyadenylation specificity factor subunit 5	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
O43809	NUDT21	Cleavage and polyadenylation specificity factor subunit 5	GO:0006378; P:mRNA polyadenylation; IMP:UniProtKB
O43809	NUDT21	Cleavage and polyadenylation specificity factor subunit 5	GO:0006397; P:mRNA processing; IDA:UniProtKB
O43809	NUDT21	Cleavage and polyadenylation specificity factor subunit 5	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
O43809	NUDT21	Cleavage and polyadenylation specificity factor subunit 5	GO:0051262; P:protein tetramerization; IDA:UniProtKB
O43809	NUDT21	Cleavage and polyadenylation specificity factor subunit 5	GO:0008380; P:RNA splicing; TAS:Reactome
O43809	NUDT21	Cleavage and polyadenylation specificity factor subunit 5	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
O43809	NUDT21	Cleavage and polyadenylation specificity factor subunit 5	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q16630	CPSF6	Cleavage and polyadenylation specificity factor subunit 6	GO:0003729; F:mRNA binding; IDA:UniProtKB
Q16630	CPSF6	Cleavage and polyadenylation specificity factor subunit 6	GO:0000166; F:nucleotide binding; IEA:InterPro
Q16630	CPSF6	Cleavage and polyadenylation specificity factor subunit 6	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q16630	CPSF6	Cleavage and polyadenylation specificity factor subunit 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q16630	CPSF6	Cleavage and polyadenylation specificity factor subunit 6	GO:0006378; P:mRNA polyadenylation; IMP:UniProtKB
Q16630	CPSF6	Cleavage and polyadenylation specificity factor subunit 6	GO:0006397; P:mRNA processing; IDA:UniProtKB
Q16630	CPSF6	Cleavage and polyadenylation specificity factor subunit 6	GO:0051262; P:protein tetramerization; IDA:UniProtKB
Q8N684	CPSF7	Cleavage and polyadenylation specificity factor subunit 7	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8N684	CPSF7	Cleavage and polyadenylation specificity factor subunit 7	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8N684	CPSF7	Cleavage and polyadenylation specificity factor subunit 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N684	CPSF7	Cleavage and polyadenylation specificity factor subunit 7	GO:0010467; P:gene expression; TAS:Reactome
Q8N684	CPSF7	Cleavage and polyadenylation specificity factor subunit 7	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q8N684	CPSF7	Cleavage and polyadenylation specificity factor subunit 7	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q8N684	CPSF7	Cleavage and polyadenylation specificity factor subunit 7	GO:0051262; P:protein tetramerization; IDA:UniProtKB
Q8N684	CPSF7	Cleavage and polyadenylation specificity factor subunit 7	GO:0008380; P:RNA splicing; TAS:Reactome
Q8N684	CPSF7	Cleavage and polyadenylation specificity factor subunit 7	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q8N684	CPSF7	Cleavage and polyadenylation specificity factor subunit 7	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0005509; F:calcium ion binding; IEA:Ensembl
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0004087; F:carbamoyl-phosphate synthase (ammonia) activity; IMP:BHF-UCL
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0004175; F:endopeptidase activity; IEA:Ensembl
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0016595; F:glutamate binding; IEA:Ensembl
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0072341; F:modified amino acid binding; IDA:UniProtKB
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0005543; F:phospholipid binding; IEA:Ensembl
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0055081; P:anion homeostasis; IEA:Ensembl
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0070409; P:carbamoyl phosphate biosynthetic process; IMP:UniProtKB
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0071320; P:cellular response to cAMP; IEA:Ensembl
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEA:Ensembl
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0071377; P:cellular response to glucagon stimulus; IEA:Ensembl
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0071400; P:cellular response to oleic acid; IEA:Ensembl
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0019240; P:citrulline biosynthetic process; NAS:BHF-UCL
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0006543; P:glutamine catabolic process; IEA:InterPro
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0005980; P:glycogen catabolic process; IMP:BHF-UCL
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0070365; P:hepatocyte differentiation; IEA:Ensembl
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0050667; P:homocysteine metabolic process; IDA:UniProtKB
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0007494; P:midgut development; IEA:Ensembl
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0046209; P:nitric oxide metabolic process; IMP:BHF-UCL
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0045909; P:positive regulation of vasodilation; IMP:BHF-UCL
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0014075; P:response to amine; IEA:Ensembl
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0043200; P:response to amino acid; IEA:Ensembl
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0071548; P:response to dexamethasone; IEA:Ensembl
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0042493; P:response to drug; IEA:Ensembl
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0032094; P:response to food; IEA:Ensembl
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0060416; P:response to growth hormone; IEA:Ensembl
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0032496; P:response to lipopolysaccharide; IDA:UniProtKB
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0042594; P:response to starvation; IEA:Ensembl
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0009636; P:response to toxic substance; IEA:Ensembl
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0010043; P:response to zinc ion; IEA:Ensembl
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0019433; P:triglyceride catabolic process; IMP:BHF-UCL
P31327	CPS1	Carbamoyl-phosphate synthase [ammonia], mitochondrial	GO:0000050; P:urea cycle; NAS:BHF-UCL
P50416	CPT1A	Carnitine O-palmitoyltransferase 1, liver isoform	GO:0004095; F:carnitine O-palmitoyltransferase activity; IDA:UniProtKB
P50416	CPT1A	Carnitine O-palmitoyltransferase 1, liver isoform	GO:0009437; P:carnitine metabolic process; IDA:UniProtKB
P50416	CPT1A	Carnitine O-palmitoyltransferase 1, liver isoform	GO:0006853; P:carnitine shuttle; TAS:Reactome
P50416	CPT1A	Carnitine O-palmitoyltransferase 1, liver isoform	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P50416	CPT1A	Carnitine O-palmitoyltransferase 1, liver isoform	GO:0071398; P:cellular response to fatty acid; IEA:Ensembl
P50416	CPT1A	Carnitine O-palmitoyltransferase 1, liver isoform	GO:0042755; P:eating behavior; IEA:Ensembl
P50416	CPT1A	Carnitine O-palmitoyltransferase 1, liver isoform	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
P50416	CPT1A	Carnitine O-palmitoyltransferase 1, liver isoform	GO:0006635; P:fatty acid beta-oxidation; TAS:ProtInc
P50416	CPT1A	Carnitine O-palmitoyltransferase 1, liver isoform	GO:0006006; P:glucose metabolic process; IEA:Ensembl
P50416	CPT1A	Carnitine O-palmitoyltransferase 1, liver isoform	GO:0001676; P:long-chain fatty acid metabolic process; IDA:UniProtKB
P50416	CPT1A	Carnitine O-palmitoyltransferase 1, liver isoform	GO:0032000; P:positive regulation of fatty acid beta-oxidation; IEA:Ensembl
P50416	CPT1A	Carnitine O-palmitoyltransferase 1, liver isoform	GO:0051260; P:protein homooligomerization; IEA:Ensembl
P50416	CPT1A	Carnitine O-palmitoyltransferase 1, liver isoform	GO:0050796; P:regulation of insulin secretion; IEA:Ensembl
P50416	CPT1A	Carnitine O-palmitoyltransferase 1, liver isoform	GO:0042493; P:response to drug; IEA:Ensembl
P50416	CPT1A	Carnitine O-palmitoyltransferase 1, liver isoform	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P50416	CPT1A	Carnitine O-palmitoyltransferase 1, liver isoform	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P50416	CPT1A	Carnitine O-palmitoyltransferase 1, liver isoform	GO:0006641; P:triglyceride metabolic process; IEA:Ensembl
Q92523	CPT1B	Carnitine O-palmitoyltransferase 1, muscle isoform	GO:0004095; F:carnitine O-palmitoyltransferase activity; TAS:ProtInc
Q92523	CPT1B	Carnitine O-palmitoyltransferase 1, muscle isoform	GO:0006853; P:carnitine shuttle; TAS:Reactome
Q92523	CPT1B	Carnitine O-palmitoyltransferase 1, muscle isoform	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q92523	CPT1B	Carnitine O-palmitoyltransferase 1, muscle isoform	GO:0006635; P:fatty acid beta-oxidation; TAS:ProtInc
Q92523	CPT1B	Carnitine O-palmitoyltransferase 1, muscle isoform	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8TCG5	CPT1C	Carnitine O-palmitoyltransferase 1, brain isoform	GO:0004095; F:carnitine O-palmitoyltransferase activity; IEA:UniProtKB-EC
Q8TCG5	CPT1C	Carnitine O-palmitoyltransferase 1, brain isoform	GO:0009437; P:carnitine metabolic process; IEA:Ensembl
Q8TCG5	CPT1C	Carnitine O-palmitoyltransferase 1, brain isoform	GO:0006635; P:fatty acid beta-oxidation; IEA:UniProtKB-UniPathway
P23786	CPT2	Carnitine O-palmitoyltransferase 2, mitochondrial	GO:0004095; F:carnitine O-palmitoyltransferase activity; NAS:UniProtKB
P23786	CPT2	Carnitine O-palmitoyltransferase 2, mitochondrial	GO:0006853; P:carnitine shuttle; TAS:Reactome
P23786	CPT2	Carnitine O-palmitoyltransferase 2, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P23786	CPT2	Carnitine O-palmitoyltransferase 2, mitochondrial	GO:0006635; P:fatty acid beta-oxidation; IEA:UniProtKB-UniPathway
P23786	CPT2	Carnitine O-palmitoyltransferase 2, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5TA50	GLTPD1	Ceramide-1-phosphate transfer protein	GO:1902387; F:ceramide 1-phosphate binding; IDA:UniProtKB
Q5TA50	GLTPD1	Ceramide-1-phosphate transfer protein	GO:1902388; F:ceramide 1-phosphate transporter activity; IDA:UniProtKB
Q5TA50	GLTPD1	Ceramide-1-phosphate transfer protein	GO:0051861; F:glycolipid binding; IEA:InterPro
Q5TA50	GLTPD1	Ceramide-1-phosphate transfer protein	GO:0005543; F:phospholipid binding; IDA:UniProtKB
Q5TA50	GLTPD1	Ceramide-1-phosphate transfer protein	GO:0005548; F:phospholipid transporter activity; IDA:UniProtKB
Q5TA50	GLTPD1	Ceramide-1-phosphate transfer protein	GO:1902389; P:ceramide 1-phosphate transport; IDA:UniProtKB
Q9H3G5	CPVL	Probable serine carboxypeptidase CPVL	GO:0004185; F:serine-type carboxypeptidase activity; IEA:InterPro
Q8N123	CPXCR1	CPX chromosomal region candidate gene 1 protein	GO:0046872; F:metal ion binding; IEA:InterPro
Q96SM3	CPXM1	Probable carboxypeptidase X1	GO:0004181; F:metallocarboxypeptidase activity; IEA:InterPro
Q96SM3	CPXM1	Probable carboxypeptidase X1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96SM3	CPXM1	Probable carboxypeptidase X1	GO:0007155; P:cell adhesion; IEA:InterPro
Q8N436	CPXM2	Inactive carboxypeptidase-like protein X2	GO:0004181; F:metallocarboxypeptidase activity; IEA:InterPro
Q8N436	CPXM2	Inactive carboxypeptidase-like protein X2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N436	CPXM2	Inactive carboxypeptidase-like protein X2	GO:0007155; P:cell adhesion; IEA:InterPro
Q6JBY9	RCSD1	CapZ-interacting protein	GO:0051015; F:actin filament binding; IPI:BHF-UCL
Q6JBY9	RCSD1	CapZ-interacting protein	GO:0071474; P:cellular hyperosmotic response; IDA:BHF-UCL
Q6JBY9	RCSD1	CapZ-interacting protein	GO:0003009; P:skeletal muscle contraction; ISS:BHF-UCL
Q9BQA9	C17orf62	Uncharacterized protein C17orf62	GO:0005515; F:protein binding; IPI:IntAct
Q53F19	C17orf85	Uncharacterized protein C17orf85	GO:0000166; F:nucleotide binding; IEA:InterPro
Q53F19	C17orf85	Uncharacterized protein C17orf85	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8TCD1	C18orf32	UPF0729 protein C18orf32	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q8TCD1	C18orf32	UPF0729 protein C18orf32	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q8TCD1	C18orf32	UPF0729 protein C18orf32	GO:0007165; P:signal transduction; IMP:GOC
P17927	CR1	Complement receptor type 1	GO:0001851; F:complement component C3b binding; IDA:UniProtKB
P17927	CR1	Complement receptor type 1	GO:0004877; F:complement component C3b receptor activity; IDA:UniProtKB
P17927	CR1	Complement receptor type 1	GO:0001855; F:complement component C4b binding; IDA:UniProtKB
P17927	CR1	Complement receptor type 1	GO:0001861; F:complement component C4b receptor activity; IDA:UniProtKB
P17927	CR1	Complement receptor type 1	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
P17927	CR1	Complement receptor type 1	GO:0002430; P:complement receptor mediated signaling pathway; IDA:GOC
P17927	CR1	Complement receptor type 1	GO:0045087; P:innate immune response; TAS:Reactome
P17927	CR1	Complement receptor type 1	GO:0045957; P:negative regulation of complement activation, alternative pathway; IDA:UniProtKB
P17927	CR1	Complement receptor type 1	GO:0045959; P:negative regulation of complement activation, classical pathway; IDA:UniProtKB
P17927	CR1	Complement receptor type 1	GO:1900004; P:negative regulation of serine-type endopeptidase activity; IDA:UniProtKB
P17927	CR1	Complement receptor type 1	GO:1900005; P:positive regulation of serine-type endopeptidase activity; IDA:UniProtKB
P17927	CR1	Complement receptor type 1	GO:0030449; P:regulation of complement activation; TAS:Reactome
P20023	CR2	Complement receptor type 2	GO:0001848; F:complement binding; IDA:UniProt
P20023	CR2	Complement receptor type 2	GO:0004875; F:complement receptor activity; NAS:UniProtKB
P20023	CR2	Complement receptor type 2	GO:0003677; F:DNA binding; IDA:UniProt
P20023	CR2	Complement receptor type 2	GO:0042803; F:protein homodimerization activity; IDA:MGI
P20023	CR2	Complement receptor type 2	GO:0004888; F:transmembrane signaling receptor activity; NAS:UniProtKB
P20023	CR2	Complement receptor type 2	GO:0030183; P:B cell differentiation; IDA:UniProt
P20023	CR2	Complement receptor type 2	GO:0042100; P:B cell proliferation; IDA:UniProt
P20023	CR2	Complement receptor type 2	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
P20023	CR2	Complement receptor type 2	GO:0006955; P:immune response; NAS:UniProtKB
P20023	CR2	Complement receptor type 2	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q96BA8	CREB3L1	Cyclic AMP-responsive element-binding protein 3-like protein 1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q96BA8	CREB3L1	Cyclic AMP-responsive element-binding protein 3-like protein 1	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q96BA8	CREB3L1	Cyclic AMP-responsive element-binding protein 3-like protein 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q96BA8	CREB3L1	Cyclic AMP-responsive element-binding protein 3-like protein 1	GO:0030500; P:regulation of bone mineralization; IEA:Ensembl
Q96BA8	CREB3L1	Cyclic AMP-responsive element-binding protein 3-like protein 1	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
Q70SY1	CREB3L2	Cyclic AMP-responsive element-binding protein 3-like protein 2	GO:0035497; F:cAMP response element binding; IMP:UniProtKB
Q70SY1	CREB3L2	Cyclic AMP-responsive element-binding protein 3-like protein 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q70SY1	CREB3L2	Cyclic AMP-responsive element-binding protein 3-like protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q70SY1	CREB3L2	Cyclic AMP-responsive element-binding protein 3-like protein 2	GO:0044212; F:transcription regulatory region DNA binding; IMP:UniProtKB
Q70SY1	CREB3L2	Cyclic AMP-responsive element-binding protein 3-like protein 2	GO:0051216; P:cartilage development; ISS:UniProtKB
Q70SY1	CREB3L2	Cyclic AMP-responsive element-binding protein 3-like protein 2	GO:0002062; P:chondrocyte differentiation; ISS:UniProtKB
Q70SY1	CREB3L2	Cyclic AMP-responsive element-binding protein 3-like protein 2	GO:0006888; P:ER to Golgi vesicle-mediated transport; IEA:Ensembl
Q70SY1	CREB3L2	Cyclic AMP-responsive element-binding protein 3-like protein 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q70SY1	CREB3L2	Cyclic AMP-responsive element-binding protein 3-like protein 2	GO:0034976; P:response to endoplasmic reticulum stress; IEP:UniProtKB
Q70SY1	CREB3L2	Cyclic AMP-responsive element-binding protein 3-like protein 2	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
Q70SY1	CREB3L2	Cyclic AMP-responsive element-binding protein 3-like protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q68CJ9	CREB3L3	Cyclic AMP-responsive element-binding protein 3-like protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q68CJ9	CREB3L3	Cyclic AMP-responsive element-binding protein 3-like protein 3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q68CJ9	CREB3L3	Cyclic AMP-responsive element-binding protein 3-like protein 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q68CJ9	CREB3L3	Cyclic AMP-responsive element-binding protein 3-like protein 3	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
Q68CJ9	CREB3L3	Cyclic AMP-responsive element-binding protein 3-like protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TEY5	CREB3L4	Cyclic AMP-responsive element-binding protein 3-like protein 4	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q8TEY5	CREB3L4	Cyclic AMP-responsive element-binding protein 3-like protein 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8TEY5	CREB3L4	Cyclic AMP-responsive element-binding protein 3-like protein 4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8TEY5	CREB3L4	Cyclic AMP-responsive element-binding protein 3-like protein 4	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
Q8TEY5	CREB3L4	Cyclic AMP-responsive element-binding protein 3-like protein 4	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q8TEY5	CREB3L4	Cyclic AMP-responsive element-binding protein 3-like protein 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NQ79	CRTAC1	Cartilage acidic protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
P78560	CRADD	Death domain-containing protein CRADD	GO:0070513; F:death domain binding; IPI:BHF-UCL
P78560	CRADD	Death domain-containing protein CRADD	GO:0002020; F:protease binding; IPI:BHF-UCL
P78560	CRADD	Death domain-containing protein CRADD	GO:0005515; F:protein binding; IPI:IntAct
P78560	CRADD	Death domain-containing protein CRADD	GO:0030674; F:protein binding, bridging; IPI:BHF-UCL
P78560	CRADD	Death domain-containing protein CRADD	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
P78560	CRADD	Death domain-containing protein CRADD	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
P78560	CRADD	Death domain-containing protein CRADD	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; IMP:UniProtKB
P78560	CRADD	Death domain-containing protein CRADD	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IC:BHF-UCL
P78560	CRADD	Death domain-containing protein CRADD	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
P05813	CRYBA1	Beta-crystallin A3	GO:0005515; F:protein binding; IPI:IntAct
P05813	CRYBA1	Beta-crystallin A3	GO:0005212; F:structural constituent of eye lens; IEA:UniProtKB-KW
P05813	CRYBA1	Beta-crystallin A3	GO:0002088; P:lens development in camera-type eye; IEA:Ensembl
P05813	CRYBA1	Beta-crystallin A3	GO:0007601; P:visual perception; IMP:UniProtKB
P53672	CRYBA2	Beta-crystallin A2	GO:0005212; F:structural constituent of eye lens; IEA:UniProtKB-KW
P53672	CRYBA2	Beta-crystallin A2	GO:0002088; P:lens development in camera-type eye; IEA:Ensembl
P53673	CRYBA4	Beta-crystallin A4	GO:0005212; F:structural constituent of eye lens; IEA:UniProtKB-KW
P53673	CRYBA4	Beta-crystallin A4	GO:0043010; P:camera-type eye development; IMP:UniProtKB
P53673	CRYBA4	Beta-crystallin A4	GO:0007601; P:visual perception; IMP:UniProtKB
P53674	CRYBB1	Beta-crystallin B1	GO:0005212; F:structural constituent of eye lens; IEA:UniProtKB-KW
P53674	CRYBB1	Beta-crystallin B1	GO:0007601; P:visual perception; TAS:ProtInc
P43320	CRYBB2	Beta-crystallin B2	GO:0042802; F:identical protein binding; IPI:IntAct
P43320	CRYBB2	Beta-crystallin B2	GO:0005212; F:structural constituent of eye lens; IEA:UniProtKB-KW
P43320	CRYBB2	Beta-crystallin B2	GO:0005198; F:structural molecule activity; NAS:ProtInc
P43320	CRYBB2	Beta-crystallin B2	GO:0043010; P:camera-type eye development; IEA:Ensembl
P43320	CRYBB2	Beta-crystallin B2	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
P43320	CRYBB2	Beta-crystallin B2	GO:0007601; P:visual perception; TAS:ProtInc
P26998	CRYBB3	Beta-crystallin B3	GO:0005212; F:structural constituent of eye lens; IEA:UniProtKB-KW
P26998	CRYBB3	Beta-crystallin B3	GO:0007601; P:visual perception; TAS:ProtInc
O60519	CREBL2	cAMP-responsive element-binding protein-like 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O60519	CREBL2	cAMP-responsive element-binding protein-like 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O60519	CREBL2	cAMP-responsive element-binding protein-like 2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
O60519	CREBL2	cAMP-responsive element-binding protein-like 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O60519	CREBL2	cAMP-responsive element-binding protein-like 2	GO:0045600; P:positive regulation of fat cell differentiation; ISS:UniProtKB
O60519	CREBL2	cAMP-responsive element-binding protein-like 2	GO:0046326; P:positive regulation of glucose import; ISS:UniProtKB
O60519	CREBL2	cAMP-responsive element-binding protein-like 2	GO:0046889; P:positive regulation of lipid biosynthetic process; ISS:UniProtKB
O60519	CREBL2	cAMP-responsive element-binding protein-like 2	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISS:UniProtKB
O60519	CREBL2	cAMP-responsive element-binding protein-like 2	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
O60519	CREBL2	cAMP-responsive element-binding protein-like 2	GO:0050821; P:protein stabilization; ISS:UniProtKB
O60519	CREBL2	cAMP-responsive element-binding protein-like 2	GO:0007165; P:signal transduction; TAS:ProtInc
O60519	CREBL2	cAMP-responsive element-binding protein-like 2	GO:0006351; P:transcription, DNA-templated; TAS:ProtInc
Q96SW2	CRBN	Protein cereblon	GO:0004176; F:ATP-dependent peptidase activity; IEA:InterPro
Q96SW2	CRBN	Protein cereblon	GO:0005515; F:protein binding; IPI:UniProtKB
Q96SW2	CRBN	Protein cereblon	GO:0034766; P:negative regulation of ion transmembrane transport; IEA:Ensembl
Q96SW2	CRBN	Protein cereblon	GO:0032463; P:negative regulation of protein homooligomerization; IEA:Ensembl
Q96SW2	CRBN	Protein cereblon	GO:0090073; P:positive regulation of protein homodimerization activity; IEA:Ensembl
Q96SW2	CRBN	Protein cereblon	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q96SW2	CRBN	Protein cereblon	GO:0016567; P:protein ubiquitination; IMP:UniProtKB
P22914	CRYGS	Beta-crystallin S	GO:0005212; F:structural constituent of eye lens; IEA:UniProtKB-KW
P22914	CRYGS	Beta-crystallin S	GO:0002088; P:lens development in camera-type eye; IEA:Ensembl
P22914	CRYGS	Beta-crystallin S	GO:0002009; P:morphogenesis of an epithelium; IEA:Ensembl
Q96D31	ORAI1	Calcium release-activated calcium channel protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96D31	ORAI1	Calcium release-activated calcium channel protein 1	GO:0015279; F:store-operated calcium channel activity; IDA:UniProtKB
Q96D31	ORAI1	Calcium release-activated calcium channel protein 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q96D31	ORAI1	Calcium release-activated calcium channel protein 1	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q96D31	ORAI1	Calcium release-activated calcium channel protein 1	GO:0051928; P:positive regulation of calcium ion transport; IDA:UniProtKB
Q96D31	ORAI1	Calcium release-activated calcium channel protein 1	GO:0051924; P:regulation of calcium ion transport; IMP:UniProtKB
Q96D31	ORAI1	Calcium release-activated calcium channel protein 1	GO:0002115; P:store-operated calcium entry; IEA:Ensembl
P23508	MCC	Colorectal mutant cancer protein	GO:0005515; F:protein binding; IPI:UniProtKB
P23508	MCC	Colorectal mutant cancer protein	GO:0004872; F:receptor activity; TAS:ProtInc
P23508	MCC	Colorectal mutant cancer protein	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:UniProtKB
P23508	MCC	Colorectal mutant cancer protein	GO:0010633; P:negative regulation of epithelial cell migration; IMP:UniProtKB
P23508	MCC	Colorectal mutant cancer protein	GO:0050680; P:negative regulation of epithelial cell proliferation; IDA:UniProtKB
P23508	MCC	Colorectal mutant cancer protein	GO:0007165; P:signal transduction; TAS:ProtInc
P23508	MCC	Colorectal mutant cancer protein	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9BU40	CHRDL1	Chordin-like protein 1	GO:0030509; P:BMP signaling pathway; TAS:Reactome
Q9BU40	CHRDL1	Chordin-like protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9BU40	CHRDL1	Chordin-like protein 1	GO:0048749; P:compound eye development; IMP:UniProtKB
Q9BU40	CHRDL1	Chordin-like protein 1	GO:0001654; P:eye development; IMP:UniProtKB
Q9BU40	CHRDL1	Chordin-like protein 1	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q9BU40	CHRDL1	Chordin-like protein 1	GO:0001503; P:ossification; IEA:UniProtKB-KW
Q6WN34	CHRDL2	Chordin-like protein 2	GO:0051216; P:cartilage development; IEA:UniProtKB-KW
Q6WN34	CHRDL2	Chordin-like protein 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q6WN34	CHRDL2	Chordin-like protein 2	GO:0001503; P:ossification; IEA:UniProtKB-KW
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0035497; F:cAMP response element binding; IDA:BHF-UCL
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IDA:BHF-UCL
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0001190; F:RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription; IDA:BHF-UCL
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:MGI
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0003712; F:transcription cofactor activity; TAS:ProtInc
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0007411; P:axon guidance; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0045087; P:innate immune response; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0007595; P:lactation; IEA:Ensembl
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0060430; P:lung saccule development; IEA:Ensembl
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0010944; P:negative regulation of transcription by competitive promoter binding; IDA:BHF-UCL
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0021983; P:pituitary gland development; IEA:Ensembl
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0045600; P:positive regulation of fat cell differentiation; ISS:UniProtKB
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0046887; P:positive regulation of hormone secretion; IEA:Ensembl
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0046889; P:positive regulation of lipid biosynthetic process; ISS:UniProtKB
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0045672; P:positive regulation of osteoclast differentiation; IEA:Ensembl
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0006468; P:protein phosphorylation; IDA:MGI
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0050821; P:protein stabilization; ISS:UniProtKB
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0008361; P:regulation of cell size; IEA:Ensembl
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0042493; P:response to drug; IEA:Ensembl
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0010033; P:response to organic substance; IDA:MGI
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0033363; P:secretory granule organization; IEA:Ensembl
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0007165; P:signal transduction; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0007268; P:synaptic transmission; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:GOC
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0060509; P:Type I pneumocyte differentiation; IEA:Ensembl
P16220	CREB1	Cyclic AMP-responsive element-binding protein 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0008140; F:cAMP response element binding protein binding; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0031726; F:CCR1 chemokine receptor binding; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0003682; F:chromatin binding; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0003677; F:DNA binding; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0046983; F:protein dimerization activity; TAS:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0042994; P:cytoplasmic sequestering of transcription factor; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0019043; P:establishment of viral latency; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0050930; P:induction of positive chemotaxis; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0045786; P:negative regulation of cell cycle; NAS:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:2000326; P:negative regulation of ligand-dependent nuclear receptor transcription coactivator activity; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0051928; P:positive regulation of calcium ion transport; IMP:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0090045; P:positive regulation of deacetylase activity; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0002230; P:positive regulation of defense response to virus by host; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0090026; P:positive regulation of monocyte chemotaxis; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0006990; P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0001558; P:regulation of cell growth; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0042127; P:regulation of cell proliferation; IMP:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0019046; P:release from viral latency; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB
O43889	CREB3	Cyclic AMP-responsive element-binding protein 3	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q02930	CREB5	Cyclic AMP-responsive element-binding protein 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q02930	CREB5	Cyclic AMP-responsive element-binding protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q02930	CREB5	Cyclic AMP-responsive element-binding protein 5	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q02930	CREB5	Cyclic AMP-responsive element-binding protein 5	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q02930	CREB5	Cyclic AMP-responsive element-binding protein 5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q02930	CREB5	Cyclic AMP-responsive element-binding protein 5	GO:0060612; P:adipose tissue development; IEA:Ensembl
Q02930	CREB5	Cyclic AMP-responsive element-binding protein 5	GO:0045444; P:fat cell differentiation; IEA:Ensembl
Q02930	CREB5	Cyclic AMP-responsive element-binding protein 5	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q02930	CREB5	Cyclic AMP-responsive element-binding protein 5	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
O75629	CREG1	Protein CREG1	GO:0010181; F:FMN binding; IEA:InterPro
O75629	CREG1	Protein CREG1	GO:0016491; F:oxidoreductase activity; IEA:InterPro
O75629	CREG1	Protein CREG1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
O75629	CREG1	Protein CREG1	GO:0008283; P:cell proliferation; TAS:ProtInc
O75629	CREG1	Protein CREG1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
O75629	CREG1	Protein CREG1	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
O75629	CREG1	Protein CREG1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q8IUH2	CREG2	Protein CREG2	GO:0010181; F:FMN binding; IEA:InterPro
Q8IUH2	CREG2	Protein CREG2	GO:0016491; F:oxidoreductase activity; IEA:InterPro
Q96HD1	CRELD1	Cysteine-rich with EGF-like domain protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96HD1	CRELD1	Cysteine-rich with EGF-like domain protein 1	GO:0003279; P:cardiac septum development; TAS:BHF-UCL
Q96HD1	CRELD1	Cysteine-rich with EGF-like domain protein 1	GO:0003197; P:endocardial cushion development; TAS:BHF-UCL
Q6UXH1	CRELD2	Cysteine-rich with EGF-like domain protein 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q6UXH1	CRELD2	Cysteine-rich with EGF-like domain protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q03060	CREM	cAMP-responsive element modulator	GO:0008140; F:cAMP response element binding protein binding; NAS:UniProtKB
Q03060	CREM	cAMP-responsive element modulator	GO:0003677; F:DNA binding; NAS:UniProtKB
Q03060	CREM	cAMP-responsive element modulator	GO:0005515; F:protein binding; IPI:UniProtKB
Q03060	CREM	cAMP-responsive element modulator	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q03060	CREM	cAMP-responsive element modulator	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q03060	CREM	cAMP-responsive element modulator	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q03060	CREM	cAMP-responsive element modulator	GO:0006687; P:glycosphingolipid metabolic process; IEA:Ensembl
Q03060	CREM	cAMP-responsive element modulator	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q03060	CREM	cAMP-responsive element modulator	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q03060	CREM	cAMP-responsive element modulator	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q03060	CREM	cAMP-responsive element modulator	GO:0007165; P:signal transduction; TAS:ProtInc
Q03060	CREM	cAMP-responsive element modulator	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q03060	CREM	cAMP-responsive element modulator	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IUR6	CREBRF	CREB3 regulatory factor	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IUR6	CREBRF	CREB3 regulatory factor	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q8IUR6	CREBRF	CREB3 regulatory factor	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8IUR6	CREBRF	CREB3 regulatory factor	GO:1900102; P:negative regulation of endoplasmic reticulum unfolded protein response; IDA:UniProtKB
Q8IUR6	CREBRF	CREB3 regulatory factor	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q8IUR6	CREBRF	CREB3 regulatory factor	GO:0032388; P:positive regulation of intracellular transport; IDA:UniProtKB
Q8IUR6	CREBRF	CREB3 regulatory factor	GO:0045732; P:positive regulation of protein catabolic process; IDA:UniProtKB
Q8IUR6	CREBRF	CREB3 regulatory factor	GO:0051222; P:positive regulation of protein transport; IDA:UniProtKB
Q8IUR6	CREBRF	CREB3 regulatory factor	GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB
Q8IUR6	CREBRF	CREB3 regulatory factor	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
Q8IUR6	CREBRF	CREB3 regulatory factor	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IUR6	CREBRF	CREB3 regulatory factor	GO:0006810; P:transport; IEA:UniProtKB-KW
O75177	SS18L1	Calcium-responsive transactivator	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
O75177	SS18L1	Calcium-responsive transactivator	GO:0016358; P:dendrite development; IEA:Ensembl
O75177	SS18L1	Calcium-responsive transactivator	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
O75177	SS18L1	Calcium-responsive transactivator	GO:0050773; P:regulation of dendrite development; IEA:Ensembl
O75177	SS18L1	Calcium-responsive transactivator	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q494W8	CHRFAM7A	CHRNA7-FAM7A fusion protein	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0015056; F:corticotrophin-releasing factor receptor activity; IDA:UniProtKB
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0051424; F:corticotropin-releasing hormone binding; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0043404; F:corticotropin-releasing hormone receptor activity; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0005515; F:protein binding; IPI:IntAct
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0007190; P:activation of adenylate cyclase activity; TAS:ProtInc
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0030325; P:adrenal gland development; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0048148; P:behavioral response to cocaine; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0048149; P:behavioral response to ethanol; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0048266; P:behavioral response to pain; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0071376; P:cellular response to corticotropin-releasing hormone stimulus; IDA:UniProtKB
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0051458; P:corticotropin secretion; ISS:UniProtKB
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0030855; P:epithelial cell differentiation; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0042596; P:fear response; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0007565; P:female pregnancy; NAS:ProtInc
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0051867; P:general adaptation syndrome, behavioral process; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0021854; P:hypothalamus development; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0006955; P:immune response; TAS:ProtInc
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0035641; P:locomotory exploration behavior; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0007613; P:memory; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0032811; P:negative regulation of epinephrine secretion; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:2000252; P:negative regulation of feeding behavior; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:1901215; P:negative regulation of neuron death; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:1901386; P:negative regulation of voltage-gated calcium channel activity; IDA:UniProtKB
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0007218; P:neuropeptide signaling pathway; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0007567; P:parturition; TAS:ProtInc
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0010579; P:positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway; IDA:UniProtKB
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0043306; P:positive regulation of mast cell degranulation; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0010578; P:regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway; IMP:UniProtKB
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:2000852; P:regulation of corticosterone secretion; ISS:UniProtKB
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0001666; P:response to hypoxia; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0035902; P:response to immobilization stress; IEA:Ensembl
P34998	CRHR1	Corticotropin-releasing factor receptor 1	GO:0008542; P:visual learning; IEA:Ensembl
Q13324	CRHR2	Corticotropin-releasing factor receptor 2	GO:0015056; F:corticotrophin-releasing factor receptor activity; TAS:ProtInc
Q13324	CRHR2	Corticotropin-releasing factor receptor 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q13324	CRHR2	Corticotropin-releasing factor receptor 2	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; TAS:ProtInc
Q13324	CRHR2	Corticotropin-releasing factor receptor 2	GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl
Q13324	CRHR2	Corticotropin-releasing factor receptor 2	GO:0043951; P:negative regulation of cAMP-mediated signaling; IEA:Ensembl
Q13324	CRHR2	Corticotropin-releasing factor receptor 2	GO:0043950; P:positive regulation of cAMP-mediated signaling; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0005179; F:hormone activity; TAS:ProtInc
P06850	CRH	Corticoliberin	GO:0005184; F:neuropeptide hormone activity; TAS:ProtInc
P06850	CRH	Corticoliberin	GO:0005515; F:protein binding; IPI:UniProtKB
P06850	CRH	Corticoliberin	GO:0005102; F:receptor binding; TAS:ProtInc
P06850	CRH	Corticoliberin	GO:0030325; P:adrenal gland development; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0008306; P:associative learning; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0071314; P:cellular response to cocaine; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0071549; P:cellular response to dexamethasone stimulus; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0016101; P:diterpenoid metabolic process; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0007631; P:feeding behavior; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0007565; P:female pregnancy; IDA:UniProtKB
P06850	CRH	Corticoliberin	GO:0033494; P:ferulate metabolic process; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0006704; P:glucocorticoid biosynthetic process; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0008628; P:hormone-mediated apoptotic signaling pathway; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0021854; P:hypothalamus development; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0006954; P:inflammatory response; IDA:UniProtKB
P06850	CRH	Corticoliberin	GO:0050801; P:ion homeostasis; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0007611; P:learning or memory; TAS:ProtInc
P06850	CRH	Corticoliberin	GO:0035641; P:locomotory exploration behavior; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0007616; P:long-term memory; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0030324; P:lung development; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0060548; P:negative regulation of cell death; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0042322; P:negative regulation of circadian sleep/wake cycle, REM sleep; NAS:BHF-UCL
P06850	CRH	Corticoliberin	GO:0032811; P:negative regulation of epinephrine secretion; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0070093; P:negative regulation of glucagon secretion; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0033685; P:negative regulation of luteinizing hormone secretion; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0010700; P:negative regulation of norepinephrine secretion; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0007567; P:parturition; TAS:ProtInc
P06850	CRH	Corticoliberin	GO:2000987; P:positive regulation of behavioral fear response; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0090280; P:positive regulation of calcium ion import; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0030819; P:positive regulation of cAMP biosynthetic process; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0010942; P:positive regulation of cell death; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0010841; P:positive regulation of circadian sleep/wake cycle, wakefulness; NAS:BHF-UCL
P06850	CRH	Corticoliberin	GO:2000854; P:positive regulation of corticosterone secretion; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0051461; P:positive regulation of corticotropin secretion; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0051464; P:positive regulation of cortisol secretion; IDA:BHF-UCL
P06850	CRH	Corticoliberin	GO:0060456; P:positive regulation of digestive system process; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:2000310; P:regulation of N-methyl-D-aspartate selective glutamate receptor activity; IDA:UniProtKB
P06850	CRH	Corticoliberin	GO:0014062; P:regulation of serotonin secretion; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0051412; P:response to corticosterone; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0042493; P:response to drug; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0043627; P:response to estrogen; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0045471; P:response to ethanol; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0045472; P:response to ether; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0035902; P:response to immobilization stress; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0048265; P:response to pain; IEA:Ensembl
P06850	CRH	Corticoliberin	GO:0007165; P:signal transduction; TAS:ProtInc
P06850	CRH	Corticoliberin	GO:0007268; P:synaptic transmission; TAS:ProtInc
P06850	CRH	Corticoliberin	GO:0001963; P:synaptic transmission, dopaminergic; IDA:UniProtKB
P11844	CRYGA	Gamma-crystallin A	GO:0005212; F:structural constituent of eye lens; NAS:UniProtKB
P11844	CRYGA	Gamma-crystallin A	GO:0002088; P:lens development in camera-type eye; IEA:Ensembl
P11844	CRYGA	Gamma-crystallin A	GO:0007601; P:visual perception; NAS:UniProtKB
P07316	CRYGB	Gamma-crystallin B	GO:0005212; F:structural constituent of eye lens; NAS:UniProtKB
P07316	CRYGB	Gamma-crystallin B	GO:0070309; P:lens fiber cell morphogenesis; IEA:Ensembl
P07316	CRYGB	Gamma-crystallin B	GO:0007601; P:visual perception; NAS:UniProtKB
P07315	CRYGC	Gamma-crystallin C	GO:0005515; F:protein binding; IPI:UniProtKB
P07315	CRYGC	Gamma-crystallin C	GO:0005212; F:structural constituent of eye lens; NAS:UniProtKB
P07315	CRYGC	Gamma-crystallin C	GO:0043010; P:camera-type eye development; IEA:Ensembl
P07315	CRYGC	Gamma-crystallin C	GO:0007601; P:visual perception; IMP:UniProtKB
P07320	CRYGD	Gamma-crystallin D	GO:0005515; F:protein binding; IPI:UniProtKB
P07320	CRYGD	Gamma-crystallin D	GO:0005212; F:structural constituent of eye lens; NAS:UniProtKB
P07320	CRYGD	Gamma-crystallin D	GO:0034614; P:cellular response to reactive oxygen species; IDA:UniProtKB
P07320	CRYGD	Gamma-crystallin D	GO:0002088; P:lens development in camera-type eye; ISS:UniProtKB
P07320	CRYGD	Gamma-crystallin D	GO:0070306; P:lens fiber cell differentiation; ISS:UniProtKB
P07320	CRYGD	Gamma-crystallin D	GO:0007601; P:visual perception; IMP:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0051424; F:corticotropin-releasing hormone binding; IDA:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0042277; F:peptide binding; ISS:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0005515; F:protein binding; IPI:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0048149; P:behavioral response to ethanol; IMP:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0071320; P:cellular response to cAMP; ISS:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0071314; P:cellular response to cocaine; ISS:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0035690; P:cellular response to drug; ISS:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0071392; P:cellular response to estradiol stimulus; IDA:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0071391; P:cellular response to estrogen stimulus; IDA:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0097211; P:cellular response to gonadotropin-releasing hormone; ISS:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0035865; P:cellular response to potassium ion; IDA:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0033554; P:cellular response to stress; IMP:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0071356; P:cellular response to tumor necrosis factor; IDA:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0007565; P:female pregnancy; IDA:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0042445; P:hormone metabolic process; IEA:Ensembl
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0009755; P:hormone-mediated signaling pathway; IDA:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0006954; P:inflammatory response; IDA:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0007611; P:learning or memory; TAS:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0002125; P:maternal aggressive behavior; IEA:Ensembl
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0051460; P:negative regulation of corticotropin secretion; IDA:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:1900011; P:negative regulation of corticotropin-releasing hormone receptor activity; IDA:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0045055; P:regulated secretory pathway; IDA:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0051459; P:regulation of corticotropin secretion; IDA:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:2000310; P:regulation of N-methyl-D-aspartate selective glutamate receptor activity; ISS:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0007165; P:signal transduction; TAS:UniProtKB
P24387	CRHBP	Corticotropin-releasing factor-binding protein	GO:0001963; P:synaptic transmission, dopaminergic; ISS:UniProtKB
Q9NZV1	CRIM1	Cysteine-rich motor neuron 1 protein	GO:0005010; F:insulin-like growth factor-activated receptor activity; TAS:ProtInc
Q9NZV1	CRIM1	Cysteine-rich motor neuron 1 protein	GO:0030165; F:PDZ domain binding; IDA:MGI
Q9NZV1	CRIM1	Cysteine-rich motor neuron 1 protein	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:InterPro
Q9NZV1	CRIM1	Cysteine-rich motor neuron 1 protein	GO:0048009; P:insulin-like growth factor receptor signaling pathway; TAS:GOC
Q9NZV1	CRIM1	Cysteine-rich motor neuron 1 protein	GO:0007399; P:nervous system development; TAS:ProtInc
Q9NZV1	CRIM1	Cysteine-rich motor neuron 1 protein	GO:0001558; P:regulation of cell growth; IEA:InterPro
P50238	CRIP1	Cysteine-rich protein 1	GO:0003680; F:AT DNA binding; IDA:UniProtKB
P50238	CRIP1	Cysteine-rich protein 1	GO:0008301; F:DNA binding, bending; IDA:UniProtKB
P50238	CRIP1	Cysteine-rich protein 1	GO:0042277; F:peptide binding; IDA:UniProtKB
P50238	CRIP1	Cysteine-rich protein 1	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P50238	CRIP1	Cysteine-rich protein 1	GO:0008283; P:cell proliferation; TAS:UniProtKB
P50238	CRIP1	Cysteine-rich protein 1	GO:0071236; P:cellular response to antibiotic; IDA:UniProtKB
P50238	CRIP1	Cysteine-rich protein 1	GO:0071493; P:cellular response to UV-B; IDA:UniProtKB
P50238	CRIP1	Cysteine-rich protein 1	GO:0007507; P:heart development; TAS:UniProtKB
P50238	CRIP1	Cysteine-rich protein 1	GO:0006955; P:immune response; IEP:UniProtKB
P50238	CRIP1	Cysteine-rich protein 1	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IDA:UniProtKB
P50238	CRIP1	Cysteine-rich protein 1	GO:0060741; P:prostate gland stromal morphogenesis; IEP:UniProtKB
P50238	CRIP1	Cysteine-rich protein 1	GO:0010468; P:regulation of gene expression; IEP:UniProtKB
P50238	CRIP1	Cysteine-rich protein 1	GO:0010033; P:response to organic substance; IEP:UniProtKB
P50238	CRIP1	Cysteine-rich protein 1	GO:0010043; P:response to zinc ion; IDA:UniProtKB
P52943	CRIP2	Cysteine-rich protein 2	GO:0008270; F:zinc ion binding; TAS:ProtInc
P52943	CRIP2	Cysteine-rich protein 2	GO:0030097; P:hemopoiesis; IEA:Ensembl
P52943	CRIP2	Cysteine-rich protein 2	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q6Q6R5	CRIP3	Cysteine-rich protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6Q6R5	CRIP3	Cysteine-rich protein 3	GO:0042098; P:T cell proliferation; IEA:Ensembl
Q9P021	CRIPT	Cysteine-rich PDZ-binding protein	GO:0008017; F:microtubule binding; ISS:UniProt
Q9P021	CRIPT	Cysteine-rich PDZ-binding protein	GO:0030165; F:PDZ domain binding; IDA:UniProt
Q9P021	CRIPT	Cysteine-rich PDZ-binding protein	GO:0005515; F:protein binding; IPI:IntAct
Q9P021	CRIPT	Cysteine-rich PDZ-binding protein	GO:0032403; F:protein complex binding; ISS:UniProt
Q9P021	CRIPT	Cysteine-rich PDZ-binding protein	GO:0031122; P:cytoplasmic microtubule organization; ISS:UniProt
Q9P021	CRIPT	Cysteine-rich PDZ-binding protein	GO:0045184; P:establishment of protein localization; ISS:UniProt
Q9P021	CRIPT	Cysteine-rich PDZ-binding protein	GO:0035372; P:protein localization to microtubule; ISS:UniProt
Q9P021	CRIPT	Cysteine-rich PDZ-binding protein	GO:1902897; P:regulation of postsynaptic density protein 95 clustering; ISS:UniProt
P54107	CRISP1	Cysteine-rich secretory protein 1	GO:0007342; P:fusion of sperm to egg plasma membrane; TAS:ProtInc
P16562	CRISP2	Cysteine-rich secretory protein 2	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
P54108	CRISP3	Cysteine-rich secretory protein 3	GO:0006952; P:defense response; NAS:UniProtKB
P54108	CRISP3	Cysteine-rich secretory protein 3	GO:0045087; P:innate immune response; NAS:UniProtKB
P46109	CRKL	Crk-like protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P46109	CRKL	Crk-like protein	GO:0005515; F:protein binding; IPI:IntAct
P46109	CRKL	Crk-like protein	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
P46109	CRKL	Crk-like protein	GO:0004871; F:signal transducer activity; TAS:ProtInc
P46109	CRKL	Crk-like protein	GO:0000186; P:activation of MAPKK activity; TAS:Reactome
P46109	CRKL	Crk-like protein	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P46109	CRKL	Crk-like protein	GO:0001568; P:blood vessel development; IEA:Ensembl
P46109	CRKL	Crk-like protein	GO:0007507; P:heart development; IEA:Ensembl
P46109	CRKL	Crk-like protein	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
P46109	CRKL	Crk-like protein	GO:0007254; P:JNK cascade; TAS:ProtInc
P46109	CRKL	Crk-like protein	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P46109	CRKL	Crk-like protein	GO:0009887; P:organ morphogenesis; IEA:Ensembl
P46109	CRKL	Crk-like protein	GO:0060017; P:parathyroid gland development; IEA:Ensembl
P46109	CRKL	Crk-like protein	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
P46109	CRKL	Crk-like protein	GO:0007265; P:Ras protein signal transduction; TAS:ProtInc
P46109	CRKL	Crk-like protein	GO:0048538; P:thymus development; IEA:Ensembl
P46108	CRK	Adapter molecule crk	GO:0046875; F:ephrin receptor binding; IPI:UniProtKB
P46108	CRK	Adapter molecule crk	GO:0005515; F:protein binding; IPI:UniProtKB
P46108	CRK	Adapter molecule crk	GO:0042169; F:SH2 domain binding; IPI:UniProtKB
P46108	CRK	Adapter molecule crk	GO:0000186; P:activation of MAPKK activity; TAS:Reactome
P46108	CRK	Adapter molecule crk	GO:0007596; P:blood coagulation; TAS:Reactome
P46108	CRK	Adapter molecule crk	GO:0048013; P:ephrin receptor signaling pathway; IDA:UniProtKB
P46108	CRK	Adapter molecule crk	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P46108	CRK	Adapter molecule crk	GO:0045087; P:innate immune response; TAS:Reactome
P46108	CRK	Adapter molecule crk	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P46108	CRK	Adapter molecule crk	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P46108	CRK	Adapter molecule crk	GO:0030168; P:platelet activation; TAS:Reactome
P46108	CRK	Adapter molecule crk	GO:0009967; P:positive regulation of signal transduction; IEA:GOC
P46108	CRK	Adapter molecule crk	GO:0032956; P:regulation of actin cytoskeleton organization; IDA:UniProtKB
P46108	CRK	Adapter molecule crk	GO:0035020; P:regulation of Rac protein signal transduction; IEA:Ensembl
P46108	CRK	Adapter molecule crk	GO:0032319; P:regulation of Rho GTPase activity; IDA:UniProtKB
P46108	CRK	Adapter molecule crk	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9H336	CRISPLD1	Cysteine-rich secretory protein LCCL domain-containing 1	GO:0060325; P:face morphogenesis; IMP:UniProt
Q9H0B8	CRISPLD2	Cysteine-rich secretory protein LCCL domain-containing 2	GO:0008201; F:heparin binding; IEA:Ensembl
Q9H0B8	CRISPLD2	Cysteine-rich secretory protein LCCL domain-containing 2	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q9H0B8	CRISPLD2	Cysteine-rich secretory protein LCCL domain-containing 2	GO:0060325; P:face morphogenesis; IMP:UniProt
Q9H0B8	CRISPLD2	Cysteine-rich secretory protein LCCL domain-containing 2	GO:0030324; P:lung development; IEA:Ensembl
O75462	CRLF1	Cytokine receptor-like factor 1	GO:0019955; F:cytokine binding; IPI:HGNC
O75462	CRLF1	Cytokine receptor-like factor 1	GO:0005515; F:protein binding; IPI:BHF-UCL
O75462	CRLF1	Cytokine receptor-like factor 1	GO:0046982; F:protein heterodimerization activity; IDA:BHF-UCL
O75462	CRLF1	Cytokine receptor-like factor 1	GO:0004872; F:receptor activity; TAS:ProtInc
O75462	CRLF1	Cytokine receptor-like factor 1	GO:2000672; P:negative regulation of motor neuron apoptotic process; IEA:Ensembl
O75462	CRLF1	Cytokine receptor-like factor 1	GO:0043524; P:negative regulation of neuron apoptotic process; IDA:BHF-UCL
O75462	CRLF1	Cytokine receptor-like factor 1	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
O75462	CRLF1	Cytokine receptor-like factor 1	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IDA:BHF-UCL
O75462	CRLF1	Cytokine receptor-like factor 1	GO:0001657; P:ureteric bud development; IEA:Ensembl
Q8IUI8	CRLF3	Cytokine receptor-like factor 3	GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:UniProtKB
Q8IUI8	CRLF3	Cytokine receptor-like factor 3	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q8IUI8	CRLF3	Cytokine receptor-like factor 3	GO:0071158; P:positive regulation of cell cycle arrest; IDA:UniProtKB
Q8IUI8	CRLF3	Cytokine receptor-like factor 3	GO:0046427; P:positive regulation of JAK-STAT cascade; IDA:UniProtKB
Q8IUI8	CRLF3	Cytokine receptor-like factor 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q8IUI8	CRLF3	Cytokine receptor-like factor 3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UJA2	CRLS1	Cardiolipin synthase	GO:0016780; F:phosphotransferase activity, for other substituted phosphate groups; IEA:InterPro
Q9UJA2	CRLS1	Cardiolipin synthase	GO:0032049; P:cardiolipin biosynthetic process; TAS:Reactome
Q9UJA2	CRLS1	Cardiolipin synthase	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9UJA2	CRLS1	Cardiolipin synthase	GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome
Q9UJA2	CRLS1	Cardiolipin synthase	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9UJA2	CRLS1	Cardiolipin synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96RY5	CRAMP1L	Protein cramped-like	GO:0003682; F:chromatin binding; IEA:InterPro
Q96RY5	CRAMP1L	Protein cramped-like	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BZJ0	CRNKL1	Crooked neck-like protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BZJ0	CRNKL1	Crooked neck-like protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9BZJ0	CRNKL1	Crooked neck-like protein 1	GO:0003723; F:RNA binding; IDA:UniProtKB
Q9BZJ0	CRNKL1	Crooked neck-like protein 1	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q9BZJ0	CRNKL1	Crooked neck-like protein 1	GO:0000245; P:spliceosomal complex assembly; IDA:UniProtKB
Q9UBG3	CRNN	Cornulin	GO:0005509; F:calcium ion binding; NAS:UniProtKB
Q9UBG3	CRNN	Cornulin	GO:0016337; P:single organismal cell-cell adhesion; IDA:UniProtKB
Q9UBG3	CRNN	Cornulin	GO:0009408; P:response to heat; IDA:UniProtKB
A5YM72	CARNS1	Carnosine synthase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
A5YM72	CARNS1	Carnosine synthase 1	GO:0016887; F:ATPase activity; IDA:MGI
A5YM72	CARNS1	Carnosine synthase 1	GO:0047730; F:carnosine synthase activity; IDA:UniProtKB
A5YM72	CARNS1	Carnosine synthase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A5YM72	CARNS1	Carnosine synthase 1	GO:0006200; P:ATP catabolic process; IDA:GOC
A5YM72	CARNS1	Carnosine synthase 1	GO:0035499; P:carnosine biosynthetic process; IDA:UniProtKB
Q5TZA2	CROCC	Rootletin	GO:0019894; F:kinesin binding; ISS:UniProtKB
Q5TZA2	CROCC	Rootletin	GO:0005515; F:protein binding; IPI:UniProtKB
Q5TZA2	CROCC	Rootletin	GO:0005198; F:structural molecule activity; ISS:UniProtKB
Q5TZA2	CROCC	Rootletin	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q5TZA2	CROCC	Rootletin	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
Q5TZA2	CROCC	Rootletin	GO:0051297; P:centrosome organization; IDA:UniProtKB
Q5TZA2	CROCC	Rootletin	GO:0008104; P:protein localization; IMP:UniProtKB
Q8N1N5	CRIPAK	Cysteine-rich PAK1 inhibitor	GO:0005515; F:protein binding; IPI:IntAct
Q8N1N5	CRIPAK	Cysteine-rich PAK1 inhibitor	GO:0033147; P:negative regulation of intracellular estrogen receptor signaling pathway; IDA:UniProtKB
Q8N1N5	CRIPAK	Cysteine-rich PAK1 inhibitor	GO:0006469; P:negative regulation of protein kinase activity; IDA:HGNC
Q8N1N5	CRIPAK	Cysteine-rich PAK1 inhibitor	GO:0051493; P:regulation of cytoskeleton organization; IDA:HGNC
Q8N1N5	CRIPAK	Cysteine-rich PAK1 inhibitor	GO:0043627; P:response to estrogen; IDA:HGNC
P02741	CRP	C-reactive protein	GO:0015485; F:cholesterol binding; IEA:Ensembl
P02741	CRP	C-reactive protein	GO:0033265; F:choline binding; TAS:BHF-UCL
P02741	CRP	C-reactive protein	GO:0030169; F:low-density lipoprotein particle binding; IDA:BHF-UCL
P02741	CRP	C-reactive protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P02741	CRP	C-reactive protein	GO:0005515; F:protein binding; IPI:IntAct
P02741	CRP	C-reactive protein	GO:0006953; P:acute-phase response; TAS:BHF-UCL
P02741	CRP	C-reactive protein	GO:0007568; P:aging; IEA:Ensembl
P02741	CRP	C-reactive protein	GO:0071277; P:cellular response to calcium ion; IEA:Ensembl
P02741	CRP	C-reactive protein	GO:0006958; P:complement activation, classical pathway; IEA:Ensembl
P02741	CRP	C-reactive protein	GO:0050830; P:defense response to Gram-positive bacterium; TAS:BHF-UCL
P02741	CRP	C-reactive protein	GO:0006954; P:inflammatory response; TAS:ProtInc
P02741	CRP	C-reactive protein	GO:0010888; P:negative regulation of lipid storage; IDA:BHF-UCL
P02741	CRP	C-reactive protein	GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; IDA:BHF-UCL
P02741	CRP	C-reactive protein	GO:0008228; P:opsonization; TAS:BHF-UCL
P02741	CRP	C-reactive protein	GO:1900006; P:positive regulation of dendrite development; IEA:Ensembl
P02741	CRP	C-reactive protein	GO:0051258; P:protein polymerization; IEA:Ensembl
P02741	CRP	C-reactive protein	GO:0045471; P:response to ethanol; IEA:Ensembl
P02741	CRP	C-reactive protein	GO:0001666; P:response to hypoxia; IEA:Ensembl
P02741	CRP	C-reactive protein	GO:0010288; P:response to lead ion; IEA:Ensembl
P02741	CRP	C-reactive protein	GO:0042060; P:wound healing; IEA:Ensembl
Q9H3Y0	R3HDML	Peptidase inhibitor R3HDML	GO:0030414; F:peptidase inhibitor activity; IEA:UniProtKB-KW
O95727	CRTAM	Cytotoxic and regulatory T-cell molecule	GO:0005102; F:receptor binding; IPI:UniProtKB
O95727	CRTAM	Cytotoxic and regulatory T-cell molecule	GO:0008037; P:cell recognition; IDA:HGNC
O95727	CRTAM	Cytotoxic and regulatory T-cell molecule	GO:0051606; P:detection of stimulus; IDA:HGNC
O95727	CRTAM	Cytotoxic and regulatory T-cell molecule	GO:0002355; P:detection of tumor cell; IDA:HGNC
O95727	CRTAM	Cytotoxic and regulatory T-cell molecule	GO:0002376; P:immune system process; IEA:UniProtKB-KW
O95727	CRTAM	Cytotoxic and regulatory T-cell molecule	GO:0050715; P:positive regulation of cytokine secretion; IDA:HGNC
O95727	CRTAM	Cytotoxic and regulatory T-cell molecule	GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; IDA:HGNC
O95727	CRTAM	Cytotoxic and regulatory T-cell molecule	GO:0002860; P:positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; IDA:HGNC
O95727	CRTAM	Cytotoxic and regulatory T-cell molecule	GO:0050776; P:regulation of immune response; TAS:Reactome
O75718	CRTAP	Cartilage-associated protein	GO:0032403; F:protein complex binding; ISS:UniProt
O75718	CRTAP	Cartilage-associated protein	GO:0061077; P:chaperone-mediated protein folding; ISS:UniProt
O75718	CRTAP	Cartilage-associated protein	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O75718	CRTAP	Cartilage-associated protein	GO:1901874; P:negative regulation of post-translational protein modification; IMP:UniProt
O75718	CRTAP	Cartilage-associated protein	GO:0018400; P:peptidyl-proline hydroxylation to 3-hydroxy-L-proline; IEA:Ensembl
O75718	CRTAP	Cartilage-associated protein	GO:0050821; P:protein stabilization; IMP:UniProt
O75718	CRTAP	Cartilage-associated protein	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q6UUV9	CRTC1	CREB-regulated transcription coactivator 1	GO:0008140; F:cAMP response element binding protein binding; IDA:UniProtKB
Q6UUV9	CRTC1	CREB-regulated transcription coactivator 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q6UUV9	CRTC1	CREB-regulated transcription coactivator 1	GO:0032793; P:positive regulation of CREB transcription factor activity; IEA:InterPro
Q6UUV9	CRTC1	CREB-regulated transcription coactivator 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q6UUV9	CRTC1	CREB-regulated transcription coactivator 1	GO:0051289; P:protein homotetramerization; IEA:InterPro
Q6UUV9	CRTC1	CREB-regulated transcription coactivator 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6UUV9	CRTC1	CREB-regulated transcription coactivator 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q53ET0	CRTC2	CREB-regulated transcription coactivator 2	GO:0008140; F:cAMP response element binding protein binding; IEA:InterPro
Q53ET0	CRTC2	CREB-regulated transcription coactivator 2	GO:0006094; P:gluconeogenesis; ISS:UniProtKB
Q53ET0	CRTC2	CREB-regulated transcription coactivator 2	GO:0042593; P:glucose homeostasis; ISS:UniProtKB
Q53ET0	CRTC2	CREB-regulated transcription coactivator 2	GO:0032793; P:positive regulation of CREB transcription factor activity; ISS:UniProtKB
Q53ET0	CRTC2	CREB-regulated transcription coactivator 2	GO:0051289; P:protein homotetramerization; IEA:InterPro
Q53ET0	CRTC2	CREB-regulated transcription coactivator 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q53ET0	CRTC2	CREB-regulated transcription coactivator 2	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q6UUV7	CRTC3	CREB-regulated transcription coactivator 3	GO:0008140; F:cAMP response element binding protein binding; IEA:InterPro
Q6UUV7	CRTC3	CREB-regulated transcription coactivator 3	GO:0032793; P:positive regulation of CREB transcription factor activity; IEA:InterPro
Q6UUV7	CRTC3	CREB-regulated transcription coactivator 3	GO:0051289; P:protein homotetramerization; IEA:InterPro
Q6UUV7	CRTC3	CREB-regulated transcription coactivator 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6UUV7	CRTC3	CREB-regulated transcription coactivator 3	GO:0016032; P:viral process; IEA:UniProtKB-KW
P82279	CRB1	Protein crumbs homolog 1	GO:0005509; F:calcium ion binding; IEA:InterPro
P82279	CRB1	Protein crumbs homolog 1	GO:0005515; F:protein binding; IPI:IntAct
P82279	CRB1	Protein crumbs homolog 1	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P82279	CRB1	Protein crumbs homolog 1	GO:0007163; P:establishment or maintenance of cell polarity; TAS:ProtInc
P82279	CRB1	Protein crumbs homolog 1	GO:0042462; P:eye photoreceptor cell development; IEA:Ensembl
P82279	CRB1	Protein crumbs homolog 1	GO:0007009; P:plasma membrane organization; IEA:Ensembl
Q5IJ48	CRB2	Protein crumbs homolog 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q5IJ48	CRB2	Protein crumbs homolog 2	GO:0072358; P:cardiovascular system development; ISS:UniProt
Q5IJ48	CRB2	Protein crumbs homolog 2	GO:0045199; P:maintenance of epithelial cell apical/basal polarity; ISS:UniProt
Q5IJ48	CRB2	Protein crumbs homolog 2	GO:0001707; P:mesoderm formation; ISS:UniProt
Q5IJ48	CRB2	Protein crumbs homolog 2	GO:0014028; P:notochord formation; ISS:UniProt
Q5IJ48	CRB2	Protein crumbs homolog 2	GO:0030513; P:positive regulation of BMP signaling pathway; ISS:UniProt
Q5IJ48	CRB2	Protein crumbs homolog 2	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; ISS:UniProt
Q5IJ48	CRB2	Protein crumbs homolog 2	GO:0001756; P:somitogenesis; ISS:UniProt
Q9BUF7	CRB3	Protein crumbs homolog 3	GO:0019904; F:protein domain specific binding; IPI:BHF-UCL
Q9BUF7	CRB3	Protein crumbs homolog 3	GO:0017124; F:SH3 domain binding; IPI:BHF-UCL
Q9BUF7	CRB3	Protein crumbs homolog 3	GO:0034329; P:cell junction assembly; TAS:Reactome
Q9BUF7	CRB3	Protein crumbs homolog 3	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q9BUF7	CRB3	Protein crumbs homolog 3	GO:0072659; P:protein localization to plasma membrane; IDA:BHF-UCL
Q9BUF7	CRB3	Protein crumbs homolog 3	GO:0070830; P:tight junction assembly; TAS:Reactome
O43186	CRX	Cone-rod homeobox protein	GO:0003682; F:chromatin binding; IEA:Ensembl
O43186	CRX	Cone-rod homeobox protein	GO:0043522; F:leucine zipper domain binding; IPI:UniProtKB
O43186	CRX	Cone-rod homeobox protein	GO:0035257; F:nuclear hormone receptor binding; ISS:UniProtKB
O43186	CRX	Cone-rod homeobox protein	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O43186	CRX	Cone-rod homeobox protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
O43186	CRX	Cone-rod homeobox protein	GO:0007623; P:circadian rhythm; IEA:Ensembl
O43186	CRX	Cone-rod homeobox protein	GO:0009887; P:organ morphogenesis; TAS:ProtInc
O43186	CRX	Cone-rod homeobox protein	GO:0046534; P:positive regulation of photoreceptor cell differentiation; IEA:Ensembl
O43186	CRX	Cone-rod homeobox protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O43186	CRX	Cone-rod homeobox protein	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
O43186	CRX	Cone-rod homeobox protein	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
O43186	CRX	Cone-rod homeobox protein	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
O43186	CRX	Cone-rod homeobox protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43186	CRX	Cone-rod homeobox protein	GO:0007601; P:visual perception; TAS:ProtInc
Q16526	CRY1	Cryptochrome-1	GO:0009882; F:blue light photoreceptor activity; NAS:UniProtKB
Q16526	CRY1	Cryptochrome-1	GO:0001047; F:core promoter binding; ISS:UniProtKB
Q16526	CRY1	Cryptochrome-1	GO:0003677; F:DNA binding; TAS:ProtInc
Q16526	CRY1	Cryptochrome-1	GO:0003913; F:DNA photolyase activity; IEA:InterPro
Q16526	CRY1	Cryptochrome-1	GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB
Q16526	CRY1	Cryptochrome-1	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
Q16526	CRY1	Cryptochrome-1	GO:0019902; F:phosphatase binding; IPI:UniProtKB
Q16526	CRY1	Cryptochrome-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q16526	CRY1	Cryptochrome-1	GO:0000989; F:transcription factor binding transcription factor activity; IDA:BHF-UCL
Q16526	CRY1	Cryptochrome-1	GO:0009785; P:blue light signaling pathway; NAS:UniProtKB
Q16526	CRY1	Cryptochrome-1	GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB
Q16526	CRY1	Cryptochrome-1	GO:0006281; P:DNA repair; IEA:InterPro
Q16526	CRY1	Cryptochrome-1	GO:0042754; P:negative regulation of circadian rhythm; ISS:UniProtKB
Q16526	CRY1	Cryptochrome-1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q16526	CRY1	Cryptochrome-1	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q16526	CRY1	Cryptochrome-1	GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW
Q16526	CRY1	Cryptochrome-1	GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB
Q16526	CRY1	Cryptochrome-1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q49AN0	CRY2	Cryptochrome-2	GO:0009882; F:blue light photoreceptor activity; NAS:UniProtKB
Q49AN0	CRY2	Cryptochrome-2	GO:0003684; F:damaged DNA binding; IDA:UniProtKB
Q49AN0	CRY2	Cryptochrome-2	GO:0003677; F:DNA binding; IDA:UniProtKB
Q49AN0	CRY2	Cryptochrome-2	GO:0003913; F:DNA photolyase activity; IEA:InterPro
Q49AN0	CRY2	Cryptochrome-2	GO:0071949; F:FAD binding; ISS:UniProtKB
Q49AN0	CRY2	Cryptochrome-2	GO:0019902; F:phosphatase binding; IPI:UniProtKB
Q49AN0	CRY2	Cryptochrome-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q49AN0	CRY2	Cryptochrome-2	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
Q49AN0	CRY2	Cryptochrome-2	GO:0000989; F:transcription factor binding transcription factor activity; IDA:BHF-UCL
Q49AN0	CRY2	Cryptochrome-2	GO:0009785; P:blue light signaling pathway; NAS:UniProtKB
Q49AN0	CRY2	Cryptochrome-2	GO:0007623; P:circadian rhythm; ISS:UniProtKB
Q49AN0	CRY2	Cryptochrome-2	GO:0006281; P:DNA repair; IEA:InterPro
Q49AN0	CRY2	Cryptochrome-2	GO:0042754; P:negative regulation of circadian rhythm; ISS:UniProtKB
Q49AN0	CRY2	Cryptochrome-2	GO:0032515; P:negative regulation of phosphoprotein phosphatase activity; IDA:UniProtKB
Q49AN0	CRY2	Cryptochrome-2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q49AN0	CRY2	Cryptochrome-2	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q49AN0	CRY2	Cryptochrome-2	GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW
Q49AN0	CRY2	Cryptochrome-2	GO:2000118; P:regulation of sodium-dependent phosphate transport; IDA:MGI
Q49AN0	CRY2	Cryptochrome-2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P02489	CRYAA	Alpha-crystallin A chain	GO:0042802; F:identical protein binding; IPI:IntAct
P02489	CRYAA	Alpha-crystallin A chain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P02489	CRYAA	Alpha-crystallin A chain	GO:0005515; F:protein binding; IPI:UniProtKB
P02489	CRYAA	Alpha-crystallin A chain	GO:0005212; F:structural constituent of eye lens; IEA:UniProtKB-KW
P02489	CRYAA	Alpha-crystallin A chain	GO:0051082; F:unfolded protein binding; IMP:UniProtKB
P02489	CRYAA	Alpha-crystallin A chain	GO:0007015; P:actin filament organization; IEA:Ensembl
P02489	CRYAA	Alpha-crystallin A chain	GO:0060561; P:apoptotic process involved in morphogenesis; IEA:Ensembl
P02489	CRYAA	Alpha-crystallin A chain	GO:0048596; P:embryonic camera-type eye morphogenesis; IEA:Ensembl
P02489	CRYAA	Alpha-crystallin A chain	GO:0070309; P:lens fiber cell morphogenesis; IEA:Ensembl
P02489	CRYAA	Alpha-crystallin A chain	GO:0007005; P:mitochondrion organization; IEA:Ensembl
P02489	CRYAA	Alpha-crystallin A chain	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P02489	CRYAA	Alpha-crystallin A chain	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
P02489	CRYAA	Alpha-crystallin A chain	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
P02489	CRYAA	Alpha-crystallin A chain	GO:0032387; P:negative regulation of intracellular transport; IDA:HGNC
P02489	CRYAA	Alpha-crystallin A chain	GO:0030307; P:positive regulation of cell growth; IEA:Ensembl
P02489	CRYAA	Alpha-crystallin A chain	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
P02489	CRYAA	Alpha-crystallin A chain	GO:0006457; P:protein folding; IEA:Ensembl
P02489	CRYAA	Alpha-crystallin A chain	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
P02489	CRYAA	Alpha-crystallin A chain	GO:0042493; P:response to drug; IEA:Ensembl
P02489	CRYAA	Alpha-crystallin A chain	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P02489	CRYAA	Alpha-crystallin A chain	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
P02489	CRYAA	Alpha-crystallin A chain	GO:0001666; P:response to hypoxia; IEA:Ensembl
P02489	CRYAA	Alpha-crystallin A chain	GO:0010288; P:response to lead ion; IEA:Ensembl
P02489	CRYAA	Alpha-crystallin A chain	GO:0070141; P:response to UV-A; IEA:Ensembl
P02489	CRYAA	Alpha-crystallin A chain	GO:0007021; P:tubulin complex assembly; IEA:Ensembl
P02489	CRYAA	Alpha-crystallin A chain	GO:0007601; P:visual perception; IMP:UniProtKB
P02511	CRYAB	Alpha-crystallin B chain	GO:0042802; F:identical protein binding; IPI:IntAct
P02511	CRYAB	Alpha-crystallin B chain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P02511	CRYAB	Alpha-crystallin B chain	GO:0005515; F:protein binding; IPI:UniProtKB
P02511	CRYAB	Alpha-crystallin B chain	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P02511	CRYAB	Alpha-crystallin B chain	GO:0005212; F:structural constituent of eye lens; IEA:UniProtKB-KW
P02511	CRYAB	Alpha-crystallin B chain	GO:0051082; F:unfolded protein binding; IPI:UniProtKB
P02511	CRYAB	Alpha-crystallin B chain	GO:0007568; P:aging; IEA:Ensembl
P02511	CRYAB	Alpha-crystallin B chain	GO:0060561; P:apoptotic process involved in morphogenesis; IEA:Ensembl
P02511	CRYAB	Alpha-crystallin B chain	GO:0071480; P:cellular response to gamma radiation; IMP:MGI
P02511	CRYAB	Alpha-crystallin B chain	GO:0006006; P:glucose metabolic process; IEA:Ensembl
P02511	CRYAB	Alpha-crystallin B chain	GO:0002088; P:lens development in camera-type eye; IEA:Ensembl
P02511	CRYAB	Alpha-crystallin B chain	GO:0031109; P:microtubule polymerization or depolymerization; IEA:Ensembl
P02511	CRYAB	Alpha-crystallin B chain	GO:0006936; P:muscle contraction; TAS:ProtInc
P02511	CRYAB	Alpha-crystallin B chain	GO:0007517; P:muscle organ development; IEA:Ensembl
P02511	CRYAB	Alpha-crystallin B chain	GO:0043066; P:negative regulation of apoptotic process; IDA:HGNC
P02511	CRYAB	Alpha-crystallin B chain	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
P02511	CRYAB	Alpha-crystallin B chain	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
P02511	CRYAB	Alpha-crystallin B chain	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
P02511	CRYAB	Alpha-crystallin B chain	GO:0032387; P:negative regulation of intracellular transport; IDA:HGNC
P02511	CRYAB	Alpha-crystallin B chain	GO:2000378; P:negative regulation of reactive oxygen species metabolic process; IEA:Ensembl
P02511	CRYAB	Alpha-crystallin B chain	GO:0006457; P:protein folding; NAS:ProtInc
P02511	CRYAB	Alpha-crystallin B chain	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
P02511	CRYAB	Alpha-crystallin B chain	GO:0010941; P:regulation of cell death; IMP:MGI
P02511	CRYAB	Alpha-crystallin B chain	GO:0032355; P:response to estradiol; IEA:Ensembl
P02511	CRYAB	Alpha-crystallin B chain	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
P02511	CRYAB	Alpha-crystallin B chain	GO:0001666; P:response to hypoxia; IEA:Ensembl
P02511	CRYAB	Alpha-crystallin B chain	GO:0051403; P:stress-activated MAPK cascade; IEA:Ensembl
P02511	CRYAB	Alpha-crystallin B chain	GO:0007021; P:tubulin complex assembly; IEA:Ensembl
Q9Y2S2	CRYL1	Lambda-crystallin homolog	GO:0003857; F:3-hydroxyacyl-CoA dehydrogenase activity; IEA:InterPro
Q9Y2S2	CRYL1	Lambda-crystallin homolog	GO:0050104; F:L-gulonate 3-dehydrogenase activity; IDA:UniProtKB
Q9Y2S2	CRYL1	Lambda-crystallin homolog	GO:0070403; F:NAD+ binding; IDA:UniProtKB
Q9Y2S2	CRYL1	Lambda-crystallin homolog	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q9Y2S2	CRYL1	Lambda-crystallin homolog	GO:0006631; P:fatty acid metabolic process; IEA:InterPro
Q14894	CRYM	Ketimine reductase mu-crystallin	GO:0050661; F:NADP binding; IDA:UniProtKB
Q14894	CRYM	Ketimine reductase mu-crystallin	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q14894	CRYM	Ketimine reductase mu-crystallin	GO:0047127; F:thiomorpholine-carboxylate dehydrogenase activity; IEA:UniProtKB-EC
Q14894	CRYM	Ketimine reductase mu-crystallin	GO:0070324; F:thyroid hormone binding; IDA:UniProtKB
Q14894	CRYM	Ketimine reductase mu-crystallin	GO:0003714; F:transcription corepressor activity; IMP:UniProtKB
Q14894	CRYM	Ketimine reductase mu-crystallin	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q14894	CRYM	Ketimine reductase mu-crystallin	GO:0007605; P:sensory perception of sound; IMP:UniProtKB
Q14894	CRYM	Ketimine reductase mu-crystallin	GO:0042403; P:thyroid hormone metabolic process; IEA:Ensembl
Q14894	CRYM	Ketimine reductase mu-crystallin	GO:0070327; P:thyroid hormone transport; IMP:UniProtKB
Q969H8	C19orf10	UPF0556 protein C19orf10	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q969H8	C19orf10	UPF0556 protein C19orf10	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q969H8	C19orf10	UPF0556 protein C19orf10	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q9NSK7	C19orf12	Protein C19orf12	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9UFG5	C19orf25	UPF0449 protein C19orf25	GO:0005515; F:protein binding; IPI:IntAct
Q0VDD7	C19orf57	Uncharacterized protein C19orf57	GO:0005515; F:protein binding; IPI:IntAct
Q0VDD7	C19orf57	Uncharacterized protein C19orf57	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
Q96EN9	C19orf60	Uncharacterized protein C19orf60	GO:0005515; F:protein binding; IPI:IntAct
Q86XI8	C19orf68	Uncharacterized protein C19orf68	GO:0005515; F:protein binding; IPI:IntAct
Q86XI8	C19orf68	Uncharacterized protein C19orf68	GO:0007275; P:multicellular organismal development; IEA:InterPro
Q86XI8	C19orf68	Uncharacterized protein C19orf68	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q9Y600	CSAD	Cysteine sulfinic acid decarboxylase	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q9Y600	CSAD	Cysteine sulfinic acid decarboxylase	GO:0004782; F:sulfinoalanine decarboxylase activity; IEA:UniProtKB-EC
Q9Y600	CSAD	Cysteine sulfinic acid decarboxylase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9Y600	CSAD	Cysteine sulfinic acid decarboxylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y600	CSAD	Cysteine sulfinic acid decarboxylase	GO:0000098; P:sulfur amino acid catabolic process; TAS:Reactome
Q9Y600	CSAD	Cysteine sulfinic acid decarboxylase	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
Q9Y600	CSAD	Cysteine sulfinic acid decarboxylase	GO:0042412; P:taurine biosynthetic process; IEA:UniProtKB-UniPathway
Q9Y5P2	CSAG2	Chondrosarcoma-associated gene 2/3 protein	GO:0042493; P:response to drug; TAS:ProtInc
Q9Y534	CSDC2	Cold shock domain-containing protein C2	GO:0003677; F:DNA binding; IEA:InterPro
Q9Y534	CSDC2	Cold shock domain-containing protein C2	GO:0003723; F:RNA binding; NAS:UniProtKB
Q9Y534	CSDC2	Cold shock domain-containing protein C2	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9Y534	CSDC2	Cold shock domain-containing protein C2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
O75534	CSDE1	Cold shock domain-containing protein E1	GO:0003677; F:DNA binding; IEA:InterPro
O75534	CSDE1	Cold shock domain-containing protein E1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75534	CSDE1	Cold shock domain-containing protein E1	GO:0008584; P:male gonad development; TAS:ProtInc
O75534	CSDE1	Cold shock domain-containing protein E1	GO:0070966; P:nuclear-transcribed mRNA catabolic process, no-go decay; IMP:UniProtKB
O75534	CSDE1	Cold shock domain-containing protein E1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q9Y2W7	KCNIP3	Calsenilin	GO:0005509; F:calcium ion binding; TAS:ProtInc
Q9Y2W7	KCNIP3	Calsenilin	GO:0003677; F:DNA binding; TAS:ProtInc
Q9Y2W7	KCNIP3	Calsenilin	GO:0005267; F:potassium channel activity; IEA:UniProtKB-KW
Q9Y2W7	KCNIP3	Calsenilin	GO:0015459; F:potassium channel regulator activity; IEA:Ensembl
Q9Y2W7	KCNIP3	Calsenilin	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q9Y2W7	KCNIP3	Calsenilin	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q9Y2W7	KCNIP3	Calsenilin	GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW
Q9Y2W7	KCNIP3	Calsenilin	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9Y2W7	KCNIP3	Calsenilin	GO:0048266; P:behavioral response to pain; IEA:Ensembl
Q9Y2W7	KCNIP3	Calsenilin	GO:0006886; P:intracellular protein transport; IEA:Ensembl
Q9Y2W7	KCNIP3	Calsenilin	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9Y2W7	KCNIP3	Calsenilin	GO:0043523; P:regulation of neuron apoptotic process; IEA:Ensembl
Q9Y2W7	KCNIP3	Calsenilin	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9Y2W7	KCNIP3	Calsenilin	GO:0019233; P:sensory perception of pain; IEA:Ensembl
Q9Y2W7	KCNIP3	Calsenilin	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y2W7	KCNIP3	Calsenilin	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0019955; F:cytokine binding; IDA:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0005011; F:macrophage colony-stimulating factor receptor activity; IMP:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0008283; P:cell proliferation; IMP:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0045217; P:cell-cell junction maintenance; IMP:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0071345; P:cellular response to cytokine stimulus; ISS:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0036006; P:cellular response to macrophage colony-stimulating factor stimulus; IMP:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0019221; P:cytokine-mediated signaling pathway; IMP:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0030097; P:hemopoiesis; IMP:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0006954; P:inflammatory response; TAS:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0038145; P:macrophage colony-stimulating factor signaling pathway; IMP:GOC
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0030225; P:macrophage differentiation; TAS:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0060603; P:mammary gland duct morphogenesis; TAS:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0030224; P:monocyte differentiation; TAS:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0030316; P:osteoclast differentiation; ISS:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0046488; P:phosphatidylinositol metabolic process; ISS:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0048015; P:phosphatidylinositol-mediated signaling; ISS:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:2000147; P:positive regulation of cell motility; IMP:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0090197; P:positive regulation of chemokine secretion; IMP:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0001934; P:positive regulation of protein phosphorylation; IMP:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0071902; P:positive regulation of protein serine/threonine kinase activity; ISS:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0061098; P:positive regulation of protein tyrosine kinase activity; IMP:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; ISS:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:2000249; P:regulation of actin cytoskeleton reorganization; ISS:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0045124; P:regulation of bone resorption; ISS:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0031529; P:ruffle organization; ISS:UniProtKB
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0007165; P:signal transduction; TAS:ProtInc
P07333	CSF1R	Macrophage colony-stimulating factor 1 receptor	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; ISS:UniProtKB
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0005125; F:cytokine activity; IDA:BHF-UCL
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0008083; F:growth factor activity; NAS:UniProtKB
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0005157; F:macrophage colony-stimulating factor receptor binding; TAS:UniProtKB
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0060444; P:branching involved in mammary gland duct morphogenesis; IEA:Ensembl
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0030154; P:cell differentiation; NAS:UniProtKB
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0008283; P:cell proliferation; NAS:UniProtKB
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0003006; P:developmental process involved in reproduction; ISS:BHF-UCL
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0030097; P:hemopoiesis; NAS:UniProtKB
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0030225; P:macrophage differentiation; TAS:UniProtKB
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0060763; P:mammary duct terminal end bud growth; IEA:Ensembl
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0060611; P:mammary gland fat development; IEA:Ensembl
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0042117; P:monocyte activation; NAS:BHF-UCL
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0042476; P:odontogenesis; IEA:Ensembl
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0001503; P:ossification; IEA:Ensembl
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0030316; P:osteoclast differentiation; IDA:BHF-UCL
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0002158; P:osteoclast proliferation; IEA:Ensembl
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0030335; P:positive regulation of cell migration; ISS:BHF-UCL
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0008284; P:positive regulation of cell proliferation; TAS:UniProtKB
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0001954; P:positive regulation of cell-matrix adhesion; ISS:BHF-UCL
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0032270; P:positive regulation of cellular protein metabolic process; IDA:BHF-UCL
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0010628; P:positive regulation of gene expression; IDA:BHF-UCL
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; IDA:BHF-UCL
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0045651; P:positive regulation of macrophage differentiation; IDA:BHF-UCL
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0045657; P:positive regulation of monocyte differentiation; ISS:BHF-UCL
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0032946; P:positive regulation of mononuclear cell proliferation; IDA:BHF-UCL
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0042488; P:positive regulation of odontogenesis of dentin-containing tooth; IEA:Ensembl
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0045672; P:positive regulation of osteoclast differentiation; IDA:BHF-UCL
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0045860; P:positive regulation of protein kinase activity; ISS:BHF-UCL
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0046579; P:positive regulation of Ras protein signal transduction; IEA:Ensembl
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0010743; P:regulation of macrophage derived foam cell differentiation; NAS:BHF-UCL
P09603	CSF1	Macrophage colony-stimulating factor 1	GO:0030278; P:regulation of ossification; IEA:Ensembl
P15509	CSF2RA	Granulocyte-macrophage colony-stimulating factor receptor subunit alpha	GO:0004896; F:cytokine receptor activity; IEA:InterPro
P15509	CSF2RA	Granulocyte-macrophage colony-stimulating factor receptor subunit alpha	GO:0004872; F:receptor activity; TAS:ProtInc
P04141	CSF2	Granulocyte-macrophage colony-stimulating factor	GO:0005129; F:granulocyte macrophage colony-stimulating factor receptor binding; TAS:ProtInc
P04141	CSF2	Granulocyte-macrophage colony-stimulating factor	GO:0005515; F:protein binding; IPI:IntAct
P04141	CSF2	Granulocyte-macrophage colony-stimulating factor	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
P04141	CSF2	Granulocyte-macrophage colony-stimulating factor	GO:0097028; P:dendritic cell differentiation; IDA:DFLAT
P04141	CSF2	Granulocyte-macrophage colony-stimulating factor	GO:0001892; P:embryonic placenta development; IEA:Ensembl
P04141	CSF2	Granulocyte-macrophage colony-stimulating factor	GO:0042045; P:epithelial fluid transport; IEA:Ensembl
P04141	CSF2	Granulocyte-macrophage colony-stimulating factor	GO:0006955; P:immune response; IEA:InterPro
P04141	CSF2	Granulocyte-macrophage colony-stimulating factor	GO:0042116; P:macrophage activation; IEA:Ensembl
P04141	CSF2	Granulocyte-macrophage colony-stimulating factor	GO:0043011; P:myeloid dendritic cell differentiation; IEA:Ensembl
P04141	CSF2	Granulocyte-macrophage colony-stimulating factor	GO:0045918; P:negative regulation of cytolysis; IDA:BHF-UCL
P04141	CSF2	Granulocyte-macrophage colony-stimulating factor	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IDA:BHF-UCL
P04141	CSF2	Granulocyte-macrophage colony-stimulating factor	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P04141	CSF2	Granulocyte-macrophage colony-stimulating factor	GO:0045740; P:positive regulation of DNA replication; IDA:BHF-UCL
P04141	CSF2	Granulocyte-macrophage colony-stimulating factor	GO:0010628; P:positive regulation of gene expression; IDA:BHF-UCL
P04141	CSF2	Granulocyte-macrophage colony-stimulating factor	GO:0032747; P:positive regulation of interleukin-23 production; IDA:BHF-UCL
P04141	CSF2	Granulocyte-macrophage colony-stimulating factor	GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; IDA:BHF-UCL
P04141	CSF2	Granulocyte-macrophage colony-stimulating factor	GO:0071803; P:positive regulation of podosome assembly; IDA:BHF-UCL
P04141	CSF2	Granulocyte-macrophage colony-stimulating factor	GO:0042523; P:positive regulation of tyrosine phosphorylation of Stat5 protein; IDA:BHF-UCL
Q99062	CSF3R	Granulocyte colony-stimulating factor receptor	GO:0004896; F:cytokine receptor activity; IEA:InterPro
Q99062	CSF3R	Granulocyte colony-stimulating factor receptor	GO:0005515; F:protein binding; IPI:IntAct
Q99062	CSF3R	Granulocyte colony-stimulating factor receptor	GO:0004872; F:receptor activity; TAS:ProtInc
Q99062	CSF3R	Granulocyte colony-stimulating factor receptor	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q99062	CSF3R	Granulocyte colony-stimulating factor receptor	GO:0006952; P:defense response; TAS:ProtInc
Q99062	CSF3R	Granulocyte colony-stimulating factor receptor	GO:0030593; P:neutrophil chemotaxis; IEA:Ensembl
Q99062	CSF3R	Granulocyte colony-stimulating factor receptor	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
Q99062	CSF3R	Granulocyte colony-stimulating factor receptor	GO:0007165; P:signal transduction; NAS:ProtInc
P09919	CSF3	Granulocyte colony-stimulating factor	GO:0005125; F:cytokine activity; NAS:UniProtKB
P09919	CSF3	Granulocyte colony-stimulating factor	GO:0019899; F:enzyme binding; IPI:UniProtKB
P09919	CSF3	Granulocyte colony-stimulating factor	GO:0005130; F:granulocyte colony-stimulating factor receptor binding; TAS:ProtInc
P09919	CSF3	Granulocyte colony-stimulating factor	GO:0071345; P:cellular response to cytokine stimulus; IDA:BHF-UCL
P09919	CSF3	Granulocyte colony-stimulating factor	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
P09919	CSF3	Granulocyte colony-stimulating factor	GO:0019221; P:cytokine-mediated signaling pathway; NAS:UniProtKB
P09919	CSF3	Granulocyte colony-stimulating factor	GO:0030851; P:granulocyte differentiation; NAS:UniProtKB
P09919	CSF3	Granulocyte colony-stimulating factor	GO:0006955; P:immune response; IEA:InterPro
P09919	CSF3	Granulocyte colony-stimulating factor	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P09919	CSF3	Granulocyte colony-stimulating factor	GO:1901215; P:negative regulation of neuron death; IEA:Ensembl
P09919	CSF3	Granulocyte colony-stimulating factor	GO:2000251; P:positive regulation of actin cytoskeleton reorganization; IDA:BHF-UCL
P09919	CSF3	Granulocyte colony-stimulating factor	GO:0030838; P:positive regulation of actin filament polymerization; IDA:BHF-UCL
P09919	CSF3	Granulocyte colony-stimulating factor	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P09919	CSF3	Granulocyte colony-stimulating factor	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:BHF-UCL
P09919	CSF3	Granulocyte colony-stimulating factor	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL
P09919	CSF3	Granulocyte colony-stimulating factor	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IDA:BHF-UCL
P09919	CSF3	Granulocyte colony-stimulating factor	GO:0032092; P:positive regulation of protein binding; IDA:BHF-UCL
P09919	CSF3	Granulocyte colony-stimulating factor	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:BHF-UCL
P09919	CSF3	Granulocyte colony-stimulating factor	GO:0042993; P:positive regulation of transcription factor import into nucleus; IDA:BHF-UCL
P09919	CSF3	Granulocyte colony-stimulating factor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q14406	CSHL1	Chorionic somatomammotropin hormone-like 1	GO:0005179; F:hormone activity; NAS:UniProtKB
Q14406	CSHL1	Chorionic somatomammotropin hormone-like 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P01243	CSH1	Chorionic somatomammotropin hormone	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P01243	CSH1	Chorionic somatomammotropin hormone	GO:0007565; P:female pregnancy; TAS:ProtInc
P01243	CSH1	Chorionic somatomammotropin hormone	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome
P01243	CSH1	Chorionic somatomammotropin hormone	GO:0007165; P:signal transduction; NAS:ProtInc
P68400	CSNK2A1	Casein kinase II subunit alpha	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P68400	CSNK2A1	Casein kinase II subunit alpha	GO:0051879; F:Hsp90 protein binding; TAS:UniProtKB
P68400	CSNK2A1	Casein kinase II subunit alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P68400	CSNK2A1	Casein kinase II subunit alpha	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
P68400	CSNK2A1	Casein kinase II subunit alpha	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P68400	CSNK2A1	Casein kinase II subunit alpha	GO:0007411; P:axon guidance; TAS:Reactome
P68400	CSNK2A1	Casein kinase II subunit alpha	GO:0061077; P:chaperone-mediated protein folding; TAS:UniProtKB
P68400	CSNK2A1	Casein kinase II subunit alpha	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P68400	CSNK2A1	Casein kinase II subunit alpha	GO:0071174; P:mitotic spindle checkpoint; IMP:UniProtKB
P68400	CSNK2A1	Casein kinase II subunit alpha	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
P68400	CSNK2A1	Casein kinase II subunit alpha	GO:0030307; P:positive regulation of cell growth; IDA:UniProtKB
P68400	CSNK2A1	Casein kinase II subunit alpha	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P68400	CSNK2A1	Casein kinase II subunit alpha	GO:0045732; P:positive regulation of protein catabolic process; IDA:UniProtKB
P68400	CSNK2A1	Casein kinase II subunit alpha	GO:0030177; P:positive regulation of Wnt signaling pathway; IMP:UniProtKB
P68400	CSNK2A1	Casein kinase II subunit alpha	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P68400	CSNK2A1	Casein kinase II subunit alpha	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P68400	CSNK2A1	Casein kinase II subunit alpha	GO:0007165; P:signal transduction; TAS:ProtInc
P68400	CSNK2A1	Casein kinase II subunit alpha	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P68400	CSNK2A1	Casein kinase II subunit alpha	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P19784	CSNK2A2	Casein kinase II subunit alpha'	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P19784	CSNK2A2	Casein kinase II subunit alpha'	GO:0005515; F:protein binding; IPI:IntAct
P19784	CSNK2A2	Casein kinase II subunit alpha'	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
P19784	CSNK2A2	Casein kinase II subunit alpha'	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
P19784	CSNK2A2	Casein kinase II subunit alpha'	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P19784	CSNK2A2	Casein kinase II subunit alpha'	GO:0007411; P:axon guidance; TAS:Reactome
P19784	CSNK2A2	Casein kinase II subunit alpha'	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P19784	CSNK2A2	Casein kinase II subunit alpha'	GO:0071174; P:mitotic spindle checkpoint; IMP:UniProtKB
P19784	CSNK2A2	Casein kinase II subunit alpha'	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P19784	CSNK2A2	Casein kinase II subunit alpha'	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P19784	CSNK2A2	Casein kinase II subunit alpha'	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q8NEV1	CSNK2A3	Casein kinase II subunit alpha 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NEV1	CSNK2A3	Casein kinase II subunit alpha 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NEV1	CSNK2A3	Casein kinase II subunit alpha 3	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q8NEV1	CSNK2A3	Casein kinase II subunit alpha 3	GO:0030307; P:positive regulation of cell growth; IDA:UniProtKB
Q8NEV1	CSNK2A3	Casein kinase II subunit alpha 3	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q8NEV1	CSNK2A3	Casein kinase II subunit alpha 3	GO:0045732; P:positive regulation of protein catabolic process; IDA:UniProtKB
Q8NEV1	CSNK2A3	Casein kinase II subunit alpha 3	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P67870	CSNK2B	Casein kinase II subunit beta	GO:0042802; F:identical protein binding; IPI:IntAct
P67870	CSNK2B	Casein kinase II subunit beta	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P67870	CSNK2B	Casein kinase II subunit beta	GO:0005515; F:protein binding; IPI:IntAct
P67870	CSNK2B	Casein kinase II subunit beta	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P67870	CSNK2B	Casein kinase II subunit beta	GO:0019887; F:protein kinase regulator activity; NAS:UniProtKB
P67870	CSNK2B	Casein kinase II subunit beta	GO:0005102; F:receptor binding; IPI:BHF-UCL
P67870	CSNK2B	Casein kinase II subunit beta	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P67870	CSNK2B	Casein kinase II subunit beta	GO:0033211; P:adiponectin-activated signaling pathway; IDA:BHF-UCL
P67870	CSNK2B	Casein kinase II subunit beta	GO:0007411; P:axon guidance; TAS:Reactome
P67870	CSNK2B	Casein kinase II subunit beta	GO:0043623; P:cellular protein complex assembly; NAS:BHF-UCL
P67870	CSNK2B	Casein kinase II subunit beta	GO:0061154; P:endothelial tube morphogenesis; IMP:BHF-UCL
P67870	CSNK2B	Casein kinase II subunit beta	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P67870	CSNK2B	Casein kinase II subunit beta	GO:0043537; P:negative regulation of blood vessel endothelial cell migration; IDA:BHF-UCL
P67870	CSNK2B	Casein kinase II subunit beta	GO:0008285; P:negative regulation of cell proliferation; TAS:BHF-UCL
P67870	CSNK2B	Casein kinase II subunit beta	GO:0032927; P:positive regulation of activin receptor signaling pathway; IMP:BHF-UCL
P67870	CSNK2B	Casein kinase II subunit beta	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
P67870	CSNK2B	Casein kinase II subunit beta	GO:0006468; P:protein phosphorylation; TAS:GOC
P67870	CSNK2B	Casein kinase II subunit beta	GO:0051101; P:regulation of DNA binding; NAS:BHF-UCL
P67870	CSNK2B	Casein kinase II subunit beta	GO:0045859; P:regulation of protein kinase activity; NAS:GOC
P67870	CSNK2B	Casein kinase II subunit beta	GO:0007165; P:signal transduction; TAS:UniProtKB
P67870	CSNK2B	Casein kinase II subunit beta	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q8WXD9	CASKIN1	Caskin-1	GO:0005515; F:protein binding; IPI:IntAct
Q8WXD9	CASKIN1	Caskin-1	GO:0007165; P:signal transduction; ISS:UniProtKB
O14936	CASK	Peripheral plasma membrane protein CASK	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O14936	CASK	Peripheral plasma membrane protein CASK	GO:0004385; F:guanylate kinase activity; TAS:ProtInc
O14936	CASK	Peripheral plasma membrane protein CASK	GO:0005515; F:protein binding; IPI:IntAct
O14936	CASK	Peripheral plasma membrane protein CASK	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
O14936	CASK	Peripheral plasma membrane protein CASK	GO:0070509; P:calcium ion import; IEA:Ensembl
O14936	CASK	Peripheral plasma membrane protein CASK	GO:0007155; P:cell adhesion; TAS:ProtInc
O14936	CASK	Peripheral plasma membrane protein CASK	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O14936	CASK	Peripheral plasma membrane protein CASK	GO:0001953; P:negative regulation of cell-matrix adhesion; IMP:BHF-UCL
O14936	CASK	Peripheral plasma membrane protein CASK	GO:0090288; P:negative regulation of cellular response to growth factor stimulus; IMP:BHF-UCL
O14936	CASK	Peripheral plasma membrane protein CASK	GO:0010839; P:negative regulation of keratinocyte proliferation; IMP:BHF-UCL
O14936	CASK	Peripheral plasma membrane protein CASK	GO:0061045; P:negative regulation of wound healing; IMP:BHF-UCL
O14936	CASK	Peripheral plasma membrane protein CASK	GO:0046939; P:nucleotide phosphorylation; TAS:GOC
O14936	CASK	Peripheral plasma membrane protein CASK	GO:0090280; P:positive regulation of calcium ion import; IEA:Ensembl
O14936	CASK	Peripheral plasma membrane protein CASK	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P41240	CSK	Tyrosine-protein kinase CSK	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P41240	CSK	Tyrosine-protein kinase CSK	GO:0042802; F:identical protein binding; IPI:IntAct
P41240	CSK	Tyrosine-protein kinase CSK	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC
P41240	CSK	Tyrosine-protein kinase CSK	GO:0005515; F:protein binding; IPI:UniProtKB
P41240	CSK	Tyrosine-protein kinase CSK	GO:0008022; F:protein C-terminus binding; TAS:ProtInc
P41240	CSK	Tyrosine-protein kinase CSK	GO:0004713; F:protein tyrosine kinase activity; TAS:Reactome
P41240	CSK	Tyrosine-protein kinase CSK	GO:0034332; P:adherens junction organization; IEA:Ensembl
P41240	CSK	Tyrosine-protein kinase CSK	GO:0007596; P:blood coagulation; TAS:Reactome
P41240	CSK	Tyrosine-protein kinase CSK	GO:0007420; P:brain development; IEA:Ensembl
P41240	CSK	Tyrosine-protein kinase CSK	GO:0071375; P:cellular response to peptide hormone stimulus; IEA:Ensembl
P41240	CSK	Tyrosine-protein kinase CSK	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P41240	CSK	Tyrosine-protein kinase CSK	GO:0045779; P:negative regulation of bone resorption; IEA:Ensembl
P41240	CSK	Tyrosine-protein kinase CSK	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P41240	CSK	Tyrosine-protein kinase CSK	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IEA:Ensembl
P41240	CSK	Tyrosine-protein kinase CSK	GO:0042997; P:negative regulation of Golgi to plasma membrane protein transport; IDA:UniProtKB
P41240	CSK	Tyrosine-protein kinase CSK	GO:0032715; P:negative regulation of interleukin-6 production; IEA:Ensembl
P41240	CSK	Tyrosine-protein kinase CSK	GO:0033673; P:negative regulation of kinase activity; IEA:Ensembl
P41240	CSK	Tyrosine-protein kinase CSK	GO:0010989; P:negative regulation of low-density lipoprotein particle clearance; IEA:Ensembl
P41240	CSK	Tyrosine-protein kinase CSK	GO:0050765; P:negative regulation of phagocytosis; IEA:Ensembl
P41240	CSK	Tyrosine-protein kinase CSK	GO:0048709; P:oligodendrocyte differentiation; IEA:Ensembl
P41240	CSK	Tyrosine-protein kinase CSK	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:GOC
P41240	CSK	Tyrosine-protein kinase CSK	GO:0030168; P:platelet activation; TAS:Reactome
P41240	CSK	Tyrosine-protein kinase CSK	GO:0043406; P:positive regulation of MAP kinase activity; IEA:Ensembl
P41240	CSK	Tyrosine-protein kinase CSK	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
P41240	CSK	Tyrosine-protein kinase CSK	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P41240	CSK	Tyrosine-protein kinase CSK	GO:0060368; P:regulation of Fc receptor mediated stimulatory signaling pathway; IEA:Ensembl
P41240	CSK	Tyrosine-protein kinase CSK	GO:0031295; P:T cell costimulation; TAS:Reactome
P41240	CSK	Tyrosine-protein kinase CSK	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q13098	GPS1	COP9 signalosome complex subunit 1	GO:0005095; F:GTPase inhibitor activity; TAS:ProtInc
Q13098	GPS1	COP9 signalosome complex subunit 1	GO:0005515; F:protein binding; IPI:IntAct
Q13098	GPS1	COP9 signalosome complex subunit 1	GO:0007049; P:cell cycle; TAS:ProtInc
Q13098	GPS1	COP9 signalosome complex subunit 1	GO:0010388; P:cullin deneddylation; IDA:UniProtKB
Q13098	GPS1	COP9 signalosome complex subunit 1	GO:0000188; P:inactivation of MAPK activity; TAS:ProtInc
Q13098	GPS1	COP9 signalosome complex subunit 1	GO:0007254; P:JNK cascade; TAS:ProtInc
P61201	COPS2	COP9 signalosome complex subunit 2	GO:0005515; F:protein binding; IPI:UniProtKB
P61201	COPS2	COP9 signalosome complex subunit 2	GO:0004871; F:signal transducer activity; NAS:UniProtKB
P61201	COPS2	COP9 signalosome complex subunit 2	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
P61201	COPS2	COP9 signalosome complex subunit 2	GO:0008283; P:cell proliferation; IEA:Ensembl
P61201	COPS2	COP9 signalosome complex subunit 2	GO:0010388; P:cullin deneddylation; IDA:UniProtKB
P61201	COPS2	COP9 signalosome complex subunit 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P61201	COPS2	COP9 signalosome complex subunit 2	GO:0030182; P:neuron differentiation; IEA:Ensembl
P61201	COPS2	COP9 signalosome complex subunit 2	GO:0007165; P:signal transduction; NAS:UniProtKB
P61201	COPS2	COP9 signalosome complex subunit 2	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
P61201	COPS2	COP9 signalosome complex subunit 2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:UniProtKB
Q9UNS2	COPS3	COP9 signalosome complex subunit 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UNS2	COPS3	COP9 signalosome complex subunit 3	GO:0010388; P:cullin deneddylation; IDA:UniProtKB
Q9UNS2	COPS3	COP9 signalosome complex subunit 3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9UNS2	COPS3	COP9 signalosome complex subunit 3	GO:0009416; P:response to light stimulus; TAS:ProtInc
Q9UNS2	COPS3	COP9 signalosome complex subunit 3	GO:0007165; P:signal transduction; TAS:ProtInc
Q9BT78	COPS4	COP9 signalosome complex subunit 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BT78	COPS4	COP9 signalosome complex subunit 4	GO:0010388; P:cullin deneddylation; IDA:UniProtKB
Q9BT78	COPS4	COP9 signalosome complex subunit 4	GO:0000338; P:protein deneddylation; IMP:UniProtKB
Q92905	COPS5	COP9 signalosome complex subunit 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q92905	COPS5	COP9 signalosome complex subunit 5	GO:0008237; F:metallopeptidase activity; IMP:UniProtKB
Q92905	COPS5	COP9 signalosome complex subunit 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q92905	COPS5	COP9 signalosome complex subunit 5	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q92905	COPS5	COP9 signalosome complex subunit 5	GO:0003743; F:translation initiation factor activity; TAS:ProtInc
Q92905	COPS5	COP9 signalosome complex subunit 5	GO:0004843; F:ubiquitin-specific protease activity; IDA:FlyBase
Q92905	COPS5	COP9 signalosome complex subunit 5	GO:0010388; P:cullin deneddylation; IDA:UniProtKB
Q92905	COPS5	COP9 signalosome complex subunit 5	GO:1990182; P:exosomal secretion; IDA:FlyBase
Q92905	COPS5	COP9 signalosome complex subunit 5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q92905	COPS5	COP9 signalosome complex subunit 5	GO:0000338; P:protein deneddylation; IMP:UniProtKB
Q92905	COPS5	COP9 signalosome complex subunit 5	GO:0016579; P:protein deubiquitination; IDA:FlyBase
Q92905	COPS5	COP9 signalosome complex subunit 5	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
Q92905	COPS5	COP9 signalosome complex subunit 5	GO:0046328; P:regulation of JNK cascade; IDA:UniProtKB
Q92905	COPS5	COP9 signalosome complex subunit 5	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q92905	COPS5	COP9 signalosome complex subunit 5	GO:0006412; P:translation; TAS:ProtInc
Q92905	COPS5	COP9 signalosome complex subunit 5	GO:0006413; P:translational initiation; TAS:GOC
Q7L5N1	COPS6	COP9 signalosome complex subunit 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q7L5N1	COPS6	COP9 signalosome complex subunit 6	GO:0010388; P:cullin deneddylation; IDA:UniProtKB
Q7L5N1	COPS6	COP9 signalosome complex subunit 6	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9UBW8	COPS7A	COP9 signalosome complex subunit 7a	GO:0010388; P:cullin deneddylation; IDA:UniProtKB
Q9H9Q2	COPS7B	COP9 signalosome complex subunit 7b	GO:0010388; P:cullin deneddylation; IDA:UniProtKB
Q99627	COPS8	COP9 signalosome complex subunit 8	GO:0007250; P:activation of NF-kappaB-inducing kinase activity; IMP:UniProt
Q99627	COPS8	COP9 signalosome complex subunit 8	GO:0010388; P:cullin deneddylation; IDA:UniProtKB
Q99627	COPS8	COP9 signalosome complex subunit 8	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProt
P13611	VCAN	Versican core protein	GO:0005509; F:calcium ion binding; IEA:InterPro
P13611	VCAN	Versican core protein	GO:0030246; F:carbohydrate binding; IEA:InterPro
P13611	VCAN	Versican core protein	GO:0005539; F:glycosaminoglycan binding; TAS:ProtInc
P13611	VCAN	Versican core protein	GO:0005540; F:hyaluronic acid binding; TAS:ProtInc
P13611	VCAN	Versican core protein	GO:0005515; F:protein binding; IPI:IntAct
P13611	VCAN	Versican core protein	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P13611	VCAN	Versican core protein	GO:0007155; P:cell adhesion; TAS:ProtInc
P13611	VCAN	Versican core protein	GO:0008037; P:cell recognition; TAS:ProtInc
P13611	VCAN	Versican core protein	GO:0030206; P:chondroitin sulfate biosynthetic process; TAS:Reactome
P13611	VCAN	Versican core protein	GO:0030207; P:chondroitin sulfate catabolic process; TAS:Reactome
P13611	VCAN	Versican core protein	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
P13611	VCAN	Versican core protein	GO:0030208; P:dermatan sulfate biosynthetic process; TAS:Reactome
P13611	VCAN	Versican core protein	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P13611	VCAN	Versican core protein	GO:0008347; P:glial cell migration; IDA:BHF-UCL
P13611	VCAN	Versican core protein	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P13611	VCAN	Versican core protein	GO:0007507; P:heart development; IEA:Ensembl
P13611	VCAN	Versican core protein	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P13611	VCAN	Versican core protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6UVK1	CSPG4	Chondroitin sulfate proteoglycan 4	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q6UVK1	CSPG4	Chondroitin sulfate proteoglycan 4	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
Q6UVK1	CSPG4	Chondroitin sulfate proteoglycan 4	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
Q6UVK1	CSPG4	Chondroitin sulfate proteoglycan 4	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q6UVK1	CSPG4	Chondroitin sulfate proteoglycan 4	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q6UVK1	CSPG4	Chondroitin sulfate proteoglycan 4	GO:0008283; P:cell proliferation; IEA:Ensembl
Q6UVK1	CSPG4	Chondroitin sulfate proteoglycan 4	GO:0030206; P:chondroitin sulfate biosynthetic process; TAS:Reactome
Q6UVK1	CSPG4	Chondroitin sulfate proteoglycan 4	GO:0030207; P:chondroitin sulfate catabolic process; TAS:Reactome
Q6UVK1	CSPG4	Chondroitin sulfate proteoglycan 4	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q6UVK1	CSPG4	Chondroitin sulfate proteoglycan 4	GO:0030208; P:dermatan sulfate biosynthetic process; TAS:Reactome
Q6UVK1	CSPG4	Chondroitin sulfate proteoglycan 4	GO:0008347; P:glial cell migration; IEA:Ensembl
Q6UVK1	CSPG4	Chondroitin sulfate proteoglycan 4	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q6UVK1	CSPG4	Chondroitin sulfate proteoglycan 4	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q6UVK1	CSPG4	Chondroitin sulfate proteoglycan 4	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
Q6UVK1	CSPG4	Chondroitin sulfate proteoglycan 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6UVK1	CSPG4	Chondroitin sulfate proteoglycan 4	GO:0048771; P:tissue remodeling; IEA:UniProtKB-KW
Q6UVK1	CSPG4	Chondroitin sulfate proteoglycan 4	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:Ensembl
O95196	CSPG5	Chondroitin sulfate proteoglycan 5	GO:0008083; F:growth factor activity; TAS:UniProtKB
O95196	CSPG5	Chondroitin sulfate proteoglycan 5	GO:0005515; F:protein binding; IPI:UniProtKB
O95196	CSPG5	Chondroitin sulfate proteoglycan 5	GO:0031103; P:axon regeneration; IEA:Ensembl
O95196	CSPG5	Chondroitin sulfate proteoglycan 5	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O95196	CSPG5	Chondroitin sulfate proteoglycan 5	GO:0030206; P:chondroitin sulfate biosynthetic process; TAS:Reactome
O95196	CSPG5	Chondroitin sulfate proteoglycan 5	GO:0030207; P:chondroitin sulfate catabolic process; TAS:Reactome
O95196	CSPG5	Chondroitin sulfate proteoglycan 5	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
O95196	CSPG5	Chondroitin sulfate proteoglycan 5	GO:0030208; P:dermatan sulfate biosynthetic process; TAS:Reactome
O95196	CSPG5	Chondroitin sulfate proteoglycan 5	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O95196	CSPG5	Chondroitin sulfate proteoglycan 5	GO:0046907; P:intracellular transport; TAS:UniProtKB
O95196	CSPG5	Chondroitin sulfate proteoglycan 5	GO:0007399; P:nervous system development; TAS:UniProtKB
O95196	CSPG5	Chondroitin sulfate proteoglycan 5	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
O95196	CSPG5	Chondroitin sulfate proteoglycan 5	GO:0050804; P:regulation of synaptic transmission; IEA:Ensembl
O95196	CSPG5	Chondroitin sulfate proteoglycan 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q1MSJ5	CSPP1	Centrosome and spindle pole-associated protein 1	GO:0051781; P:positive regulation of cell division; IMP:UniProtKB
Q1MSJ5	CSPP1	Centrosome and spindle pole-associated protein 1	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB
Q9H8E8	CSRP2BP	Cysteine-rich protein 2-binding protein	GO:0004402; F:histone acetyltransferase activity; IDA:MGI
Q9H8E8	CSRP2BP	Cysteine-rich protein 2-binding protein	GO:0030274; F:LIM domain binding; NAS:UniProtKB
Q9H8E8	CSRP2BP	Cysteine-rich protein 2-binding protein	GO:0005515; F:protein binding; IPI:IntAct
Q9H8E8	CSRP2BP	Cysteine-rich protein 2-binding protein	GO:0006325; P:chromatin organization; TAS:Reactome
Q9H8E8	CSRP2BP	Cysteine-rich protein 2-binding protein	GO:0009790; P:embryo development; IEA:Ensembl
Q9H8E8	CSRP2BP	Cysteine-rich protein 2-binding protein	GO:0000086; P:G2/M transition of mitotic cell cycle; IEA:Ensembl
Q9H8E8	CSRP2BP	Cysteine-rich protein 2-binding protein	GO:0043966; P:histone H3 acetylation; IDA:BHF-UCL
Q96S65	CSRNP1	Cysteine/serine-rich nuclear protein 1	GO:0001228; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q96S65	CSRNP1	Cysteine/serine-rich nuclear protein 1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q96S65	CSRNP1	Cysteine/serine-rich nuclear protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q96S65	CSRNP1	Cysteine/serine-rich nuclear protein 1	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q96S65	CSRNP1	Cysteine/serine-rich nuclear protein 1	GO:0060325; P:face morphogenesis; IEA:Ensembl
Q96S65	CSRNP1	Cysteine/serine-rich nuclear protein 1	GO:0060021; P:palate development; IEA:Ensembl
Q96S65	CSRNP1	Cysteine/serine-rich nuclear protein 1	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IEA:Ensembl
Q96S65	CSRNP1	Cysteine/serine-rich nuclear protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q96S65	CSRNP1	Cysteine/serine-rich nuclear protein 1	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q96S65	CSRNP1	Cysteine/serine-rich nuclear protein 1	GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl
Q9H175	CSRNP2	Cysteine/serine-rich nuclear protein 2	GO:0019902; F:phosphatase binding; IDA:UniProtKB
Q9H175	CSRNP2	Cysteine/serine-rich nuclear protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q9H175	CSRNP2	Cysteine/serine-rich nuclear protein 2	GO:0001228; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q9H175	CSRNP2	Cysteine/serine-rich nuclear protein 2	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q9H175	CSRNP2	Cysteine/serine-rich nuclear protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q9H175	CSRNP2	Cysteine/serine-rich nuclear protein 2	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9H175	CSRNP2	Cysteine/serine-rich nuclear protein 2	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q9H175	CSRNP2	Cysteine/serine-rich nuclear protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q8WYN3	CSRNP3	Cysteine/serine-rich nuclear protein 3	GO:0001228; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q8WYN3	CSRNP3	Cysteine/serine-rich nuclear protein 3	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q8WYN3	CSRNP3	Cysteine/serine-rich nuclear protein 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q8WYN3	CSRNP3	Cysteine/serine-rich nuclear protein 3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8WYN3	CSRNP3	Cysteine/serine-rich nuclear protein 3	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q8WYN3	CSRNP3	Cysteine/serine-rich nuclear protein 3	GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB
Q8WYN3	CSRNP3	Cysteine/serine-rich nuclear protein 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
P21291	CSRP1	Cysteine and glycine-rich protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P21291	CSRP1	Cysteine and glycine-rich protein 1	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q16527	CSRP2	Cysteine and glycine-rich protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q16527	CSRP2	Cysteine and glycine-rich protein 2	GO:0030154; P:cell differentiation; NAS:UniProtKB
Q16527	CSRP2	Cysteine and glycine-rich protein 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P50461	CSRP3	Cysteine and glycine-rich protein 3	GO:0042805; F:actinin binding; ISS:BHF-UCL
P50461	CSRP3	Cysteine and glycine-rich protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
P50461	CSRP3	Cysteine and glycine-rich protein 3	GO:0008307; F:structural constituent of muscle; IMP:BHF-UCL
P50461	CSRP3	Cysteine and glycine-rich protein 3	GO:0031433; F:telethonin binding; IDA:BHF-UCL
P50461	CSRP3	Cysteine and glycine-rich protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
P50461	CSRP3	Cysteine and glycine-rich protein 3	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
P50461	CSRP3	Cysteine and glycine-rich protein 3	GO:0003300; P:cardiac muscle hypertrophy; IMP:BHF-UCL
P50461	CSRP3	Cysteine and glycine-rich protein 3	GO:0048738; P:cardiac muscle tissue development; ISS:BHF-UCL
P50461	CSRP3	Cysteine and glycine-rich protein 3	GO:0055003; P:cardiac myofibril assembly; ISS:BHF-UCL
P50461	CSRP3	Cysteine and glycine-rich protein 3	GO:0006874; P:cellular calcium ion homeostasis; ISS:BHF-UCL
P50461	CSRP3	Cysteine and glycine-rich protein 3	GO:0035995; P:detection of muscle stretch; IMP:BHF-UCL
P50461	CSRP3	Cysteine and glycine-rich protein 3	GO:0033365; P:protein localization to organelle; IMP:BHF-UCL
P50461	CSRP3	Cysteine and glycine-rich protein 3	GO:0002026; P:regulation of the force of heart contraction; ISS:BHF-UCL
P50461	CSRP3	Cysteine and glycine-rich protein 3	GO:0007519; P:skeletal muscle tissue development; TAS:ProtInc
Q9H112	CST11	Cystatin-11	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q9H112	CST11	Cystatin-11	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q9H114	CSTL1	Cystatin-like 1	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
O60676	CST8	Cystatin-8	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; TAS:ProtInc
O60676	CST8	Cystatin-8	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
Q9H4G1	CST9L	Cystatin-9-like	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q5W188	CST9LP1	Putative cystatin-9-like protein CST9LP1	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q5W186	CST9	Cystatin-9	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q05048	CSTF1	Cleavage stimulation factor subunit 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q05048	CSTF1	Cleavage stimulation factor subunit 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q05048	CSTF1	Cleavage stimulation factor subunit 1	GO:0003723; F:RNA binding; TAS:ProtInc
Q05048	CSTF1	Cleavage stimulation factor subunit 1	GO:0010467; P:gene expression; TAS:Reactome
Q05048	CSTF1	Cleavage stimulation factor subunit 1	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q05048	CSTF1	Cleavage stimulation factor subunit 1	GO:0006379; P:mRNA cleavage; TAS:ProtInc
Q05048	CSTF1	Cleavage stimulation factor subunit 1	GO:0006378; P:mRNA polyadenylation; TAS:ProtInc
Q05048	CSTF1	Cleavage stimulation factor subunit 1	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q05048	CSTF1	Cleavage stimulation factor subunit 1	GO:0006396; P:RNA processing; TAS:ProtInc
Q05048	CSTF1	Cleavage stimulation factor subunit 1	GO:0008380; P:RNA splicing; TAS:Reactome
Q05048	CSTF1	Cleavage stimulation factor subunit 1	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q05048	CSTF1	Cleavage stimulation factor subunit 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
P33240	CSTF2	Cleavage stimulation factor subunit 2	GO:0000166; F:nucleotide binding; IEA:InterPro
P33240	CSTF2	Cleavage stimulation factor subunit 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P33240	CSTF2	Cleavage stimulation factor subunit 2	GO:0005515; F:protein binding; IPI:IntAct
P33240	CSTF2	Cleavage stimulation factor subunit 2	GO:0003723; F:RNA binding; TAS:ProtInc
P33240	CSTF2	Cleavage stimulation factor subunit 2	GO:0010467; P:gene expression; TAS:Reactome
P33240	CSTF2	Cleavage stimulation factor subunit 2	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
P33240	CSTF2	Cleavage stimulation factor subunit 2	GO:0006379; P:mRNA cleavage; TAS:ProtInc
P33240	CSTF2	Cleavage stimulation factor subunit 2	GO:0006378; P:mRNA polyadenylation; TAS:ProtInc
P33240	CSTF2	Cleavage stimulation factor subunit 2	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P33240	CSTF2	Cleavage stimulation factor subunit 2	GO:0008380; P:RNA splicing; TAS:Reactome
P33240	CSTF2	Cleavage stimulation factor subunit 2	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
P33240	CSTF2	Cleavage stimulation factor subunit 2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q12996	CSTF3	Cleavage stimulation factor subunit 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q12996	CSTF3	Cleavage stimulation factor subunit 3	GO:0003723; F:RNA binding; TAS:ProtInc
Q12996	CSTF3	Cleavage stimulation factor subunit 3	GO:0010467; P:gene expression; TAS:Reactome
Q12996	CSTF3	Cleavage stimulation factor subunit 3	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q12996	CSTF3	Cleavage stimulation factor subunit 3	GO:0006379; P:mRNA cleavage; TAS:ProtInc
Q12996	CSTF3	Cleavage stimulation factor subunit 3	GO:0006378; P:mRNA polyadenylation; TAS:ProtInc
Q12996	CSTF3	Cleavage stimulation factor subunit 3	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q12996	CSTF3	Cleavage stimulation factor subunit 3	GO:0008380; P:RNA splicing; TAS:Reactome
Q12996	CSTF3	Cleavage stimulation factor subunit 3	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q12996	CSTF3	Cleavage stimulation factor subunit 3	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q9H0L4	CSTF2T	Cleavage stimulation factor subunit 2 tau variant	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9H0L4	CSTF2T	Cleavage stimulation factor subunit 2 tau variant	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H0L4	CSTF2T	Cleavage stimulation factor subunit 2 tau variant	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
O94985	CLSTN1	Calsyntenin-1	GO:0001540; F:beta-amyloid binding; IDA:UniProt
O94985	CLSTN1	Calsyntenin-1	GO:0005509; F:calcium ion binding; IEA:InterPro
O94985	CLSTN1	Calsyntenin-1	GO:0019894; F:kinesin binding; IPI:UniProt
O94985	CLSTN1	Calsyntenin-1	GO:0005515; F:protein binding; IPI:IntAct
O94985	CLSTN1	Calsyntenin-1	GO:0042988; F:X11-like protein binding; IPI:UniProt
O94985	CLSTN1	Calsyntenin-1	GO:0007155; P:cell adhesion; TAS:UniProt
O94985	CLSTN1	Calsyntenin-1	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9H4D0	CLSTN2	Calsyntenin-2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9H4D0	CLSTN2	Calsyntenin-2	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9BQT9	CLSTN3	Calsyntenin-3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9BQT9	CLSTN3	Calsyntenin-3	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9P2B4	CTTNBP2NL	CTTNBP2 N-terminal-like protein	GO:0005515; F:protein binding; IPI:IntAct
Q8WYA6	CTNNBL1	Beta-catenin-like protein 1	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q8WYA6	CTNNBL1	Beta-catenin-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WYA6	CTNNBL1	Beta-catenin-like protein 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8WYA6	CTNNBL1	Beta-catenin-like protein 1	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q8WYA6	CTNNBL1	Beta-catenin-like protein 1	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q8WYA6	CTNNBL1	Beta-catenin-like protein 1	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q8WYA6	CTNNBL1	Beta-catenin-like protein 1	GO:0016445; P:somatic diversification of immunoglobulins; IMP:UniProtKB
Q13363	CTBP1	C-terminal-binding protein 1	GO:0051287; F:NAD binding; ISS:UniProtKB
Q13363	CTBP1	C-terminal-binding protein 1	GO:0016616; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; IEA:InterPro
Q13363	CTBP1	C-terminal-binding protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13363	CTBP1	C-terminal-binding protein 1	GO:0008022; F:protein C-terminus binding; TAS:ProtInc
Q13363	CTBP1	C-terminal-binding protein 1	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q13363	CTBP1	C-terminal-binding protein 1	GO:0070491; F:repressing transcription factor binding; IPI:BHF-UCL
Q13363	CTBP1	C-terminal-binding protein 1	GO:0001106; F:RNA polymerase II transcription corepressor activity; IDA:BHF-UCL
Q13363	CTBP1	C-terminal-binding protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q13363	CTBP1	C-terminal-binding protein 1	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q13363	CTBP1	C-terminal-binding protein 1	GO:0007030; P:Golgi organization; IEA:Ensembl
Q13363	CTBP1	C-terminal-binding protein 1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q13363	CTBP1	C-terminal-binding protein 1	GO:0035067; P:negative regulation of histone acetylation; IMP:BHF-UCL
Q13363	CTBP1	C-terminal-binding protein 1	GO:0090241; P:negative regulation of histone H4 acetylation; IMP:BHF-UCL
Q13363	CTBP1	C-terminal-binding protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q13363	CTBP1	C-terminal-binding protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q13363	CTBP1	C-terminal-binding protein 1	GO:0031065; P:positive regulation of histone deacetylation; IMP:BHF-UCL
Q13363	CTBP1	C-terminal-binding protein 1	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q13363	CTBP1	C-terminal-binding protein 1	GO:0051726; P:regulation of cell cycle; IMP:BHF-UCL
Q13363	CTBP1	C-terminal-binding protein 1	GO:0034401; P:regulation of transcription by chromatin organization; IMP:BHF-UCL
Q13363	CTBP1	C-terminal-binding protein 1	GO:0019079; P:viral genome replication; TAS:ProtInc
Q13363	CTBP1	C-terminal-binding protein 1	GO:0050872; P:white fat cell differentiation; ISS:UniProtKB
P56545	CTBP2	C-terminal-binding protein 2	GO:0051287; F:NAD binding; IEA:InterPro
P56545	CTBP2	C-terminal-binding protein 2	GO:0016616; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; IEA:InterPro
P56545	CTBP2	C-terminal-binding protein 2	GO:0005515; F:protein binding; IPI:IntAct
P56545	CTBP2	C-terminal-binding protein 2	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
P56545	CTBP2	C-terminal-binding protein 2	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P56545	CTBP2	C-terminal-binding protein 2	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
P56545	CTBP2	C-terminal-binding protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P56545	CTBP2	C-terminal-binding protein 2	GO:0019079; P:viral genome replication; TAS:ProtInc
P56545	CTBP2	C-terminal-binding protein 2	GO:0050872; P:white fat cell differentiation; ISS:UniProtKB
Q2NKJ3	CTC1	CST complex subunit CTC1	GO:0005515; F:protein binding; IPI:UniProtKB
Q2NKJ3	CTC1	CST complex subunit CTC1	GO:0003697; F:single-stranded DNA binding; ISS:UniProtKB
Q2NKJ3	CTC1	CST complex subunit CTC1	GO:0048539; P:bone marrow development; IEA:Ensembl
Q2NKJ3	CTC1	CST complex subunit CTC1	GO:0006974; P:cellular response to DNA damage stimulus; IEA:Ensembl
Q2NKJ3	CTC1	CST complex subunit CTC1	GO:0071425; P:hematopoietic stem cell proliferation; IEA:Ensembl
Q2NKJ3	CTC1	CST complex subunit CTC1	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q2NKJ3	CTC1	CST complex subunit CTC1	GO:0045740; P:positive regulation of DNA replication; ISS:UniProtKB
Q2NKJ3	CTC1	CST complex subunit CTC1	GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl
Q2NKJ3	CTC1	CST complex subunit CTC1	GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; IEA:Ensembl
Q2NKJ3	CTC1	CST complex subunit CTC1	GO:0090399; P:replicative senescence; IEA:Ensembl
Q2NKJ3	CTC1	CST complex subunit CTC1	GO:0048536; P:spleen development; IEA:Ensembl
Q2NKJ3	CTC1	CST complex subunit CTC1	GO:0000723; P:telomere maintenance; IMP:UniProtKB
Q2NKJ3	CTC1	CST complex subunit CTC1	GO:0010833; P:telomere maintenance via telomere lengthening; IEA:Ensembl
Q2NKJ3	CTC1	CST complex subunit CTC1	GO:0048538; P:thymus development; IEA:Ensembl
Q8NI51	CTCFL	Transcriptional repressor CTCFL	GO:0003677; F:DNA binding; IDA:UniProtKB
Q8NI51	CTCFL	Transcriptional repressor CTCFL	GO:0042393; F:histone binding; ISS:UniProtKB
Q8NI51	CTCFL	Transcriptional repressor CTCFL	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NI51	CTCFL	Transcriptional repressor CTCFL	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NI51	CTCFL	Transcriptional repressor CTCFL	GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB
Q8NI51	CTCFL	Transcriptional repressor CTCFL	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q8NI51	CTCFL	Transcriptional repressor CTCFL	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8NI51	CTCFL	Transcriptional repressor CTCFL	GO:0043046; P:DNA methylation involved in gamete generation; ISS:UniProtKB
Q8NI51	CTCFL	Transcriptional repressor CTCFL	GO:0016571; P:histone methylation; ISS:UniProtKB
Q8NI51	CTCFL	Transcriptional repressor CTCFL	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
Q8NI51	CTCFL	Transcriptional repressor CTCFL	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q8NI51	CTCFL	Transcriptional repressor CTCFL	GO:0006349; P:regulation of gene expression by genetic imprinting; ISS:UniProtKB
Q8NI51	CTCFL	Transcriptional repressor CTCFL	GO:0051569; P:regulation of histone H3-K4 methylation; IMP:UniProtKB
Q8NI51	CTCFL	Transcriptional repressor CTCFL	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P49711	CTCF	Transcriptional repressor CTCF	GO:0043035; F:chromatin insulator sequence binding; IDA:UniProtKB
P49711	CTCF	Transcriptional repressor CTCF	GO:0005515; F:protein binding; IPI:UniProtKB
P49711	CTCF	Transcriptional repressor CTCF	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
P49711	CTCF	Transcriptional repressor CTCF	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P49711	CTCF	Transcriptional repressor CTCF	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
P49711	CTCF	Transcriptional repressor CTCF	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P49711	CTCF	Transcriptional repressor CTCF	GO:0008270; F:zinc ion binding; TAS:UniProtKB
P49711	CTCF	Transcriptional repressor CTCF	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
P49711	CTCF	Transcriptional repressor CTCF	GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW
P49711	CTCF	Transcriptional repressor CTCF	GO:0010216; P:maintenance of DNA methylation; IEA:Ensembl
P49711	CTCF	Transcriptional repressor CTCF	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P49711	CTCF	Transcriptional repressor CTCF	GO:0016584; P:nucleosome positioning; IDA:UniProtKB
P49711	CTCF	Transcriptional repressor CTCF	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
P49711	CTCF	Transcriptional repressor CTCF	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P49711	CTCF	Transcriptional repressor CTCF	GO:0070602; P:regulation of centromeric sister chromatid cohesion; NAS:UniProtKB
P49711	CTCF	Transcriptional repressor CTCF	GO:0006349; P:regulation of gene expression by genetic imprinting; IEA:Ensembl
P49711	CTCF	Transcriptional repressor CTCF	GO:0040029; P:regulation of gene expression, epigenetic; IMP:UniProtKB
P49711	CTCF	Transcriptional repressor CTCF	GO:0035065; P:regulation of histone acetylation; IEA:Ensembl
P49711	CTCF	Transcriptional repressor CTCF	GO:0031060; P:regulation of histone methylation; IEA:Ensembl
P49711	CTCF	Transcriptional repressor CTCF	GO:0040030; P:regulation of molecular function, epigenetic; IMP:UniProtKB
P49711	CTCF	Transcriptional repressor CTCF	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y5B0	CTDP1	RNA polymerase II subunit A C-terminal domain phosphatase	GO:0008420; F:CTD phosphatase activity; IDA:UniProtKB
Q9Y5B0	CTDP1	RNA polymerase II subunit A C-terminal domain phosphatase	GO:0003899; F:DNA-directed RNA polymerase activity; TAS:ProtInc
Q9Y5B0	CTDP1	RNA polymerase II subunit A C-terminal domain phosphatase	GO:0010458; P:exit from mitosis; IMP:UniProtKB
Q9Y5B0	CTDP1	RNA polymerase II subunit A C-terminal domain phosphatase	GO:0010467; P:gene expression; TAS:Reactome
Q9Y5B0	CTDP1	RNA polymerase II subunit A C-terminal domain phosphatase	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
Q9Y5B0	CTDP1	RNA polymerase II subunit A C-terminal domain phosphatase	GO:0006470; P:protein dephosphorylation; IDA:UniProtKB
Q9Y5B0	CTDP1	RNA polymerase II subunit A C-terminal domain phosphatase	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q9Y5B0	CTDP1	RNA polymerase II subunit A C-terminal domain phosphatase	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q9Y5B0	CTDP1	RNA polymerase II subunit A C-terminal domain phosphatase	GO:0016032; P:viral process; TAS:Reactome
Q9GZU7	CTDSP1	Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1	GO:0008420; F:CTD phosphatase activity; IDA:UniProtKB
Q9GZU7	CTDSP1	Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9GZU7	CTDSP1	Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9GZU7	CTDSP1	Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1	GO:0050768; P:negative regulation of neurogenesis; IEA:Ensembl
Q9GZU7	CTDSP1	Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
Q9GZU7	CTDSP1	Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1	GO:0006470; P:protein dephosphorylation; IDA:UniProtKB
Q9GZU7	CTDSP1	Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O14595	CTDSP2	Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2	GO:0008420; F:CTD phosphatase activity; IDA:UniProtKB
O14595	CTDSP2	Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14595	CTDSP2	Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2	GO:0005515; F:protein binding; IPI:IntAct
O14595	CTDSP2	Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
O14595	CTDSP2	Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O14595	CTDSP2	Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
O14595	CTDSP2	Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2	GO:0006470; P:protein dephosphorylation; IDA:UniProtKB
O15194	CTDSPL	CTD small phosphatase-like protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15194	CTDSPL	CTD small phosphatase-like protein	GO:0004721; F:phosphoprotein phosphatase activity; IEA:UniProtKB-KW
Q8WVB6	CHTF18	Chromosome transmission fidelity protein 18 homolog	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8WVB6	CHTF18	Chromosome transmission fidelity protein 18 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8WVB6	CHTF18	Chromosome transmission fidelity protein 18 homolog	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q8WVB6	CHTF18	Chromosome transmission fidelity protein 18 homolog	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8WVB6	CHTF18	Chromosome transmission fidelity protein 18 homolog	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q16619	CTF1	Cardiotrophin-1	GO:0005146; F:leukemia inhibitory factor receptor binding; TAS:ProtInc
Q16619	CTF1	Cardiotrophin-1	GO:0008283; P:cell proliferation; TAS:ProtInc
Q16619	CTF1	Cardiotrophin-1	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q16619	CTF1	Cardiotrophin-1	GO:0048861; P:leukemia inhibitory factor signaling pathway; IEA:Ensembl
Q16619	CTF1	Cardiotrophin-1	GO:0007517; P:muscle organ development; TAS:ProtInc
Q16619	CTF1	Cardiotrophin-1	GO:0007399; P:nervous system development; TAS:ProtInc
Q16619	CTF1	Cardiotrophin-1	GO:0048666; P:neuron development; IEA:Ensembl
Q16619	CTF1	Cardiotrophin-1	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P0CG13	CHTF8	Chromosome transmission fidelity protein 8 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P0CG13	CHTF8	Chromosome transmission fidelity protein 8 homolog	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P0CG13	CHTF8	Chromosome transmission fidelity protein 8 homolog	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
P78358	CTAG1A	Cancer/testis antigen 1	GO:0005515; F:protein binding; IPI:IntAct
O15320	CTAGE5	cTAGE family member 5	GO:0008047; F:enzyme activator activity; TAS:ProtInc
O15320	CTAGE5	cTAGE family member 5	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
P29279	CTGF	Connective tissue growth factor	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P29279	CTGF	Connective tissue growth factor	GO:0005520; F:insulin-like growth factor binding; TAS:ProtInc
P29279	CTGF	Connective tissue growth factor	GO:0005515; F:protein binding; IPI:IntAct
P29279	CTGF	Connective tissue growth factor	GO:0001525; P:angiogenesis; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0001502; P:cartilage condensation; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0030154; P:cell differentiation; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0016477; P:cell migration; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0007160; P:cell-matrix adhesion; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P29279	CTGF	Connective tissue growth factor	GO:0035988; P:chondrocyte proliferation; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0060401; P:cytosolic calcium ion transport; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
P29279	CTGF	Connective tissue growth factor	GO:0008544; P:epidermis development; TAS:ProtInc
P29279	CTGF	Connective tissue growth factor	GO:0070278; P:extracellular matrix constituent secretion; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0010467; P:gene expression; TAS:Reactome
P29279	CTGF	Connective tissue growth factor	GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0035556; P:intracellular signal transduction; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0030324; P:lung development; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0060548; P:negative regulation of cell death; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0010260; P:organ senescence; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0001503; P:ossification; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0060452; P:positive regulation of cardiac muscle contraction; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0050867; P:positive regulation of cell activation; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0010942; P:positive regulation of cell death; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0045597; P:positive regulation of cell differentiation; IDA:BHF-UCL
P29279	CTGF	Connective tissue growth factor	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0032967; P:positive regulation of collagen biosynthetic process; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL
P29279	CTGF	Connective tissue growth factor	GO:0070318; P:positive regulation of G0 to G1 transition; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0046330; P:positive regulation of JNK cascade; IDA:BHF-UCL
P29279	CTGF	Connective tissue growth factor	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0051496; P:positive regulation of stress fiber assembly; IDA:BHF-UCL
P29279	CTGF	Connective tissue growth factor	GO:0072593; P:reactive oxygen species metabolic process; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0001558; P:regulation of cell growth; IEA:InterPro
P29279	CTGF	Connective tissue growth factor	GO:0032330; P:regulation of chondrocyte differentiation; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0043200; P:response to amino acid; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0034059; P:response to anoxia; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0032355; P:response to estradiol; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0070542; P:response to fatty acid; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0009749; P:response to glucose; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0051385; P:response to mineralocorticoid; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P29279	CTGF	Connective tissue growth factor	GO:0009611; P:response to wounding; TAS:ProtInc
P29279	CTGF	Connective tissue growth factor	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P29279	CTGF	Connective tissue growth factor	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q96CG8	CTHRC1	Collagen triple helix repeat-containing protein 1	GO:0016477; P:cell migration; IEA:Ensembl
Q96CG8	CTHRC1	Collagen triple helix repeat-containing protein 1	GO:0090103; P:cochlea morphogenesis; IEA:Ensembl
Q96CG8	CTHRC1	Collagen triple helix repeat-containing protein 1	GO:0090177; P:establishment of planar polarity involved in neural tube closure; IEA:Ensembl
Q96CG8	CTHRC1	Collagen triple helix repeat-containing protein 1	GO:0060122; P:inner ear receptor stereocilium organization; IEA:Ensembl
Q96CG8	CTHRC1	Collagen triple helix repeat-containing protein 1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEA:Ensembl
Q96CG8	CTHRC1	Collagen triple helix repeat-containing protein 1	GO:0043932; P:ossification involved in bone remodeling; IEA:Ensembl
Q96CG8	CTHRC1	Collagen triple helix repeat-containing protein 1	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
Q96CG8	CTHRC1	Collagen triple helix repeat-containing protein 1	GO:0033690; P:positive regulation of osteoblast proliferation; IEA:Ensembl
Q96CG8	CTHRC1	Collagen triple helix repeat-containing protein 1	GO:0032092; P:positive regulation of protein binding; IEA:Ensembl
Q96CG8	CTHRC1	Collagen triple helix repeat-containing protein 1	GO:0060071; P:Wnt signaling pathway, planar cell polarity pathway; IEA:Ensembl
O43310	CTIF	CBP80/20-dependent translation initiation factor	GO:0005515; F:protein binding; IPI:UniProtKB
O43310	CTIF	CBP80/20-dependent translation initiation factor	GO:0003723; F:RNA binding; IEA:InterPro
O43310	CTIF	CBP80/20-dependent translation initiation factor	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IMP:UniProtKB
O43310	CTIF	CBP80/20-dependent translation initiation factor	GO:0006446; P:regulation of translational initiation; IMP:UniProtKB
Q8WWI5	SLC44A1	Choline transporter-like protein 1	GO:0015220; F:choline transmembrane transporter activity; TAS:UniProtKB
Q8WWI5	SLC44A1	Choline transporter-like protein 1	GO:0015871; P:choline transport; TAS:UniProtKB
Q8WWI5	SLC44A1	Choline transporter-like protein 1	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q8WWI5	SLC44A1	Choline transporter-like protein 1	GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome
Q8WWI5	SLC44A1	Choline transporter-like protein 1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q8WWI5	SLC44A1	Choline transporter-like protein 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8WWI5	SLC44A1	Choline transporter-like protein 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8IWA5	SLC44A2	Choline transporter-like protein 2	GO:0015220; F:choline transmembrane transporter activity; TAS:UniProtKB
Q8IWA5	SLC44A2	Choline transporter-like protein 2	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q8IWA5	SLC44A2	Choline transporter-like protein 2	GO:0015871; P:choline transport; TAS:UniProtKB
Q8IWA5	SLC44A2	Choline transporter-like protein 2	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q8IWA5	SLC44A2	Choline transporter-like protein 2	GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome
Q8IWA5	SLC44A2	Choline transporter-like protein 2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q8IWA5	SLC44A2	Choline transporter-like protein 2	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q8IWA5	SLC44A2	Choline transporter-like protein 2	GO:0007165; P:signal transduction; IMP:GOC
Q8IWA5	SLC44A2	Choline transporter-like protein 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8IWA5	SLC44A2	Choline transporter-like protein 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8N4M1	SLC44A3	Choline transporter-like protein 3	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q8N4M1	SLC44A3	Choline transporter-like protein 3	GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome
Q8N4M1	SLC44A3	Choline transporter-like protein 3	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q8N4M1	SLC44A3	Choline transporter-like protein 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8N4M1	SLC44A3	Choline transporter-like protein 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q53GD3	SLC44A4	Choline transporter-like protein 4	GO:0008292; P:acetylcholine biosynthetic process; IMP:UniProt
Q53GD3	SLC44A4	Choline transporter-like protein 4	GO:0061526; P:acetylcholine secretion; IMP:UniProt
Q53GD3	SLC44A4	Choline transporter-like protein 4	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q53GD3	SLC44A4	Choline transporter-like protein 4	GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome
Q53GD3	SLC44A4	Choline transporter-like protein 4	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q53GD3	SLC44A4	Choline transporter-like protein 4	GO:0030307; P:positive regulation of cell growth; IMP:UniProt
Q53GD3	SLC44A4	Choline transporter-like protein 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q53GD3	SLC44A4	Choline transporter-like protein 4	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8NCS7	SLC44A5	Choline transporter-like protein 5	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q8NCS7	SLC44A5	Choline transporter-like protein 5	GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome
Q8NCS7	SLC44A5	Choline transporter-like protein 5	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q8NCS7	SLC44A5	Choline transporter-like protein 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8NCS7	SLC44A5	Choline transporter-like protein 5	GO:0055085; P:transmembrane transport; TAS:Reactome
P16410	CTLA4	Cytotoxic T-lymphocyte protein 4	GO:0005515; F:protein binding; IPI:IntAct
P16410	CTLA4	Cytotoxic T-lymphocyte protein 4	GO:0050853; P:B cell receptor signaling pathway; IMP:UniProtKB
P16410	CTLA4	Cytotoxic T-lymphocyte protein 4	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
P16410	CTLA4	Cytotoxic T-lymphocyte protein 4	GO:0006955; P:immune response; TAS:ProtInc
P16410	CTLA4	Cytotoxic T-lymphocyte protein 4	GO:0030889; P:negative regulation of B cell proliferation; IMP:UniProtKB
P16410	CTLA4	Cytotoxic T-lymphocyte protein 4	GO:0050777; P:negative regulation of immune response; IEA:Ensembl
P16410	CTLA4	Cytotoxic T-lymphocyte protein 4	GO:0045590; P:negative regulation of regulatory T cell differentiation; IDA:BHF-UCL
P16410	CTLA4	Cytotoxic T-lymphocyte protein 4	GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl
P16410	CTLA4	Cytotoxic T-lymphocyte protein 4	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
P16410	CTLA4	Cytotoxic T-lymphocyte protein 4	GO:0031295; P:T cell costimulation; TAS:Reactome
A8MT82	CTGLF11P	Putative centaurin-gamma-like family member 11P	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
A8MT82	CTGLF11P	Putative centaurin-gamma-like family member 11P	GO:0008270; F:zinc ion binding; IEA:InterPro
A8MT82	CTGLF11P	Putative centaurin-gamma-like family member 11P	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
P35221	CTNNA1	Catenin alpha-1	GO:0008013; F:beta-catenin binding; IPI:BHF-UCL
P35221	CTNNA1	Catenin alpha-1	GO:0045296; F:cadherin binding; IPI:UniProtKB
P35221	CTNNA1	Catenin alpha-1	GO:0045295; F:gamma-catenin binding; IPI:BHF-UCL
P35221	CTNNA1	Catenin alpha-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P35221	CTNNA1	Catenin alpha-1	GO:0005515; F:protein binding; IPI:HGNC
P35221	CTNNA1	Catenin alpha-1	GO:0005198; F:structural molecule activity; IEA:InterPro
P35221	CTNNA1	Catenin alpha-1	GO:0017166; F:vinculin binding; IPI:UniProtKB
P35221	CTNNA1	Catenin alpha-1	GO:0034332; P:adherens junction organization; TAS:Reactome
P35221	CTNNA1	Catenin alpha-1	GO:0007568; P:aging; IEA:Ensembl
P35221	CTNNA1	Catenin alpha-1	GO:0043297; P:apical junction assembly; NAS:UniProtKB
P35221	CTNNA1	Catenin alpha-1	GO:0031103; P:axon regeneration; IEA:Ensembl
P35221	CTNNA1	Catenin alpha-1	GO:0007155; P:cell adhesion; NAS:ProtInc
P35221	CTNNA1	Catenin alpha-1	GO:0034329; P:cell junction assembly; TAS:Reactome
P35221	CTNNA1	Catenin alpha-1	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P35221	CTNNA1	Catenin alpha-1	GO:0034613; P:cellular protein localization; IEA:Ensembl
P35221	CTNNA1	Catenin alpha-1	GO:0071681; P:cellular response to indole-3-methanol; IDA:UniProtKB
P35221	CTNNA1	Catenin alpha-1	GO:0090136; P:epithelial cell-cell adhesion; IEA:Ensembl
P35221	CTNNA1	Catenin alpha-1	GO:0007163; P:establishment or maintenance of cell polarity; IEA:Ensembl
P35221	CTNNA1	Catenin alpha-1	GO:0016264; P:gap junction assembly; IEA:Ensembl
P35221	CTNNA1	Catenin alpha-1	GO:0008584; P:male gonad development; IEA:Ensembl
P35221	CTNNA1	Catenin alpha-1	GO:0042692; P:muscle cell differentiation; TAS:Reactome
P35221	CTNNA1	Catenin alpha-1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P35221	CTNNA1	Catenin alpha-1	GO:2000146; P:negative regulation of cell motility; IEA:Ensembl
P35221	CTNNA1	Catenin alpha-1	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P35221	CTNNA1	Catenin alpha-1	GO:2001045; P:negative regulation of integrin-mediated signaling pathway; IEA:Ensembl
P35221	CTNNA1	Catenin alpha-1	GO:0007406; P:negative regulation of neuroblast proliferation; IEA:Ensembl
P35221	CTNNA1	Catenin alpha-1	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
P35221	CTNNA1	Catenin alpha-1	GO:0001541; P:ovarian follicle development; IEA:Ensembl
P35221	CTNNA1	Catenin alpha-1	GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P35221	CTNNA1	Catenin alpha-1	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
P35221	CTNNA1	Catenin alpha-1	GO:0045880; P:positive regulation of smoothened signaling pathway; IEA:Ensembl
P35221	CTNNA1	Catenin alpha-1	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P35221	CTNNA1	Catenin alpha-1	GO:0043627; P:response to estrogen; IEA:Ensembl
P26232	CTNNA2	Catenin alpha-2	GO:0005515; F:protein binding; IPI:UniProtKB
P26232	CTNNA2	Catenin alpha-2	GO:0005200; F:structural constituent of cytoskeleton; NAS:UniProtKB
P26232	CTNNA2	Catenin alpha-2	GO:0007409; P:axonogenesis; ISS:UniProtKB
P26232	CTNNA2	Catenin alpha-2	GO:0048854; P:brain morphogenesis; ISS:UniProtKB
P26232	CTNNA2	Catenin alpha-2	GO:0016337; P:single organismal cell-cell adhesion; ISS:UniProtKB
P26232	CTNNA2	Catenin alpha-2	GO:0048813; P:dendrite morphogenesis; ISS:UniProtKB
P26232	CTNNA2	Catenin alpha-2	GO:0042692; P:muscle cell differentiation; TAS:Reactome
P26232	CTNNA2	Catenin alpha-2	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
P26232	CTNNA2	Catenin alpha-2	GO:0060134; P:prepulse inhibition; ISS:UniProtKB
P26232	CTNNA2	Catenin alpha-2	GO:0021942; P:radial glia guided migration of Purkinje cell; ISS:UniProtKB
P26232	CTNNA2	Catenin alpha-2	GO:0051823; P:regulation of synapse structural plasticity; ISS:UniProtKB
Q9UI47	CTNNA3	Catenin alpha-3	GO:0045296; F:cadherin binding; TAS:UniProtKB
Q9UI47	CTNNA3	Catenin alpha-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UI47	CTNNA3	Catenin alpha-3	GO:0005198; F:structural molecule activity; IEA:InterPro
Q9UI47	CTNNA3	Catenin alpha-3	GO:0016337; P:single organismal cell-cell adhesion; IPI:UniProtKB
P35222	CTNNB1	Catenin beta-1	GO:0045294; F:alpha-catenin binding; IPI:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0050681; F:androgen receptor binding; NAS:UniProtKB
P35222	CTNNB1	Catenin beta-1	GO:0045296; F:cadherin binding; IPI:UniProtKB
P35222	CTNNB1	Catenin beta-1	GO:0003682; F:chromatin binding; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0030331; F:estrogen receptor binding; IPI:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0070411; F:I-SMAD binding; IPI:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0044325; F:ion channel binding; IPI:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0019900; F:kinase binding; IPI:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0035257; F:nuclear hormone receptor binding; IPI:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0005515; F:protein binding; IPI:IntAct
P35222	CTNNB1	Catenin beta-1	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P35222	CTNNB1	Catenin beta-1	GO:0019901; F:protein kinase binding; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
P35222	CTNNB1	Catenin beta-1	GO:0070412; F:R-SMAD binding; IPI:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0004871; F:signal transducer activity; NAS:ProtInc
P35222	CTNNB1	Catenin beta-1	GO:0046332; F:SMAD binding; IPI:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0005198; F:structural molecule activity; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0003713; F:transcription coactivator activity; IMP:UniProtKB
P35222	CTNNB1	Catenin beta-1	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P35222	CTNNB1	Catenin beta-1	GO:0034333; P:adherens junction assembly; IMP:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
P35222	CTNNB1	Catenin beta-1	GO:0009948; P:anterior/posterior axis specification; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0006915; P:apoptotic process; TAS:Reactome
P35222	CTNNB1	Catenin beta-1	GO:0045453; P:bone resorption; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0001658; P:branching involved in ureteric bud morphogenesis; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0060070; P:canonical Wnt signaling pathway; IDA:UniProtKB
P35222	CTNNB1	Catenin beta-1	GO:0044336; P:canonical Wnt signaling pathway involved in negative regulation of apoptotic process; IMP:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0061324; P:canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; ISS:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0044334; P:canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition; IMP:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0007155; P:cell adhesion; IMP:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0001708; P:cell fate specification; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0048469; P:cell maturation; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0016337; P:single organismal cell-cell adhesion; IMP:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0007160; P:cell-matrix adhesion; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
P35222	CTNNB1	Catenin beta-1	GO:0071363; P:cellular response to growth factor stimulus; IMP:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0071681; P:cellular response to indole-3-methanol; IDA:UniProtKB
P35222	CTNNB1	Catenin beta-1	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0022009; P:central nervous system vasculogenesis; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0007016; P:cytoskeletal anchoring at plasma membrane; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0048262; P:determination of dorsal/ventral asymmetry; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0009950; P:dorsal/ventral axis specification; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0007398; P:ectoderm development; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0000578; P:embryonic axis specification; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0048617; P:embryonic foregut morphogenesis; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0035050; P:embryonic heart tube development; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0030326; P:embryonic limb morphogenesis; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0036023; P:embryonic skeletal limb joint morphogenesis; ISS:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0001711; P:endodermal cell fate commitment; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0061154; P:endothelial tube morphogenesis; IMP:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0060742; P:epithelial cell differentiation involved in prostate gland development; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0001837; P:epithelial to mesenchymal transition; TAS:HGNC
P35222	CTNNB1	Catenin beta-1	GO:0060441; P:epithelial tube branching involved in lung morphogenesis; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0061198; P:fungiform papilla formation; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0001702; P:gastrulation with mouth forming second; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0035112; P:genitalia morphogenesis; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0007403; P:glial cell fate determination; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0035315; P:hair cell differentiation; TAS:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0031069; P:hair follicle morphogenesis; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0060789; P:hair follicle placode formation; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0030902; P:hindbrain development; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0045087; P:innate immune response; TAS:Reactome
P35222	CTNNB1	Catenin beta-1	GO:0021819; P:layer formation in cerebral cortex; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0002089; P:lens morphogenesis in camera-type eye; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0001889; P:liver development; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0060479; P:lung cell differentiation; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0060492; P:lung induction; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0060484; P:lung-associated mesenchyme development; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0030539; P:male genitalia development; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0060916; P:mesenchymal cell proliferation involved in lung development; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0003337; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0007494; P:midgut development; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0042692; P:muscle cell differentiation; TAS:Reactome
P35222	CTNNB1	Catenin beta-1	GO:0045445; P:myoblast differentiation; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
P35222	CTNNB1	Catenin beta-1	GO:0032331; P:negative regulation of chondrocyte differentiation; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0003136; P:negative regulation of heart induction by canonical Wnt signaling pathway; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0048715; P:negative regulation of oligodendrocyte differentiation; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0045671; P:negative regulation of osteoclast differentiation; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0033234; P:negative regulation of protein sumoylation; IDA:UniProtKB
P35222	CTNNB1	Catenin beta-1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
P35222	CTNNB1	Catenin beta-1	GO:0072079; P:nephron tubule formation; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0001840; P:neural plate development; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0001764; P:neuron migration; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0042475; P:odontogenesis of dentin-containing tooth; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0048599; P:oocyte development; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0030316; P:osteoclast differentiation; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0060066; P:oviduct development; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0031016; P:pancreas development; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0001569; P:patterning of blood vessels; IC:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P35222	CTNNB1	Catenin beta-1	GO:0061047; P:positive regulation of branching involved in lung morphogenesis; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:2000017; P:positive regulation of determination of dorsal identity; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0045603; P:positive regulation of endothelial cell differentiation; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0060769; P:positive regulation of epithelial cell proliferation involved in prostate gland development; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0045743; P:positive regulation of fibroblast growth factor receptor signaling pathway; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0010909; P:positive regulation of heparan sulfate proteoglycan biosynthetic process; IMP:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0043410; P:positive regulation of MAPK cascade; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
P35222	CTNNB1	Catenin beta-1	GO:0002052; P:positive regulation of neuroblast proliferation; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0045669; P:positive regulation of osteoblast differentiation; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P35222	CTNNB1	Catenin beta-1	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
P35222	CTNNB1	Catenin beta-1	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0034394; P:protein localization to cell surface; IMP:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0009954; P:proximal/distal pattern formation; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0045765; P:regulation of angiogenesis; TAS:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0090279; P:regulation of calcium ion import; IDA:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0030997; P:regulation of centriole-centriole cohesion; IDA:UniProtKB
P35222	CTNNB1	Catenin beta-1	GO:0070602; P:regulation of centromeric sister chromatid cohesion; IMP:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0048145; P:regulation of fibroblast proliferation; TAS:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0031641; P:regulation of myelination; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0072182; P:regulation of nephron tubule epithelial cell differentiation; ISS:UniProtKB
P35222	CTNNB1	Catenin beta-1	GO:2000008; P:regulation of protein localization to cell surface; IDA:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0003266; P:regulation of secondary heart field cardioblast proliferation; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0048660; P:regulation of smooth muscle cell proliferation; IMP:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0042129; P:regulation of T cell proliferation; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0072053; P:renal inner medulla development; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0072054; P:renal outer medulla development; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0072033; P:renal vesicle formation; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0046686; P:response to cadmium ion; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0034097; P:response to cytokine; IEA:Ensembl
P35222	CTNNB1	Catenin beta-1	GO:0042493; P:response to drug; IEP:UniProtKB
P35222	CTNNB1	Catenin beta-1	GO:0032355; P:response to estradiol; IDA:BHF-UCL
P35222	CTNNB1	Catenin beta-1	GO:0014010; P:Schwann cell proliferation; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0051145; P:smooth muscle cell differentiation; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0050808; P:synapse organization; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0048489; P:synaptic vesicle transport; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0033077; P:T cell differentiation in thymus; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0048538; P:thymus development; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0043587; P:tongue morphogenesis; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0060440; P:trachea formation; IBA:RefGenome
P35222	CTNNB1	Catenin beta-1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P35222	CTNNB1	Catenin beta-1	GO:0016055; P:Wnt signaling pathway; IDA:BHF-UCL
O60716	CTNND1	Catenin delta-1	GO:0045296; F:cadherin binding; IPI:UniProtKB
O60716	CTNND1	Catenin delta-1	GO:0005515; F:protein binding; IPI:IntAct
O60716	CTNND1	Catenin delta-1	GO:0005102; F:receptor binding; IPI:UniProtKB
O60716	CTNND1	Catenin delta-1	GO:0034332; P:adherens junction organization; TAS:Reactome
O60716	CTNND1	Catenin delta-1	GO:0007420; P:brain development; IEA:Ensembl
O60716	CTNND1	Catenin delta-1	GO:0007155; P:cell adhesion; NAS:ProtInc
O60716	CTNND1	Catenin delta-1	GO:0034329; P:cell junction assembly; TAS:Reactome
O60716	CTNND1	Catenin delta-1	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
O60716	CTNND1	Catenin delta-1	GO:0045216; P:cell-cell junction organization; TAS:Reactome
O60716	CTNND1	Catenin delta-1	GO:0060690; P:epithelial cell differentiation involved in salivary gland development; IEA:Ensembl
O60716	CTNND1	Catenin delta-1	GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
O60716	CTNND1	Catenin delta-1	GO:0001738; P:morphogenesis of a polarized epithelium; IEA:Ensembl
O60716	CTNND1	Catenin delta-1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
O60716	CTNND1	Catenin delta-1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O60716	CTNND1	Catenin delta-1	GO:0007435; P:salivary gland morphogenesis; IEA:Ensembl
O60716	CTNND1	Catenin delta-1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60716	CTNND1	Catenin delta-1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9UQB3	CTNND2	Catenin delta-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UQB3	CTNND2	Catenin delta-2	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9UQB3	CTNND2	Catenin delta-2	GO:0016337; P:single organismal cell-cell adhesion; IEA:InterPro
Q9UQB3	CTNND2	Catenin delta-2	GO:0007612; P:learning; IEA:Ensembl
Q9UQB3	CTNND2	Catenin delta-2	GO:0001763; P:morphogenesis of a branching structure; IEA:Ensembl
Q9UQB3	CTNND2	Catenin delta-2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9UQB3	CTNND2	Catenin delta-2	GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl
Q9UQB3	CTNND2	Catenin delta-2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UQB3	CTNND2	Catenin delta-2	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UQB3	CTNND2	Catenin delta-2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UBT7	CTNNAL1	Alpha-catulin	GO:0005198; F:structural molecule activity; IEA:InterPro
Q9UBT7	CTNNAL1	Alpha-catulin	GO:0007155; P:cell adhesion; IEA:InterPro
Q9UBT7	CTNNAL1	Alpha-catulin	GO:0007266; P:Rho protein signal transduction; IDA:MGI
O60931	CTNS	Cystinosin	GO:0015184; F:L-cystine transmembrane transporter activity; IMP:UniProtKB
O60931	CTNS	Cystinosin	GO:0007628; P:adult walking behavior; IEA:Ensembl
O60931	CTNS	Cystinosin	GO:0046034; P:ATP metabolic process; IMP:UniProtKB
O60931	CTNS	Cystinosin	GO:0007420; P:brain development; IMP:UniProtKB
O60931	CTNS	Cystinosin	GO:0006520; P:cellular amino acid metabolic process; NAS:UniProtKB
O60931	CTNS	Cystinosin	GO:0050890; P:cognition; IMP:UniProtKB
O60931	CTNS	Cystinosin	GO:0048058; P:compound eye corneal lens development; IEA:Ensembl
O60931	CTNS	Cystinosin	GO:0006749; P:glutathione metabolic process; IMP:UniProtKB
O60931	CTNS	Cystinosin	GO:0007625; P:grooming behavior; IEA:Ensembl
O60931	CTNS	Cystinosin	GO:0015811; P:L-cystine transport; IDA:MGI
O60931	CTNS	Cystinosin	GO:0007616; P:long-term memory; IEA:Ensembl
O60931	CTNS	Cystinosin	GO:0008542; P:visual learning; IEA:Ensembl
P30825	SLC7A1	High affinity cationic amino acid transporter 1	GO:0015181; F:arginine transmembrane transporter activity; IEA:Ensembl
P30825	SLC7A1	High affinity cationic amino acid transporter 1	GO:0006865; P:amino acid transport; TAS:Reactome
P30825	SLC7A1	High affinity cationic amino acid transporter 1	GO:0006811; P:ion transport; TAS:Reactome
P30825	SLC7A1	High affinity cationic amino acid transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P30825	SLC7A1	High affinity cationic amino acid transporter 1	GO:0006810; P:transport; NAS:ProtInc
P52569	SLC7A2	Low affinity cationic amino acid transporter 2	GO:0015174; F:basic amino acid transmembrane transporter activity; TAS:ProtInc
P52569	SLC7A2	Low affinity cationic amino acid transporter 2	GO:0005289; F:high affinity arginine transmembrane transporter activity; IEA:Ensembl
P52569	SLC7A2	Low affinity cationic amino acid transporter 2	GO:0015189; F:L-lysine transmembrane transporter activity; IEA:Ensembl
P52569	SLC7A2	Low affinity cationic amino acid transporter 2	GO:0000064; F:L-ornithine transmembrane transporter activity; IEA:Ensembl
P52569	SLC7A2	Low affinity cationic amino acid transporter 2	GO:0006865; P:amino acid transport; TAS:Reactome
P52569	SLC7A2	Low affinity cationic amino acid transporter 2	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
P52569	SLC7A2	Low affinity cationic amino acid transporter 2	GO:0006811; P:ion transport; TAS:Reactome
P52569	SLC7A2	Low affinity cationic amino acid transporter 2	GO:0042116; P:macrophage activation; IEA:Ensembl
P52569	SLC7A2	Low affinity cationic amino acid transporter 2	GO:0006809; P:nitric oxide biosynthetic process; IEA:Ensembl
P52569	SLC7A2	Low affinity cationic amino acid transporter 2	GO:0002537; P:nitric oxide production involved in inflammatory response; IEA:Ensembl
P52569	SLC7A2	Low affinity cationic amino acid transporter 2	GO:0050727; P:regulation of inflammatory response; IEA:Ensembl
P52569	SLC7A2	Low affinity cationic amino acid transporter 2	GO:0043030; P:regulation of macrophage activation; IEA:Ensembl
P52569	SLC7A2	Low affinity cationic amino acid transporter 2	GO:0055085; P:transmembrane transport; TAS:Reactome
P52569	SLC7A2	Low affinity cationic amino acid transporter 2	GO:0006810; P:transport; TAS:ProtInc
DR   GO:0015171; F:amino acid transmembrane transporter activity; IEA:InterPro
Q8WY07	SLC7A3	Cationic amino acid transporter 3	GO:0015181; F:arginine transmembrane transporter activity; IEA:Ensembl
Q8WY07	SLC7A3	Cationic amino acid transporter 3	GO:0015326; F:cationic amino acid transmembrane transporter activity; IEA:Ensembl
Q8WY07	SLC7A3	Cationic amino acid transporter 3	GO:0015189; F:L-lysine transmembrane transporter activity; IEA:Ensembl
Q8WY07	SLC7A3	Cationic amino acid transporter 3	GO:0006865; P:amino acid transport; TAS:Reactome
Q8WY07	SLC7A3	Cationic amino acid transporter 3	GO:0006811; P:ion transport; TAS:Reactome
Q8WY07	SLC7A3	Cationic amino acid transporter 3	GO:0055085; P:transmembrane transport; TAS:Reactome
O43246	SLC7A4	Cationic amino acid transporter 4	GO:0015174; F:basic amino acid transmembrane transporter activity; TAS:ProtInc
O43246	SLC7A4	Cationic amino acid transporter 4	GO:0015802; P:basic amino acid transport; TAS:GOC
O43246	SLC7A4	Cationic amino acid transporter 4	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
O43246	SLC7A4	Cationic amino acid transporter 4	GO:0006810; P:transport; TAS:ProtInc
Q6PD62	CTR9	RNA polymerase-associated protein CTR9 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q6PD62	CTR9	RNA polymerase-associated protein CTR9 homolog	GO:0071222; P:cellular response to lipopolysaccharide; ISS:UniProtKB
Q6PD62	CTR9	RNA polymerase-associated protein CTR9 homolog	GO:0001711; P:endodermal cell fate commitment; ISS:UniProtKB
Q6PD62	CTR9	RNA polymerase-associated protein CTR9 homolog	GO:0033523; P:histone H2B ubiquitination; IDA:UniProtKB
Q6PD62	CTR9	RNA polymerase-associated protein CTR9 homolog	GO:0080182; P:histone H3-K4 trimethylation; IMP:UniProtKB
Q6PD62	CTR9	RNA polymerase-associated protein CTR9 homolog	GO:0010390; P:histone monoubiquitination; IDA:UniProtKB
Q6PD62	CTR9	RNA polymerase-associated protein CTR9 homolog	GO:0070102; P:interleukin-6-mediated signaling pathway; ISS:UniProtKB
Q6PD62	CTR9	RNA polymerase-associated protein CTR9 homolog	GO:0007259; P:JAK-STAT cascade; ISS:UniProtKB
Q6PD62	CTR9	RNA polymerase-associated protein CTR9 homolog	GO:0045638; P:negative regulation of myeloid cell differentiation; IDA:UniProtKB
Q6PD62	CTR9	RNA polymerase-associated protein CTR9 homolog	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q6PD62	CTR9	RNA polymerase-associated protein CTR9 homolog	GO:0051571; P:positive regulation of histone H3-K4 methylation; IMP:UniProtKB
Q6PD62	CTR9	RNA polymerase-associated protein CTR9 homolog	GO:2001162; P:positive regulation of histone H3-K79 methylation; IMP:UniProtKB
Q6PD62	CTR9	RNA polymerase-associated protein CTR9 homolog	GO:0032968; P:positive regulation of transcription elongation from RNA polymerase II promoter; IDA:UniProtKB
Q6PD62	CTR9	RNA polymerase-associated protein CTR9 homolog	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q6PD62	CTR9	RNA polymerase-associated protein CTR9 homolog	GO:0019827; P:stem cell maintenance; IDA:UniProtKB
Q6PD62	CTR9	RNA polymerase-associated protein CTR9 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6PD62	CTR9	RNA polymerase-associated protein CTR9 homolog	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P17538	CTRB1	Chymotrypsinogen B	GO:0004252; F:serine-type endopeptidase activity; NAS:UniProtKB
P17538	CTRB1	Chymotrypsinogen B	GO:0009235; P:cobalamin metabolic process; TAS:Reactome
P17538	CTRB1	Chymotrypsinogen B	GO:0007586; P:digestion; IEA:UniProtKB-KW
P17538	CTRB1	Chymotrypsinogen B	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P17538	CTRB1	Chymotrypsinogen B	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P17538	CTRB1	Chymotrypsinogen B	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P17538	CTRB1	Chymotrypsinogen B	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P17538	CTRB1	Chymotrypsinogen B	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q6GPI1	CTRB2	Chymotrypsinogen B2	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q6GPI1	CTRB2	Chymotrypsinogen B2	GO:0009235; P:cobalamin metabolic process; TAS:Reactome
Q6GPI1	CTRB2	Chymotrypsinogen B2	GO:0007586; P:digestion; IEA:UniProtKB-KW
Q6GPI1	CTRB2	Chymotrypsinogen B2	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q6GPI1	CTRB2	Chymotrypsinogen B2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q6GPI1	CTRB2	Chymotrypsinogen B2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6GPI1	CTRB2	Chymotrypsinogen B2	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q6GPI1	CTRB2	Chymotrypsinogen B2	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q99895	CTRC	Chymotrypsin-C	GO:0008233; F:peptidase activity; TAS:ProtInc
Q99895	CTRC	Chymotrypsin-C	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q99895	CTRC	Chymotrypsin-C	GO:0006508; P:proteolysis; TAS:ProtInc
O14578	CIT	Citron Rho-interacting kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O14578	CIT	Citron Rho-interacting kinase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14578	CIT	Citron Rho-interacting kinase	GO:0030165; F:PDZ domain binding; IDA:UniProt
O14578	CIT	Citron Rho-interacting kinase	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB
O14578	CIT	Citron Rho-interacting kinase	GO:0005083; F:small GTPase regulator activity; IEA:InterPro
O14578	CIT	Citron Rho-interacting kinase	GO:0000910; P:cytokinesis; IMP:UniProtKB
O14578	CIT	Citron Rho-interacting kinase	GO:0016358; P:dendrite development; IEA:Ensembl
O14578	CIT	Citron Rho-interacting kinase	GO:0000086; P:G2/M transition of mitotic cell cycle; IEA:Ensembl
O14578	CIT	Citron Rho-interacting kinase	GO:0048699; P:generation of neurons; ISS:UniProtKB
O14578	CIT	Citron Rho-interacting kinase	GO:0007030; P:Golgi organization; IEA:Ensembl
O14578	CIT	Citron Rho-interacting kinase	GO:0035556; P:intracellular signal transduction; IEA:InterPro
O14578	CIT	Citron Rho-interacting kinase	GO:0007091; P:metaphase/anaphase transition of mitotic cell cycle; IEA:Ensembl
O14578	CIT	Citron Rho-interacting kinase	GO:0007067; P:mitosis; ISS:UniProtKB
O14578	CIT	Citron Rho-interacting kinase	GO:0000070; P:mitotic sister chromatid segregation; IEA:Ensembl
O14578	CIT	Citron Rho-interacting kinase	GO:0050774; P:negative regulation of dendrite morphogenesis; IEA:Ensembl
O14578	CIT	Citron Rho-interacting kinase	GO:0008064; P:regulation of actin polymerization or depolymerization; IEA:Ensembl
O14578	CIT	Citron Rho-interacting kinase	GO:0007283; P:spermatogenesis; IEA:Ensembl
P40313	CTRL	Chymotrypsin-like protease CTRL-1	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
P40313	CTRL	Chymotrypsin-like protease CTRL-1	GO:0007586; P:digestion; TAS:ProtInc
P40313	CTRL	Chymotrypsin-like protease CTRL-1	GO:0006508; P:proteolysis; TAS:ProtInc
Q05D32	CTDSPL2	CTD small phosphatase-like protein 2	GO:0004721; F:phosphoprotein phosphatase activity; IEA:UniProtKB-KW
Q8NEC5	CATSPER1	Cation channel sperm-associated protein 1	GO:0005227; F:calcium activated cation channel activity; IEA:InterPro
Q8NEC5	CATSPER1	Cation channel sperm-associated protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q8NEC5	CATSPER1	Cation channel sperm-associated protein 1	GO:0005245; F:voltage-gated calcium channel activity; IBA:RefGenome
Q8NEC5	CATSPER1	Cation channel sperm-associated protein 1	GO:0070509; P:calcium ion import; IBA:RefGenome
Q8NEC5	CATSPER1	Cation channel sperm-associated protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8NEC5	CATSPER1	Cation channel sperm-associated protein 1	GO:0001539; P:cilium or flagellum-dependent cell motility; IEA:Ensembl
Q8NEC5	CATSPER1	Cation channel sperm-associated protein 1	GO:0007342; P:fusion of sperm to egg plasma membrane; IEA:Ensembl
Q8NEC5	CATSPER1	Cation channel sperm-associated protein 1	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q8NEC5	CATSPER1	Cation channel sperm-associated protein 1	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
Q8NEC5	CATSPER1	Cation channel sperm-associated protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8NEC5	CATSPER1	Cation channel sperm-associated protein 1	GO:0051924; P:regulation of calcium ion transport; IEA:Ensembl
Q8NEC5	CATSPER1	Cation channel sperm-associated protein 1	GO:0007338; P:single fertilization; TAS:Reactome
Q8NEC5	CATSPER1	Cation channel sperm-associated protein 1	GO:0030317; P:sperm motility; IBA:RefGenome
Q8NEC5	CATSPER1	Cation channel sperm-associated protein 1	GO:0035036; P:sperm-egg recognition; TAS:Reactome
Q8NEC5	CATSPER1	Cation channel sperm-associated protein 1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q96P56	CATSPER2	Cation channel sperm-associated protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q96P56	CATSPER2	Cation channel sperm-associated protein 2	GO:0005245; F:voltage-gated calcium channel activity; IBA:RefGenome
Q96P56	CATSPER2	Cation channel sperm-associated protein 2	GO:0070509; P:calcium ion import; IBA:RefGenome
Q96P56	CATSPER2	Cation channel sperm-associated protein 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96P56	CATSPER2	Cation channel sperm-associated protein 2	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q96P56	CATSPER2	Cation channel sperm-associated protein 2	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
Q96P56	CATSPER2	Cation channel sperm-associated protein 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q96P56	CATSPER2	Cation channel sperm-associated protein 2	GO:0007338; P:single fertilization; TAS:Reactome
Q96P56	CATSPER2	Cation channel sperm-associated protein 2	GO:0030317; P:sperm motility; IBA:RefGenome
Q96P56	CATSPER2	Cation channel sperm-associated protein 2	GO:0035036; P:sperm-egg recognition; TAS:Reactome
Q96P56	CATSPER2	Cation channel sperm-associated protein 2	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q86XQ3	CATSPER3	Cation channel sperm-associated protein 3	GO:0005227; F:calcium activated cation channel activity; IEA:Ensembl
Q86XQ3	CATSPER3	Cation channel sperm-associated protein 3	GO:0005245; F:voltage-gated calcium channel activity; IBA:RefGenome
Q86XQ3	CATSPER3	Cation channel sperm-associated protein 3	GO:0070509; P:calcium ion import; IBA:RefGenome
Q86XQ3	CATSPER3	Cation channel sperm-associated protein 3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q86XQ3	CATSPER3	Cation channel sperm-associated protein 3	GO:0001539; P:cilium or flagellum-dependent cell motility; IEA:Ensembl
Q86XQ3	CATSPER3	Cation channel sperm-associated protein 3	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q86XQ3	CATSPER3	Cation channel sperm-associated protein 3	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
Q86XQ3	CATSPER3	Cation channel sperm-associated protein 3	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q86XQ3	CATSPER3	Cation channel sperm-associated protein 3	GO:0007338; P:single fertilization; TAS:Reactome
Q86XQ3	CATSPER3	Cation channel sperm-associated protein 3	GO:0006814; P:sodium ion transport; IEA:Ensembl
Q86XQ3	CATSPER3	Cation channel sperm-associated protein 3	GO:0030317; P:sperm motility; IBA:RefGenome
Q86XQ3	CATSPER3	Cation channel sperm-associated protein 3	GO:0035036; P:sperm-egg recognition; TAS:Reactome
Q86XQ3	CATSPER3	Cation channel sperm-associated protein 3	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q7RTX7	CATSPER4	Cation channel sperm-associated protein 4	GO:0005227; F:calcium activated cation channel activity; IEA:Ensembl
Q7RTX7	CATSPER4	Cation channel sperm-associated protein 4	GO:0005245; F:voltage-gated calcium channel activity; IBA:RefGenome
Q7RTX7	CATSPER4	Cation channel sperm-associated protein 4	GO:0070509; P:calcium ion import; IBA:RefGenome
Q7RTX7	CATSPER4	Cation channel sperm-associated protein 4	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q7RTX7	CATSPER4	Cation channel sperm-associated protein 4	GO:0001539; P:cilium or flagellum-dependent cell motility; IEA:Ensembl
Q7RTX7	CATSPER4	Cation channel sperm-associated protein 4	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q7RTX7	CATSPER4	Cation channel sperm-associated protein 4	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
Q7RTX7	CATSPER4	Cation channel sperm-associated protein 4	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q7RTX7	CATSPER4	Cation channel sperm-associated protein 4	GO:0007338; P:single fertilization; TAS:Reactome
Q7RTX7	CATSPER4	Cation channel sperm-associated protein 4	GO:0006814; P:sodium ion transport; IEA:Ensembl
Q7RTX7	CATSPER4	Cation channel sperm-associated protein 4	GO:0030317; P:sperm motility; IBA:RefGenome
Q7RTX7	CATSPER4	Cation channel sperm-associated protein 4	GO:0035036; P:sperm-egg recognition; TAS:Reactome
Q7RTX7	CATSPER4	Cation channel sperm-associated protein 4	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q9H7T0	CATSPERB	Cation channel sperm-associated protein subunit beta	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9H7T0	CATSPERB	Cation channel sperm-associated protein subunit beta	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
Q9H7T0	CATSPERB	Cation channel sperm-associated protein subunit beta	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9H7T0	CATSPERB	Cation channel sperm-associated protein subunit beta	GO:0007338; P:single fertilization; TAS:Reactome
Q9H7T0	CATSPERB	Cation channel sperm-associated protein subunit beta	GO:0035036; P:sperm-egg recognition; TAS:Reactome
Q9H7T0	CATSPERB	Cation channel sperm-associated protein subunit beta	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q86XM0	CATSPERD	Cation channel sperm-associated protein subunit delta	GO:0001539; P:cilium or flagellum-dependent cell motility; IEA:Ensembl
Q86XM0	CATSPERD	Cation channel sperm-associated protein subunit delta	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
Q86XM0	CATSPERD	Cation channel sperm-associated protein subunit delta	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q86XM0	CATSPERD	Cation channel sperm-associated protein subunit delta	GO:0007338; P:single fertilization; TAS:Reactome
Q86XM0	CATSPERD	Cation channel sperm-associated protein subunit delta	GO:0048240; P:sperm capacitation; ISS:UniProtKB
Q86XM0	CATSPERD	Cation channel sperm-associated protein subunit delta	GO:0030317; P:sperm motility; ISS:UniProtKB
Q86XM0	CATSPERD	Cation channel sperm-associated protein subunit delta	GO:0035036; P:sperm-egg recognition; TAS:Reactome
Q86XM0	CATSPERD	Cation channel sperm-associated protein subunit delta	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q6ZRH7	CATSPERG	Cation channel sperm-associated protein subunit gamma	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q6ZRH7	CATSPERG	Cation channel sperm-associated protein subunit gamma	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
Q6ZRH7	CATSPERG	Cation channel sperm-associated protein subunit gamma	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q6ZRH7	CATSPERG	Cation channel sperm-associated protein subunit gamma	GO:0007338; P:single fertilization; TAS:Reactome
Q6ZRH7	CATSPERG	Cation channel sperm-associated protein subunit gamma	GO:0035036; P:sperm-egg recognition; TAS:Reactome
Q6ZRH7	CATSPERG	Cation channel sperm-associated protein subunit gamma	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q8WZ74	CTTNBP2	Cortactin-binding protein 2	GO:0007420; P:brain development; IEA:Ensembl
Q7Z7A3	CTU1	Cytoplasmic tRNA 2-thiolation protein 1	GO:0016779; F:nucleotidyltransferase activity; IEA:UniProtKB-HAMAP
Q7Z7A3	CTU1	Cytoplasmic tRNA 2-thiolation protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z7A3	CTU1	Cytoplasmic tRNA 2-thiolation protein 1	GO:0000049; F:tRNA binding; IEA:UniProtKB-HAMAP
Q7Z7A3	CTU1	Cytoplasmic tRNA 2-thiolation protein 1	GO:0032447; P:protein urmylation; IEA:UniProtKB-HAMAP
Q7Z7A3	CTU1	Cytoplasmic tRNA 2-thiolation protein 1	GO:0034227; P:tRNA thio-modification; NAS:UniProtKB
Q7Z7A3	CTU1	Cytoplasmic tRNA 2-thiolation protein 1	GO:0002098; P:tRNA wobble uridine modification; NAS:UniProtKB
Q2VPK5	CTU2	Cytoplasmic tRNA 2-thiolation protein 2	GO:0016779; F:nucleotidyltransferase activity; IEA:UniProtKB-HAMAP
Q2VPK5	CTU2	Cytoplasmic tRNA 2-thiolation protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q2VPK5	CTU2	Cytoplasmic tRNA 2-thiolation protein 2	GO:0000049; F:tRNA binding; IEA:InterPro
Q2VPK5	CTU2	Cytoplasmic tRNA 2-thiolation protein 2	GO:0032447; P:protein urmylation; IEA:UniProtKB-HAMAP
Q2VPK5	CTU2	Cytoplasmic tRNA 2-thiolation protein 2	GO:0034227; P:tRNA thio-modification; NAS:UniProtKB
Q2VPK5	CTU2	Cytoplasmic tRNA 2-thiolation protein 2	GO:0002098; P:tRNA wobble uridine modification; NAS:UniProtKB
O43822	C21orf2	Protein C21orf2	GO:0060271; P:cilium morphogenesis; IEA:Ensembl
O43822	C21orf2	Protein C21orf2	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
O43822	C21orf2	Protein C21orf2	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
O60494	CUBN	Cubilin	GO:0005509; F:calcium ion binding; IEA:InterPro
O60494	CUBN	Cubilin	GO:0031419; F:cobalamin binding; IEA:UniProtKB-KW
O60494	CUBN	Cubilin	GO:0005515; F:protein binding; IPI:UniProt
O60494	CUBN	Cubilin	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O60494	CUBN	Cubilin	GO:0004872; F:receptor activity; TAS:ProtInc
O60494	CUBN	Cubilin	GO:0005215; F:transporter activity; TAS:ProtInc
O60494	CUBN	Cubilin	GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW
O60494	CUBN	Cubilin	GO:0009235; P:cobalamin metabolic process; TAS:Reactome
O60494	CUBN	Cubilin	GO:0015889; P:cobalamin transport; TAS:ProtInc
O60494	CUBN	Cubilin	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
O60494	CUBN	Cubilin	GO:0042953; P:lipoprotein transport; IEA:Ensembl
O60494	CUBN	Cubilin	GO:0006898; P:receptor-mediated endocytosis; NAS:UniProtKB
O60494	CUBN	Cubilin	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60494	CUBN	Cubilin	GO:0008202; P:steroid metabolic process; TAS:Reactome
O60494	CUBN	Cubilin	GO:0001894; P:tissue homeostasis; NAS:UniProtKB
O60494	CUBN	Cubilin	GO:0042359; P:vitamin D metabolic process; TAS:Reactome
O60494	CUBN	Cubilin	GO:0006766; P:vitamin metabolic process; TAS:Reactome
O60494	CUBN	Cubilin	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9H467	CUEDC2	CUE domain-containing protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q13616	CUL1	Cullin-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13616	CUL1	Cullin-1	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q13616	CUL1	Cullin-1	GO:0007050; P:cell cycle arrest; TAS:ProtInc
Q13616	CUL1	Cullin-1	GO:0008283; P:cell proliferation; IEA:Ensembl
Q13616	CUL1	Cullin-1	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q13616	CUL1	Cullin-1	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q13616	CUL1	Cullin-1	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:ProtInc
Q13616	CUL1	Cullin-1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q13616	CUL1	Cullin-1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q13616	CUL1	Cullin-1	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q13616	CUL1	Cullin-1	GO:0009887; P:organ morphogenesis; IEA:Ensembl
Q13616	CUL1	Cullin-1	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q13616	CUL1	Cullin-1	GO:0006513; P:protein monoubiquitination; IEA:Ensembl
Q13616	CUL1	Cullin-1	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q13616	CUL1	Cullin-1	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q13616	CUL1	Cullin-1	GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q13616	CUL1	Cullin-1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q13617	CUL2	Cullin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q13617	CUL2	Cullin-2	GO:0031625; F:ubiquitin protein ligase binding; IDA:UniProtKB
Q13617	CUL2	Cullin-2	GO:0007050; P:cell cycle arrest; TAS:ProtInc
Q13617	CUL2	Cullin-2	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
Q13617	CUL2	Cullin-2	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:ProtInc
Q13617	CUL2	Cullin-2	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:ProtInc
Q13617	CUL2	Cullin-2	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q13617	CUL2	Cullin-2	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q13617	CUL2	Cullin-2	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
Q13617	CUL2	Cullin-2	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q13617	CUL2	Cullin-2	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q13618	CUL3	Cullin-3	GO:0031208; F:POZ domain binding; IDA:UniProtKB
Q13618	CUL3	Cullin-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q13618	CUL3	Cullin-3	GO:0051322; P:anaphase; IMP:UniProtKB
Q13618	CUL3	Cullin-3	GO:0007050; P:cell cycle arrest; TAS:ProtInc
Q13618	CUL3	Cullin-3	GO:0016477; P:cell migration; IMP:UniProtKB
Q13618	CUL3	Cullin-3	GO:0048208; P:COPII vesicle coating; IMP:UniProtKB
Q13618	CUL3	Cullin-3	GO:0008054; P:cyclin catabolic process; IDA:MGI
Q13618	CUL3	Cullin-3	GO:0000910; P:cytokinesis; IMP:UniProtKB
Q13618	CUL3	Cullin-3	GO:0040016; P:embryonic cleavage; ISS:UniProtKB
Q13618	CUL3	Cullin-3	GO:0006888; P:ER to Golgi vesicle-mediated transport; IDA:UniProtKB
Q13618	CUL3	Cullin-3	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:ProtInc
Q13618	CUL3	Cullin-3	GO:0007369; P:gastrulation; IEA:Ensembl
Q13618	CUL3	Cullin-3	GO:0007229; P:integrin-mediated signaling pathway; ISS:UniProtKB
Q13618	CUL3	Cullin-3	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:ProtInc
Q13618	CUL3	Cullin-3	GO:0000090; P:mitotic anaphase; IMP:UniProtKB
Q13618	CUL3	Cullin-3	GO:0035024; P:negative regulation of Rho protein signal transduction; IMP:UniProtKB
Q13618	CUL3	Cullin-3	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q13618	CUL3	Cullin-3	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB
Q13618	CUL3	Cullin-3	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q13618	CUL3	Cullin-3	GO:0006513; P:protein monoubiquitination; IDA:UniProtKB
Q13618	CUL3	Cullin-3	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q13618	CUL3	Cullin-3	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q13618	CUL3	Cullin-3	GO:0017145; P:stem cell division; ISS:UniProtKB
Q13618	CUL3	Cullin-3	GO:0043149; P:stress fiber assembly; IMP:UniProtKB
Q13618	CUL3	Cullin-3	GO:0001831; P:trophectodermal cellular morphogenesis; IEA:Ensembl
Q13618	CUL3	Cullin-3	GO:0016055; P:Wnt signaling pathway; IEA:Ensembl
Q13619	CUL4A	Cullin-4A	GO:0005515; F:protein binding; IPI:UniProtKB
Q13619	CUL4A	Cullin-4A	GO:0007050; P:cell cycle arrest; TAS:ProtInc
Q13619	CUL4A	Cullin-4A	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q13619	CUL4A	Cullin-4A	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:ProtInc
Q13619	CUL4A	Cullin-4A	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:ProtInc
Q13619	CUL4A	Cullin-4A	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q13619	CUL4A	Cullin-4A	GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl
Q13619	CUL4A	Cullin-4A	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q13619	CUL4A	Cullin-4A	GO:0051246; P:regulation of protein metabolic process; IEA:Ensembl
Q13619	CUL4A	Cullin-4A	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q13619	CUL4A	Cullin-4A	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q13620	CUL4B	Cullin-4B	GO:0005515; F:protein binding; IPI:IntAct
Q13620	CUL4B	Cullin-4B	GO:0007049; P:cell cycle; NAS:UniProtKB
Q13620	CUL4B	Cullin-4B	GO:0035518; P:histone H2A monoubiquitination; IDA:UniProt
Q13620	CUL4B	Cullin-4B	GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl
Q13620	CUL4B	Cullin-4B	GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl
Q13620	CUL4B	Cullin-4B	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q13620	CUL4B	Cullin-4B	GO:0070914; P:UV-damage excision repair; IDA:UniProt
Q93034	CUL5	Cullin-5	GO:0005262; F:calcium channel activity; TAS:ProtInc
Q93034	CUL5	Cullin-5	GO:0005515; F:protein binding; IPI:UniProtKB
Q93034	CUL5	Cullin-5	GO:0004872; F:receptor activity; TAS:ProtInc
Q93034	CUL5	Cullin-5	GO:0031625; F:ubiquitin protein ligase binding; IDA:UniProtKB
Q93034	CUL5	Cullin-5	GO:0070588; P:calcium ion transmembrane transport; TAS:GOC
Q93034	CUL5	Cullin-5	GO:0007050; P:cell cycle arrest; TAS:ProtInc
Q93034	CUL5	Cullin-5	GO:0008283; P:cell proliferation; TAS:ProtInc
Q93034	CUL5	Cullin-5	GO:0051480; P:cytosolic calcium ion homeostasis; IEA:Ensembl
Q93034	CUL5	Cullin-5	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:ProtInc
Q93034	CUL5	Cullin-5	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:ProtInc
Q93034	CUL5	Cullin-5	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q93034	CUL5	Cullin-5	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q93034	CUL5	Cullin-5	GO:0006970; P:response to osmotic stress; IEA:Ensembl
Q93034	CUL5	Cullin-5	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q93034	CUL5	Cullin-5	GO:0016032; P:viral process; TAS:Reactome
Q14999	CUL7	Cullin-7	GO:0005515; F:protein binding; IPI:UniProtKB
Q14999	CUL7	Cullin-7	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q14999	CUL7	Cullin-7	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q14999	CUL7	Cullin-7	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q14999	CUL7	Cullin-7	GO:0007030; P:Golgi organization; ISS:UniProtKB
Q14999	CUL7	Cullin-7	GO:0050775; P:positive regulation of dendrite morphogenesis; IGI:UniProtKB
Q14999	CUL7	Cullin-7	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q14999	CUL7	Cullin-7	GO:0006508; P:proteolysis; NAS:UniProtKB
Q14999	CUL7	Cullin-7	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q14999	CUL7	Cullin-7	GO:0001570; P:vasculogenesis; ISS:UniProtKB
Q14999	CUL7	Cullin-7	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q8IWT3	CUL9	Cullin-9	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IWT3	CUL9	Cullin-9	GO:0005515; F:protein binding; IPI:IntAct
Q8IWT3	CUL9	Cullin-9	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IWT3	CUL9	Cullin-9	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
O60888	CUTA	Protein CutA	GO:0019899; F:enzyme binding; IPI:UniProtKB
O60888	CUTA	Protein CutA	GO:0005515; F:protein binding; IPI:IntAct
O60888	CUTA	Protein CutA	GO:0008104; P:protein localization; IDA:UniProtKB
O60888	CUTA	Protein CutA	GO:0010038; P:response to metal ion; IEA:InterPro
Q9NTM9	CUTC	Copper homeostasis protein cutC homolog	GO:0005507; F:copper ion binding; IDA:UniProtKB
Q9NTM9	CUTC	Copper homeostasis protein cutC homolog	GO:0055070; P:copper ion homeostasis; NAS:UniProtKB
Q9NTM9	CUTC	Copper homeostasis protein cutC homolog	GO:0006825; P:copper ion transport; NAS:UniProtKB
Q9NTM9	CUTC	Copper homeostasis protein cutC homolog	GO:0051262; P:protein tetramerization; IPI:UniProtKB
P39880	CUX1	Homeobox protein cut-like 1	GO:0003682; F:chromatin binding; IEA:Ensembl
P39880	CUX1	Homeobox protein cut-like 1	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; ISS:UniProt
P39880	CUX1	Homeobox protein cut-like 1	GO:0043565; F:sequence-specific DNA binding; IDA:UniProt
P39880	CUX1	Homeobox protein cut-like 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P39880	CUX1	Homeobox protein cut-like 1	GO:0042491; P:auditory receptor cell differentiation; IEA:Ensembl
P39880	CUX1	Homeobox protein cut-like 1	GO:0001822; P:kidney development; IEA:Ensembl
P39880	CUX1	Homeobox protein cut-like 1	GO:0030324; P:lung development; IEA:Ensembl
P39880	CUX1	Homeobox protein cut-like 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P39880	CUX1	Homeobox protein cut-like 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P39880	CUX1	Homeobox protein cut-like 1	GO:0050775; P:positive regulation of dendrite morphogenesis; ISS:UniProt
P39880	CUX1	Homeobox protein cut-like 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P39880	CUX1	Homeobox protein cut-like 1	GO:0000301; P:retrograde transport, vesicle recycling within Golgi; IEA:Ensembl
P39880	CUX1	Homeobox protein cut-like 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O14529	CUX2	Homeobox protein cut-like 2	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; ISS:UniProt
O14529	CUX2	Homeobox protein cut-like 2	GO:0043565; F:sequence-specific DNA binding; IDA:UniProt
O14529	CUX2	Homeobox protein cut-like 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O14529	CUX2	Homeobox protein cut-like 2	GO:0071310; P:cellular response to organic substance; IEA:Ensembl
O14529	CUX2	Homeobox protein cut-like 2	GO:0050890; P:cognition; IMP:UniProt
O14529	CUX2	Homeobox protein cut-like 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProt
O14529	CUX2	Homeobox protein cut-like 2	GO:0050775; P:positive regulation of dendrite morphogenesis; ISS:UniProt
O14529	CUX2	Homeobox protein cut-like 2	GO:0061003; P:positive regulation of dendritic spine morphogenesis; ISS:UniProt
O14529	CUX2	Homeobox protein cut-like 2	GO:2000463; P:positive regulation of excitatory postsynaptic membrane potential; ISS:UniProt
O14529	CUX2	Homeobox protein cut-like 2	GO:0010628; P:positive regulation of gene expression; ISS:UniProt
O14529	CUX2	Homeobox protein cut-like 2	GO:0051965; P:positive regulation of synapse assembly; ISS:UniProt
O14529	CUX2	Homeobox protein cut-like 2	GO:0007614; P:short-term memory; ISS:UniProt
O14529	CUX2	Homeobox protein cut-like 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86UP6	CUZD1	CUB and zona pellucida-like domain-containing protein 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q86UP6	CUZD1	CUB and zona pellucida-like domain-containing protein 1	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q86UP6	CUZD1	CUB and zona pellucida-like domain-containing protein 1	GO:0008283; P:cell proliferation; NAS:UniProtKB
Q86UP6	CUZD1	CUB and zona pellucida-like domain-containing protein 1	GO:0006931; P:substrate-dependent cell migration, cell attachment to substrate; NAS:UniProtKB
Q86UP6	CUZD1	CUB and zona pellucida-like domain-containing protein 1	GO:0032023; P:trypsinogen activation; ISS:UniProtKB
Q9P013	CWC15	Spliceosome-associated protein CWC15 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P013	CWC15	Spliceosome-associated protein CWC15 homolog	GO:0003723; F:RNA binding; ISS:UniProtKB
Q9P013	CWC15	Spliceosome-associated protein CWC15 homolog	GO:0000398; P:mRNA splicing, via spliceosome; ISS:UniProtKB
Q9HCG8	CWC22	Pre-mRNA-splicing factor CWC22 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HCG8	CWC22	Pre-mRNA-splicing factor CWC22 homolog	GO:0003723; F:RNA binding; IDA:UniProtKB
Q9HCG8	CWC22	Pre-mRNA-splicing factor CWC22 homolog	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q9HCG8	CWC22	Pre-mRNA-splicing factor CWC22 homolog	GO:0048024; P:regulation of mRNA splicing, via spliceosome; IC:UniProtKB
Q6UX04	CWC27	Peptidyl-prolyl cis-trans isomerase CWC27 homolog	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW
Q6UX04	CWC27	Peptidyl-prolyl cis-trans isomerase CWC27 homolog	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q6UX04	CWC27	Peptidyl-prolyl cis-trans isomerase CWC27 homolog	GO:0006457; P:protein folding; IEA:UniProtKB-KW
Q8TE69	CXorf40A	Protein CXorf40A	GO:0005515; F:protein binding; IPI:IntAct
Q6NSI4	CXorf57	Uncharacterized protein CXorf57	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P49238	CX3CR1	CX3C chemokine receptor 1	GO:0016495; F:C-X3-C chemokine receptor activity; IEA:Ensembl
P49238	CX3CR1	CX3C chemokine receptor 1	GO:0004950; F:chemokine receptor activity; TAS:ProtInc
P49238	CX3CR1	CX3C chemokine receptor 1	GO:0005515; F:protein binding; IPI:UniProtKB
P49238	CX3CR1	CX3C chemokine receptor 1	GO:0007155; P:cell adhesion; TAS:ProtInc
P49238	CX3CR1	CX3C chemokine receptor 1	GO:0006968; P:cellular defense response; TAS:ProtInc
P49238	CX3CR1	CX3C chemokine receptor 1	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
P49238	CX3CR1	CX3C chemokine receptor 1	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEA:Ensembl
P49238	CX3CR1	CX3C chemokine receptor 1	GO:0021795; P:cerebral cortex cell migration; IEA:Ensembl
P49238	CX3CR1	CX3C chemokine receptor 1	GO:0070098; P:chemokine-mediated signaling pathway; TAS:GOC
P49238	CX3CR1	CX3C chemokine receptor 1	GO:0006935; P:chemotaxis; TAS:ProtInc
P49238	CX3CR1	CX3C chemokine receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P49238	CX3CR1	CX3C chemokine receptor 1	GO:0048246; P:macrophage chemotaxis; IEA:Ensembl
P49238	CX3CR1	CX3C chemokine receptor 1	GO:0002282; P:microglial cell activation involved in immune response; IEA:Ensembl
P49238	CX3CR1	CX3C chemokine receptor 1	GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl
P49238	CX3CR1	CX3C chemokine receptor 1	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
P49238	CX3CR1	CX3C chemokine receptor 1	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P49238	CX3CR1	CX3C chemokine receptor 1	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
P49238	CX3CR1	CX3C chemokine receptor 1	GO:0009611; P:response to wounding; TAS:ProtInc
P49238	CX3CR1	CX3C chemokine receptor 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
P12074	COX6A1	Cytochrome c oxidase subunit 6A1, mitochondrial	GO:0004129; F:cytochrome-c oxidase activity; IEA:InterPro
P12074	COX6A1	Cytochrome c oxidase subunit 6A1, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P12074	COX6A1	Cytochrome c oxidase subunit 6A1, mitochondrial	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P12074	COX6A1	Cytochrome c oxidase subunit 6A1, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P12074	COX6A1	Cytochrome c oxidase subunit 6A1, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q02221	COX6A2	Cytochrome c oxidase subunit 6A2, mitochondrial	GO:0004129; F:cytochrome-c oxidase activity; IEA:InterPro
Q02221	COX6A2	Cytochrome c oxidase subunit 6A2, mitochondrial	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P14854	COX6B1	Cytochrome c oxidase subunit 6B1	GO:0004129; F:cytochrome-c oxidase activity; NAS:UniProtKB
P14854	COX6B1	Cytochrome c oxidase subunit 6B1	GO:0044237; P:cellular metabolic process; TAS:Reactome
P14854	COX6B1	Cytochrome c oxidase subunit 6B1	GO:1902600; P:hydrogen ion transmembrane transport; NAS:GOC
P14854	COX6B1	Cytochrome c oxidase subunit 6B1	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P14854	COX6B1	Cytochrome c oxidase subunit 6B1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P14854	COX6B1	Cytochrome c oxidase subunit 6B1	GO:0021762; P:substantia nigra development; IEP:UniProt
Q6YFQ2	COX6B2	Cytochrome c oxidase subunit 6B2	GO:0004129; F:cytochrome-c oxidase activity; IEA:InterPro
P24310	COX7A1	Cytochrome c oxidase subunit 7A1, mitochondrial	GO:0004129; F:cytochrome-c oxidase activity; TAS:ProtInc
P24310	COX7A1	Cytochrome c oxidase subunit 7A1, mitochondrial	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P24310	COX7A1	Cytochrome c oxidase subunit 7A1, mitochondrial	GO:1902600; P:hydrogen ion transmembrane transport; TAS:GOC
P14406	COX7A2	Cytochrome c oxidase subunit 7A2, mitochondrial	GO:0004129; F:cytochrome-c oxidase activity; IEA:InterPro
Q8TF08	COX7B2	Cytochrome c oxidase subunit 7B2, mitochondrial	GO:0004129; F:cytochrome-c oxidase activity; IEA:InterPro
Q969M2	GJA10	Gap junction alpha-10 protein	GO:0005243; F:gap junction channel activity; TAS:Reactome
Q969M2	GJA10	Gap junction alpha-10 protein	GO:0050908; P:detection of light stimulus involved in visual perception; IEA:Ensembl
Q969M2	GJA10	Gap junction alpha-10 protein	GO:0007276; P:gamete generation; IEA:Ensembl
Q969M2	GJA10	Gap junction alpha-10 protein	GO:0007416; P:synapse assembly; IEA:Ensembl
Q969M2	GJA10	Gap junction alpha-10 protein	GO:0007268; P:synaptic transmission; TAS:Reactome
Q969M2	GJA10	Gap junction alpha-10 protein	GO:0055085; P:transmembrane transport; TAS:GOC
P17302	GJA1	Gap junction alpha-1 protein	GO:0005243; F:gap junction channel activity; IDA:BHF-UCL
P17302	GJA1	Gap junction alpha-1 protein	GO:0015075; F:ion transmembrane transporter activity; TAS:ProtInc
P17302	GJA1	Gap junction alpha-1 protein	GO:0005515; F:protein binding; IPI:UniProtKB
P17302	GJA1	Gap junction alpha-1 protein	GO:0004871; F:signal transducer activity; IMP:UniProtKB
P17302	GJA1	Gap junction alpha-1 protein	GO:0006915; P:apoptotic process; IEA:Ensembl
P17302	GJA1	Gap junction alpha-1 protein	GO:0015867; P:ATP transport; IEA:Ensembl
P17302	GJA1	Gap junction alpha-1 protein	GO:0086014; P:atrial cardiac muscle cell action potential; TAS:BHF-UCL
P17302	GJA1	Gap junction alpha-1 protein	GO:0010644; P:cell communication by electrical coupling; IDA:BHF-UCL
P17302	GJA1	Gap junction alpha-1 protein	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P17302	GJA1	Gap junction alpha-1 protein	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P17302	GJA1	Gap junction alpha-1 protein	GO:0002544; P:chronic inflammatory response; IEA:Ensembl
P17302	GJA1	Gap junction alpha-1 protein	GO:0003158; P:endothelium development; IEA:Ensembl
P17302	GJA1	Gap junction alpha-1 protein	GO:0016264; P:gap junction assembly; TAS:UniProtKB
P17302	GJA1	Gap junction alpha-1 protein	GO:0007507; P:heart development; TAS:ProtInc
P17302	GJA1	Gap junction alpha-1 protein	GO:0034220; P:ion transmembrane transport; TAS:GOC
P17302	GJA1	Gap junction alpha-1 protein	GO:0061024; P:membrane organization; TAS:Reactome
P17302	GJA1	Gap junction alpha-1 protein	GO:0006936; P:muscle contraction; TAS:ProtInc
P17302	GJA1	Gap junction alpha-1 protein	GO:0060044; P:negative regulation of cardiac muscle cell proliferation; IEA:Ensembl
P17302	GJA1	Gap junction alpha-1 protein	GO:0048812; P:neuron projection morphogenesis; IEA:Ensembl
P17302	GJA1	Gap junction alpha-1 protein	GO:2000987; P:positive regulation of behavioral fear response; IEA:Ensembl
P17302	GJA1	Gap junction alpha-1 protein	GO:0010652; P:positive regulation of cell communication by chemical coupling; IEA:Ensembl
P17302	GJA1	Gap junction alpha-1 protein	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P17302	GJA1	Gap junction alpha-1 protein	GO:0003104; P:positive regulation of glomerular filtration; IEA:Ensembl
P17302	GJA1	Gap junction alpha-1 protein	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
P17302	GJA1	Gap junction alpha-1 protein	GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl
P17302	GJA1	Gap junction alpha-1 protein	GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl
P17302	GJA1	Gap junction alpha-1 protein	GO:0045909; P:positive regulation of vasodilation; IEA:Ensembl
P17302	GJA1	Gap junction alpha-1 protein	GO:0051259; P:protein oligomerization; IEA:Ensembl
P17302	GJA1	Gap junction alpha-1 protein	GO:0051924; P:regulation of calcium ion transport; IEA:Ensembl
P17302	GJA1	Gap junction alpha-1 protein	GO:2000810; P:regulation of tight junction assembly; IEA:Ensembl
P17302	GJA1	Gap junction alpha-1 protein	GO:0034405; P:response to fluid shear stress; IEA:Ensembl
P17302	GJA1	Gap junction alpha-1 protein	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P17302	GJA1	Gap junction alpha-1 protein	GO:0009268; P:response to pH; IEA:Ensembl
P17302	GJA1	Gap junction alpha-1 protein	GO:0007165; P:signal transduction; IMP:GOC
P17302	GJA1	Gap junction alpha-1 protein	GO:0055085; P:transmembrane transport; IDA:GOC
P17302	GJA1	Gap junction alpha-1 protein	GO:0006810; P:transport; TAS:ProtInc
P17302	GJA1	Gap junction alpha-1 protein	GO:0010232; P:vascular transport; IEA:Ensembl
Q9Y6H8	GJA3	Gap junction alpha-3 protein	GO:0005243; F:gap junction channel activity; IEA:InterPro
Q9Y6H8	GJA3	Gap junction alpha-3 protein	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9Y6H8	GJA3	Gap junction alpha-3 protein	GO:0006810; P:transport; NAS:ProtInc
Q9Y6H8	GJA3	Gap junction alpha-3 protein	GO:0007601; P:visual perception; TAS:ProtInc
P35212	GJA4	Gap junction alpha-4 protein	GO:0005515; F:protein binding; IPI:IntAct
P35212	GJA4	Gap junction alpha-4 protein	GO:0001568; P:blood vessel development; IEA:Ensembl
P35212	GJA4	Gap junction alpha-4 protein	GO:0006816; P:calcium ion transport; IEA:Ensembl
P35212	GJA4	Gap junction alpha-4 protein	GO:0007043; P:cell-cell junction assembly; TAS:ProtInc
P35212	GJA4	Gap junction alpha-4 protein	GO:0007267; P:cell-cell signaling; IEA:Ensembl
P35212	GJA4	Gap junction alpha-4 protein	GO:0003158; P:endothelium development; IEA:Ensembl
P35212	GJA4	Gap junction alpha-4 protein	GO:0048265; P:response to pain; IEA:Ensembl
P35212	GJA4	Gap junction alpha-4 protein	GO:0006810; P:transport; TAS:ProtInc
P36382	GJA5	Gap junction alpha-5 protein	GO:0086077; F:gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling; IDA:BHF-UCL
P36382	GJA5	Gap junction alpha-5 protein	GO:0086075; F:gap junction channel activity involved in cardiac conduction electrical coupling; IDA:BHF-UCL
P36382	GJA5	Gap junction alpha-5 protein	GO:0055077; F:gap junction hemi-channel activity; IDA:BHF-UCL
P36382	GJA5	Gap junction alpha-5 protein	GO:0001525; P:angiogenesis; IEP:UniProtKB
P36382	GJA5	Gap junction alpha-5 protein	GO:0048844; P:artery morphogenesis; ISS:BHF-UCL
P36382	GJA5	Gap junction alpha-5 protein	GO:0086014; P:atrial cardiac muscle cell action potential; IMP:BHF-UCL
P36382	GJA5	Gap junction alpha-5 protein	GO:0003283; P:atrial septum development; IMP:BHF-UCL
P36382	GJA5	Gap junction alpha-5 protein	GO:0060413; P:atrial septum morphogenesis; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0003294; P:atrial ventricular junction remodeling; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0086053; P:AV node cell to bundle of His cell communication by electrical coupling; IMP:BHF-UCL
P36382	GJA5	Gap junction alpha-5 protein	GO:0086069; P:bundle of His cell to Purkinje myocyte communication; IMP:BHF-UCL
P36382	GJA5	Gap junction alpha-5 protein	GO:0003161; P:cardiac conduction system development; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0010643; P:cell communication by chemical coupling; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0086064; P:cell communication by electrical coupling involved in cardiac conduction; IDA:BHF-UCL
P36382	GJA5	Gap junction alpha-5 protein	GO:0035050; P:embryonic heart tube development; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0003158; P:endothelium development; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0035922; P:foramen ovale closure; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0016264; P:gap junction assembly; IDA:BHF-UCL
P36382	GJA5	Gap junction alpha-5 protein	GO:0003174; P:mitral valve development; IMP:BHF-UCL
P36382	GJA5	Gap junction alpha-5 protein	GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0003105; P:negative regulation of glomerular filtration; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0003151; P:outflow tract morphogenesis; IMP:BHF-UCL
P36382	GJA5	Gap junction alpha-5 protein	GO:0010652; P:positive regulation of cell communication by chemical coupling; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0045909; P:positive regulation of vasodilation; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0006813; P:potassium ion transport; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0051259; P:protein oligomerization; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0003193; P:pulmonary valve formation; IMP:BHF-UCL
P36382	GJA5	Gap junction alpha-5 protein	GO:0060371; P:regulation of atrial cardiac muscle cell membrane depolarization; IMP:BHF-UCL
P36382	GJA5	Gap junction alpha-5 protein	GO:0055117; P:regulation of cardiac muscle contraction; IMP:BHF-UCL
P36382	GJA5	Gap junction alpha-5 protein	GO:0086091; P:regulation of heart rate by cardiac conduction; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:1900825; P:regulation of membrane depolarization during cardiac muscle cell action potential; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:1900133; P:regulation of renin secretion into blood stream; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0060373; P:regulation of ventricular cardiac muscle cell membrane depolarization; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0086015; P:SA node cell action potential; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0003284; P:septum primum development; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0001501; P:skeletal system development; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0055085; P:transmembrane transport; IDA:GOC
P36382	GJA5	Gap junction alpha-5 protein	GO:1990029; P:vasomotion; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0086005; P:ventricular cardiac muscle cell action potential; IEA:Ensembl
P36382	GJA5	Gap junction alpha-5 protein	GO:0003281; P:ventricular septum development; IMP:BHF-UCL
P36382	GJA5	Gap junction alpha-5 protein	GO:0060412; P:ventricular septum morphogenesis; IEA:Ensembl
P48165	GJA8	Gap junction alpha-8 protein	GO:0015267; F:channel activity; TAS:ProtInc
P48165	GJA8	Gap junction alpha-8 protein	GO:0007267; P:cell-cell signaling; IEA:Ensembl
P48165	GJA8	Gap junction alpha-8 protein	GO:0002088; P:lens development in camera-type eye; IEA:Ensembl
P48165	GJA8	Gap junction alpha-8 protein	GO:0051260; P:protein homooligomerization; IEA:Ensembl
P48165	GJA8	Gap junction alpha-8 protein	GO:0055085; P:transmembrane transport; TAS:GOC
P48165	GJA8	Gap junction alpha-8 protein	GO:0006810; P:transport; TAS:ProtInc
P48165	GJA8	Gap junction alpha-8 protein	GO:0007601; P:visual perception; TAS:ProtInc
P57773	GJA9	Gap junction alpha-9 protein	GO:0007154; P:cell communication; IEA:InterPro
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0008013; F:beta-catenin binding; IPI:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0050839; F:cell adhesion molecule binding; IPI:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0071253; F:connexin binding; ISS:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0042802; F:identical protein binding; IDA:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0005178; F:integrin binding; IPI:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0030165; F:PDZ domain binding; IPI:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0005102; F:receptor binding; IPI:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0031532; P:actin cytoskeleton reorganization; IDA:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0086067; P:AV node cell to bundle of His cell communication; ISS:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0007596; P:blood coagulation; TAS:Reactome
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0048739; P:cardiac muscle fiber development; ISS:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0045216; P:cell-cell junction organization; ISS:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0051607; P:defense response to virus; IDA:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0010669; P:epithelial structure maintenance; IMP:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0046629; P:gamma-delta T cell activation; ISS:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0008354; P:germ cell migration; ISS:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0007507; P:heart development; ISS:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0007157; P:heterophilic cell-cell adhesion; IDA:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0034109; P:homotypic cell-cell adhesion; IDA:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0050900; P:leukocyte migration; TAS:Reactome
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0007005; P:mitochondrion organization; ISS:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0060044; P:negative regulation of cardiac muscle cell proliferation; IEA:Ensembl
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0030593; P:neutrophil chemotaxis; IMP:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0050776; P:regulation of immune response; TAS:Reactome
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0070633; P:transepithelial transport; IMP:UniProtKB
P78310	CXADR	Coxsackievirus and adenovirus receptor	GO:0016032; P:viral process; IEA:UniProtKB-KW
P08034	GJB1	Gap junction beta-1 protein	GO:0005243; F:gap junction channel activity; IEA:Ensembl
P08034	GJB1	Gap junction beta-1 protein	GO:0008219; P:cell death; IEA:UniProtKB-KW
P08034	GJB1	Gap junction beta-1 protein	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P08034	GJB1	Gap junction beta-1 protein	GO:0016264; P:gap junction assembly; TAS:Reactome
P08034	GJB1	Gap junction beta-1 protein	GO:0061024; P:membrane organization; TAS:Reactome
P08034	GJB1	Gap junction beta-1 protein	GO:0007399; P:nervous system development; TAS:ProtInc
P08034	GJB1	Gap junction beta-1 protein	GO:0051259; P:protein oligomerization; IEA:Ensembl
P08034	GJB1	Gap junction beta-1 protein	GO:0015868; P:purine ribonucleotide transport; IEA:Ensembl
P08034	GJB1	Gap junction beta-1 protein	GO:0006810; P:transport; TAS:ProtInc
P29033	GJB2	Gap junction beta-2 protein	GO:0005243; F:gap junction channel activity; IEA:Ensembl
P29033	GJB2	Gap junction beta-2 protein	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P29033	GJB2	Gap junction beta-2 protein	GO:0016264; P:gap junction assembly; TAS:Reactome
P29033	GJB2	Gap junction beta-2 protein	GO:0030539; P:male genitalia development; IEA:Ensembl
P29033	GJB2	Gap junction beta-2 protein	GO:0061024; P:membrane organization; TAS:Reactome
P29033	GJB2	Gap junction beta-2 protein	GO:0007605; P:sensory perception of sound; TAS:ProtInc
P29033	GJB2	Gap junction beta-2 protein	GO:0006810; P:transport; TAS:ProtInc
O75712	GJB3	Gap junction beta-3 protein	GO:0005243; F:gap junction channel activity; NAS:UniProtKB
O75712	GJB3	Gap junction beta-3 protein	GO:0007154; P:cell communication; IEA:InterPro
O75712	GJB3	Gap junction beta-3 protein	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O75712	GJB3	Gap junction beta-3 protein	GO:0001890; P:placenta development; IEA:Ensembl
O75712	GJB3	Gap junction beta-3 protein	GO:0007605; P:sensory perception of sound; IEA:Ensembl
O75712	GJB3	Gap junction beta-3 protein	GO:0043588; P:skin development; IEA:Ensembl
O75712	GJB3	Gap junction beta-3 protein	GO:0055085; P:transmembrane transport; NAS:GOC
Q9NTQ9	GJB4	Gap junction beta-4 protein	GO:0007154; P:cell communication; IEA:InterPro
Q9NTQ9	GJB4	Gap junction beta-4 protein	GO:0042048; P:olfactory behavior; IEA:Ensembl
Q9NTQ9	GJB4	Gap junction beta-4 protein	GO:0007608; P:sensory perception of smell; IEA:Ensembl
O95377	GJB5	Gap junction beta-5 protein	GO:0007154; P:cell communication; IEA:InterPro
O95377	GJB5	Gap junction beta-5 protein	GO:0008544; P:epidermis development; TAS:ProtInc
O95377	GJB5	Gap junction beta-5 protein	GO:0060713; P:labyrinthine layer morphogenesis; IEA:Ensembl
O95377	GJB5	Gap junction beta-5 protein	GO:0060708; P:spongiotrophoblast differentiation; IEA:Ensembl
O95452	GJB6	Gap junction beta-6 protein	GO:0006915; P:apoptotic process; IEA:Ensembl
O95452	GJB6	Gap junction beta-6 protein	GO:0007154; P:cell communication; IEA:InterPro
O95452	GJB6	Gap junction beta-6 protein	GO:0042471; P:ear morphogenesis; IEA:Ensembl
O95452	GJB6	Gap junction beta-6 protein	GO:0048839; P:inner ear development; IEA:Ensembl
O95452	GJB6	Gap junction beta-6 protein	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
O95452	GJB6	Gap junction beta-6 protein	GO:0007605; P:sensory perception of sound; TAS:ProtInc
Q6PEY0	GJB7	Gap junction beta-7 protein	GO:0007154; P:cell communication; IEA:InterPro
P19875	CXCL2	C-X-C motif chemokine 2	GO:0008009; F:chemokine activity; TAS:ProtInc
P19875	CXCL2	C-X-C motif chemokine 2	GO:0005515; F:protein binding; IPI:IntAct
P19875	CXCL2	C-X-C motif chemokine 2	GO:0060326; P:cell chemotaxis; TAS:GOC
P19875	CXCL2	C-X-C motif chemokine 2	GO:0006935; P:chemotaxis; TAS:ProtInc
P19875	CXCL2	C-X-C motif chemokine 2	GO:0006955; P:immune response; IEA:InterPro
P19875	CXCL2	C-X-C motif chemokine 2	GO:0006954; P:inflammatory response; TAS:ProtInc
P19875	CXCL2	C-X-C motif chemokine 2	GO:0002237; P:response to molecule of bacterial origin; IDA:BHF-UCL
P19876	CXCL3	C-X-C motif chemokine 3	GO:0008009; F:chemokine activity; ISS:UniProtKB
P19876	CXCL3	C-X-C motif chemokine 3	GO:0006955; P:immune response; IEA:InterPro
P19876	CXCL3	C-X-C motif chemokine 3	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
P19876	CXCL3	C-X-C motif chemokine 3	GO:0030593; P:neutrophil chemotaxis; ISS:UniProtKB
P02775	PPBP	Platelet basic protein	GO:0005355; F:glucose transmembrane transporter activity; TAS:ProtInc
P02775	PPBP	Platelet basic protein	GO:0007596; P:blood coagulation; TAS:Reactome
P02775	PPBP	Platelet basic protein	GO:0060326; P:cell chemotaxis; IEA:GOC
P02775	PPBP	Platelet basic protein	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
P02775	PPBP	Platelet basic protein	GO:0015758; P:glucose transport; TAS:ProtInc
P02775	PPBP	Platelet basic protein	GO:0006955; P:immune response; IEA:InterPro
P02775	PPBP	Platelet basic protein	GO:0030168; P:platelet activation; TAS:Reactome
P02775	PPBP	Platelet basic protein	GO:0002576; P:platelet degranulation; TAS:Reactome
P02775	PPBP	Platelet basic protein	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P42830	CXCL5	C-X-C motif chemokine 5	GO:0008009; F:chemokine activity; TAS:ProtInc
P42830	CXCL5	C-X-C motif chemokine 5	GO:0060326; P:cell chemotaxis; TAS:GOC
P42830	CXCL5	C-X-C motif chemokine 5	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P42830	CXCL5	C-X-C motif chemokine 5	GO:0006935; P:chemotaxis; TAS:ProtInc
P42830	CXCL5	C-X-C motif chemokine 5	GO:0006955; P:immune response; IEA:InterPro
P42830	CXCL5	C-X-C motif chemokine 5	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P42830	CXCL5	C-X-C motif chemokine 5	GO:0007165; P:signal transduction; TAS:ProtInc
P80162	CXCL6	C-X-C motif chemokine 6	GO:0008009; F:chemokine activity; TAS:ProtInc
P80162	CXCL6	C-X-C motif chemokine 6	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P80162	CXCL6	C-X-C motif chemokine 6	GO:0060326; P:cell chemotaxis; TAS:GOC
P80162	CXCL6	C-X-C motif chemokine 6	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P80162	CXCL6	C-X-C motif chemokine 6	GO:0006935; P:chemotaxis; TAS:ProtInc
P80162	CXCL6	C-X-C motif chemokine 6	GO:0006955; P:immune response; IEA:InterPro
P80162	CXCL6	C-X-C motif chemokine 6	GO:0006954; P:inflammatory response; TAS:ProtInc
P80162	CXCL6	C-X-C motif chemokine 6	GO:0007165; P:signal transduction; TAS:ProtInc
Q07325	CXCL9	C-X-C motif chemokine 9	GO:0008009; F:chemokine activity; IDA:UniProtKB
Q07325	CXCL9	C-X-C motif chemokine 9	GO:0048248; F:CXCR3 chemokine receptor binding; IDA:UniProtKB
Q07325	CXCL9	C-X-C motif chemokine 9	GO:0005125; F:cytokine activity; TAS:ProtInc
Q07325	CXCL9	C-X-C motif chemokine 9	GO:0005515; F:protein binding; IPI:IntAct
Q07325	CXCL9	C-X-C motif chemokine 9	GO:0060326; P:cell chemotaxis; IDA:GOC
Q07325	CXCL9	C-X-C motif chemokine 9	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q07325	CXCL9	C-X-C motif chemokine 9	GO:0006968; P:cellular defense response; TAS:ProtInc
Q07325	CXCL9	C-X-C motif chemokine 9	GO:0006935; P:chemotaxis; IDA:UniProtKB
Q07325	CXCL9	C-X-C motif chemokine 9	GO:0006952; P:defense response; TAS:ProtInc
Q07325	CXCL9	C-X-C motif chemokine 9	GO:0051607; P:defense response to virus; IEA:Ensembl
Q07325	CXCL9	C-X-C motif chemokine 9	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q07325	CXCL9	C-X-C motif chemokine 9	GO:0006955; P:immune response; IEA:InterPro
Q07325	CXCL9	C-X-C motif chemokine 9	GO:0006954; P:inflammatory response; TAS:ProtInc
Q07325	CXCL9	C-X-C motif chemokine 9	GO:0030816; P:positive regulation of cAMP metabolic process; IDA:UniProtKB
Q07325	CXCL9	C-X-C motif chemokine 9	GO:0043950; P:positive regulation of cAMP-mediated signaling; IDA:UniProtKB
Q07325	CXCL9	C-X-C motif chemokine 9	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IDA:UniProtKB
Q07325	CXCL9	C-X-C motif chemokine 9	GO:0042127; P:regulation of cell proliferation; IDA:UniProtKB
Q07325	CXCL9	C-X-C motif chemokine 9	GO:0007165; P:signal transduction; TAS:ProtInc
P25024	CXCR1	C-X-C chemokine receptor type 1	GO:0004950; F:chemokine receptor activity; TAS:ProtInc
P25024	CXCR1	C-X-C chemokine receptor type 1	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P25024	CXCR1	C-X-C chemokine receptor type 1	GO:0019959; F:interleukin-8 binding; IPI:UniProtKB
P25024	CXCR1	C-X-C chemokine receptor type 1	GO:0004918; F:interleukin-8 receptor activity; IDA:UniProtKB
P25024	CXCR1	C-X-C chemokine receptor type 1	GO:0007166; P:cell surface receptor signaling pathway; IDA:UniProtKB
P25024	CXCR1	C-X-C chemokine receptor type 1	GO:0070098; P:chemokine-mediated signaling pathway; TAS:GOC
P25024	CXCR1	C-X-C chemokine receptor type 1	GO:0006935; P:chemotaxis; TAS:ProtInc
P25024	CXCR1	C-X-C chemokine receptor type 1	GO:0002407; P:dendritic cell chemotaxis; TAS:BHF-UCL
P25024	CXCR1	C-X-C chemokine receptor type 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P25024	CXCR1	C-X-C chemokine receptor type 1	GO:0006954; P:inflammatory response; TAS:ProtInc
P25024	CXCR1	C-X-C chemokine receptor type 1	GO:0038112; P:interleukin-8-mediated signaling pathway; IDA:GOC
P25024	CXCR1	C-X-C chemokine receptor type 1	GO:0031623; P:receptor internalization; IDA:UniProtKB
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0016494; F:C-X-C chemokine receptor activity; IDA:UniProtKB
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0019959; F:interleukin-8 binding; IPI:UniProtKB
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0004918; F:interleukin-8 receptor activity; IDA:UniProtKB
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0005515; F:protein binding; IPI:IntAct
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0004871; F:signal transducer activity; IDA:UniProtKB
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0002438; P:acute inflammatory response to antigenic stimulus; IEA:Ensembl
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0007166; P:cell surface receptor signaling pathway; IDA:UniProtKB
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0006968; P:cellular defense response; IDA:UniProtKB
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0070098; P:chemokine-mediated signaling pathway; IDA:GOC
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0006935; P:chemotaxis; IDA:UniProtKB
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0002407; P:dendritic cell chemotaxis; TAS:BHF-UCL
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0006954; P:inflammatory response; TAS:ProtInc
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0038112; P:interleukin-8-mediated signaling pathway; IDA:GOC
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0072173; P:metanephric tubule morphogenesis; IEA:Ensembl
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0030901; P:midbrain development; IEA:Ensembl
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0033030; P:negative regulation of neutrophil apoptotic process; IEA:Ensembl
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0042119; P:neutrophil activation; IDA:UniProtKB
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0030593; P:neutrophil chemotaxis; IDA:UniProtKB
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; IDA:UniProtKB
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0010666; P:positive regulation of cardiac muscle cell apoptotic process; IEA:Ensembl
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0090023; P:positive regulation of neutrophil chemotaxis; IEA:Ensembl
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0043117; P:positive regulation of vascular permeability; IEA:Ensembl
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0031623; P:receptor internalization; IDA:UniProtKB
P25025	CXCR2	C-X-C chemokine receptor type 2	GO:0007165; P:signal transduction; IDA:UniProtKB
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0019958; F:C-X-C chemokine binding; IDA:UniProtKB
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0016494; F:C-X-C chemokine receptor activity; IEA:Ensembl
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0019956; F:chemokine binding; IPI:BHF-UCL
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0004950; F:chemokine receptor activity; TAS:ProtInc
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0004872; F:receptor activity; IDA:UniProtKB
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0019722; P:calcium-mediated signaling; IEA:Ensembl
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0007155; P:cell adhesion; TAS:ProtInc
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0007166; P:cell surface receptor signaling pathway; IDA:BHF-UCL
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0006928; P:cellular component movement; TAS:ProtInc
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0071954; P:chemokine (C-C motif) ligand 11 production; IDA:UniProtKB
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0006935; P:chemotaxis; TAS:ProtInc
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0007186; P:G-protein coupled receptor signaling pathway; IMP:UniProtKB
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0006954; P:inflammatory response; IEA:InterPro
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0016525; P:negative regulation of angiogenesis; IDA:UniProtKB
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0001937; P:negative regulation of endothelial cell proliferation; IDA:UniProtKB
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:1900118; P:negative regulation of execution phase of apoptosis; IDA:UniProtKB
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0030816; P:positive regulation of cAMP metabolic process; IDA:UniProtKB
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0043950; P:positive regulation of cAMP-mediated signaling; IDA:UniProtKB
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0050921; P:positive regulation of chemotaxis; IDA:UniProtKB
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:1900119; P:positive regulation of execution phase of apoptosis; IDA:UniProtKB
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IMP:UniProtKB
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0002685; P:regulation of leukocyte migration; IEA:InterPro
P49682	CXCR3	C-X-C chemokine receptor type 3	GO:0010818; P:T cell chemotaxis; IEA:Ensembl
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0003779; F:actin binding; IDA:UniProtKB
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0016494; F:C-X-C chemokine receptor activity; NAS:UniProtKB
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0015026; F:coreceptor activity; TAS:ProtInc
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0032027; F:myosin light chain binding; IDA:UniProtKB
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0005515; F:protein binding; IPI:UniProtKB
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0000187; P:activation of MAPK activity; TAS:ProtInc
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0001667; P:ameboidal cell migration; IEA:Ensembl
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0006915; P:apoptotic process; TAS:ProtInc
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0007420; P:brain development; IEA:Ensembl
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0019722; P:calcium-mediated signaling; IMP:MGI
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0071345; P:cellular response to cytokine stimulus; IDA:UniProtKB
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0070098; P:chemokine-mediated signaling pathway; NAS:GOC
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0002407; P:dendritic cell chemotaxis; TAS:BHF-UCL
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0030260; P:entry into host cell; TAS:Reactome
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:UniProtKB
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0007281; P:germ cell development; IEA:Ensembl
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0008354; P:germ cell migration; IEA:Ensembl
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0006954; P:inflammatory response; TAS:ProtInc
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0008045; P:motor neuron axon guidance; IEA:Ensembl
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0043217; P:myelin maintenance; ISS:BHF-UCL
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0061351; P:neural precursor cell proliferation; IEA:Ensembl
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0001764; P:neuron migration; IEA:Ensembl
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0042119; P:neutrophil activation; IEA:InterPro
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0001569; P:patterning of blood vessels; IEA:Ensembl
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0048714; P:positive regulation of oligodendrocyte differentiation; ISS:BHF-UCL
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0030334; P:regulation of cell migration; IEA:Ensembl
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0050920; P:regulation of chemotaxis; IMP:UniProtKB
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0001666; P:response to hypoxia; IEP:UniProtKB
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0009615; P:response to virus; TAS:ProtInc
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0042098; P:T cell proliferation; IEA:Ensembl
P61073	CXCR4	C-X-C chemokine receptor type 4	GO:0016032; P:viral process; TAS:Reactome
P32302	CXCR5	C-X-C chemokine receptor type 5	GO:0016494; F:C-X-C chemokine receptor activity; IEA:InterPro
P32302	CXCR5	C-X-C chemokine receptor type 5	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P32302	CXCR5	C-X-C chemokine receptor type 5	GO:0005515; F:protein binding; IPI:IntAct
P32302	CXCR5	C-X-C chemokine receptor type 5	GO:0042113; P:B cell activation; IEA:UniProtKB-KW
P32302	CXCR5	C-X-C chemokine receptor type 5	GO:0006928; P:cellular component movement; TAS:ProtInc
P32302	CXCR5	C-X-C chemokine receptor type 5	GO:0006935; P:chemotaxis; IEA:InterPro
P32302	CXCR5	C-X-C chemokine receptor type 5	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P32302	CXCR5	C-X-C chemokine receptor type 5	GO:0006955; P:immune response; IEA:InterPro
P32302	CXCR5	C-X-C chemokine receptor type 5	GO:0048535; P:lymph node development; IEA:Ensembl
P32302	CXCR5	C-X-C chemokine receptor type 5	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProt
O00574	CXCR6	C-X-C chemokine receptor type 6	GO:0016494; F:C-X-C chemokine receptor activity; IEA:Ensembl
O00574	CXCR6	C-X-C chemokine receptor type 6	GO:0015026; F:coreceptor activity; TAS:ProtInc
O00574	CXCR6	C-X-C chemokine receptor type 6	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O00574	CXCR6	C-X-C chemokine receptor type 6	GO:0006935; P:chemotaxis; IEA:InterPro
O00574	CXCR6	C-X-C chemokine receptor type 6	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
O00574	CXCR6	C-X-C chemokine receptor type 6	GO:0006954; P:inflammatory response; IEA:InterPro
O00574	CXCR6	C-X-C chemokine receptor type 6	GO:0019079; P:viral genome replication; TAS:ProtInc
Q9UKL4	GJD2	Gap junction delta-2 protein	GO:0005243; F:gap junction channel activity; TAS:Reactome
Q9UKL4	GJD2	Gap junction delta-2 protein	GO:0001508; P:action potential; IEA:Ensembl
Q9UKL4	GJD2	Gap junction delta-2 protein	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9UKL4	GJD2	Gap junction delta-2 protein	GO:0055085; P:transmembrane transport; TAS:GOC
Q9UKL4	GJD2	Gap junction delta-2 protein	GO:0007601; P:visual perception; IEA:Ensembl
Q96KN9	GJD4	Gap junction delta-4 protein	GO:0007154; P:cell communication; IEA:InterPro
Q96KN9	GJD4	Gap junction delta-4 protein	GO:0014717; P:regulation of satellite cell activation involved in skeletal muscle regeneration; IEA:Ensembl
Q8N144	GJD3	Gap junction delta-3 protein	GO:0005216; F:ion channel activity; IEA:Ensembl
Q8N144	GJD3	Gap junction delta-3 protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N144	GJD3	Gap junction delta-3 protein	GO:0007154; P:cell communication; TAS:UniProtKB
Q8N144	GJD3	Gap junction delta-3 protein	GO:0016264; P:gap junction assembly; IDA:UniProtKB
A6NN92	GJE1	Gap junction epsilon-1 protein	GO:0007154; P:cell communication; IEA:InterPro
A6NN92	GJE1	Gap junction epsilon-1 protein	GO:0000902; P:cell morphogenesis; IEA:Ensembl
A6NN92	GJE1	Gap junction epsilon-1 protein	GO:0002088; P:lens development in camera-type eye; IEA:Ensembl
A6NN92	GJE1	Gap junction epsilon-1 protein	GO:0035265; P:organ growth; IEA:Ensembl
P36383	GJC1	Gap junction gamma-1 protein	GO:0005243; F:gap junction channel activity; IEA:Ensembl
P36383	GJC1	Gap junction gamma-1 protein	GO:0005216; F:ion channel activity; IEA:Ensembl
P36383	GJC1	Gap junction gamma-1 protein	GO:0086014; P:atrial cardiac muscle cell action potential; TAS:BHF-UCL
P36383	GJC1	Gap junction gamma-1 protein	GO:0048738; P:cardiac muscle tissue development; IEA:Ensembl
P36383	GJC1	Gap junction gamma-1 protein	GO:0048468; P:cell development; IEA:Ensembl
P36383	GJC1	Gap junction gamma-1 protein	GO:0007043; P:cell-cell junction assembly; TAS:ProtInc
P36383	GJC1	Gap junction gamma-1 protein	GO:0016264; P:gap junction assembly; TAS:Reactome
P36383	GJC1	Gap junction gamma-1 protein	GO:0061024; P:membrane organization; TAS:Reactome
P36383	GJC1	Gap junction gamma-1 protein	GO:0006936; P:muscle contraction; TAS:ProtInc
P36383	GJC1	Gap junction gamma-1 protein	GO:0007268; P:synaptic transmission; TAS:Reactome
P36383	GJC1	Gap junction gamma-1 protein	GO:0006810; P:transport; NAS:ProtInc
P36383	GJC1	Gap junction gamma-1 protein	GO:0001570; P:vasculogenesis; IEA:Ensembl
P36383	GJC1	Gap junction gamma-1 protein	GO:0007601; P:visual perception; IEA:Ensembl
Q5T442	GJC2	Gap junction gamma-2 protein	GO:0005243; F:gap junction channel activity; IEA:Ensembl
Q5T442	GJC2	Gap junction gamma-2 protein	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q5T442	GJC2	Gap junction gamma-2 protein	GO:0007267; P:cell-cell signaling; IEA:Ensembl
Q5T442	GJC2	Gap junction gamma-2 protein	GO:0009636; P:response to toxic substance; IEA:Ensembl
Q8NFK1	GJC3	Gap junction gamma-3 protein	GO:0007154; P:cell communication; IEA:InterPro
Q8NFK1	GJC3	Gap junction gamma-3 protein	GO:0042552; P:myelination; IEA:Ensembl
Q8NFK1	GJC3	Gap junction gamma-3 protein	GO:0007605; P:sensory perception of sound; IEA:Ensembl
P02778	CXCL10	C-X-C motif chemokine 10	GO:0008603; F:cAMP-dependent protein kinase regulator activity; TAS:ProtInc
P02778	CXCL10	C-X-C motif chemokine 10	GO:0008009; F:chemokine activity; IDA:UniProtKB
P02778	CXCL10	C-X-C motif chemokine 10	GO:0048248; F:CXCR3 chemokine receptor binding; IDA:UniProtKB
P02778	CXCL10	C-X-C motif chemokine 10	GO:0008201; F:heparin binding; IMP:UniProt
P02778	CXCL10	C-X-C motif chemokine 10	GO:0005515; F:protein binding; IPI:IntAct
P02778	CXCL10	C-X-C motif chemokine 10	GO:0005102; F:receptor binding; TAS:ProtInc
P02778	CXCL10	C-X-C motif chemokine 10	GO:0008015; P:blood circulation; TAS:ProtInc
P02778	CXCL10	C-X-C motif chemokine 10	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P02778	CXCL10	C-X-C motif chemokine 10	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P02778	CXCL10	C-X-C motif chemokine 10	GO:0034605; P:cellular response to heat; IEA:Ensembl
P02778	CXCL10	C-X-C motif chemokine 10	GO:0071222; P:cellular response to lipopolysaccharide; IMP:MGI
P02778	CXCL10	C-X-C motif chemokine 10	GO:0070098; P:chemokine-mediated signaling pathway; IMP:UniProt
P02778	CXCL10	C-X-C motif chemokine 10	GO:0006935; P:chemotaxis; IDA:UniProtKB
P02778	CXCL10	C-X-C motif chemokine 10	GO:0051607; P:defense response to virus; IEA:Ensembl
P02778	CXCL10	C-X-C motif chemokine 10	GO:0007186; P:G-protein coupled receptor signaling pathway; IMP:UniProtKB
P02778	CXCL10	C-X-C motif chemokine 10	GO:0006955; P:immune response; IEA:Ensembl
P02778	CXCL10	C-X-C motif chemokine 10	GO:0006954; P:inflammatory response; TAS:ProtInc
P02778	CXCL10	C-X-C motif chemokine 10	GO:0007517; P:muscle organ development; TAS:ProtInc
P02778	CXCL10	C-X-C motif chemokine 10	GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl
P02778	CXCL10	C-X-C motif chemokine 10	GO:0030816; P:positive regulation of cAMP metabolic process; IDA:UniProtKB
P02778	CXCL10	C-X-C motif chemokine 10	GO:0043950; P:positive regulation of cAMP-mediated signaling; IDA:UniProtKB
P02778	CXCL10	C-X-C motif chemokine 10	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P02778	CXCL10	C-X-C motif chemokine 10	GO:0002690; P:positive regulation of leukocyte chemotaxis; IEA:Ensembl
P02778	CXCL10	C-X-C motif chemokine 10	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IDA:UniProtKB
P02778	CXCL10	C-X-C motif chemokine 10	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:UniProtKB
P02778	CXCL10	C-X-C motif chemokine 10	GO:0009306; P:protein secretion; IEA:Ensembl
P02778	CXCL10	C-X-C motif chemokine 10	GO:0042127; P:regulation of cell proliferation; IDA:UniProtKB
P02778	CXCL10	C-X-C motif chemokine 10	GO:0045859; P:regulation of protein kinase activity; TAS:GOC
P02778	CXCL10	C-X-C motif chemokine 10	GO:0010996; P:response to auditory stimulus; IEA:Ensembl
P02778	CXCL10	C-X-C motif chemokine 10	GO:0009409; P:response to cold; IEA:Ensembl
P02778	CXCL10	C-X-C motif chemokine 10	GO:0010332; P:response to gamma radiation; IEA:Ensembl
P02778	CXCL10	C-X-C motif chemokine 10	GO:0033280; P:response to vitamin D; IEA:Ensembl
P02778	CXCL10	C-X-C motif chemokine 10	GO:0007165; P:signal transduction; TAS:ProtInc
P02778	CXCL10	C-X-C motif chemokine 10	GO:0010818; P:T cell chemotaxis; IMP:UniProt
O14625	CXCL11	C-X-C motif chemokine 11	GO:0008009; F:chemokine activity; IDA:UniProtKB
O14625	CXCL11	C-X-C motif chemokine 11	GO:0048248; F:CXCR3 chemokine receptor binding; IDA:UniProtKB
O14625	CXCL11	C-X-C motif chemokine 11	GO:0008201; F:heparin binding; IMP:UniProt
O14625	CXCL11	C-X-C motif chemokine 11	GO:0005515; F:protein binding; IPI:IntAct
O14625	CXCL11	C-X-C motif chemokine 11	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O14625	CXCL11	C-X-C motif chemokine 11	GO:0070098; P:chemokine-mediated signaling pathway; IMP:UniProt
O14625	CXCL11	C-X-C motif chemokine 11	GO:0006935; P:chemotaxis; IDA:UniProtKB
O14625	CXCL11	C-X-C motif chemokine 11	GO:0006955; P:immune response; IEA:Ensembl
O14625	CXCL11	C-X-C motif chemokine 11	GO:0006954; P:inflammatory response; TAS:ProtInc
O14625	CXCL11	C-X-C motif chemokine 11	GO:0030816; P:positive regulation of cAMP metabolic process; IDA:UniProtKB
O14625	CXCL11	C-X-C motif chemokine 11	GO:0043950; P:positive regulation of cAMP-mediated signaling; IDA:UniProtKB
O14625	CXCL11	C-X-C motif chemokine 11	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IDA:UniProtKB
O14625	CXCL11	C-X-C motif chemokine 11	GO:0042127; P:regulation of cell proliferation; IMP:UniProtKB
O14625	CXCL11	C-X-C motif chemokine 11	GO:0007165; P:signal transduction; TAS:ProtInc
O14625	CXCL11	C-X-C motif chemokine 11	GO:0010818; P:T cell chemotaxis; IMP:UniProt
O43927	CXCL13	C-X-C motif chemokine 13	GO:0031735; F:CCR10 chemokine receptor binding; IDA:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0008009; F:chemokine activity; IDA:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0048248; F:CXCR3 chemokine receptor binding; IPI:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0031724; F:CXCR5 chemokine receptor binding; IDA:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0017134; F:fibroblast growth factor binding; IDA:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0008201; F:heparin binding; IDA:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0046982; F:protein heterodimerization activity; IDA:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0048018; F:receptor agonist activity; IDA:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0032861; P:activation of Rap GTPase activity; ISS:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0035754; P:B cell chemotaxis; IDA:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0035769; P:B cell chemotaxis across high endothelial venule; IEA:Ensembl
O43927	CXCL13	C-X-C motif chemokine 13	GO:0007166; P:cell surface receptor signaling pathway; IDA:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0007267; P:cell-cell signaling; IDA:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0002544; P:chronic inflammatory response; NAS:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0042742; P:defense response to bacterium; IDA:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0035768; P:endothelial cell chemotaxis to fibroblast growth factor; IDA:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0002467; P:germinal center formation; NAS:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0006955; P:immune response; IC:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0048535; P:lymph node development; IEA:Ensembl
O43927	CXCL13	C-X-C motif chemokine 13	GO:0002518; P:lymphocyte chemotaxis across high endothelial venule; ISS:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:2000545; P:negative regulation of endothelial cell chemotaxis to fibroblast growth factor; IDA:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0033634; P:positive regulation of cell-cell adhesion mediated by integrin; ISS:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0033625; P:positive regulation of integrin activation; ISS:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0010820; P:positive regulation of T cell chemotaxis; IDA:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0045765; P:regulation of angiogenesis; NAS:BHF-UCL
O43927	CXCL13	C-X-C motif chemokine 13	GO:0002920; P:regulation of humoral immune response; NAS:BHF-UCL
O95715	CXCL14	C-X-C motif chemokine 14	GO:0008009; F:chemokine activity; TAS:ProtInc
O95715	CXCL14	C-X-C motif chemokine 14	GO:0060326; P:cell chemotaxis; TAS:GOC
O95715	CXCL14	C-X-C motif chemokine 14	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O95715	CXCL14	C-X-C motif chemokine 14	GO:0006935; P:chemotaxis; TAS:ProtInc
O95715	CXCL14	C-X-C motif chemokine 14	GO:0006955; P:immune response; IEA:InterPro
O95715	CXCL14	C-X-C motif chemokine 14	GO:0048839; P:inner ear development; IEA:Ensembl
O95715	CXCL14	C-X-C motif chemokine 14	GO:0007165; P:signal transduction; TAS:ProtInc
Q9H2A7	CXCL16	C-X-C motif chemokine 16	GO:0008009; F:chemokine activity; ISS:UniProtKB
Q9H2A7	CXCL16	C-X-C motif chemokine 16	GO:0005041; F:low-density lipoprotein receptor activity; ISS:UniProtKB
Q9H2A7	CXCL16	C-X-C motif chemokine 16	GO:0005102; F:receptor binding; NAS:UniProtKB
Q9H2A7	CXCL16	C-X-C motif chemokine 16	GO:0005044; F:scavenger receptor activity; TAS:UniProtKB
Q9H2A7	CXCL16	C-X-C motif chemokine 16	GO:0006935; P:chemotaxis; NAS:UniProtKB
Q9H2A7	CXCL16	C-X-C motif chemokine 16	GO:0048247; P:lymphocyte chemotaxis; NAS:UniProtKB
Q9H2A7	CXCL16	C-X-C motif chemokine 16	GO:0030307; P:positive regulation of cell growth; IMP:BHF-UCL
Q9H2A7	CXCL16	C-X-C motif chemokine 16	GO:0030335; P:positive regulation of cell migration; IMP:BHF-UCL
Q9H2A7	CXCL16	C-X-C motif chemokine 16	GO:0006898; P:receptor-mediated endocytosis; NAS:UniProtKB
Q9H2A7	CXCL16	C-X-C motif chemokine 16	GO:0034097; P:response to cytokine; IDA:BHF-UCL
Q9H2A7	CXCL16	C-X-C motif chemokine 16	GO:0034341; P:response to interferon-gamma; IDA:BHF-UCL
Q9H2A7	CXCL16	C-X-C motif chemokine 16	GO:0034612; P:response to tumor necrosis factor; IDA:BHF-UCL
Q9P0U4	CXXC1	CXXC-type zinc finger protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P0U4	CXXC1	CXXC-type zinc finger protein 1	GO:0045322; F:unmethylated CpG binding; IDA:UniProtKB
Q9P0U4	CXXC1	CXXC-type zinc finger protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9P0U4	CXXC1	CXXC-type zinc finger protein 1	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q9P0U4	CXXC1	CXXC-type zinc finger protein 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9P0U4	CXXC1	CXXC-type zinc finger protein 1	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q9P0U4	CXXC1	CXXC-type zinc finger protein 1	GO:0051568; P:histone H3-K4 methylation; IDA:UniProtKB
Q9P0U4	CXXC1	CXXC-type zinc finger protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9P0U4	CXXC1	CXXC-type zinc finger protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q9P0U4	CXXC1	CXXC-type zinc finger protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H2H0	CXXC4	CXXC-type zinc finger protein 4	GO:0003677; F:DNA binding; IEA:InterPro
Q9H2H0	CXXC4	CXXC-type zinc finger protein 4	GO:0030165; F:PDZ domain binding; IPI:BHF-UCL
Q9H2H0	CXXC4	CXXC-type zinc finger protein 4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H2H0	CXXC4	CXXC-type zinc finger protein 4	GO:0030178; P:negative regulation of Wnt signaling pathway; IDA:BHF-UCL
Q9H2H0	CXXC4	CXXC-type zinc finger protein 4	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9H2H0	CXXC4	CXXC-type zinc finger protein 4	GO:0007352; P:zygotic specification of dorsal/ventral axis; ISS:BHF-UCL
Q7LFL8	CXXC5	CXXC-type zinc finger protein 5	GO:0003677; F:DNA binding; IEA:InterPro
Q7LFL8	CXXC5	CXXC-type zinc finger protein 5	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q7LFL8	CXXC5	CXXC-type zinc finger protein 5	GO:0008270; F:zinc ion binding; IEA:InterPro
Q7LFL8	CXXC5	CXXC-type zinc finger protein 5	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q7LFL8	CXXC5	CXXC-type zinc finger protein 5	GO:0007165; P:signal transduction; IMP:GOC
P08574	CYC1	Cytochrome c1, heme protein, mitochondrial	GO:0045155; F:electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity; TAS:ProtInc
P08574	CYC1	Cytochrome c1, heme protein, mitochondrial	GO:0020037; F:heme binding; IEA:InterPro
P08574	CYC1	Cytochrome c1, heme protein, mitochondrial	GO:0005506; F:iron ion binding; IEA:InterPro
P08574	CYC1	Cytochrome c1, heme protein, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P08574	CYC1	Cytochrome c1, heme protein, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P08574	CYC1	Cytochrome c1, heme protein, mitochondrial	GO:0033762; P:response to glucagon; IEA:Ensembl
P08574	CYC1	Cytochrome c1, heme protein, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P13498	CYBA	Cytochrome b-245 light chain	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P13498	CYBA	Cytochrome b-245 light chain	GO:0020037; F:heme binding; IEA:InterPro
P13498	CYBA	Cytochrome b-245 light chain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P13498	CYBA	Cytochrome b-245 light chain	GO:0005515; F:protein binding; IPI:IntAct
P13498	CYBA	Cytochrome b-245 light chain	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P13498	CYBA	Cytochrome b-245 light chain	GO:0017124; F:SH3 domain binding; IPI:BHF-UCL
P13498	CYBA	Cytochrome b-245 light chain	GO:0016175; F:superoxide-generating NADPH oxidase activity; IEA:Ensembl
P13498	CYBA	Cytochrome b-245 light chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P13498	CYBA	Cytochrome b-245 light chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P13498	CYBA	Cytochrome b-245 light chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P13498	CYBA	Cytochrome b-245 light chain	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
P13498	CYBA	Cytochrome b-245 light chain	GO:0071480; P:cellular response to gamma radiation; IEA:Ensembl
P13498	CYBA	Cytochrome b-245 light chain	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
P13498	CYBA	Cytochrome b-245 light chain	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P13498	CYBA	Cytochrome b-245 light chain	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
P13498	CYBA	Cytochrome b-245 light chain	GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl
P13498	CYBA	Cytochrome b-245 light chain	GO:0017004; P:cytochrome complex assembly; IDA:BHF-UCL
P13498	CYBA	Cytochrome b-245 light chain	GO:0050665; P:hydrogen peroxide biosynthetic process; ISS:BHF-UCL
P13498	CYBA	Cytochrome b-245 light chain	GO:0006954; P:inflammatory response; IMP:BHF-UCL
P13498	CYBA	Cytochrome b-245 light chain	GO:0045087; P:innate immune response; IMP:BHF-UCL
P13498	CYBA	Cytochrome b-245 light chain	GO:0051701; P:interaction with host; TAS:Reactome
P13498	CYBA	Cytochrome b-245 light chain	GO:0003106; P:negative regulation of glomerular filtration by angiotensin; IEA:Ensembl
P13498	CYBA	Cytochrome b-245 light chain	GO:0055114; P:oxidation-reduction process; IMP:BHF-UCL
P13498	CYBA	Cytochrome b-245 light chain	GO:0090382; P:phagosome maturation; TAS:Reactome
P13498	CYBA	Cytochrome b-245 light chain	GO:0030307; P:positive regulation of cell growth; IEA:Ensembl
P13498	CYBA	Cytochrome b-245 light chain	GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl
P13498	CYBA	Cytochrome b-245 light chain	GO:0045730; P:respiratory burst; IMP:BHF-UCL
P13498	CYBA	Cytochrome b-245 light chain	GO:0042493; P:response to drug; IEA:Ensembl
P13498	CYBA	Cytochrome b-245 light chain	GO:0070555; P:response to interleukin-1; IEA:Ensembl
P13498	CYBA	Cytochrome b-245 light chain	GO:0031667; P:response to nutrient levels; IEA:Ensembl
P13498	CYBA	Cytochrome b-245 light chain	GO:0014895; P:smooth muscle hypertrophy; ISS:BHF-UCL
P13498	CYBA	Cytochrome b-245 light chain	GO:0042554; P:superoxide anion generation; IMP:BHF-UCL
P13498	CYBA	Cytochrome b-245 light chain	GO:0006801; P:superoxide metabolic process; IMP:BHF-UCL
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0050660; F:flavin adenine dinucleotide binding; IMP:BHF-UCL
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0020037; F:heme binding; IMP:BHF-UCL
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0005515; F:protein binding; IPI:BHF-UCL
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0016175; F:superoxide-generating NADPH oxidase activity; TAS:BHF-UCL
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0050665; P:hydrogen peroxide biosynthetic process; IEA:Ensembl
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0006954; P:inflammatory response; TAS:ProtInc
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0045087; P:innate immune response; IMP:BHF-UCL
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0051701; P:interaction with host; TAS:Reactome
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0090382; P:phagosome maturation; TAS:Reactome
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0045730; P:respiratory burst; IMP:BHF-UCL
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0042493; P:response to drug; IEA:Ensembl
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0007584; P:response to nutrient; IEA:Ensembl
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0042554; P:superoxide anion generation; IDA:BHF-UCL
P04839	CYBB	Cytochrome b-245 heavy chain	GO:0006801; P:superoxide metabolic process; IDA:BHF-UCL
P49447	CYB561	Cytochrome b561	GO:0000293; F:ferric-chelate reductase activity; ISS:HGNC
P49447	CYB561	Cytochrome b561	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P49447	CYB561	Cytochrome b561	GO:0022865; F:transmembrane electron transfer carrier; NAS:UniProtKB
P49447	CYB561	Cytochrome b561	GO:0022900; P:electron transport chain; NAS:UniProtKB
P49447	CYB561	Cytochrome b561	GO:0055085; P:transmembrane transport; NAS:GOC
Q8NBI2	CYB561A3	Cytochrome b ascorbate-dependent protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NBI2	CYB561A3	Cytochrome b ascorbate-dependent protein 3	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
O43169	CYB5B	Cytochrome b5 type B	GO:0020037; F:heme binding; IDA:UniProtKB
O43169	CYB5B	Cytochrome b5 type B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43169	CYB5B	Cytochrome b5 type B	GO:0055114; P:oxidation-reduction process; IEA:UniProtKB-KW
P00167	CYB5A	Cytochrome b5	GO:0004033; F:aldo-keto reductase (NADP) activity; TAS:Reactome
P00167	CYB5A	Cytochrome b5	GO:0004129; F:cytochrome-c oxidase activity; TAS:ProtInc
P00167	CYB5A	Cytochrome b5	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P00167	CYB5A	Cytochrome b5	GO:0020037; F:heme binding; IEA:InterPro
P00167	CYB5A	Cytochrome b5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P00167	CYB5A	Cytochrome b5	GO:1902600; P:hydrogen ion transmembrane transport; TAS:GOC
P00167	CYB5A	Cytochrome b5	GO:0019852; P:L-ascorbic acid metabolic process; TAS:Reactome
P00167	CYB5A	Cytochrome b5	GO:0046686; P:response to cadmium ion; IEA:Ensembl
P00167	CYB5A	Cytochrome b5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P00167	CYB5A	Cytochrome b5	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P00167	CYB5A	Cytochrome b5	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9HB71	CACYBP	Calcyclin-binding protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HB71	CACYBP	Calcyclin-binding protein	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q9HB71	CACYBP	Calcyclin-binding protein	GO:0007568; P:aging; IEA:Ensembl
Q9HB71	CACYBP	Calcyclin-binding protein	GO:0055007; P:cardiac muscle cell differentiation; IEA:Ensembl
Q9HB71	CACYBP	Calcyclin-binding protein	GO:0071277; P:cellular response to calcium ion; IEA:Ensembl
Q9HB71	CACYBP	Calcyclin-binding protein	GO:0060548; P:negative regulation of cell death; IEA:Ensembl
Q9HB71	CACYBP	Calcyclin-binding protein	GO:0045740; P:positive regulation of DNA replication; IEA:Ensembl
Q9HB71	CACYBP	Calcyclin-binding protein	GO:0060416; P:response to growth hormone; IEA:Ensembl
Q53TN4	CYBRD1	Cytochrome b reductase 1	GO:0000293; F:ferric-chelate reductase activity; IDA:HGNC
Q53TN4	CYBRD1	Cytochrome b reductase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q53TN4	CYBRD1	Cytochrome b reductase 1	GO:0016722; F:oxidoreductase activity, oxidizing metal ions; TAS:Reactome
Q53TN4	CYBRD1	Cytochrome b reductase 1	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
Q53TN4	CYBRD1	Cytochrome b reductase 1	GO:0010039; P:response to iron ion; IEA:Ensembl
Q53TN4	CYBRD1	Cytochrome b reductase 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P00156	MT-CYB	Cytochrome b	GO:0009055; F:electron carrier activity; IEA:InterPro
P00156	MT-CYB	Cytochrome b	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P00156	MT-CYB	Cytochrome b	GO:0008121; F:ubiquinol-cytochrome-c reductase activity; NAS:UniProtKB
P00156	MT-CYB	Cytochrome b	GO:0044237; P:cellular metabolic process; TAS:Reactome
P00156	MT-CYB	Cytochrome b	GO:1902600; P:hydrogen ion transmembrane transport; NAS:GOC
P00156	MT-CYB	Cytochrome b	GO:0006122; P:mitochondrial electron transport, ubiquinol to cytochrome c; NAS:UniProtKB
P00156	MT-CYB	Cytochrome b	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P00156	MT-CYB	Cytochrome b	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P99999	CYCS	Cytochrome c	GO:0045155; F:electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity; IDA:UniProtKB
P99999	CYCS	Cytochrome c	GO:0020037; F:heme binding; TAS:UniProtKB
P99999	CYCS	Cytochrome c	GO:0005506; F:iron ion binding; IEA:InterPro
P99999	CYCS	Cytochrome c	GO:0005515; F:protein binding; IPI:UniProtKB
P99999	CYCS	Cytochrome c	GO:0008635; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; TAS:UniProtKB
P99999	CYCS	Cytochrome c	GO:0006309; P:apoptotic DNA fragmentation; IMP:UniProtKB
P99999	CYCS	Cytochrome c	GO:0006915; P:apoptotic process; TAS:Reactome
P99999	CYCS	Cytochrome c	GO:0044237; P:cellular metabolic process; TAS:Reactome
P99999	CYCS	Cytochrome c	GO:0045333; P:cellular respiration; TAS:UniProtKB
P99999	CYCS	Cytochrome c	GO:0016311; P:dephosphorylation; TAS:GOC
P99999	CYCS	Cytochrome c	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
P99999	CYCS	Cytochrome c	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P99999	CYCS	Cytochrome c	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q7L576	CYFIP1	Cytoplasmic FMR1-interacting protein 1	GO:0051015; F:actin filament binding; ISS:UniProtKB
Q7L576	CYFIP1	Cytoplasmic FMR1-interacting protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q7L576	CYFIP1	Cytoplasmic FMR1-interacting protein 1	GO:0032403; F:protein complex binding; IDA:UniProt
Q7L576	CYFIP1	Cytoplasmic FMR1-interacting protein 1	GO:0048365; F:Rac GTPase binding; ISS:UniProtKB
Q7L576	CYFIP1	Cytoplasmic FMR1-interacting protein 1	GO:0048675; P:axon extension; IMP:UniProtKB
Q7L576	CYFIP1	Cytoplasmic FMR1-interacting protein 1	GO:0050890; P:cognition; IMP:UniProt
Q7L576	CYFIP1	Cytoplasmic FMR1-interacting protein 1	GO:0030032; P:lamellipodium assembly; ISS:UniProtKB
Q7L576	CYFIP1	Cytoplasmic FMR1-interacting protein 1	GO:2000601; P:positive regulation of Arp2/3 complex-mediated actin nucleation; IMP:UniProt
Q7L576	CYFIP1	Cytoplasmic FMR1-interacting protein 1	GO:0016601; P:Rac protein signal transduction; IMP:UniProt
Q7L576	CYFIP1	Cytoplasmic FMR1-interacting protein 1	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
Q7L576	CYFIP1	Cytoplasmic FMR1-interacting protein 1	GO:0031529; P:ruffle organization; ISS:UniProtKB
Q96F07	CYFIP2	Cytoplasmic FMR1-interacting protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q96F07	CYFIP2	Cytoplasmic FMR1-interacting protein 2	GO:0097202; P:activation of cysteine-type endopeptidase activity; IDA:BHF-UCL
Q96F07	CYFIP2	Cytoplasmic FMR1-interacting protein 2	GO:0006915; P:apoptotic process; IDA:UniProtKB
Q96F07	CYFIP2	Cytoplasmic FMR1-interacting protein 2	GO:0016337; P:single organismal cell-cell adhesion; IDA:UniProtKB
Q96F07	CYFIP2	Cytoplasmic FMR1-interacting protein 2	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q96F07	CYFIP2	Cytoplasmic FMR1-interacting protein 2	GO:0045087; P:innate immune response; TAS:Reactome
Q96F07	CYFIP2	Cytoplasmic FMR1-interacting protein 2	GO:0045862; P:positive regulation of proteolysis; IDA:BHF-UCL
Q8WWM9	CYGB	Cytoglobin	GO:0020037; F:heme binding; IEA:InterPro
Q8WWM9	CYGB	Cytoglobin	GO:0005506; F:iron ion binding; IEA:InterPro
Q8WWM9	CYGB	Cytoglobin	GO:0019825; F:oxygen binding; IEA:InterPro
Q8WWM9	CYGB	Cytoglobin	GO:0005344; F:oxygen transporter activity; NAS:UniProtKB
Q8WWM9	CYGB	Cytoglobin	GO:0004601; F:peroxidase activity; ISS:UniProtKB
Q8WWM9	CYGB	Cytoglobin	GO:0055114; P:oxidation-reduction process; ISS:GOC
Q8WWM9	CYGB	Cytoglobin	GO:0015671; P:oxygen transport; NAS:UniProtKB
Q8WWM9	CYGB	Cytoglobin	GO:0006979; P:response to oxidative stress; ISS:UniProtKB
Q15438	CYTH1	Cytohesin-1	GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q15438	CYTH1	Cytohesin-1	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q15438	CYTH1	Cytohesin-1	GO:0005515; F:protein binding; IPI:IntAct
Q15438	CYTH1	Cytohesin-1	GO:0090162; P:establishment of epithelial cell polarity; IEA:Ensembl
Q15438	CYTH1	Cytohesin-1	GO:0032012; P:regulation of ARF protein signal transduction; IEA:InterPro
Q15438	CYTH1	Cytohesin-1	GO:0030155; P:regulation of cell adhesion; IDA:MGI
Q15438	CYTH1	Cytohesin-1	GO:0043087; P:regulation of GTPase activity; IDA:GOC
Q15438	CYTH1	Cytohesin-1	GO:0016192; P:vesicle-mediated transport; TAS:ProtInc
Q99418	CYTH2	Cytohesin-2	GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; ISS:UniProtKB
Q99418	CYTH2	Cytohesin-2	GO:0070679; F:inositol 1,4,5 trisphosphate binding; ISS:UniProtKB
Q99418	CYTH2	Cytohesin-2	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q99418	CYTH2	Cytohesin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q99418	CYTH2	Cytohesin-2	GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc
Q99418	CYTH2	Cytohesin-2	GO:0006897; P:endocytosis; TAS:ProtInc
Q99418	CYTH2	Cytohesin-2	GO:0032012; P:regulation of ARF protein signal transduction; IEA:InterPro
Q99418	CYTH2	Cytohesin-2	GO:0030155; P:regulation of cell adhesion; IBA:RefGenome
Q99418	CYTH2	Cytohesin-2	GO:0043087; P:regulation of GTPase activity; IBA:GOC
O43739	CYTH3	Cytohesin-3	GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; IDA:UniProtKB
O43739	CYTH3	Cytohesin-3	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB
O43739	CYTH3	Cytohesin-3	GO:0090162; P:establishment of epithelial cell polarity; IEA:Ensembl
O43739	CYTH3	Cytohesin-3	GO:0048193; P:Golgi vesicle transport; IMP:UniProtKB
O43739	CYTH3	Cytohesin-3	GO:0045785; P:positive regulation of cell adhesion; IEA:Ensembl
O43739	CYTH3	Cytohesin-3	GO:0032012; P:regulation of ARF protein signal transduction; IEA:InterPro
O43739	CYTH3	Cytohesin-3	GO:0030155; P:regulation of cell adhesion; IBA:RefGenome
O43739	CYTH3	Cytohesin-3	GO:0043087; P:regulation of GTPase activity; IDA:GOC
Q9UIA0	CYTH4	Cytohesin-4	GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q9UIA0	CYTH4	Cytohesin-4	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q9UIA0	CYTH4	Cytohesin-4	GO:0032012; P:regulation of ARF protein signal transduction; IEA:InterPro
Q9UIA0	CYTH4	Cytohesin-4	GO:0030155; P:regulation of cell adhesion; IBA:RefGenome
Q9UIA0	CYTH4	Cytohesin-4	GO:0043087; P:regulation of GTPase activity; IDA:GOC
Q6ZMK1	CYHR1	Cysteine and histidine-rich protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
P35663	CYLC1	Cylicin-1	GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro
P35663	CYLC1	Cylicin-1	GO:0005198; F:structural molecule activity; NAS:UniProtKB
P35663	CYLC1	Cylicin-1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P35663	CYLC1	Cylicin-1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P35663	CYLC1	Cylicin-1	GO:0007283; P:spermatogenesis; NAS:UniProtKB
Q14093	CYLC2	Cylicin-2	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
Q14093	CYLC2	Cylicin-2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q14093	CYLC2	Cylicin-2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q14093	CYLC2	Cylicin-2	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:0061578; F:Lys63-specific deubiquitinase activity; IDA:UniProtKB
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:0070064; F:proline-rich region binding; IPI:UniProtKB
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:0045087; P:innate immune response; TAS:Reactome
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:0070266; P:necroptotic process; IBA:RefGenome
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:UniProtKB
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:0042347; P:negative regulation of NF-kappaB import into nucleus; IDA:UniProtKB
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:0070536; P:protein K63-linked deubiquitination; IDA:UniProtKB
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:2001242; P:regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:0070507; P:regulation of microtubule cytoskeleton organization; IMP:UniProtKB
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:0007346; P:regulation of mitotic cell cycle; IMP:UniProtKB
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q9NQC7	CYLD	Ubiquitin carboxyl-terminal hydrolase CYLD	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
O00622	CYR61	Protein CYR61	GO:0050840; F:extracellular matrix binding; IEA:Ensembl
O00622	CYR61	Protein CYR61	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
O00622	CYR61	Protein CYR61	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
O00622	CYR61	Protein CYR61	GO:0003278; P:apoptotic process involved in heart morphogenesis; IEA:Ensembl
O00622	CYR61	Protein CYR61	GO:0060413; P:atrial septum morphogenesis; IEA:Ensembl
O00622	CYR61	Protein CYR61	GO:0003181; P:atrioventricular valve morphogenesis; IEA:Ensembl
O00622	CYR61	Protein CYR61	GO:0008283; P:cell proliferation; TAS:ProtInc
O00622	CYR61	Protein CYR61	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
O00622	CYR61	Protein CYR61	GO:0060591; P:chondroblast differentiation; IEA:Ensembl
O00622	CYR61	Protein CYR61	GO:0060710; P:chorio-allantoic fusion; IEA:Ensembl
O00622	CYR61	Protein CYR61	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
O00622	CYR61	Protein CYR61	GO:0002041; P:intussusceptive angiogenesis; IEA:Ensembl
O00622	CYR61	Protein CYR61	GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl
O00622	CYR61	Protein CYR61	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
O00622	CYR61	Protein CYR61	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
O00622	CYR61	Protein CYR61	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
O00622	CYR61	Protein CYR61	GO:0030513; P:positive regulation of BMP signaling pathway; IGI:BHF-UCL
O00622	CYR61	Protein CYR61	GO:0061036; P:positive regulation of cartilage development; IEA:Ensembl
O00622	CYR61	Protein CYR61	GO:0030335; P:positive regulation of cell migration; IDA:BHF-UCL
O00622	CYR61	Protein CYR61	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
O00622	CYR61	Protein CYR61	GO:2000304; P:positive regulation of ceramide biosynthetic process; IEA:Ensembl
O00622	CYR61	Protein CYR61	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
O00622	CYR61	Protein CYR61	GO:0045669; P:positive regulation of osteoblast differentiation; IDA:BHF-UCL
O00622	CYR61	Protein CYR61	GO:0033690; P:positive regulation of osteoblast proliferation; IDA:BHF-UCL
O00622	CYR61	Protein CYR61	GO:0010518; P:positive regulation of phospholipase activity; IEA:Ensembl
O00622	CYR61	Protein CYR61	GO:0045860; P:positive regulation of protein kinase activity; IDA:BHF-UCL
O00622	CYR61	Protein CYR61	GO:0001934; P:positive regulation of protein phosphorylation; IDA:BHF-UCL
O00622	CYR61	Protein CYR61	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
O00622	CYR61	Protein CYR61	GO:0072593; P:reactive oxygen species metabolic process; IEA:Ensembl
O00622	CYR61	Protein CYR61	GO:0001558; P:regulation of cell growth; IEA:InterPro
O00622	CYR61	Protein CYR61	GO:0070372; P:regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL
O00622	CYR61	Protein CYR61	GO:0003281; P:ventricular septum development; IEA:Ensembl
O00622	CYR61	Protein CYR61	GO:0044319; P:wound healing, spreading of cells; IDA:BHF-UCL
Q717R9	CYS1	Cystin-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q717R9	CYS1	Cystin-1	GO:0048839; P:inner ear development; IEA:Ensembl
Q717R9	CYS1	Cystin-1	GO:0001822; P:kidney development; IEA:Ensembl
P01040	CSTA	Cystatin-A	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IDA:BHF-UCL
P01040	CSTA	Cystatin-A	GO:0002020; F:protease binding; IPI:BHF-UCL
P01040	CSTA	Cystatin-A	GO:0030674; F:protein binding, bridging; IDA:UniProtKB
P01040	CSTA	Cystatin-A	GO:0005198; F:structural molecule activity; IDA:UniProtKB
P01040	CSTA	Cystatin-A	GO:0016337; P:single organismal cell-cell adhesion; IMP:UniProtKB
P01040	CSTA	Cystatin-A	GO:0030216; P:keratinocyte differentiation; IDA:UniProtKB
P01040	CSTA	Cystatin-A	GO:0010951; P:negative regulation of endopeptidase activity; IDA:GOC
P01040	CSTA	Cystatin-A	GO:0010466; P:negative regulation of peptidase activity; IDA:BHF-UCL
P01040	CSTA	Cystatin-A	GO:0045861; P:negative regulation of proteolysis; IDA:UniProt
P01040	CSTA	Cystatin-A	GO:0018149; P:peptide cross-linking; IDA:UniProtKB
P04080	CSTB	Cystatin-B	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IDA:BHF-UCL
P04080	CSTB	Cystatin-B	GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc
P04080	CSTB	Cystatin-B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P04080	CSTB	Cystatin-B	GO:0002020; F:protease binding; IPI:BHF-UCL
P04080	CSTB	Cystatin-B	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P04080	CSTB	Cystatin-B	GO:0010951; P:negative regulation of endopeptidase activity; IDA:GOC
P04080	CSTB	Cystatin-B	GO:0010466; P:negative regulation of peptidase activity; IDA:BHF-UCL
P04080	CSTB	Cystatin-B	GO:0045861; P:negative regulation of proteolysis; IDA:UniProt
P04080	CSTB	Cystatin-B	GO:0042981; P:regulation of apoptotic process; IEA:Ensembl
P01034	CST3	Cystatin-C	GO:0001540; F:beta-amyloid binding; IPI:BHF-UCL
P01034	CST3	Cystatin-C	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IDA:BHF-UCL
P01034	CST3	Cystatin-C	GO:0004866; F:endopeptidase inhibitor activity; IDA:UniProtKB
P01034	CST3	Cystatin-C	GO:0002020; F:protease binding; IPI:BHF-UCL
P01034	CST3	Cystatin-C	GO:0005515; F:protein binding; IPI:UniProtKB
P01034	CST3	Cystatin-C	GO:0006952; P:defense response; IDA:BHF-UCL
P01034	CST3	Cystatin-C	GO:0043206; P:extracellular fibril organization; IGI:BHF-UCL
P01034	CST3	Cystatin-C	GO:0060313; P:negative regulation of blood vessel remodeling; IEP:BHF-UCL
P01034	CST3	Cystatin-C	GO:0010711; P:negative regulation of collagen catabolic process; IEP:BHF-UCL
P01034	CST3	Cystatin-C	GO:0060311; P:negative regulation of elastin catabolic process; IMP:BHF-UCL
P01034	CST3	Cystatin-C	GO:0010951; P:negative regulation of endopeptidase activity; IDA:GOC
P01034	CST3	Cystatin-C	GO:0010716; P:negative regulation of extracellular matrix disassembly; IEP:BHF-UCL
P01034	CST3	Cystatin-C	GO:0010703; P:negative regulation of histolysis; IC:BHF-UCL
P01034	CST3	Cystatin-C	GO:0010466; P:negative regulation of peptidase activity; IDA:BHF-UCL
P01034	CST3	Cystatin-C	GO:0045861; P:negative regulation of proteolysis; IDA:UniProt
P01034	CST3	Cystatin-C	GO:0034103; P:regulation of tissue remodeling; IEP:BHF-UCL
P28325	CST5	Cystatin-D	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IDA:UniProtKB
P28325	CST5	Cystatin-D	GO:0005515; F:protein binding; IPI:UniProtKB
P28325	CST5	Cystatin-D	GO:0010951; P:negative regulation of endopeptidase activity; IDA:GOC
O76096	CST7	Cystatin-F	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; TAS:ProtInc
O76096	CST7	Cystatin-F	GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc
O76096	CST7	Cystatin-F	GO:0005515; F:protein binding; IPI:IntAct
O76096	CST7	Cystatin-F	GO:0006955; P:immune response; TAS:ProtInc
O76096	CST7	Cystatin-F	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
O60759	CYTIP	Cytohesin-interacting protein	GO:0005515; F:protein binding; IPI:IntAct
O60759	CYTIP	Cytohesin-interacting protein	GO:0030155; P:regulation of cell adhesion; IDA:MGI
Q9NRR1	CYTL1	Cytokine-like protein 1	GO:0005102; F:receptor binding; TAS:ProtInc
Q9NRR1	CYTL1	Cytokine-like protein 1	GO:1990079; P:cartilage homeostasis; IEA:Ensembl
Q9NRR1	CYTL1	Cytokine-like protein 1	GO:0002062; P:chondrocyte differentiation; IEA:Ensembl
Q9NRR1	CYTL1	Cytokine-like protein 1	GO:0050650; P:chondroitin sulfate proteoglycan biosynthetic process; IEA:Ensembl
Q9NRR1	CYTL1	Cytokine-like protein 1	GO:0048839; P:inner ear development; IEA:Ensembl
Q9NRR1	CYTL1	Cytokine-like protein 1	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q9NRR1	CYTL1	Cytokine-like protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9NRR1	CYTL1	Cytokine-like protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q15828	CST6	Cystatin-M	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; TAS:ProtInc
Q15828	CST6	Cystatin-M	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q15828	CST6	Cystatin-M	GO:0008544; P:epidermis development; IEA:Ensembl
Q15828	CST6	Cystatin-M	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
P01037	CST1	Cystatin-SN	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; TAS:ProtInc
P01037	CST1	Cystatin-SN	GO:0001580; P:detection of chemical stimulus involved in sensory perception of bitter taste; IDA:UniProt
P01037	CST1	Cystatin-SN	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
Q69YQ0	SPECC1L	Cytospin-A	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q69YQ0	SPECC1L	Cytospin-A	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q5M775	SPECC1	Cytospin-B	GO:0007155; P:cell adhesion; IDA:MGI
P01036	CST4	Cystatin-S	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IDA:UniProt
P01036	CST4	Cystatin-S	GO:0001580; P:detection of chemical stimulus involved in sensory perception of bitter taste; IDA:UniProt
P01036	CST4	Cystatin-S	GO:0010951; P:negative regulation of endopeptidase activity; IDA:GOC
P01036	CST4	Cystatin-S	GO:0045861; P:negative regulation of proteolysis; IDA:UniProt
P01036	CST4	Cystatin-S	GO:0001895; P:retina homeostasis; IEP:UniProt
P09228	CST2	Cystatin-SA	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; TAS:ProtInc
P09228	CST2	Cystatin-SA	GO:0001580; P:detection of chemical stimulus involved in sensory perception of bitter taste; IDA:UniProt
P09228	CST2	Cystatin-SA	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
Q8WTQ1	DEFB104A	Beta-defensin 104	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
P81534	DEFB103A	Beta-defensin 103	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
P81534	DEFB103A	Beta-defensin 103	GO:0045087; P:innate immune response; TAS:Reactome
P81534	DEFB103A	Beta-defensin 103	GO:0006965; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; TAS:UniProtKB
Q8NG35	DEFB105A	Beta-defensin 105	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q8N104	DEFB106A	Beta-defensin 106	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q8IZN7	DEFB107A	Beta-defensin 107	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q8NET1	DEFB108B	Beta-defensin 108B	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
A8MXU0	DEFB108P1	Putative beta-defensin 108A	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
DR   GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
A8MPP1	DDX11L8	Putative ATP-dependent RNA helicase DDX11-like protein 8	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
A8MPP1	DDX11L8	Putative ATP-dependent RNA helicase DDX11-like protein 8	GO:0004003; F:ATP-dependent DNA helicase activity; IEA:InterPro
A8MPP1	DDX11L8	Putative ATP-dependent RNA helicase DDX11-like protein 8	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A8MPP1	DDX11L8	Putative ATP-dependent RNA helicase DDX11-like protein 8	GO:0005515; F:protein binding; IPI:IntAct
A8MPP1	DDX11L8	Putative ATP-dependent RNA helicase DDX11-like protein 8	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q2PZI1	DPY19L1	Probable C-mannosyltransferase DPY19L1	GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW
Q6ZPD9	DPY19L3	Probable C-mannosyltransferase DPY19L3	GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW
Q6NUT2	DPY19L2	Probable C-mannosyltransferase DPY19L2	GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW
Q6NUT2	DPY19L2	Probable C-mannosyltransferase DPY19L2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q6NUT2	DPY19L2	Probable C-mannosyltransferase DPY19L2	GO:0007286; P:spermatid development; IMP:UniProtKB
Q7Z388	DPY19L4	Probable C-mannosyltransferase DPY19L4	GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW
Q6NXN4	DPY19L2P1	Putative C-mannosyltransferase DPY19L2P1	GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW
Q6ZN68	DPY19L2P2	Putative C-mannosyltransferase DPY19L2P2	GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW
Q8N465	D2HGDH	D-2-hydroxyglutarate dehydrogenase, mitochondrial	GO:0051990; F:(R)-2-hydroxyglutarate dehydrogenase activity; ISS:HGNC
Q8N465	D2HGDH	D-2-hydroxyglutarate dehydrogenase, mitochondrial	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q8N465	D2HGDH	D-2-hydroxyglutarate dehydrogenase, mitochondrial	GO:0008762; F:UDP-N-acetylmuramate dehydrogenase activity; IEA:InterPro
Q8N465	D2HGDH	D-2-hydroxyglutarate dehydrogenase, mitochondrial	GO:0006103; P:2-oxoglutarate metabolic process; TAS:Reactome
Q8N465	D2HGDH	D-2-hydroxyglutarate dehydrogenase, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q8N465	D2HGDH	D-2-hydroxyglutarate dehydrogenase, mitochondrial	GO:0044267; P:cellular protein metabolic process; ISS:HGNC
Q8N465	D2HGDH	D-2-hydroxyglutarate dehydrogenase, mitochondrial	GO:0032025; P:response to cobalt ion; ISS:HGNC
Q8N465	D2HGDH	D-2-hydroxyglutarate dehydrogenase, mitochondrial	GO:0010042; P:response to manganese ion; ISS:HGNC
Q8N465	D2HGDH	D-2-hydroxyglutarate dehydrogenase, mitochondrial	GO:0010043; P:response to zinc ion; ISS:HGNC
Q8N465	D2HGDH	D-2-hydroxyglutarate dehydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NRG7	SDR39U1	Epimerase family protein SDR39U1	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q8WUS8	SDR42E1	Short-chain dehydrogenase/reductase family 42E member 1	GO:0003854; F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; IEA:InterPro
Q8WUS8	SDR42E1	Short-chain dehydrogenase/reductase family 42E member 1	GO:0006694; P:steroid biosynthetic process; IEA:InterPro
A6NKP2	SDR42E2	Putative short-chain dehydrogenase/reductase family 42E member 2	GO:0003854; F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; IEA:InterPro
A6NKP2	SDR42E2	Putative short-chain dehydrogenase/reductase family 42E member 2	GO:0006694; P:steroid biosynthetic process; IEA:InterPro
Q8NEP3	DNAAF1	Dynein assembly factor 1, axonemal	GO:0045502; F:dynein binding; IMP:UniProtKB
Q8NEP3	DNAAF1	Dynein assembly factor 1, axonemal	GO:0070286; P:axonemal dynein complex assembly; IMP:UniProtKB
Q8NEP3	DNAAF1	Dynein assembly factor 1, axonemal	GO:0060271; P:cilium morphogenesis; IMP:UniProtKB
Q8NEP3	DNAAF1	Dynein assembly factor 1, axonemal	GO:0003341; P:cilium movement; IMP:BHF-UCL
Q8NEP3	DNAAF1	Dynein assembly factor 1, axonemal	GO:0071907; P:determination of digestive tract left/right asymmetry; IMP:BHF-UCL
Q8NEP3	DNAAF1	Dynein assembly factor 1, axonemal	GO:0071910; P:determination of liver left/right asymmetry; IMP:BHF-UCL
Q8NEP3	DNAAF1	Dynein assembly factor 1, axonemal	GO:0035469; P:determination of pancreatic left/right asymmetry; IMP:BHF-UCL
Q8NEP3	DNAAF1	Dynein assembly factor 1, axonemal	GO:0060287; P:epithelial cilium movement involved in determination of left/right asymmetry; IC:BHF-UCL
Q8NEP3	DNAAF1	Dynein assembly factor 1, axonemal	GO:0001947; P:heart looping; IMP:BHF-UCL
Q8NEP3	DNAAF1	Dynein assembly factor 1, axonemal	GO:0036159; P:inner dynein arm assembly; IMP:BHF-UCL
Q8NEP3	DNAAF1	Dynein assembly factor 1, axonemal	GO:0060972; P:left/right pattern formation; IMP:BHF-UCL
Q8NEP3	DNAAF1	Dynein assembly factor 1, axonemal	GO:0030324; P:lung development; IMP:BHF-UCL
Q8NEP3	DNAAF1	Dynein assembly factor 1, axonemal	GO:0044458; P:motile cilium assembly; IMP:BHF-UCL
Q8NEP3	DNAAF1	Dynein assembly factor 1, axonemal	GO:0036158; P:outer dynein arm assembly; IMP:BHF-UCL
Q8NEP3	DNAAF1	Dynein assembly factor 1, axonemal	GO:0003356; P:regulation of cilium beat frequency; IMP:BHF-UCL
Q8N9W5	DNAAF3	Dynein assembly factor 3, axonemal	GO:0070286; P:axonemal dynein complex assembly; IMP:UniProtKB
Q8N9W5	DNAAF3	Dynein assembly factor 3, axonemal	GO:0044458; P:motile cilium assembly; IMP:UniProtKB
Q9Y4D1	DAAM1	Disheveled-associated activator of morphogenesis 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q9Y4D1	DAAM1	Disheveled-associated activator of morphogenesis 1	GO:0005515; F:protein binding; IPI:IntAct
Q9Y4D1	DAAM1	Disheveled-associated activator of morphogenesis 1	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
Q86T65	DAAM2	Disheveled-associated activator of morphogenesis 2	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
O75553	DAB1	Disabled homolog 1	GO:0007628; P:adult walking behavior; IEA:Ensembl
O75553	DAB1	Disabled homolog 1	GO:0021813; P:cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration; IEA:Ensembl
O75553	DAB1	Disabled homolog 1	GO:0021589; P:cerebellum structural organization; IEA:Ensembl
O75553	DAB1	Disabled homolog 1	GO:0016358; P:dendrite development; IEA:Ensembl
O75553	DAB1	Disabled homolog 1	GO:0051645; P:Golgi localization; IEA:Ensembl
O75553	DAB1	Disabled homolog 1	GO:0097477; P:lateral motor column neuron migration; IEA:Ensembl
O75553	DAB1	Disabled homolog 1	GO:0007494; P:midgut development; IEA:Ensembl
O75553	DAB1	Disabled homolog 1	GO:0048712; P:negative regulation of astrocyte differentiation; IEA:Ensembl
O75553	DAB1	Disabled homolog 1	GO:0050771; P:negative regulation of axonogenesis; IEA:Ensembl
O75553	DAB1	Disabled homolog 1	GO:0007162; P:negative regulation of cell adhesion; IEA:Ensembl
O75553	DAB1	Disabled homolog 1	GO:0046426; P:negative regulation of JAK-STAT cascade; IEA:Ensembl
O75553	DAB1	Disabled homolog 1	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
O75553	DAB1	Disabled homolog 1	GO:0045860; P:positive regulation of protein kinase activity; IEA:Ensembl
O75553	DAB1	Disabled homolog 1	GO:0021942; P:radial glia guided migration of Purkinje cell; IEA:Ensembl
O75553	DAB1	Disabled homolog 1	GO:0042493; P:response to drug; IEA:Ensembl
O75553	DAB1	Disabled homolog 1	GO:0007264; P:small GTPase mediated signal transduction; IEA:Ensembl
O75553	DAB1	Disabled homolog 1	GO:0021517; P:ventral spinal cord development; IEA:Ensembl
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0071889; F:14-3-3 protein binding; IDA:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0005123; F:death receptor binding; IPI:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0042802; F:identical protein binding; IPI:IntAct
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0019900; F:kinase binding; IPI:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0031434; F:mitogen-activated protein kinase kinase binding; IPI:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0031435; F:mitogen-activated protein kinase kinase kinase binding; IPI:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0043548; F:phosphatidylinositol 3-kinase binding; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0036312; F:phosphatidylinositol 3-kinase regulatory subunit binding; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0032266; F:phosphatidylinositol-3-phosphate binding; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0070273; F:phosphatidylinositol-4-phosphate binding; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0032403; F:protein complex binding; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0051721; F:protein phosphatase 2A binding; IDA:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0005099; F:Ras GTPase activator activity; ISS:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0017124; F:SH3 domain binding; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0035591; F:signaling adaptor activity; IDA:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0043184; F:vascular endothelial growth factor receptor 2 binding; IPI:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0007257; P:activation of JUN kinase activity; IDA:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0000185; P:activation of MAPKKK activity; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0021814; P:cell motility involved in cerebral cortex radial glia guided migration; ISS:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0044257; P:cellular protein catabolic process; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0071364; P:cellular response to epidermal growth factor stimulus; ISS:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0071347; P:cellular response to interleukin-1; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0071222; P:cellular response to lipopolysaccharide; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0071356; P:cellular response to tumor necrosis factor; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0072577; P:endothelial cell apoptotic process; TAS:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IMP:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0007252; P:I-kappaB phosphorylation; ISS:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISS:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0021819; P:layer formation in cerebral cortex; ISS:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0016525; P:negative regulation of angiogenesis; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0035414; P:negative regulation of catenin import into nucleus; ISS:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:2000599; P:negative regulation of cyclin catabolic process; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0010596; P:negative regulation of endothelial cell migration; IMP:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; ISS:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0010633; P:negative regulation of epithelial cell migration; IMP:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0050680; P:negative regulation of epithelial cell proliferation; IMP:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0010719; P:negative regulation of epithelial to mesenchymal transition; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0048147; P:negative regulation of fibroblast proliferation; ISS:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0070317; P:negative regulation of G0 to G1 transition; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0034260; P:negative regulation of GTPase activity; ISS:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0043407; P:negative regulation of MAP kinase activity; IDA:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IMP:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0043553; P:negative regulation of phosphatidylinositol 3-kinase activity; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0014067; P:negative regulation of phosphatidylinositol 3-kinase signaling; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0001933; P:negative regulation of protein phosphorylation; IMP:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0071901; P:negative regulation of protein serine/threonine kinase activity; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0034261; P:negative regulation of Ras GTPase activity; IMP:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0046580; P:negative regulation of Ras protein signal transduction; IC:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0034144; P:negative regulation of toll-like receptor 4 signaling pathway; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0030948; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; IMP:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:1900747; P:negative regulation of vascular endothelial growth factor signaling pathway; ISS:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0048812; P:neuron projection morphogenesis; ISS:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:2001235; P:positive regulation of apoptotic signaling pathway; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0071158; P:positive regulation of cell cycle arrest; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:1900006; P:positive regulation of dendrite development; ISS:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0043507; P:positive regulation of JUN kinase activity; IDA:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0043410; P:positive regulation of MAPK cascade; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:2001224; P:positive regulation of neuron migration; ISS:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:1901800; P:positive regulation of proteasomal protein catabolic process; IMP:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0045732; P:positive regulation of protein catabolic process; ISS:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0032320; P:positive regulation of Ras GTPase activity; IBA:RefGenome
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0090129; P:positive regulation of synapse maturation; ISS:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0032312; P:regulation of ARF GTPase activity; ISS:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0043122; P:regulation of I-kappaB kinase/NF-kappaB signaling; ISS:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:1900744; P:regulation of p38MAPK cascade; ISS:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0043254; P:regulation of protein complex assembly; IDA:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0006927; P:transformed cell apoptotic process; TAS:BHF-UCL
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0035148; P:tube formation; IMP:UniProtKB
Q5VWQ8	DAB2IP	Disabled homolog 2-interacting protein	GO:0036324; P:vascular endothelial growth factor receptor-2 signaling pathway; ISS:UniProtKB
P98082	DAB2	Disabled homolog 2	GO:0038024; F:cargo receptor activity; IMP:UniProtKB
P98082	DAB2	Disabled homolog 2	GO:0035615; F:clathrin adaptor activity; IMP:UniProtKB
P98082	DAB2	Disabled homolog 2	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IEA:Ensembl
P98082	DAB2	Disabled homolog 2	GO:0005515; F:protein binding; IPI:UniProtKB
P98082	DAB2	Disabled homolog 2	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P98082	DAB2	Disabled homolog 2	GO:0046332; F:SMAD binding; IDA:UniProtKB
P98082	DAB2	Disabled homolog 2	GO:0007257; P:activation of JUN kinase activity; IEA:Ensembl
P98082	DAB2	Disabled homolog 2	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P98082	DAB2	Disabled homolog 2	GO:0000904; P:cell morphogenesis involved in differentiation; IEA:Ensembl
P98082	DAB2	Disabled homolog 2	GO:0008283; P:cell proliferation; TAS:ProtInc
P98082	DAB2	Disabled homolog 2	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEA:Ensembl
P98082	DAB2	Disabled homolog 2	GO:0048268; P:clathrin coat assembly; IEA:Ensembl
P98082	DAB2	Disabled homolog 2	GO:0007492; P:endoderm development; IEA:Ensembl
P98082	DAB2	Disabled homolog 2	GO:0007588; P:excretion; IEA:Ensembl
P98082	DAB2	Disabled homolog 2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P98082	DAB2	Disabled homolog 2	GO:0061024; P:membrane organization; TAS:Reactome
P98082	DAB2	Disabled homolog 2	GO:0030099; P:myeloid cell differentiation; IEA:Ensembl
P98082	DAB2	Disabled homolog 2	GO:0060766; P:negative regulation of androgen receptor signaling pathway; IMP:UniProtKB
P98082	DAB2	Disabled homolog 2	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P98082	DAB2	Disabled homolog 2	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
P98082	DAB2	Disabled homolog 2	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl
P98082	DAB2	Disabled homolog 2	GO:0032091; P:negative regulation of protein binding; IMP:BHF-UCL
P98082	DAB2	Disabled homolog 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:BHF-UCL
P98082	DAB2	Disabled homolog 2	GO:0006907; P:pinocytosis; IEA:Ensembl
P98082	DAB2	Disabled homolog 2	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
P98082	DAB2	Disabled homolog 2	GO:2000370; P:positive regulation of clathrin-mediated endocytosis; IMP:UniProtKB
P98082	DAB2	Disabled homolog 2	GO:2000643; P:positive regulation of early endosome to late endosome transport; IMP:UniProtKB
P98082	DAB2	Disabled homolog 2	GO:0045807; P:positive regulation of endocytosis; IMP:UniProtKB
P98082	DAB2	Disabled homolog 2	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IDA:UniProtKB
P98082	DAB2	Disabled homolog 2	GO:2001046; P:positive regulation of integrin-mediated signaling pathway; IEA:Ensembl
P98082	DAB2	Disabled homolog 2	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:UniProtKB
P98082	DAB2	Disabled homolog 2	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:BHF-UCL
P98082	DAB2	Disabled homolog 2	GO:0001934; P:positive regulation of protein phosphorylation; IMP:BHF-UCL
P98082	DAB2	Disabled homolog 2	GO:0001921; P:positive regulation of receptor recycling; IEA:Ensembl
P98082	DAB2	Disabled homolog 2	GO:0060391; P:positive regulation of SMAD protein import into nucleus; IDA:UniProtKB
P98082	DAB2	Disabled homolog 2	GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IEA:Ensembl
P98082	DAB2	Disabled homolog 2	GO:0032968; P:positive regulation of transcription elongation from RNA polymerase II promoter; IEA:Ensembl
P98082	DAB2	Disabled homolog 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:BHF-UCL
P98082	DAB2	Disabled homolog 2	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
P98082	DAB2	Disabled homolog 2	GO:2000096; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; IMP:BHF-UCL
P98082	DAB2	Disabled homolog 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P98082	DAB2	Disabled homolog 2	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9UI36	DACH1	Dachshund homolog 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UI36	DACH1	Dachshund homolog 1	GO:0005515; F:protein binding; IPI:IntAct
Q9UI36	DACH1	Dachshund homolog 1	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IDA:BHF-UCL
Q9UI36	DACH1	Dachshund homolog 1	GO:0001075; F:RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity involved in preinitiation complex assembly; IEA:Ensembl
Q9UI36	DACH1	Dachshund homolog 1	GO:0008283; P:cell proliferation; IEA:Ensembl
Q9UI36	DACH1	Dachshund homolog 1	GO:0046545; P:development of primary female sexual characteristics; IEA:Ensembl
Q9UI36	DACH1	Dachshund homolog 1	GO:0030336; P:negative regulation of cell migration; IDA:BHF-UCL
Q9UI36	DACH1	Dachshund homolog 1	GO:0060244; P:negative regulation of cell proliferation involved in contact inhibition; IEA:Ensembl
Q9UI36	DACH1	Dachshund homolog 1	GO:0048147; P:negative regulation of fibroblast proliferation; IEA:Ensembl
Q9UI36	DACH1	Dachshund homolog 1	GO:0010944; P:negative regulation of transcription by competitive promoter binding; IMP:BHF-UCL
Q9UI36	DACH1	Dachshund homolog 1	GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl
Q9UI36	DACH1	Dachshund homolog 1	GO:0001967; P:suckling behavior; IEA:Ensembl
Q96NX9	DACH2	Dachshund homolog 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96NX9	DACH2	Dachshund homolog 2	GO:0046545; P:development of primary female sexual characteristics; IEA:Ensembl
Q96NX9	DACH2	Dachshund homolog 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96NX9	DACH2	Dachshund homolog 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NYF0	DACT1	Dapper homolog 1	GO:0008013; F:beta-catenin binding; IDA:UniProtKB
Q9NYF0	DACT1	Dapper homolog 1	GO:0070097; F:delta-catenin binding; ISS:UniProtKB
Q9NYF0	DACT1	Dapper homolog 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NYF0	DACT1	Dapper homolog 1	GO:0051018; F:protein kinase A binding; IDA:UniProtKB
Q9NYF0	DACT1	Dapper homolog 1	GO:0005080; F:protein kinase C binding; ISS:UniProtKB
Q9NYF0	DACT1	Dapper homolog 1	GO:0048813; P:dendrite morphogenesis; IEA:Ensembl
Q9NYF0	DACT1	Dapper homolog 1	GO:0048619; P:embryonic hindgut morphogenesis; ISS:UniProtKB
Q9NYF0	DACT1	Dapper homolog 1	GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl
Q9NYF0	DACT1	Dapper homolog 1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEA:Ensembl
Q9NYF0	DACT1	Dapper homolog 1	GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IDA:UniProtKB
Q9NYF0	DACT1	Dapper homolog 1	GO:0046329; P:negative regulation of JNK cascade; IDA:UniProtKB
Q9NYF0	DACT1	Dapper homolog 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9NYF0	DACT1	Dapper homolog 1	GO:0030178; P:negative regulation of Wnt signaling pathway; IDA:UniProtKB
Q9NYF0	DACT1	Dapper homolog 1	GO:0035413; P:positive regulation of catenin import into nucleus; IMP:UniProtKB
Q9NYF0	DACT1	Dapper homolog 1	GO:0045600; P:positive regulation of fat cell differentiation; IEA:Ensembl
Q9NYF0	DACT1	Dapper homolog 1	GO:0045732; P:positive regulation of protein catabolic process; IDA:MGI
Q9NYF0	DACT1	Dapper homolog 1	GO:0030177; P:positive regulation of Wnt signaling pathway; IDA:UniProtKB
Q9NYF0	DACT1	Dapper homolog 1	GO:0035412; P:regulation of catenin import into nucleus; IMP:UniProtKB
Q9NYF0	DACT1	Dapper homolog 1	GO:0031647; P:regulation of protein stability; IDA:UniProtKB
Q9NYF0	DACT1	Dapper homolog 1	GO:2000095; P:regulation of Wnt signaling pathway, planar cell polarity pathway; ISS:UniProtKB
Q9NYF0	DACT1	Dapper homolog 1	GO:0050808; P:synapse organization; IEA:Ensembl
Q9NYF0	DACT1	Dapper homolog 1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q96B18	DACT3	Dapper homolog 3	GO:0070097; F:delta-catenin binding; ISS:UniProtKB
Q96B18	DACT3	Dapper homolog 3	GO:0051018; F:protein kinase A binding; ISS:UniProtKB
Q96B18	DACT3	Dapper homolog 3	GO:0005080; F:protein kinase C binding; ISS:UniProtKB
Q96B18	DACT3	Dapper homolog 3	GO:0035414; P:negative regulation of catenin import into nucleus; IDA:UniProtKB
Q96B18	DACT3	Dapper homolog 3	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q96B18	DACT3	Dapper homolog 3	GO:0030178; P:negative regulation of Wnt signaling pathway; IDA:UniProtKB
Q96B18	DACT3	Dapper homolog 3	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P61803	DAD1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1	GO:0004579; F:dolichyl-diphosphooligosaccharide-protein glycotransferase activity; IEA:InterPro
P61803	DAD1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P61803	DAD1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1	GO:0001824; P:blastocyst development; IEA:Ensembl
P61803	DAD1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P61803	DAD1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
P61803	DAD1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1	GO:0043687; P:post-translational protein modification; TAS:Reactome
P61803	DAD1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1	GO:0006486; P:protein glycosylation; ISS:UniProtKB
P61803	DAD1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1	GO:0018279; P:protein N-linked glycosylation via asparagine; IC:HGNC
P61803	DAD1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1	GO:0042493; P:response to drug; IEA:Ensembl
P61803	DAD1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1	GO:0007584; P:response to nutrient; IEA:Ensembl
Q5SW24	DACT2	Dapper homolog 2	GO:0008013; F:beta-catenin binding; ISS:UniProtKB
Q5SW24	DACT2	Dapper homolog 2	GO:0070097; F:delta-catenin binding; ISS:UniProtKB
Q5SW24	DACT2	Dapper homolog 2	GO:0051018; F:protein kinase A binding; ISS:UniProtKB
Q5SW24	DACT2	Dapper homolog 2	GO:0005080; F:protein kinase C binding; ISS:UniProtKB
Q5SW24	DACT2	Dapper homolog 2	GO:0008134; F:transcription factor binding; ISS:UniProtKB
Q5SW24	DACT2	Dapper homolog 2	GO:0003382; P:epithelial cell morphogenesis; ISS:UniProtKB
Q5SW24	DACT2	Dapper homolog 2	GO:0072061; P:inner medullary collecting duct development; ISS:UniProtKB
Q5SW24	DACT2	Dapper homolog 2	GO:0007162; P:negative regulation of cell adhesion; ISS:UniProtKB
Q5SW24	DACT2	Dapper homolog 2	GO:1900108; P:negative regulation of nodal signaling pathway; ISS:UniProtKB
Q5SW24	DACT2	Dapper homolog 2	GO:0043588; P:skin development; ISS:UniProtKB
P08174	CD55	Complement decay-accelerating factor	GO:0004857; F:enzyme inhibitor activity; IEA:Ensembl
P08174	CD55	Complement decay-accelerating factor	GO:0008289; F:lipid binding; IDA:UniProt
P08174	CD55	Complement decay-accelerating factor	GO:0005515; F:protein binding; IPI:UniProt
P08174	CD55	Complement decay-accelerating factor	GO:0001618; F:virus receptor activity; IDA:UniProt
P08174	CD55	Complement decay-accelerating factor	GO:0035743; P:CD4-positive, alpha-beta T cell cytokine production; IDA:UniProt
P08174	CD55	Complement decay-accelerating factor	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
P08174	CD55	Complement decay-accelerating factor	GO:0045087; P:innate immune response; TAS:Reactome
P08174	CD55	Complement decay-accelerating factor	GO:0060137; P:maternal process involved in parturition; IEA:Ensembl
P08174	CD55	Complement decay-accelerating factor	GO:0045916; P:negative regulation of complement activation; IDA:UniProt
P08174	CD55	Complement decay-accelerating factor	GO:2000516; P:positive regulation of CD4-positive, alpha-beta T cell activation; IDA:UniProt
P08174	CD55	Complement decay-accelerating factor	GO:2000563; P:positive regulation of CD4-positive, alpha-beta T cell proliferation; IDA:UniProt
P08174	CD55	Complement decay-accelerating factor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB
P08174	CD55	Complement decay-accelerating factor	GO:0030449; P:regulation of complement activation; TAS:Reactome
P08174	CD55	Complement decay-accelerating factor	GO:0031664; P:regulation of lipopolysaccharide-mediated signaling pathway; IDA:UniProt
P08174	CD55	Complement decay-accelerating factor	GO:0045730; P:respiratory burst; NAS:UniProtKB
P08174	CD55	Complement decay-accelerating factor	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P08174	CD55	Complement decay-accelerating factor	GO:0009615; P:response to virus; IDA:GOC
P08174	CD55	Complement decay-accelerating factor	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q14118	DAG1	Dystroglycan	GO:0003779; F:actin binding; IDA:UniProtKB
Q14118	DAG1	Dystroglycan	GO:0051393; F:alpha-actinin binding; IDA:UniProtKB
Q14118	DAG1	Dystroglycan	GO:0005509; F:calcium ion binding; IEA:InterPro
Q14118	DAG1	Dystroglycan	GO:0043237; F:laminin-1 binding; ISS:UniProtKB
Q14118	DAG1	Dystroglycan	GO:0005515; F:protein binding; IPI:UniProtKB
Q14118	DAG1	Dystroglycan	GO:0042169; F:SH2 domain binding; IDA:UniProtKB
Q14118	DAG1	Dystroglycan	GO:0008307; F:structural constituent of muscle; IMP:UniProtKB
Q14118	DAG1	Dystroglycan	GO:0015631; F:tubulin binding; IDA:UniProtKB
Q14118	DAG1	Dystroglycan	GO:0017166; F:vinculin binding; IPI:UniProtKB
Q14118	DAG1	Dystroglycan	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
Q14118	DAG1	Dystroglycan	GO:0071711; P:basement membrane organization; IEA:Ensembl
Q14118	DAG1	Dystroglycan	GO:0060445; P:branching involved in salivary gland morphogenesis; IEA:Ensembl
Q14118	DAG1	Dystroglycan	GO:0016340; P:calcium-dependent cell-matrix adhesion; IEA:Ensembl
Q14118	DAG1	Dystroglycan	GO:0071679; P:commissural neuron axon guidance; IEA:Ensembl
Q14118	DAG1	Dystroglycan	GO:0007016; P:cytoskeletal anchoring at plasma membrane; IMP:UniProtKB
Q14118	DAG1	Dystroglycan	GO:0060441; P:epithelial tube branching involved in lung morphogenesis; IEA:Ensembl
Q14118	DAG1	Dystroglycan	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q14118	DAG1	Dystroglycan	GO:0006509; P:membrane protein ectodomain proteolysis; IDA:UniProtKB
Q14118	DAG1	Dystroglycan	GO:0034453; P:microtubule anchoring; IMP:UniProtKB
Q14118	DAG1	Dystroglycan	GO:0019048; P:modulation by virus of host morphology or physiology; IDA:UniProtKB
Q14118	DAG1	Dystroglycan	GO:0002011; P:morphogenesis of an epithelial sheet; IEA:Ensembl
Q14118	DAG1	Dystroglycan	GO:0022011; P:myelination in peripheral nervous system; IEA:Ensembl
Q14118	DAG1	Dystroglycan	GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB
Q14118	DAG1	Dystroglycan	GO:0043409; P:negative regulation of MAPK cascade; IMP:UniProtKB
Q14118	DAG1	Dystroglycan	GO:0051898; P:negative regulation of protein kinase B signaling; IMP:UniProtKB
Q14118	DAG1	Dystroglycan	GO:0021682; P:nerve maturation; IEA:Ensembl
Q14118	DAG1	Dystroglycan	GO:0006607; P:NLS-bearing protein import into nucleus; IDA:UniProtKB
Q14118	DAG1	Dystroglycan	GO:0043434; P:response to peptide hormone; IEA:Ensembl
Q5D0E6	DALRD3	DALR anticodon-binding domain-containing protein 3	GO:0004814; F:arginine-tRNA ligase activity; IEA:InterPro
Q5D0E6	DALRD3	DALR anticodon-binding domain-containing protein 3	GO:0005524; F:ATP binding; IEA:InterPro
Q5D0E6	DALRD3	DALR anticodon-binding domain-containing protein 3	GO:0006420; P:arginyl-tRNA aminoacylation; IEA:InterPro
Q8N907	DAND5	DAN domain family member 5	GO:0016015; F:morphogen activity; ISS:BHF-UCL
Q8N907	DAND5	DAN domain family member 5	GO:0003283; P:atrial septum development; ISS:BHF-UCL
Q8N907	DAND5	DAN domain family member 5	GO:0061371; P:determination of heart left/right asymmetry; ISS:BHF-UCL
Q8N907	DAND5	DAN domain family member 5	GO:0003140; P:determination of left/right asymmetry in lateral mesoderm; ISS:BHF-UCL
Q8N907	DAND5	DAN domain family member 5	GO:0030514; P:negative regulation of BMP signaling pathway; ISS:BHF-UCL
Q8N907	DAND5	DAN domain family member 5	GO:1900108; P:negative regulation of nodal signaling pathway; ISS:BHF-UCL
Q8N907	DAND5	DAN domain family member 5	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; ISS:BHF-UCL
Q8N907	DAND5	DAN domain family member 5	GO:0038101; P:sequestering of nodal from receptor via nodal binding; ISS:BHF-UCL
Q8N907	DAND5	DAN domain family member 5	GO:0003281; P:ventricular septum development; ISS:BHF-UCL
P59103	DAOA	D-amino acid oxidase activator	GO:0008047; F:enzyme activator activity; IDA:UniProtKB
P59103	DAOA	D-amino acid oxidase activator	GO:0019899; F:enzyme binding; IPI:UniProtKB
P59103	DAOA	D-amino acid oxidase activator	GO:1900758; P:negative regulation of D-amino-acid oxidase activity; IDA:UniProtKB
P59103	DAOA	D-amino acid oxidase activator	GO:0043085; P:positive regulation of catalytic activity; IDA:UniProtKB
P51397	DAP	Death-associated protein 1	GO:0070513; F:death domain binding; IPI:UniProtKB
P51397	DAP	Death-associated protein 1	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
P51397	DAP	Death-associated protein 1	GO:0006915; P:apoptotic process; IGI:MGI
P51397	DAP	Death-associated protein 1	GO:0097190; P:apoptotic signaling pathway; IMP:UniProtKB
P51397	DAP	Death-associated protein 1	GO:0006914; P:autophagy; IEA:UniProtKB-KW
P51397	DAP	Death-associated protein 1	GO:0034198; P:cellular response to amino acid starvation; IDA:UniProtKB
P51397	DAP	Death-associated protein 1	GO:0010507; P:negative regulation of autophagy; IMP:UniProtKB
P51397	DAP	Death-associated protein 1	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
P51397	DAP	Death-associated protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
P53355	DAPK1	Death-associated protein kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P53355	DAPK1	Death-associated protein kinase 1	GO:0005516; F:calmodulin binding; IDA:UniProtKB
P53355	DAPK1	Death-associated protein kinase 1	GO:0004683; F:calmodulin-dependent protein kinase activity; IDA:UniProtKB
P53355	DAPK1	Death-associated protein kinase 1	GO:0042802; F:identical protein binding; IPI:IntAct
P53355	DAPK1	Death-associated protein kinase 1	GO:0005515; F:protein binding; IPI:UniProtKB
P53355	DAPK1	Death-associated protein kinase 1	GO:0004672; F:protein kinase activity; IDA:MGI
P53355	DAPK1	Death-associated protein kinase 1	GO:0004674; F:protein serine/threonine kinase activity; IEA:InterPro
P53355	DAPK1	Death-associated protein kinase 1	GO:0006915; P:apoptotic process; IMP:UniProtKB
P53355	DAPK1	Death-associated protein kinase 1	GO:0097190; P:apoptotic signaling pathway; IMP:UniProtKB
P53355	DAPK1	Death-associated protein kinase 1	GO:0071346; P:cellular response to interferon-gamma; IDA:UniProtKB
P53355	DAPK1	Death-associated protein kinase 1	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
P53355	DAPK1	Death-associated protein kinase 1	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
P53355	DAPK1	Death-associated protein kinase 1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P53355	DAPK1	Death-associated protein kinase 1	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
P53355	DAPK1	Death-associated protein kinase 1	GO:0017148; P:negative regulation of translation; IDA:UniProtKB
P53355	DAPK1	Death-associated protein kinase 1	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
P53355	DAPK1	Death-associated protein kinase 1	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P53355	DAPK1	Death-associated protein kinase 1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P53355	DAPK1	Death-associated protein kinase 1	GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB
P53355	DAPK1	Death-associated protein kinase 1	GO:0010506; P:regulation of autophagy; TAS:UniProtKB
P53355	DAPK1	Death-associated protein kinase 1	GO:2000310; P:regulation of N-methyl-D-aspartate selective glutamate receptor activity; ISS:UniProtKB
P53355	DAPK1	Death-associated protein kinase 1	GO:0007165; P:signal transduction; IEA:InterPro
Q9UIK4	DAPK2	Death-associated protein kinase 2	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9UIK4	DAPK2	Death-associated protein kinase 2	GO:0005516; F:calmodulin binding; IDA:UniProtKB
Q9UIK4	DAPK2	Death-associated protein kinase 2	GO:0004683; F:calmodulin-dependent protein kinase activity; IBA:RefGenome
Q9UIK4	DAPK2	Death-associated protein kinase 2	GO:0042802; F:identical protein binding; IPI:IntAct
Q9UIK4	DAPK2	Death-associated protein kinase 2	GO:0004674; F:protein serine/threonine kinase activity; TAS:UniProtKB
Q9UIK4	DAPK2	Death-associated protein kinase 2	GO:0043276; P:anoikis; IMP:UniProtKB
Q9UIK4	DAPK2	Death-associated protein kinase 2	GO:0006915; P:apoptotic process; TAS:UniProtKB
Q9UIK4	DAPK2	Death-associated protein kinase 2	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q9UIK4	DAPK2	Death-associated protein kinase 2	GO:0046777; P:protein autophosphorylation; TAS:UniProtKB
Q9UIK4	DAPK2	Death-associated protein kinase 2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9UIK4	DAPK2	Death-associated protein kinase 2	GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB
Q9UIK4	DAPK2	Death-associated protein kinase 2	GO:0010506; P:regulation of autophagy; TAS:UniProtKB
Q9UIK4	DAPK2	Death-associated protein kinase 2	GO:2001242; P:regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
O43293	DAPK3	Death-associated protein kinase 3	GO:0005524; F:ATP binding; IDA:UniProtKB
O43293	DAPK3	Death-associated protein kinase 3	GO:0004683; F:calmodulin-dependent protein kinase activity; IBA:RefGenome
O43293	DAPK3	Death-associated protein kinase 3	GO:0042802; F:identical protein binding; IPI:IntAct
O43293	DAPK3	Death-associated protein kinase 3	GO:0043522; F:leucine zipper domain binding; IPI:UniProtKB
O43293	DAPK3	Death-associated protein kinase 3	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O43293	DAPK3	Death-associated protein kinase 3	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
O43293	DAPK3	Death-associated protein kinase 3	GO:0006915; P:apoptotic process; IDA:UniProtKB
O43293	DAPK3	Death-associated protein kinase 3	GO:0097190; P:apoptotic signaling pathway; IEA:Ensembl
O43293	DAPK3	Death-associated protein kinase 3	GO:0071346; P:cellular response to interferon-gamma; IDA:UniProtKB
O43293	DAPK3	Death-associated protein kinase 3	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
O43293	DAPK3	Death-associated protein kinase 3	GO:0000910; P:cytokinesis; TAS:UniProtKB
O43293	DAPK3	Death-associated protein kinase 3	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
O43293	DAPK3	Death-associated protein kinase 3	GO:0017148; P:negative regulation of translation; IDA:UniProtKB
O43293	DAPK3	Death-associated protein kinase 3	GO:0030182; P:neuron differentiation; IEA:Ensembl
O43293	DAPK3	Death-associated protein kinase 3	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:UniProtKB
O43293	DAPK3	Death-associated protein kinase 3	GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
O43293	DAPK3	Death-associated protein kinase 3	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
O43293	DAPK3	Death-associated protein kinase 3	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
O43293	DAPK3	Death-associated protein kinase 3	GO:2000249; P:regulation of actin cytoskeleton reorganization; TAS:UniProtKB
O43293	DAPK3	Death-associated protein kinase 3	GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB
O43293	DAPK3	Death-associated protein kinase 3	GO:0010506; P:regulation of autophagy; TAS:UniProtKB
O43293	DAPK3	Death-associated protein kinase 3	GO:2000145; P:regulation of cell motility; TAS:UniProtKB
O43293	DAPK3	Death-associated protein kinase 3	GO:0007088; P:regulation of mitosis; TAS:UniProtKB
O43293	DAPK3	Death-associated protein kinase 3	GO:0006940; P:regulation of smooth muscle contraction; TAS:UniProtKB
O43293	DAPK3	Death-associated protein kinase 3	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
O43293	DAPK3	Death-associated protein kinase 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9P219	CCDC88C	Protein Daple	GO:0030165; F:PDZ domain binding; ISS:UniProtKB
Q9P219	CCDC88C	Protein Daple	GO:0043621; F:protein self-association; ISS:UniProtKB
Q9P219	CCDC88C	Protein Daple	GO:0031648; P:protein destabilization; ISS:UniProtKB
Q9P219	CCDC88C	Protein Daple	GO:0051260; P:protein homooligomerization; ISS:UniProtKB
Q9P219	CCDC88C	Protein Daple	GO:0001932; P:regulation of protein phosphorylation; ISS:UniProtKB
Q9P219	CCDC88C	Protein Daple	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
A0PJW8	DAPL1	Death-associated protein-like 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
A0PJW8	DAPL1	Death-associated protein-like 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9UN19	DAPP1	Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB
Q9UN19	DAPP1	Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide	GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; IDA:UniProtKB
Q9UN19	DAPP1	Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide	GO:0005543; F:phospholipid binding; NAS:UniProtKB
Q9UN19	DAPP1	Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide	GO:0006470; P:protein dephosphorylation; NAS:UniProtKB
Q9UN19	DAPP1	Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UER7	DAXX	Death domain-associated protein 6	GO:0050681; F:androgen receptor binding; IPI:UniProtKB
Q9UER7	DAXX	Death domain-associated protein 6	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9UER7	DAXX	Death domain-associated protein 6	GO:0031072; F:heat shock protein binding; TAS:UniProtKB
Q9UER7	DAXX	Death domain-associated protein 6	GO:0002039; F:p53 binding; IPI:UniProtKB
Q9UER7	DAXX	Death domain-associated protein 6	GO:0005515; F:protein binding; IPI:IntAct
Q9UER7	DAXX	Death domain-associated protein 6	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q9UER7	DAXX	Death domain-associated protein 6	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q9UER7	DAXX	Death domain-associated protein 6	GO:0005057; F:receptor signaling protein activity; TAS:ProtInc
Q9UER7	DAXX	Death domain-associated protein 6	GO:0008134; F:transcription factor binding; IDA:UniProtKB
Q9UER7	DAXX	Death domain-associated protein 6	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q9UER7	DAXX	Death domain-associated protein 6	GO:0007257; P:activation of JUN kinase activity; TAS:ProtInc
Q9UER7	DAXX	Death domain-associated protein 6	GO:0030521; P:androgen receptor signaling pathway; IDA:UniProtKB
Q9UER7	DAXX	Death domain-associated protein 6	GO:0006915; P:apoptotic process; TAS:UniProtKB
Q9UER7	DAXX	Death domain-associated protein 6	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; TAS:ProtInc
Q9UER7	DAXX	Death domain-associated protein 6	GO:0000281; P:mitotic cytokinesis; IEA:Ensembl
Q9UER7	DAXX	Death domain-associated protein 6	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UER7	DAXX	Death domain-associated protein 6	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
Q9UER7	DAXX	Death domain-associated protein 6	GO:0031396; P:regulation of protein ubiquitination; IDA:UniProtKB
Q9UER7	DAXX	Death domain-associated protein 6	GO:0006355; P:regulation of transcription, DNA-templated; IDA:MGI
Q9UER7	DAXX	Death domain-associated protein 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UER7	DAXX	Death domain-associated protein 6	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9NQZ3	DAZ1	Deleted in azoospermia protein 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9NQZ3	DAZ1	Deleted in azoospermia protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NQZ3	DAZ1	Deleted in azoospermia protein 1	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9NQZ3	DAZ1	Deleted in azoospermia protein 1	GO:0008494; F:translation activator activity; IDA:UniProtKB
Q9NQZ3	DAZ1	Deleted in azoospermia protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9NQZ3	DAZ1	Deleted in azoospermia protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9NQZ3	DAZ1	Deleted in azoospermia protein 1	GO:0045948; P:positive regulation of translational initiation; IDA:UniProtKB
Q9NQZ3	DAZ1	Deleted in azoospermia protein 1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q13117	DAZ2	Deleted in azoospermia protein 2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q13117	DAZ2	Deleted in azoospermia protein 2	GO:0003723; F:RNA binding; TAS:ProtInc
Q13117	DAZ2	Deleted in azoospermia protein 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q13117	DAZ2	Deleted in azoospermia protein 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q13117	DAZ2	Deleted in azoospermia protein 2	GO:0007338; P:single fertilization; TAS:ProtInc
Q13117	DAZ2	Deleted in azoospermia protein 2	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q86SG3	DAZ4	Deleted in azoospermia protein 4	GO:0000166; F:nucleotide binding; IEA:InterPro
Q86SG3	DAZ4	Deleted in azoospermia protein 4	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q86SG3	DAZ4	Deleted in azoospermia protein 4	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q86SG3	DAZ4	Deleted in azoospermia protein 4	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q86SG3	DAZ4	Deleted in azoospermia protein 4	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q9NR90	DAZ3	Deleted in azoospermia protein 3	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9NR90	DAZ3	Deleted in azoospermia protein 3	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9NR90	DAZ3	Deleted in azoospermia protein 3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9NR90	DAZ3	Deleted in azoospermia protein 3	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9NR90	DAZ3	Deleted in azoospermia protein 3	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q92904	DAZL	Deleted in azoospermia-like	GO:0003730; F:mRNA 3'-UTR binding; IEA:Ensembl
Q92904	DAZL	Deleted in azoospermia-like	GO:0000166; F:nucleotide binding; IEA:InterPro
Q92904	DAZL	Deleted in azoospermia-like	GO:0005515; F:protein binding; IPI:UniProtKB
Q92904	DAZL	Deleted in azoospermia-like	GO:0003723; F:RNA binding; TAS:ProtInc
Q92904	DAZL	Deleted in azoospermia-like	GO:0008494; F:translation activator activity; IDA:UniProtKB
Q92904	DAZL	Deleted in azoospermia-like	GO:0007281; P:germ cell development; TAS:ProtInc
Q92904	DAZL	Deleted in azoospermia-like	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q92904	DAZL	Deleted in azoospermia-like	GO:0045836; P:positive regulation of meiosis; IEA:Ensembl
Q92904	DAZL	Deleted in azoospermia-like	GO:0045948; P:positive regulation of translational initiation; IDA:UniProtKB
Q92904	DAZL	Deleted in azoospermia-like	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q96EP5	DAZAP1	DAZ-associated protein 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q96EP5	DAZAP1	DAZ-associated protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96EP5	DAZAP1	DAZ-associated protein 1	GO:0003723; F:RNA binding; TAS:ProtInc
Q96EP5	DAZAP1	DAZ-associated protein 1	GO:0035613; F:RNA stem-loop binding; IEA:Ensembl
Q96EP5	DAZAP1	DAZ-associated protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96EP5	DAZAP1	DAZ-associated protein 1	GO:0008283; P:cell proliferation; IEA:Ensembl
Q96EP5	DAZAP1	DAZ-associated protein 1	GO:0001893; P:maternal placenta development; IEA:Ensembl
Q96EP5	DAZAP1	DAZ-associated protein 1	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q15038	DAZAP2	DAZ-associated protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q15038	DAZAP2	DAZ-associated protein 2	GO:0050699; F:WW domain binding; IPI:UniProtKB
Q30KR1	DEFB109P1	Beta-defensin 109	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q30KQ9	DEFB110	Beta-defensin 110	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q30KQ8	DEFB112	Beta-defensin 112	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q30KQ7	DEFB113	Beta-defensin 113	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q30KQ6	DEFB114	Beta-defensin 114	GO:0001530; F:lipopolysaccharide binding; IDA:UniProtKB
Q30KQ6	DEFB114	Beta-defensin 114	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q30KQ6	DEFB114	Beta-defensin 114	GO:0031665; P:negative regulation of lipopolysaccharide-mediated signaling pathway; IDA:UniProtKB
Q30KQ5	DEFB115	Beta-defensin 115	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q30KQ4	DEFB116	Beta-defensin 116	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q96PH6	DEFB118	Beta-defensin 118	GO:0007160; P:cell-matrix adhesion; NAS:UniProtKB
Q96PH6	DEFB118	Beta-defensin 118	GO:0042742; P:defense response to bacterium; TAS:UniProtKB
Q96PH6	DEFB118	Beta-defensin 118	GO:0045087; P:innate immune response; TAS:UniProtKB
Q96PH6	DEFB118	Beta-defensin 118	GO:0007283; P:spermatogenesis; NAS:UniProtKB
Q8N690	DEFB119	Beta-defensin 119	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q5J5C9	DEFB121	Beta-defensin 121	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q8N688	DEFB123	Beta-defensin 123	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q8NES8	DEFB124	Beta-defensin 124	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q8N687	DEFB125	Beta-defensin 125	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q9BYW3	DEFB126	Beta-defensin 126	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q9H1M4	DEFB127	Beta-defensin 127	GO:0042742; P:defense response to bacterium; TAS:UniProtKB
Q9H1M4	DEFB127	Beta-defensin 127	GO:0045087; P:innate immune response; TAS:UniProtKB
Q7Z7B8	DEFB128	Beta-defensin 128	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q9H1M3	DEFB129	Beta-defensin 129	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q30KQ2	DEFB130	Beta-defensin 130	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
P59861	DEFB131	Beta-defensin 131	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q7Z7B7	DEFB132	Beta-defensin 132	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q30KQ1	DEFB133	Beta-defensin 133	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q4QY38	DEFB134	Beta-defensin 134	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q30KP9	DEFB135	Beta-defensin 135	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q30KP8	DEFB136	Beta-defensin 136	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q9UBU7	DBF4	Protein DBF4 homolog A	GO:0008047; F:enzyme activator activity; TAS:ProtInc
Q9UBU7	DBF4	Protein DBF4 homolog A	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9UBU7	DBF4	Protein DBF4 homolog A	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UBU7	DBF4	Protein DBF4 homolog A	GO:0006260; P:DNA replication; TAS:Reactome
Q9UBU7	DBF4	Protein DBF4 homolog A	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q9UBU7	DBF4	Protein DBF4 homolog A	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9UBU7	DBF4	Protein DBF4 homolog A	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
Q8NFT6	DBF4B	Protein DBF4 homolog B	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8NFT6	DBF4B	Protein DBF4 homolog B	GO:0030295; F:protein kinase activator activity; IDA:UniProt
Q8NFT6	DBF4B	Protein DBF4 homolog B	GO:0019901; F:protein kinase binding; IPI:UniProt
Q8NFT6	DBF4B	Protein DBF4 homolog B	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8NFT6	DBF4B	Protein DBF4 homolog B	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8NFT6	DBF4B	Protein DBF4 homolog B	GO:0045860; P:positive regulation of protein kinase activity; IDA:GOC
Q9NR28	DIABLO	Diablo homolog, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NR28	DIABLO	Diablo homolog, mitochondrial	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:UniProtKB
Q9NR28	DIABLO	Diablo homolog, mitochondrial	GO:0008635; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; TAS:ProtInc
Q9NR28	DIABLO	Diablo homolog, mitochondrial	GO:0006915; P:apoptotic process; TAS:Reactome
Q9NR28	DIABLO	Diablo homolog, mitochondrial	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; TAS:ProtInc
Q9NR28	DIABLO	Diablo homolog, mitochondrial	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:UniProtKB
Q9NR28	DIABLO	Diablo homolog, mitochondrial	GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IEA:Ensembl
Q9NR28	DIABLO	Diablo homolog, mitochondrial	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
Q9NR28	DIABLO	Diablo homolog, mitochondrial	GO:0043065; P:positive regulation of apoptotic process; TAS:UniProtKB
Q9BQY9	DBNDD2	Dysbindin domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BQY9	DBNDD2	Dysbindin domain-containing protein 2	GO:0006469; P:negative regulation of protein kinase activity; IDA:UniProtKB
Q9UJU6	DBNL	Drebrin-like protein	GO:0003779; F:actin binding; ISS:UniProtKB
Q9UJU6	DBNL	Drebrin-like protein	GO:0051015; F:actin filament binding; ISS:UniProtKB
Q9UJU6	DBNL	Drebrin-like protein	GO:0008047; F:enzyme activator activity; TAS:ProtInc
Q9UJU6	DBNL	Drebrin-like protein	GO:0005515; F:protein binding; IPI:IntAct
Q9UJU6	DBNL	Drebrin-like protein	GO:0007257; P:activation of JUN kinase activity; TAS:ProtInc
Q9UJU6	DBNL	Drebrin-like protein	GO:0006915; P:apoptotic process; TAS:Reactome
Q9UJU6	DBNL	Drebrin-like protein	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q9UJU6	DBNL	Drebrin-like protein	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q9UJU6	DBNL	Drebrin-like protein	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q9UJU6	DBNL	Drebrin-like protein	GO:0048812; P:neuron projection morphogenesis; ISS:UniProtKB
Q9UJU6	DBNL	Drebrin-like protein	GO:0071800; P:podosome assembly; ISS:UniProtKB
Q9UJU6	DBNL	Drebrin-like protein	GO:0016601; P:Rac protein signal transduction; ISS:UniProtKB
Q9UJU6	DBNL	Drebrin-like protein	GO:0007416; P:synapse assembly; ISS:UniProtKB
Q10586	DBP	D site-binding protein	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:BHF-UCL
Q10586	DBP	D site-binding protein	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:BHF-UCL
Q10586	DBP	D site-binding protein	GO:0001889; P:liver development; IEA:Ensembl
Q10586	DBP	D site-binding protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q10586	DBP	D site-binding protein	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q10586	DBP	D site-binding protein	GO:0048511; P:rhythmic process; IEA:UniProtKB-KW
Q9UK59	DBR1	Lariat debranching enzyme	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UK59	DBR1	Lariat debranching enzyme	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UK59	DBR1	Lariat debranching enzyme	GO:0008419; F:RNA lariat debranching enzyme activity; IMP:UniProtKB
Q9UK59	DBR1	Lariat debranching enzyme	GO:0000398; P:mRNA splicing, via spliceosome; IEA:Ensembl
Q9UK59	DBR1	Lariat debranching enzyme	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; IMP:GOC
Q9UK59	DBR1	Lariat debranching enzyme	GO:0000375; P:RNA splicing, via transesterification reactions; IMP:UniProtKB
A6NMT0	DBX1	Homeobox protein DBX1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
A6NMT0	DBX1	Homeobox protein DBX1	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
A6NMT0	DBX1	Homeobox protein DBX1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q6ZNG2	DBX2	Homeobox protein DBX2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q6ZNG2	DBX2	Homeobox protein DBX2	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
O14576	DYNC1I1	Cytoplasmic dynein 1 intermediate chain 1	GO:0008017; F:microtubule binding; ISS:HGNC
O14576	DYNC1I1	Cytoplasmic dynein 1 intermediate chain 1	GO:0003777; F:microtubule motor activity; ISS:HGNC
O14576	DYNC1I1	Cytoplasmic dynein 1 intermediate chain 1	GO:0003774; F:motor activity; TAS:ProtInc
O14576	DYNC1I1	Cytoplasmic dynein 1 intermediate chain 1	GO:0005515; F:protein binding; IPI:IntAct
O14576	DYNC1I1	Cytoplasmic dynein 1 intermediate chain 1	GO:0030507; F:spectrin binding; IDA:MGI
O14576	DYNC1I1	Cytoplasmic dynein 1 intermediate chain 1	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
O14576	DYNC1I1	Cytoplasmic dynein 1 intermediate chain 1	GO:0008152; P:metabolic process; ISS:GOC
O14576	DYNC1I1	Cytoplasmic dynein 1 intermediate chain 1	GO:0007018; P:microtubule-based movement; IEA:InterPro
O14576	DYNC1I1	Cytoplasmic dynein 1 intermediate chain 1	GO:0047496; P:vesicle transport along microtubule; ISS:HGNC
Q13409	DYNC1I2	Cytoplasmic dynein 1 intermediate chain 2	GO:0003777; F:microtubule motor activity; NAS:UniProtKB
Q13409	DYNC1I2	Cytoplasmic dynein 1 intermediate chain 2	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q13409	DYNC1I2	Cytoplasmic dynein 1 intermediate chain 2	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q13409	DYNC1I2	Cytoplasmic dynein 1 intermediate chain 2	GO:0008152; P:metabolic process; NAS:GOC
Q13409	DYNC1I2	Cytoplasmic dynein 1 intermediate chain 2	GO:0007018; P:microtubule-based movement; NAS:UniProtKB
Q13409	DYNC1I2	Cytoplasmic dynein 1 intermediate chain 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q13409	DYNC1I2	Cytoplasmic dynein 1 intermediate chain 2	GO:0006810; P:transport; IEA:UniProtKB-KW
Q13409	DYNC1I2	Cytoplasmic dynein 1 intermediate chain 2	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9Y6G9	DYNC1LI1	Cytoplasmic dynein 1 light intermediate chain 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y6G9	DYNC1LI1	Cytoplasmic dynein 1 light intermediate chain 1	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q9Y6G9	DYNC1LI1	Cytoplasmic dynein 1 light intermediate chain 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y6G9	DYNC1LI1	Cytoplasmic dynein 1 light intermediate chain 1	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q9Y6G9	DYNC1LI1	Cytoplasmic dynein 1 light intermediate chain 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9Y6G9	DYNC1LI1	Cytoplasmic dynein 1 light intermediate chain 1	GO:0090267; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; IMP:UniProtKB
Q9Y6G9	DYNC1LI1	Cytoplasmic dynein 1 light intermediate chain 1	GO:0006810; P:transport; IEA:UniProtKB-KW
Q9Y6G9	DYNC1LI1	Cytoplasmic dynein 1 light intermediate chain 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
O43237	DYNC1LI2	Cytoplasmic dynein 1 light intermediate chain 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43237	DYNC1LI2	Cytoplasmic dynein 1 light intermediate chain 2	GO:0003777; F:microtubule motor activity; IEA:InterPro
O43237	DYNC1LI2	Cytoplasmic dynein 1 light intermediate chain 2	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
O43237	DYNC1LI2	Cytoplasmic dynein 1 light intermediate chain 2	GO:0051642; P:centrosome localization; IEA:Ensembl
O43237	DYNC1LI2	Cytoplasmic dynein 1 light intermediate chain 2	GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl
O43237	DYNC1LI2	Cytoplasmic dynein 1 light intermediate chain 2	GO:0007018; P:microtubule-based movement; IEA:InterPro
O43237	DYNC1LI2	Cytoplasmic dynein 1 light intermediate chain 2	GO:0006810; P:transport; IEA:UniProtKB-KW
Q8TCX1	DYNC2LI1	Cytoplasmic dynein 2 light intermediate chain 1	GO:0003774; F:motor activity; IEA:UniProtKB-KW
Q8TCX1	DYNC2LI1	Cytoplasmic dynein 2 light intermediate chain 1	GO:0005515; F:protein binding; IPI:IntAct
Q8TCX1	DYNC2LI1	Cytoplasmic dynein 2 light intermediate chain 1	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q8TCX1	DYNC2LI1	Cytoplasmic dynein 2 light intermediate chain 1	GO:0042384; P:cilium assembly; IEA:Ensembl
Q8TCX1	DYNC2LI1	Cytoplasmic dynein 2 light intermediate chain 1	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
Q5QP82	DCAF10	DDB1- and CUL4-associated factor 10	GO:0016567; P:protein ubiquitination; IC:UniProtKB
Q8TEB1	DCAF11	DDB1- and CUL4-associated factor 11	GO:0005515; F:protein binding; IPI:IntAct
Q8TEB1	DCAF11	DDB1- and CUL4-associated factor 11	GO:0016567; P:protein ubiquitination; IC:UniProtKB
Q5T6F0	DCAF12	DDB1- and CUL4-associated factor 12	GO:0016567; P:protein ubiquitination; IC:UniProtKB
Q9NV06	DCAF13	DDB1- and CUL4-associated factor 13	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NV06	DCAF13	DDB1- and CUL4-associated factor 13	GO:0016567; P:protein ubiquitination; IC:UniProtKB
Q9NV06	DCAF13	DDB1- and CUL4-associated factor 13	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q66K64	DCAF15	DDB1- and CUL4-associated factor 15	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9NXF7	DCAF16	DDB1- and CUL4-associated factor 16	GO:0005515; F:protein binding; IPI:IntAct
Q9NXF7	DCAF16	DDB1- and CUL4-associated factor 16	GO:0016567; P:protein ubiquitination; IC:UniProtKB
Q5H9S7	DCAF17	DDB1- and CUL4-associated factor 17	GO:0016567; P:protein ubiquitination; IC:UniProtKB
Q8WV16	DCAF4	DDB1- and CUL4-associated factor 4	GO:0016567; P:protein ubiquitination; IC:UniProtKB
Q96JK2	DCAF5	DDB1- and CUL4-associated factor 5	GO:0016567; P:protein ubiquitination; IC:UniProtKB
Q58WW2	DCAF6	DDB1- and CUL4-associated factor 6	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IDA:MGI
Q58WW2	DCAF6	DDB1- and CUL4-associated factor 6	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IGI:MGI
Q58WW2	DCAF6	DDB1- and CUL4-associated factor 6	GO:0016567; P:protein ubiquitination; IC:UniProtKB
P61962	DCAF7	DDB1- and CUL4-associated factor 7	GO:0005515; F:protein binding; IPI:UniProtKB
P61962	DCAF7	DDB1- and CUL4-associated factor 7	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P61962	DCAF7	DDB1- and CUL4-associated factor 7	GO:0016567; P:protein ubiquitination; IC:UniProtKB
Q5TAQ9	DCAF8	DDB1- and CUL4-associated factor 8	GO:0005515; F:protein binding; IPI:IntAct
Q5TAQ9	DCAF8	DDB1- and CUL4-associated factor 8	GO:0016567; P:protein ubiquitination; IC:UniProtKB
Q8WVC6	DCAKD	Dephospho-CoA kinase domain-containing protein	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8WVC6	DCAKD	Dephospho-CoA kinase domain-containing protein	GO:0004140; F:dephospho-CoA kinase activity; IEA:InterPro
Q8WVC6	DCAKD	Dephospho-CoA kinase domain-containing protein	GO:0015937; P:coenzyme A biosynthetic process; IEA:InterPro
P17707	AMD1	S-adenosylmethionine decarboxylase proenzyme	GO:0004014; F:adenosylmethionine decarboxylase activity; TAS:UniProtKB
P17707	AMD1	S-adenosylmethionine decarboxylase proenzyme	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P17707	AMD1	S-adenosylmethionine decarboxylase proenzyme	GO:0006595; P:polyamine metabolic process; TAS:Reactome
P17707	AMD1	S-adenosylmethionine decarboxylase proenzyme	GO:0006557; P:S-adenosylmethioninamine biosynthetic process; IEA:UniProtKB-UniPathway
P17707	AMD1	S-adenosylmethionine decarboxylase proenzyme	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P17707	AMD1	S-adenosylmethionine decarboxylase proenzyme	GO:0008295; P:spermidine biosynthetic process; IEA:UniProtKB-KW
P17707	AMD1	S-adenosylmethionine decarboxylase proenzyme	GO:0006597; P:spermine biosynthetic process; IEA:InterPro
Q8N8Z6	DCBLD1	Discoidin, CUB and LCCL domain-containing protein 1	GO:0007155; P:cell adhesion; IEA:InterPro
Q96PD2	DCBLD2	Discoidin, CUB and LCCL domain-containing protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q96PD2	DCBLD2	Discoidin, CUB and LCCL domain-containing protein 2	GO:0007155; P:cell adhesion; IEA:InterPro
Q96PD2	DCBLD2	Discoidin, CUB and LCCL domain-containing protein 2	GO:0030522; P:intracellular receptor signaling pathway; NAS:UniProtKB
Q96PD2	DCBLD2	Discoidin, CUB and LCCL domain-containing protein 2	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q96PD2	DCBLD2	Discoidin, CUB and LCCL domain-containing protein 2	GO:0042060; P:wound healing; IDA:UniProtKB
Q9BVC3	DSCC1	Sister chromatid cohesion protein DCC1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BVC3	DSCC1	Sister chromatid cohesion protein DCC1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BVC3	DSCC1	Sister chromatid cohesion protein DCC1	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q9BVC3	DSCC1	Sister chromatid cohesion protein DCC1	GO:0034088; P:maintenance of mitotic sister chromatid cohesion; IMP:UniProtKB
Q9BVC3	DSCC1	Sister chromatid cohesion protein DCC1	GO:0034421; P:post-translational protein acetylation; IMP:UniProtKB
Q9BVC3	DSCC1	Sister chromatid cohesion protein DCC1	GO:0006275; P:regulation of DNA replication; IMP:UniProtKB
P43146	DCC	Netrin receptor DCC	GO:0005042; F:netrin receptor activity; IEA:Ensembl
P43146	DCC	Netrin receptor DCC	GO:0005515; F:protein binding; IPI:UniProtKB
P43146	DCC	Netrin receptor DCC	GO:0003713; F:transcription coactivator activity; IEA:Ensembl
P43146	DCC	Netrin receptor DCC	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
P43146	DCC	Netrin receptor DCC	GO:0033564; P:anterior/posterior axon guidance; IEA:Ensembl
P43146	DCC	Netrin receptor DCC	GO:0006915; P:apoptotic process; TAS:Reactome
P43146	DCC	Netrin receptor DCC	GO:0007411; P:axon guidance; TAS:Reactome
P43146	DCC	Netrin receptor DCC	GO:0007409; P:axonogenesis; TAS:ProtInc
P43146	DCC	Netrin receptor DCC	GO:0033563; P:dorsal/ventral axon guidance; IEA:Ensembl
P43146	DCC	Netrin receptor DCC	GO:0048671; P:negative regulation of collateral sprouting; TAS:BHF-UCL
P43146	DCC	Netrin receptor DCC	GO:2000171; P:negative regulation of dendrite development; TAS:BHF-UCL
P43146	DCC	Netrin receptor DCC	GO:0010977; P:negative regulation of neuron projection development; TAS:BHF-UCL
P43146	DCC	Netrin receptor DCC	GO:0001764; P:neuron migration; IEA:Ensembl
P43146	DCC	Netrin receptor DCC	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
P43146	DCC	Netrin receptor DCC	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl
P43146	DCC	Netrin receptor DCC	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
P43146	DCC	Netrin receptor DCC	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P43146	DCC	Netrin receptor DCC	GO:0001975; P:response to amphetamine; IEA:Ensembl
P43146	DCC	Netrin receptor DCC	GO:0021965; P:spinal cord ventral commissure morphogenesis; IEA:Ensembl
A2VCK2	DCDC2B	Doublecortin domain-containing protein 2B	GO:0035556; P:intracellular signal transduction; IEA:InterPro
A8MYV0	DCDC2C	Doublecortin domain-containing protein 2C	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P59894	DCDC1	Doublecortin domain-containing protein 1	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9UHG0	DCDC2	Doublecortin domain-containing protein 2	GO:0006968; P:cellular defense response; TAS:ProtInc
Q9UHG0	DCDC2	Doublecortin domain-containing protein 2	GO:0048813; P:dendrite morphogenesis; IEA:Ensembl
Q9UHG0	DCDC2	Doublecortin domain-containing protein 2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9UHG0	DCDC2	Doublecortin domain-containing protein 2	GO:0001764; P:neuron migration; ISS:UniProtKB
Q6ZRR9	DCDC5	Doublecortin domain-containing protein 5	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P81605	DCD	Dermcidin	GO:0008233; F:peptidase activity; IEA:UniProtKB-KW
P81605	DCD	Dermcidin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P81605	DCD	Dermcidin	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
P81605	DCD	Dermcidin	GO:0050832; P:defense response to fungus; IEA:UniProtKB-KW
P81605	DCD	Dermcidin	GO:0031640; P:killing of cells of other organism; IEA:UniProtKB-KW
Q99259	GAD1	Glutamate decarboxylase 1	GO:0016831; F:carboxy-lyase activity; IEA:InterPro
Q99259	GAD1	Glutamate decarboxylase 1	GO:0016595; F:glutamate binding; IEA:Ensembl
Q99259	GAD1	Glutamate decarboxylase 1	GO:0004351; F:glutamate decarboxylase activity; IDA:UniProtKB
Q99259	GAD1	Glutamate decarboxylase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q99259	GAD1	Glutamate decarboxylase 1	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q99259	GAD1	Glutamate decarboxylase 1	GO:0019752; P:carboxylic acid metabolic process; IEA:InterPro
Q99259	GAD1	Glutamate decarboxylase 1	GO:0009449; P:gamma-aminobutyric acid biosynthetic process; IEA:Ensembl
Q99259	GAD1	Glutamate decarboxylase 1	GO:0006538; P:glutamate catabolic process; TAS:UniProtKB
Q99259	GAD1	Glutamate decarboxylase 1	GO:0006540; P:glutamate decarboxylation to succinate; TAS:ProtInc
Q99259	GAD1	Glutamate decarboxylase 1	GO:0042136; P:neurotransmitter biosynthetic process; IEA:UniProtKB-KW
Q99259	GAD1	Glutamate decarboxylase 1	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
Q99259	GAD1	Glutamate decarboxylase 1	GO:0018352; P:protein-pyridoxal-5-phosphate linkage; TAS:UniProtKB
Q99259	GAD1	Glutamate decarboxylase 1	GO:0042493; P:response to drug; IEA:Ensembl
Q99259	GAD1	Glutamate decarboxylase 1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q05329	GAD2	Glutamate decarboxylase 2	GO:0016595; F:glutamate binding; IEA:Ensembl
Q05329	GAD2	Glutamate decarboxylase 2	GO:0004351; F:glutamate decarboxylase activity; IEA:UniProtKB-EC
Q05329	GAD2	Glutamate decarboxylase 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q05329	GAD2	Glutamate decarboxylase 2	GO:0030170; F:pyridoxal phosphate binding; IEA:Ensembl
Q05329	GAD2	Glutamate decarboxylase 2	GO:0006540; P:glutamate decarboxylation to succinate; TAS:ProtInc
Q05329	GAD2	Glutamate decarboxylase 2	GO:0042136; P:neurotransmitter biosynthetic process; IEA:UniProtKB-KW
Q05329	GAD2	Glutamate decarboxylase 2	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
Q05329	GAD2	Glutamate decarboxylase 2	GO:0042493; P:response to drug; IEA:Ensembl
Q05329	GAD2	Glutamate decarboxylase 2	GO:0007268; P:synaptic transmission; TAS:Reactome
P19113	HDC	Histidine decarboxylase	GO:0004398; F:histidine decarboxylase activity; IDA:UniProtKB
P19113	HDC	Histidine decarboxylase	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
P19113	HDC	Histidine decarboxylase	GO:0042423; P:catecholamine biosynthetic process; IEA:UniProtKB-KW
P19113	HDC	Histidine decarboxylase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P19113	HDC	Histidine decarboxylase	GO:0001694; P:histamine biosynthetic process; IDA:UniProtKB
P19113	HDC	Histidine decarboxylase	GO:0006548; P:histidine catabolic process; IDA:UniProtKB
P19113	HDC	Histidine decarboxylase	GO:0006547; P:histidine metabolic process; TAS:ProtInc
P19113	HDC	Histidine decarboxylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P27707	DCK	Deoxycytidine kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P27707	DCK	Deoxycytidine kinase	GO:0004137; F:deoxycytidine kinase activity; IDA:UniProtKB
P27707	DCK	Deoxycytidine kinase	GO:0008144; F:drug binding; IDA:UniProtKB
P27707	DCK	Deoxycytidine kinase	GO:0019206; F:nucleoside kinase activity; EXP:Reactome
P27707	DCK	Deoxycytidine kinase	GO:0016773; F:phosphotransferase activity, alcohol group as acceptor; IEA:InterPro
P27707	DCK	Deoxycytidine kinase	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P27707	DCK	Deoxycytidine kinase	GO:0009157; P:deoxyribonucleoside monophosphate biosynthetic process; IDA:GOC
P27707	DCK	Deoxycytidine kinase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P27707	DCK	Deoxycytidine kinase	GO:0009165; P:nucleotide biosynthetic process; EXP:GOC
P27707	DCK	Deoxycytidine kinase	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P27707	DCK	Deoxycytidine kinase	GO:0043101; P:purine-containing compound salvage; TAS:Reactome
P27707	DCK	Deoxycytidine kinase	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
P27707	DCK	Deoxycytidine kinase	GO:0043097; P:pyrimidine nucleoside salvage; TAS:Reactome
P27707	DCK	Deoxycytidine kinase	GO:0006220; P:pyrimidine nucleotide metabolic process; IDA:UniProtKB
P27707	DCK	Deoxycytidine kinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15075	DCLK1	Serine/threonine-protein kinase DCLK1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O15075	DCLK1	Serine/threonine-protein kinase DCLK1	GO:0004672; F:protein kinase activity; TAS:ProtInc
O15075	DCLK1	Serine/threonine-protein kinase DCLK1	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
O15075	DCLK1	Serine/threonine-protein kinase DCLK1	GO:0005057; F:receptor signaling protein activity; TAS:ProtInc
O15075	DCLK1	Serine/threonine-protein kinase DCLK1	GO:0048675; P:axon extension; IEA:Ensembl
O15075	DCLK1	Serine/threonine-protein kinase DCLK1	GO:0007417; P:central nervous system development; TAS:ProtInc
O15075	DCLK1	Serine/threonine-protein kinase DCLK1	GO:0021952; P:central nervous system projection neuron axonogenesis; IEA:Ensembl
O15075	DCLK1	Serine/threonine-protein kinase DCLK1	GO:0048813; P:dendrite morphogenesis; IEA:Ensembl
O15075	DCLK1	Serine/threonine-protein kinase DCLK1	GO:0016197; P:endosomal transport; NAS:UniProtKB
O15075	DCLK1	Serine/threonine-protein kinase DCLK1	GO:0030900; P:forebrain development; IEA:Ensembl
O15075	DCLK1	Serine/threonine-protein kinase DCLK1	GO:0007399; P:nervous system development; TAS:ProtInc
O15075	DCLK1	Serine/threonine-protein kinase DCLK1	GO:0001764; P:neuron migration; IEA:Ensembl
O15075	DCLK1	Serine/threonine-protein kinase DCLK1	GO:0006468; P:protein phosphorylation; TAS:ProtInc
O15075	DCLK1	Serine/threonine-protein kinase DCLK1	GO:0009615; P:response to virus; IEP:UniProtKB
Q8N568	DCLK2	Serine/threonine-protein kinase DCLK2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8N568	DCLK2	Serine/threonine-protein kinase DCLK2	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q8N568	DCLK2	Serine/threonine-protein kinase DCLK2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9C098	DCLK3	Serine/threonine-protein kinase DCLK3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9C098	DCLK3	Serine/threonine-protein kinase DCLK3	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
O95822	MLYCD	Malonyl-CoA decarboxylase, mitochondrial	GO:0050080; F:malonyl-CoA decarboxylase activity; IDA:UniProtKB
O95822	MLYCD	Malonyl-CoA decarboxylase, mitochondrial	GO:0005102; F:receptor binding; IPI:UniProtKB
O95822	MLYCD	Malonyl-CoA decarboxylase, mitochondrial	GO:0006085; P:acetyl-CoA biosynthetic process; IDA:UniProtKB
O95822	MLYCD	Malonyl-CoA decarboxylase, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O95822	MLYCD	Malonyl-CoA decarboxylase, mitochondrial	GO:0006633; P:fatty acid biosynthetic process; IDA:UniProtKB
O95822	MLYCD	Malonyl-CoA decarboxylase, mitochondrial	GO:2001294; P:malonyl-CoA catabolic process; IDA:UniProtKB
O95822	MLYCD	Malonyl-CoA decarboxylase, mitochondrial	GO:0046321; P:positive regulation of fatty acid oxidation; IMP:UniProtKB
O95822	MLYCD	Malonyl-CoA decarboxylase, mitochondrial	GO:0010906; P:regulation of glucose metabolic process; IMP:UniProtKB
O95822	MLYCD	Malonyl-CoA decarboxylase, mitochondrial	GO:0002931; P:response to ischemia; ISS:UniProtKB
O95822	MLYCD	Malonyl-CoA decarboxylase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8IWE4	DCUN1D3	DCN1-like protein 3	GO:0030308; P:negative regulation of cell growth; IMP:UniProtKB
Q8IWE4	DCUN1D3	DCN1-like protein 3	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q8IWE4	DCUN1D3	DCN1-like protein 3	GO:0010332; P:response to gamma radiation; IDA:UniProtKB
Q8IWE4	DCUN1D3	DCN1-like protein 3	GO:0010225; P:response to UV-C; IDA:UniProtKB
Q96GG9	DCUN1D1	DCN1-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q92564	DCUN1D4	DCN1-like protein 4	GO:0005515; F:protein binding; IPI:IntAct
P11926	ODC1	Ornithine decarboxylase	GO:0004586; F:ornithine decarboxylase activity; TAS:UniProtKB
P11926	ODC1	Ornithine decarboxylase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P11926	ODC1	Ornithine decarboxylase	GO:0001822; P:kidney development; IEA:Ensembl
P11926	ODC1	Ornithine decarboxylase	GO:0006595; P:polyamine metabolic process; TAS:Reactome
P11926	ODC1	Ornithine decarboxylase	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P11926	ODC1	Ornithine decarboxylase	GO:0033387; P:putrescine biosynthetic process from ornithine; IEA:UniProtKB-UniPathway
P11926	ODC1	Ornithine decarboxylase	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P11926	ODC1	Ornithine decarboxylase	GO:0009615; P:response to virus; IEP:UniProtKB
P11926	ODC1	Ornithine decarboxylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NPI6	DCP1A	mRNA-decapping enzyme 1A	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q9NPI6	DCP1A	mRNA-decapping enzyme 1A	GO:0042802; F:identical protein binding; IPI:IntAct
Q9NPI6	DCP1A	mRNA-decapping enzyme 1A	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NPI6	DCP1A	mRNA-decapping enzyme 1A	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
Q9NPI6	DCP1A	mRNA-decapping enzyme 1A	GO:0010467; P:gene expression; TAS:Reactome
Q9NPI6	DCP1A	mRNA-decapping enzyme 1A	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9NPI6	DCP1A	mRNA-decapping enzyme 1A	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q9NPI6	DCP1A	mRNA-decapping enzyme 1A	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IEA:UniProtKB-KW
Q9NPI6	DCP1A	mRNA-decapping enzyme 1A	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q8IZD4	DCP1B	mRNA-decapping enzyme 1B	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q8IZD4	DCP1B	mRNA-decapping enzyme 1B	GO:0005515; F:protein binding; IPI:IntAct
Q8IZD4	DCP1B	mRNA-decapping enzyme 1B	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
Q8IZD4	DCP1B	mRNA-decapping enzyme 1B	GO:0010467; P:gene expression; TAS:Reactome
Q8IZD4	DCP1B	mRNA-decapping enzyme 1B	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q8IZD4	DCP1B	mRNA-decapping enzyme 1B	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q8IZD4	DCP1B	mRNA-decapping enzyme 1B	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IEA:UniProtKB-KW
Q8IZD4	DCP1B	mRNA-decapping enzyme 1B	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q8IU60	DCP2	m7GpppN-mRNA hydrolase	GO:0016896; F:exoribonuclease activity, producing 5'-phosphomonoesters; TAS:Reactome
Q8IU60	DCP2	m7GpppN-mRNA hydrolase	GO:0050072; F:m7G(5')pppN diphosphatase activity; IDA:UniProtKB
Q8IU60	DCP2	m7GpppN-mRNA hydrolase	GO:0030145; F:manganese ion binding; IEA:InterPro
Q8IU60	DCP2	m7GpppN-mRNA hydrolase	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IU60	DCP2	m7GpppN-mRNA hydrolase	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q8IU60	DCP2	m7GpppN-mRNA hydrolase	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
Q8IU60	DCP2	m7GpppN-mRNA hydrolase	GO:0010467; P:gene expression; TAS:Reactome
Q8IU60	DCP2	m7GpppN-mRNA hydrolase	GO:0071044; P:histone mRNA catabolic process; IMP:UniProtKB
Q8IU60	DCP2	m7GpppN-mRNA hydrolase	GO:0006402; P:mRNA catabolic process; IDA:UniProtKB
Q8IU60	DCP2	m7GpppN-mRNA hydrolase	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q8IU60	DCP2	m7GpppN-mRNA hydrolase	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q8IU60	DCP2	m7GpppN-mRNA hydrolase	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IMP:UniProtKB
Q8IU60	DCP2	m7GpppN-mRNA hydrolase	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q8IU60	DCP2	m7GpppN-mRNA hydrolase	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; TAS:GOC
Q96C86	DCPS	m7GpppX diphosphatase	GO:0050072; F:m7G(5')pppN diphosphatase activity; IDA:UniProtKB
Q96C86	DCPS	m7GpppX diphosphatase	GO:0005515; F:protein binding; IPI:UniProtKB
Q96C86	DCPS	m7GpppX diphosphatase	GO:0000340; F:RNA 7-methylguanosine cap binding; IDA:UniProtKB
Q96C86	DCPS	m7GpppX diphosphatase	GO:0036245; P:cellular response to menadione; IDA:UniProtKB
Q96C86	DCPS	m7GpppX diphosphatase	GO:0000290; P:deadenylation-dependent decapping of nuclear-transcribed mRNA; IEA:InterPro
Q96C86	DCPS	m7GpppX diphosphatase	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
Q96C86	DCPS	m7GpppX diphosphatase	GO:0010467; P:gene expression; TAS:Reactome
Q96C86	DCPS	m7GpppX diphosphatase	GO:0045292; P:mRNA cis splicing, via spliceosome; IDA:UniProtKB
Q96C86	DCPS	m7GpppX diphosphatase	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q96C86	DCPS	m7GpppX diphosphatase	GO:0043069; P:negative regulation of programmed cell death; IDA:UniProtKB
Q96C86	DCPS	m7GpppX diphosphatase	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:UniProtKB
Q96C86	DCPS	m7GpppX diphosphatase	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q6PJP8	DCLRE1A	DNA cross-link repair 1A protein	GO:0016787; F:hydrolase activity; IEA:InterPro
Q6PJP8	DCLRE1A	DNA cross-link repair 1A protein	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q6PJP8	DCLRE1A	DNA cross-link repair 1A protein	GO:0006289; P:nucleotide-excision repair; IEA:Ensembl
Q9H816	DCLRE1B	5' exonuclease Apollo	GO:0008409; F:5'-3' exonuclease activity; IDA:UniProtKB
Q9H816	DCLRE1B	5' exonuclease Apollo	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H816	DCLRE1B	5' exonuclease Apollo	GO:0000075; P:cell cycle checkpoint; IMP:UniProtKB
Q9H816	DCLRE1B	5' exonuclease Apollo	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q9H816	DCLRE1B	5' exonuclease Apollo	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:GOC
Q9H816	DCLRE1B	5' exonuclease Apollo	GO:0031848; P:protection from non-homologous end joining at telomere; IMP:UniProtKB
Q9H816	DCLRE1B	5' exonuclease Apollo	GO:0000723; P:telomere maintenance; IMP:UniProtKB
Q9H816	DCLRE1B	5' exonuclease Apollo	GO:0031860; P:telomeric 3' overhang formation; ISS:UniProtKB
Q9H816	DCLRE1B	5' exonuclease Apollo	GO:0031627; P:telomeric loop formation; ISS:UniProtKB
Q96SD1	DCLRE1C	Protein artemis	GO:0008409; F:5'-3' exonuclease activity; IDA:MGI
Q96SD1	DCLRE1C	Protein artemis	GO:0000014; F:single-stranded DNA endodeoxyribonuclease activity; IDA:MGI
Q96SD1	DCLRE1C	Protein artemis	GO:0030183; P:B cell differentiation; IEA:Ensembl
Q96SD1	DCLRE1C	Protein artemis	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
Q96SD1	DCLRE1C	Protein artemis	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q96SD1	DCLRE1C	Protein artemis	GO:0006302; P:double-strand break repair; IEA:Ensembl
Q96SD1	DCLRE1C	Protein artemis	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:GOC
Q96SD1	DCLRE1C	Protein artemis	GO:0010212; P:response to ionizing radiation; IEA:Ensembl
Q96SD1	DCLRE1C	Protein artemis	GO:0000723; P:telomere maintenance; IEA:Ensembl
Q5T197	DCST1	DC-STAMP domain-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H295	DCSTAMP	Dendritic cell-specific transmembrane protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H295	DCSTAMP	Dendritic cell-specific transmembrane protein	GO:0071353; P:cellular response to interleukin-4; IDA:UniProtKB
Q9H295	DCSTAMP	Dendritic cell-specific transmembrane protein	GO:0036006; P:cellular response to macrophage colony-stimulating factor stimulus; ISS:UniProtKB
Q9H295	DCSTAMP	Dendritic cell-specific transmembrane protein	GO:0071356; P:cellular response to tumor necrosis factor; ISS:UniProtKB
Q9H295	DCSTAMP	Dendritic cell-specific transmembrane protein	GO:0061025; P:membrane fusion; ISS:UniProtKB
Q9H295	DCSTAMP	Dendritic cell-specific transmembrane protein	GO:0043011; P:myeloid dendritic cell differentiation; ISS:UniProtKB
Q9H295	DCSTAMP	Dendritic cell-specific transmembrane protein	GO:0030308; P:negative regulation of cell growth; ISS:UniProtKB
Q9H295	DCSTAMP	Dendritic cell-specific transmembrane protein	GO:0030316; P:osteoclast differentiation; ISS:UniProtKB
Q9H295	DCSTAMP	Dendritic cell-specific transmembrane protein	GO:0072675; P:osteoclast fusion; ISS:UniProtKB
Q9H295	DCSTAMP	Dendritic cell-specific transmembrane protein	GO:0045780; P:positive regulation of bone resorption; ISS:UniProtKB
Q9H295	DCSTAMP	Dendritic cell-specific transmembrane protein	GO:0034241; P:positive regulation of macrophage fusion; ISS:UniProtKB
Q9H295	DCSTAMP	Dendritic cell-specific transmembrane protein	GO:0045657; P:positive regulation of monocyte differentiation; ISS:UniProtKB
P32321	DCTD	Deoxycytidylate deaminase	GO:0004132; F:dCMP deaminase activity; EXP:Reactome
P32321	DCTD	Deoxycytidylate deaminase	GO:0008270; F:zinc ion binding; IEA:InterPro
P32321	DCTD	Deoxycytidylate deaminase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P32321	DCTD	Deoxycytidylate deaminase	GO:0009165; P:nucleotide biosynthetic process; IEA:UniProtKB-KW
P32321	DCTD	Deoxycytidylate deaminase	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
P32321	DCTD	Deoxycytidylate deaminase	GO:0046134; P:pyrimidine nucleoside biosynthetic process; TAS:Reactome
P32321	DCTD	Deoxycytidylate deaminase	GO:0006220; P:pyrimidine nucleotide metabolic process; TAS:ProtInc
P32321	DCTD	Deoxycytidylate deaminase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14203	DCTN1	Dynactin subunit 1	GO:0003774; F:motor activity; IEA:UniProtKB-KW
Q14203	DCTN1	Dynactin subunit 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q14203	DCTN1	Dynactin subunit 1	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q14203	DCTN1	Dynactin subunit 1	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q14203	DCTN1	Dynactin subunit 1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q14203	DCTN1	Dynactin subunit 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q14203	DCTN1	Dynactin subunit 1	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q14203	DCTN1	Dynactin subunit 1	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q14203	DCTN1	Dynactin subunit 1	GO:0007067; P:mitosis; NAS:ProtInc
Q14203	DCTN1	Dynactin subunit 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q14203	DCTN1	Dynactin subunit 1	GO:0007399; P:nervous system development; NAS:UniProtKB
Q14203	DCTN1	Dynactin subunit 1	GO:0006810; P:transport; IEA:UniProtKB-KW
Q13561	DCTN2	Dynactin subunit 2	GO:0003774; F:motor activity; IEA:UniProtKB-KW
Q13561	DCTN2	Dynactin subunit 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q13561	DCTN2	Dynactin subunit 2	GO:0030507; F:spectrin binding; IDA:MGI
Q13561	DCTN2	Dynactin subunit 2	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q13561	DCTN2	Dynactin subunit 2	GO:0008283; P:cell proliferation; IMP:UniProtKB
Q13561	DCTN2	Dynactin subunit 2	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q13561	DCTN2	Dynactin subunit 2	GO:0007067; P:mitosis; IMP:UniProtKB
Q13561	DCTN2	Dynactin subunit 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q13561	DCTN2	Dynactin subunit 2	GO:0007052; P:mitotic spindle organization; IEA:Ensembl
O75935	DCTN3	Dynactin subunit 3	GO:0005515; F:protein binding; IPI:UniProtKB
O75935	DCTN3	Dynactin subunit 3	GO:0005198; F:structural molecule activity; TAS:ProtInc
O75935	DCTN3	Dynactin subunit 3	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
O75935	DCTN3	Dynactin subunit 3	GO:0000910; P:cytokinesis; IDA:UniProtKB
O75935	DCTN3	Dynactin subunit 3	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
O75935	DCTN3	Dynactin subunit 3	GO:0007017; P:microtubule-based process; IEA:Ensembl
O75935	DCTN3	Dynactin subunit 3	GO:0007067; P:mitosis; TAS:ProtInc
O75935	DCTN3	Dynactin subunit 3	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9UJW0	DCTN4	Dynactin subunit 4	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q9UJW0	DCTN4	Dynactin subunit 4	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q9BTE1	DCTN5	Dynactin subunit 5	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
O00399	DCTN6	Dynactin subunit 6	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q9H773	DCTPP1	dCTP pyrophosphatase 1	GO:0047840; F:dCTP diphosphatase activity; IEA:UniProtKB-EC
Q9H773	DCTPP1	dCTP pyrophosphatase 1	GO:0000287; F:magnesium ion binding; ISS:UniProtKB
Q9H773	DCTPP1	dCTP pyrophosphatase 1	GO:0047429; F:nucleoside-triphosphate diphosphatase activity; ISS:UniProtKB
Q9H773	DCTPP1	dCTP pyrophosphatase 1	GO:0032556; F:pyrimidine deoxyribonucleotide binding; IEA:Ensembl
Q9H773	DCTPP1	dCTP pyrophosphatase 1	GO:0009143; P:nucleoside triphosphate catabolic process; ISS:UniProtKB
Q9H773	DCTPP1	dCTP pyrophosphatase 1	GO:0051289; P:protein homotetramerization; IEA:Ensembl
P06132	UROD	Uroporphyrinogen decarboxylase	GO:0004853; F:uroporphyrinogen decarboxylase activity; IDA:UniProtKB
P06132	UROD	Uroporphyrinogen decarboxylase	GO:0006783; P:heme biosynthetic process; IC:UniProtKB
P06132	UROD	Uroporphyrinogen decarboxylase	GO:0006778; P:porphyrin-containing compound metabolic process; TAS:Reactome
P06132	UROD	Uroporphyrinogen decarboxylase	GO:0006782; P:protoporphyrinogen IX biosynthetic process; IEA:UniProtKB-UniPathway
P06132	UROD	Uroporphyrinogen decarboxylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q7Z4W1	DCXR	L-xylulose reductase	GO:0050038; F:L-xylulose reductase (NADP+) activity; IDA:UniProtKB
Q7Z4W1	DCXR	L-xylulose reductase	GO:0016655; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; IDA:UniProtKB
Q7Z4W1	DCXR	L-xylulose reductase	GO:0042732; P:D-xylose metabolic process; IEA:UniProtKB-KW
Q7Z4W1	DCXR	L-xylulose reductase	GO:0006006; P:glucose metabolic process; IDA:UniProtKB
Q7Z4W1	DCXR	L-xylulose reductase	GO:0006739; P:NADP metabolic process; IEA:Ensembl
Q7Z4W1	DCXR	L-xylulose reductase	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q7Z4W1	DCXR	L-xylulose reductase	GO:0051289; P:protein homotetramerization; IDA:UniProtKB
Q7Z4W1	DCXR	L-xylulose reductase	GO:0005997; P:xylulose metabolic process; IDA:UniProtKB
O43602	DCX	Neuronal migration protein doublecortin	GO:0008017; F:microtubule binding; IDA:UniProtKB
O43602	DCX	Neuronal migration protein doublecortin	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O43602	DCX	Neuronal migration protein doublecortin	GO:0048675; P:axon extension; IEA:Ensembl
O43602	DCX	Neuronal migration protein doublecortin	GO:0007411; P:axon guidance; TAS:Reactome
O43602	DCX	Neuronal migration protein doublecortin	GO:0007420; P:brain development; IEA:Ensembl
O43602	DCX	Neuronal migration protein doublecortin	GO:0007417; P:central nervous system development; TAS:ProtInc
O43602	DCX	Neuronal migration protein doublecortin	GO:0021952; P:central nervous system projection neuron axonogenesis; IEA:Ensembl
O43602	DCX	Neuronal migration protein doublecortin	GO:0048813; P:dendrite morphogenesis; IEA:Ensembl
O43602	DCX	Neuronal migration protein doublecortin	GO:0035556; P:intracellular signal transduction; IEA:InterPro
O43602	DCX	Neuronal migration protein doublecortin	GO:0007399; P:nervous system development; TAS:ProtInc
O43602	DCX	Neuronal migration protein doublecortin	GO:0001764; P:neuron migration; IDA:UniProtKB
Q9NUU7	DDX19A	ATP-dependent RNA helicase DDX19A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NUU7	DDX19A	ATP-dependent RNA helicase DDX19A	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q9NUU7	DDX19A	ATP-dependent RNA helicase DDX19A	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9NUU7	DDX19A	ATP-dependent RNA helicase DDX19A	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q9NUU7	DDX19A	ATP-dependent RNA helicase DDX19A	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q9NUU7	DDX19A	ATP-dependent RNA helicase DDX19A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9NUU7	DDX19A	ATP-dependent RNA helicase DDX19A	GO:0010043; P:response to zinc ion; IEA:Ensembl
Q9UMR2	DDX19B	ATP-dependent RNA helicase DDX19B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UMR2	DDX19B	ATP-dependent RNA helicase DDX19B	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q9UMR2	DDX19B	ATP-dependent RNA helicase DDX19B	GO:0004386; F:helicase activity; TAS:ProtInc
Q9UMR2	DDX19B	ATP-dependent RNA helicase DDX19B	GO:0003723; F:RNA binding; TAS:ProtInc
Q9UMR2	DDX19B	ATP-dependent RNA helicase DDX19B	GO:0006406; P:mRNA export from nucleus; TAS:ProtInc
Q9UMR2	DDX19B	ATP-dependent RNA helicase DDX19B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O94760	DDAH1	N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	GO:0016597; F:amino acid binding; IEA:Ensembl
O94760	DDAH1	N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	GO:0003824; F:catalytic activity; TAS:ProtInc
O94760	DDAH1	N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	GO:0016403; F:dimethylargininase activity; IDA:UniProtKB
O94760	DDAH1	N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O94760	DDAH1	N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	GO:0006527; P:arginine catabolic process; TAS:ProtInc
O94760	DDAH1	N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	GO:0000052; P:citrulline metabolic process; IDA:UniProtKB
O94760	DDAH1	N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	GO:0007263; P:nitric oxide mediated signal transduction; TAS:ProtInc
O94760	DDAH1	N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
O94760	DDAH1	N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; ISS:BHF-UCL
O94760	DDAH1	N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	GO:0003073; P:regulation of systemic arterial blood pressure; ISS:BHF-UCL
O95865	DDAH2	N(G),N(G)-dimethylarginine dimethylaminohydrolase 2	GO:0016597; F:amino acid binding; IEA:Ensembl
O95865	DDAH2	N(G),N(G)-dimethylarginine dimethylaminohydrolase 2	GO:0003824; F:catalytic activity; TAS:ProtInc
O95865	DDAH2	N(G),N(G)-dimethylarginine dimethylaminohydrolase 2	GO:0016403; F:dimethylargininase activity; IDA:UniProtKB
O95865	DDAH2	N(G),N(G)-dimethylarginine dimethylaminohydrolase 2	GO:0005515; F:protein binding; IPI:IntAct
O95865	DDAH2	N(G),N(G)-dimethylarginine dimethylaminohydrolase 2	GO:0006527; P:arginine catabolic process; TAS:ProtInc
O95865	DDAH2	N(G),N(G)-dimethylarginine dimethylaminohydrolase 2	GO:0000052; P:citrulline metabolic process; IDA:UniProtKB
O95865	DDAH2	N(G),N(G)-dimethylarginine dimethylaminohydrolase 2	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
O95865	DDAH2	N(G),N(G)-dimethylarginine dimethylaminohydrolase 2	GO:0006809; P:nitric oxide biosynthetic process; TAS:ProtInc
O95865	DDAH2	N(G),N(G)-dimethylarginine dimethylaminohydrolase 2	GO:0007263; P:nitric oxide mediated signal transduction; TAS:ProtInc
O95865	DDAH2	N(G),N(G)-dimethylarginine dimethylaminohydrolase 2	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; ISS:BHF-UCL
Q16531	DDB1	DNA damage-binding protein 1	GO:0003684; F:damaged DNA binding; TAS:ProtInc
Q16531	DDB1	DNA damage-binding protein 1	GO:0003677; F:DNA binding; TAS:ProtInc
Q16531	DDB1	DNA damage-binding protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q16531	DDB1	DNA damage-binding protein 1	GO:0006281; P:DNA repair; TAS:Reactome
Q16531	DDB1	DNA damage-binding protein 1	GO:0035518; P:histone H2A monoubiquitination; IDA:UniProt
Q16531	DDB1	DNA damage-binding protein 1	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
Q16531	DDB1	DNA damage-binding protein 1	GO:0000718; P:nucleotide-excision repair, DNA damage removal; TAS:Reactome
Q16531	DDB1	DNA damage-binding protein 1	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q16531	DDB1	DNA damage-binding protein 1	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q16531	DDB1	DNA damage-binding protein 1	GO:1901990; P:regulation of mitotic cell cycle phase transition; IMP:UniProtKB
Q16531	DDB1	DNA damage-binding protein 1	GO:0070914; P:UV-damage excision repair; IDA:UniProt
Q16531	DDB1	DNA damage-binding protein 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q16531	DDB1	DNA damage-binding protein 1	GO:0016055; P:Wnt signaling pathway; IEA:Ensembl
Q92466	DDB2	DNA damage-binding protein 2	GO:0003684; F:damaged DNA binding; TAS:ProtInc
Q92466	DDB2	DNA damage-binding protein 2	GO:0003677; F:DNA binding; TAS:ProtInc
Q92466	DDB2	DNA damage-binding protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q92466	DDB2	DNA damage-binding protein 2	GO:0006281; P:DNA repair; TAS:Reactome
Q92466	DDB2	DNA damage-binding protein 2	GO:0035518; P:histone H2A monoubiquitination; IDA:UniProt
Q92466	DDB2	DNA damage-binding protein 2	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
Q92466	DDB2	DNA damage-binding protein 2	GO:0000718; P:nucleotide-excision repair, DNA damage removal; TAS:Reactome
Q92466	DDB2	DNA damage-binding protein 2	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
Q92466	DDB2	DNA damage-binding protein 2	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q92466	DDB2	DNA damage-binding protein 2	GO:0006290; P:pyrimidine dimer repair; IEA:Ensembl
Q92466	DDB2	DNA damage-binding protein 2	GO:0009411; P:response to UV; IDA:UniProtKB
Q92466	DDB2	DNA damage-binding protein 2	GO:0070914; P:UV-damage excision repair; IDA:UniProt
P20711	DDC	Aromatic-L-amino-acid decarboxylase	GO:0016597; F:amino acid binding; IEA:Ensembl
P20711	DDC	Aromatic-L-amino-acid decarboxylase	GO:0004058; F:aromatic-L-amino-acid decarboxylase activity; IDA:UniProtKB
P20711	DDC	Aromatic-L-amino-acid decarboxylase	GO:0005515; F:protein binding; IPI:IntAct
P20711	DDC	Aromatic-L-amino-acid decarboxylase	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
P20711	DDC	Aromatic-L-amino-acid decarboxylase	GO:0042423; P:catecholamine biosynthetic process; TAS:Reactome
P20711	DDC	Aromatic-L-amino-acid decarboxylase	GO:0006520; P:cellular amino acid metabolic process; IEA:InterPro
P20711	DDC	Aromatic-L-amino-acid decarboxylase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P20711	DDC	Aromatic-L-amino-acid decarboxylase	GO:0071312; P:cellular response to alkaloid; IEA:Ensembl
P20711	DDC	Aromatic-L-amino-acid decarboxylase	GO:0035690; P:cellular response to drug; IEA:Ensembl
P20711	DDC	Aromatic-L-amino-acid decarboxylase	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P20711	DDC	Aromatic-L-amino-acid decarboxylase	GO:0007623; P:circadian rhythm; IEA:Ensembl
P20711	DDC	Aromatic-L-amino-acid decarboxylase	GO:0042416; P:dopamine biosynthetic process; IEA:UniProtKB-UniPathway
P20711	DDC	Aromatic-L-amino-acid decarboxylase	GO:0046219; P:indolalkylamine biosynthetic process; TAS:Reactome
P20711	DDC	Aromatic-L-amino-acid decarboxylase	GO:0033076; P:isoquinoline alkaloid metabolic process; IEA:Ensembl
P20711	DDC	Aromatic-L-amino-acid decarboxylase	GO:0010259; P:multicellular organismal aging; IEA:Ensembl
P20711	DDC	Aromatic-L-amino-acid decarboxylase	GO:0052314; P:phytoalexin metabolic process; IEA:Ensembl
P20711	DDC	Aromatic-L-amino-acid decarboxylase	GO:0046684; P:response to pyrethroid; IEA:Ensembl
P20711	DDC	Aromatic-L-amino-acid decarboxylase	GO:0042427; P:serotonin biosynthetic process; IEA:Ensembl
P20711	DDC	Aromatic-L-amino-acid decarboxylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P20711	DDC	Aromatic-L-amino-acid decarboxylase	GO:0015842; P:synaptic vesicle amine transport; IEA:Ensembl
Q8NEL9	DDHD1	Phospholipase DDHD1	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q8NEL9	DDHD1	Phospholipase DDHD1	GO:0046872; F:metal ion binding; IEA:InterPro
Q8NEL9	DDHD1	Phospholipase DDHD1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q8NEL9	DDHD1	Phospholipase DDHD1	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
O94830	DDHD2	Phospholipase DDHD2	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
O94830	DDHD2	Phospholipase DDHD2	GO:0046872; F:metal ion binding; IEA:InterPro
O94830	DDHD2	Phospholipase DDHD2	GO:0008219; P:cell death; IEA:UniProtKB-KW
O94830	DDHD2	Phospholipase DDHD2	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q8WTU0	DDI1	Protein DDI1 homolog 1	GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro
Q5TDH0	DDI2	Protein DDI1 homolog 2	GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0003677; F:DNA binding; IDA:UniProtKB
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0005515; F:protein binding; IPI:UniProtKB
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0001955; P:blood vessel maturation; IEA:Ensembl
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0007050; P:cell cycle arrest; IEA:UniProtKB-KW
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0045454; P:cell redox homeostasis; IDA:MGI
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0006974; P:cellular response to DNA damage stimulus; TAS:ProtInc
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0006983; P:ER overload response; IEA:Ensembl
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IDA:UniProtKB
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0042789; P:mRNA transcription from RNA polymerase II promoter; IDA:MGI
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISS:BHF-UCL
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:2000016; P:negative regulation of determination of dorsal identity; IDA:BHF-UCL
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0045662; P:negative regulation of myoblast differentiation; IEA:Ensembl
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0032757; P:positive regulation of interleukin-8 production; IMP:UniProtKB
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0043620; P:regulation of DNA-templated transcription in response to stress; TAS:BHF-UCL
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0044324; P:regulation of transcription involved in anterior/posterior axis specification; ISS:BHF-UCL
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0051209; P:release of sequestered calcium ion into cytosol; IEA:Ensembl
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0042594; P:response to starvation; IEA:Ensembl
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0006986; P:response to unfolded protein; IDA:UniProtKB
P35638	DDIT3	DNA damage-inducible transcript 3 protein	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9NX09	DDIT4	DNA damage-inducible transcript 4 protein	GO:0007420; P:brain development; ISS:UniProtKB
Q9NX09	DDIT4	DNA damage-inducible transcript 4 protein	GO:0008283; P:cell proliferation; ISS:UniProtKB
Q9NX09	DDIT4	DNA damage-inducible transcript 4 protein	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q9NX09	DDIT4	DNA damage-inducible transcript 4 protein	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; ISS:UniProtKB
Q9NX09	DDIT4	DNA damage-inducible transcript 4 protein	GO:0045820; P:negative regulation of glycolytic process; IEA:Ensembl
Q9NX09	DDIT4	DNA damage-inducible transcript 4 protein	GO:1902532; P:negative regulation of intracellular signal transduction; ISS:UniProtKB
Q9NX09	DDIT4	DNA damage-inducible transcript 4 protein	GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; ISS:UniProtKB
Q9NX09	DDIT4	DNA damage-inducible transcript 4 protein	GO:0010801; P:negative regulation of peptidyl-threonine phosphorylation; ISS:UniProtKB
Q9NX09	DDIT4	DNA damage-inducible transcript 4 protein	GO:0032007; P:negative regulation of TOR signaling; IMP:UniProtKB
Q9NX09	DDIT4	DNA damage-inducible transcript 4 protein	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q9NX09	DDIT4	DNA damage-inducible transcript 4 protein	GO:0001764; P:neuron migration; ISS:UniProtKB
Q9NX09	DDIT4	DNA damage-inducible transcript 4 protein	GO:0048011; P:neurotrophin TRK receptor signaling pathway; ISS:UniProtKB
Q9NX09	DDIT4	DNA damage-inducible transcript 4 protein	GO:1901216; P:positive regulation of neuron death; ISS:UniProtKB
Q9NX09	DDIT4	DNA damage-inducible transcript 4 protein	GO:0043241; P:protein complex disassembly; IEA:Ensembl
Q9NX09	DDIT4	DNA damage-inducible transcript 4 protein	GO:0072593; P:reactive oxygen species metabolic process; IEA:Ensembl
Q9NX09	DDIT4	DNA damage-inducible transcript 4 protein	GO:0001666; P:response to hypoxia; IDA:UniProtKB
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0005518; F:collagen binding; IDA:UniProtKB
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0038062; F:protein tyrosine kinase collagen receptor activity; IDA:UniProtKB
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; TAS:ProtInc
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0060444; P:branching involved in mammary gland duct morphogenesis; IEA:Ensembl
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0007155; P:cell adhesion; TAS:ProtInc
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0038063; P:collagen-activated tyrosine kinase receptor signaling pathway; IDA:UniProtKB
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0043583; P:ear development; IEA:Ensembl
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0007566; P:embryo implantation; IEA:Ensembl
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0007595; P:lactation; IEA:UniProtKB-KW
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0060749; P:mammary gland alveolus development; IEA:Ensembl
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0038083; P:peptidyl-tyrosine autophosphorylation; IDA:UniProtKB
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0001558; P:regulation of cell growth; IEA:Ensembl
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0001952; P:regulation of cell-matrix adhesion; IEA:Ensembl
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0010715; P:regulation of extracellular matrix disassembly; IMP:UniProtKB
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0014909; P:smooth muscle cell migration; IMP:UniProtKB
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0061302; P:smooth muscle cell-matrix adhesion; IMP:UniProtKB
Q08345	DDR1	Epithelial discoidin domain-containing receptor 1	GO:0044319; P:wound healing, spreading of cells; IMP:UniProtKB
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0005518; F:collagen binding; IDA:UniProtKB
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0005515; F:protein binding; IPI:IntAct
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0038062; F:protein tyrosine kinase collagen receptor activity; IDA:UniProtKB
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IDA:UniProtKB
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0031214; P:biomineral tissue development; ISS:UniProtKB
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0007155; P:cell adhesion; TAS:ProtInc
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0035988; P:chondrocyte proliferation; ISS:UniProtKB
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0030199; P:collagen fibril organization; ISS:UniProtKB
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0038063; P:collagen-activated tyrosine kinase receptor signaling pathway; IDA:UniProtKB
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0003416; P:endochondral bone growth; ISS:UniProtKB
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0001503; P:ossification; IEA:UniProtKB-KW
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0090091; P:positive regulation of extracellular matrix disassembly; ISS:UniProtKB
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0010763; P:positive regulation of fibroblast migration; ISS:UniProtKB
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0048146; P:positive regulation of fibroblast proliferation; ISS:UniProtKB
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0045669; P:positive regulation of osteoblast differentiation; IMP:UniProtKB
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0045860; P:positive regulation of protein kinase activity; IMP:UniProtKB
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:UniProtKB
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0030500; P:regulation of bone mineralization; IMP:UniProtKB
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0010715; P:regulation of extracellular matrix disassembly; TAS:UniProtKB
Q16832	DDR2	Discoidin domain-containing receptor 2	GO:0007165; P:signal transduction; TAS:ProtInc
Q96HY6	DDRGK1	DDRGK domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96D03	DDIT4L	DNA damage-inducible transcript 4-like protein	GO:0009968; P:negative regulation of signal transduction; IEA:InterPro
A6NHG4	DDTL	D-dopachrome decarboxylase-like protein	GO:0016829; F:lyase activity; IEA:UniProtKB-KW
Q13206	DDX10	Probable ATP-dependent RNA helicase DDX10	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13206	DDX10	Probable ATP-dependent RNA helicase DDX10	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q13206	DDX10	Probable ATP-dependent RNA helicase DDX10	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13206	DDX10	Probable ATP-dependent RNA helicase DDX10	GO:0003724; F:RNA helicase activity; TAS:ProtInc
Q13206	DDX10	Probable ATP-dependent RNA helicase DDX10	GO:0008152; P:metabolic process; TAS:GOC
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0004003; F:ATP-dependent DNA helicase activity; IEA:InterPro
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0003678; F:DNA helicase activity; TAS:ProtInc
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0008094; F:DNA-dependent ATPase activity; IDA:UniProtKB
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0004386; F:helicase activity; IDA:UniProtKB
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0005515; F:protein binding; IPI:UniProtKB
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0006200; P:ATP catabolic process; IDA:GOC
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0032508; P:DNA duplex unwinding; TAS:GOC
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:ProtInc
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0000084; P:mitotic S phase; TAS:ProtInc
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0000070; P:mitotic sister chromatid segregation; TAS:ProtInc
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0007062; P:sister chromatid cohesion; IDA:UniProtKB
Q96FC9	DDX11	Probable ATP-dependent RNA helicase DDX11	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q92771	DDX12P	Putative ATP-dependent RNA helicase DDX12	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q92771	DDX12P	Putative ATP-dependent RNA helicase DDX12	GO:0004003; F:ATP-dependent DNA helicase activity; IEA:InterPro
Q92771	DDX12P	Putative ATP-dependent RNA helicase DDX12	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q92771	DDX12P	Putative ATP-dependent RNA helicase DDX12	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q92771	DDX12P	Putative ATP-dependent RNA helicase DDX12	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q92841	DDX17	Probable ATP-dependent RNA helicase DDX17	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q92841	DDX17	Probable ATP-dependent RNA helicase DDX17	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q92841	DDX17	Probable ATP-dependent RNA helicase DDX17	GO:0030331; F:estrogen receptor binding; IDA:UniProtKB
Q92841	DDX17	Probable ATP-dependent RNA helicase DDX17	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q92841	DDX17	Probable ATP-dependent RNA helicase DDX17	GO:0005515; F:protein binding; IPI:UniProtKB
Q92841	DDX17	Probable ATP-dependent RNA helicase DDX17	GO:0003723; F:RNA binding; TAS:ProtInc
Q92841	DDX17	Probable ATP-dependent RNA helicase DDX17	GO:0003724; F:RNA helicase activity; TAS:ProtInc
Q92841	DDX17	Probable ATP-dependent RNA helicase DDX17	GO:0008186; F:RNA-dependent ATPase activity; TAS:ProtInc
Q92841	DDX17	Probable ATP-dependent RNA helicase DDX17	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q92841	DDX17	Probable ATP-dependent RNA helicase DDX17	GO:0006200; P:ATP catabolic process; TAS:GOC
Q92841	DDX17	Probable ATP-dependent RNA helicase DDX17	GO:0033148; P:positive regulation of intracellular estrogen receptor signaling pathway; IDA:UniProtKB
Q92841	DDX17	Probable ATP-dependent RNA helicase DDX17	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q92841	DDX17	Probable ATP-dependent RNA helicase DDX17	GO:2001014; P:regulation of skeletal muscle cell differentiation; IMP:UniProtKB
Q92841	DDX17	Probable ATP-dependent RNA helicase DDX17	GO:0006396; P:RNA processing; TAS:ProtInc
Q92841	DDX17	Probable ATP-dependent RNA helicase DDX17	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NVP1	DDX18	ATP-dependent RNA helicase DDX18	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NVP1	DDX18	ATP-dependent RNA helicase DDX18	GO:0004004; F:ATP-dependent RNA helicase activity; TAS:ProtInc
Q9NVP1	DDX18	ATP-dependent RNA helicase DDX18	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NVP1	DDX18	ATP-dependent RNA helicase DDX18	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NVP1	DDX18	ATP-dependent RNA helicase DDX18	GO:0006200; P:ATP catabolic process; TAS:GOC
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0008026; F:ATP-dependent helicase activity; IDA:UniProtKB
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0033677; F:DNA/RNA helicase activity; IDA:UniProtKB
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0003725; F:double-stranded RNA binding; IEA:Ensembl
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0004527; F:exonuclease activity; IEA:UniProtKB-KW
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0004518; F:nuclease activity; IDA:UniProtKB
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0008143; F:poly(A) binding; IDA:UniProtKB
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0005515; F:protein binding; IPI:UniProtKB
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0003724; F:RNA helicase activity; TAS:ProtInc
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0003712; F:transcription cofactor activity; IDA:UniProtKB
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0006200; P:ATP catabolic process; IDA:GOC
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0032508; P:DNA duplex unwinding; IDA:UniProtKB
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0006302; P:double-strand break repair; IDA:UniProtKB
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0007275; P:multicellular organismal development; IEP:UniProtKB
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:GOC
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0006446; P:regulation of translational initiation; NAS:UniProtKB
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0043330; P:response to exogenous dsRNA; IEA:Ensembl
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0009615; P:response to virus; IEA:Ensembl
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0000245; P:spliceosomal complex assembly; NAS:UniProtKB
Q92499	DDX1	ATP-dependent RNA helicase DDX1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UHI6	DDX20	Probable ATP-dependent RNA helicase DDX20	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UHI6	DDX20	Probable ATP-dependent RNA helicase DDX20	GO:0004004; F:ATP-dependent RNA helicase activity; TAS:ProtInc
Q9UHI6	DDX20	Probable ATP-dependent RNA helicase DDX20	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UHI6	DDX20	Probable ATP-dependent RNA helicase DDX20	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UHI6	DDX20	Probable ATP-dependent RNA helicase DDX20	GO:0006200; P:ATP catabolic process; TAS:GOC
Q9UHI6	DDX20	Probable ATP-dependent RNA helicase DDX20	GO:0010467; P:gene expression; TAS:Reactome
Q9UHI6	DDX20	Probable ATP-dependent RNA helicase DDX20	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
Q9UHI6	DDX20	Probable ATP-dependent RNA helicase DDX20	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UHI6	DDX20	Probable ATP-dependent RNA helicase DDX20	GO:0048477; P:oogenesis; IEA:Ensembl
Q9UHI6	DDX20	Probable ATP-dependent RNA helicase DDX20	GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB
Q9UHI6	DDX20	Probable ATP-dependent RNA helicase DDX20	GO:0050810; P:regulation of steroid biosynthetic process; IEA:Ensembl
Q9UHI6	DDX20	Probable ATP-dependent RNA helicase DDX20	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9UHI6	DDX20	Probable ATP-dependent RNA helicase DDX20	GO:0006396; P:RNA processing; TAS:ProtInc
Q9UHI6	DDX20	Probable ATP-dependent RNA helicase DDX20	GO:0000387; P:spliceosomal snRNP assembly; IDA:UniProtKB
Q9UHI6	DDX20	Probable ATP-dependent RNA helicase DDX20	GO:0000244; P:spliceosomal tri-snRNP complex assembly; TAS:ProtInc
Q9NR30	DDX21	Nucleolar RNA helicase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NR30	DDX21	Nucleolar RNA helicase 2	GO:0004004; F:ATP-dependent RNA helicase activity; TAS:ProtInc
Q9NR30	DDX21	Nucleolar RNA helicase 2	GO:0003725; F:double-stranded RNA binding; IEA:Ensembl
Q9NR30	DDX21	Nucleolar RNA helicase 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NR30	DDX21	Nucleolar RNA helicase 2	GO:0006200; P:ATP catabolic process; TAS:GOC
Q9NR30	DDX21	Nucleolar RNA helicase 2	GO:0043330; P:response to exogenous dsRNA; IEA:Ensembl
Q9NR30	DDX21	Nucleolar RNA helicase 2	GO:0009615; P:response to virus; IEA:Ensembl
Q9BUQ8	DDX23	Probable ATP-dependent RNA helicase DDX23	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BUQ8	DDX23	Probable ATP-dependent RNA helicase DDX23	GO:0004004; F:ATP-dependent RNA helicase activity; TAS:ProtInc
Q9BUQ8	DDX23	Probable ATP-dependent RNA helicase DDX23	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BUQ8	DDX23	Probable ATP-dependent RNA helicase DDX23	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BUQ8	DDX23	Probable ATP-dependent RNA helicase DDX23	GO:0006200; P:ATP catabolic process; TAS:GOC
Q9BUQ8	DDX23	Probable ATP-dependent RNA helicase DDX23	GO:0000354; P:cis assembly of pre-catalytic spliceosome; IC:HGNC
Q9BUQ8	DDX23	Probable ATP-dependent RNA helicase DDX23	GO:0010467; P:gene expression; TAS:Reactome
Q9BUQ8	DDX23	Probable ATP-dependent RNA helicase DDX23	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q9BUQ8	DDX23	Probable ATP-dependent RNA helicase DDX23	GO:0008380; P:RNA splicing; TAS:Reactome
Q9BUQ8	DDX23	Probable ATP-dependent RNA helicase DDX23	GO:0000375; P:RNA splicing, via transesterification reactions; TAS:UniProtKB
Q9GZR7	DDX24	ATP-dependent RNA helicase DDX24	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9GZR7	DDX24	ATP-dependent RNA helicase DDX24	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q9GZR7	DDX24	ATP-dependent RNA helicase DDX24	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9GZR7	DDX24	ATP-dependent RNA helicase DDX24	GO:0003724; F:RNA helicase activity; NAS:UniProtKB
Q9GZR7	DDX24	ATP-dependent RNA helicase DDX24	GO:0016070; P:RNA metabolic process; NAS:UniProtKB
Q9UHL0	DDX25	ATP-dependent RNA helicase DDX25	GO:0005524; F:ATP binding; ISS:UniProtKB
Q9UHL0	DDX25	ATP-dependent RNA helicase DDX25	GO:0004004; F:ATP-dependent RNA helicase activity; ISS:UniProtKB
Q9UHL0	DDX25	ATP-dependent RNA helicase DDX25	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9UHL0	DDX25	ATP-dependent RNA helicase DDX25	GO:0006200; P:ATP catabolic process; ISS:GOC
Q9UHL0	DDX25	ATP-dependent RNA helicase DDX25	GO:0006406; P:mRNA export from nucleus; ISS:UniProtKB
Q9UHL0	DDX25	ATP-dependent RNA helicase DDX25	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9UHL0	DDX25	ATP-dependent RNA helicase DDX25	GO:0006417; P:regulation of translation; ISS:UniProtKB
Q9UHL0	DDX25	ATP-dependent RNA helicase DDX25	GO:0007286; P:spermatid development; ISS:UniProtKB
Q9NUL7	DDX28	Probable ATP-dependent RNA helicase DDX28	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NUL7	DDX28	Probable ATP-dependent RNA helicase DDX28	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q9NUL7	DDX28	Probable ATP-dependent RNA helicase DDX28	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96GQ7	DDX27	Probable ATP-dependent RNA helicase DDX27	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96GQ7	DDX27	Probable ATP-dependent RNA helicase DDX27	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q96GQ7	DDX27	Probable ATP-dependent RNA helicase DDX27	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H8H2	DDX31	Probable ATP-dependent RNA helicase DDX31	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H8H2	DDX31	Probable ATP-dependent RNA helicase DDX31	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q9H8H2	DDX31	Probable ATP-dependent RNA helicase DDX31	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0004003; F:ATP-dependent DNA helicase activity; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0004004; F:ATP-dependent RNA helicase activity; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0016887; F:ATPase activity; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0003677; F:DNA binding; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0008190; F:eukaryotic initiation factor 4E binding; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0048027; F:mRNA 5'-UTR binding; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0008143; F:poly(A) binding; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0005515; F:protein binding; IPI:IntAct
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0043024; F:ribosomal small subunit binding; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0003723; F:RNA binding; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0035613; F:RNA stem-loop binding; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0008134; F:transcription factor binding; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0031369; F:translation initiation factor binding; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0006200; P:ATP catabolic process; IDA:GOC
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0071243; P:cellular response to arsenic-containing substance; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0071470; P:cellular response to osmotic stress; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0007059; P:chromosome segregation; IMP:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0032508; P:DNA duplex unwinding; IDA:GOC
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IMP:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0045087; P:innate immune response; IMP:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0097193; P:intrinsic apoptotic signaling pathway; IMP:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0042256; P:mature ribosome assembly; IMP:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0031333; P:negative regulation of protein complex assembly; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0017148; P:negative regulation of translation; IMP:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0030307; P:positive regulation of cell growth; IMP:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0071651; P:positive regulation of chemokine (C-C motif) ligand 5 production; TAS:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IMP:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0032728; P:positive regulation of interferon-beta production; TAS:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0045727; P:positive regulation of translation; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0045948; P:positive regulation of translational initiation; IMP:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0009615; P:response to virus; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0010501; P:RNA secondary structure unwinding; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0034063; P:stress granule assembly; IDA:UniProtKB
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O00571	DDX3X	ATP-dependent RNA helicase DDX3X	GO:0016032; P:viral process; IEA:UniProtKB-KW
O15523	DDX3Y	ATP-dependent RNA helicase DDX3Y	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O15523	DDX3Y	ATP-dependent RNA helicase DDX3Y	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
O15523	DDX3Y	ATP-dependent RNA helicase DDX3Y	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O15523	DDX3Y	ATP-dependent RNA helicase DDX3Y	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9UJV9	DDX41	Probable ATP-dependent RNA helicase DDX41	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UJV9	DDX41	Probable ATP-dependent RNA helicase DDX41	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q9UJV9	DDX41	Probable ATP-dependent RNA helicase DDX41	GO:0003677; F:DNA binding; IEA:Ensembl
Q9UJV9	DDX41	Probable ATP-dependent RNA helicase DDX41	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UJV9	DDX41	Probable ATP-dependent RNA helicase DDX41	GO:0005515; F:protein binding; IPI:IntAct
Q9UJV9	DDX41	Probable ATP-dependent RNA helicase DDX41	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UJV9	DDX41	Probable ATP-dependent RNA helicase DDX41	GO:0006915; P:apoptotic process; TAS:ProtInc
Q9UJV9	DDX41	Probable ATP-dependent RNA helicase DDX41	GO:0035458; P:cellular response to interferon-beta; IEA:Ensembl
Q9UJV9	DDX41	Probable ATP-dependent RNA helicase DDX41	GO:0051607; P:defense response to virus; IEA:Ensembl
Q9UJV9	DDX41	Probable ATP-dependent RNA helicase DDX41	GO:0045087; P:innate immune response; TAS:Reactome
Q9UJV9	DDX41	Probable ATP-dependent RNA helicase DDX41	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q9UJV9	DDX41	Probable ATP-dependent RNA helicase DDX41	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q9UJV9	DDX41	Probable ATP-dependent RNA helicase DDX41	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UJV9	DDX41	Probable ATP-dependent RNA helicase DDX41	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q9UJV9	DDX41	Probable ATP-dependent RNA helicase DDX41	GO:0032479; P:regulation of type I interferon production; TAS:Reactome
Q9UJV9	DDX41	Probable ATP-dependent RNA helicase DDX41	GO:0006396; P:RNA processing; TAS:ProtInc
Q86XP3	DDX42	ATP-dependent RNA helicase DDX42	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86XP3	DDX42	ATP-dependent RNA helicase DDX42	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q86XP3	DDX42	ATP-dependent RNA helicase DDX42	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q86XP3	DDX42	ATP-dependent RNA helicase DDX42	GO:0005515; F:protein binding; IPI:UniProtKB
Q86XP3	DDX42	ATP-dependent RNA helicase DDX42	GO:0008104; P:protein localization; IDA:UniProtKB
Q9NXZ2	DDX43	Probable ATP-dependent RNA helicase DDX43	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NXZ2	DDX43	Probable ATP-dependent RNA helicase DDX43	GO:0004004; F:ATP-dependent RNA helicase activity; TAS:ProtInc
Q9NXZ2	DDX43	Probable ATP-dependent RNA helicase DDX43	GO:0003723; F:RNA binding; TAS:ProtInc
Q9NXZ2	DDX43	Probable ATP-dependent RNA helicase DDX43	GO:0006200; P:ATP catabolic process; TAS:GOC
Q7L014	DDX46	Probable ATP-dependent RNA helicase DDX46	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q7L014	DDX46	Probable ATP-dependent RNA helicase DDX46	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q7L014	DDX46	Probable ATP-dependent RNA helicase DDX46	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7L014	DDX46	Probable ATP-dependent RNA helicase DDX46	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q7L014	DDX46	Probable ATP-dependent RNA helicase DDX46	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q9H0S4	DDX47	Probable ATP-dependent RNA helicase DDX47	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H0S4	DDX47	Probable ATP-dependent RNA helicase DDX47	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q9H0S4	DDX47	Probable ATP-dependent RNA helicase DDX47	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H0S4	DDX47	Probable ATP-dependent RNA helicase DDX47	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H0S4	DDX47	Probable ATP-dependent RNA helicase DDX47	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IDA:UniProtKB
Q9H0S4	DDX47	Probable ATP-dependent RNA helicase DDX47	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9H0S4	DDX47	Probable ATP-dependent RNA helicase DDX47	GO:0008380; P:RNA splicing; IMP:UniProtKB
Q9H0S4	DDX47	Probable ATP-dependent RNA helicase DDX47	GO:0006364; P:rRNA processing; IMP:UniProtKB
Q9Y6V7	DDX49	Probable ATP-dependent RNA helicase DDX49	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y6V7	DDX49	Probable ATP-dependent RNA helicase DDX49	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q9Y6V7	DDX49	Probable ATP-dependent RNA helicase DDX49	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NQI0	DDX4	Probable ATP-dependent RNA helicase DDX4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NQI0	DDX4	Probable ATP-dependent RNA helicase DDX4	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q9NQI0	DDX4	Probable ATP-dependent RNA helicase DDX4	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9NQI0	DDX4	Probable ATP-dependent RNA helicase DDX4	GO:0007141; P:male meiosis I; IEA:Ensembl
Q9NQI0	DDX4	Probable ATP-dependent RNA helicase DDX4	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9NQI0	DDX4	Probable ATP-dependent RNA helicase DDX4	GO:0032880; P:regulation of protein localization; IEA:Ensembl
Q9NQI0	DDX4	Probable ATP-dependent RNA helicase DDX4	GO:0030317; P:sperm motility; IMP:UniProtKB
Q9NQI0	DDX4	Probable ATP-dependent RNA helicase DDX4	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q9BQ39	DDX50	ATP-dependent RNA helicase DDX50	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BQ39	DDX50	ATP-dependent RNA helicase DDX50	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q9BQ39	DDX50	ATP-dependent RNA helicase DDX50	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8N8A6	DDX51	ATP-dependent RNA helicase DDX51	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8N8A6	DDX51	ATP-dependent RNA helicase DDX51	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q8N8A6	DDX51	ATP-dependent RNA helicase DDX51	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8N8A6	DDX51	ATP-dependent RNA helicase DDX51	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q9Y2R4	DDX52	Probable ATP-dependent RNA helicase DDX52	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y2R4	DDX52	Probable ATP-dependent RNA helicase DDX52	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q9Y2R4	DDX52	Probable ATP-dependent RNA helicase DDX52	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q86TM3	DDX53	Probable ATP-dependent RNA helicase DDX53	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86TM3	DDX53	Probable ATP-dependent RNA helicase DDX53	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q86TM3	DDX53	Probable ATP-dependent RNA helicase DDX53	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q8TDD1	DDX54	ATP-dependent RNA helicase DDX54	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8TDD1	DDX54	ATP-dependent RNA helicase DDX54	GO:0004004; F:ATP-dependent RNA helicase activity; IDA:UniProtKB
Q8TDD1	DDX54	ATP-dependent RNA helicase DDX54	GO:0030331; F:estrogen receptor binding; IDA:UniProtKB
Q8TDD1	DDX54	ATP-dependent RNA helicase DDX54	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8TDD1	DDX54	ATP-dependent RNA helicase DDX54	GO:0005102; F:receptor binding; IDA:UniProtKB
Q8TDD1	DDX54	ATP-dependent RNA helicase DDX54	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q8TDD1	DDX54	ATP-dependent RNA helicase DDX54	GO:0006200; P:ATP catabolic process; IDA:GOC
Q8TDD1	DDX54	ATP-dependent RNA helicase DDX54	GO:0030520; P:intracellular estrogen receptor signaling pathway; TAS:UniProtKB
Q8TDD1	DDX54	ATP-dependent RNA helicase DDX54	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8TDD1	DDX54	ATP-dependent RNA helicase DDX54	GO:0016070; P:RNA metabolic process; IDA:UniProtKB
Q8TDD1	DDX54	ATP-dependent RNA helicase DDX54	GO:0006396; P:RNA processing; IDA:UniProtKB
Q8TDD1	DDX54	ATP-dependent RNA helicase DDX54	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NHQ9	DDX55	ATP-dependent RNA helicase DDX55	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NHQ9	DDX55	ATP-dependent RNA helicase DDX55	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q8NHQ9	DDX55	ATP-dependent RNA helicase DDX55	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0042802; F:identical protein binding; IPI:IntAct
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0005515; F:protein binding; IPI:UniProtKB
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0003727; F:single-stranded RNA binding; IMP:UniProtKB
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0008270; F:zinc ion binding; IDA:UniProtKB
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0039528; P:cytoplasmic pattern recognition receptor signaling pathway in response to virus; TAS:UniProtKB
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0009597; P:detection of virus; IDA:BHF-UCL
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0045087; P:innate immune response; IMP:UniProtKB
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0002230; P:positive regulation of defense response to virus by host; IMP:UniProtKB
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0032727; P:positive regulation of interferon-alpha production; IDA:UniProtKB
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0032728; P:positive regulation of interferon-beta production; IMP:UniProtKB
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IC:BHF-UCL
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0042993; P:positive regulation of transcription factor import into nucleus; IDA:BHF-UCL
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0030334; P:regulation of cell migration; IDA:UniProtKB
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0034344; P:regulation of type III interferon production; TAS:UniProtKB
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0043330; P:response to exogenous dsRNA; IEA:Ensembl
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0009615; P:response to virus; TAS:UniProtKB
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0039529; P:RIG-I signaling pathway; IMP:UniProtKB
O95786	DDX58	Probable ATP-dependent RNA helicase DDX58	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9NY93	DDX56	Probable ATP-dependent RNA helicase DDX56	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NY93	DDX56	Probable ATP-dependent RNA helicase DDX56	GO:0004004; F:ATP-dependent RNA helicase activity; TAS:ProtInc
Q9NY93	DDX56	Probable ATP-dependent RNA helicase DDX56	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NY93	DDX56	Probable ATP-dependent RNA helicase DDX56	GO:0006200; P:ATP catabolic process; TAS:GOC
Q9NY93	DDX56	Probable ATP-dependent RNA helicase DDX56	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q5T1V6	DDX59	Probable ATP-dependent RNA helicase DDX59	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5T1V6	DDX59	Probable ATP-dependent RNA helicase DDX59	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q5T1V6	DDX59	Probable ATP-dependent RNA helicase DDX59	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5T1V6	DDX59	Probable ATP-dependent RNA helicase DDX59	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0050681; F:androgen receptor binding; IDA:UniProtKB
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0004004; F:ATP-dependent RNA helicase activity; IEA:Ensembl
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0030331; F:estrogen receptor binding; IDA:UniProtKB
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0036002; F:pre-mRNA binding; IDA:UniProtKB
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0005515; F:protein binding; IPI:UniProtKB
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0003724; F:RNA helicase activity; IMP:UniProtKB
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0016049; P:cell growth; NAS:UniProtKB
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0007623; P:circadian rhythm; IEA:Ensembl
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IMP:UniProtKB
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0043517; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; IMP:UniProtKB
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0033148; P:positive regulation of intracellular estrogen receptor signaling pathway; IDA:UniProtKB
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0060765; P:regulation of androgen receptor signaling pathway; IMP:UniProtKB
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0045667; P:regulation of osteoblast differentiation; ISS:UniProtKB
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:2001014; P:regulation of skeletal muscle cell differentiation; ISS:UniProtKB
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0045069; P:regulation of viral genome replication; IEA:Ensembl
P17844	DDX5	Probable ATP-dependent RNA helicase DDX5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5H9U9	DDX60L	Probable ATP-dependent RNA helicase DDX60-like	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5H9U9	DDX60L	Probable ATP-dependent RNA helicase DDX60-like	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q5H9U9	DDX60L	Probable ATP-dependent RNA helicase DDX60-like	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q8IY21	DDX60	Probable ATP-dependent RNA helicase DDX60	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IY21	DDX60	Probable ATP-dependent RNA helicase DDX60	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q8IY21	DDX60	Probable ATP-dependent RNA helicase DDX60	GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB
Q8IY21	DDX60	Probable ATP-dependent RNA helicase DDX60	GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB
Q8IY21	DDX60	Probable ATP-dependent RNA helicase DDX60	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IY21	DDX60	Probable ATP-dependent RNA helicase DDX60	GO:0003727; F:single-stranded RNA binding; IDA:UniProtKB
Q8IY21	DDX60	Probable ATP-dependent RNA helicase DDX60	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q8IY21	DDX60	Probable ATP-dependent RNA helicase DDX60	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q8IY21	DDX60	Probable ATP-dependent RNA helicase DDX60	GO:1900245; P:positive regulation of MDA-5 signaling pathway; IMP:UniProtKB
Q8IY21	DDX60	Probable ATP-dependent RNA helicase DDX60	GO:1900246; P:positive regulation of RIG-I signaling pathway; IMP:UniProtKB
Q8IY21	DDX60	Probable ATP-dependent RNA helicase DDX60	GO:0009615; P:response to virus; IDA:UniProtKB
P26196	DDX6	Probable ATP-dependent RNA helicase DDX6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P26196	DDX6	Probable ATP-dependent RNA helicase DDX6	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
P26196	DDX6	Probable ATP-dependent RNA helicase DDX6	GO:0004386; F:helicase activity; TAS:ProtInc
P26196	DDX6	Probable ATP-dependent RNA helicase DDX6	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P26196	DDX6	Probable ATP-dependent RNA helicase DDX6	GO:0005515; F:protein binding; IPI:UniProtKB
P26196	DDX6	Probable ATP-dependent RNA helicase DDX6	GO:0003724; F:RNA helicase activity; TAS:ProtInc
P26196	DDX6	Probable ATP-dependent RNA helicase DDX6	GO:0033962; P:cytoplasmic mRNA processing body assembly; IDA:MGI
P26196	DDX6	Probable ATP-dependent RNA helicase DDX6	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
P26196	DDX6	Probable ATP-dependent RNA helicase DDX6	GO:0010467; P:gene expression; TAS:Reactome
P26196	DDX6	Probable ATP-dependent RNA helicase DDX6	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P26196	DDX6	Probable ATP-dependent RNA helicase DDX6	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
P26196	DDX6	Probable ATP-dependent RNA helicase DDX6	GO:0016070; P:RNA metabolic process; TAS:Reactome
O75398	DEAF1	Deformed epidermal autoregulatory factor 1 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O75398	DEAF1	Deformed epidermal autoregulatory factor 1 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75398	DEAF1	Deformed epidermal autoregulatory factor 1 homolog	GO:0005515; F:protein binding; IPI:IntAct
O75398	DEAF1	Deformed epidermal autoregulatory factor 1 homolog	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
O75398	DEAF1	Deformed epidermal autoregulatory factor 1 homolog	GO:0048706; P:embryonic skeletal system development; ISS:UniProtKB
O75398	DEAF1	Deformed epidermal autoregulatory factor 1 homolog	GO:0007281; P:germ cell development; TAS:ProtInc
O75398	DEAF1	Deformed epidermal autoregulatory factor 1 homolog	GO:0001843; P:neural tube closure; ISS:UniProtKB
O75398	DEAF1	Deformed epidermal autoregulatory factor 1 homolog	GO:0033599; P:regulation of mammary gland epithelial cell proliferation; IDA:UniProtKB
O75398	DEAF1	Deformed epidermal autoregulatory factor 1 homolog	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O75398	DEAF1	Deformed epidermal autoregulatory factor 1 homolog	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9P2X7	DEC1	Deleted in esophageal cancer 1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q9NUI1	DECR2	Peroxisomal 2,4-dienoyl-CoA reductase	GO:0008670; F:2,4-dienoyl-CoA reductase (NADPH) activity; IDA:UniProtKB
Q9NUI1	DECR2	Peroxisomal 2,4-dienoyl-CoA reductase	GO:0005102; F:receptor binding; IPI:UniProtKB
Q9NUI1	DECR2	Peroxisomal 2,4-dienoyl-CoA reductase	GO:0019166; F:trans-2-enoyl-CoA reductase (NADPH) activity; IDA:UniProtKB
Q9NUI1	DECR2	Peroxisomal 2,4-dienoyl-CoA reductase	GO:0006636; P:unsaturated fatty acid biosynthetic process; IDA:UniProtKB
Q16698	DECR1	2,4-dienoyl-CoA reductase, mitochondrial	GO:0008670; F:2,4-dienoyl-CoA reductase (NADPH) activity; IDA:UniProtKB
Q16698	DECR1	2,4-dienoyl-CoA reductase, mitochondrial	GO:0070402; F:NADPH binding; IDA:UniProtKB
Q16698	DECR1	2,4-dienoyl-CoA reductase, mitochondrial	GO:0016651; F:oxidoreductase activity, acting on NAD(P)H; TAS:Reactome
Q16698	DECR1	2,4-dienoyl-CoA reductase, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q16698	DECR1	2,4-dienoyl-CoA reductase, mitochondrial	GO:0006635; P:fatty acid beta-oxidation; IDA:UniProtKB
Q16698	DECR1	2,4-dienoyl-CoA reductase, mitochondrial	GO:0051289; P:protein homotetramerization; IDA:UniProtKB
Q16698	DECR1	2,4-dienoyl-CoA reductase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8WXF8	DEDD2	DNA-binding death effector domain-containing protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8WXF8	DEDD2	DNA-binding death effector domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WXF8	DEDD2	DNA-binding death effector domain-containing protein 2	GO:0030159; F:receptor signaling complex scaffold activity; NAS:UniProtKB
Q8WXF8	DEDD2	DNA-binding death effector domain-containing protein 2	GO:0030262; P:apoptotic nuclear changes; IDA:UniProtKB
Q8WXF8	DEDD2	DNA-binding death effector domain-containing protein 2	GO:0019725; P:cellular homeostasis; NAS:UniProtKB
Q8WXF8	DEDD2	DNA-binding death effector domain-containing protein 2	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IMP:UniProtKB
Q8WXF8	DEDD2	DNA-binding death effector domain-containing protein 2	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
Q8WXF8	DEDD2	DNA-binding death effector domain-containing protein 2	GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB
Q8WXF8	DEDD2	DNA-binding death effector domain-containing protein 2	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB
Q8WXF8	DEDD2	DNA-binding death effector domain-containing protein 2	GO:0006396; P:RNA processing; NAS:UniProtKB
Q8WXF8	DEDD2	DNA-binding death effector domain-containing protein 2	GO:0016075; P:rRNA catabolic process; NAS:UniProtKB
Q8WXF8	DEDD2	DNA-binding death effector domain-containing protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75618	DEDD	Death effector domain-containing protein	GO:0003677; F:DNA binding; ISS:UniProtKB
O75618	DEDD	Death effector domain-containing protein	GO:0005515; F:protein binding; IPI:UniProtKB
O75618	DEDD	Death effector domain-containing protein	GO:0046697; P:decidualization; IEA:Ensembl
O75618	DEDD	Death effector domain-containing protein	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; TAS:ProtInc
O75618	DEDD	Death effector domain-containing protein	GO:0042177; P:negative regulation of protein catabolic process; IEA:Ensembl
O75618	DEDD	Death effector domain-containing protein	GO:1901837; P:negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter; IEA:Ensembl
O75618	DEDD	Death effector domain-containing protein	GO:0042981; P:regulation of apoptotic process; IEA:InterPro
O75618	DEDD	Death effector domain-containing protein	GO:0007283; P:spermatogenesis; TAS:ProtInc
O75618	DEDD	Death effector domain-containing protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P59665	DEFA1	Neutrophil defensin 1	GO:0019731; P:antibacterial humoral response; IDA:UniProt
P59665	DEFA1	Neutrophil defensin 1	GO:0006935; P:chemotaxis; TAS:ProtInc
P59665	DEFA1	Neutrophil defensin 1	GO:0050832; P:defense response to fungus; IEA:UniProtKB-KW
P59665	DEFA1	Neutrophil defensin 1	GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProt
P59665	DEFA1	Neutrophil defensin 1	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P59665	DEFA1	Neutrophil defensin 1	GO:0006955; P:immune response; TAS:ProtInc
P59665	DEFA1	Neutrophil defensin 1	GO:0045087; P:innate immune response; IDA:UniProt
P59665	DEFA1	Neutrophil defensin 1	GO:0002227; P:innate immune response in mucosa; IDA:UniProt
P59665	DEFA1	Neutrophil defensin 1	GO:0030520; P:intracellular estrogen receptor signaling pathway; IDA:UniProt
P59665	DEFA1	Neutrophil defensin 1	GO:0031640; P:killing of cells of other organism; IEA:UniProtKB-KW
P59666	DEFA3	Neutrophil defensin 3	GO:0019731; P:antibacterial humoral response; IDA:UniProt
P59666	DEFA3	Neutrophil defensin 3	GO:0050832; P:defense response to fungus; IEA:UniProtKB-KW
P59666	DEFA3	Neutrophil defensin 3	GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProt
P59666	DEFA3	Neutrophil defensin 3	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P59666	DEFA3	Neutrophil defensin 3	GO:0045087; P:innate immune response; IDA:UniProt
P59666	DEFA3	Neutrophil defensin 3	GO:0002227; P:innate immune response in mucosa; IDA:UniProt
P59666	DEFA3	Neutrophil defensin 3	GO:0030520; P:intracellular estrogen receptor signaling pathway; IDA:UniProt
P59666	DEFA3	Neutrophil defensin 3	GO:0031640; P:killing of cells of other organism; IEA:UniProtKB-KW
P12838	DEFA4	Neutrophil defensin 4	GO:0019731; P:antibacterial humoral response; IDA:UniProt
P12838	DEFA4	Neutrophil defensin 4	GO:0050832; P:defense response to fungus; IEA:UniProtKB-KW
P12838	DEFA4	Neutrophil defensin 4	GO:0045087; P:innate immune response; IDA:UniProt
P12838	DEFA4	Neutrophil defensin 4	GO:0031640; P:killing of cells of other organism; IEA:UniProtKB-KW
Q01523	DEFA5	Defensin-5	GO:0019731; P:antibacterial humoral response; IDA:UniProt
Q01523	DEFA5	Defensin-5	GO:0050832; P:defense response to fungus; IEA:UniProtKB-KW
Q01523	DEFA5	Defensin-5	GO:0045087; P:innate immune response; IDA:UniProt
Q01523	DEFA5	Defensin-5	GO:0031640; P:killing of cells of other organism; IEA:UniProtKB-KW
Q01524	DEFA6	Defensin-6	GO:0019731; P:antibacterial humoral response; IDA:UniProt
Q01524	DEFA6	Defensin-6	GO:0050832; P:defense response to fungus; IEA:UniProtKB-KW
Q01524	DEFA6	Defensin-6	GO:0045087; P:innate immune response; IDA:UniProt
Q01524	DEFA6	Defensin-6	GO:0031640; P:killing of cells of other organism; IEA:UniProtKB-KW
P60022	DEFB1	Beta-defensin 1	GO:0002526; P:acute inflammatory response; IEA:Ensembl
P60022	DEFB1	Beta-defensin 1	GO:0019731; P:antibacterial humoral response; IDA:UniProt
P60022	DEFB1	Beta-defensin 1	GO:0006935; P:chemotaxis; TAS:ProtInc
P60022	DEFB1	Beta-defensin 1	GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProt
P60022	DEFB1	Beta-defensin 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P60022	DEFB1	Beta-defensin 1	GO:0006955; P:immune response; TAS:ProtInc
P60022	DEFB1	Beta-defensin 1	GO:0045087; P:innate immune response; ISS:UniProtKB
P60022	DEFB1	Beta-defensin 1	GO:0002227; P:innate immune response in mucosa; IDA:UniProt
P60022	DEFB1	Beta-defensin 1	GO:0009617; P:response to bacterium; IDA:UniProtKB
P60022	DEFB1	Beta-defensin 1	GO:0033574; P:response to testosterone; IEA:Ensembl
Q6ZN54	DEF8	Differentially expressed in FDCP 8 homolog	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6ZN54	DEF8	Differentially expressed in FDCP 8 homolog	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9HBH1	PDF	Peptide deformylase, mitochondrial	GO:0005506; F:iron ion binding; IEA:InterPro
Q9HBH1	PDF	Peptide deformylase, mitochondrial	GO:0042586; F:peptide deformylase activity; IDA:HGNC
Q9HBH1	PDF	Peptide deformylase, mitochondrial	GO:0031365; P:N-terminal protein amino acid modification; IDA:HGNC
Q9HBH1	PDF	Peptide deformylase, mitochondrial	GO:0018206; P:peptidyl-methionine modification; IDA:HGNC
Q9HBH1	PDF	Peptide deformylase, mitochondrial	GO:0008284; P:positive regulation of cell proliferation; IMP:HGNC
Q9HBH1	PDF	Peptide deformylase, mitochondrial	GO:0006412; P:translation; IEA:UniProtKB-KW
O15121	DEGS1	Sphingolipid delta(4)-desaturase DES1	GO:0009055; F:electron carrier activity; TAS:UniProtKB
O15121	DEGS1	Sphingolipid delta(4)-desaturase DES1	GO:0016705; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; IEA:InterPro
O15121	DEGS1	Sphingolipid delta(4)-desaturase DES1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15121	DEGS1	Sphingolipid delta(4)-desaturase DES1	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
O15121	DEGS1	Sphingolipid delta(4)-desaturase DES1	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
O15121	DEGS1	Sphingolipid delta(4)-desaturase DES1	GO:0006636; P:unsaturated fatty acid biosynthetic process; TAS:ProtInc
Q6QHC5	DEGS2	Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2	GO:0042284; F:sphingolipid delta-4 desaturase activity; IEA:Ensembl
Q6QHC5	DEGS2	Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2	GO:0000170; F:sphingosine hydroxylase activity; IEA:Ensembl
Q6QHC5	DEGS2	Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2	GO:0046513; P:ceramide biosynthetic process; IEA:Ensembl
Q6QHC5	DEGS2	Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2	GO:0006633; P:fatty acid biosynthetic process; IEA:InterPro
Q6QHC5	DEGS2	Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6QHC5	DEGS2	Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2	GO:0006667; P:sphinganine metabolic process; IEA:Ensembl
Q6QHC5	DEGS2	Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
Q6QHC5	DEGS2	Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
P35659	DEK	Protein DEK	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P35659	DEK	Protein DEK	GO:0042393; F:histone binding; IDA:UniProtKB
P35659	DEK	Protein DEK	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P35659	DEK	Protein DEK	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
P35659	DEK	Protein DEK	GO:2000779; P:regulation of double-strand break repair; IMP:MGI
P35659	DEK	Protein DEK	GO:2001032; P:regulation of double-strand break repair via nonhomologous end joining; IEA:Ensembl
P35659	DEK	Protein DEK	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P35659	DEK	Protein DEK	GO:0007165; P:signal transduction; TAS:ProtInc
P35659	DEK	Protein DEK	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P35659	DEK	Protein DEK	GO:0019079; P:viral genome replication; TAS:ProtInc
Q14154	KIAA0141	Death ligand signal enhancer	GO:0005515; F:protein binding; IPI:UniProtKB
Q14154	KIAA0141	Death ligand signal enhancer	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IDA:UniProtKB
Q14154	KIAA0141	Death ligand signal enhancer	GO:0043281; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
Q08495	DMTN	Dematin	GO:0003779; F:actin binding; IDA:UniProtKB
Q08495	DMTN	Dematin	GO:0005515; F:protein binding; IPI:UniProtKB
Q08495	DMTN	Dematin	GO:0043621; F:protein self-association; IDA:UniProtKB
Q08495	DMTN	Dematin	GO:0005102; F:receptor binding; IDA:UniProtKB
Q08495	DMTN	Dematin	GO:0030507; F:spectrin binding; IDA:UniProtKB
Q08495	DMTN	Dematin	GO:0030036; P:actin cytoskeleton organization; ISS:UniProtKB
Q08495	DMTN	Dematin	GO:0051017; P:actin filament bundle assembly; IDA:UniProtKB
Q08495	DMTN	Dematin	GO:0051693; P:actin filament capping; IEA:UniProtKB-KW
Q08495	DMTN	Dematin	GO:0090527; P:actin filament reorganization; ISS:UniProtKB
Q08495	DMTN	Dematin	GO:0035585; P:calcium-mediated signaling using extracellular calcium source; ISS:UniProtKB
Q08495	DMTN	Dematin	GO:0035584; P:calcium-mediated signaling using intracellular calcium source; ISS:UniProtKB
Q08495	DMTN	Dematin	GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB
Q08495	DMTN	Dematin	GO:0071320; P:cellular response to cAMP; IDA:UniProtKB
Q08495	DMTN	Dematin	GO:0007010; P:cytoskeleton organization; TAS:UniProtKB
Q08495	DMTN	Dematin	GO:0048821; P:erythrocyte development; ISS:UniProtKB
Q08495	DMTN	Dematin	GO:0010812; P:negative regulation of cell-substrate adhesion; ISS:UniProtKB
Q08495	DMTN	Dematin	GO:0051895; P:negative regulation of focal adhesion assembly; ISS:UniProtKB
Q08495	DMTN	Dematin	GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; ISS:UniProtKB
Q08495	DMTN	Dematin	GO:0010801; P:negative regulation of peptidyl-threonine phosphorylation; ISS:UniProtKB
Q08495	DMTN	Dematin	GO:0050732; P:negative regulation of peptidyl-tyrosine phosphorylation; ISS:UniProtKB
Q08495	DMTN	Dematin	GO:0090315; P:negative regulation of protein targeting to membrane; ISS:UniProtKB
Q08495	DMTN	Dematin	GO:1900025; P:negative regulation of substrate adhesion-dependent cell spreading; ISS:UniProtKB
Q08495	DMTN	Dematin	GO:0030194; P:positive regulation of blood coagulation; ISS:UniProtKB
Q08495	DMTN	Dematin	GO:0010763; P:positive regulation of fibroblast migration; ISS:UniProtKB
Q08495	DMTN	Dematin	GO:2001046; P:positive regulation of integrin-mediated signaling pathway; ISS:UniProtKB
Q08495	DMTN	Dematin	GO:1901731; P:positive regulation of platelet aggregation; ISS:UniProtKB
Q08495	DMTN	Dematin	GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; ISS:UniProtKB
Q08495	DMTN	Dematin	GO:0090303; P:positive regulation of wound healing; ISS:UniProtKB
Q08495	DMTN	Dematin	GO:0006461; P:protein complex assembly; IDA:UniProtKB
Q08495	DMTN	Dematin	GO:0070560; P:protein secretion by platelet; ISS:UniProtKB
Q08495	DMTN	Dematin	GO:0032956; P:regulation of actin cytoskeleton organization; IDA:UniProtKB
Q08495	DMTN	Dematin	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
Q08495	DMTN	Dematin	GO:0051489; P:regulation of filopodium assembly; IMP:UniProtKB
Q08495	DMTN	Dematin	GO:0010591; P:regulation of lamellipodium assembly; IMP:UniProtKB
Q8TEH3	DENND1A	DENN domain-containing protein 1A	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q8TEH3	DENND1A	DENN domain-containing protein 1A	GO:0006897; P:endocytosis; IMP:UniProtKB
Q8TEH3	DENND1A	DENN domain-containing protein 1A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8TEH3	DENND1A	DENN domain-containing protein 1A	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
Q8TEH3	DENND1A	DENN domain-containing protein 1A	GO:0032483; P:regulation of Rab protein signal transduction; IDA:FlyBase
Q8TEH3	DENND1A	DENN domain-containing protein 1A	GO:0048488; P:synaptic vesicle endocytosis; IEA:Ensembl
Q6P3S1	DENND1B	DENN domain-containing protein 1B	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q6P3S1	DENND1B	DENN domain-containing protein 1B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q6P3S1	DENND1B	DENN domain-containing protein 1B	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
Q8IV53	DENND1C	DENN domain-containing protein 1C	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q8IV53	DENND1C	DENN domain-containing protein 1C	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
Q9ULE3	DENND2A	DENN domain-containing protein 2A	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q9ULE3	DENND2A	DENN domain-containing protein 2A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9ULE3	DENND2A	DENN domain-containing protein 2A	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
Q9ULE3	DENND2A	DENN domain-containing protein 2A	GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB
Q68D51	DENND2C	DENN domain-containing protein 2C	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q68D51	DENND2C	DENN domain-containing protein 2C	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
Q9H6A0	DENND2D	DENN domain-containing protein 2D	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q9H6A0	DENND2D	DENN domain-containing protein 2D	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
O75064	DENND4B	DENN domain-containing protein 4B	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
O75064	DENND4B	DENN domain-containing protein 4B	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
O75064	DENND4B	DENN domain-containing protein 4B	GO:0032483; P:regulation of Rab protein signal transduction; IDA:FlyBase
Q5VZ89	DENND4C	DENN domain-containing protein 4C	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q5VZ89	DENND4C	DENN domain-containing protein 4C	GO:0032869; P:cellular response to insulin stimulus; ISS:UniProtKB
Q5VZ89	DENND4C	DENN domain-containing protein 4C	GO:0072659; P:protein localization to plasma membrane; ISS:UniProtKB
Q5VZ89	DENND4C	DENN domain-containing protein 4C	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q5VZ89	DENND4C	DENN domain-containing protein 4C	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
Q6IQ26	DENND5A	DENN domain-containing protein 5A	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q6IQ26	DENND5A	DENN domain-containing protein 5A	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
Q6ZUT9	DENND5B	DENN domain-containing protein 5B	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q6ZUT9	DENND5B	DENN domain-containing protein 5B	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
Q8IWF6	DENND6A	Protein DENND6A	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q8IWF6	DENND6A	Protein DENND6A	GO:2000049; P:positive regulation of cell-cell adhesion mediated by cadherin; IDA:UniProtKB
Q8IWF6	DENND6A	Protein DENND6A	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
Q8NEG7	DENND6B	Protein DENND6B	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q8NEG7	DENND6B	Protein DENND6B	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
A2RUS2	DENND3	DENN domain-containing protein 3	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
A2RUS2	DENND3	DENN domain-containing protein 3	GO:0044257; P:cellular protein catabolic process; ISS:UniProtKB
A2RUS2	DENND3	DENN domain-containing protein 3	GO:0008333; P:endosome to lysosome transport; ISS:UniProtKB
A2RUS2	DENND3	DENN domain-containing protein 3	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
O94850	DDN	Dendrin	GO:0005515; F:protein binding; IPI:UniProtKB
O43583	DENR	Density-regulated protein	GO:0005515; F:protein binding; IPI:IntAct
O43583	DENR	Density-regulated protein	GO:0003743; F:translation initiation factor activity; IEA:InterPro
Q9Y315	DERA	Putative deoxyribose-phosphate aldolase	GO:0004139; F:deoxyribose-phosphate aldolase activity; IDA:UniProtKB
Q9Y315	DERA	Putative deoxyribose-phosphate aldolase	GO:0046121; P:deoxyribonucleoside catabolic process; IDA:UniProtKB
Q9Y315	DERA	Putative deoxyribose-phosphate aldolase	GO:0009264; P:deoxyribonucleotide catabolic process; IEA:InterPro
Q9Y315	DERA	Putative deoxyribose-phosphate aldolase	GO:0046386; P:deoxyribose phosphate catabolic process; IEA:UniProtKB-UniPathway
Q5TB30	DEPDC1	DEP domain-containing protein 1A	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q5TB30	DEPDC1	DEP domain-containing protein 1A	GO:0005515; F:protein binding; IPI:UniProtKB
Q5TB30	DEPDC1	DEP domain-containing protein 1A	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q5TB30	DEPDC1	DEP domain-containing protein 1A	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q5TB30	DEPDC1	DEP domain-containing protein 1A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WUY9	DEPDC1B	DEP domain-containing protein 1B	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q8WUY9	DEPDC1B	DEP domain-containing protein 1B	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q8WUY9	DEPDC1B	DEP domain-containing protein 1B	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q8N2C3	DEPDC4	DEP domain-containing protein 4	GO:0035556; P:intracellular signal transduction; IEA:InterPro
O75140	DEPDC5	DEP domain-containing protein 5	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
O75140	DEPDC5	DEP domain-containing protein 5	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q96QD5	DEPDC7	DEP domain-containing protein 7	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q96QD5	DEPDC7	DEP domain-containing protein 7	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9BUN8	DERL1	Derlin-1	GO:0042288; F:MHC class I protein binding; IDA:UniProtKB
Q9BUN8	DERL1	Derlin-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BUN8	DERL1	Derlin-1	GO:0004872; F:receptor activity; NAS:UniProtKB
Q9BUN8	DERL1	Derlin-1	GO:0030968; P:endoplasmic reticulum unfolded protein response; IDA:UniProtKB
Q9BUN8	DERL1	Derlin-1	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9BUN8	DERL1	Derlin-1	GO:0045184; P:establishment of protein localization; TAS:UniProtKB
Q9BUN8	DERL1	Derlin-1	GO:0019060; P:intracellular transport of viral protein in host cell; TAS:UniProtKB
Q9BUN8	DERL1	Derlin-1	GO:0006986; P:response to unfolded protein; IMP:MGI
Q9BUN8	DERL1	Derlin-1	GO:0030970; P:retrograde protein transport, ER to cytosol; IDA:UniProtKB
Q9GZP9	DERL2	Derlin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9GZP9	DERL2	Derlin-2	GO:0030968; P:endoplasmic reticulum unfolded protein response; IDA:UniProtKB
Q9GZP9	DERL2	Derlin-2	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q9GZP9	DERL2	Derlin-2	GO:0030307; P:positive regulation of cell growth; IDA:UniProtKB
Q9GZP9	DERL2	Derlin-2	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q9GZP9	DERL2	Derlin-2	GO:0030970; P:retrograde protein transport, ER to cytosol; IMP:UniProtKB
Q9GZP9	DERL2	Derlin-2	GO:0001967; P:suckling behavior; IEA:Ensembl
Q96Q80	DERL3	Derlin-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q96Q80	DERL3	Derlin-3	GO:0030968; P:endoplasmic reticulum unfolded protein response; IDA:UniProtKB
Q96Q80	DERL3	Derlin-3	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q96Q80	DERL3	Derlin-3	GO:0018279; P:protein N-linked glycosylation via asparagine; IMP:UniProtKB
Q07507	DPT	Dermatopontin	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q07507	DPT	Dermatopontin	GO:0030199; P:collagen fibril organization; IEA:Ensembl
Q07507	DPT	Dermatopontin	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q6ICB0	DESI1	Desumoylating isopeptidase 1	GO:0008233; F:peptidase activity; IEA:UniProtKB-KW
Q9BSY9	DESI2	Desumoylating isopeptidase 2	GO:0008233; F:peptidase activity; IEA:UniProtKB-KW
P17661	DES	Desmin	GO:0008092; F:cytoskeletal protein binding; IPI:BHF-UCL
P17661	DES	Desmin	GO:0042802; F:identical protein binding; IPI:IntAct
P17661	DES	Desmin	GO:0005515; F:protein binding; IPI:UniProtKB
P17661	DES	Desmin	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P17661	DES	Desmin	GO:0007010; P:cytoskeleton organization; TAS:ProtInc
P17661	DES	Desmin	GO:0006936; P:muscle contraction; TAS:ProtInc
P17661	DES	Desmin	GO:0030049; P:muscle filament sliding; TAS:Reactome
P17661	DES	Desmin	GO:0008016; P:regulation of heart contraction; TAS:ProtInc
P15924	DSP	Desmoplakin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P15924	DSP	Desmoplakin	GO:0005515; F:protein binding; IPI:UniProtKB
P15924	DSP	Desmoplakin	GO:0030674; F:protein binding, bridging; IDA:UniProtKB
P15924	DSP	Desmoplakin	GO:0005080; F:protein kinase C binding; IPI:BHF-UCL
P15924	DSP	Desmoplakin	GO:0097110; F:scaffold protein binding; IPI:BHF-UCL
P15924	DSP	Desmoplakin	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P15924	DSP	Desmoplakin	GO:0005198; F:structural molecule activity; IDA:UniProtKB
P15924	DSP	Desmoplakin	GO:0034332; P:adherens junction organization; IEA:Ensembl
P15924	DSP	Desmoplakin	GO:0006915; P:apoptotic process; TAS:Reactome
P15924	DSP	Desmoplakin	GO:0086069; P:bundle of His cell to Purkinje myocyte communication; IMP:BHF-UCL
P15924	DSP	Desmoplakin	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
P15924	DSP	Desmoplakin	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
P15924	DSP	Desmoplakin	GO:0002934; P:desmosome organization; ISS:BHF-UCL
P15924	DSP	Desmoplakin	GO:0008544; P:epidermis development; TAS:ProtInc
P15924	DSP	Desmoplakin	GO:0045109; P:intermediate filament organization; ISS:BHF-UCL
P15924	DSP	Desmoplakin	GO:0030216; P:keratinocyte differentiation; IDA:UniProtKB
P15924	DSP	Desmoplakin	GO:0018149; P:peptide cross-linking; IDA:UniProtKB
P15924	DSP	Desmoplakin	GO:0071896; P:protein localization to adherens junction; ISS:BHF-UCL
P15924	DSP	Desmoplakin	GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL
P15924	DSP	Desmoplakin	GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL
P15924	DSP	Desmoplakin	GO:0003223; P:ventricular compact myocardium morphogenesis; ISS:BHF-UCL
P15924	DSP	Desmoplakin	GO:0042060; P:wound healing; IEA:Ensembl
P60981	DSTN	Destrin	GO:0030042; P:actin filament depolymerization; IEA:InterPro
P60981	DSTN	Destrin	GO:0051014; P:actin filament severing; TAS:ProtInc
P60981	DSTN	Destrin	GO:0008154; P:actin polymerization or depolymerization; TAS:ProtInc
P60981	DSTN	Destrin	GO:0006928; P:cellular component movement; IEA:Ensembl
P60981	DSTN	Destrin	GO:0030836; P:positive regulation of actin filament depolymerization; IEA:Ensembl
Q05D60	CCDC67	Deuterosome protein 1	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
Q05D60	CCDC67	Deuterosome protein 1	GO:0098535; P:de novo centriole assembly; ISS:UniProtKB
O15263	DEFB4A	Beta-defensin 4A	GO:0006935; P:chemotaxis; TAS:ProtInc
O15263	DEFB4A	Beta-defensin 4A	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
O15263	DEFB4A	Beta-defensin 4A	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
O15263	DEFB4A	Beta-defensin 4A	GO:0006955; P:immune response; TAS:ProtInc
O15263	DEFB4A	Beta-defensin 4A	GO:0045087; P:innate immune response; TAS:Reactome
O00273	DFFA	DNA fragmentation factor subunit alpha	GO:0005515; F:protein binding; IPI:IntAct
O00273	DFFA	DNA fragmentation factor subunit alpha	GO:0006309; P:apoptotic DNA fragmentation; TAS:Reactome
O00273	DFFA	DNA fragmentation factor subunit alpha	GO:0006915; P:apoptotic process; TAS:Reactome
O00273	DFFA	DNA fragmentation factor subunit alpha	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
O00273	DFFA	DNA fragmentation factor subunit alpha	GO:1902511; P:negative regulation of apoptotic DNA fragmentation; IDA:MGI
O00273	DFFA	DNA fragmentation factor subunit alpha	GO:1900118; P:negative regulation of execution phase of apoptosis; IDA:BHF-UCL
O00273	DFFA	DNA fragmentation factor subunit alpha	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
O00273	DFFA	DNA fragmentation factor subunit alpha	GO:0070242; P:thymocyte apoptotic process; IEA:Ensembl
O76075	DFFB	DNA fragmentation factor subunit beta	GO:0004536; F:deoxyribonuclease activity; IBA:RefGenome
O76075	DFFB	DNA fragmentation factor subunit beta	GO:0003677; F:DNA binding; IEA:Ensembl
O76075	DFFB	DNA fragmentation factor subunit beta	GO:0019899; F:enzyme binding; IPI:UniProtKB
O76075	DFFB	DNA fragmentation factor subunit beta	GO:0004516; F:nicotinate phosphoribosyltransferase activity; IEA:Ensembl
O76075	DFFB	DNA fragmentation factor subunit beta	GO:0030263; P:apoptotic chromosome condensation; IDA:UniProtKB
O76075	DFFB	DNA fragmentation factor subunit beta	GO:0006309; P:apoptotic DNA fragmentation; IDA:MGI
O76075	DFFB	DNA fragmentation factor subunit beta	GO:0006915; P:apoptotic process; TAS:Reactome
O76075	DFFB	DNA fragmentation factor subunit beta	GO:0007420; P:brain development; IEA:Ensembl
O76075	DFFB	DNA fragmentation factor subunit beta	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
O60443	DFNA5	Non-syndromic hearing impairment protein 5	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O60443	DFNA5	Non-syndromic hearing impairment protein 5	GO:0060113; P:inner ear receptor cell differentiation; IEA:Ensembl
O60443	DFNA5	Non-syndromic hearing impairment protein 5	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
O60443	DFNA5	Non-syndromic hearing impairment protein 5	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IDA:UniProtKB
O60443	DFNA5	Non-syndromic hearing impairment protein 5	GO:0007605; P:sensory perception of sound; TAS:ProtInc
Q6ZPD8	DGAT2L6	Diacylglycerol O-acyltransferase 2-like protein 6	GO:0016747; F:transferase activity, transferring acyl groups other than amino-acyl groups; IEA:InterPro
Q6ZPD8	DGAT2L6	Diacylglycerol O-acyltransferase 2-like protein 6	GO:0006629; P:lipid metabolic process; IEA:UniProtKB-KW
Q6IED9	DGAT2L7P	Putative diacylglycerol O-acyltransferase 2-like protein DGAT2L7P	GO:0016747; F:transferase activity, transferring acyl groups other than amino-acyl groups; IEA:InterPro
Q6IED9	DGAT2L7P	Putative diacylglycerol O-acyltransferase 2-like protein DGAT2L7P	GO:0006629; P:lipid metabolic process; IEA:UniProtKB-KW
O75907	DGAT1	Diacylglycerol O-acyltransferase 1	GO:0003846; F:2-acylglycerol O-acyltransferase activity; IEA:Ensembl
O75907	DGAT1	Diacylglycerol O-acyltransferase 1	GO:0004144; F:diacylglycerol O-acyltransferase activity; IDA:MGI
O75907	DGAT1	Diacylglycerol O-acyltransferase 1	GO:0005515; F:protein binding; IPI:IntAct
O75907	DGAT1	Diacylglycerol O-acyltransferase 1	GO:0050252; F:retinol O-fatty-acyltransferase activity; IEA:UniProtKB-EC
O75907	DGAT1	Diacylglycerol O-acyltransferase 1	GO:0016746; F:transferase activity, transferring acyl groups; TAS:ProtInc
O75907	DGAT1	Diacylglycerol O-acyltransferase 1	GO:0036155; P:acylglycerol acyl-chain remodeling; TAS:Reactome
O75907	DGAT1	Diacylglycerol O-acyltransferase 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O75907	DGAT1	Diacylglycerol O-acyltransferase 1	GO:0046339; P:diacylglycerol metabolic process; ISS:BHF-UCL
O75907	DGAT1	Diacylglycerol O-acyltransferase 1	GO:0055089; P:fatty acid homeostasis; IEA:Ensembl
O75907	DGAT1	Diacylglycerol O-acyltransferase 1	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
O75907	DGAT1	Diacylglycerol O-acyltransferase 1	GO:0019915; P:lipid storage; ISS:BHF-UCL
O75907	DGAT1	Diacylglycerol O-acyltransferase 1	GO:0035336; P:long-chain fatty-acyl-CoA metabolic process; ISS:BHF-UCL
O75907	DGAT1	Diacylglycerol O-acyltransferase 1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
O75907	DGAT1	Diacylglycerol O-acyltransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75907	DGAT1	Diacylglycerol O-acyltransferase 1	GO:0019432; P:triglyceride biosynthetic process; IDA:UniProtKB
O75907	DGAT1	Diacylglycerol O-acyltransferase 1	GO:0006641; P:triglyceride metabolic process; TAS:ProtInc
O75907	DGAT1	Diacylglycerol O-acyltransferase 1	GO:0034379; P:very-low-density lipoprotein particle assembly; IMP:BHF-UCL
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0003846; F:2-acylglycerol O-acyltransferase activity; IEA:Ensembl
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0004144; F:diacylglycerol O-acyltransferase activity; IDA:UniProtKB
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0050252; F:retinol O-fatty-acyltransferase activity; IEA:UniProtKB-EC
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0036155; P:acylglycerol acyl-chain remodeling; TAS:Reactome
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0071400; P:cellular response to oleic acid; ISS:BHF-UCL
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0035356; P:cellular triglyceride homeostasis; ISS:BHF-UCL
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0042632; P:cholesterol homeostasis; ISS:BHF-UCL
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0046339; P:diacylglycerol metabolic process; IDA:BHF-UCL
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0060613; P:fat pad development; ISS:BHF-UCL
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0055089; P:fatty acid homeostasis; ISS:BHF-UCL
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0006071; P:glycerol metabolic process; IEA:UniProtKB-KW
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0019915; P:lipid storage; ISS:BHF-UCL
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0035336; P:long-chain fatty-acyl-CoA metabolic process; IDA:BHF-UCL
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0034383; P:low-density lipoprotein particle clearance; ISS:BHF-UCL
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0097006; P:regulation of plasma lipoprotein particle levels; ISS:BHF-UCL
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96PD7	DGAT2	Diacylglycerol O-acyltransferase 2	GO:0019432; P:triglyceride biosynthetic process; IDA:UniProtKB
Q96DF8	DGCR14	Protein DGCR14	GO:0005515; F:protein binding; IPI:IntAct
Q96DF8	DGCR14	Protein DGCR14	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q96DF8	DGCR14	Protein DGCR14	GO:0007399; P:nervous system development; ISS:UniProtKB
Q14129	DGCR6	Protein DGCR6	GO:0007155; P:cell adhesion; TAS:ProtInc
Q14129	DGCR6	Protein DGCR6	GO:0009887; P:organ morphogenesis; TAS:ProtInc
Q8WYQ5	DGCR8	Microprocessor complex subunit DGCR8	GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB
Q8WYQ5	DGCR8	Microprocessor complex subunit DGCR8	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8WYQ5	DGCR8	Microprocessor complex subunit DGCR8	GO:0005515; F:protein binding; IPI:IntAct
Q8WYQ5	DGCR8	Microprocessor complex subunit DGCR8	GO:0010467; P:gene expression; TAS:Reactome
Q8WYQ5	DGCR8	Microprocessor complex subunit DGCR8	GO:0031053; P:primary miRNA processing; IDA:MGI
P23743	DGKA	Diacylglycerol kinase alpha	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P23743	DGKA	Diacylglycerol kinase alpha	GO:0005509; F:calcium ion binding; IEA:InterPro
P23743	DGKA	Diacylglycerol kinase alpha	GO:0004143; F:diacylglycerol kinase activity; TAS:ProtInc
P23743	DGKA	Diacylglycerol kinase alpha	GO:0003951; F:NAD+ kinase activity; IEA:InterPro
P23743	DGKA	Diacylglycerol kinase alpha	GO:0005543; F:phospholipid binding; IEA:Ensembl
P23743	DGKA	Diacylglycerol kinase alpha	GO:0007596; P:blood coagulation; TAS:Reactome
P23743	DGKA	Diacylglycerol kinase alpha	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
P23743	DGKA	Diacylglycerol kinase alpha	GO:0030168; P:platelet activation; TAS:Reactome
P23743	DGKA	Diacylglycerol kinase alpha	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:InterPro
Q9Y6T7	DGKB	Diacylglycerol kinase beta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y6T7	DGKB	Diacylglycerol kinase beta	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y6T7	DGKB	Diacylglycerol kinase beta	GO:0004143; F:diacylglycerol kinase activity; IEA:UniProtKB-EC
Q9Y6T7	DGKB	Diacylglycerol kinase beta	GO:0003951; F:NAD+ kinase activity; IEA:InterPro
Q9Y6T7	DGKB	Diacylglycerol kinase beta	GO:0007596; P:blood coagulation; TAS:Reactome
Q9Y6T7	DGKB	Diacylglycerol kinase beta	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9Y6T7	DGKB	Diacylglycerol kinase beta	GO:0030168; P:platelet activation; TAS:Reactome
Q9Y6T7	DGKB	Diacylglycerol kinase beta	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:InterPro
Q16760	DGKD	Diacylglycerol kinase delta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q16760	DGKD	Diacylglycerol kinase delta	GO:0019992; F:diacylglycerol binding; NAS:UniProtKB
Q16760	DGKD	Diacylglycerol kinase delta	GO:0004143; F:diacylglycerol kinase activity; TAS:UniProtKB
Q16760	DGKD	Diacylglycerol kinase delta	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q16760	DGKD	Diacylglycerol kinase delta	GO:0003951; F:NAD+ kinase activity; IEA:InterPro
Q16760	DGKD	Diacylglycerol kinase delta	GO:0005515; F:protein binding; IPI:IntAct
Q16760	DGKD	Diacylglycerol kinase delta	GO:0046982; F:protein heterodimerization activity; IDA:MGI
Q16760	DGKD	Diacylglycerol kinase delta	GO:0042803; F:protein homodimerization activity; IDA:MGI
Q16760	DGKD	Diacylglycerol kinase delta	GO:0007596; P:blood coagulation; TAS:Reactome
Q16760	DGKD	Diacylglycerol kinase delta	GO:0016049; P:cell growth; NAS:UniProtKB
Q16760	DGKD	Diacylglycerol kinase delta	GO:0046339; P:diacylglycerol metabolic process; NAS:UniProtKB
Q16760	DGKD	Diacylglycerol kinase delta	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q16760	DGKD	Diacylglycerol kinase delta	GO:0007173; P:epidermal growth factor receptor signaling pathway; NAS:UniProtKB
Q16760	DGKD	Diacylglycerol kinase delta	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
Q16760	DGKD	Diacylglycerol kinase delta	GO:0030168; P:platelet activation; TAS:Reactome
Q16760	DGKD	Diacylglycerol kinase delta	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
Q16760	DGKD	Diacylglycerol kinase delta	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; NAS:UniProtKB
Q16760	DGKD	Diacylglycerol kinase delta	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q16760	DGKD	Diacylglycerol kinase delta	GO:0010033; P:response to organic substance; IDA:UniProtKB
Q16760	DGKD	Diacylglycerol kinase delta	GO:0019932; P:second-messenger-mediated signaling; NAS:UniProtKB
Q16760	DGKD	Diacylglycerol kinase delta	GO:0007165; P:signal transduction; TAS:UniProtKB
P52429	DGKE	Diacylglycerol kinase epsilon	GO:0005524; F:ATP binding; TAS:ProtInc
P52429	DGKE	Diacylglycerol kinase epsilon	GO:0004143; F:diacylglycerol kinase activity; TAS:ProtInc
P52429	DGKE	Diacylglycerol kinase epsilon	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P52429	DGKE	Diacylglycerol kinase epsilon	GO:0003951; F:NAD+ kinase activity; IEA:InterPro
P52429	DGKE	Diacylglycerol kinase epsilon	GO:0007596; P:blood coagulation; TAS:Reactome
P52429	DGKE	Diacylglycerol kinase epsilon	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P52429	DGKE	Diacylglycerol kinase epsilon	GO:0008654; P:phospholipid biosynthetic process; TAS:ProtInc
P52429	DGKE	Diacylglycerol kinase epsilon	GO:0030168; P:platelet activation; TAS:Reactome
P52429	DGKE	Diacylglycerol kinase epsilon	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:InterPro
P49619	DGKG	Diacylglycerol kinase gamma	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49619	DGKG	Diacylglycerol kinase gamma	GO:0005509; F:calcium ion binding; IEA:InterPro
P49619	DGKG	Diacylglycerol kinase gamma	GO:0004143; F:diacylglycerol kinase activity; TAS:ProtInc
P49619	DGKG	Diacylglycerol kinase gamma	GO:0003951; F:NAD+ kinase activity; IEA:InterPro
P49619	DGKG	Diacylglycerol kinase gamma	GO:0007596; P:blood coagulation; TAS:Reactome
P49619	DGKG	Diacylglycerol kinase gamma	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P49619	DGKG	Diacylglycerol kinase gamma	GO:0048666; P:neuron development; IEA:Ensembl
P49619	DGKG	Diacylglycerol kinase gamma	GO:0030168; P:platelet activation; TAS:Reactome
P49619	DGKG	Diacylglycerol kinase gamma	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:InterPro
P49619	DGKG	Diacylglycerol kinase gamma	GO:0007165; P:signal transduction; TAS:ProtInc
Q86XP1	DGKH	Diacylglycerol kinase eta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86XP1	DGKH	Diacylglycerol kinase eta	GO:0004143; F:diacylglycerol kinase activity; IMP:UniProtKB
Q86XP1	DGKH	Diacylglycerol kinase eta	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86XP1	DGKH	Diacylglycerol kinase eta	GO:0003951; F:NAD+ kinase activity; IEA:InterPro
Q86XP1	DGKH	Diacylglycerol kinase eta	GO:0007596; P:blood coagulation; TAS:Reactome
Q86XP1	DGKH	Diacylglycerol kinase eta	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q86XP1	DGKH	Diacylglycerol kinase eta	GO:0030168; P:platelet activation; TAS:Reactome
Q86XP1	DGKH	Diacylglycerol kinase eta	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IMP:UniProtKB
Q86XP1	DGKH	Diacylglycerol kinase eta	GO:0051259; P:protein oligomerization; IMP:UniProtKB
Q5KSL6	DGKK	Diacylglycerol kinase kappa	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5KSL6	DGKK	Diacylglycerol kinase kappa	GO:0004143; F:diacylglycerol kinase activity; IDA:HGNC
Q5KSL6	DGKK	Diacylglycerol kinase kappa	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5KSL6	DGKK	Diacylglycerol kinase kappa	GO:0003951; F:NAD+ kinase activity; IEA:InterPro
Q5KSL6	DGKK	Diacylglycerol kinase kappa	GO:0007596; P:blood coagulation; TAS:Reactome
Q5KSL6	DGKK	Diacylglycerol kinase kappa	GO:0046339; P:diacylglycerol metabolic process; IDA:HGNC
Q5KSL6	DGKK	Diacylglycerol kinase kappa	GO:0035556; P:intracellular signal transduction; IDA:HGNC
Q5KSL6	DGKK	Diacylglycerol kinase kappa	GO:0030168; P:platelet activation; TAS:Reactome
Q5KSL6	DGKK	Diacylglycerol kinase kappa	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:InterPro
Q5KSL6	DGKK	Diacylglycerol kinase kappa	GO:0006979; P:response to oxidative stress; IDA:HGNC
O75912	DGKI	Diacylglycerol kinase iota	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75912	DGKI	Diacylglycerol kinase iota	GO:0004143; F:diacylglycerol kinase activity; TAS:ProtInc
O75912	DGKI	Diacylglycerol kinase iota	GO:0005095; F:GTPase inhibitor activity; IEA:Ensembl
O75912	DGKI	Diacylglycerol kinase iota	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75912	DGKI	Diacylglycerol kinase iota	GO:0003951; F:NAD+ kinase activity; IEA:InterPro
O75912	DGKI	Diacylglycerol kinase iota	GO:0005515; F:protein binding; IPI:IntAct
O75912	DGKI	Diacylglycerol kinase iota	GO:0007596; P:blood coagulation; TAS:Reactome
O75912	DGKI	Diacylglycerol kinase iota	GO:0035556; P:intracellular signal transduction; IEA:InterPro
O75912	DGKI	Diacylglycerol kinase iota	GO:0030168; P:platelet activation; TAS:Reactome
O75912	DGKI	Diacylglycerol kinase iota	GO:0046579; P:positive regulation of Ras protein signal transduction; IEA:Ensembl
O75912	DGKI	Diacylglycerol kinase iota	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:InterPro
O75912	DGKI	Diacylglycerol kinase iota	GO:0032317; P:regulation of Rap GTPase activity; IEA:Ensembl
P52824	DGKQ	Diacylglycerol kinase theta	GO:0033613; F:activating transcription factor binding; IPI:UniProtKB
P52824	DGKQ	Diacylglycerol kinase theta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P52824	DGKQ	Diacylglycerol kinase theta	GO:0004143; F:diacylglycerol kinase activity; IDA:UniProtKB
P52824	DGKQ	Diacylglycerol kinase theta	GO:0019900; F:kinase binding; IPI:UniProtKB
P52824	DGKQ	Diacylglycerol kinase theta	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P52824	DGKQ	Diacylglycerol kinase theta	GO:0003951; F:NAD+ kinase activity; IEA:InterPro
P52824	DGKQ	Diacylglycerol kinase theta	GO:0043274; F:phospholipase binding; IPI:UniProtKB
P52824	DGKQ	Diacylglycerol kinase theta	GO:0005515; F:protein binding; IPI:UniProtKB
P52824	DGKQ	Diacylglycerol kinase theta	GO:0007596; P:blood coagulation; TAS:Reactome
P52824	DGKQ	Diacylglycerol kinase theta	GO:0019933; P:cAMP-mediated signaling; IDA:UniProtKB
P52824	DGKQ	Diacylglycerol kinase theta	GO:0007186; P:G-protein coupled receptor signaling pathway; IMP:UniProtKB
P52824	DGKQ	Diacylglycerol kinase theta	GO:0030168; P:platelet activation; TAS:Reactome
P52824	DGKQ	Diacylglycerol kinase theta	GO:0070528; P:protein kinase C signaling; IDA:UniProtKB
P52824	DGKQ	Diacylglycerol kinase theta	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:InterPro
P52824	DGKQ	Diacylglycerol kinase theta	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P52824	DGKQ	Diacylglycerol kinase theta	GO:0033198; P:response to ATP; IDA:UniProtKB
P52824	DGKQ	Diacylglycerol kinase theta	GO:0070493; P:thrombin receptor signaling pathway; IDA:UniProtKB
Q13574	DGKZ	Diacylglycerol kinase zeta	GO:0005524; F:ATP binding; TAS:ProtInc
Q13574	DGKZ	Diacylglycerol kinase zeta	GO:0004143; F:diacylglycerol kinase activity; IDA:UniProtKB
Q13574	DGKZ	Diacylglycerol kinase zeta	GO:0004857; F:enzyme inhibitor activity; IEA:Ensembl
Q13574	DGKZ	Diacylglycerol kinase zeta	GO:0001727; F:lipid kinase activity; IDA:UniProtKB
Q13574	DGKZ	Diacylglycerol kinase zeta	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13574	DGKZ	Diacylglycerol kinase zeta	GO:0003951; F:NAD+ kinase activity; IEA:InterPro
Q13574	DGKZ	Diacylglycerol kinase zeta	GO:0005515; F:protein binding; IPI:UniProtKB
Q13574	DGKZ	Diacylglycerol kinase zeta	GO:0008022; F:protein C-terminus binding; IDA:UniProtKB
Q13574	DGKZ	Diacylglycerol kinase zeta	GO:0007596; P:blood coagulation; TAS:Reactome
Q13574	DGKZ	Diacylglycerol kinase zeta	GO:0016477; P:cell migration; NAS:UniProtKB
Q13574	DGKZ	Diacylglycerol kinase zeta	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q13574	DGKZ	Diacylglycerol kinase zeta	GO:0046834; P:lipid phosphorylation; IDA:GOC
Q13574	DGKZ	Diacylglycerol kinase zeta	GO:0031571; P:mitotic G1 DNA damage checkpoint; IGI:UniProtKB
Q13574	DGKZ	Diacylglycerol kinase zeta	GO:0045930; P:negative regulation of mitotic cell cycle; IGI:UniProtKB
Q13574	DGKZ	Diacylglycerol kinase zeta	GO:0046580; P:negative regulation of Ras protein signal transduction; IEA:Ensembl
Q13574	DGKZ	Diacylglycerol kinase zeta	GO:0016310; P:phosphorylation; IDA:GOC
Q13574	DGKZ	Diacylglycerol kinase zeta	GO:0030168; P:platelet activation; TAS:Reactome
Q13574	DGKZ	Diacylglycerol kinase zeta	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:InterPro
Q9Y4D2	DAGLA	Sn1-specific diacylglycerol lipase alpha	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y4D2	DAGLA	Sn1-specific diacylglycerol lipase alpha	GO:0004806; F:triglyceride lipase activity; IEA:InterPro
Q9Y4D2	DAGLA	Sn1-specific diacylglycerol lipase alpha	GO:0019369; P:arachidonic acid metabolic process; IDA:UniProtKB
Q9Y4D2	DAGLA	Sn1-specific diacylglycerol lipase alpha	GO:0007596; P:blood coagulation; TAS:Reactome
Q9Y4D2	DAGLA	Sn1-specific diacylglycerol lipase alpha	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9Y4D2	DAGLA	Sn1-specific diacylglycerol lipase alpha	GO:0046340; P:diacylglycerol catabolic process; IDA:UniProtKB
Q9Y4D2	DAGLA	Sn1-specific diacylglycerol lipase alpha	GO:0071926; P:endocannabinoid signaling pathway; IEA:Ensembl
Q9Y4D2	DAGLA	Sn1-specific diacylglycerol lipase alpha	GO:0007405; P:neuroblast proliferation; IEA:Ensembl
Q9Y4D2	DAGLA	Sn1-specific diacylglycerol lipase alpha	GO:0042136; P:neurotransmitter biosynthetic process; IDA:UniProtKB
Q9Y4D2	DAGLA	Sn1-specific diacylglycerol lipase alpha	GO:0030168; P:platelet activation; TAS:Reactome
Q8NCG7	DAGLB	Sn1-specific diacylglycerol lipase beta	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NCG7	DAGLB	Sn1-specific diacylglycerol lipase beta	GO:0004806; F:triglyceride lipase activity; IEA:InterPro
Q8NCG7	DAGLB	Sn1-specific diacylglycerol lipase beta	GO:0019369; P:arachidonic acid metabolic process; IDA:UniProtKB
Q8NCG7	DAGLB	Sn1-specific diacylglycerol lipase beta	GO:0007596; P:blood coagulation; TAS:Reactome
Q8NCG7	DAGLB	Sn1-specific diacylglycerol lipase beta	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q8NCG7	DAGLB	Sn1-specific diacylglycerol lipase beta	GO:0007405; P:neuroblast proliferation; IEA:Ensembl
Q8NCG7	DAGLB	Sn1-specific diacylglycerol lipase beta	GO:0042136; P:neurotransmitter biosynthetic process; IEA:Ensembl
Q8NCG7	DAGLB	Sn1-specific diacylglycerol lipase beta	GO:0030168; P:platelet activation; TAS:Reactome
Q16854	DGUOK	Deoxyguanosine kinase, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q16854	DGUOK	Deoxyguanosine kinase, mitochondrial	GO:0004138; F:deoxyguanosine kinase activity; IDA:UniProtKB
Q16854	DGUOK	Deoxyguanosine kinase, mitochondrial	GO:0019206; F:nucleoside kinase activity; EXP:Reactome
Q16854	DGUOK	Deoxyguanosine kinase, mitochondrial	GO:0016773; F:phosphotransferase activity, alcohol group as acceptor; IEA:InterPro
Q16854	DGUOK	Deoxyguanosine kinase, mitochondrial	GO:0009157; P:deoxyribonucleoside monophosphate biosynthetic process; IDA:GOC
Q16854	DGUOK	Deoxyguanosine kinase, mitochondrial	GO:0046070; P:dGTP metabolic process; IEA:Ensembl
Q16854	DGUOK	Deoxyguanosine kinase, mitochondrial	GO:0008617; P:guanosine metabolic process; TAS:ProtInc
Q16854	DGUOK	Deoxyguanosine kinase, mitochondrial	GO:0010977; P:negative regulation of neuron projection development; IEA:Ensembl
Q16854	DGUOK	Deoxyguanosine kinase, mitochondrial	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q16854	DGUOK	Deoxyguanosine kinase, mitochondrial	GO:0009165; P:nucleotide biosynthetic process; EXP:GOC
Q16854	DGUOK	Deoxyguanosine kinase, mitochondrial	GO:0006468; P:protein phosphorylation; IEA:Ensembl
Q16854	DGUOK	Deoxyguanosine kinase, mitochondrial	GO:0046122; P:purine deoxyribonucleoside metabolic process; IDA:UniProtKB
Q16854	DGUOK	Deoxyguanosine kinase, mitochondrial	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
Q16854	DGUOK	Deoxyguanosine kinase, mitochondrial	GO:0043101; P:purine-containing compound salvage; TAS:Reactome
Q16854	DGUOK	Deoxyguanosine kinase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q3LXA3	DAK	Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q3LXA3	DAK	Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)	GO:0034012; F:FAD-AMP lyase (cyclizing) activity; IDA:UniProt
Q3LXA3	DAK	Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)	GO:0004371; F:glycerone kinase activity; IDA:UniProt
Q3LXA3	DAK	Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q3LXA3	DAK	Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)	GO:0050354; F:triokinase activity; IDA:UniProt
Q3LXA3	DAK	Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)	GO:0046835; P:carbohydrate phosphorylation; IDA:UniProt
Q3LXA3	DAK	Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)	GO:0044262; P:cellular carbohydrate metabolic process; IDA:UniProt
Q3LXA3	DAK	Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)	GO:0006071; P:glycerol metabolic process; IEA:InterPro
Q3LXA3	DAK	Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)	GO:0045087; P:innate immune response; TAS:Reactome
Q3LXA3	DAK	Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)	GO:0045088; P:regulation of innate immune response; IDA:UniProt
Q8NBQ5	HSD17B11	Estradiol 17-beta-dehydrogenase 11	GO:0004303; F:estradiol 17-beta-dehydrogenase activity; IEA:UniProtKB-EC
Q8NBQ5	HSD17B11	Estradiol 17-beta-dehydrogenase 11	GO:0016229; F:steroid dehydrogenase activity; IDA:HGNC
Q8NBQ5	HSD17B11	Estradiol 17-beta-dehydrogenase 11	GO:0006710; P:androgen catabolic process; IDA:HGNC
Q8NBQ5	HSD17B11	Estradiol 17-beta-dehydrogenase 11	GO:0006694; P:steroid biosynthetic process; IEA:UniProtKB-KW
Q53GQ0	HSD17B12	Estradiol 17-beta-dehydrogenase 12	GO:0004303; F:estradiol 17-beta-dehydrogenase activity; IEA:UniProtKB-EC
Q53GQ0	HSD17B12	Estradiol 17-beta-dehydrogenase 12	GO:0008201; F:heparin binding; IEA:Ensembl
Q53GQ0	HSD17B12	Estradiol 17-beta-dehydrogenase 12	GO:0005515; F:protein binding; IPI:UniProtKB
Q53GQ0	HSD17B12	Estradiol 17-beta-dehydrogenase 12	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q53GQ0	HSD17B12	Estradiol 17-beta-dehydrogenase 12	GO:0006703; P:estrogen biosynthetic process; IEA:UniProtKB-UniPathway
Q53GQ0	HSD17B12	Estradiol 17-beta-dehydrogenase 12	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q53GQ0	HSD17B12	Estradiol 17-beta-dehydrogenase 12	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-UniPathway
Q53GQ0	HSD17B12	Estradiol 17-beta-dehydrogenase 12	GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome
Q53GQ0	HSD17B12	Estradiol 17-beta-dehydrogenase 12	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
Q53GQ0	HSD17B12	Estradiol 17-beta-dehydrogenase 12	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q53GQ0	HSD17B12	Estradiol 17-beta-dehydrogenase 12	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
Q7Z5P4	HSD17B13	17-beta-hydroxysteroid dehydrogenase 13	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q9BPX1	HSD17B14	17-beta-hydroxysteroid dehydrogenase 14	GO:0004303; F:estradiol 17-beta-dehydrogenase activity; IDA:HGNC
Q9BPX1	HSD17B14	17-beta-hydroxysteroid dehydrogenase 14	GO:0005515; F:protein binding; IPI:IntAct
Q9BPX1	HSD17B14	17-beta-hydroxysteroid dehydrogenase 14	GO:0047045; F:testosterone 17-beta-dehydrogenase (NADP+) activity; IDA:HGNC
Q9BPX1	HSD17B14	17-beta-hydroxysteroid dehydrogenase 14	GO:0006706; P:steroid catabolic process; IDA:HGNC
P14061	HSD17B1	Estradiol 17-beta-dehydrogenase 1	GO:0003824; F:catalytic activity; TAS:ProtInc
P14061	HSD17B1	Estradiol 17-beta-dehydrogenase 1	GO:0004303; F:estradiol 17-beta-dehydrogenase activity; TAS:Reactome
P14061	HSD17B1	Estradiol 17-beta-dehydrogenase 1	GO:0060348; P:bone development; IEA:Ensembl
P14061	HSD17B1	Estradiol 17-beta-dehydrogenase 1	GO:0071248; P:cellular response to metal ion; IEA:Ensembl
P14061	HSD17B1	Estradiol 17-beta-dehydrogenase 1	GO:0006703; P:estrogen biosynthetic process; TAS:Reactome
P14061	HSD17B1	Estradiol 17-beta-dehydrogenase 1	GO:0008210; P:estrogen metabolic process; TAS:ProtInc
P14061	HSD17B1	Estradiol 17-beta-dehydrogenase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P14061	HSD17B1	Estradiol 17-beta-dehydrogenase 1	GO:0006694; P:steroid biosynthetic process; TAS:ProtInc
P14061	HSD17B1	Estradiol 17-beta-dehydrogenase 1	GO:0008202; P:steroid metabolic process; TAS:Reactome
P14061	HSD17B1	Estradiol 17-beta-dehydrogenase 1	GO:0061370; P:testosterone biosynthetic process; IEA:Ensembl
P37059	HSD17B2	Estradiol 17-beta-dehydrogenase 2	GO:0047006; F:17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity; TAS:BHF-UCL
P37059	HSD17B2	Estradiol 17-beta-dehydrogenase 2	GO:0004303; F:estradiol 17-beta-dehydrogenase activity; IDA:UniProtKB
P37059	HSD17B2	Estradiol 17-beta-dehydrogenase 2	GO:0047035; F:testosterone dehydrogenase (NAD+) activity; IDA:UniProtKB
P37059	HSD17B2	Estradiol 17-beta-dehydrogenase 2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P37059	HSD17B2	Estradiol 17-beta-dehydrogenase 2	GO:0001890; P:placenta development; IEA:Ensembl
P37059	HSD17B2	Estradiol 17-beta-dehydrogenase 2	GO:0032526; P:response to retinoic acid; IDA:BHF-UCL
P37059	HSD17B2	Estradiol 17-beta-dehydrogenase 2	GO:0006694; P:steroid biosynthetic process; IEA:UniProtKB-KW
P37058	HSD17B3	Testosterone 17-beta-dehydrogenase 3	GO:0047045; F:testosterone 17-beta-dehydrogenase (NADP+) activity; IEA:UniProtKB-EC
P37058	HSD17B3	Testosterone 17-beta-dehydrogenase 3	GO:0006702; P:androgen biosynthetic process; TAS:Reactome
P37058	HSD17B3	Testosterone 17-beta-dehydrogenase 3	GO:0030539; P:male genitalia development; TAS:ProtInc
P37058	HSD17B3	Testosterone 17-beta-dehydrogenase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P37058	HSD17B3	Testosterone 17-beta-dehydrogenase 3	GO:0008202; P:steroid metabolic process; TAS:Reactome
P37058	HSD17B3	Testosterone 17-beta-dehydrogenase 3	GO:0061370; P:testosterone biosynthetic process; IEA:UniProtKB-UniPathway
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0044594; F:17-beta-hydroxysteroid dehydrogenase (NAD+) activity; IDA:UniProtKB
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0003857; F:3-hydroxyacyl-CoA dehydrogenase activity; IDA:UniProtKB
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0033989; F:3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; TAS:Reactome
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0016853; F:isomerase activity; IEA:UniProtKB-KW
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0016508; F:long-chain-enoyl-CoA hydratase activity; IDA:UniProtKB
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0005102; F:receptor binding; IPI:UniProtKB
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0032934; F:sterol binding; IEA:InterPro
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0036109; P:alpha-linolenic acid metabolic process; TAS:Reactome
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0008209; P:androgen metabolic process; IDA:UniProtKB
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0006699; P:bile acid biosynthetic process; TAS:Reactome
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0008206; P:bile acid metabolic process; TAS:Reactome
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0008210; P:estrogen metabolic process; IDA:UniProtKB
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0006635; P:fatty acid beta-oxidation; IDA:UniProtKB
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0033540; P:fatty acid beta-oxidation using acyl-CoA oxidase; TAS:Reactome
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0036112; P:medium-chain fatty-acyl-CoA metabolic process; IDA:UniProtKB
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0008152; P:metabolic process; IDA:GOC
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0055114; P:oxidation-reduction process; IDA:GOC
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0060009; P:Sertoli cell development; IEA:Ensembl
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0033559; P:unsaturated fatty acid metabolic process; TAS:Reactome
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0000038; P:very long-chain fatty acid metabolic process; IEA:Ensembl
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	GO:0036111; P:very long-chain fatty-acyl-CoA metabolic process; IDA:UniProtKB
P56937	HSD17B7	3-keto-steroid reductase	GO:0000253; F:3-keto sterol reductase activity; IEA:UniProtKB-EC
P56937	HSD17B7	3-keto-steroid reductase	GO:0004303; F:estradiol 17-beta-dehydrogenase activity; TAS:ProtInc
P56937	HSD17B7	3-keto-steroid reductase	GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome
P56937	HSD17B7	3-keto-steroid reductase	GO:0006703; P:estrogen biosynthetic process; IEA:UniProtKB-UniPathway
P56937	HSD17B7	3-keto-steroid reductase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q92506	HSD17B8	Estradiol 17-beta-dehydrogenase 8	GO:0003857; F:3-hydroxyacyl-CoA dehydrogenase activity; IDA:UniProtKB
Q92506	HSD17B8	Estradiol 17-beta-dehydrogenase 8	GO:0004303; F:estradiol 17-beta-dehydrogenase activity; IDA:UniProtKB
Q92506	HSD17B8	Estradiol 17-beta-dehydrogenase 8	GO:0005515; F:protein binding; IPI:UniProtKB
Q92506	HSD17B8	Estradiol 17-beta-dehydrogenase 8	GO:0047035; F:testosterone dehydrogenase (NAD+) activity; IEA:UniProtKB-EC
Q92506	HSD17B8	Estradiol 17-beta-dehydrogenase 8	GO:0008209; P:androgen metabolic process; IEA:Ensembl
Q92506	HSD17B8	Estradiol 17-beta-dehydrogenase 8	GO:0006703; P:estrogen biosynthetic process; IDA:UniProtKB
Q92506	HSD17B8	Estradiol 17-beta-dehydrogenase 8	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-UniPathway
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0050614; F:delta24-sterol reductase activity; IEA:UniProtKB-EC
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0016628; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; IDA:MGI
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0042605; F:peptide antigen binding; IPI:UniProtKB
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0008762; F:UDP-N-acetylmuramate dehydrogenase activity; IEA:InterPro
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0042987; P:amyloid precursor protein catabolic process; IEA:Ensembl
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0007050; P:cell cycle arrest; NAS:UniProtKB
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0006695; P:cholesterol biosynthetic process; ISS:UniProtKB
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0030539; P:male genitalia development; IEA:Ensembl
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0031639; P:plasminogen activation; IEA:Ensembl
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0008104; P:protein localization; IEA:Ensembl
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0007265; P:Ras protein signal transduction; IEA:Ensembl
Q15392	DHCR24	Delta(24)-sterol reductase	GO:1901214; P:regulation of neuron death; NAS:UniProtKB
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0009725; P:response to hormone; IEA:Ensembl
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0006979; P:response to oxidative stress; IEP:UniProtKB
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0043588; P:skin development; ISS:UniProtKB
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15392	DHCR24	Delta(24)-sterol reductase	GO:0009888; P:tissue development; IMP:UniProtKB
Q9UBM7	DHCR7	7-dehydrocholesterol reductase	GO:0047598; F:7-dehydrocholesterol reductase activity; IDA:UniProtKB
Q9UBM7	DHCR7	7-dehydrocholesterol reductase	GO:0001568; P:blood vessel development; IEA:Ensembl
Q9UBM7	DHCR7	7-dehydrocholesterol reductase	GO:0030154; P:cell differentiation; IEA:Ensembl
Q9UBM7	DHCR7	7-dehydrocholesterol reductase	GO:0006695; P:cholesterol biosynthetic process; IMP:UniProtKB
Q9UBM7	DHCR7	7-dehydrocholesterol reductase	GO:0030324; P:lung development; IEA:Ensembl
Q9UBM7	DHCR7	7-dehydrocholesterol reductase	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q9UBM7	DHCR7	7-dehydrocholesterol reductase	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q9UBM7	DHCR7	7-dehydrocholesterol reductase	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q9UBM7	DHCR7	7-dehydrocholesterol reductase	GO:0045540; P:regulation of cholesterol biosynthetic process; IEA:Ensembl
Q9UBM7	DHCR7	7-dehydrocholesterol reductase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q86SQ9	DHDDS	Dehydrodolichyl diphosphate synthase	GO:0005515; F:protein binding; IPI:UniProtKB
Q86SQ9	DHDDS	Dehydrodolichyl diphosphate synthase	GO:0016765; F:transferase activity, transferring alkyl or aryl (other than methyl) groups; IEA:InterPro
Q86SQ9	DHDDS	Dehydrodolichyl diphosphate synthase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q86SQ9	DHDDS	Dehydrodolichyl diphosphate synthase	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q86SQ9	DHDDS	Dehydrodolichyl diphosphate synthase	GO:0006489; P:dolichyl diphosphate biosynthetic process; TAS:Reactome
Q86SQ9	DHDDS	Dehydrodolichyl diphosphate synthase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q86SQ9	DHDDS	Dehydrodolichyl diphosphate synthase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9UQ10	DHDH	Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase	GO:0047837; F:D-xylose 1-dehydrogenase (NADP+) activity; IEA:UniProtKB-EC
Q9UQ10	DHDH	Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase	GO:0009055; F:electron carrier activity; TAS:UniProtKB
Q9UQ10	DHDH	Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase	GO:0008746; F:NAD(P)+ transhydrogenase activity; TAS:ProtInc
Q9UQ10	DHDH	Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase	GO:0047115; F:trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity; IEA:UniProtKB-EC
Q9UQ10	DHDH	Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
Q9UQ10	DHDH	Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase	GO:0042843; P:D-xylose catabolic process; IEA:Ensembl
P00367	GLUD1	Glutamate dehydrogenase 1, mitochondrial	GO:0043531; F:ADP binding; IDA:BHF-UCL
P00367	GLUD1	Glutamate dehydrogenase 1, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P00367	GLUD1	Glutamate dehydrogenase 1, mitochondrial	GO:0004352; F:glutamate dehydrogenase (NAD+) activity; IDA:UniProtKB
P00367	GLUD1	Glutamate dehydrogenase 1, mitochondrial	GO:0004353; F:glutamate dehydrogenase [NAD(P)+] activity; IDA:BHF-UCL
P00367	GLUD1	Glutamate dehydrogenase 1, mitochondrial	GO:0005525; F:GTP binding; IDA:BHF-UCL
P00367	GLUD1	Glutamate dehydrogenase 1, mitochondrial	GO:0042802; F:identical protein binding; TAS:BHF-UCL
P00367	GLUD1	Glutamate dehydrogenase 1, mitochondrial	GO:0070728; F:leucine binding; IDA:BHF-UCL
P00367	GLUD1	Glutamate dehydrogenase 1, mitochondrial	GO:0070403; F:NAD+ binding; IDA:BHF-UCL
P00367	GLUD1	Glutamate dehydrogenase 1, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
P00367	GLUD1	Glutamate dehydrogenase 1, mitochondrial	GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome
P00367	GLUD1	Glutamate dehydrogenase 1, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P00367	GLUD1	Glutamate dehydrogenase 1, mitochondrial	GO:0006537; P:glutamate biosynthetic process; IDA:BHF-UCL
P00367	GLUD1	Glutamate dehydrogenase 1, mitochondrial	GO:0006538; P:glutamate catabolic process; IDA:UniProtKB
P00367	GLUD1	Glutamate dehydrogenase 1, mitochondrial	GO:0006541; P:glutamine metabolic process; ISS:UniProtKB
P00367	GLUD1	Glutamate dehydrogenase 1, mitochondrial	GO:0032024; P:positive regulation of insulin secretion; IMP:BHF-UCL
P00367	GLUD1	Glutamate dehydrogenase 1, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P00367	GLUD1	Glutamate dehydrogenase 1, mitochondrial	GO:0072350; P:tricarboxylic acid metabolic process; ISS:UniProtKB
P49448	GLUD2	Glutamate dehydrogenase 2, mitochondrial	GO:0043531; F:ADP binding; IDA:BHF-UCL
P49448	GLUD2	Glutamate dehydrogenase 2, mitochondrial	GO:0004352; F:glutamate dehydrogenase (NAD+) activity; IDA:UniProtKB
P49448	GLUD2	Glutamate dehydrogenase 2, mitochondrial	GO:0004353; F:glutamate dehydrogenase [NAD(P)+] activity; IDA:BHF-UCL
P49448	GLUD2	Glutamate dehydrogenase 2, mitochondrial	GO:0005525; F:GTP binding; IDA:BHF-UCL
P49448	GLUD2	Glutamate dehydrogenase 2, mitochondrial	GO:0070728; F:leucine binding; IDA:BHF-UCL
P49448	GLUD2	Glutamate dehydrogenase 2, mitochondrial	GO:0006537; P:glutamate biosynthetic process; IDA:BHF-UCL
P49448	GLUD2	Glutamate dehydrogenase 2, mitochondrial	GO:0006538; P:glutamate catabolic process; IDA:BHF-UCL
P49448	GLUD2	Glutamate dehydrogenase 2, mitochondrial	GO:0006536; P:glutamate metabolic process; IDA:UniProtKB
P49448	GLUD2	Glutamate dehydrogenase 2, mitochondrial	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
O43323	DHH	Desert hedgehog protein	GO:0005509; F:calcium ion binding; IDA:UniProtKB
O43323	DHH	Desert hedgehog protein	GO:0008233; F:peptidase activity; IEA:UniProtKB-KW
O43323	DHH	Desert hedgehog protein	GO:0005515; F:protein binding; IPI:BHF-UCL
O43323	DHH	Desert hedgehog protein	GO:0008270; F:zinc ion binding; IDA:UniProtKB
O43323	DHH	Desert hedgehog protein	GO:0007267; P:cell-cell signaling; IEA:InterPro
O43323	DHH	Desert hedgehog protein	GO:0033327; P:Leydig cell differentiation; IEA:Ensembl
O43323	DHH	Desert hedgehog protein	GO:0030238; P:male sex determination; IEA:Ensembl
O43323	DHH	Desert hedgehog protein	GO:0042552; P:myelination; IEA:Ensembl
O43323	DHH	Desert hedgehog protein	GO:0050810; P:regulation of steroid biosynthetic process; IEA:Ensembl
O43323	DHH	Desert hedgehog protein	GO:0032355; P:response to estradiol; IEA:Ensembl
O43323	DHH	Desert hedgehog protein	GO:0007286; P:spermatid development; IEA:Ensembl
Q7Z5J1	HSD11B1L	Hydroxysteroid 11-beta-dehydrogenase 1-like protein	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
P28845	HSD11B1	Corticosteroid 11-beta-dehydrogenase isozyme 1	GO:0070524; F:11-beta-hydroxysteroid dehydrogenase (NADP+) activity; IEA:UniProtKB-EC
P28845	HSD11B1	Corticosteroid 11-beta-dehydrogenase isozyme 1	GO:0003845; F:11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity; TAS:Reactome
P28845	HSD11B1	Corticosteroid 11-beta-dehydrogenase isozyme 1	GO:0006704; P:glucocorticoid biosynthetic process; TAS:Reactome
P28845	HSD11B1	Corticosteroid 11-beta-dehydrogenase isozyme 1	GO:0030324; P:lung development; IEA:Ensembl
P28845	HSD11B1	Corticosteroid 11-beta-dehydrogenase isozyme 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P28845	HSD11B1	Corticosteroid 11-beta-dehydrogenase isozyme 1	GO:0008202; P:steroid metabolic process; TAS:Reactome
P80365	HSD11B2	Corticosteroid 11-beta-dehydrogenase isozyme 2	GO:0003845; F:11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity; IEA:Ensembl
P80365	HSD11B2	Corticosteroid 11-beta-dehydrogenase isozyme 2	GO:0051287; F:NAD binding; IEA:Ensembl
P80365	HSD11B2	Corticosteroid 11-beta-dehydrogenase isozyme 2	GO:0005496; F:steroid binding; IEA:Ensembl
P80365	HSD11B2	Corticosteroid 11-beta-dehydrogenase isozyme 2	GO:0007565; P:female pregnancy; IEA:Ensembl
P80365	HSD11B2	Corticosteroid 11-beta-dehydrogenase isozyme 2	GO:0006704; P:glucocorticoid biosynthetic process; TAS:ProtInc
P80365	HSD11B2	Corticosteroid 11-beta-dehydrogenase isozyme 2	GO:0002017; P:regulation of blood volume by renal aldosterone; IEA:Ensembl
P80365	HSD11B2	Corticosteroid 11-beta-dehydrogenase isozyme 2	GO:0042493; P:response to drug; IEA:Ensembl
P80365	HSD11B2	Corticosteroid 11-beta-dehydrogenase isozyme 2	GO:0032094; P:response to food; IEA:Ensembl
P80365	HSD11B2	Corticosteroid 11-beta-dehydrogenase isozyme 2	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P80365	HSD11B2	Corticosteroid 11-beta-dehydrogenase isozyme 2	GO:0001666; P:response to hypoxia; IEA:Ensembl
P80365	HSD11B2	Corticosteroid 11-beta-dehydrogenase isozyme 2	GO:0032868; P:response to insulin; IEA:Ensembl
P09417	QDPR	Dihydropteridine reductase	GO:0004155; F:6,7-dihydropteridine reductase activity; EXP:Reactome
P09417	QDPR	Dihydropteridine reductase	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P09417	QDPR	Dihydropteridine reductase	GO:0070404; F:NADH binding; IEA:Ensembl
P09417	QDPR	Dihydropteridine reductase	GO:0070402; F:NADPH binding; IEA:Ensembl
P09417	QDPR	Dihydropteridine reductase	GO:0016491; F:oxidoreductase activity; IEA:InterPro
P09417	QDPR	Dihydropteridine reductase	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
P09417	QDPR	Dihydropteridine reductase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P09417	QDPR	Dihydropteridine reductase	GO:0035690; P:cellular response to drug; IEA:Ensembl
P09417	QDPR	Dihydropteridine reductase	GO:0051066; P:dihydrobiopterin metabolic process; TAS:ProtInc
P09417	QDPR	Dihydropteridine reductase	GO:0006559; P:L-phenylalanine catabolic process; TAS:Reactome
P09417	QDPR	Dihydropteridine reductase	GO:0001889; P:liver development; IEA:Ensembl
P09417	QDPR	Dihydropteridine reductase	GO:0010044; P:response to aluminum ion; IEA:Ensembl
P09417	QDPR	Dihydropteridine reductase	GO:0033762; P:response to glucagon; IEA:Ensembl
P09417	QDPR	Dihydropteridine reductase	GO:0010288; P:response to lead ion; IEA:Ensembl
P09417	QDPR	Dihydropteridine reductase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P09417	QDPR	Dihydropteridine reductase	GO:0006729; P:tetrahydrobiopterin biosynthetic process; IEA:UniProtKB-KW
Q6UWP2	DHRS11	Dehydrogenase/reductase SDR family member 11	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
A0PJE2	DHRS12	Dehydrogenase/reductase SDR family member 12	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q6UX07	DHRS13	Dehydrogenase/reductase SDR family member 13	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q96LJ7	DHRS1	Dehydrogenase/reductase SDR family member 1	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q13268	DHRS2	Dehydrogenase/reductase SDR family member 2, mitochondrial	GO:0004090; F:carbonyl reductase (NADPH) activity; IDA:UniProtKB
Q13268	DHRS2	Dehydrogenase/reductase SDR family member 2, mitochondrial	GO:0008207; P:C21-steroid hormone metabolic process; NAS:UniProtKB
Q13268	DHRS2	Dehydrogenase/reductase SDR family member 2, mitochondrial	GO:0034599; P:cellular response to oxidative stress; IDA:UniProtKB
Q13268	DHRS2	Dehydrogenase/reductase SDR family member 2, mitochondrial	GO:0043011; P:myeloid dendritic cell differentiation; IEP:UniProtKB
Q13268	DHRS2	Dehydrogenase/reductase SDR family member 2, mitochondrial	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q13268	DHRS2	Dehydrogenase/reductase SDR family member 2, mitochondrial	GO:0008285; P:negative regulation of cell proliferation; NAS:UniProtKB
Q13268	DHRS2	Dehydrogenase/reductase SDR family member 2, mitochondrial	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q13268	DHRS2	Dehydrogenase/reductase SDR family member 2, mitochondrial	GO:0009636; P:response to toxic substance; IDA:UniProtKB
O75911	DHRS3	Short-chain dehydrogenase/reductase 3	GO:0009055; F:electron carrier activity; TAS:UniProtKB
O75911	DHRS3	Short-chain dehydrogenase/reductase 3	GO:0052650; F:NADP-retinol dehydrogenase activity; IEA:UniProtKB-EC
O75911	DHRS3	Short-chain dehydrogenase/reductase 3	GO:0000166; F:nucleotide binding; TAS:ProtInc
O75911	DHRS3	Short-chain dehydrogenase/reductase 3	GO:0007603; P:phototransduction, visible light; TAS:Reactome
O75911	DHRS3	Short-chain dehydrogenase/reductase 3	GO:0001523; P:retinoid metabolic process; TAS:Reactome
O75911	DHRS3	Short-chain dehydrogenase/reductase 3	GO:0042572; P:retinol metabolic process; TAS:UniProtKB
O75911	DHRS3	Short-chain dehydrogenase/reductase 3	GO:0007601; P:visual perception; TAS:ProtInc
Q9BTZ2	DHRS4	Dehydrogenase/reductase SDR family member 4	GO:0000253; F:3-keto sterol reductase activity; IDA:UniProtKB
Q9BTZ2	DHRS4	Dehydrogenase/reductase SDR family member 4	GO:0018455; F:alcohol dehydrogenase [NAD(P)+] activity; IDA:UniProtKB
Q9BTZ2	DHRS4	Dehydrogenase/reductase SDR family member 4	GO:0004090; F:carbonyl reductase (NADPH) activity; IDA:UniProtKB
Q9BTZ2	DHRS4	Dehydrogenase/reductase SDR family member 4	GO:0016655; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; IDA:UniProtKB
Q9BTZ2	DHRS4	Dehydrogenase/reductase SDR family member 4	GO:0005102; F:receptor binding; IPI:UniProtKB
Q9BTZ2	DHRS4	Dehydrogenase/reductase SDR family member 4	GO:0006066; P:alcohol metabolic process; IDA:UniProtKB
Q9BTZ2	DHRS4	Dehydrogenase/reductase SDR family member 4	GO:0042180; P:cellular ketone metabolic process; IDA:UniProtKB
Q9BTZ2	DHRS4	Dehydrogenase/reductase SDR family member 4	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q9BTZ2	DHRS4	Dehydrogenase/reductase SDR family member 4	GO:0051262; P:protein tetramerization; IDA:UniProtKB
Q9BTZ2	DHRS4	Dehydrogenase/reductase SDR family member 4	GO:0008202; P:steroid metabolic process; IDA:UniProtKB
Q9Y394	DHRS7	Dehydrogenase/reductase SDR family member 7	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q9BPW9	DHRS9	Dehydrogenase/reductase SDR family member 9	GO:0004022; F:alcohol dehydrogenase (NAD) activity; IDA:UniProtKB
Q9BPW9	DHRS9	Dehydrogenase/reductase SDR family member 9	GO:0016491; F:oxidoreductase activity; IEA:InterPro
Q9BPW9	DHRS9	Dehydrogenase/reductase SDR family member 9	GO:0016854; F:racemase and epimerase activity; NAS:UniProtKB
Q9BPW9	DHRS9	Dehydrogenase/reductase SDR family member 9	GO:0004745; F:retinol dehydrogenase activity; IDA:UniProtKB
Q9BPW9	DHRS9	Dehydrogenase/reductase SDR family member 9	GO:0047035; F:testosterone dehydrogenase (NAD+) activity; IDA:UniProtKB
Q9BPW9	DHRS9	Dehydrogenase/reductase SDR family member 9	GO:0042904; P:9-cis-retinoic acid biosynthetic process; IDA:UniProtKB
Q9BPW9	DHRS9	Dehydrogenase/reductase SDR family member 9	GO:0008209; P:androgen metabolic process; IDA:UniProtKB
Q9BPW9	DHRS9	Dehydrogenase/reductase SDR family member 9	GO:0030855; P:epithelial cell differentiation; NAS:UniProtKB
Q9BPW9	DHRS9	Dehydrogenase/reductase SDR family member 9	GO:0042448; P:progesterone metabolic process; IDA:UniProtKB
Q9BPW9	DHRS9	Dehydrogenase/reductase SDR family member 9	GO:0042572; P:retinol metabolic process; NAS:UniProtKB
Q8N5I4	DHRSX	Dehydrogenase/reductase SDR family member on chromosome X	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
O14521	SDHD	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial	GO:0009055; F:electron carrier activity; TAS:UniProtKB
O14521	SDHD	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial	GO:0020037; F:heme binding; ISS:UniProtKB
O14521	SDHD	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14521	SDHD	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial	GO:0000104; F:succinate dehydrogenase activity; IDA:UniProtKB
O14521	SDHD	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial	GO:0048039; F:ubiquinone binding; ISS:UniProtKB
O14521	SDHD	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
O14521	SDHD	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O14521	SDHD	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O14521	SDHD	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; IDA:UniProtKB
Q00796	SORD	Sorbitol dehydrogenase	GO:0030246; F:carbohydrate binding; NAS:UniProtKB
Q00796	SORD	Sorbitol dehydrogenase	GO:0003939; F:L-iditol 2-dehydrogenase activity; IDA:UniProtKB
Q00796	SORD	Sorbitol dehydrogenase	GO:0051287; F:NAD binding; IDA:UniProtKB
Q00796	SORD	Sorbitol dehydrogenase	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q00796	SORD	Sorbitol dehydrogenase	GO:0046370; P:fructose biosynthetic process; IDA:UniProtKB
Q00796	SORD	Sorbitol dehydrogenase	GO:0006006; P:glucose metabolic process; TAS:UniProtKB
Q00796	SORD	Sorbitol dehydrogenase	GO:0051160; P:L-xylitol catabolic process; IDA:UniProtKB
Q00796	SORD	Sorbitol dehydrogenase	GO:0051164; P:L-xylitol metabolic process; IDA:UniProtKB
Q00796	SORD	Sorbitol dehydrogenase	GO:0006062; P:sorbitol catabolic process; IDA:UniProtKB
Q00796	SORD	Sorbitol dehydrogenase	GO:0030317; P:sperm motility; ISS:UniProtKB
Q96HY7	DHTKD1	Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial	GO:0004591; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; IEA:UniProtKB-EC
Q96HY7	DHTKD1	Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial	GO:0030976; F:thiamine pyrophosphate binding; IEA:InterPro
Q96HY7	DHTKD1	Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q96HY7	DHTKD1	Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial	GO:0006091; P:generation of precursor metabolites and energy; IMP:UniProtKB
Q96HY7	DHTKD1	Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial	GO:0006096; P:glycolytic process; IEA:UniProtKB-KW
Q96HY7	DHTKD1	Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; IEA:InterPro
O43143	DHX15	Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43143	DHX15	Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
O43143	DHX15	Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15	GO:0003725; F:double-stranded RNA binding; IDA:MGI
O43143	DHX15	Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O43143	DHX15	Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15	GO:0005515; F:protein binding; IPI:IntAct
O43143	DHX15	Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15	GO:0003724; F:RNA helicase activity; TAS:ProtInc
O43143	DHX15	Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15	GO:0006397; P:mRNA processing; TAS:ProtInc
O43143	DHX15	Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15	GO:0008380; P:RNA splicing; IC:HGNC
O60231	DHX16	Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O60231	DHX16	Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
O60231	DHX16	Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O60231	DHX16	Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16	GO:0005515; F:protein binding; IPI:IntAct
O60231	DHX16	Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16	GO:0003724; F:RNA helicase activity; TAS:ProtInc
O60231	DHX16	Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
O60231	DHX16	Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16	GO:0008380; P:RNA splicing; TAS:ProtInc
Q7Z478	DHX29	ATP-dependent RNA helicase DHX29	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q7Z478	DHX29	ATP-dependent RNA helicase DHX29	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q7Z478	DHX29	ATP-dependent RNA helicase DHX29	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7Z478	DHX29	ATP-dependent RNA helicase DHX29	GO:0043024; F:ribosomal small subunit binding; IDA:UniProtKB
Q7Z478	DHX29	ATP-dependent RNA helicase DHX29	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW
Q7L2E3	DHX30	Putative ATP-dependent RNA helicase DHX30	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q7L2E3	DHX30	Putative ATP-dependent RNA helicase DHX30	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q7L2E3	DHX30	Putative ATP-dependent RNA helicase DHX30	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q7L2E3	DHX30	Putative ATP-dependent RNA helicase DHX30	GO:0003725; F:double-stranded RNA binding; IDA:MGI
Q7L2E3	DHX30	Putative ATP-dependent RNA helicase DHX30	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7L2E3	DHX30	Putative ATP-dependent RNA helicase DHX30	GO:0005515; F:protein binding; IPI:UniProtKB
Q7L7V1	DHX32	Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q7L7V1	DHX32	Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q9H6R0	DHX33	Putative ATP-dependent RNA helicase DHX33	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H6R0	DHX33	Putative ATP-dependent RNA helicase DHX33	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q9H6R0	DHX33	Putative ATP-dependent RNA helicase DHX33	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H6R0	DHX33	Putative ATP-dependent RNA helicase DHX33	GO:0000182; F:rDNA binding; IDA:UniProtKB
Q9H6R0	DHX33	Putative ATP-dependent RNA helicase DHX33	GO:0045943; P:positive regulation of transcription from RNA polymerase I promoter; IDA:UniProtKB
Q14147	DHX34	Probable ATP-dependent RNA helicase DHX34	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q14147	DHX34	Probable ATP-dependent RNA helicase DHX34	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q14147	DHX34	Probable ATP-dependent RNA helicase DHX34	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14147	DHX34	Probable ATP-dependent RNA helicase DHX34	GO:2000623; P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IMP:UniProt
Q14147	DHX34	Probable ATP-dependent RNA helicase DHX34	GO:0000956; P:nuclear-transcribed mRNA catabolic process; IMP:UniProt
Q9H5Z1	DHX35	Probable ATP-dependent RNA helicase DHX35	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H5Z1	DHX35	Probable ATP-dependent RNA helicase DHX35	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q9H5Z1	DHX35	Probable ATP-dependent RNA helicase DHX35	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9H5Z1	DHX35	Probable ATP-dependent RNA helicase DHX35	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q9H2U1	DHX36	ATP-dependent RNA helicase DHX36	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H2U1	DHX36	ATP-dependent RNA helicase DHX36	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q9H2U1	DHX36	ATP-dependent RNA helicase DHX36	GO:0001047; F:core promoter binding; IDA:UniProtKB
Q9H2U1	DHX36	ATP-dependent RNA helicase DHX36	GO:0008094; F:DNA-dependent ATPase activity; IDA:UniProtKB
Q9H2U1	DHX36	ATP-dependent RNA helicase DHX36	GO:0003725; F:double-stranded RNA binding; IDA:MGI
Q9H2U1	DHX36	ATP-dependent RNA helicase DHX36	GO:0051880; F:G-quadruplex DNA binding; IDA:UniProtKB
Q9H2U1	DHX36	ATP-dependent RNA helicase DHX36	GO:0002151; F:G-quadruplex RNA binding; IMP:UniProtKB
Q9H2U1	DHX36	ATP-dependent RNA helicase DHX36	GO:0042826; F:histone deacetylase binding; ISS:UniProtKB
Q9H2U1	DHX36	ATP-dependent RNA helicase DHX36	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H2U1	DHX36	ATP-dependent RNA helicase DHX36	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H2U1	DHX36	ATP-dependent RNA helicase DHX36	GO:0044212; F:transcription regulatory region DNA binding; ISS:UniProtKB
Q9H2U1	DHX36	ATP-dependent RNA helicase DHX36	GO:0006200; P:ATP catabolic process; IDA:GOC
Q9H2U1	DHX36	ATP-dependent RNA helicase DHX36	GO:0045087; P:innate immune response; TAS:Reactome
Q9H2U1	DHX36	ATP-dependent RNA helicase DHX36	GO:0001503; P:ossification; ISS:UniProtKB
Q9H2U1	DHX36	ATP-dependent RNA helicase DHX36	GO:0032206; P:positive regulation of telomere maintenance; IMP:UniProtKB
Q9H2U1	DHX36	ATP-dependent RNA helicase DHX36	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q9H2U1	DHX36	ATP-dependent RNA helicase DHX36	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q9H2U1	DHX36	ATP-dependent RNA helicase DHX36	GO:0043330; P:response to exogenous dsRNA; IEA:Ensembl
Q9H2U1	DHX36	ATP-dependent RNA helicase DHX36	GO:0009615; P:response to virus; IEA:Ensembl
Q9H2U1	DHX36	ATP-dependent RNA helicase DHX36	GO:0010501; P:RNA secondary structure unwinding; IDA:UniProtKB
Q8IY37	DHX37	Probable ATP-dependent RNA helicase DHX37	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IY37	DHX37	Probable ATP-dependent RNA helicase DHX37	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q8IY37	DHX37	Probable ATP-dependent RNA helicase DHX37	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8IX18	DHX40	Probable ATP-dependent RNA helicase DHX40	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IX18	DHX40	Probable ATP-dependent RNA helicase DHX40	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q8IX18	DHX40	Probable ATP-dependent RNA helicase DHX40	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q6P158	DHX57	Putative ATP-dependent RNA helicase DHX57	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6P158	DHX57	Putative ATP-dependent RNA helicase DHX57	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q6P158	DHX57	Putative ATP-dependent RNA helicase DHX57	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6P158	DHX57	Putative ATP-dependent RNA helicase DHX57	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96C10	DHX58	Probable ATP-dependent RNA helicase DHX58	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96C10	DHX58	Probable ATP-dependent RNA helicase DHX58	GO:0003677; F:DNA binding; IEA:InterPro
Q96C10	DHX58	Probable ATP-dependent RNA helicase DHX58	GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB
Q96C10	DHX58	Probable ATP-dependent RNA helicase DHX58	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q96C10	DHX58	Probable ATP-dependent RNA helicase DHX58	GO:0005515; F:protein binding; IPI:UniProtKB
Q96C10	DHX58	Probable ATP-dependent RNA helicase DHX58	GO:0003727; F:single-stranded RNA binding; IDA:UniProtKB
Q96C10	DHX58	Probable ATP-dependent RNA helicase DHX58	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q96C10	DHX58	Probable ATP-dependent RNA helicase DHX58	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q96C10	DHX58	Probable ATP-dependent RNA helicase DHX58	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q96C10	DHX58	Probable ATP-dependent RNA helicase DHX58	GO:0045824; P:negative regulation of innate immune response; IDA:UniProtKB
Q96C10	DHX58	Probable ATP-dependent RNA helicase DHX58	GO:0039534; P:negative regulation of MDA-5 signaling pathway; IMP:UniProtKB
Q96C10	DHX58	Probable ATP-dependent RNA helicase DHX58	GO:0039536; P:negative regulation of RIG-I signaling pathway; IDA:UniProtKB
Q96C10	DHX58	Probable ATP-dependent RNA helicase DHX58	GO:0032480; P:negative regulation of type I interferon production; IDA:UniProtKB
Q96C10	DHX58	Probable ATP-dependent RNA helicase DHX58	GO:1900245; P:positive regulation of MDA-5 signaling pathway; ISS:UniProtKB
Q96C10	DHX58	Probable ATP-dependent RNA helicase DHX58	GO:1900246; P:positive regulation of RIG-I signaling pathway; ISS:UniProtKB
Q96C10	DHX58	Probable ATP-dependent RNA helicase DHX58	GO:0032481; P:positive regulation of type I interferon production; ISS:UniProtKB
Q96C10	DHX58	Probable ATP-dependent RNA helicase DHX58	GO:0045088; P:regulation of innate immune response; IDA:UniProtKB
Q96C10	DHX58	Probable ATP-dependent RNA helicase DHX58	GO:0009615; P:response to virus; ISS:UniProtKB
Q96C10	DHX58	Probable ATP-dependent RNA helicase DHX58	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q14562	DHX8	ATP-dependent RNA helicase DHX8	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q14562	DHX8	ATP-dependent RNA helicase DHX8	GO:0004004; F:ATP-dependent RNA helicase activity; TAS:ProtInc
Q14562	DHX8	ATP-dependent RNA helicase DHX8	GO:0042802; F:identical protein binding; IPI:IntAct
Q14562	DHX8	ATP-dependent RNA helicase DHX8	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14562	DHX8	ATP-dependent RNA helicase DHX8	GO:0005515; F:protein binding; IPI:UniProtKB
Q14562	DHX8	ATP-dependent RNA helicase DHX8	GO:0006200; P:ATP catabolic process; TAS:GOC
Q14562	DHX8	ATP-dependent RNA helicase DHX8	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q14562	DHX8	ATP-dependent RNA helicase DHX8	GO:0006396; P:RNA processing; TAS:ProtInc
Q14562	DHX8	ATP-dependent RNA helicase DHX8	GO:0008380; P:RNA splicing; TAS:ProtInc
Q08211	DHX9	ATP-dependent RNA helicase A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q08211	DHX9	ATP-dependent RNA helicase A	GO:0004003; F:ATP-dependent DNA helicase activity; TAS:ProtInc
Q08211	DHX9	ATP-dependent RNA helicase A	GO:0004004; F:ATP-dependent RNA helicase activity; TAS:ProtInc
Q08211	DHX9	ATP-dependent RNA helicase A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q08211	DHX9	ATP-dependent RNA helicase A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q08211	DHX9	ATP-dependent RNA helicase A	GO:0005515; F:protein binding; IPI:UniProtKB
Q08211	DHX9	ATP-dependent RNA helicase A	GO:0003724; F:RNA helicase activity; TAS:ProtInc
Q08211	DHX9	ATP-dependent RNA helicase A	GO:0001085; F:RNA polymerase II transcription factor binding; IPI:BHF-UCL
Q08211	DHX9	ATP-dependent RNA helicase A	GO:0006200; P:ATP catabolic process; TAS:GOC
Q08211	DHX9	ATP-dependent RNA helicase A	GO:0034605; P:cellular response to heat; IEA:Ensembl
Q08211	DHX9	ATP-dependent RNA helicase A	GO:0007623; P:circadian rhythm; IEA:Ensembl
Q08211	DHX9	ATP-dependent RNA helicase A	GO:0070934; P:CRD-mediated mRNA stabilization; IMP:UniProtKB
Q08211	DHX9	ATP-dependent RNA helicase A	GO:0032508; P:DNA duplex unwinding; TAS:GOC
Q08211	DHX9	ATP-dependent RNA helicase A	GO:0010467; P:gene expression; TAS:Reactome
Q08211	DHX9	ATP-dependent RNA helicase A	GO:0045087; P:innate immune response; TAS:Reactome
Q08211	DHX9	ATP-dependent RNA helicase A	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q08211	DHX9	ATP-dependent RNA helicase A	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q08211	DHX9	ATP-dependent RNA helicase A	GO:0008380; P:RNA splicing; TAS:Reactome
P49366	DHPS	Deoxyhypusine synthase	GO:0034038; F:deoxyhypusine synthase activity; TAS:Reactome
P49366	DHPS	Deoxyhypusine synthase	GO:0005515; F:protein binding; IPI:UniProtKB
P49366	DHPS	Deoxyhypusine synthase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P49366	DHPS	Deoxyhypusine synthase	GO:0050983; P:deoxyhypusine biosynthetic process from spermidine; TAS:ProtInc
P49366	DHPS	Deoxyhypusine synthase	GO:0008612; P:peptidyl-lysine modification to peptidyl-hypusine; TAS:Reactome
P49366	DHPS	Deoxyhypusine synthase	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P49366	DHPS	Deoxyhypusine synthase	GO:0043687; P:post-translational protein modification; TAS:Reactome
P49366	DHPS	Deoxyhypusine synthase	GO:0051289; P:protein homotetramerization; IEA:Ensembl
P49366	DHPS	Deoxyhypusine synthase	GO:0006412; P:translation; TAS:ProtInc
Q8TF46	DIS3L	DIS3-like exonuclease 1	GO:0000175; F:3'-5'-exoribonuclease activity; IDA:UniProtKB
Q8TF46	DIS3L	DIS3-like exonuclease 1	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q8TF46	DIS3L	DIS3-like exonuclease 1	GO:0005515; F:protein binding; IPI:IntAct
Q8TF46	DIS3L	DIS3-like exonuclease 1	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q8TF46	DIS3L	DIS3-like exonuclease 1	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; IDA:GOC
Q8TF46	DIS3L	DIS3-like exonuclease 1	GO:0016075; P:rRNA catabolic process; IDA:UniProtKB
Q8IYB7	DIS3L2	DIS3-like exonuclease 2	GO:0000175; F:3'-5'-exoribonuclease activity; IDA:UniProtKB
Q8IYB7	DIS3L2	DIS3-like exonuclease 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IYB7	DIS3L2	DIS3-like exonuclease 2	GO:0004540; F:ribonuclease activity; IDA:UniProtKB
Q8IYB7	DIS3L2	DIS3-like exonuclease 2	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q8IYB7	DIS3L2	DIS3-like exonuclease 2	GO:0010587; P:miRNA catabolic process; ISS:UniProtKB
Q8IYB7	DIS3L2	DIS3-like exonuclease 2	GO:0007067; P:mitosis; IMP:UniProtKB
Q8IYB7	DIS3L2	DIS3-like exonuclease 2	GO:0051306; P:mitotic sister chromatid separation; IMP:UniProtKB
Q8IYB7	DIS3L2	DIS3-like exonuclease 2	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q8IYB7	DIS3L2	DIS3-like exonuclease 2	GO:0000291; P:nuclear-transcribed mRNA catabolic process, exonucleolytic; IMP:UniProtKB
Q8IYB7	DIS3L2	DIS3-like exonuclease 2	GO:0034427; P:nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'; IEA:InterPro
Q8IYB7	DIS3L2	DIS3-like exonuclease 2	GO:1990074; P:polyuridylation-dependent mRNA catabolic process; ISS:UniProtKB
Q8IYB7	DIS3L2	DIS3-like exonuclease 2	GO:0090501; P:RNA phosphodiester bond hydrolysis; IDA:GOC
Q8IYB7	DIS3L2	DIS3-like exonuclease 2	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; IDA:GOC
Q8IYB7	DIS3L2	DIS3-like exonuclease 2	GO:0019827; P:stem cell maintenance; ISS:UniProtKB
Q8NDZ4	C3orf58	Deleted in autism protein 1	GO:0060038; P:cardiac muscle cell proliferation; IDA:UniProtKB
Q8NDZ4	C3orf58	Deleted in autism protein 1	GO:0014066; P:regulation of phosphatidylinositol 3-kinase signaling; IDA:UniProtKB
Q01459	CTBS	Di-N-acetylchitobiase	GO:0004568; F:chitinase activity; IEA:Ensembl
Q01459	CTBS	Di-N-acetylchitobiase	GO:0006032; P:chitin catabolic process; IEA:Ensembl
Q01459	CTBS	Di-N-acetylchitobiase	GO:0009313; P:oligosaccharide catabolic process; IEA:Ensembl
O60610	DIAPH1	Protein diaphanous homolog 1	GO:0044325; F:ion channel binding; IPI:BHF-UCL
O60610	DIAPH1	Protein diaphanous homolog 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O60610	DIAPH1	Protein diaphanous homolog 1	GO:0005515; F:protein binding; IPI:IntAct
O60610	DIAPH1	Protein diaphanous homolog 1	GO:0005102; F:receptor binding; NAS:ProtInc
O60610	DIAPH1	Protein diaphanous homolog 1	GO:0030041; P:actin filament polymerization; IEA:Ensembl
O60610	DIAPH1	Protein diaphanous homolog 1	GO:0071420; P:cellular response to histamine; IMP:BHF-UCL
O60610	DIAPH1	Protein diaphanous homolog 1	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
O60610	DIAPH1	Protein diaphanous homolog 1	GO:0031175; P:neuron projection development; IEA:Ensembl
O60610	DIAPH1	Protein diaphanous homolog 1	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
O60610	DIAPH1	Protein diaphanous homolog 1	GO:0035372; P:protein localization to microtubule; IMP:BHF-UCL
O60610	DIAPH1	Protein diaphanous homolog 1	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
O60610	DIAPH1	Protein diaphanous homolog 1	GO:0032886; P:regulation of microtubule-based process; IMP:UniProtKB
O60610	DIAPH1	Protein diaphanous homolog 1	GO:0051279; P:regulation of release of sequestered calcium ion into cytosol; IMP:BHF-UCL
O60610	DIAPH1	Protein diaphanous homolog 1	GO:0007605; P:sensory perception of sound; TAS:ProtInc
O60879	DIAPH2	Protein diaphanous homolog 2	GO:0005102; F:receptor binding; TAS:ProtInc
O60879	DIAPH2	Protein diaphanous homolog 2	GO:0030041; P:actin filament polymerization; IEA:Ensembl
O60879	DIAPH2	Protein diaphanous homolog 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O60879	DIAPH2	Protein diaphanous homolog 2	GO:0000910; P:cytokinesis; TAS:ProtInc
O60879	DIAPH2	Protein diaphanous homolog 2	GO:0007292; P:female gamete generation; TAS:ProtInc
O60879	DIAPH2	Protein diaphanous homolog 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
O60879	DIAPH2	Protein diaphanous homolog 2	GO:0048477; P:oogenesis; IEA:UniProtKB-KW
Q9NSV4	DIAPH3	Protein diaphanous homolog 3	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
Q9NSV4	DIAPH3	Protein diaphanous homolog 3	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0035198; F:miRNA binding; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0004525; F:ribonuclease III activity; IDA:UniProtKB
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0001525; P:angiogenesis; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0055013; P:cardiac muscle cell development; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0021987; P:cerebral cortex development; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0051607; P:defense response to virus; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0010467; P:gene expression; TAS:Reactome
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0071335; P:hair follicle cell proliferation; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0060119; P:inner ear receptor cell development; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0060576; P:intestinal epithelial cell development; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0030324; P:lung development; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0010626; P:negative regulation of Schwann cell proliferation; ISS:BHF-UCL
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0021675; P:nerve development; ISS:BHF-UCL
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0048812; P:neuron projection morphogenesis; ISS:BHF-UCL
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0021889; P:olfactory bulb interneuron differentiation; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0032290; P:peripheral nervous system myelin formation; ISS:BHF-UCL
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:2000630; P:positive regulation of miRNA metabolic process; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0031643; P:positive regulation of myelination; ISS:BHF-UCL
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0014040; P:positive regulation of Schwann cell differentiation; ISS:BHF-UCL
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0031054; P:pre-miRNA processing; IDA:UniProtKB
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0035196; P:production of miRNAs involved in gene silencing by miRNA; ISS:BHF-UCL
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0030422; P:production of siRNA involved in RNA interference; IDA:UniProtKB
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0070173; P:regulation of enamel mineralization; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0045664; P:regulation of neuron differentiation; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0048713; P:regulation of oligodendrocyte differentiation; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0045069; P:regulation of viral genome replication; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0090501; P:RNA phosphodiester bond hydrolysis; IDA:GOC
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; IDA:GOC
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0051225; P:spindle assembly; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0048536; P:spleen development; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0019827; P:stem cell maintenance; IEA:Ensembl
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0030423; P:targeting of mRNA for destruction involved in RNA interference; IMP:UniProtKB
Q9UPY3	DICER1	Endoribonuclease Dicer	GO:0010070; P:zygote asymmetric cell division; IEA:Ensembl
Q9UBX3	SLC25A10	Mitochondrial dicarboxylate carrier	GO:0005310; F:dicarboxylic acid transmembrane transporter activity; TAS:ProtInc
Q9UBX3	SLC25A10	Mitochondrial dicarboxylate carrier	GO:0005515; F:protein binding; IPI:IntAct
Q9UBX3	SLC25A10	Mitochondrial dicarboxylate carrier	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9UBX3	SLC25A10	Mitochondrial dicarboxylate carrier	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9UBX3	SLC25A10	Mitochondrial dicarboxylate carrier	GO:0006835; P:dicarboxylic acid transport; TAS:ProtInc
Q9UBX3	SLC25A10	Mitochondrial dicarboxylate carrier	GO:0006094; P:gluconeogenesis; TAS:Reactome
Q9UBX3	SLC25A10	Mitochondrial dicarboxylate carrier	GO:0006006; P:glucose metabolic process; TAS:Reactome
Q9UBX3	SLC25A10	Mitochondrial dicarboxylate carrier	GO:0006811; P:ion transport; TAS:Reactome
Q9UBX3	SLC25A10	Mitochondrial dicarboxylate carrier	GO:0006839; P:mitochondrial transport; IEA:InterPro
Q9UBX3	SLC25A10	Mitochondrial dicarboxylate carrier	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UBX3	SLC25A10	Mitochondrial dicarboxylate carrier	GO:0070221; P:sulfide oxidation, using sulfide:quinone oxidoreductase; TAS:Reactome
Q9UBX3	SLC25A10	Mitochondrial dicarboxylate carrier	GO:0000098; P:sulfur amino acid catabolic process; TAS:Reactome
Q9UBX3	SLC25A10	Mitochondrial dicarboxylate carrier	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
Q9UBX3	SLC25A10	Mitochondrial dicarboxylate carrier	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9BTC0	DIDO1	Death-inducer obliterator 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BTC0	DIDO1	Death-inducer obliterator 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BTC0	DIDO1	Death-inducer obliterator 1	GO:0097190; P:apoptotic signaling pathway; IEA:Ensembl
Q9BTC0	DIDO1	Death-inducer obliterator 1	GO:0006351; P:transcription, DNA-templated; IEA:InterPro
Q68CQ4	DIEXF	Digestive organ expansion factor homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q68CQ4	DIEXF	Digestive organ expansion factor homolog	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9UNQ2	DIMT1	Probable dimethyladenosine transferase	GO:0052909; F:18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity; IEA:UniProtKB-EC
Q9UNQ2	DIMT1	Probable dimethyladenosine transferase	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UNQ2	DIMT1	Probable dimethyladenosine transferase	GO:0000179; F:rRNA (adenine-N6,N6-)-dimethyltransferase activity; IEA:InterPro
Q14689	DIP2A	Disco-interacting protein 2 homolog A	GO:0003824; F:catalytic activity; IEA:InterPro
Q14689	DIP2A	Disco-interacting protein 2 homolog A	GO:0005515; F:protein binding; IPI:IntAct
Q14689	DIP2A	Disco-interacting protein 2 homolog A	GO:0006309; P:apoptotic DNA fragmentation; IMP:UniProt
Q14689	DIP2A	Disco-interacting protein 2 homolog A	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q14689	DIP2A	Disco-interacting protein 2 homolog A	GO:0010629; P:negative regulation of gene expression; IDA:UniProt
Q9P265	DIP2B	Disco-interacting protein 2 homolog B	GO:0003824; F:catalytic activity; IEA:InterPro
Q9Y2E4	DIP2C	Disco-interacting protein 2 homolog C	GO:0003824; F:catalytic activity; IEA:InterPro
Q96HU8	DIRAS2	GTP-binding protein Di-Ras2	GO:0005525; F:GTP binding; IDA:UniProt
Q96HU8	DIRAS2	GTP-binding protein Di-Ras2	GO:0006184; P:GTP catabolic process; IEA:InterPro
Q96HU8	DIRAS2	GTP-binding protein Di-Ras2	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
O95057	DIRAS1	GTP-binding protein Di-Ras1	GO:0005525; F:GTP binding; IDA:UniProt
O95057	DIRAS1	GTP-binding protein Di-Ras1	GO:0003924; F:GTPase activity; IDA:UniProt
O95057	DIRAS1	GTP-binding protein Di-Ras1	GO:0006184; P:GTP catabolic process; IDA:UniProt
O95057	DIRAS1	GTP-binding protein Di-Ras1	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
O95661	DIRAS3	GTP-binding protein Di-Ras3	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
O95661	DIRAS3	GTP-binding protein Di-Ras3	GO:0003924; F:GTPase activity; TAS:ProtInc
O95661	DIRAS3	GTP-binding protein Di-Ras3	GO:0005515; F:protein binding; IPI:IntAct
O95661	DIRAS3	GTP-binding protein Di-Ras3	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
O95661	DIRAS3	GTP-binding protein Di-Ras3	GO:0006349; P:regulation of gene expression by genetic imprinting; TAS:ProtInc
O95661	DIRAS3	GTP-binding protein Di-Ras3	GO:0007264; P:small GTPase mediated signal transduction; TAS:ProtInc
Q96SL1	DIRC2	Disrupted in renal carcinoma protein 2	GO:0006810; P:transport; IEA:UniProtKB-KW
Q9NRI5	DISC1	Disrupted in schizophrenia 1 protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NRI5	DISC1	Disrupted in schizophrenia 1 protein	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
Q9NRI5	DISC1	Disrupted in schizophrenia 1 protein	GO:0021846; P:cell proliferation in forebrain; IEA:Ensembl
Q9NRI5	DISC1	Disrupted in schizophrenia 1 protein	GO:0021799; P:cerebral cortex radially oriented cell migration; IEA:Ensembl
Q9NRI5	DISC1	Disrupted in schizophrenia 1 protein	GO:0000226; P:microtubule cytoskeleton organization; IMP:UniProtKB
Q9NRI5	DISC1	Disrupted in schizophrenia 1 protein	GO:0051560; P:mitochondrial calcium ion homeostasis; IEA:Ensembl
Q9NRI5	DISC1	Disrupted in schizophrenia 1 protein	GO:0001764; P:neuron migration; IMP:UniProtKB
Q9NRI5	DISC1	Disrupted in schizophrenia 1 protein	GO:0002052; P:positive regulation of neuroblast proliferation; IGI:UniProtKB
Q9NRI5	DISC1	Disrupted in schizophrenia 1 protein	GO:2000060; P:positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q9NRI5	DISC1	Disrupted in schizophrenia 1 protein	GO:0030177; P:positive regulation of Wnt signaling pathway; IGI:UniProtKB
Q9NRI5	DISC1	Disrupted in schizophrenia 1 protein	GO:0008104; P:protein localization; IEA:Ensembl
Q9NRI5	DISC1	Disrupted in schizophrenia 1 protein	GO:0010975; P:regulation of neuron projection development; IEA:Ensembl
Q9NRI5	DISC1	Disrupted in schizophrenia 1 protein	GO:0090128; P:regulation of synapse maturation; IEA:Ensembl
Q9NRI5	DISC1	Disrupted in schizophrenia 1 protein	GO:0031929; P:TOR signaling; IEA:Ensembl
Q96F81	DISP1	Protein dispatched homolog 1	GO:0008158; F:hedgehog receptor activity; IEA:InterPro
Q96F81	DISP1	Protein dispatched homolog 1	GO:0015197; F:peptide transporter activity; ISS:UniProtKB
Q96F81	DISP1	Protein dispatched homolog 1	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
Q96F81	DISP1	Protein dispatched homolog 1	GO:0060539; P:diaphragm development; IMP:UniProtKB
Q96F81	DISP1	Protein dispatched homolog 1	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
Q96F81	DISP1	Protein dispatched homolog 1	GO:0009880; P:embryonic pattern specification; IEA:Ensembl
Q96F81	DISP1	Protein dispatched homolog 1	GO:0007225; P:patched ligand maturation; IEA:Ensembl
Q96F81	DISP1	Protein dispatched homolog 1	GO:0015833; P:peptide transport; ISS:UniProtKB
Q96F81	DISP1	Protein dispatched homolog 1	GO:0070207; P:protein homotrimerization; ISS:UniProtKB
Q96F81	DISP1	Protein dispatched homolog 1	GO:0050708; P:regulation of protein secretion; ISS:UniProtKB
Q96F81	DISP1	Protein dispatched homolog 1	GO:0007224; P:smoothened signaling pathway; ISS:UniProtKB
A7MBM2	DISP2	Protein dispatched homolog 2	GO:0007224; P:smoothened signaling pathway; NAS:UniProtKB
Q155Q3	DIXDC1	Dixin	GO:0043015; F:gamma-tubulin binding; IDA:UniProtKB
Q155Q3	DIXDC1	Dixin	GO:0031435; F:mitogen-activated protein kinase kinase kinase binding; IBA:RefGenome
Q155Q3	DIXDC1	Dixin	GO:0005515; F:protein binding; IPI:IntAct
Q155Q3	DIXDC1	Dixin	GO:0004871; F:signal transducer activity; IEA:InterPro
Q155Q3	DIXDC1	Dixin	GO:0043010; P:camera-type eye development; IBA:RefGenome
Q155Q3	DIXDC1	Dixin	GO:0021695; P:cerebellar cortex development; IBA:RefGenome
Q155Q3	DIXDC1	Dixin	GO:0030900; P:forebrain development; IBA:RefGenome
Q155Q3	DIXDC1	Dixin	GO:0050772; P:positive regulation of axonogenesis; IBA:RefGenome
Q155Q3	DIXDC1	Dixin	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:UniProtKB
Q155Q3	DIXDC1	Dixin	GO:0046328; P:regulation of JNK cascade; IBA:RefGenome
Q155Q3	DIXDC1	Dixin	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9UBS4	DNAJB11	DnaJ homolog subfamily B member 11	GO:0005515; F:protein binding; IPI:IntAct
Q9UBS4	DNAJB11	DnaJ homolog subfamily B member 11	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q9UBS4	DNAJB11	DnaJ homolog subfamily B member 11	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UBS4	DNAJB11	DnaJ homolog subfamily B member 11	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q9UBS4	DNAJB11	DnaJ homolog subfamily B member 11	GO:0016556; P:mRNA modification; IEA:Ensembl
Q9UBS4	DNAJB11	DnaJ homolog subfamily B member 11	GO:0006457; P:protein folding; IEA:InterPro
P59910	DNAJB13	DnaJ homolog subfamily B member 13	GO:0006457; P:protein folding; IEA:InterPro
Q8IXB1	DNAJC10	DnaJ homolog subfamily C member 10	GO:0001671; F:ATPase activator activity; ISS:UniProtKB
Q8IXB1	DNAJC10	DnaJ homolog subfamily C member 10	GO:0051117; F:ATPase binding; IPI:UniProtKB
Q8IXB1	DNAJC10	DnaJ homolog subfamily C member 10	GO:0051087; F:chaperone binding; IDA:UniProtKB
Q8IXB1	DNAJC10	DnaJ homolog subfamily C member 10	GO:0015036; F:disulfide oxidoreductase activity; ISS:UniProtKB
Q8IXB1	DNAJC10	DnaJ homolog subfamily C member 10	GO:0030544; F:Hsp70 protein binding; IPI:UniProtKB
Q8IXB1	DNAJC10	DnaJ homolog subfamily C member 10	GO:0051787; F:misfolded protein binding; IDA:UniProtKB
Q8IXB1	DNAJC10	DnaJ homolog subfamily C member 10	GO:0016671; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; ISS:UniProtKB
Q8IXB1	DNAJC10	DnaJ homolog subfamily C member 10	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IXB1	DNAJC10	DnaJ homolog subfamily C member 10	GO:0015035; F:protein disulfide oxidoreductase activity; IDA:UniProtKB
Q8IXB1	DNAJC10	DnaJ homolog subfamily C member 10	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q8IXB1	DNAJC10	DnaJ homolog subfamily C member 10	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q8IXB1	DNAJC10	DnaJ homolog subfamily C member 10	GO:0006662; P:glycerol ether metabolic process; IEA:InterPro
Q8IXB1	DNAJC10	DnaJ homolog subfamily C member 10	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IDA:UniProtKB
Q8IXB1	DNAJC10	DnaJ homolog subfamily C member 10	GO:0001933; P:negative regulation of protein phosphorylation; IDA:UniProtKB
Q8IXB1	DNAJC10	DnaJ homolog subfamily C member 10	GO:0032781; P:positive regulation of ATPase activity; ISS:UniProtKB
Q8IXB1	DNAJC10	DnaJ homolog subfamily C member 10	GO:0034975; P:protein folding in endoplasmic reticulum; IDA:UniProtKB
Q8IXB1	DNAJC10	DnaJ homolog subfamily C member 10	GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB
Q9NVH1	DNAJC11	DnaJ homolog subfamily C member 11	GO:0005515; F:protein binding; IPI:IntAct
Q6Y2X3	DNAJC14	DnaJ homolog subfamily C member 14	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9Y5T4	DNAJC15	DnaJ homolog subfamily C member 15	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9Y2G8	DNAJC16	DnaJ homolog subfamily C member 16	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q9NVM6	DNAJC17	DnaJ homolog subfamily C member 17	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9NVM6	DNAJC17	DnaJ homolog subfamily C member 17	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q5F1R6	DNAJC21	DnaJ homolog subfamily C member 21	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q5F1R6	DNAJC21	DnaJ homolog subfamily C member 21	GO:0005515; F:protein binding; IPI:IntAct
Q5F1R6	DNAJC21	DnaJ homolog subfamily C member 21	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5F1R6	DNAJC21	DnaJ homolog subfamily C member 21	GO:0006457; P:protein folding; NAS:UniProtKB
Q6P3W2	DNAJC24	DnaJ homolog subfamily C member 24	GO:0001671; F:ATPase activator activity; IDA:UniProtKB
Q6P3W2	DNAJC24	DnaJ homolog subfamily C member 24	GO:0008198; F:ferrous iron binding; IDA:UniProtKB
Q6P3W2	DNAJC24	DnaJ homolog subfamily C member 24	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q6P3W2	DNAJC24	DnaJ homolog subfamily C member 24	GO:0061077; P:chaperone-mediated protein folding; TAS:UniProtKB
Q6P3W2	DNAJC24	DnaJ homolog subfamily C member 24	GO:0055114; P:oxidation-reduction process; IEA:UniProtKB-KW
Q6P3W2	DNAJC24	DnaJ homolog subfamily C member 24	GO:0017183; P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine; IEA:UniProtKB-UniPathway
Q6P3W2	DNAJC24	DnaJ homolog subfamily C member 24	GO:0032781; P:positive regulation of ATPase activity; IDA:UniProtKB
Q9NZQ0	DNAJC27	DnaJ homolog subfamily C member 27	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9NZQ0	DNAJC27	DnaJ homolog subfamily C member 27	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
O60832	DKC1	H/ACA ribonucleoprotein complex subunit 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O60832	DKC1	H/ACA ribonucleoprotein complex subunit 4	GO:0005515; F:protein binding; IPI:UniProtKB
O60832	DKC1	H/ACA ribonucleoprotein complex subunit 4	GO:0009982; F:pseudouridine synthase activity; IEA:InterPro
O60832	DKC1	H/ACA ribonucleoprotein complex subunit 4	GO:0003723; F:RNA binding; TAS:ProtInc
O60832	DKC1	H/ACA ribonucleoprotein complex subunit 4	GO:0003720; F:telomerase activity; IDA:UniProtKB
O60832	DKC1	H/ACA ribonucleoprotein complex subunit 4	GO:0008283; P:cell proliferation; TAS:ProtInc
O60832	DKC1	H/ACA ribonucleoprotein complex subunit 4	GO:0001522; P:pseudouridine synthesis; IEA:InterPro
O60832	DKC1	H/ACA ribonucleoprotein complex subunit 4	GO:0006396; P:RNA processing; TAS:ProtInc
O60832	DKC1	H/ACA ribonucleoprotein complex subunit 4	GO:0006364; P:rRNA processing; TAS:ProtInc
O60832	DKC1	H/ACA ribonucleoprotein complex subunit 4	GO:0000723; P:telomere maintenance; TAS:Reactome
O60832	DKC1	H/ACA ribonucleoprotein complex subunit 4	GO:0007004; P:telomere maintenance via telomerase; TAS:Reactome
O94907	DKK1	Dickkopf-related protein 1	GO:0008083; F:growth factor activity; TAS:ProtInc
O94907	DKK1	Dickkopf-related protein 1	GO:0050750; F:low-density lipoprotein particle receptor binding; IDA:MGI
O94907	DKK1	Dickkopf-related protein 1	GO:0005515; F:protein binding; IPI:IntAct
O94907	DKK1	Dickkopf-related protein 1	GO:0048019; F:receptor antagonist activity; IDA:BHF-UCL
O94907	DKK1	Dickkopf-related protein 1	GO:0004871; F:signal transducer activity; TAS:ProtInc
O94907	DKK1	Dickkopf-related protein 1	GO:0000904; P:cell morphogenesis involved in differentiation; IEA:Ensembl
O94907	DKK1	Dickkopf-related protein 1	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
O94907	DKK1	Dickkopf-related protein 1	GO:0001706; P:endoderm formation; IEA:Ensembl
O94907	DKK1	Dickkopf-related protein 1	GO:1900116; P:extracellular negative regulation of signal transduction; IDA:GOC
O94907	DKK1	Dickkopf-related protein 1	GO:0060325; P:face morphogenesis; IEA:Ensembl
O94907	DKK1	Dickkopf-related protein 1	GO:0030900; P:forebrain development; IEA:Ensembl
O94907	DKK1	Dickkopf-related protein 1	GO:0001942; P:hair follicle development; IEA:Ensembl
O94907	DKK1	Dickkopf-related protein 1	GO:0001707; P:mesoderm formation; IEA:Ensembl
O94907	DKK1	Dickkopf-related protein 1	GO:0030514; P:negative regulation of BMP signaling pathway; IEA:Ensembl
O94907	DKK1	Dickkopf-related protein 1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:BHF-UCL
O94907	DKK1	Dickkopf-related protein 1	GO:1901296; P:negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment; IDA:BHF-UCL
O94907	DKK1	Dickkopf-related protein 1	GO:2000726; P:negative regulation of cardiac muscle cell differentiation; IDA:BHF-UCL
O94907	DKK1	Dickkopf-related protein 1	GO:0042662; P:negative regulation of mesodermal cell fate specification; IDA:BHF-UCL
O94907	DKK1	Dickkopf-related protein 1	GO:0060394; P:negative regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
O94907	DKK1	Dickkopf-related protein 1	GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; IDA:BHF-UCL
O94907	DKK1	Dickkopf-related protein 1	GO:0031333; P:negative regulation of protein complex assembly; IDA:BHF-UCL
O94907	DKK1	Dickkopf-related protein 1	GO:0048642; P:negative regulation of skeletal muscle tissue development; IEA:Ensembl
O94907	DKK1	Dickkopf-related protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
O94907	DKK1	Dickkopf-related protein 1	GO:0090082; P:positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway; ISS:BHF-UCL
O94907	DKK1	Dickkopf-related protein 1	GO:0042663; P:regulation of endodermal cell fate specification; IDA:BHF-UCL
O94907	DKK1	Dickkopf-related protein 1	GO:0002090; P:regulation of receptor internalization; IDA:BHF-UCL
O94907	DKK1	Dickkopf-related protein 1	GO:0032526; P:response to retinoic acid; IEA:Ensembl
O94907	DKK1	Dickkopf-related protein 1	GO:0090244; P:Wnt signaling pathway involved in somitogenesis; IEA:Ensembl
Q9UBU2	DKK2	Dickkopf-related protein 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9UBU2	DKK2	Dickkopf-related protein 2	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:BHF-UCL
Q9UBU2	DKK2	Dickkopf-related protein 2	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:BHF-UCL
Q9UBU2	DKK2	Dickkopf-related protein 2	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9UBT3	DKK4	Dickkopf-related protein 4	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9UBT3	DKK4	Dickkopf-related protein 4	GO:0030178; P:negative regulation of Wnt signaling pathway; NAS:UniProtKB
Q9UBT3	DKK4	Dickkopf-related protein 4	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9UBP4	DKK3	Dickkopf-related protein 3	GO:0030325; P:adrenal gland development; IEP:UniProtKB
Q9UBP4	DKK3	Dickkopf-related protein 3	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q9UBP4	DKK3	Dickkopf-related protein 3	GO:0032348; P:negative regulation of aldosterone biosynthetic process; IDA:UniProtKB
Q9UBP4	DKK3	Dickkopf-related protein 3	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:BHF-UCL
Q9UBP4	DKK3	Dickkopf-related protein 3	GO:2000065; P:negative regulation of cortisol biosynthetic process; IDA:UniProtKB
Q9UBP4	DKK3	Dickkopf-related protein 3	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UBP4	DKK3	Dickkopf-related protein 3	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9UK85	DKKL1	Dickkopf-like protein 1	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q9UK85	DKKL1	Dickkopf-like protein 1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q9UK85	DKKL1	Dickkopf-like protein 1	GO:0045600; P:positive regulation of fat cell differentiation; IEA:Ensembl
Q9UK85	DKKL1	Dickkopf-like protein 1	GO:0007165; P:signal transduction; TAS:GOC
P09622	DLD	Dihydrolipoyl dehydrogenase, mitochondrial	GO:0004148; F:dihydrolipoyl dehydrogenase activity; TAS:ProtInc
P09622	DLD	Dihydrolipoyl dehydrogenase, mitochondrial	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
P09622	DLD	Dihydrolipoyl dehydrogenase, mitochondrial	GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome
P09622	DLD	Dihydrolipoyl dehydrogenase, mitochondrial	GO:0045454; P:cell redox homeostasis; IEA:InterPro
P09622	DLD	Dihydrolipoyl dehydrogenase, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P09622	DLD	Dihydrolipoyl dehydrogenase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P09622	DLD	Dihydrolipoyl dehydrogenase, mitochondrial	GO:0007369; P:gastrulation; IEA:Ensembl
P09622	DLD	Dihydrolipoyl dehydrogenase, mitochondrial	GO:0006554; P:lysine catabolic process; TAS:Reactome
P09622	DLD	Dihydrolipoyl dehydrogenase, mitochondrial	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; IEA:Ensembl
P09622	DLD	Dihydrolipoyl dehydrogenase, mitochondrial	GO:0006508; P:proteolysis; IEA:Ensembl
P09622	DLD	Dihydrolipoyl dehydrogenase, mitochondrial	GO:0006090; P:pyruvate metabolic process; TAS:Reactome
P09622	DLD	Dihydrolipoyl dehydrogenase, mitochondrial	GO:0010510; P:regulation of acetyl-CoA biosynthetic process from pyruvate; TAS:Reactome
P09622	DLD	Dihydrolipoyl dehydrogenase, mitochondrial	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
P09622	DLD	Dihydrolipoyl dehydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P09622	DLD	Dihydrolipoyl dehydrogenase, mitochondrial	GO:0048240; P:sperm capacitation; IEA:Ensembl
P09622	DLD	Dihydrolipoyl dehydrogenase, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; TAS:Reactome
Q9Y238	DLEC1	Deleted in lung and esophageal cancer protein 1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q12959	DLG1	Disks large homolog 1	GO:0008092; F:cytoskeletal protein binding; TAS:ProtInc
Q12959	DLG1	Disks large homolog 1	GO:0004385; F:guanylate kinase activity; TAS:ProtInc
Q12959	DLG1	Disks large homolog 1	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q12959	DLG1	Disks large homolog 1	GO:0097016; F:L27 domain binding; IPI:BHF-UCL
Q12959	DLG1	Disks large homolog 1	GO:0031434; F:mitogen-activated protein kinase kinase binding; IPI:UniProtKB
Q12959	DLG1	Disks large homolog 1	GO:0019902; F:phosphatase binding; IPI:UniProtKB
Q12959	DLG1	Disks large homolog 1	GO:0004721; F:phosphoprotein phosphatase activity; TAS:UniProtKB
Q12959	DLG1	Disks large homolog 1	GO:0015459; F:potassium channel regulator activity; NAS:UniProtKB
Q12959	DLG1	Disks large homolog 1	GO:0005515; F:protein binding; IPI:IntAct
Q12959	DLG1	Disks large homolog 1	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q12959	DLG1	Disks large homolog 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q12959	DLG1	Disks large homolog 1	GO:0007015; P:actin filament organization; IDA:UniProtKB
Q12959	DLG1	Disks large homolog 1	GO:0032147; P:activation of protein kinase activity; IEA:Ensembl
Q12959	DLG1	Disks large homolog 1	GO:0042982; P:amyloid precursor protein metabolic process; IEA:Ensembl
Q12959	DLG1	Disks large homolog 1	GO:0007411; P:axon guidance; TAS:Reactome
Q12959	DLG1	Disks large homolog 1	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
Q12959	DLG1	Disks large homolog 1	GO:0016337; P:single organismal cell-cell adhesion; IDA:UniProtKB
Q12959	DLG1	Disks large homolog 1	GO:0030866; P:cortical actin cytoskeleton organization; IDA:UniProtKB
Q12959	DLG1	Disks large homolog 1	GO:0016311; P:dephosphorylation; TAS:GOC
Q12959	DLG1	Disks large homolog 1	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
Q12959	DLG1	Disks large homolog 1	GO:0001935; P:endothelial cell proliferation; IDA:UniProtKB
Q12959	DLG1	Disks large homolog 1	GO:0007163; P:establishment or maintenance of cell polarity; TAS:UniProtKB
Q12959	DLG1	Disks large homolog 1	GO:0060022; P:hard palate development; IEA:Ensembl
Q12959	DLG1	Disks large homolog 1	GO:0001771; P:immunological synapse formation; IEA:Ensembl
Q12959	DLG1	Disks large homolog 1	GO:0002088; P:lens development in camera-type eye; IEA:Ensembl
Q12959	DLG1	Disks large homolog 1	GO:0031579; P:membrane raft organization; IEA:Ensembl
Q12959	DLG1	Disks large homolog 1	GO:0007093; P:mitotic cell cycle checkpoint; NAS:UniProtKB
Q12959	DLG1	Disks large homolog 1	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
Q12959	DLG1	Disks large homolog 1	GO:0045930; P:negative regulation of mitotic cell cycle; IMP:UniProtKB
Q12959	DLG1	Disks large homolog 1	GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl
Q12959	DLG1	Disks large homolog 1	GO:0046939; P:nucleotide phosphorylation; TAS:GOC
Q12959	DLG1	Disks large homolog 1	GO:0030432; P:peristalsis; IEA:Ensembl
Q12959	DLG1	Disks large homolog 1	GO:0030838; P:positive regulation of actin filament polymerization; IEA:Ensembl
Q12959	DLG1	Disks large homolog 1	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q12959	DLG1	Disks large homolog 1	GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; IDA:BHF-UCL
Q12959	DLG1	Disks large homolog 1	GO:0043268; P:positive regulation of potassium ion transport; IDA:BHF-UCL
Q12959	DLG1	Disks large homolog 1	GO:0072659; P:protein localization to plasma membrane; IMP:BHF-UCL
Q12959	DLG1	Disks large homolog 1	GO:0042391; P:regulation of membrane potential; IDA:BHF-UCL
Q12959	DLG1	Disks large homolog 1	GO:1902305; P:regulation of sodium ion transmembrane transport; TAS:BHF-UCL
Q12959	DLG1	Disks large homolog 1	GO:0048608; P:reproductive structure development; IEA:Ensembl
Q12959	DLG1	Disks large homolog 1	GO:0048745; P:smooth muscle tissue development; IEA:Ensembl
Q12959	DLG1	Disks large homolog 1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q12959	DLG1	Disks large homolog 1	GO:0042110; P:T cell activation; IEA:Ensembl
Q12959	DLG1	Disks large homolog 1	GO:0002369; P:T cell cytokine production; IEA:Ensembl
Q12959	DLG1	Disks large homolog 1	GO:0070830; P:tight junction assembly; IDA:BHF-UCL
Q12959	DLG1	Disks large homolog 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q15700	DLG2	Disks large homolog 2	GO:0004385; F:guanylate kinase activity; TAS:ProtInc
Q15700	DLG2	Disks large homolog 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q15700	DLG2	Disks large homolog 2	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q15700	DLG2	Disks large homolog 2	GO:0046939; P:nucleotide phosphorylation; TAS:GOC
Q15700	DLG2	Disks large homolog 2	GO:0019233; P:sensory perception of pain; IEA:Ensembl
Q15700	DLG2	Disks large homolog 2	GO:0007268; P:synaptic transmission; IEA:Ensembl
Q92796	DLG3	Disks large homolog 3	GO:0019902; F:phosphatase binding; IDA:UniProtKB
Q92796	DLG3	Disks large homolog 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q92796	DLG3	Disks large homolog 3	GO:0007411; P:axon guidance; TAS:Reactome
Q92796	DLG3	Disks large homolog 3	GO:0001736; P:establishment of planar polarity; IEA:Ensembl
Q92796	DLG3	Disks large homolog 3	GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; IEA:Ensembl
Q92796	DLG3	Disks large homolog 3	GO:0008285; P:negative regulation of cell proliferation; NAS:UniProtKB
Q92796	DLG3	Disks large homolog 3	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q92796	DLG3	Disks large homolog 3	GO:0007268; P:synaptic transmission; TAS:Reactome
P78352	DLG4	Disks large homolog 4	GO:0033130; F:acetylcholine receptor binding; ISS:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:0031697; F:beta-1 adrenergic receptor binding; ISS:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:0031748; F:D1 dopamine receptor binding; ISS:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:0035255; F:ionotropic glutamate receptor binding; ISS:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:0031812; F:P2Y1 nucleotide receptor binding; ISS:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:0030165; F:PDZ domain binding; ISS:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:0005515; F:protein binding; IPI:UniProtKB
P78352	DLG4	Disks large homolog 4	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P78352	DLG4	Disks large homolog 4	GO:0032403; F:protein complex binding; ISS:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:0019903; F:protein phosphatase binding; ISS:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:0097110; F:scaffold protein binding; ISS:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:0097113; P:alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering; ISS:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:0007411; P:axon guidance; TAS:Reactome
P78352	DLG4	Disks large homolog 4	GO:0060997; P:dendritic spine morphogenesis; ISS:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:0045184; P:establishment of protein localization; IDA:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:0007612; P:learning; TAS:ProtInc
P78352	DLG4	Disks large homolog 4	GO:0035641; P:locomotory exploration behavior; IEA:Ensembl
P78352	DLG4	Disks large homolog 4	GO:0002091; P:negative regulation of receptor internalization; ISS:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:0007399; P:nervous system development; TAS:ProtInc
P78352	DLG4	Disks large homolog 4	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
P78352	DLG4	Disks large homolog 4	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISS:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:2000463; P:positive regulation of excitatory postsynaptic membrane potential; ISS:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:0050806; P:positive regulation of synaptic transmission; ISS:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:0006461; P:protein complex assembly; IDA:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:0035418; P:protein localization to synapse; IDA:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:0097120; P:receptor localization to synapse; ISS:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:2000821; P:regulation of grooming behavior; IEA:Ensembl
P78352	DLG4	Disks large homolog 4	GO:0048169; P:regulation of long-term neuronal synaptic plasticity; ISS:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:2000310; P:regulation of N-methyl-D-aspartate selective glutamate receptor activity; ISS:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:0007165; P:signal transduction; TAS:ProtInc
P78352	DLG4	Disks large homolog 4	GO:0035176; P:social behavior; IEA:Ensembl
P78352	DLG4	Disks large homolog 4	GO:0007268; P:synaptic transmission; TAS:Reactome
P78352	DLG4	Disks large homolog 4	GO:0016188; P:synaptic vesicle maturation; ISS:BHF-UCL
P78352	DLG4	Disks large homolog 4	GO:0071625; P:vocalization behavior; IEA:Ensembl
Q8TDM6	DLG5	Disks large homolog 5	GO:0008013; F:beta-catenin binding; IDA:MGI
Q8TDM6	DLG5	Disks large homolog 5	GO:0008092; F:cytoskeletal protein binding; IDA:MGI
Q8TDM6	DLG5	Disks large homolog 5	GO:0005515; F:protein binding; IPI:IntAct
Q8TDM6	DLG5	Disks large homolog 5	GO:0030159; F:receptor signaling complex scaffold activity; NAS:UniProtKB
Q8TDM6	DLG5	Disks large homolog 5	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
Q8TDM6	DLG5	Disks large homolog 5	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
Q8TDM6	DLG5	Disks large homolog 5	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q8TDM6	DLG5	Disks large homolog 5	GO:0042981; P:regulation of apoptotic process; IEA:InterPro
Q8TDM6	DLG5	Disks large homolog 5	GO:0007165; P:signal transduction; TAS:ProtInc
O14490	DLGAP1	Disks large-associated protein 1	GO:0005515; F:protein binding; IPI:IntAct
O14490	DLGAP1	Disks large-associated protein 1	GO:0007268; P:synaptic transmission; NAS:UniProtKB
Q9P1A6	DLGAP2	Disks large-associated protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q9P1A6	DLGAP2	Disks large-associated protein 2	GO:0007270; P:neuron-neuron synaptic transmission; NAS:UniProtKB
O95886	DLGAP3	Disks large-associated protein 3	GO:0001540; F:beta-amyloid binding; IEA:Ensembl
O95886	DLGAP3	Disks large-associated protein 3	GO:0005515; F:protein binding; IPI:IntAct
O95886	DLGAP3	Disks large-associated protein 3	GO:0007267; P:cell-cell signaling; IEA:InterPro
Q9Y2H0	DLGAP4	Disks large-associated protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2H0	DLGAP4	Disks large-associated protein 4	GO:0007267; P:cell-cell signaling; IEA:InterPro
Q15398	DLGAP5	Disks large-associated protein 5	GO:0004721; F:phosphoprotein phosphatase activity; IDA:UniProtKB
Q15398	DLGAP5	Disks large-associated protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q15398	DLGAP5	Disks large-associated protein 5	GO:0008283; P:cell proliferation; NAS:UniProtKB
Q15398	DLGAP5	Disks large-associated protein 5	GO:0007267; P:cell-cell signaling; IEA:InterPro
Q15398	DLGAP5	Disks large-associated protein 5	GO:0016311; P:dephosphorylation; IDA:GOC
Q15398	DLGAP5	Disks large-associated protein 5	GO:0007079; P:mitotic chromosome movement towards spindle pole; NAS:UniProtKB
Q15398	DLGAP5	Disks large-associated protein 5	GO:0000087; P:mitotic M phase; IDA:UniProtKB
Q15398	DLGAP5	Disks large-associated protein 5	GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; NAS:UniProtKB
P80370	DLK1	Protein delta homolog 1	GO:0030154; P:cell differentiation; IEA:Ensembl
P80370	DLK1	Protein delta homolog 1	GO:0048706; P:embryonic skeletal system development; IEA:Ensembl
P80370	DLK1	Protein delta homolog 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P80370	DLK1	Protein delta homolog 1	GO:0045746; P:negative regulation of Notch signaling pathway; IEA:Ensembl
P80370	DLK1	Protein delta homolog 1	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P80370	DLK1	Protein delta homolog 1	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q6UY11	DLK2	Protein delta homolog 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q6UY11	DLK2	Protein delta homolog 2	GO:0045746; P:negative regulation of Notch signaling pathway; IEA:Ensembl
Q6UY11	DLK2	Protein delta homolog 2	GO:0045598; P:regulation of fat cell differentiation; IEA:Ensembl
O00548	DLL1	Delta-like protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
O00548	DLL1	Delta-like protein 1	GO:0005112; F:Notch binding; IPI:UniProtKB
O00548	DLL1	Delta-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
O00548	DLL1	Delta-like protein 1	GO:0030154; P:cell differentiation; TAS:UniProtKB
O00548	DLL1	Delta-like protein 1	GO:0001709; P:cell fate determination; NAS:UniProtKB
O00548	DLL1	Delta-like protein 1	GO:0007267; P:cell-cell signaling; IEA:Ensembl
O00548	DLL1	Delta-like protein 1	GO:0007386; P:compartment pattern specification; IEA:Ensembl
O00548	DLL1	Delta-like protein 1	GO:0007368; P:determination of left/right symmetry; ISS:BHF-UCL
O00548	DLL1	Delta-like protein 1	GO:0001947; P:heart looping; ISS:BHF-UCL
O00548	DLL1	Delta-like protein 1	GO:0030097; P:hemopoiesis; NAS:UniProtKB
O00548	DLL1	Delta-like protein 1	GO:0048839; P:inner ear development; IEA:Ensembl
O00548	DLL1	Delta-like protein 1	GO:0070986; P:left/right axis specification; IEA:Ensembl
O00548	DLL1	Delta-like protein 1	GO:0072070; P:loop of Henle development; IEA:Ensembl
O00548	DLL1	Delta-like protein 1	GO:0045608; P:negative regulation of auditory receptor cell differentiation; IEA:Ensembl
O00548	DLL1	Delta-like protein 1	GO:0032693; P:negative regulation of interleukin-10 production; IMP:UniProt
O00548	DLL1	Delta-like protein 1	GO:0045638; P:negative regulation of myeloid cell differentiation; IEA:Ensembl
O00548	DLL1	Delta-like protein 1	GO:0097150; P:neuronal stem cell maintenance; IEP:UniProtKB
O00548	DLL1	Delta-like protein 1	GO:0007220; P:Notch receptor processing; TAS:Reactome
O00548	DLL1	Delta-like protein 1	GO:0007219; P:Notch signaling pathway; IMP:UniProtKB
O00548	DLL1	Delta-like protein 1	GO:0045747; P:positive regulation of Notch signaling pathway; IEA:Ensembl
O00548	DLL1	Delta-like protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
O00548	DLL1	Delta-like protein 1	GO:0072014; P:proximal tubule development; IEA:Ensembl
O00548	DLL1	Delta-like protein 1	GO:0030155; P:regulation of cell adhesion; TAS:UniProtKB
O00548	DLL1	Delta-like protein 1	GO:0001757; P:somite specification; IEA:Ensembl
Q9NYJ7	DLL3	Delta-like protein 3	GO:0005112; F:Notch binding; NAS:UniProtKB
Q9NYJ7	DLL3	Delta-like protein 3	GO:0007386; P:compartment pattern specification; IEA:Ensembl
Q9NYJ7	DLL3	Delta-like protein 3	GO:0050768; P:negative regulation of neurogenesis; IEA:Ensembl
Q9NYJ7	DLL3	Delta-like protein 3	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
Q9NYJ7	DLL3	Delta-like protein 3	GO:0048339; P:paraxial mesoderm development; IEA:Ensembl
Q9NYJ7	DLL3	Delta-like protein 3	GO:0001501; P:skeletal system development; IMP:UniProtKB
Q9NYJ7	DLL3	Delta-like protein 3	GO:0001756; P:somitogenesis; IEA:Ensembl
Q9NR61	DLL4	Delta-like protein 4	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NR61	DLL4	Delta-like protein 4	GO:0005112; F:Notch binding; TAS:ProtInc
Q9NR61	DLL4	Delta-like protein 4	GO:0001525; P:angiogenesis; ISS:BHF-UCL
Q9NR61	DLL4	Delta-like protein 4	GO:0008015; P:blood circulation; TAS:ProtInc
Q9NR61	DLL4	Delta-like protein 4	GO:0072554; P:blood vessel lumenization; IEA:Ensembl
Q9NR61	DLL4	Delta-like protein 4	GO:0001974; P:blood vessel remodeling; ISS:BHF-UCL
Q9NR61	DLL4	Delta-like protein 4	GO:0003209; P:cardiac atrium morphogenesis; ISS:BHF-UCL
Q9NR61	DLL4	Delta-like protein 4	GO:0003208; P:cardiac ventricle morphogenesis; ISS:BHF-UCL
Q9NR61	DLL4	Delta-like protein 4	GO:0044344; P:cellular response to fibroblast growth factor stimulus; IDA:UniProtKB
Q9NR61	DLL4	Delta-like protein 4	GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IMP:UniProtKB
Q9NR61	DLL4	Delta-like protein 4	GO:0035912; P:dorsal aorta morphogenesis; ISS:BHF-UCL
Q9NR61	DLL4	Delta-like protein 4	GO:0090051; P:negative regulation of cell migration involved in sprouting angiogenesis; IMP:UniProtKB
Q9NR61	DLL4	Delta-like protein 4	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q9NR61	DLL4	Delta-like protein 4	GO:0010596; P:negative regulation of endothelial cell migration; IMP:UniProtKB
Q9NR61	DLL4	Delta-like protein 4	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q9NR61	DLL4	Delta-like protein 4	GO:0007220; P:Notch receptor processing; TAS:Reactome
Q9NR61	DLL4	Delta-like protein 4	GO:0061314; P:Notch signaling involved in heart development; ISS:BHF-UCL
Q9NR61	DLL4	Delta-like protein 4	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q9NR61	DLL4	Delta-like protein 4	GO:0001569; P:patterning of blood vessels; ISS:BHF-UCL
Q9NR61	DLL4	Delta-like protein 4	GO:0003344; P:pericardium morphogenesis; ISS:BHF-UCL
Q9NR61	DLL4	Delta-like protein 4	GO:2000179; P:positive regulation of neural precursor cell proliferation; ISS:UniProtKB
Q9NR61	DLL4	Delta-like protein 4	GO:0061074; P:regulation of neural retina development; ISS:UniProtKB
Q9NR61	DLL4	Delta-like protein 4	GO:0050767; P:regulation of neurogenesis; IEA:Ensembl
Q9NR61	DLL4	Delta-like protein 4	GO:0007165; P:signal transduction; TAS:ProtInc
Q9NR61	DLL4	Delta-like protein 4	GO:0060579; P:ventral spinal cord interneuron fate commitment; IMP:UniProtKB
Q9NR61	DLL4	Delta-like protein 4	GO:0003222; P:ventricular trabecula myocardium morphogenesis; ISS:BHF-UCL
Q86YH6	PDSS2	Decaprenyl-diphosphate synthase subunit 2	GO:0046982; F:protein heterodimerization activity; IDA:HGNC
Q86YH6	PDSS2	Decaprenyl-diphosphate synthase subunit 2	GO:0000010; F:trans-hexaprenyltranstransferase activity; IEA:Ensembl
Q86YH6	PDSS2	Decaprenyl-diphosphate synthase subunit 2	GO:0050347; F:trans-octaprenyltranstransferase activity; IEA:Ensembl
Q86YH6	PDSS2	Decaprenyl-diphosphate synthase subunit 2	GO:0008299; P:isoprenoid biosynthetic process; IDA:HGNC
Q86YH6	PDSS2	Decaprenyl-diphosphate synthase subunit 2	GO:0051290; P:protein heterotetramerization; IEA:Ensembl
Q86YH6	PDSS2	Decaprenyl-diphosphate synthase subunit 2	GO:0050878; P:regulation of body fluid levels; IEA:Ensembl
Q86YH6	PDSS2	Decaprenyl-diphosphate synthase subunit 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q86YH6	PDSS2	Decaprenyl-diphosphate synthase subunit 2	GO:0006744; P:ubiquinone biosynthetic process; IDA:HGNC
Q9NP97	DYNLRB1	Dynein light chain roadblock-type 1	GO:0003777; F:microtubule motor activity; NAS:UniProtKB
Q9NP97	DYNLRB1	Dynein light chain roadblock-type 1	GO:0008152; P:metabolic process; NAS:GOC
Q9NP97	DYNLRB1	Dynein light chain roadblock-type 1	GO:0007018; P:microtubule-based movement; NAS:UniProtKB
Q9NP97	DYNLRB1	Dynein light chain roadblock-type 1	GO:0006810; P:transport; IEA:UniProtKB-KW
Q9NP97	DYNLRB1	Dynein light chain roadblock-type 1	GO:0007632; P:visual behavior; ISS:UniProtKB
Q8TF09	DYNLRB2	Dynein light chain roadblock-type 2	GO:0003777; F:microtubule motor activity; NAS:UniProtKB
Q8TF09	DYNLRB2	Dynein light chain roadblock-type 2	GO:0008152; P:metabolic process; NAS:GOC
Q8TF09	DYNLRB2	Dynein light chain roadblock-type 2	GO:0007018; P:microtubule-based movement; NAS:UniProtKB
Q8TF09	DYNLRB2	Dynein light chain roadblock-type 2	GO:0006810; P:transport; IEA:UniProtKB-KW
Q07687	DLX2	Homeobox protein DLX-2	GO:0003682; F:chromatin binding; IEA:Ensembl
Q07687	DLX2	Homeobox protein DLX-2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q07687	DLX2	Homeobox protein DLX-2	GO:0003727; F:single-stranded RNA binding; IEA:Ensembl
Q07687	DLX2	Homeobox protein DLX-2	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
Q07687	DLX2	Homeobox protein DLX-2	GO:0007420; P:brain development; TAS:ProtInc
Q07687	DLX2	Homeobox protein DLX-2	GO:0048755; P:branching morphogenesis of a nerve; IEA:Ensembl
Q07687	DLX2	Homeobox protein DLX-2	GO:0051216; P:cartilage development; IEA:Ensembl
Q07687	DLX2	Homeobox protein DLX-2	GO:0021893; P:cerebral cortex GABAergic interneuron fate commitment; IEA:Ensembl
Q07687	DLX2	Homeobox protein DLX-2	GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl
Q07687	DLX2	Homeobox protein DLX-2	GO:0021766; P:hippocampus development; IEA:Ensembl
Q07687	DLX2	Homeobox protein DLX-2	GO:0045746; P:negative regulation of Notch signaling pathway; IEA:Ensembl
Q07687	DLX2	Homeobox protein DLX-2	GO:0048715; P:negative regulation of oligodendrocyte differentiation; IEA:Ensembl
Q07687	DLX2	Homeobox protein DLX-2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q07687	DLX2	Homeobox protein DLX-2	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
Q07687	DLX2	Homeobox protein DLX-2	GO:0021772; P:olfactory bulb development; IEA:Ensembl
Q07687	DLX2	Homeobox protein DLX-2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q07687	DLX2	Homeobox protein DLX-2	GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl
Q07687	DLX2	Homeobox protein DLX-2	GO:0021882; P:regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment; IEA:Ensembl
Q07687	DLX2	Homeobox protein DLX-2	GO:0021544; P:subpallium development; IEA:Ensembl
P56177	DLX1	Homeobox protein DLX-1	GO:0003682; F:chromatin binding; IEA:Ensembl
P56177	DLX1	Homeobox protein DLX-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P56177	DLX1	Homeobox protein DLX-1	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
P56177	DLX1	Homeobox protein DLX-1	GO:0021893; P:cerebral cortex GABAergic interneuron fate commitment; IEA:Ensembl
P56177	DLX1	Homeobox protein DLX-1	GO:0048706; P:embryonic skeletal system development; IEA:Ensembl
P56177	DLX1	Homeobox protein DLX-1	GO:0021766; P:hippocampus development; IEA:Ensembl
P56177	DLX1	Homeobox protein DLX-1	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P56177	DLX1	Homeobox protein DLX-1	GO:0045746; P:negative regulation of Notch signaling pathway; IEA:Ensembl
P56177	DLX1	Homeobox protein DLX-1	GO:0048715; P:negative regulation of oligodendrocyte differentiation; IEA:Ensembl
P56177	DLX1	Homeobox protein DLX-1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P56177	DLX1	Homeobox protein DLX-1	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
P56177	DLX1	Homeobox protein DLX-1	GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl
P56177	DLX1	Homeobox protein DLX-1	GO:0021882; P:regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment; IEA:Ensembl
P56177	DLX1	Homeobox protein DLX-1	GO:0021544; P:subpallium development; IEA:Ensembl
Q92988	DLX4	Homeobox protein DLX-4	GO:0005515; F:protein binding; IPI:IntAct
Q92988	DLX4	Homeobox protein DLX-4	GO:0043565; F:sequence-specific DNA binding; IDA:MGI
Q92988	DLX4	Homeobox protein DLX-4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q92988	DLX4	Homeobox protein DLX-4	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
Q92988	DLX4	Homeobox protein DLX-4	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q92988	DLX4	Homeobox protein DLX-4	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
O60479	DLX3	Homeobox protein DLX-3	GO:0003682; F:chromatin binding; IEA:Ensembl
O60479	DLX3	Homeobox protein DLX-3	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
O60479	DLX3	Homeobox protein DLX-3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O60479	DLX3	Homeobox protein DLX-3	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
O60479	DLX3	Homeobox protein DLX-3	GO:0001568; P:blood vessel development; IEA:Ensembl
O60479	DLX3	Homeobox protein DLX-3	GO:0071895; P:odontoblast differentiation; IEA:Ensembl
O60479	DLX3	Homeobox protein DLX-3	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
O60479	DLX3	Homeobox protein DLX-3	GO:0001890; P:placenta development; IEA:Ensembl
P56178	DLX5	Homeobox protein DLX-5	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; ISS:BHF-UCL
P56178	DLX5	Homeobox protein DLX-5	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; ISS:BHF-UCL
P56178	DLX5	Homeobox protein DLX-5	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P56178	DLX5	Homeobox protein DLX-5	GO:0048646; P:anatomical structure formation involved in morphogenesis; IEA:Ensembl
P56178	DLX5	Homeobox protein DLX-5	GO:0007411; P:axon guidance; IEA:Ensembl
P56178	DLX5	Homeobox protein DLX-5	GO:0030509; P:BMP signaling pathway; ISS:BHF-UCL
P56178	DLX5	Homeobox protein DLX-5	GO:0008283; P:cell proliferation; IDA:UniProtKB
P56178	DLX5	Homeobox protein DLX-5	GO:0071773; P:cellular response to BMP stimulus; ISS:BHF-UCL
P56178	DLX5	Homeobox protein DLX-5	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
P56178	DLX5	Homeobox protein DLX-5	GO:0001958; P:endochondral ossification; ISS:UniProtKB
P56178	DLX5	Homeobox protein DLX-5	GO:0030855; P:epithelial cell differentiation; IEA:Ensembl
P56178	DLX5	Homeobox protein DLX-5	GO:0060325; P:face morphogenesis; IEA:Ensembl
P56178	DLX5	Homeobox protein DLX-5	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
P56178	DLX5	Homeobox protein DLX-5	GO:0007399; P:nervous system development; TAS:ProtInc
P56178	DLX5	Homeobox protein DLX-5	GO:0060166; P:olfactory pit development; IEA:Ensembl
P56178	DLX5	Homeobox protein DLX-5	GO:0001649; P:osteoblast differentiation; ISS:UniProtKB
P56178	DLX5	Homeobox protein DLX-5	GO:0060021; P:palate development; IEA:Ensembl
P56178	DLX5	Homeobox protein DLX-5	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl
P56178	DLX5	Homeobox protein DLX-5	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
P56178	DLX5	Homeobox protein DLX-5	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
P56178	DLX5	Homeobox protein DLX-5	GO:1901522; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; ISS:BHF-UCL
P56178	DLX5	Homeobox protein DLX-5	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P56178	DLX5	Homeobox protein DLX-5	GO:0001501; P:skeletal system development; TAS:ProtInc
P56179	DLX6	Homeobox protein DLX-6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P56179	DLX6	Homeobox protein DLX-6	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
P56179	DLX6	Homeobox protein DLX-6	GO:0048646; P:anatomical structure formation involved in morphogenesis; IEA:Ensembl
P56179	DLX6	Homeobox protein DLX-6	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
P56179	DLX6	Homeobox protein DLX-6	GO:0030855; P:epithelial cell differentiation; IEA:Ensembl
P56179	DLX6	Homeobox protein DLX-6	GO:0060322; P:head development; IEA:Ensembl
P56179	DLX6	Homeobox protein DLX-6	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
P56179	DLX6	Homeobox protein DLX-6	GO:0007399; P:nervous system development; TAS:ProtInc
P56179	DLX6	Homeobox protein DLX-6	GO:0060021; P:palate development; IEA:Ensembl
P56179	DLX6	Homeobox protein DLX-6	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
P56179	DLX6	Homeobox protein DLX-6	GO:0001501; P:skeletal system development; TAS:ProtInc
Q9NPF5	DMAP1	DNA methyltransferase 1-associated protein 1	GO:0003682; F:chromatin binding; IEA:InterPro
Q9NPF5	DMAP1	DNA methyltransferase 1-associated protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NPF5	DMAP1	DNA methyltransferase 1-associated protein 1	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IDA:UniProtKB
Q9NPF5	DMAP1	DNA methyltransferase 1-associated protein 1	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
Q9NPF5	DMAP1	DNA methyltransferase 1-associated protein 1	GO:0006325; P:chromatin organization; TAS:Reactome
Q9NPF5	DMAP1	DNA methyltransferase 1-associated protein 1	GO:0006338; P:chromatin remodeling; IEA:InterPro
Q9NPF5	DMAP1	DNA methyltransferase 1-associated protein 1	GO:0006306; P:DNA methylation; TAS:UniProtKB
Q9NPF5	DMAP1	DNA methyltransferase 1-associated protein 1	GO:0006281; P:DNA repair; IEA:InterPro
Q9NPF5	DMAP1	DNA methyltransferase 1-associated protein 1	GO:0043968; P:histone H2A acetylation; IDA:UniProtKB
Q9NPF5	DMAP1	DNA methyltransferase 1-associated protein 1	GO:0043967; P:histone H4 acetylation; IDA:UniProtKB
Q9NPF5	DMAP1	DNA methyltransferase 1-associated protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9NPF5	DMAP1	DNA methyltransferase 1-associated protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB
Q9NPF5	DMAP1	DNA methyltransferase 1-associated protein 1	GO:0042993; P:positive regulation of transcription factor import into nucleus; IDA:UniProtKB
Q9NPF5	DMAP1	DNA methyltransferase 1-associated protein 1	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q9NPF5	DMAP1	DNA methyltransferase 1-associated protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P28067	HLA-DMA	HLA class II histocompatibility antigen, DM alpha chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P28067	HLA-DMA	HLA class II histocompatibility antigen, DM alpha chain	GO:0051085; P:chaperone mediated protein folding requiring cofactor; IEA:Ensembl
P28067	HLA-DMA	HLA class II histocompatibility antigen, DM alpha chain	GO:0016064; P:immunoglobulin mediated immune response; IEA:Ensembl
P28067	HLA-DMA	HLA class II histocompatibility antigen, DM alpha chain	GO:0048839; P:inner ear development; IEA:Ensembl
P28067	HLA-DMA	HLA class II histocompatibility antigen, DM alpha chain	GO:0050778; P:positive regulation of immune response; IEA:Ensembl
P28067	HLA-DMA	HLA class II histocompatibility antigen, DM alpha chain	GO:0045582; P:positive regulation of T cell differentiation; IEA:Ensembl
P28067	HLA-DMA	HLA class II histocompatibility antigen, DM alpha chain	GO:0045059; P:positive thymic T cell selection; IEA:Ensembl
P28067	HLA-DMA	HLA class II histocompatibility antigen, DM alpha chain	GO:0006461; P:protein complex assembly; IEA:Ensembl
P28067	HLA-DMA	HLA class II histocompatibility antigen, DM alpha chain	GO:0015031; P:protein transport; IEA:Ensembl
Q9UGM3	DMBT1	Deleted in malignant brain tumors 1 protein	GO:0048306; F:calcium-dependent protein binding; TAS:UniProtKB
Q9UGM3	DMBT1	Deleted in malignant brain tumors 1 protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UGM3	DMBT1	Deleted in malignant brain tumors 1 protein	GO:0005044; F:scavenger receptor activity; NAS:UniProtKB
Q9UGM3	DMBT1	Deleted in malignant brain tumors 1 protein	GO:0008329; F:signaling pattern recognition receptor activity; TAS:UniProtKB
Q9UGM3	DMBT1	Deleted in malignant brain tumors 1 protein	GO:0035375; F:zymogen binding; ISS:UniProtKB
Q9UGM3	DMBT1	Deleted in malignant brain tumors 1 protein	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q9UGM3	DMBT1	Deleted in malignant brain tumors 1 protein	GO:0030855; P:epithelial cell differentiation; NAS:UniProtKB
Q9UGM3	DMBT1	Deleted in malignant brain tumors 1 protein	GO:0043152; P:induction of bacterial agglutination; TAS:UniProtKB
Q9UGM3	DMBT1	Deleted in malignant brain tumors 1 protein	GO:0045087; P:innate immune response; TAS:UniProtKB
Q9UGM3	DMBT1	Deleted in malignant brain tumors 1 protein	GO:0001833; P:inner cell mass cell proliferation; IEA:Ensembl
Q9UGM3	DMBT1	Deleted in malignant brain tumors 1 protein	GO:0002221; P:pattern recognition receptor signaling pathway; TAS:GOC
Q9UGM3	DMBT1	Deleted in malignant brain tumors 1 protein	GO:0030858; P:positive regulation of epithelial cell differentiation; IEA:Ensembl
Q9UGM3	DMBT1	Deleted in malignant brain tumors 1 protein	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9UGM3	DMBT1	Deleted in malignant brain tumors 1 protein	GO:0006898; P:receptor-mediated endocytosis; NAS:GOC
Q9UGM3	DMBT1	Deleted in malignant brain tumors 1 protein	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q8NFW5	DMBX1	Diencephalon/mesencephalon homeobox protein 1	GO:0003677; F:DNA binding; ISS:UniProtKB
Q8NFW5	DMBX1	Diencephalon/mesencephalon homeobox protein 1	GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB
Q8NFW5	DMBX1	Diencephalon/mesencephalon homeobox protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q8NFW5	DMBX1	Diencephalon/mesencephalon homeobox protein 1	GO:0008343; P:adult feeding behavior; IEA:Ensembl
Q8NFW5	DMBX1	Diencephalon/mesencephalon homeobox protein 1	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
Q8NFW5	DMBX1	Diencephalon/mesencephalon homeobox protein 1	GO:0007420; P:brain development; ISS:UniProtKB
Q8NFW5	DMBX1	Diencephalon/mesencephalon homeobox protein 1	GO:0007417; P:central nervous system development; ISS:UniProtKB
Q8NFW5	DMBX1	Diencephalon/mesencephalon homeobox protein 1	GO:0048589; P:developmental growth; ISS:UniProtKB
Q8NFW5	DMBX1	Diencephalon/mesencephalon homeobox protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8NFW5	DMBX1	Diencephalon/mesencephalon homeobox protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q8NFW5	DMBX1	Diencephalon/mesencephalon homeobox protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P28068	HLA-DMB	HLA class II histocompatibility antigen, DM beta chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P28068	HLA-DMB	HLA class II histocompatibility antigen, DM beta chain	GO:0006955; P:immune response; IEA:InterPro
Q14565	DMC1	Meiotic recombination protein DMC1/LIM15 homolog	GO:0005524; F:ATP binding; TAS:ProtInc
Q14565	DMC1	Meiotic recombination protein DMC1/LIM15 homolog	GO:0003677; F:DNA binding; TAS:ProtInc
Q14565	DMC1	Meiotic recombination protein DMC1/LIM15 homolog	GO:0008094; F:DNA-dependent ATPase activity; IEA:InterPro
Q14565	DMC1	Meiotic recombination protein DMC1/LIM15 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q14565	DMC1	Meiotic recombination protein DMC1/LIM15 homolog	GO:0007292; P:female gamete generation; TAS:ProtInc
Q14565	DMC1	Meiotic recombination protein DMC1/LIM15 homolog	GO:0007141; P:male meiosis I; IEA:Ensembl
Q14565	DMC1	Meiotic recombination protein DMC1/LIM15 homolog	GO:0007126; P:meiotic nuclear division; TAS:ProtInc
Q14565	DMC1	Meiotic recombination protein DMC1/LIM15 homolog	GO:0001556; P:oocyte maturation; IEA:Ensembl
Q14565	DMC1	Meiotic recombination protein DMC1/LIM15 homolog	GO:0001541; P:ovarian follicle development; IEA:Ensembl
Q14565	DMC1	Meiotic recombination protein DMC1/LIM15 homolog	GO:0007131; P:reciprocal meiotic recombination; TAS:ProtInc
Q14565	DMC1	Meiotic recombination protein DMC1/LIM15 homolog	GO:0007286; P:spermatid development; IEA:Ensembl
Q14565	DMC1	Meiotic recombination protein DMC1/LIM15 homolog	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q14565	DMC1	Meiotic recombination protein DMC1/LIM15 homolog	GO:0007129; P:synapsis; IEA:Ensembl
P11532	DMD	Dystrophin	GO:0003779; F:actin binding; TAS:UniProtKB
P11532	DMD	Dystrophin	GO:0005509; F:calcium ion binding; IEA:InterPro
P11532	DMD	Dystrophin	GO:0002162; F:dystroglycan binding; IPI:UniProtKB
P11532	DMD	Dystrophin	GO:0017022; F:myosin binding; IDA:BHF-UCL
P11532	DMD	Dystrophin	GO:0050998; F:nitric-oxide synthase binding; ISS:BHF-UCL
P11532	DMD	Dystrophin	GO:0005515; F:protein binding; IPI:IntAct
P11532	DMD	Dystrophin	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P11532	DMD	Dystrophin	GO:0008307; F:structural constituent of muscle; IDA:UniProtKB
P11532	DMD	Dystrophin	GO:0017166; F:vinculin binding; IPI:BHF-UCL
P11532	DMD	Dystrophin	GO:0008270; F:zinc ion binding; IEA:InterPro
P11532	DMD	Dystrophin	GO:0086001; P:cardiac muscle cell action potential; ISS:BHF-UCL
P11532	DMD	Dystrophin	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
P11532	DMD	Dystrophin	GO:0043623; P:cellular protein complex assembly; ISS:BHF-UCL
P11532	DMD	Dystrophin	GO:0034613; P:cellular protein localization; IMP:BHF-UCL
P11532	DMD	Dystrophin	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P11532	DMD	Dystrophin	GO:0044458; P:motile cilium assembly; TAS:BHF-UCL
P11532	DMD	Dystrophin	GO:0030049; P:muscle filament sliding; TAS:Reactome
P11532	DMD	Dystrophin	GO:0007517; P:muscle organ development; NAS:ProtInc
P11532	DMD	Dystrophin	GO:1902083; P:negative regulation of peptidyl-cysteine S-nitrosylation; ISS:BHF-UCL
P11532	DMD	Dystrophin	GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; ISS:BHF-UCL
P11532	DMD	Dystrophin	GO:0043043; P:peptide biosynthetic process; IDA:UniProtKB
P11532	DMD	Dystrophin	GO:0045666; P:positive regulation of neuron differentiation; IMP:BHF-UCL
P11532	DMD	Dystrophin	GO:0010976; P:positive regulation of neuron projection development; IMP:BHF-UCL
P11532	DMD	Dystrophin	GO:2000651; P:positive regulation of sodium ion transmembrane transporter activity; ISS:BHF-UCL
P11532	DMD	Dystrophin	GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; ISS:BHF-UCL
P11532	DMD	Dystrophin	GO:0090287; P:regulation of cellular response to growth factor stimulus; IMP:BHF-UCL
P11532	DMD	Dystrophin	GO:0002027; P:regulation of heart rate; IMP:BHF-UCL
P11532	DMD	Dystrophin	GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; ISS:BHF-UCL
P11532	DMD	Dystrophin	GO:0060314; P:regulation of ryanodine-sensitive calcium-release channel activity; ISS:BHF-UCL
P11532	DMD	Dystrophin	GO:0014819; P:regulation of skeletal muscle contraction; ISS:BHF-UCL
P11532	DMD	Dystrophin	GO:0014809; P:regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; ISS:BHF-UCL
P11532	DMD	Dystrophin	GO:1901385; P:regulation of voltage-gated calcium channel activity; ISS:BHF-UCL
Q6E0U4	DMKN	Dermokine	GO:0005515; F:protein binding; IPI:IntAct
Q13316	DMP1	Dentin matrix acidic phosphoprotein 1	GO:0005509; F:calcium ion binding; TAS:ProtInc
Q13316	DMP1	Dentin matrix acidic phosphoprotein 1	GO:0050840; F:extracellular matrix binding; IEA:Ensembl
Q13316	DMP1	Dentin matrix acidic phosphoprotein 1	GO:0005178; F:integrin binding; TAS:ProtInc
Q13316	DMP1	Dentin matrix acidic phosphoprotein 1	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
Q13316	DMP1	Dentin matrix acidic phosphoprotein 1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q13316	DMP1	Dentin matrix acidic phosphoprotein 1	GO:0001503; P:ossification; TAS:ProtInc
Q13316	DMP1	Dentin matrix acidic phosphoprotein 1	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
Q6PK57	DNM1P34	Putative GED domain-containing protein DNM1P34	GO:0005525; F:GTP binding; IEA:InterPro
Q6PK57	DNM1P34	Putative GED domain-containing protein DNM1P34	GO:0003924; F:GTPase activity; IEA:InterPro
Q6ZS02	DNM1P46	Putative GED domain-containing protein DNM1P46	GO:0003924; F:GTPase activity; IEA:InterPro
Q8IXL6	FAM20C	Extracellular serine/threonine protein kinase FAM20C	GO:0005509; F:calcium ion binding; IEA:Ensembl
Q8IXL6	FAM20C	Extracellular serine/threonine protein kinase FAM20C	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProt
Q8IXL6	FAM20C	Extracellular serine/threonine protein kinase FAM20C	GO:0097187; P:dentinogenesis; IEA:Ensembl
Q8IXL6	FAM20C	Extracellular serine/threonine protein kinase FAM20C	GO:0070166; P:enamel mineralization; IEA:Ensembl
Q8IXL6	FAM20C	Extracellular serine/threonine protein kinase FAM20C	GO:0071895; P:odontoblast differentiation; IEA:Ensembl
Q8IXL6	FAM20C	Extracellular serine/threonine protein kinase FAM20C	GO:0036179; P:osteoclast maturation; IEA:Ensembl
Q8IXL6	FAM20C	Extracellular serine/threonine protein kinase FAM20C	GO:0030501; P:positive regulation of bone mineralization; IEA:Ensembl
Q8IXL6	FAM20C	Extracellular serine/threonine protein kinase FAM20C	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
Q8IXL6	FAM20C	Extracellular serine/threonine protein kinase FAM20C	GO:0006468; P:protein phosphorylation; IDA:GOC
Q8IXL6	FAM20C	Extracellular serine/threonine protein kinase FAM20C	GO:0040036; P:regulation of fibroblast growth factor receptor signaling pathway; IEA:Ensembl
Q8IXL6	FAM20C	Extracellular serine/threonine protein kinase FAM20C	GO:0051174; P:regulation of phosphorus metabolic process; IEA:Ensembl
Q8IXL6	FAM20C	Extracellular serine/threonine protein kinase FAM20C	GO:0001501; P:skeletal system development; IEA:Ensembl
Q09013	DMPK	Myotonin-protein kinase	GO:0005524; F:ATP binding; IDA:UniProtKB
Q09013	DMPK	Myotonin-protein kinase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q09013	DMPK	Myotonin-protein kinase	GO:0017020; F:myosin phosphatase regulator activity; IDA:UniProtKB
Q09013	DMPK	Myotonin-protein kinase	GO:0005515; F:protein binding; IPI:UniProtKB
Q09013	DMPK	Myotonin-protein kinase	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q09013	DMPK	Myotonin-protein kinase	GO:0006874; P:cellular calcium ion homeostasis; ISS:UniProtKB
Q09013	DMPK	Myotonin-protein kinase	GO:0010657; P:muscle cell apoptotic process; IDA:UniProtKB
Q09013	DMPK	Myotonin-protein kinase	GO:0006998; P:nuclear envelope organization; IMP:UniProtKB
Q09013	DMPK	Myotonin-protein kinase	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q09013	DMPK	Myotonin-protein kinase	GO:0050790; P:regulation of catalytic activity; IDA:GOC
Q09013	DMPK	Myotonin-protein kinase	GO:0014853; P:regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction; IEA:Ensembl
Q09013	DMPK	Myotonin-protein kinase	GO:0008016; P:regulation of heart contraction; IDA:UniProtKB
Q09013	DMPK	Myotonin-protein kinase	GO:0010830; P:regulation of myotube differentiation; ISS:UniProtKB
Q09013	DMPK	Myotonin-protein kinase	GO:0014722; P:regulation of skeletal muscle contraction by calcium ion signaling; IEA:Ensembl
Q09013	DMPK	Myotonin-protein kinase	GO:0002028; P:regulation of sodium ion transport; IEA:Ensembl
Q09013	DMPK	Myotonin-protein kinase	GO:0051823; P:regulation of synapse structural plasticity; IEA:Ensembl
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0000987; F:core promoter proximal region sequence-specific DNA binding; ISS:UniProtKB
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0000902; P:cell morphogenesis; IEA:Ensembl
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0008354; P:germ cell migration; IEA:Ensembl
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0035556; P:intracellular signal transduction; IEA:Ensembl
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0002176; P:male germ cell proliferation; ISS:UniProtKB
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0008584; P:male gonad development; TAS:ProtInc
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0030238; P:male sex determination; ISS:UniProtKB
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0046661; P:male sex differentiation; ISS:UniProtKB
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0045835; P:negative regulation of meiosis; ISS:UniProtKB
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0048599; P:oocyte development; IEA:Ensembl
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:2000020; P:positive regulation of male gonad development; IEA:Ensembl
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0060903; P:positive regulation of meiosis I; IEA:Ensembl
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0045840; P:positive regulation of mitosis; ISS:UniProtKB
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0060009; P:Sertoli cell development; IEA:Ensembl
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0060008; P:Sertoli cell differentiation; ISS:UniProtKB
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0007530; P:sex determination; TAS:ProtInc
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q9Y5R6	DMRT1	Doublesex- and mab-3-related transcription factor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y5R5	DMRT2	Doublesex- and mab-3-related transcription factor 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y5R5	DMRT2	Doublesex- and mab-3-related transcription factor 2	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q9Y5R5	DMRT2	Doublesex- and mab-3-related transcription factor 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9Y5R5	DMRT2	Doublesex- and mab-3-related transcription factor 2	GO:0048706; P:embryonic skeletal system development; IEA:Ensembl
Q9Y5R5	DMRT2	Doublesex- and mab-3-related transcription factor 2	GO:0008584; P:male gonad development; TAS:ProtInc
Q9Y5R5	DMRT2	Doublesex- and mab-3-related transcription factor 2	GO:2000287; P:positive regulation of myotome development; IEA:Ensembl
Q9Y5R5	DMRT2	Doublesex- and mab-3-related transcription factor 2	GO:0014807; P:regulation of somitogenesis; IEA:Ensembl
Q9Y5R5	DMRT2	Doublesex- and mab-3-related transcription factor 2	GO:0007530; P:sex determination; TAS:ProtInc
Q9Y5R5	DMRT2	Doublesex- and mab-3-related transcription factor 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NQL9	DMRT3	Doublesex- and mab-3-related transcription factor 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NQL9	DMRT3	Doublesex- and mab-3-related transcription factor 3	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q9NQL9	DMRT3	Doublesex- and mab-3-related transcription factor 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9NQL9	DMRT3	Doublesex- and mab-3-related transcription factor 3	GO:0007628; P:adult walking behavior; IEA:Ensembl
Q9NQL9	DMRT3	Doublesex- and mab-3-related transcription factor 3	GO:0046661; P:male sex differentiation; IEA:Ensembl
Q9NQL9	DMRT3	Doublesex- and mab-3-related transcription factor 3	GO:0042487; P:regulation of odontogenesis of dentin-containing tooth; IEA:Ensembl
Q9NQL9	DMRT3	Doublesex- and mab-3-related transcription factor 3	GO:0007548; P:sex differentiation; NAS:UniProtKB
Q9NQL9	DMRT3	Doublesex- and mab-3-related transcription factor 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NQL9	DMRT3	Doublesex- and mab-3-related transcription factor 3	GO:0019226; P:transmission of nerve impulse; IEA:Ensembl
Q9NQL9	DMRT3	Doublesex- and mab-3-related transcription factor 3	GO:0021521; P:ventral spinal cord interneuron specification; IEA:Ensembl
Q5VZB9	DMRTA1	Doublesex- and mab-3-related transcription factor A1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5VZB9	DMRTA1	Doublesex- and mab-3-related transcription factor A1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q5VZB9	DMRTA1	Doublesex- and mab-3-related transcription factor A1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q5VZB9	DMRTA1	Doublesex- and mab-3-related transcription factor A1	GO:0060179; P:male mating behavior; IEA:Ensembl
Q5VZB9	DMRTA1	Doublesex- and mab-3-related transcription factor A1	GO:0001541; P:ovarian follicle development; IEA:Ensembl
Q5VZB9	DMRTA1	Doublesex- and mab-3-related transcription factor A1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96MA1	DMRTB1	Doublesex- and mab-3-related transcription factor B1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96MA1	DMRTB1	Doublesex- and mab-3-related transcription factor B1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q96MA1	DMRTB1	Doublesex- and mab-3-related transcription factor B1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q96MA1	DMRTB1	Doublesex- and mab-3-related transcription factor B1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IXT2	DMRTC2	Doublesex- and mab-3-related transcription factor C2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IXT2	DMRTC2	Doublesex- and mab-3-related transcription factor C2	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q8IXT2	DMRTC2	Doublesex- and mab-3-related transcription factor C2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8IXT2	DMRTC2	Doublesex- and mab-3-related transcription factor C2	GO:0007141; P:male meiosis I; IEA:Ensembl
Q8IXT2	DMRTC2	Doublesex- and mab-3-related transcription factor C2	GO:1900111; P:positive regulation of histone H3-K9 dimethylation; IEA:Ensembl
Q8IXT2	DMRTC2	Doublesex- and mab-3-related transcription factor C2	GO:1900114; P:positive regulation of histone H3-K9 trimethylation; IEA:Ensembl
Q8IXT2	DMRTC2	Doublesex- and mab-3-related transcription factor C2	GO:0007548; P:sex differentiation; IEA:UniProtKB-KW
Q8IXT2	DMRTC2	Doublesex- and mab-3-related transcription factor C2	GO:0007290; P:spermatid nucleus elongation; IEA:Ensembl
Q8IXT2	DMRTC2	Doublesex- and mab-3-related transcription factor C2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5HYR2	DMRTC1	Doublesex- and mab-3-related transcription factor C1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q5HYR2	DMRTC1	Doublesex- and mab-3-related transcription factor C1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96SC8	DMRTA2	Doublesex- and mab-3-related transcription factor A2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96SC8	DMRTA2	Doublesex- and mab-3-related transcription factor A2	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q96SC8	DMRTA2	Doublesex- and mab-3-related transcription factor A2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q96SC8	DMRTA2	Doublesex- and mab-3-related transcription factor A2	GO:0071542; P:dopaminergic neuron differentiation; IEA:Ensembl
Q96SC8	DMRTA2	Doublesex- and mab-3-related transcription factor A2	GO:0048665; P:neuron fate specification; IEA:Ensembl
Q96SC8	DMRTA2	Doublesex- and mab-3-related transcription factor A2	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q9Y222	DMTF1	Cyclin-D-binding Myb-like transcription factor 1	GO:0003682; F:chromatin binding; IEA:InterPro
Q9Y222	DMTF1	Cyclin-D-binding Myb-like transcription factor 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y222	DMTF1	Cyclin-D-binding Myb-like transcription factor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9Y222	DMTF1	Cyclin-D-binding Myb-like transcription factor 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9Y222	DMTF1	Cyclin-D-binding Myb-like transcription factor 1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9Y222	DMTF1	Cyclin-D-binding Myb-like transcription factor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TDJ6	DMXL2	DmX-like protein 2	GO:0017137; F:Rab GTPase binding; IDA:MGI
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0043139; F:5'-3' DNA helicase activity; IDA:UniProtKB
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0017108; F:5'-flap endonuclease activity; IDA:UniProtKB
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0016887; F:ATPase activity; TAS:UniProtKB
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0003677; F:DNA binding; IDA:UniProtKB
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0003678; F:DNA helicase activity; IDA:UniProtKB
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0004386; F:helicase activity; TAS:UniProtKB
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0004518; F:nuclease activity; IDA:UniProtKB
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0005515; F:protein binding; IPI:UniProtKB
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0043142; F:single-stranded DNA-dependent ATPase activity; IDA:UniProtKB
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0016890; F:site-specific endodeoxyribonuclease activity, specific for altered base; IDA:UniProtKB
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0006200; P:ATP catabolic process; IDA:GOC
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0006284; P:base-excision repair; IDA:UniProtKB
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0000729; P:DNA double-strand break processing; IDA:UniProtKB
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0032508; P:DNA duplex unwinding; IDA:GOC
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0006260; P:DNA replication; IMP:UniProtKB
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0000076; P:DNA replication checkpoint; IMP:UniProtKB
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0033567; P:DNA replication, Okazaki fragment processing; IDA:UniProtKB
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0043137; P:DNA replication, removal of RNA primer; IDA:UniProtKB
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0043504; P:mitochondrial DNA repair; IDA:UniProtKB
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0006264; P:mitochondrial DNA replication; IDA:UniProtKB
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0045740; P:positive regulation of DNA replication; IDA:UniProtKB
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0000723; P:telomere maintenance; TAS:Reactome
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
P51530	DNA2	DNA replication ATP-dependent helicase/nuclease DNA2	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
Q9UI46	DNAI1	Dynein intermediate chain 1, axonemal	GO:0003774; F:motor activity; TAS:ProtInc
Q9UI46	DNAI1	Dynein intermediate chain 1, axonemal	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UI46	DNAI1	Dynein intermediate chain 1, axonemal	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
Q9UI46	DNAI1	Dynein intermediate chain 1, axonemal	GO:0003351; P:epithelial cilium movement; IEA:Ensembl
Q9UI46	DNAI1	Dynein intermediate chain 1, axonemal	GO:0008152; P:metabolic process; TAS:GOC
Q9GZS0	DNAI2	Dynein intermediate chain 2, axonemal	GO:0003777; F:microtubule motor activity; IMP:MGI
Q9GZS0	DNAI2	Dynein intermediate chain 2, axonemal	GO:0042384; P:cilium assembly; IMP:MGI
Q9GZS0	DNAI2	Dynein intermediate chain 2, axonemal	GO:0008152; P:metabolic process; IMP:GOC
O96015	DNAL4	Dynein light chain 4, axonemal	GO:0003774; F:motor activity; IEA:UniProtKB-KW
O96015	DNAL4	Dynein light chain 4, axonemal	GO:0007017; P:microtubule-based process; IEA:InterPro
O96015	DNAL4	Dynein light chain 4, axonemal	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P24855	DNASE1	Deoxyribonuclease-1	GO:0004530; F:deoxyribonuclease I activity; IEA:UniProtKB-EC
P24855	DNASE1	Deoxyribonuclease-1	GO:0005515; F:protein binding; IPI:UniProtKB
P24855	DNASE1	Deoxyribonuclease-1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8IYX4	DND1	Dead end protein homolog 1	GO:0017091; F:AU-rich element binding; IDA:UniProtKB
Q8IYX4	DND1	Dead end protein homolog 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8IYX4	DND1	Dead end protein homolog 1	GO:0007281; P:germ cell development; IEA:Ensembl
Q8IYX4	DND1	Dead end protein homolog 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8IYX4	DND1	Dead end protein homolog 1	GO:0060965; P:negative regulation of gene silencing by miRNA; IDA:UniProtKB
Q8NFT8	DNER	Delta and Notch-like epidermal growth factor-related receptor	GO:0005509; F:calcium ion binding; NAS:UniProtKB
Q8NFT8	DNER	Delta and Notch-like epidermal growth factor-related receptor	GO:0030276; F:clathrin binding; TAS:UniProtKB
Q8NFT8	DNER	Delta and Notch-like epidermal growth factor-related receptor	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NFT8	DNER	Delta and Notch-like epidermal growth factor-related receptor	GO:0004888; F:transmembrane signaling receptor activity; TAS:UniProtKB
Q8NFT8	DNER	Delta and Notch-like epidermal growth factor-related receptor	GO:0007417; P:central nervous system development; IEP:UniProtKB
Q8NFT8	DNER	Delta and Notch-like epidermal growth factor-related receptor	GO:0006897; P:endocytosis; NAS:UniProtKB
Q8NFT8	DNER	Delta and Notch-like epidermal growth factor-related receptor	GO:0010001; P:glial cell differentiation; IEA:Ensembl
Q8NFT8	DNER	Delta and Notch-like epidermal growth factor-related receptor	GO:0001764; P:neuron migration; NAS:UniProtKB
Q8NFT8	DNER	Delta and Notch-like epidermal growth factor-related receptor	GO:0007220; P:Notch receptor processing; IEA:Ensembl
Q8NFT8	DNER	Delta and Notch-like epidermal growth factor-related receptor	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q8NFT8	DNER	Delta and Notch-like epidermal growth factor-related receptor	GO:0048741; P:skeletal muscle fiber development; IEA:Ensembl
Q8NFT8	DNER	Delta and Notch-like epidermal growth factor-related receptor	GO:0007416; P:synapse assembly; NAS:UniProtKB
Q96M86	DNHD1	Dynein heavy chain domain-containing protein 1	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q96M86	DNHD1	Dynein heavy chain domain-containing protein 1	GO:0007018; P:microtubule-based movement; IEA:InterPro
P31689	DNAJA1	DnaJ homolog subfamily A member 1	GO:0005524; F:ATP binding; IEA:InterPro
P31689	DNAJA1	DnaJ homolog subfamily A member 1	GO:0051087; F:chaperone binding; IPI:UniProt
P31689	DNAJA1	DnaJ homolog subfamily A member 1	GO:0050750; F:low-density lipoprotein particle receptor binding; IDA:MGI
P31689	DNAJA1	DnaJ homolog subfamily A member 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P31689	DNAJA1	DnaJ homolog subfamily A member 1	GO:0005515; F:protein binding; IPI:IntAct
P31689	DNAJA1	DnaJ homolog subfamily A member 1	GO:0030521; P:androgen receptor signaling pathway; IEA:Ensembl
P31689	DNAJA1	DnaJ homolog subfamily A member 1	GO:0006457; P:protein folding; TAS:ProtInc
P31689	DNAJA1	DnaJ homolog subfamily A member 1	GO:0009408; P:response to heat; IEA:InterPro
P31689	DNAJA1	DnaJ homolog subfamily A member 1	GO:0006986; P:response to unfolded protein; TAS:ProtInc
P31689	DNAJA1	DnaJ homolog subfamily A member 1	GO:0030317; P:sperm motility; IEA:Ensembl
P31689	DNAJA1	DnaJ homolog subfamily A member 1	GO:0007283; P:spermatogenesis; IEA:Ensembl
O60884	DNAJA2	DnaJ homolog subfamily A member 2	GO:0005524; F:ATP binding; IEA:InterPro
O60884	DNAJA2	DnaJ homolog subfamily A member 2	GO:0051087; F:chaperone binding; IPI:UniProt
O60884	DNAJA2	DnaJ homolog subfamily A member 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60884	DNAJA2	DnaJ homolog subfamily A member 2	GO:0005515; F:protein binding; IPI:IntAct
O60884	DNAJA2	DnaJ homolog subfamily A member 2	GO:0051082; F:unfolded protein binding; IDA:UniProt
O60884	DNAJA2	DnaJ homolog subfamily A member 2	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
O60884	DNAJA2	DnaJ homolog subfamily A member 2	GO:0042026; P:protein refolding; IDA:UniProt
O60884	DNAJA2	DnaJ homolog subfamily A member 2	GO:0009408; P:response to heat; IEA:InterPro
Q8WW22	DNAJA4	DnaJ homolog subfamily A member 4	GO:0005524; F:ATP binding; IEA:InterPro
Q8WW22	DNAJA4	DnaJ homolog subfamily A member 4	GO:0051087; F:chaperone binding; IPI:UniProt
Q8WW22	DNAJA4	DnaJ homolog subfamily A member 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8WW22	DNAJA4	DnaJ homolog subfamily A member 4	GO:0051082; F:unfolded protein binding; IDA:UniProt
Q8WW22	DNAJA4	DnaJ homolog subfamily A member 4	GO:0090084; P:negative regulation of inclusion body assembly; IDA:UniProt
Q8WW22	DNAJA4	DnaJ homolog subfamily A member 4	GO:0042026; P:protein refolding; IDA:UniProt
Q8WW22	DNAJA4	DnaJ homolog subfamily A member 4	GO:0009408; P:response to heat; IEA:InterPro
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0005524; F:ATP binding; IEA:InterPro
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0005133; F:interferon-gamma receptor binding; IDA:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0051059; F:NF-kappaB binding; IPI:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0005083; F:small GTPase regulator activity; IEA:Ensembl
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0006924; P:activation-induced cell death of T cells; IEA:Ensembl
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0007569; P:cell aging; IEA:Ensembl
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0009790; P:embryo development; IEA:Ensembl
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0006264; P:mitochondrial DNA replication; IEA:Ensembl
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0060336; P:negative regulation of interferon-gamma-mediated signaling pathway; IDA:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0006469; P:negative regulation of protein kinase activity; IDA:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0007528; P:neuromuscular junction development; IDA:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0006457; P:protein folding; IDA:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0050821; P:protein stabilization; IDA:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0009408; P:response to heat; IEA:InterPro
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0034341; P:response to interferon-gamma; IDA:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0071340; P:skeletal muscle acetylcholine-gated channel clustering; ISS:UniProtKB
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0007264; P:small GTPase mediated signal transduction; IEA:Ensembl
Q96EY1	DNAJA3	DnaJ homolog subfamily A member 3, mitochondrial	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
P25685	DNAJB1	DnaJ homolog subfamily B member 1	GO:0001671; F:ATPase activator activity; IDA:BHF-UCL
P25685	DNAJB1	DnaJ homolog subfamily B member 1	GO:0051117; F:ATPase binding; IPI:BHF-UCL
P25685	DNAJB1	DnaJ homolog subfamily B member 1	GO:0051087; F:chaperone binding; IPI:UniProt
P25685	DNAJB1	DnaJ homolog subfamily B member 1	GO:0030544; F:Hsp70 protein binding; IPI:BHF-UCL
P25685	DNAJB1	DnaJ homolog subfamily B member 1	GO:0005515; F:protein binding; IPI:IntAct
P25685	DNAJB1	DnaJ homolog subfamily B member 1	GO:0051082; F:unfolded protein binding; IDA:UniProt
P25685	DNAJB1	DnaJ homolog subfamily B member 1	GO:0070389; P:chaperone cofactor-dependent protein refolding; IDA:UniProtKB
P25685	DNAJB1	DnaJ homolog subfamily B member 1	GO:0051085; P:chaperone mediated protein folding requiring cofactor; IEA:Ensembl
P25685	DNAJB1	DnaJ homolog subfamily B member 1	GO:0090084; P:negative regulation of inclusion body assembly; IDA:UniProt
P25685	DNAJB1	DnaJ homolog subfamily B member 1	GO:0032781; P:positive regulation of ATPase activity; IDA:BHF-UCL
P25685	DNAJB1	DnaJ homolog subfamily B member 1	GO:0006986; P:response to unfolded protein; TAS:ProtInc
P25686	DNAJB2	DnaJ homolog subfamily B member 2	GO:0051087; F:chaperone binding; IPI:UniProt
P25686	DNAJB2	DnaJ homolog subfamily B member 2	GO:0030544; F:Hsp70 protein binding; IPI:BHF-UCL
P25686	DNAJB2	DnaJ homolog subfamily B member 2	GO:0031593; F:polyubiquitin binding; IDA:BHF-UCL
P25686	DNAJB2	DnaJ homolog subfamily B member 2	GO:0070628; F:proteasome binding; IDA:BHF-UCL
P25686	DNAJB2	DnaJ homolog subfamily B member 2	GO:0005515; F:protein binding; IPI:BHF-UCL
P25686	DNAJB2	DnaJ homolog subfamily B member 2	GO:0051082; F:unfolded protein binding; IDA:UniProt
P25686	DNAJB2	DnaJ homolog subfamily B member 2	GO:0008219; P:cell death; IEA:UniProtKB-KW
P25686	DNAJB2	DnaJ homolog subfamily B member 2	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IDA:BHF-UCL
P25686	DNAJB2	DnaJ homolog subfamily B member 2	GO:0030308; P:negative regulation of cell growth; IGI:UniProtKB
P25686	DNAJB2	DnaJ homolog subfamily B member 2	GO:0008285; P:negative regulation of cell proliferation; IGI:UniProtKB
P25686	DNAJB2	DnaJ homolog subfamily B member 2	GO:0090084; P:negative regulation of inclusion body assembly; IDA:BHF-UCL
P25686	DNAJB2	DnaJ homolog subfamily B member 2	GO:0090086; P:negative regulation of protein deubiquitination; IDA:BHF-UCL
P25686	DNAJB2	DnaJ homolog subfamily B member 2	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:BHF-UCL
P25686	DNAJB2	DnaJ homolog subfamily B member 2	GO:0031398; P:positive regulation of protein ubiquitination; IDA:BHF-UCL
P25686	DNAJB2	DnaJ homolog subfamily B member 2	GO:0006457; P:protein folding; TAS:ProtInc
P25686	DNAJB2	DnaJ homolog subfamily B member 2	GO:0042026; P:protein refolding; IDA:UniProt
P25686	DNAJB2	DnaJ homolog subfamily B member 2	GO:0006986; P:response to unfolded protein; TAS:ProtInc
Q9UDY4	DNAJB4	DnaJ homolog subfamily B member 4	GO:0051087; F:chaperone binding; IPI:UniProt
Q9UDY4	DNAJB4	DnaJ homolog subfamily B member 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UDY4	DNAJB4	DnaJ homolog subfamily B member 4	GO:0051082; F:unfolded protein binding; TAS:ProtInc
Q9UDY4	DNAJB4	DnaJ homolog subfamily B member 4	GO:0006457; P:protein folding; IEA:InterPro
Q9UDY4	DNAJB4	DnaJ homolog subfamily B member 4	GO:0009408; P:response to heat; TAS:ProtInc
Q9UDY4	DNAJB4	DnaJ homolog subfamily B member 4	GO:0006986; P:response to unfolded protein; TAS:ProtInc
O75953	DNAJB5	DnaJ homolog subfamily B member 5	GO:0051087; F:chaperone binding; IPI:UniProt
O75953	DNAJB5	DnaJ homolog subfamily B member 5	GO:0005515; F:protein binding; IPI:IntAct
O75953	DNAJB5	DnaJ homolog subfamily B member 5	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O75953	DNAJB5	DnaJ homolog subfamily B member 5	GO:0006457; P:protein folding; IEA:InterPro
O75953	DNAJB5	DnaJ homolog subfamily B member 5	GO:0006986; P:response to unfolded protein; IEP:UniProtKB
O75190	DNAJB6	DnaJ homolog subfamily B member 6	GO:0001671; F:ATPase activator activity; IDA:UniProtKB
O75190	DNAJB6	DnaJ homolog subfamily B member 6	GO:0051087; F:chaperone binding; IDA:UniProtKB
O75190	DNAJB6	DnaJ homolog subfamily B member 6	GO:0003677; F:DNA binding; IEA:Ensembl
O75190	DNAJB6	DnaJ homolog subfamily B member 6	GO:0031072; F:heat shock protein binding; IDA:UniProtKB
O75190	DNAJB6	DnaJ homolog subfamily B member 6	GO:0005515; F:protein binding; IPI:UniProtKB
O75190	DNAJB6	DnaJ homolog subfamily B member 6	GO:0051082; F:unfolded protein binding; IDA:UniProt
O75190	DNAJB6	DnaJ homolog subfamily B member 6	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
O75190	DNAJB6	DnaJ homolog subfamily B member 6	GO:0060710; P:chorio-allantoic fusion; IEA:Ensembl
O75190	DNAJB6	DnaJ homolog subfamily B member 6	GO:0060717; P:chorion development; IEA:Ensembl
O75190	DNAJB6	DnaJ homolog subfamily B member 6	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
O75190	DNAJB6	DnaJ homolog subfamily B member 6	GO:0045109; P:intermediate filament organization; IDA:UniProtKB
O75190	DNAJB6	DnaJ homolog subfamily B member 6	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
O75190	DNAJB6	DnaJ homolog subfamily B member 6	GO:0090084; P:negative regulation of inclusion body assembly; IDA:UniProt
O75190	DNAJB6	DnaJ homolog subfamily B member 6	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
O75190	DNAJB6	DnaJ homolog subfamily B member 6	GO:0032781; P:positive regulation of ATPase activity; IDA:GOC
O75190	DNAJB6	DnaJ homolog subfamily B member 6	GO:0006457; P:protein folding; IDA:UniProtKB
O75190	DNAJB6	DnaJ homolog subfamily B member 6	GO:0034504; P:protein localization to nucleus; IEA:Ensembl
O75190	DNAJB6	DnaJ homolog subfamily B member 6	GO:0060715; P:syncytiotrophoblast cell differentiation involved in labyrinthine layer development; IEA:Ensembl
Q7Z6W7	DNAJB7	DnaJ homolog subfamily B member 7	GO:0051087; F:chaperone binding; IPI:UniProt
Q8NHS0	DNAJB8	DnaJ homolog subfamily B member 8	GO:0051087; F:chaperone binding; IPI:UniProt
Q8NHS0	DNAJB8	DnaJ homolog subfamily B member 8	GO:0044183; F:protein binding involved in protein folding; IDA:MGI
Q8NHS0	DNAJB8	DnaJ homolog subfamily B member 8	GO:0051082; F:unfolded protein binding; IDA:UniProt
Q8NHS0	DNAJB8	DnaJ homolog subfamily B member 8	GO:0061077; P:chaperone-mediated protein folding; IDA:MGI
Q8NHS0	DNAJB8	DnaJ homolog subfamily B member 8	GO:0090084; P:negative regulation of inclusion body assembly; IDA:UniProt
Q9UBS3	DNAJB9	DnaJ homolog subfamily B member 9	GO:0051787; F:misfolded protein binding; IDA:UniProtKB
Q9UBS3	DNAJB9	DnaJ homolog subfamily B member 9	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBS3	DNAJB9	DnaJ homolog subfamily B member 9	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q9UBS3	DNAJB9	DnaJ homolog subfamily B member 9	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UBS3	DNAJB9	DnaJ homolog subfamily B member 9	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q9UBS3	DNAJB9	DnaJ homolog subfamily B member 9	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q96KC8	DNAJC1	DnaJ homolog subfamily C member 1	GO:0001671; F:ATPase activator activity; TAS:UniProtKB
Q96KC8	DNAJC1	DnaJ homolog subfamily C member 1	GO:0003682; F:chromatin binding; IEA:InterPro
Q96KC8	DNAJC1	DnaJ homolog subfamily C member 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96KC8	DNAJC1	DnaJ homolog subfamily C member 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96KC8	DNAJC1	DnaJ homolog subfamily C member 1	GO:0045861; P:negative regulation of proteolysis; TAS:UniProtKB
Q96KC8	DNAJC1	DnaJ homolog subfamily C member 1	GO:0032781; P:positive regulation of ATPase activity; TAS:GOC
Q96KC8	DNAJC1	DnaJ homolog subfamily C member 1	GO:0006457; P:protein folding; IEA:Ensembl
Q96KC8	DNAJC1	DnaJ homolog subfamily C member 1	GO:0050708; P:regulation of protein secretion; IDA:UniProtKB
Q96KC8	DNAJC1	DnaJ homolog subfamily C member 1	GO:0006417; P:regulation of translation; IEA:Ensembl
Q99543	DNAJC2	DnaJ homolog subfamily C member 2	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q99543	DNAJC2	DnaJ homolog subfamily C member 2	GO:0003677; F:DNA binding; IEA:InterPro
Q99543	DNAJC2	DnaJ homolog subfamily C member 2	GO:0042393; F:histone binding; IDA:UniProtKB
Q99543	DNAJC2	DnaJ homolog subfamily C member 2	GO:0030544; F:Hsp70 protein binding; IPI:UniProtKB
Q99543	DNAJC2	DnaJ homolog subfamily C member 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q99543	DNAJC2	DnaJ homolog subfamily C member 2	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
Q99543	DNAJC2	DnaJ homolog subfamily C member 2	GO:0051083; P:'de novo' cotranslational protein folding; TAS:UniProtKB
Q99543	DNAJC2	DnaJ homolog subfamily C member 2	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q99543	DNAJC2	DnaJ homolog subfamily C member 2	GO:0006260; P:DNA replication; IEA:Ensembl
Q99543	DNAJC2	DnaJ homolog subfamily C member 2	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
Q99543	DNAJC2	DnaJ homolog subfamily C member 2	GO:2000279; P:negative regulation of DNA biosynthetic process; IEA:Ensembl
Q99543	DNAJC2	DnaJ homolog subfamily C member 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q99543	DNAJC2	DnaJ homolog subfamily C member 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13217	DNAJC3	DnaJ homolog subfamily C member 3	GO:0004860; F:protein kinase inhibitor activity; TAS:ProtInc
Q13217	DNAJC3	DnaJ homolog subfamily C member 3	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q13217	DNAJC3	DnaJ homolog subfamily C member 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q13217	DNAJC3	DnaJ homolog subfamily C member 3	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q13217	DNAJC3	DnaJ homolog subfamily C member 3	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q13217	DNAJC3	DnaJ homolog subfamily C member 3	GO:0006469; P:negative regulation of protein kinase activity; TAS:GOC
Q13217	DNAJC3	DnaJ homolog subfamily C member 3	GO:0051603; P:proteolysis involved in cellular protein catabolic process; IEA:Ensembl
Q9NNZ3	DNAJC4	DnaJ homolog subfamily C member 4	GO:0005515; F:protein binding; IPI:IntAct
Q9NNZ3	DNAJC4	DnaJ homolog subfamily C member 4	GO:0051082; F:unfolded protein binding; NAS:UniProtKB
Q9NNZ3	DNAJC4	DnaJ homolog subfamily C member 4	GO:0006457; P:protein folding; NAS:UniProtKB
Q9NNZ3	DNAJC4	DnaJ homolog subfamily C member 4	GO:0006986; P:response to unfolded protein; TAS:ProtInc
Q9H3Z4	DNAJC5	DnaJ homolog subfamily C member 5	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9H3Z4	DNAJC5	DnaJ homolog subfamily C member 5	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q9H3Z4	DNAJC5	DnaJ homolog subfamily C member 5	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
Q9H3Z4	DNAJC5	DnaJ homolog subfamily C member 5	GO:0007268; P:synaptic transmission; TAS:Reactome
Q99615	DNAJC7	DnaJ homolog subfamily C member 7	GO:0031072; F:heat shock protein binding; IPI:UniProtKB
Q99615	DNAJC7	DnaJ homolog subfamily C member 7	GO:0005515; F:protein binding; IPI:IntAct
Q99615	DNAJC7	DnaJ homolog subfamily C member 7	GO:0070389; P:chaperone cofactor-dependent protein refolding; IDA:UniProtKB
Q99615	DNAJC7	DnaJ homolog subfamily C member 7	GO:0006457; P:protein folding; TAS:ProtInc
O75937	DNAJC8	DnaJ homolog subfamily C member 8	GO:0010467; P:gene expression; TAS:Reactome
O75937	DNAJC8	DnaJ homolog subfamily C member 8	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
O75937	DNAJC8	DnaJ homolog subfamily C member 8	GO:0008380; P:RNA splicing; TAS:Reactome
Q8WXX5	DNAJC9	DnaJ homolog subfamily C member 9	GO:0035176; P:social behavior; IEP:UniProtKB
P18858	LIG1	DNA ligase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P18858	LIG1	DNA ligase 1	GO:0003677; F:DNA binding; TAS:ProtInc
P18858	LIG1	DNA ligase 1	GO:0003910; F:DNA ligase (ATP) activity; IBA:RefGenome
P18858	LIG1	DNA ligase 1	GO:0003909; F:DNA ligase activity; IDA:UniProtKB
P18858	LIG1	DNA ligase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P18858	LIG1	DNA ligase 1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P18858	LIG1	DNA ligase 1	GO:0006284; P:base-excision repair; TAS:Reactome
P18858	LIG1	DNA ligase 1	GO:0051301; P:cell division; IEA:UniProtKB-KW
P18858	LIG1	DNA ligase 1	GO:0051103; P:DNA ligation involved in DNA repair; IEA:InterPro
P18858	LIG1	DNA ligase 1	GO:0006259; P:DNA metabolic process; TAS:ProtInc
P18858	LIG1	DNA ligase 1	GO:0006281; P:DNA repair; TAS:Reactome
P18858	LIG1	DNA ligase 1	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P18858	LIG1	DNA ligase 1	GO:0006302; P:double-strand break repair; TAS:Reactome
P18858	LIG1	DNA ligase 1	GO:0000724; P:double-strand break repair via homologous recombination; TAS:Reactome
P18858	LIG1	DNA ligase 1	GO:0006303; P:double-strand break repair via nonhomologous end joining; IEA:Ensembl
P18858	LIG1	DNA ligase 1	GO:0006273; P:lagging strand elongation; IBA:RefGenome
P18858	LIG1	DNA ligase 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P18858	LIG1	DNA ligase 1	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P18858	LIG1	DNA ligase 1	GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome
P18858	LIG1	DNA ligase 1	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
P18858	LIG1	DNA ligase 1	GO:0000723; P:telomere maintenance; TAS:Reactome
P18858	LIG1	DNA ligase 1	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
P18858	LIG1	DNA ligase 1	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
P18858	LIG1	DNA ligase 1	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P49916	LIG3	DNA ligase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49916	LIG3	DNA ligase 3	GO:0003677; F:DNA binding; TAS:ProtInc
P49916	LIG3	DNA ligase 3	GO:0003910; F:DNA ligase (ATP) activity; IBA:RefGenome
P49916	LIG3	DNA ligase 3	GO:0003909; F:DNA ligase activity; IDA:UniProtKB
P49916	LIG3	DNA ligase 3	GO:0005515; F:protein binding; IPI:UniProtKB
P49916	LIG3	DNA ligase 3	GO:0008270; F:zinc ion binding; IEA:InterPro
P49916	LIG3	DNA ligase 3	GO:0006284; P:base-excision repair; TAS:Reactome
P49916	LIG3	DNA ligase 3	GO:0006288; P:base-excision repair, DNA ligation; IEA:Ensembl
P49916	LIG3	DNA ligase 3	GO:0006281; P:DNA repair; TAS:Reactome
P49916	LIG3	DNA ligase 3	GO:0006303; P:double-strand break repair via nonhomologous end joining; IEA:Ensembl
P49916	LIG3	DNA ligase 3	GO:0006273; P:lagging strand elongation; IBA:RefGenome
P49916	LIG3	DNA ligase 3	GO:0043504; P:mitochondrial DNA repair; IEA:Ensembl
P49916	LIG3	DNA ligase 3	GO:0045910; P:negative regulation of DNA recombination; IEA:Ensembl
P49916	LIG3	DNA ligase 3	GO:0006289; P:nucleotide-excision repair; IBA:RefGenome
P49916	LIG3	DNA ligase 3	GO:0007131; P:reciprocal meiotic recombination; TAS:ProtInc
P49916	LIG3	DNA ligase 3	GO:0007283; P:spermatogenesis; TAS:ProtInc
P49917	LIG4	DNA ligase 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49917	LIG4	DNA ligase 4	GO:0003677; F:DNA binding; IDA:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0003910; F:DNA ligase (ATP) activity; IDA:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0003909; F:DNA ligase activity; IDA:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0016874; F:ligase activity; IDA:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P49917	LIG4	DNA ligase 4	GO:0005515; F:protein binding; IPI:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P49917	LIG4	DNA ligase 4	GO:0051301; P:cell division; IEA:UniProtKB-KW
P49917	LIG4	DNA ligase 4	GO:0008283; P:cell proliferation; ISS:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0071285; P:cellular response to lithium ion; IEA:Ensembl
P49917	LIG4	DNA ligase 4	GO:0007417; P:central nervous system development; ISS:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0051276; P:chromosome organization; ISS:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0006266; P:DNA ligation; IDA:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0051102; P:DNA ligation involved in DNA recombination; ISS:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0051103; P:DNA ligation involved in DNA repair; IDA:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0006281; P:DNA repair; TAS:Reactome
P49917	LIG4	DNA ligase 4	GO:0006302; P:double-strand break repair; IDA:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0006303; P:double-strand break repair via nonhomologous end joining; IDA:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0075713; P:establishment of integrated proviral latency; TAS:Reactome
P49917	LIG4	DNA ligase 4	GO:0033152; P:immunoglobulin V(D)J recombination; IEA:Ensembl
P49917	LIG4	DNA ligase 4	GO:0001701; P:in utero embryonic development; ISS:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0045190; P:isotype switching; ISS:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0006273; P:lagging strand elongation; IBA:RefGenome
P49917	LIG4	DNA ligase 4	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0051402; P:neuron apoptotic process; ISS:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0006297; P:nucleotide-excision repair, DNA gap filling; IDA:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0048146; P:positive regulation of fibroblast proliferation; ISS:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0050769; P:positive regulation of neurogenesis; ISS:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0002328; P:pro-B cell differentiation; ISS:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0010332; P:response to gamma radiation; ISS:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0010165; P:response to X-ray; IMP:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0000012; P:single strand break repair; IDA:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0035019; P:somatic stem cell maintenance; ISS:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0033077; P:T cell differentiation in thymus; ISS:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0033153; P:T cell receptor V(D)J recombination; ISS:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0033151; P:V(D)J recombination; IDA:UniProtKB
P49917	LIG4	DNA ligase 4	GO:0016032; P:viral process; TAS:Reactome
Q5SXM8	DNLZ	DNL-type zinc finger protein	GO:0008270; F:zinc ion binding; IEA:InterPro
O00429	DNM1L	Dynamin-1-like protein	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
O00429	DNM1L	Dynamin-1-like protein	GO:0003924; F:GTPase activity; IEA:InterPro
O00429	DNM1L	Dynamin-1-like protein	GO:0042802; F:identical protein binding; IPI:IntAct
O00429	DNM1L	Dynamin-1-like protein	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
O00429	DNM1L	Dynamin-1-like protein	GO:0005515; F:protein binding; IPI:UniProtKB
O00429	DNM1L	Dynamin-1-like protein	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O00429	DNM1L	Dynamin-1-like protein	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
O00429	DNM1L	Dynamin-1-like protein	GO:0006915; P:apoptotic process; TAS:Reactome
O00429	DNM1L	Dynamin-1-like protein	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
O00429	DNM1L	Dynamin-1-like protein	GO:0003374; P:dynamin polymerization involved in mitochondrial fission; IDA:UniProtKB
O00429	DNM1L	Dynamin-1-like protein	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
O00429	DNM1L	Dynamin-1-like protein	GO:0006184; P:GTP catabolic process; IDA:UniProtKB
O00429	DNM1L	Dynamin-1-like protein	GO:0090149; P:membrane fission involved in mitochondrial fission; IDA:UniProtKB
O00429	DNM1L	Dynamin-1-like protein	GO:0061025; P:membrane fusion; IDA:UniProtKB
O00429	DNM1L	Dynamin-1-like protein	GO:0000266; P:mitochondrial fission; IDA:UniProtKB
O00429	DNM1L	Dynamin-1-like protein	GO:0043653; P:mitochondrial fragmentation involved in apoptotic process; IMP:UniProtKB
O00429	DNM1L	Dynamin-1-like protein	GO:0070584; P:mitochondrion morphogenesis; IMP:MGI
O00429	DNM1L	Dynamin-1-like protein	GO:0070266; P:necroptotic process; IMP:UniProtKB
O00429	DNM1L	Dynamin-1-like protein	GO:0016559; P:peroxisome fission; IDA:UniProtKB
O00429	DNM1L	Dynamin-1-like protein	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
O00429	DNM1L	Dynamin-1-like protein	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
O00429	DNM1L	Dynamin-1-like protein	GO:0090141; P:positive regulation of mitochondrial fission; TAS:BHF-UCL
O00429	DNM1L	Dynamin-1-like protein	GO:0050714; P:positive regulation of protein secretion; IDA:UniProtKB
O00429	DNM1L	Dynamin-1-like protein	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IMP:UniProtKB
O00429	DNM1L	Dynamin-1-like protein	GO:0051289; P:protein homotetramerization; IDA:UniProtKB
O00429	DNM1L	Dynamin-1-like protein	GO:0010821; P:regulation of mitochondrion organization; IMP:UniProtKB
O00429	DNM1L	Dynamin-1-like protein	GO:1900063; P:regulation of peroxisome organization; IMP:UniProtKB
O00429	DNM1L	Dynamin-1-like protein	GO:0032459; P:regulation of protein oligomerization; IDA:UniProtKB
O00429	DNM1L	Dynamin-1-like protein	GO:0001836; P:release of cytochrome c from mitochondria; IMP:UniProtKB
Q9Y6K1	DNMT3A	DNA (cytosine-5)-methyltransferase 3A	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9Y6K1	DNMT3A	DNA (cytosine-5)-methyltransferase 3A	GO:0003886; F:DNA (cytosine-5-)-methyltransferase activity; IDA:UniProtKB
Q9Y6K1	DNMT3A	DNA (cytosine-5)-methyltransferase 3A	GO:0051718; F:DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates; IEA:Ensembl
Q9Y6K1	DNMT3A	DNA (cytosine-5)-methyltransferase 3A	GO:0003677; F:DNA binding; IDA:UniProtKB
Q9Y6K1	DNMT3A	DNA (cytosine-5)-methyltransferase 3A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y6K1	DNMT3A	DNA (cytosine-5)-methyltransferase 3A	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6K1	DNMT3A	DNA (cytosine-5)-methyltransferase 3A	GO:0045322; F:unmethylated CpG binding; IEA:Ensembl
Q9Y6K1	DNMT3A	DNA (cytosine-5)-methyltransferase 3A	GO:0090116; P:C-5 methylation of cytosine; IDA:GOC
Q9Y6K1	DNMT3A	DNA (cytosine-5)-methyltransferase 3A	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
Q9Y6K1	DNMT3A	DNA (cytosine-5)-methyltransferase 3A	GO:0006306; P:DNA methylation; IDA:UniProtKB
Q9Y6K1	DNMT3A	DNA (cytosine-5)-methyltransferase 3A	GO:0043045; P:DNA methylation involved in embryo development; IEA:Ensembl
Q9Y6K1	DNMT3A	DNA (cytosine-5)-methyltransferase 3A	GO:0043046; P:DNA methylation involved in gamete generation; IEA:Ensembl
Q9Y6K1	DNMT3A	DNA (cytosine-5)-methyltransferase 3A	GO:0010424; P:DNA methylation on cytosine within a CG sequence; IEA:Ensembl
Q9Y6K1	DNMT3A	DNA (cytosine-5)-methyltransferase 3A	GO:0044027; P:hypermethylation of CpG island; IEA:Ensembl
Q9Y6K1	DNMT3A	DNA (cytosine-5)-methyltransferase 3A	GO:0006346; P:methylation-dependent chromatin silencing; IEA:Ensembl
Q9Y6K1	DNMT3A	DNA (cytosine-5)-methyltransferase 3A	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9Y6K1	DNMT3A	DNA (cytosine-5)-methyltransferase 3A	GO:0006349; P:regulation of gene expression by genetic imprinting; TAS:UniProtKB
Q9Y6K1	DNMT3A	DNA (cytosine-5)-methyltransferase 3A	GO:0046498; P:S-adenosylhomocysteine metabolic process; IEA:Ensembl
Q9Y6K1	DNMT3A	DNA (cytosine-5)-methyltransferase 3A	GO:0046499; P:S-adenosylmethioninamine metabolic process; IEA:Ensembl
Q9Y6K1	DNMT3A	DNA (cytosine-5)-methyltransferase 3A	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0003886; F:DNA (cytosine-5-)-methyltransferase activity; NAS:UniProtKB
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0051718; F:DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates; IEA:Ensembl
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0009008; F:DNA-methyltransferase activity; NAS:UniProtKB
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0045322; F:unmethylated CpG binding; IEA:Ensembl
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0006306; P:DNA methylation; NAS:UniProtKB
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0010424; P:DNA methylation on cytosine within a CG sequence; IEA:Ensembl
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0006346; P:methylation-dependent chromatin silencing; IEA:Ensembl
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0051573; P:negative regulation of histone H3-K9 methylation; IMP:UniProtKB
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0051571; P:positive regulation of histone H3-K4 methylation; IMP:UniProtKB
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0031503; P:protein complex localization; IEA:Ensembl
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0006349; P:regulation of gene expression by genetic imprinting; IEA:Ensembl
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0042493; P:response to drug; IEA:Ensembl
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0010212; P:response to ionizing radiation; IEA:Ensembl
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0046498; P:S-adenosylhomocysteine metabolic process; IEA:Ensembl
Q9UBC3	DNMT3B	DNA (cytosine-5)-methyltransferase 3B	GO:0046499; P:S-adenosylmethioninamine metabolic process; IEA:Ensembl
Q9UJW3	DNMT3L	DNA (cytosine-5)-methyltransferase 3-like	GO:0008047; F:enzyme activator activity; IDA:MGI
Q9UJW3	DNMT3L	DNA (cytosine-5)-methyltransferase 3-like	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9UJW3	DNMT3L	DNA (cytosine-5)-methyltransferase 3-like	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UJW3	DNMT3L	DNA (cytosine-5)-methyltransferase 3-like	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UJW3	DNMT3L	DNA (cytosine-5)-methyltransferase 3-like	GO:0060718; P:chorionic trophoblast cell differentiation; IEA:Ensembl
Q9UJW3	DNMT3L	DNA (cytosine-5)-methyltransferase 3-like	GO:0006306; P:DNA methylation; NAS:UniProtKB
Q9UJW3	DNMT3L	DNA (cytosine-5)-methyltransferase 3-like	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9UJW3	DNMT3L	DNA (cytosine-5)-methyltransferase 3-like	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UJW3	DNMT3L	DNA (cytosine-5)-methyltransferase 3-like	GO:0001890; P:placenta development; IEA:Ensembl
Q9UJW3	DNMT3L	DNA (cytosine-5)-methyltransferase 3-like	GO:0006349; P:regulation of gene expression by genetic imprinting; NAS:UniProtKB
Q9UJW3	DNMT3L	DNA (cytosine-5)-methyltransferase 3-like	GO:0007283; P:spermatogenesis; NAS:UniProtKB
Q6XZF7	DNMBP	Dynamin-binding protein	GO:0005515; F:protein binding; IPI:IntAct
Q6XZF7	DNMBP	Dynamin-binding protein	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q6XZF7	DNMBP	Dynamin-binding protein	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P26358	DNMT1	DNA (cytosine-5)-methyltransferase 1	GO:0003682; F:chromatin binding; IEA:InterPro
P26358	DNMT1	DNA (cytosine-5)-methyltransferase 1	GO:0003886; F:DNA (cytosine-5-)-methyltransferase activity; IDA:UniProtKB
P26358	DNMT1	DNA (cytosine-5)-methyltransferase 1	GO:0003677; F:DNA binding; IDA:UniProtKB
P26358	DNMT1	DNA (cytosine-5)-methyltransferase 1	GO:0009008; F:DNA-methyltransferase activity; IDA:UniProtKB
P26358	DNMT1	DNA (cytosine-5)-methyltransferase 1	GO:0008327; F:methyl-CpG binding; IEA:Ensembl
P26358	DNMT1	DNA (cytosine-5)-methyltransferase 1	GO:0005515; F:protein binding; IPI:UniProtKB
P26358	DNMT1	DNA (cytosine-5)-methyltransferase 1	GO:0003723; F:RNA binding; IEA:Ensembl
P26358	DNMT1	DNA (cytosine-5)-methyltransferase 1	GO:0008270; F:zinc ion binding; IEA:Ensembl
P26358	DNMT1	DNA (cytosine-5)-methyltransferase 1	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
P26358	DNMT1	DNA (cytosine-5)-methyltransferase 1	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
P26358	DNMT1	DNA (cytosine-5)-methyltransferase 1	GO:0006306; P:DNA methylation; TAS:ProtInc
P26358	DNMT1	DNA (cytosine-5)-methyltransferase 1	GO:0016458; P:gene silencing; IEA:Ensembl
P26358	DNMT1	DNA (cytosine-5)-methyltransferase 1	GO:0010216; P:maintenance of DNA methylation; IDA:UniProtKB
P26358	DNMT1	DNA (cytosine-5)-methyltransferase 1	GO:0051573; P:negative regulation of histone H3-K9 methylation; IMP:UniProtKB
P26358	DNMT1	DNA (cytosine-5)-methyltransferase 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P26358	DNMT1	DNA (cytosine-5)-methyltransferase 1	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
P26358	DNMT1	DNA (cytosine-5)-methyltransferase 1	GO:0051571; P:positive regulation of histone H3-K4 methylation; IMP:UniProtKB
P26358	DNMT1	DNA (cytosine-5)-methyltransferase 1	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P26358	DNMT1	DNA (cytosine-5)-methyltransferase 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9ULA0	DNPEP	Aspartyl aminopeptidase	GO:0004177; F:aminopeptidase activity; TAS:ProtInc
Q9ULA0	DNPEP	Aspartyl aminopeptidase	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
Q9ULA0	DNPEP	Aspartyl aminopeptidase	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9ULA0	DNPEP	Aspartyl aminopeptidase	GO:0006518; P:peptide metabolic process; TAS:ProtInc
O43598	DNPH1	2'-deoxynucleoside 5'-phosphate N-hydrolase 1	GO:0070694; F:deoxyribonucleoside 5'-monophosphate N-glycosidase activity; ISS:UniProtKB
O43598	DNPH1	2'-deoxynucleoside 5'-phosphate N-hydrolase 1	GO:0050144; F:nucleoside deoxyribosyltransferase activity; IEA:InterPro
O43598	DNPH1	2'-deoxynucleoside 5'-phosphate N-hydrolase 1	GO:0008283; P:cell proliferation; TAS:ProtInc
O43598	DNPH1	2'-deoxynucleoside 5'-phosphate N-hydrolase 1	GO:0009159; P:deoxyribonucleoside monophosphate catabolic process; ISS:UniProtKB
O43598	DNPH1	2'-deoxynucleoside 5'-phosphate N-hydrolase 1	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
O43598	DNPH1	2'-deoxynucleoside 5'-phosphate N-hydrolase 1	GO:0009116; P:nucleoside metabolic process; IEA:UniProtKB-HAMAP
O43598	DNPH1	2'-deoxynucleoside 5'-phosphate N-hydrolase 1	GO:0009117; P:nucleotide metabolic process; IEA:UniProtKB-KW
O43598	DNPH1	2'-deoxynucleoside 5'-phosphate N-hydrolase 1	GO:0030307; P:positive regulation of cell growth; ISS:UniProtKB
O00115	DNASE2	Deoxyribonuclease-2-alpha	GO:0004531; F:deoxyribonuclease II activity; IBA:RefGenome
O00115	DNASE2	Deoxyribonuclease-2-alpha	GO:0003677; F:DNA binding; TAS:ProtInc
O00115	DNASE2	Deoxyribonuclease-2-alpha	GO:0006309; P:apoptotic DNA fragmentation; IBA:RefGenome
O00115	DNASE2	Deoxyribonuclease-2-alpha	GO:0006259; P:DNA metabolic process; TAS:ProtInc
O00115	DNASE2	Deoxyribonuclease-2-alpha	GO:0030218; P:erythrocyte differentiation; IEA:Ensembl
Q8WZ79	DNASE2B	Deoxyribonuclease-2-beta	GO:0004531; F:deoxyribonuclease II activity; IBA:RefGenome
Q8WZ79	DNASE2B	Deoxyribonuclease-2-beta	GO:0006309; P:apoptotic DNA fragmentation; IBA:RefGenome
P49184	DNASE1L1	Deoxyribonuclease-1-like 1	GO:0004536; F:deoxyribonuclease activity; TAS:ProtInc
P49184	DNASE1L1	Deoxyribonuclease-1-like 1	GO:0003677; F:DNA binding; TAS:ProtInc
P49184	DNASE1L1	Deoxyribonuclease-1-like 1	GO:0016888; F:endodeoxyribonuclease activity, producing 5'-phosphomonoesters; IEA:InterPro
P49184	DNASE1L1	Deoxyribonuclease-1-like 1	GO:0006259; P:DNA metabolic process; TAS:ProtInc
Q92874	DNASE1L2	Deoxyribonuclease-1-like 2	GO:0005509; F:calcium ion binding; TAS:ProtInc
Q92874	DNASE1L2	Deoxyribonuclease-1-like 2	GO:0004536; F:deoxyribonuclease activity; TAS:ProtInc
Q92874	DNASE1L2	Deoxyribonuclease-1-like 2	GO:0003677; F:DNA binding; TAS:ProtInc
Q92874	DNASE1L2	Deoxyribonuclease-1-like 2	GO:0016888; F:endodeoxyribonuclease activity, producing 5'-phosphomonoesters; IEA:InterPro
Q92874	DNASE1L2	Deoxyribonuclease-1-like 2	GO:0006259; P:DNA metabolic process; TAS:ProtInc
Q13609	DNASE1L3	Deoxyribonuclease gamma	GO:0005509; F:calcium ion binding; TAS:ProtInc
Q13609	DNASE1L3	Deoxyribonuclease gamma	GO:0004536; F:deoxyribonuclease activity; TAS:ProtInc
Q13609	DNASE1L3	Deoxyribonuclease gamma	GO:0003677; F:DNA binding; TAS:ProtInc
Q13609	DNASE1L3	Deoxyribonuclease gamma	GO:0016888; F:endodeoxyribonuclease activity, producing 5'-phosphomonoesters; IEA:InterPro
Q13609	DNASE1L3	Deoxyribonuclease gamma	GO:0006309; P:apoptotic DNA fragmentation; IEA:Ensembl
Q13609	DNASE1L3	Deoxyribonuclease gamma	GO:0010623; P:developmental programmed cell death; IEA:Ensembl
Q13609	DNASE1L3	Deoxyribonuclease gamma	GO:0006259; P:DNA metabolic process; TAS:ProtInc
P06340	HLA-DOA	HLA class II histocompatibility antigen, DO alpha chain	GO:0032395; F:MHC class II receptor activity; TAS:UniProtKB
P06340	HLA-DOA	HLA class II histocompatibility antigen, DO alpha chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P06340	HLA-DOA	HLA class II histocompatibility antigen, DO alpha chain	GO:0006955; P:immune response; IEA:InterPro
P06340	HLA-DOA	HLA class II histocompatibility antigen, DO alpha chain	GO:0045580; P:regulation of T cell differentiation; IEA:Ensembl
P06340	HLA-DOA	HLA class II histocompatibility antigen, DO alpha chain	GO:0007165; P:signal transduction; TAS:GOC
P13765	HLA-DOB	HLA class II histocompatibility antigen, DO beta chain	GO:0032395; F:MHC class II receptor activity; TAS:UniProtKB
P13765	HLA-DOB	HLA class II histocompatibility antigen, DO beta chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P13765	HLA-DOB	HLA class II histocompatibility antigen, DO beta chain	GO:0006955; P:immune response; IEA:InterPro
P13765	HLA-DOB	HLA class II histocompatibility antigen, DO beta chain	GO:0007165; P:signal transduction; TAS:GOC
Q96BY6	DOCK10	Dedicator of cytokinesis protein 10	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:Ensembl
Q96BY6	DOCK10	Dedicator of cytokinesis protein 10	GO:0030334; P:regulation of cell migration; IDA:UniProt
Q96BY6	DOCK10	Dedicator of cytokinesis protein 10	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q5JSL3	DOCK11	Dedicator of cytokinesis protein 11	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:Ensembl
Q5JSL3	DOCK11	Dedicator of cytokinesis protein 11	GO:0007596; P:blood coagulation; TAS:Reactome
Q5JSL3	DOCK11	Dedicator of cytokinesis protein 11	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q14183	DOC2A	Double C2-like domain-containing protein alpha	GO:0005544; F:calcium-dependent phospholipid binding; IEA:UniProtKB-KW
Q14183	DOC2A	Double C2-like domain-containing protein alpha	GO:0005515; F:protein binding; IPI:UniProtKB
Q14183	DOC2A	Double C2-like domain-containing protein alpha	GO:0005215; F:transporter activity; IEA:InterPro
Q14183	DOC2A	Double C2-like domain-containing protein alpha	GO:0007399; P:nervous system development; TAS:ProtInc
Q14183	DOC2A	Double C2-like domain-containing protein alpha	GO:0017158; P:regulation of calcium ion-dependent exocytosis; IMP:UniProtKB
Q14183	DOC2A	Double C2-like domain-containing protein alpha	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q14183	DOC2A	Double C2-like domain-containing protein alpha	GO:0016079; P:synaptic vesicle exocytosis; IEA:Ensembl
Q14184	DOC2B	Double C2-like domain-containing protein beta	GO:0005544; F:calcium-dependent phospholipid binding; ISS:UniProtKB
Q14184	DOC2B	Double C2-like domain-containing protein beta	GO:0005215; F:transporter activity; IEA:InterPro
Q14184	DOC2B	Double C2-like domain-containing protein beta	GO:0048791; P:calcium ion-dependent exocytosis of neurotransmitter; ISS:UniProtKB
Q14184	DOC2B	Double C2-like domain-containing protein beta	GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; ISS:UniProtKB
Q14184	DOC2B	Double C2-like domain-containing protein beta	GO:0032024; P:positive regulation of insulin secretion; ISS:UniProtKB
Q14184	DOC2B	Double C2-like domain-containing protein beta	GO:0031340; P:positive regulation of vesicle fusion; ISS:UniProtKB
Q14184	DOC2B	Double C2-like domain-containing protein beta	GO:0008104; P:protein localization; ISS:UniProtKB
Q14185	DOCK1	Dedicator of cytokinesis protein 1	GO:0005096; F:GTPase activator activity; TAS:ProtInc
Q14185	DOCK1	Dedicator of cytokinesis protein 1	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW
Q14185	DOCK1	Dedicator of cytokinesis protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q14185	DOCK1	Dedicator of cytokinesis protein 1	GO:0006915; P:apoptotic process; TAS:ProtInc
Q14185	DOCK1	Dedicator of cytokinesis protein 1	GO:0007411; P:axon guidance; TAS:Reactome
Q14185	DOCK1	Dedicator of cytokinesis protein 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q14185	DOCK1	Dedicator of cytokinesis protein 1	GO:0016477; P:cell migration; IEA:Ensembl
Q14185	DOCK1	Dedicator of cytokinesis protein 1	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q14185	DOCK1	Dedicator of cytokinesis protein 1	GO:0045087; P:innate immune response; TAS:Reactome
Q14185	DOCK1	Dedicator of cytokinesis protein 1	GO:0007229; P:integrin-mediated signaling pathway; TAS:ProtInc
Q14185	DOCK1	Dedicator of cytokinesis protein 1	GO:0006911; P:phagocytosis, engulfment; TAS:ProtInc
Q14185	DOCK1	Dedicator of cytokinesis protein 1	GO:0043547; P:positive regulation of GTPase activity; TAS:GOC
Q14185	DOCK1	Dedicator of cytokinesis protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q14185	DOCK1	Dedicator of cytokinesis protein 1	GO:0007264; P:small GTPase mediated signal transduction; TAS:ProtInc
Q92608	DOCK2	Dedicator of cytokinesis protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q92608	DOCK2	Dedicator of cytokinesis protein 2	GO:0030675; F:Rac GTPase activator activity; IEA:Ensembl
Q92608	DOCK2	Dedicator of cytokinesis protein 2	GO:0030676; F:Rac guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q92608	DOCK2	Dedicator of cytokinesis protein 2	GO:0042608; F:T cell receptor binding; IDA:UniProtKB
Q92608	DOCK2	Dedicator of cytokinesis protein 2	GO:0030036; P:actin cytoskeleton organization; TAS:UniProtKB
Q92608	DOCK2	Dedicator of cytokinesis protein 2	GO:0046633; P:alpha-beta T cell proliferation; IEA:Ensembl
Q92608	DOCK2	Dedicator of cytokinesis protein 2	GO:0006935; P:chemotaxis; IEA:Ensembl
Q92608	DOCK2	Dedicator of cytokinesis protein 2	GO:0001768; P:establishment of T cell polarity; IEA:Ensembl
Q92608	DOCK2	Dedicator of cytokinesis protein 2	GO:0001771; P:immunological synapse formation; IEA:Ensembl
Q92608	DOCK2	Dedicator of cytokinesis protein 2	GO:0044351; P:macropinocytosis; ISS:UniProtKB
Q92608	DOCK2	Dedicator of cytokinesis protein 2	GO:0001766; P:membrane raft polarization; IEA:Ensembl
Q92608	DOCK2	Dedicator of cytokinesis protein 2	GO:0002277; P:myeloid dendritic cell activation involved in immune response; ISS:UniProtKB
Q92608	DOCK2	Dedicator of cytokinesis protein 2	GO:0045060; P:negative thymic T cell selection; IEA:Ensembl
Q92608	DOCK2	Dedicator of cytokinesis protein 2	GO:0050766; P:positive regulation of phagocytosis; ISS:UniProtKB
Q92608	DOCK2	Dedicator of cytokinesis protein 2	GO:0045059; P:positive thymic T cell selection; IEA:Ensembl
Q92608	DOCK2	Dedicator of cytokinesis protein 2	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
Q92608	DOCK2	Dedicator of cytokinesis protein 2	GO:0032314; P:regulation of Rac GTPase activity; IDA:GOC
Q92608	DOCK2	Dedicator of cytokinesis protein 2	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q92608	DOCK2	Dedicator of cytokinesis protein 2	GO:0016032; P:viral process; TAS:Reactome
Q8IZD9	DOCK3	Dedicator of cytokinesis protein 3	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW
Q8IZD9	DOCK3	Dedicator of cytokinesis protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q8IZD9	DOCK3	Dedicator of cytokinesis protein 3	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q8N1I0	DOCK4	Dedicator of cytokinesis protein 4	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW
Q8N1I0	DOCK4	Dedicator of cytokinesis protein 4	GO:0030165; F:PDZ domain binding; IPI:HGNC
Q8N1I0	DOCK4	Dedicator of cytokinesis protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N1I0	DOCK4	Dedicator of cytokinesis protein 4	GO:0030675; F:Rac GTPase activator activity; IDA:HGNC
Q8N1I0	DOCK4	Dedicator of cytokinesis protein 4	GO:0048365; F:Rac GTPase binding; IDA:HGNC
Q8N1I0	DOCK4	Dedicator of cytokinesis protein 4	GO:0030971; F:receptor tyrosine kinase binding; IPI:UniProtKB
Q8N1I0	DOCK4	Dedicator of cytokinesis protein 4	GO:0060326; P:cell chemotaxis; IMP:UniProtKB
Q8N1I0	DOCK4	Dedicator of cytokinesis protein 4	GO:0032855; P:positive regulation of Rac GTPase activity; IDA:GOC
Q8N1I0	DOCK4	Dedicator of cytokinesis protein 4	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9H7D0	DOCK5	Dedicator of cytokinesis protein 5	GO:0005085; F:guanyl-nucleotide exchange factor activity; ISS:UniProtKB
Q9H7D0	DOCK5	Dedicator of cytokinesis protein 5	GO:0043087; P:regulation of GTPase activity; ISS:GOC
Q9H7D0	DOCK5	Dedicator of cytokinesis protein 5	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q96HP0	DOCK6	Dedicator of cytokinesis protein 6	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW
Q96HP0	DOCK6	Dedicator of cytokinesis protein 6	GO:0007596; P:blood coagulation; TAS:Reactome
Q96HP0	DOCK6	Dedicator of cytokinesis protein 6	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q96N67	DOCK7	Dedicator of cytokinesis protein 7	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW
Q96N67	DOCK7	Dedicator of cytokinesis protein 7	GO:0048365; F:Rac GTPase binding; IDA:BHF-UCL
Q96N67	DOCK7	Dedicator of cytokinesis protein 7	GO:0032863; P:activation of Rac GTPase activity; IDA:BHF-UCL
Q96N67	DOCK7	Dedicator of cytokinesis protein 7	GO:0007409; P:axonogenesis; IMP:BHF-UCL
Q96N67	DOCK7	Dedicator of cytokinesis protein 7	GO:0045200; P:establishment of neuroblast polarity; IMP:BHF-UCL
Q96N67	DOCK7	Dedicator of cytokinesis protein 7	GO:0000226; P:microtubule cytoskeleton organization; IMP:BHF-UCL
Q96N67	DOCK7	Dedicator of cytokinesis protein 7	GO:0031175; P:neuron projection development; IMP:BHF-UCL
Q96N67	DOCK7	Dedicator of cytokinesis protein 7	GO:0043473; P:pigmentation; IEA:Ensembl
Q96N67	DOCK7	Dedicator of cytokinesis protein 7	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IMP:BHF-UCL
Q96N67	DOCK7	Dedicator of cytokinesis protein 7	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q8NF50	DOCK8	Dedicator of cytokinesis protein 8	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW
Q8NF50	DOCK8	Dedicator of cytokinesis protein 8	GO:0005515; F:protein binding; IPI:IntAct
Q8NF50	DOCK8	Dedicator of cytokinesis protein 8	GO:0007596; P:blood coagulation; TAS:Reactome
Q8NF50	DOCK8	Dedicator of cytokinesis protein 8	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9BZ29	DOCK9	Dedicator of cytokinesis protein 9	GO:0005515; F:protein binding; IPI:IntAct
Q9BZ29	DOCK9	Dedicator of cytokinesis protein 9	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:Ensembl
Q9BZ29	DOCK9	Dedicator of cytokinesis protein 9	GO:0007596; P:blood coagulation; TAS:Reactome
Q9BZ29	DOCK9	Dedicator of cytokinesis protein 9	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9BU89	DOHH	Deoxyhypusine hydroxylase	GO:0019135; F:deoxyhypusine monooxygenase activity; IMP:UniProtKB
Q9BU89	DOHH	Deoxyhypusine hydroxylase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BU89	DOHH	Deoxyhypusine hydroxylase	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BU89	DOHH	Deoxyhypusine hydroxylase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9BU89	DOHH	Deoxyhypusine hydroxylase	GO:0008612; P:peptidyl-lysine modification to peptidyl-hypusine; IMP:UniProtKB
Q9BU89	DOHH	Deoxyhypusine hydroxylase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q99704	DOK1	Docking protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q99704	DOK1	Docking protein 1	GO:0005057; F:receptor signaling protein activity; IEA:Ensembl
Q99704	DOK1	Docking protein 1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q99704	DOK1	Docking protein 1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q99704	DOK1	Docking protein 1	GO:0007265; P:Ras protein signal transduction; IEA:Ensembl
Q99704	DOK1	Docking protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q99704	DOK1	Docking protein 1	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc
O60496	DOK2	Docking protein 2	GO:0005057; F:receptor signaling protein activity; IEA:Ensembl
O60496	DOK2	Docking protein 2	GO:0007596; P:blood coagulation; TAS:Reactome
O60496	DOK2	Docking protein 2	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
O60496	DOK2	Docking protein 2	GO:0050900; P:leukocyte migration; TAS:Reactome
O60496	DOK2	Docking protein 2	GO:0007265; P:Ras protein signal transduction; IEA:Ensembl
O60496	DOK2	Docking protein 2	GO:0007165; P:signal transduction; TAS:ProtInc
O60496	DOK2	Docking protein 2	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:Ensembl
Q7L591	DOK3	Docking protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q7L591	DOK3	Docking protein 3	GO:0007265; P:Ras protein signal transduction; IEA:Ensembl
Q8TEW6	DOK4	Docking protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q8TEW6	DOK4	Docking protein 4	GO:0005057; F:receptor signaling protein activity; IEA:Ensembl
Q8TEW6	DOK4	Docking protein 4	GO:0000165; P:MAPK cascade; IEA:Ensembl
Q8TEW6	DOK4	Docking protein 4	GO:0007399; P:nervous system development; IEA:Ensembl
Q8TEW6	DOK4	Docking protein 4	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:Ensembl
Q9P104	DOK5	Docking protein 5	GO:0005057; F:receptor signaling protein activity; IEA:Ensembl
Q9P104	DOK5	Docking protein 5	GO:0000165; P:MAPK cascade; IEA:Ensembl
Q9P104	DOK5	Docking protein 5	GO:0007399; P:nervous system development; IEA:Ensembl
Q9P104	DOK5	Docking protein 5	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:Ensembl
Q6PKX4	DOK6	Docking protein 6	GO:0005515; F:protein binding; IPI:IntAct
Q18PE1	DOK7	Protein Dok-7	GO:0035091; F:phosphatidylinositol binding; IEA:Ensembl
Q18PE1	DOK7	Protein Dok-7	GO:0019901; F:protein kinase binding; IDA:UniProtKB
Q18PE1	DOK7	Protein Dok-7	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
Q18PE1	DOK7	Protein Dok-7	GO:0061098; P:positive regulation of protein tyrosine kinase activity; IDA:UniProtKB
Q18PE1	DOK7	Protein Dok-7	GO:0043113; P:receptor clustering; IEA:Ensembl
Q9UPQ8	DOLK	Dolichol kinase	GO:0004168; F:dolichol kinase activity; IDA:UniProtKB
Q9UPQ8	DOLK	Dolichol kinase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UPQ8	DOLK	Dolichol kinase	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q9UPQ8	DOLK	Dolichol kinase	GO:0006489; P:dolichyl diphosphate biosynthetic process; TAS:Reactome
Q9UPQ8	DOLK	Dolichol kinase	GO:0043048; P:dolichyl monophosphate biosynthetic process; IDA:UniProtKB
Q9UPQ8	DOLK	Dolichol kinase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9UPQ8	DOLK	Dolichol kinase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9NYP3	DONSON	Protein downstream neighbor of Son	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q5JWR5	DOPEY1	Protein dopey-1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9Y3R5	DOPEY2	Protein dopey-2	GO:0007029; P:endoplasmic reticulum organization; ISS:HGNC
Q9Y3R5	DOPEY2	Protein dopey-2	GO:0006895; P:Golgi to endosome transport; ISS:HGNC
Q9Y3R5	DOPEY2	Protein dopey-2	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
Q9Y3R5	DOPEY2	Protein dopey-2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P30046	DDT	D-dopachrome decarboxylase	GO:0033981; F:D-dopachrome decarboxylase activity; IEA:UniProtKB-EC
P30046	DDT	D-dopachrome decarboxylase	GO:0004167; F:dopachrome isomerase activity; TAS:ProtInc
P30046	DDT	D-dopachrome decarboxylase	GO:0042438; P:melanin biosynthetic process; IEA:UniProtKB-KW
P09172	DBH	Dopamine beta-hydroxylase	GO:0003824; F:catalytic activity; TAS:ProtInc
P09172	DBH	Dopamine beta-hydroxylase	GO:0005507; F:copper ion binding; IEA:InterPro
P09172	DBH	Dopamine beta-hydroxylase	GO:0004500; F:dopamine beta-monooxygenase activity; TAS:Reactome
P09172	DBH	Dopamine beta-hydroxylase	GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW
P09172	DBH	Dopamine beta-hydroxylase	GO:0048149; P:behavioral response to ethanol; IEA:Ensembl
P09172	DBH	Dopamine beta-hydroxylase	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
P09172	DBH	Dopamine beta-hydroxylase	GO:0042423; P:catecholamine biosynthetic process; TAS:Reactome
P09172	DBH	Dopamine beta-hydroxylase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P09172	DBH	Dopamine beta-hydroxylase	GO:0001816; P:cytokine production; IEA:Ensembl
P09172	DBH	Dopamine beta-hydroxylase	GO:0042420; P:dopamine catabolic process; IEA:Ensembl
P09172	DBH	Dopamine beta-hydroxylase	GO:0042596; P:fear response; IEA:Ensembl
P09172	DBH	Dopamine beta-hydroxylase	GO:0042593; P:glucose homeostasis; IEA:Ensembl
P09172	DBH	Dopamine beta-hydroxylase	GO:0042309; P:homoiothermy; IEA:Ensembl
P09172	DBH	Dopamine beta-hydroxylase	GO:0002443; P:leukocyte mediated immunity; IEA:Ensembl
P09172	DBH	Dopamine beta-hydroxylase	GO:0050900; P:leukocyte migration; IEA:Ensembl
P09172	DBH	Dopamine beta-hydroxylase	GO:0007626; P:locomotory behavior; IEA:Ensembl
P09172	DBH	Dopamine beta-hydroxylase	GO:0042711; P:maternal behavior; IEA:Ensembl
P09172	DBH	Dopamine beta-hydroxylase	GO:0007613; P:memory; IEA:Ensembl
P09172	DBH	Dopamine beta-hydroxylase	GO:0042421; P:norepinephrine biosynthetic process; IEA:UniProtKB-UniPathway
P09172	DBH	Dopamine beta-hydroxylase	GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl
P09172	DBH	Dopamine beta-hydroxylase	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P09172	DBH	Dopamine beta-hydroxylase	GO:2001236; P:regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl
P09172	DBH	Dopamine beta-hydroxylase	GO:0001975; P:response to amphetamine; IEA:Ensembl
P09172	DBH	Dopamine beta-hydroxylase	GO:0048265; P:response to pain; IEA:Ensembl
P09172	DBH	Dopamine beta-hydroxylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P09172	DBH	Dopamine beta-hydroxylase	GO:0007268; P:synaptic transmission; TAS:ProtInc
P09172	DBH	Dopamine beta-hydroxylase	GO:0008542; P:visual learning; IEA:Ensembl
Q86YN1	DOLPP1	Dolichyldiphosphatase 1	GO:0047874; F:dolichyldiphosphatase activity; ISS:UniProtKB
Q86YN1	DOLPP1	Dolichyldiphosphatase 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q86YN1	DOLPP1	Dolichyldiphosphatase 1	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q86YN1	DOLPP1	Dolichyldiphosphatase 1	GO:0006489; P:dolichyl diphosphate biosynthetic process; TAS:Reactome
Q86YN1	DOLPP1	Dolichyldiphosphatase 1	GO:0008610; P:lipid biosynthetic process; IBA:RefGenome
Q86YN1	DOLPP1	Dolichyldiphosphatase 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q86YN1	DOLPP1	Dolichyldiphosphatase 1	GO:0006487; P:protein N-linked glycosylation; ISS:UniProtKB
Q86YN1	DOLPP1	Dolichyldiphosphatase 1	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q8TEK3	DOT1L	Histone-lysine N-methyltransferase, H3 lysine-79 specific	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TEK3	DOT1L	Histone-lysine N-methyltransferase, H3 lysine-79 specific	GO:0018024; F:histone-lysine N-methyltransferase activity; IDA:UniProtKB
Q8TEK3	DOT1L	Histone-lysine N-methyltransferase, H3 lysine-79 specific	GO:0005515; F:protein binding; IPI:IntAct
Q8TEK3	DOT1L	Histone-lysine N-methyltransferase, H3 lysine-79 specific	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q8TEK3	DOT1L	Histone-lysine N-methyltransferase, H3 lysine-79 specific	GO:0034968; P:histone lysine methylation; IDA:GOC
Q8TEK3	DOT1L	Histone-lysine N-methyltransferase, H3 lysine-79 specific	GO:0046425; P:regulation of JAK-STAT cascade; IDA:UniProtKB
Q8TEK3	DOT1L	Histone-lysine N-methyltransferase, H3 lysine-79 specific	GO:2000677; P:regulation of transcription regulatory region DNA binding; IMP:UniProtKB
Q1HG43	DUOXA1	Dual oxidase maturation factor 1	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
Q1HG43	DUOXA1	Dual oxidase maturation factor 1	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IEA:Ensembl
Q1HG43	DUOXA1	Dual oxidase maturation factor 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q1HG44	DUOXA2	Dual oxidase maturation factor 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9UKG1	APPL1	DCC-interacting protein 13-alpha	GO:0042802; F:identical protein binding; IPI:IntAct
Q9UKG1	APPL1	DCC-interacting protein 13-alpha	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKG1	APPL1	DCC-interacting protein 13-alpha	GO:0043422; F:protein kinase B binding; IPI:BHF-UCL
Q9UKG1	APPL1	DCC-interacting protein 13-alpha	GO:0006915; P:apoptotic process; TAS:Reactome
Q9UKG1	APPL1	DCC-interacting protein 13-alpha	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9UKG1	APPL1	DCC-interacting protein 13-alpha	GO:0008283; P:cell proliferation; IDA:UniProtKB
Q9UKG1	APPL1	DCC-interacting protein 13-alpha	GO:0008286; P:insulin receptor signaling pathway; TAS:BHF-UCL
Q9UKG1	APPL1	DCC-interacting protein 13-alpha	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q9UKG1	APPL1	DCC-interacting protein 13-alpha	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
Q9UKG1	APPL1	DCC-interacting protein 13-alpha	GO:0090003; P:regulation of establishment of protein localization to plasma membrane; IMP:BHF-UCL
Q9UKG1	APPL1	DCC-interacting protein 13-alpha	GO:0046324; P:regulation of glucose import; IMP:BHF-UCL
Q9UKG1	APPL1	DCC-interacting protein 13-alpha	GO:0007165; P:signal transduction; TAS:UniProtKB
Q8NEU8	APPL2	DCC-interacting protein 13-beta	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NEU8	APPL2	DCC-interacting protein 13-beta	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8NEU8	APPL2	DCC-interacting protein 13-beta	GO:0008283; P:cell proliferation; IDA:UniProtKB
Q8NEU8	APPL2	DCC-interacting protein 13-beta	GO:0007165; P:signal transduction; TAS:UniProtKB
P20036	HLA-DPA1	HLA class II histocompatibility antigen, DP alpha 1 chain	GO:0032395; F:MHC class II receptor activity; NAS:UniProtKB
P20036	HLA-DPA1	HLA class II histocompatibility antigen, DP alpha 1 chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P20036	HLA-DPA1	HLA class II histocompatibility antigen, DP alpha 1 chain	GO:0071346; P:cellular response to interferon-gamma; IDA:UniProtKB
P20036	HLA-DPA1	HLA class II histocompatibility antigen, DP alpha 1 chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P20036	HLA-DPA1	HLA class II histocompatibility antigen, DP alpha 1 chain	GO:0006955; P:immune response; NAS:UniProtKB
P20036	HLA-DPA1	HLA class II histocompatibility antigen, DP alpha 1 chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P20036	HLA-DPA1	HLA class II histocompatibility antigen, DP alpha 1 chain	GO:0031295; P:T cell costimulation; TAS:Reactome
P20036	HLA-DPA1	HLA class II histocompatibility antigen, DP alpha 1 chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P04440	HLA-DPB1	HLA class II histocompatibility antigen, DP beta 1 chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P04440	HLA-DPB1	HLA class II histocompatibility antigen, DP beta 1 chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P04440	HLA-DPB1	HLA class II histocompatibility antigen, DP beta 1 chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P04440	HLA-DPB1	HLA class II histocompatibility antigen, DP beta 1 chain	GO:0031295; P:T cell costimulation; TAS:Reactome
P04440	HLA-DPB1	HLA class II histocompatibility antigen, DP beta 1 chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q9BVM2	DPCD	Protein DPCD	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
Q9BVM2	DPCD	Protein DPCD	GO:0003351; P:epithelial cilium movement; IEA:Ensembl
Q9BVM2	DPCD	Protein DPCD	GO:0021670; P:lateral ventricle development; IEA:Ensembl
Q9BVM2	DPCD	Protein DPCD	GO:0060972; P:left/right pattern formation; IEA:Ensembl
Q9BVM2	DPCD	Protein DPCD	GO:0030317; P:sperm motility; IEA:Ensembl
Q9BVM2	DPCD	Protein DPCD	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q9BVM2	DPCD	Protein DPCD	GO:0021678; P:third ventricle development; IEA:Ensembl
P16444	DPEP1	Dipeptidase 1	GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IMP:UniProtKB
P16444	DPEP1	Dipeptidase 1	GO:0008239; F:dipeptidyl-peptidase activity; IEA:InterPro
P16444	DPEP1	Dipeptidase 1	GO:0034235; F:GPI anchor binding; ISS:UniProtKB
P16444	DPEP1	Dipeptidase 1	GO:0070573; F:metallodipeptidase activity; IDA:UniProtKB
P16444	DPEP1	Dipeptidase 1	GO:0008235; F:metalloexopeptidase activity; TAS:UniProtKB
P16444	DPEP1	Dipeptidase 1	GO:0072341; F:modified amino acid binding; IDA:UniProtKB
P16444	DPEP1	Dipeptidase 1	GO:0005515; F:protein binding; IPI:IntAct
P16444	DPEP1	Dipeptidase 1	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P16444	DPEP1	Dipeptidase 1	GO:0016999; P:antibiotic metabolic process; IDA:UniProtKB
P16444	DPEP1	Dipeptidase 1	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P16444	DPEP1	Dipeptidase 1	GO:0072340; P:cellular lactam catabolic process; TAS:UniProtKB
P16444	DPEP1	Dipeptidase 1	GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB
P16444	DPEP1	Dipeptidase 1	GO:0035690; P:cellular response to drug; IDA:UniProtKB
P16444	DPEP1	Dipeptidase 1	GO:0071732; P:cellular response to nitric oxide; ISS:UniProtKB
P16444	DPEP1	Dipeptidase 1	GO:0006749; P:glutathione metabolic process; TAS:UniProtKB
P16444	DPEP1	Dipeptidase 1	GO:0050667; P:homocysteine metabolic process; IDA:UniProtKB
P16444	DPEP1	Dipeptidase 1	GO:0006691; P:leukotriene metabolic process; TAS:Reactome
P16444	DPEP1	Dipeptidase 1	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P16444	DPEP1	Dipeptidase 1	GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB
P16444	DPEP1	Dipeptidase 1	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
P16444	DPEP1	Dipeptidase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H4A9	DPEP2	Dipeptidase 2	GO:0016805; F:dipeptidase activity; IEA:UniProtKB-KW
Q9H4A9	DPEP2	Dipeptidase 2	GO:0008239; F:dipeptidyl-peptidase activity; IEA:InterPro
Q9H4A9	DPEP2	Dipeptidase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H4A9	DPEP2	Dipeptidase 2	GO:0008235; F:metalloexopeptidase activity; IEA:InterPro
Q9H4A9	DPEP2	Dipeptidase 2	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
Q9H4A9	DPEP2	Dipeptidase 2	GO:0006691; P:leukotriene metabolic process; TAS:Reactome
Q9H4A9	DPEP2	Dipeptidase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H4B8	DPEP3	Dipeptidase 3	GO:0016805; F:dipeptidase activity; IEA:UniProtKB-KW
Q9H4B8	DPEP3	Dipeptidase 3	GO:0008239; F:dipeptidyl-peptidase activity; IEA:InterPro
Q9H4B8	DPEP3	Dipeptidase 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H4B8	DPEP3	Dipeptidase 3	GO:0008235; F:metalloexopeptidase activity; IEA:InterPro
Q9H4B8	DPEP3	Dipeptidase 3	GO:0007140; P:male meiosis; ISS:UniProtKB
Q92782	DPF1	Zinc finger protein neuro-d4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q92782	DPF1	Zinc finger protein neuro-d4	GO:0006915; P:apoptotic process; TAS:ProtInc
Q92782	DPF1	Zinc finger protein neuro-d4	GO:0007399; P:nervous system development; ISS:UniProtKB
Q92782	DPF1	Zinc finger protein neuro-d4	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q92782	DPF1	Zinc finger protein neuro-d4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q92784	DPF3	Zinc finger protein DPF3	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q92784	DPF3	Zinc finger protein DPF3	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q92784	DPF3	Zinc finger protein DPF3	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q92784	DPF3	Zinc finger protein DPF3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q92784	DPF3	Zinc finger protein DPF3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BZG8	DPH1	Diphthamide biosynthesis protein 1	GO:0008283; P:cell proliferation; IEA:Ensembl
Q9BZG8	DPH1	Diphthamide biosynthesis protein 1	GO:0017183; P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine; IEA:UniProtKB-UniPathway
Q9BZG8	DPH1	Diphthamide biosynthesis protein 1	GO:0006412; P:translation; TAS:ProtInc
Q9BQC3	DPH2	Diphthamide biosynthesis protein 2	GO:0017183; P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine; IEA:UniProtKB-UniPathway
Q9H4G8	DPH3P1	Putative DPH3 homolog B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96FX2	DPH3	DPH3 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96FX2	DPH3	DPH3 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q96FX2	DPH3	DPH3 homolog	GO:0050709; P:negative regulation of protein secretion; IDA:UniProtKB
Q96FX2	DPH3	DPH3 homolog	GO:0017183; P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine; ISS:UniProtKB
Q96FX2	DPH3	DPH3 homolog	GO:0051099; P:positive regulation of binding; IDA:UniProtKB
Q9H2P9	DPH5	Diphthine synthase	GO:0004164; F:diphthine synthase activity; NAS:UniProtKB
Q9H2P9	DPH5	Diphthine synthase	GO:0017183; P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine; NAS:UniProtKB
Q7L8W6	DPH6	Diphthine--ammonia ligase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q7L8W6	DPH6	Diphthine--ammonia ligase	GO:0017178; F:diphthine-ammonia ligase activity; TAS:UniProtKB
Q7L8W6	DPH6	Diphthine--ammonia ligase	GO:0017183; P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine; TAS:UniProtKB
Q9BTV6	DPH7	Diphthamide biosynthesis protein 7	GO:0017183; P:peptidyl-diphthamide biosynthetic process from peptidyl-histidine; IMP:UniProtKB
O60762	DPM1	Dolichol-phosphate mannosyltransferase subunit 1	GO:0043178; F:alcohol binding; IEA:Ensembl
O60762	DPM1	Dolichol-phosphate mannosyltransferase subunit 1	GO:0004582; F:dolichyl-phosphate beta-D-mannosyltransferase activity; IDA:UniProtKB
O60762	DPM1	Dolichol-phosphate mannosyltransferase subunit 1	GO:0004169; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; IDA:HGNC
O60762	DPM1	Dolichol-phosphate mannosyltransferase subunit 1	GO:0005537; F:mannose binding; IEA:Ensembl
O60762	DPM1	Dolichol-phosphate mannosyltransferase subunit 1	GO:0005515; F:protein binding; IPI:UniProtKB
O60762	DPM1	Dolichol-phosphate mannosyltransferase subunit 1	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
O60762	DPM1	Dolichol-phosphate mannosyltransferase subunit 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O60762	DPM1	Dolichol-phosphate mannosyltransferase subunit 1	GO:0019348; P:dolichol metabolic process; IDA:MGI
O60762	DPM1	Dolichol-phosphate mannosyltransferase subunit 1	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
O60762	DPM1	Dolichol-phosphate mannosyltransferase subunit 1	GO:0019673; P:GDP-mannose metabolic process; IEA:Ensembl
O60762	DPM1	Dolichol-phosphate mannosyltransferase subunit 1	GO:0006506; P:GPI anchor biosynthetic process; IDA:UniProtKB
O60762	DPM1	Dolichol-phosphate mannosyltransferase subunit 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
O60762	DPM1	Dolichol-phosphate mannosyltransferase subunit 1	GO:0035268; P:protein mannosylation; IDA:HGNC
O60762	DPM1	Dolichol-phosphate mannosyltransferase subunit 1	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
O60762	DPM1	Dolichol-phosphate mannosyltransferase subunit 1	GO:0035269; P:protein O-linked mannosylation; IDA:HGNC
O94777	DPM2	Dolichol phosphate-mannose biosynthesis regulatory protein	GO:0004582; F:dolichyl-phosphate beta-D-mannosyltransferase activity; IEA:Ensembl
O94777	DPM2	Dolichol phosphate-mannose biosynthesis regulatory protein	GO:0030234; F:enzyme regulator activity; IEA:Ensembl
O94777	DPM2	Dolichol phosphate-mannose biosynthesis regulatory protein	GO:0005515; F:protein binding; IPI:HGNC
O94777	DPM2	Dolichol phosphate-mannose biosynthesis regulatory protein	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
O94777	DPM2	Dolichol phosphate-mannose biosynthesis regulatory protein	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O94777	DPM2	Dolichol phosphate-mannose biosynthesis regulatory protein	GO:0019348; P:dolichol metabolic process; IEA:Ensembl
O94777	DPM2	Dolichol phosphate-mannose biosynthesis regulatory protein	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
O94777	DPM2	Dolichol phosphate-mannose biosynthesis regulatory protein	GO:0006506; P:GPI anchor biosynthetic process; IDA:UniProtKB
O94777	DPM2	Dolichol phosphate-mannose biosynthesis regulatory protein	GO:0043687; P:post-translational protein modification; TAS:Reactome
O94777	DPM2	Dolichol phosphate-mannose biosynthesis regulatory protein	GO:0016254; P:preassembly of GPI anchor in ER membrane; TAS:Reactome
O94777	DPM2	Dolichol phosphate-mannose biosynthesis regulatory protein	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
O94777	DPM2	Dolichol phosphate-mannose biosynthesis regulatory protein	GO:0035269; P:protein O-linked mannosylation; TAS:HGNC
O94777	DPM2	Dolichol phosphate-mannose biosynthesis regulatory protein	GO:0031647; P:regulation of protein stability; IPI:UniProtKB
Q9P2X0	DPM3	Dolichol-phosphate mannosyltransferase subunit 3	GO:0005515; F:protein binding; IPI:IntAct
Q9P2X0	DPM3	Dolichol-phosphate mannosyltransferase subunit 3	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
Q9P2X0	DPM3	Dolichol-phosphate mannosyltransferase subunit 3	GO:0005975; P:carbohydrate metabolic process; NAS:ProtInc
Q9P2X0	DPM3	Dolichol-phosphate mannosyltransferase subunit 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9P2X0	DPM3	Dolichol-phosphate mannosyltransferase subunit 3	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q9P2X0	DPM3	Dolichol-phosphate mannosyltransferase subunit 3	GO:0006506; P:GPI anchor biosynthetic process; IDA:UniProtKB
Q9P2X0	DPM3	Dolichol-phosphate mannosyltransferase subunit 3	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9P2X0	DPM3	Dolichol-phosphate mannosyltransferase subunit 3	GO:0018406; P:protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan; TAS:HGNC
Q9P2X0	DPM3	Dolichol-phosphate mannosyltransferase subunit 3	GO:0035268; P:protein mannosylation; TAS:HGNC
Q9P2X0	DPM3	Dolichol-phosphate mannosyltransferase subunit 3	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9P2X0	DPM3	Dolichol-phosphate mannosyltransferase subunit 3	GO:0035269; P:protein O-linked mannosylation; TAS:HGNC
Q9P2X0	DPM3	Dolichol-phosphate mannosyltransferase subunit 3	GO:0031647; P:regulation of protein stability; IPI:UniProtKB
Q14181	POLA2	DNA polymerase alpha subunit B	GO:0003677; F:DNA binding; IEA:InterPro
Q14181	POLA2	DNA polymerase alpha subunit B	GO:0003887; F:DNA-directed DNA polymerase activity; IEA:InterPro
Q14181	POLA2	DNA polymerase alpha subunit B	GO:0046982; F:protein heterodimerization activity; IBA:RefGenome
Q14181	POLA2	DNA polymerase alpha subunit B	GO:0006260; P:DNA replication; NAS:UniProtKB
Q14181	POLA2	DNA polymerase alpha subunit B	GO:0006270; P:DNA replication initiation; IBA:RefGenome
Q14181	POLA2	DNA polymerase alpha subunit B	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
Q14181	POLA2	DNA polymerase alpha subunit B	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q14181	POLA2	DNA polymerase alpha subunit B	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q14181	POLA2	DNA polymerase alpha subunit B	GO:0000060; P:protein import into nucleus, translocation; IEA:Ensembl
Q14181	POLA2	DNA polymerase alpha subunit B	GO:0000723; P:telomere maintenance; TAS:Reactome
Q14181	POLA2	DNA polymerase alpha subunit B	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
Q14181	POLA2	DNA polymerase alpha subunit B	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0008408; F:3'-5' exonuclease activity; IBA:RefGenome
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0003682; F:chromatin binding; IDA:UniProtKB
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0003677; F:DNA binding; IDA:UniProtKB
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0003887; F:DNA-directed DNA polymerase activity; IMP:UniProtKB
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0000166; F:nucleotide binding; IEA:InterPro
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0005515; F:protein binding; IPI:UniProtKB
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0006284; P:base-excision repair; TAS:Reactome
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0006287; P:base-excision repair, gap-filling; IDA:UniProtKB
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0006281; P:DNA repair; TAS:Reactome
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0006260; P:DNA replication; IMP:UniProtKB
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0045004; P:DNA replication proofreading; IBA:RefGenome
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0043137; P:DNA replication, removal of RNA primer; IBA:RefGenome
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0000731; P:DNA synthesis involved in DNA repair; IDA:UniProtKB
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0055089; P:fatty acid homeostasis; IMP:UniProtKB
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IBA:GOC
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0006297; P:nucleotide-excision repair, DNA gap filling; IMP:UniProtKB
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0007346; P:regulation of mitotic cell cycle; IBA:RefGenome
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0009411; P:response to UV; TAS:ProtInc
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0000723; P:telomere maintenance; TAS:Reactome
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
P28340	POLD1	DNA polymerase delta catalytic subunit	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P49005	POLD2	DNA polymerase delta subunit 2	GO:0003677; F:DNA binding; IEA:InterPro
P49005	POLD2	DNA polymerase delta subunit 2	GO:0003887; F:DNA-directed DNA polymerase activity; IEA:UniProtKB-KW
P49005	POLD2	DNA polymerase delta subunit 2	GO:0005515; F:protein binding; IPI:UniProtKB
P49005	POLD2	DNA polymerase delta subunit 2	GO:0006284; P:base-excision repair; TAS:Reactome
P49005	POLD2	DNA polymerase delta subunit 2	GO:0006281; P:DNA repair; TAS:Reactome
P49005	POLD2	DNA polymerase delta subunit 2	GO:0006260; P:DNA replication; TAS:ProtInc
P49005	POLD2	DNA polymerase delta subunit 2	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P49005	POLD2	DNA polymerase delta subunit 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P49005	POLD2	DNA polymerase delta subunit 2	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P49005	POLD2	DNA polymerase delta subunit 2	GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome
P49005	POLD2	DNA polymerase delta subunit 2	GO:0000723; P:telomere maintenance; TAS:Reactome
P49005	POLD2	DNA polymerase delta subunit 2	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
P49005	POLD2	DNA polymerase delta subunit 2	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
P49005	POLD2	DNA polymerase delta subunit 2	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
Q15054	POLD3	DNA polymerase delta subunit 3	GO:0003887; F:DNA-directed DNA polymerase activity; NAS:UniProtKB
Q15054	POLD3	DNA polymerase delta subunit 3	GO:0005515; F:protein binding; IPI:IntAct
Q15054	POLD3	DNA polymerase delta subunit 3	GO:0006284; P:base-excision repair; TAS:Reactome
Q15054	POLD3	DNA polymerase delta subunit 3	GO:0006281; P:DNA repair; TAS:Reactome
Q15054	POLD3	DNA polymerase delta subunit 3	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
Q15054	POLD3	DNA polymerase delta subunit 3	GO:0000731; P:DNA synthesis involved in DNA repair; NAS:UniProtKB
Q15054	POLD3	DNA polymerase delta subunit 3	GO:0006298; P:mismatch repair; NAS:UniProtKB
Q15054	POLD3	DNA polymerase delta subunit 3	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q15054	POLD3	DNA polymerase delta subunit 3	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
Q15054	POLD3	DNA polymerase delta subunit 3	GO:0006297; P:nucleotide-excision repair, DNA gap filling; IMP:UniProtKB
Q15054	POLD3	DNA polymerase delta subunit 3	GO:0000723; P:telomere maintenance; TAS:Reactome
Q15054	POLD3	DNA polymerase delta subunit 3	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
Q15054	POLD3	DNA polymerase delta subunit 3	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
Q15054	POLD3	DNA polymerase delta subunit 3	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
Q9HCU8	POLD4	DNA polymerase delta subunit 4	GO:0003887; F:DNA-directed DNA polymerase activity; TAS:ProtInc
Q9HCU8	POLD4	DNA polymerase delta subunit 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HCU8	POLD4	DNA polymerase delta subunit 4	GO:0006284; P:base-excision repair; TAS:Reactome
Q9HCU8	POLD4	DNA polymerase delta subunit 4	GO:0006281; P:DNA repair; TAS:Reactome
Q9HCU8	POLD4	DNA polymerase delta subunit 4	GO:0006260; P:DNA replication; TAS:ProtInc
Q9HCU8	POLD4	DNA polymerase delta subunit 4	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
Q9HCU8	POLD4	DNA polymerase delta subunit 4	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9HCU8	POLD4	DNA polymerase delta subunit 4	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
Q9HCU8	POLD4	DNA polymerase delta subunit 4	GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome
Q9HCU8	POLD4	DNA polymerase delta subunit 4	GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl
Q9HCU8	POLD4	DNA polymerase delta subunit 4	GO:0000723; P:telomere maintenance; TAS:Reactome
Q9HCU8	POLD4	DNA polymerase delta subunit 4	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
Q9HCU8	POLD4	DNA polymerase delta subunit 4	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
Q9HCU8	POLD4	DNA polymerase delta subunit 4	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
Q07864	POLE	DNA polymerase epsilon catalytic subunit A	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
Q07864	POLE	DNA polymerase epsilon catalytic subunit A	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q07864	POLE	DNA polymerase epsilon catalytic subunit A	GO:0003677; F:DNA binding; IDA:UniProtKB
Q07864	POLE	DNA polymerase epsilon catalytic subunit A	GO:0003887; F:DNA-directed DNA polymerase activity; IMP:UniProtKB
Q07864	POLE	DNA polymerase epsilon catalytic subunit A	GO:0000166; F:nucleotide binding; IEA:InterPro
Q07864	POLE	DNA polymerase epsilon catalytic subunit A	GO:0008270; F:zinc ion binding; IEA:InterPro
Q07864	POLE	DNA polymerase epsilon catalytic subunit A	GO:0006287; P:base-excision repair, gap-filling; IDA:UniProtKB
Q07864	POLE	DNA polymerase epsilon catalytic subunit A	GO:0006281; P:DNA repair; TAS:Reactome
Q07864	POLE	DNA polymerase epsilon catalytic subunit A	GO:0006260; P:DNA replication; IMP:UniProtKB
Q07864	POLE	DNA polymerase epsilon catalytic subunit A	GO:0006270; P:DNA replication initiation; TAS:Reactome
Q07864	POLE	DNA polymerase epsilon catalytic subunit A	GO:0000731; P:DNA synthesis involved in DNA repair; IMP:UniProtKB
Q07864	POLE	DNA polymerase epsilon catalytic subunit A	GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:UniProtKB
Q07864	POLE	DNA polymerase epsilon catalytic subunit A	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q07864	POLE	DNA polymerase epsilon catalytic subunit A	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q07864	POLE	DNA polymerase epsilon catalytic subunit A	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
Q07864	POLE	DNA polymerase epsilon catalytic subunit A	GO:0006297; P:nucleotide-excision repair, DNA gap filling; IMP:UniProtKB
Q07864	POLE	DNA polymerase epsilon catalytic subunit A	GO:0000723; P:telomere maintenance; TAS:Reactome
Q07864	POLE	DNA polymerase epsilon catalytic subunit A	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
Q07864	POLE	DNA polymerase epsilon catalytic subunit A	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
Q07864	POLE	DNA polymerase epsilon catalytic subunit A	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P56282	POLE2	DNA polymerase epsilon subunit 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P56282	POLE2	DNA polymerase epsilon subunit 2	GO:0003887; F:DNA-directed DNA polymerase activity; TAS:ProtInc
P56282	POLE2	DNA polymerase epsilon subunit 2	GO:0006281; P:DNA repair; TAS:Reactome
P56282	POLE2	DNA polymerase epsilon subunit 2	GO:0006260; P:DNA replication; TAS:ProtInc
P56282	POLE2	DNA polymerase epsilon subunit 2	GO:0006270; P:DNA replication initiation; TAS:Reactome
P56282	POLE2	DNA polymerase epsilon subunit 2	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P56282	POLE2	DNA polymerase epsilon subunit 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P56282	POLE2	DNA polymerase epsilon subunit 2	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P56282	POLE2	DNA polymerase epsilon subunit 2	GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome
P56282	POLE2	DNA polymerase epsilon subunit 2	GO:0000723; P:telomere maintenance; TAS:Reactome
P56282	POLE2	DNA polymerase epsilon subunit 2	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
P56282	POLE2	DNA polymerase epsilon subunit 2	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
P56282	POLE2	DNA polymerase epsilon subunit 2	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
Q9NRF9	POLE3	DNA polymerase epsilon subunit 3	GO:0003887; F:DNA-directed DNA polymerase activity; TAS:ProtInc
Q9NRF9	POLE3	DNA polymerase epsilon subunit 3	GO:0005515; F:protein binding; IPI:IntAct
Q9NRF9	POLE3	DNA polymerase epsilon subunit 3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9NRF9	POLE3	DNA polymerase epsilon subunit 3	GO:0006260; P:DNA replication; TAS:ProtInc
Q9NRF9	POLE3	DNA polymerase epsilon subunit 3	GO:0006261; P:DNA-dependent DNA replication; TAS:GOC
Q9NRF9	POLE3	DNA polymerase epsilon subunit 3	GO:0043966; P:histone H3 acetylation; IDA:BHF-UCL
Q9NR33	POLE4	DNA polymerase epsilon subunit 4	GO:0003887; F:DNA-directed DNA polymerase activity; TAS:ProtInc
Q9NR33	POLE4	DNA polymerase epsilon subunit 4	GO:0005515; F:protein binding; IPI:IntAct
Q9NR33	POLE4	DNA polymerase epsilon subunit 4	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9NR33	POLE4	DNA polymerase epsilon subunit 4	GO:0006261; P:DNA-dependent DNA replication; TAS:GOC
Q9NR33	POLE4	DNA polymerase epsilon subunit 4	GO:0043966; P:histone H3 acetylation; IDA:BHF-UCL
P54098	POLG	DNA polymerase subunit gamma-1	GO:0003682; F:chromatin binding; IDA:UniProtKB
P54098	POLG	DNA polymerase subunit gamma-1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P54098	POLG	DNA polymerase subunit gamma-1	GO:0003887; F:DNA-directed DNA polymerase activity; IDA:MGI
P54098	POLG	DNA polymerase subunit gamma-1	GO:0004527; F:exonuclease activity; IEA:Ensembl
P54098	POLG	DNA polymerase subunit gamma-1	GO:0002020; F:protease binding; IPI:UniProtKB
P54098	POLG	DNA polymerase subunit gamma-1	GO:0005515; F:protein binding; IPI:IntAct
P54098	POLG	DNA polymerase subunit gamma-1	GO:0007568; P:aging; IEA:Ensembl
P54098	POLG	DNA polymerase subunit gamma-1	GO:0006287; P:base-excision repair, gap-filling; IDA:MGI
P54098	POLG	DNA polymerase subunit gamma-1	GO:0008219; P:cell death; IEA:UniProtKB-KW
P54098	POLG	DNA polymerase subunit gamma-1	GO:0006259; P:DNA metabolic process; TAS:ProtInc
P54098	POLG	DNA polymerase subunit gamma-1	GO:0006261; P:DNA-dependent DNA replication; TAS:ProtInc
P54098	POLG	DNA polymerase subunit gamma-1	GO:0006264; P:mitochondrial DNA replication; IEA:Ensembl
Q9UHN1	POLG2	DNA polymerase subunit gamma-2, mitochondrial	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UHN1	POLG2	DNA polymerase subunit gamma-2, mitochondrial	GO:0003887; F:DNA-directed DNA polymerase activity; TAS:ProtInc
Q9UHN1	POLG2	DNA polymerase subunit gamma-2, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q9UHN1	POLG2	DNA polymerase subunit gamma-2, mitochondrial	GO:0006281; P:DNA repair; NAS:UniProtKB
Q9UHN1	POLG2	DNA polymerase subunit gamma-2, mitochondrial	GO:0006260; P:DNA replication; NAS:UniProtKB
Q9UHN1	POLG2	DNA polymerase subunit gamma-2, mitochondrial	GO:0006261; P:DNA-dependent DNA replication; TAS:ProtInc
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0008408; F:3'-5' exonuclease activity; IBA:RefGenome
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0003682; F:chromatin binding; IDA:UniProtKB
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0003677; F:DNA binding; IDA:UniProtKB
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0003887; F:DNA-directed DNA polymerase activity; IDA:UniProtKB
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0001882; F:nucleoside binding; IEA:InterPro
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0000166; F:nucleotide binding; IDA:UniProtKB
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0005515; F:protein binding; IPI:UniProtKB
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0008283; P:cell proliferation; IDA:UniProtKB
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0006260; P:DNA replication; IMP:UniProtKB
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0006270; P:DNA replication initiation; IDA:UniProtKB
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0006269; P:DNA replication, synthesis of RNA primer; IDA:GOC
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0006271; P:DNA strand elongation involved in DNA replication; IMP:UniProtKB
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0006303; P:double-strand break repair via nonhomologous end joining; IMP:UniProtKB
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0006273; P:lagging strand elongation; IDA:UniProtKB
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0006272; P:leading strand elongation; IDA:UniProtKB
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0000084; P:mitotic S phase; IDA:UniProtKB
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IBA:GOC
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; TAS:Reactome
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0000723; P:telomere maintenance; TAS:Reactome
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0019985; P:translesion synthesis; IBA:RefGenome
P09884	POLA1	DNA polymerase alpha catalytic subunit	GO:0016032; P:viral process; IEA:UniProtKB-KW
P06746	POLB	DNA polymerase beta	GO:0003684; F:damaged DNA binding; IEA:Ensembl
P06746	POLB	DNA polymerase beta	GO:0003887; F:DNA-directed DNA polymerase activity; IDA:UniProtKB
P06746	POLB	DNA polymerase beta	GO:0019899; F:enzyme binding; IPI:UniProtKB
P06746	POLB	DNA polymerase beta	GO:0016829; F:lyase activity; IDA:UniProtKB
P06746	POLB	DNA polymerase beta	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P06746	POLB	DNA polymerase beta	GO:0008017; F:microtubule binding; IDA:MGI
P06746	POLB	DNA polymerase beta	GO:0005515; F:protein binding; IPI:UniProtKB
P06746	POLB	DNA polymerase beta	GO:0006284; P:base-excision repair; IDA:UniProtKB
P06746	POLB	DNA polymerase beta	GO:0006287; P:base-excision repair, gap-filling; IEA:Ensembl
P06746	POLB	DNA polymerase beta	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
P06746	POLB	DNA polymerase beta	GO:0071897; P:DNA biosynthetic process; IEA:Ensembl
P06746	POLB	DNA polymerase beta	GO:0006281; P:DNA repair; TAS:Reactome
P06746	POLB	DNA polymerase beta	GO:0006261; P:DNA-dependent DNA replication; TAS:ProtInc
P06746	POLB	DNA polymerase beta	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
P06746	POLB	DNA polymerase beta	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
P06746	POLB	DNA polymerase beta	GO:0006290; P:pyrimidine dimer repair; IEA:Ensembl
P06746	POLB	DNA polymerase beta	GO:0045471; P:response to ethanol; IEA:Ensembl
Q9UGP5	POLL	DNA polymerase lambda	GO:0003677; F:DNA binding; NAS:UniProtKB
Q9UGP5	POLL	DNA polymerase lambda	GO:0003887; F:DNA-directed DNA polymerase activity; NAS:UniProtKB
Q9UGP5	POLL	DNA polymerase lambda	GO:0016829; F:lyase activity; IEA:UniProtKB-KW
Q9UGP5	POLL	DNA polymerase lambda	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UGP5	POLL	DNA polymerase lambda	GO:0006260; P:DNA replication; NAS:UniProtKB
Q9UGP5	POLL	DNA polymerase lambda	GO:0006261; P:DNA-dependent DNA replication; NAS:GOC
Q9UGP5	POLL	DNA polymerase lambda	GO:0006289; P:nucleotide-excision repair; IDA:UniProtKB
Q9UGP5	POLL	DNA polymerase lambda	GO:0016446; P:somatic hypermutation of immunoglobulin genes; NAS:UniProtKB
Q9NP87	POLM	DNA-directed DNA/RNA polymerase mu	GO:0003677; F:DNA binding; IEA:InterPro
Q9NP87	POLM	DNA-directed DNA/RNA polymerase mu	GO:0003887; F:DNA-directed DNA polymerase activity; IEA:UniProtKB-KW
Q9NP87	POLM	DNA-directed DNA/RNA polymerase mu	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NP87	POLM	DNA-directed DNA/RNA polymerase mu	GO:0030183; P:B cell differentiation; IEA:Ensembl
Q9NP87	POLM	DNA-directed DNA/RNA polymerase mu	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q9NP87	POLM	DNA-directed DNA/RNA polymerase mu	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q9NP87	POLM	DNA-directed DNA/RNA polymerase mu	GO:0016446; P:somatic hypermutation of immunoglobulin genes; IEA:Ensembl
Q7Z5Q5	POLN	DNA polymerase nu	GO:0030332; F:cyclin binding; IPI:UniProt
Q7Z5Q5	POLN	DNA polymerase nu	GO:0003677; F:DNA binding; IEA:InterPro
Q7Z5Q5	POLN	DNA polymerase nu	GO:0003887; F:DNA-directed DNA polymerase activity; IEA:InterPro
Q7Z5Q5	POLN	DNA polymerase nu	GO:0005515; F:protein binding; IPI:UniProt
Q7Z5Q5	POLN	DNA polymerase nu	GO:0006261; P:DNA-dependent DNA replication; IDA:GOC
Q7Z5Q5	POLN	DNA polymerase nu	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProt
Q7Z5Q5	POLN	DNA polymerase nu	GO:0036297; P:interstrand cross-link repair; IMP:UniProt
Q7Z5Q5	POLN	DNA polymerase nu	GO:0019985; P:translesion synthesis; IDA:UniProt
O75417	POLQ	DNA polymerase theta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75417	POLQ	DNA polymerase theta	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
O75417	POLQ	DNA polymerase theta	GO:0003684; F:damaged DNA binding; TAS:ProtInc
O75417	POLQ	DNA polymerase theta	GO:0003887; F:DNA-directed DNA polymerase activity; IDA:UniProtKB
O75417	POLQ	DNA polymerase theta	GO:0043142; F:single-stranded DNA-dependent ATPase activity; IDA:UniProtKB
O75417	POLQ	DNA polymerase theta	GO:0006200; P:ATP catabolic process; IDA:GOC
O75417	POLQ	DNA polymerase theta	GO:0006281; P:DNA repair; TAS:ProtInc
O75417	POLQ	DNA polymerase theta	GO:0006261; P:DNA-dependent DNA replication; IDA:GOC
O60673	REV3L	DNA polymerase zeta catalytic subunit	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
O60673	REV3L	DNA polymerase zeta catalytic subunit	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O60673	REV3L	DNA polymerase zeta catalytic subunit	GO:0003887; F:DNA-directed DNA polymerase activity; IBA:RefGenome
O60673	REV3L	DNA polymerase zeta catalytic subunit	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60673	REV3L	DNA polymerase zeta catalytic subunit	GO:0000166; F:nucleotide binding; IEA:InterPro
O60673	REV3L	DNA polymerase zeta catalytic subunit	GO:0005515; F:protein binding; IPI:IntAct
O60673	REV3L	DNA polymerase zeta catalytic subunit	GO:0006261; P:DNA-dependent DNA replication; TAS:ProtInc
O60673	REV3L	DNA polymerase zeta catalytic subunit	GO:0019985; P:translesion synthesis; IBA:RefGenome
Q8N608	DPP10	Inactive dipeptidyl peptidase 10	GO:0008236; F:serine-type peptidase activity; IEA:InterPro
Q9UHL4	DPP7	Dipeptidyl peptidase 2	GO:0004177; F:aminopeptidase activity; IEA:UniProtKB-KW
Q9UHL4	DPP7	Dipeptidyl peptidase 2	GO:0008239; F:dipeptidyl-peptidase activity; IEA:Ensembl
Q9UHL4	DPP7	Dipeptidyl peptidase 2	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
Q9NY33	DPP3	Dipeptidyl peptidase 3	GO:0004177; F:aminopeptidase activity; IEA:UniProtKB-KW
Q9NY33	DPP3	Dipeptidyl peptidase 3	GO:0008239; F:dipeptidyl-peptidase activity; IDA:UniProtKB
Q9NY33	DPP3	Dipeptidyl peptidase 3	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
Q9NY33	DPP3	Dipeptidyl peptidase 3	GO:0005515; F:protein binding; IPI:IntAct
Q9NY33	DPP3	Dipeptidyl peptidase 3	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q9NY33	DPP3	Dipeptidyl peptidase 3	GO:0006508; P:proteolysis; IDA:UniProtKB
P27487	DPP4	Dipeptidyl peptidase 4	GO:0004177; F:aminopeptidase activity; IEA:UniProtKB-KW
P27487	DPP4	Dipeptidyl peptidase 4	GO:0008239; F:dipeptidyl-peptidase activity; IDA:UniProtKB
P27487	DPP4	Dipeptidyl peptidase 4	GO:0042802; F:identical protein binding; IPI:IntAct
P27487	DPP4	Dipeptidyl peptidase 4	GO:0002020; F:protease binding; IPI:UniProtKB
P27487	DPP4	Dipeptidyl peptidase 4	GO:0005515; F:protein binding; IPI:UniProtKB
P27487	DPP4	Dipeptidyl peptidase 4	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P27487	DPP4	Dipeptidyl peptidase 4	GO:0005102; F:receptor binding; IPI:UniProtKB
P27487	DPP4	Dipeptidyl peptidase 4	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
P27487	DPP4	Dipeptidyl peptidase 4	GO:0008236; F:serine-type peptidase activity; IDA:UniProtKB
P27487	DPP4	Dipeptidyl peptidase 4	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P27487	DPP4	Dipeptidyl peptidase 4	GO:0043542; P:endothelial cell migration; IDA:UniProtKB
P27487	DPP4	Dipeptidyl peptidase 4	GO:0010716; P:negative regulation of extracellular matrix disassembly; IDA:UniProtKB
P27487	DPP4	Dipeptidyl peptidase 4	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P27487	DPP4	Dipeptidyl peptidase 4	GO:0033632; P:regulation of cell-cell adhesion mediated by integrin; IDA:UniProtKB
P27487	DPP4	Dipeptidyl peptidase 4	GO:0001666; P:response to hypoxia; IDA:UniProtKB
P27487	DPP4	Dipeptidyl peptidase 4	GO:0042110; P:T cell activation; IDA:UniProtKB
P27487	DPP4	Dipeptidyl peptidase 4	GO:0031295; P:T cell costimulation; IDA:UniProtKB
P42658	DPP6	Dipeptidyl aminopeptidase-like protein 6	GO:0008239; F:dipeptidyl-peptidase activity; TAS:ProtInc
P42658	DPP6	Dipeptidyl aminopeptidase-like protein 6	GO:0008236; F:serine-type peptidase activity; IEA:InterPro
P42658	DPP6	Dipeptidyl aminopeptidase-like protein 6	GO:0008219; P:cell death; IEA:UniProtKB-KW
P42658	DPP6	Dipeptidyl aminopeptidase-like protein 6	GO:0019228; P:neuronal action potential; IEA:Ensembl
P42658	DPP6	Dipeptidyl aminopeptidase-like protein 6	GO:0043266; P:regulation of potassium ion transport; IEA:Ensembl
Q6V1X1	DPP8	Dipeptidyl peptidase 8	GO:0004177; F:aminopeptidase activity; IEA:UniProtKB-KW
Q6V1X1	DPP8	Dipeptidyl peptidase 8	GO:0008239; F:dipeptidyl-peptidase activity; NAS:UniProtKB
Q6V1X1	DPP8	Dipeptidyl peptidase 8	GO:0008236; F:serine-type peptidase activity; IEA:UniProtKB-KW
Q6V1X1	DPP8	Dipeptidyl peptidase 8	GO:0006955; P:immune response; TAS:UniProtKB
Q6V1X1	DPP8	Dipeptidyl peptidase 8	GO:0006508; P:proteolysis; NAS:UniProtKB
Q86TI2	DPP9	Dipeptidyl peptidase 9	GO:0004177; F:aminopeptidase activity; IEA:UniProtKB-KW
Q86TI2	DPP9	Dipeptidyl peptidase 9	GO:0042802; F:identical protein binding; IPI:IntAct
Q86TI2	DPP9	Dipeptidyl peptidase 9	GO:0008236; F:serine-type peptidase activity; IEA:UniProtKB-KW
Q7Z7J5	DPPA2	Developmental pluripotency-associated protein 2	GO:0003682; F:chromatin binding; IEA:Ensembl
Q7Z7J5	DPPA2	Developmental pluripotency-associated protein 2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q7Z7J5	DPPA2	Developmental pluripotency-associated protein 2	GO:0060484; P:lung-associated mesenchyme development; IEA:Ensembl
Q7Z7J5	DPPA2	Developmental pluripotency-associated protein 2	GO:2000648; P:positive regulation of stem cell proliferation; IEA:Ensembl
Q7Z7J5	DPPA2	Developmental pluripotency-associated protein 2	GO:0031060; P:regulation of histone methylation; IEA:Ensembl
Q7Z7J5	DPPA2	Developmental pluripotency-associated protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z7J5	DPPA2	Developmental pluripotency-associated protein 2	GO:0019827; P:stem cell maintenance; IEA:Ensembl
Q7Z7J5	DPPA2	Developmental pluripotency-associated protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6W0C5	DPPA3	Developmental pluripotency-associated protein 3	GO:0035064; F:methylated histone binding; ISS:UniProtKB
Q6W0C5	DPPA3	Developmental pluripotency-associated protein 3	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q6W0C5	DPPA3	Developmental pluripotency-associated protein 3	GO:0040016; P:embryonic cleavage; IEA:Ensembl
Q6W0C5	DPPA3	Developmental pluripotency-associated protein 3	GO:1901536; P:negative regulation of DNA demethylation; ISS:UniProtKB
Q6W0C5	DPPA3	Developmental pluripotency-associated protein 3	GO:0044726; P:protection of DNA demethylation of female pronucleus; ISS:UniProtKB
Q6W0C5	DPPA3	Developmental pluripotency-associated protein 3	GO:2000653; P:regulation of genetic imprinting; ISS:UniProtKB
Q7L190	DPPA4	Developmental pluripotency-associated protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q7L190	DPPA4	Developmental pluripotency-associated protein 4	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q7L190	DPPA4	Developmental pluripotency-associated protein 4	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7L190	DPPA4	Developmental pluripotency-associated protein 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A6NC42	DPPA5	Developmental pluripotency-associated 5 protein	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
A6NC42	DPPA5	Developmental pluripotency-associated 5 protein	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
A6NFQ7	DPRX	Divergent paired-related homeobox	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
A6NFQ7	DPRX	Divergent paired-related homeobox	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
A6NFQ7	DPRX	Divergent paired-related homeobox	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5T2R2	PDSS1	Decaprenyl-diphosphate synthase subunit 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5T2R2	PDSS1	Decaprenyl-diphosphate synthase subunit 1	GO:0046982; F:protein heterodimerization activity; IDA:HGNC
Q5T2R2	PDSS1	Decaprenyl-diphosphate synthase subunit 1	GO:0000010; F:trans-hexaprenyltranstransferase activity; IEA:Ensembl
Q5T2R2	PDSS1	Decaprenyl-diphosphate synthase subunit 1	GO:0050347; F:trans-octaprenyltranstransferase activity; IEA:Ensembl
Q5T2R2	PDSS1	Decaprenyl-diphosphate synthase subunit 1	GO:0008299; P:isoprenoid biosynthetic process; IDA:HGNC
Q5T2R2	PDSS1	Decaprenyl-diphosphate synthase subunit 1	GO:0051290; P:protein heterotetramerization; IEA:Ensembl
Q5T2R2	PDSS1	Decaprenyl-diphosphate synthase subunit 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5T2R2	PDSS1	Decaprenyl-diphosphate synthase subunit 1	GO:0006744; P:ubiquinone biosynthetic process; IDA:HGNC
Q8TB45	DEPTOR	DEP domain-containing mTOR-interacting protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TB45	DEPTOR	DEP domain-containing mTOR-interacting protein	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8TB45	DEPTOR	DEP domain-containing mTOR-interacting protein	GO:0045792; P:negative regulation of cell size; IMP:UniProtKB
Q8TB45	DEPTOR	DEP domain-containing mTOR-interacting protein	GO:0006469; P:negative regulation of protein kinase activity; IMP:UniProtKB
Q8TB45	DEPTOR	DEP domain-containing mTOR-interacting protein	GO:0032007; P:negative regulation of TOR signaling; IMP:UniProtKB
Q8TB45	DEPTOR	DEP domain-containing mTOR-interacting protein	GO:2001236; P:regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB
Q9C005	DPY30	Protein dpy-30 homolog	GO:0042802; F:identical protein binding; IPI:IntAct
Q9C005	DPY30	Protein dpy-30 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q9C005	DPY30	Protein dpy-30 homolog	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q9C005	DPY30	Protein dpy-30 homolog	GO:0016197; P:endosomal transport; IMP:UniProtKB
Q9C005	DPY30	Protein dpy-30 homolog	GO:0051568; P:histone H3-K4 methylation; IDA:UniProtKB
Q9C005	DPY30	Protein dpy-30 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9C005	DPY30	Protein dpy-30 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q12882	DPYD	Dihydropyrimidine dehydrogenase [NADP(+)]	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
Q12882	DPYD	Dihydropyrimidine dehydrogenase [NADP(+)]	GO:0004158; F:dihydroorotate oxidase activity; IEA:InterPro
Q12882	DPYD	Dihydropyrimidine dehydrogenase [NADP(+)]	GO:0017113; F:dihydropyrimidine dehydrogenase (NADP+) activity; IDA:UniProtKB
Q12882	DPYD	Dihydropyrimidine dehydrogenase [NADP(+)]	GO:0050660; F:flavin adenine dinucleotide binding; ISS:UniProtKB
Q12882	DPYD	Dihydropyrimidine dehydrogenase [NADP(+)]	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q12882	DPYD	Dihydropyrimidine dehydrogenase [NADP(+)]	GO:0050661; F:NADP binding; ISS:UniProtKB
Q12882	DPYD	Dihydropyrimidine dehydrogenase [NADP(+)]	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q12882	DPYD	Dihydropyrimidine dehydrogenase [NADP(+)]	GO:0019483; P:beta-alanine biosynthetic process; IEA:UniProtKB-UniPathway
Q12882	DPYD	Dihydropyrimidine dehydrogenase [NADP(+)]	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q12882	DPYD	Dihydropyrimidine dehydrogenase [NADP(+)]	GO:0006145; P:purine nucleobase catabolic process; IMP:UniProtKB
Q12882	DPYD	Dihydropyrimidine dehydrogenase [NADP(+)]	GO:0006208; P:pyrimidine nucleobase catabolic process; IMP:UniProtKB
Q12882	DPYD	Dihydropyrimidine dehydrogenase [NADP(+)]	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
Q12882	DPYD	Dihydropyrimidine dehydrogenase [NADP(+)]	GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome
Q12882	DPYD	Dihydropyrimidine dehydrogenase [NADP(+)]	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q12882	DPYD	Dihydropyrimidine dehydrogenase [NADP(+)]	GO:0006214; P:thymidine catabolic process; IDA:UniProtKB
Q12882	DPYD	Dihydropyrimidine dehydrogenase [NADP(+)]	GO:0006210; P:thymine catabolic process; IDA:UniProtKB
Q12882	DPYD	Dihydropyrimidine dehydrogenase [NADP(+)]	GO:0006222; P:UMP biosynthetic process; IEA:InterPro
Q12882	DPYD	Dihydropyrimidine dehydrogenase [NADP(+)]	GO:0006212; P:uracil catabolic process; IDA:UniProtKB
Q14194	CRMP1	Dihydropyrimidinase-related protein 1	GO:0016812; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides; IEA:InterPro
Q14194	CRMP1	Dihydropyrimidinase-related protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q14194	CRMP1	Dihydropyrimidinase-related protein 1	GO:0007411; P:axon guidance; TAS:Reactome
Q14194	CRMP1	Dihydropyrimidinase-related protein 1	GO:0007399; P:nervous system development; TAS:ProtInc
Q14194	CRMP1	Dihydropyrimidinase-related protein 1	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
Q14194	CRMP1	Dihydropyrimidinase-related protein 1	GO:0006208; P:pyrimidine nucleobase catabolic process; IEA:InterPro
Q16555	DPYSL2	Dihydropyrimidinase-related protein 2	GO:0004157; F:dihydropyrimidinase activity; TAS:ProtInc
Q16555	DPYSL2	Dihydropyrimidinase-related protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q16555	DPYSL2	Dihydropyrimidinase-related protein 2	GO:0007411; P:axon guidance; TAS:Reactome
Q16555	DPYSL2	Dihydropyrimidinase-related protein 2	GO:0007010; P:cytoskeleton organization; ISS:UniProtKB
Q16555	DPYSL2	Dihydropyrimidinase-related protein 2	GO:0006897; P:endocytosis; IMP:UniProtKB
Q16555	DPYSL2	Dihydropyrimidinase-related protein 2	GO:0007399; P:nervous system development; TAS:ProtInc
Q16555	DPYSL2	Dihydropyrimidinase-related protein 2	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
Q16555	DPYSL2	Dihydropyrimidinase-related protein 2	GO:0021772; P:olfactory bulb development; IEA:Ensembl
Q16555	DPYSL2	Dihydropyrimidinase-related protein 2	GO:0014049; P:positive regulation of glutamate secretion; IEA:Ensembl
Q16555	DPYSL2	Dihydropyrimidinase-related protein 2	GO:0006208; P:pyrimidine nucleobase catabolic process; IEA:InterPro
Q16555	DPYSL2	Dihydropyrimidinase-related protein 2	GO:0045664; P:regulation of neuron differentiation; IEA:Ensembl
Q16555	DPYSL2	Dihydropyrimidinase-related protein 2	GO:0001975; P:response to amphetamine; IEA:Ensembl
Q16555	DPYSL2	Dihydropyrimidinase-related protein 2	GO:0042220; P:response to cocaine; IEA:Ensembl
Q16555	DPYSL2	Dihydropyrimidinase-related protein 2	GO:0042493; P:response to drug; IEA:Ensembl
Q16555	DPYSL2	Dihydropyrimidinase-related protein 2	GO:0007165; P:signal transduction; TAS:ProtInc
Q16555	DPYSL2	Dihydropyrimidinase-related protein 2	GO:0021510; P:spinal cord development; IEA:Ensembl
Q16555	DPYSL2	Dihydropyrimidinase-related protein 2	GO:0048489; P:synaptic vesicle transport; IEA:Ensembl
Q14195	DPYSL3	Dihydropyrimidinase-related protein 3	GO:0035374; F:chondroitin sulfate binding; ISS:UniProtKB
Q14195	DPYSL3	Dihydropyrimidinase-related protein 3	GO:0016812; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides; IEA:InterPro
Q14195	DPYSL3	Dihydropyrimidinase-related protein 3	GO:0017124; F:SH3 domain binding; ISS:UniProtKB
Q14195	DPYSL3	Dihydropyrimidinase-related protein 3	GO:0051764; P:actin crosslink formation; ISS:UniProtKB
Q14195	DPYSL3	Dihydropyrimidinase-related protein 3	GO:0051017; P:actin filament bundle assembly; ISS:UniProtKB
Q14195	DPYSL3	Dihydropyrimidinase-related protein 3	GO:0007411; P:axon guidance; TAS:Reactome
Q14195	DPYSL3	Dihydropyrimidinase-related protein 3	GO:0071345; P:cellular response to cytokine stimulus; ISS:UniProtKB
Q14195	DPYSL3	Dihydropyrimidinase-related protein 3	GO:0030336; P:negative regulation of cell migration; ISS:UniProtKB
Q14195	DPYSL3	Dihydropyrimidinase-related protein 3	GO:0010977; P:negative regulation of neuron projection development; ISS:UniProtKB
Q14195	DPYSL3	Dihydropyrimidinase-related protein 3	GO:0051491; P:positive regulation of filopodium assembly; ISS:UniProtKB
Q14195	DPYSL3	Dihydropyrimidinase-related protein 3	GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB
Q14195	DPYSL3	Dihydropyrimidinase-related protein 3	GO:0051260; P:protein homooligomerization; ISS:UniProtKB
Q14195	DPYSL3	Dihydropyrimidinase-related protein 3	GO:0006208; P:pyrimidine nucleobase catabolic process; IEA:InterPro
Q14195	DPYSL3	Dihydropyrimidinase-related protein 3	GO:0048678; P:response to axon injury; ISS:UniProtKB
O14531	DPYSL4	Dihydropyrimidinase-related protein 4	GO:0016812; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides; IEA:InterPro
O14531	DPYSL4	Dihydropyrimidinase-related protein 4	GO:0007411; P:axon guidance; TAS:Reactome
O14531	DPYSL4	Dihydropyrimidinase-related protein 4	GO:0007399; P:nervous system development; TAS:ProtInc
O14531	DPYSL4	Dihydropyrimidinase-related protein 4	GO:0006208; P:pyrimidine nucleobase catabolic process; IEA:InterPro
Q9BPU6	DPYSL5	Dihydropyrimidinase-related protein 5	GO:0016812; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides; IEA:InterPro
Q9BPU6	DPYSL5	Dihydropyrimidinase-related protein 5	GO:0007411; P:axon guidance; TAS:Reactome
Q9BPU6	DPYSL5	Dihydropyrimidinase-related protein 5	GO:0007399; P:nervous system development; TAS:ProtInc
Q9BPU6	DPYSL5	Dihydropyrimidinase-related protein 5	GO:0006208; P:pyrimidine nucleobase catabolic process; IEA:InterPro
Q9BPU6	DPYSL5	Dihydropyrimidinase-related protein 5	GO:0007165; P:signal transduction; TAS:ProtInc
Q14117	DPYS	Dihydropyrimidinase	GO:0016597; F:amino acid binding; IEA:Ensembl
Q14117	DPYS	Dihydropyrimidinase	GO:0004157; F:dihydropyrimidinase activity; IDA:UniProtKB
Q14117	DPYS	Dihydropyrimidinase	GO:0002059; F:thymine binding; IEA:Ensembl
Q14117	DPYS	Dihydropyrimidinase	GO:0002058; F:uracil binding; IEA:Ensembl
Q14117	DPYS	Dihydropyrimidinase	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q14117	DPYS	Dihydropyrimidinase	GO:0019482; P:beta-alanine metabolic process; IEA:Ensembl
Q14117	DPYS	Dihydropyrimidinase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q14117	DPYS	Dihydropyrimidinase	GO:0051289; P:protein homotetramerization; ISS:UniProtKB
Q14117	DPYS	Dihydropyrimidinase	GO:0006208; P:pyrimidine nucleobase catabolic process; IDA:UniProtKB
Q14117	DPYS	Dihydropyrimidinase	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
Q14117	DPYS	Dihydropyrimidinase	GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome
Q14117	DPYS	Dihydropyrimidinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14117	DPYS	Dihydropyrimidinase	GO:0006210; P:thymine catabolic process; ISS:UniProtKB
Q14117	DPYS	Dihydropyrimidinase	GO:0006212; P:uracil catabolic process; IDA:UniProtKB
P01909	HLA-DQA1	HLA class II histocompatibility antigen, DQ alpha 1 chain	GO:0032395; F:MHC class II receptor activity; NAS:UniProtKB
P01909	HLA-DQA1	HLA class II histocompatibility antigen, DQ alpha 1 chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P01909	HLA-DQA1	HLA class II histocompatibility antigen, DQ alpha 1 chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P01909	HLA-DQA1	HLA class II histocompatibility antigen, DQ alpha 1 chain	GO:0006955; P:immune response; NAS:UniProtKB
P01909	HLA-DQA1	HLA class II histocompatibility antigen, DQ alpha 1 chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P01909	HLA-DQA1	HLA class II histocompatibility antigen, DQ alpha 1 chain	GO:0031295; P:T cell costimulation; TAS:Reactome
P01909	HLA-DQA1	HLA class II histocompatibility antigen, DQ alpha 1 chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P01906	HLA-DQA2	HLA class II histocompatibility antigen, DQ alpha 2 chain	GO:0032395; F:MHC class II receptor activity; NAS:UniProtKB
P01906	HLA-DQA2	HLA class II histocompatibility antigen, DQ alpha 2 chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P01906	HLA-DQA2	HLA class II histocompatibility antigen, DQ alpha 2 chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P01906	HLA-DQA2	HLA class II histocompatibility antigen, DQ alpha 2 chain	GO:0006955; P:immune response; NAS:UniProtKB
P01906	HLA-DQA2	HLA class II histocompatibility antigen, DQ alpha 2 chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P01906	HLA-DQA2	HLA class II histocompatibility antigen, DQ alpha 2 chain	GO:0031295; P:T cell costimulation; TAS:Reactome
P01906	HLA-DQA2	HLA class II histocompatibility antigen, DQ alpha 2 chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P01920	HLA-DQB1	HLA class II histocompatibility antigen, DQ beta 1 chain	GO:0032395; F:MHC class II receptor activity; NAS:UniProtKB
P01920	HLA-DQB1	HLA class II histocompatibility antigen, DQ beta 1 chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P01920	HLA-DQB1	HLA class II histocompatibility antigen, DQ beta 1 chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P01920	HLA-DQB1	HLA class II histocompatibility antigen, DQ beta 1 chain	GO:0002455; P:humoral immune response mediated by circulating immunoglobulin; IDA:UniProtKB
P01920	HLA-DQB1	HLA class II histocompatibility antigen, DQ beta 1 chain	GO:0006955; P:immune response; NAS:UniProtKB
P01920	HLA-DQB1	HLA class II histocompatibility antigen, DQ beta 1 chain	GO:0002381; P:immunoglobulin production involved in immunoglobulin mediated immune response; IDA:UniProtKB
P01920	HLA-DQB1	HLA class II histocompatibility antigen, DQ beta 1 chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P01920	HLA-DQB1	HLA class II histocompatibility antigen, DQ beta 1 chain	GO:0031295; P:T cell costimulation; TAS:Reactome
P01920	HLA-DQB1	HLA class II histocompatibility antigen, DQ beta 1 chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q8TE96	DQX1	ATP-dependent RNA helicase DQX1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8TE96	DQX1	ATP-dependent RNA helicase DQX1	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q8TE96	DQX1	ATP-dependent RNA helicase DQX1	GO:0003676; F:nucleic acid binding; IEA:InterPro
P05538	HLA-DQB2	HLA class II histocompatibility antigen, DQ beta 2 chain	GO:0032395; F:MHC class II receptor activity; NAS:UniProtKB
P05538	HLA-DQB2	HLA class II histocompatibility antigen, DQ beta 2 chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P05538	HLA-DQB2	HLA class II histocompatibility antigen, DQ beta 2 chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P05538	HLA-DQB2	HLA class II histocompatibility antigen, DQ beta 2 chain	GO:0006955; P:immune response; NAS:UniProtKB
P05538	HLA-DQB2	HLA class II histocompatibility antigen, DQ beta 2 chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P05538	HLA-DQB2	HLA class II histocompatibility antigen, DQ beta 2 chain	GO:0031295; P:T cell costimulation; TAS:Reactome
P05538	HLA-DQB2	HLA class II histocompatibility antigen, DQ beta 2 chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q6PKH6	DHRS4L2	Dehydrogenase/reductase SDR family member 4-like 2	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
P0CG22	DHRS4L1	Putative dehydrogenase/reductase SDR family member 4-like 2	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q8NEX9	SDR9C7	Short-chain dehydrogenase/reductase family 9C member 7	GO:0004745; F:retinol dehydrogenase activity; IDA:UniProtKB
Q8NEX9	SDR9C7	Short-chain dehydrogenase/reductase family 9C member 7	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q8N682	DRAM1	DNA damage-regulated autophagy modulator protein 1	GO:0030262; P:apoptotic nuclear changes; IDA:UniProtKB
Q8N682	DRAM1	DNA damage-regulated autophagy modulator protein 1	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q8N682	DRAM1	DNA damage-regulated autophagy modulator protein 1	GO:0097194; P:execution phase of apoptosis; IC:UniProtKB
Q6UX65	DRAM2	DNA damage-regulated autophagy modulator protein 2	GO:0030262; P:apoptotic nuclear changes; IDA:UniProtKB
Q6UX65	DRAM2	DNA damage-regulated autophagy modulator protein 2	GO:0097194; P:execution phase of apoptosis; IC:UniProtKB
Q8NBI3	DRAXIN	Draxin	GO:0007411; P:axon guidance; ISS:UniProtKB
Q8NBI3	DRAXIN	Draxin	GO:0021528; P:commissural neuron differentiation in spinal cord; ISS:UniProtKB
Q8NBI3	DRAXIN	Draxin	GO:0021516; P:dorsal spinal cord development; ISS:UniProtKB
Q8NBI3	DRAXIN	Draxin	GO:0030900; P:forebrain development; ISS:UniProtKB
Q8NBI3	DRAXIN	Draxin	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISS:UniProtKB
Q8NBI3	DRAXIN	Draxin	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P01903	HLA-DRA	HLA class II histocompatibility antigen, DR alpha chain	GO:0023026; F:MHC class II protein complex binding; IDA:UniProt
P01903	HLA-DRA	HLA class II histocompatibility antigen, DR alpha chain	GO:0032395; F:MHC class II receptor activity; NAS:UniProtKB
P01903	HLA-DRA	HLA class II histocompatibility antigen, DR alpha chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P01903	HLA-DRA	HLA class II histocompatibility antigen, DR alpha chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P01903	HLA-DRA	HLA class II histocompatibility antigen, DR alpha chain	GO:0006955; P:immune response; NAS:UniProtKB
P01903	HLA-DRA	HLA class II histocompatibility antigen, DR alpha chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P01903	HLA-DRA	HLA class II histocompatibility antigen, DR alpha chain	GO:0031295; P:T cell costimulation; TAS:Reactome
P01903	HLA-DRA	HLA class II histocompatibility antigen, DR alpha chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P79483	HLA-DRB3	HLA class II histocompatibility antigen, DR beta 3 chain	GO:0032395; F:MHC class II receptor activity; NAS:UniProtKB
P79483	HLA-DRB3	HLA class II histocompatibility antigen, DR beta 3 chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P79483	HLA-DRB3	HLA class II histocompatibility antigen, DR beta 3 chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P79483	HLA-DRB3	HLA class II histocompatibility antigen, DR beta 3 chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P79483	HLA-DRB3	HLA class II histocompatibility antigen, DR beta 3 chain	GO:0007165; P:signal transduction; NAS:ProtInc
P79483	HLA-DRB3	HLA class II histocompatibility antigen, DR beta 3 chain	GO:0031295; P:T cell costimulation; TAS:Reactome
P79483	HLA-DRB3	HLA class II histocompatibility antigen, DR beta 3 chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q30154	HLA-DRB5	HLA class II histocompatibility antigen, DR beta 5 chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q30154	HLA-DRB5	HLA class II histocompatibility antigen, DR beta 5 chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q30154	HLA-DRB5	HLA class II histocompatibility antigen, DR beta 5 chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q30154	HLA-DRB5	HLA class II histocompatibility antigen, DR beta 5 chain	GO:0031295; P:T cell costimulation; TAS:Reactome
Q30154	HLA-DRB5	HLA class II histocompatibility antigen, DR beta 5 chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P13762	HLA-DRB4	HLA class II histocompatibility antigen, DR beta 4 chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P13762	HLA-DRB4	HLA class II histocompatibility antigen, DR beta 4 chain	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P13762	HLA-DRB4	HLA class II histocompatibility antigen, DR beta 4 chain	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P13762	HLA-DRB4	HLA class II histocompatibility antigen, DR beta 4 chain	GO:0031295; P:T cell costimulation; TAS:Reactome
P13762	HLA-DRB4	HLA class II histocompatibility antigen, DR beta 4 chain	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q96MC2	DRC1	Dynein regulatory complex protein 1	GO:0070286; P:axonemal dynein complex assembly; IMP:UniProtKB
Q96MC2	DRC1	Dynein regulatory complex protein 1	GO:0071973; P:bacterial-type flagellum-dependent cell motility; IMP:UniProtKB
Q96MC2	DRC1	Dynein regulatory complex protein 1	GO:0060285; P:cilium-dependent cell motility; IMP:UniProtKB
P21728	DRD1	D(1A) dopamine receptor	GO:0035240; F:dopamine binding; IMP:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0004952; F:dopamine neurotransmitter receptor activity; IDA:MGI
P21728	DRD1	D(1A) dopamine receptor	GO:0001588; F:dopamine neurotransmitter receptor activity, coupled via Gs; IDA:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0005515; F:protein binding; IPI:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0007190; P:activation of adenylate cyclase activity; IDA:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0007191; P:adenylate cyclase-activating dopamine receptor signaling pathway; IDA:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IDA:UniProtKB
P21728	DRD1	D(1A) dopamine receptor	GO:0007628; P:adult walking behavior; ISS:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0014002; P:astrocyte development; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0001662; P:behavioral fear response; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0048148; P:behavioral response to cocaine; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0071870; P:cellular response to catecholamine stimulus; IDA:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0021853; P:cerebral cortex GABAergic interneuron migration; ISS:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0001661; P:conditioned taste aversion; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0021542; P:dentate gyrus development; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0042417; P:dopamine metabolic process; IC:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0015872; P:dopamine transport; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; IDA:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0046323; P:glucose import; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0007625; P:grooming behavior; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0046959; P:habituation; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0060292; P:long term synaptic depression; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0042711; P:maternal behavior; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0007617; P:mating behavior; ISS:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0007613; P:memory; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0019228; P:neuronal action potential; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0035106; P:operant conditioning; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0030432; P:peristalsis; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0060158; P:phospholipase C-activating dopamine receptor signaling pathway; IDA:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0010579; P:positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway; IEA:InterPro
P21728	DRD1	D(1A) dopamine receptor	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0030335; P:positive regulation of cell migration; ISS:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0051482; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway; IDA:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0043268; P:positive regulation of potassium ion transport; ISS:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IDA:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; ISS:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0060134; P:prepulse inhibition; ISS:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0006606; P:protein import into nucleus; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0042053; P:regulation of dopamine metabolic process; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0051584; P:regulation of dopamine uptake involved in synaptic transmission; IC:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0001975; P:response to amphetamine; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0042493; P:response to drug; ISS:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0046960; P:sensitization; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0021756; P:striatum development; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0007416; P:synapse assembly; ISS:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0001963; P:synaptic transmission, dopaminergic; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0001659; P:temperature homeostasis; IEA:Ensembl
P21728	DRD1	D(1A) dopamine receptor	GO:0019226; P:transmission of nerve impulse; ISS:BHF-UCL
P21728	DRD1	D(1A) dopamine receptor	GO:0042311; P:vasodilation; IEA:InterPro
P21728	DRD1	D(1A) dopamine receptor	GO:0008542; P:visual learning; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0004935; F:adrenergic receptor activity; IEA:InterPro
P14416	DRD2	D(2) dopamine receptor	GO:0035240; F:dopamine binding; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0001591; F:dopamine neurotransmitter receptor activity, coupled via Gi/Go; IDA:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0008144; F:drug binding; IDA:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0042802; F:identical protein binding; IPI:IntAct
P14416	DRD2	D(2) dopamine receptor	GO:0015459; F:potassium channel regulator activity; NAS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0005515; F:protein binding; IPI:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0032147; P:activation of protein kinase activity; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0021984; P:adenohypophysis development; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0007195; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; IDA:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0007628; P:adult walking behavior; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0050482; P:arachidonic acid secretion; IDA:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0008306; P:associative learning; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0031223; P:auditory behavior; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0007409; P:axonogenesis; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0048148; P:behavioral response to cocaine; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0048149; P:behavioral response to ethanol; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0048755; P:branching morphogenesis of a nerve; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0006874; P:cellular calcium ion homeostasis; IC:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0021853; P:cerebral cortex GABAergic interneuron migration; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0032922; P:circadian regulation of gene expression; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0042417; P:dopamine metabolic process; IC:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0007631; P:feeding behavior; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0002031; P:G-protein coupled receptor internalization; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0007625; P:grooming behavior; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0035556; P:intracellular signal transduction; IDA:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0007626; P:locomotory behavior; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0007616; P:long-term memory; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0007194; P:negative regulation of adenylate cyclase activity; IDA:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0045776; P:negative regulation of blood pressure; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0030336; P:negative regulation of cell migration; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0008285; P:negative regulation of cell proliferation; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0042321; P:negative regulation of circadian sleep/wake cycle, sleep; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0051481; P:negative regulation of cytosolic calcium ion concentration; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0060160; P:negative regulation of dopamine receptor signaling pathway; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0033602; P:negative regulation of dopamine secretion; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0046676; P:negative regulation of insulin secretion; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0051898; P:negative regulation of protein kinase B signaling; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0050709; P:negative regulation of protein secretion; IDA:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0051967; P:negative regulation of synaptic transmission, glutamatergic; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:1901386; P:negative regulation of voltage-gated calcium channel activity; IDA:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0001976; P:neurological system process involved in regulation of systemic arterial blood pressure; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0007270; P:neuron-neuron synaptic transmission; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0021769; P:orbitofrontal cortex development; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0030432; P:peristalsis; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0046488; P:phosphatidylinositol metabolic process; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0060158; P:phospholipase C-activating dopamine receptor signaling pathway; IGI:MGI
P14416	DRD2	D(2) dopamine receptor	GO:0043473; P:pigmentation; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProt
P14416	DRD2	D(2) dopamine receptor	GO:0051482; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway; IDA:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0051586; P:positive regulation of dopamine uptake involved in synaptic transmission; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0045745; P:positive regulation of G-protein coupled receptor protein signaling pathway; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0060124; P:positive regulation of growth hormone secretion; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:1900273; P:positive regulation of long-term synaptic potentiation; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0002052; P:positive regulation of neuroblast proliferation; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0002092; P:positive regulation of receptor internalization; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0035815; P:positive regulation of renal sodium excretion; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0035810; P:positive regulation of urine volume; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0060134; P:prepulse inhibition; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0008104; P:protein localization; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0030814; P:regulation of cAMP metabolic process; IDA:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0051584; P:regulation of dopamine uptake involved in synaptic transmission; IC:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0002027; P:regulation of heart rate; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0090325; P:regulation of locomotion involved in locomotory behavior; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0048169; P:regulation of long-term neuronal synaptic plasticity; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0043666; P:regulation of phosphoprotein phosphatase activity; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0043266; P:regulation of potassium ion transport; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0002028; P:regulation of sodium ion transport; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0051823; P:regulation of synapse structural plasticity; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0032228; P:regulation of synaptic transmission, GABAergic; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0051209; P:release of sequestered calcium ion into cytosol; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0001975; P:response to amphetamine; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0048678; P:response to axon injury; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0042220; P:response to cocaine; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0042493; P:response to drug; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0034776; P:response to histamine; IDA:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0001666; P:response to hypoxia; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0014854; P:response to inactivity; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0010039; P:response to iron ion; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0009416; P:response to light stimulus; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0043278; P:response to morphine; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0035094; P:response to nicotine; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0009636; P:response to toxic substance; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0007608; P:sensory perception of smell; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0021756; P:striatum development; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0007416; P:synapse assembly; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0001963; P:synaptic transmission, dopaminergic; IEA:Ensembl
P14416	DRD2	D(2) dopamine receptor	GO:0001659; P:temperature homeostasis; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0008542; P:visual learning; ISS:BHF-UCL
P14416	DRD2	D(2) dopamine receptor	GO:0016055; P:Wnt signaling pathway; IEA:Ensembl
P35462	DRD3	D(3) dopamine receptor	GO:0035240; F:dopamine binding; IEA:Ensembl
P35462	DRD3	D(3) dopamine receptor	GO:0001591; F:dopamine neurotransmitter receptor activity, coupled via Gi/Go; IDA:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0008144; F:drug binding; IDA:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P35462	DRD3	D(3) dopamine receptor	GO:0046717; P:acid secretion; ISS:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0007191; P:adenylate cyclase-activating dopamine receptor signaling pathway; IDA:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0007195; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; IDA:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0050482; P:arachidonic acid secretion; IDA:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0048148; P:behavioral response to cocaine; IEP:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0006874; P:cellular calcium ion homeostasis; IDA:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0032922; P:circadian regulation of gene expression; ISS:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0042417; P:dopamine metabolic process; IC:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0002031; P:G-protein coupled receptor internalization; IDA:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0035483; P:gastric emptying; IEA:Ensembl
P35462	DRD3	D(3) dopamine receptor	GO:0007612; P:learning; NAS:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0007611; P:learning or memory; NAS:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0007626; P:locomotory behavior; ISS:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0050883; P:musculoskeletal movement, spinal reflex action; ISS:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0007194; P:negative regulation of adenylate cyclase activity; IDA:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0045776; P:negative regulation of blood pressure; ISS:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0060160; P:negative regulation of dopamine receptor signaling pathway; IEA:Ensembl
P35462	DRD3	D(3) dopamine receptor	GO:0048715; P:negative regulation of oligodendrocyte differentiation; ISS:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0051898; P:negative regulation of protein kinase B signaling; ISS:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0050709; P:negative regulation of protein secretion; IDA:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0032416; P:negative regulation of sodium:proton antiporter activity; IEA:Ensembl
P35462	DRD3	D(3) dopamine receptor	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P35462	DRD3	D(3) dopamine receptor	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P35462	DRD3	D(3) dopamine receptor	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProt
P35462	DRD3	D(3) dopamine receptor	GO:0060161; P:positive regulation of dopamine receptor signaling pathway; ISS:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0045840; P:positive regulation of mitosis; ISS:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0035815; P:positive regulation of renal sodium excretion; IEA:Ensembl
P35462	DRD3	D(3) dopamine receptor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P35462	DRD3	D(3) dopamine receptor	GO:0060134; P:prepulse inhibition; IMP:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0002016; P:regulation of blood volume by renin-angiotensin; IEA:Ensembl
P35462	DRD3	D(3) dopamine receptor	GO:0030814; P:regulation of cAMP metabolic process; IDA:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0045187; P:regulation of circadian sleep/wake cycle, sleep; IEA:Ensembl
P35462	DRD3	D(3) dopamine receptor	GO:0014059; P:regulation of dopamine secretion; ISS:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0051584; P:regulation of dopamine uptake involved in synaptic transmission; IC:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0019216; P:regulation of lipid metabolic process; IEA:Ensembl
P35462	DRD3	D(3) dopamine receptor	GO:0090325; P:regulation of locomotion involved in locomotory behavior; IEA:Ensembl
P35462	DRD3	D(3) dopamine receptor	GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl
P35462	DRD3	D(3) dopamine receptor	GO:0001975; P:response to amphetamine; IEA:Ensembl
P35462	DRD3	D(3) dopamine receptor	GO:0042220; P:response to cocaine; IEP:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0042493; P:response to drug; ISS:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0034776; P:response to histamine; IDA:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0043278; P:response to morphine; ISS:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0035176; P:social behavior; NAS:BHF-UCL
P35462	DRD3	D(3) dopamine receptor	GO:0001963; P:synaptic transmission, dopaminergic; IEA:Ensembl
P35462	DRD3	D(3) dopamine receptor	GO:0008542; P:visual learning; ISS:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0035240; F:dopamine binding; IDA:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0004952; F:dopamine neurotransmitter receptor activity; IDA:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0001591; F:dopamine neurotransmitter receptor activity, coupled via Gi/Go; IDA:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0008144; F:drug binding; IDA:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0042802; F:identical protein binding; IPI:IntAct
P21917	DRD4	D(4) dopamine receptor	GO:0015459; F:potassium channel regulator activity; NAS:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0005515; F:protein binding; IPI:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0017124; F:SH3 domain binding; IDA:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0000187; P:activation of MAPK activity; IDA:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0007195; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; IDA:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0008344; P:adult locomotory behavior; ISS:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0050482; P:arachidonic acid secretion; IDA:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0001662; P:behavioral fear response; NAS:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0048148; P:behavioral response to cocaine; ISS:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0048149; P:behavioral response to ethanol; TAS:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0006874; P:cellular calcium ion homeostasis; IC:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0007623; P:circadian rhythm; IEA:Ensembl
P21917	DRD4	D(4) dopamine receptor	GO:0042417; P:dopamine metabolic process; IC:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0007212; P:dopamine receptor signaling pathway; IDA:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0042596; P:fear response; ISS:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0007194; P:negative regulation of adenylate cyclase activity; IDA:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0030818; P:negative regulation of cAMP biosynthetic process; IDA:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0050709; P:negative regulation of protein secretion; IDA:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:1901386; P:negative regulation of voltage-gated calcium channel activity; IDA:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0008355; P:olfactory learning; IEA:Ensembl
P21917	DRD4	D(4) dopamine receptor	GO:0009648; P:photoperiodism; IEA:Ensembl
P21917	DRD4	D(4) dopamine receptor	GO:0051586; P:positive regulation of dopamine uptake involved in synaptic transmission; IC:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:2000463; P:positive regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
P21917	DRD4	D(4) dopamine receptor	GO:0033674; P:positive regulation of kinase activity; IDA:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0060406; P:positive regulation of penile erection; IEA:Ensembl
P21917	DRD4	D(4) dopamine receptor	GO:0032417; P:positive regulation of sodium:proton antiporter activity; IDA:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0050848; P:regulation of calcium-mediated signaling; IEA:Ensembl
P21917	DRD4	D(4) dopamine receptor	GO:0042053; P:regulation of dopamine metabolic process; ISS:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0060080; P:regulation of inhibitory postsynaptic membrane potential; ISS:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0046928; P:regulation of neurotransmitter secretion; IEA:Ensembl
P21917	DRD4	D(4) dopamine receptor	GO:0001975; P:response to amphetamine; ISS:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0034776; P:response to histamine; IDA:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0048545; P:response to steroid hormone; IEA:Ensembl
P21917	DRD4	D(4) dopamine receptor	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
P21917	DRD4	D(4) dopamine receptor	GO:0007614; P:short-term memory; IEA:Ensembl
P21917	DRD4	D(4) dopamine receptor	GO:0035176; P:social behavior; NAS:BHF-UCL
P21917	DRD4	D(4) dopamine receptor	GO:0001963; P:synaptic transmission, dopaminergic; IEA:Ensembl
P21918	DRD5	D(1B) dopamine receptor	GO:0035240; F:dopamine binding; IDA:UniProtKB
P21918	DRD5	D(1B) dopamine receptor	GO:0004952; F:dopamine neurotransmitter receptor activity; IDA:UniProtKB
P21918	DRD5	D(1B) dopamine receptor	GO:0001588; F:dopamine neurotransmitter receptor activity, coupled via Gs; TAS:BHF-UCL
P21918	DRD5	D(1B) dopamine receptor	GO:0007190; P:activation of adenylate cyclase activity; TAS:BHF-UCL
P21918	DRD5	D(1B) dopamine receptor	GO:0007191; P:adenylate cyclase-activating dopamine receptor signaling pathway; IDA:UniProtKB
P21918	DRD5	D(1B) dopamine receptor	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IDA:UniProtKB
P21918	DRD5	D(1B) dopamine receptor	GO:0008306; P:associative learning; IEA:Ensembl
P21918	DRD5	D(1B) dopamine receptor	GO:0006874; P:cellular calcium ion homeostasis; TAS:BHF-UCL
P21918	DRD5	D(1B) dopamine receptor	GO:0071870; P:cellular response to catecholamine stimulus; IDA:BHF-UCL
P21918	DRD5	D(1B) dopamine receptor	GO:0060292; P:long term synaptic depression; IEA:Ensembl
P21918	DRD5	D(1B) dopamine receptor	GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl
P21918	DRD5	D(1B) dopamine receptor	GO:0033861; P:negative regulation of NAD(P)H oxidase activity; IDA:UniProtKB
P21918	DRD5	D(1B) dopamine receptor	GO:0001994; P:norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure; IEA:Ensembl
P21918	DRD5	D(1B) dopamine receptor	GO:0060158; P:phospholipase C-activating dopamine receptor signaling pathway; TAS:BHF-UCL
P21918	DRD5	D(1B) dopamine receptor	GO:0045762; P:positive regulation of adenylate cyclase activity; IDA:UniProtKB
P21918	DRD5	D(1B) dopamine receptor	GO:0010579; P:positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway; IEA:InterPro
P21918	DRD5	D(1B) dopamine receptor	GO:0072593; P:reactive oxygen species metabolic process; IDA:UniProtKB
P21918	DRD5	D(1B) dopamine receptor	GO:0045924; P:regulation of female receptivity; IEA:Ensembl
P21918	DRD5	D(1B) dopamine receptor	GO:0001992; P:regulation of systemic arterial blood pressure by vasopressin; IEA:Ensembl
P21918	DRD5	D(1B) dopamine receptor	GO:0001975; P:response to amphetamine; IEA:Ensembl
P21918	DRD5	D(1B) dopamine receptor	GO:0042220; P:response to cocaine; IEA:Ensembl
P21918	DRD5	D(1B) dopamine receptor	GO:0046960; P:sensitization; IEA:Ensembl
P21918	DRD5	D(1B) dopamine receptor	GO:0007268; P:synaptic transmission; NAS:UniProtKB
P21918	DRD5	D(1B) dopamine receptor	GO:0001963; P:synaptic transmission, dopaminergic; NAS:UniProtKB
P21918	DRD5	D(1B) dopamine receptor	GO:0019226; P:transmission of nerve impulse; IEA:Ensembl
P21918	DRD5	D(1B) dopamine receptor	GO:0042060; P:wound healing; IEA:Ensembl
Q16643	DBN1	Drebrin	GO:0003779; F:actin binding; NAS:UniProtKB
Q16643	DBN1	Drebrin	GO:0005522; F:profilin binding; ISS:UniProtKB
Q16643	DBN1	Drebrin	GO:0005515; F:protein binding; IPI:IntAct
Q16643	DBN1	Drebrin	GO:0007015; P:actin filament organization; ISS:UniProtKB
Q16643	DBN1	Drebrin	GO:0010643; P:cell communication by chemical coupling; IEA:Ensembl
Q16643	DBN1	Drebrin	GO:0010644; P:cell communication by electrical coupling; IEA:Ensembl
Q16643	DBN1	Drebrin	GO:0032507; P:maintenance of protein location in cell; IEA:Ensembl
Q16643	DBN1	Drebrin	GO:0061351; P:neural precursor cell proliferation; IEA:Ensembl
Q16643	DBN1	Drebrin	GO:0050773; P:regulation of dendrite development; NAS:UniProtKB
Q16643	DBN1	Drebrin	GO:0048168; P:regulation of neuronal synaptic plasticity; NAS:UniProtKB
Q9Y295	DRG1	Developmentally-regulated GTP-binding protein 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9Y295	DRG1	Developmentally-regulated GTP-binding protein 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q9Y295	DRG1	Developmentally-regulated GTP-binding protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y295	DRG1	Developmentally-regulated GTP-binding protein 1	GO:0008134; F:transcription factor binding; TAS:ProtInc
Q9Y295	DRG1	Developmentally-regulated GTP-binding protein 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q9Y295	DRG1	Developmentally-regulated GTP-binding protein 1	GO:0006351; P:transcription, DNA-templated; TAS:ProtInc
P55039	DRG2	Developmentally-regulated GTP-binding protein 2	GO:0005525; F:GTP binding; TAS:ProtInc
P55039	DRG2	Developmentally-regulated GTP-binding protein 2	GO:0007165; P:signal transduction; TAS:ProtInc
A6NNA5	DRGX	Dorsal root ganglia homeobox protein	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
A6NNA5	DRGX	Dorsal root ganglia homeobox protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
A6NNA5	DRGX	Dorsal root ganglia homeobox protein	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
A6NNA5	DRGX	Dorsal root ganglia homeobox protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13474	DRP2	Dystrophin-related protein 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q13474	DRP2	Dystrophin-related protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13474	DRP2	Dystrophin-related protein 2	GO:0007417; P:central nervous system development; TAS:ProtInc
A6NNS2	DHRS7C	Dehydrogenase/reductase SDR family member 7C	GO:0016491; F:oxidoreductase activity; IEA:InterPro
A6NNS2	DHRS7C	Dehydrogenase/reductase SDR family member 7C	GO:0004745; F:retinol dehydrogenase activity; IEA:Ensembl
A6NNS2	DHRS7C	Dehydrogenase/reductase SDR family member 7C	GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; IEA:Ensembl
Q6IAN0	DHRS7B	Dehydrogenase/reductase SDR family member 7B	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q6B8I1	DUSP13	Dual specificity protein phosphatase 13 isoform A	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q6B8I1	DUSP13	Dual specificity protein phosphatase 13 isoform A	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro
Q9UII6	DUSP13	Dual specificity protein phosphatase 13 isoform B	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q9UII6	DUSP13	Dual specificity protein phosphatase 13 isoform B	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q9UII6	DUSP13	Dual specificity protein phosphatase 13 isoform B	GO:0007126; P:meiotic nuclear division; TAS:ProtInc
Q9UII6	DUSP13	Dual specificity protein phosphatase 13 isoform B	GO:0006470; P:protein dephosphorylation; IBA:RefGenome
Q9UII6	DUSP13	Dual specificity protein phosphatase 13 isoform B	GO:0007283; P:spermatogenesis; TAS:ProtInc
DR   GO:0009607; P:response to biotic stimulus; IEA:InterPro
Q08554	DSC1	Desmocollin-1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q08554	DSC1	Desmocollin-1	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q02487	DSC2	Desmocollin-2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q02487	DSC2	Desmocollin-2	GO:0005515; F:protein binding; IPI:IntAct
Q02487	DSC2	Desmocollin-2	GO:0086069; P:bundle of His cell to Purkinje myocyte communication; IMP:BHF-UCL
Q02487	DSC2	Desmocollin-2	GO:0086042; P:cardiac muscle cell-cardiac muscle cell adhesion; IMP:UniProt
Q02487	DSC2	Desmocollin-2	GO:0007155; P:cell adhesion; TAS:ProtInc
Q02487	DSC2	Desmocollin-2	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q02487	DSC2	Desmocollin-2	GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL
Q02487	DSC2	Desmocollin-2	GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL
Q14574	DSC3	Desmocollin-3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q14574	DSC3	Desmocollin-3	GO:0045295; F:gamma-catenin binding; IPI:BHF-UCL
Q14574	DSC3	Desmocollin-3	GO:0007155; P:cell adhesion; TAS:ProtInc
Q14574	DSC3	Desmocollin-3	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q14574	DSC3	Desmocollin-3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q14574	DSC3	Desmocollin-3	GO:0050821; P:protein stabilization; IDA:BHF-UCL
O60469	DSCAM	Down syndrome cell adhesion molecule	GO:0005515; F:protein binding; IPI:UniProtKB
O60469	DSCAM	Down syndrome cell adhesion molecule	GO:0007155; P:cell adhesion; TAS:ProtInc
O60469	DSCAM	Down syndrome cell adhesion molecule	GO:0048813; P:dendrite morphogenesis; IEA:Ensembl
O60469	DSCAM	Down syndrome cell adhesion molecule	GO:0070593; P:dendrite self-avoidance; ISS:UniProtKB
O60469	DSCAM	Down syndrome cell adhesion molecule	GO:0007626; P:locomotory behavior; IEA:Ensembl
O60469	DSCAM	Down syndrome cell adhesion molecule	GO:0007162; P:negative regulation of cell adhesion; ISS:UniProtKB
O60469	DSCAM	Down syndrome cell adhesion molecule	GO:0007399; P:nervous system development; TAS:ProtInc
O60469	DSCAM	Down syndrome cell adhesion molecule	GO:0048842; P:positive regulation of axon extension involved in axon guidance; IDA:UniProtKB
O60469	DSCAM	Down syndrome cell adhesion molecule	GO:0042327; P:positive regulation of phosphorylation; IDA:UniProtKB
O60469	DSCAM	Down syndrome cell adhesion molecule	GO:0060060; P:post-embryonic retina morphogenesis in camera-type eye; IEA:Ensembl
Q8TD84	DSCAML1	Down syndrome cell adhesion molecule-like protein 1	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q8TD84	DSCAML1	Down syndrome cell adhesion molecule-like protein 1	GO:0007409; P:axonogenesis; NAS:UniProtKB
Q8TD84	DSCAML1	Down syndrome cell adhesion molecule-like protein 1	GO:0007420; P:brain development; IDA:UniProtKB
Q8TD84	DSCAML1	Down syndrome cell adhesion molecule-like protein 1	GO:0001709; P:cell fate determination; NAS:UniProtKB
Q8TD84	DSCAML1	Down syndrome cell adhesion molecule-like protein 1	GO:0007417; P:central nervous system development; NAS:UniProtKB
Q8TD84	DSCAML1	Down syndrome cell adhesion molecule-like protein 1	GO:0070593; P:dendrite self-avoidance; IEA:Ensembl
Q8TD84	DSCAML1	Down syndrome cell adhesion molecule-like protein 1	GO:0009953; P:dorsal/ventral pattern formation; NAS:UniProtKB
Q8TD84	DSCAML1	Down syndrome cell adhesion molecule-like protein 1	GO:0048704; P:embryonic skeletal system morphogenesis; IDA:UniProtKB
Q8TD84	DSCAML1	Down syndrome cell adhesion molecule-like protein 1	GO:0007156; P:homophilic cell adhesion; IDA:UniProtKB
Q8TD84	DSCAML1	Down syndrome cell adhesion molecule-like protein 1	GO:0007162; P:negative regulation of cell adhesion; IEA:Ensembl
P57055	RIPPLY3	Protein ripply3	GO:0007507; P:heart development; IEA:Ensembl
P57055	RIPPLY3	Protein ripply3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P57055	RIPPLY3	Protein ripply3	GO:0060037; P:pharyngeal system development; IEA:Ensembl
P57055	RIPPLY3	Protein ripply3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IZU8	DSEL	Dermatan-sulfate epimerase-like protein	GO:0016853; F:isomerase activity; IEA:UniProtKB-KW
Q8IZU8	DSEL	Dermatan-sulfate epimerase-like protein	GO:0008146; F:sulfotransferase activity; IEA:InterPro
Q8IZU8	DSEL	Dermatan-sulfate epimerase-like protein	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q8IZU8	DSEL	Dermatan-sulfate epimerase-like protein	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q8IZU8	DSEL	Dermatan-sulfate epimerase-like protein	GO:0030208; P:dermatan sulfate biosynthetic process; TAS:Reactome
Q8IZU8	DSEL	Dermatan-sulfate epimerase-like protein	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q8IZU8	DSEL	Dermatan-sulfate epimerase-like protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UL01	DSE	Dermatan-sulfate epimerase	GO:0047757; F:chondroitin-glucuronate 5-epimerase activity; IDA:HGNC
Q9UL01	DSE	Dermatan-sulfate epimerase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9UL01	DSE	Dermatan-sulfate epimerase	GO:0030206; P:chondroitin sulfate biosynthetic process; IEA:UniProtKB-UniPathway
Q9UL01	DSE	Dermatan-sulfate epimerase	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q9UL01	DSE	Dermatan-sulfate epimerase	GO:0030208; P:dermatan sulfate biosynthetic process; IDA:UniProtKB
Q9UL01	DSE	Dermatan-sulfate epimerase	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9UL01	DSE	Dermatan-sulfate epimerase	GO:0015012; P:heparan sulfate proteoglycan biosynthetic process; IEA:UniProtKB-UniPathway
Q9UL01	DSE	Dermatan-sulfate epimerase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q02413	DSG1	Desmoglein-1	GO:0005509; F:calcium ion binding; NAS:UniProtKB
Q02413	DSG1	Desmoglein-1	GO:0045295; F:gamma-catenin binding; IPI:BHF-UCL
Q02413	DSG1	Desmoglein-1	GO:0015643; F:toxic substance binding; NAS:UniProtKB
Q02413	DSG1	Desmoglein-1	GO:0006915; P:apoptotic process; TAS:Reactome
Q02413	DSG1	Desmoglein-1	GO:0016339; P:calcium-dependent cell-cell adhesion; NAS:UniProtKB
Q02413	DSG1	Desmoglein-1	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
Q02413	DSG1	Desmoglein-1	GO:0007043; P:cell-cell junction assembly; NAS:UniProtKB
Q02413	DSG1	Desmoglein-1	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q02413	DSG1	Desmoglein-1	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q02413	DSG1	Desmoglein-1	GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
Q02413	DSG1	Desmoglein-1	GO:0050821; P:protein stabilization; IDA:BHF-UCL
Q02413	DSG1	Desmoglein-1	GO:0032570; P:response to progesterone; IEA:Ensembl
Q14126	DSG2	Desmoglein-2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q14126	DSG2	Desmoglein-2	GO:0006915; P:apoptotic process; TAS:Reactome
Q14126	DSG2	Desmoglein-2	GO:0086069; P:bundle of His cell to Purkinje myocyte communication; IMP:BHF-UCL
Q14126	DSG2	Desmoglein-2	GO:0007155; P:cell adhesion; IDA:UniProtKB
Q14126	DSG2	Desmoglein-2	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q14126	DSG2	Desmoglein-2	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q14126	DSG2	Desmoglein-2	GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
Q14126	DSG2	Desmoglein-2	GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL
Q14126	DSG2	Desmoglein-2	GO:0032570; P:response to progesterone; IEA:Ensembl
Q14126	DSG2	Desmoglein-2	GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL
P32926	DSG3	Desmoglein-3	GO:0005509; F:calcium ion binding; IEA:InterPro
P32926	DSG3	Desmoglein-3	GO:0006915; P:apoptotic process; TAS:Reactome
P32926	DSG3	Desmoglein-3	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
P32926	DSG3	Desmoglein-3	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q86SJ6	DSG4	Desmoglein-4	GO:0005509; F:calcium ion binding; IEA:Ensembl
Q86SJ6	DSG4	Desmoglein-4	GO:0042640; P:anagen; IEA:Ensembl
Q86SJ6	DSG4	Desmoglein-4	GO:0030509; P:BMP signaling pathway; IEA:Ensembl
Q86SJ6	DSG4	Desmoglein-4	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q86SJ6	DSG4	Desmoglein-4	GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
Q9H410	DSN1	Kinetochore-associated protein DSN1 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H410	DSN1	Kinetochore-associated protein DSN1 homolog	GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW
Q9H410	DSN1	Kinetochore-associated protein DSN1 homolog	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9H410	DSN1	Kinetochore-associated protein DSN1 homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9NZW4	DSPP	Dentin sialophosphoprotein	GO:0005509; F:calcium ion binding; TAS:ProtInc
Q9NZW4	DSPP	Dentin sialophosphoprotein	GO:0005518; F:collagen binding; TAS:ProtInc
Q9NZW4	DSPP	Dentin sialophosphoprotein	GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc
Q9NZW4	DSPP	Dentin sialophosphoprotein	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
Q9NZW4	DSPP	Dentin sialophosphoprotein	GO:0071460; P:cellular response to cell-matrix adhesion; IEA:Ensembl
Q9NZW4	DSPP	Dentin sialophosphoprotein	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q9NZW4	DSPP	Dentin sialophosphoprotein	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q9NZW4	DSPP	Dentin sialophosphoprotein	GO:0001503; P:ossification; TAS:ProtInc
Q9NZW4	DSPP	Dentin sialophosphoprotein	GO:0001501; P:skeletal system development; TAS:ProtInc
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0003726; F:double-stranded RNA adenosine deaminase activity; NAS:UniProtKB
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0005515; F:protein binding; IPI:IntAct
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0006382; P:adenosine to inosine editing; IDA:UniProtKB
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0016553; P:base conversion or substitution editing; IDA:MGI
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0010467; P:gene expression; TAS:Reactome
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0045087; P:innate immune response; TAS:UniProtKB
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0016556; P:mRNA modification; TAS:Reactome
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0044387; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; IDA:UniProtKB
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0045070; P:positive regulation of viral genome replication; IDA:UniProtKB
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0006611; P:protein export from nucleus; IDA:UniProtKB
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0006606; P:protein import into nucleus; IDA:UniProtKB
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0035455; P:response to interferon-alpha; IDA:UniProtKB
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0009615; P:response to virus; IMP:UniProtKB
P55265	ADAR	Double-stranded RNA-specific adenosine deaminase	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P60896	SHFM1	26S proteasome complex subunit DSS1	GO:0008233; F:peptidase activity; IDA:UniProtKB
P60896	SHFM1	26S proteasome complex subunit DSS1	GO:0005515; F:protein binding; IPI:UniProtKB
P60896	SHFM1	26S proteasome complex subunit DSS1	GO:0000724; P:double-strand break repair via homologous recombination; IEA:Ensembl
P60896	SHFM1	26S proteasome complex subunit DSS1	GO:0006508; P:proteolysis; IDA:UniProtKB
Q96EV8	DTNBP1	Dysbindin	GO:0005515; F:protein binding; IPI:UniProtKB
Q96EV8	DTNBP1	Dysbindin	GO:0031532; P:actin cytoskeleton reorganization; ISS:UniProtKB
Q96EV8	DTNBP1	Dysbindin	GO:0008089; P:anterograde axon cargo transport; ISS:UniProtKB
Q96EV8	DTNBP1	Dysbindin	GO:0048490; P:anterograde synaptic vesicle transport; ISS:UniProtKB
Q96EV8	DTNBP1	Dysbindin	GO:0007596; P:blood coagulation; IEA:Ensembl
Q96EV8	DTNBP1	Dysbindin	GO:0032438; P:melanosome organization; NAS:UniProtKB
Q96EV8	DTNBP1	Dysbindin	GO:0061024; P:membrane organization; TAS:Reactome
Q96EV8	DTNBP1	Dysbindin	GO:0031175; P:neuron projection development; IDA:UniProtKB
Q96EV8	DTNBP1	Dysbindin	GO:0048812; P:neuron projection morphogenesis; ISS:UniProtKB
Q96EV8	DTNBP1	Dysbindin	GO:0060155; P:platelet dense granule organization; IEA:Ensembl
Q96EV8	DTNBP1	Dysbindin	GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB
Q96EV8	DTNBP1	Dysbindin	GO:0001956; P:positive regulation of neurotransmitter secretion; ISS:UniProtKB
Q96EV8	DTNBP1	Dysbindin	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
Q96EV8	DTNBP1	Dysbindin	GO:0060159; P:regulation of dopamine receptor signaling pathway; ISS:UniProtKB
Q96EV8	DTNBP1	Dysbindin	GO:0014059; P:regulation of dopamine secretion; ISS:UniProtKB
Q8TEA8	DTD1	D-tyrosyl-tRNA(Tyr) deacylase 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TEA8	DTD1	D-tyrosyl-tRNA(Tyr) deacylase 1	GO:0016788; F:hydrolase activity, acting on ester bonds; IEA:InterPro
Q8TEA8	DTD1	D-tyrosyl-tRNA(Tyr) deacylase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TEA8	DTD1	D-tyrosyl-tRNA(Tyr) deacylase 1	GO:0019478; P:D-amino acid catabolic process; IEA:InterPro
Q8TEA8	DTD1	D-tyrosyl-tRNA(Tyr) deacylase 1	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q96FN9	DTD2	Probable D-tyrosyl-tRNA(Tyr) deacylase 2	GO:0016788; F:hydrolase activity, acting on ester bonds; IEA:InterPro
Q96FN9	DTD2	Probable D-tyrosyl-tRNA(Tyr) deacylase 2	GO:0005515; F:protein binding; IPI:UniProt
Q96FN9	DTD2	Probable D-tyrosyl-tRNA(Tyr) deacylase 2	GO:0019478; P:D-amino acid catabolic process; IEA:InterPro
Q6ZMT9	DTHD1	Death domain-containing protein 1	GO:0007165; P:signal transduction; IEA:InterPro
Q9NZJ0	DTL	Denticleless protein homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NZJ0	DTL	Denticleless protein homolog	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q9NZJ0	DTL	Denticleless protein homolog	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q9NZJ0	DTL	Denticleless protein homolog	GO:0031572; P:G2 DNA damage checkpoint; IMP:UniProtKB
Q9NZJ0	DTL	Denticleless protein homolog	GO:0006513; P:protein monoubiquitination; IDA:UniProtKB
Q9NZJ0	DTL	Denticleless protein homolog	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q9NZJ0	DTL	Denticleless protein homolog	GO:0051726; P:regulation of cell cycle; IMP:UniProtKB
Q9NZJ0	DTL	Denticleless protein homolog	GO:0009411; P:response to UV; IDA:UniProtKB
Q9NZJ0	DTL	Denticleless protein homolog	GO:0019985; P:translesion synthesis; IDA:UniProtKB
Q9NZJ0	DTL	Denticleless protein homolog	GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9Y4J8	DTNA	Dystrobrevin alpha	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y4J8	DTNA	Dystrobrevin alpha	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y4J8	DTNA	Dystrobrevin alpha	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y4J8	DTNA	Dystrobrevin alpha	GO:0007274; P:neuromuscular synaptic transmission; TAS:ProtInc
Q9Y4J8	DTNA	Dystrobrevin alpha	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y4J8	DTNA	Dystrobrevin alpha	GO:0006941; P:striated muscle contraction; TAS:ProtInc
Q9Y4J8	DTNA	Dystrobrevin alpha	GO:0007268; P:synaptic transmission; TAS:ProtInc
O60941	DTNB	Dystrobrevin beta	GO:0005509; F:calcium ion binding; IEA:InterPro
O60941	DTNB	Dystrobrevin beta	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86Y01	DTX1	E3 ubiquitin-protein ligase DTX1	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q86Y01	DTX1	E3 ubiquitin-protein ligase DTX1	GO:0005112; F:Notch binding; IDA:UniProtKB
Q86Y01	DTX1	E3 ubiquitin-protein ligase DTX1	GO:0005515; F:protein binding; IPI:UniProtKB
Q86Y01	DTX1	E3 ubiquitin-protein ligase DTX1	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q86Y01	DTX1	E3 ubiquitin-protein ligase DTX1	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q86Y01	DTX1	E3 ubiquitin-protein ligase DTX1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86Y01	DTX1	E3 ubiquitin-protein ligase DTX1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q86Y01	DTX1	E3 ubiquitin-protein ligase DTX1	GO:0010001; P:glial cell differentiation; IEA:Ensembl
Q86Y01	DTX1	E3 ubiquitin-protein ligase DTX1	GO:0045665; P:negative regulation of neuron differentiation; IGI:UniProtKB
Q86Y01	DTX1	E3 ubiquitin-protein ligase DTX1	GO:0045581; P:negative regulation of T cell differentiation; IEA:Ensembl
Q86Y01	DTX1	E3 ubiquitin-protein ligase DTX1	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q86Y01	DTX1	E3 ubiquitin-protein ligase DTX1	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q86Y01	DTX1	E3 ubiquitin-protein ligase DTX1	GO:0008593; P:regulation of Notch signaling pathway; IGI:UniProtKB
Q86Y01	DTX1	E3 ubiquitin-protein ligase DTX1	GO:2001141; P:regulation of RNA biosynthetic process; TAS:GOC
Q86Y01	DTX1	E3 ubiquitin-protein ligase DTX1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q86Y01	DTX1	E3 ubiquitin-protein ligase DTX1	GO:0006351; P:transcription, DNA-templated; NAS:UniProtKB
Q86UW9	DTX2	Probable E3 ubiquitin-protein ligase DTX2	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q86UW9	DTX2	Probable E3 ubiquitin-protein ligase DTX2	GO:0005515; F:protein binding; IPI:IntAct
Q86UW9	DTX2	Probable E3 ubiquitin-protein ligase DTX2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86UW9	DTX2	Probable E3 ubiquitin-protein ligase DTX2	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
Q86UW9	DTX2	Probable E3 ubiquitin-protein ligase DTX2	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8TDB6	DTX3L	E3 ubiquitin-protein ligase DTX3L	GO:0042393; F:histone binding; IDA:UniProtKB
Q8TDB6	DTX3L	E3 ubiquitin-protein ligase DTX3L	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TDB6	DTX3L	E3 ubiquitin-protein ligase DTX3L	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q8TDB6	DTX3L	E3 ubiquitin-protein ligase DTX3L	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TDB6	DTX3L	E3 ubiquitin-protein ligase DTX3L	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
Q8TDB6	DTX3L	E3 ubiquitin-protein ligase DTX3L	GO:0006302; P:double-strand break repair; IMP:UniProtKB
Q8TDB6	DTX3L	E3 ubiquitin-protein ligase DTX3L	GO:0010390; P:histone monoubiquitination; IDA:UniProtKB
Q8N9I9	DTX3	Probable E3 ubiquitin-protein ligase DTX3	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q8N9I9	DTX3	Probable E3 ubiquitin-protein ligase DTX3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N9I9	DTX3	Probable E3 ubiquitin-protein ligase DTX3	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
Q8N9I9	DTX3	Probable E3 ubiquitin-protein ligase DTX3	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9Y2E6	DTX4	E3 ubiquitin-protein ligase DTX4	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9Y2E6	DTX4	E3 ubiquitin-protein ligase DTX4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y2E6	DTX4	E3 ubiquitin-protein ligase DTX4	GO:0045087; P:innate immune response; TAS:Reactome
Q9Y2E6	DTX4	E3 ubiquitin-protein ligase DTX4	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
Q9Y2E6	DTX4	E3 ubiquitin-protein ligase DTX4	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q9Y2E6	DTX4	E3 ubiquitin-protein ligase DTX4	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9Y2E6	DTX4	E3 ubiquitin-protein ligase DTX4	GO:0032479; P:regulation of type I interferon production; TAS:Reactome
P0CJ85	DUX4L2	Double homeobox protein 4-like protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P0CJ85	DUX4L2	Double homeobox protein 4-like protein 2	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
P0CJ85	DUX4L2	Double homeobox protein 4-like protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P0CJ86	DUX4L3	Double homeobox protein 4-like protein 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P0CJ86	DUX4L3	Double homeobox protein 4-like protein 3	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
P0CJ86	DUX4L3	Double homeobox protein 4-like protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P0CJ90	DUX4L7	Double homeobox protein 4-like protein 7	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P0CJ90	DUX4L7	Double homeobox protein 4-like protein 7	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
P0CJ90	DUX4L7	Double homeobox protein 4-like protein 7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P0CJ87	DUX4L4	Double homeobox protein 4-like protein 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P0CJ87	DUX4L4	Double homeobox protein 4-like protein 4	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
P0CJ87	DUX4L4	Double homeobox protein 4-like protein 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P0CJ88	DUX4L5	Double homeobox protein 4-like protein 5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P0CJ88	DUX4L5	Double homeobox protein 4-like protein 5	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
P0CJ88	DUX4L5	Double homeobox protein 4-like protein 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P0CJ89	DUX4L6	Double homeobox protein 4-like protein 6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P0CJ89	DUX4L6	Double homeobox protein 4-like protein 6	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
P0CJ89	DUX4L6	Double homeobox protein 4-like protein 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NRD9	DUOX1	Dual oxidase 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NRD9	DUOX1	Dual oxidase 1	GO:0020037; F:heme binding; IEA:InterPro
Q9NRD9	DUOX1	Dual oxidase 1	GO:0016174; F:NAD(P)H oxidase activity; NAS:UniProtKB
Q9NRD9	DUOX1	Dual oxidase 1	GO:0050661; F:NADP binding; NAS:UniProtKB
Q9NRD9	DUOX1	Dual oxidase 1	GO:0004601; F:peroxidase activity; IEA:UniProtKB-KW
Q9NRD9	DUOX1	Dual oxidase 1	GO:0042335; P:cuticle development; IMP:UniProtKB
Q9NRD9	DUOX1	Dual oxidase 1	GO:0019221; P:cytokine-mediated signaling pathway; IDA:UniProtKB
Q9NRD9	DUOX1	Dual oxidase 1	GO:0042446; P:hormone biosynthetic process; IEA:UniProtKB-KW
Q9NRD9	DUOX1	Dual oxidase 1	GO:0050665; P:hydrogen peroxide biosynthetic process; NAS:UniProtKB
Q9NRD9	DUOX1	Dual oxidase 1	GO:0042744; P:hydrogen peroxide catabolic process; IEA:UniProtKB-KW
Q9NRD9	DUOX1	Dual oxidase 1	GO:0055114; P:oxidation-reduction process; TAS:UniProtKB
Q9NRD9	DUOX1	Dual oxidase 1	GO:0051591; P:response to cAMP; IDA:UniProtKB
Q9NRD9	DUOX1	Dual oxidase 1	GO:0042554; P:superoxide anion generation; NAS:UniProtKB
Q9NRD9	DUOX1	Dual oxidase 1	GO:0006590; P:thyroid hormone generation; IEA:UniProtKB-UniPathway
Q9NRD8	DUOX2	Dual oxidase 2	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q9NRD8	DUOX2	Dual oxidase 2	GO:0020037; F:heme binding; IEA:InterPro
Q9NRD8	DUOX2	Dual oxidase 2	GO:0016174; F:NAD(P)H oxidase activity; IDA:UniProtKB
Q9NRD8	DUOX2	Dual oxidase 2	GO:0004601; F:peroxidase activity; IEA:UniProtKB-KW
Q9NRD8	DUOX2	Dual oxidase 2	GO:0048855; P:adenohypophysis morphogenesis; IEA:Ensembl
Q9NRD8	DUOX2	Dual oxidase 2	GO:0030282; P:bone mineralization; IEA:Ensembl
Q9NRD8	DUOX2	Dual oxidase 2	GO:0042335; P:cuticle development; ISS:UniProtKB
Q9NRD8	DUOX2	Dual oxidase 2	GO:0019221; P:cytokine-mediated signaling pathway; IDA:UniProtKB
Q9NRD8	DUOX2	Dual oxidase 2	GO:0009566; P:fertilization; IEA:Ensembl
Q9NRD8	DUOX2	Dual oxidase 2	GO:0042446; P:hormone biosynthetic process; IEA:UniProtKB-KW
Q9NRD8	DUOX2	Dual oxidase 2	GO:0042744; P:hydrogen peroxide catabolic process; IEA:UniProtKB-KW
Q9NRD8	DUOX2	Dual oxidase 2	GO:0048839; P:inner ear development; IEA:Ensembl
Q9NRD8	DUOX2	Dual oxidase 2	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q9NRD8	DUOX2	Dual oxidase 2	GO:0055114; P:oxidation-reduction process; TAS:UniProtKB
Q9NRD8	DUOX2	Dual oxidase 2	GO:0051591; P:response to cAMP; IDA:UniProtKB
Q9NRD8	DUOX2	Dual oxidase 2	GO:0009615; P:response to virus; IDA:UniProtKB
Q9NRD8	DUOX2	Dual oxidase 2	GO:0030878; P:thyroid gland development; IEA:Ensembl
Q9NRD8	DUOX2	Dual oxidase 2	GO:0006590; P:thyroid hormone generation; IEA:UniProtKB-UniPathway
Q68J44	DUPD1	Dual specificity phosphatase DUPD1	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q68J44	DUPD1	Dual specificity phosphatase DUPD1	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q68J44	DUPD1	Dual specificity phosphatase DUPD1	GO:0006470; P:protein dephosphorylation; IBA:RefGenome
Q9Y6W6	DUSP10	Dual specificity protein phosphatase 10	GO:0033549; F:MAP kinase phosphatase activity; IDA:UniProtKB
Q9Y6W6	DUSP10	Dual specificity protein phosphatase 10	GO:0017017; F:MAP kinase tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q9Y6W6	DUSP10	Dual specificity protein phosphatase 10	GO:0016791; F:phosphatase activity; IDA:UniProtKB
Q9Y6W6	DUSP10	Dual specificity protein phosphatase 10	GO:0004721; F:phosphoprotein phosphatase activity; TAS:ProtInc
Q9Y6W6	DUSP10	Dual specificity protein phosphatase 10	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q9Y6W6	DUSP10	Dual specificity protein phosphatase 10	GO:0000188; P:inactivation of MAPK activity; IDA:UniProtKB
Q9Y6W6	DUSP10	Dual specificity protein phosphatase 10	GO:0007254; P:JNK cascade; TAS:ProtInc
Q9Y6W6	DUSP10	Dual specificity protein phosphatase 10	GO:0046329; P:negative regulation of JNK cascade; IBA:RefGenome
Q9Y6W6	DUSP10	Dual specificity protein phosphatase 10	GO:0043508; P:negative regulation of JUN kinase activity; IBA:RefGenome
Q9Y6W6	DUSP10	Dual specificity protein phosphatase 10	GO:0060266; P:negative regulation of respiratory burst involved in inflammatory response; IEA:Ensembl
Q9Y6W6	DUSP10	Dual specificity protein phosphatase 10	GO:0032873; P:negative regulation of stress-activated MAPK cascade; IBA:RefGenome
Q9Y6W6	DUSP10	Dual specificity protein phosphatase 10	GO:0006470; P:protein dephosphorylation; IDA:UniProtKB
Q9Y6W6	DUSP10	Dual specificity protein phosphatase 10	GO:0002819; P:regulation of adaptive immune response; IEA:Ensembl
Q9Y6W6	DUSP10	Dual specificity protein phosphatase 10	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
Q9Y6W6	DUSP10	Dual specificity protein phosphatase 10	GO:0006950; P:response to stress; TAS:ProtInc
O75319	DUSP11	RNA/RNP complex-1-interacting phosphatase	GO:0098519; F:nucleotide phosphatase activity, acting on free nucleotides; IMP:UniProtKB
O75319	DUSP11	RNA/RNP complex-1-interacting phosphatase	GO:0016791; F:phosphatase activity; IDA:UniProtKB
O75319	DUSP11	RNA/RNP complex-1-interacting phosphatase	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75319	DUSP11	RNA/RNP complex-1-interacting phosphatase	GO:0004651; F:polynucleotide 5'-phosphatase activity; IDA:UniProtKB
O75319	DUSP11	RNA/RNP complex-1-interacting phosphatase	GO:0004725; F:protein tyrosine phosphatase activity; TAS:ProtInc
O75319	DUSP11	RNA/RNP complex-1-interacting phosphatase	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro
O75319	DUSP11	RNA/RNP complex-1-interacting phosphatase	GO:0003723; F:RNA binding; TAS:ProtInc
O75319	DUSP11	RNA/RNP complex-1-interacting phosphatase	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
O75319	DUSP11	RNA/RNP complex-1-interacting phosphatase	GO:0098507; P:polynucleotide 5' dephosphorylation; IDA:UniProtKB
O75319	DUSP11	RNA/RNP complex-1-interacting phosphatase	GO:0016070; P:RNA metabolic process; IDA:UniProtKB
O75319	DUSP11	RNA/RNP complex-1-interacting phosphatase	GO:0006396; P:RNA processing; TAS:ProtInc
Q9UNI6	DUSP12	Dual specificity protein phosphatase 12	GO:0004725; F:protein tyrosine phosphatase activity; TAS:ProtInc
Q9UNI6	DUSP12	Dual specificity protein phosphatase 12	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q9UNI6	DUSP12	Dual specificity protein phosphatase 12	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q9UNI6	DUSP12	Dual specificity protein phosphatase 12	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q9UNI6	DUSP12	Dual specificity protein phosphatase 12	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
Q9UNI6	DUSP12	Dual specificity protein phosphatase 12	GO:0033133; P:positive regulation of glucokinase activity; IBA:RefGenome
Q9UNI6	DUSP12	Dual specificity protein phosphatase 12	GO:0006470; P:protein dephosphorylation; IBA:RefGenome
O95147	DUSP14	Dual specificity protein phosphatase 14	GO:0017017; F:MAP kinase tyrosine/serine/threonine phosphatase activity; IEA:InterPro
O95147	DUSP14	Dual specificity protein phosphatase 14	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O95147	DUSP14	Dual specificity protein phosphatase 14	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
O95147	DUSP14	Dual specificity protein phosphatase 14	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
O95147	DUSP14	Dual specificity protein phosphatase 14	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IBA:RefGenome
Q9H1R2	DUSP15	Dual specificity protein phosphatase 15	GO:0005515; F:protein binding; IPI:IntAct
Q9H1R2	DUSP15	Dual specificity protein phosphatase 15	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q9H1R2	DUSP15	Dual specificity protein phosphatase 15	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q9H1R2	DUSP15	Dual specificity protein phosphatase 15	GO:0006470; P:protein dephosphorylation; IBA:RefGenome
Q9BY84	DUSP16	Dual specificity protein phosphatase 16	GO:0017017; F:MAP kinase tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q9BY84	DUSP16	Dual specificity protein phosphatase 16	GO:0004721; F:phosphoprotein phosphatase activity; TAS:UniProtKB
Q9BY84	DUSP16	Dual specificity protein phosphatase 16	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q9BY84	DUSP16	Dual specificity protein phosphatase 16	GO:0016311; P:dephosphorylation; TAS:UniProtKB
Q9BY84	DUSP16	Dual specificity protein phosphatase 16	GO:0000188; P:inactivation of MAPK activity; TAS:UniProtKB
Q9BY84	DUSP16	Dual specificity protein phosphatase 16	GO:0045204; P:MAPK export from nucleus; TAS:UniProtKB
Q9BY84	DUSP16	Dual specificity protein phosphatase 16	GO:0045209; P:MAPK phosphatase export from nucleus, leptomycin B sensitive; TAS:UniProtKB
Q9BY84	DUSP16	Dual specificity protein phosphatase 16	GO:0006470; P:protein dephosphorylation; IBA:RefGenome
Q8NEJ0	DUSP18	Dual specificity protein phosphatase 18	GO:0017017; F:MAP kinase tyrosine/serine/threonine phosphatase activity; IEA:InterPro
Q8NEJ0	DUSP18	Dual specificity protein phosphatase 18	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
Q8NEJ0	DUSP18	Dual specificity protein phosphatase 18	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q8NEJ0	DUSP18	Dual specificity protein phosphatase 18	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:UniProtKB
Q8WTR2	DUSP19	Dual specificity protein phosphatase 19	GO:0008579; F:JUN kinase phosphatase activity; IBA:RefGenome
Q8WTR2	DUSP19	Dual specificity protein phosphatase 19	GO:0005078; F:MAP-kinase scaffold activity; ISS:BHF-UCL
Q8WTR2	DUSP19	Dual specificity protein phosphatase 19	GO:0031435; F:mitogen-activated protein kinase kinase kinase binding; ISS:BHF-UCL
Q8WTR2	DUSP19	Dual specificity protein phosphatase 19	GO:0030295; F:protein kinase activator activity; ISS:BHF-UCL
Q8WTR2	DUSP19	Dual specificity protein phosphatase 19	GO:0004860; F:protein kinase inhibitor activity; ISS:BHF-UCL
Q8WTR2	DUSP19	Dual specificity protein phosphatase 19	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q8WTR2	DUSP19	Dual specificity protein phosphatase 19	GO:0008330; F:protein tyrosine/threonine phosphatase activity; IEA:Ensembl
Q8WTR2	DUSP19	Dual specificity protein phosphatase 19	GO:0000188; P:inactivation of MAPK activity; IEA:Ensembl
Q8WTR2	DUSP19	Dual specificity protein phosphatase 19	GO:0007254; P:JNK cascade; IBA:RefGenome
Q8WTR2	DUSP19	Dual specificity protein phosphatase 19	GO:0046329; P:negative regulation of JNK cascade; ISS:BHF-UCL
Q8WTR2	DUSP19	Dual specificity protein phosphatase 19	GO:0043508; P:negative regulation of JUN kinase activity; ISS:BHF-UCL
Q8WTR2	DUSP19	Dual specificity protein phosphatase 19	GO:0006469; P:negative regulation of protein kinase activity; ISS:BHF-UCL
Q8WTR2	DUSP19	Dual specificity protein phosphatase 19	GO:0046330; P:positive regulation of JNK cascade; ISS:BHF-UCL
Q8WTR2	DUSP19	Dual specificity protein phosphatase 19	GO:0043507; P:positive regulation of JUN kinase activity; ISS:BHF-UCL
Q8WTR2	DUSP19	Dual specificity protein phosphatase 19	GO:0043410; P:positive regulation of MAPK cascade; ISS:BHF-UCL
Q8WTR2	DUSP19	Dual specificity protein phosphatase 19	GO:0045860; P:positive regulation of protein kinase activity; ISS:BHF-UCL
Q8WTR2	DUSP19	Dual specificity protein phosphatase 19	GO:0006470; P:protein dephosphorylation; IBA:RefGenome
Q6P1R4	DUS1L	tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q6P1R4	DUS1L	tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like	GO:0017150; F:tRNA dihydrouridine synthase activity; IEA:InterPro
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0017017; F:MAP kinase tyrosine/serine/threonine phosphatase activity; ISS:UniProtKB
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0004726; F:non-membrane spanning protein tyrosine phosphatase activity; TAS:ProtInc
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0005515; F:protein binding; IPI:IntAct
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0008330; F:protein tyrosine/threonine phosphatase activity; IEA:Ensembl
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0032870; P:cellular response to hormone stimulus; IEA:Ensembl
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0001706; P:endoderm formation; IBA:RefGenome
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0000188; P:inactivation of MAPK activity; ISS:UniProtKB
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0035556; P:intracellular signal transduction; IEA:Ensembl
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0071850; P:mitotic cell cycle arrest; ISS:UniProtKB
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0043407; P:negative regulation of MAP kinase activity; IDA:UniProtKB
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0043409; P:negative regulation of MAPK cascade; ISS:UniProtKB
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0051447; P:negative regulation of meiotic cell cycle; ISS:UniProtKB
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0035970; P:peptidyl-threonine dephosphorylation; ISS:UniProtKB
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0035335; P:peptidyl-tyrosine dephosphorylation; ISS:UniProtKB
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0006470; P:protein dephosphorylation; IBA:RefGenome
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0042981; P:regulation of apoptotic process; IBA:RefGenome
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0090266; P:regulation of mitotic cell cycle spindle assembly checkpoint; ISS:UniProtKB
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0051592; P:response to calcium ion; IEA:Ensembl
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0051591; P:response to cAMP; IEA:Ensembl
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0032355; P:response to estradiol; IEA:Ensembl
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0009416; P:response to light stimulus; IEA:Ensembl
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0006979; P:response to oxidative stress; TAS:ProtInc
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0032526; P:response to retinoic acid; IEA:Ensembl
P28562	DUSP1	Dual specificity protein phosphatase 1	GO:0033574; P:response to testosterone; IEA:Ensembl
Q9H596	DUSP21	Dual specificity protein phosphatase 21	GO:0017017; F:MAP kinase tyrosine/serine/threonine phosphatase activity; IEA:InterPro
Q9H596	DUSP21	Dual specificity protein phosphatase 21	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
Q9H596	DUSP21	Dual specificity protein phosphatase 21	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q9H596	DUSP21	Dual specificity protein phosphatase 21	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:UniProtKB
Q9NRW4	DUSP22	Dual specificity protein phosphatase 22	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q9NRW4	DUSP22	Dual specificity protein phosphatase 22	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q9NRW4	DUSP22	Dual specificity protein phosphatase 22	GO:0006915; P:apoptotic process; TAS:ProtInc
Q9NRW4	DUSP22	Dual specificity protein phosphatase 22	GO:0008283; P:cell proliferation; TAS:ProtInc
Q9NRW4	DUSP22	Dual specificity protein phosphatase 22	GO:0000188; P:inactivation of MAPK activity; TAS:ProtInc
Q9NRW4	DUSP22	Dual specificity protein phosphatase 22	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q9NRW4	DUSP22	Dual specificity protein phosphatase 22	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:MGI
Q9NRW4	DUSP22	Dual specificity protein phosphatase 22	GO:0046330; P:positive regulation of JNK cascade; IBA:RefGenome
Q9NRW4	DUSP22	Dual specificity protein phosphatase 22	GO:0006470; P:protein dephosphorylation; IBA:RefGenome
Q9NRW4	DUSP22	Dual specificity protein phosphatase 22	GO:0042127; P:regulation of cell proliferation; IBA:RefGenome
Q9NRW4	DUSP22	Dual specificity protein phosphatase 22	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IBA:RefGenome
Q9BVJ7	DUSP23	Dual specificity protein phosphatase 23	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q9BVJ7	DUSP23	Dual specificity protein phosphatase 23	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro
Q9BV47	DUSP26	Dual specificity protein phosphatase 26	GO:0002039; F:p53 binding; IPI:UniProt
Q9BV47	DUSP26	Dual specificity protein phosphatase 26	GO:0004721; F:phosphoprotein phosphatase activity; IDA:UniProt
Q9BV47	DUSP26	Dual specificity protein phosphatase 26	GO:0004647; F:phosphoserine phosphatase activity; IDA:UniProt
Q9BV47	DUSP26	Dual specificity protein phosphatase 26	GO:0005515; F:protein binding; IPI:IntAct
Q9BV47	DUSP26	Dual specificity protein phosphatase 26	GO:0004725; F:protein tyrosine phosphatase activity; IMP:UniProt
Q9BV47	DUSP26	Dual specificity protein phosphatase 26	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q9BV47	DUSP26	Dual specificity protein phosphatase 26	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:UniProt
Q9BV47	DUSP26	Dual specificity protein phosphatase 26	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IDA:UniProt
Q9BV47	DUSP26	Dual specificity protein phosphatase 26	GO:0044387; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; IMP:UniProt
Q9BV47	DUSP26	Dual specificity protein phosphatase 26	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProt
Q9BV47	DUSP26	Dual specificity protein phosphatase 26	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IMP:GOC
Q9BV47	DUSP26	Dual specificity protein phosphatase 26	GO:0045785; P:positive regulation of cell adhesion; IMP:UniProt
Q9BV47	DUSP26	Dual specificity protein phosphatase 26	GO:1902310; P:positive regulation of peptidyl-serine dephosphorylation; IDA:UniProt
Q9BV47	DUSP26	Dual specificity protein phosphatase 26	GO:0006470; P:protein dephosphorylation; IDA:UniProt
Q5VZP5	DUSP27	Inactive dual specificity phosphatase 27	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q5VZP5	DUSP27	Inactive dual specificity phosphatase 27	GO:0006470; P:protein dephosphorylation; IBA:RefGenome
Q4G0W2	DUSP28	Dual specificity phosphatase 28	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q4G0W2	DUSP28	Dual specificity phosphatase 28	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q4G0W2	DUSP28	Dual specificity phosphatase 28	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IBA:RefGenome
Q9NX74	DUS2	tRNA-dihydrouridine(20) synthase [NAD(P)+]-like	GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB
Q9NX74	DUS2	tRNA-dihydrouridine(20) synthase [NAD(P)+]-like	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q9NX74	DUS2	tRNA-dihydrouridine(20) synthase [NAD(P)+]-like	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NX74	DUS2	tRNA-dihydrouridine(20) synthase [NAD(P)+]-like	GO:0004860; F:protein kinase inhibitor activity; IDA:UniProtKB
Q9NX74	DUS2	tRNA-dihydrouridine(20) synthase [NAD(P)+]-like	GO:0017150; F:tRNA dihydrouridine synthase activity; IEA:InterPro
Q9NX74	DUS2	tRNA-dihydrouridine(20) synthase [NAD(P)+]-like	GO:0060548; P:negative regulation of cell death; IDA:UniProtKB
Q9NX74	DUS2	tRNA-dihydrouridine(20) synthase [NAD(P)+]-like	GO:0006469; P:negative regulation of protein kinase activity; IDA:GOC
Q05923	DUSP2	Dual specificity protein phosphatase 2	GO:0017017; F:MAP kinase tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q05923	DUSP2	Dual specificity protein phosphatase 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q05923	DUSP2	Dual specificity protein phosphatase 2	GO:0004725; F:protein tyrosine phosphatase activity; TAS:ProtInc
Q05923	DUSP2	Dual specificity protein phosphatase 2	GO:0008330; F:protein tyrosine/threonine phosphatase activity; TAS:ProtInc
Q05923	DUSP2	Dual specificity protein phosphatase 2	GO:0001706; P:endoderm formation; IBA:RefGenome
Q05923	DUSP2	Dual specificity protein phosphatase 2	GO:0000188; P:inactivation of MAPK activity; IBA:RefGenome
Q05923	DUSP2	Dual specificity protein phosphatase 2	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
Q05923	DUSP2	Dual specificity protein phosphatase 2	GO:0006470; P:protein dephosphorylation; IBA:RefGenome
Q05923	DUSP2	Dual specificity protein phosphatase 2	GO:0042981; P:regulation of apoptotic process; IBA:RefGenome
Q96G46	DUS3L	tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q96G46	DUS3L	tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96G46	DUS3L	tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96G46	DUS3L	tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like	GO:0017150; F:tRNA dihydrouridine synthase activity; IEA:InterPro
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0033549; F:MAP kinase phosphatase activity; IMP:UniProtKB
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IDA:UniProtKB
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0000188; P:inactivation of MAPK activity; IMP:UniProtKB
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0045087; P:innate immune response; TAS:Reactome
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0046329; P:negative regulation of JNK cascade; IDA:UniProtKB
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0043409; P:negative regulation of MAPK cascade; IMP:UniProtKB
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0050868; P:negative regulation of T cell activation; IDA:UniProtKB
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0050860; P:negative regulation of T cell receptor signaling pathway; IDA:UniProtKB
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:UniProtKB
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0045931; P:positive regulation of mitotic cell cycle; IMP:UniProtKB
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P51452	DUSP3	Dual specificity protein phosphatase 3	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
O95620	DUS4L	tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
O95620	DUS4L	tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like	GO:0017150; F:tRNA dihydrouridine synthase activity; IEA:InterPro
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0017017; F:MAP kinase tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0008330; F:protein tyrosine/threonine phosphatase activity; TAS:ProtInc
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0001706; P:endoderm formation; IBA:RefGenome
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0000188; P:inactivation of MAPK activity; IBA:RefGenome
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0045087; P:innate immune response; TAS:Reactome
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0000165; P:MAPK cascade; TAS:ProtInc
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0006470; P:protein dephosphorylation; IBA:RefGenome
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q13115	DUSP4	Dual specificity protein phosphatase 4	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q16690	DUSP5	Dual specificity protein phosphatase 5	GO:0017017; F:MAP kinase tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q16690	DUSP5	Dual specificity protein phosphatase 5	GO:0005515; F:protein binding; IPI:IntAct
Q16690	DUSP5	Dual specificity protein phosphatase 5	GO:0004725; F:protein tyrosine phosphatase activity; TAS:ProtInc
Q16690	DUSP5	Dual specificity protein phosphatase 5	GO:0001706; P:endoderm formation; IBA:RefGenome
Q16690	DUSP5	Dual specificity protein phosphatase 5	GO:0000188; P:inactivation of MAPK activity; IBA:RefGenome
Q16690	DUSP5	Dual specificity protein phosphatase 5	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
Q16690	DUSP5	Dual specificity protein phosphatase 5	GO:0006470; P:protein dephosphorylation; IBA:RefGenome
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0017017; F:MAP kinase tyrosine/serine/threonine phosphatase activity; IDA:UniProtKB
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0030154; P:cell differentiation; IEA:Ensembl
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0009953; P:dorsal/ventral pattern formation; IBA:RefGenome
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0000188; P:inactivation of MAPK activity; IDA:UniProtKB
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0045087; P:innate immune response; TAS:Reactome
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IMP:UniProtKB
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:UniProtKB
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0042663; P:regulation of endodermal cell fate specification; IBA:RefGenome
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0040036; P:regulation of fibroblast growth factor receptor signaling pathway; IBA:RefGenome
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0060420; P:regulation of heart growth; IBA:RefGenome
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0042493; P:response to drug; IEA:Ensembl
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0051409; P:response to nitrosative stress; IEP:UniProtKB
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q16828	DUSP6	Dual specificity protein phosphatase 6	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0017017; F:MAP kinase tyrosine/serine/threonine phosphatase activity; IDA:UniProtKB
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0005515; F:protein binding; IPI:IntAct
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0000188; P:inactivation of MAPK activity; IBA:RefGenome
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0045087; P:innate immune response; TAS:Reactome
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0043407; P:negative regulation of MAP kinase activity; IDA:UniProtKB
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:UniProtKB
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q16829	DUSP7	Dual specificity protein phosphatase 7	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q13202	DUSP8	Dual specificity protein phosphatase 8	GO:0017017; F:MAP kinase tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q13202	DUSP8	Dual specificity protein phosphatase 8	GO:0004725; F:protein tyrosine phosphatase activity; TAS:ProtInc
Q13202	DUSP8	Dual specificity protein phosphatase 8	GO:0000188; P:inactivation of MAPK activity; IBA:RefGenome
Q13202	DUSP8	Dual specificity protein phosphatase 8	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
Q13202	DUSP8	Dual specificity protein phosphatase 8	GO:0006470; P:protein dephosphorylation; IBA:RefGenome
Q99956	DUSP9	Dual specificity protein phosphatase 9	GO:0017017; F:MAP kinase tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q99956	DUSP9	Dual specificity protein phosphatase 9	GO:0004721; F:phosphoprotein phosphatase activity; TAS:ProtInc
Q99956	DUSP9	Dual specificity protein phosphatase 9	GO:0005515; F:protein binding; IPI:IntAct
Q99956	DUSP9	Dual specificity protein phosphatase 9	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q99956	DUSP9	Dual specificity protein phosphatase 9	GO:0000188; P:inactivation of MAPK activity; IBA:RefGenome
Q99956	DUSP9	Dual specificity protein phosphatase 9	GO:0007254; P:JNK cascade; TAS:ProtInc
Q99956	DUSP9	Dual specificity protein phosphatase 9	GO:0006470; P:protein dephosphorylation; IBA:RefGenome
Q6XUX3	DSTYK	Dual serine/threonine and tyrosine protein kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6XUX3	DSTYK	Dual serine/threonine and tyrosine protein kinase	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q6XUX3	DSTYK	Dual serine/threonine and tyrosine protein kinase	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC
Q6XUX3	DSTYK	Dual serine/threonine and tyrosine protein kinase	GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW
DR   GO:0016787; F:hydrolase activity; IEA:InterPro
DR   GO:0046080; P:dUTP metabolic process; IEA:InterPro
P33316	DUT	Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial	GO:0004170; F:dUTP diphosphatase activity; EXP:Reactome
P33316	DUT	Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P33316	DUT	Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
P33316	DUT	Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial	GO:0006260; P:DNA replication; TAS:ProtInc
P33316	DUT	Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial	GO:0006226; P:dUMP biosynthetic process; IEA:UniProtKB-UniPathway
P33316	DUT	Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial	GO:0046080; P:dUTP metabolic process; IEA:InterPro
P33316	DUT	Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
P33316	DUT	Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P33316	DUT	Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
P33316	DUT	Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial	GO:0046134; P:pyrimidine nucleoside biosynthetic process; TAS:Reactome
P33316	DUT	Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43812	DUX1	Double homeobox protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O43812	DUX1	Double homeobox protein 1	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
O43812	DUX1	Double homeobox protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q6RFH8	DUX4L9	Double homeobox protein 4C	GO:0005515; F:protein binding; IPI:UniProtKB
Q6RFH8	DUX4L9	Double homeobox protein 4C	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q6RFH8	DUX4L9	Double homeobox protein 4C	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
Q6RFH8	DUX4L9	Double homeobox protein 4C	GO:0008283; P:cell proliferation; IDA:UniProtKB
Q6RFH8	DUX4L9	Double homeobox protein 4C	GO:0010468; P:regulation of gene expression; IDA:UniProtKB
Q6RFH8	DUX4L9	Double homeobox protein 4C	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75505	DUX2	Putative double homeobox protein 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O75505	DUX2	Putative double homeobox protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q96PT4	DUX3	Putative double homeobox protein 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q96PT4	DUX3	Putative double homeobox protein 3	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
Q96PT3	DUX5	Double homeobox protein 5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q96PT3	DUX5	Double homeobox protein 5	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
A6NLW8	DUXA	Double homeobox protein A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
A6NLW8	DUXA	Double homeobox protein A	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
A6NLW8	DUXA	Double homeobox protein A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UBX2	DUX4	Double homeobox protein 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9UBX2	DUX4	Double homeobox protein 4	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
Q9UBX2	DUX4	Double homeobox protein 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0019899; F:enzyme binding; IPI:UniProtKB
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0005109; F:frizzled binding; IPI:UniProtKB
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0042802; F:identical protein binding; IPI:IntAct
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0005515; F:protein binding; IPI:UniProtKB
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0048365; F:Rac GTPase binding; IBA:RefGenome
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0004871; F:signal transducer activity; IEA:InterPro
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0048675; P:axon extension; IBA:RefGenome
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0007411; P:axon guidance; IBA:RefGenome
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0060070; P:canonical Wnt signaling pathway; IDA:BHF-UCL
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0090103; P:cochlea morphogenesis; IBA:RefGenome
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0048668; P:collateral sprouting; IBA:RefGenome
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0060026; P:convergent extension; IBA:RefGenome
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0022007; P:convergent extension involved in neural plate elongation; IEA:Ensembl
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0031122; P:cytoplasmic microtubule organization; IEA:Ensembl
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0048813; P:dendrite morphogenesis; ISS:BHF-UCL
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0035556; P:intracellular signal transduction; IEA:InterPro
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0032091; P:negative regulation of protein binding; IDA:BHF-UCL
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0006469; P:negative regulation of protein kinase activity; IDA:BHF-UCL
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0021915; P:neural tube development; IEP:BHF-UCL
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0007528; P:neuromuscular junction development; ISS:BHF-UCL
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0007269; P:neurotransmitter secretion; ISS:BHF-UCL
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0090179; P:planar cell polarity pathway involved in neural tube closure; IBA:RefGenome
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:BHF-UCL
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0030177; P:positive regulation of Wnt signaling pathway; IDA:BHF-UCL
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0060134; P:prepulse inhibition; IEA:Ensembl
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0035372; P:protein localization to microtubule; IEA:Ensembl
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0034504; P:protein localization to nucleus; IMP:BHF-UCL
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0043113; P:receptor clustering; ISS:BHF-UCL
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0001505; P:regulation of neurotransmitter levels; ISS:BHF-UCL
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0071340; P:skeletal muscle acetylcholine-gated channel clustering; IBA:RefGenome
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0035176; P:social behavior; IEA:Ensembl
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0050808; P:synapse organization; ISS:BHF-UCL
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
O14640	DVL1	Segment polarity protein dishevelled homolog DVL-1	GO:0060071; P:Wnt signaling pathway, planar cell polarity pathway; IDA:BHF-UCL
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0005109; F:frizzled binding; IPI:UniProtKB
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0042802; F:identical protein binding; IPI:IntAct
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0005515; F:protein binding; IPI:UniProtKB
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0004871; F:signal transducer activity; IEA:InterPro
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0060070; P:canonical Wnt signaling pathway; IDA:BHF-UCL
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0044340; P:canonical Wnt signaling pathway involved in regulation of cell proliferation; IDA:BHF-UCL
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0021535; P:cell migration in hindbrain; IBA:RefGenome
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0034613; P:cellular protein localization; IEA:Ensembl
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0090103; P:cochlea morphogenesis; IBA:RefGenome
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0060026; P:convergent extension; IBA:RefGenome
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0022007; P:convergent extension involved in neural plate elongation; IEA:Ensembl
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0007507; P:heart development; ISS:BHF-UCL
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0003007; P:heart morphogenesis; IBA:RefGenome
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0035329; P:hippo signaling; TAS:Reactome
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0001843; P:neural tube closure; ISS:BHF-UCL
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0035567; P:non-canonical Wnt signaling pathway; IMP:BHF-UCL
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0003151; P:outflow tract morphogenesis; ISS:BHF-UCL
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0090179; P:planar cell polarity pathway involved in neural tube closure; IBA:RefGenome
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0043507; P:positive regulation of JUN kinase activity; IDA:BHF-UCL
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0001934; P:positive regulation of protein phosphorylation; IMP:BHF-UCL
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0061098; P:positive regulation of protein tyrosine kinase activity; IEA:Ensembl
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0007379; P:segment specification; ISS:BHF-UCL
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0016055; P:Wnt signaling pathway; IGI:MGI
O14641	DVL2	Segment polarity protein dishevelled homolog DVL-2	GO:0060071; P:Wnt signaling pathway, planar cell polarity pathway; IDA:BHF-UCL
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0008013; F:beta-catenin binding; IDA:BHF-UCL
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0005109; F:frizzled binding; IPI:UniProtKB
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0002020; F:protease binding; IPI:UniProtKB
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0046982; F:protein heterodimerization activity; IDA:BHF-UCL
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0005102; F:receptor binding; IPI:BHF-UCL
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0004871; F:signal transducer activity; IEA:InterPro
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0060070; P:canonical Wnt signaling pathway; IDA:BHF-UCL
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0090103; P:cochlea morphogenesis; IBA:RefGenome
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0060026; P:convergent extension; IBA:RefGenome
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0035567; P:non-canonical Wnt signaling pathway; IMP:BHF-UCL
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0038031; P:non-canonical Wnt signaling pathway via JNK cascade; ISS:BHF-UCL
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0003148; P:outflow tract septum morphogenesis; IBA:RefGenome
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0090179; P:planar cell polarity pathway involved in neural tube closure; IBA:RefGenome
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0043507; P:positive regulation of JUN kinase activity; IMP:BHF-UCL
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0001934; P:positive regulation of protein phosphorylation; IMP:BHF-UCL
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0042493; P:response to drug; IEA:Ensembl
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0016055; P:Wnt signaling pathway; IDA:BHF-UCL
Q92997	DVL3	Segment polarity protein dishevelled homolog DVL-3	GO:0060071; P:Wnt signaling pathway, planar cell polarity pathway; IDA:BHF-UCL
P54792	DVL1P1	Putative segment polarity protein dishevelled homolog DVL1P1	GO:0005515; F:protein binding; IPI:IntAct
P54792	DVL1P1	Putative segment polarity protein dishevelled homolog DVL1P1	GO:0004871; F:signal transducer activity; IEA:InterPro
P54792	DVL1P1	Putative segment polarity protein dishevelled homolog DVL1P1	GO:0007507; P:heart development; NAS:BHF-UCL
P54792	DVL1P1	Putative segment polarity protein dishevelled homolog DVL1P1	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P54792	DVL1P1	Putative segment polarity protein dishevelled homolog DVL1P1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
O00148	DDX39A	ATP-dependent RNA helicase DDX39A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O00148	DDX39A	ATP-dependent RNA helicase DDX39A	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
O00148	DDX39A	ATP-dependent RNA helicase DDX39A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O00148	DDX39A	ATP-dependent RNA helicase DDX39A	GO:0005515; F:protein binding; IPI:UniProtKB
O00148	DDX39A	ATP-dependent RNA helicase DDX39A	GO:0006406; P:mRNA export from nucleus; IGI:UniProtKB
O00148	DDX39A	ATP-dependent RNA helicase DDX39A	GO:0000398; P:mRNA splicing, via spliceosome; IGI:UniProtKB
Q13838	DDX39B	Spliceosome RNA helicase DDX39B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13838	DDX39B	Spliceosome RNA helicase DDX39B	GO:0043008; F:ATP-dependent protein binding; IDA:BHF-UCL
Q13838	DDX39B	Spliceosome RNA helicase DDX39B	GO:0004004; F:ATP-dependent RNA helicase activity; IDA:UniProtKB
Q13838	DDX39B	Spliceosome RNA helicase DDX39B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13838	DDX39B	Spliceosome RNA helicase DDX39B	GO:0005515; F:protein binding; IPI:UniProtKB
Q13838	DDX39B	Spliceosome RNA helicase DDX39B	GO:0008186; F:RNA-dependent ATPase activity; IDA:UniProtKB
Q13838	DDX39B	Spliceosome RNA helicase DDX39B	GO:0030621; F:U4 snRNA binding; IDA:BHF-UCL
Q13838	DDX39B	Spliceosome RNA helicase DDX39B	GO:0017070; F:U6 snRNA binding; IDA:BHF-UCL
Q13838	DDX39B	Spliceosome RNA helicase DDX39B	GO:0006200; P:ATP catabolic process; IDA:GOC
Q13838	DDX39B	Spliceosome RNA helicase DDX39B	GO:0006406; P:mRNA export from nucleus; IDA:UniProtKB
Q13838	DDX39B	Spliceosome RNA helicase DDX39B	GO:0000398; P:mRNA splicing, via spliceosome; IGI:UniProtKB
Q13838	DDX39B	Spliceosome RNA helicase DDX39B	GO:2000002; P:negative regulation of DNA damage checkpoint; IMP:UniProtKB
Q13838	DDX39B	Spliceosome RNA helicase DDX39B	GO:0032786; P:positive regulation of DNA-templated transcription, elongation; IMP:UniProtKB
Q13838	DDX39B	Spliceosome RNA helicase DDX39B	GO:0010501; P:RNA secondary structure unwinding; IDA:BHF-UCL
Q13838	DDX39B	Spliceosome RNA helicase DDX39B	GO:0008380; P:RNA splicing; IDA:BHF-UCL
Q13838	DDX39B	Spliceosome RNA helicase DDX39B	GO:0000245; P:spliceosomal complex assembly; IDA:BHF-UCL
Q13838	DDX39B	Spliceosome RNA helicase DDX39B	GO:0046784; P:viral mRNA export from host cell nucleus; IDA:UniProtKB
O77932	DXO	Decapping and exoribonuclease protein	GO:0008409; F:5'-3' exonuclease activity; ISS:UniProtKB
O77932	DXO	Decapping and exoribonuclease protein	GO:0000287; F:magnesium ion binding; ISS:UniProtKB
O77932	DXO	Decapping and exoribonuclease protein	GO:0003729; F:mRNA binding; ISS:UniProtKB
O77932	DXO	Decapping and exoribonuclease protein	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
O77932	DXO	Decapping and exoribonuclease protein	GO:0034353; F:RNA pyrophosphohydrolase activity; ISS:UniProtKB
O77932	DXO	Decapping and exoribonuclease protein	GO:0008152; P:metabolic process; ISS:UniProtKB
O77932	DXO	Decapping and exoribonuclease protein	GO:0006402; P:mRNA catabolic process; ISS:UniProtKB
O77932	DXO	Decapping and exoribonuclease protein	GO:0071028; P:nuclear mRNA surveillance; ISS:UniProtKB
O77932	DXO	Decapping and exoribonuclease protein	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; ISS:UniProtKB
O77932	DXO	Decapping and exoribonuclease protein	GO:0050779; P:RNA destabilization; ISS:UniProtKB
Q8IVF4	DNAH10	Dynein heavy chain 10, axonemal	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IVF4	DNAH10	Dynein heavy chain 10, axonemal	GO:0016887; F:ATPase activity; IEA:InterPro
Q8IVF4	DNAH10	Dynein heavy chain 10, axonemal	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q8IVF4	DNAH10	Dynein heavy chain 10, axonemal	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q96DT5	DNAH11	Dynein heavy chain 11, axonemal	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96DT5	DNAH11	Dynein heavy chain 11, axonemal	GO:0016887; F:ATPase activity; IEA:InterPro
Q96DT5	DNAH11	Dynein heavy chain 11, axonemal	GO:0003777; F:microtubule motor activity; IEA:Ensembl
Q96DT5	DNAH11	Dynein heavy chain 11, axonemal	GO:0001539; P:cilium or flagellum-dependent cell motility; IEA:Ensembl
Q96DT5	DNAH11	Dynein heavy chain 11, axonemal	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
Q96DT5	DNAH11	Dynein heavy chain 11, axonemal	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q6ZR08	DNAH12	Dynein heavy chain 12, axonemal	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6ZR08	DNAH12	Dynein heavy chain 12, axonemal	GO:0016887; F:ATPase activity; IEA:InterPro
Q6ZR08	DNAH12	Dynein heavy chain 12, axonemal	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q6ZR08	DNAH12	Dynein heavy chain 12, axonemal	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q0VDD8	DNAH14	Dynein heavy chain 14, axonemal	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q0VDD8	DNAH14	Dynein heavy chain 14, axonemal	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q0VDD8	DNAH14	Dynein heavy chain 14, axonemal	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q9UFH2	DNAH17	Dynein heavy chain 17, axonemal	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UFH2	DNAH17	Dynein heavy chain 17, axonemal	GO:0016887; F:ATPase activity; IEA:InterPro
Q9UFH2	DNAH17	Dynein heavy chain 17, axonemal	GO:0003777; F:microtubule motor activity; NAS:UniProtKB
Q9UFH2	DNAH17	Dynein heavy chain 17, axonemal	GO:0001539; P:cilium or flagellum-dependent cell motility; NAS:UniProtKB
Q9UFH2	DNAH17	Dynein heavy chain 17, axonemal	GO:0008152; P:metabolic process; NAS:GOC
Q9UFH2	DNAH17	Dynein heavy chain 17, axonemal	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q9P2D7	DNAH1	Dynein heavy chain 1, axonemal	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9P2D7	DNAH1	Dynein heavy chain 1, axonemal	GO:0016887; F:ATPase activity; IEA:InterPro
Q9P2D7	DNAH1	Dynein heavy chain 1, axonemal	GO:0003777; F:microtubule motor activity; NAS:UniProtKB
Q9P2D7	DNAH1	Dynein heavy chain 1, axonemal	GO:0001539; P:cilium or flagellum-dependent cell motility; NAS:UniProtKB
Q9P2D7	DNAH1	Dynein heavy chain 1, axonemal	GO:0008152; P:metabolic process; NAS:GOC
Q9P2D7	DNAH1	Dynein heavy chain 1, axonemal	GO:0007018; P:microtubule-based movement; IEA:Ensembl
Q9P2D7	DNAH1	Dynein heavy chain 1, axonemal	GO:0009612; P:response to mechanical stimulus; NAS:UniProtKB
Q9P225	DNAH2	Dynein heavy chain 2, axonemal	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9P225	DNAH2	Dynein heavy chain 2, axonemal	GO:0016887; F:ATPase activity; IEA:InterPro
Q9P225	DNAH2	Dynein heavy chain 2, axonemal	GO:0003777; F:microtubule motor activity; NAS:UniProtKB
Q9P225	DNAH2	Dynein heavy chain 2, axonemal	GO:0001539; P:cilium or flagellum-dependent cell motility; NAS:UniProtKB
Q9P225	DNAH2	Dynein heavy chain 2, axonemal	GO:0008152; P:metabolic process; NAS:GOC
Q9P225	DNAH2	Dynein heavy chain 2, axonemal	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q8TD57	DNAH3	Dynein heavy chain 3, axonemal	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8TD57	DNAH3	Dynein heavy chain 3, axonemal	GO:0003777; F:microtubule motor activity; NAS:UniProtKB
Q8TD57	DNAH3	Dynein heavy chain 3, axonemal	GO:0001539; P:cilium or flagellum-dependent cell motility; NAS:UniProtKB
Q8TD57	DNAH3	Dynein heavy chain 3, axonemal	GO:0008152; P:metabolic process; NAS:GOC
Q8TD57	DNAH3	Dynein heavy chain 3, axonemal	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q8TE73	DNAH5	Dynein heavy chain 5, axonemal	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8TE73	DNAH5	Dynein heavy chain 5, axonemal	GO:0016887; F:ATPase activity; IEA:InterPro
Q8TE73	DNAH5	Dynein heavy chain 5, axonemal	GO:0003777; F:microtubule motor activity; NAS:UniProtKB
Q8TE73	DNAH5	Dynein heavy chain 5, axonemal	GO:0001539; P:cilium or flagellum-dependent cell motility; IEA:Ensembl
Q8TE73	DNAH5	Dynein heavy chain 5, axonemal	GO:0008152; P:metabolic process; NAS:GOC
Q8TE73	DNAH5	Dynein heavy chain 5, axonemal	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q9C0G6	DNAH6	Dynein heavy chain 6, axonemal	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9C0G6	DNAH6	Dynein heavy chain 6, axonemal	GO:0016887; F:ATPase activity; IEA:InterPro
Q9C0G6	DNAH6	Dynein heavy chain 6, axonemal	GO:0003777; F:microtubule motor activity; NAS:UniProtKB
Q9C0G6	DNAH6	Dynein heavy chain 6, axonemal	GO:0008152; P:metabolic process; NAS:GOC
Q9C0G6	DNAH6	Dynein heavy chain 6, axonemal	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q8WXX0	DNAH7	Dynein heavy chain 7, axonemal	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8WXX0	DNAH7	Dynein heavy chain 7, axonemal	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8WXX0	DNAH7	Dynein heavy chain 7, axonemal	GO:0003777; F:microtubule motor activity; NAS:UniProtKB
Q8WXX0	DNAH7	Dynein heavy chain 7, axonemal	GO:0001539; P:cilium or flagellum-dependent cell motility; NAS:UniProtKB
Q8WXX0	DNAH7	Dynein heavy chain 7, axonemal	GO:0008152; P:metabolic process; NAS:GOC
Q8WXX0	DNAH7	Dynein heavy chain 7, axonemal	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q96JB1	DNAH8	Dynein heavy chain 8, axonemal	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96JB1	DNAH8	Dynein heavy chain 8, axonemal	GO:0016887; F:ATPase activity; IEA:InterPro
Q96JB1	DNAH8	Dynein heavy chain 8, axonemal	GO:0003777; F:microtubule motor activity; NAS:UniProtKB
Q96JB1	DNAH8	Dynein heavy chain 8, axonemal	GO:0001539; P:cilium or flagellum-dependent cell motility; NAS:UniProtKB
Q96JB1	DNAH8	Dynein heavy chain 8, axonemal	GO:0008152; P:metabolic process; NAS:GOC
Q96JB1	DNAH8	Dynein heavy chain 8, axonemal	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q9NYC9	DNAH9	Dynein heavy chain 9, axonemal	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NYC9	DNAH9	Dynein heavy chain 9, axonemal	GO:0016887; F:ATPase activity; IEA:InterPro
Q9NYC9	DNAH9	Dynein heavy chain 9, axonemal	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q9NYC9	DNAH9	Dynein heavy chain 9, axonemal	GO:0003774; F:motor activity; TAS:ProtInc
Q9NYC9	DNAH9	Dynein heavy chain 9, axonemal	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
Q9NYC9	DNAH9	Dynein heavy chain 9, axonemal	GO:0006928; P:cellular component movement; TAS:ProtInc
Q9NYC9	DNAH9	Dynein heavy chain 9, axonemal	GO:0008152; P:metabolic process; TAS:GOC
Q9NYC9	DNAH9	Dynein heavy chain 9, axonemal	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q9NYC9	DNAH9	Dynein heavy chain 9, axonemal	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q14204	DYNC1H1	Cytoplasmic dynein 1 heavy chain 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q14204	DYNC1H1	Cytoplasmic dynein 1 heavy chain 1	GO:0016887; F:ATPase activity; IEA:InterPro
Q14204	DYNC1H1	Cytoplasmic dynein 1 heavy chain 1	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q14204	DYNC1H1	Cytoplasmic dynein 1 heavy chain 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14204	DYNC1H1	Cytoplasmic dynein 1 heavy chain 1	GO:0005515; F:protein binding; IPI:IntAct
Q14204	DYNC1H1	Cytoplasmic dynein 1 heavy chain 1	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q14204	DYNC1H1	Cytoplasmic dynein 1 heavy chain 1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q14204	DYNC1H1	Cytoplasmic dynein 1 heavy chain 1	GO:0033962; P:cytoplasmic mRNA processing body assembly; ISS:BHF-UCL
Q14204	DYNC1H1	Cytoplasmic dynein 1 heavy chain 1	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q14204	DYNC1H1	Cytoplasmic dynein 1 heavy chain 1	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q14204	DYNC1H1	Cytoplasmic dynein 1 heavy chain 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q14204	DYNC1H1	Cytoplasmic dynein 1 heavy chain 1	GO:0007052; P:mitotic spindle organization; NAS:UniProtKB
Q14204	DYNC1H1	Cytoplasmic dynein 1 heavy chain 1	GO:0034063; P:stress granule assembly; ISS:BHF-UCL
Q14204	DYNC1H1	Cytoplasmic dynein 1 heavy chain 1	GO:0006810; P:transport; IEA:UniProtKB-KW
Q8NCM8	DYNC2H1	Cytoplasmic dynein 2 heavy chain 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NCM8	DYNC2H1	Cytoplasmic dynein 2 heavy chain 1	GO:0016887; F:ATPase activity; IEA:InterPro
Q8NCM8	DYNC2H1	Cytoplasmic dynein 2 heavy chain 1	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q8NCM8	DYNC2H1	Cytoplasmic dynein 2 heavy chain 1	GO:0003774; F:motor activity; NAS:UniProtKB
Q8NCM8	DYNC2H1	Cytoplasmic dynein 2 heavy chain 1	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q8NCM8	DYNC2H1	Cytoplasmic dynein 2 heavy chain 1	GO:0008105; P:asymmetric protein localization; IEA:Ensembl
Q8NCM8	DYNC2H1	Cytoplasmic dynein 2 heavy chain 1	GO:0042384; P:cilium assembly; IEA:Ensembl
Q8NCM8	DYNC2H1	Cytoplasmic dynein 2 heavy chain 1	GO:0001539; P:cilium or flagellum-dependent cell motility; IEA:InterPro
Q8NCM8	DYNC2H1	Cytoplasmic dynein 2 heavy chain 1	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
Q8NCM8	DYNC2H1	Cytoplasmic dynein 2 heavy chain 1	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
Q8NCM8	DYNC2H1	Cytoplasmic dynein 2 heavy chain 1	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
Q8NCM8	DYNC2H1	Cytoplasmic dynein 2 heavy chain 1	GO:0030900; P:forebrain development; IEA:Ensembl
Q8NCM8	DYNC2H1	Cytoplasmic dynein 2 heavy chain 1	GO:0007030; P:Golgi organization; IDA:UniProtKB
Q8NCM8	DYNC2H1	Cytoplasmic dynein 2 heavy chain 1	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q8NCM8	DYNC2H1	Cytoplasmic dynein 2 heavy chain 1	GO:0016485; P:protein processing; IEA:Ensembl
Q8NCM8	DYNC2H1	Cytoplasmic dynein 2 heavy chain 1	GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl
P63167	DYNLL1	Dynein light chain 1, cytoplasmic	GO:0003774; F:motor activity; TAS:ProtInc
P63167	DYNLL1	Dynein light chain 1, cytoplasmic	GO:0030235; F:nitric-oxide synthase regulator activity; IEA:Ensembl
P63167	DYNLL1	Dynein light chain 1, cytoplasmic	GO:0005515; F:protein binding; IPI:UniProtKB
P63167	DYNLL1	Dynein light chain 1, cytoplasmic	GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc
P63167	DYNLL1	Dynein light chain 1, cytoplasmic	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P63167	DYNLL1	Dynein light chain 1, cytoplasmic	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P63167	DYNLL1	Dynein light chain 1, cytoplasmic	GO:0006915; P:apoptotic process; TAS:Reactome
P63167	DYNLL1	Dynein light chain 1, cytoplasmic	GO:0007292; P:female gamete generation; TAS:ProtInc
P63167	DYNLL1	Dynein light chain 1, cytoplasmic	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P63167	DYNLL1	Dynein light chain 1, cytoplasmic	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
P63167	DYNLL1	Dynein light chain 1, cytoplasmic	GO:0007017; P:microtubule-based process; IEA:InterPro
P63167	DYNLL1	Dynein light chain 1, cytoplasmic	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P63167	DYNLL1	Dynein light chain 1, cytoplasmic	GO:0042326; P:negative regulation of phosphorylation; IDA:UniProtKB
P63167	DYNLL1	Dynein light chain 1, cytoplasmic	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
P63167	DYNLL1	Dynein light chain 1, cytoplasmic	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P63167	DYNLL1	Dynein light chain 1, cytoplasmic	GO:0021762; P:substantia nigra development; IEP:UniProt
P63167	DYNLL1	Dynein light chain 1, cytoplasmic	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P63167	DYNLL1	Dynein light chain 1, cytoplasmic	GO:0006810; P:transport; IEA:UniProtKB-KW
P63167	DYNLL1	Dynein light chain 1, cytoplasmic	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q96FJ2	DYNLL2	Dynein light chain 2, cytoplasmic	GO:0003774; F:motor activity; IEA:UniProtKB-KW
Q96FJ2	DYNLL2	Dynein light chain 2, cytoplasmic	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q96FJ2	DYNLL2	Dynein light chain 2, cytoplasmic	GO:0006915; P:apoptotic process; TAS:Reactome
Q96FJ2	DYNLL2	Dynein light chain 2, cytoplasmic	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
Q96FJ2	DYNLL2	Dynein light chain 2, cytoplasmic	GO:0007017; P:microtubule-based process; IEA:InterPro
Q96FJ2	DYNLL2	Dynein light chain 2, cytoplasmic	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
Q96FJ2	DYNLL2	Dynein light chain 2, cytoplasmic	GO:0008039; P:synaptic target recognition; IEA:Ensembl
Q96FJ2	DYNLL2	Dynein light chain 2, cytoplasmic	GO:0006810; P:transport; IEA:UniProtKB-KW
P63172	DYNLT1	Dynein light chain Tctex-type 1	GO:0042802; F:identical protein binding; IPI:UniProtKB
P63172	DYNLT1	Dynein light chain Tctex-type 1	GO:0003774; F:motor activity; IEA:UniProtKB-KW
P63172	DYNLT1	Dynein light chain Tctex-type 1	GO:0005515; F:protein binding; IPI:UniProtKB
P63172	DYNLT1	Dynein light chain Tctex-type 1	GO:0000132; P:establishment of mitotic spindle orientation; ISS:UniProtKB
P63172	DYNLT1	Dynein light chain Tctex-type 1	GO:0019060; P:intracellular transport of viral protein in host cell; IMP:UniProtKB
P63172	DYNLT1	Dynein light chain Tctex-type 1	GO:0075521; P:microtubule-dependent intracellular transport of viral material towards nucleus; IEA:UniProtKB-KW
P63172	DYNLT1	Dynein light chain Tctex-type 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P63172	DYNLT1	Dynein light chain Tctex-type 1	GO:0050768; P:negative regulation of neurogenesis; ISS:UniProtKB
P63172	DYNLT1	Dynein light chain Tctex-type 1	GO:0048812; P:neuron projection morphogenesis; IEA:Ensembl
P63172	DYNLT1	Dynein light chain Tctex-type 1	GO:0051493; P:regulation of cytoskeleton organization; IEA:Ensembl
P63172	DYNLT1	Dynein light chain Tctex-type 1	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; ISS:UniProtKB
P63172	DYNLT1	Dynein light chain Tctex-type 1	GO:0032314; P:regulation of Rac GTPase activity; IEA:Ensembl
P63172	DYNLT1	Dynein light chain Tctex-type 1	GO:0046718; P:viral entry into host cell; IEA:UniProtKB-KW
P51808	DYNLT3	Dynein light chain Tctex-type 3	GO:0003774; F:motor activity; IEA:UniProtKB-KW
P51808	DYNLT3	Dynein light chain Tctex-type 3	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P51808	DYNLT3	Dynein light chain Tctex-type 3	GO:0007346; P:regulation of mitotic cell cycle; ISS:UniProtKB
P51808	DYNLT3	Dynein light chain Tctex-type 3	GO:0006810; P:transport; IEA:UniProtKB-KW
Q7RTS9	DYM	Dymeclin	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q7RTS9	DYM	Dymeclin	GO:0005515; F:protein binding; IPI:UniProtKB
Q7RTS9	DYM	Dymeclin	GO:0060348; P:bone development; IMP:UniProtKB
Q7RTS9	DYM	Dymeclin	GO:0007030; P:Golgi organization; IMP:UniProtKB
Q05193	DNM1	Dynamin-1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q05193	DNM1	Dynamin-1	GO:0003924; F:GTPase activity; TAS:ProtInc
Q05193	DNM1	Dynamin-1	GO:0042802; F:identical protein binding; IPI:IntAct
Q05193	DNM1	Dynamin-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q05193	DNM1	Dynamin-1	GO:0005515; F:protein binding; IPI:IntAct
Q05193	DNM1	Dynamin-1	GO:0006897; P:endocytosis; IMP:BHF-UCL
Q05193	DNM1	Dynamin-1	GO:0007032; P:endosome organization; IMP:BHF-UCL
Q05193	DNM1	Dynamin-1	GO:0006184; P:GTP catabolic process; TAS:GOC
Q05193	DNM1	Dynamin-1	GO:0031623; P:receptor internalization; IEA:Ensembl
Q05193	DNM1	Dynamin-1	GO:0006898; P:receptor-mediated endocytosis; IMP:UniProtKB
P50570	DNM2	Dynamin-2	GO:0019899; F:enzyme binding; NAS:UniProtKB
P50570	DNM2	Dynamin-2	GO:0005525; F:GTP binding; NAS:UniProtKB
P50570	DNM2	Dynamin-2	GO:0003924; F:GTPase activity; NAS:UniProtKB
P50570	DNM2	Dynamin-2	GO:0008017; F:microtubule binding; NAS:UniProtKB
P50570	DNM2	Dynamin-2	GO:0005515; F:protein binding; IPI:UniProtKB
P50570	DNM2	Dynamin-2	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P50570	DNM2	Dynamin-2	GO:0008219; P:cell death; IEA:UniProtKB-KW
P50570	DNM2	Dynamin-2	GO:0006897; P:endocytosis; NAS:UniProtKB
P50570	DNM2	Dynamin-2	GO:0000086; P:G2/M transition of mitotic cell cycle; NAS:UniProtKB
P50570	DNM2	Dynamin-2	GO:0006184; P:GTP catabolic process; NAS:GOC
P50570	DNM2	Dynamin-2	GO:0061024; P:membrane organization; TAS:Reactome
P50570	DNM2	Dynamin-2	GO:0046209; P:nitric oxide metabolic process; TAS:Reactome
P50570	DNM2	Dynamin-2	GO:0043065; P:positive regulation of apoptotic process; NAS:UniProtKB
P50570	DNM2	Dynamin-2	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
P50570	DNM2	Dynamin-2	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
P50570	DNM2	Dynamin-2	GO:0031623; P:receptor internalization; IMP:BHF-UCL
P50570	DNM2	Dynamin-2	GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome
P50570	DNM2	Dynamin-2	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P50570	DNM2	Dynamin-2	GO:0007165; P:signal transduction; NAS:UniProtKB
P50570	DNM2	Dynamin-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P50570	DNM2	Dynamin-2	GO:0048489; P:synaptic vesicle transport; NAS:UniProtKB
P50570	DNM2	Dynamin-2	GO:0033572; P:transferrin transport; IMP:BHF-UCL
Q8N1N2	DYNAP	Dynactin-associated protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N1N2	DYNAP	Dynactin-associated protein	GO:0032148; P:activation of protein kinase B activity; IDA:UniProtKB
Q8N1N2	DYNAP	Dynactin-associated protein	GO:1901625; P:cellular response to ergosterol; IDA:UniProtKB
Q8N1N2	DYNAP	Dynactin-associated protein	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q8N1N2	DYNAP	Dynactin-associated protein	GO:0042981; P:regulation of apoptotic process; IDA:UniProtKB
Q9UQ16	DNM3	Dynamin-3	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9UQ16	DNM3	Dynamin-3	GO:0003924; F:GTPase activity; IEA:InterPro
Q9UQ16	DNM3	Dynamin-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UQ16	DNM3	Dynamin-3	GO:0006897; P:endocytosis; ISS:UniProtKB
Q9UQ16	DNM3	Dynamin-3	GO:0046847; P:filopodium assembly; ISS:UniProtKB
Q9UQ16	DNM3	Dynamin-3	GO:0006184; P:GTP catabolic process; ISS:GOC
Q9UQ16	DNM3	Dynamin-3	GO:0007416; P:synapse assembly; ISS:UniProtKB
Q13627	DYRK1A	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13627	DYRK1A	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:MGI
Q13627	DYRK1A	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	GO:0005515; F:protein binding; IPI:IntAct
Q13627	DYRK1A	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q13627	DYRK1A	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	GO:0043621; F:protein self-association; ISS:UniProtKB
Q13627	DYRK1A	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB
Q13627	DYRK1A	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC
Q13627	DYRK1A	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	GO:0004713; F:protein tyrosine kinase activity; ISS:UniProtKB
Q13627	DYRK1A	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	GO:0048156; F:tau protein binding; ISS:BHF-UCL
Q13627	DYRK1A	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	GO:0007623; P:circadian rhythm; ISS:UniProtKB
Q13627	DYRK1A	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q13627	DYRK1A	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	GO:0043518; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; ISS:BHF-UCL
Q13627	DYRK1A	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	GO:0007399; P:nervous system development; TAS:ProtInc
Q13627	DYRK1A	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl
Q13627	DYRK1A	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	GO:0018107; P:peptidyl-threonine phosphorylation; ISS:BHF-UCL
Q13627	DYRK1A	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	GO:0018108; P:peptidyl-tyrosine phosphorylation; ISS:UniProtKB
Q13627	DYRK1A	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	GO:0090312; P:positive regulation of protein deacetylation; ISS:BHF-UCL
Q13627	DYRK1A	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	GO:0046777; P:protein autophosphorylation; ISS:UniProtKB
Q13627	DYRK1A	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
Q9Y463	DYRK1B	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y463	DYRK1B	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y463	DYRK1B	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q9Y463	DYRK1B	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q9Y463	DYRK1B	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC
Q9Y463	DYRK1B	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW
Q9Y463	DYRK1B	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q9Y463	DYRK1B	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	GO:0007520; P:myoblast fusion; IEA:Ensembl
Q9Y463	DYRK1B	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9Y463	DYRK1B	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q92630	DYRK2	Dual specificity tyrosine-phosphorylation-regulated kinase 2	GO:0005524; F:ATP binding; IDA:UniProtKB
Q92630	DYRK2	Dual specificity tyrosine-phosphorylation-regulated kinase 2	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q92630	DYRK2	Dual specificity tyrosine-phosphorylation-regulated kinase 2	GO:0030145; F:manganese ion binding; IDA:UniProtKB
Q92630	DYRK2	Dual specificity tyrosine-phosphorylation-regulated kinase 2	GO:0005515; F:protein binding; IPI:IntAct
Q92630	DYRK2	Dual specificity tyrosine-phosphorylation-regulated kinase 2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q92630	DYRK2	Dual specificity tyrosine-phosphorylation-regulated kinase 2	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC
Q92630	DYRK2	Dual specificity tyrosine-phosphorylation-regulated kinase 2	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
Q92630	DYRK2	Dual specificity tyrosine-phosphorylation-regulated kinase 2	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
Q92630	DYRK2	Dual specificity tyrosine-phosphorylation-regulated kinase 2	GO:0006974; P:cellular response to DNA damage stimulus; IEP:UniProtKB
Q92630	DYRK2	Dual specificity tyrosine-phosphorylation-regulated kinase 2	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IDA:UniProtKB
Q92630	DYRK2	Dual specificity tyrosine-phosphorylation-regulated kinase 2	GO:0051534; P:negative regulation of NFAT protein import into nucleus; IMP:UniProtKB
Q92630	DYRK2	Dual specificity tyrosine-phosphorylation-regulated kinase 2	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:GOC
Q92630	DYRK2	Dual specificity tyrosine-phosphorylation-regulated kinase 2	GO:0045725; P:positive regulation of glycogen biosynthetic process; IDA:UniProtKB
Q92630	DYRK2	Dual specificity tyrosine-phosphorylation-regulated kinase 2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q92630	DYRK2	Dual specificity tyrosine-phosphorylation-regulated kinase 2	GO:0007224; P:smoothened signaling pathway; IMP:UniProtKB
O43781	DYRK3	Dual specificity tyrosine-phosphorylation-regulated kinase 3	GO:0005524; F:ATP binding; IDA:UniProtKB
O43781	DYRK3	Dual specificity tyrosine-phosphorylation-regulated kinase 3	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
O43781	DYRK3	Dual specificity tyrosine-phosphorylation-regulated kinase 3	GO:0004672; F:protein kinase activity; IDA:UniProtKB
O43781	DYRK3	Dual specificity tyrosine-phosphorylation-regulated kinase 3	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
O43781	DYRK3	Dual specificity tyrosine-phosphorylation-regulated kinase 3	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC
O43781	DYRK3	Dual specificity tyrosine-phosphorylation-regulated kinase 3	GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW
O43781	DYRK3	Dual specificity tyrosine-phosphorylation-regulated kinase 3	GO:0030218; P:erythrocyte differentiation; IDA:UniProtKB
O43781	DYRK3	Dual specificity tyrosine-phosphorylation-regulated kinase 3	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9NR20	DYRK4	Dual specificity tyrosine-phosphorylation-regulated kinase 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NR20	DYRK4	Dual specificity tyrosine-phosphorylation-regulated kinase 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NR20	DYRK4	Dual specificity tyrosine-phosphorylation-regulated kinase 4	GO:0005515; F:protein binding; IPI:IntAct
Q9NR20	DYRK4	Dual specificity tyrosine-phosphorylation-regulated kinase 4	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q9NR20	DYRK4	Dual specificity tyrosine-phosphorylation-regulated kinase 4	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC
Q9NR20	DYRK4	Dual specificity tyrosine-phosphorylation-regulated kinase 4	GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW
Q86XF0	DHFRL1	Dihydrofolate reductase, mitochondrial	GO:0004146; F:dihydrofolate reductase activity; IMP:UniProtKB
Q86XF0	DHFRL1	Dihydrofolate reductase, mitochondrial	GO:0003729; F:mRNA binding; IDA:UniProtKB
Q86XF0	DHFRL1	Dihydrofolate reductase, mitochondrial	GO:0050661; F:NADP binding; IEA:InterPro
Q86XF0	DHFRL1	Dihydrofolate reductase, mitochondrial	GO:0006545; P:glycine biosynthetic process; IEA:InterPro
Q86XF0	DHFRL1	Dihydrofolate reductase, mitochondrial	GO:0009165; P:nucleotide biosynthetic process; IEA:InterPro
Q86XF0	DHFRL1	Dihydrofolate reductase, mitochondrial	GO:0006730; P:one-carbon metabolic process; IEA:UniProtKB-KW
Q86XF0	DHFRL1	Dihydrofolate reductase, mitochondrial	GO:0046654; P:tetrahydrofolate biosynthetic process; IEA:UniProtKB-UniPathway
Q86XF0	DHFRL1	Dihydrofolate reductase, mitochondrial	GO:0046653; P:tetrahydrofolate metabolic process; IDA:UniProtKB
Q86XF0	DHFRL1	Dihydrofolate reductase, mitochondrial	GO:0046105; P:thymidine biosynthetic process; IDA:UniProtKB
P00374	DHFR	Dihydrofolate reductase	GO:0004146; F:dihydrofolate reductase activity; IDA:UniProtKB
P00374	DHFR	Dihydrofolate reductase	GO:0008144; F:drug binding; IDA:UniProtKB
P00374	DHFR	Dihydrofolate reductase	GO:0003729; F:mRNA binding; IDA:UniProtKB
P00374	DHFR	Dihydrofolate reductase	GO:0050661; F:NADP binding; IEA:InterPro
P00374	DHFR	Dihydrofolate reductase	GO:0046655; P:folic acid metabolic process; TAS:Reactome
P00374	DHFR	Dihydrofolate reductase	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P00374	DHFR	Dihydrofolate reductase	GO:0006545; P:glycine biosynthetic process; IEA:InterPro
P00374	DHFR	Dihydrofolate reductase	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P00374	DHFR	Dihydrofolate reductase	GO:0046209; P:nitric oxide metabolic process; TAS:Reactome
P00374	DHFR	Dihydrofolate reductase	GO:0009165; P:nucleotide biosynthetic process; IEA:InterPro
P00374	DHFR	Dihydrofolate reductase	GO:0006730; P:one-carbon metabolic process; IEA:UniProtKB-KW
P00374	DHFR	Dihydrofolate reductase	GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome
P00374	DHFR	Dihydrofolate reductase	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; TAS:Reactome
P00374	DHFR	Dihydrofolate reductase	GO:0031427; P:response to methotrexate; IEA:UniProtKB-KW
P00374	DHFR	Dihydrofolate reductase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P00374	DHFR	Dihydrofolate reductase	GO:0046654; P:tetrahydrofolate biosynthetic process; IEA:UniProtKB-UniPathway
P00374	DHFR	Dihydrofolate reductase	GO:0046653; P:tetrahydrofolate metabolic process; IDA:UniProtKB
P00374	DHFR	Dihydrofolate reductase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P00374	DHFR	Dihydrofolate reductase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
O75923	DYSF	Dysferlin	GO:0005509; F:calcium ion binding; IDA:UniProtKB
O75923	DYSF	Dysferlin	GO:0005544; F:calcium-dependent phospholipid binding; IMP:UniProtKB
O75923	DYSF	Dysferlin	GO:0005543; F:phospholipid binding; IDA:UniProtKB
O75923	DYSF	Dysferlin	GO:0005515; F:protein binding; IPI:IntAct
O75923	DYSF	Dysferlin	GO:0001778; P:plasma membrane repair; IEA:Ensembl
O75923	DYSF	Dysferlin	GO:0006906; P:vesicle fusion; IEA:Ensembl
Q03001	DST	Dystonin	GO:0005509; F:calcium ion binding; IEA:InterPro
Q03001	DST	Dystonin	GO:0005178; F:integrin binding; IPI:UniProtKB
Q03001	DST	Dystonin	GO:0051010; F:microtubule plus-end binding; IDA:UniProtKB
Q03001	DST	Dystonin	GO:0005515; F:protein binding; IPI:UniProtKB
Q03001	DST	Dystonin	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q03001	DST	Dystonin	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q03001	DST	Dystonin	GO:0007409; P:axonogenesis; IEA:Ensembl
Q03001	DST	Dystonin	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q03001	DST	Dystonin	GO:0007050; P:cell cycle arrest; IEA:InterPro
Q03001	DST	Dystonin	GO:0048870; P:cell motility; IMP:UniProtKB
Q03001	DST	Dystonin	GO:0031122; P:cytoplasmic microtubule organization; IEA:Ensembl
Q03001	DST	Dystonin	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q03001	DST	Dystonin	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q03001	DST	Dystonin	GO:0031581; P:hemidesmosome assembly; IDA:UniProtKB
Q03001	DST	Dystonin	GO:0007229; P:integrin-mediated signaling pathway; NAS:UniProtKB
Q03001	DST	Dystonin	GO:0045104; P:intermediate filament cytoskeleton organization; IEP:UniProtKB
Q03001	DST	Dystonin	GO:0030011; P:maintenance of cell polarity; IMP:UniProtKB
Q03001	DST	Dystonin	GO:0000226; P:microtubule cytoskeleton organization; IDA:UniProtKB
Q03001	DST	Dystonin	GO:0031110; P:regulation of microtubule polymerization or depolymerization; IEA:Ensembl
Q03001	DST	Dystonin	GO:0009611; P:response to wounding; IDA:UniProtKB
Q03001	DST	Dystonin	GO:0008090; P:retrograde axon cargo transport; IEA:Ensembl
A2CJ06	DYTN	Dystrotelin	GO:0005509; F:calcium ion binding; IEA:InterPro
A2CJ06	DYTN	Dystrotelin	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WXU2	DYX1C1	Dyslexia susceptibility 1 candidate gene 1 protein	GO:0030331; F:estrogen receptor binding; IDA:UniProtKB
Q8WXU2	DYX1C1	Dyslexia susceptibility 1 candidate gene 1 protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WXU2	DYX1C1	Dyslexia susceptibility 1 candidate gene 1 protein	GO:0003341; P:cilium movement; IMP:UniProtKB
Q8WXU2	DYX1C1	Dyslexia susceptibility 1 candidate gene 1 protein	GO:0007368; P:determination of left/right symmetry; IMP:UniProtKB
Q8WXU2	DYX1C1	Dyslexia susceptibility 1 candidate gene 1 protein	GO:0036159; P:inner dynein arm assembly; IMP:UniProtKB
Q8WXU2	DYX1C1	Dyslexia susceptibility 1 candidate gene 1 protein	GO:0001764; P:neuron migration; ISS:UniProtKB
Q8WXU2	DYX1C1	Dyslexia susceptibility 1 candidate gene 1 protein	GO:0036158; P:outer dynein arm assembly; IMP:UniProtKB
Q8WXU2	DYX1C1	Dyslexia susceptibility 1 candidate gene 1 protein	GO:0033146; P:regulation of intracellular estrogen receptor signaling pathway; IDA:UniProtKB
Q8WXU2	DYX1C1	Dyslexia susceptibility 1 candidate gene 1 protein	GO:0061136; P:regulation of proteasomal protein catabolic process; IDA:UniProtKB
Q9NVP4	DZANK1	Double zinc ribbon and ankyrin repeat-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IYY4	DZIP1L	Zinc finger protein DZIP1L	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IYY4	DZIP1L	Zinc finger protein DZIP1L	GO:0042384; P:cilium assembly; IMP:BHF-UCL
Q86YF9	DZIP1	Zinc finger protein DZIP1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86YF9	DZIP1	Zinc finger protein DZIP1	GO:0005515; F:protein binding; IPI:UniProtKB
Q86YF9	DZIP1	Zinc finger protein DZIP1	GO:0042384; P:cilium assembly; IMP:BHF-UCL
Q86YF9	DZIP1	Zinc finger protein DZIP1	GO:0007281; P:germ cell development; NAS:UniProtKB
Q86YF9	DZIP1	Zinc finger protein DZIP1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q86YF9	DZIP1	Zinc finger protein DZIP1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q86Y13	DZIP3	E3 ubiquitin-protein ligase DZIP3	GO:0019902; F:phosphatase binding; IDA:UniProtKB
Q86Y13	DZIP3	E3 ubiquitin-protein ligase DZIP3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q86Y13	DZIP3	E3 ubiquitin-protein ligase DZIP3	GO:0031593; F:polyubiquitin binding; IDA:UniProtKB
Q86Y13	DZIP3	E3 ubiquitin-protein ligase DZIP3	GO:0005515; F:protein binding; IPI:IntAct
Q86Y13	DZIP3	E3 ubiquitin-protein ligase DZIP3	GO:0003723; F:RNA binding; IDA:UniProtKB
Q86Y13	DZIP3	E3 ubiquitin-protein ligase DZIP3	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q86Y13	DZIP3	E3 ubiquitin-protein ligase DZIP3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86Y13	DZIP3	E3 ubiquitin-protein ligase DZIP3	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q9BQI3	EIF2AK1	Eukaryotic translation initiation factor 2-alpha kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BQI3	EIF2AK1	Eukaryotic translation initiation factor 2-alpha kinase 1	GO:0004694; F:eukaryotic translation initiation factor 2alpha kinase activity; IDA:UniProtKB
Q9BQI3	EIF2AK1	Eukaryotic translation initiation factor 2-alpha kinase 1	GO:0020037; F:heme binding; ISS:UniProtKB
Q9BQI3	EIF2AK1	Eukaryotic translation initiation factor 2-alpha kinase 1	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q9BQI3	EIF2AK1	Eukaryotic translation initiation factor 2-alpha kinase 1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q9BQI3	EIF2AK1	Eukaryotic translation initiation factor 2-alpha kinase 1	GO:0046986; P:negative regulation of hemoglobin biosynthetic process; ISS:UniProtKB
Q9BQI3	EIF2AK1	Eukaryotic translation initiation factor 2-alpha kinase 1	GO:0045993; P:negative regulation of translational initiation by iron; NAS:UniProtKB
Q9BQI3	EIF2AK1	Eukaryotic translation initiation factor 2-alpha kinase 1	GO:0046777; P:protein autophosphorylation; ISS:UniProtKB
Q9BQI3	EIF2AK1	Eukaryotic translation initiation factor 2-alpha kinase 1	GO:0046501; P:protoporphyrinogen IX metabolic process; IEA:Ensembl
Q9BQI3	EIF2AK1	Eukaryotic translation initiation factor 2-alpha kinase 1	GO:0010999; P:regulation of eIF2 alpha phosphorylation by heme; IEA:Ensembl
Q9BQI3	EIF2AK1	Eukaryotic translation initiation factor 2-alpha kinase 1	GO:0009605; P:response to external stimulus; IEP:UniProtKB
Q9BQI3	EIF2AK1	Eukaryotic translation initiation factor 2-alpha kinase 1	GO:0006950; P:response to stress; IEP:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0003725; F:double-stranded RNA binding; IDA:MGI
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0004694; F:eukaryotic translation initiation factor 2alpha kinase activity; TAS:ProtInc
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0005515; F:protein binding; IPI:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0004672; F:protein kinase activity; IDA:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:ProtInc
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0000186; P:activation of MAPKK activity; IMP:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0030968; P:endoplasmic reticulum unfolded protein response; IEA:Ensembl
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0030683; P:evasion or tolerance by virus of host immune response; TAS:Reactome
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0019048; P:modulation by virus of host morphology or physiology; TAS:Reactome
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0019054; P:modulation by virus of host process; TAS:Reactome
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0033689; P:negative regulation of osteoblast proliferation; IMP:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0017148; P:negative regulation of translation; IDA:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0045071; P:negative regulation of viral genome replication; IMP:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0032722; P:positive regulation of chemokine production; ISS:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0001819; P:positive regulation of cytokine production; ISS:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:1901224; P:positive regulation of NIK/NF-kappaB signaling; ISS:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0032874; P:positive regulation of stress-activated MAPK cascade; ISS:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:1901532; P:regulation of hematopoietic progenitor cell differentiation; ISS:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:1902036; P:regulation of hematopoietic stem cell differentiation; ISS:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:1902033; P:regulation of hematopoietic stem cell proliferation; ISS:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:1900225; P:regulation of NLRP3 inflammasome complex assembly; ISS:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0035455; P:response to interferon-alpha; IDA:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0009615; P:response to virus; IMP:UniProtKB
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0006412; P:translation; IEA:Ensembl
P19525	EIF2AK2	Interferon-induced, double-stranded RNA-activated protein kinase	GO:0019058; P:viral life cycle; TAS:Reactome
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0019899; F:enzyme binding; IPI:UniProt
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0004694; F:eukaryotic translation initiation factor 2alpha kinase activity; IDA:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0042802; F:identical protein binding; IPI:IntAct
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; ISS:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0030282; P:bone mineralization; ISS:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0019722; P:calcium-mediated signaling; ISS:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0002063; P:chondrocyte development; ISS:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0031018; P:endocrine pancreas development; IMP:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0007029; P:endoplasmic reticulum organization; ISS:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0030968; P:endoplasmic reticulum unfolded protein response; IDA:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0006983; P:ER overload response; IDA:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0045444; P:fat cell differentiation; IEA:Ensembl
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0030073; P:insulin secretion; ISS:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0048009; P:insulin-like growth factor receptor signaling pathway; ISS:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IEA:Ensembl
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0007595; P:lactation; IEA:Ensembl
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0031642; P:negative regulation of myelination; ISS:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0017148; P:negative regulation of translation; TAS:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0032057; P:negative regulation of translational initiation in response to stress; TAS:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0001503; P:ossification; IMP:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0032092; P:positive regulation of protein binding; IEA:Ensembl
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0009967; P:positive regulation of signal transduction; IEA:Ensembl
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0051260; P:protein homooligomerization; IMP:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0019217; P:regulation of fatty acid metabolic process; IEA:Ensembl
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0034976; P:response to endoplasmic reticulum stress; IMP:BHF-UCL
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0001501; P:skeletal system development; ISS:UniProtKB
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0032933; P:SREBP signaling pathway; IEA:Ensembl
Q9NZJ5	EIF2AK3	Eukaryotic translation initiation factor 2-alpha kinase 3	GO:0006412; P:translation; IEA:Ensembl
Q9P2K8	EIF2AK4	Eukaryotic translation initiation factor 2-alpha kinase 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9P2K8	EIF2AK4	Eukaryotic translation initiation factor 2-alpha kinase 4	GO:0004694; F:eukaryotic translation initiation factor 2alpha kinase activity; ISS:UniProtKB
Q9P2K8	EIF2AK4	Eukaryotic translation initiation factor 2-alpha kinase 4	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB
Q9P2K8	EIF2AK4	Eukaryotic translation initiation factor 2-alpha kinase 4	GO:0009267; P:cellular response to starvation; IEA:Ensembl
Q9P2K8	EIF2AK4	Eukaryotic translation initiation factor 2-alpha kinase 4	GO:0030968; P:endoplasmic reticulum unfolded protein response; IEA:Ensembl
Q9P2K8	EIF2AK4	Eukaryotic translation initiation factor 2-alpha kinase 4	GO:0017148; P:negative regulation of translation; IEA:Ensembl
Q9P2K8	EIF2AK4	Eukaryotic translation initiation factor 2-alpha kinase 4	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
Q9P2K8	EIF2AK4	Eukaryotic translation initiation factor 2-alpha kinase 4	GO:0006446; P:regulation of translational initiation; ISS:UniProtKB
Q9P2K8	EIF2AK4	Eukaryotic translation initiation factor 2-alpha kinase 4	GO:0043558; P:regulation of translational initiation in response to stress; IEA:Ensembl
Q01094	E2F1	Transcription factor E2F1	GO:0001047; F:core promoter binding; IDA:UniProtKB
Q01094	E2F1	Transcription factor E2F1	GO:0003677; F:DNA binding; IDA:UniProtKB
Q01094	E2F1	Transcription factor E2F1	GO:0005515; F:protein binding; IPI:UniProtKB
Q01094	E2F1	Transcription factor E2F1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q01094	E2F1	Transcription factor E2F1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q01094	E2F1	Transcription factor E2F1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q01094	E2F1	Transcription factor E2F1	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q01094	E2F1	Transcription factor E2F1	GO:0043276; P:anoikis; IEA:Ensembl
Q01094	E2F1	Transcription factor E2F1	GO:0006915; P:apoptotic process; TAS:Reactome
Q01094	E2F1	Transcription factor E2F1	GO:0008283; P:cell proliferation; TAS:ProtInc
Q01094	E2F1	Transcription factor E2F1	GO:0071398; P:cellular response to fatty acid; IEA:Ensembl
Q01094	E2F1	Transcription factor E2F1	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
Q01094	E2F1	Transcription factor E2F1	GO:0000077; P:DNA damage checkpoint; IMP:UniProtKB
Q01094	E2F1	Transcription factor E2F1	GO:0030900; P:forebrain development; IEA:Ensembl
Q01094	E2F1	Transcription factor E2F1	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q01094	E2F1	Transcription factor E2F1	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
Q01094	E2F1	Transcription factor E2F1	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IEA:Ensembl
Q01094	E2F1	Transcription factor E2F1	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IMP:UniProtKB
Q01094	E2F1	Transcription factor E2F1	GO:1990086; P:lens fiber cell apoptotic process; IEA:Ensembl
Q01094	E2F1	Transcription factor E2F1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q01094	E2F1	Transcription factor E2F1	GO:0000080; P:mitotic G1 phase; TAS:ProtInc
Q01094	E2F1	Transcription factor E2F1	GO:0000085; P:mitotic G2 phase; TAS:Reactome
Q01094	E2F1	Transcription factor E2F1	GO:0048255; P:mRNA stabilization; IDA:BHF-UCL
Q01094	E2F1	Transcription factor E2F1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q01094	E2F1	Transcription factor E2F1	GO:0071930; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; IMP:BHF-UCL
Q01094	E2F1	Transcription factor E2F1	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:BHF-UCL
Q01094	E2F1	Transcription factor E2F1	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q01094	E2F1	Transcription factor E2F1	GO:0048146; P:positive regulation of fibroblast proliferation; IMP:BHF-UCL
Q01094	E2F1	Transcription factor E2F1	GO:0010628; P:positive regulation of gene expression; IDA:BHF-UCL
Q01094	E2F1	Transcription factor E2F1	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
Q01094	E2F1	Transcription factor E2F1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q01094	E2F1	Transcription factor E2F1	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:BHF-UCL
Q01094	E2F1	Transcription factor E2F1	GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; IMP:BHF-UCL
Q01094	E2F1	Transcription factor E2F1	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q01094	E2F1	Transcription factor E2F1	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q01094	E2F1	Transcription factor E2F1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14209	E2F2	Transcription factor E2F2	GO:0001047; F:core promoter binding; IDA:UniProtKB
Q14209	E2F2	Transcription factor E2F2	GO:0003677; F:DNA binding; TAS:ProtInc
Q14209	E2F2	Transcription factor E2F2	GO:0005515; F:protein binding; IPI:UniProtKB
Q14209	E2F2	Transcription factor E2F2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
Q14209	E2F2	Transcription factor E2F2	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q14209	E2F2	Transcription factor E2F2	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IEA:Ensembl
Q14209	E2F2	Transcription factor E2F2	GO:1990086; P:lens fiber cell apoptotic process; IEA:Ensembl
Q14209	E2F2	Transcription factor E2F2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q14209	E2F2	Transcription factor E2F2	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
Q14209	E2F2	Transcription factor E2F2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:ProtInc
O00716	E2F3	Transcription factor E2F3	GO:0001047; F:core promoter binding; IDA:UniProtKB
O00716	E2F3	Transcription factor E2F3	GO:0005515; F:protein binding; IPI:UniProtKB
O00716	E2F3	Transcription factor E2F3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O00716	E2F3	Transcription factor E2F3	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O00716	E2F3	Transcription factor E2F3	GO:0000085; P:mitotic G2 phase; TAS:Reactome
O00716	E2F3	Transcription factor E2F3	GO:0007219; P:Notch signaling pathway; TAS:Reactome
O00716	E2F3	Transcription factor E2F3	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
O00716	E2F3	Transcription factor E2F3	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
O00716	E2F3	Transcription factor E2F3	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:ProtInc
Q16254	E2F4	Transcription factor E2F4	GO:0003677; F:DNA binding; IMP:UniProtKB
Q16254	E2F4	Transcription factor E2F4	GO:0005515; F:protein binding; IPI:UniProtKB
Q16254	E2F4	Transcription factor E2F4	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q16254	E2F4	Transcription factor E2F4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q16254	E2F4	Transcription factor E2F4	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q16254	E2F4	Transcription factor E2F4	GO:0008015; P:blood circulation; IEA:Ensembl
Q16254	E2F4	Transcription factor E2F4	GO:0006884; P:cell volume homeostasis; IEA:Ensembl
Q16254	E2F4	Transcription factor E2F4	GO:0042384; P:cilium assembly; IEA:Ensembl
Q16254	E2F4	Transcription factor E2F4	GO:0002064; P:epithelial cell development; IEA:Ensembl
Q16254	E2F4	Transcription factor E2F4	GO:0010467; P:gene expression; TAS:Reactome
Q16254	E2F4	Transcription factor E2F4	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q16254	E2F4	Transcription factor E2F4	GO:0009887; P:organ morphogenesis; IEA:Ensembl
Q16254	E2F4	Transcription factor E2F4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
Q16254	E2F4	Transcription factor E2F4	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q16254	E2F4	Transcription factor E2F4	GO:0008361; P:regulation of cell size; IEA:Ensembl
Q16254	E2F4	Transcription factor E2F4	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; IEA:Ensembl
Q16254	E2F4	Transcription factor E2F4	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q16254	E2F4	Transcription factor E2F4	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
Q16254	E2F4	Transcription factor E2F4	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q15329	E2F5	Transcription factor E2F5	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q15329	E2F5	Transcription factor E2F5	GO:0005515; F:protein binding; IPI:UniProtKB
Q15329	E2F5	Transcription factor E2F5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
Q15329	E2F5	Transcription factor E2F5	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q15329	E2F5	Transcription factor E2F5	GO:0010467; P:gene expression; TAS:Reactome
Q15329	E2F5	Transcription factor E2F5	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q15329	E2F5	Transcription factor E2F5	GO:0009887; P:organ morphogenesis; IEA:Ensembl
Q15329	E2F5	Transcription factor E2F5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
Q15329	E2F5	Transcription factor E2F5	GO:0051726; P:regulation of cell cycle; IEA:InterPro
Q15329	E2F5	Transcription factor E2F5	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q15329	E2F5	Transcription factor E2F5	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
Q15329	E2F5	Transcription factor E2F5	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
O75461	E2F6	Transcription factor E2F6	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O75461	E2F6	Transcription factor E2F6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O75461	E2F6	Transcription factor E2F6	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
O75461	E2F6	Transcription factor E2F6	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O75461	E2F6	Transcription factor E2F6	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; IEA:Ensembl
O75461	E2F6	Transcription factor E2F6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96AV8	E2F7	Transcription factor E2F7	GO:0001047; F:core promoter binding; IDA:UniProtKB
Q96AV8	E2F7	Transcription factor E2F7	GO:0042802; F:identical protein binding; IPI:IntAct
Q96AV8	E2F7	Transcription factor E2F7	GO:0005515; F:protein binding; IPI:IntAct
Q96AV8	E2F7	Transcription factor E2F7	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q96AV8	E2F7	Transcription factor E2F7	GO:0003714; F:transcription corepressor activity; ISS:UniProtKB
Q96AV8	E2F7	Transcription factor E2F7	GO:0060718; P:chorionic trophoblast cell differentiation; ISS:UniProtKB
Q96AV8	E2F7	Transcription factor E2F7	GO:0030330; P:DNA damage response, signal transduction by p53 class mediator; IDA:UniProtKB
Q96AV8	E2F7	Transcription factor E2F7	GO:0070365; P:hepatocyte differentiation; ISS:UniProtKB
Q96AV8	E2F7	Transcription factor E2F7	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q96AV8	E2F7	Transcription factor E2F7	GO:0032466; P:negative regulation of cytokinesis; ISS:UniProtKB
Q96AV8	E2F7	Transcription factor E2F7	GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; ISS:UniProtKB
Q96AV8	E2F7	Transcription factor E2F7	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q96AV8	E2F7	Transcription factor E2F7	GO:0071930; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; IDA:UniProtKB
Q96AV8	E2F7	Transcription factor E2F7	GO:0001890; P:placenta development; ISS:UniProtKB
Q96AV8	E2F7	Transcription factor E2F7	GO:0032877; P:positive regulation of DNA endoreduplication; ISS:UniProtKB
Q96AV8	E2F7	Transcription factor E2F7	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q96AV8	E2F7	Transcription factor E2F7	GO:0002040; P:sprouting angiogenesis; IMP:UniProtKB
Q96AV8	E2F7	Transcription factor E2F7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96AV8	E2F7	Transcription factor E2F7	GO:0060707; P:trophoblast giant cell differentiation; ISS:UniProtKB
A0AVK6	E2F8	Transcription factor E2F8	GO:0001047; F:core promoter binding; IDA:UniProtKB
A0AVK6	E2F8	Transcription factor E2F8	GO:0005515; F:protein binding; IPI:IntAct
A0AVK6	E2F8	Transcription factor E2F8	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IMP:UniProtKB
A0AVK6	E2F8	Transcription factor E2F8	GO:0003714; F:transcription corepressor activity; ISS:UniProtKB
A0AVK6	E2F8	Transcription factor E2F8	GO:0033301; P:cell cycle comprising mitosis without cytokinesis; ISS:UniProtKB
A0AVK6	E2F8	Transcription factor E2F8	GO:0008283; P:cell proliferation; IEA:Ensembl
A0AVK6	E2F8	Transcription factor E2F8	GO:0060718; P:chorionic trophoblast cell differentiation; ISS:UniProtKB
A0AVK6	E2F8	Transcription factor E2F8	GO:0070365; P:hepatocyte differentiation; ISS:UniProtKB
A0AVK6	E2F8	Transcription factor E2F8	GO:0032466; P:negative regulation of cytokinesis; ISS:UniProtKB
A0AVK6	E2F8	Transcription factor E2F8	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
A0AVK6	E2F8	Transcription factor E2F8	GO:0001890; P:placenta development; ISS:UniProtKB
A0AVK6	E2F8	Transcription factor E2F8	GO:0032877; P:positive regulation of DNA endoreduplication; ISS:UniProtKB
A0AVK6	E2F8	Transcription factor E2F8	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
A0AVK6	E2F8	Transcription factor E2F8	GO:0002040; P:sprouting angiogenesis; IMP:UniProtKB
A0AVK6	E2F8	Transcription factor E2F8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A0AVK6	E2F8	Transcription factor E2F8	GO:0060707; P:trophoblast giant cell differentiation; ISS:UniProtKB
Q9H4G0	EPB41L1	Band 4.1-like protein 1	GO:0005198; F:structural molecule activity; IEA:InterPro
Q9H4G0	EPB41L1	Band 4.1-like protein 1	GO:0030866; P:cortical actin cytoskeleton organization; IEA:InterPro
Q9H4G0	EPB41L1	Band 4.1-like protein 1	GO:0007268; P:synaptic transmission; TAS:Reactome
O43491	EPB41L2	Band 4.1-like protein 2	GO:0005198; F:structural molecule activity; IEA:InterPro
O43491	EPB41L2	Band 4.1-like protein 2	GO:0030866; P:cortical actin cytoskeleton organization; IEA:InterPro
Q9Y2J2	EPB41L3	Band 4.1-like protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y2J2	EPB41L3	Band 4.1-like protein 3	GO:0005200; F:structural constituent of cytoskeleton; TAS:BHF-UCL
Q9Y2J2	EPB41L3	Band 4.1-like protein 3	GO:0005198; F:structural molecule activity; IEA:InterPro
Q9Y2J2	EPB41L3	Band 4.1-like protein 3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9Y2J2	EPB41L3	Band 4.1-like protein 3	GO:0030866; P:cortical actin cytoskeleton organization; IEA:InterPro
Q9Y2J2	EPB41L3	Band 4.1-like protein 3	GO:0030865; P:cortical cytoskeleton organization; TAS:BHF-UCL
Q9Y2J2	EPB41L3	Band 4.1-like protein 3	GO:0007016; P:cytoskeletal anchoring at plasma membrane; TAS:BHF-UCL
Q9Y2J2	EPB41L3	Band 4.1-like protein 3	GO:0043217; P:myelin maintenance; ISS:BHF-UCL
Q9Y2J2	EPB41L3	Band 4.1-like protein 3	GO:0048812; P:neuron projection morphogenesis; ISS:BHF-UCL
Q9Y2J2	EPB41L3	Band 4.1-like protein 3	GO:0030913; P:paranodal junction assembly; ISS:BHF-UCL
Q9Y2J2	EPB41L3	Band 4.1-like protein 3	GO:0071205; P:protein localization to juxtaparanode region of axon; ISS:BHF-UCL
Q9Y2J2	EPB41L3	Band 4.1-like protein 3	GO:0002175; P:protein localization to paranode region of axon; ISS:BHF-UCL
Q9Y2J2	EPB41L3	Band 4.1-like protein 3	GO:0072659; P:protein localization to plasma membrane; ISS:BHF-UCL
Q9Y2J2	EPB41L3	Band 4.1-like protein 3	GO:0008360; P:regulation of cell shape; ISS:BHF-UCL
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0031032; P:actomyosin structure organization; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0003383; P:apical constriction; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0048319; P:axial mesoderm morphogenesis; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0007398; P:ectoderm development; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0048617; P:embryonic foregut morphogenesis; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0007492; P:endoderm development; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0001837; P:epithelial to mesenchymal transition; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0070986; P:left/right axis specification; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0007509; P:mesoderm migration involved in gastrulation; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0022408; P:negative regulation of cell-cell adhesion; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0032091; P:negative regulation of protein binding; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0001839; P:neural plate morphogenesis; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0048339; P:paraxial mesoderm development; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0010634; P:positive regulation of epithelial cell migration; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0051894; P:positive regulation of focal adhesion assembly; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0032092; P:positive regulation of protein binding; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0010608; P:posttranscriptional regulation of gene expression; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0070201; P:regulation of establishment of protein localization; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0032525; P:somite rostral/caudal axis specification; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0006931; P:substrate-dependent cell migration, cell attachment to substrate; IEA:Ensembl
Q9HCM4	EPB41L5	Band 4.1-like protein 5	GO:0009826; P:unidimensional cell growth; IEA:Ensembl
Q9H329	EPB41L4B	Band 4.1-like protein 4B	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
Q9H329	EPB41L4B	Band 4.1-like protein 4B	GO:0031032; P:actomyosin structure organization; IDA:MGI
Q66K89	E4F1	Transcription factor E4F1	GO:0035497; F:cAMP response element binding; IDA:UniProtKB
Q66K89	E4F1	Transcription factor E4F1	GO:0003677; F:DNA binding; TAS:ProtInc
Q66K89	E4F1	Transcription factor E4F1	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q66K89	E4F1	Transcription factor E4F1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q66K89	E4F1	Transcription factor E4F1	GO:0005515; F:protein binding; IPI:UniProtKB
Q66K89	E4F1	Transcription factor E4F1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q66K89	E4F1	Transcription factor E4F1	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q66K89	E4F1	Transcription factor E4F1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q66K89	E4F1	Transcription factor E4F1	GO:0008283; P:cell proliferation; TAS:ProtInc
Q66K89	E4F1	Transcription factor E4F1	GO:0006260; P:DNA replication; IEA:Ensembl
Q66K89	E4F1	Transcription factor E4F1	GO:0009790; P:embryo development; IEA:Ensembl
Q66K89	E4F1	Transcription factor E4F1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q66K89	E4F1	Transcription factor E4F1	GO:0071850; P:mitotic cell cycle arrest; TAS:UniProtKB
Q66K89	E4F1	Transcription factor E4F1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q66K89	E4F1	Transcription factor E4F1	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q66K89	E4F1	Transcription factor E4F1	GO:0010564; P:regulation of cell cycle process; IDA:UniProtKB
Q66K89	E4F1	Transcription factor E4F1	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q66K89	E4F1	Transcription factor E4F1	GO:0009794; P:regulation of mitotic cell cycle, embryonic; IEA:Ensembl
Q66K89	E4F1	Transcription factor E4F1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q66K89	E4F1	Transcription factor E4F1	GO:0016032; P:viral process; IEA:UniProtKB-KW
A6NLF2	TCEB3CL2	RNA polymerase II transcription factor SIII subunit A3-like-2	GO:0003677; F:DNA binding; IEA:InterPro
A6NLF2	TCEB3CL2	RNA polymerase II transcription factor SIII subunit A3-like-2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A6NLF2	TCEB3CL2	RNA polymerase II transcription factor SIII subunit A3-like-2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q3SY89	TCEB3CL	RNA polymerase II transcription factor SIII subunit A3-like-1	GO:0003677; F:DNA binding; IEA:InterPro
Q3SY89	TCEB3CL	RNA polymerase II transcription factor SIII subunit A3-like-1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q3SY89	TCEB3CL	RNA polymerase II transcription factor SIII subunit A3-like-1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0016595; F:glutamate binding; IEA:Ensembl
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0005314; F:high-affinity glutamate transmembrane transporter activity; IEA:Ensembl
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0005313; F:L-glutamate transmembrane transporter activity; IDA:BHF-UCL
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0017153; F:sodium:dicarboxylate symporter activity; IEA:InterPro
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0031223; P:auditory behavior; IEA:Ensembl
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0048667; P:cell morphogenesis involved in neuron differentiation; IEA:Ensembl
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0021545; P:cranial nerve development; IEA:Ensembl
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0070779; P:D-aspartate import; IDA:UniProtKB
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0009449; P:gamma-aminobutyric acid biosynthetic process; IEA:Ensembl
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0006537; P:glutamate biosynthetic process; IEA:Ensembl
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0006811; P:ion transport; TAS:Reactome
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0051938; P:L-glutamate import; IDA:UniProtKB
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0001504; P:neurotransmitter uptake; TAS:ProtInc
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0050806; P:positive regulation of synaptic transmission; IEA:Ensembl
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0046677; P:response to antibiotic; IEA:Ensembl
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0042493; P:response to drug; IEA:Ensembl
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0009416; P:response to light stimulus; IEA:Ensembl
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0009611; P:response to wounding; IEA:Ensembl
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0007605; P:sensory perception of sound; IEA:Ensembl
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0007268; P:synaptic transmission; TAS:ProtInc
P43003	SLC1A3	Excitatory amino acid transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P43004	SLC1A2	Excitatory amino acid transporter 2	GO:0015501; F:glutamate:sodium symporter activity; IEA:Ensembl
P43004	SLC1A2	Excitatory amino acid transporter 2	GO:0005313; F:L-glutamate transmembrane transporter activity; IDA:BHF-UCL
P43004	SLC1A2	Excitatory amino acid transporter 2	GO:0005515; F:protein binding; IPI:IntAct
P43004	SLC1A2	Excitatory amino acid transporter 2	GO:0017153; F:sodium:dicarboxylate symporter activity; IEA:InterPro
P43004	SLC1A2	Excitatory amino acid transporter 2	GO:0030534; P:adult behavior; IEA:Ensembl
P43004	SLC1A2	Excitatory amino acid transporter 2	GO:0031668; P:cellular response to extracellular stimulus; IEA:Ensembl
P43004	SLC1A2	Excitatory amino acid transporter 2	GO:0070779; P:D-aspartate import; IDA:UniProtKB
P43004	SLC1A2	Excitatory amino acid transporter 2	GO:0006811; P:ion transport; TAS:Reactome
P43004	SLC1A2	Excitatory amino acid transporter 2	GO:0051938; P:L-glutamate import; IDA:UniProtKB
P43004	SLC1A2	Excitatory amino acid transporter 2	GO:0035264; P:multicellular organism growth; IEA:Ensembl
P43004	SLC1A2	Excitatory amino acid transporter 2	GO:0010259; P:multicellular organismal aging; IEA:Ensembl
P43004	SLC1A2	Excitatory amino acid transporter 2	GO:0046326; P:positive regulation of glucose import; IEA:Ensembl
P43004	SLC1A2	Excitatory amino acid transporter 2	GO:0043200; P:response to amino acid; IEA:Ensembl
P43004	SLC1A2	Excitatory amino acid transporter 2	GO:0042493; P:response to drug; IEA:Ensembl
P43004	SLC1A2	Excitatory amino acid transporter 2	GO:0009611; P:response to wounding; IEA:Ensembl
P43004	SLC1A2	Excitatory amino acid transporter 2	GO:0007268; P:synaptic transmission; TAS:ProtInc
P43004	SLC1A2	Excitatory amino acid transporter 2	GO:0021537; P:telencephalon development; IEA:Ensembl
P43004	SLC1A2	Excitatory amino acid transporter 2	GO:0055085; P:transmembrane transport; TAS:Reactome
P43004	SLC1A2	Excitatory amino acid transporter 2	GO:0007632; P:visual behavior; IEA:Ensembl
P43005	SLC1A1	Excitatory amino acid transporter 3	GO:0016595; F:glutamate binding; IEA:Ensembl
P43005	SLC1A1	Excitatory amino acid transporter 3	GO:0015501; F:glutamate:sodium symporter activity; IEA:Ensembl
P43005	SLC1A1	Excitatory amino acid transporter 3	GO:0005313; F:L-glutamate transmembrane transporter activity; IDA:BHF-UCL
P43005	SLC1A1	Excitatory amino acid transporter 3	GO:0017153; F:sodium:dicarboxylate symporter activity; IEA:InterPro
P43005	SLC1A1	Excitatory amino acid transporter 3	GO:0070779; P:D-aspartate import; IDA:UniProtKB
P43005	SLC1A1	Excitatory amino acid transporter 3	GO:0006811; P:ion transport; TAS:Reactome
P43005	SLC1A1	Excitatory amino acid transporter 3	GO:0051938; P:L-glutamate import; IDA:UniProtKB
P43005	SLC1A1	Excitatory amino acid transporter 3	GO:0051260; P:protein homooligomerization; IEA:Ensembl
P43005	SLC1A1	Excitatory amino acid transporter 3	GO:0007268; P:synaptic transmission; TAS:ProtInc
P43005	SLC1A1	Excitatory amino acid transporter 3	GO:0055085; P:transmembrane transport; TAS:Reactome
P48664	SLC1A6	Excitatory amino acid transporter 4	GO:0015183; F:L-aspartate transmembrane transporter activity; TAS:ProtInc
P48664	SLC1A6	Excitatory amino acid transporter 4	GO:0005313; F:L-glutamate transmembrane transporter activity; IEA:Ensembl
P48664	SLC1A6	Excitatory amino acid transporter 4	GO:0017153; F:sodium:dicarboxylate symporter activity; IEA:InterPro
P48664	SLC1A6	Excitatory amino acid transporter 4	GO:0015810; P:aspartate transport; TAS:ProtInc
P48664	SLC1A6	Excitatory amino acid transporter 4	GO:0006811; P:ion transport; TAS:Reactome
P48664	SLC1A6	Excitatory amino acid transporter 4	GO:0015813; P:L-glutamate transport; TAS:ProtInc
P48664	SLC1A6	Excitatory amino acid transporter 4	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
P48664	SLC1A6	Excitatory amino acid transporter 4	GO:0007268; P:synaptic transmission; TAS:ProtInc
P48664	SLC1A6	Excitatory amino acid transporter 4	GO:0055085; P:transmembrane transport; TAS:Reactome
O00341	SLC1A7	Excitatory amino acid transporter 5	GO:0005313; F:L-glutamate transmembrane transporter activity; TAS:UniProtKB
O00341	SLC1A7	Excitatory amino acid transporter 5	GO:0017153; F:sodium:dicarboxylate symporter activity; IEA:InterPro
O00341	SLC1A7	Excitatory amino acid transporter 5	GO:0006835; P:dicarboxylic acid transport; TAS:UniProtKB
O00341	SLC1A7	Excitatory amino acid transporter 5	GO:0006811; P:ion transport; TAS:Reactome
O00341	SLC1A7	Excitatory amino acid transporter 5	GO:0015813; P:L-glutamate transport; TAS:GOC
O00341	SLC1A7	Excitatory amino acid transporter 5	GO:0055085; P:transmembrane transport; TAS:Reactome
Q96JC9	EAF1	ELL-associated factor 1	GO:0005515; F:protein binding; IPI:IntAct
Q96JC9	EAF1	ELL-associated factor 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96JC9	EAF1	ELL-associated factor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96CJ1	EAF2	ELL-associated factor 2	GO:0005515; F:protein binding; IPI:IntAct
Q96CJ1	EAF2	ELL-associated factor 2	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q96CJ1	EAF2	ELL-associated factor 2	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
Q96CJ1	EAF2	ELL-associated factor 2	GO:0060770; P:negative regulation of epithelial cell proliferation involved in prostate gland development; IEA:Ensembl
Q96CJ1	EAF2	ELL-associated factor 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q96CJ1	EAF2	ELL-associated factor 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HAF1	MEAF6	Chromatin modification-related protein MEAF6	GO:0005515; F:protein binding; IPI:IntAct
Q9HAF1	MEAF6	Chromatin modification-related protein MEAF6	GO:0006325; P:chromatin organization; TAS:Reactome
Q9HAF1	MEAF6	Chromatin modification-related protein MEAF6	GO:0043968; P:histone H2A acetylation; IDA:UniProtKB
Q9HAF1	MEAF6	Chromatin modification-related protein MEAF6	GO:0044154; P:histone H3-K14 acetylation; IDA:UniProtKB
Q9HAF1	MEAF6	Chromatin modification-related protein MEAF6	GO:0043983; P:histone H4-K12 acetylation; IDA:UniProtKB
Q9HAF1	MEAF6	Chromatin modification-related protein MEAF6	GO:0043981; P:histone H4-K5 acetylation; IDA:UniProtKB
Q9HAF1	MEAF6	Chromatin modification-related protein MEAF6	GO:0043982; P:histone H4-K8 acetylation; IDA:UniProtKB
Q9HAF1	MEAF6	Chromatin modification-related protein MEAF6	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9HAF1	MEAF6	Chromatin modification-related protein MEAF6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q56P03	EAPP	E2F-associated phosphoprotein	GO:0034244; P:negative regulation of transcription elongation from RNA polymerase II promoter; IDA:MGI
Q56P03	EAPP	E2F-associated phosphoprotein	GO:0008284; P:positive regulation of cell proliferation; IDA:MGI
Q56P03	EAPP	E2F-associated phosphoprotein	GO:0032968; P:positive regulation of transcription elongation from RNA polymerase II promoter; IDA:MGI
Q99848	EBNA1BP2	Probable rRNA-processing protein EBP2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q99848	EBNA1BP2	Probable rRNA-processing protein EBP2	GO:0042254; P:ribosome biogenesis; IEA:UniProtKB-KW
Q9BY08	EBPL	Emopamil-binding protein-like	GO:0047750; F:cholestenol delta-isomerase activity; IEA:InterPro
Q9BY08	EBPL	Emopamil-binding protein-like	GO:0016125; P:sterol metabolic process; IEA:InterPro
Q15125	EBP	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	GO:0000247; F:C-8 sterol isomerase activity; IEA:Ensembl
Q15125	EBP	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	GO:0047750; F:cholestenol delta-isomerase activity; IEA:UniProtKB-EC
Q15125	EBP	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	GO:0015238; F:drug transmembrane transporter activity; TAS:ProtInc
Q15125	EBP	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	GO:0004769; F:steroid delta-isomerase activity; TAS:ProtInc
Q15125	EBP	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q15125	EBP	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome
Q15125	EBP	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	GO:0008203; P:cholesterol metabolic process; TAS:ProtInc
Q15125	EBP	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	GO:0006855; P:drug transmembrane transport; TAS:GOC
Q15125	EBP	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	GO:0030097; P:hemopoiesis; IEA:Ensembl
Q15125	EBP	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	GO:0007165; P:signal transduction; TAS:GOC
Q15125	EBP	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	GO:0001501; P:skeletal system development; TAS:ProtInc
Q15125	EBP	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P42892	ECE1	Endothelin-converting enzyme 1	GO:0004175; F:endopeptidase activity; IDA:BHF-UCL
P42892	ECE1	Endothelin-converting enzyme 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P42892	ECE1	Endothelin-converting enzyme 1	GO:0004222; F:metalloendopeptidase activity; ISS:BHF-UCL
P42892	ECE1	Endothelin-converting enzyme 1	GO:0017046; F:peptide hormone binding; IC:BHF-UCL
P42892	ECE1	Endothelin-converting enzyme 1	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P42892	ECE1	Endothelin-converting enzyme 1	GO:0010815; P:bradykinin catabolic process; IDA:BHF-UCL
P42892	ECE1	Endothelin-converting enzyme 1	GO:0010816; P:calcitonin catabolic process; IDA:BHF-UCL
P42892	ECE1	Endothelin-converting enzyme 1	GO:0043583; P:ear development; IMP:BHF-UCL
P42892	ECE1	Endothelin-converting enzyme 1	GO:0042733; P:embryonic digit morphogenesis; IMP:BHF-UCL
P42892	ECE1	Endothelin-converting enzyme 1	GO:0034959; P:endothelin maturation; IDA:BHF-UCL
P42892	ECE1	Endothelin-converting enzyme 1	GO:0007507; P:heart development; IMP:BHF-UCL
P42892	ECE1	Endothelin-converting enzyme 1	GO:0042447; P:hormone catabolic process; IDA:BHF-UCL
P42892	ECE1	Endothelin-converting enzyme 1	GO:0016486; P:peptide hormone processing; IDA:BHF-UCL
P42892	ECE1	Endothelin-converting enzyme 1	GO:0060037; P:pharyngeal system development; IEA:Ensembl
P42892	ECE1	Endothelin-converting enzyme 1	GO:0001921; P:positive regulation of receptor recycling; IMP:BHF-UCL
P42892	ECE1	Endothelin-converting enzyme 1	GO:0016485; P:protein processing; IDA:BHF-UCL
P42892	ECE1	Endothelin-converting enzyme 1	GO:0003100; P:regulation of systemic arterial blood pressure by endothelin; IC:BHF-UCL
P42892	ECE1	Endothelin-converting enzyme 1	GO:0019229; P:regulation of vasoconstriction; IC:BHF-UCL
P42892	ECE1	Endothelin-converting enzyme 1	GO:0010814; P:substance P catabolic process; IDA:BHF-UCL
O60344	ECE2	Endothelin-converting enzyme 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60344	ECE2	Endothelin-converting enzyme 2	GO:0004222; F:metalloendopeptidase activity; IDA:UniProtKB
O60344	ECE2	Endothelin-converting enzyme 2	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
O60344	ECE2	Endothelin-converting enzyme 2	GO:0007420; P:brain development; ISS:UniProtKB
O60344	ECE2	Endothelin-converting enzyme 2	GO:0010002; P:cardioblast differentiation; ISS:UniProtKB
O60344	ECE2	Endothelin-converting enzyme 2	GO:0007267; P:cell-cell signaling; TAS:UniProtKB
O60344	ECE2	Endothelin-converting enzyme 2	GO:0007507; P:heart development; ISS:UniProtKB
O60344	ECE2	Endothelin-converting enzyme 2	GO:0016486; P:peptide hormone processing; IDA:UniProtKB
O95672	ECEL1	Endothelin-converting enzyme-like 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95672	ECEL1	Endothelin-converting enzyme-like 1	GO:0004222; F:metalloendopeptidase activity; IEA:Ensembl
O95672	ECEL1	Endothelin-converting enzyme-like 1	GO:0008237; F:metallopeptidase activity; TAS:ProtInc
O95672	ECEL1	Endothelin-converting enzyme-like 1	GO:0007218; P:neuropeptide signaling pathway; TAS:ProtInc
O95672	ECEL1	Endothelin-converting enzyme-like 1	GO:0003016; P:respiratory system process; ISS:UniProtKB
Q13011	ECH1	Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial	GO:0016853; F:isomerase activity; IEA:UniProtKB-KW
Q13011	ECH1	Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q13011	ECH1	Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial	GO:0005102; F:receptor binding; IPI:UniProtKB
Q13011	ECH1	Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial	GO:0006635; P:fatty acid beta-oxidation; IEA:UniProtKB-UniPathway
P40939	HADHA	Trifunctional enzyme subunit alpha, mitochondrial	GO:0003857; F:3-hydroxyacyl-CoA dehydrogenase activity; TAS:ProtInc
P40939	HADHA	Trifunctional enzyme subunit alpha, mitochondrial	GO:0003985; F:acetyl-CoA C-acetyltransferase activity; TAS:ProtInc
P40939	HADHA	Trifunctional enzyme subunit alpha, mitochondrial	GO:0003988; F:acetyl-CoA C-acyltransferase activity; IEA:Ensembl
P40939	HADHA	Trifunctional enzyme subunit alpha, mitochondrial	GO:0003824; F:catalytic activity; IEA:InterPro
P40939	HADHA	Trifunctional enzyme subunit alpha, mitochondrial	GO:0004300; F:enoyl-CoA hydratase activity; IEA:Ensembl
P40939	HADHA	Trifunctional enzyme subunit alpha, mitochondrial	GO:0000062; F:fatty-acyl-CoA binding; IEA:Ensembl
P40939	HADHA	Trifunctional enzyme subunit alpha, mitochondrial	GO:0016509; F:long-chain-3-hydroxyacyl-CoA dehydrogenase activity; IEA:Ensembl
P40939	HADHA	Trifunctional enzyme subunit alpha, mitochondrial	GO:0016508; F:long-chain-enoyl-CoA hydratase activity; IEA:Ensembl
P40939	HADHA	Trifunctional enzyme subunit alpha, mitochondrial	GO:0051287; F:NAD binding; IEA:Ensembl
P40939	HADHA	Trifunctional enzyme subunit alpha, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
P40939	HADHA	Trifunctional enzyme subunit alpha, mitochondrial	GO:0035965; P:cardiolipin acyl-chain remodeling; TAS:Reactome
P40939	HADHA	Trifunctional enzyme subunit alpha, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P40939	HADHA	Trifunctional enzyme subunit alpha, mitochondrial	GO:0006635; P:fatty acid beta-oxidation; TAS:Reactome
P40939	HADHA	Trifunctional enzyme subunit alpha, mitochondrial	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
P40939	HADHA	Trifunctional enzyme subunit alpha, mitochondrial	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P40939	HADHA	Trifunctional enzyme subunit alpha, mitochondrial	GO:0042493; P:response to drug; IEA:Ensembl
P40939	HADHA	Trifunctional enzyme subunit alpha, mitochondrial	GO:0032868; P:response to insulin; IEA:Ensembl
P40939	HADHA	Trifunctional enzyme subunit alpha, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P55084	HADHB	Trifunctional enzyme subunit beta, mitochondrial	GO:0003857; F:3-hydroxyacyl-CoA dehydrogenase activity; TAS:ProtInc
P55084	HADHB	Trifunctional enzyme subunit beta, mitochondrial	GO:0003988; F:acetyl-CoA C-acyltransferase activity; TAS:ProtInc
P55084	HADHB	Trifunctional enzyme subunit beta, mitochondrial	GO:0004300; F:enoyl-CoA hydratase activity; TAS:ProtInc
P55084	HADHB	Trifunctional enzyme subunit beta, mitochondrial	GO:0000062; F:fatty-acyl-CoA binding; IEA:Ensembl
P55084	HADHB	Trifunctional enzyme subunit beta, mitochondrial	GO:0016509; F:long-chain-3-hydroxyacyl-CoA dehydrogenase activity; IEA:Ensembl
P55084	HADHB	Trifunctional enzyme subunit beta, mitochondrial	GO:0016508; F:long-chain-enoyl-CoA hydratase activity; IEA:Ensembl
P55084	HADHB	Trifunctional enzyme subunit beta, mitochondrial	GO:0051287; F:NAD binding; IEA:Ensembl
P55084	HADHB	Trifunctional enzyme subunit beta, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P55084	HADHB	Trifunctional enzyme subunit beta, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
P55084	HADHB	Trifunctional enzyme subunit beta, mitochondrial	GO:0016747; F:transferase activity, transferring acyl groups other than amino-acyl groups; IEA:InterPro
P55084	HADHB	Trifunctional enzyme subunit beta, mitochondrial	GO:0035965; P:cardiolipin acyl-chain remodeling; TAS:Reactome
P55084	HADHB	Trifunctional enzyme subunit beta, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P55084	HADHB	Trifunctional enzyme subunit beta, mitochondrial	GO:0006635; P:fatty acid beta-oxidation; TAS:Reactome
P55084	HADHB	Trifunctional enzyme subunit beta, mitochondrial	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
P55084	HADHB	Trifunctional enzyme subunit beta, mitochondrial	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P55084	HADHB	Trifunctional enzyme subunit beta, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NTX5	ECHDC1	Ethylmalonyl-CoA decarboxylase	GO:0016831; F:carboxy-lyase activity; ISS:UniProtKB
Q9NTX5	ECHDC1	Ethylmalonyl-CoA decarboxylase	GO:0004492; F:methylmalonyl-CoA decarboxylase activity; IEA:UniProtKB-EC
Q86YB7	ECHDC2	Enoyl-CoA hydratase domain-containing protein 2, mitochondrial	GO:0016829; F:lyase activity; IEA:UniProtKB-KW
Q86YB7	ECHDC2	Enoyl-CoA hydratase domain-containing protein 2, mitochondrial	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW
Q96DC8	ECHDC3	Enoyl-CoA hydratase domain-containing protein 3, mitochondrial	GO:0003824; F:catalytic activity; IEA:InterPro
P30084	ECHS1	Enoyl-CoA hydratase, mitochondrial	GO:0004300; F:enoyl-CoA hydratase activity; TAS:Reactome
P30084	ECHS1	Enoyl-CoA hydratase, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
P30084	ECHS1	Enoyl-CoA hydratase, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P30084	ECHS1	Enoyl-CoA hydratase, mitochondrial	GO:0006635; P:fatty acid beta-oxidation; TAS:Reactome
P30084	ECHS1	Enoyl-CoA hydratase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q08426	EHHADH	Peroxisomal bifunctional enzyme	GO:0003857; F:3-hydroxyacyl-CoA dehydrogenase activity; NAS:UniProtKB
Q08426	EHHADH	Peroxisomal bifunctional enzyme	GO:0050662; F:coenzyme binding; IEA:InterPro
Q08426	EHHADH	Peroxisomal bifunctional enzyme	GO:0004165; F:dodecenoyl-CoA delta-isomerase activity; IEA:UniProtKB-EC
Q08426	EHHADH	Peroxisomal bifunctional enzyme	GO:0004300; F:enoyl-CoA hydratase activity; NAS:UniProtKB
Q08426	EHHADH	Peroxisomal bifunctional enzyme	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q08426	EHHADH	Peroxisomal bifunctional enzyme	GO:0005102; F:receptor binding; IPI:UniProtKB
Q08426	EHHADH	Peroxisomal bifunctional enzyme	GO:0006635; P:fatty acid beta-oxidation; NAS:UniProtKB
Q08426	EHHADH	Peroxisomal bifunctional enzyme	GO:0006475; P:internal protein amino acid acetylation; IDA:UniProtKB
P42126	ECI1	Enoyl-CoA delta isomerase 1, mitochondrial	GO:0004165; F:dodecenoyl-CoA delta-isomerase activity; NAS:UniProtKB
P42126	ECI1	Enoyl-CoA delta isomerase 1, mitochondrial	GO:0016860; F:intramolecular oxidoreductase activity; TAS:Reactome
P42126	ECI1	Enoyl-CoA delta isomerase 1, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P42126	ECI1	Enoyl-CoA delta isomerase 1, mitochondrial	GO:0006635; P:fatty acid beta-oxidation; NAS:UniProtKB
P42126	ECI1	Enoyl-CoA delta isomerase 1, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75521	ECI2	Enoyl-CoA delta isomerase 2, mitochondrial	GO:0004165; F:dodecenoyl-CoA delta-isomerase activity; IDA:UniProtKB
O75521	ECI2	Enoyl-CoA delta isomerase 2, mitochondrial	GO:0000062; F:fatty-acyl-CoA binding; IEA:InterPro
O75521	ECI2	Enoyl-CoA delta isomerase 2, mitochondrial	GO:0005102; F:receptor binding; IPI:UniProtKB
O75521	ECI2	Enoyl-CoA delta isomerase 2, mitochondrial	GO:0009062; P:fatty acid catabolic process; IDA:UniProtKB
Q16610	ECM1	Extracellular matrix protein 1	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q16610	ECM1	Extracellular matrix protein 1	GO:0043236; F:laminin binding; IPI:UniProtKB
Q16610	ECM1	Extracellular matrix protein 1	GO:0002020; F:protease binding; IPI:UniProtKB
Q16610	ECM1	Extracellular matrix protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q16610	ECM1	Extracellular matrix protein 1	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q16610	ECM1	Extracellular matrix protein 1	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q16610	ECM1	Extracellular matrix protein 1	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q16610	ECM1	Extracellular matrix protein 1	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
Q16610	ECM1	Extracellular matrix protein 1	GO:0006954; P:inflammatory response; IEA:Ensembl
Q16610	ECM1	Extracellular matrix protein 1	GO:0030502; P:negative regulation of bone mineralization; IDA:UniProtKB
Q16610	ECM1	Extracellular matrix protein 1	GO:0001960; P:negative regulation of cytokine-mediated signaling pathway; IEA:Ensembl
Q16610	ECM1	Extracellular matrix protein 1	GO:0010466; P:negative regulation of peptidase activity; IDA:UniProtKB
Q16610	ECM1	Extracellular matrix protein 1	GO:0001503; P:ossification; IEA:UniProtKB-KW
Q16610	ECM1	Extracellular matrix protein 1	GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB
Q16610	ECM1	Extracellular matrix protein 1	GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:UniProtKB
Q16610	ECM1	Extracellular matrix protein 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q16610	ECM1	Extracellular matrix protein 1	GO:2000404; P:regulation of T cell migration; IEA:Ensembl
Q16610	ECM1	Extracellular matrix protein 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q16610	ECM1	Extracellular matrix protein 1	GO:0002828; P:regulation of type 2 immune response; IEA:Ensembl
Q16610	ECM1	Extracellular matrix protein 1	GO:0007165; P:signal transduction; IMP:GOC
Q5VYK3	ECM29	Proteasome-associated protein ECM29 homolog	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
O94769	ECM2	Extracellular matrix protein 2	GO:0008201; F:heparin binding; IEA:Ensembl
O94769	ECM2	Extracellular matrix protein 2	GO:0005178; F:integrin binding; TAS:ProtInc
O94769	ECM2	Extracellular matrix protein 2	GO:0007160; P:cell-matrix adhesion; TAS:ProtInc
O94769	ECM2	Extracellular matrix protein 2	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
O94769	ECM2	Extracellular matrix protein 2	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
P12724	RNASE3	Eosinophil cationic protein	GO:0016892; F:endoribonuclease activity, producing 3'-phosphomonoesters; IEA:InterPro
P12724	RNASE3	Eosinophil cationic protein	GO:0003676; F:nucleic acid binding; IEA:InterPro
P12724	RNASE3	Eosinophil cationic protein	GO:0004540; F:ribonuclease activity; TAS:ProtInc
P12724	RNASE3	Eosinophil cationic protein	GO:0019731; P:antibacterial humoral response; IDA:UniProt
P12724	RNASE3	Eosinophil cationic protein	GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProt
P12724	RNASE3	Eosinophil cationic protein	GO:0002227; P:innate immune response in mucosa; IDA:UniProt
P12724	RNASE3	Eosinophil cationic protein	GO:0006401; P:RNA catabolic process; TAS:ProtInc
P12724	RNASE3	Eosinophil cationic protein	GO:0090501; P:RNA phosphodiester bond hydrolysis; TAS:GOC
Q19T08	ECSCR	Endothelial cell-specific chemotaxis regulator	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q19T08	ECSCR	Endothelial cell-specific chemotaxis regulator	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q19T08	ECSCR	Endothelial cell-specific chemotaxis regulator	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q19T08	ECSCR	Endothelial cell-specific chemotaxis regulator	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
Q9BQ95	ECSIT	Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial	GO:0016651; F:oxidoreductase activity, acting on NAD(P)H; IDA:UniProtKB
Q9BQ95	ECSIT	Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BQ95	ECSIT	Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q9BQ95	ECSIT	Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial	GO:0004871; F:signal transducer activity; IEA:Ensembl
Q9BQ95	ECSIT	Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial	GO:0030509; P:BMP signaling pathway; IEA:Ensembl
Q9BQ95	ECSIT	Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q9BQ95	ECSIT	Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial	GO:0001707; P:mesoderm formation; IEA:Ensembl
Q9BQ95	ECSIT	Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial	GO:0055114; P:oxidation-reduction process; IDA:GOC
Q9BQ95	ECSIT	Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial	GO:0051341; P:regulation of oxidoreductase activity; IDA:UniProtKB
Q008S8	ECT2L	Epithelial cell-transforming sequence 2 oncogene-like	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q9H8V3	ECT2	Protein ECT2	GO:0005096; F:GTPase activator activity; IMP:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0032147; P:activation of protein kinase activity; IDA:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0032863; P:activation of Rac GTPase activity; IMP:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0032862; P:activation of Rho GTPase activity; IDA:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q9H8V3	ECT2	Protein ECT2	GO:0000902; P:cell morphogenesis; IEA:Ensembl
Q9H8V3	ECT2	Protein ECT2	GO:0071277; P:cellular response to calcium ion; IDA:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0070301; P:cellular response to hydrogen peroxide; IDA:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0071479; P:cellular response to ionizing radiation; IDA:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0000910; P:cytokinesis; IMP:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9H8V3	ECT2	Protein ECT2	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0043089; P:positive regulation of Cdc42 GTPase activity; IDA:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0032467; P:positive regulation of cytokinesis; IDA:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0042307; P:positive regulation of protein import into nucleus; ISS:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0032321; P:positive regulation of Rho GTPase activity; IDA:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9H8V3	ECT2	Protein ECT2	GO:0051988; P:regulation of attachment of spindle microtubules to kinetochore; IMP:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0045859; P:regulation of protein kinase activity; IDA:UniProtKB
Q9H8V3	ECT2	Protein ECT2	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q9H8V3	ECT2	Protein ECT2	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9H8V3	ECT2	Protein ECT2	GO:0070830; P:tight junction assembly; IMP:UniProtKB
Q8WWZ3	EDARADD	Ectodysplasin-A receptor-associated adapter protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8WWZ3	EDARADD	Ectodysplasin-A receptor-associated adapter protein	GO:0001942; P:hair follicle development; IEA:Ensembl
Q8WWZ3	EDARADD	Ectodysplasin-A receptor-associated adapter protein	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
Q8WWZ3	EDARADD	Ectodysplasin-A receptor-associated adapter protein	GO:0007165; P:signal transduction; IEA:InterPro
Q8WWZ3	EDARADD	Ectodysplasin-A receptor-associated adapter protein	GO:0061153; P:trachea gland development; IEA:Ensembl
Q9UNE0	EDAR	Tumor necrosis factor receptor superfamily member EDAR	GO:0005515; F:protein binding; IPI:HGNC
Q9UNE0	EDAR	Tumor necrosis factor receptor superfamily member EDAR	GO:0004872; F:receptor activity; IDA:HGNC
Q9UNE0	EDAR	Tumor necrosis factor receptor superfamily member EDAR	GO:0004888; F:transmembrane signaling receptor activity; NAS:UniProtKB
Q9UNE0	EDAR	Tumor necrosis factor receptor superfamily member EDAR	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9UNE0	EDAR	Tumor necrosis factor receptor superfamily member EDAR	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9UNE0	EDAR	Tumor necrosis factor receptor superfamily member EDAR	GO:0008544; P:epidermis development; TAS:HGNC
Q9UNE0	EDAR	Tumor necrosis factor receptor superfamily member EDAR	GO:0001942; P:hair follicle development; IEA:Ensembl
Q9UNE0	EDAR	Tumor necrosis factor receptor superfamily member EDAR	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
Q9UNE0	EDAR	Tumor necrosis factor receptor superfamily member EDAR	GO:0043473; P:pigmentation; IEA:Ensembl
Q9UNE0	EDAR	Tumor necrosis factor receptor superfamily member EDAR	GO:0042346; P:positive regulation of NF-kappaB import into nucleus; IEA:Ensembl
Q9UNE0	EDAR	Tumor necrosis factor receptor superfamily member EDAR	GO:0060662; P:salivary gland cavitation; IEA:Ensembl
Q92838	EDA	Ectodysplasin-A	GO:0005515; F:protein binding; IPI:UniProtKB
Q92838	EDA	Ectodysplasin-A	GO:0005102; F:receptor binding; IDA:HGNC
Q92838	EDA	Ectodysplasin-A	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q92838	EDA	Ectodysplasin-A	GO:0007160; P:cell-matrix adhesion; IEA:Ensembl
Q92838	EDA	Ectodysplasin-A	GO:0007398; P:ectoderm development; TAS:ProtInc
Q92838	EDA	Ectodysplasin-A	GO:0010467; P:gene expression; IEA:Ensembl
Q92838	EDA	Ectodysplasin-A	GO:0060789; P:hair follicle placode formation; IEA:Ensembl
Q92838	EDA	Ectodysplasin-A	GO:0006955; P:immune response; IEA:InterPro
Q92838	EDA	Ectodysplasin-A	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
Q92838	EDA	Ectodysplasin-A	GO:0043473; P:pigmentation; IEA:Ensembl
Q92838	EDA	Ectodysplasin-A	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl
Q92838	EDA	Ectodysplasin-A	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
Q92838	EDA	Ectodysplasin-A	GO:0042346; P:positive regulation of NF-kappaB import into nucleus; IEA:Ensembl
Q92838	EDA	Ectodysplasin-A	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:HGNC
Q92838	EDA	Ectodysplasin-A	GO:0060662; P:salivary gland cavitation; IEA:Ensembl
Q92838	EDA	Ectodysplasin-A	GO:0007165; P:signal transduction; TAS:ProtInc
Q92838	EDA	Ectodysplasin-A	GO:0061153; P:trachea gland development; IEA:Ensembl
Q96F86	EDC3	Enhancer of mRNA-decapping protein 3	GO:0042802; F:identical protein binding; IPI:IntAct
Q96F86	EDC3	Enhancer of mRNA-decapping protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q96F86	EDC3	Enhancer of mRNA-decapping protein 3	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q96F86	EDC3	Enhancer of mRNA-decapping protein 3	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
Q96F86	EDC3	Enhancer of mRNA-decapping protein 3	GO:0010467; P:gene expression; TAS:Reactome
Q96F86	EDC3	Enhancer of mRNA-decapping protein 3	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q96F86	EDC3	Enhancer of mRNA-decapping protein 3	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q96F86	EDC3	Enhancer of mRNA-decapping protein 3	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q6P2E9	EDC4	Enhancer of mRNA-decapping protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q6P2E9	EDC4	Enhancer of mRNA-decapping protein 4	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
Q6P2E9	EDC4	Enhancer of mRNA-decapping protein 4	GO:0010467; P:gene expression; TAS:Reactome
Q6P2E9	EDC4	Enhancer of mRNA-decapping protein 4	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q6P2E9	EDC4	Enhancer of mRNA-decapping protein 4	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q6P2E9	EDC4	Enhancer of mRNA-decapping protein 4	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q92611	EDEM1	ER degradation-enhancing alpha-mannosidase-like protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q92611	EDEM1	ER degradation-enhancing alpha-mannosidase-like protein 1	GO:0051787; F:misfolded protein binding; IDA:UniProtKB
Q92611	EDEM1	ER degradation-enhancing alpha-mannosidase-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q92611	EDEM1	ER degradation-enhancing alpha-mannosidase-like protein 1	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q92611	EDEM1	ER degradation-enhancing alpha-mannosidase-like protein 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q92611	EDEM1	ER degradation-enhancing alpha-mannosidase-like protein 1	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q92611	EDEM1	ER degradation-enhancing alpha-mannosidase-like protein 1	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; ISS:UniProtKB
Q92611	EDEM1	ER degradation-enhancing alpha-mannosidase-like protein 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q92611	EDEM1	ER degradation-enhancing alpha-mannosidase-like protein 1	GO:0006457; P:protein folding; TAS:Reactome
Q92611	EDEM1	ER degradation-enhancing alpha-mannosidase-like protein 1	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9BV94	EDEM2	ER degradation-enhancing alpha-mannosidase-like protein 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9BV94	EDEM2	ER degradation-enhancing alpha-mannosidase-like protein 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9BV94	EDEM2	ER degradation-enhancing alpha-mannosidase-like protein 2	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9BV94	EDEM2	ER degradation-enhancing alpha-mannosidase-like protein 2	GO:0006457; P:protein folding; TAS:Reactome
Q9BV94	EDEM2	ER degradation-enhancing alpha-mannosidase-like protein 2	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9BV94	EDEM2	ER degradation-enhancing alpha-mannosidase-like protein 2	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
Q9BZQ6	EDEM3	ER degradation-enhancing alpha-mannosidase-like protein 3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9BZQ6	EDEM3	ER degradation-enhancing alpha-mannosidase-like protein 3	GO:0004569; F:glycoprotein endo-alpha-1,2-mannosidase activity; IEA:Ensembl
Q9BZQ6	EDEM3	ER degradation-enhancing alpha-mannosidase-like protein 3	GO:0004571; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; IEA:UniProtKB-EC
Q9BZQ6	EDEM3	ER degradation-enhancing alpha-mannosidase-like protein 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9BZQ6	EDEM3	ER degradation-enhancing alpha-mannosidase-like protein 3	GO:0006516; P:glycoprotein catabolic process; IEA:Ensembl
Q9BZQ6	EDEM3	ER degradation-enhancing alpha-mannosidase-like protein 3	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9BZQ6	EDEM3	ER degradation-enhancing alpha-mannosidase-like protein 3	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q9BZQ6	EDEM3	ER degradation-enhancing alpha-mannosidase-like protein 3	GO:0006457; P:protein folding; TAS:Reactome
Q9BZQ6	EDEM3	ER degradation-enhancing alpha-mannosidase-like protein 3	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9BZQ6	EDEM3	ER degradation-enhancing alpha-mannosidase-like protein 3	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
O60869	EDF1	Endothelial differentiation-related factor 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O60869	EDF1	Endothelial differentiation-related factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
O60869	EDF1	Endothelial differentiation-related factor 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O60869	EDF1	Endothelial differentiation-related factor 1	GO:0003713; F:transcription coactivator activity; IMP:UniProtKB
O60869	EDF1	Endothelial differentiation-related factor 1	GO:0045446; P:endothelial cell differentiation; TAS:UniProtKB
O60869	EDF1	Endothelial differentiation-related factor 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
O60869	EDF1	Endothelial differentiation-related factor 1	GO:0043388; P:positive regulation of DNA binding; IDA:UniProtKB
O60869	EDF1	Endothelial differentiation-related factor 1	GO:0045893; P:positive regulation of transcription, DNA-templated; TAS:UniProtKB
O60869	EDF1	Endothelial differentiation-related factor 1	GO:0019216; P:regulation of lipid metabolic process; TAS:UniProtKB
O60869	EDF1	Endothelial differentiation-related factor 1	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
O60869	EDF1	Endothelial differentiation-related factor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43854	EDIL3	EGF-like repeat and discoidin I-like domain-containing protein 3	GO:0005509; F:calcium ion binding; IEA:InterPro
O43854	EDIL3	EGF-like repeat and discoidin I-like domain-containing protein 3	GO:0005178; F:integrin binding; TAS:ProtInc
O43854	EDIL3	EGF-like repeat and discoidin I-like domain-containing protein 3	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
O43854	EDIL3	EGF-like repeat and discoidin I-like domain-containing protein 3	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
O43854	EDIL3	EGF-like repeat and discoidin I-like domain-containing protein 3	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0005125; F:cytokine activity; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0031707; F:endothelin A receptor binding; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0031708; F:endothelin B receptor binding; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0005179; F:hormone activity; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0005515; F:protein binding; IPI:IntAct
P05305	EDN1	Endothelin-1	GO:0014824; P:artery smooth muscle contraction; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0007589; P:body fluid secretion; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0019722; P:calcium-mediated signaling; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0051216; P:cartilage development; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0016049; P:cell growth; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0007166; P:cell surface receptor signaling pathway; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0007267; P:cell-cell signaling; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0071347; P:cellular response to interleukin-1; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0042045; P:epithelial fluid transport; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0015758; P:glucose transport; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0007507; P:heart development; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0001821; P:histamine secretion; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0048016; P:inositol phosphate-mediated signaling; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0045321; P:leukocyte activation; TAS:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0060137; P:maternal process involved in parturition; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0051899; P:membrane depolarization; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0042474; P:middle ear morphogenesis; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0010259; P:multicellular organismal aging; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0030195; P:negative regulation of blood coagulation; TAS:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0030818; P:negative regulation of cAMP biosynthetic process; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0032269; P:negative regulation of cellular protein metabolic process; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0046888; P:negative regulation of hormone secretion; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0051771; P:negative regulation of nitric-oxide synthase biosynthetic process; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0034392; P:negative regulation of smooth muscle cell apoptotic process; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0014032; P:neural crest cell development; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0030185; P:nitric oxide transport; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0001569; P:patterning of blood vessels; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0030072; P:peptide hormone secretion; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0014065; P:phosphatidylinositol 3-kinase signaling; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0031583; P:phospholipase D-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0010613; P:positive regulation of cardiac muscle hypertrophy; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0030335; P:positive regulation of cell migration; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0045793; P:positive regulation of cell size; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0070101; P:positive regulation of chemokine-mediated signaling pathway; IC:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0051482; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0010595; P:positive regulation of endothelial cell migration; TAS:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0010460; P:positive regulation of heart rate; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0046887; P:positive regulation of hormone secretion; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0043507; P:positive regulation of JUN kinase activity; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0043406; P:positive regulation of MAP kinase activity; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0045840; P:positive regulation of mitosis; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0090023; P:positive regulation of neutrophil chemotaxis; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; TAS:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0042482; P:positive regulation of odontogenesis; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0060585; P:positive regulation of prostaglandin-endoperoxide synthase activity; IMP:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0010870; P:positive regulation of receptor biosynthetic process; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0035815; P:positive regulation of renal sodium excretion; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0060298; P:positive regulation of sarcomere organization; IMP:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0045987; P:positive regulation of smooth muscle contraction; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0035810; P:positive regulation of urine volume; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0001516; P:prostaglandin biosynthetic process; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0042313; P:protein kinase C deactivation; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0006885; P:regulation of pH; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0051930; P:regulation of sensory perception of pain; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0003100; P:regulation of systemic arterial blood pressure by endothelin; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0019229; P:regulation of vasoconstriction; IEA:InterPro
P05305	EDN1	Endothelin-1	GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0043200; P:response to amino acid; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0042493; P:response to drug; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0001666; P:response to hypoxia; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0035094; P:response to nicotine; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0033574; P:response to testosterone; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0043179; P:rhythmic excitation; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0042554; P:superoxide anion generation; IEA:Ensembl
P05305	EDN1	Endothelin-1	GO:0042310; P:vasoconstriction; IDA:BHF-UCL
P05305	EDN1	Endothelin-1	GO:0014826; P:vein smooth muscle contraction; IDA:BHF-UCL
P20800	EDN2	Endothelin-2	GO:0005179; F:hormone activity; IDA:BHF-UCL
P20800	EDN2	Endothelin-2	GO:0014824; P:artery smooth muscle contraction; IDA:BHF-UCL
P20800	EDN2	Endothelin-2	GO:0019722; P:calcium-mediated signaling; IDA:BHF-UCL
P20800	EDN2	Endothelin-2	GO:0007166; P:cell surface receptor signaling pathway; IC:BHF-UCL
P20800	EDN2	Endothelin-2	GO:0019221; P:cytokine-mediated signaling pathway; IDA:BHF-UCL
P20800	EDN2	Endothelin-2	GO:0003058; P:hormonal regulation of the force of heart contraction; TAS:BHF-UCL
P20800	EDN2	Endothelin-2	GO:0048016; P:inositol phosphate-mediated signaling; IDA:BHF-UCL
P20800	EDN2	Endothelin-2	GO:0042116; P:macrophage activation; IDA:BHF-UCL
P20800	EDN2	Endothelin-2	GO:0048246; P:macrophage chemotaxis; IDA:BHF-UCL
P20800	EDN2	Endothelin-2	GO:0030593; P:neutrophil chemotaxis; IDA:BHF-UCL
P20800	EDN2	Endothelin-2	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P20800	EDN2	Endothelin-2	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:BHF-UCL
P20800	EDN2	Endothelin-2	GO:0010460; P:positive regulation of heart rate; IDA:BHF-UCL
P20800	EDN2	Endothelin-2	GO:0002690; P:positive regulation of leukocyte chemotaxis; IDA:BHF-UCL
P20800	EDN2	Endothelin-2	GO:0060585; P:positive regulation of prostaglandin-endoperoxide synthase activity; IMP:BHF-UCL
P20800	EDN2	Endothelin-2	GO:0045987; P:positive regulation of smooth muscle contraction; IEA:Ensembl
P20800	EDN2	Endothelin-2	GO:0003099; P:positive regulation of the force of heart contraction by chemical signal; TAS:BHF-UCL
P20800	EDN2	Endothelin-2	GO:0001516; P:prostaglandin biosynthetic process; IDA:BHF-UCL
P20800	EDN2	Endothelin-2	GO:0003100; P:regulation of systemic arterial blood pressure by endothelin; IDA:BHF-UCL
P20800	EDN2	Endothelin-2	GO:0019229; P:regulation of vasoconstriction; IEA:InterPro
P20800	EDN2	Endothelin-2	GO:0042310; P:vasoconstriction; IDA:BHF-UCL
P20800	EDN2	Endothelin-2	GO:0014826; P:vein smooth muscle contraction; IDA:BHF-UCL
P14138	EDN3	Endothelin-3	GO:0005179; F:hormone activity; IDA:BHF-UCL
P14138	EDN3	Endothelin-3	GO:0005102; F:receptor binding; TAS:ProtInc
P14138	EDN3	Endothelin-3	GO:0008015; P:blood circulation; TAS:ProtInc
P14138	EDN3	Endothelin-3	GO:0007166; P:cell surface receptor signaling pathway; IDA:BHF-UCL
P14138	EDN3	Endothelin-3	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P14138	EDN3	Endothelin-3	GO:0048016; P:inositol phosphate-mediated signaling; IDA:BHF-UCL
P14138	EDN3	Endothelin-3	GO:0030318; P:melanocyte differentiation; IEA:Ensembl
P14138	EDN3	Endothelin-3	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P14138	EDN3	Endothelin-3	GO:0001755; P:neural crest cell migration; IEA:Ensembl
P14138	EDN3	Endothelin-3	GO:0030182; P:neuron differentiation; IEA:Ensembl
P14138	EDN3	Endothelin-3	GO:0030593; P:neutrophil chemotaxis; IDA:BHF-UCL
P14138	EDN3	Endothelin-3	GO:0030072; P:peptide hormone secretion; IDA:BHF-UCL
P14138	EDN3	Endothelin-3	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P14138	EDN3	Endothelin-3	GO:0010460; P:positive regulation of heart rate; IDA:BHF-UCL
P14138	EDN3	Endothelin-3	GO:0046887; P:positive regulation of hormone secretion; IDA:BHF-UCL
P14138	EDN3	Endothelin-3	GO:0002690; P:positive regulation of leukocyte chemotaxis; IDA:BHF-UCL
P14138	EDN3	Endothelin-3	GO:0043406; P:positive regulation of MAP kinase activity; IDA:BHF-UCL
P14138	EDN3	Endothelin-3	GO:0045840; P:positive regulation of mitosis; IDA:BHF-UCL
P14138	EDN3	Endothelin-3	GO:0048070; P:regulation of developmental pigmentation; IEA:Ensembl
P14138	EDN3	Endothelin-3	GO:0003100; P:regulation of systemic arterial blood pressure by endothelin; IDA:BHF-UCL
P14138	EDN3	Endothelin-3	GO:0019229; P:regulation of vasoconstriction; IEA:InterPro
P14138	EDN3	Endothelin-3	GO:0007165; P:signal transduction; TAS:ProtInc
P14138	EDN3	Endothelin-3	GO:0042310; P:vasoconstriction; IDA:BHF-UCL
P14138	EDN3	Endothelin-3	GO:0014826; P:vein smooth muscle contraction; IDA:BHF-UCL
P25101	EDNRA	Endothelin-1 receptor	GO:0004962; F:endothelin receptor activity; NAS:UniProtKB
P25101	EDNRA	Endothelin-1 receptor	GO:0004435; F:phosphatidylinositol phospholipase C activity; TAS:ProtInc
P25101	EDNRA	Endothelin-1 receptor	GO:0005515; F:protein binding; IPI:IntAct
P25101	EDNRA	Endothelin-1 receptor	GO:0007190; P:activation of adenylate cyclase activity; TAS:ProtInc
P25101	EDNRA	Endothelin-1 receptor	GO:0007202; P:activation of phospholipase C activity; TAS:ProtInc
P25101	EDNRA	Endothelin-1 receptor	GO:0007568; P:aging; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0014824; P:artery smooth muscle contraction; IMP:BHF-UCL
P25101	EDNRA	Endothelin-1 receptor	GO:0008283; P:cell proliferation; NAS:UniProtKB
P25101	EDNRA	Endothelin-1 receptor	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0048484; P:enteric nervous system development; IEA:InterPro
P25101	EDNRA	Endothelin-1 receptor	GO:0048144; P:fibroblast proliferation; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
P25101	EDNRA	Endothelin-1 receptor	GO:0003094; P:glomerular filtration; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0015758; P:glucose transport; ISS:UniProtKB
P25101	EDNRA	Endothelin-1 receptor	GO:0060322; P:head development; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0007507; P:heart development; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0001821; P:histamine secretion; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0060137; P:maternal process involved in parturition; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0008152; P:metabolic process; TAS:GOC
P25101	EDNRA	Endothelin-1 receptor	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0030818; P:negative regulation of cAMP biosynthetic process; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0014032; P:neural crest cell development; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0001569; P:patterning of blood vessels; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0043084; P:penile erection; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
P25101	EDNRA	Endothelin-1 receptor	GO:0051482; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0050729; P:positive regulation of inflammatory response; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0090184; P:positive regulation of kidney development; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0090023; P:positive regulation of neutrophil chemotaxis; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0042482; P:positive regulation of odontogenesis; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0008217; P:regulation of blood pressure; IEA:InterPro
P25101	EDNRA	Endothelin-1 receptor	GO:0050678; P:regulation of epithelial cell proliferation; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0007585; P:respiratory gaseous exchange; ISS:UniProtKB
P25101	EDNRA	Endothelin-1 receptor	GO:0001666; P:response to hypoxia; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0043278; P:response to morphine; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0007266; P:Rho protein signal transduction; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0007165; P:signal transduction; TAS:ProtInc
P25101	EDNRA	Endothelin-1 receptor	GO:0048659; P:smooth muscle cell proliferation; IEA:Ensembl
P25101	EDNRA	Endothelin-1 receptor	GO:0006939; P:smooth muscle contraction; NAS:UniProtKB
P25101	EDNRA	Endothelin-1 receptor	GO:0042310; P:vasoconstriction; IMP:BHF-UCL
P24530	EDNRB	Endothelin B receptor	GO:0004962; F:endothelin receptor activity; IDA:BHF-UCL
P24530	EDNRB	Endothelin B receptor	GO:0017046; F:peptide hormone binding; IPI:BHF-UCL
P24530	EDNRB	Endothelin B receptor	GO:0005515; F:protein binding; IPI:IntAct
P24530	EDNRB	Endothelin B receptor	GO:0007568; P:aging; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P24530	EDNRB	Endothelin B receptor	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0019934; P:cGMP-mediated signaling; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0086100; P:endothelin receptor signaling pathway; IDA:GOC
P24530	EDNRB	Endothelin B receptor	GO:0048484; P:enteric nervous system development; ISS:BHF-UCL
P24530	EDNRB	Endothelin B receptor	GO:0035645; P:enteric smooth muscle cell differentiation; ISS:BHF-UCL
P24530	EDNRB	Endothelin B receptor	GO:0042045; P:epithelial fluid transport; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0048246; P:macrophage chemotaxis; IMP:BHF-UCL
P24530	EDNRB	Endothelin B receptor	GO:0030318; P:melanocyte differentiation; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0007194; P:negative regulation of adenylate cyclase activity; TAS:ProtInc
P24530	EDNRB	Endothelin B receptor	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0032269; P:negative regulation of cellular protein metabolic process; IMP:BHF-UCL
P24530	EDNRB	Endothelin B receptor	GO:0014043; P:negative regulation of neuron maturation; ISS:BHF-UCL
P24530	EDNRB	Endothelin B receptor	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P24530	EDNRB	Endothelin B receptor	GO:0007399; P:nervous system development; TAS:ProtInc
P24530	EDNRB	Endothelin B receptor	GO:0001755; P:neural crest cell migration; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0007422; P:peripheral nervous system development; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; TAS:ProtInc
P24530	EDNRB	Endothelin B receptor	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0060406; P:positive regulation of penile erection; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0035815; P:positive regulation of renal sodium excretion; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0035810; P:positive regulation of urine volume; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0007497; P:posterior midgut development; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0008217; P:regulation of blood pressure; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0050678; P:regulation of epithelial cell proliferation; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0031620; P:regulation of fever generation; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0006885; P:regulation of pH; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0051930; P:regulation of sensory perception of pain; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0048265; P:response to pain; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0042310; P:vasoconstriction; IMP:BHF-UCL
P24530	EDNRB	Endothelin B receptor	GO:0042311; P:vasodilation; IEA:Ensembl
P24530	EDNRB	Endothelin B receptor	GO:0014826; P:vein smooth muscle contraction; IMP:BHF-UCL
Q3B7T1	EDRF1	Erythroid differentiation-related factor 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q3B7T1	EDRF1	Erythroid differentiation-related factor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15075	EEA1	Early endosome antigen 1	GO:0005545; F:1-phosphatidylinositol binding; IDA:UniProtKB
Q15075	EEA1	Early endosome antigen 1	GO:0005516; F:calmodulin binding; NAS:UniProtKB
Q15075	EEA1	Early endosome antigen 1	GO:0030742; F:GTP-dependent protein binding; IDA:UniProtKB
Q15075	EEA1	Early endosome antigen 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15075	EEA1	Early endosome antigen 1	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q15075	EEA1	Early endosome antigen 1	GO:0008270; F:zinc ion binding; TAS:UniProtKB
Q15075	EEA1	Early endosome antigen 1	GO:0045022; P:early endosome to late endosome transport; NAS:UniProtKB
Q15075	EEA1	Early endosome antigen 1	GO:0006897; P:endocytosis; IMP:UniProtKB
Q15075	EEA1	Early endosome antigen 1	GO:0016189; P:synaptic vesicle to endosome fusion; TAS:UniProtKB
Q15075	EEA1	Early endosome antigen 1	GO:0006906; P:vesicle fusion; IMP:UniProtKB
O75530	EED	Polycomb protein EED	GO:0003682; F:chromatin binding; IEA:Ensembl
O75530	EED	Polycomb protein EED	GO:0042054; F:histone methyltransferase activity; IDA:MGI
O75530	EED	Polycomb protein EED	GO:0042802; F:identical protein binding; IPI:IntAct
O75530	EED	Polycomb protein EED	GO:0005515; F:protein binding; IPI:UniProtKB
O75530	EED	Polycomb protein EED	GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB
O75530	EED	Polycomb protein EED	GO:0061087; P:positive regulation of histone H3-K27 methylation; IEA:Ensembl
O75530	EED	Polycomb protein EED	GO:0006349; P:regulation of gene expression by genetic imprinting; IEA:Ensembl
O75530	EED	Polycomb protein EED	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7L9B9	EEPD1	Endonuclease/exonuclease/phosphatase family domain-containing protein 1	GO:0003677; F:DNA binding; IEA:InterPro
Q7L9B9	EEPD1	Endonuclease/exonuclease/phosphatase family domain-containing protein 1	GO:0006281; P:DNA repair; IEA:InterPro
P68104	EEF1A1	Elongation factor 1-alpha 1	GO:0005525; F:GTP binding; TAS:UniProtKB
P68104	EEF1A1	Elongation factor 1-alpha 1	GO:0003924; F:GTPase activity; IEA:InterPro
P68104	EEF1A1	Elongation factor 1-alpha 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P68104	EEF1A1	Elongation factor 1-alpha 1	GO:0005515; F:protein binding; IPI:UniProtKB
P68104	EEF1A1	Elongation factor 1-alpha 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P68104	EEF1A1	Elongation factor 1-alpha 1	GO:0003746; F:translation elongation factor activity; TAS:UniProtKB
P68104	EEF1A1	Elongation factor 1-alpha 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P68104	EEF1A1	Elongation factor 1-alpha 1	GO:0071364; P:cellular response to epidermal growth factor stimulus; IDA:UniProtKB
P68104	EEF1A1	Elongation factor 1-alpha 1	GO:0010467; P:gene expression; TAS:Reactome
P68104	EEF1A1	Elongation factor 1-alpha 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P68104	EEF1A1	Elongation factor 1-alpha 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P68104	EEF1A1	Elongation factor 1-alpha 1	GO:0006412; P:translation; TAS:Reactome
P68104	EEF1A1	Elongation factor 1-alpha 1	GO:0006414; P:translational elongation; TAS:UniProtKB
Q05639	EEF1A2	Elongation factor 1-alpha 2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q05639	EEF1A2	Elongation factor 1-alpha 2	GO:0003924; F:GTPase activity; IEA:InterPro
Q05639	EEF1A2	Elongation factor 1-alpha 2	GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-KW
Q05639	EEF1A2	Elongation factor 1-alpha 2	GO:0008135; F:translation factor activity, nucleic acid binding; NAS:ProtInc
Q05639	EEF1A2	Elongation factor 1-alpha 2	GO:1900119; P:positive regulation of execution phase of apoptosis; IEA:Ensembl
Q05639	EEF1A2	Elongation factor 1-alpha 2	GO:0010035; P:response to inorganic substance; IEA:Ensembl
Q5VTE0	EEF1A1P5	Putative elongation factor 1-alpha-like 3	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q5VTE0	EEF1A1P5	Putative elongation factor 1-alpha-like 3	GO:0003924; F:GTPase activity; IEA:InterPro
Q5VTE0	EEF1A1P5	Putative elongation factor 1-alpha-like 3	GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-KW
P24534	EEF1B2	Elongation factor 1-beta	GO:0005515; F:protein binding; IPI:IntAct
P24534	EEF1B2	Elongation factor 1-beta	GO:0003746; F:translation elongation factor activity; NAS:UniProtKB
P24534	EEF1B2	Elongation factor 1-beta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P24534	EEF1B2	Elongation factor 1-beta	GO:0010467; P:gene expression; TAS:Reactome
P24534	EEF1B2	Elongation factor 1-beta	GO:0006412; P:translation; TAS:Reactome
P24534	EEF1B2	Elongation factor 1-beta	GO:0006414; P:translational elongation; NAS:UniProtKB
Q658K8	EEF1DP3	Putative elongation factor 1-delta-like protein	GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-KW
P29692	EEF1D	Elongation factor 1-delta	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P29692	EEF1D	Elongation factor 1-delta	GO:0005515; F:protein binding; IPI:IntAct
P29692	EEF1D	Elongation factor 1-delta	GO:0004871; F:signal transducer activity; IMP:UniProtKB
P29692	EEF1D	Elongation factor 1-delta	GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-KW
P29692	EEF1D	Elongation factor 1-delta	GO:0008135; F:translation factor activity, nucleic acid binding; TAS:ProtInc
P29692	EEF1D	Elongation factor 1-delta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P29692	EEF1D	Elongation factor 1-delta	GO:0010467; P:gene expression; TAS:Reactome
P29692	EEF1D	Elongation factor 1-delta	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
P29692	EEF1D	Elongation factor 1-delta	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P29692	EEF1D	Elongation factor 1-delta	GO:0007165; P:signal transduction; IMP:GOC
P29692	EEF1D	Elongation factor 1-delta	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P29692	EEF1D	Elongation factor 1-delta	GO:0006412; P:translation; TAS:Reactome
P29692	EEF1D	Elongation factor 1-delta	GO:0006414; P:translational elongation; TAS:Reactome
P26641	EEF1G	Elongation factor 1-gamma	GO:0005515; F:protein binding; IPI:UniProtKB
P26641	EEF1G	Elongation factor 1-gamma	GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-KW
P26641	EEF1G	Elongation factor 1-gamma	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P26641	EEF1G	Elongation factor 1-gamma	GO:0010467; P:gene expression; TAS:Reactome
P26641	EEF1G	Elongation factor 1-gamma	GO:0009615; P:response to virus; IEP:UniProtKB
P26641	EEF1G	Elongation factor 1-gamma	GO:0006412; P:translation; TAS:Reactome
P26641	EEF1G	Elongation factor 1-gamma	GO:0006414; P:translational elongation; TAS:Reactome
O00418	EEF2K	Eukaryotic elongation factor 2 kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O00418	EEF2K	Eukaryotic elongation factor 2 kinase	GO:0005509; F:calcium ion binding; IEA:InterPro
O00418	EEF2K	Eukaryotic elongation factor 2 kinase	GO:0005516; F:calmodulin binding; IDA:UniProtKB
O00418	EEF2K	Eukaryotic elongation factor 2 kinase	GO:0004686; F:elongation factor-2 kinase activity; IDA:UniProtKB
O00418	EEF2K	Eukaryotic elongation factor 2 kinase	GO:0004672; F:protein kinase activity; TAS:ProtInc
O00418	EEF2K	Eukaryotic elongation factor 2 kinase	GO:0008135; F:translation factor activity, nucleic acid binding; TAS:ProtInc
O00418	EEF2K	Eukaryotic elongation factor 2 kinase	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
O00418	EEF2K	Eukaryotic elongation factor 2 kinase	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
O00418	EEF2K	Eukaryotic elongation factor 2 kinase	GO:0031952; P:regulation of protein autophosphorylation; IEA:Ensembl
O00418	EEF2K	Eukaryotic elongation factor 2 kinase	GO:0006414; P:translational elongation; TAS:ProtInc
P13639	EEF2	Elongation factor 2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P13639	EEF2	Elongation factor 2	GO:0003924; F:GTPase activity; IEA:Ensembl
P13639	EEF2	Elongation factor 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P13639	EEF2	Elongation factor 2	GO:0019901; F:protein kinase binding; IPI:UniProt
P13639	EEF2	Elongation factor 2	GO:0008494; F:translation activator activity; IGI:UniProt
P13639	EEF2	Elongation factor 2	GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-KW
P13639	EEF2	Elongation factor 2	GO:0008219; P:cell death; IEA:UniProtKB-KW
P13639	EEF2	Elongation factor 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P13639	EEF2	Elongation factor 2	GO:0010467; P:gene expression; TAS:Reactome
P13639	EEF2	Elongation factor 2	GO:0010628; P:positive regulation of gene expression; IGI:UniProt
P13639	EEF2	Elongation factor 2	GO:0045727; P:positive regulation of translation; IGI:UniProt
P13639	EEF2	Elongation factor 2	GO:0006412; P:translation; TAS:Reactome
P13639	EEF2	Elongation factor 2	GO:0006414; P:translational elongation; TAS:Reactome
A6NFE3	EFCAB10	EF-hand calcium-binding domain-containing protein 10	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9BUY7	EFCAB11	EF-hand calcium-binding domain-containing protein 11	GO:0005509; F:calcium ion binding; IEA:InterPro
Q6NXP0	EFCAB12	EF-hand calcium-binding domain-containing protein 12	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8IY85	EFCAB13	EF-hand calcium-binding domain-containing protein 13	GO:0005509; F:calcium ion binding; IEA:InterPro
O75071	EFCAB14	EF-hand calcium-binding domain-containing protein 14	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8N4Y2	EFCAB4A	EF-hand calcium-binding domain-containing protein 4A	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8N4Y2	EFCAB4A	EF-hand calcium-binding domain-containing protein 4A	GO:0034613; P:cellular protein localization; IEA:Ensembl
Q8N4Y2	EFCAB4A	EF-hand calcium-binding domain-containing protein 4A	GO:2001256; P:regulation of store-operated calcium entry; IEA:Ensembl
Q8N4Y2	EFCAB4A	EF-hand calcium-binding domain-containing protein 4A	GO:0002115; P:store-operated calcium entry; IMP:UniProtKB
Q9BSW2	EFCAB4B	EF-hand calcium-binding domain-containing protein 4B	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q9BSW2	EFCAB4B	EF-hand calcium-binding domain-containing protein 4B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BSW2	EFCAB4B	EF-hand calcium-binding domain-containing protein 4B	GO:0032237; P:activation of store-operated calcium channel activity; IMP:UniProtKB
Q9BSW2	EFCAB4B	EF-hand calcium-binding domain-containing protein 4B	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q9BSW2	EFCAB4B	EF-hand calcium-binding domain-containing protein 4B	GO:0051928; P:positive regulation of calcium ion transport; IMP:UniProtKB
Q9BSW2	EFCAB4B	EF-hand calcium-binding domain-containing protein 4B	GO:0002115; P:store-operated calcium entry; IMP:UniProtKB
Q9HAE3	EFCAB1	EF-hand calcium-binding domain-containing protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8N7B9	EFCAB3	EF-hand calcium-binding domain-containing protein 3	GO:0005509; F:calcium ion binding; IEA:InterPro
A4FU69	EFCAB5	EF-hand calcium-binding domain-containing protein 5	GO:0005509; F:calcium ion binding; IEA:InterPro
Q5VUJ9	EFCAB2	EF-hand calcium-binding domain-containing protein 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q5THR3	EFCAB6	EF-hand calcium-binding domain-containing protein 6	GO:0005509; F:calcium ion binding; IEA:InterPro
Q5THR3	EFCAB6	EF-hand calcium-binding domain-containing protein 6	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5THR3	EFCAB6	EF-hand calcium-binding domain-containing protein 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A8MWE9	EFCAB8	EF-hand calcium-binding domain-containing protein 8	GO:0005509; F:calcium ion binding; IEA:InterPro
A8K855	EFCAB7	EF-hand calcium-binding domain-containing protein 7	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9HA90	EFCC1	EF-hand and coiled-coil domain-containing protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
A8MZ26	EFCAB9	EF-hand calcium-binding domain-containing protein 9	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96RP9	GFM1	Elongation factor G, mitochondrial	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q96RP9	GFM1	Elongation factor G, mitochondrial	GO:0003924; F:GTPase activity; IDA:UniProtKB
Q96RP9	GFM1	Elongation factor G, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96RP9	GFM1	Elongation factor G, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q96RP9	GFM1	Elongation factor G, mitochondrial	GO:0003746; F:translation elongation factor activity; IDA:UniProtKB
Q96RP9	GFM1	Elongation factor G, mitochondrial	GO:0006184; P:GTP catabolic process; IDA:GOC
Q96RP9	GFM1	Elongation factor G, mitochondrial	GO:0070125; P:mitochondrial translational elongation; IDA:UniProtKB
Q5JVL4	EFHC1	EF-hand domain-containing protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q5JVL4	EFHC1	EF-hand domain-containing protein 1	GO:0008022; F:protein C-terminus binding; ISS:UniProtKB
Q8N7U6	EFHB	EF-hand domain-containing family member B	GO:0005509; F:calcium ion binding; IEA:InterPro
Q5JST6	EFHC2	EF-hand domain-containing family member C2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96C19	EFHD2	EF-hand domain-containing protein D2	GO:0005509; F:calcium ion binding; IEA:Ensembl
Q9BUP0	EFHD1	EF-hand domain-containing protein D1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9BUP0	EFHD1	EF-hand domain-containing protein D1	GO:0031175; P:neuron projection development; IEA:Ensembl
P20827	EFNA1	Ephrin-A1	GO:0046875; F:ephrin receptor binding; IPI:UniProtKB
P20827	EFNA1	Ephrin-A1	GO:0005515; F:protein binding; IPI:IntAct
P20827	EFNA1	Ephrin-A1	GO:0005102; F:receptor binding; TAS:ProtInc
P20827	EFNA1	Ephrin-A1	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
P20827	EFNA1	Ephrin-A1	GO:0001525; P:angiogenesis; IBA:RefGenome
P20827	EFNA1	Ephrin-A1	GO:0003180; P:aortic valve morphogenesis; ISS:BHF-UCL
P20827	EFNA1	Ephrin-A1	GO:0007411; P:axon guidance; IBA:RefGenome
P20827	EFNA1	Ephrin-A1	GO:0016477; P:cell migration; IDA:UniProtKB
P20827	EFNA1	Ephrin-A1	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P20827	EFNA1	Ephrin-A1	GO:0003199; P:endocardial cushion to mesenchymal transition involved in heart valve formation; ISS:BHF-UCL
P20827	EFNA1	Ephrin-A1	GO:0048013; P:ephrin receptor signaling pathway; IDA:UniProtKB
P20827	EFNA1	Ephrin-A1	GO:0003183; P:mitral valve morphogenesis; ISS:BHF-UCL
P20827	EFNA1	Ephrin-A1	GO:0061002; P:negative regulation of dendritic spine morphogenesis; ISS:UniProtKB
P20827	EFNA1	Ephrin-A1	GO:0010719; P:negative regulation of epithelial to mesenchymal transition; ISS:BHF-UCL
P20827	EFNA1	Ephrin-A1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P20827	EFNA1	Ephrin-A1	GO:0014028; P:notochord formation; IEA:Ensembl
P20827	EFNA1	Ephrin-A1	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P20827	EFNA1	Ephrin-A1	GO:0045765; P:regulation of angiogenesis; IEA:Ensembl
P20827	EFNA1	Ephrin-A1	GO:0050770; P:regulation of axonogenesis; IEA:Ensembl
P20827	EFNA1	Ephrin-A1	GO:0043535; P:regulation of blood vessel endothelial cell migration; IEA:Ensembl
P20827	EFNA1	Ephrin-A1	GO:0033628; P:regulation of cell adhesion mediated by integrin; IDA:UniProtKB
P20827	EFNA1	Ephrin-A1	GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; ISS:UniProtKB
P20827	EFNA1	Ephrin-A1	GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:UniProtKB
O43921	EFNA2	Ephrin-A2	GO:0046875; F:ephrin receptor binding; IBA:RefGenome
O43921	EFNA2	Ephrin-A2	GO:0007411; P:axon guidance; IBA:RefGenome
O43921	EFNA2	Ephrin-A2	GO:0046849; P:bone remodeling; ISS:UniProtKB
O43921	EFNA2	Ephrin-A2	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O43921	EFNA2	Ephrin-A2	GO:0048013; P:ephrin receptor signaling pathway; ISS:UniProtKB
O43921	EFNA2	Ephrin-A2	GO:0021772; P:olfactory bulb development; IEA:Ensembl
O43921	EFNA2	Ephrin-A2	GO:0030316; P:osteoclast differentiation; ISS:UniProtKB
P52798	EFNA4	Ephrin-A4	GO:0046875; F:ephrin receptor binding; IPI:UniProtKB
P52798	EFNA4	Ephrin-A4	GO:0005515; F:protein binding; IPI:UniProtKB
P52798	EFNA4	Ephrin-A4	GO:0005005; F:transmembrane-ephrin receptor activity; TAS:ProtInc
P52798	EFNA4	Ephrin-A4	GO:0007411; P:axon guidance; IBA:RefGenome
P52798	EFNA4	Ephrin-A4	GO:0046849; P:bone remodeling; IBA:RefGenome
P52798	EFNA4	Ephrin-A4	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P52798	EFNA4	Ephrin-A4	GO:0048013; P:ephrin receptor signaling pathway; IBA:RefGenome
P52798	EFNA4	Ephrin-A4	GO:0030316; P:osteoclast differentiation; IBA:RefGenome
P52797	EFNA3	Ephrin-A3	GO:0046875; F:ephrin receptor binding; IPI:UniProtKB
P52797	EFNA3	Ephrin-A3	GO:0005005; F:transmembrane-ephrin receptor activity; TAS:ProtInc
P52797	EFNA3	Ephrin-A3	GO:0007411; P:axon guidance; IBA:RefGenome
P52797	EFNA3	Ephrin-A3	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P52797	EFNA3	Ephrin-A3	GO:0048013; P:ephrin receptor signaling pathway; ISS:UniProtKB
P52803	EFNA5	Ephrin-A5	GO:0045499; F:chemorepellent activity; IEA:Ensembl
P52803	EFNA5	Ephrin-A5	GO:0046875; F:ephrin receptor binding; IPI:UniProtKB
P52803	EFNA5	Ephrin-A5	GO:0007411; P:axon guidance; IBA:RefGenome
P52803	EFNA5	Ephrin-A5	GO:0048013; P:ephrin receptor signaling pathway; IDA:UniProtKB
P52803	EFNA5	Ephrin-A5	GO:0007399; P:nervous system development; TAS:ProtInc
P52803	EFNA5	Ephrin-A5	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISS:UniProtKB
P52803	EFNA5	Ephrin-A5	GO:0032956; P:regulation of actin cytoskeleton organization; IDA:UniProtKB
P52803	EFNA5	Ephrin-A5	GO:0022407; P:regulation of cell-cell adhesion; IDA:UniProtKB
P52803	EFNA5	Ephrin-A5	GO:0051893; P:regulation of focal adhesion assembly; IDA:UniProtKB
P52803	EFNA5	Ephrin-A5	GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB
P52803	EFNA5	Ephrin-A5	GO:0070507; P:regulation of microtubule cytoskeleton organization; IDA:UniProtKB
P52803	EFNA5	Ephrin-A5	GO:0032314; P:regulation of Rac GTPase activity; ISS:UniProtKB
P52803	EFNA5	Ephrin-A5	GO:0032319; P:regulation of Rho GTPase activity; IDA:UniProtKB
P52803	EFNA5	Ephrin-A5	GO:0031290; P:retinal ganglion cell axon guidance; IEA:Ensembl
P98172	EFNB1	Ephrin-B1	GO:0046875; F:ephrin receptor binding; IBA:RefGenome
P98172	EFNB1	Ephrin-B1	GO:0005515; F:protein binding; IPI:UniProtKB
P98172	EFNB1	Ephrin-B1	GO:0007411; P:axon guidance; IBA:RefGenome
P98172	EFNB1	Ephrin-B1	GO:0007155; P:cell adhesion; TAS:ProtInc
P98172	EFNB1	Ephrin-B1	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P98172	EFNB1	Ephrin-B1	GO:0009880; P:embryonic pattern specification; IEA:Ensembl
P98172	EFNB1	Ephrin-B1	GO:0048013; P:ephrin receptor signaling pathway; IBA:RefGenome
P98172	EFNB1	Ephrin-B1	GO:0001755; P:neural crest cell migration; IEA:Ensembl
P98172	EFNB1	Ephrin-B1	GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl
P52799	EFNB2	Ephrin-B2	GO:0046875; F:ephrin receptor binding; IPI:UniProtKB
P52799	EFNB2	Ephrin-B2	GO:0005515; F:protein binding; IPI:IntAct
P52799	EFNB2	Ephrin-B2	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P52799	EFNB2	Ephrin-B2	GO:0007411; P:axon guidance; IBA:RefGenome
P52799	EFNB2	Ephrin-B2	GO:0007155; P:cell adhesion; IDA:UniProtKB
P52799	EFNB2	Ephrin-B2	GO:0002042; P:cell migration involved in sprouting angiogenesis; IDA:UniProtKB
P52799	EFNB2	Ephrin-B2	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P52799	EFNB2	Ephrin-B2	GO:0048013; P:ephrin receptor signaling pathway; IDA:UniProtKB
P52799	EFNB2	Ephrin-B2	GO:0001945; P:lymph vessel development; IEA:Ensembl
P52799	EFNB2	Ephrin-B2	GO:0010839; P:negative regulation of keratinocyte proliferation; IEA:Ensembl
P52799	EFNB2	Ephrin-B2	GO:0009887; P:organ morphogenesis; IEA:Ensembl
P52799	EFNB2	Ephrin-B2	GO:2000727; P:positive regulation of cardiac muscle cell differentiation; ISS:BHF-UCL
P52799	EFNB2	Ephrin-B2	GO:0050920; P:regulation of chemotaxis; IDA:UniProtKB
P52799	EFNB2	Ephrin-B2	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q15768	EFNB3	Ephrin-B3	GO:0046875; F:ephrin receptor binding; IDA:MGI
Q15768	EFNB3	Ephrin-B3	GO:0005005; F:transmembrane-ephrin receptor activity; TAS:ProtInc
Q15768	EFNB3	Ephrin-B3	GO:0007628; P:adult walking behavior; IEA:Ensembl
Q15768	EFNB3	Ephrin-B3	GO:0016198; P:axon choice point recognition; IEA:Ensembl
Q15768	EFNB3	Ephrin-B3	GO:0007411; P:axon guidance; IBA:RefGenome
Q15768	EFNB3	Ephrin-B3	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q15768	EFNB3	Ephrin-B3	GO:0048013; P:ephrin receptor signaling pathway; IDA:MGI
Q15768	EFNB3	Ephrin-B3	GO:0007399; P:nervous system development; TAS:ProtInc
Q15768	EFNB3	Ephrin-B3	GO:0016032; P:viral process; IEA:UniProtKB-KW
O43281	EFS	Embryonal Fyn-associated substrate	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
O43281	EFS	Embryonal Fyn-associated substrate	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
O43281	EFS	Embryonal Fyn-associated substrate	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
P43897	TSFM	Elongation factor Ts, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P43897	TSFM	Elongation factor Ts, mitochondrial	GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-HAMAP
P43897	TSFM	Elongation factor Ts, mitochondrial	GO:0032784; P:regulation of DNA-templated transcription, elongation; TAS:ProtInc
P43897	TSFM	Elongation factor Ts, mitochondrial	GO:0006414; P:translational elongation; TAS:ProtInc
P49411	TUFM	Elongation factor Tu, mitochondrial	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P49411	TUFM	Elongation factor Tu, mitochondrial	GO:0003924; F:GTPase activity; IEA:InterPro
P49411	TUFM	Elongation factor Tu, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P49411	TUFM	Elongation factor Tu, mitochondrial	GO:0003746; F:translation elongation factor activity; IDA:UniProtKB
P49411	TUFM	Elongation factor Tu, mitochondrial	GO:0006414; P:translational elongation; IDA:UniProtKB
Q8IUX8	EGFL6	Epidermal growth factor-like protein 6	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8IUX8	EGFL6	Epidermal growth factor-like protein 6	GO:0005178; F:integrin binding; TAS:ProtInc
Q8IUX8	EGFL6	Epidermal growth factor-like protein 6	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q8IUX8	EGFL6	Epidermal growth factor-like protein 6	GO:0007049; P:cell cycle; TAS:ProtInc
Q8IUX8	EGFL6	Epidermal growth factor-like protein 6	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8IUX8	EGFL6	Epidermal growth factor-like protein 6	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q8IUX8	EGFL6	Epidermal growth factor-like protein 6	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8IUX8	EGFL6	Epidermal growth factor-like protein 6	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
Q9UHF1	EGFL7	Epidermal growth factor-like protein 7	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UHF1	EGFL7	Epidermal growth factor-like protein 7	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q9UHF1	EGFL7	Epidermal growth factor-like protein 7	GO:0001568; P:blood vessel development; ISS:UniProtKB
Q9UHF1	EGFL7	Epidermal growth factor-like protein 7	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
Q9UHF1	EGFL7	Epidermal growth factor-like protein 7	GO:0045746; P:negative regulation of Notch signaling pathway; IMP:MGI
Q9UHF1	EGFL7	Epidermal growth factor-like protein 7	GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:MGI
Q9UHF1	EGFL7	Epidermal growth factor-like protein 7	GO:0001570; P:vasculogenesis; ISS:UniProtKB
Q99944	EGFL8	Epidermal growth factor-like protein 8	GO:0005509; F:calcium ion binding; IEA:InterPro
Q63HQ2	EGFLAM	Pikachurin	GO:0005539; F:glycosaminoglycan binding; IEA:Ensembl
Q63HQ2	EGFLAM	Pikachurin	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q63HQ2	EGFLAM	Pikachurin	GO:0019800; P:peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan; IEA:Ensembl
Q63HQ2	EGFLAM	Pikachurin	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0051015; F:actin filament binding; IDA:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P00533	EGFR	Epidermal growth factor receptor	GO:0003682; F:chromatin binding; IDA:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0003690; F:double-stranded DNA binding; NAS:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0019899; F:enzyme binding; IPI:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0005006; F:epidermal growth factor-activated receptor activity; IDA:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0042802; F:identical protein binding; IPI:IntAct
P00533	EGFR	Epidermal growth factor receptor	GO:0004709; F:MAP kinase kinase kinase activity; NAS:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0004716; F:receptor signaling protein tyrosine kinase activity; IEA:InterPro
P00533	EGFR	Epidermal growth factor receptor	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; TAS:Reactome
P00533	EGFR	Epidermal growth factor receptor	GO:0004888; F:transmembrane signaling receptor activity; IDA:MGI
P00533	EGFR	Epidermal growth factor receptor	GO:0043006; P:activation of phospholipase A2 activity by calcium-mediated signaling; TAS:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0007202; P:activation of phospholipase C activity; TAS:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0019694; P:alkanesulfonate metabolic process; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0048143; P:astrocyte activation; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0007411; P:axon guidance; TAS:Reactome
P00533	EGFR	Epidermal growth factor receptor	GO:0008283; P:cell proliferation; IDA:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0007166; P:cell surface receptor signaling pathway; IDA:MGI
P00533	EGFR	Epidermal growth factor receptor	GO:0016337; P:single organismal cell-cell adhesion; IMP:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0071549; P:cellular response to dexamethasone stimulus; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0035690; P:cellular response to drug; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0071364; P:cellular response to epidermal growth factor stimulus; ISS:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0071392; P:cellular response to estradiol stimulus; IDA:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0021795; P:cerebral cortex cell migration; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0007623; P:circadian rhythm; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0048546; P:digestive tract morphogenesis; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0016101; P:diterpenoid metabolic process; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0001892; P:embryonic placenta development; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0007173; P:epidermal growth factor receptor signaling pathway; IDA:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P00533	EGFR	Epidermal growth factor receptor	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P00533	EGFR	Epidermal growth factor receptor	GO:0001942; P:hair follicle development; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0042743; P:hydrogen peroxide metabolic process; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0045087; P:innate immune response; TAS:Reactome
P00533	EGFR	Epidermal growth factor receptor	GO:0007611; P:learning or memory; ISS:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0001889; P:liver development; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0030324; P:lung development; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0010960; P:magnesium ion homeostasis; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0000165; P:MAPK cascade; NAS:GOC
P00533	EGFR	Epidermal growth factor receptor	GO:0060571; P:morphogenesis of an epithelial fold; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
P00533	EGFR	Epidermal growth factor receptor	GO:0045930; P:negative regulation of mitotic cell cycle; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0042177; P:negative regulation of protein catabolic process; IDA:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P00533	EGFR	Epidermal growth factor receptor	GO:0001503; P:ossification; NAS:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0042698; P:ovulation cycle; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:GOC
P00533	EGFR	Epidermal growth factor receptor	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P00533	EGFR	Epidermal growth factor receptor	GO:0005976; P:polysaccharide metabolic process; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0035413; P:positive regulation of catenin import into nucleus; IMP:BHF-UCL
P00533	EGFR	Epidermal growth factor receptor	GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0008284; P:positive regulation of cell proliferation; IDA:MGI
P00533	EGFR	Epidermal growth factor receptor	GO:0031659; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle; IDA:BHF-UCL
P00533	EGFR	Epidermal growth factor receptor	GO:0045739; P:positive regulation of DNA repair; IDA:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0045740; P:positive regulation of DNA replication; IDA:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0050729; P:positive regulation of inflammatory response; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0043406; P:positive regulation of MAP kinase activity; IDA:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IDA:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0042327; P:positive regulation of phosphorylation; IDA:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0051897; P:positive regulation of protein kinase B signaling; IMP:BHF-UCL
P00533	EGFR	Epidermal growth factor receptor	GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0032930; P:positive regulation of superoxide anion generation; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0045909; P:positive regulation of vasodilation; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0046777; P:protein autophosphorylation; IMP:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0051205; P:protein insertion into membrane; TAS:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0050999; P:regulation of nitric-oxide synthase activity; IDA:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; IMP:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0051592; P:response to calcium ion; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0033590; P:response to cobalamin; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0033594; P:response to hydroxyisoflavone; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0006970; P:response to osmotic stress; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0006979; P:response to oxidative stress; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0006950; P:response to stress; NAS:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0070141; P:response to UV-A; IDA:BHF-UCL
P00533	EGFR	Epidermal growth factor receptor	GO:0007435; P:salivary gland morphogenesis; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0007165; P:signal transduction; IDA:UniProtKB
P00533	EGFR	Epidermal growth factor receptor	GO:0043586; P:tongue development; IEA:Ensembl
P00533	EGFR	Epidermal growth factor receptor	GO:0006412; P:translation; IEA:Ensembl
P01133	EGF	Pro-epidermal growth factor	GO:0005509; F:calcium ion binding; IEA:InterPro
P01133	EGF	Pro-epidermal growth factor	GO:0005154; F:epidermal growth factor receptor binding; TAS:UniProtKB
P01133	EGF	Pro-epidermal growth factor	GO:0008083; F:growth factor activity; IDA:HGNC
P01133	EGF	Pro-epidermal growth factor	GO:0005515; F:protein binding; IPI:IntAct
P01133	EGF	Pro-epidermal growth factor	GO:0030297; F:transmembrane receptor protein tyrosine kinase activator activity; TAS:UniProtKB
P01133	EGF	Pro-epidermal growth factor	GO:0000186; P:activation of MAPKK activity; IEA:Ensembl
P01133	EGF	Pro-epidermal growth factor	GO:0007171; P:activation of transmembrane receptor protein tyrosine kinase activity; TAS:GOC
P01133	EGF	Pro-epidermal growth factor	GO:0001525; P:angiogenesis; IDA:HGNC
P01133	EGF	Pro-epidermal growth factor	GO:0007596; P:blood coagulation; TAS:Reactome
P01133	EGF	Pro-epidermal growth factor	GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl
P01133	EGF	Pro-epidermal growth factor	GO:0006260; P:DNA replication; TAS:ProtInc
P01133	EGF	Pro-epidermal growth factor	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P01133	EGF	Pro-epidermal growth factor	GO:0070371; P:ERK1 and ERK2 cascade; IDA:UniProtKB
P01133	EGF	Pro-epidermal growth factor	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P01133	EGF	Pro-epidermal growth factor	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P01133	EGF	Pro-epidermal growth factor	GO:0045087; P:innate immune response; TAS:Reactome
P01133	EGF	Pro-epidermal growth factor	GO:0060749; P:mammary gland alveolus development; IEA:Ensembl
P01133	EGF	Pro-epidermal growth factor	GO:0090370; P:negative regulation of cholesterol efflux; IEA:Ensembl
P01133	EGF	Pro-epidermal growth factor	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
P01133	EGF	Pro-epidermal growth factor	GO:0051048; P:negative regulation of secretion; IDA:BHF-UCL
P01133	EGF	Pro-epidermal growth factor	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P01133	EGF	Pro-epidermal growth factor	GO:0018108; P:peptidyl-tyrosine phosphorylation; IEA:Ensembl
P01133	EGF	Pro-epidermal growth factor	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P01133	EGF	Pro-epidermal growth factor	GO:0030168; P:platelet activation; TAS:Reactome
P01133	EGF	Pro-epidermal growth factor	GO:0002576; P:platelet degranulation; TAS:Reactome
P01133	EGF	Pro-epidermal growth factor	GO:0035413; P:positive regulation of catenin import into nucleus; IDA:BHF-UCL
P01133	EGF	Pro-epidermal growth factor	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P01133	EGF	Pro-epidermal growth factor	GO:0021940; P:positive regulation of cerebellar granule cell precursor proliferation; IEA:Ensembl
P01133	EGF	Pro-epidermal growth factor	GO:0043388; P:positive regulation of DNA binding; ISS:UniProtKB
P01133	EGF	Pro-epidermal growth factor	GO:0045741; P:positive regulation of epidermal growth factor-activated receptor activity; TAS:UniProtKB
P01133	EGF	Pro-epidermal growth factor	GO:1900127; P:positive regulation of hyaluronan biosynthetic process; IDA:UniProtKB
P01133	EGF	Pro-epidermal growth factor	GO:0043406; P:positive regulation of MAP kinase activity; IDA:HGNC
P01133	EGF	Pro-epidermal growth factor	GO:0045840; P:positive regulation of mitosis; IDA:HGNC
P01133	EGF	Pro-epidermal growth factor	GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IDA:UniProtKB
P01133	EGF	Pro-epidermal growth factor	GO:0042327; P:positive regulation of phosphorylation; IDA:HGNC
P01133	EGF	Pro-epidermal growth factor	GO:2000060; P:positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IEA:Ensembl
P01133	EGF	Pro-epidermal growth factor	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P01133	EGF	Pro-epidermal growth factor	GO:0090279; P:regulation of calcium ion import; IDA:BHF-UCL
P01133	EGF	Pro-epidermal growth factor	GO:2000008; P:regulation of protein localization to cell surface; IDA:BHF-UCL
P01133	EGF	Pro-epidermal growth factor	GO:0007165; P:signal transduction; TAS:Reactome
P01133	EGF	Pro-epidermal growth factor	GO:0007262; P:STAT protein import into nucleus; ISS:UniProtKB
Q9GZT9	EGLN1	Egl nine homolog 1	GO:0019899; F:enzyme binding; ISS:BHF-UCL
Q9GZT9	EGLN1	Egl nine homolog 1	GO:0005506; F:iron ion binding; IEA:InterPro
Q9GZT9	EGLN1	Egl nine homolog 1	GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW
Q9GZT9	EGLN1	Egl nine homolog 1	GO:0031545; F:peptidyl-proline 4-dioxygenase activity; IDA:FlyBase
Q9GZT9	EGLN1	Egl nine homolog 1	GO:0031543; F:peptidyl-proline dioxygenase activity; TAS:HGNC
Q9GZT9	EGLN1	Egl nine homolog 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9GZT9	EGLN1	Egl nine homolog 1	GO:0055008; P:cardiac muscle tissue morphogenesis; IEA:Ensembl
Q9GZT9	EGLN1	Egl nine homolog 1	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
Q9GZT9	EGLN1	Egl nine homolog 1	GO:0060347; P:heart trabecula formation; IEA:Ensembl
Q9GZT9	EGLN1	Egl nine homolog 1	GO:0060711; P:labyrinthine layer development; IEA:Ensembl
Q9GZT9	EGLN1	Egl nine homolog 1	GO:0030821; P:negative regulation of cAMP catabolic process; ISS:BHF-UCL
Q9GZT9	EGLN1	Egl nine homolog 1	GO:0051344; P:negative regulation of cyclic-nucleotide phosphodiesterase activity; ISS:BHF-UCL
Q9GZT9	EGLN1	Egl nine homolog 1	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:HGNC
Q9GZT9	EGLN1	Egl nine homolog 1	GO:0032364; P:oxygen homeostasis; IDA:HGNC
Q9GZT9	EGLN1	Egl nine homolog 1	GO:0018401; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; IDA:FlyBase
Q9GZT9	EGLN1	Egl nine homolog 1	GO:0045765; P:regulation of angiogenesis; ISS:UniProtKB
Q9GZT9	EGLN1	Egl nine homolog 1	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
Q9GZT9	EGLN1	Egl nine homolog 1	GO:0001666; P:response to hypoxia; IDA:HGNC
Q9GZT9	EGLN1	Egl nine homolog 1	GO:0071731; P:response to nitric oxide; IDA:UniProtKB
Q9GZT9	EGLN1	Egl nine homolog 1	GO:0060412; P:ventricular septum morphogenesis; IEA:Ensembl
Q96KS0	EGLN2	Egl nine homolog 2	GO:0008198; F:ferrous iron binding; NAS:UniProtKB
Q96KS0	EGLN2	Egl nine homolog 2	GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW
Q96KS0	EGLN2	Egl nine homolog 2	GO:0016706; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; IDA:UniProtKB
Q96KS0	EGLN2	Egl nine homolog 2	GO:0019826; F:oxygen sensor activity; IDA:UniProtKB
Q96KS0	EGLN2	Egl nine homolog 2	GO:0031545; F:peptidyl-proline 4-dioxygenase activity; IDA:FlyBase
Q96KS0	EGLN2	Egl nine homolog 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q96KS0	EGLN2	Egl nine homolog 2	GO:0045454; P:cell redox homeostasis; IDA:UniProtKB
Q96KS0	EGLN2	Egl nine homolog 2	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
Q96KS0	EGLN2	Egl nine homolog 2	GO:0030520; P:intracellular estrogen receptor signaling pathway; NAS:UniProtKB
Q96KS0	EGLN2	Egl nine homolog 2	GO:0018401; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; IDA:FlyBase
Q96KS0	EGLN2	Egl nine homolog 2	GO:0045732; P:positive regulation of protein catabolic process; IDA:UniProtKB
Q96KS0	EGLN2	Egl nine homolog 2	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
Q96KS0	EGLN2	Egl nine homolog 2	GO:0043523; P:regulation of neuron apoptotic process; IMP:UniProtKB
Q96KS0	EGLN2	Egl nine homolog 2	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
Q96KS0	EGLN2	Egl nine homolog 2	GO:0001666; P:response to hypoxia; IDA:UniProtKB
Q9H6Z9	EGLN3	Egl nine homolog 3	GO:0005506; F:iron ion binding; IEA:InterPro
Q9H6Z9	EGLN3	Egl nine homolog 3	GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW
Q9H6Z9	EGLN3	Egl nine homolog 3	GO:0031545; F:peptidyl-proline 4-dioxygenase activity; IDA:FlyBase
Q9H6Z9	EGLN3	Egl nine homolog 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H6Z9	EGLN3	Egl nine homolog 3	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IEP:UniProtKB
Q9H6Z9	EGLN3	Egl nine homolog 3	GO:0006915; P:apoptotic process; IEP:UniProtKB
Q9H6Z9	EGLN3	Egl nine homolog 3	GO:0006974; P:cellular response to DNA damage stimulus; IEA:UniProtKB-KW
Q9H6Z9	EGLN3	Egl nine homolog 3	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
Q9H6Z9	EGLN3	Egl nine homolog 3	GO:0018401; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; IDA:FlyBase
Q9H6Z9	EGLN3	Egl nine homolog 3	GO:0018126; P:protein hydroxylation; IDA:UniProtKB
Q9H6Z9	EGLN3	Egl nine homolog 3	GO:0042127; P:regulation of cell proliferation; IEP:UniProtKB
Q9H6Z9	EGLN3	Egl nine homolog 3	GO:0043523; P:regulation of neuron apoptotic process; ISS:UniProtKB
Q9H6Z9	EGLN3	Egl nine homolog 3	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
Q9H6Z9	EGLN3	Egl nine homolog 3	GO:0001666; P:response to hypoxia; IEP:UniProtKB
P17813	ENG	Endoglin	GO:0048185; F:activin binding; TAS:BHF-UCL
P17813	ENG	Endoglin	GO:0005534; F:galactose binding; IDA:BHF-UCL
P17813	ENG	Endoglin	GO:0005539; F:glycosaminoglycan binding; IDA:BHF-UCL
P17813	ENG	Endoglin	GO:0005515; F:protein binding; IPI:IntAct
P17813	ENG	Endoglin	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P17813	ENG	Endoglin	GO:0050431; F:transforming growth factor beta binding; IPI:BHF-UCL
P17813	ENG	Endoglin	GO:0005072; F:transforming growth factor beta receptor, cytoplasmic mediator activity; IDA:BHF-UCL
P17813	ENG	Endoglin	GO:0005024; F:transforming growth factor beta-activated receptor activity; IDA:BHF-UCL
P17813	ENG	Endoglin	GO:0004888; F:transmembrane signaling receptor activity; NAS:BHF-UCL
P17813	ENG	Endoglin	GO:0034713; F:type I transforming growth factor beta receptor binding; IPI:BHF-UCL
P17813	ENG	Endoglin	GO:0005114; F:type II transforming growth factor beta receptor binding; IPI:BHF-UCL
P17813	ENG	Endoglin	GO:0048844; P:artery morphogenesis; ISS:BHF-UCL
P17813	ENG	Endoglin	GO:0030509; P:BMP signaling pathway; TAS:BHF-UCL
P17813	ENG	Endoglin	GO:0060348; P:bone development; IEA:Ensembl
P17813	ENG	Endoglin	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P17813	ENG	Endoglin	GO:0060326; P:cell chemotaxis; IMP:BHF-UCL
P17813	ENG	Endoglin	GO:0016477; P:cell migration; IMP:BHF-UCL
P17813	ENG	Endoglin	GO:0003273; P:cell migration involved in endocardial cushion formation; IEA:Ensembl
P17813	ENG	Endoglin	GO:0048870; P:cell motility; IMP:BHF-UCL
P17813	ENG	Endoglin	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P17813	ENG	Endoglin	GO:0022009; P:central nervous system vasculogenesis; IMP:BHF-UCL
P17813	ENG	Endoglin	GO:0001300; P:chronological cell aging; IEA:Ensembl
P17813	ENG	Endoglin	GO:0070483; P:detection of hypoxia; IDA:BHF-UCL
P17813	ENG	Endoglin	GO:0070278; P:extracellular matrix constituent secretion; IEA:Ensembl
P17813	ENG	Endoglin	GO:0022617; P:extracellular matrix disassembly; IMP:BHF-UCL
P17813	ENG	Endoglin	GO:0001947; P:heart looping; ISS:BHF-UCL
P17813	ENG	Endoglin	GO:0035556; P:intracellular signal transduction; IDA:GOC
P17813	ENG	Endoglin	GO:0030336; P:negative regulation of cell migration; IDA:BHF-UCL
P17813	ENG	Endoglin	GO:0001937; P:negative regulation of endothelial cell proliferation; IMP:BHF-UCL
P17813	ENG	Endoglin	GO:0051001; P:negative regulation of nitric-oxide synthase activity; IMP:BHF-UCL
P17813	ENG	Endoglin	GO:0060394; P:negative regulation of pathway-restricted SMAD protein phosphorylation; IMP:BHF-UCL
P17813	ENG	Endoglin	GO:0031953; P:negative regulation of protein autophosphorylation; IDA:BHF-UCL
P17813	ENG	Endoglin	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P17813	ENG	Endoglin	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:BHF-UCL
P17813	ENG	Endoglin	GO:0001569; P:patterning of blood vessels; ISS:BHF-UCL
P17813	ENG	Endoglin	GO:0030513; P:positive regulation of BMP signaling pathway; IDA:BHF-UCL
P17813	ENG	Endoglin	GO:0032967; P:positive regulation of collagen biosynthetic process; IEA:Ensembl
P17813	ENG	Endoglin	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P17813	ENG	Endoglin	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
P17813	ENG	Endoglin	GO:0001934; P:positive regulation of protein phosphorylation; IDA:BHF-UCL
P17813	ENG	Endoglin	GO:0003084; P:positive regulation of systemic arterial blood pressure; IMP:BHF-UCL
P17813	ENG	Endoglin	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P17813	ENG	Endoglin	GO:0030155; P:regulation of cell adhesion; TAS:BHF-UCL
P17813	ENG	Endoglin	GO:0042127; P:regulation of cell proliferation; TAS:BHF-UCL
P17813	ENG	Endoglin	GO:0042325; P:regulation of phosphorylation; TAS:BHF-UCL
P17813	ENG	Endoglin	GO:0006355; P:regulation of transcription, DNA-templated; IMP:HGNC
P17813	ENG	Endoglin	GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IDA:HGNC
P17813	ENG	Endoglin	GO:0031960; P:response to corticosteroid; IEA:Ensembl
P17813	ENG	Endoglin	GO:0001666; P:response to hypoxia; IDA:BHF-UCL
P17813	ENG	Endoglin	GO:0036273; P:response to statin; IEA:Ensembl
P17813	ENG	Endoglin	GO:0071559; P:response to transforming growth factor beta; IEA:Ensembl
P17813	ENG	Endoglin	GO:0048745; P:smooth muscle tissue development; ISS:BHF-UCL
P17813	ENG	Endoglin	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
P17813	ENG	Endoglin	GO:0001570; P:vasculogenesis; IMP:BHF-UCL
P17813	ENG	Endoglin	GO:0048845; P:venous blood vessel morphogenesis; ISS:BHF-UCL
P17813	ENG	Endoglin	GO:0042060; P:wound healing; IMP:BHF-UCL
P18146	EGR1	Early growth response protein 1	GO:0003677; F:DNA binding; IDA:UniProtKB
P18146	EGR1	Early growth response protein 1	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0035035; F:histone acetyltransferase binding; IPI:BHF-UCL
P18146	EGR1	Early growth response protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P18146	EGR1	Early growth response protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P18146	EGR1	Early growth response protein 1	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
P18146	EGR1	Early growth response protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P18146	EGR1	Early growth response protein 1	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IDA:UniProtKB
P18146	EGR1	Early growth response protein 1	GO:0030509; P:BMP signaling pathway; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0071236; P:cellular response to antibiotic; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0071320; P:cellular response to cAMP; IBA:RefGenome
P18146	EGR1	Early growth response protein 1	GO:0035690; P:cellular response to drug; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0071480; P:cellular response to gamma radiation; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0071371; P:cellular response to gonadotropin stimulus; IBA:RefGenome
P18146	EGR1	Early growth response protein 1	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0071504; P:cellular response to heparin; ISS:UniProtKB
P18146	EGR1	Early growth response protein 1	GO:0071455; P:cellular response to hyperoxia; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0071317; P:cellular response to isoquinoline alkaloid; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0071506; P:cellular response to mycophenolic acid; ISS:UniProtKB
P18146	EGR1	Early growth response protein 1	GO:0071383; P:cellular response to steroid hormone stimulus; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0007623; P:circadian rhythm; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P18146	EGR1	Early growth response protein 1	GO:0072110; P:glomerular mesangial cell proliferation; ISS:UniProtKB
P18146	EGR1	Early growth response protein 1	GO:0070498; P:interleukin-1-mediated signaling pathway; IMP:BHF-UCL
P18146	EGR1	Early growth response protein 1	GO:0007611; P:learning or memory; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0043066; P:negative regulation of apoptotic process; IBA:RefGenome
P18146	EGR1	Early growth response protein 1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0048709; P:oligodendrocyte differentiation; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0072303; P:positive regulation of glomerular metanephric mesangial cell proliferation; ISS:UniProtKB
P18146	EGR1	Early growth response protein 1	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P18146	EGR1	Early growth response protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P18146	EGR1	Early growth response protein 1	GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IBA:RefGenome
P18146	EGR1	Early growth response protein 1	GO:0033233; P:regulation of protein sumoylation; IDA:BHF-UCL
P18146	EGR1	Early growth response protein 1	GO:0001975; P:response to amphetamine; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0034465; P:response to carbon monoxide; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0042220; P:response to cocaine; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0051602; P:response to electrical stimulus; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0045471; P:response to ethanol; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0009749; P:response to glucose; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0071873; P:response to norepinephrine; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0031667; P:response to nutrient levels; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0035914; P:skeletal muscle cell differentiation; IBA:RefGenome
P18146	EGR1	Early growth response protein 1	GO:0030217; P:T cell differentiation; IEA:Ensembl
P18146	EGR1	Early growth response protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:BHF-UCL
P18146	EGR1	Early growth response protein 1	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0003682; F:chromatin binding; ISS:UniProtKB
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0005515; F:protein binding; IPI:UniProtKB
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0001102; F:RNA polymerase II activating transcription factor binding; ISS:BHF-UCL
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0044212; F:transcription regulatory region DNA binding; ISS:UniProtKB
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0007420; P:brain development; TAS:ProtInc
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0035284; P:brain segmentation; IEA:Ensembl
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0008219; P:cell death; IEA:UniProtKB-KW
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0071320; P:cellular response to cAMP; IBA:RefGenome
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0071371; P:cellular response to gonadotropin stimulus; IBA:RefGenome
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0021612; P:facial nerve structural organization; IEA:Ensembl
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0045444; P:fat cell differentiation; ISS:BHF-UCL
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0007611; P:learning or memory; IEA:Ensembl
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0008045; P:motor neuron axon guidance; IEA:Ensembl
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0042552; P:myelination; IBA:RefGenome
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0043066; P:negative regulation of apoptotic process; IBA:RefGenome
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0007422; P:peripheral nervous system development; TAS:ProtInc
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0006611; P:protein export from nucleus; ISS:UniProtKB
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0016925; P:protein sumoylation; IEA:UniProtKB-UniPathway
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0048168; P:regulation of neuronal synaptic plasticity; IBA:RefGenome
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0030278; P:regulation of ossification; IEA:Ensembl
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0032868; P:response to insulin; IEA:Ensembl
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0021660; P:rhombomere 3 formation; IEA:Ensembl
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0021666; P:rhombomere 5 formation; IEA:Ensembl
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0007622; P:rhythmic behavior; IEA:Ensembl
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0014037; P:Schwann cell differentiation; IEA:Ensembl
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0035914; P:skeletal muscle cell differentiation; IBA:RefGenome
P11161	EGR2	E3 SUMO-protein ligase EGR2	GO:0006366; P:transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q06889	EGR3	Early growth response protein 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q06889	EGR3	Early growth response protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q06889	EGR3	Early growth response protein 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q06889	EGR3	Early growth response protein 3	GO:0002042; P:cell migration involved in sprouting angiogenesis; IDA:BHF-UCL
Q06889	EGR3	Early growth response protein 3	GO:0071320; P:cellular response to cAMP; IBA:RefGenome
Q06889	EGR3	Early growth response protein 3	GO:0044344; P:cellular response to fibroblast growth factor stimulus; IMP:BHF-UCL
Q06889	EGR3	Early growth response protein 3	GO:0071371; P:cellular response to gonadotropin stimulus; IBA:RefGenome
Q06889	EGR3	Early growth response protein 3	GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IMP:BHF-UCL
Q06889	EGR3	Early growth response protein 3	GO:0007623; P:circadian rhythm; TAS:ProtInc
Q06889	EGR3	Early growth response protein 3	GO:0035767; P:endothelial cell chemotaxis; IMP:BHF-UCL
Q06889	EGR3	Early growth response protein 3	GO:0007517; P:muscle organ development; TAS:ProtInc
Q06889	EGR3	Early growth response protein 3	GO:0043066; P:negative regulation of apoptotic process; IMP:BHF-UCL
Q06889	EGR3	Early growth response protein 3	GO:0007274; P:neuromuscular synaptic transmission; IEA:Ensembl
Q06889	EGR3	Early growth response protein 3	GO:0007422; P:peripheral nervous system development; IEA:Ensembl
Q06889	EGR3	Early growth response protein 3	GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:BHF-UCL
Q06889	EGR3	Early growth response protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q05215	EGR4	Early growth response protein 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q05215	EGR4	Early growth response protein 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q05215	EGR4	Early growth response protein 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
Q05215	EGR4	Early growth response protein 4	GO:0071320; P:cellular response to cAMP; IBA:RefGenome
Q05215	EGR4	Early growth response protein 4	GO:0071371; P:cellular response to gonadotropin stimulus; IBA:RefGenome
Q05215	EGR4	Early growth response protein 4	GO:0043066; P:negative regulation of apoptotic process; IBA:RefGenome
Q05215	EGR4	Early growth response protein 4	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q05215	EGR4	Early growth response protein 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H4M9	EHD1	EH domain-containing protein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H4M9	EHD1	EH domain-containing protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9H4M9	EHD1	EH domain-containing protein 1	GO:0005525; F:GTP binding; IEA:InterPro
Q9H4M9	EHD1	EH domain-containing protein 1	GO:0003924; F:GTPase activity; IEA:InterPro
Q9H4M9	EHD1	EH domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H4M9	EHD1	EH domain-containing protein 1	GO:0017137; F:Rab GTPase binding; IPI:UniProtKB
Q9H4M9	EHD1	EH domain-containing protein 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q9H4M9	EHD1	EH domain-containing protein 1	GO:1990090; P:cellular response to nerve growth factor stimulus; ISS:UniProtKB
Q9H4M9	EHD1	EH domain-containing protein 1	GO:0042632; P:cholesterol homeostasis; ISS:BHF-UCL
Q9H4M9	EHD1	EH domain-containing protein 1	GO:0032456; P:endocytic recycling; IMP:UniProtKB
Q9H4M9	EHD1	EH domain-containing protein 1	GO:0006897; P:endocytosis; IMP:UniProtKB
Q9H4M9	EHD1	EH domain-containing protein 1	GO:0006886; P:intracellular protein transport; IMP:UniProtKB
Q9H4M9	EHD1	EH domain-containing protein 1	GO:0034383; P:low-density lipoprotein particle clearance; ISS:BHF-UCL
Q9H4M9	EHD1	EH domain-containing protein 1	GO:0031175; P:neuron projection development; ISS:UniProtKB
Q9H4M9	EHD1	EH domain-containing protein 1	GO:0010886; P:positive regulation of cholesterol storage; ISS:BHF-UCL
Q9H4M9	EHD1	EH domain-containing protein 1	GO:2001137; P:positive regulation of endocytic recycling; ISS:UniProtKB
Q9H4M9	EHD1	EH domain-containing protein 1	GO:1901741; P:positive regulation of myoblast fusion; ISS:UniProtKB
Q9H4M9	EHD1	EH domain-containing protein 1	GO:0051260; P:protein homooligomerization; IPI:UniProtKB
Q9NZN4	EHD2	EH domain-containing protein 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NZN4	EHD2	EH domain-containing protein 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NZN4	EHD2	EH domain-containing protein 2	GO:0005525; F:GTP binding; IEA:InterPro
Q9NZN4	EHD2	EH domain-containing protein 2	GO:0003924; F:GTPase activity; IEA:InterPro
Q9NZN4	EHD2	EH domain-containing protein 2	GO:0003676; F:nucleic acid binding; TAS:ProtInc
Q9NZN4	EHD2	EH domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NZN4	EHD2	EH domain-containing protein 2	GO:0007596; P:blood coagulation; TAS:Reactome
Q9NZN4	EHD2	EH domain-containing protein 2	GO:0030866; P:cortical actin cytoskeleton organization; IEA:Ensembl
Q9NZN4	EHD2	EH domain-containing protein 2	GO:0032456; P:endocytic recycling; IGI:UniProtKB
Q9NZN4	EHD2	EH domain-containing protein 2	GO:0006897; P:endocytosis; IEA:Ensembl
Q9NZN4	EHD2	EH domain-containing protein 2	GO:2001137; P:positive regulation of endocytic recycling; ISS:UniProtKB
Q9NZN4	EHD2	EH domain-containing protein 2	GO:1901741; P:positive regulation of myoblast fusion; ISS:UniProtKB
Q9NZN4	EHD2	EH domain-containing protein 2	GO:0072659; P:protein localization to plasma membrane; ISS:UniProtKB
Q9NZN3	EHD3	EH domain-containing protein 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NZN3	EHD3	EH domain-containing protein 3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NZN3	EHD3	EH domain-containing protein 3	GO:0005525; F:GTP binding; IEA:InterPro
Q9NZN3	EHD3	EH domain-containing protein 3	GO:0003924; F:GTPase activity; IEA:InterPro
Q9NZN3	EHD3	EH domain-containing protein 3	GO:0003676; F:nucleic acid binding; TAS:ProtInc
Q9NZN3	EHD3	EH domain-containing protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NZN3	EHD3	EH domain-containing protein 3	GO:0007596; P:blood coagulation; TAS:Reactome
Q9NZN3	EHD3	EH domain-containing protein 3	GO:0032456; P:endocytic recycling; IDA:UniProtKB
Q9NZN3	EHD3	EH domain-containing protein 3	GO:0051260; P:protein homooligomerization; IPI:UniProtKB
Q9NZN3	EHD3	EH domain-containing protein 3	GO:0072661; P:protein targeting to plasma membrane; IGI:MGI
Q9NZN3	EHD3	EH domain-containing protein 3	GO:0086036; P:regulation of cardiac muscle cell membrane potential; IGI:MGI
Q9NZC4	EHF	ETS homologous factor	GO:0003677; F:DNA binding; IDA:UniProtKB
Q9NZC4	EHF	ETS homologous factor	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9NZC4	EHF	ETS homologous factor	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q9NZC4	EHF	ETS homologous factor	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9NZC4	EHF	ETS homologous factor	GO:0008283; P:cell proliferation; TAS:UniProtKB
Q9NZC4	EHF	ETS homologous factor	GO:0030855; P:epithelial cell differentiation; IEP:UniProtKB
Q9NZC4	EHF	ETS homologous factor	GO:0007275; P:multicellular organismal development; TAS:UniProtKB
Q9NZC4	EHF	ETS homologous factor	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9NZC4	EHF	ETS homologous factor	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q9NZC4	EHF	ETS homologous factor	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q9H223	EHD4	EH domain-containing protein 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H223	EHD4	EH domain-containing protein 4	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9H223	EHD4	EH domain-containing protein 4	GO:0005525; F:GTP binding; IEA:InterPro
Q9H223	EHD4	EH domain-containing protein 4	GO:0003924; F:GTPase activity; IEA:InterPro
Q9H223	EHD4	EH domain-containing protein 4	GO:0003676; F:nucleic acid binding; TAS:ProtInc
Q9H223	EHD4	EH domain-containing protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H223	EHD4	EH domain-containing protein 4	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
Q9H223	EHD4	EH domain-containing protein 4	GO:0032456; P:endocytic recycling; IGI:UniProtKB
Q9H223	EHD4	EH domain-containing protein 4	GO:0006907; P:pinocytosis; IEA:Ensembl
Q9H223	EHD4	EH domain-containing protein 4	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
Q9H223	EHD4	EH domain-containing protein 4	GO:0051260; P:protein homooligomerization; IPI:UniProtKB
Q9H223	EHD4	EH domain-containing protein 4	GO:0030100; P:regulation of endocytosis; IEA:Ensembl
Q9H9B1	EHMT1	Histone-lysine N-methyltransferase EHMT1	GO:0046976; F:histone methyltransferase activity (H3-K27 specific); ISS:UniProtKB
Q9H9B1	EHMT1	Histone-lysine N-methyltransferase EHMT1	GO:0046974; F:histone methyltransferase activity (H3-K9 specific); ISS:UniProtKB
Q9H9B1	EHMT1	Histone-lysine N-methyltransferase EHMT1	GO:0018024; F:histone-lysine N-methyltransferase activity; IDA:UniProtKB
Q9H9B1	EHMT1	Histone-lysine N-methyltransferase EHMT1	GO:0008168; F:methyltransferase activity; IDA:UniProtKB
Q9H9B1	EHMT1	Histone-lysine N-methyltransferase EHMT1	GO:0002039; F:p53 binding; IPI:UniProtKB
Q9H9B1	EHMT1	Histone-lysine N-methyltransferase EHMT1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H9B1	EHMT1	Histone-lysine N-methyltransferase EHMT1	GO:0016279; F:protein-lysine N-methyltransferase activity; IDA:UniProtKB
Q9H9B1	EHMT1	Histone-lysine N-methyltransferase EHMT1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H9B1	EHMT1	Histone-lysine N-methyltransferase EHMT1	GO:0016568; P:chromatin modification; IDA:UniProtKB
Q9H9B1	EHMT1	Histone-lysine N-methyltransferase EHMT1	GO:0006306; P:DNA methylation; ISS:UniProtKB
Q9H9B1	EHMT1	Histone-lysine N-methyltransferase EHMT1	GO:0009790; P:embryo development; ISS:UniProtKB
Q9H9B1	EHMT1	Histone-lysine N-methyltransferase EHMT1	GO:0016571; P:histone methylation; IDA:UniProtKB
Q9H9B1	EHMT1	Histone-lysine N-methyltransferase EHMT1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9H9B1	EHMT1	Histone-lysine N-methyltransferase EHMT1	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q9H9B1	EHMT1	Histone-lysine N-methyltransferase EHMT1	GO:0018027; P:peptidyl-lysine dimethylation; IDA:UniProtKB
Q9H9B1	EHMT1	Histone-lysine N-methyltransferase EHMT1	GO:0018026; P:peptidyl-lysine monomethylation; ISS:UniProtKB
Q96KQ7	EHMT2	Histone-lysine N-methyltransferase EHMT2	GO:0070742; F:C2H2 zinc finger domain binding; IPI:UniProt
Q96KQ7	EHMT2	Histone-lysine N-methyltransferase EHMT2	GO:0046976; F:histone methyltransferase activity (H3-K27 specific); ISS:UniProtKB
Q96KQ7	EHMT2	Histone-lysine N-methyltransferase EHMT2	GO:0046974; F:histone methyltransferase activity (H3-K9 specific); ISS:UniProtKB
Q96KQ7	EHMT2	Histone-lysine N-methyltransferase EHMT2	GO:0018024; F:histone-lysine N-methyltransferase activity; IMP:UniProtKB
Q96KQ7	EHMT2	Histone-lysine N-methyltransferase EHMT2	GO:0002039; F:p53 binding; IPI:UniProtKB
Q96KQ7	EHMT2	Histone-lysine N-methyltransferase EHMT2	GO:0005515; F:protein binding; IPI:UniProtKB
Q96KQ7	EHMT2	Histone-lysine N-methyltransferase EHMT2	GO:0016279; F:protein-lysine N-methyltransferase activity; IDA:UniProtKB
Q96KQ7	EHMT2	Histone-lysine N-methyltransferase EHMT2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96KQ7	EHMT2	Histone-lysine N-methyltransferase EHMT2	GO:0006306; P:DNA methylation; ISS:UniProtKB
Q96KQ7	EHMT2	Histone-lysine N-methyltransferase EHMT2	GO:0010424; P:DNA methylation on cytosine within a CG sequence; IEA:Ensembl
Q96KQ7	EHMT2	Histone-lysine N-methyltransferase EHMT2	GO:0009566; P:fertilization; IEA:Ensembl
Q96KQ7	EHMT2	Histone-lysine N-methyltransferase EHMT2	GO:0016571; P:histone methylation; IMP:UniProtKB
Q96KQ7	EHMT2	Histone-lysine N-methyltransferase EHMT2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q96KQ7	EHMT2	Histone-lysine N-methyltransferase EHMT2	GO:0035265; P:organ growth; IEA:Ensembl
Q96KQ7	EHMT2	Histone-lysine N-methyltransferase EHMT2	GO:0018027; P:peptidyl-lysine dimethylation; IDA:UniProtKB
Q96KQ7	EHMT2	Histone-lysine N-methyltransferase EHMT2	GO:0006275; P:regulation of DNA replication; IMP:UniProtKB
Q96KQ7	EHMT2	Histone-lysine N-methyltransferase EHMT2	GO:0007286; P:spermatid development; IEA:Ensembl
Q96KQ7	EHMT2	Histone-lysine N-methyltransferase EHMT2	GO:0007130; P:synaptonemal complex assembly; IEA:Ensembl
O14681	EI24	Etoposide-induced protein 2.4 homolog	GO:0006915; P:apoptotic process; TAS:ProtInc
O14681	EI24	Etoposide-induced protein 2.4 homolog	GO:0006914; P:autophagy; IEA:UniProtKB-KW
O14681	EI24	Etoposide-induced protein 2.4 homolog	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
O14681	EI24	Etoposide-induced protein 2.4 homolog	GO:0030308; P:negative regulation of cell growth; IDA:MGI
O14681	EI24	Etoposide-induced protein 2.4 homolog	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
O14681	EI24	Etoposide-induced protein 2.4 homolog	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl
O14681	EI24	Etoposide-induced protein 2.4 homolog	GO:0042493; P:response to drug; IEA:Ensembl
Q14232	EIF2B1	Translation initiation factor eIF-2B subunit alpha	GO:0030234; F:enzyme regulator activity; IEA:Ensembl
Q14232	EIF2B1	Translation initiation factor eIF-2B subunit alpha	GO:0019003; F:GDP binding; IEA:Ensembl
Q14232	EIF2B1	Translation initiation factor eIF-2B subunit alpha	GO:0005525; F:GTP binding; IEA:Ensembl
Q14232	EIF2B1	Translation initiation factor eIF-2B subunit alpha	GO:0005515; F:protein binding; IPI:IntAct
Q14232	EIF2B1	Translation initiation factor eIF-2B subunit alpha	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW
Q14232	EIF2B1	Translation initiation factor eIF-2B subunit alpha	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q14232	EIF2B1	Translation initiation factor eIF-2B subunit alpha	GO:0051716; P:cellular response to stimulus; IDA:UniProtKB
Q14232	EIF2B1	Translation initiation factor eIF-2B subunit alpha	GO:0010467; P:gene expression; TAS:Reactome
Q14232	EIF2B1	Translation initiation factor eIF-2B subunit alpha	GO:0032057; P:negative regulation of translational initiation in response to stress; IEA:Ensembl
Q14232	EIF2B1	Translation initiation factor eIF-2B subunit alpha	GO:0014003; P:oligodendrocyte development; IMP:UniProtKB
Q14232	EIF2B1	Translation initiation factor eIF-2B subunit alpha	GO:0043087; P:regulation of GTPase activity; IDA:GOC
Q14232	EIF2B1	Translation initiation factor eIF-2B subunit alpha	GO:0006446; P:regulation of translational initiation; IBA:RefGenome
Q14232	EIF2B1	Translation initiation factor eIF-2B subunit alpha	GO:0009749; P:response to glucose; ISS:UniProtKB
Q14232	EIF2B1	Translation initiation factor eIF-2B subunit alpha	GO:0009408; P:response to heat; ISS:UniProtKB
Q14232	EIF2B1	Translation initiation factor eIF-2B subunit alpha	GO:0043434; P:response to peptide hormone; ISS:UniProtKB
Q14232	EIF2B1	Translation initiation factor eIF-2B subunit alpha	GO:0006412; P:translation; TAS:Reactome
Q14232	EIF2B1	Translation initiation factor eIF-2B subunit alpha	GO:0006413; P:translational initiation; IDA:UniProtKB
P49770	EIF2B2	Translation initiation factor eIF-2B subunit beta	GO:0005524; F:ATP binding; IDA:UniProtKB
P49770	EIF2B2	Translation initiation factor eIF-2B subunit beta	GO:0005525; F:GTP binding; IDA:UniProtKB
P49770	EIF2B2	Translation initiation factor eIF-2B subunit beta	GO:0005515; F:protein binding; IPI:UniProtKB
P49770	EIF2B2	Translation initiation factor eIF-2B subunit beta	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW
P49770	EIF2B2	Translation initiation factor eIF-2B subunit beta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P49770	EIF2B2	Translation initiation factor eIF-2B subunit beta	GO:0051716; P:cellular response to stimulus; IDA:UniProtKB
P49770	EIF2B2	Translation initiation factor eIF-2B subunit beta	GO:0007417; P:central nervous system development; IMP:UniProtKB
P49770	EIF2B2	Translation initiation factor eIF-2B subunit beta	GO:0010467; P:gene expression; TAS:Reactome
P49770	EIF2B2	Translation initiation factor eIF-2B subunit beta	GO:0042552; P:myelination; IMP:UniProtKB
P49770	EIF2B2	Translation initiation factor eIF-2B subunit beta	GO:0014003; P:oligodendrocyte development; IMP:UniProtKB
P49770	EIF2B2	Translation initiation factor eIF-2B subunit beta	GO:0001541; P:ovarian follicle development; IMP:UniProtKB
P49770	EIF2B2	Translation initiation factor eIF-2B subunit beta	GO:0043087; P:regulation of GTPase activity; IDA:GOC
P49770	EIF2B2	Translation initiation factor eIF-2B subunit beta	GO:0006446; P:regulation of translational initiation; TAS:UniProtKB
P49770	EIF2B2	Translation initiation factor eIF-2B subunit beta	GO:0009749; P:response to glucose; ISS:UniProtKB
P49770	EIF2B2	Translation initiation factor eIF-2B subunit beta	GO:0009408; P:response to heat; ISS:UniProtKB
P49770	EIF2B2	Translation initiation factor eIF-2B subunit beta	GO:0043434; P:response to peptide hormone; ISS:UniProtKB
P49770	EIF2B2	Translation initiation factor eIF-2B subunit beta	GO:0006412; P:translation; TAS:Reactome
P49770	EIF2B2	Translation initiation factor eIF-2B subunit beta	GO:0006413; P:translational initiation; IDA:UniProtKB
Q9UI10	EIF2B4	Translation initiation factor eIF-2B subunit delta	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UI10	EIF2B4	Translation initiation factor eIF-2B subunit delta	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW
Q9UI10	EIF2B4	Translation initiation factor eIF-2B subunit delta	GO:0031369; F:translation initiation factor binding; ISS:UniProtKB
Q9UI10	EIF2B4	Translation initiation factor eIF-2B subunit delta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UI10	EIF2B4	Translation initiation factor eIF-2B subunit delta	GO:0051716; P:cellular response to stimulus; IDA:UniProtKB
Q9UI10	EIF2B4	Translation initiation factor eIF-2B subunit delta	GO:0010467; P:gene expression; TAS:Reactome
Q9UI10	EIF2B4	Translation initiation factor eIF-2B subunit delta	GO:0042552; P:myelination; IMP:UniProtKB
Q9UI10	EIF2B4	Translation initiation factor eIF-2B subunit delta	GO:0045947; P:negative regulation of translational initiation; IBA:RefGenome
Q9UI10	EIF2B4	Translation initiation factor eIF-2B subunit delta	GO:0032057; P:negative regulation of translational initiation in response to stress; ISS:UniProtKB
Q9UI10	EIF2B4	Translation initiation factor eIF-2B subunit delta	GO:0014003; P:oligodendrocyte development; IMP:UniProtKB
Q9UI10	EIF2B4	Translation initiation factor eIF-2B subunit delta	GO:0001541; P:ovarian follicle development; IMP:UniProtKB
Q9UI10	EIF2B4	Translation initiation factor eIF-2B subunit delta	GO:0043087; P:regulation of GTPase activity; IDA:GOC
Q9UI10	EIF2B4	Translation initiation factor eIF-2B subunit delta	GO:0006417; P:regulation of translation; NAS:UniProtKB
Q9UI10	EIF2B4	Translation initiation factor eIF-2B subunit delta	GO:0006446; P:regulation of translational initiation; IBA:RefGenome
Q9UI10	EIF2B4	Translation initiation factor eIF-2B subunit delta	GO:0009749; P:response to glucose; ISS:UniProtKB
Q9UI10	EIF2B4	Translation initiation factor eIF-2B subunit delta	GO:0009408; P:response to heat; ISS:UniProtKB
Q9UI10	EIF2B4	Translation initiation factor eIF-2B subunit delta	GO:0043434; P:response to peptide hormone; ISS:UniProtKB
Q9UI10	EIF2B4	Translation initiation factor eIF-2B subunit delta	GO:0006412; P:translation; TAS:Reactome
Q9UI10	EIF2B4	Translation initiation factor eIF-2B subunit delta	GO:0006413; P:translational initiation; IDA:UniProtKB
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0005085; F:guanyl-nucleotide exchange factor activity; IMP:UniProtKB
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0005515; F:protein binding; IPI:UniProtKB
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0003743; F:translation initiation factor activity; NAS:UniProtKB
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0031369; F:translation initiation factor binding; ISS:UniProtKB
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0014002; P:astrocyte development; IMP:UniProtKB
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0048708; P:astrocyte differentiation; IMP:UniProtKB
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0035690; P:cellular response to drug; IDA:UniProtKB
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0010467; P:gene expression; TAS:Reactome
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0042552; P:myelination; IMP:UniProtKB
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0032057; P:negative regulation of translational initiation in response to stress; ISS:UniProtKB
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0014003; P:oligodendrocyte development; IMP:UniProtKB
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0001541; P:ovarian follicle development; IMP:UniProtKB
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0045948; P:positive regulation of translational initiation; ISS:UniProtKB
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0043087; P:regulation of GTPase activity; IDA:GOC
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0034976; P:response to endoplasmic reticulum stress; IMP:UniProtKB
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0009749; P:response to glucose; ISS:UniProtKB
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0009408; P:response to heat; IMP:UniProtKB
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0043434; P:response to peptide hormone; ISS:UniProtKB
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0006412; P:translation; TAS:Reactome
Q13144	EIF2B5	Translation initiation factor eIF-2B subunit epsilon	GO:0006413; P:translational initiation; IDA:UniProtKB
Q9NR50	EIF2B3	Translation initiation factor eIF-2B subunit gamma	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:Ensembl
Q9NR50	EIF2B3	Translation initiation factor eIF-2B subunit gamma	GO:0016779; F:nucleotidyltransferase activity; IEA:InterPro
Q9NR50	EIF2B3	Translation initiation factor eIF-2B subunit gamma	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NR50	EIF2B3	Translation initiation factor eIF-2B subunit gamma	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW
Q9NR50	EIF2B3	Translation initiation factor eIF-2B subunit gamma	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9NR50	EIF2B3	Translation initiation factor eIF-2B subunit gamma	GO:0051716; P:cellular response to stimulus; IDA:UniProtKB
Q9NR50	EIF2B3	Translation initiation factor eIF-2B subunit gamma	GO:0010467; P:gene expression; TAS:Reactome
Q9NR50	EIF2B3	Translation initiation factor eIF-2B subunit gamma	GO:0032057; P:negative regulation of translational initiation in response to stress; ISS:UniProtKB
Q9NR50	EIF2B3	Translation initiation factor eIF-2B subunit gamma	GO:0014003; P:oligodendrocyte development; IMP:UniProtKB
Q9NR50	EIF2B3	Translation initiation factor eIF-2B subunit gamma	GO:0043087; P:regulation of GTPase activity; IDA:GOC
Q9NR50	EIF2B3	Translation initiation factor eIF-2B subunit gamma	GO:0009749; P:response to glucose; ISS:UniProtKB
Q9NR50	EIF2B3	Translation initiation factor eIF-2B subunit gamma	GO:0009408; P:response to heat; ISS:UniProtKB
Q9NR50	EIF2B3	Translation initiation factor eIF-2B subunit gamma	GO:0043434; P:response to peptide hormone; ISS:UniProtKB
Q9NR50	EIF2B3	Translation initiation factor eIF-2B subunit gamma	GO:0006412; P:translation; TAS:Reactome
Q9NR50	EIF2B3	Translation initiation factor eIF-2B subunit gamma	GO:0006413; P:translational initiation; IDA:UniProtKB
Q96D98	EID2B	EP300-interacting inhibitor of differentiation 2B	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96D98	EID2B	EP300-interacting inhibitor of differentiation 2B	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
Q96D98	EID2B	EP300-interacting inhibitor of differentiation 2B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96D98	EID2B	EP300-interacting inhibitor of differentiation 2B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N6I1	EID2	EP300-interacting inhibitor of differentiation 2	GO:0005515; F:protein binding; IPI:IntAct
Q8N6I1	EID2	EP300-interacting inhibitor of differentiation 2	GO:0046332; F:SMAD binding; IDA:HGNC
Q8N6I1	EID2	EP300-interacting inhibitor of differentiation 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8N6I1	EID2	EP300-interacting inhibitor of differentiation 2	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
Q8N6I1	EID2	EP300-interacting inhibitor of differentiation 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:HGNC
Q8N6I1	EID2	EP300-interacting inhibitor of differentiation 2	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:HGNC
Q8N6I1	EID2	EP300-interacting inhibitor of differentiation 2	GO:0042127; P:regulation of cell proliferation; IDA:HGNC
Q8N6I1	EID2	EP300-interacting inhibitor of differentiation 2	GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IDA:HGNC
Q8N6I1	EID2	EP300-interacting inhibitor of differentiation 2	GO:0007183; P:SMAD protein complex assembly; IDA:HGNC
Q8N6I1	EID2	EP300-interacting inhibitor of differentiation 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N6I1	EID2	EP300-interacting inhibitor of differentiation 2	GO:0007181; P:transforming growth factor beta receptor complex assembly; IDA:HGNC
Q9Y6B2	EID1	EP300-interacting inhibitor of differentiation 1	GO:0035035; F:histone acetyltransferase binding; IDA:UniProtKB
Q9Y6B2	EID1	EP300-interacting inhibitor of differentiation 1	GO:0035034; F:histone acetyltransferase regulator activity; IDA:UniProtKB
Q9Y6B2	EID1	EP300-interacting inhibitor of differentiation 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6B2	EID1	EP300-interacting inhibitor of differentiation 1	GO:0003714; F:transcription corepressor activity; ISS:UniProtKB
Q9Y6B2	EID1	EP300-interacting inhibitor of differentiation 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9Y6B2	EID1	EP300-interacting inhibitor of differentiation 1	GO:0030154; P:cell differentiation; IDA:UniProtKB
Q9Y6B2	EID1	EP300-interacting inhibitor of differentiation 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q9Y6B2	EID1	EP300-interacting inhibitor of differentiation 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9Y6B2	EID1	EP300-interacting inhibitor of differentiation 1	GO:0035065; P:regulation of histone acetylation; IDA:GOC
Q9Y6B2	EID1	EP300-interacting inhibitor of differentiation 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N140	EID3	EP300-interacting inhibitor of differentiation 3	GO:0042802; F:identical protein binding; IPI:IntAct
Q8N140	EID3	EP300-interacting inhibitor of differentiation 3	GO:0005515; F:protein binding; IPI:IntAct
Q8N140	EID3	EP300-interacting inhibitor of differentiation 3	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q8N140	EID3	EP300-interacting inhibitor of differentiation 3	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q8N140	EID3	EP300-interacting inhibitor of differentiation 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N140	EID3	EP300-interacting inhibitor of differentiation 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N9N8	EIF1AD	Probable RNA-binding protein EIF1AD	GO:0003743; F:translation initiation factor activity; IEA:InterPro
O60739	EIF1B	Eukaryotic translation initiation factor 1b	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O60739	EIF1B	Eukaryotic translation initiation factor 1b	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW
O60739	EIF1B	Eukaryotic translation initiation factor 1b	GO:0006446; P:regulation of translational initiation; NAS:UniProtKB
P41567	EIF1	Eukaryotic translation initiation factor 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P41567	EIF1	Eukaryotic translation initiation factor 1	GO:0008135; F:translation factor activity, nucleic acid binding; TAS:ProtInc
P41567	EIF1	Eukaryotic translation initiation factor 1	GO:0003743; F:translation initiation factor activity; NAS:UniProtKB
P41567	EIF1	Eukaryotic translation initiation factor 1	GO:0009048; P:dosage compensation by inactivation of X chromosome; IEA:Ensembl
P41567	EIF1	Eukaryotic translation initiation factor 1	GO:0006446; P:regulation of translational initiation; TAS:ProtInc
P41567	EIF1	Eukaryotic translation initiation factor 1	GO:0006950; P:response to stress; NAS:UniProtKB
Q9BY44	EIF2A	Eukaryotic translation initiation factor 2A	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BY44	EIF2A	Eukaryotic translation initiation factor 2A	GO:0043022; F:ribosome binding; IMP:UniProtKB
Q9BY44	EIF2A	Eukaryotic translation initiation factor 2A	GO:0003743; F:translation initiation factor activity; IMP:UniProtKB
Q9BY44	EIF2A	Eukaryotic translation initiation factor 2A	GO:0000049; F:tRNA binding; IMP:UniProtKB
Q9BY44	EIF2A	Eukaryotic translation initiation factor 2A	GO:0009967; P:positive regulation of signal transduction; IEA:Ensembl
Q9BY44	EIF2A	Eukaryotic translation initiation factor 2A	GO:0006468; P:protein phosphorylation; IEA:Ensembl
Q9BY44	EIF2A	Eukaryotic translation initiation factor 2A	GO:0006417; P:regulation of translation; IMP:UniProtKB
Q9BY44	EIF2A	Eukaryotic translation initiation factor 2A	GO:0042255; P:ribosome assembly; IMP:UniProtKB
Q9BY44	EIF2A	Eukaryotic translation initiation factor 2A	GO:0032933; P:SREBP signaling pathway; IEA:Ensembl
P41214	EIF2D	Eukaryotic translation initiation factor 2D	GO:0004872; F:receptor activity; TAS:ProtInc
P41214	EIF2D	Eukaryotic translation initiation factor 2D	GO:0003743; F:translation initiation factor activity; IDA:UniProtKB
P41214	EIF2D	Eukaryotic translation initiation factor 2D	GO:0006886; P:intracellular protein transport; TAS:ProtInc
Q14152	EIF3A	Eukaryotic translation initiation factor 3 subunit A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14152	EIF3A	Eukaryotic translation initiation factor 3 subunit A	GO:0005515; F:protein binding; IPI:UniProtKB
Q14152	EIF3A	Eukaryotic translation initiation factor 3 subunit A	GO:0005198; F:structural molecule activity; NAS:UniProtKB
Q14152	EIF3A	Eukaryotic translation initiation factor 3 subunit A	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-HAMAP
Q14152	EIF3A	Eukaryotic translation initiation factor 3 subunit A	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q14152	EIF3A	Eukaryotic translation initiation factor 3 subunit A	GO:0001732; P:formation of translation initiation complex; IDA:UniProtKB
Q14152	EIF3A	Eukaryotic translation initiation factor 3 subunit A	GO:0001731; P:formation of translation preinitiation complex; IEA:UniProtKB-HAMAP
Q14152	EIF3A	Eukaryotic translation initiation factor 3 subunit A	GO:0010467; P:gene expression; TAS:Reactome
Q14152	EIF3A	Eukaryotic translation initiation factor 3 subunit A	GO:0006446; P:regulation of translational initiation; IEA:UniProtKB-HAMAP
Q14152	EIF3A	Eukaryotic translation initiation factor 3 subunit A	GO:0006412; P:translation; TAS:Reactome
Q14152	EIF3A	Eukaryotic translation initiation factor 3 subunit A	GO:0006413; P:translational initiation; IC:UniProtKB
P55884	EIF3B	Eukaryotic translation initiation factor 3 subunit B	GO:0000166; F:nucleotide binding; IEA:InterPro
P55884	EIF3B	Eukaryotic translation initiation factor 3 subunit B	GO:0005515; F:protein binding; IPI:UniProtKB
P55884	EIF3B	Eukaryotic translation initiation factor 3 subunit B	GO:0032947; F:protein complex scaffold; TAS:UniProtKB
P55884	EIF3B	Eukaryotic translation initiation factor 3 subunit B	GO:0003743; F:translation initiation factor activity; IDA:UniProtKB
P55884	EIF3B	Eukaryotic translation initiation factor 3 subunit B	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P55884	EIF3B	Eukaryotic translation initiation factor 3 subunit B	GO:0001731; P:formation of translation preinitiation complex; IEA:UniProtKB-HAMAP
P55884	EIF3B	Eukaryotic translation initiation factor 3 subunit B	GO:0010467; P:gene expression; TAS:Reactome
P55884	EIF3B	Eukaryotic translation initiation factor 3 subunit B	GO:0006446; P:regulation of translational initiation; IDA:UniProtKB
P55884	EIF3B	Eukaryotic translation initiation factor 3 subunit B	GO:0006412; P:translation; TAS:Reactome
P55884	EIF3B	Eukaryotic translation initiation factor 3 subunit B	GO:0006413; P:translational initiation; IDA:UniProtKB
Q99613	EIF3C	Eukaryotic translation initiation factor 3 subunit C	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q99613	EIF3C	Eukaryotic translation initiation factor 3 subunit C	GO:0005515; F:protein binding; IPI:IntAct
Q99613	EIF3C	Eukaryotic translation initiation factor 3 subunit C	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-HAMAP
Q99613	EIF3C	Eukaryotic translation initiation factor 3 subunit C	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q99613	EIF3C	Eukaryotic translation initiation factor 3 subunit C	GO:0001731; P:formation of translation preinitiation complex; IEA:UniProtKB-HAMAP
Q99613	EIF3C	Eukaryotic translation initiation factor 3 subunit C	GO:0010467; P:gene expression; TAS:Reactome
Q99613	EIF3C	Eukaryotic translation initiation factor 3 subunit C	GO:0006446; P:regulation of translational initiation; IEA:UniProtKB-HAMAP
Q99613	EIF3C	Eukaryotic translation initiation factor 3 subunit C	GO:0006412; P:translation; TAS:Reactome
Q99613	EIF3C	Eukaryotic translation initiation factor 3 subunit C	GO:0006413; P:translational initiation; IDA:UniProtKB
O15371	EIF3D	Eukaryotic translation initiation factor 3 subunit D	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O15371	EIF3D	Eukaryotic translation initiation factor 3 subunit D	GO:0005515; F:protein binding; IPI:IntAct
O15371	EIF3D	Eukaryotic translation initiation factor 3 subunit D	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-HAMAP
O15371	EIF3D	Eukaryotic translation initiation factor 3 subunit D	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O15371	EIF3D	Eukaryotic translation initiation factor 3 subunit D	GO:0001732; P:formation of translation initiation complex; IEA:Ensembl
O15371	EIF3D	Eukaryotic translation initiation factor 3 subunit D	GO:0001731; P:formation of translation preinitiation complex; IEA:UniProtKB-HAMAP
O15371	EIF3D	Eukaryotic translation initiation factor 3 subunit D	GO:0010467; P:gene expression; TAS:Reactome
O15371	EIF3D	Eukaryotic translation initiation factor 3 subunit D	GO:0006446; P:regulation of translational initiation; IEA:UniProtKB-HAMAP
O15371	EIF3D	Eukaryotic translation initiation factor 3 subunit D	GO:0006412; P:translation; TAS:Reactome
O15371	EIF3D	Eukaryotic translation initiation factor 3 subunit D	GO:0006413; P:translational initiation; IDA:UniProtKB
P60228	EIF3E	Eukaryotic translation initiation factor 3 subunit E	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P60228	EIF3E	Eukaryotic translation initiation factor 3 subunit E	GO:0005515; F:protein binding; IPI:UniProtKB
P60228	EIF3E	Eukaryotic translation initiation factor 3 subunit E	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
P60228	EIF3E	Eukaryotic translation initiation factor 3 subunit E	GO:0003743; F:translation initiation factor activity; IC:UniProtKB
P60228	EIF3E	Eukaryotic translation initiation factor 3 subunit E	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P60228	EIF3E	Eukaryotic translation initiation factor 3 subunit E	GO:0001731; P:formation of translation preinitiation complex; IEA:UniProtKB-HAMAP
P60228	EIF3E	Eukaryotic translation initiation factor 3 subunit E	GO:0010467; P:gene expression; TAS:Reactome
P60228	EIF3E	Eukaryotic translation initiation factor 3 subunit E	GO:0045947; P:negative regulation of translational initiation; NAS:UniProtKB
P60228	EIF3E	Eukaryotic translation initiation factor 3 subunit E	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IMP:UniProtKB
P60228	EIF3E	Eukaryotic translation initiation factor 3 subunit E	GO:0006446; P:regulation of translational initiation; NAS:UniProtKB
P60228	EIF3E	Eukaryotic translation initiation factor 3 subunit E	GO:0006412; P:translation; TAS:Reactome
P60228	EIF3E	Eukaryotic translation initiation factor 3 subunit E	GO:0006413; P:translational initiation; IDA:UniProtKB
O00303	EIF3F	Eukaryotic translation initiation factor 3 subunit F	GO:0005515; F:protein binding; IPI:UniProtKB
O00303	EIF3F	Eukaryotic translation initiation factor 3 subunit F	GO:0003743; F:translation initiation factor activity; TAS:UniProtKB
O00303	EIF3F	Eukaryotic translation initiation factor 3 subunit F	GO:0004843; F:ubiquitin-specific protease activity; IDA:FlyBase
O00303	EIF3F	Eukaryotic translation initiation factor 3 subunit F	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O00303	EIF3F	Eukaryotic translation initiation factor 3 subunit F	GO:0001731; P:formation of translation preinitiation complex; IEA:UniProtKB-HAMAP
O00303	EIF3F	Eukaryotic translation initiation factor 3 subunit F	GO:0010467; P:gene expression; TAS:Reactome
O00303	EIF3F	Eukaryotic translation initiation factor 3 subunit F	GO:0016579; P:protein deubiquitination; IDA:FlyBase
O00303	EIF3F	Eukaryotic translation initiation factor 3 subunit F	GO:0006446; P:regulation of translational initiation; IEA:UniProtKB-HAMAP
O00303	EIF3F	Eukaryotic translation initiation factor 3 subunit F	GO:0006412; P:translation; TAS:Reactome
O00303	EIF3F	Eukaryotic translation initiation factor 3 subunit F	GO:0006413; P:translational initiation; IDA:UniProtKB
O75821	EIF3G	Eukaryotic translation initiation factor 3 subunit G	GO:0000166; F:nucleotide binding; IEA:InterPro
O75821	EIF3G	Eukaryotic translation initiation factor 3 subunit G	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75821	EIF3G	Eukaryotic translation initiation factor 3 subunit G	GO:0005515; F:protein binding; IPI:UniProtKB
O75821	EIF3G	Eukaryotic translation initiation factor 3 subunit G	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-HAMAP
O75821	EIF3G	Eukaryotic translation initiation factor 3 subunit G	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O75821	EIF3G	Eukaryotic translation initiation factor 3 subunit G	GO:0001731; P:formation of translation preinitiation complex; IEA:UniProtKB-HAMAP
O75821	EIF3G	Eukaryotic translation initiation factor 3 subunit G	GO:0010467; P:gene expression; TAS:Reactome
O75821	EIF3G	Eukaryotic translation initiation factor 3 subunit G	GO:0006446; P:regulation of translational initiation; IEA:UniProtKB-HAMAP
O75821	EIF3G	Eukaryotic translation initiation factor 3 subunit G	GO:0006412; P:translation; TAS:Reactome
O75821	EIF3G	Eukaryotic translation initiation factor 3 subunit G	GO:0006413; P:translational initiation; IDA:UniProtKB
O15372	EIF3H	Eukaryotic translation initiation factor 3 subunit H	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O15372	EIF3H	Eukaryotic translation initiation factor 3 subunit H	GO:0005515; F:protein binding; IPI:UniProtKB
O15372	EIF3H	Eukaryotic translation initiation factor 3 subunit H	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-HAMAP
O15372	EIF3H	Eukaryotic translation initiation factor 3 subunit H	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O15372	EIF3H	Eukaryotic translation initiation factor 3 subunit H	GO:0001731; P:formation of translation preinitiation complex; IEA:UniProtKB-HAMAP
O15372	EIF3H	Eukaryotic translation initiation factor 3 subunit H	GO:0010467; P:gene expression; TAS:Reactome
O15372	EIF3H	Eukaryotic translation initiation factor 3 subunit H	GO:0006446; P:regulation of translational initiation; TAS:UniProtKB
O15372	EIF3H	Eukaryotic translation initiation factor 3 subunit H	GO:0006412; P:translation; TAS:Reactome
O15372	EIF3H	Eukaryotic translation initiation factor 3 subunit H	GO:0006413; P:translational initiation; IDA:UniProtKB
Q13347	EIF3I	Eukaryotic translation initiation factor 3 subunit I	GO:0005515; F:protein binding; IPI:IntAct
Q13347	EIF3I	Eukaryotic translation initiation factor 3 subunit I	GO:0003743; F:translation initiation factor activity; IDA:UniProtKB
Q13347	EIF3I	Eukaryotic translation initiation factor 3 subunit I	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q13347	EIF3I	Eukaryotic translation initiation factor 3 subunit I	GO:0001731; P:formation of translation preinitiation complex; IEA:UniProtKB-HAMAP
Q13347	EIF3I	Eukaryotic translation initiation factor 3 subunit I	GO:0010467; P:gene expression; TAS:Reactome
Q13347	EIF3I	Eukaryotic translation initiation factor 3 subunit I	GO:0006446; P:regulation of translational initiation; IEA:UniProtKB-HAMAP
Q13347	EIF3I	Eukaryotic translation initiation factor 3 subunit I	GO:0006412; P:translation; TAS:Reactome
Q13347	EIF3I	Eukaryotic translation initiation factor 3 subunit I	GO:0006413; P:translational initiation; IDA:UniProtKB
O75822	EIF3J	Eukaryotic translation initiation factor 3 subunit J	GO:0005515; F:protein binding; IPI:IntAct
O75822	EIF3J	Eukaryotic translation initiation factor 3 subunit J	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW
O75822	EIF3J	Eukaryotic translation initiation factor 3 subunit J	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O75822	EIF3J	Eukaryotic translation initiation factor 3 subunit J	GO:0001731; P:formation of translation preinitiation complex; IEA:UniProtKB-HAMAP
O75822	EIF3J	Eukaryotic translation initiation factor 3 subunit J	GO:0010467; P:gene expression; TAS:Reactome
O75822	EIF3J	Eukaryotic translation initiation factor 3 subunit J	GO:0006446; P:regulation of translational initiation; IEA:UniProtKB-HAMAP
O75822	EIF3J	Eukaryotic translation initiation factor 3 subunit J	GO:0006412; P:translation; TAS:Reactome
O75822	EIF3J	Eukaryotic translation initiation factor 3 subunit J	GO:0006413; P:translational initiation; IC:UniProtKB
Q9UBQ5	EIF3K	Eukaryotic translation initiation factor 3 subunit K	GO:0005515; F:protein binding; IPI:IntAct
Q9UBQ5	EIF3K	Eukaryotic translation initiation factor 3 subunit K	GO:0043022; F:ribosome binding; IEA:InterPro
Q9UBQ5	EIF3K	Eukaryotic translation initiation factor 3 subunit K	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-HAMAP
Q9UBQ5	EIF3K	Eukaryotic translation initiation factor 3 subunit K	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UBQ5	EIF3K	Eukaryotic translation initiation factor 3 subunit K	GO:0001731; P:formation of translation preinitiation complex; IEA:UniProtKB-HAMAP
Q9UBQ5	EIF3K	Eukaryotic translation initiation factor 3 subunit K	GO:0010467; P:gene expression; TAS:Reactome
Q9UBQ5	EIF3K	Eukaryotic translation initiation factor 3 subunit K	GO:0006446; P:regulation of translational initiation; IEA:UniProtKB-HAMAP
Q9UBQ5	EIF3K	Eukaryotic translation initiation factor 3 subunit K	GO:0006412; P:translation; TAS:Reactome
Q9UBQ5	EIF3K	Eukaryotic translation initiation factor 3 subunit K	GO:0006413; P:translational initiation; IDA:UniProtKB
Q9Y262	EIF3L	Eukaryotic translation initiation factor 3 subunit L	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y262	EIF3L	Eukaryotic translation initiation factor 3 subunit L	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y262	EIF3L	Eukaryotic translation initiation factor 3 subunit L	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-HAMAP
Q9Y262	EIF3L	Eukaryotic translation initiation factor 3 subunit L	GO:0001731; P:formation of translation preinitiation complex; IEA:UniProtKB-HAMAP
Q9Y262	EIF3L	Eukaryotic translation initiation factor 3 subunit L	GO:0006446; P:regulation of translational initiation; IEA:UniProtKB-HAMAP
Q9Y262	EIF3L	Eukaryotic translation initiation factor 3 subunit L	GO:0006413; P:translational initiation; IDA:UniProtKB
Q7L2H7	EIF3M	Eukaryotic translation initiation factor 3 subunit M	GO:0005515; F:protein binding; IPI:UniProtKB
Q7L2H7	EIF3M	Eukaryotic translation initiation factor 3 subunit M	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-HAMAP
Q7L2H7	EIF3M	Eukaryotic translation initiation factor 3 subunit M	GO:0002183; P:cytoplasmic translational initiation; IBA:RefGenome
Q7L2H7	EIF3M	Eukaryotic translation initiation factor 3 subunit M	GO:0001731; P:formation of translation preinitiation complex; IEA:UniProtKB-HAMAP
Q7L2H7	EIF3M	Eukaryotic translation initiation factor 3 subunit M	GO:0006446; P:regulation of translational initiation; IEA:UniProtKB-HAMAP
Q7L2H7	EIF3M	Eukaryotic translation initiation factor 3 subunit M	GO:0006413; P:translational initiation; IC:UniProtKB
B5ME19	EIF3CL	Eukaryotic translation initiation factor 3 subunit C-like protein	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-HAMAP
B5ME19	EIF3CL	Eukaryotic translation initiation factor 3 subunit C-like protein	GO:0001731; P:formation of translation preinitiation complex; IEA:UniProtKB-HAMAP
B5ME19	EIF3CL	Eukaryotic translation initiation factor 3 subunit C-like protein	GO:0006446; P:regulation of translational initiation; IEA:UniProtKB-HAMAP
Q9HBU6	ETNK1	Ethanolamine kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9HBU6	ETNK1	Ethanolamine kinase 1	GO:0004305; F:ethanolamine kinase activity; IDA:UniProtKB
Q9HBU6	ETNK1	Ethanolamine kinase 1	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9HBU6	ETNK1	Ethanolamine kinase 1	GO:0006646; P:phosphatidylethanolamine biosynthetic process; IDA:UniProtKB
Q9HBU6	ETNK1	Ethanolamine kinase 1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9HBU6	ETNK1	Ethanolamine kinase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NVF9	ETNK2	Ethanolamine kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NVF9	ETNK2	Ethanolamine kinase 2	GO:0004305; F:ethanolamine kinase activity; IEA:UniProtKB-EC
Q9NVF9	ETNK2	Ethanolamine kinase 2	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9NVF9	ETNK2	Ethanolamine kinase 2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9NVF9	ETNK2	Ethanolamine kinase 2	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q9NVF9	ETNK2	Ethanolamine kinase 2	GO:0006646; P:phosphatidylethanolamine biosynthetic process; TAS:Reactome
Q9NVF9	ETNK2	Ethanolamine kinase 2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9NVF9	ETNK2	Ethanolamine kinase 2	GO:0001890; P:placenta development; IEA:Ensembl
Q9NVF9	ETNK2	Ethanolamine kinase 2	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q9NVF9	ETNK2	Ethanolamine kinase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P19957	PI3	Elafin	GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc
P19957	PI3	Elafin	GO:0004867; F:serine-type endopeptidase inhibitor activity; TAS:ProtInc
P19957	PI3	Elafin	GO:0007620; P:copulation; IEA:InterPro
P19957	PI3	Elafin	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
Q15717	ELAVL1	ELAV-like protein 1	GO:0017091; F:AU-rich element binding; IDA:UniProtKB
Q15717	ELAVL1	ELAV-like protein 1	GO:0003725; F:double-stranded RNA binding; IDA:MGI
Q15717	ELAVL1	ELAV-like protein 1	GO:0035925; F:mRNA 3'-UTR AU-rich region binding; IDA:MGI
Q15717	ELAVL1	ELAV-like protein 1	GO:0003730; F:mRNA 3'-UTR binding; ISS:UniProtKB
Q15717	ELAVL1	ELAV-like protein 1	GO:0003729; F:mRNA binding; TAS:ProtInc
Q15717	ELAVL1	ELAV-like protein 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q15717	ELAVL1	ELAV-like protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15717	ELAVL1	ELAV-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15717	ELAVL1	ELAV-like protein 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q15717	ELAVL1	ELAV-like protein 1	GO:0003723; F:RNA binding; IDA:UniProtKB
Q15717	ELAVL1	ELAV-like protein 1	GO:0070935; P:3'-UTR-mediated mRNA stabilization; IDA:UniProtKB
Q15717	ELAVL1	ELAV-like protein 1	GO:0010467; P:gene expression; TAS:Reactome
Q15717	ELAVL1	ELAV-like protein 1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q15717	ELAVL1	ELAV-like protein 1	GO:0048255; P:mRNA stabilization; IMP:UniProtKB
Q15717	ELAVL1	ELAV-like protein 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q15717	ELAVL1	ELAV-like protein 1	GO:0045727; P:positive regulation of translation; IDA:MGI
Q15717	ELAVL1	ELAV-like protein 1	GO:2000036; P:regulation of stem cell maintenance; ISS:UniProtKB
Q15717	ELAVL1	ELAV-like protein 1	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q12926	ELAVL2	ELAV-like protein 2	GO:0003730; F:mRNA 3'-UTR binding; TAS:ProtInc
Q12926	ELAVL2	ELAV-like protein 2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q12926	ELAVL2	ELAV-like protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q12926	ELAVL2	ELAV-like protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q12926	ELAVL2	ELAV-like protein 2	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
Q14576	ELAVL3	ELAV-like protein 3	GO:0017091; F:AU-rich element binding; IDA:UniProtKB
Q14576	ELAVL3	ELAV-like protein 3	GO:0000166; F:nucleotide binding; IEA:InterPro
Q14576	ELAVL3	ELAV-like protein 3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q14576	ELAVL3	ELAV-like protein 3	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
P26378	ELAVL4	ELAV-like protein 4	GO:0017091; F:AU-rich element binding; IDA:UniProtKB
P26378	ELAVL4	ELAV-like protein 4	GO:0003730; F:mRNA 3'-UTR binding; TAS:ProtInc
P26378	ELAVL4	ELAV-like protein 4	GO:0000166; F:nucleotide binding; IEA:InterPro
P26378	ELAVL4	ELAV-like protein 4	GO:0003723; F:RNA binding; TAS:ProtInc
P26378	ELAVL4	ELAV-like protein 4	GO:0006397; P:mRNA processing; TAS:ProtInc
P26378	ELAVL4	ELAV-like protein 4	GO:0006396; P:RNA processing; TAS:ProtInc
P0DMC3	APELA	Apelin receptor early endogenous ligand	GO:0031704; F:apelin receptor binding; ISS:UniProtKB
P0DMC3	APELA	Apelin receptor early endogenous ligand	GO:0005179; F:hormone activity; ISS:UniProtKB
P0DMC3	APELA	Apelin receptor early endogenous ligand	GO:0060183; P:apelin receptor signaling pathway; ISS:UniProtKB
P0DMC3	APELA	Apelin receptor early endogenous ligand	GO:0090134; P:cell migration involved in mesendoderm migration; ISS:UniProtKB
P0DMC3	APELA	Apelin receptor early endogenous ligand	GO:0007492; P:endoderm development; ISS:UniProtKB
P0DMC3	APELA	Apelin receptor early endogenous ligand	GO:0007507; P:heart development; ISS:UniProtKB
P0DMC3	APELA	Apelin receptor early endogenous ligand	GO:0090133; P:mesendoderm migration; ISS:UniProtKB
P32519	ELF1	ETS-related transcription factor Elf-1	GO:0005515; F:protein binding; IPI:UniProtKB
P32519	ELF1	ETS-related transcription factor Elf-1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P32519	ELF1	ETS-related transcription factor Elf-1	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
P32519	ELF1	ETS-related transcription factor Elf-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P32519	ELF1	ETS-related transcription factor Elf-1	GO:0030154; P:cell differentiation; IBA:RefGenome
P32519	ELF1	ETS-related transcription factor Elf-1	GO:0050860; P:negative regulation of T cell receptor signaling pathway; IEA:Ensembl
P32519	ELF1	ETS-related transcription factor Elf-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P32519	ELF1	ETS-related transcription factor Elf-1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P32519	ELF1	ETS-related transcription factor Elf-1	GO:0001817; P:regulation of cytokine production; IEA:Ensembl
P32519	ELF1	ETS-related transcription factor Elf-1	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q15723	ELF2	ETS-related transcription factor Elf-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q15723	ELF2	ETS-related transcription factor Elf-2	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q15723	ELF2	ETS-related transcription factor Elf-2	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q15723	ELF2	ETS-related transcription factor Elf-2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q15723	ELF2	ETS-related transcription factor Elf-2	GO:0030154; P:cell differentiation; IBA:RefGenome
Q15723	ELF2	ETS-related transcription factor Elf-2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q15723	ELF2	ETS-related transcription factor Elf-2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q15723	ELF2	ETS-related transcription factor Elf-2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q15723	ELF2	ETS-related transcription factor Elf-2	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
P78545	ELF3	ETS-related transcription factor Elf-3	GO:0005515; F:protein binding; IPI:UniProtKB
P78545	ELF3	ETS-related transcription factor Elf-3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P78545	ELF3	ETS-related transcription factor Elf-3	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
P78545	ELF3	ETS-related transcription factor Elf-3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
P78545	ELF3	ETS-related transcription factor Elf-3	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
P78545	ELF3	ETS-related transcription factor Elf-3	GO:0001824; P:blastocyst development; IEA:Ensembl
P78545	ELF3	ETS-related transcription factor Elf-3	GO:0008544; P:epidermis development; NAS:UniProtKB
P78545	ELF3	ETS-related transcription factor Elf-3	GO:0030855; P:epithelial cell differentiation; IEP:UniProtKB
P78545	ELF3	ETS-related transcription factor Elf-3	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
P78545	ELF3	ETS-related transcription factor Elf-3	GO:0006954; P:inflammatory response; IEP:UniProtKB
P78545	ELF3	ETS-related transcription factor Elf-3	GO:0060056; P:mammary gland involution; ISS:UniProtKB
P78545	ELF3	ETS-related transcription factor Elf-3	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P78545	ELF3	ETS-related transcription factor Elf-3	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P78545	ELF3	ETS-related transcription factor Elf-3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P78545	ELF3	ETS-related transcription factor Elf-3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P78545	ELF3	ETS-related transcription factor Elf-3	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
P78545	ELF3	ETS-related transcription factor Elf-3	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q99607	ELF4	ETS-related transcription factor Elf-4	GO:0005515; F:protein binding; IPI:UniProtKB
Q99607	ELF4	ETS-related transcription factor Elf-4	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q99607	ELF4	ETS-related transcription factor Elf-4	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q99607	ELF4	ETS-related transcription factor Elf-4	GO:0030154; P:cell differentiation; IBA:RefGenome
Q99607	ELF4	ETS-related transcription factor Elf-4	GO:0001787; P:natural killer cell proliferation; ISS:UniProtKB
Q99607	ELF4	ETS-related transcription factor Elf-4	GO:0001866; P:NK T cell proliferation; ISS:UniProtKB
Q99607	ELF4	ETS-related transcription factor Elf-4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q99607	ELF4	ETS-related transcription factor Elf-4	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q99607	ELF4	ETS-related transcription factor Elf-4	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q9UKW6	ELF5	ETS-related transcription factor Elf-5	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9UKW6	ELF5	ETS-related transcription factor Elf-5	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q9UKW6	ELF5	ETS-related transcription factor Elf-5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9UKW6	ELF5	ETS-related transcription factor Elf-5	GO:0030154; P:cell differentiation; IBA:RefGenome
Q9UKW6	ELF5	ETS-related transcription factor Elf-5	GO:0008283; P:cell proliferation; TAS:ProtInc
Q9UKW6	ELF5	ETS-related transcription factor Elf-5	GO:0007398; P:ectoderm development; IEA:Ensembl
Q9UKW6	ELF5	ETS-related transcription factor Elf-5	GO:0060644; P:mammary gland epithelial cell differentiation; IEA:Ensembl
Q9UKW6	ELF5	ETS-related transcription factor Elf-5	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q9UKW6	ELF5	ETS-related transcription factor Elf-5	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P0C7U0	ELFN1	Protein ELFN1	GO:0019902; F:phosphatase binding; IDA:UniProtKB
P0C7U0	ELFN1	Protein ELFN1	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
P0C7U0	ELFN1	Protein ELFN1	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
P0C7U0	ELFN1	Protein ELFN1	GO:0050808; P:synapse organization; ISS:UniProtKB
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0005515; F:protein binding; IPI:UniProtKB
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0030154; P:cell differentiation; IBA:RefGenome
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0045087; P:innate immune response; TAS:Reactome
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
P19419	ELK1	ETS domain-containing protein Elk-1	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P41970	ELK3	ETS domain-containing protein Elk-3	GO:0005515; F:protein binding; IPI:IntAct
P41970	ELK3	ETS domain-containing protein Elk-3	GO:0032422; F:purine-rich negative regulatory element binding; IDA:HGNC
P41970	ELK3	ETS domain-containing protein Elk-3	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
P41970	ELK3	ETS domain-containing protein Elk-3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
P41970	ELK3	ETS domain-containing protein Elk-3	GO:0003714; F:transcription corepressor activity; IDA:HGNC
P41970	ELK3	ETS domain-containing protein Elk-3	GO:0001525; P:angiogenesis; IEA:Ensembl
P41970	ELK3	ETS domain-containing protein Elk-3	GO:0030154; P:cell differentiation; IBA:RefGenome
P41970	ELK3	ETS domain-containing protein Elk-3	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:HGNC
P41970	ELK3	ETS domain-containing protein Elk-3	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
P41970	ELK3	ETS domain-containing protein Elk-3	GO:0007165; P:signal transduction; TAS:ProtInc
P41970	ELK3	ETS domain-containing protein Elk-3	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
P41970	ELK3	ETS domain-containing protein Elk-3	GO:0042060; P:wound healing; IEA:Ensembl
P28324	ELK4	ETS domain-containing protein Elk-4	GO:0003682; F:chromatin binding; IDA:UniProtKB
P28324	ELK4	ETS domain-containing protein Elk-4	GO:0001047; F:core promoter binding; TAS:UniProtKB
P28324	ELK4	ETS domain-containing protein Elk-4	GO:0003677; F:DNA binding; TAS:ProtInc
P28324	ELK4	ETS domain-containing protein Elk-4	GO:0005515; F:protein binding; IPI:UniProtKB
P28324	ELK4	ETS domain-containing protein Elk-4	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P28324	ELK4	ETS domain-containing protein Elk-4	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
P28324	ELK4	ETS domain-containing protein Elk-4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
P28324	ELK4	ETS domain-containing protein Elk-4	GO:0003712; F:transcription cofactor activity; TAS:ProtInc
P28324	ELK4	ETS domain-containing protein Elk-4	GO:0030154; P:cell differentiation; IBA:RefGenome
P28324	ELK4	ETS domain-containing protein Elk-4	GO:0070932; P:histone H3 deacetylation; IDA:UniProtKB
P28324	ELK4	ETS domain-containing protein Elk-4	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
P28324	ELK4	ETS domain-containing protein Elk-4	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
O00472	ELL2	RNA polymerase II elongation factor ELL2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O00472	ELL2	RNA polymerase II elongation factor ELL2	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:ProtInc
Q9HB65	ELL3	RNA polymerase II elongation factor ELL3	GO:0035326; F:enhancer binding; ISS:UniProtKB
Q9HB65	ELL3	RNA polymerase II elongation factor ELL3	GO:0006354; P:DNA-templated transcription, elongation; IDA:UniProtKB
Q9HB65	ELL3	RNA polymerase II elongation factor ELL3	GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IEA:Ensembl
Q9HB65	ELL3	RNA polymerase II elongation factor ELL3	GO:0032786; P:positive regulation of DNA-templated transcription, elongation; IDA:UniProtKB
Q9HB65	ELL3	RNA polymerase II elongation factor ELL3	GO:2000179; P:positive regulation of neural precursor cell proliferation; IEA:Ensembl
Q9HB65	ELL3	RNA polymerase II elongation factor ELL3	GO:0050769; P:positive regulation of neurogenesis; IEA:Ensembl
Q9HB65	ELL3	RNA polymerase II elongation factor ELL3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9HB65	ELL3	RNA polymerase II elongation factor ELL3	GO:0010717; P:regulation of epithelial to mesenchymal transition; ISS:UniProtKB
Q9HB65	ELL3	RNA polymerase II elongation factor ELL3	GO:0007283; P:spermatogenesis; NAS:UniProtKB
Q9HB65	ELL3	RNA polymerase II elongation factor ELL3	GO:0048863; P:stem cell differentiation; ISS:UniProtKB
Q9HB65	ELL3	RNA polymerase II elongation factor ELL3	GO:0006368; P:transcription elongation from RNA polymerase II promoter; IDA:UniProtKB
Q9HB65	ELL3	RNA polymerase II elongation factor ELL3	GO:0006366; P:transcription from RNA polymerase II promoter; ISS:UniProtKB
P55199	ELL	RNA polymerase II elongation factor ELL	GO:0019902; F:phosphatase binding; IDA:UniProtKB
P55199	ELL	RNA polymerase II elongation factor ELL	GO:0005515; F:protein binding; IPI:IntAct
P55199	ELL	RNA polymerase II elongation factor ELL	GO:0010467; P:gene expression; TAS:Reactome
P55199	ELL	RNA polymerase II elongation factor ELL	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P55199	ELL	RNA polymerase II elongation factor ELL	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
P55199	ELL	RNA polymerase II elongation factor ELL	GO:0032786; P:positive regulation of DNA-templated transcription, elongation; TAS:ProtInc
P55199	ELL	RNA polymerase II elongation factor ELL	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P55199	ELL	RNA polymerase II elongation factor ELL	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P55199	ELL	RNA polymerase II elongation factor ELL	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
P55199	ELL	RNA polymerase II elongation factor ELL	GO:0016032; P:viral process; TAS:Reactome
Q8N336	ELMOD1	ELMO domain-containing protein 1	GO:0005096; F:GTPase activator activity; IDA:UniProtKB
Q8N336	ELMOD1	ELMO domain-containing protein 1	GO:0006909; P:phagocytosis; IEA:InterPro
Q8N336	ELMOD1	ELMO domain-containing protein 1	GO:0043547; P:positive regulation of GTPase activity; IDA:GOC
Q8IZ81	ELMOD2	ELMO domain-containing protein 2	GO:0005096; F:GTPase activator activity; IDA:UniProtKB
Q8IZ81	ELMOD2	ELMO domain-containing protein 2	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q8IZ81	ELMOD2	ELMO domain-containing protein 2	GO:0006909; P:phagocytosis; IEA:InterPro
Q8IZ81	ELMOD2	ELMO domain-containing protein 2	GO:0043547; P:positive regulation of GTPase activity; IDA:GOC
Q8IZ81	ELMOD2	ELMO domain-containing protein 2	GO:0050688; P:regulation of defense response to virus; IDA:UniProtKB
Q92556	ELMO1	Engulfment and cell motility protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q92556	ELMO1	Engulfment and cell motility protein 1	GO:0017124; F:SH3 domain binding; IPI:UniProtKB
Q92556	ELMO1	Engulfment and cell motility protein 1	GO:0030036; P:actin cytoskeleton organization; IGI:UniProtKB
Q92556	ELMO1	Engulfment and cell motility protein 1	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q92556	ELMO1	Engulfment and cell motility protein 1	GO:0006928; P:cellular component movement; IGI:UniProtKB
Q92556	ELMO1	Engulfment and cell motility protein 1	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q92556	ELMO1	Engulfment and cell motility protein 1	GO:0045087; P:innate immune response; TAS:Reactome
Q92556	ELMO1	Engulfment and cell motility protein 1	GO:0006911; P:phagocytosis, engulfment; IGI:UniProtKB
Q92556	ELMO1	Engulfment and cell motility protein 1	GO:0016601; P:Rac protein signal transduction; IGI:UniProtKB
Q92556	ELMO1	Engulfment and cell motility protein 1	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
Q92556	ELMO1	Engulfment and cell motility protein 1	GO:0016032; P:viral process; TAS:Reactome
Q96FG2	ELMOD3	ELMO domain-containing protein 3	GO:0006909; P:phagocytosis; IEA:InterPro
Q96JJ3	ELMO2	Engulfment and cell motility protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q96JJ3	ELMO2	Engulfment and cell motility protein 2	GO:0030971; F:receptor tyrosine kinase binding; IPI:UniProtKB
Q96JJ3	ELMO2	Engulfment and cell motility protein 2	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q96JJ3	ELMO2	Engulfment and cell motility protein 2	GO:0060326; P:cell chemotaxis; IMP:UniProtKB
Q96JJ3	ELMO2	Engulfment and cell motility protein 2	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q96JJ3	ELMO2	Engulfment and cell motility protein 2	GO:0045087; P:innate immune response; TAS:Reactome
Q96BJ8	ELMO3	Engulfment and cell motility protein 3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q96BJ8	ELMO3	Engulfment and cell motility protein 3	GO:0006909; P:phagocytosis; IEA:UniProtKB-KW
P08246	ELANE	Neutrophil elastase	GO:0019955; F:cytokine binding; IPI:UniProtKB
P08246	ELANE	Neutrophil elastase	GO:0004175; F:endopeptidase activity; IDA:UniProtKB
P08246	ELANE	Neutrophil elastase	GO:0008201; F:heparin binding; IDA:MGI
P08246	ELANE	Neutrophil elastase	GO:0008233; F:peptidase activity; IDA:MGI
P08246	ELANE	Neutrophil elastase	GO:0002020; F:protease binding; IPI:BHF-UCL
P08246	ELANE	Neutrophil elastase	GO:0005515; F:protein binding; IPI:UniProtKB
P08246	ELANE	Neutrophil elastase	GO:0001106; F:RNA polymerase II transcription corepressor activity; IMP:UniProt
P08246	ELANE	Neutrophil elastase	GO:0004252; F:serine-type endopeptidase activity; IEA:Ensembl
P08246	ELANE	Neutrophil elastase	GO:0002438; P:acute inflammatory response to antigenic stimulus; IEA:Ensembl
P08246	ELANE	Neutrophil elastase	GO:0006874; P:cellular calcium ion homeostasis; NAS:UniProtKB
P08246	ELANE	Neutrophil elastase	GO:0030574; P:collagen catabolic process; TAS:Reactome
P08246	ELANE	Neutrophil elastase	GO:0042742; P:defense response to bacterium; IDA:UniProtKB
P08246	ELANE	Neutrophil elastase	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P08246	ELANE	Neutrophil elastase	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P08246	ELANE	Neutrophil elastase	GO:0050900; P:leukocyte migration; IEA:Ensembl
P08246	ELANE	Neutrophil elastase	GO:0045079; P:negative regulation of chemokine biosynthetic process; IDA:UniProtKB
P08246	ELANE	Neutrophil elastase	GO:0050922; P:negative regulation of chemotaxis; NAS:UniProtKB
P08246	ELANE	Neutrophil elastase	GO:0044130; P:negative regulation of growth of symbiont in host; IEA:Ensembl
P08246	ELANE	Neutrophil elastase	GO:0050728; P:negative regulation of inflammatory response; NAS:UniProtKB
P08246	ELANE	Neutrophil elastase	GO:0045415; P:negative regulation of interleukin-8 biosynthetic process; IDA:UniProtKB
P08246	ELANE	Neutrophil elastase	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProt
P08246	ELANE	Neutrophil elastase	GO:0070947; P:neutrophil mediated killing of fungus; IEA:Ensembl
P08246	ELANE	Neutrophil elastase	GO:0006909; P:phagocytosis; IEA:Ensembl
P08246	ELANE	Neutrophil elastase	GO:0050778; P:positive regulation of immune response; IEA:Ensembl
P08246	ELANE	Neutrophil elastase	GO:0045416; P:positive regulation of interleukin-8 biosynthetic process; IDA:UniProtKB
P08246	ELANE	Neutrophil elastase	GO:0043406; P:positive regulation of MAP kinase activity; NAS:UniProtKB
P08246	ELANE	Neutrophil elastase	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IDA:UniProtKB
P08246	ELANE	Neutrophil elastase	GO:0030163; P:protein catabolic process; NAS:UniProtKB
P08246	ELANE	Neutrophil elastase	GO:0006508; P:proteolysis; IDA:MGI
P08246	ELANE	Neutrophil elastase	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P08246	ELANE	Neutrophil elastase	GO:0009411; P:response to UV; IDA:UniProtKB
P08246	ELANE	Neutrophil elastase	GO:0001878; P:response to yeast; IEA:Ensembl
P15502	ELN	Elastin	GO:0050840; F:extracellular matrix binding; IEA:Ensembl
P15502	ELN	Elastin	GO:0030023; F:extracellular matrix constituent conferring elasticity; IEA:Ensembl
P15502	ELN	Elastin	GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc
P15502	ELN	Elastin	GO:0005515; F:protein binding; IPI:IntAct
P15502	ELN	Elastin	GO:0008015; P:blood circulation; TAS:ProtInc
P15502	ELN	Elastin	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
P15502	ELN	Elastin	GO:0008283; P:cell proliferation; TAS:ProtInc
P15502	ELN	Elastin	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P15502	ELN	Elastin	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P15502	ELN	Elastin	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P15502	ELN	Elastin	GO:0030833; P:regulation of actin filament polymerization; IEA:Ensembl
P15502	ELN	Elastin	GO:0007585; P:respiratory gaseous exchange; TAS:ProtInc
P15502	ELN	Elastin	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
P15502	ELN	Elastin	GO:0043149; P:stress fiber assembly; IEA:Ensembl
Q8NG57	TCEB3C	RNA polymerase II transcription factor SIII subunit A3	GO:0003677; F:DNA binding; IEA:InterPro
Q8NG57	TCEB3C	RNA polymerase II transcription factor SIII subunit A3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NG57	TCEB3C	RNA polymerase II transcription factor SIII subunit A3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14241	TCEB3	Transcription elongation factor B polypeptide 3	GO:0003677; F:DNA binding; IEA:InterPro
Q14241	TCEB3	Transcription elongation factor B polypeptide 3	GO:0010467; P:gene expression; TAS:Reactome
Q14241	TCEB3	Transcription elongation factor B polypeptide 3	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
Q14241	TCEB3	Transcription elongation factor B polypeptide 3	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q14241	TCEB3	Transcription elongation factor B polypeptide 3	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q14241	TCEB3	Transcription elongation factor B polypeptide 3	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q14241	TCEB3	Transcription elongation factor B polypeptide 3	GO:0016032; P:viral process; TAS:Reactome
Q15370	TCEB2	Transcription elongation factor B polypeptide 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q15370	TCEB2	Transcription elongation factor B polypeptide 2	GO:0031625; F:ubiquitin protein ligase binding; IDA:UniProtKB
Q15370	TCEB2	Transcription elongation factor B polypeptide 2	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
Q15370	TCEB2	Transcription elongation factor B polypeptide 2	GO:0010467; P:gene expression; TAS:Reactome
Q15370	TCEB2	Transcription elongation factor B polypeptide 2	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
Q15370	TCEB2	Transcription elongation factor B polypeptide 2	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q15370	TCEB2	Transcription elongation factor B polypeptide 2	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q15370	TCEB2	Transcription elongation factor B polypeptide 2	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
Q15370	TCEB2	Transcription elongation factor B polypeptide 2	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q15370	TCEB2	Transcription elongation factor B polypeptide 2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q15370	TCEB2	Transcription elongation factor B polypeptide 2	GO:0016032; P:viral process; TAS:Reactome
Q8IYF1	TCEB3B	RNA polymerase II transcription factor SIII subunit A2	GO:0003677; F:DNA binding; IEA:InterPro
Q8IYF1	TCEB3B	RNA polymerase II transcription factor SIII subunit A2	GO:0032784; P:regulation of DNA-templated transcription, elongation; TAS:ProtInc
Q8IYF1	TCEB3B	RNA polymerase II transcription factor SIII subunit A2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q15369	TCEB1	Transcription elongation factor B polypeptide 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15369	TCEB1	Transcription elongation factor B polypeptide 1	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
Q15369	TCEB1	Transcription elongation factor B polypeptide 1	GO:0010467; P:gene expression; TAS:Reactome
Q15369	TCEB1	Transcription elongation factor B polypeptide 1	GO:0032968; P:positive regulation of transcription elongation from RNA polymerase II promoter; IEA:Ensembl
Q15369	TCEB1	Transcription elongation factor B polypeptide 1	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
Q15369	TCEB1	Transcription elongation factor B polypeptide 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q15369	TCEB1	Transcription elongation factor B polypeptide 1	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
Q15369	TCEB1	Transcription elongation factor B polypeptide 1	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q15369	TCEB1	Transcription elongation factor B polypeptide 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q15369	TCEB1	Transcription elongation factor B polypeptide 1	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q15369	TCEB1	Transcription elongation factor B polypeptide 1	GO:0016032; P:viral process; TAS:Reactome
P60002	ELOF1	Transcription elongation factor 1 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P60002	ELOF1	Transcription elongation factor 1 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P60002	ELOF1	Transcription elongation factor 1 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NXB9	ELOVL2	Elongation of very long chain fatty acids protein 2	GO:0009922; F:fatty acid elongase activity; IDA:UniProtKB
Q9NXB9	ELOVL2	Elongation of very long chain fatty acids protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NXB9	ELOVL2	Elongation of very long chain fatty acids protein 2	GO:0036109; P:alpha-linolenic acid metabolic process; TAS:Reactome
Q9NXB9	ELOVL2	Elongation of very long chain fatty acids protein 2	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9NXB9	ELOVL2	Elongation of very long chain fatty acids protein 2	GO:0034626; P:fatty acid elongation, polyunsaturated fatty acid; IDA:UniProtKB
Q9NXB9	ELOVL2	Elongation of very long chain fatty acids protein 2	GO:0043651; P:linoleic acid metabolic process; TAS:Reactome
Q9NXB9	ELOVL2	Elongation of very long chain fatty acids protein 2	GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome
Q9NXB9	ELOVL2	Elongation of very long chain fatty acids protein 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NXB9	ELOVL2	Elongation of very long chain fatty acids protein 2	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
Q9NXB9	ELOVL2	Elongation of very long chain fatty acids protein 2	GO:0006636; P:unsaturated fatty acid biosynthetic process; IEA:UniProtKB-UniPathway
Q9NXB9	ELOVL2	Elongation of very long chain fatty acids protein 2	GO:0033559; P:unsaturated fatty acid metabolic process; TAS:Reactome
Q9NXB9	ELOVL2	Elongation of very long chain fatty acids protein 2	GO:0042761; P:very long-chain fatty acid biosynthetic process; IDA:UniProtKB
Q9BW60	ELOVL1	Elongation of very long chain fatty acids protein 1	GO:0009922; F:fatty acid elongase activity; IDA:UniProtKB
Q9BW60	ELOVL1	Elongation of very long chain fatty acids protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BW60	ELOVL1	Elongation of very long chain fatty acids protein 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9BW60	ELOVL1	Elongation of very long chain fatty acids protein 1	GO:0034625; P:fatty acid elongation, monounsaturated fatty acid; IDA:UniProtKB
Q9BW60	ELOVL1	Elongation of very long chain fatty acids protein 1	GO:0019367; P:fatty acid elongation, saturated fatty acid; IDA:UniProtKB
Q9BW60	ELOVL1	Elongation of very long chain fatty acids protein 1	GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome
Q9BW60	ELOVL1	Elongation of very long chain fatty acids protein 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BW60	ELOVL1	Elongation of very long chain fatty acids protein 1	GO:0030148; P:sphingolipid biosynthetic process; IMP:UniProtKB
Q9BW60	ELOVL1	Elongation of very long chain fatty acids protein 1	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
Q9BW60	ELOVL1	Elongation of very long chain fatty acids protein 1	GO:0042761; P:very long-chain fatty acid biosynthetic process; IDA:UniProtKB
Q9HB03	ELOVL3	Elongation of very long chain fatty acids protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HB03	ELOVL3	Elongation of very long chain fatty acids protein 3	GO:0016740; F:transferase activity; IEA:UniProtKB-KW
Q9HB03	ELOVL3	Elongation of very long chain fatty acids protein 3	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9HB03	ELOVL3	Elongation of very long chain fatty acids protein 3	GO:0034625; P:fatty acid elongation, monounsaturated fatty acid; IDA:UniProtKB
Q9HB03	ELOVL3	Elongation of very long chain fatty acids protein 3	GO:0034626; P:fatty acid elongation, polyunsaturated fatty acid; IDA:UniProtKB
Q9HB03	ELOVL3	Elongation of very long chain fatty acids protein 3	GO:0019367; P:fatty acid elongation, saturated fatty acid; IDA:UniProtKB
Q9HB03	ELOVL3	Elongation of very long chain fatty acids protein 3	GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome
Q9HB03	ELOVL3	Elongation of very long chain fatty acids protein 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9HB03	ELOVL3	Elongation of very long chain fatty acids protein 3	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
Q9HB03	ELOVL3	Elongation of very long chain fatty acids protein 3	GO:0042761; P:very long-chain fatty acid biosynthetic process; IDA:UniProtKB
Q9GZR5	ELOVL4	Elongation of very long chain fatty acids protein 4	GO:0008020; F:G-protein coupled photoreceptor activity; NAS:UniProtKB
Q9GZR5	ELOVL4	Elongation of very long chain fatty acids protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9GZR5	ELOVL4	Elongation of very long chain fatty acids protein 4	GO:0016740; F:transferase activity; IEA:UniProtKB-KW
Q9GZR5	ELOVL4	Elongation of very long chain fatty acids protein 4	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9GZR5	ELOVL4	Elongation of very long chain fatty acids protein 4	GO:0009584; P:detection of visible light; NAS:GOC
Q9GZR5	ELOVL4	Elongation of very long chain fatty acids protein 4	GO:0006633; P:fatty acid biosynthetic process; NAS:UniProtKB
Q9GZR5	ELOVL4	Elongation of very long chain fatty acids protein 4	GO:0019367; P:fatty acid elongation, saturated fatty acid; IDA:UniProtKB
Q9GZR5	ELOVL4	Elongation of very long chain fatty acids protein 4	GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome
Q9GZR5	ELOVL4	Elongation of very long chain fatty acids protein 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9GZR5	ELOVL4	Elongation of very long chain fatty acids protein 4	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
Q9GZR5	ELOVL4	Elongation of very long chain fatty acids protein 4	GO:0042761; P:very long-chain fatty acid biosynthetic process; IDA:UniProtKB
Q9NYP7	ELOVL5	Elongation of very long chain fatty acids protein 5	GO:0009922; F:fatty acid elongase activity; IDA:UniProtKB
Q9NYP7	ELOVL5	Elongation of very long chain fatty acids protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NYP7	ELOVL5	Elongation of very long chain fatty acids protein 5	GO:0036109; P:alpha-linolenic acid metabolic process; TAS:Reactome
Q9NYP7	ELOVL5	Elongation of very long chain fatty acids protein 5	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9NYP7	ELOVL5	Elongation of very long chain fatty acids protein 5	GO:0034625; P:fatty acid elongation, monounsaturated fatty acid; IDA:UniProtKB
Q9NYP7	ELOVL5	Elongation of very long chain fatty acids protein 5	GO:0034626; P:fatty acid elongation, polyunsaturated fatty acid; IDA:UniProtKB
Q9NYP7	ELOVL5	Elongation of very long chain fatty acids protein 5	GO:0043651; P:linoleic acid metabolic process; TAS:Reactome
Q9NYP7	ELOVL5	Elongation of very long chain fatty acids protein 5	GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome
Q9NYP7	ELOVL5	Elongation of very long chain fatty acids protein 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NYP7	ELOVL5	Elongation of very long chain fatty acids protein 5	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
Q9NYP7	ELOVL5	Elongation of very long chain fatty acids protein 5	GO:0006636; P:unsaturated fatty acid biosynthetic process; IEA:UniProtKB-UniPathway
Q9NYP7	ELOVL5	Elongation of very long chain fatty acids protein 5	GO:0033559; P:unsaturated fatty acid metabolic process; TAS:Reactome
Q9NYP7	ELOVL5	Elongation of very long chain fatty acids protein 5	GO:0042761; P:very long-chain fatty acid biosynthetic process; IDA:UniProtKB
Q9H5J4	ELOVL6	Elongation of very long chain fatty acids protein 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H5J4	ELOVL6	Elongation of very long chain fatty acids protein 6	GO:0016747; F:transferase activity, transferring acyl groups other than amino-acyl groups; IEA:Ensembl
Q9H5J4	ELOVL6	Elongation of very long chain fatty acids protein 6	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9H5J4	ELOVL6	Elongation of very long chain fatty acids protein 6	GO:0019367; P:fatty acid elongation, saturated fatty acid; IDA:UniProtKB
Q9H5J4	ELOVL6	Elongation of very long chain fatty acids protein 6	GO:0042759; P:long-chain fatty acid biosynthetic process; IDA:UniProtKB
Q9H5J4	ELOVL6	Elongation of very long chain fatty acids protein 6	GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome
Q9H5J4	ELOVL6	Elongation of very long chain fatty acids protein 6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H5J4	ELOVL6	Elongation of very long chain fatty acids protein 6	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
A1L3X0	ELOVL7	Elongation of very long chain fatty acids protein 7	GO:0005515; F:protein binding; IPI:UniProtKB
A1L3X0	ELOVL7	Elongation of very long chain fatty acids protein 7	GO:0016740; F:transferase activity; IEA:UniProtKB-KW
A1L3X0	ELOVL7	Elongation of very long chain fatty acids protein 7	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
A1L3X0	ELOVL7	Elongation of very long chain fatty acids protein 7	GO:0034626; P:fatty acid elongation, polyunsaturated fatty acid; IDA:UniProtKB
A1L3X0	ELOVL7	Elongation of very long chain fatty acids protein 7	GO:0019367; P:fatty acid elongation, saturated fatty acid; IDA:UniProtKB
A1L3X0	ELOVL7	Elongation of very long chain fatty acids protein 7	GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome
A1L3X0	ELOVL7	Elongation of very long chain fatty acids protein 7	GO:0044281; P:small molecule metabolic process; TAS:Reactome
A1L3X0	ELOVL7	Elongation of very long chain fatty acids protein 7	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
A1L3X0	ELOVL7	Elongation of very long chain fatty acids protein 7	GO:0042761; P:very long-chain fatty acid biosynthetic process; IDA:UniProtKB
O95163	IKBKAP	Elongator complex protein 1	GO:0008607; F:phosphorylase kinase regulator activity; IDA:UniProtKB
O95163	IKBKAP	Elongator complex protein 1	GO:0005515; F:protein binding; IPI:IntAct
O95163	IKBKAP	Elongator complex protein 1	GO:0004871; F:signal transducer activity; TAS:ProtInc
O95163	IKBKAP	Elongator complex protein 1	GO:0006325; P:chromatin organization; TAS:Reactome
O95163	IKBKAP	Elongator complex protein 1	GO:0006955; P:immune response; TAS:ProtInc
O95163	IKBKAP	Elongator complex protein 1	GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB
O95163	IKBKAP	Elongator complex protein 1	GO:0006461; P:protein complex assembly; TAS:ProtInc
O95163	IKBKAP	Elongator complex protein 1	GO:0006468; P:protein phosphorylation; TAS:ProtInc
O95163	IKBKAP	Elongator complex protein 1	GO:0045859; P:regulation of protein kinase activity; IDA:GOC
O95163	IKBKAP	Elongator complex protein 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O95163	IKBKAP	Elongator complex protein 1	GO:0007165; P:signal transduction; TAS:GOC
O95163	IKBKAP	Elongator complex protein 1	GO:0006368; P:transcription elongation from RNA polymerase II promoter; IDA:HGNC
Q6IA86	ELP2	Elongator complex protein 2	GO:0006325; P:chromatin organization; TAS:Reactome
Q6IA86	ELP2	Elongator complex protein 2	GO:0046425; P:regulation of JAK-STAT cascade; IEA:Ensembl
Q6IA86	ELP2	Elongator complex protein 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:HGNC
Q6IA86	ELP2	Elongator complex protein 2	GO:0006368; P:transcription elongation from RNA polymerase II promoter; IC:HGNC
Q9H9T3	ELP3	Elongator complex protein 3	GO:0004402; F:histone acetyltransferase activity; IEA:UniProtKB-EC
Q9H9T3	ELP3	Elongator complex protein 3	GO:0051536; F:iron-sulfur cluster binding; IEA:UniProtKB-KW
Q9H9T3	ELP3	Elongator complex protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H9T3	ELP3	Elongator complex protein 3	GO:0008607; F:phosphorylase kinase regulator activity; IDA:UniProtKB
Q9H9T3	ELP3	Elongator complex protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q9H9T3	ELP3	Elongator complex protein 3	GO:0006325; P:chromatin organization; TAS:Reactome
Q9H9T3	ELP3	Elongator complex protein 3	GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB
Q9H9T3	ELP3	Elongator complex protein 3	GO:0045859; P:regulation of protein kinase activity; IDA:GOC
Q9H9T3	ELP3	Elongator complex protein 3	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9H9T3	ELP3	Elongator complex protein 3	GO:0006368; P:transcription elongation from RNA polymerase II promoter; IDA:HGNC
Q96EB1	ELP4	Elongator complex protein 4	GO:0008607; F:phosphorylase kinase regulator activity; IDA:UniProtKB
Q96EB1	ELP4	Elongator complex protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q96EB1	ELP4	Elongator complex protein 4	GO:0006325; P:chromatin organization; TAS:Reactome
Q96EB1	ELP4	Elongator complex protein 4	GO:0016573; P:histone acetylation; IDA:GOC
Q96EB1	ELP4	Elongator complex protein 4	GO:0045859; P:regulation of protein kinase activity; IDA:GOC
Q96EB1	ELP4	Elongator complex protein 4	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q96EB1	ELP4	Elongator complex protein 4	GO:0006368; P:transcription elongation from RNA polymerase II promoter; IC:HGNC
Q0PNE2	ELP6	Elongator complex protein 6	GO:0006325; P:chromatin organization; TAS:Reactome
Q0PNE2	ELP6	Elongator complex protein 6	GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB
Q0PNE2	ELP6	Elongator complex protein 6	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q0PNE2	ELP6	Elongator complex protein 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TE02	ELP5	Elongator complex protein 5	GO:0005515; F:protein binding; IPI:IntAct
Q8TE02	ELP5	Elongator complex protein 5	GO:0006325; P:chromatin organization; TAS:Reactome
Q8TE02	ELP5	Elongator complex protein 5	GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB
Q8TE02	ELP5	Elongator complex protein 5	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8TE02	ELP5	Elongator complex protein 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HBW9	ELTD1	EGF, latrophilin and seven transmembrane domain-containing protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9HBW9	ELTD1	EGF, latrophilin and seven transmembrane domain-containing protein 1	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q9HBW9	ELTD1	EGF, latrophilin and seven transmembrane domain-containing protein 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q9HBW9	ELTD1	EGF, latrophilin and seven transmembrane domain-containing protein 1	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q8WYP5	AHCTF1	Protein ELYS	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8WYP5	AHCTF1	Protein ELYS	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q8WYP5	AHCTF1	Protein ELYS	GO:0000910; P:cytokinesis; IMP:UniProtKB
Q8WYP5	AHCTF1	Protein ELYS	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8WYP5	AHCTF1	Protein ELYS	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q8WYP5	AHCTF1	Protein ELYS	GO:0051292; P:nuclear pore complex assembly; IMP:UniProtKB
Q8WYP5	AHCTF1	Protein ELYS	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q00013	MPP1	55 kDa erythrocyte membrane protein	GO:0004385; F:guanylate kinase activity; TAS:ProtInc
Q00013	MPP1	55 kDa erythrocyte membrane protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q00013	MPP1	55 kDa erythrocyte membrane protein	GO:0046939; P:nucleotide phosphorylation; TAS:GOC
Q00013	MPP1	55 kDa erythrocyte membrane protein	GO:0090022; P:regulation of neutrophil chemotaxis; ISS:UniProtKB
Q00013	MPP1	55 kDa erythrocyte membrane protein	GO:0007165; P:signal transduction; TAS:ProtInc
O00423	EML1	Echinoderm microtubule-associated protein-like 1	GO:0005509; F:calcium ion binding; NAS:UniProtKB
O00423	EML1	Echinoderm microtubule-associated protein-like 1	GO:0005515; F:protein binding; IPI:IntAct
O95834	EML2	Echinoderm microtubule-associated protein-like 2	GO:0007605; P:sensory perception of sound; TAS:ProtInc
O95834	EML2	Echinoderm microtubule-associated protein-like 2	GO:0007601; P:visual perception; TAS:ProtInc
Q9HC35	EML4	Echinoderm microtubule-associated protein-like 4	GO:0007017; P:microtubule-based process; NAS:UniProtKB
Q9HC35	EML4	Echinoderm microtubule-associated protein-like 4	GO:0007067; P:mitosis; NAS:UniProtKB
Q9HC35	EML4	Echinoderm microtubule-associated protein-like 4	GO:0007026; P:negative regulation of microtubule depolymerization; IEA:Ensembl
Q05BV3	EML5	Echinoderm microtubule-associated protein-like 5	GO:0003824; F:catalytic activity; IEA:InterPro
Q5T6L9	ERMARD	Endoplasmic reticulum membrane-associated RNA degradation protein	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q6PCB8	EMB	Embigin	GO:0097159; F:organic cyclic compound binding; IEA:Ensembl
Q6PCB8	EMB	Embigin	GO:0007155; P:cell adhesion; IEA:Ensembl
Q6PCB8	EMB	Embigin	GO:0035879; P:plasma membrane lactate transport; ISS:UniProtKB
Q5J8M3	EMC4	ER membrane protein complex subunit 4	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9NPA0	EMC7	ER membrane protein complex subunit 7	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q9NPA0	EMC7	ER membrane protein complex subunit 7	GO:0017076; F:purine nucleotide binding; NAS:UniProtKB
P50402	EMD	Emerin	GO:0003779; F:actin binding; IDA:UniProtKB
P50402	EMD	Emerin	GO:0048487; F:beta-tubulin binding; IDA:UniProtKB
P50402	EMD	Emerin	GO:0005515; F:protein binding; IPI:UniProtKB
P50402	EMD	Emerin	GO:0071363; P:cellular response to growth factor stimulus; IMP:BHF-UCL
P50402	EMD	Emerin	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P50402	EMD	Emerin	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
P50402	EMD	Emerin	GO:0007084; P:mitotic nuclear envelope reassembly; TAS:Reactome
P50402	EMD	Emerin	GO:0006936; P:muscle contraction; TAS:ProtInc
P50402	EMD	Emerin	GO:0007517; P:muscle organ development; TAS:ProtInc
P50402	EMD	Emerin	GO:0035414; P:negative regulation of catenin import into nucleus; IMP:BHF-UCL
P50402	EMD	Emerin	GO:0048147; P:negative regulation of fibroblast proliferation; IMP:BHF-UCL
P50402	EMD	Emerin	GO:0046827; P:positive regulation of protein export from nucleus; IMP:BHF-UCL
P50402	EMD	Emerin	GO:0060828; P:regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
P50402	EMD	Emerin	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q96AY2	EME1	Crossover junction endonuclease EME1	GO:0003677; F:DNA binding; IEA:InterPro
Q96AY2	EME1	Crossover junction endonuclease EME1	GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW
Q96AY2	EME1	Crossover junction endonuclease EME1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96AY2	EME1	Crossover junction endonuclease EME1	GO:0005515; F:protein binding; IPI:IntAct
Q96AY2	EME1	Crossover junction endonuclease EME1	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q96AY2	EME1	Crossover junction endonuclease EME1	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
A4GXA9	EME2	Probable crossover junction endonuclease EME2	GO:0003677; F:DNA binding; IEA:InterPro
A4GXA9	EME2	Probable crossover junction endonuclease EME2	GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW
A4GXA9	EME2	Probable crossover junction endonuclease EME2	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
A4GXA9	EME2	Probable crossover junction endonuclease EME2	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q9Y6C2	EMILIN1	EMILIN-1	GO:0030023; F:extracellular matrix constituent conferring elasticity; IEA:Ensembl
Q9Y6C2	EMILIN1	EMILIN-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6C2	EMILIN1	EMILIN-1	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9Y6C2	EMILIN1	EMILIN-1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q9Y6C2	EMILIN1	EMILIN-1	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
Q9BXX0	EMILIN2	EMILIN-2	GO:0030023; F:extracellular matrix constituent conferring elasticity; NAS:UniProtKB
Q9BXX0	EMILIN2	EMILIN-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BXX0	EMILIN2	EMILIN-2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P54849	EMP1	Epithelial membrane protein 1	GO:0016049; P:cell growth; IEA:InterPro
P54849	EMP1	Epithelial membrane protein 1	GO:0008283; P:cell proliferation; TAS:ProtInc
P54849	EMP1	Epithelial membrane protein 1	GO:0008544; P:epidermis development; TAS:ProtInc
P54849	EMP1	Epithelial membrane protein 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P54851	EMP2	Epithelial membrane protein 2	GO:0005178; F:integrin binding; IPI:MGI
P54851	EMP2	Epithelial membrane protein 2	GO:0008283; P:cell proliferation; TAS:ProtInc
P54851	EMP2	Epithelial membrane protein 2	GO:0001954; P:positive regulation of cell-matrix adhesion; IDA:MGI
P54851	EMP2	Epithelial membrane protein 2	GO:2001046; P:positive regulation of integrin-mediated signaling pathway; IDA:MGI
P54852	EMP3	Epithelial membrane protein 3	GO:0016049; P:cell growth; IEA:InterPro
P54852	EMP3	Epithelial membrane protein 3	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q14246	EMR1	EGF-like module-containing mucin-like hormone receptor-like 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q14246	EMR1	EGF-like module-containing mucin-like hormone receptor-like 1	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q14246	EMR1	EGF-like module-containing mucin-like hormone receptor-like 1	GO:0007155; P:cell adhesion; TAS:ProtInc
Q14246	EMR1	EGF-like module-containing mucin-like hormone receptor-like 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q14246	EMR1	EGF-like module-containing mucin-like hormone receptor-like 1	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q9UHX3	EMR2	EGF-like module-containing mucin-like hormone receptor-like 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UHX3	EMR2	EGF-like module-containing mucin-like hormone receptor-like 2	GO:0035374; F:chondroitin sulfate binding; IMP:UniProtKB
Q9UHX3	EMR2	EGF-like module-containing mucin-like hormone receptor-like 2	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q9UHX3	EMR2	EGF-like module-containing mucin-like hormone receptor-like 2	GO:0007155; P:cell adhesion; IMP:UniProtKB
Q9UHX3	EMR2	EGF-like module-containing mucin-like hormone receptor-like 2	GO:0016477; P:cell migration; IMP:UniProtKB
Q9UHX3	EMR2	EGF-like module-containing mucin-like hormone receptor-like 2	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q9UHX3	EMR2	EGF-like module-containing mucin-like hormone receptor-like 2	GO:0071621; P:granulocyte chemotaxis; IMP:UniProtKB
Q9UHX3	EMR2	EGF-like module-containing mucin-like hormone receptor-like 2	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q9UHX3	EMR2	EGF-like module-containing mucin-like hormone receptor-like 2	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q86SQ3	EMR4P	Putative EGF-like module-containing mucin-like hormone receptor-like 4	GO:0005509; F:calcium ion binding; IEA:InterPro
Q86SQ3	EMR4P	Putative EGF-like module-containing mucin-like hormone receptor-like 4	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q86SQ3	EMR4P	Putative EGF-like module-containing mucin-like hormone receptor-like 4	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q86SQ3	EMR4P	Putative EGF-like module-containing mucin-like hormone receptor-like 4	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q9BY15	EMR3	EGF-like module-containing mucin-like hormone receptor-like 3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9BY15	EMR3	EGF-like module-containing mucin-like hormone receptor-like 3	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q9BY15	EMR3	EGF-like module-containing mucin-like hormone receptor-like 3	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q9BY15	EMR3	EGF-like module-containing mucin-like hormone receptor-like 3	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q9H4I9	SMDT1	Essential MCU regulator, mitochondrial	GO:0051560; P:mitochondrial calcium ion homeostasis; IMP:UniProtKB
Q9H4I9	SMDT1	Essential MCU regulator, mitochondrial	GO:0006851; P:mitochondrial calcium ion transport; IMP:UniProtKB
Q6PJG2	ELMSAN1	ELM2 and SANT domain-containing protein 1	GO:0003682; F:chromatin binding; IEA:InterPro
Q6PJG2	ELMSAN1	ELM2 and SANT domain-containing protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6PJG2	ELMSAN1	ELM2 and SANT domain-containing protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6PJG2	ELMSAN1	ELM2 and SANT domain-containing protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z589	EMSY	Protein EMSY	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q7Z589	EMSY	Protein EMSY	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q7Z589	EMSY	Protein EMSY	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z589	EMSY	Protein EMSY	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q04741	EMX1	Homeobox protein EMX1	GO:0005515; F:protein binding; IPI:UniProtKB
Q04741	EMX1	Homeobox protein EMX1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q04741	EMX1	Homeobox protein EMX1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q04741	EMX1	Homeobox protein EMX1	GO:0048854; P:brain morphogenesis; IEA:Ensembl
Q04741	EMX1	Homeobox protein EMX1	GO:0021895; P:cerebral cortex neuron differentiation; IEA:Ensembl
Q04741	EMX1	Homeobox protein EMX1	GO:0021796; P:cerebral cortex regionalization; IEA:Ensembl
Q04741	EMX1	Homeobox protein EMX1	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q04741	EMX1	Homeobox protein EMX1	GO:0042493; P:response to drug; IEA:Ensembl
Q04743	EMX2	Homeobox protein EMX2	GO:0005515; F:protein binding; IPI:IntAct
Q04743	EMX2	Homeobox protein EMX2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q04743	EMX2	Homeobox protein EMX2	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
Q04743	EMX2	Homeobox protein EMX2	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q04743	EMX2	Homeobox protein EMX2	GO:0021846; P:cell proliferation in forebrain; IEA:Ensembl
Q04743	EMX2	Homeobox protein EMX2	GO:0021796; P:cerebral cortex regionalization; IEA:Ensembl
Q04743	EMX2	Homeobox protein EMX2	GO:0021542; P:dentate gyrus development; IEA:Ensembl
Q04743	EMX2	Homeobox protein EMX2	GO:0021885; P:forebrain cell migration; IEA:Ensembl
Q04743	EMX2	Homeobox protein EMX2	GO:0030182; P:neuron differentiation; IEA:Ensembl
Q04743	EMX2	Homeobox protein EMX2	GO:0072001; P:renal system development; IEA:Ensembl
Q04743	EMX2	Homeobox protein EMX2	GO:0042493; P:response to drug; IEA:Ensembl
Q8N8S7	ENAH	Protein enabled homolog	GO:0005515; F:protein binding; IPI:IntAct
Q8N8S7	ENAH	Protein enabled homolog	GO:0050699; F:WW domain binding; IPI:UniProtKB
Q8N8S7	ENAH	Protein enabled homolog	GO:0008154; P:actin polymerization or depolymerization; IEA:Ensembl
Q8N8S7	ENAH	Protein enabled homolog	GO:0007411; P:axon guidance; TAS:Reactome
Q8N8S7	ENAH	Protein enabled homolog	GO:0046907; P:intracellular transport; IEA:InterPro
Q8N8S7	ENAH	Protein enabled homolog	GO:0001843; P:neural tube closure; IEA:Ensembl
Q8N8S7	ENAH	Protein enabled homolog	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q9NRM1	ENAM	Enamelin	GO:0097186; P:amelogenesis; IEA:Ensembl
Q9NRM1	ENAM	Enamelin	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
Q8NFI3	ENGASE	Cytosolic endo-beta-N-acetylglucosaminidase	GO:0033925; F:mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity; IEA:UniProtKB-EC
O14682	ENC1	Ectoderm-neural cortex protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
O14682	ENC1	Ectoderm-neural cortex protein 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
O14682	ENC1	Ectoderm-neural cortex protein 1	GO:0017148; P:negative regulation of translation; IDA:UniProtKB
O14682	ENC1	Ectoderm-neural cortex protein 1	GO:0007399; P:nervous system development; TAS:ProtInc
O14682	ENC1	Ectoderm-neural cortex protein 1	GO:0010499; P:proteasomal ubiquitin-independent protein catabolic process; IDA:UniProtKB
O14682	ENC1	Ectoderm-neural cortex protein 1	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
O94919	ENDOD1	Endonuclease domain-containing 1 protein	GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW
O94919	ENDOD1	Endonuclease domain-containing 1 protein	GO:0046872; F:metal ion binding; IEA:InterPro
O94919	ENDOD1	Endonuclease domain-containing 1 protein	GO:0003676; F:nucleic acid binding; IEA:InterPro
P21128	ENDOU	Poly(U)-specific endoribonuclease	GO:0004521; F:endoribonuclease activity; IDA:UniProtKB
P21128	ENDOU	Poly(U)-specific endoribonuclease	GO:0008083; F:growth factor activity; NAS:UniProtKB
P21128	ENDOU	Poly(U)-specific endoribonuclease	GO:0030145; F:manganese ion binding; TAS:UniProtKB
P21128	ENDOU	Poly(U)-specific endoribonuclease	GO:0030247; F:polysaccharide binding; IEA:InterPro
P21128	ENDOU	Poly(U)-specific endoribonuclease	GO:0003723; F:RNA binding; IDA:UniProtKB
P21128	ENDOU	Poly(U)-specific endoribonuclease	GO:0005044; F:scavenger receptor activity; IEA:InterPro
P21128	ENDOU	Poly(U)-specific endoribonuclease	GO:0008236; F:serine-type peptidase activity; IDA:UniProtKB
P21128	ENDOU	Poly(U)-specific endoribonuclease	GO:0007565; P:female pregnancy; IEP:UniProtKB
P21128	ENDOU	Poly(U)-specific endoribonuclease	GO:0006955; P:immune response; IEA:InterPro
P21128	ENDOU	Poly(U)-specific endoribonuclease	GO:0006508; P:proteolysis; IDA:UniProtKB
P21128	ENDOU	Poly(U)-specific endoribonuclease	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; IDA:GOC
Q8N8Q3	ENDOV	Endonuclease V	GO:0016888; F:endodeoxyribonuclease activity, producing 5'-phosphomonoesters; ISS:UniProtKB
Q8N8Q3	ENDOV	Endonuclease V	GO:0016891; F:endoribonuclease activity, producing 5'-phosphomonoesters; IDA:UniProtKB
Q8N8Q3	ENDOV	Endonuclease V	GO:0000287; F:magnesium ion binding; ISS:UniProtKB
Q8N8Q3	ENDOV	Endonuclease V	GO:0003727; F:single-stranded RNA binding; IDA:UniProtKB
Q8N8Q3	ENDOV	Endonuclease V	GO:0043566; F:structure-specific DNA binding; IDA:UniProtKB
Q8N8Q3	ENDOV	Endonuclease V	GO:0000737; P:DNA catabolic process, endonucleolytic; ISS:GOC
Q8N8Q3	ENDOV	Endonuclease V	GO:0006281; P:DNA repair; ISS:UniProtKB
Q8N8Q3	ENDOV	Endonuclease V	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; IDA:GOC
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
Q69384	ERVK6	HERV-K_7p22.1 provirus ancestral Env polyprotein	GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
Q03111	MLLT1	Protein ENL	GO:0003677; F:DNA binding; TAS:ProtInc
Q03111	MLLT1	Protein ENL	GO:0005515; F:protein binding; IPI:IntAct
Q03111	MLLT1	Protein ENL	GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl
Q03111	MLLT1	Protein ENL	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q03111	MLLT1	Protein ENL	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
A6NNW6	ENO4	Enolase-like protein ENO4	GO:0000287; F:magnesium ion binding; IEA:InterPro
A6NNW6	ENO4	Enolase-like protein ENO4	GO:0004634; F:phosphopyruvate hydratase activity; IEA:InterPro
A6NNW6	ENO4	Enolase-like protein ENO4	GO:0006096; P:glycolytic process; IEA:InterPro
P06733	ENO1	Alpha-enolase	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P06733	ENO1	Alpha-enolase	GO:0000287; F:magnesium ion binding; IEA:InterPro
P06733	ENO1	Alpha-enolase	GO:0004634; F:phosphopyruvate hydratase activity; TAS:ProtInc
P06733	ENO1	Alpha-enolase	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P06733	ENO1	Alpha-enolase	GO:0005515; F:protein binding; IPI:UniProtKB
P06733	ENO1	Alpha-enolase	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P06733	ENO1	Alpha-enolase	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
P06733	ENO1	Alpha-enolase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P06733	ENO1	Alpha-enolase	GO:0006094; P:gluconeogenesis; TAS:Reactome
P06733	ENO1	Alpha-enolase	GO:0006006; P:glucose metabolic process; TAS:Reactome
P06733	ENO1	Alpha-enolase	GO:0006096; P:glycolytic process; TAS:Reactome
P06733	ENO1	Alpha-enolase	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
P06733	ENO1	Alpha-enolase	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P06733	ENO1	Alpha-enolase	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P06733	ENO1	Alpha-enolase	GO:0009615; P:response to virus; IEP:UniProtKB
P06733	ENO1	Alpha-enolase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P06733	ENO1	Alpha-enolase	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P13929	ENO3	Beta-enolase	GO:0000287; F:magnesium ion binding; IEA:InterPro
P13929	ENO3	Beta-enolase	GO:0004634; F:phosphopyruvate hydratase activity; TAS:ProtInc
P13929	ENO3	Beta-enolase	GO:0007568; P:aging; IEA:Ensembl
P13929	ENO3	Beta-enolase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P13929	ENO3	Beta-enolase	GO:0006094; P:gluconeogenesis; TAS:Reactome
P13929	ENO3	Beta-enolase	GO:0006006; P:glucose metabolic process; TAS:Reactome
P13929	ENO3	Beta-enolase	GO:0006096; P:glycolytic process; TAS:Reactome
P13929	ENO3	Beta-enolase	GO:0042493; P:response to drug; IEA:Ensembl
P13929	ENO3	Beta-enolase	GO:0043403; P:skeletal muscle tissue regeneration; IEA:Ensembl
P13929	ENO3	Beta-enolase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q7L5Y1	ENOSF1	Mitochondrial enolase superfamily member 1	GO:0016853; F:isomerase activity; IEA:UniProtKB-KW
Q7L5Y1	ENOSF1	Mitochondrial enolase superfamily member 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7L5Y1	ENOSF1	Mitochondrial enolase superfamily member 1	GO:0009063; P:cellular amino acid catabolic process; IEA:InterPro
P09104	ENO2	Gamma-enolase	GO:0000287; F:magnesium ion binding; IEA:InterPro
P09104	ENO2	Gamma-enolase	GO:0004634; F:phosphopyruvate hydratase activity; TAS:ProtInc
P09104	ENO2	Gamma-enolase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P09104	ENO2	Gamma-enolase	GO:0006094; P:gluconeogenesis; TAS:Reactome
P09104	ENO2	Gamma-enolase	GO:0006006; P:glucose metabolic process; TAS:Reactome
P09104	ENO2	Gamma-enolase	GO:0006096; P:glycolytic process; TAS:Reactome
P09104	ENO2	Gamma-enolase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UHY7	ENOPH1	Enolase-phosphatase E1	GO:0043874; F:acireductone synthase activity; IDA:UniProtKB
Q9UHY7	ENOPH1	Enolase-phosphatase E1	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q9UHY7	ENOPH1	Enolase-phosphatase E1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9UHY7	ENOPH1	Enolase-phosphatase E1	GO:0016311; P:dephosphorylation; IDA:GOC
Q9UHY7	ENOPH1	Enolase-phosphatase E1	GO:0019509; P:L-methionine salvage from methylthioadenosine; IDA:UniProtKB
Q9UHY7	ENOPH1	Enolase-phosphatase E1	GO:0006595; P:polyamine metabolic process; TAS:Reactome
Q9UHY7	ENOPH1	Enolase-phosphatase E1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UHY7	ENOPH1	Enolase-phosphatase E1	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
Q8TC92	ENOX1	Ecto-NOX disulfide-thiol exchanger 1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8TC92	ENOX1	Ecto-NOX disulfide-thiol exchanger 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8TC92	ENOX1	Ecto-NOX disulfide-thiol exchanger 1	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q8TC92	ENOX1	Ecto-NOX disulfide-thiol exchanger 1	GO:0048511; P:rhythmic process; IEA:UniProtKB-KW
Q16206	ENOX2	Ecto-NOX disulfide-thiol exchanger 2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q16206	ENOX2	Ecto-NOX disulfide-thiol exchanger 2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q16206	ENOX2	Ecto-NOX disulfide-thiol exchanger 2	GO:0015035; F:protein disulfide oxidoreductase activity; IDA:UniProtKB
Q16206	ENOX2	Ecto-NOX disulfide-thiol exchanger 2	GO:0016049; P:cell growth; NAS:UniProtKB
Q16206	ENOX2	Ecto-NOX disulfide-thiol exchanger 2	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q16206	ENOX2	Ecto-NOX disulfide-thiol exchanger 2	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q16206	ENOX2	Ecto-NOX disulfide-thiol exchanger 2	GO:0007624; P:ultradian rhythm; IDA:UniProtKB
Q58FF3	HSP90B2P	Putative endoplasmin-like protein	GO:0005524; F:ATP binding; IEA:InterPro
Q58FF3	HSP90B2P	Putative endoplasmin-like protein	GO:0006457; P:protein folding; IEA:InterPro
Q58FF3	HSP90B2P	Putative endoplasmin-like protein	GO:0006950; P:response to stress; IEA:UniProtKB-KW
P14625	HSP90B1	Endoplasmin	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P14625	HSP90B1	Endoplasmin	GO:0005509; F:calcium ion binding; TAS:UniProtKB
P14625	HSP90B1	Endoplasmin	GO:0050750; F:low-density lipoprotein particle receptor binding; IDA:MGI
P14625	HSP90B1	Endoplasmin	GO:0005515; F:protein binding; IPI:UniProtKB
P14625	HSP90B1	Endoplasmin	GO:0019903; F:protein phosphatase binding; IDA:MGI
P14625	HSP90B1	Endoplasmin	GO:0003723; F:RNA binding; IDA:UniProtKB
P14625	HSP90B1	Endoplasmin	GO:0046790; F:virion binding; IPI:UniProtKB
P14625	HSP90B1	Endoplasmin	GO:0031247; P:actin rod assembly; IDA:MGI
P14625	HSP90B1	Endoplasmin	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P14625	HSP90B1	Endoplasmin	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P14625	HSP90B1	Endoplasmin	GO:0071318; P:cellular response to ATP; IDA:MGI
P14625	HSP90B1	Endoplasmin	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P14625	HSP90B1	Endoplasmin	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
P14625	HSP90B1	Endoplasmin	GO:0045087; P:innate immune response; TAS:Reactome
P14625	HSP90B1	Endoplasmin	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P14625	HSP90B1	Endoplasmin	GO:0006457; P:protein folding; IEA:InterPro
P14625	HSP90B1	Endoplasmin	GO:0015031; P:protein transport; NAS:UniProtKB
P14625	HSP90B1	Endoplasmin	GO:0043666; P:regulation of phosphoprotein phosphatase activity; IDA:MGI
P14625	HSP90B1	Endoplasmin	GO:0001666; P:response to hypoxia; IDA:UniProtKB
P14625	HSP90B1	Endoplasmin	GO:0051208; P:sequestering of calcium ion; NAS:UniProtKB
P14625	HSP90B1	Endoplasmin	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0050656; F:3'-phosphoadenosine 5'-phosphosulfate binding; IC:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0005524; F:ATP binding; IDA:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0005509; F:calcium ion binding; ISS:UniProtKB
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0005158; F:insulin receptor binding; IDA:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0035529; F:NADH pyrophosphatase activity; IEA:UniProtKB-EC
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0003676; F:nucleic acid binding; IEA:InterPro
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0047429; F:nucleoside-triphosphate diphosphatase activity; IDA:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0004551; F:nucleotide diphosphatase activity; IDA:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0004528; F:phosphodiesterase I activity; ISS:UniProtKB
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0030247; F:polysaccharide binding; IEA:InterPro
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0005515; F:protein binding; IPI:IntAct
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0005044; F:scavenger receptor activity; IEA:InterPro
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0008270; F:zinc ion binding; ISS:UniProtKB
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; IDA:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0006200; P:ATP catabolic process; ISS:UniProtKB
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0046849; P:bone remodeling; IEA:Ensembl
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0030643; P:cellular phosphate ion homeostasis; IDA:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0032869; P:cellular response to insulin stimulus; IDA:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0006091; P:generation of precursor metabolites and energy; IDA:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0006955; P:immune response; IEA:InterPro
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0030505; P:inorganic diphosphate transport; IDA:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0030308; P:negative regulation of cell growth; IDA:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0045599; P:negative regulation of fat cell differentiation; IDA:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0046325; P:negative regulation of glucose import; IDA:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0045719; P:negative regulation of glycogen biosynthetic process; IDA:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0046627; P:negative regulation of insulin receptor signaling pathway; IDA:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0030279; P:negative regulation of ossification; IEA:Ensembl
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0031953; P:negative regulation of protein autophosphorylation; IDA:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; ISS:GOC
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0009143; P:nucleoside triphosphate catabolic process; IDA:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0006796; P:phosphate-containing compound metabolic process; IDA:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0030500; P:regulation of bone mineralization; IC:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0006771; P:riboflavin metabolic process; TAS:Reactome
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0030730; P:sequestering of triglyceride; IDA:BHF-UCL
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P22413	ENPP1	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q13822	ENPP2	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	GO:0047391; F:alkylglycerophosphoethanolamine phosphodiesterase activity; IEA:UniProtKB-EC
Q13822	ENPP2	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	GO:0005509; F:calcium ion binding; ISS:UniProtKB
Q13822	ENPP2	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	GO:0016787; F:hydrolase activity; TAS:UniProtKB
Q13822	ENPP2	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	GO:0004622; F:lysophospholipase activity; IDA:UniProtKB
Q13822	ENPP2	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q13822	ENPP2	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	GO:0004551; F:nucleotide diphosphatase activity; TAS:ProtInc
Q13822	ENPP2	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	GO:0004528; F:phosphodiesterase I activity; TAS:ProtInc
Q13822	ENPP2	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	GO:0030247; F:polysaccharide binding; IEA:InterPro
Q13822	ENPP2	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	GO:0005044; F:scavenger receptor activity; IEA:InterPro
Q13822	ENPP2	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	GO:0008134; F:transcription factor binding; TAS:ProtInc
Q13822	ENPP2	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	GO:0008270; F:zinc ion binding; ISS:UniProtKB
Q13822	ENPP2	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	GO:0006928; P:cellular component movement; TAS:ProtInc
Q13822	ENPP2	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	GO:0006935; P:chemotaxis; NAS:UniProtKB
Q13822	ENPP2	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q13822	ENPP2	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	GO:0006955; P:immune response; IEA:InterPro
Q13822	ENPP2	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; TAS:GOC
Q13822	ENPP2	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	GO:0006796; P:phosphate-containing compound metabolic process; TAS:ProtInc
Q13822	ENPP2	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	GO:0034638; P:phosphatidylcholine catabolic process; IDA:UniProtKB
Q13822	ENPP2	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	GO:0009395; P:phospholipid catabolic process; IDA:UniProt
Q13822	ENPP2	Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	GO:0030334; P:regulation of cell migration; IDA:UniProtKB
O14638	ENPP3	Ectonucleotide pyrophosphatase/phosphodiesterase family member 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14638	ENPP3	Ectonucleotide pyrophosphatase/phosphodiesterase family member 3	GO:0035529; F:NADH pyrophosphatase activity; IEA:UniProtKB-EC
O14638	ENPP3	Ectonucleotide pyrophosphatase/phosphodiesterase family member 3	GO:0003676; F:nucleic acid binding; IEA:InterPro
O14638	ENPP3	Ectonucleotide pyrophosphatase/phosphodiesterase family member 3	GO:0047429; F:nucleoside-triphosphate diphosphatase activity; IDA:BHF-UCL
O14638	ENPP3	Ectonucleotide pyrophosphatase/phosphodiesterase family member 3	GO:0004551; F:nucleotide diphosphatase activity; TAS:ProtInc
O14638	ENPP3	Ectonucleotide pyrophosphatase/phosphodiesterase family member 3	GO:0004528; F:phosphodiesterase I activity; TAS:ProtInc
O14638	ENPP3	Ectonucleotide pyrophosphatase/phosphodiesterase family member 3	GO:0030247; F:polysaccharide binding; IEA:InterPro
O14638	ENPP3	Ectonucleotide pyrophosphatase/phosphodiesterase family member 3	GO:0005044; F:scavenger receptor activity; IEA:InterPro
O14638	ENPP3	Ectonucleotide pyrophosphatase/phosphodiesterase family member 3	GO:0006955; P:immune response; IEA:InterPro
O14638	ENPP3	Ectonucleotide pyrophosphatase/phosphodiesterase family member 3	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; TAS:GOC
O14638	ENPP3	Ectonucleotide pyrophosphatase/phosphodiesterase family member 3	GO:0009143; P:nucleoside triphosphate catabolic process; IDA:BHF-UCL
O14638	ENPP3	Ectonucleotide pyrophosphatase/phosphodiesterase family member 3	GO:0006796; P:phosphate-containing compound metabolic process; IDA:BHF-UCL
Q9Y6X5	ENPP4	Bis(5'-adenosyl)-triphosphatase ENPP4	GO:0047710; F:bis(5'-adenosyl)-triphosphatase activity; IDA:UniProt
Q9Y6X5	ENPP4	Bis(5'-adenosyl)-triphosphatase ENPP4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y6X5	ENPP4	Bis(5'-adenosyl)-triphosphatase ENPP4	GO:0007596; P:blood coagulation; IEA:UniProtKB-KW
Q9Y6X5	ENPP4	Bis(5'-adenosyl)-triphosphatase ENPP4	GO:0030194; P:positive regulation of blood coagulation; IDA:UniProt
Q9Y6X5	ENPP4	Bis(5'-adenosyl)-triphosphatase ENPP4	GO:0046130; P:purine ribonucleoside catabolic process; IDA:UniProt
Q9UJA9	ENPP5	Ectonucleotide pyrophosphatase/phosphodiesterase family member 5	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q9UJA9	ENPP5	Ectonucleotide pyrophosphatase/phosphodiesterase family member 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UJA9	ENPP5	Ectonucleotide pyrophosphatase/phosphodiesterase family member 5	GO:0007154; P:cell communication; IEA:Ensembl
Q6UWR7	ENPP6	Ectonucleotide pyrophosphatase/phosphodiesterase family member 6	GO:0047390; F:glycerophosphocholine cholinephosphodiesterase activity; IDA:UniProtKB
Q6UWR7	ENPP6	Ectonucleotide pyrophosphatase/phosphodiesterase family member 6	GO:0008889; F:glycerophosphodiester phosphodiesterase activity; IEA:Ensembl
Q6UWR7	ENPP6	Ectonucleotide pyrophosphatase/phosphodiesterase family member 6	GO:0008081; F:phosphoric diester hydrolase activity; IDA:UniProtKB
Q6UWR7	ENPP6	Ectonucleotide pyrophosphatase/phosphodiesterase family member 6	GO:0019695; P:choline metabolic process; IDA:UniProtKB
Q6UWR7	ENPP6	Ectonucleotide pyrophosphatase/phosphodiesterase family member 6	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q6UWR7	ENPP6	Ectonucleotide pyrophosphatase/phosphodiesterase family member 6	GO:0006629; P:lipid metabolic process; IDA:UniProtKB
Q6UWV6	ENPP7	Ectonucleotide pyrophosphatase/phosphodiesterase family member 7	GO:0004767; F:sphingomyelin phosphodiesterase activity; IDA:UniProtKB
Q6UWV6	ENPP7	Ectonucleotide pyrophosphatase/phosphodiesterase family member 7	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
Q6UWV6	ENPP7	Ectonucleotide pyrophosphatase/phosphodiesterase family member 7	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q6UWV6	ENPP7	Ectonucleotide pyrophosphatase/phosphodiesterase family member 7	GO:0008156; P:negative regulation of DNA replication; IDA:UniProtKB
Q6UWV6	ENPP7	Ectonucleotide pyrophosphatase/phosphodiesterase family member 7	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6UWV6	ENPP7	Ectonucleotide pyrophosphatase/phosphodiesterase family member 7	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q6UWV6	ENPP7	Ectonucleotide pyrophosphatase/phosphodiesterase family member 7	GO:0006684; P:sphingomyelin metabolic process; IDA:UniProtKB
O43768	ENSA	Alpha-endosulfine	GO:0008200; F:ion channel inhibitor activity; TAS:ProtInc
O43768	ENSA	Alpha-endosulfine	GO:0019212; F:phosphatase inhibitor activity; ISS:UniProtKB
O43768	ENSA	Alpha-endosulfine	GO:0051721; F:protein phosphatase 2A binding; ISS:UniProtKB
O43768	ENSA	Alpha-endosulfine	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
O43768	ENSA	Alpha-endosulfine	GO:0008601; F:protein phosphatase type 2A regulator activity; ISS:UniProtKB
O43768	ENSA	Alpha-endosulfine	GO:0005102; F:receptor binding; TAS:ProtInc
O43768	ENSA	Alpha-endosulfine	GO:0000086; P:G2/M transition of mitotic cell cycle; ISS:UniProtKB
O43768	ENSA	Alpha-endosulfine	GO:0007067; P:mitosis; ISS:UniProtKB
O43768	ENSA	Alpha-endosulfine	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O43768	ENSA	Alpha-endosulfine	GO:0043086; P:negative regulation of catalytic activity; ISS:GOC
O43768	ENSA	Alpha-endosulfine	GO:0050790; P:regulation of catalytic activity; ISS:GOC
O43768	ENSA	Alpha-endosulfine	GO:0009749; P:response to glucose; IEA:Ensembl
O43768	ENSA	Alpha-endosulfine	GO:0007584; P:response to nutrient; TAS:ProtInc
O43768	ENSA	Alpha-endosulfine	GO:0006810; P:transport; TAS:ProtInc
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0019058; P:viral life cycle; IEA:InterPro
P98073	TMPRSS15	Enteropeptidase	GO:0005044; F:scavenger receptor activity; IEA:InterPro
P98073	TMPRSS15	Enteropeptidase	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
P49961	ENTPD1	Ectonucleoside triphosphate diphosphohydrolase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49961	ENTPD1	Ectonucleoside triphosphate diphosphohydrolase 1	GO:0017110; F:nucleoside-diphosphatase activity; IEA:Ensembl
P49961	ENTPD1	Ectonucleoside triphosphate diphosphohydrolase 1	GO:0017111; F:nucleoside-triphosphatase activity; IEA:Ensembl
P49961	ENTPD1	Ectonucleoside triphosphate diphosphohydrolase 1	GO:0005515; F:protein binding; IPI:IntAct
P49961	ENTPD1	Ectonucleoside triphosphate diphosphohydrolase 1	GO:0006200; P:ATP catabolic process; IEA:Ensembl
P49961	ENTPD1	Ectonucleoside triphosphate diphosphohydrolase 1	GO:0007596; P:blood coagulation; TAS:ProtInc
P49961	ENTPD1	Ectonucleoside triphosphate diphosphohydrolase 1	GO:0007155; P:cell adhesion; NAS:ProtInc
P49961	ENTPD1	Ectonucleoside triphosphate diphosphohydrolase 1	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:Ensembl
P49961	ENTPD1	Ectonucleoside triphosphate diphosphohydrolase 1	GO:0030168; P:platelet activation; IEA:Ensembl
P49961	ENTPD1	Ectonucleoside triphosphate diphosphohydrolase 1	GO:0009181; P:purine ribonucleoside diphosphate catabolic process; IEA:Ensembl
Q9Y5L3	ENTPD2	Ectonucleoside triphosphate diphosphohydrolase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y5L3	ENTPD2	Ectonucleoside triphosphate diphosphohydrolase 2	GO:0017110; F:nucleoside-diphosphatase activity; IEA:Ensembl
Q9Y5L3	ENTPD2	Ectonucleoside triphosphate diphosphohydrolase 2	GO:0017111; F:nucleoside-triphosphatase activity; IEA:Ensembl
Q9Y5L3	ENTPD2	Ectonucleoside triphosphate diphosphohydrolase 2	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:Ensembl
Q9Y5L3	ENTPD2	Ectonucleoside triphosphate diphosphohydrolase 2	GO:0030168; P:platelet activation; IEA:Ensembl
Q9Y5L3	ENTPD2	Ectonucleoside triphosphate diphosphohydrolase 2	GO:0009181; P:purine ribonucleoside diphosphate catabolic process; IEA:Ensembl
O75355	ENTPD3	Ectonucleoside triphosphate diphosphohydrolase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75355	ENTPD3	Ectonucleoside triphosphate diphosphohydrolase 3	GO:0017110; F:nucleoside-diphosphatase activity; IEA:Ensembl
O75355	ENTPD3	Ectonucleoside triphosphate diphosphohydrolase 3	GO:0017111; F:nucleoside-triphosphatase activity; IEA:Ensembl
O75355	ENTPD3	Ectonucleoside triphosphate diphosphohydrolase 3	GO:0009134; P:nucleoside diphosphate catabolic process; IEA:Ensembl
O75355	ENTPD3	Ectonucleoside triphosphate diphosphohydrolase 3	GO:0009143; P:nucleoside triphosphate catabolic process; IEA:Ensembl
Q9Y227	ENTPD4	Ectonucleoside triphosphate diphosphohydrolase 4	GO:0045134; F:uridine-diphosphatase activity; IDA:UniProtKB
Q9Y227	ENTPD4	Ectonucleoside triphosphate diphosphohydrolase 4	GO:0006256; P:UDP catabolic process; IDA:UniProtKB
O75356	ENTPD5	Ectonucleoside triphosphate diphosphohydrolase 5	GO:0004382; F:guanosine-diphosphatase activity; ISS:UniProtKB
O75356	ENTPD5	Ectonucleoside triphosphate diphosphohydrolase 5	GO:0045134; F:uridine-diphosphatase activity; ISS:UniProtKB
O75356	ENTPD5	Ectonucleoside triphosphate diphosphohydrolase 5	GO:0051084; P:'de novo' posttranslational protein folding; ISS:UniProtKB
O75356	ENTPD5	Ectonucleoside triphosphate diphosphohydrolase 5	GO:0046034; P:ATP metabolic process; ISS:UniProtKB
O75356	ENTPD5	Ectonucleoside triphosphate diphosphohydrolase 5	GO:0016049; P:cell growth; ISS:UniProtKB
O75356	ENTPD5	Ectonucleoside triphosphate diphosphohydrolase 5	GO:0008283; P:cell proliferation; ISS:UniProtKB
O75356	ENTPD5	Ectonucleoside triphosphate diphosphohydrolase 5	GO:0006096; P:glycolytic process; IEA:Ensembl
O75356	ENTPD5	Ectonucleoside triphosphate diphosphohydrolase 5	GO:0045821; P:positive regulation of glycolytic process; ISS:UniProtKB
O75356	ENTPD5	Ectonucleoside triphosphate diphosphohydrolase 5	GO:0006487; P:protein N-linked glycosylation; ISS:UniProtKB
O75356	ENTPD5	Ectonucleoside triphosphate diphosphohydrolase 5	GO:0014066; P:regulation of phosphatidylinositol 3-kinase signaling; ISS:UniProtKB
O75354	ENTPD6	Ectonucleoside triphosphate diphosphohydrolase 6	GO:0008894; F:guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity; IEA:Ensembl
O75354	ENTPD6	Ectonucleoside triphosphate diphosphohydrolase 6	GO:0017111; F:nucleoside-triphosphatase activity; IEA:Ensembl
O75354	ENTPD6	Ectonucleoside triphosphate diphosphohydrolase 6	GO:0045134; F:uridine-diphosphatase activity; IEA:UniProtKB-EC
O75354	ENTPD6	Ectonucleoside triphosphate diphosphohydrolase 6	GO:0051592; P:response to calcium ion; IEA:Ensembl
O75354	ENTPD6	Ectonucleoside triphosphate diphosphohydrolase 6	GO:0032026; P:response to magnesium ion; IEA:Ensembl
Q9NQZ7	ENTPD7	Ectonucleoside triphosphate diphosphohydrolase 7	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q9NQZ7	ENTPD7	Ectonucleoside triphosphate diphosphohydrolase 7	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5MY95	ENTPD8	Ectonucleoside triphosphate diphosphohydrolase 8	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5MY95	ENTPD8	Ectonucleoside triphosphate diphosphohydrolase 8	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5MY95	ENTPD8	Ectonucleoside triphosphate diphosphohydrolase 8	GO:0017110; F:nucleoside-diphosphatase activity; IEA:Ensembl
Q5MY95	ENTPD8	Ectonucleoside triphosphate diphosphohydrolase 8	GO:0017111; F:nucleoside-triphosphatase activity; IEA:Ensembl
Q5MY95	ENTPD8	Ectonucleoside triphosphate diphosphohydrolase 8	GO:0009133; P:nucleoside diphosphate biosynthetic process; IEA:Ensembl
Q5MY95	ENTPD8	Ectonucleoside triphosphate diphosphohydrolase 8	GO:0009124; P:nucleoside monophosphate biosynthetic process; IEA:Ensembl
Q9UQF0	ERVW-1	HERV-W_7q21.2 provirus ancestral Env polyprotein	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q9UQF0	ERVW-1	HERV-W_7q21.2 provirus ancestral Env polyprotein	GO:0006949; P:syncytium formation; TAS:ProtInc
Q9NPA8	ENY2	Transcription and mRNA export factor ENY2	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IDA:UniProtKB
Q9NPA8	ENY2	Transcription and mRNA export factor ENY2	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q9NPA8	ENY2	Transcription and mRNA export factor ENY2	GO:0006325; P:chromatin organization; TAS:Reactome
Q9NPA8	ENY2	Transcription and mRNA export factor ENY2	GO:0016578; P:histone deubiquitination; IDA:UniProtKB
Q9NPA8	ENY2	Transcription and mRNA export factor ENY2	GO:0006406; P:mRNA export from nucleus; IEA:UniProtKB-HAMAP
Q9NPA8	ENY2	Transcription and mRNA export factor ENY2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9NPA8	ENY2	Transcription and mRNA export factor ENY2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9NPA8	ENY2	Transcription and mRNA export factor ENY2	GO:0006368; P:transcription elongation from RNA polymerase II promoter; IEA:UniProtKB-HAMAP
Q5NDL2	EOGT	EGF domain-specific O-linked N-acetylglucosamine transferase	GO:0016262; F:protein N-acetylglucosaminyltransferase activity; ISS:UniProtKB
Q5NDL2	EOGT	EGF domain-specific O-linked N-acetylglucosamine transferase	GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW
Q5NDL2	EOGT	EGF domain-specific O-linked N-acetylglucosamine transferase	GO:0006493; P:protein O-linked glycosylation; ISS:UniProtKB
O95936	EOMES	Eomesodermin homolog	GO:0003682; F:chromatin binding; IEA:Ensembl
O95936	EOMES	Eomesodermin homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O95936	EOMES	Eomesodermin homolog	GO:0001102; F:RNA polymerase II activating transcription factor binding; ISS:BHF-UCL
O95936	EOMES	Eomesodermin homolog	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl
O95936	EOMES	Eomesodermin homolog	GO:0001191; F:RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription; ISS:BHF-UCL
O95936	EOMES	Eomesodermin homolog	GO:0043565; F:sequence-specific DNA binding; IDA:MGI
O95936	EOMES	Eomesodermin homolog	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O95936	EOMES	Eomesodermin homolog	GO:0007420; P:brain development; IMP:UniProtKB
O95936	EOMES	Eomesodermin homolog	GO:0010002; P:cardioblast differentiation; IEA:Ensembl
O95936	EOMES	Eomesodermin homolog	GO:0002302; P:CD8-positive, alpha-beta T cell differentiation involved in immune response; IMP:UniProtKB
O95936	EOMES	Eomesodermin homolog	GO:0060706; P:cell differentiation involved in embryonic placenta development; ISS:UniProtKB
O95936	EOMES	Eomesodermin homolog	GO:0021895; P:cerebral cortex neuron differentiation; IEA:Ensembl
O95936	EOMES	Eomesodermin homolog	GO:0021796; P:cerebral cortex regionalization; IEA:Ensembl
O95936	EOMES	Eomesodermin homolog	GO:0001706; P:endoderm formation; ISS:UniProtKB
O95936	EOMES	Eomesodermin homolog	GO:0001714; P:endodermal cell fate specification; IEA:Ensembl
O95936	EOMES	Eomesodermin homolog	GO:0032609; P:interferon-gamma production; IEA:Ensembl
O95936	EOMES	Eomesodermin homolog	GO:0001707; P:mesoderm formation; ISS:UniProtKB
O95936	EOMES	Eomesodermin homolog	GO:0060809; P:mesodermal to mesenchymal transition involved in gastrulation; ISS:UniProtKB
O95936	EOMES	Eomesodermin homolog	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
O95936	EOMES	Eomesodermin homolog	GO:0021772; P:olfactory bulb development; IEA:Ensembl
O95936	EOMES	Eomesodermin homolog	GO:0045597; P:positive regulation of cell differentiation; IEA:Ensembl
O95936	EOMES	Eomesodermin homolog	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
O95936	EOMES	Eomesodermin homolog	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
O95936	EOMES	Eomesodermin homolog	GO:0045664; P:regulation of neuron differentiation; IEA:Ensembl
O95936	EOMES	Eomesodermin homolog	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
O95936	EOMES	Eomesodermin homolog	GO:0019827; P:stem cell maintenance; IEA:Ensembl
O95936	EOMES	Eomesodermin homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95936	EOMES	Eomesodermin homolog	GO:0001829; P:trophectodermal cell differentiation; IEA:Ensembl
Q9UBC2	EPS15L1	Epidermal growth factor receptor substrate 15-like 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UBC2	EPS15L1	Epidermal growth factor receptor substrate 15-like 1	GO:0005515; F:protein binding; IPI:IntAct
Q9UBC2	EPS15L1	Epidermal growth factor receptor substrate 15-like 1	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q9UBC2	EPS15L1	Epidermal growth factor receptor substrate 15-like 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q9UBC2	EPS15L1	Epidermal growth factor receptor substrate 15-like 1	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
Q09472	EP300	Histone acetyltransferase p300	GO:0016407; F:acetyltransferase activity; IDA:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0033613; F:activating transcription factor binding; IPI:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0050681; F:androgen receptor binding; IPI:BHF-UCL
Q09472	EP300	Histone acetyltransferase p300	GO:0003823; F:antigen binding; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0008013; F:beta-catenin binding; IPI:BHF-UCL
Q09472	EP300	Histone acetyltransferase p300	GO:0003682; F:chromatin binding; IMP:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0031490; F:chromatin DNA binding; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0001047; F:core promoter binding; IDA:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0003677; F:DNA binding; IDA:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0004402; F:histone acetyltransferase activity; IDA:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0004468; F:lysine N-acetyltransferase activity; IDA:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0035257; F:nuclear hormone receptor binding; IPI:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0005515; F:protein binding; IPI:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
Q09472	EP300	Histone acetyltransferase p300	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0016746; F:transferase activity, transferring acyl groups; IDA:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0008270; F:zinc ion binding; IEA:InterPro
Q09472	EP300	Histone acetyltransferase p300	GO:0006915; P:apoptotic process; IMP:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
Q09472	EP300	Histone acetyltransferase p300	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0006325; P:chromatin organization; TAS:Reactome
Q09472	EP300	Histone acetyltransferase p300	GO:0048565; P:digestive tract development; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q09472	EP300	Histone acetyltransferase p300	GO:0007507; P:heart development; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0043969; P:histone H2B acetylation; IDA:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0043967; P:histone H4 acetylation; IMP:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0045087; P:innate immune response; TAS:Reactome
Q09472	EP300	Histone acetyltransferase p300	GO:0018393; P:internal peptidyl-lysine acetylation; IDA:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0006475; P:internal protein amino acid acetylation; IDA:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IDA:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0001889; P:liver development; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0030324; P:lung development; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q09472	EP300	Histone acetyltransferase p300	GO:0018076; P:N-terminal peptidyl-lysine acetylation; IDA:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0007399; P:nervous system development; TAS:ProtInc
Q09472	EP300	Histone acetyltransferase p300	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q09472	EP300	Histone acetyltransferase p300	GO:0009887; P:organ morphogenesis; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0043923; P:positive regulation by host of viral transcription; IDA:BHF-UCL
Q09472	EP300	Histone acetyltransferase p300	GO:0045773; P:positive regulation of axon extension; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0010942; P:positive regulation of cell death; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0045793; P:positive regulation of cell size; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0032967; P:positive regulation of collagen biosynthetic process; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0043388; P:positive regulation of DNA binding; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0010560; P:positive regulation of glycoprotein biosynthetic process; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0032092; P:positive regulation of protein binding; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0033160; P:positive regulation of protein import into nucleus, translocation; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0050714; P:positive regulation of protein secretion; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0045862; P:positive regulation of proteolysis; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0060298; P:positive regulation of sarcomere organization; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0045727; P:positive regulation of translation; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q09472	EP300	Histone acetyltransferase p300	GO:0043491; P:protein kinase B signaling; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0065004; P:protein-DNA complex assembly; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0060765; P:regulation of androgen receptor signaling pathway; IDA:BHF-UCL
Q09472	EP300	Histone acetyltransferase p300	GO:0060177; P:regulation of angiotensin metabolic process; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0051726; P:regulation of cell cycle; TAS:Reactome
Q09472	EP300	Histone acetyltransferase p300	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
Q09472	EP300	Histone acetyltransferase p300	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0090043; P:regulation of tubulin deacetylation; IDA:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0051592; P:response to calcium ion; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0032025; P:response to cobalt ion; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0042493; P:response to drug; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0043627; P:response to estrogen; IDA:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0045471; P:response to ethanol; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0070542; P:response to fatty acid; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0009749; P:response to glucose; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0001666; P:response to hypoxia; IDA:UniProtKB
Q09472	EP300	Histone acetyltransferase p300	GO:0032526; P:response to retinoic acid; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0034612; P:response to tumor necrosis factor; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0001756; P:somitogenesis; IEA:Ensembl
Q09472	EP300	Histone acetyltransferase p300	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q09472	EP300	Histone acetyltransferase p300	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q14507	EDDM3A	Epididymal secretory protein E3-alpha	GO:0007321; P:sperm displacement; TAS:ProtInc
Q96L91	EP400	E1A-binding protein p400	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96L91	EP400	E1A-binding protein p400	GO:0003682; F:chromatin binding; IEA:InterPro
Q96L91	EP400	E1A-binding protein p400	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96L91	EP400	E1A-binding protein p400	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q96L91	EP400	E1A-binding protein p400	GO:0006325; P:chromatin organization; TAS:Reactome
Q96L91	EP400	E1A-binding protein p400	GO:0043968; P:histone H2A acetylation; IDA:UniProtKB
Q96L91	EP400	E1A-binding protein p400	GO:0043967; P:histone H4 acetylation; IDA:UniProtKB
A6NDY0	PABPN1L	Embryonic polyadenylate-binding protein 2	GO:0000166; F:nucleotide binding; IEA:InterPro
A6NDY0	PABPN1L	Embryonic polyadenylate-binding protein 2	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q14236	EPAG	Early lymphoid activation gene protein	GO:0004871; F:signal transducer activity; NAS:UniProtKB
Q14236	EPAG	Early lymphoid activation gene protein	GO:0007165; P:signal transduction; NAS:UniProtKB
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0003677; F:DNA binding; IGI:MGI
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0035035; F:histone acetyltransferase binding; IPI:UniProtKB
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0004871; F:signal transducer activity; IEA:InterPro
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0048469; P:cell maturation; IEA:Ensembl
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0071456; P:cellular response to hypoxia; IDA:UniProtKB
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0001892; P:embryonic placenta development; IEA:Ensembl
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0030218; P:erythrocyte differentiation; IEA:Ensembl
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0030324; P:lung development; IEA:Ensembl
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0007005; P:mitochondrion organization; IEA:Ensembl
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0048625; P:myoblast fate commitment; ISS:BHF-UCL
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0042415; P:norepinephrine metabolic process; IEA:Ensembl
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0002027; P:regulation of heart rate; IEA:Ensembl
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0043619; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; IEA:Ensembl
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0001666; P:response to hypoxia; IDA:MGI
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0043129; P:surfactant homeostasis; IEA:Ensembl
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q99814	EPAS1	Endothelial PAS domain-containing protein 1	GO:0007601; P:visual perception; IEA:Ensembl
P16452	EPB42	Erythrocyte membrane protein band 4.2	GO:0005524; F:ATP binding; TAS:ProtInc
P16452	EPB42	Erythrocyte membrane protein band 4.2	GO:0005515; F:protein binding; IPI:IntAct
P16452	EPB42	Erythrocyte membrane protein band 4.2	GO:0003810; F:protein-glutamine gamma-glutamyltransferase activity; IEA:InterPro
P16452	EPB42	Erythrocyte membrane protein band 4.2	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P16452	EPB42	Erythrocyte membrane protein band 4.2	GO:0000902; P:cell morphogenesis; IEA:Ensembl
P16452	EPB42	Erythrocyte membrane protein band 4.2	GO:0043249; P:erythrocyte maturation; IEA:UniProtKB-KW
P16452	EPB42	Erythrocyte membrane protein band 4.2	GO:0020027; P:hemoglobin metabolic process; IEA:Ensembl
P16452	EPB42	Erythrocyte membrane protein band 4.2	GO:0055072; P:iron ion homeostasis; IEA:Ensembl
P16452	EPB42	Erythrocyte membrane protein band 4.2	GO:0018149; P:peptide cross-linking; IEA:InterPro
P16452	EPB42	Erythrocyte membrane protein band 4.2	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
P16452	EPB42	Erythrocyte membrane protein band 4.2	GO:0048536; P:spleen development; IEA:Ensembl
Q9H2F5	EPC1	Enhancer of polycomb homolog 1	GO:0006325; P:chromatin organization; TAS:Reactome
Q9H2F5	EPC1	Enhancer of polycomb homolog 1	GO:0043968; P:histone H2A acetylation; IDA:UniProtKB
Q9H2F5	EPC1	Enhancer of polycomb homolog 1	GO:0043967; P:histone H4 acetylation; IDA:UniProtKB
Q9H2F5	EPC1	Enhancer of polycomb homolog 1	GO:0045814; P:negative regulation of gene expression, epigenetic; IDA:MGI
Q9H2F5	EPC1	Enhancer of polycomb homolog 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q9H2F5	EPC1	Enhancer of polycomb homolog 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9H2F5	EPC1	Enhancer of polycomb homolog 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q9H2F5	EPC1	Enhancer of polycomb homolog 1	GO:0045893; P:positive regulation of transcription, DNA-templated; TAS:UniProtKB
Q9H2F5	EPC1	Enhancer of polycomb homolog 1	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q9H2F5	EPC1	Enhancer of polycomb homolog 1	GO:0006351; P:transcription, DNA-templated; TAS:UniProtKB
Q52LR7	EPC2	Enhancer of polycomb homolog 2	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q52LR7	EPC2	Enhancer of polycomb homolog 2	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q52LR7	EPC2	Enhancer of polycomb homolog 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q52LR7	EPC2	Enhancer of polycomb homolog 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P16422	EPCAM	Epithelial cell adhesion molecule	GO:0005515; F:protein binding; IPI:UniProtKB
P16422	EPCAM	Epithelial cell adhesion molecule	GO:0032403; F:protein complex binding; IDA:UniProt
P16422	EPCAM	Epithelial cell adhesion molecule	GO:2000048; P:negative regulation of cell-cell adhesion mediated by cadherin; IDA:UniProt
P16422	EPCAM	Epithelial cell adhesion molecule	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P16422	EPCAM	Epithelial cell adhesion molecule	GO:2000648; P:positive regulation of stem cell proliferation; IMP:UniProt
P16422	EPCAM	Epithelial cell adhesion molecule	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProt
P16422	EPCAM	Epithelial cell adhesion molecule	GO:0023019; P:signal transduction involved in regulation of gene expression; IMP:UniProt
P16422	EPCAM	Epithelial cell adhesion molecule	GO:0048863; P:stem cell differentiation; IMP:UniProt
P16422	EPCAM	Epithelial cell adhesion molecule	GO:0001657; P:ureteric bud development; IEA:Ensembl
Q9UNN8	PROCR	Endothelial protein C receptor	GO:0005515; F:protein binding; IPI:IntAct
Q9UNN8	PROCR	Endothelial protein C receptor	GO:0004872; F:receptor activity; TAS:ProtInc
Q9UNN8	PROCR	Endothelial protein C receptor	GO:0019882; P:antigen processing and presentation; IEA:InterPro
Q9UNN8	PROCR	Endothelial protein C receptor	GO:0007596; P:blood coagulation; IEA:UniProtKB-KW
Q9UNN8	PROCR	Endothelial protein C receptor	GO:0006955; P:immune response; IEA:InterPro
Q9UNN8	PROCR	Endothelial protein C receptor	GO:0050819; P:negative regulation of coagulation; IMP:BHF-UCL
Q9UM22	EPDR1	Mammalian ependymin-related protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UM22	EPDR1	Mammalian ependymin-related protein 1	GO:0007160; P:cell-matrix adhesion; IEA:InterPro
Q9HCE0	EPG5	Ectopic P granules protein 5 homolog	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q6UW88	EPGN	Epigen	GO:0005154; F:epidermal growth factor receptor binding; IDA:HGNC
Q6UW88	EPGN	Epigen	GO:0008083; F:growth factor activity; IDA:HGNC
Q6UW88	EPGN	Epigen	GO:0004708; F:MAP kinase kinase activity; ISS:HGNC
Q6UW88	EPGN	Epigen	GO:0000187; P:activation of MAPK activity; ISS:HGNC
Q6UW88	EPGN	Epigen	GO:0001525; P:angiogenesis; IDA:HGNC
Q6UW88	EPGN	Epigen	GO:0008284; P:positive regulation of cell proliferation; IDA:HGNC
Q6UW88	EPGN	Epigen	GO:0045741; P:positive regulation of epidermal growth factor-activated receptor activity; IDA:HGNC
Q6UW88	EPGN	Epigen	GO:0050679; P:positive regulation of epithelial cell proliferation; ISS:HGNC
Q6UW88	EPGN	Epigen	GO:0043406; P:positive regulation of MAP kinase activity; IDA:HGNC
Q6UW88	EPGN	Epigen	GO:0045840; P:positive regulation of mitosis; IDA:HGNC
P21709	EPHA1	Ephrin type-A receptor 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P21709	EPHA1	Ephrin type-A receptor 1	GO:0004672; F:protein kinase activity; IDA:UniProtKB
P21709	EPHA1	Ephrin type-A receptor 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P21709	EPHA1	Ephrin type-A receptor 1	GO:0005005; F:transmembrane-ephrin receptor activity; IDA:UniProtKB
P21709	EPHA1	Ephrin type-A receptor 1	GO:0032862; P:activation of Rho GTPase activity; IDA:UniProtKB
P21709	EPHA1	Ephrin type-A receptor 1	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P21709	EPHA1	Ephrin type-A receptor 1	GO:0007166; P:cell surface receptor signaling pathway; IDA:UniProtKB
P21709	EPHA1	Ephrin type-A receptor 1	GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB
P21709	EPHA1	Ephrin type-A receptor 1	GO:0006469; P:negative regulation of protein kinase activity; IDA:UniProtKB
P21709	EPHA1	Ephrin type-A receptor 1	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P21709	EPHA1	Ephrin type-A receptor 1	GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB
P21709	EPHA1	Ephrin type-A receptor 1	GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB
P21709	EPHA1	Ephrin type-A receptor 1	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
P21709	EPHA1	Ephrin type-A receptor 1	GO:0001954; P:positive regulation of cell-matrix adhesion; IDA:UniProtKB
P21709	EPHA1	Ephrin type-A receptor 1	GO:0051496; P:positive regulation of stress fiber assembly; ISS:UniProtKB
P21709	EPHA1	Ephrin type-A receptor 1	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P21709	EPHA1	Ephrin type-A receptor 1	GO:0032314; P:regulation of Rac GTPase activity; IDA:UniProtKB
P21709	EPHA1	Ephrin type-A receptor 1	GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P29317	EPHA2	Ephrin type-A receptor 2	GO:0005003; F:ephrin receptor activity; IEA:InterPro
P29317	EPHA2	Ephrin type-A receptor 2	GO:0005515; F:protein binding; IPI:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IDA:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0032863; P:activation of Rac GTPase activity; IMP:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P29317	EPHA2	Ephrin type-A receptor 2	GO:0048320; P:axial mesoderm formation; IEA:Ensembl
P29317	EPHA2	Ephrin type-A receptor 2	GO:0046849; P:bone remodeling; ISS:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0060444; P:branching involved in mammary gland duct morphogenesis; ISS:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P29317	EPHA2	Ephrin type-A receptor 2	GO:0060326; P:cell chemotaxis; IMP:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0048013; P:ephrin receptor signaling pathway; IDA:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IDA:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0030216; P:keratinocyte differentiation; IMP:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0070309; P:lens fiber cell morphogenesis; ISS:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0033598; P:mammary gland epithelial cell proliferation; ISS:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P29317	EPHA2	Ephrin type-A receptor 2	GO:0051898; P:negative regulation of protein kinase B signaling; IDA:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0021915; P:neural tube development; IEA:Ensembl
P29317	EPHA2	Ephrin type-A receptor 2	GO:0030182; P:neuron differentiation; IEA:Ensembl
P29317	EPHA2	Ephrin type-A receptor 2	GO:0060035; P:notochord cell development; IEA:Ensembl
P29317	EPHA2	Ephrin type-A receptor 2	GO:0014028; P:notochord formation; IEA:Ensembl
P29317	EPHA2	Ephrin type-A receptor 2	GO:0001649; P:osteoblast differentiation; ISS:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0030316; P:osteoclast differentiation; ISS:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:GOC
P29317	EPHA2	Ephrin type-A receptor 2	GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; IMP:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl
P29317	EPHA2	Ephrin type-A receptor 2	GO:0043491; P:protein kinase B signaling; IDA:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0045765; P:regulation of angiogenesis; ISS:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0043535; P:regulation of blood vessel endothelial cell migration; ISS:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0033628; P:regulation of cell adhesion mediated by integrin; IDA:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0070372; P:regulation of ERK1 and ERK2 cascade; IMP:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0010591; P:regulation of lamellipodium assembly; IMP:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0070848; P:response to growth factor; IMP:UniProtKB
P29317	EPHA2	Ephrin type-A receptor 2	GO:0001501; P:skeletal system development; IEA:Ensembl
P29317	EPHA2	Ephrin type-A receptor 2	GO:0001570; P:vasculogenesis; IEA:Ensembl
P29317	EPHA2	Ephrin type-A receptor 2	GO:0016032; P:viral process; IEA:UniProtKB-KW
P29320	EPHA3	Ephrin type-A receptor 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P29320	EPHA3	Ephrin type-A receptor 3	GO:0005004; F:GPI-linked ephrin receptor activity; IDA:UniProtKB
P29320	EPHA3	Ephrin type-A receptor 3	GO:0005515; F:protein binding; IPI:UniProtKB
P29320	EPHA3	Ephrin type-A receptor 3	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P29320	EPHA3	Ephrin type-A receptor 3	GO:0016477; P:cell migration; ISS:UniProtKB
P29320	EPHA3	Ephrin type-A receptor 3	GO:0071300; P:cellular response to retinoic acid; IMP:BHF-UCL
P29320	EPHA3	Ephrin type-A receptor 3	GO:0048013; P:ephrin receptor signaling pathway; IDA:UniProtKB
P29320	EPHA3	Ephrin type-A receptor 3	GO:0097156; P:fasciculation of motor neuron axon; ISS:UniProtKB
P29320	EPHA3	Ephrin type-A receptor 3	GO:0097155; P:fasciculation of sensory neuron axon; ISS:UniProtKB
P29320	EPHA3	Ephrin type-A receptor 3	GO:0010976; P:positive regulation of neuron projection development; IMP:BHF-UCL
P29320	EPHA3	Ephrin type-A receptor 3	GO:0032956; P:regulation of actin cytoskeleton organization; IDA:UniProtKB
P29320	EPHA3	Ephrin type-A receptor 3	GO:0010717; P:regulation of epithelial to mesenchymal transition; ISS:UniProtKB
P29320	EPHA3	Ephrin type-A receptor 3	GO:0051893; P:regulation of focal adhesion assembly; IDA:UniProtKB
P29320	EPHA3	Ephrin type-A receptor 3	GO:0070507; P:regulation of microtubule cytoskeleton organization; IDA:UniProtKB
P29320	EPHA3	Ephrin type-A receptor 3	GO:0032319; P:regulation of Rho GTPase activity; IDA:UniProtKB
P54764	EPHA4	Ephrin type-A receptor 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P54764	EPHA4	Ephrin type-A receptor 4	GO:0097161; F:DH domain binding; IDA:UniProtKB
P54764	EPHA4	Ephrin type-A receptor 4	GO:0005004; F:GPI-linked ephrin receptor activity; ISS:UniProtKB
P54764	EPHA4	Ephrin type-A receptor 4	GO:0042731; F:PH domain binding; IPI:UniProtKB
P54764	EPHA4	Ephrin type-A receptor 4	GO:0005515; F:protein binding; IPI:UniProtKB
P54764	EPHA4	Ephrin type-A receptor 4	GO:0004672; F:protein kinase activity; IDA:UniProtKB
P54764	EPHA4	Ephrin type-A receptor 4	GO:0005005; F:transmembrane-ephrin receptor activity; ISS:UniProtKB
P54764	EPHA4	Ephrin type-A receptor 4	GO:0007628; P:adult walking behavior; IEA:Ensembl
P54764	EPHA4	Ephrin type-A receptor 4	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P54764	EPHA4	Ephrin type-A receptor 4	GO:0021957; P:corticospinal tract morphogenesis; ISS:UniProtKB
P54764	EPHA4	Ephrin type-A receptor 4	GO:0097156; P:fasciculation of motor neuron axon; ISS:UniProtKB
P54764	EPHA4	Ephrin type-A receptor 4	GO:0097155; P:fasciculation of sensory neuron axon; ISS:UniProtKB
P54764	EPHA4	Ephrin type-A receptor 4	GO:0008347; P:glial cell migration; IEA:Ensembl
P54764	EPHA4	Ephrin type-A receptor 4	GO:0008045; P:motor neuron axon guidance; ISS:UniProtKB
P54764	EPHA4	Ephrin type-A receptor 4	GO:0048681; P:negative regulation of axon regeneration; ISS:UniProtKB
P54764	EPHA4	Ephrin type-A receptor 4	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P54764	EPHA4	Ephrin type-A receptor 4	GO:0050775; P:positive regulation of dendrite morphogenesis; IEA:Ensembl
P54764	EPHA4	Ephrin type-A receptor 4	GO:0043507; P:positive regulation of JUN kinase activity; IEA:Ensembl
P54764	EPHA4	Ephrin type-A receptor 4	GO:2001108; P:positive regulation of Rho guanyl-nucleotide exchange factor activity; IDA:UniProtKB
P54764	EPHA4	Ephrin type-A receptor 4	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P54764	EPHA4	Ephrin type-A receptor 4	GO:0048710; P:regulation of astrocyte differentiation; ISS:UniProtKB
P54764	EPHA4	Ephrin type-A receptor 4	GO:0050770; P:regulation of axonogenesis; ISS:UniProtKB
P54764	EPHA4	Ephrin type-A receptor 4	GO:0061001; P:regulation of dendritic spine morphogenesis; ISS:UniProtKB
P54764	EPHA4	Ephrin type-A receptor 4	GO:0032314; P:regulation of Rac GTPase activity; ISS:UniProtKB
P54764	EPHA4	Ephrin type-A receptor 4	GO:0032317; P:regulation of Rap GTPase activity; ISS:UniProtKB
P54756	EPHA5	Ephrin type-A receptor 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P54756	EPHA5	Ephrin type-A receptor 5	GO:0005003; F:ephrin receptor activity; ISS:UniProtKB
P54756	EPHA5	Ephrin type-A receptor 5	GO:0005004; F:GPI-linked ephrin receptor activity; ISS:UniProtKB
P54756	EPHA5	Ephrin type-A receptor 5	GO:0005005; F:transmembrane-ephrin receptor activity; NAS:UniProtKB
P54756	EPHA5	Ephrin type-A receptor 5	GO:0007411; P:axon guidance; ISS:UniProtKB
P54756	EPHA5	Ephrin type-A receptor 5	GO:0019933; P:cAMP-mediated signaling; ISS:UniProtKB
P54756	EPHA5	Ephrin type-A receptor 5	GO:0048013; P:ephrin receptor signaling pathway; ISS:UniProtKB
P54756	EPHA5	Ephrin type-A receptor 5	GO:0021766; P:hippocampus development; ISS:UniProtKB
P54756	EPHA5	Ephrin type-A receptor 5	GO:0051964; P:negative regulation of synapse assembly; IEA:Ensembl
P54756	EPHA5	Ephrin type-A receptor 5	GO:0048666; P:neuron development; IEP:UniProtKB
P54756	EPHA5	Ephrin type-A receptor 5	GO:0032793; P:positive regulation of CREB transcription factor activity; ISS:UniProtKB
P54756	EPHA5	Ephrin type-A receptor 5	GO:0032956; P:regulation of actin cytoskeleton organization; ISS:UniProtKB
P54756	EPHA5	Ephrin type-A receptor 5	GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB
P54756	EPHA5	Ephrin type-A receptor 5	GO:0032314; P:regulation of Rac GTPase activity; ISS:UniProtKB
Q9UF33	EPHA6	Ephrin type-A receptor 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UF33	EPHA6	Ephrin type-A receptor 6	GO:0005003; F:ephrin receptor activity; IEA:InterPro
Q9UF33	EPHA6	Ephrin type-A receptor 6	GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW
Q15375	EPHA7	Ephrin type-A receptor 7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q15375	EPHA7	Ephrin type-A receptor 7	GO:0008046; F:axon guidance receptor activity; ISS:UniProtKB
Q15375	EPHA7	Ephrin type-A receptor 7	GO:0045499; F:chemorepellent activity; ISS:UniProtKB
Q15375	EPHA7	Ephrin type-A receptor 7	GO:0005004; F:GPI-linked ephrin receptor activity; ISS:UniProtKB
Q15375	EPHA7	Ephrin type-A receptor 7	GO:0005515; F:protein binding; IPI:IntAct
Q15375	EPHA7	Ephrin type-A receptor 7	GO:0004713; F:protein tyrosine kinase activity; ISS:UniProtKB
Q15375	EPHA7	Ephrin type-A receptor 7	GO:0007420; P:brain development; ISS:UniProtKB
Q15375	EPHA7	Ephrin type-A receptor 7	GO:0048755; P:branching morphogenesis of a nerve; ISS:UniProtKB
Q15375	EPHA7	Ephrin type-A receptor 7	GO:0048013; P:ephrin receptor signaling pathway; IDA:UniProtKB
Q15375	EPHA7	Ephrin type-A receptor 7	GO:0050919; P:negative chemotaxis; ISS:UniProtKB
Q15375	EPHA7	Ephrin type-A receptor 7	GO:0018108; P:peptidyl-tyrosine phosphorylation; ISS:GOC
Q15375	EPHA7	Ephrin type-A receptor 7	GO:0016310; P:phosphorylation; ISS:UniProtKB
Q15375	EPHA7	Ephrin type-A receptor 7	GO:0043525; P:positive regulation of neuron apoptotic process; ISS:UniProtKB
Q15375	EPHA7	Ephrin type-A receptor 7	GO:0022407; P:regulation of cell-cell adhesion; ISS:UniProtKB
Q15375	EPHA7	Ephrin type-A receptor 7	GO:0043281; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; ISS:UniProtKB
Q15375	EPHA7	Ephrin type-A receptor 7	GO:0070372; P:regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
Q15375	EPHA7	Ephrin type-A receptor 7	GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
Q15375	EPHA7	Ephrin type-A receptor 7	GO:0031952; P:regulation of protein autophosphorylation; ISS:UniProtKB
Q15375	EPHA7	Ephrin type-A receptor 7	GO:0031290; P:retinal ganglion cell axon guidance; IEA:Ensembl
P29322	EPHA8	Ephrin type-A receptor 8	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P29322	EPHA8	Ephrin type-A receptor 8	GO:0005004; F:GPI-linked ephrin receptor activity; ISS:UniProtKB
P29322	EPHA8	Ephrin type-A receptor 8	GO:0007411; P:axon guidance; ISS:UniProtKB
P29322	EPHA8	Ephrin type-A receptor 8	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P29322	EPHA8	Ephrin type-A receptor 8	GO:0048013; P:ephrin receptor signaling pathway; ISS:UniProtKB
P29322	EPHA8	Ephrin type-A receptor 8	GO:0031175; P:neuron projection development; ISS:UniProtKB
P29322	EPHA8	Ephrin type-A receptor 8	GO:0016322; P:neuron remodeling; ISS:UniProtKB
P29322	EPHA8	Ephrin type-A receptor 8	GO:0043410; P:positive regulation of MAPK cascade; ISS:UniProtKB
P29322	EPHA8	Ephrin type-A receptor 8	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; ISS:UniProtKB
P29322	EPHA8	Ephrin type-A receptor 8	GO:0046777; P:protein autophosphorylation; ISS:UniProtKB
P29322	EPHA8	Ephrin type-A receptor 8	GO:0030155; P:regulation of cell adhesion; ISS:UniProtKB
P29322	EPHA8	Ephrin type-A receptor 8	GO:0033628; P:regulation of cell adhesion mediated by integrin; ISS:UniProtKB
P29322	EPHA8	Ephrin type-A receptor 8	GO:0006929; P:substrate-dependent cell migration; ISS:UniProtKB
Q5JZY3	EPHA10	Ephrin type-A receptor 10	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5JZY3	EPHA10	Ephrin type-A receptor 10	GO:0005003; F:ephrin receptor activity; IEA:InterPro
Q5JZY3	EPHA10	Ephrin type-A receptor 10	GO:0005515; F:protein binding; IPI:UniProtKB
Q5JZY3	EPHA10	Ephrin type-A receptor 10	GO:0005005; F:transmembrane-ephrin receptor activity; IDA:UniProtKB
Q5JZY3	EPHA10	Ephrin type-A receptor 10	GO:0048013; P:ephrin receptor signaling pathway; IDA:GOC
P54762	EPHB1	Ephrin type-B receptor 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P54762	EPHB1	Ephrin type-B receptor 1	GO:0008046; F:axon guidance receptor activity; IEA:Ensembl
P54762	EPHB1	Ephrin type-B receptor 1	GO:0005515; F:protein binding; IPI:UniProtKB
P54762	EPHB1	Ephrin type-B receptor 1	GO:0005005; F:transmembrane-ephrin receptor activity; IDA:UniProtKB
P54762	EPHB1	Ephrin type-B receptor 1	GO:0001525; P:angiogenesis; IDA:UniProtKB
P54762	EPHB1	Ephrin type-B receptor 1	GO:0007411; P:axon guidance; ISS:UniProtKB
P54762	EPHB1	Ephrin type-B receptor 1	GO:0048593; P:camera-type eye morphogenesis; IEA:Ensembl
P54762	EPHB1	Ephrin type-B receptor 1	GO:0060326; P:cell chemotaxis; IDA:UniProtKB
P54762	EPHB1	Ephrin type-B receptor 1	GO:0031589; P:cell-substrate adhesion; IDA:UniProtKB
P54762	EPHB1	Ephrin type-B receptor 1	GO:0021952; P:central nervous system projection neuron axonogenesis; ISS:UniProtKB
P54762	EPHB1	Ephrin type-B receptor 1	GO:0060996; P:dendritic spine development; ISS:UniProtKB
P54762	EPHB1	Ephrin type-B receptor 1	GO:0060997; P:dendritic spine morphogenesis; ISS:UniProtKB
P54762	EPHB1	Ephrin type-B receptor 1	GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; ISS:UniProtKB
P54762	EPHB1	Ephrin type-B receptor 1	GO:0048013; P:ephrin receptor signaling pathway; IDA:UniProtKB
P54762	EPHB1	Ephrin type-B receptor 1	GO:0030010; P:establishment of cell polarity; ISS:UniProtKB
P54762	EPHB1	Ephrin type-B receptor 1	GO:0061351; P:neural precursor cell proliferation; ISS:UniProtKB
P54762	EPHB1	Ephrin type-B receptor 1	GO:0022008; P:neurogenesis; ISS:UniProtKB
P54762	EPHB1	Ephrin type-B receptor 1	GO:0021631; P:optic nerve morphogenesis; IEA:Ensembl
P54762	EPHB1	Ephrin type-B receptor 1	GO:0051965; P:positive regulation of synapse assembly; ISS:UniProtKB
P54762	EPHB1	Ephrin type-B receptor 1	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P54762	EPHB1	Ephrin type-B receptor 1	GO:0070372; P:regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P54762	EPHB1	Ephrin type-B receptor 1	GO:0046328; P:regulation of JNK cascade; IDA:UniProtKB
P54762	EPHB1	Ephrin type-B receptor 1	GO:0031290; P:retinal ganglion cell axon guidance; ISS:UniProtKB
P29323	EPHB2	Ephrin type-B receptor 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P29323	EPHB2	Ephrin type-B receptor 2	GO:0008046; F:axon guidance receptor activity; IEA:Ensembl
P29323	EPHB2	Ephrin type-B receptor 2	GO:0005515; F:protein binding; IPI:IntAct
P29323	EPHB2	Ephrin type-B receptor 2	GO:0004713; F:protein tyrosine kinase activity; ISS:UniProtKB
P29323	EPHB2	Ephrin type-B receptor 2	GO:0005005; F:transmembrane-ephrin receptor activity; ISS:UniProtKB
P29323	EPHB2	Ephrin type-B receptor 2	GO:0001525; P:angiogenesis; ISS:UniProtKB
P29323	EPHB2	Ephrin type-B receptor 2	GO:0007411; P:axon guidance; ISS:UniProtKB
P29323	EPHB2	Ephrin type-B receptor 2	GO:0007413; P:axonal fasciculation; ISS:UniProtKB
P29323	EPHB2	Ephrin type-B receptor 2	GO:0048593; P:camera-type eye morphogenesis; IEA:Ensembl
P29323	EPHB2	Ephrin type-B receptor 2	GO:0021952; P:central nervous system projection neuron axonogenesis; IEA:Ensembl
P29323	EPHB2	Ephrin type-B receptor 2	GO:0071679; P:commissural neuron axon guidance; ISS:UniProtKB
P29323	EPHB2	Ephrin type-B receptor 2	GO:0022038; P:corpus callosum development; ISS:UniProtKB
P29323	EPHB2	Ephrin type-B receptor 2	GO:0060996; P:dendritic spine development; ISS:UniProtKB
P29323	EPHB2	Ephrin type-B receptor 2	GO:0060997; P:dendritic spine morphogenesis; ISS:UniProtKB
P29323	EPHB2	Ephrin type-B receptor 2	GO:0048013; P:ephrin receptor signaling pathway; ISS:UniProtKB
P29323	EPHB2	Ephrin type-B receptor 2	GO:0042472; P:inner ear morphogenesis; ISS:UniProtKB
P29323	EPHB2	Ephrin type-B receptor 2	GO:0007612; P:learning; IEA:Ensembl
P29323	EPHB2	Ephrin type-B receptor 2	GO:0050771; P:negative regulation of axonogenesis; IEA:Ensembl
P29323	EPHB2	Ephrin type-B receptor 2	GO:0007399; P:nervous system development; TAS:UniProtKB
P29323	EPHB2	Ephrin type-B receptor 2	GO:0021631; P:optic nerve morphogenesis; IEA:Ensembl
P29323	EPHB2	Ephrin type-B receptor 2	GO:0060021; P:palate development; ISS:UniProtKB
P29323	EPHB2	Ephrin type-B receptor 2	GO:0018108; P:peptidyl-tyrosine phosphorylation; ISS:UniProtKB
P29323	EPHB2	Ephrin type-B receptor 2	GO:0016310; P:phosphorylation; ISS:UniProtKB
P29323	EPHB2	Ephrin type-B receptor 2	GO:0048170; P:positive regulation of long-term neuronal synaptic plasticity; IEA:Ensembl
P29323	EPHB2	Ephrin type-B receptor 2	GO:0051965; P:positive regulation of synapse assembly; ISS:UniProtKB
P29323	EPHB2	Ephrin type-B receptor 2	GO:0050878; P:regulation of body fluid levels; ISS:UniProtKB
P29323	EPHB2	Ephrin type-B receptor 2	GO:0031290; P:retinal ganglion cell axon guidance; IEA:Ensembl
P29323	EPHB2	Ephrin type-B receptor 2	GO:0001655; P:urogenital system development; ISS:UniProtKB
P54753	EPHB3	Ephrin type-B receptor 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P54753	EPHB3	Ephrin type-B receptor 3	GO:0008046; F:axon guidance receptor activity; IEA:Ensembl
P54753	EPHB3	Ephrin type-B receptor 3	GO:0005003; F:ephrin receptor activity; IDA:UniProtKB
P54753	EPHB3	Ephrin type-B receptor 3	GO:0001525; P:angiogenesis; ISS:UniProtKB
P54753	EPHB3	Ephrin type-B receptor 3	GO:0007411; P:axon guidance; ISS:UniProtKB
P54753	EPHB3	Ephrin type-B receptor 3	GO:0007413; P:axonal fasciculation; ISS:UniProtKB
P54753	EPHB3	Ephrin type-B receptor 3	GO:0016477; P:cell migration; IDA:UniProtKB
P54753	EPHB3	Ephrin type-B receptor 3	GO:0021952; P:central nervous system projection neuron axonogenesis; IEA:Ensembl
P54753	EPHB3	Ephrin type-B receptor 3	GO:0022038; P:corpus callosum development; ISS:UniProtKB
P54753	EPHB3	Ephrin type-B receptor 3	GO:0060996; P:dendritic spine development; ISS:UniProtKB
P54753	EPHB3	Ephrin type-B receptor 3	GO:0060997; P:dendritic spine morphogenesis; ISS:UniProtKB
P54753	EPHB3	Ephrin type-B receptor 3	GO:0048546; P:digestive tract morphogenesis; ISS:UniProtKB
P54753	EPHB3	Ephrin type-B receptor 3	GO:0048013; P:ephrin receptor signaling pathway; IDA:UniProtKB
P54753	EPHB3	Ephrin type-B receptor 3	GO:0060021; P:palate development; ISS:UniProtKB
P54753	EPHB3	Ephrin type-B receptor 3	GO:0051965; P:positive regulation of synapse assembly; ISS:UniProtKB
P54753	EPHB3	Ephrin type-B receptor 3	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P54753	EPHB3	Ephrin type-B receptor 3	GO:0050770; P:regulation of axonogenesis; ISS:UniProtKB
P54753	EPHB3	Ephrin type-B receptor 3	GO:0043088; P:regulation of Cdc42 GTPase activity; IDA:UniProtKB
P54753	EPHB3	Ephrin type-B receptor 3	GO:0022407; P:regulation of cell-cell adhesion; IDA:UniProtKB
P54753	EPHB3	Ephrin type-B receptor 3	GO:0032314; P:regulation of Rac GTPase activity; IDA:UniProtKB
P54753	EPHB3	Ephrin type-B receptor 3	GO:0031290; P:retinal ganglion cell axon guidance; IEA:Ensembl
P54753	EPHB3	Ephrin type-B receptor 3	GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:UniProtKB
P54753	EPHB3	Ephrin type-B receptor 3	GO:0048538; P:thymus development; ISS:UniProtKB
P54753	EPHB3	Ephrin type-B receptor 3	GO:0001655; P:urogenital system development; ISS:UniProtKB
P54760	EPHB4	Ephrin type-B receptor 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P54760	EPHB4	Ephrin type-B receptor 4	GO:0005003; F:ephrin receptor activity; IDA:UniProtKB
P54760	EPHB4	Ephrin type-B receptor 4	GO:0005515; F:protein binding; IPI:UniProtKB
P54760	EPHB4	Ephrin type-B receptor 4	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IDA:UniProtKB
P54760	EPHB4	Ephrin type-B receptor 4	GO:0001525; P:angiogenesis; ISS:UniProtKB
P54760	EPHB4	Ephrin type-B receptor 4	GO:0007155; P:cell adhesion; IDA:UniProtKB
P54760	EPHB4	Ephrin type-B receptor 4	GO:0002042; P:cell migration involved in sprouting angiogenesis; IDA:UniProtKB
P54760	EPHB4	Ephrin type-B receptor 4	GO:0048013; P:ephrin receptor signaling pathway; IDA:UniProtKB
P54760	EPHB4	Ephrin type-B receptor 4	GO:0003007; P:heart morphogenesis; ISS:UniProtKB
P54760	EPHB4	Ephrin type-B receptor 4	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:GOC
P54760	EPHB4	Ephrin type-B receptor 4	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
O15197	EPHB6	Ephrin type-B receptor 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O15197	EPHB6	Ephrin type-B receptor 6	GO:0005003; F:ephrin receptor activity; TAS:ProtInc
O15197	EPHB6	Ephrin type-B receptor 6	GO:0004872; F:receptor activity; TAS:ProtInc
O15197	EPHB6	Ephrin type-B receptor 6	GO:0055074; P:calcium ion homeostasis; IEA:Ensembl
O15197	EPHB6	Ephrin type-B receptor 6	GO:0035898; P:parathyroid hormone secretion; IEA:Ensembl
Q9H6B9	EPHX3	Epoxide hydrolase 3	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q8IUS5	EPHX4	Epoxide hydrolase 4	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
P58107	EPPK1	Epiplakin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O95278	EPM2A	Laforin	GO:0019203; F:carbohydrate phosphatase activity; EXP:Reactome
O95278	EPM2A	Laforin	GO:0005515; F:protein binding; IPI:UniProtKB
O95278	EPM2A	Laforin	GO:0004722; F:protein serine/threonine phosphatase activity; IDA:UniProtKB
O95278	EPM2A	Laforin	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
O95278	EPM2A	Laforin	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro
O95278	EPM2A	Laforin	GO:2001070; F:starch binding; IEA:InterPro
O95278	EPM2A	Laforin	GO:0006914; P:autophagy; IEA:UniProtKB-KW
O95278	EPM2A	Laforin	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O95278	EPM2A	Laforin	GO:0006006; P:glucose metabolic process; TAS:Reactome
O95278	EPM2A	Laforin	GO:0005978; P:glycogen biosynthetic process; TAS:Reactome
O95278	EPM2A	Laforin	GO:0005977; P:glycogen metabolic process; NAS:UniProtKB
O95278	EPM2A	Laforin	GO:0046959; P:habituation; IEA:Ensembl
O95278	EPM2A	Laforin	GO:0007399; P:nervous system development; IEA:Ensembl
O95278	EPM2A	Laforin	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:GOC
O95278	EPM2A	Laforin	GO:0006470; P:protein dephosphorylation; IDA:UniProtKB
O95278	EPM2A	Laforin	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y6I3	EPN1	Epsin-1	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q9Y6I3	EPN1	Epsin-1	GO:0048568; P:embryonic organ development; IEA:Ensembl
Q9Y6I3	EPN1	Epsin-1	GO:0006897; P:endocytosis; TAS:ProtInc
Q9Y6I3	EPN1	Epsin-1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q9Y6I3	EPN1	Epsin-1	GO:0007565; P:female pregnancy; IEA:Ensembl
Q9Y6I3	EPN1	Epsin-1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9Y6I3	EPN1	Epsin-1	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
Q9Y6I3	EPN1	Epsin-1	GO:0007219; P:Notch signaling pathway; IEA:Ensembl
O95208	EPN2	Epsin-2	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
O95208	EPN2	Epsin-2	GO:0048568; P:embryonic organ development; IEA:Ensembl
O95208	EPN2	Epsin-2	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
O95208	EPN2	Epsin-2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O95208	EPN2	Epsin-2	GO:0007219; P:Notch signaling pathway; IEA:Ensembl
Q9H201	EPN3	Epsin-3	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q9H201	EPN3	Epsin-3	GO:0005515; F:protein binding; IPI:UniProt
Q14677	CLINT1	Clathrin interactor 1	GO:0030276; F:clathrin binding; IPI:BHF-UCL
Q14677	CLINT1	Clathrin interactor 1	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q14677	CLINT1	Clathrin interactor 1	GO:0005515; F:protein binding; IPI:IntAct
Q14677	CLINT1	Clathrin interactor 1	GO:0048268; P:clathrin coat assembly; IEA:Ensembl
Q14677	CLINT1	Clathrin interactor 1	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q14677	CLINT1	Clathrin interactor 1	GO:0061024; P:membrane organization; TAS:Reactome
Q14677	CLINT1	Clathrin interactor 1	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
P19235	EPOR	Erythropoietin receptor	GO:0004900; F:erythropoietin receptor activity; IDA:UniProtKB
P19235	EPOR	Erythropoietin receptor	GO:0042802; F:identical protein binding; IPI:IntAct
P19235	EPOR	Erythropoietin receptor	GO:0005515; F:protein binding; IPI:IntAct
P19235	EPOR	Erythropoietin receptor	GO:0007420; P:brain development; IEA:Ensembl
P19235	EPOR	Erythropoietin receptor	GO:0046697; P:decidualization; IEA:Ensembl
P19235	EPOR	Erythropoietin receptor	GO:0009790; P:embryo development; IEA:Ensembl
P19235	EPOR	Erythropoietin receptor	GO:0038162; P:erythropoietin-mediated signaling pathway; IDA:GOC
P19235	EPOR	Erythropoietin receptor	GO:0007507; P:heart development; IEA:Ensembl
P19235	EPOR	Erythropoietin receptor	GO:0007165; P:signal transduction; NAS:ProtInc
P01588	EPO	Erythropoietin	GO:0005515; F:protein binding; IPI:IntAct
P01588	EPO	Erythropoietin	GO:0030295; F:protein kinase activator activity; IEA:Ensembl
P01588	EPO	Erythropoietin	GO:0007568; P:aging; IEA:Ensembl
P01588	EPO	Erythropoietin	GO:0006915; P:apoptotic process; IEA:Ensembl
P01588	EPO	Erythropoietin	GO:0008015; P:blood circulation; NAS:ProtInc
P01588	EPO	Erythropoietin	GO:0071474; P:cellular hyperosmotic response; IDA:BHF-UCL
P01588	EPO	Erythropoietin	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
P01588	EPO	Erythropoietin	GO:0007566; P:embryo implantation; IEA:Ensembl
P01588	EPO	Erythropoietin	GO:0043249; P:erythrocyte maturation; IEA:UniProtKB-KW
P01588	EPO	Erythropoietin	GO:0042541; P:hemoglobin biosynthetic process; IEA:Ensembl
P01588	EPO	Erythropoietin	GO:0010523; P:negative regulation of calcium ion transport into cytosol; IDA:BHF-UCL
P01588	EPO	Erythropoietin	GO:2001258; P:negative regulation of cation channel activity; IDA:BHF-UCL
P01588	EPO	Erythropoietin	GO:1902251; P:negative regulation of erythrocyte apoptotic process; IDA:BHF-UCL
P01588	EPO	Erythropoietin	GO:1902219; P:negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress; IDA:BHF-UCL
P01588	EPO	Erythropoietin	GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl
P01588	EPO	Erythropoietin	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P01588	EPO	Erythropoietin	GO:0045740; P:positive regulation of DNA replication; IDA:BHF-UCL
P01588	EPO	Erythropoietin	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P01588	EPO	Erythropoietin	GO:0046579; P:positive regulation of Ras protein signal transduction; IDA:BHF-UCL
P01588	EPO	Erythropoietin	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
P01588	EPO	Erythropoietin	GO:0042523; P:positive regulation of tyrosine phosphorylation of Stat5 protein; IDA:BHF-UCL
P01588	EPO	Erythropoietin	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
P01588	EPO	Erythropoietin	GO:0048678; P:response to axon injury; IEA:Ensembl
P01588	EPO	Erythropoietin	GO:0051602; P:response to electrical stimulus; IEA:Ensembl
P01588	EPO	Erythropoietin	GO:0043627; P:response to estrogen; IEA:Ensembl
P01588	EPO	Erythropoietin	GO:0055093; P:response to hyperoxia; IEA:Ensembl
P01588	EPO	Erythropoietin	GO:0070555; P:response to interleukin-1; IEA:Ensembl
P01588	EPO	Erythropoietin	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P01588	EPO	Erythropoietin	GO:0009651; P:response to salt stress; IEA:Ensembl
P01588	EPO	Erythropoietin	GO:0033574; P:response to testosterone; IEA:Ensembl
P01588	EPO	Erythropoietin	GO:0033189; P:response to vitamin A; IEA:Ensembl
P01588	EPO	Erythropoietin	GO:0007165; P:signal transduction; NAS:ProtInc
O95925	EPPIN	Eppin	GO:0005515; F:protein binding; IPI:UniProtKB
O95925	EPPIN	Eppin	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
O95925	EPPIN	Eppin	GO:0042742; P:defense response to bacterium; IDA:UniProtKB
O95925	EPPIN	Eppin	GO:0010466; P:negative regulation of peptidase activity; IDA:UniProtKB
P42566	EPS15	Epidermal growth factor receptor substrate 15	GO:0005509; F:calcium ion binding; IEA:InterPro
P42566	EPS15	Epidermal growth factor receptor substrate 15	GO:0005515; F:protein binding; IPI:IntAct
P42566	EPS15	Epidermal growth factor receptor substrate 15	GO:0008283; P:cell proliferation; TAS:ProtInc
P42566	EPS15	Epidermal growth factor receptor substrate 15	GO:0048268; P:clathrin coat assembly; IDA:BHF-UCL
P42566	EPS15	Epidermal growth factor receptor substrate 15	GO:0032456; P:endocytic recycling; IC:BHF-UCL
P42566	EPS15	Epidermal growth factor receptor substrate 15	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
P42566	EPS15	Epidermal growth factor receptor substrate 15	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P42566	EPS15	Epidermal growth factor receptor substrate 15	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
P42566	EPS15	Epidermal growth factor receptor substrate 15	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P42566	EPS15	Epidermal growth factor receptor substrate 15	GO:0016050; P:vesicle organization; TAS:UniProtKB
Q12929	EPS8	Epidermal growth factor receptor kinase substrate 8	GO:0003779; F:actin binding; ISS:UniProtKB
Q12929	EPS8	Epidermal growth factor receptor kinase substrate 8	GO:0005515; F:protein binding; IPI:IntAct
Q12929	EPS8	Epidermal growth factor receptor kinase substrate 8	GO:0048365; F:Rac GTPase binding; ISS:UniProtKB
Q12929	EPS8	Epidermal growth factor receptor kinase substrate 8	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
Q12929	EPS8	Epidermal growth factor receptor kinase substrate 8	GO:0051764; P:actin crosslink formation; ISS:UniProtKB
Q12929	EPS8	Epidermal growth factor receptor kinase substrate 8	GO:0031532; P:actin cytoskeleton reorganization; IEA:Ensembl
Q12929	EPS8	Epidermal growth factor receptor kinase substrate 8	GO:0051017; P:actin filament bundle assembly; ISS:UniProtKB
Q12929	EPS8	Epidermal growth factor receptor kinase substrate 8	GO:0070358; P:actin polymerization-dependent cell motility; ISS:UniProtKB
Q12929	EPS8	Epidermal growth factor receptor kinase substrate 8	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
Q12929	EPS8	Epidermal growth factor receptor kinase substrate 8	GO:0051016; P:barbed-end actin filament capping; ISS:UniProtKB
Q12929	EPS8	Epidermal growth factor receptor kinase substrate 8	GO:0048149; P:behavioral response to ethanol; IEA:Ensembl
Q12929	EPS8	Epidermal growth factor receptor kinase substrate 8	GO:0008283; P:cell proliferation; TAS:ProtInc
Q12929	EPS8	Epidermal growth factor receptor kinase substrate 8	GO:0036336; P:dendritic cell migration; ISS:UniProtKB
Q12929	EPS8	Epidermal growth factor receptor kinase substrate 8	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:ProtInc
Q12929	EPS8	Epidermal growth factor receptor kinase substrate 8	GO:0010458; P:exit from mitosis; ISS:UniProtKB
Q12929	EPS8	Epidermal growth factor receptor kinase substrate 8	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
Q12929	EPS8	Epidermal growth factor receptor kinase substrate 8	GO:0016601; P:Rac protein signal transduction; ISS:UniProtKB
Q12929	EPS8	Epidermal growth factor receptor kinase substrate 8	GO:0030832; P:regulation of actin filament length; ISS:UniProtKB
Q12929	EPS8	Epidermal growth factor receptor kinase substrate 8	GO:0008360; P:regulation of cell shape; ISS:UniProtKB
Q12929	EPS8	Epidermal growth factor receptor kinase substrate 8	GO:0007165; P:signal transduction; TAS:ProtInc
Q9C0D9	EPT1	Ethanolaminephosphotransferase 1	GO:0004307; F:ethanolaminephosphotransferase activity; IEA:UniProtKB-EC
Q9C0D9	EPT1	Ethanolaminephosphotransferase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9C0D9	EPT1	Ethanolaminephosphotransferase 1	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9C0D9	EPT1	Ethanolaminephosphotransferase 1	GO:0006646; P:phosphatidylethanolamine biosynthetic process; TAS:Reactome
Q9C0D9	EPT1	Ethanolaminephosphotransferase 1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9C0D9	EPT1	Ethanolaminephosphotransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99645	EPYC	Epiphycan	GO:0005539; F:glycosaminoglycan binding; TAS:ProtInc
Q99645	EPYC	Epiphycan	GO:0007565; P:female pregnancy; TAS:ProtInc
Q9NQ60	EQTN	Equatorin	GO:0060478; P:acrosomal vesicle exocytosis; IEA:Ensembl
Q9NQ60	EQTN	Equatorin	GO:0006897; P:endocytosis; IEA:Ensembl
Q9NQ60	EQTN	Equatorin	GO:0007342; P:fusion of sperm to egg plasma membrane; IEA:Ensembl
Q5T890	ERCC6L2	DNA excision repair protein ERCC-6-like 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5T890	ERCC6L2	DNA excision repair protein ERCC-6-like 2	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q5T890	ERCC6L2	DNA excision repair protein ERCC-6-like 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5T890	ERCC6L2	DNA excision repair protein ERCC-6-like 2	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
O75616	ERAL1	GTPase Era, mitochondrial	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
O75616	ERAL1	GTPase Era, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75616	ERAL1	GTPase Era, mitochondrial	GO:0043024; F:ribosomal small subunit binding; IDA:UniProtKB
O75616	ERAL1	GTPase Era, mitochondrial	GO:0019843; F:rRNA binding; IDA:UniProtKB
O75616	ERAL1	GTPase Era, mitochondrial	GO:0000028; P:ribosomal small subunit assembly; IMP:UniProtKB
Q9NZ08	ERAP1	Endoplasmic reticulum aminopeptidase 1	GO:0004177; F:aminopeptidase activity; IDA:UniProtKB
Q9NZ08	ERAP1	Endoplasmic reticulum aminopeptidase 1	GO:0005151; F:interleukin-1, Type II receptor binding; TAS:HGNC
Q9NZ08	ERAP1	Endoplasmic reticulum aminopeptidase 1	GO:0005138; F:interleukin-6 receptor binding; IPI:UniProtKB
Q9NZ08	ERAP1	Endoplasmic reticulum aminopeptidase 1	GO:0008235; F:metalloexopeptidase activity; IDA:UniProtKB
Q9NZ08	ERAP1	Endoplasmic reticulum aminopeptidase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NZ08	ERAP1	Endoplasmic reticulum aminopeptidase 1	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9NZ08	ERAP1	Endoplasmic reticulum aminopeptidase 1	GO:0001525; P:angiogenesis; TAS:HGNC
Q9NZ08	ERAP1	Endoplasmic reticulum aminopeptidase 1	GO:0019885; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; NAS:UniProtKB
Q9NZ08	ERAP1	Endoplasmic reticulum aminopeptidase 1	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q9NZ08	ERAP1	Endoplasmic reticulum aminopeptidase 1	GO:0045444; P:fat cell differentiation; NAS:UniProtKB
Q9NZ08	ERAP1	Endoplasmic reticulum aminopeptidase 1	GO:0006509; P:membrane protein ectodomain proteolysis; IDA:UniProtKB
Q9NZ08	ERAP1	Endoplasmic reticulum aminopeptidase 1	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
Q9NZ08	ERAP1	Endoplasmic reticulum aminopeptidase 1	GO:0008217; P:regulation of blood pressure; NAS:UniProtKB
Q9NZ08	ERAP1	Endoplasmic reticulum aminopeptidase 1	GO:0045088; P:regulation of innate immune response; NAS:UniProtKB
Q9NZ08	ERAP1	Endoplasmic reticulum aminopeptidase 1	GO:0009617; P:response to bacterium; IEP:BHF-UCL
Q6P179	ERAP2	Endoplasmic reticulum aminopeptidase 2	GO:0004177; F:aminopeptidase activity; IDA:HGNC
Q6P179	ERAP2	Endoplasmic reticulum aminopeptidase 2	GO:0008237; F:metallopeptidase activity; IDA:HGNC
Q6P179	ERAP2	Endoplasmic reticulum aminopeptidase 2	GO:0008270; F:zinc ion binding; TAS:HGNC
Q6P179	ERAP2	Endoplasmic reticulum aminopeptidase 2	GO:0019885; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; TAS:HGNC
Q6P179	ERAP2	Endoplasmic reticulum aminopeptidase 2	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q6P179	ERAP2	Endoplasmic reticulum aminopeptidase 2	GO:0008217; P:regulation of blood pressure; TAS:HGNC
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0005006; F:epidermal growth factor-activated receptor activity; NAS:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0043125; F:ErbB-3 class receptor binding; TAS:ProtInc
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0042802; F:identical protein binding; IPI:IntAct
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0005515; F:protein binding; IPI:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0046983; F:protein dimerization activity; NAS:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0004713; F:protein tyrosine kinase activity; IDA:BHF-UCL
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0004716; F:receptor signaling protein tyrosine kinase activity; TAS:ProtInc
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0001042; F:RNA polymerase I core binding; IDA:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IDA:BHF-UCL
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0004888; F:transmembrane signaling receptor activity; IDA:BHF-UCL
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0007411; P:axon guidance; TAS:Reactome
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0008283; P:cell proliferation; TAS:ProtInc
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0007166; P:cell surface receptor signaling pathway; IDA:MGI
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0007167; P:enzyme linked receptor protein signaling pathway; TAS:ProtInc
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0007507; P:heart development; TAS:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0045087; P:innate immune response; TAS:Reactome
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0030879; P:mammary gland development; TAS:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0008045; P:motor neuron axon guidance; IEA:Ensembl
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0042552; P:myelination; IEA:Ensembl
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0033088; P:negative regulation of immature T cell proliferation in thymus; IEA:Ensembl
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0007399; P:nervous system development; TAS:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:GOC
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0007422; P:peripheral nervous system development; IEA:Ensembl
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0014065; P:phosphatidylinositol 3-kinase signaling; IDA:BHF-UCL
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0048015; P:phosphatidylinositol-mediated signaling; NAS:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0045785; P:positive regulation of cell adhesion; IDA:BHF-UCL
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0030307; P:positive regulation of cell growth; IMP:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0043406; P:positive regulation of MAP kinase activity; IDA:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0001934; P:positive regulation of protein phosphorylation; ISS:BHF-UCL
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0032321; P:positive regulation of Rho GTPase activity; ISS:BHF-UCL
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0045943; P:positive regulation of transcription from RNA polymerase I promoter; IMP:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0045945; P:positive regulation of transcription from RNA polymerase III promoter; IDA:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0045727; P:positive regulation of translation; IMP:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0046777; P:protein autophosphorylation; IDA:BHF-UCL
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0045765; P:regulation of angiogenesis; NAS:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0070372; P:regulation of ERK1 and ERK2 cascade; IMP:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0032886; P:regulation of microtubule-based process; IDA:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0007165; P:signal transduction; IDA:UniProtKB
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0023014; P:signal transduction by phosphorylation; TAS:GOC
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IDA:BHF-UCL
P04626	ERBB2	Receptor tyrosine-protein kinase erbB-2	GO:0042060; P:wound healing; IDA:BHF-UCL
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0019838; F:growth factor binding; IPI:BHF-UCL
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0005515; F:protein binding; IPI:UniProtKB
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0042803; F:protein homodimerization activity; NAS:BHF-UCL
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0004672; F:protein kinase activity; IEA:InterPro
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0030296; F:protein tyrosine kinase activator activity; IDA:BHF-UCL
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0004888; F:transmembrane signaling receptor activity; ISS:BHF-UCL
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0021545; P:cranial nerve development; ISS:BHF-UCL
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0003197; P:endocardial cushion development; IEA:Ensembl
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IMP:BHF-UCL
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0007507; P:heart development; ISS:BHF-UCL
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0045087; P:innate immune response; TAS:Reactome
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0007162; P:negative regulation of cell adhesion; IDA:BHF-UCL
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:BHF-UCL
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0051048; P:negative regulation of secretion; IDA:BHF-UCL
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0009968; P:negative regulation of signal transduction; IDA:BHF-UCL
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0051402; P:neuron apoptotic process; IMP:BHF-UCL
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0007422; P:peripheral nervous system development; ISS:BHF-UCL
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0014065; P:phosphatidylinositol 3-kinase signaling; IDA:BHF-UCL
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; TAS:BHF-UCL
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0061098; P:positive regulation of protein tyrosine kinase activity; IMP:BHF-UCL
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0042127; P:regulation of cell proliferation; IDA:BHF-UCL
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0014037; P:Schwann cell differentiation; ISS:BHF-UCL
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0007165; P:signal transduction; IDA:UniProtKB
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; ISS:BHF-UCL
P21860	ERBB3	Receptor tyrosine-protein kinase erbB-3	GO:0042060; P:wound healing; NAS:BHF-UCL
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0005154; F:epidermal growth factor receptor binding; IPI:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0005515; F:protein binding; IPI:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0004716; F:receptor signaling protein tyrosine kinase activity; IEA:InterPro
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0044212; F:transcription regulatory region DNA binding; IMP:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IDA:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0061026; P:cardiac muscle tissue regeneration; ISS:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0045165; P:cell fate commitment; IEA:Ensembl
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0016477; P:cell migration; IDA:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0008283; P:cell proliferation; TAS:ProtInc
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0021551; P:central nervous system morphogenesis; ISS:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0009880; P:embryonic pattern specification; ISS:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0007507; P:heart development; ISS:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0045087; P:innate immune response; TAS:Reactome
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0007595; P:lactation; IMP:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0060749; P:mammary gland alveolus development; ISS:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0060644; P:mammary gland epithelial cell differentiation; ISS:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0043653; P:mitochondrial fragmentation involved in apoptotic process; IMP:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0007399; P:nervous system development; ISS:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0001755; P:neural crest cell migration; ISS:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0021889; P:olfactory bulb interneuron differentiation; ISS:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0060045; P:positive regulation of cardiac muscle cell proliferation; ISS:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IDA:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0001934; P:positive regulation of protein phosphorylation; TAS:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:2000366; P:positive regulation of STAT protein import into nucleus; IMP:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0042523; P:positive regulation of tyrosine phosphorylation of Stat5 protein; IMP:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0030334; P:regulation of cell migration; ISS:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0007165; P:signal transduction; IDA:UniProtKB
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15303	ERBB4	Receptor tyrosine-protein kinase erbB-4	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IDA:UniProtKB
O15083	ERC2	ERC protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q2NKX8	ERCC6L	DNA excision repair protein ERCC-6-like	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q2NKX8	ERCC6L	DNA excision repair protein ERCC-6-like	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q2NKX8	ERCC6L	DNA excision repair protein ERCC-6-like	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q2NKX8	ERCC6L	DNA excision repair protein ERCC-6-like	GO:0005515; F:protein binding; IPI:IntAct
Q2NKX8	ERCC6L	DNA excision repair protein ERCC-6-like	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q2NKX8	ERCC6L	DNA excision repair protein ERCC-6-like	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0003684; F:damaged DNA binding; IDA:UniProtKB
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0005515; F:protein binding; IPI:UniProtKB
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0008283; P:cell proliferation; IEA:Ensembl
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0051276; P:chromosome organization; IEA:Ensembl
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0006310; P:DNA recombination; IGI:MGI
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0006281; P:DNA repair; TAS:Reactome
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0006302; P:double-strand break repair; IEA:Ensembl
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0048568; P:embryonic organ development; IEA:Ensembl
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0007281; P:germ cell development; IEA:Ensembl
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0045190; P:isotype switching; IEA:Ensembl
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0008584; P:male gonad development; IEA:Ensembl
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0006312; P:mitotic recombination; IMP:UniProtKB
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0035264; P:multicellular organism growth; IEA:Ensembl
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0010259; P:multicellular organismal aging; IEA:Ensembl
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0032205; P:negative regulation of telomere maintenance; IMP:UniProtKB
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0006289; P:nucleotide-excision repair; IDA:MGI
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0000718; P:nucleotide-excision repair, DNA damage removal; TAS:Reactome
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0006295; P:nucleotide-excision repair, DNA incision, 3'-to lesion; IMP:UniProtKB
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0006296; P:nucleotide-excision repair, DNA incision, 5'-to lesion; IMP:UniProtKB
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0048477; P:oogenesis; IEA:Ensembl
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0035166; P:post-embryonic hemopoiesis; IEA:Ensembl
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0000720; P:pyrimidine dimer repair by nucleotide-excision repair; IEA:Ensembl
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0001302; P:replicative cell aging; IEA:Ensembl
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0007584; P:response to nutrient; IEA:Ensembl
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0006979; P:response to oxidative stress; IMP:UniProtKB
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0009744; P:response to sucrose; IEA:Ensembl
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0010165; P:response to X-ray; IEA:Ensembl
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0007283; P:spermatogenesis; IEA:Ensembl
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0006949; P:syncytium formation; IEA:Ensembl
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P07992	ERCC1	DNA excision repair protein ERCC-1	GO:0009650; P:UV protection; IEA:Ensembl
P28715	ERCC5	DNA repair protein complementing XP-G cells	GO:0000405; F:bubble DNA binding; IDA:UniProtKB
P28715	ERCC5	DNA repair protein complementing XP-G cells	GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB
P28715	ERCC5	DNA repair protein complementing XP-G cells	GO:0004520; F:endodeoxyribonuclease activity; IDA:UniProtKB
P28715	ERCC5	DNA repair protein complementing XP-G cells	GO:0004519; F:endonuclease activity; TAS:Reactome
P28715	ERCC5	DNA repair protein complementing XP-G cells	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P28715	ERCC5	DNA repair protein complementing XP-G cells	GO:0005515; F:protein binding; IPI:UniProtKB
P28715	ERCC5	DNA repair protein complementing XP-G cells	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P28715	ERCC5	DNA repair protein complementing XP-G cells	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
P28715	ERCC5	DNA repair protein complementing XP-G cells	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
P28715	ERCC5	DNA repair protein complementing XP-G cells	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
P28715	ERCC5	DNA repair protein complementing XP-G cells	GO:0006281; P:DNA repair; TAS:Reactome
P28715	ERCC5	DNA repair protein complementing XP-G cells	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P28715	ERCC5	DNA repair protein complementing XP-G cells	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P28715	ERCC5	DNA repair protein complementing XP-G cells	GO:0000718; P:nucleotide-excision repair, DNA damage removal; TAS:Reactome
P28715	ERCC5	DNA repair protein complementing XP-G cells	GO:0006295; P:nucleotide-excision repair, DNA incision, 3'-to lesion; IDA:UniProtKB
P28715	ERCC5	DNA repair protein complementing XP-G cells	GO:0009411; P:response to UV; IDA:UniProtKB
P28715	ERCC5	DNA repair protein complementing XP-G cells	GO:0010225; P:response to UV-C; IMP:UniProtKB
P28715	ERCC5	DNA repair protein complementing XP-G cells	GO:0006283; P:transcription-coupled nucleotide-excision repair; IMP:UniProtKB
P28715	ERCC5	DNA repair protein complementing XP-G cells	GO:0009650; P:UV protection; IGI:MGI
Q13216	ERCC8	DNA excision repair protein ERCC-8	GO:0005515; F:protein binding; IPI:UniProtKB
Q13216	ERCC8	DNA excision repair protein ERCC-8	GO:0032403; F:protein complex binding; IDA:UniProtKB
Q13216	ERCC8	DNA excision repair protein ERCC-8	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q13216	ERCC8	DNA excision repair protein ERCC-8	GO:0006281; P:DNA repair; TAS:Reactome
Q13216	ERCC8	DNA excision repair protein ERCC-8	GO:0006289; P:nucleotide-excision repair; IMP:UniProtKB
Q13216	ERCC8	DNA excision repair protein ERCC-8	GO:0045739; P:positive regulation of DNA repair; IMP:UniProtKB
Q13216	ERCC8	DNA excision repair protein ERCC-8	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q13216	ERCC8	DNA excision repair protein ERCC-8	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
Q13216	ERCC8	DNA excision repair protein ERCC-8	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q13216	ERCC8	DNA excision repair protein ERCC-8	GO:0006979; P:response to oxidative stress; IDA:UniProtKB
Q13216	ERCC8	DNA excision repair protein ERCC-8	GO:0009411; P:response to UV; IDA:UniProtKB
Q13216	ERCC8	DNA excision repair protein ERCC-8	GO:0010165; P:response to X-ray; IEA:Ensembl
Q13216	ERCC8	DNA excision repair protein ERCC-8	GO:0006283; P:transcription-coupled nucleotide-excision repair; IMP:UniProtKB
P24390	KDELR1	ER lumen protein-retaining receptor 1	GO:0005046; F:KDEL sequence binding; TAS:ProtInc
P24390	KDELR1	ER lumen protein-retaining receptor 1	GO:0006886; P:intracellular protein transport; TAS:ProtInc
P24390	KDELR1	ER lumen protein-retaining receptor 1	GO:0006621; P:protein retention in ER lumen; IEA:InterPro
P24390	KDELR1	ER lumen protein-retaining receptor 1	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0000441; ?:?; IEA:Ensembl
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0043139; F:5'-3' DNA helicase activity; IDA:UniProtKB
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0004003; F:ATP-dependent DNA helicase activity; IEA:InterPro
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0008094; F:DNA-dependent ATPase activity; TAS:UniProtKB
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0005515; F:protein binding; IPI:UniProtKB
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0007568; P:aging; IEA:Ensembl
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0006915; P:apoptotic process; IMP:UniProtKB
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0006200; P:ATP catabolic process; IDA:GOC
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0030282; P:bone mineralization; IEA:Ensembl
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0008283; P:cell proliferation; IEA:Ensembl
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0032289; P:central nervous system myelin formation; IEA:Ensembl
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0007059; P:chromosome segregation; IMP:UniProtKB
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0032508; P:DNA duplex unwinding; IDA:GOC
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0006281; P:DNA repair; TAS:Reactome
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0040016; P:embryonic cleavage; IEA:Ensembl
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0043249; P:erythrocyte maturation; IEA:Ensembl
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0010467; P:gene expression; TAS:Reactome
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0035315; P:hair cell differentiation; IMP:UniProtKB
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0048820; P:hair follicle maturation; IEA:Ensembl
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0060218; P:hematopoietic stem cell differentiation; IEA:Ensembl
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0035264; P:multicellular organism growth; IEA:Ensembl
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0006289; P:nucleotide-excision repair; NAS:UniProtKB
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0000718; P:nucleotide-excision repair, DNA damage removal; TAS:Reactome
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0033683; P:nucleotide-excision repair, DNA incision; IMP:UniProtKB
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0043388; P:positive regulation of DNA binding; IEA:Ensembl
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0009791; P:post-embryonic development; IEA:Ensembl
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0006468; P:protein phosphorylation; IDA:GOC
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:1901990; P:regulation of mitotic cell cycle phase transition; IMP:UniProtKB
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0001666; P:response to hypoxia; IEA:Ensembl
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0006979; P:response to oxidative stress; IMP:UniProtKB
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0021510; P:spinal cord development; IEA:Ensembl
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0006283; P:transcription-coupled nucleotide-excision repair; IDA:UniProtKB
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0009650; P:UV protection; IGI:MGI
P18074	ERCC2	TFIIH basal transcription factor complex helicase XPD subunit	GO:0016032; P:viral process; TAS:Reactome
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0000441; ?:?; IEA:Ensembl
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0043138; F:3'-5' DNA helicase activity; IDA:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0004003; F:ATP-dependent DNA helicase activity; IEA:Ensembl
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0016887; F:ATPase activity; IDA:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0003684; F:damaged DNA binding; NAS:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0032564; F:dATP binding; IEA:Ensembl
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0003677; F:DNA binding; TAS:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0005525; F:GTP binding; IEA:Ensembl
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0042277; F:peptide binding; IEA:Ensembl
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0005515; F:protein binding; IPI:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0008353; F:RNA polymerase II carboxy-terminal domain kinase activity; IEA:Ensembl
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0008134; F:transcription factor binding; IDA:MGI
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0006915; P:apoptotic process; IMP:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0006281; P:DNA repair; IMP:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0006265; P:DNA topological change; IMP:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0010467; P:gene expression; TAS:Reactome
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0035315; P:hair cell differentiation; IMP:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0006289; P:nucleotide-excision repair; IMP:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0000718; P:nucleotide-excision repair, DNA damage removal; TAS:Reactome
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0000717; P:nucleotide-excision repair, DNA duplex unwinding; IMP:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0033683; P:nucleotide-excision repair, DNA incision; IMP:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0008104; P:protein localization; IMP:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:1901990; P:regulation of mitotic cell cycle phase transition; IMP:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0001666; P:response to hypoxia; IEA:Ensembl
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0006979; P:response to oxidative stress; IMP:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0009411; P:response to UV; IMP:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0006283; P:transcription-coupled nucleotide-excision repair; IDA:UniProtKB
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0009650; P:UV protection; IEA:Ensembl
P19447	ERCC3	TFIIH basal transcription factor complex helicase XPB subunit	GO:0016032; P:viral process; TAS:Reactome
P33947	KDELR2	ER lumen protein-retaining receptor 2	GO:0005046; F:KDEL sequence binding; TAS:ProtInc
P33947	KDELR2	ER lumen protein-retaining receptor 2	GO:0006886; P:intracellular protein transport; TAS:ProtInc
P33947	KDELR2	ER lumen protein-retaining receptor 2	GO:0006621; P:protein retention in ER lumen; IEA:InterPro
P33947	KDELR2	ER lumen protein-retaining receptor 2	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0005524; F:ATP binding; IDA:UniProtKB
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0003677; F:DNA binding; IDA:UniProtKB
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0008094; F:DNA-dependent ATPase activity; IDA:UniProtKB
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0005515; F:protein binding; IPI:UniProtKB
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0032403; F:protein complex binding; IDA:UniProtKB
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0007256; P:activation of JNKK activity; IEA:Ensembl
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0007257; P:activation of JUN kinase activity; IEA:Ensembl
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0006200; P:ATP catabolic process; IDA:GOC
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0006284; P:base-excision repair; IMP:UniProtKB
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0006281; P:DNA repair; TAS:Reactome
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0045494; P:photoreceptor cell maintenance; IEA:Ensembl
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0032786; P:positive regulation of DNA-templated transcription, elongation; IDA:UniProtKB
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0006290; P:pyrimidine dimer repair; IEA:Ensembl
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0032784; P:regulation of DNA-templated transcription, elongation; IDA:UniProtKB
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0010332; P:response to gamma radiation; IEA:Ensembl
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0006979; P:response to oxidative stress; IDA:UniProtKB
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0000303; P:response to superoxide; IEA:Ensembl
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0009636; P:response to toxic substance; IEA:Ensembl
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0009411; P:response to UV; IDA:UniProtKB
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0010224; P:response to UV-B; IEA:Ensembl
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0010165; P:response to X-ray; IEA:Ensembl
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0006366; P:transcription from RNA polymerase II promoter; NAS:UniProtKB
Q03468	ERCC6	DNA excision repair protein ERCC-6	GO:0006283; P:transcription-coupled nucleotide-excision repair; IMP:UniProtKB
O43731	KDELR3	ER lumen protein-retaining receptor 3	GO:0046923; F:ER retention sequence binding; IEA:InterPro
O43731	KDELR3	ER lumen protein-retaining receptor 3	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
O43731	KDELR3	ER lumen protein-retaining receptor 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O43731	KDELR3	ER lumen protein-retaining receptor 3	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
O43731	KDELR3	ER lumen protein-retaining receptor 3	GO:0006621; P:protein retention in ER lumen; IEA:InterPro
O43731	KDELR3	ER lumen protein-retaining receptor 3	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O43731	KDELR3	ER lumen protein-retaining receptor 3	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
O14944	EREG	Proepiregulin	GO:0005154; F:epidermal growth factor receptor binding; ISS:UniProtKB
O14944	EREG	Proepiregulin	GO:0005515; F:protein binding; IPI:UniProtKB
O14944	EREG	Proepiregulin	GO:0009653; P:anatomical structure morphogenesis; TAS:UniProtKB
O14944	EREG	Proepiregulin	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
O14944	EREG	Proepiregulin	GO:0007267; P:cell-cell signaling; IDA:UniProtKB
O14944	EREG	Proepiregulin	GO:0019221; P:cytokine-mediated signaling pathway; IDA:UniProtKB
O14944	EREG	Proepiregulin	GO:0007173; P:epidermal growth factor receptor signaling pathway; ISS:UniProtKB
O14944	EREG	Proepiregulin	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O14944	EREG	Proepiregulin	GO:0007143; P:female meiotic division; ISS:UniProtKB
O14944	EREG	Proepiregulin	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
O14944	EREG	Proepiregulin	GO:0045087; P:innate immune response; TAS:Reactome
O14944	EREG	Proepiregulin	GO:0030216; P:keratinocyte differentiation; TAS:UniProtKB
O14944	EREG	Proepiregulin	GO:0043616; P:keratinocyte proliferation; IDA:UniProtKB
O14944	EREG	Proepiregulin	GO:0042700; P:luteinizing hormone signaling pathway; ISS:UniProtKB
O14944	EREG	Proepiregulin	GO:0009299; P:mRNA transcription; IDA:UniProtKB
O14944	EREG	Proepiregulin	GO:0008285; P:negative regulation of cell proliferation; ISS:UniProtKB
O14944	EREG	Proepiregulin	GO:0050680; P:negative regulation of epithelial cell proliferation; TAS:UniProtKB
O14944	EREG	Proepiregulin	GO:0051151; P:negative regulation of smooth muscle cell differentiation; IDA:UniProtKB
O14944	EREG	Proepiregulin	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
O14944	EREG	Proepiregulin	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O14944	EREG	Proepiregulin	GO:0001556; P:oocyte maturation; ISS:UniProtKB
O14944	EREG	Proepiregulin	GO:0009887; P:organ morphogenesis; TAS:UniProtKB
O14944	EREG	Proepiregulin	GO:0001550; P:ovarian cumulus expansion; ISS:UniProtKB
O14944	EREG	Proepiregulin	GO:0030728; P:ovulation; ISS:UniProtKB
O14944	EREG	Proepiregulin	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
O14944	EREG	Proepiregulin	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
O14944	EREG	Proepiregulin	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
O14944	EREG	Proepiregulin	GO:0042108; P:positive regulation of cytokine biosynthetic process; IDA:UniProtKB
O14944	EREG	Proepiregulin	GO:0001819; P:positive regulation of cytokine production; ISS:UniProtKB
O14944	EREG	Proepiregulin	GO:0045740; P:positive regulation of DNA replication; IDA:UniProtKB
O14944	EREG	Proepiregulin	GO:0045741; P:positive regulation of epidermal growth factor-activated receptor activity; ISS:UniProtKB
O14944	EREG	Proepiregulin	GO:0048146; P:positive regulation of fibroblast proliferation; IDA:UniProtKB
O14944	EREG	Proepiregulin	GO:0045089; P:positive regulation of innate immune response; ISS:UniProtKB
O14944	EREG	Proepiregulin	GO:0045410; P:positive regulation of interleukin-6 biosynthetic process; ISS:UniProtKB
O14944	EREG	Proepiregulin	GO:0045840; P:positive regulation of mitosis; ISS:UniProtKB
O14944	EREG	Proepiregulin	GO:0042327; P:positive regulation of phosphorylation; IDA:UniProtKB
O14944	EREG	Proepiregulin	GO:0045860; P:positive regulation of protein kinase activity; IDA:UniProtKB
O14944	EREG	Proepiregulin	GO:0048661; P:positive regulation of smooth muscle cell proliferation; ISS:UniProtKB
O14944	EREG	Proepiregulin	GO:0048160; P:primary follicle stage; ISS:UniProtKB
O14944	EREG	Proepiregulin	GO:0043434; P:response to peptide hormone; IEA:Ensembl
O14944	EREG	Proepiregulin	GO:0042060; P:wound healing; TAS:UniProtKB
P62495	ETF1	Eukaryotic peptide chain release factor subunit 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62495	ETF1	Eukaryotic peptide chain release factor subunit 1	GO:0005515; F:protein binding; IPI:UniProtKB
P62495	ETF1	Eukaryotic peptide chain release factor subunit 1	GO:0043022; F:ribosome binding; TAS:UniProtKB
P62495	ETF1	Eukaryotic peptide chain release factor subunit 1	GO:0003723; F:RNA binding; TAS:ProtInc
P62495	ETF1	Eukaryotic peptide chain release factor subunit 1	GO:0003747; F:translation release factor activity; TAS:UniProtKB
P62495	ETF1	Eukaryotic peptide chain release factor subunit 1	GO:0016149; F:translation release factor activity, codon specific; IEA:InterPro
P62495	ETF1	Eukaryotic peptide chain release factor subunit 1	GO:0008079; F:translation termination factor activity; TAS:ProtInc
P62495	ETF1	Eukaryotic peptide chain release factor subunit 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62495	ETF1	Eukaryotic peptide chain release factor subunit 1	GO:0010467; P:gene expression; TAS:Reactome
P62495	ETF1	Eukaryotic peptide chain release factor subunit 1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62495	ETF1	Eukaryotic peptide chain release factor subunit 1	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62495	ETF1	Eukaryotic peptide chain release factor subunit 1	GO:0006479; P:protein methylation; IDA:MGI
P62495	ETF1	Eukaryotic peptide chain release factor subunit 1	GO:0006449; P:regulation of translational termination; TAS:ProtInc
P62495	ETF1	Eukaryotic peptide chain release factor subunit 1	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62495	ETF1	Eukaryotic peptide chain release factor subunit 1	GO:0006412; P:translation; TAS:Reactome
P62495	ETF1	Eukaryotic peptide chain release factor subunit 1	GO:0006415; P:translational termination; TAS:Reactome
P15170	GSPT1	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P15170	GSPT1	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A	GO:0003924; F:GTPase activity; TAS:UniProtKB
P15170	GSPT1	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P15170	GSPT1	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A	GO:0005515; F:protein binding; IPI:IntAct
P15170	GSPT1	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A	GO:0003747; F:translation release factor activity; IMP:UniProtKB
P15170	GSPT1	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:UniProtKB
P15170	GSPT1	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A	GO:0006184; P:GTP catabolic process; TAS:GOC
P15170	GSPT1	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:UniProtKB
P15170	GSPT1	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A	GO:0006479; P:protein methylation; IDA:MGI
P15170	GSPT1	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A	GO:0006415; P:translational termination; IMP:GOC
Q8IYD1	GSPT2	Eukaryotic peptide chain release factor GTP-binding subunit ERF3B	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q8IYD1	GSPT2	Eukaryotic peptide chain release factor GTP-binding subunit ERF3B	GO:0003924; F:GTPase activity; IEA:InterPro
Q8IYD1	GSPT2	Eukaryotic peptide chain release factor GTP-binding subunit ERF3B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IYD1	GSPT2	Eukaryotic peptide chain release factor GTP-binding subunit ERF3B	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IYD1	GSPT2	Eukaryotic peptide chain release factor GTP-binding subunit ERF3B	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8IYD1	GSPT2	Eukaryotic peptide chain release factor GTP-binding subunit ERF3B	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8IYD1	GSPT2	Eukaryotic peptide chain release factor GTP-binding subunit ERF3B	GO:0010467; P:gene expression; TAS:Reactome
Q8IYD1	GSPT2	Eukaryotic peptide chain release factor GTP-binding subunit ERF3B	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q8IYD1	GSPT2	Eukaryotic peptide chain release factor GTP-binding subunit ERF3B	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
Q8IYD1	GSPT2	Eukaryotic peptide chain release factor GTP-binding subunit ERF3B	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q8IYD1	GSPT2	Eukaryotic peptide chain release factor GTP-binding subunit ERF3B	GO:0006412; P:translation; TAS:Reactome
Q8IYD1	GSPT2	Eukaryotic peptide chain release factor GTP-binding subunit ERF3B	GO:0006415; P:translational termination; TAS:Reactome
P50548	ERF	ETS domain-containing transcription factor ERF	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P50548	ERF	ETS domain-containing transcription factor ERF	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
P50548	ERF	ETS domain-containing transcription factor ERF	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
P50548	ERF	ETS domain-containing transcription factor ERF	GO:0007049; P:cell cycle; NAS:UniProtKB
P50548	ERF	ETS domain-containing transcription factor ERF	GO:0030154; P:cell differentiation; IBA:RefGenome
P50548	ERF	ETS domain-containing transcription factor ERF	GO:0060710; P:chorio-allantoic fusion; IEA:Ensembl
P50548	ERF	ETS domain-containing transcription factor ERF	GO:0010668; P:ectodermal cell differentiation; IEA:Ensembl
P50548	ERF	ETS domain-containing transcription factor ERF	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P50548	ERF	ETS domain-containing transcription factor ERF	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
P50548	ERF	ETS domain-containing transcription factor ERF	GO:0060707; P:trophoblast giant cell differentiation; IEA:Ensembl
Q14534	SQLE	Squalene monooxygenase	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q14534	SQLE	Squalene monooxygenase	GO:0004506; F:squalene monooxygenase activity; NAS:UniProtKB
Q14534	SQLE	Squalene monooxygenase	GO:0006725; P:cellular aromatic compound metabolic process; IEA:Ensembl
Q14534	SQLE	Squalene monooxygenase	GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome
Q14534	SQLE	Squalene monooxygenase	GO:0010033; P:response to organic substance; IEA:Ensembl
Q14534	SQLE	Squalene monooxygenase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14534	SQLE	Squalene monooxygenase	GO:0016126; P:sterol biosynthetic process; NAS:UniProtKB
O76062	TM7SF2	Delta(14)-sterol reductase	GO:0050613; F:delta14-sterol reductase activity; IEA:UniProtKB-EC
O76062	TM7SF2	Delta(14)-sterol reductase	GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome
O76062	TM7SF2	Delta(14)-sterol reductase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UKR5	C14orf1	Probable ergosterol biosynthetic protein 28	GO:0016126; P:sterol biosynthetic process; IEA:UniProtKB-KW
P48449	LSS	Lanosterol synthase	GO:0000250; F:lanosterol synthase activity; TAS:ProtInc
P48449	LSS	Lanosterol synthase	GO:0006695; P:cholesterol biosynthetic process; IMP:BHF-UCL
P48449	LSS	Lanosterol synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P48449	LSS	Lanosterol synthase	GO:0008202; P:steroid metabolic process; TAS:ProtInc
Q969X5	ERGIC1	Endoplasmic reticulum-Golgi intermediate compartment protein 1	GO:0005515; F:protein binding; IPI:HGNC
Q969X5	ERGIC1	Endoplasmic reticulum-Golgi intermediate compartment protein 1	GO:0006888; P:ER to Golgi vesicle-mediated transport; IDA:HGNC
Q96RQ1	ERGIC2	Endoplasmic reticulum-Golgi intermediate compartment protein 2	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q9Y282	ERGIC3	Endoplasmic reticulum-Golgi intermediate compartment protein 3	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
P11308	ERG	Transcriptional regulator ERG	GO:0003677; F:DNA binding; TAS:ProtInc
P11308	ERG	Transcriptional regulator ERG	GO:0005515; F:protein binding; IPI:IntAct
P11308	ERG	Transcriptional regulator ERG	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P11308	ERG	Transcriptional regulator ERG	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
P11308	ERG	Transcriptional regulator ERG	GO:0004871; F:signal transducer activity; TAS:ProtInc
P11308	ERG	Transcriptional regulator ERG	GO:0030154; P:cell differentiation; IBA:RefGenome
P11308	ERG	Transcriptional regulator ERG	GO:0008283; P:cell proliferation; TAS:ProtInc
P11308	ERG	Transcriptional regulator ERG	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P11308	ERG	Transcriptional regulator ERG	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P11308	ERG	Transcriptional regulator ERG	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
P11308	ERG	Transcriptional regulator ERG	GO:0007165; P:signal transduction; TAS:ProtInc
P11308	ERG	Transcriptional regulator ERG	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
P84090	ERH	Enhancer of rudimentary homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P84090	ERH	Enhancer of rudimentary homolog	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P84090	ERH	Enhancer of rudimentary homolog	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
P84090	ERH	Enhancer of rudimentary homolog	GO:0006213; P:pyrimidine nucleoside metabolic process; TAS:ProtInc
Q8IV48	ERI1	3'-5' exoribonuclease 1	GO:0008408; F:3'-5' exonuclease activity; IDA:UniProtKB
Q8IV48	ERI1	3'-5' exoribonuclease 1	GO:0071207; F:histone pre-mRNA stem-loop binding; ISS:UniProtKB
Q8IV48	ERI1	3'-5' exoribonuclease 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IV48	ERI1	3'-5' exoribonuclease 1	GO:0043022; F:ribosome binding; ISS:UniProtKB
Q8IV48	ERI1	3'-5' exoribonuclease 1	GO:0019843; F:rRNA binding; ISS:UniProtKB
Q8IV48	ERI1	3'-5' exoribonuclease 1	GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW
Q8IV48	ERI1	3'-5' exoribonuclease 1	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:GOC
Q8IV48	ERI1	3'-5' exoribonuclease 1	GO:0031125; P:rRNA 3'-end processing; ISS:UniProtKB
O43414	ERI3	ERI1 exoribonuclease 3	GO:0004527; F:exonuclease activity; IEA:UniProtKB-KW
O43414	ERI3	ERI1 exoribonuclease 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43414	ERI3	ERI1 exoribonuclease 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
A8K979	ERI2	ERI1 exoribonuclease 2	GO:0004527; F:exonuclease activity; IEA:UniProtKB-KW
A8K979	ERI2	ERI1 exoribonuclease 2	GO:0003676; F:nucleic acid binding; IEA:InterPro
A8K979	ERI2	ERI1 exoribonuclease 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96DZ1	ERLEC1	Endoplasmic reticulum lectin 1	GO:0001948; F:glycoprotein binding; IDA:UniProtKB
Q96DZ1	ERLEC1	Endoplasmic reticulum lectin 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96DZ1	ERLEC1	Endoplasmic reticulum lectin 1	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
O75477	ERLIN1	Erlin-1	GO:0005515; F:protein binding; IPI:UniProtKB
O75477	ERLIN1	Erlin-1	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
O94905	ERLIN2	Erlin-2	GO:0005515; F:protein binding; IPI:UniProtKB
O94905	ERLIN2	Erlin-2	GO:0008219; P:cell death; IEA:UniProtKB-KW
O94905	ERLIN2	Erlin-2	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q8TAM6	ERMN	Ermin	GO:0007015; P:actin filament organization; IDA:UniProt
Q8TAM6	ERMN	Ermin	GO:0001763; P:morphogenesis of a branching structure; IEA:Ensembl
Q8TAM6	ERMN	Ermin	GO:0031344; P:regulation of cell projection organization; IDA:UniProt
Q8TAM6	ERMN	Ermin	GO:0008360; P:regulation of cell shape; IDA:UniProt
Q7Z2K6	ERMP1	Endoplasmic reticulum metallopeptidase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z2K6	ERMP1	Endoplasmic reticulum metallopeptidase 1	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
O75460	ERN1	Serine/threonine-protein kinase/endoribonuclease IRE1	GO:0005524; F:ATP binding; IDA:UniProtKB
O75460	ERN1	Serine/threonine-protein kinase/endoribonuclease IRE1	GO:0004521; F:endoribonuclease activity; IDA:UniProtKB
O75460	ERN1	Serine/threonine-protein kinase/endoribonuclease IRE1	GO:0019899; F:enzyme binding; IPI:UniProt
O75460	ERN1	Serine/threonine-protein kinase/endoribonuclease IRE1	GO:0042802; F:identical protein binding; IPI:IntAct
O75460	ERN1	Serine/threonine-protein kinase/endoribonuclease IRE1	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
O75460	ERN1	Serine/threonine-protein kinase/endoribonuclease IRE1	GO:0005515; F:protein binding; IPI:IntAct
O75460	ERN1	Serine/threonine-protein kinase/endoribonuclease IRE1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
O75460	ERN1	Serine/threonine-protein kinase/endoribonuclease IRE1	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; IDA:UniProtKB
O75460	ERN1	Serine/threonine-protein kinase/endoribonuclease IRE1	GO:0007050; P:cell cycle arrest; ISS:UniProtKB
O75460	ERN1	Serine/threonine-protein kinase/endoribonuclease IRE1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O75460	ERN1	Serine/threonine-protein kinase/endoribonuclease IRE1	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
O75460	ERN1	Serine/threonine-protein kinase/endoribonuclease IRE1	GO:0070055; P:HAC1-type intron splice site recognition and cleavage; IDA:WormBase
O75460	ERN1	Serine/threonine-protein kinase/endoribonuclease IRE1	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IEA:Ensembl
O75460	ERN1	Serine/threonine-protein kinase/endoribonuclease IRE1	GO:1900103; P:positive regulation of endoplasmic reticulum unfolded protein response; IMP:UniProtKB
O75460	ERN1	Serine/threonine-protein kinase/endoribonuclease IRE1	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
O75460	ERN1	Serine/threonine-protein kinase/endoribonuclease IRE1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
O75460	ERN1	Serine/threonine-protein kinase/endoribonuclease IRE1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O75460	ERN1	Serine/threonine-protein kinase/endoribonuclease IRE1	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; IDA:GOC
O75460	ERN1	Serine/threonine-protein kinase/endoribonuclease IRE1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q76MJ5	ERN2	Serine/threonine-protein kinase/endoribonuclease IRE2	GO:0005524; F:ATP binding; IDA:UniProtKB
Q76MJ5	ERN2	Serine/threonine-protein kinase/endoribonuclease IRE2	GO:0004519; F:endonuclease activity; IDA:UniProtKB
Q76MJ5	ERN2	Serine/threonine-protein kinase/endoribonuclease IRE2	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q76MJ5	ERN2	Serine/threonine-protein kinase/endoribonuclease IRE2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q76MJ5	ERN2	Serine/threonine-protein kinase/endoribonuclease IRE2	GO:0004540; F:ribonuclease activity; IEA:InterPro
Q76MJ5	ERN2	Serine/threonine-protein kinase/endoribonuclease IRE2	GO:0030263; P:apoptotic chromosome condensation; IMP:UniProtKB
Q76MJ5	ERN2	Serine/threonine-protein kinase/endoribonuclease IRE2	GO:0007050; P:cell cycle arrest; IEA:Ensembl
Q76MJ5	ERN2	Serine/threonine-protein kinase/endoribonuclease IRE2	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IEA:Ensembl
Q76MJ5	ERN2	Serine/threonine-protein kinase/endoribonuclease IRE2	GO:0006397; P:mRNA processing; IEA:InterPro
Q76MJ5	ERN2	Serine/threonine-protein kinase/endoribonuclease IRE2	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q76MJ5	ERN2	Serine/threonine-protein kinase/endoribonuclease IRE2	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:GOC
Q76MJ5	ERN2	Serine/threonine-protein kinase/endoribonuclease IRE2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q76MJ5	ERN2	Serine/threonine-protein kinase/endoribonuclease IRE2	GO:0016075; P:rRNA catabolic process; IDA:UniProtKB
Q76MJ5	ERN2	Serine/threonine-protein kinase/endoribonuclease IRE2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96HE7	ERO1L	ERO1-like protein alpha	GO:0016491; F:oxidoreductase activity; IDA:UniProtKB
Q96HE7	ERO1L	ERO1-like protein alpha	GO:0016671; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; IEA:InterPro
Q96HE7	ERO1L	ERO1-like protein alpha	GO:0005515; F:protein binding; IPI:IntAct
Q96HE7	ERO1L	ERO1-like protein alpha	GO:0003756; F:protein disulfide isomerase activity; IEA:InterPro
Q96HE7	ERO1L	ERO1-like protein alpha	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
Q96HE7	ERO1L	ERO1-like protein alpha	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q96HE7	ERO1L	ERO1-like protein alpha	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q96HE7	ERO1L	ERO1-like protein alpha	GO:0051085; P:chaperone mediated protein folding requiring cofactor; IDA:UniProtKB
Q96HE7	ERO1L	ERO1-like protein alpha	GO:0030968; P:endoplasmic reticulum unfolded protein response; IEA:Ensembl
Q96HE7	ERO1L	ERO1-like protein alpha	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISS:UniProtKB
Q96HE7	ERO1L	ERO1-like protein alpha	GO:0006457; P:protein folding; TAS:ProtInc
Q96HE7	ERO1L	ERO1-like protein alpha	GO:0051209; P:release of sequestered calcium ion into cytosol; ISS:UniProtKB
Q96HE7	ERO1L	ERO1-like protein alpha	GO:0034976; P:response to endoplasmic reticulum stress; ISS:UniProtKB
Q96HE7	ERO1L	ERO1-like protein alpha	GO:0009266; P:response to temperature stimulus; TAS:ProtInc
Q86YB8	ERO1LB	ERO1-like protein beta	GO:0016491; F:oxidoreductase activity; NAS:UniProtKB
Q86YB8	ERO1LB	ERO1-like protein beta	GO:0016671; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; IEA:InterPro
Q86YB8	ERO1LB	ERO1-like protein beta	GO:0005515; F:protein binding; IPI:IntAct
Q86YB8	ERO1LB	ERO1-like protein beta	GO:0003756; F:protein disulfide isomerase activity; IEA:InterPro
Q86YB8	ERO1LB	ERO1-like protein beta	GO:0051082; F:unfolded protein binding; NAS:UniProtKB
Q86YB8	ERO1LB	ERO1-like protein beta	GO:0006457; P:protein folding; TAS:UniProtKB
P30040	ERP29	Endoplasmic reticulum resident protein 29	GO:0005515; F:protein binding; IPI:IntAct
P30040	ERP29	Endoplasmic reticulum resident protein 29	GO:0003756; F:protein disulfide isomerase activity; TAS:ProtInc
P30040	ERP29	Endoplasmic reticulum resident protein 29	GO:0006886; P:intracellular protein transport; TAS:ProtInc
P30040	ERP29	Endoplasmic reticulum resident protein 29	GO:0006457; P:protein folding; TAS:ProtInc
P30040	ERP29	Endoplasmic reticulum resident protein 29	GO:0009306; P:protein secretion; IEA:InterPro
Q9BS26	ERP44	Endoplasmic reticulum resident protein 44	GO:0005515; F:protein binding; IPI:IntAct
Q9BS26	ERP44	Endoplasmic reticulum resident protein 44	GO:0003756; F:protein disulfide isomerase activity; IDA:UniProtKB
Q9BS26	ERP44	Endoplasmic reticulum resident protein 44	GO:0045454; P:cell redox homeostasis; TAS:UniProtKB
Q9BS26	ERP44	Endoplasmic reticulum resident protein 44	GO:0009100; P:glycoprotein metabolic process; IDA:UniProtKB
Q9BS26	ERP44	Endoplasmic reticulum resident protein 44	GO:0006457; P:protein folding; IDA:UniProtKB
Q9BS26	ERP44	Endoplasmic reticulum resident protein 44	GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB
Q9BS26	ERP44	Endoplasmic reticulum resident protein 44	GO:0006986; P:response to unfolded protein; IDA:UniProtKB
P11474	ESRRA	Steroid hormone receptor ERR1	GO:0003677; F:DNA binding; TAS:ProtInc
P11474	ESRRA	Steroid hormone receptor ERR1	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; TAS:ProtInc
P11474	ESRRA	Steroid hormone receptor ERR1	GO:0005515; F:protein binding; IPI:UniProtKB
P11474	ESRRA	Steroid hormone receptor ERR1	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P11474	ESRRA	Steroid hormone receptor ERR1	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
P11474	ESRRA	Steroid hormone receptor ERR1	GO:0005496; F:steroid binding; IEA:InterPro
P11474	ESRRA	Steroid hormone receptor ERR1	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P11474	ESRRA	Steroid hormone receptor ERR1	GO:0008270; F:zinc ion binding; IEA:InterPro
P11474	ESRRA	Steroid hormone receptor ERR1	GO:0051216; P:cartilage development; IEA:Ensembl
P11474	ESRRA	Steroid hormone receptor ERR1	GO:0010467; P:gene expression; TAS:Reactome
P11474	ESRRA	Steroid hormone receptor ERR1	GO:0030522; P:intracellular receptor signaling pathway; TAS:GOC
P11474	ESRRA	Steroid hormone receptor ERR1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P11474	ESRRA	Steroid hormone receptor ERR1	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P11474	ESRRA	Steroid hormone receptor ERR1	GO:0045667; P:regulation of osteoblast differentiation; IEA:Ensembl
P11474	ESRRA	Steroid hormone receptor ERR1	GO:0045670; P:regulation of osteoclast differentiation; IEA:Ensembl
P11474	ESRRA	Steroid hormone receptor ERR1	GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB
P11474	ESRRA	Steroid hormone receptor ERR1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
O95718	ESRRB	Steroid hormone receptor ERR2	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; TAS:ProtInc
O95718	ESRRB	Steroid hormone receptor ERR2	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; ISS:BHF-UCL
O95718	ESRRB	Steroid hormone receptor ERR2	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
O95718	ESRRB	Steroid hormone receptor ERR2	GO:0005496; F:steroid binding; IEA:InterPro
O95718	ESRRB	Steroid hormone receptor ERR2	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
O95718	ESRRB	Steroid hormone receptor ERR2	GO:0003713; F:transcription coactivator activity; ISS:BHF-UCL
O95718	ESRRB	Steroid hormone receptor ERR2	GO:0008134; F:transcription factor binding; ISS:BHF-UCL
O95718	ESRRB	Steroid hormone receptor ERR2	GO:0008270; F:zinc ion binding; IEA:InterPro
O95718	ESRRB	Steroid hormone receptor ERR2	GO:0010467; P:gene expression; TAS:Reactome
O95718	ESRRB	Steroid hormone receptor ERR2	GO:0030522; P:intracellular receptor signaling pathway; TAS:GOC
O95718	ESRRB	Steroid hormone receptor ERR2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
O95718	ESRRB	Steroid hormone receptor ERR2	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
O95718	ESRRB	Steroid hormone receptor ERR2	GO:0019827; P:stem cell maintenance; IEA:Ensembl
O95718	ESRRB	Steroid hormone receptor ERR2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
O95718	ESRRB	Steroid hormone receptor ERR2	GO:0001834; P:trophectodermal cell proliferation; IEA:Ensembl
O95718	ESRRB	Steroid hormone receptor ERR2	GO:0001831; P:trophectodermal cellular morphogenesis; IEA:Ensembl
P62508	ESRRG	Estrogen-related receptor gamma	GO:0050682; F:AF-2 domain binding; ISS:UniProtKB
P62508	ESRRG	Estrogen-related receptor gamma	GO:0005515; F:protein binding; IPI:UniProtKB
P62508	ESRRG	Estrogen-related receptor gamma	GO:0003708; F:retinoic acid receptor activity; IEA:InterPro
P62508	ESRRG	Estrogen-related receptor gamma	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P62508	ESRRG	Estrogen-related receptor gamma	GO:0005496; F:steroid binding; IEA:InterPro
P62508	ESRRG	Estrogen-related receptor gamma	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P62508	ESRRG	Estrogen-related receptor gamma	GO:0008270; F:zinc ion binding; IEA:InterPro
P62508	ESRRG	Estrogen-related receptor gamma	GO:0010467; P:gene expression; TAS:Reactome
P62508	ESRRG	Estrogen-related receptor gamma	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
P62508	ESRRG	Estrogen-related receptor gamma	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
P62508	ESRRG	Estrogen-related receptor gamma	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q9UJM3	ERRFI1	ERBB receptor feedback inhibitor 1	GO:0005515; F:protein binding; IPI:IntAct
Q9UJM3	ERRFI1	ERBB receptor feedback inhibitor 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q9UJM3	ERRFI1	ERBB receptor feedback inhibitor 1	GO:0005100; F:Rho GTPase activator activity; TAS:ProtInc
Q9UJM3	ERRFI1	ERBB receptor feedback inhibitor 1	GO:0048286; P:lung alveolus development; ISS:UniProtKB
Q9UJM3	ERRFI1	ERBB receptor feedback inhibitor 1	GO:0060428; P:lung epithelium development; ISS:UniProtKB
Q9UJM3	ERRFI1	ERBB receptor feedback inhibitor 1	GO:0060426; P:lung vasculature development; ISS:UniProtKB
Q9UJM3	ERRFI1	ERBB receptor feedback inhibitor 1	GO:0007175; P:negative regulation of epidermal growth factor-activated receptor activity; IDA:UniProtKB
Q9UJM3	ERRFI1	ERBB receptor feedback inhibitor 1	GO:0031953; P:negative regulation of protein autophosphorylation; IDA:UniProtKB
Q9UJM3	ERRFI1	ERBB receptor feedback inhibitor 1	GO:0032321; P:positive regulation of Rho GTPase activity; TAS:GOC
Q9UJM3	ERRFI1	ERBB receptor feedback inhibitor 1	GO:0045616; P:regulation of keratinocyte differentiation; ISS:UniProtKB
Q9UJM3	ERRFI1	ERBB receptor feedback inhibitor 1	GO:0006950; P:response to stress; TAS:ProtInc
Q9UJM3	ERRFI1	ERBB receptor feedback inhibitor 1	GO:0043589; P:skin morphogenesis; ISS:UniProtKB
Q8TE68	EPS8L1	Epidermal growth factor receptor kinase substrate 8-like protein 1	GO:0003779; F:actin binding; IDA:UniProt
Q8TE68	EPS8L1	Epidermal growth factor receptor kinase substrate 8-like protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q8TE68	EPS8L1	Epidermal growth factor receptor kinase substrate 8-like protein 1	GO:0042608; F:T cell receptor binding; IPI:UniProt
Q8TE68	EPS8L1	Epidermal growth factor receptor kinase substrate 8-like protein 1	GO:1900029; P:positive regulation of ruffle assembly; IGI:UniProt
Q8TE68	EPS8L1	Epidermal growth factor receptor kinase substrate 8-like protein 1	GO:0032314; P:regulation of Rac GTPase activity; IDA:GOC
Q8TE68	EPS8L1	Epidermal growth factor receptor kinase substrate 8-like protein 1	GO:0032319; P:regulation of Rho GTPase activity; IDA:GOC
Q8TE68	EPS8L1	Epidermal growth factor receptor kinase substrate 8-like protein 1	GO:0035023; P:regulation of Rho protein signal transduction; IDA:UniProt
Q8TE68	EPS8L1	Epidermal growth factor receptor kinase substrate 8-like protein 1	GO:0007266; P:Rho protein signal transduction; IDA:UniProt
Q9H6S3	EPS8L2	Epidermal growth factor receptor kinase substrate 8-like protein 2	GO:0003779; F:actin binding; IDA:UniProt
Q9H6S3	EPS8L2	Epidermal growth factor receptor kinase substrate 8-like protein 2	GO:1900029; P:positive regulation of ruffle assembly; IGI:UniProt
Q9H6S3	EPS8L2	Epidermal growth factor receptor kinase substrate 8-like protein 2	GO:0032314; P:regulation of Rac GTPase activity; IDA:GOC
Q9H6S3	EPS8L2	Epidermal growth factor receptor kinase substrate 8-like protein 2	GO:0032319; P:regulation of Rho GTPase activity; IDA:GOC
Q9H6S3	EPS8L2	Epidermal growth factor receptor kinase substrate 8-like protein 2	GO:0035023; P:regulation of Rho protein signal transduction; IDA:UniProt
Q9H6S3	EPS8L2	Epidermal growth factor receptor kinase substrate 8-like protein 2	GO:0007266; P:Rho protein signal transduction; IDA:UniProt
Q96AP7	ESAM	Endothelial cell-selective adhesion molecule	GO:0007596; P:blood coagulation; TAS:Reactome
Q96AP7	ESAM	Endothelial cell-selective adhesion molecule	GO:0007156; P:homophilic cell adhesion; IEA:Ensembl
Q96AP7	ESAM	Endothelial cell-selective adhesion molecule	GO:0050900; P:leukocyte migration; TAS:Reactome
Q5FWF5	ESCO1	N-acetyltransferase ESCO1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5FWF5	ESCO1	N-acetyltransferase ESCO1	GO:0016746; F:transferase activity, transferring acyl groups; IEA:UniProtKB-KW
Q5FWF5	ESCO1	N-acetyltransferase ESCO1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q5FWF5	ESCO1	N-acetyltransferase ESCO1	GO:0034421; P:post-translational protein acetylation; IMP:UniProtKB
Q5FWF5	ESCO1	N-acetyltransferase ESCO1	GO:0006275; P:regulation of DNA replication; IMP:UniProtKB
Q56NI9	ESCO2	N-acetyltransferase ESCO2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q56NI9	ESCO2	N-acetyltransferase ESCO2	GO:0016746; F:transferase activity, transferring acyl groups; IEA:UniProtKB-KW
Q56NI9	ESCO2	N-acetyltransferase ESCO2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q56NI9	ESCO2	N-acetyltransferase ESCO2	GO:0034421; P:post-translational protein acetylation; IMP:UniProtKB
Q56NI9	ESCO2	N-acetyltransferase ESCO2	GO:0006275; P:regulation of DNA replication; IMP:UniProtKB
Q9H501	ESF1	ESF1 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H501	ESF1	ESF1 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H501	ESF1	ESF1 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NQ30	ESM1	Endothelial cell-specific molecule 1	GO:0005171; F:hepatocyte growth factor receptor binding; IPI:UniProt
Q9NQ30	ESM1	Endothelial cell-specific molecule 1	GO:0005178; F:integrin binding; IPI:UniProt
Q9NQ30	ESM1	Endothelial cell-specific molecule 1	GO:0001525; P:angiogenesis; IEP:UniProtKB
Q9NQ30	ESM1	Endothelial cell-specific molecule 1	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProt
Q9NQ30	ESM1	Endothelial cell-specific molecule 1	GO:1902204; P:positive regulation of hepatocyte growth factor receptor signaling pathway; IDA:UniProt
Q9NQ30	ESM1	Endothelial cell-specific molecule 1	GO:0001558; P:regulation of cell growth; IEA:InterPro
Q9NQ30	ESM1	Endothelial cell-specific molecule 1	GO:0002040; P:sprouting angiogenesis; IMP:UniProt
Q96BH3	ELSPBP1	Epididymal sperm-binding protein 1	GO:0007338; P:single fertilization; IEA:UniProtKB-KW
Q14674	ESPL1	Separin	GO:0003824; F:catalytic activity; NAS:UniProtKB
Q14674	ESPL1	Separin	GO:0008234; F:cysteine-type peptidase activity; NAS:UniProtKB
Q14674	ESPL1	Separin	GO:0005515; F:protein binding; IPI:UniProtKB
Q14674	ESPL1	Separin	GO:0006915; P:apoptotic process; TAS:UniProtKB
Q14674	ESPL1	Separin	GO:0000910; P:cytokinesis; NAS:UniProtKB
Q14674	ESPL1	Separin	GO:0040001; P:establishment of mitotic spindle localization; NAS:UniProtKB
Q14674	ESPL1	Separin	GO:0045143; P:homologous chromosome segregation; IEA:Ensembl
Q14674	ESPL1	Separin	GO:0000212; P:meiotic spindle organization; IEA:Ensembl
Q14674	ESPL1	Separin	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q14674	ESPL1	Separin	GO:0000070; P:mitotic sister chromatid segregation; IMP:UniProtKB
Q14674	ESPL1	Separin	GO:0045875; P:negative regulation of sister chromatid cohesion; NAS:UniProtKB
Q14674	ESPL1	Separin	GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; NAS:UniProtKB
B1AK53	ESPN	Espin	GO:0051015; F:actin filament binding; ISS:UniProtKB
B1AK53	ESPN	Espin	GO:0017124; F:SH3 domain binding; ISS:UniProtKB
B1AK53	ESPN	Espin	GO:0007626; P:locomotory behavior; IEA:Ensembl
B1AK53	ESPN	Espin	GO:0051494; P:negative regulation of cytoskeleton organization; IEA:Ensembl
B1AK53	ESPN	Espin	GO:0030046; P:parallel actin filament bundle assembly; IEA:Ensembl
B1AK53	ESPN	Espin	GO:0051491; P:positive regulation of filopodium assembly; IEA:Ensembl
B1AK53	ESPN	Espin	GO:0007605; P:sensory perception of sound; IEA:UniProtKB-KW
P03372	ESR1	Estrogen receptor	GO:0008013; F:beta-catenin binding; IPI:BHF-UCL
P03372	ESR1	Estrogen receptor	GO:0003682; F:chromatin binding; IEA:Ensembl
P03372	ESR1	Estrogen receptor	GO:0001046; F:core promoter sequence-specific DNA binding; IDA:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0019899; F:enzyme binding; IPI:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0030284; F:estrogen receptor activity; NAS:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0034056; F:estrogen response element binding; IDA:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0038052; F:estrogen-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; IGI:MGI
P03372	ESR1	Estrogen receptor	GO:0042802; F:identical protein binding; IPI:IntAct
P03372	ESR1	Estrogen receptor	GO:0030235; F:nitric-oxide synthase regulator activity; NAS:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0005515; F:protein binding; IPI:IntAct
P03372	ESR1	Estrogen receptor	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:BHF-UCL
P03372	ESR1	Estrogen receptor	GO:0005496; F:steroid binding; ISS:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0003707; F:steroid hormone receptor activity; TAS:ProtInc
P03372	ESR1	Estrogen receptor	GO:0008270; F:zinc ion binding; IEA:InterPro
P03372	ESR1	Estrogen receptor	GO:0008209; P:androgen metabolic process; IEA:Ensembl
P03372	ESR1	Estrogen receptor	GO:0001547; P:antral ovarian follicle growth; IEA:Ensembl
P03372	ESR1	Estrogen receptor	GO:0071392; P:cellular response to estradiol stimulus; ISS:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0006338; P:chromatin remodeling; NAS:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0002064; P:epithelial cell development; IEA:Ensembl
P03372	ESR1	Estrogen receptor	GO:0060750; P:epithelial cell proliferation involved in mammary gland duct elongation; IEA:Ensembl
P03372	ESR1	Estrogen receptor	GO:0010467; P:gene expression; TAS:Reactome
P03372	ESR1	Estrogen receptor	GO:0030520; P:intracellular estrogen receptor signaling pathway; NAS:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0030518; P:intracellular steroid hormone receptor signaling pathway; ISS:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0008584; P:male gonad development; IEA:Ensembl
P03372	ESR1	Estrogen receptor	GO:0060749; P:mammary gland alveolus development; IEA:Ensembl
P03372	ESR1	Estrogen receptor	GO:0060745; P:mammary gland branching involved in pregnancy; IEA:Ensembl
P03372	ESR1	Estrogen receptor	GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; ISS:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISS:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl
P03372	ESR1	Estrogen receptor	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IDA:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0051000; P:positive regulation of nitric-oxide synthase activity; IDA:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0010863; P:positive regulation of phospholipase C activity; ISS:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0048386; P:positive regulation of retinoic acid receptor signaling pathway; IDA:BHF-UCL
P03372	ESR1	Estrogen receptor	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0060527; P:prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis; IEA:Ensembl
P03372	ESR1	Estrogen receptor	GO:0060523; P:prostate epithelial cord elongation; IEA:Ensembl
P03372	ESR1	Estrogen receptor	GO:0042981; P:regulation of apoptotic process; IEA:Ensembl
P03372	ESR1	Estrogen receptor	GO:0060687; P:regulation of branching involved in prostate gland morphogenesis; IEA:Ensembl
P03372	ESR1	Estrogen receptor	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0032355; P:response to estradiol; IDA:BHF-UCL
P03372	ESR1	Estrogen receptor	GO:0043627; P:response to estrogen; IDA:UniProtKB
P03372	ESR1	Estrogen receptor	GO:0007165; P:signal transduction; TAS:ProtInc
P03372	ESR1	Estrogen receptor	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P03372	ESR1	Estrogen receptor	GO:0006351; P:transcription, DNA-templated; TAS:ProtInc
P03372	ESR1	Estrogen receptor	GO:0060065; P:uterus development; IEA:Ensembl
P03372	ESR1	Estrogen receptor	GO:0060068; P:vagina development; IEA:Ensembl
Q92731	ESR2	Estrogen receptor beta	GO:0001046; F:core promoter sequence-specific DNA binding; IDA:UniProtKB
Q92731	ESR2	Estrogen receptor beta	GO:0003677; F:DNA binding; TAS:ProtInc
Q92731	ESR2	Estrogen receptor beta	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q92731	ESR2	Estrogen receptor beta	GO:0030284; F:estrogen receptor activity; TAS:UniProtKB
Q92731	ESR2	Estrogen receptor beta	GO:0034056; F:estrogen response element binding; IDA:UniProtKB
Q92731	ESR2	Estrogen receptor beta	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; NAS:UniProtKB
Q92731	ESR2	Estrogen receptor beta	GO:0005515; F:protein binding; IPI:UniProtKB
Q92731	ESR2	Estrogen receptor beta	GO:0048019; F:receptor antagonist activity; NAS:UniProtKB
Q92731	ESR2	Estrogen receptor beta	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q92731	ESR2	Estrogen receptor beta	GO:0005496; F:steroid binding; ISS:UniProtKB
Q92731	ESR2	Estrogen receptor beta	GO:0003707; F:steroid hormone receptor activity; TAS:ProtInc
Q92731	ESR2	Estrogen receptor beta	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q92731	ESR2	Estrogen receptor beta	GO:0008270; F:zinc ion binding; IEA:InterPro
Q92731	ESR2	Estrogen receptor beta	GO:0007420; P:brain development; IEA:Ensembl
Q92731	ESR2	Estrogen receptor beta	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q92731	ESR2	Estrogen receptor beta	GO:0060743; P:epithelial cell maturation involved in prostate gland development; IEA:Ensembl
Q92731	ESR2	Estrogen receptor beta	GO:1900116; P:extracellular negative regulation of signal transduction; NAS:GOC
Q92731	ESR2	Estrogen receptor beta	GO:0010467; P:gene expression; TAS:Reactome
Q92731	ESR2	Estrogen receptor beta	GO:0008628; P:hormone-mediated apoptotic signaling pathway; IEA:Ensembl
Q92731	ESR2	Estrogen receptor beta	GO:0030520; P:intracellular estrogen receptor signaling pathway; TAS:UniProtKB
Q92731	ESR2	Estrogen receptor beta	GO:0060766; P:negative regulation of androgen receptor signaling pathway; IEA:Ensembl
Q92731	ESR2	Estrogen receptor beta	GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB
Q92731	ESR2	Estrogen receptor beta	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
Q92731	ESR2	Estrogen receptor beta	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q92731	ESR2	Estrogen receptor beta	GO:0001764; P:neuron migration; IEA:Ensembl
Q92731	ESR2	Estrogen receptor beta	GO:0001541; P:ovarian follicle development; IEA:Ensembl
Q92731	ESR2	Estrogen receptor beta	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q92731	ESR2	Estrogen receptor beta	GO:0060740; P:prostate gland epithelium morphogenesis; IEA:Ensembl
Q92731	ESR2	Estrogen receptor beta	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q92731	ESR2	Estrogen receptor beta	GO:0007165; P:signal transduction; TAS:ProtInc
Q92731	ESR2	Estrogen receptor beta	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q92731	ESR2	Estrogen receptor beta	GO:0060065; P:uterus development; IEA:Ensembl
Q92731	ESR2	Estrogen receptor beta	GO:0060068; P:vagina development; IEA:Ensembl
Q6NXG1	ESRP1	Epithelial splicing regulatory protein 1	GO:0003729; F:mRNA binding; IDA:UniProtKB
Q6NXG1	ESRP1	Epithelial splicing regulatory protein 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q6NXG1	ESRP1	Epithelial splicing regulatory protein 1	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q6NXG1	ESRP1	Epithelial splicing regulatory protein 1	GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB
Q6NXG1	ESRP1	Epithelial splicing regulatory protein 1	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q9H6T0	ESRP2	Epithelial splicing regulatory protein 2	GO:0003729; F:mRNA binding; IDA:UniProtKB
Q9H6T0	ESRP2	Epithelial splicing regulatory protein 2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9H6T0	ESRP2	Epithelial splicing regulatory protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H6T0	ESRP2	Epithelial splicing regulatory protein 2	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9H6T0	ESRP2	Epithelial splicing regulatory protein 2	GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB
Q9H6T0	ESRP2	Epithelial splicing regulatory protein 2	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q86US8	SMG6	Telomerase-binding protein EST1A	GO:0004521; F:endoribonuclease activity; IDA:UniProtKB
Q86US8	SMG6	Telomerase-binding protein EST1A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86US8	SMG6	Telomerase-binding protein EST1A	GO:0005515; F:protein binding; IPI:UniProtKB
Q86US8	SMG6	Telomerase-binding protein EST1A	GO:0042162; F:telomeric DNA binding; IDA:HGNC
Q86US8	SMG6	Telomerase-binding protein EST1A	GO:0010467; P:gene expression; TAS:Reactome
Q86US8	SMG6	Telomerase-binding protein EST1A	GO:0006406; P:mRNA export from nucleus; TAS:HGNC
Q86US8	SMG6	Telomerase-binding protein EST1A	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q86US8	SMG6	Telomerase-binding protein EST1A	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IMP:UniProtKB
Q86US8	SMG6	Telomerase-binding protein EST1A	GO:0035303; P:regulation of dephosphorylation; TAS:HGNC
Q86US8	SMG6	Telomerase-binding protein EST1A	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q86US8	SMG6	Telomerase-binding protein EST1A	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; IDA:GOC
Q86US8	SMG6	Telomerase-binding protein EST1A	GO:0000723; P:telomere maintenance; IMP:HGNC
P23141	CES1	Liver carboxylesterase 1	GO:0052689; F:carboxylic ester hydrolase activity; TAS:ProtInc
P23141	CES1	Liver carboxylesterase 1	GO:0047374; F:methylumbelliferyl-acetate deacetylase activity; IEA:UniProtKB-EC
P23141	CES1	Liver carboxylesterase 1	GO:0030855; P:epithelial cell differentiation; IDA:UniProt
P23141	CES1	Liver carboxylesterase 1	GO:0008152; P:metabolic process; TAS:ProtInc
P23141	CES1	Liver carboxylesterase 1	GO:0009636; P:response to toxic substance; TAS:ProtInc
O00748	CES2	Cocaine esterase	GO:0052689; F:carboxylic ester hydrolase activity; TAS:ProtInc
O00748	CES2	Cocaine esterase	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
O00748	CES2	Cocaine esterase	GO:0047374; F:methylumbelliferyl-acetate deacetylase activity; IEA:UniProtKB-EC
O00748	CES2	Cocaine esterase	GO:0009056; P:catabolic process; TAS:ProtInc
Q6UWW8	CES3	Carboxylesterase 3	GO:0052689; F:carboxylic ester hydrolase activity; IEA:UniProtKB-EC
Q5XG92	CES4A	Carboxylesterase 4A	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q6NT32	CES5A	Carboxylesterase 5A	GO:0052689; F:carboxylic ester hydrolase activity; IEA:UniProtKB-EC
P10768	ESD	S-formylglutathione hydrolase	GO:0052689; F:carboxylic ester hydrolase activity; NAS:UniProtKB
P10768	ESD	S-formylglutathione hydrolase	GO:0047374; F:methylumbelliferyl-acetate deacetylase activity; IEA:UniProtKB-EC
P10768	ESD	S-formylglutathione hydrolase	GO:0018738; F:S-formylglutathione hydrolase activity; IEA:UniProtKB-EC
P10768	ESD	S-formylglutathione hydrolase	GO:0046294; P:formaldehyde catabolic process; IEA:InterPro
Q8N693	ESX1	Homeobox protein ESX1	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q8N693	ESX1	Homeobox protein ESX1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8N693	ESX1	Homeobox protein ESX1	GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl
Q8N693	ESX1	Homeobox protein ESX1	GO:0060713; P:labyrinthine layer morphogenesis; IEA:Ensembl
Q8N693	ESX1	Homeobox protein ESX1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q8N693	ESX1	Homeobox protein ESX1	GO:0051726; P:regulation of cell cycle; IDA:UniProtKB
Q8N693	ESX1	Homeobox protein ESX1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8N693	ESX1	Homeobox protein ESX1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BSJ8	ESYT1	Extended synaptotagmin-1	GO:0005515; F:protein binding; IPI:IntAct
A0FGR8	ESYT2	Extended synaptotagmin-2	GO:0005544; F:calcium-dependent phospholipid binding; IDA:FlyBase
A0FGR8	ESYT2	Extended synaptotagmin-2	GO:0005515; F:protein binding; IPI:IntAct
A0FGR9	ESYT3	Extended synaptotagmin-3	GO:0005515; F:protein binding; IPI:IntAct
O60883	GPR37L1	Prosaposin receptor GPR37L1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O60883	GPR37L1	Prosaposin receptor GPR37L1	GO:0005515; F:protein binding; IPI:IntAct
P13804	ETFA	Electron transfer flavoprotein subunit alpha, mitochondrial	GO:0009055; F:electron carrier activity; IDA:UniProtKB
P13804	ETFA	Electron transfer flavoprotein subunit alpha, mitochondrial	GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB
P13804	ETFA	Electron transfer flavoprotein subunit alpha, mitochondrial	GO:0016491; F:oxidoreductase activity; IDA:UniProtKB
P13804	ETFA	Electron transfer flavoprotein subunit alpha, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P13804	ETFA	Electron transfer flavoprotein subunit alpha, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P13804	ETFA	Electron transfer flavoprotein subunit alpha, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P38117	ETFB	Electron transfer flavoprotein subunit beta	GO:0009055; F:electron carrier activity; TAS:ProtInc
P38117	ETFB	Electron transfer flavoprotein subunit beta	GO:0044237; P:cellular metabolic process; TAS:Reactome
P38117	ETFB	Electron transfer flavoprotein subunit beta	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P38117	ETFB	Electron transfer flavoprotein subunit beta	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16134	ETFDH	Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial	GO:0051539; F:4 iron, 4 sulfur cluster binding; IDA:UniProtKB
Q16134	ETFDH	Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial	GO:0009055; F:electron carrier activity; IDA:UniProtKB
Q16134	ETFDH	Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial	GO:0004174; F:electron-transferring-flavoprotein dehydrogenase activity; IDA:UniProtKB
Q16134	ETFDH	Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial	GO:0050660; F:flavin adenine dinucleotide binding; ISS:UniProtKB
Q16134	ETFDH	Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q16134	ETFDH	Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial	GO:0016491; F:oxidoreductase activity; IDA:UniProtKB
Q16134	ETFDH	Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial	GO:0043783; F:oxidoreductase activity, oxidizing metal ions with flavin as acceptor; ISS:UniProtKB
Q16134	ETFDH	Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial	GO:0048038; F:quinone binding; IDA:UniProtKB
Q16134	ETFDH	Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial	GO:0048039; F:ubiquinone binding; IDA:UniProtKB
Q16134	ETFDH	Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q16134	ETFDH	Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial	GO:0022900; P:electron transport chain; IDA:UniProtKB
Q16134	ETFDH	Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial	GO:0033539; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; IMP:BHF-UCL
Q16134	ETFDH	Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
Q16134	ETFDH	Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial	GO:0006979; P:response to oxidative stress; ISS:UniProtKB
Q16134	ETFDH	Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95571	ETHE1	Persulfide dioxygenase ETHE1, mitochondrial	GO:0016787; F:hydrolase activity; IEA:InterPro
O95571	ETHE1	Persulfide dioxygenase ETHE1, mitochondrial	GO:0005506; F:iron ion binding; IDA:UniProtKB
O95571	ETHE1	Persulfide dioxygenase ETHE1, mitochondrial	GO:0050313; F:sulfur dioxygenase activity; IDA:UniProtKB
O95571	ETHE1	Persulfide dioxygenase ETHE1, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
O95571	ETHE1	Persulfide dioxygenase ETHE1, mitochondrial	GO:0006749; P:glutathione metabolic process; IDA:UniProtKB
O95571	ETHE1	Persulfide dioxygenase ETHE1, mitochondrial	GO:0070813; P:hydrogen sulfide metabolic process; IDA:UniProtKB
O95571	ETHE1	Persulfide dioxygenase ETHE1, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95571	ETHE1	Persulfide dioxygenase ETHE1, mitochondrial	GO:0070221; P:sulfide oxidation, using sulfide:quinone oxidoreductase; TAS:Reactome
O95571	ETHE1	Persulfide dioxygenase ETHE1, mitochondrial	GO:0000098; P:sulfur amino acid catabolic process; TAS:Reactome
O95571	ETHE1	Persulfide dioxygenase ETHE1, mitochondrial	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
P14921	ETS1	Protein C-ets-1	GO:0003677; F:DNA binding; ISS:UniProtKB
P14921	ETS1	Protein C-ets-1	GO:0005515; F:protein binding; IPI:UniProtKB
P14921	ETS1	Protein C-ets-1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P14921	ETS1	Protein C-ets-1	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
P14921	ETS1	Protein C-ets-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P14921	ETS1	Protein C-ets-1	GO:0008134; F:transcription factor binding; NAS:UniProtKB
P14921	ETS1	Protein C-ets-1	GO:0060055; P:angiogenesis involved in wound healing; IEA:Ensembl
P14921	ETS1	Protein C-ets-1	GO:0030262; P:apoptotic nuclear changes; IDA:UniProtKB
P14921	ETS1	Protein C-ets-1	GO:0048870; P:cell motility; IMP:BHF-UCL
P14921	ETS1	Protein C-ets-1	GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl
P14921	ETS1	Protein C-ets-1	GO:0060206; P:estrous cycle phase; IEA:Ensembl
P14921	ETS1	Protein C-ets-1	GO:0097194; P:execution phase of apoptosis; IDA:UniProtKB
P14921	ETS1	Protein C-ets-1	GO:0007565; P:female pregnancy; IEA:Ensembl
P14921	ETS1	Protein C-ets-1	GO:0021854; P:hypothalamus development; IEA:Ensembl
P14921	ETS1	Protein C-ets-1	GO:0006955; P:immune response; TAS:ProtInc
P14921	ETS1	Protein C-ets-1	GO:0045786; P:negative regulation of cell cycle; IDA:UniProtKB
P14921	ETS1	Protein C-ets-1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P14921	ETS1	Protein C-ets-1	GO:0021983; P:pituitary gland development; IEA:Ensembl
P14921	ETS1	Protein C-ets-1	GO:0030578; P:PML body organization; IDA:BHF-UCL
P14921	ETS1	Protein C-ets-1	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
P14921	ETS1	Protein C-ets-1	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P14921	ETS1	Protein C-ets-1	GO:0051272; P:positive regulation of cellular component movement; IMP:BHF-UCL
P14921	ETS1	Protein C-ets-1	GO:0010595; P:positive regulation of endothelial cell migration; IMP:UniProtKB
P14921	ETS1	Protein C-ets-1	GO:0045648; P:positive regulation of erythrocyte differentiation; IDA:UniProtKB
P14921	ETS1	Protein C-ets-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P14921	ETS1	Protein C-ets-1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
P14921	ETS1	Protein C-ets-1	GO:0045765; P:regulation of angiogenesis; IMP:UniProtKB
P14921	ETS1	Protein C-ets-1	GO:0010715; P:regulation of extracellular matrix disassembly; IEA:Ensembl
P14921	ETS1	Protein C-ets-1	GO:0046677; P:response to antibiotic; IDA:UniProtKB
P14921	ETS1	Protein C-ets-1	GO:0032355; P:response to estradiol; IEA:Ensembl
P14921	ETS1	Protein C-ets-1	GO:0001666; P:response to hypoxia; IEA:Ensembl
P14921	ETS1	Protein C-ets-1	GO:0070555; P:response to interleukin-1; IEA:Ensembl
P14921	ETS1	Protein C-ets-1	GO:0034616; P:response to laminar fluid shear stress; IEA:Ensembl
P14921	ETS1	Protein C-ets-1	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P14921	ETS1	Protein C-ets-1	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
P15036	ETS2	Protein C-ets-2	GO:0003677; F:DNA binding; TAS:ProtInc
P15036	ETS2	Protein C-ets-2	GO:0005515; F:protein binding; IPI:IntAct
P15036	ETS2	Protein C-ets-2	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl
P15036	ETS2	Protein C-ets-2	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
P15036	ETS2	Protein C-ets-2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P15036	ETS2	Protein C-ets-2	GO:0030154; P:cell differentiation; IBA:RefGenome
P15036	ETS2	Protein C-ets-2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P15036	ETS2	Protein C-ets-2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
P15036	ETS2	Protein C-ets-2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
P15036	ETS2	Protein C-ets-2	GO:0001501; P:skeletal system development; TAS:ProtInc
P15036	ETS2	Protein C-ets-2	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q7Z2Z2	EFTUD1	Elongation factor Tu GTP-binding domain-containing protein 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q7Z2Z2	EFTUD1	Elongation factor Tu GTP-binding domain-containing protein 1	GO:0003924; F:GTPase activity; IDA:UniProtKB
Q7Z2Z2	EFTUD1	Elongation factor Tu GTP-binding domain-containing protein 1	GO:0043022; F:ribosome binding; IMP:UniProtKB
Q7Z2Z2	EFTUD1	Elongation factor Tu GTP-binding domain-containing protein 1	GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-KW
Q7Z2Z2	EFTUD1	Elongation factor Tu GTP-binding domain-containing protein 1	GO:0006184; P:GTP catabolic process; IDA:UniProtKB
Q7Z2Z2	EFTUD1	Elongation factor Tu GTP-binding domain-containing protein 1	GO:0042256; P:mature ribosome assembly; IMP:UniProtKB
P50549	ETV1	ETS translocation variant 1	GO:0005515; F:protein binding; IPI:IntAct
P50549	ETV1	ETS translocation variant 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P50549	ETV1	ETS translocation variant 1	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
P50549	ETV1	ETS translocation variant 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P50549	ETV1	ETS translocation variant 1	GO:0007411; P:axon guidance; IEA:Ensembl
P50549	ETV1	ETS translocation variant 1	GO:0030154; P:cell differentiation; IBA:RefGenome
P50549	ETV1	ETS translocation variant 1	GO:0007638; P:mechanosensory behavior; IEA:Ensembl
P50549	ETV1	ETS translocation variant 1	GO:0007517; P:muscle organ development; IEA:Ensembl
P50549	ETV1	ETS translocation variant 1	GO:0048935; P:peripheral nervous system neuron development; TAS:BHF-UCL
P50549	ETV1	ETS translocation variant 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P50549	ETV1	ETS translocation variant 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
P50549	ETV1	ETS translocation variant 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
O00321	ETV2	ETS translocation variant 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O00321	ETV2	ETS translocation variant 2	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
O00321	ETV2	ETS translocation variant 2	GO:0001824; P:blastocyst development; IEA:Ensembl
O00321	ETV2	ETS translocation variant 2	GO:0048514; P:blood vessel morphogenesis; IEA:Ensembl
O00321	ETV2	ETS translocation variant 2	GO:0060803; P:BMP signaling pathway involved in mesodermal cell fate specification; IEA:Ensembl
O00321	ETV2	ETS translocation variant 2	GO:0030154; P:cell differentiation; IBA:RefGenome
O00321	ETV2	ETS translocation variant 2	GO:0030218; P:erythrocyte differentiation; IEA:Ensembl
O00321	ETV2	ETS translocation variant 2	GO:0007219; P:Notch signaling pathway; IEA:Ensembl
O00321	ETV2	ETS translocation variant 2	GO:0001890; P:placenta development; IEA:Ensembl
O00321	ETV2	ETS translocation variant 2	GO:0045603; P:positive regulation of endothelial cell differentiation; IEA:Ensembl
O00321	ETV2	ETS translocation variant 2	GO:2000382; P:positive regulation of mesoderm development; IEA:Ensembl
O00321	ETV2	ETS translocation variant 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O00321	ETV2	ETS translocation variant 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
O00321	ETV2	ETS translocation variant 2	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
O00321	ETV2	ETS translocation variant 2	GO:0016055; P:Wnt signaling pathway; IEA:Ensembl
Q6ZN32	ETV3L	ETS translocation variant 3-like protein	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q6ZN32	ETV3L	ETS translocation variant 3-like protein	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q6ZN32	ETV3L	ETS translocation variant 3-like protein	GO:0030154; P:cell differentiation; IBA:RefGenome
Q6ZN32	ETV3L	ETS translocation variant 3-like protein	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q6ZN32	ETV3L	ETS translocation variant 3-like protein	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
P41162	ETV3	ETS translocation variant 3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P41162	ETV3	ETS translocation variant 3	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
P41162	ETV3	ETS translocation variant 3	GO:0030154; P:cell differentiation; IBA:RefGenome
P41162	ETV3	ETS translocation variant 3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P41162	ETV3	ETS translocation variant 3	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
P41162	ETV3	ETS translocation variant 3	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
P43268	ETV4	ETS translocation variant 4	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P43268	ETV4	ETS translocation variant 4	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
P43268	ETV4	ETS translocation variant 4	GO:0060444; P:branching involved in mammary gland duct morphogenesis; IEA:Ensembl
P43268	ETV4	ETS translocation variant 4	GO:0030154; P:cell differentiation; IBA:RefGenome
P43268	ETV4	ETS translocation variant 4	GO:0008045; P:motor neuron axon guidance; IEA:Ensembl
P43268	ETV4	ETS translocation variant 4	GO:0033600; P:negative regulation of mammary gland epithelial cell proliferation; IEA:Ensembl
P43268	ETV4	ETS translocation variant 4	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P43268	ETV4	ETS translocation variant 4	GO:0060762; P:regulation of branching involved in mammary gland duct morphogenesis; IEA:Ensembl
P43268	ETV4	ETS translocation variant 4	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
P43268	ETV4	ETS translocation variant 4	GO:0048863; P:stem cell differentiation; IEA:Ensembl
P43268	ETV4	ETS translocation variant 4	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
P41161	ETV5	ETS translocation variant 5	GO:0003677; F:DNA binding; TAS:ProtInc
P41161	ETV5	ETS translocation variant 5	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P41161	ETV5	ETS translocation variant 5	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
P41161	ETV5	ETS translocation variant 5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P41161	ETV5	ETS translocation variant 5	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P41161	ETV5	ETS translocation variant 5	GO:0030154; P:cell differentiation; IBA:RefGenome
P41161	ETV5	ETS translocation variant 5	GO:0034599; P:cellular response to oxidative stress; IDA:UniProtKB
P41161	ETV5	ETS translocation variant 5	GO:0007626; P:locomotory behavior; IEA:Ensembl
P41161	ETV5	ETS translocation variant 5	GO:0048133; P:male germ-line stem cell division; IEA:Ensembl
P41161	ETV5	ETS translocation variant 5	GO:0007274; P:neuromuscular synaptic transmission; IEA:Ensembl
P41161	ETV5	ETS translocation variant 5	GO:0060252; P:positive regulation of glial cell proliferation; IEA:Ensembl
P41161	ETV5	ETS translocation variant 5	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P41161	ETV5	ETS translocation variant 5	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P41161	ETV5	ETS translocation variant 5	GO:0060762; P:regulation of branching involved in mammary gland duct morphogenesis; IEA:Ensembl
P41161	ETV5	ETS translocation variant 5	GO:0050807; P:regulation of synapse organization; IEA:Ensembl
P41161	ETV5	ETS translocation variant 5	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
P41161	ETV5	ETS translocation variant 5	GO:0071340; P:skeletal muscle acetylcholine-gated channel clustering; IEA:Ensembl
P41161	ETV5	ETS translocation variant 5	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
P41212	ETV6	Transcription factor ETV6	GO:0005515; F:protein binding; IPI:IntAct
P41212	ETV6	Transcription factor ETV6	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P41212	ETV6	Transcription factor ETV6	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P41212	ETV6	Transcription factor ETV6	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
P41212	ETV6	Transcription factor ETV6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P41212	ETV6	Transcription factor ETV6	GO:0030154; P:cell differentiation; IBA:RefGenome
P41212	ETV6	Transcription factor ETV6	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
P41212	ETV6	Transcription factor ETV6	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q9Y603	ETV7	Transcription factor ETV7	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y603	ETV7	Transcription factor ETV7	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9Y603	ETV7	Transcription factor ETV7	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q9Y603	ETV7	Transcription factor ETV7	GO:0030154; P:cell differentiation; IBA:RefGenome
Q9Y603	ETV7	Transcription factor ETV7	GO:0009887; P:organ morphogenesis; TAS:ProtInc
Q9Y603	ETV7	Transcription factor ETV7	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q9Y603	ETV7	Transcription factor ETV7	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9H8M9	EVA1A	Protein eva-1 homolog A	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9H8M9	EVA1A	Protein eva-1 homolog A	GO:0006914; P:autophagy; IEA:UniProtKB-KW
P58658	EVA1C	Protein eva-1 homolog C	GO:0030246; F:carbohydrate binding; IEA:InterPro
P57679	EVC	Ellis-van Creveld syndrome protein	GO:0051216; P:cartilage development; IEA:Ensembl
P57679	EVC	Ellis-van Creveld syndrome protein	GO:0003416; P:endochondral bone growth; ISS:UniProtKB
P57679	EVC	Ellis-van Creveld syndrome protein	GO:0007517; P:muscle organ development; TAS:ProtInc
P57679	EVC	Ellis-van Creveld syndrome protein	GO:0045880; P:positive regulation of smoothened signaling pathway; ISS:UniProtKB
P57679	EVC	Ellis-van Creveld syndrome protein	GO:0001501; P:skeletal system development; TAS:ProtInc
P57679	EVC	Ellis-van Creveld syndrome protein	GO:0007224; P:smoothened signaling pathway; IEA:InterPro
P22794	EVI2A	Protein EVI2A	GO:0004888; F:transmembrane signaling receptor activity; NAS:UniProtKB
P22794	EVI2A	Protein EVI2A	GO:0007165; P:signal transduction; NAS:GOC
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0003677; F:DNA binding; ISS:UniProtKB
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0005515; F:protein binding; IPI:UniProtKB
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0030900; P:forebrain development; IEA:Ensembl
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0071425; P:hematopoietic stem cell proliferation; ISS:UniProtKB
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0006954; P:inflammatory response; IEA:Ensembl
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0046329; P:negative regulation of JNK cascade; IMP:UniProtKB
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0043069; P:negative regulation of programmed cell death; IMP:UniProtKB
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0001780; P:neutrophil homeostasis; IEA:Ensembl
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0060039; P:pericardium development; IEA:Ensembl
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0051726; P:regulation of cell cycle; IDA:UniProtKB
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0072001; P:renal system development; IEA:Ensembl
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0009617; P:response to bacterium; IEA:Ensembl
Q03112	MECOM	MDS1 and EVI1 complex locus protein EVI1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60447	EVI5	Ecotropic viral integration site 5 protein homolog	GO:0005515; F:protein binding; IPI:IntAct
O60447	EVI5	Ecotropic viral integration site 5 protein homolog	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
O60447	EVI5	Ecotropic viral integration site 5 protein homolog	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
O60447	EVI5	Ecotropic viral integration site 5 protein homolog	GO:0051301; P:cell division; IEA:UniProtKB-KW
O60447	EVI5	Ecotropic viral integration site 5 protein homolog	GO:0008283; P:cell proliferation; TAS:ProtInc
O60447	EVI5	Ecotropic viral integration site 5 protein homolog	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q96CN4	EVI5L	EVI5-like protein	GO:0005515; F:protein binding; IPI:IntAct
Q96CN4	EVI5L	EVI5-like protein	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q9UI08	EVL	Ena/VASP-like protein	GO:0005522; F:profilin binding; ISS:UniProtKB
Q9UI08	EVL	Ena/VASP-like protein	GO:0005515; F:protein binding; IPI:IntAct
Q9UI08	EVL	Ena/VASP-like protein	GO:0017124; F:SH3 domain binding; ISS:UniProtKB
Q9UI08	EVL	Ena/VASP-like protein	GO:0007015; P:actin filament organization; TAS:ProtInc
Q9UI08	EVL	Ena/VASP-like protein	GO:0008154; P:actin polymerization or depolymerization; ISS:UniProtKB
Q9UI08	EVL	Ena/VASP-like protein	GO:0007411; P:axon guidance; TAS:Reactome
Q9UI08	EVL	Ena/VASP-like protein	GO:0007166; P:cell surface receptor signaling pathway; NAS:UniProtKB
Q9UI08	EVL	Ena/VASP-like protein	GO:0010633; P:negative regulation of epithelial cell migration; IMP:UniProt
Q9UI08	EVL	Ena/VASP-like protein	GO:1900028; P:negative regulation of ruffle assembly; IMP:UniProt
Q9UI08	EVL	Ena/VASP-like protein	GO:0007399; P:nervous system development; NAS:UniProtKB
Q9UI08	EVL	Ena/VASP-like protein	GO:0009887; P:organ morphogenesis; NAS:UniProtKB
Q9UI08	EVL	Ena/VASP-like protein	GO:0051496; P:positive regulation of stress fiber assembly; IMP:UniProt
Q9UI08	EVL	Ena/VASP-like protein	GO:0051289; P:protein homotetramerization; IEA:InterPro
Q92817	EVPL	Envoplakin	GO:0030674; F:protein binding, bridging; IDA:UniProtKB
Q92817	EVPL	Envoplakin	GO:0005198; F:structural molecule activity; IDA:UniProtKB
Q92817	EVPL	Envoplakin	GO:0008544; P:epidermis development; TAS:ProtInc
Q92817	EVPL	Envoplakin	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q92817	EVPL	Envoplakin	GO:0030216; P:keratinocyte differentiation; IDA:UniProtKB
Q92817	EVPL	Envoplakin	GO:0018149; P:peptide cross-linking; IDA:UniProtKB
P49640	EVX1	Homeobox even-skipped homolog protein 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P49640	EVX1	Homeobox even-skipped homolog protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P49640	EVX1	Homeobox even-skipped homolog protein 1	GO:0009792; P:embryo development ending in birth or egg hatching; IEA:Ensembl
P49640	EVX1	Homeobox even-skipped homolog protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P49640	EVX1	Homeobox even-skipped homolog protein 1	GO:0021913; P:regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification; IEA:Ensembl
Q03828	EVX2	Homeobox even-skipped homolog protein 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q03828	EVX2	Homeobox even-skipped homolog protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q03828	EVX2	Homeobox even-skipped homolog protein 2	GO:0035108; P:limb morphogenesis; IEA:Ensembl
Q01844	EWSR1	RNA-binding protein EWS	GO:0042802; F:identical protein binding; IPI:IntAct
Q01844	EWSR1	RNA-binding protein EWS	GO:0000166; F:nucleotide binding; IEA:InterPro
Q01844	EWSR1	RNA-binding protein EWS	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q01844	EWSR1	RNA-binding protein EWS	GO:0005515; F:protein binding; IPI:UniProtKB
Q01844	EWSR1	RNA-binding protein EWS	GO:0003723; F:RNA binding; TAS:ProtInc
Q01844	EWSR1	RNA-binding protein EWS	GO:0008270; F:zinc ion binding; IEA:InterPro
Q01844	EWSR1	RNA-binding protein EWS	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q01844	EWSR1	RNA-binding protein EWS	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86VI1	EXOC3L1	Exocyst complex component 3-like protein	GO:0006887; P:exocytosis; ISS:UniProtKB
Q86VI1	EXOC3L1	Exocyst complex component 3-like protein	GO:0030072; P:peptide hormone secretion; ISS:UniProtKB
Q2M3D2	EXOC3L2	Exocyst complex component 3-like protein 2	GO:0006887; P:exocytosis; IEA:InterPro
Q17RC7	EXOC3L4	Exocyst complex component 3-like protein 4	GO:0006887; P:exocytosis; IEA:InterPro
Q9Y2D4	EXOC6B	Exocyst complex component 6B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9Y2D4	EXOC6B	Exocyst complex component 6B	GO:0006904; P:vesicle docking involved in exocytosis; IEA:InterPro
Q8NHP7	EXD1	Exonuclease 3'-5' domain-containing protein 1	GO:0008408; F:3'-5' exonuclease activity; IEA:InterPro
Q8NHP7	EXD1	Exonuclease 3'-5' domain-containing protein 1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9NVH0	EXD2	Exonuclease 3'-5' domain-containing protein 2	GO:0008408; F:3'-5' exonuclease activity; IEA:InterPro
Q9NVH0	EXD2	Exonuclease 3'-5' domain-containing protein 2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9UQ84	EXO1	Exonuclease 1	GO:0035312; F:5'-3' exodeoxyribonuclease activity; IDA:UniProtKB
Q9UQ84	EXO1	Exonuclease 1	GO:0008409; F:5'-3' exonuclease activity; ISS:UniProtKB
Q9UQ84	EXO1	Exonuclease 1	GO:0003677; F:DNA binding; IDA:UniProtKB
Q9UQ84	EXO1	Exonuclease 1	GO:0051908; F:double-stranded DNA 5'-3' exodeoxyribonuclease activity; IDA:UniProtKB
Q9UQ84	EXO1	Exonuclease 1	GO:0004527; F:exonuclease activity; TAS:ProtInc
Q9UQ84	EXO1	Exonuclease 1	GO:0048256; F:flap endonuclease activity; IDA:UniProtKB
Q9UQ84	EXO1	Exonuclease 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UQ84	EXO1	Exonuclease 1	GO:0005515; F:protein binding; IPI:IntAct
Q9UQ84	EXO1	Exonuclease 1	GO:0004523; F:RNA-DNA hybrid ribonuclease activity; TAS:ProtInc
Q9UQ84	EXO1	Exonuclease 1	GO:0045145; F:single-stranded DNA 5'-3' exodeoxyribonuclease activity; IDA:UniProtKB
Q9UQ84	EXO1	Exonuclease 1	GO:0043566; F:structure-specific DNA binding; IEA:Ensembl
Q9UQ84	EXO1	Exonuclease 1	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
Q9UQ84	EXO1	Exonuclease 1	GO:0000738; P:DNA catabolic process, exonucleolytic; IDA:GOC
Q9UQ84	EXO1	Exonuclease 1	GO:0006310; P:DNA recombination; IGI:UniProtKB
Q9UQ84	EXO1	Exonuclease 1	GO:0006281; P:DNA repair; TAS:ProtInc
Q9UQ84	EXO1	Exonuclease 1	GO:0002455; P:humoral immune response mediated by circulating immunoglobulin; IEA:Ensembl
Q9UQ84	EXO1	Exonuclease 1	GO:0045190; P:isotype switching; IEA:Ensembl
Q9UQ84	EXO1	Exonuclease 1	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q9UQ84	EXO1	Exonuclease 1	GO:0006298; P:mismatch repair; IDA:UniProtKB
Q9UQ84	EXO1	Exonuclease 1	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; ISS:GOC
Q9UQ84	EXO1	Exonuclease 1	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; TAS:GOC
Q9UQ84	EXO1	Exonuclease 1	GO:0016446; P:somatic hypermutation of immunoglobulin genes; IEA:Ensembl
Q9H790	EXO5	Exonuclease V	GO:0051539; F:4 iron, 4 sulfur cluster binding; IDA:UniProtKB
Q9H790	EXO5	Exonuclease V	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H790	EXO5	Exonuclease V	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H790	EXO5	Exonuclease V	GO:0042803; F:protein homodimerization activity; TAS:UniProtKB
Q9H790	EXO5	Exonuclease V	GO:0008310; F:single-stranded DNA 3'-5' exodeoxyribonuclease activity; TAS:UniProtKB
Q9H790	EXO5	Exonuclease V	GO:0045145; F:single-stranded DNA 5'-3' exodeoxyribonuclease activity; IDA:UniProtKB
Q9H790	EXO5	Exonuclease V	GO:0000738; P:DNA catabolic process, exonucleolytic; IDA:GOC
Q9H790	EXO5	Exonuclease V	GO:0036297; P:interstrand cross-link repair; IMP:UniProtKB
Q9NV70	EXOC1	Exocyst complex component 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NV70	EXOC1	Exocyst complex component 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9NV70	EXOC1	Exocyst complex component 1	GO:0006887; P:exocytosis; NAS:UniProtKB
Q9NV70	EXOC1	Exocyst complex component 1	GO:0061024; P:membrane organization; TAS:Reactome
Q9NV70	EXOC1	Exocyst complex component 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96KP1	EXOC2	Exocyst complex component 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q96KP1	EXOC2	Exocyst complex component 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q96KP1	EXOC2	Exocyst complex component 2	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q96KP1	EXOC2	Exocyst complex component 2	GO:0061024; P:membrane organization; TAS:Reactome
Q96KP1	EXOC2	Exocyst complex component 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O60645	EXOC3	Exocyst complex component 3	GO:0005515; F:protein binding; IPI:UniProtKB
O60645	EXOC3	Exocyst complex component 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O60645	EXOC3	Exocyst complex component 3	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
O60645	EXOC3	Exocyst complex component 3	GO:0061024; P:membrane organization; TAS:Reactome
O60645	EXOC3	Exocyst complex component 3	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96A65	EXOC4	Exocyst complex component 4	GO:0005515; F:protein binding; IPI:IntAct
Q96A65	EXOC4	Exocyst complex component 4	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q96A65	EXOC4	Exocyst complex component 4	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q96A65	EXOC4	Exocyst complex component 4	GO:0061024; P:membrane organization; TAS:Reactome
Q96A65	EXOC4	Exocyst complex component 4	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96A65	EXOC4	Exocyst complex component 4	GO:0006904; P:vesicle docking involved in exocytosis; IEA:InterPro
O00471	EXOC5	Exocyst complex component 5	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O00471	EXOC5	Exocyst complex component 5	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
O00471	EXOC5	Exocyst complex component 5	GO:0061024; P:membrane organization; TAS:Reactome
O00471	EXOC5	Exocyst complex component 5	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:ProtInc
O00471	EXOC5	Exocyst complex component 5	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O00471	EXOC5	Exocyst complex component 5	GO:0048278; P:vesicle docking; IEA:InterPro
Q8TAG9	EXOC6	Exocyst complex component 6	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8TAG9	EXOC6	Exocyst complex component 6	GO:0030218; P:erythrocyte differentiation; IEA:Ensembl
Q8TAG9	EXOC6	Exocyst complex component 6	GO:0061024; P:membrane organization; TAS:Reactome
Q8TAG9	EXOC6	Exocyst complex component 6	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8TAG9	EXOC6	Exocyst complex component 6	GO:0006904; P:vesicle docking involved in exocytosis; IEA:InterPro
Q9UPT5	EXOC7	Exocyst complex component 7	GO:0005515; F:protein binding; IPI:IntAct
Q9UPT5	EXOC7	Exocyst complex component 7	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UPT5	EXOC7	Exocyst complex component 7	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q9UPT5	EXOC7	Exocyst complex component 7	GO:0061024; P:membrane organization; TAS:Reactome
Q9UPT5	EXOC7	Exocyst complex component 7	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8IYI6	EXOC8	Exocyst complex component 8	GO:0005515; F:protein binding; IPI:IntAct
Q8IYI6	EXOC8	Exocyst complex component 8	GO:0034613; P:cellular protein localization; IEA:Ensembl
Q8IYI6	EXOC8	Exocyst complex component 8	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8IYI6	EXOC8	Exocyst complex component 8	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q8IYI6	EXOC8	Exocyst complex component 8	GO:0061024; P:membrane organization; TAS:Reactome
Q8IYI6	EXOC8	Exocyst complex component 8	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9Y2C4	EXOG	Nuclease EXOG, mitochondrial	GO:0004519; F:endonuclease activity; NAS:UniProtKB
Q9Y2C4	EXOG	Nuclease EXOG, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y2C4	EXOG	Nuclease EXOG, mitochondrial	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9Y2C4	EXOG	Nuclease EXOG, mitochondrial	GO:0000737; P:DNA catabolic process, endonucleolytic; IBA:RefGenome
Q13868	EXOSC2	Exosome complex component RRP4	GO:0000175; F:3'-5'-exoribonuclease activity; TAS:ProtInc
Q13868	EXOSC2	Exosome complex component RRP4	GO:0008312; F:7S RNA binding; TAS:ProtInc
Q13868	EXOSC2	Exosome complex component RRP4	GO:0005515; F:protein binding; IPI:IntAct
Q13868	EXOSC2	Exosome complex component RRP4	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
Q13868	EXOSC2	Exosome complex component RRP4	GO:0010467; P:gene expression; TAS:Reactome
Q13868	EXOSC2	Exosome complex component RRP4	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q13868	EXOSC2	Exosome complex component RRP4	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q13868	EXOSC2	Exosome complex component RRP4	GO:0030307; P:positive regulation of cell growth; IMP:UniProtKB
Q13868	EXOSC2	Exosome complex component RRP4	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q13868	EXOSC2	Exosome complex component RRP4	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; TAS:GOC
Q13868	EXOSC2	Exosome complex component RRP4	GO:0006364; P:rRNA processing; TAS:ProtInc
Q9Y3B2	EXOSC1	Exosome complex component CSL4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y3B2	EXOSC1	Exosome complex component CSL4	GO:0003723; F:RNA binding; NAS:UniProtKB
Q9Y3B2	EXOSC1	Exosome complex component CSL4	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
Q9Y3B2	EXOSC1	Exosome complex component CSL4	GO:0010467; P:gene expression; TAS:Reactome
Q9Y3B2	EXOSC1	Exosome complex component CSL4	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9Y3B2	EXOSC1	Exosome complex component CSL4	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q9Y3B2	EXOSC1	Exosome complex component CSL4	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9Y3B2	EXOSC1	Exosome complex component CSL4	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q9NQT5	EXOSC3	Exosome complex component RRP40	GO:0000175; F:3'-5'-exoribonuclease activity; NAS:UniProtKB
Q9NQT5	EXOSC3	Exosome complex component RRP40	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NQT5	EXOSC3	Exosome complex component RRP40	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9NQT5	EXOSC3	Exosome complex component RRP40	GO:0071034; P:CUT catabolic process; IMP:UniProtKB
Q9NQT5	EXOSC3	Exosome complex component RRP40	GO:0045006; P:DNA deamination; IDA:UniProtKB
Q9NQT5	EXOSC3	Exosome complex component RRP40	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; IMP:UniProtKB
Q9NQT5	EXOSC3	Exosome complex component RRP40	GO:0010467; P:gene expression; TAS:Reactome
Q9NQT5	EXOSC3	Exosome complex component RRP40	GO:0045190; P:isotype switching; ISS:UniProtKB
Q9NQT5	EXOSC3	Exosome complex component RRP40	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9NQT5	EXOSC3	Exosome complex component RRP40	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q9NQT5	EXOSC3	Exosome complex component RRP40	GO:0045830; P:positive regulation of isotype switching; IEA:Ensembl
Q9NQT5	EXOSC3	Exosome complex component RRP40	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9NQT5	EXOSC3	Exosome complex component RRP40	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; NAS:GOC
Q9NQT5	EXOSC3	Exosome complex component RRP40	GO:0006364; P:rRNA processing; IDA:UniProtKB
Q9NPD3	EXOSC4	Exosome complex component RRP41	GO:0000175; F:3'-5'-exoribonuclease activity; NAS:UniProtKB
Q9NPD3	EXOSC4	Exosome complex component RRP41	GO:0017091; F:AU-rich element binding; IDA:UniProtKB
Q9NPD3	EXOSC4	Exosome complex component RRP41	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NPD3	EXOSC4	Exosome complex component RRP41	GO:0051607; P:defense response to virus; IMP:MGI
Q9NPD3	EXOSC4	Exosome complex component RRP41	GO:0045006; P:DNA deamination; IDA:UniProtKB
Q9NPD3	EXOSC4	Exosome complex component RRP41	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
Q9NPD3	EXOSC4	Exosome complex component RRP41	GO:0010467; P:gene expression; TAS:Reactome
Q9NPD3	EXOSC4	Exosome complex component RRP41	GO:0071044; P:histone mRNA catabolic process; IMP:UniProtKB
Q9NPD3	EXOSC4	Exosome complex component RRP41	GO:0000460; P:maturation of 5.8S rRNA; IMP:UniProtKB
Q9NPD3	EXOSC4	Exosome complex component RRP41	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9NPD3	EXOSC4	Exosome complex component RRP41	GO:0071028; P:nuclear mRNA surveillance; IMP:UniProtKB
Q9NPD3	EXOSC4	Exosome complex component RRP41	GO:0000956; P:nuclear-transcribed mRNA catabolic process; IMP:UniProtKB
Q9NPD3	EXOSC4	Exosome complex component RRP41	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q9NPD3	EXOSC4	Exosome complex component RRP41	GO:0030307; P:positive regulation of cell growth; IMP:UniProtKB
Q9NPD3	EXOSC4	Exosome complex component RRP41	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9NPD3	EXOSC4	Exosome complex component RRP41	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; NAS:GOC
Q9NPD3	EXOSC4	Exosome complex component RRP41	GO:0006364; P:rRNA processing; NAS:UniProtKB
Q9NQT4	EXOSC5	Exosome complex component RRP46	GO:0000175; F:3'-5'-exoribonuclease activity; NAS:UniProtKB
Q9NQT4	EXOSC5	Exosome complex component RRP46	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NQT4	EXOSC5	Exosome complex component RRP46	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9NQT4	EXOSC5	Exosome complex component RRP46	GO:0051607; P:defense response to virus; IMP:MGI
Q9NQT4	EXOSC5	Exosome complex component RRP46	GO:0045006; P:DNA deamination; IDA:UniProtKB
Q9NQT4	EXOSC5	Exosome complex component RRP46	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; IMP:UniProtKB
Q9NQT4	EXOSC5	Exosome complex component RRP46	GO:0010467; P:gene expression; TAS:Reactome
Q9NQT4	EXOSC5	Exosome complex component RRP46	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9NQT4	EXOSC5	Exosome complex component RRP46	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q9NQT4	EXOSC5	Exosome complex component RRP46	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9NQT4	EXOSC5	Exosome complex component RRP46	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; NAS:GOC
Q9NQT4	EXOSC5	Exosome complex component RRP46	GO:0006364; P:rRNA processing; NAS:UniProtKB
Q5RKV6	EXOSC6	Exosome complex component MTR3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q5RKV6	EXOSC6	Exosome complex component MTR3	GO:0045006; P:DNA deamination; IDA:UniProtKB
Q5RKV6	EXOSC6	Exosome complex component MTR3	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
Q5RKV6	EXOSC6	Exosome complex component MTR3	GO:0010467; P:gene expression; TAS:Reactome
Q5RKV6	EXOSC6	Exosome complex component MTR3	GO:0045190; P:isotype switching; ISS:UniProtKB
Q5RKV6	EXOSC6	Exosome complex component MTR3	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q5RKV6	EXOSC6	Exosome complex component MTR3	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q5RKV6	EXOSC6	Exosome complex component MTR3	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q5RKV6	EXOSC6	Exosome complex component MTR3	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q15024	EXOSC7	Exosome complex component RRP42	GO:0000175; F:3'-5'-exoribonuclease activity; TAS:UniProtKB
Q15024	EXOSC7	Exosome complex component RRP42	GO:0005515; F:protein binding; IPI:UniProtKB
Q15024	EXOSC7	Exosome complex component RRP42	GO:0003723; F:RNA binding; TAS:UniProtKB
Q15024	EXOSC7	Exosome complex component RRP42	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
Q15024	EXOSC7	Exosome complex component RRP42	GO:0010467; P:gene expression; TAS:Reactome
Q15024	EXOSC7	Exosome complex component RRP42	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q15024	EXOSC7	Exosome complex component RRP42	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q15024	EXOSC7	Exosome complex component RRP42	GO:0006401; P:RNA catabolic process; NAS:UniProtKB
Q15024	EXOSC7	Exosome complex component RRP42	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q15024	EXOSC7	Exosome complex component RRP42	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; TAS:GOC
Q15024	EXOSC7	Exosome complex component RRP42	GO:0006364; P:rRNA processing; TAS:UniProtKB
Q96B26	EXOSC8	Exosome complex component RRP43	GO:0017091; F:AU-rich element binding; IDA:UniProtKB
Q96B26	EXOSC8	Exosome complex component RRP43	GO:0005515; F:protein binding; IPI:IntAct
Q96B26	EXOSC8	Exosome complex component RRP43	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
Q96B26	EXOSC8	Exosome complex component RRP43	GO:0010467; P:gene expression; TAS:Reactome
Q96B26	EXOSC8	Exosome complex component RRP43	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q96B26	EXOSC8	Exosome complex component RRP43	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q96B26	EXOSC8	Exosome complex component RRP43	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q96B26	EXOSC8	Exosome complex component RRP43	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q06265	EXOSC9	Exosome complex component RRP45	GO:0000175; F:3'-5'-exoribonuclease activity; NAS:UniProtKB
Q06265	EXOSC9	Exosome complex component RRP45	GO:0017091; F:AU-rich element binding; IDA:UniProtKB
Q06265	EXOSC9	Exosome complex component RRP45	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q06265	EXOSC9	Exosome complex component RRP45	GO:0005515; F:protein binding; IPI:IntAct
Q06265	EXOSC9	Exosome complex component RRP45	GO:0003723; F:RNA binding; NAS:UniProtKB
Q06265	EXOSC9	Exosome complex component RRP45	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; IMP:UniProtKB
Q06265	EXOSC9	Exosome complex component RRP45	GO:0010467; P:gene expression; TAS:Reactome
Q06265	EXOSC9	Exosome complex component RRP45	GO:0006955; P:immune response; NAS:UniProtKB
Q06265	EXOSC9	Exosome complex component RRP45	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q06265	EXOSC9	Exosome complex component RRP45	GO:0071028; P:nuclear mRNA surveillance; IMP:UniProtKB
Q06265	EXOSC9	Exosome complex component RRP45	GO:0071035; P:nuclear polyadenylation-dependent rRNA catabolic process; IMP:UniProtKB
Q06265	EXOSC9	Exosome complex component RRP45	GO:0000956; P:nuclear-transcribed mRNA catabolic process; IMP:UniProtKB
Q06265	EXOSC9	Exosome complex component RRP45	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q06265	EXOSC9	Exosome complex component RRP45	GO:0030307; P:positive regulation of cell growth; IMP:UniProtKB
Q06265	EXOSC9	Exosome complex component RRP45	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q06265	EXOSC9	Exosome complex component RRP45	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; NAS:GOC
Q06265	EXOSC9	Exosome complex component RRP45	GO:0006364; P:rRNA processing; NAS:UniProtKB
Q01780	EXOSC10	Exosome component 10	GO:0008408; F:3'-5' exonuclease activity; IEA:InterPro
Q01780	EXOSC10	Exosome component 10	GO:0004532; F:exoribonuclease activity; IDA:UniProtKB
Q01780	EXOSC10	Exosome component 10	GO:0000166; F:nucleotide binding; IEA:InterPro
Q01780	EXOSC10	Exosome component 10	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q01780	EXOSC10	Exosome component 10	GO:0005515; F:protein binding; IPI:UniProtKB
Q01780	EXOSC10	Exosome component 10	GO:0071034; P:CUT catabolic process; IMP:UniProtKB
Q01780	EXOSC10	Exosome component 10	GO:0009048; P:dosage compensation by inactivation of X chromosome; IEA:Ensembl
Q01780	EXOSC10	Exosome component 10	GO:0071044; P:histone mRNA catabolic process; IMP:UniProtKB
Q01780	EXOSC10	Exosome component 10	GO:0000460; P:maturation of 5.8S rRNA; IMP:UniProtKB
Q01780	EXOSC10	Exosome component 10	GO:0071028; P:nuclear mRNA surveillance; IMP:UniProtKB
Q01780	EXOSC10	Exosome component 10	GO:0071035; P:nuclear polyadenylation-dependent rRNA catabolic process; IMP:UniProtKB
Q01780	EXOSC10	Exosome component 10	GO:0071048; P:nuclear retention of unspliced pre-mRNA at the site of transcription; IMP:UniProtKB
Q01780	EXOSC10	Exosome component 10	GO:0000956; P:nuclear-transcribed mRNA catabolic process; IMP:UniProtKB
Q01780	EXOSC10	Exosome component 10	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IMP:UniProtKB
Q01780	EXOSC10	Exosome component 10	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; IDA:GOC
Q8NEV8	EXPH5	Exophilin-5	GO:0017137; F:Rab GTPase binding; IPI:UniProtKB
Q8NEV8	EXPH5	Exophilin-5	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q8NEV8	EXPH5	Exophilin-5	GO:0003334; P:keratinocyte development; IMP:UniProtKB
Q8NEV8	EXPH5	Exophilin-5	GO:0071985; P:multivesicular body sorting pathway; IMP:UniProtKB
Q8NEV8	EXPH5	Exophilin-5	GO:0045921; P:positive regulation of exocytosis; IMP:UniProtKB
Q8NEV8	EXPH5	Exophilin-5	GO:0050714; P:positive regulation of protein secretion; IMP:UniProtKB
Q16394	EXT1	Exostosin-1	GO:0008375; F:acetylglucosaminyltransferase activity; IDA:BHF-UCL
Q16394	EXT1	Exostosin-1	GO:0050508; F:glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; ISS:UniProtKB
Q16394	EXT1	Exostosin-1	GO:0015020; F:glucuronosyltransferase activity; IDA:BHF-UCL
Q16394	EXT1	Exostosin-1	GO:0042328; F:heparan sulfate N-acetylglucosaminyltransferase activity; NAS:BHF-UCL
Q16394	EXT1	Exostosin-1	GO:0050509; F:N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity; ISS:UniProtKB
Q16394	EXT1	Exostosin-1	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
Q16394	EXT1	Exostosin-1	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
Q16394	EXT1	Exostosin-1	GO:0016757; F:transferase activity, transferring glycosyl groups; IDA:BHF-UCL
Q16394	EXT1	Exostosin-1	GO:0007411; P:axon guidance; IEA:Ensembl
Q16394	EXT1	Exostosin-1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q16394	EXT1	Exostosin-1	GO:0033692; P:cellular polysaccharide biosynthetic process; IDA:BHF-UCL
Q16394	EXT1	Exostosin-1	GO:0072498; P:embryonic skeletal joint development; IEA:Ensembl
Q16394	EXT1	Exostosin-1	GO:0007492; P:endoderm development; IEA:Ensembl
Q16394	EXT1	Exostosin-1	GO:0007369; P:gastrulation; IEA:Ensembl
Q16394	EXT1	Exostosin-1	GO:0006024; P:glycosaminoglycan biosynthetic process; IDA:BHF-UCL
Q16394	EXT1	Exostosin-1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q16394	EXT1	Exostosin-1	GO:0015012; P:heparan sulfate proteoglycan biosynthetic process; ISS:UniProtKB
Q16394	EXT1	Exostosin-1	GO:0015014; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; IMP:BHF-UCL
Q16394	EXT1	Exostosin-1	GO:0007498; P:mesoderm development; IEA:Ensembl
Q16394	EXT1	Exostosin-1	GO:0021772; P:olfactory bulb development; IEA:Ensembl
Q16394	EXT1	Exostosin-1	GO:0001503; P:ossification; IMP:BHF-UCL
Q16394	EXT1	Exostosin-1	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q16394	EXT1	Exostosin-1	GO:0007165; P:signal transduction; TAS:ProtInc
Q16394	EXT1	Exostosin-1	GO:0001501; P:skeletal system development; TAS:ProtInc
Q16394	EXT1	Exostosin-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q93063	EXT2	Exostosin-2	GO:0050508; F:glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; IEA:UniProtKB-EC
Q93063	EXT2	Exostosin-2	GO:0015020; F:glucuronosyltransferase activity; IDA:BHF-UCL
Q93063	EXT2	Exostosin-2	GO:0042328; F:heparan sulfate N-acetylglucosaminyltransferase activity; NAS:BHF-UCL
Q93063	EXT2	Exostosin-2	GO:0050509; F:N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity; NAS:BHF-UCL
Q93063	EXT2	Exostosin-2	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
Q93063	EXT2	Exostosin-2	GO:0016757; F:transferase activity, transferring glycosyl groups; IDA:BHF-UCL
Q93063	EXT2	Exostosin-2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q93063	EXT2	Exostosin-2	GO:0030154; P:cell differentiation; IEA:Ensembl
Q93063	EXT2	Exostosin-2	GO:0033692; P:cellular polysaccharide biosynthetic process; IDA:BHF-UCL
Q93063	EXT2	Exostosin-2	GO:0006024; P:glycosaminoglycan biosynthetic process; IDA:BHF-UCL
Q93063	EXT2	Exostosin-2	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q93063	EXT2	Exostosin-2	GO:0015012; P:heparan sulfate proteoglycan biosynthetic process; IMP:BHF-UCL
Q93063	EXT2	Exostosin-2	GO:0015014; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; IMP:BHF-UCL
Q93063	EXT2	Exostosin-2	GO:0001707; P:mesoderm formation; IEA:Ensembl
Q93063	EXT2	Exostosin-2	GO:0001503; P:ossification; IMP:BHF-UCL
Q93063	EXT2	Exostosin-2	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q93063	EXT2	Exostosin-2	GO:0007165; P:signal transduction; TAS:ProtInc
Q93063	EXT2	Exostosin-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q92935	EXTL1	Exostosin-like 1	GO:0050508; F:glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; IEA:UniProtKB-EC
Q92935	EXTL1	Exostosin-like 1	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q92935	EXTL1	Exostosin-like 1	GO:0001501; P:skeletal system development; TAS:ProtInc
Q9UBQ6	EXTL2	Exostosin-like 2	GO:0035248; F:alpha-1,4-N-acetylgalactosaminyltransferase activity; IDA:UniProtKB
Q9UBQ6	EXTL2	Exostosin-like 2	GO:0001888; F:glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; IDA:UniProtKB
Q9UBQ6	EXTL2	Exostosin-like 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UBQ6	EXTL2	Exostosin-like 2	GO:0015012; P:heparan sulfate proteoglycan biosynthetic process; IEA:UniProtKB-UniPathway
Q9UBQ6	EXTL2	Exostosin-like 2	GO:0006044; P:N-acetylglucosamine metabolic process; IDA:UniProtKB
Q9UBQ6	EXTL2	Exostosin-like 2	GO:0019276; P:UDP-N-acetylgalactosamine metabolic process; IDA:UniProtKB
O43909	EXTL3	Exostosin-like 3	GO:0001888; F:glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; IEA:UniProtKB-EC
O43909	EXTL3	Exostosin-like 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43909	EXTL3	Exostosin-like 3	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
O43909	EXTL3	Exostosin-like 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O43909	EXTL3	Exostosin-like 3	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
O43909	EXTL3	Exostosin-like 3	GO:0015012; P:heparan sulfate proteoglycan biosynthetic process; IEA:UniProtKB-UniPathway
O43909	EXTL3	Exostosin-like 3	GO:0030307; P:positive regulation of cell growth; IEA:Ensembl
O00167	EYA2	Eyes absent homolog 2	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
O00167	EYA2	Eyes absent homolog 2	GO:0005515; F:protein binding; IPI:UniProtKB
O00167	EYA2	Eyes absent homolog 2	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
O00167	EYA2	Eyes absent homolog 2	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
O00167	EYA2	Eyes absent homolog 2	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
O00167	EYA2	Eyes absent homolog 2	GO:0016576; P:histone dephosphorylation; IDA:UniProtKB
O00167	EYA2	Eyes absent homolog 2	GO:0007501; P:mesodermal cell fate specification; TAS:ProtInc
O00167	EYA2	Eyes absent homolog 2	GO:0097345; P:mitochondrial outer membrane permeabilization; IEA:Ensembl
O00167	EYA2	Eyes absent homolog 2	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:GOC
O00167	EYA2	Eyes absent homolog 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O00167	EYA2	Eyes absent homolog 2	GO:0014706; P:striated muscle tissue development; IEA:Ensembl
O00167	EYA2	Eyes absent homolog 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q99502	EYA1	Eyes absent homolog 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q99502	EYA1	Eyes absent homolog 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q99502	EYA1	Eyes absent homolog 1	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
Q99502	EYA1	Eyes absent homolog 1	GO:0003723; F:RNA binding; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q99502	EYA1	Eyes absent homolog 1	GO:0035909; P:aorta morphogenesis; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0034613; P:cellular protein localization; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0090103; P:cochlea morphogenesis; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0006302; P:double-strand break repair; IMP:UniProtKB
Q99502	EYA1	Eyes absent homolog 1	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0000132; P:establishment of mitotic spindle orientation; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0035088; P:establishment or maintenance of apical/basal cell polarity; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0016576; P:histone dephosphorylation; IDA:UniProtKB
Q99502	EYA1	Eyes absent homolog 1	GO:0060487; P:lung epithelial cell differentiation; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0001656; P:metanephros development; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0042474; P:middle ear morphogenesis; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0048665; P:neuron fate specification; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0071600; P:otic vesicle morphogenesis; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0042473; P:outer ear morphogenesis; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0003151; P:outflow tract morphogenesis; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0007389; P:pattern specification process; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0060037; P:pharyngeal system development; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0045739; P:positive regulation of DNA repair; IMP:UniProtKB
Q99502	EYA1	Eyes absent homolog 1	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0045747; P:positive regulation of Notch signaling pathway; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0072513; P:positive regulation of secondary heart field cardioblast proliferation; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0016925; P:protein sumoylation; ISS:UniProtKB
Q99502	EYA1	Eyes absent homolog 1	GO:0045664; P:regulation of neuron differentiation; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0010212; P:response to ionizing radiation; IDA:UniProtKB
Q99502	EYA1	Eyes absent homolog 1	GO:0048752; P:semicircular canal morphogenesis; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0007605; P:sensory perception of sound; TAS:ProtInc
Q99502	EYA1	Eyes absent homolog 1	GO:0014706; P:striated muscle tissue development; IEA:Ensembl
Q99502	EYA1	Eyes absent homolog 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q99504	EYA3	Eyes absent homolog 3	GO:0003682; F:chromatin binding; IEA:Ensembl
Q99504	EYA3	Eyes absent homolog 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q99504	EYA3	Eyes absent homolog 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q99504	EYA3	Eyes absent homolog 3	GO:0004725; F:protein tyrosine phosphatase activity; IEA:Ensembl
Q99504	EYA3	Eyes absent homolog 3	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:Ensembl
Q99504	EYA3	Eyes absent homolog 3	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q99504	EYA3	Eyes absent homolog 3	GO:0006302; P:double-strand break repair; IMP:UniProtKB
Q99504	EYA3	Eyes absent homolog 3	GO:0016576; P:histone dephosphorylation; IDA:UniProtKB
Q99504	EYA3	Eyes absent homolog 3	GO:0007275; P:multicellular organismal development; IEA:InterPro
Q99504	EYA3	Eyes absent homolog 3	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:GOC
Q99504	EYA3	Eyes absent homolog 3	GO:0045739; P:positive regulation of DNA repair; IMP:UniProtKB
Q99504	EYA3	Eyes absent homolog 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q99504	EYA3	Eyes absent homolog 3	GO:0010212; P:response to ionizing radiation; IDA:UniProtKB
Q99504	EYA3	Eyes absent homolog 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q99504	EYA3	Eyes absent homolog 3	GO:0007601; P:visual perception; TAS:ProtInc
O95677	EYA4	Eyes absent homolog 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95677	EYA4	Eyes absent homolog 4	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
O95677	EYA4	Eyes absent homolog 4	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
O95677	EYA4	Eyes absent homolog 4	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
O95677	EYA4	Eyes absent homolog 4	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
O95677	EYA4	Eyes absent homolog 4	GO:0048839; P:inner ear development; IEA:Ensembl
O95677	EYA4	Eyes absent homolog 4	GO:0042474; P:middle ear morphogenesis; IEA:Ensembl
O95677	EYA4	Eyes absent homolog 4	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O95677	EYA4	Eyes absent homolog 4	GO:0007605; P:sensory perception of sound; IEA:Ensembl
O95677	EYA4	Eyes absent homolog 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95677	EYA4	Eyes absent homolog 4	GO:0007601; P:visual perception; TAS:ProtInc
Q5T1H1	EYS	Protein eyes shut homolog	GO:0005509; F:calcium ion binding; IEA:InterPro
Q5T1H1	EYS	Protein eyes shut homolog	GO:0050908; P:detection of light stimulus involved in visual perception; IMP:UniProt
Q5T1H1	EYS	Protein eyes shut homolog	GO:0043403; P:skeletal muscle tissue regeneration; IMP:UniProt
Q92800	EZH1	Histone-lysine N-methyltransferase EZH1	GO:0003682; F:chromatin binding; TAS:ProtInc
Q92800	EZH1	Histone-lysine N-methyltransferase EZH1	GO:0046976; F:histone methyltransferase activity (H3-K27 specific); IEA:Ensembl
Q92800	EZH1	Histone-lysine N-methyltransferase EZH1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q92800	EZH1	Histone-lysine N-methyltransferase EZH1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q92800	EZH1	Histone-lysine N-methyltransferase EZH1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0031490; F:chromatin DNA binding; IDA:UniProt
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0001047; F:core promoter binding; IEA:Ensembl
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0003677; F:DNA binding; TAS:ProtInc
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0042054; F:histone methyltransferase activity; IDA:MGI
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0046976; F:histone methyltransferase activity (H3-K27 specific); TAS:UniProtKB
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0005515; F:protein binding; IPI:UniProtKB
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0003723; F:RNA binding; IEA:Ensembl
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0021695; P:cerebellar cortex development; IEA:Ensembl
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0006325; P:chromatin organization; TAS:ProtInc
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0070314; P:G1 to G0 transition; IEA:Ensembl
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0070734; P:histone H3-K27 methylation; IDA:UniProtKB
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0045605; P:negative regulation of epidermal cell differentiation; IEA:Ensembl
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0045814; P:negative regulation of gene expression, epigenetic; IDA:UniProtKB
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IMP:UniProtKB
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0051154; P:negative regulation of striated muscle cell differentiation; IEA:Ensembl
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0034244; P:negative regulation of transcription elongation from RNA polymerase II promoter; IEA:Ensembl
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IDA:UniProtKB
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0043406; P:positive regulation of MAP kinase activity; IDA:UniProtKB
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IDA:UniProtKB
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0032320; P:positive regulation of Ras GTPase activity; IDA:UniProtKB
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0014013; P:regulation of gliogenesis; IEA:Ensembl
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
Q15910	EZH2	Histone-lysine N-methyltransferase EZH2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P15311	EZR	Ezrin	GO:0051015; F:actin filament binding; IDA:UniProtKB
P15311	EZR	Ezrin	GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL
P15311	EZR	Ezrin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P15311	EZR	Ezrin	GO:0005515; F:protein binding; IPI:UniProtKB
P15311	EZR	Ezrin	GO:0051017; P:actin filament bundle assembly; IDA:UniProtKB
P15311	EZR	Ezrin	GO:0007411; P:axon guidance; TAS:Reactome
P15311	EZR	Ezrin	GO:0007016; P:cytoskeletal anchoring at plasma membrane; NAS:UniProtKB
P15311	EZR	Ezrin	GO:0061028; P:establishment of endothelial barrier; IGI:UniProt
P15311	EZR	Ezrin	GO:0035088; P:establishment or maintenance of apical/basal cell polarity; IEA:Ensembl
P15311	EZR	Ezrin	GO:0046847; P:filopodium assembly; IEA:Ensembl
P15311	EZR	Ezrin	GO:0007159; P:leukocyte cell-cell adhesion; IEP:BHF-UCL
P15311	EZR	Ezrin	GO:0022614; P:membrane to membrane docking; IEP:BHF-UCL
P15311	EZR	Ezrin	GO:0010628; P:positive regulation of gene expression; IGI:UniProt
P15311	EZR	Ezrin	GO:0031623; P:receptor internalization; IEA:Ensembl
P15311	EZR	Ezrin	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
Q8N5W9	FAM101B	Protein FAM101B	GO:0031005; F:filamin binding; IDA:MGI
Q8N5W9	FAM101B	Protein FAM101B	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
Q8N5W9	FAM101B	Protein FAM101B	GO:0001837; P:epithelial to mesenchymal transition; IEA:Ensembl
O95990	FAM107A	Protein FAM107A	GO:0001558; P:regulation of cell growth; IDA:UniProtKB
P50502	ST13	Hsc70-interacting protein	GO:0032564; F:dATP binding; IEA:Ensembl
P50502	ST13	Hsc70-interacting protein	GO:0005515; F:protein binding; IPI:IntAct
P50502	ST13	Hsc70-interacting protein	GO:0030674; F:protein binding, bridging; TAS:ProtInc
P50502	ST13	Hsc70-interacting protein	GO:0070389; P:chaperone cofactor-dependent protein refolding; IEA:Ensembl
P50502	ST13	Hsc70-interacting protein	GO:0061084; P:negative regulation of protein refolding; IEA:Ensembl
P50502	ST13	Hsc70-interacting protein	GO:0006457; P:protein folding; TAS:ProtInc
P50502	ST13	Hsc70-interacting protein	GO:0051260; P:protein homooligomerization; IEA:Ensembl
Q70Z53	FRA10AC1	Protein FRA10AC1	GO:0005515; F:protein binding; IPI:IntAct
Q1W6H9	FAM110C	Protein FAM110C	GO:0043014; F:alpha-tubulin binding; IDA:UniProtKB
Q1W6H9	FAM110C	Protein FAM110C	GO:0005515; F:protein binding; IPI:IntAct
Q1W6H9	FAM110C	Protein FAM110C	GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB
Q1W6H9	FAM110C	Protein FAM110C	GO:0051897; P:positive regulation of protein kinase B signaling; IMP:UniProtKB
Q1W6H9	FAM110C	Protein FAM110C	GO:0060491; P:regulation of cell projection assembly; IMP:UniProtKB
Q96PZ2	FAM111A	Protein FAM111A	GO:0003824; F:catalytic activity; IEA:InterPro
Q96PZ2	FAM111A	Protein FAM111A	GO:0005515; F:protein binding; IPI:UniProtKB
Q96PZ2	FAM111A	Protein FAM111A	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q96PZ2	FAM111A	Protein FAM111A	GO:0000087; P:mitotic M phase; IEP:UniProtKB
Q96PZ2	FAM111A	Protein FAM111A	GO:0045071; P:negative regulation of viral genome replication; IMP:UniProtKB
Q96PZ2	FAM111A	Protein FAM111A	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9BQ89	FAM110A	Protein FAM110A	GO:0005515; F:protein binding; IPI:IntAct
Q9NRY5	FAM114A2	Protein FAM114A2	GO:0017076; F:purine nucleotide binding; NAS:UniProtKB
Q6SJ93	FAM111B	Protein FAM111B	GO:0003824; F:catalytic activity; IEA:InterPro
Q9NZB2	FAM120A	Constitutive coactivator of PPAR-gamma-like protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96EK7	FAM120B	Constitutive coactivator of peroxisome proliferator-activated receptor gamma	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96EK7	FAM120B	Constitutive coactivator of peroxisome proliferator-activated receptor gamma	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96EK7	FAM120B	Constitutive coactivator of peroxisome proliferator-activated receptor gamma	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NX05	FAM120C	Constitutive coactivator of PPAR-gamma-like protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H5Z6	FAM124B	Protein FAM124B	GO:0005515; F:protein binding; IPI:IntAct
Q4G0M1	FAM132B	Protein FAM132B	GO:2000193; P:positive regulation of fatty acid transport; IEA:Ensembl
Q4G0M1	FAM132B	Protein FAM132B	GO:0019217; P:regulation of fatty acid metabolic process; IEA:Ensembl
Q5T7M4	FAM132A	Protein FAM132A	GO:0045721; P:negative regulation of gluconeogenesis; IEA:Ensembl
Q5T7M4	FAM132A	Protein FAM132A	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
Q5T7M4	FAM132A	Protein FAM132A	GO:0046326; P:positive regulation of glucose import; IEA:Ensembl
Q5T7M4	FAM132A	Protein FAM132A	GO:0046628; P:positive regulation of insulin receptor signaling pathway; IEA:Ensembl
Q5T7M4	FAM132A	Protein FAM132A	GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl
Q5T7M4	FAM132A	Protein FAM132A	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
Q5BKY9	FAM133B	Protein FAM133B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H6L5	FAM134B	Protein FAM134B	GO:0019233; P:sensory perception of pain; IMP:UniProtKB
P00488	F13A1	Coagulation factor XIII A chain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P00488	F13A1	Coagulation factor XIII A chain	GO:0003810; F:protein-glutamine gamma-glutamyltransferase activity; TAS:Reactome
P00488	F13A1	Coagulation factor XIII A chain	GO:0007596; P:blood coagulation; TAS:Reactome
P00488	F13A1	Coagulation factor XIII A chain	GO:0018149; P:peptide cross-linking; IEA:Ensembl
P00488	F13A1	Coagulation factor XIII A chain	GO:0030168; P:platelet activation; TAS:Reactome
P00488	F13A1	Coagulation factor XIII A chain	GO:0002576; P:platelet degranulation; TAS:Reactome
P05160	F13B	Coagulation factor XIII B chain	GO:0007596; P:blood coagulation; TAS:Reactome
Q8IYX7	FAM154A	Protein FAM154A	GO:0005515; F:protein binding; IPI:IntAct
Q3B820	FAM161A	Protein FAM161A	GO:0005515; F:protein binding; IPI:UniProtKB
Q3B820	FAM161A	Protein FAM161A	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q3B820	FAM161A	Protein FAM161A	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q3B820	FAM161A	Protein FAM161A	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q96A26	FAM162A	Protein FAM162A	GO:0005515; F:protein binding; IPI:IntAct
Q96A26	FAM162A	Protein FAM162A	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
Q96A26	FAM162A	Protein FAM162A	GO:0071456; P:cellular response to hypoxia; IDA:UniProtKB
Q96A26	FAM162A	Protein FAM162A	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
Q96A26	FAM162A	Protein FAM162A	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q96A26	FAM162A	Protein FAM162A	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IDA:UniProtKB
Q96A26	FAM162A	Protein FAM162A	GO:0006927; P:transformed cell apoptotic process; IDA:UniProtKB
Q8N612	FAM160A2	FTS and Hook-interacting protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N612	FAM160A2	FTS and Hook-interacting protein	GO:0045022; P:early endosome to late endosome transport; IMP:UniProtKB
Q8N612	FAM160A2	FTS and Hook-interacting protein	GO:0007032; P:endosome organization; IMP:UniProtKB
Q8N612	FAM160A2	FTS and Hook-interacting protein	GO:0008333; P:endosome to lysosome transport; IMP:UniProtKB
Q8N612	FAM160A2	FTS and Hook-interacting protein	GO:0007040; P:lysosome organization; IMP:UniProtKB
Q8N612	FAM160A2	FTS and Hook-interacting protein	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P09467	FBP1	Fructose-1,6-bisphosphatase 1	GO:0016208; F:AMP binding; IDA:UniProtKB
P09467	FBP1	Fructose-1,6-bisphosphatase 1	GO:0042132; F:fructose 1,6-bisphosphate 1-phosphatase activity; IDA:UniProtKB
P09467	FBP1	Fructose-1,6-bisphosphatase 1	GO:0042802; F:identical protein binding; IPI:IntAct
P09467	FBP1	Fructose-1,6-bisphosphatase 1	GO:0046872; F:metal ion binding; IMP:UniProtKB
P09467	FBP1	Fructose-1,6-bisphosphatase 1	GO:0048029; F:monosaccharide binding; ISS:UniProtKB
P09467	FBP1	Fructose-1,6-bisphosphatase 1	GO:0005515; F:protein binding; IPI:UniProtKB
P09467	FBP1	Fructose-1,6-bisphosphatase 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P09467	FBP1	Fructose-1,6-bisphosphatase 1	GO:0035690; P:cellular response to drug; IDA:UniProtKB
P09467	FBP1	Fructose-1,6-bisphosphatase 1	GO:0071286; P:cellular response to magnesium ion; IDA:UniProtKB
P09467	FBP1	Fructose-1,6-bisphosphatase 1	GO:0016311; P:dephosphorylation; IDA:UniProtKB
P09467	FBP1	Fructose-1,6-bisphosphatase 1	GO:0006002; P:fructose 6-phosphate metabolic process; IDA:UniProtKB
P09467	FBP1	Fructose-1,6-bisphosphatase 1	GO:0006000; P:fructose metabolic process; TAS:ProtInc
P09467	FBP1	Fructose-1,6-bisphosphatase 1	GO:0006094; P:gluconeogenesis; IMP:UniProtKB
P09467	FBP1	Fructose-1,6-bisphosphatase 1	GO:0006006; P:glucose metabolic process; TAS:Reactome
P09467	FBP1	Fructose-1,6-bisphosphatase 1	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
P09467	FBP1	Fructose-1,6-bisphosphatase 1	GO:0045820; P:negative regulation of glycolytic process; IDA:UniProtKB
P09467	FBP1	Fructose-1,6-bisphosphatase 1	GO:0046580; P:negative regulation of Ras protein signal transduction; IDA:UniProtKB
P09467	FBP1	Fructose-1,6-bisphosphatase 1	GO:0051289; P:protein homotetramerization; IDA:UniProtKB
P09467	FBP1	Fructose-1,6-bisphosphatase 1	GO:0006111; P:regulation of gluconeogenesis; IMP:UniProtKB
P09467	FBP1	Fructose-1,6-bisphosphatase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00757	FBP2	Fructose-1,6-bisphosphatase isozyme 2	GO:0042132; F:fructose 1,6-bisphosphate 1-phosphatase activity; IEA:UniProtKB-EC
O00757	FBP2	Fructose-1,6-bisphosphatase isozyme 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O00757	FBP2	Fructose-1,6-bisphosphatase isozyme 2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O00757	FBP2	Fructose-1,6-bisphosphatase isozyme 2	GO:0006000; P:fructose metabolic process; TAS:ProtInc
O00757	FBP2	Fructose-1,6-bisphosphatase isozyme 2	GO:0006094; P:gluconeogenesis; TAS:Reactome
O00757	FBP2	Fructose-1,6-bisphosphatase isozyme 2	GO:0006006; P:glucose metabolic process; TAS:Reactome
O00757	FBP2	Fructose-1,6-bisphosphatase isozyme 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
A1A519	FAM170A	Protein FAM170A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A1A519	FAM170A	Protein FAM170A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A1A519	FAM170A	Protein FAM170A	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
A1A519	FAM170A	Protein FAM170A	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
Q6P995	FAM171B	Protein FAM171B	GO:0003677; F:DNA binding; IEA:InterPro
Q6UWZ7	FAM175A	BRCA1-A complex subunit Abraxas	GO:0031593; F:polyubiquitin binding; IDA:UniProtKB
Q6UWZ7	FAM175A	BRCA1-A complex subunit Abraxas	GO:0005515; F:protein binding; IPI:UniProtKB
Q6UWZ7	FAM175A	BRCA1-A complex subunit Abraxas	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q6UWZ7	FAM175A	BRCA1-A complex subunit Abraxas	GO:0006302; P:double-strand break repair; IMP:UniProtKB
Q6UWZ7	FAM175A	BRCA1-A complex subunit Abraxas	GO:0031572; P:G2 DNA damage checkpoint; IMP:UniProtKB
Q6UWZ7	FAM175A	BRCA1-A complex subunit Abraxas	GO:0045739; P:positive regulation of DNA repair; IMP:UniProtKB
Q6UWZ7	FAM175A	BRCA1-A complex subunit Abraxas	GO:0010212; P:response to ionizing radiation; IMP:UniProtKB
Q15018	FAM175B	BRISC complex subunit Abro1	GO:0031593; F:polyubiquitin binding; IDA:UniProtKB
Q9H8M7	FAM188A	Protein FAM188A	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9H8M7	FAM188A	Protein FAM188A	GO:0005515; F:protein binding; IPI:IntAct
Q9H8M7	FAM188A	Protein FAM188A	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P81408	FAM189B	Protein FAM189B	GO:0005515; F:protein binding; IPI:IntAct
P81408	FAM189B	Protein FAM189B	GO:0050699; F:WW domain binding; IPI:UniProtKB
P0CF97	FAM200B	Putative protein FAM200B	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8TCP9	FAM200A	Protein FAM200A	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9NX38	FAM206A	Protein Simiate	GO:0006546; P:glycine catabolic process; IEA:InterPro
Q9UK61	FAM208A	Protein FAM208A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96EL1	FAM212A	Protein FAM212A	GO:0021915; P:neural tube development; IEA:Ensembl
Q9BRX8	FAM213A	Redox-regulatory protein FAM213A	GO:0016209; F:antioxidant activity; IDA:UniProtKB
Q9BRX8	FAM213A	Redox-regulatory protein FAM213A	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q9BRX8	FAM213A	Redox-regulatory protein FAM213A	GO:0045670; P:regulation of osteoclast differentiation; IDA:UniProtKB
Q9Y5M1	FAM215A	Putative protein FAM215A	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0003873; F:6-phosphofructo-2-kinase activity; IEA:InterPro
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0005524; F:ATP binding; IEA:InterPro
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0004331; F:fructose-2,6-bisphosphate 2-phosphatase activity; IEA:InterPro
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0070095; F:fructose-6-phosphate binding; IEA:Ensembl
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0005515; F:protein binding; IPI:UniProtKB
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0016311; P:dephosphorylation; IDA:GOC
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0006003; P:fructose 2,6-bisphosphate metabolic process; IEA:InterPro
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0006000; P:fructose metabolic process; IEA:InterPro
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0006094; P:gluconeogenesis; TAS:UniProtKB
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0006006; P:glucose metabolic process; TAS:Reactome
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0006096; P:glycolytic process; TAS:UniProtKB
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0035556; P:intracellular signal transduction; TAS:Reactome
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0031100; P:organ regeneration; IEA:Ensembl
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0033133; P:positive regulation of glucokinase activity; IEA:Ensembl
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0051591; P:response to cAMP; IEA:Ensembl
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0033762; P:response to glucagon; IEA:Ensembl
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0032868; P:response to insulin; IEA:Ensembl
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0042594; P:response to starvation; IEA:Ensembl
P16118	PFKFB1	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60825	PFKFB2	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2	GO:0003873; F:6-phosphofructo-2-kinase activity; IDA:UniProtKB
O60825	PFKFB2	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O60825	PFKFB2	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2	GO:0004331; F:fructose-2,6-bisphosphate 2-phosphatase activity; IEA:UniProtKB-EC
O60825	PFKFB2	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2	GO:0005515; F:protein binding; IPI:UniProtKB
O60825	PFKFB2	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O60825	PFKFB2	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O60825	PFKFB2	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2	GO:0046835; P:carbohydrate phosphorylation; IDA:GOC
O60825	PFKFB2	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2	GO:0006003; P:fructose 2,6-bisphosphate metabolic process; IEA:InterPro
O60825	PFKFB2	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2	GO:0006000; P:fructose metabolic process; TAS:ProtInc
O60825	PFKFB2	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2	GO:0006007; P:glucose catabolic process; IEA:Ensembl
O60825	PFKFB2	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2	GO:0006006; P:glucose metabolic process; TAS:Reactome
O60825	PFKFB2	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2	GO:0006096; P:glycolytic process; IDA:UniProtKB
O60825	PFKFB2	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2	GO:0006089; P:lactate metabolic process; IEA:Ensembl
O60825	PFKFB2	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2	GO:0033133; P:positive regulation of glucokinase activity; IEA:Ensembl
O60825	PFKFB2	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2	GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl
O60825	PFKFB2	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2	GO:0006090; P:pyruvate metabolic process; IEA:Ensembl
O60825	PFKFB2	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2	GO:0009749; P:response to glucose; IEA:Ensembl
O60825	PFKFB2	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16875	PFKFB3	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3	GO:0003873; F:6-phosphofructo-2-kinase activity; NAS:UniProtKB
Q16875	PFKFB3	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q16875	PFKFB3	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3	GO:0004331; F:fructose-2,6-bisphosphate 2-phosphatase activity; IEA:UniProtKB-EC
Q16875	PFKFB3	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q16875	PFKFB3	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3	GO:0046835; P:carbohydrate phosphorylation; NAS:GOC
Q16875	PFKFB3	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3	GO:0006003; P:fructose 2,6-bisphosphate metabolic process; IEA:InterPro
Q16875	PFKFB3	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3	GO:0006000; P:fructose metabolic process; IEA:InterPro
Q16875	PFKFB3	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3	GO:0006006; P:glucose metabolic process; TAS:Reactome
Q16875	PFKFB3	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3	GO:0006096; P:glycolytic process; TAS:Reactome
Q16875	PFKFB3	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16877	PFKFB4	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4	GO:0003873; F:6-phosphofructo-2-kinase activity; NAS:UniProtKB
Q16877	PFKFB4	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q16877	PFKFB4	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4	GO:0004331; F:fructose-2,6-bisphosphate 2-phosphatase activity; IEA:UniProtKB-EC
Q16877	PFKFB4	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q16877	PFKFB4	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4	GO:0046835; P:carbohydrate phosphorylation; NAS:GOC
Q16877	PFKFB4	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4	GO:0006003; P:fructose 2,6-bisphosphate metabolic process; IEA:InterPro
Q16877	PFKFB4	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4	GO:0006000; P:fructose metabolic process; IEA:InterPro
Q16877	PFKFB4	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4	GO:0006006; P:glucose metabolic process; TAS:Reactome
Q16877	PFKFB4	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4	GO:0006096; P:glycolytic process; TAS:Reactome
Q16877	PFKFB4	6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
A6NJQ4	FAM90A8P	Putative protein FAM90A8P	GO:0003676; F:nucleic acid binding; IEA:InterPro
A6NJQ4	FAM90A8P	Putative protein FAM90A8P	GO:0008270; F:zinc ion binding; IEA:InterPro
A6NDY2	FAM90A10P	Putative protein FAM90A10P	GO:0003676; F:nucleic acid binding; IEA:InterPro
A6NDY2	FAM90A10P	Putative protein FAM90A10P	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86YD7	FAM90A1	Protein FAM90A1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q86YD7	FAM90A1	Protein FAM90A1	GO:0008270; F:zinc ion binding; IEA:InterPro
A8MXJ8	FAM90A5P	Putative protein FAM90A5P	GO:0003676; F:nucleic acid binding; IEA:InterPro
A8MXJ8	FAM90A5P	Putative protein FAM90A5P	GO:0008270; F:zinc ion binding; IEA:InterPro
P0C7W8	FAM90A13P	Putative protein FAM90A13P	GO:0003676; F:nucleic acid binding; IEA:InterPro
P0C7W8	FAM90A13P	Putative protein FAM90A13P	GO:0008270; F:zinc ion binding; IEA:InterPro
A8MX19	FAM90A12P	Putative protein FAM90A12P	GO:0003676; F:nucleic acid binding; IEA:InterPro
A8MX19	FAM90A12P	Putative protein FAM90A12P	GO:0008270; F:zinc ion binding; IEA:InterPro
P0C7W9	FAM90A14P	Putative protein FAM90A14P	GO:0003676; F:nucleic acid binding; IEA:InterPro
P0C7W9	FAM90A14P	Putative protein FAM90A14P	GO:0008270; F:zinc ion binding; IEA:InterPro
P0C7V4	FAM90A15P	Putative protein FAM90A15P	GO:0003676; F:nucleic acid binding; IEA:InterPro
P0C7V4	FAM90A15P	Putative protein FAM90A15P	GO:0008270; F:zinc ion binding; IEA:InterPro
A6NIJ5	FAM90A20P	Putative protein FAM90A20P	GO:0003676; F:nucleic acid binding; IEA:InterPro
A6NIJ5	FAM90A20P	Putative protein FAM90A20P	GO:0008270; F:zinc ion binding; IEA:InterPro
A6NKC0	FAM90A7P	Putative protein FAM90A7P	GO:0003676; F:nucleic acid binding; IEA:InterPro
A6NKC0	FAM90A7P	Putative protein FAM90A7P	GO:0008270; F:zinc ion binding; IEA:InterPro
A6NEW6	FAM90A16P	Putative protein FAM90A16P/FAM90A17P	GO:0003676; F:nucleic acid binding; IEA:InterPro
A6NEW6	FAM90A16P	Putative protein FAM90A16P/FAM90A17P	GO:0008270; F:zinc ion binding; IEA:InterPro
A8MWA6	FAM90A22P	Putative protein FAM90A22P	GO:0003676; F:nucleic acid binding; IEA:InterPro
A8MWA6	FAM90A22P	Putative protein FAM90A22P	GO:0008270; F:zinc ion binding; IEA:InterPro
A6NNH2	FAM90A27P	Protein FAM90A27P	GO:0003676; F:nucleic acid binding; IEA:InterPro
A6NNH2	FAM90A27P	Protein FAM90A27P	GO:0008270; F:zinc ion binding; IEA:InterPro
P0C7X0	FAM90A24P	Putative protein FAM90A24P	GO:0003676; F:nucleic acid binding; IEA:InterPro
P0C7X0	FAM90A24P	Putative protein FAM90A24P	GO:0008270; F:zinc ion binding; IEA:InterPro
A6NE21	FAM90A18P	Putative protein FAM90A18P/FAM90A19P	GO:0003676; F:nucleic acid binding; IEA:InterPro
A6NE21	FAM90A18P	Putative protein FAM90A18P/FAM90A19P	GO:0008270; F:zinc ion binding; IEA:InterPro
A8MXZ1	FAM90A23P	Putative protein FAM90A23P	GO:0003676; F:nucleic acid binding; IEA:InterPro
A8MXZ1	FAM90A23P	Putative protein FAM90A23P	GO:0008270; F:zinc ion binding; IEA:InterPro
A6NNJ1	FAM90A9P	Putative protein FAM90A9P	GO:0003676; F:nucleic acid binding; IEA:InterPro
A6NNJ1	FAM90A9P	Putative protein FAM90A9P	GO:0008270; F:zinc ion binding; IEA:InterPro
P00742	F10	Coagulation factor X	GO:0005509; F:calcium ion binding; IEA:InterPro
P00742	F10	Coagulation factor X	GO:0005543; F:phospholipid binding; IDA:BHF-UCL
P00742	F10	Coagulation factor X	GO:0005515; F:protein binding; IPI:UniProtKB
P00742	F10	Coagulation factor X	GO:0004252; F:serine-type endopeptidase activity; IDA:BHF-UCL
P00742	F10	Coagulation factor X	GO:0007596; P:blood coagulation; IC:BHF-UCL
P00742	F10	Coagulation factor X	GO:0007598; P:blood coagulation, extrinsic pathway; TAS:Reactome
P00742	F10	Coagulation factor X	GO:0007597; P:blood coagulation, intrinsic pathway; TAS:Reactome
P00742	F10	Coagulation factor X	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P00742	F10	Coagulation factor X	GO:0017187; P:peptidyl-glutamic acid carboxylation; TAS:Reactome
P00742	F10	Coagulation factor X	GO:0030335; P:positive regulation of cell migration; TAS:BHF-UCL
P00742	F10	Coagulation factor X	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:BHF-UCL
P00742	F10	Coagulation factor X	GO:0043687; P:post-translational protein modification; TAS:Reactome
P00742	F10	Coagulation factor X	GO:0006508; P:proteolysis; TAS:Reactome
P03951	F11	Coagulation factor XI	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P03951	F11	Coagulation factor XI	GO:0005515; F:protein binding; IPI:UniProtKB
P03951	F11	Coagulation factor XI	GO:0070009; F:serine-type aminopeptidase activity; IEA:Ensembl
P03951	F11	Coagulation factor XI	GO:0004252; F:serine-type endopeptidase activity; NAS:UniProtKB
P03951	F11	Coagulation factor XI	GO:0007596; P:blood coagulation; NAS:UniProtKB
P03951	F11	Coagulation factor XI	GO:0007597; P:blood coagulation, intrinsic pathway; TAS:Reactome
P03951	F11	Coagulation factor XI	GO:0031639; P:plasminogen activation; IDA:BHF-UCL
P03951	F11	Coagulation factor XI	GO:0051919; P:positive regulation of fibrinolysis; IDA:BHF-UCL
P00748	F12	Coagulation factor XII	GO:0051787; F:misfolded protein binding; IC:BHF-UCL
P00748	F12	Coagulation factor XII	GO:0005515; F:protein binding; IPI:UniProtKB
P00748	F12	Coagulation factor XII	GO:0070009; F:serine-type aminopeptidase activity; IEA:Ensembl
P00748	F12	Coagulation factor XII	GO:0004252; F:serine-type endopeptidase activity; IDA:BHF-UCL
P00748	F12	Coagulation factor XII	GO:0007596; P:blood coagulation; TAS:Reactome
P00748	F12	Coagulation factor XII	GO:0007597; P:blood coagulation, intrinsic pathway; IC:BHF-UCL
P00748	F12	Coagulation factor XII	GO:0002542; P:Factor XII activation; IDA:BHF-UCL
P00748	F12	Coagulation factor XII	GO:0042730; P:fibrinolysis; IEA:UniProtKB-KW
P00748	F12	Coagulation factor XII	GO:0045087; P:innate immune response; TAS:BHF-UCL
P00748	F12	Coagulation factor XII	GO:0002353; P:plasma kallikrein-kinin cascade; IDA:BHF-UCL
P00748	F12	Coagulation factor XII	GO:0030194; P:positive regulation of blood coagulation; IDA:BHF-UCL
P00748	F12	Coagulation factor XII	GO:0051919; P:positive regulation of fibrinolysis; IDA:BHF-UCL
P00748	F12	Coagulation factor XII	GO:0010756; P:positive regulation of plasminogen activation; IDA:BHF-UCL
P00748	F12	Coagulation factor XII	GO:0016540; P:protein autoprocessing; IDA:BHF-UCL
P00748	F12	Coagulation factor XII	GO:0016485; P:protein processing; IDA:BHF-UCL
P00748	F12	Coagulation factor XII	GO:0051788; P:response to misfolded protein; IDA:BHF-UCL
P00748	F12	Coagulation factor XII	GO:0031638; P:zymogen activation; IDA:BHF-UCL
O94988	FAM13A	Protein FAM13A	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
O94988	FAM13A	Protein FAM13A	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
O94988	FAM13A	Protein FAM13A	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9NYF5	FAM13B	Protein FAM13B	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q9NYF5	FAM13B	Protein FAM13B	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q9NYF5	FAM13B	Protein FAM13B	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q96MK3	FAM20A	Protein FAM20A	GO:0070166; P:enamel mineralization; IEA:Ensembl
Q641Q2	FAM21A	WASH complex subunit FAM21A	GO:0042147; P:retrograde transport, endosome to Golgi; ISS:UniProtKB
Q5SNT6	FAM21B	WASH complex subunit FAM21B	GO:0042147; P:retrograde transport, endosome to Golgi; ISS:UniProtKB
Q5SRD0	FAM21D	Putative WASH complex subunit FAM21	GO:0042147; P:retrograde transport, endosome to Golgi; ISS:UniProtKB
Q9Y4E1	FAM21C	WASH complex subunit FAM21C	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y4E1	FAM21C	WASH complex subunit FAM21C	GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB
Q5JW98	FAM26D	Protein FAM26D	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q8N5C1	FAM26E	Protein FAM26E	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q5R3K3	FAM26F	Protein FAM26F	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q7L5A8	FA2H	Fatty acid 2-hydroxylase	GO:0080132; F:fatty acid alpha-hydroxylase activity; IEA:Ensembl
Q7L5A8	FA2H	Fatty acid 2-hydroxylase	GO:0020037; F:heme binding; IEA:InterPro
Q7L5A8	FA2H	Fatty acid 2-hydroxylase	GO:0005506; F:iron ion binding; IEA:InterPro
Q7L5A8	FA2H	Fatty acid 2-hydroxylase	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q7L5A8	FA2H	Fatty acid 2-hydroxylase	GO:0032286; P:central nervous system myelin maintenance; IEA:Ensembl
Q7L5A8	FA2H	Fatty acid 2-hydroxylase	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
Q7L5A8	FA2H	Fatty acid 2-hydroxylase	GO:0030258; P:lipid modification; IEA:Ensembl
Q7L5A8	FA2H	Fatty acid 2-hydroxylase	GO:0032287; P:peripheral nervous system myelin maintenance; IEA:Ensembl
Q7L5A8	FA2H	Fatty acid 2-hydroxylase	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q7L5A8	FA2H	Fatty acid 2-hydroxylase	GO:0042634; P:regulation of hair cycle; IEA:Ensembl
Q7L5A8	FA2H	Fatty acid 2-hydroxylase	GO:0001949; P:sebaceous gland cell differentiation; IEA:Ensembl
Q7L5A8	FA2H	Fatty acid 2-hydroxylase	GO:0006665; P:sphingolipid metabolic process; IEA:InterPro
Q9Y421	FAM32A	Protein FAM32A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y421	FAM32A	Protein FAM32A	GO:0005515; F:protein binding; IPI:IntAct
Q9Y421	FAM32A	Protein FAM32A	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9Y421	FAM32A	Protein FAM32A	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q96IP4	FAM46A	Protein FAM46A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14320	FAM50A	Protein FAM50A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14320	FAM50A	Protein FAM50A	GO:0007283; P:spermatogenesis; NAS:UniProtKB
Q71RH2	FAM57B	Protein FAM57B	GO:0006629; P:lipid metabolic process; IEA:UniProtKB-KW
Q8N1B3	FAM58A	Cyclin-related protein FAM58A	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N1B3	FAM58A	Cyclin-related protein FAM58A	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:InterPro
Q8N1B3	FAM58A	Cyclin-related protein FAM58A	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
P0C7Q3	FAM58BP	Putative cyclin-related protein FAM58B	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:InterPro
P0C7Q3	FAM58BP	Putative cyclin-related protein FAM58B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
P12259	F5	Coagulation factor V	GO:0005507; F:copper ion binding; IEA:InterPro
P12259	F5	Coagulation factor V	GO:0005515; F:protein binding; IPI:UniProtKB
P12259	F5	Coagulation factor V	GO:0004252; F:serine-type endopeptidase activity; IEA:Ensembl
P12259	F5	Coagulation factor V	GO:0008015; P:blood circulation; IEA:Ensembl
P12259	F5	Coagulation factor V	GO:0007596; P:blood coagulation; TAS:Reactome
P12259	F5	Coagulation factor V	GO:0007155; P:cell adhesion; IEA:InterPro
P12259	F5	Coagulation factor V	GO:0030168; P:platelet activation; TAS:Reactome
P12259	F5	Coagulation factor V	GO:0002576; P:platelet degranulation; TAS:Reactome
Q9NP50	FAM60A	Protein FAM60A	GO:0005515; F:protein binding; IPI:IntAct
Q9NP50	FAM60A	Protein FAM60A	GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB
Q9BSJ6	FAM64A	Protein FAM64A	GO:0005515; F:protein binding; IPI:IntAct
Q9BSJ6	FAM64A	Protein FAM64A	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9Y4F9	FAM65B	Protein FAM65B	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9Y4F9	FAM65B	Protein FAM65B	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
Q0P6D2	FAM69C	Protein FAM69C	GO:0016772; F:transferase activity, transferring phosphorus-containing groups; IEA:InterPro
Q7L4E1	FAM73B	Protein FAM73B	GO:0060348; P:bone development; IEA:Ensembl
P08709	F7	Coagulation factor VII	GO:0005509; F:calcium ion binding; IEA:InterPro
P08709	F7	Coagulation factor VII	GO:0001948; F:glycoprotein binding; IPI:BHF-UCL
P08709	F7	Coagulation factor VII	GO:0005515; F:protein binding; IPI:IntAct
P08709	F7	Coagulation factor VII	GO:0004252; F:serine-type endopeptidase activity; TAS:ProtInc
P08709	F7	Coagulation factor VII	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
P08709	F7	Coagulation factor VII	GO:0007596; P:blood coagulation; TAS:Reactome
P08709	F7	Coagulation factor VII	GO:0007598; P:blood coagulation, extrinsic pathway; TAS:Reactome
P08709	F7	Coagulation factor VII	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P08709	F7	Coagulation factor VII	GO:0007623; P:circadian rhythm; IEA:Ensembl
P08709	F7	Coagulation factor VII	GO:0031100; P:organ regeneration; IEA:Ensembl
P08709	F7	Coagulation factor VII	GO:0017187; P:peptidyl-glutamic acid carboxylation; TAS:Reactome
P08709	F7	Coagulation factor VII	GO:0030194; P:positive regulation of blood coagulation; IEA:Ensembl
P08709	F7	Coagulation factor VII	GO:0030335; P:positive regulation of cell migration; TAS:BHF-UCL
P08709	F7	Coagulation factor VII	GO:0002690; P:positive regulation of leukocyte chemotaxis; IDA:BHF-UCL
P08709	F7	Coagulation factor VII	GO:0010641; P:positive regulation of platelet-derived growth factor receptor signaling pathway; IDA:BHF-UCL
P08709	F7	Coagulation factor VII	GO:0050927; P:positive regulation of positive chemotaxis; IDA:BHF-UCL
P08709	F7	Coagulation factor VII	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:BHF-UCL
P08709	F7	Coagulation factor VII	GO:0043687; P:post-translational protein modification; TAS:Reactome
P08709	F7	Coagulation factor VII	GO:0006508; P:proteolysis; TAS:Reactome
P08709	F7	Coagulation factor VII	GO:0043627; P:response to estrogen; IEA:Ensembl
P08709	F7	Coagulation factor VII	GO:0060416; P:response to growth hormone; IEA:Ensembl
P08709	F7	Coagulation factor VII	GO:0032571; P:response to vitamin K; IEA:Ensembl
Q9H4H8	FAM83D	Protein FAM83D	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q6ZRV2	FAM83H	Protein FAM83H	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
Q96KN1	FAM84B	Protein FAM84B	GO:0005515; F:protein binding; IPI:HGNC
Q8N5H3	FAM89B	Protein FAM89B	GO:0001222; F:transcription corepressor binding; ISS:UniProtKB
Q8N5H3	FAM89B	Protein FAM89B	GO:0060392; P:negative regulation of SMAD protein import into nucleus; ISS:UniProtKB
Q8N5H3	FAM89B	Protein FAM89B	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; ISS:UniProtKB
P00451	F8	Coagulation factor VIII	GO:0005507; F:copper ion binding; IEA:InterPro
P00451	F8	Coagulation factor VIII	GO:0016491; F:oxidoreductase activity; IEA:InterPro
P00451	F8	Coagulation factor VIII	GO:0005515; F:protein binding; IPI:UniProtKB
P00451	F8	Coagulation factor VIII	GO:0004252; F:serine-type endopeptidase activity; IEA:Ensembl
P00451	F8	Coagulation factor VIII	GO:0006953; P:acute-phase response; IEA:UniProtKB-KW
P00451	F8	Coagulation factor VIII	GO:0007596; P:blood coagulation; TAS:Reactome
P00451	F8	Coagulation factor VIII	GO:0007597; P:blood coagulation, intrinsic pathway; TAS:Reactome
P00451	F8	Coagulation factor VIII	GO:0007155; P:cell adhesion; IEA:InterPro
P00451	F8	Coagulation factor VIII	GO:0030168; P:platelet activation; TAS:Reactome
P00451	F8	Coagulation factor VIII	GO:0002576; P:platelet degranulation; TAS:Reactome
Q9H5X1	FAM96A	MIP18 family protein FAM96A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H5X1	FAM96A	MIP18 family protein FAM96A	GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW
Q8NCA5	FAM98A	Protein FAM98A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q52LJ0	FAM98B	Protein FAM98B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P00740	F9	Coagulation factor IX	GO:0005509; F:calcium ion binding; IEA:InterPro
P00740	F9	Coagulation factor IX	GO:0004252; F:serine-type endopeptidase activity; TAS:ProtInc
P00740	F9	Coagulation factor IX	GO:0007596; P:blood coagulation; TAS:Reactome
P00740	F9	Coagulation factor IX	GO:0007598; P:blood coagulation, extrinsic pathway; TAS:Reactome
P00740	F9	Coagulation factor IX	GO:0007597; P:blood coagulation, intrinsic pathway; TAS:Reactome
P00740	F9	Coagulation factor IX	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P00740	F9	Coagulation factor IX	GO:0017187; P:peptidyl-glutamic acid carboxylation; TAS:Reactome
P00740	F9	Coagulation factor IX	GO:0043687; P:post-translational protein modification; TAS:Reactome
P00740	F9	Coagulation factor IX	GO:0006508; P:proteolysis; TAS:Reactome
P16930	FAH	Fumarylacetoacetase	GO:0004334; F:fumarylacetoacetase activity; EXP:Reactome
P16930	FAH	Fumarylacetoacetase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P16930	FAH	Fumarylacetoacetase	GO:0006527; P:arginine catabolic process; IEA:Ensembl
P16930	FAH	Fumarylacetoacetase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P16930	FAH	Fumarylacetoacetase	GO:0006559; P:L-phenylalanine catabolic process; TAS:Reactome
P16930	FAH	Fumarylacetoacetase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P16930	FAH	Fumarylacetoacetase	GO:0006572; P:tyrosine catabolic process; TAS:ProtInc
O00519	FAAH	Fatty-acid amide hydrolase 1	GO:0047372; F:acylglycerol lipase activity; IEA:Ensembl
O00519	FAAH	Fatty-acid amide hydrolase 1	GO:0016884; F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor; IEA:InterPro
O00519	FAAH	Fatty-acid amide hydrolase 1	GO:0017064; F:fatty acid amide hydrolase activity; IDA:UniProtKB
O00519	FAAH	Fatty-acid amide hydrolase 1	GO:0009062; P:fatty acid catabolic process; IDA:UniProtKB
Q6GMR7	FAAH2	Fatty-acid amide hydrolase 2	GO:0016884; F:carbon-nitrogen ligase activity, with glutamine as amido-N-donor; IEA:InterPro
Q6GMR7	FAAH2	Fatty-acid amide hydrolase 2	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q8IVS2	MCAT	Malonyl-CoA-acyl carrier protein transacylase, mitochondrial	GO:0004314; F:[acyl-carrier-protein] S-malonyltransferase activity; IDA:UniProtKB
Q8IVS2	MCAT	Malonyl-CoA-acyl carrier protein transacylase, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IVS2	MCAT	Malonyl-CoA-acyl carrier protein transacylase, mitochondrial	GO:0016740; F:transferase activity; IDA:UniProtKB
Q8IVS2	MCAT	Malonyl-CoA-acyl carrier protein transacylase, mitochondrial	GO:0006633; P:fatty acid biosynthetic process; IDA:UniProtKB
Q8IVS2	MCAT	Malonyl-CoA-acyl carrier protein transacylase, mitochondrial	GO:0008152; P:metabolic process; IDA:UniProtKB
P15090	FABP4	Fatty acid-binding protein, adipocyte	GO:0005504; F:fatty acid binding; TAS:ProtInc
P15090	FABP4	Fatty acid-binding protein, adipocyte	GO:0005215; F:transporter activity; IEA:InterPro
P15090	FABP4	Fatty acid-binding protein, adipocyte	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
P15090	FABP4	Fatty acid-binding protein, adipocyte	GO:0071285; P:cellular response to lithium ion; IEA:Ensembl
P15090	FABP4	Fatty acid-binding protein, adipocyte	GO:0042632; P:cholesterol homeostasis; IEA:Ensembl
P15090	FABP4	Fatty acid-binding protein, adipocyte	GO:0001816; P:cytokine production; IEA:Ensembl
P15090	FABP4	Fatty acid-binding protein, adipocyte	GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl
P15090	FABP4	Fatty acid-binding protein, adipocyte	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
P15090	FABP4	Fatty acid-binding protein, adipocyte	GO:0050729; P:positive regulation of inflammatory response; IEA:Ensembl
P15090	FABP4	Fatty acid-binding protein, adipocyte	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P15090	FABP4	Fatty acid-binding protein, adipocyte	GO:0019433; P:triglyceride catabolic process; TAS:Reactome
P15090	FABP4	Fatty acid-binding protein, adipocyte	GO:0050872; P:white fat cell differentiation; IEA:Ensembl
Q01469	FABP5	Fatty acid-binding protein, epidermal	GO:0005504; F:fatty acid binding; TAS:ProtInc
Q01469	FABP5	Fatty acid-binding protein, epidermal	GO:0008289; F:lipid binding; TAS:ProtInc
Q01469	FABP5	Fatty acid-binding protein, epidermal	GO:0005515; F:protein binding; IPI:UniProtKB
Q01469	FABP5	Fatty acid-binding protein, epidermal	GO:0005215; F:transporter activity; IEA:InterPro
Q01469	FABP5	Fatty acid-binding protein, epidermal	GO:0008544; P:epidermis development; TAS:ProtInc
Q01469	FABP5	Fatty acid-binding protein, epidermal	GO:0006006; P:glucose metabolic process; IEA:Ensembl
Q01469	FABP5	Fatty acid-binding protein, epidermal	GO:0015758; P:glucose transport; IEA:Ensembl
Q01469	FABP5	Fatty acid-binding protein, epidermal	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q01469	FABP5	Fatty acid-binding protein, epidermal	GO:0006656; P:phosphatidylcholine biosynthetic process; IEA:Ensembl
Q01469	FABP5	Fatty acid-binding protein, epidermal	GO:0009611; P:response to wounding; IEA:Ensembl
P51161	FABP6	Gastrotropin	GO:0008289; F:lipid binding; TAS:ProtInc
P51161	FABP6	Gastrotropin	GO:0005215; F:transporter activity; IEA:InterPro
P51161	FABP6	Gastrotropin	GO:0015721; P:bile acid and bile salt transport; TAS:Reactome
P51161	FABP6	Gastrotropin	GO:0008206; P:bile acid metabolic process; TAS:Reactome
P51161	FABP6	Gastrotropin	GO:0006629; P:lipid metabolic process; NAS:ProtInc
P51161	FABP6	Gastrotropin	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P51161	FABP6	Gastrotropin	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15540	FABP7	Fatty acid-binding protein, brain	GO:0008289; F:lipid binding; TAS:ProtInc
O15540	FABP7	Fatty acid-binding protein, brain	GO:0005215; F:transporter activity; IEA:InterPro
O15540	FABP7	Fatty acid-binding protein, brain	GO:0021846; P:cell proliferation in forebrain; IEA:Ensembl
O15540	FABP7	Fatty acid-binding protein, brain	GO:0050673; P:epithelial cell proliferation; IEA:Ensembl
O15540	FABP7	Fatty acid-binding protein, brain	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
O15540	FABP7	Fatty acid-binding protein, brain	GO:0007399; P:nervous system development; TAS:ProtInc
O15540	FABP7	Fatty acid-binding protein, brain	GO:0022008; P:neurogenesis; IEA:Ensembl
O15540	FABP7	Fatty acid-binding protein, brain	GO:0060134; P:prepulse inhibition; IEA:Ensembl
Q0Z7S8	FABP9	Fatty acid-binding protein 9	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q0Z7S8	FABP9	Fatty acid-binding protein 9	GO:0005215; F:transporter activity; IEA:InterPro
Q0Z7S8	FABP9	Fatty acid-binding protein 9	GO:0001675; P:acrosome assembly; IEA:Ensembl
P05413	FABP3	Fatty acid-binding protein, heart	GO:0008092; F:cytoskeletal protein binding; IPI:UniProtKB
P05413	FABP3	Fatty acid-binding protein, heart	GO:0050543; F:icosatetraenoic acid binding; IEA:Ensembl
P05413	FABP3	Fatty acid-binding protein, heart	GO:0036041; F:long-chain fatty acid binding; IDA:BHF-UCL
P05413	FABP3	Fatty acid-binding protein, heart	GO:0005324; F:long-chain fatty acid transporter activity; IEA:Ensembl
P05413	FABP3	Fatty acid-binding protein, heart	GO:0070538; F:oleic acid binding; IDA:BHF-UCL
P05413	FABP3	Fatty acid-binding protein, heart	GO:0005515; F:protein binding; IPI:IntAct
P05413	FABP3	Fatty acid-binding protein, heart	GO:0042632; P:cholesterol homeostasis; ISS:BHF-UCL
P05413	FABP3	Fatty acid-binding protein, heart	GO:0006631; P:fatty acid metabolic process; IEA:Ensembl
P05413	FABP3	Fatty acid-binding protein, heart	GO:0044539; P:long-chain fatty acid import; ISS:BHF-UCL
P05413	FABP3	Fatty acid-binding protein, heart	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P05413	FABP3	Fatty acid-binding protein, heart	GO:0055091; P:phospholipid homeostasis; ISS:BHF-UCL
P05413	FABP3	Fatty acid-binding protein, heart	GO:0071073; P:positive regulation of phospholipid biosynthetic process; IC:BHF-UCL
P05413	FABP3	Fatty acid-binding protein, heart	GO:0046320; P:regulation of fatty acid oxidation; ISS:BHF-UCL
P05413	FABP3	Fatty acid-binding protein, heart	GO:0042493; P:response to drug; IEA:Ensembl
P05413	FABP3	Fatty acid-binding protein, heart	GO:0070542; P:response to fatty acid; IEA:Ensembl
P05413	FABP3	Fatty acid-binding protein, heart	GO:0032868; P:response to insulin; IEA:Ensembl
P12104	FABP2	Fatty acid-binding protein, intestinal	GO:0005504; F:fatty acid binding; TAS:ProtInc
P12104	FABP2	Fatty acid-binding protein, intestinal	GO:0005215; F:transporter activity; IEA:InterPro
P12104	FABP2	Fatty acid-binding protein, intestinal	GO:0007586; P:digestion; TAS:ProtInc
P07148	FABP1	Fatty acid-binding protein, liver	GO:0016209; F:antioxidant activity; IDA:UniProtKB
P07148	FABP1	Fatty acid-binding protein, liver	GO:0032052; F:bile acid binding; IEA:Ensembl
P07148	FABP1	Fatty acid-binding protein, liver	GO:0003682; F:chromatin binding; IEA:Ensembl
P07148	FABP1	Fatty acid-binding protein, liver	GO:0008144; F:drug binding; IEA:Ensembl
P07148	FABP1	Fatty acid-binding protein, liver	GO:0005504; F:fatty acid binding; IEA:Ensembl
P07148	FABP1	Fatty acid-binding protein, liver	GO:0005324; F:long-chain fatty acid transporter activity; IEA:Ensembl
P07148	FABP1	Fatty acid-binding protein, liver	GO:0005543; F:phospholipid binding; IEA:Ensembl
P07148	FABP1	Fatty acid-binding protein, liver	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P07148	FABP1	Fatty acid-binding protein, liver	GO:0070301; P:cellular response to hydrogen peroxide; IDA:UniProtKB
P07148	FABP1	Fatty acid-binding protein, liver	GO:0071456; P:cellular response to hypoxia; IDA:UniProtKB
P07148	FABP1	Fatty acid-binding protein, liver	GO:0050892; P:intestinal absorption; IEA:Ensembl
P07148	FABP1	Fatty acid-binding protein, liver	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P07148	FABP1	Fatty acid-binding protein, liver	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P07148	FABP1	Fatty acid-binding protein, liver	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P07148	FABP1	Fatty acid-binding protein, liver	GO:0032000; P:positive regulation of fatty acid beta-oxidation; IEA:Ensembl
P07148	FABP1	Fatty acid-binding protein, liver	GO:0051345; P:positive regulation of hydrolase activity; IEA:Ensembl
P07148	FABP1	Fatty acid-binding protein, liver	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BXW9	FANCD2	Fanconi anemia group D2 protein	GO:0070182; F:DNA polymerase binding; IPI:UniProt
Q9BXW9	FANCD2	Fanconi anemia group D2 protein	GO:0005515; F:protein binding; IPI:IntAct
Q9BXW9	FANCD2	Fanconi anemia group D2 protein	GO:0006281; P:DNA repair; TAS:Reactome
Q9BXW9	FANCD2	Fanconi anemia group D2 protein	GO:0007276; P:gamete generation; IEA:Ensembl
Q9BXW9	FANCD2	Fanconi anemia group D2 protein	GO:0010332; P:response to gamma radiation; IDA:UniProtKB
Q9BXW9	FANCD2	Fanconi anemia group D2 protein	GO:0007129; P:synapsis; IEA:Ensembl
Q9Y256	RCE1	CAAX prenyl protease 2	GO:0004197; F:cysteine-type endopeptidase activity; IDA:UniProtKB
Q9Y256	RCE1	CAAX prenyl protease 2	GO:0004222; F:metalloendopeptidase activity; TAS:ProtInc
Q9Y256	RCE1	CAAX prenyl protease 2	GO:0071586; P:CAAX-box protein processing; IMP:UniProtKB
Q9Y256	RCE1	CAAX prenyl protease 2	GO:0006508; P:proteolysis; TAS:ProtInc
O75844	ZMPSTE24	CAAX prenyl protease 1 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75844	ZMPSTE24	CAAX prenyl protease 1 homolog	GO:0004222; F:metalloendopeptidase activity; IEA:Ensembl
O75844	ZMPSTE24	CAAX prenyl protease 1 homolog	GO:0008235; F:metalloexopeptidase activity; TAS:ProtInc
O75844	ZMPSTE24	CAAX prenyl protease 1 homolog	GO:0006998; P:nuclear envelope organization; IEA:Ensembl
O75844	ZMPSTE24	CAAX prenyl protease 1 homolog	GO:0030327; P:prenylated protein catabolic process; IEA:Ensembl
O75844	ZMPSTE24	CAAX prenyl protease 1 homolog	GO:0006508; P:proteolysis; TAS:ProtInc
Q8WVX9	FAR1	Fatty acyl-CoA reductase 1	GO:0080019; F:fatty-acyl-CoA reductase (alcohol-forming) activity; IDA:UniProtKB
Q8WVX9	FAR1	Fatty acyl-CoA reductase 1	GO:0050062; F:long-chain-fatty-acyl-CoA reductase activity; IEA:Ensembl
Q8WVX9	FAR1	Fatty acyl-CoA reductase 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q8WVX9	FAR1	Fatty acyl-CoA reductase 1	GO:0008611; P:ether lipid biosynthetic process; IMP:UniProtKB
Q8WVX9	FAR1	Fatty acyl-CoA reductase 1	GO:0046474; P:glycerophospholipid biosynthetic process; IDA:UniProtKB
Q8WVX9	FAR1	Fatty acyl-CoA reductase 1	GO:0035336; P:long-chain fatty-acyl-CoA metabolic process; IDA:UniProtKB
Q8WVX9	FAR1	Fatty acyl-CoA reductase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8WVX9	FAR1	Fatty acyl-CoA reductase 1	GO:0010025; P:wax biosynthetic process; IEA:Ensembl
Q8NFF5	FLAD1	FAD synthase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NFF5	FLAD1	FAD synthase	GO:0003919; F:FMN adenylyltransferase activity; IEA:UniProtKB-EC
Q8NFF5	FLAD1	FAD synthase	GO:0006747; P:FAD biosynthetic process; IEA:UniProtKB-UniPathway
Q8NFF5	FLAD1	FAD synthase	GO:0006777; P:Mo-molybdopterin cofactor biosynthetic process; IEA:InterPro
Q8NFF5	FLAD1	FAD synthase	GO:0006771; P:riboflavin metabolic process; TAS:Reactome
Q8NFF5	FLAD1	FAD synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8NFF5	FLAD1	FAD synthase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q8NFF5	FLAD1	FAD synthase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q96K12	FAR2	Fatty acyl-CoA reductase 2	GO:0080019; F:fatty-acyl-CoA reductase (alcohol-forming) activity; IDA:UniProtKB
Q96K12	FAR2	Fatty acyl-CoA reductase 2	GO:0050062; F:long-chain-fatty-acyl-CoA reductase activity; IEA:Ensembl
Q96K12	FAR2	Fatty acyl-CoA reductase 2	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q96K12	FAR2	Fatty acyl-CoA reductase 2	GO:0008611; P:ether lipid biosynthetic process; TAS:Reactome
Q96K12	FAR2	Fatty acyl-CoA reductase 2	GO:0035336; P:long-chain fatty-acyl-CoA metabolic process; IDA:UniProtKB
Q96K12	FAR2	Fatty acyl-CoA reductase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q13158	FADD	FAS-associated death domain protein	GO:0035877; F:death effector domain binding; IPI:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0005123; F:death receptor binding; TAS:ProtInc
Q13158	FADD	FAS-associated death domain protein	GO:0042802; F:identical protein binding; IPI:IntAct
Q13158	FADD	FAS-associated death domain protein	GO:0002020; F:protease binding; IPI:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0032813; F:tumor necrosis factor receptor superfamily binding; IPI:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0097202; P:activation of cysteine-type endopeptidase activity; IDA:BHF-UCL
Q13158	FADD	FAS-associated death domain protein	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:Reactome
Q13158	FADD	FAS-associated death domain protein	GO:0006915; P:apoptotic process; IMP:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0097190; P:apoptotic signaling pathway; IDA:BHF-UCL
Q13158	FADD	FAS-associated death domain protein	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0051607; P:defense response to virus; IMP:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
Q13158	FADD	FAS-associated death domain protein	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; TAS:ProtInc
Q13158	FADD	FAS-associated death domain protein	GO:0045087; P:innate immune response; TAS:Reactome
Q13158	FADD	FAS-associated death domain protein	GO:0048535; P:lymph node development; ISS:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0097049; P:motor neuron apoptotic process; IEA:Ensembl
Q13158	FADD	FAS-associated death domain protein	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q13158	FADD	FAS-associated death domain protein	GO:0097527; P:necroptotic signaling pathway; IMP:BHF-UCL
Q13158	FADD	FAS-associated death domain protein	GO:0070236; P:negative regulation of activation-induced cell death of T cells; ISS:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0042104; P:positive regulation of activated T cell proliferation; ISS:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0002821; P:positive regulation of adaptive immune response; ISS:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:2000454; P:positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation; ISS:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
Q13158	FADD	FAS-associated death domain protein	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0032729; P:positive regulation of interferon-gamma production; ISS:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0032757; P:positive regulation of interleukin-8 production; IDA:BHF-UCL
Q13158	FADD	FAS-associated death domain protein	GO:0045651; P:positive regulation of macrophage differentiation; IMP:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0045862; P:positive regulation of proteolysis; IDA:BHF-UCL
Q13158	FADD	FAS-associated death domain protein	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; ISS:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q13158	FADD	FAS-associated death domain protein	GO:0032760; P:positive regulation of tumor necrosis factor production; IDA:BHF-UCL
Q13158	FADD	FAS-associated death domain protein	GO:0060340; P:positive regulation of type I interferon-mediated signaling pathway; IMP:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q13158	FADD	FAS-associated death domain protein	GO:2001239; P:regulation of extrinsic apoptotic signaling pathway in absence of ligand; TAS:Reactome
Q13158	FADD	FAS-associated death domain protein	GO:0048536; P:spleen development; ISS:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0033077; P:T cell differentiation in thymus; ISS:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0043029; P:T cell homeostasis; ISS:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0048538; P:thymus development; ISS:UniProtKB
Q13158	FADD	FAS-associated death domain protein	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q13158	FADD	FAS-associated death domain protein	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q13158	FADD	FAS-associated death domain protein	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q13158	FADD	FAS-associated death domain protein	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q13158	FADD	FAS-associated death domain protein	GO:0016032; P:viral process; IEA:UniProtKB-KW
O60427	FADS1	Fatty acid desaturase 1	GO:0000248; F:C-5 sterol desaturase activity; TAS:ProtInc
O60427	FADS1	Fatty acid desaturase 1	GO:0020037; F:heme binding; IEA:InterPro
O60427	FADS1	Fatty acid desaturase 1	GO:0005506; F:iron ion binding; IEA:InterPro
O60427	FADS1	Fatty acid desaturase 1	GO:0016491; F:oxidoreductase activity; IDA:UniProtKB
O60427	FADS1	Fatty acid desaturase 1	GO:0007568; P:aging; IEA:Ensembl
O60427	FADS1	Fatty acid desaturase 1	GO:0036109; P:alpha-linolenic acid metabolic process; TAS:Reactome
O60427	FADS1	Fatty acid desaturase 1	GO:0019369; P:arachidonic acid metabolic process; IEA:Ensembl
O60427	FADS1	Fatty acid desaturase 1	GO:0007267; P:cell-cell signaling; NAS:UniProtKB
O60427	FADS1	Fatty acid desaturase 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O60427	FADS1	Fatty acid desaturase 1	GO:0009267; P:cellular response to starvation; IDA:UniProtKB
O60427	FADS1	Fatty acid desaturase 1	GO:0046456; P:icosanoid biosynthetic process; TAS:UniProtKB
O60427	FADS1	Fatty acid desaturase 1	GO:0043651; P:linoleic acid metabolic process; TAS:Reactome
O60427	FADS1	Fatty acid desaturase 1	GO:0008654; P:phospholipid biosynthetic process; TAS:UniProtKB
O60427	FADS1	Fatty acid desaturase 1	GO:0045595; P:regulation of cell differentiation; NAS:UniProtKB
O60427	FADS1	Fatty acid desaturase 1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
O60427	FADS1	Fatty acid desaturase 1	GO:0032868; P:response to insulin; IEA:Ensembl
O60427	FADS1	Fatty acid desaturase 1	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
O60427	FADS1	Fatty acid desaturase 1	GO:0009744; P:response to sucrose; IEA:Ensembl
O60427	FADS1	Fatty acid desaturase 1	GO:0033189; P:response to vitamin A; IEA:Ensembl
O60427	FADS1	Fatty acid desaturase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60427	FADS1	Fatty acid desaturase 1	GO:0006636; P:unsaturated fatty acid biosynthetic process; IDA:UniProtKB
O60427	FADS1	Fatty acid desaturase 1	GO:0033559; P:unsaturated fatty acid metabolic process; TAS:Reactome
O95864	FADS2	Fatty acid desaturase 2	GO:0020037; F:heme binding; IEA:InterPro
O95864	FADS2	Fatty acid desaturase 2	GO:0005506; F:iron ion binding; IEA:InterPro
O95864	FADS2	Fatty acid desaturase 2	GO:0016717; F:oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water; IEA:InterPro
O95864	FADS2	Fatty acid desaturase 2	GO:0004768; F:stearoyl-CoA 9-desaturase activity; IEA:Ensembl
O95864	FADS2	Fatty acid desaturase 2	GO:0036109; P:alpha-linolenic acid metabolic process; TAS:Reactome
O95864	FADS2	Fatty acid desaturase 2	GO:0006633; P:fatty acid biosynthetic process; IEA:InterPro
O95864	FADS2	Fatty acid desaturase 2	GO:0043651; P:linoleic acid metabolic process; TAS:Reactome
O95864	FADS2	Fatty acid desaturase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95864	FADS2	Fatty acid desaturase 2	GO:0006636; P:unsaturated fatty acid biosynthetic process; TAS:ProtInc
O95864	FADS2	Fatty acid desaturase 2	GO:0033559; P:unsaturated fatty acid metabolic process; TAS:Reactome
Q9Y5Q0	FADS3	Fatty acid desaturase 3	GO:0020037; F:heme binding; IEA:InterPro
Q9Y5Q0	FADS3	Fatty acid desaturase 3	GO:0005506; F:iron ion binding; IEA:InterPro
Q9Y5Q0	FADS3	Fatty acid desaturase 3	GO:0016717; F:oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water; IEA:InterPro
Q9Y5Q0	FADS3	Fatty acid desaturase 3	GO:0006636; P:unsaturated fatty acid biosynthetic process; NAS:UniProtKB
Q8N9I5	FADS6	Fatty acid desaturase 6	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q8N9I5	FADS6	Fatty acid desaturase 6	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
Q9UNN5	FAF1	FAS-associated factor 1	GO:0031072; F:heat shock protein binding; IDA:UniProtKB
Q9UNN5	FAF1	FAS-associated factor 1	GO:0051059; F:NF-kappaB binding; IPI:UniProtKB
Q9UNN5	FAF1	FAS-associated factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UNN5	FAF1	FAS-associated factor 1	GO:0019901; F:protein kinase binding; IDA:UniProtKB
Q9UNN5	FAF1	FAS-associated factor 1	GO:0019887; F:protein kinase regulator activity; NAS:UniProtKB
Q9UNN5	FAF1	FAS-associated factor 1	GO:0043130; F:ubiquitin binding; IDA:BHF-UCL
Q9UNN5	FAF1	FAS-associated factor 1	GO:0031625; F:ubiquitin protein ligase binding; IDA:BHF-UCL
Q9UNN5	FAF1	FAS-associated factor 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9UNN5	FAF1	FAS-associated factor 1	GO:0008219; P:cell death; IMP:UniProtKB
Q9UNN5	FAF1	FAS-associated factor 1	GO:0007253; P:cytoplasmic sequestering of NF-kappaB; IMP:UniProtKB
Q9UNN5	FAF1	FAS-associated factor 1	GO:0043065; P:positive regulation of apoptotic process; NAS:UniProtKB
Q9UNN5	FAF1	FAS-associated factor 1	GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
Q9UNN5	FAF1	FAS-associated factor 1	GO:0031334; P:positive regulation of protein complex assembly; IMP:UniProtKB
Q9UNN5	FAF1	FAS-associated factor 1	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; NAS:UniProtKB
Q9UNN5	FAF1	FAS-associated factor 1	GO:0030155; P:regulation of cell adhesion; IEA:Ensembl
Q9UNN5	FAF1	FAS-associated factor 1	GO:0042176; P:regulation of protein catabolic process; IMP:UniProtKB
Q9UNN5	FAF1	FAS-associated factor 1	GO:0045859; P:regulation of protein kinase activity; NAS:GOC
Q96CS3	FAF2	FAS-associated factor 2	GO:0035473; F:lipase binding; IDA:MGI
Q96CS3	FAF2	FAS-associated factor 2	GO:0055102; F:lipase inhibitor activity; IDA:MGI
Q96CS3	FAF2	FAS-associated factor 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q96CS3	FAF2	FAS-associated factor 2	GO:0043130; F:ubiquitin binding; IDA:BHF-UCL
Q96CS3	FAF2	FAS-associated factor 2	GO:0031625; F:ubiquitin protein ligase binding; IDA:BHF-UCL
Q96CS3	FAF2	FAS-associated factor 2	GO:0034389; P:lipid particle organization; IMP:MGI
Q96CS3	FAF2	FAS-associated factor 2	GO:0043086; P:negative regulation of catalytic activity; IDA:GOC
Q96CS3	FAF2	FAS-associated factor 2	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
Q96GK7	FAHD2A	Fumarylacetoacetate hydrolase domain-containing protein 2A	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q96GK7	FAHD2A	Fumarylacetoacetate hydrolase domain-containing protein 2A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6P2I3	FAHD2B	Fumarylacetoacetate hydrolase domain-containing protein 2B	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q6P2I3	FAHD2B	Fumarylacetoacetate hydrolase domain-containing protein 2B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6P587	FAHD1	Acylpyruvase FAHD1, mitochondrial	GO:0018773; F:acetylpyruvate hydrolase activity; IDA:UniProtKB
Q6P587	FAHD1	Acylpyruvase FAHD1, mitochondrial	GO:0047621; F:acylpyruvate hydrolase activity; IEA:UniProtKB-EC
Q6P587	FAHD1	Acylpyruvase FAHD1, mitochondrial	GO:0034545; F:fumarylpyruvate hydrolase activity; IDA:UniProtKB
Q6P587	FAHD1	Acylpyruvase FAHD1, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60667	FAIM3	Fas apoptotic inhibitory molecule 3	GO:0006968; P:cellular defense response; TAS:ProtInc
O60667	FAIM3	Fas apoptotic inhibitory molecule 3	GO:0002376; P:immune system process; IEA:UniProtKB-KW
O60667	FAIM3	Fas apoptotic inhibitory molecule 3	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
Q9NVQ4	FAIM	Fas apoptotic inhibitory molecule 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9NVQ4	FAIM	Fas apoptotic inhibitory molecule 1	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
Q9NVQ4	FAIM	Fas apoptotic inhibitory molecule 1	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
Q05397	PTK2	Focal adhesion kinase 1	GO:0003779; F:actin binding; IDA:BHF-UCL
Q05397	PTK2	Focal adhesion kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q05397	PTK2	Focal adhesion kinase 1	GO:0008432; F:JUN kinase binding; IDA:BHF-UCL
Q05397	PTK2	Focal adhesion kinase 1	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0004672; F:protein kinase activity; TAS:Reactome
Q05397	PTK2	Focal adhesion kinase 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0042169; F:SH2 domain binding; IPI:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0004871; F:signal transducer activity; IEA:InterPro
Q05397	PTK2	Focal adhesion kinase 1	GO:0001525; P:angiogenesis; TAS:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0006915; P:apoptotic process; TAS:Reactome
Q05397	PTK2	Focal adhesion kinase 1	GO:0007411; P:axon guidance; TAS:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q05397	PTK2	Focal adhesion kinase 1	GO:0048870; P:cell motility; TAS:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q05397	PTK2	Focal adhesion kinase 1	GO:0021955; P:central nervous system neuron axonogenesis; IEA:Ensembl
Q05397	PTK2	Focal adhesion kinase 1	GO:0009790; P:embryo development; TAS:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0043542; P:endothelial cell migration; IEA:Ensembl
Q05397	PTK2	Focal adhesion kinase 1	GO:0048013; P:ephrin receptor signaling pathway; IDA:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0030010; P:establishment of cell polarity; TAS:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0040023; P:establishment of nucleus localization; IEA:Ensembl
Q05397	PTK2	Focal adhesion kinase 1	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q05397	PTK2	Focal adhesion kinase 1	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q05397	PTK2	Focal adhesion kinase 1	GO:0060396; P:growth hormone receptor signaling pathway; IDA:BHF-UCL
Q05397	PTK2	Focal adhesion kinase 1	GO:0003007; P:heart morphogenesis; TAS:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0045087; P:innate immune response; TAS:Reactome
Q05397	PTK2	Focal adhesion kinase 1	GO:0007229; P:integrin-mediated signaling pathway; IMP:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl
Q05397	PTK2	Focal adhesion kinase 1	GO:2000811; P:negative regulation of anoikis; IMP:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0050771; P:negative regulation of axonogenesis; IEA:Ensembl
Q05397	PTK2	Focal adhesion kinase 1	GO:0022408; P:negative regulation of cell-cell adhesion; IDA:BHF-UCL
Q05397	PTK2	Focal adhesion kinase 1	GO:0046621; P:negative regulation of organ growth; IEA:Ensembl
Q05397	PTK2	Focal adhesion kinase 1	GO:0051964; P:negative regulation of synapse assembly; IEA:Ensembl
Q05397	PTK2	Focal adhesion kinase 1	GO:0038007; P:netrin-activated signaling pathway; TAS:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0001764; P:neuron migration; IEA:Ensembl
Q05397	PTK2	Focal adhesion kinase 1	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0001890; P:placenta development; TAS:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0030168; P:platelet activation; TAS:Reactome
Q05397	PTK2	Focal adhesion kinase 1	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; TAS:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IMP:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0045860; P:positive regulation of protein kinase activity; IMP:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0051897; P:positive regulation of protein kinase B signaling; IMP:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0001934; P:positive regulation of protein phosphorylation; IMP:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:2000060; P:positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ISS:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0033628; P:regulation of cell adhesion mediated by integrin; IDA:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0042127; P:regulation of cell proliferation; IMP:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0051493; P:regulation of cytoskeleton organization; TAS:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0010594; P:regulation of endothelial cell migration; TAS:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0051893; P:regulation of focal adhesion assembly; TAS:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0045667; P:regulation of osteoblast differentiation; IMP:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0032319; P:regulation of Rho GTPase activity; TAS:UniProtKB
Q05397	PTK2	Focal adhesion kinase 1	GO:0007172; P:signal complex assembly; IEA:InterPro
Q05397	PTK2	Focal adhesion kinase 1	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0005515; F:protein binding; IPI:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0004713; F:protein tyrosine kinase activity; TAS:ProtInc
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0004871; F:signal transducer activity; NAS:ProtInc
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0042976; P:activation of Janus kinase activity; IMP:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0032863; P:activation of Rac GTPase activity; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0006915; P:apoptotic process; TAS:ProtInc
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0043534; P:blood vessel endothelial cell migration; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0045453; P:bone resorption; ISS:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0007166; P:cell surface receptor signaling pathway; IMP:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0071300; P:cellular response to retinoic acid; IMP:BHF-UCL
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0070098; P:chemokine-mediated signaling pathway; ISS:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0007173; P:epidermal growth factor receptor signaling pathway; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0048041; P:focal adhesion assembly; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0014009; P:glial cell proliferation; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0007229; P:integrin-mediated signaling pathway; IMP:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0000165; P:MAPK cascade; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0002315; P:marginal zone B cell differentiation; ISS:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0030502; P:negative regulation of bone mineralization; ISS:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0010656; P:negative regulation of muscle cell apoptotic process; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0045638; P:negative regulation of myeloid cell differentiation; IMP:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0043267; P:negative regulation of potassium ion transport; IDA:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0031175; P:neuron projection development; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0001556; P:oocyte maturation; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0030838; P:positive regulation of actin filament polymerization; IMP:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:2000538; P:positive regulation of B cell chemotaxis; ISS:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0030307; P:positive regulation of cell growth; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0001954; P:positive regulation of cell-matrix adhesion; IMP:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0010595; P:positive regulation of endothelial cell migration; IDA:BHF-UCL
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0046330; P:positive regulation of JNK cascade; IMP:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0043507; P:positive regulation of JUN kinase activity; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0010976; P:positive regulation of neuron projection development; IMP:BHF-UCL
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0051000; P:positive regulation of nitric-oxide synthase activity; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; ISS:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0045860; P:positive regulation of protein kinase activity; IMP:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:2000060; P:positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0045727; P:positive regulation of translation; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0046777; P:protein autophosphorylation; TAS:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:2000249; P:regulation of actin cytoskeleton reorganization; ISS:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0050848; P:regulation of calcium-mediated signaling; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0030155; P:regulation of cell adhesion; IMP:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0030826; P:regulation of cGMP biosynthetic process; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0010752; P:regulation of cGMP-mediated signaling; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:2000114; P:regulation of establishment of cell polarity; ISS:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0032960; P:regulation of inositol trisphosphate biosynthetic process; ISS:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0010758; P:regulation of macrophage chemotaxis; ISS:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0045428; P:regulation of nitric oxide biosynthetic process; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:2000058; P:regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0051279; P:regulation of release of sequestered calcium ion into cytosol; ISS:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0051592; P:response to calcium ion; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0051591; P:response to cAMP; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0042220; P:response to cocaine; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0042493; P:response to drug; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0045471; P:response to ethanol; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0009749; P:response to glucose; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0009725; P:response to hormone; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0010226; P:response to lithium ion; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0006970; P:response to osmotic stress; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0006950; P:response to stress; TAS:ProtInc
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0007172; P:signal complex assembly; TAS:ProtInc
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0007165; P:signal transduction; TAS:ProtInc
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0002040; P:sprouting angiogenesis; ISS:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0043149; P:stress fiber assembly; IEA:Ensembl
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IMP:UniProtKB
Q14289	PTK2B	Protein-tyrosine kinase 2-beta	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IMP:BHF-UCL
Q53R41	FASTKD1	FAST kinase domain-containing protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q53R41	FASTKD1	FAST kinase domain-containing protein 1	GO:0004672; F:protein kinase activity; IEA:InterPro
Q53R41	FASTKD1	FAST kinase domain-containing protein 1	GO:0045333; P:cellular respiration; ISS:UniProtKB
Q9NYY8	FASTKD2	FAST kinase domain-containing protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NYY8	FASTKD2	FAST kinase domain-containing protein 2	GO:0004672; F:protein kinase activity; IEA:InterPro
Q9NYY8	FASTKD2	FAST kinase domain-containing protein 2	GO:0045333; P:cellular respiration; ISS:UniProtKB
Q7L8L6	FASTKD5	FAST kinase domain-containing protein 5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7L8L6	FASTKD5	FAST kinase domain-containing protein 5	GO:0004672; F:protein kinase activity; IEA:InterPro
Q7L8L6	FASTKD5	FAST kinase domain-containing protein 5	GO:0045333; P:cellular respiration; ISS:UniProtKB
Q14CZ7	FASTKD3	FAST kinase domain-containing protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14CZ7	FASTKD3	FAST kinase domain-containing protein 3	GO:0004672; F:protein kinase activity; IEA:InterPro
Q14CZ7	FASTKD3	FAST kinase domain-containing protein 3	GO:0045333; P:cellular respiration; IMP:UniProtKB
P58499	FAM3B	Protein FAM3B	GO:0005125; F:cytokine activity; NAS:UniProtKB
P58499	FAM3B	Protein FAM3B	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P58499	FAM3B	Protein FAM3B	GO:0030073; P:insulin secretion; IDA:UniProtKB
Q92520	FAM3C	Protein FAM3C	GO:0005125; F:cytokine activity; NAS:UniProtKB
Q92520	FAM3C	Protein FAM3C	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q96BQ1	FAM3D	Protein FAM3D	GO:0005125; F:cytokine activity; NAS:UniProtKB
Q96BQ1	FAM3D	Protein FAM3D	GO:0046676; P:negative regulation of insulin secretion; IDA:UniProtKB
Q8IZU1	FAM9A	Protein FAM9A	GO:0005515; F:protein binding; IPI:IntAct
O15360	FANCA	Fanconi anemia group A protein	GO:0005515; F:protein binding; IPI:UniProtKB
O15360	FANCA	Fanconi anemia group A protein	GO:0006281; P:DNA repair; TAS:Reactome
O15360	FANCA	Fanconi anemia group A protein	GO:0008585; P:female gonad development; IEA:Ensembl
O15360	FANCA	Fanconi anemia group A protein	GO:0008584; P:male gonad development; IEA:Ensembl
O15360	FANCA	Fanconi anemia group A protein	GO:0007140; P:male meiosis; IEA:Ensembl
O15360	FANCA	Fanconi anemia group A protein	GO:0006461; P:protein complex assembly; TAS:ProtInc
O15360	FANCA	Fanconi anemia group A protein	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q8NB91	FANCB	Fanconi anemia group B protein	GO:0005515; F:protein binding; IPI:IntAct
Q8NB91	FANCB	Fanconi anemia group B protein	GO:0006281; P:DNA repair; TAS:Reactome
Q9Y2M0	FAN1	Fanconi-associated nuclease 1	GO:0008409; F:5'-3' exonuclease activity; IDA:UniProtKB
Q9Y2M0	FAN1	Fanconi-associated nuclease 1	GO:0017108; F:5'-flap endonuclease activity; IDA:UniProtKB
Q9Y2M0	FAN1	Fanconi-associated nuclease 1	GO:0003677; F:DNA binding; IEA:InterPro
Q9Y2M0	FAN1	Fanconi-associated nuclease 1	GO:0000287; F:magnesium ion binding; TAS:UniProtKB
Q9Y2M0	FAN1	Fanconi-associated nuclease 1	GO:0004528; F:phosphodiesterase I activity; IEA:UniProtKB-EC
Q9Y2M0	FAN1	Fanconi-associated nuclease 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y2M0	FAN1	Fanconi-associated nuclease 1	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
Q9Y2M0	FAN1	Fanconi-associated nuclease 1	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
Q9Y2M0	FAN1	Fanconi-associated nuclease 1	GO:0006281; P:DNA repair; IMP:UniProtKB
Q9Y2M0	FAN1	Fanconi-associated nuclease 1	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
Q9Y2M0	FAN1	Fanconi-associated nuclease 1	GO:0006289; P:nucleotide-excision repair; IMP:UniProtKB
Q9Y2M0	FAN1	Fanconi-associated nuclease 1	GO:0033683; P:nucleotide-excision repair, DNA incision; IDA:UniProtKB
Q00597	FANCC	Fanconi anemia group C protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q00597	FANCC	Fanconi anemia group C protein	GO:0006281; P:DNA repair; TAS:Reactome
Q00597	FANCC	Fanconi anemia group C protein	GO:0007281; P:germ cell development; IEA:Ensembl
Q00597	FANCC	Fanconi anemia group C protein	GO:0002262; P:myeloid cell homeostasis; IEA:Ensembl
Q00597	FANCC	Fanconi anemia group C protein	GO:0006289; P:nucleotide-excision repair; IEA:Ensembl
Q00597	FANCC	Fanconi anemia group C protein	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q00597	FANCC	Fanconi anemia group C protein	GO:0019430; P:removal of superoxide radicals; IEA:Ensembl
Q9HB96	FANCE	Fanconi anemia group E protein	GO:0006281; P:DNA repair; TAS:Reactome
Q9NPI8	FANCF	Fanconi anemia group F protein	GO:0005515; F:protein binding; IPI:IntAct
Q9NPI8	FANCF	Fanconi anemia group F protein	GO:0006281; P:DNA repair; TAS:Reactome
O15287	FANCG	Fanconi anemia group G protein	GO:0003684; F:damaged DNA binding; TAS:ProtInc
O15287	FANCG	Fanconi anemia group G protein	GO:0005515; F:protein binding; IPI:UniProtKB
O15287	FANCG	Fanconi anemia group G protein	GO:0000075; P:cell cycle checkpoint; TAS:ProtInc
O15287	FANCG	Fanconi anemia group G protein	GO:0006281; P:DNA repair; TAS:Reactome
O15287	FANCG	Fanconi anemia group G protein	GO:0007005; P:mitochondrion organization; IMP:UniProtKB
O15287	FANCG	Fanconi anemia group G protein	GO:0001541; P:ovarian follicle development; IEA:Ensembl
O15287	FANCG	Fanconi anemia group G protein	GO:0009314; P:response to radiation; IEA:Ensembl
O15287	FANCG	Fanconi anemia group G protein	GO:0007286; P:spermatid development; IEA:Ensembl
Q9NVI1	FANCI	Fanconi anemia group I protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NVI1	FANCI	Fanconi anemia group I protein	GO:0070182; F:DNA polymerase binding; IPI:UniProt
Q9NVI1	FANCI	Fanconi anemia group I protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NVI1	FANCI	Fanconi anemia group I protein	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9NVI1	FANCI	Fanconi anemia group I protein	GO:0006281; P:DNA repair; TAS:Reactome
Q9NVI1	FANCI	Fanconi anemia group I protein	GO:0031398; P:positive regulation of protein ubiquitination; IDA:MGI
Q9BX63	BRIP1	Fanconi anemia group J protein	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
Q9BX63	BRIP1	Fanconi anemia group J protein	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BX63	BRIP1	Fanconi anemia group J protein	GO:0004003; F:ATP-dependent DNA helicase activity; NAS:UniProtKB
Q9BX63	BRIP1	Fanconi anemia group J protein	GO:0003677; F:DNA binding; NAS:UniProtKB
Q9BX63	BRIP1	Fanconi anemia group J protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BX63	BRIP1	Fanconi anemia group J protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BX63	BRIP1	Fanconi anemia group J protein	GO:0000077; P:DNA damage checkpoint; NAS:UniProtKB
Q9BX63	BRIP1	Fanconi anemia group J protein	GO:0032508; P:DNA duplex unwinding; NAS:GOC
Q9BX63	BRIP1	Fanconi anemia group J protein	GO:0006302; P:double-strand break repair; NAS:UniProtKB
Q9BX63	BRIP1	Fanconi anemia group J protein	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q9BX63	BRIP1	Fanconi anemia group J protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NW38	FANCL	E3 ubiquitin-protein ligase FANCL	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q9NW38	FANCL	E3 ubiquitin-protein ligase FANCL	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9NW38	FANCL	E3 ubiquitin-protein ligase FANCL	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NW38	FANCL	E3 ubiquitin-protein ligase FANCL	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
Q9NW38	FANCL	E3 ubiquitin-protein ligase FANCL	GO:0006281; P:DNA repair; IMP:UniProtKB
Q9NW38	FANCL	E3 ubiquitin-protein ligase FANCL	GO:0007276; P:gamete generation; IEA:Ensembl
Q9NW38	FANCL	E3 ubiquitin-protein ligase FANCL	GO:0006513; P:protein monoubiquitination; IDA:UniProtKB
Q9NW38	FANCL	E3 ubiquitin-protein ligase FANCL	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q8IYD8	FANCM	Fanconi anemia group M protein	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IYD8	FANCM	Fanconi anemia group M protein	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q8IYD8	FANCM	Fanconi anemia group M protein	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q8IYD8	FANCM	Fanconi anemia group M protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IYD8	FANCM	Fanconi anemia group M protein	GO:0004518; F:nuclease activity; IEA:InterPro
Q8IYD8	FANCM	Fanconi anemia group M protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IYD8	FANCM	Fanconi anemia group M protein	GO:0006259; P:DNA metabolic process; IEA:InterPro
Q8IYD8	FANCM	Fanconi anemia group M protein	GO:0006281; P:DNA repair; TAS:Reactome
Q8IYD8	FANCM	Fanconi anemia group M protein	GO:0031297; P:replication fork processing; IMP:UniProtKB
Q8IYD8	FANCM	Fanconi anemia group M protein	GO:0000712; P:resolution of meiotic recombination intermediates; IMP:UniProtKB
Q92636	NSMAF	Protein FAN	GO:0005515; F:protein binding; IPI:IntAct
Q92636	NSMAF	Protein FAN	GO:0005057; F:receptor signaling protein activity; TAS:ProtInc
Q92636	NSMAF	Protein FAN	GO:0016230; F:sphingomyelin phosphodiesterase activator activity; IEA:Ensembl
Q92636	NSMAF	Protein FAN	GO:0006672; P:ceramide metabolic process; TAS:ProtInc
Q92636	NSMAF	Protein FAN	GO:0035556; P:intracellular signal transduction; TAS:GOC
Q92636	NSMAF	Protein FAN	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q92636	NSMAF	Protein FAN	GO:0007165; P:signal transduction; TAS:ProtInc
Q6NZ36	FAAP20	Fanconi anemia-associated protein of 20 kDa	GO:0070530; F:K63-linked polyubiquitin binding; IDA:UniProtKB
Q6NZ36	FAAP20	Fanconi anemia-associated protein of 20 kDa	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6NZ36	FAAP20	Fanconi anemia-associated protein of 20 kDa	GO:0031593; F:polyubiquitin binding; IDA:UniProtKB
Q6NZ36	FAAP20	Fanconi anemia-associated protein of 20 kDa	GO:0005515; F:protein binding; IPI:UniProtKB
Q6NZ36	FAAP20	Fanconi anemia-associated protein of 20 kDa	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
Q6NZ36	FAAP20	Fanconi anemia-associated protein of 20 kDa	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q6NZ36	FAAP20	Fanconi anemia-associated protein of 20 kDa	GO:0036297; P:interstrand cross-link repair; IMP:UniProtKB
Q6NZ36	FAAP20	Fanconi anemia-associated protein of 20 kDa	GO:0019985; P:translesion synthesis; IMP:UniProtKB
Q9BTP7	FAAP24	Fanconi anemia-associated protein of 24 kDa	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q9BTP7	FAAP24	Fanconi anemia-associated protein of 24 kDa	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BTP7	FAAP24	Fanconi anemia-associated protein of 24 kDa	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BTP7	FAAP24	Fanconi anemia-associated protein of 24 kDa	GO:0006281; P:DNA repair; TAS:Reactome
Q9Y4F1	FARP1	FERM, RhoGEF and pleckstrin domain-containing protein 1	GO:0030676; F:Rac guanyl-nucleotide exchange factor activity; ISS:UniProtKB
Q9Y4F1	FARP1	FERM, RhoGEF and pleckstrin domain-containing protein 1	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; TAS:ProtInc
Q9Y4F1	FARP1	FERM, RhoGEF and pleckstrin domain-containing protein 1	GO:0048813; P:dendrite morphogenesis; ISS:UniProtKB
Q9Y4F1	FARP1	FERM, RhoGEF and pleckstrin domain-containing protein 1	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q9Y4F1	FARP1	FERM, RhoGEF and pleckstrin domain-containing protein 1	GO:0032314; P:regulation of Rac GTPase activity; ISS:GOC
Q9Y4F1	FARP1	FERM, RhoGEF and pleckstrin domain-containing protein 1	GO:0032319; P:regulation of Rho GTPase activity; TAS:GOC
Q9Y4F1	FARP1	FERM, RhoGEF and pleckstrin domain-containing protein 1	GO:0007416; P:synapse assembly; ISS:UniProtKB
O94887	FARP2	FERM, RhoGEF and pleckstrin domain-containing protein 2	GO:0030676; F:Rac guanyl-nucleotide exchange factor activity; ISS:UniProtKB
O94887	FARP2	FERM, RhoGEF and pleckstrin domain-containing protein 2	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
O94887	FARP2	FERM, RhoGEF and pleckstrin domain-containing protein 2	GO:0031532; P:actin cytoskeleton reorganization; ISS:UniProtKB
O94887	FARP2	FERM, RhoGEF and pleckstrin domain-containing protein 2	GO:0007411; P:axon guidance; TAS:Reactome
O94887	FARP2	FERM, RhoGEF and pleckstrin domain-containing protein 2	GO:0007155; P:cell adhesion; ISS:UniProtKB
O94887	FARP2	FERM, RhoGEF and pleckstrin domain-containing protein 2	GO:0016322; P:neuron remodeling; IDA:MGI
O94887	FARP2	FERM, RhoGEF and pleckstrin domain-containing protein 2	GO:0030316; P:osteoclast differentiation; ISS:UniProtKB
O94887	FARP2	FERM, RhoGEF and pleckstrin domain-containing protein 2	GO:0071800; P:podosome assembly; ISS:UniProtKB
O94887	FARP2	FERM, RhoGEF and pleckstrin domain-containing protein 2	GO:0016601; P:Rac protein signal transduction; IDA:MGI
O94887	FARP2	FERM, RhoGEF and pleckstrin domain-containing protein 2	GO:0033623; P:regulation of integrin activation; ISS:UniProtKB
O94887	FARP2	FERM, RhoGEF and pleckstrin domain-containing protein 2	GO:0032314; P:regulation of Rac GTPase activity; ISS:GOC
O94887	FARP2	FERM, RhoGEF and pleckstrin domain-containing protein 2	GO:0032319; P:regulation of Rho GTPase activity; IDA:GOC
O94887	FARP2	FERM, RhoGEF and pleckstrin domain-containing protein 2	GO:0071526; P:semaphorin-plexin signaling pathway; ISS:UniProtKB
Q14296	FASTK	Fas-activated serine/threonine kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q14296	FASTK	Fas-activated serine/threonine kinase	GO:0033867; F:Fas-activated serine/threonine kinase activity; IEA:UniProtKB-EC
Q14296	FASTK	Fas-activated serine/threonine kinase	GO:0005515; F:protein binding; IPI:UniProtKB
Q14296	FASTK	Fas-activated serine/threonine kinase	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q14296	FASTK	Fas-activated serine/threonine kinase	GO:0097190; P:apoptotic signaling pathway; TAS:ProtInc
Q14296	FASTK	Fas-activated serine/threonine kinase	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q14296	FASTK	Fas-activated serine/threonine kinase	GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB
P49327	FASN	Fatty acid synthase	GO:0047451; F:3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity; IEA:UniProtKB-EC
P49327	FASN	Fatty acid synthase	GO:0004317; F:3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity; IEA:InterPro
P49327	FASN	Fatty acid synthase	GO:0004316; F:3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; IEA:UniProtKB-EC
P49327	FASN	Fatty acid synthase	GO:0004315; F:3-oxoacyl-[acyl-carrier-protein] synthase activity; IEA:UniProtKB-EC
P49327	FASN	Fatty acid synthase	GO:0004313; F:[acyl-carrier-protein] S-acetyltransferase activity; IEA:UniProtKB-EC
P49327	FASN	Fatty acid synthase	GO:0004314; F:[acyl-carrier-protein] S-malonyltransferase activity; IEA:UniProtKB-EC
P49327	FASN	Fatty acid synthase	GO:0008144; F:drug binding; IEA:Ensembl
P49327	FASN	Fatty acid synthase	GO:0047117; F:enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity; IEA:UniProtKB-EC
P49327	FASN	Fatty acid synthase	GO:0004319; F:enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity; IEA:InterPro
P49327	FASN	Fatty acid synthase	GO:0004312; F:fatty acid synthase activity; TAS:Reactome
P49327	FASN	Fatty acid synthase	GO:0016295; F:myristoyl-[acyl-carrier-protein] hydrolase activity; IEA:UniProtKB-EC
P49327	FASN	Fatty acid synthase	GO:0070402; F:NADPH binding; IEA:Ensembl
P49327	FASN	Fatty acid synthase	GO:0004320; F:oleoyl-[acyl-carrier-protein] hydrolase activity; IEA:UniProtKB-EC
P49327	FASN	Fatty acid synthase	GO:0016296; F:palmitoyl-[acyl-carrier-protein] hydrolase activity; IEA:UniProtKB-EC
P49327	FASN	Fatty acid synthase	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P49327	FASN	Fatty acid synthase	GO:0005515; F:protein binding; IPI:UniProtKB
P49327	FASN	Fatty acid synthase	GO:0008270; F:zinc ion binding; IEA:InterPro
P49327	FASN	Fatty acid synthase	GO:0006084; P:acetyl-CoA metabolic process; IEA:Ensembl
P49327	FASN	Fatty acid synthase	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P49327	FASN	Fatty acid synthase	GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl
P49327	FASN	Fatty acid synthase	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P49327	FASN	Fatty acid synthase	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
P49327	FASN	Fatty acid synthase	GO:0006631; P:fatty acid metabolic process; TAS:ProtInc
P49327	FASN	Fatty acid synthase	GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome
P49327	FASN	Fatty acid synthase	GO:0015939; P:pantothenate metabolic process; TAS:Reactome
P49327	FASN	Fatty acid synthase	GO:0031325; P:positive regulation of cellular metabolic process; TAS:Reactome
P49327	FASN	Fatty acid synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P49327	FASN	Fatty acid synthase	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
P49327	FASN	Fatty acid synthase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P49327	FASN	Fatty acid synthase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q14517	FAT1	Protocadherin Fat 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q14517	FAT1	Protocadherin Fat 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q14517	FAT1	Protocadherin Fat 1	GO:0007015; P:actin filament organization; ISS:UniProtKB
Q14517	FAT1	Protocadherin Fat 1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q14517	FAT1	Protocadherin Fat 1	GO:0007155; P:cell adhesion; TAS:ProtInc
Q14517	FAT1	Protocadherin Fat 1	GO:0016477; P:cell migration; ISS:UniProtKB
Q14517	FAT1	Protocadherin Fat 1	GO:0016337; P:single organismal cell-cell adhesion; ISS:UniProtKB
Q14517	FAT1	Protocadherin Fat 1	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q14517	FAT1	Protocadherin Fat 1	GO:0007163; P:establishment or maintenance of cell polarity; ISS:UniProtKB
Q14517	FAT1	Protocadherin Fat 1	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9NYQ8	FAT2	Protocadherin Fat 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NYQ8	FAT2	Protocadherin Fat 2	GO:0010631; P:epithelial cell migration; IMP:UniProtKB
Q9NYQ8	FAT2	Protocadherin Fat 2	GO:0007156; P:homophilic cell adhesion; ISS:UniProtKB
Q8TDW7	FAT3	Protocadherin Fat 3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8TDW7	FAT3	Protocadherin Fat 3	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q8TDW7	FAT3	Protocadherin Fat 3	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q6V0I7	FAT4	Protocadherin Fat 4	GO:0005509; F:calcium ion binding; IEA:InterPro
Q6V0I7	FAT4	Protocadherin Fat 4	GO:0005515; F:protein binding; IPI:IntAct
Q6V0I7	FAT4	Protocadherin Fat 4	GO:0021987; P:cerebral cortex development; ISS:UniProtKB
Q6V0I7	FAT4	Protocadherin Fat 4	GO:0007157; P:heterophilic cell-cell adhesion; ISS:UniProtKB
Q6V0I7	FAT4	Protocadherin Fat 4	GO:0035329; P:hippo signaling; ISS:UniProtKB
Q6V0I7	FAT4	Protocadherin Fat 4	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q6V0I7	FAT4	Protocadherin Fat 4	GO:0022008; P:neurogenesis; ISS:UniProtKB
A8MUU1	FABP5P3	Putative fatty acid-binding protein 5-like protein 3	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
A8MUU1	FABP5P3	Putative fatty acid-binding protein 5-like protein 3	GO:0005215; F:transporter activity; IEA:InterPro
Q8N539	FIBCD1	Fibrinogen C domain-containing protein 1	GO:0008061; F:chitin binding; IDA:UniProtKB
Q8N539	FIBCD1	Fibrinogen C domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TES7	FBF1	Fas-binding factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TES7	FBF1	Fas-binding factor 1	GO:0043297; P:apical junction assembly; IMP:UniProtKB
Q8TES7	FBF1	Fas-binding factor 1	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q8TES7	FBF1	Fas-binding factor 1	GO:0090162; P:establishment of epithelial cell polarity; IMP:UniProtKB
Q8WUP2	FBLIM1	Filamin-binding LIM protein 1	GO:0031005; F:filamin binding; IDA:UniProtKB
Q8WUP2	FBLIM1	Filamin-binding LIM protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WUP2	FBLIM1	Filamin-binding LIM protein 1	GO:0034329; P:cell junction assembly; TAS:Reactome
Q8WUP2	FBLIM1	Filamin-binding LIM protein 1	GO:0016337; P:single organismal cell-cell adhesion; IMP:UniProtKB
Q8WUP2	FBLIM1	Filamin-binding LIM protein 1	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
Q8WUP2	FBLIM1	Filamin-binding LIM protein 1	GO:0033623; P:regulation of integrin activation; IMP:UniProtKB
A6NHQ2	FBLL1	rRNA/tRNA 2'-O-methyltransferase fibrillarin-like protein 1	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
A6NHQ2	FBLL1	rRNA/tRNA 2'-O-methyltransferase fibrillarin-like protein 1	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
A6NHQ2	FBLL1	rRNA/tRNA 2'-O-methyltransferase fibrillarin-like protein 1	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
A6NHQ2	FBLL1	rRNA/tRNA 2'-O-methyltransferase fibrillarin-like protein 1	GO:0008033; P:tRNA processing; IEA:InterPro
P23142	FBLN1	Fibulin-1	GO:0005509; F:calcium ion binding; IEA:InterPro
P23142	FBLN1	Fibulin-1	GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc
P23142	FBLN1	Fibulin-1	GO:0016504; F:peptidase activator activity; IEA:Ensembl
P23142	FBLN1	Fibulin-1	GO:0007566; P:embryo implantation; IEA:Ensembl
P23142	FBLN1	Fibulin-1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P23142	FBLN1	Fibulin-1	GO:0016032; P:viral process; IEA:UniProtKB-KW
P98095	FBLN2	Fibulin-2	GO:0005509; F:calcium ion binding; TAS:ProtInc
P98095	FBLN2	Fibulin-2	GO:0050840; F:extracellular matrix binding; IEA:Ensembl
P98095	FBLN2	Fibulin-2	GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc
P98095	FBLN2	Fibulin-2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P98095	FBLN2	Fibulin-2	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
Q12805	EFEMP1	EGF-containing fibulin-like extracellular matrix protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q12805	EFEMP1	EGF-containing fibulin-like extracellular matrix protein 1	GO:0005154; F:epidermal growth factor receptor binding; IDA:UniProtKB
Q12805	EFEMP1	EGF-containing fibulin-like extracellular matrix protein 1	GO:0005006; F:epidermal growth factor-activated receptor activity; IDA:UniProtKB
Q12805	EFEMP1	EGF-containing fibulin-like extracellular matrix protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q12805	EFEMP1	EGF-containing fibulin-like extracellular matrix protein 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; IDA:UniProtKB
Q12805	EFEMP1	EGF-containing fibulin-like extracellular matrix protein 1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q12805	EFEMP1	EGF-containing fibulin-like extracellular matrix protein 1	GO:0032331; P:negative regulation of chondrocyte differentiation; IDA:UniProtKB
Q12805	EFEMP1	EGF-containing fibulin-like extracellular matrix protein 1	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
Q12805	EFEMP1	EGF-containing fibulin-like extracellular matrix protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q12805	EFEMP1	EGF-containing fibulin-like extracellular matrix protein 1	GO:0007601; P:visual perception; TAS:ProtInc
O95967	EFEMP2	EGF-containing fibulin-like extracellular matrix protein 2	GO:0005509; F:calcium ion binding; IEA:InterPro
O95967	EFEMP2	EGF-containing fibulin-like extracellular matrix protein 2	GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc
O95967	EFEMP2	EGF-containing fibulin-like extracellular matrix protein 2	GO:0005515; F:protein binding; IPI:IntAct
O95967	EFEMP2	EGF-containing fibulin-like extracellular matrix protein 2	GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro
O95967	EFEMP2	EGF-containing fibulin-like extracellular matrix protein 2	GO:0007596; P:blood coagulation; IEA:InterPro
O95967	EFEMP2	EGF-containing fibulin-like extracellular matrix protein 2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q9UBX5	FBLN5	Fibulin-5	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UBX5	FBLN5	Fibulin-5	GO:0005178; F:integrin binding; TAS:ProtInc
Q9UBX5	FBLN5	Fibulin-5	GO:0005515; F:protein binding; IPI:IntAct
Q9UBX5	FBLN5	Fibulin-5	GO:0008022; F:protein C-terminus binding; IPI:BHF-UCL
Q9UBX5	FBLN5	Fibulin-5	GO:0007160; P:cell-matrix adhesion; TAS:ProtInc
Q9UBX5	FBLN5	Fibulin-5	GO:0048251; P:elastic fiber assembly; ISS:BHF-UCL
Q9UBX5	FBLN5	Fibulin-5	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q9UBX5	FBLN5	Fibulin-5	GO:0034394; P:protein localization to cell surface; ISS:BHF-UCL
Q9UBX5	FBLN5	Fibulin-5	GO:0001558; P:regulation of cell growth; IEA:Ensembl
Q9UBX5	FBLN5	Fibulin-5	GO:2000121; P:regulation of removal of superoxide radicals; ISS:BHF-UCL
Q53RD9	FBLN7	Fibulin-7	GO:0005509; F:calcium ion binding; IEA:InterPro
Q53RD9	FBLN7	Fibulin-7	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
Q53RD9	FBLN7	Fibulin-7	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P35555	FBN1	Fibrillin-1	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P35555	FBN1	Fibrillin-1	GO:0005201; F:extracellular matrix structural constituent; IDA:UniProtKB
P35555	FBN1	Fibrillin-1	GO:0005515; F:protein binding; IPI:UniProtKB
P35555	FBN1	Fibrillin-1	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P35555	FBN1	Fibrillin-1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P35555	FBN1	Fibrillin-1	GO:0007507; P:heart development; IMP:UniProtKB
P35555	FBN1	Fibrillin-1	GO:0001822; P:kidney development; IEA:Ensembl
P35555	FBN1	Fibrillin-1	GO:0035582; P:sequestering of BMP in extracellular matrix; ISS:BHF-UCL
P35555	FBN1	Fibrillin-1	GO:0035583; P:sequestering of TGFbeta in extracellular matrix; ISS:BHF-UCL
P35555	FBN1	Fibrillin-1	GO:0001501; P:skeletal system development; IMP:UniProtKB
P35556	FBN2	Fibrillin-2	GO:0005509; F:calcium ion binding; IEA:InterPro
P35556	FBN2	Fibrillin-2	GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc
P35556	FBN2	Fibrillin-2	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P35556	FBN2	Fibrillin-2	GO:0060346; P:bone trabecula formation; ISS:BHF-UCL
P35556	FBN2	Fibrillin-2	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
P35556	FBN2	Fibrillin-2	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P35556	FBN2	Fibrillin-2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P35556	FBN2	Fibrillin-2	GO:0030501; P:positive regulation of bone mineralization; ISS:BHF-UCL
P35556	FBN2	Fibrillin-2	GO:0045669; P:positive regulation of osteoblast differentiation; ISS:BHF-UCL
P35556	FBN2	Fibrillin-2	GO:0035583; P:sequestering of TGFbeta in extracellular matrix; ISS:BHF-UCL
Q75N90	FBN3	Fibrillin-3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q75N90	FBN3	Fibrillin-3	GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro
A6NFH5	FABP12	Fatty acid-binding protein 12	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
A6NFH5	FABP12	Fatty acid-binding protein 12	GO:0005215; F:transporter activity; IEA:InterPro
Q5T0N5	FNBP1L	Formin-binding protein 1-like	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q5T0N5	FNBP1L	Formin-binding protein 1-like	GO:0005515; F:protein binding; IPI:IntAct
Q5T0N5	FNBP1L	Formin-binding protein 1-like	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q5T0N5	FNBP1L	Formin-binding protein 1-like	GO:0072583; P:clathrin-mediated endocytosis; IDA:BHF-UCL
Q5T0N5	FNBP1L	Formin-binding protein 1-like	GO:0006900; P:membrane budding; IDA:BHF-UCL
Q5T0N5	FNBP1L	Formin-binding protein 1-like	GO:0010324; P:membrane invagination; IDA:BHF-UCL
Q5T0N5	FNBP1L	Formin-binding protein 1-like	GO:0097320; P:membrane tubulation; IDA:BHF-UCL
Q5T0N5	FNBP1L	Formin-binding protein 1-like	GO:0051491; P:positive regulation of filopodium assembly; IDA:BHF-UCL
Q5T0N5	FNBP1L	Formin-binding protein 1-like	GO:0016050; P:vesicle organization; IDA:BHF-UCL
Q5T0N5	FNBP1L	Formin-binding protein 1-like	GO:0030050; P:vesicle transport along actin filament; IDA:BHF-UCL
P22087	FBL	rRNA 2'-O-methyltransferase fibrillarin	GO:1990259; F:histone-glutamine methyltransferase activity; IDA:UniProtKB
P22087	FBL	rRNA 2'-O-methyltransferase fibrillarin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P22087	FBL	rRNA 2'-O-methyltransferase fibrillarin	GO:0005515; F:protein binding; IPI:UniProtKB
P22087	FBL	rRNA 2'-O-methyltransferase fibrillarin	GO:0003723; F:RNA binding; TAS:ProtInc
P22087	FBL	rRNA 2'-O-methyltransferase fibrillarin	GO:1990258; P:histone glutamine methylation; IDA:UniProtKB
P22087	FBL	rRNA 2'-O-methyltransferase fibrillarin	GO:0006364; P:rRNA processing; TAS:ProtInc
P22087	FBL	rRNA 2'-O-methyltransferase fibrillarin	GO:0016074; P:snoRNA metabolic process; IEA:Ensembl
P22087	FBL	rRNA 2'-O-methyltransferase fibrillarin	GO:0008033; P:tRNA processing; IEA:InterPro
Q9HCM7	FBRSL1	Fibrosin-1-like protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P0C2W1	FBXO45	F-box/SPRY domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P0C2W1	FBXO45	F-box/SPRY domain-containing protein 1	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
P0C2W1	FBXO45	F-box/SPRY domain-containing protein 1	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
P0C2W1	FBXO45	F-box/SPRY domain-containing protein 1	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB
P0C2W1	FBXO45	F-box/SPRY domain-containing protein 1	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
P0C2W1	FBXO45	F-box/SPRY domain-containing protein 1	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0005515; F:protein binding; IPI:IntAct
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0060444; P:branching involved in mammary gland duct morphogenesis; IEA:Ensembl
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0033598; P:mammary gland epithelial cell proliferation; IEA:Ensembl
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; TAS:BHF-UCL
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0045879; P:negative regulation of smoothened signaling pathway; TAS:BHF-UCL
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0042753; P:positive regulation of circadian rhythm; IEA:Ensembl
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0045862; P:positive regulation of proteolysis; IMP:UniProtKB
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0006470; P:protein dephosphorylation; IEA:Ensembl
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0031648; P:protein destabilization; IMP:UniProtKB
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0000209; P:protein polyubiquitination; IEA:Ensembl
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0043122; P:regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0061136; P:regulation of proteasomal protein catabolic process; IEA:Ensembl
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IBA:RefGenome
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0016032; P:viral process; TAS:Reactome
Q9Y297	BTRC	F-box/WD repeat-containing protein 1A	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9UKB1	FBXW11	F-box/WD repeat-containing protein 11	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKB1	FBXW11	F-box/WD repeat-containing protein 11	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9UKB1	FBXW11	F-box/WD repeat-containing protein 11	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q9UKB1	FBXW11	F-box/WD repeat-containing protein 11	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9UKB1	FBXW11	F-box/WD repeat-containing protein 11	GO:0042347; P:negative regulation of NF-kappaB import into nucleus; IEA:Ensembl
Q9UKB1	FBXW11	F-box/WD repeat-containing protein 11	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q9UKB1	FBXW11	F-box/WD repeat-containing protein 11	GO:0042753; P:positive regulation of circadian rhythm; ISS:UniProtKB
Q9UKB1	FBXW11	F-box/WD repeat-containing protein 11	GO:0045862; P:positive regulation of proteolysis; IMP:UniProtKB
Q9UKB1	FBXW11	F-box/WD repeat-containing protein 11	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q9UKB1	FBXW11	F-box/WD repeat-containing protein 11	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9UKB1	FBXW11	F-box/WD repeat-containing protein 11	GO:0006470; P:protein dephosphorylation; ISS:UniProtKB
Q9UKB1	FBXW11	F-box/WD repeat-containing protein 11	GO:0031648; P:protein destabilization; IMP:UniProtKB
Q9UKB1	FBXW11	F-box/WD repeat-containing protein 11	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q9UKB1	FBXW11	F-box/WD repeat-containing protein 11	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q9UKB1	FBXW11	F-box/WD repeat-containing protein 11	GO:0048511; P:rhythmic process; IEA:UniProtKB-KW
Q9UKB1	FBXW11	F-box/WD repeat-containing protein 11	GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9UKB1	FBXW11	F-box/WD repeat-containing protein 11	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9UK96	FBXO10	F-box only protein 10	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UK96	FBXO10	F-box only protein 10	GO:0004842; F:ubiquitin-protein ligase activity; NAS:UniProtKB
Q9UK96	FBXO10	F-box only protein 10	GO:0016567; P:protein ubiquitination; NAS:UniProtKB
Q9UK96	FBXO10	F-box only protein 10	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q9UK96	FBXO10	F-box only protein 10	GO:0042981; P:regulation of apoptotic process; IMP:UniProtKB
Q86XK2	FBXO11	F-box only protein 11	GO:0005515; F:protein binding; IPI:IntAct
Q86XK2	FBXO11	F-box only protein 11	GO:0016274; F:protein-arginine N-methyltransferase activity; IDA:BHF-UCL
Q86XK2	FBXO11	F-box only protein 11	GO:0004842; F:ubiquitin-protein ligase activity; NAS:UniProtKB
Q86XK2	FBXO11	F-box only protein 11	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86XK2	FBXO11	F-box only protein 11	GO:0006464; P:cellular protein modification process; IDA:HGNC
Q86XK2	FBXO11	F-box only protein 11	GO:0035246; P:peptidyl-arginine N-methylation; IDA:GOC
Q86XK2	FBXO11	F-box only protein 11	GO:0016567; P:protein ubiquitination; NAS:UniProtKB
Q86XK2	FBXO11	F-box only protein 11	GO:0007605; P:sensory perception of sound; IEA:Ensembl
Q86XK2	FBXO11	F-box only protein 11	GO:0006511; P:ubiquitin-dependent protein catabolic process; NAS:UniProtKB
Q96EF6	FBXO17	F-box only protein 17	GO:0001948; F:glycoprotein binding; IDA:UniProtKB
Q96EF6	FBXO17	F-box only protein 17	GO:0005515; F:protein binding; IPI:UniProtKB
Q96EF6	FBXO17	F-box only protein 17	GO:0030163; P:protein catabolic process; IEA:InterPro
Q8NFZ0	FBXO18	F-box only protein 18	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NFZ0	FBXO18	F-box only protein 18	GO:0004003; F:ATP-dependent DNA helicase activity; IEA:InterPro
Q8NFZ0	FBXO18	F-box only protein 18	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NFZ0	FBXO18	F-box only protein 18	GO:0005515; F:protein binding; IPI:IntAct
O94952	FBXO21	F-box only protein 21	GO:0003677; F:DNA binding; IEA:InterPro
O94952	FBXO21	F-box only protein 21	GO:0004842; F:ubiquitin-protein ligase activity; NAS:UniProtKB
O94952	FBXO21	F-box only protein 21	GO:0016567; P:protein ubiquitination; NAS:GOC
O94952	FBXO21	F-box only protein 21	GO:0006511; P:ubiquitin-dependent protein catabolic process; NAS:UniProtKB
Q8NEZ5	FBXO22	F-box only protein 22	GO:0004842; F:ubiquitin-protein ligase activity; TAS:ProtInc
Q8NEZ5	FBXO22	F-box only protein 22	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q8NEZ5	FBXO22	F-box only protein 22	GO:0009267; P:cellular response to starvation; IEA:Ensembl
Q8NEZ5	FBXO22	F-box only protein 22	GO:0006913; P:nucleocytoplasmic transport; IEA:Ensembl
Q8NEZ5	FBXO22	F-box only protein 22	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q8NEZ5	FBXO22	F-box only protein 22	GO:2000060; P:positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q8NEZ5	FBXO22	F-box only protein 22	GO:0000209; P:protein polyubiquitination; IEA:Ensembl
Q8NEZ5	FBXO22	F-box only protein 22	GO:0048742; P:regulation of skeletal muscle fiber development; IEA:Ensembl
Q8NEZ5	FBXO22	F-box only protein 22	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
O75426	FBXO24	F-box only protein 24	GO:0004842; F:ubiquitin-protein ligase activity; NAS:UniProtKB
O75426	FBXO24	F-box only protein 24	GO:0016567; P:protein ubiquitination; NAS:UniProtKB
Q8TCJ0	FBXO25	F-box only protein 25	GO:0005515; F:protein binding; IPI:IntAct
Q8TCJ0	FBXO25	F-box only protein 25	GO:0004842; F:ubiquitin-protein ligase activity; NAS:UniProtKB
Q8TCJ0	FBXO25	F-box only protein 25	GO:0016567; P:protein ubiquitination; ISS:UniProtKB
Q8NI29	FBXO27	F-box only protein 27	GO:0001948; F:glycoprotein binding; IDA:UniProtKB
Q8NI29	FBXO27	F-box only protein 27	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NI29	FBXO27	F-box only protein 27	GO:0030163; P:protein catabolic process; IEA:InterPro
Q9UK22	FBXO2	F-box only protein 2	GO:0001540; F:beta-amyloid binding; IEA:Ensembl
Q9UK22	FBXO2	F-box only protein 2	GO:0030246; F:carbohydrate binding; IEA:Ensembl
Q9UK22	FBXO2	F-box only protein 2	GO:0004842; F:ubiquitin-protein ligase activity; TAS:ProtInc
Q9UK22	FBXO2	F-box only protein 2	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q9UK22	FBXO2	F-box only protein 2	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q9UK22	FBXO2	F-box only protein 2	GO:0006516; P:glycoprotein catabolic process; ISS:UniProtKB
Q9UK22	FBXO2	F-box only protein 2	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q9UK22	FBXO2	F-box only protein 2	GO:0016567; P:protein ubiquitination; ISS:UniProtKB
Q9UK22	FBXO2	F-box only protein 2	GO:0006508; P:proteolysis; TAS:ProtInc
Q9UK22	FBXO2	F-box only protein 2	GO:0031396; P:regulation of protein ubiquitination; IEA:Ensembl
Q9UK22	FBXO2	F-box only protein 2	GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; ISS:UniProtKB
Q8TB52	FBXO30	F-box only protein 30	GO:0004842; F:ubiquitin-protein ligase activity; IEA:InterPro
Q8TB52	FBXO30	F-box only protein 30	GO:0008270; F:zinc ion binding; IEA:InterPro
Q969P5	FBXO32	F-box only protein 32	GO:0005515; F:protein binding; IPI:IntAct
Q969P5	FBXO32	F-box only protein 32	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q969P5	FBXO32	F-box only protein 32	GO:0014894; P:response to denervation involved in regulation of muscle adaptation; ISS:UniProtKB
Q5XUX0	FBXO31	F-box only protein 31	GO:0030332; F:cyclin binding; IPI:UniProtKB
Q5XUX0	FBXO31	F-box only protein 31	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q5XUX0	FBXO31	F-box only protein 31	GO:0008054; P:cyclin catabolic process; IMP:UniProtKB
Q5XUX0	FBXO31	F-box only protein 31	GO:0031571; P:mitotic G1 DNA damage checkpoint; IMP:UniProtKB
Q5XUX0	FBXO31	F-box only protein 31	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q5XUX0	FBXO31	F-box only protein 31	GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q7Z6M2	FBXO33	F-box only protein 33	GO:0005515; F:protein binding; IPI:IntAct
Q7Z6M2	FBXO33	F-box only protein 33	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9UK99	FBXO3	F-box only protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q9UK99	FBXO3	F-box only protein 3	GO:0004842; F:ubiquitin-protein ligase activity; TAS:ProtInc
Q9UK99	FBXO3	F-box only protein 3	GO:0016567; P:protein ubiquitination; TAS:GOC
Q9UK99	FBXO3	F-box only protein 3	GO:0006508; P:proteolysis; TAS:ProtInc
Q9UH90	FBXO40	F-box only protein 40	GO:0004842; F:ubiquitin-protein ligase activity; IEA:InterPro
Q9UH90	FBXO40	F-box only protein 40	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UH90	FBXO40	F-box only protein 40	GO:0042692; P:muscle cell differentiation; ISS:UniProtKB
Q4G163	FBXO43	F-box only protein 43	GO:0008270; F:zinc ion binding; IEA:InterPro
Q4G163	FBXO43	F-box only protein 43	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q4G163	FBXO43	F-box only protein 43	GO:0045835; P:negative regulation of meiosis; IEA:Ensembl
Q4G163	FBXO43	F-box only protein 43	GO:0042177; P:negative regulation of protein catabolic process; IEA:Ensembl
Q4G163	FBXO43	F-box only protein 43	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9H4M3	FBXO44	F-box only protein 44	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H4M3	FBXO44	F-box only protein 44	GO:0030163; P:protein catabolic process; IEA:InterPro
Q6PJ61	FBXO46	F-box only protein 46	GO:0005515; F:protein binding; IPI:IntAct
Q9UKT5	FBXO4	F-box only protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKT5	FBXO4	F-box only protein 4	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q9UKT5	FBXO4	F-box only protein 4	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9UKT5	FBXO4	F-box only protein 4	GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB
Q9UKT5	FBXO4	F-box only protein 4	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q9UKT5	FBXO4	F-box only protein 4	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q9UKT5	FBXO4	F-box only protein 4	GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9UKT5	FBXO4	F-box only protein 4	GO:0000723; P:telomere maintenance; IMP:UniProtKB
Q9UKT5	FBXO4	F-box only protein 4	GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q6ZVX7	NCCRP1	F-box only protein 50	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q6ZVX7	NCCRP1	F-box only protein 50	GO:0030163; P:protein catabolic process; IEA:InterPro
Q9NRD1	FBXO6	F-box only protein 6	GO:0030246; F:carbohydrate binding; IEA:Ensembl
Q9NRD1	FBXO6	F-box only protein 6	GO:0001948; F:glycoprotein binding; ISS:UniProtKB
Q9NRD1	FBXO6	F-box only protein 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NRD1	FBXO6	F-box only protein 6	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q9NRD1	FBXO6	F-box only protein 6	GO:0000077; P:DNA damage checkpoint; TAS:UniProtKB
Q9NRD1	FBXO6	F-box only protein 6	GO:0006281; P:DNA repair; TAS:UniProtKB
Q9NRD1	FBXO6	F-box only protein 6	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; ISS:UniProtKB
Q9NRD1	FBXO6	F-box only protein 6	GO:0006516; P:glycoprotein catabolic process; IEA:Ensembl
Q9NRD1	FBXO6	F-box only protein 6	GO:0006508; P:proteolysis; TAS:ProtInc
Q9NRD1	FBXO6	F-box only protein 6	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
Q9NRD1	FBXO6	F-box only protein 6	GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9UKT4	FBXO5	F-box only protein 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UKT4	FBXO5	F-box only protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKT4	FBXO5	F-box only protein 5	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q9UKT4	FBXO5	F-box only protein 5	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q9UKT4	FBXO5	F-box only protein 5	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q9UKT4	FBXO5	F-box only protein 5	GO:0060565; P:inhibition of mitotic anaphase-promoting complex activity; IDA:UniProtKB
Q9UKT4	FBXO5	F-box only protein 5	GO:0007091; P:metaphase/anaphase transition of mitotic cell cycle; TAS:Reactome
Q9UKT4	FBXO5	F-box only protein 5	GO:0046785; P:microtubule polymerization; IEA:Ensembl
Q9UKT4	FBXO5	F-box only protein 5	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9UKT4	FBXO5	F-box only protein 5	GO:0045835; P:negative regulation of meiosis; IEA:Ensembl
Q9UKT4	FBXO5	F-box only protein 5	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; IDA:UniProtKB
Q9UKT4	FBXO5	F-box only protein 5	GO:0001556; P:oocyte maturation; IEA:Ensembl
Q9UKT4	FBXO5	F-box only protein 5	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UKT4	FBXO5	F-box only protein 5	GO:0007346; P:regulation of mitotic cell cycle; ISS:UniProtKB
Q9UKT4	FBXO5	F-box only protein 5	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; TAS:Reactome
Q9UKT4	FBXO5	F-box only protein 5	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UKT4	FBXO5	F-box only protein 5	GO:0007057; P:spindle assembly involved in female meiosis I; IEA:Ensembl
Q9UKT4	FBXO5	F-box only protein 5	GO:0016050; P:vesicle organization; IEA:Ensembl
Q9Y3I1	FBXO7	F-box only protein 7	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3I1	FBXO7	F-box only protein 7	GO:0004842; F:ubiquitin-protein ligase activity; TAS:ProtInc
Q9Y3I1	FBXO7	F-box only protein 7	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9Y3I1	FBXO7	F-box only protein 7	GO:0000422; P:mitochondrion degradation; IMP:UniProtKB
Q9Y3I1	FBXO7	F-box only protein 7	GO:0006626; P:protein targeting to mitochondrion; IMP:UniProtKB
Q9Y3I1	FBXO7	F-box only protein 7	GO:0016567; P:protein ubiquitination; IMP:UniProtKB
Q9Y3I1	FBXO7	F-box only protein 7	GO:0031647; P:regulation of protein stability; IDA:UniProtKB
Q9Y3I1	FBXO7	F-box only protein 7	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
Q9NRD0	FBXO8	F-box only protein 8	GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; IBA:RefGenome
Q9NRD0	FBXO8	F-box only protein 8	GO:0030036; P:actin cytoskeleton organization; IBA:RefGenome
Q9NRD0	FBXO8	F-box only protein 8	GO:0032012; P:regulation of ARF protein signal transduction; IEA:InterPro
Q9NRD0	FBXO8	F-box only protein 8	GO:0043087; P:regulation of GTPase activity; IBA:GOC
Q9NRD0	FBXO8	F-box only protein 8	GO:0006511; P:ubiquitin-dependent protein catabolic process; NAS:UniProtKB
Q9UK97	FBXO9	F-box only protein 9	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UK97	FBXO9	F-box only protein 9	GO:0004842; F:ubiquitin-protein ligase activity; NAS:UniProtKB
Q9UK97	FBXO9	F-box only protein 9	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q9UK97	FBXO9	F-box only protein 9	GO:0032006; P:regulation of TOR signaling; IMP:UniProtKB
Q9UK97	FBXO9	F-box only protein 9	GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9UKC9	FBXL2	F-box/LRR-repeat protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKC9	FBXL2	F-box/LRR-repeat protein 2	GO:0004842; F:ubiquitin-protein ligase activity; TAS:ProtInc
Q9UKC9	FBXL2	F-box/LRR-repeat protein 2	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q9UKC9	FBXL2	F-box/LRR-repeat protein 2	GO:0006513; P:protein monoubiquitination; IEA:Ensembl
Q9UKC9	FBXL2	F-box/LRR-repeat protein 2	GO:0006508; P:proteolysis; TAS:ProtInc
Q9UKC9	FBXL2	F-box/LRR-repeat protein 2	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q9UKC9	FBXL2	F-box/LRR-repeat protein 2	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9UKT7	FBXL3	F-box/LRR-repeat protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKT7	FBXL3	F-box/LRR-repeat protein 3	GO:0004842; F:ubiquitin-protein ligase activity; NAS:UniProtKB
Q9UKT7	FBXL3	F-box/LRR-repeat protein 3	GO:0043153; P:entrainment of circadian clock by photoperiod; ISS:UniProtKB
Q9UKT7	FBXL3	F-box/LRR-repeat protein 3	GO:0016567; P:protein ubiquitination; ISS:UniProtKB
Q9UKT7	FBXL3	F-box/LRR-repeat protein 3	GO:0042752; P:regulation of circadian rhythm; IMP:UniProtKB
Q9UKT7	FBXL3	F-box/LRR-repeat protein 3	GO:0048511; P:rhythmic process; IEA:UniProtKB-KW
Q9UKT7	FBXL3	F-box/LRR-repeat protein 3	GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9UKA2	FBXL4	F-box/LRR-repeat protein 4	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
Q9UKA1	FBXL5	F-box/LRR-repeat protein 5	GO:0005506; F:iron ion binding; IDA:UniProtKB
Q9UKA1	FBXL5	F-box/LRR-repeat protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKA1	FBXL5	F-box/LRR-repeat protein 5	GO:0004842; F:ubiquitin-protein ligase activity; NAS:UniProtKB
Q9UKA1	FBXL5	F-box/LRR-repeat protein 5	GO:0055072; P:iron ion homeostasis; IMP:UniProtKB
Q9UKA1	FBXL5	F-box/LRR-repeat protein 5	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q9UKA1	FBXL5	F-box/LRR-repeat protein 5	GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q8N531	FBXL6	F-box/LRR-repeat protein 6	GO:0004842; F:ubiquitin-protein ligase activity; TAS:ProtInc
Q8N531	FBXL6	F-box/LRR-repeat protein 6	GO:0016567; P:protein ubiquitination; TAS:GOC
Q8N531	FBXL6	F-box/LRR-repeat protein 6	GO:0006508; P:proteolysis; TAS:ProtInc
Q9UJT9	FBXL7	F-box/LRR-repeat protein 7	GO:0004842; F:ubiquitin-protein ligase activity; NAS:UniProtKB
Q9UJT9	FBXL7	F-box/LRR-repeat protein 7	GO:0008283; P:cell proliferation; IEA:Ensembl
Q9UJT9	FBXL7	F-box/LRR-repeat protein 7	GO:0000086; P:G2/M transition of mitotic cell cycle; IEA:Ensembl
Q9UJT9	FBXL7	F-box/LRR-repeat protein 7	GO:0007067; P:mitosis; IEA:Ensembl
Q9UJT9	FBXL7	F-box/LRR-repeat protein 7	GO:0016567; P:protein ubiquitination; ISS:UniProtKB
Q9UJT9	FBXL7	F-box/LRR-repeat protein 7	GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q9UJT9	FBXL7	F-box/LRR-repeat protein 7	GO:0006511; P:ubiquitin-dependent protein catabolic process; NAS:UniProtKB
Q96CD0	FBXL8	F-box/LRR-repeat protein 8	GO:0005515; F:protein binding; IPI:IntAct
Q9UKT8	FBXW2	F-box/WD repeat-containing protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q9UKT8	FBXW2	F-box/WD repeat-containing protein 2	GO:0004842; F:ubiquitin-protein ligase activity; TAS:ProtInc
Q9UKT8	FBXW2	F-box/WD repeat-containing protein 2	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q9UKT8	FBXW2	F-box/WD repeat-containing protein 2	GO:0016567; P:protein ubiquitination; TAS:GOC
Q9UKT8	FBXW2	F-box/WD repeat-containing protein 2	GO:0006508; P:proteolysis; TAS:ProtInc
P57775	FBXW4	F-box/WD repeat-containing protein 4	GO:0051216; P:cartilage development; IEA:Ensembl
P57775	FBXW4	F-box/WD repeat-containing protein 4	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
P57775	FBXW4	F-box/WD repeat-containing protein 4	GO:0030326; P:embryonic limb morphogenesis; NAS:UniProtKB
P57775	FBXW4	F-box/WD repeat-containing protein 4	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl
P57775	FBXW4	F-box/WD repeat-containing protein 4	GO:0006511; P:ubiquitin-dependent protein catabolic process; NAS:UniProtKB
P57775	FBXW4	F-box/WD repeat-containing protein 4	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q969U6	FBXW5	F-box/WD repeat-containing protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q969U6	FBXW5	F-box/WD repeat-containing protein 5	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q969U6	FBXW5	F-box/WD repeat-containing protein 5	GO:0051298; P:centrosome duplication; IMP:UniProtKB
Q969U6	FBXW5	F-box/WD repeat-containing protein 5	GO:0007067; P:mitosis; IEA:Ensembl
Q969U6	FBXW5	F-box/WD repeat-containing protein 5	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q969U6	FBXW5	F-box/WD repeat-containing protein 5	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q969U6	FBXW5	F-box/WD repeat-containing protein 5	GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0042802; F:identical protein binding; IPI:IntAct
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0005515; F:protein binding; IPI:IntAct
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0034644; P:cellular response to UV; IDA:UniProtKB
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0055088; P:lipid homeostasis; ISS:BHF-UCL
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0030324; P:lung development; IEA:Ensembl
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0032876; P:negative regulation of DNA endoreduplication; IMP:BHF-UCL
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:2000346; P:negative regulation of hepatocyte proliferation; ISS:BHF-UCL
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0045746; P:negative regulation of Notch signaling pathway; ISS:BHF-UCL
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:2000639; P:negative regulation of SREBP signaling pathway; ISS:BHF-UCL
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0010868; P:negative regulation of triglyceride biosynthetic process; ISS:BHF-UCL
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0045741; P:positive regulation of epidermal growth factor-activated receptor activity; IDA:BHF-UCL
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:BHF-UCL
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:2000060; P:positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:BHF-UCL
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0050821; P:protein stabilization; IDA:BHF-UCL
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0010883; P:regulation of lipid storage; ISS:BHF-UCL
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0032880; P:regulation of protein localization; ISS:BHF-UCL
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0007062; P:sister chromatid cohesion; IMP:BHF-UCL
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0001944; P:vasculature development; TAS:BHF-UCL
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q969H0	FBXW7	F-box/WD repeat-containing protein 7	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q8N3Y1	FBXW8	F-box/WD repeat-containing protein 8	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N3Y1	FBXW8	F-box/WD repeat-containing protein 8	GO:0007030; P:Golgi organization; IGI:UniProtKB
Q8N3Y1	FBXW8	F-box/WD repeat-containing protein 8	GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl
Q8N3Y1	FBXW8	F-box/WD repeat-containing protein 8	GO:0050775; P:positive regulation of dendrite morphogenesis; IDA:UniProtKB
Q8N3Y1	FBXW8	F-box/WD repeat-containing protein 8	GO:0060712; P:spongiotrophoblast layer development; IEA:Ensembl
Q5XUX1	FBXW9	F-box/WD repeat-containing protein 9	GO:0005515; F:protein binding; IPI:IntAct
Q5XUX1	FBXW9	F-box/WD repeat-containing protein 9	GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IBA:RefGenome
Q8WWV6	FCAMR	High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor	GO:0002376; P:immune system process; IEA:UniProtKB-KW
P24071	FCAR	Immunoglobulin alpha Fc receptor	GO:0006955; P:immune response; TAS:ProtInc
P06734	FCER2	Low affinity immunoglobulin epsilon Fc receptor	GO:0030246; F:carbohydrate binding; IEA:InterPro
P06734	FCER2	Low affinity immunoglobulin epsilon Fc receptor	GO:0005178; F:integrin binding; TAS:ProtInc
P06734	FCER2	Low affinity immunoglobulin epsilon Fc receptor	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P06734	FCER2	Low affinity immunoglobulin epsilon Fc receptor	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P06734	FCER2	Low affinity immunoglobulin epsilon Fc receptor	GO:0002925; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; IEA:Ensembl
P06734	FCER2	Low affinity immunoglobulin epsilon Fc receptor	GO:0051712; P:positive regulation of killing of cells of other organism; IDA:BHF-UCL
P06734	FCER2	Low affinity immunoglobulin epsilon Fc receptor	GO:0051000; P:positive regulation of nitric-oxide synthase activity; IDA:BHF-UCL
P06734	FCER2	Low affinity immunoglobulin epsilon Fc receptor	GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; IDA:BHF-UCL
P12319	FCER1A	High affinity immunoglobulin epsilon receptor subunit alpha	GO:0019767; F:IgE receptor activity; IEA:Ensembl
P12319	FCER1A	High affinity immunoglobulin epsilon receptor subunit alpha	GO:0007257; P:activation of JUN kinase activity; IEA:Ensembl
P12319	FCER1A	High affinity immunoglobulin epsilon receptor subunit alpha	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P12319	FCER1A	High affinity immunoglobulin epsilon receptor subunit alpha	GO:0045087; P:innate immune response; TAS:Reactome
P12319	FCER1A	High affinity immunoglobulin epsilon receptor subunit alpha	GO:0019370; P:leukotriene biosynthetic process; IEA:Ensembl
P12319	FCER1A	High affinity immunoglobulin epsilon receptor subunit alpha	GO:0050850; P:positive regulation of calcium-mediated signaling; IEA:Ensembl
P12319	FCER1A	High affinity immunoglobulin epsilon receptor subunit alpha	GO:0045425; P:positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process; IEA:Ensembl
P12319	FCER1A	High affinity immunoglobulin epsilon receptor subunit alpha	GO:0045401; P:positive regulation of interleukin-3 biosynthetic process; IEA:Ensembl
P12319	FCER1A	High affinity immunoglobulin epsilon receptor subunit alpha	GO:0043306; P:positive regulation of mast cell degranulation; IEA:Ensembl
P12319	FCER1A	High affinity immunoglobulin epsilon receptor subunit alpha	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
P12319	FCER1A	High affinity immunoglobulin epsilon receptor subunit alpha	GO:0001812; P:positive regulation of type I hypersensitivity; IEA:Ensembl
P12319	FCER1A	High affinity immunoglobulin epsilon receptor subunit alpha	GO:0001820; P:serotonin secretion; IEA:Ensembl
Q01362	MS4A2	High affinity immunoglobulin epsilon receptor subunit beta	GO:0007202; P:activation of phospholipase C activity; IEA:Ensembl
Q01362	MS4A2	High affinity immunoglobulin epsilon receptor subunit beta	GO:0050663; P:cytokine secretion; IEA:Ensembl
Q01362	MS4A2	High affinity immunoglobulin epsilon receptor subunit beta	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q01362	MS4A2	High affinity immunoglobulin epsilon receptor subunit beta	GO:0006955; P:immune response; IMP:UniProtKB
Q01362	MS4A2	High affinity immunoglobulin epsilon receptor subunit beta	GO:0006954; P:inflammatory response; IEA:Ensembl
Q01362	MS4A2	High affinity immunoglobulin epsilon receptor subunit beta	GO:0045087; P:innate immune response; TAS:Reactome
Q01362	MS4A2	High affinity immunoglobulin epsilon receptor subunit beta	GO:0043306; P:positive regulation of mast cell degranulation; IEA:Ensembl
Q01362	MS4A2	High affinity immunoglobulin epsilon receptor subunit beta	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
Q01362	MS4A2	High affinity immunoglobulin epsilon receptor subunit beta	GO:0051279; P:regulation of release of sequestered calcium ion into cytosol; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0019767; F:IgE receptor activity; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0005515; F:protein binding; IPI:IntAct
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0007596; P:blood coagulation; TAS:Reactome
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0042742; P:defense response to bacterium; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0002431; P:Fc receptor mediated stimulatory signaling pathway; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0016064; P:immunoglobulin mediated immune response; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0045087; P:innate immune response; TAS:Reactome
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0050900; P:leukocyte migration; TAS:Reactome
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0045576; P:mast cell activation; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0033026; P:negative regulation of mast cell apoptotic process; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0002283; P:neutrophil activation involved in immune response; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0030593; P:neutrophil chemotaxis; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0006911; P:phagocytosis, engulfment; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0030168; P:platelet activation; TAS:Reactome
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0032733; P:positive regulation of interleukin-10 production; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0032765; P:positive regulation of mast cell cytokine production; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0043306; P:positive regulation of mast cell degranulation; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0050766; P:positive regulation of phagocytosis; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0032760; P:positive regulation of tumor necrosis factor production; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0001812; P:positive regulation of type I hypersensitivity; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0001798; P:positive regulation of type IIa hypersensitivity; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0001805; P:positive regulation of type III hypersensitivity; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0010543; P:regulation of platelet activation; IEA:Ensembl
P30273	FCER1G	High affinity immunoglobulin epsilon receptor subunit gamma	GO:0002554; P:serotonin secretion by platelet; IEA:Ensembl
Q9Y324	FCF1	rRNA-processing protein FCF1 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y324	FCF1	rRNA-processing protein FCF1 homolog	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
P12318	FCGR2A	Low affinity immunoglobulin gamma Fc region receptor II-a	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P12318	FCGR2A	Low affinity immunoglobulin gamma Fc region receptor II-a	GO:0045087; P:innate immune response; TAS:Reactome
P31994	FCGR2B	Low affinity immunoglobulin gamma Fc region receptor II-b	GO:0005515; F:protein binding; IPI:IntAct
P31994	FCGR2B	Low affinity immunoglobulin gamma Fc region receptor II-b	GO:0006955; P:immune response; TAS:ProtInc
P31994	FCGR2B	Low affinity immunoglobulin gamma Fc region receptor II-b	GO:0050776; P:regulation of immune response; TAS:Reactome
P31994	FCGR2B	Low affinity immunoglobulin gamma Fc region receptor II-b	GO:0007165; P:signal transduction; TAS:ProtInc
P31994	FCGR2B	Low affinity immunoglobulin gamma Fc region receptor II-b	GO:0016032; P:viral process; IEA:UniProtKB-KW
P31995	FCGR2C	Low affinity immunoglobulin gamma Fc region receptor II-c	GO:0005515; F:protein binding; IPI:IntAct
P31995	FCGR2C	Low affinity immunoglobulin gamma Fc region receptor II-c	GO:0004888; F:transmembrane signaling receptor activity; NAS:UniProtKB
P31995	FCGR2C	Low affinity immunoglobulin gamma Fc region receptor II-c	GO:0006955; P:immune response; NAS:UniProtKB
P31995	FCGR2C	Low affinity immunoglobulin gamma Fc region receptor II-c	GO:0007165; P:signal transduction; NAS:GOC
P08637	FCGR3A	Low affinity immunoglobulin gamma Fc region receptor III-A	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P08637	FCGR3A	Low affinity immunoglobulin gamma Fc region receptor III-A	GO:0006955; P:immune response; TAS:ProtInc
P08637	FCGR3A	Low affinity immunoglobulin gamma Fc region receptor III-A	GO:0045087; P:innate immune response; TAS:Reactome
P08637	FCGR3A	Low affinity immunoglobulin gamma Fc region receptor III-A	GO:0050776; P:regulation of immune response; TAS:Reactome
O75015	FCGR3B	Low affinity immunoglobulin gamma Fc region receptor III-B	GO:0006955; P:immune response; TAS:ProtInc
Q9Y6R7	FCGBP	IgGFc-binding protein	GO:0005515; F:protein binding; IPI:UniProtKB
P12314	FCGR1A	High affinity immunoglobulin gamma Fc receptor I	GO:0005515; F:protein binding; IPI:BHF-UCL
P12314	FCGR1A	High affinity immunoglobulin gamma Fc receptor I	GO:0005057; F:receptor signaling protein activity; TAS:ProtInc
P12314	FCGR1A	High affinity immunoglobulin gamma Fc receptor I	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P12314	FCGR1A	High affinity immunoglobulin gamma Fc receptor I	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P12314	FCGR1A	High affinity immunoglobulin gamma Fc receptor I	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P12314	FCGR1A	High affinity immunoglobulin gamma Fc receptor I	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P12314	FCGR1A	High affinity immunoglobulin gamma Fc receptor I	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P12314	FCGR1A	High affinity immunoglobulin gamma Fc receptor I	GO:0006955; P:immune response; TAS:ProtInc
P12314	FCGR1A	High affinity immunoglobulin gamma Fc receptor I	GO:0045087; P:innate immune response; TAS:Reactome
P12314	FCGR1A	High affinity immunoglobulin gamma Fc receptor I	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P12314	FCGR1A	High affinity immunoglobulin gamma Fc receptor I	GO:0035556; P:intracellular signal transduction; TAS:GOC
P12314	FCGR1A	High affinity immunoglobulin gamma Fc receptor I	GO:0006911; P:phagocytosis, engulfment; TAS:ProtInc
P12314	FCGR1A	High affinity immunoglobulin gamma Fc receptor I	GO:0007165; P:signal transduction; TAS:ProtInc
Q92637	FCGR1B	High affinity immunoglobulin gamma Fc receptor IB	GO:0019763; F:immunoglobulin receptor activity; NAS:UniProtKB
Q92637	FCGR1B	High affinity immunoglobulin gamma Fc receptor IB	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q92637	FCGR1B	High affinity immunoglobulin gamma Fc receptor IB	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q92637	FCGR1B	High affinity immunoglobulin gamma Fc receptor IB	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q92637	FCGR1B	High affinity immunoglobulin gamma Fc receptor IB	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q92637	FCGR1B	High affinity immunoglobulin gamma Fc receptor IB	GO:0038093; P:Fc receptor signaling pathway; NAS:GOC
Q92637	FCGR1B	High affinity immunoglobulin gamma Fc receptor IB	GO:0006955; P:immune response; NAS:UniProtKB
Q92637	FCGR1B	High affinity immunoglobulin gamma Fc receptor IB	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
A6NKC4	FCGR1C	Putative high affinity immunoglobulin gamma Fc receptor IC	GO:0002376; P:immune system process; IEA:UniProtKB-KW
P55899	FCGRT	IgG receptor FcRn large subunit p51	GO:0003823; F:antigen binding; IBA:RefGenome
P55899	FCGRT	IgG receptor FcRn large subunit p51	GO:0030881; F:beta-2-microglobulin binding; IBA:RefGenome
P55899	FCGRT	IgG receptor FcRn large subunit p51	GO:0019864; F:IgG binding; IDA:UniProtKB
P55899	FCGRT	IgG receptor FcRn large subunit p51	GO:0019770; F:IgG receptor activity; IBA:RefGenome
P55899	FCGRT	IgG receptor FcRn large subunit p51	GO:0019882; P:antigen processing and presentation; IBA:RefGenome
P55899	FCGRT	IgG receptor FcRn large subunit p51	GO:0038094; P:Fc-gamma receptor signaling pathway; IBA:GOC
P55899	FCGRT	IgG receptor FcRn large subunit p51	GO:0002416; P:IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor; NAS:UniProtKB
P55899	FCGRT	IgG receptor FcRn large subunit p51	GO:0006955; P:immune response; IEA:InterPro
O14526	FCHO1	FCH domain only protein 1	GO:0035612; F:AP-2 adaptor complex binding; IDA:MGI
O14526	FCHO1	FCH domain only protein 1	GO:0005515; F:protein binding; IPI:IntAct
O14526	FCHO1	FCH domain only protein 1	GO:0048268; P:clathrin coat assembly; IMP:UniProtKB
O14526	FCHO1	FCH domain only protein 1	GO:0072583; P:clathrin-mediated endocytosis; IMP:UniProtKB
Q0JRZ9	FCHO2	FCH domain only protein 2	GO:0035091; F:phosphatidylinositol binding; ISS:UniProtKB
Q0JRZ9	FCHO2	FCH domain only protein 2	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISS:UniProtKB
Q0JRZ9	FCHO2	FCH domain only protein 2	GO:0001786; F:phosphatidylserine binding; ISS:UniProtKB
Q0JRZ9	FCHO2	FCH domain only protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q0JRZ9	FCHO2	FCH domain only protein 2	GO:0048268; P:clathrin coat assembly; IMP:UniProtKB
Q0JRZ9	FCHO2	FCH domain only protein 2	GO:0072583; P:clathrin-mediated endocytosis; IMP:UniProtKB
Q0JRZ9	FCHO2	FCH domain only protein 2	GO:0010324; P:membrane invagination; ISS:UniProtKB
Q0JRZ9	FCHO2	FCH domain only protein 2	GO:0072659; P:protein localization to plasma membrane; ISS:UniProtKB
Q13630	TSTA3	GDP-L-fucose synthase	GO:0050662; F:coenzyme binding; IEA:InterPro
Q13630	TSTA3	GDP-L-fucose synthase	GO:0009055; F:electron carrier activity; TAS:UniProtKB
Q13630	TSTA3	GDP-L-fucose synthase	GO:0042356; F:GDP-4-dehydro-D-rhamnose reductase activity; TAS:UniProtKB
Q13630	TSTA3	GDP-L-fucose synthase	GO:0050577; F:GDP-L-fucose synthase activity; IDA:UniProtKB
Q13630	TSTA3	GDP-L-fucose synthase	GO:0016853; F:isomerase activity; IEA:UniProtKB-KW
Q13630	TSTA3	GDP-L-fucose synthase	GO:0042351; P:'de novo' GDP-L-fucose biosynthetic process; IDA:UniProtKB
Q13630	TSTA3	GDP-L-fucose synthase	GO:0019835; P:cytolysis; IEA:Ensembl
Q13630	TSTA3	GDP-L-fucose synthase	GO:0019673; P:GDP-mannose metabolic process; IDA:UniProtKB
Q13630	TSTA3	GDP-L-fucose synthase	GO:0007159; P:leukocyte cell-cell adhesion; NAS:UniProtKB
O00602	FCN1	Ficolin-1	GO:0003823; F:antigen binding; TAS:ProtInc
O00602	FCN1	Ficolin-1	GO:0005509; F:calcium ion binding; TAS:ProtInc
O00602	FCN1	Ficolin-1	GO:0030246; F:carbohydrate binding; TAS:ProtInc
O00602	FCN1	Ficolin-1	GO:0005515; F:protein binding; IPI:IntAct
O00602	FCN1	Ficolin-1	GO:0006956; P:complement activation; TAS:Reactome
O00602	FCN1	Ficolin-1	GO:0001867; P:complement activation, lectin pathway; TAS:Reactome
O00602	FCN1	Ficolin-1	GO:0045087; P:innate immune response; TAS:Reactome
O00602	FCN1	Ficolin-1	GO:0008228; P:opsonization; TAS:ProtInc
Q15485	FCN2	Ficolin-2	GO:0003823; F:antigen binding; TAS:ProtInc
Q15485	FCN2	Ficolin-2	GO:0005509; F:calcium ion binding; TAS:ProtInc
Q15485	FCN2	Ficolin-2	GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB
Q15485	FCN2	Ficolin-2	GO:0030246; F:carbohydrate binding; TAS:ProtInc
Q15485	FCN2	Ficolin-2	GO:0005515; F:protein binding; IPI:IntAct
Q15485	FCN2	Ficolin-2	GO:0006956; P:complement activation; TAS:Reactome
Q15485	FCN2	Ficolin-2	GO:0001867; P:complement activation, lectin pathway; TAS:Reactome
Q15485	FCN2	Ficolin-2	GO:0045087; P:innate immune response; TAS:Reactome
Q15485	FCN2	Ficolin-2	GO:0008228; P:opsonization; TAS:ProtInc
O75636	FCN3	Ficolin-3	GO:0030246; F:carbohydrate binding; TAS:ProtInc
O75636	FCN3	Ficolin-3	GO:0005515; F:protein binding; IPI:UniProtKB
O75636	FCN3	Ficolin-3	GO:0006956; P:complement activation; TAS:Reactome
O75636	FCN3	Ficolin-3	GO:0001867; P:complement activation, lectin pathway; IDA:UniProtKB
O75636	FCN3	Ficolin-3	GO:0045087; P:innate immune response; TAS:Reactome
Q96LA5	FCRL2	Fc receptor-like protein 2	GO:0005070; F:SH3/SH2 adaptor activity; IPI:UniProtKB
Q96LA5	FCRL2	Fc receptor-like protein 2	GO:0007267; P:cell-cell signaling; NAS:UniProtKB
Q96LA5	FCRL2	Fc receptor-like protein 2	GO:0009967; P:positive regulation of signal transduction; IPI:GOC
Q96PJ5	FCRL4	Fc receptor-like protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q96PJ5	FCRL4	Fc receptor-like protein 4	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q7L513	FCRLA	Fc receptor-like A	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O94868	FCHSD2	FCH and double SH3 domains protein 2	GO:0005515; F:protein binding; IPI:IntAct
P37268	FDFT1	Squalene synthase	GO:0004310; F:farnesyl-diphosphate farnesyltransferase activity; TAS:Reactome
P37268	FDFT1	Squalene synthase	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
P37268	FDFT1	Squalene synthase	GO:0051996; F:squalene synthase activity; IEA:UniProtKB-EC
P37268	FDFT1	Squalene synthase	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P37268	FDFT1	Squalene synthase	GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome
P37268	FDFT1	Squalene synthase	GO:0045338; P:farnesyl diphosphate metabolic process; IEA:Ensembl
P37268	FDFT1	Squalene synthase	GO:0008299; P:isoprenoid biosynthetic process; IEA:UniProtKB-KW
P37268	FDFT1	Squalene synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P37268	FDFT1	Squalene synthase	GO:0006694; P:steroid biosynthetic process; TAS:ProtInc
Q9BRP7	FDXACB1	Ferredoxin-fold anticodon-binding domain-containing protein 1	GO:0005524; F:ATP binding; IEA:InterPro
Q9BRP7	FDXACB1	Ferredoxin-fold anticodon-binding domain-containing protein 1	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q9BRP7	FDXACB1	Ferredoxin-fold anticodon-binding domain-containing protein 1	GO:0004826; F:phenylalanine-tRNA ligase activity; IEA:InterPro
Q9BRP7	FDXACB1	Ferredoxin-fold anticodon-binding domain-containing protein 1	GO:0000049; F:tRNA binding; IEA:InterPro
Q9BRP7	FDXACB1	Ferredoxin-fold anticodon-binding domain-containing protein 1	GO:0006432; P:phenylalanyl-tRNA aminoacylation; IEA:InterPro
Q9BRP7	FDXACB1	Ferredoxin-fold anticodon-binding domain-containing protein 1	GO:0008033; P:tRNA processing; IEA:InterPro
Q9BSK4	FEM1A	Protein fem-1 homolog A	GO:0031867; F:EP4 subtype prostaglandin E2 receptor binding; IPI:UniProtKB
Q9BSK4	FEM1A	Protein fem-1 homolog A	GO:0004842; F:ubiquitin-protein ligase activity; ISS:UniProtKB
Q9BSK4	FEM1A	Protein fem-1 homolog A	GO:0050728; P:negative regulation of inflammatory response; IDA:UniProtKB
Q9BSK4	FEM1A	Protein fem-1 homolog A	GO:0051438; P:regulation of ubiquitin-protein ligase activity; ISS:UniProtKB
Q9UK73	FEM1B	Protein fem-1 homolog B	GO:0005123; F:death receptor binding; IMP:UniProtKB
Q9UK73	FEM1B	Protein fem-1 homolog B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UK73	FEM1B	Protein fem-1 homolog B	GO:0004842; F:ubiquitin-protein ligase activity; IMP:UniProtKB
Q9UK73	FEM1B	Protein fem-1 homolog B	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q9UK73	FEM1B	Protein fem-1 homolog B	GO:0060442; P:branching involved in prostate gland morphogenesis; IEA:Ensembl
Q9UK73	FEM1B	Protein fem-1 homolog B	GO:0060743; P:epithelial cell maturation involved in prostate gland development; IEA:Ensembl
Q9UK73	FEM1B	Protein fem-1 homolog B	GO:2000001; P:regulation of DNA damage checkpoint; IMP:UniProtKB
Q9UK73	FEM1B	Protein fem-1 homolog B	GO:1902041; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; IMP:UniProtKB
Q9UK73	FEM1B	Protein fem-1 homolog B	GO:0051438; P:regulation of ubiquitin-protein ligase activity; IMP:UniProtKB
Q96JP0	FEM1C	Protein fem-1 homolog C	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
P39748	FEN1	Flap endonuclease 1	GO:0008409; F:5'-3' exonuclease activity; IDA:UniProtKB
P39748	FEN1	Flap endonuclease 1	GO:0017108; F:5'-flap endonuclease activity; IDA:UniProtKB
P39748	FEN1	Flap endonuclease 1	GO:0003684; F:damaged DNA binding; TAS:ProtInc
P39748	FEN1	Flap endonuclease 1	GO:0003677; F:DNA binding; IMP:UniProtKB
P39748	FEN1	Flap endonuclease 1	GO:0003690; F:double-stranded DNA binding; TAS:ProtInc
P39748	FEN1	Flap endonuclease 1	GO:0008309; F:double-stranded DNA exodeoxyribonuclease activity; TAS:ProtInc
P39748	FEN1	Flap endonuclease 1	GO:0004519; F:endonuclease activity; TAS:ProtInc
P39748	FEN1	Flap endonuclease 1	GO:0004527; F:exonuclease activity; TAS:ProtInc
P39748	FEN1	Flap endonuclease 1	GO:0000287; F:magnesium ion binding; IEA:UniProtKB-HAMAP
P39748	FEN1	Flap endonuclease 1	GO:0030145; F:manganese ion binding; IEA:Ensembl
P39748	FEN1	Flap endonuclease 1	GO:0005515; F:protein binding; IPI:UniProtKB
P39748	FEN1	Flap endonuclease 1	GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IDA:UniProtKB
P39748	FEN1	Flap endonuclease 1	GO:0006284; P:base-excision repair; TAS:Reactome
P39748	FEN1	Flap endonuclease 1	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
P39748	FEN1	Flap endonuclease 1	GO:0000738; P:DNA catabolic process, exonucleolytic; TAS:GOC
P39748	FEN1	Flap endonuclease 1	GO:0006281; P:DNA repair; NAS:UniProtKB
P39748	FEN1	Flap endonuclease 1	GO:0006260; P:DNA replication; NAS:UniProtKB
P39748	FEN1	Flap endonuclease 1	GO:0043137; P:DNA replication, removal of RNA primer; IDA:UniProtKB
P39748	FEN1	Flap endonuclease 1	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P39748	FEN1	Flap endonuclease 1	GO:0006302; P:double-strand break repair; TAS:ProtInc
P39748	FEN1	Flap endonuclease 1	GO:0007613; P:memory; IEA:Ensembl
P39748	FEN1	Flap endonuclease 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P39748	FEN1	Flap endonuclease 1	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:GOC
P39748	FEN1	Flap endonuclease 1	GO:0048015; P:phosphatidylinositol-mediated signaling; NAS:UniProtKB
P39748	FEN1	Flap endonuclease 1	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; IDA:GOC
P39748	FEN1	Flap endonuclease 1	GO:0000723; P:telomere maintenance; TAS:Reactome
P39748	FEN1	Flap endonuclease 1	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
P39748	FEN1	Flap endonuclease 1	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
P39748	FEN1	Flap endonuclease 1	GO:0009650; P:UV protection; TAS:ProtInc
Q96RJ6	FERD3L	Fer3-like protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96RJ6	FERD3L	Fer3-like protein	GO:0048468; P:cell development; IEA:Ensembl
Q96RJ6	FERD3L	Fer3-like protein	GO:0033504; P:floor plate development; IEA:Ensembl
Q96RJ6	FERD3L	Fer3-like protein	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q96RJ6	FERD3L	Fer3-like protein	GO:0050767; P:regulation of neurogenesis; IEA:Ensembl
Q96RJ6	FERD3L	Fer3-like protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BQL6	FERMT1	Fermitin family homolog 1	GO:0007155; P:cell adhesion; IDA:UniProtKB
Q9BQL6	FERMT1	Fermitin family homolog 1	GO:0090162; P:establishment of epithelial cell polarity; IDA:UniProtKB
Q9BQL6	FERMT1	Fermitin family homolog 1	GO:0051546; P:keratinocyte migration; IDA:UniProtKB
Q9BQL6	FERMT1	Fermitin family homolog 1	GO:0043616; P:keratinocyte proliferation; IDA:UniProtKB
Q96AC1	FERMT2	Fermitin family homolog 2	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB
Q96AC1	FERMT2	Fermitin family homolog 2	GO:0005515; F:protein binding; IPI:IntAct
Q96AC1	FERMT2	Fermitin family homolog 2	GO:0034329; P:cell junction assembly; TAS:Reactome
Q96AC1	FERMT2	Fermitin family homolog 2	GO:0007160; P:cell-matrix adhesion; IMP:UniProtKB
Q96AC1	FERMT2	Fermitin family homolog 2	GO:0048041; P:focal adhesion assembly; ISS:UniProtKB
Q96AC1	FERMT2	Fermitin family homolog 2	GO:0033622; P:integrin activation; IMP:UniProtKB
Q96AC1	FERMT2	Fermitin family homolog 2	GO:0007229; P:integrin-mediated signaling pathway; IMP:UniProtKB
Q96AC1	FERMT2	Fermitin family homolog 2	GO:0072657; P:protein localization to membrane; ISS:UniProtKB
Q96AC1	FERMT2	Fermitin family homolog 2	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
Q96AC1	FERMT2	Fermitin family homolog 2	GO:0034446; P:substrate adhesion-dependent cell spreading; ISS:UniProtKB
Q96AC1	FERMT2	Fermitin family homolog 2	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IMP:UniProtKB
Q96AC1	FERMT2	Fermitin family homolog 2	GO:0016055; P:Wnt signaling pathway; IMP:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P16591	FER	Tyrosine-protein kinase Fer	GO:0005154; F:epidermal growth factor receptor binding; IDA:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0008289; F:lipid binding; IDA:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0005515; F:protein binding; IPI:IntAct
P16591	FER	Tyrosine-protein kinase Fer	GO:0004713; F:protein tyrosine kinase activity; TAS:ProtInc
P16591	FER	Tyrosine-protein kinase Fer	GO:0031532; P:actin cytoskeleton reorganization; ISS:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0008283; P:cell proliferation; IMP:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0044331; P:cell-cell adhesion mediated by cadherin; ISS:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0032869; P:cellular response to insulin stimulus; ISS:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0036006; P:cellular response to macrophage colony-stimulating factor stimulus; IMP:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0034614; P:cellular response to reactive oxygen species; ISS:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0006935; P:chemotaxis; IEA:Ensembl
P16591	FER	Tyrosine-protein kinase Fer	GO:0019221; P:cytokine-mediated signaling pathway; IMP:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0050904; P:diapedesis; ISS:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0035426; P:extracellular matrix-cell signaling; ISS:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0038095; P:Fc-epsilon receptor signaling pathway; ISS:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0038028; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; ISS:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0070102; P:interleukin-6-mediated signaling pathway; IMP:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
P16591	FER	Tyrosine-protein kinase Fer	GO:0038109; P:Kit signaling pathway; ISS:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0000226; P:microtubule cytoskeleton organization; IMP:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0000278; P:mitotic cell cycle; IMP:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0033007; P:negative regulation of mast cell activation involved in immune response; ISS:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; ISS:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0030838; P:positive regulation of actin filament polymerization; IMP:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0008284; P:positive regulation of cell proliferation; TAS:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P16591	FER	Tyrosine-protein kinase Fer	GO:0042058; P:regulation of epidermal growth factor receptor signaling pathway; IMP:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0010762; P:regulation of fibroblast migration; IEA:Ensembl
P16591	FER	Tyrosine-protein kinase Fer	GO:0010591; P:regulation of lamellipodium assembly; IDA:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0001932; P:regulation of protein phosphorylation; ISS:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0032496; P:response to lipopolysaccharide; ISS:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0036119; P:response to platelet-derived growth factor; ISS:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0034446; P:substrate adhesion-dependent cell spreading; ISS:UniProtKB
P16591	FER	Tyrosine-protein kinase Fer	GO:0042503; P:tyrosine phosphorylation of Stat3 protein; IDA:UniProtKB
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0034987; F:immunoglobulin receptor binding; IDA:UniProtKB
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0005515; F:protein binding; IPI:IntAct
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0007411; P:axon guidance; TAS:Reactome
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0008283; P:cell proliferation; TAS:ProtInc
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:2000251; P:positive regulation of actin cytoskeleton reorganization; IMP:UniProtKB
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0031116; P:positive regulation of microtubule polymerization; IMP:UniProtKB
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0045639; P:positive regulation of myeloid cell differentiation; IMP:UniProtKB
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0010976; P:positive regulation of neuron projection development; IMP:UniProtKB
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0030155; P:regulation of cell adhesion; IMP:UniProtKB
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0045595; P:regulation of cell differentiation; IMP:UniProtKB
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:2000145; P:regulation of cell motility; IMP:UniProtKB
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0042127; P:regulation of cell proliferation; IMP:UniProtKB
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0043304; P:regulation of mast cell degranulation; IMP:UniProtKB
P07332	FES	Tyrosine-protein kinase Fes/Fps	GO:0060627; P:regulation of vesicle-mediated transport; TAS:UniProtKB
P02771	AFP	Alpha-fetoprotein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P02771	AFP	Alpha-fetoprotein	GO:0001542; P:ovulation from ovarian follicle; IEA:Ensembl
P02771	AFP	Alpha-fetoprotein	GO:0042448; P:progesterone metabolic process; IEA:Ensembl
P02771	AFP	Alpha-fetoprotein	GO:0060395; P:SMAD protein signal transduction; IEA:Ensembl
P02771	AFP	Alpha-fetoprotein	GO:0006810; P:transport; IEA:InterPro
P02765	AHSG	Alpha-2-HS-glycoprotein	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IEA:InterPro
P02765	AHSG	Alpha-2-HS-glycoprotein	GO:0019210; F:kinase inhibitor activity; NAS:UniProtKB
P02765	AHSG	Alpha-2-HS-glycoprotein	GO:0006953; P:acute-phase response; IDA:UniProtKB
P02765	AHSG	Alpha-2-HS-glycoprotein	GO:0030502; P:negative regulation of bone mineralization; ISS:UniProtKB
P02765	AHSG	Alpha-2-HS-glycoprotein	GO:0046627; P:negative regulation of insulin receptor signaling pathway; NAS:UniProtKB
P02765	AHSG	Alpha-2-HS-glycoprotein	GO:0042326; P:negative regulation of phosphorylation; NAS:GOC
P02765	AHSG	Alpha-2-HS-glycoprotein	GO:0001503; P:ossification; IEA:Ensembl
P02765	AHSG	Alpha-2-HS-glycoprotein	GO:0006907; P:pinocytosis; NAS:UniProtKB
P02765	AHSG	Alpha-2-HS-glycoprotein	GO:0050766; P:positive regulation of phagocytosis; IDA:UniProtKB
P02765	AHSG	Alpha-2-HS-glycoprotein	GO:0030500; P:regulation of bone mineralization; NAS:UniProtKB
P02765	AHSG	Alpha-2-HS-glycoprotein	GO:0050727; P:regulation of inflammatory response; IMP:UniProtKB
P02765	AHSG	Alpha-2-HS-glycoprotein	GO:0001501; P:skeletal system development; NAS:UniProtKB
Q9UGM5	FETUB	Fetuin-B	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IEA:InterPro
Q9UGM5	FETUB	Fetuin-B	GO:0008191; F:metalloendopeptidase inhibitor activity; ISS:UniProtKB
Q9UGM5	FETUB	Fetuin-B	GO:0007339; P:binding of sperm to zona pellucida; ISS:UniProtKB
Q9UGM5	FETUB	Fetuin-B	GO:0010951; P:negative regulation of endopeptidase activity; ISS:UniProtKB
Q9UGM5	FETUB	Fetuin-B	GO:0007338; P:single fertilization; ISS:UniProtKB
Q99581	FEV	Protein FEV	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
Q99581	FEV	Protein FEV	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q99581	FEV	Protein FEV	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q99581	FEV	Protein FEV	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q99581	FEV	Protein FEV	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q99581	FEV	Protein FEV	GO:0030154; P:cell differentiation; IBA:RefGenome
Q99581	FEV	Protein FEV	GO:0048665; P:neuron fate specification; IEA:Ensembl
Q99581	FEV	Protein FEV	GO:0042551; P:neuron maturation; IEA:Ensembl
Q99581	FEV	Protein FEV	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q99581	FEV	Protein FEV	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q99581	FEV	Protein FEV	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q99689	FEZ1	Fasciculation and elongation protein zeta-1	GO:0005515; F:protein binding; IPI:IntAct
Q99689	FEZ1	Fasciculation and elongation protein zeta-1	GO:0007411; P:axon guidance; TAS:ProtInc
Q99689	FEZ1	Fasciculation and elongation protein zeta-1	GO:0007155; P:cell adhesion; TAS:ProtInc
Q99689	FEZ1	Fasciculation and elongation protein zeta-1	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
Q99689	FEZ1	Fasciculation and elongation protein zeta-1	GO:0051654; P:establishment of mitochondrion localization; IEA:Ensembl
Q99689	FEZ1	Fasciculation and elongation protein zeta-1	GO:0007399; P:nervous system development; TAS:ProtInc
Q99689	FEZ1	Fasciculation and elongation protein zeta-1	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
Q99689	FEZ1	Fasciculation and elongation protein zeta-1	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
Q99689	FEZ1	Fasciculation and elongation protein zeta-1	GO:0006810; P:transport; IEA:UniProtKB-KW
Q9UHY8	FEZ2	Fasciculation and elongation protein zeta-2	GO:0005515; F:protein binding; IPI:IntAct
Q9UHY8	FEZ2	Fasciculation and elongation protein zeta-2	GO:0007411; P:axon guidance; TAS:ProtInc
Q9UHY8	FEZ2	Fasciculation and elongation protein zeta-2	GO:0007399; P:nervous system development; TAS:ProtInc
Q9UHY8	FEZ2	Fasciculation and elongation protein zeta-2	GO:0007165; P:signal transduction; TAS:ProtInc
A0PJY2	FEZF1	Fez family zinc finger protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A0PJY2	FEZF1	Fez family zinc finger protein 1	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl
A0PJY2	FEZF1	Fez family zinc finger protein 1	GO:0007411; P:axon guidance; IEA:Ensembl
A0PJY2	FEZF1	Fez family zinc finger protein 1	GO:0021797; P:forebrain anterior/posterior pattern specification; IEA:Ensembl
A0PJY2	FEZF1	Fez family zinc finger protein 1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
A0PJY2	FEZF1	Fez family zinc finger protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
A0PJY2	FEZF1	Fez family zinc finger protein 1	GO:0001764; P:neuron migration; IEA:Ensembl
A0PJY2	FEZF1	Fez family zinc finger protein 1	GO:0021772; P:olfactory bulb development; IEA:Ensembl
A0PJY2	FEZF1	Fez family zinc finger protein 1	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
A0PJY2	FEZF1	Fez family zinc finger protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
A0PJY2	FEZF1	Fez family zinc finger protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TBJ5	FEZF2	Fez family zinc finger protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TBJ5	FEZF2	Fez family zinc finger protein 2	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl
Q8TBJ5	FEZF2	Fez family zinc finger protein 2	GO:0007411; P:axon guidance; IEA:Ensembl
Q8TBJ5	FEZF2	Fez family zinc finger protein 2	GO:0007413; P:axonal fasciculation; IEA:Ensembl
Q8TBJ5	FEZF2	Fez family zinc finger protein 2	GO:0021853; P:cerebral cortex GABAergic interneuron migration; IEA:Ensembl
Q8TBJ5	FEZF2	Fez family zinc finger protein 2	GO:0016358; P:dendrite development; IEA:Ensembl
Q8TBJ5	FEZF2	Fez family zinc finger protein 2	GO:0021542; P:dentate gyrus development; IEA:Ensembl
Q8TBJ5	FEZF2	Fez family zinc finger protein 2	GO:0021797; P:forebrain anterior/posterior pattern specification; IEA:Ensembl
Q8TBJ5	FEZF2	Fez family zinc finger protein 2	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q8TBJ5	FEZF2	Fez family zinc finger protein 2	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q8TBJ5	FEZF2	Fez family zinc finger protein 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8TBJ5	FEZF2	Fez family zinc finger protein 2	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
Q8TBJ5	FEZF2	Fez family zinc finger protein 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q8TBJ5	FEZF2	Fez family zinc finger protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O14842	FFAR1	Free fatty acid receptor 1	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O14842	FFAR1	Free fatty acid receptor 1	GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:Reactome
O14842	FFAR1	Free fatty acid receptor 1	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
O14842	FFAR1	Free fatty acid receptor 1	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
O14842	FFAR1	Free fatty acid receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
O14842	FFAR1	Free fatty acid receptor 1	GO:0042593; P:glucose homeostasis; IEA:Ensembl
O14842	FFAR1	Free fatty acid receptor 1	GO:0030073; P:insulin secretion; IEA:Ensembl
O14842	FFAR1	Free fatty acid receptor 1	GO:0043087; P:regulation of GTPase activity; TAS:GOC
O14842	FFAR1	Free fatty acid receptor 1	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
O14842	FFAR1	Free fatty acid receptor 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15552	FFAR2	Free fatty acid receptor 2	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O15552	FFAR2	Free fatty acid receptor 2	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
O15552	FFAR2	Free fatty acid receptor 2	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
O14843	FFAR3	Free fatty acid receptor 3	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O14843	FFAR3	Free fatty acid receptor 3	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
O14843	FFAR3	Free fatty acid receptor 3	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q5NUL3	FFAR4	Free fatty acid receptor 4	GO:0005504; F:fatty acid binding; ISS:UniProtKB
Q5NUL3	FFAR4	Free fatty acid receptor 4	GO:0008527; F:taste receptor activity; IEA:Ensembl
Q5NUL3	FFAR4	Free fatty acid receptor 4	GO:0046879; P:hormone secretion; IEA:Ensembl
Q5NUL3	FFAR4	Free fatty acid receptor 4	GO:0050710; P:negative regulation of cytokine secretion; ISS:UniProtKB
Q5NUL3	FFAR4	Free fatty acid receptor 4	GO:0050728; P:negative regulation of inflammatory response; ISS:UniProtKB
Q5NUL3	FFAR4	Free fatty acid receptor 4	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
Q5NUL3	FFAR4	Free fatty acid receptor 4	GO:0010827; P:regulation of glucose transport; ISS:UniProtKB
P98174	FGD1	FYVE, RhoGEF and PH domain-containing protein 1	GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:UniProtKB
P98174	FGD1	FYVE, RhoGEF and PH domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P98174	FGD1	FYVE, RhoGEF and PH domain-containing protein 1	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
P98174	FGD1	FYVE, RhoGEF and PH domain-containing protein 1	GO:0031267; F:small GTPase binding; IDA:UniProtKB
P98174	FGD1	FYVE, RhoGEF and PH domain-containing protein 1	GO:0030036; P:actin cytoskeleton organization; IDA:UniProtKB
P98174	FGD1	FYVE, RhoGEF and PH domain-containing protein 1	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
P98174	FGD1	FYVE, RhoGEF and PH domain-containing protein 1	GO:0007010; P:cytoskeleton organization; ISS:UniProtKB
P98174	FGD1	FYVE, RhoGEF and PH domain-containing protein 1	GO:0046847; P:filopodium assembly; IDA:UniProtKB
P98174	FGD1	FYVE, RhoGEF and PH domain-containing protein 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P98174	FGD1	FYVE, RhoGEF and PH domain-containing protein 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P98174	FGD1	FYVE, RhoGEF and PH domain-containing protein 1	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P98174	FGD1	FYVE, RhoGEF and PH domain-containing protein 1	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
P98174	FGD1	FYVE, RhoGEF and PH domain-containing protein 1	GO:0043088; P:regulation of Cdc42 GTPase activity; IDA:UniProtKB
P98174	FGD1	FYVE, RhoGEF and PH domain-containing protein 1	GO:0008360; P:regulation of cell shape; ISS:UniProtKB
P98174	FGD1	FYVE, RhoGEF and PH domain-containing protein 1	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P98174	FGD1	FYVE, RhoGEF and PH domain-containing protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
P98174	FGD1	FYVE, RhoGEF and PH domain-containing protein 1	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q7Z6J4	FGD2	FYVE, RhoGEF and PH domain-containing protein 2	GO:0005085; F:guanyl-nucleotide exchange factor activity; ISS:UniProtKB
Q7Z6J4	FGD2	FYVE, RhoGEF and PH domain-containing protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z6J4	FGD2	FYVE, RhoGEF and PH domain-containing protein 2	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q7Z6J4	FGD2	FYVE, RhoGEF and PH domain-containing protein 2	GO:0031267; F:small GTPase binding; ISS:UniProtKB
Q7Z6J4	FGD2	FYVE, RhoGEF and PH domain-containing protein 2	GO:0030036; P:actin cytoskeleton organization; ISS:UniProtKB
Q7Z6J4	FGD2	FYVE, RhoGEF and PH domain-containing protein 2	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q7Z6J4	FGD2	FYVE, RhoGEF and PH domain-containing protein 2	GO:0007010; P:cytoskeleton organization; ISS:UniProtKB
Q7Z6J4	FGD2	FYVE, RhoGEF and PH domain-containing protein 2	GO:0046847; P:filopodium assembly; ISS:UniProtKB
Q7Z6J4	FGD2	FYVE, RhoGEF and PH domain-containing protein 2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q7Z6J4	FGD2	FYVE, RhoGEF and PH domain-containing protein 2	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q7Z6J4	FGD2	FYVE, RhoGEF and PH domain-containing protein 2	GO:0043088; P:regulation of Cdc42 GTPase activity; ISS:UniProtKB
Q7Z6J4	FGD2	FYVE, RhoGEF and PH domain-containing protein 2	GO:0008360; P:regulation of cell shape; ISS:UniProtKB
Q7Z6J4	FGD2	FYVE, RhoGEF and PH domain-containing protein 2	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q7Z6J4	FGD2	FYVE, RhoGEF and PH domain-containing protein 2	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q5JSP0	FGD3	FYVE, RhoGEF and PH domain-containing protein 3	GO:0005085; F:guanyl-nucleotide exchange factor activity; ISS:UniProtKB
Q5JSP0	FGD3	FYVE, RhoGEF and PH domain-containing protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5JSP0	FGD3	FYVE, RhoGEF and PH domain-containing protein 3	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q5JSP0	FGD3	FYVE, RhoGEF and PH domain-containing protein 3	GO:0031267; F:small GTPase binding; ISS:UniProtKB
Q5JSP0	FGD3	FYVE, RhoGEF and PH domain-containing protein 3	GO:0030036; P:actin cytoskeleton organization; ISS:UniProtKB
Q5JSP0	FGD3	FYVE, RhoGEF and PH domain-containing protein 3	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q5JSP0	FGD3	FYVE, RhoGEF and PH domain-containing protein 3	GO:0007010; P:cytoskeleton organization; ISS:UniProtKB
Q5JSP0	FGD3	FYVE, RhoGEF and PH domain-containing protein 3	GO:0046847; P:filopodium assembly; ISS:UniProtKB
Q5JSP0	FGD3	FYVE, RhoGEF and PH domain-containing protein 3	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q5JSP0	FGD3	FYVE, RhoGEF and PH domain-containing protein 3	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q5JSP0	FGD3	FYVE, RhoGEF and PH domain-containing protein 3	GO:0043088; P:regulation of Cdc42 GTPase activity; ISS:UniProtKB
Q5JSP0	FGD3	FYVE, RhoGEF and PH domain-containing protein 3	GO:0008360; P:regulation of cell shape; ISS:UniProtKB
Q5JSP0	FGD3	FYVE, RhoGEF and PH domain-containing protein 3	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q5JSP0	FGD3	FYVE, RhoGEF and PH domain-containing protein 3	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q96M96	FGD4	FYVE, RhoGEF and PH domain-containing protein 4	GO:0005085; F:guanyl-nucleotide exchange factor activity; ISS:UniProtKB
Q96M96	FGD4	FYVE, RhoGEF and PH domain-containing protein 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96M96	FGD4	FYVE, RhoGEF and PH domain-containing protein 4	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q96M96	FGD4	FYVE, RhoGEF and PH domain-containing protein 4	GO:0031267; F:small GTPase binding; ISS:UniProtKB
Q96M96	FGD4	FYVE, RhoGEF and PH domain-containing protein 4	GO:0030036; P:actin cytoskeleton organization; ISS:UniProtKB
Q96M96	FGD4	FYVE, RhoGEF and PH domain-containing protein 4	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q96M96	FGD4	FYVE, RhoGEF and PH domain-containing protein 4	GO:0007010; P:cytoskeleton organization; ISS:UniProtKB
Q96M96	FGD4	FYVE, RhoGEF and PH domain-containing protein 4	GO:0046847; P:filopodium assembly; ISS:UniProtKB
Q96M96	FGD4	FYVE, RhoGEF and PH domain-containing protein 4	GO:0030032; P:lamellipodium assembly; IEA:Ensembl
Q96M96	FGD4	FYVE, RhoGEF and PH domain-containing protein 4	GO:0030035; P:microspike assembly; IEA:Ensembl
Q96M96	FGD4	FYVE, RhoGEF and PH domain-containing protein 4	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q96M96	FGD4	FYVE, RhoGEF and PH domain-containing protein 4	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q96M96	FGD4	FYVE, RhoGEF and PH domain-containing protein 4	GO:0043088; P:regulation of Cdc42 GTPase activity; ISS:UniProtKB
Q96M96	FGD4	FYVE, RhoGEF and PH domain-containing protein 4	GO:0008360; P:regulation of cell shape; ISS:UniProtKB
Q96M96	FGD4	FYVE, RhoGEF and PH domain-containing protein 4	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q96M96	FGD4	FYVE, RhoGEF and PH domain-containing protein 4	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q6ZNL6	FGD5	FYVE, RhoGEF and PH domain-containing protein 5	GO:0005085; F:guanyl-nucleotide exchange factor activity; ISS:UniProtKB
Q6ZNL6	FGD5	FYVE, RhoGEF and PH domain-containing protein 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZNL6	FGD5	FYVE, RhoGEF and PH domain-containing protein 5	GO:0005515; F:protein binding; IPI:IntAct
Q6ZNL6	FGD5	FYVE, RhoGEF and PH domain-containing protein 5	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q6ZNL6	FGD5	FYVE, RhoGEF and PH domain-containing protein 5	GO:0031267; F:small GTPase binding; ISS:UniProtKB
Q6ZNL6	FGD5	FYVE, RhoGEF and PH domain-containing protein 5	GO:0030036; P:actin cytoskeleton organization; ISS:UniProtKB
Q6ZNL6	FGD5	FYVE, RhoGEF and PH domain-containing protein 5	GO:0007010; P:cytoskeleton organization; ISS:UniProtKB
Q6ZNL6	FGD5	FYVE, RhoGEF and PH domain-containing protein 5	GO:0046847; P:filopodium assembly; ISS:UniProtKB
Q6ZNL6	FGD5	FYVE, RhoGEF and PH domain-containing protein 5	GO:0043088; P:regulation of Cdc42 GTPase activity; ISS:UniProtKB
Q6ZNL6	FGD5	FYVE, RhoGEF and PH domain-containing protein 5	GO:0008360; P:regulation of cell shape; ISS:UniProtKB
Q6ZV73	FGD6	FYVE, RhoGEF and PH domain-containing protein 6	GO:0005085; F:guanyl-nucleotide exchange factor activity; ISS:UniProtKB
Q6ZV73	FGD6	FYVE, RhoGEF and PH domain-containing protein 6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZV73	FGD6	FYVE, RhoGEF and PH domain-containing protein 6	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q6ZV73	FGD6	FYVE, RhoGEF and PH domain-containing protein 6	GO:0031267; F:small GTPase binding; ISS:UniProtKB
Q6ZV73	FGD6	FYVE, RhoGEF and PH domain-containing protein 6	GO:0030036; P:actin cytoskeleton organization; ISS:UniProtKB
Q6ZV73	FGD6	FYVE, RhoGEF and PH domain-containing protein 6	GO:0007010; P:cytoskeleton organization; ISS:UniProtKB
Q6ZV73	FGD6	FYVE, RhoGEF and PH domain-containing protein 6	GO:0046847; P:filopodium assembly; ISS:UniProtKB
Q6ZV73	FGD6	FYVE, RhoGEF and PH domain-containing protein 6	GO:0043088; P:regulation of Cdc42 GTPase activity; ISS:UniProtKB
Q6ZV73	FGD6	FYVE, RhoGEF and PH domain-containing protein 6	GO:0008360; P:regulation of cell shape; ISS:UniProtKB
P61328	FGF12	Fibroblast growth factor 12	GO:0008083; F:growth factor activity; TAS:ProtInc
P61328	FGF12	Fibroblast growth factor 12	GO:0008201; F:heparin binding; IDA:MGI
P61328	FGF12	Fibroblast growth factor 12	GO:0044325; F:ion channel binding; ISS:BHF-UCL
P61328	FGF12	Fibroblast growth factor 12	GO:0017080; F:sodium channel regulator activity; ISS:BHF-UCL
P61328	FGF12	Fibroblast growth factor 12	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P61328	FGF12	Fibroblast growth factor 12	GO:0086002; P:cardiac muscle cell action potential involved in contraction; NAS:BHF-UCL
P61328	FGF12	Fibroblast growth factor 12	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P61328	FGF12	Fibroblast growth factor 12	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IEA:InterPro
P61328	FGF12	Fibroblast growth factor 12	GO:0007507; P:heart development; TAS:ProtInc
P61328	FGF12	Fibroblast growth factor 12	GO:0007254; P:JNK cascade; IPI:MGI
P61328	FGF12	Fibroblast growth factor 12	GO:2001258; P:negative regulation of cation channel activity; IEA:Ensembl
P61328	FGF12	Fibroblast growth factor 12	GO:0007399; P:nervous system development; TAS:ProtInc
P61328	FGF12	Fibroblast growth factor 12	GO:0050905; P:neuromuscular process; IEA:Ensembl
P61328	FGF12	Fibroblast growth factor 12	GO:0010765; P:positive regulation of sodium ion transport; IEA:Ensembl
P61328	FGF12	Fibroblast growth factor 12	GO:0003254; P:regulation of membrane depolarization; IEA:Ensembl
P61328	FGF12	Fibroblast growth factor 12	GO:1902305; P:regulation of sodium ion transmembrane transport; ISS:BHF-UCL
P61328	FGF12	Fibroblast growth factor 12	GO:2000649; P:regulation of sodium ion transmembrane transporter activity; ISS:BHF-UCL
P61328	FGF12	Fibroblast growth factor 12	GO:0007165; P:signal transduction; TAS:ProtInc
P61328	FGF12	Fibroblast growth factor 12	GO:0007268; P:synaptic transmission; IEA:Ensembl
Q92914	FGF11	Fibroblast growth factor 11	GO:0008083; F:growth factor activity; TAS:ProtInc
Q92914	FGF11	Fibroblast growth factor 11	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q92914	FGF11	Fibroblast growth factor 11	GO:0007399; P:nervous system development; TAS:ProtInc
Q92914	FGF11	Fibroblast growth factor 11	GO:0007165; P:signal transduction; TAS:ProtInc
O43320	FGF16	Fibroblast growth factor 16	GO:0008083; F:growth factor activity; TAS:ProtInc
O43320	FGF16	Fibroblast growth factor 16	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O43320	FGF16	Fibroblast growth factor 16	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O43320	FGF16	Fibroblast growth factor 16	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O43320	FGF16	Fibroblast growth factor 16	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
O43320	FGF16	Fibroblast growth factor 16	GO:0045087; P:innate immune response; TAS:Reactome
O43320	FGF16	Fibroblast growth factor 16	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
O43320	FGF16	Fibroblast growth factor 16	GO:0008152; P:metabolic process; TAS:ProtInc
O43320	FGF16	Fibroblast growth factor 16	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O43320	FGF16	Fibroblast growth factor 16	GO:0009887; P:organ morphogenesis; TAS:ProtInc
O43320	FGF16	Fibroblast growth factor 16	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
O43320	FGF16	Fibroblast growth factor 16	GO:0009266; P:response to temperature stimulus; TAS:ProtInc
O43320	FGF16	Fibroblast growth factor 16	GO:0007165; P:signal transduction; TAS:ProtInc
O60258	FGF17	Fibroblast growth factor 17	GO:0008083; F:growth factor activity; TAS:ProtInc
O60258	FGF17	Fibroblast growth factor 17	GO:0005105; F:type 1 fibroblast growth factor receptor binding; IDA:UniProtKB
O60258	FGF17	Fibroblast growth factor 17	GO:0005111; F:type 2 fibroblast growth factor receptor binding; IDA:UniProtKB
O60258	FGF17	Fibroblast growth factor 17	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O60258	FGF17	Fibroblast growth factor 17	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O60258	FGF17	Fibroblast growth factor 17	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O60258	FGF17	Fibroblast growth factor 17	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
O60258	FGF17	Fibroblast growth factor 17	GO:0045087; P:innate immune response; TAS:Reactome
O60258	FGF17	Fibroblast growth factor 17	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
O60258	FGF17	Fibroblast growth factor 17	GO:0007399; P:nervous system development; TAS:ProtInc
O60258	FGF17	Fibroblast growth factor 17	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O60258	FGF17	Fibroblast growth factor 17	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
O60258	FGF17	Fibroblast growth factor 17	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
O60258	FGF17	Fibroblast growth factor 17	GO:0007165; P:signal transduction; TAS:ProtInc
Q92913	FGF13	Fibroblast growth factor 13	GO:0048487; F:beta-tubulin binding; ISS:UniProtKB
Q92913	FGF13	Fibroblast growth factor 13	GO:0008083; F:growth factor activity; TAS:ProtInc
Q92913	FGF13	Fibroblast growth factor 13	GO:0044325; F:ion channel binding; ISS:UniProtKB
Q92913	FGF13	Fibroblast growth factor 13	GO:0008017; F:microtubule binding; ISS:UniProtKB
Q92913	FGF13	Fibroblast growth factor 13	GO:0005515; F:protein binding; IPI:UniProtKB
Q92913	FGF13	Fibroblast growth factor 13	GO:0030295; F:protein kinase activator activity; IGI:MGI
Q92913	FGF13	Fibroblast growth factor 13	GO:0017080; F:sodium channel regulator activity; IDA:UniProtKB
Q92913	FGF13	Fibroblast growth factor 13	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q92913	FGF13	Fibroblast growth factor 13	GO:0021795; P:cerebral cortex cell migration; ISS:UniProtKB
Q92913	FGF13	Fibroblast growth factor 13	GO:0045200; P:establishment of neuroblast polarity; ISS:UniProtKB
Q92913	FGF13	Fibroblast growth factor 13	GO:0021766; P:hippocampus development; ISS:UniProtKB
Q92913	FGF13	Fibroblast growth factor 13	GO:0007612; P:learning; ISS:UniProtKB
Q92913	FGF13	Fibroblast growth factor 13	GO:0000165; P:MAPK cascade; IDA:MGI
Q92913	FGF13	Fibroblast growth factor 13	GO:0007613; P:memory; ISS:UniProtKB
Q92913	FGF13	Fibroblast growth factor 13	GO:0046785; P:microtubule polymerization; ISS:UniProtKB
Q92913	FGF13	Fibroblast growth factor 13	GO:0048671; P:negative regulation of collateral sprouting; ISS:UniProtKB
Q92913	FGF13	Fibroblast growth factor 13	GO:0007026; P:negative regulation of microtubule depolymerization; ISS:UniProtKB
Q92913	FGF13	Fibroblast growth factor 13	GO:0007399; P:nervous system development; TAS:ProtInc
Q92913	FGF13	Fibroblast growth factor 13	GO:0001764; P:neuron migration; ISS:UniProtKB
Q92913	FGF13	Fibroblast growth factor 13	GO:0045860; P:positive regulation of protein kinase activity; IGI:GOC
Q92913	FGF13	Fibroblast growth factor 13	GO:0072659; P:protein localization to plasma membrane; ISS:UniProtKB
Q92913	FGF13	Fibroblast growth factor 13	GO:0007165; P:signal transduction; TAS:ProtInc
O15520	FGF10	Fibroblast growth factor 10	GO:0042056; F:chemoattractant activity; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0005104; F:fibroblast growth factor receptor binding; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0008083; F:growth factor activity; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0008201; F:heparin binding; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0005111; F:type 2 fibroblast growth factor receptor binding; IPI:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0031532; P:actin cytoskeleton reorganization; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0000187; P:activation of MAPK activity; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0001525; P:angiogenesis; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0060667; P:branch elongation involved in salivary gland morphogenesis; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0048754; P:branching morphogenesis of an epithelial tube; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0060436; P:bronchiole morphogenesis; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0060447; P:bud outgrowth involved in lung branching; IDA:MGI
O15520	FGF10	Fibroblast growth factor 10	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0031076; P:embryonic camera-type eye development; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0048557; P:embryonic digestive tract morphogenesis; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0030538; P:embryonic genitalia morphogenesis; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0009880; P:embryonic pattern specification; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O15520	FGF10	Fibroblast growth factor 10	GO:0010631; P:epithelial cell migration; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0050673; P:epithelial cell proliferation; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0060664; P:epithelial cell proliferation involved in salivary gland morphogenesis; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0070371; P:ERK1 and ERK2 cascade; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O15520	FGF10	Fibroblast growth factor 10	GO:0048807; P:female genitalia morphogenesis; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
O15520	FGF10	Fibroblast growth factor 10	GO:0060595; P:fibroblast growth factor receptor signaling pathway involved in mammary gland specification; IDA:MGI
O15520	FGF10	Fibroblast growth factor 10	GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0070384; P:Harderian gland development; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0050930; P:induction of positive chemotaxis; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0045087; P:innate immune response; TAS:Reactome
O15520	FGF10	Fibroblast growth factor 10	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
O15520	FGF10	Fibroblast growth factor 10	GO:0043616; P:keratinocyte proliferation; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0032808; P:lacrimal gland development; IMP:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0060174; P:limb bud formation; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0060428; P:lung epithelium development; IDA:MGI
O15520	FGF10	Fibroblast growth factor 10	GO:0061115; P:lung proximal/distal axis specification; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0060430; P:lung saccule development; IMP:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0048808; P:male genitalia morphogenesis; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0060615; P:mammary gland bud formation; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0060915; P:mesenchymal cell differentiation involved in lung development; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0060496; P:mesenchymal-epithelial cell signaling involved in lung development; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0001823; P:mesonephros development; IEP:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0001656; P:metanephros development; IEP:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0003338; P:metanephros morphogenesis; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0042693; P:muscle cell fate commitment; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0071157; P:negative regulation of cell cycle arrest; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O15520	FGF10	Fibroblast growth factor 10	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0001759; P:organ induction; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0030916; P:otic vesicle formation; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0031016; P:pancreas development; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
O15520	FGF10	Fibroblast growth factor 10	GO:0021983; P:pituitary gland development; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0050918; P:positive chemotaxis; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0032781; P:positive regulation of ATPase activity; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0031659; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0045739; P:positive regulation of DNA repair; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0045740; P:positive regulation of DNA replication; IMP:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0010634; P:positive regulation of epithelial cell migration; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0060054; P:positive regulation of epithelial cell proliferation involved in wound healing; NAS:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0071338; P:positive regulation of hair follicle cell proliferation; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0051549; P:positive regulation of keratinocyte migration; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0010838; P:positive regulation of keratinocyte proliferation; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0050671; P:positive regulation of lymphocyte proliferation; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0043410; P:positive regulation of MAPK cascade; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0045931; P:positive regulation of mitotic cell cycle; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0045747; P:positive regulation of Notch signaling pathway; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0046579; P:positive regulation of Ras protein signal transduction; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0050677; P:positive regulation of urothelial cell proliferation; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0070352; P:positive regulation of white fat cell proliferation; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0034394; P:protein localization to cell surface; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0060019; P:radial glial cell differentiation; ISS:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0032925; P:regulation of activin receptor signaling pathway; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0060665; P:regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0060685; P:regulation of prostatic bud formation; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0046877; P:regulation of saliva secretion; IMP:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0008589; P:regulation of smoothened signaling pathway; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0032355; P:response to estradiol; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0007431; P:salivary gland development; IMP:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0061033; P:secretion by lung epithelial cell involved in lung growth; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0060879; P:semicircular canal fusion; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0051145; P:smooth muscle cell differentiation; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0048536; P:spleen development; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0060661; P:submandibular salivary gland formation; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0070075; P:tear secretion; IMP:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0048538; P:thymus development; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0030878; P:thyroid gland development; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0042246; P:tissue regeneration; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0060510; P:Type II pneumocyte differentiation; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0050674; P:urothelial cell proliferation; IDA:UniProtKB
O15520	FGF10	Fibroblast growth factor 10	GO:0050872; P:white fat cell differentiation; IEA:Ensembl
O15520	FGF10	Fibroblast growth factor 10	GO:0042060; P:wound healing; IDA:UniProtKB
Q92915	FGF14	Fibroblast growth factor 14	GO:0008083; F:growth factor activity; TAS:ProtInc
Q92915	FGF14	Fibroblast growth factor 14	GO:0008201; F:heparin binding; IDA:MGI
Q92915	FGF14	Fibroblast growth factor 14	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
Q92915	FGF14	Fibroblast growth factor 14	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q92915	FGF14	Fibroblast growth factor 14	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q92915	FGF14	Fibroblast growth factor 14	GO:0007254; P:JNK cascade; IPI:MGI
Q92915	FGF14	Fibroblast growth factor 14	GO:0007399; P:nervous system development; TAS:ProtInc
Q92915	FGF14	Fibroblast growth factor 14	GO:0050905; P:neuromuscular process; IEA:Ensembl
Q92915	FGF14	Fibroblast growth factor 14	GO:0010765; P:positive regulation of sodium ion transport; IEA:Ensembl
Q92915	FGF14	Fibroblast growth factor 14	GO:0007165; P:signal transduction; TAS:ProtInc
Q92915	FGF14	Fibroblast growth factor 14	GO:0007268; P:synaptic transmission; IEA:Ensembl
O95750	FGF19	Fibroblast growth factor 19	GO:0005104; F:fibroblast growth factor receptor binding; IPI:UniProtKB
O95750	FGF19	Fibroblast growth factor 19	GO:0005515; F:protein binding; IPI:UniProtKB
O95750	FGF19	Fibroblast growth factor 19	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O95750	FGF19	Fibroblast growth factor 19	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O95750	FGF19	Fibroblast growth factor 19	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IGI:MGI
O95750	FGF19	Fibroblast growth factor 19	GO:0007507; P:heart development; IEA:Ensembl
O95750	FGF19	Fibroblast growth factor 19	GO:0045087; P:innate immune response; TAS:Reactome
O95750	FGF19	Fibroblast growth factor 19	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
O95750	FGF19	Fibroblast growth factor 19	GO:0070858; P:negative regulation of bile acid biosynthetic process; IDA:UniProtKB
O95750	FGF19	Fibroblast growth factor 19	GO:0007399; P:nervous system development; TAS:ProtInc
O95750	FGF19	Fibroblast growth factor 19	GO:0001755; P:neural crest cell migration; IEA:Ensembl
O95750	FGF19	Fibroblast growth factor 19	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O95750	FGF19	Fibroblast growth factor 19	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
O95750	FGF19	Fibroblast growth factor 19	GO:0008284; P:positive regulation of cell proliferation; IGI:MGI
O95750	FGF19	Fibroblast growth factor 19	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
O95750	FGF19	Fibroblast growth factor 19	GO:0046326; P:positive regulation of glucose import; IDA:UniProtKB
O95750	FGF19	Fibroblast growth factor 19	GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB
O76093	FGF18	Fibroblast growth factor 18	GO:0008083; F:growth factor activity; TAS:ProtInc
O76093	FGF18	Fibroblast growth factor 18	GO:0005105; F:type 1 fibroblast growth factor receptor binding; IDA:UniProtKB
O76093	FGF18	Fibroblast growth factor 18	GO:0005111; F:type 2 fibroblast growth factor receptor binding; IDA:UniProtKB
O76093	FGF18	Fibroblast growth factor 18	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
O76093	FGF18	Fibroblast growth factor 18	GO:0001525; P:angiogenesis; IEA:Ensembl
O76093	FGF18	Fibroblast growth factor 18	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O76093	FGF18	Fibroblast growth factor 18	GO:0002063; P:chondrocyte development; IEA:Ensembl
O76093	FGF18	Fibroblast growth factor 18	GO:0001958; P:endochondral ossification; IEA:Ensembl
O76093	FGF18	Fibroblast growth factor 18	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O76093	FGF18	Fibroblast growth factor 18	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O76093	FGF18	Fibroblast growth factor 18	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
O76093	FGF18	Fibroblast growth factor 18	GO:0045087; P:innate immune response; TAS:Reactome
O76093	FGF18	Fibroblast growth factor 18	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
O76093	FGF18	Fibroblast growth factor 18	GO:0001957; P:intramembranous ossification; IEA:Ensembl
O76093	FGF18	Fibroblast growth factor 18	GO:0030324; P:lung development; IEA:Ensembl
O76093	FGF18	Fibroblast growth factor 18	GO:0007399; P:nervous system development; IEA:Ensembl
O76093	FGF18	Fibroblast growth factor 18	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O76093	FGF18	Fibroblast growth factor 18	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
O76093	FGF18	Fibroblast growth factor 18	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
O76093	FGF18	Fibroblast growth factor 18	GO:0032332; P:positive regulation of chondrocyte differentiation; IEA:Ensembl
O76093	FGF18	Fibroblast growth factor 18	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl
O76093	FGF18	Fibroblast growth factor 18	GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; IEA:Ensembl
O76093	FGF18	Fibroblast growth factor 18	GO:0007165; P:signal transduction; TAS:ProtInc
P05230	FGF1	Fibroblast growth factor 1	GO:0005104; F:fibroblast growth factor receptor binding; IPI:MGI
P05230	FGF1	Fibroblast growth factor 1	GO:0008083; F:growth factor activity; IDA:UniProtKB
P05230	FGF1	Fibroblast growth factor 1	GO:0008201; F:heparin binding; IDA:UniProtKB
P05230	FGF1	Fibroblast growth factor 1	GO:0005515; F:protein binding; IPI:IntAct
P05230	FGF1	Fibroblast growth factor 1	GO:0044548; F:S100 protein binding; IPI:UniProtKB
P05230	FGF1	Fibroblast growth factor 1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P05230	FGF1	Fibroblast growth factor 1	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P05230	FGF1	Fibroblast growth factor 1	GO:0060681; P:branch elongation involved in ureteric bud branching; IDA:UniProtKB
P05230	FGF1	Fibroblast growth factor 1	GO:0034605; P:cellular response to heat; IDA:UniProtKB
P05230	FGF1	Fibroblast growth factor 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P05230	FGF1	Fibroblast growth factor 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P05230	FGF1	Fibroblast growth factor 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IDA:UniProtKB
P05230	FGF1	Fibroblast growth factor 1	GO:0045087; P:innate immune response; TAS:Reactome
P05230	FGF1	Fibroblast growth factor 1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P05230	FGF1	Fibroblast growth factor 1	GO:0030324; P:lung development; IEA:Ensembl
P05230	FGF1	Fibroblast growth factor 1	GO:0072163; P:mesonephric epithelium development; IDA:UniProtKB
P05230	FGF1	Fibroblast growth factor 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P05230	FGF1	Fibroblast growth factor 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P05230	FGF1	Fibroblast growth factor 1	GO:0001759; P:organ induction; IEA:Ensembl
P05230	FGF1	Fibroblast growth factor 1	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P05230	FGF1	Fibroblast growth factor 1	GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB
P05230	FGF1	Fibroblast growth factor 1	GO:0051781; P:positive regulation of cell division; IDA:UniProtKB
P05230	FGF1	Fibroblast growth factor 1	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
P05230	FGF1	Fibroblast growth factor 1	GO:0008284; P:positive regulation of cell proliferation; IGI:MGI
P05230	FGF1	Fibroblast growth factor 1	GO:0045542; P:positive regulation of cholesterol biosynthetic process; IDA:BHF-UCL
P05230	FGF1	Fibroblast growth factor 1	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
P05230	FGF1	Fibroblast growth factor 1	GO:1902533; P:positive regulation of intracellular signal transduction; IDA:BHF-UCL
P05230	FGF1	Fibroblast growth factor 1	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
P05230	FGF1	Fibroblast growth factor 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P05230	FGF1	Fibroblast growth factor 1	GO:0007165; P:signal transduction; NAS:ProtInc
Q9NP95	FGF20	Fibroblast growth factor 20	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9NP95	FGF20	Fibroblast growth factor 20	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q9NP95	FGF20	Fibroblast growth factor 20	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9NP95	FGF20	Fibroblast growth factor 20	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q9NP95	FGF20	Fibroblast growth factor 20	GO:0045087; P:innate immune response; TAS:Reactome
Q9NP95	FGF20	Fibroblast growth factor 20	GO:0060113; P:inner ear receptor cell differentiation; IEA:Ensembl
Q9NP95	FGF20	Fibroblast growth factor 20	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q9NP95	FGF20	Fibroblast growth factor 20	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9NP95	FGF20	Fibroblast growth factor 20	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q9NP95	FGF20	Fibroblast growth factor 20	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q9NP95	FGF20	Fibroblast growth factor 20	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl
Q9NP95	FGF20	Fibroblast growth factor 20	GO:0060043; P:regulation of cardiac muscle cell proliferation; IEA:Ensembl
Q9NP95	FGF20	Fibroblast growth factor 20	GO:0007165; P:signal transduction; TAS:ProtInc
Q9HCT0	FGF22	Fibroblast growth factor 22	GO:0030154; P:cell differentiation; NAS:UniProtKB
Q9HCT0	FGF22	Fibroblast growth factor 22	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q9HCT0	FGF22	Fibroblast growth factor 22	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9HCT0	FGF22	Fibroblast growth factor 22	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q9HCT0	FGF22	Fibroblast growth factor 22	GO:0045087; P:innate immune response; TAS:Reactome
Q9HCT0	FGF22	Fibroblast growth factor 22	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q9HCT0	FGF22	Fibroblast growth factor 22	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9HCT0	FGF22	Fibroblast growth factor 22	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q9GZV9	FGF23	Fibroblast growth factor 23	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9GZV9	FGF23	Fibroblast growth factor 23	GO:0030643; P:cellular phosphate ion homeostasis; IEA:Ensembl
Q9GZV9	FGF23	Fibroblast growth factor 23	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q9GZV9	FGF23	Fibroblast growth factor 23	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9GZV9	FGF23	Fibroblast growth factor 23	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q9GZV9	FGF23	Fibroblast growth factor 23	GO:0045087; P:innate immune response; TAS:Reactome
Q9GZV9	FGF23	Fibroblast growth factor 23	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q9GZV9	FGF23	Fibroblast growth factor 23	GO:0030502; P:negative regulation of bone mineralization; IDA:UniProtKB
Q9GZV9	FGF23	Fibroblast growth factor 23	GO:0046888; P:negative regulation of hormone secretion; ISS:UniProtKB
Q9GZV9	FGF23	Fibroblast growth factor 23	GO:0045668; P:negative regulation of osteoblast differentiation; IDA:UniProtKB
Q9GZV9	FGF23	Fibroblast growth factor 23	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9GZV9	FGF23	Fibroblast growth factor 23	GO:0055062; P:phosphate ion homeostasis; IMP:UniProtKB
Q9GZV9	FGF23	Fibroblast growth factor 23	GO:0006796; P:phosphate-containing compound metabolic process; IEA:Ensembl
Q9GZV9	FGF23	Fibroblast growth factor 23	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q9GZV9	FGF23	Fibroblast growth factor 23	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl
Q9GZV9	FGF23	Fibroblast growth factor 23	GO:0090080; P:positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway; IEA:Ensembl
Q9GZV9	FGF23	Fibroblast growth factor 23	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q9GZV9	FGF23	Fibroblast growth factor 23	GO:0010980; P:positive regulation of vitamin D 24-hydroxylase activity; IDA:UniProtKB
Q9GZV9	FGF23	Fibroblast growth factor 23	GO:0010966; P:regulation of phosphate transport; IDA:UniProtKB
Q9GZV9	FGF23	Fibroblast growth factor 23	GO:0042369; P:vitamin D catabolic process; IDA:UniProtKB
Q9NSA1	FGF21	Fibroblast growth factor 21	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NSA1	FGF21	Fibroblast growth factor 21	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9NSA1	FGF21	Fibroblast growth factor 21	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q9NSA1	FGF21	Fibroblast growth factor 21	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
Q9NSA1	FGF21	Fibroblast growth factor 21	GO:0046326; P:positive regulation of glucose import; IDA:UniProtKB
Q9NSA1	FGF21	Fibroblast growth factor 21	GO:0045716; P:positive regulation of low-density lipoprotein particle receptor biosynthetic process; NAS:BHF-UCL
Q9NSA1	FGF21	Fibroblast growth factor 21	GO:0090080; P:positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway; IEA:Ensembl
Q9NSA1	FGF21	Fibroblast growth factor 21	GO:0010988; P:regulation of low-density lipoprotein particle clearance; NAS:BHF-UCL
Q9NSA1	FGF21	Fibroblast growth factor 21	GO:0007165; P:signal transduction; TAS:ProtInc
P09038	FGF2	Fibroblast growth factor 2	GO:0042056; F:chemoattractant activity; IDA:BHF-UCL
P09038	FGF2	Fibroblast growth factor 2	GO:0005125; F:cytokine activity; IDA:BHF-UCL
P09038	FGF2	Fibroblast growth factor 2	GO:0005104; F:fibroblast growth factor receptor binding; IPI:MGI
P09038	FGF2	Fibroblast growth factor 2	GO:0008083; F:growth factor activity; IDA:BHF-UCL
P09038	FGF2	Fibroblast growth factor 2	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P09038	FGF2	Fibroblast growth factor 2	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IDA:UniProtKB
P09038	FGF2	Fibroblast growth factor 2	GO:0005515; F:protein binding; IPI:UniProtKB
P09038	FGF2	Fibroblast growth factor 2	GO:0000187; P:activation of MAPK activity; TAS:ProtInc
P09038	FGF2	Fibroblast growth factor 2	GO:0000186; P:activation of MAPKK activity; IEA:Ensembl
P09038	FGF2	Fibroblast growth factor 2	GO:0001658; P:branching involved in ureteric bud morphogenesis; IDA:UniProtKB
P09038	FGF2	Fibroblast growth factor 2	GO:0006700; P:C21-steroid hormone biosynthetic process; IEA:Ensembl
P09038	FGF2	Fibroblast growth factor 2	GO:0002042; P:cell migration involved in sprouting angiogenesis; IDA:BHF-UCL
P09038	FGF2	Fibroblast growth factor 2	GO:0006935; P:chemotaxis; TAS:ProtInc
P09038	FGF2	Fibroblast growth factor 2	GO:0060591; P:chondroblast differentiation; IDA:UniProtKB
P09038	FGF2	Fibroblast growth factor 2	GO:0060128; P:corticotropin hormone secreting cell differentiation; IEA:Ensembl
P09038	FGF2	Fibroblast growth factor 2	GO:0048598; P:embryonic morphogenesis; TAS:DFLAT
P09038	FGF2	Fibroblast growth factor 2	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P09038	FGF2	Fibroblast growth factor 2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P09038	FGF2	Fibroblast growth factor 2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P09038	FGF2	Fibroblast growth factor 2	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IDA:UniProtKB
P09038	FGF2	Fibroblast growth factor 2	GO:0010001; P:glial cell differentiation; IEA:Ensembl
P09038	FGF2	Fibroblast growth factor 2	GO:0030214; P:hyaluronan catabolic process; IDA:UniProtKB
P09038	FGF2	Fibroblast growth factor 2	GO:0045087; P:innate immune response; TAS:Reactome
P09038	FGF2	Fibroblast growth factor 2	GO:0032958; P:inositol phosphate biosynthetic process; IDA:DFLAT
P09038	FGF2	Fibroblast growth factor 2	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P09038	FGF2	Fibroblast growth factor 2	GO:0030324; P:lung development; IEA:Ensembl
P09038	FGF2	Fibroblast growth factor 2	GO:0060644; P:mammary gland epithelial cell differentiation; IEA:Ensembl
P09038	FGF2	Fibroblast growth factor 2	GO:0000189; P:MAPK import into nucleus; IEA:Ensembl
P09038	FGF2	Fibroblast growth factor 2	GO:0043537; P:negative regulation of blood vessel endothelial cell migration; IDA:BHF-UCL
P09038	FGF2	Fibroblast growth factor 2	GO:0060548; P:negative regulation of cell death; IDA:UniProtKB
P09038	FGF2	Fibroblast growth factor 2	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
P09038	FGF2	Fibroblast growth factor 2	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P09038	FGF2	Fibroblast growth factor 2	GO:0010764; P:negative regulation of fibroblast migration; IDA:UniProtKB
P09038	FGF2	Fibroblast growth factor 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
P09038	FGF2	Fibroblast growth factor 2	GO:0061045; P:negative regulation of wound healing; IDA:UniProtKB
P09038	FGF2	Fibroblast growth factor 2	GO:0007399; P:nervous system development; TAS:ProtInc
P09038	FGF2	Fibroblast growth factor 2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P09038	FGF2	Fibroblast growth factor 2	GO:0001759; P:organ induction; IEA:Ensembl
P09038	FGF2	Fibroblast growth factor 2	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P09038	FGF2	Fibroblast growth factor 2	GO:0006661; P:phosphatidylinositol biosynthetic process; IDA:DFLAT
P09038	FGF2	Fibroblast growth factor 2	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P09038	FGF2	Fibroblast growth factor 2	GO:0050918; P:positive chemotaxis; IDA:GOC
P09038	FGF2	Fibroblast growth factor 2	GO:0045766; P:positive regulation of angiogenesis; IDA:DFLAT
P09038	FGF2	Fibroblast growth factor 2	GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IDA:BHF-UCL
P09038	FGF2	Fibroblast growth factor 2	GO:0060045; P:positive regulation of cardiac muscle cell proliferation; IDA:BHF-UCL
P09038	FGF2	Fibroblast growth factor 2	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P09038	FGF2	Fibroblast growth factor 2	GO:0042660; P:positive regulation of cell fate specification; IDA:MGI
P09038	FGF2	Fibroblast growth factor 2	GO:0008284; P:positive regulation of cell proliferation; IGI:MGI
P09038	FGF2	Fibroblast growth factor 2	GO:0021940; P:positive regulation of cerebellar granule cell precursor proliferation; IEA:Ensembl
P09038	FGF2	Fibroblast growth factor 2	GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:BHF-UCL
P09038	FGF2	Fibroblast growth factor 2	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P09038	FGF2	Fibroblast growth factor 2	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
P09038	FGF2	Fibroblast growth factor 2	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IDA:DFLAT
P09038	FGF2	Fibroblast growth factor 2	GO:0010863; P:positive regulation of phospholipase C activity; IDA:DFLAT
P09038	FGF2	Fibroblast growth factor 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P09038	FGF2	Fibroblast growth factor 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P09038	FGF2	Fibroblast growth factor 2	GO:0007265; P:Ras protein signal transduction; TAS:ProtInc
P09038	FGF2	Fibroblast growth factor 2	GO:0045765; P:regulation of angiogenesis; TAS:DFLAT
P09038	FGF2	Fibroblast growth factor 2	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
P09038	FGF2	Fibroblast growth factor 2	GO:0046668; P:regulation of retinal cell programmed cell death; IEA:Ensembl
P09038	FGF2	Fibroblast growth factor 2	GO:0051209; P:release of sequestered calcium ion into cytosol; IDA:DFLAT
P09038	FGF2	Fibroblast growth factor 2	GO:0048678; P:response to axon injury; IEA:Ensembl
P09038	FGF2	Fibroblast growth factor 2	GO:0007165; P:signal transduction; NAS:ProtInc
P09038	FGF2	Fibroblast growth factor 2	GO:0048864; P:stem cell development; IEA:Ensembl
P09038	FGF2	Fibroblast growth factor 2	GO:0021762; P:substantia nigra development; IEA:Ensembl
P09038	FGF2	Fibroblast growth factor 2	GO:0060129; P:thyroid-stimulating hormone-secreting cell differentiation; IEA:Ensembl
P09038	FGF2	Fibroblast growth factor 2	GO:0042060; P:wound healing; TAS:DFLAT
P11487	FGF3	Fibroblast growth factor 3	GO:0008083; F:growth factor activity; TAS:ProtInc
P11487	FGF3	Fibroblast growth factor 3	GO:0005515; F:protein binding; IPI:UniProtKB
P11487	FGF3	Fibroblast growth factor 3	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P11487	FGF3	Fibroblast growth factor 3	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P11487	FGF3	Fibroblast growth factor 3	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P11487	FGF3	Fibroblast growth factor 3	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P11487	FGF3	Fibroblast growth factor 3	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IGI:MGI
P11487	FGF3	Fibroblast growth factor 3	GO:0045087; P:innate immune response; TAS:Reactome
P11487	FGF3	Fibroblast growth factor 3	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P11487	FGF3	Fibroblast growth factor 3	GO:0055026; P:negative regulation of cardiac muscle tissue development; IMP:BHF-UCL
P11487	FGF3	Fibroblast growth factor 3	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P11487	FGF3	Fibroblast growth factor 3	GO:0001759; P:organ induction; IEA:Ensembl
P11487	FGF3	Fibroblast growth factor 3	GO:0030916; P:otic vesicle formation; IEA:Ensembl
P11487	FGF3	Fibroblast growth factor 3	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P11487	FGF3	Fibroblast growth factor 3	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P11487	FGF3	Fibroblast growth factor 3	GO:0008284; P:positive regulation of cell proliferation; IGI:MGI
P11487	FGF3	Fibroblast growth factor 3	GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl
P11487	FGF3	Fibroblast growth factor 3	GO:0048752; P:semicircular canal morphogenesis; IEA:Ensembl
P11487	FGF3	Fibroblast growth factor 3	GO:0007165; P:signal transduction; TAS:ProtInc
P11487	FGF3	Fibroblast growth factor 3	GO:0048538; P:thymus development; IEA:Ensembl
P08620	FGF4	Fibroblast growth factor 4	GO:0008083; F:growth factor activity; TAS:ProtInc
P08620	FGF4	Fibroblast growth factor 4	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P08620	FGF4	Fibroblast growth factor 4	GO:0060561; P:apoptotic process involved in morphogenesis; IEA:Ensembl
P08620	FGF4	Fibroblast growth factor 4	GO:0001502; P:cartilage condensation; IEA:Ensembl
P08620	FGF4	Fibroblast growth factor 4	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P08620	FGF4	Fibroblast growth factor 4	GO:0060591; P:chondroblast differentiation; IDA:UniProtKB
P08620	FGF4	Fibroblast growth factor 4	GO:0060363; P:cranial suture morphogenesis; IEA:Ensembl
P08620	FGF4	Fibroblast growth factor 4	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
P08620	FGF4	Fibroblast growth factor 4	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P08620	FGF4	Fibroblast growth factor 4	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P08620	FGF4	Fibroblast growth factor 4	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IGI:MGI
P08620	FGF4	Fibroblast growth factor 4	GO:0045087; P:innate immune response; TAS:Reactome
P08620	FGF4	Fibroblast growth factor 4	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P08620	FGF4	Fibroblast growth factor 4	GO:0010463; P:mesenchymal cell proliferation; IDA:UniProtKB
P08620	FGF4	Fibroblast growth factor 4	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P08620	FGF4	Fibroblast growth factor 4	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P08620	FGF4	Fibroblast growth factor 4	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
P08620	FGF4	Fibroblast growth factor 4	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P08620	FGF4	Fibroblast growth factor 4	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P08620	FGF4	Fibroblast growth factor 4	GO:0008284; P:positive regulation of cell proliferation; IGI:MGI
P08620	FGF4	Fibroblast growth factor 4	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P08620	FGF4	Fibroblast growth factor 4	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
P08620	FGF4	Fibroblast growth factor 4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P08620	FGF4	Fibroblast growth factor 4	GO:0007165; P:signal transduction; TAS:ProtInc
P08620	FGF4	Fibroblast growth factor 4	GO:0019827; P:stem cell maintenance; IEA:Ensembl
P12034	FGF5	Fibroblast growth factor 5	GO:0005104; F:fibroblast growth factor receptor binding; IDA:MGI
P12034	FGF5	Fibroblast growth factor 5	GO:0008283; P:cell proliferation; TAS:ProtInc
P12034	FGF5	Fibroblast growth factor 5	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P12034	FGF5	Fibroblast growth factor 5	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P12034	FGF5	Fibroblast growth factor 5	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P12034	FGF5	Fibroblast growth factor 5	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IDA:MGI
P12034	FGF5	Fibroblast growth factor 5	GO:0010001; P:glial cell differentiation; IEA:Ensembl
P12034	FGF5	Fibroblast growth factor 5	GO:0045087; P:innate immune response; TAS:Reactome
P12034	FGF5	Fibroblast growth factor 5	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P12034	FGF5	Fibroblast growth factor 5	GO:0007399; P:nervous system development; TAS:ProtInc
P12034	FGF5	Fibroblast growth factor 5	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P12034	FGF5	Fibroblast growth factor 5	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P12034	FGF5	Fibroblast growth factor 5	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P12034	FGF5	Fibroblast growth factor 5	GO:0008284; P:positive regulation of cell proliferation; IDA:MGI
P12034	FGF5	Fibroblast growth factor 5	GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl
P10767	FGF6	Fibroblast growth factor 6	GO:0008083; F:growth factor activity; TAS:ProtInc
P10767	FGF6	Fibroblast growth factor 6	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P10767	FGF6	Fibroblast growth factor 6	GO:0001502; P:cartilage condensation; IEA:Ensembl
P10767	FGF6	Fibroblast growth factor 6	GO:0008283; P:cell proliferation; TAS:ProtInc
P10767	FGF6	Fibroblast growth factor 6	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P10767	FGF6	Fibroblast growth factor 6	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P10767	FGF6	Fibroblast growth factor 6	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P10767	FGF6	Fibroblast growth factor 6	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IGI:MGI
P10767	FGF6	Fibroblast growth factor 6	GO:0045087; P:innate immune response; TAS:Reactome
P10767	FGF6	Fibroblast growth factor 6	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P10767	FGF6	Fibroblast growth factor 6	GO:0045445; P:myoblast differentiation; IEA:Ensembl
P10767	FGF6	Fibroblast growth factor 6	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P10767	FGF6	Fibroblast growth factor 6	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P10767	FGF6	Fibroblast growth factor 6	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P10767	FGF6	Fibroblast growth factor 6	GO:0008284; P:positive regulation of cell proliferation; IGI:MGI
P10767	FGF6	Fibroblast growth factor 6	GO:0007165; P:signal transduction; TAS:ProtInc
P21781	FGF7	Fibroblast growth factor 7	GO:0042056; F:chemoattractant activity; IDA:UniProtKB
P21781	FGF7	Fibroblast growth factor 7	GO:0008083; F:growth factor activity; TAS:ProtInc
P21781	FGF7	Fibroblast growth factor 7	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P21781	FGF7	Fibroblast growth factor 7	GO:0005515; F:protein binding; IPI:IntAct
P21781	FGF7	Fibroblast growth factor 7	GO:0031532; P:actin cytoskeleton reorganization; IDA:UniProtKB
P21781	FGF7	Fibroblast growth factor 7	GO:0060445; P:branching involved in salivary gland morphogenesis; IEA:Ensembl
P21781	FGF7	Fibroblast growth factor 7	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P21781	FGF7	Fibroblast growth factor 7	GO:0008544; P:epidermis development; TAS:ProtInc
P21781	FGF7	Fibroblast growth factor 7	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P21781	FGF7	Fibroblast growth factor 7	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IGI:MGI
P21781	FGF7	Fibroblast growth factor 7	GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl
P21781	FGF7	Fibroblast growth factor 7	GO:0045087; P:innate immune response; TAS:Reactome
P21781	FGF7	Fibroblast growth factor 7	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P21781	FGF7	Fibroblast growth factor 7	GO:0010463; P:mesenchymal cell proliferation; IDA:UniProtKB
P21781	FGF7	Fibroblast growth factor 7	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P21781	FGF7	Fibroblast growth factor 7	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P21781	FGF7	Fibroblast growth factor 7	GO:0050918; P:positive chemotaxis; IDA:UniProtKB
P21781	FGF7	Fibroblast growth factor 7	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P21781	FGF7	Fibroblast growth factor 7	GO:0008284; P:positive regulation of cell proliferation; IGI:MGI
P21781	FGF7	Fibroblast growth factor 7	GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:UniProtKB
P21781	FGF7	Fibroblast growth factor 7	GO:0060501; P:positive regulation of epithelial cell proliferation involved in lung morphogenesis; IDA:MGI
P21781	FGF7	Fibroblast growth factor 7	GO:0051549; P:positive regulation of keratinocyte migration; IDA:UniProtKB
P21781	FGF7	Fibroblast growth factor 7	GO:0010838; P:positive regulation of keratinocyte proliferation; IDA:UniProtKB
P21781	FGF7	Fibroblast growth factor 7	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P21781	FGF7	Fibroblast growth factor 7	GO:0034394; P:protein localization to cell surface; IDA:UniProtKB
P21781	FGF7	Fibroblast growth factor 7	GO:0060665; P:regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling; IEA:Ensembl
P21781	FGF7	Fibroblast growth factor 7	GO:0009611; P:response to wounding; TAS:ProtInc
P21781	FGF7	Fibroblast growth factor 7	GO:0061033; P:secretion by lung epithelial cell involved in lung growth; IDA:UniProtKB
P21781	FGF7	Fibroblast growth factor 7	GO:0007165; P:signal transduction; NAS:ProtInc
P55075	FGF8	Fibroblast growth factor 8	GO:0042056; F:chemoattractant activity; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0008083; F:growth factor activity; IDA:UniProtKB
P55075	FGF8	Fibroblast growth factor 8	GO:0005105; F:type 1 fibroblast growth factor receptor binding; IDA:UniProtKB
P55075	FGF8	Fibroblast growth factor 8	GO:0005111; F:type 2 fibroblast growth factor receptor binding; IDA:UniProtKB
P55075	FGF8	Fibroblast growth factor 8	GO:0009653; P:anatomical structure morphogenesis; NAS:UniProtKB
P55075	FGF8	Fibroblast growth factor 8	GO:0035909; P:aorta morphogenesis; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0006915; P:apoptotic process; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0030509; P:BMP signaling pathway; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0060348; P:bone development; IMP:UniProtKB
P55075	FGF8	Fibroblast growth factor 8	GO:0060445; P:branching involved in salivary gland morphogenesis; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0090134; P:cell migration involved in mesendoderm migration; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0021846; P:cell proliferation in forebrain; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0060128; P:corticotropin hormone secreting cell differentiation; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0071542; P:dopaminergic neuron differentiation; IDA:UniProtKB
P55075	FGF8	Fibroblast growth factor 8	GO:0033563; P:dorsal/ventral axon guidance; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P55075	FGF8	Fibroblast growth factor 8	GO:0003198; P:epithelial to mesenchymal transition involved in endocardial cushion formation; ISS:BHF-UCL
P55075	FGF8	Fibroblast growth factor 8	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P55075	FGF8	Fibroblast growth factor 8	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IGI:MGI
P55075	FGF8	Fibroblast growth factor 8	GO:0021798; P:forebrain dorsal/ventral pattern formation; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0048853; P:forebrain morphogenesis; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0021884; P:forebrain neuron development; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0007369; P:gastrulation; NAS:UniProtKB
P55075	FGF8	Fibroblast growth factor 8	GO:0008406; P:gonad development; IMP:UniProtKB
P55075	FGF8	Fibroblast growth factor 8	GO:0001947; P:heart looping; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0045087; P:innate immune response; TAS:Reactome
P55075	FGF8	Fibroblast growth factor 8	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P55075	FGF8	Fibroblast growth factor 8	GO:0060425; P:lung morphogenesis; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0030539; P:male genitalia development; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0000165; P:MAPK cascade; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0008078; P:mesodermal cell migration; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0001823; P:mesonephros development; IEP:UniProtKB
P55075	FGF8	Fibroblast growth factor 8	GO:0001656; P:metanephros development; IEP:UniProtKB
P55075	FGF8	Fibroblast growth factor 8	GO:0030917; P:midbrain-hindbrain boundary development; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0008045; P:motor neuron axon guidance; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0055026; P:negative regulation of cardiac muscle tissue development; IMP:BHF-UCL
P55075	FGF8	Fibroblast growth factor 8	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0001839; P:neural plate morphogenesis; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0060563; P:neuroepithelial cell differentiation; IDA:UniProtKB
P55075	FGF8	Fibroblast growth factor 8	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P55075	FGF8	Fibroblast growth factor 8	GO:0042476; P:odontogenesis; IEP:UniProtKB
P55075	FGF8	Fibroblast growth factor 8	GO:0001759; P:organ induction; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0030916; P:otic vesicle formation; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0003148; P:outflow tract septum morphogenesis; ISS:UniProtKB
P55075	FGF8	Fibroblast growth factor 8	GO:0021543; P:pallium development; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0001569; P:patterning of blood vessels; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0060037; P:pharyngeal system development; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P55075	FGF8	Fibroblast growth factor 8	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P55075	FGF8	Fibroblast growth factor 8	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P55075	FGF8	Fibroblast growth factor 8	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0045840; P:positive regulation of mitosis; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0046622; P:positive regulation of organ growth; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0042487; P:regulation of odontogenesis of dentin-containing tooth; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0042493; P:response to drug; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0006979; P:response to oxidative stress; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0021544; P:subpallium development; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0030878; P:thyroid gland development; IEA:Ensembl
P55075	FGF8	Fibroblast growth factor 8	GO:0060129; P:thyroid-stimulating hormone-secreting cell differentiation; IEA:Ensembl
Q14512	FGFBP1	Fibroblast growth factor-binding protein 1	GO:0008201; F:heparin binding; TAS:ProtInc
Q14512	FGFBP1	Fibroblast growth factor-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q14512	FGFBP1	Fibroblast growth factor-binding protein 1	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q14512	FGFBP1	Fibroblast growth factor-binding protein 1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q14512	FGFBP1	Fibroblast growth factor-binding protein 1	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q14512	FGFBP1	Fibroblast growth factor-binding protein 1	GO:0045743; P:positive regulation of fibroblast growth factor receptor signaling pathway; IEA:Ensembl
Q14512	FGFBP1	Fibroblast growth factor-binding protein 1	GO:0007165; P:signal transduction; NAS:ProtInc
P31371	FGF9	Fibroblast growth factor 9	GO:0008083; F:growth factor activity; TAS:ProtInc
P31371	FGF9	Fibroblast growth factor 9	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P31371	FGF9	Fibroblast growth factor 9	GO:0001525; P:angiogenesis; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P31371	FGF9	Fibroblast growth factor 9	GO:0002062; P:chondrocyte differentiation; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0048566; P:embryonic digestive tract development; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0048706; P:embryonic skeletal system development; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P31371	FGF9	Fibroblast growth factor 9	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P31371	FGF9	Fibroblast growth factor 9	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IGI:MGI
P31371	FGF9	Fibroblast growth factor 9	GO:0045087; P:innate immune response; TAS:Reactome
P31371	FGF9	Fibroblast growth factor 9	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P31371	FGF9	Fibroblast growth factor 9	GO:0060484; P:lung-associated mesenchyme development; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0008584; P:male gonad development; IEP:UniProtKB
P31371	FGF9	Fibroblast growth factor 9	GO:0030238; P:male sex determination; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0030178; P:negative regulation of Wnt signaling pathway; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P31371	FGF9	Fibroblast growth factor 9	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P31371	FGF9	Fibroblast growth factor 9	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0060045; P:positive regulation of cardiac muscle cell proliferation; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P31371	FGF9	Fibroblast growth factor 9	GO:0008284; P:positive regulation of cell proliferation; IDA:MGI
P31371	FGF9	Fibroblast growth factor 9	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0045880; P:positive regulation of smoothened signaling pathway; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0006606; P:protein import into nucleus; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0048505; P:regulation of timing of cell differentiation; IEA:Ensembl
P31371	FGF9	Fibroblast growth factor 9	GO:0007165; P:signal transduction; TAS:ProtInc
P31371	FGF9	Fibroblast growth factor 9	GO:0021762; P:substantia nigra development; IEP:UniProt
Q8TAT2	FGFBP3	Fibroblast growth factor-binding protein 3	GO:0017134; F:fibroblast growth factor binding; IPI:MGI
Q8TAT2	FGFBP3	Fibroblast growth factor-binding protein 3	GO:0008201; F:heparin binding; IDA:MGI
Q8TAT2	FGFBP3	Fibroblast growth factor-binding protein 3	GO:0045743; P:positive regulation of fibroblast growth factor receptor signaling pathway; IGI:MGI
Q8TAT2	FGFBP3	Fibroblast growth factor-binding protein 3	GO:0043117; P:positive regulation of vascular permeability; IDA:MGI
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0017134; F:fibroblast growth factor binding; IDA:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0005007; F:fibroblast growth factor-activated receptor activity; IDA:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0008201; F:heparin binding; IDA:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0042802; F:identical protein binding; IPI:IntAct
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0005515; F:protein binding; IPI:IntAct
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0001525; P:angiogenesis; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0060117; P:auditory receptor cell development; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0007411; P:axon guidance; TAS:Reactome
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0060445; P:branching involved in salivary gland morphogenesis; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0048469; P:cell maturation; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0016477; P:cell migration; TAS:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0002062; P:chondrocyte differentiation; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0043009; P:chordate embryonic development; TAS:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IDA:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0035607; P:fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0045087; P:innate immune response; TAS:Reactome
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0060484; P:lung-associated mesenchyme development; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0000165; P:MAPK cascade; TAS:ProtInc
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0048762; P:mesenchymal cell differentiation; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0030901; P:midbrain development; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0042474; P:middle ear morphogenesis; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0001764; P:neuron migration; TAS:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0001759; P:organ induction; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0042473; P:outer ear morphogenesis; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0048339; P:paraxial mesoderm development; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0060045; P:positive regulation of cardiac muscle cell proliferation; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0045787; P:positive regulation of cell cycle; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0043406; P:positive regulation of MAP kinase activity; IDA:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0043410; P:positive regulation of MAPK cascade; IMP:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0090080; P:positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0045666; P:positive regulation of neuron differentiation; IMP:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; TAS:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0010518; P:positive regulation of phospholipase activity; TAS:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0010863; P:positive regulation of phospholipase C activity; IDA:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0006468; P:protein phosphorylation; NAS:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0060665; P:regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0045595; P:regulation of cell differentiation; TAS:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:2001239; P:regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0048378; P:regulation of lateral mesodermal cell fate specification; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0007605; P:sensory perception of sound; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0001501; P:skeletal system development; TAS:ProtInc
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0048705; P:skeletal system morphogenesis; TAS:UniProtKB
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0001657; P:ureteric bud development; IEA:Ensembl
P11362	FGFR1	Fibroblast growth factor receptor 1	GO:0021847; P:ventricular zone neuroblast division; IEA:Ensembl
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0017134; F:fibroblast growth factor binding; IDA:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0005007; F:fibroblast growth factor-activated receptor activity; IDA:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0005515; F:protein binding; IPI:IntAct
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0004713; F:protein tyrosine kinase activity; NAS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0001525; P:angiogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0007409; P:axonogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060348; P:bone development; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0030282; P:bone mineralization; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060349; P:bone morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060667; P:branch elongation involved in salivary gland morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060670; P:branching involved in labyrinthine layer morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060442; P:branching involved in prostate gland morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060445; P:branching involved in salivary gland morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0048755; P:branching morphogenesis of a nerve; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060449; P:bud elongation involved in lung branching; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0045165; P:cell fate commitment; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0007267; P:cell-cell signaling; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060365; P:coronal suture morphogenesis; IEA:Ensembl
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0048565; P:digestive tract development; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0048701; P:embryonic cranial skeleton morphogenesis; IMP:BHF-UCL
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0048557; P:embryonic digestive tract morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0048568; P:embryonic organ development; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0048562; P:embryonic organ morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0009880; P:embryonic pattern specification; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0061031; P:endodermal digestive tract morphogenesis; IEA:Ensembl
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0048730; P:epidermis morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0030855; P:epithelial cell differentiation; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060664; P:epithelial cell proliferation involved in salivary gland morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0001837; P:epithelial to mesenchymal transition; IEA:Ensembl
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IDA:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0035603; P:fibroblast growth factor receptor signaling pathway involved in hemopoiesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060595; P:fibroblast growth factor receptor signaling pathway involved in mammary gland specification; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0035602; P:fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0035607; P:fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0035604; P:fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0022612; P:gland morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0031069; P:hair follicle morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0001701; P:in utero embryonic development; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0045087; P:innate immune response; TAS:Reactome
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0042472; P:inner ear morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0032808; P:lacrimal gland development; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060601; P:lateral sprouting from an epithelium; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0070307; P:lens fiber cell development; IEA:Ensembl
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060174; P:limb bud formation; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0048286; P:lung alveolus development; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0030324; P:lung development; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060463; P:lung lobe morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060484; P:lung-associated mesenchyme development; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060615; P:mammary gland bud formation; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0003149; P:membranous septum morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0048762; P:mesenchymal cell differentiation; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060915; P:mesenchymal cell differentiation involved in lung development; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060916; P:mesenchymal cell proliferation involved in lung development; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0048333; P:mesodermal cell differentiation; IEA:Ensembl
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0030901; P:midbrain development; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0016331; P:morphogenesis of embryonic epithelium; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0035264; P:multicellular organism growth; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0045839; P:negative regulation of mitosis; IEA:Ensembl
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0042476; P:odontogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0021769; P:orbitofrontal cortex development; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0035265; P:organ growth; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0009887; P:organ morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0030916; P:otic vesicle formation; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0003148; P:outflow tract septum morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060045; P:positive regulation of cardiac muscle cell proliferation; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0045787; P:positive regulation of cell cycle; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0051781; P:positive regulation of cell division; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0050679; P:positive regulation of epithelial cell proliferation; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060501; P:positive regulation of epithelial cell proliferation involved in lung morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0043410; P:positive regulation of MAPK cascade; IMP:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0002053; P:positive regulation of mesenchymal cell proliferation; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0010518; P:positive regulation of phospholipase activity; IMP:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0030177; P:positive regulation of Wnt signaling pathway; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0009791; P:post-embryonic development; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060527; P:prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060523; P:prostate epithelial cord elongation; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060512; P:prostate gland morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0021860; P:pyramidal neuron development; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060687; P:regulation of branching involved in prostate gland morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0010453; P:regulation of cell fate commitment; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0070372; P:regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0040036; P:regulation of fibroblast growth factor receptor signaling pathway; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060688; P:regulation of morphogenesis of a branching structure; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0040014; P:regulation of multicellular organism growth; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0045667; P:regulation of osteoblast differentiation; TAS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0033688; P:regulation of osteoblast proliferation; TAS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0051150; P:regulation of smooth muscle cell differentiation; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0008589; P:regulation of smoothened signaling pathway; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0048608; P:reproductive structure development; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0048705; P:skeletal system morphogenesis; TAS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0060529; P:squamous basal epithelial stem cell differentiation involved in prostate gland acinus development; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0048489; P:synaptic vesicle transport; IEA:Ensembl
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0001657; P:ureteric bud development; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; ISS:UniProtKB
P21802	FGFR2	Fibroblast growth factor receptor 2	GO:0021847; P:ventricular zone neuroblast division; ISS:UniProtKB
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0017134; F:fibroblast growth factor binding; IDA:UniProtKB
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0005007; F:fibroblast growth factor-activated receptor activity; IMP:UniProtKB
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0005515; F:protein binding; IPI:IntAct
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0061144; P:alveolar secondary septum development; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0060385; P:axonogenesis involved in innervation; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0070977; P:bone maturation; ISS:BHF-UCL
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0060349; P:bone morphogenesis; TAS:UniProtKB
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0007267; P:cell-cell signaling; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0022010; P:central nervous system myelination; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0002062; P:chondrocyte differentiation; TAS:UniProtKB
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0035988; P:chondrocyte proliferation; TAS:UniProtKB
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0090102; P:cochlea development; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0048546; P:digestive tract morphogenesis; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0003416; P:endochondral bone growth; TAS:UniProtKB
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0001958; P:endochondral ossification; TAS:UniProtKB
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0072148; P:epithelial cell fate commitment; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:1902178; P:fibroblast growth factor receptor apoptotic signaling pathway; IMP:UniProtKB
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IDA:UniProtKB
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0045087; P:innate immune response; TAS:Reactome
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0060113; P:inner ear receptor cell differentiation; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0007259; P:JAK-STAT cascade; TAS:ProtInc
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0070307; P:lens fiber cell development; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0002089; P:lens morphogenesis in camera-type eye; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0000165; P:MAPK cascade; TAS:ProtInc
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0002009; P:morphogenesis of an epithelium; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0048712; P:negative regulation of astrocyte differentiation; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0048640; P:negative regulation of developmental growth; ISS:BHF-UCL
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0045839; P:negative regulation of mitosis; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0045879; P:negative regulation of smoothened signaling pathway; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0045597; P:positive regulation of cell differentiation; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0043410; P:positive regulation of MAPK cascade; IMP:UniProtKB
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0090080; P:positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IMP:UniProtKB
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0010518; P:positive regulation of phospholipase activity; IMP:UniProtKB
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0031398; P:positive regulation of protein ubiquitination; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0042511; P:positive regulation of tyrosine phosphorylation of Stat1 protein; IMP:UniProtKB
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IMP:UniProtKB
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0048678; P:response to axon injury; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0001501; P:skeletal system development; TAS:ProtInc
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
P22607	FGFR3	Fibroblast growth factor receptor 3	GO:0021762; P:substantia nigra development; IEA:Ensembl
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0017134; F:fibroblast growth factor binding; IDA:UniProtKB
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0005007; F:fibroblast growth factor-activated receptor activity; IDA:UniProtKB
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0008201; F:heparin binding; IDA:UniProtKB
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0004713; F:protein tyrosine kinase activity; TAS:Reactome
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0061144; P:alveolar secondary septum development; IEA:Ensembl
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0016477; P:cell migration; IMP:UniProtKB
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IDA:UniProtKB
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0042593; P:glucose homeostasis; ISS:UniProtKB
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0045087; P:innate immune response; TAS:Reactome
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0001759; P:organ induction; IEA:Ensembl
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0055062; P:phosphate ion homeostasis; ISS:UniProtKB
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:2000573; P:positive regulation of DNA biosynthetic process; IMP:UniProtKB
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0048554; P:positive regulation of metalloenzyme activity; IMP:UniProtKB
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0045862; P:positive regulation of proteolysis; IMP:UniProtKB
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0070857; P:regulation of bile acid biosynthetic process; IMP:UniProtKB
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:2000188; P:regulation of cholesterol homeostasis; ISS:UniProtKB
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0010715; P:regulation of extracellular matrix disassembly; IMP:UniProtKB
P22455	FGFR4	Fibroblast growth factor receptor 4	GO:0019216; P:regulation of lipid metabolic process; ISS:UniProtKB
Q96C11	FGGY	FGGY carbohydrate kinase domain-containing protein	GO:0016301; F:kinase activity; IEA:UniProtKB-KW
Q96C11	FGGY	FGGY carbohydrate kinase domain-containing protein	GO:0016773; F:phosphotransferase activity, alcohol group as acceptor; IEA:InterPro
Q96C11	FGGY	FGGY carbohydrate kinase domain-containing protein	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q96C11	FGGY	FGGY carbohydrate kinase domain-containing protein	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q96C11	FGGY	FGGY carbohydrate kinase domain-containing protein	GO:0070050; P:neuron cellular homeostasis; IMP:UniProtKB
Q08830	FGL1	Fibrinogen-like protein 1	GO:0035634; P:response to stilbenoid; IEA:Ensembl
Q9NVK5	FGFR1OP2	FGFR1 oncogene partner 2	GO:0042060; P:wound healing; IEA:Ensembl
Q8N441	FGFRL1	Fibroblast growth factor receptor-like 1	GO:0005007; F:fibroblast growth factor-activated receptor activity; IDA:UniProtKB
Q8N441	FGFRL1	Fibroblast growth factor receptor-like 1	GO:0008201; F:heparin binding; IDA:UniProtKB
Q8N441	FGFRL1	Fibroblast growth factor receptor-like 1	GO:0060539; P:diaphragm development; IEA:Ensembl
Q8N441	FGFRL1	Fibroblast growth factor receptor-like 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IDA:GOC
Q8N441	FGFRL1	Fibroblast growth factor receptor-like 1	GO:0003179; P:heart valve morphogenesis; IEA:Ensembl
Q8N441	FGFRL1	Fibroblast growth factor receptor-like 1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q8N441	FGFRL1	Fibroblast growth factor receptor-like 1	GO:0001501; P:skeletal system development; IEA:Ensembl
Q8N441	FGFRL1	Fibroblast growth factor receptor-like 1	GO:0060412; P:ventricular septum morphogenesis; IEA:Ensembl
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0034988; F:Fc-gamma receptor I complex binding; IDA:UniProtKB
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0034987; F:immunoglobulin receptor binding; ISS:UniProtKB
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0001784; F:phosphotyrosine binding; ISS:UniProtKB
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0005515; F:protein binding; IPI:IntAct
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0019901; F:protein kinase binding; ISS:UniProtKB
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0007596; P:blood coagulation; TAS:Reactome
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0050830; P:defense response to Gram-positive bacterium; ISS:UniProtKB
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0002768; P:immune response-regulating cell surface receptor signaling pathway; TAS:UniProtKB
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0045087; P:innate immune response; TAS:Reactome
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0007229; P:integrin-mediated signaling pathway; IMP:UniProtKB
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0050715; P:positive regulation of cytokine secretion; ISS:UniProtKB
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0043306; P:positive regulation of mast cell degranulation; ISS:UniProtKB
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IMP:UniProtKB
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IMP:UniProtKB
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0008360; P:regulation of cell shape; ISS:UniProtKB
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0045088; P:regulation of innate immune response; ISS:UniProtKB
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0050764; P:regulation of phagocytosis; ISS:UniProtKB
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0045859; P:regulation of protein kinase activity; ISS:UniProtKB
P09769	FGR	Tyrosine-protein kinase Fgr	GO:0009615; P:response to virus; TAS:ProtInc
P49789	FHIT	Bis(5'-adenosyl)-triphosphatase	GO:0047710; F:bis(5'-adenosyl)-triphosphatase activity; IDA:UniProtKB
P49789	FHIT	Bis(5'-adenosyl)-triphosphatase	GO:0003824; F:catalytic activity; TAS:ProtInc
P49789	FHIT	Bis(5'-adenosyl)-triphosphatase	GO:0016787; F:hydrolase activity; IDA:UniProtKB
P49789	FHIT	Bis(5'-adenosyl)-triphosphatase	GO:0042802; F:identical protein binding; IPI:IntAct
P49789	FHIT	Bis(5'-adenosyl)-triphosphatase	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
P49789	FHIT	Bis(5'-adenosyl)-triphosphatase	GO:0005515; F:protein binding; IPI:IntAct
P49789	FHIT	Bis(5'-adenosyl)-triphosphatase	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P49789	FHIT	Bis(5'-adenosyl)-triphosphatase	GO:0006260; P:DNA replication; IEA:Ensembl
P49789	FHIT	Bis(5'-adenosyl)-triphosphatase	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IMP:UniProtKB
P49789	FHIT	Bis(5'-adenosyl)-triphosphatase	GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB
P49789	FHIT	Bis(5'-adenosyl)-triphosphatase	GO:0009117; P:nucleotide metabolic process; TAS:ProtInc
P49789	FHIT	Bis(5'-adenosyl)-triphosphatase	GO:0006163; P:purine nucleotide metabolic process; IDA:UniProtKB
P49789	FHIT	Bis(5'-adenosyl)-triphosphatase	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P49789	FHIT	Bis(5'-adenosyl)-triphosphatase	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BXU8	FTHL17	Ferritin heavy polypeptide-like 17	GO:0008199; F:ferric iron binding; IEA:InterPro
Q9BXU8	FTHL17	Ferritin heavy polypeptide-like 17	GO:0006879; P:cellular iron ion homeostasis; IEA:UniProtKB-KW
Q9BXU8	FTHL17	Ferritin heavy polypeptide-like 17	GO:0006826; P:iron ion transport; IEA:InterPro
P0C7X4	FTH1P19	Putative ferritin heavy polypeptide-like 19	GO:0008199; F:ferric iron binding; IEA:InterPro
P0C7X4	FTH1P19	Putative ferritin heavy polypeptide-like 19	GO:0006879; P:cellular iron ion homeostasis; IEA:UniProtKB-KW
P0C7X4	FTH1P19	Putative ferritin heavy polypeptide-like 19	GO:0006826; P:iron ion transport; IEA:InterPro
Q13642	FHL1	Four and a half LIM domains protein 1	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q13642	FHL1	Four and a half LIM domains protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q13642	FHL1	Four and a half LIM domains protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13642	FHL1	Four and a half LIM domains protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q13642	FHL1	Four and a half LIM domains protein 1	GO:0007517; P:muscle organ development; NAS:UniProtKB
Q13642	FHL1	Four and a half LIM domains protein 1	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q13642	FHL1	Four and a half LIM domains protein 1	GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IDA:UniProtKB
Q13642	FHL1	Four and a half LIM domains protein 1	GO:0010972; P:negative regulation of G2/M transition of mitotic cell cycle; IDA:UniProtKB
Q13642	FHL1	Four and a half LIM domains protein 1	GO:0009887; P:organ morphogenesis; NAS:UniProtKB
Q13642	FHL1	Four and a half LIM domains protein 1	GO:0043268; P:positive regulation of potassium ion transport; IDA:BHF-UCL
Q13642	FHL1	Four and a half LIM domains protein 1	GO:0003254; P:regulation of membrane depolarization; IDA:BHF-UCL
Q13642	FHL1	Four and a half LIM domains protein 1	GO:1901016; P:regulation of potassium ion transmembrane transporter activity; IDA:BHF-UCL
Q13643	FHL3	Four and a half LIM domains protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13643	FHL3	Four and a half LIM domains protein 3	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
Q13643	FHL3	Four and a half LIM domains protein 3	GO:0007517; P:muscle organ development; TAS:ProtInc
Q14192	FHL2	Four and a half LIM domains protein 2	GO:0050681; F:androgen receptor binding; NAS:UniProtKB
Q14192	FHL2	Four and a half LIM domains protein 2	GO:0042802; F:identical protein binding; IPI:IntAct
Q14192	FHL2	Four and a half LIM domains protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q14192	FHL2	Four and a half LIM domains protein 2	GO:0003713; F:transcription coactivator activity; NAS:UniProtKB
Q14192	FHL2	Four and a half LIM domains protein 2	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q14192	FHL2	Four and a half LIM domains protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q14192	FHL2	Four and a half LIM domains protein 2	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
Q14192	FHL2	Four and a half LIM domains protein 2	GO:0055014; P:atrial cardiac muscle cell development; IEA:Ensembl
Q14192	FHL2	Four and a half LIM domains protein 2	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q14192	FHL2	Four and a half LIM domains protein 2	GO:0060347; P:heart trabecula formation; IEA:Ensembl
Q14192	FHL2	Four and a half LIM domains protein 2	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q14192	FHL2	Four and a half LIM domains protein 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q14192	FHL2	Four and a half LIM domains protein 2	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
Q14192	FHL2	Four and a half LIM domains protein 2	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
Q14192	FHL2	Four and a half LIM domains protein 2	GO:0009725; P:response to hormone; IMP:BHF-UCL
Q14192	FHL2	Four and a half LIM domains protein 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14192	FHL2	Four and a half LIM domains protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14192	FHL2	Four and a half LIM domains protein 2	GO:0055015; P:ventricular cardiac muscle cell development; IEA:Ensembl
Q5TD97	FHL5	Four and a half LIM domains protein 5	GO:0005515; F:protein binding; IPI:IntAct
Q5TD97	FHL5	Four and a half LIM domains protein 5	GO:0003713; F:transcription coactivator activity; IEA:Ensembl
Q5TD97	FHL5	Four and a half LIM domains protein 5	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5TD97	FHL5	Four and a half LIM domains protein 5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9Y613	FHOD1	FH1/FH2 domain-containing protein 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q9Y613	FHOD1	FH1/FH2 domain-containing protein 1	GO:0005515; F:protein binding; IPI:BHF-UCL
Q9Y613	FHOD1	FH1/FH2 domain-containing protein 1	GO:0051496; P:positive regulation of stress fiber assembly; IDA:BHF-UCL
Q9Y613	FHOD1	FH1/FH2 domain-containing protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q2V2M9	FHOD3	FH1/FH2 domain-containing protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q2V2M9	FHOD3	FH1/FH2 domain-containing protein 3	GO:0051639; P:actin filament network formation; IEA:Ensembl
Q2V2M9	FHOD3	FH1/FH2 domain-containing protein 3	GO:0030837; P:negative regulation of actin filament polymerization; IEA:Ensembl
Q2V2M9	FHOD3	FH1/FH2 domain-containing protein 3	GO:0045214; P:sarcomere organization; IEA:Ensembl
Q03591	CFHR1	Complement factor H-related protein 1	GO:0006956; P:complement activation; TAS:ProtInc
Q92496	CFHR4	Complement factor H-related protein 4	GO:0005319; F:lipid transporter activity; TAS:ProtInc
Q92496	CFHR4	Complement factor H-related protein 4	GO:0006869; P:lipid transport; TAS:GOC
Q9BXR6	CFHR5	Complement factor H-related protein 5	GO:0006957; P:complement activation, alternative pathway; NAS:UniProtKB
P02671	FGA	Fibrinogen alpha chain	GO:0005515; F:protein binding; IPI:UniProtKB
P02671	FGA	Fibrinogen alpha chain	GO:0005198; F:structural molecule activity; IDA:BHF-UCL
P02671	FGA	Fibrinogen alpha chain	GO:0007596; P:blood coagulation; TAS:Reactome
P02671	FGA	Fibrinogen alpha chain	GO:0072377; P:blood coagulation, common pathway; IMP:BHF-UCL
P02671	FGA	Fibrinogen alpha chain	GO:0007160; P:cell-matrix adhesion; IDA:BHF-UCL
P02671	FGA	Fibrinogen alpha chain	GO:0043623; P:cellular protein complex assembly; IDA:BHF-UCL
P02671	FGA	Fibrinogen alpha chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P02671	FGA	Fibrinogen alpha chain	GO:2000261; P:negative regulation of blood coagulation, common pathway; TAS:BHF-UCL
P02671	FGA	Fibrinogen alpha chain	GO:2000352; P:negative regulation of endothelial cell apoptotic process; IDA:BHF-UCL
P02671	FGA	Fibrinogen alpha chain	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IDA:BHF-UCL
P02671	FGA	Fibrinogen alpha chain	GO:0030168; P:platelet activation; TAS:Reactome
P02671	FGA	Fibrinogen alpha chain	GO:0070527; P:platelet aggregation; IDA:BHF-UCL
P02671	FGA	Fibrinogen alpha chain	GO:0002576; P:platelet degranulation; TAS:Reactome
P02671	FGA	Fibrinogen alpha chain	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL
P02671	FGA	Fibrinogen alpha chain	GO:0045921; P:positive regulation of exocytosis; IDA:BHF-UCL
P02671	FGA	Fibrinogen alpha chain	GO:0034116; P:positive regulation of heterotypic cell-cell adhesion; IDA:BHF-UCL
P02671	FGA	Fibrinogen alpha chain	GO:0090277; P:positive regulation of peptide hormone secretion; IDA:BHF-UCL
P02671	FGA	Fibrinogen alpha chain	GO:0050714; P:positive regulation of protein secretion; IDA:BHF-UCL
P02671	FGA	Fibrinogen alpha chain	GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; NAS:BHF-UCL
P02671	FGA	Fibrinogen alpha chain	GO:0045907; P:positive regulation of vasoconstriction; IDA:BHF-UCL
P02671	FGA	Fibrinogen alpha chain	GO:0051258; P:protein polymerization; IDA:BHF-UCL
P02671	FGA	Fibrinogen alpha chain	GO:0051592; P:response to calcium ion; IDA:BHF-UCL
P02671	FGA	Fibrinogen alpha chain	GO:0007165; P:signal transduction; IEA:InterPro
P02675	FGB	Fibrinogen beta chain	GO:0051087; F:chaperone binding; IPI:BHF-UCL
P02675	FGB	Fibrinogen beta chain	GO:0005515; F:protein binding; IPI:IntAct
P02675	FGB	Fibrinogen beta chain	GO:0005198; F:structural molecule activity; IDA:BHF-UCL
P02675	FGB	Fibrinogen beta chain	GO:0007596; P:blood coagulation; TAS:Reactome
P02675	FGB	Fibrinogen beta chain	GO:0007160; P:cell-matrix adhesion; IDA:BHF-UCL
P02675	FGB	Fibrinogen beta chain	GO:0043623; P:cellular protein complex assembly; IDA:BHF-UCL
P02675	FGB	Fibrinogen beta chain	GO:0071347; P:cellular response to interleukin-1; IEA:Ensembl
P02675	FGB	Fibrinogen beta chain	GO:0044320; P:cellular response to leptin stimulus; IEA:Ensembl
P02675	FGB	Fibrinogen beta chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P02675	FGB	Fibrinogen beta chain	GO:2000352; P:negative regulation of endothelial cell apoptotic process; IDA:BHF-UCL
P02675	FGB	Fibrinogen beta chain	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IDA:BHF-UCL
P02675	FGB	Fibrinogen beta chain	GO:0030168; P:platelet activation; TAS:Reactome
P02675	FGB	Fibrinogen beta chain	GO:0070527; P:platelet aggregation; IDA:BHF-UCL
P02675	FGB	Fibrinogen beta chain	GO:0002576; P:platelet degranulation; TAS:Reactome
P02675	FGB	Fibrinogen beta chain	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL
P02675	FGB	Fibrinogen beta chain	GO:0045921; P:positive regulation of exocytosis; IDA:BHF-UCL
P02675	FGB	Fibrinogen beta chain	GO:0034116; P:positive regulation of heterotypic cell-cell adhesion; IDA:BHF-UCL
P02675	FGB	Fibrinogen beta chain	GO:0090277; P:positive regulation of peptide hormone secretion; IDA:BHF-UCL
P02675	FGB	Fibrinogen beta chain	GO:0050714; P:positive regulation of protein secretion; IDA:BHF-UCL
P02675	FGB	Fibrinogen beta chain	GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; NAS:BHF-UCL
P02675	FGB	Fibrinogen beta chain	GO:0045907; P:positive regulation of vasoconstriction; IDA:BHF-UCL
P02675	FGB	Fibrinogen beta chain	GO:0051258; P:protein polymerization; IDA:BHF-UCL
P02675	FGB	Fibrinogen beta chain	GO:0051592; P:response to calcium ion; IDA:BHF-UCL
P02675	FGB	Fibrinogen beta chain	GO:0007165; P:signal transduction; IEA:InterPro
P02679	FGG	Fibrinogen gamma chain	GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL
P02679	FGG	Fibrinogen gamma chain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P02679	FGG	Fibrinogen gamma chain	GO:0005102; F:receptor binding; IPI:BHF-UCL
P02679	FGG	Fibrinogen gamma chain	GO:0005198; F:structural molecule activity; IDA:BHF-UCL
P02679	FGG	Fibrinogen gamma chain	GO:0007596; P:blood coagulation; TAS:Reactome
P02679	FGG	Fibrinogen gamma chain	GO:0007160; P:cell-matrix adhesion; IDA:BHF-UCL
P02679	FGG	Fibrinogen gamma chain	GO:0043623; P:cellular protein complex assembly; IDA:BHF-UCL
P02679	FGG	Fibrinogen gamma chain	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P02679	FGG	Fibrinogen gamma chain	GO:2000352; P:negative regulation of endothelial cell apoptotic process; IDA:BHF-UCL
P02679	FGG	Fibrinogen gamma chain	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IDA:BHF-UCL
P02679	FGG	Fibrinogen gamma chain	GO:0030168; P:platelet activation; TAS:Reactome
P02679	FGG	Fibrinogen gamma chain	GO:0070527; P:platelet aggregation; IDA:BHF-UCL
P02679	FGG	Fibrinogen gamma chain	GO:0002576; P:platelet degranulation; TAS:Reactome
P02679	FGG	Fibrinogen gamma chain	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL
P02679	FGG	Fibrinogen gamma chain	GO:0045921; P:positive regulation of exocytosis; IDA:BHF-UCL
P02679	FGG	Fibrinogen gamma chain	GO:0034116; P:positive regulation of heterotypic cell-cell adhesion; IDA:BHF-UCL
P02679	FGG	Fibrinogen gamma chain	GO:0090277; P:positive regulation of peptide hormone secretion; IDA:BHF-UCL
P02679	FGG	Fibrinogen gamma chain	GO:0050714; P:positive regulation of protein secretion; IDA:BHF-UCL
P02679	FGG	Fibrinogen gamma chain	GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; NAS:BHF-UCL
P02679	FGG	Fibrinogen gamma chain	GO:0045907; P:positive regulation of vasoconstriction; IDA:BHF-UCL
P02679	FGG	Fibrinogen gamma chain	GO:0051258; P:protein polymerization; IMP:BHF-UCL
P02679	FGG	Fibrinogen gamma chain	GO:0051592; P:response to calcium ion; IDA:BHF-UCL
P02679	FGG	Fibrinogen gamma chain	GO:0007165; P:signal transduction; IEA:InterPro
O43427	FIBP	Acidic fibroblast growth factor intracellular-binding protein	GO:0017134; F:fibroblast growth factor binding; IPI:MGI
O43427	FIBP	Acidic fibroblast growth factor intracellular-binding protein	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:ProtInc
Q9BVA6	FICD	Adenosine monophosphate-protein transferase FICD	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BVA6	FICD	Adenosine monophosphate-protein transferase FICD	GO:0070733; F:protein adenylyltransferase activity; IDA:UniProtKB
Q9BVA6	FICD	Adenosine monophosphate-protein transferase FICD	GO:0034259; P:negative regulation of Rho GTPase activity; TAS:UniProtKB
Q9BVA6	FICD	Adenosine monophosphate-protein transferase FICD	GO:0018117; P:protein adenylylation; IDA:UniProtKB
Q92562	FIG4	Polyphosphoinositide phosphatase	GO:0043813; F:phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; TAS:Reactome
Q92562	FIG4	Polyphosphoinositide phosphatase	GO:0004438; F:phosphatidylinositol-3-phosphatase activity; IEA:Ensembl
Q92562	FIG4	Polyphosphoinositide phosphatase	GO:0043812; F:phosphatidylinositol-4-phosphate phosphatase activity; IEA:Ensembl
Q92562	FIG4	Polyphosphoinositide phosphatase	GO:0005515; F:protein binding; IPI:UniProtKB
Q92562	FIG4	Polyphosphoinositide phosphatase	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q92562	FIG4	Polyphosphoinositide phosphatase	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q92562	FIG4	Polyphosphoinositide phosphatase	GO:0032288; P:myelin assembly; IEA:Ensembl
Q92562	FIG4	Polyphosphoinositide phosphatase	GO:0031642; P:negative regulation of myelination; IEA:Ensembl
Q92562	FIG4	Polyphosphoinositide phosphatase	GO:0048666; P:neuron development; IEA:Ensembl
Q92562	FIG4	Polyphosphoinositide phosphatase	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q92562	FIG4	Polyphosphoinositide phosphatase	GO:0036092; P:phosphatidylinositol-3-phosphate biosynthetic process; TAS:GOC
Q92562	FIG4	Polyphosphoinositide phosphatase	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q92562	FIG4	Polyphosphoinositide phosphatase	GO:0043473; P:pigmentation; IEA:Ensembl
Q92562	FIG4	Polyphosphoinositide phosphatase	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
Q92562	FIG4	Polyphosphoinositide phosphatase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q92562	FIG4	Polyphosphoinositide phosphatase	GO:0007033; P:vacuole organization; IEA:Ensembl
Q6PIW4	FIGNL1	Fidgetin-like protein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6PIW4	FIGNL1	Fidgetin-like protein 1	GO:0016787; F:hydrolase activity; ISS:UniProtKB
Q6PIW4	FIGNL1	Fidgetin-like protein 1	GO:0000287; F:magnesium ion binding; ISS:UniProtKB
Q6PIW4	FIGNL1	Fidgetin-like protein 1	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q6PIW4	FIGNL1	Fidgetin-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q6PIW4	FIGNL1	Fidgetin-like protein 1	GO:0046034; P:ATP metabolic process; ISS:UniProtKB
Q6PIW4	FIGNL1	Fidgetin-like protein 1	GO:0071479; P:cellular response to ionizing radiation; IDA:UniProtKB
Q6PIW4	FIGNL1	Fidgetin-like protein 1	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB
Q6PIW4	FIGNL1	Fidgetin-like protein 1	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl
Q6PIW4	FIGNL1	Fidgetin-like protein 1	GO:0001649; P:osteoblast differentiation; ISS:UniProtKB
Q6PIW4	FIGNL1	Fidgetin-like protein 1	GO:0033687; P:osteoblast proliferation; ISS:UniProtKB
Q6PIW4	FIGNL1	Fidgetin-like protein 1	GO:0051726; P:regulation of cell cycle; ISS:UniProtKB
Q6PIW4	FIGNL1	Fidgetin-like protein 1	GO:0010569; P:regulation of double-strand break repair via homologous recombination; IDA:UniProtKB
A6NMB9	FIGNL2	Putative fidgetin-like protein 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
A6NMB9	FIGNL2	Putative fidgetin-like protein 2	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q6QHK4	FIGLA	Factor in the germline alpha	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6QHK4	FIGLA	Factor in the germline alpha	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q6QHK4	FIGLA	Factor in the germline alpha	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q6QHK4	FIGLA	Factor in the germline alpha	GO:0048599; P:oocyte development; NAS:UniProtKB
Q6QHK4	FIGLA	Factor in the germline alpha	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6QHK4	FIGLA	Factor in the germline alpha	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5HY92	FIGN	Fidgetin	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5HY92	FIGN	Fidgetin	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q5HY92	FIGN	Fidgetin	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P20930	FLG	Filaggrin	GO:0005509; F:calcium ion binding; IEA:InterPro
P20930	FLG	Filaggrin	GO:0005198; F:structural molecule activity; NAS:UniProtKB
P20930	FLG	Filaggrin	GO:0061436; P:establishment of skin barrier; IEP:UniProt
P20930	FLG	Filaggrin	GO:0030216; P:keratinocyte differentiation; TAS:BHF-UCL
P20930	FLG	Filaggrin	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
Q5D862	FLG2	Filaggrin-2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q5D862	FLG2	Filaggrin-2	GO:0005198; F:structural molecule activity; IEA:InterPro
Q5D862	FLG2	Filaggrin-2	GO:0061436; P:establishment of skin barrier; IEP:UniProt
P02751	FN1	Fibronectin	GO:0005518; F:collagen binding; NAS:UniProtKB
P02751	FN1	Fibronectin	GO:0008201; F:heparin binding; NAS:UniProtKB
P02751	FN1	Fibronectin	GO:0005178; F:integrin binding; IDA:UniProt
P02751	FN1	Fibronectin	GO:0016504; F:peptidase activator activity; IEA:Ensembl
P02751	FN1	Fibronectin	GO:0002020; F:protease binding; IPI:BHF-UCL
P02751	FN1	Fibronectin	GO:0005515; F:protein binding; IPI:IntAct
P02751	FN1	Fibronectin	GO:0006953; P:acute-phase response; IEA:UniProtKB-KW
P02751	FN1	Fibronectin	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P02751	FN1	Fibronectin	GO:0007596; P:blood coagulation; TAS:Reactome
P02751	FN1	Fibronectin	GO:0007161; P:calcium-independent cell-matrix adhesion; IEA:Ensembl
P02751	FN1	Fibronectin	GO:0007155; P:cell adhesion; NAS:UniProtKB
P02751	FN1	Fibronectin	GO:0007044; P:cell-substrate junction assembly; IEA:Ensembl
P02751	FN1	Fibronectin	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P02751	FN1	Fibronectin	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P02751	FN1	Fibronectin	GO:0050900; P:leukocyte migration; TAS:Reactome
P02751	FN1	Fibronectin	GO:0018149; P:peptide cross-linking; IDA:BHF-UCL
P02751	FN1	Fibronectin	GO:0030168; P:platelet activation; TAS:Reactome
P02751	FN1	Fibronectin	GO:0002576; P:platelet degranulation; TAS:Reactome
P02751	FN1	Fibronectin	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
P02751	FN1	Fibronectin	GO:0009611; P:response to wounding; NAS:UniProtKB
P02751	FN1	Fibronectin	GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:BHF-UCL
Q6UN15	FIP1L1	Pre-mRNA 3'-end-processing factor FIP1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6UN15	FIP1L1	Pre-mRNA 3'-end-processing factor FIP1	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9Y3D6	FIS1	Mitochondrial fission 1 protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y3D6	FIS1	Mitochondrial fission 1 protein	GO:0005102; F:receptor binding; IPI:UniProtKB
Q9Y3D6	FIS1	Mitochondrial fission 1 protein	GO:0035584; P:calcium-mediated signaling using intracellular calcium source; IMP:UniProtKB
Q9Y3D6	FIS1	Mitochondrial fission 1 protein	GO:0000266; P:mitochondrial fission; IDA:UniProtKB
Q9Y3D6	FIS1	Mitochondrial fission 1 protein	GO:0043653; P:mitochondrial fragmentation involved in apoptotic process; IDA:UniProtKB
Q9Y3D6	FIS1	Mitochondrial fission 1 protein	GO:0008053; P:mitochondrial fusion; IMP:UniProtKB
Q9Y3D6	FIS1	Mitochondrial fission 1 protein	GO:0000422; P:mitochondrion degradation; IDA:UniProtKB
Q9Y3D6	FIS1	Mitochondrial fission 1 protein	GO:0070584; P:mitochondrion morphogenesis; IMP:UniProtKB
Q9Y3D6	FIS1	Mitochondrial fission 1 protein	GO:0032471; P:negative regulation of endoplasmic reticulum calcium ion concentration; IMP:UniProtKB
Q9Y3D6	FIS1	Mitochondrial fission 1 protein	GO:0016559; P:peroxisome fission; IDA:UniProtKB
Q9Y3D6	FIS1	Mitochondrial fission 1 protein	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
Q9Y3D6	FIS1	Mitochondrial fission 1 protein	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IMP:UniProtKB
Q9Y3D6	FIS1	Mitochondrial fission 1 protein	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
Q9Y3D6	FIS1	Mitochondrial fission 1 protein	GO:0051561; P:positive regulation of mitochondrial calcium ion concentration; IMP:UniProtKB
Q9Y3D6	FIS1	Mitochondrial fission 1 protein	GO:0090141; P:positive regulation of mitochondrial fission; IDA:UniProtKB
Q9Y3D6	FIS1	Mitochondrial fission 1 protein	GO:0090314; P:positive regulation of protein targeting to membrane; IDA:UniProtKB
Q9Y3D6	FIS1	Mitochondrial fission 1 protein	GO:0051260; P:protein homooligomerization; IMP:UniProtKB
Q9Y3D6	FIS1	Mitochondrial fission 1 protein	GO:0006626; P:protein targeting to mitochondrion; IMP:UniProtKB
Q9Y3D6	FIS1	Mitochondrial fission 1 protein	GO:0010821; P:regulation of mitochondrion organization; IMP:UniProtKB
Q9Y3D6	FIS1	Mitochondrial fission 1 protein	GO:0001836; P:release of cytochrome c from mitochondria; IMP:UniProtKB
A5D6W6	FITM1	Fat storage-inducing transmembrane protein 1	GO:0034389; P:lipid particle organization; ISS:BHF-UCL
A5D6W6	FITM1	Fat storage-inducing transmembrane protein 1	GO:0010890; P:positive regulation of sequestering of triglyceride; ISS:BHF-UCL
Q8N6M3	FITM2	Fat storage-inducing transmembrane protein 2	GO:0035356; P:cellular triglyceride homeostasis; ISS:BHF-UCL
Q8N6M3	FITM2	Fat storage-inducing transmembrane protein 2	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q8N6M3	FITM2	Fat storage-inducing transmembrane protein 2	GO:0034389; P:lipid particle organization; ISS:UniProtKB
Q8N6M3	FITM2	Fat storage-inducing transmembrane protein 2	GO:0010890; P:positive regulation of sequestering of triglyceride; ISS:BHF-UCL
Q8N6M3	FITM2	Fat storage-inducing transmembrane protein 2	GO:0022604; P:regulation of cell morphogenesis; IMP:UniProtKB
Q8N6M3	FITM2	Fat storage-inducing transmembrane protein 2	GO:0010866; P:regulation of triglyceride biosynthetic process; ISS:BHF-UCL
Q96SL8	FIZ1	Flt3-interacting zinc finger protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96SL8	FIZ1	Flt3-interacting zinc finger protein 1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q96SL8	FIZ1	Flt3-interacting zinc finger protein 1	GO:0019901; F:protein kinase binding; ISS:UniProtKB
Q96SL8	FIZ1	Flt3-interacting zinc finger protein 1	GO:0005102; F:receptor binding; ISS:UniProtKB
Q96SL8	FIZ1	Flt3-interacting zinc finger protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96SL8	FIZ1	Flt3-interacting zinc finger protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96AY3	FKBP10	Peptidyl-prolyl cis-trans isomerase FKBP10	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96AY3	FKBP10	Peptidyl-prolyl cis-trans isomerase FKBP10	GO:0005528; F:FK506 binding; IBA:RefGenome
Q96AY3	FKBP10	Peptidyl-prolyl cis-trans isomerase FKBP10	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IBA:RefGenome
Q96AY3	FKBP10	Peptidyl-prolyl cis-trans isomerase FKBP10	GO:0018208; P:peptidyl-proline modification; IBA:RefGenome
Q96AY3	FKBP10	Peptidyl-prolyl cis-trans isomerase FKBP10	GO:0006457; P:protein folding; IEA:UniProtKB-KW
Q96AY3	FKBP10	Peptidyl-prolyl cis-trans isomerase FKBP10	GO:0000413; P:protein peptidyl-prolyl isomerization; IBA:GOC
Q9NYL4	FKBP11	Peptidyl-prolyl cis-trans isomerase FKBP11	GO:0005528; F:FK506 binding; IBA:RefGenome
Q9NYL4	FKBP11	Peptidyl-prolyl cis-trans isomerase FKBP11	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IBA:RefGenome
Q9NYL4	FKBP11	Peptidyl-prolyl cis-trans isomerase FKBP11	GO:0018208; P:peptidyl-proline modification; IBA:RefGenome
Q9NYL4	FKBP11	Peptidyl-prolyl cis-trans isomerase FKBP11	GO:0006457; P:protein folding; IEA:UniProtKB-KW
Q9NYL4	FKBP11	Peptidyl-prolyl cis-trans isomerase FKBP11	GO:0000413; P:protein peptidyl-prolyl isomerization; IBA:GOC
Q9NWM8	FKBP14	Peptidyl-prolyl cis-trans isomerase FKBP14	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NWM8	FKBP14	Peptidyl-prolyl cis-trans isomerase FKBP14	GO:0005528; F:FK506 binding; IBA:RefGenome
Q9NWM8	FKBP14	Peptidyl-prolyl cis-trans isomerase FKBP14	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IBA:RefGenome
Q9NWM8	FKBP14	Peptidyl-prolyl cis-trans isomerase FKBP14	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q9NWM8	FKBP14	Peptidyl-prolyl cis-trans isomerase FKBP14	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9NWM8	FKBP14	Peptidyl-prolyl cis-trans isomerase FKBP14	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q9NWM8	FKBP14	Peptidyl-prolyl cis-trans isomerase FKBP14	GO:0018208; P:peptidyl-proline modification; IBA:RefGenome
Q9NWM8	FKBP14	Peptidyl-prolyl cis-trans isomerase FKBP14	GO:0006457; P:protein folding; IEA:UniProtKB-KW
Q9NWM8	FKBP14	Peptidyl-prolyl cis-trans isomerase FKBP14	GO:0000413; P:protein peptidyl-prolyl isomerization; IBA:GOC
Q5T1M5	FKBP15	FK506-binding protein 15	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q5T1M5	FKBP15	FK506-binding protein 15	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q5T1M5	FKBP15	FK506-binding protein 15	GO:0006457; P:protein folding; IEA:InterPro
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0048185; F:activin binding; IPI:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0005528; F:FK506 binding; IDA:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0044325; F:ion channel binding; ISS:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0005527; F:macrolide binding; NAS:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IDA:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0005515; F:protein binding; IPI:UniProtKB
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0004871; F:signal transducer activity; IMP:UniProtKB
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0046332; F:SMAD binding; IPI:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0005160; F:transforming growth factor beta receptor binding; ISS:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0034713; F:type I transforming growth factor beta receptor binding; ISS:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0006458; P:'de novo' protein folding; TAS:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0034205; P:beta-amyloid formation; IDA:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0070588; P:calcium ion transmembrane transport; TAS:GOC
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0043206; P:extracellular fibril organization; IDA:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0003007; P:heart morphogenesis; ISS:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0060347; P:heart trabecula formation; ISS:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0032513; P:negative regulation of protein phosphatase type 2B activity; IDA:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0018208; P:peptidyl-proline modification; IBA:RefGenome
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0032092; P:positive regulation of protein binding; IDA:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0031398; P:positive regulation of protein ubiquitination; IDA:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0006457; P:protein folding; NAS:UniProtKB
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0022417; P:protein maturation by protein folding; TAS:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0000413; P:protein peptidyl-prolyl isomerization; IDA:GOC
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0042026; P:protein refolding; TAS:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0032925; P:regulation of activin receptor signaling pathway; IDA:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0050776; P:regulation of immune response; IMP:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0060314; P:regulation of ryanodine-sensitive calcium-release channel activity; IDA:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0007183; P:SMAD protein complex assembly; IDA:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0042110; P:T cell activation; NAS:BHF-UCL
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P62942	FKBP1A	Peptidyl-prolyl cis-trans isomerase FKBP1A	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; ISS:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0019855; F:calcium channel inhibitor activity; IDA:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0030551; F:cyclic nucleotide binding; IEA:Ensembl
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0005528; F:FK506 binding; IDA:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0044325; F:ion channel binding; ISS:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IDA:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0005515; F:protein binding; IPI:IntAct
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0005102; F:receptor binding; IPI:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0006458; P:'de novo' protein folding; TAS:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0070588; P:calcium ion transmembrane transport; TAS:GOC
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0035584; P:calcium-mediated signaling using intracellular calcium source; TAS:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0086064; P:cell communication by electrical coupling involved in cardiac conduction; TAS:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0051480; P:cytosolic calcium ion homeostasis; IDA:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0030073; P:insulin secretion; IEA:Ensembl
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0010459; P:negative regulation of heart rate; ISS:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0061179; P:negative regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0032513; P:negative regulation of protein phosphatase type 2B activity; IDA:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0051280; P:negative regulation of release of sequestered calcium ion into cytosol; IDA:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0060315; P:negative regulation of ryanodine-sensitive calcium-release channel activity; IDA:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0019227; P:neuronal action potential propagation; IEA:Ensembl
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0018208; P:peptidyl-proline modification; IBA:RefGenome
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0048680; P:positive regulation of axon regeneration; IEA:Ensembl
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0051284; P:positive regulation of sequestering of calcium ion; IDA:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0022417; P:protein maturation by protein folding; TAS:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0000413; P:protein peptidyl-prolyl isomerization; IDA:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0042026; P:protein refolding; TAS:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; ISS:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; IDA:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0060314; P:regulation of ryanodine-sensitive calcium-release channel activity; IDA:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0014808; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; IEA:Ensembl
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0009749; P:response to glucose; IEA:Ensembl
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0051775; P:response to redox state; IDA:BHF-UCL
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0033197; P:response to vitamin E; IEA:Ensembl
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0006939; P:smooth muscle contraction; IEA:Ensembl
P68106	FKBP1B	Peptidyl-prolyl cis-trans isomerase FKBP1B	GO:0042098; P:T cell proliferation; IEA:Ensembl
Q75LS8	FKBP9L	Putative FK506-binding protein 9-like protein	GO:0005509; F:calcium ion binding; IEA:InterPro
Q75LS8	FKBP9L	Putative FK506-binding protein 9-like protein	GO:0006457; P:protein folding; IEA:InterPro
P26885	FKBP2	Peptidyl-prolyl cis-trans isomerase FKBP2	GO:0005528; F:FK506 binding; IBA:RefGenome
P26885	FKBP2	Peptidyl-prolyl cis-trans isomerase FKBP2	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IBA:RefGenome
P26885	FKBP2	Peptidyl-prolyl cis-trans isomerase FKBP2	GO:0005515; F:protein binding; IPI:IntAct
P26885	FKBP2	Peptidyl-prolyl cis-trans isomerase FKBP2	GO:0018208; P:peptidyl-proline modification; IBA:RefGenome
P26885	FKBP2	Peptidyl-prolyl cis-trans isomerase FKBP2	GO:0006457; P:protein folding; IEA:UniProtKB-KW
P26885	FKBP2	Peptidyl-prolyl cis-trans isomerase FKBP2	GO:0000413; P:protein peptidyl-prolyl isomerization; IBA:GOC
Q00688	FKBP3	Peptidyl-prolyl cis-trans isomerase FKBP3	GO:0005528; F:FK506 binding; IBA:RefGenome
Q00688	FKBP3	Peptidyl-prolyl cis-trans isomerase FKBP3	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IBA:RefGenome
Q00688	FKBP3	Peptidyl-prolyl cis-trans isomerase FKBP3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q00688	FKBP3	Peptidyl-prolyl cis-trans isomerase FKBP3	GO:0005515; F:protein binding; IPI:IntAct
Q00688	FKBP3	Peptidyl-prolyl cis-trans isomerase FKBP3	GO:0004872; F:receptor activity; TAS:ProtInc
Q00688	FKBP3	Peptidyl-prolyl cis-trans isomerase FKBP3	GO:0018208; P:peptidyl-proline modification; IBA:RefGenome
Q00688	FKBP3	Peptidyl-prolyl cis-trans isomerase FKBP3	GO:0006457; P:protein folding; IEA:UniProtKB-KW
Q00688	FKBP3	Peptidyl-prolyl cis-trans isomerase FKBP3	GO:0000413; P:protein peptidyl-prolyl isomerization; IBA:GOC
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0005524; F:ATP binding; IEA:Ensembl
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0005528; F:FK506 binding; TAS:UniProtKB
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0005525; F:GTP binding; IEA:Ensembl
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0031072; F:heat shock protein binding; IPI:UniProtKB
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IDA:UniProtKB
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0005515; F:protein binding; IPI:UniProtKB
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0030674; F:protein binding, bridging; TAS:ProtInc
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0030521; P:androgen receptor signaling pathway; IEA:Ensembl
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0061077; P:chaperone-mediated protein folding; IDA:UniProtKB
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0006825; P:copper ion transport; IEA:Ensembl
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0007566; P:embryo implantation; IEA:Ensembl
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0046661; P:male sex differentiation; IEA:Ensembl
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0031115; P:negative regulation of microtubule polymerization; IEA:Ensembl
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0031111; P:negative regulation of microtubule polymerization or depolymerization; ISS:UniProtKB
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0010977; P:negative regulation of neuron projection development; ISS:UniProtKB
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0018208; P:peptidyl-proline modification; IBA:RefGenome
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0030850; P:prostate gland development; IEA:Ensembl
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0031503; P:protein complex localization; IEA:Ensembl
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0006457; P:protein folding; TAS:ProtInc
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0000413; P:protein peptidyl-prolyl isomerization; IDA:GOC
Q02790	FKBP4	Peptidyl-prolyl cis-trans isomerase FKBP4	GO:0006463; P:steroid hormone receptor complex assembly; IEA:Ensembl
Q13451	FKBP5	Peptidyl-prolyl cis-trans isomerase FKBP5	GO:0005528; F:FK506 binding; IBA:RefGenome
Q13451	FKBP5	Peptidyl-prolyl cis-trans isomerase FKBP5	GO:0031072; F:heat shock protein binding; IPI:UniProtKB
Q13451	FKBP5	Peptidyl-prolyl cis-trans isomerase FKBP5	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IDA:UniProtKB
Q13451	FKBP5	Peptidyl-prolyl cis-trans isomerase FKBP5	GO:0061077; P:chaperone-mediated protein folding; IDA:UniProtKB
Q13451	FKBP5	Peptidyl-prolyl cis-trans isomerase FKBP5	GO:0018208; P:peptidyl-proline modification; IBA:RefGenome
Q13451	FKBP5	Peptidyl-prolyl cis-trans isomerase FKBP5	GO:0006457; P:protein folding; TAS:ProtInc
Q13451	FKBP5	Peptidyl-prolyl cis-trans isomerase FKBP5	GO:0000413; P:protein peptidyl-prolyl isomerization; IDA:GOC
Q9Y680	FKBP7	Peptidyl-prolyl cis-trans isomerase FKBP7	GO:0005509; F:calcium ion binding; IEA:Ensembl
Q9Y680	FKBP7	Peptidyl-prolyl cis-trans isomerase FKBP7	GO:0005528; F:FK506 binding; IBA:RefGenome
Q9Y680	FKBP7	Peptidyl-prolyl cis-trans isomerase FKBP7	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IBA:RefGenome
Q9Y680	FKBP7	Peptidyl-prolyl cis-trans isomerase FKBP7	GO:0018208; P:peptidyl-proline modification; IBA:RefGenome
Q9Y680	FKBP7	Peptidyl-prolyl cis-trans isomerase FKBP7	GO:0006457; P:protein folding; IEA:UniProtKB-KW
Q9Y680	FKBP7	Peptidyl-prolyl cis-trans isomerase FKBP7	GO:0000413; P:protein peptidyl-prolyl isomerization; IBA:GOC
Q14318	FKBP8	Peptidyl-prolyl cis-trans isomerase FKBP8	GO:0005528; F:FK506 binding; IBA:RefGenome
Q14318	FKBP8	Peptidyl-prolyl cis-trans isomerase FKBP8	GO:0042802; F:identical protein binding; IPI:IntAct
Q14318	FKBP8	Peptidyl-prolyl cis-trans isomerase FKBP8	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14318	FKBP8	Peptidyl-prolyl cis-trans isomerase FKBP8	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IBA:RefGenome
Q14318	FKBP8	Peptidyl-prolyl cis-trans isomerase FKBP8	GO:0005515; F:protein binding; IPI:IntAct
Q14318	FKBP8	Peptidyl-prolyl cis-trans isomerase FKBP8	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q14318	FKBP8	Peptidyl-prolyl cis-trans isomerase FKBP8	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
Q14318	FKBP8	Peptidyl-prolyl cis-trans isomerase FKBP8	GO:0018208; P:peptidyl-proline modification; IBA:RefGenome
Q14318	FKBP8	Peptidyl-prolyl cis-trans isomerase FKBP8	GO:0006457; P:protein folding; IEA:UniProtKB-KW
Q14318	FKBP8	Peptidyl-prolyl cis-trans isomerase FKBP8	GO:0000413; P:protein peptidyl-prolyl isomerization; IBA:GOC
Q14318	FKBP8	Peptidyl-prolyl cis-trans isomerase FKBP8	GO:0016032; P:viral process; IEA:UniProtKB-KW
O75344	FKBP6	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	GO:0005528; F:FK506 binding; IBA:RefGenome
O75344	FKBP6	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	GO:0051879; F:Hsp90 protein binding; ISS:UniProtKB
O75344	FKBP6	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IBA:RefGenome
O75344	FKBP6	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O75344	FKBP6	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	GO:0043046; P:DNA methylation involved in gamete generation; ISS:UniProtKB
O75344	FKBP6	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	GO:0031047; P:gene silencing by RNA; ISS:UniProtKB
O75344	FKBP6	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	GO:0007126; P:meiotic nuclear division; ISS:UniProtKB
O75344	FKBP6	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	GO:0018208; P:peptidyl-proline modification; IBA:RefGenome
O75344	FKBP6	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	GO:0034587; P:piRNA metabolic process; ISS:UniProtKB
O75344	FKBP6	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	GO:0006457; P:protein folding; ISS:UniProtKB
O75344	FKBP6	Inactive peptidyl-prolyl cis-trans isomerase FKBP6	GO:0007283; P:spermatogenesis; ISS:UniProtKB
O95302	FKBP9	Peptidyl-prolyl cis-trans isomerase FKBP9	GO:0005509; F:calcium ion binding; IEA:InterPro
O95302	FKBP9	Peptidyl-prolyl cis-trans isomerase FKBP9	GO:0005528; F:FK506 binding; IBA:RefGenome
O95302	FKBP9	Peptidyl-prolyl cis-trans isomerase FKBP9	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IBA:RefGenome
O95302	FKBP9	Peptidyl-prolyl cis-trans isomerase FKBP9	GO:0018208; P:peptidyl-proline modification; IBA:RefGenome
O95302	FKBP9	Peptidyl-prolyl cis-trans isomerase FKBP9	GO:0006457; P:protein folding; IEA:InterPro
O95302	FKBP9	Peptidyl-prolyl cis-trans isomerase FKBP9	GO:0000413; P:protein peptidyl-prolyl isomerization; IBA:GOC
Q9UIM3	FKBPL	FK506-binding protein-like	GO:0005528; F:FK506 binding; IBA:RefGenome
Q9UIM3	FKBPL	FK506-binding protein-like	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IBA:RefGenome
Q9UIM3	FKBPL	FK506-binding protein-like	GO:0018208; P:peptidyl-proline modification; IBA:RefGenome
Q9UIM3	FKBPL	FK506-binding protein-like	GO:0000413; P:protein peptidyl-prolyl isomerization; IBA:GOC
Q9UIM3	FKBPL	FK506-binding protein-like	GO:0009314; P:response to radiation; NAS:UniProtKB
Q9H9S5	FKRP	Fukutin-related protein	GO:0016740; F:transferase activity; IEA:UniProtKB-KW
Q9H9S5	FKRP	Fukutin-related protein	GO:0009101; P:glycoprotein biosynthetic process; IEA:Ensembl
Q9H9S5	FKRP	Fukutin-related protein	GO:0016485; P:protein processing; IEA:Ensembl
O75072	FKTN	Fukutin	GO:0016740; F:transferase activity; IEA:UniProtKB-KW
O75072	FKTN	Fukutin	GO:0007517; P:muscle organ development; TAS:ProtInc
O75072	FKTN	Fukutin	GO:0008285; P:negative regulation of cell proliferation; IMP:BHF-UCL
O75072	FKTN	Fukutin	GO:0046329; P:negative regulation of JNK cascade; IMP:BHF-UCL
O75072	FKTN	Fukutin	GO:0007399; P:nervous system development; TAS:ProtInc
O75072	FKTN	Fukutin	GO:0060049; P:regulation of protein glycosylation; NAS:BHF-UCL
Q15007	WTAP	Pre-mRNA-splicing regulator WTAP	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q15007	WTAP	Pre-mRNA-splicing regulator WTAP	GO:0080009; P:mRNA methylation; IMP:UniProtKB
Q15007	WTAP	Pre-mRNA-splicing regulator WTAP	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q15007	WTAP	Pre-mRNA-splicing regulator WTAP	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IMP:UniProtKB
Q15007	WTAP	Pre-mRNA-splicing regulator WTAP	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q8NFG4	FLCN	Folliculin	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0032403; F:protein complex binding; IDA:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0007043; P:cell-cell junction assembly; ISS:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0030097; P:hemopoiesis; ISS:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0001701; P:in utero embryonic development; ISS:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:2001170; P:negative regulation of ATP biosynthetic process; ISS:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:1901723; P:negative regulation of cell proliferation involved in kidney development; ISS:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:2000506; P:negative regulation of energy homeostasis; ISS:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0010629; P:negative regulation of gene expression; ISS:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0010823; P:negative regulation of mitochondrion organization; ISS:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0051898; P:negative regulation of protein kinase B signaling; ISS:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:1900181; P:negative regulation of protein localization to nucleus; IDA:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0035024; P:negative regulation of Rho protein signal transduction; IMP:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0032007; P:negative regulation of TOR signaling; ISS:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0045785; P:positive regulation of cell adhesion; IMP:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0032008; P:positive regulation of TOR signaling; ISS:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0032465; P:regulation of cytokinesis; IMP:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0035065; P:regulation of histone acetylation; ISS:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:2000973; P:regulation of pro-B cell differentiation; ISS:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0001932; P:regulation of protein phosphorylation; IDA:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0032006; P:regulation of TOR signaling; ISS:UniProtKB
Q8NFG4	FLCN	Folliculin	GO:0031929; P:TOR signaling; IMP:UniProtKB
Q01543	FLI1	Friend leukemia integration 1 transcription factor	GO:0003677; F:DNA binding; TAS:ProtInc
Q01543	FLI1	Friend leukemia integration 1 transcription factor	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q01543	FLI1	Friend leukemia integration 1 transcription factor	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q01543	FLI1	Friend leukemia integration 1 transcription factor	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q01543	FLI1	Friend leukemia integration 1 transcription factor	GO:0030154; P:cell differentiation; IBA:RefGenome
Q01543	FLI1	Friend leukemia integration 1 transcription factor	GO:0007599; P:hemostasis; TAS:ProtInc
Q01543	FLI1	Friend leukemia integration 1 transcription factor	GO:0009887; P:organ morphogenesis; TAS:ProtInc
Q01543	FLI1	Friend leukemia integration 1 transcription factor	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q01543	FLI1	Friend leukemia integration 1 transcription factor	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q13045	FLII	Protein flightless-1 homolog	GO:0003779; F:actin binding; TAS:ProtInc
Q13045	FLII	Protein flightless-1 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q13045	FLII	Protein flightless-1 homolog	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q13045	FLII	Protein flightless-1 homolog	GO:0006936; P:muscle contraction; TAS:ProtInc
Q13045	FLII	Protein flightless-1 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q13045	FLII	Protein flightless-1 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P21333	FLNA	Filamin-A	GO:0051015; F:actin filament binding; IDA:BHF-UCL
P21333	FLNA	Filamin-A	GO:0034988; F:Fc-gamma receptor I complex binding; IDA:BHF-UCL
P21333	FLNA	Filamin-A	GO:0001948; F:glycoprotein binding; IDA:BHF-UCL
P21333	FLNA	Filamin-A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P21333	FLNA	Filamin-A	GO:0005515; F:protein binding; IPI:UniProtKB
P21333	FLNA	Filamin-A	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
P21333	FLNA	Filamin-A	GO:0048365; F:Rac GTPase binding; IDA:BHF-UCL
P21333	FLNA	Filamin-A	GO:0017160; F:Ral GTPase binding; IDA:BHF-UCL
P21333	FLNA	Filamin-A	GO:0017048; F:Rho GTPase binding; IDA:BHF-UCL
P21333	FLNA	Filamin-A	GO:0004871; F:signal transducer activity; IMP:UniProtKB
P21333	FLNA	Filamin-A	GO:0031267; F:small GTPase binding; IDA:BHF-UCL
P21333	FLNA	Filamin-A	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P21333	FLNA	Filamin-A	GO:0051764; P:actin crosslink formation; IDA:BHF-UCL
P21333	FLNA	Filamin-A	GO:0031532; P:actin cytoskeleton reorganization; IDA:BHF-UCL
P21333	FLNA	Filamin-A	GO:0007195; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; IMP:BHF-UCL
P21333	FLNA	Filamin-A	GO:0007596; P:blood coagulation; TAS:Reactome
P21333	FLNA	Filamin-A	GO:0034329; P:cell junction assembly; TAS:Reactome
P21333	FLNA	Filamin-A	GO:0042384; P:cilium assembly; IMP:UniProtKB
P21333	FLNA	Filamin-A	GO:0051220; P:cytoplasmic sequestering of protein; IMP:BHF-UCL
P21333	FLNA	Filamin-A	GO:0045022; P:early endosome to late endosome transport; IEA:Ensembl
P21333	FLNA	Filamin-A	GO:0001837; P:epithelial to mesenchymal transition; IEA:Ensembl
P21333	FLNA	Filamin-A	GO:0045184; P:establishment of protein localization; IDA:BHF-UCL
P21333	FLNA	Filamin-A	GO:0042789; P:mRNA transcription from RNA polymerase II promoter; IEA:Ensembl
P21333	FLNA	Filamin-A	GO:0042177; P:negative regulation of protein catabolic process; IMP:BHF-UCL
P21333	FLNA	Filamin-A	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P21333	FLNA	Filamin-A	GO:0030168; P:platelet activation; TAS:Reactome
P21333	FLNA	Filamin-A	GO:0002576; P:platelet degranulation; TAS:Reactome
P21333	FLNA	Filamin-A	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
P21333	FLNA	Filamin-A	GO:0042993; P:positive regulation of transcription factor import into nucleus; IMP:UniProtKB
P21333	FLNA	Filamin-A	GO:0034394; P:protein localization to cell surface; IDA:BHF-UCL
P21333	FLNA	Filamin-A	GO:0050821; P:protein stabilization; IMP:BHF-UCL
P21333	FLNA	Filamin-A	GO:0043113; P:receptor clustering; IDA:BHF-UCL
P21333	FLNA	Filamin-A	GO:0090307; P:spindle assembly involved in mitosis; IDA:MGI
O75369	FLNB	Filamin-B	GO:0003779; F:actin binding; NAS:UniProtKB
O75369	FLNB	Filamin-B	GO:0042802; F:identical protein binding; IPI:IntAct
O75369	FLNB	Filamin-B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75369	FLNB	Filamin-B	GO:0005515; F:protein binding; IPI:UniProtKB
O75369	FLNB	Filamin-B	GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc
O75369	FLNB	Filamin-B	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O75369	FLNB	Filamin-B	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
O75369	FLNB	Filamin-B	GO:0007016; P:cytoskeletal anchoring at plasma membrane; TAS:ProtInc
O75369	FLNB	Filamin-B	GO:0007165; P:signal transduction; TAS:ProtInc
O75369	FLNB	Filamin-B	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
Q14315	FLNC	Filamin-C	GO:0030506; F:ankyrin binding; IPI:BHF-UCL
Q14315	FLNC	Filamin-C	GO:0008092; F:cytoskeletal protein binding; IPI:UniProtKB
Q14315	FLNC	Filamin-C	GO:0005515; F:protein binding; IPI:UniProtKB
Q14315	FLNC	Filamin-C	GO:0034329; P:cell junction assembly; TAS:Reactome
Q14315	FLNC	Filamin-C	GO:0048747; P:muscle fiber development; IEA:Ensembl
O75955	FLOT1	Flotillin-1	GO:0005515; F:protein binding; IPI:IntAct
O75955	FLOT1	Flotillin-1	GO:0007409; P:axonogenesis; IEA:Ensembl
O75955	FLOT1	Flotillin-1	GO:0072659; P:protein localization to plasma membrane; IEA:Ensembl
O75955	FLOT1	Flotillin-1	GO:0035023; P:regulation of Rho protein signal transduction; IEA:Ensembl
Q14254	FLOT2	Flotillin-2	GO:0005515; F:protein binding; IPI:IntAct
Q14254	FLOT2	Flotillin-2	GO:0007155; P:cell adhesion; NAS:ProtInc
Q14254	FLOT2	Flotillin-2	GO:0008544; P:epidermis development; TAS:ProtInc
Q9UGQ2	CACFD1	Calcium channel flower homolog	GO:0005262; F:calcium channel activity; IEA:InterPro
Q9UGQ2	CACFD1	Calcium channel flower homolog	GO:0048488; P:synaptic vesicle endocytosis; IEA:InterPro
Q9NZU1	FLRT1	Leucine-rich repeat transmembrane protein FLRT1	GO:0030674; F:protein binding, bridging; NAS:UniProtKB
Q9NZU1	FLRT1	Leucine-rich repeat transmembrane protein FLRT1	GO:0005057; F:receptor signaling protein activity; NAS:UniProtKB
Q9NZU1	FLRT1	Leucine-rich repeat transmembrane protein FLRT1	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9NZU1	FLRT1	Leucine-rich repeat transmembrane protein FLRT1	GO:0035556; P:intracellular signal transduction; NAS:GOC
O43155	FLRT2	Leucine-rich repeat transmembrane protein FLRT2	GO:0030674; F:protein binding, bridging; NAS:UniProtKB
O43155	FLRT2	Leucine-rich repeat transmembrane protein FLRT2	GO:0005057; F:receptor signaling protein activity; NAS:UniProtKB
O43155	FLRT2	Leucine-rich repeat transmembrane protein FLRT2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
O43155	FLRT2	Leucine-rich repeat transmembrane protein FLRT2	GO:0035556; P:intracellular signal transduction; NAS:GOC
Q9NZU0	FLRT3	Leucine-rich repeat transmembrane protein FLRT3	GO:0030674; F:protein binding, bridging; NAS:UniProtKB
Q9NZU0	FLRT3	Leucine-rich repeat transmembrane protein FLRT3	GO:0005057; F:receptor signaling protein activity; NAS:UniProtKB
Q9NZU0	FLRT3	Leucine-rich repeat transmembrane protein FLRT3	GO:0007411; P:axon guidance; IEA:Ensembl
Q9NZU0	FLRT3	Leucine-rich repeat transmembrane protein FLRT3	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9NZU0	FLRT3	Leucine-rich repeat transmembrane protein FLRT3	GO:0035556; P:intracellular signal transduction; NAS:GOC
P49771	FLT3LG	Fms-related tyrosine kinase 3 ligand	GO:0005102; F:receptor binding; TAS:ProtInc
P49771	FLT3LG	Fms-related tyrosine kinase 3 ligand	GO:0035162; P:embryonic hemopoiesis; IDA:DFLAT
P49771	FLT3LG	Fms-related tyrosine kinase 3 ligand	GO:0030098; P:lymphocyte differentiation; IEA:Ensembl
P49771	FLT3LG	Fms-related tyrosine kinase 3 ligand	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P49771	FLT3LG	Fms-related tyrosine kinase 3 ligand	GO:0032825; P:positive regulation of natural killer cell differentiation; IEA:Ensembl
P49771	FLT3LG	Fms-related tyrosine kinase 3 ligand	GO:0007165; P:signal transduction; TAS:ProtInc
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0004896; F:cytokine receptor activity; ISS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0005515; F:protein binding; IPI:IntAct
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0042803; F:protein homodimerization activity; TAS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; TAS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0005021; F:vascular endothelial growth factor-activated receptor activity; TAS:ProtInc
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0030183; P:B cell differentiation; ISS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0071345; P:cellular response to cytokine stimulus; ISS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0035726; P:common myeloid progenitor cell proliferation; ISS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0019221; P:cytokine-mediated signaling pathway; ISS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0097028; P:dendritic cell differentiation; ISS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0030097; P:hemopoiesis; IDA:MGI
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0001776; P:leukocyte homeostasis; ISS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0046651; P:lymphocyte proliferation; ISS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0002318; P:myeloid progenitor cell differentiation; ISS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0045578; P:negative regulation of B cell differentiation; IEA:Ensembl
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0008284; P:positive regulation of cell proliferation; TAS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0043406; P:positive regulation of MAP kinase activity; TAS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0043410; P:positive regulation of MAPK cascade; TAS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; TAS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; TAS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; TAS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0002328; P:pro-B cell differentiation; ISS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0002572; P:pro-T cell differentiation; IEA:Ensembl
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0046777; P:protein autophosphorylation; TAS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc
P36888	FLT3	Receptor-type tyrosine-protein kinase FLT3	GO:0038084; P:vascular endothelial growth factor signaling pathway; TAS:GOC
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0015232; F:heme transporter activity; IDA:UniProtKB
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0005215; F:transporter activity; TAS:ProtInc
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0001568; P:blood vessel development; IEA:Ensembl
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0030218; P:erythrocyte differentiation; IDA:MGI
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0043249; P:erythrocyte maturation; IEA:UniProtKB-KW
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0060323; P:head morphogenesis; IEA:Ensembl
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0097037; P:heme export; IMP:UniProtKB
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0015886; P:heme transport; IMP:MGI
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0006839; P:mitochondrial transport; IDA:MGI
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0046620; P:regulation of organ growth; IEA:Ensembl
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0048536; P:spleen development; IEA:Ensembl
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9Y5Y0	FLVCR1	Feline leukemia virus subgroup C receptor-related protein 1	GO:0006810; P:transport; TAS:ProtInc
Q9UPI3	FLVCR2	Feline leukemia virus subgroup C receptor-related protein 2	GO:0020037; F:heme binding; IDA:UniProtKB
Q9UPI3	FLVCR2	Feline leukemia virus subgroup C receptor-related protein 2	GO:0015232; F:heme transporter activity; IDA:UniProtKB
Q9UPI3	FLVCR2	Feline leukemia virus subgroup C receptor-related protein 2	GO:0015886; P:heme transport; IDA:GOC
Q9UPI3	FLVCR2	Feline leukemia virus subgroup C receptor-related protein 2	GO:0055085; P:transmembrane transport; IEA:InterPro
Q68DA7	FMN1	Formin-1	GO:0003677; F:DNA binding; IEA:Ensembl
Q68DA7	FMN1	Formin-1	GO:0045010; P:actin nucleation; IEA:InterPro
Q68DA7	FMN1	Formin-1	GO:0035136; P:forelimb morphogenesis; IEA:Ensembl
Q68DA7	FMN1	Formin-1	GO:0010467; P:gene expression; IEA:Ensembl
Q68DA7	FMN1	Formin-1	GO:0035137; P:hindlimb morphogenesis; IEA:Ensembl
Q68DA7	FMN1	Formin-1	GO:0051127; P:positive regulation of actin nucleation; IEA:Ensembl
Q68DA7	FMN1	Formin-1	GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl
Q9NZ56	FMN2	Formin-2	GO:0003779; F:actin binding; IDA:UniProtKB
Q9NZ56	FMN2	Formin-2	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
Q9NZ56	FMN2	Formin-2	GO:0071456; P:cellular response to hypoxia; IMP:UniProtKB
Q9NZ56	FMN2	Formin-2	GO:0051295; P:establishment of meiotic spindle localization; ISS:BHF-UCL
Q9NZ56	FMN2	Formin-2	GO:0070649; P:formin-nucleated actin cable assembly; ISS:UniProtKB
Q9NZ56	FMN2	Formin-2	GO:0051758; P:homologous chromosome movement towards spindle pole involved in homologous chromosome segregation; ISS:BHF-UCL
Q9NZ56	FMN2	Formin-2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9NZ56	FMN2	Formin-2	GO:0046907; P:intracellular transport; ISS:UniProtKB
Q9NZ56	FMN2	Formin-2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9NZ56	FMN2	Formin-2	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q9NZ56	FMN2	Formin-2	GO:0042177; P:negative regulation of protein catabolic process; IMP:UniProtKB
Q9NZ56	FMN2	Formin-2	GO:0048477; P:oogenesis; ISS:BHF-UCL
Q9NZ56	FMN2	Formin-2	GO:0040038; P:polar body extrusion after meiotic divisions; ISS:BHF-UCL
Q9NZ56	FMN2	Formin-2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9NZ56	FMN2	Formin-2	GO:0016192; P:vesicle-mediated transport; ISS:UniProtKB
Q96PY5	FMNL2	Formin-like protein 2	GO:0030866; P:cortical actin cytoskeleton organization; IMP:UniProtKB
Q96PY5	FMNL2	Formin-like protein 2	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q96PY5	FMNL2	Formin-like protein 2	GO:0022604; P:regulation of cell morphogenesis; IMP:UniProtKB
Q8IVF7	FMNL3	Formin-like protein 3	GO:0032794; F:GTPase activating protein binding; ISS:UniProtKB
Q8IVF7	FMNL3	Formin-like protein 3	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
Q8IVF7	FMNL3	Formin-like protein 3	GO:0016477; P:cell migration; IMP:UniProtKB
Q8IVF7	FMNL3	Formin-like protein 3	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q8IVF7	FMNL3	Formin-like protein 3	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
O95466	FMNL1	Formin-like protein 1	GO:0051015; F:actin filament binding; ISS:UniProtKB
O95466	FMNL1	Formin-like protein 1	GO:0032794; F:GTPase activating protein binding; IDA:UniProtKB
O95466	FMNL1	Formin-like protein 1	GO:0005515; F:protein binding; IPI:IntAct
O95466	FMNL1	Formin-like protein 1	GO:0048365; F:Rac GTPase binding; ISS:UniProtKB
O95466	FMNL1	Formin-like protein 1	GO:0051014; P:actin filament severing; ISS:UniProtKB
O95466	FMNL1	Formin-like protein 1	GO:0030866; P:cortical actin cytoskeleton organization; IMP:UniProtKB
O95466	FMNL1	Formin-like protein 1	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
O95466	FMNL1	Formin-like protein 1	GO:0006929; P:substrate-dependent cell migration; IEA:Ensembl
Q01740	FMO1	Dimethylaniline monooxygenase [N-oxide-forming] 1	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q01740	FMO1	Dimethylaniline monooxygenase [N-oxide-forming] 1	GO:0004497; F:monooxygenase activity; IDA:MGI
Q01740	FMO1	Dimethylaniline monooxygenase [N-oxide-forming] 1	GO:0004499; F:N,N-dimethylaniline monooxygenase activity; IEA:InterPro
Q01740	FMO1	Dimethylaniline monooxygenase [N-oxide-forming] 1	GO:0050661; F:NADP binding; IEA:InterPro
Q01740	FMO1	Dimethylaniline monooxygenase [N-oxide-forming] 1	GO:0070995; P:NADPH oxidation; IDA:BHF-UCL
Q01740	FMO1	Dimethylaniline monooxygenase [N-oxide-forming] 1	GO:0006082; P:organic acid metabolic process; IDA:BHF-UCL
Q01740	FMO1	Dimethylaniline monooxygenase [N-oxide-forming] 1	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
Q01740	FMO1	Dimethylaniline monooxygenase [N-oxide-forming] 1	GO:0006970; P:response to osmotic stress; IEA:Ensembl
Q01740	FMO1	Dimethylaniline monooxygenase [N-oxide-forming] 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q01740	FMO1	Dimethylaniline monooxygenase [N-oxide-forming] 1	GO:0009404; P:toxin metabolic process; IDA:BHF-UCL
Q01740	FMO1	Dimethylaniline monooxygenase [N-oxide-forming] 1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q99518	FMO2	Dimethylaniline monooxygenase [N-oxide-forming] 2	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q99518	FMO2	Dimethylaniline monooxygenase [N-oxide-forming] 2	GO:0004497; F:monooxygenase activity; TAS:Reactome
Q99518	FMO2	Dimethylaniline monooxygenase [N-oxide-forming] 2	GO:0004499; F:N,N-dimethylaniline monooxygenase activity; IDA:BHF-UCL
Q99518	FMO2	Dimethylaniline monooxygenase [N-oxide-forming] 2	GO:0050661; F:NADP binding; IEA:InterPro
Q99518	FMO2	Dimethylaniline monooxygenase [N-oxide-forming] 2	GO:0017144; P:drug metabolic process; IDA:BHF-UCL
Q99518	FMO2	Dimethylaniline monooxygenase [N-oxide-forming] 2	GO:0006739; P:NADP metabolic process; IDA:BHF-UCL
Q99518	FMO2	Dimethylaniline monooxygenase [N-oxide-forming] 2	GO:0070995; P:NADPH oxidation; IDA:UniProtKB
Q99518	FMO2	Dimethylaniline monooxygenase [N-oxide-forming] 2	GO:0006082; P:organic acid metabolic process; IDA:BHF-UCL
Q99518	FMO2	Dimethylaniline monooxygenase [N-oxide-forming] 2	GO:0072592; P:oxygen metabolic process; IEA:Ensembl
Q99518	FMO2	Dimethylaniline monooxygenase [N-oxide-forming] 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99518	FMO2	Dimethylaniline monooxygenase [N-oxide-forming] 2	GO:0009404; P:toxin metabolic process; IDA:BHF-UCL
Q99518	FMO2	Dimethylaniline monooxygenase [N-oxide-forming] 2	GO:0006805; P:xenobiotic metabolic process; IDA:BHF-UCL
P31513	FMO3	Dimethylaniline monooxygenase [N-oxide-forming] 3	GO:0016597; F:amino acid binding; IEA:Ensembl
P31513	FMO3	Dimethylaniline monooxygenase [N-oxide-forming] 3	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
P31513	FMO3	Dimethylaniline monooxygenase [N-oxide-forming] 3	GO:0004499; F:N,N-dimethylaniline monooxygenase activity; TAS:Reactome
P31513	FMO3	Dimethylaniline monooxygenase [N-oxide-forming] 3	GO:0050661; F:NADP binding; IEA:Ensembl
P31513	FMO3	Dimethylaniline monooxygenase [N-oxide-forming] 3	GO:0034899; F:trimethylamine monooxygenase activity; IEA:UniProtKB-EC
P31513	FMO3	Dimethylaniline monooxygenase [N-oxide-forming] 3	GO:0017144; P:drug metabolic process; IEA:Ensembl
P31513	FMO3	Dimethylaniline monooxygenase [N-oxide-forming] 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P31513	FMO3	Dimethylaniline monooxygenase [N-oxide-forming] 3	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P31512	FMO4	Dimethylaniline monooxygenase [N-oxide-forming] 4	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
P31512	FMO4	Dimethylaniline monooxygenase [N-oxide-forming] 4	GO:0004499; F:N,N-dimethylaniline monooxygenase activity; NAS:UniProtKB
P31512	FMO4	Dimethylaniline monooxygenase [N-oxide-forming] 4	GO:0050661; F:NADP binding; IEA:InterPro
P49326	FMO5	Dimethylaniline monooxygenase [N-oxide-forming] 5	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
P49326	FMO5	Dimethylaniline monooxygenase [N-oxide-forming] 5	GO:0004499; F:N,N-dimethylaniline monooxygenase activity; IEA:UniProtKB-EC
P49326	FMO5	Dimethylaniline monooxygenase [N-oxide-forming] 5	GO:0050661; F:NADP binding; IEA:InterPro
O60774	FMO6P	Putative dimethylaniline monooxygenase [N-oxide-forming] 6	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
O60774	FMO6P	Putative dimethylaniline monooxygenase [N-oxide-forming] 6	GO:0004499; F:N,N-dimethylaniline monooxygenase activity; IEA:UniProtKB-EC
O60774	FMO6P	Putative dimethylaniline monooxygenase [N-oxide-forming] 6	GO:0050661; F:NADP binding; IEA:InterPro
Q06828	FMOD	Fibromodulin	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q06828	FMOD	Fibromodulin	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q06828	FMOD	Fibromodulin	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q06828	FMOD	Fibromodulin	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
Q06828	FMOD	Fibromodulin	GO:0042340; P:keratan sulfate catabolic process; TAS:Reactome
Q06828	FMOD	Fibromodulin	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
Q06828	FMOD	Fibromodulin	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q06828	FMOD	Fibromodulin	GO:0007181; P:transforming growth factor beta receptor complex assembly; TAS:ProtInc
Q06787	FMR1	Fragile X mental retardation protein 1	GO:0003729; F:mRNA binding; TAS:ProtInc
Q06787	FMR1	Fragile X mental retardation protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q06787	FMR1	Fragile X mental retardation protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q06787	FMR1	Fragile X mental retardation protein 1	GO:0003723; F:RNA binding; TAS:ProtInc
Q06787	FMR1	Fragile X mental retardation protein 1	GO:0007417; P:central nervous system development; IEA:Ensembl
Q06787	FMR1	Fragile X mental retardation protein 1	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q06787	FMR1	Fragile X mental retardation protein 1	GO:0045947; P:negative regulation of translational initiation; ISS:UniProtKB
Q96DP5	MTFMT	Methionyl-tRNA formyltransferase, mitochondrial	GO:0004479; F:methionyl-tRNA formyltransferase activity; IEA:UniProtKB-EC
Q9H479	FN3K	Fructosamine-3-kinase	GO:0030387; F:fructosamine-3-kinase activity; NAS:UniProtKB
Q9H479	FN3K	Fructosamine-3-kinase	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
Q9H479	FN3K	Fructosamine-3-kinase	GO:0030393; P:fructoselysine metabolic process; NAS:UniProtKB
Q96RU3	FNBP1	Formin-binding protein 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q96RU3	FNBP1	Formin-binding protein 1	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q96RU3	FNBP1	Formin-binding protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96RU3	FNBP1	Formin-binding protein 1	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q8N3X1	FNBP4	Formin-binding protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2H6	FNDC3A	Fibronectin type-III domain-containing protein 3A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y2H6	FNDC3A	Fibronectin type-III domain-containing protein 3A	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
Q9Y2H6	FNDC3A	Fibronectin type-III domain-containing protein 3A	GO:0009566; P:fertilization; IEA:Ensembl
Q9Y2H6	FNDC3A	Fibronectin type-III domain-containing protein 3A	GO:0060009; P:Sertoli cell development; IEA:Ensembl
Q9Y2H6	FNDC3A	Fibronectin type-III domain-containing protein 3A	GO:0007286; P:spermatid development; IEA:Ensembl
Q53EP0	FNDC3B	Fibronectin type III domain-containing protein 3B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q53EP0	FNDC3B	Fibronectin type III domain-containing protein 3B	GO:0045600; P:positive regulation of fat cell differentiation; IEA:Ensembl
Q4ZHG4	FNDC1	Fibronectin type III domain-containing protein 1	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
Q4ZHG4	FNDC1	Fibronectin type III domain-containing protein 1	GO:0010666; P:positive regulation of cardiac muscle cell apoptotic process; IEA:Ensembl
Q4ZHG4	FNDC1	Fibronectin type III domain-containing protein 1	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
Q4ZHG4	FNDC1	Fibronectin type III domain-containing protein 1	GO:0051223; P:regulation of protein transport; IEA:Ensembl
Q8NAU1	FNDC5	Fibronectin type III domain-containing protein 5	GO:0090336; P:positive regulation of brown fat cell differentiation; ISS:UniProtKB
Q8NAU1	FNDC5	Fibronectin type III domain-containing protein 5	GO:0014850; P:response to muscle activity; ISS:UniProtKB
Q8TF40	FNIP1	Folliculin-interacting protein 1	GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q8TF40	FNIP1	Folliculin-interacting protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TF40	FNIP1	Folliculin-interacting protein 1	GO:0009267; P:cellular response to starvation; ISS:UniProtKB
Q8TF40	FNIP1	Folliculin-interacting protein 1	GO:0002327; P:immature B cell differentiation; ISS:UniProtKB
Q8TF40	FNIP1	Folliculin-interacting protein 1	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; ISS:UniProtKB
Q8TF40	FNIP1	Folliculin-interacting protein 1	GO:0032007; P:negative regulation of TOR signaling; ISS:UniProtKB
Q8TF40	FNIP1	Folliculin-interacting protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q8TF40	FNIP1	Folliculin-interacting protein 1	GO:0002904; P:positive regulation of B cell apoptotic process; ISS:UniProtKB
Q8TF40	FNIP1	Folliculin-interacting protein 1	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:UniProtKB
Q8TF40	FNIP1	Folliculin-interacting protein 1	GO:0001934; P:positive regulation of protein phosphorylation; IMP:UniProtKB
Q8TF40	FNIP1	Folliculin-interacting protein 1	GO:0043087; P:regulation of GTPase activity; IDA:GOC
Q8TF40	FNIP1	Folliculin-interacting protein 1	GO:2000973; P:regulation of pro-B cell differentiation; ISS:UniProtKB
Q8TF40	FNIP1	Folliculin-interacting protein 1	GO:0001932; P:regulation of protein phosphorylation; IDA:UniProtKB
Q8TF40	FNIP1	Folliculin-interacting protein 1	GO:0031929; P:TOR signaling; IMP:UniProtKB
Q9P278	FNIP2	Folliculin-interacting protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P278	FNIP2	Folliculin-interacting protein 2	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; ISS:UniProtKB
Q9P278	FNIP2	Folliculin-interacting protein 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9P278	FNIP2	Folliculin-interacting protein 2	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:UniProtKB
Q9P278	FNIP2	Folliculin-interacting protein 2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9P278	FNIP2	Folliculin-interacting protein 2	GO:0001932; P:regulation of protein phosphorylation; IDA:UniProtKB
P49354	FNTA	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha	GO:0043014; F:alpha-tubulin binding; IDA:BHF-UCL
P49354	FNTA	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha	GO:0004662; F:CAAX-protein geranylgeranyltransferase activity; IEA:UniProtKB-EC
P49354	FNTA	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha	GO:0008017; F:microtubule binding; IDA:BHF-UCL
P49354	FNTA	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha	GO:0005515; F:protein binding; IPI:IntAct
P49354	FNTA	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha	GO:0004660; F:protein farnesyltransferase activity; IDA:UniProtKB
P49354	FNTA	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha	GO:0004661; F:protein geranylgeranyltransferase activity; IDA:UniProtKB
P49354	FNTA	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha	GO:0006915; P:apoptotic process; TAS:Reactome
P49354	FNTA	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
P49354	FNTA	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P49354	FNTA	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha	GO:0090045; P:positive regulation of deacetylase activity; IDA:BHF-UCL
P49354	FNTA	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha	GO:0090044; P:positive regulation of tubulin deacetylation; IDA:BHF-UCL
P49354	FNTA	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha	GO:0018343; P:protein farnesylation; IDA:UniProtKB
P49354	FNTA	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha	GO:0018344; P:protein geranylgeranylation; IDA:UniProtKB
P49354	FNTA	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
P49354	FNTA	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
P49354	FNTA	Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:ProtInc
P49356	FNTB	Protein farnesyltransferase subunit beta	GO:0004311; F:farnesyltranstransferase activity; IEA:Ensembl
P49356	FNTB	Protein farnesyltransferase subunit beta	GO:0005515; F:protein binding; IPI:IntAct
P49356	FNTB	Protein farnesyltransferase subunit beta	GO:0004660; F:protein farnesyltransferase activity; IDA:UniProtKB
P49356	FNTB	Protein farnesyltransferase subunit beta	GO:0016740; F:transferase activity; IEA:UniProtKB-KW
P49356	FNTB	Protein farnesyltransferase subunit beta	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P49356	FNTB	Protein farnesyltransferase subunit beta	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P49356	FNTB	Protein farnesyltransferase subunit beta	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P49356	FNTB	Protein farnesyltransferase subunit beta	GO:0045787; P:positive regulation of cell cycle; IEA:Ensembl
P49356	FNTB	Protein farnesyltransferase subunit beta	GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl
P49356	FNTB	Protein farnesyltransferase subunit beta	GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; IEA:Ensembl
P49356	FNTB	Protein farnesyltransferase subunit beta	GO:0018343; P:protein farnesylation; IEA:InterPro
P49356	FNTB	Protein farnesyltransferase subunit beta	GO:0042127; P:regulation of cell proliferation; IEA:InterPro
P49356	FNTB	Protein farnesyltransferase subunit beta	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
P49356	FNTB	Protein farnesyltransferase subunit beta	GO:0034097; P:response to cytokine; IEA:Ensembl
P49356	FNTB	Protein farnesyltransferase subunit beta	GO:0010035; P:response to inorganic substance; IEA:Ensembl
P49356	FNTB	Protein farnesyltransferase subunit beta	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P49356	FNTB	Protein farnesyltransferase subunit beta	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
P49356	FNTB	Protein farnesyltransferase subunit beta	GO:0042060; P:wound healing; IEA:Ensembl
Q5VW36	FOCAD	Focadhesin	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0005515; F:protein binding; IPI:IntAct
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IDA:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0001085; F:RNA polymerase II transcription factor binding; IPI:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0060413; P:atrial septum morphogenesis; ISS:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0003181; P:atrioventricular valve morphogenesis; ISS:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0007596; P:blood coagulation; TAS:Reactome
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0055008; P:cardiac muscle tissue morphogenesis; ISS:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0060318; P:definitive erythrocyte differentiation; IEA:Ensembl
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0035162; P:embryonic hemopoiesis; ISS:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0030218; P:erythrocyte differentiation; ISS:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0030851; P:granulocyte differentiation; IEA:Ensembl
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0035855; P:megakaryocyte development; IEA:Ensembl
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0030219; P:megakaryocyte differentiation; ISS:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0003192; P:mitral valve formation; ISS:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0045599; P:negative regulation of fat cell differentiation; ISS:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0045403; P:negative regulation of interleukin-4 biosynthetic process; IDA:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0060377; P:negative regulation of mast cell differentiation; ISS:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0032091; P:negative regulation of protein binding; ISS:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:GOC
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0003151; P:outflow tract morphogenesis; ISS:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0030220; P:platelet formation; IGI:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0045078; P:positive regulation of interferon-gamma biosynthetic process; IDA:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0060319; P:primitive erythrocyte differentiation; IEA:Ensembl
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0032642; P:regulation of chemokine production; IEA:Ensembl
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0010724; P:regulation of definitive erythrocyte differentiation; IDA:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0002295; P:T-helper cell lineage commitment; IC:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0071733; P:transcriptional activation by promoter-enhancer looping; ISS:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0003195; P:tricuspid valve formation; ISS:BHF-UCL
Q8IX07	ZFPM1	Zinc finger protein ZFPM1	GO:0060412; P:ventricular septum morphogenesis; ISS:BHF-UCL
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:0001071; F:nucleic acid binding transcription factor activity; IEA:Ensembl
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:0001105; F:RNA polymerase II transcription coactivator activity; NAS:BHF-UCL
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:0003714; F:transcription corepressor activity; IDA:BHF-UCL
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:0008270; F:zinc ion binding; NAS:BHF-UCL
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:0007596; P:blood coagulation; TAS:Reactome
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:0048568; P:embryonic organ development; IEA:Ensembl
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:0030324; P:lung development; IEA:Ensembl
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:0060548; P:negative regulation of cell death; IEA:Ensembl
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:0045599; P:negative regulation of fat cell differentiation; IMP:UniProtKB
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:2000195; P:negative regulation of female gonad development; IEA:Ensembl
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:0003148; P:outflow tract septum morphogenesis; IMP:BHF-UCL
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:2000020; P:positive regulation of male gonad development; IEA:Ensembl
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:0003221; P:right ventricular cardiac muscle tissue morphogenesis; IMP:BHF-UCL
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q8WW38	ZFPM2	Zinc finger protein ZFPM2	GO:0060412; P:ventricular septum morphogenesis; IMP:BHF-UCL
Q9HBA9	FOLH1B	Putative N-acetylated-alpha-linked acidic dipeptidase	GO:0016805; F:dipeptidase activity; IEA:UniProtKB-KW
Q9HBA9	FOLH1B	Putative N-acetylated-alpha-linked acidic dipeptidase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HBA9	FOLH1B	Putative N-acetylated-alpha-linked acidic dipeptidase	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
Q05932	FPGS	Folylpolyglutamate synthase, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q05932	FPGS	Folylpolyglutamate synthase, mitochondrial	GO:0004326; F:tetrahydrofolylpolyglutamate synthase activity; TAS:ProtInc
Q05932	FPGS	Folylpolyglutamate synthase, mitochondrial	GO:0007420; P:brain development; IEA:Ensembl
Q05932	FPGS	Folylpolyglutamate synthase, mitochondrial	GO:0046655; P:folic acid metabolic process; TAS:Reactome
Q05932	FPGS	Folylpolyglutamate synthase, mitochondrial	GO:0001889; P:liver development; IEA:Ensembl
Q05932	FPGS	Folylpolyglutamate synthase, mitochondrial	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
Q05932	FPGS	Folylpolyglutamate synthase, mitochondrial	GO:0006730; P:one-carbon metabolic process; IEA:UniProtKB-KW
Q05932	FPGS	Folylpolyglutamate synthase, mitochondrial	GO:0031100; P:organ regeneration; IEA:Ensembl
Q05932	FPGS	Folylpolyglutamate synthase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q05932	FPGS	Folylpolyglutamate synthase, mitochondrial	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q05932	FPGS	Folylpolyglutamate synthase, mitochondrial	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q04609	FOLH1	Glutamate carboxypeptidase 2	GO:0004180; F:carboxypeptidase activity; IEA:UniProtKB-KW
Q04609	FOLH1	Glutamate carboxypeptidase 2	GO:0016805; F:dipeptidase activity; IEA:UniProtKB-KW
Q04609	FOLH1	Glutamate carboxypeptidase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q04609	FOLH1	Glutamate carboxypeptidase 2	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
Q04609	FOLH1	Glutamate carboxypeptidase 2	GO:0008233; F:peptidase activity; NAS:UniProtKB
Q04609	FOLH1	Glutamate carboxypeptidase 2	GO:0006760; P:folic acid-containing compound metabolic process; IEA:Ensembl
Q04609	FOLH1	Glutamate carboxypeptidase 2	GO:0006508; P:proteolysis; NAS:UniProtKB
P15328	FOLR1	Folate receptor alpha	GO:0005542; F:folic acid binding; IDA:UniProtKB
P15328	FOLR1	Folate receptor alpha	GO:0008517; F:folic acid transporter activity; IMP:UniProtKB
P15328	FOLR1	Folate receptor alpha	GO:0004872; F:receptor activity; TAS:ProtInc
P15328	FOLR1	Folate receptor alpha	GO:0008219; P:cell death; IEA:UniProtKB-KW
P15328	FOLR1	Folate receptor alpha	GO:0046655; P:folic acid metabolic process; IEA:Ensembl
P15328	FOLR1	Folate receptor alpha	GO:0015884; P:folic acid transport; IMP:UniProtKB
P15328	FOLR1	Folate receptor alpha	GO:0006898; P:receptor-mediated endocytosis; TAS:ProtInc
P14207	FOLR2	Folate receptor beta	GO:0005542; F:folic acid binding; IDA:UniProtKB
P14207	FOLR2	Folate receptor beta	GO:0008517; F:folic acid transporter activity; IDA:UniProtKB
P14207	FOLR2	Folate receptor beta	GO:0015884; P:folic acid transport; IDA:UniProtKB
P41439	FOLR3	Folate receptor gamma	GO:0005542; F:folic acid binding; TAS:ProtInc
P41439	FOLR3	Folate receptor gamma	GO:0015884; P:folic acid transport; TAS:ProtInc
E5RQL4	FTCDNL1	Formiminotransferase N-terminal subdomain-containing protein	GO:0005542; F:folic acid binding; IEA:InterPro
E5RQL4	FTCDNL1	Formiminotransferase N-terminal subdomain-containing protein	GO:0016740; F:transferase activity; IEA:InterPro
Q96NB1	FOPNL	LisH domain-containing protein FOPNL	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q96NB1	FOPNL	LisH domain-containing protein FOPNL	GO:0034453; P:microtubule anchoring; IEA:InterPro
P53539	FOSB	Protein fosB	GO:0003677; F:DNA binding; TAS:ProtInc
P53539	FOSB	Protein fosB	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
P53539	FOSB	Protein fosB	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P53539	FOSB	Protein fosB	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P53539	FOSB	Protein fosB	GO:0008134; F:transcription factor binding; TAS:ProtInc
P53539	FOSB	Protein fosB	GO:0071277; P:cellular response to calcium ion; IEA:Ensembl
P53539	FOSB	Protein fosB	GO:0032870; P:cellular response to hormone stimulus; IEA:Ensembl
P53539	FOSB	Protein fosB	GO:0007565; P:female pregnancy; IEA:Ensembl
P53539	FOSB	Protein fosB	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P53539	FOSB	Protein fosB	GO:0051591; P:response to cAMP; IEA:Ensembl
P53539	FOSB	Protein fosB	GO:0051412; P:response to corticosterone; IEA:Ensembl
P53539	FOSB	Protein fosB	GO:0042493; P:response to drug; IEA:Ensembl
P53539	FOSB	Protein fosB	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P53539	FOSB	Protein fosB	GO:0043278; P:response to morphine; IEA:Ensembl
P53539	FOSB	Protein fosB	GO:0032570; P:response to progesterone; IEA:Ensembl
P53539	FOSB	Protein fosB	GO:0006366; P:transcription from RNA polymerase II promoter; IEA:Ensembl
P15408	FOSL2	Fos-related antigen 2	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
P15408	FOSL2	Fos-related antigen 2	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl
P15408	FOSL2	Fos-related antigen 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P15408	FOSL2	Fos-related antigen 2	GO:0008219; P:cell death; TAS:ProtInc
P15408	FOSL2	Fos-related antigen 2	GO:0032870; P:cellular response to hormone stimulus; IEA:Ensembl
P15408	FOSL2	Fos-related antigen 2	GO:0007565; P:female pregnancy; IEA:Ensembl
P15408	FOSL2	Fos-related antigen 2	GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl
P15408	FOSL2	Fos-related antigen 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P15408	FOSL2	Fos-related antigen 2	GO:0051591; P:response to cAMP; IEA:Ensembl
P15408	FOSL2	Fos-related antigen 2	GO:0051412; P:response to corticosterone; IEA:Ensembl
P15408	FOSL2	Fos-related antigen 2	GO:0042493; P:response to drug; IEA:Ensembl
P15408	FOSL2	Fos-related antigen 2	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P15408	FOSL2	Fos-related antigen 2	GO:0043278; P:response to morphine; IEA:Ensembl
P15408	FOSL2	Fos-related antigen 2	GO:0032570; P:response to progesterone; IEA:Ensembl
P15408	FOSL2	Fos-related antigen 2	GO:0006366; P:transcription from RNA polymerase II promoter; IEA:Ensembl
P15407	FOSL1	Fos-related antigen 1	GO:0005515; F:protein binding; IPI:IntAct
P15407	FOSL1	Fos-related antigen 1	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl
P15407	FOSL1	Fos-related antigen 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P15407	FOSL1	Fos-related antigen 1	GO:0006968; P:cellular defense response; TAS:ProtInc
P15407	FOSL1	Fos-related antigen 1	GO:0031668; P:cellular response to extracellular stimulus; IEA:Ensembl
P15407	FOSL1	Fos-related antigen 1	GO:0006935; P:chemotaxis; TAS:ProtInc
P15407	FOSL1	Fos-related antigen 1	GO:0007565; P:female pregnancy; IEA:Ensembl
P15407	FOSL1	Fos-related antigen 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P15407	FOSL1	Fos-related antigen 1	GO:0007612; P:learning; IEA:Ensembl
P15407	FOSL1	Fos-related antigen 1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P15407	FOSL1	Fos-related antigen 1	GO:0060674; P:placenta blood vessel development; IEA:Ensembl
P15407	FOSL1	Fos-related antigen 1	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P15407	FOSL1	Fos-related antigen 1	GO:0045787; P:positive regulation of cell cycle; IEA:Ensembl
P15407	FOSL1	Fos-related antigen 1	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P15407	FOSL1	Fos-related antigen 1	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P15407	FOSL1	Fos-related antigen 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P15407	FOSL1	Fos-related antigen 1	GO:0051591; P:response to cAMP; IEA:Ensembl
P15407	FOSL1	Fos-related antigen 1	GO:0051412; P:response to corticosterone; IEA:Ensembl
P15407	FOSL1	Fos-related antigen 1	GO:0034097; P:response to cytokine; IEA:Ensembl
P15407	FOSL1	Fos-related antigen 1	GO:0042493; P:response to drug; IEA:Ensembl
P15407	FOSL1	Fos-related antigen 1	GO:0009629; P:response to gravity; IEA:Ensembl
P15407	FOSL1	Fos-related antigen 1	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
P15407	FOSL1	Fos-related antigen 1	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P15407	FOSL1	Fos-related antigen 1	GO:0032570; P:response to progesterone; IEA:Ensembl
P15407	FOSL1	Fos-related antigen 1	GO:0009615; P:response to virus; TAS:ProtInc
P15407	FOSL1	Fos-related antigen 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P15407	FOSL1	Fos-related antigen 1	GO:0007296; P:vitellogenesis; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0005515; F:protein binding; IPI:IntAct
P01100	FOS	Proto-oncogene c-Fos	GO:0070412; F:R-SMAD binding; IPI:BHF-UCL
P01100	FOS	Proto-oncogene c-Fos	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P01100	FOS	Proto-oncogene c-Fos	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
P01100	FOS	Proto-oncogene c-Fos	GO:0007568; P:aging; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0071277; P:cellular response to calcium ion; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0031668; P:cellular response to extracellular stimulus; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0032870; P:cellular response to hormone stimulus; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0034614; P:cellular response to reactive oxygen species; IDA:BHF-UCL
P01100	FOS	Proto-oncogene c-Fos	GO:0001661; P:conditioned taste aversion; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0006306; P:DNA methylation; TAS:ProtInc
P01100	FOS	Proto-oncogene c-Fos	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P01100	FOS	Proto-oncogene c-Fos	GO:0007565; P:female pregnancy; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0006954; P:inflammatory response; TAS:ProtInc
P01100	FOS	Proto-oncogene c-Fos	GO:0045087; P:innate immune response; TAS:Reactome
P01100	FOS	Proto-oncogene c-Fos	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P01100	FOS	Proto-oncogene c-Fos	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P01100	FOS	Proto-oncogene c-Fos	GO:0007399; P:nervous system development; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0045672; P:positive regulation of osteoclast differentiation; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
P01100	FOS	Proto-oncogene c-Fos	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; TAS:Reactome
P01100	FOS	Proto-oncogene c-Fos	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P01100	FOS	Proto-oncogene c-Fos	GO:0051591; P:response to cAMP; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0009409; P:response to cold; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0051412; P:response to corticosterone; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0034097; P:response to cytokine; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0042493; P:response to drug; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0009629; P:response to gravity; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0009416; P:response to light stimulus; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0032570; P:response to progesterone; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0009636; P:response to toxic substance; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0030431; P:sleep; IEA:Ensembl
P01100	FOS	Proto-oncogene c-Fos	GO:0060395; P:SMAD protein signal transduction; IDA:BHF-UCL
P01100	FOS	Proto-oncogene c-Fos	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P01100	FOS	Proto-oncogene c-Fos	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P01100	FOS	Proto-oncogene c-Fos	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P01100	FOS	Proto-oncogene c-Fos	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P01100	FOS	Proto-oncogene c-Fos	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P01100	FOS	Proto-oncogene c-Fos	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P01100	FOS	Proto-oncogene c-Fos	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P01100	FOS	Proto-oncogene c-Fos	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P01100	FOS	Proto-oncogene c-Fos	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P01100	FOS	Proto-oncogene c-Fos	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P01100	FOS	Proto-oncogene c-Fos	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P01100	FOS	Proto-oncogene c-Fos	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
P01100	FOS	Proto-oncogene c-Fos	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0003677; F:DNA binding; IDA:UniProtKB
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0008301; F:DNA binding, bending; IBA:RefGenome
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; ISS:BHF-UCL
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0008134; F:transcription factor binding; IBA:RefGenome
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0048646; P:anatomical structure formation involved in morphogenesis; IEA:Ensembl
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0006338; P:chromatin remodeling; ISS:UniProtKB
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0009790; P:embryo development; IBA:RefGenome
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0060743; P:epithelial cell maturation involved in prostate gland development; IBA:RefGenome
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0060441; P:epithelial tube branching involved in lung morphogenesis; IEA:Ensembl
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0060738; P:epithelial-mesenchymal signaling involved in prostate gland development; IBA:RefGenome
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0042593; P:glucose homeostasis; IEA:Ensembl
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0042445; P:hormone metabolic process; IEA:Ensembl
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0060487; P:lung epithelial cell differentiation; IEA:Ensembl
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0010719; P:negative regulation of epithelial to mesenchymal transition; IMP:BHF-UCL
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0048665; P:neuron fate specification; IBA:RefGenome
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0007389; P:pattern specification process; IBA:RefGenome
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:2000049; P:positive regulation of cell-cell adhesion mediated by cadherin; IC:BHF-UCL
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0033148; P:positive regulation of intracellular estrogen receptor signaling pathway; IMP:UniProtKB
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0045931; P:positive regulation of mitotic cell cycle; IMP:UniProtKB
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:UniProtKB
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0045880; P:positive regulation of smoothened signaling pathway; IEA:Ensembl
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0060740; P:prostate gland epithelium morphogenesis; IBA:RefGenome
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0060741; P:prostate gland stromal morphogenesis; IBA:RefGenome
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0032355; P:response to estradiol; IDA:UniProtKB
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0060528; P:secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development; IBA:RefGenome
P55317	FOXA1	Hepatocyte nuclear factor 3-alpha	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0003677; F:DNA binding; IDA:UniProtKB
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:BHF-UCL
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0001205; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0008134; F:transcription factor binding; IBA:RefGenome
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0044212; F:transcription regulatory region DNA binding; IMP:UniProtKB
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0048468; P:cell development; IEA:Ensembl
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0021533; P:cell differentiation in hindbrain; IEA:Ensembl
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0061448; P:connective tissue development; IEA:Ensembl
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0071542; P:dopaminergic neuron differentiation; IEA:Ensembl
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0001705; P:ectoderm formation; IEA:Ensembl
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0031018; P:endocrine pancreas development; IDA:BHF-UCL
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0060441; P:epithelial tube branching involved in lung morphogenesis; IEA:Ensembl
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0042593; P:glucose homeostasis; IBA:RefGenome
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0001701; P:in utero embryonic development; IBA:RefGenome
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0060487; P:lung epithelial cell differentiation; IEA:Ensembl
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:2000971; P:negative regulation of detection of glucose; ISS:BHF-UCL
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0010719; P:negative regulation of epithelial to mesenchymal transition; IMP:BHF-UCL
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0033132; P:negative regulation of glucokinase activity; ISS:BHF-UCL
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0000433; P:negative regulation of transcription from RNA polymerase II promoter by glucose; ISS:BHF-UCL
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0048665; P:neuron fate specification; IBA:RefGenome
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0007389; P:pattern specification process; IBA:RefGenome
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:2000049; P:positive regulation of cell-cell adhesion mediated by cadherin; IC:BHF-UCL
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0040019; P:positive regulation of embryonic development; ISS:UniProtKB
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:2000543; P:positive regulation of gastrulation; ISS:UniProtKB
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0045666; P:positive regulation of neuron differentiation; IBA:RefGenome
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0045880; P:positive regulation of smoothened signaling pathway; IEA:Ensembl
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0000432; P:positive regulation of transcription from RNA polymerase II promoter by glucose; ISS:BHF-UCL
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0045945; P:positive regulation of transcription from RNA polymerase III promoter; IEA:Ensembl
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0090009; P:primitive streak formation; ISS:UniProtKB
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0030193; P:regulation of blood coagulation; IDA:UniProtKB
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0010817; P:regulation of hormone levels; IBA:RefGenome
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; ISS:BHF-UCL
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0019218; P:regulation of steroid metabolic process; IEA:Ensembl
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:2000976; P:regulation of transcription from RNA polymerase II promoter involved in detection of glucose; ISS:BHF-UCL
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0070741; P:response to interleukin-6; TAS:UniProtKB
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0032525; P:somite rostral/caudal axis specification; IEA:Ensembl
Q9Y261	FOXA2	Hepatocyte nuclear factor 3-beta	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0008301; F:DNA binding, bending; IBA:RefGenome
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0008134; F:transcription factor binding; IBA:RefGenome
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0044212; F:transcription regulatory region DNA binding; IMP:UniProtKB
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0001678; P:cellular glucose homeostasis; TAS:UniProtKB
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0009267; P:cellular response to starvation; IEA:Ensembl
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0009790; P:embryo development; IBA:RefGenome
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0031018; P:endocrine pancreas development; TAS:Reactome
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0048665; P:neuron fate specification; IBA:RefGenome
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0007389; P:pattern specification process; IBA:RefGenome
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0045666; P:positive regulation of neuron differentiation; IBA:RefGenome
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0010817; P:regulation of hormone levels; IBA:RefGenome
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0009888; P:tissue development; IBA:RefGenome
P55318	FOXA3	Hepatocyte nuclear factor 3-gamma	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q5VYV0	FOXB2	Forkhead box protein B2	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q5VYV0	FOXB2	Forkhead box protein B2	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q5VYV0	FOXB2	Forkhead box protein B2	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q5VYV0	FOXB2	Forkhead box protein B2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q5VYV0	FOXB2	Forkhead box protein B2	GO:0008134; F:transcription factor binding; IBA:RefGenome
Q5VYV0	FOXB2	Forkhead box protein B2	GO:0009790; P:embryo development; IBA:RefGenome
Q5VYV0	FOXB2	Forkhead box protein B2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q5VYV0	FOXB2	Forkhead box protein B2	GO:0048513; P:organ development; IBA:RefGenome
Q5VYV0	FOXB2	Forkhead box protein B2	GO:0007389; P:pattern specification process; IBA:RefGenome
Q5VYV0	FOXB2	Forkhead box protein B2	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q5VYV0	FOXB2	Forkhead box protein B2	GO:0009888; P:tissue development; IBA:RefGenome
Q5VYV0	FOXB2	Forkhead box protein B2	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q99853	FOXB1	Forkhead box protein B1	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q99853	FOXB1	Forkhead box protein B1	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q99853	FOXB1	Forkhead box protein B1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q99853	FOXB1	Forkhead box protein B1	GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB
Q99853	FOXB1	Forkhead box protein B1	GO:0008134; F:transcription factor binding; IBA:RefGenome
Q99853	FOXB1	Forkhead box protein B1	GO:0007412; P:axon target recognition; ISS:UniProtKB
Q99853	FOXB1	Forkhead box protein B1	GO:0061381; P:cell migration in diencephalon; ISS:UniProtKB
Q99853	FOXB1	Forkhead box protein B1	GO:0009790; P:embryo development; IBA:RefGenome
Q99853	FOXB1	Forkhead box protein B1	GO:0061030; P:epithelial cell differentiation involved in mammary gland alveolus development; ISS:UniProtKB
Q99853	FOXB1	Forkhead box protein B1	GO:0033504; P:floor plate development; ISS:UniProtKB
Q99853	FOXB1	Forkhead box protein B1	GO:0021855; P:hypothalamus cell migration; ISS:UniProtKB
Q99853	FOXB1	Forkhead box protein B1	GO:0061379; P:inferior colliculus development; ISS:UniProtKB
Q99853	FOXB1	Forkhead box protein B1	GO:0007595; P:lactation; ISS:UniProtKB
Q99853	FOXB1	Forkhead box protein B1	GO:0061377; P:mammary gland lobule development; ISS:UniProtKB
Q99853	FOXB1	Forkhead box protein B1	GO:0021767; P:mammillary body development; ISS:UniProtKB
Q99853	FOXB1	Forkhead box protein B1	GO:0061374; P:mammillothalamic axonal tract development; ISS:UniProtKB
Q99853	FOXB1	Forkhead box protein B1	GO:0030901; P:midbrain development; ISS:UniProtKB
Q99853	FOXB1	Forkhead box protein B1	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB
Q99853	FOXB1	Forkhead box protein B1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q99853	FOXB1	Forkhead box protein B1	GO:0048513; P:organ development; IBA:RefGenome
Q99853	FOXB1	Forkhead box protein B1	GO:0007389; P:pattern specification process; IBA:RefGenome
Q99853	FOXB1	Forkhead box protein B1	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q99853	FOXB1	Forkhead box protein B1	GO:0001756; P:somitogenesis; ISS:UniProtKB
Q99853	FOXB1	Forkhead box protein B1	GO:0021510; P:spinal cord development; IEA:Ensembl
Q99853	FOXB1	Forkhead box protein B1	GO:0022029; P:telencephalon cell migration; ISS:UniProtKB
Q99853	FOXB1	Forkhead box protein B1	GO:0021794; P:thalamus development; IEA:Ensembl
Q99853	FOXB1	Forkhead box protein B1	GO:0009888; P:tissue development; IBA:RefGenome
Q99853	FOXB1	Forkhead box protein B1	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q99853	FOXB1	Forkhead box protein B1	GO:0001655; P:urogenital system development; IEA:Ensembl
Q99853	FOXB1	Forkhead box protein B1	GO:0008542; P:visual learning; ISS:UniProtKB
Q12948	FOXC1	Forkhead box protein C1	GO:0031490; F:chromatin DNA binding; IBA:RefGenome
Q12948	FOXC1	Forkhead box protein C1	GO:0003677; F:DNA binding; IDA:UniProtKB
Q12948	FOXC1	Forkhead box protein C1	GO:0008301; F:DNA binding, bending; IDA:UniProtKB
Q12948	FOXC1	Forkhead box protein C1	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q12948	FOXC1	Forkhead box protein C1	GO:0005515; F:protein binding; IPI:UniProtKB
Q12948	FOXC1	Forkhead box protein C1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q12948	FOXC1	Forkhead box protein C1	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q12948	FOXC1	Forkhead box protein C1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q12948	FOXC1	Forkhead box protein C1	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q12948	FOXC1	Forkhead box protein C1	GO:0044212; F:transcription regulatory region DNA binding; ISS:BHF-UCL
Q12948	FOXC1	Forkhead box protein C1	GO:0048844; P:artery morphogenesis; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0007420; P:brain development; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0043010; P:camera-type eye development; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0060038; P:cardiac muscle cell proliferation; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0030199; P:collagen fibril organization; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0009790; P:embryo development; IBA:RefGenome
Q12948	FOXC1	Forkhead box protein C1	GO:0035050; P:embryonic heart tube development; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0001654; P:eye development; IDA:MGI
Q12948	FOXC1	Forkhead box protein C1	GO:0008354; P:germ cell migration; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0030203; P:glycosaminoglycan metabolic process; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0007507; P:heart development; IDA:MGI
Q12948	FOXC1	Forkhead box protein C1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0001822; P:kidney development; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0032808; P:lacrimal gland development; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0001945; P:lymph vessel development; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0043066; P:negative regulation of apoptotic process; IBA:RefGenome
Q12948	FOXC1	Forkhead box protein C1	GO:1902257; P:negative regulation of apoptotic process involved in outflow tract morphogenesis; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0045930; P:negative regulation of mitotic cell cycle; IDA:UniProtKB
Q12948	FOXC1	Forkhead box protein C1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q12948	FOXC1	Forkhead box protein C1	GO:0014032; P:neural crest cell development; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0007219; P:Notch signaling pathway; IBA:RefGenome
Q12948	FOXC1	Forkhead box protein C1	GO:0042475; P:odontogenesis of dentin-containing tooth; IMP:UniProtKB
Q12948	FOXC1	Forkhead box protein C1	GO:0001503; P:ossification; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0001541; P:ovarian follicle development; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0048341; P:paraxial mesoderm formation; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0007389; P:pattern specification process; IBA:RefGenome
Q12948	FOXC1	Forkhead box protein C1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q12948	FOXC1	Forkhead box protein C1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q12948	FOXC1	Forkhead box protein C1	GO:0050880; P:regulation of blood vessel size; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0046620; P:regulation of organ growth; IBA:RefGenome
Q12948	FOXC1	Forkhead box protein C1	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q12948	FOXC1	Forkhead box protein C1	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q12948	FOXC1	Forkhead box protein C1	GO:0001501; P:skeletal system development; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0001756; P:somitogenesis; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0009888; P:tissue development; IBA:RefGenome
Q12948	FOXC1	Forkhead box protein C1	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q12948	FOXC1	Forkhead box protein C1	GO:0001657; P:ureteric bud development; IEA:Ensembl
Q12948	FOXC1	Forkhead box protein C1	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IBA:RefGenome
Q12948	FOXC1	Forkhead box protein C1	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IEA:Ensembl
Q99958	FOXC2	Forkhead box protein C2	GO:0031490; F:chromatin DNA binding; IDA:UniProtKB
Q99958	FOXC2	Forkhead box protein C2	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:BHF-UCL
Q99958	FOXC2	Forkhead box protein C2	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q99958	FOXC2	Forkhead box protein C2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q99958	FOXC2	Forkhead box protein C2	GO:0008134; F:transcription factor binding; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0044212; F:transcription regulatory region DNA binding; ISS:BHF-UCL
Q99958	FOXC2	Forkhead box protein C2	GO:0048844; P:artery morphogenesis; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0001974; P:blood vessel remodeling; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0043010; P:camera-type eye development; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0060038; P:cardiac muscle cell proliferation; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0030199; P:collagen fibril organization; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0035050; P:embryonic heart tube development; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0048703; P:embryonic viscerocranium morphogenesis; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0072011; P:glomerular endothelium development; IEA:Ensembl
Q99958	FOXC2	Forkhead box protein C2	GO:0072144; P:glomerular mesangial cell development; IEA:Ensembl
Q99958	FOXC2	Forkhead box protein C2	GO:0072112; P:glomerular visceral epithelial cell differentiation; IEA:Ensembl
Q99958	FOXC2	Forkhead box protein C2	GO:0007507; P:heart development; IMP:DFLAT
Q99958	FOXC2	Forkhead box protein C2	GO:0008286; P:insulin receptor signaling pathway; IDA:UniProtKB
Q99958	FOXC2	Forkhead box protein C2	GO:0001946; P:lymphangiogenesis; IMP:UniProtKB
Q99958	FOXC2	Forkhead box protein C2	GO:0007498; P:mesoderm development; NAS:UniProtKB
Q99958	FOXC2	Forkhead box protein C2	GO:0001656; P:metanephros development; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0043066; P:negative regulation of apoptotic process; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:1902257; P:negative regulation of apoptotic process involved in outflow tract morphogenesis; IEA:Ensembl
Q99958	FOXC2	Forkhead box protein C2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q99958	FOXC2	Forkhead box protein C2	GO:0014032; P:neural crest cell development; IEA:Ensembl
Q99958	FOXC2	Forkhead box protein C2	GO:0007219; P:Notch signaling pathway; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0001503; P:ossification; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0048343; P:paraxial mesodermal cell fate commitment; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0001569; P:patterning of blood vessels; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0033630; P:positive regulation of cell adhesion mediated by integrin; ISS:BHF-UCL
Q99958	FOXC2	Forkhead box protein C2	GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; ISS:BHF-UCL
Q99958	FOXC2	Forkhead box protein C2	GO:0010595; P:positive regulation of endothelial cell migration; ISS:BHF-UCL
Q99958	FOXC2	Forkhead box protein C2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q99958	FOXC2	Forkhead box protein C2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q99958	FOXC2	Forkhead box protein C2	GO:0035470; P:positive regulation of vascular wound healing; ISS:BHF-UCL
Q99958	FOXC2	Forkhead box protein C2	GO:0050880; P:regulation of blood vessel size; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0046620; P:regulation of organ growth; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0009725; P:response to hormone; IDA:UniProtKB
Q99958	FOXC2	Forkhead box protein C2	GO:0001756; P:somitogenesis; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q99958	FOXC2	Forkhead box protein C2	GO:0001657; P:ureteric bud development; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IBA:RefGenome
Q99958	FOXC2	Forkhead box protein C2	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IBA:RefGenome
Q16676	FOXD1	Forkhead box protein D1	GO:0003677; F:DNA binding; IDA:MGI
Q16676	FOXD1	Forkhead box protein D1	GO:0008301; F:DNA binding, bending; IDA:UniProtKB
Q16676	FOXD1	Forkhead box protein D1	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q16676	FOXD1	Forkhead box protein D1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q16676	FOXD1	Forkhead box protein D1	GO:0060678; P:dichotomous subdivision of terminal units involved in ureteric bud branching; ISS:UniProtKB
Q16676	FOXD1	Forkhead box protein D1	GO:0072213; P:metanephric capsule development; ISS:UniProtKB
Q16676	FOXD1	Forkhead box protein D1	GO:0072267; P:metanephric capsule specification; ISS:UniProtKB
Q16676	FOXD1	Forkhead box protein D1	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q16676	FOXD1	Forkhead box protein D1	GO:0030513; P:positive regulation of BMP signaling pathway; ISS:UniProtKB
Q16676	FOXD1	Forkhead box protein D1	GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB
Q16676	FOXD1	Forkhead box protein D1	GO:0090184; P:positive regulation of kidney development; ISS:UniProtKB
Q16676	FOXD1	Forkhead box protein D1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60548	FOXD2	Forkhead box protein D2	GO:0008301; F:DNA binding, bending; IBA:RefGenome
O60548	FOXD2	Forkhead box protein D2	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
O60548	FOXD2	Forkhead box protein D2	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
O60548	FOXD2	Forkhead box protein D2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O60548	FOXD2	Forkhead box protein D2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O60548	FOXD2	Forkhead box protein D2	GO:0008134; F:transcription factor binding; IBA:RefGenome
O60548	FOXD2	Forkhead box protein D2	GO:0048846; P:axon extension involved in axon guidance; IBA:RefGenome
O60548	FOXD2	Forkhead box protein D2	GO:0001658; P:branching involved in ureteric bud morphogenesis; IBA:RefGenome
O60548	FOXD2	Forkhead box protein D2	GO:0051216; P:cartilage development; IBA:RefGenome
O60548	FOXD2	Forkhead box protein D2	GO:0009790; P:embryo development; IBA:RefGenome
O60548	FOXD2	Forkhead box protein D2	GO:0048484; P:enteric nervous system development; IBA:RefGenome
O60548	FOXD2	Forkhead box protein D2	GO:0050935; P:iridophore differentiation; IBA:RefGenome
O60548	FOXD2	Forkhead box protein D2	GO:0001822; P:kidney development; IBA:RefGenome
O60548	FOXD2	Forkhead box protein D2	GO:0048937; P:lateral line nerve glial cell development; IBA:RefGenome
O60548	FOXD2	Forkhead box protein D2	GO:0030318; P:melanocyte differentiation; IBA:RefGenome
O60548	FOXD2	Forkhead box protein D2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
O60548	FOXD2	Forkhead box protein D2	GO:0001755; P:neural crest cell migration; IBA:RefGenome
O60548	FOXD2	Forkhead box protein D2	GO:0007389; P:pattern specification process; IBA:RefGenome
O60548	FOXD2	Forkhead box protein D2	GO:0007422; P:peripheral nervous system development; IBA:RefGenome
O60548	FOXD2	Forkhead box protein D2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
O60548	FOXD2	Forkhead box protein D2	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
O60548	FOXD2	Forkhead box protein D2	GO:0048485; P:sympathetic nervous system development; IBA:RefGenome
O60548	FOXD2	Forkhead box protein D2	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0005515; F:protein binding; IPI:IntAct
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:BHF-UCL
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0001227; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IDA:BHF-UCL
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0008134; F:transcription factor binding; IBA:RefGenome
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0048846; P:axon extension involved in axon guidance; IBA:RefGenome
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0001658; P:branching involved in ureteric bud morphogenesis; IBA:RefGenome
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0051216; P:cartilage development; IBA:RefGenome
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0001892; P:embryonic placenta development; IBA:RefGenome
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0048484; P:enteric nervous system development; IBA:RefGenome
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0001701; P:in utero embryonic development; ISS:UniProtKB
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0050935; P:iridophore differentiation; IBA:RefGenome
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0001822; P:kidney development; IBA:RefGenome
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0048937; P:lateral line nerve glial cell development; IBA:RefGenome
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0030318; P:melanocyte differentiation; IBA:RefGenome
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0001755; P:neural crest cell migration; IBA:RefGenome
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0007389; P:pattern specification process; IBA:RefGenome
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0007422; P:peripheral nervous system development; IBA:RefGenome
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0048485; P:sympathetic nervous system development; IBA:RefGenome
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q9UJU5	FOXD3	Forkhead box protein D3	GO:0001829; P:trophectodermal cell differentiation; IBA:RefGenome
Q12950	FOXD4	Forkhead box protein D4	GO:0008301; F:DNA binding, bending; ISS:UniProtKB
Q12950	FOXD4	Forkhead box protein D4	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q12950	FOXD4	Forkhead box protein D4	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q12950	FOXD4	Forkhead box protein D4	GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB
Q12950	FOXD4	Forkhead box protein D4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:UniProtKB
Q12950	FOXD4	Forkhead box protein D4	GO:0008134; F:transcription factor binding; IBA:RefGenome
Q12950	FOXD4	Forkhead box protein D4	GO:0048846; P:axon extension involved in axon guidance; IBA:RefGenome
Q12950	FOXD4	Forkhead box protein D4	GO:0001658; P:branching involved in ureteric bud morphogenesis; IBA:RefGenome
Q12950	FOXD4	Forkhead box protein D4	GO:0051216; P:cartilage development; IBA:RefGenome
Q12950	FOXD4	Forkhead box protein D4	GO:0009790; P:embryo development; IBA:RefGenome
Q12950	FOXD4	Forkhead box protein D4	GO:0048484; P:enteric nervous system development; IBA:RefGenome
Q12950	FOXD4	Forkhead box protein D4	GO:0050935; P:iridophore differentiation; IBA:RefGenome
Q12950	FOXD4	Forkhead box protein D4	GO:0001822; P:kidney development; IBA:RefGenome
Q12950	FOXD4	Forkhead box protein D4	GO:0048937; P:lateral line nerve glial cell development; IBA:RefGenome
Q12950	FOXD4	Forkhead box protein D4	GO:0030318; P:melanocyte differentiation; IBA:RefGenome
Q12950	FOXD4	Forkhead box protein D4	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q12950	FOXD4	Forkhead box protein D4	GO:0001755; P:neural crest cell migration; IBA:RefGenome
Q12950	FOXD4	Forkhead box protein D4	GO:0007389; P:pattern specification process; IBA:RefGenome
Q12950	FOXD4	Forkhead box protein D4	GO:0007422; P:peripheral nervous system development; IBA:RefGenome
Q12950	FOXD4	Forkhead box protein D4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q12950	FOXD4	Forkhead box protein D4	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q12950	FOXD4	Forkhead box protein D4	GO:0048485; P:sympathetic nervous system development; IBA:RefGenome
Q12950	FOXD4	Forkhead box protein D4	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
O00358	FOXE1	Forkhead box protein E1	GO:0003677; F:DNA binding; IDA:UniProtKB
O00358	FOXE1	Forkhead box protein E1	GO:0008301; F:DNA binding, bending; IBA:RefGenome
O00358	FOXE1	Forkhead box protein E1	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
O00358	FOXE1	Forkhead box protein E1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
O00358	FOXE1	Forkhead box protein E1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
O00358	FOXE1	Forkhead box protein E1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
O00358	FOXE1	Forkhead box protein E1	GO:0008134; F:transcription factor binding; IBA:RefGenome
O00358	FOXE1	Forkhead box protein E1	GO:0009653; P:anatomical structure morphogenesis; NAS:UniProtKB
O00358	FOXE1	Forkhead box protein E1	GO:0016477; P:cell migration; ISS:UniProtKB
O00358	FOXE1	Forkhead box protein E1	GO:0048562; P:embryonic organ morphogenesis; ISS:UniProtKB
O00358	FOXE1	Forkhead box protein E1	GO:0031069; P:hair follicle morphogenesis; ISS:UniProtKB
O00358	FOXE1	Forkhead box protein E1	GO:0060022; P:hard palate development; IMP:UniProtKB
O00358	FOXE1	Forkhead box protein E1	GO:0002089; P:lens morphogenesis in camera-type eye; IBA:RefGenome
O00358	FOXE1	Forkhead box protein E1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
O00358	FOXE1	Forkhead box protein E1	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
O00358	FOXE1	Forkhead box protein E1	GO:0007389; P:pattern specification process; IBA:RefGenome
O00358	FOXE1	Forkhead box protein E1	GO:0060465; P:pharynx development; IEP:UniProtKB
O00358	FOXE1	Forkhead box protein E1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O00358	FOXE1	Forkhead box protein E1	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
O00358	FOXE1	Forkhead box protein E1	GO:0060023; P:soft palate development; IMP:UniProtKB
O00358	FOXE1	Forkhead box protein E1	GO:0048538; P:thymus development; IEP:UniProtKB
O00358	FOXE1	Forkhead box protein E1	GO:0030878; P:thyroid gland development; IMP:UniProtKB
O00358	FOXE1	Forkhead box protein E1	GO:0006590; P:thyroid hormone generation; ISS:UniProtKB
Q13461	FOXE3	Forkhead box protein E3	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q13461	FOXE3	Forkhead box protein E3	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q13461	FOXE3	Forkhead box protein E3	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q13461	FOXE3	Forkhead box protein E3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q13461	FOXE3	Forkhead box protein E3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:UniProtKB
Q13461	FOXE3	Forkhead box protein E3	GO:0008134; F:transcription factor binding; IBA:RefGenome
Q13461	FOXE3	Forkhead box protein E3	GO:0048468; P:cell development; IEA:Ensembl
Q13461	FOXE3	Forkhead box protein E3	GO:0048562; P:embryonic organ morphogenesis; IBA:RefGenome
Q13461	FOXE3	Forkhead box protein E3	GO:0031069; P:hair follicle morphogenesis; IBA:RefGenome
Q13461	FOXE3	Forkhead box protein E3	GO:0060022; P:hard palate development; IBA:RefGenome
Q13461	FOXE3	Forkhead box protein E3	GO:0002089; P:lens morphogenesis in camera-type eye; IBA:RefGenome
Q13461	FOXE3	Forkhead box protein E3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q13461	FOXE3	Forkhead box protein E3	GO:0007389; P:pattern specification process; IBA:RefGenome
Q13461	FOXE3	Forkhead box protein E3	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
Q13461	FOXE3	Forkhead box protein E3	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q13461	FOXE3	Forkhead box protein E3	GO:0060023; P:soft palate development; IBA:RefGenome
Q13461	FOXE3	Forkhead box protein E3	GO:0030878; P:thyroid gland development; IBA:RefGenome
Q13461	FOXE3	Forkhead box protein E3	GO:0006590; P:thyroid hormone generation; IBA:RefGenome
Q13461	FOXE3	Forkhead box protein E3	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:MGI
Q12946	FOXF1	Forkhead box protein F1	GO:0003677; F:DNA binding; IDA:UniProtKB
Q12946	FOXF1	Forkhead box protein F1	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q12946	FOXF1	Forkhead box protein F1	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q12946	FOXF1	Forkhead box protein F1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q12946	FOXF1	Forkhead box protein F1	GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB
Q12946	FOXF1	Forkhead box protein F1	GO:0008134; F:transcription factor binding; IBA:RefGenome
Q12946	FOXF1	Forkhead box protein F1	GO:0044212; F:transcription regulatory region DNA binding; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0001568; P:blood vessel development; IMP:DFLAT
Q12946	FOXF1	Forkhead box protein F1	GO:0060446; P:branching involved in open tracheal system development; IMP:DFLAT
Q12946	FOXF1	Forkhead box protein F1	GO:0003214; P:cardiac left ventricle morphogenesis; IMP:DFLAT
Q12946	FOXF1	Forkhead box protein F1	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0071345; P:cellular response to cytokine stimulus; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0014822; P:detection of wounding; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0048565; P:digestive tract development; IMP:DFLAT
Q12946	FOXF1	Forkhead box protein F1	GO:0097070; P:ductus arteriosus closure; IMP:DFLAT
Q12946	FOXF1	Forkhead box protein F1	GO:0048557; P:embryonic digestive tract morphogenesis; IMP:DFLAT
Q12946	FOXF1	Forkhead box protein F1	GO:0048613; P:embryonic ectodermal digestive tract morphogenesis; IMP:DFLAT
Q12946	FOXF1	Forkhead box protein F1	GO:0048617; P:embryonic foregut morphogenesis; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0003197; P:endocardial cushion development; IMP:DFLAT
Q12946	FOXF1	Forkhead box protein F1	GO:0061030; P:epithelial cell differentiation involved in mammary gland alveolus development; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0060441; P:epithelial tube branching involved in lung morphogenesis; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0045198; P:establishment of epithelial cell apical/basal polarity; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0007507; P:heart development; IMP:DFLAT
Q12946	FOXF1	Forkhead box protein F1	GO:0001701; P:in utero embryonic development; IMP:DFLAT
Q12946	FOXF1	Forkhead box protein F1	GO:0048371; P:lateral mesodermal cell differentiation; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0048286; P:lung alveolus development; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0030324; P:lung development; IMP:DFLAT
Q12946	FOXF1	Forkhead box protein F1	GO:0060463; P:lung lobe morphogenesis; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0060426; P:lung vasculature development; IMP:DFLAT
Q12946	FOXF1	Forkhead box protein F1	GO:0090131; P:mesenchyme migration; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0007494; P:midgut development; IMP:DFLAT
Q12946	FOXF1	Forkhead box protein F1	GO:0001763; P:morphogenesis of a branching structure; IMP:DFLAT
Q12946	FOXF1	Forkhead box protein F1	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0043305; P:negative regulation of mast cell degranulation; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q12946	FOXF1	Forkhead box protein F1	GO:0031016; P:pancreas development; IMP:DFLAT
Q12946	FOXF1	Forkhead box protein F1	GO:0007389; P:pattern specification process; IBA:RefGenome
Q12946	FOXF1	Forkhead box protein F1	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q12946	FOXF1	Forkhead box protein F1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q12946	FOXF1	Forkhead box protein F1	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q12946	FOXF1	Forkhead box protein F1	GO:0051150; P:regulation of smooth muscle cell differentiation; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0072001; P:renal system development; IMP:DFLAT
Q12946	FOXF1	Forkhead box protein F1	GO:0030323; P:respiratory tube development; IMP:DFLAT
Q12946	FOXF1	Forkhead box protein F1	GO:0060461; P:right lung morphogenesis; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0051145; P:smooth muscle cell differentiation; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0001756; P:somitogenesis; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0060438; P:trachea development; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q12946	FOXF1	Forkhead box protein F1	GO:0072189; P:ureter development; IMP:DFLAT
Q12946	FOXF1	Forkhead box protein F1	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q12946	FOXF1	Forkhead box protein F1	GO:0060841; P:venous blood vessel development; IMP:DFLAT
Q12947	FOXF2	Forkhead box protein F2	GO:0003677; F:DNA binding; IDA:MGI
Q12947	FOXF2	Forkhead box protein F2	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q12947	FOXF2	Forkhead box protein F2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q12947	FOXF2	Forkhead box protein F2	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q12947	FOXF2	Forkhead box protein F2	GO:0048596; P:embryonic camera-type eye morphogenesis; IEA:Ensembl
Q12947	FOXF2	Forkhead box protein F2	GO:0048566; P:embryonic digestive tract development; IEA:Ensembl
Q12947	FOXF2	Forkhead box protein F2	GO:0001837; P:epithelial to mesenchymal transition; NAS:UniProtKB
Q12947	FOXF2	Forkhead box protein F2	GO:0042249; P:establishment of planar polarity of embryonic epithelium; IEA:Ensembl
Q12947	FOXF2	Forkhead box protein F2	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q12947	FOXF2	Forkhead box protein F2	GO:0048806; P:genitalia development; IMP:UniProtKB
Q12947	FOXF2	Forkhead box protein F2	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q12947	FOXF2	Forkhead box protein F2	GO:0060021; P:palate development; IMP:UniProtKB
Q12947	FOXF2	Forkhead box protein F2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q12947	FOXF2	Forkhead box protein F2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q12947	FOXF2	Forkhead box protein F2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P55316	FOXG1	Forkhead box protein G1	GO:0003677; F:DNA binding; TAS:ProtInc
P55316	FOXG1	Forkhead box protein G1	GO:0005515; F:protein binding; IPI:UniProtKB
P55316	FOXG1	Forkhead box protein G1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P55316	FOXG1	Forkhead box protein G1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P55316	FOXG1	Forkhead box protein G1	GO:0007568; P:aging; IEA:Ensembl
P55316	FOXG1	Forkhead box protein G1	GO:0016199; P:axon midline choice point recognition; IEA:Ensembl
P55316	FOXG1	Forkhead box protein G1	GO:0007420; P:brain development; TAS:ProtInc
P55316	FOXG1	Forkhead box protein G1	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
P55316	FOXG1	Forkhead box protein G1	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
P55316	FOXG1	Forkhead box protein G1	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
P55316	FOXG1	Forkhead box protein G1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P55316	FOXG1	Forkhead box protein G1	GO:0048664; P:neuron fate determination; IEA:Ensembl
P55316	FOXG1	Forkhead box protein G1	GO:0045787; P:positive regulation of cell cycle; IEA:Ensembl
P55316	FOXG1	Forkhead box protein G1	GO:0002052; P:positive regulation of neuroblast proliferation; IEA:Ensembl
P55316	FOXG1	Forkhead box protein G1	GO:0021852; P:pyramidal neuron migration; IEA:Ensembl
P55316	FOXG1	Forkhead box protein G1	GO:0007346; P:regulation of mitotic cell cycle; IEA:Ensembl
P55316	FOXG1	Forkhead box protein G1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75593	FOXH1	Forkhead box protein H1	GO:0050681; F:androgen receptor binding; IPI:BHF-UCL
O75593	FOXH1	Forkhead box protein H1	GO:0070410; F:co-SMAD binding; IMP:BHF-UCL
O75593	FOXH1	Forkhead box protein H1	GO:0008301; F:DNA binding, bending; IBA:RefGenome
O75593	FOXH1	Forkhead box protein H1	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
O75593	FOXH1	Forkhead box protein H1	GO:0005515; F:protein binding; IPI:UniProtKB
O75593	FOXH1	Forkhead box protein H1	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
O75593	FOXH1	Forkhead box protein H1	GO:0070412; F:R-SMAD binding; IMP:BHF-UCL
O75593	FOXH1	Forkhead box protein H1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
O75593	FOXH1	Forkhead box protein H1	GO:0001205; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
O75593	FOXH1	Forkhead box protein H1	GO:0001104; F:RNA polymerase II transcription cofactor activity; IEA:Ensembl
O75593	FOXH1	Forkhead box protein H1	GO:0001190; F:RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
O75593	FOXH1	Forkhead box protein H1	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
O75593	FOXH1	Forkhead box protein H1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:BHF-UCL
O75593	FOXH1	Forkhead box protein H1	GO:0008134; F:transcription factor binding; IBA:RefGenome
O75593	FOXH1	Forkhead box protein H1	GO:0044212; F:transcription regulatory region DNA binding; ISS:BHF-UCL
O75593	FOXH1	Forkhead box protein H1	GO:0035909; P:aorta morphogenesis; IEA:Ensembl
O75593	FOXH1	Forkhead box protein H1	GO:0048318; P:axial mesoderm development; IBA:RefGenome
O75593	FOXH1	Forkhead box protein H1	GO:0001568; P:blood vessel development; IBA:RefGenome
O75593	FOXH1	Forkhead box protein H1	GO:0003215; P:cardiac right ventricle morphogenesis; IEA:Ensembl
O75593	FOXH1	Forkhead box protein H1	GO:0042074; P:cell migration involved in gastrulation; IBA:RefGenome
O75593	FOXH1	Forkhead box protein H1	GO:0035054; P:embryonic heart tube anterior/posterior pattern specification; IBA:RefGenome
O75593	FOXH1	Forkhead box protein H1	GO:0021508; P:floor plate formation; IBA:RefGenome
O75593	FOXH1	Forkhead box protein H1	GO:0001947; P:heart looping; IBA:RefGenome
O75593	FOXH1	Forkhead box protein H1	GO:2000824; P:negative regulation of androgen receptor activity; IDA:BHF-UCL
O75593	FOXH1	Forkhead box protein H1	GO:0060766; P:negative regulation of androgen receptor signaling pathway; IDA:BHF-UCL
O75593	FOXH1	Forkhead box protein H1	GO:0033147; P:negative regulation of intracellular estrogen receptor signaling pathway; IDA:BHF-UCL
O75593	FOXH1	Forkhead box protein H1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
O75593	FOXH1	Forkhead box protein H1	GO:1900164; P:nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry; NAS:BHF-UCL
O75593	FOXH1	Forkhead box protein H1	GO:0003151; P:outflow tract morphogenesis; IEA:Ensembl
O75593	FOXH1	Forkhead box protein H1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O75593	FOXH1	Forkhead box protein H1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O75593	FOXH1	Forkhead box protein H1	GO:0003139; P:secondary heart field specification; IEA:Ensembl
O75593	FOXH1	Forkhead box protein H1	GO:0010159; P:specification of organ position; IBA:RefGenome
O75593	FOXH1	Forkhead box protein H1	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
O75593	FOXH1	Forkhead box protein H1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:UniProtKB
O75593	FOXH1	Forkhead box protein H1	GO:0003222; P:ventricular trabecula myocardium morphogenesis; IEA:Ensembl
Q12951	FOXI1	Forkhead box protein I1	GO:0008301; F:DNA binding, bending; NAS:UniProtKB
Q12951	FOXI1	Forkhead box protein I1	GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB
Q12951	FOXI1	Forkhead box protein I1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q12951	FOXI1	Forkhead box protein I1	GO:0044212; F:transcription regulatory region DNA binding; ISS:UniProtKB
Q12951	FOXI1	Forkhead box protein I1	GO:0009790; P:embryo development; NAS:UniProtKB
Q12951	FOXI1	Forkhead box protein I1	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q12951	FOXI1	Forkhead box protein I1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q12951	FOXI1	Forkhead box protein I1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZQN5	FOXI2	Forkhead box protein I2	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q6ZQN5	FOXI2	Forkhead box protein I2	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q6ZQN5	FOXI2	Forkhead box protein I2	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6ZQN5	FOXI2	Forkhead box protein I2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q6ZQN5	FOXI2	Forkhead box protein I2	GO:0008134; F:transcription factor binding; IBA:RefGenome
Q6ZQN5	FOXI2	Forkhead box protein I2	GO:0009653; P:anatomical structure morphogenesis; IBA:RefGenome
Q6ZQN5	FOXI2	Forkhead box protein I2	GO:0009790; P:embryo development; IBA:RefGenome
Q6ZQN5	FOXI2	Forkhead box protein I2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q6ZQN5	FOXI2	Forkhead box protein I2	GO:0048513; P:organ development; IBA:RefGenome
Q6ZQN5	FOXI2	Forkhead box protein I2	GO:0007389; P:pattern specification process; IBA:RefGenome
Q6ZQN5	FOXI2	Forkhead box protein I2	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6ZQN5	FOXI2	Forkhead box protein I2	GO:0009888; P:tissue development; IBA:RefGenome
Q6ZQN5	FOXI2	Forkhead box protein I2	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
A8MTJ6	FOXI3	Forkhead box protein I3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
A8MTJ6	FOXI3	Forkhead box protein I3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
A8MTJ6	FOXI3	Forkhead box protein I3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9P0K8	FOXJ2	Forkhead box protein J2	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q9P0K8	FOXJ2	Forkhead box protein J2	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q9P0K8	FOXJ2	Forkhead box protein J2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9P0K8	FOXJ2	Forkhead box protein J2	GO:0009790; P:embryo development; IBA:RefGenome
Q9P0K8	FOXJ2	Forkhead box protein J2	GO:0007389; P:pattern specification process; IBA:RefGenome
Q9P0K8	FOXJ2	Forkhead box protein J2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9P0K8	FOXJ2	Forkhead box protein J2	GO:0009888; P:tissue development; IBA:RefGenome
Q9P0K8	FOXJ2	Forkhead box protein J2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UPW0	FOXJ3	Forkhead box protein J3	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q9UPW0	FOXJ3	Forkhead box protein J3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9UPW0	FOXJ3	Forkhead box protein J3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9UPW0	FOXJ3	Forkhead box protein J3	GO:0009790; P:embryo development; IBA:RefGenome
Q9UPW0	FOXJ3	Forkhead box protein J3	GO:0007389; P:pattern specification process; IBA:RefGenome
Q9UPW0	FOXJ3	Forkhead box protein J3	GO:0045893; P:positive regulation of transcription, DNA-templated; IBA:RefGenome
Q9UPW0	FOXJ3	Forkhead box protein J3	GO:0009888; P:tissue development; IBA:RefGenome
Q9UPW0	FOXJ3	Forkhead box protein J3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q92949	FOXJ1	Forkhead box protein J1	GO:0003677; F:DNA binding; NAS:UniProtKB
Q92949	FOXJ1	Forkhead box protein J1	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q92949	FOXJ1	Forkhead box protein J1	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q92949	FOXJ1	Forkhead box protein J1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q92949	FOXJ1	Forkhead box protein J1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q92949	FOXJ1	Forkhead box protein J1	GO:0008134; F:transcription factor binding; IBA:RefGenome
Q92949	FOXJ1	Forkhead box protein J1	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IDA:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0030036; P:actin cytoskeleton organization; ISS:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0032862; P:activation of Rho GTPase activity; ISS:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0007420; P:brain development; ISS:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0002508; P:central tolerance induction; ISS:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0042384; P:cilium assembly; ISS:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0060429; P:epithelium development; ISS:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0035089; P:establishment of apical/basal cell polarity; ISS:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0072016; P:glomerular parietal epithelial cell development; IEP:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0001947; P:heart looping; IBA:RefGenome
Q92949	FOXJ1	Forkhead box protein J1	GO:0006959; P:humoral immune response; ISS:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0060972; P:left/right pattern formation; IBA:RefGenome
Q92949	FOXJ1	Forkhead box protein J1	GO:0050900; P:leukocyte migration; ISS:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0060428; P:lung epithelium development; IEP:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0035502; P:metanephric part of ureteric bud development; IEP:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0050869; P:negative regulation of B cell activation; ISS:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0002635; P:negative regulation of germinal center formation; ISS:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0002924; P:negative regulation of humoral immune response mediated by circulating immunoglobulin; ISS:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0045409; P:negative regulation of interleukin-6 biosynthetic process; ISS:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; ISS:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0033085; P:negative regulation of T cell differentiation in thymus; ISS:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0042130; P:negative regulation of T cell proliferation; IBA:RefGenome
Q92949	FOXJ1	Forkhead box protein J1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0007389; P:pattern specification process; ISS:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0002897; P:positive regulation of central B cell tolerance induction; ISS:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:1901248; P:positive regulation of lung ciliated cell differentiation; IDA:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q92949	FOXJ1	Forkhead box protein J1	GO:0007283; P:spermatogenesis; NAS:UniProtKB
Q92949	FOXJ1	Forkhead box protein J1	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
P85037	FOXK1	Forkhead box protein K1	GO:0008301; F:DNA binding, bending; IBA:RefGenome
P85037	FOXK1	Forkhead box protein K1	GO:0000287; F:magnesium ion binding; IBA:RefGenome
P85037	FOXK1	Forkhead box protein K1	GO:0005515; F:protein binding; IPI:IntAct
P85037	FOXK1	Forkhead box protein K1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P85037	FOXK1	Forkhead box protein K1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P85037	FOXK1	Forkhead box protein K1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P85037	FOXK1	Forkhead box protein K1	GO:0009790; P:embryo development; IBA:RefGenome
P85037	FOXK1	Forkhead box protein K1	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
P85037	FOXK1	Forkhead box protein K1	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
P85037	FOXK1	Forkhead box protein K1	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
P85037	FOXK1	Forkhead box protein K1	GO:0007389; P:pattern specification process; IBA:RefGenome
P85037	FOXK1	Forkhead box protein K1	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P85037	FOXK1	Forkhead box protein K1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P85037	FOXK1	Forkhead box protein K1	GO:0009888; P:tissue development; IBA:RefGenome
P85037	FOXK1	Forkhead box protein K1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q01167	FOXK2	Forkhead box protein K2	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q01167	FOXK2	Forkhead box protein K2	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q01167	FOXK2	Forkhead box protein K2	GO:0005515; F:protein binding; IPI:IntAct
Q01167	FOXK2	Forkhead box protein K2	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q01167	FOXK2	Forkhead box protein K2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q01167	FOXK2	Forkhead box protein K2	GO:0009790; P:embryo development; IBA:RefGenome
Q01167	FOXK2	Forkhead box protein K2	GO:0007389; P:pattern specification process; IBA:RefGenome
Q01167	FOXK2	Forkhead box protein K2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q01167	FOXK2	Forkhead box protein K2	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q01167	FOXK2	Forkhead box protein K2	GO:0009888; P:tissue development; IBA:RefGenome
Q01167	FOXK2	Forkhead box protein K2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q12952	FOXL1	Forkhead box protein L1	GO:0003677; F:DNA binding; IDA:MGI
Q12952	FOXL1	Forkhead box protein L1	GO:0008301; F:DNA binding, bending; NAS:UniProtKB
Q12952	FOXL1	Forkhead box protein L1	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q12952	FOXL1	Forkhead box protein L1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q12952	FOXL1	Forkhead box protein L1	GO:0007420; P:brain development; IBA:RefGenome
Q12952	FOXL1	Forkhead box protein L1	GO:0043010; P:camera-type eye development; IBA:RefGenome
Q12952	FOXL1	Forkhead box protein L1	GO:0009790; P:embryo development; IBA:RefGenome
Q12952	FOXL1	Forkhead box protein L1	GO:0007507; P:heart development; IMP:DFLAT
Q12952	FOXL1	Forkhead box protein L1	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
Q12952	FOXL1	Forkhead box protein L1	GO:0009887; P:organ morphogenesis; ISS:UniProtKB
Q12952	FOXL1	Forkhead box protein L1	GO:0007389; P:pattern specification process; IBA:RefGenome
Q12952	FOXL1	Forkhead box protein L1	GO:0061146; P:Peyer's patch morphogenesis; IEA:Ensembl
Q12952	FOXL1	Forkhead box protein L1	GO:0030166; P:proteoglycan biosynthetic process; ISS:UniProtKB
Q12952	FOXL1	Forkhead box protein L1	GO:0030111; P:regulation of Wnt signaling pathway; ISS:UniProtKB
Q12952	FOXL1	Forkhead box protein L1	GO:0009888; P:tissue development; IBA:RefGenome
Q12952	FOXL1	Forkhead box protein L1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q12952	FOXL1	Forkhead box protein L1	GO:0007495; P:visceral mesoderm-endoderm interaction involved in midgut development; ISS:UniProtKB
P58012	FOXL2	Forkhead box protein L2	GO:0043028; F:cysteine-type endopeptidase regulator activity involved in apoptotic process; IMP:UniProtKB
P58012	FOXL2	Forkhead box protein L2	GO:0003677; F:DNA binding; IDA:UniProtKB
P58012	FOXL2	Forkhead box protein L2	GO:0008301; F:DNA binding, bending; IBA:RefGenome
P58012	FOXL2	Forkhead box protein L2	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
P58012	FOXL2	Forkhead box protein L2	GO:0030331; F:estrogen receptor binding; IBA:RefGenome
P58012	FOXL2	Forkhead box protein L2	GO:0005515; F:protein binding; IPI:UniProtKB
P58012	FOXL2	Forkhead box protein L2	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P58012	FOXL2	Forkhead box protein L2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P58012	FOXL2	Forkhead box protein L2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
P58012	FOXL2	Forkhead box protein L2	GO:0008134; F:transcription factor binding; IBA:RefGenome
P58012	FOXL2	Forkhead box protein L2	GO:0031624; F:ubiquitin conjugating enzyme binding; IPI:UniProtKB
P58012	FOXL2	Forkhead box protein L2	GO:0006309; P:apoptotic DNA fragmentation; IMP:UniProtKB
P58012	FOXL2	Forkhead box protein L2	GO:0030154; P:cell differentiation; NAS:UniProtKB
P58012	FOXL2	Forkhead box protein L2	GO:0048048; P:embryonic eye morphogenesis; IBA:RefGenome
P58012	FOXL2	Forkhead box protein L2	GO:0002074; P:extraocular skeletal muscle development; IMP:UniProtKB
P58012	FOXL2	Forkhead box protein L2	GO:0019101; P:female somatic sex determination; IBA:RefGenome
P58012	FOXL2	Forkhead box protein L2	GO:0060014; P:granulosa cell differentiation; IEA:Ensembl
P58012	FOXL2	Forkhead box protein L2	GO:0042703; P:menstruation; IMP:UniProtKB
P58012	FOXL2	Forkhead box protein L2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
P58012	FOXL2	Forkhead box protein L2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P58012	FOXL2	Forkhead box protein L2	GO:0001541; P:ovarian follicle development; IMP:UniProtKB
P58012	FOXL2	Forkhead box protein L2	GO:0007389; P:pattern specification process; IBA:RefGenome
P58012	FOXL2	Forkhead box protein L2	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
P58012	FOXL2	Forkhead box protein L2	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
P58012	FOXL2	Forkhead box protein L2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
P58012	FOXL2	Forkhead box protein L2	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
P58012	FOXL2	Forkhead box protein L2	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P58012	FOXL2	Forkhead box protein L2	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q08050	FOXM1	Forkhead box protein M1	GO:0003677; F:DNA binding; IDA:UniProtKB
Q08050	FOXM1	Forkhead box protein M1	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q08050	FOXM1	Forkhead box protein M1	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q08050	FOXM1	Forkhead box protein M1	GO:0005515; F:protein binding; IPI:IntAct
Q08050	FOXM1	Forkhead box protein M1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q08050	FOXM1	Forkhead box protein M1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q08050	FOXM1	Forkhead box protein M1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q08050	FOXM1	Forkhead box protein M1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q08050	FOXM1	Forkhead box protein M1	GO:0008134; F:transcription factor binding; IBA:RefGenome
Q08050	FOXM1	Forkhead box protein M1	GO:0044212; F:transcription regulatory region DNA binding; IEA:Ensembl
Q08050	FOXM1	Forkhead box protein M1	GO:0007049; P:cell cycle; TAS:UniProtKB
Q08050	FOXM1	Forkhead box protein M1	GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IMP:UniProtKB
Q08050	FOXM1	Forkhead box protein M1	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q08050	FOXM1	Forkhead box protein M1	GO:0009790; P:embryo development; IBA:RefGenome
Q08050	FOXM1	Forkhead box protein M1	GO:0000086; P:G2/M transition of mitotic cell cycle; IDA:UniProtKB
Q08050	FOXM1	Forkhead box protein M1	GO:0001889; P:liver development; IBA:RefGenome
Q08050	FOXM1	Forkhead box protein M1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q08050	FOXM1	Forkhead box protein M1	GO:0090344; P:negative regulation of cell aging; IMP:UniProtKB
Q08050	FOXM1	Forkhead box protein M1	GO:0032873; P:negative regulation of stress-activated MAPK cascade; IMP:BHF-UCL
Q08050	FOXM1	Forkhead box protein M1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q08050	FOXM1	Forkhead box protein M1	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:BHF-UCL
Q08050	FOXM1	Forkhead box protein M1	GO:0007389; P:pattern specification process; IBA:RefGenome
Q08050	FOXM1	Forkhead box protein M1	GO:0008284; P:positive regulation of cell proliferation; IMP:BHF-UCL
Q08050	FOXM1	Forkhead box protein M1	GO:2000781; P:positive regulation of double-strand break repair; IMP:UniProtKB
Q08050	FOXM1	Forkhead box protein M1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q08050	FOXM1	Forkhead box protein M1	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q08050	FOXM1	Forkhead box protein M1	GO:0051726; P:regulation of cell cycle; TAS:Reactome
Q08050	FOXM1	Forkhead box protein M1	GO:0071156; P:regulation of cell cycle arrest; IMP:BHF-UCL
Q08050	FOXM1	Forkhead box protein M1	GO:0001558; P:regulation of cell growth; TAS:UniProtKB
Q08050	FOXM1	Forkhead box protein M1	GO:0042127; P:regulation of cell proliferation; NAS:UniProtKB
Q08050	FOXM1	Forkhead box protein M1	GO:0046578; P:regulation of Ras protein signal transduction; IMP:BHF-UCL
Q08050	FOXM1	Forkhead box protein M1	GO:2000377; P:regulation of reactive oxygen species metabolic process; IMP:BHF-UCL
Q08050	FOXM1	Forkhead box protein M1	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q08050	FOXM1	Forkhead box protein M1	GO:0006355; P:regulation of transcription, DNA-templated; IDA:GOC
Q08050	FOXM1	Forkhead box protein M1	GO:0009888; P:tissue development; IBA:RefGenome
Q08050	FOXM1	Forkhead box protein M1	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q08050	FOXM1	Forkhead box protein M1	GO:0001570; P:vasculogenesis; IBA:RefGenome
O15353	FOXN1	Forkhead box protein N1	GO:0008301; F:DNA binding, bending; IBA:RefGenome
O15353	FOXN1	Forkhead box protein N1	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
O15353	FOXN1	Forkhead box protein N1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
O15353	FOXN1	Forkhead box protein N1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O15353	FOXN1	Forkhead box protein N1	GO:0008134; F:transcription factor binding; IBA:RefGenome
O15353	FOXN1	Forkhead box protein N1	GO:0006952; P:defense response; TAS:ProtInc
O15353	FOXN1	Forkhead box protein N1	GO:0009790; P:embryo development; IBA:RefGenome
O15353	FOXN1	Forkhead box protein N1	GO:0008544; P:epidermis development; TAS:ProtInc
O15353	FOXN1	Forkhead box protein N1	GO:0050673; P:epithelial cell proliferation; IEA:Ensembl
O15353	FOXN1	Forkhead box protein N1	GO:0001942; P:hair follicle development; IEA:Ensembl
O15353	FOXN1	Forkhead box protein N1	GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
O15353	FOXN1	Forkhead box protein N1	GO:0002260; P:lymphocyte homeostasis; IEA:Ensembl
O15353	FOXN1	Forkhead box protein N1	GO:0035878; P:nail development; IEA:Ensembl
O15353	FOXN1	Forkhead box protein N1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
O15353	FOXN1	Forkhead box protein N1	GO:0009887; P:organ morphogenesis; TAS:ProtInc
O15353	FOXN1	Forkhead box protein N1	GO:0007389; P:pattern specification process; IBA:RefGenome
O15353	FOXN1	Forkhead box protein N1	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
O15353	FOXN1	Forkhead box protein N1	GO:0033081; P:regulation of T cell differentiation in thymus; IEA:Ensembl
O15353	FOXN1	Forkhead box protein N1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O15353	FOXN1	Forkhead box protein N1	GO:0048538; P:thymus development; IEA:Ensembl
O15353	FOXN1	Forkhead box protein N1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P32314	FOXN2	Forkhead box protein N2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P32314	FOXN2	Forkhead box protein N2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P32314	FOXN2	Forkhead box protein N2	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
P32314	FOXN2	Forkhead box protein N2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O00409	FOXN3	Forkhead box protein N3	GO:0005515; F:protein binding; IPI:UniProtKB
O00409	FOXN3	Forkhead box protein N3	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
O00409	FOXN3	Forkhead box protein N3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O00409	FOXN3	Forkhead box protein N3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O00409	FOXN3	Forkhead box protein N3	GO:0000077; P:DNA damage checkpoint; TAS:ProtInc
O00409	FOXN3	Forkhead box protein N3	GO:0000085; P:mitotic G2 phase; TAS:ProtInc
O00409	FOXN3	Forkhead box protein N3	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
O00409	FOXN3	Forkhead box protein N3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96NZ1	FOXN4	Forkhead box protein N4	GO:0003682; F:chromatin binding; ISS:UniProtKB
Q96NZ1	FOXN4	Forkhead box protein N4	GO:0001158; F:enhancer sequence-specific DNA binding; IDA:UniProtKB
Q96NZ1	FOXN4	Forkhead box protein N4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q96NZ1	FOXN4	Forkhead box protein N4	GO:0035881; P:amacrine cell differentiation; ISS:UniProtKB
Q96NZ1	FOXN4	Forkhead box protein N4	GO:0036302; P:atrioventricular canal development; ISS:UniProtKB
Q96NZ1	FOXN4	Forkhead box protein N4	GO:0001947; P:heart looping; ISS:UniProtKB
Q96NZ1	FOXN4	Forkhead box protein N4	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q96NZ1	FOXN4	Forkhead box protein N4	GO:0008016; P:regulation of heart contraction; ISS:UniProtKB
Q96NZ1	FOXN4	Forkhead box protein N4	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
Q96NZ1	FOXN4	Forkhead box protein N4	GO:0010842; P:retina layer formation; ISS:UniProtKB
Q96NZ1	FOXN4	Forkhead box protein N4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96NZ1	FOXN4	Forkhead box protein N4	GO:0060579; P:ventral spinal cord interneuron fate commitment; ISS:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0003682; F:chromatin binding; ISS:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q12778	FOXO1	Forkhead box protein O1	GO:0005515; F:protein binding; IPI:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0051721; F:protein phosphatase 2A binding; ISS:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IEA:Ensembl
Q12778	FOXO1	Forkhead box protein O1	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q12778	FOXO1	Forkhead box protein O1	GO:0001568; P:blood vessel development; IBA:RefGenome
Q12778	FOXO1	Forkhead box protein O1	GO:0001678; P:cellular glucose homeostasis; ISS:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0070417; P:cellular response to cold; ISS:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0006974; P:cellular response to DNA damage stimulus; ISS:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0032869; P:cellular response to insulin stimulus; ISS:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0071732; P:cellular response to nitric oxide; ISS:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0034599; P:cellular response to oxidative stress; ISS:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0009267; P:cellular response to starvation; ISS:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0009790; P:embryo development; IBA:RefGenome
Q12778	FOXO1	Forkhead box protein O1	GO:0031018; P:endocrine pancreas development; TAS:Reactome
Q12778	FOXO1	Forkhead box protein O1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q12778	FOXO1	Forkhead box protein O1	GO:0045444; P:fat cell differentiation; ISS:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q12778	FOXO1	Forkhead box protein O1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q12778	FOXO1	Forkhead box protein O1	GO:0045087; P:innate immune response; TAS:Reactome
Q12778	FOXO1	Forkhead box protein O1	GO:0008286; P:insulin receptor signaling pathway; ISS:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0045599; P:negative regulation of fat cell differentiation; ISS:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0032873; P:negative regulation of stress-activated MAPK cascade; IDA:BHF-UCL
Q12778	FOXO1	Forkhead box protein O1	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q12778	FOXO1	Forkhead box protein O1	GO:0007389; P:pattern specification process; IBA:RefGenome
Q12778	FOXO1	Forkhead box protein O1	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q12778	FOXO1	Forkhead box protein O1	GO:0045722; P:positive regulation of gluconeogenesis; IEA:Ensembl
Q12778	FOXO1	Forkhead box protein O1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0006473; P:protein acetylation; ISS:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q12778	FOXO1	Forkhead box protein O1	GO:2000505; P:regulation of energy homeostasis; ISS:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0035947; P:regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q12778	FOXO1	Forkhead box protein O1	GO:0001659; P:temperature homeostasis; ISS:UniProtKB
Q12778	FOXO1	Forkhead box protein O1	GO:0009888; P:tissue development; IBA:RefGenome
O43524	FOXO3	Forkhead box protein O3	GO:0003677; F:DNA binding; IDA:UniProtKB
O43524	FOXO3	Forkhead box protein O3	GO:0008301; F:DNA binding, bending; IBA:RefGenome
O43524	FOXO3	Forkhead box protein O3	GO:0005515; F:protein binding; IPI:UniProtKB
O43524	FOXO3	Forkhead box protein O3	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O43524	FOXO3	Forkhead box protein O3	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
O43524	FOXO3	Forkhead box protein O3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:MGI
O43524	FOXO3	Forkhead box protein O3	GO:0001547; P:antral ovarian follicle growth; IEA:Ensembl
O43524	FOXO3	Forkhead box protein O3	GO:0006974; P:cellular response to DNA damage stimulus; IBA:RefGenome
O43524	FOXO3	Forkhead box protein O3	GO:0030330; P:DNA damage response, signal transduction by p53 class mediator; IEA:Ensembl
O43524	FOXO3	Forkhead box protein O3	GO:0009790; P:embryo development; IBA:RefGenome
O43524	FOXO3	Forkhead box protein O3	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O43524	FOXO3	Forkhead box protein O3	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
O43524	FOXO3	Forkhead box protein O3	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O43524	FOXO3	Forkhead box protein O3	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
O43524	FOXO3	Forkhead box protein O3	GO:0042593; P:glucose homeostasis; IEA:Ensembl
O43524	FOXO3	Forkhead box protein O3	GO:0001544; P:initiation of primordial ovarian follicle growth; IEA:Ensembl
O43524	FOXO3	Forkhead box protein O3	GO:0045087; P:innate immune response; TAS:Reactome
O43524	FOXO3	Forkhead box protein O3	GO:0008286; P:insulin receptor signaling pathway; IBA:RefGenome
O43524	FOXO3	Forkhead box protein O3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
O43524	FOXO3	Forkhead box protein O3	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O43524	FOXO3	Forkhead box protein O3	GO:0001556; P:oocyte maturation; IEA:Ensembl
O43524	FOXO3	Forkhead box protein O3	GO:0001542; P:ovulation from ovarian follicle; IEA:Ensembl
O43524	FOXO3	Forkhead box protein O3	GO:0007389; P:pattern specification process; IBA:RefGenome
O43524	FOXO3	Forkhead box protein O3	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
O43524	FOXO3	Forkhead box protein O3	GO:0045648; P:positive regulation of erythrocyte differentiation; IDA:MGI
O43524	FOXO3	Forkhead box protein O3	GO:0043525; P:positive regulation of neuron apoptotic process; IMP:UniProtKB
O43524	FOXO3	Forkhead box protein O3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O43524	FOXO3	Forkhead box protein O3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O43524	FOXO3	Forkhead box protein O3	GO:0042127; P:regulation of cell proliferation; IBA:RefGenome
O43524	FOXO3	Forkhead box protein O3	GO:0006417; P:regulation of translation; IDA:UniProtKB
O43524	FOXO3	Forkhead box protein O3	GO:0009888; P:tissue development; IBA:RefGenome
O43524	FOXO3	Forkhead box protein O3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A8MYZ6	FOXO6	Forkhead box protein O6	GO:0005515; F:protein binding; IPI:IntAct
A8MYZ6	FOXO6	Forkhead box protein O6	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
A8MYZ6	FOXO6	Forkhead box protein O6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
A8MYZ6	FOXO6	Forkhead box protein O6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P98177	FOXO4	Forkhead box protein O4	GO:0003677; F:DNA binding; IDA:UniProtKB
P98177	FOXO4	Forkhead box protein O4	GO:0008301; F:DNA binding, bending; IBA:RefGenome
P98177	FOXO4	Forkhead box protein O4	GO:0019899; F:enzyme binding; IPI:UniProtKB
P98177	FOXO4	Forkhead box protein O4	GO:0005515; F:protein binding; IPI:UniProtKB
P98177	FOXO4	Forkhead box protein O4	GO:0043565; F:sequence-specific DNA binding; IMP:UniProtKB
P98177	FOXO4	Forkhead box protein O4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P98177	FOXO4	Forkhead box protein O4	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P98177	FOXO4	Forkhead box protein O4	GO:0007050; P:cell cycle arrest; IDA:UniProtKB
P98177	FOXO4	Forkhead box protein O4	GO:0009790; P:embryo development; IBA:RefGenome
P98177	FOXO4	Forkhead box protein O4	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P98177	FOXO4	Forkhead box protein O4	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P98177	FOXO4	Forkhead box protein O4	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P98177	FOXO4	Forkhead box protein O4	GO:0045087; P:innate immune response; TAS:Reactome
P98177	FOXO4	Forkhead box protein O4	GO:0008286; P:insulin receptor signaling pathway; IDA:UniProtKB
P98177	FOXO4	Forkhead box protein O4	GO:0007095; P:mitotic G2 DNA damage checkpoint; IBA:RefGenome
P98177	FOXO4	Forkhead box protein O4	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
P98177	FOXO4	Forkhead box protein O4	GO:0016525; P:negative regulation of angiogenesis; IDA:UniProtKB
P98177	FOXO4	Forkhead box protein O4	GO:0043066; P:negative regulation of apoptotic process; IBA:RefGenome
P98177	FOXO4	Forkhead box protein O4	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
P98177	FOXO4	Forkhead box protein O4	GO:0070317; P:negative regulation of G0 to G1 transition; IDA:UniProtKB
P98177	FOXO4	Forkhead box protein O4	GO:0051151; P:negative regulation of smooth muscle cell differentiation; IDA:UniProtKB
P98177	FOXO4	Forkhead box protein O4	GO:0032873; P:negative regulation of stress-activated MAPK cascade; IBA:RefGenome
P98177	FOXO4	Forkhead box protein O4	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P98177	FOXO4	Forkhead box protein O4	GO:0007389; P:pattern specification process; IBA:RefGenome
P98177	FOXO4	Forkhead box protein O4	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P98177	FOXO4	Forkhead box protein O4	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P98177	FOXO4	Forkhead box protein O4	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
P98177	FOXO4	Forkhead box protein O4	GO:0048863; P:stem cell differentiation; IMP:UniProtKB
P98177	FOXO4	Forkhead box protein O4	GO:0009888; P:tissue development; IBA:RefGenome
P98177	FOXO4	Forkhead box protein O4	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9H334	FOXP1	Forkhead box protein P1	GO:0003682; F:chromatin binding; IBA:RefGenome
Q9H334	FOXP1	Forkhead box protein P1	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q9H334	FOXP1	Forkhead box protein P1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H334	FOXP1	Forkhead box protein P1	GO:0046982; F:protein heterodimerization activity; IBA:RefGenome
Q9H334	FOXP1	Forkhead box protein P1	GO:0042803; F:protein homodimerization activity; IBA:RefGenome
Q9H334	FOXP1	Forkhead box protein P1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9H334	FOXP1	Forkhead box protein P1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9H334	FOXP1	Forkhead box protein P1	GO:0055007; P:cardiac muscle cell differentiation; IBA:RefGenome
Q9H334	FOXP1	Forkhead box protein P1	GO:0009790; P:embryo development; IBA:RefGenome
Q9H334	FOXP1	Forkhead box protein P1	GO:0033152; P:immunoglobulin V(D)J recombination; IBA:RefGenome
Q9H334	FOXP1	Forkhead box protein P1	GO:0030324; P:lung development; IBA:RefGenome
Q9H334	FOXP1	Forkhead box protein P1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9H334	FOXP1	Forkhead box protein P1	GO:0007389; P:pattern specification process; IBA:RefGenome
Q9H334	FOXP1	Forkhead box protein P1	GO:0050679; P:positive regulation of epithelial cell proliferation; IBA:RefGenome
Q9H334	FOXP1	Forkhead box protein P1	GO:0002639; P:positive regulation of immunoglobulin production; IBA:RefGenome
Q9H334	FOXP1	Forkhead box protein P1	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IBA:RefGenome
Q9H334	FOXP1	Forkhead box protein P1	GO:0002329; P:pre-B cell differentiation; IBA:RefGenome
Q9H334	FOXP1	Forkhead box protein P1	GO:0007519; P:skeletal muscle tissue development; IBA:RefGenome
Q9H334	FOXP1	Forkhead box protein P1	GO:0048745; P:smooth muscle tissue development; IBA:RefGenome
Q9H334	FOXP1	Forkhead box protein P1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15409	FOXP2	Forkhead box protein P2	GO:0003682; F:chromatin binding; IBA:RefGenome
O15409	FOXP2	Forkhead box protein P2	GO:0003677; F:DNA binding; IDA:UniProtKB
O15409	FOXP2	Forkhead box protein P2	GO:0008301; F:DNA binding, bending; IBA:RefGenome
O15409	FOXP2	Forkhead box protein P2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15409	FOXP2	Forkhead box protein P2	GO:0046982; F:protein heterodimerization activity; IBA:RefGenome
O15409	FOXP2	Forkhead box protein P2	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O15409	FOXP2	Forkhead box protein P2	GO:0043565; F:sequence-specific DNA binding; IDA:BHF-UCL
O15409	FOXP2	Forkhead box protein P2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
O15409	FOXP2	Forkhead box protein P2	GO:0043010; P:camera-type eye development; IBA:RefGenome
O15409	FOXP2	Forkhead box protein P2	GO:0021757; P:caudate nucleus development; IMP:UniProtKB
O15409	FOXP2	Forkhead box protein P2	GO:0021549; P:cerebellum development; IBA:RefGenome
O15409	FOXP2	Forkhead box protein P2	GO:0021987; P:cerebral cortex development; IEP:BHF-UCL
O15409	FOXP2	Forkhead box protein P2	GO:0009790; P:embryo development; IBA:RefGenome
O15409	FOXP2	Forkhead box protein P2	GO:0040007; P:growth; IBA:RefGenome
O15409	FOXP2	Forkhead box protein P2	GO:0048286; P:lung alveolus development; IBA:RefGenome
O15409	FOXP2	Forkhead box protein P2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
O15409	FOXP2	Forkhead box protein P2	GO:0007389; P:pattern specification process; IBA:RefGenome
O15409	FOXP2	Forkhead box protein P2	GO:0060501; P:positive regulation of epithelial cell proliferation involved in lung morphogenesis; IBA:RefGenome
O15409	FOXP2	Forkhead box protein P2	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IBA:RefGenome
O15409	FOXP2	Forkhead box protein P2	GO:0009791; P:post-embryonic development; IBA:RefGenome
O15409	FOXP2	Forkhead box protein P2	GO:0021758; P:putamen development; IMP:UniProtKB
O15409	FOXP2	Forkhead box protein P2	GO:0060013; P:righting reflex; IBA:RefGenome
O15409	FOXP2	Forkhead box protein P2	GO:0007519; P:skeletal muscle tissue development; IBA:RefGenome
O15409	FOXP2	Forkhead box protein P2	GO:0048745; P:smooth muscle tissue development; IBA:RefGenome
O15409	FOXP2	Forkhead box protein P2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15409	FOXP2	Forkhead box protein P2	GO:0042297; P:vocal learning; IBA:RefGenome
Q8IVH2	FOXP4	Forkhead box protein P4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IVH2	FOXP4	Forkhead box protein P4	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q8IVH2	FOXP4	Forkhead box protein P4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8IVH2	FOXP4	Forkhead box protein P4	GO:0048617; P:embryonic foregut morphogenesis; IEA:Ensembl
Q8IVH2	FOXP4	Forkhead box protein P4	GO:0007507; P:heart development; IEA:Ensembl
Q8IVH2	FOXP4	Forkhead box protein P4	GO:0061140; P:lung secretory cell differentiation; IEA:Ensembl
Q8IVH2	FOXP4	Forkhead box protein P4	GO:1901250; P:negative regulation of lung goblet cell differentiation; IEA:Ensembl
Q8IVH2	FOXP4	Forkhead box protein P4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9C009	FOXQ1	Forkhead box protein Q1	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q9C009	FOXQ1	Forkhead box protein Q1	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q9C009	FOXQ1	Forkhead box protein Q1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9C009	FOXQ1	Forkhead box protein Q1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9C009	FOXQ1	Forkhead box protein Q1	GO:0008134; F:transcription factor binding; IBA:RefGenome
Q9C009	FOXQ1	Forkhead box protein Q1	GO:0009790; P:embryo development; IBA:RefGenome
Q9C009	FOXQ1	Forkhead box protein Q1	GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl
Q9C009	FOXQ1	Forkhead box protein Q1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q9C009	FOXQ1	Forkhead box protein Q1	GO:0007389; P:pattern specification process; IBA:RefGenome
Q9C009	FOXQ1	Forkhead box protein Q1	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9C009	FOXQ1	Forkhead box protein Q1	GO:0009888; P:tissue development; IBA:RefGenome
Q9C009	FOXQ1	Forkhead box protein Q1	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0003682; F:chromatin binding; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0035035; F:histone acetyltransferase binding; IPI:BHF-UCL
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0051059; F:NF-kappaB binding; NAS:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0051525; F:NFAT protein binding; IPI:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0046982; F:protein heterodimerization activity; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0003714; F:transcription corepressor activity; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0001782; P:B cell homeostasis; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0055007; P:cardiac muscle cell differentiation; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0002361; P:CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation; IEA:Ensembl
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0006338; P:chromatin remodeling; NAS:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0001816; P:cytokine production; IEA:Ensembl
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0009790; P:embryo development; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0033152; P:immunoglobulin V(D)J recombination; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0030324; P:lung development; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0002262; P:myeloid cell homeostasis; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0046007; P:negative regulation of activated T cell proliferation; NAS:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0002677; P:negative regulation of chronic inflammatory response; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0032792; P:negative regulation of CREB transcription factor activity; IDA:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0042036; P:negative regulation of cytokine biosynthetic process; IDA:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0050710; P:negative regulation of cytokine secretion; IDA:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0035067; P:negative regulation of histone acetylation; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0031064; P:negative regulation of histone deacetylation; IGI:BHF-UCL
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0050777; P:negative regulation of immune response; IDA:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0045077; P:negative regulation of interferon-gamma biosynthetic process; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0032689; P:negative regulation of interferon-gamma production; IDA:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0032693; P:negative regulation of interleukin-10 production; IDA:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0045085; P:negative regulation of interleukin-2 biosynthetic process; IMP:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0032703; P:negative regulation of interleukin-2 production; IDA:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0032713; P:negative regulation of interleukin-4 production; IDA:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0032714; P:negative regulation of interleukin-5 production; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0032715; P:negative regulation of interleukin-6 production; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0048294; P:negative regulation of isotype switching to IgE isotypes; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0002725; P:negative regulation of T cell cytokine production; IDA:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0042130; P:negative regulation of T cell proliferation; IDA:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0032720; P:negative regulation of tumor necrosis factor production; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0007389; P:pattern specification process; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0032831; P:positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0050679; P:positive regulation of epithelial cell proliferation; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0035066; P:positive regulation of histone acetylation; IMP:BHF-UCL
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0033092; P:positive regulation of immature T cell proliferation in thymus; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0002639; P:positive regulation of immunoglobulin production; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0032753; P:positive regulation of interleukin-4 production; IEA:Ensembl
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0002851; P:positive regulation of peripheral T cell tolerance induction; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0002669; P:positive regulation of T cell anergy; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0032914; P:positive regulation of transforming growth factor beta1 production; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0002329; P:pre-B cell differentiation; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0048302; P:regulation of isotype switching to IgG isotypes; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0009615; P:response to virus; IEP:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0042110; P:T cell activation; IDA:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0043029; P:T cell homeostasis; NAS:UniProtKB
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0002456; P:T cell mediated immunity; IEA:Ensembl
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0050852; P:T cell receptor signaling pathway; IBA:RefGenome
Q9BZS1	FOXP3	Forkhead box protein P3	GO:0002513; P:tolerance induction to self antigen; IBA:RefGenome
Q6PJQ5	FOXR2	Forkhead box protein R2	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q6PJQ5	FOXR2	Forkhead box protein R2	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q6PJQ5	FOXR2	Forkhead box protein R2	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6PJQ5	FOXR2	Forkhead box protein R2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q6PJQ5	FOXR2	Forkhead box protein R2	GO:0008134; F:transcription factor binding; IBA:RefGenome
Q6PJQ5	FOXR2	Forkhead box protein R2	GO:0009790; P:embryo development; IBA:RefGenome
Q6PJQ5	FOXR2	Forkhead box protein R2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q6PJQ5	FOXR2	Forkhead box protein R2	GO:0048513; P:organ development; IBA:RefGenome
Q6PJQ5	FOXR2	Forkhead box protein R2	GO:0007389; P:pattern specification process; IBA:RefGenome
Q6PJQ5	FOXR2	Forkhead box protein R2	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6PJQ5	FOXR2	Forkhead box protein R2	GO:0009888; P:tissue development; IBA:RefGenome
Q6PJQ5	FOXR2	Forkhead box protein R2	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q6PIV2	FOXR1	Forkhead box protein R1	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q6PIV2	FOXR1	Forkhead box protein R1	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q6PIV2	FOXR1	Forkhead box protein R1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6PIV2	FOXR1	Forkhead box protein R1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q6PIV2	FOXR1	Forkhead box protein R1	GO:0008134; F:transcription factor binding; IBA:RefGenome
Q6PIV2	FOXR1	Forkhead box protein R1	GO:0009790; P:embryo development; IBA:RefGenome
Q6PIV2	FOXR1	Forkhead box protein R1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q6PIV2	FOXR1	Forkhead box protein R1	GO:0048513; P:organ development; IBA:RefGenome
Q6PIV2	FOXR1	Forkhead box protein R1	GO:0007389; P:pattern specification process; IBA:RefGenome
Q6PIV2	FOXR1	Forkhead box protein R1	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6PIV2	FOXR1	Forkhead box protein R1	GO:0009888; P:tissue development; IBA:RefGenome
Q6PIV2	FOXR1	Forkhead box protein R1	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
O43638	FOXS1	Forkhead box protein S1	GO:0031490; F:chromatin DNA binding; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0003677; F:DNA binding; ISS:UniProtKB
O43638	FOXS1	Forkhead box protein S1	GO:0008301; F:DNA binding, bending; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O43638	FOXS1	Forkhead box protein S1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:UniProtKB
O43638	FOXS1	Forkhead box protein S1	GO:0008134; F:transcription factor binding; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0048844; P:artery morphogenesis; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0001568; P:blood vessel development; ISS:UniProtKB
O43638	FOXS1	Forkhead box protein S1	GO:0001974; P:blood vessel remodeling; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0043010; P:camera-type eye development; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0060038; P:cardiac muscle cell proliferation; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0030199; P:collagen fibril organization; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0035050; P:embryonic heart tube development; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0008286; P:insulin receptor signaling pathway; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0001946; P:lymphangiogenesis; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0043066; P:negative regulation of apoptotic process; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
O43638	FOXS1	Forkhead box protein S1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
O43638	FOXS1	Forkhead box protein S1	GO:0050885; P:neuromuscular process controlling balance; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0007219; P:Notch signaling pathway; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0001503; P:ossification; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0048343; P:paraxial mesodermal cell fate commitment; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0001569; P:patterning of blood vessels; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0040018; P:positive regulation of multicellular organism growth; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0050880; P:regulation of blood vessel size; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0046620; P:regulation of organ growth; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0001756; P:somitogenesis; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
O43638	FOXS1	Forkhead box protein S1	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IBA:RefGenome
O43638	FOXS1	Forkhead box protein S1	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IBA:RefGenome
Q0VG06	FAAP100	Fanconi anemia-associated protein of 100 kDa	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q0VG06	FAAP100	Fanconi anemia-associated protein of 100 kDa	GO:0005515; F:protein binding; IPI:IntAct
Q0VG06	FAAP100	Fanconi anemia-associated protein of 100 kDa	GO:0006281; P:DNA repair; TAS:Reactome
O14772	FPGT	Fucose-1-phosphate guanylyltransferase	GO:0003824; F:catalytic activity; TAS:ProtInc
O14772	FPGT	Fucose-1-phosphate guanylyltransferase	GO:0047341; F:fucose-1-phosphate guanylyltransferase activity; IEA:UniProtKB-EC
O14772	FPGT	Fucose-1-phosphate guanylyltransferase	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
O14772	FPGT	Fucose-1-phosphate guanylyltransferase	GO:0006004; P:fucose metabolic process; TAS:ProtInc
P14324	FDPS	Farnesyl pyrophosphate synthase	GO:0004161; F:dimethylallyltranstransferase activity; IEA:UniProtKB-EC
P14324	FDPS	Farnesyl pyrophosphate synthase	GO:0004337; F:geranyltranstransferase activity; IEA:UniProtKB-EC
P14324	FDPS	Farnesyl pyrophosphate synthase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P14324	FDPS	Farnesyl pyrophosphate synthase	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P14324	FDPS	Farnesyl pyrophosphate synthase	GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome
P14324	FDPS	Farnesyl pyrophosphate synthase	GO:0045337; P:farnesyl diphosphate biosynthetic process; IEA:UniProtKB-UniPathway
P14324	FDPS	Farnesyl pyrophosphate synthase	GO:0033384; P:geranyl diphosphate biosynthetic process; IEA:UniProtKB-UniPathway
P14324	FDPS	Farnesyl pyrophosphate synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P14324	FDPS	Farnesyl pyrophosphate synthase	GO:0016032; P:viral process; IEA:UniProtKB-KW
P21462	FPR1	fMet-Leu-Phe receptor	GO:0004982; F:N-formyl peptide receptor activity; IDA:MGI
P21462	FPR1	fMet-Leu-Phe receptor	GO:0005515; F:protein binding; IPI:IntAct
P21462	FPR1	fMet-Leu-Phe receptor	GO:0004872; F:receptor activity; TAS:ProtInc
P21462	FPR1	fMet-Leu-Phe receptor	GO:0000187; P:activation of MAPK activity; TAS:ProtInc
P21462	FPR1	fMet-Leu-Phe receptor	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; TAS:ProtInc
P21462	FPR1	fMet-Leu-Phe receptor	GO:0006928; P:cellular component movement; TAS:ProtInc
P21462	FPR1	fMet-Leu-Phe receptor	GO:0006935; P:chemotaxis; TAS:ProtInc
P21462	FPR1	fMet-Leu-Phe receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P21462	FPR1	fMet-Leu-Phe receptor	GO:0007263; P:nitric oxide mediated signal transduction; TAS:ProtInc
P21462	FPR1	fMet-Leu-Phe receptor	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; IDA:MGI
P21462	FPR1	fMet-Leu-Phe receptor	GO:0007165; P:signal transduction; TAS:ProtInc
P25090	FPR2	N-formyl peptide receptor 2	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P25090	FPR2	N-formyl peptide receptor 2	GO:0004982; F:N-formyl peptide receptor activity; TAS:ProtInc
P25090	FPR2	N-formyl peptide receptor 2	GO:0007155; P:cell adhesion; TAS:ProtInc
P25090	FPR2	N-formyl peptide receptor 2	GO:0006928; P:cellular component movement; TAS:ProtInc
P25090	FPR2	N-formyl peptide receptor 2	GO:0006935; P:chemotaxis; TAS:ProtInc
P25090	FPR2	N-formyl peptide receptor 2	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P25090	FPR2	N-formyl peptide receptor 2	GO:0006954; P:inflammatory response; TAS:ProtInc
P25089	FPR3	N-formyl peptide receptor 3	GO:0004982; F:N-formyl peptide receptor activity; TAS:ProtInc
P25089	FPR3	N-formyl peptide receptor 3	GO:0006928; P:cellular component movement; TAS:ProtInc
P25089	FPR3	N-formyl peptide receptor 3	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
P25089	FPR3	N-formyl peptide receptor 3	GO:0007165; P:signal transduction; TAS:ProtInc
Q9P2B2	PTGFRN	Prostaglandin F2 receptor negative regulator	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P2B2	PTGFRN	Prostaglandin F2 receptor negative regulator	GO:0034389; P:lipid particle organization; IEA:Ensembl
O95684	FGFR1OP	FGFR1 oncogene partner	GO:0005515; F:protein binding; IPI:UniProtKB
O95684	FGFR1OP	FGFR1 oncogene partner	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O95684	FGFR1OP	FGFR1 oncogene partner	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O95684	FGFR1OP	FGFR1 oncogene partner	GO:0004713; F:protein tyrosine kinase activity; TAS:Reactome
O95684	FGFR1OP	FGFR1 oncogene partner	GO:0030292; F:protein tyrosine kinase inhibitor activity; IDA:UniProtKB
O95684	FGFR1OP	FGFR1 oncogene partner	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
O95684	FGFR1OP	FGFR1 oncogene partner	GO:0034453; P:microtubule anchoring; IEA:InterPro
O95684	FGFR1OP	FGFR1 oncogene partner	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O95684	FGFR1OP	FGFR1 oncogene partner	GO:0006469; P:negative regulation of protein kinase activity; IDA:UniProtKB
O95684	FGFR1OP	FGFR1 oncogene partner	GO:0061099; P:negative regulation of protein tyrosine kinase activity; IDA:GOC
O95684	FGFR1OP	FGFR1 oncogene partner	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:GOC
O95684	FGFR1OP	FGFR1 oncogene partner	GO:0030307; P:positive regulation of cell growth; IDA:UniProtKB
O95684	FGFR1OP	FGFR1 oncogene partner	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
O95684	FGFR1OP	FGFR1 oncogene partner	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q86XX4	FRAS1	Extracellular matrix protein FRAS1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86XX4	FRAS1	Extracellular matrix protein FRAS1	GO:0007154; P:cell communication; IEA:InterPro
Q86XX4	FRAS1	Extracellular matrix protein FRAS1	GO:0002009; P:morphogenesis of an epithelium; IEA:Ensembl
Q86XX4	FRAS1	Extracellular matrix protein FRAS1	GO:0015031; P:protein transport; IEA:Ensembl
Q86XX4	FRAS1	Extracellular matrix protein FRAS1	GO:0043588; P:skin development; IEA:Ensembl
Q92837	FRAT1	Proto-oncogene FRAT1	GO:0000578; P:embryonic axis specification; IEA:Ensembl
Q92837	FRAT1	Proto-oncogene FRAT1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
O75474	FRAT2	GSK-3-binding protein FRAT2	GO:0008283; P:cell proliferation; NAS:UniProtKB
O75474	FRAT2	GSK-3-binding protein FRAT2	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
O75474	FRAT2	GSK-3-binding protein FRAT2	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q16595	FXN	Frataxin, mitochondrial	GO:0051537; F:2 iron, 2 sulfur cluster binding; IDA:BHF-UCL
Q16595	FXN	Frataxin, mitochondrial	GO:0008199; F:ferric iron binding; IDA:BHF-UCL
Q16595	FXN	Frataxin, mitochondrial	GO:0008198; F:ferrous iron binding; IDA:BHF-UCL
Q16595	FXN	Frataxin, mitochondrial	GO:0004322; F:ferroxidase activity; IDA:UniProtKB
Q16595	FXN	Frataxin, mitochondrial	GO:0034986; F:iron chaperone activity; IDA:BHF-UCL
Q16595	FXN	Frataxin, mitochondrial	GO:0051536; F:iron-sulfur cluster binding; IDA:BHF-UCL
Q16595	FXN	Frataxin, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q16595	FXN	Frataxin, mitochondrial	GO:0007628; P:adult walking behavior; IEA:Ensembl
Q16595	FXN	Frataxin, mitochondrial	GO:0009060; P:aerobic respiration; IEA:Ensembl
Q16595	FXN	Frataxin, mitochondrial	GO:0006879; P:cellular iron ion homeostasis; IMP:BHF-UCL
Q16595	FXN	Frataxin, mitochondrial	GO:0070301; P:cellular response to hydrogen peroxide; IDA:UniProtKB
Q16595	FXN	Frataxin, mitochondrial	GO:0009792; P:embryo development ending in birth or egg hatching; IEA:Ensembl
Q16595	FXN	Frataxin, mitochondrial	GO:0006783; P:heme biosynthetic process; NAS:BHF-UCL
Q16595	FXN	Frataxin, mitochondrial	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q16595	FXN	Frataxin, mitochondrial	GO:0018283; P:iron incorporation into metallo-sulfur cluster; IDA:BHF-UCL
Q16595	FXN	Frataxin, mitochondrial	GO:0007005; P:mitochondrion organization; IEA:Ensembl
Q16595	FXN	Frataxin, mitochondrial	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q16595	FXN	Frataxin, mitochondrial	GO:0040015; P:negative regulation of multicellular organism growth; IEA:Ensembl
Q16595	FXN	Frataxin, mitochondrial	GO:0046621; P:negative regulation of organ growth; IEA:Ensembl
Q16595	FXN	Frataxin, mitochondrial	GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; IMP:UniProtKB
Q16595	FXN	Frataxin, mitochondrial	GO:0006119; P:oxidative phosphorylation; IEA:Ensembl
Q16595	FXN	Frataxin, mitochondrial	GO:0030307; P:positive regulation of cell growth; IMP:BHF-UCL
Q16595	FXN	Frataxin, mitochondrial	GO:0008284; P:positive regulation of cell proliferation; IMP:BHF-UCL
Q16595	FXN	Frataxin, mitochondrial	GO:0051349; P:positive regulation of lyase activity; IDA:UniProtKB
Q16595	FXN	Frataxin, mitochondrial	GO:0048554; P:positive regulation of metalloenzyme activity; IMP:BHF-UCL
Q16595	FXN	Frataxin, mitochondrial	GO:0051353; P:positive regulation of oxidoreductase activity; IMP:BHF-UCL
Q16595	FXN	Frataxin, mitochondrial	GO:0051347; P:positive regulation of transferase activity; IMP:BHF-UCL
Q16595	FXN	Frataxin, mitochondrial	GO:0019230; P:proprioception; IEA:Ensembl
Q16595	FXN	Frataxin, mitochondrial	GO:0016540; P:protein autoprocessing; IDA:BHF-UCL
Q16595	FXN	Frataxin, mitochondrial	GO:0010722; P:regulation of ferrochelatase activity; IDA:BHF-UCL
Q16595	FXN	Frataxin, mitochondrial	GO:0010039; P:response to iron ion; IMP:BHF-UCL
Q16595	FXN	Frataxin, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5H8C1	FREM1	FRAS1-related extracellular matrix protein 1	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q5H8C1	FREM1	FRAS1-related extracellular matrix protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5H8C1	FREM1	FRAS1-related extracellular matrix protein 1	GO:0007154; P:cell communication; IEA:InterPro
Q5H8C1	FREM1	FRAS1-related extracellular matrix protein 1	GO:0007160; P:cell-matrix adhesion; IEA:Ensembl
Q5H8C1	FREM1	FRAS1-related extracellular matrix protein 1	GO:0097094; P:craniofacial suture morphogenesis; IMP:UniProtKB
Q5SZK8	FREM2	FRAS1-related extracellular matrix protein 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q5SZK8	FREM2	FRAS1-related extracellular matrix protein 2	GO:0007154; P:cell communication; IEA:InterPro
Q5SZK8	FREM2	FRAS1-related extracellular matrix protein 2	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q5SZK8	FREM2	FRAS1-related extracellular matrix protein 2	GO:0048839; P:inner ear development; IEA:Ensembl
Q5SZK8	FREM2	FRAS1-related extracellular matrix protein 2	GO:0002009; P:morphogenesis of an epithelium; IEA:Ensembl
P0C091	FREM3	FRAS1-related extracellular matrix protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P0C091	FREM3	FRAS1-related extracellular matrix protein 3	GO:0007155; P:cell adhesion; NAS:BHF-UCL
P0C091	FREM3	FRAS1-related extracellular matrix protein 3	GO:0007154; P:cell communication; IEA:InterPro
Q14331	FRG1	Protein FRG1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14331	FRG1	Protein FRG1	GO:0005515; F:protein binding; IPI:IntAct
Q14331	FRG1	Protein FRG1	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q14331	FRG1	Protein FRG1	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
P02794	FTH1	Ferritin heavy chain	GO:0008199; F:ferric iron binding; IEA:InterPro
P02794	FTH1	Ferritin heavy chain	GO:0004322; F:ferroxidase activity; IEA:UniProtKB-EC
P02794	FTH1	Ferritin heavy chain	GO:0005506; F:iron ion binding; TAS:ProtInc
P02794	FTH1	Ferritin heavy chain	GO:0005515; F:protein binding; IPI:IntAct
P02794	FTH1	Ferritin heavy chain	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
P02794	FTH1	Ferritin heavy chain	GO:0006955; P:immune response; ISS:UniProtKB
P02794	FTH1	Ferritin heavy chain	GO:0006880; P:intracellular sequestering of iron ion; IDA:UniProtKB
P02794	FTH1	Ferritin heavy chain	GO:0006826; P:iron ion transport; IEA:InterPro
P02794	FTH1	Ferritin heavy chain	GO:0061024; P:membrane organization; TAS:Reactome
P02794	FTH1	Ferritin heavy chain	GO:0008285; P:negative regulation of cell proliferation; ISS:UniProtKB
P02794	FTH1	Ferritin heavy chain	GO:0048147; P:negative regulation of fibroblast proliferation; IDA:UniProtKB
P02794	FTH1	Ferritin heavy chain	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
P02794	FTH1	Ferritin heavy chain	GO:0055085; P:transmembrane transport; TAS:Reactome
P02792	FTL	Ferritin light chain	GO:0008199; F:ferric iron binding; IEA:InterPro
P02792	FTL	Ferritin light chain	GO:0042802; F:identical protein binding; IPI:IntAct
P02792	FTL	Ferritin light chain	GO:0005506; F:iron ion binding; IDA:UniProtKB
P02792	FTL	Ferritin light chain	GO:0005515; F:protein binding; IPI:IntAct
P02792	FTL	Ferritin light chain	GO:0008219; P:cell death; IEA:UniProtKB-KW
P02792	FTL	Ferritin light chain	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
P02792	FTL	Ferritin light chain	GO:0055072; P:iron ion homeostasis; TAS:UniProtKB
P02792	FTL	Ferritin light chain	GO:0006826; P:iron ion transport; IEA:InterPro
P02792	FTL	Ferritin light chain	GO:0061024; P:membrane organization; TAS:Reactome
P02792	FTL	Ferritin light chain	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
P02792	FTL	Ferritin light chain	GO:0055085; P:transmembrane transport; TAS:Reactome
O95876	WDPCP	WD repeat-containing and planar cell polarity effector protein fritz homolog	GO:0060271; P:cilium morphogenesis; ISS:UniProtKB
O95876	WDPCP	WD repeat-containing and planar cell polarity effector protein fritz homolog	GO:0016476; P:regulation of embryonic cell shape; ISS:UniProtKB
O95876	WDPCP	WD repeat-containing and planar cell polarity effector protein fritz homolog	GO:0032880; P:regulation of protein localization; ISS:UniProtKB
O95876	WDPCP	WD repeat-containing and planar cell polarity effector protein fritz homolog	GO:0032185; P:septin cytoskeleton organization; ISS:UniProtKB
P42685	FRK	Tyrosine-protein kinase FRK	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P42685	FRK	Tyrosine-protein kinase FRK	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; TAS:ProtInc
P42685	FRK	Tyrosine-protein kinase FRK	GO:0005515; F:protein binding; IPI:UniProtKB
P42685	FRK	Tyrosine-protein kinase FRK	GO:0030154; P:cell differentiation; IEA:Ensembl
P42685	FRK	Tyrosine-protein kinase FRK	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P42685	FRK	Tyrosine-protein kinase FRK	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:GOC
P42685	FRK	Tyrosine-protein kinase FRK	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q9P2Q2	FRMD4A	FERM domain-containing protein 4A	GO:0090162; P:establishment of epithelial cell polarity; IEA:Ensembl
Q9Y2L6	FRMD4B	FERM domain-containing protein 4B	GO:0090162; P:establishment of epithelial cell polarity; IEA:Ensembl
Q96NE9	FRMD6	FERM domain-containing protein 6	GO:0003383; P:apical constriction; IEA:Ensembl
Q96NE9	FRMD6	FERM domain-containing protein 6	GO:0034613; P:cellular protein localization; IEA:Ensembl
Q96NE9	FRMD6	FERM domain-containing protein 6	GO:0032970; P:regulation of actin filament-based process; IEA:Ensembl
Q6ZUT3	FRMD7	FERM domain-containing protein 7	GO:0010975; P:regulation of neuron projection development; ISS:UniProtKB
Q7Z6J6	FRMD5	FERM domain-containing protein 5	GO:0005515; F:protein binding; IPI:IntAct
Q68DX3	FRMPD2	FERM and PDZ domain-containing protein 2	GO:0005545; F:1-phosphatidylinositol binding; IDA:UniProtKB
Q68DX3	FRMPD2	FERM and PDZ domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q68DX3	FRMPD2	FERM and PDZ domain-containing protein 2	GO:0070830; P:tight junction assembly; IMP:UniProtKB
Q14CM0	FRMPD4	FERM and PDZ domain-containing protein 4	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProtKB
Q14CM0	FRMPD4	FERM and PDZ domain-containing protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q14CM0	FRMPD4	FERM and PDZ domain-containing protein 4	GO:0051835; P:positive regulation of synapse structural plasticity; IMP:UniProtKB
Q6ZNA5	FRRS1	Ferric-chelate reductase 1	GO:0000293; F:ferric-chelate reductase activity; ISS:UniProtKB
Q6ZNA5	FRRS1	Ferric-chelate reductase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0005104; F:fibroblast growth factor receptor binding; IPI:MGI
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0005168; F:neurotrophin TRKA receptor binding; IPI:UniProtKB
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0019211; F:phosphatase activator activity; TAS:UniProtKB
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0005068; F:transmembrane receptor protein tyrosine kinase adaptor activity; TAS:UniProtKB
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0000186; P:activation of MAPKK activity; TAS:Reactome
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0008595; P:anterior/posterior axis specification, embryo; IEA:Ensembl
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:UniProtKB
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0030900; P:forebrain development; IEA:Ensembl
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:UniProtKB
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0045087; P:innate immune response; TAS:Reactome
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0007405; P:neuroblast proliferation; IEA:Ensembl
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0046619; P:optic placode formation involved in camera-type eye formation; IEA:Ensembl
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0001759; P:organ induction; IEA:Ensembl
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0060527; P:prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis; IEA:Ensembl
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0050678; P:regulation of epithelial cell proliferation; IEA:Ensembl
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0007185; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; TAS:UniProtKB
Q8WU20	FRS2	Fibroblast growth factor receptor substrate 2	GO:0003281; P:ventricular septum development; IEA:Ensembl
O43559	FRS3	Fibroblast growth factor receptor substrate 3	GO:0005104; F:fibroblast growth factor receptor binding; IPI:MGI
O43559	FRS3	Fibroblast growth factor receptor substrate 3	GO:0005515; F:protein binding; IPI:IntAct
O43559	FRS3	Fibroblast growth factor receptor substrate 3	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IGI:MGI
O43559	FRS3	Fibroblast growth factor receptor substrate 3	GO:0007165; P:signal transduction; TAS:ProtInc
O94915	FRYL	Protein furry homolog-like	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O94915	FRYL	Protein furry homolog-like	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A8MWK0	FADS2P1	Putative fatty acid desaturase 2-like protein FADS2P1	GO:0020037; F:heme binding; IEA:InterPro
A8MWK0	FADS2P1	Putative fatty acid desaturase 2-like protein FADS2P1	GO:0005506; F:iron ion binding; IEA:InterPro
A8MWK0	FADS2P1	Putative fatty acid desaturase 2-like protein FADS2P1	GO:0016717; F:oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water; IEA:InterPro
A8MWK0	FADS2P1	Putative fatty acid desaturase 2-like protein FADS2P1	GO:0006636; P:unsaturated fatty acid biosynthetic process; IEA:UniProtKB-UniPathway
O95073	FSBP	Fibrinogen silencer-binding protein	GO:0005515; F:protein binding; IPI:UniProtKB
O95073	FSBP	Fibrinogen silencer-binding protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O95073	FSBP	Fibrinogen silencer-binding protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5H9T9	FSCB	Fibrous sheath CABYR-binding protein	GO:0005509; F:calcium ion binding; IEA:Ensembl
Q5H9T9	FSCB	Fibrous sheath CABYR-binding protein	GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl
Q16658	FSCN1	Fascin	GO:0003779; F:actin binding; IDA:UniProtKB
Q16658	FSCN1	Fascin	GO:0051015; F:actin filament binding; IDA:UniProtKB
Q16658	FSCN1	Fascin	GO:0008144; F:drug binding; IDA:UniProtKB
Q16658	FSCN1	Fascin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q16658	FSCN1	Fascin	GO:0005515; F:protein binding; IPI:IntAct
Q16658	FSCN1	Fascin	GO:0030036; P:actin cytoskeleton organization; IDA:UniProtKB
Q16658	FSCN1	Fascin	GO:0051017; P:actin filament bundle assembly; IDA:UniProtKB
Q16658	FSCN1	Fascin	GO:0016477; P:cell migration; IMP:UniProtKB
Q16658	FSCN1	Fascin	GO:0048870; P:cell motility; IDA:UniProtKB
Q16658	FSCN1	Fascin	GO:0008283; P:cell proliferation; TAS:ProtInc
O14926	FSCN2	Fascin-2	GO:0003779; F:actin binding; ISS:UniProtKB
O14926	FSCN2	Fascin-2	GO:0051015; F:actin filament binding; ISS:UniProtKB
O14926	FSCN2	Fascin-2	GO:0030036; P:actin cytoskeleton organization; ISS:UniProtKB
O14926	FSCN2	Fascin-2	GO:0051017; P:actin filament bundle assembly; TAS:ProtInc
O14926	FSCN2	Fascin-2	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
O14926	FSCN2	Fascin-2	GO:0042462; P:eye photoreceptor cell development; IEA:Ensembl
O14926	FSCN2	Fascin-2	GO:0007601; P:visual perception; TAS:ProtInc
Q9BTV5	FSD1	Fibronectin type III and SPRY domain-containing protein 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P01225	FSHB	Follitropin subunit beta	GO:0005179; F:hormone activity; TAS:ProtInc
P01225	FSHB	Follitropin subunit beta	GO:0005515; F:protein binding; IPI:IntAct
P01225	FSHB	Follitropin subunit beta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P01225	FSHB	Follitropin subunit beta	GO:0007292; P:female gamete generation; TAS:ProtInc
P01225	FSHB	Follitropin subunit beta	GO:0007565; P:female pregnancy; TAS:ProtInc
P01225	FSHB	Follitropin subunit beta	GO:0042699; P:follicle-stimulating hormone signaling pathway; IEA:Ensembl
P01225	FSHB	Follitropin subunit beta	GO:0016486; P:peptide hormone processing; TAS:Reactome
P01225	FSHB	Follitropin subunit beta	GO:0045780; P:positive regulation of bone resorption; IEA:Ensembl
P01225	FSHB	Follitropin subunit beta	GO:0030335; P:positive regulation of cell migration; NAS:BHF-UCL
P01225	FSHB	Follitropin subunit beta	GO:0008284; P:positive regulation of cell proliferation; NAS:BHF-UCL
P01225	FSHB	Follitropin subunit beta	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; NAS:BHF-UCL
P01225	FSHB	Follitropin subunit beta	GO:0006701; P:progesterone biosynthetic process; TAS:BHF-UCL
P01225	FSHB	Follitropin subunit beta	GO:0045670; P:regulation of osteoclast differentiation; IEA:Ensembl
P01225	FSHB	Follitropin subunit beta	GO:0060011; P:Sertoli cell proliferation; IEA:Ensembl
P01225	FSHB	Follitropin subunit beta	GO:0007165; P:signal transduction; TAS:ProtInc
P01225	FSHB	Follitropin subunit beta	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEP:BHF-UCL
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0004963; F:follicle-stimulating hormone receptor activity; TAS:ProtInc
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0017046; F:peptide hormone binding; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0005515; F:protein binding; IPI:IntAct
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0071711; P:basement membrane organization; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0009992; P:cellular water homeostasis; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0007292; P:female gamete generation; TAS:ProtInc
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0008585; P:female gonad development; TAS:ProtInc
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0008406; P:gonad development; TAS:ProtInc
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0007626; P:locomotory behavior; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0008584; P:male gonad development; IEP:UniProtKB
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0045779; P:negative regulation of bone resorption; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0031175; P:neuron projection development; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0033148; P:positive regulation of intracellular estrogen receptor signaling pathway; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0001545; P:primary ovarian follicle growth; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0060408; P:regulation of acetylcholine metabolic process; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0033044; P:regulation of chromosome organization; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0032350; P:regulation of hormone metabolic process; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0043408; P:regulation of MAPK cascade; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0045670; P:regulation of osteoclast differentiation; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0010640; P:regulation of platelet-derived growth factor receptor signaling pathway; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0001932; P:regulation of protein phosphorylation; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0003073; P:regulation of systemic arterial blood pressure; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0060009; P:Sertoli cell development; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0060011; P:Sertoli cell proliferation; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0007283; P:spermatogenesis; TAS:ProtInc
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0035093; P:spermatogenesis, exchange of chromosomal proteins; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0045056; P:transcytosis; IEA:Ensembl
P23945	FSHR	Follicle-stimulating hormone receptor	GO:0060065; P:uterus development; IEA:Ensembl
Q12841	FSTL1	Follistatin-related protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q12841	FSTL1	Follistatin-related protein 1	GO:0008201; F:heparin binding; TAS:ProtInc
Q12841	FSTL1	Follistatin-related protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q12841	FSTL1	Follistatin-related protein 1	GO:0030509; P:BMP signaling pathway; TAS:Reactome
O95633	FSTL3	Follistatin-related protein 3	GO:0048185; F:activin binding; IPI:UniProtKB
O95633	FSTL3	Follistatin-related protein 3	GO:0001968; F:fibronectin binding; IPI:UniProtKB
O95633	FSTL3	Follistatin-related protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
O95633	FSTL3	Follistatin-related protein 3	GO:0030325; P:adrenal gland development; IEA:Ensembl
O95633	FSTL3	Follistatin-related protein 3	GO:0071248; P:cellular response to metal ion; IEA:Ensembl
O95633	FSTL3	Follistatin-related protein 3	GO:0002244; P:hematopoietic progenitor cell differentiation; IDA:UniProtKB
O95633	FSTL3	Follistatin-related protein 3	GO:0001822; P:kidney development; IEA:Ensembl
O95633	FSTL3	Follistatin-related protein 3	GO:0030324; P:lung development; IEA:Ensembl
O95633	FSTL3	Follistatin-related protein 3	GO:0008584; P:male gonad development; IEA:Ensembl
O95633	FSTL3	Follistatin-related protein 3	GO:0032926; P:negative regulation of activin receptor signaling pathway; IDA:UniProtKB
O95633	FSTL3	Follistatin-related protein 3	GO:0030514; P:negative regulation of BMP signaling pathway; IDA:UniProtKB
O95633	FSTL3	Follistatin-related protein 3	GO:0045671; P:negative regulation of osteoclast differentiation; IDA:UniProtKB
O95633	FSTL3	Follistatin-related protein 3	GO:0090101; P:negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway; IDA:UniProtKB
O95633	FSTL3	Follistatin-related protein 3	GO:0001503; P:ossification; IEA:UniProtKB-KW
O95633	FSTL3	Follistatin-related protein 3	GO:0022409; P:positive regulation of cell-cell adhesion; IDA:UniProtKB
O95633	FSTL3	Follistatin-related protein 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O95633	FSTL3	Follistatin-related protein 3	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O95633	FSTL3	Follistatin-related protein 3	GO:0007283; P:spermatogenesis; IEA:Ensembl
O95633	FSTL3	Follistatin-related protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N475	FSTL5	Follistatin-related protein 5	GO:0005509; F:calcium ion binding; IEA:InterPro
Q6MZW2	FSTL4	Follistatin-related protein 4	GO:0005509; F:calcium ion binding; IEA:InterPro
P19883	FST	Follistatin	GO:0048185; F:activin binding; IPI:UniProtKB
P19883	FST	Follistatin	GO:0005515; F:protein binding; IPI:UniProtKB
P19883	FST	Follistatin	GO:0004871; F:signal transducer activity; NAS:UniProtKB
P19883	FST	Follistatin	GO:0030509; P:BMP signaling pathway; IEA:Ensembl
P19883	FST	Follistatin	GO:0008585; P:female gonad development; IEA:Ensembl
P19883	FST	Follistatin	GO:0007276; P:gamete generation; IEA:Ensembl
P19883	FST	Follistatin	GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl
P19883	FST	Follistatin	GO:0002244; P:hematopoietic progenitor cell differentiation; IDA:UniProtKB
P19883	FST	Follistatin	GO:0043616; P:keratinocyte proliferation; IEA:Ensembl
P19883	FST	Follistatin	GO:0032926; P:negative regulation of activin receptor signaling pathway; IDA:UniProtKB
P19883	FST	Follistatin	GO:0045596; P:negative regulation of cell differentiation; IEA:Ensembl
P19883	FST	Follistatin	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P19883	FST	Follistatin	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
P19883	FST	Follistatin	GO:0007389; P:pattern specification process; IEA:Ensembl
P19883	FST	Follistatin	GO:0051798; P:positive regulation of hair follicle development; IDA:MGI
O95954	FTCD	Formimidoyltransferase-cyclodeaminase	GO:0005542; F:folic acid binding; IEA:UniProtKB-KW
O95954	FTCD	Formimidoyltransferase-cyclodeaminase	GO:0030412; F:formimidoyltetrahydrofolate cyclodeaminase activity; EXP:Reactome
O95954	FTCD	Formimidoyltransferase-cyclodeaminase	GO:0030409; F:glutamate formimidoyltransferase activity; IEA:UniProtKB-EC
O95954	FTCD	Formimidoyltransferase-cyclodeaminase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
O95954	FTCD	Formimidoyltransferase-cyclodeaminase	GO:0007010; P:cytoskeleton organization; IEA:Ensembl
O95954	FTCD	Formimidoyltransferase-cyclodeaminase	GO:0006760; P:folic acid-containing compound metabolic process; TAS:ProtInc
O95954	FTCD	Formimidoyltransferase-cyclodeaminase	GO:0006548; P:histidine catabolic process; TAS:Reactome
O95954	FTCD	Formimidoyltransferase-cyclodeaminase	GO:0019556; P:histidine catabolic process to glutamate and formamide; IEA:UniProtKB-UniPathway
O95954	FTCD	Formimidoyltransferase-cyclodeaminase	GO:0019557; P:histidine catabolic process to glutamate and formate; IEA:UniProtKB-UniPathway
O95954	FTCD	Formimidoyltransferase-cyclodeaminase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95954	FTCD	Formimidoyltransferase-cyclodeaminase	GO:0035999; P:tetrahydrofolate interconversion; IEA:UniProtKB-UniPathway
Q8N4E7	FTMT	Ferritin, mitochondrial	GO:0008199; F:ferric iron binding; IEA:InterPro
Q8N4E7	FTMT	Ferritin, mitochondrial	GO:0004322; F:ferroxidase activity; IEA:UniProtKB-EC
Q8N4E7	FTMT	Ferritin, mitochondrial	GO:0006879; P:cellular iron ion homeostasis; IDA:BHF-UCL
Q8N4E7	FTMT	Ferritin, mitochondrial	GO:0006826; P:iron ion transport; IEA:InterPro
Q8N4E7	FTMT	Ferritin, mitochondrial	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
Q8N4E7	FTMT	Ferritin, mitochondrial	GO:0051349; P:positive regulation of lyase activity; IDA:BHF-UCL
Q8N4E7	FTMT	Ferritin, mitochondrial	GO:0051353; P:positive regulation of oxidoreductase activity; IDA:BHF-UCL
Q8N4E7	FTMT	Ferritin, mitochondrial	GO:0051347; P:positive regulation of transferase activity; IDA:BHF-UCL
Q68CZ1	RPGRIP1L	Protein fantom	GO:0005515; F:protein binding; IPI:UniProtKB
Q68CZ1	RPGRIP1L	Protein fantom	GO:0031870; F:thromboxane A2 receptor binding; IPI:UniProtKB
Q68CZ1	RPGRIP1L	Protein fantom	GO:0043010; P:camera-type eye development; IEA:Ensembl
Q68CZ1	RPGRIP1L	Protein fantom	GO:0021549; P:cerebellum development; IEA:Ensembl
Q68CZ1	RPGRIP1L	Protein fantom	GO:0042384; P:cilium assembly; IEA:Ensembl
Q68CZ1	RPGRIP1L	Protein fantom	GO:0022038; P:corpus callosum development; IEA:Ensembl
Q68CZ1	RPGRIP1L	Protein fantom	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
Q68CZ1	RPGRIP1L	Protein fantom	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
Q68CZ1	RPGRIP1L	Protein fantom	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
Q68CZ1	RPGRIP1L	Protein fantom	GO:0007163; P:establishment or maintenance of cell polarity; IEA:Ensembl
Q68CZ1	RPGRIP1L	Protein fantom	GO:0060322; P:head development; IEA:Ensembl
Q68CZ1	RPGRIP1L	Protein fantom	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q68CZ1	RPGRIP1L	Protein fantom	GO:0001822; P:kidney development; IEA:Ensembl
Q68CZ1	RPGRIP1L	Protein fantom	GO:0021670; P:lateral ventricle development; IEA:Ensembl
Q68CZ1	RPGRIP1L	Protein fantom	GO:0001889; P:liver development; IEA:Ensembl
Q68CZ1	RPGRIP1L	Protein fantom	GO:0045744; P:negative regulation of G-protein coupled receptor protein signaling pathway; IDA:UniProtKB
Q68CZ1	RPGRIP1L	Protein fantom	GO:0021532; P:neural tube patterning; IEA:Ensembl
Q68CZ1	RPGRIP1L	Protein fantom	GO:0043584; P:nose development; IEA:Ensembl
Q68CZ1	RPGRIP1L	Protein fantom	GO:0021772; P:olfactory bulb development; IEA:Ensembl
Q68CZ1	RPGRIP1L	Protein fantom	GO:0060039; P:pericardium development; IEA:Ensembl
Q68CZ1	RPGRIP1L	Protein fantom	GO:0008589; P:regulation of smoothened signaling pathway; IEA:Ensembl
Q9C0B1	FTO	Alpha-ketoglutarate-dependent dioxygenase FTO	GO:0043734; F:DNA-N1-methyladenine dioxygenase activity; IDA:UniProtKB
Q9C0B1	FTO	Alpha-ketoglutarate-dependent dioxygenase FTO	GO:0008198; F:ferrous iron binding; IDA:UniProtKB
Q9C0B1	FTO	Alpha-ketoglutarate-dependent dioxygenase FTO	GO:0035516; F:oxidative DNA demethylase activity; IDA:UniProtKB
Q9C0B1	FTO	Alpha-ketoglutarate-dependent dioxygenase FTO	GO:0035515; F:oxidative RNA demethylase activity; IDA:UniProtKB
Q9C0B1	FTO	Alpha-ketoglutarate-dependent dioxygenase FTO	GO:0060612; P:adipose tissue development; IEA:Ensembl
Q9C0B1	FTO	Alpha-ketoglutarate-dependent dioxygenase FTO	GO:0006307; P:DNA dealkylation involved in DNA repair; IDA:UniProtKB
Q9C0B1	FTO	Alpha-ketoglutarate-dependent dioxygenase FTO	GO:0080111; P:DNA demethylation; IDA:BHF-UCL
Q9C0B1	FTO	Alpha-ketoglutarate-dependent dioxygenase FTO	GO:0070989; P:oxidative demethylation; IDA:BHF-UCL
Q9C0B1	FTO	Alpha-ketoglutarate-dependent dioxygenase FTO	GO:0035552; P:oxidative single-stranded DNA demethylation; IDA:UniProtKB
Q9C0B1	FTO	Alpha-ketoglutarate-dependent dioxygenase FTO	GO:0035553; P:oxidative single-stranded RNA demethylation; IDA:UniProtKB
Q9C0B1	FTO	Alpha-ketoglutarate-dependent dioxygenase FTO	GO:0010883; P:regulation of lipid storage; IEA:Ensembl
Q9C0B1	FTO	Alpha-ketoglutarate-dependent dioxygenase FTO	GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl
Q9C0B1	FTO	Alpha-ketoglutarate-dependent dioxygenase FTO	GO:0044065; P:regulation of respiratory system process; IEA:Ensembl
Q9C0B1	FTO	Alpha-ketoglutarate-dependent dioxygenase FTO	GO:0070350; P:regulation of white fat cell proliferation; IEA:Ensembl
Q9C0B1	FTO	Alpha-ketoglutarate-dependent dioxygenase FTO	GO:0042245; P:RNA repair; IDA:BHF-UCL
Q9C0B1	FTO	Alpha-ketoglutarate-dependent dioxygenase FTO	GO:0001659; P:temperature homeostasis; IEA:Ensembl
Q96AE4	FUBP1	Far upstream element-binding protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96AE4	FUBP1	Far upstream element-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q96AE4	FUBP1	Far upstream element-binding protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q96AE4	FUBP1	Far upstream element-binding protein 1	GO:0003697; F:single-stranded DNA binding; TAS:ProtInc
Q96AE4	FUBP1	Far upstream element-binding protein 1	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
Q96AE4	FUBP1	Far upstream element-binding protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q92945	KHSRP	Far upstream element-binding protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q92945	KHSRP	Far upstream element-binding protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q92945	KHSRP	Far upstream element-binding protein 2	GO:0010467; P:gene expression; TAS:Reactome
Q92945	KHSRP	Far upstream element-binding protein 2	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q92945	KHSRP	Far upstream element-binding protein 2	GO:0006397; P:mRNA processing; TAS:ProtInc
Q92945	KHSRP	Far upstream element-binding protein 2	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q92945	KHSRP	Far upstream element-binding protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q92945	KHSRP	Far upstream element-binding protein 2	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q92945	KHSRP	Far upstream element-binding protein 2	GO:0008380; P:RNA splicing; TAS:UniProtKB
Q92945	KHSRP	Far upstream element-binding protein 2	GO:0000375; P:RNA splicing, via transesterification reactions; TAS:UniProtKB
Q92945	KHSRP	Far upstream element-binding protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96I24	FUBP3	Far upstream element-binding protein 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96I24	FUBP3	Far upstream element-binding protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96I24	FUBP3	Far upstream element-binding protein 3	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
Q96I24	FUBP3	Far upstream element-binding protein 3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q96I24	FUBP3	Far upstream element-binding protein 3	GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB
A2VDF0	FUOM	Fucose mutarotase	GO:0042806; F:fucose binding; ISS:UniProtKB
A2VDF0	FUOM	Fucose mutarotase	GO:0016857; F:racemase and epimerase activity, acting on carbohydrates and derivatives; ISS:UniProtKB
A2VDF0	FUOM	Fucose mutarotase	GO:0006004; P:fucose metabolic process; ISS:UniProtKB
Q9BTY2	FUCA2	Plasma alpha-L-fucosidase	GO:0004560; F:alpha-L-fucosidase activity; IDA:UniProt
Q9BTY2	FUCA2	Plasma alpha-L-fucosidase	GO:0042806; F:fucose binding; IBA:RefGenome
Q9BTY2	FUCA2	Plasma alpha-L-fucosidase	GO:0006004; P:fucose metabolic process; IDA:UniProt
Q9BTY2	FUCA2	Plasma alpha-L-fucosidase	GO:0016139; P:glycoside catabolic process; IDA:UniProt
Q9BTY2	FUCA2	Plasma alpha-L-fucosidase	GO:2000535; P:regulation of entry of bacterium into host cell; IMP:UniProt
Q9BTY2	FUCA2	Plasma alpha-L-fucosidase	GO:0009617; P:response to bacterium; IMP:UniProt
P04066	FUCA1	Tissue alpha-L-fucosidase	GO:0004560; F:alpha-L-fucosidase activity; TAS:UniProtKB
P04066	FUCA1	Tissue alpha-L-fucosidase	GO:0042806; F:fucose binding; IBA:RefGenome
P04066	FUCA1	Tissue alpha-L-fucosidase	GO:0006004; P:fucose metabolic process; IDA:UniProt
P04066	FUCA1	Tissue alpha-L-fucosidase	GO:0006027; P:glycosaminoglycan catabolic process; NAS:UniProtKB
P04066	FUCA1	Tissue alpha-L-fucosidase	GO:0016139; P:glycoside catabolic process; IDA:UniProt
Q96A29	SLC35C1	GDP-fucose transporter 1	GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW
Q96A29	SLC35C1	GDP-fucose transporter 1	GO:0030259; P:lipid glycosylation; IEA:Ensembl
Q96A29	SLC35C1	GDP-fucose transporter 1	GO:0045746; P:negative regulation of Notch signaling pathway; IEA:Ensembl
Q96A29	SLC35C1	GDP-fucose transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8N0W3	FUK	L-fucose kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8N0W3	FUK	L-fucose kinase	GO:0050201; F:fucokinase activity; NAS:UniProtKB
P07954	FH	Fumarate hydratase, mitochondrial	GO:0004333; F:fumarate hydratase activity; EXP:Reactome
P07954	FH	Fumarate hydratase, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P07954	FH	Fumarate hydratase, mitochondrial	GO:0006106; P:fumarate metabolic process; TAS:ProtInc
P07954	FH	Fumarate hydratase, mitochondrial	GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl
P07954	FH	Fumarate hydratase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P07954	FH	Fumarate hydratase, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; TAS:Reactome
Q8IVP5	FUNDC1	FUN14 domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IVP5	FUNDC1	FUN14 domain-containing protein 1	GO:0000422; P:mitochondrion degradation; IDA:UniProtKB
Q8IVP5	FUNDC1	FUN14 domain-containing protein 1	GO:0001666; P:response to hypoxia; IDA:UniProtKB
P09958	FURIN	Furin	GO:0004175; F:endopeptidase activity; IDA:BHF-UCL
P09958	FURIN	Furin	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P09958	FURIN	Furin	GO:0048406; F:nerve growth factor binding; IDA:BHF-UCL
P09958	FURIN	Furin	GO:0008233; F:peptidase activity; IDA:UniProtKB
P09958	FURIN	Furin	GO:0042277; F:peptide binding; IDA:BHF-UCL
P09958	FURIN	Furin	GO:0002020; F:protease binding; IPI:BHF-UCL
P09958	FURIN	Furin	GO:0004252; F:serine-type endopeptidase activity; IDA:BHF-UCL
P09958	FURIN	Furin	GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:BHF-UCL
P09958	FURIN	Furin	GO:0008283; P:cell proliferation; IMP:BHF-UCL
P09958	FURIN	Furin	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P09958	FURIN	Furin	GO:0030574; P:collagen catabolic process; TAS:Reactome
P09958	FURIN	Furin	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P09958	FURIN	Furin	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P09958	FURIN	Furin	GO:0010951; P:negative regulation of endopeptidase activity; IDA:GOC
P09958	FURIN	Furin	GO:0032804; P:negative regulation of low-density lipoprotein particle receptor catabolic process; IDA:HGNC
P09958	FURIN	Furin	GO:0032911; P:negative regulation of transforming growth factor beta1 production; IMP:BHF-UCL
P09958	FURIN	Furin	GO:0032455; P:nerve growth factor processing; TAS:Reactome
P09958	FURIN	Furin	GO:0032902; P:nerve growth factor production; IDA:BHF-UCL
P09958	FURIN	Furin	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P09958	FURIN	Furin	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P09958	FURIN	Furin	GO:0043043; P:peptide biosynthetic process; IDA:BHF-UCL
P09958	FURIN	Furin	GO:0016486; P:peptide hormone processing; IDA:BHF-UCL
P09958	FURIN	Furin	GO:0017187; P:peptidyl-glutamic acid carboxylation; TAS:Reactome
P09958	FURIN	Furin	GO:0051044; P:positive regulation of membrane protein ectodomain proteolysis; IC:BHF-UCL
P09958	FURIN	Furin	GO:0043687; P:post-translational protein modification; TAS:Reactome
P09958	FURIN	Furin	GO:0016485; P:protein processing; IDA:UniProtKB
P09958	FURIN	Furin	GO:0006508; P:proteolysis; TAS:Reactome
P09958	FURIN	Furin	GO:0052548; P:regulation of endopeptidase activity; IDA:BHF-UCL
P09958	FURIN	Furin	GO:0042176; P:regulation of protein catabolic process; IMP:BHF-UCL
P09958	FURIN	Furin	GO:0009966; P:regulation of signal transduction; IEA:Ensembl
P09958	FURIN	Furin	GO:0032940; P:secretion by cell; IDA:BHF-UCL
P09958	FURIN	Furin	GO:0006465; P:signal peptide processing; IDA:HGNC
P09958	FURIN	Furin	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P09958	FURIN	Furin	GO:0019058; P:viral life cycle; IEP:BHF-UCL
P09958	FURIN	Furin	GO:0016032; P:viral process; TAS:Reactome
P09958	FURIN	Furin	GO:0019082; P:viral protein processing; TAS:Reactome
P09958	FURIN	Furin	GO:0019068; P:virion assembly; TAS:Reactome
P35637	FUS	RNA-binding protein FUS	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P35637	FUS	RNA-binding protein FUS	GO:0042802; F:identical protein binding; IPI:IntAct
P35637	FUS	RNA-binding protein FUS	GO:0000166; F:nucleotide binding; IEA:InterPro
P35637	FUS	RNA-binding protein FUS	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P35637	FUS	RNA-binding protein FUS	GO:0005515; F:protein binding; IPI:UniProtKB
P35637	FUS	RNA-binding protein FUS	GO:0003723; F:RNA binding; TAS:ProtInc
P35637	FUS	RNA-binding protein FUS	GO:0008270; F:zinc ion binding; IEA:InterPro
P35637	FUS	RNA-binding protein FUS	GO:0008219; P:cell death; IEA:UniProtKB-KW
P35637	FUS	RNA-binding protein FUS	GO:0010467; P:gene expression; TAS:Reactome
P35637	FUS	RNA-binding protein FUS	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P35637	FUS	RNA-binding protein FUS	GO:0008380; P:RNA splicing; TAS:Reactome
Q6P4F1	FUT10	Alpha-(1,3)-fucosyltransferase 10	GO:0046920; F:alpha-(1->3)-fucosyltransferase activity; TAS:UniProtKB
Q6P4F1	FUT10	Alpha-(1,3)-fucosyltransferase 10	GO:0009790; P:embryo development; NAS:UniProtKB
Q6P4F1	FUT10	Alpha-(1,3)-fucosyltransferase 10	GO:0009566; P:fertilization; NAS:UniProtKB
Q6P4F1	FUT10	Alpha-(1,3)-fucosyltransferase 10	GO:0036065; P:fucosylation; TAS:GOC
Q6P4F1	FUT10	Alpha-(1,3)-fucosyltransferase 10	GO:0030097; P:hemopoiesis; NAS:UniProtKB
Q6P4F1	FUT10	Alpha-(1,3)-fucosyltransferase 10	GO:0042355; P:L-fucose catabolic process; NAS:UniProtKB
Q6P4F1	FUT10	Alpha-(1,3)-fucosyltransferase 10	GO:0007399; P:nervous system development; NAS:UniProtKB
Q6P4F1	FUT10	Alpha-(1,3)-fucosyltransferase 10	GO:0006457; P:protein folding; NAS:UniProtKB
Q6P4F1	FUT10	Alpha-(1,3)-fucosyltransferase 10	GO:0006486; P:protein glycosylation; TAS:UniProtKB
Q6P4F1	FUT10	Alpha-(1,3)-fucosyltransferase 10	GO:0006605; P:protein targeting; NAS:UniProtKB
Q6P4F1	FUT10	Alpha-(1,3)-fucosyltransferase 10	GO:0042060; P:wound healing; NAS:UniProtKB
Q495W5	FUT11	Alpha-(1,3)-fucosyltransferase 11	GO:0046920; F:alpha-(1->3)-fucosyltransferase activity; IEA:InterPro
Q495W5	FUT11	Alpha-(1,3)-fucosyltransferase 11	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
P19526	FUT1	Galactoside 2-alpha-L-fucosyltransferase 1	GO:0008417; F:fucosyltransferase activity; TAS:ProtInc
P19526	FUT1	Galactoside 2-alpha-L-fucosyltransferase 1	GO:0008107; F:galactoside 2-alpha-L-fucosyltransferase activity; TAS:UniProtKB
P19526	FUT1	Galactoside 2-alpha-L-fucosyltransferase 1	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
P19526	FUT1	Galactoside 2-alpha-L-fucosyltransferase 1	GO:0042355; P:L-fucose catabolic process; NAS:UniProtKB
P19526	FUT1	Galactoside 2-alpha-L-fucosyltransferase 1	GO:0006486; P:protein glycosylation; TAS:UniProtKB
Q10981	FUT2	Galactoside 2-alpha-L-fucosyltransferase 2	GO:0008417; F:fucosyltransferase activity; TAS:ProtInc
Q10981	FUT2	Galactoside 2-alpha-L-fucosyltransferase 2	GO:0008107; F:galactoside 2-alpha-L-fucosyltransferase activity; TAS:UniProtKB
Q10981	FUT2	Galactoside 2-alpha-L-fucosyltransferase 2	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
Q10981	FUT2	Galactoside 2-alpha-L-fucosyltransferase 2	GO:0036065; P:fucosylation; TAS:GOC
Q10981	FUT2	Galactoside 2-alpha-L-fucosyltransferase 2	GO:0042355; P:L-fucose catabolic process; NAS:UniProtKB
Q10981	FUT2	Galactoside 2-alpha-L-fucosyltransferase 2	GO:0006486; P:protein glycosylation; TAS:UniProtKB
P21217	FUT3	Galactoside 3(4)-L-fucosyltransferase	GO:0017060; F:3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity; IEA:UniProtKB-EC
P21217	FUT3	Galactoside 3(4)-L-fucosyltransferase	GO:0046920; F:alpha-(1->3)-fucosyltransferase activity; IDA:BHF-UCL
P21217	FUT3	Galactoside 3(4)-L-fucosyltransferase	GO:0008417; F:fucosyltransferase activity; IDA:BHF-UCL
P21217	FUT3	Galactoside 3(4)-L-fucosyltransferase	GO:0009988; P:cell-cell recognition; IC:BHF-UCL
P21217	FUT3	Galactoside 3(4)-L-fucosyltransferase	GO:0036065; P:fucosylation; IDA:GOC
P21217	FUT3	Galactoside 3(4)-L-fucosyltransferase	GO:0043413; P:macromolecule glycosylation; IDA:BHF-UCL
P21217	FUT3	Galactoside 3(4)-L-fucosyltransferase	GO:0009312; P:oligosaccharide biosynthetic process; IDA:BHF-UCL
P21217	FUT3	Galactoside 3(4)-L-fucosyltransferase	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
P22083	FUT4	Alpha-(1,3)-fucosyltransferase 4	GO:0046920; F:alpha-(1->3)-fucosyltransferase activity; TAS:UniProtKB
P22083	FUT4	Alpha-(1,3)-fucosyltransferase 4	GO:0008417; F:fucosyltransferase activity; TAS:ProtInc
P22083	FUT4	Alpha-(1,3)-fucosyltransferase 4	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
P22083	FUT4	Alpha-(1,3)-fucosyltransferase 4	GO:0036065; P:fucosylation; TAS:GOC
P22083	FUT4	Alpha-(1,3)-fucosyltransferase 4	GO:0042355; P:L-fucose catabolic process; NAS:UniProtKB
P22083	FUT4	Alpha-(1,3)-fucosyltransferase 4	GO:0006486; P:protein glycosylation; TAS:UniProtKB
Q11128	FUT5	Alpha-(1,3)-fucosyltransferase 5	GO:0017060; F:3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity; IEA:UniProtKB-EC
Q11128	FUT5	Alpha-(1,3)-fucosyltransferase 5	GO:0046920; F:alpha-(1->3)-fucosyltransferase activity; TAS:UniProtKB
Q11128	FUT5	Alpha-(1,3)-fucosyltransferase 5	GO:0008417; F:fucosyltransferase activity; TAS:ProtInc
Q11128	FUT5	Alpha-(1,3)-fucosyltransferase 5	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
Q11128	FUT5	Alpha-(1,3)-fucosyltransferase 5	GO:0036065; P:fucosylation; TAS:GOC
Q11128	FUT5	Alpha-(1,3)-fucosyltransferase 5	GO:0042355; P:L-fucose catabolic process; NAS:UniProtKB
Q11128	FUT5	Alpha-(1,3)-fucosyltransferase 5	GO:0006486; P:protein glycosylation; TAS:UniProtKB
P51993	FUT6	Alpha-(1,3)-fucosyltransferase 6	GO:0017060; F:3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity; IEA:UniProtKB-EC
P51993	FUT6	Alpha-(1,3)-fucosyltransferase 6	GO:0046920; F:alpha-(1->3)-fucosyltransferase activity; TAS:UniProtKB
P51993	FUT6	Alpha-(1,3)-fucosyltransferase 6	GO:0008417; F:fucosyltransferase activity; TAS:ProtInc
P51993	FUT6	Alpha-(1,3)-fucosyltransferase 6	GO:0036065; P:fucosylation; TAS:GOC
P51993	FUT6	Alpha-(1,3)-fucosyltransferase 6	GO:0042355; P:L-fucose catabolic process; NAS:UniProtKB
P51993	FUT6	Alpha-(1,3)-fucosyltransferase 6	GO:0006486; P:protein glycosylation; TAS:UniProtKB
Q11130	FUT7	Alpha-(1,3)-fucosyltransferase 7	GO:0046920; F:alpha-(1->3)-fucosyltransferase activity; TAS:UniProtKB
Q11130	FUT7	Alpha-(1,3)-fucosyltransferase 7	GO:0008417; F:fucosyltransferase activity; TAS:ProtInc
Q11130	FUT7	Alpha-(1,3)-fucosyltransferase 7	GO:0002361; P:CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation; IEA:Ensembl
Q11130	FUT7	Alpha-(1,3)-fucosyltransferase 7	GO:0036065; P:fucosylation; TAS:GOC
Q11130	FUT7	Alpha-(1,3)-fucosyltransferase 7	GO:0042355; P:L-fucose catabolic process; NAS:UniProtKB
Q11130	FUT7	Alpha-(1,3)-fucosyltransferase 7	GO:0002522; P:leukocyte migration involved in immune response; IEA:Ensembl
Q11130	FUT7	Alpha-(1,3)-fucosyltransferase 7	GO:0006486; P:protein glycosylation; TAS:UniProtKB
Q9BYC5	FUT8	Alpha-(1,6)-fucosyltransferase	GO:0008424; F:glycoprotein 6-alpha-L-fucosyltransferase activity; IDA:UniProtKB
Q9BYC5	FUT8	Alpha-(1,6)-fucosyltransferase	GO:0016477; P:cell migration; IEA:Ensembl
Q9BYC5	FUT8	Alpha-(1,6)-fucosyltransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9BYC5	FUT8	Alpha-(1,6)-fucosyltransferase	GO:0046368; P:GDP-L-fucose metabolic process; IDA:UniProtKB
Q9BYC5	FUT8	Alpha-(1,6)-fucosyltransferase	GO:0001701; P:in utero embryonic development; NAS:UniProtKB
Q9BYC5	FUT8	Alpha-(1,6)-fucosyltransferase	GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl
Q9BYC5	FUT8	Alpha-(1,6)-fucosyltransferase	GO:0042355; P:L-fucose catabolic process; NAS:UniProtKB
Q9BYC5	FUT8	Alpha-(1,6)-fucosyltransferase	GO:0036071; P:N-glycan fucosylation; IDA:GOC
Q9BYC5	FUT8	Alpha-(1,6)-fucosyltransferase	GO:0006491; P:N-glycan processing; TAS:UniProtKB
Q9BYC5	FUT8	Alpha-(1,6)-fucosyltransferase	GO:0009312; P:oligosaccharide biosynthetic process; TAS:ProtInc
Q9BYC5	FUT8	Alpha-(1,6)-fucosyltransferase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9BYC5	FUT8	Alpha-(1,6)-fucosyltransferase	GO:0033578; P:protein glycosylation in Golgi; IEA:InterPro
Q9BYC5	FUT8	Alpha-(1,6)-fucosyltransferase	GO:0006487; P:protein N-linked glycosylation; TAS:ProtInc
Q9BYC5	FUT8	Alpha-(1,6)-fucosyltransferase	GO:0018279; P:protein N-linked glycosylation via asparagine; IDA:UniProtKB
Q9BYC5	FUT8	Alpha-(1,6)-fucosyltransferase	GO:0043112; P:receptor metabolic process; IEA:Ensembl
Q9BYC5	FUT8	Alpha-(1,6)-fucosyltransferase	GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl
Q9BYC5	FUT8	Alpha-(1,6)-fucosyltransferase	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl
Q9Y231	FUT9	Alpha-(1,3)-fucosyltransferase 9	GO:0046920; F:alpha-(1->3)-fucosyltransferase activity; TAS:UniProtKB
Q9Y231	FUT9	Alpha-(1,3)-fucosyltransferase 9	GO:0008417; F:fucosyltransferase activity; TAS:ProtInc
Q9Y231	FUT9	Alpha-(1,3)-fucosyltransferase 9	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
Q9Y231	FUT9	Alpha-(1,3)-fucosyltransferase 9	GO:0036065; P:fucosylation; TAS:GOC
Q9Y231	FUT9	Alpha-(1,3)-fucosyltransferase 9	GO:0042355; P:L-fucose catabolic process; NAS:UniProtKB
Q9Y231	FUT9	Alpha-(1,3)-fucosyltransferase 9	GO:0007399; P:nervous system development; IEA:Ensembl
Q9Y231	FUT9	Alpha-(1,3)-fucosyltransferase 9	GO:0006486; P:protein glycosylation; TAS:UniProtKB
Q9BT04	FUZ	Protein fuzzy homolog	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q9BT04	FUZ	Protein fuzzy homolog	GO:0010172; P:embryonic body morphogenesis; ISS:UniProtKB
Q9BT04	FUZ	Protein fuzzy homolog	GO:0048704; P:embryonic skeletal system morphogenesis; ISS:UniProtKB
Q9BT04	FUZ	Protein fuzzy homolog	GO:0001736; P:establishment of planar polarity; ISS:UniProtKB
Q9BT04	FUZ	Protein fuzzy homolog	GO:0001942; P:hair follicle development; ISS:UniProtKB
Q9BT04	FUZ	Protein fuzzy homolog	GO:0001843; P:neural tube closure; ISS:UniProtKB
Q9BT04	FUZ	Protein fuzzy homolog	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9BT04	FUZ	Protein fuzzy homolog	GO:0008589; P:regulation of smoothened signaling pathway; ISS:UniProtKB
Q9BT04	FUZ	Protein fuzzy homolog	GO:0021513; P:spinal cord dorsal/ventral patterning; IEA:Ensembl
Q4VC44	FLYWCH1	FLYWCH-type zinc finger-containing protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q4VC44	FLYWCH1	FLYWCH-type zinc finger-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96CP2	FLYWCH2	FLYWCH family member 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0008134; F:transcription factor binding; IBA:RefGenome
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0048846; P:axon extension involved in axon guidance; IBA:RefGenome
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0001658; P:branching involved in ureteric bud morphogenesis; IBA:RefGenome
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0051216; P:cartilage development; IBA:RefGenome
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0009790; P:embryo development; IBA:RefGenome
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0048484; P:enteric nervous system development; IBA:RefGenome
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0050935; P:iridophore differentiation; IBA:RefGenome
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0001822; P:kidney development; IBA:RefGenome
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0048937; P:lateral line nerve glial cell development; IBA:RefGenome
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0030318; P:melanocyte differentiation; IBA:RefGenome
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0001755; P:neural crest cell migration; IBA:RefGenome
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0007389; P:pattern specification process; IBA:RefGenome
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0007422; P:peripheral nervous system development; IBA:RefGenome
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0048485; P:sympathetic nervous system development; IBA:RefGenome
Q6VB85	FOXD4L2	Forkhead box protein D4-like 2	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0008134; F:transcription factor binding; IBA:RefGenome
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0048846; P:axon extension involved in axon guidance; IBA:RefGenome
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0001658; P:branching involved in ureteric bud morphogenesis; IBA:RefGenome
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0051216; P:cartilage development; IBA:RefGenome
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0009790; P:embryo development; IBA:RefGenome
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0048484; P:enteric nervous system development; IBA:RefGenome
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0050935; P:iridophore differentiation; IBA:RefGenome
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0001822; P:kidney development; IBA:RefGenome
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0048937; P:lateral line nerve glial cell development; IBA:RefGenome
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0030318; P:melanocyte differentiation; IBA:RefGenome
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0001755; P:neural crest cell migration; IBA:RefGenome
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0007389; P:pattern specification process; IBA:RefGenome
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0007422; P:peripheral nervous system development; IBA:RefGenome
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0048485; P:sympathetic nervous system development; IBA:RefGenome
Q6VB84	FOXD4L3	Forkhead box protein D4-like 3	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q8WXT5	FOXD4L4	Forkhead box protein D4-like 4	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q8WXT5	FOXD4L4	Forkhead box protein D4-like 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8WXT5	FOXD4L4	Forkhead box protein D4-like 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0008134; F:transcription factor binding; IBA:RefGenome
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0048846; P:axon extension involved in axon guidance; IBA:RefGenome
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0001658; P:branching involved in ureteric bud morphogenesis; IBA:RefGenome
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0051216; P:cartilage development; IBA:RefGenome
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0009790; P:embryo development; IBA:RefGenome
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0048484; P:enteric nervous system development; IBA:RefGenome
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0050935; P:iridophore differentiation; IBA:RefGenome
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0001822; P:kidney development; IBA:RefGenome
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0048937; P:lateral line nerve glial cell development; IBA:RefGenome
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0030318; P:melanocyte differentiation; IBA:RefGenome
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0001755; P:neural crest cell migration; IBA:RefGenome
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0007389; P:pattern specification process; IBA:RefGenome
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0007422; P:peripheral nervous system development; IBA:RefGenome
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0048485; P:sympathetic nervous system development; IBA:RefGenome
Q9NU39	FOXD4L1	Forkhead box protein D4-like 1	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0008134; F:transcription factor binding; IBA:RefGenome
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0048846; P:axon extension involved in axon guidance; IBA:RefGenome
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0001658; P:branching involved in ureteric bud morphogenesis; IBA:RefGenome
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0051216; P:cartilage development; IBA:RefGenome
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0009790; P:embryo development; IBA:RefGenome
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0048484; P:enteric nervous system development; IBA:RefGenome
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0050935; P:iridophore differentiation; IBA:RefGenome
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0001822; P:kidney development; IBA:RefGenome
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0048937; P:lateral line nerve glial cell development; IBA:RefGenome
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0030318; P:melanocyte differentiation; IBA:RefGenome
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0001755; P:neural crest cell migration; IBA:RefGenome
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0007389; P:pattern specification process; IBA:RefGenome
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0007422; P:peripheral nervous system development; IBA:RefGenome
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0048485; P:sympathetic nervous system development; IBA:RefGenome
Q5VV16	FOXD4L5	Forkhead box protein D4-like 5	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0008301; F:DNA binding, bending; IBA:RefGenome
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0008134; F:transcription factor binding; IBA:RefGenome
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0048846; P:axon extension involved in axon guidance; IBA:RefGenome
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0001658; P:branching involved in ureteric bud morphogenesis; IBA:RefGenome
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0051216; P:cartilage development; IBA:RefGenome
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0009790; P:embryo development; IBA:RefGenome
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0048484; P:enteric nervous system development; IBA:RefGenome
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0050935; P:iridophore differentiation; IBA:RefGenome
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0001822; P:kidney development; IBA:RefGenome
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0048937; P:lateral line nerve glial cell development; IBA:RefGenome
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0030318; P:melanocyte differentiation; IBA:RefGenome
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0001755; P:neural crest cell migration; IBA:RefGenome
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0007389; P:pattern specification process; IBA:RefGenome
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0007422; P:peripheral nervous system development; IBA:RefGenome
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0048485; P:sympathetic nervous system development; IBA:RefGenome
Q3SYB3	FOXD4L6	Forkhead box protein D4-like 6	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q96IV6	FAXDC2	Fatty acid hydroxylase domain-containing protein 2	GO:0005506; F:iron ion binding; IEA:InterPro
Q96IV6	FAXDC2	Fatty acid hydroxylase domain-containing protein 2	GO:0016491; F:oxidoreductase activity; IEA:InterPro
Q96IV6	FAXDC2	Fatty acid hydroxylase domain-containing protein 2	GO:0006633; P:fatty acid biosynthetic process; IEA:InterPro
Q9NXK8	FBXL12	F-box/LRR-repeat protein 12	GO:0005515; F:protein binding; IPI:IntAct
Q9NXK8	FBXL12	F-box/LRR-repeat protein 12	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9NXK8	FBXL12	F-box/LRR-repeat protein 12	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q8N1E6	FBXL14	F-box/LRR-repeat protein 14	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N1E6	FBXL14	F-box/LRR-repeat protein 14	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q8N1E6	FBXL14	F-box/LRR-repeat protein 14	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9H469	FBXL15	F-box/LRR-repeat protein 15	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H469	FBXL15	F-box/LRR-repeat protein 15	GO:0030282; P:bone mineralization; ISS:UniProtKB
Q9H469	FBXL15	F-box/LRR-repeat protein 15	GO:0009953; P:dorsal/ventral pattern formation; ISS:UniProtKB
Q9H469	FBXL15	F-box/LRR-repeat protein 15	GO:0000086; P:G2/M transition of mitotic cell cycle; IMP:UniProtKB
Q9H469	FBXL15	F-box/LRR-repeat protein 15	GO:0030513; P:positive regulation of BMP signaling pathway; IMP:UniProtKB
Q9H469	FBXL15	F-box/LRR-repeat protein 15	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q9H469	FBXL15	F-box/LRR-repeat protein 15	GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q6PCT2	FBXL19	F-box/LRR-repeat protein 19	GO:0003677; F:DNA binding; IEA:InterPro
Q6PCT2	FBXL19	F-box/LRR-repeat protein 19	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6PCT2	FBXL19	F-box/LRR-repeat protein 19	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:MGI
Q9UKT6	FBXL21	F-box/LRR-repeat protein 21	GO:0004842; F:ubiquitin-protein ligase activity; NAS:UniProtKB
Q9UKT6	FBXL21	F-box/LRR-repeat protein 21	GO:0043153; P:entrainment of circadian clock by photoperiod; ISS:UniProtKB
Q9UKT6	FBXL21	F-box/LRR-repeat protein 21	GO:0016567; P:protein ubiquitination; ISS:UniProtKB
Q9UKT6	FBXL21	F-box/LRR-repeat protein 21	GO:0048511; P:rhythmic process; IEA:UniProtKB-KW
Q6P050	FBXL22	F-box and leucine-rich protein 22	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
P51114	FXR1	Fragile X mental retardation syndrome-related protein 1	GO:0002151; F:G-quadruplex RNA binding; IEA:Ensembl
P51114	FXR1	Fragile X mental retardation syndrome-related protein 1	GO:0003730; F:mRNA 3'-UTR binding; IEA:Ensembl
P51114	FXR1	Fragile X mental retardation syndrome-related protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P51114	FXR1	Fragile X mental retardation syndrome-related protein 1	GO:0003723; F:RNA binding; TAS:ProtInc
P51114	FXR1	Fragile X mental retardation syndrome-related protein 1	GO:0006915; P:apoptotic process; TAS:ProtInc
P51114	FXR1	Fragile X mental retardation syndrome-related protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P51114	FXR1	Fragile X mental retardation syndrome-related protein 1	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
P51114	FXR1	Fragile X mental retardation syndrome-related protein 1	GO:0017148; P:negative regulation of translation; IEA:Ensembl
P51116	FXR2	Fragile X mental retardation syndrome-related protein 2	GO:0042802; F:identical protein binding; IPI:IntAct
P51116	FXR2	Fragile X mental retardation syndrome-related protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P51116	FXR2	Fragile X mental retardation syndrome-related protein 2	GO:0005515; F:protein binding; IPI:IntAct
P51116	FXR2	Fragile X mental retardation syndrome-related protein 2	GO:0003723; F:RNA binding; TAS:ProtInc
Q96CU9	FOXRED1	FAD-dependent oxidoreductase domain-containing protein 1	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q8IWF2	FOXRED2	FAD-dependent oxidoreductase domain-containing protein 2	GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB
Q8IWF2	FOXRED2	FAD-dependent oxidoreductase domain-containing protein 2	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q8IWF2	FOXRED2	FAD-dependent oxidoreductase domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IWF2	FOXRED2	FAD-dependent oxidoreductase domain-containing protein 2	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q14802	FXYD3	FXYD domain-containing ion transport regulator 3	GO:0005254; F:chloride channel activity; TAS:ProtInc
Q14802	FXYD3	FXYD domain-containing ion transport regulator 3	GO:1902476; P:chloride transmembrane transport; TAS:GOC
Q14802	FXYD3	FXYD domain-containing ion transport regulator 3	GO:0006821; P:chloride transport; TAS:ProtInc
Q14802	FXYD3	FXYD domain-containing ion transport regulator 3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q14802	FXYD3	FXYD domain-containing ion transport regulator 3	GO:0050790; P:regulation of catalytic activity; IEA:Ensembl
Q14802	FXYD3	FXYD domain-containing ion transport regulator 3	GO:0055085; P:transmembrane transport; TAS:Reactome
P59646	FXYD4	FXYD domain-containing ion transport regulator 4	GO:0005267; F:potassium channel activity; IEA:Ensembl
P59646	FXYD4	FXYD domain-containing ion transport regulator 4	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P59646	FXYD4	FXYD domain-containing ion transport regulator 4	GO:0055085; P:transmembrane transport; TAS:Reactome
Q96DB9	FXYD5	FXYD domain-containing ion transport regulator 5	GO:0003779; F:actin binding; IDA:UniProtKB
Q96DB9	FXYD5	FXYD domain-containing ion transport regulator 5	GO:0045296; F:cadherin binding; IDA:UniProtKB
Q96DB9	FXYD5	FXYD domain-containing ion transport regulator 5	GO:0005216; F:ion channel activity; IEA:InterPro
Q96DB9	FXYD5	FXYD domain-containing ion transport regulator 5	GO:0030033; P:microvillus assembly; NAS:UniProtKB
Q96DB9	FXYD5	FXYD domain-containing ion transport regulator 5	GO:0046588; P:negative regulation of calcium-dependent cell-cell adhesion; NAS:UniProtKB
Q9H0Q3	FXYD6	FXYD domain-containing ion transport regulator 6	GO:0005216; F:ion channel activity; IEA:InterPro
Q9H0Q3	FXYD6	FXYD domain-containing ion transport regulator 6	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9H0Q3	FXYD6	FXYD domain-containing ion transport regulator 6	GO:0055085; P:transmembrane transport; TAS:Reactome
P58549	FXYD7	FXYD domain-containing ion transport regulator 7	GO:0005216; F:ion channel activity; IEA:InterPro
P58549	FXYD7	FXYD domain-containing ion transport regulator 7	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P58549	FXYD7	FXYD domain-containing ion transport regulator 7	GO:0043269; P:regulation of ion transport; IEA:Ensembl
P58549	FXYD7	FXYD domain-containing ion transport regulator 7	GO:0055085; P:transmembrane transport; TAS:Reactome
P58550	FXYD6P3	Putative FXYD domain-containing ion transport regulator 8	GO:0005216; F:ion channel activity; IEA:InterPro
O15117	FYB	FYN-binding protein	GO:0005515; F:protein binding; IPI:IntAct
O15117	FYB	FYN-binding protein	GO:0005102; F:receptor binding; TAS:UniProtKB
O15117	FYB	FYN-binding protein	GO:0006955; P:immune response; TAS:ProtInc
O15117	FYB	FYN-binding protein	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
O15117	FYB	FYN-binding protein	GO:0006607; P:NLS-bearing protein import into nucleus; TAS:ProtInc
O15117	FYB	FYN-binding protein	GO:0006468; P:protein phosphorylation; TAS:ProtInc
O15117	FYB	FYN-binding protein	GO:0007165; P:signal transduction; TAS:ProtInc
O15117	FYB	FYN-binding protein	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q9BQS8	FYCO1	FYVE and coiled-coil domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BQS8	FYCO1	FYVE and coiled-coil domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BQS8	FYCO1	FYVE and coiled-coil domain-containing protein 1	GO:0072383; P:plus-end-directed vesicle transport along microtubule; IMP:UniProtKB
Q9BQS8	FYCO1	FYVE and coiled-coil domain-containing protein 1	GO:0006810; P:transport; IEA:InterPro
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0046875; F:ephrin receptor binding; IPI:UniProtKB
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0001948; F:glycoprotein binding; IPI:BHF-UCL
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0070851; F:growth factor receptor binding; IPI:UniProtKB
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; NAS:UniProtKB
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0005515; F:protein binding; IPI:UniProtKB
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0004713; F:protein tyrosine kinase activity; EXP:Reactome
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0050798; P:activated T cell proliferation; IEA:Ensembl
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0007411; P:axon guidance; TAS:Reactome
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0007596; P:blood coagulation; TAS:Reactome
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0006816; P:calcium ion transport; NAS:UniProtKB
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0071375; P:cellular response to peptide hormone stimulus; IEA:Ensembl
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0048813; P:dendrite morphogenesis; IEA:Ensembl
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; IEA:Ensembl
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0007631; P:feeding behavior; TAS:ProtInc
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0030900; P:forebrain development; IEA:Ensembl
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0045087; P:innate immune response; TAS:Reactome
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0007612; P:learning; TAS:ProtInc
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0050900; P:leukocyte migration; TAS:Reactome
P06241	FYN	Tyrosine-protein kinase Fyn	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0042177; P:negative regulation of protein catabolic process; IEA:Ensembl
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0001764; P:neuron migration; IEA:Ensembl
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0030168; P:platelet activation; TAS:Reactome
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
P06241	FYN	Tyrosine-protein kinase Fyn	GO:1900182; P:positive regulation of protein localization to nucleus; IEA:Ensembl
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0006468; P:protein phosphorylation; NAS:UniProtKB
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0008360; P:regulation of cell shape; IEA:Ensembl
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0042493; P:response to drug; IEA:Ensembl
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0045471; P:response to ethanol; IEA:Ensembl
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0031295; P:T cell costimulation; TAS:Reactome
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0050852; P:T cell receptor signaling pathway; IDA:UniProtKB
P06241	FYN	Tyrosine-protein kinase Fyn	GO:0016032; P:viral process; TAS:Reactome
Q9Y2I7	PIKFYVE	1-phosphatidylinositol 3-phosphate 5-kinase	GO:0000285; F:1-phosphatidylinositol-3-phosphate 5-kinase activity; IEA:UniProtKB-EC
Q9Y2I7	PIKFYVE	1-phosphatidylinositol 3-phosphate 5-kinase	GO:0016308; F:1-phosphatidylinositol-4-phosphate 5-kinase activity; TAS:HGNC
Q9Y2I7	PIKFYVE	1-phosphatidylinositol 3-phosphate 5-kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y2I7	PIKFYVE	1-phosphatidylinositol 3-phosphate 5-kinase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y2I7	PIKFYVE	1-phosphatidylinositol 3-phosphate 5-kinase	GO:0043813; F:phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; TAS:Reactome
Q9Y2I7	PIKFYVE	1-phosphatidylinositol 3-phosphate 5-kinase	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y2I7	PIKFYVE	1-phosphatidylinositol 3-phosphate 5-kinase	GO:0044267; P:cellular protein metabolic process; IEA:InterPro
Q9Y2I7	PIKFYVE	1-phosphatidylinositol 3-phosphate 5-kinase	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9Y2I7	PIKFYVE	1-phosphatidylinositol 3-phosphate 5-kinase	GO:0032288; P:myelin assembly; IEA:Ensembl
Q9Y2I7	PIKFYVE	1-phosphatidylinositol 3-phosphate 5-kinase	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q9Y2I7	PIKFYVE	1-phosphatidylinositol 3-phosphate 5-kinase	GO:0046854; P:phosphatidylinositol phosphorylation; TAS:GOC
Q9Y2I7	PIKFYVE	1-phosphatidylinositol 3-phosphate 5-kinase	GO:0036092; P:phosphatidylinositol-3-phosphate biosynthetic process; TAS:GOC
Q9Y2I7	PIKFYVE	1-phosphatidylinositol 3-phosphate 5-kinase	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9Y2I7	PIKFYVE	1-phosphatidylinositol 3-phosphate 5-kinase	GO:0034504; P:protein localization to nucleus; IMP:UniProtKB
Q9Y2I7	PIKFYVE	1-phosphatidylinositol 3-phosphate 5-kinase	GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB
Q9Y2I7	PIKFYVE	1-phosphatidylinositol 3-phosphate 5-kinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9ULW2	FZD10	Frizzled-10	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9ULW2	FZD10	Frizzled-10	GO:0030165; F:PDZ domain binding; IBA:RefGenome
Q9ULW2	FZD10	Frizzled-10	GO:0005515; F:protein binding; IPI:UniProtKB
Q9ULW2	FZD10	Frizzled-10	GO:0042813; F:Wnt-activated receptor activity; IBA:RefGenome
Q9ULW2	FZD10	Frizzled-10	GO:0017147; F:Wnt-protein binding; IBA:RefGenome
Q9ULW2	FZD10	Frizzled-10	GO:0007420; P:brain development; IBA:RefGenome
Q9ULW2	FZD10	Frizzled-10	GO:0060070; P:canonical Wnt signaling pathway; IBA:RefGenome
Q9ULW2	FZD10	Frizzled-10	GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB
Q9ULW2	FZD10	Frizzled-10	GO:0009790; P:embryo development; IBA:RefGenome
Q9ULW2	FZD10	Frizzled-10	GO:0008406; P:gonad development; IBA:RefGenome
Q9ULW2	FZD10	Frizzled-10	GO:0034259; P:negative regulation of Rho GTPase activity; IMP:BHF-UCL
Q9ULW2	FZD10	Frizzled-10	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q9ULW2	FZD10	Frizzled-10	GO:0038031; P:non-canonical Wnt signaling pathway via JNK cascade; IMP:BHF-UCL
Q9ULW2	FZD10	Frizzled-10	GO:0043507; P:positive regulation of JUN kinase activity; IMP:BHF-UCL
Q9ULW2	FZD10	Frizzled-10	GO:0032855; P:positive regulation of Rac GTPase activity; IMP:BHF-UCL
Q9ULW2	FZD10	Frizzled-10	GO:0032956; P:regulation of actin cytoskeleton organization; IMP:BHF-UCL
Q9ULW2	FZD10	Frizzled-10	GO:0001944; P:vasculature development; IBA:RefGenome
Q9UP38	FZD1	Frizzled-1	GO:0005109; F:frizzled binding; IPI:UniProtKB
Q9UP38	FZD1	Frizzled-1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9UP38	FZD1	Frizzled-1	GO:0030165; F:PDZ domain binding; IPI:UniProtKB
Q9UP38	FZD1	Frizzled-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UP38	FZD1	Frizzled-1	GO:0005102; F:receptor binding; IPI:BHF-UCL
Q9UP38	FZD1	Frizzled-1	GO:0042813; F:Wnt-activated receptor activity; IDA:BHF-UCL
Q9UP38	FZD1	Frizzled-1	GO:0017147; F:Wnt-protein binding; IPI:UniProtKB
Q9UP38	FZD1	Frizzled-1	GO:0035425; P:autocrine signaling; IDA:BHF-UCL
Q9UP38	FZD1	Frizzled-1	GO:0007409; P:axonogenesis; IBA:RefGenome
Q9UP38	FZD1	Frizzled-1	GO:0007420; P:brain development; IBA:RefGenome
Q9UP38	FZD1	Frizzled-1	GO:0060070; P:canonical Wnt signaling pathway; IDA:UniProtKB
Q9UP38	FZD1	Frizzled-1	GO:0044338; P:canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation; IMP:BHF-UCL
Q9UP38	FZD1	Frizzled-1	GO:0044339; P:canonical Wnt signaling pathway involved in osteoblast differentiation; IMP:BHF-UCL
Q9UP38	FZD1	Frizzled-1	GO:0007267; P:cell-cell signaling; IDA:BHF-UCL
Q9UP38	FZD1	Frizzled-1	GO:0009790; P:embryo development; IBA:RefGenome
Q9UP38	FZD1	Frizzled-1	GO:0030855; P:epithelial cell differentiation; IBA:RefGenome
Q9UP38	FZD1	Frizzled-1	GO:0007199; P:G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger; IBA:RefGenome
Q9UP38	FZD1	Frizzled-1	GO:0008406; P:gonad development; IBA:RefGenome
Q9UP38	FZD1	Frizzled-1	GO:0060022; P:hard palate development; IEA:Ensembl
Q9UP38	FZD1	Frizzled-1	GO:0048286; P:lung alveolus development; IBA:RefGenome
Q9UP38	FZD1	Frizzled-1	GO:0003149; P:membranous septum morphogenesis; IEA:Ensembl
Q9UP38	FZD1	Frizzled-1	GO:0003150; P:muscular septum morphogenesis; IEA:Ensembl
Q9UP38	FZD1	Frizzled-1	GO:0030514; P:negative regulation of BMP signaling pathway; IBA:RefGenome
Q9UP38	FZD1	Frizzled-1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IBA:RefGenome
Q9UP38	FZD1	Frizzled-1	GO:0035414; P:negative regulation of catenin import into nucleus; IEA:Ensembl
Q9UP38	FZD1	Frizzled-1	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q9UP38	FZD1	Frizzled-1	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q9UP38	FZD1	Frizzled-1	GO:0003151; P:outflow tract morphogenesis; IEA:Ensembl
Q9UP38	FZD1	Frizzled-1	GO:0090179; P:planar cell polarity pathway involved in neural tube closure; IEA:Ensembl
Q9UP38	FZD1	Frizzled-1	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
Q9UP38	FZD1	Frizzled-1	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q9UP38	FZD1	Frizzled-1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
Q9UP38	FZD1	Frizzled-1	GO:0042493; P:response to drug; IMP:BHF-UCL
Q9UP38	FZD1	Frizzled-1	GO:0001944; P:vasculature development; IBA:RefGenome
Q9UP38	FZD1	Frizzled-1	GO:0007223; P:Wnt signaling pathway, calcium modulating pathway; IBA:RefGenome
Q14332	FZD2	Frizzled-2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q14332	FZD2	Frizzled-2	GO:0030165; F:PDZ domain binding; IPI:UniProtKB
Q14332	FZD2	Frizzled-2	GO:0042813; F:Wnt-activated receptor activity; IBA:RefGenome
Q14332	FZD2	Frizzled-2	GO:0017147; F:Wnt-protein binding; IBA:RefGenome
Q14332	FZD2	Frizzled-2	GO:0007409; P:axonogenesis; IBA:RefGenome
Q14332	FZD2	Frizzled-2	GO:0007420; P:brain development; IBA:RefGenome
Q14332	FZD2	Frizzled-2	GO:0060070; P:canonical Wnt signaling pathway; IDA:UniProtKB
Q14332	FZD2	Frizzled-2	GO:0007267; P:cell-cell signaling; IEA:Ensembl
Q14332	FZD2	Frizzled-2	GO:0090103; P:cochlea morphogenesis; IEA:Ensembl
Q14332	FZD2	Frizzled-2	GO:0009790; P:embryo development; IBA:RefGenome
Q14332	FZD2	Frizzled-2	GO:0030855; P:epithelial cell differentiation; IBA:RefGenome
Q14332	FZD2	Frizzled-2	GO:0007199; P:G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger; IBA:RefGenome
Q14332	FZD2	Frizzled-2	GO:0008406; P:gonad development; IBA:RefGenome
Q14332	FZD2	Frizzled-2	GO:0060022; P:hard palate development; IEA:Ensembl
Q14332	FZD2	Frizzled-2	GO:0060119; P:inner ear receptor cell development; IEA:Ensembl
Q14332	FZD2	Frizzled-2	GO:0003149; P:membranous septum morphogenesis; IEA:Ensembl
Q14332	FZD2	Frizzled-2	GO:0003150; P:muscular septum morphogenesis; IEA:Ensembl
Q14332	FZD2	Frizzled-2	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q14332	FZD2	Frizzled-2	GO:0003151; P:outflow tract morphogenesis; IEA:Ensembl
Q14332	FZD2	Frizzled-2	GO:0090179; P:planar cell polarity pathway involved in neural tube closure; IEA:Ensembl
Q14332	FZD2	Frizzled-2	GO:0030825; P:positive regulation of cGMP metabolic process; IMP:BHF-UCL
Q14332	FZD2	Frizzled-2	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q14332	FZD2	Frizzled-2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
Q14332	FZD2	Frizzled-2	GO:0007608; P:sensory perception of smell; IEA:Ensembl
Q14332	FZD2	Frizzled-2	GO:0001944; P:vasculature development; IBA:RefGenome
Q14332	FZD2	Frizzled-2	GO:0007223; P:Wnt signaling pathway, calcium modulating pathway; IBA:RefGenome
Q9NPG1	FZD3	Frizzled-3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9NPG1	FZD3	Frizzled-3	GO:0030165; F:PDZ domain binding; IPI:UniProtKB
Q9NPG1	FZD3	Frizzled-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NPG1	FZD3	Frizzled-3	GO:0042813; F:Wnt-activated receptor activity; IC:BHF-UCL
Q9NPG1	FZD3	Frizzled-3	GO:0017147; F:Wnt-protein binding; IPI:UniProtKB
Q9NPG1	FZD3	Frizzled-3	GO:0060070; P:canonical Wnt signaling pathway; IDA:UniProtKB
Q9NPG1	FZD3	Frizzled-3	GO:0033278; P:cell proliferation in midbrain; IBA:RefGenome
Q9NPG1	FZD3	Frizzled-3	GO:0071679; P:commissural neuron axon guidance; IBA:RefGenome
Q9NPG1	FZD3	Frizzled-3	GO:0001736; P:establishment of planar polarity; IBA:RefGenome
Q9NPG1	FZD3	Frizzled-3	GO:0021754; P:facial nucleus development; IBA:RefGenome
Q9NPG1	FZD3	Frizzled-3	GO:0007199; P:G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger; IBA:RefGenome
Q9NPG1	FZD3	Frizzled-3	GO:0008406; P:gonad development; IBA:RefGenome
Q9NPG1	FZD3	Frizzled-3	GO:0001942; P:hair follicle development; IEA:Ensembl
Q9NPG1	FZD3	Frizzled-3	GO:0042472; P:inner ear morphogenesis; IBA:RefGenome
Q9NPG1	FZD3	Frizzled-3	GO:0001843; P:neural tube closure; IBA:RefGenome
Q9NPG1	FZD3	Frizzled-3	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q9NPG1	FZD3	Frizzled-3	GO:0001764; P:neuron migration; IEA:Ensembl
Q9NPG1	FZD3	Frizzled-3	GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl
Q9NPG1	FZD3	Frizzled-3	GO:0001944; P:vasculature development; IBA:RefGenome
Q9ULV1	FZD4	Frizzled-4	GO:0019955; F:cytokine binding; IPI:BHF-UCL
Q9ULV1	FZD4	Frizzled-4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9ULV1	FZD4	Frizzled-4	GO:0030165; F:PDZ domain binding; IDA:UniProtKB
Q9ULV1	FZD4	Frizzled-4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9ULV1	FZD4	Frizzled-4	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
Q9ULV1	FZD4	Frizzled-4	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q9ULV1	FZD4	Frizzled-4	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q9ULV1	FZD4	Frizzled-4	GO:0042813; F:Wnt-activated receptor activity; IDA:BHF-UCL
Q9ULV1	FZD4	Frizzled-4	GO:0017147; F:Wnt-protein binding; IBA:RefGenome
Q9ULV1	FZD4	Frizzled-4	GO:0007420; P:brain development; IBA:RefGenome
Q9ULV1	FZD4	Frizzled-4	GO:0060070; P:canonical Wnt signaling pathway; IDA:UniProtKB
Q9ULV1	FZD4	Frizzled-4	GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB
Q9ULV1	FZD4	Frizzled-4	GO:0061301; P:cerebellum vasculature morphogenesis; IEA:Ensembl
Q9ULV1	FZD4	Frizzled-4	GO:0009790; P:embryo development; IBA:RefGenome
Q9ULV1	FZD4	Frizzled-4	GO:0035426; P:extracellular matrix-cell signaling; IEA:Ensembl
Q9ULV1	FZD4	Frizzled-4	GO:0031987; P:locomotion involved in locomotory behavior; IEA:Ensembl
Q9ULV1	FZD4	Frizzled-4	GO:0010812; P:negative regulation of cell-substrate adhesion; IMP:BHF-UCL
Q9ULV1	FZD4	Frizzled-4	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q9ULV1	FZD4	Frizzled-4	GO:0043507; P:positive regulation of JUN kinase activity; IEA:Ensembl
Q9ULV1	FZD4	Frizzled-4	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q9ULV1	FZD4	Frizzled-4	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
Q9ULV1	FZD4	Frizzled-4	GO:0042701; P:progesterone secretion; IBA:RefGenome
Q9ULV1	FZD4	Frizzled-4	GO:0030947; P:regulation of vascular endothelial growth factor receptor signaling pathway; IBA:RefGenome
Q9ULV1	FZD4	Frizzled-4	GO:0061299; P:retina vasculature morphogenesis in camera-type eye; IMP:BHF-UCL
Q9ULV1	FZD4	Frizzled-4	GO:0061304; P:retinal blood vessel morphogenesis; IEA:Ensembl
Q9ULV1	FZD4	Frizzled-4	GO:0007605; P:sensory perception of sound; IEA:Ensembl
Q9ULV1	FZD4	Frizzled-4	GO:0034446; P:substrate adhesion-dependent cell spreading; IBA:RefGenome
Q9ULV1	FZD4	Frizzled-4	GO:0001570; P:vasculogenesis; IBA:RefGenome
Q9ULV1	FZD4	Frizzled-4	GO:0016055; P:Wnt signaling pathway; IDA:BHF-UCL
Q9ULV1	FZD4	Frizzled-4	GO:0007223; P:Wnt signaling pathway, calcium modulating pathway; IDA:BHF-UCL
Q13467	FZD5	Frizzled-5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q13467	FZD5	Frizzled-5	GO:0030165; F:PDZ domain binding; IBA:RefGenome
Q13467	FZD5	Frizzled-5	GO:0005515; F:protein binding; IPI:UniProtKB
Q13467	FZD5	Frizzled-5	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
Q13467	FZD5	Frizzled-5	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q13467	FZD5	Frizzled-5	GO:0042813; F:Wnt-activated receptor activity; IC:BHF-UCL
Q13467	FZD5	Frizzled-5	GO:0017147; F:Wnt-protein binding; IPI:UniProtKB
Q13467	FZD5	Frizzled-5	GO:0001525; P:angiogenesis; IBA:RefGenome
Q13467	FZD5	Frizzled-5	GO:0008595; P:anterior/posterior axis specification, embryo; IDA:BHF-UCL
Q13467	FZD5	Frizzled-5	GO:0006915; P:apoptotic process; IBA:RefGenome
Q13467	FZD5	Frizzled-5	GO:0060561; P:apoptotic process involved in morphogenesis; IEA:Ensembl
Q13467	FZD5	Frizzled-5	GO:0007409; P:axonogenesis; IBA:RefGenome
Q13467	FZD5	Frizzled-5	GO:0007420; P:brain development; IBA:RefGenome
Q13467	FZD5	Frizzled-5	GO:0060070; P:canonical Wnt signaling pathway; IDA:BHF-UCL
Q13467	FZD5	Frizzled-5	GO:0048469; P:cell maturation; IEA:Ensembl
Q13467	FZD5	Frizzled-5	GO:0071219; P:cellular response to molecule of bacterial origin; IDA:BHF-UCL
Q13467	FZD5	Frizzled-5	GO:0000578; P:embryonic axis specification; IDA:BHF-UCL
Q13467	FZD5	Frizzled-5	GO:0031076; P:embryonic camera-type eye development; IBA:RefGenome
Q13467	FZD5	Frizzled-5	GO:0008406; P:gonad development; IBA:RefGenome
Q13467	FZD5	Frizzled-5	GO:0060716; P:labyrinthine layer blood vessel development; IBA:RefGenome
Q13467	FZD5	Frizzled-5	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q13467	FZD5	Frizzled-5	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q13467	FZD5	Frizzled-5	GO:0032729; P:positive regulation of interferon-gamma production; IMP:BHF-UCL
Q13467	FZD5	Frizzled-5	GO:0043507; P:positive regulation of JUN kinase activity; IEA:Ensembl
Q13467	FZD5	Frizzled-5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q13467	FZD5	Frizzled-5	GO:0031077; P:post-embryonic camera-type eye development; IBA:RefGenome
Q13467	FZD5	Frizzled-5	GO:0060061; P:Spemann organizer formation; IDA:BHF-UCL
Q13467	FZD5	Frizzled-5	GO:0033077; P:T cell differentiation in thymus; IBA:RefGenome
Q13467	FZD5	Frizzled-5	GO:0044332; P:Wnt signaling pathway involved in dorsal/ventral axis specification; IDA:BHF-UCL
O60353	FZD6	Frizzled-6	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O60353	FZD6	Frizzled-6	GO:0030165; F:PDZ domain binding; IBA:RefGenome
O60353	FZD6	Frizzled-6	GO:0005515; F:protein binding; IPI:UniProtKB
O60353	FZD6	Frizzled-6	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
O60353	FZD6	Frizzled-6	GO:0042813; F:Wnt-activated receptor activity; IDA:BHF-UCL
O60353	FZD6	Frizzled-6	GO:0017147; F:Wnt-protein binding; ISS:BHF-UCL
O60353	FZD6	Frizzled-6	GO:0001525; P:angiogenesis; IBA:RefGenome
O60353	FZD6	Frizzled-6	GO:0007409; P:axonogenesis; IBA:RefGenome
O60353	FZD6	Frizzled-6	GO:0033278; P:cell proliferation in midbrain; IBA:RefGenome
O60353	FZD6	Frizzled-6	GO:0001736; P:establishment of planar polarity; IBA:RefGenome
O60353	FZD6	Frizzled-6	GO:0007199; P:G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger; IBA:RefGenome
O60353	FZD6	Frizzled-6	GO:0008406; P:gonad development; IBA:RefGenome
O60353	FZD6	Frizzled-6	GO:0001942; P:hair follicle development; IEA:Ensembl
O60353	FZD6	Frizzled-6	GO:0042472; P:inner ear morphogenesis; IBA:RefGenome
O60353	FZD6	Frizzled-6	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
O60353	FZD6	Frizzled-6	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
O60353	FZD6	Frizzled-6	GO:0001843; P:neural tube closure; IBA:RefGenome
O60353	FZD6	Frizzled-6	GO:0035567; P:non-canonical Wnt signaling pathway; IDA:BHF-UCL
O60353	FZD6	Frizzled-6	GO:0030168; P:platelet activation; IEA:Ensembl
O60353	FZD6	Frizzled-6	GO:0060071; P:Wnt signaling pathway, planar cell polarity pathway; IEA:Ensembl
O75084	FZD7	Frizzled-7	GO:0005109; F:frizzled binding; IPI:UniProtKB
O75084	FZD7	Frizzled-7	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O75084	FZD7	Frizzled-7	GO:0030165; F:PDZ domain binding; IPI:UniProtKB
O75084	FZD7	Frizzled-7	GO:0005515; F:protein binding; IPI:IntAct
O75084	FZD7	Frizzled-7	GO:0042813; F:Wnt-activated receptor activity; IBA:RefGenome
O75084	FZD7	Frizzled-7	GO:0017147; F:Wnt-protein binding; IPI:BHF-UCL
O75084	FZD7	Frizzled-7	GO:0007409; P:axonogenesis; IBA:RefGenome
O75084	FZD7	Frizzled-7	GO:0007420; P:brain development; IBA:RefGenome
O75084	FZD7	Frizzled-7	GO:0060070; P:canonical Wnt signaling pathway; IDA:UniProtKB
O75084	FZD7	Frizzled-7	GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB
O75084	FZD7	Frizzled-7	GO:0007199; P:G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger; IBA:RefGenome
O75084	FZD7	Frizzled-7	GO:0008406; P:gonad development; IBA:RefGenome
O75084	FZD7	Frizzled-7	GO:0060231; P:mesenchymal to epithelial transition; IMP:BHF-UCL
O75084	FZD7	Frizzled-7	GO:0010812; P:negative regulation of cell-substrate adhesion; IMP:BHF-UCL
O75084	FZD7	Frizzled-7	GO:0042666; P:negative regulation of ectodermal cell fate specification; IMP:BHF-UCL
O75084	FZD7	Frizzled-7	GO:0030182; P:neuron differentiation; ISS:UniProtKB
O75084	FZD7	Frizzled-7	GO:0038031; P:non-canonical Wnt signaling pathway via JNK cascade; IMP:BHF-UCL
O75084	FZD7	Frizzled-7	GO:0060054; P:positive regulation of epithelial cell proliferation involved in wound healing; IMP:BHF-UCL
O75084	FZD7	Frizzled-7	GO:0046330; P:positive regulation of JNK cascade; IC:BHF-UCL
O75084	FZD7	Frizzled-7	GO:0042327; P:positive regulation of phosphorylation; IDA:BHF-UCL
O75084	FZD7	Frizzled-7	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
O75084	FZD7	Frizzled-7	GO:0035412; P:regulation of catenin import into nucleus; IMP:BHF-UCL
O75084	FZD7	Frizzled-7	GO:0006355; P:regulation of transcription, DNA-templated; IMP:BHF-UCL
O75084	FZD7	Frizzled-7	GO:0014834; P:satellite cell maintenance involved in skeletal muscle regeneration; IEA:Ensembl
O75084	FZD7	Frizzled-7	GO:0048103; P:somatic stem cell division; IEA:Ensembl
O75084	FZD7	Frizzled-7	GO:0019827; P:stem cell maintenance; IMP:BHF-UCL
O75084	FZD7	Frizzled-7	GO:0034446; P:substrate adhesion-dependent cell spreading; IEA:Ensembl
O75084	FZD7	Frizzled-7	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
O75084	FZD7	Frizzled-7	GO:0001944; P:vasculature development; IBA:RefGenome
O75084	FZD7	Frizzled-7	GO:0007223; P:Wnt signaling pathway, calcium modulating pathway; IBA:RefGenome
Q9H461	FZD8	Frizzled-8	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9H461	FZD8	Frizzled-8	GO:0030165; F:PDZ domain binding; IPI:BHF-UCL
Q9H461	FZD8	Frizzled-8	GO:0005515; F:protein binding; IPI:IntAct
Q9H461	FZD8	Frizzled-8	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q9H461	FZD8	Frizzled-8	GO:0042813; F:Wnt-activated receptor activity; TAS:UniProtKB
Q9H461	FZD8	Frizzled-8	GO:0017147; F:Wnt-protein binding; IBA:RefGenome
Q9H461	FZD8	Frizzled-8	GO:0007409; P:axonogenesis; IBA:RefGenome
Q9H461	FZD8	Frizzled-8	GO:0007420; P:brain development; IBA:RefGenome
Q9H461	FZD8	Frizzled-8	GO:0060070; P:canonical Wnt signaling pathway; IBA:RefGenome
Q9H461	FZD8	Frizzled-8	GO:0009790; P:embryo development; IBA:RefGenome
Q9H461	FZD8	Frizzled-8	GO:0008406; P:gonad development; IBA:RefGenome
Q9H461	FZD8	Frizzled-8	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9H461	FZD8	Frizzled-8	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q9H461	FZD8	Frizzled-8	GO:0043507; P:positive regulation of JUN kinase activity; IEA:Ensembl
Q9H461	FZD8	Frizzled-8	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9H461	FZD8	Frizzled-8	GO:0033077; P:T cell differentiation in thymus; IBA:RefGenome
Q9H461	FZD8	Frizzled-8	GO:0001944; P:vasculature development; IBA:RefGenome
O00144	FZD9	Frizzled-9	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O00144	FZD9	Frizzled-9	GO:0030165; F:PDZ domain binding; IBA:RefGenome
O00144	FZD9	Frizzled-9	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
O00144	FZD9	Frizzled-9	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
O00144	FZD9	Frizzled-9	GO:0042813; F:Wnt-activated receptor activity; IBA:RefGenome
O00144	FZD9	Frizzled-9	GO:0017147; F:Wnt-protein binding; IPI:UniProtKB
O00144	FZD9	Frizzled-9	GO:0030183; P:B cell differentiation; IBA:RefGenome
O00144	FZD9	Frizzled-9	GO:0007420; P:brain development; IBA:RefGenome
O00144	FZD9	Frizzled-9	GO:0060070; P:canonical Wnt signaling pathway; IBA:RefGenome
O00144	FZD9	Frizzled-9	GO:0009790; P:embryo development; IBA:RefGenome
O00144	FZD9	Frizzled-9	GO:0008406; P:gonad development; IBA:RefGenome
O00144	FZD9	Frizzled-9	GO:0007611; P:learning or memory; IEA:Ensembl
O00144	FZD9	Frizzled-9	GO:0007399; P:nervous system development; TAS:ProtInc
O00144	FZD9	Frizzled-9	GO:0007405; P:neuroblast proliferation; IBA:RefGenome
O00144	FZD9	Frizzled-9	GO:0001944; P:vasculature development; IBA:RefGenome
Q9UM11	FZR1	Fizzy-related protein homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UM11	FZR1	Fizzy-related protein homolog	GO:0051488; P:activation of anaphase-promoting complex activity; IDA:UniProtKB
Q9UM11	FZR1	Fizzy-related protein homolog	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9UM11	FZR1	Fizzy-related protein homolog	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q9UM11	FZR1	Fizzy-related protein homolog	GO:0031572; P:G2 DNA damage checkpoint; IDA:UniProtKB
Q9UM11	FZR1	Fizzy-related protein homolog	GO:0070306; P:lens fiber cell differentiation; IEA:Ensembl
Q9UM11	FZR1	Fizzy-related protein homolog	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9UM11	FZR1	Fizzy-related protein homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9UM11	FZR1	Fizzy-related protein homolog	GO:0090344; P:negative regulation of cell aging; IEA:Ensembl
Q9UM11	FZR1	Fizzy-related protein homolog	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UM11	FZR1	Fizzy-related protein homolog	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q9UM11	FZR1	Fizzy-related protein homolog	GO:0045732; P:positive regulation of protein catabolic process; IGI:UniProtKB
Q9UM11	FZR1	Fizzy-related protein homolog	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UM11	FZR1	Fizzy-related protein homolog	GO:0070979; P:protein K11-linked ubiquitination; TAS:UniProtKB
Q9UM11	FZR1	Fizzy-related protein homolog	GO:0040020; P:regulation of meiosis; IEA:Ensembl
Q9UM11	FZR1	Fizzy-related protein homolog	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P27469	G0S2	G0/G1 switch protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
P27469	G0S2	G0/G1 switch protein 2	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P27469	G0S2	G0/G1 switch protein 2	GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:UniProtKB
P27469	G0S2	G0/G1 switch protein 2	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IDA:UniProtKB
P27469	G0S2	G0/G1 switch protein 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q7L622	G2E3	G2/M phase-specific E3 ubiquitin-protein ligase	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q7L622	G2E3	G2/M phase-specific E3 ubiquitin-protein ligase	GO:0008270; F:zinc ion binding; IEA:InterPro
Q7L622	G2E3	G2/M phase-specific E3 ubiquitin-protein ligase	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q7L622	G2E3	G2/M phase-specific E3 ubiquitin-protein ligase	GO:0001824; P:blastocyst development; IEA:Ensembl
Q7L622	G2E3	G2/M phase-specific E3 ubiquitin-protein ligase	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl
Q7L622	G2E3	G2/M phase-specific E3 ubiquitin-protein ligase	GO:0000209; P:protein polyubiquitination; IEA:Ensembl
Q8NGA4	GPR32P1	Putative G-protein coupled receptor GPR32P1	GO:0004982; F:N-formyl peptide receptor activity; IEA:InterPro
Q13283	G3BP1	Ras GTPase-activating protein-binding protein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13283	G3BP1	Ras GTPase-activating protein-binding protein 1	GO:0004003; F:ATP-dependent DNA helicase activity; TAS:ProtInc
Q13283	G3BP1	Ras GTPase-activating protein-binding protein 1	GO:0004004; F:ATP-dependent RNA helicase activity; TAS:ProtInc
Q13283	G3BP1	Ras GTPase-activating protein-binding protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q13283	G3BP1	Ras GTPase-activating protein-binding protein 1	GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW
Q13283	G3BP1	Ras GTPase-activating protein-binding protein 1	GO:0003729; F:mRNA binding; IEA:Ensembl
Q13283	G3BP1	Ras GTPase-activating protein-binding protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13283	G3BP1	Ras GTPase-activating protein-binding protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13283	G3BP1	Ras GTPase-activating protein-binding protein 1	GO:0006200; P:ATP catabolic process; TAS:GOC
Q13283	G3BP1	Ras GTPase-activating protein-binding protein 1	GO:0032508; P:DNA duplex unwinding; TAS:GOC
Q13283	G3BP1	Ras GTPase-activating protein-binding protein 1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEA:Ensembl
Q13283	G3BP1	Ras GTPase-activating protein-binding protein 1	GO:0007265; P:Ras protein signal transduction; TAS:ProtInc
Q13283	G3BP1	Ras GTPase-activating protein-binding protein 1	GO:0006810; P:transport; IEA:UniProtKB-KW
Q9UN86	G3BP2	Ras GTPase-activating protein-binding protein 2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9UN86	G3BP2	Ras GTPase-activating protein-binding protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UN86	G3BP2	Ras GTPase-activating protein-binding protein 2	GO:0030159; F:receptor signaling complex scaffold activity; NAS:UniProtKB
Q9UN86	G3BP2	Ras GTPase-activating protein-binding protein 2	GO:0007253; P:cytoplasmic sequestering of NF-kappaB; NAS:UniProtKB
Q9UN86	G3BP2	Ras GTPase-activating protein-binding protein 2	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q9UN86	G3BP2	Ras GTPase-activating protein-binding protein 2	GO:0007265; P:Ras protein signal transduction; NAS:UniProtKB
O14556	GAPDHS	Glyceraldehyde-3-phosphate dehydrogenase, testis-specific	GO:0004365; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity; TAS:UniProtKB
O14556	GAPDHS	Glyceraldehyde-3-phosphate dehydrogenase, testis-specific	GO:0051287; F:NAD binding; IEA:InterPro
O14556	GAPDHS	Glyceraldehyde-3-phosphate dehydrogenase, testis-specific	GO:0050661; F:NADP binding; IEA:InterPro
O14556	GAPDHS	Glyceraldehyde-3-phosphate dehydrogenase, testis-specific	GO:0005515; F:protein binding; IPI:UniProtKB
O14556	GAPDHS	Glyceraldehyde-3-phosphate dehydrogenase, testis-specific	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O14556	GAPDHS	Glyceraldehyde-3-phosphate dehydrogenase, testis-specific	GO:0006094; P:gluconeogenesis; TAS:Reactome
O14556	GAPDHS	Glyceraldehyde-3-phosphate dehydrogenase, testis-specific	GO:0006006; P:glucose metabolic process; TAS:Reactome
O14556	GAPDHS	Glyceraldehyde-3-phosphate dehydrogenase, testis-specific	GO:0006096; P:glycolytic process; TAS:Reactome
O14556	GAPDHS	Glyceraldehyde-3-phosphate dehydrogenase, testis-specific	GO:0045821; P:positive regulation of glycolytic process; TAS:UniProtKB
O14556	GAPDHS	Glyceraldehyde-3-phosphate dehydrogenase, testis-specific	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O14556	GAPDHS	Glyceraldehyde-3-phosphate dehydrogenase, testis-specific	GO:0030317; P:sperm motility; ISS:UniProtKB
O14556	GAPDHS	Glyceraldehyde-3-phosphate dehydrogenase, testis-specific	GO:0007286; P:spermatid development; IEA:Ensembl
P04406	GAPDH	Glyceraldehyde-3-phosphate dehydrogenase	GO:0004365; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity; ISS:UniProtKB
P04406	GAPDH	Glyceraldehyde-3-phosphate dehydrogenase	GO:0042802; F:identical protein binding; IPI:IntAct
P04406	GAPDH	Glyceraldehyde-3-phosphate dehydrogenase	GO:0008017; F:microtubule binding; ISS:UniProtKB
P04406	GAPDH	Glyceraldehyde-3-phosphate dehydrogenase	GO:0051287; F:NAD binding; IEA:InterPro
P04406	GAPDH	Glyceraldehyde-3-phosphate dehydrogenase	GO:0050661; F:NADP binding; IEA:InterPro
P04406	GAPDH	Glyceraldehyde-3-phosphate dehydrogenase	GO:0035605; F:peptidyl-cysteine S-nitrosylase activity; ISS:UniProtKB
P04406	GAPDH	Glyceraldehyde-3-phosphate dehydrogenase	GO:0005515; F:protein binding; IPI:UniProtKB
P04406	GAPDH	Glyceraldehyde-3-phosphate dehydrogenase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P04406	GAPDH	Glyceraldehyde-3-phosphate dehydrogenase	GO:0071346; P:cellular response to interferon-gamma; IDA:UniProtKB
P04406	GAPDH	Glyceraldehyde-3-phosphate dehydrogenase	GO:0006094; P:gluconeogenesis; TAS:Reactome
P04406	GAPDH	Glyceraldehyde-3-phosphate dehydrogenase	GO:0006006; P:glucose metabolic process; TAS:Reactome
P04406	GAPDH	Glyceraldehyde-3-phosphate dehydrogenase	GO:0006096; P:glycolytic process; TAS:Reactome
P04406	GAPDH	Glyceraldehyde-3-phosphate dehydrogenase	GO:0000226; P:microtubule cytoskeleton organization; ISS:UniProtKB
P04406	GAPDH	Glyceraldehyde-3-phosphate dehydrogenase	GO:0017148; P:negative regulation of translation; IDA:UniProtKB
P04406	GAPDH	Glyceraldehyde-3-phosphate dehydrogenase	GO:0051402; P:neuron apoptotic process; ISS:UniProtKB
P04406	GAPDH	Glyceraldehyde-3-phosphate dehydrogenase	GO:0035606; P:peptidyl-cysteine S-trans-nitrosylation; ISS:UniProtKB
P04406	GAPDH	Glyceraldehyde-3-phosphate dehydrogenase	GO:0050821; P:protein stabilization; ISS:UniProtKB
P04406	GAPDH	Glyceraldehyde-3-phosphate dehydrogenase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99999	GAL3ST1	Galactosylceramide sulfotransferase	GO:0001733; F:galactosylceramide sulfotransferase activity; IEA:UniProtKB-EC
Q99999	GAL3ST1	Galactosylceramide sulfotransferase	GO:0008146; F:sulfotransferase activity; TAS:ProtInc
Q99999	GAL3ST1	Galactosylceramide sulfotransferase	GO:0006682; P:galactosylceramide biosynthetic process; IEA:Ensembl
Q99999	GAL3ST1	Galactosylceramide sulfotransferase	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
Q99999	GAL3ST1	Galactosylceramide sulfotransferase	GO:0042552; P:myelination; IEA:Ensembl
Q99999	GAL3ST1	Galactosylceramide sulfotransferase	GO:0006487; P:protein N-linked glycosylation; TAS:ProtInc
Q99999	GAL3ST1	Galactosylceramide sulfotransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99999	GAL3ST1	Galactosylceramide sulfotransferase	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q99999	GAL3ST1	Galactosylceramide sulfotransferase	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q9H3Q3	GAL3ST2	Galactose-3-O-sulfotransferase 2	GO:0001733; F:galactosylceramide sulfotransferase activity; IEA:InterPro
Q9H3Q3	GAL3ST2	Galactose-3-O-sulfotransferase 2	GO:0008146; F:sulfotransferase activity; IDA:UniProtKB
Q9H3Q3	GAL3ST2	Galactose-3-O-sulfotransferase 2	GO:0009058; P:biosynthetic process; IEA:InterPro
Q96A11	GAL3ST3	Galactose-3-O-sulfotransferase 3	GO:0050656; F:3'-phosphoadenosine 5'-phosphosulfate binding; NAS:UniProtKB
Q96A11	GAL3ST3	Galactose-3-O-sulfotransferase 3	GO:0030246; F:carbohydrate binding; NAS:UniProtKB
Q96A11	GAL3ST3	Galactose-3-O-sulfotransferase 3	GO:0050694; F:galactose 3-O-sulfotransferase activity; IDA:UniProtKB
Q96A11	GAL3ST3	Galactose-3-O-sulfotransferase 3	GO:0001733; F:galactosylceramide sulfotransferase activity; IEA:InterPro
Q96A11	GAL3ST3	Galactose-3-O-sulfotransferase 3	GO:0050698; F:proteoglycan sulfotransferase activity; NAS:UniProtKB
Q96A11	GAL3ST3	Galactose-3-O-sulfotransferase 3	GO:0005996; P:monosaccharide metabolic process; NAS:UniProtKB
Q96A11	GAL3ST3	Galactose-3-O-sulfotransferase 3	GO:0009311; P:oligosaccharide metabolic process; NAS:UniProtKB
Q96A11	GAL3ST3	Galactose-3-O-sulfotransferase 3	GO:0030309; P:poly-N-acetyllactosamine metabolic process; NAS:UniProtKB
Q96A11	GAL3ST3	Galactose-3-O-sulfotransferase 3	GO:0030166; P:proteoglycan biosynthetic process; NAS:UniProtKB
Q96A11	GAL3ST3	Galactose-3-O-sulfotransferase 3	GO:0006790; P:sulfur compound metabolic process; NAS:UniProtKB
Q96RP7	GAL3ST4	Galactose-3-O-sulfotransferase 4	GO:0050656; F:3'-phosphoadenosine 5'-phosphosulfate binding; NAS:UniProtKB
Q96RP7	GAL3ST4	Galactose-3-O-sulfotransferase 4	GO:0050694; F:galactose 3-O-sulfotransferase activity; IDA:UniProtKB
Q96RP7	GAL3ST4	Galactose-3-O-sulfotransferase 4	GO:0001733; F:galactosylceramide sulfotransferase activity; IEA:InterPro
Q96RP7	GAL3ST4	Galactose-3-O-sulfotransferase 4	GO:0050698; F:proteoglycan sulfotransferase activity; NAS:UniProtKB
Q96RP7	GAL3ST4	Galactose-3-O-sulfotransferase 4	GO:0007267; P:cell-cell signaling; NAS:UniProtKB
Q96RP7	GAL3ST4	Galactose-3-O-sulfotransferase 4	GO:0009100; P:glycoprotein metabolic process; NAS:UniProtKB
Q96RP7	GAL3ST4	Galactose-3-O-sulfotransferase 4	GO:0009311; P:oligosaccharide metabolic process; NAS:UniProtKB
Q96RP7	GAL3ST4	Galactose-3-O-sulfotransferase 4	GO:0030166; P:proteoglycan biosynthetic process; NAS:UniProtKB
Q96RP7	GAL3ST4	Galactose-3-O-sulfotransferase 4	GO:0006790; P:sulfur compound metabolic process; NAS:UniProtKB
Q8TAE8	GADD45GIP1	Growth arrest and DNA damage-inducible proteins-interacting protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q8TAE8	GADD45GIP1	Growth arrest and DNA damage-inducible proteins-interacting protein 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8TAE8	GADD45GIP1	Growth arrest and DNA damage-inducible proteins-interacting protein 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
O95866	G6B	Protein G6b	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
Q9NQR9	G6PC2	Glucose-6-phosphatase 2	GO:0004346; F:glucose-6-phosphatase activity; IEA:UniProtKB-EC
Q9NQR9	G6PC2	Glucose-6-phosphatase 2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9NQR9	G6PC2	Glucose-6-phosphatase 2	GO:0006094; P:gluconeogenesis; IEA:UniProtKB-UniPathway
Q9NQR9	G6PC2	Glucose-6-phosphatase 2	GO:0042593; P:glucose homeostasis; IMP:BHF-UCL
Q9NQR9	G6PC2	Glucose-6-phosphatase 2	GO:0015758; P:glucose transport; TAS:Reactome
Q9NQR9	G6PC2	Glucose-6-phosphatase 2	GO:0008645; P:hexose transport; TAS:Reactome
Q9NQR9	G6PC2	Glucose-6-phosphatase 2	GO:0050796; P:regulation of insulin secretion; IMP:BHF-UCL
Q9NQR9	G6PC2	Glucose-6-phosphatase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NQR9	G6PC2	Glucose-6-phosphatase 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9BUM1	G6PC3	Glucose-6-phosphatase 3	GO:0004346; F:glucose-6-phosphatase activity; IEA:UniProtKB-EC
Q9BUM1	G6PC3	Glucose-6-phosphatase 3	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9BUM1	G6PC3	Glucose-6-phosphatase 3	GO:0006094; P:gluconeogenesis; IEA:UniProtKB-UniPathway
Q9BUM1	G6PC3	Glucose-6-phosphatase 3	GO:0051156; P:glucose 6-phosphate metabolic process; IEA:Ensembl
Q9BUM1	G6PC3	Glucose-6-phosphatase 3	GO:0015758; P:glucose transport; TAS:Reactome
Q9BUM1	G6PC3	Glucose-6-phosphatase 3	GO:0015760; P:glucose-6-phosphate transport; IEA:Ensembl
Q9BUM1	G6PC3	Glucose-6-phosphatase 3	GO:0008645; P:hexose transport; TAS:Reactome
Q9BUM1	G6PC3	Glucose-6-phosphatase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BUM1	G6PC3	Glucose-6-phosphatase 3	GO:0055085; P:transmembrane transport; TAS:Reactome
P35575	G6PC	Glucose-6-phosphatase	GO:0004346; F:glucose-6-phosphatase activity; IDA:UniProtKB
P35575	G6PC	Glucose-6-phosphatase	GO:0042301; F:phosphate ion binding; IMP:UniProtKB
P35575	G6PC	Glucose-6-phosphatase	GO:0016773; F:phosphotransferase activity, alcohol group as acceptor; IEA:Ensembl
P35575	G6PC	Glucose-6-phosphatase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P35575	G6PC	Glucose-6-phosphatase	GO:0042632; P:cholesterol homeostasis; IEA:Ensembl
P35575	G6PC	Glucose-6-phosphatase	GO:0016311; P:dephosphorylation; IDA:GOC
P35575	G6PC	Glucose-6-phosphatase	GO:0006094; P:gluconeogenesis; IMP:UniProtKB
P35575	G6PC	Glucose-6-phosphatase	GO:0051156; P:glucose 6-phosphate metabolic process; IEA:Ensembl
P35575	G6PC	Glucose-6-phosphatase	GO:0042593; P:glucose homeostasis; IMP:UniProtKB
P35575	G6PC	Glucose-6-phosphatase	GO:0015758; P:glucose transport; TAS:Reactome
P35575	G6PC	Glucose-6-phosphatase	GO:0015760; P:glucose-6-phosphate transport; IEA:Ensembl
P35575	G6PC	Glucose-6-phosphatase	GO:0005980; P:glycogen catabolic process; IEA:Ensembl
P35575	G6PC	Glucose-6-phosphatase	GO:0005977; P:glycogen metabolic process; TAS:ProtInc
P35575	G6PC	Glucose-6-phosphatase	GO:0008645; P:hexose transport; TAS:Reactome
P35575	G6PC	Glucose-6-phosphatase	GO:0035264; P:multicellular organism growth; IEA:Ensembl
P35575	G6PC	Glucose-6-phosphatase	GO:0010468; P:regulation of gene expression; IEA:Ensembl
P35575	G6PC	Glucose-6-phosphatase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P35575	G6PC	Glucose-6-phosphatase	GO:0008202; P:steroid metabolic process; IEA:Ensembl
P35575	G6PC	Glucose-6-phosphatase	GO:0055085; P:transmembrane transport; TAS:Reactome
P35575	G6PC	Glucose-6-phosphatase	GO:0006641; P:triglyceride metabolic process; IEA:Ensembl
P35575	G6PC	Glucose-6-phosphatase	GO:0046415; P:urate metabolic process; IEA:Ensembl
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0005536; F:glucose binding; IDA:BHF-UCL
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0004345; F:glucose-6-phosphate dehydrogenase activity; IDA:UniProtKB
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0050661; F:NADP binding; IDA:BHF-UCL
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0005515; F:protein binding; IPI:IntAct
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0034599; P:cellular response to oxidative stress; IMP:BHF-UCL
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0006695; P:cholesterol biosynthetic process; IMP:BHF-UCL
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0001816; P:cytokine production; IMP:BHF-UCL
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0043249; P:erythrocyte maturation; IMP:BHF-UCL
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0051156; P:glucose 6-phosphate metabolic process; IDA:UniProtKB
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0006749; P:glutathione metabolic process; IMP:BHF-UCL
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0006629; P:lipid metabolic process; TAS:BHF-UCL
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0006739; P:NADP metabolic process; IDA:UniProtKB
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0006740; P:NADPH regeneration; IMP:BHF-UCL
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0010734; P:negative regulation of protein glutathionylation; IMP:BHF-UCL
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0055114; P:oxidation-reduction process; IMP:BHF-UCL
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0019322; P:pentose biosynthetic process; IDA:BHF-UCL
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0006098; P:pentose-phosphate shunt; IDA:BHF-UCL
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0009051; P:pentose-phosphate shunt, oxidative branch; IMP:BHF-UCL
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0043523; P:regulation of neuron apoptotic process; IEA:Ensembl
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0045471; P:response to ethanol; IEA:Ensembl
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0032094; P:response to food; IEA:Ensembl
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0046390; P:ribose phosphate biosynthetic process; IMP:BHF-UCL
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	GO:0021762; P:substantia nigra development; IEP:UniProt
O95479	H6PD	GDH/6PGL endoplasmic bifunctional protein	GO:0017057; F:6-phosphogluconolactonase activity; IEA:UniProtKB-EC
O95479	H6PD	GDH/6PGL endoplasmic bifunctional protein	GO:0030246; F:carbohydrate binding; IEA:Ensembl
O95479	H6PD	GDH/6PGL endoplasmic bifunctional protein	GO:0047936; F:glucose 1-dehydrogenase [NAD(P)] activity; IEA:UniProtKB-EC
O95479	H6PD	GDH/6PGL endoplasmic bifunctional protein	GO:0004345; F:glucose-6-phosphate dehydrogenase activity; TAS:ProtInc
O95479	H6PD	GDH/6PGL endoplasmic bifunctional protein	GO:0050661; F:NADP binding; IEA:Ensembl
O95479	H6PD	GDH/6PGL endoplasmic bifunctional protein	GO:0006098; P:pentose-phosphate shunt; IEA:Ensembl
O95479	H6PD	GDH/6PGL endoplasmic bifunctional protein	GO:0097305; P:response to alcohol; IEA:Ensembl
P06744	GPI	Glucose-6-phosphate isomerase	GO:0004347; F:glucose-6-phosphate isomerase activity; TAS:Reactome
P06744	GPI	Glucose-6-phosphate isomerase	GO:0016866; F:intramolecular transferase activity; IEA:Ensembl
P06744	GPI	Glucose-6-phosphate isomerase	GO:0048029; F:monosaccharide binding; IEA:Ensembl
P06744	GPI	Glucose-6-phosphate isomerase	GO:0046185; P:aldehyde catabolic process; IEA:Ensembl
P06744	GPI	Glucose-6-phosphate isomerase	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P06744	GPI	Glucose-6-phosphate isomerase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P06744	GPI	Glucose-6-phosphate isomerase	GO:0006094; P:gluconeogenesis; TAS:Reactome
P06744	GPI	Glucose-6-phosphate isomerase	GO:0051156; P:glucose 6-phosphate metabolic process; IEA:Ensembl
P06744	GPI	Glucose-6-phosphate isomerase	GO:0006006; P:glucose metabolic process; TAS:Reactome
P06744	GPI	Glucose-6-phosphate isomerase	GO:0006096; P:glycolytic process; TAS:Reactome
P06744	GPI	Glucose-6-phosphate isomerase	GO:0007599; P:hemostasis; TAS:ProtInc
P06744	GPI	Glucose-6-phosphate isomerase	GO:0006959; P:humoral immune response; TAS:ProtInc
P06744	GPI	Glucose-6-phosphate isomerase	GO:0007611; P:learning or memory; IEA:Ensembl
P06744	GPI	Glucose-6-phosphate isomerase	GO:0019242; P:methylglyoxal biosynthetic process; IEA:Ensembl
P06744	GPI	Glucose-6-phosphate isomerase	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
P06744	GPI	Glucose-6-phosphate isomerase	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P06744	GPI	Glucose-6-phosphate isomerase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43826	SLC37A4	Glucose-6-phosphate translocase	GO:0015152; F:glucose-6-phosphate transmembrane transporter activity; IDA:UniProtKB
O43826	SLC37A4	Glucose-6-phosphate translocase	GO:0005215; F:transporter activity; NAS:UniProtKB
O43826	SLC37A4	Glucose-6-phosphate translocase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O43826	SLC37A4	Glucose-6-phosphate translocase	GO:0042593; P:glucose homeostasis; IDA:UniProtKB
O43826	SLC37A4	Glucose-6-phosphate translocase	GO:0006006; P:glucose metabolic process; NAS:UniProtKB
O43826	SLC37A4	Glucose-6-phosphate translocase	GO:0015758; P:glucose transport; TAS:Reactome
O43826	SLC37A4	Glucose-6-phosphate translocase	GO:0015760; P:glucose-6-phosphate transport; IDA:UniProtKB
O43826	SLC37A4	Glucose-6-phosphate translocase	GO:0008645; P:hexose transport; TAS:Reactome
O43826	SLC37A4	Glucose-6-phosphate translocase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43826	SLC37A4	Glucose-6-phosphate translocase	GO:0055085; P:transmembrane transport; TAS:Reactome
O43826	SLC37A4	Glucose-6-phosphate translocase	GO:0006810; P:transport; NAS:UniProtKB
Q99501	GAS2L1	GAS2-like protein 1	GO:0008093; F:cytoskeletal adaptor activity; IDA:UniProtKB
Q99501	GAS2L1	GAS2-like protein 1	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q99501	GAS2L1	GAS2-like protein 1	GO:0046966; F:thyroid hormone receptor binding; IDA:UniProtKB
Q99501	GAS2L1	GAS2-like protein 1	GO:0007050; P:cell cycle arrest; ISS:UniProtKB
Q99501	GAS2L1	GAS2-like protein 1	GO:0009267; P:cellular response to starvation; ISS:UniProtKB
Q99501	GAS2L1	GAS2-like protein 1	GO:0097067; P:cellular response to thyroid hormone stimulus; IDA:UniProtKB
Q99501	GAS2L1	GAS2-like protein 1	GO:0001578; P:microtubule bundle formation; IMP:UniProtKB
Q99501	GAS2L1	GAS2-like protein 1	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q99501	GAS2L1	GAS2-like protein 1	GO:0045647; P:negative regulation of erythrocyte differentiation; IDA:UniProtKB
Q99501	GAS2L1	GAS2-like protein 1	GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB
Q99501	GAS2L1	GAS2-like protein 1	GO:0007026; P:negative regulation of microtubule depolymerization; IMP:UniProtKB
Q99501	GAS2L1	GAS2-like protein 1	GO:0051726; P:regulation of cell cycle; IDA:UniProtKB
Q8NHY3	GAS2L2	GAS2-like protein 2	GO:0051015; F:actin filament binding; IDA:UniProtKB
Q8NHY3	GAS2L2	GAS2-like protein 2	GO:0008093; F:cytoskeletal adaptor activity; IDA:UniProtKB
Q8NHY3	GAS2L2	GAS2-like protein 2	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q8NHY3	GAS2L2	GAS2-like protein 2	GO:0007050; P:cell cycle arrest; IEA:InterPro
Q8NHY3	GAS2L2	GAS2-like protein 2	GO:0001578; P:microtubule bundle formation; IMP:UniProtKB
Q8NHY3	GAS2L2	GAS2-like protein 2	GO:0007026; P:negative regulation of microtubule depolymerization; IMP:UniProtKB
Q86XJ1	GAS2L3	GAS2-like protein 3	GO:0003779; F:actin binding; IDA:UniProtKB
Q86XJ1	GAS2L3	GAS2-like protein 3	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q86XJ1	GAS2L3	GAS2-like protein 3	GO:0030036; P:actin cytoskeleton organization; IDA:UniProtKB
Q86XJ1	GAS2L3	GAS2-like protein 3	GO:0007050; P:cell cycle arrest; IEA:InterPro
Q86XJ1	GAS2L3	GAS2-like protein 3	GO:0000226; P:microtubule cytoskeleton organization; IDA:UniProtKB
P24522	GADD45A	Growth arrest and DNA damage-inducible protein GADD45 alpha	GO:0001047; F:core promoter binding; IEA:Ensembl
P24522	GADD45A	Growth arrest and DNA damage-inducible protein GADD45 alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P24522	GADD45A	Growth arrest and DNA damage-inducible protein GADD45 alpha	GO:0000185; P:activation of MAPKKK activity; IDA:UniProtKB
P24522	GADD45A	Growth arrest and DNA damage-inducible protein GADD45 alpha	GO:0006915; P:apoptotic process; TAS:ProtInc
P24522	GADD45A	Growth arrest and DNA damage-inducible protein GADD45 alpha	GO:0007050; P:cell cycle arrest; TAS:ProtInc
P24522	GADD45A	Growth arrest and DNA damage-inducible protein GADD45 alpha	GO:0071479; P:cellular response to ionizing radiation; IMP:BHF-UCL
P24522	GADD45A	Growth arrest and DNA damage-inducible protein GADD45 alpha	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
P24522	GADD45A	Growth arrest and DNA damage-inducible protein GADD45 alpha	GO:0007098; P:centrosome cycle; IEA:Ensembl
P24522	GADD45A	Growth arrest and DNA damage-inducible protein GADD45 alpha	GO:0006281; P:DNA repair; TAS:ProtInc
P24522	GADD45A	Growth arrest and DNA damage-inducible protein GADD45 alpha	GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl
P24522	GADD45A	Growth arrest and DNA damage-inducible protein GADD45 alpha	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P24522	GADD45A	Growth arrest and DNA damage-inducible protein GADD45 alpha	GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB
P24522	GADD45A	Growth arrest and DNA damage-inducible protein GADD45 alpha	GO:1900745; P:positive regulation of p38MAPK cascade; IDA:UniProtKB
P24522	GADD45A	Growth arrest and DNA damage-inducible protein GADD45 alpha	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IMP:BHF-UCL
P24522	GADD45A	Growth arrest and DNA damage-inducible protein GADD45 alpha	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
P24522	GADD45A	Growth arrest and DNA damage-inducible protein GADD45 alpha	GO:0042770; P:signal transduction in response to DNA damage; IMP:BHF-UCL
O75293	GADD45B	Growth arrest and DNA damage-inducible protein GADD45 beta	GO:0005515; F:protein binding; IPI:IntAct
O75293	GADD45B	Growth arrest and DNA damage-inducible protein GADD45 beta	GO:0000186; P:activation of MAPKK activity; IEA:Ensembl
O75293	GADD45B	Growth arrest and DNA damage-inducible protein GADD45 beta	GO:0000185; P:activation of MAPKKK activity; IDA:UniProtKB
O75293	GADD45B	Growth arrest and DNA damage-inducible protein GADD45 beta	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O75293	GADD45B	Growth arrest and DNA damage-inducible protein GADD45 beta	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O75293	GADD45B	Growth arrest and DNA damage-inducible protein GADD45 beta	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
O75293	GADD45B	Growth arrest and DNA damage-inducible protein GADD45 beta	GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl
O75293	GADD45B	Growth arrest and DNA damage-inducible protein GADD45 beta	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
O75293	GADD45B	Growth arrest and DNA damage-inducible protein GADD45 beta	GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB
O75293	GADD45B	Growth arrest and DNA damage-inducible protein GADD45 beta	GO:1900745; P:positive regulation of p38MAPK cascade; IDA:UniProtKB
O75293	GADD45B	Growth arrest and DNA damage-inducible protein GADD45 beta	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
O75293	GADD45B	Growth arrest and DNA damage-inducible protein GADD45 beta	GO:0006950; P:response to stress; IEA:InterPro
O95257	GADD45G	Growth arrest and DNA damage-inducible protein GADD45 gamma	GO:0005515; F:protein binding; IPI:IntAct
O95257	GADD45G	Growth arrest and DNA damage-inducible protein GADD45 gamma	GO:0000186; P:activation of MAPKK activity; IEA:Ensembl
O95257	GADD45G	Growth arrest and DNA damage-inducible protein GADD45 gamma	GO:0000185; P:activation of MAPKKK activity; IDA:UniProtKB
O95257	GADD45G	Growth arrest and DNA damage-inducible protein GADD45 gamma	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O95257	GADD45G	Growth arrest and DNA damage-inducible protein GADD45 gamma	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O95257	GADD45G	Growth arrest and DNA damage-inducible protein GADD45 gamma	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
O95257	GADD45G	Growth arrest and DNA damage-inducible protein GADD45 gamma	GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl
O95257	GADD45G	Growth arrest and DNA damage-inducible protein GADD45 gamma	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
O95257	GADD45G	Growth arrest and DNA damage-inducible protein GADD45 gamma	GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB
O95257	GADD45G	Growth arrest and DNA damage-inducible protein GADD45 gamma	GO:1900745; P:positive regulation of p38MAPK cascade; IDA:UniProtKB
O95257	GADD45G	Growth arrest and DNA damage-inducible protein GADD45 gamma	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
O95257	GADD45G	Growth arrest and DNA damage-inducible protein GADD45 gamma	GO:0006950; P:response to stress; IEA:InterPro
Q13480	GAB1	GRB2-associated-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q13480	GAB1	GRB2-associated-binding protein 1	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
Q13480	GAB1	GRB2-associated-binding protein 1	GO:0004871; F:signal transducer activity; IEA:Ensembl
Q13480	GAB1	GRB2-associated-binding protein 1	GO:0007257; P:activation of JUN kinase activity; IEA:Ensembl
Q13480	GAB1	GRB2-associated-binding protein 1	GO:0008283; P:cell proliferation; TAS:ProtInc
Q13480	GAB1	GRB2-associated-binding protein 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q13480	GAB1	GRB2-associated-binding protein 1	GO:0008544; P:epidermis development; IEA:Ensembl
Q13480	GAB1	GRB2-associated-binding protein 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q13480	GAB1	GRB2-associated-binding protein 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q13480	GAB1	GRB2-associated-binding protein 1	GO:0007507; P:heart development; IEA:Ensembl
Q13480	GAB1	GRB2-associated-binding protein 1	GO:0045087; P:innate immune response; TAS:Reactome
Q13480	GAB1	GRB2-associated-binding protein 1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q13480	GAB1	GRB2-associated-binding protein 1	GO:0070102; P:interleukin-6-mediated signaling pathway; IEA:Ensembl
Q13480	GAB1	GRB2-associated-binding protein 1	GO:0060711; P:labyrinthine layer development; IEA:Ensembl
Q13480	GAB1	GRB2-associated-binding protein 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q13480	GAB1	GRB2-associated-binding protein 1	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q13480	GAB1	GRB2-associated-binding protein 1	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IEA:Ensembl
Q13480	GAB1	GRB2-associated-binding protein 1	GO:0030334; P:regulation of cell migration; IEA:Ensembl
Q13480	GAB1	GRB2-associated-binding protein 1	GO:0006979; P:response to oxidative stress; IEA:Ensembl
Q9UQC2	GAB2	GRB2-associated-binding protein 2	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; ISS:UniProtKB
Q9UQC2	GAB2	GRB2-associated-binding protein 2	GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; ISS:UniProtKB
Q9UQC2	GAB2	GRB2-associated-binding protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UQC2	GAB2	GRB2-associated-binding protein 2	GO:0005068; F:transmembrane receptor protein tyrosine kinase adaptor activity; IDA:UniProtKB
Q9UQC2	GAB2	GRB2-associated-binding protein 2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9UQC2	GAB2	GRB2-associated-binding protein 2	GO:0045087; P:innate immune response; TAS:Reactome
Q9UQC2	GAB2	GRB2-associated-binding protein 2	GO:0030316; P:osteoclast differentiation; IMP:UniProtKB
Q9UQC2	GAB2	GRB2-associated-binding protein 2	GO:0048015; P:phosphatidylinositol-mediated signaling; ISS:UniProtKB
Q9UQC2	GAB2	GRB2-associated-binding protein 2	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q9UQC2	GAB2	GRB2-associated-binding protein 2	GO:0043306; P:positive regulation of mast cell degranulation; ISS:UniProtKB
Q9UQC2	GAB2	GRB2-associated-binding protein 2	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IDA:GOC
Q8WWW8	GAB3	GRB2-associated-binding protein 3	GO:0030225; P:macrophage differentiation; IEA:Ensembl
Q2WGN9	GAB4	GRB2-associated-binding protein 4	GO:0016477; P:cell migration; IEA:Ensembl
Q2WGN9	GAB4	GRB2-associated-binding protein 4	GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl
Q06547	GABPB1	GA-binding protein subunit beta-1	GO:0005515; F:protein binding; IPI:IntAct
Q06547	GABPB1	GA-binding protein subunit beta-1	GO:0046982; F:protein heterodimerization activity; IDA:MGI
Q06547	GABPB1	GA-binding protein subunit beta-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q06547	GABPB1	GA-binding protein subunit beta-1	GO:0044212; F:transcription regulatory region DNA binding; IDA:MGI
Q06547	GABPB1	GA-binding protein subunit beta-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q06547	GABPB1	GA-binding protein subunit beta-1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q06547	GABPB1	GA-binding protein subunit beta-1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TAK5	GABPB2	GA-binding protein subunit beta-2	GO:0046982; F:protein heterodimerization activity; IDA:MGI
Q8TAK5	GABPB2	GA-binding protein subunit beta-2	GO:0044212; F:transcription regulatory region DNA binding; IDA:MGI
Q8TAK5	GABPB2	GA-binding protein subunit beta-2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q8TAK5	GABPB2	GA-binding protein subunit beta-2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q06546	GABPA	GA-binding protein alpha chain	GO:0003682; F:chromatin binding; IEA:Ensembl
Q06546	GABPA	GA-binding protein alpha chain	GO:0003677; F:DNA binding; TAS:ProtInc
Q06546	GABPA	GA-binding protein alpha chain	GO:0005515; F:protein binding; IPI:IntAct
Q06546	GABPA	GA-binding protein alpha chain	GO:0046982; F:protein heterodimerization activity; IDA:MGI
Q06546	GABPA	GA-binding protein alpha chain	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:BHF-UCL
Q06546	GABPA	GA-binding protein alpha chain	GO:0001228; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:BHF-UCL
Q06546	GABPA	GA-binding protein alpha chain	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q06546	GABPA	GA-binding protein alpha chain	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q06546	GABPA	GA-binding protein alpha chain	GO:0044212; F:transcription regulatory region DNA binding; IDA:MGI
Q06546	GABPA	GA-binding protein alpha chain	GO:0030154; P:cell differentiation; IBA:RefGenome
Q06546	GABPA	GA-binding protein alpha chain	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q06546	GABPA	GA-binding protein alpha chain	GO:0045653; P:negative regulation of megakaryocyte differentiation; IEA:Ensembl
Q06546	GABPA	GA-binding protein alpha chain	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q06546	GABPA	GA-binding protein alpha chain	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q06546	GABPA	GA-binding protein alpha chain	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9UBS5	GABBR1	Gamma-aminobutyric acid type B receptor subunit 1	GO:0004965; F:G-protein coupled GABA receptor activity; IDA:UniProtKB
Q9UBS5	GABBR1	Gamma-aminobutyric acid type B receptor subunit 1	GO:0005515; F:protein binding; IPI:IntAct
Q9UBS5	GABBR1	Gamma-aminobutyric acid type B receptor subunit 1	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IDA:UniProtKB
Q9UBS5	GABBR1	Gamma-aminobutyric acid type B receptor subunit 1	GO:0007214; P:gamma-aminobutyric acid signaling pathway; IDA:UniProtKB
Q9UBS5	GABBR1	Gamma-aminobutyric acid type B receptor subunit 1	GO:0007194; P:negative regulation of adenylate cyclase activity; TAS:ProtInc
Q9UBS5	GABBR1	Gamma-aminobutyric acid type B receptor subunit 1	GO:0007268; P:synaptic transmission; TAS:Reactome
O75899	GABBR2	Gamma-aminobutyric acid type B receptor subunit 2	GO:0004965; F:G-protein coupled GABA receptor activity; TAS:ProtInc
O75899	GABBR2	Gamma-aminobutyric acid type B receptor subunit 2	GO:0005515; F:protein binding; IPI:IntAct
O75899	GABBR2	Gamma-aminobutyric acid type B receptor subunit 2	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
O75899	GABBR2	Gamma-aminobutyric acid type B receptor subunit 2	GO:0007214; P:gamma-aminobutyric acid signaling pathway; IDA:UniProtKB
O75899	GABBR2	Gamma-aminobutyric acid type B receptor subunit 2	GO:0007194; P:negative regulation of adenylate cyclase activity; TAS:ProtInc
O75899	GABBR2	Gamma-aminobutyric acid type B receptor subunit 2	GO:0007268; P:synaptic transmission; TAS:Reactome
P80404	ABAT	4-aminobutyrate aminotransferase, mitochondrial	GO:0047298; F:(S)-3-amino-2-methylpropionate transaminase activity; IEA:UniProtKB-EC
P80404	ABAT	4-aminobutyrate aminotransferase, mitochondrial	GO:0003867; F:4-aminobutyrate transaminase activity; TAS:Reactome
P80404	ABAT	4-aminobutyrate aminotransferase, mitochondrial	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P80404	ABAT	4-aminobutyrate aminotransferase, mitochondrial	GO:0030170; F:pyridoxal phosphate binding; IDA:UniProtKB
P80404	ABAT	4-aminobutyrate aminotransferase, mitochondrial	GO:0032145; F:succinate-semialdehyde dehydrogenase binding; ISS:UniProtKB
P80404	ABAT	4-aminobutyrate aminotransferase, mitochondrial	GO:0048148; P:behavioral response to cocaine; ISS:UniProtKB
P80404	ABAT	4-aminobutyrate aminotransferase, mitochondrial	GO:0007620; P:copulation; IEA:Ensembl
P80404	ABAT	4-aminobutyrate aminotransferase, mitochondrial	GO:0009450; P:gamma-aminobutyric acid catabolic process; NAS:UniProtKB
P80404	ABAT	4-aminobutyrate aminotransferase, mitochondrial	GO:0007626; P:locomotory behavior; IEA:Ensembl
P80404	ABAT	4-aminobutyrate aminotransferase, mitochondrial	GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl
P80404	ABAT	4-aminobutyrate aminotransferase, mitochondrial	GO:0042135; P:neurotransmitter catabolic process; NAS:UniProtKB
P80404	ABAT	4-aminobutyrate aminotransferase, mitochondrial	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
P80404	ABAT	4-aminobutyrate aminotransferase, mitochondrial	GO:0042493; P:response to drug; IEA:Ensembl
P80404	ABAT	4-aminobutyrate aminotransferase, mitochondrial	GO:0045471; P:response to ethanol; IEA:Ensembl
P80404	ABAT	4-aminobutyrate aminotransferase, mitochondrial	GO:0001666; P:response to hypoxia; IEA:Ensembl
P80404	ABAT	4-aminobutyrate aminotransferase, mitochondrial	GO:0010039; P:response to iron ion; IEA:Ensembl
P80404	ABAT	4-aminobutyrate aminotransferase, mitochondrial	GO:0035094; P:response to nicotine; IEA:Ensembl
P80404	ABAT	4-aminobutyrate aminotransferase, mitochondrial	GO:0007268; P:synaptic transmission; TAS:Reactome
Q6ZQY3	GADL1	Glutamate decarboxylase-like protein 1	GO:0004068; F:aspartate 1-decarboxylase activity; IEA:UniProtKB-EC
Q6ZQY3	GADL1	Glutamate decarboxylase-like protein 1	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q6ZQY3	GADL1	Glutamate decarboxylase-like protein 1	GO:0019752; P:carboxylic acid metabolic process; IEA:InterPro
Q13065	GAGE1	G antigen 1	GO:0006968; P:cellular defense response; TAS:ProtInc
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0016032; P:viral process; IEA:InterPro
DR   GO:0007586; P:digestion; NAS:UniProtKB
DR   GO:0003676; F:nucleic acid binding; IEA:InterPro
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0008270; F:zinc ion binding; IEA:InterPro
DR   GO:0016032; P:viral process; IEA:InterPro
DR   GO:0003676; F:nucleic acid binding; IEA:InterPro
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0008270; F:zinc ion binding; IEA:InterPro
DR   GO:0016032; P:viral process; IEA:InterPro
DR   GO:0003676; F:nucleic acid binding; IEA:InterPro
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0008270; F:zinc ion binding; IEA:InterPro
DR   GO:0016032; P:viral process; IEA:InterPro
DR   GO:0003676; F:nucleic acid binding; IEA:InterPro
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0008270; F:zinc ion binding; IEA:InterPro
DR   GO:0016032; P:viral process; IEA:InterPro
Q7LDI9	ERVK6	HERV-K_7p22.1 provirus ancestral Gag polyprotein	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q7LDI9	ERVK6	HERV-K_7p22.1 provirus ancestral Gag polyprotein	GO:0005198; F:structural molecule activity; IEA:InterPro
Q7LDI9	ERVK6	HERV-K_7p22.1 provirus ancestral Gag polyprotein	GO:0008270; F:zinc ion binding; IEA:InterPro
Q7LDI9	ERVK6	HERV-K_7p22.1 provirus ancestral Gag polyprotein	GO:0016032; P:viral process; IEA:InterPro
DR   GO:0003676; F:nucleic acid binding; IEA:InterPro
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0008270; F:zinc ion binding; IEA:InterPro
DR   GO:0016032; P:viral process; IEA:InterPro
DR   GO:0003676; F:nucleic acid binding; IEA:InterPro
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0008270; F:zinc ion binding; IEA:InterPro
DR   GO:0016032; P:viral process; IEA:InterPro
DR   GO:0003676; F:nucleic acid binding; IEA:InterPro
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0008270; F:zinc ion binding; IEA:InterPro
DR   GO:0016032; P:viral process; IEA:InterPro
DR   GO:0003676; F:nucleic acid binding; IEA:InterPro
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0008270; F:zinc ion binding; IEA:InterPro
DR   GO:0016032; P:viral process; IEA:InterPro
Q9HDB9	ERVK-5	HERV-K_3q12.3 provirus ancestral Gag polyprotein	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9HDB9	ERVK-5	HERV-K_3q12.3 provirus ancestral Gag polyprotein	GO:0005198; F:structural molecule activity; IEA:InterPro
Q9HDB9	ERVK-5	HERV-K_3q12.3 provirus ancestral Gag polyprotein	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9HDB9	ERVK-5	HERV-K_3q12.3 provirus ancestral Gag polyprotein	GO:0016032; P:viral process; IEA:InterPro
O14976	GAK	Cyclin-G-associated kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O14976	GAK	Cyclin-G-associated kinase	GO:0005515; F:protein binding; IPI:IntAct
O14976	GAK	Cyclin-G-associated kinase	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
O14976	GAK	Cyclin-G-associated kinase	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P22466	GAL	Galanin peptides	GO:0005184; F:neuropeptide hormone activity; NAS:UniProtKB
P22466	GAL	Galanin peptides	GO:0005515; F:protein binding; IPI:IntAct
P22466	GAL	Galanin peptides	GO:0019933; P:cAMP-mediated signaling; IDA:UniProt
P22466	GAL	Galanin peptides	GO:0007631; P:feeding behavior; IEA:Ensembl
P22466	GAL	Galanin peptides	GO:0006954; P:inflammatory response; IEA:Ensembl
P22466	GAL	Galanin peptides	GO:0030073; P:insulin secretion; NAS:UniProtKB
P22466	GAL	Galanin peptides	GO:0050672; P:negative regulation of lymphocyte proliferation; IEA:Ensembl
P22466	GAL	Galanin peptides	GO:1902891; P:negative regulation of root hair elongation; IDA:UniProt
P22466	GAL	Galanin peptides	GO:0007399; P:nervous system development; IEA:Ensembl
P22466	GAL	Galanin peptides	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
P22466	GAL	Galanin peptides	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P22466	GAL	Galanin peptides	GO:0051795; P:positive regulation of catagen; IDA:UniProt
P22466	GAL	Galanin peptides	GO:0051464; P:positive regulation of cortisol secretion; IDA:UniProt
P22466	GAL	Galanin peptides	GO:1902608; P:positive regulation of large conductance calcium-activated potassium channel activity; IDA:UniProt
P22466	GAL	Galanin peptides	GO:0010737; P:protein kinase A signaling; IDA:UniProt
P22466	GAL	Galanin peptides	GO:0031943; P:regulation of glucocorticoid metabolic process; IEA:Ensembl
P22466	GAL	Galanin peptides	GO:0042493; P:response to drug; IEA:Ensembl
P22466	GAL	Galanin peptides	GO:0043627; P:response to estrogen; IEA:Ensembl
P22466	GAL	Galanin peptides	GO:0032868; P:response to insulin; IEA:Ensembl
P54803	GALC	Galactocerebrosidase	GO:0004336; F:galactosylceramidase activity; ISS:UniProtKB
P54803	GALC	Galactocerebrosidase	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
P54803	GALC	Galactocerebrosidase	GO:0006683; P:galactosylceramide catabolic process; ISS:UniProtKB
P54803	GALC	Galactocerebrosidase	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
P54803	GALC	Galactocerebrosidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P54803	GALC	Galactocerebrosidase	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q14376	GALE	UDP-glucose 4-epimerase	GO:0050662; F:coenzyme binding; IEA:InterPro
Q14376	GALE	UDP-glucose 4-epimerase	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q14376	GALE	UDP-glucose 4-epimerase	GO:0003978; F:UDP-glucose 4-epimerase activity; IDA:UniProtKB
Q14376	GALE	UDP-glucose 4-epimerase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q14376	GALE	UDP-glucose 4-epimerase	GO:0044237; P:cellular metabolic process; IEA:InterPro
Q14376	GALE	UDP-glucose 4-epimerase	GO:0019388; P:galactose catabolic process; IDA:UniProtKB
Q14376	GALE	UDP-glucose 4-epimerase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P51570	GALK1	Galactokinase	GO:0005524; F:ATP binding; IDA:UniProtKB
P51570	GALK1	Galactokinase	GO:0004335; F:galactokinase activity; IDA:UniProtKB
P51570	GALK1	Galactokinase	GO:0005534; F:galactose binding; IDA:UniProtKB
P51570	GALK1	Galactokinase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P51570	GALK1	Galactokinase	GO:0019402; P:galactitol metabolic process; IEA:Ensembl
P51570	GALK1	Galactokinase	GO:0019388; P:galactose catabolic process; TAS:Reactome
P51570	GALK1	Galactokinase	GO:0006012; P:galactose metabolic process; IMP:UniProtKB
P51570	GALK1	Galactokinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q01415	GALK2	N-acetylgalactosamine kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q01415	GALK2	N-acetylgalactosamine kinase	GO:0004335; F:galactokinase activity; IDA:UniProtKB
Q01415	GALK2	N-acetylgalactosamine kinase	GO:0033858; F:N-acetylgalactosamine kinase activity; IEA:UniProtKB-EC
Q01415	GALK2	N-acetylgalactosamine kinase	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
Q01415	GALK2	N-acetylgalactosamine kinase	GO:0006012; P:galactose metabolic process; IEA:InterPro
Q96C23	GALM	Aldose 1-epimerase	GO:0004034; F:aldose 1-epimerase activity; IDA:UniProt
Q96C23	GALM	Aldose 1-epimerase	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q96C23	GALM	Aldose 1-epimerase	GO:0006012; P:galactose metabolic process; IDA:UniProt
Q96C23	GALM	Aldose 1-epimerase	GO:0006006; P:glucose metabolic process; IDA:UniProt
P34059	GALNS	N-acetylgalactosamine-6-sulfatase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P34059	GALNS	N-acetylgalactosamine-6-sulfatase	GO:0003943; F:N-acetylgalactosamine-4-sulfatase activity; TAS:ProtInc
P34059	GALNS	N-acetylgalactosamine-6-sulfatase	GO:0043890; F:N-acetylgalactosamine-6-sulfatase activity; IEA:UniProtKB-EC
P34059	GALNS	N-acetylgalactosamine-6-sulfatase	GO:0008484; F:sulfuric ester hydrolase activity; IDA:MGI
P34059	GALNS	N-acetylgalactosamine-6-sulfatase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P34059	GALNS	N-acetylgalactosamine-6-sulfatase	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P34059	GALNS	N-acetylgalactosamine-6-sulfatase	GO:0042340; P:keratan sulfate catabolic process; TAS:Reactome
P34059	GALNS	N-acetylgalactosamine-6-sulfatase	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
P34059	GALNS	N-acetylgalactosamine-6-sulfatase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UBC7	GALP	Galanin-like peptide	GO:0042595; P:behavioral response to starvation; IEA:Ensembl
Q9UBC7	GALP	Galanin-like peptide	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
Q9UBC7	GALP	Galanin-like peptide	GO:0032098; P:regulation of appetite; IEA:Ensembl
Q9UBC7	GALP	Galanin-like peptide	GO:0032868; P:response to insulin; IEA:Ensembl
P47211	GALR1	Galanin receptor type 1	GO:0004966; F:galanin receptor activity; TAS:ProtInc
P47211	GALR1	Galanin receptor type 1	GO:0042923; F:neuropeptide binding; IEA:Ensembl
P47211	GALR1	Galanin receptor type 1	GO:0005515; F:protein binding; IPI:IntAct
P47211	GALR1	Galanin receptor type 1	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P47211	GALR1	Galanin receptor type 1	GO:0007586; P:digestion; TAS:ProtInc
P47211	GALR1	Galanin receptor type 1	GO:0007194; P:negative regulation of adenylate cyclase activity; TAS:ProtInc
P47211	GALR1	Galanin receptor type 1	GO:0007218; P:neuropeptide signaling pathway; TAS:ProtInc
P47211	GALR1	Galanin receptor type 1	GO:0051464; P:positive regulation of cortisol secretion; IMP:UniProt
P47211	GALR1	Galanin receptor type 1	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:InterPro
O43603	GALR2	Galanin receptor type 2	GO:0004966; F:galanin receptor activity; TAS:ProtInc
O43603	GALR2	Galanin receptor type 2	GO:0005515; F:protein binding; IPI:IntAct
O43603	GALR2	Galanin receptor type 2	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; TAS:ProtInc
O43603	GALR2	Galanin receptor type 2	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
O43603	GALR2	Galanin receptor type 2	GO:0007586; P:digestion; TAS:ProtInc
O43603	GALR2	Galanin receptor type 2	GO:0007631; P:feeding behavior; TAS:ProtInc
O43603	GALR2	Galanin receptor type 2	GO:0007611; P:learning or memory; TAS:ProtInc
O43603	GALR2	Galanin receptor type 2	GO:0007275; P:multicellular organismal development; TAS:ProtInc
O43603	GALR2	Galanin receptor type 2	GO:0006936; P:muscle contraction; TAS:ProtInc
O43603	GALR2	Galanin receptor type 2	GO:0007194; P:negative regulation of adenylate cyclase activity; IEA:InterPro
O43603	GALR2	Galanin receptor type 2	GO:0031175; P:neuron projection development; IEA:Ensembl
O43603	GALR2	Galanin receptor type 2	GO:0007218; P:neuropeptide signaling pathway; TAS:GOC
O43603	GALR2	Galanin receptor type 2	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
O43603	GALR2	Galanin receptor type 2	GO:1902608; P:positive regulation of large conductance calcium-activated potassium channel activity; IMP:UniProt
O43603	GALR2	Galanin receptor type 2	GO:0007268; P:synaptic transmission; TAS:ProtInc
O60755	GALR3	Galanin receptor type 3	GO:0004966; F:galanin receptor activity; TAS:ProtInc
O60755	GALR3	Galanin receptor type 3	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IEA:Ensembl
O60755	GALR3	Galanin receptor type 3	GO:0007631; P:feeding behavior; TAS:ProtInc
O60755	GALR3	Galanin receptor type 3	GO:0007611; P:learning or memory; TAS:ProtInc
O60755	GALR3	Galanin receptor type 3	GO:0007194; P:negative regulation of adenylate cyclase activity; TAS:ProtInc
O60755	GALR3	Galanin receptor type 3	GO:0007218; P:neuropeptide signaling pathway; TAS:ProtInc
O60755	GALR3	Galanin receptor type 3	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q10472	GALNT1	Polypeptide N-acetylgalactosaminyltransferase 1	GO:0030145; F:manganese ion binding; IDA:BHF-UCL
Q10472	GALNT1	Polypeptide N-acetylgalactosaminyltransferase 1	GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IDA:BHF-UCL
Q10472	GALNT1	Polypeptide N-acetylgalactosaminyltransferase 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q10472	GALNT1	Polypeptide N-acetylgalactosaminyltransferase 1	GO:0016266; P:O-glycan processing; TAS:Reactome
Q10472	GALNT1	Polypeptide N-acetylgalactosaminyltransferase 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q10472	GALNT1	Polypeptide N-acetylgalactosaminyltransferase 1	GO:0006493; P:protein O-linked glycosylation; ISS:UniProtKB
Q10472	GALNT1	Polypeptide N-acetylgalactosaminyltransferase 1	GO:0018242; P:protein O-linked glycosylation via serine; IDA:BHF-UCL
Q10472	GALNT1	Polypeptide N-acetylgalactosaminyltransferase 1	GO:0018243; P:protein O-linked glycosylation via threonine; IDA:BHF-UCL
Q10471	GALNT2	Polypeptide N-acetylgalactosaminyltransferase 2	GO:0030145; F:manganese ion binding; IDA:UniProtKB
Q10471	GALNT2	Polypeptide N-acetylgalactosaminyltransferase 2	GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IDA:UniProtKB
Q10471	GALNT2	Polypeptide N-acetylgalactosaminyltransferase 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q10471	GALNT2	Polypeptide N-acetylgalactosaminyltransferase 2	GO:0002378; P:immunoglobulin biosynthetic process; IDA:BHF-UCL
Q10471	GALNT2	Polypeptide N-acetylgalactosaminyltransferase 2	GO:0016266; P:O-glycan processing; TAS:Reactome
Q10471	GALNT2	Polypeptide N-acetylgalactosaminyltransferase 2	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q10471	GALNT2	Polypeptide N-acetylgalactosaminyltransferase 2	GO:0006493; P:protein O-linked glycosylation; IDA:UniProtKB
Q10471	GALNT2	Polypeptide N-acetylgalactosaminyltransferase 2	GO:0018242; P:protein O-linked glycosylation via serine; IDA:BHF-UCL
Q10471	GALNT2	Polypeptide N-acetylgalactosaminyltransferase 2	GO:0018243; P:protein O-linked glycosylation via threonine; IDA:BHF-UCL
Q14435	GALNT3	Polypeptide N-acetylgalactosaminyltransferase 3	GO:0005509; F:calcium ion binding; IDA:BHF-UCL
Q14435	GALNT3	Polypeptide N-acetylgalactosaminyltransferase 3	GO:0030145; F:manganese ion binding; IDA:BHF-UCL
Q14435	GALNT3	Polypeptide N-acetylgalactosaminyltransferase 3	GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IDA:BHF-UCL
Q14435	GALNT3	Polypeptide N-acetylgalactosaminyltransferase 3	GO:0005975; P:carbohydrate metabolic process; NAS:ProtInc
Q14435	GALNT3	Polypeptide N-acetylgalactosaminyltransferase 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q14435	GALNT3	Polypeptide N-acetylgalactosaminyltransferase 3	GO:0016266; P:O-glycan processing; TAS:Reactome
Q14435	GALNT3	Polypeptide N-acetylgalactosaminyltransferase 3	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q14435	GALNT3	Polypeptide N-acetylgalactosaminyltransferase 3	GO:0018242; P:protein O-linked glycosylation via serine; IDA:BHF-UCL
Q14435	GALNT3	Polypeptide N-acetylgalactosaminyltransferase 3	GO:0018243; P:protein O-linked glycosylation via threonine; IDA:UniProtKB
Q8N4A0	GALNT4	Polypeptide N-acetylgalactosaminyltransferase 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N4A0	GALNT4	Polypeptide N-acetylgalactosaminyltransferase 4	GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; TAS:ProtInc
Q8N4A0	GALNT4	Polypeptide N-acetylgalactosaminyltransferase 4	GO:0005975; P:carbohydrate metabolic process; NAS:ProtInc
Q8N4A0	GALNT4	Polypeptide N-acetylgalactosaminyltransferase 4	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8N4A0	GALNT4	Polypeptide N-acetylgalactosaminyltransferase 4	GO:0016266; P:O-glycan processing; TAS:Reactome
Q8N4A0	GALNT4	Polypeptide N-acetylgalactosaminyltransferase 4	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q7Z7M9	GALNT5	Polypeptide N-acetylgalactosaminyltransferase 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z7M9	GALNT5	Polypeptide N-acetylgalactosaminyltransferase 5	GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IDA:UniProtKB
Q7Z7M9	GALNT5	Polypeptide N-acetylgalactosaminyltransferase 5	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q7Z7M9	GALNT5	Polypeptide N-acetylgalactosaminyltransferase 5	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:UniProtKB
Q7Z7M9	GALNT5	Polypeptide N-acetylgalactosaminyltransferase 5	GO:0016266; P:O-glycan processing; TAS:Reactome
Q7Z7M9	GALNT5	Polypeptide N-acetylgalactosaminyltransferase 5	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q8NCL4	GALNT6	Polypeptide N-acetylgalactosaminyltransferase 6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NCL4	GALNT6	Polypeptide N-acetylgalactosaminyltransferase 6	GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; TAS:ProtInc
Q8NCL4	GALNT6	Polypeptide N-acetylgalactosaminyltransferase 6	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8NCL4	GALNT6	Polypeptide N-acetylgalactosaminyltransferase 6	GO:0016266; P:O-glycan processing; TAS:Reactome
Q8NCL4	GALNT6	Polypeptide N-acetylgalactosaminyltransferase 6	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q8NCL4	GALNT6	Polypeptide N-acetylgalactosaminyltransferase 6	GO:0006493; P:protein O-linked glycosylation; TAS:ProtInc
Q86SF2	GALNT7	N-acetylgalactosaminyltransferase 7	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86SF2	GALNT7	N-acetylgalactosaminyltransferase 7	GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; TAS:ProtInc
Q86SF2	GALNT7	N-acetylgalactosaminyltransferase 7	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
Q86SF2	GALNT7	N-acetylgalactosaminyltransferase 7	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q86SF2	GALNT7	N-acetylgalactosaminyltransferase 7	GO:0016266; P:O-glycan processing; TAS:Reactome
Q86SF2	GALNT7	N-acetylgalactosaminyltransferase 7	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q86SF2	GALNT7	N-acetylgalactosaminyltransferase 7	GO:0006493; P:protein O-linked glycosylation; TAS:ProtInc
Q9NY28	GALNT8	Probable polypeptide N-acetylgalactosaminyltransferase 8	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NY28	GALNT8	Probable polypeptide N-acetylgalactosaminyltransferase 8	GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; TAS:ProtInc
Q9NY28	GALNT8	Probable polypeptide N-acetylgalactosaminyltransferase 8	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9NY28	GALNT8	Probable polypeptide N-acetylgalactosaminyltransferase 8	GO:0016266; P:O-glycan processing; TAS:Reactome
Q9NY28	GALNT8	Probable polypeptide N-acetylgalactosaminyltransferase 8	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9HCQ5	GALNT9	Polypeptide N-acetylgalactosaminyltransferase 9	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HCQ5	GALNT9	Polypeptide N-acetylgalactosaminyltransferase 9	GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; NAS:UniProtKB
Q9HCQ5	GALNT9	Polypeptide N-acetylgalactosaminyltransferase 9	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9HCQ5	GALNT9	Polypeptide N-acetylgalactosaminyltransferase 9	GO:0016266; P:O-glycan processing; TAS:Reactome
Q9HCQ5	GALNT9	Polypeptide N-acetylgalactosaminyltransferase 9	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9HCQ5	GALNT9	Polypeptide N-acetylgalactosaminyltransferase 9	GO:0006493; P:protein O-linked glycosylation; NAS:UniProtKB
P07902	GALT	Galactose-1-phosphate uridylyltransferase	GO:0008108; F:UDP-glucose:hexose-1-phosphate uridylyltransferase activity; IEA:UniProtKB-EC
P07902	GALT	Galactose-1-phosphate uridylyltransferase	GO:0008270; F:zinc ion binding; IEA:InterPro
P07902	GALT	Galactose-1-phosphate uridylyltransferase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P07902	GALT	Galactose-1-phosphate uridylyltransferase	GO:0019388; P:galactose catabolic process; TAS:Reactome
P07902	GALT	Galactose-1-phosphate uridylyltransferase	GO:0006012; P:galactose metabolic process; TAS:ProtInc
P07902	GALT	Galactose-1-phosphate uridylyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P07902	GALT	Galactose-1-phosphate uridylyltransferase	GO:0006258; P:UDP-glucose catabolic process; IEA:Ensembl
Q14353	GAMT	Guanidinoacetate N-methyltransferase	GO:0030731; F:guanidinoacetate N-methyltransferase activity; IMP:UniProtKB
Q14353	GAMT	Guanidinoacetate N-methyltransferase	GO:0008168; F:methyltransferase activity; TAS:ProtInc
Q14353	GAMT	Guanidinoacetate N-methyltransferase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q14353	GAMT	Guanidinoacetate N-methyltransferase	GO:0006601; P:creatine biosynthetic process; IDA:UniProtKB
Q14353	GAMT	Guanidinoacetate N-methyltransferase	GO:0006600; P:creatine metabolic process; TAS:Reactome
Q14353	GAMT	Guanidinoacetate N-methyltransferase	GO:0006936; P:muscle contraction; TAS:ProtInc
Q14353	GAMT	Guanidinoacetate N-methyltransferase	GO:0009887; P:organ morphogenesis; IEA:Ensembl
Q14353	GAMT	Guanidinoacetate N-methyltransferase	GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl
Q14353	GAMT	Guanidinoacetate N-methyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14353	GAMT	Guanidinoacetate N-methyltransferase	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q14697	GANAB	Neutral alpha-glucosidase AB	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q14697	GANAB	Neutral alpha-glucosidase AB	GO:0033919; F:glucan 1,3-alpha-glucosidase activity; IEA:UniProtKB-EC
Q14697	GANAB	Neutral alpha-glucosidase AB	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14697	GANAB	Neutral alpha-glucosidase AB	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q14697	GANAB	Neutral alpha-glucosidase AB	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q14697	GANAB	Neutral alpha-glucosidase AB	GO:0006457; P:protein folding; TAS:Reactome
Q14697	GANAB	Neutral alpha-glucosidase AB	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q8TET4	GANC	Neutral alpha-glucosidase C	GO:0004558; F:alpha-glucosidase activity; NAS:UniProtKB
Q8TET4	GANC	Neutral alpha-glucosidase C	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q8TET4	GANC	Neutral alpha-glucosidase C	GO:0032450; F:maltose alpha-glucosidase activity; IEA:UniProtKB-EC
Q8TET4	GANC	Neutral alpha-glucosidase C	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
O60318	MCM3AP	Germinal-center associated nuclear protein	GO:0003677; F:DNA binding; TAS:ProtInc
O60318	MCM3AP	Germinal-center associated nuclear protein	GO:0016746; F:transferase activity, transferring acyl groups; IEA:UniProtKB-KW
O60318	MCM3AP	Germinal-center associated nuclear protein	GO:0006260; P:DNA replication; TAS:ProtInc
O60318	MCM3AP	Germinal-center associated nuclear protein	GO:0002376; P:immune system process; IEA:UniProtKB-KW
O60318	MCM3AP	Germinal-center associated nuclear protein	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
O60318	MCM3AP	Germinal-center associated nuclear protein	GO:0006606; P:protein import into nucleus; TAS:ProtInc
Q9H2C0	GAN	Gigaxonin	GO:0005515; F:protein binding; IPI:IntAct
Q9H2C0	GAN	Gigaxonin	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9H2C0	GAN	Gigaxonin	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q14C86	GAPVD1	GTPase-activating protein and VPS9 domain-containing protein 1	GO:0032794; F:GTPase activating protein binding; IMP:UniProtKB
Q14C86	GAPVD1	GTPase-activating protein and VPS9 domain-containing protein 1	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q14C86	GAPVD1	GTPase-activating protein and VPS9 domain-containing protein 1	GO:0005085; F:guanyl-nucleotide exchange factor activity; IMP:UniProtKB
Q14C86	GAPVD1	GTPase-activating protein and VPS9 domain-containing protein 1	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q14C86	GAPVD1	GTPase-activating protein and VPS9 domain-containing protein 1	GO:0043087; P:regulation of GTPase activity; IMP:GOC
Q14C86	GAPVD1	GTPase-activating protein and VPS9 domain-containing protein 1	GO:0051223; P:regulation of protein transport; IMP:UniProtKB
Q14C86	GAPVD1	GTPase-activating protein and VPS9 domain-containing protein 1	GO:0051056; P:regulation of small GTPase mediated signal transduction; IEA:InterPro
Q14C86	GAPVD1	GTPase-activating protein and VPS9 domain-containing protein 1	GO:0007165; P:signal transduction; IEA:InterPro
Q9H4G4	GLIPR2	Golgi-associated plant pathogenesis-related protein 1	GO:0042803; F:protein homodimerization activity; IDA:UniProt
Q9H4G4	GLIPR2	Golgi-associated plant pathogenesis-related protein 1	GO:0010634; P:positive regulation of epithelial cell migration; IDA:UniProt
Q9H4G4	GLIPR2	Golgi-associated plant pathogenesis-related protein 1	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IDA:UniProt
Q9H4G4	GLIPR2	Golgi-associated plant pathogenesis-related protein 1	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProt
Q8N292	GAPT	Protein GAPT	GO:0042113; P:B cell activation; IEA:UniProtKB-KW
Q9NY12	GAR1	H/ACA ribonucleoprotein complex subunit 1	GO:0005261; F:cation channel activity; TAS:ProtInc
Q9NY12	GAR1	H/ACA ribonucleoprotein complex subunit 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NY12	GAR1	H/ACA ribonucleoprotein complex subunit 1	GO:0006812; P:cation transport; TAS:GOC
Q9NY12	GAR1	H/ACA ribonucleoprotein complex subunit 1	GO:0001522; P:pseudouridine synthesis; IEA:InterPro
Q9NY12	GAR1	H/ACA ribonucleoprotein complex subunit 1	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q9H706	GAREM	GRB2-associated and regulator of MAPK protein	GO:0070064; F:proline-rich region binding; IDA:UniProtKB
Q9H706	GAREM	GRB2-associated and regulator of MAPK protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H706	GAREM	GRB2-associated and regulator of MAPK protein	GO:0071364; P:cellular response to epidermal growth factor stimulus; IDA:UniProtKB
Q9H706	GAREM	GRB2-associated and regulator of MAPK protein	GO:0007173; P:epidermal growth factor receptor signaling pathway; IDA:UniProtKB
Q9H706	GAREM	GRB2-associated and regulator of MAPK protein	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
Q9H706	GAREM	GRB2-associated and regulator of MAPK protein	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q9H706	GAREM	GRB2-associated and regulator of MAPK protein	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB
Q5VVW2	GARNL3	GTPase-activating Rap/Ran-GAP domain-like protein 3	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q5VVW2	GARNL3	GTPase-activating Rap/Ran-GAP domain-like protein 3	GO:0005083; F:small GTPase regulator activity; IEA:InterPro
Q5VVW2	GARNL3	GTPase-activating Rap/Ran-GAP domain-like protein 3	GO:0051056; P:regulation of small GTPase mediated signal transduction; IEA:InterPro
P54826	GAS1	Growth arrest-specific protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P54826	GAS1	Growth arrest-specific protein 1	GO:0007411; P:axon guidance; IEA:Ensembl
P54826	GAS1	Growth arrest-specific protein 1	GO:0043010; P:camera-type eye development; IEA:Ensembl
P54826	GAS1	Growth arrest-specific protein 1	GO:0007050; P:cell cycle arrest; IEA:UniProtKB-KW
P54826	GAS1	Growth arrest-specific protein 1	GO:0045165; P:cell fate commitment; ISS:UniProtKB
P54826	GAS1	Growth arrest-specific protein 1	GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IEP:UniProtKB
P54826	GAS1	Growth arrest-specific protein 1	GO:0021587; P:cerebellum morphogenesis; IEA:Ensembl
P54826	GAS1	Growth arrest-specific protein 1	GO:0048589; P:developmental growth; ISS:UniProtKB
P54826	GAS1	Growth arrest-specific protein 1	GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl
P54826	GAS1	Growth arrest-specific protein 1	GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl
P54826	GAS1	Growth arrest-specific protein 1	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
P54826	GAS1	Growth arrest-specific protein 1	GO:0048592; P:eye morphogenesis; IEA:Ensembl
P54826	GAS1	Growth arrest-specific protein 1	GO:0042474; P:middle ear morphogenesis; IEA:Ensembl
P54826	GAS1	Growth arrest-specific protein 1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P54826	GAS1	Growth arrest-specific protein 1	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
P54826	GAS1	Growth arrest-specific protein 1	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
P54826	GAS1	Growth arrest-specific protein 1	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P54826	GAS1	Growth arrest-specific protein 1	GO:0045930; P:negative regulation of mitotic cell cycle; IDA:UniProtKB
P54826	GAS1	Growth arrest-specific protein 1	GO:0010955; P:negative regulation of protein processing; IMP:UniProtKB
P54826	GAS1	Growth arrest-specific protein 1	GO:0045879; P:negative regulation of smoothened signaling pathway; IEA:Ensembl
P54826	GAS1	Growth arrest-specific protein 1	GO:0042476; P:odontogenesis; IEA:Ensembl
P54826	GAS1	Growth arrest-specific protein 1	GO:0042473; P:outer ear morphogenesis; IEA:Ensembl
P54826	GAS1	Growth arrest-specific protein 1	GO:0060021; P:palate development; IEA:Ensembl
P54826	GAS1	Growth arrest-specific protein 1	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
P54826	GAS1	Growth arrest-specific protein 1	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl
P54826	GAS1	Growth arrest-specific protein 1	GO:0045880; P:positive regulation of smoothened signaling pathway; IEA:Ensembl
P54826	GAS1	Growth arrest-specific protein 1	GO:0012501; P:programmed cell death; IEA:Ensembl
P54826	GAS1	Growth arrest-specific protein 1	GO:0042981; P:regulation of apoptotic process; ISS:UniProtKB
P54826	GAS1	Growth arrest-specific protein 1	GO:0060628; P:regulation of ER to Golgi vesicle-mediated transport; IMP:UniProtKB
P54826	GAS1	Growth arrest-specific protein 1	GO:0008589; P:regulation of smoothened signaling pathway; ISS:UniProtKB
O43903	GAS2	Growth arrest-specific protein 2	GO:0006915; P:apoptotic process; TAS:Reactome
O43903	GAS2	Growth arrest-specific protein 2	GO:0007050; P:cell cycle arrest; IEA:UniProtKB-KW
O43903	GAS2	Growth arrest-specific protein 2	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
O43903	GAS2	Growth arrest-specific protein 2	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
Q14393	GAS6	Growth arrest-specific protein 6	GO:0060090; F:binding, bridging; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0005509; F:calcium ion binding; IEA:InterPro
Q14393	GAS6	Growth arrest-specific protein 6	GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0001786; F:phosphatidylserine binding; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0030296; F:protein tyrosine kinase activator activity; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0048018; F:receptor agonist activity; IDA:MGI
Q14393	GAS6	Growth arrest-specific protein 6	GO:0005102; F:receptor binding; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0030971; F:receptor tyrosine kinase binding; IPI:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0005245; F:voltage-gated calcium channel activity; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0032148; P:activation of protein kinase B activity; ISS:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0043277; P:apoptotic cell clearance; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0035754; P:B cell chemotaxis; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0007596; P:blood coagulation; TAS:Reactome
Q14393	GAS6	Growth arrest-specific protein 6	GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0007155; P:cell adhesion; TAS:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0007050; P:cell cycle arrest; TAS:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0016477; P:cell migration; TAS:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0008283; P:cell proliferation; TAS:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0031589; P:cell-substrate adhesion; IEA:Ensembl
Q14393	GAS6	Growth arrest-specific protein 6	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q14393	GAS6	Growth arrest-specific protein 6	GO:0035690; P:cellular response to drug; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0071333; P:cellular response to glucose stimulus; ISS:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
Q14393	GAS6	Growth arrest-specific protein 6	GO:0035457; P:cellular response to interferon-alpha; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0009267; P:cellular response to starvation; IEA:Ensembl
Q14393	GAS6	Growth arrest-specific protein 6	GO:0071307; P:cellular response to vitamin K; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0097028; P:dendritic cell differentiation; IEP:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0007167; P:enzyme linked receptor protein signaling pathway; IEA:Ensembl
Q14393	GAS6	Growth arrest-specific protein 6	GO:0085029; P:extracellular matrix assembly; ISS:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0019064; P:fusion of virus membrane with host plasma membrane; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0097241; P:hematopoietic stem cell migration to bone marrow; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0050900; P:leukocyte migration; TAS:Reactome
Q14393	GAS6	Growth arrest-specific protein 6	GO:0010934; P:macrophage cytokine production; IEA:Ensembl
Q14393	GAS6	Growth arrest-specific protein 6	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0070168; P:negative regulation of biomineral tissue development; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:2000669; P:negative regulation of dendritic cell apoptotic process; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:2000352; P:negative regulation of endothelial cell apoptotic process; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:2000270; P:negative regulation of fibroblast apoptotic process; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0032689; P:negative regulation of interferon-gamma production; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0050711; P:negative regulation of interleukin-1 secretion; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0032715; P:negative regulation of interleukin-6 production; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:1900165; P:negative regulation of interleukin-6 secretion; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:1900142; P:negative regulation of oligodendrocyte apoptotic process; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0033159; P:negative regulation of protein import into nucleus, translocation; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:2000533; P:negative regulation of renal albumin absorption; ISS:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0032720; P:negative regulation of tumor necrosis factor production; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0001764; P:neuron migration; IEA:Ensembl
Q14393	GAS6	Growth arrest-specific protein 6	GO:0031100; P:organ regeneration; IEA:Ensembl
Q14393	GAS6	Growth arrest-specific protein 6	GO:0017187; P:peptidyl-glutamic acid carboxylation; TAS:Reactome
Q14393	GAS6	Growth arrest-specific protein 6	GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0006909; P:phagocytosis; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0030168; P:platelet activation; TAS:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0070527; P:platelet aggregation; TAS:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0002576; P:platelet degranulation; TAS:Reactome
Q14393	GAS6	Growth arrest-specific protein 6	GO:0001961; P:positive regulation of cytokine-mediated signaling pathway; IMP:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:2000510; P:positive regulation of dendritic cell chemotaxis; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:MGI
Q14393	GAS6	Growth arrest-specific protein 6	GO:0048146; P:positive regulation of fibroblast proliferation; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0003104; P:positive regulation of glomerular filtration; ISS:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0032825; P:positive regulation of natural killer cell differentiation; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0050766; P:positive regulation of phagocytosis; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0046827; P:positive regulation of protein export from nucleus; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0045860; P:positive regulation of protein kinase activity; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0061098; P:positive regulation of protein tyrosine kinase activity; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0032008; P:positive regulation of TOR signaling; ISS:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q14393	GAS6	Growth arrest-specific protein 6	GO:0043491; P:protein kinase B signaling; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0072661; P:protein targeting to plasma membrane; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0006508; P:proteolysis; TAS:Reactome
Q14393	GAS6	Growth arrest-specific protein 6	GO:0046813; P:receptor-mediated virion attachment to host cell; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q14393	GAS6	Growth arrest-specific protein 6	GO:0007165; P:signal transduction; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0046718; P:viral entry into host cell; IDA:UniProtKB
Q14393	GAS6	Growth arrest-specific protein 6	GO:0019079; P:viral genome replication; IDA:UniProtKB
O60861	GAS7	Growth arrest-specific protein 7	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O60861	GAS7	Growth arrest-specific protein 7	GO:0051017; P:actin filament bundle assembly; IEA:Ensembl
O60861	GAS7	Growth arrest-specific protein 7	GO:0030041; P:actin filament polymerization; IEA:Ensembl
O60861	GAS7	Growth arrest-specific protein 7	GO:0007050; P:cell cycle arrest; TAS:ProtInc
O60861	GAS7	Growth arrest-specific protein 7	GO:0048812; P:neuron projection morphogenesis; IEA:Ensembl
O60861	GAS7	Growth arrest-specific protein 7	GO:0008360; P:regulation of cell shape; IEA:Ensembl
O60861	GAS7	Growth arrest-specific protein 7	GO:0006355; P:regulation of transcription, DNA-templated; TAS:GOC
O95995	GAS8	Growth arrest-specific protein 8	GO:0048870; P:cell motility; IEA:InterPro
O95995	GAS8	Growth arrest-specific protein 8	GO:0034613; P:cellular protein localization; IEA:Ensembl
O95995	GAS8	Growth arrest-specific protein 8	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
O95995	GAS8	Growth arrest-specific protein 8	GO:0030317; P:sperm motility; IEA:Ensembl
Q5JY77	GPRASP1	G-protein coupled receptor-associated sorting protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q5JY77	GPRASP1	G-protein coupled receptor-associated sorting protein 1	GO:0008333; P:endosome to lysosome transport; IMP:UniProtKB
Q5JY77	GPRASP1	G-protein coupled receptor-associated sorting protein 1	GO:1990172; P:G-protein coupled receptor catabolic process; IMP:UniProtKB
Q96D09	GPRASP2	G-protein coupled receptor-associated sorting protein 2	GO:0001540; F:beta-amyloid binding; IEA:Ensembl
P32239	CCKBR	Gastrin/cholecystokinin type B receptor	GO:0046935; F:1-phosphatidylinositol-3-kinase regulator activity; TAS:ProtInc
P32239	CCKBR	Gastrin/cholecystokinin type B receptor	GO:0004951; F:cholecystokinin receptor activity; TAS:ProtInc
P32239	CCKBR	Gastrin/cholecystokinin type B receptor	GO:0015054; F:gastrin receptor activity; IDA:UniProtKB
P32239	CCKBR	Gastrin/cholecystokinin type B receptor	GO:0004435; F:phosphatidylinositol phospholipase C activity; TAS:ProtInc
P32239	CCKBR	Gastrin/cholecystokinin type B receptor	GO:0005515; F:protein binding; IPI:IntAct
P32239	CCKBR	Gastrin/cholecystokinin type B receptor	GO:0031741; F:type B gastrin/cholecystokinin receptor binding; IDA:NTNU_SB
P32239	CCKBR	Gastrin/cholecystokinin type B receptor	GO:0008283; P:cell proliferation; TAS:ProtInc
P32239	CCKBR	Gastrin/cholecystokinin type B receptor	GO:0007166; P:cell surface receptor signaling pathway; NAS:UniProtKB
P32239	CCKBR	Gastrin/cholecystokinin type B receptor	GO:0038188; P:cholecystokinin signaling pathway; TAS:GOC
P32239	CCKBR	Gastrin/cholecystokinin type B receptor	GO:0007586; P:digestion; TAS:ProtInc
P32239	CCKBR	Gastrin/cholecystokinin type B receptor	GO:0048565; P:digestive tract development; IEA:Ensembl
P32239	CCKBR	Gastrin/cholecystokinin type B receptor	GO:0007631; P:feeding behavior; TAS:ProtInc
P32239	CCKBR	Gastrin/cholecystokinin type B receptor	GO:0001696; P:gastric acid secretion; IEA:Ensembl
P32239	CCKBR	Gastrin/cholecystokinin type B receptor	GO:0048732; P:gland development; IEA:Ensembl
P32239	CCKBR	Gastrin/cholecystokinin type B receptor	GO:0008152; P:metabolic process; TAS:GOC
P32239	CCKBR	Gastrin/cholecystokinin type B receptor	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; TAS:ProtInc
P32239	CCKBR	Gastrin/cholecystokinin type B receptor	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P32239	CCKBR	Gastrin/cholecystokinin type B receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB
P32239	CCKBR	Gastrin/cholecystokinin type B receptor	GO:0043551; P:regulation of phosphatidylinositol 3-kinase activity; TAS:GOC
P32239	CCKBR	Gastrin/cholecystokinin type B receptor	GO:0007600; P:sensory perception; TAS:ProtInc
P01350	GAST	Gastrin	GO:0005179; F:hormone activity; TAS:ProtInc
P01350	GAST	Gastrin	GO:0005515; F:protein binding; IPI:IntAct
P01350	GAST	Gastrin	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:Ensembl
P01350	GAST	Gastrin	GO:0007165; P:signal transduction; NAS:ProtInc
P15976	GATA1	Erythroid transcription factor	GO:0070742; F:C2H2 zinc finger domain binding; IPI:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0031490; F:chromatin DNA binding; IDA:UniProtKB
P15976	GATA1	Erythroid transcription factor	GO:0003677; F:DNA binding; IDA:UniProtKB
P15976	GATA1	Erythroid transcription factor	GO:0008301; F:DNA binding, bending; IEA:Ensembl
P15976	GATA1	Erythroid transcription factor	GO:0001158; F:enhancer sequence-specific DNA binding; IEA:Ensembl
P15976	GATA1	Erythroid transcription factor	GO:0005515; F:protein binding; IPI:UniProtKB
P15976	GATA1	Erythroid transcription factor	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl
P15976	GATA1	Erythroid transcription factor	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IDA:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P15976	GATA1	Erythroid transcription factor	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0001085; F:RNA polymerase II transcription factor binding; IPI:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0043565; F:sequence-specific DNA binding; IMP:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IMP:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0008270; F:zinc ion binding; IEA:InterPro
P15976	GATA1	Erythroid transcription factor	GO:0030221; P:basophil differentiation; IEP:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0007596; P:blood coagulation; TAS:Reactome
P15976	GATA1	Erythroid transcription factor	GO:0007267; P:cell-cell signaling; IEA:Ensembl
P15976	GATA1	Erythroid transcription factor	GO:0097067; P:cellular response to thyroid hormone stimulus; IDA:UniProtKB
P15976	GATA1	Erythroid transcription factor	GO:0097028; P:dendritic cell differentiation; IEA:Ensembl
P15976	GATA1	Erythroid transcription factor	GO:0035162; P:embryonic hemopoiesis; IEA:Ensembl
P15976	GATA1	Erythroid transcription factor	GO:0030222; P:eosinophil differentiation; IEP:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0035854; P:eosinophil fate commitment; IDA:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0048821; P:erythrocyte development; IMP:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0030218; P:erythrocyte differentiation; IEP:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P15976	GATA1	Erythroid transcription factor	GO:0008584; P:male gonad development; IMP:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0030219; P:megakaryocyte differentiation; IMP:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P15976	GATA1	Erythroid transcription factor	GO:0030502; P:negative regulation of bone mineralization; IEA:Ensembl
P15976	GATA1	Erythroid transcription factor	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P15976	GATA1	Erythroid transcription factor	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IMP:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P15976	GATA1	Erythroid transcription factor	GO:2000678; P:negative regulation of transcription regulatory region DNA binding; IDA:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0070527; P:platelet aggregation; IMP:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0030220; P:platelet formation; IMP:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0045648; P:positive regulation of erythrocyte differentiation; IMP:UniProtKB
P15976	GATA1	Erythroid transcription factor	GO:0033690; P:positive regulation of osteoblast proliferation; IEA:Ensembl
P15976	GATA1	Erythroid transcription factor	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IMP:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0010724; P:regulation of definitive erythrocyte differentiation; IDA:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0010559; P:regulation of glycoprotein biosynthetic process; IMP:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:BHF-UCL
P15976	GATA1	Erythroid transcription factor	GO:0071733; P:transcriptional activation by promoter-enhancer looping; ISS:BHF-UCL
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0070742; F:C2H2 zinc finger domain binding; IPI:BHF-UCL
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0003682; F:chromatin binding; IDA:MGI
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0001158; F:enhancer sequence-specific DNA binding; IDA:MGI
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0005515; F:protein binding; IPI:UniProtKB
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IEA:Ensembl
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0008270; F:zinc ion binding; IEA:InterPro
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0007596; P:blood coagulation; TAS:Reactome
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0021533; P:cell differentiation in hindbrain; IEA:Ensembl
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0001709; P:cell fate determination; IEA:Ensembl
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0048469; P:cell maturation; IEA:Ensembl
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0021954; P:central nervous system neuron development; IEA:Ensembl
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0060216; P:definitive hemopoiesis; IEA:Ensembl
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0001892; P:embryonic placenta development; IEA:Ensembl
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0035854; P:eosinophil fate commitment; IDA:BHF-UCL
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0045599; P:negative regulation of fat cell differentiation; IMP:UniProtKB
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0070345; P:negative regulation of fat cell proliferation; IMP:UniProtKB
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0045650; P:negative regulation of macrophage differentiation; IEA:Ensembl
P23769	GATA2	Endothelial transcription factor GATA-2	GO:2000178; P:negative regulation of neural precursor cell proliferation; IDA:MGI
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0045746; P:negative regulation of Notch signaling pathway; IDA:MGI
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0048663; P:neuron fate commitment; IEA:Ensembl
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0006909; P:phagocytosis; IEA:UniProtKB-KW
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0021983; P:pituitary gland development; IEA:Ensembl
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0045766; P:positive regulation of angiogenesis; IDA:MGI
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0045648; P:positive regulation of erythrocyte differentiation; IEA:Ensembl
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0045654; P:positive regulation of megakaryocyte differentiation; IEA:Ensembl
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0050766; P:positive regulation of phagocytosis; ISS:UniProtKB
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0035065; P:regulation of histone acetylation; IEA:Ensembl
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0060872; P:semicircular canal development; IEA:Ensembl
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0001655; P:urogenital system development; IEA:Ensembl
P23769	GATA2	Endothelial transcription factor GATA-2	GO:0021514; P:ventral spinal cord interneuron differentiation; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0000987; F:core promoter proximal region sequence-specific DNA binding; IDA:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0001046; F:core promoter sequence-specific DNA binding; IDA:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0003677; F:DNA binding; TAS:ProtInc
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0070888; F:E-box binding; IDA:BHF-UCL
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0001158; F:enhancer sequence-specific DNA binding; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0071837; F:HMG box domain binding; IPI:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0001071; F:nucleic acid binding transcription factor activity; IDA:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0005515; F:protein binding; IPI:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IMP:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IDA:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0008270; F:zinc ion binding; IEA:InterPro
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0048646; P:anatomical structure formation involved in morphogenesis; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0003180; P:aortic valve morphogenesis; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0007411; P:axon guidance; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0007596; P:blood coagulation; TAS:Reactome
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0061290; P:canonical Wnt signaling pathway involved in metanephric kidney development; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0003215; P:cardiac right ventricle morphogenesis; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0001709; P:cell fate determination; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0048469; P:cell maturation; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0071773; P:cellular response to BMP stimulus; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0035457; P:cellular response to interferon-alpha; IEP:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0071353; P:cellular response to interleukin-4; IEP:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0071356; P:cellular response to tumor necrosis factor; IEP:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0006952; P:defense response; TAS:ProtInc
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0048589; P:developmental growth; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0043583; P:ear development; IMP:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0035162; P:embryonic hemopoiesis; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0030218; P:erythrocyte differentiation; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0006959; P:humoral immune response; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0072643; P:interferon-gamma secretion; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0072602; P:interleukin-4 secretion; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0001822; P:kidney development; IMP:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0002088; P:lens development in camera-type eye; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0072676; P:lymphocyte migration; IDA:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0008584; P:male gonad development; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0060374; P:mast cell differentiation; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0060231; P:mesenchymal to epithelial transition; IDA:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0001823; P:mesonephros development; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0045786; P:negative regulation of cell cycle; IMP:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:2000146; P:negative regulation of cell motility; IMP:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0008285; P:negative regulation of cell proliferation; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:2000607; P:negative regulation of cell proliferation involved in mesonephros development; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:2000352; P:negative regulation of endothelial cell apoptotic process; IMP:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0045599; P:negative regulation of fat cell differentiation; IMP:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:2000703; P:negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:2000734; P:negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0050728; P:negative regulation of inflammatory response; IMP:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0032689; P:negative regulation of interferon-gamma production; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0032703; P:negative regulation of interleukin-2 production; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0033600; P:negative regulation of mammary gland epithelial cell proliferation; IDA:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0072179; P:nephric duct formation; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0072178; P:nephric duct morphogenesis; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0001764; P:neuron migration; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0042421; P:norepinephrine biosynthetic process; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0071599; P:otic vesicle development; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0060017; P:parathyroid gland development; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0035898; P:parathyroid hormone secretion; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0060037; P:pharyngeal system development; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0014065; P:phosphatidylinositol 3-kinase signaling; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0010595; P:positive regulation of endothelial cell migration; IMP:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0032736; P:positive regulation of interleukin-13 production; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:2000667; P:positive regulation of interleukin-13 secretion; IDA:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0032753; P:positive regulation of interleukin-4 production; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0032754; P:positive regulation of interleukin-5 production; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:2000664; P:positive regulation of interleukin-5 secretion; IDA:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0051897; P:positive regulation of protein kinase B signaling; IMP:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0009967; P:positive regulation of signal transduction; IMP:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0045582; P:positive regulation of T cell differentiation; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:2000611; P:positive regulation of thyroid hormone generation; IMP:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:2000679; P:positive regulation of transcription regulatory region DNA binding; IMP:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0072107; P:positive regulation of ureteric bud formation; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0009791; P:post-embryonic development; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0002572; P:pro-T cell differentiation; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0043370; P:regulation of CD4-positive, alpha-beta T cell differentiation; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:2000683; P:regulation of cellular response to X-ray; IMP:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0042035; P:regulation of cytokine biosynthetic process; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:2000114; P:regulation of establishment of cell polarity; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0061085; P:regulation of histone H3-K27 methylation; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0051569; P:regulation of histone H3-K4 methylation; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0072182; P:regulation of nephron tubule epithelial cell differentiation; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0043523; P:regulation of neuron apoptotic process; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0042493; P:response to drug; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0043627; P:response to estrogen; IEP:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0045471; P:response to ethanol; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0010332; P:response to gamma radiation; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0009615; P:response to virus; IEP:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0007165; P:signal transduction; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0048485; P:sympathetic nervous system development; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0050852; P:T cell receptor signaling pathway; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0045064; P:T-helper 2 cell differentiation; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0045061; P:thymic T cell selection; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0048538; P:thymus development; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0031929; P:TOR signaling; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0001806; P:type IV hypersensitivity; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0035799; P:ureter maturation; IEA:Ensembl
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0060676; P:ureteric bud formation; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0060065; P:uterus development; ISS:UniProtKB
P23771	GATA3	Trans-acting T-cell-specific transcription factor GATA-3	GO:0003281; P:ventricular septum development; ISS:UniProtKB
P43694	GATA4	Transcription factor GATA-4	GO:0033613; F:activating transcription factor binding; ISS:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0003682; F:chromatin binding; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0070410; F:co-SMAD binding; IPI:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0003677; F:DNA binding; ISS:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0001158; F:enhancer sequence-specific DNA binding; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0005515; F:protein binding; IPI:UniProtKB
P43694	GATA4	Transcription factor GATA-4	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0001076; F:RNA polymerase II transcription factor binding transcription factor activity; IDA:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0043565; F:sequence-specific DNA binding; ISS:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
P43694	GATA4	Transcription factor GATA-4	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P43694	GATA4	Transcription factor GATA-4	GO:0008270; F:zinc ion binding; IEA:InterPro
P43694	GATA4	Transcription factor GATA-4	GO:0060413; P:atrial septum morphogenesis; IMP:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0003289; P:atrial septum primum morphogenesis; ISS:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0003290; P:atrial septum secundum morphogenesis; IMP:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0003181; P:atrioventricular valve morphogenesis; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0007596; P:blood coagulation; TAS:Reactome
P43694	GATA4	Transcription factor GATA-4	GO:0030509; P:BMP signaling pathway; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0014898; P:cardiac muscle hypertrophy in response to stress; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0003215; P:cardiac right ventricle morphogenesis; ISS:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0003208; P:cardiac ventricle morphogenesis; TAS:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0061049; P:cell growth involved in cardiac muscle cell development; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0007267; P:cell-cell signaling; ISS:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0048557; P:embryonic digestive tract morphogenesis; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0048617; P:embryonic foregut morphogenesis; ISS:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0035054; P:embryonic heart tube anterior/posterior pattern specification; ISS:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0003197; P:endocardial cushion development; IMP:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0007492; P:endoderm development; TAS:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0001706; P:endoderm formation; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0072148; P:epithelial cell fate commitment; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0001947; P:heart looping; ISS:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0060575; P:intestinal epithelial cell differentiation; IDA:MGI
P43694	GATA4	Transcription factor GATA-4	GO:0060464; P:lung lobe formation; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0008584; P:male gonad development; IMP:UniProtKB
P43694	GATA4	Transcription factor GATA-4	GO:0010507; P:negative regulation of autophagy; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0045766; P:positive regulation of angiogenesis; ISS:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0030513; P:positive regulation of BMP signaling pathway; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0060045; P:positive regulation of cardiac muscle cell proliferation; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0051891; P:positive regulation of cardioblast differentiation; ISS:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0010575; P:positive regulation vascular endothelial growth factor production; ISS:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0086004; P:regulation of cardiac muscle cell contraction; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0006355; P:regulation of transcription, DNA-templated; ISS:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0042493; P:response to drug; IMP:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0043627; P:response to estrogen; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0072520; P:seminiferous tubule development; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0060008; P:Sertoli cell differentiation; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0060395; P:SMAD protein signal transduction; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0007283; P:spermatogenesis; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0006366; P:transcription from RNA polymerase II promoter; ISS:BHF-UCL
P43694	GATA4	Transcription factor GATA-4	GO:0003229; P:ventricular cardiac muscle tissue development; IEA:Ensembl
P43694	GATA4	Transcription factor GATA-4	GO:0003281; P:ventricular septum development; ISS:BHF-UCL
Q9BWX5	GATA5	Transcription factor GATA-5	GO:0001158; F:enhancer sequence-specific DNA binding; IEA:Ensembl
Q9BWX5	GATA5	Transcription factor GATA-5	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q9BWX5	GATA5	Transcription factor GATA-5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9BWX5	GATA5	Transcription factor GATA-5	GO:0044212; F:transcription regulatory region DNA binding; IDA:MGI
Q9BWX5	GATA5	Transcription factor GATA-5	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BWX5	GATA5	Transcription factor GATA-5	GO:0007596; P:blood coagulation; TAS:Reactome
Q9BWX5	GATA5	Transcription factor GATA-5	GO:0071773; P:cellular response to BMP stimulus; IEA:Ensembl
Q9BWX5	GATA5	Transcription factor GATA-5	GO:0060575; P:intestinal epithelial cell differentiation; IDA:MGI
Q9BWX5	GATA5	Transcription factor GATA-5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q92908	GATA6	Transcription factor GATA-6	GO:0003682; F:chromatin binding; IEA:Ensembl
Q92908	GATA6	Transcription factor GATA-6	GO:0005515; F:protein binding; IPI:UniProtKB
Q92908	GATA6	Transcription factor GATA-6	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q92908	GATA6	Transcription factor GATA-6	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl
Q92908	GATA6	Transcription factor GATA-6	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q92908	GATA6	Transcription factor GATA-6	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IMP:UniProtKB
Q92908	GATA6	Transcription factor GATA-6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q92908	GATA6	Transcription factor GATA-6	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q92908	GATA6	Transcription factor GATA-6	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q92908	GATA6	Transcription factor GATA-6	GO:0008270; F:zinc ion binding; IEA:InterPro
Q92908	GATA6	Transcription factor GATA-6	GO:0007596; P:blood coagulation; TAS:Reactome
Q92908	GATA6	Transcription factor GATA-6	GO:0055007; P:cardiac muscle cell differentiation; IEA:Ensembl
Q92908	GATA6	Transcription factor GATA-6	GO:0014898; P:cardiac muscle hypertrophy in response to stress; IEA:Ensembl
Q92908	GATA6	Transcription factor GATA-6	GO:0060947; P:cardiac vascular smooth muscle cell differentiation; IMP:UniProtKB
Q92908	GATA6	Transcription factor GATA-6	GO:0071773; P:cellular response to BMP stimulus; IEA:Ensembl
Q92908	GATA6	Transcription factor GATA-6	GO:0071371; P:cellular response to gonadotropin stimulus; IEA:Ensembl
Q92908	GATA6	Transcription factor GATA-6	GO:0071456; P:cellular response to hypoxia; IDA:UniProtKB
Q92908	GATA6	Transcription factor GATA-6	GO:0060486; P:Clara cell differentiation; IEA:Ensembl
Q92908	GATA6	Transcription factor GATA-6	GO:0007493; P:endodermal cell fate determination; IEA:Ensembl
Q92908	GATA6	Transcription factor GATA-6	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q92908	GATA6	Transcription factor GATA-6	GO:0060575; P:intestinal epithelial cell differentiation; IDA:MGI
Q92908	GATA6	Transcription factor GATA-6	GO:0001889; P:liver development; IEA:Ensembl
Q92908	GATA6	Transcription factor GATA-6	GO:0060430; P:lung saccule development; IEA:Ensembl
Q92908	GATA6	Transcription factor GATA-6	GO:0008584; P:male gonad development; IEP:UniProtKB
Q92908	GATA6	Transcription factor GATA-6	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q92908	GATA6	Transcription factor GATA-6	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q92908	GATA6	Transcription factor GATA-6	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q92908	GATA6	Transcription factor GATA-6	GO:0032911; P:negative regulation of transforming growth factor beta1 production; IMP:UniProtKB
Q92908	GATA6	Transcription factor GATA-6	GO:0032912; P:negative regulation of transforming growth factor beta2 production; IMP:UniProtKB
Q92908	GATA6	Transcription factor GATA-6	GO:0048645; P:organ formation; IEA:Ensembl
Q92908	GATA6	Transcription factor GATA-6	GO:0003148; P:outflow tract septum morphogenesis; IMP:BHF-UCL
Q92908	GATA6	Transcription factor GATA-6	GO:0003310; P:pancreatic A cell differentiation; IEA:Ensembl
Q92908	GATA6	Transcription factor GATA-6	GO:0006644; P:phospholipid metabolic process; IEA:Ensembl
Q92908	GATA6	Transcription factor GATA-6	GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB
Q92908	GATA6	Transcription factor GATA-6	GO:0060045; P:positive regulation of cardiac muscle cell proliferation; IEA:Ensembl
Q92908	GATA6	Transcription factor GATA-6	GO:0051891; P:positive regulation of cardioblast differentiation; IEA:Ensembl
Q92908	GATA6	Transcription factor GATA-6	GO:0071158; P:positive regulation of cell cycle arrest; IDA:UniProtKB
Q92908	GATA6	Transcription factor GATA-6	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q92908	GATA6	Transcription factor GATA-6	GO:0042493; P:response to drug; IMP:UniProtKB
Q92908	GATA6	Transcription factor GATA-6	GO:0043627; P:response to estrogen; IEA:Ensembl
Q92908	GATA6	Transcription factor GATA-6	GO:0070848; P:response to growth factor; IDA:UniProtKB
Q92908	GATA6	Transcription factor GATA-6	GO:0051145; P:smooth muscle cell differentiation; IMP:UniProtKB
Q92908	GATA6	Transcription factor GATA-6	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q92908	GATA6	Transcription factor GATA-6	GO:0035239; P:tube morphogenesis; IEA:Ensembl
Q92908	GATA6	Transcription factor GATA-6	GO:0003309; P:type B pancreatic cell differentiation; IEA:Ensembl
Q92908	GATA6	Transcription factor GATA-6	GO:0060510; P:Type II pneumocyte differentiation; IEA:Ensembl
Q9H0R6	QRSL1	Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H0R6	QRSL1	Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial	GO:0050567; F:glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity; IDA:UniProtKB
Q9H0R6	QRSL1	Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial	GO:0070681; P:glutaminyl-tRNAGln biosynthesis via transamidation; IDA:UniProtKB
Q9H0R6	QRSL1	Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial	GO:0032543; P:mitochondrial translation; IMP:UniProtKB
O75879	PET112	Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75879	PET112	Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial	GO:0050567; F:glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity; IDA:UniProtKB
O75879	PET112	Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial	GO:0008135; F:translation factor activity, nucleic acid binding; TAS:ProtInc
O75879	PET112	Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial	GO:0070681; P:glutaminyl-tRNAGln biosynthesis via transamidation; IDA:UniProtKB
O75879	PET112	Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial	GO:0032543; P:mitochondrial translation; IMP:UniProtKB
O75879	PET112	Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial	GO:0006412; P:translation; TAS:ProtInc
O43716	GATC	Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43716	GATC	Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial	GO:0050567; F:glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity; IDA:UniProtKB
O43716	GATC	Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial	GO:0070681; P:glutaminyl-tRNAGln biosynthesis via transamidation; IDA:UniProtKB
O43716	GATC	Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial	GO:0032543; P:mitochondrial translation; IMP:UniProtKB
O43716	GATC	Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial	GO:0006450; P:regulation of translational fidelity; IEA:InterPro
Q8WUU5	GATAD1	GATA zinc finger domain-containing protein 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q8WUU5	GATAD1	GATA zinc finger domain-containing protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8WUU5	GATAD1	GATA zinc finger domain-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
P50440	GATM	Glycine amidinotransferase, mitochondrial	GO:0015068; F:glycine amidinotransferase activity; IDA:MGI
P50440	GATM	Glycine amidinotransferase, mitochondrial	GO:0016813; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines; IEA:InterPro
P50440	GATM	Glycine amidinotransferase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P50440	GATM	Glycine amidinotransferase, mitochondrial	GO:0006601; P:creatine biosynthetic process; IDA:MGI
P50440	GATM	Glycine amidinotransferase, mitochondrial	GO:0006600; P:creatine metabolic process; TAS:Reactome
P50440	GATM	Glycine amidinotransferase, mitochondrial	GO:0009790; P:embryo development; IEA:Ensembl
P50440	GATM	Glycine amidinotransferase, mitochondrial	GO:0046689; P:response to mercury ion; IEA:Ensembl
P50440	GATM	Glycine amidinotransferase, mitochondrial	GO:0007584; P:response to nutrient; IEA:Ensembl
P50440	GATM	Glycine amidinotransferase, mitochondrial	GO:0006979; P:response to oxidative stress; IEA:Ensembl
P50440	GATM	Glycine amidinotransferase, mitochondrial	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P50440	GATM	Glycine amidinotransferase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P50440	GATM	Glycine amidinotransferase, mitochondrial	GO:0042246; P:tissue regeneration; IEA:Ensembl
Q9HCG7	GBA2	Non-lysosomal glucosylceramidase	GO:0008422; F:beta-glucosidase activity; IDA:UniProtKB
Q9HCG7	GBA2	Non-lysosomal glucosylceramidase	GO:0004348; F:glucosylceramidase activity; IEA:UniProtKB-EC
Q9HCG7	GBA2	Non-lysosomal glucosylceramidase	GO:0008206; P:bile acid metabolic process; IDA:UniProtKB
Q9HCG7	GBA2	Non-lysosomal glucosylceramidase	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9HCG7	GBA2	Non-lysosomal glucosylceramidase	GO:0021954; P:central nervous system neuron development; IMP:UniProtKB
Q9HCG7	GBA2	Non-lysosomal glucosylceramidase	GO:0006680; P:glucosylceramide catabolic process; IEA:InterPro
Q9HCG7	GBA2	Non-lysosomal glucosylceramidase	GO:0016139; P:glycoside catabolic process; IDA:UniProtKB
Q9HCG7	GBA2	Non-lysosomal glucosylceramidase	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
Q9HCG7	GBA2	Non-lysosomal glucosylceramidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9HCG7	GBA2	Non-lysosomal glucosylceramidase	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q9H227	GBA3	Cytosolic beta-glucosidase	GO:0004565; F:beta-galactosidase activity; IDA:UniProtKB
Q9H227	GBA3	Cytosolic beta-glucosidase	GO:0008422; F:beta-glucosidase activity; IDA:UniProtKB
Q9H227	GBA3	Cytosolic beta-glucosidase	GO:0017042; F:glycosylceramidase activity; IDA:UniProtKB
Q9H227	GBA3	Cytosolic beta-glucosidase	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q9H227	GBA3	Cytosolic beta-glucosidase	GO:0016139; P:glycoside catabolic process; IDA:UniProtKB
Q9H227	GBA3	Cytosolic beta-glucosidase	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
Q9H227	GBA3	Cytosolic beta-glucosidase	GO:0046477; P:glycosylceramide catabolic process; IMP:UniProtKB
Q9H227	GBA3	Cytosolic beta-glucosidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H227	GBA3	Cytosolic beta-glucosidase	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0003924; F:GTPase activity; IDA:MGI
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0051020; F:GTPase binding; IPI:UniProtKB
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0005515; F:protein binding; IPI:IntAct
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0032403; F:protein complex binding; IDA:MGI
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0007191; P:adenylate cyclase-activating dopamine receptor signaling pathway; ISS:BHF-UCL
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0007596; P:blood coagulation; TAS:Reactome
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0010659; P:cardiac muscle cell apoptotic process; IEA:Ensembl
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0008283; P:cell proliferation; IEA:Ensembl
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0071870; P:cellular response to catecholamine stimulus; ISS:BHF-UCL
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0071380; P:cellular response to prostaglandin E stimulus; ISS:BHF-UCL
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0007213; P:G-protein coupled acetylcholine receptor signaling pathway; TAS:ProtInc
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0006184; P:GTP catabolic process; IDA:GOC
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0030168; P:platelet activation; TAS:Reactome
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0007265; P:Ras protein signal transduction; TAS:ProtInc
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0050909; P:sensory perception of taste; IEA:Ensembl
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0007165; P:signal transduction; TAS:ProtInc
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P62873	GNB1	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1	GO:0007268; P:synaptic transmission; TAS:Reactome
P62879	GNB2	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2	GO:0005246; F:calcium channel regulator activity; IEA:Ensembl
P62879	GNB2	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2	GO:0003924; F:GTPase activity; TAS:ProtInc
P62879	GNB2	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2	GO:0051020; F:GTPase binding; IPI:UniProtKB
P62879	GNB2	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2	GO:0005515; F:protein binding; IPI:UniProtKB
P62879	GNB2	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2	GO:0032403; F:protein complex binding; IDA:MGI
P62879	GNB2	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
P62879	GNB2	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
P62879	GNB2	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P62879	GNB2	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P62879	GNB2	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2	GO:0006184; P:GTP catabolic process; TAS:GOC
P62879	GNB2	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P62879	GNB2	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2	GO:0007268; P:synaptic transmission; TAS:Reactome
P16520	GNB3	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3	GO:0003924; F:GTPase activity; TAS:ProtInc
P16520	GNB3	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3	GO:0051020; F:GTPase binding; IPI:UniProtKB
P16520	GNB3	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3	GO:0005515; F:protein binding; IPI:IntAct
P16520	GNB3	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
P16520	GNB3	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
P16520	GNB3	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P16520	GNB3	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P16520	GNB3	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3	GO:0006184; P:GTP catabolic process; TAS:GOC
P16520	GNB3	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3	GO:0008217; P:regulation of blood pressure; TAS:ProtInc
P16520	GNB3	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P16520	GNB3	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9HAV0	GNB4	Guanine nucleotide-binding protein subunit beta-4	GO:0032403; F:protein complex binding; IDA:MGI
Q9HAV0	GNB4	Guanine nucleotide-binding protein subunit beta-4	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
Q9HAV0	GNB4	Guanine nucleotide-binding protein subunit beta-4	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9HAV0	GNB4	Guanine nucleotide-binding protein subunit beta-4	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
Q9HAV0	GNB4	Guanine nucleotide-binding protein subunit beta-4	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q9HAV0	GNB4	Guanine nucleotide-binding protein subunit beta-4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9HAV0	GNB4	Guanine nucleotide-binding protein subunit beta-4	GO:0021762; P:substantia nigra development; IEP:UniProt
O14775	GNB5	Guanine nucleotide-binding protein subunit beta-5	GO:0051087; F:chaperone binding; IPI:UniProt
O14775	GNB5	Guanine nucleotide-binding protein subunit beta-5	GO:0031682; F:G-protein gamma-subunit binding; IPI:UniProt
O14775	GNB5	Guanine nucleotide-binding protein subunit beta-5	GO:0003924; F:GTPase activity; NAS:UniProtKB
O14775	GNB5	Guanine nucleotide-binding protein subunit beta-5	GO:0005515; F:protein binding; IPI:UniProt
O14775	GNB5	Guanine nucleotide-binding protein subunit beta-5	GO:0004871; F:signal transducer activity; NAS:UniProtKB
O14775	GNB5	Guanine nucleotide-binding protein subunit beta-5	GO:0006184; P:GTP catabolic process; NAS:GOC
O14775	GNB5	Guanine nucleotide-binding protein subunit beta-5	GO:1901386; P:negative regulation of voltage-gated calcium channel activity; IDA:UniProt
O14775	GNB5	Guanine nucleotide-binding protein subunit beta-5	GO:0007603; P:phototransduction, visible light; TAS:Reactome
O14775	GNB5	Guanine nucleotide-binding protein subunit beta-5	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
O14775	GNB5	Guanine nucleotide-binding protein subunit beta-5	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
O14775	GNB5	Guanine nucleotide-binding protein subunit beta-5	GO:0007165; P:signal transduction; NAS:UniProtKB
Q92538	GBF1	Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1	GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; IBA:RefGenome
Q92538	GBF1	Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1	GO:0005515; F:protein binding; IPI:IntAct
Q92538	GBF1	Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1	GO:0048205; P:COPI coating of Golgi vesicle; TAS:Reactome
Q92538	GBF1	Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1	GO:0061024; P:membrane organization; TAS:Reactome
Q92538	GBF1	Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
Q92538	GBF1	Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1	GO:0032012; P:regulation of ARF protein signal transduction; IEA:InterPro
Q92538	GBF1	Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1	GO:0043087; P:regulation of GTPase activity; IBA:GOC
Q92538	GBF1	Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; TAS:Reactome
Q92538	GBF1	Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1	GO:0016192; P:vesicle-mediated transport; IBA:RefGenome
Q92538	GBF1	Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
P50151	GNG10	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10	GO:0003924; F:GTPase activity; TAS:ProtInc
P50151	GNG10	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
P50151	GNG10	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
P50151	GNG10	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P50151	GNG10	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:InterPro
P50151	GNG10	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10	GO:0006184; P:GTP catabolic process; TAS:GOC
P50151	GNG10	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10	GO:0007165; P:signal transduction; TAS:ProtInc
P50151	GNG10	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P50151	GNG10	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10	GO:0007268; P:synaptic transmission; TAS:Reactome
P61952	GNG11	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11	GO:0003924; F:GTPase activity; TAS:ProtInc
P61952	GNG11	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
P61952	GNG11	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
P61952	GNG11	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P61952	GNG11	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:InterPro
P61952	GNG11	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11	GO:0006184; P:GTP catabolic process; TAS:GOC
P61952	GNG11	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11	GO:0007165; P:signal transduction; TAS:ProtInc
P61952	GNG11	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UBI6	GNG12	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12	GO:0030165; F:PDZ domain binding; IDA:MGI
Q9UBI6	GNG12	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12	GO:0042301; F:phosphate ion binding; IEA:Ensembl
Q9UBI6	GNG12	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
Q9UBI6	GNG12	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
Q9UBI6	GNG12	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12	GO:0021987; P:cerebral cortex development; IEA:Ensembl
Q9UBI6	GNG12	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q9UBI6	GNG12	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:InterPro
Q9UBI6	GNG12	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
Q9UBI6	GNG12	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UBI6	GNG12	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UBI6	GNG12	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9P2W3	GNG13	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13	GO:0031681; F:G-protein beta-subunit binding; IPI:UniProt
Q9P2W3	GNG13	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
Q9P2W3	GNG13	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
Q9P2W3	GNG13	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q9P2W3	GNG13	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
Q9P2W3	GNG13	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13	GO:0050909; P:sensory perception of taste; IEA:Ensembl
Q9P2W3	GNG13	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P63211	GNGT1	Guanine nucleotide-binding protein G(T) subunit gamma-T1	GO:0003924; F:GTPase activity; TAS:ProtInc
P63211	GNGT1	Guanine nucleotide-binding protein G(T) subunit gamma-T1	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
P63211	GNGT1	Guanine nucleotide-binding protein G(T) subunit gamma-T1	GO:0010659; P:cardiac muscle cell apoptotic process; IEA:Ensembl
P63211	GNGT1	Guanine nucleotide-binding protein G(T) subunit gamma-T1	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
P63211	GNGT1	Guanine nucleotide-binding protein G(T) subunit gamma-T1	GO:0042462; P:eye photoreceptor cell development; IEA:Ensembl
P63211	GNGT1	Guanine nucleotide-binding protein G(T) subunit gamma-T1	GO:0006184; P:GTP catabolic process; TAS:GOC
P63211	GNGT1	Guanine nucleotide-binding protein G(T) subunit gamma-T1	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P63211	GNGT1	Guanine nucleotide-binding protein G(T) subunit gamma-T1	GO:0008104; P:protein localization; IEA:Ensembl
P63211	GNGT1	Guanine nucleotide-binding protein G(T) subunit gamma-T1	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
P63211	GNGT1	Guanine nucleotide-binding protein G(T) subunit gamma-T1	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
P63211	GNGT1	Guanine nucleotide-binding protein G(T) subunit gamma-T1	GO:0007165; P:signal transduction; NAS:ProtInc
P63211	GNGT1	Guanine nucleotide-binding protein G(T) subunit gamma-T1	GO:0007268; P:synaptic transmission; TAS:Reactome
P59768	GNG2	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2	GO:0031681; F:G-protein beta-subunit binding; IPI:UniProt
P59768	GNG2	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
P59768	GNG2	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2	GO:0007191; P:adenylate cyclase-activating dopamine receptor signaling pathway; ISS:BHF-UCL
P59768	GNG2	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2	GO:0007596; P:blood coagulation; TAS:Reactome
P59768	GNG2	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2	GO:0008283; P:cell proliferation; IEA:Ensembl
P59768	GNG2	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2	GO:0071870; P:cellular response to catecholamine stimulus; ISS:BHF-UCL
P59768	GNG2	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
P59768	GNG2	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2	GO:0071380; P:cellular response to prostaglandin E stimulus; ISS:BHF-UCL
P59768	GNG2	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P59768	GNG2	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2	GO:0030168; P:platelet activation; TAS:Reactome
P59768	GNG2	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P59768	GNG2	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2	GO:0007268; P:synaptic transmission; TAS:Reactome
P63215	GNG3	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3	GO:0003924; F:GTPase activity; TAS:ProtInc
P63215	GNG3	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
P63215	GNG3	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3	GO:0000187; P:activation of MAPK activity; TAS:ProtInc
P63215	GNG3	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
P63215	GNG3	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P63215	GNG3	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:Ensembl
P63215	GNG3	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3	GO:0006184; P:GTP catabolic process; TAS:GOC
P63215	GNG3	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P63215	GNG3	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P63215	GNG3	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3	GO:0007268; P:synaptic transmission; TAS:Reactome
P50150	GNG4	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
P50150	GNG4	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
P50150	GNG4	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P50150	GNG4	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:InterPro
P50150	GNG4	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4	GO:0030308; P:negative regulation of cell growth; IMP:BHF-UCL
P50150	GNG4	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; TAS:ProtInc
P50150	GNG4	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P50150	GNG4	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4	GO:0007268; P:synaptic transmission; TAS:Reactome
P63218	GNG5	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5	GO:0003924; F:GTPase activity; NAS:UniProtKB
P63218	GNG5	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5	GO:0030165; F:PDZ domain binding; IDA:MGI
P63218	GNG5	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5	GO:0004871; F:signal transducer activity; NAS:UniProtKB
P63218	GNG5	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
P63218	GNG5	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P63218	GNG5	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
P63218	GNG5	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5	GO:0006184; P:GTP catabolic process; NAS:GOC
P63218	GNG5	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5	GO:0007165; P:signal transduction; NAS:UniProtKB
P63218	GNG5	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P63218	GNG5	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5	GO:0007268; P:synaptic transmission; TAS:Reactome
O60262	GNG7	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
O60262	GNG7	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7	GO:0001662; P:behavioral fear response; IEA:Ensembl
O60262	GNG7	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
O60262	GNG7	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
O60262	GNG7	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:InterPro
O60262	GNG7	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7	GO:0007626; P:locomotory behavior; IEA:Ensembl
O60262	GNG7	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7	GO:0007168; P:receptor guanylyl cyclase signaling pathway; IEA:Ensembl
O60262	GNG7	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7	GO:0045761; P:regulation of adenylate cyclase activity; IEA:Ensembl
O60262	GNG7	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; TAS:ProtInc
O60262	GNG7	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60262	GNG7	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9UK08	GNG8	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8	GO:0003924; F:GTPase activity; NAS:UniProtKB
Q9UK08	GNG8	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8	GO:0005515; F:protein binding; IPI:IntAct
Q9UK08	GNG8	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8	GO:0004871; F:signal transducer activity; NAS:UniProtKB
Q9UK08	GNG8	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
Q9UK08	GNG8	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q9UK08	GNG8	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
Q9UK08	GNG8	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8	GO:0006184; P:GTP catabolic process; NAS:GOC
Q9UK08	GNG8	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8	GO:0007399; P:nervous system development; IEA:Ensembl
Q9UK08	GNG8	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UK08	GNG8	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8	GO:0007268; P:synaptic transmission; TAS:Reactome
Q8N5D6	GBGT1	Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1	GO:0047277; F:globoside alpha-N-acetylgalactosaminyltransferase activity; IEA:Ensembl
Q8N5D6	GBGT1	Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N5D6	GBGT1	Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1	GO:0009247; P:glycolipid biosynthetic process; TAS:ProtInc
Q8N5D6	GBGT1	Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
O14610	GNGT2	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2	GO:0003924; F:GTPase activity; NAS:UniProtKB
O14610	GNGT2	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2	GO:0004871; F:signal transducer activity; NAS:UniProtKB
O14610	GNGT2	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
O14610	GNGT2	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2	GO:0006184; P:GTP catabolic process; IDA:GOC
O14610	GNGT2	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2	GO:0007602; P:phototransduction; NAS:UniProtKB
O14610	GNGT2	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2	GO:0007268; P:synaptic transmission; TAS:Reactome
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; IMP:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0008200; F:ion channel inhibitor activity; ISS:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0005515; F:protein binding; IPI:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0032947; F:protein complex scaffold; TAS:BHF-UCL
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0005080; F:protein kinase C binding; IDA:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0030292; F:protein tyrosine kinase inhibitor activity; IDA:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0005102; F:receptor binding; NAS:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0030971; F:receptor tyrosine kinase binding; IDA:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0042169; F:SH2 domain binding; IDA:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0007369; P:gastrulation; IEA:UniProtKB-KW
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0050765; P:negative regulation of phagocytosis; IMP:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0051898; P:negative regulation of protein kinase B signaling; IMP:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0061099; P:negative regulation of protein tyrosine kinase activity; IDA:GOC
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0017148; P:negative regulation of translation; ISS:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0030178; P:negative regulation of Wnt signaling pathway; ISS:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0030822; P:positive regulation of cAMP catabolic process; IMP:BHF-UCL
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0051343; P:positive regulation of cyclic-nucleotide phosphodiesterase activity; IMP:BHF-UCL
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:2000543; P:positive regulation of gastrulation; ISS:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0043547; P:positive regulation of GTPase activity; IDA:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0051901; P:positive regulation of mitochondrial depolarization; IMP:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0032464; P:positive regulation of protein homooligomerization; IDA:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0051726; P:regulation of cell cycle; IDA:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0051302; P:regulation of cell division; ISS:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:2000114; P:regulation of establishment of cell polarity; ISS:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0090003; P:regulation of establishment of protein localization to plasma membrane; IEA:Ensembl
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0032880; P:regulation of protein localization; ISS:UniProtKB
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0048511; P:rhythmic process; IEA:UniProtKB-KW
P63244	GNB2L1	Guanine nucleotide-binding protein subunit beta-2-like 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
P32455	GBP1	Interferon-induced guanylate-binding protein 1	GO:0005525; F:GTP binding; TAS:ProtInc
P32455	GBP1	Interferon-induced guanylate-binding protein 1	GO:0003924; F:GTPase activity; IEA:InterPro
P32455	GBP1	Interferon-induced guanylate-binding protein 1	GO:0042802; F:identical protein binding; IPI:IntAct
P32455	GBP1	Interferon-induced guanylate-binding protein 1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P32455	GBP1	Interferon-induced guanylate-binding protein 1	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P32455	GBP1	Interferon-induced guanylate-binding protein 1	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P32456	GBP2	Interferon-induced guanylate-binding protein 2	GO:0005525; F:GTP binding; TAS:ProtInc
P32456	GBP2	Interferon-induced guanylate-binding protein 2	GO:0003924; F:GTPase activity; IEA:InterPro
P32456	GBP2	Interferon-induced guanylate-binding protein 2	GO:0005515; F:protein binding; IPI:IntAct
P32456	GBP2	Interferon-induced guanylate-binding protein 2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P32456	GBP2	Interferon-induced guanylate-binding protein 2	GO:0006955; P:immune response; TAS:ProtInc
P32456	GBP2	Interferon-induced guanylate-binding protein 2	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P32456	GBP2	Interferon-induced guanylate-binding protein 2	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q96PP9	GBP4	Guanylate-binding protein 4	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q96PP9	GBP4	Guanylate-binding protein 4	GO:0003924; F:GTPase activity; IEA:InterPro
Q9H0R5	GBP3	Guanylate-binding protein 3	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9H0R5	GBP3	Guanylate-binding protein 3	GO:0003924; F:GTPase activity; IEA:InterPro
Q9H0R5	GBP3	Guanylate-binding protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q9H0R5	GBP3	Guanylate-binding protein 3	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q96PP8	GBP5	Guanylate-binding protein 5	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q96PP8	GBP5	Guanylate-binding protein 5	GO:0003924; F:GTPase activity; IEA:InterPro
Q96PP8	GBP5	Guanylate-binding protein 5	GO:0042802; F:identical protein binding; IPI:IntAct
Q96PP8	GBP5	Guanylate-binding protein 5	GO:0071346; P:cellular response to interferon-gamma; IEA:Ensembl
Q6ZN66	GBP6	Guanylate-binding protein 6	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q6ZN66	GBP6	Guanylate-binding protein 6	GO:0003924; F:GTPase activity; IEA:InterPro
Q6ZN66	GBP6	Guanylate-binding protein 6	GO:0071346; P:cellular response to interferon-gamma; ISS:UniProt
Q6ZN66	GBP6	Guanylate-binding protein 6	GO:0042742; P:defense response to bacterium; ISS:UniProt
Q6ZN66	GBP6	Guanylate-binding protein 6	GO:0006955; P:immune response; ISS:UniProt
Q8N8V2	GBP7	Guanylate-binding protein 7	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q8N8V2	GBP7	Guanylate-binding protein 7	GO:0003924; F:GTPase activity; IEA:InterPro
P14867	GABRA1	Gamma-aminobutyric acid receptor subunit alpha-1	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
P14867	GABRA1	Gamma-aminobutyric acid receptor subunit alpha-1	GO:0008144; F:drug binding; ISS:BHF-UCL
P14867	GABRA1	Gamma-aminobutyric acid receptor subunit alpha-1	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
P14867	GABRA1	Gamma-aminobutyric acid receptor subunit alpha-1	GO:0004890; F:GABA-A receptor activity; TAS:ProtInc
P14867	GABRA1	Gamma-aminobutyric acid receptor subunit alpha-1	GO:0007214; P:gamma-aminobutyric acid signaling pathway; TAS:ProtInc
P14867	GABRA1	Gamma-aminobutyric acid receptor subunit alpha-1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P14867	GABRA1	Gamma-aminobutyric acid receptor subunit alpha-1	GO:0007268; P:synaptic transmission; TAS:Reactome
P14867	GABRA1	Gamma-aminobutyric acid receptor subunit alpha-1	GO:0051932; P:synaptic transmission, GABAergic; ISS:BHF-UCL
P14867	GABRA1	Gamma-aminobutyric acid receptor subunit alpha-1	GO:0055085; P:transmembrane transport; TAS:Reactome
P14867	GABRA1	Gamma-aminobutyric acid receptor subunit alpha-1	GO:0006810; P:transport; TAS:ProtInc
P47869	GABRA2	Gamma-aminobutyric acid receptor subunit alpha-2	GO:0008503; F:benzodiazepine receptor activity; IMP:UniProtKB
P47869	GABRA2	Gamma-aminobutyric acid receptor subunit alpha-2	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
P47869	GABRA2	Gamma-aminobutyric acid receptor subunit alpha-2	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
P47869	GABRA2	Gamma-aminobutyric acid receptor subunit alpha-2	GO:0004890; F:GABA-A receptor activity; IEA:InterPro
P47869	GABRA2	Gamma-aminobutyric acid receptor subunit alpha-2	GO:0007214; P:gamma-aminobutyric acid signaling pathway; IMP:UniProtKB
P47869	GABRA2	Gamma-aminobutyric acid receptor subunit alpha-2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P47869	GABRA2	Gamma-aminobutyric acid receptor subunit alpha-2	GO:0006836; P:neurotransmitter transport; IMP:UniProtKB
P47869	GABRA2	Gamma-aminobutyric acid receptor subunit alpha-2	GO:0001505; P:regulation of neurotransmitter levels; IMP:UniProtKB
P47869	GABRA2	Gamma-aminobutyric acid receptor subunit alpha-2	GO:0007268; P:synaptic transmission; TAS:Reactome
P47869	GABRA2	Gamma-aminobutyric acid receptor subunit alpha-2	GO:0055085; P:transmembrane transport; TAS:Reactome
P34903	GABRA3	Gamma-aminobutyric acid receptor subunit alpha-3	GO:0008503; F:benzodiazepine receptor activity; TAS:ProtInc
P34903	GABRA3	Gamma-aminobutyric acid receptor subunit alpha-3	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
P34903	GABRA3	Gamma-aminobutyric acid receptor subunit alpha-3	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
P34903	GABRA3	Gamma-aminobutyric acid receptor subunit alpha-3	GO:0004890; F:GABA-A receptor activity; IEA:InterPro
P34903	GABRA3	Gamma-aminobutyric acid receptor subunit alpha-3	GO:0007214; P:gamma-aminobutyric acid signaling pathway; TAS:ProtInc
P34903	GABRA3	Gamma-aminobutyric acid receptor subunit alpha-3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P34903	GABRA3	Gamma-aminobutyric acid receptor subunit alpha-3	GO:0007268; P:synaptic transmission; TAS:Reactome
P34903	GABRA3	Gamma-aminobutyric acid receptor subunit alpha-3	GO:0055085; P:transmembrane transport; TAS:Reactome
P34903	GABRA3	Gamma-aminobutyric acid receptor subunit alpha-3	GO:0006810; P:transport; TAS:ProtInc
P48169	GABRA4	Gamma-aminobutyric acid receptor subunit alpha-4	GO:0008503; F:benzodiazepine receptor activity; TAS:ProtInc
P48169	GABRA4	Gamma-aminobutyric acid receptor subunit alpha-4	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
P48169	GABRA4	Gamma-aminobutyric acid receptor subunit alpha-4	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
P48169	GABRA4	Gamma-aminobutyric acid receptor subunit alpha-4	GO:0004890; F:GABA-A receptor activity; IEA:InterPro
P48169	GABRA4	Gamma-aminobutyric acid receptor subunit alpha-4	GO:0007417; P:central nervous system development; IEA:Ensembl
P48169	GABRA4	Gamma-aminobutyric acid receptor subunit alpha-4	GO:0007214; P:gamma-aminobutyric acid signaling pathway; TAS:ProtInc
P48169	GABRA4	Gamma-aminobutyric acid receptor subunit alpha-4	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P48169	GABRA4	Gamma-aminobutyric acid receptor subunit alpha-4	GO:2001023; P:regulation of response to drug; IEA:Ensembl
P48169	GABRA4	Gamma-aminobutyric acid receptor subunit alpha-4	GO:0007268; P:synaptic transmission; TAS:Reactome
P48169	GABRA4	Gamma-aminobutyric acid receptor subunit alpha-4	GO:0055085; P:transmembrane transport; TAS:Reactome
P48169	GABRA4	Gamma-aminobutyric acid receptor subunit alpha-4	GO:0006810; P:transport; TAS:ProtInc
P31644	GABRA5	Gamma-aminobutyric acid receptor subunit alpha-5	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
P31644	GABRA5	Gamma-aminobutyric acid receptor subunit alpha-5	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
P31644	GABRA5	Gamma-aminobutyric acid receptor subunit alpha-5	GO:0004890; F:GABA-A receptor activity; IEA:Ensembl
P31644	GABRA5	Gamma-aminobutyric acid receptor subunit alpha-5	GO:0004872; F:receptor activity; TAS:ProtInc
P31644	GABRA5	Gamma-aminobutyric acid receptor subunit alpha-5	GO:0005215; F:transporter activity; TAS:ProtInc
P31644	GABRA5	Gamma-aminobutyric acid receptor subunit alpha-5	GO:0008306; P:associative learning; IEA:Ensembl
P31644	GABRA5	Gamma-aminobutyric acid receptor subunit alpha-5	GO:0001662; P:behavioral fear response; IEA:Ensembl
P31644	GABRA5	Gamma-aminobutyric acid receptor subunit alpha-5	GO:0007420; P:brain development; IEA:Ensembl
P31644	GABRA5	Gamma-aminobutyric acid receptor subunit alpha-5	GO:0090102; P:cochlea development; IEA:Ensembl
P31644	GABRA5	Gamma-aminobutyric acid receptor subunit alpha-5	GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:InterPro
P31644	GABRA5	Gamma-aminobutyric acid receptor subunit alpha-5	GO:0060119; P:inner ear receptor cell development; IEA:Ensembl
P31644	GABRA5	Gamma-aminobutyric acid receptor subunit alpha-5	GO:0060384; P:innervation; IEA:Ensembl
P31644	GABRA5	Gamma-aminobutyric acid receptor subunit alpha-5	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P31644	GABRA5	Gamma-aminobutyric acid receptor subunit alpha-5	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P31644	GABRA5	Gamma-aminobutyric acid receptor subunit alpha-5	GO:0007605; P:sensory perception of sound; IEA:Ensembl
P31644	GABRA5	Gamma-aminobutyric acid receptor subunit alpha-5	GO:0007165; P:signal transduction; TAS:ProtInc
P31644	GABRA5	Gamma-aminobutyric acid receptor subunit alpha-5	GO:0007268; P:synaptic transmission; TAS:Reactome
P31644	GABRA5	Gamma-aminobutyric acid receptor subunit alpha-5	GO:0055085; P:transmembrane transport; TAS:Reactome
P31644	GABRA5	Gamma-aminobutyric acid receptor subunit alpha-5	GO:0006810; P:transport; TAS:ProtInc
Q16445	GABRA6	Gamma-aminobutyric acid receptor subunit alpha-6	GO:0008503; F:benzodiazepine receptor activity; TAS:ProtInc
Q16445	GABRA6	Gamma-aminobutyric acid receptor subunit alpha-6	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
Q16445	GABRA6	Gamma-aminobutyric acid receptor subunit alpha-6	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
Q16445	GABRA6	Gamma-aminobutyric acid receptor subunit alpha-6	GO:0004890; F:GABA-A receptor activity; IEA:InterPro
Q16445	GABRA6	Gamma-aminobutyric acid receptor subunit alpha-6	GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:InterPro
Q16445	GABRA6	Gamma-aminobutyric acid receptor subunit alpha-6	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q16445	GABRA6	Gamma-aminobutyric acid receptor subunit alpha-6	GO:0007165; P:signal transduction; TAS:ProtInc
Q16445	GABRA6	Gamma-aminobutyric acid receptor subunit alpha-6	GO:0007268; P:synaptic transmission; TAS:Reactome
Q16445	GABRA6	Gamma-aminobutyric acid receptor subunit alpha-6	GO:0055085; P:transmembrane transport; TAS:Reactome
Q16445	GABRA6	Gamma-aminobutyric acid receptor subunit alpha-6	GO:0006810; P:transport; TAS:ProtInc
O95166	GABARAP	Gamma-aminobutyric acid receptor-associated protein	GO:0048487; F:beta-tubulin binding; IDA:UniProtKB
O95166	GABARAP	Gamma-aminobutyric acid receptor-associated protein	GO:0050811; F:GABA receptor binding; IPI:UniProtKB
O95166	GABARAP	Gamma-aminobutyric acid receptor-associated protein	GO:0005515; F:protein binding; IPI:UniProtKB
O95166	GABARAP	Gamma-aminobutyric acid receptor-associated protein	GO:0006914; P:autophagy; IEA:UniProtKB-KW
O95166	GABARAP	Gamma-aminobutyric acid receptor-associated protein	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IDA:UniProtKB
O95166	GABARAP	Gamma-aminobutyric acid receptor-associated protein	GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl
O95166	GABARAP	Gamma-aminobutyric acid receptor-associated protein	GO:0006605; P:protein targeting; TAS:ProtInc
O95166	GABARAP	Gamma-aminobutyric acid receptor-associated protein	GO:0007268; P:synaptic transmission; TAS:ProtInc
P18505	GABRB1	Gamma-aminobutyric acid receptor subunit beta-1	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
P18505	GABRB1	Gamma-aminobutyric acid receptor subunit beta-1	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
P18505	GABRB1	Gamma-aminobutyric acid receptor subunit beta-1	GO:0004890; F:GABA-A receptor activity; TAS:ProtInc
P18505	GABRB1	Gamma-aminobutyric acid receptor subunit beta-1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P18505	GABRB1	Gamma-aminobutyric acid receptor subunit beta-1	GO:0007165; P:signal transduction; TAS:ProtInc
P18505	GABRB1	Gamma-aminobutyric acid receptor subunit beta-1	GO:0007268; P:synaptic transmission; TAS:Reactome
P18505	GABRB1	Gamma-aminobutyric acid receptor subunit beta-1	GO:0055085; P:transmembrane transport; TAS:Reactome
P18505	GABRB1	Gamma-aminobutyric acid receptor subunit beta-1	GO:0006810; P:transport; TAS:ProtInc
P47870	GABRB2	Gamma-aminobutyric acid receptor subunit beta-2	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
P47870	GABRB2	Gamma-aminobutyric acid receptor subunit beta-2	GO:0004890; F:GABA-A receptor activity; ISS:BHF-UCL
P47870	GABRB2	Gamma-aminobutyric acid receptor subunit beta-2	GO:0005237; F:inhibitory extracellular ligand-gated ion channel activity; IEA:Ensembl
P47870	GABRB2	Gamma-aminobutyric acid receptor subunit beta-2	GO:0090102; P:cochlea development; IEA:Ensembl
P47870	GABRB2	Gamma-aminobutyric acid receptor subunit beta-2	GO:0007214; P:gamma-aminobutyric acid signaling pathway; TAS:ProtInc
P47870	GABRB2	Gamma-aminobutyric acid receptor subunit beta-2	GO:0060119; P:inner ear receptor cell development; IEA:Ensembl
P47870	GABRB2	Gamma-aminobutyric acid receptor subunit beta-2	GO:0060384; P:innervation; IEA:Ensembl
P47870	GABRB2	Gamma-aminobutyric acid receptor subunit beta-2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P47870	GABRB2	Gamma-aminobutyric acid receptor subunit beta-2	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P47870	GABRB2	Gamma-aminobutyric acid receptor subunit beta-2	GO:0007605; P:sensory perception of sound; IEA:Ensembl
P47870	GABRB2	Gamma-aminobutyric acid receptor subunit beta-2	GO:0007268; P:synaptic transmission; TAS:Reactome
P47870	GABRB2	Gamma-aminobutyric acid receptor subunit beta-2	GO:0051932; P:synaptic transmission, GABAergic; ISS:BHF-UCL
P47870	GABRB2	Gamma-aminobutyric acid receptor subunit beta-2	GO:0055085; P:transmembrane transport; TAS:Reactome
P47870	GABRB2	Gamma-aminobutyric acid receptor subunit beta-2	GO:0006810; P:transport; TAS:ProtInc
P28472	GABRB3	Gamma-aminobutyric acid receptor subunit beta-3	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
P28472	GABRB3	Gamma-aminobutyric acid receptor subunit beta-3	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
P28472	GABRB3	Gamma-aminobutyric acid receptor subunit beta-3	GO:0004890; F:GABA-A receptor activity; TAS:ProtInc
P28472	GABRB3	Gamma-aminobutyric acid receptor subunit beta-3	GO:0090102; P:cochlea development; IEA:Ensembl
P28472	GABRB3	Gamma-aminobutyric acid receptor subunit beta-3	GO:0060119; P:inner ear receptor cell development; IEA:Ensembl
P28472	GABRB3	Gamma-aminobutyric acid receptor subunit beta-3	GO:0060384; P:innervation; IEA:Ensembl
P28472	GABRB3	Gamma-aminobutyric acid receptor subunit beta-3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P28472	GABRB3	Gamma-aminobutyric acid receptor subunit beta-3	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P28472	GABRB3	Gamma-aminobutyric acid receptor subunit beta-3	GO:0007605; P:sensory perception of sound; IEA:Ensembl
P28472	GABRB3	Gamma-aminobutyric acid receptor subunit beta-3	GO:0007165; P:signal transduction; TAS:ProtInc
P28472	GABRB3	Gamma-aminobutyric acid receptor subunit beta-3	GO:0007268; P:synaptic transmission; TAS:Reactome
P28472	GABRB3	Gamma-aminobutyric acid receptor subunit beta-3	GO:0055085; P:transmembrane transport; TAS:Reactome
P28472	GABRB3	Gamma-aminobutyric acid receptor subunit beta-3	GO:0006810; P:transport; TAS:ProtInc
O14764	GABRD	Gamma-aminobutyric acid receptor subunit delta	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
O14764	GABRD	Gamma-aminobutyric acid receptor subunit delta	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
O14764	GABRD	Gamma-aminobutyric acid receptor subunit delta	GO:0004890; F:GABA-A receptor activity; TAS:ProtInc
O14764	GABRD	Gamma-aminobutyric acid receptor subunit delta	GO:0007165; P:signal transduction; TAS:ProtInc
O14764	GABRD	Gamma-aminobutyric acid receptor subunit delta	GO:0007268; P:synaptic transmission; IEA:Ensembl
O14764	GABRD	Gamma-aminobutyric acid receptor subunit delta	GO:0006810; P:transport; TAS:ProtInc
P78334	GABRE	Gamma-aminobutyric acid receptor subunit epsilon	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
P78334	GABRE	Gamma-aminobutyric acid receptor subunit epsilon	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
P78334	GABRE	Gamma-aminobutyric acid receptor subunit epsilon	GO:0004890; F:GABA-A receptor activity; TAS:ProtInc
P78334	GABRE	Gamma-aminobutyric acid receptor subunit epsilon	GO:0007214; P:gamma-aminobutyric acid signaling pathway; TAS:ProtInc
P78334	GABRE	Gamma-aminobutyric acid receptor subunit epsilon	GO:0006810; P:transport; TAS:ProtInc
Q8N1C3	GABRG1	Gamma-aminobutyric acid receptor subunit gamma-1	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
Q8N1C3	GABRG1	Gamma-aminobutyric acid receptor subunit gamma-1	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
Q8N1C3	GABRG1	Gamma-aminobutyric acid receptor subunit gamma-1	GO:0004890; F:GABA-A receptor activity; IEA:Ensembl
Q8N1C3	GABRG1	Gamma-aminobutyric acid receptor subunit gamma-1	GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:InterPro
Q8N1C3	GABRG1	Gamma-aminobutyric acid receptor subunit gamma-1	GO:0007268; P:synaptic transmission; IEA:Ensembl
P18507	GABRG2	Gamma-aminobutyric acid receptor subunit gamma-2	GO:0008503; F:benzodiazepine receptor activity; TAS:ProtInc
P18507	GABRG2	Gamma-aminobutyric acid receptor subunit gamma-2	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
P18507	GABRG2	Gamma-aminobutyric acid receptor subunit gamma-2	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
P18507	GABRG2	Gamma-aminobutyric acid receptor subunit gamma-2	GO:0004890; F:GABA-A receptor activity; IEA:Ensembl
P18507	GABRG2	Gamma-aminobutyric acid receptor subunit gamma-2	GO:0005515; F:protein binding; IPI:UniProtKB
P18507	GABRG2	Gamma-aminobutyric acid receptor subunit gamma-2	GO:0030534; P:adult behavior; IEA:Ensembl
P18507	GABRG2	Gamma-aminobutyric acid receptor subunit gamma-2	GO:0007214; P:gamma-aminobutyric acid signaling pathway; TAS:ProtInc
P18507	GABRG2	Gamma-aminobutyric acid receptor subunit gamma-2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P18507	GABRG2	Gamma-aminobutyric acid receptor subunit gamma-2	GO:0009791; P:post-embryonic development; IEA:Ensembl
P18507	GABRG2	Gamma-aminobutyric acid receptor subunit gamma-2	GO:0007268; P:synaptic transmission; TAS:Reactome
P18507	GABRG2	Gamma-aminobutyric acid receptor subunit gamma-2	GO:0051932; P:synaptic transmission, GABAergic; ISS:BHF-UCL
P18507	GABRG2	Gamma-aminobutyric acid receptor subunit gamma-2	GO:0055085; P:transmembrane transport; TAS:Reactome
P18507	GABRG2	Gamma-aminobutyric acid receptor subunit gamma-2	GO:0006810; P:transport; TAS:ProtInc
Q99928	GABRG3	Gamma-aminobutyric acid receptor subunit gamma-3	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
Q99928	GABRG3	Gamma-aminobutyric acid receptor subunit gamma-3	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
Q99928	GABRG3	Gamma-aminobutyric acid receptor subunit gamma-3	GO:0004890; F:GABA-A receptor activity; IEA:Ensembl
Q99928	GABRG3	Gamma-aminobutyric acid receptor subunit gamma-3	GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:InterPro
Q99928	GABRG3	Gamma-aminobutyric acid receptor subunit gamma-3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q99928	GABRG3	Gamma-aminobutyric acid receptor subunit gamma-3	GO:0042493; P:response to drug; IEA:Ensembl
Q99928	GABRG3	Gamma-aminobutyric acid receptor subunit gamma-3	GO:0007268; P:synaptic transmission; TAS:Reactome
Q99928	GABRG3	Gamma-aminobutyric acid receptor subunit gamma-3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9H0R8	GABARAPL1	Gamma-aminobutyric acid receptor-associated protein-like 1	GO:0048487; F:beta-tubulin binding; ISS:UniProtKB
Q9H0R8	GABARAPL1	Gamma-aminobutyric acid receptor-associated protein-like 1	GO:0050811; F:GABA receptor binding; ISS:UniProtKB
Q9H0R8	GABARAPL1	Gamma-aminobutyric acid receptor-associated protein-like 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H0R8	GABARAPL1	Gamma-aminobutyric acid receptor-associated protein-like 1	GO:0006914; P:autophagy; IEA:UniProtKB-KW
P60520	GABARAPL2	Gamma-aminobutyric acid receptor-associated protein-like 2	GO:0051117; F:ATPase binding; ISS:UniProtKB
P60520	GABARAPL2	Gamma-aminobutyric acid receptor-associated protein-like 2	GO:0048487; F:beta-tubulin binding; ISS:UniProtKB
P60520	GABARAPL2	Gamma-aminobutyric acid receptor-associated protein-like 2	GO:0050811; F:GABA receptor binding; ISS:UniProtKB
P60520	GABARAPL2	Gamma-aminobutyric acid receptor-associated protein-like 2	GO:0008017; F:microtubule binding; NAS:UniProtKB
P60520	GABARAPL2	Gamma-aminobutyric acid receptor-associated protein-like 2	GO:0005515; F:protein binding; IPI:UniProtKB
P60520	GABARAPL2	Gamma-aminobutyric acid receptor-associated protein-like 2	GO:0000149; F:SNARE binding; ISS:UniProtKB
P60520	GABARAPL2	Gamma-aminobutyric acid receptor-associated protein-like 2	GO:0006914; P:autophagy; NAS:UniProtKB
P60520	GABARAPL2	Gamma-aminobutyric acid receptor-associated protein-like 2	GO:0006891; P:intra-Golgi vesicle-mediated transport; ISS:UniProtKB
P60520	GABARAPL2	Gamma-aminobutyric acid receptor-associated protein-like 2	GO:1901799; P:negative regulation of proteasomal protein catabolic process; IMP:BHF-UCL
P60520	GABARAPL2	Gamma-aminobutyric acid receptor-associated protein-like 2	GO:0032781; P:positive regulation of ATPase activity; ISS:UniProtKB
P60520	GABARAPL2	Gamma-aminobutyric acid receptor-associated protein-like 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9BY60	GABARAPL3	Gamma-aminobutyric acid receptor-associated protein-like 3	GO:0006914; P:autophagy; IEA:UniProtKB-KW
O00591	GABRP	Gamma-aminobutyric acid receptor subunit pi	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
O00591	GABRP	Gamma-aminobutyric acid receptor subunit pi	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
O00591	GABRP	Gamma-aminobutyric acid receptor subunit pi	GO:0004890; F:GABA-A receptor activity; TAS:ProtInc
O00591	GABRP	Gamma-aminobutyric acid receptor subunit pi	GO:0007165; P:signal transduction; TAS:GOC
P24046	GABRR1	Gamma-aminobutyric acid receptor subunit rho-1	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
P24046	GABRR1	Gamma-aminobutyric acid receptor subunit rho-1	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
P24046	GABRR1	Gamma-aminobutyric acid receptor subunit rho-1	GO:0004890; F:GABA-A receptor activity; TAS:ProtInc
P24046	GABRR1	Gamma-aminobutyric acid receptor subunit rho-1	GO:0007214; P:gamma-aminobutyric acid signaling pathway; TAS:ProtInc
P24046	GABRR1	Gamma-aminobutyric acid receptor subunit rho-1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P24046	GABRR1	Gamma-aminobutyric acid receptor subunit rho-1	GO:0007268; P:synaptic transmission; TAS:Reactome
P24046	GABRR1	Gamma-aminobutyric acid receptor subunit rho-1	GO:0055085; P:transmembrane transport; TAS:Reactome
P24046	GABRR1	Gamma-aminobutyric acid receptor subunit rho-1	GO:0006810; P:transport; TAS:ProtInc
P28476	GABRR2	Gamma-aminobutyric acid receptor subunit rho-2	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
P28476	GABRR2	Gamma-aminobutyric acid receptor subunit rho-2	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
P28476	GABRR2	Gamma-aminobutyric acid receptor subunit rho-2	GO:0004890; F:GABA-A receptor activity; TAS:ProtInc
P28476	GABRR2	Gamma-aminobutyric acid receptor subunit rho-2	GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:Ensembl
P28476	GABRR2	Gamma-aminobutyric acid receptor subunit rho-2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P28476	GABRR2	Gamma-aminobutyric acid receptor subunit rho-2	GO:0007165; P:signal transduction; TAS:ProtInc
P28476	GABRR2	Gamma-aminobutyric acid receptor subunit rho-2	GO:0007268; P:synaptic transmission; TAS:Reactome
P28476	GABRR2	Gamma-aminobutyric acid receptor subunit rho-2	GO:0055085; P:transmembrane transport; TAS:Reactome
P28476	GABRR2	Gamma-aminobutyric acid receptor subunit rho-2	GO:0006810; P:transport; TAS:ProtInc
P28476	GABRR2	Gamma-aminobutyric acid receptor subunit rho-2	GO:0007601; P:visual perception; IEA:Ensembl
A8MPY1	GABRR3	Gamma-aminobutyric acid receptor subunit rho-3	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
A8MPY1	GABRR3	Gamma-aminobutyric acid receptor subunit rho-3	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
A8MPY1	GABRR3	Gamma-aminobutyric acid receptor subunit rho-3	GO:0004890; F:GABA-A receptor activity; NAS:UniProtKB
A8MPY1	GABRR3	Gamma-aminobutyric acid receptor subunit rho-3	GO:0007214; P:gamma-aminobutyric acid signaling pathway; NAS:UniProtKB
A8MPY1	GABRR3	Gamma-aminobutyric acid receptor subunit rho-3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
A8MPY1	GABRR3	Gamma-aminobutyric acid receptor subunit rho-3	GO:0007268; P:synaptic transmission; NAS:UniProtKB
A8MPY1	GABRR3	Gamma-aminobutyric acid receptor subunit rho-3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UN88	GABRQ	Gamma-aminobutyric acid receptor subunit theta	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
Q9UN88	GABRQ	Gamma-aminobutyric acid receptor subunit theta	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
Q9UN88	GABRQ	Gamma-aminobutyric acid receptor subunit theta	GO:0004890; F:GABA-A receptor activity; IEA:InterPro
Q9UN88	GABRQ	Gamma-aminobutyric acid receptor subunit theta	GO:0005326; F:neurotransmitter transporter activity; TAS:ProtInc
Q9UN88	GABRQ	Gamma-aminobutyric acid receptor subunit theta	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q9UN88	GABRQ	Gamma-aminobutyric acid receptor subunit theta	GO:0006836; P:neurotransmitter transport; TAS:GOC
Q9UN88	GABRQ	Gamma-aminobutyric acid receptor subunit theta	GO:0007165; P:signal transduction; TAS:ProtInc
Q14549	GBX1	Homeobox protein GBX-1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q14549	GBX1	Homeobox protein GBX-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q14549	GBX1	Homeobox protein GBX-1	GO:0007628; P:adult walking behavior; IEA:Ensembl
Q14549	GBX1	Homeobox protein GBX-1	GO:0019230; P:proprioception; IEA:Ensembl
Q14549	GBX1	Homeobox protein GBX-1	GO:0097374; P:sensory neuron axon guidance; IEA:Ensembl
Q14549	GBX1	Homeobox protein GBX-1	GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl
Q14549	GBX1	Homeobox protein GBX-1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P52951	GBX2	Homeobox protein GBX-2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P52951	GBX2	Homeobox protein GBX-2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P52951	GBX2	Homeobox protein GBX-2	GO:0048483; P:autonomic nervous system development; IEA:Ensembl
P52951	GBX2	Homeobox protein GBX-2	GO:0007411; P:axon guidance; IEA:Ensembl
P52951	GBX2	Homeobox protein GBX-2	GO:0021930; P:cerebellar granule cell precursor proliferation; IEA:Ensembl
P52951	GBX2	Homeobox protein GBX-2	GO:0021549; P:cerebellum development; IEA:Ensembl
P52951	GBX2	Homeobox protein GBX-2	GO:0021884; P:forebrain neuron development; IEA:Ensembl
P52951	GBX2	Homeobox protein GBX-2	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
P52951	GBX2	Homeobox protein GBX-2	GO:0021555; P:midbrain-hindbrain boundary morphogenesis; IEA:Ensembl
P52951	GBX2	Homeobox protein GBX-2	GO:0007399; P:nervous system development; TAS:ProtInc
P52951	GBX2	Homeobox protein GBX-2	GO:0001755; P:neural crest cell migration; IEA:Ensembl
P52951	GBX2	Homeobox protein GBX-2	GO:0001569; P:patterning of blood vessels; IEA:Ensembl
P52951	GBX2	Homeobox protein GBX-2	GO:0021568; P:rhombomere 2 development; IEA:Ensembl
P52951	GBX2	Homeobox protein GBX-2	GO:0021794; P:thalamus development; IEA:Ensembl
P52951	GBX2	Homeobox protein GBX-2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96CN9	GCC1	GRIP and coiled-coil domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q96CN9	GCC1	GRIP and coiled-coil domain-containing protein 1	GO:0000042; P:protein targeting to Golgi; IEA:InterPro
Q8IWJ2	GCC2	GRIP and coiled-coil domain-containing protein 2	GO:0042802; F:identical protein binding; IPI:IntAct
Q8IWJ2	GCC2	GRIP and coiled-coil domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IWJ2	GCC2	GRIP and coiled-coil domain-containing protein 2	GO:0090161; P:Golgi ribbon formation; IMP:UniProtKB
Q8IWJ2	GCC2	GRIP and coiled-coil domain-containing protein 2	GO:0034499; P:late endosome to Golgi transport; IMP:UniProtKB
Q8IWJ2	GCC2	GRIP and coiled-coil domain-containing protein 2	GO:0034453; P:microtubule anchoring; IMP:UniProtKB
Q8IWJ2	GCC2	GRIP and coiled-coil domain-containing protein 2	GO:0031023; P:microtubule organizing center organization; IMP:UniProtKB
Q8IWJ2	GCC2	GRIP and coiled-coil domain-containing protein 2	GO:0034067; P:protein localization to Golgi apparatus; IMP:UniProtKB
Q8IWJ2	GCC2	GRIP and coiled-coil domain-containing protein 2	GO:0000042; P:protein targeting to Golgi; IEA:InterPro
Q8IWJ2	GCC2	GRIP and coiled-coil domain-containing protein 2	GO:0006622; P:protein targeting to lysosome; IMP:UniProtKB
Q8IWJ2	GCC2	GRIP and coiled-coil domain-containing protein 2	GO:0071955; P:recycling endosome to Golgi transport; IMP:UniProtKB
Q8IWJ2	GCC2	GRIP and coiled-coil domain-containing protein 2	GO:0070861; P:regulation of protein exit from endoplasmic reticulum; IMP:UniProtKB
Q8IWJ2	GCC2	GRIP and coiled-coil domain-containing protein 2	GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB
Q92947	GCDH	Glutaryl-CoA dehydrogenase, mitochondrial	GO:0000062; F:fatty-acyl-CoA binding; IEA:Ensembl
Q92947	GCDH	Glutaryl-CoA dehydrogenase, mitochondrial	GO:0050660; F:flavin adenine dinucleotide binding; IEA:Ensembl
Q92947	GCDH	Glutaryl-CoA dehydrogenase, mitochondrial	GO:0004361; F:glutaryl-CoA dehydrogenase activity; EXP:Reactome
Q92947	GCDH	Glutaryl-CoA dehydrogenase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q92947	GCDH	Glutaryl-CoA dehydrogenase, mitochondrial	GO:0019395; P:fatty acid oxidation; IEA:Ensembl
Q92947	GCDH	Glutaryl-CoA dehydrogenase, mitochondrial	GO:0046949; P:fatty-acyl-CoA biosynthetic process; IEA:Ensembl
Q92947	GCDH	Glutaryl-CoA dehydrogenase, mitochondrial	GO:0006554; P:lysine catabolic process; TAS:Reactome
Q92947	GCDH	Glutaryl-CoA dehydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q92947	GCDH	Glutaryl-CoA dehydrogenase, mitochondrial	GO:0006568; P:tryptophan metabolic process; IEA:UniProtKB-UniPathway
P16383	GCFC2	GC-rich sequence DNA-binding factor 2	GO:0003677; F:DNA binding; IEA:InterPro
P16383	GCFC2	GC-rich sequence DNA-binding factor 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P16383	GCFC2	GC-rich sequence DNA-binding factor 2	GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB
P16383	GCFC2	GC-rich sequence DNA-binding factor 2	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P16383	GCFC2	GC-rich sequence DNA-binding factor 2	GO:0000245; P:spliceosomal complex assembly; IMP:UniProtKB
P16383	GCFC2	GC-rich sequence DNA-binding factor 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P30793	GCH1	GTP cyclohydrolase 1	GO:0005509; F:calcium ion binding; IEA:Ensembl
P30793	GCH1	GTP cyclohydrolase 1	GO:0050662; F:coenzyme binding; IEA:Ensembl
P30793	GCH1	GTP cyclohydrolase 1	GO:0005525; F:GTP binding; IDA:UniProtKB
P30793	GCH1	GTP cyclohydrolase 1	GO:0003934; F:GTP cyclohydrolase I activity; IDA:UniProtKB
P30793	GCH1	GTP cyclohydrolase 1	GO:0005515; F:protein binding; IPI:UniProtKB
P30793	GCH1	GTP cyclohydrolase 1	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P30793	GCH1	GTP cyclohydrolase 1	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P30793	GCH1	GTP cyclohydrolase 1	GO:0035998; P:7,8-dihydroneopterin 3'-triphosphate biosynthetic process; IEA:UniProtKB-UniPathway
P30793	GCH1	GTP cyclohydrolase 1	GO:0042416; P:dopamine biosynthetic process; IDA:UniProtKB
P30793	GCH1	GTP cyclohydrolase 1	GO:0006184; P:GTP catabolic process; IDA:UniProtKB
P30793	GCH1	GTP cyclohydrolase 1	GO:0008152; P:metabolic process; IDA:GOC
P30793	GCH1	GTP cyclohydrolase 1	GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl
P30793	GCH1	GTP cyclohydrolase 1	GO:0050884; P:neuromuscular process controlling posture; IMP:MGI
P30793	GCH1	GTP cyclohydrolase 1	GO:0006809; P:nitric oxide biosynthetic process; NAS:UniProtKB
P30793	GCH1	GTP cyclohydrolase 1	GO:0046209; P:nitric oxide metabolic process; TAS:Reactome
P30793	GCH1	GTP cyclohydrolase 1	GO:0051000; P:positive regulation of nitric-oxide synthase activity; IDA:UniProtKB
P30793	GCH1	GTP cyclohydrolase 1	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P30793	GCH1	GTP cyclohydrolase 1	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
P30793	GCH1	GTP cyclohydrolase 1	GO:0042559; P:pteridine-containing compound biosynthetic process; IDA:UniProtKB
P30793	GCH1	GTP cyclohydrolase 1	GO:0008217; P:regulation of blood pressure; IMP:UniProtKB
P30793	GCH1	GTP cyclohydrolase 1	GO:0014916; P:regulation of lung blood pressure; IEA:Ensembl
P30793	GCH1	GTP cyclohydrolase 1	GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome
P30793	GCH1	GTP cyclohydrolase 1	GO:0034341; P:response to interferon-gamma; IDA:UniProtKB
P30793	GCH1	GTP cyclohydrolase 1	GO:0032496; P:response to lipopolysaccharide; IDA:UniProtKB
P30793	GCH1	GTP cyclohydrolase 1	GO:0048265; P:response to pain; ISS:UniProtKB
P30793	GCH1	GTP cyclohydrolase 1	GO:0034612; P:response to tumor necrosis factor; IDA:UniProtKB
P30793	GCH1	GTP cyclohydrolase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P30793	GCH1	GTP cyclohydrolase 1	GO:0006729; P:tetrahydrobiopterin biosynthetic process; IDA:UniProtKB
P30793	GCH1	GTP cyclohydrolase 1	GO:0046654; P:tetrahydrofolate biosynthetic process; IEA:InterPro
P30793	GCH1	GTP cyclohydrolase 1	GO:0042311; P:vasodilation; IEA:Ensembl
Q14397	GCKR	Glucokinase regulatory protein	GO:0030246; F:carbohydrate binding; IEA:Ensembl
Q14397	GCKR	Glucokinase regulatory protein	GO:0004857; F:enzyme inhibitor activity; IEA:Ensembl
Q14397	GCKR	Glucokinase regulatory protein	GO:0070095; F:fructose-6-phosphate binding; IDA:UniProtKB
Q14397	GCKR	Glucokinase regulatory protein	GO:0016301; F:kinase activity; IEA:UniProtKB-KW
Q14397	GCKR	Glucokinase regulatory protein	GO:0005515; F:protein binding; IPI:IntAct
Q14397	GCKR	Glucokinase regulatory protein	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q14397	GCKR	Glucokinase regulatory protein	GO:0001678; P:cellular glucose homeostasis; IEA:Ensembl
Q14397	GCKR	Glucokinase regulatory protein	GO:0015758; P:glucose transport; TAS:Reactome
Q14397	GCKR	Glucokinase regulatory protein	GO:0008645; P:hexose transport; TAS:Reactome
Q14397	GCKR	Glucokinase regulatory protein	GO:0033132; P:negative regulation of glucokinase activity; IDA:UniProtKB
Q14397	GCKR	Glucokinase regulatory protein	GO:0033133; P:positive regulation of glucokinase activity; IEA:Ensembl
Q14397	GCKR	Glucokinase regulatory protein	GO:0000060; P:protein import into nucleus, translocation; ISS:BHF-UCL
Q14397	GCKR	Glucokinase regulatory protein	GO:0010827; P:regulation of glucose transport; TAS:Reactome
Q14397	GCKR	Glucokinase regulatory protein	GO:0009750; P:response to fructose; IDA:BHF-UCL
Q14397	GCKR	Glucokinase regulatory protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14397	GCKR	Glucokinase regulatory protein	GO:0055085; P:transmembrane transport; TAS:Reactome
Q14397	GCKR	Glucokinase regulatory protein	GO:0070328; P:triglyceride homeostasis; IMP:BHF-UCL
Q14397	GCKR	Glucokinase regulatory protein	GO:0046415; P:urate metabolic process; IMP:BHF-UCL
Q9NP62	GCM1	Chorion-specific transcription factor GCMa	GO:0003677; F:DNA binding; TAS:ProtInc
Q9NP62	GCM1	Chorion-specific transcription factor GCMa	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:MGI
Q9NP62	GCM1	Chorion-specific transcription factor GCMa	GO:0008134; F:transcription factor binding; IPI:MGI
Q9NP62	GCM1	Chorion-specific transcription factor GCMa	GO:0008270; F:zinc ion binding; IEA:Ensembl
Q9NP62	GCM1	Chorion-specific transcription factor GCMa	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q9NP62	GCM1	Chorion-specific transcription factor GCMa	GO:0060018; P:astrocyte fate commitment; IEA:Ensembl
Q9NP62	GCM1	Chorion-specific transcription factor GCMa	GO:0060670; P:branching involved in labyrinthine layer morphogenesis; IEA:Ensembl
Q9NP62	GCM1	Chorion-specific transcription factor GCMa	GO:0060706; P:cell differentiation involved in embryonic placenta development; IEA:Ensembl
Q9NP62	GCM1	Chorion-specific transcription factor GCMa	GO:0060143; P:positive regulation of syncytium formation by plasma membrane fusion; IEA:Ensembl
Q9NP62	GCM1	Chorion-specific transcription factor GCMa	GO:0006355; P:regulation of transcription, DNA-templated; IDA:MGI
Q9NP62	GCM1	Chorion-specific transcription factor GCMa	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75603	GCM2	Chorion-specific transcription factor GCMb	GO:0003677; F:DNA binding; TAS:ProtInc
O75603	GCM2	Chorion-specific transcription factor GCMb	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75603	GCM2	Chorion-specific transcription factor GCMb	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
O75603	GCM2	Chorion-specific transcription factor GCMb	GO:0030154; P:cell differentiation; IEA:Ensembl
O75603	GCM2	Chorion-specific transcription factor GCMb	GO:0006874; P:cellular calcium ion homeostasis; IMP:UniProtKB
O75603	GCM2	Chorion-specific transcription factor GCMb	GO:0030643; P:cellular phosphate ion homeostasis; IMP:UniProtKB
O75603	GCM2	Chorion-specific transcription factor GCMb	GO:0071310; P:cellular response to organic substance; IEA:Ensembl
O75603	GCM2	Chorion-specific transcription factor GCMb	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
O75603	GCM2	Chorion-specific transcription factor GCMb	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
O75603	GCM2	Chorion-specific transcription factor GCMb	GO:0060017; P:parathyroid gland development; IMP:UniProtKB
O75603	GCM2	Chorion-specific transcription factor GCMb	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O75603	GCM2	Chorion-specific transcription factor GCMb	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q92616	GCN1L1	Translational activator GCN1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q92616	GCN1L1	Translational activator GCN1	GO:0008135; F:translation factor activity, nucleic acid binding; NAS:UniProtKB
Q92616	GCN1L1	Translational activator GCN1	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q92616	GCN1L1	Translational activator GCN1	GO:0006412; P:translation; NAS:GOC
Q02742	GCNT1	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase	GO:0003829; F:beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity; TAS:ProtInc
Q02742	GCNT1	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase	GO:0005515; F:protein binding; IPI:UniProtKB
Q02742	GCNT1	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase	GO:0060352; P:cell adhesion molecule production; IMP:UniProtKB
Q02742	GCNT1	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q02742	GCNT1	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase	GO:0009101; P:glycoprotein biosynthetic process; IMP:UniProtKB
Q02742	GCNT1	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase	GO:0060993; P:kidney morphogenesis; IEA:Ensembl
Q02742	GCNT1	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase	GO:0050901; P:leukocyte tethering or rolling; IMP:UniProtKB
Q02742	GCNT1	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase	GO:0016266; P:O-glycan processing; TAS:Reactome
Q02742	GCNT1	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q02742	GCNT1	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase	GO:0032868; P:response to insulin; IEA:Ensembl
Q02742	GCNT1	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase	GO:0048729; P:tissue morphogenesis; IEA:Ensembl
O95395	GCNT3	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3	GO:0047225; F:acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity; IEA:Ensembl
O95395	GCNT3	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3	GO:0003829; F:beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity; IEA:UniProtKB-EC
O95395	GCNT3	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3	GO:0008109; F:N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity; TAS:ProtInc
O95395	GCNT3	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3	GO:0005975; P:carbohydrate metabolic process; NAS:ProtInc
O95395	GCNT3	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O95395	GCNT3	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3	GO:0002426; P:immunoglobulin production in mucosal tissue; IEA:Ensembl
O95395	GCNT3	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3	GO:0050892; P:intestinal absorption; IEA:Ensembl
O95395	GCNT3	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3	GO:0060993; P:kidney morphogenesis; IEA:Ensembl
O95395	GCNT3	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3	GO:0016266; P:O-glycan processing; TAS:Reactome
O95395	GCNT3	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3	GO:0043687; P:post-translational protein modification; TAS:Reactome
O95395	GCNT3	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3	GO:0006493; P:protein O-linked glycosylation; TAS:ProtInc
O95395	GCNT3	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3	GO:0048729; P:tissue morphogenesis; IEA:Ensembl
Q9P109	GCNT4	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4	GO:0003829; F:beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity; IEA:UniProtKB-EC
Q9P109	GCNT4	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4	GO:0008109; F:N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity; TAS:ProtInc
Q9P109	GCNT4	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
Q9P109	GCNT4	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9P109	GCNT4	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4	GO:0048872; P:homeostasis of number of cells; IEA:Ensembl
Q9P109	GCNT4	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4	GO:0002121; P:inter-male aggressive behavior; IEA:Ensembl
Q9P109	GCNT4	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4	GO:0060993; P:kidney morphogenesis; IEA:Ensembl
Q9P109	GCNT4	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4	GO:0016266; P:O-glycan processing; TAS:Reactome
Q9P109	GCNT4	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9P109	GCNT4	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4	GO:0006493; P:protein O-linked glycosylation; TAS:ProtInc
Q9P109	GCNT4	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4	GO:0042403; P:thyroid hormone metabolic process; IEA:Ensembl
Q9P109	GCNT4	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4	GO:0048729; P:tissue morphogenesis; IEA:Ensembl
Q5T4J0	GCNT6	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 6	GO:0008375; F:acetylglucosaminyltransferase activity; IEA:InterPro
Q5T4J0	GCNT6	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 6	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q6ZNI0	GCNT7	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7	GO:0008375; F:acetylglucosaminyltransferase activity; IEA:InterPro
Q6ZNI0	GCNT7	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q9BSJ2	TUBGCP2	Gamma-tubulin complex component 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BSJ2	TUBGCP2	Gamma-tubulin complex component 2	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q9BSJ2	TUBGCP2	Gamma-tubulin complex component 2	GO:0007020; P:microtubule nucleation; TAS:ProtInc
Q9BSJ2	TUBGCP2	Gamma-tubulin complex component 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9BSJ2	TUBGCP2	Gamma-tubulin complex component 2	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q96CW5	TUBGCP3	Gamma-tubulin complex component 3	GO:0043015; F:gamma-tubulin binding; IDA:UniProtKB
Q96CW5	TUBGCP3	Gamma-tubulin complex component 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q96CW5	TUBGCP3	Gamma-tubulin complex component 3	GO:0005200; F:structural constituent of cytoskeleton; NAS:UniProtKB
Q96CW5	TUBGCP3	Gamma-tubulin complex component 3	GO:0005198; F:structural molecule activity; NAS:ProtInc
Q96CW5	TUBGCP3	Gamma-tubulin complex component 3	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q96CW5	TUBGCP3	Gamma-tubulin complex component 3	GO:0007020; P:microtubule nucleation; NAS:UniProtKB
Q96CW5	TUBGCP3	Gamma-tubulin complex component 3	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q96CW5	TUBGCP3	Gamma-tubulin complex component 3	GO:0007338; P:single fertilization; NAS:UniProtKB
Q9UGJ1	TUBGCP4	Gamma-tubulin complex component 4	GO:0005200; F:structural constituent of cytoskeleton; NAS:UniProtKB
Q9UGJ1	TUBGCP4	Gamma-tubulin complex component 4	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q9UGJ1	TUBGCP4	Gamma-tubulin complex component 4	GO:0007020; P:microtubule nucleation; NAS:UniProtKB
Q9UGJ1	TUBGCP4	Gamma-tubulin complex component 4	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9UGJ1	TUBGCP4	Gamma-tubulin complex component 4	GO:0006461; P:protein complex assembly; NAS:ProtInc
Q96RT8	TUBGCP5	Gamma-tubulin complex component 5	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q96RT8	TUBGCP5	Gamma-tubulin complex component 5	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q96RT8	TUBGCP5	Gamma-tubulin complex component 5	GO:0007020; P:microtubule nucleation; IDA:UniProtKB
Q96RT8	TUBGCP5	Gamma-tubulin complex component 5	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9H3P7	ACBD3	Golgi resident protein GCP60	GO:0000062; F:fatty-acyl-CoA binding; IEA:InterPro
Q9H3P7	ACBD3	Golgi resident protein GCP60	GO:0005515; F:protein binding; IPI:IntAct
Q9H3P7	ACBD3	Golgi resident protein GCP60	GO:0006694; P:steroid biosynthetic process; IEA:UniProtKB-KW
Q9H3P7	ACBD3	Golgi resident protein GCP60	GO:0006810; P:transport; IEA:InterPro
Q96RT7	TUBGCP6	Gamma-tubulin complex component 6	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q96RT7	TUBGCP6	Gamma-tubulin complex component 6	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q96RT7	TUBGCP6	Gamma-tubulin complex component 6	GO:0007020; P:microtubule nucleation; IDA:UniProtKB
Q96RT7	TUBGCP6	Gamma-tubulin complex component 6	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P04150	NR3C1	Glucocorticoid receptor	GO:0004883; F:glucocorticoid receptor activity; TAS:ProtInc
P04150	NR3C1	Glucocorticoid receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P04150	NR3C1	Glucocorticoid receptor	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P04150	NR3C1	Glucocorticoid receptor	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P04150	NR3C1	Glucocorticoid receptor	GO:0005496; F:steroid binding; IEA:UniProtKB-KW
P04150	NR3C1	Glucocorticoid receptor	GO:0008270; F:zinc ion binding; IEA:InterPro
P04150	NR3C1	Glucocorticoid receptor	GO:0030325; P:adrenal gland development; IEA:Ensembl
P04150	NR3C1	Glucocorticoid receptor	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
P04150	NR3C1	Glucocorticoid receptor	GO:0010467; P:gene expression; TAS:Reactome
P04150	NR3C1	Glucocorticoid receptor	GO:0008211; P:glucocorticoid metabolic process; IEA:Ensembl
P04150	NR3C1	Glucocorticoid receptor	GO:0060603; P:mammary gland duct morphogenesis; IEA:Ensembl
P04150	NR3C1	Glucocorticoid receptor	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
P04150	NR3C1	Glucocorticoid receptor	GO:0031946; P:regulation of glucocorticoid biosynthetic process; IEA:Ensembl
P04150	NR3C1	Glucocorticoid receptor	GO:0006111; P:regulation of gluconeogenesis; IEA:Ensembl
P04150	NR3C1	Glucocorticoid receptor	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
P04150	NR3C1	Glucocorticoid receptor	GO:0007165; P:signal transduction; TAS:ProtInc
P04150	NR3C1	Glucocorticoid receptor	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P04150	NR3C1	Glucocorticoid receptor	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P04150	NR3C1	Glucocorticoid receptor	GO:0006351; P:transcription, DNA-templated; TAS:ProtInc
Q8N6F7	GCSAM	Germinal center-associated signaling and motility protein	GO:0003779; F:actin binding; IPI:UniProtKB
Q8N6F7	GCSAM	Germinal center-associated signaling and motility protein	GO:0045159; F:myosin II binding; IPI:UniProtKB
Q8N6F7	GCSAM	Germinal center-associated signaling and motility protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N6F7	GCSAM	Germinal center-associated signaling and motility protein	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q8N6F7	GCSAM	Germinal center-associated signaling and motility protein	GO:2000402; P:negative regulation of lymphocyte migration; IMP:UniProtKB
Q8N6F7	GCSAM	Germinal center-associated signaling and motility protein	GO:0050855; P:regulation of B cell receptor signaling pathway; IMP:UniProtKB
P23434	GCSH	Glycine cleavage system H protein, mitochondrial	GO:0004047; F:aminomethyltransferase activity; TAS:ProtInc
P23434	GCSH	Glycine cleavage system H protein, mitochondrial	GO:0006546; P:glycine catabolic process; TAS:ProtInc
P23434	GCSH	Glycine cleavage system H protein, mitochondrial	GO:0019464; P:glycine decarboxylation via glycine cleavage system; IEA:Ensembl
P23434	GCSH	Glycine cleavage system H protein, mitochondrial	GO:0032259; P:methylation; TAS:GOC
P23378	GLDC	Glycine dehydrogenase (decarboxylating), mitochondrial	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P23378	GLDC	Glycine dehydrogenase (decarboxylating), mitochondrial	GO:0004375; F:glycine dehydrogenase (decarboxylating) activity; TAS:ProtInc
P23378	GLDC	Glycine dehydrogenase (decarboxylating), mitochondrial	GO:0016829; F:lyase activity; IEA:InterPro
P23378	GLDC	Glycine dehydrogenase (decarboxylating), mitochondrial	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
P23378	GLDC	Glycine dehydrogenase (decarboxylating), mitochondrial	GO:0006546; P:glycine catabolic process; TAS:ProtInc
P48728	AMT	Aminomethyltransferase, mitochondrial	GO:0004047; F:aminomethyltransferase activity; IEA:UniProtKB-EC
P48728	AMT	Aminomethyltransferase, mitochondrial	GO:0008483; F:transaminase activity; IEA:UniProtKB-KW
P48728	AMT	Aminomethyltransferase, mitochondrial	GO:0006546; P:glycine catabolic process; TAS:ProtInc
P33402	GUCY1A2	Guanylate cyclase soluble subunit alpha-2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P33402	GUCY1A2	Guanylate cyclase soluble subunit alpha-2	GO:0004383; F:guanylate cyclase activity; TAS:ProtInc
P33402	GUCY1A2	Guanylate cyclase soluble subunit alpha-2	GO:0020037; F:heme binding; IEA:InterPro
P33402	GUCY1A2	Guanylate cyclase soluble subunit alpha-2	GO:0007596; P:blood coagulation; TAS:Reactome
P33402	GUCY1A2	Guanylate cyclase soluble subunit alpha-2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P33402	GUCY1A2	Guanylate cyclase soluble subunit alpha-2	GO:0030828; P:positive regulation of cGMP biosynthetic process; IEA:Ensembl
P33402	GUCY1A2	Guanylate cyclase soluble subunit alpha-2	GO:0007165; P:signal transduction; TAS:ProtInc
Q02108	GUCY1A3	Guanylate cyclase soluble subunit alpha-3	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q02108	GUCY1A3	Guanylate cyclase soluble subunit alpha-3	GO:0004383; F:guanylate cyclase activity; TAS:ProtInc
Q02108	GUCY1A3	Guanylate cyclase soluble subunit alpha-3	GO:0020037; F:heme binding; IEA:InterPro
Q02108	GUCY1A3	Guanylate cyclase soluble subunit alpha-3	GO:0004872; F:receptor activity; TAS:ProtInc
Q02108	GUCY1A3	Guanylate cyclase soluble subunit alpha-3	GO:0008015; P:blood circulation; TAS:ProtInc
Q02108	GUCY1A3	Guanylate cyclase soluble subunit alpha-3	GO:0007596; P:blood coagulation; TAS:Reactome
Q02108	GUCY1A3	Guanylate cyclase soluble subunit alpha-3	GO:0007263; P:nitric oxide mediated signal transduction; TAS:ProtInc
Q02108	GUCY1A3	Guanylate cyclase soluble subunit alpha-3	GO:0030828; P:positive regulation of cGMP biosynthetic process; IEA:Ensembl
Q02108	GUCY1A3	Guanylate cyclase soluble subunit alpha-3	GO:0008217; P:regulation of blood pressure; IEA:Ensembl
Q02108	GUCY1A3	Guanylate cyclase soluble subunit alpha-3	GO:0060087; P:relaxation of vascular smooth muscle; IEA:Ensembl
Q02108	GUCY1A3	Guanylate cyclase soluble subunit alpha-3	GO:0052565; P:response to defense-related host nitric oxide production; IEA:Ensembl
Q02153	GUCY1B3	Guanylate cyclase soluble subunit beta-1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q02153	GUCY1B3	Guanylate cyclase soluble subunit beta-1	GO:0004383; F:guanylate cyclase activity; IEA:InterPro
Q02153	GUCY1B3	Guanylate cyclase soluble subunit beta-1	GO:0020037; F:heme binding; IEA:InterPro
Q02153	GUCY1B3	Guanylate cyclase soluble subunit beta-1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q02153	GUCY1B3	Guanylate cyclase soluble subunit beta-1	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
Q02153	GUCY1B3	Guanylate cyclase soluble subunit beta-1	GO:0004872; F:receptor activity; TAS:ProtInc
Q02153	GUCY1B3	Guanylate cyclase soluble subunit beta-1	GO:0008015; P:blood circulation; TAS:ProtInc
Q02153	GUCY1B3	Guanylate cyclase soluble subunit beta-1	GO:0007596; P:blood coagulation; TAS:Reactome
Q02153	GUCY1B3	Guanylate cyclase soluble subunit beta-1	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q02153	GUCY1B3	Guanylate cyclase soluble subunit beta-1	GO:0007263; P:nitric oxide mediated signal transduction; TAS:ProtInc
O75343	GUCY1B2	Guanylate cyclase soluble subunit beta-2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
O75343	GUCY1B2	Guanylate cyclase soluble subunit beta-2	GO:0004383; F:guanylate cyclase activity; IEA:UniProtKB-EC
O75343	GUCY1B2	Guanylate cyclase soluble subunit beta-2	GO:0020037; F:heme binding; IEA:InterPro
O75343	GUCY1B2	Guanylate cyclase soluble subunit beta-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75343	GUCY1B2	Guanylate cyclase soluble subunit beta-2	GO:0007596; P:blood coagulation; TAS:Reactome
O75343	GUCY1B2	Guanylate cyclase soluble subunit beta-2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8TB36	GDAP1	Ganglioside-induced differentiation-associated protein 1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q8TB36	GDAP1	Ganglioside-induced differentiation-associated protein 1	GO:0000266; P:mitochondrial fission; IDA:UniProtKB
Q8TB36	GDAP1	Ganglioside-induced differentiation-associated protein 1	GO:0006626; P:protein targeting to mitochondrion; IMP:UniProtKB
Q8TB36	GDAP1	Ganglioside-induced differentiation-associated protein 1	GO:0032526; P:response to retinoic acid; IEA:Ensembl
Q9NXN4	GDAP2	Ganglioside-induced differentiation-associated protein 2	GO:0032526; P:response to retinoic acid; IEA:Ensembl
P16260	SLC25A16	Graves disease carrier protein	GO:0015297; F:antiporter activity; NAS:UniProtKB
P16260	SLC25A16	Graves disease carrier protein	GO:0009108; P:coenzyme biosynthetic process; TAS:Reactome
P16260	SLC25A16	Graves disease carrier protein	GO:0015939; P:pantothenate metabolic process; TAS:Reactome
P16260	SLC25A16	Graves disease carrier protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P16260	SLC25A16	Graves disease carrier protein	GO:0006810; P:transport; NAS:UniProtKB
P16260	SLC25A16	Graves disease carrier protein	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P16260	SLC25A16	Graves disease carrier protein	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9NZC3	GDE1	Glycerophosphodiester phosphodiesterase 1	GO:0008889; F:glycerophosphodiester phosphodiesterase activity; TAS:UniProtKB
Q9NZC3	GDE1	Glycerophosphodiester phosphodiesterase 1	GO:0047395; F:glycerophosphoinositol glycerophosphodiesterase activity; IEA:UniProtKB-EC
Q9NZC3	GDE1	Glycerophosphodiester phosphodiesterase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NZC3	GDE1	Glycerophosphodiester phosphodiesterase 1	GO:0006071; P:glycerol metabolic process; IEA:InterPro
Q9NZC3	GDE1	Glycerophosphodiester phosphodiesterase 1	GO:0006629; P:lipid metabolic process; TAS:UniProtKB
P35573	AGL	Glycogen debranching enzyme	GO:0004134; F:4-alpha-glucanotransferase activity; IBA:RefGenome
P35573	AGL	Glycogen debranching enzyme	GO:0004135; F:amylo-alpha-1,6-glucosidase activity; IBA:RefGenome
P35573	AGL	Glycogen debranching enzyme	GO:0004133; F:glycogen debranching enzyme activity; TAS:ProtInc
P35573	AGL	Glycogen debranching enzyme	GO:0030247; F:polysaccharide binding; IEA:Ensembl
P35573	AGL	Glycogen debranching enzyme	GO:0005515; F:protein binding; IPI:UniProtKB
P35573	AGL	Glycogen debranching enzyme	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P35573	AGL	Glycogen debranching enzyme	GO:0006006; P:glucose metabolic process; TAS:Reactome
P35573	AGL	Glycogen debranching enzyme	GO:0005978; P:glycogen biosynthetic process; IEA:UniProtKB-KW
P35573	AGL	Glycogen debranching enzyme	GO:0005980; P:glycogen catabolic process; IBA:RefGenome
P35573	AGL	Glycogen debranching enzyme	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P35573	AGL	Glycogen debranching enzyme	GO:0007584; P:response to nutrient; IEA:Ensembl
P35573	AGL	Glycogen debranching enzyme	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95390	GDF11	Growth/differentiation factor 11	GO:0048593; P:camera-type eye morphogenesis; IEA:Ensembl
O95390	GDF11	Growth/differentiation factor 11	GO:0048469; P:cell maturation; IEA:Ensembl
O95390	GDF11	Growth/differentiation factor 11	GO:0040007; P:growth; IEA:InterPro
O95390	GDF11	Growth/differentiation factor 11	GO:0007498; P:mesoderm development; TAS:UniProtKB
O95390	GDF11	Growth/differentiation factor 11	GO:0001656; P:metanephros development; IEA:Ensembl
O95390	GDF11	Growth/differentiation factor 11	GO:0045596; P:negative regulation of cell differentiation; IEA:Ensembl
O95390	GDF11	Growth/differentiation factor 11	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
O95390	GDF11	Growth/differentiation factor 11	GO:0007399; P:nervous system development; TAS:UniProtKB
O95390	GDF11	Growth/differentiation factor 11	GO:0031016; P:pancreas development; IEA:Ensembl
O95390	GDF11	Growth/differentiation factor 11	GO:0001501; P:skeletal system development; TAS:UniProtKB
O95390	GDF11	Growth/differentiation factor 11	GO:0021512; P:spinal cord anterior/posterior patterning; IEA:Ensembl
O95390	GDF11	Growth/differentiation factor 11	GO:0001657; P:ureteric bud development; IEA:Ensembl
P27539	GDF1	Embryonic growth/differentiation factor 1	GO:0040007; P:growth; IEA:InterPro
Q99988	GDF15	Growth/differentiation factor 15	GO:0005125; F:cytokine activity; TAS:ProtInc
Q99988	GDF15	Growth/differentiation factor 15	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q99988	GDF15	Growth/differentiation factor 15	GO:0007165; P:signal transduction; TAS:ProtInc
Q99988	GDF15	Growth/differentiation factor 15	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:ProtInc
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0005515; F:protein binding; IPI:BHF-UCL
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0032924; P:activin receptor signaling pathway; IDA:BHF-UCL
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0001525; P:angiogenesis; IMP:UniProtKB
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0048514; P:blood vessel morphogenesis; IDA:DFLAT
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0051216; P:cartilage development; TAS:DFLAT
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0006879; P:cellular iron ion homeostasis; TAS:DFLAT
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0040007; P:growth; IEA:InterPro
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0016525; P:negative regulation of angiogenesis; TAS:DFLAT
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0043537; P:negative regulation of blood vessel endothelial cell migration; TAS:DFLAT
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0030308; P:negative regulation of cell growth; IDA:BHF-UCL
Q9UK05	GDF2	Growth/differentiation factor 2	GO:2000279; P:negative regulation of DNA biosynthetic process; IDA:BHF-UCL
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0008156; P:negative regulation of DNA replication; TAS:DFLAT
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0010596; P:negative regulation of endothelial cell migration; IDA:BHF-UCL
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0001937; P:negative regulation of endothelial cell proliferation; IDA:DFLAT
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0001503; P:ossification; TAS:DFLAT
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0060389; P:pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0001569; P:patterning of blood vessels; IDA:DFLAT
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0045766; P:positive regulation of angiogenesis; IDA:DFLAT
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0030513; P:positive regulation of BMP signaling pathway; IEA:Ensembl
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0045603; P:positive regulation of endothelial cell differentiation; IEA:Ensembl
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:DFLAT
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0032757; P:positive regulation of interleukin-8 production; IDA:BHF-UCL
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
Q9UK05	GDF2	Growth/differentiation factor 2	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q9NR23	GDF3	Growth/differentiation factor 3	GO:0019901; F:protein kinase binding; IPI:UniProt
Q9NR23	GDF3	Growth/differentiation factor 3	GO:0007492; P:endoderm development; IEA:Ensembl
Q9NR23	GDF3	Growth/differentiation factor 3	GO:0001654; P:eye development; IMP:UniProtKB
Q9NR23	GDF3	Growth/differentiation factor 3	GO:0048859; P:formation of anatomical boundary; IEA:Ensembl
Q9NR23	GDF3	Growth/differentiation factor 3	GO:0040007; P:growth; IEA:InterPro
Q9NR23	GDF3	Growth/differentiation factor 3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9NR23	GDF3	Growth/differentiation factor 3	GO:0007498; P:mesoderm development; IEA:Ensembl
Q9NR23	GDF3	Growth/differentiation factor 3	GO:0030514; P:negative regulation of BMP signaling pathway; IDA:UniProt
Q9NR23	GDF3	Growth/differentiation factor 3	GO:0045605; P:negative regulation of epidermal cell differentiation; IDA:UniProt
Q9NR23	GDF3	Growth/differentiation factor 3	GO:0030903; P:notochord development; IEA:Ensembl
Q9NR23	GDF3	Growth/differentiation factor 3	GO:0090009; P:primitive streak formation; IEA:Ensembl
Q9NR23	GDF3	Growth/differentiation factor 3	GO:0010453; P:regulation of cell fate commitment; IDA:UniProt
Q9NR23	GDF3	Growth/differentiation factor 3	GO:0002021; P:response to dietary excess; IEA:Ensembl
Q9NR23	GDF3	Growth/differentiation factor 3	GO:0007165; P:signal transduction; IEA:Ensembl
Q9NR23	GDF3	Growth/differentiation factor 3	GO:0001501; P:skeletal system development; IMP:UniProtKB
Q9NR23	GDF3	Growth/differentiation factor 3	GO:0032525; P:somite rostral/caudal axis specification; IEA:Ensembl
P43026	GDF5	Growth/differentiation factor 5	GO:0008083; F:growth factor activity; TAS:ProtInc
P43026	GDF5	Growth/differentiation factor 5	GO:0005515; F:protein binding; IPI:IntAct
P43026	GDF5	Growth/differentiation factor 5	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P43026	GDF5	Growth/differentiation factor 5	GO:0002062; P:chondrocyte differentiation; IEA:Ensembl
P43026	GDF5	Growth/differentiation factor 5	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
P43026	GDF5	Growth/differentiation factor 5	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P43026	GDF5	Growth/differentiation factor 5	GO:0035136; P:forelimb morphogenesis; IEA:Ensembl
P43026	GDF5	Growth/differentiation factor 5	GO:0040007; P:growth; IEA:InterPro
P43026	GDF5	Growth/differentiation factor 5	GO:0035137; P:hindlimb morphogenesis; IEA:Ensembl
P43026	GDF5	Growth/differentiation factor 5	GO:0050680; P:negative regulation of epithelial cell proliferation; IDA:BHF-UCL
P43026	GDF5	Growth/differentiation factor 5	GO:2001054; P:negative regulation of mesenchymal cell apoptotic process; IEA:Ensembl
P43026	GDF5	Growth/differentiation factor 5	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P43026	GDF5	Growth/differentiation factor 5	GO:0032332; P:positive regulation of chondrocyte differentiation; IEA:Ensembl
P43026	GDF5	Growth/differentiation factor 5	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P43026	GDF5	Growth/differentiation factor 5	GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl
P43026	GDF5	Growth/differentiation factor 5	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:ProtInc
Q6KF10	GDF6	Growth/differentiation factor 6	GO:0032924; P:activin receptor signaling pathway; IDA:BHF-UCL
Q6KF10	GDF6	Growth/differentiation factor 6	GO:0006915; P:apoptotic process; ISS:UniProtKB
Q6KF10	GDF6	Growth/differentiation factor 6	GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL
Q6KF10	GDF6	Growth/differentiation factor 6	GO:0040007; P:growth; IEA:InterPro
Q6KF10	GDF6	Growth/differentiation factor 6	GO:0060389; P:pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
Q6KF10	GDF6	Growth/differentiation factor 6	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
Q6KF10	GDF6	Growth/differentiation factor 6	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
Q6KF10	GDF6	Growth/differentiation factor 6	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
Q6KF10	GDF6	Growth/differentiation factor 6	GO:1990009; P:retinal cell apoptotic process; ISS:UniProtKB
Q7Z4P5	GDF7	Growth/differentiation factor 7	GO:0005515; F:protein binding; IPI:BHF-UCL
Q7Z4P5	GDF7	Growth/differentiation factor 7	GO:0032924; P:activin receptor signaling pathway; IDA:BHF-UCL
Q7Z4P5	GDF7	Growth/differentiation factor 7	GO:0007411; P:axon guidance; IEA:Ensembl
Q7Z4P5	GDF7	Growth/differentiation factor 7	GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL
Q7Z4P5	GDF7	Growth/differentiation factor 7	GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl
Q7Z4P5	GDF7	Growth/differentiation factor 7	GO:0045165; P:cell fate commitment; IEA:Ensembl
Q7Z4P5	GDF7	Growth/differentiation factor 7	GO:0030855; P:epithelial cell differentiation; IEA:Ensembl
Q7Z4P5	GDF7	Growth/differentiation factor 7	GO:0048853; P:forebrain morphogenesis; IEA:Ensembl
Q7Z4P5	GDF7	Growth/differentiation factor 7	GO:0022612; P:gland morphogenesis; IEA:Ensembl
Q7Z4P5	GDF7	Growth/differentiation factor 7	GO:0040007; P:growth; IEA:InterPro
Q7Z4P5	GDF7	Growth/differentiation factor 7	GO:0030901; P:midbrain development; IEA:Ensembl
Q7Z4P5	GDF7	Growth/differentiation factor 7	GO:0060571; P:morphogenesis of an epithelial fold; IEA:Ensembl
Q7Z4P5	GDF7	Growth/differentiation factor 7	GO:0060389; P:pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
Q7Z4P5	GDF7	Growth/differentiation factor 7	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
Q7Z4P5	GDF7	Growth/differentiation factor 7	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
Q7Z4P5	GDF7	Growth/differentiation factor 7	GO:2001051; P:positive regulation of tendon cell differentiation; IEA:Ensembl
Q7Z4P5	GDF7	Growth/differentiation factor 7	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
Q7Z4P5	GDF7	Growth/differentiation factor 7	GO:0048608; P:reproductive structure development; IEA:Ensembl
Q7Z4P5	GDF7	Growth/differentiation factor 7	GO:0021509; P:roof plate formation; IEA:Ensembl
Q7Z4P5	GDF7	Growth/differentiation factor 7	GO:0021527; P:spinal cord association neuron differentiation; IEA:Ensembl
O14793	MSTN	Growth/differentiation factor 8	GO:0008083; F:growth factor activity; TAS:ProtInc
O14793	MSTN	Growth/differentiation factor 8	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
O14793	MSTN	Growth/differentiation factor 8	GO:0042802; F:identical protein binding; IPI:IntAct
O14793	MSTN	Growth/differentiation factor 8	GO:0005515; F:protein binding; IPI:IntAct
O14793	MSTN	Growth/differentiation factor 8	GO:0005102; F:receptor binding; IPI:HGNC
O14793	MSTN	Growth/differentiation factor 8	GO:0007517; P:muscle organ development; TAS:ProtInc
O14793	MSTN	Growth/differentiation factor 8	GO:0014741; P:negative regulation of muscle hypertrophy; IEA:Ensembl
O14793	MSTN	Growth/differentiation factor 8	GO:0048632; P:negative regulation of skeletal muscle tissue growth; IEA:Ensembl
O14793	MSTN	Growth/differentiation factor 8	GO:0022602; P:ovulation cycle process; IEA:Ensembl
O14793	MSTN	Growth/differentiation factor 8	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:HGNC
O14793	MSTN	Growth/differentiation factor 8	GO:0051602; P:response to electrical stimulus; IEA:Ensembl
O14793	MSTN	Growth/differentiation factor 8	GO:0043627; P:response to estrogen; IEA:Ensembl
O14793	MSTN	Growth/differentiation factor 8	GO:0045471; P:response to ethanol; IEA:Ensembl
O14793	MSTN	Growth/differentiation factor 8	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
O14793	MSTN	Growth/differentiation factor 8	GO:0009629; P:response to gravity; IEA:Ensembl
O14793	MSTN	Growth/differentiation factor 8	GO:0009408; P:response to heat; IEA:Ensembl
O14793	MSTN	Growth/differentiation factor 8	GO:0014850; P:response to muscle activity; IEA:Ensembl
O14793	MSTN	Growth/differentiation factor 8	GO:0033574; P:response to testosterone; IEA:Ensembl
O14793	MSTN	Growth/differentiation factor 8	GO:0014732; P:skeletal muscle atrophy; IEA:Ensembl
O14793	MSTN	Growth/differentiation factor 8	GO:0043403; P:skeletal muscle tissue regeneration; IEA:Ensembl
O14793	MSTN	Growth/differentiation factor 8	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl
O60383	GDF9	Growth/differentiation factor 9	GO:0008083; F:growth factor activity; TAS:ProtInc
O60383	GDF9	Growth/differentiation factor 9	GO:0007292; P:female gamete generation; TAS:ProtInc
O60383	GDF9	Growth/differentiation factor 9	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
O60383	GDF9	Growth/differentiation factor 9	GO:0001555; P:oocyte growth; IEA:Ensembl
O60383	GDF9	Growth/differentiation factor 9	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
O60383	GDF9	Growth/differentiation factor 9	GO:2000870; P:regulation of progesterone secretion; IDA:UniProtKB
O60383	GDF9	Growth/differentiation factor 9	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:ProtInc
P31150	GDI1	Rab GDP dissociation inhibitor alpha	GO:0005092; F:GDP-dissociation inhibitor activity; TAS:ProtInc
P31150	GDI1	Rab GDP dissociation inhibitor alpha	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
P31150	GDI1	Rab GDP dissociation inhibitor alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P31150	GDI1	Rab GDP dissociation inhibitor alpha	GO:0005093; F:Rab GDP-dissociation inhibitor activity; ISS:UniProtKB
P31150	GDI1	Rab GDP dissociation inhibitor alpha	GO:0050771; P:negative regulation of axonogenesis; ISS:UniProtKB
P31150	GDI1	Rab GDP dissociation inhibitor alpha	GO:0090315; P:negative regulation of protein targeting to membrane; IMP:UniProtKB
P31150	GDI1	Rab GDP dissociation inhibitor alpha	GO:0015031; P:protein transport; IEA:InterPro
P31150	GDI1	Rab GDP dissociation inhibitor alpha	GO:0032482; P:Rab protein signal transduction; ISS:UniProtKB
P31150	GDI1	Rab GDP dissociation inhibitor alpha	GO:0050790; P:regulation of catalytic activity; ISS:GOC
P31150	GDI1	Rab GDP dissociation inhibitor alpha	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P31150	GDI1	Rab GDP dissociation inhibitor alpha	GO:0051592; P:response to calcium ion; IEA:Ensembl
P31150	GDI1	Rab GDP dissociation inhibitor alpha	GO:0007165; P:signal transduction; TAS:ProtInc
P31150	GDI1	Rab GDP dissociation inhibitor alpha	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P50395	GDI2	Rab GDP dissociation inhibitor beta	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P50395	GDI2	Rab GDP dissociation inhibitor beta	GO:0005515; F:protein binding; IPI:UniProtKB
P50395	GDI2	Rab GDP dissociation inhibitor beta	GO:0005093; F:Rab GDP-dissociation inhibitor activity; TAS:ProtInc
P50395	GDI2	Rab GDP dissociation inhibitor beta	GO:0005097; F:Rab GTPase activator activity; IEA:Ensembl
P50395	GDI2	Rab GDP dissociation inhibitor beta	GO:0015031; P:protein transport; IEA:InterPro
P50395	GDI2	Rab GDP dissociation inhibitor beta	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P50395	GDI2	Rab GDP dissociation inhibitor beta	GO:0007165; P:signal transduction; TAS:UniProtKB
P50395	GDI2	Rab GDP dissociation inhibitor beta	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P52565	ARHGDIA	Rho GDP-dissociation inhibitor 1	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
P52565	ARHGDIA	Rho GDP-dissociation inhibitor 1	GO:0005515; F:protein binding; IPI:IntAct
P52565	ARHGDIA	Rho GDP-dissociation inhibitor 1	GO:0005094; F:Rho GDP-dissociation inhibitor activity; TAS:ProtInc
P52565	ARHGDIA	Rho GDP-dissociation inhibitor 1	GO:0006928; P:cellular component movement; TAS:UniProtKB
P52565	ARHGDIA	Rho GDP-dissociation inhibitor 1	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
P52565	ARHGDIA	Rho GDP-dissociation inhibitor 1	GO:0050771; P:negative regulation of axonogenesis; TAS:Reactome
P52565	ARHGDIA	Rho GDP-dissociation inhibitor 1	GO:0007162; P:negative regulation of cell adhesion; TAS:ProtInc
P52565	ARHGDIA	Rho GDP-dissociation inhibitor 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P52565	ARHGDIA	Rho GDP-dissociation inhibitor 1	GO:0050772; P:positive regulation of axonogenesis; TAS:Reactome
P52565	ARHGDIA	Rho GDP-dissociation inhibitor 1	GO:0050770; P:regulation of axonogenesis; TAS:Reactome
P52565	ARHGDIA	Rho GDP-dissociation inhibitor 1	GO:0050790; P:regulation of catalytic activity; TAS:GOC
P52565	ARHGDIA	Rho GDP-dissociation inhibitor 1	GO:0032880; P:regulation of protein localization; IEA:Ensembl
P52565	ARHGDIA	Rho GDP-dissociation inhibitor 1	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P52565	ARHGDIA	Rho GDP-dissociation inhibitor 1	GO:0007266; P:Rho protein signal transduction; TAS:ProtInc
P52565	ARHGDIA	Rho GDP-dissociation inhibitor 1	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P52566	ARHGDIB	Rho GDP-dissociation inhibitor 2	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
P52566	ARHGDIB	Rho GDP-dissociation inhibitor 2	GO:0005094; F:Rho GDP-dissociation inhibitor activity; TAS:ProtInc
P52566	ARHGDIB	Rho GDP-dissociation inhibitor 2	GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc
P52566	ARHGDIB	Rho GDP-dissociation inhibitor 2	GO:0006928; P:cellular component movement; TAS:UniProtKB
P52566	ARHGDIB	Rho GDP-dissociation inhibitor 2	GO:0006955; P:immune response; TAS:ProtInc
P52566	ARHGDIB	Rho GDP-dissociation inhibitor 2	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P52566	ARHGDIB	Rho GDP-dissociation inhibitor 2	GO:0007162; P:negative regulation of cell adhesion; TAS:ProtInc
P52566	ARHGDIB	Rho GDP-dissociation inhibitor 2	GO:0050790; P:regulation of catalytic activity; TAS:GOC
P52566	ARHGDIB	Rho GDP-dissociation inhibitor 2	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P52566	ARHGDIB	Rho GDP-dissociation inhibitor 2	GO:0007266; P:Rho protein signal transduction; TAS:ProtInc
P52566	ARHGDIB	Rho GDP-dissociation inhibitor 2	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q99819	ARHGDIG	Rho GDP-dissociation inhibitor 3	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q99819	ARHGDIG	Rho GDP-dissociation inhibitor 3	GO:0005094; F:Rho GDP-dissociation inhibitor activity; TAS:ProtInc
Q99819	ARHGDIG	Rho GDP-dissociation inhibitor 3	GO:0007162; P:negative regulation of cell adhesion; TAS:ProtInc
Q99819	ARHGDIG	Rho GDP-dissociation inhibitor 3	GO:0050790; P:regulation of catalytic activity; TAS:GOC
Q99819	ARHGDIG	Rho GDP-dissociation inhibitor 3	GO:0032880; P:regulation of protein localization; IEA:Ensembl
Q99819	ARHGDIG	Rho GDP-dissociation inhibitor 3	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q99819	ARHGDIG	Rho GDP-dissociation inhibitor 3	GO:0007266; P:Rho protein signal transduction; TAS:ProtInc
Q99819	ARHGDIG	Rho GDP-dissociation inhibitor 3	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0005102; F:receptor binding; TAS:ProtInc
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0008344; P:adult locomotory behavior; TAS:BHF-UCL
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0007411; P:axon guidance; TAS:Reactome
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0001658; P:branching involved in ureteric bud morphogenesis; ISS:UniProtKB
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0048484; P:enteric nervous system development; ISS:UniProtKB
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0003337; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; IEA:Ensembl
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0001656; P:metanephros development; ISS:UniProtKB
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0048255; P:mRNA stabilization; IDA:BHF-UCL
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IDA:UniProtKB
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0043524; P:negative regulation of neuron apoptotic process; IDA:UniProtKB
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0007399; P:nervous system development; TAS:ProtInc
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0001755; P:neural crest cell migration; IDA:MGI
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0031175; P:neuron projection development; IDA:MGI
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0001759; P:organ induction; IEA:Ensembl
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0030432; P:peristalsis; ISS:UniProtKB
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; IDA:UniProtKB
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0033603; P:positive regulation of dopamine secretion; TAS:BHF-UCL
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0072108; P:positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; IEA:Ensembl
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0032770; P:positive regulation of monooxygenase activity; IDA:BHF-UCL
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0072107; P:positive regulation of ureteric bud formation; IDA:UniProtKB
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0021784; P:postganglionic parasympathetic nervous system development; ISS:UniProtKB
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0001941; P:postsynaptic membrane organization; IEA:Ensembl
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0051584; P:regulation of dopamine uptake involved in synaptic transmission; IDA:UniProtKB
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0060688; P:regulation of morphogenesis of a branching structure; ISS:UniProtKB
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0007165; P:signal transduction; TAS:ProtInc
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0048485; P:sympathetic nervous system development; ISS:UniProtKB
P39905	GDNF	Glial cell line-derived neurotrophic factor	GO:0060676; P:ureteric bud formation; IEA:Ensembl
P07093	SERPINE2	Glia-derived nexin	GO:0005539; F:glycosaminoglycan binding; IDA:BHF-UCL
P07093	SERPINE2	Glia-derived nexin	GO:0008201; F:heparin binding; IDA:BHF-UCL
P07093	SERPINE2	Glia-derived nexin	GO:0005515; F:protein binding; IPI:UniProtKB
P07093	SERPINE2	Glia-derived nexin	GO:0005102; F:receptor binding; IPI:BHF-UCL
P07093	SERPINE2	Glia-derived nexin	GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:BHF-UCL
P07093	SERPINE2	Glia-derived nexin	GO:0007596; P:blood coagulation; IEA:Ensembl
P07093	SERPINE2	Glia-derived nexin	GO:0021683; P:cerebellar granular layer morphogenesis; IEA:Ensembl
P07093	SERPINE2	Glia-derived nexin	GO:0050974; P:detection of mechanical stimulus involved in sensory perception; IEA:Ensembl
P07093	SERPINE2	Glia-derived nexin	GO:0060384; P:innervation; IEA:Ensembl
P07093	SERPINE2	Glia-derived nexin	GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl
P07093	SERPINE2	Glia-derived nexin	GO:0042628; P:mating plug formation; IEA:Ensembl
P07093	SERPINE2	Glia-derived nexin	GO:0030195; P:negative regulation of blood coagulation; IDA:BHF-UCL
P07093	SERPINE2	Glia-derived nexin	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
P07093	SERPINE2	Glia-derived nexin	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P07093	SERPINE2	Glia-derived nexin	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P07093	SERPINE2	Glia-derived nexin	GO:0014067; P:negative regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl
P07093	SERPINE2	Glia-derived nexin	GO:0010757; P:negative regulation of plasminogen activation; IMP:BHF-UCL
P07093	SERPINE2	Glia-derived nexin	GO:0010544; P:negative regulation of platelet activation; IEA:Ensembl
P07093	SERPINE2	Glia-derived nexin	GO:0090331; P:negative regulation of platelet aggregation; ISS:BHF-UCL
P07093	SERPINE2	Glia-derived nexin	GO:0042177; P:negative regulation of protein catabolic process; IEA:Ensembl
P07093	SERPINE2	Glia-derived nexin	GO:0010955; P:negative regulation of protein processing; IC:BHF-UCL
P07093	SERPINE2	Glia-derived nexin	GO:0045861; P:negative regulation of proteolysis; IDA:BHF-UCL
P07093	SERPINE2	Glia-derived nexin	GO:0045879; P:negative regulation of smoothened signaling pathway; IEA:Ensembl
P07093	SERPINE2	Glia-derived nexin	GO:0010766; P:negative regulation of sodium ion transport; IEA:Ensembl
P07093	SERPINE2	Glia-derived nexin	GO:0048711; P:positive regulation of astrocyte differentiation; IDA:BHF-UCL
P07093	SERPINE2	Glia-derived nexin	GO:0030334; P:regulation of cell migration; NAS:UniProtKB
P07093	SERPINE2	Glia-derived nexin	GO:0051966; P:regulation of synaptic transmission, glutamatergic; IEA:Ensembl
P07093	SERPINE2	Glia-derived nexin	GO:0048505; P:regulation of timing of cell differentiation; IEA:Ensembl
P07093	SERPINE2	Glia-derived nexin	GO:0032940; P:secretion by cell; IEA:Ensembl
P07093	SERPINE2	Glia-derived nexin	GO:0033363; P:secretory granule organization; IEA:Ensembl
P07093	SERPINE2	Glia-derived nexin	GO:0061108; P:seminal vesicle epithelium development; IEA:Ensembl
Q8N9F7	GDPD1	Glycerophosphodiester phosphodiesterase domain-containing protein 1	GO:0008889; F:glycerophosphodiester phosphodiesterase activity; IEA:InterPro
Q8N9F7	GDPD1	Glycerophosphodiester phosphodiesterase domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N9F7	GDPD1	Glycerophosphodiester phosphodiesterase domain-containing protein 1	GO:0006071; P:glycerol metabolic process; IEA:InterPro
Q8N9F7	GDPD1	Glycerophosphodiester phosphodiesterase domain-containing protein 1	GO:0006629; P:lipid metabolic process; IEA:InterPro
Q9HCC8	GDPD2	Glycerophosphoinositol inositolphosphodiesterase GDPD2	GO:0008889; F:glycerophosphodiester phosphodiesterase activity; IEA:InterPro
Q9HCC8	GDPD2	Glycerophosphoinositol inositolphosphodiesterase GDPD2	GO:0047394; F:glycerophosphoinositol inositolphosphodiesterase activity; IEA:UniProtKB-EC
Q9HCC8	GDPD2	Glycerophosphoinositol inositolphosphodiesterase GDPD2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HCC8	GDPD2	Glycerophosphoinositol inositolphosphodiesterase GDPD2	GO:0006071; P:glycerol metabolic process; IEA:InterPro
Q9HCC8	GDPD2	Glycerophosphoinositol inositolphosphodiesterase GDPD2	GO:0006629; P:lipid metabolic process; IEA:InterPro
Q7L5L3	GDPD3	Glycerophosphodiester phosphodiesterase domain-containing protein 3	GO:0008889; F:glycerophosphodiester phosphodiesterase activity; IEA:InterPro
Q7L5L3	GDPD3	Glycerophosphodiester phosphodiesterase domain-containing protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7L5L3	GDPD3	Glycerophosphodiester phosphodiesterase domain-containing protein 3	GO:0006071; P:glycerol metabolic process; IEA:InterPro
Q7L5L3	GDPD3	Glycerophosphodiester phosphodiesterase domain-containing protein 3	GO:0006629; P:lipid metabolic process; IEA:InterPro
Q6W3E5	GDPD4	Glycerophosphodiester phosphodiesterase domain-containing protein 4	GO:0008889; F:glycerophosphodiester phosphodiesterase activity; IEA:InterPro
Q6W3E5	GDPD4	Glycerophosphodiester phosphodiesterase domain-containing protein 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6W3E5	GDPD4	Glycerophosphodiester phosphodiesterase domain-containing protein 4	GO:0006071; P:glycerol metabolic process; IEA:InterPro
Q6W3E5	GDPD4	Glycerophosphodiester phosphodiesterase domain-containing protein 4	GO:0006629; P:lipid metabolic process; IEA:InterPro
Q8WTR4	GDPD5	Glycerophosphodiester phosphodiesterase domain-containing protein 5	GO:0008889; F:glycerophosphodiester phosphodiesterase activity; IEA:InterPro
Q8WTR4	GDPD5	Glycerophosphodiester phosphodiesterase domain-containing protein 5	GO:0021895; P:cerebral cortex neuron differentiation; IEA:Ensembl
Q8WTR4	GDPD5	Glycerophosphodiester phosphodiesterase domain-containing protein 5	GO:0006071; P:glycerol metabolic process; IEA:InterPro
Q8WTR4	GDPD5	Glycerophosphodiester phosphodiesterase domain-containing protein 5	GO:0006629; P:lipid metabolic process; IEA:InterPro
Q8WTR4	GDPD5	Glycerophosphodiester phosphodiesterase domain-containing protein 5	GO:0045746; P:negative regulation of Notch signaling pathway; IEA:Ensembl
Q8WTR4	GDPD5	Glycerophosphodiester phosphodiesterase domain-containing protein 5	GO:0031175; P:neuron projection development; IEA:Ensembl
Q8WTR4	GDPD5	Glycerophosphodiester phosphodiesterase domain-containing protein 5	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
Q8WTR4	GDPD5	Glycerophosphodiester phosphodiesterase domain-containing protein 5	GO:0048505; P:regulation of timing of cell differentiation; IEA:Ensembl
Q8WTR4	GDPD5	Glycerophosphodiester phosphodiesterase domain-containing protein 5	GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl
Q6ZNW5	GDPGP1	GDP-D-glucose phosphorylase 1	GO:0080048; F:GDP-D-glucose phosphorylase activity; IDA:UniProtKB
Q6ZNW5	GDPGP1	GDP-D-glucose phosphorylase 1	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW
Q6ZNW5	GDPGP1	GDP-D-glucose phosphorylase 1	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q6ZNW5	GDPGP1	GDP-D-glucose phosphorylase 1	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
Q6ZNW5	GDPGP1	GDP-D-glucose phosphorylase 1	GO:0016779; F:nucleotidyltransferase activity; IEA:UniProtKB-KW
Q6ZNW5	GDPGP1	GDP-D-glucose phosphorylase 1	GO:0006006; P:glucose metabolic process; IMP:UniProtKB
P52306	RAP1GDS1	Rap1 GTPase-GDP dissociation stimulator 1	GO:0005096; F:GTPase activator activity; NAS:UniProtKB
P52306	RAP1GDS1	Rap1 GTPase-GDP dissociation stimulator 1	GO:0031034; P:myosin filament assembly; IEA:Ensembl
P52306	RAP1GDS1	Rap1 GTPase-GDP dissociation stimulator 1	GO:0032321; P:positive regulation of Rho GTPase activity; IEA:Ensembl
P52306	RAP1GDS1	Rap1 GTPase-GDP dissociation stimulator 1	GO:0014829; P:vascular smooth muscle contraction; IEA:Ensembl
P06396	GSN	Gelsolin	GO:0005509; F:calcium ion binding; TAS:ProtInc
P06396	GSN	Gelsolin	GO:0005515; F:protein binding; IPI:IntAct
P06396	GSN	Gelsolin	GO:0030041; P:actin filament polymerization; IDA:UniProtKB
P06396	GSN	Gelsolin	GO:0051014; P:actin filament severing; IDA:UniProtKB
P06396	GSN	Gelsolin	GO:0007568; P:aging; IEA:Ensembl
P06396	GSN	Gelsolin	GO:0006915; P:apoptotic process; TAS:Reactome
P06396	GSN	Gelsolin	GO:0051016; P:barbed-end actin filament capping; TAS:ProtInc
P06396	GSN	Gelsolin	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
P06396	GSN	Gelsolin	GO:0071276; P:cellular response to cadmium ion; IEA:Ensembl
P06396	GSN	Gelsolin	GO:0060271; P:cilium morphogenesis; IMP:UniProtKB
P06396	GSN	Gelsolin	GO:0014003; P:oligodendrocyte development; IEA:Ensembl
P06396	GSN	Gelsolin	GO:0048015; P:phosphatidylinositol-mediated signaling; IEA:Ensembl
P06396	GSN	Gelsolin	GO:0030155; P:regulation of cell adhesion; IEA:Ensembl
P06396	GSN	Gelsolin	GO:0045471; P:response to ethanol; IEA:Ensembl
P06396	GSN	Gelsolin	GO:0051593; P:response to folic acid; IEA:Ensembl
P06396	GSN	Gelsolin	GO:0042246; P:tissue regeneration; IEA:Ensembl
P06396	GSN	Gelsolin	GO:0016192; P:vesicle-mediated transport; IEA:Ensembl
A6NCL1	GMNC	Geminin coiled-coil domain-containing protein 1	GO:0003682; F:chromatin binding; ISS:UniProtKB
A6NCL1	GMNC	Geminin coiled-coil domain-containing protein 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
A6NCL1	GMNC	Geminin coiled-coil domain-containing protein 1	GO:0008283; P:cell proliferation; ISS:UniProtKB
A6NCL1	GMNC	Geminin coiled-coil domain-containing protein 1	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
A6NCL1	GMNC	Geminin coiled-coil domain-containing protein 1	GO:0006275; P:regulation of DNA replication; IEA:InterPro
O14893	GEMIN2	Gem-associated protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
O14893	GEMIN2	Gem-associated protein 2	GO:0010467; P:gene expression; TAS:Reactome
O14893	GEMIN2	Gem-associated protein 2	GO:0006397; P:mRNA processing; TAS:ProtInc
O14893	GEMIN2	Gem-associated protein 2	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
O14893	GEMIN2	Gem-associated protein 2	GO:0016070; P:RNA metabolic process; TAS:Reactome
O14893	GEMIN2	Gem-associated protein 2	GO:0008380; P:RNA splicing; TAS:UniProtKB
O14893	GEMIN2	Gem-associated protein 2	GO:0000375; P:RNA splicing, via transesterification reactions; TAS:UniProtKB
O14893	GEMIN2	Gem-associated protein 2	GO:0000245; P:spliceosomal complex assembly; TAS:ProtInc
O14893	GEMIN2	Gem-associated protein 2	GO:0000387; P:spliceosomal snRNP assembly; IDA:UniProtKB
P57678	GEMIN4	Gem-associated protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
P57678	GEMIN4	Gem-associated protein 4	GO:0010467; P:gene expression; TAS:Reactome
P57678	GEMIN4	Gem-associated protein 4	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
P57678	GEMIN4	Gem-associated protein 4	GO:0016070; P:RNA metabolic process; TAS:Reactome
P57678	GEMIN4	Gem-associated protein 4	GO:0006364; P:rRNA processing; TAS:ProtInc
P57678	GEMIN4	Gem-associated protein 4	GO:0000387; P:spliceosomal snRNP assembly; IDA:UniProtKB
Q8TEQ6	GEMIN5	Gem-associated protein 5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8TEQ6	GEMIN5	Gem-associated protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TEQ6	GEMIN5	Gem-associated protein 5	GO:0017069; F:snRNA binding; IDA:UniProtKB
Q8TEQ6	GEMIN5	Gem-associated protein 5	GO:0010467; P:gene expression; TAS:Reactome
Q8TEQ6	GEMIN5	Gem-associated protein 5	GO:0000398; P:mRNA splicing, via spliceosome; TAS:UniProtKB
Q8TEQ6	GEMIN5	Gem-associated protein 5	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
Q8TEQ6	GEMIN5	Gem-associated protein 5	GO:0006461; P:protein complex assembly; TAS:UniProtKB
Q8TEQ6	GEMIN5	Gem-associated protein 5	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q8TEQ6	GEMIN5	Gem-associated protein 5	GO:0000387; P:spliceosomal snRNP assembly; IDA:UniProtKB
Q8WXD5	GEMIN6	Gem-associated protein 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WXD5	GEMIN6	Gem-associated protein 6	GO:0010467; P:gene expression; TAS:Reactome
Q8WXD5	GEMIN6	Gem-associated protein 6	GO:0000398; P:mRNA splicing, via spliceosome; TAS:UniProtKB
Q8WXD5	GEMIN6	Gem-associated protein 6	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
Q8WXD5	GEMIN6	Gem-associated protein 6	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q8WXD5	GEMIN6	Gem-associated protein 6	GO:0000245; P:spliceosomal complex assembly; IEA:InterPro
Q8WXD5	GEMIN6	Gem-associated protein 6	GO:0000387; P:spliceosomal snRNP assembly; IDA:UniProtKB
Q9H840	GEMIN7	Gem-associated protein 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H840	GEMIN7	Gem-associated protein 7	GO:0010467; P:gene expression; TAS:Reactome
Q9H840	GEMIN7	Gem-associated protein 7	GO:0000398; P:mRNA splicing, via spliceosome; TAS:UniProtKB
Q9H840	GEMIN7	Gem-associated protein 7	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
Q9H840	GEMIN7	Gem-associated protein 7	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9H840	GEMIN7	Gem-associated protein 7	GO:0000387; P:spliceosomal snRNP assembly; IDA:UniProtKB
Q9NWZ8	GEMIN8	Gem-associated protein 8	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NWZ8	GEMIN8	Gem-associated protein 8	GO:0000387; P:spliceosomal snRNP assembly; IDA:UniProtKB
O75496	GMNN	Geminin	GO:0042826; F:histone deacetylase binding; IPI:UniProtKB
O75496	GMNN	Geminin	GO:0005515; F:protein binding; IPI:UniProtKB
O75496	GMNN	Geminin	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
O75496	GMNN	Geminin	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O75496	GMNN	Geminin	GO:0045786; P:negative regulation of cell cycle; IDA:UniProtKB
O75496	GMNN	Geminin	GO:0008156; P:negative regulation of DNA replication; IDA:UniProtKB
O75496	GMNN	Geminin	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
O75496	GMNN	Geminin	GO:0009887; P:organ morphogenesis; IEA:Ensembl
O75496	GMNN	Geminin	GO:0006461; P:protein complex assembly; IEA:Ensembl
P55040	GEM	GTP-binding protein GEM	GO:0019003; F:GDP binding; IDA:BHF-UCL
P55040	GEM	GTP-binding protein GEM	GO:0005525; F:GTP binding; IDA:BHF-UCL
P55040	GEM	GTP-binding protein GEM	GO:0003924; F:GTPase activity; IDA:BHF-UCL
P55040	GEM	GTP-binding protein GEM	GO:0000287; F:magnesium ion binding; IDA:BHF-UCL
P55040	GEM	GTP-binding protein GEM	GO:0005515; F:protein binding; IPI:IntAct
P55040	GEM	GTP-binding protein GEM	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P55040	GEM	GTP-binding protein GEM	GO:0051276; P:chromosome organization; IMP:UniProtKB
P55040	GEM	GTP-binding protein GEM	GO:0006955; P:immune response; TAS:ProtInc
P55040	GEM	GTP-binding protein GEM	GO:0051310; P:metaphase plate congression; IMP:UniProt
P55040	GEM	GTP-binding protein GEM	GO:0007067; P:mitosis; IMP:UniProtKB
P55040	GEM	GTP-binding protein GEM	GO:0007165; P:signal transduction; TAS:ProtInc
P55040	GEM	GTP-binding protein GEM	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q17RS7	GEN1	Flap endonuclease GEN homolog 1	GO:0008821; F:crossover junction endodeoxyribonuclease activity; IMP:UniProtKB
Q17RS7	GEN1	Flap endonuclease GEN homolog 1	GO:0003677; F:DNA binding; IEA:InterPro
Q17RS7	GEN1	Flap endonuclease GEN homolog 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q17RS7	GEN1	Flap endonuclease GEN homolog 1	GO:0000737; P:DNA catabolic process, endonucleolytic; IMP:GOC
Q17RS7	GEN1	Flap endonuclease GEN homolog 1	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
Q17RS7	GEN1	Flap endonuclease GEN homolog 1	GO:0090267; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; IMP:UniProtKB
Q17RS7	GEN1	Flap endonuclease GEN homolog 1	GO:0010824; P:regulation of centrosome duplication; IMP:UniProtKB
Q17RS7	GEN1	Flap endonuclease GEN homolog 1	GO:0071140; P:resolution of mitotic recombination intermediates; IMP:UniProtKB
Q17RS7	GEN1	Flap endonuclease GEN homolog 1	GO:0071139; P:resolution of recombination intermediates; IMP:UniProtKB
Q9NQX3	GPHN	Gephyrin	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NQX3	GPHN	Gephyrin	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NQX3	GPHN	Gephyrin	GO:0061598; F:molybdopterin adenylyltransferase activity; IEA:UniProtKB-EC
Q9NQX3	GPHN	Gephyrin	GO:0061599; F:molybdopterin molybdotransferase activity; IEA:UniProtKB-EC
Q9NQX3	GPHN	Gephyrin	GO:0016740; F:transferase activity; TAS:Reactome
Q9NQX3	GPHN	Gephyrin	GO:0007529; P:establishment of synaptic specificity at neuromuscular junction; IEA:Ensembl
Q9NQX3	GPHN	Gephyrin	GO:0006777; P:Mo-molybdopterin cofactor biosynthetic process; IEA:UniProtKB-KW
Q9NQX3	GPHN	Gephyrin	GO:0032324; P:molybdopterin cofactor biosynthetic process; TAS:Reactome
Q9NQX3	GPHN	Gephyrin	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NQX3	GPHN	Gephyrin	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9NQX3	GPHN	Gephyrin	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q7L5D6	GET4	Golgi to ER traffic protein 4 homolog	GO:0071816; P:tail-anchored membrane protein insertion into ER membrane; IMP:UniProtKB
Q7L5D6	GET4	Golgi to ER traffic protein 4 homolog	GO:0006810; P:transport; IEA:UniProtKB-KW
P14136	GFAP	Glial fibrillary acidic protein	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P14136	GFAP	Glial fibrillary acidic protein	GO:0014002; P:astrocyte development; IEA:Ensembl
P14136	GFAP	Glial fibrillary acidic protein	GO:0060020; P:Bergmann glial cell differentiation; IEA:Ensembl
P14136	GFAP	Glial fibrillary acidic protein	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
P14136	GFAP	Glial fibrillary acidic protein	GO:0045109; P:intermediate filament organization; IEA:Ensembl
P14136	GFAP	Glial fibrillary acidic protein	GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl
P14136	GFAP	Glial fibrillary acidic protein	GO:0010977; P:negative regulation of neuron projection development; IEA:Ensembl
P14136	GFAP	Glial fibrillary acidic protein	GO:0031102; P:neuron projection regeneration; IEA:Ensembl
P14136	GFAP	Glial fibrillary acidic protein	GO:0010625; P:positive regulation of Schwann cell proliferation; IEA:Ensembl
P14136	GFAP	Glial fibrillary acidic protein	GO:0051580; P:regulation of neurotransmitter uptake; IEA:Ensembl
P14136	GFAP	Glial fibrillary acidic protein	GO:0009611; P:response to wounding; IEA:Ensembl
Q5VTD9	GFI1B	Zinc finger protein Gfi-1b	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5VTD9	GFI1B	Zinc finger protein Gfi-1b	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5VTD9	GFI1B	Zinc finger protein Gfi-1b	GO:0005515; F:protein binding; IPI:UniProtKB
Q5VTD9	GFI1B	Zinc finger protein Gfi-1b	GO:0001085; F:RNA polymerase II transcription factor binding; IPI:BHF-UCL
Q5VTD9	GFI1B	Zinc finger protein Gfi-1b	GO:0008283; P:cell proliferation; TAS:ProtInc
Q5VTD9	GFI1B	Zinc finger protein Gfi-1b	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q5VTD9	GFI1B	Zinc finger protein Gfi-1b	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q5VTD9	GFI1B	Zinc finger protein Gfi-1b	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q5VTD9	GFI1B	Zinc finger protein Gfi-1b	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IDA:UniProt
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0042491; P:auditory receptor cell differentiation; IEA:Ensembl
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0045165; P:cell fate commitment; IEA:Ensembl
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0071222; P:cellular response to lipopolysaccharide; IEP:UniProtKB
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0007638; P:mechanosensory behavior; IEA:Ensembl
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0010956; P:negative regulation of calcidiol 1-monooxygenase activity; IDA:BHF-UCL
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0009996; P:negative regulation of cell fate specification; IEA:Ensembl
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0010977; P:negative regulation of neuron projection development; IDA:UniProtKB
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; ISS:UniProtKB
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0010957; P:negative regulation of vitamin D biosynthetic process; IC:BHF-UCL
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0042660; P:positive regulation of cell fate specification; IEA:Ensembl
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0070105; P:positive regulation of interleukin-6-mediated signaling pathway; IDA:UniProtKB
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0034121; P:regulation of toll-like receptor signaling pathway; IDA:UniProtKB
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; TAS:ProtInc
Q99684	GFI1	Zinc finger protein Gfi-1	GO:0016032; P:viral process; TAS:ProtInc
Q9NXC2	GFOD1	Glucose-fructose oxidoreductase domain-containing protein 1	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q3B7J2	GFOD2	Glucose-fructose oxidoreductase domain-containing protein 2	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q3B7J2	GFOD2	Glucose-fructose oxidoreductase domain-containing protein 2	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q06210	GFPT1	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1	GO:0016597; F:amino acid binding; IEA:Ensembl
Q06210	GFPT1	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1	GO:0030246; F:carbohydrate binding; IEA:Ensembl
Q06210	GFPT1	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1	GO:0004360; F:glutamine-fructose-6-phosphate transaminase (isomerizing) activity; TAS:ProtInc
Q06210	GFPT1	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q06210	GFPT1	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1	GO:0016051; P:carbohydrate biosynthetic process; IEA:InterPro
Q06210	GFPT1	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q06210	GFPT1	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1	GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl
Q06210	GFPT1	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1	GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB
Q06210	GFPT1	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q06210	GFPT1	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q06210	GFPT1	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1	GO:0006112; P:energy reserve metabolic process; TAS:ProtInc
Q06210	GFPT1	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1	GO:0006002; P:fructose 6-phosphate metabolic process; TAS:ProtInc
Q06210	GFPT1	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1	GO:0006042; P:glucosamine biosynthetic process; IEA:Ensembl
Q06210	GFPT1	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1	GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW
Q06210	GFPT1	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1	GO:0045719; P:negative regulation of glycogen biosynthetic process; IEA:Ensembl
Q06210	GFPT1	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q06210	GFPT1	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1	GO:0051289; P:protein homotetramerization; IEA:Ensembl
Q06210	GFPT1	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q06210	GFPT1	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1	GO:0009744; P:response to sucrose; IEA:Ensembl
Q06210	GFPT1	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1	GO:0006048; P:UDP-N-acetylglucosamine biosynthetic process; TAS:Reactome
O94808	GFPT2	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2	GO:0030246; F:carbohydrate binding; IEA:InterPro
O94808	GFPT2	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2	GO:0004360; F:glutamine-fructose-6-phosphate transaminase (isomerizing) activity; TAS:ProtInc
O94808	GFPT2	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2	GO:0016051; P:carbohydrate biosynthetic process; IEA:InterPro
O94808	GFPT2	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O94808	GFPT2	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
O94808	GFPT2	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2	GO:0006112; P:energy reserve metabolic process; TAS:ProtInc
O94808	GFPT2	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2	GO:0006002; P:fructose 6-phosphate metabolic process; TAS:ProtInc
O94808	GFPT2	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2	GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW
O94808	GFPT2	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2	GO:0043687; P:post-translational protein modification; TAS:Reactome
O94808	GFPT2	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
O94808	GFPT2	Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2	GO:0006048; P:UDP-N-acetylglucosamine biosynthetic process; TAS:Reactome
P56159	GFRA1	GDNF family receptor alpha-1	GO:0016167; F:glial cell-derived neurotrophic factor receptor activity; TAS:ProtInc
P56159	GFRA1	GDNF family receptor alpha-1	GO:0005102; F:receptor binding; TAS:ProtInc
P56159	GFRA1	GDNF family receptor alpha-1	GO:0007411; P:axon guidance; TAS:Reactome
P56159	GFRA1	GDNF family receptor alpha-1	GO:0007166; P:cell surface receptor signaling pathway; NAS:UniProtKB
P56159	GFRA1	GDNF family receptor alpha-1	GO:0035860; P:glial cell-derived neurotrophic factor receptor signaling pathway; TAS:GOC
O00451	GFRA2	GDNF family receptor alpha-2	GO:0016167; F:glial cell-derived neurotrophic factor receptor activity; TAS:ProtInc
O00451	GFRA2	GDNF family receptor alpha-2	GO:0031953; P:negative regulation of protein autophosphorylation; IEA:Ensembl
O00451	GFRA2	GDNF family receptor alpha-2	GO:0007399; P:nervous system development; IEA:Ensembl
O00451	GFRA2	GDNF family receptor alpha-2	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc
O60609	GFRA3	GDNF family receptor alpha-3	GO:0008046; F:axon guidance receptor activity; IEA:Ensembl
O60609	GFRA3	GDNF family receptor alpha-3	GO:0005102; F:receptor binding; TAS:ProtInc
O60609	GFRA3	GDNF family receptor alpha-3	GO:0007399; P:nervous system development; TAS:ProtInc
O60609	GFRA3	GDNF family receptor alpha-3	GO:0001764; P:neuron migration; IEA:Ensembl
O60609	GFRA3	GDNF family receptor alpha-3	GO:0007422; P:peripheral nervous system development; TAS:ProtInc
O60609	GFRA3	GDNF family receptor alpha-3	GO:0007165; P:signal transduction; TAS:ProtInc
O60609	GFRA3	GDNF family receptor alpha-3	GO:0048485; P:sympathetic nervous system development; IEA:Ensembl
Q9GZZ7	GFRA4	GDNF family receptor alpha-4	GO:0016167; F:glial cell-derived neurotrophic factor receptor activity; IEA:Ensembl
Q9GZZ7	GFRA4	GDNF family receptor alpha-4	GO:0030279; P:negative regulation of ossification; IEA:Ensembl
Q6UXV0	GFRAL	GDNF family receptor alpha-like	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
Q6UXV0	GFRAL	GDNF family receptor alpha-like	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q6UXV0	GFRAL	GDNF family receptor alpha-like	GO:0031098; P:stress-activated protein kinase signaling cascade; IEA:Ensembl
P30047	GCHFR	GTP cyclohydrolase 1 feedback regulatory protein	GO:0016597; F:amino acid binding; IEA:Ensembl
P30047	GCHFR	GTP cyclohydrolase 1 feedback regulatory protein	GO:0004857; F:enzyme inhibitor activity; IEA:Ensembl
P30047	GCHFR	GTP cyclohydrolase 1 feedback regulatory protein	GO:0005515; F:protein binding; IPI:UniProtKB
P30047	GCHFR	GTP cyclohydrolase 1 feedback regulatory protein	GO:0009890; P:negative regulation of biosynthetic process; IEA:InterPro
P30047	GCHFR	GTP cyclohydrolase 1 feedback regulatory protein	GO:0043105; P:negative regulation of GTP cyclohydrolase I activity; IEA:Ensembl
P30047	GCHFR	GTP cyclohydrolase 1 feedback regulatory protein	GO:0042133; P:neurotransmitter metabolic process; TAS:ProtInc
P30047	GCHFR	GTP cyclohydrolase 1 feedback regulatory protein	GO:0006809; P:nitric oxide biosynthetic process; TAS:ProtInc
P30047	GCHFR	GTP cyclohydrolase 1 feedback regulatory protein	GO:0046209; P:nitric oxide metabolic process; TAS:Reactome
P30047	GCHFR	GTP cyclohydrolase 1 feedback regulatory protein	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P30047	GCHFR	GTP cyclohydrolase 1 feedback regulatory protein	GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome
P30047	GCHFR	GTP cyclohydrolase 1 feedback regulatory protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
I3L273	GFY	Golgi-associated olfactory signaling regulator	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
I3L273	GFY	Golgi-associated olfactory signaling regulator	GO:0007608; P:sensory perception of smell; ISS:UniProtKB
Q9UJY5	GGA1	ADP-ribosylation factor-binding protein GGA1	GO:0005515; F:protein binding; IPI:IntAct
Q9UJY5	GGA1	ADP-ribosylation factor-binding protein GGA1	GO:0006886; P:intracellular protein transport; TAS:UniProtKB
Q9UJY5	GGA1	ADP-ribosylation factor-binding protein GGA1	GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl
Q9UJY5	GGA1	ADP-ribosylation factor-binding protein GGA1	GO:0016192; P:vesicle-mediated transport; IEA:InterPro
Q9UJY4	GGA2	ADP-ribosylation factor-binding protein GGA2	GO:0030306; F:ADP-ribosylation factor binding; IDA:UniProtKB
Q9UJY4	GGA2	ADP-ribosylation factor-binding protein GGA2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UJY4	GGA2	ADP-ribosylation factor-binding protein GGA2	GO:0006886; P:intracellular protein transport; NAS:UniProtKB
Q9UJY4	GGA2	ADP-ribosylation factor-binding protein GGA2	GO:0016192; P:vesicle-mediated transport; IEA:InterPro
Q9NZ52	GGA3	ADP-ribosylation factor-binding protein GGA3	GO:0030306; F:ADP-ribosylation factor binding; IDA:UniProtKB
Q9NZ52	GGA3	ADP-ribosylation factor-binding protein GGA3	GO:0005515; F:protein binding; IPI:IntAct
Q9NZ52	GGA3	ADP-ribosylation factor-binding protein GGA3	GO:0006886; P:intracellular protein transport; NAS:UniProtKB
Q9NZ52	GGA3	ADP-ribosylation factor-binding protein GGA3	GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl
Q9NZ52	GGA3	ADP-ribosylation factor-binding protein GGA3	GO:0016192; P:vesicle-mediated transport; IEA:InterPro
Q9BVM4	GGACT	Gamma-glutamylaminecyclotransferase	GO:0003839; F:gamma-glutamylcyclotransferase activity; IDA:UniProtKB
Q9BVM4	GGACT	Gamma-glutamylaminecyclotransferase	GO:0042219; P:cellular modified amino acid catabolic process; IDA:UniProtKB
O75223	GGCT	Gamma-glutamylcyclotransferase	GO:0003839; F:gamma-glutamylcyclotransferase activity; IDA:UniProtKB
O75223	GGCT	Gamma-glutamylcyclotransferase	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O75223	GGCT	Gamma-glutamylcyclotransferase	GO:0006750; P:glutathione biosynthetic process; TAS:Reactome
O75223	GGCT	Gamma-glutamylcyclotransferase	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
O75223	GGCT	Gamma-glutamylcyclotransferase	GO:0001836; P:release of cytochrome c from mitochondria; IMP:UniProtKB
O75223	GGCT	Gamma-glutamylcyclotransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75223	GGCT	Gamma-glutamylcyclotransferase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9UEU5	GAGE2D	G antigen 2D	GO:0005515; F:protein binding; IPI:IntAct
Q9UEU5	GAGE2D	G antigen 2D	GO:0006968; P:cellular defense response; TAS:ProtInc
Q92820	GGH	Gamma-glutamyl hydrolase	GO:0008238; F:exopeptidase activity; TAS:ProtInc
Q92820	GGH	Gamma-glutamyl hydrolase	GO:0034722; F:gamma-glutamyl-peptidase activity; IDA:UniProtKB
Q92820	GGH	Gamma-glutamyl hydrolase	GO:0008242; F:omega peptidase activity; TAS:ProtInc
Q92820	GGH	Gamma-glutamyl hydrolase	GO:0006541; P:glutamine metabolic process; IEA:InterPro
Q92820	GGH	Gamma-glutamyl hydrolase	GO:0006508; P:proteolysis; IDA:GOC
Q92820	GGH	Gamma-glutamyl hydrolase	GO:0042493; P:response to drug; IEA:Ensembl
Q92820	GGH	Gamma-glutamyl hydrolase	GO:0045471; P:response to ethanol; IEA:Ensembl
Q92820	GGH	Gamma-glutamyl hydrolase	GO:0032868; P:response to insulin; IEA:Ensembl
Q92820	GGH	Gamma-glutamyl hydrolase	GO:0010043; P:response to zinc ion; IEA:Ensembl
Q5YKI7	GGNBP1	Putative gametogenetin-binding protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q5YKI7	GGNBP1	Putative gametogenetin-binding protein 1	GO:0000266; P:mitochondrial fission; IEA:Ensembl
Q5YKI7	GGNBP1	Putative gametogenetin-binding protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q5YKI7	GGNBP1	Putative gametogenetin-binding protein 1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q9H3C7	GGNBP2	Gametogenetin-binding protein 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9H3C7	GGNBP2	Gametogenetin-binding protein 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9H3C7	GGNBP2	Gametogenetin-binding protein 2	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q86UU5	GGN	Gametogenetin	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q86UU5	GGN	Gametogenetin	GO:0007276; P:gamete generation; ISS:UniProtKB
Q86UU5	GGN	Gametogenetin	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q86UU5	GGN	Gametogenetin	GO:0008104; P:protein localization; IEA:Ensembl
Q86UU5	GGN	Gametogenetin	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
O95749	GGPS1	Geranylgeranyl pyrophosphate synthase	GO:0004161; F:dimethylallyltranstransferase activity; IEA:UniProtKB-EC
O95749	GGPS1	Geranylgeranyl pyrophosphate synthase	GO:0004311; F:farnesyltranstransferase activity; IDA:UniProtKB
O95749	GGPS1	Geranylgeranyl pyrophosphate synthase	GO:0004337; F:geranyltranstransferase activity; IEA:UniProtKB-EC
O95749	GGPS1	Geranylgeranyl pyrophosphate synthase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95749	GGPS1	Geranylgeranyl pyrophosphate synthase	GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome
O95749	GGPS1	Geranylgeranyl pyrophosphate synthase	GO:0045337; P:farnesyl diphosphate biosynthetic process; IEA:UniProtKB-UniPathway
O95749	GGPS1	Geranylgeranyl pyrophosphate synthase	GO:0033384; P:geranyl diphosphate biosynthetic process; IEA:UniProtKB-UniPathway
O95749	GGPS1	Geranylgeranyl pyrophosphate synthase	GO:0033386; P:geranylgeranyl diphosphate biosynthetic process; IEA:UniProtKB-UniPathway
O95749	GGPS1	Geranylgeranyl pyrophosphate synthase	GO:0006720; P:isoprenoid metabolic process; IDA:UniProtKB
O95749	GGPS1	Geranylgeranyl pyrophosphate synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P19440	GGT1	Gamma-glutamyltranspeptidase 1	GO:0003840; F:gamma-glutamyltransferase activity; IDA:UniProtKB
P19440	GGT1	Gamma-glutamyltranspeptidase 1	GO:0036374; F:glutathione hydrolase activity; IDA:UniProtKB
P19440	GGT1	Gamma-glutamyltranspeptidase 1	GO:0005515; F:protein binding; IPI:UniProtKB
P19440	GGT1	Gamma-glutamyltranspeptidase 1	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P19440	GGT1	Gamma-glutamyltranspeptidase 1	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
P19440	GGT1	Gamma-glutamyltranspeptidase 1	GO:0019344; P:cysteine biosynthetic process; ISS:UniProtKB
P19440	GGT1	Gamma-glutamyltranspeptidase 1	GO:0006536; P:glutamate metabolic process; IDA:UniProtKB
P19440	GGT1	Gamma-glutamyltranspeptidase 1	GO:0006750; P:glutathione biosynthetic process; ISS:UniProtKB
P19440	GGT1	Gamma-glutamyltranspeptidase 1	GO:0006751; P:glutathione catabolic process; IDA:UniProtKB
P19440	GGT1	Gamma-glutamyltranspeptidase 1	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
P19440	GGT1	Gamma-glutamyltranspeptidase 1	GO:0006749; P:glutathione metabolic process; TAS:UniProtKB
P19440	GGT1	Gamma-glutamyltranspeptidase 1	GO:0019370; P:leukotriene biosynthetic process; IMP:UniProtKB
P19440	GGT1	Gamma-glutamyltranspeptidase 1	GO:0006691; P:leukotriene metabolic process; TAS:Reactome
P19440	GGT1	Gamma-glutamyltranspeptidase 1	GO:0002682; P:regulation of immune system process; ISS:UniProtKB
P19440	GGT1	Gamma-glutamyltranspeptidase 1	GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB
P19440	GGT1	Gamma-glutamyltranspeptidase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P19440	GGT1	Gamma-glutamyltranspeptidase 1	GO:0007283; P:spermatogenesis; ISS:UniProtKB
P19440	GGT1	Gamma-glutamyltranspeptidase 1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P19440	GGT1	Gamma-glutamyltranspeptidase 1	GO:0031638; P:zymogen activation; IDA:UniProtKB
P36268	GGT2	Inactive gamma-glutamyltranspeptidase 2	GO:0003840; F:gamma-glutamyltransferase activity; TAS:UniProtKB
P36268	GGT2	Inactive gamma-glutamyltranspeptidase 2	GO:0006750; P:glutathione biosynthetic process; TAS:Reactome
P36268	GGT2	Inactive gamma-glutamyltranspeptidase 2	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
P36268	GGT2	Inactive gamma-glutamyltranspeptidase 2	GO:0006749; P:glutathione metabolic process; TAS:UniProtKB
P36268	GGT2	Inactive gamma-glutamyltranspeptidase 2	GO:0019370; P:leukotriene biosynthetic process; ISS:UniProtKB
P36268	GGT2	Inactive gamma-glutamyltranspeptidase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P36268	GGT2	Inactive gamma-glutamyltranspeptidase 2	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
A6NGU5	GGT3P	Putative gamma-glutamyltranspeptidase 3	GO:0003840; F:gamma-glutamyltransferase activity; TAS:UniProtKB
A6NGU5	GGT3P	Putative gamma-glutamyltranspeptidase 3	GO:0036374; F:glutathione hydrolase activity; IEA:UniProtKB-EC
A6NGU5	GGT3P	Putative gamma-glutamyltranspeptidase 3	GO:0006750; P:glutathione biosynthetic process; IEA:UniProtKB-KW
A6NGU5	GGT3P	Putative gamma-glutamyltranspeptidase 3	GO:0006749; P:glutathione metabolic process; TAS:UniProtKB
A6NGU5	GGT3P	Putative gamma-glutamyltranspeptidase 3	GO:0019370; P:leukotriene biosynthetic process; ISS:UniProtKB
P36269	GGT5	Gamma-glutamyltransferase 5	GO:0003840; F:gamma-glutamyltransferase activity; TAS:UniProtKB
P36269	GGT5	Gamma-glutamyltransferase 5	GO:0036374; F:glutathione hydrolase activity; IEA:UniProtKB-EC
P36269	GGT5	Gamma-glutamyltransferase 5	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P36269	GGT5	Gamma-glutamyltransferase 5	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
P36269	GGT5	Gamma-glutamyltransferase 5	GO:0006750; P:glutathione biosynthetic process; IEA:UniProtKB-KW
P36269	GGT5	Gamma-glutamyltransferase 5	GO:0006749; P:glutathione metabolic process; TAS:UniProtKB
P36269	GGT5	Gamma-glutamyltransferase 5	GO:0006954; P:inflammatory response; IEA:Ensembl
P36269	GGT5	Gamma-glutamyltransferase 5	GO:0019370; P:leukotriene biosynthetic process; ISS:UniProtKB
P36269	GGT5	Gamma-glutamyltransferase 5	GO:0006691; P:leukotriene metabolic process; TAS:Reactome
P36269	GGT5	Gamma-glutamyltransferase 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6P531	GGT6	Gamma-glutamyltransferase 6	GO:0003840; F:gamma-glutamyltransferase activity; TAS:UniProtKB
Q6P531	GGT6	Gamma-glutamyltransferase 6	GO:0036374; F:glutathione hydrolase activity; IEA:UniProtKB-EC
Q6P531	GGT6	Gamma-glutamyltransferase 6	GO:0006750; P:glutathione biosynthetic process; IEA:UniProtKB-KW
Q6P531	GGT6	Gamma-glutamyltransferase 6	GO:0006749; P:glutathione metabolic process; TAS:UniProtKB
Q6P531	GGT6	Gamma-glutamyltransferase 6	GO:0019370; P:leukotriene biosynthetic process; ISS:UniProtKB
Q9UJ14	GGT7	Gamma-glutamyltransferase 7	GO:0003840; F:gamma-glutamyltransferase activity; TAS:UniProtKB
Q9UJ14	GGT7	Gamma-glutamyltransferase 7	GO:0036374; F:glutathione hydrolase activity; IEA:UniProtKB-EC
Q9UJ14	GGT7	Gamma-glutamyltransferase 7	GO:0006750; P:glutathione biosynthetic process; IEA:UniProtKB-KW
Q9UJ14	GGT7	Gamma-glutamyltransferase 7	GO:0006749; P:glutathione metabolic process; TAS:UniProtKB
Q9UJ14	GGT7	Gamma-glutamyltransferase 7	GO:0019370; P:leukotriene biosynthetic process; ISS:UniProtKB
Q4G0N0	GGTA1P	Inactive N-acetyllactosaminide alpha-1,3-galactosyltransferase	GO:0003840; F:gamma-glutamyltransferase activity; TAS:UniProtKB
Q4G0N0	GGTA1P	Inactive N-acetyllactosaminide alpha-1,3-galactosyltransferase	GO:0016758; F:transferase activity, transferring hexosyl groups; IEA:InterPro
Q4G0N0	GGTA1P	Inactive N-acetyllactosaminide alpha-1,3-galactosyltransferase	GO:0006749; P:glutathione metabolic process; TAS:UniProtKB
Q4G0N0	GGTA1P	Inactive N-acetyllactosaminide alpha-1,3-galactosyltransferase	GO:0019370; P:leukotriene biosynthetic process; ISS:UniProtKB
Q4G0N0	GGTA1P	Inactive N-acetyllactosaminide alpha-1,3-galactosyltransferase	GO:0033580; P:protein galactosylation at cell surface; ISS:UniProtKB
Q9BX51	GGTLC1	Gamma-glutamyltransferase light chain 1	GO:0003840; F:gamma-glutamyltransferase activity; TAS:UniProtKB
Q9BX51	GGTLC1	Gamma-glutamyltransferase light chain 1	GO:0006749; P:glutathione metabolic process; TAS:UniProtKB
Q9BX51	GGTLC1	Gamma-glutamyltransferase light chain 1	GO:0019370; P:leukotriene biosynthetic process; ISS:UniProtKB
Q14390	GGTLC2	Gamma-glutamyltransferase light chain 2	GO:0003840; F:gamma-glutamyltransferase activity; TAS:UniProtKB
Q14390	GGTLC2	Gamma-glutamyltransferase light chain 2	GO:0006749; P:glutathione metabolic process; NAS:UniProtKB
Q14390	GGTLC2	Gamma-glutamyltransferase light chain 2	GO:0019370; P:leukotriene biosynthetic process; ISS:UniProtKB
B5MD39	GGTLC3	Putative gamma-glutamyltransferase light chain 3	GO:0003840; F:gamma-glutamyltransferase activity; TAS:UniProtKB
B5MD39	GGTLC3	Putative gamma-glutamyltransferase light chain 3	GO:0006749; P:glutathione metabolic process; TAS:UniProtKB
B5MD39	GGTLC3	Putative gamma-glutamyltransferase light chain 3	GO:0019370; P:leukotriene biosynthetic process; ISS:UniProtKB
Q9H936	SLC25A22	Mitochondrial glutamate carrier 1	GO:0005313; F:L-glutamate transmembrane transporter activity; IDA:UniProtKB
Q9H936	SLC25A22	Mitochondrial glutamate carrier 1	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q9H936	SLC25A22	Mitochondrial glutamate carrier 1	GO:0015813; P:L-glutamate transport; IDA:UniProtKB
Q9H1K4	SLC25A18	Mitochondrial glutamate carrier 2	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q9H3K2	GHITM	Growth hormone-inducible transmembrane protein	GO:0005515; F:protein binding; IPI:IntAct
Q9H3K2	GHITM	Growth hormone-inducible transmembrane protein	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0004930; F:G-protein coupled receptor activity; IC:BHF-UCL
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0019838; F:growth factor binding; IPI:BHF-UCL
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0016520; F:growth hormone-releasing hormone receptor activity; IMP:BHF-UCL
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0017046; F:peptide hormone binding; IPI:BHF-UCL
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0005515; F:protein binding; IPI:BHF-UCL
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0007190; P:activation of adenylate cyclase activity; IEA:Ensembl
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IDA:BHF-UCL
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0019933; P:cAMP-mediated signaling; IMP:BHF-UCL
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0048469; P:cell maturation; IEA:Ensembl
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0008340; P:determination of adult lifespan; IEA:Ensembl
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0030252; P:growth hormone secretion; IEA:Ensembl
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0042445; P:hormone metabolic process; IEA:Ensembl
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0007595; P:lactation; IEA:Ensembl
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0048609; P:multicellular organismal reproductive process; NAS:BHF-UCL
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:BHF-UCL
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0060124; P:positive regulation of growth hormone secretion; NAS:BHF-UCL
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0043568; P:positive regulation of insulin-like growth factor receptor signaling pathway; NAS:BHF-UCL
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0040018; P:positive regulation of multicellular organism growth; IMP:BHF-UCL
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0033143; P:regulation of intracellular steroid hormone receptor signaling pathway; IEA:Ensembl
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0051246; P:regulation of protein metabolic process; IEA:Ensembl
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0043627; P:response to estrogen; IDA:BHF-UCL
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0051384; P:response to glucocorticoid; IDA:BHF-UCL
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0032868; P:response to insulin; IMP:BHF-UCL
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0060133; P:somatotropin secreting cell development; IEA:Ensembl
Q02643	GHRHR	Growth hormone-releasing hormone receptor	GO:0030104; P:water homeostasis; IEA:Ensembl
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0001664; F:G-protein coupled receptor binding; ISS:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0031768; F:ghrelin receptor binding; ISS:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0016608; F:growth hormone-releasing hormone activity; ISS:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0030296; F:protein tyrosine kinase activator activity; IMP:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0008154; P:actin polymerization or depolymerization; IDA:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0000187; P:activation of MAPK activity; IMP:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0008343; P:adult feeding behavior; ISS:HGNC
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0051216; P:cartilage development; NAS:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0043400; P:cortisol secretion; NAS:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0046697; P:decidualization; IDA:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0016358; P:dendrite development; IDA:MGI
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0007186; P:G-protein coupled receptor signaling pathway; ISS:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0001696; P:gastric acid secretion; IEA:Ensembl
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0006006; P:glucose metabolic process; NAS:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0030252; P:growth hormone secretion; TAS:HGNC
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0009755; P:hormone-mediated signaling pathway; TAS:HGNC
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0016525; P:negative regulation of angiogenesis; NAS:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0042322; P:negative regulation of circadian sleep/wake cycle, REM sleep; IDA:BHF-UCL
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0001937; P:negative regulation of endothelial cell proliferation; IDA:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0050728; P:negative regulation of inflammatory response; IDA:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0046676; P:negative regulation of insulin secretion; IEA:Ensembl
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0032691; P:negative regulation of interleukin-1 beta production; IDA:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0045409; P:negative regulation of interleukin-6 biosynthetic process; IDA:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0040013; P:negative regulation of locomotion; IEA:Ensembl
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0042536; P:negative regulation of tumor necrosis factor biosynthetic process; IDA:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0032100; P:positive regulation of appetite; ISS:HGNC
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0046010; P:positive regulation of circadian sleep/wake cycle, non-REM sleep; IDA:BHF-UCL
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0051461; P:positive regulation of corticotropin secretion; IDA:BHF-UCL
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0051464; P:positive regulation of cortisol secretion; IDA:BHF-UCL
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISS:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0060399; P:positive regulation of growth hormone receptor signaling pathway; IC:BHF-UCL
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0060124; P:positive regulation of growth hormone secretion; IDA:BHF-UCL
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0032024; P:positive regulation of insulin secretion; ISS:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0040018; P:positive regulation of multicellular organism growth; IC:HGNC
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0061098; P:positive regulation of protein tyrosine kinase activity; IMP:GOC
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0051965; P:positive regulation of synapse assembly; IDA:MGI
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0042127; P:regulation of cell proliferation; IDA:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0043627; P:response to estrogen; IDA:UniProtKB
Q9UBU3	GHRL	Appetite-regulating hormone	GO:0009725; P:response to hormone; IDA:UniProtKB
P10912	GHR	Growth hormone receptor	GO:0019838; F:growth factor binding; IPI:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0004903; F:growth hormone receptor activity; IEA:Ensembl
P10912	GHR	Growth hormone receptor	GO:0017046; F:peptide hormone binding; IPI:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0070064; F:proline-rich region binding; ISS:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0005515; F:protein binding; IPI:IntAct
P10912	GHR	Growth hormone receptor	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0019901; F:protein kinase binding; ISS:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0006103; P:2-oxoglutarate metabolic process; ISS:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0042977; P:activation of JAK2 kinase activity; ISS:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0000187; P:activation of MAPK activity; ISS:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0000255; P:allantoin metabolic process; ISS:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; IEA:Ensembl
P10912	GHR	Growth hormone receptor	GO:0032870; P:cellular response to hormone stimulus; IMP:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl
P10912	GHR	Growth hormone receptor	GO:0006101; P:citrate metabolic process; ISS:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0006600; P:creatine metabolic process; ISS:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0046449; P:creatinine metabolic process; ISS:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
P10912	GHR	Growth hormone receptor	GO:0006631; P:fatty acid metabolic process; ISS:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0060396; P:growth hormone receptor signaling pathway; IMP:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0009755; P:hormone-mediated signaling pathway; IEA:Ensembl
P10912	GHR	Growth hormone receptor	GO:0048009; P:insulin-like growth factor receptor signaling pathway; IMP:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0006549; P:isoleucine metabolic process; ISS:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0007259; P:JAK-STAT cascade; ISS:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome
P10912	GHR	Growth hormone receptor	GO:0044236; P:multicellular organismal metabolic process; IMP:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:1901215; P:negative regulation of neuron death; IEA:Ensembl
P10912	GHR	Growth hormone receptor	GO:0006107; P:oxaloacetate metabolic process; ISS:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0045597; P:positive regulation of cell differentiation; IEA:Ensembl
P10912	GHR	Growth hormone receptor	GO:0040018; P:positive regulation of multicellular organism growth; IMP:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISS:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; ISS:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0042523; P:positive regulation of tyrosine phosphorylation of Stat5 protein; ISS:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0031623; P:receptor internalization; IDA:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0040014; P:regulation of multicellular organism growth; ISS:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0046898; P:response to cycloheximide; IDA:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0032355; P:response to estradiol; IDA:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0032094; P:response to food; IEA:Ensembl
P10912	GHR	Growth hormone receptor	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P10912	GHR	Growth hormone receptor	GO:0070555; P:response to interleukin-1; IEA:Ensembl
P10912	GHR	Growth hormone receptor	GO:0043278; P:response to morphine; IEA:Ensembl
P10912	GHR	Growth hormone receptor	GO:0006105; P:succinate metabolic process; ISS:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0019530; P:taurine metabolic process; ISS:BHF-UCL
P10912	GHR	Growth hormone receptor	GO:0006573; P:valine metabolic process; ISS:BHF-UCL
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0004930; F:G-protein coupled receptor activity; IDA:HGNC
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0001616; F:growth hormone secretagogue receptor activity; IDA:HGNC
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0016520; F:growth hormone-releasing hormone receptor activity; IDA:HGNC
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0017046; F:peptide hormone binding; IEA:Ensembl
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0008154; P:actin polymerization or depolymerization; IDA:UniProtKB
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0008343; P:adult feeding behavior; ISS:HGNC
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0046697; P:decidualization; IDA:UniProtKB
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:HGNC
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0030252; P:growth hormone secretion; TAS:HGNC
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0009755; P:hormone-mediated signaling pathway; IDA:HGNC
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0050728; P:negative regulation of inflammatory response; IDA:UniProtKB
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0046676; P:negative regulation of insulin secretion; IEA:Ensembl
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0032691; P:negative regulation of interleukin-1 beta production; IDA:UniProtKB
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0045409; P:negative regulation of interleukin-6 biosynthetic process; IDA:UniProtKB
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0042536; P:negative regulation of tumor necrosis factor biosynthetic process; IDA:UniProtKB
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0032100; P:positive regulation of appetite; ISS:HGNC
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0045923; P:positive regulation of fatty acid metabolic process; IEA:Ensembl
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0043568; P:positive regulation of insulin-like growth factor receptor signaling pathway; IEA:Ensembl
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0040018; P:positive regulation of multicellular organism growth; IMP:HGNC
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0043134; P:regulation of hindgut contraction; IEA:Ensembl
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0051963; P:regulation of synapse assembly; IEA:Ensembl
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0032094; P:response to food; IEA:Ensembl
Q92847	GHSR	Growth hormone secretagogue receptor type 1	GO:0009725; P:response to hormone; IDA:UniProtKB
P13284	IFI30	Gamma-interferon-inducible lysosomal thiol reductase	GO:0016667; F:oxidoreductase activity, acting on a sulfur group of donors; IMP:UniProtKB
P13284	IFI30	Gamma-interferon-inducible lysosomal thiol reductase	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; ISS:UniProtKB
P13284	IFI30	Gamma-interferon-inducible lysosomal thiol reductase	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P13284	IFI30	Gamma-interferon-inducible lysosomal thiol reductase	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P13284	IFI30	Gamma-interferon-inducible lysosomal thiol reductase	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P13284	IFI30	Gamma-interferon-inducible lysosomal thiol reductase	GO:0048147; P:negative regulation of fibroblast proliferation; IEA:Ensembl
P13284	IFI30	Gamma-interferon-inducible lysosomal thiol reductase	GO:0050821; P:protein stabilization; IEA:Ensembl
Q8WWP7	GIMAP1	GTPase IMAP family member 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q8WWP7	GIMAP1	GTPase IMAP family member 1	GO:0030183; P:B cell differentiation; IEA:Ensembl
Q8WWP7	GIMAP1	GTPase IMAP family member 1	GO:0030217; P:T cell differentiation; IEA:Ensembl
Q9UG22	GIMAP2	GTPase IMAP family member 2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9NUV9	GIMAP4	GTPase IMAP family member 4	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q96F15	GIMAP5	GTPase IMAP family member 5	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q96F15	GIMAP5	GTPase IMAP family member 5	GO:0043011; P:myeloid dendritic cell differentiation; IEA:Ensembl
Q96F15	GIMAP5	GTPase IMAP family member 5	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q96F15	GIMAP5	GTPase IMAP family member 5	GO:0032689; P:negative regulation of interferon-gamma production; IEA:Ensembl
Q96F15	GIMAP5	GTPase IMAP family member 5	GO:0050995; P:negative regulation of lipid catabolic process; IEA:Ensembl
Q96F15	GIMAP5	GTPase IMAP family member 5	GO:0045019; P:negative regulation of nitric oxide biosynthetic process; IEA:Ensembl
Q96F15	GIMAP5	GTPase IMAP family member 5	GO:0050868; P:negative regulation of T cell activation; IEA:Ensembl
Q96F15	GIMAP5	GTPase IMAP family member 5	GO:0010524; P:positive regulation of calcium ion transport into cytosol; IEA:Ensembl
Q96F15	GIMAP5	GTPase IMAP family member 5	GO:0032831; P:positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation; IEA:Ensembl
Q96F15	GIMAP5	GTPase IMAP family member 5	GO:0045588; P:positive regulation of gamma-delta T cell differentiation; IEA:Ensembl
Q96F15	GIMAP5	GTPase IMAP family member 5	GO:0002925; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; IEA:Ensembl
Q96F15	GIMAP5	GTPase IMAP family member 5	GO:0045838; P:positive regulation of membrane potential; IEA:Ensembl
Q96F15	GIMAP5	GTPase IMAP family member 5	GO:0002729; P:positive regulation of natural killer cell cytokine production; IEA:Ensembl
Q96F15	GIMAP5	GTPase IMAP family member 5	GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; IEA:Ensembl
Q96F15	GIMAP5	GTPase IMAP family member 5	GO:0046902; P:regulation of mitochondrial membrane permeability; IEA:Ensembl
Q96F15	GIMAP5	GTPase IMAP family member 5	GO:0030217; P:T cell differentiation; IEA:Ensembl
Q96F15	GIMAP5	GTPase IMAP family member 5	GO:0043029; P:T cell homeostasis; IEA:Ensembl
Q96F15	GIMAP5	GTPase IMAP family member 5	GO:0001659; P:temperature homeostasis; IEA:Ensembl
Q6P9H5	GIMAP6	GTPase IMAP family member 6	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q8NHV1	GIMAP7	GTPase IMAP family member 7	GO:0005525; F:GTP binding; IDA:UniProtKB
Q8NHV1	GIMAP7	GTPase IMAP family member 7	GO:0003924; F:GTPase activity; IDA:UniProtKB
Q8NHV1	GIMAP7	GTPase IMAP family member 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NHV1	GIMAP7	GTPase IMAP family member 7	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q8NHV1	GIMAP7	GTPase IMAP family member 7	GO:0006184; P:GTP catabolic process; IDA:UniProtKB
Q8ND71	GIMAP8	GTPase IMAP family member 8	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P0DJR0	GIMD1	GTPase IMAP family member GIMD1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9NXP7	GIN1	Gypsy retrotransposon integrase-like protein 1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9NXP7	GIN1	Gypsy retrotransposon integrase-like protein 1	GO:0015074; P:DNA integration; IEA:InterPro
O14908	GIPC1	PDZ domain-containing protein GIPC1	GO:0003779; F:actin binding; ISS:BHF-UCL
O14908	GIPC1	PDZ domain-containing protein GIPC1	GO:0017022; F:myosin binding; ISS:BHF-UCL
O14908	GIPC1	PDZ domain-containing protein GIPC1	GO:0005515; F:protein binding; IPI:UniProtKB
O14908	GIPC1	PDZ domain-containing protein GIPC1	GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
O14908	GIPC1	PDZ domain-containing protein GIPC1	GO:0005102; F:receptor binding; IPI:UniProtKB
O14908	GIPC1	PDZ domain-containing protein GIPC1	GO:0043542; P:endothelial cell migration; ISS:BHF-UCL
O14908	GIPC1	PDZ domain-containing protein GIPC1	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
O14908	GIPC1	PDZ domain-containing protein GIPC1	GO:0014047; P:glutamate secretion; ISS:BHF-UCL
O14908	GIPC1	PDZ domain-containing protein GIPC1	GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; ISS:BHF-UCL
O14908	GIPC1	PDZ domain-containing protein GIPC1	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProt
O14908	GIPC1	PDZ domain-containing protein GIPC1	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; ISS:BHF-UCL
O14908	GIPC1	PDZ domain-containing protein GIPC1	GO:0006605; P:protein targeting; ISS:BHF-UCL
O14908	GIPC1	PDZ domain-containing protein GIPC1	GO:0031647; P:regulation of protein stability; ISS:BHF-UCL
O14908	GIPC1	PDZ domain-containing protein GIPC1	GO:0048167; P:regulation of synaptic plasticity; ISS:BHF-UCL
O14908	GIPC1	PDZ domain-containing protein GIPC1	GO:0007268; P:synaptic transmission; ISS:BHF-UCL
P48546	GIPR	Gastric inhibitory polypeptide receptor	GO:0016519; F:gastric inhibitory peptide receptor activity; IEA:Ensembl
P48546	GIPR	Gastric inhibitory polypeptide receptor	GO:0017046; F:peptide hormone binding; IEA:Ensembl
P48546	GIPR	Gastric inhibitory polypeptide receptor	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
P48546	GIPR	Gastric inhibitory polypeptide receptor	GO:0007190; P:activation of adenylate cyclase activity; TAS:ProtInc
P48546	GIPR	Gastric inhibitory polypeptide receptor	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P48546	GIPR	Gastric inhibitory polypeptide receptor	GO:0002029; P:desensitization of G-protein coupled receptor protein signaling pathway; IEA:Ensembl
P48546	GIPR	Gastric inhibitory polypeptide receptor	GO:0031018; P:endocrine pancreas development; IEA:Ensembl
P48546	GIPR	Gastric inhibitory polypeptide receptor	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P48546	GIPR	Gastric inhibitory polypeptide receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P48546	GIPR	Gastric inhibitory polypeptide receptor	GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl
P48546	GIPR	Gastric inhibitory polypeptide receptor	GO:0048678; P:response to axon injury; IEA:Ensembl
P48546	GIPR	Gastric inhibitory polypeptide receptor	GO:0051592; P:response to calcium ion; IEA:Ensembl
P48546	GIPR	Gastric inhibitory polypeptide receptor	GO:0070542; P:response to fatty acid; IEA:Ensembl
P48546	GIPR	Gastric inhibitory polypeptide receptor	GO:0009749; P:response to glucose; IEA:Ensembl
P48546	GIPR	Gastric inhibitory polypeptide receptor	GO:0007584; P:response to nutrient; TAS:ProtInc
P09681	GIP	Gastric inhibitory polypeptide	GO:0005179; F:hormone activity; TAS:ProtInc
P09681	GIP	Gastric inhibitory polypeptide	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P09681	GIP	Gastric inhibitory polypeptide	GO:0055123; P:digestive system development; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0031018; P:endocrine pancreas development; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0035640; P:exploration behavior; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0007565; P:female pregnancy; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0007613; P:memory; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0043950; P:positive regulation of cAMP-mediated signaling; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0070094; P:positive regulation of glucagon secretion; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0010828; P:positive regulation of glucose transport; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P09681	GIP	Gastric inhibitory polypeptide	GO:0043200; P:response to amino acid; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0048678; P:response to axon injury; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0042493; P:response to drug; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0009749; P:response to glucose; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0033993; P:response to lipid; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0010269; P:response to selenium ion; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0042594; P:response to starvation; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P09681	GIP	Gastric inhibitory polypeptide	GO:0007165; P:signal transduction; TAS:ProtInc
P09681	GIP	Gastric inhibitory polypeptide	GO:0070328; P:triglyceride homeostasis; IEA:Ensembl
Q9Y2X7	GIT1	ARF GTPase-activating protein GIT1	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q9Y2X7	GIT1	ARF GTPase-activating protein GIT1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y2X7	GIT1	ARF GTPase-activating protein GIT1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y2X7	GIT1	ARF GTPase-activating protein GIT1	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
Q9Y2X7	GIT1	ARF GTPase-activating protein GIT1	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; TAS:ProtInc
Q14161	GIT2	ARF GTPase-activating protein GIT2	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q14161	GIT2	ARF GTPase-activating protein GIT2	GO:0005515; F:protein binding; IPI:IntAct
Q14161	GIT2	ARF GTPase-activating protein GIT2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q14161	GIT2	ARF GTPase-activating protein GIT2	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
Q14161	GIT2	ARF GTPase-activating protein GIT2	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; TAS:ProtInc
Q5VSY0	GKAP1	G kinase-anchoring protein 1	GO:0007165; P:signal transduction; ISS:UniProtKB
Q9NS71	GKN1	Gastrokine-1	GO:0007586; P:digestion; NAS:UniProtKB
Q9NS71	GKN1	Gastrokine-1	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
Q9NS71	GKN1	Gastrokine-1	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q96MS3	GLT1D1	Glycosyltransferase 1 domain-containing protein 1	GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW
Q96MS3	GLT1D1	Glycosyltransferase 1 domain-containing protein 1	GO:0009058; P:biosynthetic process; IEA:InterPro
DR   GO:0016758; F:transferase activity, transferring hexosyl groups; IEA:InterPro
DR   GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q7Z4J2	GLT6D1	Glycosyltransferase 6 domain-containing protein 1	GO:0016758; F:transferase activity, transferring hexosyl groups; IEA:InterPro
Q7Z4J2	GLT6D1	Glycosyltransferase 6 domain-containing protein 1	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q68CQ7	GLT8D1	Glycosyltransferase 8 domain-containing protein 1	GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW
Q9H1C3	GLT8D2	Glycosyltransferase 8 domain-containing protein 2	GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW
Q6UWU2	GLB1L	Beta-galactosidase-1-like protein	GO:0004565; F:beta-galactosidase activity; IEA:InterPro
Q6UWU2	GLB1L	Beta-galactosidase-1-like protein	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q8IW92	GLB1L2	Beta-galactosidase-1-like protein 2	GO:0004565; F:beta-galactosidase activity; IEA:InterPro
Q8IW92	GLB1L2	Beta-galactosidase-1-like protein 2	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q8NCI6	GLB1L3	Beta-galactosidase-1-like protein 3	GO:0004565; F:beta-galactosidase activity; IEA:InterPro
Q8NCI6	GLB1L3	Beta-galactosidase-1-like protein 3	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
O94923	GLCE	D-glucuronyl C5-epimerase	GO:0047464; F:heparosan-N-sulfate-glucuronate 5-epimerase activity; IMP:UniProtKB
O94923	GLCE	D-glucuronyl C5-epimerase	GO:0016857; F:racemase and epimerase activity, acting on carbohydrates and derivatives; ISS:UniProtKB
O94923	GLCE	D-glucuronyl C5-epimerase	GO:0050379; F:UDP-glucuronate 5'-epimerase activity; IDA:HGNC
O94923	GLCE	D-glucuronyl C5-epimerase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O94923	GLCE	D-glucuronyl C5-epimerase	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
O94923	GLCE	D-glucuronyl C5-epimerase	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O94923	GLCE	D-glucuronyl C5-epimerase	GO:0015012; P:heparan sulfate proteoglycan biosynthetic process; IDA:UniProtKB
O94923	GLCE	D-glucuronyl C5-epimerase	GO:0030210; P:heparin biosynthetic process; ISS:UniProtKB
O94923	GLCE	D-glucuronyl C5-epimerase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8IVK1	GLYCAM1	Putative glycosylation-dependent cell adhesion molecule 1	GO:0050776; P:regulation of immune response; TAS:Reactome
P04062	GBA	Glucosylceramidase	GO:0004348; F:glucosylceramidase activity; IEA:InterPro
P04062	GBA	Glucosylceramidase	GO:0005515; F:protein binding; IPI:UniProtKB
P04062	GBA	Glucosylceramidase	GO:0005102; F:receptor binding; ISS:BHF-UCL
P04062	GBA	Glucosylceramidase	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
P04062	GBA	Glucosylceramidase	GO:0008219; P:cell death; IEA:UniProtKB-KW
P04062	GBA	Glucosylceramidase	GO:0071356; P:cellular response to tumor necrosis factor; IMP:BHF-UCL
P04062	GBA	Glucosylceramidase	GO:0046513; P:ceramide biosynthetic process; IMP:BHF-UCL
P04062	GBA	Glucosylceramidase	GO:0006680; P:glucosylceramide catabolic process; IMP:BHF-UCL
P04062	GBA	Glucosylceramidase	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
P04062	GBA	Glucosylceramidase	GO:0050728; P:negative regulation of inflammatory response; IC:BHF-UCL
P04062	GBA	Glucosylceramidase	GO:0032715; P:negative regulation of interleukin-6 production; IDA:BHF-UCL
P04062	GBA	Glucosylceramidase	GO:0043407; P:negative regulation of MAP kinase activity; IMP:BHF-UCL
P04062	GBA	Glucosylceramidase	GO:0035307; P:positive regulation of protein dephosphorylation; IMP:BHF-UCL
P04062	GBA	Glucosylceramidase	GO:0033561; P:regulation of water loss via skin; IEA:Ensembl
P04062	GBA	Glucosylceramidase	GO:0043627; P:response to estrogen; IEA:Ensembl
P04062	GBA	Glucosylceramidase	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P04062	GBA	Glucosylceramidase	GO:0009268; P:response to pH; IEA:Ensembl
P04062	GBA	Glucosylceramidase	GO:0033574; P:response to testosterone; IEA:Ensembl
P04062	GBA	Glucosylceramidase	GO:0097066; P:response to thyroid hormone; IEA:Ensembl
P04062	GBA	Glucosylceramidase	GO:0043589; P:skin morphogenesis; IEA:Ensembl
P04062	GBA	Glucosylceramidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P04062	GBA	Glucosylceramidase	GO:0006665; P:sphingolipid metabolic process; IEA:InterPro
P04062	GBA	Glucosylceramidase	GO:0046512; P:sphingosine biosynthetic process; IMP:BHF-UCL
P04062	GBA	Glucosylceramidase	GO:0023021; P:termination of signal transduction; IMP:BHF-UCL
Q9Y223	GNE	Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase	GO:0005524; F:ATP binding; IEA:InterPro
Q9Y223	GNE	Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q9Y223	GNE	Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y223	GNE	Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase	GO:0009384; F:N-acylmannosamine kinase activity; IEA:InterPro
Q9Y223	GNE	Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase	GO:0008761; F:UDP-N-acetylglucosamine 2-epimerase activity; IEA:InterPro
Q9Y223	GNE	Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase	GO:0046835; P:carbohydrate phosphorylation; TAS:GOC
Q9Y223	GNE	Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9Y223	GNE	Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase	GO:0009103; P:lipopolysaccharide biosynthetic process; IEA:InterPro
Q9Y223	GNE	Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase	GO:0006045; P:N-acetylglucosamine biosynthetic process; IEA:UniProtKB-UniPathway
Q9Y223	GNE	Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase	GO:0046380; P:N-acetylneuraminate biosynthetic process; IEA:InterPro
Q9Y223	GNE	Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase	GO:0006054; P:N-acetylneuraminate metabolic process; TAS:ProtInc
Q9Y223	GNE	Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase	GO:0006047; P:UDP-N-acetylglucosamine metabolic process; IEA:InterPro
Q8IVS8	GLYCTK	Glycerate kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IVS8	GLYCTK	Glycerate kinase	GO:0008887; F:glycerate kinase activity; IDA:UniProtKB
Q8IVS8	GLYCTK	Glycerate kinase	GO:0005515; F:protein binding; IPI:IntAct
Q8IVS8	GLYCTK	Glycerate kinase	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q6PIY7	PAPD4	Poly(A) RNA polymerase GLD2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6PIY7	PAPD4	Poly(A) RNA polymerase GLD2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6PIY7	PAPD4	Poly(A) RNA polymerase GLD2	GO:0004652; F:polynucleotide adenylyltransferase activity; IDA:UniProtKB
Q6PIY7	PAPD4	Poly(A) RNA polymerase GLD2	GO:0071044; P:histone mRNA catabolic process; IMP:UniProtKB
Q6PIY7	PAPD4	Poly(A) RNA polymerase GLD2	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q6PIY7	PAPD4	Poly(A) RNA polymerase GLD2	GO:0043631; P:RNA polyadenylation; IDA:UniProtKB
Q6ZMI3	GLDN	Gliomedin	GO:0045162; P:clustering of voltage-gated sodium channels; IEA:Ensembl
Q6ZMI3	GLDN	Gliomedin	GO:0034113; P:heterotypic cell-cell adhesion; IEA:Ensembl
Q6ZMI3	GLDN	Gliomedin	GO:0032528; P:microvillus organization; IEA:Ensembl
Q53GS7	GLE1	Nucleoporin GLE1	GO:0042802; F:identical protein binding; IPI:IntAct
Q53GS7	GLE1	Nucleoporin GLE1	GO:0005515; F:protein binding; IPI:IntAct
Q53GS7	GLE1	Nucleoporin GLE1	GO:0006406; P:mRNA export from nucleus; TAS:ProtInc
Q53GS7	GLE1	Nucleoporin GLE1	GO:0016973; P:poly(A)+ mRNA export from nucleus; IEA:InterPro
Q53GS7	GLE1	Nucleoporin GLE1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q04446	GBE1	1,4-alpha-glucan-branching enzyme	GO:0003844; F:1,4-alpha-glucan branching enzyme activity; TAS:ProtInc
Q04446	GBE1	1,4-alpha-glucan-branching enzyme	GO:0043169; F:cation binding; IEA:InterPro
Q04446	GBE1	1,4-alpha-glucan-branching enzyme	GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro
Q04446	GBE1	1,4-alpha-glucan-branching enzyme	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q04446	GBE1	1,4-alpha-glucan-branching enzyme	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
Q04446	GBE1	1,4-alpha-glucan-branching enzyme	GO:0006006; P:glucose metabolic process; TAS:Reactome
Q04446	GBE1	1,4-alpha-glucan-branching enzyme	GO:0005978; P:glycogen biosynthetic process; TAS:Reactome
Q04446	GBE1	1,4-alpha-glucan-branching enzyme	GO:0005977; P:glycogen metabolic process; TAS:ProtInc
Q04446	GBE1	1,4-alpha-glucan-branching enzyme	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P01215	CGA	Glycoprotein hormones alpha chain	GO:0005179; F:hormone activity; TAS:ProtInc
P01215	CGA	Glycoprotein hormones alpha chain	GO:0005515; F:protein binding; IPI:IntAct
P01215	CGA	Glycoprotein hormones alpha chain	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P01215	CGA	Glycoprotein hormones alpha chain	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P01215	CGA	Glycoprotein hormones alpha chain	GO:0032870; P:cellular response to hormone stimulus; IEA:Ensembl
P01215	CGA	Glycoprotein hormones alpha chain	GO:0048589; P:developmental growth; IEA:Ensembl
P01215	CGA	Glycoprotein hormones alpha chain	GO:0046884; P:follicle-stimulating hormone secretion; IEA:Ensembl
P01215	CGA	Glycoprotein hormones alpha chain	GO:0008406; P:gonad development; IEA:Ensembl
P01215	CGA	Glycoprotein hormones alpha chain	GO:0032275; P:luteinizing hormone secretion; IEA:Ensembl
P01215	CGA	Glycoprotein hormones alpha chain	GO:0046621; P:negative regulation of organ growth; IEA:Ensembl
P01215	CGA	Glycoprotein hormones alpha chain	GO:0016486; P:peptide hormone processing; TAS:Reactome
P01215	CGA	Glycoprotein hormones alpha chain	GO:0030335; P:positive regulation of cell migration; NAS:BHF-UCL
P01215	CGA	Glycoprotein hormones alpha chain	GO:0008284; P:positive regulation of cell proliferation; NAS:BHF-UCL
P01215	CGA	Glycoprotein hormones alpha chain	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; NAS:BHF-UCL
P01215	CGA	Glycoprotein hormones alpha chain	GO:0007165; P:signal transduction; TAS:ProtInc
P01215	CGA	Glycoprotein hormones alpha chain	GO:0030878; P:thyroid gland development; IEA:Ensembl
P01215	CGA	Glycoprotein hormones alpha chain	GO:0006590; P:thyroid hormone generation; IEA:Ensembl
P08151	GLI1	Zinc finger protein GLI1	GO:0003682; F:chromatin binding; IEA:Ensembl
P08151	GLI1	Zinc finger protein GLI1	GO:0003677; F:DNA binding; IEA:Ensembl
P08151	GLI1	Zinc finger protein GLI1	GO:0046872; F:metal ion binding; IEA:InterPro
P08151	GLI1	Zinc finger protein GLI1	GO:0005515; F:protein binding; IPI:UniProtKB
P08151	GLI1	Zinc finger protein GLI1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P08151	GLI1	Zinc finger protein GLI1	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P08151	GLI1	Zinc finger protein GLI1	GO:0021696; P:cerebellar cortex morphogenesis; IEA:Ensembl
P08151	GLI1	Zinc finger protein GLI1	GO:0048546; P:digestive tract morphogenesis; TAS:BHF-UCL
P08151	GLI1	Zinc finger protein GLI1	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
P08151	GLI1	Zinc finger protein GLI1	GO:0009913; P:epidermal cell differentiation; IDA:UniProtKB
P08151	GLI1	Zinc finger protein GLI1	GO:0030324; P:lung development; IEA:Ensembl
P08151	GLI1	Zinc finger protein GLI1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:UniProtKB
P08151	GLI1	Zinc finger protein GLI1	GO:0060032; P:notochord regression; IEA:Ensembl
P08151	GLI1	Zinc finger protein GLI1	GO:0001649; P:osteoblast differentiation; IDA:UniProtKB
P08151	GLI1	Zinc finger protein GLI1	GO:0021983; P:pituitary gland development; IEA:Ensembl
P08151	GLI1	Zinc finger protein GLI1	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
P08151	GLI1	Zinc finger protein GLI1	GO:0045740; P:positive regulation of DNA replication; IDA:UniProtKB
P08151	GLI1	Zinc finger protein GLI1	GO:0045880; P:positive regulation of smoothened signaling pathway; IDA:UniProtKB
P08151	GLI1	Zinc finger protein GLI1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P08151	GLI1	Zinc finger protein GLI1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P08151	GLI1	Zinc finger protein GLI1	GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl
P08151	GLI1	Zinc finger protein GLI1	GO:0008589; P:regulation of smoothened signaling pathway; TAS:UniProtKB
P08151	GLI1	Zinc finger protein GLI1	GO:0007224; P:smoothened signaling pathway; IDA:UniProtKB
P08151	GLI1	Zinc finger protein GLI1	GO:0021938; P:smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation; IEA:Ensembl
P08151	GLI1	Zinc finger protein GLI1	GO:0007283; P:spermatogenesis; IEA:Ensembl
P08151	GLI1	Zinc finger protein GLI1	GO:0007418; P:ventral midline development; IEA:Ensembl
P10070	GLI2	Zinc finger protein GLI2	GO:0003682; F:chromatin binding; IEA:Ensembl
P10070	GLI2	Zinc finger protein GLI2	GO:0005515; F:protein binding; IPI:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0044212; F:transcription regulatory region DNA binding; IEA:Ensembl
P10070	GLI2	Zinc finger protein GLI2	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0007411; P:axon guidance; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0048754; P:branching morphogenesis of an epithelial tube; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0008283; P:cell proliferation; IDA:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
P10070	GLI2	Zinc finger protein GLI2	GO:0021696; P:cerebellar cortex morphogenesis; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0002062; P:chondrocyte differentiation; IEA:Ensembl
P10070	GLI2	Zinc finger protein GLI2	GO:0090103; P:cochlea morphogenesis; IEA:Ensembl
P10070	GLI2	Zinc finger protein GLI2	GO:0048589; P:developmental growth; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0048566; P:embryonic digestive tract development; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
P10070	GLI2	Zinc finger protein GLI2	GO:0009913; P:epidermal cell differentiation; IDA:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0021508; P:floor plate formation; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0060322; P:head development; IEA:Ensembl
P10070	GLI2	Zinc finger protein GLI2	GO:0007507; P:heart development; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0030902; P:hindbrain development; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0007442; P:hindgut morphogenesis; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P10070	GLI2	Zinc finger protein GLI2	GO:0001822; P:kidney development; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0030324; P:lung development; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0030879; P:mammary gland development; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0060603; P:mammary gland duct morphogenesis; IEA:Ensembl
P10070	GLI2	Zinc finger protein GLI2	GO:0032331; P:negative regulation of chondrocyte differentiation; IEA:Ensembl
P10070	GLI2	Zinc finger protein GLI2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0048666; P:neuron development; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0060032; P:notochord regression; IEA:Ensembl
P10070	GLI2	Zinc finger protein GLI2	GO:0042475; P:odontogenesis of dentin-containing tooth; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0002076; P:osteoblast development; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0001649; P:osteoblast differentiation; IDA:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0007389; P:pattern specification process; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0021983; P:pituitary gland development; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0045740; P:positive regulation of DNA replication; IDA:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P10070	GLI2	Zinc finger protein GLI2	GO:0033089; P:positive regulation of T cell differentiation in thymus; ISS:BHF-UCL
P10070	GLI2	Zinc finger protein GLI2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0060513; P:prostatic bud formation; IEA:Ensembl
P10070	GLI2	Zinc finger protein GLI2	GO:0009954; P:proximal/distal pattern formation; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0008589; P:regulation of smoothened signaling pathway; IEA:Ensembl
P10070	GLI2	Zinc finger protein GLI2	GO:0006355; P:regulation of transcription, DNA-templated; IDA:GOC
P10070	GLI2	Zinc finger protein GLI2	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P10070	GLI2	Zinc finger protein GLI2	GO:0001501; P:skeletal system development; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0007224; P:smoothened signaling pathway; IDA:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0060831; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; IEA:Ensembl
P10070	GLI2	Zinc finger protein GLI2	GO:0021938; P:smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation; IEA:Ensembl
P10070	GLI2	Zinc finger protein GLI2	GO:0021776; P:smoothened signaling pathway involved in spinal cord motor neuron cell fate specification; IEA:Ensembl
P10070	GLI2	Zinc finger protein GLI2	GO:0021775; P:smoothened signaling pathway involved in ventral spinal cord interneuron specification; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0021513; P:spinal cord dorsal/ventral patterning; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0021965; P:spinal cord ventral commissure morphogenesis; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P10070	GLI2	Zinc finger protein GLI2	GO:0035295; P:tube development; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0007418; P:ventral midline development; ISS:UniProtKB
P10070	GLI2	Zinc finger protein GLI2	GO:0021517; P:ventral spinal cord development; ISS:UniProtKB
P10071	GLI3	Transcriptional activator GLI3	GO:0008013; F:beta-catenin binding; IPI:UniProtKB
P10071	GLI3	Transcriptional activator GLI3	GO:0003682; F:chromatin binding; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0035035; F:histone acetyltransferase binding; IPI:UniProtKB
P10071	GLI3	Transcriptional activator GLI3	GO:0042826; F:histone deacetylase binding; IDA:UniProtKB
P10071	GLI3	Transcriptional activator GLI3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P10071	GLI3	Transcriptional activator GLI3	GO:0005515; F:protein binding; IPI:UniProtKB
P10071	GLI3	Transcriptional activator GLI3	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:MGI
P10071	GLI3	Transcriptional activator GLI3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P10071	GLI3	Transcriptional activator GLI3	GO:0060873; P:anterior semicircular canal development; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0060840; P:artery development; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0007411; P:axon guidance; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0048593; P:camera-type eye morphogenesis; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0061005; P:cell differentiation involved in kidney development; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0021801; P:cerebral cortex radial glia guided migration; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0048589; P:developmental growth; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0048566; P:embryonic digestive tract development; TAS:BHF-UCL
P10071	GLI3	Transcriptional activator GLI3	GO:0048557; P:embryonic digestive tract morphogenesis; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0042733; P:embryonic digit morphogenesis; TAS:BHF-UCL
P10071	GLI3	Transcriptional activator GLI3	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0021798; P:forebrain dorsal/ventral pattern formation; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0021861; P:forebrain radial glial cell differentiation; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0060364; P:frontal suture morphogenesis; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0007507; P:heart development; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0007442; P:hindgut morphogenesis; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0060366; P:lambdoid suture morphogenesis; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0022018; P:lateral ganglionic eminence cell proliferation; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0060875; P:lateral semicircular canal development; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0035108; P:limb morphogenesis; IMP:UniProtKB
P10071	GLI3	Transcriptional activator GLI3	GO:0030324; P:lung development; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0060594; P:mammary gland specification; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0030318; P:melanocyte differentiation; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0001656; P:metanephros development; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0046639; P:negative regulation of alpha-beta T cell differentiation; ISS:BHF-UCL
P10071	GLI3	Transcriptional activator GLI3	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:UniProtKB
P10071	GLI3	Transcriptional activator GLI3	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0045879; P:negative regulation of smoothened signaling pathway; ISS:BHF-UCL
P10071	GLI3	Transcriptional activator GLI3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P10071	GLI3	Transcriptional activator GLI3	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P10071	GLI3	Transcriptional activator GLI3	GO:0045060; P:negative thymic T cell selection; ISS:BHF-UCL
P10071	GLI3	Transcriptional activator GLI3	GO:0043585; P:nose morphogenesis; TAS:BHF-UCL
P10071	GLI3	Transcriptional activator GLI3	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0048709; P:oligodendrocyte differentiation; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0021631; P:optic nerve morphogenesis; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0060021; P:palate development; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0046638; P:positive regulation of alpha-beta T cell differentiation; ISS:BHF-UCL
P10071	GLI3	Transcriptional activator GLI3	GO:0032332; P:positive regulation of chondrocyte differentiation; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0002052; P:positive regulation of neuroblast proliferation; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0042307; P:positive regulation of protein import into nucleus; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P10071	GLI3	Transcriptional activator GLI3	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
P10071	GLI3	Transcriptional activator GLI3	GO:0016485; P:protein processing; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0043627; P:response to estrogen; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0060367; P:sagittal suture morphogenesis; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0007224; P:smoothened signaling pathway; TAS:BHF-UCL
P10071	GLI3	Transcriptional activator GLI3	GO:0060831; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0021776; P:smoothened signaling pathway involved in spinal cord motor neuron cell fate specification; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0021775; P:smoothened signaling pathway involved in ventral spinal cord interneuron specification; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0033077; P:T cell differentiation in thymus; ISS:BHF-UCL
P10071	GLI3	Transcriptional activator GLI3	GO:0070242; P:thymocyte apoptotic process; ISS:BHF-UCL
P10071	GLI3	Transcriptional activator GLI3	GO:0043586; P:tongue development; IEA:Ensembl
P10071	GLI3	Transcriptional activator GLI3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P10071	GLI3	Transcriptional activator GLI3	GO:0042060; P:wound healing; IEA:Ensembl
P10075	GLI4	Zinc finger protein GLI4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P10075	GLI4	Zinc finger protein GLI4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P10075	GLI4	Zinc finger protein GLI4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P10075	GLI4	Zinc finger protein GLI4	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P48060	GLIPR1	Glioma pathogenesis-related protein 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P48060	GLIPR1	Glioma pathogenesis-related protein 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8NBF1	GLIS1	Zinc finger protein GLIS1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NBF1	GLIS1	Zinc finger protein GLIS1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NBF1	GLIS1	Zinc finger protein GLIS1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q8NBF1	GLIS1	Zinc finger protein GLIS1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q8NBF1	GLIS1	Zinc finger protein GLIS1	GO:0006366; P:transcription from RNA polymerase II promoter; ISS:UniProtKB
Q9BZE0	GLIS2	Zinc finger protein GLIS2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BZE0	GLIS2	Zinc finger protein GLIS2	GO:0005515; F:protein binding; IPI:IntAct
Q9BZE0	GLIS2	Zinc finger protein GLIS2	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; ISS:BHF-UCL
Q9BZE0	GLIS2	Zinc finger protein GLIS2	GO:0044212; F:transcription regulatory region DNA binding; ISS:BHF-UCL
Q9BZE0	GLIS2	Zinc finger protein GLIS2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9BZE0	GLIS2	Zinc finger protein GLIS2	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
Q9BZE0	GLIS2	Zinc finger protein GLIS2	GO:0045879; P:negative regulation of smoothened signaling pathway; ISS:UniProtKB
Q9BZE0	GLIS2	Zinc finger protein GLIS2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q9BZE0	GLIS2	Zinc finger protein GLIS2	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q9BZE0	GLIS2	Zinc finger protein GLIS2	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q9BZE0	GLIS2	Zinc finger protein GLIS2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q9BZE0	GLIS2	Zinc finger protein GLIS2	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q8NEA6	GLIS3	Zinc finger protein GLIS3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NEA6	GLIS3	Zinc finger protein GLIS3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NEA6	GLIS3	Zinc finger protein GLIS3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q8NEA6	GLIS3	Zinc finger protein GLIS3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q8NEA6	GLIS3	Zinc finger protein GLIS3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q8NEA6	GLIS3	Zinc finger protein GLIS3	GO:0006366; P:transcription from RNA polymerase II promoter; ISS:UniProtKB
Q92990	GLMN	Glomulin	GO:0005171; F:hepatocyte growth factor receptor binding; IPI:UniProtKB
Q92990	GLMN	Glomulin	GO:0005515; F:protein binding; IPI:UniProtKB
Q92990	GLMN	Glomulin	GO:0031625; F:ubiquitin protein ligase binding; IDA:MGI
Q92990	GLMN	Glomulin	GO:0055105; F:ubiquitin-protein ligase inhibitor activity; IGI:MGI
Q92990	GLMN	Glomulin	GO:0042692; P:muscle cell differentiation; IMP:UniProtKB
Q92990	GLMN	Glomulin	GO:0031397; P:negative regulation of protein ubiquitination; IGI:GOC
Q92990	GLMN	Glomulin	GO:0042130; P:negative regulation of T cell proliferation; IDA:UniProtKB
Q92990	GLMN	Glomulin	GO:0001843; P:neural tube closure; IEA:Ensembl
Q92990	GLMN	Glomulin	GO:0050715; P:positive regulation of cytokine secretion; IMP:UniProtKB
Q92990	GLMN	Glomulin	GO:0045086; P:positive regulation of interleukin-2 biosynthetic process; IMP:UniProtKB
Q92990	GLMN	Glomulin	GO:0042327; P:positive regulation of phosphorylation; IDA:UniProtKB
Q92990	GLMN	Glomulin	GO:0040029; P:regulation of gene expression, epigenetic; IMP:UniProtKB
Q92990	GLMN	Glomulin	GO:0032434; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:MGI
Q92990	GLMN	Glomulin	GO:0001570; P:vasculogenesis; IMP:UniProtKB
P15104	GLUL	Glutamine synthetase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P15104	GLUL	Glutamine synthetase	GO:0016595; F:glutamate binding; IEA:Ensembl
P15104	GLUL	Glutamine synthetase	GO:0004351; F:glutamate decarboxylase activity; IEA:UniProtKB-EC
P15104	GLUL	Glutamine synthetase	GO:0004356; F:glutamate-ammonia ligase activity; EXP:Reactome
P15104	GLUL	Glutamine synthetase	GO:0042802; F:identical protein binding; IPI:IntAct
P15104	GLUL	Glutamine synthetase	GO:0000287; F:magnesium ion binding; IEA:Ensembl
P15104	GLUL	Glutamine synthetase	GO:0030145; F:manganese ion binding; IEA:Ensembl
P15104	GLUL	Glutamine synthetase	GO:0008283; P:cell proliferation; IDA:UniProtKB
P15104	GLUL	Glutamine synthetase	GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome
P15104	GLUL	Glutamine synthetase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P15104	GLUL	Glutamine synthetase	GO:0006538; P:glutamate catabolic process; TAS:BHF-UCL
P15104	GLUL	Glutamine synthetase	GO:0006542; P:glutamine biosynthetic process; TAS:BHF-UCL
P15104	GLUL	Glutamine synthetase	GO:0001504; P:neurotransmitter uptake; TAS:Reactome
P15104	GLUL	Glutamine synthetase	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
P15104	GLUL	Glutamine synthetase	GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl
P15104	GLUL	Glutamine synthetase	GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IEA:Ensembl
P15104	GLUL	Glutamine synthetase	GO:0051260; P:protein homooligomerization; IEA:Ensembl
P15104	GLUL	Glutamine synthetase	GO:0009749; P:response to glucose; IEA:Ensembl
P15104	GLUL	Glutamine synthetase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P15104	GLUL	Glutamine synthetase	GO:0007268; P:synaptic transmission; TAS:Reactome
Q16775	HAGH	Hydroxyacylglutathione hydrolase, mitochondrial	GO:0004416; F:hydroxyacylglutathione hydrolase activity; IDA:UniProtKB
Q16775	HAGH	Hydroxyacylglutathione hydrolase, mitochondrial	GO:0008270; F:zinc ion binding; IEA:InterPro
Q16775	HAGH	Hydroxyacylglutathione hydrolase, mitochondrial	GO:0006750; P:glutathione biosynthetic process; IDA:UniProtKB
P43220	GLP1R	Glucagon-like peptide 1 receptor	GO:0004967; F:glucagon receptor activity; IEA:InterPro
P43220	GLP1R	Glucagon-like peptide 1 receptor	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
P43220	GLP1R	Glucagon-like peptide 1 receptor	GO:0007190; P:activation of adenylate cyclase activity; TAS:ProtInc
P43220	GLP1R	Glucagon-like peptide 1 receptor	GO:0019933; P:cAMP-mediated signaling; IDA:UniProtKB
P43220	GLP1R	Glucagon-like peptide 1 receptor	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P43220	GLP1R	Glucagon-like peptide 1 receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB
P43220	GLP1R	Glucagon-like peptide 1 receptor	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P43220	GLP1R	Glucagon-like peptide 1 receptor	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95838	GLP2R	Glucagon-like peptide 2 receptor	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O95838	GLP2R	Glucagon-like peptide 2 receptor	GO:0004967; F:glucagon receptor activity; IEA:Ensembl
O95838	GLP2R	Glucagon-like peptide 2 receptor	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; TAS:ProtInc
O95838	GLP2R	Glucagon-like peptide 2 receptor	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q9H4A5	GOLPH3L	Golgi phosphoprotein 3-like	GO:0070273; F:phosphatidylinositol-4-phosphate binding; IDA:UniProtKB
Q9H4A5	GOLPH3L	Golgi phosphoprotein 3-like	GO:0005515; F:protein binding; IPI:IntAct
Q9H4A5	GOLPH3L	Golgi phosphoprotein 3-like	GO:0007030; P:Golgi organization; IMP:UniProtKB
Q9H4A5	GOLPH3L	Golgi phosphoprotein 3-like	GO:0050714; P:positive regulation of protein secretion; IMP:UniProtKB
P02724	GYPA	Glycophorin-A	GO:0042802; F:identical protein binding; IPI:IntAct
P02724	GYPA	Glycophorin-A	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
P02724	GYPA	Glycophorin-A	GO:0007016; P:cytoskeletal anchoring at plasma membrane; IEA:Ensembl
P02724	GYPA	Glycophorin-A	GO:0047484; P:regulation of response to osmotic stress; IEA:Ensembl
P02724	GYPA	Glycophorin-A	GO:0016032; P:viral process; IEA:UniProtKB-KW
P04921	GYPC	Glycophorin-C	GO:0005515; F:protein binding; IPI:UniProtKB
Q14410	GK2	Glycerol kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q14410	GK2	Glycerol kinase 2	GO:0004370; F:glycerol kinase activity; NAS:UniProtKB
Q14410	GK2	Glycerol kinase 2	GO:0019563; P:glycerol catabolic process; IEA:UniProtKB-UniPathway
Q14410	GK2	Glycerol kinase 2	GO:0006072; P:glycerol-3-phosphate metabolic process; IEA:InterPro
Q14409	GK3P	Putative glycerol kinase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q14409	GK3P	Putative glycerol kinase 3	GO:0004370; F:glycerol kinase activity; NAS:UniProtKB
Q14409	GK3P	Putative glycerol kinase 3	GO:0019563; P:glycerol catabolic process; IEA:UniProtKB-UniPathway
Q14409	GK3P	Putative glycerol kinase 3	GO:0006072; P:glycerol-3-phosphate metabolic process; IEA:InterPro
Q6ZS86	GK5	Putative glycerol kinase 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6ZS86	GK5	Putative glycerol kinase 5	GO:0004370; F:glycerol kinase activity; IEA:UniProtKB-EC
Q6ZS86	GK5	Putative glycerol kinase 5	GO:0019563; P:glycerol catabolic process; IEA:UniProtKB-UniPathway
P32189	GK	Glycerol kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P32189	GK	Glycerol kinase	GO:0004370; F:glycerol kinase activity; NAS:UniProtKB
P32189	GK	Glycerol kinase	GO:0005515; F:protein binding; IPI:IntAct
P32189	GK	Glycerol kinase	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P32189	GK	Glycerol kinase	GO:0019563; P:glycerol catabolic process; IEA:UniProtKB-UniPathway
P32189	GK	Glycerol kinase	GO:0006071; P:glycerol metabolic process; IMP:BHF-UCL
P32189	GK	Glycerol kinase	GO:0046167; P:glycerol-3-phosphate biosynthetic process; IMP:BHF-UCL
P32189	GK	Glycerol kinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P32189	GK	Glycerol kinase	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
P32189	GK	Glycerol kinase	GO:0006641; P:triglyceride metabolic process; IMP:BHF-UCL
P57057	SLC37A1	Glycerol-3-phosphate transporter	GO:0005215; F:transporter activity; IEA:InterPro
P57057	SLC37A1	Glycerol-3-phosphate transporter	GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW
P57057	SLC37A1	Glycerol-3-phosphate transporter	GO:0055085; P:transmembrane transport; IEA:InterPro
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0016934; F:extracellular-glycine-gated chloride channel activity; IDA:UniProtKB
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0016594; F:glycine binding; IDA:UniProtKB
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0005515; F:protein binding; IPI:UniProtKB
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0030977; F:taurine binding; IDA:UniProtKB
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0022824; F:transmitter-gated ion channel activity; IEA:InterPro
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0007340; P:acrosome reaction; IEA:Ensembl
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0001508; P:action potential; IEA:Ensembl
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0007628; P:adult walking behavior; IEA:Ensembl
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:1902476; P:chloride transmembrane transport; IDA:GOC
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0006821; P:chloride transport; IDA:UniProtKB
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0006811; P:ion transport; IDA:UniProtKB
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0006936; P:muscle contraction; IMP:UniProtKB
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0051970; P:negative regulation of transmission of nerve impulse; IMP:UniProtKB
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0050884; P:neuromuscular process controlling posture; IEA:Ensembl
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0007218; P:neuropeptide signaling pathway; IDA:UniProtKB
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:2000344; P:positive regulation of acrosome reaction; IMP:UniProtKB
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0060080; P:regulation of inhibitory postsynaptic membrane potential; IEA:Ensembl
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0042391; P:regulation of membrane potential; IMP:MGI
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0002087; P:regulation of respiratory gaseous exchange by neurological system process; IEA:Ensembl
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0060013; P:righting reflex; IEA:Ensembl
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0001964; P:startle response; IMP:UniProtKB
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0060012; P:synaptic transmission, glycinergic; IEA:Ensembl
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0055085; P:transmembrane transport; TAS:Reactome
P23415	GLRA1	Glycine receptor subunit alpha-1	GO:0007601; P:visual perception; IEA:Ensembl
P23416	GLRA2	Glycine receptor subunit alpha-2	GO:0016934; F:extracellular-glycine-gated chloride channel activity; IDA:UniProtKB
P23416	GLRA2	Glycine receptor subunit alpha-2	GO:0016594; F:glycine binding; IDA:UniProtKB
P23416	GLRA2	Glycine receptor subunit alpha-2	GO:0022824; F:transmitter-gated ion channel activity; IEA:InterPro
P23416	GLRA2	Glycine receptor subunit alpha-2	GO:1902476; P:chloride transmembrane transport; IDA:GOC
P23416	GLRA2	Glycine receptor subunit alpha-2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P23416	GLRA2	Glycine receptor subunit alpha-2	GO:0006811; P:ion transport; IDA:UniProtKB
P23416	GLRA2	Glycine receptor subunit alpha-2	GO:0007218; P:neuropeptide signaling pathway; IDA:UniProtKB
P23416	GLRA2	Glycine receptor subunit alpha-2	GO:0007416; P:synapse assembly; IEA:Ensembl
P23416	GLRA2	Glycine receptor subunit alpha-2	GO:0055085; P:transmembrane transport; TAS:Reactome
O75311	GLRA3	Glycine receptor subunit alpha-3	GO:0016934; F:extracellular-glycine-gated chloride channel activity; IEA:InterPro
O75311	GLRA3	Glycine receptor subunit alpha-3	GO:0016594; F:glycine binding; IEA:InterPro
O75311	GLRA3	Glycine receptor subunit alpha-3	GO:0022824; F:transmitter-gated ion channel activity; IEA:InterPro
O75311	GLRA3	Glycine receptor subunit alpha-3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
O75311	GLRA3	Glycine receptor subunit alpha-3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q5JXX5	GLRA4	Glycine receptor subunit alpha-4	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
Q5JXX5	GLRA4	Glycine receptor subunit alpha-4	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
Q5JXX5	GLRA4	Glycine receptor subunit alpha-4	GO:0016594; F:glycine binding; IEA:InterPro
Q5JXX5	GLRA4	Glycine receptor subunit alpha-4	GO:0022824; F:transmitter-gated ion channel activity; IEA:InterPro
P48167	GLRB	Glycine receptor subunit beta	GO:0016934; F:extracellular-glycine-gated chloride channel activity; TAS:Reactome
P48167	GLRB	Glycine receptor subunit beta	GO:0016933; F:extracellular-glycine-gated ion channel activity; IMP:UniProtKB
P48167	GLRB	Glycine receptor subunit beta	GO:0016594; F:glycine binding; IEA:Ensembl
P48167	GLRB	Glycine receptor subunit beta	GO:0005515; F:protein binding; IPI:UniProtKB
P48167	GLRB	Glycine receptor subunit beta	GO:0007340; P:acrosome reaction; IEA:Ensembl
P48167	GLRB	Glycine receptor subunit beta	GO:0007628; P:adult walking behavior; IEA:Ensembl
P48167	GLRB	Glycine receptor subunit beta	GO:1902476; P:chloride transmembrane transport; IDA:GOC
P48167	GLRB	Glycine receptor subunit beta	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P48167	GLRB	Glycine receptor subunit beta	GO:0006811; P:ion transport; IDA:UniProtKB
P48167	GLRB	Glycine receptor subunit beta	GO:0007399; P:nervous system development; IMP:UniProtKB
P48167	GLRB	Glycine receptor subunit beta	GO:0007218; P:neuropeptide signaling pathway; IDA:UniProtKB
P48167	GLRB	Glycine receptor subunit beta	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P48167	GLRB	Glycine receptor subunit beta	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
P48167	GLRB	Glycine receptor subunit beta	GO:0060013; P:righting reflex; IEA:Ensembl
P48167	GLRB	Glycine receptor subunit beta	GO:0001964; P:startle response; IMP:UniProtKB
P48167	GLRB	Glycine receptor subunit beta	GO:0007268; P:synaptic transmission; IMP:UniProtKB
P48167	GLRB	Glycine receptor subunit beta	GO:0060012; P:synaptic transmission, glycinergic; IEA:Ensembl
P48167	GLRB	Glycine receptor subunit beta	GO:0055085; P:transmembrane transport; TAS:Reactome
P48167	GLRB	Glycine receptor subunit beta	GO:0007601; P:visual perception; IEA:Ensembl
P35754	GLRX	Glutaredoxin-1	GO:0009055; F:electron carrier activity; IEA:InterPro
P35754	GLRX	Glutaredoxin-1	GO:0015038; F:glutathione disulfide oxidoreductase activity; TAS:ProtInc
P35754	GLRX	Glutaredoxin-1	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
P35754	GLRX	Glutaredoxin-1	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
P35754	GLRX	Glutaredoxin-1	GO:0045454; P:cell redox homeostasis; IEA:InterPro
P35754	GLRX	Glutaredoxin-1	GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome
P35754	GLRX	Glutaredoxin-1	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P35754	GLRX	Glutaredoxin-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NS18	GLRX2	Glutaredoxin-2, mitochondrial	GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:UniProtKB-KW
Q9NS18	GLRX2	Glutaredoxin-2, mitochondrial	GO:0008794; F:arsenate reductase (glutaredoxin) activity; TAS:UniProtKB
Q9NS18	GLRX2	Glutaredoxin-2, mitochondrial	GO:0009055; F:electron carrier activity; NAS:UniProtKB
Q9NS18	GLRX2	Glutaredoxin-2, mitochondrial	GO:0015038; F:glutathione disulfide oxidoreductase activity; TAS:UniProtKB
Q9NS18	GLRX2	Glutaredoxin-2, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NS18	GLRX2	Glutaredoxin-2, mitochondrial	GO:0003756; F:protein disulfide isomerase activity; TAS:UniProtKB
Q9NS18	GLRX2	Glutaredoxin-2, mitochondrial	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
Q9NS18	GLRX2	Glutaredoxin-2, mitochondrial	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q9NS18	GLRX2	Glutaredoxin-2, mitochondrial	GO:0030154; P:cell differentiation; NAS:UniProtKB
Q9NS18	GLRX2	Glutaredoxin-2, mitochondrial	GO:0045454; P:cell redox homeostasis; TAS:UniProtKB
Q9NS18	GLRX2	Glutaredoxin-2, mitochondrial	GO:0042262; P:DNA protection; NAS:UniProtKB
Q9NS18	GLRX2	Glutaredoxin-2, mitochondrial	GO:0006749; P:glutathione metabolic process; TAS:UniProtKB
Q9NS18	GLRX2	Glutaredoxin-2, mitochondrial	GO:0006457; P:protein folding; TAS:GOC
Q9NS18	GLRX2	Glutaredoxin-2, mitochondrial	GO:0009966; P:regulation of signal transduction; NAS:UniProtKB
Q9NS18	GLRX2	Glutaredoxin-2, mitochondrial	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9NS18	GLRX2	Glutaredoxin-2, mitochondrial	GO:0042542; P:response to hydrogen peroxide; IDA:UniProtKB
Q9NS18	GLRX2	Glutaredoxin-2, mitochondrial	GO:0010033; P:response to organic substance; IDA:UniProtKB
Q9NS18	GLRX2	Glutaredoxin-2, mitochondrial	GO:0051775; P:response to redox state; TAS:UniProtKB
Q9NS18	GLRX2	Glutaredoxin-2, mitochondrial	GO:0009266; P:response to temperature stimulus; NAS:UniProtKB
O76003	GLRX3	Glutaredoxin-3	GO:0009055; F:electron carrier activity; IEA:InterPro
O76003	GLRX3	Glutaredoxin-3	GO:0051536; F:iron-sulfur cluster binding; IEA:UniProtKB-KW
O76003	GLRX3	Glutaredoxin-3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O76003	GLRX3	Glutaredoxin-3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O76003	GLRX3	Glutaredoxin-3	GO:0005515; F:protein binding; IPI:IntAct
O76003	GLRX3	Glutaredoxin-3	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
O76003	GLRX3	Glutaredoxin-3	GO:0045454; P:cell redox homeostasis; IEA:InterPro
O76003	GLRX3	Glutaredoxin-3	GO:0010614; P:negative regulation of cardiac muscle hypertrophy; ISS:UniProtKB
O76003	GLRX3	Glutaredoxin-3	GO:0002026; P:regulation of the force of heart contraction; ISS:UniProtKB
Q86SX6	GLRX5	Glutaredoxin-related protein 5, mitochondrial	GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:UniProtKB-KW
Q86SX6	GLRX5	Glutaredoxin-related protein 5, mitochondrial	GO:0009055; F:electron carrier activity; IEA:InterPro
Q86SX6	GLRX5	Glutaredoxin-related protein 5, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86SX6	GLRX5	Glutaredoxin-related protein 5, mitochondrial	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
Q86SX6	GLRX5	Glutaredoxin-related protein 5, mitochondrial	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q86SX6	GLRX5	Glutaredoxin-related protein 5, mitochondrial	GO:0030097; P:hemopoiesis; ISS:UniProtKB
P47871	GCGR	Glucagon receptor	GO:0004967; F:glucagon receptor activity; IDA:UniProtKB
P47871	GCGR	Glucagon receptor	GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:Reactome
P47871	GCGR	Glucagon receptor	GO:0017046; F:peptide hormone binding; IEA:Ensembl
P47871	GCGR	Glucagon receptor	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P47871	GCGR	Glucagon receptor	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IMP:UniProtKB
P47871	GCGR	Glucagon receptor	GO:0071377; P:cellular response to glucagon stimulus; IDA:UniProtKB
P47871	GCGR	Glucagon receptor	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P47871	GCGR	Glucagon receptor	GO:0006887; P:exocytosis; IEA:Ensembl
P47871	GCGR	Glucagon receptor	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P47871	GCGR	Glucagon receptor	GO:0042593; P:glucose homeostasis; ISS:UniProtKB
P47871	GCGR	Glucagon receptor	GO:0009755; P:hormone-mediated signaling pathway; IEA:Ensembl
P47871	GCGR	Glucagon receptor	GO:0008217; P:regulation of blood pressure; TAS:ProtInc
P47871	GCGR	Glucagon receptor	GO:0070873; P:regulation of glycogen metabolic process; ISS:UniProtKB
P47871	GCGR	Glucagon receptor	GO:0043087; P:regulation of GTPase activity; TAS:GOC
P47871	GCGR	Glucagon receptor	GO:0007584; P:response to nutrient; TAS:ProtInc
P47871	GCGR	Glucagon receptor	GO:0042594; P:response to starvation; ISS:UniProtKB
P47871	GCGR	Glucagon receptor	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O94925	GLS	Glutaminase kidney isoform, mitochondrial	GO:0004359; F:glutaminase activity; IDA:UniProtKB
O94925	GLS	Glutaminase kidney isoform, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
O94925	GLS	Glutaminase kidney isoform, mitochondrial	GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome
O94925	GLS	Glutaminase kidney isoform, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
O94925	GLS	Glutaminase kidney isoform, mitochondrial	GO:0006537; P:glutamate biosynthetic process; IDA:UniProtKB
O94925	GLS	Glutaminase kidney isoform, mitochondrial	GO:0014047; P:glutamate secretion; TAS:Reactome
O94925	GLS	Glutaminase kidney isoform, mitochondrial	GO:0006543; P:glutamine catabolic process; IDA:UniProtKB
O94925	GLS	Glutaminase kidney isoform, mitochondrial	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
O94925	GLS	Glutaminase kidney isoform, mitochondrial	GO:0051289; P:protein homotetramerization; IDA:UniProtKB
O94925	GLS	Glutaminase kidney isoform, mitochondrial	GO:0002087; P:regulation of respiratory gaseous exchange by neurological system process; IEA:Ensembl
O94925	GLS	Glutaminase kidney isoform, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O94925	GLS	Glutaminase kidney isoform, mitochondrial	GO:0001967; P:suckling behavior; IEA:Ensembl
O94925	GLS	Glutaminase kidney isoform, mitochondrial	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9UI32	GLS2	Glutaminase liver isoform, mitochondrial	GO:0004359; F:glutaminase activity; TAS:ProtInc
Q9UI32	GLS2	Glutaminase liver isoform, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UI32	GLS2	Glutaminase liver isoform, mitochondrial	GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome
Q9UI32	GLS2	Glutaminase liver isoform, mitochondrial	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
Q9UI32	GLS2	Glutaminase liver isoform, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9UI32	GLS2	Glutaminase liver isoform, mitochondrial	GO:0014047; P:glutamate secretion; TAS:Reactome
Q9UI32	GLS2	Glutaminase liver isoform, mitochondrial	GO:0006541; P:glutamine metabolic process; IEA:InterPro
Q9UI32	GLS2	Glutaminase liver isoform, mitochondrial	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
Q9UI32	GLS2	Glutaminase liver isoform, mitochondrial	GO:0072593; P:reactive oxygen species metabolic process; IMP:MGI
Q9UI32	GLS2	Glutaminase liver isoform, mitochondrial	GO:0042981; P:regulation of apoptotic process; IMP:MGI
Q9UI32	GLS2	Glutaminase liver isoform, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UI32	GLS2	Glutaminase liver isoform, mitochondrial	GO:0007268; P:synaptic transmission; TAS:Reactome
Q86SR1	GALNT10	Polypeptide N-acetylgalactosaminyltransferase 10	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86SR1	GALNT10	Polypeptide N-acetylgalactosaminyltransferase 10	GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IEA:UniProtKB-EC
Q86SR1	GALNT10	Polypeptide N-acetylgalactosaminyltransferase 10	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q86SR1	GALNT10	Polypeptide N-acetylgalactosaminyltransferase 10	GO:0016266; P:O-glycan processing; TAS:Reactome
Q86SR1	GALNT10	Polypeptide N-acetylgalactosaminyltransferase 10	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q8NCW6	GALNT11	Polypeptide N-acetylgalactosaminyltransferase 11	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NCW6	GALNT11	Polypeptide N-acetylgalactosaminyltransferase 11	GO:0005112; F:Notch binding; IDA:UniProtKB
Q8NCW6	GALNT11	Polypeptide N-acetylgalactosaminyltransferase 11	GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IDA:UniProtKB
Q8NCW6	GALNT11	Polypeptide N-acetylgalactosaminyltransferase 11	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8NCW6	GALNT11	Polypeptide N-acetylgalactosaminyltransferase 11	GO:0060271; P:cilium morphogenesis; ISS:UniProtKB
Q8NCW6	GALNT11	Polypeptide N-acetylgalactosaminyltransferase 11	GO:0007368; P:determination of left/right symmetry; ISS:UniProtKB
Q8NCW6	GALNT11	Polypeptide N-acetylgalactosaminyltransferase 11	GO:0007220; P:Notch receptor processing; ISS:UniProtKB
Q8NCW6	GALNT11	Polypeptide N-acetylgalactosaminyltransferase 11	GO:0061314; P:Notch signaling involved in heart development; ISS:UniProtKB
Q8NCW6	GALNT11	Polypeptide N-acetylgalactosaminyltransferase 11	GO:0016266; P:O-glycan processing; TAS:Reactome
Q8NCW6	GALNT11	Polypeptide N-acetylgalactosaminyltransferase 11	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q8NCW6	GALNT11	Polypeptide N-acetylgalactosaminyltransferase 11	GO:0018243; P:protein O-linked glycosylation via threonine; IDA:UniProtKB
Q8NCW6	GALNT11	Polypeptide N-acetylgalactosaminyltransferase 11	GO:0008593; P:regulation of Notch signaling pathway; ISS:UniProtKB
Q8IXK2	GALNT12	Polypeptide N-acetylgalactosaminyltransferase 12	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IXK2	GALNT12	Polypeptide N-acetylgalactosaminyltransferase 12	GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IEA:UniProtKB-EC
Q8IXK2	GALNT12	Polypeptide N-acetylgalactosaminyltransferase 12	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8IXK2	GALNT12	Polypeptide N-acetylgalactosaminyltransferase 12	GO:0016266; P:O-glycan processing; TAS:Reactome
Q8IXK2	GALNT12	Polypeptide N-acetylgalactosaminyltransferase 12	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q8IUC8	GALNT13	Polypeptide N-acetylgalactosaminyltransferase 13	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IUC8	GALNT13	Polypeptide N-acetylgalactosaminyltransferase 13	GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IEA:UniProtKB-EC
Q8IUC8	GALNT13	Polypeptide N-acetylgalactosaminyltransferase 13	GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW
Q8IUC8	GALNT13	Polypeptide N-acetylgalactosaminyltransferase 13	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8IUC8	GALNT13	Polypeptide N-acetylgalactosaminyltransferase 13	GO:0016266; P:O-glycan processing; TAS:Reactome
Q8IUC8	GALNT13	Polypeptide N-acetylgalactosaminyltransferase 13	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q8IUC8	GALNT13	Polypeptide N-acetylgalactosaminyltransferase 13	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q96FL9	GALNT14	Polypeptide N-acetylgalactosaminyltransferase 14	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96FL9	GALNT14	Polypeptide N-acetylgalactosaminyltransferase 14	GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IEA:UniProtKB-EC
Q96FL9	GALNT14	Polypeptide N-acetylgalactosaminyltransferase 14	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q96FL9	GALNT14	Polypeptide N-acetylgalactosaminyltransferase 14	GO:0016266; P:O-glycan processing; TAS:Reactome
Q96FL9	GALNT14	Polypeptide N-acetylgalactosaminyltransferase 14	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q8N3T1	GALNT15	Polypeptide N-acetylgalactosaminyltransferase 15	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N3T1	GALNT15	Polypeptide N-acetylgalactosaminyltransferase 15	GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IEA:UniProtKB-EC
Q8N3T1	GALNT15	Polypeptide N-acetylgalactosaminyltransferase 15	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8N3T1	GALNT15	Polypeptide N-acetylgalactosaminyltransferase 15	GO:0016266; P:O-glycan processing; TAS:Reactome
Q8N3T1	GALNT15	Polypeptide N-acetylgalactosaminyltransferase 15	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q8N428	GALNT16	Polypeptide N-acetylgalactosaminyltransferase 16	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N428	GALNT16	Polypeptide N-acetylgalactosaminyltransferase 16	GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IEA:UniProtKB-EC
Q8N428	GALNT16	Polypeptide N-acetylgalactosaminyltransferase 16	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q6P9A2	GALNT18	Polypeptide N-acetylgalactosaminyltransferase 18	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6P9A2	GALNT18	Polypeptide N-acetylgalactosaminyltransferase 18	GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IEA:UniProtKB-EC
Q6P9A2	GALNT18	Polypeptide N-acetylgalactosaminyltransferase 18	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
A6NH11	GLTPD2	Glycolipid transfer protein domain-containing protein 2	GO:0051861; F:glycolipid binding; IEA:InterPro
A6NH11	GLTPD2	Glycolipid transfer protein domain-containing protein 2	GO:0017089; F:glycolipid transporter activity; IEA:InterPro
Q6IS24	WBSCR17	Putative polypeptide N-acetylgalactosaminyltransferase-like protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6IS24	WBSCR17	Putative polypeptide N-acetylgalactosaminyltransferase-like protein 3	GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IEA:UniProtKB-EC
Q6IS24	WBSCR17	Putative polypeptide N-acetylgalactosaminyltransferase-like protein 3	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q7Z4T8	GALNTL5	Inactive polypeptide N-acetylgalactosaminyltransferase-like protein 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z4T8	GALNTL5	Inactive polypeptide N-acetylgalactosaminyltransferase-like protein 5	GO:0007286; P:spermatid development; IMP:UniProtKB
Q49A17	GALNTL6	Polypeptide N-acetylgalactosaminyltransferase-like 6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q49A17	GALNTL6	Polypeptide N-acetylgalactosaminyltransferase-like 6	GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IEA:UniProtKB-EC
Q49A17	GALNTL6	Polypeptide N-acetylgalactosaminyltransferase-like 6	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q9NZD2	GLTP	Glycolipid transfer protein	GO:0051861; F:glycolipid binding; IDA:HGNC
Q9NZD2	GLTP	Glycolipid transfer protein	GO:0017089; F:glycolipid transporter activity; IDA:HGNC
Q9NZD2	GLTP	Glycolipid transfer protein	GO:0008289; F:lipid binding; IDA:HGNC
Q9NZD2	GLTP	Glycolipid transfer protein	GO:0046836; P:glycolipid transport; IDA:HGNC
P14314	PRKCSH	Glucosidase 2 subunit beta	GO:0005509; F:calcium ion binding; IEA:InterPro
P14314	PRKCSH	Glucosidase 2 subunit beta	GO:0044325; F:ion channel binding; IPI:UniProt
P14314	PRKCSH	Glucosidase 2 subunit beta	GO:0051219; F:phosphoprotein binding; IPI:UniProt
P14314	PRKCSH	Glucosidase 2 subunit beta	GO:0005080; F:protein kinase C binding; IPI:UniProtKB
P14314	PRKCSH	Glucosidase 2 subunit beta	GO:0003723; F:RNA binding; IEA:Ensembl
P14314	PRKCSH	Glucosidase 2 subunit beta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P14314	PRKCSH	Glucosidase 2 subunit beta	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P14314	PRKCSH	Glucosidase 2 subunit beta	GO:0045087; P:innate immune response; TAS:Reactome
P14314	PRKCSH	Glucosidase 2 subunit beta	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
P14314	PRKCSH	Glucosidase 2 subunit beta	GO:0001889; P:liver development; IEA:Ensembl
P14314	PRKCSH	Glucosidase 2 subunit beta	GO:0006491; P:N-glycan processing; IEA:InterPro
P14314	PRKCSH	Glucosidase 2 subunit beta	GO:0010977; P:negative regulation of neuron projection development; IEA:Ensembl
P14314	PRKCSH	Glucosidase 2 subunit beta	GO:0006807; P:nitrogen compound metabolic process; IEA:Ensembl
P14314	PRKCSH	Glucosidase 2 subunit beta	GO:0043687; P:post-translational protein modification; TAS:Reactome
P14314	PRKCSH	Glucosidase 2 subunit beta	GO:0006457; P:protein folding; TAS:Reactome
P14314	PRKCSH	Glucosidase 2 subunit beta	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P14314	PRKCSH	Glucosidase 2 subunit beta	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
P14314	PRKCSH	Glucosidase 2 subunit beta	GO:0072001; P:renal system development; IEA:Ensembl
P01275	GCG	Glucagon	GO:0031769; F:glucagon receptor binding; IBA:RefGenome
P01275	GCG	Glucagon	GO:0005179; F:hormone activity; IBA:RefGenome
P01275	GCG	Glucagon	GO:0042802; F:identical protein binding; IPI:IntAct
P01275	GCG	Glucagon	GO:0005515; F:protein binding; IPI:IntAct
P01275	GCG	Glucagon	GO:0005102; F:receptor binding; TAS:ProtInc
P01275	GCG	Glucagon	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IBA:RefGenome
P01275	GCG	Glucagon	GO:0008283; P:cell proliferation; TAS:ProtInc
P01275	GCG	Glucagon	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P01275	GCG	Glucagon	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
P01275	GCG	Glucagon	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P01275	GCG	Glucagon	GO:0007631; P:feeding behavior; TAS:ProtInc
P01275	GCG	Glucagon	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P01275	GCG	Glucagon	GO:0043066; P:negative regulation of apoptotic process; IBA:RefGenome
P01275	GCG	Glucagon	GO:1900118; P:negative regulation of execution phase of apoptosis; IEA:Ensembl
P01275	GCG	Glucagon	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl
P01275	GCG	Glucagon	GO:0090280; P:positive regulation of calcium ion import; IEA:Ensembl
P01275	GCG	Glucagon	GO:0030819; P:positive regulation of cAMP biosynthetic process; IEA:Ensembl
P01275	GCG	Glucagon	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl
P01275	GCG	Glucagon	GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IBA:RefGenome
P01275	GCG	Glucagon	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IEA:Ensembl
P01275	GCG	Glucagon	GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IEA:Ensembl
P01275	GCG	Glucagon	GO:0032092; P:positive regulation of protein binding; IEA:Ensembl
P01275	GCG	Glucagon	GO:0045860; P:positive regulation of protein kinase activity; IEA:Ensembl
P01275	GCG	Glucagon	GO:0010737; P:protein kinase A signaling; IBA:RefGenome
P01275	GCG	Glucagon	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P01275	GCG	Glucagon	GO:0042594; P:response to starvation; IBA:RefGenome
P01275	GCG	Glucagon	GO:0007165; P:signal transduction; TAS:ProtInc
P01275	GCG	Glucagon	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6IB77	GLYAT	Glycine N-acyltransferase	GO:0047961; F:glycine N-acyltransferase activity; IEA:UniProtKB-EC
Q6IB77	GLYAT	Glycine N-acyltransferase	GO:0047962; F:glycine N-benzoyltransferase activity; ISS:UniProtKB
Q6IB77	GLYAT	Glycine N-acyltransferase	GO:0016746; F:transferase activity, transferring acyl groups; TAS:ProtInc
Q6IB77	GLYAT	Glycine N-acyltransferase	GO:0006637; P:acyl-CoA metabolic process; TAS:ProtInc
Q6IB77	GLYAT	Glycine N-acyltransferase	GO:0006544; P:glycine metabolic process; ISS:UniProtKB
Q6IB77	GLYAT	Glycine N-acyltransferase	GO:0032787; P:monocarboxylic acid metabolic process; ISS:UniProtKB
Q6IB77	GLYAT	Glycine N-acyltransferase	GO:0009636; P:response to toxic substance; TAS:ProtInc
Q6IB77	GLYAT	Glycine N-acyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6IB77	GLYAT	Glycine N-acyltransferase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P34896	SHMT1	Serine hydroxymethyltransferase, cytosolic	GO:0016597; F:amino acid binding; IEA:Ensembl
P34896	SHMT1	Serine hydroxymethyltransferase, cytosolic	GO:0004372; F:glycine hydroxymethyltransferase activity; IEA:UniProtKB-EC
P34896	SHMT1	Serine hydroxymethyltransferase, cytosolic	GO:0008732; F:L-allo-threonine aldolase activity; IEA:Ensembl
P34896	SHMT1	Serine hydroxymethyltransferase, cytosolic	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
P34896	SHMT1	Serine hydroxymethyltransferase, cytosolic	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P34896	SHMT1	Serine hydroxymethyltransferase, cytosolic	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
P34896	SHMT1	Serine hydroxymethyltransferase, cytosolic	GO:0045329; P:carnitine biosynthetic process; TAS:Reactome
P34896	SHMT1	Serine hydroxymethyltransferase, cytosolic	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P34896	SHMT1	Serine hydroxymethyltransferase, cytosolic	GO:0046655; P:folic acid metabolic process; IDA:UniProtKB
P34896	SHMT1	Serine hydroxymethyltransferase, cytosolic	GO:0019264; P:glycine biosynthetic process from serine; IEA:Ensembl
P34896	SHMT1	Serine hydroxymethyltransferase, cytosolic	GO:0006565; P:L-serine catabolic process; IDA:UniProtKB
P34896	SHMT1	Serine hydroxymethyltransferase, cytosolic	GO:0051289; P:protein homotetramerization; IEA:Ensembl
P34896	SHMT1	Serine hydroxymethyltransferase, cytosolic	GO:0051262; P:protein tetramerization; IDA:UniProtKB
P34896	SHMT1	Serine hydroxymethyltransferase, cytosolic	GO:0009113; P:purine nucleobase biosynthetic process; IDA:UniProtKB
P34896	SHMT1	Serine hydroxymethyltransferase, cytosolic	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P34896	SHMT1	Serine hydroxymethyltransferase, cytosolic	GO:0035999; P:tetrahydrofolate interconversion; IEA:UniProtKB-UniPathway
P34896	SHMT1	Serine hydroxymethyltransferase, cytosolic	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P34896	SHMT1	Serine hydroxymethyltransferase, cytosolic	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
O15488	GYG2	Glycogenin-2	GO:0008466; F:glycogenin glucosyltransferase activity; EXP:Reactome
O15488	GYG2	Glycogenin-2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O15488	GYG2	Glycogenin-2	GO:0006006; P:glucose metabolic process; TAS:Reactome
O15488	GYG2	Glycogenin-2	GO:0005978; P:glycogen biosynthetic process; TAS:Reactome
O15488	GYG2	Glycogenin-2	GO:0005980; P:glycogen catabolic process; TAS:Reactome
O15488	GYG2	Glycogenin-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P46976	GYG1	Glycogenin-1	GO:0005536; F:glucose binding; IEA:Ensembl
P46976	GYG1	Glycogenin-1	GO:0008466; F:glycogenin glucosyltransferase activity; EXP:Reactome
P46976	GYG1	Glycogenin-1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P46976	GYG1	Glycogenin-1	GO:0005515; F:protein binding; IPI:UniProtKB
P46976	GYG1	Glycogenin-1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P46976	GYG1	Glycogenin-1	GO:0006006; P:glucose metabolic process; TAS:Reactome
P46976	GYG1	Glycogenin-1	GO:0005978; P:glycogen biosynthetic process; TAS:Reactome
P46976	GYG1	Glycogenin-1	GO:0005980; P:glycogen catabolic process; TAS:Reactome
P46976	GYG1	Glycogenin-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8WU03	GLYATL2	Glycine N-acyltransferase-like protein 2	GO:0047961; F:glycine N-acyltransferase activity; IEA:UniProtKB-EC
Q969I3	GLYATL1	Glycine N-acyltransferase-like protein 1	GO:0047946; F:glutamine N-acyltransferase activity; IEA:UniProtKB-EC
Q969I3	GLYATL1	Glycine N-acyltransferase-like protein 1	GO:0047961; F:glycine N-acyltransferase activity; IEA:InterPro
Q5SZD4	GLYATL3	Glycine N-acyltransferase-like protein 3	GO:0047961; F:glycine N-acyltransferase activity; IEA:InterPro
P34897	SHMT2	Serine hydroxymethyltransferase, mitochondrial	GO:0016597; F:amino acid binding; IEA:Ensembl
P34897	SHMT2	Serine hydroxymethyltransferase, mitochondrial	GO:0003682; F:chromatin binding; IDA:UniProtKB
P34897	SHMT2	Serine hydroxymethyltransferase, mitochondrial	GO:0004372; F:glycine hydroxymethyltransferase activity; IDA:UniProtKB
P34897	SHMT2	Serine hydroxymethyltransferase, mitochondrial	GO:0008732; F:L-allo-threonine aldolase activity; IEA:Ensembl
P34897	SHMT2	Serine hydroxymethyltransferase, mitochondrial	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
P34897	SHMT2	Serine hydroxymethyltransferase, mitochondrial	GO:0019264; P:glycine biosynthetic process from serine; IEA:Ensembl
P34897	SHMT2	Serine hydroxymethyltransferase, mitochondrial	GO:0006564; P:L-serine biosynthetic process; IEA:Ensembl
P34897	SHMT2	Serine hydroxymethyltransferase, mitochondrial	GO:0006730; P:one-carbon metabolic process; IDA:UniProtKB
P34897	SHMT2	Serine hydroxymethyltransferase, mitochondrial	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P34897	SHMT2	Serine hydroxymethyltransferase, mitochondrial	GO:0051289; P:protein homotetramerization; IEA:Ensembl
P34897	SHMT2	Serine hydroxymethyltransferase, mitochondrial	GO:0035999; P:tetrahydrofolate interconversion; IEA:UniProtKB-UniPathway
Q49A26	GLYR1	Putative oxidoreductase GLYR1	GO:0050662; F:coenzyme binding; IEA:InterPro
Q49A26	GLYR1	Putative oxidoreductase GLYR1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q49A26	GLYR1	Putative oxidoreductase GLYR1	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q49A26	GLYR1	Putative oxidoreductase GLYR1	GO:0004616; F:phosphogluconate dehydrogenase (decarboxylating) activity; IEA:InterPro
Q49A26	GLYR1	Putative oxidoreductase GLYR1	GO:0006098; P:pentose-phosphate shunt; IEA:InterPro
Q96IK5	GMCL1	Germ cell-less protein-like 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96IK5	GMCL1	Germ cell-less protein-like 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q96IK5	GMCL1	Germ cell-less protein-like 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:Ensembl
Q96IK5	GMCL1	Germ cell-less protein-like 1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q8NEA9	GMCL1P1	Putative germ cell-less protein-like 1-like	GO:0005515; F:protein binding; IPI:IntAct
Q8NEA9	GMCL1P1	Putative germ cell-less protein-like 1-like	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8NEA9	GMCL1P1	Putative germ cell-less protein-like 1-like	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8NEA9	GMCL1P1	Putative germ cell-less protein-like 1-like	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8NEA9	GMCL1P1	Putative germ cell-less protein-like 1-like	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
O60547	GMDS	GDP-mannose 4,6 dehydratase	GO:0008446; F:GDP-mannose 4,6-dehydratase activity; IDA:UniProtKB
O60547	GMDS	GDP-mannose 4,6 dehydratase	GO:0070401; F:NADP+ binding; IDA:UniProtKB
O60547	GMDS	GDP-mannose 4,6 dehydratase	GO:0042351; P:'de novo' GDP-L-fucose biosynthetic process; IDA:UniProtKB
O60547	GMDS	GDP-mannose 4,6 dehydratase	GO:0019673; P:GDP-mannose metabolic process; IDA:UniProtKB
O60547	GMDS	GDP-mannose 4,6 dehydratase	GO:0007219; P:Notch signaling pathway; ISS:UniProtKB
Q9Y692	GMEB1	Glucocorticoid modulatory element-binding protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y692	GMEB1	Glucocorticoid modulatory element-binding protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y692	GMEB1	Glucocorticoid modulatory element-binding protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q9Y692	GMEB1	Glucocorticoid modulatory element-binding protein 1	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q9Y692	GMEB1	Glucocorticoid modulatory element-binding protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UKD1	GMEB2	Glucocorticoid modulatory element-binding protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UKD1	GMEB2	Glucocorticoid modulatory element-binding protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UKD1	GMEB2	Glucocorticoid modulatory element-binding protein 2	GO:0003713; F:transcription coactivator activity; IEA:InterPro
Q9UKD1	GMEB2	Glucocorticoid modulatory element-binding protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UKD1	GMEB2	Glucocorticoid modulatory element-binding protein 2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
O60234	GMFG	Glia maturation factor gamma	GO:0008047; F:enzyme activator activity; TAS:ProtInc
O60234	GMFG	Glia maturation factor gamma	GO:0004860; F:protein kinase inhibitor activity; TAS:ProtInc
O60234	GMFG	Glia maturation factor gamma	GO:0006469; P:negative regulation of protein kinase activity; TAS:GOC
O60234	GMFG	Glia maturation factor gamma	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
O60234	GMFG	Glia maturation factor gamma	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P60983	GMFB	Glia maturation factor beta	GO:0008047; F:enzyme activator activity; TAS:ProtInc
P60983	GMFB	Glia maturation factor beta	GO:0004860; F:protein kinase inhibitor activity; TAS:ProtInc
P60983	GMFB	Glia maturation factor beta	GO:0004871; F:signal transducer activity; TAS:ProtInc
P60983	GMFB	Glia maturation factor beta	GO:0006469; P:negative regulation of protein kinase activity; TAS:GOC
P60983	GMFB	Glia maturation factor beta	GO:0007399; P:nervous system development; TAS:ProtInc
P60983	GMFB	Glia maturation factor beta	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
P60983	GMFB	Glia maturation factor beta	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P60983	GMFB	Glia maturation factor beta	GO:0007165; P:signal transduction; TAS:ProtInc
Q9P107	GMIP	GEM-interacting protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9P107	GMIP	GEM-interacting protein	GO:0005515; F:protein binding; IPI:HGNC
Q9P107	GMIP	GEM-interacting protein	GO:0005100; F:Rho GTPase activator activity; IDA:HGNC
Q9P107	GMIP	GEM-interacting protein	GO:0035556; P:intracellular signal transduction; IDA:HGNC
Q9P107	GMIP	GEM-interacting protein	GO:0034259; P:negative regulation of Rho GTPase activity; IDA:BHF-UCL
Q9P107	GMIP	GEM-interacting protein	GO:0032321; P:positive regulation of Rho GTPase activity; IDA:GOC
Q9P107	GMIP	GEM-interacting protein	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q9P107	GMIP	GEM-interacting protein	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q99445	GML	Glycosyl-phosphatidylinositol-anchored molecule-like protein	GO:0006915; P:apoptotic process; TAS:ProtInc
Q99445	GML	Glycosyl-phosphatidylinositol-anchored molecule-like protein	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:ProtInc
Q99445	GML	Glycosyl-phosphatidylinositol-anchored molecule-like protein	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q96IJ6	GMPPA	Mannose-1-phosphate guanyltransferase alpha	GO:0016779; F:nucleotidyltransferase activity; IEA:InterPro
Q96IJ6	GMPPA	Mannose-1-phosphate guanyltransferase alpha	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q96IJ6	GMPPA	Mannose-1-phosphate guanyltransferase alpha	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q96IJ6	GMPPA	Mannose-1-phosphate guanyltransferase alpha	GO:0009298; P:GDP-mannose biosynthetic process; TAS:Reactome
Q96IJ6	GMPPA	Mannose-1-phosphate guanyltransferase alpha	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q96IJ6	GMPPA	Mannose-1-phosphate guanyltransferase alpha	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9Y5P6	GMPPB	Mannose-1-phosphate guanyltransferase beta	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9Y5P6	GMPPB	Mannose-1-phosphate guanyltransferase beta	GO:0004475; F:mannose-1-phosphate guanylyltransferase activity; IEA:UniProtKB-EC
Q9Y5P6	GMPPB	Mannose-1-phosphate guanyltransferase beta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9Y5P6	GMPPB	Mannose-1-phosphate guanyltransferase beta	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q9Y5P6	GMPPB	Mannose-1-phosphate guanyltransferase beta	GO:0009298; P:GDP-mannose biosynthetic process; TAS:Reactome
Q9Y5P6	GMPPB	Mannose-1-phosphate guanyltransferase beta	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9Y5P6	GMPPB	Mannose-1-phosphate guanyltransferase beta	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
P36959	GMPR	GMP reductase 1	GO:0003920; F:GMP reductase activity; TAS:ProtInc
P36959	GMPR	GMP reductase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P36959	GMPR	GMP reductase 1	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P36959	GMPR	GMP reductase 1	GO:0009117; P:nucleotide metabolic process; IEA:InterPro
P36959	GMPR	GMP reductase 1	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P36959	GMPR	GMP reductase 1	GO:0043101; P:purine-containing compound salvage; TAS:Reactome
P36959	GMPR	GMP reductase 1	GO:0009409; P:response to cold; TAS:ProtInc
P36959	GMPR	GMP reductase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9P2T1	GMPR2	GMP reductase 2	GO:0003920; F:GMP reductase activity; IEA:UniProtKB-EC
Q9P2T1	GMPR2	GMP reductase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9P2T1	GMPR2	GMP reductase 2	GO:0046037; P:GMP metabolic process; IDA:UniProtKB
Q9P2T1	GMPR2	GMP reductase 2	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q9P2T1	GMPR2	GMP reductase 2	GO:0009117; P:nucleotide metabolic process; IEA:InterPro
Q9P2T1	GMPR2	GMP reductase 2	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
Q9P2T1	GMPR2	GMP reductase 2	GO:0043101; P:purine-containing compound salvage; TAS:Reactome
Q9P2T1	GMPR2	GMP reductase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P29992	GNA11	Guanine nucleotide-binding protein subunit alpha-11	GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:RefGenome
P29992	GNA11	Guanine nucleotide-binding protein subunit alpha-11	GO:0001664; F:G-protein coupled receptor binding; IBA:RefGenome
P29992	GNA11	Guanine nucleotide-binding protein subunit alpha-11	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P29992	GNA11	Guanine nucleotide-binding protein subunit alpha-11	GO:0003924; F:GTPase activity; TAS:ProtInc
P29992	GNA11	Guanine nucleotide-binding protein subunit alpha-11	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P29992	GNA11	Guanine nucleotide-binding protein subunit alpha-11	GO:0004871; F:signal transducer activity; IBA:RefGenome
P29992	GNA11	Guanine nucleotide-binding protein subunit alpha-11	GO:0001508; P:action potential; IBA:RefGenome
P29992	GNA11	Guanine nucleotide-binding protein subunit alpha-11	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IBA:RefGenome
P29992	GNA11	Guanine nucleotide-binding protein subunit alpha-11	GO:0007596; P:blood coagulation; TAS:Reactome
P29992	GNA11	Guanine nucleotide-binding protein subunit alpha-11	GO:0048066; P:developmental pigmentation; IEA:Ensembl
P29992	GNA11	Guanine nucleotide-binding protein subunit alpha-11	GO:0007507; P:heart development; IEA:Ensembl
P29992	GNA11	Guanine nucleotide-binding protein subunit alpha-11	GO:0060158; P:phospholipase C-activating dopamine receptor signaling pathway; IBA:RefGenome
P29992	GNA11	Guanine nucleotide-binding protein subunit alpha-11	GO:0030168; P:platelet activation; TAS:Reactome
P29992	GNA11	Guanine nucleotide-binding protein subunit alpha-11	GO:0045634; P:regulation of melanocyte differentiation; IEA:Ensembl
P29992	GNA11	Guanine nucleotide-binding protein subunit alpha-11	GO:0007165; P:signal transduction; TAS:ProtInc
P29992	GNA11	Guanine nucleotide-binding protein subunit alpha-11	GO:0001501; P:skeletal system development; IEA:Ensembl
Q03113	GNA12	Guanine nucleotide-binding protein subunit alpha-12	GO:0031752; F:D5 dopamine receptor binding; IBA:RefGenome
Q03113	GNA12	Guanine nucleotide-binding protein subunit alpha-12	GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:RefGenome
Q03113	GNA12	Guanine nucleotide-binding protein subunit alpha-12	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q03113	GNA12	Guanine nucleotide-binding protein subunit alpha-12	GO:0003924; F:GTPase activity; IBA:RefGenome
Q03113	GNA12	Guanine nucleotide-binding protein subunit alpha-12	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q03113	GNA12	Guanine nucleotide-binding protein subunit alpha-12	GO:0005515; F:protein binding; IPI:UniProtKB
Q03113	GNA12	Guanine nucleotide-binding protein subunit alpha-12	GO:0004871; F:signal transducer activity; IBA:RefGenome
Q03113	GNA12	Guanine nucleotide-binding protein subunit alpha-12	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IBA:RefGenome
Q03113	GNA12	Guanine nucleotide-binding protein subunit alpha-12	GO:0007596; P:blood coagulation; TAS:Reactome
Q03113	GNA12	Guanine nucleotide-binding protein subunit alpha-12	GO:0030154; P:cell differentiation; IEA:Ensembl
Q03113	GNA12	Guanine nucleotide-binding protein subunit alpha-12	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
Q03113	GNA12	Guanine nucleotide-binding protein subunit alpha-12	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q03113	GNA12	Guanine nucleotide-binding protein subunit alpha-12	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q03113	GNA12	Guanine nucleotide-binding protein subunit alpha-12	GO:0030168; P:platelet activation; TAS:Reactome
Q03113	GNA12	Guanine nucleotide-binding protein subunit alpha-12	GO:0008360; P:regulation of cell shape; IEA:Ensembl
Q03113	GNA12	Guanine nucleotide-binding protein subunit alpha-12	GO:0010762; P:regulation of fibroblast migration; ISS:UniProtKB
Q03113	GNA12	Guanine nucleotide-binding protein subunit alpha-12	GO:0032434; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q03113	GNA12	Guanine nucleotide-binding protein subunit alpha-12	GO:0032006; P:regulation of TOR signaling; IMP:UniProtKB
Q03113	GNA12	Guanine nucleotide-binding protein subunit alpha-12	GO:0042493; P:response to drug; IEA:Ensembl
Q03113	GNA12	Guanine nucleotide-binding protein subunit alpha-12	GO:0007266; P:Rho protein signal transduction; IBA:RefGenome
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0031752; F:D5 dopamine receptor binding; IBA:RefGenome
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:RefGenome
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0003924; F:GTPase activity; IBA:RefGenome
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0005515; F:protein binding; IPI:UniProtKB
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0004871; F:signal transducer activity; IBA:RefGenome
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0031702; F:type 1 angiotensin receptor binding; IBA:RefGenome
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0031584; P:activation of phospholipase D activity; IBA:RefGenome
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IBA:RefGenome
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0007596; P:blood coagulation; TAS:Reactome
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0030154; P:cell differentiation; IEA:Ensembl
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0006928; P:cellular component movement; TAS:ProtInc
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0001569; P:patterning of blood vessels; IEA:Ensembl
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0030168; P:platelet activation; TAS:Reactome
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0030334; P:regulation of cell migration; IEA:Ensembl
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0008360; P:regulation of cell shape; IEA:Ensembl
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0007266; P:Rho protein signal transduction; IBA:RefGenome
Q14344	GNA13	Guanine nucleotide-binding protein subunit alpha-13	GO:0007165; P:signal transduction; TAS:ProtInc
O95837	GNA14	Guanine nucleotide-binding protein subunit alpha-14	GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:RefGenome
O95837	GNA14	Guanine nucleotide-binding protein subunit alpha-14	GO:0001664; F:G-protein coupled receptor binding; IBA:RefGenome
O95837	GNA14	Guanine nucleotide-binding protein subunit alpha-14	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
O95837	GNA14	Guanine nucleotide-binding protein subunit alpha-14	GO:0003924; F:GTPase activity; TAS:ProtInc
O95837	GNA14	Guanine nucleotide-binding protein subunit alpha-14	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95837	GNA14	Guanine nucleotide-binding protein subunit alpha-14	GO:0004871; F:signal transducer activity; IBA:RefGenome
O95837	GNA14	Guanine nucleotide-binding protein subunit alpha-14	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IBA:RefGenome
O95837	GNA14	Guanine nucleotide-binding protein subunit alpha-14	GO:0007596; P:blood coagulation; TAS:Reactome
O95837	GNA14	Guanine nucleotide-binding protein subunit alpha-14	GO:0060158; P:phospholipase C-activating dopamine receptor signaling pathway; IBA:RefGenome
O95837	GNA14	Guanine nucleotide-binding protein subunit alpha-14	GO:0030168; P:platelet activation; TAS:Reactome
O95837	GNA14	Guanine nucleotide-binding protein subunit alpha-14	GO:0007165; P:signal transduction; TAS:ProtInc
P30679	GNA15	Guanine nucleotide-binding protein subunit alpha-15	GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:RefGenome
P30679	GNA15	Guanine nucleotide-binding protein subunit alpha-15	GO:0001664; F:G-protein coupled receptor binding; IBA:RefGenome
P30679	GNA15	Guanine nucleotide-binding protein subunit alpha-15	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P30679	GNA15	Guanine nucleotide-binding protein subunit alpha-15	GO:0003924; F:GTPase activity; TAS:ProtInc
P30679	GNA15	Guanine nucleotide-binding protein subunit alpha-15	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P30679	GNA15	Guanine nucleotide-binding protein subunit alpha-15	GO:0004871; F:signal transducer activity; IGI:UniProtKB
P30679	GNA15	Guanine nucleotide-binding protein subunit alpha-15	GO:0007202; P:activation of phospholipase C activity; TAS:ProtInc
P30679	GNA15	Guanine nucleotide-binding protein subunit alpha-15	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IBA:RefGenome
P30679	GNA15	Guanine nucleotide-binding protein subunit alpha-15	GO:0007596; P:blood coagulation; TAS:Reactome
P30679	GNA15	Guanine nucleotide-binding protein subunit alpha-15	GO:0060158; P:phospholipase C-activating dopamine receptor signaling pathway; IBA:RefGenome
P30679	GNA15	Guanine nucleotide-binding protein subunit alpha-15	GO:0007207; P:phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway; TAS:ProtInc
P30679	GNA15	Guanine nucleotide-binding protein subunit alpha-15	GO:0030168; P:platelet activation; TAS:Reactome
P30679	GNA15	Guanine nucleotide-binding protein subunit alpha-15	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IGI:UniProtKB
Q96EK6	GNPNAT1	Glucosamine 6-phosphate N-acetyltransferase	GO:0004343; F:glucosamine 6-phosphate N-acetyltransferase activity; TAS:Reactome
Q96EK6	GNPNAT1	Glucosamine 6-phosphate N-acetyltransferase	GO:0048029; F:monosaccharide binding; IEA:Ensembl
Q96EK6	GNPNAT1	Glucosamine 6-phosphate N-acetyltransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q96EK6	GNPNAT1	Glucosamine 6-phosphate N-acetyltransferase	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q96EK6	GNPNAT1	Glucosamine 6-phosphate N-acetyltransferase	GO:0006041; P:glucosamine metabolic process; IEA:Ensembl
Q96EK6	GNPNAT1	Glucosamine 6-phosphate N-acetyltransferase	GO:0001889; P:liver development; IEA:Ensembl
Q96EK6	GNPNAT1	Glucosamine 6-phosphate N-acetyltransferase	GO:0006044; P:N-acetylglucosamine metabolic process; IEA:Ensembl
Q96EK6	GNPNAT1	Glucosamine 6-phosphate N-acetyltransferase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q96EK6	GNPNAT1	Glucosamine 6-phosphate N-acetyltransferase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q96EK6	GNPNAT1	Glucosamine 6-phosphate N-acetyltransferase	GO:0006048; P:UDP-N-acetylglucosamine biosynthetic process; TAS:Reactome
P63096	GNAI1	Guanine nucleotide-binding protein G(i) subunit alpha-1	GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:RefGenome
P63096	GNAI1	Guanine nucleotide-binding protein G(i) subunit alpha-1	GO:0031821; F:G-protein coupled serotonin receptor binding; IBA:RefGenome
P63096	GNAI1	Guanine nucleotide-binding protein G(i) subunit alpha-1	GO:0005525; F:GTP binding; ISS:BHF-UCL
P63096	GNAI1	Guanine nucleotide-binding protein G(i) subunit alpha-1	GO:0003924; F:GTPase activity; IBA:RefGenome
P63096	GNAI1	Guanine nucleotide-binding protein G(i) subunit alpha-1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P63096	GNAI1	Guanine nucleotide-binding protein G(i) subunit alpha-1	GO:0005515; F:protein binding; IPI:IntAct
P63096	GNAI1	Guanine nucleotide-binding protein G(i) subunit alpha-1	GO:0004871; F:signal transducer activity; IBA:RefGenome
P63096	GNAI1	Guanine nucleotide-binding protein G(i) subunit alpha-1	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:Reactome
P63096	GNAI1	Guanine nucleotide-binding protein G(i) subunit alpha-1	GO:0007596; P:blood coagulation; TAS:Reactome
P63096	GNAI1	Guanine nucleotide-binding protein G(i) subunit alpha-1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P63096	GNAI1	Guanine nucleotide-binding protein G(i) subunit alpha-1	GO:0051301; P:cell division; IMP:UniProtKB
P63096	GNAI1	Guanine nucleotide-binding protein G(i) subunit alpha-1	GO:0007186; P:G-protein coupled receptor signaling pathway; ISS:BHF-UCL
P63096	GNAI1	Guanine nucleotide-binding protein G(i) subunit alpha-1	GO:0030168; P:platelet activation; TAS:Reactome
P63096	GNAI1	Guanine nucleotide-binding protein G(i) subunit alpha-1	GO:0043434; P:response to peptide hormone; ISS:BHF-UCL
P63096	GNAI1	Guanine nucleotide-binding protein G(i) subunit alpha-1	GO:0007268; P:synaptic transmission; TAS:Reactome
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:RefGenome
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0001664; F:G-protein coupled receptor binding; IBA:RefGenome
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0003924; F:GTPase activity; IEA:InterPro
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0005515; F:protein binding; IPI:IntAct
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0000186; P:activation of MAPKK activity; IEA:Ensembl
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0001973; P:adenosine receptor signaling pathway; IEA:Ensembl
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:Reactome
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IEA:InterPro
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0007596; P:blood coagulation; TAS:Reactome
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0051301; P:cell division; IMP:UniProtKB
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0008283; P:cell proliferation; IEA:Ensembl
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0007213; P:G-protein coupled acetylcholine receptor signaling pathway; IEA:Ensembl
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:Ensembl
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0007194; P:negative regulation of adenylate cyclase activity; TAS:ProtInc
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0050805; P:negative regulation of synaptic transmission; IEA:Ensembl
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0030168; P:platelet activation; TAS:Reactome
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0051924; P:regulation of calcium ion transport; IEA:Ensembl
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0007584; P:response to nutrient; TAS:ProtInc
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0007165; P:signal transduction; TAS:ProtInc
P04899	GNAI2	Guanine nucleotide-binding protein G(i) subunit alpha-2	GO:0007268; P:synaptic transmission; TAS:Reactome
P08754	GNAI3	Guanine nucleotide-binding protein G(k) subunit alpha	GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:RefGenome
P08754	GNAI3	Guanine nucleotide-binding protein G(k) subunit alpha	GO:0031821; F:G-protein coupled serotonin receptor binding; IBA:RefGenome
P08754	GNAI3	Guanine nucleotide-binding protein G(k) subunit alpha	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P08754	GNAI3	Guanine nucleotide-binding protein G(k) subunit alpha	GO:0003924; F:GTPase activity; IBA:RefGenome
P08754	GNAI3	Guanine nucleotide-binding protein G(k) subunit alpha	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P08754	GNAI3	Guanine nucleotide-binding protein G(k) subunit alpha	GO:0004871; F:signal transducer activity; IBA:RefGenome
P08754	GNAI3	Guanine nucleotide-binding protein G(k) subunit alpha	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:Reactome
P08754	GNAI3	Guanine nucleotide-binding protein G(k) subunit alpha	GO:0007596; P:blood coagulation; TAS:Reactome
P08754	GNAI3	Guanine nucleotide-binding protein G(k) subunit alpha	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P08754	GNAI3	Guanine nucleotide-binding protein G(k) subunit alpha	GO:0051301; P:cell division; IDA:UniProtKB
P08754	GNAI3	Guanine nucleotide-binding protein G(k) subunit alpha	GO:0007194; P:negative regulation of adenylate cyclase activity; TAS:ProtInc
P08754	GNAI3	Guanine nucleotide-binding protein G(k) subunit alpha	GO:0030168; P:platelet activation; TAS:Reactome
P08754	GNAI3	Guanine nucleotide-binding protein G(k) subunit alpha	GO:0007268; P:synaptic transmission; TAS:Reactome
P08754	GNAI3	Guanine nucleotide-binding protein G(k) subunit alpha	GO:0006810; P:transport; NAS:ProtInc
P08754	GNAI3	Guanine nucleotide-binding protein G(k) subunit alpha	GO:0006906; P:vesicle fusion; IEA:Ensembl
P38405	GNAL	Guanine nucleotide-binding protein G(olf) subunit alpha	GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:RefGenome
P38405	GNAL	Guanine nucleotide-binding protein G(olf) subunit alpha	GO:0001664; F:G-protein coupled receptor binding; IBA:RefGenome
P38405	GNAL	Guanine nucleotide-binding protein G(olf) subunit alpha	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P38405	GNAL	Guanine nucleotide-binding protein G(olf) subunit alpha	GO:0003924; F:GTPase activity; TAS:ProtInc
P38405	GNAL	Guanine nucleotide-binding protein G(olf) subunit alpha	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P38405	GNAL	Guanine nucleotide-binding protein G(olf) subunit alpha	GO:0004871; F:signal transducer activity; IBA:RefGenome
P38405	GNAL	Guanine nucleotide-binding protein G(olf) subunit alpha	GO:0007190; P:activation of adenylate cyclase activity; IEA:Ensembl
P38405	GNAL	Guanine nucleotide-binding protein G(olf) subunit alpha	GO:0007191; P:adenylate cyclase-activating dopamine receptor signaling pathway; IBA:RefGenome
P38405	GNAL	Guanine nucleotide-binding protein G(olf) subunit alpha	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; TAS:Reactome
P38405	GNAL	Guanine nucleotide-binding protein G(olf) subunit alpha	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:Reactome
P38405	GNAL	Guanine nucleotide-binding protein G(olf) subunit alpha	GO:0001975; P:response to amphetamine; IEA:Ensembl
P38405	GNAL	Guanine nucleotide-binding protein G(olf) subunit alpha	GO:0031000; P:response to caffeine; IEA:Ensembl
P38405	GNAL	Guanine nucleotide-binding protein G(olf) subunit alpha	GO:0007608; P:sensory perception of smell; IBA:RefGenome
P38405	GNAL	Guanine nucleotide-binding protein G(olf) subunit alpha	GO:0007165; P:signal transduction; TAS:ProtInc
P38405	GNAL	Guanine nucleotide-binding protein G(olf) subunit alpha	GO:0007268; P:synaptic transmission; TAS:Reactome
P09471	GNAO1	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:RefGenome
P09471	GNAO1	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0031821; F:G-protein coupled serotonin receptor binding; IBA:RefGenome
P09471	GNAO1	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P09471	GNAO1	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0003924; F:GTPase activity; IBA:RefGenome
P09471	GNAO1	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P09471	GNAO1	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0004871; F:signal transducer activity; IBA:RefGenome
P09471	GNAO1	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IBA:RefGenome
P09471	GNAO1	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0007568; P:aging; IEA:Ensembl
P09471	GNAO1	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0007212; P:dopamine receptor signaling pathway; IBA:RefGenome
P09471	GNAO1	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0030900; P:forebrain development; IEA:Ensembl
P09471	GNAO1	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0007626; P:locomotory behavior; IEA:Ensembl
P09471	GNAO1	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0006936; P:muscle contraction; TAS:ProtInc
P09471	GNAO1	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0051926; P:negative regulation of calcium ion transport; IEA:Ensembl
P09471	GNAO1	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0031175; P:neuron projection development; IEA:Ensembl
P09471	GNAO1	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0043547; P:positive regulation of GTPase activity; IEA:Ensembl
P09471	GNAO1	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0008016; P:regulation of heart contraction; IEA:Ensembl
P09471	GNAO1	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0034097; P:response to cytokine; IEA:Ensembl
P09471	GNAO1	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0042493; P:response to drug; IEA:Ensembl
P09471	GNAO1	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
P09471	GNAO1	Guanine nucleotide-binding protein G(o) subunit alpha	GO:0043278; P:response to morphine; IEA:Ensembl
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:RefGenome
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0001664; F:G-protein coupled receptor binding; IBA:RefGenome
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0005096; F:GTPase activator activity; IDA:UniProtKB
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0003924; F:GTPase activity; TAS:ProtInc
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0004871; F:signal transducer activity; IBA:RefGenome
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0001508; P:action potential; IBA:RefGenome
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0007202; P:activation of phospholipase C activity; TAS:ProtInc
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IBA:RefGenome
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0007596; P:blood coagulation; TAS:Reactome
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0048066; P:developmental pigmentation; IEA:Ensembl
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0021884; P:forebrain neuron development; IEA:Ensembl
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0007215; P:glutamate receptor signaling pathway; IBA:RefGenome
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0007507; P:heart development; IEA:Ensembl
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0042711; P:maternal behavior; IEA:Ensembl
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0006469; P:negative regulation of protein kinase activity; IMP:BHF-UCL
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0016322; P:neuron remodeling; IEA:Ensembl
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0060158; P:phospholipase C-activating dopamine receptor signaling pathway; IBA:RefGenome
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0030168; P:platelet activation; TAS:Reactome
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0043547; P:positive regulation of GTPase activity; IDA:GOC
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0009791; P:post-embryonic development; IEA:Ensembl
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0050821; P:protein stabilization; IMP:BHF-UCL
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0035412; P:regulation of catenin import into nucleus; IMP:BHF-UCL
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0045634; P:regulation of melanocyte differentiation; IEA:Ensembl
P50148	GNAQ	Guanine nucleotide-binding protein G(q) subunit alpha	GO:0001501; P:skeletal system development; IEA:Ensembl
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:RefGenome
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0003924; F:GTPase activity; IBA:RefGenome
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0035255; F:ionotropic glutamate receptor binding; IBA:RefGenome
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0031852; F:mu-type opioid receptor binding; IBA:RefGenome
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0005515; F:protein binding; IPI:IntAct
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0004871; F:signal transducer activity; IBA:RefGenome
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0007191; P:adenylate cyclase-activating dopamine receptor signaling pathway; IBA:RefGenome
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IMP:UniProt
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0060348; P:bone development; IMP:UniProt
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0051216; P:cartilage development; IEA:Ensembl
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0050890; P:cognition; IMP:UniProt
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0048589; P:developmental growth; IMP:UniProt
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0006306; P:DNA methylation; IEA:Ensembl
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0001958; P:endochondral ossification; IEA:Ensembl
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0006112; P:energy reserve metabolic process; IEA:Ensembl
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0071514; P:genetic imprinting; IEA:Ensembl
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0060789; P:hair follicle placode formation; IMP:UniProt
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0070527; P:platelet aggregation; IMP:UniProt
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0045672; P:positive regulation of osteoclast differentiation; IEA:Ensembl
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0040032; P:post-embryonic body morphogenesis; IEA:Ensembl
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0042493; P:response to drug; IEA:Ensembl
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0007606; P:sensory perception of chemical stimulus; IBA:RefGenome
Q5JWF2	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas	GO:0001894; P:tissue homeostasis; IEA:Ensembl
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0004016; F:adenylate cyclase activity; TAS:Reactome
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0003924; F:GTPase activity; TAS:UniProtKB
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0005515; F:protein binding; IPI:IntAct
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0004871; F:signal transducer activity; IDA:UniProtKB
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0007190; P:activation of adenylate cyclase activity; TAS:UniProtKB
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0071880; P:adenylate cyclase-activating adrenergic receptor signaling pathway; IDA:UniProtKB
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0007191; P:adenylate cyclase-activating dopamine receptor signaling pathway; ISS:BHF-UCL
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IDA:UniProt
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0007596; P:blood coagulation; TAS:Reactome
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0060348; P:bone development; IDA:UniProt
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0006171; P:cAMP biosynthetic process; TAS:GOC
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0071870; P:cellular response to catecholamine stimulus; ISS:BHF-UCL
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0071380; P:cellular response to prostaglandin E stimulus; ISS:BHF-UCL
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0050890; P:cognition; IDA:UniProt
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0048589; P:developmental growth; IDA:UniProt
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0060789; P:hair follicle placode formation; IDA:UniProt
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0046907; P:intracellular transport; NAS:UniProtKB
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0070527; P:platelet aggregation; IDA:UniProt
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:UniProtKB
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0043950; P:positive regulation of cAMP-mediated signaling; IDA:UniProtKB
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0032320; P:positive regulation of Ras GTPase activity; IDA:UniProtKB
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0007608; P:sensory perception of smell; TAS:UniProtKB
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0055085; P:transmembrane transport; TAS:Reactome
P63092	GNAS	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short	GO:0006833; P:water transport; TAS:Reactome
O95467	GNAS	Neuroendocrine secretory protein 55	GO:0007565; P:female pregnancy; NAS:UniProtKB
O95467	GNAS	Neuroendocrine secretory protein 55	GO:0040015; P:negative regulation of multicellular organism growth; ISS:UniProt
O95467	GNAS	Neuroendocrine secretory protein 55	GO:0009306; P:protein secretion; NAS:UniProtKB
O95467	GNAS	Neuroendocrine secretory protein 55	GO:0071107; P:response to parathyroid hormone; IMP:UniProt
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0000035; F:acyl binding; ISS:UniProtKB
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:RefGenome
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0001664; F:G-protein coupled receptor binding; IBA:RefGenome
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0019003; F:GDP binding; ISS:UniProtKB
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0005525; F:GTP binding; ISS:UniProtKB
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0003924; F:GTPase activity; NAS:UniProtKB
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0019901; F:protein kinase binding; ISS:UniProtKB
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0004871; F:signal transducer activity; IBA:RefGenome
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IBA:RefGenome
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0008283; P:cell proliferation; IEA:Ensembl
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0071257; P:cellular response to electrical stimulus; IEA:Ensembl
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0001580; P:detection of chemical stimulus involved in sensory perception of bitter taste; IBA:RefGenome
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0050908; P:detection of light stimulus involved in visual perception; IMP:UniProtKB
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0042462; P:eye photoreceptor cell development; IEA:Ensembl
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0051344; P:negative regulation of cyclic-nucleotide phosphodiesterase activity; ISS:UniProtKB
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0007603; P:phototransduction, visible light; IMP:UniProtKB
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0051343; P:positive regulation of cyclic-nucleotide phosphodiesterase activity; IEA:Ensembl
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0009642; P:response to light intensity; IEA:Ensembl
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0009416; P:response to light stimulus; ISS:UniProtKB
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0050917; P:sensory perception of umami taste; IBA:RefGenome
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0007165; P:signal transduction; NAS:UniProtKB
P11488	GNAT1	Guanine nucleotide-binding protein G(t) subunit alpha-1	GO:0007601; P:visual perception; TAS:UniProtKB
P19087	GNAT2	Guanine nucleotide-binding protein G(t) subunit alpha-2	GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:RefGenome
P19087	GNAT2	Guanine nucleotide-binding protein G(t) subunit alpha-2	GO:0008020; F:G-protein coupled photoreceptor activity; NAS:UniProtKB
P19087	GNAT2	Guanine nucleotide-binding protein G(t) subunit alpha-2	GO:0001664; F:G-protein coupled receptor binding; IBA:RefGenome
P19087	GNAT2	Guanine nucleotide-binding protein G(t) subunit alpha-2	GO:0005525; F:GTP binding; NAS:UniProtKB
P19087	GNAT2	Guanine nucleotide-binding protein G(t) subunit alpha-2	GO:0003924; F:GTPase activity; IBA:RefGenome
P19087	GNAT2	Guanine nucleotide-binding protein G(t) subunit alpha-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P19087	GNAT2	Guanine nucleotide-binding protein G(t) subunit alpha-2	GO:0004871; F:signal transducer activity; IBA:RefGenome
P19087	GNAT2	Guanine nucleotide-binding protein G(t) subunit alpha-2	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IBA:RefGenome
P19087	GNAT2	Guanine nucleotide-binding protein G(t) subunit alpha-2	GO:0001580; P:detection of chemical stimulus involved in sensory perception of bitter taste; IBA:RefGenome
P19087	GNAT2	Guanine nucleotide-binding protein G(t) subunit alpha-2	GO:0050908; P:detection of light stimulus involved in visual perception; IMP:UniProtKB
P19087	GNAT2	Guanine nucleotide-binding protein G(t) subunit alpha-2	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
P19087	GNAT2	Guanine nucleotide-binding protein G(t) subunit alpha-2	GO:0007602; P:phototransduction; NAS:UniProtKB
P19087	GNAT2	Guanine nucleotide-binding protein G(t) subunit alpha-2	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P19087	GNAT2	Guanine nucleotide-binding protein G(t) subunit alpha-2	GO:0009642; P:response to light intensity; IEA:Ensembl
P19087	GNAT2	Guanine nucleotide-binding protein G(t) subunit alpha-2	GO:0046549; P:retinal cone cell development; IEA:Ensembl
P19087	GNAT2	Guanine nucleotide-binding protein G(t) subunit alpha-2	GO:0007601; P:visual perception; NAS:UniProtKB
P19086	GNAZ	Guanine nucleotide-binding protein G(z) subunit alpha	GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:RefGenome
P19086	GNAZ	Guanine nucleotide-binding protein G(z) subunit alpha	GO:0031821; F:G-protein coupled serotonin receptor binding; IBA:RefGenome
P19086	GNAZ	Guanine nucleotide-binding protein G(z) subunit alpha	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P19086	GNAZ	Guanine nucleotide-binding protein G(z) subunit alpha	GO:0003924; F:GTPase activity; IBA:RefGenome
P19086	GNAZ	Guanine nucleotide-binding protein G(z) subunit alpha	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P19086	GNAZ	Guanine nucleotide-binding protein G(z) subunit alpha	GO:0005057; F:receptor signaling protein activity; TAS:ProtInc
P19086	GNAZ	Guanine nucleotide-binding protein G(z) subunit alpha	GO:0004871; F:signal transducer activity; IBA:RefGenome
P19086	GNAZ	Guanine nucleotide-binding protein G(z) subunit alpha	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IEA:Ensembl
P19086	GNAZ	Guanine nucleotide-binding protein G(z) subunit alpha	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IBA:RefGenome
P19086	GNAZ	Guanine nucleotide-binding protein G(z) subunit alpha	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P19086	GNAZ	Guanine nucleotide-binding protein G(z) subunit alpha	GO:0035556; P:intracellular signal transduction; TAS:GOC
Q9BYB4	GNB1L	Guanine nucleotide-binding protein subunit beta-like protein 1	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
Q9BYB4	GNB1L	Guanine nucleotide-binding protein subunit beta-like protein 1	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
Q9BYB4	GNB1L	Guanine nucleotide-binding protein subunit beta-like protein 1	GO:0035176; P:social behavior; IEA:Ensembl
Q12967	RALGDS	Ral guanine nucleotide dissociation stimulator	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW
Q12967	RALGDS	Ral guanine nucleotide dissociation stimulator	GO:0005515; F:protein binding; IPI:IntAct
Q12967	RALGDS	Ral guanine nucleotide dissociation stimulator	GO:0005083; F:small GTPase regulator activity; IDA:UniProtKB
Q12967	RALGDS	Ral guanine nucleotide dissociation stimulator	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q12967	RALGDS	Ral guanine nucleotide dissociation stimulator	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
Q12967	RALGDS	Ral guanine nucleotide dissociation stimulator	GO:0050790; P:regulation of catalytic activity; IDA:GOC
Q12967	RALGDS	Ral guanine nucleotide dissociation stimulator	GO:0051056; P:regulation of small GTPase mediated signal transduction; IEA:InterPro
A8MTJ3	GNAT3	Guanine nucleotide-binding protein G(t) subunit alpha-3	GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:RefGenome
A8MTJ3	GNAT3	Guanine nucleotide-binding protein G(t) subunit alpha-3	GO:0001664; F:G-protein coupled receptor binding; IBA:RefGenome
A8MTJ3	GNAT3	Guanine nucleotide-binding protein G(t) subunit alpha-3	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
A8MTJ3	GNAT3	Guanine nucleotide-binding protein G(t) subunit alpha-3	GO:0003924; F:GTPase activity; IBA:RefGenome
A8MTJ3	GNAT3	Guanine nucleotide-binding protein G(t) subunit alpha-3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A8MTJ3	GNAT3	Guanine nucleotide-binding protein G(t) subunit alpha-3	GO:0004871; F:signal transducer activity; IBA:RefGenome
A8MTJ3	GNAT3	Guanine nucleotide-binding protein G(t) subunit alpha-3	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:Reactome
A8MTJ3	GNAT3	Guanine nucleotide-binding protein G(t) subunit alpha-3	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IBA:RefGenome
A8MTJ3	GNAT3	Guanine nucleotide-binding protein G(t) subunit alpha-3	GO:0007596; P:blood coagulation; TAS:Reactome
A8MTJ3	GNAT3	Guanine nucleotide-binding protein G(t) subunit alpha-3	GO:0001580; P:detection of chemical stimulus involved in sensory perception of bitter taste; IBA:RefGenome
A8MTJ3	GNAT3	Guanine nucleotide-binding protein G(t) subunit alpha-3	GO:0030168; P:platelet activation; TAS:Reactome
A8MTJ3	GNAT3	Guanine nucleotide-binding protein G(t) subunit alpha-3	GO:0035094; P:response to nicotine; IEA:Ensembl
A8MTJ3	GNAT3	Guanine nucleotide-binding protein G(t) subunit alpha-3	GO:0050916; P:sensory perception of sweet taste; IBA:RefGenome
A8MTJ3	GNAT3	Guanine nucleotide-binding protein G(t) subunit alpha-3	GO:0050917; P:sensory perception of umami taste; IBA:RefGenome
A8MTJ3	GNAT3	Guanine nucleotide-binding protein G(t) subunit alpha-3	GO:0007268; P:synaptic transmission; TAS:Reactome
P36915	GNL1	Guanine nucleotide-binding protein-like 1	GO:0005525; F:GTP binding; NAS:UniProtKB
P36915	GNL1	Guanine nucleotide-binding protein-like 1	GO:0003924; F:GTPase activity; IBA:RefGenome
P36915	GNL1	Guanine nucleotide-binding protein-like 1	GO:0005198; F:structural molecule activity; NAS:UniProtKB
P36915	GNL1	Guanine nucleotide-binding protein-like 1	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
P36915	GNL1	Guanine nucleotide-binding protein-like 1	GO:0006184; P:GTP catabolic process; IBA:GOC
P36915	GNL1	Guanine nucleotide-binding protein-like 1	GO:0042254; P:ribosome biogenesis; IBA:RefGenome
P36915	GNL1	Guanine nucleotide-binding protein-like 1	GO:0007165; P:signal transduction; NAS:UniProtKB
P36915	GNL1	Guanine nucleotide-binding protein-like 1	GO:0002456; P:T cell mediated immunity; NAS:UniProtKB
P22749	GNLY	Granulysin	GO:0006968; P:cellular defense response; TAS:ProtInc
P22749	GNLY	Granulysin	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
P22749	GNLY	Granulysin	GO:0050832; P:defense response to fungus; IEA:UniProtKB-KW
P22749	GNLY	Granulysin	GO:0031640; P:killing of cells of other organism; IEA:UniProtKB-KW
Q14749	GNMT	Glycine N-methyltransferase	GO:0005542; F:folic acid binding; IEA:UniProtKB-KW
Q14749	GNMT	Glycine N-methyltransferase	GO:0016594; F:glycine binding; IDA:UniProtKB
Q14749	GNMT	Glycine N-methyltransferase	GO:0017174; F:glycine N-methyltransferase activity; IDA:UniProtKB
Q14749	GNMT	Glycine N-methyltransferase	GO:0005515; F:protein binding; IPI:IntAct
Q14749	GNMT	Glycine N-methyltransferase	GO:0006464; P:cellular protein modification process; NAS:UniProtKB
Q14749	GNMT	Glycine N-methyltransferase	GO:0005977; P:glycogen metabolic process; IEA:Ensembl
Q14749	GNMT	Glycine N-methyltransferase	GO:0006555; P:methionine metabolic process; IEA:Ensembl
Q14749	GNMT	Glycine N-methyltransferase	GO:0006730; P:one-carbon metabolic process; IEA:Ensembl
Q14749	GNMT	Glycine N-methyltransferase	GO:0051289; P:protein homotetramerization; IPI:UniProtKB
Q14749	GNMT	Glycine N-methyltransferase	GO:0006111; P:regulation of gluconeogenesis; IEA:Ensembl
Q14749	GNMT	Glycine N-methyltransferase	GO:0046500; P:S-adenosylmethionine metabolic process; IDA:UniProtKB
Q9BVP2	GNL3	Guanine nucleotide-binding protein-like 3	GO:0005525; F:GTP binding; ISS:UniProtKB
Q9BVP2	GNL3	Guanine nucleotide-binding protein-like 3	GO:0003924; F:GTPase activity; IBA:RefGenome
Q9BVP2	GNL3	Guanine nucleotide-binding protein-like 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BVP2	GNL3	Guanine nucleotide-binding protein-like 3	GO:0005515; F:protein binding; IPI:IntAct
Q9BVP2	GNL3	Guanine nucleotide-binding protein-like 3	GO:0008283; P:cell proliferation; IEA:Ensembl
Q9BVP2	GNL3	Guanine nucleotide-binding protein-like 3	GO:0006184; P:GTP catabolic process; IBA:GOC
Q9BVP2	GNL3	Guanine nucleotide-binding protein-like 3	GO:0042127; P:regulation of cell proliferation; ISS:UniProtKB
Q9BVP2	GNL3	Guanine nucleotide-binding protein-like 3	GO:0042254; P:ribosome biogenesis; IBA:RefGenome
Q9NVN8	GNL3L	Guanine nucleotide-binding protein-like 3-like protein	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9NVN8	GNL3L	Guanine nucleotide-binding protein-like 3-like protein	GO:0003924; F:GTPase activity; IBA:RefGenome
Q9NVN8	GNL3L	Guanine nucleotide-binding protein-like 3-like protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NVN8	GNL3L	Guanine nucleotide-binding protein-like 3-like protein	GO:0005515; F:protein binding; IPI:IntAct
Q9NVN8	GNL3L	Guanine nucleotide-binding protein-like 3-like protein	GO:0006184; P:GTP catabolic process; IBA:GOC
Q9NVN8	GNL3L	Guanine nucleotide-binding protein-like 3-like protein	GO:0042254; P:ribosome biogenesis; IBA:RefGenome
O15228	GNPAT	Dihydroxyacetone phosphate acyltransferase	GO:0016287; F:glycerone-phosphate O-acyltransferase activity; IDA:UniProtKB
O15228	GNPAT	Dihydroxyacetone phosphate acyltransferase	GO:0016290; F:palmitoyl-CoA hydrolase activity; IDA:UniProtKB
O15228	GNPAT	Dihydroxyacetone phosphate acyltransferase	GO:0005102; F:receptor binding; IPI:UniProtKB
O15228	GNPAT	Dihydroxyacetone phosphate acyltransferase	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O15228	GNPAT	Dihydroxyacetone phosphate acyltransferase	GO:0021587; P:cerebellum morphogenesis; IEA:Ensembl
O15228	GNPAT	Dihydroxyacetone phosphate acyltransferase	GO:0008611; P:ether lipid biosynthetic process; IDA:UniProtKB
O15228	GNPAT	Dihydroxyacetone phosphate acyltransferase	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
O15228	GNPAT	Dihydroxyacetone phosphate acyltransferase	GO:0030913; P:paranodal junction assembly; IEA:Ensembl
O15228	GNPAT	Dihydroxyacetone phosphate acyltransferase	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
O15228	GNPAT	Dihydroxyacetone phosphate acyltransferase	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
O15228	GNPAT	Dihydroxyacetone phosphate acyltransferase	GO:0042493; P:response to drug; IEA:Ensembl
O15228	GNPAT	Dihydroxyacetone phosphate acyltransferase	GO:0070542; P:response to fatty acid; IEA:Ensembl
O15228	GNPAT	Dihydroxyacetone phosphate acyltransferase	GO:0007584; P:response to nutrient; IEA:Ensembl
O15228	GNPAT	Dihydroxyacetone phosphate acyltransferase	GO:0042594; P:response to starvation; IEA:Ensembl
O15228	GNPAT	Dihydroxyacetone phosphate acyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15228	GNPAT	Dihydroxyacetone phosphate acyltransferase	GO:0007416; P:synapse assembly; IEA:Ensembl
P46926	GNPDA1	Glucosamine-6-phosphate isomerase 1	GO:0004342; F:glucosamine-6-phosphate deaminase activity; IMP:UniProtKB
P46926	GNPDA1	Glucosamine-6-phosphate isomerase 1	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
P46926	GNPDA1	Glucosamine-6-phosphate isomerase 1	GO:0005975; P:carbohydrate metabolic process; IEA:UniProtKB-KW
P46926	GNPDA1	Glucosamine-6-phosphate isomerase 1	GO:0006091; P:generation of precursor metabolites and energy; IMP:UniProtKB
P46926	GNPDA1	Glucosamine-6-phosphate isomerase 1	GO:0006043; P:glucosamine catabolic process; IMP:UniProtKB
P46926	GNPDA1	Glucosamine-6-phosphate isomerase 1	GO:0006044; P:N-acetylglucosamine metabolic process; IEA:InterPro
P46926	GNPDA1	Glucosamine-6-phosphate isomerase 1	GO:0007338; P:single fertilization; TAS:ProtInc
Q8TDQ7	GNPDA2	Glucosamine-6-phosphate isomerase 2	GO:0004342; F:glucosamine-6-phosphate deaminase activity; IEA:UniProtKB-EC
Q8TDQ7	GNPDA2	Glucosamine-6-phosphate isomerase 2	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q8TDQ7	GNPDA2	Glucosamine-6-phosphate isomerase 2	GO:0005975; P:carbohydrate metabolic process; IEA:UniProtKB-KW
Q8TDQ7	GNPDA2	Glucosamine-6-phosphate isomerase 2	GO:0006044; P:N-acetylglucosamine metabolic process; IEA:InterPro
Q3T906	GNPTAB	N-acetylglucosamine-1-phosphotransferase subunits alpha/beta	GO:0005509; F:calcium ion binding; IEA:InterPro
Q3T906	GNPTAB	N-acetylglucosamine-1-phosphotransferase subunits alpha/beta	GO:0003976; F:UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity; IDA:UniProtKB
Q3T906	GNPTAB	N-acetylglucosamine-1-phosphotransferase subunits alpha/beta	GO:0046835; P:carbohydrate phosphorylation; IDA:UniProtKB
Q3T906	GNPTAB	N-acetylglucosamine-1-phosphotransferase subunits alpha/beta	GO:0030154; P:cell differentiation; IEA:InterPro
Q3T906	GNPTAB	N-acetylglucosamine-1-phosphotransferase subunits alpha/beta	GO:0007040; P:lysosome organization; IMP:UniProtKB
Q3T906	GNPTAB	N-acetylglucosamine-1-phosphotransferase subunits alpha/beta	GO:0009306; P:protein secretion; IEA:Ensembl
Q9UJJ9	GNPTG	N-acetylglucosamine-1-phosphotransferase subunit gamma	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q9UJJ9	GNPTG	N-acetylglucosamine-1-phosphotransferase subunit gamma	GO:0046835; P:carbohydrate phosphorylation; IDA:UniProtKB
Q9UJJ9	GNPTG	N-acetylglucosamine-1-phosphotransferase subunit gamma	GO:0016256; P:N-glycan processing to lysosome; IEA:Ensembl
P30968	GNRHR	Gonadotropin-releasing hormone receptor	GO:0004968; F:gonadotropin-releasing hormone receptor activity; TAS:ProtInc
P30968	GNRHR	Gonadotropin-releasing hormone receptor	GO:0097211; P:cellular response to gonadotropin-releasing hormone; TAS:GOC
P30968	GNRHR	Gonadotropin-releasing hormone receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P30968	GNRHR	Gonadotropin-releasing hormone receptor	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q96P88	GNRHR2	Putative gonadotropin-releasing hormone II receptor	GO:0016500; F:protein-hormone receptor activity; IEA:InterPro
P15586	GNS	N-acetylglucosamine-6-sulfatase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P15586	GNS	N-acetylglucosamine-6-sulfatase	GO:0008449; F:N-acetylglucosamine-6-sulfatase activity; TAS:ProtInc
P15586	GNS	N-acetylglucosamine-6-sulfatase	GO:0005515; F:protein binding; IPI:IntAct
P15586	GNS	N-acetylglucosamine-6-sulfatase	GO:0008484; F:sulfuric ester hydrolase activity; IDA:MGI
P15586	GNS	N-acetylglucosamine-6-sulfatase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P15586	GNS	N-acetylglucosamine-6-sulfatase	GO:0006027; P:glycosaminoglycan catabolic process; TAS:ProtInc
P15586	GNS	N-acetylglucosamine-6-sulfatase	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P15586	GNS	N-acetylglucosamine-6-sulfatase	GO:0042340; P:keratan sulfate catabolic process; TAS:Reactome
P15586	GNS	N-acetylglucosamine-6-sulfatase	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
P15586	GNS	N-acetylglucosamine-6-sulfatase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q06430	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform B	GO:0008109; F:N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity; TAS:ProtInc
Q06430	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform B	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:ProtInc
Q06430	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform B	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q06430	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform B	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q8N0V5	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform A	GO:0008109; F:N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity; IMP:UniProt
Q8N0V5	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform A	GO:0036438; P:maintenance of lens transparency; IMP:UniProt
Q8N0V5	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform A	GO:0010812; P:negative regulation of cell-substrate adhesion; IMP:UniProt
Q8N0V5	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform A	GO:0030335; P:positive regulation of cell migration; IMP:UniProt
Q8N0V5	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform A	GO:0008284; P:positive regulation of cell proliferation; ISS:UniProt
Q8N0V5	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform A	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IMP:UniProt
Q8N0V5	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform A	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProt
Q8N0V5	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform A	GO:0034116; P:positive regulation of heterotypic cell-cell adhesion; IMP:UniProt
Q8N0V5	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform A	GO:0051897; P:positive regulation of protein kinase B signaling; IMP:UniProt
Q8N0V5	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform A	GO:0010608; P:posttranscriptional regulation of gene expression; IMP:UniProt
Q8N0V5	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform A	GO:0006486; P:protein glycosylation; IMP:UniProt
Q8N0V5	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform A	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IMP:UniProt
Q8NFS9	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform C	GO:0008109; F:N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity; IMP:UniProt
Q8NFS9	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform C	GO:0036438; P:maintenance of lens transparency; IMP:UniProt
Q8NFS9	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform C	GO:0010812; P:negative regulation of cell-substrate adhesion; ISS:UniProt
Q8NFS9	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform C	GO:0030335; P:positive regulation of cell migration; ISS:UniProt
Q8NFS9	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform C	GO:0008284; P:positive regulation of cell proliferation; ISS:UniProt
Q8NFS9	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform C	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; ISS:UniProt
Q8NFS9	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform C	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProt
Q8NFS9	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform C	GO:0034116; P:positive regulation of heterotypic cell-cell adhesion; ISS:UniProt
Q8NFS9	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform C	GO:0051897; P:positive regulation of protein kinase B signaling; ISS:UniProt
Q8NFS9	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform C	GO:0010608; P:posttranscriptional regulation of gene expression; ISS:UniProt
Q8NFS9	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform C	GO:0006486; P:protein glycosylation; IMP:UniProt
Q8NFS9	GCNT2	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, isoform C	GO:0007179; P:transforming growth factor beta receptor signaling pathway; ISS:UniProt
Q5T6J7	IDNK	Probable gluconokinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5T6J7	IDNK	Probable gluconokinase	GO:0046316; F:gluconokinase activity; IEA:UniProtKB-EC
Q5T6J7	IDNK	Probable gluconokinase	GO:0046177; P:D-gluconate catabolic process; IEA:UniProtKB-UniPathway
Q9H2G9	BLZF1	Golgin-45	GO:0003677; F:DNA binding; NAS:UniProtKB
Q9H2G9	BLZF1	Golgin-45	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9H2G9	BLZF1	Golgin-45	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9H2G9	BLZF1	Golgin-45	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q9H2G9	BLZF1	Golgin-45	GO:0008283; P:cell proliferation; TAS:ProtInc
Q9H2G9	BLZF1	Golgin-45	GO:0007030; P:Golgi organization; IDA:MGI
Q9H2G9	BLZF1	Golgin-45	GO:0043001; P:Golgi to plasma membrane protein transport; IDA:MGI
Q9H2G9	BLZF1	Golgin-45	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9H2G9	BLZF1	Golgin-45	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
Q9H2G9	BLZF1	Golgin-45	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
A6NCC3	GOLGA8O	Golgin subfamily A member 8O	GO:0005515; F:protein binding; IPI:IntAct
Q08379	GOLGA2	Golgin subfamily A member 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q08379	GOLGA2	Golgin subfamily A member 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q92805	GOLGA1	Golgin subfamily A member 1	GO:0000042; P:protein targeting to Golgi; IEA:InterPro
Q08378	GOLGA3	Golgin subfamily A member 3	GO:0005515; F:protein binding; IPI:UniProt
Q08378	GOLGA3	Golgin subfamily A member 3	GO:0005215; F:transporter activity; NAS:UniProtKB
Q08378	GOLGA3	Golgin subfamily A member 3	GO:0006891; P:intra-Golgi vesicle-mediated transport; NAS:UniProtKB
Q13439	GOLGA4	Golgin subfamily A member 4	GO:0051020; F:GTPase binding; IPI:UniProtKB
Q13439	GOLGA4	Golgin subfamily A member 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q13439	GOLGA4	Golgin subfamily A member 4	GO:0043001; P:Golgi to plasma membrane protein transport; IDA:UniProtKB
Q13439	GOLGA4	Golgin subfamily A member 4	GO:0000042; P:protein targeting to Golgi; IEA:InterPro
Q13439	GOLGA4	Golgin subfamily A member 4	GO:0016192; P:vesicle-mediated transport; TAS:ProtInc
Q8TBA6	GOLGA5	Golgin subfamily A member 5	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q8TBA6	GOLGA5	Golgin subfamily A member 5	GO:0017137; F:Rab GTPase binding; IDA:UniProtKB
Q8TBA6	GOLGA5	Golgin subfamily A member 5	GO:0007030; P:Golgi organization; IMP:UniProtKB
Q8TBA6	GOLGA5	Golgin subfamily A member 5	GO:0048193; P:Golgi vesicle transport; IMP:UniProtKB
Q7Z5G4	GOLGA7	Golgin subfamily A member 7	GO:0005515; F:protein binding; IPI:UniProt
Q7Z5G4	GOLGA7	Golgin subfamily A member 7	GO:0043001; P:Golgi to plasma membrane protein transport; IDA:UniProt
Q7Z5G4	GOLGA7	Golgin subfamily A member 7	GO:0018230; P:peptidyl-L-cysteine S-palmitoylation; IDA:UniProt
Q7Z5G4	GOLGA7	Golgin subfamily A member 7	GO:0050821; P:protein stabilization; IDA:UniProt
O00461	GOLIM4	Golgi integral membrane protein 4	GO:0006810; P:transport; IEA:UniProtKB-KW
Q86XS8	RNF130	E3 ubiquitin-protein ligase RNF130	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q86XS8	RNF130	E3 ubiquitin-protein ligase RNF130	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86XS8	RNF130	E3 ubiquitin-protein ligase RNF130	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q86XS8	RNF130	E3 ubiquitin-protein ligase RNF130	GO:0012501; P:programmed cell death; ISS:UniProtKB
Q8NBJ4	GOLM1	Golgi membrane protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NBJ4	GOLM1	Golgi membrane protein 1	GO:0006997; P:nucleus organization; IEA:Ensembl
Q8NBJ4	GOLM1	Golgi membrane protein 1	GO:0019216; P:regulation of lipid metabolic process; IEA:Ensembl
Q9H4A6	GOLPH3	Golgi phosphoprotein 3	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9H4A6	GOLPH3	Golgi phosphoprotein 3	GO:0070273; F:phosphatidylinositol-4-phosphate binding; IDA:UniProtKB
Q9H4A6	GOLPH3	Golgi phosphoprotein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H4A6	GOLPH3	Golgi phosphoprotein 3	GO:0060352; P:cell adhesion molecule production; IMP:UniProtKB
Q9H4A6	GOLPH3	Golgi phosphoprotein 3	GO:0016477; P:cell migration; IMP:UniProtKB
Q9H4A6	GOLPH3	Golgi phosphoprotein 3	GO:0008283; P:cell proliferation; IMP:UniProtKB
Q9H4A6	GOLPH3	Golgi phosphoprotein 3	GO:0010467; P:gene expression; IMP:UniProtKB
Q9H4A6	GOLPH3	Golgi phosphoprotein 3	GO:0009101; P:glycoprotein biosynthetic process; IMP:UniProtKB
Q9H4A6	GOLPH3	Golgi phosphoprotein 3	GO:0007030; P:Golgi organization; IMP:UniProtKB
Q9H4A6	GOLPH3	Golgi phosphoprotein 3	GO:0043001; P:Golgi to plasma membrane protein transport; IMP:UniProtKB
Q9H4A6	GOLPH3	Golgi phosphoprotein 3	GO:0048194; P:Golgi vesicle budding; IMP:UniProtKB
Q9H4A6	GOLPH3	Golgi phosphoprotein 3	GO:0030032; P:lamellipodium assembly; IMP:UniProtKB
Q9H4A6	GOLPH3	Golgi phosphoprotein 3	GO:0050901; P:leukocyte tethering or rolling; IMP:UniProtKB
Q9H4A6	GOLPH3	Golgi phosphoprotein 3	GO:0050714; P:positive regulation of protein secretion; IMP:UniProtKB
Q9H4A6	GOLPH3	Golgi phosphoprotein 3	GO:0032008; P:positive regulation of TOR signaling; IMP:UniProtKB
Q9H4A6	GOLPH3	Golgi phosphoprotein 3	GO:0045053; P:protein retention in Golgi apparatus; IMP:UniProtKB
Q9H4A6	GOLPH3	Golgi phosphoprotein 3	GO:0009306; P:protein secretion; IMP:UniProtKB
Q9H4A6	GOLPH3	Golgi phosphoprotein 3	GO:0010821; P:regulation of mitochondrion organization; IDA:UniProtKB
Q14789	GOLGB1	Golgin subfamily B member 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14789	GOLGB1	Golgin subfamily B member 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q14789	GOLGB1	Golgin subfamily B member 1	GO:0007030; P:Golgi organization; TAS:ProtInc
P01148	GNRH1	Progonadoliberin-1	GO:0005183; F:gonadotropin hormone-releasing hormone activity; TAS:ProtInc
P01148	GNRH1	Progonadoliberin-1	GO:0005179; F:hormone activity; TAS:ProtInc
P01148	GNRH1	Progonadoliberin-1	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P01148	GNRH1	Progonadoliberin-1	GO:0007565; P:female pregnancy; IEA:Ensembl
P01148	GNRH1	Progonadoliberin-1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P01148	GNRH1	Progonadoliberin-1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P01148	GNRH1	Progonadoliberin-1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P01148	GNRH1	Progonadoliberin-1	GO:2001223; P:negative regulation of neuron migration; IEA:Ensembl
P01148	GNRH1	Progonadoliberin-1	GO:0042698; P:ovulation cycle; IEA:Ensembl
P01148	GNRH1	Progonadoliberin-1	GO:0010468; P:regulation of gene expression; IEA:Ensembl
P01148	GNRH1	Progonadoliberin-1	GO:2000354; P:regulation of ovarian follicle development; IEA:Ensembl
P01148	GNRH1	Progonadoliberin-1	GO:0031960; P:response to corticosteroid; IEA:Ensembl
P01148	GNRH1	Progonadoliberin-1	GO:0045471; P:response to ethanol; IEA:Ensembl
P01148	GNRH1	Progonadoliberin-1	GO:0007165; P:signal transduction; TAS:ProtInc
O43555	GNRH2	Progonadoliberin-2	GO:0005179; F:hormone activity; TAS:ProtInc
O43555	GNRH2	Progonadoliberin-2	GO:0007275; P:multicellular organismal development; IEA:InterPro
O43555	GNRH2	Progonadoliberin-2	GO:0007165; P:signal transduction; TAS:ProtInc
Q3T8J9	GON4L	GON-4-like protein	GO:0003682; F:chromatin binding; IEA:InterPro
Q3T8J9	GON4L	GON-4-like protein	GO:0003677; F:DNA binding; IEA:InterPro
Q3T8J9	GON4L	GON-4-like protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q9HD26	GOPC	Golgi-associated PDZ and coiled-coil motif-containing protein	GO:0044325; F:ion channel binding; IPI:UniProtKB
Q9HD26	GOPC	Golgi-associated PDZ and coiled-coil motif-containing protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HD26	GOPC	Golgi-associated PDZ and coiled-coil motif-containing protein	GO:0005083; F:small GTPase regulator activity; IEA:Ensembl
Q9HD26	GOPC	Golgi-associated PDZ and coiled-coil motif-containing protein	GO:0045176; P:apical protein localization; NAS:UniProtKB
Q9HD26	GOPC	Golgi-associated PDZ and coiled-coil motif-containing protein	GO:0043004; P:cytoplasmic sequestering of CFTR protein; NAS:UniProtKB
Q9HD26	GOPC	Golgi-associated PDZ and coiled-coil motif-containing protein	GO:0006888; P:ER to Golgi vesicle-mediated transport; NAS:UniProtKB
Q9HD26	GOPC	Golgi-associated PDZ and coiled-coil motif-containing protein	GO:0006893; P:Golgi to plasma membrane transport; NAS:UniProtKB
Q9HD26	GOPC	Golgi-associated PDZ and coiled-coil motif-containing protein	GO:0051260; P:protein homooligomerization; IPI:UniProtKB
Q9HD26	GOPC	Golgi-associated PDZ and coiled-coil motif-containing protein	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9HD26	GOPC	Golgi-associated PDZ and coiled-coil motif-containing protein	GO:0007289; P:spermatid nucleus differentiation; IEA:Ensembl
Q5T7V8	GORAB	RAB6-interacting golgin	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BQQ3	GORASP1	Golgi reassembly-stacking protein 1	GO:0007030; P:Golgi organization; ISS:UniProtKB
Q9BQQ3	GORASP1	Golgi reassembly-stacking protein 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9BQQ3	GORASP1	Golgi reassembly-stacking protein 1	GO:0050774; P:negative regulation of dendrite morphogenesis; IMP:UniProtKB
Q9BQQ3	GORASP1	Golgi reassembly-stacking protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9H8Y8	GORASP2	Golgi reassembly-stacking protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q9H8Y8	GORASP2	Golgi reassembly-stacking protein 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9H8Y8	GORASP2	Golgi reassembly-stacking protein 2	GO:0006996; P:organelle organization; IMP:UniProtKB
Q8IX06	REXO1L1P	Putative exonuclease GOR	GO:0004527; F:exonuclease activity; IEA:UniProtKB-KW
Q8IX06	REXO1L1P	Putative exonuclease GOR	GO:0003676; F:nucleic acid binding; IEA:InterPro
O95249	GOSR1	Golgi SNAP receptor complex member 1	GO:0005484; F:SNAP receptor activity; IDA:HGNC
O95249	GOSR1	Golgi SNAP receptor complex member 1	GO:0006888; P:ER to Golgi vesicle-mediated transport; IEA:Ensembl
O95249	GOSR1	Golgi SNAP receptor complex member 1	GO:0006891; P:intra-Golgi vesicle-mediated transport; TAS:ProtInc
O95249	GOSR1	Golgi SNAP receptor complex member 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O95249	GOSR1	Golgi SNAP receptor complex member 1	GO:0042147; P:retrograde transport, endosome to Golgi; IDA:HGNC
O14653	GOSR2	Golgi SNAP receptor complex member 2	GO:0005215; F:transporter activity; TAS:ProtInc
O14653	GOSR2	Golgi SNAP receptor complex member 2	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
O14653	GOSR2	Golgi SNAP receptor complex member 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O14653	GOSR2	Golgi SNAP receptor complex member 2	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
O14653	GOSR2	Golgi SNAP receptor complex member 2	GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:ProtInc
O14653	GOSR2	Golgi SNAP receptor complex member 2	GO:0061025; P:membrane fusion; TAS:ProtInc
O14653	GOSR2	Golgi SNAP receptor complex member 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q6ZVE7	GOLT1A	Vesicle transport protein GOT1A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q6ZVE7	GOLT1A	Vesicle transport protein GOT1A	GO:0016192; P:vesicle-mediated transport; IEA:InterPro
Q9Y3E0	GOLT1B	Vesicle transport protein GOT1B	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q9Y3E0	GOLT1B	Vesicle transport protein GOT1B	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q9Y3E0	GOLT1B	Vesicle transport protein GOT1B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9Y3E0	GOLT1B	Vesicle transport protein GOT1B	GO:0007165; P:signal transduction; IMP:GOC
Q9Y3E0	GOLT1B	Vesicle transport protein GOT1B	GO:0016192; P:vesicle-mediated transport; IEA:InterPro
Q96P66	GPR101	Probable G-protein coupled receptor 101	GO:0004935; F:adrenergic receptor activity; IEA:InterPro
Q5T601	GPR110	Probable G-protein coupled receptor 110	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q5T601	GPR110	Probable G-protein coupled receptor 110	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q5T601	GPR110	Probable G-protein coupled receptor 110	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q8IZF7	GPR111	Probable G-protein coupled receptor 111	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q8IZF7	GPR111	Probable G-protein coupled receptor 111	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q8IZF7	GPR111	Probable G-protein coupled receptor 111	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q8IZF6	GPR112	Probable G-protein coupled receptor 112	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q8IZF6	GPR112	Probable G-protein coupled receptor 112	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q8IZF6	GPR112	Probable G-protein coupled receptor 112	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q8IZF5	GPR113	Probable G-protein coupled receptor 113	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q8IZF5	GPR113	Probable G-protein coupled receptor 113	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q8IZF5	GPR113	Probable G-protein coupled receptor 113	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q8IZF4	GPR114	Probable G-protein coupled receptor 114	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q8IZF4	GPR114	Probable G-protein coupled receptor 114	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q8IZF4	GPR114	Probable G-protein coupled receptor 114	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q8IZF3	GPR115	Probable G-protein coupled receptor 115	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q8IZF3	GPR115	Probable G-protein coupled receptor 115	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q8IZF3	GPR115	Probable G-protein coupled receptor 115	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q8IZF2	GPR116	Probable G-protein coupled receptor 116	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q8IZF2	GPR116	Probable G-protein coupled receptor 116	GO:0006112; P:energy reserve metabolic process; IEA:Ensembl
Q8IZF2	GPR116	Probable G-protein coupled receptor 116	GO:0045444; P:fat cell differentiation; IEA:Ensembl
Q8IZF2	GPR116	Probable G-protein coupled receptor 116	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q8IZF2	GPR116	Probable G-protein coupled receptor 116	GO:0042593; P:glucose homeostasis; IEA:Ensembl
Q8IZF2	GPR116	Probable G-protein coupled receptor 116	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q8IZF2	GPR116	Probable G-protein coupled receptor 116	GO:0019216; P:regulation of lipid metabolic process; IEA:Ensembl
Q8IZF2	GPR116	Probable G-protein coupled receptor 116	GO:0043129; P:surfactant homeostasis; IEA:Ensembl
Q8TDV5	GPR119	Glucose-dependent insulinotropic receptor	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8TDV5	GPR119	Glucose-dependent insulinotropic receptor	GO:0031210; F:phosphatidylcholine binding; IEA:Ensembl
Q8TDV5	GPR119	Glucose-dependent insulinotropic receptor	GO:0030073; P:insulin secretion; IEA:Ensembl
Q86SQ6	GPR123	Probable G-protein coupled receptor 123	GO:0004930; F:G-protein coupled receptor activity; NAS:UniProtKB
Q86SQ6	GPR123	Probable G-protein coupled receptor 123	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q86SQ6	GPR123	Probable G-protein coupled receptor 123	GO:0007165; P:signal transduction; NAS:UniProtKB
Q96PE1	GPR124	G-protein coupled receptor 124	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q96PE1	GPR124	G-protein coupled receptor 124	GO:0007417; P:central nervous system development; ISS:UniProtKB
Q96PE1	GPR124	G-protein coupled receptor 124	GO:0043542; P:endothelial cell migration; ISS:UniProtKB
Q96PE1	GPR124	G-protein coupled receptor 124	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q96PE1	GPR124	G-protein coupled receptor 124	GO:1900747; P:negative regulation of vascular endothelial growth factor signaling pathway; IEA:Ensembl
Q96PE1	GPR124	G-protein coupled receptor 124	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q96PE1	GPR124	G-protein coupled receptor 124	GO:0010595; P:positive regulation of endothelial cell migration; IEA:Ensembl
Q96PE1	GPR124	G-protein coupled receptor 124	GO:0045765; P:regulation of angiogenesis; ISS:UniProtKB
Q96PE1	GPR124	G-protein coupled receptor 124	GO:0050920; P:regulation of chemotaxis; ISS:UniProtKB
Q96PE1	GPR124	G-protein coupled receptor 124	GO:0090210; P:regulation of establishment of blood-brain barrier; IEA:Ensembl
Q96PE1	GPR124	G-protein coupled receptor 124	GO:0002040; P:sprouting angiogenesis; ISS:UniProtKB
Q8IWK6	GPR125	Probable G-protein coupled receptor 125	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q8IWK6	GPR125	Probable G-protein coupled receptor 125	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q8IWK6	GPR125	Probable G-protein coupled receptor 125	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q86SQ4	GPR126	G-protein coupled receptor 126	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q86SQ4	GPR126	G-protein coupled receptor 126	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q86SQ4	GPR126	G-protein coupled receptor 126	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q96K78	GPR128	Probable G-protein coupled receptor 128	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q96K78	GPR128	Probable G-protein coupled receptor 128	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q96K78	GPR128	Probable G-protein coupled receptor 128	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q9UNW8	GPR132	Probable G-protein coupled receptor 132	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9UNW8	GPR132	Probable G-protein coupled receptor 132	GO:0000082; P:G1/S transition of mitotic cell cycle; IEA:Ensembl
Q9UNW8	GPR132	Probable G-protein coupled receptor 132	GO:0006950; P:response to stress; IEA:UniProtKB-KW
Q6QNK2	GPR133	Probable G-protein coupled receptor 133	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q6QNK2	GPR133	Probable G-protein coupled receptor 133	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q6QNK2	GPR133	Probable G-protein coupled receptor 133	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q8IZ08	GPR135	Probable G-protein coupled receptor 135	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q6DWJ6	GPR139	Probable G-protein coupled receptor 139	GO:0008188; F:neuropeptide receptor activity; IEA:Ensembl
Q6DWJ6	GPR139	Probable G-protein coupled receptor 139	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:MGI
Q6DWJ6	GPR139	Probable G-protein coupled receptor 139	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
Q7Z602	GPR141	Probable G-protein coupled receptor 141	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q7Z601	GPR142	Probable G-protein coupled receptor 142	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P51810	GPR143	G-protein coupled receptor 143	GO:0035240; F:dopamine binding; IDA:UniProtKB
P51810	GPR143	G-protein coupled receptor 143	GO:0004930; F:G-protein coupled receptor activity; IDA:UniProtKB
P51810	GPR143	G-protein coupled receptor 143	GO:0072544; F:L-DOPA binding; IDA:UniProtKB
P51810	GPR143	G-protein coupled receptor 143	GO:0035643; F:L-DOPA receptor activity; IDA:UniProtKB
P51810	GPR143	G-protein coupled receptor 143	GO:0005515; F:protein binding; IPI:UniProtKB
P51810	GPR143	G-protein coupled receptor 143	GO:0072545; F:tyrosine binding; IDA:UniProtKB
P51810	GPR143	G-protein coupled receptor 143	GO:0035584; P:calcium-mediated signaling using intracellular calcium source; IDA:UniProtKB
P51810	GPR143	G-protein coupled receptor 143	GO:0006726; P:eye pigment biosynthetic process; TAS:ProtInc
P51810	GPR143	G-protein coupled receptor 143	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:UniProtKB
P51810	GPR143	G-protein coupled receptor 143	GO:0032400; P:melanosome localization; IDA:UniProtKB
P51810	GPR143	G-protein coupled receptor 143	GO:0032438; P:melanosome organization; IMP:UniProtKB
P51810	GPR143	G-protein coupled receptor 143	GO:0032402; P:melanosome transport; IDA:UniProtKB
P51810	GPR143	G-protein coupled receptor 143	GO:0007218; P:neuropeptide signaling pathway; IDA:GOC
P51810	GPR143	G-protein coupled receptor 143	GO:0048015; P:phosphatidylinositol-mediated signaling; IDA:UniProtKB
P51810	GPR143	G-protein coupled receptor 143	GO:0050848; P:regulation of calcium-mediated signaling; IDA:UniProtKB
P51810	GPR143	G-protein coupled receptor 143	GO:0007165; P:signal transduction; TAS:ProtInc
P51810	GPR143	G-protein coupled receptor 143	GO:0007601; P:visual perception; TAS:ProtInc
Q7Z7M1	GPR144	Probable G-protein coupled receptor 144	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q7Z7M1	GPR144	Probable G-protein coupled receptor 144	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q7Z7M1	GPR144	Probable G-protein coupled receptor 144	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q96CH1	GPR146	Probable G-protein coupled receptor 146	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8TDV2	GPR148	Probable G-protein coupled receptor 148	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q86SP6	GPR149	Probable G-protein coupled receptor 149	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q86SP6	GPR149	Probable G-protein coupled receptor 149	GO:0001547; P:antral ovarian follicle growth; IEA:Ensembl
Q86SP6	GPR149	Probable G-protein coupled receptor 149	GO:0060206; P:estrous cycle phase; IEA:Ensembl
Q86SP6	GPR149	Probable G-protein coupled receptor 149	GO:0060280; P:negative regulation of ovulation; IEA:Ensembl
Q86SP6	GPR149	Probable G-protein coupled receptor 149	GO:0001546; P:preantral ovarian follicle growth; IEA:Ensembl
Q8NGU9	GPR150	Probable G-protein coupled receptor 150	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8TDV0	GPR151	Probable G-protein coupled receptor 151	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8TDT2	GPR152	Probable G-protein coupled receptor 152	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q6NV75	GPR153	Probable G-protein coupled receptor 153	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q7Z3F1	GPR155	Integral membrane protein GPR155	GO:0050890; P:cognition; IMP:UniProt
Q7Z3F1	GPR155	Integral membrane protein GPR155	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q7Z3F1	GPR155	Integral membrane protein GPR155	GO:0055085; P:transmembrane transport; IEA:InterPro
Q8NFN8	GPR156	Probable G-protein coupled receptor 156	GO:0004965; F:G-protein coupled GABA receptor activity; IEA:InterPro
Q5UAW9	GPR157	Probable G-protein coupled receptor 157	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q5T848	GPR158	Probable G-protein coupled receptor 158	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q5T848	GPR158	Probable G-protein coupled receptor 158	GO:0072659; P:protein localization to plasma membrane; IEA:Ensembl
Q5T848	GPR158	Probable G-protein coupled receptor 158	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; IEA:Ensembl
Q9UJ42	GPR160	Probable G-protein coupled receptor 160	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8N6U8	GPR161	G-protein coupled receptor 161	GO:0004930; F:G-protein coupled receptor activity; ISS:UniProtKB
Q8N6U8	GPR161	G-protein coupled receptor 161	GO:0007186; P:G-protein coupled receptor signaling pathway; ISS:UniProtKB
Q8N6U8	GPR161	G-protein coupled receptor 161	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8N6U8	GPR161	G-protein coupled receptor 161	GO:1901621; P:negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; ISS:UniProtKB
Q8N6U8	GPR161	G-protein coupled receptor 161	GO:0030819; P:positive regulation of cAMP biosynthetic process; ISS:UniProtKB
Q16538	GPR162	Probable G-protein coupled receptor 162	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O14626	GPR171	Probable G-protein coupled receptor 171	GO:0004930; F:G-protein coupled receptor activity; NAS:UniProtKB
O14626	GPR171	Probable G-protein coupled receptor 171	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
Q9NS66	GPR173	Probable G-protein coupled receptor 173	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q9NS66	GPR173	Probable G-protein coupled receptor 173	GO:0004968; F:gonadotropin-releasing hormone receptor activity; IEA:Ensembl
Q9NS66	GPR173	Probable G-protein coupled receptor 173	GO:2001223; P:negative regulation of neuron migration; IEA:Ensembl
Q9NS66	GPR173	Probable G-protein coupled receptor 173	GO:0007165; P:signal transduction; TAS:ProtInc
Q9BXC1	GPR174	Probable G-protein coupled receptor 174	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q14439	GPR176	Probable G-protein coupled receptor 176	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q14439	GPR176	Probable G-protein coupled receptor 176	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q14439	GPR176	Probable G-protein coupled receptor 176	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q6PRD1	GPR179	Probable G-protein coupled receptor 179	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q6PRD1	GPR179	Probable G-protein coupled receptor 179	GO:0072659; P:protein localization to plasma membrane; IEA:Ensembl
Q6PRD1	GPR179	Probable G-protein coupled receptor 179	GO:0007601; P:visual perception; IMP:UniProtKB
Q86V85	GPR180	Integral membrane protein GPR180	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:InterPro
Q86V85	GPR180	Integral membrane protein GPR180	GO:0019236; P:response to pheromone; IEA:InterPro
O15218	GPR182	G-protein coupled receptor 182	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O15218	GPR182	G-protein coupled receptor 182	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
O15218	GPR182	G-protein coupled receptor 182	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P32249	GPR183	G-protein coupled receptor 183	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P32249	GPR183	G-protein coupled receptor 183	GO:0008142; F:oxysterol binding; IDA:UniProtKB
P32249	GPR183	G-protein coupled receptor 183	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:UniProtKB
P32249	GPR183	G-protein coupled receptor 183	GO:0006959; P:humoral immune response; ISS:UniProtKB
P32249	GPR183	G-protein coupled receptor 183	GO:0006955; P:immune response; TAS:ProtInc
P32249	GPR183	G-protein coupled receptor 183	GO:0002313; P:mature B cell differentiation involved in immune response; ISS:UniProtKB
P32249	GPR183	G-protein coupled receptor 183	GO:0030890; P:positive regulation of B cell proliferation; IDA:UniProtKB
P32249	GPR183	G-protein coupled receptor 183	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P07359	GP1BA	Platelet glycoprotein Ib alpha chain	GO:0005515; F:protein binding; IPI:UniProtKB
P07359	GP1BA	Platelet glycoprotein Ib alpha chain	GO:0015057; F:thrombin receptor activity; TAS:UniProtKB
P07359	GP1BA	Platelet glycoprotein Ib alpha chain	GO:0007596; P:blood coagulation; IMP:MGI
P07359	GP1BA	Platelet glycoprotein Ib alpha chain	GO:0007597; P:blood coagulation, intrinsic pathway; TAS:Reactome
P07359	GP1BA	Platelet glycoprotein Ib alpha chain	GO:0007155; P:cell adhesion; IDA:MGI
P07359	GP1BA	Platelet glycoprotein Ib alpha chain	GO:0000902; P:cell morphogenesis; IEA:Ensembl
P07359	GP1BA	Platelet glycoprotein Ib alpha chain	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P07359	GP1BA	Platelet glycoprotein Ib alpha chain	GO:0042730; P:fibrinolysis; IDA:UniProtKB
P07359	GP1BA	Platelet glycoprotein Ib alpha chain	GO:0030168; P:platelet activation; TAS:UniProtKB
P07359	GP1BA	Platelet glycoprotein Ib alpha chain	GO:0030193; P:regulation of blood coagulation; TAS:UniProtKB
P07359	GP1BA	Platelet glycoprotein Ib alpha chain	GO:0070493; P:thrombin receptor signaling pathway; TAS:GOC
P13224	GP1BB	Platelet glycoprotein Ib beta chain	GO:0005515; F:protein binding; IPI:UniProtKB
P13224	GP1BB	Platelet glycoprotein Ib beta chain	GO:0004888; F:transmembrane signaling receptor activity; NAS:ProtInc
P13224	GP1BB	Platelet glycoprotein Ib beta chain	GO:0007596; P:blood coagulation; TAS:Reactome
P13224	GP1BB	Platelet glycoprotein Ib beta chain	GO:0007597; P:blood coagulation, intrinsic pathway; TAS:Reactome
P13224	GP1BB	Platelet glycoprotein Ib beta chain	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P13224	GP1BB	Platelet glycoprotein Ib beta chain	GO:0007166; P:cell surface receptor signaling pathway; NAS:ProtInc
P13224	GP1BB	Platelet glycoprotein Ib beta chain	GO:0030168; P:platelet activation; NAS:UniProtKB
P55259	GP2	Pancreatic secretory granule membrane major glycoprotein GP2	GO:0003823; F:antigen binding; IEA:Ensembl
P55259	GP2	Pancreatic secretory granule membrane major glycoprotein GP2	GO:0002412; P:antigen transcytosis by M cells in mucosal-associated lymphoid tissue; IEA:Ensembl
Q99795	GPA33	Cell surface A33 antigen	GO:0004872; F:receptor activity; TAS:ProtInc
O43292	GPAA1	Glycosylphosphatidylinositol anchor attachment 1 protein	GO:0005515; F:protein binding; IPI:UniProtKB
O43292	GPAA1	Glycosylphosphatidylinositol anchor attachment 1 protein	GO:0015631; F:tubulin binding; NAS:UniProtKB
O43292	GPAA1	Glycosylphosphatidylinositol anchor attachment 1 protein	GO:0016255; P:attachment of GPI anchor to protein; NAS:UniProtKB
O43292	GPAA1	Glycosylphosphatidylinositol anchor attachment 1 protein	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
O43292	GPAA1	Glycosylphosphatidylinositol anchor attachment 1 protein	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O43292	GPAA1	Glycosylphosphatidylinositol anchor attachment 1 protein	GO:0043687; P:post-translational protein modification; TAS:Reactome
O43292	GPAA1	Glycosylphosphatidylinositol anchor attachment 1 protein	GO:0006461; P:protein complex assembly; NAS:UniProtKB
O43292	GPAA1	Glycosylphosphatidylinositol anchor attachment 1 protein	GO:0006621; P:protein retention in ER lumen; NAS:UniProtKB
O95872	GPANK1	G patch domain and ankyrin repeat-containing protein 1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9HCL2	GPAM	Glycerol-3-phosphate acyltransferase 1, mitochondrial	GO:0004366; F:glycerol-3-phosphate O-acyltransferase activity; IMP:UniProtKB
Q9HCL2	GPAM	Glycerol-3-phosphate acyltransferase 1, mitochondrial	GO:0006637; P:acyl-CoA metabolic process; IEA:Ensembl
Q9HCL2	GPAM	Glycerol-3-phosphate acyltransferase 1, mitochondrial	GO:0016024; P:CDP-diacylglycerol biosynthetic process; IEA:UniProtKB-UniPathway
Q9HCL2	GPAM	Glycerol-3-phosphate acyltransferase 1, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9HCL2	GPAM	Glycerol-3-phosphate acyltransferase 1, mitochondrial	GO:0051607; P:defense response to virus; IEA:Ensembl
Q9HCL2	GPAM	Glycerol-3-phosphate acyltransferase 1, mitochondrial	GO:0055089; P:fatty acid homeostasis; IEA:Ensembl
Q9HCL2	GPAM	Glycerol-3-phosphate acyltransferase 1, mitochondrial	GO:0006631; P:fatty acid metabolic process; IEA:Ensembl
Q9HCL2	GPAM	Glycerol-3-phosphate acyltransferase 1, mitochondrial	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9HCL2	GPAM	Glycerol-3-phosphate acyltransferase 1, mitochondrial	GO:0070970; P:interleukin-2 secretion; IEA:Ensembl
Q9HCL2	GPAM	Glycerol-3-phosphate acyltransferase 1, mitochondrial	GO:0070236; P:negative regulation of activation-induced cell death of T cells; IEA:Ensembl
Q9HCL2	GPAM	Glycerol-3-phosphate acyltransferase 1, mitochondrial	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
Q9HCL2	GPAM	Glycerol-3-phosphate acyltransferase 1, mitochondrial	GO:0055091; P:phospholipid homeostasis; IEA:Ensembl
Q9HCL2	GPAM	Glycerol-3-phosphate acyltransferase 1, mitochondrial	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9HCL2	GPAM	Glycerol-3-phosphate acyltransferase 1, mitochondrial	GO:0042104; P:positive regulation of activated T cell proliferation; IEA:Ensembl
Q9HCL2	GPAM	Glycerol-3-phosphate acyltransferase 1, mitochondrial	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
Q9HCL2	GPAM	Glycerol-3-phosphate acyltransferase 1, mitochondrial	GO:0050707; P:regulation of cytokine secretion; IEA:Ensembl
Q9HCL2	GPAM	Glycerol-3-phosphate acyltransferase 1, mitochondrial	GO:0009749; P:response to glucose; IEA:Ensembl
Q9HCL2	GPAM	Glycerol-3-phosphate acyltransferase 1, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9HCL2	GPAM	Glycerol-3-phosphate acyltransferase 1, mitochondrial	GO:0019432; P:triglyceride biosynthetic process; IDA:UniProtKB
Q6NUI2	GPAT2	Glycerol-3-phosphate acyltransferase 2, mitochondrial	GO:0004366; F:glycerol-3-phosphate O-acyltransferase activity; ISS:UniProtKB
Q6NUI2	GPAT2	Glycerol-3-phosphate acyltransferase 2, mitochondrial	GO:0016024; P:CDP-diacylglycerol biosynthetic process; IEA:UniProtKB-UniPathway
Q6NUI2	GPAT2	Glycerol-3-phosphate acyltransferase 2, mitochondrial	GO:0006072; P:glycerol-3-phosphate metabolic process; ISS:UniProtKB
Q6NUI2	GPAT2	Glycerol-3-phosphate acyltransferase 2, mitochondrial	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q6NUI2	GPAT2	Glycerol-3-phosphate acyltransferase 2, mitochondrial	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
Q6NUI2	GPAT2	Glycerol-3-phosphate acyltransferase 2, mitochondrial	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q6NUI2	GPAT2	Glycerol-3-phosphate acyltransferase 2, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6NUI2	GPAT2	Glycerol-3-phosphate acyltransferase 2, mitochondrial	GO:0019432; P:triglyceride biosynthetic process; ISS:UniProtKB
Q53EU6	AGPAT9	Glycerol-3-phosphate acyltransferase 3	GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; IEA:UniProtKB-EC
Q53EU6	AGPAT9	Glycerol-3-phosphate acyltransferase 3	GO:0004366; F:glycerol-3-phosphate O-acyltransferase activity; IDA:UniProtKB
Q53EU6	AGPAT9	Glycerol-3-phosphate acyltransferase 3	GO:0016024; P:CDP-diacylglycerol biosynthetic process; IEA:UniProtKB-UniPathway
Q53EU6	AGPAT9	Glycerol-3-phosphate acyltransferase 3	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q53EU6	AGPAT9	Glycerol-3-phosphate acyltransferase 3	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q53EU6	AGPAT9	Glycerol-3-phosphate acyltransferase 3	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
Q53EU6	AGPAT9	Glycerol-3-phosphate acyltransferase 3	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q53EU6	AGPAT9	Glycerol-3-phosphate acyltransferase 3	GO:0032006; P:regulation of TOR signaling; IDA:UniProtKB
Q53EU6	AGPAT9	Glycerol-3-phosphate acyltransferase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q53EU6	AGPAT9	Glycerol-3-phosphate acyltransferase 3	GO:0019432; P:triglyceride biosynthetic process; IDA:UniProtKB
Q86UL3	AGPAT6	Glycerol-3-phosphate acyltransferase 4	GO:0004366; F:glycerol-3-phosphate O-acyltransferase activity; IDA:UniProtKB
Q86UL3	AGPAT6	Glycerol-3-phosphate acyltransferase 4	GO:0006637; P:acyl-CoA metabolic process; IDA:UniProtKB
Q86UL3	AGPAT6	Glycerol-3-phosphate acyltransferase 4	GO:0016024; P:CDP-diacylglycerol biosynthetic process; IEA:UniProtKB-UniPathway
Q86UL3	AGPAT6	Glycerol-3-phosphate acyltransferase 4	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q86UL3	AGPAT6	Glycerol-3-phosphate acyltransferase 4	GO:0046339; P:diacylglycerol metabolic process; IEA:Ensembl
Q86UL3	AGPAT6	Glycerol-3-phosphate acyltransferase 4	GO:0006631; P:fatty acid metabolic process; IEA:Ensembl
Q86UL3	AGPAT6	Glycerol-3-phosphate acyltransferase 4	GO:0002071; P:glandular epithelial cell maturation; IEA:Ensembl
Q86UL3	AGPAT6	Glycerol-3-phosphate acyltransferase 4	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q86UL3	AGPAT6	Glycerol-3-phosphate acyltransferase 4	GO:0007595; P:lactation; ISS:UniProtKB
Q86UL3	AGPAT6	Glycerol-3-phosphate acyltransferase 4	GO:0008610; P:lipid biosynthetic process; ISS:UniProtKB
Q86UL3	AGPAT6	Glycerol-3-phosphate acyltransferase 4	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
Q86UL3	AGPAT6	Glycerol-3-phosphate acyltransferase 4	GO:0006656; P:phosphatidylcholine biosynthetic process; IDA:UniProtKB
Q86UL3	AGPAT6	Glycerol-3-phosphate acyltransferase 4	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q86UL3	AGPAT6	Glycerol-3-phosphate acyltransferase 4	GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl
Q86UL3	AGPAT6	Glycerol-3-phosphate acyltransferase 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q86UL3	AGPAT6	Glycerol-3-phosphate acyltransferase 4	GO:0019432; P:triglyceride biosynthetic process; ISS:UniProtKB
Q8TDU6	GPBAR1	G-protein coupled bile acid receptor 1	GO:0038181; F:bile acid receptor activity; IDA:UniProtKB
Q8TDU6	GPBAR1	G-protein coupled bile acid receptor 1	GO:0038182; F:G-protein coupled bile acid receptor activity; NAS:UniProtKB
Q8TDU6	GPBAR1	G-protein coupled bile acid receptor 1	GO:0038184; P:cell surface bile acid receptor signaling pathway; IC:UniProtKB
Q86WP2	GPBP1	Vasculin	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86WP2	GPBP1	Vasculin	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q86WP2	GPBP1	Vasculin	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q86WP2	GPBP1	Vasculin	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HC44	GPBP1L1	Vasculin-like protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9HC44	GPBP1L1	Vasculin-like protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9HC44	GPBP1L1	Vasculin-like protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:InterPro
Q9HC44	GPBP1L1	Vasculin-like protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P35052	GPC1	Glypican-1	GO:0005507; F:copper ion binding; IDA:UniProtKB
P35052	GPC1	Glypican-1	GO:0017134; F:fibroblast growth factor binding; ISS:UniProtKB
P35052	GPC1	Glypican-1	GO:0043236; F:laminin binding; ISS:UniProtKB
P35052	GPC1	Glypican-1	GO:0007411; P:axon guidance; TAS:Reactome
P35052	GPC1	Glypican-1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P35052	GPC1	Glypican-1	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
P35052	GPC1	Glypican-1	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
P35052	GPC1	Glypican-1	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
P35052	GPC1	Glypican-1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P35052	GPC1	Glypican-1	GO:0030200; P:heparan sulfate proteoglycan catabolic process; IDA:UniProtKB
P35052	GPC1	Glypican-1	GO:0032288; P:myelin assembly; ISS:UniProtKB
P35052	GPC1	Glypican-1	GO:0040037; P:negative regulation of fibroblast growth factor receptor signaling pathway; ISS:UniProtKB
P35052	GPC1	Glypican-1	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P35052	GPC1	Glypican-1	GO:2001016; P:positive regulation of skeletal muscle cell differentiation; ISS:UniProtKB
P35052	GPC1	Glypican-1	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P35052	GPC1	Glypican-1	GO:0014037; P:Schwann cell differentiation; ISS:UniProtKB
P35052	GPC1	Glypican-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8N158	GPC2	Glypican-2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q8N158	GPC2	Glypican-2	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q8N158	GPC2	Glypican-2	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
Q8N158	GPC2	Glypican-2	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
Q8N158	GPC2	Glypican-2	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q8N158	GPC2	Glypican-2	GO:0030182; P:neuron differentiation; IEA:Ensembl
Q8N158	GPC2	Glypican-2	GO:0007603; P:phototransduction, visible light; TAS:Reactome
Q8N158	GPC2	Glypican-2	GO:0001523; P:retinoid metabolic process; TAS:Reactome
Q8N158	GPC2	Glypican-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8N158	GPC2	Glypican-2	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:0060422; F:peptidyl-dipeptidase inhibitor activity; IDA:UniProtKB
P51654	GPC3	Glypican-3	GO:0005515; F:protein binding; IPI:UniProtKB
P51654	GPC3	Glypican-3	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P51654	GPC3	Glypican-3	GO:0009948; P:anterior/posterior axis specification; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:0010171; P:body morphogenesis; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:0030282; P:bone mineralization; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P51654	GPC3	Glypican-3	GO:0072203; P:cell proliferation involved in metanephros development; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
P51654	GPC3	Glypican-3	GO:0060976; P:coronary vasculature development; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
P51654	GPC3	Glypican-3	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
P51654	GPC3	Glypican-3	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P51654	GPC3	Glypican-3	GO:0030324; P:lung development; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:0072138; P:mesenchymal cell proliferation involved in ureteric bud development; ISS:UniProtKB
P51654	GPC3	Glypican-3	GO:0072180; P:mesonephric duct morphogenesis; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:0045926; P:negative regulation of growth; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:0045879; P:negative regulation of smoothened signaling pathway; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:0030316; P:osteoclast differentiation; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P51654	GPC3	Glypican-3	GO:0030513; P:positive regulation of BMP signaling pathway; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:0045807; P:positive regulation of endocytosis; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:0046326; P:positive regulation of glucose import; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:0045880; P:positive regulation of smoothened signaling pathway; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:2000096; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; IEA:Ensembl
P51654	GPC3	Glypican-3	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P51654	GPC3	Glypican-3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75487	GPC4	Glypican-4	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
O75487	GPC4	Glypican-4	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O75487	GPC4	Glypican-4	GO:0008283; P:cell proliferation; TAS:ProtInc
O75487	GPC4	Glypican-4	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
O75487	GPC4	Glypican-4	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
O75487	GPC4	Glypican-4	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
O75487	GPC4	Glypican-4	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O75487	GPC4	Glypican-4	GO:0007603; P:phototransduction, visible light; TAS:Reactome
O75487	GPC4	Glypican-4	GO:0001523; P:retinoid metabolic process; TAS:Reactome
O75487	GPC4	Glypican-4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NZH0	GPRC5B	G-protein coupled receptor family C group 5 member B	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9NZH0	GPRC5B	G-protein coupled receptor family C group 5 member B	GO:0001664; F:G-protein coupled receptor binding; ISS:UniProt
Q9NZH0	GPRC5B	G-protein coupled receptor family C group 5 member B	GO:0030295; F:protein kinase activator activity; IDA:MGI
Q9NZH0	GPRC5B	G-protein coupled receptor family C group 5 member B	GO:0019901; F:protein kinase binding; ISS:UniProt
Q9NZH0	GPRC5B	G-protein coupled receptor family C group 5 member B	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q9NZH0	GPRC5B	G-protein coupled receptor family C group 5 member B	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; ISS:UniProt
Q9NZH0	GPRC5B	G-protein coupled receptor family C group 5 member B	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; ISS:UniProt
Q9NZH0	GPRC5B	G-protein coupled receptor family C group 5 member B	GO:0050729; P:positive regulation of inflammatory response; ISS:UniProt
Q9NZH0	GPRC5B	G-protein coupled receptor family C group 5 member B	GO:0060907; P:positive regulation of macrophage cytokine production; ISS:UniProt
Q9NZH0	GPRC5B	G-protein coupled receptor family C group 5 member B	GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProt
Q9NZH0	GPRC5B	G-protein coupled receptor family C group 5 member B	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
Q9NZH0	GPRC5B	G-protein coupled receptor family C group 5 member B	GO:0061098; P:positive regulation of protein tyrosine kinase activity; ISS:UniProt
Q9NQ84	GPRC5C	G-protein coupled receptor family C group 5 member C	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q9NQ84	GPRC5C	G-protein coupled receptor family C group 5 member C	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q9NZD1	GPRC5D	G-protein coupled receptor family C group 5 member D	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P78333	GPC5	Glypican-5	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P78333	GPC5	Glypican-5	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
P78333	GPC5	Glypican-5	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
P78333	GPC5	Glypican-5	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
P78333	GPC5	Glypican-5	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P78333	GPC5	Glypican-5	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P78333	GPC5	Glypican-5	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P78333	GPC5	Glypican-5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5T6X5	GPRC6A	G-protein coupled receptor family C group 6 member A	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q5T6X5	GPRC6A	G-protein coupled receptor family C group 6 member A	GO:0019722; P:calcium-mediated signaling; IEA:Ensembl
Q5T6X5	GPRC6A	G-protein coupled receptor family C group 6 member A	GO:0043200; P:response to amino acid; IDA:UniProtKB
Q9Y625	GPC6	Glypican-6	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9Y625	GPC6	Glypican-6	GO:0016477; P:cell migration; IDA:UniProtKB
Q9Y625	GPC6	Glypican-6	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q9Y625	GPC6	Glypican-6	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
Q9Y625	GPC6	Glypican-6	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
Q9Y625	GPC6	Glypican-6	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9Y625	GPC6	Glypican-6	GO:0007603; P:phototransduction, visible light; TAS:Reactome
Q9Y625	GPC6	Glypican-6	GO:0001523; P:retinoid metabolic process; TAS:Reactome
Q9Y625	GPC6	Glypican-6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NPB8	GPCPD1	Glycerophosphocholine phosphodiesterase GPCPD1	GO:0047389; F:glycerophosphocholine phosphodiesterase activity; IEA:UniProtKB-EC
Q9NPB8	GPCPD1	Glycerophosphocholine phosphodiesterase GPCPD1	GO:0008889; F:glycerophosphodiester phosphodiesterase activity; IEA:InterPro
Q9NPB8	GPCPD1	Glycerophosphocholine phosphodiesterase GPCPD1	GO:2001070; F:starch binding; IEA:InterPro
Q9NPB8	GPCPD1	Glycerophosphocholine phosphodiesterase GPCPD1	GO:0006071; P:glycerol metabolic process; IEA:InterPro
Q9NPB8	GPCPD1	Glycerophosphocholine phosphodiesterase GPCPD1	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9NPB8	GPCPD1	Glycerophosphocholine phosphodiesterase GPCPD1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9NPB8	GPCPD1	Glycerophosphocholine phosphodiesterase GPCPD1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:0004367; F:glycerol-3-phosphate dehydrogenase [NAD+] activity; IEA:UniProtKB-EC
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:0051287; F:NAD binding; IEA:InterPro
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:0017080; F:sodium channel regulator activity; IMP:BHF-UCL
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:0046168; P:glycerol-3-phosphate catabolic process; IEA:InterPro
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:0019674; P:NAD metabolic process; IMP:BHF-UCL
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:0006734; P:NADH metabolic process; IEA:Ensembl
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; IMP:BHF-UCL
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:0090038; P:negative regulation of protein kinase C signaling; IMP:BHF-UCL
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:2000010; P:positive regulation of protein localization to cell surface; IMP:BHF-UCL
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:0010765; P:positive regulation of sodium ion transport; IMP:BHF-UCL
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:0002027; P:regulation of heart rate; IMP:BHF-UCL
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:2000649; P:regulation of sodium ion transmembrane transporter activity; IMP:BHF-UCL
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:0060373; P:regulation of ventricular cardiac muscle cell membrane depolarization; IMP:BHF-UCL
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
Q8N335	GPD1L	Glycerol-3-phosphate dehydrogenase 1-like protein	GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL
P21695	GPD1	Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic	GO:0004367; F:glycerol-3-phosphate dehydrogenase [NAD+] activity; TAS:ProtInc
P21695	GPD1	Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic	GO:0004368; F:glycerol-3-phosphate dehydrogenase activity; IEA:Ensembl
P21695	GPD1	Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic	GO:0051287; F:NAD binding; IEA:Ensembl
P21695	GPD1	Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P21695	GPD1	Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic	GO:0071320; P:cellular response to cAMP; IEA:Ensembl
P21695	GPD1	Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic	GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl
P21695	GPD1	Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic	GO:0006094; P:gluconeogenesis; IEA:Ensembl
P21695	GPD1	Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic	GO:0046168; P:glycerol-3-phosphate catabolic process; IEA:InterPro
P21695	GPD1	Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
P21695	GPD1	Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic	GO:0006116; P:NADH oxidation; IEA:Ensembl
P21695	GPD1	Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
P21695	GPD1	Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P21695	GPD1	Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P21695	GPD1	Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
P43304	GPD2	Glycerol-3-phosphate dehydrogenase, mitochondrial	GO:0005509; F:calcium ion binding; TAS:ProtInc
P43304	GPD2	Glycerol-3-phosphate dehydrogenase, mitochondrial	GO:0004368; F:glycerol-3-phosphate dehydrogenase activity; TAS:ProtInc
P43304	GPD2	Glycerol-3-phosphate dehydrogenase, mitochondrial	GO:0052591; F:sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity; IEA:UniProtKB-EC
P43304	GPD2	Glycerol-3-phosphate dehydrogenase, mitochondrial	GO:0043010; P:camera-type eye development; IEA:Ensembl
P43304	GPD2	Glycerol-3-phosphate dehydrogenase, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P43304	GPD2	Glycerol-3-phosphate dehydrogenase, mitochondrial	GO:0006094; P:gluconeogenesis; IEA:Ensembl
P43304	GPD2	Glycerol-3-phosphate dehydrogenase, mitochondrial	GO:0019563; P:glycerol catabolic process; IEA:UniProtKB-UniPathway
P43304	GPD2	Glycerol-3-phosphate dehydrogenase, mitochondrial	GO:0006072; P:glycerol-3-phosphate metabolic process; IEA:Ensembl
P43304	GPD2	Glycerol-3-phosphate dehydrogenase, mitochondrial	GO:0035264; P:multicellular organism growth; IEA:Ensembl
P43304	GPD2	Glycerol-3-phosphate dehydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0030284; F:estrogen receptor activity; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0017082; F:mineralocorticoid receptor activity; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0005496; F:steroid binding; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0030263; P:apoptotic chromosome condensation; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0071392; P:cellular response to estradiol stimulus; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0071333; P:cellular response to glucose stimulus; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0071389; P:cellular response to mineralocorticoid stimulus; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0071375; P:cellular response to peptide hormone stimulus; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0071356; P:cellular response to tumor necrosis factor; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0051480; P:cytosolic calcium ion homeostasis; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0030518; P:intracellular steroid hormone receptor signaling pathway; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0031959; P:mineralocorticoid receptor signaling pathway; ISS:GOC
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0071157; P:negative regulation of cell cycle arrest; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0008285; P:negative regulation of cell proliferation; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0051053; P:negative regulation of DNA metabolic process; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0045599; P:negative regulation of fat cell differentiation; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0010629; P:negative regulation of gene expression; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0050728; P:negative regulation of inflammatory response; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0002695; P:negative regulation of leukocyte activation; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0051055; P:negative regulation of lipid biosynthetic process; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0019228; P:neuronal action potential; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0030264; P:nuclear fragmentation involved in apoptotic nuclear change; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0010579; P:positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:2000353; P:positive regulation of endothelial cell apoptotic process; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0045742; P:positive regulation of epidermal growth factor receptor signaling pathway; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0045745; P:positive regulation of G-protein coupled receptor protein signaling pathway; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0032962; P:positive regulation of inositol trisphosphate biosynthetic process; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0032024; P:positive regulation of insulin secretion; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0043410; P:positive regulation of MAPK cascade; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0050769; P:positive regulation of neurogenesis; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0001956; P:positive regulation of neurotransmitter secretion; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0070474; P:positive regulation of uterine smooth muscle contraction; IDA:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0045909; P:positive regulation of vasodilation; ISS:UniProtKB
Q99527	GPER1	G-protein coupled estrogen receptor 1	GO:0043401; P:steroid hormone mediated signaling pathway; IDA:GOC
B7ZAQ6	GPR89A	Golgi pH regulator A	GO:0004871; F:signal transducer activity; IMP:UniProtKB
B7ZAQ6	GPR89A	Golgi pH regulator A	GO:0008308; F:voltage-gated anion channel activity; IDA:UniProtKB
B7ZAQ6	GPR89A	Golgi pH regulator A	GO:0051452; P:intracellular pH reduction; IDA:UniProtKB
B7ZAQ6	GPR89A	Golgi pH regulator A	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
B7ZAQ6	GPR89A	Golgi pH regulator A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
B7ZAQ6	GPR89A	Golgi pH regulator A	GO:0044070; P:regulation of anion transport; IDA:GOC
B7ZAQ6	GPR89A	Golgi pH regulator A	GO:0007165; P:signal transduction; IMP:GOC
P0CG08	GPR89B	Golgi pH regulator B	GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW
P0CG08	GPR89B	Golgi pH regulator B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q92643	PIGK	GPI-anchor transamidase	GO:0004197; F:cysteine-type endopeptidase activity; IEA:InterPro
Q92643	PIGK	GPI-anchor transamidase	GO:0003923; F:GPI-anchor transamidase activity; IMP:UniProtKB
Q92643	PIGK	GPI-anchor transamidase	GO:0005515; F:protein binding; IPI:UniProtKB
Q92643	PIGK	GPI-anchor transamidase	GO:0003756; F:protein disulfide isomerase activity; TAS:UniProtKB
Q92643	PIGK	GPI-anchor transamidase	GO:0016255; P:attachment of GPI anchor to protein; TAS:UniProtKB
Q92643	PIGK	GPI-anchor transamidase	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
Q92643	PIGK	GPI-anchor transamidase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q92643	PIGK	GPI-anchor transamidase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q92643	PIGK	GPI-anchor transamidase	GO:0006457; P:protein folding; TAS:GOC
P14770	GP9	Platelet glycoprotein IX	GO:0007596; P:blood coagulation; TAS:Reactome
P14770	GP9	Platelet glycoprotein IX	GO:0007597; P:blood coagulation, intrinsic pathway; TAS:Reactome
P14770	GP9	Platelet glycoprotein IX	GO:0007155; P:cell adhesion; NAS:ProtInc
P14770	GP9	Platelet glycoprotein IX	GO:0030168; P:platelet activation; TAS:Reactome
Q92917	GPKOW	G patch domain and KOW motifs-containing protein	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q92917	GPKOW	G patch domain and KOW motifs-containing protein	GO:0005515; F:protein binding; IPI:IntAct
P51674	GPM6A	Neuronal membrane glycoprotein M6-a	GO:0005262; F:calcium channel activity; IEA:Ensembl
P51674	GPM6A	Neuronal membrane glycoprotein M6-a	GO:0003407; P:neural retina development; ISS:UniProtKB
P51674	GPM6A	Neuronal membrane glycoprotein M6-a	GO:0001764; P:neuron migration; IDA:UniProtKB
P51674	GPM6A	Neuronal membrane glycoprotein M6-a	GO:0048812; P:neuron projection morphogenesis; ISS:UniProtKB
P51674	GPM6A	Neuronal membrane glycoprotein M6-a	GO:0051491; P:positive regulation of filopodium assembly; ISS:UniProtKB
P51674	GPM6A	Neuronal membrane glycoprotein M6-a	GO:0048863; P:stem cell differentiation; IDA:UniProtKB
P51674	GPM6A	Neuronal membrane glycoprotein M6-a	GO:0007416; P:synapse assembly; ISS:UniProtKB
Q13491	GPM6B	Neuronal membrane glycoprotein M6-b	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q13491	GPM6B	Neuronal membrane glycoprotein M6-b	GO:0085029; P:extracellular matrix assembly; IMP:UniProtKB
Q13491	GPM6B	Neuronal membrane glycoprotein M6-b	GO:2000009; P:negative regulation of protein localization to cell surface; ISS:UniProtKB
Q13491	GPM6B	Neuronal membrane glycoprotein M6-b	GO:0051612; P:negative regulation of serotonin uptake; ISS:UniProtKB
Q13491	GPM6B	Neuronal membrane glycoprotein M6-b	GO:0007399; P:nervous system development; NAS:UniProtKB
Q13491	GPM6B	Neuronal membrane glycoprotein M6-b	GO:0001503; P:ossification; IEA:UniProtKB-KW
Q13491	GPM6B	Neuronal membrane glycoprotein M6-b	GO:0030501; P:positive regulation of bone mineralization; IMP:UniProtKB
Q13491	GPM6B	Neuronal membrane glycoprotein M6-b	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q13491	GPM6B	Neuronal membrane glycoprotein M6-b	GO:0032956; P:regulation of actin cytoskeleton organization; IMP:UniProtKB
Q13491	GPM6B	Neuronal membrane glycoprotein M6-b	GO:0051893; P:regulation of focal adhesion assembly; IMP:UniProtKB
Q9H9Y4	GPN2	GPN-loop GTPase 2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9HCN4	GPN1	GPN-loop GTPase 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9HCN4	GPN1	GPN-loop GTPase 1	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q9HCN4	GPN1	GPN-loop GTPase 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9UHW5	GPN3	GPN-loop GTPase 3	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q14956	GPNMB	Transmembrane glycoprotein NMB	GO:0008201; F:heparin binding; IEA:Ensembl
Q14956	GPNMB	Transmembrane glycoprotein NMB	GO:0030282; P:bone mineralization; IEA:Ensembl
Q14956	GPNMB	Transmembrane glycoprotein NMB	GO:0007155; P:cell adhesion; IEA:Ensembl
Q14956	GPNMB	Transmembrane glycoprotein NMB	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q14956	GPNMB	Transmembrane glycoprotein NMB	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
P47775	GPR12	G-protein coupled receptor 12	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P47775	GPR12	G-protein coupled receptor 12	GO:0031210; F:phosphatidylcholine binding; IEA:Ensembl
P47775	GPR12	G-protein coupled receptor 12	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
P47775	GPR12	G-protein coupled receptor 12	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P49685	GPR15	G-protein coupled receptor 15	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P49685	GPR15	G-protein coupled receptor 15	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q13304	GPR17	Uracil nucleotide/cysteinyl leukotriene receptor	GO:0004950; F:chemokine receptor activity; TAS:ProtInc
Q13304	GPR17	Uracil nucleotide/cysteinyl leukotriene receptor	GO:0070098; P:chemokine-mediated signaling pathway; TAS:GOC
Q13304	GPR17	Uracil nucleotide/cysteinyl leukotriene receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q14330	GPR18	N-arachidonyl glycine receptor	GO:0004930; F:G-protein coupled receptor activity; NAS:UniProtKB
Q14330	GPR18	N-arachidonyl glycine receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
Q15760	GPR19	Probable G-protein coupled receptor 19	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q15760	GPR19	Probable G-protein coupled receptor 19	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P46091	GPR1	G-protein coupled receptor 1	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P46091	GPR1	G-protein coupled receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q99678	GPR20	G-protein coupled receptor 20	GO:0004930; F:G-protein coupled receptor activity; IDA:UniProtKB
Q99678	GPR20	G-protein coupled receptor 20	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:UniProtKB
Q99679	GPR21	Probable G-protein coupled receptor 21	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q99679	GPR21	Probable G-protein coupled receptor 21	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q99679	GPR21	Probable G-protein coupled receptor 21	GO:0042593; P:glucose homeostasis; IEA:Ensembl
Q99679	GPR21	Probable G-protein coupled receptor 21	GO:0046627; P:negative regulation of insulin receptor signaling pathway; IEA:Ensembl
Q99679	GPR21	Probable G-protein coupled receptor 21	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
Q99680	GPR22	Probable G-protein coupled receptor 22	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q99680	GPR22	Probable G-protein coupled receptor 22	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
O00155	GPR25	Probable G-protein coupled receptor 25	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O00155	GPR25	Probable G-protein coupled receptor 25	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q8NDV2	GPR26	G-protein coupled receptor 26	GO:0004930; F:G-protein coupled receptor activity; IDA:UniProtKB
Q8NDV2	GPR26	G-protein coupled receptor 26	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IDA:UniProtKB
Q9NS67	GPR27	Probable G-protein coupled receptor 27	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q9NS67	GPR27	Probable G-protein coupled receptor 27	GO:0007165; P:signal transduction; TAS:ProtInc
O00270	GPR31	12-(S)-hydroxy-5,8,10,14-eicosatetraenoic acid receptor	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O00270	GPR31	12-(S)-hydroxy-5,8,10,14-eicosatetraenoic acid receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
O75388	GPR32	Probable G-protein coupled receptor 32	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O75388	GPR32	Probable G-protein coupled receptor 32	GO:0004982; F:N-formyl peptide receptor activity; IEA:InterPro
O75388	GPR32	Probable G-protein coupled receptor 32	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q49SQ1	GPR33	Probable G-protein coupled receptor 33	GO:0004982; F:N-formyl peptide receptor activity; IEA:InterPro
Q9HC97	GPR35	G-protein coupled receptor 35	GO:0004930; F:G-protein coupled receptor activity; IDA:UniProtKB
Q9HC97	GPR35	G-protein coupled receptor 35	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:UniProtKB
Q9UPC5	GPR34	Probable G-protein coupled receptor 34	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q9UPC5	GPR34	Probable G-protein coupled receptor 34	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
O15354	GPR37	Prosaposin receptor GPR37	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O15354	GPR37	Prosaposin receptor GPR37	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
O43194	GPR39	G-protein coupled receptor 39	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O43194	GPR39	G-protein coupled receptor 39	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43194	GPR39	G-protein coupled receptor 39	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P46089	GPR3	G-protein coupled receptor 3	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P46089	GPR3	G-protein coupled receptor 3	GO:0005515; F:protein binding; IPI:IntAct
P46089	GPR3	G-protein coupled receptor 3	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; TAS:ProtInc
P46089	GPR3	G-protein coupled receptor 3	GO:0040020; P:regulation of meiosis; IEA:Ensembl
O15529	GPR42	G-protein coupled receptor 42	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O15529	GPR42	G-protein coupled receptor 42	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q9Y5Y3	GPR45	Probable G-protein coupled receptor 45	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P46093	GPR4	G-protein coupled receptor 4	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P46093	GPR4	G-protein coupled receptor 4	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q9Y2T5	GPR52	Probable G-protein coupled receptor 52	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q9Y2T5	GPR52	Probable G-protein coupled receptor 52	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q9Y2T6	GPR55	G-protein coupled receptor 55	GO:0004949; F:cannabinoid receptor activity; IDA:UniProtKB
Q9Y2T6	GPR55	G-protein coupled receptor 55	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q9Y2T6	GPR55	G-protein coupled receptor 55	GO:0007202; P:activation of phospholipase C activity; IDA:UniProtKB
Q9Y2T6	GPR55	G-protein coupled receptor 55	GO:0045453; P:bone resorption; IDA:UniProtKB
Q9Y2T6	GPR55	G-protein coupled receptor 55	GO:0038171; P:cannabinoid signaling pathway; IDA:GOC
Q9Y2T6	GPR55	G-protein coupled receptor 55	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q9Y2T6	GPR55	G-protein coupled receptor 55	GO:0045671; P:negative regulation of osteoclast differentiation; IDA:UniProtKB
Q9Y2T6	GPR55	G-protein coupled receptor 55	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
Q9Y2T6	GPR55	G-protein coupled receptor 55	GO:0035025; P:positive regulation of Rho protein signal transduction; IDA:UniProtKB
Q9Y653	GPR56	G-protein coupled receptor 56	GO:0005518; F:collagen binding; ISS:UniProtKB
Q9Y653	GPR56	G-protein coupled receptor 56	GO:0050840; F:extracellular matrix binding; ISS:UniProtKB
Q9Y653	GPR56	G-protein coupled receptor 56	GO:0004930; F:G-protein coupled receptor activity; ISS:UniProtKB
Q9Y653	GPR56	G-protein coupled receptor 56	GO:0001525; P:angiogenesis; IDA:UniProtKB
Q9Y653	GPR56	G-protein coupled receptor 56	GO:0007420; P:brain development; IMP:GDB
Q9Y653	GPR56	G-protein coupled receptor 56	GO:0007155; P:cell adhesion; IDA:GDB
Q9Y653	GPR56	G-protein coupled receptor 56	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9Y653	GPR56	G-protein coupled receptor 56	GO:0021801; P:cerebral cortex radial glia guided migration; ISS:UniProtKB
Q9Y653	GPR56	G-protein coupled receptor 56	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q9Y653	GPR56	G-protein coupled receptor 56	GO:0021819; P:layer formation in cerebral cortex; ISS:UniProtKB
Q9Y653	GPR56	G-protein coupled receptor 56	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q9Y653	GPR56	G-protein coupled receptor 56	GO:2001223; P:negative regulation of neuron migration; ISS:UniProtKB
Q9Y653	GPR56	G-protein coupled receptor 56	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q9Y653	GPR56	G-protein coupled receptor 56	GO:0045785; P:positive regulation of cell adhesion; IDA:UniProtKB
Q9Y653	GPR56	G-protein coupled receptor 56	GO:0035025; P:positive regulation of Rho protein signal transduction; ISS:UniProtKB
Q9Y653	GPR56	G-protein coupled receptor 56	GO:0070528; P:protein kinase C signaling; IDA:UniProtKB
Q9Y653	GPR56	G-protein coupled receptor 56	GO:0007266; P:Rho protein signal transduction; IDA:UniProtKB
Q9Y653	GPR56	G-protein coupled receptor 56	GO:0010573; P:vascular endothelial growth factor production; IDA:UniProtKB
Q9BZJ7	GPR62	Probable G-protein coupled receptor 62	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9BZJ6	GPR63	Probable G-protein coupled receptor 63	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8IZP9	GPR64	G-protein coupled receptor 64	GO:0004930; F:G-protein coupled receptor activity; IEA:InterPro
Q8IZP9	GPR64	G-protein coupled receptor 64	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q8IZP9	GPR64	G-protein coupled receptor 64	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q8IZP9	GPR64	G-protein coupled receptor 64	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q9BZJ8	GPR61	Probable G-protein coupled receptor 61	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P46095	GPR6	G-protein coupled receptor 6	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P46095	GPR6	G-protein coupled receptor 6	GO:0038036; F:sphingosine-1-phosphate receptor activity; IEA:Ensembl
P46095	GPR6	G-protein coupled receptor 6	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P46095	GPR6	G-protein coupled receptor 6	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
O95800	GPR75	Probable G-protein coupled receptor 75	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O95800	GPR75	Probable G-protein coupled receptor 75	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q96P69	GPR78	G-protein coupled receptor 78	GO:0004930; F:G-protein coupled receptor activity; IDA:UniProtKB
Q96P69	GPR78	G-protein coupled receptor 78	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IDA:UniProtKB
Q96P67	GPR82	Probable G-protein coupled receptor 82	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9NYM4	GPR83	Probable G-protein coupled receptor 83	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q9NYM4	GPR83	Probable G-protein coupled receptor 83	GO:0004983; F:neuropeptide Y receptor activity; IEA:InterPro
Q9NYM4	GPR83	Probable G-protein coupled receptor 83	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
Q9NQS5	GPR84	G-protein coupled receptor 84	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P60893	GPR85	Probable G-protein coupled receptor 85	GO:0004930; F:G-protein coupled receptor activity; TAS:UniProtKB
P60893	GPR85	Probable G-protein coupled receptor 85	GO:0007165; P:signal transduction; TAS:UniProtKB
Q9GZN0	GPR88	Probable G-protein coupled receptor 88	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9GZN0	GPR88	Probable G-protein coupled receptor 88	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
Q9GZN0	GPR88	Probable G-protein coupled receptor 88	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q9GZN0	GPR88	Probable G-protein coupled receptor 88	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q9GZN0	GPR88	Probable G-protein coupled receptor 88	GO:0019228; P:neuronal action potential; IEA:Ensembl
Q9BY21	GPR87	G-protein coupled receptor 87	GO:0045028; F:G-protein coupled purinergic nucleotide receptor activity; IEA:InterPro
Q9BY21	GPR87	G-protein coupled receptor 87	GO:0007194; P:negative regulation of adenylate cyclase activity; IEA:InterPro
Q86Y34	GPR97	Probable G-protein coupled receptor 97	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q86Y34	GPR97	Probable G-protein coupled receptor 97	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q8WXG9	GPR98	G-protein coupled receptor 98	GO:0005509; F:calcium ion binding; IDA:HGNC
Q8WXG9	GPR98	G-protein coupled receptor 98	GO:0004930; F:G-protein coupled receptor activity; NAS:UniProtKB
Q8WXG9	GPR98	G-protein coupled receptor 98	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WXG9	GPR98	G-protein coupled receptor 98	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
Q8WXG9	GPR98	G-protein coupled receptor 98	GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; IEA:Ensembl
Q8WXG9	GPR98	G-protein coupled receptor 98	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q8WXG9	GPR98	G-protein coupled receptor 98	GO:0060122; P:inner ear receptor stereocilium organization; IEA:Ensembl
Q8WXG9	GPR98	G-protein coupled receptor 98	GO:0048496; P:maintenance of organ identity; IMP:HGNC
Q8WXG9	GPR98	G-protein coupled receptor 98	GO:0007399; P:nervous system development; NAS:UniProtKB
Q8WXG9	GPR98	G-protein coupled receptor 98	GO:0050877; P:neurological system process; IMP:HGNC
Q8WXG9	GPR98	G-protein coupled receptor 98	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q8WXG9	GPR98	G-protein coupled receptor 98	GO:0045494; P:photoreceptor cell maintenance; IMP:HGNC
Q8WXG9	GPR98	G-protein coupled receptor 98	GO:0050953; P:sensory perception of light stimulus; IMP:HGNC
Q8WXG9	GPR98	G-protein coupled receptor 98	GO:0007605; P:sensory perception of sound; IMP:HGNC
Q8WXG9	GPR98	G-protein coupled receptor 98	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q6UWM5	GLIPR1L1	GLIPR1-like protein 1	GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl
Q13227	GPS2	G protein pathway suppressor 2	GO:0005095; F:GTPase inhibitor activity; TAS:ProtInc
Q13227	GPS2	G protein pathway suppressor 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q13227	GPS2	G protein pathway suppressor 2	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q13227	GPS2	G protein pathway suppressor 2	GO:0007049; P:cell cycle; TAS:ProtInc
Q13227	GPS2	G protein pathway suppressor 2	GO:0000188; P:inactivation of MAPK activity; TAS:ProtInc
Q13227	GPS2	G protein pathway suppressor 2	GO:0007254; P:JNK cascade; TAS:ProtInc
Q13227	GPS2	G protein pathway suppressor 2	GO:0046329; P:negative regulation of JNK cascade; IDA:UniProtKB
Q13227	GPS2	G protein pathway suppressor 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q86YR5	GPSM1	G-protein-signaling modulator 1	GO:0005092; F:GDP-dissociation inhibitor activity; IEA:InterPro
Q86YR5	GPSM1	G-protein-signaling modulator 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q86YR5	GPSM1	G-protein-signaling modulator 1	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q86YR5	GPSM1	G-protein-signaling modulator 1	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; IEA:InterPro
P81274	GPSM2	G-protein-signaling modulator 2	GO:0030695; F:GTPase regulator activity; IEA:InterPro
P81274	GPSM2	G-protein-signaling modulator 2	GO:0042802; F:identical protein binding; IPI:IntAct
P81274	GPSM2	G-protein-signaling modulator 2	GO:0005515; F:protein binding; IPI:UniProtKB
P81274	GPSM2	G-protein-signaling modulator 2	GO:0000132; P:establishment of mitotic spindle orientation; IEA:Ensembl
P81274	GPSM2	G-protein-signaling modulator 2	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P81274	GPSM2	G-protein-signaling modulator 2	GO:0060487; P:lung epithelial cell differentiation; IEA:Ensembl
Q9Y4H4	GPSM3	G-protein-signaling modulator 3	GO:0030695; F:GTPase regulator activity; IEA:InterPro
Q8N954	GPATCH11	G patch domain-containing protein 11	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9NWQ4	GPATCH2L	G patch domain-containing protein 2-like	GO:0005515; F:protein binding; IPI:IntAct
Q9BRR8	GPATCH1	G patch domain-containing protein 1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9BRR8	GPATCH1	G patch domain-containing protein 1	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q9NW75	GPATCH2	G patch domain-containing protein 2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9NW75	GPATCH2	G patch domain-containing protein 2	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q96I76	GPATCH3	G patch domain-containing protein 3	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q5T3I0	GPATCH4	G patch domain-containing protein 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UKJ3	GPATCH8	G patch domain-containing protein 8	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UKJ3	GPATCH8	G patch domain-containing protein 8	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UKJ3	GPATCH8	G patch domain-containing protein 8	GO:0005515; F:protein binding; IPI:IntAct
Q9H3H5	DPAGT1	UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase	GO:0008963; F:phospho-N-acetylmuramoyl-pentapeptide-transferase activity; IEA:InterPro
Q9H3H5	DPAGT1	UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase	GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW
Q9H3H5	DPAGT1	UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase	GO:0003975; F:UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity; IDA:UniProtKB
Q9H3H5	DPAGT1	UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9H3H5	DPAGT1	UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase	GO:0019408; P:dolichol biosynthetic process; IDA:UniProtKB
Q9H3H5	DPAGT1	UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q9H3H5	DPAGT1	UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9H3H5	DPAGT1	UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase	GO:0006487; P:protein N-linked glycosylation; IMP:UniProtKB
Q9H3H5	DPAGT1	UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9H3H5	DPAGT1	UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase	GO:0051259; P:protein oligomerization; ISS:UniProtKB
Q9H3H5	DPAGT1	UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase	GO:0006047; P:UDP-N-acetylglucosamine metabolic process; IEA:Ensembl
Q9HCN6	GP6	Platelet glycoprotein VI	GO:0005518; F:collagen binding; TAS:UniProtKB
Q9HCN6	GP6	Platelet glycoprotein VI	GO:0005515; F:protein binding; IPI:IntAct
Q9HCN6	GP6	Platelet glycoprotein VI	GO:0004872; F:receptor activity; TAS:UniProtKB
Q9HCN6	GP6	Platelet glycoprotein VI	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q9HCN6	GP6	Platelet glycoprotein VI	GO:0007596; P:blood coagulation; TAS:Reactome
Q9HCN6	GP6	Platelet glycoprotein VI	GO:0007167; P:enzyme linked receptor protein signaling pathway; TAS:ProtInc
Q9HCN6	GP6	Platelet glycoprotein VI	GO:0050900; P:leukocyte migration; TAS:Reactome
Q9HCN6	GP6	Platelet glycoprotein VI	GO:0030168; P:platelet activation; NAS:UniProtKB
P40197	GP5	Platelet glycoprotein V	GO:0007596; P:blood coagulation; TAS:Reactome
P40197	GP5	Platelet glycoprotein V	GO:0007597; P:blood coagulation, intrinsic pathway; TAS:Reactome
P40197	GP5	Platelet glycoprotein V	GO:0007155; P:cell adhesion; NAS:ProtInc
P40197	GP5	Platelet glycoprotein V	GO:0007160; P:cell-matrix adhesion; IEA:Ensembl
P40197	GP5	Platelet glycoprotein V	GO:0010544; P:negative regulation of platelet activation; IEA:Ensembl
P40197	GP5	Platelet glycoprotein V	GO:0030168; P:platelet activation; TAS:Reactome
P07203	GPX1	Glutathione peroxidase 1	GO:0043295; F:glutathione binding; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0004602; F:glutathione peroxidase activity; IDA:BHF-UCL
P07203	GPX1	Glutathione peroxidase 1	GO:0047066; F:phospholipid-hydroperoxide glutathione peroxidase activity; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0008430; F:selenium binding; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0017124; F:SH3 domain binding; IPI:BHF-UCL
P07203	GPX1	Glutathione peroxidase 1	GO:0007568; P:aging; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0060055; P:angiogenesis involved in wound healing; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P07203	GPX1	Glutathione peroxidase 1	GO:0043534; P:blood vessel endothelial cell migration; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0045454; P:cell redox homeostasis; IDA:BHF-UCL
P07203	GPX1	Glutathione peroxidase 1	GO:0001885; P:endothelial cell development; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0045444; P:fat cell differentiation; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0006749; P:glutathione metabolic process; IDA:BHF-UCL
P07203	GPX1	Glutathione peroxidase 1	GO:0060047; P:heart contraction; IMP:BHF-UCL
P07203	GPX1	Glutathione peroxidase 1	GO:0042744; P:hydrogen peroxide catabolic process; IDA:BHF-UCL
P07203	GPX1	Glutathione peroxidase 1	GO:0051702; P:interaction with symbiont; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0019372; P:lipoxygenase pathway; TAS:Reactome
P07203	GPX1	Glutathione peroxidase 1	GO:0051450; P:myoblast proliferation; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:BHF-UCL
P07203	GPX1	Glutathione peroxidase 1	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IMP:BHF-UCL
P07203	GPX1	Glutathione peroxidase 1	GO:0002862; P:negative regulation of inflammatory response to antigenic stimulus; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:1902176; P:negative regulation of intrinsic apoptotic signaling pathway in response to oxidative stress; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; IMP:BHF-UCL
P07203	GPX1	Glutathione peroxidase 1	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P07203	GPX1	Glutathione peroxidase 1	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0018158; P:protein oxidation; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P07203	GPX1	Glutathione peroxidase 1	GO:0006195; P:purine nucleotide catabolic process; TAS:Reactome
P07203	GPX1	Glutathione peroxidase 1	GO:0040029; P:regulation of gene expression, epigenetic; IDA:BHF-UCL
P07203	GPX1	Glutathione peroxidase 1	GO:0033599; P:regulation of mammary gland epithelial cell proliferation; IMP:BHF-UCL
P07203	GPX1	Glutathione peroxidase 1	GO:0043523; P:regulation of neuron apoptotic process; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0061136; P:regulation of proteasomal protein catabolic process; IDA:BHF-UCL
P07203	GPX1	Glutathione peroxidase 1	GO:0032355; P:response to estradiol; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0051593; P:response to folic acid; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0010332; P:response to gamma radiation; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0009749; P:response to glucose; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0042542; P:response to hydrogen peroxide; IMP:BHF-UCL
P07203	GPX1	Glutathione peroxidase 1	GO:0006982; P:response to lipid hydroperoxide; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0035094; P:response to nicotine; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0010269; P:response to selenium ion; IMP:BHF-UCL
P07203	GPX1	Glutathione peroxidase 1	GO:0009609; P:response to symbiotic bacterium; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0009636; P:response to toxic substance; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0009410; P:response to xenobiotic stimulus; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0007605; P:sensory perception of sound; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0048741; P:skeletal muscle fiber development; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0043403; P:skeletal muscle tissue regeneration; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P07203	GPX1	Glutathione peroxidase 1	GO:0001659; P:temperature homeostasis; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0006641; P:triglyceride metabolic process; IEA:Ensembl
P07203	GPX1	Glutathione peroxidase 1	GO:0009650; P:UV protection; IMP:BHF-UCL
P07203	GPX1	Glutathione peroxidase 1	GO:0042311; P:vasodilation; IEA:Ensembl
P18283	GPX2	Glutathione peroxidase 2	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P18283	GPX2	Glutathione peroxidase 2	GO:0004602; F:glutathione peroxidase activity; TAS:Reactome
P18283	GPX2	Glutathione peroxidase 2	GO:0051702; P:interaction with symbiont; IEA:Ensembl
P18283	GPX2	Glutathione peroxidase 2	GO:0002862; P:negative regulation of inflammatory response to antigenic stimulus; IEA:Ensembl
P18283	GPX2	Glutathione peroxidase 2	GO:0006979; P:response to oxidative stress; IEA:InterPro
P18283	GPX2	Glutathione peroxidase 2	GO:0009609; P:response to symbiotic bacterium; IEA:Ensembl
P18283	GPX2	Glutathione peroxidase 2	GO:0001659; P:temperature homeostasis; IEA:Ensembl
P22352	GPX3	Glutathione peroxidase 3	GO:0004602; F:glutathione peroxidase activity; IDA:UniProtKB
P22352	GPX3	Glutathione peroxidase 3	GO:0008430; F:selenium binding; IDA:UniProtKB
P22352	GPX3	Glutathione peroxidase 3	GO:0008134; F:transcription factor binding; TAS:UniProtKB
P22352	GPX3	Glutathione peroxidase 3	GO:0042744; P:hydrogen peroxide catabolic process; TAS:UniProtKB
P22352	GPX3	Glutathione peroxidase 3	GO:0051289; P:protein homotetramerization; IDA:UniProtKB
P22352	GPX3	Glutathione peroxidase 3	GO:0006982; P:response to lipid hydroperoxide; TAS:UniProtKB
P36969	GPX4	Phospholipid hydroperoxide glutathione peroxidase, mitochondrial	GO:0043295; F:glutathione binding; IEA:Ensembl
P36969	GPX4	Phospholipid hydroperoxide glutathione peroxidase, mitochondrial	GO:0004602; F:glutathione peroxidase activity; TAS:UniProtKB
P36969	GPX4	Phospholipid hydroperoxide glutathione peroxidase, mitochondrial	GO:0047066; F:phospholipid-hydroperoxide glutathione peroxidase activity; IEA:UniProtKB-EC
P36969	GPX4	Phospholipid hydroperoxide glutathione peroxidase, mitochondrial	GO:0008430; F:selenium binding; IEA:Ensembl
P36969	GPX4	Phospholipid hydroperoxide glutathione peroxidase, mitochondrial	GO:0007568; P:aging; IEA:Ensembl
P36969	GPX4	Phospholipid hydroperoxide glutathione peroxidase, mitochondrial	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P36969	GPX4	Phospholipid hydroperoxide glutathione peroxidase, mitochondrial	GO:0006325; P:chromatin organization; IEA:Ensembl
P36969	GPX4	Phospholipid hydroperoxide glutathione peroxidase, mitochondrial	GO:0006749; P:glutathione metabolic process; IEA:Ensembl
P36969	GPX4	Phospholipid hydroperoxide glutathione peroxidase, mitochondrial	GO:0042744; P:hydrogen peroxide catabolic process; IEA:Ensembl
P36969	GPX4	Phospholipid hydroperoxide glutathione peroxidase, mitochondrial	GO:0019372; P:lipoxygenase pathway; TAS:Reactome
P36969	GPX4	Phospholipid hydroperoxide glutathione peroxidase, mitochondrial	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P36969	GPX4	Phospholipid hydroperoxide glutathione peroxidase, mitochondrial	GO:0055114; P:oxidation-reduction process; TAS:UniProtKB
P36969	GPX4	Phospholipid hydroperoxide glutathione peroxidase, mitochondrial	GO:0006644; P:phospholipid metabolic process; TAS:UniProtKB
P36969	GPX4	Phospholipid hydroperoxide glutathione peroxidase, mitochondrial	GO:0050727; P:regulation of inflammatory response; IEA:Ensembl
P36969	GPX4	Phospholipid hydroperoxide glutathione peroxidase, mitochondrial	GO:0032355; P:response to estradiol; IEA:Ensembl
P36969	GPX4	Phospholipid hydroperoxide glutathione peroxidase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P36969	GPX4	Phospholipid hydroperoxide glutathione peroxidase, mitochondrial	GO:0007283; P:spermatogenesis; IEA:Ensembl
O75715	GPX5	Epididymal secretory glutathione peroxidase	GO:0004602; F:glutathione peroxidase activity; IEA:UniProtKB-EC
O75715	GPX5	Epididymal secretory glutathione peroxidase	GO:0006629; P:lipid metabolic process; NAS:ProtInc
O75715	GPX5	Epididymal secretory glutathione peroxidase	GO:0006979; P:response to oxidative stress; IEA:InterPro
P59796	GPX6	Glutathione peroxidase 6	GO:0004602; F:glutathione peroxidase activity; IEA:UniProtKB-EC
P59796	GPX6	Glutathione peroxidase 6	GO:0006979; P:response to oxidative stress; IEA:InterPro
Q96SL4	GPX7	Glutathione peroxidase 7	GO:0004602; F:glutathione peroxidase activity; IEA:UniProtKB-EC
Q96SL4	GPX7	Glutathione peroxidase 7	GO:0004601; F:peroxidase activity; EXP:Reactome
Q96SL4	GPX7	Glutathione peroxidase 7	GO:0006979; P:response to oxidative stress; IEA:InterPro
Q8TED1	GPX8	Probable glutathione peroxidase 8	GO:0004602; F:glutathione peroxidase activity; IEA:UniProtKB-EC
Q8TED1	GPX8	Probable glutathione peroxidase 8	GO:0004601; F:peroxidase activity; EXP:Reactome
Q8TED1	GPX8	Probable glutathione peroxidase 8	GO:0006979; P:response to oxidative stress; IEA:InterPro
P12544	GZMA	Granzyme A	GO:0005515; F:protein binding; IPI:UniProtKB
P12544	GZMA	Granzyme A	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P12544	GZMA	Granzyme A	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
P12544	GZMA	Granzyme A	GO:0006915; P:apoptotic process; TAS:UniProtKB
P12544	GZMA	Granzyme A	GO:0019835; P:cytolysis; IEA:UniProtKB-KW
P12544	GZMA	Granzyme A	GO:0006955; P:immune response; TAS:UniProtKB
P12544	GZMA	Granzyme A	GO:0043392; P:negative regulation of DNA binding; IDA:UniProtKB
P12544	GZMA	Granzyme A	GO:0032078; P:negative regulation of endodeoxyribonuclease activity; IDA:UniProtKB
P12544	GZMA	Granzyme A	GO:0051354; P:negative regulation of oxidoreductase activity; IDA:UniProtKB
P12544	GZMA	Granzyme A	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P12544	GZMA	Granzyme A	GO:0051603; P:proteolysis involved in cellular protein catabolic process; IDA:UniProtKB
P10144	GZMB	Granzyme B	GO:0005515; F:protein binding; IPI:UniProtKB
P10144	GZMB	Granzyme B	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
P10144	GZMB	Granzyme B	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
P10144	GZMB	Granzyme B	GO:0006915; P:apoptotic process; TAS:UniProtKB
P10144	GZMB	Granzyme B	GO:0019835; P:cytolysis; IEA:UniProtKB-KW
P10144	GZMB	Granzyme B	GO:0008626; P:granzyme-mediated apoptotic signaling pathway; IBA:RefGenome
P10144	GZMB	Granzyme B	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
P10144	GZMB	Granzyme B	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P10144	GZMB	Granzyme B	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
P10144	GZMB	Granzyme B	GO:0006508; P:proteolysis; IBA:RefGenome
P20718	GZMH	Granzyme H	GO:0004252; F:serine-type endopeptidase activity; NAS:UniProtKB
P20718	GZMH	Granzyme H	GO:0006915; P:apoptotic process; NAS:UniProtKB
P20718	GZMH	Granzyme H	GO:0019835; P:cytolysis; IEA:UniProtKB-KW
P20718	GZMH	Granzyme H	GO:0006508; P:proteolysis; IBA:RefGenome
P49863	GZMK	Granzyme K	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
P49863	GZMK	Granzyme K	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
Q6IC98	GRAMD4	GRAM domain-containing protein 4	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P51124	GZMM	Granzyme M	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
P51124	GZMM	Granzyme M	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
P51124	GZMM	Granzyme M	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P51124	GZMM	Granzyme M	GO:0019835; P:cytolysis; IEA:UniProtKB-KW
P51124	GZMM	Granzyme M	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
P28676	GCA	Grancalcin	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P28676	GCA	Grancalcin	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; IBA:RefGenome
P28676	GCA	Grancalcin	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P28676	GCA	Grancalcin	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P28676	GCA	Grancalcin	GO:0061025; P:membrane fusion; TAS:ProtInc
P28676	GCA	Grancalcin	GO:0006508; P:proteolysis; IBA:RefGenome
O75791	GRAP2	GRB2-related adapter protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
O75791	GRAP2	GRB2-related adapter protein 2	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
O75791	GRAP2	GRB2-related adapter protein 2	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O75791	GRAP2	GRB2-related adapter protein 2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O75791	GRAP2	GRB2-related adapter protein 2	GO:0045087; P:innate immune response; TAS:Reactome
O75791	GRAP2	GRB2-related adapter protein 2	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
O75791	GRAP2	GRB2-related adapter protein 2	GO:0007265; P:Ras protein signal transduction; TAS:ProtInc
O75791	GRAP2	GRB2-related adapter protein 2	GO:0031295; P:T cell costimulation; TAS:Reactome
O75791	GRAP2	GRB2-related adapter protein 2	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q13588	GRAP	GRB2-related adapter protein	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
Q13588	GRAP	GRB2-related adapter protein	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q13588	GRAP	GRB2-related adapter protein	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
Q13588	GRAP	GRB2-related adapter protein	GO:0007265; P:Ras protein signal transduction; TAS:ProtInc
Q7Z6J2	GRASP	General receptor for phosphoinositides 1-associated scaffold protein	GO:0008104; P:protein localization; IEA:Ensembl
Q7Z6J2	GRASP	General receptor for phosphoinositides 1-associated scaffold protein	GO:0007165; P:signal transduction; IEA:Ensembl
Q13322	GRB10	Growth factor receptor-bound protein 10	GO:0005158; F:insulin receptor binding; ISS:BHF-UCL
Q13322	GRB10	Growth factor receptor-bound protein 10	GO:0005515; F:protein binding; IPI:UniProtKB
Q13322	GRB10	Growth factor receptor-bound protein 10	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
Q13322	GRB10	Growth factor receptor-bound protein 10	GO:0008286; P:insulin receptor signaling pathway; ISS:BHF-UCL
Q13322	GRB10	Growth factor receptor-bound protein 10	GO:0048009; P:insulin-like growth factor receptor signaling pathway; IEA:Ensembl
Q13322	GRB10	Growth factor receptor-bound protein 10	GO:0046325; P:negative regulation of glucose import; ISS:BHF-UCL
Q13322	GRB10	Growth factor receptor-bound protein 10	GO:0045719; P:negative regulation of glycogen biosynthetic process; IEA:Ensembl
Q13322	GRB10	Growth factor receptor-bound protein 10	GO:0046627; P:negative regulation of insulin receptor signaling pathway; ISS:BHF-UCL
Q13322	GRB10	Growth factor receptor-bound protein 10	GO:0042326; P:negative regulation of phosphorylation; IEA:Ensembl
Q13322	GRB10	Growth factor receptor-bound protein 10	GO:0030178; P:negative regulation of Wnt signaling pathway; IDA:UniProtKB
Q13322	GRB10	Growth factor receptor-bound protein 10	GO:0042327; P:positive regulation of phosphorylation; IEA:Ensembl
Q13322	GRB10	Growth factor receptor-bound protein 10	GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; IDA:UniProtKB
Q13322	GRB10	Growth factor receptor-bound protein 10	GO:0032868; P:response to insulin; ISS:BHF-UCL
Q14449	GRB14	Growth factor receptor-bound protein 14	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
Q14449	GRB14	Growth factor receptor-bound protein 14	GO:0007596; P:blood coagulation; TAS:Reactome
Q14449	GRB14	Growth factor receptor-bound protein 14	GO:0050900; P:leukocyte migration; TAS:Reactome
Q14449	GRB14	Growth factor receptor-bound protein 14	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
Q14449	GRB14	Growth factor receptor-bound protein 14	GO:0007165; P:signal transduction; TAS:ProtInc
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0046875; F:ephrin receptor binding; IPI:UniProtKB
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0005154; F:epidermal growth factor receptor binding; IPI:UniProtKB
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0042802; F:identical protein binding; IPI:IntAct
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0043560; F:insulin receptor substrate binding; IPI:UniProtKB
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0005168; F:neurotrophin TRKA receptor binding; IPI:UniProtKB
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0017124; F:SH3 domain binding; IDA:UniProtKB
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0005070; F:SH3/SH2 adaptor activity; TAS:UniProtKB
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0007568; P:aging; IEA:Ensembl
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0048646; P:anatomical structure formation involved in morphogenesis; IEA:Ensembl
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0007411; P:axon guidance; TAS:Reactome
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0007596; P:blood coagulation; TAS:Reactome
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0060670; P:branching involved in labyrinthine layer morphogenesis; IEA:Ensembl
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0007267; P:cell-cell signaling; TAS:UniProtKB
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0071479; P:cellular response to ionizing radiation; IMP:BHF-UCL
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:UniProtKB
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0045087; P:innate immune response; TAS:Reactome
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0008286; P:insulin receptor signaling pathway; IPI:UniProtKB
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0050900; P:leukocyte migration; TAS:Reactome
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0030168; P:platelet activation; TAS:Reactome
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0030838; P:positive regulation of actin filament polymerization; IEA:Ensembl
P62993	GRB2	Growth factor receptor-bound protein 2	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IMP:BHF-UCL
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0007265; P:Ras protein signal transduction; TAS:UniProtKB
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0031623; P:receptor internalization; IMP:BHF-UCL
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0043408; P:regulation of MAPK cascade; IEA:Ensembl
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0042770; P:signal transduction in response to DNA damage; IMP:BHF-UCL
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0031295; P:T cell costimulation; TAS:Reactome
P62993	GRB2	Growth factor receptor-bound protein 2	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q14451	GRB7	Growth factor receptor-bound protein 7	GO:0042802; F:identical protein binding; IPI:IntAct
Q14451	GRB7	Growth factor receptor-bound protein 7	GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB
Q14451	GRB7	Growth factor receptor-bound protein 7	GO:0005515; F:protein binding; IPI:IntAct
Q14451	GRB7	Growth factor receptor-bound protein 7	GO:0019901; F:protein kinase binding; IDA:UniProtKB
Q14451	GRB7	Growth factor receptor-bound protein 7	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q14451	GRB7	Growth factor receptor-bound protein 7	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
Q14451	GRB7	Growth factor receptor-bound protein 7	GO:0007596; P:blood coagulation; TAS:Reactome
Q14451	GRB7	Growth factor receptor-bound protein 7	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:ProtInc
Q14451	GRB7	Growth factor receptor-bound protein 7	GO:0050900; P:leukocyte migration; TAS:Reactome
Q14451	GRB7	Growth factor receptor-bound protein 7	GO:0017148; P:negative regulation of translation; ISS:UniProtKB
Q14451	GRB7	Growth factor receptor-bound protein 7	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
Q14451	GRB7	Growth factor receptor-bound protein 7	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
Q14451	GRB7	Growth factor receptor-bound protein 7	GO:0034063; P:stress granule assembly; ISS:UniProtKB
A8MXD5	GRXCR1	Glutaredoxin domain-containing cysteine-rich protein 1	GO:0009055; F:electron carrier activity; IEA:InterPro
A8MXD5	GRXCR1	Glutaredoxin domain-containing cysteine-rich protein 1	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
A8MXD5	GRXCR1	Glutaredoxin domain-containing cysteine-rich protein 1	GO:0042491; P:auditory receptor cell differentiation; IEA:Ensembl
A8MXD5	GRXCR1	Glutaredoxin domain-containing cysteine-rich protein 1	GO:0045454; P:cell redox homeostasis; IEA:InterPro
A8MXD5	GRXCR1	Glutaredoxin domain-containing cysteine-rich protein 1	GO:0060119; P:inner ear receptor cell development; ISS:UniProtKB
A8MXD5	GRXCR1	Glutaredoxin domain-containing cysteine-rich protein 1	GO:0060122; P:inner ear receptor stereocilium organization; ISS:UniProtKB
A8MXD5	GRXCR1	Glutaredoxin domain-containing cysteine-rich protein 1	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
A8MXD5	GRXCR1	Glutaredoxin domain-containing cysteine-rich protein 1	GO:0048563; P:post-embryonic organ morphogenesis; IEA:Ensembl
A8MXD5	GRXCR1	Glutaredoxin domain-containing cysteine-rich protein 1	GO:0007605; P:sensory perception of sound; ISS:UniProtKB
A8MXD5	GRXCR1	Glutaredoxin domain-containing cysteine-rich protein 1	GO:0060118; P:vestibular receptor cell development; ISS:UniProtKB
A4D2P6	GRID2IP	Delphilin	GO:0060292; P:long term synaptic depression; IEA:Ensembl
Q3V6T2	CCDC88A	Girdin	GO:0003779; F:actin binding; IDA:UniProtKB
Q3V6T2	CCDC88A	Girdin	GO:0008017; F:microtubule binding; ISS:UniProtKB
Q3V6T2	CCDC88A	Girdin	GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB
Q3V6T2	CCDC88A	Girdin	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q3V6T2	CCDC88A	Girdin	GO:0043422; F:protein kinase B binding; IPI:UniProtKB
Q3V6T2	CCDC88A	Girdin	GO:0032148; P:activation of protein kinase B activity; ISS:UniProtKB
Q3V6T2	CCDC88A	Girdin	GO:0016477; P:cell migration; IMP:UniProtKB
Q3V6T2	CCDC88A	Girdin	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q3V6T2	CCDC88A	Girdin	GO:0030032; P:lamellipodium assembly; IMP:UniProtKB
Q3V6T2	CCDC88A	Girdin	GO:0061024; P:membrane organization; IDA:UniProtKB
Q3V6T2	CCDC88A	Girdin	GO:0032956; P:regulation of actin cytoskeleton organization; IMP:UniProtKB
Q3V6T2	CCDC88A	Girdin	GO:0042127; P:regulation of cell proliferation; ISS:UniProtKB
Q3V6T2	CCDC88A	Girdin	GO:0006275; P:regulation of DNA replication; ISS:UniProtKB
Q3V6T2	CCDC88A	Girdin	GO:0010975; P:regulation of neuron projection development; ISS:UniProtKB
Q3V6T2	CCDC88A	Girdin	GO:0001932; P:regulation of protein phosphorylation; ISS:UniProtKB
Q3V6T2	CCDC88A	Girdin	GO:0031929; P:TOR signaling; ISS:UniProtKB
Q9H772	GREM2	Gremlin-2	GO:0008201; F:heparin binding; ISS:UniProtKB
Q9H772	GREM2	Gremlin-2	GO:0030509; P:BMP signaling pathway; TAS:Reactome
Q9H772	GREM2	Gremlin-2	GO:0019221; P:cytokine-mediated signaling pathway; ISS:UniProtKB
Q9H772	GREM2	Gremlin-2	GO:0010172; P:embryonic body morphogenesis; ISS:UniProtKB
Q9H772	GREM2	Gremlin-2	GO:0060300; P:regulation of cytokine activity; ISS:UniProtKB
O60565	GREM1	Gremlin-1	GO:0036122; F:BMP binding; ISS:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0016015; F:morphogen activity; ISS:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0005515; F:protein binding; IPI:IntAct
O60565	GREM1	Gremlin-1	GO:0048018; F:receptor agonist activity; ISS:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0030297; F:transmembrane receptor protein tyrosine kinase activator activity; ISS:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0043184; F:vascular endothelial growth factor receptor 2 binding; ISS:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0007171; P:activation of transmembrane receptor protein tyrosine kinase activity; ISS:GOC
O60565	GREM1	Gremlin-1	GO:0006915; P:apoptotic process; IEA:Ensembl
O60565	GREM1	Gremlin-1	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
O60565	GREM1	Gremlin-1	GO:0002042; P:cell migration involved in sprouting angiogenesis; ISS:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0000902; P:cell morphogenesis; IDA:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0007267; P:cell-cell signaling; IEA:Ensembl
O60565	GREM1	Gremlin-1	GO:0030199; P:collagen fibril organization; IMP:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0048263; P:determination of dorsal identity; IMP:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
O60565	GREM1	Gremlin-1	GO:0003337; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; IEA:Ensembl
O60565	GREM1	Gremlin-1	GO:0030514; P:negative regulation of BMP signaling pathway; IMP:UniProtKB
O60565	GREM1	Gremlin-1	GO:0030502; P:negative regulation of bone mineralization; IMP:BHF-UCL
O60565	GREM1	Gremlin-1	GO:1900158; P:negative regulation of bone mineralization involved in bone maturation; IMP:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0046851; P:negative regulation of bone remodeling; IMP:BHF-UCL
O60565	GREM1	Gremlin-1	GO:1900155; P:negative regulation of bone trabecula formation; IMP:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0090191; P:negative regulation of branching involved in ureteric bud morphogenesis; IEA:Ensembl
O60565	GREM1	Gremlin-1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
O60565	GREM1	Gremlin-1	GO:0090027; P:negative regulation of monocyte chemotaxis; ISS:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0033689; P:negative regulation of osteoblast proliferation; IMP:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0090291; P:negative regulation of osteoclast proliferation; IMP:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0060394; P:negative regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
O60565	GREM1	Gremlin-1	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
O60565	GREM1	Gremlin-1	GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; IEA:Ensembl
O60565	GREM1	Gremlin-1	GO:2000727; P:positive regulation of cardiac muscle cell differentiation; ISS:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0042346; P:positive regulation of NF-kappaB import into nucleus; IEA:Ensembl
O60565	GREM1	Gremlin-1	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:Ensembl
O60565	GREM1	Gremlin-1	GO:1900086; P:positive regulation of peptidyl-tyrosine autophosphorylation; ISS:BHF-UCL
O60565	GREM1	Gremlin-1	GO:2000273; P:positive regulation of receptor activity; ISS:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0002092; P:positive regulation of receptor internalization; ISS:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0051973; P:positive regulation of telomerase activity; IDA:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0003257; P:positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; ISS:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl
O60565	GREM1	Gremlin-1	GO:0010717; P:regulation of epithelial to mesenchymal transition; IMP:UniProtKB
O60565	GREM1	Gremlin-1	GO:0051893; P:regulation of focal adhesion assembly; IEA:Ensembl
O60565	GREM1	Gremlin-1	GO:0007165; P:signal transduction; ISS:BHF-UCL
O60565	GREM1	Gremlin-1	GO:0060676; P:ureteric bud formation; IEA:Ensembl
Q9NZI5	GRHL1	Grainyhead-like protein 1 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NZI5	GRHL1	Grainyhead-like protein 1 homolog	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9NZI5	GRHL1	Grainyhead-like protein 1 homolog	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9NZI5	GRHL1	Grainyhead-like protein 1 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NZI5	GRHL1	Grainyhead-like protein 1 homolog	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NZI5	GRHL1	Grainyhead-like protein 1 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TE85	GRHL3	Grainyhead-like protein 3 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TE85	GRHL3	Grainyhead-like protein 3 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q8TE85	GRHL3	Grainyhead-like protein 3 homolog	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IEA:Ensembl
Q8TE85	GRHL3	Grainyhead-like protein 3 homolog	GO:0007417; P:central nervous system development; IEA:Ensembl
Q8TE85	GRHL3	Grainyhead-like protein 3 homolog	GO:0090103; P:cochlea morphogenesis; IEA:Ensembl
Q8TE85	GRHL3	Grainyhead-like protein 3 homolog	GO:0007398; P:ectoderm development; IEA:Ensembl
Q8TE85	GRHL3	Grainyhead-like protein 3 homolog	GO:0008544; P:epidermis development; IEA:Ensembl
Q8TE85	GRHL3	Grainyhead-like protein 3 homolog	GO:0001736; P:establishment of planar polarity; IEA:Ensembl
Q8TE85	GRHL3	Grainyhead-like protein 3 homolog	GO:0061029; P:eyelid development in camera-type eye; IEA:Ensembl
Q8TE85	GRHL3	Grainyhead-like protein 3 homolog	GO:0007389; P:pattern specification process; IEA:Ensembl
Q8TE85	GRHL3	Grainyhead-like protein 3 homolog	GO:0090179; P:planar cell polarity pathway involved in neural tube closure; IEA:Ensembl
Q8TE85	GRHL3	Grainyhead-like protein 3 homolog	GO:0032321; P:positive regulation of Rho GTPase activity; IEA:Ensembl
Q8TE85	GRHL3	Grainyhead-like protein 3 homolog	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8TE85	GRHL3	Grainyhead-like protein 3 homolog	GO:0032956; P:regulation of actin cytoskeleton organization; IGI:MGI
Q8TE85	GRHL3	Grainyhead-like protein 3 homolog	GO:0042060; P:wound healing; IEA:Ensembl
Q6ISB3	GRHL2	Grainyhead-like protein 2 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ISB3	GRHL2	Grainyhead-like protein 2 homolog	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q6ISB3	GRHL2	Grainyhead-like protein 2 homolog	GO:0001843; P:neural tube closure; IEA:Ensembl
Q6ISB3	GRHL2	Grainyhead-like protein 2 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ISB3	GRHL2	Grainyhead-like protein 2 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UBQ7	GRHPR	Glyoxylate reductase/hydroxypyruvate reductase	GO:0031406; F:carboxylic acid binding; IEA:Ensembl
Q9UBQ7	GRHPR	Glyoxylate reductase/hydroxypyruvate reductase	GO:0008465; F:glycerate dehydrogenase activity; IDA:UniProtKB
Q9UBQ7	GRHPR	Glyoxylate reductase/hydroxypyruvate reductase	GO:0030267; F:glyoxylate reductase (NADP) activity; IDA:UniProtKB
Q9UBQ7	GRHPR	Glyoxylate reductase/hydroxypyruvate reductase	GO:0016618; F:hydroxypyruvate reductase activity; IDA:UniProtKB
Q9UBQ7	GRHPR	Glyoxylate reductase/hydroxypyruvate reductase	GO:0051287; F:NAD binding; TAS:UniProtKB
Q9UBQ7	GRHPR	Glyoxylate reductase/hydroxypyruvate reductase	GO:0070402; F:NADPH binding; IDA:UniProtKB
Q9UBQ7	GRHPR	Glyoxylate reductase/hydroxypyruvate reductase	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q9UBQ7	GRHPR	Glyoxylate reductase/hydroxypyruvate reductase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9UBQ7	GRHPR	Glyoxylate reductase/hydroxypyruvate reductase	GO:0043648; P:dicarboxylic acid metabolic process; IEA:Ensembl
Q9UBQ7	GRHPR	Glyoxylate reductase/hydroxypyruvate reductase	GO:0007588; P:excretion; IMP:UniProtKB
Q9UBQ7	GRHPR	Glyoxylate reductase/hydroxypyruvate reductase	GO:0046487; P:glyoxylate metabolic process; TAS:Reactome
Q9UBQ7	GRHPR	Glyoxylate reductase/hydroxypyruvate reductase	GO:0008152; P:metabolic process; NAS:UniProtKB
Q9UBQ7	GRHPR	Glyoxylate reductase/hydroxypyruvate reductase	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q9UBQ7	GRHPR	Glyoxylate reductase/hydroxypyruvate reductase	GO:0051259; P:protein oligomerization; IDA:UniProtKB
Q9UBQ7	GRHPR	Glyoxylate reductase/hydroxypyruvate reductase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P42261	GRIA1	Glutamate receptor 1	GO:0004971; F:alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; IDA:UniProtKB
P42261	GRIA1	Glutamate receptor 1	GO:0005234; F:extracellular-glutamate-gated ion channel activity; IBA:RefGenome
P42261	GRIA1	Glutamate receptor 1	GO:0008066; F:glutamate receptor activity; TAS:ProtInc
P42261	GRIA1	Glutamate receptor 1	GO:0030165; F:PDZ domain binding; ISS:BHF-UCL
P42261	GRIA1	Glutamate receptor 1	GO:0005515; F:protein binding; IPI:UniProtKB
P42261	GRIA1	Glutamate receptor 1	GO:0034220; P:ion transmembrane transport; IBA:GOC
P42261	GRIA1	Glutamate receptor 1	GO:0035235; P:ionotropic glutamate receptor signaling pathway; IDA:GOC
P42261	GRIA1	Glutamate receptor 1	GO:0007616; P:long-term memory; IEA:Ensembl
P42261	GRIA1	Glutamate receptor 1	GO:0031623; P:receptor internalization; IEA:Ensembl
P42261	GRIA1	Glutamate receptor 1	GO:0007165; P:signal transduction; TAS:ProtInc
P42261	GRIA1	Glutamate receptor 1	GO:0007268; P:synaptic transmission; TAS:Reactome
P42261	GRIA1	Glutamate receptor 1	GO:0035249; P:synaptic transmission, glutamatergic; IBA:RefGenome
P42262	GRIA2	Glutamate receptor 2	GO:0004971; F:alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; ISS:UniProtKB
P42262	GRIA2	Glutamate receptor 2	GO:0005234; F:extracellular-glutamate-gated ion channel activity; IBA:RefGenome
P42262	GRIA2	Glutamate receptor 2	GO:0004970; F:ionotropic glutamate receptor activity; IDA:UniProtKB
P42262	GRIA2	Glutamate receptor 2	GO:0005515; F:protein binding; IPI:IntAct
P42262	GRIA2	Glutamate receptor 2	GO:0034220; P:ion transmembrane transport; IBA:GOC
P42262	GRIA2	Glutamate receptor 2	GO:0035235; P:ionotropic glutamate receptor signaling pathway; IDA:UniProtKB
P42262	GRIA2	Glutamate receptor 2	GO:0007165; P:signal transduction; TAS:ProtInc
P42262	GRIA2	Glutamate receptor 2	GO:0007268; P:synaptic transmission; TAS:Reactome
P42262	GRIA2	Glutamate receptor 2	GO:0035249; P:synaptic transmission, glutamatergic; IBA:RefGenome
P42263	GRIA3	Glutamate receptor 3	GO:0004971; F:alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; IDA:UniProtKB
P42263	GRIA3	Glutamate receptor 3	GO:0005234; F:extracellular-glutamate-gated ion channel activity; IBA:RefGenome
P42263	GRIA3	Glutamate receptor 3	GO:0007215; P:glutamate receptor signaling pathway; TAS:ProtInc
P42263	GRIA3	Glutamate receptor 3	GO:0034220; P:ion transmembrane transport; IBA:GOC
P42263	GRIA3	Glutamate receptor 3	GO:0035235; P:ionotropic glutamate receptor signaling pathway; IDA:GOC
P42263	GRIA3	Glutamate receptor 3	GO:0007268; P:synaptic transmission; TAS:Reactome
P42263	GRIA3	Glutamate receptor 3	GO:0035249; P:synaptic transmission, glutamatergic; IBA:RefGenome
P42263	GRIA3	Glutamate receptor 3	GO:0006810; P:transport; TAS:ProtInc
P48058	GRIA4	Glutamate receptor 4	GO:0004971; F:alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; IDA:UniProtKB
P48058	GRIA4	Glutamate receptor 4	GO:0005234; F:extracellular-glutamate-gated ion channel activity; IBA:RefGenome
P48058	GRIA4	Glutamate receptor 4	GO:0004970; F:ionotropic glutamate receptor activity; ISS:UniProtKB
P48058	GRIA4	Glutamate receptor 4	GO:0007215; P:glutamate receptor signaling pathway; TAS:ProtInc
P48058	GRIA4	Glutamate receptor 4	GO:0034220; P:ion transmembrane transport; IBA:GOC
P48058	GRIA4	Glutamate receptor 4	GO:0035235; P:ionotropic glutamate receptor signaling pathway; IDA:GOC
P48058	GRIA4	Glutamate receptor 4	GO:0007268; P:synaptic transmission; TAS:Reactome
P48058	GRIA4	Glutamate receptor 4	GO:0035249; P:synaptic transmission, glutamatergic; IBA:RefGenome
P48058	GRIA4	Glutamate receptor 4	GO:0006810; P:transport; TAS:ProtInc
Q9ULK0	GRID1	Glutamate receptor ionotropic, delta-1	GO:0005234; F:extracellular-glutamate-gated ion channel activity; IBA:RefGenome
Q9ULK0	GRID1	Glutamate receptor ionotropic, delta-1	GO:0004970; F:ionotropic glutamate receptor activity; IBA:RefGenome
Q9ULK0	GRID1	Glutamate receptor ionotropic, delta-1	GO:0034220; P:ion transmembrane transport; IBA:RefGenome
Q9ULK0	GRID1	Glutamate receptor ionotropic, delta-1	GO:0035235; P:ionotropic glutamate receptor signaling pathway; IBA:RefGenome
Q9ULK0	GRID1	Glutamate receptor ionotropic, delta-1	GO:0035176; P:social behavior; ISS:UniProt
Q9ULK0	GRID1	Glutamate receptor ionotropic, delta-1	GO:0035249; P:synaptic transmission, glutamatergic; IBA:RefGenome
O43424	GRID2	Glutamate receptor ionotropic, delta-2	GO:0005234; F:extracellular-glutamate-gated ion channel activity; IEA:InterPro
O43424	GRID2	Glutamate receptor ionotropic, delta-2	GO:0008066; F:glutamate receptor activity; TAS:ProtInc
O43424	GRID2	Glutamate receptor ionotropic, delta-2	GO:0004970; F:ionotropic glutamate receptor activity; IEA:InterPro
O43424	GRID2	Glutamate receptor ionotropic, delta-2	GO:0030165; F:PDZ domain binding; ISS:BHF-UCL
O43424	GRID2	Glutamate receptor ionotropic, delta-2	GO:0097110; F:scaffold protein binding; ISS:BHF-UCL
O43424	GRID2	Glutamate receptor ionotropic, delta-2	GO:0034613; P:cellular protein localization; ISS:BHF-UCL
O43424	GRID2	Glutamate receptor ionotropic, delta-2	GO:0021707; P:cerebellar granule cell differentiation; ISS:BHF-UCL
O43424	GRID2	Glutamate receptor ionotropic, delta-2	GO:0007215; P:glutamate receptor signaling pathway; TAS:ProtInc
O43424	GRID2	Glutamate receptor ionotropic, delta-2	GO:0007157; P:heterophilic cell-cell adhesion; ISS:BHF-UCL
O43424	GRID2	Glutamate receptor ionotropic, delta-2	GO:0034220; P:ion transmembrane transport; IBA:RefGenome
O43424	GRID2	Glutamate receptor ionotropic, delta-2	GO:0035235; P:ionotropic glutamate receptor signaling pathway; IBA:RefGenome
O43424	GRID2	Glutamate receptor ionotropic, delta-2	GO:0060134; P:prepulse inhibition; ISS:BHF-UCL
O43424	GRID2	Glutamate receptor ionotropic, delta-2	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; ISS:BHF-UCL
O43424	GRID2	Glutamate receptor ionotropic, delta-2	GO:0043523; P:regulation of neuron apoptotic process; ISS:BHF-UCL
O43424	GRID2	Glutamate receptor ionotropic, delta-2	GO:0010975; P:regulation of neuron projection development; IEA:Ensembl
O43424	GRID2	Glutamate receptor ionotropic, delta-2	GO:0035249; P:synaptic transmission, glutamatergic; ISS:BHF-UCL
O43424	GRID2	Glutamate receptor ionotropic, delta-2	GO:0006810; P:transport; TAS:ProtInc
A4D1Z8	GRIFIN	Putative grifin	GO:0030246; F:carbohydrate binding; IEA:InterPro
P39086	GRIK1	Glutamate receptor ionotropic, kainate 1	GO:0005234; F:extracellular-glutamate-gated ion channel activity; IBA:RefGenome
P39086	GRIK1	Glutamate receptor ionotropic, kainate 1	GO:0015277; F:kainate selective glutamate receptor activity; IDA:UniProtKB
P39086	GRIK1	Glutamate receptor ionotropic, kainate 1	GO:0030534; P:adult behavior; IEA:Ensembl
P39086	GRIK1	Glutamate receptor ionotropic, kainate 1	GO:0048266; P:behavioral response to pain; IEA:Ensembl
P39086	GRIK1	Glutamate receptor ionotropic, kainate 1	GO:0007417; P:central nervous system development; TAS:ProtInc
P39086	GRIK1	Glutamate receptor ionotropic, kainate 1	GO:0007215; P:glutamate receptor signaling pathway; TAS:ProtInc
P39086	GRIK1	Glutamate receptor ionotropic, kainate 1	GO:0034220; P:ion transmembrane transport; IBA:GOC
P39086	GRIK1	Glutamate receptor ionotropic, kainate 1	GO:0035235; P:ionotropic glutamate receptor signaling pathway; IDA:GOC
P39086	GRIK1	Glutamate receptor ionotropic, kainate 1	GO:0051967; P:negative regulation of synaptic transmission, glutamatergic; IEA:Ensembl
P39086	GRIK1	Glutamate receptor ionotropic, kainate 1	GO:0007399; P:nervous system development; TAS:ProtInc
P39086	GRIK1	Glutamate receptor ionotropic, kainate 1	GO:0014054; P:positive regulation of gamma-aminobutyric acid secretion; IEA:Ensembl
P39086	GRIK1	Glutamate receptor ionotropic, kainate 1	GO:0032230; P:positive regulation of synaptic transmission, GABAergic; IEA:Ensembl
P39086	GRIK1	Glutamate receptor ionotropic, kainate 1	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
P39086	GRIK1	Glutamate receptor ionotropic, kainate 1	GO:0060080; P:regulation of inhibitory postsynaptic membrane potential; IEA:Ensembl
P39086	GRIK1	Glutamate receptor ionotropic, kainate 1	GO:0051966; P:regulation of synaptic transmission, glutamatergic; TAS:UniProtKB
P39086	GRIK1	Glutamate receptor ionotropic, kainate 1	GO:0007268; P:synaptic transmission; TAS:Reactome
P39086	GRIK1	Glutamate receptor ionotropic, kainate 1	GO:0035249; P:synaptic transmission, glutamatergic; IBA:RefGenome
P39086	GRIK1	Glutamate receptor ionotropic, kainate 1	GO:0006810; P:transport; TAS:ProtInc
Q13002	GRIK2	Glutamate receptor ionotropic, kainate 2	GO:0005234; F:extracellular-glutamate-gated ion channel activity; IBA:RefGenome
Q13002	GRIK2	Glutamate receptor ionotropic, kainate 2	GO:0015277; F:kainate selective glutamate receptor activity; IDA:UniProtKB
Q13002	GRIK2	Glutamate receptor ionotropic, kainate 2	GO:0001662; P:behavioral fear response; IEA:Ensembl
Q13002	GRIK2	Glutamate receptor ionotropic, kainate 2	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
Q13002	GRIK2	Glutamate receptor ionotropic, kainate 2	GO:0007215; P:glutamate receptor signaling pathway; TAS:ProtInc
Q13002	GRIK2	Glutamate receptor ionotropic, kainate 2	GO:0006886; P:intracellular protein transport; IEA:Ensembl
Q13002	GRIK2	Glutamate receptor ionotropic, kainate 2	GO:0034220; P:ion transmembrane transport; IBA:GOC
Q13002	GRIK2	Glutamate receptor ionotropic, kainate 2	GO:0035235; P:ionotropic glutamate receptor signaling pathway; IBA:RefGenome
Q13002	GRIK2	Glutamate receptor ionotropic, kainate 2	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q13002	GRIK2	Glutamate receptor ionotropic, kainate 2	GO:0051967; P:negative regulation of synaptic transmission, glutamatergic; IEA:Ensembl
Q13002	GRIK2	Glutamate receptor ionotropic, kainate 2	GO:0019228; P:neuronal action potential; IEA:Ensembl
Q13002	GRIK2	Glutamate receptor ionotropic, kainate 2	GO:0050806; P:positive regulation of synaptic transmission; IMP:UniProtKB
Q13002	GRIK2	Glutamate receptor ionotropic, kainate 2	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
Q13002	GRIK2	Glutamate receptor ionotropic, kainate 2	GO:0060080; P:regulation of inhibitory postsynaptic membrane potential; IEA:Ensembl
Q13002	GRIK2	Glutamate receptor ionotropic, kainate 2	GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IEA:Ensembl
Q13002	GRIK2	Glutamate receptor ionotropic, kainate 2	GO:0048172; P:regulation of short-term neuronal synaptic plasticity; IMP:UniProtKB
Q13002	GRIK2	Glutamate receptor ionotropic, kainate 2	GO:0050804; P:regulation of synaptic transmission; IDA:UniProtKB
Q13002	GRIK2	Glutamate receptor ionotropic, kainate 2	GO:0007268; P:synaptic transmission; TAS:Reactome
Q13002	GRIK2	Glutamate receptor ionotropic, kainate 2	GO:0035249; P:synaptic transmission, glutamatergic; IBA:RefGenome
Q13002	GRIK2	Glutamate receptor ionotropic, kainate 2	GO:0006810; P:transport; NAS:ProtInc
Q13003	GRIK3	Glutamate receptor ionotropic, kainate 3	GO:0001640; F:adenylate cyclase inhibiting G-protein coupled glutamate receptor activity; IDA:UniProtKB
Q13003	GRIK3	Glutamate receptor ionotropic, kainate 3	GO:0005234; F:extracellular-glutamate-gated ion channel activity; IBA:RefGenome
Q13003	GRIK3	Glutamate receptor ionotropic, kainate 3	GO:0008066; F:glutamate receptor activity; TAS:UniProtKB
Q13003	GRIK3	Glutamate receptor ionotropic, kainate 3	GO:0004970; F:ionotropic glutamate receptor activity; ISS:UniProtKB
Q13003	GRIK3	Glutamate receptor ionotropic, kainate 3	GO:0015277; F:kainate selective glutamate receptor activity; IDA:UniProtKB
Q13003	GRIK3	Glutamate receptor ionotropic, kainate 3	GO:0007196; P:adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway; IDA:GOC
Q13003	GRIK3	Glutamate receptor ionotropic, kainate 3	GO:0007216; P:G-protein coupled glutamate receptor signaling pathway; IDA:UniProtKB
Q13003	GRIK3	Glutamate receptor ionotropic, kainate 3	GO:0007215; P:glutamate receptor signaling pathway; IDA:UniProtKB
Q13003	GRIK3	Glutamate receptor ionotropic, kainate 3	GO:0034220; P:ion transmembrane transport; IBA:GOC
Q13003	GRIK3	Glutamate receptor ionotropic, kainate 3	GO:0035235; P:ionotropic glutamate receptor signaling pathway; IDA:GOC
Q13003	GRIK3	Glutamate receptor ionotropic, kainate 3	GO:0051967; P:negative regulation of synaptic transmission, glutamatergic; ISS:UniProtKB
Q13003	GRIK3	Glutamate receptor ionotropic, kainate 3	GO:0042391; P:regulation of membrane potential; ISS:UniProtKB
Q13003	GRIK3	Glutamate receptor ionotropic, kainate 3	GO:0007268; P:synaptic transmission; TAS:Reactome
Q13003	GRIK3	Glutamate receptor ionotropic, kainate 3	GO:0035249; P:synaptic transmission, glutamatergic; IBA:RefGenome
Q16099	GRIK4	Glutamate receptor ionotropic, kainate 4	GO:0005234; F:extracellular-glutamate-gated ion channel activity; IBA:RefGenome
Q16099	GRIK4	Glutamate receptor ionotropic, kainate 4	GO:0015277; F:kainate selective glutamate receptor activity; IBA:RefGenome
Q16099	GRIK4	Glutamate receptor ionotropic, kainate 4	GO:0007215; P:glutamate receptor signaling pathway; TAS:ProtInc
Q16099	GRIK4	Glutamate receptor ionotropic, kainate 4	GO:0034220; P:ion transmembrane transport; IBA:RefGenome
Q16099	GRIK4	Glutamate receptor ionotropic, kainate 4	GO:0035235; P:ionotropic glutamate receptor signaling pathway; IBA:RefGenome
Q16099	GRIK4	Glutamate receptor ionotropic, kainate 4	GO:0031960; P:response to corticosteroid; IEA:Ensembl
Q16099	GRIK4	Glutamate receptor ionotropic, kainate 4	GO:0007268; P:synaptic transmission; TAS:Reactome
Q16099	GRIK4	Glutamate receptor ionotropic, kainate 4	GO:0035249; P:synaptic transmission, glutamatergic; IBA:RefGenome
Q16099	GRIK4	Glutamate receptor ionotropic, kainate 4	GO:0006810; P:transport; TAS:ProtInc
Q16478	GRIK5	Glutamate receptor ionotropic, kainate 5	GO:0005234; F:extracellular-glutamate-gated ion channel activity; IBA:RefGenome
Q16478	GRIK5	Glutamate receptor ionotropic, kainate 5	GO:0015277; F:kainate selective glutamate receptor activity; IDA:UniProtKB
Q16478	GRIK5	Glutamate receptor ionotropic, kainate 5	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
Q16478	GRIK5	Glutamate receptor ionotropic, kainate 5	GO:0051649; P:establishment of localization in cell; IEA:Ensembl
Q16478	GRIK5	Glutamate receptor ionotropic, kainate 5	GO:0034220; P:ion transmembrane transport; IBA:GOC
Q16478	GRIK5	Glutamate receptor ionotropic, kainate 5	GO:0035235; P:ionotropic glutamate receptor signaling pathway; IDA:GOC
Q16478	GRIK5	Glutamate receptor ionotropic, kainate 5	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
Q16478	GRIK5	Glutamate receptor ionotropic, kainate 5	GO:0006621; P:protein retention in ER lumen; IEA:Ensembl
Q16478	GRIK5	Glutamate receptor ionotropic, kainate 5	GO:0043113; P:receptor clustering; IEA:Ensembl
Q16478	GRIK5	Glutamate receptor ionotropic, kainate 5	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
Q16478	GRIK5	Glutamate receptor ionotropic, kainate 5	GO:0031630; P:regulation of synaptic vesicle fusion to presynaptic membrane; IEA:Ensembl
Q16478	GRIK5	Glutamate receptor ionotropic, kainate 5	GO:0007268; P:synaptic transmission; TAS:Reactome
Q16478	GRIK5	Glutamate receptor ionotropic, kainate 5	GO:0035249; P:synaptic transmission, glutamatergic; IBA:RefGenome
Q7Z2K8	GPRIN1	G protein-regulated inducer of neurite outgrowth 1	GO:0031175; P:neuron projection development; IEA:Ensembl
O60269	GPRIN2	G protein-regulated inducer of neurite outgrowth 2	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3R0	GRIP1	Glutamate receptor-interacting protein 1	GO:0050681; F:androgen receptor binding; NAS:UniProtKB
Q9Y3R0	GRIP1	Glutamate receptor-interacting protein 1	GO:0008013; F:beta-catenin binding; TAS:AgBase
Q9Y3R0	GRIP1	Glutamate receptor-interacting protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3R0	GRIP1	Glutamate receptor-interacting protein 1	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q9Y3R0	GRIP1	Glutamate receptor-interacting protein 1	GO:0030159; F:receptor signaling complex scaffold activity; NAS:UniProtKB
Q9Y3R0	GRIP1	Glutamate receptor-interacting protein 1	GO:0003713; F:transcription coactivator activity; NAS:UniProtKB
Q9Y3R0	GRIP1	Glutamate receptor-interacting protein 1	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
Q9Y3R0	GRIP1	Glutamate receptor-interacting protein 1	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
Q9Y3R0	GRIP1	Glutamate receptor-interacting protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
Q9Y3R0	GRIP1	Glutamate receptor-interacting protein 1	GO:0008104; P:protein localization; IEA:Ensembl
Q9Y3R0	GRIP1	Glutamate receptor-interacting protein 1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9C0E4	GRIP2	Glutamate receptor-interacting protein 2	GO:0007268; P:synaptic transmission; TAS:Reactome
P32298	GRK4	G protein-coupled receptor kinase 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P32298	GRK4	G protein-coupled receptor kinase 4	GO:0004703; F:G-protein coupled receptor kinase activity; IEA:UniProtKB-EC
P32298	GRK4	G protein-coupled receptor kinase 4	GO:0050254; F:rhodopsin kinase activity; IEA:Ensembl
P32298	GRK4	G protein-coupled receptor kinase 4	GO:0002031; P:G-protein coupled receptor internalization; IEA:Ensembl
P32298	GRK4	G protein-coupled receptor kinase 4	GO:0031623; P:receptor internalization; IDA:UniProtKB
P32298	GRK4	G protein-coupled receptor kinase 4	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; TAS:ProtInc
P32298	GRK4	G protein-coupled receptor kinase 4	GO:0007165; P:signal transduction; IEA:InterPro
P32298	GRK4	G protein-coupled receptor kinase 4	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
P34947	GRK5	G protein-coupled receptor kinase 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P34947	GRK5	G protein-coupled receptor kinase 5	GO:0004703; F:G-protein coupled receptor kinase activity; IEA:UniProtKB-EC
P34947	GRK5	G protein-coupled receptor kinase 5	GO:0005543; F:phospholipid binding; TAS:ProtInc
P34947	GRK5	G protein-coupled receptor kinase 5	GO:0005515; F:protein binding; IPI:UniProtKB
P34947	GRK5	G protein-coupled receptor kinase 5	GO:0005080; F:protein kinase C binding; TAS:ProtInc
P34947	GRK5	G protein-coupled receptor kinase 5	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P34947	GRK5	G protein-coupled receptor kinase 5	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; TAS:ProtInc
P34947	GRK5	G protein-coupled receptor kinase 5	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P34947	GRK5	G protein-coupled receptor kinase 5	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P34947	GRK5	G protein-coupled receptor kinase 5	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P34947	GRK5	G protein-coupled receptor kinase 5	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; TAS:ProtInc
P34947	GRK5	G protein-coupled receptor kinase 5	GO:0007217; P:tachykinin receptor signaling pathway; IDA:BHF-UCL
P34947	GRK5	G protein-coupled receptor kinase 5	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
P34947	GRK5	G protein-coupled receptor kinase 5	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P43250	GRK6	G protein-coupled receptor kinase 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P43250	GRK6	G protein-coupled receptor kinase 6	GO:0004703; F:G-protein coupled receptor kinase activity; IEA:UniProtKB-EC
P43250	GRK6	G protein-coupled receptor kinase 6	GO:0005515; F:protein binding; IPI:IntAct
P43250	GRK6	G protein-coupled receptor kinase 6	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; TAS:ProtInc
P43250	GRK6	G protein-coupled receptor kinase 6	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
P43250	GRK6	G protein-coupled receptor kinase 6	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q8WTQ7	GRK7	G protein-coupled receptor kinase 7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8WTQ7	GRK7	G protein-coupled receptor kinase 7	GO:0004703; F:G-protein coupled receptor kinase activity; IEA:UniProtKB-EC
Q8WTQ7	GRK7	G protein-coupled receptor kinase 7	GO:0050254; F:rhodopsin kinase activity; IDA:UniProtKB
Q8WTQ7	GRK7	G protein-coupled receptor kinase 7	GO:0046777; P:protein autophosphorylation; IMP:UniProtKB
Q8WTQ7	GRK7	G protein-coupled receptor kinase 7	GO:0007165; P:signal transduction; IEA:InterPro
Q8WTQ7	GRK7	G protein-coupled receptor kinase 7	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
Q8WTQ7	GRK7	G protein-coupled receptor kinase 7	GO:0007601; P:visual perception; IEA:UniProtKB-KW
P0CAP2	POLR2M	DNA-directed RNA polymerase II subunit GRINL1A	GO:0003899; F:DNA-directed RNA polymerase activity; IEA:UniProtKB-KW
P0CAP2	POLR2M	DNA-directed RNA polymerase II subunit GRINL1A	GO:0051685; P:maintenance of ER location; IEA:Ensembl
Q13255	GRM1	Metabotropic glutamate receptor 1	GO:0004930; F:G-protein coupled receptor activity; TAS:UniProtKB
Q13255	GRM1	Metabotropic glutamate receptor 1	GO:0008066; F:glutamate receptor activity; TAS:UniProtKB
Q13255	GRM1	Metabotropic glutamate receptor 1	GO:0005515; F:protein binding; IPI:IntAct
Q13255	GRM1	Metabotropic glutamate receptor 1	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
Q13255	GRM1	Metabotropic glutamate receptor 1	GO:0000186; P:activation of MAPKK activity; IEA:Ensembl
Q13255	GRM1	Metabotropic glutamate receptor 1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q13255	GRM1	Metabotropic glutamate receptor 1	GO:0071257; P:cellular response to electrical stimulus; IEA:Ensembl
Q13255	GRM1	Metabotropic glutamate receptor 1	GO:0007216; P:G-protein coupled glutamate receptor signaling pathway; IBA:RefGenome
Q13255	GRM1	Metabotropic glutamate receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q13255	GRM1	Metabotropic glutamate receptor 1	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q13255	GRM1	Metabotropic glutamate receptor 1	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IBA:RefGenome
Q13255	GRM1	Metabotropic glutamate receptor 1	GO:0051930; P:regulation of sensory perception of pain; IEA:Ensembl
Q13255	GRM1	Metabotropic glutamate receptor 1	GO:0051966; P:regulation of synaptic transmission, glutamatergic; IBA:RefGenome
Q13255	GRM1	Metabotropic glutamate receptor 1	GO:0019233; P:sensory perception of pain; IEA:Ensembl
Q13255	GRM1	Metabotropic glutamate receptor 1	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q14416	GRM2	Metabotropic glutamate receptor 2	GO:0005246; F:calcium channel regulator activity; IBA:RefGenome
Q14416	GRM2	Metabotropic glutamate receptor 2	GO:0004930; F:G-protein coupled receptor activity; TAS:UniProtKB
Q14416	GRM2	Metabotropic glutamate receptor 2	GO:0008066; F:glutamate receptor activity; TAS:UniProtKB
Q14416	GRM2	Metabotropic glutamate receptor 2	GO:0001641; F:group II metabotropic glutamate receptor activity; IBA:RefGenome
Q14416	GRM2	Metabotropic glutamate receptor 2	GO:0007196; P:adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway; IBA:RefGenome
Q14416	GRM2	Metabotropic glutamate receptor 2	GO:0014047; P:glutamate secretion; IEA:Ensembl
Q14416	GRM2	Metabotropic glutamate receptor 2	GO:0007194; P:negative regulation of adenylate cyclase activity; TAS:ProtInc
Q14416	GRM2	Metabotropic glutamate receptor 2	GO:0051966; P:regulation of synaptic transmission, glutamatergic; IBA:RefGenome
Q14416	GRM2	Metabotropic glutamate receptor 2	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q14832	GRM3	Metabotropic glutamate receptor 3	GO:0005246; F:calcium channel regulator activity; IEA:Ensembl
Q14832	GRM3	Metabotropic glutamate receptor 3	GO:0004930; F:G-protein coupled receptor activity; TAS:UniProtKB
Q14832	GRM3	Metabotropic glutamate receptor 3	GO:0008066; F:glutamate receptor activity; TAS:UniProtKB
Q14832	GRM3	Metabotropic glutamate receptor 3	GO:0001641; F:group II metabotropic glutamate receptor activity; IBA:RefGenome
Q14832	GRM3	Metabotropic glutamate receptor 3	GO:0007196; P:adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway; IBA:RefGenome
Q14832	GRM3	Metabotropic glutamate receptor 3	GO:0007194; P:negative regulation of adenylate cyclase activity; TAS:ProtInc
Q14832	GRM3	Metabotropic glutamate receptor 3	GO:0051966; P:regulation of synaptic transmission, glutamatergic; IBA:RefGenome
Q14832	GRM3	Metabotropic glutamate receptor 3	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q14833	GRM4	Metabotropic glutamate receptor 4	GO:0004930; F:G-protein coupled receptor activity; IMP:UniProtKB
Q14833	GRM4	Metabotropic glutamate receptor 4	GO:0008066; F:glutamate receptor activity; IMP:UniProtKB
Q14833	GRM4	Metabotropic glutamate receptor 4	GO:0001642; F:group III metabotropic glutamate receptor activity; IBA:RefGenome
Q14833	GRM4	Metabotropic glutamate receptor 4	GO:0000187; P:activation of MAPK activity; IDA:UniProtKB
Q14833	GRM4	Metabotropic glutamate receptor 4	GO:0007196; P:adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway; IMP:UniProtKB
Q14833	GRM4	Metabotropic glutamate receptor 4	GO:0007612; P:learning; IEA:Ensembl
Q14833	GRM4	Metabotropic glutamate receptor 4	GO:0007269; P:neurotransmitter secretion; TAS:UniProtKB
Q14833	GRM4	Metabotropic glutamate receptor 4	GO:0043410; P:positive regulation of MAPK cascade; IEP:UniProtKB
Q14833	GRM4	Metabotropic glutamate receptor 4	GO:0043523; P:regulation of neuron apoptotic process; TAS:UniProtKB
Q14833	GRM4	Metabotropic glutamate receptor 4	GO:0051966; P:regulation of synaptic transmission, glutamatergic; IBA:RefGenome
Q14833	GRM4	Metabotropic glutamate receptor 4	GO:0007268; P:synaptic transmission; TAS:ProtInc
P41594	GRM5	Metabotropic glutamate receptor 5	GO:0004930; F:G-protein coupled receptor activity; TAS:UniProtKB
P41594	GRM5	Metabotropic glutamate receptor 5	GO:0008066; F:glutamate receptor activity; IDA:UniProtKB
P41594	GRM5	Metabotropic glutamate receptor 5	GO:0000185; P:activation of MAPKKK activity; IEA:Ensembl
P41594	GRM5	Metabotropic glutamate receptor 5	GO:0002029; P:desensitization of G-protein coupled receptor protein signaling pathway; IEA:Ensembl
P41594	GRM5	Metabotropic glutamate receptor 5	GO:0007216; P:G-protein coupled glutamate receptor signaling pathway; IMP:UniProtKB
P41594	GRM5	Metabotropic glutamate receptor 5	GO:0007612; P:learning; IEA:Ensembl
P41594	GRM5	Metabotropic glutamate receptor 5	GO:0007626; P:locomotory behavior; IEA:Ensembl
P41594	GRM5	Metabotropic glutamate receptor 5	GO:0040013; P:negative regulation of locomotion; IEA:Ensembl
P41594	GRM5	Metabotropic glutamate receptor 5	GO:0007206; P:phospholipase C-activating G-protein coupled glutamate receptor signaling pathway; TAS:ProtInc
P41594	GRM5	Metabotropic glutamate receptor 5	GO:0048170; P:positive regulation of long-term neuronal synaptic plasticity; IEA:Ensembl
P41594	GRM5	Metabotropic glutamate receptor 5	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IBA:RefGenome
P41594	GRM5	Metabotropic glutamate receptor 5	GO:0006468; P:protein phosphorylation; IEA:Ensembl
P41594	GRM5	Metabotropic glutamate receptor 5	GO:0051966; P:regulation of synaptic transmission, glutamatergic; IBA:RefGenome
P41594	GRM5	Metabotropic glutamate receptor 5	GO:0006355; P:regulation of transcription, DNA-templated; IEA:Ensembl
P41594	GRM5	Metabotropic glutamate receptor 5	GO:0007268; P:synaptic transmission; TAS:ProtInc
O15303	GRM6	Metabotropic glutamate receptor 6	GO:0004930; F:G-protein coupled receptor activity; TAS:UniProtKB
O15303	GRM6	Metabotropic glutamate receptor 6	GO:0008066; F:glutamate receptor activity; IMP:UniProtKB
O15303	GRM6	Metabotropic glutamate receptor 6	GO:0001642; F:group III metabotropic glutamate receptor activity; IBA:RefGenome
O15303	GRM6	Metabotropic glutamate receptor 6	GO:0005515; F:protein binding; IPI:UniProtKB
O15303	GRM6	Metabotropic glutamate receptor 6	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
O15303	GRM6	Metabotropic glutamate receptor 6	GO:0007196; P:adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway; IBA:RefGenome
O15303	GRM6	Metabotropic glutamate receptor 6	GO:0050908; P:detection of light stimulus involved in visual perception; IMP:UniProtKB
O15303	GRM6	Metabotropic glutamate receptor 6	GO:0009584; P:detection of visible light; TAS:ProtInc
O15303	GRM6	Metabotropic glutamate receptor 6	GO:0007216; P:G-protein coupled glutamate receptor signaling pathway; IMP:UniProtKB
O15303	GRM6	Metabotropic glutamate receptor 6	GO:0007626; P:locomotory behavior; IEA:Ensembl
O15303	GRM6	Metabotropic glutamate receptor 6	GO:0090280; P:positive regulation of calcium ion import; IMP:UniProtKB
O15303	GRM6	Metabotropic glutamate receptor 6	GO:0051966; P:regulation of synaptic transmission, glutamatergic; IBA:RefGenome
O15303	GRM6	Metabotropic glutamate receptor 6	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
O15303	GRM6	Metabotropic glutamate receptor 6	GO:0007268; P:synaptic transmission; IEA:Ensembl
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0010855; F:adenylate cyclase inhibitor activity; IDA:UniProtKB
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0005246; F:calcium channel regulator activity; IBA:RefGenome
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0016595; F:glutamate binding; IDA:UniProtKB
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0008066; F:glutamate receptor activity; IDA:UniProtKB
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0001642; F:group III metabotropic glutamate receptor activity; IDA:UniProtKB
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0030165; F:PDZ domain binding; NAS:UniProtKB
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0070905; F:serine binding; IDA:UniProtKB
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0005245; F:voltage-gated calcium channel activity; IEA:Ensembl
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0007196; P:adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway; IDA:UniProtKB
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0030534; P:adult behavior; IEA:Ensembl
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0001661; P:conditioned taste aversion; IEA:Ensembl
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0033555; P:multicellular organismal response to stress; IEA:Ensembl
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0007194; P:negative regulation of adenylate cyclase activity; IDA:UniProtKB
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0030818; P:negative regulation of cAMP biosynthetic process; IDA:UniProtKB
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0014050; P:negative regulation of glutamate secretion; ISS:UniProtKB
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0031279; P:regulation of cyclase activity; IDA:GOC
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0051966; P:regulation of synaptic transmission, glutamatergic; IBA:RefGenome
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0007608; P:sensory perception of smell; IEA:UniProtKB-KW
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0007605; P:sensory perception of sound; IMP:UniProtKB
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0007614; P:short-term memory; IEA:Ensembl
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0007268; P:synaptic transmission; IDA:UniProtKB
Q14831	GRM7	Metabotropic glutamate receptor 7	GO:0019226; P:transmission of nerve impulse; IEA:Ensembl
O00222	GRM8	Metabotropic glutamate receptor 8	GO:0004930; F:G-protein coupled receptor activity; IMP:UniProtKB
O00222	GRM8	Metabotropic glutamate receptor 8	GO:0008066; F:glutamate receptor activity; IMP:UniProtKB
O00222	GRM8	Metabotropic glutamate receptor 8	GO:0001642; F:group III metabotropic glutamate receptor activity; IBA:RefGenome
O00222	GRM8	Metabotropic glutamate receptor 8	GO:0007196; P:adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway; IMP:UniProtKB
O00222	GRM8	Metabotropic glutamate receptor 8	GO:0030818; P:negative regulation of cAMP biosynthetic process; IDA:UniProtKB
O00222	GRM8	Metabotropic glutamate receptor 8	GO:0051966; P:regulation of synaptic transmission, glutamatergic; IBA:RefGenome
O00222	GRM8	Metabotropic glutamate receptor 8	GO:0007608; P:sensory perception of smell; IEA:UniProtKB-KW
O00222	GRM8	Metabotropic glutamate receptor 8	GO:0007601; P:visual perception; TAS:ProtInc
P28799	GRN	Granulins	GO:0008083; F:growth factor activity; TAS:ProtInc
P28799	GRN	Granulins	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P28799	GRN	Granulins	GO:0005515; F:protein binding; IPI:IntAct
P28799	GRN	Granulins	GO:0001835; P:blastocyst hatching; IEA:Ensembl
P28799	GRN	Granulins	GO:0008219; P:cell death; IEA:UniProtKB-KW
P28799	GRN	Granulins	GO:0007566; P:embryo implantation; IEA:Ensembl
P28799	GRN	Granulins	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
P28799	GRN	Granulins	GO:0007165; P:signal transduction; NAS:ProtInc
P09341	CXCL1	Growth-regulated alpha protein	GO:0008009; F:chemokine activity; TAS:ProtInc
P09341	CXCL1	Growth-regulated alpha protein	GO:0008047; F:enzyme activator activity; TAS:ProtInc
P09341	CXCL1	Growth-regulated alpha protein	GO:0005102; F:receptor binding; TAS:ProtInc
P09341	CXCL1	Growth-regulated alpha protein	GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc
P09341	CXCL1	Growth-regulated alpha protein	GO:0060326; P:cell chemotaxis; TAS:GOC
P09341	CXCL1	Growth-regulated alpha protein	GO:0008283; P:cell proliferation; TAS:ProtInc
P09341	CXCL1	Growth-regulated alpha protein	GO:0006935; P:chemotaxis; TAS:ProtInc
P09341	CXCL1	Growth-regulated alpha protein	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P09341	CXCL1	Growth-regulated alpha protein	GO:0006955; P:immune response; IEA:InterPro
P09341	CXCL1	Growth-regulated alpha protein	GO:0006954; P:inflammatory response; TAS:ProtInc
P09341	CXCL1	Growth-regulated alpha protein	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
P09341	CXCL1	Growth-regulated alpha protein	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P09341	CXCL1	Growth-regulated alpha protein	GO:0007399; P:nervous system development; TAS:ProtInc
P09341	CXCL1	Growth-regulated alpha protein	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
P09341	CXCL1	Growth-regulated alpha protein	GO:0007165; P:signal transduction; TAS:ProtInc
O95267	RASGRP1	RAS guanyl-releasing protein 1	GO:0005509; F:calcium ion binding; TAS:ProtInc
O95267	RASGRP1	RAS guanyl-releasing protein 1	GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:Reactome
O95267	RASGRP1	RAS guanyl-releasing protein 1	GO:0008289; F:lipid binding; TAS:ProtInc
O95267	RASGRP1	RAS guanyl-releasing protein 1	GO:0032862; P:activation of Rho GTPase activity; IEA:Ensembl
O95267	RASGRP1	RAS guanyl-releasing protein 1	GO:0007596; P:blood coagulation; TAS:Reactome
O95267	RASGRP1	RAS guanyl-releasing protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O95267	RASGRP1	RAS guanyl-releasing protein 1	GO:0001816; P:cytokine production; IEA:Ensembl
O95267	RASGRP1	RAS guanyl-releasing protein 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O95267	RASGRP1	RAS guanyl-releasing protein 1	GO:0002437; P:inflammatory response to antigenic stimulus; IEA:Ensembl
O95267	RASGRP1	RAS guanyl-releasing protein 1	GO:0045087; P:innate immune response; TAS:Reactome
O95267	RASGRP1	RAS guanyl-releasing protein 1	GO:0043303; P:mast cell degranulation; IEA:Ensembl
O95267	RASGRP1	RAS guanyl-releasing protein 1	GO:0030168; P:platelet activation; TAS:Reactome
O95267	RASGRP1	RAS guanyl-releasing protein 1	GO:0007265; P:Ras protein signal transduction; TAS:ProtInc
O95267	RASGRP1	RAS guanyl-releasing protein 1	GO:0014066; P:regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl
O95267	RASGRP1	RAS guanyl-releasing protein 1	GO:0032252; P:secretory granule localization; IEA:Ensembl
O95267	RASGRP1	RAS guanyl-releasing protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
O95267	RASGRP1	RAS guanyl-releasing protein 1	GO:0047496; P:vesicle transport along microtubule; IEA:Ensembl
Q7LDG7	RASGRP2	RAS guanyl-releasing protein 2	GO:0005509; F:calcium ion binding; NAS:UniProtKB
Q7LDG7	RASGRP2	RAS guanyl-releasing protein 2	GO:0019992; F:diacylglycerol binding; NAS:UniProtKB
Q7LDG7	RASGRP2	RAS guanyl-releasing protein 2	GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:UniProtKB
Q7LDG7	RASGRP2	RAS guanyl-releasing protein 2	GO:0008289; F:lipid binding; TAS:UniProtKB
Q7LDG7	RASGRP2	RAS guanyl-releasing protein 2	GO:0007596; P:blood coagulation; TAS:Reactome
Q7LDG7	RASGRP2	RAS guanyl-releasing protein 2	GO:0030168; P:platelet activation; TAS:Reactome
Q7LDG7	RASGRP2	RAS guanyl-releasing protein 2	GO:0007265; P:Ras protein signal transduction; NAS:UniProtKB
Q7LDG7	RASGRP2	RAS guanyl-releasing protein 2	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
Q7LDG7	RASGRP2	RAS guanyl-releasing protein 2	GO:0043087; P:regulation of GTPase activity; TAS:GOC
Q7LDG7	RASGRP2	RAS guanyl-releasing protein 2	GO:0051056; P:regulation of small GTPase mediated signal transduction; IEA:InterPro
Q7LDG7	RASGRP2	RAS guanyl-releasing protein 2	GO:0007165; P:signal transduction; TAS:UniProtKB
Q8IV61	RASGRP3	Ras guanyl-releasing protein 3	GO:0005509; F:calcium ion binding; NAS:UniProtKB
Q8IV61	RASGRP3	Ras guanyl-releasing protein 3	GO:0019992; F:diacylglycerol binding; NAS:UniProtKB
Q8IV61	RASGRP3	Ras guanyl-releasing protein 3	GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:Reactome
Q8IV61	RASGRP3	Ras guanyl-releasing protein 3	GO:0046582; F:Rap GTPase activator activity; IDA:UniProtKB
Q8IV61	RASGRP3	Ras guanyl-releasing protein 3	GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; IEA:Ensembl
Q8IV61	RASGRP3	Ras guanyl-releasing protein 3	GO:0004871; F:signal transducer activity; TAS:UniProtKB
Q8IV61	RASGRP3	Ras guanyl-releasing protein 3	GO:0000165; P:MAPK cascade; NAS:UniProtKB
Q8IV61	RASGRP3	Ras guanyl-releasing protein 3	GO:0032854; P:positive regulation of Rap GTPase activity; IDA:GOC
Q8IV61	RASGRP3	Ras guanyl-releasing protein 3	GO:0007265; P:Ras protein signal transduction; IEA:Ensembl
Q8IV61	RASGRP3	Ras guanyl-releasing protein 3	GO:0007264; P:small GTPase mediated signal transduction; TAS:UniProtKB
Q8TDF6	RASGRP4	RAS guanyl-releasing protein 4	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8TDF6	RASGRP4	RAS guanyl-releasing protein 4	GO:0019992; F:diacylglycerol binding; TAS:UniProtKB
Q8TDF6	RASGRP4	RAS guanyl-releasing protein 4	GO:0030742; F:GTP-dependent protein binding; NAS:UniProtKB
Q8TDF6	RASGRP4	RAS guanyl-releasing protein 4	GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q8TDF6	RASGRP4	RAS guanyl-releasing protein 4	GO:0007202; P:activation of phospholipase C activity; NAS:UniProtKB
Q8TDF6	RASGRP4	RAS guanyl-releasing protein 4	GO:0016049; P:cell growth; IDA:UniProtKB
Q8TDF6	RASGRP4	RAS guanyl-releasing protein 4	GO:0008283; P:cell proliferation; IDA:UniProtKB
Q8TDF6	RASGRP4	RAS guanyl-releasing protein 4	GO:0030099; P:myeloid cell differentiation; TAS:UniProtKB
Q8TDF6	RASGRP4	RAS guanyl-releasing protein 4	GO:0046579; P:positive regulation of Ras protein signal transduction; IDA:UniProtKB
Q8TDF6	RASGRP4	RAS guanyl-releasing protein 4	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; NAS:UniProtKB
Q8TDF6	RASGRP4	RAS guanyl-releasing protein 4	GO:0032318; P:regulation of Ras GTPase activity; IDA:GOC
Q8TDF6	RASGRP4	RAS guanyl-releasing protein 4	GO:0009991; P:response to extracellular stimulus; IDA:UniProtKB
Q8TDF6	RASGRP4	RAS guanyl-releasing protein 4	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q8TDF6	RASGRP4	RAS guanyl-releasing protein 4	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; NAS:UniProtKB
P38646	HSPA9	Stress-70 protein, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P38646	HSPA9	Stress-70 protein, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P38646	HSPA9	Stress-70 protein, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
P38646	HSPA9	Stress-70 protein, mitochondrial	GO:0051082; F:unfolded protein binding; TAS:UniProtKB
P38646	HSPA9	Stress-70 protein, mitochondrial	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P38646	HSPA9	Stress-70 protein, mitochondrial	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
P38646	HSPA9	Stress-70 protein, mitochondrial	GO:0006611; P:protein export from nucleus; IEA:Ensembl
P38646	HSPA9	Stress-70 protein, mitochondrial	GO:0006457; P:protein folding; IEA:InterPro
P38646	HSPA9	Stress-70 protein, mitochondrial	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0016887; F:ATPase activity; ISS:UniProtKB
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0005509; F:calcium ion binding; TAS:UniProtKB
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0051087; F:chaperone binding; TAS:BHF-UCL
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0051787; F:misfolded protein binding; IDA:UniProtKB
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0005515; F:protein binding; IPI:UniProtKB
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0043022; F:ribosome binding; IEA:Ensembl
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0051082; F:unfolded protein binding; TAS:UniProtKB
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0006200; P:ATP catabolic process; ISS:GOC
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0007596; P:blood coagulation; TAS:Reactome
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0071236; P:cellular response to antibiotic; IEA:Ensembl
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0042149; P:cellular response to glucose starvation; IDA:UniProtKB
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0021680; P:cerebellar Purkinje cell layer development; IEA:Ensembl
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0021589; P:cerebellum structural organization; IEA:Ensembl
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:BHF-UCL
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0006983; P:ER overload response; IEA:Ensembl
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; TAS:BHF-UCL
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0035437; P:maintenance of protein localization in endoplasmic reticulum; IMP:UniProtKB
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0030168; P:platelet activation; TAS:Reactome
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0002576; P:platelet degranulation; TAS:Reactome
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0031398; P:positive regulation of protein ubiquitination; IEA:Ensembl
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0060904; P:regulation of protein folding in endoplasmic reticulum; TAS:BHF-UCL
P11021	HSPA5	78 kDa glucose-regulated protein	GO:0021762; P:substantia nigra development; IEP:UniProt
Q9HAV7	GRPEL1	GrpE protein homolog 1, mitochondrial	GO:0000774; F:adenyl-nucleotide exchange factor activity; IEA:InterPro
Q9HAV7	GRPEL1	GrpE protein homolog 1, mitochondrial	GO:0051082; F:unfolded protein binding; IDA:UniProtKB
Q9HAV7	GRPEL1	GrpE protein homolog 1, mitochondrial	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9HAV7	GRPEL1	GrpE protein homolog 1, mitochondrial	GO:0006457; P:protein folding; IEA:InterPro
Q9HAV7	GRPEL1	GrpE protein homolog 1, mitochondrial	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
Q8TAA5	GRPEL2	GrpE protein homolog 2, mitochondrial	GO:0000774; F:adenyl-nucleotide exchange factor activity; IEA:InterPro
Q8TAA5	GRPEL2	GrpE protein homolog 2, mitochondrial	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8TAA5	GRPEL2	GrpE protein homolog 2, mitochondrial	GO:0006457; P:protein folding; IEA:InterPro
Q8TAA5	GRPEL2	GrpE protein homolog 2, mitochondrial	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
P30550	GRPR	Gastrin-releasing peptide receptor	GO:0004946; F:bombesin receptor activity; IEA:InterPro
P30550	GRPR	Gastrin-releasing peptide receptor	GO:0008528; F:G-protein coupled peptide receptor activity; TAS:ProtInc
P30550	GRPR	Gastrin-releasing peptide receptor	GO:0008283; P:cell proliferation; TAS:ProtInc
P30550	GRPR	Gastrin-releasing peptide receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P30550	GRPR	Gastrin-releasing peptide receptor	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P07492	GRP	Gastrin-releasing peptide	GO:0005184; F:neuropeptide hormone activity; IDA:MGI
P07492	GRP	Gastrin-releasing peptide	GO:0005102; F:receptor binding; NAS:ProtInc
P07492	GRP	Gastrin-releasing peptide	GO:0007218; P:neuropeptide signaling pathway; IDA:MGI
P07492	GRP	Gastrin-releasing peptide	GO:0007165; P:signal transduction; NAS:ProtInc
Q12849	GRSF1	G-rich sequence factor 1	GO:0003729; F:mRNA binding; TAS:ProtInc
Q12849	GRSF1	G-rich sequence factor 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q12849	GRSF1	G-rich sequence factor 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q12849	GRSF1	G-rich sequence factor 1	GO:0003723; F:RNA binding; TAS:ProtInc
Q12849	GRSF1	G-rich sequence factor 1	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q12849	GRSF1	G-rich sequence factor 1	GO:0016331; P:morphogenesis of embryonic epithelium; IEA:Ensembl
Q12849	GRSF1	G-rich sequence factor 1	GO:0006378; P:mRNA polyadenylation; TAS:ProtInc
Q12849	GRSF1	G-rich sequence factor 1	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q5TC63	GRTP1	Growth hormone-regulated TBC protein 1	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q9BQ67	GRWD1	Glutamate-rich WD repeat-containing protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
A4D1B5	GSAP	Gamma-secretase-activating protein	GO:0001540; F:beta-amyloid binding; IDA:UniProtKB
A4D1B5	GSAP	Gamma-secretase-activating protein	GO:0034205; P:beta-amyloid formation; IDA:UniProtKB
A4D1B5	GSAP	Gamma-secretase-activating protein	GO:0030162; P:regulation of proteolysis; IDA:UniProtKB
Q9NZM4	GLTSCR1	Glioma tumor suppressor candidate region gene 1 protein	GO:0005515; F:protein binding; IPI:IntAct
O15499	GSC2	Homeobox protein goosecoid-2	GO:0003677; F:DNA binding; TAS:ProtInc
O15499	GSC2	Homeobox protein goosecoid-2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O15499	GSC2	Homeobox protein goosecoid-2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:MGI
O15499	GSC2	Homeobox protein goosecoid-2	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
O15499	GSC2	Homeobox protein goosecoid-2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q9NZM5	GLTSCR2	Glioma tumor suppressor candidate region gene 2 protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P56915	GSC	Homeobox protein goosecoid	GO:0001103; F:RNA polymerase II repressing transcription factor binding; ISS:BHF-UCL
P56915	GSC	Homeobox protein goosecoid	GO:0001085; F:RNA polymerase II transcription factor binding; ISS:BHF-UCL
P56915	GSC	Homeobox protein goosecoid	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P56915	GSC	Homeobox protein goosecoid	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P56915	GSC	Homeobox protein goosecoid	GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl
P56915	GSC	Homeobox protein goosecoid	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P56915	GSC	Homeobox protein goosecoid	GO:0030900; P:forebrain development; IEA:Ensembl
P56915	GSC	Homeobox protein goosecoid	GO:0007369; P:gastrulation; NAS:UniProtKB
P56915	GSC	Homeobox protein goosecoid	GO:0042474; P:middle ear morphogenesis; ISS:UniProtKB
P56915	GSC	Homeobox protein goosecoid	GO:0048644; P:muscle organ morphogenesis; IEA:Ensembl
P56915	GSC	Homeobox protein goosecoid	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P56915	GSC	Homeobox protein goosecoid	GO:0030178; P:negative regulation of Wnt signaling pathway; IEA:Ensembl
P56915	GSC	Homeobox protein goosecoid	GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl
Q96QA5	GSDMA	Gasdermin-A	GO:0006915; P:apoptotic process; IDA:UniProtKB
Q14687	GSE1	Genetic suppressor element 1	GO:0005515; F:protein binding; IPI:IntAct
P57764	GSDMD	Gasdermin-D	GO:0031668; P:cellular response to extracellular stimulus; IEA:Ensembl
Q6UXU4	GSG1L	Germ cell-specific gene 1-like protein	GO:2000311; P:regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; IEA:Ensembl
P48507	GCLM	Glutamate--cysteine ligase regulatory subunit	GO:0004357; F:glutamate-cysteine ligase activity; IEA:Ensembl
P48507	GCLM	Glutamate--cysteine ligase regulatory subunit	GO:0035226; F:glutamate-cysteine ligase catalytic subunit binding; IPI:UniProtKB
P48507	GCLM	Glutamate--cysteine ligase regulatory subunit	GO:0008637; P:apoptotic mitochondrial changes; IEA:Ensembl
P48507	GCLM	Glutamate--cysteine ligase regulatory subunit	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P48507	GCLM	Glutamate--cysteine ligase regulatory subunit	GO:0006534; P:cysteine metabolic process; IEA:Ensembl
P48507	GCLM	Glutamate--cysteine ligase regulatory subunit	GO:0006536; P:glutamate metabolic process; IDA:UniProtKB
P48507	GCLM	Glutamate--cysteine ligase regulatory subunit	GO:0006750; P:glutathione biosynthetic process; IDA:UniProtKB
P48507	GCLM	Glutamate--cysteine ligase regulatory subunit	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
P48507	GCLM	Glutamate--cysteine ligase regulatory subunit	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl
P48507	GCLM	Glutamate--cysteine ligase regulatory subunit	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P48507	GCLM	Glutamate--cysteine ligase regulatory subunit	GO:0035229; P:positive regulation of glutamate-cysteine ligase activity; IEA:Ensembl
P48507	GCLM	Glutamate--cysteine ligase regulatory subunit	GO:0050880; P:regulation of blood vessel size; IMP:UniProtKB
P48507	GCLM	Glutamate--cysteine ligase regulatory subunit	GO:0051900; P:regulation of mitochondrial depolarization; IEA:Ensembl
P48507	GCLM	Glutamate--cysteine ligase regulatory subunit	GO:0042493; P:response to drug; IDA:UniProtKB
P48507	GCLM	Glutamate--cysteine ligase regulatory subunit	GO:0051409; P:response to nitrosative stress; IEA:Ensembl
P48507	GCLM	Glutamate--cysteine ligase regulatory subunit	GO:0006979; P:response to oxidative stress; IDA:UniProtKB
P48507	GCLM	Glutamate--cysteine ligase regulatory subunit	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P48507	GCLM	Glutamate--cysteine ligase regulatory subunit	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
P48507	GCLM	Glutamate--cysteine ligase regulatory subunit	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0043531; F:ADP binding; IDA:UniProtKB
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0050662; F:coenzyme binding; IPI:UniProtKB
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0016595; F:glutamate binding; IDA:UniProtKB
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0004357; F:glutamate-cysteine ligase activity; IDA:UniProtKB
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0008637; P:apoptotic mitochondrial changes; IEA:Ensembl
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0045454; P:cell redox homeostasis; IDA:UniProtKB
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0006534; P:cysteine metabolic process; IDA:UniProtKB
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0006536; P:glutamate metabolic process; IDA:UniProtKB
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0006750; P:glutathione biosynthetic process; IDA:UniProtKB
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0019852; P:L-ascorbic acid metabolic process; IEA:Ensembl
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0031397; P:negative regulation of protein ubiquitination; IEA:Ensembl
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IEA:Ensembl
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0050880; P:regulation of blood vessel size; IMP:UniProtKB
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0051900; P:regulation of mitochondrial depolarization; IEA:Ensembl
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0046685; P:response to arsenic-containing substance; IEA:Ensembl
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0009408; P:response to heat; IDA:UniProtKB
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0009725; P:response to hormone; IDA:UniProtKB
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0051409; P:response to nitrosative stress; IEA:Ensembl
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0006979; P:response to oxidative stress; IDA:UniProtKB
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
P48506	GCLC	Glutamate--cysteine ligase catalytic subunit	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P48637	GSS	Glutathione synthetase	GO:0005524; F:ATP binding; IDA:UniProtKB
P48637	GSS	Glutathione synthetase	GO:0043295; F:glutathione binding; IDA:UniProtKB
P48637	GSS	Glutathione synthetase	GO:0004363; F:glutathione synthase activity; TAS:Reactome
P48637	GSS	Glutathione synthetase	GO:0016594; F:glycine binding; IEA:Ensembl
P48637	GSS	Glutathione synthetase	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
P48637	GSS	Glutathione synthetase	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P48637	GSS	Glutathione synthetase	GO:0007568; P:aging; IEA:Ensembl
P48637	GSS	Glutathione synthetase	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
P48637	GSS	Glutathione synthetase	GO:0006750; P:glutathione biosynthetic process; TAS:Reactome
P48637	GSS	Glutathione synthetase	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
P48637	GSS	Glutathione synthetase	GO:0007399; P:nervous system development; TAS:ProtInc
P48637	GSS	Glutathione synthetase	GO:0043200; P:response to amino acid; IEA:Ensembl
P48637	GSS	Glutathione synthetase	GO:0046686; P:response to cadmium ion; IEA:Ensembl
P48637	GSS	Glutathione synthetase	GO:0031667; P:response to nutrient levels; IEA:Ensembl
P48637	GSS	Glutathione synthetase	GO:0006979; P:response to oxidative stress; TAS:ProtInc
P48637	GSS	Glutathione synthetase	GO:0034612; P:response to tumor necrosis factor; IEA:Ensembl
P48637	GSS	Glutathione synthetase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P48637	GSS	Glutathione synthetase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P00390	GSR	Glutathione reductase, mitochondrial	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P00390	GSR	Glutathione reductase, mitochondrial	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
P00390	GSR	Glutathione reductase, mitochondrial	GO:0004362; F:glutathione-disulfide reductase activity; TAS:Reactome
P00390	GSR	Glutathione reductase, mitochondrial	GO:0050661; F:NADP binding; IEA:InterPro
P00390	GSR	Glutathione reductase, mitochondrial	GO:0045454; P:cell redox homeostasis; IEA:InterPro
P00390	GSR	Glutathione reductase, mitochondrial	GO:0006749; P:glutathione metabolic process; IEA:InterPro
P00390	GSR	Glutathione reductase, mitochondrial	GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome
P00390	GSR	Glutathione reductase, mitochondrial	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P00390	GSR	Glutathione reductase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0005515; F:protein binding; IPI:IntAct
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0034236; F:protein kinase A catalytic subunit binding; IPI:BHF-UCL
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0004674; F:protein serine/threonine kinase activity; IDA:BHF-UCL
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0050321; F:tau-protein kinase activity; TAS:UniProtKB
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0003214; P:cardiac left ventricle morphogenesis; ISS:BHF-UCL
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0032869; P:cellular response to insulin stimulus; IMP:BHF-UCL
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0036016; P:cellular response to interleukin-3; ISS:UniProtKB
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; ISS:UniProtKB
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0005977; P:glycogen metabolic process; IEA:UniProtKB-KW
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0045087; P:innate immune response; TAS:Reactome
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0008286; P:insulin receptor signaling pathway; ISS:BHF-UCL
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; TAS:UniProtKB
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0061052; P:negative regulation of cell growth involved in cardiac muscle cell development; ISS:BHF-UCL
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0046325; P:negative regulation of glucose import; IMP:BHF-UCL
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:2000466; P:negative regulation of glycogen (starch) synthase activity; TAS:UniProtKB
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0045719; P:negative regulation of glycogen biosynthetic process; TAS:UniProtKB
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0046627; P:negative regulation of insulin receptor signaling pathway; IMP:BHF-UCL
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0032007; P:negative regulation of TOR signaling; ISS:BHF-UCL
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0051348; P:negative regulation of transferase activity; IMP:BHF-UCL
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:2000077; P:negative regulation of type B pancreatic cell development; TAS:UniProtKB
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0010905; P:negative regulation of UDP-glucose catabolic process; IC:UniProtKB
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0071879; P:positive regulation of adrenergic receptor signaling pathway; ISS:BHF-UCL
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0030819; P:positive regulation of cAMP biosynthetic process; ISS:BHF-UCL
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:2000467; P:positive regulation of glycogen (starch) synthase activity; ISS:BHF-UCL
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0045823; P:positive regulation of heart contraction; ISS:BHF-UCL
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:1901030; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; ISS:UniProtKB
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0045732; P:positive regulation of protein catabolic process; NAS:BHF-UCL
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0006468; P:protein phosphorylation; IDA:BHF-UCL
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0003073; P:regulation of systemic arterial blood pressure; ISS:BHF-UCL
P49840	GSK3A	Glycogen synthase kinase-3 alpha	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0008013; F:beta-catenin binding; IPI:BHF-UCL
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0016301; F:kinase activity; IDA:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0051059; F:NF-kappaB binding; IPI:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0002039; F:p53 binding; IDA:MGI
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0005515; F:protein binding; IPI:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0034236; F:protein kinase A catalytic subunit binding; IPI:BHF-UCL
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0001085; F:RNA polymerase II transcription factor binding; IPI:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0050321; F:tau-protein kinase activity; IDA:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0031625; F:ubiquitin protein ligase binding; IPI:BHF-UCL
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0007411; P:axon guidance; TAS:Reactome
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0060070; P:canonical Wnt signaling pathway; IC:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0044337; P:canonical Wnt signaling pathway involved in positive regulation of apoptotic process; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0016477; P:cell migration; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0036016; P:cellular response to interleukin-3; ISS:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0007623; P:circadian rhythm; ISS:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0001837; P:epithelial to mesenchymal transition; IMP:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0006983; P:ER overload response; IDA:MGI
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0030010; P:establishment of cell polarity; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; ISS:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0045444; P:fat cell differentiation; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0005977; P:glycogen metabolic process; IDA:BHF-UCL
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0021766; P:hippocampus development; IMP:BHF-UCL
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0044027; P:hypermethylation of CpG island; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0045087; P:innate immune response; TAS:Reactome
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0035556; P:intracellular signal transduction; IDA:MGI
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0007520; P:myoblast fusion; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0043066; P:negative regulation of apoptotic process; IDA:MGI
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; TAS:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0010614; P:negative regulation of cardiac muscle hypertrophy; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0050774; P:negative regulation of dendrite morphogenesis; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:2000466; P:negative regulation of glycogen (starch) synthase activity; TAS:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0045719; P:negative regulation of glycogen biosynthetic process; TAS:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0043407; P:negative regulation of MAP kinase activity; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0051534; P:negative regulation of NFAT protein import into nucleus; IMP:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0032091; P:negative regulation of protein binding; IDA:BHF-UCL
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0031333; P:negative regulation of protein complex assembly; IMP:BHF-UCL
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:2000077; P:negative regulation of type B pancreatic cell development; TAS:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0009887; P:organ morphogenesis; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0001954; P:positive regulation of cell-matrix adhesion; IMP:BHF-UCL
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:1901030; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; ISS:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0032092; P:positive regulation of protein binding; ISS:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0045732; P:positive regulation of protein catabolic process; IC:BHF-UCL
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0031334; P:positive regulation of protein complex assembly; IDA:BHF-UCL
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0046827; P:positive regulation of protein export from nucleus; IDA:MGI
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0032855; P:positive regulation of Rac GTPase activity; IMP:BHF-UCL
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:2000738; P:positive regulation of stem cell differentiation; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0006611; P:protein export from nucleus; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0035372; P:protein localization to microtubule; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0000320; P:re-entry into mitotic cell cycle; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0006349; P:regulation of gene expression by genetic imprinting; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0032886; P:regulation of microtubule-based process; IMP:UniProtKB
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0048168; P:regulation of neuronal synaptic plasticity; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0042493; P:response to drug; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0010226; P:response to lithium ion; IEA:Ensembl
P49841	GSK3B	Glycogen synthase kinase-3 beta	GO:0071109; P:superior temporal gyrus development; IMP:BHF-UCL
Q92896	GLG1	Golgi apparatus protein 1	GO:0005102; F:receptor binding; TAS:ProtInc
Q92896	GLG1	Golgi apparatus protein 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q92896	GLG1	Golgi apparatus protein 1	GO:0060349; P:bone morphogenesis; IEA:Ensembl
Q92896	GLG1	Golgi apparatus protein 1	GO:0050900; P:leukocyte migration; TAS:Reactome
Q92896	GLG1	Golgi apparatus protein 1	GO:0010955; P:negative regulation of protein processing; IEA:Ensembl
Q92896	GLG1	Golgi apparatus protein 1	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl
Q92896	GLG1	Golgi apparatus protein 1	GO:0032330; P:regulation of chondrocyte differentiation; IEA:Ensembl
P0CG29	GSTT2	Glutathione S-transferase theta-2	GO:0004364; F:glutathione transferase activity; IEA:UniProtKB-EC
P08263	GSTA1	Glutathione S-transferase A1	GO:0004364; F:glutathione transferase activity; IDA:UniProtKB
P08263	GSTA1	Glutathione S-transferase A1	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
P08263	GSTA1	Glutathione S-transferase A1	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
P08263	GSTA1	Glutathione S-transferase A1	GO:0006749; P:glutathione metabolic process; IDA:UniProtKB
P08263	GSTA1	Glutathione S-transferase A1	GO:0008152; P:metabolic process; IC:UniProtKB
P08263	GSTA1	Glutathione S-transferase A1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P08263	GSTA1	Glutathione S-transferase A1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P09210	GSTA2	Glutathione S-transferase A2	GO:0004364; F:glutathione transferase activity; ISS:UniProtKB
P09210	GSTA2	Glutathione S-transferase A2	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
P09210	GSTA2	Glutathione S-transferase A2	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
P09210	GSTA2	Glutathione S-transferase A2	GO:0006749; P:glutathione metabolic process; ISS:UniProtKB
P09210	GSTA2	Glutathione S-transferase A2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P09210	GSTA2	Glutathione S-transferase A2	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q16772	GSTA3	Glutathione S-transferase A3	GO:0004364; F:glutathione transferase activity; ISS:UniProtKB
Q16772	GSTA3	Glutathione S-transferase A3	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
Q16772	GSTA3	Glutathione S-transferase A3	GO:0006749; P:glutathione metabolic process; ISS:UniProtKB
Q16772	GSTA3	Glutathione S-transferase A3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16772	GSTA3	Glutathione S-transferase A3	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
O15217	GSTA4	Glutathione S-transferase A4	GO:0004364; F:glutathione transferase activity; IDA:UniProtKB
O15217	GSTA4	Glutathione S-transferase A4	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
O15217	GSTA4	Glutathione S-transferase A4	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
O15217	GSTA4	Glutathione S-transferase A4	GO:0006749; P:glutathione metabolic process; IDA:UniProtKB
O15217	GSTA4	Glutathione S-transferase A4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15217	GSTA4	Glutathione S-transferase A4	GO:0006805; P:xenobiotic metabolic process; IDA:UniProtKB
Q7RTV2	GSTA5	Glutathione S-transferase A5	GO:0004364; F:glutathione transferase activity; ISS:UniProtKB
Q7RTV2	GSTA5	Glutathione S-transferase A5	GO:0006749; P:glutathione metabolic process; ISS:UniProtKB
Q8NEC7	GSTCD	Glutathione S-transferase C-terminal domain-containing protein	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2Q3	GSTK1	Glutathione S-transferase kappa 1	GO:0004602; F:glutathione peroxidase activity; IDA:UniProtKB
Q9Y2Q3	GSTK1	Glutathione S-transferase kappa 1	GO:0004364; F:glutathione transferase activity; IDA:UniProtKB
Q9Y2Q3	GSTK1	Glutathione S-transferase kappa 1	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
Q9Y2Q3	GSTK1	Glutathione S-transferase kappa 1	GO:0005102; F:receptor binding; IPI:UniProtKB
Q9Y2Q3	GSTK1	Glutathione S-transferase kappa 1	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
Q9Y2Q3	GSTK1	Glutathione S-transferase kappa 1	GO:0006749; P:glutathione metabolic process; IEA:Ensembl
Q9Y2Q3	GSTK1	Glutathione S-transferase kappa 1	GO:0055114; P:oxidation-reduction process; IDA:GOC
P09488	GSTM1	Glutathione S-transferase Mu 1	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P09488	GSTM1	Glutathione S-transferase Mu 1	GO:0043295; F:glutathione binding; IDA:BHF-UCL
P09488	GSTM1	Glutathione S-transferase Mu 1	GO:0004364; F:glutathione transferase activity; IDA:BHF-UCL
P09488	GSTM1	Glutathione S-transferase Mu 1	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P09488	GSTM1	Glutathione S-transferase Mu 1	GO:0070458; P:cellular detoxification of nitrogen compound; IDA:BHF-UCL
P09488	GSTM1	Glutathione S-transferase Mu 1	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
P09488	GSTM1	Glutathione S-transferase Mu 1	GO:0006749; P:glutathione metabolic process; IDA:BHF-UCL
P09488	GSTM1	Glutathione S-transferase Mu 1	GO:0018916; P:nitrobenzene metabolic process; IDA:BHF-UCL
P09488	GSTM1	Glutathione S-transferase Mu 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P09488	GSTM1	Glutathione S-transferase Mu 1	GO:0042178; P:xenobiotic catabolic process; IDA:BHF-UCL
P09488	GSTM1	Glutathione S-transferase Mu 1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P28161	GSTM2	Glutathione S-transferase Mu 2	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P28161	GSTM2	Glutathione S-transferase Mu 2	GO:0043295; F:glutathione binding; IDA:BHF-UCL
P28161	GSTM2	Glutathione S-transferase Mu 2	GO:0004364; F:glutathione transferase activity; IDA:UniProtKB
P28161	GSTM2	Glutathione S-transferase Mu 2	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P28161	GSTM2	Glutathione S-transferase Mu 2	GO:0005102; F:receptor binding; IPI:BHF-UCL
P28161	GSTM2	Glutathione S-transferase Mu 2	GO:0070458; P:cellular detoxification of nitrogen compound; IDA:BHF-UCL
P28161	GSTM2	Glutathione S-transferase Mu 2	GO:0071313; P:cellular response to caffeine; IDA:BHF-UCL
P28161	GSTM2	Glutathione S-transferase Mu 2	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
P28161	GSTM2	Glutathione S-transferase Mu 2	GO:0006749; P:glutathione metabolic process; IDA:UniProtKB
P28161	GSTM2	Glutathione S-transferase Mu 2	GO:0060315; P:negative regulation of ryanodine-sensitive calcium-release channel activity; IDA:BHF-UCL
P28161	GSTM2	Glutathione S-transferase Mu 2	GO:0018916; P:nitrobenzene metabolic process; IDA:BHF-UCL
P28161	GSTM2	Glutathione S-transferase Mu 2	GO:0060316; P:positive regulation of ryanodine-sensitive calcium-release channel activity; IDA:BHF-UCL
P28161	GSTM2	Glutathione S-transferase Mu 2	GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; IC:BHF-UCL
P28161	GSTM2	Glutathione S-transferase Mu 2	GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; IDA:BHF-UCL
P28161	GSTM2	Glutathione S-transferase Mu 2	GO:0014809; P:regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; IC:BHF-UCL
P28161	GSTM2	Glutathione S-transferase Mu 2	GO:0055119; P:relaxation of cardiac muscle; TAS:BHF-UCL
P28161	GSTM2	Glutathione S-transferase Mu 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P28161	GSTM2	Glutathione S-transferase Mu 2	GO:0042178; P:xenobiotic catabolic process; IDA:UniProtKB
P28161	GSTM2	Glutathione S-transferase Mu 2	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P21266	GSTM3	Glutathione S-transferase Mu 3	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P21266	GSTM3	Glutathione S-transferase Mu 3	GO:0043295; F:glutathione binding; IDA:BHF-UCL
P21266	GSTM3	Glutathione S-transferase Mu 3	GO:0004364; F:glutathione transferase activity; IDA:UniProtKB
P21266	GSTM3	Glutathione S-transferase Mu 3	GO:0042802; F:identical protein binding; IPI:IntAct
P21266	GSTM3	Glutathione S-transferase Mu 3	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P21266	GSTM3	Glutathione S-transferase Mu 3	GO:0070458; P:cellular detoxification of nitrogen compound; IDA:BHF-UCL
P21266	GSTM3	Glutathione S-transferase Mu 3	GO:0008065; P:establishment of blood-nerve barrier; TAS:ProtInc
P21266	GSTM3	Glutathione S-transferase Mu 3	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
P21266	GSTM3	Glutathione S-transferase Mu 3	GO:0006749; P:glutathione metabolic process; IDA:UniProtKB
P21266	GSTM3	Glutathione S-transferase Mu 3	GO:0018916; P:nitrobenzene metabolic process; IDA:BHF-UCL
P21266	GSTM3	Glutathione S-transferase Mu 3	GO:0043627; P:response to estrogen; IEP:UniProtKB
P21266	GSTM3	Glutathione S-transferase Mu 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P21266	GSTM3	Glutathione S-transferase Mu 3	GO:0042178; P:xenobiotic catabolic process; IDA:BHF-UCL
P21266	GSTM3	Glutathione S-transferase Mu 3	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q03013	GSTM4	Glutathione S-transferase Mu 4	GO:0019899; F:enzyme binding; IPI:BHF-UCL
Q03013	GSTM4	Glutathione S-transferase Mu 4	GO:0043295; F:glutathione binding; IDA:BHF-UCL
Q03013	GSTM4	Glutathione S-transferase Mu 4	GO:0004364; F:glutathione transferase activity; IDA:BHF-UCL
Q03013	GSTM4	Glutathione S-transferase Mu 4	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q03013	GSTM4	Glutathione S-transferase Mu 4	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
Q03013	GSTM4	Glutathione S-transferase Mu 4	GO:0006749; P:glutathione metabolic process; IDA:BHF-UCL
Q03013	GSTM4	Glutathione S-transferase Mu 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q03013	GSTM4	Glutathione S-transferase Mu 4	GO:0042178; P:xenobiotic catabolic process; IDA:BHF-UCL
Q03013	GSTM4	Glutathione S-transferase Mu 4	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P46439	GSTM5	Glutathione S-transferase Mu 5	GO:0004364; F:glutathione transferase activity; IDA:UniProtKB
P46439	GSTM5	Glutathione S-transferase Mu 5	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
P46439	GSTM5	Glutathione S-transferase Mu 5	GO:0006749; P:glutathione metabolic process; IDA:UniProtKB
P46439	GSTM5	Glutathione S-transferase Mu 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P46439	GSTM5	Glutathione S-transferase Mu 5	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P78417	GSTO1	Glutathione S-transferase omega-1	GO:0045174; F:glutathione dehydrogenase (ascorbate) activity; IDA:UniProtKB
P78417	GSTO1	Glutathione S-transferase omega-1	GO:0004364; F:glutathione transferase activity; IDA:UniProtKB
P78417	GSTO1	Glutathione S-transferase omega-1	GO:0050610; F:methylarsonate reductase activity; IEA:UniProtKB-EC
P78417	GSTO1	Glutathione S-transferase omega-1	GO:0016491; F:oxidoreductase activity; IDA:UniProtKB
P78417	GSTO1	Glutathione S-transferase omega-1	GO:0071243; P:cellular response to arsenic-containing substance; IDA:UniProtKB
P78417	GSTO1	Glutathione S-transferase omega-1	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
P78417	GSTO1	Glutathione S-transferase omega-1	GO:0019852; P:L-ascorbic acid metabolic process; IDA:UniProtKB
P78417	GSTO1	Glutathione S-transferase omega-1	GO:0060315; P:negative regulation of ryanodine-sensitive calcium-release channel activity; IDA:BHF-UCL
P78417	GSTO1	Glutathione S-transferase omega-1	GO:0060316; P:positive regulation of ryanodine-sensitive calcium-release channel activity; IDA:BHF-UCL
P78417	GSTO1	Glutathione S-transferase omega-1	GO:0014810; P:positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion; IC:BHF-UCL
P78417	GSTO1	Glutathione S-transferase omega-1	GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; IC:BHF-UCL
P78417	GSTO1	Glutathione S-transferase omega-1	GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; IDA:BHF-UCL
P78417	GSTO1	Glutathione S-transferase omega-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P78417	GSTO1	Glutathione S-transferase omega-1	GO:0042178; P:xenobiotic catabolic process; IDA:UniProtKB
P78417	GSTO1	Glutathione S-transferase omega-1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9H4Y5	GSTO2	Glutathione S-transferase omega-2	GO:0045174; F:glutathione dehydrogenase (ascorbate) activity; IDA:UniProtKB
Q9H4Y5	GSTO2	Glutathione S-transferase omega-2	GO:0004364; F:glutathione transferase activity; IEA:UniProtKB-EC
Q9H4Y5	GSTO2	Glutathione S-transferase omega-2	GO:0050610; F:methylarsonate reductase activity; IEA:UniProtKB-EC
Q9H4Y5	GSTO2	Glutathione S-transferase omega-2	GO:0016491; F:oxidoreductase activity; IDA:UniProtKB
Q9H4Y5	GSTO2	Glutathione S-transferase omega-2	GO:0071243; P:cellular response to arsenic-containing substance; IDA:UniProtKB
Q9H4Y5	GSTO2	Glutathione S-transferase omega-2	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
Q9H4Y5	GSTO2	Glutathione S-transferase omega-2	GO:0019852; P:L-ascorbic acid metabolic process; IDA:UniProtKB
Q9H4Y5	GSTO2	Glutathione S-transferase omega-2	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q9H4Y5	GSTO2	Glutathione S-transferase omega-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H4Y5	GSTO2	Glutathione S-transferase omega-2	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9H4Y5	GSTO2	Glutathione S-transferase omega-2	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9H4Y5	GSTO2	Glutathione S-transferase omega-2	GO:0006805; P:xenobiotic metabolic process; IDA:UniProtKB
P09211	GSTP1	Glutathione S-transferase P	GO:0035731; F:dinitrosyl-iron complex binding; IDA:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0004364; F:glutathione transferase activity; IDA:UniProtKB
P09211	GSTP1	Glutathione S-transferase P	GO:0008432; F:JUN kinase binding; ISS:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0019207; F:kinase regulator activity; ISS:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0070026; F:nitric oxide binding; NAS:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0005515; F:protein binding; IPI:IntAct
P09211	GSTP1	Glutathione S-transferase P	GO:0035730; F:S-nitrosoglutathione binding; IDA:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0071222; P:cellular response to lipopolysaccharide; ISS:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0007417; P:central nervous system development; TAS:ProtInc
P09211	GSTP1	Glutathione S-transferase P	GO:0035726; P:common myeloid progenitor cell proliferation; ISS:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
P09211	GSTP1	Glutathione S-transferase P	GO:0006749; P:glutathione metabolic process; IDA:UniProtKB
P09211	GSTP1	Glutathione S-transferase P	GO:0002674; P:negative regulation of acute inflammatory response; NAS:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
P09211	GSTP1	Glutathione S-transferase P	GO:0009890; P:negative regulation of biosynthetic process; IDA:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IDA:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0048147; P:negative regulation of fibroblast proliferation; ISS:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; ISS:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0032691; P:negative regulation of interleukin-1 beta production; IDA:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0043508; P:negative regulation of JUN kinase activity; IDA:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0070664; P:negative regulation of leukocyte proliferation; ISS:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0043407; P:negative regulation of MAP kinase activity; IDA:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0043409; P:negative regulation of MAPK cascade; NAS:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0071638; P:negative regulation of monocyte chemotactic protein-1 production; IDA:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0051771; P:negative regulation of nitric-oxide synthase biosynthetic process; IDA:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0006469; P:negative regulation of protein kinase activity; IDA:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0032873; P:negative regulation of stress-activated MAPK cascade; ISS:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0032720; P:negative regulation of tumor necrosis factor production; IDA:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; IC:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0035732; P:nitric oxide storage; NAS:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0032930; P:positive regulation of superoxide anion generation; ISS:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0070372; P:regulation of ERK1 and ERK2 cascade; ISS:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0032872; P:regulation of stress-activated MAPK cascade; ISS:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0000302; P:response to reactive oxygen species; ISS:BHF-UCL
P09211	GSTP1	Glutathione S-transferase P	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P09211	GSTP1	Glutathione S-transferase P	GO:0006805; P:xenobiotic metabolic process; IDA:UniProtKB
P30711	GSTT1	Glutathione S-transferase theta-1	GO:0004602; F:glutathione peroxidase activity; IDA:UniProtKB
P30711	GSTT1	Glutathione S-transferase theta-1	GO:0004364; F:glutathione transferase activity; IDA:UniProtKB
P30711	GSTT1	Glutathione S-transferase theta-1	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
P30711	GSTT1	Glutathione S-transferase theta-1	GO:0006749; P:glutathione metabolic process; IDA:UniProtKB
P30711	GSTT1	Glutathione S-transferase theta-1	GO:0055114; P:oxidation-reduction process; IDA:GOC
P30711	GSTT1	Glutathione S-transferase theta-1	GO:0042493; P:response to drug; IEA:Ensembl
P30711	GSTT1	Glutathione S-transferase theta-1	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P30711	GSTT1	Glutathione S-transferase theta-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P30711	GSTT1	Glutathione S-transferase theta-1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P0CG30	GSTT2B	Glutathione S-transferase theta-2B	GO:0004364; F:glutathione transferase activity; NAS:UniProtKB
P0CG30	GSTT2B	Glutathione S-transferase theta-2B	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
P0CG30	GSTT2B	Glutathione S-transferase theta-2B	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P0CG30	GSTT2B	Glutathione S-transferase theta-2B	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9H4S2	GSX1	GS homeobox 1	GO:0043565; F:sequence-specific DNA binding; IDA:MGI
Q9H4S2	GSX1	GS homeobox 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9H4S2	GSX1	GS homeobox 1	GO:0021984; P:adenohypophysis development; IEA:Ensembl
Q9H4S2	GSX1	GS homeobox 1	GO:0021854; P:hypothalamus development; IEA:Ensembl
Q9H4S2	GSX1	GS homeobox 1	GO:0048663; P:neuron fate commitment; IEA:Ensembl
Q9H4S2	GSX1	GS homeobox 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q9H4S2	GSX1	GS homeobox 1	GO:0021527; P:spinal cord association neuron differentiation; IEA:Ensembl
Q9H4S2	GSX1	GS homeobox 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BZM3	GSX2	GS homeobox 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9BZM3	GSX2	GS homeobox 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9BZM3	GSX2	GS homeobox 2	GO:0021798; P:forebrain dorsal/ventral pattern formation; IEA:Ensembl
Q9BZM3	GSX2	GS homeobox 2	GO:0048853; P:forebrain morphogenesis; IEA:Ensembl
Q9BZM3	GSX2	GS homeobox 2	GO:0021575; P:hindbrain morphogenesis; IEA:Ensembl
Q9BZM3	GSX2	GS homeobox 2	GO:0048665; P:neuron fate specification; IEA:Ensembl
Q9BZM3	GSX2	GS homeobox 2	GO:0021889; P:olfactory bulb interneuron differentiation; IEA:Ensembl
Q9BZM3	GSX2	GS homeobox 2	GO:0045747; P:positive regulation of Notch signaling pathway; IEA:Ensembl
Q9BZM3	GSX2	GS homeobox 2	GO:0048714; P:positive regulation of oligodendrocyte differentiation; IEA:Ensembl
Q9BZM3	GSX2	GS homeobox 2	GO:0002087; P:regulation of respiratory gaseous exchange by neurological system process; IEA:Ensembl
Q9BZM3	GSX2	GS homeobox 2	GO:0021527; P:spinal cord association neuron differentiation; IEA:Ensembl
Q9BZM3	GSX2	GS homeobox 2	GO:0060163; P:subpallium neuron fate commitment; IEA:Ensembl
Q9BZM3	GSX2	GS homeobox 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NBJ5	COLGALT1	Procollagen galactosyltransferase 1	GO:0050211; F:procollagen galactosyltransferase activity; IEA:UniProtKB-EC
Q8NBJ5	COLGALT1	Procollagen galactosyltransferase 1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q8NBJ5	COLGALT1	Procollagen galactosyltransferase 1	GO:0009103; P:lipopolysaccharide biosynthetic process; IEA:InterPro
Q8IYK4	COLGALT2	Procollagen galactosyltransferase 2	GO:0050211; F:procollagen galactosyltransferase activity; IEA:UniProtKB-EC
Q8IYK4	COLGALT2	Procollagen galactosyltransferase 2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q8IYK4	COLGALT2	Procollagen galactosyltransferase 2	GO:0009103; P:lipopolysaccharide biosynthetic process; IEA:InterPro
Q9UHL9	GTF2IRD1	General transcription factor II-I repeat domain-containing protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UHL9	GTF2IRD1	General transcription factor II-I repeat domain-containing protein 1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9UHL9	GTF2IRD1	General transcription factor II-I repeat domain-containing protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9UHL9	GTF2IRD1	General transcription factor II-I repeat domain-containing protein 1	GO:0009790; P:embryo development; IEA:Ensembl
Q9UHL9	GTF2IRD1	General transcription factor II-I repeat domain-containing protein 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; NAS:GOC
Q9UHL9	GTF2IRD1	General transcription factor II-I repeat domain-containing protein 1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9UHL9	GTF2IRD1	General transcription factor II-I repeat domain-containing protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; NAS:GOC
Q5T4B2	CERCAM	Probable inactive glycosyltransferase 25 family member 3	GO:0007155; P:cell adhesion; IDA:MGI
Q5T4B2	CERCAM	Probable inactive glycosyltransferase 25 family member 3	GO:0006928; P:cellular component movement; TAS:ProtInc
Q5T4B2	CERCAM	Probable inactive glycosyltransferase 25 family member 3	GO:0007159; P:leukocyte cell-cell adhesion; TAS:ProtInc
Q5T4B2	CERCAM	Probable inactive glycosyltransferase 25 family member 3	GO:0009103; P:lipopolysaccharide biosynthetic process; IEA:InterPro
Q86UP8	GTF2IRD2	General transcription factor II-I repeat domain-containing protein 2A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86UP8	GTF2IRD2	General transcription factor II-I repeat domain-containing protein 2A	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q86UP8	GTF2IRD2	General transcription factor II-I repeat domain-containing protein 2A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6EKJ0	GTF2IRD2B	General transcription factor II-I repeat domain-containing protein 2B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6EKJ0	GTF2IRD2B	General transcription factor II-I repeat domain-containing protein 2B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6EKJ0	GTF2IRD2B	General transcription factor II-I repeat domain-containing protein 2B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q4AE62	GTDC1	Glycosyltransferase-like domain-containing protein 1	GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW
Q4AE62	GTDC1	Glycosyltransferase-like domain-containing protein 1	GO:0009058; P:biosynthetic process; IEA:InterPro
P78347	GTF2I	General transcription factor II-I	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P78347	GTF2I	General transcription factor II-I	GO:0005515; F:protein binding; IPI:IntAct
P78347	GTF2I	General transcription factor II-I	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
P78347	GTF2I	General transcription factor II-I	GO:0009790; P:embryo development; IEA:Ensembl
P78347	GTF2I	General transcription factor II-I	GO:0016525; P:negative regulation of angiogenesis; IDA:MGI
P78347	GTF2I	General transcription factor II-I	GO:0051481; P:negative regulation of cytosolic calcium ion concentration; IEA:Ensembl
P78347	GTF2I	General transcription factor II-I	GO:0007165; P:signal transduction; TAS:ProtInc
P78347	GTF2I	General transcription factor II-I	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P78347	GTF2I	General transcription factor II-I	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:ProtInc
O00178	GTPBP1	GTP-binding protein 1	GO:0005525; F:GTP binding; TAS:ProtInc
O00178	GTPBP1	GTP-binding protein 1	GO:0003924; F:GTPase activity; ISS:UniProtKB
O00178	GTPBP1	GTP-binding protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O00178	GTPBP1	GTP-binding protein 1	GO:0006184; P:GTP catabolic process; ISS:UniProtKB
O00178	GTPBP1	GTP-binding protein 1	GO:0006955; P:immune response; TAS:ProtInc
O00178	GTPBP1	GTP-binding protein 1	GO:0061014; P:positive regulation of mRNA catabolic process; ISS:UniProtKB
O00178	GTPBP1	GTP-binding protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q9BX10	GTPBP2	GTP-binding protein 2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9BX10	GTPBP2	GTP-binding protein 2	GO:0003924; F:GTPase activity; IEA:InterPro
Q9BX10	GTPBP2	GTP-binding protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q969Y2	GTPBP3	tRNA modification GTPase GTPBP3, mitochondrial	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q969Y2	GTPBP3	tRNA modification GTPase GTPBP3, mitochondrial	GO:0003924; F:GTPase activity; IEA:InterPro
Q969Y2	GTPBP3	tRNA modification GTPase GTPBP3, mitochondrial	GO:0006400; P:tRNA modification; IEA:InterPro
O43824	GTPBP6	Putative GTP-binding protein 6	GO:0005525; F:GTP binding; TAS:ProtInc
Q8N3Z3	GTPBP8	GTP-binding protein 8	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q8N3Z3	GTPBP8	GTP-binding protein 8	GO:0000917; P:barrier septum assembly; IEA:InterPro
A4D1E9	GTPBP10	GTP-binding protein 10	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
A4D1E9	GTPBP10	GTP-binding protein 10	GO:0003924; F:GTPase activity; IEA:InterPro
A4D1E9	GTPBP10	GTP-binding protein 10	GO:0000287; F:magnesium ion binding; IEA:InterPro
A4D1E9	GTPBP10	GTP-binding protein 10	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
A4D1E9	GTPBP10	GTP-binding protein 10	GO:0042254; P:ribosome biogenesis; IEA:UniProtKB-KW
Q9GZT8	NIF3L1	Putative GTP cyclohydrolase 1 type 2 NIF3L1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9GZT8	NIF3L1	Putative GTP cyclohydrolase 1 type 2 NIF3L1	GO:0003934; F:GTP cyclohydrolase I activity; IEA:UniProtKB-EC
Q9GZT8	NIF3L1	Putative GTP cyclohydrolase 1 type 2 NIF3L1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9GZT8	NIF3L1	Putative GTP cyclohydrolase 1 type 2 NIF3L1	GO:0005515; F:protein binding; IPI:IntAct
Q9GZT8	NIF3L1	Putative GTP cyclohydrolase 1 type 2 NIF3L1	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
Q9GZT8	NIF3L1	Putative GTP cyclohydrolase 1 type 2 NIF3L1	GO:0035998; P:7,8-dihydroneopterin 3'-triphosphate biosynthetic process; IEA:UniProtKB-UniPathway
Q9GZT8	NIF3L1	Putative GTP cyclohydrolase 1 type 2 NIF3L1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
O95528	SLC2A10	Solute carrier family 2, facilitated glucose transporter member 10	GO:0005351; F:sugar:proton symporter activity; NAS:UniProtKB
O95528	SLC2A10	Solute carrier family 2, facilitated glucose transporter member 10	GO:0015758; P:glucose transport; NAS:UniProtKB
O95528	SLC2A10	Solute carrier family 2, facilitated glucose transporter member 10	GO:0015992; P:proton transport; NAS:GOC
O95528	SLC2A10	Solute carrier family 2, facilitated glucose transporter member 10	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9BYW1	SLC2A11	Solute carrier family 2, facilitated glucose transporter member 11	GO:0022891; F:substrate-specific transmembrane transporter activity; IEA:InterPro
Q9BYW1	SLC2A11	Solute carrier family 2, facilitated glucose transporter member 11	GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW
Q9BYW1	SLC2A11	Solute carrier family 2, facilitated glucose transporter member 11	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8TD20	SLC2A12	Solute carrier family 2, facilitated glucose transporter member 12	GO:0022891; F:substrate-specific transmembrane transporter activity; IEA:InterPro
Q8TD20	SLC2A12	Solute carrier family 2, facilitated glucose transporter member 12	GO:0015758; P:glucose transport; IEA:Ensembl
Q8TD20	SLC2A12	Solute carrier family 2, facilitated glucose transporter member 12	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8TDB8	SLC2A14	Solute carrier family 2, facilitated glucose transporter member 14	GO:0005355; F:glucose transmembrane transporter activity; IEA:InterPro
Q8TDB8	SLC2A14	Solute carrier family 2, facilitated glucose transporter member 14	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8TDB8	SLC2A14	Solute carrier family 2, facilitated glucose transporter member 14	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8TDB8	SLC2A14	Solute carrier family 2, facilitated glucose transporter member 14	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
P11166	SLC2A1	Solute carrier family 2, facilitated glucose transporter member 1	GO:0055056; F:D-glucose transmembrane transporter activity; IEA:Ensembl
P11166	SLC2A1	Solute carrier family 2, facilitated glucose transporter member 1	GO:0033300; F:dehydroascorbic acid transporter activity; IEA:Ensembl
P11166	SLC2A1	Solute carrier family 2, facilitated glucose transporter member 1	GO:0005355; F:glucose transmembrane transporter activity; TAS:ProtInc
P11166	SLC2A1	Solute carrier family 2, facilitated glucose transporter member 1	GO:0042802; F:identical protein binding; IPI:IntAct
P11166	SLC2A1	Solute carrier family 2, facilitated glucose transporter member 1	GO:0005515; F:protein binding; IPI:UniProtKB
P11166	SLC2A1	Solute carrier family 2, facilitated glucose transporter member 1	GO:0043621; F:protein self-association; IDA:UniProtKB
P11166	SLC2A1	Solute carrier family 2, facilitated glucose transporter member 1	GO:0042910; F:xenobiotic transporter activity; IEA:Ensembl
P11166	SLC2A1	Solute carrier family 2, facilitated glucose transporter member 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P11166	SLC2A1	Solute carrier family 2, facilitated glucose transporter member 1	GO:0042149; P:cellular response to glucose starvation; IEA:Ensembl
P11166	SLC2A1	Solute carrier family 2, facilitated glucose transporter member 1	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P11166	SLC2A1	Solute carrier family 2, facilitated glucose transporter member 1	GO:0015758; P:glucose transport; TAS:Reactome
P11166	SLC2A1	Solute carrier family 2, facilitated glucose transporter member 1	GO:0008645; P:hexose transport; TAS:Reactome
P11166	SLC2A1	Solute carrier family 2, facilitated glucose transporter member 1	GO:0019852; P:L-ascorbic acid metabolic process; TAS:Reactome
P11166	SLC2A1	Solute carrier family 2, facilitated glucose transporter member 1	GO:0006461; P:protein complex assembly; IDA:UniProtKB
P11166	SLC2A1	Solute carrier family 2, facilitated glucose transporter member 1	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P11166	SLC2A1	Solute carrier family 2, facilitated glucose transporter member 1	GO:0006970; P:response to osmotic stress; IEA:Ensembl
P11166	SLC2A1	Solute carrier family 2, facilitated glucose transporter member 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P11166	SLC2A1	Solute carrier family 2, facilitated glucose transporter member 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P11166	SLC2A1	Solute carrier family 2, facilitated glucose transporter member 1	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P11166	SLC2A1	Solute carrier family 2, facilitated glucose transporter member 1	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
P11168	SLC2A2	Solute carrier family 2, facilitated glucose transporter member 2	GO:0055056; F:D-glucose transmembrane transporter activity; IEA:Ensembl
P11168	SLC2A2	Solute carrier family 2, facilitated glucose transporter member 2	GO:0033300; F:dehydroascorbic acid transporter activity; IEA:Ensembl
P11168	SLC2A2	Solute carrier family 2, facilitated glucose transporter member 2	GO:0005355; F:glucose transmembrane transporter activity; EXP:Reactome
P11168	SLC2A2	Solute carrier family 2, facilitated glucose transporter member 2	GO:0015149; F:hexose transmembrane transporter activity; TAS:Reactome
P11168	SLC2A2	Solute carrier family 2, facilitated glucose transporter member 2	GO:0022891; F:substrate-specific transmembrane transporter activity; IEA:InterPro
P11168	SLC2A2	Solute carrier family 2, facilitated glucose transporter member 2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P11168	SLC2A2	Solute carrier family 2, facilitated glucose transporter member 2	GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW
P11168	SLC2A2	Solute carrier family 2, facilitated glucose transporter member 2	GO:0031018; P:endocrine pancreas development; TAS:Reactome
P11168	SLC2A2	Solute carrier family 2, facilitated glucose transporter member 2	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P11168	SLC2A2	Solute carrier family 2, facilitated glucose transporter member 2	GO:0015758; P:glucose transport; TAS:Reactome
P11168	SLC2A2	Solute carrier family 2, facilitated glucose transporter member 2	GO:0035428; P:hexose transmembrane transport; TAS:GOC
P11168	SLC2A2	Solute carrier family 2, facilitated glucose transporter member 2	GO:0008645; P:hexose transport; TAS:Reactome
P11168	SLC2A2	Solute carrier family 2, facilitated glucose transporter member 2	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P11168	SLC2A2	Solute carrier family 2, facilitated glucose transporter member 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P11168	SLC2A2	Solute carrier family 2, facilitated glucose transporter member 2	GO:0055085; P:transmembrane transport; TAS:Reactome
P11169	SLC2A3	Solute carrier family 2, facilitated glucose transporter member 3	GO:0005355; F:glucose transmembrane transporter activity; TAS:ProtInc
P11169	SLC2A3	Solute carrier family 2, facilitated glucose transporter member 3	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P11169	SLC2A3	Solute carrier family 2, facilitated glucose transporter member 3	GO:0015758; P:glucose transport; TAS:Reactome
P11169	SLC2A3	Solute carrier family 2, facilitated glucose transporter member 3	GO:0008645; P:hexose transport; TAS:Reactome
P11169	SLC2A3	Solute carrier family 2, facilitated glucose transporter member 3	GO:0019852; P:L-ascorbic acid metabolic process; TAS:Reactome
P11169	SLC2A3	Solute carrier family 2, facilitated glucose transporter member 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P11169	SLC2A3	Solute carrier family 2, facilitated glucose transporter member 3	GO:0055085; P:transmembrane transport; TAS:Reactome
P11169	SLC2A3	Solute carrier family 2, facilitated glucose transporter member 3	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P11169	SLC2A3	Solute carrier family 2, facilitated glucose transporter member 3	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
P14672	SLC2A4	Solute carrier family 2, facilitated glucose transporter member 4	GO:0055056; F:D-glucose transmembrane transporter activity; IEA:Ensembl
P14672	SLC2A4	Solute carrier family 2, facilitated glucose transporter member 4	GO:0005355; F:glucose transmembrane transporter activity; TAS:ProtInc
P14672	SLC2A4	Solute carrier family 2, facilitated glucose transporter member 4	GO:0005515; F:protein binding; IPI:UniProtKB
P14672	SLC2A4	Solute carrier family 2, facilitated glucose transporter member 4	GO:0010021; P:amylopectin biosynthetic process; IEA:Ensembl
P14672	SLC2A4	Solute carrier family 2, facilitated glucose transporter member 4	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
P14672	SLC2A4	Solute carrier family 2, facilitated glucose transporter member 4	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P14672	SLC2A4	Solute carrier family 2, facilitated glucose transporter member 4	GO:0032869; P:cellular response to insulin stimulus; IDA:UniProtKB
P14672	SLC2A4	Solute carrier family 2, facilitated glucose transporter member 4	GO:0071470; P:cellular response to osmotic stress; IEA:Ensembl
P14672	SLC2A4	Solute carrier family 2, facilitated glucose transporter member 4	GO:0042593; P:glucose homeostasis; IDA:BHF-UCL
P14672	SLC2A4	Solute carrier family 2, facilitated glucose transporter member 4	GO:0046323; P:glucose import; NAS:BHF-UCL
P14672	SLC2A4	Solute carrier family 2, facilitated glucose transporter member 4	GO:0015758; P:glucose transport; TAS:UniProtKB
P14672	SLC2A4	Solute carrier family 2, facilitated glucose transporter member 4	GO:0008645; P:hexose transport; TAS:Reactome
P14672	SLC2A4	Solute carrier family 2, facilitated glucose transporter member 4	GO:0061024; P:membrane organization; TAS:Reactome
P14672	SLC2A4	Solute carrier family 2, facilitated glucose transporter member 4	GO:0045471; P:response to ethanol; IEA:Ensembl
P14672	SLC2A4	Solute carrier family 2, facilitated glucose transporter member 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P14672	SLC2A4	Solute carrier family 2, facilitated glucose transporter member 4	GO:0055085; P:transmembrane transport; TAS:Reactome
P22732	SLC2A5	Solute carrier family 2, facilitated glucose transporter member 5	GO:0005353; F:fructose transmembrane transporter activity; TAS:ProtInc
P22732	SLC2A5	Solute carrier family 2, facilitated glucose transporter member 5	GO:0005355; F:glucose transmembrane transporter activity; TAS:ProtInc
P22732	SLC2A5	Solute carrier family 2, facilitated glucose transporter member 5	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P22732	SLC2A5	Solute carrier family 2, facilitated glucose transporter member 5	GO:0071332; P:cellular response to fructose stimulus; ISS:UniProtKB
P22732	SLC2A5	Solute carrier family 2, facilitated glucose transporter member 5	GO:0015755; P:fructose transport; TAS:ProtInc
P22732	SLC2A5	Solute carrier family 2, facilitated glucose transporter member 5	GO:0015758; P:glucose transport; TAS:ProtInc
P22732	SLC2A5	Solute carrier family 2, facilitated glucose transporter member 5	GO:0008645; P:hexose transport; TAS:Reactome
P22732	SLC2A5	Solute carrier family 2, facilitated glucose transporter member 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P22732	SLC2A5	Solute carrier family 2, facilitated glucose transporter member 5	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UGQ3	SLC2A6	Solute carrier family 2, facilitated glucose transporter member 6	GO:0005355; F:glucose transmembrane transporter activity; NAS:UniProtKB
Q9UGQ3	SLC2A6	Solute carrier family 2, facilitated glucose transporter member 6	GO:0015758; P:glucose transport; NAS:GOC
Q9UGQ3	SLC2A6	Solute carrier family 2, facilitated glucose transporter member 6	GO:0055085; P:transmembrane transport; TAS:Reactome
Q6PXP3	SLC2A7	Solute carrier family 2, facilitated glucose transporter member 7	GO:0022891; F:substrate-specific transmembrane transporter activity; IEA:InterPro
Q6PXP3	SLC2A7	Solute carrier family 2, facilitated glucose transporter member 7	GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW
Q6PXP3	SLC2A7	Solute carrier family 2, facilitated glucose transporter member 7	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9NY64	SLC2A8	Solute carrier family 2, facilitated glucose transporter member 8	GO:0005536; F:glucose binding; IEA:Ensembl
Q9NY64	SLC2A8	Solute carrier family 2, facilitated glucose transporter member 8	GO:0005355; F:glucose transmembrane transporter activity; TAS:ProtInc
Q9NY64	SLC2A8	Solute carrier family 2, facilitated glucose transporter member 8	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
Q9NY64	SLC2A8	Solute carrier family 2, facilitated glucose transporter member 8	GO:0015758; P:glucose transport; TAS:ProtInc
Q9NY64	SLC2A8	Solute carrier family 2, facilitated glucose transporter member 8	GO:0008286; P:insulin receptor signaling pathway; IEA:Ensembl
Q9NY64	SLC2A8	Solute carrier family 2, facilitated glucose transporter member 8	GO:0007141; P:male meiosis I; IEA:Ensembl
Q9NY64	SLC2A8	Solute carrier family 2, facilitated glucose transporter member 8	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q9NY64	SLC2A8	Solute carrier family 2, facilitated glucose transporter member 8	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9NRM0	SLC2A9	Solute carrier family 2, facilitated glucose transporter member 9	GO:0005355; F:glucose transmembrane transporter activity; IEA:Ensembl
Q9NRM0	SLC2A9	Solute carrier family 2, facilitated glucose transporter member 9	GO:0005351; F:sugar:proton symporter activity; NAS:UniProtKB
Q9NRM0	SLC2A9	Solute carrier family 2, facilitated glucose transporter member 9	GO:0015758; P:glucose transport; NAS:UniProtKB
Q9NRM0	SLC2A9	Solute carrier family 2, facilitated glucose transporter member 9	GO:0015992; P:proton transport; NAS:GOC
Q9NRM0	SLC2A9	Solute carrier family 2, facilitated glucose transporter member 9	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9NRM0	SLC2A9	Solute carrier family 2, facilitated glucose transporter member 9	GO:0046415; P:urate metabolic process; IMP:UniProtKB
Q8WW33	GTSF1	Gametocyte-specific factor 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NYZ3	GTSE1	G2 and S phase-expressed protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NYZ3	GTSE1	G2 and S phase-expressed protein 1	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; NAS:UniProtKB
Q9NYZ3	GTSE1	G2 and S phase-expressed protein 1	GO:0007017; P:microtubule-based process; NAS:UniProtKB
Q9NYZ3	GTSE1	G2 and S phase-expressed protein 1	GO:0000085; P:mitotic G2 phase; NAS:UniProtKB
Q9H1H1	GTSF1L	Gametocyte-specific factor 1-like	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P49915	GMPS	GMP synthase [glutamine-hydrolyzing]	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49915	GMPS	GMP synthase [glutamine-hydrolyzing]	GO:0003922; F:GMP synthase (glutamine-hydrolyzing) activity; IEA:UniProtKB-EC
P49915	GMPS	GMP synthase [glutamine-hydrolyzing]	GO:0003921; F:GMP synthase activity; TAS:ProtInc
P49915	GMPS	GMP synthase [glutamine-hydrolyzing]	GO:0016462; F:pyrophosphatase activity; IEA:InterPro
P49915	GMPS	GMP synthase [glutamine-hydrolyzing]	GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW
P49915	GMPS	GMP synthase [glutamine-hydrolyzing]	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P49915	GMPS	GMP synthase [glutamine-hydrolyzing]	GO:0009113; P:purine nucleobase biosynthetic process; TAS:ProtInc
P49915	GMPS	GMP synthase [glutamine-hydrolyzing]	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P49915	GMPS	GMP synthase [glutamine-hydrolyzing]	GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome
P49915	GMPS	GMP synthase [glutamine-hydrolyzing]	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y2T3	GDA	Guanine deaminase	GO:0008892; F:guanine deaminase activity; EXP:Reactome
Q9Y2T3	GDA	Guanine deaminase	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q9Y2T3	GDA	Guanine deaminase	GO:0006147; P:guanine catabolic process; IEA:UniProtKB-UniPathway
Q9Y2T3	GDA	Guanine deaminase	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y2T3	GDA	Guanine deaminase	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
Q9Y2T3	GDA	Guanine deaminase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q9Y2T3	GDA	Guanine deaminase	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
Q9Y2T3	GDA	Guanine deaminase	GO:0006195; P:purine nucleotide catabolic process; TAS:Reactome
Q9Y2T3	GDA	Guanine deaminase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P43080	GUCA1A	Guanylyl cyclase-activating protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
P43080	GUCA1A	Guanylyl cyclase-activating protein 1	GO:0008048; F:calcium sensitive guanylate cyclase activator activity; TAS:ProtInc
P43080	GUCA1A	Guanylyl cyclase-activating protein 1	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P43080	GUCA1A	Guanylyl cyclase-activating protein 1	GO:0030828; P:positive regulation of cGMP biosynthetic process; IEA:Ensembl
P43080	GUCA1A	Guanylyl cyclase-activating protein 1	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
P43080	GUCA1A	Guanylyl cyclase-activating protein 1	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
P43080	GUCA1A	Guanylyl cyclase-activating protein 1	GO:0007165; P:signal transduction; NAS:ProtInc
P43080	GUCA1A	Guanylyl cyclase-activating protein 1	GO:0007601; P:visual perception; TAS:ProtInc
Q9UMX6	GUCA1B	Guanylyl cyclase-activating protein 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UMX6	GUCA1B	Guanylyl cyclase-activating protein 2	GO:0008048; F:calcium sensitive guanylate cyclase activator activity; TAS:ProtInc
Q9UMX6	GUCA1B	Guanylyl cyclase-activating protein 2	GO:0007589; P:body fluid secretion; TAS:ProtInc
Q9UMX6	GUCA1B	Guanylyl cyclase-activating protein 2	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9UMX6	GUCA1B	Guanylyl cyclase-activating protein 2	GO:0007603; P:phototransduction, visible light; TAS:Reactome
Q9UMX6	GUCA1B	Guanylyl cyclase-activating protein 2	GO:0031284; P:positive regulation of guanylate cyclase activity; TAS:GOC
Q9UMX6	GUCA1B	Guanylyl cyclase-activating protein 2	GO:0007168; P:receptor guanylyl cyclase signaling pathway; TAS:ProtInc
Q9UMX6	GUCA1B	Guanylyl cyclase-activating protein 2	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
Q9UMX6	GUCA1B	Guanylyl cyclase-activating protein 2	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
Q9UMX6	GUCA1B	Guanylyl cyclase-activating protein 2	GO:0007601; P:visual perception; IEA:UniProtKB-KW
O95843	GUCA1C	Guanylyl cyclase-activating protein 3	GO:0005509; F:calcium ion binding; IEA:InterPro
O95843	GUCA1C	Guanylyl cyclase-activating protein 3	GO:0008048; F:calcium sensitive guanylate cyclase activator activity; TAS:ProtInc
O95843	GUCA1C	Guanylyl cyclase-activating protein 3	GO:0007603; P:phototransduction, visible light; TAS:Reactome
O95843	GUCA1C	Guanylyl cyclase-activating protein 3	GO:0031284; P:positive regulation of guanylate cyclase activity; TAS:GOC
O95843	GUCA1C	Guanylyl cyclase-activating protein 3	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
O95843	GUCA1C	Guanylyl cyclase-activating protein 3	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
O95843	GUCA1C	Guanylyl cyclase-activating protein 3	GO:0007165; P:signal transduction; TAS:ProtInc
O95843	GUCA1C	Guanylyl cyclase-activating protein 3	GO:0007601; P:visual perception; TAS:ProtInc
Q02747	GUCA2A	Guanylin	GO:0030250; F:guanylate cyclase activator activity; NAS:UniProtKB
Q02747	GUCA2A	Guanylin	GO:0005179; F:hormone activity; NAS:UniProtKB
Q16661	GUCA2B	Guanylate cyclase activator 2B	GO:0008048; F:calcium sensitive guanylate cyclase activator activity; TAS:ProtInc
Q16661	GUCA2B	Guanylate cyclase activator 2B	GO:0007589; P:body fluid secretion; IEA:Ensembl
Q16661	GUCA2B	Guanylate cyclase activator 2B	GO:0006182; P:cGMP biosynthetic process; IEA:Ensembl
Q16661	GUCA2B	Guanylate cyclase activator 2B	GO:0007588; P:excretion; TAS:ProtInc
Q16661	GUCA2B	Guanylate cyclase activator 2B	GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl
Q16661	GUCA2B	Guanylate cyclase activator 2B	GO:0031284; P:positive regulation of guanylate cyclase activity; TAS:GOC
P25092	GUCY2C	Heat-stable enterotoxin receptor	GO:0005524; F:ATP binding; IEA:InterPro
P25092	GUCY2C	Heat-stable enterotoxin receptor	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P25092	GUCY2C	Heat-stable enterotoxin receptor	GO:0004383; F:guanylate cyclase activity; TAS:ProtInc
P25092	GUCY2C	Heat-stable enterotoxin receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P25092	GUCY2C	Heat-stable enterotoxin receptor	GO:0004672; F:protein kinase activity; IEA:InterPro
P25092	GUCY2C	Heat-stable enterotoxin receptor	GO:0015643; F:toxic substance binding; IEA:Ensembl
P25092	GUCY2C	Heat-stable enterotoxin receptor	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P25092	GUCY2C	Heat-stable enterotoxin receptor	GO:0007168; P:receptor guanylyl cyclase signaling pathway; TAS:ProtInc
P25092	GUCY2C	Heat-stable enterotoxin receptor	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P25092	GUCY2C	Heat-stable enterotoxin receptor	GO:0009636; P:response to toxic substance; IEA:Ensembl
Q02846	GUCY2D	Retinal guanylyl cyclase 1	GO:0005524; F:ATP binding; IEA:InterPro
Q02846	GUCY2D	Retinal guanylyl cyclase 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q02846	GUCY2D	Retinal guanylyl cyclase 1	GO:0004383; F:guanylate cyclase activity; TAS:ProtInc
Q02846	GUCY2D	Retinal guanylyl cyclase 1	GO:0004672; F:protein kinase activity; IEA:InterPro
Q02846	GUCY2D	Retinal guanylyl cyclase 1	GO:0004872; F:receptor activity; TAS:ProtInc
Q02846	GUCY2D	Retinal guanylyl cyclase 1	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q02846	GUCY2D	Retinal guanylyl cyclase 1	GO:0007603; P:phototransduction, visible light; TAS:Reactome
Q02846	GUCY2D	Retinal guanylyl cyclase 1	GO:0007168; P:receptor guanylyl cyclase signaling pathway; TAS:ProtInc
Q02846	GUCY2D	Retinal guanylyl cyclase 1	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
Q02846	GUCY2D	Retinal guanylyl cyclase 1	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
Q02846	GUCY2D	Retinal guanylyl cyclase 1	GO:0007601; P:visual perception; TAS:ProtInc
P51841	GUCY2F	Retinal guanylyl cyclase 2	GO:0005524; F:ATP binding; IEA:InterPro
P51841	GUCY2F	Retinal guanylyl cyclase 2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P51841	GUCY2F	Retinal guanylyl cyclase 2	GO:0004383; F:guanylate cyclase activity; TAS:ProtInc
P51841	GUCY2F	Retinal guanylyl cyclase 2	GO:0004672; F:protein kinase activity; IEA:InterPro
P51841	GUCY2F	Retinal guanylyl cyclase 2	GO:0004872; F:receptor activity; TAS:ProtInc
P51841	GUCY2F	Retinal guanylyl cyclase 2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P51841	GUCY2F	Retinal guanylyl cyclase 2	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P51841	GUCY2F	Retinal guanylyl cyclase 2	GO:0007168; P:receptor guanylyl cyclase signaling pathway; TAS:ProtInc
P51841	GUCY2F	Retinal guanylyl cyclase 2	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
P51841	GUCY2F	Retinal guanylyl cyclase 2	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
P51841	GUCY2F	Retinal guanylyl cyclase 2	GO:0007601; P:visual perception; TAS:ProtInc
Q8N442	GUF1	Translation factor GUF1, mitochondrial	GO:0005525; F:GTP binding; IEA:UniProtKB-HAMAP
Q8N442	GUF1	Translation factor GUF1, mitochondrial	GO:0003924; F:GTPase activity; IEA:UniProtKB-HAMAP
Q8N442	GUF1	Translation factor GUF1, mitochondrial	GO:0043022; F:ribosome binding; IEA:UniProtKB-HAMAP
Q8N442	GUF1	Translation factor GUF1, mitochondrial	GO:0045727; P:positive regulation of translation; IEA:UniProtKB-HAMAP
Q8N442	GUF1	Translation factor GUF1, mitochondrial	GO:0006412; P:translation; IEA:UniProtKB-KW
Q9UBP9	GULP1	PTB domain-containing engulfment adapter protein 1	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q9UBP9	GULP1	PTB domain-containing engulfment adapter protein 1	GO:0006915; P:apoptotic process; TAS:ProtInc
Q9UBP9	GULP1	PTB domain-containing engulfment adapter protein 1	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q9UBP9	GULP1	PTB domain-containing engulfment adapter protein 1	GO:0006911; P:phagocytosis, engulfment; IDA:MGI
Q9UBP9	GULP1	PTB domain-containing engulfment adapter protein 1	GO:0007165; P:signal transduction; TAS:GOC
Q15486	GUSBP1	Putative inactive beta-glucuronidase-like protein SMA3	GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro
Q15486	GUSBP1	Putative inactive beta-glucuronidase-like protein SMA3	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q15486	GUSBP1	Putative inactive beta-glucuronidase-like protein SMA3	GO:0007399; P:nervous system development; TAS:ProtInc
Q15486	GUSBP1	Putative inactive beta-glucuronidase-like protein SMA3	GO:0001501; P:skeletal system development; TAS:ProtInc
Q7Z2Y8	GVINP1	Interferon-induced very large GTPase 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q96GX5	MASTL	Serine/threonine-protein kinase greatwall	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96GX5	MASTL	Serine/threonine-protein kinase greatwall	GO:0016301; F:kinase activity; IDA:UniProtKB
Q96GX5	MASTL	Serine/threonine-protein kinase greatwall	GO:0051721; F:protein phosphatase 2A binding; ISS:UniProtKB
Q96GX5	MASTL	Serine/threonine-protein kinase greatwall	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q96GX5	MASTL	Serine/threonine-protein kinase greatwall	GO:0006974; P:cellular response to DNA damage stimulus; ISS:UniProtKB
Q96GX5	MASTL	Serine/threonine-protein kinase greatwall	GO:0000086; P:G2/M transition of mitotic cell cycle; IMP:UniProtKB
Q96GX5	MASTL	Serine/threonine-protein kinase greatwall	GO:0007067; P:mitosis; IMP:UniProtKB
Q96GX5	MASTL	Serine/threonine-protein kinase greatwall	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q96GX5	MASTL	Serine/threonine-protein kinase greatwall	GO:0034048; P:negative regulation of protein phosphatase type 2A activity; IMP:UniProtKB
Q96GX5	MASTL	Serine/threonine-protein kinase greatwall	GO:0051726; P:regulation of cell cycle; IMP:UniProtKB
Q4G148	GXYLT1	Glucoside xylosyltransferase 1	GO:0035252; F:UDP-xylosyltransferase activity; IDA:UniProtKB
Q4G148	GXYLT1	Glucoside xylosyltransferase 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q4G148	GXYLT1	Glucoside xylosyltransferase 1	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q4G148	GXYLT1	Glucoside xylosyltransferase 1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q4G148	GXYLT1	Glucoside xylosyltransferase 1	GO:0016266; P:O-glycan processing; IDA:UniProtKB
Q4G148	GXYLT1	Glucoside xylosyltransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
A0PJZ3	GXYLT2	Glucoside xylosyltransferase 2	GO:0035252; F:UDP-xylosyltransferase activity; IDA:UniProtKB
A0PJZ3	GXYLT2	Glucoside xylosyltransferase 2	GO:0016266; P:O-glycan processing; IDA:UniProtKB
P13807	GYS1	Glycogen [starch] synthase, muscle	GO:0005536; F:glucose binding; IEA:Ensembl
P13807	GYS1	Glycogen [starch] synthase, muscle	GO:0004373; F:glycogen (starch) synthase activity; IDA:UniProtKB
P13807	GYS1	Glycogen [starch] synthase, muscle	GO:0061547; F:glycogen synthase activity, transferring glucose-1-phosphate; EXP:Reactome
P13807	GYS1	Glycogen [starch] synthase, muscle	GO:0005515; F:protein binding; IPI:UniProtKB
P13807	GYS1	Glycogen [starch] synthase, muscle	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P13807	GYS1	Glycogen [starch] synthase, muscle	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P13807	GYS1	Glycogen [starch] synthase, muscle	GO:0006006; P:glucose metabolic process; TAS:Reactome
P13807	GYS1	Glycogen [starch] synthase, muscle	GO:0005978; P:glycogen biosynthetic process; IDA:UniProtKB
P13807	GYS1	Glycogen [starch] synthase, muscle	GO:0007507; P:heart development; IEA:Ensembl
P13807	GYS1	Glycogen [starch] synthase, muscle	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P54840	GYS2	Glycogen [starch] synthase, liver	GO:0004373; F:glycogen (starch) synthase activity; IDA:UniProtKB
P54840	GYS2	Glycogen [starch] synthase, liver	GO:0061547; F:glycogen synthase activity, transferring glucose-1-phosphate; TAS:Reactome
P54840	GYS2	Glycogen [starch] synthase, liver	GO:0042803; F:protein homodimerization activity; TAS:UniProtKB
P54840	GYS2	Glycogen [starch] synthase, liver	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P54840	GYS2	Glycogen [starch] synthase, liver	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P54840	GYS2	Glycogen [starch] synthase, liver	GO:0006006; P:glucose metabolic process; TAS:Reactome
P54840	GYS2	Glycogen [starch] synthase, liver	GO:0005978; P:glycogen biosynthetic process; IDA:UniProtKB
P54840	GYS2	Glycogen [starch] synthase, liver	GO:0009749; P:response to glucose; ISS:UniProtKB
P54840	GYS2	Glycogen [starch] synthase, liver	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H116	GZF1	GDNF-inducible zinc finger protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H116	GZF1	GDNF-inducible zinc finger protein 1	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q9H116	GZF1	GDNF-inducible zinc finger protein 1	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
Q9H116	GZF1	GDNF-inducible zinc finger protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9H116	GZF1	GDNF-inducible zinc finger protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9H116	GZF1	GDNF-inducible zinc finger protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P07305	H1F0	Histone H1.0	GO:0031490; F:chromatin DNA binding; IDA:UniProt
P07305	H1F0	Histone H1.0	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P07305	H1F0	Histone H1.0	GO:0005515; F:protein binding; IPI:IntAct
P07305	H1F0	Histone H1.0	GO:0006309; P:apoptotic DNA fragmentation; TAS:Reactome
P07305	H1F0	Histone H1.0	GO:0006915; P:apoptotic process; TAS:Reactome
P07305	H1F0	Histone H1.0	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
P07305	H1F0	Histone H1.0	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q02539	HIST1H1A	Histone H1.1	GO:0031490; F:chromatin DNA binding; IMP:UniProt
Q02539	HIST1H1A	Histone H1.1	GO:0005515; F:protein binding; IPI:IntAct
Q02539	HIST1H1A	Histone H1.1	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q02539	HIST1H1A	Histone H1.1	GO:0007283; P:spermatogenesis; TAS:ProtInc
P16403	HIST1H1C	Histone H1.2	GO:0031490; F:chromatin DNA binding; IDA:UniProt
P16403	HIST1H1C	Histone H1.2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P16403	HIST1H1C	Histone H1.2	GO:0005515; F:protein binding; IPI:UniProt
P16403	HIST1H1C	Histone H1.2	GO:0006334; P:nucleosome assembly; IEA:InterPro
P16403	HIST1H1C	Histone H1.2	GO:0016584; P:nucleosome positioning; IEA:Ensembl
P16402	HIST1H1D	Histone H1.3	GO:0031490; F:chromatin DNA binding; IDA:UniProt
P16402	HIST1H1D	Histone H1.3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P16402	HIST1H1D	Histone H1.3	GO:0006334; P:nucleosome assembly; IEA:InterPro
P16402	HIST1H1D	Histone H1.3	GO:0016584; P:nucleosome positioning; IEA:Ensembl
P10412	HIST1H1E	Histone H1.4	GO:0031490; F:chromatin DNA binding; IMP:UniProt
P10412	HIST1H1E	Histone H1.4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P10412	HIST1H1E	Histone H1.4	GO:0005515; F:protein binding; IPI:UniProtKB
P10412	HIST1H1E	Histone H1.4	GO:0006334; P:nucleosome assembly; IEA:InterPro
P10412	HIST1H1E	Histone H1.4	GO:0016584; P:nucleosome positioning; IEA:Ensembl
P16401	HIST1H1B	Histone H1.5	GO:0031490; F:chromatin DNA binding; IMP:UniProt
P16401	HIST1H1B	Histone H1.5	GO:0042826; F:histone deacetylase binding; IPI:UniProt
P16401	HIST1H1B	Histone H1.5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P16401	HIST1H1B	Histone H1.5	GO:0006325; P:chromatin organization; IMP:UniProt
P16401	HIST1H1B	Histone H1.5	GO:0071169; P:establishment of protein localization to chromatin; IMP:UniProt
P16401	HIST1H1B	Histone H1.5	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProt
P16401	HIST1H1B	Histone H1.5	GO:0006334; P:nucleosome assembly; IEA:InterPro
P16401	HIST1H1B	Histone H1.5	GO:0030307; P:positive regulation of cell growth; IMP:UniProt
P16401	HIST1H1B	Histone H1.5	GO:0051574; P:positive regulation of histone H3-K9 methylation; IMP:UniProt
P16401	HIST1H1B	Histone H1.5	GO:0050821; P:protein stabilization; IMP:UniProt
O14756	HSD17B6	17-beta-hydroxysteroid dehydrogenase type 6	GO:0003824; F:catalytic activity; TAS:ProtInc
O14756	HSD17B6	17-beta-hydroxysteroid dehydrogenase type 6	GO:0009055; F:electron carrier activity; TAS:UniProtKB
O14756	HSD17B6	17-beta-hydroxysteroid dehydrogenase type 6	GO:0004303; F:estradiol 17-beta-dehydrogenase activity; IEA:UniProtKB-EC
O14756	HSD17B6	17-beta-hydroxysteroid dehydrogenase type 6	GO:0016491; F:oxidoreductase activity; NAS:UniProtKB
O14756	HSD17B6	17-beta-hydroxysteroid dehydrogenase type 6	GO:0004745; F:retinol dehydrogenase activity; IEA:UniProtKB-EC
O14756	HSD17B6	17-beta-hydroxysteroid dehydrogenase type 6	GO:0047035; F:testosterone dehydrogenase (NAD+) activity; IEA:UniProtKB-EC
O14756	HSD17B6	17-beta-hydroxysteroid dehydrogenase type 6	GO:0006702; P:androgen biosynthetic process; NAS:UniProtKB
O14756	HSD17B6	17-beta-hydroxysteroid dehydrogenase type 6	GO:0006710; P:androgen catabolic process; TAS:UniProtKB
Q53T59	HS1BP3	HCLS1-binding protein 3	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
Q75WM6	H1FNT	Testis-specific H1 histone	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q75WM6	H1FNT	Testis-specific H1 histone	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q75WM6	H1FNT	Testis-specific H1 histone	GO:0030261; P:chromosome condensation; IEA:UniProtKB-KW
Q75WM6	H1FNT	Testis-specific H1 histone	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q75WM6	H1FNT	Testis-specific H1 histone	GO:0035092; P:sperm chromatin condensation; ISS:UniProtKB
Q75WM6	H1FNT	Testis-specific H1 histone	GO:0007290; P:spermatid nucleus elongation; ISS:UniProtKB
Q8IZA3	H1FOO	Histone H1oo	GO:0031492; F:nucleosomal DNA binding; ISS:UniProt
Q8IZA3	H1FOO	Histone H1oo	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q8IZA3	H1FOO	Histone H1oo	GO:2000737; P:negative regulation of stem cell differentiation; ISS:UniProt
Q8IZA3	H1FOO	Histone H1oo	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q8IZA3	H1FOO	Histone H1oo	GO:0016584; P:nucleosome positioning; ISS:UniProt
Q8IZA3	H1FOO	Histone H1oo	GO:0044030; P:regulation of DNA methylation; ISS:UniProt
P22492	HIST1H1T	Histone H1t	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P22492	HIST1H1T	Histone H1t	GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl
P22492	HIST1H1T	Histone H1t	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P22492	HIST1H1T	Histone H1t	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P22492	HIST1H1T	Histone H1t	GO:0006334; P:nucleosome assembly; IEA:InterPro
P22492	HIST1H1T	Histone H1t	GO:0030317; P:sperm motility; IEA:Ensembl
P22492	HIST1H1T	Histone H1t	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q92522	H1FX	Histone H1x	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q92522	H1FX	Histone H1x	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q92522	H1FX	Histone H1x	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q96QV6	HIST1H2AA	Histone H2A type 1-A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96QV6	HIST1H2AA	Histone H2A type 1-A	GO:0006334; P:nucleosome assembly; IEA:InterPro
P04908	HIST1H2AB	Histone H2A type 1-B/E	GO:0003677; F:DNA binding; NAS:UniProtKB
P04908	HIST1H2AB	Histone H2A type 1-B/E	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q93077	HIST1H2AC	Histone H2A type 1-C	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q93077	HIST1H2AC	Histone H2A type 1-C	GO:0006334; P:nucleosome assembly; IEA:InterPro
P20671	HIST1H2AD	Histone H2A type 1-D	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P20671	HIST1H2AD	Histone H2A type 1-D	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q96KK5	HIST1H2AH	Histone H2A type 1-H	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96KK5	HIST1H2AH	Histone H2A type 1-H	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q99878	HIST1H2AJ	Histone H2A type 1-J	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q99878	HIST1H2AJ	Histone H2A type 1-J	GO:0006334; P:nucleosome assembly; IEA:InterPro
P0C0S8	HIST1H2AG	Histone H2A type 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P0C0S8	HIST1H2AG	Histone H2A type 1	GO:0019899; F:enzyme binding; IPI:UniProtKB
P0C0S8	HIST1H2AG	Histone H2A type 1	GO:0005515; F:protein binding; IPI:IntAct
P0C0S8	HIST1H2AG	Histone H2A type 1	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q6FI13	HIST2H2AA3	Histone H2A type 2-A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6FI13	HIST2H2AA3	Histone H2A type 2-A	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q8IUE6	HIST2H2AB	Histone H2A type 2-B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IUE6	HIST2H2AB	Histone H2A type 2-B	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q16777	HIST2H2AC	Histone H2A type 2-C	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q16777	HIST2H2AC	Histone H2A type 2-C	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q7L7L0	HIST3H2A	Histone H2A type 3	GO:0003677; F:DNA binding; IDA:UniProt
Q7L7L0	HIST3H2A	Histone H2A type 3	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q7L7L0	HIST3H2A	Histone H2A type 3	GO:0006337; P:nucleosome disassembly; IMP:UniProt
Q7L7L0	HIST3H2A	Histone H2A type 3	GO:0070914; P:UV-damage excision repair; IMP:UniProt
P0C5Y9	H2AFB1	Histone H2A-Bbd type 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P0C5Y9	H2AFB1	Histone H2A-Bbd type 1	GO:0006397; P:mRNA processing; IMP:UniProtKB
P0C5Y9	H2AFB1	Histone H2A-Bbd type 1	GO:0006334; P:nucleosome assembly; IDA:UniProtKB
P0C5Z0	H2AFB2	Histone H2A-Bbd type 2/3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P0C5Z0	H2AFB2	Histone H2A-Bbd type 2/3	GO:0006397; P:mRNA processing; IMP:UniProtKB
P0C5Z0	H2AFB2	Histone H2A-Bbd type 2/3	GO:0006334; P:nucleosome assembly; IDA:UniProtKB
Q9BTM1	H2AFJ	Histone H2A.J	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BTM1	H2AFJ	Histone H2A.J	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q9P0M6	H2AFY2	Core histone macro-H2A.2	GO:0031490; F:chromatin DNA binding; IDA:UniProt
Q9P0M6	H2AFY2	Core histone macro-H2A.2	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProt
Q9P0M6	H2AFY2	Core histone macro-H2A.2	GO:0007420; P:brain development; IMP:UniProt
Q9P0M6	H2AFY2	Core histone macro-H2A.2	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q9P0M6	H2AFY2	Core histone macro-H2A.2	GO:0007549; P:dosage compensation; IDA:MGI
Q9P0M6	H2AFY2	Core histone macro-H2A.2	GO:0071169; P:establishment of protein localization to chromatin; IMP:UniProt
Q9P0M6	H2AFY2	Core histone macro-H2A.2	GO:0045814; P:negative regulation of gene expression, epigenetic; IMP:UniProt
Q9P0M6	H2AFY2	Core histone macro-H2A.2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProt
Q9P0M6	H2AFY2	Core histone macro-H2A.2	GO:1901837; P:negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter; IGI:UniProt
Q9P0M6	H2AFY2	Core histone macro-H2A.2	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q71UI9	H2AFV	Histone H2A.V	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q71UI9	H2AFV	Histone H2A.V	GO:0006334; P:nucleosome assembly; IEA:InterPro
P16104	H2AFX	Histone H2AX	GO:0003684; F:damaged DNA binding; IEA:Ensembl
P16104	H2AFX	Histone H2AX	GO:0003677; F:DNA binding; NAS:UniProtKB
P16104	H2AFX	Histone H2AX	GO:0019899; F:enzyme binding; IPI:UniProtKB
P16104	H2AFX	Histone H2AX	GO:0042393; F:histone binding; IPI:UniProtKB
P16104	H2AFX	Histone H2AX	GO:0005515; F:protein binding; IPI:UniProtKB
P16104	H2AFX	Histone H2AX	GO:0006974; P:cellular response to DNA damage stimulus; IDA:BHF-UCL
P16104	H2AFX	Histone H2AX	GO:0000077; P:DNA damage checkpoint; IDA:UniProtKB
P16104	H2AFX	Histone H2AX	GO:0006281; P:DNA repair; TAS:Reactome
P16104	H2AFX	Histone H2AX	GO:0006302; P:double-strand break repair; NAS:UniProtKB
P16104	H2AFX	Histone H2AX	GO:0000724; P:double-strand break repair via homologous recombination; TAS:Reactome
P16104	H2AFX	Histone H2AX	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
P16104	H2AFX	Histone H2AX	GO:0006334; P:nucleosome assembly; NAS:UniProtKB
P16104	H2AFX	Histone H2AX	GO:0045739; P:positive regulation of DNA repair; NAS:UniProtKB
P16104	H2AFX	Histone H2AX	GO:0010212; P:response to ionizing radiation; NAS:UniProtKB
P16104	H2AFX	Histone H2AX	GO:0007283; P:spermatogenesis; IEA:Ensembl
O75367	H2AFY	Core histone macro-H2A.1	GO:0031490; F:chromatin DNA binding; IDA:UniProt
O75367	H2AFY	Core histone macro-H2A.1	GO:0003677; F:DNA binding; NAS:UniProtKB
O75367	H2AFY	Core histone macro-H2A.1	GO:0010385; F:double-stranded methylated DNA binding; IDA:UniProt
O75367	H2AFY	Core histone macro-H2A.1	GO:0005515; F:protein binding; IPI:IntAct
O75367	H2AFY	Core histone macro-H2A.1	GO:0019901; F:protein kinase binding; IPI:UniProt
O75367	H2AFY	Core histone macro-H2A.1	GO:0030291; F:protein serine/threonine kinase inhibitor activity; IMP:UniProt
O75367	H2AFY	Core histone macro-H2A.1	GO:0000182; F:rDNA binding; IDA:UniProt
O75367	H2AFY	Core histone macro-H2A.1	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProt
O75367	H2AFY	Core histone macro-H2A.1	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
O75367	H2AFY	Core histone macro-H2A.1	GO:0007549; P:dosage compensation; IDA:MGI
O75367	H2AFY	Core histone macro-H2A.1	GO:0071169; P:establishment of protein localization to chromatin; IMP:UniProt
O75367	H2AFY	Core histone macro-H2A.1	GO:1902750; P:negative regulation of cell cycle G2/M phase transition; IMP:UniProt
O75367	H2AFY	Core histone macro-H2A.1	GO:0045814; P:negative regulation of gene expression, epigenetic; IMP:UniProt
O75367	H2AFY	Core histone macro-H2A.1	GO:0033128; P:negative regulation of histone phosphorylation; IMP:UniProt
O75367	H2AFY	Core histone macro-H2A.1	GO:0071901; P:negative regulation of protein serine/threonine kinase activity; IMP:UniProt
O75367	H2AFY	Core histone macro-H2A.1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProt
O75367	H2AFY	Core histone macro-H2A.1	GO:1901837; P:negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter; IMP:UniProt
O75367	H2AFY	Core histone macro-H2A.1	GO:0006334; P:nucleosome assembly; NAS:UniProtKB
P0C0S5	H2AFZ	Histone H2A.Z	GO:0031490; F:chromatin DNA binding; IDA:UniProt
P0C0S5	H2AFZ	Histone H2A.Z	GO:0031492; F:nucleosomal DNA binding; IDA:UniProt
P0C0S5	H2AFZ	Histone H2A.Z	GO:0005515; F:protein binding; IPI:IntAct
P0C0S5	H2AFZ	Histone H2A.Z	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:UniProt
P0C0S5	H2AFZ	Histone H2A.Z	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IDA:UniProt
P0C0S5	H2AFZ	Histone H2A.Z	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IDA:UniProt
P0C0S5	H2AFZ	Histone H2A.Z	GO:0071392; P:cellular response to estradiol stimulus; IMP:UniProt
P0C0S5	H2AFZ	Histone H2A.Z	GO:0006334; P:nucleosome assembly; IEA:InterPro
P0C0S5	H2AFZ	Histone H2A.Z	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProt
Q96A08	HIST1H2BA	Histone H2B type 1-A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96A08	HIST1H2BA	Histone H2B type 1-A	GO:0071229; P:cellular response to acid; IEA:Ensembl
Q96A08	HIST1H2BA	Histone H2B type 1-A	GO:0006325; P:chromatin organization; TAS:Reactome
Q96A08	HIST1H2BA	Histone H2B type 1-A	GO:0006954; P:inflammatory response; IEA:Ensembl
Q96A08	HIST1H2BA	Histone H2B type 1-A	GO:0071674; P:mononuclear cell migration; IEA:Ensembl
Q96A08	HIST1H2BA	Histone H2B type 1-A	GO:0006334; P:nucleosome assembly; ISS:UniProtKB
Q96A08	HIST1H2BA	Histone H2B type 1-A	GO:0006337; P:nucleosome disassembly; ISS:UniProtKB
Q96A08	HIST1H2BA	Histone H2B type 1-A	GO:0031639; P:plasminogen activation; IEA:Ensembl
Q96A08	HIST1H2BA	Histone H2B type 1-A	GO:0051099; P:positive regulation of binding; IEA:Ensembl
Q96A08	HIST1H2BA	Histone H2B type 1-A	GO:0035093; P:spermatogenesis, exchange of chromosomal proteins; ISS:UniProtKB
P33778	HIST1H2BB	Histone H2B type 1-B	GO:0003677; F:DNA binding; NAS:UniProtKB
P33778	HIST1H2BB	Histone H2B type 1-B	GO:0005515; F:protein binding; IPI:UniProt
P33778	HIST1H2BB	Histone H2B type 1-B	GO:0006325; P:chromatin organization; TAS:Reactome
P33778	HIST1H2BB	Histone H2B type 1-B	GO:0006334; P:nucleosome assembly; NAS:UniProtKB
P62807	HIST1H2BC	Histone H2B type 1-C/E/F/G/I	GO:0003677; F:DNA binding; NAS:UniProtKB
P62807	HIST1H2BC	Histone H2B type 1-C/E/F/G/I	GO:0019731; P:antibacterial humoral response; IDA:UniProt
P62807	HIST1H2BC	Histone H2B type 1-C/E/F/G/I	GO:0006325; P:chromatin organization; TAS:Reactome
P62807	HIST1H2BC	Histone H2B type 1-C/E/F/G/I	GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProt
P62807	HIST1H2BC	Histone H2B type 1-C/E/F/G/I	GO:0002227; P:innate immune response in mucosa; IDA:UniProt
P62807	HIST1H2BC	Histone H2B type 1-C/E/F/G/I	GO:0006334; P:nucleosome assembly; NAS:UniProtKB
P58876	HIST1H2BD	Histone H2B type 1-D	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P58876	HIST1H2BD	Histone H2B type 1-D	GO:0006325; P:chromatin organization; TAS:Reactome
P58876	HIST1H2BD	Histone H2B type 1-D	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q93079	HIST1H2BH	Histone H2B type 1-H	GO:0003677; F:DNA binding; NAS:UniProtKB
Q93079	HIST1H2BH	Histone H2B type 1-H	GO:0006325; P:chromatin organization; TAS:Reactome
Q93079	HIST1H2BH	Histone H2B type 1-H	GO:0006334; P:nucleosome assembly; NAS:UniProtKB
P06899	HIST1H2BJ	Histone H2B type 1-J	GO:0003677; F:DNA binding; NAS:UniProtKB
P06899	HIST1H2BJ	Histone H2B type 1-J	GO:0019731; P:antibacterial humoral response; IDA:UniProt
P06899	HIST1H2BJ	Histone H2B type 1-J	GO:0006325; P:chromatin organization; TAS:Reactome
P06899	HIST1H2BJ	Histone H2B type 1-J	GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProt
P06899	HIST1H2BJ	Histone H2B type 1-J	GO:0002227; P:innate immune response in mucosa; IDA:UniProt
P06899	HIST1H2BJ	Histone H2B type 1-J	GO:0006334; P:nucleosome assembly; NAS:UniProtKB
O60814	HIST1H2BK	Histone H2B type 1-K	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O60814	HIST1H2BK	Histone H2B type 1-K	GO:0019731; P:antibacterial humoral response; IDA:UniProt
O60814	HIST1H2BK	Histone H2B type 1-K	GO:0006325; P:chromatin organization; TAS:Reactome
O60814	HIST1H2BK	Histone H2B type 1-K	GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProt
O60814	HIST1H2BK	Histone H2B type 1-K	GO:0002227; P:innate immune response in mucosa; IDA:UniProt
O60814	HIST1H2BK	Histone H2B type 1-K	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q99880	HIST1H2BL	Histone H2B type 1-L	GO:0003677; F:DNA binding; NAS:UniProtKB
Q99880	HIST1H2BL	Histone H2B type 1-L	GO:0006325; P:chromatin organization; TAS:Reactome
Q99880	HIST1H2BL	Histone H2B type 1-L	GO:0006334; P:nucleosome assembly; NAS:UniProtKB
Q99879	HIST1H2BM	Histone H2B type 1-M	GO:0003677; F:DNA binding; NAS:UniProtKB
Q99879	HIST1H2BM	Histone H2B type 1-M	GO:0006325; P:chromatin organization; TAS:Reactome
Q99879	HIST1H2BM	Histone H2B type 1-M	GO:0006334; P:nucleosome assembly; NAS:UniProtKB
Q99877	HIST1H2BN	Histone H2B type 1-N	GO:0003677; F:DNA binding; NAS:UniProtKB
Q99877	HIST1H2BN	Histone H2B type 1-N	GO:0006325; P:chromatin organization; TAS:Reactome
Q99877	HIST1H2BN	Histone H2B type 1-N	GO:0006334; P:nucleosome assembly; NAS:UniProtKB
P23527	HIST1H2BO	Histone H2B type 1-O	GO:0003677; F:DNA binding; NAS:UniProtKB
P23527	HIST1H2BO	Histone H2B type 1-O	GO:0006325; P:chromatin organization; TAS:Reactome
P23527	HIST1H2BO	Histone H2B type 1-O	GO:0006334; P:nucleosome assembly; NAS:UniProtKB
Q6DN03	HIST2H2BC	Putative histone H2B type 2-C	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6DN03	HIST2H2BC	Putative histone H2B type 2-C	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q6DRA6	HIST2H2BD	Putative histone H2B type 2-D	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6DRA6	HIST2H2BD	Putative histone H2B type 2-D	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q16778	HIST2H2BE	Histone H2B type 2-E	GO:0003677; F:DNA binding; NAS:UniProtKB
Q16778	HIST2H2BE	Histone H2B type 2-E	GO:0019731; P:antibacterial humoral response; IDA:UniProt
Q16778	HIST2H2BE	Histone H2B type 2-E	GO:0006325; P:chromatin organization; TAS:Reactome
Q16778	HIST2H2BE	Histone H2B type 2-E	GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProt
Q16778	HIST2H2BE	Histone H2B type 2-E	GO:0002227; P:innate immune response in mucosa; IDA:UniProt
Q16778	HIST2H2BE	Histone H2B type 2-E	GO:0006334; P:nucleosome assembly; NAS:UniProtKB
Q5QNW6	HIST2H2BF	Histone H2B type 2-F	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5QNW6	HIST2H2BF	Histone H2B type 2-F	GO:0006325; P:chromatin organization; TAS:Reactome
Q5QNW6	HIST2H2BF	Histone H2B type 2-F	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q8N257	HIST3H2BB	Histone H2B type 3-B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N257	HIST3H2BB	Histone H2B type 3-B	GO:0006325; P:chromatin organization; TAS:Reactome
Q8N257	HIST3H2BB	Histone H2B type 3-B	GO:0006334; P:nucleosome assembly; IEA:InterPro
P57053	H2BFS	Histone H2B type F-S	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P57053	H2BFS	Histone H2B type F-S	GO:0019731; P:antibacterial humoral response; IDA:UniProt
P57053	H2BFS	Histone H2B type F-S	GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProt
P57053	H2BFS	Histone H2B type F-S	GO:0002227; P:innate immune response in mucosa; IDA:UniProt
P57053	H2BFS	Histone H2B type F-S	GO:0006334; P:nucleosome assembly; IEA:InterPro
P57053	H2BFS	Histone H2B type F-S	GO:0021762; P:substantia nigra development; IEP:UniProt
P0C1H6	H2BFM	Histone H2B type F-M	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P0C1H6	H2BFM	Histone H2B type F-M	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q7Z2G1	H2BFWT	Histone H2B type W-T	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7Z2G1	H2BFWT	Histone H2B type W-T	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q16695	HIST3H3	Histone H3.1t	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q16695	HIST3H3	Histone H3.1t	GO:0005515; F:protein binding; IPI:IntAct
Q16695	HIST3H3	Histone H3.1t	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q16695	HIST3H3	Histone H3.1t	GO:0000723; P:telomere maintenance; TAS:Reactome
P68431	HIST1H3A	Histone H3.1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P68431	HIST1H3A	Histone H3.1	GO:0005515; F:protein binding; IPI:IntAct
P68431	HIST1H3A	Histone H3.1	GO:0007596; P:blood coagulation; TAS:Reactome
P68431	HIST1H3A	Histone H3.1	GO:0006325; P:chromatin organization; TAS:Reactome
P68431	HIST1H3A	Histone H3.1	GO:0006335; P:DNA replication-dependent nucleosome assembly; IDA:UniProt
P68431	HIST1H3A	Histone H3.1	GO:0060968; P:regulation of gene silencing; IDA:BHF-UCL
Q71DI3	HIST2H3A	Histone H3.2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q71DI3	HIST2H3A	Histone H3.2	GO:0005515; F:protein binding; IPI:IntAct
Q71DI3	HIST2H3A	Histone H3.2	GO:0007596; P:blood coagulation; TAS:Reactome
Q71DI3	HIST2H3A	Histone H3.2	GO:0006334; P:nucleosome assembly; IEA:InterPro
P84243	H3F3A	Histone H3.3	GO:0031492; F:nucleosomal DNA binding; IDA:UniProt
P84243	H3F3A	Histone H3.3	GO:0005515; F:protein binding; IPI:UniProtKB
P84243	H3F3A	Histone H3.3	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IDA:UniProt
P84243	H3F3A	Histone H3.3	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IDA:UniProt
P84243	H3F3A	Histone H3.3	GO:0007596; P:blood coagulation; TAS:Reactome
P84243	H3F3A	Histone H3.3	GO:0007420; P:brain development; IEA:Ensembl
P84243	H3F3A	Histone H3.3	GO:0006336; P:DNA replication-independent nucleosome assembly; IDA:UniProt
P84243	H3F3A	Histone H3.3	GO:0030307; P:positive regulation of cell growth; IMP:UniProt
P84243	H3F3A	Histone H3.3	GO:0009725; P:response to hormone; IEA:Ensembl
Q6NXT2	H3F3C	Histone H3.3C	GO:0031492; F:nucleosomal DNA binding; IDA:UniProt
Q6NXT2	H3F3C	Histone H3.3C	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q6NXT2	H3F3C	Histone H3.3C	GO:0030307; P:positive regulation of cell growth; IMP:UniProt
Q99525	HIST1H4G	Histone H4-like protein type G	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q99525	HIST1H4G	Histone H4-like protein type G	GO:0006334; P:nucleosome assembly; IEA:InterPro
P62805	HIST1H4A	Histone H4	GO:0003677; F:DNA binding; TAS:UniProtKB
P62805	HIST1H4A	Histone H4	GO:0035575; F:histone demethylase activity (H4-K20 specific); TAS:Reactome
P62805	HIST1H4A	Histone H4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62805	HIST1H4A	Histone H4	GO:0005515; F:protein binding; IPI:UniProtKB
P62805	HIST1H4A	Histone H4	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
P62805	HIST1H4A	Histone H4	GO:0006325; P:chromatin organization; NAS:UniProtKB
P62805	HIST1H4A	Histone H4	GO:0006335; P:DNA replication-dependent nucleosome assembly; IDA:UniProt
P62805	HIST1H4A	Histone H4	GO:0006336; P:DNA replication-independent nucleosome assembly; IDA:UniProt
P62805	HIST1H4A	Histone H4	GO:0035574; P:histone H4-K20 demethylation; TAS:GOC
P62805	HIST1H4A	Histone H4	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P62805	HIST1H4A	Histone H4	GO:0045653; P:negative regulation of megakaryocyte differentiation; IDA:UniProtKB
P62805	HIST1H4A	Histone H4	GO:0006334; P:nucleosome assembly; TAS:Reactome
P62805	HIST1H4A	Histone H4	GO:0048015; P:phosphatidylinositol-mediated signaling; NAS:UniProtKB
P62805	HIST1H4A	Histone H4	GO:0000723; P:telomere maintenance; TAS:Reactome
O60243	HS6ST1	Heparan-sulfate 6-O-sulfotransferase 1	GO:0008146; F:sulfotransferase activity; TAS:ProtInc
O60243	HS6ST1	Heparan-sulfate 6-O-sulfotransferase 1	GO:0001525; P:angiogenesis; IEA:Ensembl
O60243	HS6ST1	Heparan-sulfate 6-O-sulfotransferase 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O60243	HS6ST1	Heparan-sulfate 6-O-sulfotransferase 1	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
O60243	HS6ST1	Heparan-sulfate 6-O-sulfotransferase 1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O60243	HS6ST1	Heparan-sulfate 6-O-sulfotransferase 1	GO:0015015; P:heparan sulfate proteoglycan biosynthetic process, enzymatic modification; TAS:ProtInc
O60243	HS6ST1	Heparan-sulfate 6-O-sulfotransferase 1	GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl
O60243	HS6ST1	Heparan-sulfate 6-O-sulfotransferase 1	GO:0048286; P:lung alveolus development; IEA:Ensembl
O60243	HS6ST1	Heparan-sulfate 6-O-sulfotransferase 1	GO:0048666; P:neuron development; IMP:UniProtKB
O60243	HS6ST1	Heparan-sulfate 6-O-sulfotransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96MM7	HS6ST2	Heparan-sulfate 6-O-sulfotransferase 2	GO:0008146; F:sulfotransferase activity; IEA:InterPro
Q96MM7	HS6ST2	Heparan-sulfate 6-O-sulfotransferase 2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q96MM7	HS6ST2	Heparan-sulfate 6-O-sulfotransferase 2	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
Q96MM7	HS6ST2	Heparan-sulfate 6-O-sulfotransferase 2	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q96MM7	HS6ST2	Heparan-sulfate 6-O-sulfotransferase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8IZP7	HS6ST3	Heparan-sulfate 6-O-sulfotransferase 3	GO:0008146; F:sulfotransferase activity; IEA:InterPro
Q58FF8	HSP90AB2P	Putative heat shock protein HSP 90-beta 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q58FF8	HSP90AB2P	Putative heat shock protein HSP 90-beta 2	GO:0006457; P:protein folding; IEA:InterPro
Q58FF8	HSP90AB2P	Putative heat shock protein HSP 90-beta 2	GO:0006950; P:response to stress; IEA:UniProtKB-KW
Q58FF7	HSP90AB3P	Putative heat shock protein HSP 90-beta-3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q58FF7	HSP90AB3P	Putative heat shock protein HSP 90-beta-3	GO:0006457; P:protein folding; IEA:InterPro
Q58FF7	HSP90AB3P	Putative heat shock protein HSP 90-beta-3	GO:0006950; P:response to stress; IEA:UniProtKB-KW
Q58FF6	HSP90AB4P	Putative heat shock protein HSP 90-beta 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q58FF6	HSP90AB4P	Putative heat shock protein HSP 90-beta 4	GO:0006457; P:protein folding; IEA:InterPro
Q58FF6	HSP90AB4P	Putative heat shock protein HSP 90-beta 4	GO:0006950; P:response to stress; IEA:UniProtKB-KW
Q14520	HABP2	Hyaluronan-binding protein 2	GO:0005539; F:glycosaminoglycan binding; TAS:ProtInc
Q14520	HABP2	Hyaluronan-binding protein 2	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q14520	HABP2	Hyaluronan-binding protein 2	GO:0007155; P:cell adhesion; TAS:ProtInc
Q5JVS0	HABP4	Intracellular hyaluronan-binding protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q5JVS0	HABP4	Intracellular hyaluronan-binding protein 4	GO:0007596; P:blood coagulation; TAS:Reactome
Q5JVS0	HABP4	Intracellular hyaluronan-binding protein 4	GO:0071260; P:cellular response to mechanical stimulus; ISS:UniProtKB
Q5JVS0	HABP4	Intracellular hyaluronan-binding protein 4	GO:0043392; P:negative regulation of DNA binding; IDA:UniProtKB
Q5JVS0	HABP4	Intracellular hyaluronan-binding protein 4	GO:0030168; P:platelet activation; TAS:Reactome
Q5JVS0	HABP4	Intracellular hyaluronan-binding protein 4	GO:0002576; P:platelet degranulation; TAS:Reactome
Q5JVS0	HABP4	Intracellular hyaluronan-binding protein 4	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5JVS0	HABP4	Intracellular hyaluronan-binding protein 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
B0YJ81	PTPLA	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 1	GO:0016829; F:lyase activity; IEA:UniProtKB-KW
B0YJ81	PTPLA	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 1	GO:0004725; F:protein tyrosine phosphatase activity; TAS:ProtInc
B0YJ81	PTPLA	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 1	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
B0YJ81	PTPLA	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
B0YJ81	PTPLA	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 1	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
B0YJ81	PTPLA	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 1	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
B0YJ81	PTPLA	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 1	GO:0007165; P:signal transduction; NAS:ProtInc
Q6Y1H2	PTPLB	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 2	GO:0016829; F:lyase activity; IEA:UniProtKB-KW
Q6Y1H2	PTPLB	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 2	GO:0005515; F:protein binding; IPI:IntAct
Q6Y1H2	PTPLB	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 2	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
Q9P035	PTPLAD1	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 3	GO:0005096; F:GTPase activator activity; TAS:ProtInc
Q9P035	PTPLAD1	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 3	GO:0016829; F:lyase activity; IEA:UniProtKB-KW
Q9P035	PTPLAD1	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 3	GO:0005515; F:protein binding; IPI:IntAct
Q9P035	PTPLAD1	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 3	GO:0007257; P:activation of JUN kinase activity; TAS:ProtInc
Q9P035	PTPLAD1	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 3	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
Q9P035	PTPLAD1	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 3	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:ProtInc
Q9P035	PTPLAD1	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 3	GO:0043547; P:positive regulation of GTPase activity; TAS:GOC
Q9P035	PTPLAD1	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 3	GO:0016601; P:Rac protein signal transduction; NAS:UniProtKB
Q9P035	PTPLAD1	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 3	GO:0007266; P:Rho protein signal transduction; IEA:Ensembl
Q9P035	PTPLAD1	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 3	GO:0007264; P:small GTPase mediated signal transduction; TAS:ProtInc
Q5VWC8	PTPLAD2	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 4	GO:0016829; F:lyase activity; IEA:UniProtKB-KW
Q5VWC8	PTPLAD2	Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 4	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
Q8IYU2	HACE1	E3 ubiquitin-protein ligase HACE1	GO:0017137; F:Rab GTPase binding; IDA:UniProtKB
Q8IYU2	HACE1	E3 ubiquitin-protein ligase HACE1	GO:0048365; F:Rac GTPase binding; IPI:UniProtKB
Q8IYU2	HACE1	E3 ubiquitin-protein ligase HACE1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q8IYU2	HACE1	E3 ubiquitin-protein ligase HACE1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8IYU2	HACE1	E3 ubiquitin-protein ligase HACE1	GO:0007030; P:Golgi organization; IDA:UniProtKB
Q8IYU2	HACE1	E3 ubiquitin-protein ligase HACE1	GO:0061025; P:membrane fusion; IMP:UniProtKB
Q8IYU2	HACE1	E3 ubiquitin-protein ligase HACE1	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
Q8IYU2	HACE1	E3 ubiquitin-protein ligase HACE1	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q8IYU2	HACE1	E3 ubiquitin-protein ligase HACE1	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q8IYU2	HACE1	E3 ubiquitin-protein ligase HACE1	GO:0016601; P:Rac protein signal transduction; TAS:UniProtKB
Q8IYU2	HACE1	E3 ubiquitin-protein ligase HACE1	GO:0030334; P:regulation of cell migration; IMP:UniProtKB
Q8IYU2	HACE1	E3 ubiquitin-protein ligase HACE1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8IYU2	HACE1	E3 ubiquitin-protein ligase HACE1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UJ83	HACL1	2-hydroxyacyl-CoA lyase 1	GO:0016830; F:carbon-carbon lyase activity; IDA:UniProtKB
Q9UJ83	HACL1	2-hydroxyacyl-CoA lyase 1	GO:0003824; F:catalytic activity; IEA:InterPro
Q9UJ83	HACL1	2-hydroxyacyl-CoA lyase 1	GO:0048037; F:cofactor binding; IDA:UniProtKB
Q9UJ83	HACL1	2-hydroxyacyl-CoA lyase 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q9UJ83	HACL1	2-hydroxyacyl-CoA lyase 1	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q9UJ83	HACL1	2-hydroxyacyl-CoA lyase 1	GO:0005102; F:receptor binding; IPI:UniProtKB
Q9UJ83	HACL1	2-hydroxyacyl-CoA lyase 1	GO:0030976; F:thiamine pyrophosphate binding; IDA:UniProtKB
Q9UJ83	HACL1	2-hydroxyacyl-CoA lyase 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9UJ83	HACL1	2-hydroxyacyl-CoA lyase 1	GO:0001561; P:fatty acid alpha-oxidation; IDA:HGNC
Q9UJ83	HACL1	2-hydroxyacyl-CoA lyase 1	GO:0051259; P:protein oligomerization; IDA:UniProtKB
Q9UJ83	HACL1	2-hydroxyacyl-CoA lyase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43593	HR	Lysine-specific demethylase hairless	GO:0003677; F:DNA binding; NAS:UniProtKB
O43593	HR	Lysine-specific demethylase hairless	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43593	HR	Lysine-specific demethylase hairless	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
O43593	HR	Lysine-specific demethylase hairless	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
O43593	HR	Lysine-specific demethylase hairless	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
O43593	HR	Lysine-specific demethylase hairless	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
O43593	HR	Lysine-specific demethylase hairless	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6PII5	HAGHL	Hydroxyacylglutathione hydrolase-like protein	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q6PII5	HAGHL	Hydroxyacylglutathione hydrolase-like protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q75N03	CBLL1	E3 ubiquitin-protein ligase Hakai	GO:0005515; F:protein binding; IPI:UniProtKB
Q75N03	CBLL1	E3 ubiquitin-protein ligase Hakai	GO:0004842; F:ubiquitin-protein ligase activity; ISS:UniProtKB
Q75N03	CBLL1	E3 ubiquitin-protein ligase Hakai	GO:0008270; F:zinc ion binding; IEA:InterPro
Q75N03	CBLL1	E3 ubiquitin-protein ligase Hakai	GO:0016337; P:single organismal cell-cell adhesion; IDA:UniProtKB
Q75N03	CBLL1	E3 ubiquitin-protein ligase Hakai	GO:0007162; P:negative regulation of cell adhesion; ISS:UniProtKB
Q75N03	CBLL1	E3 ubiquitin-protein ligase Hakai	GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB
Q75N03	CBLL1	E3 ubiquitin-protein ligase Hakai	GO:0045807; P:positive regulation of endocytosis; ISS:UniProtKB
Q75N03	CBLL1	E3 ubiquitin-protein ligase Hakai	GO:0016567; P:protein ubiquitination; TAS:UniProtKB
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0043425; F:bHLH transcription factor binding; IPI:BHF-UCL
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0042802; F:identical protein binding; ISS:BHF-UCL
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0005515; F:protein binding; IPI:BHF-UCL
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0042803; F:protein homodimerization activity; NAS:BHF-UCL
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0003713; F:transcription coactivator activity; IDA:BHF-UCL
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0001525; P:angiogenesis; ISS:BHF-UCL
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0001824; P:blastocyst development; IEP:BHF-UCL
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0003218; P:cardiac left ventricle formation; IMP:BHF-UCL
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0003219; P:cardiac right ventricle formation; IMP:BHF-UCL
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0060411; P:cardiac septum morphogenesis; IMP:BHF-UCL
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0060536; P:cartilage morphogenesis; IEA:Ensembl
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0035050; P:embryonic heart tube development; ISS:BHF-UCL
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0003144; P:embryonic heart tube formation; IEA:Ensembl
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0007507; P:heart development; ISS:BHF-UCL
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0001947; P:heart looping; ISS:BHF-UCL
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0060485; P:mesenchyme development; IEA:Ensembl
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0001707; P:mesoderm formation; IEA:Ensembl
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:BHF-UCL
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0001829; P:trophectodermal cell differentiation; IEP:BHF-UCL
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0060707; P:trophoblast giant cell differentiation; IEA:Ensembl
O96004	HAND1	Heart- and neural crest derivatives-expressed protein 1	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IMP:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0033613; F:activating transcription factor binding; ISS:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0003680; F:AT DNA binding; IDA:UniProtKB
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0070888; F:E-box binding; IDA:UniProtKB
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:UniProtKB
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0003713; F:transcription coactivator activity; ISS:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0008134; F:transcription factor binding; ISS:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0007512; P:adult heart development; IEP:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0006915; P:apoptotic process; ISS:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0003278; P:apoptotic process involved in heart morphogenesis; IEA:Ensembl
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0061309; P:cardiac neural crest cell development involved in outflow tract morphogenesis; ISS:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0003253; P:cardiac neural crest cell migration involved in outflow tract morphogenesis; IEA:Ensembl
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0003219; P:cardiac right ventricle formation; IEA:Ensembl
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0060536; P:cartilage morphogenesis; IEA:Ensembl
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0061325; P:cell proliferation involved in outflow tract morphogenesis; IEA:Ensembl
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0060982; P:coronary artery morphogenesis; IEA:Ensembl
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0007507; P:heart development; NAS:UniProtKB
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0001947; P:heart looping; ISS:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0003007; P:heart morphogenesis; ISS:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0001701; P:in utero embryonic development; ISS:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0010463; P:mesenchymal cell proliferation; IEA:Ensembl
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; ISS:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0043392; P:negative regulation of DNA binding; IEA:Ensembl
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0014032; P:neural crest cell development; ISS:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0003357; P:noradrenergic neuron differentiation; NAS:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0060021; P:palate development; IEA:Ensembl
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0048935; P:peripheral nervous system neuron development; IEA:Ensembl
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:2000764; P:positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis; ISS:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:2000763; P:positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process; ISS:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:2000679; P:positive regulation of transcription regulatory region DNA binding; IDA:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0003266; P:regulation of secondary heart field cardioblast proliferation; ISS:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0006355; P:regulation of transcription, DNA-templated; ISS:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0001967; P:suckling behavior; IEA:Ensembl
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0048485; P:sympathetic nervous system development; IEA:Ensembl
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0048538; P:thymus development; ISS:BHF-UCL
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0043586; P:tongue development; IEA:Ensembl
P61296	HAND2	Heart- and neural crest derivatives-expressed protein 2	GO:0061032; P:visceral serous pericardium development; IEA:Ensembl
Q9UJM8	HAO1	Hydroxyacid oxidase 1	GO:0003973; F:(S)-2-hydroxy-acid oxidase activity; IDA:UniProtKB
Q9UJM8	HAO1	Hydroxyacid oxidase 1	GO:0010181; F:FMN binding; IDA:UniProtKB
Q9UJM8	HAO1	Hydroxyacid oxidase 1	GO:0008891; F:glycolate oxidase activity; IDA:UniProtKB
Q9UJM8	HAO1	Hydroxyacid oxidase 1	GO:0047969; F:glyoxylate oxidase activity; TAS:Reactome
Q9UJM8	HAO1	Hydroxyacid oxidase 1	GO:0052853; F:long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity; IEA:UniProtKB-EC
Q9UJM8	HAO1	Hydroxyacid oxidase 1	GO:0052854; F:medium-chain-(S)-2-hydroxy-acid oxidase activity; IEA:UniProtKB-EC
Q9UJM8	HAO1	Hydroxyacid oxidase 1	GO:0005102; F:receptor binding; IPI:UniProtKB
Q9UJM8	HAO1	Hydroxyacid oxidase 1	GO:0052852; F:very-long-chain-(S)-2-hydroxy-acid oxidase activity; IEA:UniProtKB-EC
Q9UJM8	HAO1	Hydroxyacid oxidase 1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9UJM8	HAO1	Hydroxyacid oxidase 1	GO:0001561; P:fatty acid alpha-oxidation; IDA:UniProtKB
Q9UJM8	HAO1	Hydroxyacid oxidase 1	GO:0046296; P:glycolate catabolic process; IDA:UniProtKB
Q9UJM8	HAO1	Hydroxyacid oxidase 1	GO:0046487; P:glyoxylate metabolic process; TAS:Reactome
Q9UJM8	HAO1	Hydroxyacid oxidase 1	GO:0006979; P:response to oxidative stress; IEA:Ensembl
Q9UJM8	HAO1	Hydroxyacid oxidase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NYQ3	HAO2	Hydroxyacid oxidase 2	GO:0003973; F:(S)-2-hydroxy-acid oxidase activity; IDA:UniProtKB
Q9NYQ3	HAO2	Hydroxyacid oxidase 2	GO:0010181; F:FMN binding; IEA:Ensembl
Q9NYQ3	HAO2	Hydroxyacid oxidase 2	GO:0052853; F:long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity; IDA:UniProtKB
Q9NYQ3	HAO2	Hydroxyacid oxidase 2	GO:0052854; F:medium-chain-(S)-2-hydroxy-acid oxidase activity; IEA:UniProtKB-EC
Q9NYQ3	HAO2	Hydroxyacid oxidase 2	GO:0005102; F:receptor binding; IPI:UniProtKB
Q9NYQ3	HAO2	Hydroxyacid oxidase 2	GO:0052852; F:very-long-chain-(S)-2-hydroxy-acid oxidase activity; IEA:UniProtKB-EC
Q9NYQ3	HAO2	Hydroxyacid oxidase 2	GO:0019395; P:fatty acid oxidation; IDA:UniProtKB
Q9NYQ3	HAO2	Hydroxyacid oxidase 2	GO:0018924; P:mandelate metabolic process; IEA:Ensembl
Q9NYQ3	HAO2	Hydroxyacid oxidase 2	GO:0051260; P:protein homooligomerization; IEA:Ensembl
P54257	HAP1	Huntingtin-associated protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P54257	HAP1	Huntingtin-associated protein 1	GO:0007420; P:brain development; NAS:UniProtKB
P54257	HAP1	Huntingtin-associated protein 1	GO:0008104; P:protein localization; IMP:UniProtKB
P54257	HAP1	Huntingtin-associated protein 1	GO:0007268; P:synaptic transmission; TAS:ProtInc
P54257	HAP1	Huntingtin-associated protein 1	GO:0047496; P:vesicle transport along microtubule; IEA:Ensembl
Q13442	PDAP1	28 kDa heat- and acid-stable phosphoprotein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13442	PDAP1	28 kDa heat- and acid-stable phosphoprotein	GO:0008283; P:cell proliferation; TAS:ProtInc
Q13442	PDAP1	28 kDa heat- and acid-stable phosphoprotein	GO:0007165; P:signal transduction; TAS:ProtInc
Q96MB7	HARBI1	Putative nuclease HARBI1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96MB7	HARBI1	Putative nuclease HARBI1	GO:0004518; F:nuclease activity; IEA:UniProtKB-KW
Q8TF76	GSG2	Serine/threonine-protein kinase haspin	GO:0005524; F:ATP binding; IDA:UniProtKB
Q8TF76	GSG2	Serine/threonine-protein kinase haspin	GO:0003677; F:DNA binding; IEA:Ensembl
Q8TF76	GSG2	Serine/threonine-protein kinase haspin	GO:0072354; F:histone kinase activity (H3-T3 specific); IMP:UniProtKB
Q8TF76	GSG2	Serine/threonine-protein kinase haspin	GO:0005515; F:protein binding; IPI:IntAct
Q8TF76	GSG2	Serine/threonine-protein kinase haspin	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q8TF76	GSG2	Serine/threonine-protein kinase haspin	GO:2000751; P:histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore; IMP:UniProtKB
Q8TF76	GSG2	Serine/threonine-protein kinase haspin	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q8TF76	GSG2	Serine/threonine-protein kinase haspin	GO:0007064; P:mitotic sister chromatid cohesion; IMP:UniProtKB
Q8TF76	GSG2	Serine/threonine-protein kinase haspin	GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl
Q8TF76	GSG2	Serine/threonine-protein kinase haspin	GO:0071459; P:protein localization to chromosome, centromeric region; IMP:UniProtKB
Q8TF76	GSG2	Serine/threonine-protein kinase haspin	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q8TF76	GSG2	Serine/threonine-protein kinase haspin	GO:0090231; P:regulation of spindle checkpoint; IMP:UniProtKB
O14929	HAT1	Histone acetyltransferase type B catalytic subunit	GO:0004402; F:histone acetyltransferase activity; TAS:ProtInc
O14929	HAT1	Histone acetyltransferase type B catalytic subunit	GO:0005515; F:protein binding; IPI:IntAct
O14929	HAT1	Histone acetyltransferase type B catalytic subunit	GO:0006325; P:chromatin organization; TAS:Reactome
O14929	HAT1	Histone acetyltransferase type B catalytic subunit	GO:0006348; P:chromatin silencing at telomere; IEA:InterPro
O14929	HAT1	Histone acetyltransferase type B catalytic subunit	GO:0006323; P:DNA packaging; TAS:ProtInc
O14929	HAT1	Histone acetyltransferase type B catalytic subunit	GO:0006335; P:DNA replication-dependent nucleosome assembly; IDA:UniProt
O14929	HAT1	Histone acetyltransferase type B catalytic subunit	GO:0006336; P:DNA replication-independent nucleosome assembly; IDA:UniProt
O14929	HAT1	Histone acetyltransferase type B catalytic subunit	GO:0006475; P:internal protein amino acid acetylation; TAS:ProtInc
O14929	HAT1	Histone acetyltransferase type B catalytic subunit	GO:0007584; P:response to nutrient; IEA:Ensembl
Q96CS2	HAUS1	HAUS augmin-like complex subunit 1	GO:0005515; F:protein binding; IPI:IntAct
Q96CS2	HAUS1	HAUS augmin-like complex subunit 1	GO:0051297; P:centrosome organization; IMP:UniProtKB
Q96CS2	HAUS1	HAUS augmin-like complex subunit 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q96CS2	HAUS1	HAUS augmin-like complex subunit 1	GO:0051225; P:spindle assembly; IMP:UniProtKB
Q68CZ6	HAUS3	HAUS augmin-like complex subunit 3	GO:0051297; P:centrosome organization; IMP:UniProtKB
Q68CZ6	HAUS3	HAUS augmin-like complex subunit 3	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q68CZ6	HAUS3	HAUS augmin-like complex subunit 3	GO:0051225; P:spindle assembly; IMP:UniProtKB
Q9NVX0	HAUS2	HAUS augmin-like complex subunit 2	GO:0051297; P:centrosome organization; IMP:UniProtKB
Q9NVX0	HAUS2	HAUS augmin-like complex subunit 2	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q9NVX0	HAUS2	HAUS augmin-like complex subunit 2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9NVX0	HAUS2	HAUS augmin-like complex subunit 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9NVX0	HAUS2	HAUS augmin-like complex subunit 2	GO:0051225; P:spindle assembly; IMP:UniProtKB
O94927	HAUS5	HAUS augmin-like complex subunit 5	GO:0051297; P:centrosome organization; IMP:UniProtKB
O94927	HAUS5	HAUS augmin-like complex subunit 5	GO:0007067; P:mitosis; IEA:UniProtKB-KW
O94927	HAUS5	HAUS augmin-like complex subunit 5	GO:0051225; P:spindle assembly; IMP:UniProtKB
Q7Z4H7	HAUS6	HAUS augmin-like complex subunit 6	GO:0051297; P:centrosome organization; IMP:UniProtKB
Q7Z4H7	HAUS6	HAUS augmin-like complex subunit 6	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q7Z4H7	HAUS6	HAUS augmin-like complex subunit 6	GO:0051225; P:spindle assembly; IMP:UniProtKB
Q9H6D7	HAUS4	HAUS augmin-like complex subunit 4	GO:0051297; P:centrosome organization; IMP:UniProtKB
Q9H6D7	HAUS4	HAUS augmin-like complex subunit 4	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9H6D7	HAUS4	HAUS augmin-like complex subunit 4	GO:0051225; P:spindle assembly; IMP:UniProtKB
Q99871	HAUS7	HAUS augmin-like complex subunit 7	GO:0031996; F:thioesterase binding; IPI:UniProtKB
Q99871	HAUS7	HAUS augmin-like complex subunit 7	GO:0051297; P:centrosome organization; IMP:UniProtKB
Q99871	HAUS7	HAUS augmin-like complex subunit 7	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q99871	HAUS7	HAUS augmin-like complex subunit 7	GO:0051225; P:spindle assembly; IMP:UniProtKB
Q9BT25	HAUS8	HAUS augmin-like complex subunit 8	GO:0051297; P:centrosome organization; IMP:UniProtKB
Q9BT25	HAUS8	HAUS augmin-like complex subunit 8	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9BT25	HAUS8	HAUS augmin-like complex subunit 8	GO:0051225; P:spindle assembly; IMP:UniProtKB
Q96D42	HAVCR1	Hepatitis A virus cellular receptor 1	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
Q96D42	HAVCR1	Hepatitis A virus cellular receptor 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
O00165	HAX1	HCLS1-associated protein X-1	GO:0019966; F:interleukin-1 binding; IDA:UniProtKB
O00165	HAX1	HCLS1-associated protein X-1	GO:0005515; F:protein binding; IPI:UniProtKB
O00165	HAX1	HCLS1-associated protein X-1	GO:0047485; F:protein N-terminus binding; IDA:UniProtKB
O00165	HAX1	HCLS1-associated protein X-1	GO:0071345; P:cellular response to cytokine stimulus; IMP:BHF-UCL
O00165	HAX1	HCLS1-associated protein X-1	GO:2000251; P:positive regulation of actin cytoskeleton reorganization; IMP:BHF-UCL
O00165	HAX1	HCLS1-associated protein X-1	GO:0030854; P:positive regulation of granulocyte differentiation; IMP:BHF-UCL
O00165	HAX1	HCLS1-associated protein X-1	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IMP:BHF-UCL
O00165	HAX1	HCLS1-associated protein X-1	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IMP:BHF-UCL
O00165	HAX1	HCLS1-associated protein X-1	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IMP:BHF-UCL
O00165	HAX1	HCLS1-associated protein X-1	GO:0051897; P:positive regulation of protein kinase B signaling; IMP:BHF-UCL
O00165	HAX1	HCLS1-associated protein X-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
O00165	HAX1	HCLS1-associated protein X-1	GO:0030833; P:regulation of actin filament polymerization; IMP:BHF-UCL
P09105	HBQ1	Hemoglobin subunit theta-1	GO:0020037; F:heme binding; IEA:InterPro
P09105	HBQ1	Hemoglobin subunit theta-1	GO:0005506; F:iron ion binding; IEA:InterPro
P09105	HBQ1	Hemoglobin subunit theta-1	GO:0019825; F:oxygen binding; IEA:InterPro
P09105	HBQ1	Hemoglobin subunit theta-1	GO:0005344; F:oxygen transporter activity; IEA:UniProtKB-KW
P09105	HBQ1	Hemoglobin subunit theta-1	GO:0015671; P:oxygen transport; TAS:ProtInc
P02008	HBZ	Hemoglobin subunit zeta	GO:0020037; F:heme binding; IEA:InterPro
P02008	HBZ	Hemoglobin subunit zeta	GO:0005506; F:iron ion binding; IEA:InterPro
P02008	HBZ	Hemoglobin subunit zeta	GO:0019825; F:oxygen binding; IEA:InterPro
P02008	HBZ	Hemoglobin subunit zeta	GO:0005344; F:oxygen transporter activity; TAS:ProtInc
P02008	HBZ	Hemoglobin subunit zeta	GO:0005515; F:protein binding; IPI:IntAct
P02008	HBZ	Hemoglobin subunit zeta	GO:0043249; P:erythrocyte maturation; IEA:Ensembl
P02008	HBZ	Hemoglobin subunit zeta	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P69905	HBA1	Hemoglobin subunit alpha	GO:0020037; F:heme binding; IEA:InterPro
P69905	HBA1	Hemoglobin subunit alpha	GO:0005506; F:iron ion binding; IEA:InterPro
P69905	HBA1	Hemoglobin subunit alpha	GO:0019825; F:oxygen binding; IEA:InterPro
P69905	HBA1	Hemoglobin subunit alpha	GO:0005344; F:oxygen transporter activity; IEA:UniProtKB-KW
P69905	HBA1	Hemoglobin subunit alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P69905	HBA1	Hemoglobin subunit alpha	GO:0015701; P:bicarbonate transport; TAS:Reactome
P69905	HBA1	Hemoglobin subunit alpha	GO:0042744; P:hydrogen peroxide catabolic process; IDA:BHF-UCL
P69905	HBA1	Hemoglobin subunit alpha	GO:0055114; P:oxidation-reduction process; IDA:GOC
P69905	HBA1	Hemoglobin subunit alpha	GO:0015671; P:oxygen transport; TAS:UniProtKB
P69905	HBA1	Hemoglobin subunit alpha	GO:0010942; P:positive regulation of cell death; IDA:BHF-UCL
P69905	HBA1	Hemoglobin subunit alpha	GO:0051291; P:protein heterooligomerization; IDA:BHF-UCL
P69905	HBA1	Hemoglobin subunit alpha	GO:0042542; P:response to hydrogen peroxide; IDA:BHF-UCL
P69905	HBA1	Hemoglobin subunit alpha	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P68871	HBB	Hemoglobin subunit beta	GO:0020037; F:heme binding; IEA:InterPro
P68871	HBB	Hemoglobin subunit beta	GO:0030492; F:hemoglobin binding; IDA:UniProtKB
P68871	HBB	Hemoglobin subunit beta	GO:0005506; F:iron ion binding; IEA:InterPro
P68871	HBB	Hemoglobin subunit beta	GO:0019825; F:oxygen binding; IDA:UniProtKB
P68871	HBB	Hemoglobin subunit beta	GO:0005344; F:oxygen transporter activity; NAS:UniProtKB
P68871	HBB	Hemoglobin subunit beta	GO:0005515; F:protein binding; IPI:IntAct
P68871	HBB	Hemoglobin subunit beta	GO:0015701; P:bicarbonate transport; TAS:Reactome
P68871	HBB	Hemoglobin subunit beta	GO:0007596; P:blood coagulation; TAS:Reactome
P68871	HBB	Hemoglobin subunit beta	GO:0042744; P:hydrogen peroxide catabolic process; IDA:BHF-UCL
P68871	HBB	Hemoglobin subunit beta	GO:0030185; P:nitric oxide transport; NAS:UniProtKB
P68871	HBB	Hemoglobin subunit beta	GO:0055114; P:oxidation-reduction process; IDA:GOC
P68871	HBB	Hemoglobin subunit beta	GO:0015671; P:oxygen transport; NAS:UniProtKB
P68871	HBB	Hemoglobin subunit beta	GO:0010942; P:positive regulation of cell death; IDA:BHF-UCL
P68871	HBB	Hemoglobin subunit beta	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; NAS:UniProtKB
P68871	HBB	Hemoglobin subunit beta	GO:0051291; P:protein heterooligomerization; IDA:BHF-UCL
P68871	HBB	Hemoglobin subunit beta	GO:0008217; P:regulation of blood pressure; IEA:UniProtKB-KW
P68871	HBB	Hemoglobin subunit beta	GO:0050880; P:regulation of blood vessel size; IEA:UniProtKB-KW
P68871	HBB	Hemoglobin subunit beta	GO:0070293; P:renal absorption; IMP:UniProtKB
P68871	HBB	Hemoglobin subunit beta	GO:0042542; P:response to hydrogen peroxide; IDA:BHF-UCL
P68871	HBB	Hemoglobin subunit beta	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P02042	HBD	Hemoglobin subunit delta	GO:0020037; F:heme binding; IEA:InterPro
P02042	HBD	Hemoglobin subunit delta	GO:0005506; F:iron ion binding; IEA:InterPro
P02042	HBD	Hemoglobin subunit delta	GO:0019825; F:oxygen binding; IEA:InterPro
P02042	HBD	Hemoglobin subunit delta	GO:0005344; F:oxygen transporter activity; IEA:UniProtKB-KW
P02042	HBD	Hemoglobin subunit delta	GO:0007596; P:blood coagulation; TAS:Reactome
Q99075	HBEGF	Proheparin-binding EGF-like growth factor	GO:0005154; F:epidermal growth factor receptor binding; TAS:ProtInc
Q99075	HBEGF	Proheparin-binding EGF-like growth factor	GO:0008083; F:growth factor activity; IDA:UniProtKB
Q99075	HBEGF	Proheparin-binding EGF-like growth factor	GO:0008201; F:heparin binding; IMP:UniProtKB
Q99075	HBEGF	Proheparin-binding EGF-like growth factor	GO:0007173; P:epidermal growth factor receptor signaling pathway; IMP:BHF-UCL
Q99075	HBEGF	Proheparin-binding EGF-like growth factor	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q99075	HBEGF	Proheparin-binding EGF-like growth factor	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q99075	HBEGF	Proheparin-binding EGF-like growth factor	GO:0045087; P:innate immune response; TAS:Reactome
Q99075	HBEGF	Proheparin-binding EGF-like growth factor	GO:0007517; P:muscle organ development; TAS:ProtInc
Q99075	HBEGF	Proheparin-binding EGF-like growth factor	GO:0051545; P:negative regulation of elastin biosynthetic process; IEA:Ensembl
Q99075	HBEGF	Proheparin-binding EGF-like growth factor	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q99075	HBEGF	Proheparin-binding EGF-like growth factor	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q99075	HBEGF	Proheparin-binding EGF-like growth factor	GO:0030307; P:positive regulation of cell growth; IEA:Ensembl
Q99075	HBEGF	Proheparin-binding EGF-like growth factor	GO:0030335; P:positive regulation of cell migration; IMP:BHF-UCL
Q99075	HBEGF	Proheparin-binding EGF-like growth factor	GO:0051549; P:positive regulation of keratinocyte migration; IEA:Ensembl
Q99075	HBEGF	Proheparin-binding EGF-like growth factor	GO:0051897; P:positive regulation of protein kinase B signaling; IMP:BHF-UCL
Q99075	HBEGF	Proheparin-binding EGF-like growth factor	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
Q99075	HBEGF	Proheparin-binding EGF-like growth factor	GO:0090303; P:positive regulation of wound healing; IMP:BHF-UCL
Q99075	HBEGF	Proheparin-binding EGF-like growth factor	GO:0008016; P:regulation of heart contraction; IEA:Ensembl
Q99075	HBEGF	Proheparin-binding EGF-like growth factor	GO:0007165; P:signal transduction; TAS:ProtInc
Q99075	HBEGF	Proheparin-binding EGF-like growth factor	GO:0035313; P:wound healing, spreading of epidermal cells; IEA:Ensembl
P02100	HBE1	Hemoglobin subunit epsilon	GO:0020037; F:heme binding; IEA:InterPro
P02100	HBE1	Hemoglobin subunit epsilon	GO:0005506; F:iron ion binding; IEA:InterPro
P02100	HBE1	Hemoglobin subunit epsilon	GO:0019825; F:oxygen binding; IEA:InterPro
P02100	HBE1	Hemoglobin subunit epsilon	GO:0005344; F:oxygen transporter activity; TAS:ProtInc
P02100	HBE1	Hemoglobin subunit epsilon	GO:0007596; P:blood coagulation; TAS:Reactome
P02100	HBE1	Hemoglobin subunit epsilon	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P02100	HBE1	Hemoglobin subunit epsilon	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P69891	HBG1	Hemoglobin subunit gamma-1	GO:0020037; F:heme binding; IEA:InterPro
P69891	HBG1	Hemoglobin subunit gamma-1	GO:0005506; F:iron ion binding; IEA:InterPro
P69891	HBG1	Hemoglobin subunit gamma-1	GO:0019825; F:oxygen binding; IEA:InterPro
P69891	HBG1	Hemoglobin subunit gamma-1	GO:0005344; F:oxygen transporter activity; IEA:UniProtKB-KW
P69891	HBG1	Hemoglobin subunit gamma-1	GO:0007596; P:blood coagulation; TAS:Reactome
P69892	HBG2	Hemoglobin subunit gamma-2	GO:0020037; F:heme binding; IEA:InterPro
P69892	HBG2	Hemoglobin subunit gamma-2	GO:0005506; F:iron ion binding; IEA:InterPro
P69892	HBG2	Hemoglobin subunit gamma-2	GO:0019825; F:oxygen binding; IEA:InterPro
P69892	HBG2	Hemoglobin subunit gamma-2	GO:0005344; F:oxygen transporter activity; IEA:UniProtKB-KW
P69892	HBG2	Hemoglobin subunit gamma-2	GO:0007596; P:blood coagulation; TAS:Reactome
Q6B0K9	HBM	Hemoglobin subunit mu	GO:0020037; F:heme binding; IEA:InterPro
Q6B0K9	HBM	Hemoglobin subunit mu	GO:0005506; F:iron ion binding; IEA:InterPro
Q6B0K9	HBM	Hemoglobin subunit mu	GO:0019825; F:oxygen binding; IEA:InterPro
Q6B0K9	HBM	Hemoglobin subunit mu	GO:0005344; F:oxygen transporter activity; IEA:UniProtKB-KW
O60381	HBP1	HMG box-containing protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O60381	HBP1	HMG box-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
O60381	HBP1	HMG box-containing protein 1	GO:0003723; F:RNA binding; IEA:InterPro
O60381	HBP1	HMG box-containing protein 1	GO:0007050; P:cell cycle arrest; NAS:UniProtKB
O60381	HBP1	HMG box-containing protein 1	GO:0043268; P:positive regulation of potassium ion transport; IEA:Ensembl
O60381	HBP1	HMG box-containing protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O60381	HBP1	HMG box-containing protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60381	HBP1	HMG box-containing protein 1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9Y450	HBS1L	HBS1-like protein	GO:0005525; F:GTP binding; TAS:ProtInc
Q9Y450	HBS1L	HBS1-like protein	GO:0003924; F:GTPase activity; IEA:InterPro
Q9Y450	HBS1L	HBS1-like protein	GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-KW
Q9Y450	HBS1L	HBS1-like protein	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y450	HBS1L	HBS1-like protein	GO:0006412; P:translation; TAS:ProtInc
Q9BXC0	HCAR1	Hydroxycarboxylic acid receptor 1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9BXC0	HCAR1	Hydroxycarboxylic acid receptor 1	GO:0032355; P:response to estradiol; IDA:BHF-UCL
Q8TDS4	HCAR2	Hydroxycarboxylic acid receptor 2	GO:0070553; F:nicotinic acid receptor activity; ISS:UniProtKB
Q8TDS4	HCAR2	Hydroxycarboxylic acid receptor 2	GO:0050995; P:negative regulation of lipid catabolic process; ISS:UniProtKB
Q8TDS4	HCAR2	Hydroxycarboxylic acid receptor 2	GO:0001781; P:neutrophil apoptotic process; IDA:UniProtKB
Q8TDS4	HCAR2	Hydroxycarboxylic acid receptor 2	GO:0070165; P:positive regulation of adiponectin secretion; ISS:UniProtKB
Q8TDS4	HCAR2	Hydroxycarboxylic acid receptor 2	GO:0033031; P:positive regulation of neutrophil apoptotic process; IDA:UniProtKB
P49019	HCAR3	Hydroxycarboxylic acid receptor 3	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P49019	HCAR3	Hydroxycarboxylic acid receptor 3	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q99714	HSD17B10	3-hydroxyacyl-CoA dehydrogenase type-2	GO:0047015; F:3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity; IEA:UniProtKB-EC
Q99714	HSD17B10	3-hydroxyacyl-CoA dehydrogenase type-2	GO:0003857; F:3-hydroxyacyl-CoA dehydrogenase activity; EXP:Reactome
Q99714	HSD17B10	3-hydroxyacyl-CoA dehydrogenase type-2	GO:0008709; F:cholate 7-alpha-dehydrogenase activity; TAS:ProtInc
Q99714	HSD17B10	3-hydroxyacyl-CoA dehydrogenase type-2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q99714	HSD17B10	3-hydroxyacyl-CoA dehydrogenase type-2	GO:0005515; F:protein binding; IPI:IntAct
Q99714	HSD17B10	3-hydroxyacyl-CoA dehydrogenase type-2	GO:0030283; F:testosterone dehydrogenase [NAD(P)] activity; IEA:UniProtKB-EC
Q99714	HSD17B10	3-hydroxyacyl-CoA dehydrogenase type-2	GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome
Q99714	HSD17B10	3-hydroxyacyl-CoA dehydrogenase type-2	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q99714	HSD17B10	3-hydroxyacyl-CoA dehydrogenase type-2	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q99714	HSD17B10	3-hydroxyacyl-CoA dehydrogenase type-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99714	HSD17B10	3-hydroxyacyl-CoA dehydrogenase type-2	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q16836	HADH	Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial	GO:0003857; F:3-hydroxyacyl-CoA dehydrogenase activity; TAS:Reactome
Q16836	HADH	Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial	GO:0070403; F:NAD+ binding; IEA:InterPro
Q16836	HADH	Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q16836	HADH	Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial	GO:0006635; P:fatty acid beta-oxidation; TAS:Reactome
Q16836	HADH	Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial	GO:0046676; P:negative regulation of insulin secretion; IEA:Ensembl
Q16836	HADH	Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial	GO:0014823; P:response to activity; IEA:Ensembl
Q16836	HADH	Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial	GO:0042493; P:response to drug; IEA:Ensembl
Q16836	HADH	Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial	GO:0032868; P:response to insulin; IEA:Ensembl
Q16836	HADH	Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P51610	HCFC1	Host cell factor 1	GO:0003682; F:chromatin binding; IDA:UniProtKB
P51610	HCFC1	Host cell factor 1	GO:0042802; F:identical protein binding; IPI:IntAct
P51610	HCFC1	Host cell factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
P51610	HCFC1	Host cell factor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
P51610	HCFC1	Host cell factor 1	GO:0003713; F:transcription coactivator activity; IMP:UniProtKB
P51610	HCFC1	Host cell factor 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P51610	HCFC1	Host cell factor 1	GO:0006325; P:chromatin organization; TAS:Reactome
P51610	HCFC1	Host cell factor 1	GO:0043984; P:histone H4-K16 acetylation; IDA:UniProtKB
P51610	HCFC1	Host cell factor 1	GO:0043981; P:histone H4-K5 acetylation; IDA:UniProtKB
P51610	HCFC1	Host cell factor 1	GO:0043982; P:histone H4-K8 acetylation; IDA:UniProtKB
P51610	HCFC1	Host cell factor 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
P51610	HCFC1	Host cell factor 1	GO:0045787; P:positive regulation of cell cycle; TAS:UniProtKB
P51610	HCFC1	Host cell factor 1	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
P51610	HCFC1	Host cell factor 1	GO:0050821; P:protein stabilization; IDA:UniProtKB
P51610	HCFC1	Host cell factor 1	GO:0043254; P:regulation of protein complex assembly; IDA:UniProtKB
P51610	HCFC1	Host cell factor 1	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
P51610	HCFC1	Host cell factor 1	GO:0019046; P:release from viral latency; NAS:UniProtKB
P51610	HCFC1	Host cell factor 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9Y5Z7	HCFC2	Host cell factor 2	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q9Y5Z7	HCFC2	Host cell factor 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q9Y5Z7	HCFC2	Host cell factor 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9Y5Z7	HCFC2	Host cell factor 2	GO:0016032; P:viral process; TAS:ProtInc
P08631	HCK	Tyrosine-protein kinase HCK	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P08631	HCK	Tyrosine-protein kinase HCK	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC
P08631	HCK	Tyrosine-protein kinase HCK	GO:0005515; F:protein binding; IPI:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0004713; F:protein tyrosine kinase activity; IMP:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0007155; P:cell adhesion; TAS:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0019221; P:cytokine-mediated signaling pathway; TAS:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P08631	HCK	Tyrosine-protein kinase HCK	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
P08631	HCK	Tyrosine-protein kinase HCK	GO:0045087; P:innate immune response; TAS:Reactome
P08631	HCK	Tyrosine-protein kinase HCK	GO:0002758; P:innate immune response-activating signal transduction; TAS:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0007229; P:integrin-mediated signaling pathway; TAS:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0043299; P:leukocyte degranulation; TAS:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0002522; P:leukocyte migration involved in immune response; TAS:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; TAS:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0007498; P:mesoderm development; TAS:ProtInc
P08631	HCK	Tyrosine-protein kinase HCK	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0018108; P:peptidyl-tyrosine phosphorylation; IMP:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:2000251; P:positive regulation of actin cytoskeleton reorganization; IDA:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0030838; P:positive regulation of actin filament polymerization; TAS:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0046777; P:protein autophosphorylation; IMP:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P08631	HCK	Tyrosine-protein kinase HCK	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
P08631	HCK	Tyrosine-protein kinase HCK	GO:0050727; P:regulation of inflammatory response; TAS:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0050764; P:regulation of phagocytosis; IMP:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0071801; P:regulation of podosome assembly; IDA:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IMP:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0045728; P:respiratory burst after phagocytosis; TAS:UniProtKB
P08631	HCK	Tyrosine-protein kinase HCK	GO:0016032; P:viral process; TAS:Reactome
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0005515; F:protein binding; IPI:IntAct
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0001085; F:RNA polymerase II transcription factor binding; IPI:BHF-UCL
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0030041; P:actin filament polymerization; IEA:InterPro
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0071345; P:cellular response to cytokine stimulus; IMP:BHF-UCL
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0030218; P:erythrocyte differentiation; ISS:UniProtKB
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:2000107; P:negative regulation of leukocyte apoptotic process; IMP:BHF-UCL
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:2000251; P:positive regulation of actin cytoskeleton reorganization; IC:BHF-UCL
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0030854; P:positive regulation of granulocyte differentiation; IMP:BHF-UCL
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0045651; P:positive regulation of macrophage differentiation; IEA:Ensembl
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IMP:BHF-UCL
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IMP:BHF-UCL
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IMP:BHF-UCL
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0051897; P:positive regulation of protein kinase B signaling; IMP:BHF-UCL
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0042993; P:positive regulation of transcription factor import into nucleus; IMP:BHF-UCL
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; ISS:UniProtKB
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0030833; P:regulation of actin filament polymerization; IMP:BHF-UCL
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
P14317	HCLS1	Hematopoietic lineage cell-specific protein	GO:0009725; P:response to hormone; ISS:UniProtKB
O60741	HCN1	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	GO:0030552; F:cAMP binding; ISS:UniProtKB
O60741	HCN1	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	GO:0005222; F:intracellular cAMP activated cation channel activity; ISS:UniProtKB
O60741	HCN1	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	GO:0005267; F:potassium channel activity; NAS:UniProtKB
O60741	HCN1	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	GO:0005249; F:voltage-gated potassium channel activity; ISS:UniProtKB
O60741	HCN1	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	GO:0005248; F:voltage-gated sodium channel activity; IMP:UniProt
O60741	HCN1	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	GO:0045176; P:apical protein localization; IEA:Ensembl
O60741	HCN1	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	GO:0071320; P:cellular response to cAMP; ISS:UniProtKB
O60741	HCN1	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	GO:0071805; P:potassium ion transmembrane transport; ISS:UniProtKB
O60741	HCN1	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	GO:0006813; P:potassium ion transport; NAS:UniProtKB
O60741	HCN1	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	GO:0042391; P:regulation of membrane potential; IMP:UniProt
O60741	HCN1	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	GO:0046549; P:retinal cone cell development; IEA:Ensembl
O60741	HCN1	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	GO:0035725; P:sodium ion transmembrane transport; IMP:UniProt
O60741	HCN1	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9UL51	HCN2	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2	GO:0030552; F:cAMP binding; IEA:UniProtKB-KW
Q9UL51	HCN2	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2	GO:0042802; F:identical protein binding; IPI:IntAct
Q9UL51	HCN2	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2	GO:0005222; F:intracellular cAMP activated cation channel activity; IDA:UniProtKB
Q9UL51	HCN2	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2	GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB
Q9UL51	HCN2	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2	GO:0005248; F:voltage-gated sodium channel activity; IMP:UniProt
Q9UL51	HCN2	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9UL51	HCN2	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2	GO:0071320; P:cellular response to cAMP; IDA:UniProtKB
Q9UL51	HCN2	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2	GO:0071321; P:cellular response to cGMP; IDA:UniProt
Q9UL51	HCN2	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2	GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB
Q9UL51	HCN2	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2	GO:0042391; P:regulation of membrane potential; IMP:UniProt
Q9UL51	HCN2	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2	GO:0035725; P:sodium ion transmembrane transport; IMP:UniProt
Q9UL51	HCN2	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9Y3Q4	HCN4	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	GO:0030552; F:cAMP binding; IEA:UniProtKB-KW
Q9Y3Q4	HCN4	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	GO:0005261; F:cation channel activity; TAS:ProtInc
Q9Y3Q4	HCN4	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	GO:0042802; F:identical protein binding; IPI:IntAct
Q9Y3Q4	HCN4	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	GO:0005222; F:intracellular cAMP activated cation channel activity; IDA:UniProtKB
Q9Y3Q4	HCN4	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB
Q9Y3Q4	HCN4	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	GO:0005248; F:voltage-gated sodium channel activity; IMP:UniProt
Q9Y3Q4	HCN4	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	GO:0008015; P:blood circulation; NAS:ProtInc
Q9Y3Q4	HCN4	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	GO:0006812; P:cation transport; TAS:ProtInc
Q9Y3Q4	HCN4	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	GO:0071320; P:cellular response to cAMP; IDA:UniProtKB
Q9Y3Q4	HCN4	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	GO:0071321; P:cellular response to cGMP; IDA:UniProt
Q9Y3Q4	HCN4	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9Y3Q4	HCN4	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	GO:0006936; P:muscle contraction; TAS:ProtInc
Q9Y3Q4	HCN4	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB
Q9Y3Q4	HCN4	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	GO:0002027; P:regulation of heart rate; IMP:UniProtKB
Q9Y3Q4	HCN4	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	GO:0042391; P:regulation of membrane potential; IMP:UniProt
Q9Y3Q4	HCN4	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	GO:0035725; P:sodium ion transmembrane transport; IMP:UniProt
Q9Y3Q4	HCN4	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9P1Z3	HCN3	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3	GO:0030552; F:cAMP binding; IEA:UniProtKB-KW
Q9P1Z3	HCN3	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3	GO:0005249; F:voltage-gated potassium channel activity; IMP:UniProt
Q9P1Z3	HCN3	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3	GO:0005248; F:voltage-gated sodium channel activity; IMP:UniProt
Q9P1Z3	HCN3	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3	GO:0071805; P:potassium ion transmembrane transport; IMP:UniProt
Q9P1Z3	HCN3	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3	GO:0042391; P:regulation of membrane potential; IMP:UniProt
Q9P1Z3	HCN3	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3	GO:0035725; P:sodium ion transmembrane transport; IMP:UniProt
Q9P1Z3	HCN3	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3	GO:0007268; P:synaptic transmission; TAS:Reactome
Q6MZN7	HCP5	HLA class I histocompatibility antigen protein P5	GO:0006952; P:defense response; TAS:UniProtKB
Q9UBK5	HCST	Hematopoietic cell signal transducer	GO:0043548; F:phosphatidylinositol 3-kinase binding; IDA:UniProtKB
Q9UBK5	HCST	Hematopoietic cell signal transducer	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBK5	HCST	Hematopoietic cell signal transducer	GO:0005102; F:receptor binding; IPI:UniProtKB
Q9UBK5	HCST	Hematopoietic cell signal transducer	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IDA:UniProtKB
Q9UBK5	HCST	Hematopoietic cell signal transducer	GO:0050776; P:regulation of immune response; TAS:Reactome
Q96DB2	HDAC11	Histone deacetylase 11	GO:0004407; F:histone deacetylase activity; IDA:UniProtKB
Q96DB2	HDAC11	Histone deacetylase 11	GO:0032041; F:NAD-dependent histone deacetylase activity (H3-K14 specific); IEA:UniProtKB-EC
Q96DB2	HDAC11	Histone deacetylase 11	GO:0097372; F:NAD-dependent histone deacetylase activity (H3-K18 specific); IEA:UniProtKB-EC
Q96DB2	HDAC11	Histone deacetylase 11	GO:0046969; F:NAD-dependent histone deacetylase activity (H3-K9 specific); IEA:UniProtKB-EC
Q96DB2	HDAC11	Histone deacetylase 11	GO:0046970; F:NAD-dependent histone deacetylase activity (H4-K16 specific); IEA:UniProtKB-EC
Q96DB2	HDAC11	Histone deacetylase 11	GO:0008134; F:transcription factor binding; TAS:UniProtKB
Q96DB2	HDAC11	Histone deacetylase 11	GO:0016568; P:chromatin modification; TAS:UniProtKB
Q96DB2	HDAC11	Histone deacetylase 11	GO:0016575; P:histone deacetylation; IDA:UniProtKB
Q96DB2	HDAC11	Histone deacetylase 11	GO:0014003; P:oligodendrocyte development; IEA:Ensembl
Q96DB2	HDAC11	Histone deacetylase 11	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96DB2	HDAC11	Histone deacetylase 11	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q969S8	HDAC10	Histone deacetylase 10	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q969S8	HDAC10	Histone deacetylase 10	GO:0004407; F:histone deacetylase activity; IDA:UniProtKB
Q969S8	HDAC10	Histone deacetylase 10	GO:0042826; F:histone deacetylase binding; IDA:UniProtKB
Q969S8	HDAC10	Histone deacetylase 10	GO:0032041; F:NAD-dependent histone deacetylase activity (H3-K14 specific); IEA:UniProtKB-EC
Q969S8	HDAC10	Histone deacetylase 10	GO:0097372; F:NAD-dependent histone deacetylase activity (H3-K18 specific); IEA:UniProtKB-EC
Q969S8	HDAC10	Histone deacetylase 10	GO:0046969; F:NAD-dependent histone deacetylase activity (H3-K9 specific); IEA:UniProtKB-EC
Q969S8	HDAC10	Histone deacetylase 10	GO:0046970; F:NAD-dependent histone deacetylase activity (H4-K16 specific); IEA:UniProtKB-EC
Q969S8	HDAC10	Histone deacetylase 10	GO:0005515; F:protein binding; IPI:UniProtKB
Q969S8	HDAC10	Histone deacetylase 10	GO:0033558; F:protein deacetylase activity; IDA:UniProtKB
Q969S8	HDAC10	Histone deacetylase 10	GO:0016568; P:chromatin modification; NAS:UniProtKB
Q969S8	HDAC10	Histone deacetylase 10	GO:0016575; P:histone deacetylation; IDA:UniProtKB
Q969S8	HDAC10	Histone deacetylase 10	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q969S8	HDAC10	Histone deacetylase 10	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q969S8	HDAC10	Histone deacetylase 10	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q969S8	HDAC10	Histone deacetylase 10	GO:0014003; P:oligodendrocyte development; IEA:Ensembl
Q969S8	HDAC10	Histone deacetylase 10	GO:0006476; P:protein deacetylation; IDA:UniProtKB
Q969S8	HDAC10	Histone deacetylase 10	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q969S8	HDAC10	Histone deacetylase 10	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13547	HDAC1	Histone deacetylase 1	GO:0033613; F:activating transcription factor binding; IPI:UniProtKB
Q13547	HDAC1	Histone deacetylase 1	GO:0001047; F:core promoter binding; IDA:UniProtKB
Q13547	HDAC1	Histone deacetylase 1	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q13547	HDAC1	Histone deacetylase 1	GO:0004407; F:histone deacetylase activity; IMP:UniProtKB
Q13547	HDAC1	Histone deacetylase 1	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
Q13547	HDAC1	Histone deacetylase 1	GO:0032041; F:NAD-dependent histone deacetylase activity (H3-K14 specific); IEA:UniProtKB-EC
Q13547	HDAC1	Histone deacetylase 1	GO:0097372; F:NAD-dependent histone deacetylase activity (H3-K18 specific); IEA:UniProtKB-EC
Q13547	HDAC1	Histone deacetylase 1	GO:0046969; F:NAD-dependent histone deacetylase activity (H3-K9 specific); IEA:UniProtKB-EC
Q13547	HDAC1	Histone deacetylase 1	GO:0046970; F:NAD-dependent histone deacetylase activity (H4-K16 specific); IEA:UniProtKB-EC
Q13547	HDAC1	Histone deacetylase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13547	HDAC1	Histone deacetylase 1	GO:0033558; F:protein deacetylase activity; IDA:UniProtKB
Q13547	HDAC1	Histone deacetylase 1	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:BHF-UCL
Q13547	HDAC1	Histone deacetylase 1	GO:0001106; F:RNA polymerase II transcription corepressor activity; IDA:BHF-UCL
Q13547	HDAC1	Histone deacetylase 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q13547	HDAC1	Histone deacetylase 1	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q13547	HDAC1	Histone deacetylase 1	GO:0043044; P:ATP-dependent chromatin remodeling; IDA:UniProt
Q13547	HDAC1	Histone deacetylase 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q13547	HDAC1	Histone deacetylase 1	GO:0016568; P:chromatin modification; TAS:UniProtKB
Q13547	HDAC1	Histone deacetylase 1	GO:0006338; P:chromatin remodeling; IC:BHF-UCL
Q13547	HDAC1	Histone deacetylase 1	GO:0042733; P:embryonic digit morphogenesis; ISS:BHF-UCL
Q13547	HDAC1	Histone deacetylase 1	GO:0009913; P:epidermal cell differentiation; ISS:BHF-UCL
Q13547	HDAC1	Histone deacetylase 1	GO:0061029; P:eyelid development in camera-type eye; ISS:BHF-UCL
Q13547	HDAC1	Histone deacetylase 1	GO:0061198; P:fungiform papilla formation; ISS:BHF-UCL
Q13547	HDAC1	Histone deacetylase 1	GO:0010467; P:gene expression; TAS:Reactome
Q13547	HDAC1	Histone deacetylase 1	GO:0060789; P:hair follicle placode formation; ISS:BHF-UCL
Q13547	HDAC1	Histone deacetylase 1	GO:0016575; P:histone deacetylation; IMP:UniProtKB
Q13547	HDAC1	Histone deacetylase 1	GO:0070932; P:histone H3 deacetylation; IDA:BHF-UCL
Q13547	HDAC1	Histone deacetylase 1	GO:0070933; P:histone H4 deacetylation; IDA:BHF-UCL
Q13547	HDAC1	Histone deacetylase 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q13547	HDAC1	Histone deacetylase 1	GO:0043922; P:negative regulation by host of viral transcription; IMP:UniProtKB
Q13547	HDAC1	Histone deacetylase 1	GO:0060766; P:negative regulation of androgen receptor signaling pathway; IDA:BHF-UCL
Q13547	HDAC1	Histone deacetylase 1	GO:0043066; P:negative regulation of apoptotic process; ISS:BHF-UCL
Q13547	HDAC1	Histone deacetylase 1	GO:0045786; P:negative regulation of cell cycle; TAS:Reactome
Q13547	HDAC1	Histone deacetylase 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q13547	HDAC1	Histone deacetylase 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q13547	HDAC1	Histone deacetylase 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q13547	HDAC1	Histone deacetylase 1	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q13547	HDAC1	Histone deacetylase 1	GO:0042475; P:odontogenesis of dentin-containing tooth; ISS:BHF-UCL
Q13547	HDAC1	Histone deacetylase 1	GO:0008284; P:positive regulation of cell proliferation; IMP:BHF-UCL
Q13547	HDAC1	Histone deacetylase 1	GO:0010870; P:positive regulation of receptor biosynthetic process; IMP:BHF-UCL
Q13547	HDAC1	Histone deacetylase 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q13547	HDAC1	Histone deacetylase 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
Q13547	HDAC1	Histone deacetylase 1	GO:0006476; P:protein deacetylation; IDA:UniProtKB
Q13547	HDAC1	Histone deacetylase 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q13547	HDAC1	Histone deacetylase 1	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
Q13547	HDAC1	Histone deacetylase 1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q13547	HDAC1	Histone deacetylase 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q92769	HDAC2	Histone deacetylase 2	GO:0003682; F:chromatin binding; ISS:UniProtKB
Q92769	HDAC2	Histone deacetylase 2	GO:0031490; F:chromatin DNA binding; IEA:Ensembl
Q92769	HDAC2	Histone deacetylase 2	GO:0001047; F:core promoter binding; IEA:Ensembl
Q92769	HDAC2	Histone deacetylase 2	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q92769	HDAC2	Histone deacetylase 2	GO:0004407; F:histone deacetylase activity; IDA:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0032041; F:NAD-dependent histone deacetylase activity (H3-K14 specific); IEA:UniProtKB-EC
Q92769	HDAC2	Histone deacetylase 2	GO:0097372; F:NAD-dependent histone deacetylase activity (H3-K18 specific); IEA:UniProtKB-EC
Q92769	HDAC2	Histone deacetylase 2	GO:0046969; F:NAD-dependent histone deacetylase activity (H3-K9 specific); IEA:UniProtKB-EC
Q92769	HDAC2	Histone deacetylase 2	GO:0046970; F:NAD-dependent histone deacetylase activity (H4-K16 specific); IEA:UniProtKB-EC
Q92769	HDAC2	Histone deacetylase 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q92769	HDAC2	Histone deacetylase 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q92769	HDAC2	Histone deacetylase 2	GO:0033558; F:protein deacetylase activity; IMP:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0043565; F:sequence-specific DNA binding; IDA:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q92769	HDAC2	Histone deacetylase 2	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0043044; P:ATP-dependent chromatin remodeling; IDA:UniProt
Q92769	HDAC2	Histone deacetylase 2	GO:0007596; P:blood coagulation; TAS:Reactome
Q92769	HDAC2	Histone deacetylase 2	GO:0055013; P:cardiac muscle cell development; IEA:Ensembl
Q92769	HDAC2	Histone deacetylase 2	GO:0034605; P:cellular response to heat; IEA:Ensembl
Q92769	HDAC2	Histone deacetylase 2	GO:0006338; P:chromatin remodeling; IC:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0016358; P:dendrite development; ISS:UniProtKB
Q92769	HDAC2	Histone deacetylase 2	GO:0042733; P:embryonic digit morphogenesis; ISS:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0009913; P:epidermal cell differentiation; ISS:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0061029; P:eyelid development in camera-type eye; ISS:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0061198; P:fungiform papilla formation; ISS:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0060789; P:hair follicle placode formation; ISS:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0021766; P:hippocampus development; IEA:Ensembl
Q92769	HDAC2	Histone deacetylase 2	GO:0016575; P:histone deacetylation; IMP:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0006344; P:maintenance of chromatin silencing; IMP:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0043066; P:negative regulation of apoptotic process; ISS:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEA:Ensembl
Q92769	HDAC2	Histone deacetylase 2	GO:0060044; P:negative regulation of cardiac muscle cell proliferation; IEA:Ensembl
Q92769	HDAC2	Histone deacetylase 2	GO:0045786; P:negative regulation of cell cycle; TAS:Reactome
Q92769	HDAC2	Histone deacetylase 2	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl
Q92769	HDAC2	Histone deacetylase 2	GO:0045347; P:negative regulation of MHC class II biosynthetic process; IC:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0010977; P:negative regulation of neuron projection development; ISS:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q92769	HDAC2	Histone deacetylase 2	GO:0042475; P:odontogenesis of dentin-containing tooth; ISS:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0008284; P:positive regulation of cell proliferation; IMP:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0032967; P:positive regulation of collagen biosynthetic process; IC:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0048714; P:positive regulation of oligodendrocyte differentiation; IEA:Ensembl
Q92769	HDAC2	Histone deacetylase 2	GO:0045862; P:positive regulation of proteolysis; IMP:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0010870; P:positive regulation of receptor biosynthetic process; IMP:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q92769	HDAC2	Histone deacetylase 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IC:BHF-UCL
Q92769	HDAC2	Histone deacetylase 2	GO:0090311; P:regulation of protein deacetylation; IEA:Ensembl
Q92769	HDAC2	Histone deacetylase 2	GO:0051896; P:regulation of protein kinase B signaling; IEA:Ensembl
Q92769	HDAC2	Histone deacetylase 2	GO:0060297; P:regulation of sarcomere organization; IEA:Ensembl
Q92769	HDAC2	Histone deacetylase 2	GO:0042220; P:response to cocaine; IEA:Ensembl
Q92769	HDAC2	Histone deacetylase 2	GO:0042493; P:response to drug; IEA:Ensembl
Q92769	HDAC2	Histone deacetylase 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15379	HDAC3	Histone deacetylase 3	GO:0003682; F:chromatin binding; IDA:UniProtKB
O15379	HDAC3	Histone deacetylase 3	GO:0031490; F:chromatin DNA binding; IEA:Ensembl
O15379	HDAC3	Histone deacetylase 3	GO:0030332; F:cyclin binding; IPI:UniProtKB
O15379	HDAC3	Histone deacetylase 3	GO:0019899; F:enzyme binding; IPI:UniProtKB
O15379	HDAC3	Histone deacetylase 3	GO:0004407; F:histone deacetylase activity; IMP:UniProtKB
O15379	HDAC3	Histone deacetylase 3	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
O15379	HDAC3	Histone deacetylase 3	GO:0032041; F:NAD-dependent histone deacetylase activity (H3-K14 specific); IEA:UniProtKB-EC
O15379	HDAC3	Histone deacetylase 3	GO:0097372; F:NAD-dependent histone deacetylase activity (H3-K18 specific); IEA:UniProtKB-EC
O15379	HDAC3	Histone deacetylase 3	GO:0046969; F:NAD-dependent histone deacetylase activity (H3-K9 specific); IEA:UniProtKB-EC
O15379	HDAC3	Histone deacetylase 3	GO:0046970; F:NAD-dependent histone deacetylase activity (H4-K16 specific); IEA:UniProtKB-EC
O15379	HDAC3	Histone deacetylase 3	GO:0005515; F:protein binding; IPI:UniProtKB
O15379	HDAC3	Histone deacetylase 3	GO:0033558; F:protein deacetylase activity; IDA:UniProtKB
O15379	HDAC3	Histone deacetylase 3	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
O15379	HDAC3	Histone deacetylase 3	GO:0008134; F:transcription factor binding; IPI:UniProtKB
O15379	HDAC3	Histone deacetylase 3	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O15379	HDAC3	Histone deacetylase 3	GO:0016568; P:chromatin modification; TAS:UniProtKB
O15379	HDAC3	Histone deacetylase 3	GO:0032922; P:circadian regulation of gene expression; IEA:Ensembl
O15379	HDAC3	Histone deacetylase 3	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
O15379	HDAC3	Histone deacetylase 3	GO:0045786; P:negative regulation of cell cycle; TAS:Reactome
O15379	HDAC3	Histone deacetylase 3	GO:0046329; P:negative regulation of JNK cascade; IMP:UniProtKB
O15379	HDAC3	Histone deacetylase 3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O15379	HDAC3	Histone deacetylase 3	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
O15379	HDAC3	Histone deacetylase 3	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O15379	HDAC3	Histone deacetylase 3	GO:0007219; P:Notch signaling pathway; TAS:Reactome
O15379	HDAC3	Histone deacetylase 3	GO:0006476; P:protein deacetylation; IDA:UniProtKB
O15379	HDAC3	Histone deacetylase 3	GO:0007346; P:regulation of mitotic cell cycle; IEA:Ensembl
O15379	HDAC3	Histone deacetylase 3	GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl
O15379	HDAC3	Histone deacetylase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15379	HDAC3	Histone deacetylase 3	GO:0051225; P:spindle assembly; IMP:UniProtKB
O15379	HDAC3	Histone deacetylase 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P56524	HDAC4	Histone deacetylase 4	GO:0033613; F:activating transcription factor binding; IPI:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0001047; F:core promoter binding; IEA:Ensembl
P56524	HDAC4	Histone deacetylase 4	GO:0004407; F:histone deacetylase activity; IDA:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0032041; F:NAD-dependent histone deacetylase activity (H3-K14 specific); IEA:UniProtKB-EC
P56524	HDAC4	Histone deacetylase 4	GO:0097372; F:NAD-dependent histone deacetylase activity (H3-K18 specific); IEA:UniProtKB-EC
P56524	HDAC4	Histone deacetylase 4	GO:0046969; F:NAD-dependent histone deacetylase activity (H3-K9 specific); IEA:UniProtKB-EC
P56524	HDAC4	Histone deacetylase 4	GO:0046970; F:NAD-dependent histone deacetylase activity (H4-K16 specific); IEA:UniProtKB-EC
P56524	HDAC4	Histone deacetylase 4	GO:0030955; F:potassium ion binding; IDA:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0005515; F:protein binding; IPI:UniProtKB
P56524	HDAC4	Histone deacetylase 4	GO:0033558; F:protein deacetylase activity; IDA:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0070491; F:repressing transcription factor binding; IPI:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
P56524	HDAC4	Histone deacetylase 4	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0008270; F:zinc ion binding; IDA:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0042113; P:B cell activation; TAS:UniProtKB
P56524	HDAC4	Histone deacetylase 4	GO:0030183; P:B cell differentiation; TAS:UniProtKB
P56524	HDAC4	Histone deacetylase 4	GO:0014898; P:cardiac muscle hypertrophy in response to stress; TAS:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0006338; P:chromatin remodeling; IDA:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0016575; P:histone deacetylation; IDA:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0070932; P:histone H3 deacetylation; IDA:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0070933; P:histone H4 deacetylation; IDA:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0006954; P:inflammatory response; TAS:UniProtKB
P56524	HDAC4	Histone deacetylase 4	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P56524	HDAC4	Histone deacetylase 4	GO:0045820; P:negative regulation of glycolytic process; ISS:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0010832; P:negative regulation of myotube differentiation; IMP:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl
P56524	HDAC4	Histone deacetylase 4	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0007399; P:nervous system development; TAS:UniProtKB
P56524	HDAC4	Histone deacetylase 4	GO:0002076; P:osteoblast development; IEA:Ensembl
P56524	HDAC4	Histone deacetylase 4	GO:0034983; P:peptidyl-lysine deacetylation; IDA:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0008284; P:positive regulation of cell proliferation; IMP:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0033235; P:positive regulation of protein sumoylation; IDA:UniProtKB
P56524	HDAC4	Histone deacetylase 4	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0010882; P:regulation of cardiac muscle contraction by calcium ion signaling; IEA:Ensembl
P56524	HDAC4	Histone deacetylase 4	GO:0043393; P:regulation of protein binding; IMP:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0048742; P:regulation of skeletal muscle fiber development; IEA:Ensembl
P56524	HDAC4	Histone deacetylase 4	GO:0014894; P:response to denervation involved in regulation of muscle adaptation; ISS:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0042493; P:response to drug; IEA:Ensembl
P56524	HDAC4	Histone deacetylase 4	GO:0070555; P:response to interleukin-1; IMP:BHF-UCL
P56524	HDAC4	Histone deacetylase 4	GO:0001501; P:skeletal system development; IEA:Ensembl
P56524	HDAC4	Histone deacetylase 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0004407; F:histone deacetylase activity; IDA:BHF-UCL
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0032041; F:NAD-dependent histone deacetylase activity (H3-K14 specific); IEA:UniProtKB-EC
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0097372; F:NAD-dependent histone deacetylase activity (H3-K18 specific); IEA:UniProtKB-EC
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0046969; F:NAD-dependent histone deacetylase activity (H3-K9 specific); IEA:UniProtKB-EC
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0046970; F:NAD-dependent histone deacetylase activity (H4-K16 specific); IEA:UniProtKB-EC
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0005080; F:protein kinase C binding; IPI:UniProtKB
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0070491; F:repressing transcription factor binding; IPI:BHF-UCL
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0042113; P:B cell activation; TAS:UniProtKB
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0030183; P:B cell differentiation; TAS:UniProtKB
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0032869; P:cellular response to insulin stimulus; NAS:BHF-UCL
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0016568; P:chromatin modification; TAS:UniProtKB
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0006325; P:chromatin organization; TAS:UniProtKB
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0006338; P:chromatin remodeling; TAS:ProtInc
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0006342; P:chromatin silencing; TAS:ProtInc
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0007507; P:heart development; IEA:Ensembl
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0016575; P:histone deacetylation; IDA:BHF-UCL
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0006954; P:inflammatory response; TAS:UniProtKB
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0033555; P:multicellular organismal response to stress; IEA:Ensembl
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0090051; P:negative regulation of cell migration involved in sprouting angiogenesis; IMP:BHF-UCL
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0010832; P:negative regulation of myotube differentiation; IMP:BHF-UCL
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0045892; P:negative regulation of transcription, DNA-templated; TAS:UniProtKB
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0002076; P:osteoblast development; IEA:Ensembl
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0010830; P:regulation of myotube differentiation; ISS:UniProtKB
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0043393; P:regulation of protein binding; IMP:BHF-UCL
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0048742; P:regulation of skeletal muscle fiber development; IEA:Ensembl
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0042220; P:response to cocaine; IEA:Ensembl
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0042493; P:response to drug; IEA:Ensembl
Q9UQL6	HDAC5	Histone deacetylase 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0043014; F:alpha-tubulin binding; IDA:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0008013; F:beta-catenin binding; IPI:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0070840; F:dynein complex binding; IDA:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0019899; F:enzyme binding; ISS:UniProtKB
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0004407; F:histone deacetylase activity; IDA:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0042826; F:histone deacetylase binding; IPI:UniProtKB
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0051879; F:Hsp90 protein binding; IDA:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0008017; F:microtubule binding; ISS:UniProtKB
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0032041; F:NAD-dependent histone deacetylase activity (H3-K14 specific); IEA:UniProtKB-EC
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0097372; F:NAD-dependent histone deacetylase activity (H3-K18 specific); IEA:UniProtKB-EC
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0046969; F:NAD-dependent histone deacetylase activity (H3-K9 specific); IEA:UniProtKB-EC
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0046970; F:NAD-dependent histone deacetylase activity (H4-K16 specific); IEA:UniProtKB-EC
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0031593; F:polyubiquitin binding; IDA:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0048156; F:tau protein binding; IDA:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0042903; F:tubulin deacetylase activity; IDA:UniProtKB
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0070842; P:aggresome assembly; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0070301; P:cellular response to hydrogen peroxide; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0071218; P:cellular response to misfolded protein; IEA:Ensembl
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0035967; P:cellular response to topologically incorrect protein; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0016575; P:histone deacetylation; ISS:UniProtKB
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0070846; P:Hsp90 deacetylation; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0006886; P:intracellular protein transport; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0032418; P:lysosome localization; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0016236; P:macroautophagy; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0006515; P:misfolded or incompletely synthesized protein catabolic process; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0010727; P:negative regulation of hydrogen peroxide metabolic process; IC:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0007026; P:negative regulation of microtubule depolymerization; IEA:Ensembl
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0051354; P:negative regulation of oxidoreductase activity; IC:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0043242; P:negative regulation of protein complex disassembly; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0045861; P:negative regulation of proteolysis; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0034983; P:peptidyl-lysine deacetylation; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0070845; P:polyubiquitinated misfolded protein transport; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0090035; P:positive regulation of chaperone-mediated protein complex assembly; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0010634; P:positive regulation of epithelial cell migration; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:1901300; P:positive regulation of hydrogen peroxide-mediated programmed cell death; IDA:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0010870; P:positive regulation of receptor biosynthetic process; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0009967; P:positive regulation of signal transduction; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0043241; P:protein complex disassembly; IEA:Ensembl
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0006476; P:protein deacetylation; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0000209; P:protein polyubiquitination; IEA:Ensembl
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0060765; P:regulation of androgen receptor signaling pathway; TAS:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0070201; P:regulation of establishment of protein localization; IEA:Ensembl
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0060632; P:regulation of microtubule-based movement; IC:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0010469; P:regulation of receptor activity; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0070848; P:response to growth factor; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0051788; P:response to misfolded protein; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0010033; P:response to organic substance; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0009636; P:response to toxic substance; IMP:BHF-UCL
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0090042; P:tubulin deacetylation; ISS:UniProtKB
Q9UBN7	HDAC6	Histone deacetylase 6	GO:0043162; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; IEA:Ensembl
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0071889; F:14-3-3 protein binding; IDA:UniProtKB
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0033613; F:activating transcription factor binding; IPI:UniProtKB
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0003682; F:chromatin binding; IEA:Ensembl
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0032041; F:NAD-dependent histone deacetylase activity (H3-K14 specific); IEA:UniProtKB-EC
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0097372; F:NAD-dependent histone deacetylase activity (H3-K18 specific); IEA:UniProtKB-EC
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0046969; F:NAD-dependent histone deacetylase activity (H3-K9 specific); IEA:UniProtKB-EC
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0046970; F:NAD-dependent histone deacetylase activity (H4-K16 specific); IEA:UniProtKB-EC
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0005080; F:protein kinase C binding; IPI:UniProtKB
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0070491; F:repressing transcription factor binding; IPI:BHF-UCL
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0007043; P:cell-cell junction assembly; IEA:Ensembl
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0032703; P:negative regulation of interleukin-2 production; IDA:BHF-UCL
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0045668; P:negative regulation of osteoblast differentiation; IMP:UniProtKB
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; IMP:BHF-UCL
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WUI4	HDAC7	Histone deacetylase 7	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q9BY41	HDAC8	Histone deacetylase 8	GO:0004407; F:histone deacetylase activity; TAS:UniProtKB
Q9BY41	HDAC8	Histone deacetylase 8	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BY41	HDAC8	Histone deacetylase 8	GO:0032041; F:NAD-dependent histone deacetylase activity (H3-K14 specific); IEA:UniProtKB-EC
Q9BY41	HDAC8	Histone deacetylase 8	GO:0097372; F:NAD-dependent histone deacetylase activity (H3-K18 specific); IEA:UniProtKB-EC
Q9BY41	HDAC8	Histone deacetylase 8	GO:0046969; F:NAD-dependent histone deacetylase activity (H3-K9 specific); IEA:UniProtKB-EC
Q9BY41	HDAC8	Histone deacetylase 8	GO:0046970; F:NAD-dependent histone deacetylase activity (H4-K16 specific); IEA:UniProtKB-EC
Q9BY41	HDAC8	Histone deacetylase 8	GO:0008134; F:transcription factor binding; TAS:UniProtKB
Q9BY41	HDAC8	Histone deacetylase 8	GO:0006333; P:chromatin assembly or disassembly; TAS:ProtInc
Q9BY41	HDAC8	Histone deacetylase 8	GO:0016568; P:chromatin modification; TAS:UniProtKB
Q9BY41	HDAC8	Histone deacetylase 8	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9BY41	HDAC8	Histone deacetylase 8	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9BY41	HDAC8	Histone deacetylase 8	GO:0071922; P:regulation of cohesin localization to chromatin; IMP:UniProtKB
Q9BY41	HDAC8	Histone deacetylase 8	GO:0007062; P:sister chromatid cohesion; IMP:UniProtKB
Q9BY41	HDAC8	Histone deacetylase 8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0004407; F:histone deacetylase activity; IDA:BHF-UCL
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0042826; F:histone deacetylase binding; IDA:BHF-UCL
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0032041; F:NAD-dependent histone deacetylase activity (H3-K14 specific); IEA:UniProtKB-EC
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0097372; F:NAD-dependent histone deacetylase activity (H3-K18 specific); IEA:UniProtKB-EC
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0046969; F:NAD-dependent histone deacetylase activity (H3-K9 specific); IEA:UniProtKB-EC
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0046970; F:NAD-dependent histone deacetylase activity (H4-K16 specific); IEA:UniProtKB-EC
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0005515; F:protein binding; IPI:IntAct
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0033558; F:protein deacetylase activity; IDA:BHF-UCL
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0005080; F:protein kinase C binding; IPI:UniProtKB
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0070491; F:repressing transcription factor binding; IDA:BHF-UCL
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0003714; F:transcription corepressor activity; ISS:BHF-UCL
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0042113; P:B cell activation; TAS:UniProtKB
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0030183; P:B cell differentiation; TAS:UniProtKB
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0032869; P:cellular response to insulin stimulus; IDA:BHF-UCL
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0007507; P:heart development; ISS:BHF-UCL
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0016575; P:histone deacetylation; IDA:BHF-UCL
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0070932; P:histone H3 deacetylation; IDA:BHF-UCL
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0070933; P:histone H4 deacetylation; IDA:BHF-UCL
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0006954; P:inflammatory response; TAS:UniProtKB
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0034983; P:peptidyl-lysine deacetylation; IDA:BHF-UCL
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; IMP:BHF-UCL
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0048742; P:regulation of skeletal muscle fiber development; ISS:UniProtKB
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0051153; P:regulation of striated muscle cell differentiation; ISS:UniProtKB
Q9UKV0	HDAC9	Histone deacetylase 9	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IV16	GPIHBP1	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	GO:0035478; F:chylomicron binding; IDA:BHF-UCL
Q8IV16	GPIHBP1	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	GO:0008035; F:high-density lipoprotein particle binding; IEA:Ensembl
Q8IV16	GPIHBP1	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	GO:0035473; F:lipase binding; IPI:BHF-UCL
Q8IV16	GPIHBP1	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q8IV16	GPIHBP1	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	GO:0071813; F:lipoprotein particle binding; IDA:UniProtKB
Q8IV16	GPIHBP1	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	GO:0008320; F:protein transmembrane transporter activity; ISS:BHF-UCL
Q8IV16	GPIHBP1	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	GO:0042632; P:cholesterol homeostasis; ISS:BHF-UCL
Q8IV16	GPIHBP1	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	GO:0006886; P:intracellular protein transport; ISS:BHF-UCL
Q8IV16	GPIHBP1	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	GO:0006869; P:lipid transport; IEA:Ensembl
Q8IV16	GPIHBP1	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	GO:0090321; P:positive regulation of chylomicron remnant clearance; ISS:BHF-UCL
Q8IV16	GPIHBP1	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	GO:0051006; P:positive regulation of lipoprotein lipase activity; IMP:BHF-UCL
Q8IV16	GPIHBP1	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	GO:0017038; P:protein import; ISS:BHF-UCL
Q8IV16	GPIHBP1	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	GO:0034394; P:protein localization to cell surface; ISS:BHF-UCL
Q8IV16	GPIHBP1	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	GO:0050821; P:protein stabilization; ISS:BHF-UCL
Q8IV16	GPIHBP1	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	GO:0071806; P:protein transmembrane transport; ISS:GOC
Q8IV16	GPIHBP1	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	GO:0071503; P:response to heparin; IMP:BHF-UCL
Q8IV16	GPIHBP1	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	GO:0045056; P:transcytosis; ISS:BHF-UCL
Q8IV16	GPIHBP1	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	GO:0070328; P:triglyceride homeostasis; IMP:BHF-UCL
Q9UBI9	HECA	Headcase protein homolog	GO:0030323; P:respiratory tube development; NAS:UniProtKB
Q7Z4H3	HDDC2	HD domain-containing protein 2	GO:0046872; F:metal ion binding; IEA:InterPro
Q7Z4H3	HDDC2	HD domain-containing protein 2	GO:0008081; F:phosphoric diester hydrolase activity; IEA:InterPro
Q7Z4H3	HDDC2	HD domain-containing protein 2	GO:0005515; F:protein binding; IPI:IntAct
P51858	HDGF	Hepatoma-derived growth factor	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P51858	HDGF	Hepatoma-derived growth factor	GO:0008201; F:heparin binding; TAS:ProtInc
P51858	HDGF	Hepatoma-derived growth factor	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
P51858	HDGF	Hepatoma-derived growth factor	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P51858	HDGF	Hepatoma-derived growth factor	GO:0001106; F:RNA polymerase II transcription corepressor activity; IDA:BHF-UCL
P51858	HDGF	Hepatoma-derived growth factor	GO:0001222; F:transcription corepressor binding; IPI:BHF-UCL
P51858	HDGF	Hepatoma-derived growth factor	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P51858	HDGF	Hepatoma-derived growth factor	GO:0008283; P:cell proliferation; TAS:ProtInc
P51858	HDGF	Hepatoma-derived growth factor	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P51858	HDGF	Hepatoma-derived growth factor	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P51858	HDGF	Hepatoma-derived growth factor	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P51858	HDGF	Hepatoma-derived growth factor	GO:0007165; P:signal transduction; NAS:ProtInc
Q5TGJ6	HDGFL1	Hepatoma-derived growth factor-like protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q5TGJ6	HDGFL1	Hepatoma-derived growth factor-like protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q5TGJ6	HDGFL1	Hepatoma-derived growth factor-like protein 1	GO:0034504; P:protein localization to nucleus; IEA:Ensembl
Q7Z4V5	HDGFRP2	Hepatoma-derived growth factor-related protein 2	GO:0003682; F:chromatin binding; IEA:Ensembl
Q7Z4V5	HDGFRP2	Hepatoma-derived growth factor-related protein 2	GO:0003677; F:DNA binding; IEA:InterPro
Q7Z4V5	HDGFRP2	Hepatoma-derived growth factor-related protein 2	GO:0006351; P:transcription, DNA-templated; IEA:InterPro
Q9Y3E1	HDGFRP3	Hepatoma-derived growth factor-related protein 3	GO:0008283; P:cell proliferation; NAS:UniProtKB
Q9H0R4	HDHD2	Haloacid dehalogenase-like hydrolase domain-containing protein 2	GO:0019899; F:enzyme binding; IPI:UniProt
Q9H0R4	HDHD2	Haloacid dehalogenase-like hydrolase domain-containing protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q08623	HDHD1	Pseudouridine-5'-monophosphatase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q08623	HDHD1	Pseudouridine-5'-monophosphatase	GO:0016791; F:phosphatase activity; IEA:UniProtKB-EC
Q08623	HDHD1	Pseudouridine-5'-monophosphatase	GO:0009117; P:nucleotide metabolic process; IEA:UniProtKB-KW
Q9BSH5	HDHD3	Haloacid dehalogenase-like hydrolase domain-containing protein 3	GO:0016787; F:hydrolase activity; IEA:InterPro
Q9BSH5	HDHD3	Haloacid dehalogenase-like hydrolase domain-containing protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q7Z353	HDX	Highly divergent homeobox	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q7Z353	HDX	Highly divergent homeobox	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P42858	HTT	Huntingtin	GO:0048487; F:beta-tubulin binding; IDA:UniProtKB
P42858	HTT	Huntingtin	GO:0050809; F:diazepam binding; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0034452; F:dynactin binding; IPI:UniProtKB
P42858	HTT	Huntingtin	GO:0045505; F:dynein intermediate chain binding; IDA:UniProtKB
P42858	HTT	Huntingtin	GO:0042802; F:identical protein binding; IPI:IntAct
P42858	HTT	Huntingtin	GO:0002039; F:p53 binding; IPI:UniProtKB
P42858	HTT	Huntingtin	GO:0005515; F:protein binding; IPI:UniProtKB
P42858	HTT	Huntingtin	GO:0008134; F:transcription factor binding; IBA:RefGenome
P42858	HTT	Huntingtin	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0008088; P:axon cargo transport; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0007569; P:cell aging; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0000052; P:citrulline metabolic process; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0008340; P:determination of adult lifespan; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0007212; P:dopamine receptor signaling pathway; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0007029; P:endoplasmic reticulum organization; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0016197; P:endosomal transport; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0006888; P:ER to Golgi vesicle-mediated transport; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0000132; P:establishment of mitotic spindle orientation; IMP:UniProtKB
P42858	HTT	Huntingtin	GO:0007030; P:Golgi organization; IMP:UniProtKB
P42858	HTT	Huntingtin	GO:0007625; P:grooming behavior; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0042445; P:hormone metabolic process; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0030073; P:insulin secretion; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0055072; P:iron ion homeostasis; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0051938; P:L-glutamate import; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0019244; P:lactate biosynthetic process from pyruvate; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0007626; P:locomotory behavior; IEA:Ensembl
P42858	HTT	Huntingtin	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB
P42858	HTT	Huntingtin	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0021990; P:neural plate formation; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0048666; P:neuron development; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0021988; P:olfactory lobe development; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0048513; P:organ development; IBA:RefGenome
P42858	HTT	Huntingtin	GO:0048341; P:paraxial mesoderm formation; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0006606; P:protein import into nucleus; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0019805; P:quinolinate biosynthetic process; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0046902; P:regulation of mitochondrial membrane permeability; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0051881; P:regulation of mitochondrial membrane potential; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0046825; P:regulation of protein export from nucleus; IMP:UniProtKB
P42858	HTT	Huntingtin	GO:0034047; P:regulation of protein phosphatase type 2A activity; IMP:dictyBase
P42858	HTT	Huntingtin	GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0051592; P:response to calcium ion; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; IMP:UniProtKB
P42858	HTT	Huntingtin	GO:0035176; P:social behavior; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0007283; P:spermatogenesis; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0021756; P:striatum development; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0000050; P:urea cycle; IEA:Ensembl
P42858	HTT	Huntingtin	GO:0047496; P:vesicle transport along microtubule; IMP:UniProtKB
P42858	HTT	Huntingtin	GO:0008542; P:visual learning; IEA:Ensembl
Q9H583	HEATR1	HEAT repeat-containing protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H583	HEATR1	HEAT repeat-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9H583	HEATR1	HEAT repeat-containing protein 1	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q6AI08	HEATR6	HEAT repeat-containing protein 6	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NRV9	HEBP1	Heme-binding protein 1	GO:0020037; F:heme binding; ISS:UniProtKB
Q9NRV9	HEBP1	Heme-binding protein 1	GO:0007623; P:circadian rhythm; TAS:ProtInc
Q9Y5Z4	HEBP2	Heme-binding protein 2	GO:0005515; F:protein binding; IPI:UniProt
Q9Y5Z4	HEBP2	Heme-binding protein 2	GO:0010917; P:negative regulation of mitochondrial membrane potential; IMP:UniProt
Q9Y5Z4	HEBP2	Heme-binding protein 2	GO:0035794; P:positive regulation of mitochondrial membrane permeability; IMP:UniProt
Q9Y5Z4	HEBP2	Heme-binding protein 2	GO:0010940; P:positive regulation of necrotic cell death; IMP:UniProt
A8MVW5	HEPACAM2	HEPACAM family member 2	GO:0005515; F:protein binding; IPI:UniProtKB
A8MVW5	HEPACAM2	HEPACAM family member 2	GO:0051297; P:centrosome organization; IMP:UniProtKB
A8MVW5	HEPACAM2	HEPACAM family member 2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q14CZ8	HEPACAM	Hepatocyte cell adhesion molecule	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q14CZ8	HEPACAM	Hepatocyte cell adhesion molecule	GO:0007050; P:cell cycle arrest; IEA:UniProtKB-KW
Q14CZ8	HEPACAM	Hepatocyte cell adhesion molecule	GO:0034613; P:cellular protein localization; IEA:Ensembl
Q14CZ8	HEPACAM	Hepatocyte cell adhesion molecule	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q9ULT8	HECTD1	E3 ubiquitin-protein ligase HECTD1	GO:0046872; F:metal ion binding; IEA:InterPro
Q9ULT8	HECTD1	E3 ubiquitin-protein ligase HECTD1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9ULT8	HECTD1	E3 ubiquitin-protein ligase HECTD1	GO:0004842; F:ubiquitin-protein ligase activity; IBA:RefGenome
Q9ULT8	HECTD1	E3 ubiquitin-protein ligase HECTD1	GO:0001843; P:neural tube closure; IEA:Ensembl
Q9ULT8	HECTD1	E3 ubiquitin-protein ligase HECTD1	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:RefGenome
Q5U5R9	HECTD2	Probable E3 ubiquitin-protein ligase HECTD2	GO:0004842; F:ubiquitin-protein ligase activity; IBA:RefGenome
Q5U5R9	HECTD2	Probable E3 ubiquitin-protein ligase HECTD2	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:RefGenome
Q5T447	HECTD3	E3 ubiquitin-protein ligase HECTD3	GO:0005515; F:protein binding; IPI:UniProtKB
Q5T447	HECTD3	E3 ubiquitin-protein ligase HECTD3	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q5T447	HECTD3	E3 ubiquitin-protein ligase HECTD3	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q5T447	HECTD3	E3 ubiquitin-protein ligase HECTD3	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:RefGenome
Q9Y4D8	HECTD4	Probable E3 ubiquitin-protein ligase HECTD4	GO:0004842; F:ubiquitin-protein ligase activity; IBA:RefGenome
Q9Y4D8	HECTD4	Probable E3 ubiquitin-protein ligase HECTD4	GO:0042593; P:glucose homeostasis; IMP:UniProt
Q9Y4D8	HECTD4	Probable E3 ubiquitin-protein ligase HECTD4	GO:0006006; P:glucose metabolic process; IMP:UniProt
Q9Y4D8	HECTD4	Probable E3 ubiquitin-protein ligase HECTD4	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:RefGenome
Q76N89	HECW1	E3 ubiquitin-protein ligase HECW1	GO:0004842; F:ubiquitin-protein ligase activity; IEA:InterPro
Q76N89	HECW1	E3 ubiquitin-protein ligase HECW1	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:RefGenome
Q9P2P5	HECW2	E3 ubiquitin-protein ligase HECW2	GO:0004842; F:ubiquitin-protein ligase activity; IBA:RefGenome
Q9P2P5	HECW2	E3 ubiquitin-protein ligase HECW2	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:RefGenome
Q9ULI3	HEG1	Protein HEG homolog 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9ULI3	HEG1	Protein HEG homolog 1	GO:0003209; P:cardiac atrium morphogenesis; IEA:Ensembl
Q9ULI3	HEG1	Protein HEG homolog 1	GO:0045216; P:cell-cell junction organization; IEA:Ensembl
Q9ULI3	HEG1	Protein HEG homolog 1	GO:0001886; P:endothelial cell morphogenesis; IEA:Ensembl
Q9ULI3	HEG1	Protein HEG homolog 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9ULI3	HEG1	Protein HEG homolog 1	GO:0030324; P:lung development; IEA:Ensembl
Q9ULI3	HEG1	Protein HEG homolog 1	GO:0003017; P:lymph circulation; IEA:Ensembl
Q9ULI3	HEG1	Protein HEG homolog 1	GO:0001945; P:lymph vessel development; IEA:Ensembl
Q9ULI3	HEG1	Protein HEG homolog 1	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q9ULI3	HEG1	Protein HEG homolog 1	GO:0060039; P:pericardium development; IEA:Ensembl
Q9ULI3	HEG1	Protein HEG homolog 1	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q9ULI3	HEG1	Protein HEG homolog 1	GO:0050878; P:regulation of body fluid levels; IEA:Ensembl
Q9ULI3	HEG1	Protein HEG homolog 1	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q9ULI3	HEG1	Protein HEG homolog 1	GO:0048845; P:venous blood vessel morphogenesis; IEA:Ensembl
Q9ULI3	HEG1	Protein HEG homolog 1	GO:0003281; P:ventricular septum development; IEA:Ensembl
Q8NG08	HELB	DNA helicase B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NG08	HELB	DNA helicase B	GO:0043141; F:ATP-dependent 5'-3' DNA helicase activity; IDA:UniProtKB
Q8NG08	HELB	DNA helicase B	GO:0017116; F:single-stranded DNA-dependent ATP-dependent DNA helicase activity; IDA:UniProtKB
Q8NG08	HELB	DNA helicase B	GO:0032508; P:DNA duplex unwinding; IDA:GOC
Q8NG08	HELB	DNA helicase B	GO:0006260; P:DNA replication; IMP:UniProtKB
Q8NG08	HELB	DNA helicase B	GO:0006269; P:DNA replication, synthesis of RNA primer; IDA:UniProtKB
Q9NRZ9	HELLS	Lymphoid-specific helicase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NRZ9	HELLS	Lymphoid-specific helicase	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9NRZ9	HELLS	Lymphoid-specific helicase	GO:0003677; F:DNA binding; IEA:InterPro
Q9NRZ9	HELLS	Lymphoid-specific helicase	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q9NRZ9	HELLS	Lymphoid-specific helicase	GO:0005515; F:protein binding; IPI:IntAct
Q9NRZ9	HELLS	Lymphoid-specific helicase	GO:0031508; P:centromeric heterochromatin assembly; ISS:UniProtKB
Q9NRZ9	HELLS	Lymphoid-specific helicase	GO:0046651; P:lymphocyte proliferation; ISS:UniProtKB
Q9NRZ9	HELLS	Lymphoid-specific helicase	GO:0010216; P:maintenance of DNA methylation; ISS:UniProtKB
Q9NRZ9	HELLS	Lymphoid-specific helicase	GO:0006346; P:methylation-dependent chromatin silencing; ISS:UniProtKB
Q9NRZ9	HELLS	Lymphoid-specific helicase	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9NRZ9	HELLS	Lymphoid-specific helicase	GO:0007275; P:multicellular organismal development; ISS:UniProtKB
Q9NRZ9	HELLS	Lymphoid-specific helicase	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q9NRZ9	HELLS	Lymphoid-specific helicase	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl
Q9NRZ9	HELLS	Lymphoid-specific helicase	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NRZ9	HELLS	Lymphoid-specific helicase	GO:0001655; P:urogenital system development; IEA:Ensembl
Q8TDG4	HELQ	Helicase POLQ-like	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8TDG4	HELQ	Helicase POLQ-like	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q8TDG4	HELQ	Helicase POLQ-like	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8TDG4	HELQ	Helicase POLQ-like	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProt
A6NFD8	HELT	Hairy and enhancer of split-related protein HELT	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A6NFD8	HELT	Hairy and enhancer of split-related protein HELT	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
A6NFD8	HELT	Hairy and enhancer of split-related protein HELT	GO:0007417; P:central nervous system development; IEA:Ensembl
A6NFD8	HELT	Hairy and enhancer of split-related protein HELT	GO:0021858; P:GABAergic neuron differentiation in basal ganglia; IEA:Ensembl
A6NFD8	HELT	Hairy and enhancer of split-related protein HELT	GO:0035264; P:multicellular organism growth; IEA:Ensembl
A6NFD8	HELT	Hairy and enhancer of split-related protein HELT	GO:0010259; P:multicellular organismal aging; IEA:Ensembl
A6NFD8	HELT	Hairy and enhancer of split-related protein HELT	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
A6NFD8	HELT	Hairy and enhancer of split-related protein HELT	GO:0009791; P:post-embryonic development; IEA:Ensembl
A6NFD8	HELT	Hairy and enhancer of split-related protein HELT	GO:0001967; P:suckling behavior; IEA:Ensembl
A6NFD8	HELT	Hairy and enhancer of split-related protein HELT	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BYK8	HELZ2	Helicase with zinc finger domain 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BYK8	HELZ2	Helicase with zinc finger domain 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BYK8	HELZ2	Helicase with zinc finger domain 2	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q9BYK8	HELZ2	Helicase with zinc finger domain 2	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IDA:UniProtKB
Q9BYK8	HELZ2	Helicase with zinc finger domain 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BYK8	HELZ2	Helicase with zinc finger domain 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BYK8	HELZ2	Helicase with zinc finger domain 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BYK8	HELZ2	Helicase with zinc finger domain 2	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9BYK8	HELZ2	Helicase with zinc finger domain 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9BYK8	HELZ2	Helicase with zinc finger domain 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BYK8	HELZ2	Helicase with zinc finger domain 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P42694	HELZ	Probable helicase with zinc finger domain	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P42694	HELZ	Probable helicase with zinc finger domain	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
P42694	HELZ	Probable helicase with zinc finger domain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P42694	HELZ	Probable helicase with zinc finger domain	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P22557	ALAS2	5-aminolevulinate synthase, erythroid-specific, mitochondrial	GO:0003870; F:5-aminolevulinate synthase activity; IDA:UniProtKB
P22557	ALAS2	5-aminolevulinate synthase, erythroid-specific, mitochondrial	GO:0050662; F:coenzyme binding; ISS:UniProtKB
P22557	ALAS2	5-aminolevulinate synthase, erythroid-specific, mitochondrial	GO:0016594; F:glycine binding; ISS:UniProtKB
P22557	ALAS2	5-aminolevulinate synthase, erythroid-specific, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
P22557	ALAS2	5-aminolevulinate synthase, erythroid-specific, mitochondrial	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
P22557	ALAS2	5-aminolevulinate synthase, erythroid-specific, mitochondrial	GO:0006879; P:cellular iron ion homeostasis; ISS:UniProtKB
P22557	ALAS2	5-aminolevulinate synthase, erythroid-specific, mitochondrial	GO:0030218; P:erythrocyte differentiation; ISS:UniProtKB
P22557	ALAS2	5-aminolevulinate synthase, erythroid-specific, mitochondrial	GO:0006783; P:heme biosynthetic process; ISS:UniProtKB
P22557	ALAS2	5-aminolevulinate synthase, erythroid-specific, mitochondrial	GO:0042541; P:hemoglobin biosynthetic process; ISS:UniProtKB
P22557	ALAS2	5-aminolevulinate synthase, erythroid-specific, mitochondrial	GO:0032364; P:oxygen homeostasis; NAS:UniProtKB
P22557	ALAS2	5-aminolevulinate synthase, erythroid-specific, mitochondrial	GO:0006778; P:porphyrin-containing compound metabolic process; TAS:Reactome
P22557	ALAS2	5-aminolevulinate synthase, erythroid-specific, mitochondrial	GO:0006782; P:protoporphyrinogen IX biosynthetic process; IEA:UniProtKB-UniPathway
P22557	ALAS2	5-aminolevulinate synthase, erythroid-specific, mitochondrial	GO:0001666; P:response to hypoxia; IDA:UniProtKB
P22557	ALAS2	5-aminolevulinate synthase, erythroid-specific, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P13196	ALAS1	5-aminolevulinate synthase, nonspecific, mitochondrial	GO:0003870; F:5-aminolevulinate synthase activity; IEA:UniProtKB-EC
P13196	ALAS1	5-aminolevulinate synthase, nonspecific, mitochondrial	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
P13196	ALAS1	5-aminolevulinate synthase, nonspecific, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P13196	ALAS1	5-aminolevulinate synthase, nonspecific, mitochondrial	GO:0006783; P:heme biosynthetic process; TAS:Reactome
P13196	ALAS1	5-aminolevulinate synthase, nonspecific, mitochondrial	GO:0006778; P:porphyrin-containing compound metabolic process; TAS:Reactome
P13196	ALAS1	5-aminolevulinate synthase, nonspecific, mitochondrial	GO:0006782; P:protoporphyrinogen IX biosynthetic process; IEA:UniProtKB-UniPathway
P13196	ALAS1	5-aminolevulinate synthase, nonspecific, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P13716	ALAD	Delta-aminolevulinic acid dehydratase	GO:0003824; F:catalytic activity; TAS:ProtInc
P13716	ALAD	Delta-aminolevulinic acid dehydratase	GO:0042802; F:identical protein binding; IPI:UniProtKB
P13716	ALAD	Delta-aminolevulinic acid dehydratase	GO:0032791; F:lead ion binding; IDA:UniProtKB
P13716	ALAD	Delta-aminolevulinic acid dehydratase	GO:0004655; F:porphobilinogen synthase activity; IDA:UniProtKB
P13716	ALAD	Delta-aminolevulinic acid dehydratase	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P13716	ALAD	Delta-aminolevulinic acid dehydratase	GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl
P13716	ALAD	Delta-aminolevulinic acid dehydratase	GO:0006783; P:heme biosynthetic process; IDA:UniProtKB
P13716	ALAD	Delta-aminolevulinic acid dehydratase	GO:0006778; P:porphyrin-containing compound metabolic process; TAS:Reactome
P13716	ALAD	Delta-aminolevulinic acid dehydratase	GO:0051260; P:protein homooligomerization; IPI:UniProtKB
P13716	ALAD	Delta-aminolevulinic acid dehydratase	GO:0006782; P:protoporphyrinogen IX biosynthetic process; IEA:UniProtKB-UniPathway
P13716	ALAD	Delta-aminolevulinic acid dehydratase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P08397	HMBS	Porphobilinogen deaminase	GO:0004418; F:hydroxymethylbilane synthase activity; IDA:UniProtKB
P08397	HMBS	Porphobilinogen deaminase	GO:0006783; P:heme biosynthetic process; IC:UniProtKB
P08397	HMBS	Porphobilinogen deaminase	GO:0018160; P:peptidyl-pyrromethane cofactor linkage; IEA:InterPro
P08397	HMBS	Porphobilinogen deaminase	GO:0006778; P:porphyrin-containing compound metabolic process; TAS:Reactome
P08397	HMBS	Porphobilinogen deaminase	GO:0006782; P:protoporphyrinogen IX biosynthetic process; IEA:UniProtKB-UniPathway
P08397	HMBS	Porphobilinogen deaminase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P10746	UROS	Uroporphyrinogen-III synthase	GO:0048037; F:cofactor binding; IEA:Ensembl
P10746	UROS	Uroporphyrinogen-III synthase	GO:0004852; F:uroporphyrinogen-III synthase activity; IDA:UniProtKB
P10746	UROS	Uroporphyrinogen-III synthase	GO:0071418; P:cellular response to amine stimulus; IEA:Ensembl
P10746	UROS	Uroporphyrinogen-III synthase	GO:0071243; P:cellular response to arsenic-containing substance; IEA:Ensembl
P10746	UROS	Uroporphyrinogen-III synthase	GO:0006783; P:heme biosynthetic process; IDA:UniProtKB
P10746	UROS	Uroporphyrinogen-III synthase	GO:0006778; P:porphyrin-containing compound metabolic process; TAS:Reactome
P10746	UROS	Uroporphyrinogen-III synthase	GO:0006782; P:protoporphyrinogen IX biosynthetic process; IEA:UniProtKB-UniPathway
P10746	UROS	Uroporphyrinogen-III synthase	GO:0046677; P:response to antibiotic; IEA:Ensembl
P10746	UROS	Uroporphyrinogen-III synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P10746	UROS	Uroporphyrinogen-III synthase	GO:0006780; P:uroporphyrinogen III biosynthetic process; IDA:UniProtKB
P36551	CPOX	Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial	GO:0004109; F:coproporphyrinogen oxidase activity; TAS:Reactome
P36551	CPOX	Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P36551	CPOX	Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial	GO:0005212; F:structural constituent of eye lens; IEA:Ensembl
P36551	CPOX	Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial	GO:0006783; P:heme biosynthetic process; TAS:Reactome
P36551	CPOX	Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial	GO:0006778; P:porphyrin-containing compound metabolic process; TAS:Reactome
P36551	CPOX	Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial	GO:0006782; P:protoporphyrinogen IX biosynthetic process; IEA:UniProtKB-UniPathway
P36551	CPOX	Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial	GO:0046685; P:response to arsenic-containing substance; IEA:Ensembl
P36551	CPOX	Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial	GO:0017085; P:response to insecticide; IEA:Ensembl
P36551	CPOX	Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial	GO:0010039; P:response to iron ion; IEA:Ensembl
P36551	CPOX	Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial	GO:0010288; P:response to lead ion; IEA:Ensembl
P36551	CPOX	Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial	GO:0051597; P:response to methylmercury; IEA:Ensembl
P36551	CPOX	Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BXL5	HEMGN	Hemogen	GO:0005515; F:protein binding; IPI:IntAct
Q9BXL5	HEMGN	Hemogen	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9BXL5	HEMGN	Hemogen	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9BXL5	HEMGN	Hemogen	GO:0045667; P:regulation of osteoblast differentiation; IEA:Ensembl
P22830	FECH	Ferrochelatase, mitochondrial	GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:UniProtKB-KW
P22830	FECH	Ferrochelatase, mitochondrial	GO:0004325; F:ferrochelatase activity; IDA:BHF-UCL
P22830	FECH	Ferrochelatase, mitochondrial	GO:0008198; F:ferrous iron binding; TAS:ProtInc
P22830	FECH	Ferrochelatase, mitochondrial	GO:0020037; F:heme binding; IEA:Ensembl
P22830	FECH	Ferrochelatase, mitochondrial	GO:0030350; F:iron-responsive element binding; IEA:Ensembl
P22830	FECH	Ferrochelatase, mitochondrial	GO:0005515; F:protein binding; IPI:BHF-UCL
P22830	FECH	Ferrochelatase, mitochondrial	GO:0071549; P:cellular response to dexamethasone stimulus; IEA:Ensembl
P22830	FECH	Ferrochelatase, mitochondrial	GO:0008203; P:cholesterol metabolic process; IEA:Ensembl
P22830	FECH	Ferrochelatase, mitochondrial	GO:0009589; P:detection of UV; IEA:Ensembl
P22830	FECH	Ferrochelatase, mitochondrial	GO:0030218; P:erythrocyte differentiation; IEA:Ensembl
P22830	FECH	Ferrochelatase, mitochondrial	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P22830	FECH	Ferrochelatase, mitochondrial	GO:0006783; P:heme biosynthetic process; TAS:Reactome
P22830	FECH	Ferrochelatase, mitochondrial	GO:0055072; P:iron ion homeostasis; IEA:Ensembl
P22830	FECH	Ferrochelatase, mitochondrial	GO:0006778; P:porphyrin-containing compound metabolic process; TAS:Reactome
P22830	FECH	Ferrochelatase, mitochondrial	GO:0046501; P:protoporphyrinogen IX metabolic process; IDA:BHF-UCL
P22830	FECH	Ferrochelatase, mitochondrial	GO:0010999; P:regulation of eIF2 alpha phosphorylation by heme; IEA:Ensembl
P22830	FECH	Ferrochelatase, mitochondrial	GO:0046984; P:regulation of hemoglobin biosynthetic process; IEA:Ensembl
P22830	FECH	Ferrochelatase, mitochondrial	GO:0046685; P:response to arsenic-containing substance; IEA:Ensembl
P22830	FECH	Ferrochelatase, mitochondrial	GO:0042493; P:response to drug; IEA:Ensembl
P22830	FECH	Ferrochelatase, mitochondrial	GO:0045471; P:response to ethanol; IEA:Ensembl
P22830	FECH	Ferrochelatase, mitochondrial	GO:0017085; P:response to insecticide; IEA:Ensembl
P22830	FECH	Ferrochelatase, mitochondrial	GO:0010288; P:response to lead ion; IEA:Ensembl
P22830	FECH	Ferrochelatase, mitochondrial	GO:0009416; P:response to light stimulus; TAS:ProtInc
P22830	FECH	Ferrochelatase, mitochondrial	GO:0051597; P:response to methylmercury; IEA:Ensembl
P22830	FECH	Ferrochelatase, mitochondrial	GO:0070541; P:response to platinum ion; IEA:Ensembl
P22830	FECH	Ferrochelatase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P22830	FECH	Ferrochelatase, mitochondrial	GO:0034379; P:very-low-density lipoprotein particle assembly; IEA:Ensembl
Q9Y5R4	HEMK1	HemK methyltransferase family member 1	GO:0003677; F:DNA binding; IEA:InterPro
Q9Y5R4	HEMK1	HemK methyltransferase family member 1	GO:0008170; F:N-methyltransferase activity; IEA:InterPro
Q9Y5R4	HEMK1	HemK methyltransferase family member 1	GO:0008276; F:protein methyltransferase activity; IEA:InterPro
Q9Y5R4	HEMK1	HemK methyltransferase family member 1	GO:0006306; P:DNA methylation; IEA:InterPro
Q9Y5N5	N6AMT1	HemK methyltransferase family member 2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9Y5N5	N6AMT1	HemK methyltransferase family member 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y5N5	N6AMT1	HemK methyltransferase family member 2	GO:0008276; F:protein methyltransferase activity; IDA:MGI
Q9Y5N5	N6AMT1	HemK methyltransferase family member 2	GO:0030307; P:positive regulation of cell growth; IDA:MGI
Q9Y5N5	N6AMT1	HemK methyltransferase family member 2	GO:0006479; P:protein methylation; IDA:GOC
P02790	HPX	Hemopexin	GO:0015232; F:heme transporter activity; TAS:ProtInc
P02790	HPX	Hemopexin	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
P02790	HPX	Hemopexin	GO:0005515; F:protein binding; IPI:UniProtKB
P02790	HPX	Hemopexin	GO:0008270; F:zinc ion binding; IEA:InterPro
P02790	HPX	Hemopexin	GO:0006879; P:cellular iron ion homeostasis; TAS:ProtInc
P02790	HPX	Hemopexin	GO:0042168; P:heme metabolic process; IEA:Ensembl
P02790	HPX	Hemopexin	GO:0015886; P:heme transport; TAS:ProtInc
P02790	HPX	Hemopexin	GO:0020027; P:hemoglobin metabolic process; IEA:Ensembl
P02790	HPX	Hemopexin	GO:0002925; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; IEA:Ensembl
P02790	HPX	Hemopexin	GO:0002639; P:positive regulation of immunoglobulin production; IEA:Ensembl
P02790	HPX	Hemopexin	GO:0060335; P:positive regulation of interferon-gamma-mediated signaling pathway; IEA:Ensembl
P02790	HPX	Hemopexin	GO:0042511; P:positive regulation of tyrosine phosphorylation of Stat1 protein; IEA:Ensembl
P02790	HPX	Hemopexin	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q02575	NHLH1	Helix-loop-helix protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q02575	NHLH1	Helix-loop-helix protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q02575	NHLH1	Helix-loop-helix protein 1	GO:0007417; P:central nervous system development; TAS:ProtInc
Q02575	NHLH1	Helix-loop-helix protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q02575	NHLH1	Helix-loop-helix protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q02577	NHLH2	Helix-loop-helix protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q02577	NHLH2	Helix-loop-helix protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q02577	NHLH2	Helix-loop-helix protein 2	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
Q02577	NHLH2	Helix-loop-helix protein 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q02577	NHLH2	Helix-loop-helix protein 2	GO:0007417; P:central nervous system development; TAS:ProtInc
Q02577	NHLH2	Helix-loop-helix protein 2	GO:0007617; P:mating behavior; IEA:Ensembl
Q02577	NHLH2	Helix-loop-helix protein 2	GO:0042698; P:ovulation cycle; IEA:Ensembl
Q02577	NHLH2	Helix-loop-helix protein 2	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; TAS:BHF-UCL
Q02577	NHLH2	Helix-loop-helix protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:BHF-UCL
Q02577	NHLH2	Helix-loop-helix protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5T8I9	HENMT1	Small RNA 2'-O-methyltransferase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5T8I9	HENMT1	Small RNA 2'-O-methyltransferase	GO:0008171; F:O-methyltransferase activity; ISS:UniProtKB
Q5T8I9	HENMT1	Small RNA 2'-O-methyltransferase	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q5T8I9	HENMT1	Small RNA 2'-O-methyltransferase	GO:0008173; F:RNA methyltransferase activity; ISS:UniProtKB
Q5T8I9	HENMT1	Small RNA 2'-O-methyltransferase	GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW
Q5T8I9	HENMT1	Small RNA 2'-O-methyltransferase	GO:0034587; P:piRNA metabolic process; ISS:UniProtKB
Q5T8I9	HENMT1	Small RNA 2'-O-methyltransferase	GO:0001510; P:RNA methylation; ISS:UniProtKB
P05546	SERPIND1	Heparin cofactor 2	GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc
P05546	SERPIND1	Heparin cofactor 2	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P05546	SERPIND1	Heparin cofactor 2	GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome
P05546	SERPIND1	Heparin cofactor 2	GO:0007596; P:blood coagulation; IEA:UniProtKB-KW
P05546	SERPIND1	Heparin cofactor 2	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
P05546	SERPIND1	Heparin cofactor 2	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P05546	SERPIND1	Heparin cofactor 2	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
P81172	HAMP	Hepcidin	GO:0006879; P:cellular iron ion homeostasis; IEA:Ensembl
P81172	HAMP	Hepcidin	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
P81172	HAMP	Hepcidin	GO:0050832; P:defense response to fungus; IEA:UniProtKB-KW
P81172	HAMP	Hepcidin	GO:0006955; P:immune response; TAS:UniProtKB
P81172	HAMP	Hepcidin	GO:0031640; P:killing of cells of other organism; IEA:UniProtKB-KW
Q9BQS7	HEPH	Hephaestin	GO:0005507; F:copper ion binding; IMP:UniProt
Q9BQS7	HEPH	Hephaestin	GO:0008198; F:ferrous iron binding; IMP:UniProt
Q9BQS7	HEPH	Hephaestin	GO:0004322; F:ferroxidase activity; IMP:UniProt
Q9BQS7	HEPH	Hephaestin	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
Q9BQS7	HEPH	Hephaestin	GO:0006825; P:copper ion transport; IEA:UniProtKB-KW
Q9BQS7	HEPH	Hephaestin	GO:0006826; P:iron ion transport; IMP:UniProt
Q9BQS7	HEPH	Hephaestin	GO:0055085; P:transmembrane transport; TAS:Reactome
P05981	HPN	Serine protease hepsin	GO:0015269; F:calcium-activated potassium channel activity; ISS:UniProtKB
P05981	HPN	Serine protease hepsin	GO:0008233; F:peptidase activity; IDA:UniProtKB
P05981	HPN	Serine protease hepsin	GO:0005515; F:protein binding; IPI:UniProtKB
P05981	HPN	Serine protease hepsin	GO:0005044; F:scavenger receptor activity; IEA:InterPro
P05981	HPN	Serine protease hepsin	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
P05981	HPN	Serine protease hepsin	GO:0070008; F:serine-type exopeptidase activity; IEA:InterPro
P05981	HPN	Serine protease hepsin	GO:0008236; F:serine-type peptidase activity; IDA:UniProtKB
P05981	HPN	Serine protease hepsin	GO:0034769; P:basement membrane disassembly; IDA:UniProtKB
P05981	HPN	Serine protease hepsin	GO:0090103; P:cochlea morphogenesis; ISS:UniProtKB
P05981	HPN	Serine protease hepsin	GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; ISS:UniProtKB
P05981	HPN	Serine protease hepsin	GO:0060429; P:epithelium development; IEA:Ensembl
P05981	HPN	Serine protease hepsin	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P05981	HPN	Serine protease hepsin	GO:0050680; P:negative regulation of epithelial cell proliferation; IDA:UniProtKB
P05981	HPN	Serine protease hepsin	GO:0010719; P:negative regulation of epithelial to mesenchymal transition; IDA:UniProtKB
P05981	HPN	Serine protease hepsin	GO:0097195; P:pilomotor reflex; ISS:UniProtKB
P05981	HPN	Serine protease hepsin	GO:0043923; P:positive regulation by host of viral transcription; IDA:UniProtKB
P05981	HPN	Serine protease hepsin	GO:0030307; P:positive regulation of cell growth; IMP:UniProtKB
P05981	HPN	Serine protease hepsin	GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB
P05981	HPN	Serine protease hepsin	GO:2000347; P:positive regulation of hepatocyte proliferation; IDA:UniProtKB
P05981	HPN	Serine protease hepsin	GO:0010756; P:positive regulation of plasminogen activation; IDA:UniProtKB
P05981	HPN	Serine protease hepsin	GO:2000611; P:positive regulation of thyroid hormone generation; ISS:UniProtKB
P05981	HPN	Serine protease hepsin	GO:0071805; P:potassium ion transmembrane transport; ISS:UniProtKB
P05981	HPN	Serine protease hepsin	GO:0006508; P:proteolysis; IDA:UniProtKB
P05981	HPN	Serine protease hepsin	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
P05981	HPN	Serine protease hepsin	GO:0097066; P:response to thyroid hormone; ISS:UniProtKB
Q15751	HERC1	Probable E3 ubiquitin-protein ligase HERC1	GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; TAS:ProtInc
Q15751	HERC1	Probable E3 ubiquitin-protein ligase HERC1	GO:0004842; F:ubiquitin-protein ligase activity; IEA:InterPro
Q15751	HERC1	Probable E3 ubiquitin-protein ligase HERC1	GO:0021702; P:cerebellar Purkinje cell differentiation; IEA:Ensembl
Q15751	HERC1	Probable E3 ubiquitin-protein ligase HERC1	GO:0010507; P:negative regulation of autophagy; IEA:Ensembl
Q15751	HERC1	Probable E3 ubiquitin-protein ligase HERC1	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q15751	HERC1	Probable E3 ubiquitin-protein ligase HERC1	GO:0031175; P:neuron projection development; IEA:Ensembl
Q15751	HERC1	Probable E3 ubiquitin-protein ligase HERC1	GO:0043087; P:regulation of GTPase activity; TAS:GOC
Q15751	HERC1	Probable E3 ubiquitin-protein ligase HERC1	GO:0006810; P:transport; IEA:UniProtKB-KW
O95714	HERC2	E3 ubiquitin-protein ligase HERC2	GO:0005085; F:guanyl-nucleotide exchange factor activity; NAS:UniProtKB
O95714	HERC2	E3 ubiquitin-protein ligase HERC2	GO:0020037; F:heme binding; IEA:InterPro
O95714	HERC2	E3 ubiquitin-protein ligase HERC2	GO:0005515; F:protein binding; IPI:UniProtKB
O95714	HERC2	E3 ubiquitin-protein ligase HERC2	GO:0032183; F:SUMO binding; IDA:UniProtKB
O95714	HERC2	E3 ubiquitin-protein ligase HERC2	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
O95714	HERC2	E3 ubiquitin-protein ligase HERC2	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
O95714	HERC2	E3 ubiquitin-protein ligase HERC2	GO:0008270; F:zinc ion binding; IEA:InterPro
O95714	HERC2	E3 ubiquitin-protein ligase HERC2	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
O95714	HERC2	E3 ubiquitin-protein ligase HERC2	GO:0006281; P:DNA repair; IDA:UniProtKB
O95714	HERC2	E3 ubiquitin-protein ligase HERC2	GO:0006886; P:intracellular protein transport; NAS:UniProtKB
O95714	HERC2	E3 ubiquitin-protein ligase HERC2	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
O95714	HERC2	E3 ubiquitin-protein ligase HERC2	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:RefGenome
O95714	HERC2	E3 ubiquitin-protein ligase HERC2	GO:0043087; P:regulation of GTPase activity; NAS:GOC
O95714	HERC2	E3 ubiquitin-protein ligase HERC2	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q15034	HERC3	Probable E3 ubiquitin-protein ligase HERC3	GO:0004842; F:ubiquitin-protein ligase activity; IBA:RefGenome
Q15034	HERC3	Probable E3 ubiquitin-protein ligase HERC3	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:RefGenome
Q5GLZ8	HERC4	Probable E3 ubiquitin-protein ligase HERC4	GO:0004842; F:ubiquitin-protein ligase activity; IBA:RefGenome
Q5GLZ8	HERC4	Probable E3 ubiquitin-protein ligase HERC4	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q5GLZ8	HERC4	Probable E3 ubiquitin-protein ligase HERC4	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:RefGenome
Q5GLZ8	HERC4	Probable E3 ubiquitin-protein ligase HERC4	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q9UII4	HERC5	E3 ISG15--protein ligase HERC5	GO:0042296; F:ISG15 ligase activity; IDA:UniProtKB
Q9UII4	HERC5	E3 ISG15--protein ligase HERC5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UII4	HERC5	E3 ISG15--protein ligase HERC5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UII4	HERC5	E3 ISG15--protein ligase HERC5	GO:0004842; F:ubiquitin-protein ligase activity; IBA:RefGenome
Q9UII4	HERC5	E3 ISG15--protein ligase HERC5	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q9UII4	HERC5	E3 ISG15--protein ligase HERC5	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q9UII4	HERC5	E3 ISG15--protein ligase HERC5	GO:0045087; P:innate immune response; TAS:Reactome
Q9UII4	HERC5	E3 ISG15--protein ligase HERC5	GO:0032020; P:ISG15-protein conjugation; IDA:UniProtKB
Q9UII4	HERC5	E3 ISG15--protein ligase HERC5	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
Q9UII4	HERC5	E3 ISG15--protein ligase HERC5	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:RefGenome
Q9UII4	HERC5	E3 ISG15--protein ligase HERC5	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
Q9UII4	HERC5	E3 ISG15--protein ligase HERC5	GO:0050688; P:regulation of defense response to virus; IDA:UniProtKB
Q8IVU3	HERC6	Probable E3 ubiquitin-protein ligase HERC6	GO:0004842; F:ubiquitin-protein ligase activity; IBA:RefGenome
Q8IVU3	HERC6	Probable E3 ubiquitin-protein ligase HERC6	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:RefGenome
Q9BSE4	HERPUD2	Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
Q9BSE4	HERPUD2	Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q15011	HERPUD1	Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q15011	HERPUD1	Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
Q15011	HERPUD1	Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q15011	HERPUD1	Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q15011	HERPUD1	Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
Q15011	HERPUD1	Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein	GO:0032092; P:positive regulation of protein binding; IEA:Ensembl
Q15011	HERPUD1	Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein	GO:0031396; P:regulation of protein ubiquitination; IEA:Ensembl
Q15011	HERPUD1	Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein	GO:0006986; P:response to unfolded protein; IEP:UniProtKB
Q15011	HERPUD1	Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q9Y543	HES2	Transcription factor HES-2	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
Q9Y543	HES2	Transcription factor HES-2	GO:0008134; F:transcription factor binding; NAS:UniProtKB
Q9Y543	HES2	Transcription factor HES-2	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q9Y543	HES2	Transcription factor HES-2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14469	HES1	Transcription factor HES-1	GO:0003677; F:DNA binding; TAS:ProtInc
Q14469	HES1	Transcription factor HES-1	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
Q14469	HES1	Transcription factor HES-1	GO:0071820; F:N-box binding; ISS:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:0005515; F:protein binding; IPI:IntAct
Q14469	HES1	Transcription factor HES-1	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; ISS:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:0008134; F:transcription factor binding; NAS:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:0021984; P:adenohypophysis development; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0048844; P:artery morphogenesis; ISS:BHF-UCL
Q14469	HES1	Transcription factor HES-1	GO:0035910; P:ascending aorta morphogenesis; ISS:BHF-UCL
Q14469	HES1	Transcription factor HES-1	GO:0042668; P:auditory receptor cell fate determination; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0061309; P:cardiac neural crest cell development involved in outflow tract morphogenesis; ISS:BHF-UCL
Q14469	HES1	Transcription factor HES-1	GO:0007155; P:cell adhesion; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0048469; P:cell maturation; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0016477; P:cell migration; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0048667; P:cell morphogenesis involved in neuron differentiation; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0090102; P:cochlea development; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0072049; P:comma-shaped body morphogenesis; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0061009; P:common bile duct development; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0003143; P:embryonic heart tube morphogenesis; ISS:BHF-UCL
Q14469	HES1	Transcription factor HES-1	GO:0031018; P:endocrine pancreas development; TAS:Reactome
Q14469	HES1	Transcription factor HES-1	GO:0021861; P:forebrain radial glial cell differentiation; ISS:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:0072012; P:glomerulus vasculature development; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0021575; P:hindbrain morphogenesis; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0046331; P:lateral inhibition; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0001889; P:liver development; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0030324; P:lung development; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0072282; P:metanephric nephron tubule morphogenesis; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0030901; P:midbrain development; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0021555; P:midbrain-hindbrain boundary morphogenesis; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0045608; P:negative regulation of auditory receptor cell differentiation; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:2000978; P:negative regulation of forebrain neuron differentiation; ISS:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:0060253; P:negative regulation of glial cell proliferation; ISS:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:0048715; P:negative regulation of oligodendrocyte differentiation; ISS:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:2000227; P:negative regulation of pancreatic A cell differentiation; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:2000974; P:negative regulation of pro-B cell differentiation; IMP:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:2000737; P:negative regulation of stem cell differentiation; IMP:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:0061106; P:negative regulation of stomach neuroendocrine cell differentiation; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
Q14469	HES1	Transcription factor HES-1	GO:0007399; P:nervous system development; TAS:ProtInc
Q14469	HES1	Transcription factor HES-1	GO:0097150; P:neuronal stem cell maintenance; IEP:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:0007219; P:Notch signaling pathway; IDA:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:0021557; P:oculomotor nerve development; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0003151; P:outflow tract morphogenesis; ISS:BHF-UCL
Q14469	HES1	Transcription factor HES-1	GO:0060037; P:pharyngeal system development; ISS:BHF-UCL
Q14469	HES1	Transcription factor HES-1	GO:0048711; P:positive regulation of astrocyte differentiation; ISS:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:0030513; P:positive regulation of BMP signaling pathway; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0008284; P:positive regulation of cell proliferation; ISS:BHF-UCL
Q14469	HES1	Transcription factor HES-1	GO:0043388; P:positive regulation of DNA binding; ISS:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:0046427; P:positive regulation of JAK-STAT cascade; ISS:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:0045977; P:positive regulation of mitotic cell cycle, embryonic; ISS:BHF-UCL
Q14469	HES1	Transcription factor HES-1	GO:0045747; P:positive regulation of Notch signaling pathway; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q14469	HES1	Transcription factor HES-1	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; ISS:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:0006461; P:protein complex assembly; ISS:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:0045598; P:regulation of fat cell differentiation; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0003266; P:regulation of secondary heart field cardioblast proliferation; ISS:BHF-UCL
Q14469	HES1	Transcription factor HES-1	GO:0060164; P:regulation of timing of neuron differentiation; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0072141; P:renal interstitial cell development; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0072050; P:S-shaped body morphogenesis; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0007262; P:STAT protein import into nucleus; ISS:UniProtKB
Q14469	HES1	Transcription factor HES-1	GO:0021537; P:telencephalon development; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0048538; P:thymus development; ISS:BHF-UCL
Q14469	HES1	Transcription factor HES-1	GO:0021558; P:trochlear nerve development; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0060675; P:ureteric bud morphogenesis; IEA:Ensembl
Q14469	HES1	Transcription factor HES-1	GO:0097084; P:vascular smooth muscle cell development; ISS:BHF-UCL
Q14469	HES1	Transcription factor HES-1	GO:0003281; P:ventricular septum development; ISS:BHF-UCL
Q14469	HES1	Transcription factor HES-1	GO:0060412; P:ventricular septum morphogenesis; ISS:BHF-UCL
Q5TGS1	HES3	Transcription factor HES-3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5TGS1	HES3	Transcription factor HES-3	GO:0008134; F:transcription factor binding; NAS:UniProtKB
Q5TGS1	HES3	Transcription factor HES-3	GO:0021575; P:hindbrain morphogenesis; IEA:Ensembl
Q5TGS1	HES3	Transcription factor HES-3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q5TGS1	HES3	Transcription factor HES-3	GO:0030901; P:midbrain development; IEA:Ensembl
Q5TGS1	HES3	Transcription factor HES-3	GO:0021555; P:midbrain-hindbrain boundary morphogenesis; IEA:Ensembl
Q5TGS1	HES3	Transcription factor HES-3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q5TGS1	HES3	Transcription factor HES-3	GO:0021557; P:oculomotor nerve development; IEA:Ensembl
Q5TGS1	HES3	Transcription factor HES-3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q5TGS1	HES3	Transcription factor HES-3	GO:0060164; P:regulation of timing of neuron differentiation; IEA:Ensembl
Q5TGS1	HES3	Transcription factor HES-3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5TGS1	HES3	Transcription factor HES-3	GO:0021558; P:trochlear nerve development; IEA:Ensembl
Q9HCC6	HES4	Transcription factor HES-4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9HCC6	HES4	Transcription factor HES-4	GO:0008134; F:transcription factor binding; NAS:UniProtKB
Q9HCC6	HES4	Transcription factor HES-4	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9HCC6	HES4	Transcription factor HES-4	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q9HCC6	HES4	Transcription factor HES-4	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9HCC6	HES4	Transcription factor HES-4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5TA89	HES5	Transcription factor HES-5	GO:0003682; F:chromatin binding; IEA:Ensembl
Q5TA89	HES5	Transcription factor HES-5	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
Q5TA89	HES5	Transcription factor HES-5	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0008134; F:transcription factor binding; NAS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0048708; P:astrocyte differentiation; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0042491; P:auditory receptor cell differentiation; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0042668; P:auditory receptor cell fate determination; IEA:Ensembl
Q5TA89	HES5	Transcription factor HES-5	GO:0007420; P:brain development; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0043010; P:camera-type eye development; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0051216; P:cartilage development; IDA:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0007155; P:cell adhesion; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0048469; P:cell maturation; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0022010; P:central nervous system myelination; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0072049; P:comma-shaped body morphogenesis; IEA:Ensembl
Q5TA89	HES5	Transcription factor HES-5	GO:0021861; P:forebrain radial glial cell differentiation; IEA:Ensembl
Q5TA89	HES5	Transcription factor HES-5	GO:0021781; P:glial cell fate commitment; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0072282; P:metanephric nephron tubule morphogenesis; IEA:Ensembl
Q5TA89	HES5	Transcription factor HES-5	GO:0048712; P:negative regulation of astrocyte differentiation; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:2000978; P:negative regulation of forebrain neuron differentiation; IEA:Ensembl
Q5TA89	HES5	Transcription factor HES-5	GO:2000981; P:negative regulation of inner ear receptor cell differentiation; IEA:Ensembl
Q5TA89	HES5	Transcription factor HES-5	GO:0045665; P:negative regulation of neuron differentiation; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0048715; P:negative regulation of oligodendrocyte differentiation; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:2000974; P:negative regulation of pro-B cell differentiation; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:2000737; P:negative regulation of stem cell differentiation; IMP:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0021915; P:neural tube development; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0097150; P:neuronal stem cell maintenance; IEP:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0007219; P:Notch signaling pathway; IMP:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0014003; P:oligodendrocyte development; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0030513; P:positive regulation of BMP signaling pathway; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0046427; P:positive regulation of JAK-STAT cascade; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0045747; P:positive regulation of Notch signaling pathway; IEA:Ensembl
Q5TA89	HES5	Transcription factor HES-5	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IGI:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q5TA89	HES5	Transcription factor HES-5	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0006461; P:protein complex assembly; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0045595; P:regulation of cell differentiation; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0031641; P:regulation of myelination; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0050767; P:regulation of neurogenesis; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0072050; P:S-shaped body morphogenesis; IEA:Ensembl
Q5TA89	HES5	Transcription factor HES-5	GO:0007224; P:smoothened signaling pathway; ISS:UniProtKB
Q5TA89	HES5	Transcription factor HES-5	GO:0072086; P:specification of loop of Henle identity; IEA:Ensembl
Q5TA89	HES5	Transcription factor HES-5	GO:0021537; P:telencephalon development; ISS:UniProtKB
Q96HZ4	HES6	Transcription cofactor HES-6	GO:0003677; F:DNA binding; IEA:InterPro
Q96HZ4	HES6	Transcription cofactor HES-6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q96HZ4	HES6	Transcription cofactor HES-6	GO:0003712; F:transcription cofactor activity; ISS:UniProtKB
Q96HZ4	HES6	Transcription cofactor HES-6	GO:0008134; F:transcription factor binding; NAS:UniProtKB
Q96HZ4	HES6	Transcription cofactor HES-6	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96HZ4	HES6	Transcription cofactor HES-6	GO:0007399; P:nervous system development; IEA:Ensembl
Q96HZ4	HES6	Transcription cofactor HES-6	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q96HZ4	HES6	Transcription cofactor HES-6	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
Q96HZ4	HES6	Transcription cofactor HES-6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BYE0	HES7	Transcription factor HES-7	GO:0003677; F:DNA binding; NAS:UniProtKB
Q9BYE0	HES7	Transcription factor HES-7	GO:0008134; F:transcription factor binding; NAS:UniProtKB
Q9BYE0	HES7	Transcription factor HES-7	GO:0007498; P:mesoderm development; NAS:UniProtKB
Q9BYE0	HES7	Transcription factor HES-7	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9BYE0	HES7	Transcription factor HES-7	GO:0007219; P:Notch signaling pathway; IEA:Ensembl
Q9BYE0	HES7	Transcription factor HES-7	GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl
Q9BYE0	HES7	Transcription factor HES-7	GO:0014807; P:regulation of somitogenesis; IEA:Ensembl
Q9BYE0	HES7	Transcription factor HES-7	GO:0048511; P:rhythmic process; IEA:Ensembl
Q9BYE0	HES7	Transcription factor HES-7	GO:0001501; P:skeletal system development; IEA:Ensembl
Q9BYE0	HES7	Transcription factor HES-7	GO:0001756; P:somitogenesis; IEA:Ensembl
Q9BYE0	HES7	Transcription factor HES-7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UBX0	HESX1	Homeobox expressed in ES cells 1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9UBX0	HESX1	Homeobox expressed in ES cells 1	GO:0003677; F:DNA binding; TAS:ProtInc
Q9UBX0	HESX1	Homeobox expressed in ES cells 1	GO:0005515; F:protein binding; IPI:IntAct
Q9UBX0	HESX1	Homeobox expressed in ES cells 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9UBX0	HESX1	Homeobox expressed in ES cells 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9UBX0	HESX1	Homeobox expressed in ES cells 1	GO:0007420; P:brain development; TAS:ProtInc
Q9UBX0	HESX1	Homeobox expressed in ES cells 1	GO:0048853; P:forebrain morphogenesis; IEA:Ensembl
Q9UBX0	HESX1	Homeobox expressed in ES cells 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q9UBX0	HESX1	Homeobox expressed in ES cells 1	GO:0043584; P:nose development; IEA:Ensembl
Q9UBX0	HESX1	Homeobox expressed in ES cells 1	GO:0030916; P:otic vesicle formation; IEA:Ensembl
Q9UBX0	HESX1	Homeobox expressed in ES cells 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0004563; F:beta-N-acetylhexosaminidase activity; IEA:UniProtKB-EC
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0046982; F:protein heterodimerization activity; IDA:MGI
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0007628; P:adult walking behavior; IEA:Ensembl
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0008219; P:cell death; IEA:UniProtKB-KW
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0048667; P:cell morphogenesis involved in neuron differentiation; IEA:Ensembl
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0030207; P:chondroitin sulfate catabolic process; TAS:Reactome
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0006689; P:ganglioside catabolic process; IEA:Ensembl
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0030214; P:hyaluronan catabolic process; TAS:Reactome
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0030212; P:hyaluronan metabolic process; TAS:Reactome
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0042340; P:keratan sulfate catabolic process; TAS:Reactome
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0019915; P:lipid storage; IEA:Ensembl
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0007040; P:lysosome organization; IEA:Ensembl
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0042552; P:myelination; IEA:Ensembl
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0050884; P:neuromuscular process controlling posture; IEA:Ensembl
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0007605; P:sensory perception of sound; IEA:Ensembl
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0019953; P:sexual reproduction; IEA:Ensembl
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0001501; P:skeletal system development; IEA:Ensembl
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P06865	HEXA	Beta-hexosaminidase subunit alpha	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0004563; F:beta-N-acetylhexosaminidase activity; TAS:ProtInc
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0046982; F:protein heterodimerization activity; IDA:MGI
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0042803; F:protein homodimerization activity; IDA:MGI
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0043615; P:astrocyte cell migration; IEA:Ensembl
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0008219; P:cell death; IEA:UniProtKB-KW
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0044267; P:cellular protein metabolic process; IEA:Ensembl
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0030207; P:chondroitin sulfate catabolic process; TAS:Reactome
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0006689; P:ganglioside catabolic process; IEA:Ensembl
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0030214; P:hyaluronan catabolic process; TAS:Reactome
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0030212; P:hyaluronan metabolic process; TAS:Reactome
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0042340; P:keratan sulfate catabolic process; TAS:Reactome
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0019915; P:lipid storage; IEA:Ensembl
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0007626; P:locomotory behavior; IEA:Ensembl
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0007040; P:lysosome organization; IEA:Ensembl
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0008049; P:male courtship behavior; IEA:Ensembl
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0042552; P:myelination; IEA:Ensembl
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0009313; P:oligosaccharide catabolic process; IEA:Ensembl
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0048477; P:oogenesis; IEA:Ensembl
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0007341; P:penetration of zona pellucida; IEA:Ensembl
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0008654; P:phospholipid biosynthetic process; IEA:Ensembl
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0008360; P:regulation of cell shape; IEA:Ensembl
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0007605; P:sensory perception of sound; IEA:Ensembl
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0001501; P:skeletal system development; IEA:Ensembl
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P07686	HEXB	Beta-hexosaminidase subunit beta	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q8WVB3	HEXDC	Hexosaminidase D	GO:0004563; F:beta-N-acetylhexosaminidase activity; IEA:UniProtKB-EC
Q8WVB3	HEXDC	Hexosaminidase D	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
O94992	HEXIM1	Protein HEXIM1	GO:0004861; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; IDA:HGNC
O94992	HEXIM1	Protein HEXIM1	GO:0005515; F:protein binding; IPI:IntAct
O94992	HEXIM1	Protein HEXIM1	GO:0017069; F:snRNA binding; IDA:HGNC
O94992	HEXIM1	Protein HEXIM1	GO:0007507; P:heart development; IEA:Ensembl
O94992	HEXIM1	Protein HEXIM1	GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:HGNC
O94992	HEXIM1	Protein HEXIM1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:HGNC
O94992	HEXIM1	Protein HEXIM1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:HGNC
O94992	HEXIM1	Protein HEXIM1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96MH2	HEXIM2	Protein HEXIM2	GO:0004861; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; IDA:HGNC
Q96MH2	HEXIM2	Protein HEXIM2	GO:0005515; F:protein binding; IPI:HGNC
Q96MH2	HEXIM2	Protein HEXIM2	GO:0017069; F:snRNA binding; IDA:HGNC
Q96MH2	HEXIM2	Protein HEXIM2	GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:HGNC
Q96MH2	HEXIM2	Protein HEXIM2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:HGNC
Q96MH2	HEXIM2	Protein HEXIM2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:HGNC
Q96MH2	HEXIM2	Protein HEXIM2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0035939; F:microsatellite binding; IDA:UniProtKB
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0000988; F:protein binding transcription factor activity; IDA:UniProtKB
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0000983; F:RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0008134; F:transcription factor binding; NAS:UniProtKB
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0001525; P:angiogenesis; IEP:UniProtKB
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0009948; P:anterior/posterior axis specification; IEA:Ensembl
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0060842; P:arterial endothelial cell differentiation; ISS:BHF-UCL
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0003190; P:atrioventricular valve formation; ISS:BHF-UCL
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0060317; P:cardiac epithelial to mesenchymal transition; ISS:BHF-UCL
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0060411; P:cardiac septum morphogenesis; ISS:BHF-UCL
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0003208; P:cardiac ventricle morphogenesis; ISS:BHF-UCL
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0071385; P:cellular response to glucocorticoid stimulus; IEA:Ensembl
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0035912; P:dorsal aorta morphogenesis; ISS:BHF-UCL
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0003203; P:endocardial cushion morphogenesis; ISS:BHF-UCL
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0003199; P:endocardial cushion to mesenchymal transition involved in heart valve formation; IEA:Ensembl
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0003198; P:epithelial to mesenchymal transition involved in endocardial cushion formation; ISS:UniProtKB
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0060347; P:heart trabecula formation; ISS:BHF-UCL
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0060716; P:labyrinthine layer blood vessel development; ISS:BHF-UCL
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0045746; P:negative regulation of Notch signaling pathway; IDA:BHF-UCL
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:2000820; P:negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation; IDA:BHF-UCL
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:2000678; P:negative regulation of transcription regulatory region DNA binding; IDA:BHF-UCL
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0061314; P:Notch signaling involved in heart development; IC:BHF-UCL
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0007219; P:Notch signaling pathway; IDA:UniProtKB
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0002076; P:osteoblast development; IEA:Ensembl
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0003184; P:pulmonary valve morphogenesis; ISS:BHF-UCL
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:2001212; P:regulation of vasculogenesis; ISS:BHF-UCL
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; ISS:GOC
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0036304; P:umbilical cord morphogenesis; ISS:BHF-UCL
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0060412; P:ventricular septum morphogenesis; ISS:BHF-UCL
Q9Y5J3	HEY1	Hairy/enhancer-of-split related with YRPW motif protein 1	GO:0003222; P:ventricular trabecula myocardium morphogenesis; IEA:Ensembl
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0035939; F:microsatellite binding; IDA:UniProtKB
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0000988; F:protein binding transcription factor activity; IDA:UniProtKB
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0000983; F:RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0043565; F:sequence-specific DNA binding; IDA:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0008134; F:transcription factor binding; NAS:UniProtKB
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0009948; P:anterior/posterior axis specification; IEA:Ensembl
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0060842; P:arterial endothelial cell differentiation; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0035910; P:ascending aorta morphogenesis; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0060413; P:atrial septum morphogenesis; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0003171; P:atrioventricular valve development; IEA:Ensembl
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0060317; P:cardiac epithelial to mesenchymal transition; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0003214; P:cardiac left ventricle morphogenesis; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0014898; P:cardiac muscle hypertrophy in response to stress; IEA:Ensembl
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0003215; P:cardiac right ventricle morphogenesis; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0060411; P:cardiac septum morphogenesis; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0060948; P:cardiac vascular smooth muscle cell development; IEA:Ensembl
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0003208; P:cardiac ventricle morphogenesis; ISS:UniProtKB
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0045165; P:cell fate commitment; IEA:Ensembl
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0090102; P:cochlea development; IEA:Ensembl
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0060977; P:coronary vasculature morphogenesis; IEA:Ensembl
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0035912; P:dorsal aorta morphogenesis; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0003199; P:endocardial cushion to mesenchymal transition involved in heart valve formation; IEA:Ensembl
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0060347; P:heart trabecula formation; IEA:Ensembl
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0060716; P:labyrinthine layer blood vessel development; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0014031; P:mesenchymal cell development; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0003150; P:muscular septum morphogenesis; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IEA:Ensembl
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:2000723; P:negative regulation of cardiac vascular smooth muscle cell differentiation; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0010629; P:negative regulation of gene expression; ISS:UniProtKB
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0045746; P:negative regulation of Notch signaling pathway; IEA:Ensembl
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0010621; P:negative regulation of transcription by transcription factor localization; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:2000820; P:negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0060633; P:negative regulation of transcription initiation from RNA polymerase II promoter; IDA:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:2000678; P:negative regulation of transcription regulatory region DNA binding; IDA:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0061314; P:Notch signaling involved in heart development; IC:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0007219; P:Notch signaling pathway; ISS:UniProtKB
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0003151; P:outflow tract morphogenesis; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0060045; P:positive regulation of cardiac muscle cell proliferation; IEA:Ensembl
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0010460; P:positive regulation of heart rate; IEA:Ensembl
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0065004; P:protein-DNA complex assembly; IEA:Ensembl
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0061156; P:pulmonary artery morphogenesis; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0003184; P:pulmonary valve morphogenesis; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0045607; P:regulation of auditory receptor cell differentiation; IEA:Ensembl
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:2001212; P:regulation of vasculogenesis; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0051145; P:smooth muscle cell differentiation; NAS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0006366; P:transcription from RNA polymerase II promoter; ISS:GOC
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0003195; P:tricuspid valve formation; IEA:Ensembl
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0003186; P:tricuspid valve morphogenesis; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0036304; P:umbilical cord morphogenesis; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0097084; P:vascular smooth muscle cell development; IEP:UniProtKB
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0001570; P:vasculogenesis; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0055015; P:ventricular cardiac muscle cell development; ISS:UniProtKB
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0060412; P:ventricular septum morphogenesis; ISS:BHF-UCL
Q9UBP5	HEY2	Hairy/enhancer-of-split related with YRPW motif protein 2	GO:0003222; P:ventricular trabecula myocardium morphogenesis; IEA:Ensembl
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0050683; F:AF-1 domain binding; IPI:UniProtKB
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0035939; F:microsatellite binding; IDA:UniProtKB
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0000988; F:protein binding transcription factor activity; IDA:UniProtKB
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0000983; F:RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0001106; F:RNA polymerase II transcription corepressor activity; IEA:Ensembl
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0008134; F:transcription factor binding; NAS:UniProtKB
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0003181; P:atrioventricular valve morphogenesis; ISS:BHF-UCL
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0060317; P:cardiac epithelial to mesenchymal transition; ISS:BHF-UCL
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0003208; P:cardiac ventricle morphogenesis; ISS:BHF-UCL
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0071773; P:cellular response to BMP stimulus; IEA:Ensembl
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0003203; P:endocardial cushion morphogenesis; ISS:BHF-UCL
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0003198; P:epithelial to mesenchymal transition involved in endocardial cushion formation; ISS:UniProtKB
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0032835; P:glomerulus development; IEA:Ensembl
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0014031; P:mesenchymal cell development; ISS:BHF-UCL
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:2000824; P:negative regulation of androgen receptor activity; IDA:UniProtKB
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0060766; P:negative regulation of androgen receptor signaling pathway; IDA:UniProtKB
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0007219; P:Notch signaling pathway; IDA:UniProtKB
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0003151; P:outflow tract morphogenesis; ISS:BHF-UCL
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0072014; P:proximal tubule development; IEA:Ensembl
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0003184; P:pulmonary valve morphogenesis; ISS:BHF-UCL
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0006366; P:transcription from RNA polymerase II promoter; ISS:GOC
Q9NQ87	HEYL	Hairy/enhancer-of-split related with YRPW motif-like protein	GO:0060412; P:ventricular septum morphogenesis; ISS:BHF-UCL
Q30201	HFE	Hereditary hemochromatosis protein	GO:0003823; F:antigen binding; IBA:RefGenome
Q30201	HFE	Hereditary hemochromatosis protein	GO:0042605; F:peptide antigen binding; IEA:InterPro
Q30201	HFE	Hereditary hemochromatosis protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q30201	HFE	Hereditary hemochromatosis protein	GO:0005102; F:receptor binding; IPI:UniProtKB
Q30201	HFE	Hereditary hemochromatosis protein	GO:0019882; P:antigen processing and presentation; IBA:RefGenome
Q30201	HFE	Hereditary hemochromatosis protein	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW
Q30201	HFE	Hereditary hemochromatosis protein	GO:0006879; P:cellular iron ion homeostasis; TAS:ProtInc
Q30201	HFE	Hereditary hemochromatosis protein	GO:0010106; P:cellular response to iron ion starvation; IEA:Ensembl
Q30201	HFE	Hereditary hemochromatosis protein	GO:0007565; P:female pregnancy; IEA:Ensembl
Q30201	HFE	Hereditary hemochromatosis protein	GO:0042446; P:hormone biosynthetic process; IEA:Ensembl
Q30201	HFE	Hereditary hemochromatosis protein	GO:0006955; P:immune response; IEA:InterPro
Q30201	HFE	Hereditary hemochromatosis protein	GO:0097459; P:iron ion import into cell; IDA:UniProtKB
Q30201	HFE	Hereditary hemochromatosis protein	GO:0060586; P:multicellular organismal iron ion homeostasis; IEA:Ensembl
Q30201	HFE	Hereditary hemochromatosis protein	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
Q30201	HFE	Hereditary hemochromatosis protein	GO:0006461; P:protein complex assembly; TAS:ProtInc
A2PYH4	HFM1	Probable ATP-dependent DNA helicase HFM1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
A2PYH4	HFM1	Probable ATP-dependent DNA helicase HFM1	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
A2PYH4	HFM1	Probable ATP-dependent DNA helicase HFM1	GO:0003676; F:nucleic acid binding; IEA:InterPro
A2PYH4	HFM1	Probable ATP-dependent DNA helicase HFM1	GO:0000712; P:resolution of meiotic recombination intermediates; IEA:Ensembl
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0001540; F:beta-amyloid binding; IPI:BHF-UCL
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0019955; F:cytokine binding; IPI:UniProtKB
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0004896; F:cytokine receptor activity; IDA:BHF-UCL
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0042802; F:identical protein binding; TAS:UniProtKB
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0035718; F:macrophage migration inhibitory factor binding; IPI:BHF-UCL
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0042289; F:MHC class II protein binding; NAS:UniProtKB
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0005515; F:protein binding; IPI:IntAct
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0019883; P:antigen processing and presentation of endogenous antigen; NAS:UniProtKB
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0008283; P:cell proliferation; IDA:UniProtKB
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0051085; P:chaperone mediated protein folding requiring cofactor; IEA:Ensembl
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0006952; P:defense response; IEA:Ensembl
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0016064; P:immunoglobulin mediated immune response; ISS:UniProtKB
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0006886; P:intracellular protein transport; ISS:UniProtKB
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0035691; P:macrophage migration inhibitory factor signaling pathway; IEA:Ensembl
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0043518; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; IDA:BHF-UCL
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IMP:BHF-UCL
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0002906; P:negative regulation of mature B cell apoptotic process; IEA:Ensembl
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0002792; P:negative regulation of peptide secretion; IDA:BHF-UCL
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0045581; P:negative regulation of T cell differentiation; IEA:Ensembl
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0045060; P:negative thymic T cell selection; IEA:Ensembl
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0030890; P:positive regulation of B cell proliferation; IMP:BHF-UCL
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:2000343; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; ISS:BHF-UCL
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0001961; P:positive regulation of cytokine-mediated signaling pathway; IMP:BHF-UCL
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0002606; P:positive regulation of dendritic cell antigen processing and presentation; IEA:Ensembl
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0048146; P:positive regulation of fibroblast proliferation; IMP:BHF-UCL
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0060907; P:positive regulation of macrophage cytokine production; ISS:BHF-UCL
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0090023; P:positive regulation of neutrophil chemotaxis; ISS:BHF-UCL
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0045582; P:positive regulation of T cell differentiation; IEA:Ensembl
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0002830; P:positive regulation of type 2 immune response; IEA:Ensembl
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0045059; P:positive thymic T cell selection; IEA:Ensembl
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0001516; P:prostaglandin biosynthetic process; IDA:UniProtKB
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0006461; P:protein complex assembly; ISS:UniProtKB
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0043030; P:regulation of macrophage activation; NAS:UniProtKB
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0007165; P:signal transduction; IDA:UniProtKB
P04233	CD74	HLA class II histocompatibility antigen gamma chain	GO:0045058; P:T cell selection; NAS:UniProtKB
B2RPK0	HMGB1P1	Putative high mobility group protein B1-like 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q93099	HGD	Homogentisate 1,2-dioxygenase	GO:0004411; F:homogentisate 1,2-dioxygenase activity; EXP:Reactome
Q93099	HGD	Homogentisate 1,2-dioxygenase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q93099	HGD	Homogentisate 1,2-dioxygenase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q93099	HGD	Homogentisate 1,2-dioxygenase	GO:0006559; P:L-phenylalanine catabolic process; TAS:Reactome
Q93099	HGD	Homogentisate 1,2-dioxygenase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q93099	HGD	Homogentisate 1,2-dioxygenase	GO:0006572; P:tyrosine catabolic process; TAS:ProtInc
Q04756	HGFAC	Hepatocyte growth factor activator	GO:0004252; F:serine-type endopeptidase activity; TAS:ProtInc
Q04756	HGFAC	Hepatocyte growth factor activator	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
Q04756	HGFAC	Hepatocyte growth factor activator	GO:0006508; P:proteolysis; TAS:ProtInc
P26927	MST1	Hepatocyte growth factor-like protein	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
P14210	HGF	Hepatocyte growth factor	GO:0003824; F:catalytic activity; IEA:InterPro
P14210	HGF	Hepatocyte growth factor	GO:0042056; F:chemoattractant activity; IDA:BHF-UCL
P14210	HGF	Hepatocyte growth factor	GO:0008083; F:growth factor activity; NAS:UniProtKB
P14210	HGF	Hepatocyte growth factor	GO:0042802; F:identical protein binding; IPI:IntAct
P14210	HGF	Hepatocyte growth factor	GO:0005515; F:protein binding; IPI:IntAct
P14210	HGF	Hepatocyte growth factor	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
P14210	HGF	Hepatocyte growth factor	GO:0007596; P:blood coagulation; TAS:Reactome
P14210	HGF	Hepatocyte growth factor	GO:0060326; P:cell chemotaxis; IDA:BHF-UCL
P14210	HGF	Hepatocyte growth factor	GO:0035729; P:cellular response to hepatocyte growth factor stimulus; IDA:BHF-UCL
P14210	HGF	Hepatocyte growth factor	GO:0001837; P:epithelial to mesenchymal transition; TAS:HGNC
P14210	HGF	Hepatocyte growth factor	GO:0048012; P:hepatocyte growth factor receptor signaling pathway; IDA:BHF-UCL
P14210	HGF	Hepatocyte growth factor	GO:0030212; P:hyaluronan metabolic process; IEA:Ensembl
P14210	HGF	Hepatocyte growth factor	GO:0001889; P:liver development; IEA:Ensembl
P14210	HGF	Hepatocyte growth factor	GO:0007067; P:mitosis; NAS:UniProtKB
P14210	HGF	Hepatocyte growth factor	GO:0051450; P:myoblast proliferation; IEA:Ensembl
P14210	HGF	Hepatocyte growth factor	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P14210	HGF	Hepatocyte growth factor	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:BHF-UCL
P14210	HGF	Hepatocyte growth factor	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
P14210	HGF	Hepatocyte growth factor	GO:1901299; P:negative regulation of hydrogen peroxide-mediated programmed cell death; IDA:BHF-UCL
P14210	HGF	Hepatocyte growth factor	GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; IDA:BHF-UCL
P14210	HGF	Hepatocyte growth factor	GO:0031100; P:organ regeneration; IEA:Ensembl
P14210	HGF	Hepatocyte growth factor	GO:0030168; P:platelet activation; TAS:Reactome
P14210	HGF	Hepatocyte growth factor	GO:0002576; P:platelet degranulation; TAS:Reactome
P14210	HGF	Hepatocyte growth factor	GO:0050918; P:positive chemotaxis; IDA:GOC
P14210	HGF	Hepatocyte growth factor	GO:0030335; P:positive regulation of cell migration; IDA:BHF-UCL
P14210	HGF	Hepatocyte growth factor	GO:2000573; P:positive regulation of DNA biosynthetic process; IDA:UniProtKB
P14210	HGF	Hepatocyte growth factor	GO:0045669; P:positive regulation of osteoblast differentiation; NAS:BHF-UCL
P14210	HGF	Hepatocyte growth factor	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL
P14210	HGF	Hepatocyte growth factor	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IDA:BHF-UCL
P14210	HGF	Hepatocyte growth factor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; NAS:BHF-UCL
P14210	HGF	Hepatocyte growth factor	GO:0060665; P:regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling; IDA:MGI
Q68CP4	HGSNAT	Heparan-alpha-glucosaminide N-acetyltransferase	GO:0015019; F:heparan-alpha-glucosaminide N-acetyltransferase activity; IEA:UniProtKB-EC
Q68CP4	HGSNAT	Heparan-alpha-glucosaminide N-acetyltransferase	GO:0016746; F:transferase activity, transferring acyl groups; IDA:UniProtKB
Q68CP4	HGSNAT	Heparan-alpha-glucosaminide N-acetyltransferase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q68CP4	HGSNAT	Heparan-alpha-glucosaminide N-acetyltransferase	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
Q68CP4	HGSNAT	Heparan-alpha-glucosaminide N-acetyltransferase	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q68CP4	HGSNAT	Heparan-alpha-glucosaminide N-acetyltransferase	GO:0007041; P:lysosomal transport; IDA:UniProtKB
Q68CP4	HGSNAT	Heparan-alpha-glucosaminide N-acetyltransferase	GO:0051259; P:protein oligomerization; IDA:UniProtKB
Q68CP4	HGSNAT	Heparan-alpha-glucosaminide N-acetyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O14964	HGS	Hepatocyte growth factor-regulated tyrosine kinase substrate	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14964	HGS	Hepatocyte growth factor-regulated tyrosine kinase substrate	GO:0005515; F:protein binding; IPI:UniProtKB
O14964	HGS	Hepatocyte growth factor-regulated tyrosine kinase substrate	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
O14964	HGS	Hepatocyte growth factor-regulated tyrosine kinase substrate	GO:0016197; P:endosomal transport; NAS:UniProtKB
O14964	HGS	Hepatocyte growth factor-regulated tyrosine kinase substrate	GO:0008333; P:endosome to lysosome transport; IEA:Ensembl
O14964	HGS	Hepatocyte growth factor-regulated tyrosine kinase substrate	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O14964	HGS	Hepatocyte growth factor-regulated tyrosine kinase substrate	GO:0006886; P:intracellular protein transport; IEA:InterPro
O14964	HGS	Hepatocyte growth factor-regulated tyrosine kinase substrate	GO:0061024; P:membrane organization; TAS:Reactome
O14964	HGS	Hepatocyte growth factor-regulated tyrosine kinase substrate	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
O14964	HGS	Hepatocyte growth factor-regulated tyrosine kinase substrate	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
O14964	HGS	Hepatocyte growth factor-regulated tyrosine kinase substrate	GO:0046426; P:negative regulation of JAK-STAT cascade; IDA:HGNC
O14964	HGS	Hepatocyte growth factor-regulated tyrosine kinase substrate	GO:0042176; P:regulation of protein catabolic process; TAS:HGNC
O14964	HGS	Hepatocyte growth factor-regulated tyrosine kinase substrate	GO:0007165; P:signal transduction; TAS:ProtInc
Q9HCP6	HHATL	Protein-cysteine N-palmitoyltransferase HHAT-like protein	GO:0060262; P:negative regulation of N-terminal protein palmitoylation; ISS:UniProtKB
Q5VTY9	HHAT	Protein-cysteine N-palmitoyltransferase HHAT	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q5VTY9	HHAT	Protein-cysteine N-palmitoyltransferase HHAT	GO:0016409; F:palmitoyltransferase activity; IEA:Ensembl
Q5VTY9	HHAT	Protein-cysteine N-palmitoyltransferase HHAT	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q5VTY9	HHAT	Protein-cysteine N-palmitoyltransferase HHAT	GO:0018345; P:protein palmitoylation; IEA:Ensembl
Q5VTY9	HHAT	Protein-cysteine N-palmitoyltransferase HHAT	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0003682; F:chromatin binding; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0008301; F:DNA binding, bending; IDA:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0008190; F:eukaryotic initiation factor 4E binding; IDA:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0005515; F:protein binding; IPI:UniProtKB
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0070491; F:repressing transcription factor binding; IDA:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0043565; F:sequence-specific DNA binding; IDA:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0017025; F:TBP-class protein binding; TAS:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0009952; P:anterior/posterior pattern specification; ISS:UniProtKB
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0030183; P:B cell differentiation; ISS:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0030154; P:cell differentiation; IC:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0008283; P:cell proliferation; IDA:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0061009; P:common bile duct development; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0071103; P:DNA conformation change; IDA:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0035050; P:embryonic heart tube development; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0007492; P:endoderm development; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0048853; P:forebrain morphogenesis; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0061010; P:gall bladder development; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0061011; P:hepatic duct development; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0061017; P:hepatoblast differentiation; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0070365; P:hepatocyte differentiation; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0022027; P:interkinetic nuclear migration; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0006406; P:mRNA export from nucleus; IDA:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0002573; P:myeloid leukocyte differentiation; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0016525; P:negative regulation of angiogenesis; ISS:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0010944; P:negative regulation of transcription by competitive promoter binding; TAS:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0010621; P:negative regulation of transcription by transcription factor localization; IC:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0030948; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; ISS:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0031016; P:pancreas development; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0016973; P:poly(A)+ mRNA export from nucleus; IMP:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0030177; P:positive regulation of Wnt signaling pathway; ISS:UniProtKB
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0060431; P:primary lung bud formation; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0090009; P:primitive streak formation; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0034504; P:protein localization to nucleus; IDA:BHF-UCL
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0043434; P:response to peptide hormone; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0009611; P:response to wounding; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0030878; P:thyroid gland development; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q03014	HHEX	Hematopoietically-expressed homeobox protein HHEX	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q96QV1	HHIP	Hedgehog-interacting protein	GO:0097108; F:hedgehog family protein binding; IPI:BHF-UCL
Q96QV1	HHIP	Hedgehog-interacting protein	GO:0016901; F:oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor; IEA:InterPro
Q96QV1	HHIP	Hedgehog-interacting protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q96QV1	HHIP	Hedgehog-interacting protein	GO:0048038; F:quinone binding; IEA:InterPro
Q96QV1	HHIP	Hedgehog-interacting protein	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q96QV1	HHIP	Hedgehog-interacting protein	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q96QV1	HHIP	Hedgehog-interacting protein	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
Q96QV1	HHIP	Hedgehog-interacting protein	GO:0060441; P:epithelial tube branching involved in lung morphogenesis; IEA:Ensembl
Q96QV1	HHIP	Hedgehog-interacting protein	GO:0009968; P:negative regulation of signal transduction; IDA:UniProtKB
Q96QV1	HHIP	Hedgehog-interacting protein	GO:0045879; P:negative regulation of smoothened signaling pathway; ISS:BHF-UCL
Q96QV1	HHIP	Hedgehog-interacting protein	GO:0007405; P:neuroblast proliferation; IEA:Ensembl
Q96QV1	HHIP	Hedgehog-interacting protein	GO:0040036; P:regulation of fibroblast growth factor receptor signaling pathway; IEA:Ensembl
Q96QV1	HHIP	Hedgehog-interacting protein	GO:0048705; P:skeletal system morphogenesis; ISS:BHF-UCL
Q96QV1	HHIP	Hedgehog-interacting protein	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
Q9XRX5	HHLA3	HERV-H LTR-associating protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q9UM44	HHLA2	HERV-H LTR-associating protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UM44	HHLA2	HERV-H LTR-associating protein 2	GO:0042104; P:positive regulation of activated T cell proliferation; IDA:UniProtKB
Q9UM44	HHLA2	HERV-H LTR-associating protein 2	GO:0001819; P:positive regulation of cytokine production; IDA:UniProtKB
Q9UM44	HHLA2	HERV-H LTR-associating protein 2	GO:0031295; P:T cell costimulation; IDA:UniProtKB
Q5SR56	HIATL1	Hippocampus abundant transcript-like protein 1	GO:0005215; F:transporter activity; IEA:InterPro
Q5SR56	HIATL1	Hippocampus abundant transcript-like protein 1	GO:0055085; P:transmembrane transport; IEA:InterPro
Q96MC6	HIAT1	Hippocampus abundant transcript 1 protein	GO:0005215; F:transporter activity; IEA:InterPro
Q96MC6	HIAT1	Hippocampus abundant transcript 1 protein	GO:0055085; P:transmembrane transport; IEA:InterPro
Q5VZR4	HIATL2	Hippocampus abundant transcript-like protein 2	GO:0005215; F:transporter activity; IEA:InterPro
Q5VZR4	HIATL2	Hippocampus abundant transcript-like protein 2	GO:0055085; P:transmembrane transport; IEA:InterPro
Q6NVY1	HIBCH	3-hydroxyisobutyryl-CoA hydrolase, mitochondrial	GO:0003860; F:3-hydroxyisobutyryl-CoA hydrolase activity; IDA:UniProtKB
Q6NVY1	HIBCH	3-hydroxyisobutyryl-CoA hydrolase, mitochondrial	GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome
Q6NVY1	HIBCH	3-hydroxyisobutyryl-CoA hydrolase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q6NVY1	HIBCH	3-hydroxyisobutyryl-CoA hydrolase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6NVY1	HIBCH	3-hydroxyisobutyryl-CoA hydrolase, mitochondrial	GO:0006574; P:valine catabolic process; IEA:UniProtKB-UniPathway
Q14526	HIC1	Hypermethylated in cancer 1 protein	GO:0042826; F:histone deacetylase binding; IDA:UniProtKB
Q14526	HIC1	Hypermethylated in cancer 1 protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14526	HIC1	Hypermethylated in cancer 1 protein	GO:0005515; F:protein binding; IPI:IntAct
Q14526	HIC1	Hypermethylated in cancer 1 protein	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q14526	HIC1	Hypermethylated in cancer 1 protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q14526	HIC1	Hypermethylated in cancer 1 protein	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IDA:UniProtKB
Q14526	HIC1	Hypermethylated in cancer 1 protein	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q14526	HIC1	Hypermethylated in cancer 1 protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q14526	HIC1	Hypermethylated in cancer 1 protein	GO:0030178; P:negative regulation of Wnt signaling pathway; IDA:UniProtKB
Q14526	HIC1	Hypermethylated in cancer 1 protein	GO:0043517; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; ISS:UniProtKB
Q14526	HIC1	Hypermethylated in cancer 1 protein	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q14526	HIC1	Hypermethylated in cancer 1 protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14526	HIC1	Hypermethylated in cancer 1 protein	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q96JB3	HIC2	Hypermethylated in cancer 2 protein	GO:0003677; F:DNA binding; NAS:UniProtKB
Q96JB3	HIC2	Hypermethylated in cancer 2 protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96JB3	HIC2	Hypermethylated in cancer 2 protein	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q96JB3	HIC2	Hypermethylated in cancer 2 protein	GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB
Q96JB3	HIC2	Hypermethylated in cancer 2 protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IV36	HID1	Protein HID1	GO:0005515; F:protein binding; IPI:IntAct
Q8IV36	HID1	Protein HID1	GO:0006886; P:intracellular protein transport; IDA:UniProtKB
Q8IV36	HID1	Protein HID1	GO:0031001; P:response to brefeldin A; IDA:UniProtKB
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0035035; F:histone acetyltransferase binding; IPI:UniProtKB
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0051879; F:Hsp90 protein binding; IDA:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0035257; F:nuclear hormone receptor binding; IPI:UniProtKB
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0005515; F:protein binding; IPI:UniProtKB
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0001076; F:RNA polymerase II transcription factor binding transcription factor activity; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0004871; F:signal transducer activity; IEA:InterPro
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0000989; F:transcription factor binding transcription factor activity; IDA:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0001525; P:angiogenesis; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0019896; P:axon transport of mitochondrion; IMP:UniProtKB
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0001922; P:B-1 B cell homeostasis; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0003208; P:cardiac ventricle morphogenesis; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0051216; P:cartilage development; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0006879; P:cellular iron ion homeostasis; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0071456; P:cellular response to hypoxia; IDA:UniProtKB
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0071347; P:cellular response to interleukin-1; IEP:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0021987; P:cerebral cortex development; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0032963; P:collagen metabolic process; ISS:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0002248; P:connective tissue replacement involved in inflammatory response wound healing; ISS:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0048546; P:digestive tract morphogenesis; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0071542; P:dopaminergic neuron differentiation; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0051541; P:elastin metabolic process; ISS:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0035162; P:embryonic hemopoiesis; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0001892; P:embryonic placenta development; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0061030; P:epithelial cell differentiation involved in mammary gland alveolus development; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0001837; P:epithelial to mesenchymal transition; ISS:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0042593; P:glucose homeostasis; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0001947; P:heart looping; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0042541; P:hemoglobin biosynthetic process; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0060574; P:intestinal epithelial cell maturation; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0006089; P:lactate metabolic process; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0007595; P:lactation; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0042789; P:mRNA transcription from RNA polymerase II promoter; IC:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0046716; P:muscle cell cellular homeostasis; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0030502; P:negative regulation of bone mineralization; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0045926; P:negative regulation of growth; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:2001054; P:negative regulation of mesenchymal cell apoptotic process; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0070244; P:negative regulation of thymocyte apoptotic process; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0032007; P:negative regulation of TOR signaling; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0001755; P:neural crest cell migration; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0021502; P:neural fold elevation formation; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0003151; P:outflow tract morphogenesis; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0032364; P:oxygen homeostasis; IDA:HGNC
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0045766; P:positive regulation of angiogenesis; IC:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0032722; P:positive regulation of chemokine production; TAS:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0070101; P:positive regulation of chemokine-mediated signaling pathway; IC:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0001938; P:positive regulation of endothelial cell proliferation; IC:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0010634; P:positive regulation of epithelial cell migration; ISS:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0045648; P:positive regulation of erythrocyte differentiation; IC:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0045821; P:positive regulation of glycolytic process; IC:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0046886; P:positive regulation of hormone biosynthetic process; IDA:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0002052; P:positive regulation of neuroblast proliferation; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0051000; P:positive regulation of nitric-oxide synthase activity; TAS:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0010870; P:positive regulation of receptor biosynthetic process; IMP:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0061419; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; IDA:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; IC:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0010575; P:positive regulation vascular endothelial growth factor production; IMP:UniProtKB
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0010468; P:regulation of gene expression; IDA:UniProtKB
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0043619; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; IDA:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0032909; P:regulation of transforming growth factor beta2 production; IMP:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0001666; P:response to hypoxia; IDA:UniProtKB
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0014850; P:response to muscle activity; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0061298; P:retina vasculature development in camera-type eye; IEA:Ensembl
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0007165; P:signal transduction; IMP:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0010573; P:vascular endothelial growth factor production; IDA:BHF-UCL
Q16665	HIF1A	Hypoxia-inducible factor 1-alpha	GO:0008542; P:visual learning; IEA:Ensembl
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0071532; F:ankyrin repeat binding; IPI:UniProtKB
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0031406; F:carboxylic acid binding; IDA:UniProtKB
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0048037; F:cofactor binding; IDA:UniProtKB
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0005506; F:iron ion binding; IDA:UniProtKB
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0051059; F:NF-kappaB binding; IPI:UniProtKB
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0005112; F:Notch binding; IPI:UniProtKB
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0016706; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; EXP:Reactome
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0019826; F:oxygen sensor activity; NAS:UniProtKB
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0036140; F:peptidyl-asparagine 3-dioxygenase activity; IDA:UniProtKB
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0036139; F:peptidyl-histidine dioxygenase activity; IDA:UniProtKB
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0045746; P:negative regulation of Notch signaling pathway; IDA:UniProtKB
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0061428; P:negative regulation of transcription from RNA polymerase II promoter in response to hypoxia; IDA:UniProtKB
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0042265; P:peptidyl-asparagine hydroxylation; IDA:UniProtKB
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0042264; P:peptidyl-aspartic acid hydroxylation; IDA:UniProtKB
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0036138; P:peptidyl-histidine hydroxylation; IDA:UniProtKB
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0045663; P:positive regulation of myoblast differentiation; IDA:UniProtKB
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:2001214; P:positive regulation of vasculogenesis; NAS:UniProtKB
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
Q9NWT6	HIF1AN	Hypoxia-inducible factor 1-alpha inhibitor	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2N7	HIF3A	Hypoxia-inducible factor 3-alpha	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y2N7	HIF3A	Hypoxia-inducible factor 3-alpha	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q9Y2N7	HIF3A	Hypoxia-inducible factor 3-alpha	GO:0004871; F:signal transducer activity; IEA:InterPro
Q9Y2N7	HIF3A	Hypoxia-inducible factor 3-alpha	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q9Y2N7	HIF3A	Hypoxia-inducible factor 3-alpha	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q9Y2N7	HIF3A	Hypoxia-inducible factor 3-alpha	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
Q9Y2N7	HIF3A	Hypoxia-inducible factor 3-alpha	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9Y2N7	HIF3A	Hypoxia-inducible factor 3-alpha	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
Q9Y2N7	HIF3A	Hypoxia-inducible factor 3-alpha	GO:0006366; P:transcription from RNA polymerase II promoter; IEA:Ensembl
Q9Y241	HIGD1A	HIG1 domain family member 1A, mitochondrial	GO:0043066; P:negative regulation of apoptotic process; IDA:MGI
Q9Y241	HIGD1A	HIG1 domain family member 1A, mitochondrial	GO:0055114; P:oxidation-reduction process; IEA:UniProtKB-KW
Q9Y241	HIGD1A	HIG1 domain family member 1A, mitochondrial	GO:0006950; P:response to stress; IEA:UniProtKB-KW
Q9BW72	HIGD2A	HIG1 domain family member 2A, mitochondrial	GO:0043066; P:negative regulation of apoptotic process; IDA:MGI
Q9BW72	HIGD2A	HIG1 domain family member 2A, mitochondrial	GO:0055114; P:oxidation-reduction process; IEA:UniProtKB-KW
Q53FT3	C11orf73	Protein Hikeshi	GO:0030544; F:Hsp70 protein binding; IDA:UniProtKB
Q53FT3	C11orf73	Protein Hikeshi	GO:0008565; F:protein transporter activity; IDA:UniProtKB
Q53FT3	C11orf73	Protein Hikeshi	GO:0034605; P:cellular response to heat; IDA:UniProtKB
Q53FT3	C11orf73	Protein Hikeshi	GO:0007030; P:Golgi organization; IEA:Ensembl
Q53FT3	C11orf73	Protein Hikeshi	GO:0030324; P:lung development; IEA:Ensembl
Q53FT3	C11orf73	Protein Hikeshi	GO:0006606; P:protein import into nucleus; IDA:UniProtKB
Q53FT3	C11orf73	Protein Hikeshi	GO:0015031; P:protein transport; IDA:UniProtKB
P60008	HILS1	Spermatid-specific linker histone H1-like protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P60008	HILS1	Spermatid-specific linker histone H1-like protein	GO:0042393; F:histone binding; IDA:UniProtKB
P60008	HILS1	Spermatid-specific linker histone H1-like protein	GO:0003676; F:nucleic acid binding; IDA:UniProtKB
P60008	HILS1	Spermatid-specific linker histone H1-like protein	GO:0006338; P:chromatin remodeling; NAS:UniProtKB
P60008	HILS1	Spermatid-specific linker histone H1-like protein	GO:0006342; P:chromatin silencing; IDA:UniProtKB
P60008	HILS1	Spermatid-specific linker histone H1-like protein	GO:0030261; P:chromosome condensation; IDA:UniProtKB
P60008	HILS1	Spermatid-specific linker histone H1-like protein	GO:0007281; P:germ cell development; IDA:UniProtKB
P60008	HILS1	Spermatid-specific linker histone H1-like protein	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P60008	HILS1	Spermatid-specific linker histone H1-like protein	GO:0006334; P:nucleosome assembly; IEA:InterPro
P60008	HILS1	Spermatid-specific linker histone H1-like protein	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P60008	HILS1	Spermatid-specific linker histone H1-like protein	GO:0007283; P:spermatogenesis; IDA:UniProtKB
P60008	HILS1	Spermatid-specific linker histone H1-like protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0003677; F:DNA binding; IDA:UniProtKB
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0042393; F:histone binding; IPI:UniProtKB
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IMP:UniProtKB
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0000077; P:DNA damage checkpoint; IMP:UniProtKB
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0006281; P:DNA repair; IMP:UniProtKB
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0045184; P:establishment of protein localization; IMP:UniProtKB
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:UniProtKB
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0001701; P:in utero embryonic development; ISS:UniProtKB
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0045445; P:myoblast differentiation; IMP:UniProtKB
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0010468; P:regulation of gene expression; IMP:UniProtKB
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; IMP:UniProtKB
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB
Q9BQA5	HINFP	Histone H4 transcription factor	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P49773	HINT1	Histidine triad nucleotide-binding protein 1	GO:0016787; F:hydrolase activity; IDA:UniProtKB
P49773	HINT1	Histidine triad nucleotide-binding protein 1	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
P49773	HINT1	Histidine triad nucleotide-binding protein 1	GO:0005080; F:protein kinase C binding; TAS:ProtInc
P49773	HINT1	Histidine triad nucleotide-binding protein 1	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IMP:UniProtKB
P49773	HINT1	Histidine triad nucleotide-binding protein 1	GO:0009154; P:purine ribonucleotide catabolic process; IDA:UniProtKB
P49773	HINT1	Histidine triad nucleotide-binding protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB
P49773	HINT1	Histidine triad nucleotide-binding protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
P49773	HINT1	Histidine triad nucleotide-binding protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BX68	HINT2	Histidine triad nucleotide-binding protein 2, mitochondrial	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q9BX68	HINT2	Histidine triad nucleotide-binding protein 2, mitochondrial	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
Q9BX68	HINT2	Histidine triad nucleotide-binding protein 2, mitochondrial	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9BX68	HINT2	Histidine triad nucleotide-binding protein 2, mitochondrial	GO:0006694; P:steroid biosynthetic process; IEA:UniProtKB-KW
Q9NQE9	HINT3	Histidine triad nucleotide-binding protein 3	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q9NQE9	HINT3	Histidine triad nucleotide-binding protein 3	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
O75146	HIP1R	Huntingtin-interacting protein 1-related protein	GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB
O75146	HIP1R	Huntingtin-interacting protein 1-related protein	GO:0005515; F:protein binding; IPI:UniProtKB
O75146	HIP1R	Huntingtin-interacting protein 1-related protein	GO:0006898; P:receptor-mediated endocytosis; IMP:UniProtKB
O00291	HIP1	Huntingtin-interacting protein 1	GO:0030276; F:clathrin binding; IDA:MGI
O00291	HIP1	Huntingtin-interacting protein 1	GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB
O00291	HIP1	Huntingtin-interacting protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
O00291	HIP1	Huntingtin-interacting protein 1	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
O00291	HIP1	Huntingtin-interacting protein 1	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:MGI
O00291	HIP1	Huntingtin-interacting protein 1	GO:0006915; P:apoptotic process; IDA:MGI
O00291	HIP1	Huntingtin-interacting protein 1	GO:0097190; P:apoptotic signaling pathway; IDA:UniProtKB
O00291	HIP1	Huntingtin-interacting protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O00291	HIP1	Huntingtin-interacting protein 1	GO:0048268; P:clathrin coat assembly; IDA:UniProtKB
O00291	HIP1	Huntingtin-interacting protein 1	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
O00291	HIP1	Huntingtin-interacting protein 1	GO:0048260; P:positive regulation of receptor-mediated endocytosis; IMP:UniProtKB
O00291	HIP1	Huntingtin-interacting protein 1	GO:0042981; P:regulation of apoptotic process; IDA:MGI
O00291	HIP1	Huntingtin-interacting protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O00291	HIP1	Huntingtin-interacting protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0005515; F:protein binding; IPI:IntAct
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0060216; P:definitive hemopoiesis; ISS:UniProtKB
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0048596; P:embryonic camera-type eye morphogenesis; IEA:Ensembl
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0060059; P:embryonic retina morphogenesis in camera-type eye; IEA:Ensembl
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0072577; P:endothelial cell apoptotic process; IDA:UniProtKB
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:UniProtKB
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0001654; P:eye development; ISS:UniProtKB
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IEA:Ensembl
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0061072; P:iris morphogenesis; IEA:Ensembl
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0060235; P:lens induction in camera-type eye; IEA:Ensembl
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0030182; P:neuron differentiation; IEA:Ensembl
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0045766; P:positive regulation of angiogenesis; ISS:UniProtKB
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0016926; P:protein desumoylation; IDA:UniProtKB
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0010803; P:regulation of tumor necrosis factor-mediated signaling pathway; IDA:UniProtKB
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0010842; P:retina layer formation; IEA:Ensembl
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
Q86Z02	HIPK1	Homeodomain-interacting protein kinase 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0004674; F:protein serine/threonine kinase activity; ISS:BHF-UCL
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0001102; F:RNA polymerase II activating transcription factor binding; ISS:BHF-UCL
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0001105; F:RNA polymerase II transcription coactivator activity; IEA:Ensembl
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0046332; F:SMAD binding; IPI:UniProtKB
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0046790; F:virion binding; IPI:UniProtKB
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0007628; P:adult walking behavior; IEA:Ensembl
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0071456; P:cellular response to hypoxia; TAS:UniProtKB
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IDA:BHF-UCL
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0048596; P:embryonic camera-type eye morphogenesis; IEA:Ensembl
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0060059; P:embryonic retina morphogenesis in camera-type eye; IEA:Ensembl
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0030218; P:erythrocyte differentiation; ISS:UniProtKB
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0001654; P:eye development; ISS:UniProtKB
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0097193; P:intrinsic apoptotic signaling pathway; NAS:UniProtKB
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; TAS:UniProtKB
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0061072; P:iris morphogenesis; IEA:Ensembl
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0060235; P:lens induction in camera-type eye; IEA:Ensembl
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0019048; P:modulation by virus of host morphology or physiology; NAS:UniProtKB
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0030514; P:negative regulation of BMP signaling pathway; IMP:UniProtKB
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0030182; P:neuron differentiation; IEA:Ensembl
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0018105; P:peptidyl-serine phosphorylation; ISS:BHF-UCL
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0018107; P:peptidyl-threonine phosphorylation; ISS:BHF-UCL
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0030578; P:PML body organization; TAS:UniProtKB
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0043388; P:positive regulation of DNA binding; IEA:Ensembl
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0046330; P:positive regulation of JNK cascade; IMP:UniProtKB
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0032092; P:positive regulation of protein binding; ISS:BHF-UCL
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:BHF-UCL
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IMP:UniProtKB
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0051726; P:regulation of cell cycle; TAS:UniProtKB
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0010842; P:retina layer formation; IEA:Ensembl
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0060395; P:SMAD protein signal transduction; IDA:UniProtKB
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl
Q9H2X6	HIPK2	Homeodomain-interacting protein kinase 2	GO:0050882; P:voluntary musculoskeletal movement; IEA:Ensembl
Q9H422	HIPK3	Homeodomain-interacting protein kinase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H422	HIPK3	Homeodomain-interacting protein kinase 3	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q9H422	HIPK3	Homeodomain-interacting protein kinase 3	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB
Q9H422	HIPK3	Homeodomain-interacting protein kinase 3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9H422	HIPK3	Homeodomain-interacting protein kinase 3	GO:0009299; P:mRNA transcription; IDA:UniProtKB
Q9H422	HIPK3	Homeodomain-interacting protein kinase 3	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q9H422	HIPK3	Homeodomain-interacting protein kinase 3	GO:0043508; P:negative regulation of JUN kinase activity; ISS:UniProtKB
Q9H422	HIPK3	Homeodomain-interacting protein kinase 3	GO:0018105; P:peptidyl-serine phosphorylation; ISS:UniProtKB
Q9H422	HIPK3	Homeodomain-interacting protein kinase 3	GO:0018107; P:peptidyl-threonine phosphorylation; ISS:UniProtKB
Q9H422	HIPK3	Homeodomain-interacting protein kinase 3	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9H422	HIPK3	Homeodomain-interacting protein kinase 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NE63	HIPK4	Homeodomain-interacting protein kinase 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NE63	HIPK4	Homeodomain-interacting protein kinase 4	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q96JK4	HHIPL1	HHIP-like protein 1	GO:0016901; F:oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor; IEA:InterPro
Q96JK4	HHIPL1	HHIP-like protein 1	GO:0048038; F:quinone binding; IEA:InterPro
Q96JK4	HHIPL1	HHIP-like protein 1	GO:0005044; F:scavenger receptor activity; IEA:InterPro
Q96JK4	HHIPL1	HHIP-like protein 1	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q6UWX4	HHIPL2	HHIP-like protein 2	GO:0016901; F:oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor; IEA:InterPro
Q6UWX4	HHIPL2	HHIP-like protein 2	GO:0048038; F:quinone binding; IEA:InterPro
Q6UWX4	HHIPL2	HHIP-like protein 2	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
P54198	HIRA	Protein HIRA	GO:0003682; F:chromatin binding; IEA:InterPro
P54198	HIRA	Protein HIRA	GO:0005515; F:protein binding; IPI:UniProtKB
P54198	HIRA	Protein HIRA	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P54198	HIRA	Protein HIRA	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
P54198	HIRA	Protein HIRA	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P54198	HIRA	Protein HIRA	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
P54198	HIRA	Protein HIRA	GO:0006336; P:DNA replication-independent nucleosome assembly; IDA:UniProt
P54198	HIRA	Protein HIRA	GO:0007369; P:gastrulation; IEA:Ensembl
P54198	HIRA	Protein HIRA	GO:0042692; P:muscle cell differentiation; IEA:Ensembl
P54198	HIRA	Protein HIRA	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
P54198	HIRA	Protein HIRA	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P54198	HIRA	Protein HIRA	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BW71	HIRIP3	HIRA-interacting protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BW71	HIRIP3	HIRA-interacting protein 3	GO:0006333; P:chromatin assembly or disassembly; TAS:ProtInc
P15515	HTN1	Histatin-1	GO:0005515; F:protein binding; IPI:IntAct
P15515	HTN1	Histatin-1	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
P15515	HTN1	Histatin-1	GO:0042742; P:defense response to bacterium; NAS:UniProtKB
P15515	HTN1	Histatin-1	GO:0050832; P:defense response to fungus; IEA:UniProtKB-KW
P15515	HTN1	Histatin-1	GO:0031640; P:killing of cells of other organism; IEA:UniProtKB-KW
P15516	HTN3	Histatin-3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P15516	HTN3	Histatin-3	GO:0005515; F:protein binding; IPI:IntAct
P15516	HTN3	Histatin-3	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
P15516	HTN3	Histatin-3	GO:0042742; P:defense response to bacterium; NAS:UniProtKB
P15516	HTN3	Histatin-3	GO:0050832; P:defense response to fungus; IEA:UniProtKB-KW
P15516	HTN3	Histatin-3	GO:0031640; P:killing of cells of other organism; IEA:UniProtKB-KW
Q8NCD3	HJURP	Holliday junction recognition protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NCD3	HJURP	Holliday junction recognition protein	GO:0042393; F:histone binding; IDA:UniProtKB
Q8NCD3	HJURP	Holliday junction recognition protein	GO:0042802; F:identical protein binding; IPI:IntAct
Q8NCD3	HJURP	Holliday junction recognition protein	GO:0005515; F:protein binding; IPI:IntAct
Q8NCD3	HJURP	Holliday junction recognition protein	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8NCD3	HJURP	Holliday junction recognition protein	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; IMP:UniProtKB
Q8NCD3	HJURP	Holliday junction recognition protein	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q8NCD3	HJURP	Holliday junction recognition protein	GO:0006334; P:nucleosome assembly; TAS:Reactome
Q8NCD3	HJURP	Holliday junction recognition protein	GO:0051101; P:regulation of DNA binding; IDA:UniProtKB
Q8NCD3	HJURP	Holliday junction recognition protein	GO:0043254; P:regulation of protein complex assembly; IDA:UniProtKB
Q2TB90	HKDC1	Putative hexokinase HKDC1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q2TB90	HKDC1	Putative hexokinase HKDC1	GO:0008865; F:fructokinase activity; IBA:RefGenome
Q2TB90	HKDC1	Putative hexokinase HKDC1	GO:0004340; F:glucokinase activity; IBA:RefGenome
Q2TB90	HKDC1	Putative hexokinase HKDC1	GO:0019158; F:mannokinase activity; IBA:RefGenome
Q2TB90	HKDC1	Putative hexokinase HKDC1	GO:0046835; P:carbohydrate phosphorylation; IBA:GOC
Q2TB90	HKDC1	Putative hexokinase HKDC1	GO:0001678; P:cellular glucose homeostasis; IBA:RefGenome
Q2TB90	HKDC1	Putative hexokinase HKDC1	GO:0051156; P:glucose 6-phosphate metabolic process; IBA:GOC
Q2TB90	HKDC1	Putative hexokinase HKDC1	GO:0006096; P:glycolytic process; IBA:RefGenome
Q2TB90	HKDC1	Putative hexokinase HKDC1	GO:0019318; P:hexose metabolic process; IEA:UniProtKB-UniPathway
P10072	HKR1	Krueppel-related zinc finger protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P10072	HKR1	Krueppel-related zinc finger protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P10072	HKR1	Krueppel-related zinc finger protein 1	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
P10072	HKR1	Krueppel-related zinc finger protein 1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P10072	HKR1	Krueppel-related zinc finger protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P13747	HLA-E	HLA class I histocompatibility antigen, alpha chain E	GO:0042288; F:MHC class I protein binding; IDA:UniProt
P13747	HLA-E	HLA class I histocompatibility antigen, alpha chain E	GO:0042605; F:peptide antigen binding; IDA:UniProt
P13747	HLA-E	HLA class I histocompatibility antigen, alpha chain E	GO:0005102; F:receptor binding; IBA:RefGenome
P13747	HLA-E	HLA class I histocompatibility antigen, alpha chain E	GO:0002476; P:antigen processing and presentation of endogenous peptide antigen via MHC class Ib; IDA:UniProt
P13747	HLA-E	HLA class I histocompatibility antigen, alpha chain E	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P13747	HLA-E	HLA class I histocompatibility antigen, alpha chain E	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P13747	HLA-E	HLA class I histocompatibility antigen, alpha chain E	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P13747	HLA-E	HLA class I histocompatibility antigen, alpha chain E	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P13747	HLA-E	HLA class I histocompatibility antigen, alpha chain E	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P13747	HLA-E	HLA class I histocompatibility antigen, alpha chain E	GO:0045087; P:innate immune response; TAS:Reactome
P13747	HLA-E	HLA class I histocompatibility antigen, alpha chain E	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P13747	HLA-E	HLA class I histocompatibility antigen, alpha chain E	GO:0002717; P:positive regulation of natural killer cell mediated immunity; IDA:UniProt
P13747	HLA-E	HLA class I histocompatibility antigen, alpha chain E	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P13747	HLA-E	HLA class I histocompatibility antigen, alpha chain E	GO:0042270; P:protection from natural killer cell mediated cytotoxicity; IDA:UniProt
P13747	HLA-E	HLA class I histocompatibility antigen, alpha chain E	GO:0050776; P:regulation of immune response; TAS:Reactome
P13747	HLA-E	HLA class I histocompatibility antigen, alpha chain E	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P30511	HLA-F	HLA class I histocompatibility antigen, alpha chain F	GO:0042605; F:peptide antigen binding; IBA:RefGenome
P30511	HLA-F	HLA class I histocompatibility antigen, alpha chain F	GO:0005102; F:receptor binding; IBA:RefGenome
P30511	HLA-F	HLA class I histocompatibility antigen, alpha chain F	GO:0046978; F:TAP1 binding; IPI:UniProt
P30511	HLA-F	HLA class I histocompatibility antigen, alpha chain F	GO:0046979; F:TAP2 binding; IPI:UniProt
P30511	HLA-F	HLA class I histocompatibility antigen, alpha chain F	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30511	HLA-F	HLA class I histocompatibility antigen, alpha chain F	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30511	HLA-F	HLA class I histocompatibility antigen, alpha chain F	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P30511	HLA-F	HLA class I histocompatibility antigen, alpha chain F	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30511	HLA-F	HLA class I histocompatibility antigen, alpha chain F	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P30511	HLA-F	HLA class I histocompatibility antigen, alpha chain F	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P30511	HLA-F	HLA class I histocompatibility antigen, alpha chain F	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P30511	HLA-F	HLA class I histocompatibility antigen, alpha chain F	GO:0050776; P:regulation of immune response; TAS:Reactome
P30511	HLA-F	HLA class I histocompatibility antigen, alpha chain F	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P17693	HLA-G	HLA class I histocompatibility antigen, alpha chain G	GO:0042605; F:peptide antigen binding; IBA:RefGenome
P17693	HLA-G	HLA class I histocompatibility antigen, alpha chain G	GO:0042803; F:protein homodimerization activity; NAS:BHF-UCL
P17693	HLA-G	HLA class I histocompatibility antigen, alpha chain G	GO:0005102; F:receptor binding; IPI:BHF-UCL
P17693	HLA-G	HLA class I histocompatibility antigen, alpha chain G	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P17693	HLA-G	HLA class I histocompatibility antigen, alpha chain G	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P17693	HLA-G	HLA class I histocompatibility antigen, alpha chain G	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
P17693	HLA-G	HLA class I histocompatibility antigen, alpha chain G	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P17693	HLA-G	HLA class I histocompatibility antigen, alpha chain G	GO:0006968; P:cellular defense response; TAS:ProtInc
P17693	HLA-G	HLA class I histocompatibility antigen, alpha chain G	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P17693	HLA-G	HLA class I histocompatibility antigen, alpha chain G	GO:0002767; P:immune response-inhibiting cell surface receptor signaling pathway; IDA:BHF-UCL
P17693	HLA-G	HLA class I histocompatibility antigen, alpha chain G	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P17693	HLA-G	HLA class I histocompatibility antigen, alpha chain G	GO:2001199; P:negative regulation of dendritic cell differentiation; IDA:BHF-UCL
P17693	HLA-G	HLA class I histocompatibility antigen, alpha chain G	GO:0042130; P:negative regulation of T cell proliferation; IDA:BHF-UCL
P17693	HLA-G	HLA class I histocompatibility antigen, alpha chain G	GO:0032735; P:positive regulation of interleukin-12 production; IDA:BHF-UCL
P17693	HLA-G	HLA class I histocompatibility antigen, alpha chain G	GO:0045591; P:positive regulation of regulatory T cell differentiation; IMP:BHF-UCL
P17693	HLA-G	HLA class I histocompatibility antigen, alpha chain G	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P17693	HLA-G	HLA class I histocompatibility antigen, alpha chain G	GO:0002666; P:positive regulation of T cell tolerance induction; IMP:BHF-UCL
P17693	HLA-G	HLA class I histocompatibility antigen, alpha chain G	GO:0050776; P:regulation of immune response; TAS:Reactome
P17693	HLA-G	HLA class I histocompatibility antigen, alpha chain G	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P01893	HLA-H	Putative HLA class I histocompatibility antigen, alpha chain H	GO:0042605; F:peptide antigen binding; IEA:InterPro
P01893	HLA-H	Putative HLA class I histocompatibility antigen, alpha chain H	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW
P01893	HLA-H	Putative HLA class I histocompatibility antigen, alpha chain H	GO:0006955; P:immune response; NAS:UniProtKB
P01893	HLA-H	Putative HLA class I histocompatibility antigen, alpha chain H	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
Q16534	HLF	Hepatic leukemia factor	GO:0003677; F:DNA binding; TAS:ProtInc
Q16534	HLF	Hepatic leukemia factor	GO:0003690; F:double-stranded DNA binding; TAS:ProtInc
Q16534	HLF	Hepatic leukemia factor	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q16534	HLF	Hepatic leukemia factor	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q16534	HLF	Hepatic leukemia factor	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q16534	HLF	Hepatic leukemia factor	GO:0048511; P:rhythmic process; IEA:UniProtKB-KW
Q16534	HLF	Hepatic leukemia factor	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q16534	HLF	Hepatic leukemia factor	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9Y5L2	HILPDA	Hypoxia-inducible lipid droplet-associated protein	GO:0005515; F:protein binding; IPI:IntAct
Q9Y5L2	HILPDA	Hypoxia-inducible lipid droplet-associated protein	GO:0005102; F:receptor binding; IPI:BHF-UCL
Q9Y5L2	HILPDA	Hypoxia-inducible lipid droplet-associated protein	GO:0035425; P:autocrine signaling; IDA:BHF-UCL
Q9Y5L2	HILPDA	Hypoxia-inducible lipid droplet-associated protein	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
Q9Y5L2	HILPDA	Hypoxia-inducible lipid droplet-associated protein	GO:0001819; P:positive regulation of cytokine production; IDA:UniProtKB
Q9Y5L2	HILPDA	Hypoxia-inducible lipid droplet-associated protein	GO:0010884; P:positive regulation of lipid storage; IDA:UniProtKB
Q9Y5L2	HILPDA	Hypoxia-inducible lipid droplet-associated protein	GO:0006950; P:response to stress; NAS:UniProtKB
Q14527	HLTF	Helicase-like transcription factor	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q14527	HLTF	Helicase-like transcription factor	GO:0016887; F:ATPase activity; IEA:Ensembl
Q14527	HLTF	Helicase-like transcription factor	GO:0003677; F:DNA binding; TAS:ProtInc
Q14527	HLTF	Helicase-like transcription factor	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q14527	HLTF	Helicase-like transcription factor	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q14527	HLTF	Helicase-like transcription factor	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14527	HLTF	Helicase-like transcription factor	GO:0005515; F:protein binding; IPI:UniProtKB
Q14527	HLTF	Helicase-like transcription factor	GO:0008270; F:zinc ion binding; IEA:InterPro
Q14527	HLTF	Helicase-like transcription factor	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q14527	HLTF	Helicase-like transcription factor	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q14527	HLTF	Helicase-like transcription factor	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q14527	HLTF	Helicase-like transcription factor	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
Q14527	HLTF	Helicase-like transcription factor	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14774	HLX	H2.0-like homeobox protein	GO:0005515; F:protein binding; IPI:IntAct
Q14774	HLX	H2.0-like homeobox protein	GO:0043565; F:sequence-specific DNA binding; IDA:MGI
Q14774	HLX	H2.0-like homeobox protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q14774	HLX	H2.0-like homeobox protein	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
Q14774	HLX	H2.0-like homeobox protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q14774	HLX	H2.0-like homeobox protein	GO:0048557; P:embryonic digestive tract morphogenesis; IEA:Ensembl
Q14774	HLX	H2.0-like homeobox protein	GO:0048484; P:enteric nervous system development; IEA:Ensembl
Q14774	HLX	H2.0-like homeobox protein	GO:0001889; P:liver development; IEA:Ensembl
Q14774	HLX	H2.0-like homeobox protein	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q14774	HLX	H2.0-like homeobox protein	GO:0045629; P:negative regulation of T-helper 2 cell differentiation; IEA:Ensembl
Q14774	HLX	H2.0-like homeobox protein	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q14774	HLX	H2.0-like homeobox protein	GO:0046622; P:positive regulation of organ growth; IEA:Ensembl
Q14774	HLX	H2.0-like homeobox protein	GO:0045627; P:positive regulation of T-helper 1 cell differentiation; IEA:Ensembl
Q14774	HLX	H2.0-like homeobox protein	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
Q14774	HLX	H2.0-like homeobox protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TCT9	HM13	Minor histocompatibility antigen H13	GO:0042500; F:aspartic endopeptidase activity, intramembrane cleaving; IMP:UniProtKB
Q8TCT9	HM13	Minor histocompatibility antigen H13	GO:0008233; F:peptidase activity; IDA:UniProtKB
Q8TCT9	HM13	Minor histocompatibility antigen H13	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TCT9	HM13	Minor histocompatibility antigen H13	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q8TCT9	HM13	Minor histocompatibility antigen H13	GO:0033619; P:membrane protein proteolysis; IDA:UniProtKB
Q9NP66	HMG20A	High mobility group protein 20A	GO:0003677; F:DNA binding; NAS:UniProtKB
Q9NP66	HMG20A	High mobility group protein 20A	GO:0005515; F:protein binding; IPI:IntAct
Q9NP66	HMG20A	High mobility group protein 20A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9NP66	HMG20A	High mobility group protein 20A	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q9NP66	HMG20A	High mobility group protein 20A	GO:0006325; P:chromatin organization; NAS:UniProtKB
Q9NP66	HMG20A	High mobility group protein 20A	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
Q9NP66	HMG20A	High mobility group protein 20A	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9NP66	HMG20A	High mobility group protein 20A	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9NP66	HMG20A	High mobility group protein 20A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9P0W2	HMG20B	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9P0W2	HMG20B	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related	GO:0005515; F:protein binding; IPI:IntAct
Q9P0W2	HMG20B	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related	GO:0007596; P:blood coagulation; TAS:Reactome
Q9P0W2	HMG20B	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9P0W2	HMG20B	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q9P0W2	HMG20B	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related	GO:0033234; P:negative regulation of protein sumoylation; IEA:Ensembl
Q9P0W2	HMG20B	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
Q9P0W2	HMG20B	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9P0W2	HMG20B	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q9P0W2	HMG20B	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6NT76	HMBOX1	Homeobox-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q6NT76	HMBOX1	Homeobox-containing protein 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q6NT76	HMBOX1	Homeobox-containing protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q6NT76	HMBOX1	Homeobox-containing protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q6NT76	HMBOX1	Homeobox-containing protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:InterPro
Q6NT76	HMBOX1	Homeobox-containing protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96FZ2	HMCES	Embryonic stem cell-specific 5-hydroxymethylcytosine-binding protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96FZ2	HMCES	Embryonic stem cell-specific 5-hydroxymethylcytosine-binding protein	GO:0008233; F:peptidase activity; IEA:UniProtKB-KW
Q96RW7	HMCN1	Hemicentin-1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96RW7	HMCN1	Hemicentin-1	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q96RW7	HMCN1	Hemicentin-1	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q8NDA2	HMCN2	Hemicentin-2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8NDA2	HMCN2	Hemicentin-2	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0008144; F:drug binding; IEA:Ensembl
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0004421; F:hydroxymethylglutaryl-CoA synthase activity; TAS:ProtInc
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0016853; F:isomerase activity; IEA:Ensembl
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0043177; F:organic acid binding; IEA:Ensembl
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0007420; P:brain development; IEA:Ensembl
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0071397; P:cellular response to cholesterol; IEA:Ensembl
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; IEA:Ensembl
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0008299; P:isoprenoid biosynthetic process; IEA:InterPro
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0006629; P:lipid metabolic process; NAS:ProtInc
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0001889; P:liver development; IEA:Ensembl
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0008584; P:male gonad development; IEA:Ensembl
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0001101; P:response to acid; IEA:Ensembl
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0042493; P:response to drug; IEA:Ensembl
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0055094; P:response to lipoprotein particle; IEA:Ensembl
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0009645; P:response to low light intensity stimulus; IEA:Ensembl
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0014074; P:response to purine-containing compound; IEA:Ensembl
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0046690; P:response to tellurium ion; IEA:Ensembl
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0033197; P:response to vitamin E; IEA:Ensembl
Q01581	HMGCS1	Hydroxymethylglutaryl-CoA synthase, cytoplasmic	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P54868	HMGCS2	Hydroxymethylglutaryl-CoA synthase, mitochondrial	GO:0004421; F:hydroxymethylglutaryl-CoA synthase activity; IEA:UniProtKB-EC
P54868	HMGCS2	Hydroxymethylglutaryl-CoA synthase, mitochondrial	GO:0046950; P:cellular ketone body metabolic process; TAS:Reactome
P54868	HMGCS2	Hydroxymethylglutaryl-CoA synthase, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P54868	HMGCS2	Hydroxymethylglutaryl-CoA synthase, mitochondrial	GO:0006695; P:cholesterol biosynthetic process; IEA:UniProtKB-KW
P54868	HMGCS2	Hydroxymethylglutaryl-CoA synthase, mitochondrial	GO:0008299; P:isoprenoid biosynthetic process; IEA:InterPro
P54868	HMGCS2	Hydroxymethylglutaryl-CoA synthase, mitochondrial	GO:0046951; P:ketone body biosynthetic process; TAS:Reactome
P54868	HMGCS2	Hydroxymethylglutaryl-CoA synthase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0050662; F:coenzyme binding; IDA:UniProtKB
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0004420; F:hydroxymethylglutaryl-CoA reductase (NADPH) activity; IEA:UniProtKB-EC
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0042282; F:hydroxymethylglutaryl-CoA reductase activity; IDA:UniProtKB
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0070402; F:NADPH binding; IDA:UniProtKB
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0005515; F:protein binding; IPI:IntAct
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0007568; P:aging; IEA:Ensembl
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0015936; P:coenzyme A metabolic process; IEA:InterPro
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0009790; P:embryo development; IEA:Ensembl
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0008299; P:isoprenoid biosynthetic process; IEA:Ensembl
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0045445; P:myoblast differentiation; IEA:Ensembl
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0061179; P:negative regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0043407; P:negative regulation of MAP kinase activity; IEA:Ensembl
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0010664; P:negative regulation of striated muscle cell apoptotic process; IEA:Ensembl
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0045908; P:negative regulation of vasodilation; IEA:Ensembl
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0061045; P:negative regulation of wound healing; IEA:Ensembl
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0010666; P:positive regulation of cardiac muscle cell apoptotic process; IEA:Ensembl
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0048643; P:positive regulation of skeletal muscle tissue development; IEA:Ensembl
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0032874; P:positive regulation of stress-activated MAPK cascade; IEA:Ensembl
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0051262; P:protein tetramerization; IDA:UniProtKB
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0045471; P:response to ethanol; IEA:Ensembl
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0007584; P:response to nutrient; IEA:Ensembl
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0006743; P:ubiquinone metabolic process; IEA:Ensembl
P04035	HMGCR	3-hydroxy-3-methylglutaryl-coenzyme A reductase	GO:0008542; P:visual learning; IEA:Ensembl
Q05925	EN1	Homeobox protein engrailed-1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q05925	EN1	Homeobox protein engrailed-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q05925	EN1	Homeobox protein engrailed-1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q05925	EN1	Homeobox protein engrailed-1	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
Q05925	EN1	Homeobox protein engrailed-1	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
Q05925	EN1	Homeobox protein engrailed-1	GO:0030902; P:hindbrain development; IEA:Ensembl
Q05925	EN1	Homeobox protein engrailed-1	GO:0030901; P:midbrain development; IEA:Ensembl
Q05925	EN1	Homeobox protein engrailed-1	GO:0030917; P:midbrain-hindbrain boundary development; IEA:Ensembl
Q05925	EN1	Homeobox protein engrailed-1	GO:0048666; P:neuron development; IEA:Ensembl
Q05925	EN1	Homeobox protein engrailed-1	GO:0043473; P:pigmentation; IEA:Ensembl
Q05925	EN1	Homeobox protein engrailed-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q05925	EN1	Homeobox protein engrailed-1	GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl
Q05925	EN1	Homeobox protein engrailed-1	GO:0042220; P:response to cocaine; IEA:Ensembl
Q05925	EN1	Homeobox protein engrailed-1	GO:0001501; P:skeletal system development; TAS:ProtInc
P19622	EN2	Homeobox protein engrailed-2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P19622	EN2	Homeobox protein engrailed-2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P19622	EN2	Homeobox protein engrailed-2	GO:0030902; P:hindbrain development; IEA:Ensembl
P19622	EN2	Homeobox protein engrailed-2	GO:0030901; P:midbrain development; IEA:Ensembl
P19622	EN2	Homeobox protein engrailed-2	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P19622	EN2	Homeobox protein engrailed-2	GO:0048666; P:neuron development; IEA:Ensembl
P19622	EN2	Homeobox protein engrailed-2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0051575; F:5'-deoxyribose-5-phosphate lyase activity; IDA:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0003680; F:AT DNA binding; TAS:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0003677; F:DNA binding; TAS:ProtInc
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0003906; F:DNA-(apurinic or apyrimidinic site) lyase activity; IDA:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0019899; F:enzyme binding; IPI:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IMP:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0042975; F:peroxisome proliferator activated receptor binding; IDA:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0005515; F:protein binding; IPI:IntAct
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0042974; F:retinoic acid receptor binding; IDA:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0046965; F:retinoid X receptor binding; IDA:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IMP:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0008134; F:transcription factor binding; IDA:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0006284; P:base-excision repair; IDA:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0006268; P:DNA unwinding involved in DNA replication; NAS:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0075713; P:establishment of integrated proviral latency; TAS:Reactome
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0031936; P:negative regulation of chromatin silencing; TAS:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0006337; P:nucleosome disassembly; TAS:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0090402; P:oncogene-induced cell senescence; IDA:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:2000774; P:positive regulation of cellular senescence; IMP:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0006461; P:protein complex assembly; TAS:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0009615; P:response to virus; IEP:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0035986; P:senescence-associated heterochromatin focus assembly; IDA:UniProtKB
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	GO:0016032; P:viral process; TAS:Reactome
P52926	HMGA2	High mobility group protein HMGI-C	GO:0051575; F:5'-deoxyribose-5-phosphate lyase activity; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0003680; F:AT DNA binding; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0070742; F:C2H2 zinc finger domain binding; IMP:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0035497; F:cAMP response element binding; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0001047; F:core promoter binding; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0003677; F:DNA binding; NAS:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0008301; F:DNA binding, bending; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0003906; F:DNA-(apurinic or apyrimidinic site) lyase activity; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0004677; F:DNA-dependent protein kinase activity; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0035501; F:MH1 domain binding; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0035500; F:MH2 domain binding; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0031492; F:nucleosomal DNA binding; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0005515; F:protein binding; IPI:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0000975; F:regulatory region DNA binding; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0046332; F:SMAD binding; IPI:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0030325; P:adrenal gland development; IEA:Ensembl
P52926	HMGA2	High mobility group protein HMGI-C	GO:0006284; P:base-excision repair; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0021846; P:cell proliferation in forebrain; IEA:Ensembl
P52926	HMGA2	High mobility group protein HMGI-C	GO:0002062; P:chondrocyte differentiation; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0035988; P:chondrocyte proliferation; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0006325; P:chromatin organization; TAS:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0031052; P:chromosome breakage; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0030261; P:chromosome condensation; IEA:UniProtKB-KW
P52926	HMGA2	High mobility group protein HMGI-C	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
P52926	HMGA2	High mobility group protein HMGI-C	GO:0042769; P:DNA damage response, detection of DNA damage; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0035987; P:endodermal cell differentiation; IMP:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0001837; P:epithelial to mesenchymal transition; IMP:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0045444; P:fat cell differentiation; IMP:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0060613; P:fat pad development; IEA:Ensembl
P52926	HMGA2	High mobility group protein HMGI-C	GO:0031507; P:heterochromatin assembly; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0035978; P:histone H2A-S139 phosphorylation; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0008584; P:male gonad development; IEA:Ensembl
P52926	HMGA2	High mobility group protein HMGI-C	GO:0048762; P:mesenchymal cell differentiation; IMP:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0048333; P:mesodermal cell differentiation; IMP:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0003131; P:mesodermal-endodermal cell signaling; IMP:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P52926	HMGA2	High mobility group protein HMGI-C	GO:0007095; P:mitotic G2 DNA damage checkpoint; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P52926	HMGA2	High mobility group protein HMGI-C	GO:0043922; P:negative regulation by host of viral transcription; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0048712; P:negative regulation of astrocyte differentiation; IEA:Ensembl
P52926	HMGA2	High mobility group protein HMGI-C	GO:0043392; P:negative regulation of DNA binding; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:2001033; P:negative regulation of double-strand break repair via nonhomologous end joining; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0033144; P:negative regulation of intracellular steroid hormone receptor signaling pathway; IEA:Ensembl
P52926	HMGA2	High mobility group protein HMGI-C	GO:0046426; P:negative regulation of JAK-STAT cascade; IEA:Ensembl
P52926	HMGA2	High mobility group protein HMGI-C	GO:0045869; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0090402; P:oncogene-induced cell senescence; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0021983; P:pituitary gland development; IEA:Ensembl
P52926	HMGA2	High mobility group protein HMGI-C	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0071158; P:positive regulation of cell cycle arrest; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:2000685; P:positive regulation of cellular response to X-ray; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:2000774; P:positive regulation of cellular senescence; IMP:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
P52926	HMGA2	High mobility group protein HMGI-C	GO:2001022; P:positive regulation of response to DNA damage stimulus; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P52926	HMGA2	High mobility group protein HMGI-C	GO:2000648; P:positive regulation of stem cell proliferation; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:2000679; P:positive regulation of transcription regulatory region DNA binding; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0010564; P:regulation of cell cycle process; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:2001038; P:regulation of cellular response to drug; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0060123; P:regulation of growth hormone secretion; IEA:Ensembl
P52926	HMGA2	High mobility group protein HMGI-C	GO:2000036; P:regulation of stem cell maintenance; IMP:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0009615; P:response to virus; IEP:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0035986; P:senescence-associated heterochromatin focus assembly; IDA:UniProtKB
P52926	HMGA2	High mobility group protein HMGI-C	GO:0007165; P:signal transduction; IEA:Ensembl
P52926	HMGA2	High mobility group protein HMGI-C	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
P52926	HMGA2	High mobility group protein HMGI-C	GO:0007283; P:spermatogenesis; IEA:Ensembl
P52926	HMGA2	High mobility group protein HMGI-C	GO:0048863; P:stem cell differentiation; IEP:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0042056; F:chemoattractant activity; ISS:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0005125; F:cytokine activity; ISS:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0003684; F:damaged DNA binding; ISS:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0008301; F:DNA binding, bending; IMP:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0003690; F:double-stranded DNA binding; ISS:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0005515; F:protein binding; IPI:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0050786; F:RAGE receptor binding; ISS:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0070491; F:repressing transcription factor binding; IPI:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0003697; F:single-stranded DNA binding; ISS:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0006309; P:apoptotic DNA fragmentation; TAS:Reactome
P09429	HMGB1	High mobility group protein B1	GO:0006915; P:apoptotic process; TAS:Reactome
P09429	HMGB1	High mobility group protein B1	GO:0006288; P:base-excision repair, DNA ligation; IDA:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
P09429	HMGB1	High mobility group protein B1	GO:0002407; P:dendritic cell chemotaxis; ISS:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0051103; P:DNA ligation involved in DNA repair; ISS:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0006310; P:DNA recombination; ISS:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0006265; P:DNA topological change; ISS:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0002437; P:inflammatory response to antigenic stimulus; IEP:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0045087; P:innate immune response; TAS:Reactome
P09429	HMGB1	High mobility group protein B1	GO:0001773; P:myeloid dendritic cell activation; ISS:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:2000426; P:negative regulation of apoptotic cell clearance; IEA:Ensembl
P09429	HMGB1	High mobility group protein B1	GO:0017055; P:negative regulation of RNA polymerase II transcriptional preinitiation complex assembly; IDA:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0031175; P:neuron projection development; ISS:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0050918; P:positive chemotaxis; ISS:GOC
P09429	HMGB1	High mobility group protein B1	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0043388; P:positive regulation of DNA binding; IDA:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P09429	HMGB1	High mobility group protein B1	GO:0033151; P:V(D)J recombination; IDA:UniProtKB
Q8WW32	HMGB4	High mobility group protein B4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O15347	HMGB3	High mobility group protein B3	GO:0008301; F:DNA binding, bending; ISS:UniProtKB
O15347	HMGB3	High mobility group protein B3	GO:0003690; F:double-stranded DNA binding; ISS:UniProtKB
O15347	HMGB3	High mobility group protein B3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O15347	HMGB3	High mobility group protein B3	GO:0006310; P:DNA recombination; ISS:UniProtKB
O15347	HMGB3	High mobility group protein B3	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P26583	HMGB2	High mobility group protein B2	GO:0042056; F:chemoattractant activity; IDA:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0003684; F:damaged DNA binding; IDA:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0003677; F:DNA binding; IMP:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0008301; F:DNA binding, bending; IDA:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0003690; F:double-stranded DNA binding; ISS:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0005515; F:protein binding; IPI:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0050786; F:RAGE receptor binding; IGI:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0003697; F:single-stranded DNA binding; ISS:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0006309; P:apoptotic DNA fragmentation; TAS:Reactome
P26583	HMGB2	High mobility group protein B2	GO:0006915; P:apoptotic process; TAS:Reactome
P26583	HMGB2	High mobility group protein B2	GO:0006288; P:base-excision repair, DNA ligation; IDA:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0060326; P:cell chemotaxis; IDA:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
P26583	HMGB2	High mobility group protein B2	GO:0071222; P:cellular response to lipopolysaccharide; IEP:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0006325; P:chromatin organization; NAS:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0051103; P:DNA ligation involved in DNA repair; ISS:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0006265; P:DNA topological change; ISS:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0008584; P:male gonad development; IEA:Ensembl
P26583	HMGB2	High mobility group protein B2	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
P26583	HMGB2	High mobility group protein B2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
P26583	HMGB2	High mobility group protein B2	GO:0006334; P:nucleosome assembly; NAS:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0048015; P:phosphatidylinositol-mediated signaling; NAS:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0050918; P:positive chemotaxis; IDA:GOC
P26583	HMGB2	High mobility group protein B2	GO:0043388; P:positive regulation of DNA binding; IDA:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0045648; P:positive regulation of erythrocyte differentiation; IMP:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0045654; P:positive regulation of megakaryocyte differentiation; IMP:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0032075; P:positive regulation of nuclease activity; IDA:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P26583	HMGB2	High mobility group protein B2	GO:0048545; P:response to steroid hormone; IEA:Ensembl
P26583	HMGB2	High mobility group protein B2	GO:0007289; P:spermatid nucleus differentiation; IEA:Ensembl
P26583	HMGB2	High mobility group protein B2	GO:0033151; P:V(D)J recombination; ISS:UniProtKB
Q8TB92	HMGCLL1	3-hydroxymethyl-3-methylglutaryl-CoA lyase, cytoplasmic	GO:0004419; F:hydroxymethylglutaryl-CoA lyase activity; IDA:UniProtKB
Q8TB92	HMGCLL1	3-hydroxymethyl-3-methylglutaryl-CoA lyase, cytoplasmic	GO:0046872; F:metal ion binding; ISS:UniProtKB
Q8TB92	HMGCLL1	3-hydroxymethyl-3-methylglutaryl-CoA lyase, cytoplasmic	GO:0046951; P:ketone body biosynthetic process; IDA:UniProtKB
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0031406; F:carboxylic acid binding; IEA:Ensembl
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0000062; F:fatty-acyl-CoA binding; IEA:Ensembl
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0004419; F:hydroxymethylglutaryl-CoA lyase activity; IDA:UniProtKB
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0030145; F:manganese ion binding; IDA:UniProtKB
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0046872; F:metal ion binding; IDA:UniProtKB
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0005102; F:receptor binding; IPI:UniProtKB
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0006637; P:acyl-CoA metabolic process; IEA:Ensembl
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0046950; P:cellular ketone body metabolic process; TAS:Reactome
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0009790; P:embryo development; IEA:Ensembl
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0046951; P:ketone body biosynthetic process; IDA:UniProtKB
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0006552; P:leucine catabolic process; NAS:UniProtKB
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0001889; P:liver development; IEA:Ensembl
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0007005; P:mitochondrion organization; IEA:Ensembl
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0051262; P:protein tetramerization; IDA:UniProtKB
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0070542; P:response to fatty acid; IEA:Ensembl
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0007584; P:response to nutrient; IEA:Ensembl
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0042594; P:response to starvation; IEA:Ensembl
P35914	HMGCL	Hydroxymethylglutaryl-CoA lyase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P05114	HMGN1	Non-histone chromosomal protein HMG-14	GO:0003682; F:chromatin binding; IEA:Ensembl
P05114	HMGN1	Non-histone chromosomal protein HMG-14	GO:0003677; F:DNA binding; TAS:ProtInc
P05114	HMGN1	Non-histone chromosomal protein HMG-14	GO:0006325; P:chromatin organization; IEA:Ensembl
P05114	HMGN1	Non-histone chromosomal protein HMG-14	GO:0032786; P:positive regulation of DNA-templated transcription, elongation; TAS:ProtInc
P05114	HMGN1	Non-histone chromosomal protein HMG-14	GO:0048597; P:post-embryonic camera-type eye morphogenesis; IEA:Ensembl
P05114	HMGN1	Non-histone chromosomal protein HMG-14	GO:0000720; P:pyrimidine dimer repair by nucleotide-excision repair; IEA:Ensembl
P05114	HMGN1	Non-histone chromosomal protein HMG-14	GO:0040034; P:regulation of development, heterochronic; IEA:Ensembl
P05114	HMGN1	Non-histone chromosomal protein HMG-14	GO:0050678; P:regulation of epithelial cell proliferation; IEA:Ensembl
P05114	HMGN1	Non-histone chromosomal protein HMG-14	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P05114	HMGN1	Non-histone chromosomal protein HMG-14	GO:0010224; P:response to UV-B; IEA:Ensembl
P05114	HMGN1	Non-histone chromosomal protein HMG-14	GO:0010225; P:response to UV-C; IEA:Ensembl
P05114	HMGN1	Non-histone chromosomal protein HMG-14	GO:0006283; P:transcription-coupled nucleotide-excision repair; IEA:Ensembl
P05204	HMGN2	Non-histone chromosomal protein HMG-17	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P05204	HMGN2	Non-histone chromosomal protein HMG-17	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15651	HMGN3	High mobility group nucleosome-binding domain-containing protein 3	GO:0003682; F:chromatin binding; IEA:Ensembl
Q15651	HMGN3	High mobility group nucleosome-binding domain-containing protein 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q15651	HMGN3	High mobility group nucleosome-binding domain-containing protein 3	GO:0046966; F:thyroid hormone receptor binding; NAS:UniProtKB
Q15651	HMGN3	High mobility group nucleosome-binding domain-containing protein 3	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q15651	HMGN3	High mobility group nucleosome-binding domain-containing protein 3	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q15651	HMGN3	High mobility group nucleosome-binding domain-containing protein 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q15651	HMGN3	High mobility group nucleosome-binding domain-containing protein 3	GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl
P82970	HMGN5	High mobility group nucleosome-binding domain-containing protein 5	GO:0003682; F:chromatin binding; NAS:UniProtKB
P82970	HMGN5	High mobility group nucleosome-binding domain-containing protein 5	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P82970	HMGN5	High mobility group nucleosome-binding domain-containing protein 5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P82970	HMGN5	High mobility group nucleosome-binding domain-containing protein 5	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
P82970	HMGN5	High mobility group nucleosome-binding domain-containing protein 5	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
P82970	HMGN5	High mobility group nucleosome-binding domain-containing protein 5	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P82970	HMGN5	High mobility group nucleosome-binding domain-containing protein 5	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P82970	HMGN5	High mobility group nucleosome-binding domain-containing protein 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O00479	HMGN4	High mobility group nucleosome-binding domain-containing protein 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q12766	HMGXB3	HMG domain-containing protein 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q12766	HMGXB3	HMG domain-containing protein 3	GO:0016301; F:kinase activity; NAS:UniProtKB
Q12766	HMGXB3	HMG domain-containing protein 3	GO:0016310; P:phosphorylation; NAS:GOC
Q9UGU5	HMGXB4	HMG domain-containing protein 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UGU5	HMGXB4	HMG domain-containing protein 4	GO:0008333; P:endosome to lysosome transport; NAS:UniProtKB
Q9UGU5	HMGXB4	HMG domain-containing protein 4	GO:0030178; P:negative regulation of Wnt signaling pathway; ISS:UniProtKB
Q9UGU5	HMGXB4	HMG domain-containing protein 4	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q92619	HMHA1	Minor histocompatibility protein HA-1	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q92619	HMHA1	Minor histocompatibility protein HA-1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q92619	HMHA1	Minor histocompatibility protein HA-1	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q92619	HMHA1	Minor histocompatibility protein HA-1	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
O97980	HMHB1	Minor histocompatibility protein HB-1	GO:0002376; P:immune system process; IEA:UniProtKB-KW
O75330	HMMR	Hyaluronan mediated motility receptor	GO:0005540; F:hyaluronic acid binding; IEA:UniProtKB-KW
O75330	HMMR	Hyaluronan mediated motility receptor	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O75330	HMMR	Hyaluronan mediated motility receptor	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O75330	HMMR	Hyaluronan mediated motility receptor	GO:0030214; P:hyaluronan catabolic process; TAS:Reactome
O75330	HMMR	Hyaluronan mediated motility receptor	GO:0030212; P:hyaluronan metabolic process; TAS:Reactome
O75330	HMMR	Hyaluronan mediated motility receptor	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P09601	HMOX1	Heme oxygenase 1	GO:0019899; F:enzyme binding; ISS:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0020037; F:heme binding; IDA:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0004392; F:heme oxygenase (decyclizing) activity; IMP:UniProtKB
P09601	HMOX1	Heme oxygenase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P09601	HMOX1	Heme oxygenase 1	GO:0004630; F:phospholipase D activity; IEA:Ensembl
P09601	HMOX1	Heme oxygenase 1	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P09601	HMOX1	Heme oxygenase 1	GO:0004871; F:signal transducer activity; IMP:UniProtKB
P09601	HMOX1	Heme oxygenase 1	GO:0001525; P:angiogenesis; TAS:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0008219; P:cell death; ISS:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
P09601	HMOX1	Heme oxygenase 1	GO:0071243; P:cellular response to arsenic-containing substance; IEA:Ensembl
P09601	HMOX1	Heme oxygenase 1	GO:0071276; P:cellular response to cadmium ion; IEA:Ensembl
P09601	HMOX1	Heme oxygenase 1	GO:0071456; P:cellular response to hypoxia; IEP:UniProtKB
P09601	HMOX1	Heme oxygenase 1	GO:0031670; P:cellular response to nutrient; IEA:Ensembl
P09601	HMOX1	Heme oxygenase 1	GO:0001935; P:endothelial cell proliferation; TAS:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0034101; P:erythrocyte homeostasis; IMP:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0007588; P:excretion; IC:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0042167; P:heme catabolic process; IDA:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0006788; P:heme oxidation; IDA:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0035556; P:intracellular signal transduction; TAS:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
P09601	HMOX1	Heme oxygenase 1	GO:0055072; P:iron ion homeostasis; IDA:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0034383; P:low-density lipoprotein particle clearance; TAS:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0043392; P:negative regulation of DNA binding; IEA:Ensembl
P09601	HMOX1	Heme oxygenase 1	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IMP:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0002686; P:negative regulation of leukocyte migration; TAS:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0032764; P:negative regulation of mast cell cytokine production; IEA:Ensembl
P09601	HMOX1	Heme oxygenase 1	GO:0043305; P:negative regulation of mast cell degranulation; IEA:Ensembl
P09601	HMOX1	Heme oxygenase 1	GO:0010656; P:negative regulation of muscle cell apoptotic process; IEA:Ensembl
P09601	HMOX1	Heme oxygenase 1	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P09601	HMOX1	Heme oxygenase 1	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P09601	HMOX1	Heme oxygenase 1	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IDA:UniProtKB
P09601	HMOX1	Heme oxygenase 1	GO:0006778; P:porphyrin-containing compound metabolic process; TAS:Reactome
P09601	HMOX1	Heme oxygenase 1	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
P09601	HMOX1	Heme oxygenase 1	GO:0045080; P:positive regulation of chemokine biosynthetic process; TAS:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
P09601	HMOX1	Heme oxygenase 1	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IDA:UniProtKB
P09601	HMOX1	Heme oxygenase 1	GO:0045909; P:positive regulation of vasodilation; IC:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
P09601	HMOX1	Heme oxygenase 1	GO:0045765; P:regulation of angiogenesis; TAS:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0008217; P:regulation of blood pressure; IEA:Ensembl
P09601	HMOX1	Heme oxygenase 1	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0043619; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; ISS:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0043627; P:response to estrogen; IEA:Ensembl
P09601	HMOX1	Heme oxygenase 1	GO:0042542; P:response to hydrogen peroxide; ISS:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0035094; P:response to nicotine; IDA:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0006979; P:response to oxidative stress; IMP:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0007264; P:small GTPase mediated signal transduction; IEA:Ensembl
P09601	HMOX1	Heme oxygenase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P09601	HMOX1	Heme oxygenase 1	GO:0014806; P:smooth muscle hyperplasia; TAS:BHF-UCL
P09601	HMOX1	Heme oxygenase 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P09601	HMOX1	Heme oxygenase 1	GO:0002246; P:wound healing involved in inflammatory response; IMP:BHF-UCL
P30519	HMOX2	Heme oxygenase 2	GO:0004392; F:heme oxygenase (decyclizing) activity; IDA:UniProtKB
P30519	HMOX2	Heme oxygenase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P30519	HMOX2	Heme oxygenase 2	GO:0005515; F:protein binding; IPI:UniProtKB
P30519	HMOX2	Heme oxygenase 2	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
P30519	HMOX2	Heme oxygenase 2	GO:0042167; P:heme catabolic process; TAS:Reactome
P30519	HMOX2	Heme oxygenase 2	GO:0006788; P:heme oxidation; IEA:InterPro
P30519	HMOX2	Heme oxygenase 2	GO:0006778; P:porphyrin-containing compound metabolic process; TAS:Reactome
P30519	HMOX2	Heme oxygenase 2	GO:0001666; P:response to hypoxia; IDA:UniProtKB
P30519	HMOX2	Heme oxygenase 2	GO:0006979; P:response to oxidative stress; IEA:Ensembl
P30519	HMOX2	Heme oxygenase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P30519	HMOX2	Heme oxygenase 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q95460	MR1	Major histocompatibility complex class I-related gene protein	GO:0003823; F:antigen binding; IBA:RefGenome
Q95460	MR1	Major histocompatibility complex class I-related gene protein	GO:0032393; F:MHC class I receptor activity; TAS:UniProtKB
Q95460	MR1	Major histocompatibility complex class I-related gene protein	GO:0042605; F:peptide antigen binding; IEA:InterPro
Q95460	MR1	Major histocompatibility complex class I-related gene protein	GO:0019882; P:antigen processing and presentation; IBA:RefGenome
Q95460	MR1	Major histocompatibility complex class I-related gene protein	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW
Q95460	MR1	Major histocompatibility complex class I-related gene protein	GO:0002367; P:cytokine production involved in immune response; IEA:Ensembl
Q95460	MR1	Major histocompatibility complex class I-related gene protein	GO:0050829; P:defense response to Gram-negative bacterium; IEA:Ensembl
Q95460	MR1	Major histocompatibility complex class I-related gene protein	GO:0006955; P:immune response; TAS:ProtInc
Q95460	MR1	Major histocompatibility complex class I-related gene protein	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q95460	MR1	Major histocompatibility complex class I-related gene protein	GO:0032611; P:interleukin-1 beta production; IEA:Ensembl
Q95460	MR1	Major histocompatibility complex class I-related gene protein	GO:0032620; P:interleukin-17 production; IEA:Ensembl
Q95460	MR1	Major histocompatibility complex class I-related gene protein	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
Q95460	MR1	Major histocompatibility complex class I-related gene protein	GO:0007165; P:signal transduction; TAS:GOC
A8MTL9	HMSD	Serpin-like protein HMSD	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q9NP08	HMX1	Homeobox protein HMX1	GO:0003677; F:DNA binding; IMP:UniProtKB
Q9NP08	HMX1	Homeobox protein HMX1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9NP08	HMX1	Homeobox protein HMX1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9NP08	HMX1	Homeobox protein HMX1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9NP08	HMX1	Homeobox protein HMX1	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q9NP08	HMX1	Homeobox protein HMX1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A2RU54	HMX2	Homeobox protein HMX2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
A2RU54	HMX2	Homeobox protein HMX2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
A2RU54	HMX2	Homeobox protein HMX2	GO:0007420; P:brain development; IEA:Ensembl
A2RU54	HMX2	Homeobox protein HMX2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
A2RU54	HMX2	Homeobox protein HMX2	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
A2RU54	HMX2	Homeobox protein HMX2	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
A2RU54	HMX2	Homeobox protein HMX2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A6NHT5	HMX3	Homeobox protein HMX3	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
A6NHT5	HMX3	Homeobox protein HMX3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
A6NHT5	HMX3	Homeobox protein HMX3	GO:0007420; P:brain development; IEA:Ensembl
A6NHT5	HMX3	Homeobox protein HMX3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
A6NHT5	HMX3	Homeobox protein HMX3	GO:0007566; P:embryo implantation; IEA:Ensembl
A6NHT5	HMX3	Homeobox protein HMX3	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
A6NHT5	HMX3	Homeobox protein HMX3	GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
A6NHT5	HMX3	Homeobox protein HMX3	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
A6NHT5	HMX3	Homeobox protein HMX3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P20823	HNF1A	Hepatocyte nuclear factor 1-alpha	GO:0003677; F:DNA binding; IDA:UniProtKB
P20823	HNF1A	Hepatocyte nuclear factor 1-alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P20823	HNF1A	Hepatocyte nuclear factor 1-alpha	GO:0046983; F:protein dimerization activity; IPI:UniProtKB
P20823	HNF1A	Hepatocyte nuclear factor 1-alpha	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
P20823	HNF1A	Hepatocyte nuclear factor 1-alpha	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P20823	HNF1A	Hepatocyte nuclear factor 1-alpha	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; ISS:BHF-UCL
P20823	HNF1A	Hepatocyte nuclear factor 1-alpha	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P20823	HNF1A	Hepatocyte nuclear factor 1-alpha	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P20823	HNF1A	Hepatocyte nuclear factor 1-alpha	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P20823	HNF1A	Hepatocyte nuclear factor 1-alpha	GO:0042593; P:glucose homeostasis; IMP:UniProtKB
P20823	HNF1A	Hepatocyte nuclear factor 1-alpha	GO:0046323; P:glucose import; IMP:UniProtKB
P20823	HNF1A	Hepatocyte nuclear factor 1-alpha	GO:0030073; P:insulin secretion; IMP:UniProtKB
P20823	HNF1A	Hepatocyte nuclear factor 1-alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P20823	HNF1A	Hepatocyte nuclear factor 1-alpha	GO:0060261; P:positive regulation of transcription initiation from RNA polymerase II promoter; IGI:UniProtKB
P20823	HNF1A	Hepatocyte nuclear factor 1-alpha	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P20823	HNF1A	Hepatocyte nuclear factor 1-alpha	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P20823	HNF1A	Hepatocyte nuclear factor 1-alpha	GO:0035623; P:renal glucose absorption; IMP:UniProtKB
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0003677; F:DNA binding; IDA:UniProtKB
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0005515; F:protein binding; IPI:UniProtKB
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0044212; F:transcription regulatory region DNA binding; IEA:Ensembl
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0048557; P:embryonic digestive tract morphogenesis; IEA:Ensembl
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0031018; P:endocrine pancreas development; IMP:UniProtKB
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0001714; P:endodermal cell fate specification; IEA:Ensembl
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0050673; P:epithelial cell proliferation; IEA:Ensembl
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0048806; P:genitalia development; IMP:UniProtKB
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0061017; P:hepatoblast differentiation; IEA:Ensembl
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0030902; P:hindbrain development; IEA:Ensembl
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0001826; P:inner cell mass cell differentiation; IEA:Ensembl
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0030073; P:insulin secretion; IEA:Ensembl
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0001822; P:kidney development; IDA:UniProtKB
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0072181; P:mesonephric duct formation; IEA:Ensembl
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0061296; P:negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis; IEA:Ensembl
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:1900212; P:negative regulation of mesenchymal cell apoptotic process involved in metanephros development; IEA:Ensembl
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0060261; P:positive regulation of transcription initiation from RNA polymerase II promoter; IDA:UniProtKB
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0039020; P:pronephric nephron tubule development; IGI:UniProtKB
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0048793; P:pronephros development; IMP:UniProtKB
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0072095; P:regulation of branch elongation involved in ureteric bud branching; IEA:Ensembl
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0042663; P:regulation of endodermal cell fate specification; IEA:Ensembl
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0035565; P:regulation of pronephros size; IMP:UniProtKB
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0030111; P:regulation of Wnt signaling pathway; IEA:Ensembl
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0009749; P:response to glucose; IEA:Ensembl
P35680	HNF1B	Hepatocyte nuclear factor 1-beta	GO:0060677; P:ureteric bud elongation; IEA:Ensembl
Q14541	HNF4G	Hepatocyte nuclear factor 4-gamma	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; IEA:InterPro
Q14541	HNF4G	Hepatocyte nuclear factor 4-gamma	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q14541	HNF4G	Hepatocyte nuclear factor 4-gamma	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q14541	HNF4G	Hepatocyte nuclear factor 4-gamma	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
Q14541	HNF4G	Hepatocyte nuclear factor 4-gamma	GO:0008270; F:zinc ion binding; IEA:InterPro
Q14541	HNF4G	Hepatocyte nuclear factor 4-gamma	GO:0031018; P:endocrine pancreas development; TAS:Reactome
Q14541	HNF4G	Hepatocyte nuclear factor 4-gamma	GO:0010467; P:gene expression; TAS:Reactome
Q14541	HNF4G	Hepatocyte nuclear factor 4-gamma	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q14541	HNF4G	Hepatocyte nuclear factor 4-gamma	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q14541	HNF4G	Hepatocyte nuclear factor 4-gamma	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0003677; F:DNA binding; IDA:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0005504; F:fatty acid binding; IDA:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; IEA:InterPro
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0005102; F:receptor binding; IDA:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0001102; F:RNA polymerase II activating transcription factor binding; ISS:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; ISS:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0008270; F:zinc ion binding; IEA:InterPro
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0007596; P:blood coagulation; IDA:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0031018; P:endocrine pancreas development; TAS:Reactome
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0010467; P:gene expression; TAS:Reactome
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0042593; P:glucose homeostasis; ISS:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0055088; P:lipid homeostasis; IMP:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0006629; P:lipid metabolic process; IEA:Ensembl
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0030308; P:negative regulation of cell growth; IMP:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0008285; P:negative regulation of cell proliferation; IMP:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0006591; P:ornithine metabolic process; IMP:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0055091; P:phospholipid homeostasis; ISS:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:2000189; P:positive regulation of cholesterol homeostasis; ISS:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0010470; P:regulation of gastrulation; IEA:Ensembl
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0060398; P:regulation of growth hormone receptor signaling pathway; NAS:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0050796; P:regulation of insulin secretion; ISS:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0019216; P:regulation of lipid metabolic process; IDA:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0009749; P:response to glucose; ISS:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0007548; P:sex differentiation; IEA:Ensembl
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0060395; P:SMAD protein signal transduction; IEA:Ensembl
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0070328; P:triglyceride homeostasis; ISS:BHF-UCL
P41235	HNF4A	Hepatocyte nuclear factor 4-alpha	GO:0006805; P:xenobiotic metabolic process; IMP:BHF-UCL
Q9UBC0	ONECUT1	Hepatocyte nuclear factor 6	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; ISS:BHF-UCL
Q9UBC0	ONECUT1	Hepatocyte nuclear factor 6	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9UBC0	ONECUT1	Hepatocyte nuclear factor 6	GO:0030183; P:B cell differentiation; IEA:Ensembl
Q9UBC0	ONECUT1	Hepatocyte nuclear factor 6	GO:0045165; P:cell fate commitment; IEA:Ensembl
Q9UBC0	ONECUT1	Hepatocyte nuclear factor 6	GO:0042384; P:cilium assembly; IEA:Ensembl
Q9UBC0	ONECUT1	Hepatocyte nuclear factor 6	GO:0031018; P:endocrine pancreas development; TAS:Reactome
Q9UBC0	ONECUT1	Hepatocyte nuclear factor 6	GO:0007492; P:endoderm development; IEA:Ensembl
Q9UBC0	ONECUT1	Hepatocyte nuclear factor 6	GO:0002064; P:epithelial cell development; IEA:Ensembl
Q9UBC0	ONECUT1	Hepatocyte nuclear factor 6	GO:0006006; P:glucose metabolic process; IEA:Ensembl
Q9UBC0	ONECUT1	Hepatocyte nuclear factor 6	GO:0001889; P:liver development; IEA:Ensembl
Q9UBC0	ONECUT1	Hepatocyte nuclear factor 6	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl
Q9UBC0	ONECUT1	Hepatocyte nuclear factor 6	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
Q9UBC0	ONECUT1	Hepatocyte nuclear factor 6	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q9UBC0	ONECUT1	Hepatocyte nuclear factor 6	GO:0001952; P:regulation of cell-matrix adhesion; IEA:Ensembl
Q9UBC0	ONECUT1	Hepatocyte nuclear factor 6	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9UBC0	ONECUT1	Hepatocyte nuclear factor 6	GO:0048536; P:spleen development; IEA:Ensembl
P50135	HNMT	Histamine N-methyltransferase	GO:0046539; F:histamine N-methyltransferase activity; IEA:UniProtKB-EC
P50135	HNMT	Histamine N-methyltransferase	GO:0007420; P:brain development; IEA:Ensembl
P50135	HNMT	Histamine N-methyltransferase	GO:0006972; P:hyperosmotic response; IEA:Ensembl
P50135	HNMT	Histamine N-methyltransferase	GO:0007585; P:respiratory gaseous exchange; TAS:ProtInc
P50135	HNMT	Histamine N-methyltransferase	GO:0014075; P:response to amine; IEA:Ensembl
P50135	HNMT	Histamine N-methyltransferase	GO:0042220; P:response to cocaine; IEA:Ensembl
P50135	HNMT	Histamine N-methyltransferase	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P50135	HNMT	Histamine N-methyltransferase	GO:0070555; P:response to interleukin-1; IEA:Ensembl
P50135	HNMT	Histamine N-methyltransferase	GO:0002347; P:response to tumor cell; IEA:Ensembl
O14979	HNRNPDL	Heterogeneous nuclear ribonucleoprotein D-like	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O14979	HNRNPDL	Heterogeneous nuclear ribonucleoprotein D-like	GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB
O14979	HNRNPDL	Heterogeneous nuclear ribonucleoprotein D-like	GO:0000166; F:nucleotide binding; IEA:InterPro
O14979	HNRNPDL	Heterogeneous nuclear ribonucleoprotein D-like	GO:0008143; F:poly(A) binding; IDA:UniProtKB
O14979	HNRNPDL	Heterogeneous nuclear ribonucleoprotein D-like	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O14979	HNRNPDL	Heterogeneous nuclear ribonucleoprotein D-like	GO:0034046; F:poly(G) binding; IDA:UniProtKB
O14979	HNRNPDL	Heterogeneous nuclear ribonucleoprotein D-like	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
O14979	HNRNPDL	Heterogeneous nuclear ribonucleoprotein D-like	GO:0010468; P:regulation of gene expression; IDA:UniProtKB
O14979	HNRNPDL	Heterogeneous nuclear ribonucleoprotein D-like	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O14979	HNRNPDL	Heterogeneous nuclear ribonucleoprotein D-like	GO:0006396; P:RNA processing; NAS:UniProtKB
O14979	HNRNPDL	Heterogeneous nuclear ribonucleoprotein D-like	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60812	HNRNPCL1	Heterogeneous nuclear ribonucleoprotein C-like 1	GO:0000166; F:nucleotide binding; IEA:InterPro
O60812	HNRNPCL1	Heterogeneous nuclear ribonucleoprotein C-like 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P31943	HNRNPH1	Heterogeneous nuclear ribonucleoprotein H	GO:0000166; F:nucleotide binding; IEA:InterPro
P31943	HNRNPH1	Heterogeneous nuclear ribonucleoprotein H	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P31943	HNRNPH1	Heterogeneous nuclear ribonucleoprotein H	GO:0008266; F:poly(U) RNA binding; TAS:ProtInc
P31943	HNRNPH1	Heterogeneous nuclear ribonucleoprotein H	GO:0005515; F:protein binding; IPI:UniProtKB
P31943	HNRNPH1	Heterogeneous nuclear ribonucleoprotein H	GO:0003723; F:RNA binding; IDA:UniProtKB
P31943	HNRNPH1	Heterogeneous nuclear ribonucleoprotein H	GO:0010467; P:gene expression; TAS:Reactome
P31943	HNRNPH1	Heterogeneous nuclear ribonucleoprotein H	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P31943	HNRNPH1	Heterogeneous nuclear ribonucleoprotein H	GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB
P31943	HNRNPH1	Heterogeneous nuclear ribonucleoprotein H	GO:0006396; P:RNA processing; TAS:ProtInc
P31943	HNRNPH1	Heterogeneous nuclear ribonucleoprotein H	GO:0008380; P:RNA splicing; TAS:Reactome
P55795	HNRNPH2	Heterogeneous nuclear ribonucleoprotein H2	GO:0000166; F:nucleotide binding; IEA:InterPro
P55795	HNRNPH2	Heterogeneous nuclear ribonucleoprotein H2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P55795	HNRNPH2	Heterogeneous nuclear ribonucleoprotein H2	GO:0003723; F:RNA binding; TAS:ProtInc
P55795	HNRNPH2	Heterogeneous nuclear ribonucleoprotein H2	GO:0010467; P:gene expression; TAS:Reactome
P55795	HNRNPH2	Heterogeneous nuclear ribonucleoprotein H2	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P55795	HNRNPH2	Heterogeneous nuclear ribonucleoprotein H2	GO:0008380; P:RNA splicing; TAS:Reactome
P31942	HNRNPH3	Heterogeneous nuclear ribonucleoprotein H3	GO:0000166; F:nucleotide binding; IEA:InterPro
P31942	HNRNPH3	Heterogeneous nuclear ribonucleoprotein H3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P31942	HNRNPH3	Heterogeneous nuclear ribonucleoprotein H3	GO:0005515; F:protein binding; IPI:UniProt
P31942	HNRNPH3	Heterogeneous nuclear ribonucleoprotein H3	GO:0003723; F:RNA binding; NAS:UniProtKB
P31942	HNRNPH3	Heterogeneous nuclear ribonucleoprotein H3	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
P31942	HNRNPH3	Heterogeneous nuclear ribonucleoprotein H3	GO:0000398; P:mRNA splicing, via spliceosome; NAS:UniProtKB
P31942	HNRNPH3	Heterogeneous nuclear ribonucleoprotein H3	GO:0006396; P:RNA processing; TAS:ProtInc
P31942	HNRNPH3	Heterogeneous nuclear ribonucleoprotein H3	GO:0008380; P:RNA splicing; TAS:ProtInc
Q9BUJ2	HNRNPUL1	Heterogeneous nuclear ribonucleoprotein U-like protein 1	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9BUJ2	HNRNPUL1	Heterogeneous nuclear ribonucleoprotein U-like protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BUJ2	HNRNPUL1	Heterogeneous nuclear ribonucleoprotein U-like protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9BUJ2	HNRNPUL1	Heterogeneous nuclear ribonucleoprotein U-like protein 1	GO:0003723; F:RNA binding; TAS:ProtInc
Q9BUJ2	HNRNPUL1	Heterogeneous nuclear ribonucleoprotein U-like protein 1	GO:0010467; P:gene expression; TAS:Reactome
Q9BUJ2	HNRNPUL1	Heterogeneous nuclear ribonucleoprotein U-like protein 1	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q9BUJ2	HNRNPUL1	Heterogeneous nuclear ribonucleoprotein U-like protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9BUJ2	HNRNPUL1	Heterogeneous nuclear ribonucleoprotein U-like protein 1	GO:0009615; P:response to virus; TAS:ProtInc
Q9BUJ2	HNRNPUL1	Heterogeneous nuclear ribonucleoprotein U-like protein 1	GO:0006396; P:RNA processing; TAS:ProtInc
Q9BUJ2	HNRNPUL1	Heterogeneous nuclear ribonucleoprotein U-like protein 1	GO:0008380; P:RNA splicing; TAS:Reactome
Q9BUJ2	HNRNPUL1	Heterogeneous nuclear ribonucleoprotein U-like protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q1KMD3	HNRNPUL2	Heterogeneous nuclear ribonucleoprotein U-like protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8WVV9	HNRNPLL	Heterogeneous nuclear ribonucleoprotein L-like	GO:0003729; F:mRNA binding; IDA:UniProtKB
Q8WVV9	HNRNPLL	Heterogeneous nuclear ribonucleoprotein L-like	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8WVV9	HNRNPLL	Heterogeneous nuclear ribonucleoprotein L-like	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8WVV9	HNRNPLL	Heterogeneous nuclear ribonucleoprotein L-like	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WVV9	HNRNPLL	Heterogeneous nuclear ribonucleoprotein L-like	GO:0003723; F:RNA binding; IEA:InterPro
Q8WVV9	HNRNPLL	Heterogeneous nuclear ribonucleoprotein L-like	GO:0006397; P:mRNA processing; IEA:InterPro
Q8WVV9	HNRNPLL	Heterogeneous nuclear ribonucleoprotein L-like	GO:0033120; P:positive regulation of RNA splicing; IDA:UniProtKB
P07910	HNRNPC	Heterogeneous nuclear ribonucleoproteins C1/C2	GO:0042802; F:identical protein binding; IPI:IntAct
P07910	HNRNPC	Heterogeneous nuclear ribonucleoproteins C1/C2	GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProt
P07910	HNRNPC	Heterogeneous nuclear ribonucleoproteins C1/C2	GO:0031492; F:nucleosomal DNA binding; IDA:UniProt
P07910	HNRNPC	Heterogeneous nuclear ribonucleoproteins C1/C2	GO:0000166; F:nucleotide binding; IEA:InterPro
P07910	HNRNPC	Heterogeneous nuclear ribonucleoproteins C1/C2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P07910	HNRNPC	Heterogeneous nuclear ribonucleoproteins C1/C2	GO:0008266; F:poly(U) RNA binding; IDA:UniProt
P07910	HNRNPC	Heterogeneous nuclear ribonucleoproteins C1/C2	GO:0005515; F:protein binding; IPI:UniProtKB
P07910	HNRNPC	Heterogeneous nuclear ribonucleoproteins C1/C2	GO:0003723; F:RNA binding; NAS:HGNC
P07910	HNRNPC	Heterogeneous nuclear ribonucleoproteins C1/C2	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:UniProt
P07910	HNRNPC	Heterogeneous nuclear ribonucleoproteins C1/C2	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IDA:UniProt
P07910	HNRNPC	Heterogeneous nuclear ribonucleoproteins C1/C2	GO:0070935; P:3'-UTR-mediated mRNA stabilization; IMP:UniProt
P07910	HNRNPC	Heterogeneous nuclear ribonucleoproteins C1/C2	GO:0043044; P:ATP-dependent chromatin remodeling; IDA:UniProt
P07910	HNRNPC	Heterogeneous nuclear ribonucleoproteins C1/C2	GO:0010467; P:gene expression; TAS:Reactome
P07910	HNRNPC	Heterogeneous nuclear ribonucleoproteins C1/C2	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P07910	HNRNPC	Heterogeneous nuclear ribonucleoproteins C1/C2	GO:0008380; P:RNA splicing; TAS:Reactome
Q14103	HNRNPD	Heterogeneous nuclear ribonucleoprotein D0	GO:0000166; F:nucleotide binding; IEA:InterPro
Q14103	HNRNPD	Heterogeneous nuclear ribonucleoprotein D0	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14103	HNRNPD	Heterogeneous nuclear ribonucleoprotein D0	GO:0005515; F:protein binding; IPI:IntAct
Q14103	HNRNPD	Heterogeneous nuclear ribonucleoprotein D0	GO:0003723; F:RNA binding; IDA:UniProtKB
Q14103	HNRNPD	Heterogeneous nuclear ribonucleoprotein D0	GO:0042162; F:telomeric DNA binding; IDA:UniProtKB
Q14103	HNRNPD	Heterogeneous nuclear ribonucleoprotein D0	GO:0010467; P:gene expression; TAS:Reactome
Q14103	HNRNPD	Heterogeneous nuclear ribonucleoprotein D0	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q14103	HNRNPD	Heterogeneous nuclear ribonucleoprotein D0	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q14103	HNRNPD	Heterogeneous nuclear ribonucleoprotein D0	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
Q14103	HNRNPD	Heterogeneous nuclear ribonucleoprotein D0	GO:0043488; P:regulation of mRNA stability; IEA:Ensembl
Q14103	HNRNPD	Heterogeneous nuclear ribonucleoprotein D0	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q14103	HNRNPD	Heterogeneous nuclear ribonucleoprotein D0	GO:0006401; P:RNA catabolic process; TAS:ProtInc
Q14103	HNRNPD	Heterogeneous nuclear ribonucleoprotein D0	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q14103	HNRNPD	Heterogeneous nuclear ribonucleoprotein D0	GO:0006396; P:RNA processing; TAS:ProtInc
Q14103	HNRNPD	Heterogeneous nuclear ribonucleoprotein D0	GO:0008380; P:RNA splicing; TAS:Reactome
Q14103	HNRNPD	Heterogeneous nuclear ribonucleoprotein D0	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P52597	HNRNPF	Heterogeneous nuclear ribonucleoprotein F	GO:0000166; F:nucleotide binding; IEA:InterPro
P52597	HNRNPF	Heterogeneous nuclear ribonucleoprotein F	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P52597	HNRNPF	Heterogeneous nuclear ribonucleoprotein F	GO:0005515; F:protein binding; IPI:UniProtKB
P52597	HNRNPF	Heterogeneous nuclear ribonucleoprotein F	GO:0003723; F:RNA binding; TAS:ProtInc
P52597	HNRNPF	Heterogeneous nuclear ribonucleoprotein F	GO:0003727; F:single-stranded RNA binding; IDA:UniProtKB
P52597	HNRNPF	Heterogeneous nuclear ribonucleoprotein F	GO:0010467; P:gene expression; TAS:Reactome
P52597	HNRNPF	Heterogeneous nuclear ribonucleoprotein F	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P52597	HNRNPF	Heterogeneous nuclear ribonucleoprotein F	GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB
P52597	HNRNPF	Heterogeneous nuclear ribonucleoprotein F	GO:0006396; P:RNA processing; TAS:ProtInc
P52597	HNRNPF	Heterogeneous nuclear ribonucleoprotein F	GO:0008380; P:RNA splicing; TAS:Reactome
P61978	HNRNPK	Heterogeneous nuclear ribonucleoprotein K	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P61978	HNRNPK	Heterogeneous nuclear ribonucleoprotein K	GO:0005515; F:protein binding; IPI:IntAct
P61978	HNRNPK	Heterogeneous nuclear ribonucleoprotein K	GO:0003723; F:RNA binding; TAS:ProtInc
P61978	HNRNPK	Heterogeneous nuclear ribonucleoprotein K	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IMP:BHF-UCL
P61978	HNRNPK	Heterogeneous nuclear ribonucleoprotein K	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IMP:BHF-UCL
P61978	HNRNPK	Heterogeneous nuclear ribonucleoprotein K	GO:0003697; F:single-stranded DNA binding; TAS:BHF-UCL
P61978	HNRNPK	Heterogeneous nuclear ribonucleoprotein K	GO:0010467; P:gene expression; TAS:Reactome
P61978	HNRNPK	Heterogeneous nuclear ribonucleoprotein K	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P61978	HNRNPK	Heterogeneous nuclear ribonucleoprotein K	GO:0045716; P:positive regulation of low-density lipoprotein particle receptor biosynthetic process; IMP:BHF-UCL
P61978	HNRNPK	Heterogeneous nuclear ribonucleoprotein K	GO:0048260; P:positive regulation of receptor-mediated endocytosis; IMP:BHF-UCL
P61978	HNRNPK	Heterogeneous nuclear ribonucleoprotein K	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P61978	HNRNPK	Heterogeneous nuclear ribonucleoprotein K	GO:0072369; P:regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P61978	HNRNPK	Heterogeneous nuclear ribonucleoprotein K	GO:0010988; P:regulation of low-density lipoprotein particle clearance; IMP:BHF-UCL
P61978	HNRNPK	Heterogeneous nuclear ribonucleoprotein K	GO:0006396; P:RNA processing; TAS:ProtInc
P61978	HNRNPK	Heterogeneous nuclear ribonucleoprotein K	GO:0008380; P:RNA splicing; TAS:Reactome
P61978	HNRNPK	Heterogeneous nuclear ribonucleoprotein K	GO:0007165; P:signal transduction; TAS:ProtInc
P61978	HNRNPK	Heterogeneous nuclear ribonucleoprotein K	GO:0016032; P:viral process; IEA:UniProtKB-KW
P52272	HNRNPM	Heterogeneous nuclear ribonucleoprotein M	GO:0000166; F:nucleotide binding; IEA:InterPro
P52272	HNRNPM	Heterogeneous nuclear ribonucleoprotein M	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P52272	HNRNPM	Heterogeneous nuclear ribonucleoprotein M	GO:0005515; F:protein binding; IPI:IntAct
P52272	HNRNPM	Heterogeneous nuclear ribonucleoprotein M	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P52272	HNRNPM	Heterogeneous nuclear ribonucleoprotein M	GO:0003723; F:RNA binding; NAS:HGNC
P52272	HNRNPM	Heterogeneous nuclear ribonucleoprotein M	GO:0000380; P:alternative mRNA splicing, via spliceosome; IMP:BHF-UCL
P52272	HNRNPM	Heterogeneous nuclear ribonucleoprotein M	GO:0010467; P:gene expression; TAS:Reactome
P52272	HNRNPM	Heterogeneous nuclear ribonucleoprotein M	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P52272	HNRNPM	Heterogeneous nuclear ribonucleoprotein M	GO:0008380; P:RNA splicing; TAS:Reactome
P14866	HNRNPL	Heterogeneous nuclear ribonucleoprotein L	GO:0000166; F:nucleotide binding; IEA:InterPro
P14866	HNRNPL	Heterogeneous nuclear ribonucleoprotein L	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P14866	HNRNPL	Heterogeneous nuclear ribonucleoprotein L	GO:0005515; F:protein binding; IPI:UniProtKB
P14866	HNRNPL	Heterogeneous nuclear ribonucleoprotein L	GO:0003723; F:RNA binding; TAS:ProtInc
P14866	HNRNPL	Heterogeneous nuclear ribonucleoprotein L	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P14866	HNRNPL	Heterogeneous nuclear ribonucleoprotein L	GO:0010467; P:gene expression; TAS:Reactome
P14866	HNRNPL	Heterogeneous nuclear ribonucleoprotein L	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P14866	HNRNPL	Heterogeneous nuclear ribonucleoprotein L	GO:0006396; P:RNA processing; TAS:ProtInc
P14866	HNRNPL	Heterogeneous nuclear ribonucleoprotein L	GO:0008380; P:RNA splicing; TAS:Reactome
O60506	SYNCRIP	Heterogeneous nuclear ribonucleoprotein Q	GO:0000166; F:nucleotide binding; IEA:InterPro
O60506	SYNCRIP	Heterogeneous nuclear ribonucleoprotein Q	GO:0008143; F:poly(A) binding; IEA:Ensembl
O60506	SYNCRIP	Heterogeneous nuclear ribonucleoprotein Q	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O60506	SYNCRIP	Heterogeneous nuclear ribonucleoprotein Q	GO:0005515; F:protein binding; IPI:IntAct
O60506	SYNCRIP	Heterogeneous nuclear ribonucleoprotein Q	GO:0003723; F:RNA binding; TAS:ProtInc
O60506	SYNCRIP	Heterogeneous nuclear ribonucleoprotein Q	GO:0071346; P:cellular response to interferon-gamma; IDA:UniProtKB
O60506	SYNCRIP	Heterogeneous nuclear ribonucleoprotein Q	GO:0070934; P:CRD-mediated mRNA stabilization; IMP:UniProtKB
O60506	SYNCRIP	Heterogeneous nuclear ribonucleoprotein Q	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
O60506	SYNCRIP	Heterogeneous nuclear ribonucleoprotein Q	GO:0017148; P:negative regulation of translation; IDA:UniProtKB
O60506	SYNCRIP	Heterogeneous nuclear ribonucleoprotein Q	GO:0006396; P:RNA processing; TAS:ProtInc
O60506	SYNCRIP	Heterogeneous nuclear ribonucleoprotein Q	GO:0008380; P:RNA splicing; TAS:ProtInc
O60506	SYNCRIP	Heterogeneous nuclear ribonucleoprotein Q	GO:0016032; P:viral process; IEA:UniProtKB-KW
O43390	HNRNPR	Heterogeneous nuclear ribonucleoprotein R	GO:0003676; F:nucleic acid binding; IEA:InterPro
O43390	HNRNPR	Heterogeneous nuclear ribonucleoprotein R	GO:0000166; F:nucleotide binding; IEA:InterPro
O43390	HNRNPR	Heterogeneous nuclear ribonucleoprotein R	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O43390	HNRNPR	Heterogeneous nuclear ribonucleoprotein R	GO:0005515; F:protein binding; IPI:IntAct
O43390	HNRNPR	Heterogeneous nuclear ribonucleoprotein R	GO:0003723; F:RNA binding; NAS:UniProtKB
O43390	HNRNPR	Heterogeneous nuclear ribonucleoprotein R	GO:0010467; P:gene expression; TAS:Reactome
O43390	HNRNPR	Heterogeneous nuclear ribonucleoprotein R	GO:0006397; P:mRNA processing; NAS:UniProtKB
O43390	HNRNPR	Heterogeneous nuclear ribonucleoprotein R	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
O43390	HNRNPR	Heterogeneous nuclear ribonucleoprotein R	GO:0008380; P:RNA splicing; TAS:Reactome
Q00839	HNRNPU	Heterogeneous nuclear ribonucleoprotein U	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q00839	HNRNPU	Heterogeneous nuclear ribonucleoprotein U	GO:0003677; F:DNA binding; TAS:ProtInc
Q00839	HNRNPU	Heterogeneous nuclear ribonucleoprotein U	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q00839	HNRNPU	Heterogeneous nuclear ribonucleoprotein U	GO:0005515; F:protein binding; IPI:UniProtKB
Q00839	HNRNPU	Heterogeneous nuclear ribonucleoprotein U	GO:0003723; F:RNA binding; TAS:ProtInc
Q00839	HNRNPU	Heterogeneous nuclear ribonucleoprotein U	GO:0070934; P:CRD-mediated mRNA stabilization; IMP:UniProtKB
Q00839	HNRNPU	Heterogeneous nuclear ribonucleoprotein U	GO:0010467; P:gene expression; TAS:Reactome
Q00839	HNRNPU	Heterogeneous nuclear ribonucleoprotein U	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q00839	HNRNPU	Heterogeneous nuclear ribonucleoprotein U	GO:0006396; P:RNA processing; TAS:ProtInc
Q00839	HNRNPU	Heterogeneous nuclear ribonucleoprotein U	GO:0008380; P:RNA splicing; TAS:Reactome
Q86XE5	HOGA1	4-hydroxy-2-oxoglutarate aldolase, mitochondrial	GO:0008700; F:4-hydroxy-2-oxoglutarate aldolase activity; ISS:UniProtKB
Q86XE5	HOGA1	4-hydroxy-2-oxoglutarate aldolase, mitochondrial	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
Q86XE5	HOGA1	4-hydroxy-2-oxoglutarate aldolase, mitochondrial	GO:0019470; P:4-hydroxyproline catabolic process; IDA:BHF-UCL
Q86XE5	HOGA1	4-hydroxy-2-oxoglutarate aldolase, mitochondrial	GO:0009436; P:glyoxylate catabolic process; IMP:UniProtKB
Q86XE5	HOGA1	4-hydroxy-2-oxoglutarate aldolase, mitochondrial	GO:0046487; P:glyoxylate metabolic process; IDA:BHF-UCL
Q86XE5	HOGA1	4-hydroxy-2-oxoglutarate aldolase, mitochondrial	GO:0033609; P:oxalate metabolic process; IMP:BHF-UCL
Q86XE5	HOGA1	4-hydroxy-2-oxoglutarate aldolase, mitochondrial	GO:0042866; P:pyruvate biosynthetic process; IDA:BHF-UCL
Q9BYM8	RBCK1	RanBP-type and C3HC4-type zinc finger-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BYM8	RBCK1	RanBP-type and C3HC4-type zinc finger-containing protein 1	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
Q9BYM8	RBCK1	RanBP-type and C3HC4-type zinc finger-containing protein 1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9BYM8	RBCK1	RanBP-type and C3HC4-type zinc finger-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BYM8	RBCK1	RanBP-type and C3HC4-type zinc finger-containing protein 1	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q9BYM8	RBCK1	RanBP-type and C3HC4-type zinc finger-containing protein 1	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q9BYM8	RBCK1	RanBP-type and C3HC4-type zinc finger-containing protein 1	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl
Q9BYM8	RBCK1	RanBP-type and C3HC4-type zinc finger-containing protein 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q9BYM8	RBCK1	RanBP-type and C3HC4-type zinc finger-containing protein 1	GO:0042346; P:positive regulation of NF-kappaB import into nucleus; IEA:Ensembl
Q9BYM8	RBCK1	RanBP-type and C3HC4-type zinc finger-containing protein 1	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q9BYM8	RBCK1	RanBP-type and C3HC4-type zinc finger-containing protein 1	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q9BYM8	RBCK1	RanBP-type and C3HC4-type zinc finger-containing protein 1	GO:0097039; P:protein linear polyubiquitination; IDA:UniProtKB
Q9BYM8	RBCK1	RanBP-type and C3HC4-type zinc finger-containing protein 1	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q9BYM8	RBCK1	RanBP-type and C3HC4-type zinc finger-containing protein 1	GO:0050852; P:T cell receptor signaling pathway; IDA:UniProtKB
Q9BYM8	RBCK1	RanBP-type and C3HC4-type zinc finger-containing protein 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q86YM7	HOMER1	Homer protein homolog 1	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q86YM7	HOMER1	Homer protein homolog 1	GO:0035591; F:signaling adaptor activity; IC:BHF-UCL
Q86YM7	HOMER1	Homer protein homolog 1	GO:0048148; P:behavioral response to cocaine; IEA:Ensembl
Q86YM7	HOMER1	Homer protein homolog 1	GO:0048875; P:chemical homeostasis within a tissue; IEA:Ensembl
Q86YM7	HOMER1	Homer protein homolog 1	GO:0007623; P:circadian rhythm; IEA:Ensembl
Q86YM7	HOMER1	Homer protein homolog 1	GO:0007206; P:phospholipase C-activating G-protein coupled glutamate receptor signaling pathway; TAS:ProtInc
Q86YM7	HOMER1	Homer protein homolog 1	GO:0051928; P:positive regulation of calcium ion transport; IEA:Ensembl
Q86YM7	HOMER1	Homer protein homolog 1	GO:0009967; P:positive regulation of signal transduction; IC:BHF-UCL
Q86YM7	HOMER1	Homer protein homolog 1	GO:0035418; P:protein localization to synapse; IEA:Ensembl
Q86YM7	HOMER1	Homer protein homolog 1	GO:0090279; P:regulation of calcium ion import; IEA:Ensembl
Q86YM7	HOMER1	Homer protein homolog 1	GO:2001257; P:regulation of cation channel activity; TAS:BHF-UCL
Q86YM7	HOMER1	Homer protein homolog 1	GO:2001256; P:regulation of store-operated calcium entry; TAS:BHF-UCL
Q86YM7	HOMER1	Homer protein homolog 1	GO:0051592; P:response to calcium ion; IDA:BHF-UCL
Q86YM7	HOMER1	Homer protein homolog 1	GO:0035094; P:response to nicotine; IEA:Ensembl
Q86YM7	HOMER1	Homer protein homolog 1	GO:0003009; P:skeletal muscle contraction; IEA:Ensembl
Q86YM7	HOMER1	Homer protein homolog 1	GO:0048741; P:skeletal muscle fiber development; IEA:Ensembl
Q86YM7	HOMER1	Homer protein homolog 1	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q9NSB8	HOMER2	Homer protein homolog 2	GO:0048148; P:behavioral response to cocaine; IEA:Ensembl
Q9NSB8	HOMER2	Homer protein homolog 2	GO:0035584; P:calcium-mediated signaling using intracellular calcium source; IEA:Ensembl
Q9NSB8	HOMER2	Homer protein homolog 2	GO:0048875; P:chemical homeostasis within a tissue; IEA:Ensembl
Q9NSB8	HOMER2	Homer protein homolog 2	GO:0007216; P:G-protein coupled glutamate receptor signaling pathway; TAS:ProtInc
Q9NSB8	HOMER2	Homer protein homolog 2	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; IEA:Ensembl
Q9NSC5	HOMER3	Homer protein homolog 3	GO:0005515; F:protein binding; IPI:IntAct
Q9NSC5	HOMER3	Homer protein homolog 3	GO:0007216; P:G-protein coupled glutamate receptor signaling pathway; TAS:ProtInc
Q9NSC5	HOMER3	Homer protein homolog 3	GO:0006605; P:protein targeting; TAS:UniProtKB
Q8IX15	HOMEZ	Homeobox and leucine zipper protein Homez	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q8IX15	HOMEZ	Homeobox and leucine zipper protein Homez	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8IX15	HOMEZ	Homeobox and leucine zipper protein Homez	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UJC3	HOOK1	Protein Hook homolog 1	GO:0042802; F:identical protein binding; IPI:UniProtKB
Q9UJC3	HOOK1	Protein Hook homolog 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UJC3	HOOK1	Protein Hook homolog 1	GO:0045022; P:early endosome to late endosome transport; IMP:UniProtKB
Q9UJC3	HOOK1	Protein Hook homolog 1	GO:0007032; P:endosome organization; IMP:UniProtKB
Q9UJC3	HOOK1	Protein Hook homolog 1	GO:0008333; P:endosome to lysosome transport; IMP:UniProtKB
Q9UJC3	HOOK1	Protein Hook homolog 1	GO:0007040; P:lysosome organization; IMP:UniProtKB
Q9UJC3	HOOK1	Protein Hook homolog 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9UJC3	HOOK1	Protein Hook homolog 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9UJC3	HOOK1	Protein Hook homolog 1	GO:0007286; P:spermatid development; IEA:Ensembl
Q86VS8	HOOK3	Protein Hook homolog 3	GO:0042802; F:identical protein binding; IPI:UniProtKB
Q86VS8	HOOK3	Protein Hook homolog 3	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q86VS8	HOOK3	Protein Hook homolog 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q86VS8	HOOK3	Protein Hook homolog 3	GO:0031122; P:cytoplasmic microtubule organization; IMP:UniProtKB
Q86VS8	HOOK3	Protein Hook homolog 3	GO:0045022; P:early endosome to late endosome transport; IMP:UniProtKB
Q86VS8	HOOK3	Protein Hook homolog 3	GO:0007032; P:endosome organization; IMP:UniProtKB
Q86VS8	HOOK3	Protein Hook homolog 3	GO:0008333; P:endosome to lysosome transport; IMP:UniProtKB
Q86VS8	HOOK3	Protein Hook homolog 3	GO:0051645; P:Golgi localization; IMP:UniProtKB
Q86VS8	HOOK3	Protein Hook homolog 3	GO:0022027; P:interkinetic nuclear migration; ISS:BHF-UCL
Q86VS8	HOOK3	Protein Hook homolog 3	GO:0007040; P:lysosome organization; IMP:UniProtKB
Q86VS8	HOOK3	Protein Hook homolog 3	GO:0034454; P:microtubule anchoring at centrosome; ISS:BHF-UCL
Q86VS8	HOOK3	Protein Hook homolog 3	GO:0050768; P:negative regulation of neurogenesis; ISS:BHF-UCL
Q86VS8	HOOK3	Protein Hook homolog 3	GO:0097150; P:neuronal stem cell maintenance; IEA:Ensembl
Q86VS8	HOOK3	Protein Hook homolog 3	GO:0071539; P:protein localization to centrosome; ISS:BHF-UCL
Q86VS8	HOOK3	Protein Hook homolog 3	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96ED9	HOOK2	Protein Hook homolog 2	GO:0042802; F:identical protein binding; IPI:UniProtKB
Q96ED9	HOOK2	Protein Hook homolog 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q96ED9	HOOK2	Protein Hook homolog 2	GO:0045022; P:early endosome to late endosome transport; IMP:UniProtKB
Q96ED9	HOOK2	Protein Hook homolog 2	GO:0006897; P:endocytosis; TAS:ProtInc
Q96ED9	HOOK2	Protein Hook homolog 2	GO:0007032; P:endosome organization; IMP:UniProtKB
Q96ED9	HOOK2	Protein Hook homolog 2	GO:0008333; P:endosome to lysosome transport; IMP:UniProtKB
Q96ED9	HOOK2	Protein Hook homolog 2	GO:0007040; P:lysosome organization; IMP:UniProtKB
Q96ED9	HOOK2	Protein Hook homolog 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9P2W1	PSMC3IP	Homologous-pairing protein 2 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9P2W1	PSMC3IP	Homologous-pairing protein 2 homolog	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IMP:UniProtKB
Q9P2W1	PSMC3IP	Homologous-pairing protein 2 homolog	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q9P2W1	PSMC3IP	Homologous-pairing protein 2 homolog	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q9P2W1	PSMC3IP	Homologous-pairing protein 2 homolog	GO:2001141; P:regulation of RNA biosynthetic process; IMP:GOC
Q9BPY8	HOPX	Homeodomain-only protein	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9BPY8	HOPX	Homeodomain-only protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9BPY8	HOPX	Homeodomain-only protein	GO:0007507; P:heart development; IEA:Ensembl
Q9BPY8	HOPX	Homeodomain-only protein	GO:0016575; P:histone deacetylation; IEA:Ensembl
Q9BPY8	HOPX	Homeodomain-only protein	GO:0048286; P:lung alveolus development; IEA:Ensembl
Q9BPY8	HOPX	Homeodomain-only protein	GO:0045596; P:negative regulation of cell differentiation; IDA:MGI
Q9BPY8	HOPX	Homeodomain-only protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9BPY8	HOPX	Homeodomain-only protein	GO:0043415; P:positive regulation of skeletal muscle tissue regeneration; IEA:Ensembl
Q9BPY8	HOPX	Homeodomain-only protein	GO:0051155; P:positive regulation of striated muscle cell differentiation; IEA:Ensembl
Q9BPY8	HOPX	Homeodomain-only protein	GO:0008016; P:regulation of heart contraction; IEA:Ensembl
Q9BPY8	HOPX	Homeodomain-only protein	GO:0043393; P:regulation of protein binding; IEA:Ensembl
Q9BPY8	HOPX	Homeodomain-only protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BPY8	HOPX	Homeodomain-only protein	GO:0001829; P:trophectodermal cell differentiation; IDA:MGI
Q86X24	HORMAD1	HORMA domain-containing protein 1	GO:0001824; P:blastocyst development; ISS:UniProtKB
Q86X24	HORMAD1	HORMA domain-containing protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q86X24	HORMAD1	HORMA domain-containing protein 1	GO:0042138; P:meiotic DNA double-strand break formation; ISS:UniProtKB
Q86X24	HORMAD1	HORMA domain-containing protein 1	GO:0007126; P:meiotic nuclear division; ISS:UniProtKB
Q86X24	HORMAD1	HORMA domain-containing protein 1	GO:0051598; P:meiotic recombination checkpoint; ISS:UniProtKB
Q86X24	HORMAD1	HORMA domain-containing protein 1	GO:0051177; P:meiotic sister chromatid cohesion; ISS:UniProtKB
Q86X24	HORMAD1	HORMA domain-containing protein 1	GO:0048477; P:oogenesis; ISS:UniProtKB
Q86X24	HORMAD1	HORMA domain-containing protein 1	GO:0060629; P:regulation of homologous chromosome segregation; ISS:UniProtKB
Q86X24	HORMAD1	HORMA domain-containing protein 1	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q86X24	HORMAD1	HORMA domain-containing protein 1	GO:0007130; P:synaptonemal complex assembly; ISS:UniProtKB
Q8N7B1	HORMAD2	HORMA domain-containing protein 2	GO:0007126; P:meiotic nuclear division; ISS:UniProtKB
Q8N7B1	HORMAD2	HORMA domain-containing protein 2	GO:0051177; P:meiotic sister chromatid cohesion; ISS:UniProtKB
Q86YZ3	HRNR	Hornerin	GO:0005509; F:calcium ion binding; IEA:InterPro
Q86YZ3	HRNR	Hornerin	GO:0061436; P:establishment of skin barrier; IEP:UniProt
Q86YZ3	HRNR	Hornerin	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q8IWW8	ADHFE1	Hydroxyacid-oxoacid transhydrogenase, mitochondrial	GO:0047988; F:hydroxyacid-oxoacid transhydrogenase activity; IDA:UniProtKB
Q8IWW8	ADHFE1	Hydroxyacid-oxoacid transhydrogenase, mitochondrial	GO:0046872; F:metal ion binding; IEA:InterPro
Q8IWW8	ADHFE1	Hydroxyacid-oxoacid transhydrogenase, mitochondrial	GO:0006103; P:2-oxoglutarate metabolic process; TAS:Reactome
Q8IWW8	ADHFE1	Hydroxyacid-oxoacid transhydrogenase, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q8IWW8	ADHFE1	Hydroxyacid-oxoacid transhydrogenase, mitochondrial	GO:0015993; P:molecular hydrogen transport; IDA:UniProtKB
Q8IWW8	ADHFE1	Hydroxyacid-oxoacid transhydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5SSJ5	HP1BP3	Heterochromatin protein 1-binding protein 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5SSJ5	HP1BP3	Heterochromatin protein 1-binding protein 3	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q9NZL4	HSPBP1	Hsp70-binding protein 1	GO:0004857; F:enzyme inhibitor activity; TAS:ProtInc
Q9NZL4	HSPBP1	Hsp70-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NZL4	HSPBP1	Hsp70-binding protein 1	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
Q9NZL4	HSPBP1	Hsp70-binding protein 1	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:BHF-UCL
Q9NZL4	HSPBP1	Hsp70-binding protein 1	GO:0031398; P:positive regulation of protein ubiquitination; IDA:BHF-UCL
Q9NZL4	HSPBP1	Hsp70-binding protein 1	GO:0006457; P:protein folding; TAS:ProtInc
P84074	HPCA	Neuron-specific calcium-binding protein hippocalcin	GO:0003779; F:actin binding; IDA:UniProtKB
P84074	HPCA	Neuron-specific calcium-binding protein hippocalcin	GO:0005509; F:calcium ion binding; NAS:UniProtKB
P84074	HPCA	Neuron-specific calcium-binding protein hippocalcin	GO:0048839; P:inner ear development; IEA:Ensembl
P37235	HPCAL1	Hippocalcin-like protein 1	GO:0005509; F:calcium ion binding; TAS:ProtInc
Q9UM19	HPCAL4	Hippocalcin-like protein 4	GO:0005246; F:calcium channel regulator activity; IEA:Ensembl
Q9UM19	HPCAL4	Hippocalcin-like protein 4	GO:0005509; F:calcium ion binding; TAS:ProtInc
Q9UM19	HPCAL4	Hippocalcin-like protein 4	GO:0007417; P:central nervous system development; TAS:ProtInc
Q96IR7	HPDL	4-hydroxyphenylpyruvate dioxygenase-like protein	GO:0003868; F:4-hydroxyphenylpyruvate dioxygenase activity; IEA:InterPro
Q96IR7	HPDL	4-hydroxyphenylpyruvate dioxygenase-like protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96IR7	HPDL	4-hydroxyphenylpyruvate dioxygenase-like protein	GO:0009072; P:aromatic amino acid family metabolic process; IEA:InterPro
O60760	HPGDS	Hematopoietic prostaglandin D synthase	GO:0005509; F:calcium ion binding; IDA:UniProtKB
O60760	HPGDS	Hematopoietic prostaglandin D synthase	GO:0004364; F:glutathione transferase activity; IEA:UniProtKB-EC
O60760	HPGDS	Hematopoietic prostaglandin D synthase	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
O60760	HPGDS	Hematopoietic prostaglandin D synthase	GO:0004667; F:prostaglandin-D synthase activity; IDA:UniProtKB
O60760	HPGDS	Hematopoietic prostaglandin D synthase	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
O60760	HPGDS	Hematopoietic prostaglandin D synthase	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
O60760	HPGDS	Hematopoietic prostaglandin D synthase	GO:0019371; P:cyclooxygenase pathway; TAS:Reactome
O60760	HPGDS	Hematopoietic prostaglandin D synthase	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
O60760	HPGDS	Hematopoietic prostaglandin D synthase	GO:0007626; P:locomotory behavior; TAS:ProtInc
O60760	HPGDS	Hematopoietic prostaglandin D synthase	GO:0006693; P:prostaglandin metabolic process; IDA:UniProtKB
O60760	HPGDS	Hematopoietic prostaglandin D synthase	GO:0007165; P:signal transduction; NAS:ProtInc
O60760	HPGDS	Hematopoietic prostaglandin D synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60760	HPGDS	Hematopoietic prostaglandin D synthase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q6MZM0	HEPHL1	Hephaestin-like protein 1	GO:0005507; F:copper ion binding; IEA:InterPro
Q6MZM0	HEPHL1	Hephaestin-like protein 1	GO:0004322; F:ferroxidase activity; IDA:MGI
Q6MZM0	HEPHL1	Hephaestin-like protein 1	GO:0006825; P:copper ion transport; IEA:UniProtKB-KW
Q6MZM0	HEPHL1	Hephaestin-like protein 1	GO:0055114; P:oxidation-reduction process; IC:MGI
P10915	HAPLN1	Hyaluronan and proteoglycan link protein 1	GO:0005540; F:hyaluronic acid binding; IEA:UniProtKB-KW
P10915	HAPLN1	Hyaluronan and proteoglycan link protein 1	GO:0007155; P:cell adhesion; IEA:InterPro
P10915	HAPLN1	Hyaluronan and proteoglycan link protein 1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q9GZV7	HAPLN2	Hyaluronan and proteoglycan link protein 2	GO:0005540; F:hyaluronic acid binding; IEA:UniProtKB-KW
Q9GZV7	HAPLN2	Hyaluronan and proteoglycan link protein 2	GO:0007155; P:cell adhesion; IEA:InterPro
Q96S86	HAPLN3	Hyaluronan and proteoglycan link protein 3	GO:0005540; F:hyaluronic acid binding; IEA:UniProtKB-KW
Q96S86	HAPLN3	Hyaluronan and proteoglycan link protein 3	GO:0007155; P:cell adhesion; IEA:InterPro
Q86UW8	HAPLN4	Hyaluronan and proteoglycan link protein 4	GO:0005540; F:hyaluronic acid binding; IEA:UniProtKB-KW
Q86UW8	HAPLN4	Hyaluronan and proteoglycan link protein 4	GO:0007155; P:cell adhesion; IEA:InterPro
P32754	HPD	4-hydroxyphenylpyruvate dioxygenase	GO:0003868; F:4-hydroxyphenylpyruvate dioxygenase activity; ISS:UniProtKB
P32754	HPD	4-hydroxyphenylpyruvate dioxygenase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P32754	HPD	4-hydroxyphenylpyruvate dioxygenase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P32754	HPD	4-hydroxyphenylpyruvate dioxygenase	GO:0006559; P:L-phenylalanine catabolic process; TAS:Reactome
P32754	HPD	4-hydroxyphenylpyruvate dioxygenase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P32754	HPD	4-hydroxyphenylpyruvate dioxygenase	GO:0006572; P:tyrosine catabolic process; ISS:UniProtKB
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0052657; F:guanine phosphoribosyltransferase activity; IDA:UniProtKB
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0004422; F:hypoxanthine phosphoribosyltransferase activity; IDA:UniProtKB
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0005515; F:protein binding; IPI:IntAct
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0006168; P:adenine salvage; IBA:RefGenome
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0021954; P:central nervous system neuron development; IEA:Ensembl
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0021895; P:cerebral cortex neuron differentiation; IEA:Ensembl
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0019835; P:cytolysis; IEA:Ensembl
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0048813; P:dendrite morphogenesis; IEA:Ensembl
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0042417; P:dopamine metabolic process; IEA:Ensembl
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0046038; P:GMP catabolic process; IDA:UniProtKB
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0032263; P:GMP salvage; IBA:RefGenome
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0007625; P:grooming behavior; IEA:Ensembl
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0006178; P:guanine salvage; IDA:UniProtKB
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0046100; P:hypoxanthine metabolic process; IMP:UniProtKB
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0043103; P:hypoxanthine salvage; IDA:UniProtKB
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0046040; P:IMP metabolic process; IDA:UniProtKB
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0032264; P:IMP salvage; IBA:RefGenome
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0007626; P:locomotory behavior; IEA:Ensembl
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0046651; P:lymphocyte proliferation; IEA:Ensembl
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0045964; P:positive regulation of dopamine metabolic process; IMP:UniProtKB
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0051289; P:protein homotetramerization; IDA:UniProtKB
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0006164; P:purine nucleotide biosynthetic process; IMP:UniProtKB
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0006166; P:purine ribonucleoside salvage; IMP:UniProtKB
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0043101; P:purine-containing compound salvage; TAS:Reactome
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0001975; P:response to amphetamine; IEA:Ensembl
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P00492	HPRT1	Hypoxanthine-guanine phosphoribosyltransferase	GO:0021756; P:striatum development; IEA:Ensembl
Q92902	HPS1	Hermansky-Pudlak syndrome 1 protein	GO:0005515; F:protein binding; IPI:IntAct
Q92902	HPS1	Hermansky-Pudlak syndrome 1 protein	GO:0046983; F:protein dimerization activity; IPI:UniProtKB
Q92902	HPS1	Hermansky-Pudlak syndrome 1 protein	GO:0007596; P:blood coagulation; IEA:Ensembl
Q92902	HPS1	Hermansky-Pudlak syndrome 1 protein	GO:0048069; P:eye pigmentation; IEA:Ensembl
Q92902	HPS1	Hermansky-Pudlak syndrome 1 protein	GO:0007040; P:lysosome organization; TAS:ProtInc
Q92902	HPS1	Hermansky-Pudlak syndrome 1 protein	GO:0030318; P:melanocyte differentiation; IEA:Ensembl
Q92902	HPS1	Hermansky-Pudlak syndrome 1 protein	GO:0032816; P:positive regulation of natural killer cell activation; IEA:Ensembl
Q92902	HPS1	Hermansky-Pudlak syndrome 1 protein	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
Q92902	HPS1	Hermansky-Pudlak syndrome 1 protein	GO:0033299; P:secretion of lysosomal enzymes; IEA:Ensembl
Q92902	HPS1	Hermansky-Pudlak syndrome 1 protein	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q9NQG7	HPS4	Hermansky-Pudlak syndrome 4 protein	GO:0005515; F:protein binding; IPI:IntAct
Q9NQG7	HPS4	Hermansky-Pudlak syndrome 4 protein	GO:0046983; F:protein dimerization activity; IPI:UniProtKB
Q9NQG7	HPS4	Hermansky-Pudlak syndrome 4 protein	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q9NQG7	HPS4	Hermansky-Pudlak syndrome 4 protein	GO:0007596; P:blood coagulation; IEA:Ensembl
Q9NQG7	HPS4	Hermansky-Pudlak syndrome 4 protein	GO:0007599; P:hemostasis; TAS:UniProtKB
Q9NQG7	HPS4	Hermansky-Pudlak syndrome 4 protein	GO:0007040; P:lysosome organization; IDA:UniProtKB
Q9NQG7	HPS4	Hermansky-Pudlak syndrome 4 protein	GO:0030318; P:melanocyte differentiation; IEA:Ensembl
Q9NQG7	HPS4	Hermansky-Pudlak syndrome 4 protein	GO:0048075; P:positive regulation of eye pigmentation; TAS:UniProtKB
Q9NQG7	HPS4	Hermansky-Pudlak syndrome 4 protein	GO:0050821; P:protein stabilization; IPI:UniProtKB
Q9NQG7	HPS4	Hermansky-Pudlak syndrome 4 protein	GO:0006605; P:protein targeting; IDA:UniProtKB
Q969F9	HPS3	Hermansky-Pudlak syndrome 3 protein	GO:0006996; P:organelle organization; IEA:Ensembl
Q969F9	HPS3	Hermansky-Pudlak syndrome 3 protein	GO:0043473; P:pigmentation; IEA:Ensembl
Q9UPZ3	HPS5	Hermansky-Pudlak syndrome 5 protein	GO:0007596; P:blood coagulation; IEA:Ensembl
Q9UPZ3	HPS5	Hermansky-Pudlak syndrome 5 protein	GO:0006996; P:organelle organization; IEA:Ensembl
Q9UPZ3	HPS5	Hermansky-Pudlak syndrome 5 protein	GO:0043473; P:pigmentation; IEA:Ensembl
Q86YV9	HPS6	Hermansky-Pudlak syndrome 6 protein	GO:0007596; P:blood coagulation; IEA:Ensembl
Q86YV9	HPS6	Hermansky-Pudlak syndrome 6 protein	GO:0030318; P:melanocyte differentiation; IEA:Ensembl
Q86YV9	HPS6	Hermansky-Pudlak syndrome 6 protein	GO:0006996; P:organelle organization; IEA:Ensembl
Q8WWQ2	HPSE2	Inactive heparanase-2	GO:0043395; F:heparan sulfate proteoglycan binding; IDA:UniProtKB
Q8WWQ2	HPSE2	Inactive heparanase-2	GO:0030305; F:heparanase activity; TAS:UniProtKB
Q8WWQ2	HPSE2	Inactive heparanase-2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q8WWQ2	HPSE2	Inactive heparanase-2	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
Q8WWQ2	HPSE2	Inactive heparanase-2	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q8WWQ2	HPSE2	Inactive heparanase-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y251	HPSE	Heparanase	GO:0004566; F:beta-glucuronidase activity; TAS:ProtInc
Q9Y251	HPSE	Heparanase	GO:0030305; F:heparanase activity; IDA:UniProtKB
Q9Y251	HPSE	Heparanase	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y251	HPSE	Heparanase	GO:0046983; F:protein dimerization activity; IDA:UniProtKB
Q9Y251	HPSE	Heparanase	GO:0045545; F:syndecan binding; IDA:UniProtKB
Q9Y251	HPSE	Heparanase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9Y251	HPSE	Heparanase	GO:0007160; P:cell-matrix adhesion; IDA:UniProtKB
Q9Y251	HPSE	Heparanase	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
Q9Y251	HPSE	Heparanase	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9Y251	HPSE	Heparanase	GO:0030200; P:heparan sulfate proteoglycan catabolic process; IDA:UniProtKB
Q9Y251	HPSE	Heparanase	GO:0030194; P:positive regulation of blood coagulation; IDA:UniProtKB
Q9Y251	HPSE	Heparanase	GO:0051798; P:positive regulation of hair follicle development; IEA:Ensembl
Q9Y251	HPSE	Heparanase	GO:0033690; P:positive regulation of osteoblast proliferation; IDA:UniProtKB
Q9Y251	HPSE	Heparanase	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:UniProtKB
Q9Y251	HPSE	Heparanase	GO:0010575; P:positive regulation vascular endothelial growth factor production; IDA:UniProtKB
Q9Y251	HPSE	Heparanase	GO:0006029; P:proteoglycan metabolic process; TAS:ProtInc
Q9Y251	HPSE	Heparanase	GO:0051797; P:regulation of hair follicle development; IDA:UniProtKB
Q9Y251	HPSE	Heparanase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y251	HPSE	Heparanase	GO:0061042; P:vascular wound healing; IEA:Ensembl
P00738	HP	Haptoglobin	GO:0016209; F:antioxidant activity; IEA:UniProtKB-KW
P00738	HP	Haptoglobin	GO:0003824; F:catalytic activity; IEA:InterPro
P00738	HP	Haptoglobin	GO:0030492; F:hemoglobin binding; IDA:BHF-UCL
P00738	HP	Haptoglobin	GO:0005515; F:protein binding; IPI:IntAct
P00738	HP	Haptoglobin	GO:0006953; P:acute-phase response; IEA:UniProtKB-KW
P00738	HP	Haptoglobin	GO:0006952; P:defense response; TAS:ProtInc
P00738	HP	Haptoglobin	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
P00738	HP	Haptoglobin	GO:0002376; P:immune system process; IEA:UniProtKB-KW
P00738	HP	Haptoglobin	GO:2000296; P:negative regulation of hydrogen peroxide catabolic process; IDA:BHF-UCL
P00738	HP	Haptoglobin	GO:0051354; P:negative regulation of oxidoreductase activity; IDA:BHF-UCL
P00738	HP	Haptoglobin	GO:0010942; P:positive regulation of cell death; IDA:BHF-UCL
P00738	HP	Haptoglobin	GO:0042542; P:response to hydrogen peroxide; IDA:BHF-UCL
P00739	HPR	Haptoglobin-related protein	GO:0003824; F:catalytic activity; IEA:InterPro
P00739	HPR	Haptoglobin-related protein	GO:0030492; F:hemoglobin binding; NAS:UniProtKB
Q9BVR0	HERC2P3	Putative HERC2-like protein 3	GO:0046872; F:metal ion binding; IEA:InterPro
Q9BVR0	HERC2P3	Putative HERC2-like protein 3	GO:0004842; F:ubiquitin-protein ligase activity; IEA:InterPro
Q6P1K1	SLC48A1	Heme transporter HRG1	GO:0015232; F:heme transporter activity; IEA:InterPro
Q6P1K1	SLC48A1	Heme transporter HRG1	GO:0015886; P:heme transport; IMP:MGI
P04196	HRG	Histidine-rich glycoprotein	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IEA:InterPro
P04196	HRG	Histidine-rich glycoprotein	GO:0020037; F:heme binding; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0043395; F:heparan sulfate proteoglycan binding; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0008201; F:heparin binding; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0019865; F:immunoglobulin binding; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0046872; F:metal ion binding; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0005515; F:protein binding; IPI:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0005102; F:receptor binding; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:Ensembl
P04196	HRG	Histidine-rich glycoprotein	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P04196	HRG	Histidine-rich glycoprotein	GO:0007596; P:blood coagulation; TAS:Reactome
P04196	HRG	Histidine-rich glycoprotein	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
P04196	HRG	Histidine-rich glycoprotein	GO:0050832; P:defense response to fungus; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0042730; P:fibrinolysis; TAS:Reactome
P04196	HRG	Histidine-rich glycoprotein	GO:0016525; P:negative regulation of angiogenesis; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0043537; P:negative regulation of blood vessel endothelial cell migration; ISS:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0007162; P:negative regulation of cell adhesion; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0033629; P:negative regulation of cell adhesion mediated by integrin; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:2001027; P:negative regulation of endothelial cell chemotaxis; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0051918; P:negative regulation of fibrinolysis; IEA:Ensembl
P04196	HRG	Histidine-rich glycoprotein	GO:0010593; P:negative regulation of lamellipodium assembly; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:1900747; P:negative regulation of vascular endothelial growth factor signaling pathway; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0030168; P:platelet activation; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0002576; P:platelet degranulation; TAS:Reactome
P04196	HRG	Histidine-rich glycoprotein	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:2000504; P:positive regulation of blood vessel remodeling; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0051894; P:positive regulation of focal adhesion assembly; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0002839; P:positive regulation of immune response to tumor cell; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0032956; P:regulation of actin cytoskeleton organization; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0030193; P:regulation of blood coagulation; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0010468; P:regulation of gene expression; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0010543; P:regulation of platelet activation; ISS:UniProtKB
P04196	HRG	Histidine-rich glycoprotein	GO:0043254; P:regulation of protein complex assembly; IDA:UniProtKB
P35367	HRH1	Histamine H1 receptor	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P35367	HRH1	Histamine H1 receptor	GO:0004969; F:histamine receptor activity; ISS:BHF-UCL
P35367	HRH1	Histamine H1 receptor	GO:0071420; P:cellular response to histamine; ISS:BHF-UCL
P35367	HRH1	Histamine H1 receptor	GO:0048245; P:eosinophil chemotaxis; IEA:InterPro
P35367	HRH1	Histamine H1 receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P35367	HRH1	Histamine H1 receptor	GO:0006954; P:inflammatory response; TAS:ProtInc
P35367	HRH1	Histamine H1 receptor	GO:0048016; P:inositol phosphate-mediated signaling; ISS:BHF-UCL
P35367	HRH1	Histamine H1 receptor	GO:0007613; P:memory; IEA:Ensembl
P35367	HRH1	Histamine H1 receptor	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; TAS:ProtInc
P35367	HRH1	Histamine H1 receptor	GO:0032962; P:positive regulation of inositol trisphosphate biosynthetic process; ISS:BHF-UCL
P35367	HRH1	Histamine H1 receptor	GO:0045907; P:positive regulation of vasoconstriction; IEA:InterPro
P35367	HRH1	Histamine H1 receptor	GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl
P35367	HRH1	Histamine H1 receptor	GO:0043114; P:regulation of vascular permeability; IEA:InterPro
P35367	HRH1	Histamine H1 receptor	GO:0008542; P:visual learning; IEA:Ensembl
P25021	HRH2	Histamine H2 receptor	GO:0004969; F:histamine receptor activity; TAS:ProtInc
P25021	HRH2	Histamine H2 receptor	GO:0048565; P:digestive tract development; IEA:Ensembl
P25021	HRH2	Histamine H2 receptor	GO:0003382; P:epithelial cell morphogenesis; IEA:Ensembl
P25021	HRH2	Histamine H2 receptor	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P25021	HRH2	Histamine H2 receptor	GO:0001698; P:gastrin-induced gastric acid secretion; IEA:Ensembl
P25021	HRH2	Histamine H2 receptor	GO:0048732; P:gland development; IEA:Ensembl
P25021	HRH2	Histamine H2 receptor	GO:0001697; P:histamine-induced gastric acid secretion; IEA:Ensembl
P25021	HRH2	Histamine H2 receptor	GO:0006955; P:immune response; TAS:ProtInc
P25021	HRH2	Histamine H2 receptor	GO:0007613; P:memory; IEA:Ensembl
P25021	HRH2	Histamine H2 receptor	GO:0045907; P:positive regulation of vasoconstriction; IEA:InterPro
P25021	HRH2	Histamine H2 receptor	GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl
P25021	HRH2	Histamine H2 receptor	GO:0008542; P:visual learning; IEA:Ensembl
Q9Y5N1	HRH3	Histamine H3 receptor	GO:0008144; F:drug binding; IEA:Ensembl
Q9Y5N1	HRH3	Histamine H3 receptor	GO:0004969; F:histamine receptor activity; TAS:ProtInc
Q9Y5N1	HRH3	Histamine H3 receptor	GO:0007420; P:brain development; IEA:Ensembl
Q9Y5N1	HRH3	Histamine H3 receptor	GO:0042756; P:drinking behavior; IEA:Ensembl
Q9Y5N1	HRH3	Histamine H3 receptor	GO:0042755; P:eating behavior; IEA:Ensembl
Q9Y5N1	HRH3	Histamine H3 receptor	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
Q9Y5N1	HRH3	Histamine H3 receptor	GO:0007612; P:learning; IEA:Ensembl
Q9Y5N1	HRH3	Histamine H3 receptor	GO:0007613; P:memory; IEA:Ensembl
Q9Y5N1	HRH3	Histamine H3 receptor	GO:0007194; P:negative regulation of adenylate cyclase activity; IEA:Ensembl
Q9Y5N1	HRH3	Histamine H3 receptor	GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl
Q9Y5N1	HRH3	Histamine H3 receptor	GO:0014053; P:negative regulation of gamma-aminobutyric acid secretion; IEA:Ensembl
Q9Y5N1	HRH3	Histamine H3 receptor	GO:0014050; P:negative regulation of glutamate secretion; IEA:Ensembl
Q9Y5N1	HRH3	Histamine H3 receptor	GO:0014063; P:negative regulation of serotonin secretion; IEA:Ensembl
Q9Y5N1	HRH3	Histamine H3 receptor	GO:0007269; P:neurotransmitter secretion; TAS:ProtInc
Q9Y5N1	HRH3	Histamine H3 receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
Q9Y5N1	HRH3	Histamine H3 receptor	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
Q9Y5N1	HRH3	Histamine H3 receptor	GO:0014061; P:regulation of norepinephrine secretion; IEA:Ensembl
Q9Y5N1	HRH3	Histamine H3 receptor	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
Q9H3N8	HRH4	Histamine H4 receptor	GO:0004969; F:histamine receptor activity; NAS:UniProtKB
Q9H3N8	HRH4	Histamine H4 receptor	GO:0006954; P:inflammatory response; IEA:InterPro
Q9H3N8	HRH4	Histamine H4 receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:InterPro
Q9H3N8	HRH4	Histamine H4 receptor	GO:0043408; P:regulation of MAPK cascade; IEA:InterPro
O00198	HRK	Activator of apoptosis harakiri	GO:0005515; F:protein binding; IPI:IntAct
O00198	HRK	Activator of apoptosis harakiri	GO:0006915; P:apoptotic process; TAS:ProtInc
O00198	HRK	Activator of apoptosis harakiri	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
O00198	HRK	Activator of apoptosis harakiri	GO:0032464; P:positive regulation of protein homooligomerization; IDA:BHF-UCL
O00198	HRK	Activator of apoptosis harakiri	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IDA:BHF-UCL
P53816	PLA2G16	HRAS-like suppressor 3	GO:0052740; F:1-acyl-2-lysophosphatidylserine acylhydrolase activity; IEA:UniProtKB-EC
P53816	PLA2G16	HRAS-like suppressor 3	GO:0008970; F:phosphatidylcholine 1-acylhydrolase activity; IEA:UniProtKB-EC
P53816	PLA2G16	HRAS-like suppressor 3	GO:0052739; F:phosphatidylserine 1-acylhydrolase activity; IEA:UniProtKB-EC
P53816	PLA2G16	HRAS-like suppressor 3	GO:0004623; F:phospholipase A2 activity; IDA:UniProtKB
P53816	PLA2G16	HRAS-like suppressor 3	GO:0005515; F:protein binding; IPI:IntAct
P53816	PLA2G16	HRAS-like suppressor 3	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
P53816	PLA2G16	HRAS-like suppressor 3	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
P53816	PLA2G16	HRAS-like suppressor 3	GO:0045786; P:negative regulation of cell cycle; IEA:Ensembl
P53816	PLA2G16	HRAS-like suppressor 3	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
P53816	PLA2G16	HRAS-like suppressor 3	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
P53816	PLA2G16	HRAS-like suppressor 3	GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome
P53816	PLA2G16	HRAS-like suppressor 3	GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome
P53816	PLA2G16	HRAS-like suppressor 3	GO:0006644; P:phospholipid metabolic process; IDA:UniProtKB
P53816	PLA2G16	HRAS-like suppressor 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NWW9	HRASLS2	HRAS-like suppressor 2	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q9NWW9	HRASLS2	HRAS-like suppressor 2	GO:0016746; F:transferase activity, transferring acyl groups; IEA:UniProtKB-KW
Q9NWW9	HRASLS2	HRAS-like suppressor 2	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q9UL19	RARRES3	Retinoic acid receptor responder protein 3	GO:0004623; F:phospholipase A2 activity; IDA:UniProtKB
Q9UL19	RARRES3	Retinoic acid receptor responder protein 3	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q9UL19	RARRES3	Retinoic acid receptor responder protein 3	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q9UL19	RARRES3	Retinoic acid receptor responder protein 3	GO:0006644; P:phospholipid metabolic process; IDA:UniProtKB
Q96KN8	HRASLS5	Ca(2+)-independent N-acyltransferase	GO:0016746; F:transferase activity, transferring acyl groups; IEA:UniProtKB-KW
Q9HDD0	HRASLS	Phospholipid-metabolizing enzyme A-C1	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q9HDD0	HRASLS	Phospholipid-metabolizing enzyme A-C1	GO:0016740; F:transferase activity; IEA:UniProtKB-KW
Q9HDD0	HRASLS	Phospholipid-metabolizing enzyme A-C1	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q92598	HSPH1	Heat shock protein 105 kDa	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q92598	HSPH1	Heat shock protein 105 kDa	GO:0005515; F:protein binding; IPI:IntAct
Q92598	HSPH1	Heat shock protein 105 kDa	GO:0051085; P:chaperone mediated protein folding requiring cofactor; IEA:Ensembl
Q92598	HSPH1	Heat shock protein 105 kDa	GO:0045345; P:positive regulation of MHC class I biosynthetic process; TAS:BHF-UCL
Q92598	HSPH1	Heat shock protein 105 kDa	GO:0051135; P:positive regulation of NK T cell activation; TAS:BHF-UCL
Q92598	HSPH1	Heat shock protein 105 kDa	GO:0006986; P:response to unfolded protein; TAS:ProtInc
Q96MM6	HSPA12B	Heat shock 70 kDa protein 12B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43301	HSPA12A	Heat shock 70 kDa protein 12A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q7LGA3	HS2ST1	Heparan sulfate 2-O-sulfotransferase 1	GO:0008146; F:sulfotransferase activity; IEA:InterPro
Q7LGA3	HS2ST1	Heparan sulfate 2-O-sulfotransferase 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q7LGA3	HS2ST1	Heparan sulfate 2-O-sulfotransferase 1	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
Q7LGA3	HS2ST1	Heparan sulfate 2-O-sulfotransferase 1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q7LGA3	HS2ST1	Heparan sulfate 2-O-sulfotransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O14792	HS3ST1	Heparan sulfate glucosamine 3-O-sulfotransferase 1	GO:0008467; F:[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity; IEA:UniProtKB-EC
O14792	HS3ST1	Heparan sulfate glucosamine 3-O-sulfotransferase 1	GO:0008146; F:sulfotransferase activity; TAS:ProtInc
O14792	HS3ST1	Heparan sulfate glucosamine 3-O-sulfotransferase 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O14792	HS3ST1	Heparan sulfate glucosamine 3-O-sulfotransferase 1	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
O14792	HS3ST1	Heparan sulfate glucosamine 3-O-sulfotransferase 1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O14792	HS3ST1	Heparan sulfate glucosamine 3-O-sulfotransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y661	HS3ST4	Heparan sulfate glucosamine 3-O-sulfotransferase 4	GO:0008467; F:[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity; NAS:UniProtKB
Q9Y661	HS3ST4	Heparan sulfate glucosamine 3-O-sulfotransferase 4	GO:0030201; P:heparan sulfate proteoglycan metabolic process; NAS:UniProtKB
Q9Y278	HS3ST2	Heparan sulfate glucosamine 3-O-sulfotransferase 2	GO:0033871; F:[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity; IEA:UniProtKB-EC
Q9Y278	HS3ST2	Heparan sulfate glucosamine 3-O-sulfotransferase 2	GO:0008146; F:sulfotransferase activity; TAS:ProtInc
Q9Y278	HS3ST2	Heparan sulfate glucosamine 3-O-sulfotransferase 2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9Y278	HS3ST2	Heparan sulfate glucosamine 3-O-sulfotransferase 2	GO:0007623; P:circadian rhythm; IEA:Ensembl
Q9Y278	HS3ST2	Heparan sulfate glucosamine 3-O-sulfotransferase 2	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
Q9Y278	HS3ST2	Heparan sulfate glucosamine 3-O-sulfotransferase 2	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9Y278	HS3ST2	Heparan sulfate glucosamine 3-O-sulfotransferase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8IZT8	HS3ST5	Heparan sulfate glucosamine 3-O-sulfotransferase 5	GO:0050656; F:3'-phosphoadenosine 5'-phosphosulfate binding; NAS:UniProtKB
Q8IZT8	HS3ST5	Heparan sulfate glucosamine 3-O-sulfotransferase 5	GO:0008467; F:[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity; IDA:UniProtKB
Q8IZT8	HS3ST5	Heparan sulfate glucosamine 3-O-sulfotransferase 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IZT8	HS3ST5	Heparan sulfate glucosamine 3-O-sulfotransferase 5	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q8IZT8	HS3ST5	Heparan sulfate glucosamine 3-O-sulfotransferase 5	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
Q8IZT8	HS3ST5	Heparan sulfate glucosamine 3-O-sulfotransferase 5	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q8IZT8	HS3ST5	Heparan sulfate glucosamine 3-O-sulfotransferase 5	GO:0015015; P:heparan sulfate proteoglycan biosynthetic process, enzymatic modification; IDA:UniProtKB
Q8IZT8	HS3ST5	Heparan sulfate glucosamine 3-O-sulfotransferase 5	GO:0050819; P:negative regulation of coagulation; IDA:UniProtKB
Q8IZT8	HS3ST5	Heparan sulfate glucosamine 3-O-sulfotransferase 5	GO:0006477; P:protein sulfation; IDA:UniProtKB
Q8IZT8	HS3ST5	Heparan sulfate glucosamine 3-O-sulfotransferase 5	GO:0046596; P:regulation of viral entry into host cell; IDA:UniProtKB
Q8IZT8	HS3ST5	Heparan sulfate glucosamine 3-O-sulfotransferase 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96QI5	HS3ST6	Heparan sulfate glucosamine 3-O-sulfotransferase 6	GO:0008467; F:[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity; ISS:UniProtKB
Q96QI5	HS3ST6	Heparan sulfate glucosamine 3-O-sulfotransferase 6	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q96QI5	HS3ST6	Heparan sulfate glucosamine 3-O-sulfotransferase 6	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
Q96QI5	HS3ST6	Heparan sulfate glucosamine 3-O-sulfotransferase 6	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q96QI5	HS3ST6	Heparan sulfate glucosamine 3-O-sulfotransferase 6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y663	HS3ST3A1	Heparan sulfate glucosamine 3-O-sulfotransferase 3A1	GO:0033872; F:[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity; IEA:UniProtKB-EC
Q9Y663	HS3ST3A1	Heparan sulfate glucosamine 3-O-sulfotransferase 3A1	GO:0008146; F:sulfotransferase activity; TAS:ProtInc
Q9Y663	HS3ST3A1	Heparan sulfate glucosamine 3-O-sulfotransferase 3A1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9Y663	HS3ST3A1	Heparan sulfate glucosamine 3-O-sulfotransferase 3A1	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
Q9Y663	HS3ST3A1	Heparan sulfate glucosamine 3-O-sulfotransferase 3A1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9Y663	HS3ST3A1	Heparan sulfate glucosamine 3-O-sulfotransferase 3A1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y662	HS3ST3B1	Heparan sulfate glucosamine 3-O-sulfotransferase 3B1	GO:0008467; F:[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity; TAS:ProtInc
Q9Y662	HS3ST3B1	Heparan sulfate glucosamine 3-O-sulfotransferase 3B1	GO:0033872; F:[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity; IEA:UniProtKB-EC
Q9Y662	HS3ST3B1	Heparan sulfate glucosamine 3-O-sulfotransferase 3B1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9Y662	HS3ST3B1	Heparan sulfate glucosamine 3-O-sulfotransferase 3B1	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
Q9Y662	HS3ST3B1	Heparan sulfate glucosamine 3-O-sulfotransferase 3B1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9Y662	HS3ST3B1	Heparan sulfate glucosamine 3-O-sulfotransferase 3B1	GO:0015012; P:heparan sulfate proteoglycan biosynthetic process; TAS:ProtInc
Q9Y662	HS3ST3B1	Heparan sulfate glucosamine 3-O-sulfotransferase 3B1	GO:0015015; P:heparan sulfate proteoglycan biosynthetic process, enzymatic modification; TAS:ProtInc
Q9Y662	HS3ST3B1	Heparan sulfate glucosamine 3-O-sulfotransferase 3B1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P34931	HSPA1L	Heat shock 70 kDa protein 1-like	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P34931	HSPA1L	Heat shock 70 kDa protein 1-like	GO:0051082; F:unfolded protein binding; IDA:UniProt
P34931	HSPA1L	Heat shock 70 kDa protein 1-like	GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl
P34931	HSPA1L	Heat shock 70 kDa protein 1-like	GO:0042026; P:protein refolding; IDA:UniProt
P34931	HSPA1L	Heat shock 70 kDa protein 1-like	GO:0006986; P:response to unfolded protein; TAS:ProtInc
O95757	HSPA4L	Heat shock 70 kDa protein 4L	GO:0005524; F:ATP binding; ISS:UniProtKB
O95757	HSPA4L	Heat shock 70 kDa protein 4L	GO:0006457; P:protein folding; ISS:UniProtKB
O95757	HSPA4L	Heat shock 70 kDa protein 4L	GO:0006986; P:response to unfolded protein; ISS:UniProtKB
Q14568	HSP90AA2	Putative heat shock protein HSP 90-alpha A2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q14568	HSP90AA2	Putative heat shock protein HSP 90-alpha A2	GO:0006457; P:protein folding; IEA:InterPro
Q14568	HSP90AA2	Putative heat shock protein HSP 90-alpha A2	GO:0006950; P:response to stress; IEA:UniProtKB-KW
Q58FG0	HSP90AA5P	Putative heat shock protein HSP 90-alpha A5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q58FG0	HSP90AA5P	Putative heat shock protein HSP 90-alpha A5	GO:0006457; P:protein folding; IEA:InterPro
Q58FG0	HSP90AA5P	Putative heat shock protein HSP 90-alpha A5	GO:0006950; P:response to stress; IEA:UniProtKB-KW
Q58FG1	HSP90AA4P	Putative heat shock protein HSP 90-alpha A4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q58FG1	HSP90AA4P	Putative heat shock protein HSP 90-alpha A4	GO:0006457; P:protein folding; IEA:InterPro
Q58FG1	HSP90AA4P	Putative heat shock protein HSP 90-alpha A4	GO:0006950; P:response to stress; IEA:UniProtKB-KW
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0005524; F:ATP binding; TAS:UniProtKB
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0016887; F:ATPase activity; IDA:UniProtKB
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0042802; F:identical protein binding; IPI:IntAct
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0023026; F:MHC class II protein complex binding; IDA:UniProt
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0030235; F:nitric-oxide synthase regulator activity; IDA:UniProtKB
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0000166; F:nucleotide binding; TAS:UniProtKB
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0042803; F:protein homodimerization activity; TAS:UniProtKB
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0030911; F:TPR domain binding; IDA:UniProtKB
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0006200; P:ATP catabolic process; IDA:GOC
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0007411; P:axon guidance; TAS:Reactome
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0051131; P:chaperone-mediated protein complex assembly; IDA:BHF-UCL
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0045087; P:innate immune response; TAS:Reactome
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0006839; P:mitochondrial transport; TAS:UniProtKB
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0046209; P:nitric oxide metabolic process; TAS:Reactome
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; ISS:UniProtKB
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0045040; P:protein import into mitochondrial outer membrane; IDA:BHF-UCL
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0042026; P:protein refolding; TAS:UniProtKB
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0006986; P:response to unfolded protein; NAS:UniProtKB
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0007165; P:signal transduction; NAS:UniProtKB
P07900	HSP90AA1	Heat shock protein HSP 90-alpha	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0002135; F:CTP binding; IEA:Ensembl
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0032564; F:dATP binding; IEA:Ensembl
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0003725; F:double-stranded RNA binding; IDA:MGI
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0005525; F:GTP binding; IEA:Ensembl
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0023026; F:MHC class II protein complex binding; IDA:UniProt
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0030235; F:nitric-oxide synthase regulator activity; ISS:UniProtKB
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0005515; F:protein binding; IPI:UniProtKB
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0030911; F:TPR domain binding; ISS:UniProtKB
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0002134; F:UTP binding; IEA:Ensembl
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0007411; P:axon guidance; TAS:Reactome
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0045087; P:innate immune response; TAS:Reactome
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:MGI
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0001890; P:placenta development; IEA:Ensembl
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0045793; P:positive regulation of cell size; IEA:Ensembl
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; ISS:UniProtKB
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0032092; P:positive regulation of protein binding; IEA:Ensembl
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0033160; P:positive regulation of protein import into nucleus, translocation; IEA:Ensembl
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IEA:Ensembl
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0006457; P:protein folding; IEA:InterPro
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; IMP:MGI
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; IMP:MGI
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0009651; P:response to salt stress; IEA:Ensembl
P08238	HSP90AB1	Heat shock protein HSP 90-beta	GO:0006986; P:response to unfolded protein; NAS:UniProtKB
O75506	HSBP1	Heat shock factor-binding protein 1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
O75506	HSBP1	Heat shock factor-binding protein 1	GO:0006936; P:muscle contraction; IEA:Ensembl
O75506	HSBP1	Heat shock factor-binding protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q8IWL3	HSCB	Iron-sulfur cluster co-chaperone protein HscB, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IWL3	HSCB	Iron-sulfur cluster co-chaperone protein HscB, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IWL3	HSCB	Iron-sulfur cluster co-chaperone protein HscB, mitochondrial	GO:0016226; P:iron-sulfur cluster assembly; IMP:UniProtKB
Q8IWL3	HSCB	Iron-sulfur cluster co-chaperone protein HscB, mitochondrial	GO:0006457; P:protein folding; IEA:InterPro
Q8IWL3	HSCB	Iron-sulfur cluster co-chaperone protein HscB, mitochondrial	GO:0051259; P:protein oligomerization; IEA:InterPro
Q3SXM5	HSDL1	Inactive hydroxysteroid dehydrogenase-like protein 1	GO:0016491; F:oxidoreductase activity; IEA:InterPro
Q6YN16	HSDL2	Hydroxysteroid dehydrogenase-like protein 2	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q6YN16	HSDL2	Hydroxysteroid dehydrogenase-like protein 2	GO:0032934; F:sterol binding; IEA:InterPro
Q00613	HSF1	Heat shock factor protein 1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q00613	HSF1	Heat shock factor protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q00613	HSF1	Heat shock factor protein 1	GO:0001162; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding; IDA:MGI
Q00613	HSF1	Heat shock factor protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q00613	HSF1	Heat shock factor protein 1	GO:0034605; P:cellular response to heat; IDA:UniProtKB
Q00613	HSF1	Heat shock factor protein 1	GO:0006952; P:defense response; IEA:Ensembl
Q00613	HSF1	Heat shock factor protein 1	GO:0001892; P:embryonic placenta development; IEA:Ensembl
Q00613	HSF1	Heat shock factor protein 1	GO:0060136; P:embryonic process involved in female pregnancy; IEA:Ensembl
Q00613	HSF1	Heat shock factor protein 1	GO:0007143; P:female meiotic division; IEA:Ensembl
Q00613	HSF1	Heat shock factor protein 1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q00613	HSF1	Heat shock factor protein 1	GO:0032720; P:negative regulation of tumor necrosis factor production; IEA:Ensembl
Q00613	HSF1	Heat shock factor protein 1	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
Q00613	HSF1	Heat shock factor protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q00613	HSF1	Heat shock factor protein 1	GO:0006468; P:protein phosphorylation; IEA:Ensembl
Q00613	HSF1	Heat shock factor protein 1	GO:0090231; P:regulation of spindle checkpoint; IEA:Ensembl
Q00613	HSF1	Heat shock factor protein 1	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
Q00613	HSF1	Heat shock factor protein 1	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q00613	HSF1	Heat shock factor protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75031	HSF2BP	Heat shock factor 2-binding protein	GO:0007283; P:spermatogenesis; TAS:ProtInc
O75031	HSF2BP	Heat shock factor 2-binding protein	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q03933	HSF2	Heat shock factor protein 2	GO:0001162; F:RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding; IDA:MGI
Q03933	HSF2	Heat shock factor protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q03933	HSF2	Heat shock factor protein 2	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q03933	HSF2	Heat shock factor protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q03933	HSF2	Heat shock factor protein 2	GO:0006950; P:response to stress; IEA:UniProtKB-KW
Q03933	HSF2	Heat shock factor protein 2	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q03933	HSF2	Heat shock factor protein 2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9ULV5	HSF4	Heat shock factor protein 4	GO:0019903; F:protein phosphatase binding; IPI:UniProt
Q9ULV5	HSF4	Heat shock factor protein 4	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q9ULV5	HSF4	Heat shock factor protein 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9ULV5	HSF4	Heat shock factor protein 4	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q9ULV5	HSF4	Heat shock factor protein 4	GO:0043010; P:camera-type eye development; IEA:Ensembl
Q9ULV5	HSF4	Heat shock factor protein 4	GO:0048468; P:cell development; IEA:Ensembl
Q9ULV5	HSF4	Heat shock factor protein 4	GO:0033169; P:histone H3-K9 demethylation; IEA:Ensembl
Q9ULV5	HSF4	Heat shock factor protein 4	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9ULV5	HSF4	Heat shock factor protein 4	GO:0045597; P:positive regulation of cell differentiation; IEA:Ensembl
Q9ULV5	HSF4	Heat shock factor protein 4	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q9ULV5	HSF4	Heat shock factor protein 4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9ULV5	HSF4	Heat shock factor protein 4	GO:0070207; P:protein homotrimerization; IEA:Ensembl
Q9ULV5	HSF4	Heat shock factor protein 4	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
Q9ULV5	HSF4	Heat shock factor protein 4	GO:0006950; P:response to stress; IEA:UniProtKB-KW
Q9ULV5	HSF4	Heat shock factor protein 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q4G112	HSF5	Heat shock factor protein 5	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q4G112	HSF5	Heat shock factor protein 5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q4G112	HSF5	Heat shock factor protein 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UBD0	HSFX1	Heat shock transcription factor, X-linked	GO:0005515; F:protein binding; IPI:IntAct
Q9UBD0	HSFX1	Heat shock transcription factor, X-linked	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9UBD0	HSFX1	Heat shock transcription factor, X-linked	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9UBD0	HSFX1	Heat shock transcription factor, X-linked	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96LI6	HSFY1	Heat shock transcription factor, Y-linked	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q96LI6	HSFY1	Heat shock transcription factor, Y-linked	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q96LI6	HSFY1	Heat shock transcription factor, Y-linked	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P48723	HSPA13	Heat shock 70 kDa protein 13	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P04553	PRM1	Sperm protamine P1	GO:0003677; F:DNA binding; TAS:ProtInc
P04553	PRM1	Sperm protamine P1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P04553	PRM1	Sperm protamine P1	GO:0030261; P:chromosome condensation; IEA:UniProtKB-KW
P04553	PRM1	Sperm protamine P1	GO:0006323; P:DNA packaging; TAS:ProtInc
P04553	PRM1	Sperm protamine P1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P04553	PRM1	Sperm protamine P1	GO:0007283; P:spermatogenesis; TAS:ProtInc
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0005524; F:ATP binding; IDA:BHF-UCL
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0016887; F:ATPase activity; IDA:BHF-UCL
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0042623; F:ATPase activity, coupled; IDA:UniProt
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0003725; F:double-stranded RNA binding; IDA:MGI
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0031072; F:heat shock protein binding; IPI:BHF-UCL
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0005515; F:protein binding; IPI:UniProtKB
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0044183; F:protein binding involved in protein folding; IDA:BHF-UCL
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0031625; F:ubiquitin protein ligase binding; IPI:BHF-UCL
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0051082; F:unfolded protein binding; TAS:UniProtKB
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0006200; P:ATP catabolic process; IDA:BHF-UCL
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0070370; P:cellular heat acclimation; IMP:UniProt
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0034605; P:cellular response to heat; IDA:UniProt
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0010467; P:gene expression; TAS:Reactome
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0006402; P:mRNA catabolic process; IDA:UniProtKB
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0060548; P:negative regulation of cell death; IMP:UniProt
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0030308; P:negative regulation of cell growth; IMP:UniProtKB
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IMP:BHF-UCL
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0090084; P:negative regulation of inclusion body assembly; IDA:BHF-UCL
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0045648; P:positive regulation of erythrocyte differentiation; IMP:UniProtKB
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0042026; P:protein refolding; IDA:BHF-UCL
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0006986; P:response to unfolded protein; IDA:UniProtKB
P08107	HSPA1A	Heat shock 70 kDa protein 1A/1B	GO:0016070; P:RNA metabolic process; TAS:Reactome
P54652	HSPA2	Heat shock-related 70 kDa protein 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P54652	HSPA2	Heat shock-related 70 kDa protein 2	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P54652	HSPA2	Heat shock-related 70 kDa protein 2	GO:0051861; F:glycolipid binding; IEA:Ensembl
P54652	HSPA2	Heat shock-related 70 kDa protein 2	GO:0005515; F:protein binding; IPI:IntAct
P54652	HSPA2	Heat shock-related 70 kDa protein 2	GO:0051082; F:unfolded protein binding; IDA:UniProt
P54652	HSPA2	Heat shock-related 70 kDa protein 2	GO:0007140; P:male meiosis; TAS:ProtInc
P54652	HSPA2	Heat shock-related 70 kDa protein 2	GO:0007141; P:male meiosis I; IEA:Ensembl
P54652	HSPA2	Heat shock-related 70 kDa protein 2	GO:0090084; P:negative regulation of inclusion body assembly; IDA:UniProt
P54652	HSPA2	Heat shock-related 70 kDa protein 2	GO:0031662; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle; IEA:Ensembl
P54652	HSPA2	Heat shock-related 70 kDa protein 2	GO:0042026; P:protein refolding; IDA:UniProt
P54652	HSPA2	Heat shock-related 70 kDa protein 2	GO:0006986; P:response to unfolded protein; TAS:ProtInc
P54652	HSPA2	Heat shock-related 70 kDa protein 2	GO:0007286; P:spermatid development; TAS:ProtInc
P54652	HSPA2	Heat shock-related 70 kDa protein 2	GO:0070194; P:synaptonemal complex disassembly; IEA:Ensembl
P34932	HSPA4	Heat shock 70 kDa protein 4	GO:0005524; F:ATP binding; NAS:UniProtKB
P34932	HSPA4	Heat shock 70 kDa protein 4	GO:0051131; P:chaperone-mediated protein complex assembly; IDA:BHF-UCL
P34932	HSPA4	Heat shock 70 kDa protein 4	GO:0045040; P:protein import into mitochondrial outer membrane; IDA:BHF-UCL
P34932	HSPA4	Heat shock 70 kDa protein 4	GO:0006986; P:response to unfolded protein; NAS:UniProtKB
P17066	HSPA6	Heat shock 70 kDa protein 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P17066	HSPA6	Heat shock 70 kDa protein 6	GO:0042623; F:ATPase activity, coupled; IDA:UniProt
P17066	HSPA6	Heat shock 70 kDa protein 6	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P17066	HSPA6	Heat shock 70 kDa protein 6	GO:0031072; F:heat shock protein binding; IPI:UniProt
P17066	HSPA6	Heat shock 70 kDa protein 6	GO:0051082; F:unfolded protein binding; IDA:UniProt
P17066	HSPA6	Heat shock 70 kDa protein 6	GO:0006200; P:ATP catabolic process; IDA:UniProt
P17066	HSPA6	Heat shock 70 kDa protein 6	GO:0034605; P:cellular response to heat; IDA:UniProt
P17066	HSPA6	Heat shock 70 kDa protein 6	GO:0042026; P:protein refolding; IDA:UniProt
P17066	HSPA6	Heat shock 70 kDa protein 6	GO:0006986; P:response to unfolded protein; TAS:ProtInc
P48741	HSPA7	Putative heat shock 70 kDa protein 7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P48741	HSPA7	Putative heat shock 70 kDa protein 7	GO:0006950; P:response to stress; IEA:UniProtKB-KW
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0005524; F:ATP binding; IDA:BHF-UCL
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0016887; F:ATPase activity; IDA:BHF-UCL
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0042623; F:ATPase activity, coupled; NAS:UniProtKB
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0031072; F:heat shock protein binding; IPI:BHF-UCL
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0023026; F:MHC class II protein complex binding; IDA:UniProt
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0005515; F:protein binding; IPI:UniProtKB
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0051082; F:unfolded protein binding; IDA:UniProt
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0006200; P:ATP catabolic process; IDA:BHF-UCL
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0007411; P:axon guidance; TAS:Reactome
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0051085; P:chaperone mediated protein folding requiring cofactor; IEA:Ensembl
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0010467; P:gene expression; TAS:Reactome
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0061024; P:membrane organization; TAS:Reactome
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0006457; P:protein folding; NAS:UniProtKB
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0042026; P:protein refolding; IDA:UniProt
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0006986; P:response to unfolded protein; NAS:UniProtKB
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0016070; P:RNA metabolic process; TAS:Reactome
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0007268; P:synaptic transmission; TAS:Reactome
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P11142	HSPA8	Heat shock cognate 71 kDa protein	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q0VDF9	HSPA14	Heat shock 70 kDa protein 14	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q0VDF9	HSPA14	Heat shock 70 kDa protein 14	GO:0005515; F:protein binding; IPI:UniProtKB
Q0VDF9	HSPA14	Heat shock 70 kDa protein 14	GO:0051083; P:'de novo' cotranslational protein folding; TAS:UniProtKB
P04792	HSPB1	Heat shock protein beta-1	GO:0042802; F:identical protein binding; IPI:IntAct
P04792	HSPB1	Heat shock protein beta-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P04792	HSPB1	Heat shock protein beta-1	GO:0005515; F:protein binding; IPI:IntAct
P04792	HSPB1	Heat shock protein beta-1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P04792	HSPB1	Heat shock protein beta-1	GO:0005080; F:protein kinase C binding; ISS:BHF-UCL
P04792	HSPB1	Heat shock protein beta-1	GO:0008426; F:protein kinase C inhibitor activity; ISS:BHF-UCL
P04792	HSPB1	Heat shock protein beta-1	GO:0043130; F:ubiquitin binding; ISS:BHF-UCL
P04792	HSPB1	Heat shock protein beta-1	GO:0008219; P:cell death; IEA:UniProtKB-KW
P04792	HSPB1	Heat shock protein beta-1	GO:0006928; P:cellular component movement; TAS:UniProtKB
P04792	HSPB1	Heat shock protein beta-1	GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IMP:BHF-UCL
P04792	HSPB1	Heat shock protein beta-1	GO:0010467; P:gene expression; TAS:Reactome
P04792	HSPB1	Heat shock protein beta-1	GO:0035556; P:intracellular signal transduction; IMP:BHF-UCL
P04792	HSPB1	Heat shock protein beta-1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P04792	HSPB1	Heat shock protein beta-1	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
P04792	HSPB1	Heat shock protein beta-1	GO:1902176; P:negative regulation of intrinsic apoptotic signaling pathway in response to oxidative stress; ISS:BHF-UCL
P04792	HSPB1	Heat shock protein beta-1	GO:0006469; P:negative regulation of protein kinase activity; ISS:BHF-UCL
P04792	HSPB1	Heat shock protein beta-1	GO:0071901; P:negative regulation of protein serine/threonine kinase activity; ISS:GOC
P04792	HSPB1	Heat shock protein beta-1	GO:0045766; P:positive regulation of angiogenesis; IMP:BHF-UCL
P04792	HSPB1	Heat shock protein beta-1	GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IMP:BHF-UCL
P04792	HSPB1	Heat shock protein beta-1	GO:2001028; P:positive regulation of endothelial cell chemotaxis; IMP:BHF-UCL
P04792	HSPB1	Heat shock protein beta-1	GO:0038033; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; IMP:BHF-UCL
P04792	HSPB1	Heat shock protein beta-1	GO:0032731; P:positive regulation of interleukin-1 beta production; ISS:BHF-UCL
P04792	HSPB1	Heat shock protein beta-1	GO:0042535; P:positive regulation of tumor necrosis factor biosynthetic process; ISS:BHF-UCL
P04792	HSPB1	Heat shock protein beta-1	GO:0043122; P:regulation of I-kappaB kinase/NF-kappaB signaling; ISS:BHF-UCL
P04792	HSPB1	Heat shock protein beta-1	GO:0006446; P:regulation of translational initiation; TAS:ProtInc
P04792	HSPB1	Heat shock protein beta-1	GO:0006986; P:response to unfolded protein; NAS:UniProtKB
P04792	HSPB1	Heat shock protein beta-1	GO:0009615; P:response to virus; IEP:UniProtKB
P04792	HSPB1	Heat shock protein beta-1	GO:0001895; P:retina homeostasis; IEP:UniProt
P04792	HSPB1	Heat shock protein beta-1	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q16082	HSPB2	Heat shock protein beta-2	GO:0008047; F:enzyme activator activity; TAS:ProtInc
Q16082	HSPB2	Heat shock protein beta-2	GO:0005515; F:protein binding; IPI:IntAct
Q16082	HSPB2	Heat shock protein beta-2	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
Q16082	HSPB2	Heat shock protein beta-2	GO:0006986; P:response to unfolded protein; NAS:ProtInc
Q12988	HSPB3	Heat shock protein beta-3	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q12988	HSPB3	Heat shock protein beta-3	GO:0006986; P:response to unfolded protein; TAS:ProtInc
O14558	HSPB6	Heat shock protein beta-6	GO:0005515; F:protein binding; IPI:IntAct
O14558	HSPB6	Heat shock protein beta-6	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
O14558	HSPB6	Heat shock protein beta-6	GO:0005212; F:structural constituent of eye lens; IEA:InterPro
O14558	HSPB6	Heat shock protein beta-6	GO:0006937; P:regulation of muscle contraction; IEA:Ensembl
O14558	HSPB6	Heat shock protein beta-6	GO:0006950; P:response to stress; IEA:UniProtKB-KW
Q9UBY9	HSPB7	Heat shock protein beta-7	GO:0005515; F:protein binding; IPI:IntAct
Q9UBY9	HSPB7	Heat shock protein beta-7	GO:0008022; F:protein C-terminus binding; TAS:ProtInc
Q9UBY9	HSPB7	Heat shock protein beta-7	GO:0008016; P:regulation of heart contraction; TAS:ProtInc
Q9UBY9	HSPB7	Heat shock protein beta-7	GO:0006986; P:response to unfolded protein; TAS:ProtInc
Q9UJY1	HSPB8	Heat shock protein beta-8	GO:0042802; F:identical protein binding; IPI:IntAct
Q9UJY1	HSPB8	Heat shock protein beta-8	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UJY1	HSPB8	Heat shock protein beta-8	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9UJY1	HSPB8	Heat shock protein beta-8	GO:0006950; P:response to stress; IEA:UniProtKB-KW
Q9BQS6	HSPB9	Heat shock protein beta-9	GO:0005515; F:protein binding; IPI:IntAct
Q9BQS6	HSPB9	Heat shock protein beta-9	GO:0006950; P:response to stress; IEA:UniProtKB-KW
Q9BUP3	HTATIP2	Oxidoreductase HTATIP2	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q9BUP3	HTATIP2	Oxidoreductase HTATIP2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BUP3	HTATIP2	Oxidoreductase HTATIP2	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q9BUP3	HTATIP2	Oxidoreductase HTATIP2	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q9BUP3	HTATIP2	Oxidoreductase HTATIP2	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9BUP3	HTATIP2	Oxidoreductase HTATIP2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9BUP3	HTATIP2	Oxidoreductase HTATIP2	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
Q9BUP3	HTATIP2	Oxidoreductase HTATIP2	GO:0051170; P:nuclear import; IDA:UniProtKB
Q9BUP3	HTATIP2	Oxidoreductase HTATIP2	GO:0045765; P:regulation of angiogenesis; IDA:UniProtKB
Q9BUP3	HTATIP2	Oxidoreductase HTATIP2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9BUP3	HTATIP2	Oxidoreductase HTATIP2	GO:0016032; P:viral process; IEA:UniProtKB-KW
P86397	RPP14	Hydroxyacyl-thioester dehydratase type 2, mitochondrial	GO:0016829; F:lyase activity; IEA:UniProtKB-KW
P86397	RPP14	Hydroxyacyl-thioester dehydratase type 2, mitochondrial	GO:0016491; F:oxidoreductase activity; IEA:InterPro
P86397	RPP14	Hydroxyacyl-thioester dehydratase type 2, mitochondrial	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW
Q99081	TCF12	Transcription factor 12	GO:0070888; F:E-box binding; IEA:Ensembl
Q99081	TCF12	Transcription factor 12	GO:0005515; F:protein binding; IPI:BHF-UCL
Q99081	TCF12	Transcription factor 12	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q99081	TCF12	Transcription factor 12	GO:0006955; P:immune response; TAS:ProtInc
Q99081	TCF12	Transcription factor 12	GO:0007517; P:muscle organ development; TAS:ProtInc
Q99081	TCF12	Transcription factor 12	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
Q99081	TCF12	Transcription factor 12	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q99081	TCF12	Transcription factor 12	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q99081	TCF12	Transcription factor 12	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q92743	HTRA1	Serine protease HTRA1	GO:0004252; F:serine-type endopeptidase activity; TAS:ProtInc
Q92743	HTRA1	Serine protease HTRA1	GO:0008236; F:serine-type peptidase activity; ISS:UniProtKB
Q92743	HTRA1	Serine protease HTRA1	GO:0030514; P:negative regulation of BMP signaling pathway; IEA:Ensembl
Q92743	HTRA1	Serine protease HTRA1	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl
Q92743	HTRA1	Serine protease HTRA1	GO:0006508; P:proteolysis; ISS:UniProtKB
Q92743	HTRA1	Serine protease HTRA1	GO:0001558; P:regulation of cell growth; IEA:InterPro
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0008233; F:peptidase activity; IDA:UniProtKB
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0004252; F:serine-type endopeptidase activity; IMP:UniProtKB
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0008236; F:serine-type peptidase activity; IDA:UniProtKB
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0051082; F:unfolded protein binding; NAS:UniProtKB
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0007628; P:adult walking behavior; IEA:Ensembl
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0071363; P:cellular response to growth factor stimulus; IMP:UniProtKB
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0034605; P:cellular response to heat; IDA:UniProtKB
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0006672; P:ceramide metabolic process; IEA:Ensembl
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0097194; P:execution phase of apoptosis; TAS:UniProtKB
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0030900; P:forebrain development; IEA:Ensembl
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IMP:ParkinsonsUK-UCL
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0007005; P:mitochondrion organization; IEA:Ensembl
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0045786; P:negative regulation of cell cycle; TAS:UniProtKB
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0060548; P:negative regulation of cell death; IEA:Ensembl
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0048666; P:neuron development; IEA:Ensembl
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0019742; P:pentacyclic triterpenoid metabolic process; IEA:Ensembl
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0010942; P:positive regulation of cell death; IDA:UniProtKB
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:2001269; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; IMP:ParkinsonsUK-UCL
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IMP:UniProtKB
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0016540; P:protein autoprocessing; TAS:ParkinsonsUK-UCL
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0006508; P:proteolysis; IMP:UniProtKB
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl
O43464	HTRA2	Serine protease HTRA2, mitochondrial	GO:0009635; P:response to herbicide; IEA:Ensembl
P83110	HTRA3	Serine protease HTRA3	GO:0004175; F:endopeptidase activity; IDA:BHF-UCL
P83110	HTRA3	Serine protease HTRA3	GO:0005515; F:protein binding; IPI:UniProtKB
P83110	HTRA3	Serine protease HTRA3	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
P83110	HTRA3	Serine protease HTRA3	GO:0008236; F:serine-type peptidase activity; IDA:UniProtKB
P83110	HTRA3	Serine protease HTRA3	GO:0030514; P:negative regulation of BMP signaling pathway; ISS:UniProtKB
P83110	HTRA3	Serine protease HTRA3	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; ISS:UniProtKB
P83110	HTRA3	Serine protease HTRA3	GO:0006508; P:proteolysis; IDA:UniProtKB
P83110	HTRA3	Serine protease HTRA3	GO:0001558; P:regulation of cell growth; IEA:InterPro
P83105	HTRA4	Serine protease HTRA4	GO:0004175; F:endopeptidase activity; IDA:BHF-UCL
P83105	HTRA4	Serine protease HTRA4	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
P83105	HTRA4	Serine protease HTRA4	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; ISS:UniProtKB
P83105	HTRA4	Serine protease HTRA4	GO:0006508; P:proteolysis; IDA:BHF-UCL
P83105	HTRA4	Serine protease HTRA4	GO:0001558; P:regulation of cell growth; IEA:InterPro
O43719	HTATSF1	HIV Tat-specific factor 1	GO:0000166; F:nucleotide binding; IEA:InterPro
O43719	HTATSF1	HIV Tat-specific factor 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O43719	HTATSF1	HIV Tat-specific factor 1	GO:0032784; P:regulation of DNA-templated transcription, elongation; TAS:ProtInc
O43719	HTATSF1	HIV Tat-specific factor 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O43719	HTATSF1	HIV Tat-specific factor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43719	HTATSF1	HIV Tat-specific factor 1	GO:0019079; P:viral genome replication; TAS:ProtInc
Q8TDB4	MGARP	Protein MGARP	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TDB4	MGARP	Protein MGARP	GO:0008089; P:anterograde axon cargo transport; ISS:UniProtKB
Q8TDB4	MGARP	Protein MGARP	GO:0019896; P:axon transport of mitochondrion; ISS:UniProtKB
Q8TDB4	MGARP	Protein MGARP	GO:0097211; P:cellular response to gonadotropin-releasing hormone; ISS:UniProtKB
Q8TDB4	MGARP	Protein MGARP	GO:0071456; P:cellular response to hypoxia; ISS:UniProtKB
Q8TDB4	MGARP	Protein MGARP	GO:0071383; P:cellular response to steroid hormone stimulus; ISS:UniProtKB
Q8TDB4	MGARP	Protein MGARP	GO:0010822; P:positive regulation of mitochondrion organization; ISS:UniProtKB
Q8TDB4	MGARP	Protein MGARP	GO:0006626; P:protein targeting to mitochondrion; ISS:UniProtKB
Q8TDB4	MGARP	Protein MGARP	GO:0008090; P:retrograde axon cargo transport; ISS:UniProtKB
Q8IVG9	MT-RNR2	Putative humanin peptide	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IVG9	MT-RNR2	Putative humanin peptide	GO:0048019; F:receptor antagonist activity; IDA:UniProtKB
Q8IVG9	MT-RNR2	Putative humanin peptide	GO:0005102; F:receptor binding; TAS:UniProtKB
Q8IVG9	MT-RNR2	Putative humanin peptide	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8IVG9	MT-RNR2	Putative humanin peptide	GO:0006879; P:cellular iron ion homeostasis; NAS:UniProtKB
Q8IVG9	MT-RNR2	Putative humanin peptide	GO:1900116; P:extracellular negative regulation of signal transduction; IDA:GOC
Q8IVG9	MT-RNR2	Putative humanin peptide	GO:0030595; P:leukocyte chemotaxis; IDA:UniProtKB
Q8IVG9	MT-RNR2	Putative humanin peptide	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P57058	HUNK	Hormonally up-regulated neu tumor-associated kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P57058	HUNK	Hormonally up-regulated neu tumor-associated kinase	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
P57058	HUNK	Hormonally up-regulated neu tumor-associated kinase	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P57058	HUNK	Hormonally up-regulated neu tumor-associated kinase	GO:0007165; P:signal transduction; TAS:ProtInc
Q8NHY5	HUS1B	Checkpoint protein HUS1B	GO:0000077; P:DNA damage checkpoint; IEA:InterPro
Q8NHY5	HUS1B	Checkpoint protein HUS1B	GO:0006281; P:DNA repair; IEA:InterPro
O60921	HUS1	Checkpoint protein HUS1	GO:0005515; F:protein binding; IPI:UniProtKB
O60921	HUS1	Checkpoint protein HUS1	GO:0006974; P:cellular response to DNA damage stimulus; TAS:ProtInc
O60921	HUS1	Checkpoint protein HUS1	GO:0071479; P:cellular response to ionizing radiation; IDA:UniProtKB
O60921	HUS1	Checkpoint protein HUS1	GO:0000077; P:DNA damage checkpoint; IMP:UniProtKB
O60921	HUS1	Checkpoint protein HUS1	GO:0006281; P:DNA repair; TAS:ProtInc
O60921	HUS1	Checkpoint protein HUS1	GO:0006260; P:DNA replication; TAS:Reactome
O60921	HUS1	Checkpoint protein HUS1	GO:0000724; P:double-strand break repair via homologous recombination; IEA:Ensembl
O60921	HUS1	Checkpoint protein HUS1	GO:0009790; P:embryo development; IEA:Ensembl
O60921	HUS1	Checkpoint protein HUS1	GO:0007093; P:mitotic cell cycle checkpoint; IEA:Ensembl
O60921	HUS1	Checkpoint protein HUS1	GO:0008156; P:negative regulation of DNA replication; IEA:Ensembl
O60921	HUS1	Checkpoint protein HUS1	GO:0006468; P:protein phosphorylation; IEA:Ensembl
O60921	HUS1	Checkpoint protein HUS1	GO:0001932; P:regulation of protein phosphorylation; IEA:Ensembl
O60921	HUS1	Checkpoint protein HUS1	GO:0009411; P:response to UV; IEA:Ensembl
P42357	HAL	Histidine ammonia-lyase	GO:0004397; F:histidine ammonia-lyase activity; IEA:UniProtKB-EC
P42357	HAL	Histidine ammonia-lyase	GO:0009058; P:biosynthetic process; IEA:InterPro
P42357	HAL	Histidine ammonia-lyase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P42357	HAL	Histidine ammonia-lyase	GO:0006548; P:histidine catabolic process; TAS:Reactome
P42357	HAL	Histidine ammonia-lyase	GO:0019556; P:histidine catabolic process to glutamate and formamide; IEA:UniProtKB-UniPathway
P42357	HAL	Histidine ammonia-lyase	GO:0019557; P:histidine catabolic process to glutamate and formate; IEA:UniProtKB-UniPathway
P42357	HAL	Histidine ammonia-lyase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96NU7	AMDHD1	Probable imidazolonepropionase	GO:0050480; F:imidazolonepropionase activity; IEA:UniProtKB-EC
Q96NU7	AMDHD1	Probable imidazolonepropionase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96NU7	AMDHD1	Probable imidazolonepropionase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q96NU7	AMDHD1	Probable imidazolonepropionase	GO:0006548; P:histidine catabolic process; TAS:Reactome
Q96NU7	AMDHD1	Probable imidazolonepropionase	GO:0019556; P:histidine catabolic process to glutamate and formamide; IEA:UniProtKB-UniPathway
Q96NU7	AMDHD1	Probable imidazolonepropionase	GO:0019557; P:histidine catabolic process to glutamate and formate; IEA:UniProtKB-UniPathway
Q96NU7	AMDHD1	Probable imidazolonepropionase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96N76	UROC1	Urocanate hydratase	GO:0016153; F:urocanate hydratase activity; IDA:BHF-UCL
Q96N76	UROC1	Urocanate hydratase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q96N76	UROC1	Urocanate hydratase	GO:0006548; P:histidine catabolic process; IMP:BHF-UCL
Q96N76	UROC1	Urocanate hydratase	GO:0019556; P:histidine catabolic process to glutamate and formamide; IEA:UniProtKB-UniPathway
Q96N76	UROC1	Urocanate hydratase	GO:0019557; P:histidine catabolic process to glutamate and formate; IEA:UniProtKB-UniPathway
Q96N76	UROC1	Urocanate hydratase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q7Z6Z7	HUWE1	E3 ubiquitin-protein ligase HUWE1	GO:0003677; F:DNA binding; ISS:UniProtKB
Q7Z6Z7	HUWE1	E3 ubiquitin-protein ligase HUWE1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7Z6Z7	HUWE1	E3 ubiquitin-protein ligase HUWE1	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z6Z7	HUWE1	E3 ubiquitin-protein ligase HUWE1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q7Z6Z7	HUWE1	E3 ubiquitin-protein ligase HUWE1	GO:0006284; P:base-excision repair; IMP:UniProtKB
Q7Z6Z7	HUWE1	E3 ubiquitin-protein ligase HUWE1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q7Z6Z7	HUWE1	E3 ubiquitin-protein ligase HUWE1	GO:0016574; P:histone ubiquitination; IDA:UniProtKB
Q7Z6Z7	HUWE1	E3 ubiquitin-protein ligase HUWE1	GO:0006513; P:protein monoubiquitination; IDA:UniProtKB
Q7Z6Z7	HUWE1	E3 ubiquitin-protein ligase HUWE1	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q7Z6Z7	HUWE1	E3 ubiquitin-protein ligase HUWE1	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:RefGenome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006955; P:immune response; NAS:UniProtKB
Q96D96	HVCN1	Voltage-gated hydrogen channel 1	GO:0022843; F:voltage-gated cation channel activity; TAS:Reactome
Q96D96	HVCN1	Voltage-gated hydrogen channel 1	GO:0030171; F:voltage-gated proton channel activity; IDA:UniProtKB
Q96D96	HVCN1	Voltage-gated hydrogen channel 1	GO:0071467; P:cellular response to pH; IDA:UniProtKB
Q96D96	HVCN1	Voltage-gated hydrogen channel 1	GO:0071294; P:cellular response to zinc ion; IDA:UniProtKB
Q96D96	HVCN1	Voltage-gated hydrogen channel 1	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
Q96D96	HVCN1	Voltage-gated hydrogen channel 1	GO:0015992; P:proton transport; IDA:UniProtKB
Q96D96	HVCN1	Voltage-gated hydrogen channel 1	GO:0009268; P:response to pH; ISS:HGNC
Q96D96	HVCN1	Voltage-gated hydrogen channel 1	GO:0010043; P:response to zinc ion; IDA:HGNC
Q96D96	HVCN1	Voltage-gated hydrogen channel 1	GO:0007338; P:single fertilization; TAS:Reactome
Q96D96	HVCN1	Voltage-gated hydrogen channel 1	GO:0035036; P:sperm-egg recognition; TAS:Reactome
P31260	HOXA10	Homeobox protein Hox-A10	GO:0042826; F:histone deacetylase binding; IPI:UniProtKB
P31260	HOXA10	Homeobox protein Hox-A10	GO:0005515; F:protein binding; IPI:IntAct
P31260	HOXA10	Homeobox protein Hox-A10	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P31260	HOXA10	Homeobox protein Hox-A10	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P31260	HOXA10	Homeobox protein Hox-A10	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P31260	HOXA10	Homeobox protein Hox-A10	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
P31260	HOXA10	Homeobox protein Hox-A10	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P31260	HOXA10	Homeobox protein Hox-A10	GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl
P31260	HOXA10	Homeobox protein Hox-A10	GO:0001501; P:skeletal system development; IEA:Ensembl
P31260	HOXA10	Homeobox protein Hox-A10	GO:0007283; P:spermatogenesis; TAS:ProtInc
P31260	HOXA10	Homeobox protein Hox-A10	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P31270	HOXA11	Homeobox protein Hox-A11	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P31270	HOXA11	Homeobox protein Hox-A11	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P31270	HOXA11	Homeobox protein Hox-A11	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P31270	HOXA11	Homeobox protein Hox-A11	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P31270	HOXA11	Homeobox protein Hox-A11	GO:0001658; P:branching involved in ureteric bud morphogenesis; ISS:UniProtKB
P31270	HOXA11	Homeobox protein Hox-A11	GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; ISS:UniProtKB
P31270	HOXA11	Homeobox protein Hox-A11	GO:0048589; P:developmental growth; ISS:UniProtKB
P31270	HOXA11	Homeobox protein Hox-A11	GO:0009953; P:dorsal/ventral pattern formation; ISS:UniProtKB
P31270	HOXA11	Homeobox protein Hox-A11	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
P31270	HOXA11	Homeobox protein Hox-A11	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
P31270	HOXA11	Homeobox protein Hox-A11	GO:0030326; P:embryonic limb morphogenesis; ISS:UniProtKB
P31270	HOXA11	Homeobox protein Hox-A11	GO:0060272; P:embryonic skeletal joint morphogenesis; IEA:Ensembl
P31270	HOXA11	Homeobox protein Hox-A11	GO:0007501; P:mesodermal cell fate specification; ISS:UniProtKB
P31270	HOXA11	Homeobox protein Hox-A11	GO:0001656; P:metanephros development; IEA:Ensembl
P31270	HOXA11	Homeobox protein Hox-A11	GO:0007275; P:multicellular organismal development; ISS:UniProtKB
P31270	HOXA11	Homeobox protein Hox-A11	GO:0001759; P:organ induction; IEA:Ensembl
P31270	HOXA11	Homeobox protein Hox-A11	GO:0010720; P:positive regulation of cell development; ISS:UniProtKB
P31270	HOXA11	Homeobox protein Hox-A11	GO:0032332; P:positive regulation of chondrocyte differentiation; ISS:UniProtKB
P31270	HOXA11	Homeobox protein Hox-A11	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
P31270	HOXA11	Homeobox protein Hox-A11	GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl
P31270	HOXA11	Homeobox protein Hox-A11	GO:0001501; P:skeletal system development; ISS:UniProtKB
P31270	HOXA11	Homeobox protein Hox-A11	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P31271	HOXA13	Homeobox protein Hox-A13	GO:0003677; F:DNA binding; TAS:ProtInc
P31271	HOXA13	Homeobox protein Hox-A13	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P31271	HOXA13	Homeobox protein Hox-A13	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P31271	HOXA13	Homeobox protein Hox-A13	GO:0044212; F:transcription regulatory region DNA binding; IEA:Ensembl
P31271	HOXA13	Homeobox protein Hox-A13	GO:0048844; P:artery morphogenesis; IEA:Ensembl
P31271	HOXA13	Homeobox protein Hox-A13	GO:0060442; P:branching involved in prostate gland morphogenesis; IEA:Ensembl
P31271	HOXA13	Homeobox protein Hox-A13	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
P31271	HOXA13	Homeobox protein Hox-A13	GO:0060847; P:endothelial cell fate specification; IEA:Ensembl
P31271	HOXA13	Homeobox protein Hox-A13	GO:0001886; P:endothelial cell morphogenesis; IEA:Ensembl
P31271	HOXA13	Homeobox protein Hox-A13	GO:0048839; P:inner ear development; IEA:Ensembl
P31271	HOXA13	Homeobox protein Hox-A13	GO:0030539; P:male genitalia development; IEA:Ensembl
P31271	HOXA13	Homeobox protein Hox-A13	GO:2001055; P:positive regulation of mesenchymal cell apoptotic process; IEA:Ensembl
P31271	HOXA13	Homeobox protein Hox-A13	GO:0045840; P:positive regulation of mitosis; IEA:Ensembl
P31271	HOXA13	Homeobox protein Hox-A13	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P31271	HOXA13	Homeobox protein Hox-A13	GO:0030510; P:regulation of BMP signaling pathway; IEA:Ensembl
P31271	HOXA13	Homeobox protein Hox-A13	GO:0001501; P:skeletal system development; TAS:ProtInc
P31271	HOXA13	Homeobox protein Hox-A13	GO:0001894; P:tissue homeostasis; IEA:Ensembl
P31271	HOXA13	Homeobox protein Hox-A13	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P31271	HOXA13	Homeobox protein Hox-A13	GO:0001570; P:vasculogenesis; IEA:Ensembl
P31271	HOXA13	Homeobox protein Hox-A13	GO:0003281; P:ventricular septum development; IEA:Ensembl
P49639	HOXA1	Homeobox protein Hox-A1	GO:0005515; F:protein binding; IPI:IntAct
P49639	HOXA1	Homeobox protein Hox-A1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P49639	HOXA1	Homeobox protein Hox-A1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P49639	HOXA1	Homeobox protein Hox-A1	GO:0021599; P:abducens nerve formation; IMP:DFLAT
P49639	HOXA1	Homeobox protein Hox-A1	GO:0009653; P:anatomical structure morphogenesis; IMP:DFLAT
P49639	HOXA1	Homeobox protein Hox-A1	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P49639	HOXA1	Homeobox protein Hox-A1	GO:0060840; P:artery development; IMP:DFLAT
P49639	HOXA1	Homeobox protein Hox-A1	GO:0048844; P:artery morphogenesis; IMP:DFLAT
P49639	HOXA1	Homeobox protein Hox-A1	GO:0021953; P:central nervous system neuron differentiation; IEA:Ensembl
P49639	HOXA1	Homeobox protein Hox-A1	GO:0090102; P:cochlea development; IMP:DFLAT
P49639	HOXA1	Homeobox protein Hox-A1	GO:0090103; P:cochlea morphogenesis; IMP:DFLAT
P49639	HOXA1	Homeobox protein Hox-A1	GO:0050890; P:cognition; IDA:DFLAT
P49639	HOXA1	Homeobox protein Hox-A1	GO:0048702; P:embryonic neurocranium morphogenesis; IMP:DFLAT
P49639	HOXA1	Homeobox protein Hox-A1	GO:0021612; P:facial nerve structural organization; IEA:Ensembl
P49639	HOXA1	Homeobox protein Hox-A1	GO:0021754; P:facial nucleus development; IEA:Ensembl
P49639	HOXA1	Homeobox protein Hox-A1	GO:0048839; P:inner ear development; IMP:DFLAT
P49639	HOXA1	Homeobox protein Hox-A1	GO:0008045; P:motor neuron axon guidance; IEA:Ensembl
P49639	HOXA1	Homeobox protein Hox-A1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P49639	HOXA1	Homeobox protein Hox-A1	GO:0050905; P:neuromuscular process; IDA:DFLAT
P49639	HOXA1	Homeobox protein Hox-A1	GO:0007634; P:optokinetic behavior; IDA:DFLAT
P49639	HOXA1	Homeobox protein Hox-A1	GO:0042473; P:outer ear morphogenesis; IDA:DFLAT
P49639	HOXA1	Homeobox protein Hox-A1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P49639	HOXA1	Homeobox protein Hox-A1	GO:0050795; P:regulation of behavior; IDA:DFLAT
P49639	HOXA1	Homeobox protein Hox-A1	GO:0021569; P:rhombomere 3 development; IEA:Ensembl
P49639	HOXA1	Homeobox protein Hox-A1	GO:0021570; P:rhombomere 4 development; IEA:Ensembl
P49639	HOXA1	Homeobox protein Hox-A1	GO:0021571; P:rhombomere 5 development; IEA:Ensembl
P49639	HOXA1	Homeobox protein Hox-A1	GO:0060876; P:semicircular canal formation; IMP:DFLAT
P49639	HOXA1	Homeobox protein Hox-A1	GO:0007605; P:sensory perception of sound; IDA:DFLAT
P49639	HOXA1	Homeobox protein Hox-A1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43364	HOXA2	Homeobox protein Hox-A2	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
O43364	HOXA2	Homeobox protein Hox-A2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O43364	HOXA2	Homeobox protein Hox-A2	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
O43364	HOXA2	Homeobox protein Hox-A2	GO:0035284; P:brain segmentation; IEA:Ensembl
O43364	HOXA2	Homeobox protein Hox-A2	GO:0001709; P:cell fate determination; IEA:Ensembl
O43364	HOXA2	Homeobox protein Hox-A2	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
O43364	HOXA2	Homeobox protein Hox-A2	GO:0048703; P:embryonic viscerocranium morphogenesis; IEA:Ensembl
O43364	HOXA2	Homeobox protein Hox-A2	GO:0042474; P:middle ear morphogenesis; IEA:Ensembl
O43364	HOXA2	Homeobox protein Hox-A2	GO:0008045; P:motor neuron axon guidance; IEA:Ensembl
O43364	HOXA2	Homeobox protein Hox-A2	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
O43364	HOXA2	Homeobox protein Hox-A2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O43364	HOXA2	Homeobox protein Hox-A2	GO:0002076; P:osteoblast development; IEA:Ensembl
O43364	HOXA2	Homeobox protein Hox-A2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O43364	HOXA2	Homeobox protein Hox-A2	GO:0021568; P:rhombomere 2 development; IEA:Ensembl
O43364	HOXA2	Homeobox protein Hox-A2	GO:0021658; P:rhombomere 3 morphogenesis; IEA:Ensembl
O43364	HOXA2	Homeobox protein Hox-A2	GO:0007379; P:segment specification; IEA:Ensembl
O43364	HOXA2	Homeobox protein Hox-A2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43365	HOXA3	Homeobox protein Hox-A3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O43365	HOXA3	Homeobox protein Hox-A3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O43365	HOXA3	Homeobox protein Hox-A3	GO:0001525; P:angiogenesis; IEP:UniProtKB
O43365	HOXA3	Homeobox protein Hox-A3	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
O43365	HOXA3	Homeobox protein Hox-A3	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
O43365	HOXA3	Homeobox protein Hox-A3	GO:0051216; P:cartilage development; IEA:Ensembl
O43365	HOXA3	Homeobox protein Hox-A3	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
O43365	HOXA3	Homeobox protein Hox-A3	GO:0021615; P:glossopharyngeal nerve morphogenesis; IEA:Ensembl
O43365	HOXA3	Homeobox protein Hox-A3	GO:0048645; P:organ formation; IEA:Ensembl
O43365	HOXA3	Homeobox protein Hox-A3	GO:0060017; P:parathyroid gland development; IEA:Ensembl
O43365	HOXA3	Homeobox protein Hox-A3	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
O43365	HOXA3	Homeobox protein Hox-A3	GO:0010159; P:specification of organ position; IEA:Ensembl
O43365	HOXA3	Homeobox protein Hox-A3	GO:0048538; P:thymus development; IEA:Ensembl
O43365	HOXA3	Homeobox protein Hox-A3	GO:0030878; P:thyroid gland development; IEA:Ensembl
O43365	HOXA3	Homeobox protein Hox-A3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q00056	HOXA4	Homeobox protein Hox-A4	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q00056	HOXA4	Homeobox protein Hox-A4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q00056	HOXA4	Homeobox protein Hox-A4	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q00056	HOXA4	Homeobox protein Hox-A4	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q00056	HOXA4	Homeobox protein Hox-A4	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
Q00056	HOXA4	Homeobox protein Hox-A4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P20719	HOXA5	Homeobox protein Hox-A5	GO:0003677; F:DNA binding; IDA:UniProtKB
P20719	HOXA5	Homeobox protein Hox-A5	GO:0005515; F:protein binding; IPI:UniProtKB
P20719	HOXA5	Homeobox protein Hox-A5	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P20719	HOXA5	Homeobox protein Hox-A5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P20719	HOXA5	Homeobox protein Hox-A5	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P20719	HOXA5	Homeobox protein Hox-A5	GO:0060435; P:bronchiole development; IEA:Ensembl
P20719	HOXA5	Homeobox protein Hox-A5	GO:0016477; P:cell migration; IEA:Ensembl
P20719	HOXA5	Homeobox protein Hox-A5	GO:0060764; P:cell-cell signaling involved in mammary gland development; IEA:Ensembl
P20719	HOXA5	Homeobox protein Hox-A5	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P20719	HOXA5	Homeobox protein Hox-A5	GO:0060441; P:epithelial tube branching involved in lung morphogenesis; IEA:Ensembl
P20719	HOXA5	Homeobox protein Hox-A5	GO:0060574; P:intestinal epithelial cell maturation; IEA:Ensembl
P20719	HOXA5	Homeobox protein Hox-A5	GO:0048286; P:lung alveolus development; IEA:Ensembl
P20719	HOXA5	Homeobox protein Hox-A5	GO:0060480; P:lung goblet cell differentiation; IEA:Ensembl
P20719	HOXA5	Homeobox protein Hox-A5	GO:0060484; P:lung-associated mesenchyme development; IEA:Ensembl
P20719	HOXA5	Homeobox protein Hox-A5	GO:0060749; P:mammary gland alveolus development; IEA:Ensembl
P20719	HOXA5	Homeobox protein Hox-A5	GO:0060644; P:mammary gland epithelial cell differentiation; IEA:Ensembl
P20719	HOXA5	Homeobox protein Hox-A5	GO:0060638; P:mesenchymal-epithelial cell signaling; IEA:Ensembl
P20719	HOXA5	Homeobox protein Hox-A5	GO:0035264; P:multicellular organism growth; IEA:Ensembl
P20719	HOXA5	Homeobox protein Hox-A5	GO:0016525; P:negative regulation of angiogenesis; IMP:UniProtKB
P20719	HOXA5	Homeobox protein Hox-A5	GO:0045647; P:negative regulation of erythrocyte differentiation; IDA:UniProtKB
P20719	HOXA5	Homeobox protein Hox-A5	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P20719	HOXA5	Homeobox protein Hox-A5	GO:0045639; P:positive regulation of myeloid cell differentiation; IDA:UniProtKB
P20719	HOXA5	Homeobox protein Hox-A5	GO:0010870; P:positive regulation of receptor biosynthetic process; IDA:UniProtKB
P20719	HOXA5	Homeobox protein Hox-A5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P20719	HOXA5	Homeobox protein Hox-A5	GO:0033599; P:regulation of mammary gland epithelial cell proliferation; IEA:Ensembl
P20719	HOXA5	Homeobox protein Hox-A5	GO:0003016; P:respiratory system process; IEA:Ensembl
P20719	HOXA5	Homeobox protein Hox-A5	GO:0030878; P:thyroid gland development; IEA:Ensembl
P20719	HOXA5	Homeobox protein Hox-A5	GO:0060535; P:trachea cartilage morphogenesis; IEA:Ensembl
P20719	HOXA5	Homeobox protein Hox-A5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P31267	HOXA6	Homeobox protein Hox-A6	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P31267	HOXA6	Homeobox protein Hox-A6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P31267	HOXA6	Homeobox protein Hox-A6	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P31267	HOXA6	Homeobox protein Hox-A6	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P31267	HOXA6	Homeobox protein Hox-A6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P31268	HOXA7	Homeobox protein Hox-A7	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
P31268	HOXA7	Homeobox protein Hox-A7	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P31268	HOXA7	Homeobox protein Hox-A7	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P31268	HOXA7	Homeobox protein Hox-A7	GO:0001525; P:angiogenesis; IEP:UniProtKB
P31268	HOXA7	Homeobox protein Hox-A7	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P31268	HOXA7	Homeobox protein Hox-A7	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P31268	HOXA7	Homeobox protein Hox-A7	GO:0001953; P:negative regulation of cell-matrix adhesion; IDA:UniProtKB
P31268	HOXA7	Homeobox protein Hox-A7	GO:0045617; P:negative regulation of keratinocyte differentiation; IDA:MGI
P31268	HOXA7	Homeobox protein Hox-A7	GO:0002686; P:negative regulation of leukocyte migration; IDA:UniProtKB
P31268	HOXA7	Homeobox protein Hox-A7	GO:0045656; P:negative regulation of monocyte differentiation; IDA:UniProtKB
P31268	HOXA7	Homeobox protein Hox-A7	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P31268	HOXA7	Homeobox protein Hox-A7	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P31268	HOXA7	Homeobox protein Hox-A7	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P31268	HOXA7	Homeobox protein Hox-A7	GO:0048863; P:stem cell differentiation; IEA:Ensembl
P31268	HOXA7	Homeobox protein Hox-A7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P31269	HOXA9	Homeobox protein Hox-A9	GO:0019899; F:enzyme binding; IPI:UniProtKB
P31269	HOXA9	Homeobox protein Hox-A9	GO:0005515; F:protein binding; IPI:IntAct
P31269	HOXA9	Homeobox protein Hox-A9	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P31269	HOXA9	Homeobox protein Hox-A9	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P31269	HOXA9	Homeobox protein Hox-A9	GO:0042118; P:endothelial cell activation; IMP:UniProtKB
P31269	HOXA9	Homeobox protein Hox-A9	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P31269	HOXA9	Homeobox protein Hox-A9	GO:0045638; P:negative regulation of myeloid cell differentiation; ISS:UniProtKB
P31269	HOXA9	Homeobox protein Hox-A9	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q92826	HOXB13	Homeobox protein Hox-B13	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q92826	HOXB13	Homeobox protein Hox-B13	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q92826	HOXB13	Homeobox protein Hox-B13	GO:0001525; P:angiogenesis; IEP:UniProtKB
Q92826	HOXB13	Homeobox protein Hox-B13	GO:0008544; P:epidermis development; TAS:ProtInc
Q92826	HOXB13	Homeobox protein Hox-B13	GO:0060743; P:epithelial cell maturation involved in prostate gland development; IEA:Ensembl
Q92826	HOXB13	Homeobox protein Hox-B13	GO:0060527; P:prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis; IEA:Ensembl
Q92826	HOXB13	Homeobox protein Hox-B13	GO:0040008; P:regulation of growth; IEA:Ensembl
Q92826	HOXB13	Homeobox protein Hox-B13	GO:0033574; P:response to testosterone; IEA:Ensembl
Q92826	HOXB13	Homeobox protein Hox-B13	GO:0009611; P:response to wounding; TAS:ProtInc
Q92826	HOXB13	Homeobox protein Hox-B13	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P14653	HOXB1	Homeobox protein Hox-B1	GO:0003677; F:DNA binding; IDA:UniProtKB
P14653	HOXB1	Homeobox protein Hox-B1	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P14653	HOXB1	Homeobox protein Hox-B1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P14653	HOXB1	Homeobox protein Hox-B1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P14653	HOXB1	Homeobox protein Hox-B1	GO:0048646; P:anatomical structure formation involved in morphogenesis; IEA:Ensembl
P14653	HOXB1	Homeobox protein Hox-B1	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P14653	HOXB1	Homeobox protein Hox-B1	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P14653	HOXB1	Homeobox protein Hox-B1	GO:0021612; P:facial nerve structural organization; IEA:Ensembl
P14653	HOXB1	Homeobox protein Hox-B1	GO:0021754; P:facial nucleus development; IEA:Ensembl
P14653	HOXB1	Homeobox protein Hox-B1	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
P14653	HOXB1	Homeobox protein Hox-B1	GO:0007389; P:pattern specification process; TAS:UniProtKB
P14653	HOXB1	Homeobox protein Hox-B1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P14653	HOXB1	Homeobox protein Hox-B1	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
P14653	HOXB1	Homeobox protein Hox-B1	GO:0021570; P:rhombomere 4 development; IEA:Ensembl
P14653	HOXB1	Homeobox protein Hox-B1	GO:0021571; P:rhombomere 5 development; IEA:Ensembl
P14653	HOXB1	Homeobox protein Hox-B1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P14652	HOXB2	Homeobox protein Hox-B2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P14652	HOXB2	Homeobox protein Hox-B2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P14652	HOXB2	Homeobox protein Hox-B2	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P14652	HOXB2	Homeobox protein Hox-B2	GO:0008015; P:blood circulation; TAS:ProtInc
P14652	HOXB2	Homeobox protein Hox-B2	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
P14652	HOXB2	Homeobox protein Hox-B2	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P14652	HOXB2	Homeobox protein Hox-B2	GO:0021612; P:facial nerve structural organization; IEA:Ensembl
P14652	HOXB2	Homeobox protein Hox-B2	GO:0002011; P:morphogenesis of an epithelial sheet; IEA:Ensembl
P14652	HOXB2	Homeobox protein Hox-B2	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P14652	HOXB2	Homeobox protein Hox-B2	GO:0048857; P:neural nucleus development; IEA:Ensembl
P14652	HOXB2	Homeobox protein Hox-B2	GO:0021569; P:rhombomere 3 development; IEA:Ensembl
P14652	HOXB2	Homeobox protein Hox-B2	GO:0021570; P:rhombomere 4 development; IEA:Ensembl
P14652	HOXB2	Homeobox protein Hox-B2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P14651	HOXB3	Homeobox protein Hox-B3	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl
P14651	HOXB3	Homeobox protein Hox-B3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P14651	HOXB3	Homeobox protein Hox-B3	GO:0001525; P:angiogenesis; IEP:UniProtKB
P14651	HOXB3	Homeobox protein Hox-B3	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P14651	HOXB3	Homeobox protein Hox-B3	GO:0051216; P:cartilage development; IEA:Ensembl
P14651	HOXB3	Homeobox protein Hox-B3	GO:0060216; P:definitive hemopoiesis; IEA:Ensembl
P14651	HOXB3	Homeobox protein Hox-B3	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P14651	HOXB3	Homeobox protein Hox-B3	GO:0060324; P:face development; IEA:Ensembl
P14651	HOXB3	Homeobox protein Hox-B3	GO:0021615; P:glossopharyngeal nerve morphogenesis; IEA:Ensembl
P14651	HOXB3	Homeobox protein Hox-B3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P14651	HOXB3	Homeobox protein Hox-B3	GO:0050767; P:regulation of neurogenesis; IEA:Ensembl
P14651	HOXB3	Homeobox protein Hox-B3	GO:0021546; P:rhombomere development; IEA:Ensembl
P14651	HOXB3	Homeobox protein Hox-B3	GO:0030878; P:thyroid gland development; IEA:Ensembl
P14651	HOXB3	Homeobox protein Hox-B3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17483	HOXB4	Homeobox protein Hox-B4	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P17483	HOXB4	Homeobox protein Hox-B4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P17483	HOXB4	Homeobox protein Hox-B4	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P17483	HOXB4	Homeobox protein Hox-B4	GO:0048539; P:bone marrow development; IEA:Ensembl
P17483	HOXB4	Homeobox protein Hox-B4	GO:0008283; P:cell proliferation; IEA:Ensembl
P17483	HOXB4	Homeobox protein Hox-B4	GO:0060216; P:definitive hemopoiesis; IEA:Ensembl
P17483	HOXB4	Homeobox protein Hox-B4	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P17483	HOXB4	Homeobox protein Hox-B4	GO:0060218; P:hematopoietic stem cell differentiation; IDA:BHF-UCL
P17483	HOXB4	Homeobox protein Hox-B4	GO:0002011; P:morphogenesis of an epithelial sheet; IEA:Ensembl
P17483	HOXB4	Homeobox protein Hox-B4	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P17483	HOXB4	Homeobox protein Hox-B4	GO:2000738; P:positive regulation of stem cell differentiation; IDA:BHF-UCL
P17483	HOXB4	Homeobox protein Hox-B4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P17483	HOXB4	Homeobox protein Hox-B4	GO:0048103; P:somatic stem cell division; IEA:Ensembl
P17483	HOXB4	Homeobox protein Hox-B4	GO:0048536; P:spleen development; IEA:Ensembl
P17483	HOXB4	Homeobox protein Hox-B4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P09067	HOXB5	Homeobox protein Hox-B5	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IEA:Ensembl
P09067	HOXB5	Homeobox protein Hox-B5	GO:0001205; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P09067	HOXB5	Homeobox protein Hox-B5	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P09067	HOXB5	Homeobox protein Hox-B5	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P09067	HOXB5	Homeobox protein Hox-B5	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P09067	HOXB5	Homeobox protein Hox-B5	GO:0045446; P:endothelial cell differentiation; IEA:Ensembl
P17509	HOXB6	Homeobox protein Hox-B6	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P17509	HOXB6	Homeobox protein Hox-B6	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P17509	HOXB6	Homeobox protein Hox-B6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P17509	HOXB6	Homeobox protein Hox-B6	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P17509	HOXB6	Homeobox protein Hox-B6	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P17509	HOXB6	Homeobox protein Hox-B6	GO:0034101; P:erythrocyte homeostasis; IEA:Ensembl
P17509	HOXB6	Homeobox protein Hox-B6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P09629	HOXB7	Homeobox protein Hox-B7	GO:0005515; F:protein binding; IPI:IntAct
P09629	HOXB7	Homeobox protein Hox-B7	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P09629	HOXB7	Homeobox protein Hox-B7	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
P09629	HOXB7	Homeobox protein Hox-B7	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P09629	HOXB7	Homeobox protein Hox-B7	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P09629	HOXB7	Homeobox protein Hox-B7	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
P09629	HOXB7	Homeobox protein Hox-B7	GO:0030099; P:myeloid cell differentiation; IEA:Ensembl
P09629	HOXB7	Homeobox protein Hox-B7	GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; IEA:Ensembl
P09629	HOXB7	Homeobox protein Hox-B7	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P09629	HOXB7	Homeobox protein Hox-B7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17481	HOXB8	Homeobox protein Hox-B8	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P17481	HOXB8	Homeobox protein Hox-B8	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
P17481	HOXB8	Homeobox protein Hox-B8	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P17481	HOXB8	Homeobox protein Hox-B8	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P17481	HOXB8	Homeobox protein Hox-B8	GO:0021516; P:dorsal spinal cord development; IEA:Ensembl
P17481	HOXB8	Homeobox protein Hox-B8	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P17481	HOXB8	Homeobox protein Hox-B8	GO:0007625; P:grooming behavior; IEA:Ensembl
P17481	HOXB8	Homeobox protein Hox-B8	GO:0045638; P:negative regulation of myeloid cell differentiation; ISS:UniProtKB
P17481	HOXB8	Homeobox protein Hox-B8	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P17481	HOXB8	Homeobox protein Hox-B8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17482	HOXB9	Homeobox protein Hox-B9	GO:0005515; F:protein binding; IPI:UniProtKB
P17482	HOXB9	Homeobox protein Hox-B9	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P17482	HOXB9	Homeobox protein Hox-B9	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P17482	HOXB9	Homeobox protein Hox-B9	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P17482	HOXB9	Homeobox protein Hox-B9	GO:0060070; P:canonical Wnt signaling pathway; IMP:UniProtKB
P17482	HOXB9	Homeobox protein Hox-B9	GO:0060326; P:cell chemotaxis; IDA:UniProtKB
P17482	HOXB9	Homeobox protein Hox-B9	GO:0048706; P:embryonic skeletal system development; IEA:Ensembl
P17482	HOXB9	Homeobox protein Hox-B9	GO:0030879; P:mammary gland development; IEA:Ensembl
P17482	HOXB9	Homeobox protein Hox-B9	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P17482	HOXB9	Homeobox protein Hox-B9	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43248	HOXC11	Homeobox protein Hox-C11	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB
O43248	HOXC11	Homeobox protein Hox-C11	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:NTNU_SB
O43248	HOXC11	Homeobox protein Hox-C11	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
O43248	HOXC11	Homeobox protein Hox-C11	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
O43248	HOXC11	Homeobox protein Hox-C11	GO:0060272; P:embryonic skeletal joint morphogenesis; IEA:Ensembl
O43248	HOXC11	Homeobox protein Hox-C11	GO:0007492; P:endoderm development; TAS:ProtInc
O43248	HOXC11	Homeobox protein Hox-C11	GO:0001656; P:metanephros development; IEA:Ensembl
O43248	HOXC11	Homeobox protein Hox-C11	GO:0001759; P:organ induction; IEA:Ensembl
O43248	HOXC11	Homeobox protein Hox-C11	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB
O43248	HOXC11	Homeobox protein Hox-C11	GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl
P31275	HOXC12	Homeobox protein Hox-C12	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P31275	HOXC12	Homeobox protein Hox-C12	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P31275	HOXC12	Homeobox protein Hox-C12	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P31275	HOXC12	Homeobox protein Hox-C12	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P31276	HOXC13	Homeobox protein Hox-C13	GO:0003682; F:chromatin binding; IEA:Ensembl
P31276	HOXC13	Homeobox protein Hox-C13	GO:0005515; F:protein binding; IPI:IntAct
P31276	HOXC13	Homeobox protein Hox-C13	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P31276	HOXC13	Homeobox protein Hox-C13	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P31276	HOXC13	Homeobox protein Hox-C13	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P31276	HOXC13	Homeobox protein Hox-C13	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P31276	HOXC13	Homeobox protein Hox-C13	GO:0001942; P:hair follicle development; IEA:Ensembl
P31276	HOXC13	Homeobox protein Hox-C13	GO:0035878; P:nail development; IEA:Ensembl
P31276	HOXC13	Homeobox protein Hox-C13	GO:0043587; P:tongue morphogenesis; IEA:Ensembl
Q9NYD6	HOXC10	Homeobox protein Hox-C10	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9NYD6	HOXC10	Homeobox protein Hox-C10	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9NYD6	HOXC10	Homeobox protein Hox-C10	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q9NYD6	HOXC10	Homeobox protein Hox-C10	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
Q9NYD6	HOXC10	Homeobox protein Hox-C10	GO:0050905; P:neuromuscular process; IEA:Ensembl
Q9NYD6	HOXC10	Homeobox protein Hox-C10	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q9NYD6	HOXC10	Homeobox protein Hox-C10	GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl
Q9NYD6	HOXC10	Homeobox protein Hox-C10	GO:0001501; P:skeletal system development; IEA:Ensembl
Q9NYD6	HOXC10	Homeobox protein Hox-C10	GO:0021520; P:spinal cord motor neuron cell fate specification; IEA:Ensembl
Q9NYD6	HOXC10	Homeobox protein Hox-C10	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P09017	HOXC4	Homeobox protein Hox-C4	GO:0005515; F:protein binding; IPI:IntAct
P09017	HOXC4	Homeobox protein Hox-C4	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P09017	HOXC4	Homeobox protein Hox-C4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P09017	HOXC4	Homeobox protein Hox-C4	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P09017	HOXC4	Homeobox protein Hox-C4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q00444	HOXC5	Homeobox protein Hox-C5	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q00444	HOXC5	Homeobox protein Hox-C5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q00444	HOXC5	Homeobox protein Hox-C5	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q00444	HOXC5	Homeobox protein Hox-C5	GO:0048706; P:embryonic skeletal system development; IEA:Ensembl
Q00444	HOXC5	Homeobox protein Hox-C5	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q00444	HOXC5	Homeobox protein Hox-C5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P09630	HOXC6	Homeobox protein Hox-C6	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P09630	HOXC6	Homeobox protein Hox-C6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P09630	HOXC6	Homeobox protein Hox-C6	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
P09630	HOXC6	Homeobox protein Hox-C6	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P09630	HOXC6	Homeobox protein Hox-C6	GO:0048706; P:embryonic skeletal system development; IEA:Ensembl
P09630	HOXC6	Homeobox protein Hox-C6	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P09630	HOXC6	Homeobox protein Hox-C6	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P09630	HOXC6	Homeobox protein Hox-C6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P31273	HOXC8	Homeobox protein Hox-C8	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P31273	HOXC8	Homeobox protein Hox-C8	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
P31273	HOXC8	Homeobox protein Hox-C8	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P31273	HOXC8	Homeobox protein Hox-C8	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P31273	HOXC8	Homeobox protein Hox-C8	GO:0030182; P:neuron differentiation; IEA:Ensembl
P31273	HOXC8	Homeobox protein Hox-C8	GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl
P31273	HOXC8	Homeobox protein Hox-C8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P31274	HOXC9	Homeobox protein Hox-C9	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P31274	HOXC9	Homeobox protein Hox-C9	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P31274	HOXC9	Homeobox protein Hox-C9	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P31274	HOXC9	Homeobox protein Hox-C9	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P31274	HOXC9	Homeobox protein Hox-C9	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P28358	HOXD10	Homeobox protein Hox-D10	GO:0003682; F:chromatin binding; IEA:Ensembl
P28358	HOXD10	Homeobox protein Hox-D10	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P28358	HOXD10	Homeobox protein Hox-D10	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P28358	HOXD10	Homeobox protein Hox-D10	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P28358	HOXD10	Homeobox protein Hox-D10	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P28358	HOXD10	Homeobox protein Hox-D10	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
P28358	HOXD10	Homeobox protein Hox-D10	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P28358	HOXD10	Homeobox protein Hox-D10	GO:0035136; P:forelimb morphogenesis; IEA:Ensembl
P28358	HOXD10	Homeobox protein Hox-D10	GO:0035137; P:hindlimb morphogenesis; IEA:Ensembl
P28358	HOXD10	Homeobox protein Hox-D10	GO:0050905; P:neuromuscular process; IEA:Ensembl
P28358	HOXD10	Homeobox protein Hox-D10	GO:0048935; P:peripheral nervous system neuron development; IEA:Ensembl
P28358	HOXD10	Homeobox protein Hox-D10	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P28358	HOXD10	Homeobox protein Hox-D10	GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl
P28358	HOXD10	Homeobox protein Hox-D10	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
P28358	HOXD10	Homeobox protein Hox-D10	GO:0021520; P:spinal cord motor neuron cell fate specification; IEA:Ensembl
P28358	HOXD10	Homeobox protein Hox-D10	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P31277	HOXD11	Homeobox protein Hox-D11	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P31277	HOXD11	Homeobox protein Hox-D11	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P31277	HOXD11	Homeobox protein Hox-D11	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P31277	HOXD11	Homeobox protein Hox-D11	GO:0001658; P:branching involved in ureteric bud morphogenesis; ISS:UniProtKB
P31277	HOXD11	Homeobox protein Hox-D11	GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; IEA:Ensembl
P31277	HOXD11	Homeobox protein Hox-D11	GO:0048589; P:developmental growth; IEA:Ensembl
P31277	HOXD11	Homeobox protein Hox-D11	GO:0009953; P:dorsal/ventral pattern formation; ISS:UniProtKB
P31277	HOXD11	Homeobox protein Hox-D11	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
P31277	HOXD11	Homeobox protein Hox-D11	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
P31277	HOXD11	Homeobox protein Hox-D11	GO:0060272; P:embryonic skeletal joint morphogenesis; IEA:Ensembl
P31277	HOXD11	Homeobox protein Hox-D11	GO:0001656; P:metanephros development; IEA:Ensembl
P31277	HOXD11	Homeobox protein Hox-D11	GO:0001759; P:organ induction; IEA:Ensembl
P31277	HOXD11	Homeobox protein Hox-D11	GO:0010720; P:positive regulation of cell development; IEA:Ensembl
P31277	HOXD11	Homeobox protein Hox-D11	GO:0032332; P:positive regulation of chondrocyte differentiation; IEA:Ensembl
P31277	HOXD11	Homeobox protein Hox-D11	GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl
P31277	HOXD11	Homeobox protein Hox-D11	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P35452	HOXD12	Homeobox protein Hox-D12	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P35452	HOXD12	Homeobox protein Hox-D12	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P35452	HOXD12	Homeobox protein Hox-D12	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
P35452	HOXD12	Homeobox protein Hox-D12	GO:0007389; P:pattern specification process; IEA:Ensembl
P35452	HOXD12	Homeobox protein Hox-D12	GO:0001501; P:skeletal system development; IEA:Ensembl
P35452	HOXD12	Homeobox protein Hox-D12	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P35453	HOXD13	Homeobox protein Hox-D13	GO:0003682; F:chromatin binding; IEA:Ensembl
P35453	HOXD13	Homeobox protein Hox-D13	GO:0003677; F:DNA binding; TAS:ProtInc
P35453	HOXD13	Homeobox protein Hox-D13	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P35453	HOXD13	Homeobox protein Hox-D13	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P35453	HOXD13	Homeobox protein Hox-D13	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P35453	HOXD13	Homeobox protein Hox-D13	GO:0060602; P:branch elongation of an epithelium; IEA:Ensembl
P35453	HOXD13	Homeobox protein Hox-D13	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
P35453	HOXD13	Homeobox protein Hox-D13	GO:0048619; P:embryonic hindgut morphogenesis; IEA:Ensembl
P35453	HOXD13	Homeobox protein Hox-D13	GO:0030539; P:male genitalia development; IEA:Ensembl
P35453	HOXD13	Homeobox protein Hox-D13	GO:0060571; P:morphogenesis of an epithelial fold; IEA:Ensembl
P35453	HOXD13	Homeobox protein Hox-D13	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P35453	HOXD13	Homeobox protein Hox-D13	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P35453	HOXD13	Homeobox protein Hox-D13	GO:0060527; P:prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis; IEA:Ensembl
P35453	HOXD13	Homeobox protein Hox-D13	GO:0060687; P:regulation of branching involved in prostate gland morphogenesis; IEA:Ensembl
P35453	HOXD13	Homeobox protein Hox-D13	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P35453	HOXD13	Homeobox protein Hox-D13	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
P35453	HOXD13	Homeobox protein Hox-D13	GO:0001501; P:skeletal system development; TAS:ProtInc
P35453	HOXD13	Homeobox protein Hox-D13	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9GZZ0	HOXD1	Homeobox protein Hox-D1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9GZZ0	HOXD1	Homeobox protein Hox-D1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9GZZ0	HOXD1	Homeobox protein Hox-D1	GO:0048706; P:embryonic skeletal system development; IEA:Ensembl
Q9GZZ0	HOXD1	Homeobox protein Hox-D1	GO:0030182; P:neuron differentiation; IEA:Ensembl
Q9GZZ0	HOXD1	Homeobox protein Hox-D1	GO:0019233; P:sensory perception of pain; IEA:Ensembl
Q9GZZ0	HOXD1	Homeobox protein Hox-D1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P31249	HOXD3	Homeobox protein Hox-D3	GO:0005515; F:protein binding; IPI:IntAct
P31249	HOXD3	Homeobox protein Hox-D3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P31249	HOXD3	Homeobox protein Hox-D3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P31249	HOXD3	Homeobox protein Hox-D3	GO:0009952; P:anterior/posterior pattern specification; ISS:UniProtKB
P31249	HOXD3	Homeobox protein Hox-D3	GO:0051216; P:cartilage development; ISS:UniProtKB
P31249	HOXD3	Homeobox protein Hox-D3	GO:0007160; P:cell-matrix adhesion; IDA:UniProtKB
P31249	HOXD3	Homeobox protein Hox-D3	GO:0048704; P:embryonic skeletal system morphogenesis; ISS:UniProtKB
P31249	HOXD3	Homeobox protein Hox-D3	GO:0021615; P:glossopharyngeal nerve morphogenesis; IEA:Ensembl
P31249	HOXD3	Homeobox protein Hox-D3	GO:0007219; P:Notch signaling pathway; IMP:UniProtKB
P31249	HOXD3	Homeobox protein Hox-D3	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
P31249	HOXD3	Homeobox protein Hox-D3	GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB
P31249	HOXD3	Homeobox protein Hox-D3	GO:0030878; P:thyroid gland development; ISS:UniProtKB
P31249	HOXD3	Homeobox protein Hox-D3	GO:0006351; P:transcription, DNA-templated; IMP:UniProtKB
P09016	HOXD4	Homeobox protein Hox-D4	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P09016	HOXD4	Homeobox protein Hox-D4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P09016	HOXD4	Homeobox protein Hox-D4	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
P09016	HOXD4	Homeobox protein Hox-D4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P13378	HOXD8	Homeobox protein Hox-D8	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P13378	HOXD8	Homeobox protein Hox-D8	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P13378	HOXD8	Homeobox protein Hox-D8	GO:0008595; P:anterior/posterior axis specification, embryo; NAS:UniProtKB
P13378	HOXD8	Homeobox protein Hox-D8	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P13378	HOXD8	Homeobox protein Hox-D8	GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl
P13378	HOXD8	Homeobox protein Hox-D8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P28356	HOXD9	Homeobox protein Hox-D9	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P28356	HOXD9	Homeobox protein Hox-D9	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P28356	HOXD9	Homeobox protein Hox-D9	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P28356	HOXD9	Homeobox protein Hox-D9	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P28356	HOXD9	Homeobox protein Hox-D9	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
P28356	HOXD9	Homeobox protein Hox-D9	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P28356	HOXD9	Homeobox protein Hox-D9	GO:0035137; P:hindlimb morphogenesis; IEA:Ensembl
P28356	HOXD9	Homeobox protein Hox-D9	GO:0030879; P:mammary gland development; IEA:Ensembl
P28356	HOXD9	Homeobox protein Hox-D9	GO:0048935; P:peripheral nervous system neuron development; IEA:Ensembl
P28356	HOXD9	Homeobox protein Hox-D9	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P28356	HOXD9	Homeobox protein Hox-D9	GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl
P28356	HOXD9	Homeobox protein Hox-D9	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
P28356	HOXD9	Homeobox protein Hox-D9	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P19367	HK1	Hexokinase-1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P19367	HK1	Hexokinase-1	GO:0008865; F:fructokinase activity; IBA:RefGenome
P19367	HK1	Hexokinase-1	GO:0004340; F:glucokinase activity; IBA:RefGenome
P19367	HK1	Hexokinase-1	GO:0004396; F:hexokinase activity; TAS:ProtInc
P19367	HK1	Hexokinase-1	GO:0019158; F:mannokinase activity; IBA:RefGenome
P19367	HK1	Hexokinase-1	GO:0005515; F:protein binding; IPI:IntAct
P19367	HK1	Hexokinase-1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P19367	HK1	Hexokinase-1	GO:0046835; P:carbohydrate phosphorylation; IBA:GOC
P19367	HK1	Hexokinase-1	GO:0008219; P:cell death; IEA:UniProtKB-KW
P19367	HK1	Hexokinase-1	GO:0001678; P:cellular glucose homeostasis; IBA:RefGenome
P19367	HK1	Hexokinase-1	GO:0051156; P:glucose 6-phosphate metabolic process; IBA:GOC
P19367	HK1	Hexokinase-1	GO:0015758; P:glucose transport; TAS:Reactome
P19367	HK1	Hexokinase-1	GO:0006096; P:glycolytic process; IBA:RefGenome
P19367	HK1	Hexokinase-1	GO:0019318; P:hexose metabolic process; IEA:UniProtKB-UniPathway
P19367	HK1	Hexokinase-1	GO:0008645; P:hexose transport; TAS:Reactome
P19367	HK1	Hexokinase-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P19367	HK1	Hexokinase-1	GO:0055085; P:transmembrane transport; TAS:Reactome
P52789	HK2	Hexokinase-2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P52789	HK2	Hexokinase-2	GO:0008865; F:fructokinase activity; IBA:RefGenome
P52789	HK2	Hexokinase-2	GO:0004340; F:glucokinase activity; IBA:RefGenome
P52789	HK2	Hexokinase-2	GO:0005536; F:glucose binding; IEA:Ensembl
P52789	HK2	Hexokinase-2	GO:0004396; F:hexokinase activity; TAS:ProtInc
P52789	HK2	Hexokinase-2	GO:0019158; F:mannokinase activity; IBA:RefGenome
P52789	HK2	Hexokinase-2	GO:0008637; P:apoptotic mitochondrial changes; IDA:MGI
P52789	HK2	Hexokinase-2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P52789	HK2	Hexokinase-2	GO:0001678; P:cellular glucose homeostasis; IBA:RefGenome
P52789	HK2	Hexokinase-2	GO:0051156; P:glucose 6-phosphate metabolic process; IBA:GOC
P52789	HK2	Hexokinase-2	GO:0006006; P:glucose metabolic process; IEA:Ensembl
P52789	HK2	Hexokinase-2	GO:0015758; P:glucose transport; TAS:Reactome
P52789	HK2	Hexokinase-2	GO:0006096; P:glycolytic process; IBA:RefGenome
P52789	HK2	Hexokinase-2	GO:0008645; P:hexose transport; TAS:Reactome
P52789	HK2	Hexokinase-2	GO:0007595; P:lactation; IEA:Ensembl
P52789	HK2	Hexokinase-2	GO:0046324; P:regulation of glucose import; IEA:Ensembl
P52789	HK2	Hexokinase-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P52789	HK2	Hexokinase-2	GO:0055085; P:transmembrane transport; TAS:Reactome
P52790	HK3	Hexokinase-3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P52790	HK3	Hexokinase-3	GO:0008865; F:fructokinase activity; IBA:RefGenome
P52790	HK3	Hexokinase-3	GO:0004340; F:glucokinase activity; IBA:RefGenome
P52790	HK3	Hexokinase-3	GO:0004396; F:hexokinase activity; IDA:MGI
P52790	HK3	Hexokinase-3	GO:0042562; F:hormone binding; IEA:Ensembl
P52790	HK3	Hexokinase-3	GO:0019158; F:mannokinase activity; IBA:RefGenome
P52790	HK3	Hexokinase-3	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P52790	HK3	Hexokinase-3	GO:0046835; P:carbohydrate phosphorylation; IDA:GOC
P52790	HK3	Hexokinase-3	GO:0001678; P:cellular glucose homeostasis; IBA:RefGenome
P52790	HK3	Hexokinase-3	GO:0051156; P:glucose 6-phosphate metabolic process; IBA:GOC
P52790	HK3	Hexokinase-3	GO:0015758; P:glucose transport; TAS:Reactome
P52790	HK3	Hexokinase-3	GO:0006096; P:glycolytic process; IEA:UniProtKB-KW
P52790	HK3	Hexokinase-3	GO:0019318; P:hexose metabolic process; IEA:UniProtKB-UniPathway
P52790	HK3	Hexokinase-3	GO:0008645; P:hexose transport; TAS:Reactome
P52790	HK3	Hexokinase-3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P52790	HK3	Hexokinase-3	GO:0055085; P:transmembrane transport; TAS:Reactome
P35557	GCK	Glucokinase	GO:0043531; F:ADP binding; IEA:Ensembl
P35557	GCK	Glucokinase	GO:0005524; F:ATP binding; IDA:UniProtKB
P35557	GCK	Glucokinase	GO:0004340; F:glucokinase activity; IDA:UniProtKB
P35557	GCK	Glucokinase	GO:0005536; F:glucose binding; IDA:UniProtKB
P35557	GCK	Glucokinase	GO:0000287; F:magnesium ion binding; IEA:Ensembl
P35557	GCK	Glucokinase	GO:0005515; F:protein binding; IPI:UniProtKB
P35557	GCK	Glucokinase	GO:0070509; P:calcium ion import; IEA:Ensembl
P35557	GCK	Glucokinase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P35557	GCK	Glucokinase	GO:0001678; P:cellular glucose homeostasis; IBA:RefGenome
P35557	GCK	Glucokinase	GO:0042149; P:cellular response to glucose starvation; IEA:Ensembl
P35557	GCK	Glucokinase	GO:0032869; P:cellular response to insulin stimulus; ISS:BHF-UCL
P35557	GCK	Glucokinase	GO:0044320; P:cellular response to leptin stimulus; ISS:BHF-UCL
P35557	GCK	Glucokinase	GO:0051594; P:detection of glucose; IMP:UniProtKB
P35557	GCK	Glucokinase	GO:0031018; P:endocrine pancreas development; TAS:Reactome
P35557	GCK	Glucokinase	GO:0006003; P:fructose 2,6-bisphosphate metabolic process; IEA:Ensembl
P35557	GCK	Glucokinase	GO:0042593; P:glucose homeostasis; IMP:UniProtKB
P35557	GCK	Glucokinase	GO:0006006; P:glucose metabolic process; IEA:Ensembl
P35557	GCK	Glucokinase	GO:0015758; P:glucose transport; TAS:Reactome
P35557	GCK	Glucokinase	GO:0005978; P:glycogen biosynthetic process; IEA:Ensembl
P35557	GCK	Glucokinase	GO:0006096; P:glycolytic process; IEA:UniProtKB-KW
P35557	GCK	Glucokinase	GO:0008645; P:hexose transport; TAS:Reactome
P35557	GCK	Glucokinase	GO:0006739; P:NADP metabolic process; IEA:Ensembl
P35557	GCK	Glucokinase	GO:0032811; P:negative regulation of epinephrine secretion; IEA:Ensembl
P35557	GCK	Glucokinase	GO:0045721; P:negative regulation of gluconeogenesis; IMP:UniProtKB
P35557	GCK	Glucokinase	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P35557	GCK	Glucokinase	GO:0045725; P:positive regulation of glycogen biosynthetic process; IMP:UniProtKB
P35557	GCK	Glucokinase	GO:0045821; P:positive regulation of glycolytic process; IEA:Ensembl
P35557	GCK	Glucokinase	GO:0032024; P:positive regulation of insulin secretion; IMP:UniProtKB
P35557	GCK	Glucokinase	GO:0042327; P:positive regulation of phosphorylation; IEA:Ensembl
P35557	GCK	Glucokinase	GO:0010827; P:regulation of glucose transport; TAS:Reactome
P35557	GCK	Glucokinase	GO:0006110; P:regulation of glycolytic process; NAS:BHF-UCL
P35557	GCK	Glucokinase	GO:0050796; P:regulation of insulin secretion; IMP:BHF-UCL
P35557	GCK	Glucokinase	GO:0043266; P:regulation of potassium ion transport; IEA:Ensembl
P35557	GCK	Glucokinase	GO:0019932; P:second-messenger-mediated signaling; IEA:Ensembl
P35557	GCK	Glucokinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P35557	GCK	Glucokinase	GO:0055085; P:transmembrane transport; TAS:Reactome
Q12794	HYAL1	Hyaluronidase-1	GO:0050501; F:hyaluronan synthase activity; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0004415; F:hyalurononglucosaminidase activity; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0008134; F:transcription factor binding; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q12794	HYAL1	Hyaluronidase-1	GO:0051216; P:cartilage development; IEP:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0044344; P:cellular response to fibroblast growth factor stimulus; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0071347; P:cellular response to interleukin-1; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0071467; P:cellular response to pH; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0036120; P:cellular response to platelet-derived growth factor stimulus; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0071356; P:cellular response to tumor necrosis factor; IEP:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0071493; P:cellular response to UV-B; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0030207; P:chondroitin sulfate catabolic process; TAS:Reactome
Q12794	HYAL1	Hyaluronidase-1	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q12794	HYAL1	Hyaluronidase-1	GO:0060272; P:embryonic skeletal joint morphogenesis; IEA:Ensembl
Q12794	HYAL1	Hyaluronidase-1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q12794	HYAL1	Hyaluronidase-1	GO:0030213; P:hyaluronan biosynthetic process; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0030214; P:hyaluronan catabolic process; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0030212; P:hyaluronan metabolic process; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0006954; P:inflammatory response; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0045785; P:positive regulation of cell adhesion; IMP:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0030307; P:positive regulation of cell growth; IMP:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0010634; P:positive regulation of epithelial cell migration; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0045927; P:positive regulation of growth; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:1900106; P:positive regulation of hyaluranon cable assembly; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0046677; P:response to antibiotic; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0000302; P:response to reactive oxygen species; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0009615; P:response to virus; IDA:UniProtKB
Q12794	HYAL1	Hyaluronidase-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q12891	HYAL2	Hyaluronidase-2	GO:0019899; F:enzyme binding; IPI:BHF-UCL
Q12891	HYAL2	Hyaluronidase-2	GO:0005540; F:hyaluronic acid binding; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0033906; F:hyaluronoglucuronidase activity; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0004415; F:hyalurononglucosaminidase activity; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0030294; F:receptor signaling protein tyrosine kinase inhibitor activity; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0030971; F:receptor tyrosine kinase binding; IPI:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0050431; F:transforming growth factor beta binding; ISS:BHF-UCL
Q12891	HYAL2	Hyaluronidase-2	GO:0001618; F:virus receptor activity; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q12891	HYAL2	Hyaluronidase-2	GO:0051216; P:cartilage development; IEP:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0044344; P:cellular response to fibroblast growth factor stimulus; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0071347; P:cellular response to interleukin-1; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IDA:BHF-UCL
Q12891	HYAL2	Hyaluronidase-2	GO:0071356; P:cellular response to tumor necrosis factor; IEP:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0071493; P:cellular response to UV-B; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0051607; P:defense response to virus; IEA:Ensembl
Q12891	HYAL2	Hyaluronidase-2	GO:0019064; P:fusion of virus membrane with host plasma membrane; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0006027; P:glycosaminoglycan catabolic process; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q12891	HYAL2	Hyaluronidase-2	GO:0002244; P:hematopoietic progenitor cell differentiation; IEA:Ensembl
Q12891	HYAL2	Hyaluronidase-2	GO:0030214; P:hyaluronan catabolic process; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0030212; P:hyaluronan metabolic process; TAS:Reactome
Q12891	HYAL2	Hyaluronidase-2	GO:0001822; P:kidney development; ISS:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0042117; P:monocyte activation; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0010259; P:multicellular organismal aging; IEA:Ensembl
Q12891	HYAL2	Hyaluronidase-2	GO:0060586; P:multicellular organismal iron ion homeostasis; IEA:Ensembl
Q12891	HYAL2	Hyaluronidase-2	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0010764; P:negative regulation of fibroblast migration; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0043407; P:negative regulation of MAP kinase activity; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0051898; P:negative regulation of protein kinase B signaling; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0061099; P:negative regulation of protein tyrosine kinase activity; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; ISS:BHF-UCL
Q12891	HYAL2	Hyaluronidase-2	GO:0050729; P:positive regulation of inflammatory response; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:2000778; P:positive regulation of interleukin-6 secretion; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:2000484; P:positive regulation of interleukin-8 secretion; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0042307; P:positive regulation of protein import into nucleus; ISS:BHF-UCL
Q12891	HYAL2	Hyaluronidase-2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q12891	HYAL2	Hyaluronidase-2	GO:0035810; P:positive regulation of urine volume; ISS:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0070295; P:renal water absorption; ISS:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0046677; P:response to antibiotic; IEP:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0000302; P:response to reactive oxygen species; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0009615; P:response to virus; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl
Q12891	HYAL2	Hyaluronidase-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q12891	HYAL2	Hyaluronidase-2	GO:0019087; P:transformation of host cell by virus; IDA:UniProtKB
Q12891	HYAL2	Hyaluronidase-2	GO:0046718; P:viral entry into host cell; ISS:UniProtKB
Q2M3T9	HYAL4	Hyaluronidase-4	GO:0004415; F:hyalurononglucosaminidase activity; TAS:ProtInc
Q2M3T9	HYAL4	Hyaluronidase-4	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q2M3T9	HYAL4	Hyaluronidase-4	GO:0030207; P:chondroitin sulfate catabolic process; IEA:Ensembl
Q2M3T9	HYAL4	Hyaluronidase-4	GO:0006027; P:glycosaminoglycan catabolic process; TAS:ProtInc
O43820	HYAL3	Hyaluronidase-3	GO:0033906; F:hyaluronoglucuronidase activity; IDA:UniProtKB
O43820	HYAL3	Hyaluronidase-3	GO:0004415; F:hyalurononglucosaminidase activity; IDA:UniProtKB
O43820	HYAL3	Hyaluronidase-3	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
O43820	HYAL3	Hyaluronidase-3	GO:0051216; P:cartilage development; IEP:UniProtKB
O43820	HYAL3	Hyaluronidase-3	GO:0071347; P:cellular response to interleukin-1; IDA:UniProtKB
O43820	HYAL3	Hyaluronidase-3	GO:0071356; P:cellular response to tumor necrosis factor; IEP:UniProtKB
O43820	HYAL3	Hyaluronidase-3	GO:0071493; P:cellular response to UV-B; IDA:UniProtKB
O43820	HYAL3	Hyaluronidase-3	GO:0030214; P:hyaluronan catabolic process; IDA:UniProtKB
O43820	HYAL3	Hyaluronidase-3	GO:0006954; P:inflammatory response; IDA:UniProtKB
O43820	HYAL3	Hyaluronidase-3	GO:0046677; P:response to antibiotic; IEP:UniProtKB
O43820	HYAL3	Hyaluronidase-3	GO:0009615; P:response to virus; IDA:UniProtKB
P38567	SPAM1	Hyaluronidase PH-20	GO:0004415; F:hyalurononglucosaminidase activity; IEA:UniProtKB-EC
P38567	SPAM1	Hyaluronidase PH-20	GO:0007339; P:binding of sperm to zona pellucida; TAS:ProtInc
P38567	SPAM1	Hyaluronidase PH-20	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
P38567	SPAM1	Hyaluronidase PH-20	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P38567	SPAM1	Hyaluronidase PH-20	GO:0007342; P:fusion of sperm to egg plasma membrane; IEA:InterPro
P38567	SPAM1	Hyaluronidase PH-20	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
P38567	SPAM1	Hyaluronidase PH-20	GO:0007338; P:single fertilization; TAS:Reactome
P38567	SPAM1	Hyaluronidase PH-20	GO:0035036; P:sperm-egg recognition; TAS:Reactome
Q92839	HAS1	Hyaluronan synthase 1	GO:0050501; F:hyaluronan synthase activity; ISS:UniProtKB
Q92839	HAS1	Hyaluronan synthase 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q92839	HAS1	Hyaluronan synthase 1	GO:0007155; P:cell adhesion; TAS:ProtInc
Q92839	HAS1	Hyaluronan synthase 1	GO:0036120; P:cellular response to platelet-derived growth factor stimulus; IDA:UniProtKB
Q92839	HAS1	Hyaluronan synthase 1	GO:0085029; P:extracellular matrix assembly; ISS:UniProtKB
Q92839	HAS1	Hyaluronan synthase 1	GO:0045226; P:extracellular polysaccharide biosynthetic process; ISS:UniProtKB
Q92839	HAS1	Hyaluronan synthase 1	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:ProtInc
Q92839	HAS1	Hyaluronan synthase 1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q92839	HAS1	Hyaluronan synthase 1	GO:0030213; P:hyaluronan biosynthetic process; TAS:Reactome
Q92839	HAS1	Hyaluronan synthase 1	GO:0030212; P:hyaluronan metabolic process; TAS:Reactome
Q92839	HAS1	Hyaluronan synthase 1	GO:0010764; P:negative regulation of fibroblast migration; IMP:UniProtKB
Q92839	HAS1	Hyaluronan synthase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q92819	HAS2	Hyaluronan synthase 2	GO:0050501; F:hyaluronan synthase activity; ISS:UniProtKB
Q92819	HAS2	Hyaluronan synthase 2	GO:0036302; P:atrioventricular canal development; ISS:UniProtKB
Q92819	HAS2	Hyaluronan synthase 2	GO:0060349; P:bone morphogenesis; IEA:Ensembl
Q92819	HAS2	Hyaluronan synthase 2	GO:0071498; P:cellular response to fluid shear stress; IEP:BHF-UCL
Q92819	HAS2	Hyaluronan synthase 2	GO:0071347; P:cellular response to interleukin-1; IEP:BHF-UCL
Q92819	HAS2	Hyaluronan synthase 2	GO:0036120; P:cellular response to platelet-derived growth factor stimulus; IDA:UniProtKB
Q92819	HAS2	Hyaluronan synthase 2	GO:0071356; P:cellular response to tumor necrosis factor; IEP:BHF-UCL
Q92819	HAS2	Hyaluronan synthase 2	GO:0090500; P:endocardial cushion to mesenchymal transition; ISS:UniProtKB
Q92819	HAS2	Hyaluronan synthase 2	GO:0085029; P:extracellular matrix assembly; ISS:UniProtKB
Q92819	HAS2	Hyaluronan synthase 2	GO:0045226; P:extracellular polysaccharide biosynthetic process; ISS:UniProtKB
Q92819	HAS2	Hyaluronan synthase 2	GO:0030213; P:hyaluronan biosynthetic process; IDA:UniProtKB
Q92819	HAS2	Hyaluronan synthase 2	GO:0001822; P:kidney development; ISS:UniProtKB
Q92819	HAS2	Hyaluronan synthase 2	GO:0030335; P:positive regulation of cell migration; IMP:BHF-UCL
Q92819	HAS2	Hyaluronan synthase 2	GO:0008284; P:positive regulation of cell proliferation; IMP:BHF-UCL
Q92819	HAS2	Hyaluronan synthase 2	GO:1900625; P:positive regulation of monocyte aggregation; IMP:BHF-UCL
Q92819	HAS2	Hyaluronan synthase 2	GO:0035810; P:positive regulation of urine volume; ISS:UniProtKB
Q92819	HAS2	Hyaluronan synthase 2	GO:0070295; P:renal water absorption; ISS:UniProtKB
Q92819	HAS2	Hyaluronan synthase 2	GO:0001570; P:vasculogenesis; ISS:UniProtKB
O00219	HAS3	Hyaluronan synthase 3	GO:0050501; F:hyaluronan synthase activity; IDA:UniProtKB
O00219	HAS3	Hyaluronan synthase 3	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O00219	HAS3	Hyaluronan synthase 3	GO:0085029; P:extracellular matrix assembly; ISS:UniProtKB
O00219	HAS3	Hyaluronan synthase 3	GO:0045226; P:extracellular polysaccharide biosynthetic process; ISS:UniProtKB
O00219	HAS3	Hyaluronan synthase 3	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O00219	HAS3	Hyaluronan synthase 3	GO:0030213; P:hyaluronan biosynthetic process; IDA:UniProtKB
O00219	HAS3	Hyaluronan synthase 3	GO:0030212; P:hyaluronan metabolic process; TAS:Reactome
O00219	HAS3	Hyaluronan synthase 3	GO:1900106; P:positive regulation of hyaluranon cable assembly; IDA:UniProtKB
O00219	HAS3	Hyaluronan synthase 3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O00219	HAS3	Hyaluronan synthase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BYI3	FAM126A	Hyccin	GO:0004871; F:signal transducer activity; NAS:UniProtKB
Q9BYI3	FAM126A	Hyccin	GO:0007165; P:signal transduction; NAS:GOC
P07099	EPHX1	Epoxide hydrolase 1	GO:0033961; F:cis-stilbene-oxide hydrolase activity; IEA:UniProtKB-EC
P07099	EPHX1	Epoxide hydrolase 1	GO:0004301; F:epoxide hydrolase activity; TAS:ProtInc
P07099	EPHX1	Epoxide hydrolase 1	GO:0019439; P:aromatic compound catabolic process; IEA:UniProtKB-KW
P07099	EPHX1	Epoxide hydrolase 1	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P07099	EPHX1	Epoxide hydrolase 1	GO:0009636; P:response to toxic substance; IEA:UniProtKB-KW
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0033885; F:10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity; IEA:UniProtKB-EC
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0004301; F:epoxide hydrolase activity; IDA:UniProtKB
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0042577; F:lipid phosphatase activity; IDA:UniProtKB
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0016791; F:phosphatase activity; IDA:UniProtKB
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0005102; F:receptor binding; IPI:UniProtKB
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0015643; F:toxic substance binding; IDA:UniProtKB
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0006874; P:cellular calcium ion homeostasis; NAS:UniProtKB
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0042632; P:cholesterol homeostasis; IDA:UniProtKB
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0016311; P:dephosphorylation; IDA:UniProtKB
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0017144; P:drug metabolic process; NAS:UniProtKB
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0019373; P:epoxygenase P450 pathway; TAS:Reactome
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0006954; P:inflammatory response; NAS:UniProtKB
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0046839; P:phospholipid dephosphorylation; IDA:UniProtKB
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0045909; P:positive regulation of vasodilation; NAS:UniProtKB
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0072593; P:reactive oxygen species metabolic process; NAS:UniProtKB
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0008217; P:regulation of blood pressure; NAS:UniProtKB
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0090181; P:regulation of cholesterol metabolic process; IMP:UniProtKB
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0009636; P:response to toxic substance; NAS:UniProtKB
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0046272; P:stilbene catabolic process; IDA:UniProtKB
P34913	EPHX2	Bifunctional epoxide hydrolase 2	GO:0006805; P:xenobiotic metabolic process; NAS:UniProtKB
Q5T013	HYI	Putative hydroxypyruvate isomerase	GO:0008903; F:hydroxypyruvate isomerase activity; IEA:UniProtKB-EC
A2RU49	HYKK	Hydroxylysine kinase	GO:0047992; F:hydroxylysine kinase activity; IEA:UniProtKB-EC
A2RU49	HYKK	Hydroxylysine kinase	GO:0016772; F:transferase activity, transferring phosphorus-containing groups; IEA:InterPro
Q9Y4L1	HYOU1	Hypoxia up-regulated protein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y4L1	HYOU1	Hypoxia up-regulated protein 1	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q9Y4L1	HYOU1	Hypoxia up-regulated protein 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9Y4L1	HYOU1	Hypoxia up-regulated protein 1	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q9Y4L1	HYOU1	Hypoxia up-regulated protein 1	GO:0002931; P:response to ischemia; IEA:Ensembl
Q9Y4L1	HYOU1	Hypoxia up-regulated protein 1	GO:0006950; P:response to stress; TAS:ProtInc
Q13651	IL10RA	Interleukin-10 receptor subunit alpha	GO:0004920; F:interleukin-10 receptor activity; TAS:ProtInc
Q13651	IL10RA	Interleukin-10 receptor subunit alpha	GO:0005515; F:protein binding; IPI:IntAct
Q13651	IL10RA	Interleukin-10 receptor subunit alpha	GO:0004872; F:receptor activity; TAS:ProtInc
Q13651	IL10RA	Interleukin-10 receptor subunit alpha	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q13651	IL10RA	Interleukin-10 receptor subunit alpha	GO:0019221; P:cytokine-mediated signaling pathway; TAS:GOC
Q13651	IL10RA	Interleukin-10 receptor subunit alpha	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
Q13651	IL10RA	Interleukin-10 receptor subunit alpha	GO:0007165; P:signal transduction; TAS:GOC
Q08334	IL10RB	Interleukin-10 receptor subunit beta	GO:0005515; F:protein binding; IPI:UniProtKB
Q08334	IL10RB	Interleukin-10 receptor subunit beta	GO:0004872; F:receptor activity; TAS:ProtInc
Q08334	IL10RB	Interleukin-10 receptor subunit beta	GO:0019221; P:cytokine-mediated signaling pathway; TAS:GOC
Q08334	IL10RB	Interleukin-10 receptor subunit beta	GO:0006955; P:immune response; TAS:ProtInc
Q08334	IL10RB	Interleukin-10 receptor subunit beta	GO:0006954; P:inflammatory response; TAS:ProtInc
Q08334	IL10RB	Interleukin-10 receptor subunit beta	GO:0007165; P:signal transduction; TAS:ProtInc
Q14626	IL11RA	Interleukin-11 receptor subunit alpha	GO:0004896; F:cytokine receptor activity; IEA:InterPro
Q14626	IL11RA	Interleukin-11 receptor subunit alpha	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q14626	IL11RA	Interleukin-11 receptor subunit alpha	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q14626	IL11RA	Interleukin-11 receptor subunit alpha	GO:0032502; P:developmental process; IMP:UniProtKB
Q14626	IL11RA	Interleukin-11 receptor subunit alpha	GO:0060322; P:head development; IMP:UniProtKB
Q14626	IL11RA	Interleukin-11 receptor subunit alpha	GO:0007165; P:signal transduction; TAS:GOC
P42701	IL12RB1	Interleukin-12 receptor subunit beta-1	GO:0004896; F:cytokine receptor activity; TAS:UniProtKB
P42701	IL12RB1	Interleukin-12 receptor subunit beta-1	GO:0071346; P:cellular response to interferon-gamma; IDA:BHF-UCL
P42701	IL12RB1	Interleukin-12 receptor subunit beta-1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:BHF-UCL
P42701	IL12RB1	Interleukin-12 receptor subunit beta-1	GO:0035722; P:interleukin-12-mediated signaling pathway; IDA:GOC
P42701	IL12RB1	Interleukin-12 receptor subunit beta-1	GO:0038155; P:interleukin-23-mediated signaling pathway; IDA:GOC
P42701	IL12RB1	Interleukin-12 receptor subunit beta-1	GO:0018108; P:peptidyl-tyrosine phosphorylation; IEA:Ensembl
P42701	IL12RB1	Interleukin-12 receptor subunit beta-1	GO:0042104; P:positive regulation of activated T cell proliferation; IDA:BHF-UCL
P42701	IL12RB1	Interleukin-12 receptor subunit beta-1	GO:0002230; P:positive regulation of defense response to virus by host; IDA:BHF-UCL
P42701	IL12RB1	Interleukin-12 receptor subunit beta-1	GO:0032729; P:positive regulation of interferon-gamma production; IDA:BHF-UCL
P42701	IL12RB1	Interleukin-12 receptor subunit beta-1	GO:0043382; P:positive regulation of memory T cell differentiation; ISS:BHF-UCL
P42701	IL12RB1	Interleukin-12 receptor subunit beta-1	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; ISS:BHF-UCL
P42701	IL12RB1	Interleukin-12 receptor subunit beta-1	GO:0002827; P:positive regulation of T-helper 1 type immune response; IDA:BHF-UCL
P42701	IL12RB1	Interleukin-12 receptor subunit beta-1	GO:2000330; P:positive regulation of T-helper 17 cell lineage commitment; ISS:BHF-UCL
P42701	IL12RB1	Interleukin-12 receptor subunit beta-1	GO:2000318; P:positive regulation of T-helper 17 type immune response; ISS:BHF-UCL
P42701	IL12RB1	Interleukin-12 receptor subunit beta-1	GO:0007165; P:signal transduction; IC:BHF-UCL
Q99665	IL12RB2	Interleukin-12 receptor subunit beta-2	GO:0004896; F:cytokine receptor activity; TAS:UniProtKB
Q99665	IL12RB2	Interleukin-12 receptor subunit beta-2	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q99665	IL12RB2	Interleukin-12 receptor subunit beta-2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:GOC
Q99665	IL12RB2	Interleukin-12 receptor subunit beta-2	GO:0032609; P:interferon-gamma production; IEA:Ensembl
Q99665	IL12RB2	Interleukin-12 receptor subunit beta-2	GO:0018108; P:peptidyl-tyrosine phosphorylation; IEA:Ensembl
Q99665	IL12RB2	Interleukin-12 receptor subunit beta-2	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q99665	IL12RB2	Interleukin-12 receptor subunit beta-2	GO:0032729; P:positive regulation of interferon-gamma production; IDA:BHF-UCL
Q99665	IL12RB2	Interleukin-12 receptor subunit beta-2	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P78552	IL13RA1	Interleukin-13 receptor subunit alpha-1	GO:0016515; F:interleukin-13 receptor activity; IEA:Ensembl
P78552	IL13RA1	Interleukin-13 receptor subunit alpha-1	GO:0005515; F:protein binding; IPI:IntAct
P78552	IL13RA1	Interleukin-13 receptor subunit alpha-1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P78552	IL13RA1	Interleukin-13 receptor subunit alpha-1	GO:0030890; P:positive regulation of B cell proliferation; IEA:Ensembl
P78552	IL13RA1	Interleukin-13 receptor subunit alpha-1	GO:0002639; P:positive regulation of immunoglobulin production; IEA:Ensembl
Q14627	IL13RA2	Interleukin-13 receptor subunit alpha-2	GO:0004896; F:cytokine receptor activity; TAS:UniProtKB
Q14627	IL13RA2	Interleukin-13 receptor subunit alpha-2	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q14627	IL13RA2	Interleukin-13 receptor subunit alpha-2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:GOC
Q14627	IL13RA2	Interleukin-13 receptor subunit alpha-2	GO:0007165; P:signal transduction; TAS:GOC
Q13261	IL15RA	Interleukin-15 receptor subunit alpha	GO:0004896; F:cytokine receptor activity; TAS:UniProtKB
Q13261	IL15RA	Interleukin-15 receptor subunit alpha	GO:0005515; F:protein binding; IPI:IntAct
Q13261	IL15RA	Interleukin-15 receptor subunit alpha	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q13261	IL15RA	Interleukin-15 receptor subunit alpha	GO:0008283; P:cell proliferation; TAS:ProtInc
Q13261	IL15RA	Interleukin-15 receptor subunit alpha	GO:0019221; P:cytokine-mediated signaling pathway; TAS:GOC
Q13261	IL15RA	Interleukin-15 receptor subunit alpha	GO:0007259; P:JAK-STAT cascade; IEA:Ensembl
Q13261	IL15RA	Interleukin-15 receptor subunit alpha	GO:0010977; P:negative regulation of neuron projection development; IEA:Ensembl
Q13261	IL15RA	Interleukin-15 receptor subunit alpha	GO:0032825; P:positive regulation of natural killer cell differentiation; IEA:Ensembl
Q13261	IL15RA	Interleukin-15 receptor subunit alpha	GO:0031667; P:response to nutrient levels; IEA:Ensembl
Q13261	IL15RA	Interleukin-15 receptor subunit alpha	GO:0007165; P:signal transduction; TAS:ProtInc
Q96F46	IL17RA	Interleukin-17 receptor A	GO:0030368; F:interleukin-17 receptor activity; NAS:UniProtKB
Q96F46	IL17RA	Interleukin-17 receptor A	GO:0005515; F:protein binding; IPI:IntAct
Q96F46	IL17RA	Interleukin-17 receptor A	GO:0007166; P:cell surface receptor signaling pathway; NAS:UniProtKB
Q96F46	IL17RA	Interleukin-17 receptor A	GO:0019221; P:cytokine-mediated signaling pathway; NAS:GOC
Q96F46	IL17RA	Interleukin-17 receptor A	GO:0072537; P:fibroblast activation; IDA:BHF-UCL
Q96F46	IL17RA	Interleukin-17 receptor A	GO:1900017; P:positive regulation of cytokine production involved in inflammatory response; IEA:Ensembl
Q96F46	IL17RA	Interleukin-17 receptor A	GO:0032747; P:positive regulation of interleukin-23 production; IDA:BHF-UCL
Q9NRM6	IL17RB	Interleukin-17 receptor B	GO:0004896; F:cytokine receptor activity; NAS:UniProtKB
Q9NRM6	IL17RB	Interleukin-17 receptor B	GO:0019221; P:cytokine-mediated signaling pathway; NAS:GOC
Q9NRM6	IL17RB	Interleukin-17 receptor B	GO:0006952; P:defense response; TAS:ProtInc
Q9NRM6	IL17RB	Interleukin-17 receptor B	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
Q8NAC3	IL17RC	Interleukin-17 receptor C	GO:0030368; F:interleukin-17 receptor activity; IDA:MGI
Q8NAC3	IL17RC	Interleukin-17 receptor C	GO:0019221; P:cytokine-mediated signaling pathway; IDA:GOC
Q8NAC3	IL17RC	Interleukin-17 receptor C	GO:1900017; P:positive regulation of cytokine production involved in inflammatory response; IEA:Ensembl
Q8NFM7	IL17RD	Interleukin-17 receptor D	GO:0007165; P:signal transduction; IEA:InterPro
O95998	IL18BP	Interleukin-18-binding protein	GO:0042007; F:interleukin-18 binding; IDA:UniProtKB
O95998	IL18BP	Interleukin-18-binding protein	GO:0048019; F:receptor antagonist activity; TAS:UniProtKB
O95998	IL18BP	Interleukin-18-binding protein	GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl
O95998	IL18BP	Interleukin-18-binding protein	GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl
O95998	IL18BP	Interleukin-18-binding protein	GO:1900116; P:extracellular negative regulation of signal transduction; TAS:GOC
O95998	IL18BP	Interleukin-18-binding protein	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
O95998	IL18BP	Interleukin-18-binding protein	GO:0042088; P:T-helper 1 type immune response; IDA:UniProtKB
O95256	IL18RAP	Interleukin-18 receptor accessory protein	GO:0004872; F:receptor activity; TAS:ProtInc
O95256	IL18RAP	Interleukin-18 receptor accessory protein	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
O95256	IL18RAP	Interleukin-18 receptor accessory protein	GO:0006955; P:immune response; TAS:ProtInc
O95256	IL18RAP	Interleukin-18 receptor accessory protein	GO:0006954; P:inflammatory response; TAS:ProtInc
Q8NFR9	IL17RE	Interleukin-17 receptor E	GO:0005515; F:protein binding; IPI:IntAct
Q8NFR9	IL17RE	Interleukin-17 receptor E	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q9H9L3	ISG20L2	Interferon-stimulated 20 kDa exonuclease-like 2	GO:0004527; F:exonuclease activity; IEA:UniProtKB-KW
Q9H9L3	ISG20L2	Interferon-stimulated 20 kDa exonuclease-like 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H9L3	ISG20L2	Interferon-stimulated 20 kDa exonuclease-like 2	GO:0005515; F:protein binding; IPI:IntAct
Q9H9L3	ISG20L2	Interferon-stimulated 20 kDa exonuclease-like 2	GO:0042254; P:ribosome biogenesis; IEA:UniProtKB-KW
Q9UHF4	IL20RA	Interleukin-20 receptor subunit alpha	GO:0019221; P:cytokine-mediated signaling pathway; IEA:Ensembl
Q9UHF4	IL20RA	Interleukin-20 receptor subunit alpha	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl
Q9UHF4	IL20RA	Interleukin-20 receptor subunit alpha	GO:0045124; P:regulation of bone resorption; IEA:Ensembl
Q969J5	IL22RA2	Interleukin-22 receptor subunit alpha-2	GO:0042017; F:interleukin-22 binding; IDA:UniProtKB
Q969J5	IL22RA2	Interleukin-22 receptor subunit alpha-2	GO:0042018; F:interleukin-22 receptor activity; IDA:UniProtKB
Q969J5	IL22RA2	Interleukin-22 receptor subunit alpha-2	GO:0019221; P:cytokine-mediated signaling pathway; IDA:GOC
Q969J5	IL22RA2	Interleukin-22 receptor subunit alpha-2	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
Q969J5	IL22RA2	Interleukin-22 receptor subunit alpha-2	GO:0042516; P:regulation of tyrosine phosphorylation of Stat3 protein; ISS:UniProtKB
Q6UXL0	IL20RB	Interleukin-20 receptor subunit beta	GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl
Q6UXL0	IL20RB	Interleukin-20 receptor subunit beta	GO:0002765; P:immune response-inhibiting signal transduction; IEA:Ensembl
Q6UXL0	IL20RB	Interleukin-20 receptor subunit beta	GO:0002437; P:inflammatory response to antigenic stimulus; IEA:Ensembl
Q6UXL0	IL20RB	Interleukin-20 receptor subunit beta	GO:0032689; P:negative regulation of interferon-gamma production; IEA:Ensembl
Q6UXL0	IL20RB	Interleukin-20 receptor subunit beta	GO:0032703; P:negative regulation of interleukin-2 production; IEA:Ensembl
Q6UXL0	IL20RB	Interleukin-20 receptor subunit beta	GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl
Q6UXL0	IL20RB	Interleukin-20 receptor subunit beta	GO:0001808; P:negative regulation of type IV hypersensitivity; IEA:Ensembl
Q6UXL0	IL20RB	Interleukin-20 receptor subunit beta	GO:0032733; P:positive regulation of interleukin-10 production; IEA:Ensembl
Q6UXL0	IL20RB	Interleukin-20 receptor subunit beta	GO:0032753; P:positive regulation of interleukin-4 production; IEA:Ensembl
Q8N6P7	IL22RA1	Interleukin-22 receptor subunit alpha-1	GO:0004904; F:interferon receptor activity; TAS:UniProtKB
Q8N6P7	IL22RA1	Interleukin-22 receptor subunit alpha-1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:GOC
Q8N6P7	IL22RA1	Interleukin-22 receptor subunit alpha-1	GO:0050829; P:defense response to Gram-negative bacterium; IEA:Ensembl
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0020037; F:heme binding; IEA:InterPro
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0033754; F:indoleamine 2,3-dioxygenase activity; IEA:UniProtKB-EC
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0004833; F:tryptophan 2,3-dioxygenase activity; EXP:Reactome
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0002534; P:cytokine production involved in inflammatory response; IEA:Ensembl
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0007565; P:female pregnancy; TAS:ProtInc
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0034276; P:kynurenic acid biosynthetic process; IEA:Ensembl
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0033555; P:multicellular organismal response to stress; IEA:Ensembl
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0046007; P:negative regulation of activated T cell proliferation; IEA:Ensembl
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0032693; P:negative regulation of interleukin-10 production; IEA:Ensembl
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0070233; P:negative regulation of T cell apoptotic process; IEA:Ensembl
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0002678; P:positive regulation of chronic inflammatory response; IEA:Ensembl
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0032735; P:positive regulation of interleukin-12 production; IEA:Ensembl
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0002666; P:positive regulation of T cell tolerance induction; IEA:Ensembl
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0002830; P:positive regulation of type 2 immune response; IEA:Ensembl
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0036269; P:swimming behavior; IEA:Ensembl
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0006569; P:tryptophan catabolic process; TAS:Reactome
P14902	IDO1	Indoleamine 2,3-dioxygenase 1	GO:0019441; P:tryptophan catabolic process to kynurenine; IEA:UniProtKB-UniPathway
Q6ZQW0	IDO2	Indoleamine 2,3-dioxygenase 2	GO:0020037; F:heme binding; IEA:InterPro
Q6ZQW0	IDO2	Indoleamine 2,3-dioxygenase 2	GO:0033754; F:indoleamine 2,3-dioxygenase activity; IDA:UniProtKB
Q6ZQW0	IDO2	Indoleamine 2,3-dioxygenase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZQW0	IDO2	Indoleamine 2,3-dioxygenase 2	GO:0004833; F:tryptophan 2,3-dioxygenase activity; EXP:Reactome
Q6ZQW0	IDO2	Indoleamine 2,3-dioxygenase 2	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q6ZQW0	IDO2	Indoleamine 2,3-dioxygenase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6ZQW0	IDO2	Indoleamine 2,3-dioxygenase 2	GO:0006569; P:tryptophan catabolic process; TAS:Reactome
Q6ZQW0	IDO2	Indoleamine 2,3-dioxygenase 2	GO:0019441; P:tryptophan catabolic process to kynurenine; IDA:UniProtKB
Q6UWB1	IL27RA	Interleukin-27 receptor subunit alpha	GO:0045509; F:interleukin-27 receptor activity; IEA:Ensembl
Q6UWB1	IL27RA	Interleukin-27 receptor subunit alpha	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q6UWB1	IL27RA	Interleukin-27 receptor subunit alpha	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q6UWB1	IL27RA	Interleukin-27 receptor subunit alpha	GO:0050830; P:defense response to Gram-positive bacterium; IEA:Ensembl
Q6UWB1	IL27RA	Interleukin-27 receptor subunit alpha	GO:0006955; P:immune response; TAS:ProtInc
Q6UWB1	IL27RA	Interleukin-27 receptor subunit alpha	GO:0002829; P:negative regulation of type 2 immune response; IEA:Ensembl
Q6UWB1	IL27RA	Interleukin-27 receptor subunit alpha	GO:0032729; P:positive regulation of interferon-gamma production; IEA:Ensembl
Q6UWB1	IL27RA	Interleukin-27 receptor subunit alpha	GO:0002827; P:positive regulation of T-helper 1 type immune response; IEA:Ensembl
Q6UWB1	IL27RA	Interleukin-27 receptor subunit alpha	GO:0048302; P:regulation of isotype switching to IgG isotypes; IEA:Ensembl
Q7Z5L9	IRF2BP2	Interferon regulatory factor 2-binding protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z5L9	IRF2BP2	Interferon regulatory factor 2-binding protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z5L9	IRF2BP2	Interferon regulatory factor 2-binding protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IU81	IRF2BP1	Interferon regulatory factor 2-binding protein 1	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q8IU81	IRF2BP1	Interferon regulatory factor 2-binding protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IU81	IRF2BP1	Interferon regulatory factor 2-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q8IU81	IRF2BP1	Interferon regulatory factor 2-binding protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8IU81	IRF2BP1	Interferon regulatory factor 2-binding protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H1B7	IRF2BPL	Interferon regulatory factor 2-binding protein-like	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UBH0	IL36RN	Interleukin-36 receptor antagonist protein	GO:0005152; F:interleukin-1 receptor antagonist activity; TAS:ProtInc
Q9UBH0	IL36RN	Interleukin-36 receptor antagonist protein	GO:0001960; P:negative regulation of cytokine-mediated signaling pathway; TAS:GOC
Q9UBH0	IL36RN	Interleukin-36 receptor antagonist protein	GO:0032715; P:negative regulation of interleukin-6 production; IEA:Ensembl
A6NMX2	EIF4E1B	Eukaryotic translation initiation factor 4E type 1B	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW
A6NMX2	EIF4E1B	Eukaryotic translation initiation factor 4E type 1B	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q14642	INPP5A	Type I inositol 1,4,5-trisphosphate 5-phosphatase	GO:0052659; F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; IEA:UniProtKB-EC
Q14642	INPP5A	Type I inositol 1,4,5-trisphosphate 5-phosphatase	GO:0052658; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; IEA:UniProtKB-EC
Q14642	INPP5A	Type I inositol 1,4,5-trisphosphate 5-phosphatase	GO:0004445; F:inositol-polyphosphate 5-phosphatase activity; NAS:UniProtKB
Q14642	INPP5A	Type I inositol 1,4,5-trisphosphate 5-phosphatase	GO:0042731; F:PH domain binding; IPI:BHF-UCL
Q14642	INPP5A	Type I inositol 1,4,5-trisphosphate 5-phosphatase	GO:0005515; F:protein binding; IPI:IntAct
Q14642	INPP5A	Type I inositol 1,4,5-trisphosphate 5-phosphatase	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q14642	INPP5A	Type I inositol 1,4,5-trisphosphate 5-phosphatase	GO:0046856; P:phosphatidylinositol dephosphorylation; IEA:InterPro
Q14642	INPP5A	Type I inositol 1,4,5-trisphosphate 5-phosphatase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P32019	INPP5B	Type II inositol 1,4,5-trisphosphate 5-phosphatase	GO:0052658; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; IDA:UniProtKB
P32019	INPP5B	Type II inositol 1,4,5-trisphosphate 5-phosphatase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P32019	INPP5B	Type II inositol 1,4,5-trisphosphate 5-phosphatase	GO:0004439; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; IDA:UniProtKB
P32019	INPP5B	Type II inositol 1,4,5-trisphosphate 5-phosphatase	GO:0005515; F:protein binding; IPI:UniProtKB
P32019	INPP5B	Type II inositol 1,4,5-trisphosphate 5-phosphatase	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P32019	INPP5B	Type II inositol 1,4,5-trisphosphate 5-phosphatase	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
P32019	INPP5B	Type II inositol 1,4,5-trisphosphate 5-phosphatase	GO:0046856; P:phosphatidylinositol dephosphorylation; IDA:UniProtKB
P32019	INPP5B	Type II inositol 1,4,5-trisphosphate 5-phosphatase	GO:0070613; P:regulation of protein processing; IEA:Ensembl
P32019	INPP5B	Type II inositol 1,4,5-trisphosphate 5-phosphatase	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P32019	INPP5B	Type II inositol 1,4,5-trisphosphate 5-phosphatase	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P32019	INPP5B	Type II inositol 1,4,5-trisphosphate 5-phosphatase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P32019	INPP5B	Type II inositol 1,4,5-trisphosphate 5-phosphatase	GO:0030317; P:sperm motility; IEA:Ensembl
P32019	INPP5B	Type II inositol 1,4,5-trisphosphate 5-phosphatase	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q2TAA2	IAH1	Isoamyl acetate-hydrolyzing esterase 1 homolog	GO:0016788; F:hydrolase activity, acting on ester bonds; IEA:InterPro
Q2TAA2	IAH1	Isoamyl acetate-hydrolyzing esterase 1 homolog	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
P10997	IAPP	Islet amyloid polypeptide	GO:0042802; F:identical protein binding; IPI:IntAct
P10997	IAPP	Islet amyloid polypeptide	GO:0005102; F:receptor binding; TAS:ProtInc
P10997	IAPP	Islet amyloid polypeptide	GO:0006915; P:apoptotic process; TAS:ProtInc
P10997	IAPP	Islet amyloid polypeptide	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P10997	IAPP	Islet amyloid polypeptide	GO:0042755; P:eating behavior; IEA:Ensembl
P10997	IAPP	Islet amyloid polypeptide	GO:0031018; P:endocrine pancreas development; TAS:Reactome
P10997	IAPP	Islet amyloid polypeptide	GO:0045779; P:negative regulation of bone resorption; IEA:Ensembl
P10997	IAPP	Islet amyloid polypeptide	GO:0045596; P:negative regulation of cell differentiation; IEA:Ensembl
P10997	IAPP	Islet amyloid polypeptide	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P10997	IAPP	Islet amyloid polypeptide	GO:0007165; P:signal transduction; TAS:ProtInc
Q8WUF5	PPP1R13L	RelA-associated inhibitor	GO:0042802; F:identical protein binding; IPI:IntAct
Q8WUF5	PPP1R13L	RelA-associated inhibitor	GO:0005515; F:protein binding; IPI:IntAct
Q8WUF5	PPP1R13L	RelA-associated inhibitor	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q8WUF5	PPP1R13L	RelA-associated inhibitor	GO:0008134; F:transcription factor binding; TAS:ProtInc
Q8WUF5	PPP1R13L	RelA-associated inhibitor	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8WUF5	PPP1R13L	RelA-associated inhibitor	GO:0060048; P:cardiac muscle contraction; IEA:Ensembl
Q8WUF5	PPP1R13L	RelA-associated inhibitor	GO:0003215; P:cardiac right ventricle morphogenesis; IEA:Ensembl
Q8WUF5	PPP1R13L	RelA-associated inhibitor	GO:0031076; P:embryonic camera-type eye development; IEA:Ensembl
Q8WUF5	PPP1R13L	RelA-associated inhibitor	GO:0042633; P:hair cycle; IEA:Ensembl
Q8WUF5	PPP1R13L	RelA-associated inhibitor	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q8WUF5	PPP1R13L	RelA-associated inhibitor	GO:0048871; P:multicellular organismal homeostasis; IEA:Ensembl
Q8WUF5	PPP1R13L	RelA-associated inhibitor	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8WUF5	PPP1R13L	RelA-associated inhibitor	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q8WUF5	PPP1R13L	RelA-associated inhibitor	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WUF5	PPP1R13L	RelA-associated inhibitor	GO:0003229; P:ventricular cardiac muscle tissue development; IEA:Ensembl
P08833	IGFBP1	Insulin-like growth factor-binding protein 1	GO:0005520; F:insulin-like growth factor binding; TAS:ProtInc
P08833	IGFBP1	Insulin-like growth factor-binding protein 1	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P08833	IGFBP1	Insulin-like growth factor-binding protein 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P08833	IGFBP1	Insulin-like growth factor-binding protein 1	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P08833	IGFBP1	Insulin-like growth factor-binding protein 1	GO:0008286; P:insulin receptor signaling pathway; IEA:Ensembl
P08833	IGFBP1	Insulin-like growth factor-binding protein 1	GO:0030307; P:positive regulation of cell growth; IEA:Ensembl
P08833	IGFBP1	Insulin-like growth factor-binding protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
P08833	IGFBP1	Insulin-like growth factor-binding protein 1	GO:0042246; P:tissue regeneration; IEA:Ensembl
P18065	IGFBP2	Insulin-like growth factor-binding protein 2	GO:0031994; F:insulin-like growth factor I binding; IDA:UniProtKB
P18065	IGFBP2	Insulin-like growth factor-binding protein 2	GO:0031995; F:insulin-like growth factor II binding; ISS:UniProtKB
P18065	IGFBP2	Insulin-like growth factor-binding protein 2	GO:0005515; F:protein binding; IPI:IntAct
P18065	IGFBP2	Insulin-like growth factor-binding protein 2	GO:0007568; P:aging; IEA:Ensembl
P18065	IGFBP2	Insulin-like growth factor-binding protein 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P18065	IGFBP2	Insulin-like growth factor-binding protein 2	GO:0032870; P:cellular response to hormone stimulus; IEA:Ensembl
P18065	IGFBP2	Insulin-like growth factor-binding protein 2	GO:0007565; P:female pregnancy; IEA:Ensembl
P18065	IGFBP2	Insulin-like growth factor-binding protein 2	GO:0042104; P:positive regulation of activated T cell proliferation; IDA:BHF-UCL
P18065	IGFBP2	Insulin-like growth factor-binding protein 2	GO:0001558; P:regulation of cell growth; IEA:InterPro
P18065	IGFBP2	Insulin-like growth factor-binding protein 2	GO:0043567; P:regulation of insulin-like growth factor receptor signaling pathway; ISS:UniProtKB
P18065	IGFBP2	Insulin-like growth factor-binding protein 2	GO:0042493; P:response to drug; IEA:Ensembl
P18065	IGFBP2	Insulin-like growth factor-binding protein 2	GO:0032355; P:response to estradiol; IEA:Ensembl
P18065	IGFBP2	Insulin-like growth factor-binding protein 2	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P18065	IGFBP2	Insulin-like growth factor-binding protein 2	GO:0010226; P:response to lithium ion; IEA:Ensembl
P18065	IGFBP2	Insulin-like growth factor-binding protein 2	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P18065	IGFBP2	Insulin-like growth factor-binding protein 2	GO:0007584; P:response to nutrient; IEA:Ensembl
P18065	IGFBP2	Insulin-like growth factor-binding protein 2	GO:0032526; P:response to retinoic acid; IEA:Ensembl
P18065	IGFBP2	Insulin-like growth factor-binding protein 2	GO:0007165; P:signal transduction; IEA:Ensembl
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0005520; F:insulin-like growth factor binding; NAS:UniProtKB
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0031994; F:insulin-like growth factor I binding; IPI:BHF-UCL
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0046872; F:metal ion binding; NAS:UniProtKB
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0008160; F:protein tyrosine phosphatase activator activity; IDA:UniProtKB
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0008285; P:negative regulation of cell proliferation; IGI:MGI
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0001933; P:negative regulation of protein phosphorylation; IDA:MGI
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0009968; P:negative regulation of signal transduction; NAS:UniProtKB
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0014912; P:negative regulation of smooth muscle cell migration; IDA:BHF-UCL
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IDA:BHF-UCL
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0043085; P:positive regulation of catalytic activity; IDA:GOC
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0043568; P:positive regulation of insulin-like growth factor receptor signaling pathway; IEA:Ensembl
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0045663; P:positive regulation of myoblast differentiation; IDA:UniProtKB
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0006468; P:protein phosphorylation; IDA:MGI
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0001558; P:regulation of cell growth; IEA:Ensembl
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0010906; P:regulation of glucose metabolic process; IEA:Ensembl
P17936	IGFBP3	Insulin-like growth factor-binding protein 3	GO:0044342; P:type B pancreatic cell proliferation; IEA:Ensembl
P22692	IGFBP4	Insulin-like growth factor-binding protein 4	GO:0008283; P:cell proliferation; TAS:ProtInc
P22692	IGFBP4	Insulin-like growth factor-binding protein 4	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P22692	IGFBP4	Insulin-like growth factor-binding protein 4	GO:0006259; P:DNA metabolic process; TAS:ProtInc
P22692	IGFBP4	Insulin-like growth factor-binding protein 4	GO:0006954; P:inflammatory response; IEA:Ensembl
P22692	IGFBP4	Insulin-like growth factor-binding protein 4	GO:0043568; P:positive regulation of insulin-like growth factor receptor signaling pathway; IEA:Ensembl
P22692	IGFBP4	Insulin-like growth factor-binding protein 4	GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl
P22692	IGFBP4	Insulin-like growth factor-binding protein 4	GO:0001558; P:regulation of cell growth; IEA:Ensembl
P22692	IGFBP4	Insulin-like growth factor-binding protein 4	GO:0010906; P:regulation of glucose metabolic process; IEA:Ensembl
P22692	IGFBP4	Insulin-like growth factor-binding protein 4	GO:0007165; P:signal transduction; TAS:ProtInc
P22692	IGFBP4	Insulin-like growth factor-binding protein 4	GO:0001501; P:skeletal system development; TAS:ProtInc
P22692	IGFBP4	Insulin-like growth factor-binding protein 4	GO:0044342; P:type B pancreatic cell proliferation; IEA:Ensembl
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0031994; F:insulin-like growth factor I binding; IPI:BHF-UCL
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0005515; F:protein binding; IPI:BHF-UCL
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0071320; P:cellular response to cAMP; IDA:UniProtKB
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0071407; P:cellular response to organic cyclic compound; IDA:UniProtKB
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0042593; P:glucose homeostasis; IEA:Ensembl
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0006006; P:glucose metabolic process; IEA:Ensembl
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0035556; P:intracellular signal transduction; IEA:Ensembl
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0060056; P:mammary gland involution; IEA:Ensembl
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0030336; P:negative regulation of cell migration; IDA:BHF-UCL
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0043569; P:negative regulation of insulin-like growth factor receptor signaling pathway; IDA:BHF-UCL
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0014912; P:negative regulation of smooth muscle cell migration; IDA:BHF-UCL
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IDA:BHF-UCL
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0017148; P:negative regulation of translation; IDA:BHF-UCL
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0043568; P:positive regulation of insulin-like growth factor receptor signaling pathway; IEA:Ensembl
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0001558; P:regulation of cell growth; IEA:Ensembl
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0010906; P:regulation of glucose metabolic process; IEA:Ensembl
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0007165; P:signal transduction; NAS:ProtInc
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0048630; P:skeletal muscle tissue growth; IEA:Ensembl
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl
P24593	IGFBP5	Insulin-like growth factor-binding protein 5	GO:0044342; P:type B pancreatic cell proliferation; IEA:Ensembl
P24592	IGFBP6	Insulin-like growth factor-binding protein 6	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P24592	IGFBP6	Insulin-like growth factor-binding protein 6	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P24592	IGFBP6	Insulin-like growth factor-binding protein 6	GO:0001558; P:regulation of cell growth; IEA:InterPro
P24592	IGFBP6	Insulin-like growth factor-binding protein 6	GO:0007165; P:signal transduction; NAS:ProtInc
Q16270	IGFBP7	Insulin-like growth factor-binding protein 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q16270	IGFBP7	Insulin-like growth factor-binding protein 7	GO:0007155; P:cell adhesion; IDA:UniProtKB
Q16270	IGFBP7	Insulin-like growth factor-binding protein 7	GO:0032870; P:cellular response to hormone stimulus; IEA:Ensembl
Q16270	IGFBP7	Insulin-like growth factor-binding protein 7	GO:0007566; P:embryo implantation; IEA:Ensembl
Q16270	IGFBP7	Insulin-like growth factor-binding protein 7	GO:0048839; P:inner ear development; IEA:Ensembl
Q16270	IGFBP7	Insulin-like growth factor-binding protein 7	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q16270	IGFBP7	Insulin-like growth factor-binding protein 7	GO:0001558; P:regulation of cell growth; IEA:InterPro
Q16270	IGFBP7	Insulin-like growth factor-binding protein 7	GO:0050810; P:regulation of steroid biosynthetic process; IEA:Ensembl
Q16270	IGFBP7	Insulin-like growth factor-binding protein 7	GO:0051414; P:response to cortisol; IEA:Ensembl
Q16270	IGFBP7	Insulin-like growth factor-binding protein 7	GO:0009408; P:response to heat; IEA:Ensembl
Q16270	IGFBP7	Insulin-like growth factor-binding protein 7	GO:0032526; P:response to retinoic acid; IEA:Ensembl
Q8WX77	IGFBPL1	Insulin-like growth factor-binding protein-like 1	GO:0001558; P:regulation of cell growth; IEA:InterPro
Q9P2D0	IBTK	Inhibitor of Bruton tyrosine kinase	GO:0019901; F:protein kinase binding; IDA:MGI
Q9P2D0	IBTK	Inhibitor of Bruton tyrosine kinase	GO:0030292; F:protein tyrosine kinase inhibitor activity; IDA:MGI
Q9P2D0	IBTK	Inhibitor of Bruton tyrosine kinase	GO:0001933; P:negative regulation of protein phosphorylation; IDA:MGI
Q9P2D0	IBTK	Inhibitor of Bruton tyrosine kinase	GO:0061099; P:negative regulation of protein tyrosine kinase activity; IDA:GOC
Q9P2D0	IBTK	Inhibitor of Bruton tyrosine kinase	GO:0051209; P:release of sequestered calcium ion into cytosol; IDA:MGI
P05155	SERPING1	Plasma protease C1 inhibitor	GO:0005515; F:protein binding; IPI:UniProtKB
P05155	SERPING1	Plasma protease C1 inhibitor	GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:UniProtKB
P05155	SERPING1	Plasma protease C1 inhibitor	GO:0008015; P:blood circulation; TAS:ProtInc
P05155	SERPING1	Plasma protease C1 inhibitor	GO:0007596; P:blood coagulation; TAS:Reactome
P05155	SERPING1	Plasma protease C1 inhibitor	GO:0007597; P:blood coagulation, intrinsic pathway; TAS:Reactome
P05155	SERPING1	Plasma protease C1 inhibitor	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
P05155	SERPING1	Plasma protease C1 inhibitor	GO:0042730; P:fibrinolysis; IEA:UniProtKB-KW
P05155	SERPING1	Plasma protease C1 inhibitor	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
P05155	SERPING1	Plasma protease C1 inhibitor	GO:0001869; P:negative regulation of complement activation, lectin pathway; IDA:UniProtKB
P05155	SERPING1	Plasma protease C1 inhibitor	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P05155	SERPING1	Plasma protease C1 inhibitor	GO:0030168; P:platelet activation; TAS:Reactome
P05155	SERPING1	Plasma protease C1 inhibitor	GO:0002576; P:platelet degranulation; TAS:Reactome
Q05084	ICA1	Islet cell autoantigen 1	GO:0006836; P:neurotransmitter transport; IEA:UniProtKB-KW
P20810	CAST	Calpastatin	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
P20810	CAST	Calpastatin	GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc
P20810	CAST	Calpastatin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P20810	CAST	Calpastatin	GO:0005515; F:protein binding; IPI:IntAct
P20810	CAST	Calpastatin	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
P20810	CAST	Calpastatin	GO:2000675; P:negative regulation of type B pancreatic cell apoptotic process; IDA:BHF-UCL
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0005178; F:integrin binding; IPI:BHF-UCL
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0005515; F:protein binding; IPI:UniProtKB
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0004872; F:receptor activity; TAS:ProtInc
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0051856; ?:?; IDA:BHF-UCL
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0007155; P:cell adhesion; IDA:BHF-UCL
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0033627; P:cell adhesion mediated by integrin; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0007569; P:cell aging; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0071312; P:cellular response to alkaloid; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0071347; P:cellular response to interleukin-1; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0031669; P:cellular response to nutrient levels; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0061028; P:establishment of endothelial barrier; IGI:UniProt
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0007157; P:heterophilic cell-cell adhesion; TAS:BHF-UCL
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0007159; P:leukocyte cell-cell adhesion; IMP:BHF-UCL
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0050900; P:leukocyte migration; IEP:BHF-UCL
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0022614; P:membrane to membrane docking; IEP:BHF-UCL
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0051926; P:negative regulation of calcium ion transport; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:2000352; P:negative regulation of endothelial cell apoptotic process; IDA:BHF-UCL
P05362	ICAM1	Intercellular adhesion molecule 1	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IDA:BHF-UCL
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0001541; P:ovarian follicle development; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0030838; P:positive regulation of actin filament polymerization; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0002693; P:positive regulation of cellular extravasation; IMP:BHF-UCL
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:BHF-UCL
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0032321; P:positive regulation of Rho GTPase activity; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0046813; P:receptor-mediated virion attachment to host cell; IDA:BHF-UCL
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0030155; P:regulation of cell adhesion; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0008360; P:regulation of cell shape; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0050776; P:regulation of immune response; TAS:Reactome
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0001910; P:regulation of leukocyte mediated cytotoxicity; TAS:BHF-UCL
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0043200; P:response to amino acid; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0001975; P:response to amphetamine; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0046688; P:response to copper ion; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0042493; P:response to drug; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0045471; P:response to ethanol; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0034698; P:response to gonadotropin; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0010212; P:response to ionizing radiation; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0010477; P:response to sulfur dioxide; IEA:Ensembl
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0002291; P:T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; IMP:BHF-UCL
P05362	ICAM1	Intercellular adhesion molecule 1	GO:0002457; P:T cell antigen processing and presentation; IEA:Ensembl
P13598	ICAM2	Intercellular adhesion molecule 2	GO:0005178; F:integrin binding; IPI:BHF-UCL
P13598	ICAM2	Intercellular adhesion molecule 2	GO:0016337; P:single organismal cell-cell adhesion; IEA:InterPro
P13598	ICAM2	Intercellular adhesion molecule 2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P13598	ICAM2	Intercellular adhesion molecule 2	GO:0050776; P:regulation of immune response; TAS:Reactome
P32942	ICAM3	Intercellular adhesion molecule 3	GO:0005178; F:integrin binding; IPI:BHF-UCL
P32942	ICAM3	Intercellular adhesion molecule 3	GO:0005515; F:protein binding; IPI:BHF-UCL
P32942	ICAM3	Intercellular adhesion molecule 3	GO:0005102; F:receptor binding; TAS:ProtInc
P32942	ICAM3	Intercellular adhesion molecule 3	GO:0016337; P:single organismal cell-cell adhesion; IEA:InterPro
P32942	ICAM3	Intercellular adhesion molecule 3	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P32942	ICAM3	Intercellular adhesion molecule 3	GO:0050776; P:regulation of immune response; TAS:Reactome
Q9UMF0	ICAM5	Intercellular adhesion molecule 5	GO:0005515; F:protein binding; IPI:IntAct
Q9UMF0	ICAM5	Intercellular adhesion molecule 5	GO:0016337; P:single organismal cell-cell adhesion; IEA:InterPro
Q9UMF0	ICAM5	Intercellular adhesion molecule 5	GO:0006909; P:phagocytosis; IEA:Ensembl
Q14773	ICAM4	Intercellular adhesion molecule 4	GO:0005178; F:integrin binding; TAS:ProtInc
Q14773	ICAM4	Intercellular adhesion molecule 4	GO:0016337; P:single organismal cell-cell adhesion; IEA:InterPro
Q14773	ICAM4	Intercellular adhesion molecule 4	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q14773	ICAM4	Intercellular adhesion molecule 4	GO:0050776; P:regulation of immune response; TAS:Reactome
Q8WWN9	IPCEF1	Interactor protein for cytohesin exchange factors 1	GO:0005344; F:oxygen transporter activity; NAS:UniProtKB
Q8WWN9	IPCEF1	Interactor protein for cytohesin exchange factors 1	GO:0004601; F:peroxidase activity; ISS:UniProtKB
Q8WWN9	IPCEF1	Interactor protein for cytohesin exchange factors 1	GO:0055114; P:oxidation-reduction process; ISS:GOC
Q8WWN9	IPCEF1	Interactor protein for cytohesin exchange factors 1	GO:0015671; P:oxygen transport; NAS:UniProtKB
Q8WWN9	IPCEF1	Interactor protein for cytohesin exchange factors 1	GO:0006979; P:response to oxidative stress; ISS:UniProtKB
Q9UPZ9	ICK	Serine/threonine-protein kinase ICK	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9UPZ9	ICK	Serine/threonine-protein kinase ICK	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC
Q9UPZ9	ICK	Serine/threonine-protein kinase ICK	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q9UPZ9	ICK	Serine/threonine-protein kinase ICK	GO:0005515; F:protein binding; IPI:IntAct
Q9UPZ9	ICK	Serine/threonine-protein kinase ICK	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9UPZ9	ICK	Serine/threonine-protein kinase ICK	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q9UPZ9	ICK	Serine/threonine-protein kinase ICK	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9UPZ9	ICK	Serine/threonine-protein kinase ICK	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9UPZ9	ICK	Serine/threonine-protein kinase ICK	GO:0007165; P:signal transduction; TAS:UniProtKB
P54105	CLNS1A	Methylosome subunit pICln	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P54105	CLNS1A	Methylosome subunit pICln	GO:0005515; F:protein binding; IPI:UniProtKB
P54105	CLNS1A	Methylosome subunit pICln	GO:0010467; P:gene expression; TAS:Reactome
P54105	CLNS1A	Methylosome subunit pICln	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
P54105	CLNS1A	Methylosome subunit pICln	GO:0016070; P:RNA metabolic process; TAS:Reactome
P54105	CLNS1A	Methylosome subunit pICln	GO:0000387; P:spliceosomal snRNP assembly; IDA:UniProtKB
O60725	ICMT	Protein-S-isoprenylcysteine O-methyltransferase	GO:0008140; F:cAMP response element binding protein binding; IEA:Ensembl
O60725	ICMT	Protein-S-isoprenylcysteine O-methyltransferase	GO:0003880; F:protein C-terminal carboxyl O-methyltransferase activity; TAS:ProtInc
O60725	ICMT	Protein-S-isoprenylcysteine O-methyltransferase	GO:0004671; F:protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity; IEA:UniProtKB-EC
O60725	ICMT	Protein-S-isoprenylcysteine O-methyltransferase	GO:0006481; P:C-terminal protein methylation; TAS:ProtInc
O60725	ICMT	Protein-S-isoprenylcysteine O-methyltransferase	GO:0006464; P:cellular protein modification process; TAS:ProtInc
O60725	ICMT	Protein-S-isoprenylcysteine O-methyltransferase	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O60725	ICMT	Protein-S-isoprenylcysteine O-methyltransferase	GO:0001889; P:liver development; IEA:Ensembl
O60725	ICMT	Protein-S-isoprenylcysteine O-methyltransferase	GO:0035264; P:multicellular organism growth; IEA:Ensembl
O60725	ICMT	Protein-S-isoprenylcysteine O-methyltransferase	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
O60725	ICMT	Protein-S-isoprenylcysteine O-methyltransferase	GO:0006612; P:protein targeting to membrane; TAS:ProtInc
O60725	ICMT	Protein-S-isoprenylcysteine O-methyltransferase	GO:0046578; P:regulation of Ras protein signal transduction; IEA:Ensembl
Q9Y6W8	ICOS	Inducible T-cell costimulator	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
Q9Y6W8	ICOS	Inducible T-cell costimulator	GO:0006955; P:immune response; NAS:UniProtKB
Q9Y6W8	ICOS	Inducible T-cell costimulator	GO:0031295; P:T cell costimulation; TAS:Reactome
Q9Y6W8	ICOS	Inducible T-cell costimulator	GO:0002517; P:T cell tolerance induction; IEA:Ensembl
O75144	ICOSLG	ICOS ligand	GO:0005102; F:receptor binding; TAS:UniProtKB
O75144	ICOSLG	ICOS ligand	GO:0042113; P:B cell activation; IEA:UniProtKB-KW
O75144	ICOSLG	ICOS ligand	GO:0006952; P:defense response; NAS:UniProtKB
O75144	ICOSLG	ICOS ligand	GO:0006972; P:hyperosmotic response; NAS:UniProtKB
O75144	ICOSLG	ICOS ligand	GO:0042104; P:positive regulation of activated T cell proliferation; TAS:UniProtKB
O75144	ICOSLG	ICOS ligand	GO:0045404; P:positive regulation of interleukin-4 biosynthetic process; IEA:Ensembl
O75144	ICOSLG	ICOS ligand	GO:0007165; P:signal transduction; NAS:UniProtKB
O75144	ICOSLG	ICOS ligand	GO:0042110; P:T cell activation; NAS:UniProtKB
O75144	ICOSLG	ICOS ligand	GO:0031295; P:T cell costimulation; TAS:Reactome
Q14197	ICT1	Peptidyl-tRNA hydrolase ICT1, mitochondrial	GO:0004045; F:aminoacyl-tRNA hydrolase activity; IDA:UniProtKB
Q14197	ICT1	Peptidyl-tRNA hydrolase ICT1, mitochondrial	GO:0016150; F:translation release factor activity, codon nonspecific; IDA:UniProtKB
Q14197	ICT1	Peptidyl-tRNA hydrolase ICT1, mitochondrial	GO:0070126; P:mitochondrial translational termination; IDA:UniProtKB
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0005515; F:protein binding; IPI:IntAct
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0001525; P:angiogenesis; TAS:BHF-UCL
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0043534; P:blood vessel endothelial cell migration; TAS:BHF-UCL
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0048514; P:blood vessel morphogenesis; TAS:BHF-UCL
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0030509; P:BMP signaling pathway; IEA:Ensembl
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0032963; P:collagen metabolic process; IEA:Ensembl
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0001886; P:endothelial cell morphogenesis; IEA:Ensembl
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0007507; P:heart development; IEA:Ensembl
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0060425; P:lung morphogenesis; IEA:Ensembl
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0060426; P:lung vasculature development; IEA:Ensembl
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0043392; P:negative regulation of DNA binding; IEA:Ensembl
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:GDB
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0010621; P:negative regulation of transcription by transcription factor localization; TAS:BHF-UCL
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:GDB
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0031648; P:protein destabilization; IEA:Ensembl
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0045765; P:regulation of angiogenesis; IEA:Ensembl
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0043408; P:regulation of MAPK cascade; IEA:Ensembl
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0046677; P:response to antibiotic; IEA:Ensembl
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0006351; P:transcription, DNA-templated; IEA:Ensembl
P41134	ID1	DNA-binding protein inhibitor ID-1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:BHF-UCL
Q14602	ID2B	Putative DNA-binding protein inhibitor ID-2B	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0060612; P:adipose tissue development; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0003166; P:bundle of His development; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0048469; P:cell maturation; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0071285; P:cellular response to lithium ion; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0090398; P:cellular senescence; ISS:UniProtKB
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0048557; P:embryonic digestive tract morphogenesis; ISS:UniProtKB
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0061031; P:endodermal digestive tract morphogenesis; ISS:UniProtKB
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0009649; P:entrainment of circadian clock; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0043353; P:enucleate erythrocyte differentiation; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0061030; P:epithelial cell differentiation involved in mammary gland alveolus development; ISS:UniProtKB
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0060749; P:mammary gland alveolus development; ISS:UniProtKB
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0033598; P:mammary gland epithelial cell proliferation; ISS:UniProtKB
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0003149; P:membranous septum morphogenesis; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0001656; P:metanephros development; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0001779; P:natural killer cell differentiation; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0045578; P:negative regulation of B cell differentiation; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0043392; P:negative regulation of DNA binding; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0010629; P:negative regulation of gene expression; ISS:UniProtKB
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:2000178; P:negative regulation of neural precursor cell proliferation; ISS:UniProtKB
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0045665; P:negative regulation of neuron differentiation; ISS:UniProtKB
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0048715; P:negative regulation of oligodendrocyte differentiation; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:GDB
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:GDB
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0048663; P:neuron fate commitment; ISS:UniProtKB
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0021772; P:olfactory bulb development; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0014003; P:oligodendrocyte development; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0048541; P:Peyer's patch development; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0048711; P:positive regulation of astrocyte differentiation; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0045777; P:positive regulation of blood pressure; ISS:UniProtKB
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0045787; P:positive regulation of cell cycle; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0071158; P:positive regulation of cell cycle arrest; ISS:UniProtKB
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0045648; P:positive regulation of erythrocyte differentiation; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0045600; P:positive regulation of fat cell differentiation; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0045651; P:positive regulation of macrophage differentiation; IEA:Ensembl
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0048661; P:positive regulation of smooth muscle cell proliferation; ISS:UniProtKB
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0071931; P:positive regulation of transcription involved in G1/S transition of mitotic cell cycle; IC:BHF-UCL
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; IMP:BHF-UCL
Q02363	ID2	DNA-binding protein inhibitor ID-2	GO:0019216; P:regulation of lipid metabolic process; IEA:Ensembl
Q02535	ID3	DNA-binding protein inhibitor ID-3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q02535	ID3	DNA-binding protein inhibitor ID-3	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q02535	ID3	DNA-binding protein inhibitor ID-3	GO:0007417; P:central nervous system development; IEA:Ensembl
Q02535	ID3	DNA-binding protein inhibitor ID-3	GO:0030855; P:epithelial cell differentiation; IEA:Ensembl
Q02535	ID3	DNA-binding protein inhibitor ID-3	GO:0007507; P:heart development; IEA:Ensembl
Q02535	ID3	DNA-binding protein inhibitor ID-3	GO:0001656; P:metanephros development; IEA:Ensembl
Q02535	ID3	DNA-binding protein inhibitor ID-3	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q02535	ID3	DNA-binding protein inhibitor ID-3	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
Q02535	ID3	DNA-binding protein inhibitor ID-3	GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl
Q02535	ID3	DNA-binding protein inhibitor ID-3	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:GDB
Q02535	ID3	DNA-binding protein inhibitor ID-3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q02535	ID3	DNA-binding protein inhibitor ID-3	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:GDB
Q02535	ID3	DNA-binding protein inhibitor ID-3	GO:0030182; P:neuron differentiation; IEA:Ensembl
Q02535	ID3	DNA-binding protein inhibitor ID-3	GO:0030903; P:notochord development; IEA:Ensembl
Q02535	ID3	DNA-binding protein inhibitor ID-3	GO:0042476; P:odontogenesis; IEA:Ensembl
Q02535	ID3	DNA-binding protein inhibitor ID-3	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q02535	ID3	DNA-binding protein inhibitor ID-3	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
Q02535	ID3	DNA-binding protein inhibitor ID-3	GO:0006275; P:regulation of DNA replication; IEA:Ensembl
Q02535	ID3	DNA-binding protein inhibitor ID-3	GO:0009611; P:response to wounding; IEA:Ensembl
Q02535	ID3	DNA-binding protein inhibitor ID-3	GO:0006351; P:transcription, DNA-templated; IEA:Ensembl
P47928	ID4	DNA-binding protein inhibitor ID-4	GO:0005515; F:protein binding; IPI:IntAct
P47928	ID4	DNA-binding protein inhibitor ID-4	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
P47928	ID4	DNA-binding protein inhibitor ID-4	GO:0034613; P:cellular protein localization; IEA:Ensembl
P47928	ID4	DNA-binding protein inhibitor ID-4	GO:0022010; P:central nervous system myelination; IEA:Ensembl
P47928	ID4	DNA-binding protein inhibitor ID-4	GO:0021895; P:cerebral cortex neuron differentiation; IEA:Ensembl
P47928	ID4	DNA-binding protein inhibitor ID-4	GO:0045444; P:fat cell differentiation; IEA:Ensembl
P47928	ID4	DNA-binding protein inhibitor ID-4	GO:0000082; P:G1/S transition of mitotic cell cycle; IEA:Ensembl
P47928	ID4	DNA-binding protein inhibitor ID-4	GO:0021766; P:hippocampus development; IEA:Ensembl
P47928	ID4	DNA-binding protein inhibitor ID-4	GO:0048712; P:negative regulation of astrocyte differentiation; IEA:Ensembl
P47928	ID4	DNA-binding protein inhibitor ID-4	GO:0045599; P:negative regulation of fat cell differentiation; IEA:Ensembl
P47928	ID4	DNA-binding protein inhibitor ID-4	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
P47928	ID4	DNA-binding protein inhibitor ID-4	GO:0048715; P:negative regulation of oligodendrocyte differentiation; IEA:Ensembl
P47928	ID4	DNA-binding protein inhibitor ID-4	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P47928	ID4	DNA-binding protein inhibitor ID-4	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:GDB
P47928	ID4	DNA-binding protein inhibitor ID-4	GO:0007405; P:neuroblast proliferation; IEA:Ensembl
P47928	ID4	DNA-binding protein inhibitor ID-4	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P47928	ID4	DNA-binding protein inhibitor ID-4	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
P47928	ID4	DNA-binding protein inhibitor ID-4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P47928	ID4	DNA-binding protein inhibitor ID-4	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P98153	DGCR2	Integral membrane protein DGCR2/IDD	GO:0030246; F:carbohydrate binding; IEA:InterPro
P98153	DGCR2	Integral membrane protein DGCR2/IDD	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P98153	DGCR2	Integral membrane protein DGCR2/IDD	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P14735	IDE	Insulin-degrading enzyme	GO:0005524; F:ATP binding; IDA:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:0016887; F:ATPase activity; IEA:Ensembl
P14735	IDE	Insulin-degrading enzyme	GO:0001540; F:beta-amyloid binding; IEA:Ensembl
P14735	IDE	Insulin-degrading enzyme	GO:0031626; F:beta-endorphin binding; IEA:Ensembl
P14735	IDE	Insulin-degrading enzyme	GO:0001948; F:glycoprotein binding; IPI:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:0043559; F:insulin binding; IDA:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:0004222; F:metalloendopeptidase activity; IDA:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:0042277; F:peptide binding; IPI:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:0005515; F:protein binding; IPI:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:0005102; F:receptor binding; IPI:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:0043130; F:ubiquitin binding; IPI:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:0050435; P:beta-amyloid metabolic process; IDA:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:0010815; P:bradykinin catabolic process; IDA:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:0008340; P:determination of adult lifespan; IDA:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:0042447; P:hormone catabolic process; IEA:Ensembl
P14735	IDE	Insulin-degrading enzyme	GO:1901143; P:insulin catabolic process; IDA:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:1901142; P:insulin metabolic process; IDA:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:0008286; P:insulin receptor signaling pathway; NAS:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:0045861; P:negative regulation of proteolysis; IEA:Ensembl
P14735	IDE	Insulin-degrading enzyme	GO:0032461; P:positive regulation of protein oligomerization; IDA:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P14735	IDE	Insulin-degrading enzyme	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:0051289; P:protein homotetramerization; IEA:Ensembl
P14735	IDE	Insulin-degrading enzyme	GO:0006508; P:proteolysis; IDA:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:0051603; P:proteolysis involved in cellular protein catabolic process; IDA:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:0010992; P:ubiquitin homeostasis; IDA:UniProtKB
P14735	IDE	Insulin-degrading enzyme	GO:0016032; P:viral process; IEA:UniProtKB-KW
P50213	IDH3A	Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial	GO:0004449; F:isocitrate dehydrogenase (NAD+) activity; IEA:UniProtKB-EC
P50213	IDH3A	Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial	GO:0000287; F:magnesium ion binding; IEA:InterPro
P50213	IDH3A	Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial	GO:0051287; F:NAD binding; IEA:InterPro
P50213	IDH3A	Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial	GO:0005975; P:carbohydrate metabolic process; NAS:ProtInc
P50213	IDH3A	Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P50213	IDH3A	Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P50213	IDH3A	Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; TAS:Reactome
O43837	IDH3B	Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial	GO:0009055; F:electron carrier activity; TAS:UniProtKB
O43837	IDH3B	Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial	GO:0004449; F:isocitrate dehydrogenase (NAD+) activity; TAS:ProtInc
O43837	IDH3B	Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial	GO:0000287; F:magnesium ion binding; IEA:InterPro
O43837	IDH3B	Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial	GO:0051287; F:NAD binding; IEA:InterPro
O43837	IDH3B	Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial	GO:0006103; P:2-oxoglutarate metabolic process; IEA:Ensembl
O43837	IDH3B	Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
O43837	IDH3B	Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial	GO:0006102; P:isocitrate metabolic process; TAS:ProtInc
O43837	IDH3B	Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial	GO:0006734; P:NADH metabolic process; IEA:Ensembl
O43837	IDH3B	Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43837	IDH3B	Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; TAS:Reactome
P51553	IDH3G	Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P51553	IDH3G	Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial	GO:0004449; F:isocitrate dehydrogenase (NAD+) activity; ISS:UniProtKB
P51553	IDH3G	Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial	GO:0000287; F:magnesium ion binding; IEA:InterPro
P51553	IDH3G	Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial	GO:0051287; F:NAD binding; IEA:InterPro
P51553	IDH3G	Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial	GO:0005975; P:carbohydrate metabolic process; NAS:ProtInc
P51553	IDH3G	Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P51553	IDH3G	Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial	GO:0006102; P:isocitrate metabolic process; ISS:UniProtKB
P51553	IDH3G	Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P51553	IDH3G	Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; TAS:Reactome
O75874	IDH1	Isocitrate dehydrogenase [NADP] cytoplasmic	GO:0004450; F:isocitrate dehydrogenase (NADP+) activity; IDA:UniProtKB
O75874	IDH1	Isocitrate dehydrogenase [NADP] cytoplasmic	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
O75874	IDH1	Isocitrate dehydrogenase [NADP] cytoplasmic	GO:0051287; F:NAD binding; IEA:InterPro
O75874	IDH1	Isocitrate dehydrogenase [NADP] cytoplasmic	GO:0050661; F:NADP binding; IEA:Ensembl
O75874	IDH1	Isocitrate dehydrogenase [NADP] cytoplasmic	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
O75874	IDH1	Isocitrate dehydrogenase [NADP] cytoplasmic	GO:0005102; F:receptor binding; IPI:UniProtKB
O75874	IDH1	Isocitrate dehydrogenase [NADP] cytoplasmic	GO:0006103; P:2-oxoglutarate metabolic process; IDA:UniProtKB
O75874	IDH1	Isocitrate dehydrogenase [NADP] cytoplasmic	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O75874	IDH1	Isocitrate dehydrogenase [NADP] cytoplasmic	GO:0008585; P:female gonad development; IEA:Ensembl
O75874	IDH1	Isocitrate dehydrogenase [NADP] cytoplasmic	GO:0006749; P:glutathione metabolic process; IEA:Ensembl
O75874	IDH1	Isocitrate dehydrogenase [NADP] cytoplasmic	GO:0006097; P:glyoxylate cycle; IEA:UniProtKB-KW
O75874	IDH1	Isocitrate dehydrogenase [NADP] cytoplasmic	GO:0006102; P:isocitrate metabolic process; IDA:UniProtKB
O75874	IDH1	Isocitrate dehydrogenase [NADP] cytoplasmic	GO:0006740; P:NADPH regeneration; TAS:Reactome
O75874	IDH1	Isocitrate dehydrogenase [NADP] cytoplasmic	GO:0006979; P:response to oxidative stress; IEA:Ensembl
O75874	IDH1	Isocitrate dehydrogenase [NADP] cytoplasmic	GO:0048545; P:response to steroid hormone; IEA:Ensembl
O75874	IDH1	Isocitrate dehydrogenase [NADP] cytoplasmic	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75874	IDH1	Isocitrate dehydrogenase [NADP] cytoplasmic	GO:0006099; P:tricarboxylic acid cycle; IEA:UniProtKB-KW
P48735	IDH2	Isocitrate dehydrogenase [NADP], mitochondrial	GO:0004450; F:isocitrate dehydrogenase (NADP+) activity; ISS:UniProtKB
P48735	IDH2	Isocitrate dehydrogenase [NADP], mitochondrial	GO:0000287; F:magnesium ion binding; ISS:UniProtKB
P48735	IDH2	Isocitrate dehydrogenase [NADP], mitochondrial	GO:0051287; F:NAD binding; IEA:InterPro
P48735	IDH2	Isocitrate dehydrogenase [NADP], mitochondrial	GO:0006103; P:2-oxoglutarate metabolic process; ISS:UniProtKB
P48735	IDH2	Isocitrate dehydrogenase [NADP], mitochondrial	GO:0005975; P:carbohydrate metabolic process; NAS:ProtInc
P48735	IDH2	Isocitrate dehydrogenase [NADP], mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P48735	IDH2	Isocitrate dehydrogenase [NADP], mitochondrial	GO:0006097; P:glyoxylate cycle; IEA:UniProtKB-KW
P48735	IDH2	Isocitrate dehydrogenase [NADP], mitochondrial	GO:0006102; P:isocitrate metabolic process; ISS:UniProtKB
P48735	IDH2	Isocitrate dehydrogenase [NADP], mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P48735	IDH2	Isocitrate dehydrogenase [NADP], mitochondrial	GO:0006099; P:tricarboxylic acid cycle; TAS:Reactome
Q13907	IDI1	Isopentenyl-diphosphate Delta-isomerase 1	GO:0016787; F:hydrolase activity; IEA:InterPro
Q13907	IDI1	Isopentenyl-diphosphate Delta-isomerase 1	GO:0004452; F:isopentenyl-diphosphate delta-isomerase activity; IDA:UniProtKB
Q13907	IDI1	Isopentenyl-diphosphate Delta-isomerase 1	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q13907	IDI1	Isopentenyl-diphosphate Delta-isomerase 1	GO:0030145; F:manganese ion binding; IDA:UniProtKB
Q13907	IDI1	Isopentenyl-diphosphate Delta-isomerase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13907	IDI1	Isopentenyl-diphosphate Delta-isomerase 1	GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome
Q13907	IDI1	Isopentenyl-diphosphate Delta-isomerase 1	GO:0050992; P:dimethylallyl diphosphate biosynthetic process; IEA:UniProtKB-UniPathway
Q13907	IDI1	Isopentenyl-diphosphate Delta-isomerase 1	GO:0008299; P:isoprenoid biosynthetic process; IDA:UniProtKB
Q13907	IDI1	Isopentenyl-diphosphate Delta-isomerase 1	GO:0035634; P:response to stilbenoid; IEA:Ensembl
Q13907	IDI1	Isopentenyl-diphosphate Delta-isomerase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BXS1	IDI2	Isopentenyl-diphosphate delta-isomerase 2	GO:0016787; F:hydrolase activity; IEA:InterPro
Q9BXS1	IDI2	Isopentenyl-diphosphate delta-isomerase 2	GO:0004452; F:isopentenyl-diphosphate delta-isomerase activity; IDA:UniProtKB
Q9BXS1	IDI2	Isopentenyl-diphosphate delta-isomerase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BXS1	IDI2	Isopentenyl-diphosphate delta-isomerase 2	GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome
Q9BXS1	IDI2	Isopentenyl-diphosphate delta-isomerase 2	GO:0050992; P:dimethylallyl diphosphate biosynthetic process; IEA:UniProtKB-UniPathway
Q9BXS1	IDI2	Isopentenyl-diphosphate delta-isomerase 2	GO:0046490; P:isopentenyl diphosphate metabolic process; IDA:MGI
Q9BXS1	IDI2	Isopentenyl-diphosphate delta-isomerase 2	GO:0008299; P:isoprenoid biosynthetic process; IDA:UniProtKB
Q9BXS1	IDI2	Isopentenyl-diphosphate delta-isomerase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O14645	DNALI1	Axonemal dynein light intermediate polypeptide 1	GO:0003777; F:microtubule motor activity; TAS:ProtInc
O14645	DNALI1	Axonemal dynein light intermediate polypeptide 1	GO:0005515; F:protein binding; IPI:IntAct
O14645	DNALI1	Axonemal dynein light intermediate polypeptide 1	GO:0006928; P:cellular component movement; TAS:ProtInc
O14645	DNALI1	Axonemal dynein light intermediate polypeptide 1	GO:0008152; P:metabolic process; TAS:GOC
O14645	DNALI1	Axonemal dynein light intermediate polypeptide 1	GO:0007338; P:single fertilization; TAS:ProtInc
P22304	IDS	Iduronate 2-sulfatase	GO:0004423; F:iduronate-2-sulfatase activity; TAS:Reactome
P22304	IDS	Iduronate 2-sulfatase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P22304	IDS	Iduronate 2-sulfatase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P22304	IDS	Iduronate 2-sulfatase	GO:0030207; P:chondroitin sulfate catabolic process; TAS:Reactome
P22304	IDS	Iduronate 2-sulfatase	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
P22304	IDS	Iduronate 2-sulfatase	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
P22304	IDS	Iduronate 2-sulfatase	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P22304	IDS	Iduronate 2-sulfatase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P35475	IDUA	Alpha-L-iduronidase	GO:0003940; F:L-iduronidase activity; IDA:UniProtKB
P35475	IDUA	Alpha-L-iduronidase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P35475	IDUA	Alpha-L-iduronidase	GO:0000902; P:cell morphogenesis; IEA:Ensembl
P35475	IDUA	Alpha-L-iduronidase	GO:0048878; P:chemical homeostasis; IEA:Ensembl
P35475	IDUA	Alpha-L-iduronidase	GO:0030207; P:chondroitin sulfate catabolic process; TAS:Reactome
P35475	IDUA	Alpha-L-iduronidase	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
P35475	IDUA	Alpha-L-iduronidase	GO:0030209; P:dermatan sulfate catabolic process; IDA:UniProtKB
P35475	IDUA	Alpha-L-iduronidase	GO:0005984; P:disaccharide metabolic process; TAS:ProtInc
P35475	IDUA	Alpha-L-iduronidase	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
P35475	IDUA	Alpha-L-iduronidase	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P35475	IDUA	Alpha-L-iduronidase	GO:0035108; P:limb morphogenesis; IEA:Ensembl
P35475	IDUA	Alpha-L-iduronidase	GO:0007040; P:lysosome organization; IEA:Ensembl
P35475	IDUA	Alpha-L-iduronidase	GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl
P35475	IDUA	Alpha-L-iduronidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P46695	IER3	Radiation-inducible immediate-early gene IEX-1	GO:0005515; F:protein binding; IPI:IntAct
P46695	IER3	Radiation-inducible immediate-early gene IEX-1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P46695	IER3	Radiation-inducible immediate-early gene IEX-1	GO:0006915; P:apoptotic process; TAS:ProtInc
P46695	IER3	Radiation-inducible immediate-early gene IEX-1	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
P46695	IER3	Radiation-inducible immediate-early gene IEX-1	GO:0007095; P:mitotic G2 DNA damage checkpoint; IEA:Ensembl
P46695	IER3	Radiation-inducible immediate-early gene IEX-1	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
P46695	IER3	Radiation-inducible immediate-early gene IEX-1	GO:0045820; P:negative regulation of glycolytic process; IEA:Ensembl
P46695	IER3	Radiation-inducible immediate-early gene IEX-1	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
P46695	IER3	Radiation-inducible immediate-early gene IEX-1	GO:1901029; P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; IEA:Ensembl
P46695	IER3	Radiation-inducible immediate-early gene IEX-1	GO:0003085; P:negative regulation of systemic arterial blood pressure; IEA:Ensembl
P46695	IER3	Radiation-inducible immediate-early gene IEX-1	GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl
P46695	IER3	Radiation-inducible immediate-early gene IEX-1	GO:0006282; P:regulation of DNA repair; IEA:Ensembl
P46695	IER3	Radiation-inducible immediate-early gene IEX-1	GO:0046822; P:regulation of nucleocytoplasmic transport; IEA:Ensembl
P46695	IER3	Radiation-inducible immediate-early gene IEX-1	GO:2000377; P:regulation of reactive oxygen species metabolic process; IEA:Ensembl
P46695	IER3	Radiation-inducible immediate-early gene IEX-1	GO:2001020; P:regulation of response to DNA damage stimulus; IMP:MGI
P46695	IER3	Radiation-inducible immediate-early gene IEX-1	GO:0001562; P:response to protozoan; IEA:Ensembl
Q9HBG6	IFT122	Intraflagellar transport protein 122 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q9HBG6	IFT122	Intraflagellar transport protein 122 homolog	GO:0048593; P:camera-type eye morphogenesis; ISS:UniProtKB
Q9HBG6	IFT122	Intraflagellar transport protein 122 homolog	GO:0060830; P:ciliary receptor clustering involved in smoothened signaling pathway; IEA:Ensembl
Q9HBG6	IFT122	Intraflagellar transport protein 122 homolog	GO:0060271; P:cilium morphogenesis; ISS:UniProtKB
Q9HBG6	IFT122	Intraflagellar transport protein 122 homolog	GO:0010172; P:embryonic body morphogenesis; ISS:UniProtKB
Q9HBG6	IFT122	Intraflagellar transport protein 122 homolog	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
Q9HBG6	IFT122	Intraflagellar transport protein 122 homolog	GO:0035050; P:embryonic heart tube development; ISS:UniProtKB
Q9HBG6	IFT122	Intraflagellar transport protein 122 homolog	GO:0035721; P:intraciliary retrograde transport; ISS:UniProtKB
Q9HBG6	IFT122	Intraflagellar transport protein 122 homolog	GO:0060173; P:limb development; ISS:UniProtKB
Q9HBG6	IFT122	Intraflagellar transport protein 122 homolog	GO:0045879; P:negative regulation of smoothened signaling pathway; ISS:UniProtKB
Q9HBG6	IFT122	Intraflagellar transport protein 122 homolog	GO:0001843; P:neural tube closure; ISS:UniProtKB
Q9HBG6	IFT122	Intraflagellar transport protein 122 homolog	GO:0060831; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; IEA:Ensembl
Q96RY7	IFT140	Intraflagellar transport protein 140 homolog	GO:0042384; P:cilium assembly; IEA:Ensembl
Q96RY7	IFT140	Intraflagellar transport protein 140 homolog	GO:0061512; P:protein localization to cilium; IMP:UniProt
Q96RY7	IFT140	Intraflagellar transport protein 140 homolog	GO:1902017; P:regulation of cilium assembly; IMP:UniProt
Q96RY7	IFT140	Intraflagellar transport protein 140 homolog	GO:0072001; P:renal system development; IMP:UniProt
Q96RY7	IFT140	Intraflagellar transport protein 140 homolog	GO:0060041; P:retina development in camera-type eye; IMP:UniProt
Q96RY7	IFT140	Intraflagellar transport protein 140 homolog	GO:0048705; P:skeletal system morphogenesis; IMP:UniProt
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0005515; F:protein binding; IPI:IntAct
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0008134; F:transcription factor binding; IDA:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0097202; P:activation of cysteine-type endopeptidase activity; IMP:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0002218; P:activation of innate immune response; IDA:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0008283; P:cell proliferation; NAS:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0042149; P:cellular response to glucose starvation; IDA:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0071479; P:cellular response to ionizing radiation; IDA:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0051607; P:defense response to virus; IMP:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0030097; P:hemopoiesis; NAS:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0045087; P:innate immune response; TAS:Reactome
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IMP:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IDA:MGI
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0030224; P:monocyte differentiation; IDA:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0030099; P:myeloid cell differentiation; NAS:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:2000117; P:negative regulation of cysteine-type endopeptidase activity; IDA:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0043392; P:negative regulation of DNA binding; IDA:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0045824; P:negative regulation of innate immune response; IDA:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0001819; P:positive regulation of cytokine production; TAS:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0032731; P:positive regulation of interleukin-1 beta production; IDA:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0010506; P:regulation of autophagy; IEP:UniProtKB
Q16666	IFI16	Gamma-interferon-inducible protein 16	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UG01	IFT172	Intraflagellar transport protein 172 homolog	GO:0042384; P:cilium assembly; IDA:UniProtKB
Q9UG01	IFT172	Intraflagellar transport protein 172 homolog	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
Q9UG01	IFT172	Intraflagellar transport protein 172 homolog	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
Q9UG01	IFT172	Intraflagellar transport protein 172 homolog	GO:0001841; P:neural tube formation; IEA:Ensembl
Q9UG01	IFT172	Intraflagellar transport protein 172 homolog	GO:0016485; P:protein processing; IEA:Ensembl
Q9UG01	IFT172	Intraflagellar transport protein 172 homolog	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
Q9UG01	IFT172	Intraflagellar transport protein 172 homolog	GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl
P47813	EIF1AX	Eukaryotic translation initiation factor 1A, X-chromosomal	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P47813	EIF1AX	Eukaryotic translation initiation factor 1A, X-chromosomal	GO:0008135; F:translation factor activity, nucleic acid binding; TAS:ProtInc
P47813	EIF1AX	Eukaryotic translation initiation factor 1A, X-chromosomal	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW
P47813	EIF1AX	Eukaryotic translation initiation factor 1A, X-chromosomal	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P47813	EIF1AX	Eukaryotic translation initiation factor 1A, X-chromosomal	GO:0010467; P:gene expression; TAS:Reactome
P47813	EIF1AX	Eukaryotic translation initiation factor 1A, X-chromosomal	GO:0006412; P:translation; TAS:Reactome
P47813	EIF1AX	Eukaryotic translation initiation factor 1A, X-chromosomal	GO:0006413; P:translational initiation; TAS:Reactome
O14602	EIF1AY	Eukaryotic translation initiation factor 1A, Y-chromosomal	GO:0005515; F:protein binding; IPI:IntAct
O14602	EIF1AY	Eukaryotic translation initiation factor 1A, Y-chromosomal	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW
P05198	EIF2S1	Eukaryotic translation initiation factor 2 subunit 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P05198	EIF2S1	Eukaryotic translation initiation factor 2 subunit 1	GO:0005515; F:protein binding; IPI:UniProtKB
P05198	EIF2S1	Eukaryotic translation initiation factor 2 subunit 1	GO:0043022; F:ribosome binding; IDA:UniProtKB
P05198	EIF2S1	Eukaryotic translation initiation factor 2 subunit 1	GO:0003743; F:translation initiation factor activity; IDA:UniProtKB
P05198	EIF2S1	Eukaryotic translation initiation factor 2 subunit 1	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P05198	EIF2S1	Eukaryotic translation initiation factor 2 subunit 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P05198	EIF2S1	Eukaryotic translation initiation factor 2 subunit 1	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P05198	EIF2S1	Eukaryotic translation initiation factor 2 subunit 1	GO:0010467; P:gene expression; TAS:Reactome
P05198	EIF2S1	Eukaryotic translation initiation factor 2 subunit 1	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
P05198	EIF2S1	Eukaryotic translation initiation factor 2 subunit 1	GO:0043558; P:regulation of translational initiation in response to stress; IEA:Ensembl
P05198	EIF2S1	Eukaryotic translation initiation factor 2 subunit 1	GO:0006412; P:translation; TAS:Reactome
P05198	EIF2S1	Eukaryotic translation initiation factor 2 subunit 1	GO:0006413; P:translational initiation; TAS:Reactome
Q9NZI8	IGF2BP1	Insulin-like growth factor 2 mRNA-binding protein 1	GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB
Q9NZI8	IGF2BP1	Insulin-like growth factor 2 mRNA-binding protein 1	GO:0048027; F:mRNA 5'-UTR binding; IDA:BHF-UCL
Q9NZI8	IGF2BP1	Insulin-like growth factor 2 mRNA-binding protein 1	GO:0003729; F:mRNA binding; IDA:UniProtKB
Q9NZI8	IGF2BP1	Insulin-like growth factor 2 mRNA-binding protein 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9NZI8	IGF2BP1	Insulin-like growth factor 2 mRNA-binding protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NZI8	IGF2BP1	Insulin-like growth factor 2 mRNA-binding protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NZI8	IGF2BP1	Insulin-like growth factor 2 mRNA-binding protein 1	GO:0045182; F:translation regulator activity; IDA:BHF-UCL
Q9NZI8	IGF2BP1	Insulin-like growth factor 2 mRNA-binding protein 1	GO:0070934; P:CRD-mediated mRNA stabilization; IDA:UniProtKB
Q9NZI8	IGF2BP1	Insulin-like growth factor 2 mRNA-binding protein 1	GO:0010467; P:gene expression; TAS:Reactome
Q9NZI8	IGF2BP1	Insulin-like growth factor 2 mRNA-binding protein 1	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q9NZI8	IGF2BP1	Insulin-like growth factor 2 mRNA-binding protein 1	GO:0017148; P:negative regulation of translation; IDA:BHF-UCL
Q9NZI8	IGF2BP1	Insulin-like growth factor 2 mRNA-binding protein 1	GO:0042035; P:regulation of cytokine biosynthetic process; IC:BHF-UCL
Q9NZI8	IGF2BP1	Insulin-like growth factor 2 mRNA-binding protein 1	GO:0010610; P:regulation of mRNA stability involved in response to stress; IMP:UniProtKB
Q9Y6M1	IGF2BP2	Insulin-like growth factor 2 mRNA-binding protein 2	GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB
Q9Y6M1	IGF2BP2	Insulin-like growth factor 2 mRNA-binding protein 2	GO:0048027; F:mRNA 5'-UTR binding; IDA:BHF-UCL
Q9Y6M1	IGF2BP2	Insulin-like growth factor 2 mRNA-binding protein 2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9Y6M1	IGF2BP2	Insulin-like growth factor 2 mRNA-binding protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y6M1	IGF2BP2	Insulin-like growth factor 2 mRNA-binding protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6M1	IGF2BP2	Insulin-like growth factor 2 mRNA-binding protein 2	GO:0045182; F:translation regulator activity; ISS:BHF-UCL
Q9Y6M1	IGF2BP2	Insulin-like growth factor 2 mRNA-binding protein 2	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q9Y6M1	IGF2BP2	Insulin-like growth factor 2 mRNA-binding protein 2	GO:0010467; P:gene expression; TAS:Reactome
Q9Y6M1	IGF2BP2	Insulin-like growth factor 2 mRNA-binding protein 2	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q9Y6M1	IGF2BP2	Insulin-like growth factor 2 mRNA-binding protein 2	GO:0017148; P:negative regulation of translation; ISS:BHF-UCL
Q9Y6M1	IGF2BP2	Insulin-like growth factor 2 mRNA-binding protein 2	GO:0042035; P:regulation of cytokine biosynthetic process; IC:BHF-UCL
O00425	IGF2BP3	Insulin-like growth factor 2 mRNA-binding protein 3	GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB
O00425	IGF2BP3	Insulin-like growth factor 2 mRNA-binding protein 3	GO:0048027; F:mRNA 5'-UTR binding; IDA:BHF-UCL
O00425	IGF2BP3	Insulin-like growth factor 2 mRNA-binding protein 3	GO:0000166; F:nucleotide binding; IEA:InterPro
O00425	IGF2BP3	Insulin-like growth factor 2 mRNA-binding protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O00425	IGF2BP3	Insulin-like growth factor 2 mRNA-binding protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
O00425	IGF2BP3	Insulin-like growth factor 2 mRNA-binding protein 3	GO:0003723; F:RNA binding; TAS:ProtInc
O00425	IGF2BP3	Insulin-like growth factor 2 mRNA-binding protein 3	GO:0045182; F:translation regulator activity; ISS:BHF-UCL
O00425	IGF2BP3	Insulin-like growth factor 2 mRNA-binding protein 3	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
O00425	IGF2BP3	Insulin-like growth factor 2 mRNA-binding protein 3	GO:0010467; P:gene expression; TAS:Reactome
O00425	IGF2BP3	Insulin-like growth factor 2 mRNA-binding protein 3	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
O00425	IGF2BP3	Insulin-like growth factor 2 mRNA-binding protein 3	GO:0017148; P:negative regulation of translation; ISS:BHF-UCL
O00425	IGF2BP3	Insulin-like growth factor 2 mRNA-binding protein 3	GO:0042035; P:regulation of cytokine biosynthetic process; IC:BHF-UCL
O00425	IGF2BP3	Insulin-like growth factor 2 mRNA-binding protein 3	GO:0006412; P:translation; TAS:ProtInc
P20042	EIF2S2	Eukaryotic translation initiation factor 2 subunit 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P20042	EIF2S2	Eukaryotic translation initiation factor 2 subunit 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P20042	EIF2S2	Eukaryotic translation initiation factor 2 subunit 2	GO:0005515; F:protein binding; IPI:IntAct
P20042	EIF2S2	Eukaryotic translation initiation factor 2 subunit 2	GO:0003723; F:RNA binding; TAS:ProtInc
P20042	EIF2S2	Eukaryotic translation initiation factor 2 subunit 2	GO:0008135; F:translation factor activity, nucleic acid binding; TAS:ProtInc
P20042	EIF2S2	Eukaryotic translation initiation factor 2 subunit 2	GO:0003743; F:translation initiation factor activity; IDA:UniProtKB
P20042	EIF2S2	Eukaryotic translation initiation factor 2 subunit 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P20042	EIF2S2	Eukaryotic translation initiation factor 2 subunit 2	GO:0010467; P:gene expression; TAS:Reactome
P20042	EIF2S2	Eukaryotic translation initiation factor 2 subunit 2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P20042	EIF2S2	Eukaryotic translation initiation factor 2 subunit 2	GO:0002176; P:male germ cell proliferation; IEA:Ensembl
P20042	EIF2S2	Eukaryotic translation initiation factor 2 subunit 2	GO:0008584; P:male gonad development; IEA:Ensembl
P20042	EIF2S2	Eukaryotic translation initiation factor 2 subunit 2	GO:0006412; P:translation; TAS:Reactome
P20042	EIF2S2	Eukaryotic translation initiation factor 2 subunit 2	GO:0006413; P:translational initiation; TAS:Reactome
Q2VIR3	EIF2S3L	Putative eukaryotic translation initiation factor 2 subunit 3-like protein	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q2VIR3	EIF2S3L	Putative eukaryotic translation initiation factor 2 subunit 3-like protein	GO:0003924; F:GTPase activity; IEA:InterPro
Q2VIR3	EIF2S3L	Putative eukaryotic translation initiation factor 2 subunit 3-like protein	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW
P41091	EIF2S3	Eukaryotic translation initiation factor 2 subunit 3	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P41091	EIF2S3	Eukaryotic translation initiation factor 2 subunit 3	GO:0003924; F:GTPase activity; TAS:ProtInc
P41091	EIF2S3	Eukaryotic translation initiation factor 2 subunit 3	GO:0005515; F:protein binding; IPI:IntAct
P41091	EIF2S3	Eukaryotic translation initiation factor 2 subunit 3	GO:0008135; F:translation factor activity, nucleic acid binding; IDA:UniProtKB
P41091	EIF2S3	Eukaryotic translation initiation factor 2 subunit 3	GO:0003743; F:translation initiation factor activity; IDA:UniProtKB
P41091	EIF2S3	Eukaryotic translation initiation factor 2 subunit 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P41091	EIF2S3	Eukaryotic translation initiation factor 2 subunit 3	GO:0010467; P:gene expression; TAS:Reactome
P41091	EIF2S3	Eukaryotic translation initiation factor 2 subunit 3	GO:0006184; P:GTP catabolic process; TAS:GOC
P41091	EIF2S3	Eukaryotic translation initiation factor 2 subunit 3	GO:0006412; P:translation; TAS:Reactome
P41091	EIF2S3	Eukaryotic translation initiation factor 2 subunit 3	GO:0006413; P:translational initiation; IDA:UniProtKB
P46199	MTIF2	Translation initiation factor IF-2, mitochondrial	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P46199	MTIF2	Translation initiation factor IF-2, mitochondrial	GO:0003924; F:GTPase activity; IEA:InterPro
P46199	MTIF2	Translation initiation factor IF-2, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P46199	MTIF2	Translation initiation factor IF-2, mitochondrial	GO:0043024; F:ribosomal small subunit binding; ISS:HGNC
P46199	MTIF2	Translation initiation factor IF-2, mitochondrial	GO:0008135; F:translation factor activity, nucleic acid binding; ISS:HGNC
P46199	MTIF2	Translation initiation factor IF-2, mitochondrial	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW
P46199	MTIF2	Translation initiation factor IF-2, mitochondrial	GO:0001732; P:formation of translation initiation complex; ISS:BHF-UCL
P46199	MTIF2	Translation initiation factor IF-2, mitochondrial	GO:0006446; P:regulation of translational initiation; ISS:HGNC
P46199	MTIF2	Translation initiation factor IF-2, mitochondrial	GO:0032790; P:ribosome disassembly; ISS:BHF-UCL
O60841	EIF5B	Eukaryotic translation initiation factor 5B	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
O60841	EIF5B	Eukaryotic translation initiation factor 5B	GO:0003924; F:GTPase activity; IEA:InterPro
O60841	EIF5B	Eukaryotic translation initiation factor 5B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O60841	EIF5B	Eukaryotic translation initiation factor 5B	GO:0005515; F:protein binding; IPI:IntAct
O60841	EIF5B	Eukaryotic translation initiation factor 5B	GO:0003743; F:translation initiation factor activity; IDA:UniProtKB
O60841	EIF5B	Eukaryotic translation initiation factor 5B	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O60841	EIF5B	Eukaryotic translation initiation factor 5B	GO:0010467; P:gene expression; TAS:Reactome
O60841	EIF5B	Eukaryotic translation initiation factor 5B	GO:0006446; P:regulation of translational initiation; IDA:UniProtKB
O60841	EIF5B	Eukaryotic translation initiation factor 5B	GO:0006412; P:translation; TAS:Reactome
O60841	EIF5B	Eukaryotic translation initiation factor 5B	GO:0006413; P:translational initiation; TAS:Reactome
Q9H2K0	MTIF3	Translation initiation factor IF-3, mitochondrial	GO:0043024; F:ribosomal small subunit binding; IDA:BHF-UCL
Q9H2K0	MTIF3	Translation initiation factor IF-3, mitochondrial	GO:0008135; F:translation factor activity, nucleic acid binding; IDA:BHF-UCL
Q9H2K0	MTIF3	Translation initiation factor IF-3, mitochondrial	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW
Q9H2K0	MTIF3	Translation initiation factor IF-3, mitochondrial	GO:0001732; P:formation of translation initiation complex; IDA:BHF-UCL
Q9H2K0	MTIF3	Translation initiation factor IF-3, mitochondrial	GO:0006446; P:regulation of translational initiation; IDA:BHF-UCL
Q9H2K0	MTIF3	Translation initiation factor IF-3, mitochondrial	GO:0032790; P:ribosome disassembly; IDA:BHF-UCL
Q53G44	IFI44L	Interferon-induced protein 44-like	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q53G44	IFI44L	Interferon-induced protein 44-like	GO:0006955; P:immune response; IEA:Ensembl
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0003725; F:double-stranded RNA binding; IDA:MGI
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0004386; F:helicase activity; TAS:UniProtKB
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0003729; F:mRNA binding; TAS:UniProtKB
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0005515; F:protein binding; IPI:UniProtKB
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0000339; F:RNA cap binding; TAS:UniProtKB
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0008135; F:translation factor activity, nucleic acid binding; TAS:UniProtKB
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0010467; P:gene expression; TAS:Reactome
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0031100; P:organ regeneration; IEA:Ensembl
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0016070; P:RNA metabolic process; TAS:Reactome
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0006412; P:translation; TAS:Reactome
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0006413; P:translational initiation; TAS:Reactome
P60842	EIF4A1	Eukaryotic initiation factor 4A-I	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q14240	EIF4A2	Eukaryotic initiation factor 4A-II	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q14240	EIF4A2	Eukaryotic initiation factor 4A-II	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q14240	EIF4A2	Eukaryotic initiation factor 4A-II	GO:0004386; F:helicase activity; TAS:ProtInc
Q14240	EIF4A2	Eukaryotic initiation factor 4A-II	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14240	EIF4A2	Eukaryotic initiation factor 4A-II	GO:0005515; F:protein binding; IPI:IntAct
Q14240	EIF4A2	Eukaryotic initiation factor 4A-II	GO:0003743; F:translation initiation factor activity; TAS:ProtInc
Q14240	EIF4A2	Eukaryotic initiation factor 4A-II	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q14240	EIF4A2	Eukaryotic initiation factor 4A-II	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q14240	EIF4A2	Eukaryotic initiation factor 4A-II	GO:0010467; P:gene expression; TAS:Reactome
Q14240	EIF4A2	Eukaryotic initiation factor 4A-II	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q14240	EIF4A2	Eukaryotic initiation factor 4A-II	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q14240	EIF4A2	Eukaryotic initiation factor 4A-II	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
Q14240	EIF4A2	Eukaryotic initiation factor 4A-II	GO:0006446; P:regulation of translational initiation; TAS:ProtInc
Q14240	EIF4A2	Eukaryotic initiation factor 4A-II	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q14240	EIF4A2	Eukaryotic initiation factor 4A-II	GO:0006412; P:translation; TAS:Reactome
Q14240	EIF4A2	Eukaryotic initiation factor 4A-II	GO:0006413; P:translational initiation; TAS:Reactome
Q14240	EIF4A2	Eukaryotic initiation factor 4A-II	GO:0016032; P:viral process; IEA:UniProtKB-KW
P38919	EIF4A3	Eukaryotic initiation factor 4A-III	GO:0005524; F:ATP binding; IDA:HGNC
P38919	EIF4A3	Eukaryotic initiation factor 4A-III	GO:0004004; F:ATP-dependent RNA helicase activity; IDA:HGNC
P38919	EIF4A3	Eukaryotic initiation factor 4A-III	GO:0003729; F:mRNA binding; IDA:UniProtKB
P38919	EIF4A3	Eukaryotic initiation factor 4A-III	GO:0008143; F:poly(A) binding; IDA:HGNC
P38919	EIF4A3	Eukaryotic initiation factor 4A-III	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P38919	EIF4A3	Eukaryotic initiation factor 4A-III	GO:0005515; F:protein binding; IPI:UniProtKB
P38919	EIF4A3	Eukaryotic initiation factor 4A-III	GO:0006200; P:ATP catabolic process; IDA:GOC
P38919	EIF4A3	Eukaryotic initiation factor 4A-III	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P38919	EIF4A3	Eukaryotic initiation factor 4A-III	GO:0010467; P:gene expression; TAS:Reactome
P38919	EIF4A3	Eukaryotic initiation factor 4A-III	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P38919	EIF4A3	Eukaryotic initiation factor 4A-III	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P38919	EIF4A3	Eukaryotic initiation factor 4A-III	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
P38919	EIF4A3	Eukaryotic initiation factor 4A-III	GO:0017148; P:negative regulation of translation; IDA:HGNC
P38919	EIF4A3	Eukaryotic initiation factor 4A-III	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
P38919	EIF4A3	Eukaryotic initiation factor 4A-III	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IMP:UniProtKB
P38919	EIF4A3	Eukaryotic initiation factor 4A-III	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
P38919	EIF4A3	Eukaryotic initiation factor 4A-III	GO:0045727; P:positive regulation of translation; IMP:UniProtKB
P38919	EIF4A3	Eukaryotic initiation factor 4A-III	GO:0016070; P:RNA metabolic process; TAS:Reactome
P38919	EIF4A3	Eukaryotic initiation factor 4A-III	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
P23588	EIF4B	Eukaryotic translation initiation factor 4B	GO:0000166; F:nucleotide binding; IEA:InterPro
P23588	EIF4B	Eukaryotic translation initiation factor 4B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P23588	EIF4B	Eukaryotic translation initiation factor 4B	GO:0005515; F:protein binding; IPI:IntAct
P23588	EIF4B	Eukaryotic translation initiation factor 4B	GO:0003723; F:RNA binding; TAS:ProtInc
P23588	EIF4B	Eukaryotic translation initiation factor 4B	GO:0003743; F:translation initiation factor activity; TAS:ProtInc
P23588	EIF4B	Eukaryotic translation initiation factor 4B	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P23588	EIF4B	Eukaryotic translation initiation factor 4B	GO:0010467; P:gene expression; TAS:Reactome
P23588	EIF4B	Eukaryotic translation initiation factor 4B	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P23588	EIF4B	Eukaryotic translation initiation factor 4B	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P23588	EIF4B	Eukaryotic translation initiation factor 4B	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
P23588	EIF4B	Eukaryotic translation initiation factor 4B	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
P23588	EIF4B	Eukaryotic translation initiation factor 4B	GO:0006446; P:regulation of translational initiation; TAS:ProtInc
P23588	EIF4B	Eukaryotic translation initiation factor 4B	GO:0016070; P:RNA metabolic process; TAS:Reactome
P23588	EIF4B	Eukaryotic translation initiation factor 4B	GO:0006412; P:translation; TAS:Reactome
P23588	EIF4B	Eukaryotic translation initiation factor 4B	GO:0006413; P:translational initiation; TAS:Reactome
O60573	EIF4E2	Eukaryotic translation initiation factor 4E type 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O60573	EIF4E2	Eukaryotic translation initiation factor 4E type 2	GO:0005515; F:protein binding; IPI:UniProtKB
O60573	EIF4E2	Eukaryotic translation initiation factor 4E type 2	GO:0000339; F:RNA cap binding; TAS:ProtInc
O60573	EIF4E2	Eukaryotic translation initiation factor 4E type 2	GO:0008135; F:translation factor activity, nucleic acid binding; TAS:ProtInc
O60573	EIF4E2	Eukaryotic translation initiation factor 4E type 2	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW
O60573	EIF4E2	Eukaryotic translation initiation factor 4E type 2	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
O60573	EIF4E2	Eukaryotic translation initiation factor 4E type 2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
O60573	EIF4E2	Eukaryotic translation initiation factor 4E type 2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O60573	EIF4E2	Eukaryotic translation initiation factor 4E type 2	GO:0017148; P:negative regulation of translation; IMP:MGI
Q8N5X7	EIF4E3	Eukaryotic translation initiation factor 4E type 3	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW
Q8N5X7	EIF4E3	Eukaryotic translation initiation factor 4E type 3	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q8N5X7	EIF4E3	Eukaryotic translation initiation factor 4E type 3	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
P06730	EIF4E	Eukaryotic translation initiation factor 4E	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P06730	EIF4E	Eukaryotic translation initiation factor 4E	GO:0005515; F:protein binding; IPI:UniProtKB
P06730	EIF4E	Eukaryotic translation initiation factor 4E	GO:0000339; F:RNA cap binding; TAS:ProtInc
P06730	EIF4E	Eukaryotic translation initiation factor 4E	GO:0003743; F:translation initiation factor activity; IDA:UniProtKB
P06730	EIF4E	Eukaryotic translation initiation factor 4E	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P06730	EIF4E	Eukaryotic translation initiation factor 4E	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P06730	EIF4E	Eukaryotic translation initiation factor 4E	GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:UniProtKB
P06730	EIF4E	Eukaryotic translation initiation factor 4E	GO:0010467; P:gene expression; TAS:Reactome
P06730	EIF4E	Eukaryotic translation initiation factor 4E	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P06730	EIF4E	Eukaryotic translation initiation factor 4E	GO:0030324; P:lung development; IEA:Ensembl
P06730	EIF4E	Eukaryotic translation initiation factor 4E	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
P06730	EIF4E	Eukaryotic translation initiation factor 4E	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P06730	EIF4E	Eukaryotic translation initiation factor 4E	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
P06730	EIF4E	Eukaryotic translation initiation factor 4E	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
P06730	EIF4E	Eukaryotic translation initiation factor 4E	GO:0045931; P:positive regulation of mitotic cell cycle; IMP:UniProtKB
P06730	EIF4E	Eukaryotic translation initiation factor 4E	GO:0006417; P:regulation of translation; IDA:UniProtKB
P06730	EIF4E	Eukaryotic translation initiation factor 4E	GO:0016070; P:RNA metabolic process; TAS:Reactome
P06730	EIF4E	Eukaryotic translation initiation factor 4E	GO:0006412; P:translation; TAS:Reactome
P06730	EIF4E	Eukaryotic translation initiation factor 4E	GO:0006413; P:translational initiation; TAS:Reactome
P06730	EIF4E	Eukaryotic translation initiation factor 4E	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q04637	EIF4G1	Eukaryotic translation initiation factor 4 gamma 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q04637	EIF4G1	Eukaryotic translation initiation factor 4 gamma 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q04637	EIF4G1	Eukaryotic translation initiation factor 4 gamma 1	GO:0008135; F:translation factor activity, nucleic acid binding; TAS:ProtInc
Q04637	EIF4G1	Eukaryotic translation initiation factor 4 gamma 1	GO:0003743; F:translation initiation factor activity; TAS:UniProtKB
Q04637	EIF4G1	Eukaryotic translation initiation factor 4 gamma 1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q04637	EIF4G1	Eukaryotic translation initiation factor 4 gamma 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q04637	EIF4G1	Eukaryotic translation initiation factor 4 gamma 1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q04637	EIF4G1	Eukaryotic translation initiation factor 4 gamma 1	GO:0010467; P:gene expression; TAS:Reactome
Q04637	EIF4G1	Eukaryotic translation initiation factor 4 gamma 1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q04637	EIF4G1	Eukaryotic translation initiation factor 4 gamma 1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q04637	EIF4G1	Eukaryotic translation initiation factor 4 gamma 1	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q04637	EIF4G1	Eukaryotic translation initiation factor 4 gamma 1	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
Q04637	EIF4G1	Eukaryotic translation initiation factor 4 gamma 1	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
Q04637	EIF4G1	Eukaryotic translation initiation factor 4 gamma 1	GO:0006446; P:regulation of translational initiation; IMP:UniProtKB
Q04637	EIF4G1	Eukaryotic translation initiation factor 4 gamma 1	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q04637	EIF4G1	Eukaryotic translation initiation factor 4 gamma 1	GO:0006412; P:translation; TAS:Reactome
Q04637	EIF4G1	Eukaryotic translation initiation factor 4 gamma 1	GO:0006413; P:translational initiation; TAS:Reactome
Q04637	EIF4G1	Eukaryotic translation initiation factor 4 gamma 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
P78344	EIF4G2	Eukaryotic translation initiation factor 4 gamma 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P78344	EIF4G2	Eukaryotic translation initiation factor 4 gamma 2	GO:0005515; F:protein binding; IPI:IntAct
P78344	EIF4G2	Eukaryotic translation initiation factor 4 gamma 2	GO:0008135; F:translation factor activity, nucleic acid binding; IDA:UniProtKB
P78344	EIF4G2	Eukaryotic translation initiation factor 4 gamma 2	GO:0003743; F:translation initiation factor activity; IDA:UniProtKB
P78344	EIF4G2	Eukaryotic translation initiation factor 4 gamma 2	GO:0007050; P:cell cycle arrest; TAS:ProtInc
P78344	EIF4G2	Eukaryotic translation initiation factor 4 gamma 2	GO:0008219; P:cell death; TAS:ProtInc
P78344	EIF4G2	Eukaryotic translation initiation factor 4 gamma 2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P78344	EIF4G2	Eukaryotic translation initiation factor 4 gamma 2	GO:0006446; P:regulation of translational initiation; IDA:UniProtKB
O43432	EIF4G3	Eukaryotic translation initiation factor 4 gamma 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O43432	EIF4G3	Eukaryotic translation initiation factor 4 gamma 3	GO:0003723; F:RNA binding; IEA:InterPro
O43432	EIF4G3	Eukaryotic translation initiation factor 4 gamma 3	GO:0000339; F:RNA cap binding; TAS:ProtInc
O43432	EIF4G3	Eukaryotic translation initiation factor 4 gamma 3	GO:0008135; F:translation factor activity, nucleic acid binding; TAS:ProtInc
O43432	EIF4G3	Eukaryotic translation initiation factor 4 gamma 3	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW
O43432	EIF4G3	Eukaryotic translation initiation factor 4 gamma 3	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
O43432	EIF4G3	Eukaryotic translation initiation factor 4 gamma 3	GO:0060903; P:positive regulation of meiosis I; IEA:Ensembl
O43432	EIF4G3	Eukaryotic translation initiation factor 4 gamma 3	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
O43432	EIF4G3	Eukaryotic translation initiation factor 4 gamma 3	GO:0045727; P:positive regulation of translation; IEA:Ensembl
O43432	EIF4G3	Eukaryotic translation initiation factor 4 gamma 3	GO:0006446; P:regulation of translational initiation; TAS:ProtInc
O43432	EIF4G3	Eukaryotic translation initiation factor 4 gamma 3	GO:0007283; P:spermatogenesis; IEA:Ensembl
O43432	EIF4G3	Eukaryotic translation initiation factor 4 gamma 3	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q15056	EIF4H	Eukaryotic translation initiation factor 4H	GO:0000166; F:nucleotide binding; IEA:InterPro
Q15056	EIF4H	Eukaryotic translation initiation factor 4H	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15056	EIF4H	Eukaryotic translation initiation factor 4H	GO:0005515; F:protein binding; IPI:IntAct
Q15056	EIF4H	Eukaryotic translation initiation factor 4H	GO:0003723; F:RNA binding; TAS:ProtInc
Q15056	EIF4H	Eukaryotic translation initiation factor 4H	GO:0008135; F:translation factor activity, nucleic acid binding; TAS:ProtInc
Q15056	EIF4H	Eukaryotic translation initiation factor 4H	GO:0003743; F:translation initiation factor activity; TAS:ProtInc
Q15056	EIF4H	Eukaryotic translation initiation factor 4H	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q15056	EIF4H	Eukaryotic translation initiation factor 4H	GO:0048589; P:developmental growth; IEA:Ensembl
Q15056	EIF4H	Eukaryotic translation initiation factor 4H	GO:0010467; P:gene expression; TAS:Reactome
Q15056	EIF4H	Eukaryotic translation initiation factor 4H	GO:0006446; P:regulation of translational initiation; TAS:ProtInc
Q15056	EIF4H	Eukaryotic translation initiation factor 4H	GO:0019953; P:sexual reproduction; IEA:Ensembl
Q15056	EIF4H	Eukaryotic translation initiation factor 4H	GO:0006412; P:translation; TAS:Reactome
Q15056	EIF4H	Eukaryotic translation initiation factor 4H	GO:0006413; P:translational initiation; TAS:Reactome
Q15056	EIF4H	Eukaryotic translation initiation factor 4H	GO:0016032; P:viral process; IEA:UniProtKB-KW
P63241	EIF5A	Eukaryotic translation initiation factor 5A-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P63241	EIF5A	Eukaryotic translation initiation factor 5A-1	GO:0005515; F:protein binding; IPI:UniProtKB
P63241	EIF5A	Eukaryotic translation initiation factor 5A-1	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
P63241	EIF5A	Eukaryotic translation initiation factor 5A-1	GO:0043022; F:ribosome binding; IEA:InterPro
P63241	EIF5A	Eukaryotic translation initiation factor 5A-1	GO:0003723; F:RNA binding; IDA:UniProtKB
P63241	EIF5A	Eukaryotic translation initiation factor 5A-1	GO:0003746; F:translation elongation factor activity; ISS:UniProtKB
P63241	EIF5A	Eukaryotic translation initiation factor 5A-1	GO:0017070; F:U6 snRNA binding; IDA:UniProtKB
P63241	EIF5A	Eukaryotic translation initiation factor 5A-1	GO:0006915; P:apoptotic process; IDA:UniProtKB
P63241	EIF5A	Eukaryotic translation initiation factor 5A-1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P63241	EIF5A	Eukaryotic translation initiation factor 5A-1	GO:0006406; P:mRNA export from nucleus; IMP:UniProtKB
P63241	EIF5A	Eukaryotic translation initiation factor 5A-1	GO:0006913; P:nucleocytoplasmic transport; IMP:UniProtKB
P63241	EIF5A	Eukaryotic translation initiation factor 5A-1	GO:0008612; P:peptidyl-lysine modification to peptidyl-hypusine; TAS:Reactome
P63241	EIF5A	Eukaryotic translation initiation factor 5A-1	GO:0008284; P:positive regulation of cell proliferation; IGI:UniProtKB
P63241	EIF5A	Eukaryotic translation initiation factor 5A-1	GO:0045901; P:positive regulation of translational elongation; ISS:UniProtKB
P63241	EIF5A	Eukaryotic translation initiation factor 5A-1	GO:0045905; P:positive regulation of translational termination; IEA:InterPro
P63241	EIF5A	Eukaryotic translation initiation factor 5A-1	GO:0043687; P:post-translational protein modification; TAS:Reactome
P63241	EIF5A	Eukaryotic translation initiation factor 5A-1	GO:0006611; P:protein export from nucleus; IMP:UniProtKB
P63241	EIF5A	Eukaryotic translation initiation factor 5A-1	GO:0006452; P:translational frameshifting; IEA:InterPro
Q9GZV4	EIF5A2	Eukaryotic translation initiation factor 5A-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9GZV4	EIF5A2	Eukaryotic translation initiation factor 5A-2	GO:0043022; F:ribosome binding; IEA:InterPro
Q9GZV4	EIF5A2	Eukaryotic translation initiation factor 5A-2	GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-KW
Q9GZV4	EIF5A2	Eukaryotic translation initiation factor 5A-2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9GZV4	EIF5A2	Eukaryotic translation initiation factor 5A-2	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q9GZV4	EIF5A2	Eukaryotic translation initiation factor 5A-2	GO:0008612; P:peptidyl-lysine modification to peptidyl-hypusine; TAS:Reactome
Q9GZV4	EIF5A2	Eukaryotic translation initiation factor 5A-2	GO:0010509; P:polyamine homeostasis; NAS:UniProtKB
Q9GZV4	EIF5A2	Eukaryotic translation initiation factor 5A-2	GO:0008284; P:positive regulation of cell proliferation; IGI:UniProtKB
Q9GZV4	EIF5A2	Eukaryotic translation initiation factor 5A-2	GO:0045901; P:positive regulation of translational elongation; IEA:InterPro
Q9GZV4	EIF5A2	Eukaryotic translation initiation factor 5A-2	GO:0045905; P:positive regulation of translational termination; IEA:InterPro
Q9GZV4	EIF5A2	Eukaryotic translation initiation factor 5A-2	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9GZV4	EIF5A2	Eukaryotic translation initiation factor 5A-2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9GZV4	EIF5A2	Eukaryotic translation initiation factor 5A-2	GO:0007283; P:spermatogenesis; NAS:UniProtKB
Q9GZV4	EIF5A2	Eukaryotic translation initiation factor 5A-2	GO:0006452; P:translational frameshifting; IEA:InterPro
Q6IS14	EIF5AL1	Eukaryotic translation initiation factor 5A-1-like	GO:0043022; F:ribosome binding; IEA:InterPro
Q6IS14	EIF5AL1	Eukaryotic translation initiation factor 5A-1-like	GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-KW
Q6IS14	EIF5AL1	Eukaryotic translation initiation factor 5A-1-like	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q6IS14	EIF5AL1	Eukaryotic translation initiation factor 5A-1-like	GO:0008612; P:peptidyl-lysine modification to peptidyl-hypusine; IEA:InterPro
Q6IS14	EIF5AL1	Eukaryotic translation initiation factor 5A-1-like	GO:0045901; P:positive regulation of translational elongation; IEA:InterPro
Q6IS14	EIF5AL1	Eukaryotic translation initiation factor 5A-1-like	GO:0045905; P:positive regulation of translational termination; IEA:InterPro
Q6IS14	EIF5AL1	Eukaryotic translation initiation factor 5A-1-like	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q6IS14	EIF5AL1	Eukaryotic translation initiation factor 5A-1-like	GO:0006452; P:translational frameshifting; IEA:InterPro
P55010	EIF5	Eukaryotic translation initiation factor 5	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P55010	EIF5	Eukaryotic translation initiation factor 5	GO:0003924; F:GTPase activity; TAS:ProtInc
P55010	EIF5	Eukaryotic translation initiation factor 5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P55010	EIF5	Eukaryotic translation initiation factor 5	GO:0008135; F:translation factor activity, nucleic acid binding; TAS:ProtInc
P55010	EIF5	Eukaryotic translation initiation factor 5	GO:0003743; F:translation initiation factor activity; NAS:UniProtKB
P55010	EIF5	Eukaryotic translation initiation factor 5	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P55010	EIF5	Eukaryotic translation initiation factor 5	GO:0010467; P:gene expression; TAS:Reactome
P55010	EIF5	Eukaryotic translation initiation factor 5	GO:0006184; P:GTP catabolic process; TAS:GOC
P55010	EIF5	Eukaryotic translation initiation factor 5	GO:0006446; P:regulation of translational initiation; TAS:ProtInc
P55010	EIF5	Eukaryotic translation initiation factor 5	GO:0006412; P:translation; TAS:Reactome
P55010	EIF5	Eukaryotic translation initiation factor 5	GO:0006413; P:translational initiation; NAS:UniProtKB
P56537	EIF6	Eukaryotic translation initiation factor 6	GO:0005515; F:protein binding; IPI:IntAct
P56537	EIF6	Eukaryotic translation initiation factor 6	GO:0043023; F:ribosomal large subunit binding; IEA:UniProtKB-HAMAP
P56537	EIF6	Eukaryotic translation initiation factor 6	GO:0043022; F:ribosome binding; IDA:UniProtKB
P56537	EIF6	Eukaryotic translation initiation factor 6	GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-HAMAP
P56537	EIF6	Eukaryotic translation initiation factor 6	GO:0042256; P:mature ribosome assembly; IMP:UniProtKB
P56537	EIF6	Eukaryotic translation initiation factor 6	GO:0042273; P:ribosomal large subunit biogenesis; IEA:UniProtKB-HAMAP
P56537	EIF6	Eukaryotic translation initiation factor 6	GO:0000054; P:ribosomal subunit export from nucleus; IEA:UniProtKB-HAMAP
Q5TF58	IFFO2	Intermediate filament family orphan 2	GO:0005198; F:structural molecule activity; IEA:InterPro
P40305	IFI27	Interferon alpha-inducible protein 27, mitochondrial	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P40305	IFI27	Interferon alpha-inducible protein 27, mitochondrial	GO:0097190; P:apoptotic signaling pathway; IDA:UniProtKB
P40305	IFI27	Interferon alpha-inducible protein 27, mitochondrial	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P40305	IFI27	Interferon alpha-inducible protein 27, mitochondrial	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q8TCB0	IFI44	Interferon-induced protein 44	GO:0009615; P:response to virus; TAS:ProtInc
P09912	IFI6	Interferon alpha-inducible protein 6	GO:0005515; F:protein binding; IPI:HGNC
P09912	IFI6	Interferon alpha-inducible protein 6	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P09912	IFI6	Interferon alpha-inducible protein 6	GO:0006955; P:immune response; TAS:ProtInc
P09912	IFI6	Interferon alpha-inducible protein 6	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:HGNC
P09912	IFI6	Interferon alpha-inducible protein 6	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IMP:BHF-UCL
P09912	IFI6	Interferon alpha-inducible protein 6	GO:0051902; P:negative regulation of mitochondrial depolarization; IMP:HGNC
P09912	IFI6	Interferon alpha-inducible protein 6	GO:0001836; P:release of cytochrome c from mitochondria; IMP:HGNC
P09912	IFI6	Interferon alpha-inducible protein 6	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q9BYX4	IFIH1	Interferon-induced helicase C domain-containing protein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BYX4	IFIH1	Interferon-induced helicase C domain-containing protein 1	GO:0003677; F:DNA binding; IEA:InterPro
Q9BYX4	IFIH1	Interferon-induced helicase C domain-containing protein 1	GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB
Q9BYX4	IFIH1	Interferon-induced helicase C domain-containing protein 1	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q9BYX4	IFIH1	Interferon-induced helicase C domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BYX4	IFIH1	Interferon-induced helicase C domain-containing protein 1	GO:0043021; F:ribonucleoprotein complex binding; IPI:UniProtKB
Q9BYX4	IFIH1	Interferon-induced helicase C domain-containing protein 1	GO:0003727; F:single-stranded RNA binding; IDA:UniProtKB
Q9BYX4	IFIH1	Interferon-induced helicase C domain-containing protein 1	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q9BYX4	IFIH1	Interferon-induced helicase C domain-containing protein 1	GO:0039528; P:cytoplasmic pattern recognition receptor signaling pathway in response to virus; TAS:UniProtKB
Q9BYX4	IFIH1	Interferon-induced helicase C domain-containing protein 1	GO:0009597; P:detection of virus; TAS:BHF-UCL
Q9BYX4	IFIH1	Interferon-induced helicase C domain-containing protein 1	GO:0045087; P:innate immune response; TAS:UniProtKB
Q9BYX4	IFIH1	Interferon-induced helicase C domain-containing protein 1	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
Q9BYX4	IFIH1	Interferon-induced helicase C domain-containing protein 1	GO:0032727; P:positive regulation of interferon-alpha production; IMP:UniProtKB
Q9BYX4	IFIH1	Interferon-induced helicase C domain-containing protein 1	GO:0032728; P:positive regulation of interferon-beta production; IMP:UniProtKB
Q9BYX4	IFIH1	Interferon-induced helicase C domain-containing protein 1	GO:0016925; P:protein sumoylation; IDA:UniProtKB
Q9BYX4	IFIH1	Interferon-induced helicase C domain-containing protein 1	GO:0042981; P:regulation of apoptotic process; IEA:InterPro
Q9BYX4	IFIH1	Interferon-induced helicase C domain-containing protein 1	GO:0034344; P:regulation of type III interferon production; TAS:UniProtKB
Q9BYX4	IFIH1	Interferon-induced helicase C domain-containing protein 1	GO:0009615; P:response to virus; TAS:UniProtKB
Q9BYX4	IFIH1	Interferon-induced helicase C domain-containing protein 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
P09914	IFIT1	Interferon-induced protein with tetratricopeptide repeats 1	GO:0005515; F:protein binding; IPI:UniProtKB
P09914	IFIT1	Interferon-induced protein with tetratricopeptide repeats 1	GO:0003723; F:RNA binding; IDA:UniProtKB
P09914	IFIT1	Interferon-induced protein with tetratricopeptide repeats 1	GO:0071360; P:cellular response to exogenous dsRNA; IDA:BHF-UCL
P09914	IFIT1	Interferon-induced protein with tetratricopeptide repeats 1	GO:0071357; P:cellular response to type I interferon; IDA:BHF-UCL
P09914	IFIT1	Interferon-induced protein with tetratricopeptide repeats 1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P09914	IFIT1	Interferon-induced protein with tetratricopeptide repeats 1	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P09914	IFIT1	Interferon-induced protein with tetratricopeptide repeats 1	GO:0019060; P:intracellular transport of viral protein in host cell; IDA:BHF-UCL
P09914	IFIT1	Interferon-induced protein with tetratricopeptide repeats 1	GO:0050689; P:negative regulation of defense response to virus by host; IDA:BHF-UCL
P09914	IFIT1	Interferon-induced protein with tetratricopeptide repeats 1	GO:0051097; P:negative regulation of helicase activity; IDA:BHF-UCL
P09914	IFIT1	Interferon-induced protein with tetratricopeptide repeats 1	GO:0032091; P:negative regulation of protein binding; IDA:BHF-UCL
P09914	IFIT1	Interferon-induced protein with tetratricopeptide repeats 1	GO:0045071; P:negative regulation of viral genome replication; IMP:UniProtKB
P09914	IFIT1	Interferon-induced protein with tetratricopeptide repeats 1	GO:0045070; P:positive regulation of viral genome replication; IDA:BHF-UCL
P09914	IFIT1	Interferon-induced protein with tetratricopeptide repeats 1	GO:0009615; P:response to virus; IMP:UniProtKB
P09914	IFIT1	Interferon-induced protein with tetratricopeptide repeats 1	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P09913	IFIT2	Interferon-induced protein with tetratricopeptide repeats 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P09913	IFIT2	Interferon-induced protein with tetratricopeptide repeats 2	GO:0005515; F:protein binding; IPI:UniProtKB
P09913	IFIT2	Interferon-induced protein with tetratricopeptide repeats 2	GO:0008637; P:apoptotic mitochondrial changes; TAS:UniProtKB
P09913	IFIT2	Interferon-induced protein with tetratricopeptide repeats 2	GO:0035457; P:cellular response to interferon-alpha; IEA:Ensembl
P09913	IFIT2	Interferon-induced protein with tetratricopeptide repeats 2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P09913	IFIT2	Interferon-induced protein with tetratricopeptide repeats 2	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P09913	IFIT2	Interferon-induced protein with tetratricopeptide repeats 2	GO:0032091; P:negative regulation of protein binding; IDA:BHF-UCL
P09913	IFIT2	Interferon-induced protein with tetratricopeptide repeats 2	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P09913	IFIT2	Interferon-induced protein with tetratricopeptide repeats 2	GO:0009615; P:response to virus; IMP:UniProtKB
P09913	IFIT2	Interferon-induced protein with tetratricopeptide repeats 2	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
O14879	IFIT3	Interferon-induced protein with tetratricopeptide repeats 3	GO:0042802; F:identical protein binding; IPI:IntAct
O14879	IFIT3	Interferon-induced protein with tetratricopeptide repeats 3	GO:0005515; F:protein binding; IPI:UniProtKB
O14879	IFIT3	Interferon-induced protein with tetratricopeptide repeats 3	GO:0035457; P:cellular response to interferon-alpha; IEA:InterPro
O14879	IFIT3	Interferon-induced protein with tetratricopeptide repeats 3	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
O14879	IFIT3	Interferon-induced protein with tetratricopeptide repeats 3	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
O14879	IFIT3	Interferon-induced protein with tetratricopeptide repeats 3	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
O14879	IFIT3	Interferon-induced protein with tetratricopeptide repeats 3	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
O14879	IFIT3	Interferon-induced protein with tetratricopeptide repeats 3	GO:0009615; P:response to virus; IMP:UniProtKB
O14879	IFIT3	Interferon-induced protein with tetratricopeptide repeats 3	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q13325	IFIT5	Interferon-induced protein with tetratricopeptide repeats 5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13325	IFIT5	Interferon-induced protein with tetratricopeptide repeats 5	GO:0003723; F:RNA binding; IDA:UniProtKB
Q13325	IFIT5	Interferon-induced protein with tetratricopeptide repeats 5	GO:0003727; F:single-stranded RNA binding; IDA:UniProtKB
Q13325	IFIT5	Interferon-induced protein with tetratricopeptide repeats 5	GO:0000049; F:tRNA binding; IDA:UniProtKB
Q13325	IFIT5	Interferon-induced protein with tetratricopeptide repeats 5	GO:0051607; P:defense response to virus; IMP:UniProtKB
Q13325	IFIT5	Interferon-induced protein with tetratricopeptide repeats 5	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q6K0P9	PYHIN1	Pyrin and HIN domain-containing protein 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
A6NMD0	IFITM10	Interferon-induced transmembrane protein 10	GO:0009607; P:response to biotic stimulus; IEA:InterPro
P13164	IFITM1	Interferon-induced transmembrane protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P13164	IFITM1	Interferon-induced transmembrane protein 1	GO:0005057; F:receptor signaling protein activity; TAS:ProtInc
P13164	IFITM1	Interferon-induced transmembrane protein 1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P13164	IFITM1	Interferon-induced transmembrane protein 1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P13164	IFITM1	Interferon-induced transmembrane protein 1	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P13164	IFITM1	Interferon-induced transmembrane protein 1	GO:0035556; P:intracellular signal transduction; TAS:GOC
P13164	IFITM1	Interferon-induced transmembrane protein 1	GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB
P13164	IFITM1	Interferon-induced transmembrane protein 1	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
P13164	IFITM1	Interferon-induced transmembrane protein 1	GO:0046597; P:negative regulation of viral entry into host cell; IDA:UniProtKB
P13164	IFITM1	Interferon-induced transmembrane protein 1	GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB
P13164	IFITM1	Interferon-induced transmembrane protein 1	GO:0001503; P:ossification; IEA:UniProtKB-KW
P13164	IFITM1	Interferon-induced transmembrane protein 1	GO:0045669; P:positive regulation of osteoblast differentiation; IMP:UniProtKB
P13164	IFITM1	Interferon-induced transmembrane protein 1	GO:0050776; P:regulation of immune response; TAS:Reactome
P13164	IFITM1	Interferon-induced transmembrane protein 1	GO:0035455; P:response to interferon-alpha; IDA:UniProtKB
P13164	IFITM1	Interferon-induced transmembrane protein 1	GO:0035456; P:response to interferon-beta; IDA:UniProtKB
P13164	IFITM1	Interferon-induced transmembrane protein 1	GO:0034341; P:response to interferon-gamma; IDA:UniProtKB
P13164	IFITM1	Interferon-induced transmembrane protein 1	GO:0009615; P:response to virus; IDA:UniProtKB
P13164	IFITM1	Interferon-induced transmembrane protein 1	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q01628	IFITM3	Interferon-induced transmembrane protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q01628	IFITM3	Interferon-induced transmembrane protein 3	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q01628	IFITM3	Interferon-induced transmembrane protein 3	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q01628	IFITM3	Interferon-induced transmembrane protein 3	GO:0006955; P:immune response; TAS:ProtInc
Q01628	IFITM3	Interferon-induced transmembrane protein 3	GO:0046597; P:negative regulation of viral entry into host cell; IDA:UniProtKB
Q01628	IFITM3	Interferon-induced transmembrane protein 3	GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB
Q01628	IFITM3	Interferon-induced transmembrane protein 3	GO:0032897; P:negative regulation of viral transcription; IDA:UniProtKB
Q01628	IFITM3	Interferon-induced transmembrane protein 3	GO:0035455; P:response to interferon-alpha; IDA:UniProtKB
Q01628	IFITM3	Interferon-induced transmembrane protein 3	GO:0035456; P:response to interferon-beta; IDA:UniProtKB
Q01628	IFITM3	Interferon-induced transmembrane protein 3	GO:0034341; P:response to interferon-gamma; IDA:UniProtKB
Q01628	IFITM3	Interferon-induced transmembrane protein 3	GO:0009615; P:response to virus; IDA:UniProtKB
Q01628	IFITM3	Interferon-induced transmembrane protein 3	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q01629	IFITM2	Interferon-induced transmembrane protein 2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q01629	IFITM2	Interferon-induced transmembrane protein 2	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q01629	IFITM2	Interferon-induced transmembrane protein 2	GO:0006955; P:immune response; TAS:ProtInc
Q01629	IFITM2	Interferon-induced transmembrane protein 2	GO:0046597; P:negative regulation of viral entry into host cell; IDA:UniProtKB
Q01629	IFITM2	Interferon-induced transmembrane protein 2	GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB
Q01629	IFITM2	Interferon-induced transmembrane protein 2	GO:0035455; P:response to interferon-alpha; IDA:UniProtKB
Q01629	IFITM2	Interferon-induced transmembrane protein 2	GO:0035456; P:response to interferon-beta; IDA:UniProtKB
Q01629	IFITM2	Interferon-induced transmembrane protein 2	GO:0034341; P:response to interferon-gamma; IDA:UniProtKB
Q01629	IFITM2	Interferon-induced transmembrane protein 2	GO:0009615; P:response to virus; IDA:UniProtKB
Q01629	IFITM2	Interferon-induced transmembrane protein 2	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
A6NNB3	IFITM5	Interferon-induced transmembrane protein 5	GO:0030282; P:bone mineralization; IEA:Ensembl
A6NNB3	IFITM5	Interferon-induced transmembrane protein 5	GO:0030500; P:regulation of bone mineralization; IEA:UniProtKB-KW
A6NNB3	IFITM5	Interferon-induced transmembrane protein 5	GO:0009607; P:response to biotic stimulus; IEA:InterPro
P05015	IFNA16	Interferon alpha-16	GO:0005125; F:cytokine activity; IBA:RefGenome
P05015	IFNA16	Interferon alpha-16	GO:0005132; F:type I interferon receptor binding; IBA:RefGenome
P05015	IFNA16	Interferon alpha-16	GO:0002250; P:adaptive immune response; IBA:RefGenome
P05015	IFNA16	Interferon alpha-16	GO:0030183; P:B cell differentiation; IBA:RefGenome
P05015	IFNA16	Interferon alpha-16	GO:0042100; P:B cell proliferation; IBA:RefGenome
P05015	IFNA16	Interferon alpha-16	GO:0007596; P:blood coagulation; TAS:Reactome
P05015	IFNA16	Interferon alpha-16	GO:0019221; P:cytokine-mediated signaling pathway; IBA:RefGenome
P05015	IFNA16	Interferon alpha-16	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P05015	IFNA16	Interferon alpha-16	GO:0006959; P:humoral immune response; IBA:RefGenome
P05015	IFNA16	Interferon alpha-16	GO:0045087; P:innate immune response; IBA:RefGenome
P05015	IFNA16	Interferon alpha-16	GO:0002323; P:natural killer cell activation involved in immune response; IBA:RefGenome
P05015	IFNA16	Interferon alpha-16	GO:0033141; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; IBA:RefGenome
P05015	IFNA16	Interferon alpha-16	GO:0045343; P:regulation of MHC class I biosynthetic process; IBA:RefGenome
P05015	IFNA16	Interferon alpha-16	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P05015	IFNA16	Interferon alpha-16	GO:0043330; P:response to exogenous dsRNA; IBA:RefGenome
P05015	IFNA16	Interferon alpha-16	GO:0002286; P:T cell activation involved in immune response; IBA:RefGenome
P05015	IFNA16	Interferon alpha-16	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P01566	IFNA10	Interferon alpha-10	GO:0005125; F:cytokine activity; IBA:RefGenome
P01566	IFNA10	Interferon alpha-10	GO:0005132; F:type I interferon receptor binding; IBA:RefGenome
P01566	IFNA10	Interferon alpha-10	GO:0002250; P:adaptive immune response; IBA:RefGenome
P01566	IFNA10	Interferon alpha-10	GO:0030183; P:B cell differentiation; IBA:RefGenome
P01566	IFNA10	Interferon alpha-10	GO:0042100; P:B cell proliferation; IBA:RefGenome
P01566	IFNA10	Interferon alpha-10	GO:0007596; P:blood coagulation; TAS:Reactome
P01566	IFNA10	Interferon alpha-10	GO:0019221; P:cytokine-mediated signaling pathway; IBA:RefGenome
P01566	IFNA10	Interferon alpha-10	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P01566	IFNA10	Interferon alpha-10	GO:0006959; P:humoral immune response; IBA:RefGenome
P01566	IFNA10	Interferon alpha-10	GO:0045087; P:innate immune response; IBA:RefGenome
P01566	IFNA10	Interferon alpha-10	GO:0002323; P:natural killer cell activation involved in immune response; IBA:RefGenome
P01566	IFNA10	Interferon alpha-10	GO:0033141; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; IBA:RefGenome
P01566	IFNA10	Interferon alpha-10	GO:0045343; P:regulation of MHC class I biosynthetic process; IBA:RefGenome
P01566	IFNA10	Interferon alpha-10	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P01566	IFNA10	Interferon alpha-10	GO:0043330; P:response to exogenous dsRNA; IBA:RefGenome
P01566	IFNA10	Interferon alpha-10	GO:0002286; P:T cell activation involved in immune response; IBA:RefGenome
P01566	IFNA10	Interferon alpha-10	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P01570	IFNA14	Interferon alpha-14	GO:0005125; F:cytokine activity; IBA:RefGenome
P01570	IFNA14	Interferon alpha-14	GO:0005126; F:cytokine receptor binding; TAS:ProtInc
P01570	IFNA14	Interferon alpha-14	GO:0005132; F:type I interferon receptor binding; IBA:RefGenome
P01570	IFNA14	Interferon alpha-14	GO:0002250; P:adaptive immune response; IBA:RefGenome
P01570	IFNA14	Interferon alpha-14	GO:0030183; P:B cell differentiation; IBA:RefGenome
P01570	IFNA14	Interferon alpha-14	GO:0042100; P:B cell proliferation; IBA:RefGenome
P01570	IFNA14	Interferon alpha-14	GO:0007596; P:blood coagulation; TAS:Reactome
P01570	IFNA14	Interferon alpha-14	GO:0019221; P:cytokine-mediated signaling pathway; IBA:RefGenome
P01570	IFNA14	Interferon alpha-14	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P01570	IFNA14	Interferon alpha-14	GO:0006959; P:humoral immune response; IBA:RefGenome
P01570	IFNA14	Interferon alpha-14	GO:0045087; P:innate immune response; IBA:RefGenome
P01570	IFNA14	Interferon alpha-14	GO:0002323; P:natural killer cell activation involved in immune response; IBA:RefGenome
P01570	IFNA14	Interferon alpha-14	GO:0033141; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; IBA:RefGenome
P01570	IFNA14	Interferon alpha-14	GO:0045343; P:regulation of MHC class I biosynthetic process; IBA:RefGenome
P01570	IFNA14	Interferon alpha-14	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P01570	IFNA14	Interferon alpha-14	GO:0043330; P:response to exogenous dsRNA; IBA:RefGenome
P01570	IFNA14	Interferon alpha-14	GO:0002286; P:T cell activation involved in immune response; IBA:RefGenome
P01570	IFNA14	Interferon alpha-14	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P01571	IFNA17	Interferon alpha-17	GO:0005125; F:cytokine activity; IBA:RefGenome
P01571	IFNA17	Interferon alpha-17	GO:0005132; F:type I interferon receptor binding; IBA:RefGenome
P01571	IFNA17	Interferon alpha-17	GO:0002250; P:adaptive immune response; IBA:RefGenome
P01571	IFNA17	Interferon alpha-17	GO:0030183; P:B cell differentiation; IBA:RefGenome
P01571	IFNA17	Interferon alpha-17	GO:0042100; P:B cell proliferation; IBA:RefGenome
P01571	IFNA17	Interferon alpha-17	GO:0007596; P:blood coagulation; TAS:Reactome
P01571	IFNA17	Interferon alpha-17	GO:0019221; P:cytokine-mediated signaling pathway; IBA:RefGenome
P01571	IFNA17	Interferon alpha-17	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P01571	IFNA17	Interferon alpha-17	GO:0006959; P:humoral immune response; IBA:RefGenome
P01571	IFNA17	Interferon alpha-17	GO:0045087; P:innate immune response; IBA:RefGenome
P01571	IFNA17	Interferon alpha-17	GO:0002323; P:natural killer cell activation involved in immune response; IBA:RefGenome
P01571	IFNA17	Interferon alpha-17	GO:0033141; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; IBA:RefGenome
P01571	IFNA17	Interferon alpha-17	GO:0045343; P:regulation of MHC class I biosynthetic process; IBA:RefGenome
P01571	IFNA17	Interferon alpha-17	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P01571	IFNA17	Interferon alpha-17	GO:0043330; P:response to exogenous dsRNA; IBA:RefGenome
P01571	IFNA17	Interferon alpha-17	GO:0009615; P:response to virus; TAS:ProtInc
P01571	IFNA17	Interferon alpha-17	GO:0002286; P:T cell activation involved in immune response; IBA:RefGenome
P01571	IFNA17	Interferon alpha-17	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P01568	IFNA21	Interferon alpha-21	GO:0005125; F:cytokine activity; IBA:RefGenome
P01568	IFNA21	Interferon alpha-21	GO:0005126; F:cytokine receptor binding; TAS:ProtInc
P01568	IFNA21	Interferon alpha-21	GO:0005132; F:type I interferon receptor binding; IBA:RefGenome
P01568	IFNA21	Interferon alpha-21	GO:0002250; P:adaptive immune response; IBA:RefGenome
P01568	IFNA21	Interferon alpha-21	GO:0030183; P:B cell differentiation; IBA:RefGenome
P01568	IFNA21	Interferon alpha-21	GO:0042100; P:B cell proliferation; IBA:RefGenome
P01568	IFNA21	Interferon alpha-21	GO:0007596; P:blood coagulation; TAS:Reactome
P01568	IFNA21	Interferon alpha-21	GO:0019221; P:cytokine-mediated signaling pathway; IBA:RefGenome
P01568	IFNA21	Interferon alpha-21	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P01568	IFNA21	Interferon alpha-21	GO:0006959; P:humoral immune response; IBA:RefGenome
P01568	IFNA21	Interferon alpha-21	GO:0045087; P:innate immune response; IBA:RefGenome
P01568	IFNA21	Interferon alpha-21	GO:0002323; P:natural killer cell activation involved in immune response; IBA:RefGenome
P01568	IFNA21	Interferon alpha-21	GO:0033141; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; IBA:RefGenome
P01568	IFNA21	Interferon alpha-21	GO:0045343; P:regulation of MHC class I biosynthetic process; IBA:RefGenome
P01568	IFNA21	Interferon alpha-21	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P01568	IFNA21	Interferon alpha-21	GO:0043330; P:response to exogenous dsRNA; IBA:RefGenome
P01568	IFNA21	Interferon alpha-21	GO:0002286; P:T cell activation involved in immune response; IBA:RefGenome
P01568	IFNA21	Interferon alpha-21	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P01562	IFNA1	Interferon alpha-1/13	GO:0005125; F:cytokine activity; IBA:RefGenome
P01562	IFNA1	Interferon alpha-1/13	GO:0005132; F:type I interferon receptor binding; IBA:RefGenome
P01562	IFNA1	Interferon alpha-1/13	GO:0002250; P:adaptive immune response; IBA:RefGenome
P01562	IFNA1	Interferon alpha-1/13	GO:0030183; P:B cell differentiation; IBA:RefGenome
P01562	IFNA1	Interferon alpha-1/13	GO:0042100; P:B cell proliferation; IBA:RefGenome
P01562	IFNA1	Interferon alpha-1/13	GO:0007596; P:blood coagulation; TAS:Reactome
P01562	IFNA1	Interferon alpha-1/13	GO:0019221; P:cytokine-mediated signaling pathway; IBA:RefGenome
P01562	IFNA1	Interferon alpha-1/13	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P01562	IFNA1	Interferon alpha-1/13	GO:0006959; P:humoral immune response; IBA:RefGenome
P01562	IFNA1	Interferon alpha-1/13	GO:0045087; P:innate immune response; IBA:RefGenome
P01562	IFNA1	Interferon alpha-1/13	GO:0002323; P:natural killer cell activation involved in immune response; IBA:RefGenome
P01562	IFNA1	Interferon alpha-1/13	GO:0033141; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; IBA:RefGenome
P01562	IFNA1	Interferon alpha-1/13	GO:0045343; P:regulation of MHC class I biosynthetic process; IBA:RefGenome
P01562	IFNA1	Interferon alpha-1/13	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P01562	IFNA1	Interferon alpha-1/13	GO:0043330; P:response to exogenous dsRNA; IBA:RefGenome
P01562	IFNA1	Interferon alpha-1/13	GO:0002286; P:T cell activation involved in immune response; IBA:RefGenome
P01562	IFNA1	Interferon alpha-1/13	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P01563	IFNA2	Interferon alpha-2	GO:0005515; F:protein binding; IPI:UniProtKB
P01563	IFNA2	Interferon alpha-2	GO:0005132; F:type I interferon receptor binding; TAS:ProtInc
P01563	IFNA2	Interferon alpha-2	GO:0006915; P:apoptotic process; TAS:ProtInc
P01563	IFNA2	Interferon alpha-2	GO:0007596; P:blood coagulation; TAS:Reactome
P01563	IFNA2	Interferon alpha-2	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P01563	IFNA2	Interferon alpha-2	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P01563	IFNA2	Interferon alpha-2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P01563	IFNA2	Interferon alpha-2	GO:0051607; P:defense response to virus; IDA:BHF-UCL
P01563	IFNA2	Interferon alpha-2	GO:0006954; P:inflammatory response; TAS:ProtInc
P01563	IFNA2	Interferon alpha-2	GO:0045087; P:innate immune response; TAS:Reactome
P01563	IFNA2	Interferon alpha-2	GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB
P01563	IFNA2	Interferon alpha-2	GO:2000666; P:negative regulation of interleukin-13 secretion; IDA:UniProtKB
P01563	IFNA2	Interferon alpha-2	GO:2000663; P:negative regulation of interleukin-5 secretion; IDA:UniProtKB
P01563	IFNA2	Interferon alpha-2	GO:0045581; P:negative regulation of T cell differentiation; IDA:UniProtKB
P01563	IFNA2	Interferon alpha-2	GO:2000552; P:negative regulation of T-helper 2 cell cytokine production; IDA:UniProtKB
P01563	IFNA2	Interferon alpha-2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P01563	IFNA2	Interferon alpha-2	GO:0046597; P:negative regulation of viral entry into host cell; IDA:BHF-UCL
P01563	IFNA2	Interferon alpha-2	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IDA:BHF-UCL
P01563	IFNA2	Interferon alpha-2	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P01563	IFNA2	Interferon alpha-2	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P05014	IFNA4	Interferon alpha-4	GO:0005125; F:cytokine activity; IBA:RefGenome
P05014	IFNA4	Interferon alpha-4	GO:0005132; F:type I interferon receptor binding; IBA:RefGenome
P05014	IFNA4	Interferon alpha-4	GO:0002250; P:adaptive immune response; IBA:RefGenome
P05014	IFNA4	Interferon alpha-4	GO:0030183; P:B cell differentiation; IBA:RefGenome
P05014	IFNA4	Interferon alpha-4	GO:0042100; P:B cell proliferation; IBA:RefGenome
P05014	IFNA4	Interferon alpha-4	GO:0007596; P:blood coagulation; TAS:Reactome
P05014	IFNA4	Interferon alpha-4	GO:0019221; P:cytokine-mediated signaling pathway; IBA:RefGenome
P05014	IFNA4	Interferon alpha-4	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P05014	IFNA4	Interferon alpha-4	GO:0006959; P:humoral immune response; IBA:RefGenome
P05014	IFNA4	Interferon alpha-4	GO:0045087; P:innate immune response; IBA:RefGenome
P05014	IFNA4	Interferon alpha-4	GO:0002323; P:natural killer cell activation involved in immune response; IBA:RefGenome
P05014	IFNA4	Interferon alpha-4	GO:0033141; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; IBA:RefGenome
P05014	IFNA4	Interferon alpha-4	GO:0045343; P:regulation of MHC class I biosynthetic process; IBA:RefGenome
P05014	IFNA4	Interferon alpha-4	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P05014	IFNA4	Interferon alpha-4	GO:0043330; P:response to exogenous dsRNA; IBA:RefGenome
P05014	IFNA4	Interferon alpha-4	GO:0009615; P:response to virus; TAS:ProtInc
P05014	IFNA4	Interferon alpha-4	GO:0002286; P:T cell activation involved in immune response; IBA:RefGenome
P05014	IFNA4	Interferon alpha-4	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P01569	IFNA5	Interferon alpha-5	GO:0005125; F:cytokine activity; IBA:RefGenome
P01569	IFNA5	Interferon alpha-5	GO:0005126; F:cytokine receptor binding; TAS:ProtInc
P01569	IFNA5	Interferon alpha-5	GO:0005132; F:type I interferon receptor binding; IBA:RefGenome
P01569	IFNA5	Interferon alpha-5	GO:0002250; P:adaptive immune response; IBA:RefGenome
P01569	IFNA5	Interferon alpha-5	GO:0030183; P:B cell differentiation; IBA:RefGenome
P01569	IFNA5	Interferon alpha-5	GO:0042100; P:B cell proliferation; IBA:RefGenome
P01569	IFNA5	Interferon alpha-5	GO:0007596; P:blood coagulation; TAS:Reactome
P01569	IFNA5	Interferon alpha-5	GO:0019221; P:cytokine-mediated signaling pathway; IBA:RefGenome
P01569	IFNA5	Interferon alpha-5	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P01569	IFNA5	Interferon alpha-5	GO:0006959; P:humoral immune response; IBA:RefGenome
P01569	IFNA5	Interferon alpha-5	GO:0045087; P:innate immune response; IBA:RefGenome
P01569	IFNA5	Interferon alpha-5	GO:0002323; P:natural killer cell activation involved in immune response; IBA:RefGenome
P01569	IFNA5	Interferon alpha-5	GO:0033141; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; IBA:RefGenome
P01569	IFNA5	Interferon alpha-5	GO:0045343; P:regulation of MHC class I biosynthetic process; IBA:RefGenome
P01569	IFNA5	Interferon alpha-5	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P01569	IFNA5	Interferon alpha-5	GO:0043330; P:response to exogenous dsRNA; IBA:RefGenome
P01569	IFNA5	Interferon alpha-5	GO:0002286; P:T cell activation involved in immune response; IBA:RefGenome
P01569	IFNA5	Interferon alpha-5	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P05013	IFNA6	Interferon alpha-6	GO:0005125; F:cytokine activity; IBA:RefGenome
P05013	IFNA6	Interferon alpha-6	GO:0005132; F:type I interferon receptor binding; IBA:RefGenome
P05013	IFNA6	Interferon alpha-6	GO:0002250; P:adaptive immune response; IBA:RefGenome
P05013	IFNA6	Interferon alpha-6	GO:0030183; P:B cell differentiation; IBA:RefGenome
P05013	IFNA6	Interferon alpha-6	GO:0042100; P:B cell proliferation; IBA:RefGenome
P05013	IFNA6	Interferon alpha-6	GO:0007596; P:blood coagulation; TAS:Reactome
P05013	IFNA6	Interferon alpha-6	GO:0019221; P:cytokine-mediated signaling pathway; IBA:RefGenome
P05013	IFNA6	Interferon alpha-6	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P05013	IFNA6	Interferon alpha-6	GO:0006959; P:humoral immune response; IBA:RefGenome
P05013	IFNA6	Interferon alpha-6	GO:0045087; P:innate immune response; IBA:RefGenome
P05013	IFNA6	Interferon alpha-6	GO:0002323; P:natural killer cell activation involved in immune response; IBA:RefGenome
P05013	IFNA6	Interferon alpha-6	GO:0033141; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; IBA:RefGenome
P05013	IFNA6	Interferon alpha-6	GO:0045343; P:regulation of MHC class I biosynthetic process; IBA:RefGenome
P05013	IFNA6	Interferon alpha-6	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P05013	IFNA6	Interferon alpha-6	GO:0043330; P:response to exogenous dsRNA; IBA:RefGenome
P05013	IFNA6	Interferon alpha-6	GO:0002286; P:T cell activation involved in immune response; IBA:RefGenome
P05013	IFNA6	Interferon alpha-6	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P01567	IFNA7	Interferon alpha-7	GO:0005125; F:cytokine activity; IBA:RefGenome
P01567	IFNA7	Interferon alpha-7	GO:0005132; F:type I interferon receptor binding; IBA:RefGenome
P01567	IFNA7	Interferon alpha-7	GO:0002250; P:adaptive immune response; IBA:RefGenome
P01567	IFNA7	Interferon alpha-7	GO:0030183; P:B cell differentiation; IBA:RefGenome
P01567	IFNA7	Interferon alpha-7	GO:0042100; P:B cell proliferation; IBA:RefGenome
P01567	IFNA7	Interferon alpha-7	GO:0007596; P:blood coagulation; TAS:Reactome
P01567	IFNA7	Interferon alpha-7	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P01567	IFNA7	Interferon alpha-7	GO:0019221; P:cytokine-mediated signaling pathway; IBA:RefGenome
P01567	IFNA7	Interferon alpha-7	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P01567	IFNA7	Interferon alpha-7	GO:0006959; P:humoral immune response; IBA:RefGenome
P01567	IFNA7	Interferon alpha-7	GO:0045087; P:innate immune response; IBA:RefGenome
P01567	IFNA7	Interferon alpha-7	GO:0002323; P:natural killer cell activation involved in immune response; IBA:RefGenome
P01567	IFNA7	Interferon alpha-7	GO:0033141; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; IBA:RefGenome
P01567	IFNA7	Interferon alpha-7	GO:0045343; P:regulation of MHC class I biosynthetic process; IBA:RefGenome
P01567	IFNA7	Interferon alpha-7	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P01567	IFNA7	Interferon alpha-7	GO:0043330; P:response to exogenous dsRNA; IBA:RefGenome
P01567	IFNA7	Interferon alpha-7	GO:0009615; P:response to virus; TAS:ProtInc
P01567	IFNA7	Interferon alpha-7	GO:0002286; P:T cell activation involved in immune response; IBA:RefGenome
P01567	IFNA7	Interferon alpha-7	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P32881	IFNA8	Interferon alpha-8	GO:0005125; F:cytokine activity; IBA:RefGenome
P32881	IFNA8	Interferon alpha-8	GO:0005126; F:cytokine receptor binding; TAS:ProtInc
P32881	IFNA8	Interferon alpha-8	GO:0005132; F:type I interferon receptor binding; IBA:RefGenome
P32881	IFNA8	Interferon alpha-8	GO:0002250; P:adaptive immune response; IBA:RefGenome
P32881	IFNA8	Interferon alpha-8	GO:0030183; P:B cell differentiation; IBA:RefGenome
P32881	IFNA8	Interferon alpha-8	GO:0042100; P:B cell proliferation; IBA:RefGenome
P32881	IFNA8	Interferon alpha-8	GO:0007596; P:blood coagulation; TAS:Reactome
P32881	IFNA8	Interferon alpha-8	GO:0019221; P:cytokine-mediated signaling pathway; IBA:RefGenome
P32881	IFNA8	Interferon alpha-8	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P32881	IFNA8	Interferon alpha-8	GO:0006959; P:humoral immune response; IBA:RefGenome
P32881	IFNA8	Interferon alpha-8	GO:0045087; P:innate immune response; IBA:RefGenome
P32881	IFNA8	Interferon alpha-8	GO:0002323; P:natural killer cell activation involved in immune response; IBA:RefGenome
P32881	IFNA8	Interferon alpha-8	GO:0033141; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; IBA:RefGenome
P32881	IFNA8	Interferon alpha-8	GO:0045343; P:regulation of MHC class I biosynthetic process; IBA:RefGenome
P32881	IFNA8	Interferon alpha-8	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P32881	IFNA8	Interferon alpha-8	GO:0043330; P:response to exogenous dsRNA; IBA:RefGenome
P32881	IFNA8	Interferon alpha-8	GO:0002286; P:T cell activation involved in immune response; IBA:RefGenome
P32881	IFNA8	Interferon alpha-8	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P01574	IFNB1	Interferon beta	GO:0005125; F:cytokine activity; IDA:BHF-UCL
P01574	IFNB1	Interferon beta	GO:0005132; F:type I interferon receptor binding; NAS:UniProtKB
P01574	IFNB1	Interferon beta	GO:0002250; P:adaptive immune response; IEA:Ensembl
P01574	IFNB1	Interferon beta	GO:0002312; P:B cell activation involved in immune response; IMP:UniProtKB
P01574	IFNB1	Interferon beta	GO:0030183; P:B cell differentiation; IBA:RefGenome
P01574	IFNB1	Interferon beta	GO:0042100; P:B cell proliferation; NAS:UniProtKB
P01574	IFNB1	Interferon beta	GO:0007596; P:blood coagulation; TAS:Reactome
P01574	IFNB1	Interferon beta	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P01574	IFNB1	Interferon beta	GO:0071360; P:cellular response to exogenous dsRNA; TAS:BHF-UCL
P01574	IFNB1	Interferon beta	GO:0019221; P:cytokine-mediated signaling pathway; IBA:RefGenome
P01574	IFNB1	Interferon beta	GO:0042742; P:defense response to bacterium; IEA:Ensembl
P01574	IFNB1	Interferon beta	GO:0051607; P:defense response to virus; TAS:BHF-UCL
P01574	IFNB1	Interferon beta	GO:0006959; P:humoral immune response; IBA:RefGenome
P01574	IFNB1	Interferon beta	GO:0045087; P:innate immune response; TAS:Reactome
P01574	IFNB1	Interferon beta	GO:0030101; P:natural killer cell activation; NAS:UniProtKB
P01574	IFNB1	Interferon beta	GO:0002323; P:natural killer cell activation involved in immune response; IBA:RefGenome
P01574	IFNB1	Interferon beta	GO:0045581; P:negative regulation of T cell differentiation; IDA:UniProtKB
P01574	IFNB1	Interferon beta	GO:2000552; P:negative regulation of T-helper 2 cell cytokine production; IDA:UniProtKB
P01574	IFNB1	Interferon beta	GO:0045071; P:negative regulation of viral genome replication; IDA:BHF-UCL
P01574	IFNB1	Interferon beta	GO:2001235; P:positive regulation of apoptotic signaling pathway; IDA:UniProtKB
P01574	IFNB1	Interferon beta	GO:0045089; P:positive regulation of innate immune response; NAS:UniProtKB
P01574	IFNB1	Interferon beta	GO:0033141; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; IDA:BHF-UCL
P01574	IFNB1	Interferon beta	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P01574	IFNB1	Interferon beta	GO:0045343; P:regulation of MHC class I biosynthetic process; NAS:UniProtKB
P01574	IFNB1	Interferon beta	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P01574	IFNB1	Interferon beta	GO:0043330; P:response to exogenous dsRNA; IDA:MGI
P01574	IFNB1	Interferon beta	GO:0009615; P:response to virus; NAS:UniProtKB
P01574	IFNB1	Interferon beta	GO:0002286; P:T cell activation involved in immune response; IBA:RefGenome
P01574	IFNB1	Interferon beta	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q86WN2	IFNE	Interferon epsilon	GO:0005125; F:cytokine activity; IBA:RefGenome
Q86WN2	IFNE	Interferon epsilon	GO:0005132; F:type I interferon receptor binding; IBA:RefGenome
Q86WN2	IFNE	Interferon epsilon	GO:0002250; P:adaptive immune response; IBA:RefGenome
Q86WN2	IFNE	Interferon epsilon	GO:0030183; P:B cell differentiation; IBA:RefGenome
Q86WN2	IFNE	Interferon epsilon	GO:0042100; P:B cell proliferation; IBA:RefGenome
Q86WN2	IFNE	Interferon epsilon	GO:0019221; P:cytokine-mediated signaling pathway; IBA:RefGenome
Q86WN2	IFNE	Interferon epsilon	GO:0042742; P:defense response to bacterium; ISS:UniProtKB
Q86WN2	IFNE	Interferon epsilon	GO:0051607; P:defense response to virus; ISS:UniProtKB
Q86WN2	IFNE	Interferon epsilon	GO:0006959; P:humoral immune response; IBA:RefGenome
Q86WN2	IFNE	Interferon epsilon	GO:0045087; P:innate immune response; IBA:RefGenome
Q86WN2	IFNE	Interferon epsilon	GO:0002323; P:natural killer cell activation involved in immune response; IBA:RefGenome
Q86WN2	IFNE	Interferon epsilon	GO:0033141; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; IBA:RefGenome
Q86WN2	IFNE	Interferon epsilon	GO:0045343; P:regulation of MHC class I biosynthetic process; IBA:RefGenome
Q86WN2	IFNE	Interferon epsilon	GO:0043330; P:response to exogenous dsRNA; IBA:RefGenome
Q86WN2	IFNE	Interferon epsilon	GO:0002286; P:T cell activation involved in immune response; IBA:RefGenome
P01579	IFNG	Interferon gamma	GO:0005125; F:cytokine activity; IBA:RefGenome
P01579	IFNG	Interferon gamma	GO:0005133; F:interferon-gamma receptor binding; TAS:ProtInc
P01579	IFNG	Interferon gamma	GO:0002250; P:adaptive immune response; IBA:RefGenome
P01579	IFNG	Interferon gamma	GO:0019882; P:antigen processing and presentation; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0006915; P:apoptotic process; IGI:MGI
P01579	IFNG	Interferon gamma	GO:0002302; P:CD8-positive, alpha-beta T cell differentiation involved in immune response; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0007050; P:cell cycle arrest; IDA:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P01579	IFNG	Interferon gamma	GO:0006928; P:cellular component movement; TAS:ProtInc
P01579	IFNG	Interferon gamma	GO:0071351; P:cellular response to interleukin-18; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P01579	IFNG	Interferon gamma	GO:0042742; P:defense response to bacterium; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0042832; P:defense response to protozoan; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P01579	IFNG	Interferon gamma	GO:0030968; P:endoplasmic reticulum unfolded protein response; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0006959; P:humoral immune response; IBA:RefGenome
P01579	IFNG	Interferon gamma	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P01579	IFNG	Interferon gamma	GO:0044130; P:negative regulation of growth of symbiont in host; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0032700; P:negative regulation of interleukin-17 production; IDA:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0003340; P:negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; ISS:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0072308; P:negative regulation of metanephric nephron tubule epithelial cell differentiation; ISS:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0031642; P:negative regulation of myelination; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IDA:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0001781; P:neutrophil apoptotic process; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0030593; P:neutrophil chemotaxis; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0060559; P:positive regulation of calcidiol 1-monooxygenase activity; IDA:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0045785; P:positive regulation of cell adhesion; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0045080; P:positive regulation of chemokine biosynthetic process; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0060550; P:positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity; IDA:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0060552; P:positive regulation of fructose 1,6-bisphosphate metabolic process; IDA:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0050718; P:positive regulation of interleukin-1 beta secretion; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0045084; P:positive regulation of interleukin-12 biosynthetic process; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0032735; P:positive regulation of interleukin-12 production; IDA:UniProtKB
P01579	IFNG	Interferon gamma	GO:0032747; P:positive regulation of interleukin-23 production; IDA:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0045410; P:positive regulation of interleukin-6 biosynthetic process; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0048304; P:positive regulation of isotype switching to IgG isotypes; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0051712; P:positive regulation of killing of cells of other organism; IDA:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0051044; P:positive regulation of membrane protein ectodomain proteolysis; IDA:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0002053; P:positive regulation of mesenchymal cell proliferation; ISS:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0045348; P:positive regulation of MHC class II biosynthetic process; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IDA:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0045672; P:positive regulation of osteoclast differentiation; IDA:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0033141; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; NAS:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0034393; P:positive regulation of smooth muscle cell apoptotic process; IDA:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0032224; P:positive regulation of synaptic transmission, cholinergic; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:2000309; P:positive regulation of tumor necrosis factor (ligand) superfamily member 11 production; IDA:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0032760; P:positive regulation of tumor necrosis factor production; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0042511; P:positive regulation of tyrosine phosphorylation of Stat1 protein; IDA:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0060557; P:positive regulation of vitamin D biosynthetic process; IDA:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0000060; P:protein import into nucleus, translocation; IDA:UniProtKB
P01579	IFNG	Interferon gamma	GO:0050796; P:regulation of insulin secretion; IDA:BHF-UCL
P01579	IFNG	Interferon gamma	GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; TAS:Reactome
P01579	IFNG	Interferon gamma	GO:0002026; P:regulation of the force of heart contraction; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0042493; P:response to drug; IEA:Ensembl
P01579	IFNG	Interferon gamma	GO:0009615; P:response to virus; IDA:MGI
Q8IU54	IFNL1	Interferon lambda-1	GO:0032003; F:interleukin-28 receptor binding; IPI:UniProtKB
Q8IU54	IFNL1	Interferon lambda-1	GO:0005102; F:receptor binding; IDA:UniProtKB
Q8IU54	IFNL1	Interferon lambda-1	GO:0051607; P:defense response to virus; IDA:UniProtKB
Q8IU54	IFNL1	Interferon lambda-1	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q8IU54	IFNL1	Interferon lambda-1	GO:0032696; P:negative regulation of interleukin-13 production; IDA:UniProtKB
Q8IU54	IFNL1	Interferon lambda-1	GO:0032714; P:negative regulation of interleukin-5 production; IDA:UniProtKB
Q8IU54	IFNL1	Interferon lambda-1	GO:0043381; P:negative regulation of memory T cell differentiation; IDA:UniProtKB
Q8IU54	IFNL1	Interferon lambda-1	GO:0045581; P:negative regulation of T cell differentiation; IDA:UniProtKB
Q8IU54	IFNL1	Interferon lambda-1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q8IU54	IFNL1	Interferon lambda-1	GO:0002829; P:negative regulation of type 2 immune response; IDA:UniProtKB
Q8IU54	IFNL1	Interferon lambda-1	GO:0050778; P:positive regulation of immune response; TAS:UniProtKB
Q8IU54	IFNL1	Interferon lambda-1	GO:0032729; P:positive regulation of interferon-gamma production; IDA:UniProtKB
Q8IU54	IFNL1	Interferon lambda-1	GO:0046427; P:positive regulation of JAK-STAT cascade; IDA:UniProtKB
Q8IU54	IFNL1	Interferon lambda-1	GO:0045345; P:positive regulation of MHC class I biosynthetic process; IDA:UniProtKB
Q8IU54	IFNL1	Interferon lambda-1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q8IU54	IFNL1	Interferon lambda-1	GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; IDA:UniProtKB
Q9P0W0	IFNK	Interferon kappa	GO:0005125; F:cytokine activity; IBA:RefGenome
Q9P0W0	IFNK	Interferon kappa	GO:0005132; F:type I interferon receptor binding; IDA:UniProtKB
Q9P0W0	IFNK	Interferon kappa	GO:0002250; P:adaptive immune response; IBA:RefGenome
Q9P0W0	IFNK	Interferon kappa	GO:0030183; P:B cell differentiation; IBA:RefGenome
Q9P0W0	IFNK	Interferon kappa	GO:0042100; P:B cell proliferation; IBA:RefGenome
Q9P0W0	IFNK	Interferon kappa	GO:0019221; P:cytokine-mediated signaling pathway; IDA:UniProtKB
Q9P0W0	IFNK	Interferon kappa	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q9P0W0	IFNK	Interferon kappa	GO:0006959; P:humoral immune response; IBA:RefGenome
Q9P0W0	IFNK	Interferon kappa	GO:0045087; P:innate immune response; IBA:RefGenome
Q9P0W0	IFNK	Interferon kappa	GO:0030101; P:natural killer cell activation; NAS:UniProtKB
Q9P0W0	IFNK	Interferon kappa	GO:0002323; P:natural killer cell activation involved in immune response; IBA:RefGenome
Q9P0W0	IFNK	Interferon kappa	GO:0008285; P:negative regulation of cell proliferation; NAS:UniProtKB
Q9P0W0	IFNK	Interferon kappa	GO:0045089; P:positive regulation of innate immune response; TAS:UniProtKB
Q9P0W0	IFNK	Interferon kappa	GO:0033141; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; IBA:RefGenome
Q9P0W0	IFNK	Interferon kappa	GO:0045343; P:regulation of MHC class I biosynthetic process; IBA:RefGenome
Q9P0W0	IFNK	Interferon kappa	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q9P0W0	IFNK	Interferon kappa	GO:0043330; P:response to exogenous dsRNA; IBA:RefGenome
Q9P0W0	IFNK	Interferon kappa	GO:0009615; P:response to virus; IEP:UniProtKB
Q9P0W0	IFNK	Interferon kappa	GO:0002286; P:T cell activation involved in immune response; IBA:RefGenome
Q8IZJ0	IFNL2	Interferon lambda-2	GO:0051607; P:defense response to virus; ISS:UniProtKB
Q8IZJ0	IFNL2	Interferon lambda-2	GO:0002385; P:mucosal immune response; ISS:UniProtKB
Q8IZI9	IFNL3	Interferon lambda-3	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
K9M1U5	IFNL4	Interferon lambda-4	GO:0005125; F:cytokine activity; IMP:UniProtKB
K9M1U5	IFNL4	Interferon lambda-4	GO:0051607; P:defense response to virus; IMP:UniProtKB
K9M1U5	IFNL4	Interferon lambda-4	GO:0042508; P:tyrosine phosphorylation of Stat1 protein; IMP:UniProtKB
K9M1U5	IFNL4	Interferon lambda-4	GO:0042502; P:tyrosine phosphorylation of Stat2 protein; IDA:UniProtKB
P05000	IFNW1	Interferon omega-1	GO:0005125; F:cytokine activity; IBA:RefGenome
P05000	IFNW1	Interferon omega-1	GO:0005126; F:cytokine receptor binding; TAS:ProtInc
P05000	IFNW1	Interferon omega-1	GO:0005132; F:type I interferon receptor binding; IBA:RefGenome
P05000	IFNW1	Interferon omega-1	GO:0002250; P:adaptive immune response; IBA:RefGenome
P05000	IFNW1	Interferon omega-1	GO:0030183; P:B cell differentiation; IBA:RefGenome
P05000	IFNW1	Interferon omega-1	GO:0042100; P:B cell proliferation; IBA:RefGenome
P05000	IFNW1	Interferon omega-1	GO:0007050; P:cell cycle arrest; TAS:ProtInc
P05000	IFNW1	Interferon omega-1	GO:0019221; P:cytokine-mediated signaling pathway; IBA:RefGenome
P05000	IFNW1	Interferon omega-1	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P05000	IFNW1	Interferon omega-1	GO:0006959; P:humoral immune response; IBA:RefGenome
P05000	IFNW1	Interferon omega-1	GO:0045087; P:innate immune response; IBA:RefGenome
P05000	IFNW1	Interferon omega-1	GO:0002323; P:natural killer cell activation involved in immune response; IBA:RefGenome
P05000	IFNW1	Interferon omega-1	GO:0033141; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; IBA:RefGenome
P05000	IFNW1	Interferon omega-1	GO:0045343; P:regulation of MHC class I biosynthetic process; IBA:RefGenome
P05000	IFNW1	Interferon omega-1	GO:0043330; P:response to exogenous dsRNA; IBA:RefGenome
P05000	IFNW1	Interferon omega-1	GO:0009615; P:response to virus; TAS:ProtInc
P05000	IFNW1	Interferon omega-1	GO:0002286; P:T cell activation involved in immune response; IBA:RefGenome
O00458	IFRD1	Interferon-related developmental regulator 1	GO:0007527; P:adult somatic muscle development; IEA:Ensembl
O00458	IFRD1	Interferon-related developmental regulator 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
O00458	IFRD1	Interferon-related developmental regulator 1	GO:0007518; P:myoblast fate determination; TAS:ProtInc
Q12894	IFRD2	Interferon-related developmental regulator 2	GO:0005515; F:protein binding; IPI:IntAct
Q8IY31	IFT20	Intraflagellar transport protein 20 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IY31	IFT20	Intraflagellar transport protein 20 homolog	GO:0051642; P:centrosome localization; IEA:Ensembl
Q8IY31	IFT20	Intraflagellar transport protein 20 homolog	GO:0042384; P:cilium assembly; IMP:MGI
Q8IY31	IFT20	Intraflagellar transport protein 20 homolog	GO:0034067; P:protein localization to Golgi apparatus; IMP:MGI
Q8IY31	IFT20	Intraflagellar transport protein 20 homolog	GO:2000785; P:regulation of autophagic vacuole assembly; ISS:UniProtKB
Q8IY31	IFT20	Intraflagellar transport protein 20 homolog	GO:1902017; P:regulation of cilium assembly; ISS:UniProtKB
Q5T764	IFIT1B	Interferon-induced protein with tetratricopeptide repeats 1B	GO:0071360; P:cellular response to exogenous dsRNA; IEA:InterPro
Q5T764	IFIT1B	Interferon-induced protein with tetratricopeptide repeats 1B	GO:0071357; P:cellular response to type I interferon; IEA:InterPro
Q5T764	IFIT1B	Interferon-induced protein with tetratricopeptide repeats 1B	GO:0050688; P:regulation of defense response to virus; IEA:InterPro
Q5T764	IFIT1B	Interferon-induced protein with tetratricopeptide repeats 1B	GO:0009615; P:response to virus; IEA:InterPro
Q9H7X7	IFT22	Intraflagellar transport protein 22 homolog	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9H7X7	IFT22	Intraflagellar transport protein 22 homolog	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9Y547	HSPB11	Intraflagellar transport protein 25 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y547	HSPB11	Intraflagellar transport protein 25 homolog	GO:0007155; P:cell adhesion; IEA:InterPro
Q9Y547	HSPB11	Intraflagellar transport protein 25 homolog	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9Y547	HSPB11	Intraflagellar transport protein 25 homolog	GO:0006950; P:response to stress; IEA:UniProtKB-KW
Q9BW83	IFT27	Intraflagellar transport protein 27 homolog	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9BW83	IFT27	Intraflagellar transport protein 27 homolog	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q96FT9	IFT43	Intraflagellar transport protein 43 homolog	GO:0060271; P:cilium morphogenesis; IMP:UniProtKB
Q96FT9	IFT43	Intraflagellar transport protein 43 homolog	GO:0035721; P:intraciliary retrograde transport; IMP:UniProtKB
Q9NQC8	IFT46	Intraflagellar transport protein 46 homolog	GO:0008022; F:protein C-terminus binding; ISS:BHF-UCL
Q9NQC8	IFT46	Intraflagellar transport protein 46 homolog	GO:0042384; P:cilium assembly; ISS:BHF-UCL
Q9NQC8	IFT46	Intraflagellar transport protein 46 homolog	GO:0042073; P:intraciliary transport; ISS:BHF-UCL
Q9NQC8	IFT46	Intraflagellar transport protein 46 homolog	GO:0050821; P:protein stabilization; ISS:BHF-UCL
Q9Y366	IFT52	Intraflagellar transport protein 52 homolog	GO:0008022; F:protein C-terminus binding; ISS:BHF-UCL
Q9Y366	IFT52	Intraflagellar transport protein 52 homolog	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
Q9Y366	IFT52	Intraflagellar transport protein 52 homolog	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
Q9Y366	IFT52	Intraflagellar transport protein 52 homolog	GO:0001947; P:heart looping; IEA:Ensembl
Q9Y366	IFT52	Intraflagellar transport protein 52 homolog	GO:0001841; P:neural tube formation; IEA:Ensembl
Q9Y366	IFT52	Intraflagellar transport protein 52 homolog	GO:0045862; P:positive regulation of proteolysis; IEA:Ensembl
Q9Y366	IFT52	Intraflagellar transport protein 52 homolog	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
Q9NWB7	IFT57	Intraflagellar transport protein 57 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NWB7	IFT57	Intraflagellar transport protein 57 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NWB7	IFT57	Intraflagellar transport protein 57 homolog	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:MGI
Q9NWB7	IFT57	Intraflagellar transport protein 57 homolog	GO:0006915; P:apoptotic process; IDA:MGI
Q9NWB7	IFT57	Intraflagellar transport protein 57 homolog	GO:0042981; P:regulation of apoptotic process; IDA:MGI
Q9NWB7	IFT57	Intraflagellar transport protein 57 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NWB7	IFT57	Intraflagellar transport protein 57 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96LB3	IFT74	Intraflagellar transport protein 74 homolog	GO:0048487; F:beta-tubulin binding; IDA:UniProtKB
Q96LB3	IFT74	Intraflagellar transport protein 74 homolog	GO:0003682; F:chromatin binding; IEA:Ensembl
Q96LB3	IFT74	Intraflagellar transport protein 74 homolog	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q96LB3	IFT74	Intraflagellar transport protein 74 homolog	GO:0035735; P:intraciliary transport involved in cilium morphogenesis; IMP:UniProtKB
Q96LB3	IFT74	Intraflagellar transport protein 74 homolog	GO:0033630; P:positive regulation of cell adhesion mediated by integrin; IEA:Ensembl
Q96LB3	IFT74	Intraflagellar transport protein 74 homolog	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9P2H3	IFT80	Intraflagellar transport protein 80 homolog	GO:0060349; P:bone morphogenesis; IEA:Ensembl
Q9P2H3	IFT80	Intraflagellar transport protein 80 homolog	GO:0002062; P:chondrocyte differentiation; IEA:Ensembl
Q9P2H3	IFT80	Intraflagellar transport protein 80 homolog	GO:0042384; P:cilium assembly; IEA:Ensembl
Q9P2H3	IFT80	Intraflagellar transport protein 80 homolog	GO:2000051; P:negative regulation of non-canonical Wnt signaling pathway; IEA:Ensembl
Q9P2H3	IFT80	Intraflagellar transport protein 80 homolog	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
Q9P2H3	IFT80	Intraflagellar transport protein 80 homolog	GO:0045880; P:positive regulation of smoothened signaling pathway; IEA:Ensembl
Q9P2H3	IFT80	Intraflagellar transport protein 80 homolog	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
Q8WYA0	IFT81	Intraflagellar transport protein 81 homolog	GO:0015631; F:tubulin binding; IDA:UniProtKB
Q8WYA0	IFT81	Intraflagellar transport protein 81 homolog	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q8WYA0	IFT81	Intraflagellar transport protein 81 homolog	GO:0035735; P:intraciliary transport involved in cilium morphogenesis; IMP:UniProtKB
Q8WYA0	IFT81	Intraflagellar transport protein 81 homolog	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:0060411; P:cardiac septum morphogenesis; IEA:Ensembl
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:0060271; P:cilium morphogenesis; ISS:UniProtKB
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:0048568; P:embryonic organ development; IEA:Ensembl
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:0003382; P:epithelial cell morphogenesis; IEA:Ensembl
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:0001654; P:eye development; IEA:Ensembl
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:0048853; P:forebrain morphogenesis; IEA:Ensembl
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:0060426; P:lung vasculature development; IEA:Ensembl
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:0060021; P:palate development; IEA:Ensembl
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:0045862; P:positive regulation of proteolysis; IEA:Ensembl
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:0008104; P:protein localization; IEA:Ensembl
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:0016485; P:protein processing; IEA:Ensembl
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:2000785; P:regulation of autophagic vacuole assembly; ISS:UniProtKB
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:1902017; P:regulation of cilium assembly; ISS:UniProtKB
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:0042487; P:regulation of odontogenesis of dentin-containing tooth; IEA:Ensembl
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:0021513; P:spinal cord dorsal/ventral patterning; IEA:Ensembl
Q13099	IFT88	Intraflagellar transport protein 88 homolog	GO:0021537; P:telencephalon development; IEA:Ensembl
P27352	GIF	Gastric intrinsic factor	GO:0031419; F:cobalamin binding; IDA:UniProtKB
P27352	GIF	Gastric intrinsic factor	GO:0009235; P:cobalamin metabolic process; IBA:RefGenome
P27352	GIF	Gastric intrinsic factor	GO:0015889; P:cobalamin transport; IMP:UniProtKB
P27352	GIF	Gastric intrinsic factor	GO:0006824; P:cobalt ion transport; IEA:UniProtKB-KW
P27352	GIF	Gastric intrinsic factor	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P27352	GIF	Gastric intrinsic factor	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P27352	GIF	Gastric intrinsic factor	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
P09565	ORFNames=GIG44, PP9974	Putative insulin-like growth factor 2-associated protein	GO:0005520; F:insulin-like growth factor binding; NAS:UniProtKB
P78318	IGBP1	Immunoglobulin-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
P78318	IGBP1	Immunoglobulin-binding protein 1	GO:0008601; F:protein phosphatase type 2A regulator activity; IDA:UniProtKB
P78318	IGBP1	Immunoglobulin-binding protein 1	GO:0042113; P:B cell activation; IEA:UniProtKB-KW
P78318	IGBP1	Immunoglobulin-binding protein 1	GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl
P78318	IGBP1	Immunoglobulin-binding protein 1	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
P78318	IGBP1	Immunoglobulin-binding protein 1	GO:0035308; P:negative regulation of protein dephosphorylation; IEA:Ensembl
P78318	IGBP1	Immunoglobulin-binding protein 1	GO:0032873; P:negative regulation of stress-activated MAPK cascade; IMP:UniProtKB
P78318	IGBP1	Immunoglobulin-binding protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
P78318	IGBP1	Immunoglobulin-binding protein 1	GO:0035306; P:positive regulation of dephosphorylation; IEA:Ensembl
P78318	IGBP1	Immunoglobulin-binding protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P78318	IGBP1	Immunoglobulin-binding protein 1	GO:0060632; P:regulation of microtubule-based movement; IMP:UniProtKB
P78318	IGBP1	Immunoglobulin-binding protein 1	GO:0070555; P:response to interleukin-1; IMP:UniProtKB
P78318	IGBP1	Immunoglobulin-binding protein 1	GO:0034612; P:response to tumor necrosis factor; IMP:UniProtKB
P78318	IGBP1	Immunoglobulin-binding protein 1	GO:0007165; P:signal transduction; NAS:UniProtKB
Q8IVU1	IGDCC3	Immunoglobulin superfamily DCC subclass member 3	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0042802; F:identical protein binding; IPI:IntAct
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0043559; F:insulin binding; IPI:BHF-UCL
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0005158; F:insulin receptor binding; IDA:BHF-UCL
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0043560; F:insulin receptor substrate binding; IPI:UniProtKB
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0005520; F:insulin-like growth factor binding; IDA:UniProtKB
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0031994; F:insulin-like growth factor I binding; IPI:BHF-UCL
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0005010; F:insulin-like growth factor-activated receptor activity; IDA:UniProtKB
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0043548; F:phosphatidylinositol 3-kinase binding; IPI:UniProtKB
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0007409; P:axonogenesis; IEA:Ensembl
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0007420; P:brain development; IEA:Ensembl
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0030010; P:establishment of cell polarity; IEA:Ensembl
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0031017; P:exocrine pancreas development; IEA:Ensembl
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0006955; P:immune response; IMP:BHF-UCL
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0051389; P:inactivation of MAPKK activity; IDA:UniProtKB
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0008286; P:insulin receptor signaling pathway; TAS:ProtInc
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0048009; P:insulin-like growth factor receptor signaling pathway; IDA:UniProtKB
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0030238; P:male sex determination; IEA:Ensembl
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0030879; P:mammary gland development; IEA:Ensembl
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0010656; P:negative regulation of muscle cell apoptotic process; IEA:Ensembl
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0051898; P:negative regulation of protein kinase B signaling; IEA:Ensembl
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:GOC
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0014065; P:phosphatidylinositol 3-kinase signaling; IC:BHF-UCL
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0048015; P:phosphatidylinositol-mediated signaling; IDA:BHF-UCL
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0030335; P:positive regulation of cell migration; IMP:BHF-UCL
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0032467; P:positive regulation of cytokinesis; IEA:Ensembl
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0045740; P:positive regulation of DNA replication; IMP:BHF-UCL
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0090031; P:positive regulation of steroid hormone biosynthetic process; IEA:Ensembl
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0060740; P:prostate gland epithelium morphogenesis; IEA:Ensembl
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0051262; P:protein tetramerization; IDA:UniProtKB
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0046328; P:regulation of JNK cascade; IDA:UniProtKB
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0033197; P:response to vitamin E; IEA:Ensembl
P08069	IGF1R	Insulin-like growth factor 1 receptor	GO:0007165; P:signal transduction; TAS:ProtInc
P05019	IGF1	Insulin-like growth factor I	GO:0005179; F:hormone activity; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0005158; F:insulin receptor binding; IPI:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0005159; F:insulin-like growth factor receptor binding; IPI:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0005178; F:integrin binding; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0005515; F:protein binding; IPI:IntAct
P05019	IGF1	Insulin-like growth factor I	GO:0007596; P:blood coagulation; TAS:Reactome
P05019	IGF1	Insulin-like growth factor I	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0035630; P:bone mineralization involved in bone maturation; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0006928; P:cellular component movement; TAS:ProtInc
P05019	IGF1	Insulin-like growth factor I	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P05019	IGF1	Insulin-like growth factor I	GO:0050650; P:chondroitin sulfate proteoglycan biosynthetic process; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0006260; P:DNA replication; TAS:ProtInc
P05019	IGF1	Insulin-like growth factor I	GO:0031017; P:exocrine pancreas development; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0010001; P:glial cell differentiation; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0009441; P:glycolate metabolic process; TAS:ProtInc
P05019	IGF1	Insulin-like growth factor I	GO:0048839; P:inner ear development; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0048009; P:insulin-like growth factor receptor signaling pathway; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0048286; P:lung alveolus development; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0060463; P:lung lobe morphogenesis; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0060426; P:lung vasculature development; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0030879; P:mammary gland development; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0035264; P:multicellular organism growth; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0014896; P:muscle hypertrophy; IMP:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0007517; P:muscle organ development; TAS:ProtInc
P05019	IGF1	Insulin-like growth factor I	GO:0045445; P:myoblast differentiation; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0051450; P:myoblast proliferation; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0014904; P:myotube cell development; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0060766; P:negative regulation of androgen receptor signaling pathway; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; ISS:UniProtKB
P05019	IGF1	Insulin-like growth factor I	GO:0034392; P:negative regulation of smooth muscle cell apoptotic process; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0048015; P:phosphatidylinositol-mediated signaling; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0030168; P:platelet activation; TAS:Reactome
P05019	IGF1	Insulin-like growth factor I	GO:0002576; P:platelet degranulation; TAS:Reactome
P05019	IGF1	Insulin-like growth factor I	GO:0042104; P:positive regulation of activated T cell proliferation; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0070886; P:positive regulation of calcineurin-NFAT signaling cascade; IDA:UniProtKB
P05019	IGF1	Insulin-like growth factor I	GO:0010613; P:positive regulation of cardiac muscle hypertrophy; IDA:UniProtKB
P05019	IGF1	Insulin-like growth factor I	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0021940; P:positive regulation of cerebellar granule cell precursor proliferation; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0043388; P:positive regulation of DNA binding; IDA:UniProtKB
P05019	IGF1	Insulin-like growth factor I	GO:0045740; P:positive regulation of DNA replication; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0048146; P:positive regulation of fibroblast proliferation; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0046326; P:positive regulation of glucose import; IDA:UniProtKB
P05019	IGF1	Insulin-like growth factor I	GO:0045725; P:positive regulation of glycogen biosynthetic process; IDA:UniProtKB
P05019	IGF1	Insulin-like growth factor I	GO:0045821; P:positive regulation of glycolytic process; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0043568; P:positive regulation of insulin-like growth factor receptor signaling pathway; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0043410; P:positive regulation of MAPK cascade; IDA:UniProtKB
P05019	IGF1	Insulin-like growth factor I	GO:0045840; P:positive regulation of mitosis; IDA:UniProtKB
P05019	IGF1	Insulin-like growth factor I	GO:2000288; P:positive regulation of myoblast proliferation; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0045669; P:positive regulation of osteoblast differentiation; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0033160; P:positive regulation of protein import into nucleus, translocation; IDA:UniProtKB
P05019	IGF1	Insulin-like growth factor I	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0046579; P:positive regulation of Ras protein signal transduction; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0014911; P:positive regulation of smooth muscle cell migration; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P05019	IGF1	Insulin-like growth factor I	GO:0042523; P:positive regulation of tyrosine phosphorylation of Stat5 protein; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0060527; P:prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0060736; P:prostate gland growth; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0060741; P:prostate gland stromal morphogenesis; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0030166; P:proteoglycan biosynthetic process; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0007265; P:Ras protein signal transduction; TAS:ProtInc
P05019	IGF1	Insulin-like growth factor I	GO:0032878; P:regulation of establishment or maintenance of cell polarity; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0040014; P:regulation of multicellular organism growth; IEP:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0014834; P:satellite cell maintenance involved in skeletal muscle regeneration; IDA:BHF-UCL
P05019	IGF1	Insulin-like growth factor I	GO:0007165; P:signal transduction; TAS:ProtInc
P05019	IGF1	Insulin-like growth factor I	GO:0001501; P:skeletal system development; TAS:ProtInc
P05019	IGF1	Insulin-like growth factor I	GO:0060509; P:Type I pneumocyte differentiation; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0060510; P:Type II pneumocyte differentiation; IEA:Ensembl
P05019	IGF1	Insulin-like growth factor I	GO:0030104; P:water homeostasis; IEA:Ensembl
P01344	IGF2	Insulin-like growth factor II	GO:0008083; F:growth factor activity; IDA:BHF-UCL
P01344	IGF2	Insulin-like growth factor II	GO:0005158; F:insulin receptor binding; IPI:BHF-UCL
P01344	IGF2	Insulin-like growth factor II	GO:0005159; F:insulin-like growth factor receptor binding; TAS:ProtInc
P01344	IGF2	Insulin-like growth factor II	GO:0005515; F:protein binding; IPI:UniProtKB
P01344	IGF2	Insulin-like growth factor II	GO:0043539; F:protein serine/threonine kinase activator activity; ISS:BHF-UCL
P01344	IGF2	Insulin-like growth factor II	GO:0030546; F:receptor activator activity; ISS:BHF-UCL
P01344	IGF2	Insulin-like growth factor II	GO:0007596; P:blood coagulation; TAS:Reactome
P01344	IGF2	Insulin-like growth factor II	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P01344	IGF2	Insulin-like growth factor II	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P01344	IGF2	Insulin-like growth factor II	GO:0031017; P:exocrine pancreas development; IEA:Ensembl
P01344	IGF2	Insulin-like growth factor II	GO:0007565; P:female pregnancy; IEA:Ensembl
P01344	IGF2	Insulin-like growth factor II	GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW
P01344	IGF2	Insulin-like growth factor II	GO:0008286; P:insulin receptor signaling pathway; TAS:ProtInc
P01344	IGF2	Insulin-like growth factor II	GO:0038028; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; ISS:BHF-UCL
P01344	IGF2	Insulin-like growth factor II	GO:0007613; P:memory; IEA:Ensembl
P01344	IGF2	Insulin-like growth factor II	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P01344	IGF2	Insulin-like growth factor II	GO:0009887; P:organ morphogenesis; IEA:Ensembl
P01344	IGF2	Insulin-like growth factor II	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
P01344	IGF2	Insulin-like growth factor II	GO:0030168; P:platelet activation; TAS:Reactome
P01344	IGF2	Insulin-like growth factor II	GO:0002576; P:platelet degranulation; TAS:Reactome
P01344	IGF2	Insulin-like growth factor II	GO:0042104; P:positive regulation of activated T cell proliferation; IDA:BHF-UCL
P01344	IGF2	Insulin-like growth factor II	GO:0043085; P:positive regulation of catalytic activity; ISS:BHF-UCL
P01344	IGF2	Insulin-like growth factor II	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P01344	IGF2	Insulin-like growth factor II	GO:0008284; P:positive regulation of cell proliferation; IC:BHF-UCL
P01344	IGF2	Insulin-like growth factor II	GO:2000467; P:positive regulation of glycogen (starch) synthase activity; ISS:BHF-UCL
P01344	IGF2	Insulin-like growth factor II	GO:0045725; P:positive regulation of glycogen biosynthetic process; ISS:BHF-UCL
P01344	IGF2	Insulin-like growth factor II	GO:0046628; P:positive regulation of insulin receptor signaling pathway; IDA:BHF-UCL
P01344	IGF2	Insulin-like growth factor II	GO:0043410; P:positive regulation of MAPK cascade; IDA:BHF-UCL
P01344	IGF2	Insulin-like growth factor II	GO:0045840; P:positive regulation of mitosis; IDA:BHF-UCL
P01344	IGF2	Insulin-like growth factor II	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISS:BHF-UCL
P01344	IGF2	Insulin-like growth factor II	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:BHF-UCL
P01344	IGF2	Insulin-like growth factor II	GO:0001934; P:positive regulation of protein phosphorylation; ISS:BHF-UCL
P01344	IGF2	Insulin-like growth factor II	GO:0090031; P:positive regulation of steroid hormone biosynthetic process; IEA:Ensembl
P01344	IGF2	Insulin-like growth factor II	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P01344	IGF2	Insulin-like growth factor II	GO:0006349; P:regulation of gene expression by genetic imprinting; TAS:ProtInc
P01344	IGF2	Insulin-like growth factor II	GO:0006355; P:regulation of transcription, DNA-templated; NAS:BHF-UCL
P01344	IGF2	Insulin-like growth factor II	GO:0042493; P:response to drug; IEA:Ensembl
P01344	IGF2	Insulin-like growth factor II	GO:0032355; P:response to estradiol; IEA:Ensembl
P01344	IGF2	Insulin-like growth factor II	GO:0045471; P:response to ethanol; IEA:Ensembl
P01344	IGF2	Insulin-like growth factor II	GO:0035094; P:response to nicotine; IEA:Ensembl
P01344	IGF2	Insulin-like growth factor II	GO:0031667; P:response to nutrient levels; IEA:Ensembl
P01344	IGF2	Insulin-like growth factor II	GO:0009314; P:response to radiation; IEA:Ensembl
P01344	IGF2	Insulin-like growth factor II	GO:0001501; P:skeletal system development; TAS:ProtInc
P01344	IGF2	Insulin-like growth factor II	GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl
Q6UW32	IGFL1	Insulin growth factor-like family member 1	GO:0005515; F:protein binding; IPI:IntAct
Q9H665	IGFLR1	IGF-like family receptor 1	GO:0005515; F:protein binding; IPI:IntAct
P01876	IGHA1	Ig alpha-1 chain C region	GO:0003823; F:antigen binding; NAS:UniProtKB
P01876	IGHA1	Ig alpha-1 chain C region	GO:0019731; P:antibacterial humoral response; IDA:UniProt
P01876	IGHA1	Ig alpha-1 chain C region	GO:0003094; P:glomerular filtration; IMP:UniProt
P01876	IGHA1	Ig alpha-1 chain C region	GO:0006955; P:immune response; NAS:UniProtKB
P01876	IGHA1	Ig alpha-1 chain C region	GO:0060267; P:positive regulation of respiratory burst; IDA:UniProt
P01876	IGHA1	Ig alpha-1 chain C region	GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW
P01876	IGHA1	Ig alpha-1 chain C region	GO:0001895; P:retina homeostasis; IEP:UniProt
P01877	IGHA2	Ig alpha-2 chain C region	GO:0003823; F:antigen binding; TAS:UniProtKB
P01877	IGHA2	Ig alpha-2 chain C region	GO:0019731; P:antibacterial humoral response; IDA:UniProt
P01877	IGHA2	Ig alpha-2 chain C region	GO:0003094; P:glomerular filtration; IMP:UniProt
P01877	IGHA2	Ig alpha-2 chain C region	GO:0006955; P:immune response; NAS:UniProtKB
P01877	IGHA2	Ig alpha-2 chain C region	GO:0060267; P:positive regulation of respiratory burst; IDA:UniProt
P01877	IGHA2	Ig alpha-2 chain C region	GO:0001895; P:retina homeostasis; IEP:UniProt
P01880	IGHD	Ig delta chain C region	GO:0003823; F:antigen binding; NAS:UniProtKB
P01880	IGHD	Ig delta chain C region	GO:0006955; P:immune response; NAS:UniProtKB
P01854	IGHE	Ig epsilon chain C region	GO:0003823; F:antigen binding; NAS:UniProtKB
P01854	IGHE	Ig epsilon chain C region	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P01854	IGHE	Ig epsilon chain C region	GO:0006955; P:immune response; NAS:UniProtKB
P01854	IGHE	Ig epsilon chain C region	GO:0045087; P:innate immune response; TAS:Reactome
P01857	IGHG1	Ig gamma-1 chain C region	GO:0003823; F:antigen binding; TAS:UniProtKB
P01857	IGHG1	Ig gamma-1 chain C region	GO:0005515; F:protein binding; IPI:IntAct
P01857	IGHG1	Ig gamma-1 chain C region	GO:0006956; P:complement activation; TAS:Reactome
P01857	IGHG1	Ig gamma-1 chain C region	GO:0006958; P:complement activation, classical pathway; TAS:Reactome
P01857	IGHG1	Ig gamma-1 chain C region	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P01857	IGHG1	Ig gamma-1 chain C region	GO:0045087; P:innate immune response; TAS:Reactome
P01859	IGHG2	Ig gamma-2 chain C region	GO:0003823; F:antigen binding; IEA:UniProtKB-KW
P01859	IGHG2	Ig gamma-2 chain C region	GO:0005515; F:protein binding; IPI:IntAct
P01859	IGHG2	Ig gamma-2 chain C region	GO:0006956; P:complement activation; TAS:Reactome
P01859	IGHG2	Ig gamma-2 chain C region	GO:0006958; P:complement activation, classical pathway; TAS:Reactome
P01859	IGHG2	Ig gamma-2 chain C region	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P01859	IGHG2	Ig gamma-2 chain C region	GO:0045087; P:innate immune response; TAS:Reactome
P01860	IGHG3	Ig gamma-3 chain C region	GO:0003823; F:antigen binding; IEA:UniProtKB-KW
P01860	IGHG3	Ig gamma-3 chain C region	GO:0006956; P:complement activation; TAS:Reactome
P01860	IGHG3	Ig gamma-3 chain C region	GO:0006958; P:complement activation, classical pathway; TAS:Reactome
P01860	IGHG3	Ig gamma-3 chain C region	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P01860	IGHG3	Ig gamma-3 chain C region	GO:0045087; P:innate immune response; TAS:Reactome
P01860	IGHG3	Ig gamma-3 chain C region	GO:0001895; P:retina homeostasis; IEP:UniProt
P01861	IGHG4	Ig gamma-4 chain C region	GO:0003823; F:antigen binding; IEA:UniProtKB-KW
P01861	IGHG4	Ig gamma-4 chain C region	GO:0006956; P:complement activation; TAS:Reactome
P01861	IGHG4	Ig gamma-4 chain C region	GO:0006958; P:complement activation, classical pathway; TAS:Reactome
P01861	IGHG4	Ig gamma-4 chain C region	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P01861	IGHG4	Ig gamma-4 chain C region	GO:0045087; P:innate immune response; TAS:Reactome
P01871	IGHM	Ig mu chain C region	GO:0003823; F:antigen binding; IEA:UniProtKB-KW
P01871	IGHM	Ig mu chain C region	GO:0002250; P:adaptive immune response; IDA:UniProt
P01871	IGHM	Ig mu chain C region	GO:0019731; P:antibacterial humoral response; IDA:UniProt
P01871	IGHM	Ig mu chain C region	GO:0050829; P:defense response to Gram-negative bacterium; IDA:UniProt
P01871	IGHM	Ig mu chain C region	GO:0045087; P:innate immune response; IDA:UniProt
P01591	IGJ	Immunoglobulin J chain	GO:0003823; F:antigen binding; NAS:UniProtKB
P01591	IGJ	Immunoglobulin J chain	GO:0019862; F:IgA binding; IMP:UniProt
P01591	IGJ	Immunoglobulin J chain	GO:0042803; F:protein homodimerization activity; IDA:UniProt
P01591	IGJ	Immunoglobulin J chain	GO:0002250; P:adaptive immune response; IDA:UniProt
P01591	IGJ	Immunoglobulin J chain	GO:0019731; P:antibacterial humoral response; IDA:UniProt
P01591	IGJ	Immunoglobulin J chain	GO:0003094; P:glomerular filtration; IMP:UniProt
P01591	IGJ	Immunoglobulin J chain	GO:0006955; P:immune response; NAS:UniProtKB
P01591	IGJ	Immunoglobulin J chain	GO:0045087; P:innate immune response; IDA:UniProt
P01591	IGJ	Immunoglobulin J chain	GO:0032461; P:positive regulation of protein oligomerization; IMP:UniProt
P01591	IGJ	Immunoglobulin J chain	GO:0060267; P:positive regulation of respiratory burst; IDA:UniProt
P01591	IGJ	Immunoglobulin J chain	GO:0001895; P:retina homeostasis; IEP:UniProt
P01834	IGKC	Ig kappa chain C region	GO:0003823; F:antigen binding; NAS:UniProtKB
P01834	IGKC	Ig kappa chain C region	GO:0006956; P:complement activation; TAS:Reactome
P01834	IGKC	Ig kappa chain C region	GO:0006958; P:complement activation, classical pathway; TAS:Reactome
P01834	IGKC	Ig kappa chain C region	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P01834	IGKC	Ig kappa chain C region	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P01834	IGKC	Ig kappa chain C region	GO:0006955; P:immune response; NAS:UniProtKB
P01834	IGKC	Ig kappa chain C region	GO:0045087; P:innate immune response; TAS:Reactome
P01834	IGKC	Ig kappa chain C region	GO:0050776; P:regulation of immune response; TAS:Reactome
P01834	IGKC	Ig kappa chain C region	GO:0001895; P:retina homeostasis; IEP:UniProt
P15814	IGLL1	Immunoglobulin lambda-like polypeptide 1	GO:0006955; P:immune response; NAS:UniProtKB
Q6WRI0	IGSF10	Immunoglobulin superfamily member 10	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q6WRI0	IGSF10	Immunoglobulin superfamily member 10	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q6WRI0	IGSF10	Immunoglobulin superfamily member 10	GO:0001503; P:ossification; IEA:UniProtKB-KW
Q5DX21	IGSF11	Immunoglobulin superfamily member 11	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q5DX21	IGSF11	Immunoglobulin superfamily member 11	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q8N6C5	IGSF1	Immunoglobulin superfamily member 1	GO:0015026; F:coreceptor activity; IEA:Ensembl
Q8N6C5	IGSF1	Immunoglobulin superfamily member 1	GO:0034711; F:inhibin binding; IDA:UniProtKB
Q8N6C5	IGSF1	Immunoglobulin superfamily member 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N6C5	IGSF1	Immunoglobulin superfamily member 1	GO:0004872; F:receptor activity; IDA:UniProtKB
Q8N6C5	IGSF1	Immunoglobulin superfamily member 1	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q8N6C5	IGSF1	Immunoglobulin superfamily member 1	GO:0007165; P:signal transduction; IDA:UniProtKB
Q93033	CD101	Immunoglobulin superfamily member 2	GO:0016812; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides; IEA:InterPro
Q93033	CD101	Immunoglobulin superfamily member 2	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
O75054	IGSF3	Immunoglobulin superfamily member 3	GO:0032808; P:lacrimal gland development; IMP:UniProt
Q9NSI5	IGSF5	Immunoglobulin superfamily member 5	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
O95976	IGSF6	Immunoglobulin superfamily member 6	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
O95976	IGSF6	Immunoglobulin superfamily member 6	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
O95976	IGSF6	Immunoglobulin superfamily member 6	GO:0006955; P:immune response; TAS:ProtInc
Q969P0	IGSF8	Immunoglobulin superfamily member 8	GO:0005515; F:protein binding; IPI:UniProtKB
Q969P0	IGSF8	Immunoglobulin superfamily member 8	GO:0008283; P:cell proliferation; NAS:UniProtKB
Q969P0	IGSF8	Immunoglobulin superfamily member 8	GO:0006928; P:cellular component movement; NAS:UniProtKB
Q969P0	IGSF8	Immunoglobulin superfamily member 8	GO:0007399; P:nervous system development; NAS:UniProtKB
Q969P0	IGSF8	Immunoglobulin superfamily member 8	GO:0007338; P:single fertilization; NAS:UniProtKB
Q969P0	IGSF8	Immunoglobulin superfamily member 8	GO:0007519; P:skeletal muscle tissue development; NAS:UniProtKB
Q14623	IHH	Indian hedgehog protein	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q14623	IHH	Indian hedgehog protein	GO:0005113; F:patched binding; IPI:UniProtKB
Q14623	IHH	Indian hedgehog protein	GO:0008233; F:peptidase activity; IEA:UniProtKB-KW
Q14623	IHH	Indian hedgehog protein	GO:0045453; P:bone resorption; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0060220; P:camera-type eye photoreceptor cell fate commitment; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0051216; P:cartilage development; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0001708; P:cell fate specification; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0048469; P:cell maturation; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0007267; P:cell-cell signaling; IEA:InterPro
Q14623	IHH	Indian hedgehog protein	GO:0035988; P:chondrocyte proliferation; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0048596; P:embryonic camera-type eye morphogenesis; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0048557; P:embryonic digestive tract morphogenesis; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0009880; P:embryonic pattern specification; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0072498; P:embryonic skeletal joint development; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0003382; P:epithelial cell morphogenesis; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0090136; P:epithelial cell-cell adhesion; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0060323; P:head morphogenesis; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0001947; P:heart looping; ISS:BHF-UCL
Q14623	IHH	Indian hedgehog protein	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0016539; P:intein-mediated protein splicing; IEA:InterPro
Q14623	IHH	Indian hedgehog protein	GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0046639; P:negative regulation of alpha-beta T cell differentiation; ISS:BHF-UCL
Q14623	IHH	Indian hedgehog protein	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0048074; P:negative regulation of eye pigmentation; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0033088; P:negative regulation of immature T cell proliferation in thymus; ISS:BHF-UCL
Q14623	IHH	Indian hedgehog protein	GO:0009968; P:negative regulation of signal transduction; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0033085; P:negative regulation of T cell differentiation in thymus; ISS:BHF-UCL
Q14623	IHH	Indian hedgehog protein	GO:0048666; P:neuron development; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0031016; P:pancreas development; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0001569; P:patterning of blood vessels; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0046638; P:positive regulation of alpha-beta T cell differentiation; ISS:BHF-UCL
Q14623	IHH	Indian hedgehog protein	GO:0032332; P:positive regulation of chondrocyte differentiation; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0032967; P:positive regulation of collagen biosynthetic process; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0045880; P:positive regulation of smoothened signaling pathway; ISS:BHF-UCL
Q14623	IHH	Indian hedgehog protein	GO:0033089; P:positive regulation of T cell differentiation in thymus; ISS:BHF-UCL
Q14623	IHH	Indian hedgehog protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0006029; P:proteoglycan metabolic process; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0040008; P:regulation of growth; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0032355; P:response to estradiol; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0003406; P:retinal pigment epithelium development; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0001501; P:skeletal system development; IMP:UniProtKB
Q14623	IHH	Indian hedgehog protein	GO:0048745; P:smooth muscle tissue development; IEA:Ensembl
Q14623	IHH	Indian hedgehog protein	GO:0007224; P:smoothened signaling pathway; IDA:UniProtKB
Q14623	IHH	Indian hedgehog protein	GO:0061053; P:somite development; ISS:BHF-UCL
Q14623	IHH	Indian hedgehog protein	GO:0030704; P:vitelline membrane formation; IEA:Ensembl
Q6NXR0	IRGC	Interferon-inducible GTPase 5	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q6NXR0	IRGC	Interferon-inducible GTPase 5	GO:0016817; F:hydrolase activity, acting on acid anhydrides; IEA:InterPro
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0019899; F:enzyme binding; IPI:UniProtKB
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0042802; F:identical protein binding; IPI:IntAct
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0051059; F:NF-kappaB binding; IPI:UniProtKB
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0008139; F:nuclear localization sequence binding; IPI:UniProtKB
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0008134; F:transcription factor binding; TAS:ProtInc
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0006915; P:apoptotic process; TAS:ProtInc
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0070417; P:cellular response to cold; NAS:BHF-UCL
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0007253; P:cytoplasmic sequestering of NF-kappaB; IMP:BHF-UCL
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0042994; P:cytoplasmic sequestering of transcription factor; IDA:UniProtKB
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0045087; P:innate immune response; TAS:Reactome
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IEA:Ensembl
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0043392; P:negative regulation of DNA binding; NAS:UniProtKB
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0010888; P:negative regulation of lipid storage; IMP:BHF-UCL
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; IMP:BHF-UCL
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0045638; P:negative regulation of myeloid cell differentiation; IEA:Ensembl
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:MGI
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0045746; P:negative regulation of Notch signaling pathway; IEA:Ensembl
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0070427; P:nucleotide-binding oligomerization domain containing 1 signaling pathway; IEA:Ensembl
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0070431; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; IEA:Ensembl
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0032270; P:positive regulation of cellular protein metabolic process; IMP:BHF-UCL
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0010875; P:positive regulation of cholesterol efflux; IMP:BHF-UCL
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:Reactome
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0000060; P:protein import into nucleus, translocation; IEA:Ensembl
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0042345; P:regulation of NF-kappaB import into nucleus; NAS:UniProtKB
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0043330; P:response to exogenous dsRNA; IEA:Ensembl
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0032495; P:response to muramyl dipeptide; IEA:Ensembl
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P25963	NFKBIA	NF-kappa-B inhibitor alpha	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q15653	NFKBIB	NF-kappa-B inhibitor beta	GO:0005515; F:protein binding; IPI:UniProtKB
Q15653	NFKBIB	NF-kappa-B inhibitor beta	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q15653	NFKBIB	NF-kappa-B inhibitor beta	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q15653	NFKBIB	NF-kappa-B inhibitor beta	GO:0045087; P:innate immune response; TAS:Reactome
Q15653	NFKBIB	NF-kappa-B inhibitor beta	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q15653	NFKBIB	NF-kappa-B inhibitor beta	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q15653	NFKBIB	NF-kappa-B inhibitor beta	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:Reactome
Q15653	NFKBIB	NF-kappa-B inhibitor beta	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q15653	NFKBIB	NF-kappa-B inhibitor beta	GO:0007165; P:signal transduction; TAS:ProtInc
Q15653	NFKBIB	NF-kappa-B inhibitor beta	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q15653	NFKBIB	NF-kappa-B inhibitor beta	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q15653	NFKBIB	NF-kappa-B inhibitor beta	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q15653	NFKBIB	NF-kappa-B inhibitor beta	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q15653	NFKBIB	NF-kappa-B inhibitor beta	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q15653	NFKBIB	NF-kappa-B inhibitor beta	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q15653	NFKBIB	NF-kappa-B inhibitor beta	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q15653	NFKBIB	NF-kappa-B inhibitor beta	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q15653	NFKBIB	NF-kappa-B inhibitor beta	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q15653	NFKBIB	NF-kappa-B inhibitor beta	GO:0006351; P:transcription, DNA-templated; TAS:ProtInc
Q15653	NFKBIB	NF-kappa-B inhibitor beta	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q8NI38	NFKBID	NF-kappa-B inhibitor delta	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q8NI38	NFKBID	NF-kappa-B inhibitor delta	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
Q8NI38	NFKBID	NF-kappa-B inhibitor delta	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IEA:Ensembl
Q8NI38	NFKBID	NF-kappa-B inhibitor delta	GO:0033085; P:negative regulation of T cell differentiation in thymus; IEA:Ensembl
Q8NI38	NFKBID	NF-kappa-B inhibitor delta	GO:0070245; P:positive regulation of thymocyte apoptotic process; IEA:Ensembl
O00221	NFKBIE	NF-kappa-B inhibitor epsilon	GO:0005515; F:protein binding; IPI:IntAct
O00221	NFKBIE	NF-kappa-B inhibitor epsilon	GO:0042994; P:cytoplasmic sequestering of transcription factor; TAS:ProtInc
O00221	NFKBIE	NF-kappa-B inhibitor epsilon	GO:0042942; P:D-serine transport; IEA:Ensembl
Q9UBC1	NFKBIL1	NF-kappa-B inhibitor-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBC1	NFKBIL1	NF-kappa-B inhibitor-like protein 1	GO:0071222; P:cellular response to lipopolysaccharide; IDA:UniProtKB
Q9UBC1	NFKBIL1	NF-kappa-B inhibitor-like protein 1	GO:0042994; P:cytoplasmic sequestering of transcription factor; TAS:ProtInc
Q9UBC1	NFKBIL1	NF-kappa-B inhibitor-like protein 1	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
Q9UBC1	NFKBIL1	NF-kappa-B inhibitor-like protein 1	GO:0031665; P:negative regulation of lipopolysaccharide-mediated signaling pathway; IDA:UniProtKB
Q9UBC1	NFKBIL1	NF-kappa-B inhibitor-like protein 1	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q9UBC1	NFKBIL1	NF-kappa-B inhibitor-like protein 1	GO:0034122; P:negative regulation of toll-like receptor signaling pathway; IDA:UniProtKB
Q9UBC1	NFKBIL1	NF-kappa-B inhibitor-like protein 1	GO:0032720; P:negative regulation of tumor necrosis factor production; IMP:UniProtKB
Q5VVH5	IRAK1BP1	Interleukin-1 receptor-associated kinase 1-binding protein 1	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; ISS:UniProtKB
Q5VVH5	IRAK1BP1	Interleukin-1 receptor-associated kinase 1-binding protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5VVH5	IRAK1BP1	Interleukin-1 receptor-associated kinase 1-binding protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BYH8	NFKBIZ	NF-kappa-B inhibitor zeta	GO:0006954; P:inflammatory response; IEA:Ensembl
Q9BYH8	NFKBIZ	NF-kappa-B inhibitor zeta	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9BYH8	NFKBIZ	NF-kappa-B inhibitor zeta	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q70UQ0	IKBIP	Inhibitor of nuclear factor kappa-B kinase-interacting protein	GO:0005515; F:protein binding; IPI:HGNC
Q70UQ0	IKBIP	Inhibitor of nuclear factor kappa-B kinase-interacting protein	GO:0010165; P:response to X-ray; TAS:BHF-UCL
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0008384; F:IkappaB kinase activity; TAS:UniProtKB
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0005515; F:protein binding; IPI:UniProtKB
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0004672; F:protein kinase activity; IDA:UniProtKB
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0097110; F:scaffold protein binding; IDA:MGI
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0071356; P:cellular response to tumor necrosis factor; IDA:UniProtKB
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:UniProtKB
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0007252; P:I-kappaB phosphorylation; TAS:ProtInc
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0006955; P:immune response; TAS:ProtInc
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0006954; P:inflammatory response; TAS:UniProtKB
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0045087; P:innate immune response; TAS:UniProtKB
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0007595; P:lactation; IEA:Ensembl
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0060749; P:mammary gland alveolus development; IEA:Ensembl
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0033598; P:mammary gland epithelial cell proliferation; IEA:Ensembl
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0002011; P:morphogenesis of an epithelial sheet; IEA:Ensembl
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0030316; P:osteoclast differentiation; IEA:Ensembl
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:UniProtKB
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0043200; P:response to amino acid; IEA:Ensembl
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0042493; P:response to drug; IEA:Ensembl
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0033194; P:response to hydroperoxide; IEA:Ensembl
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0009636; P:response to toxic substance; IEA:Ensembl
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0009615; P:response to virus; TAS:UniProtKB
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0007266; P:Rho protein signal transduction; IEA:Ensembl
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0003009; P:skeletal muscle contraction; IEA:Ensembl
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
O15111	CHUK	Inhibitor of nuclear factor kappa-B kinase subunit alpha	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0008384; F:IkappaB kinase activity; TAS:UniProtKB
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0005515; F:protein binding; IPI:UniProtKB
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0004672; F:protein kinase activity; IDA:UniProtKB
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0004674; F:protein serine/threonine kinase activity; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0097110; F:scaffold protein binding; IDA:MGI
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0001782; P:B cell homeostasis; IEA:Ensembl
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0071356; P:cellular response to tumor necrosis factor; IDA:UniProtKB
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:UniProtKB
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0007252; P:I-kappaB phosphorylation; TAS:GOC
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0006954; P:inflammatory response; TAS:UniProtKB
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0045087; P:innate immune response; TAS:UniProtKB
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:2001259; P:positive regulation of cation channel activity; IEA:Ensembl
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:UniProtKB
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0010765; P:positive regulation of sodium ion transport; IEA:Ensembl
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0009615; P:response to virus; TAS:UniProtKB
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0042501; P:serine phosphorylation of STAT protein; IDA:UniProtKB
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
O14920	IKBKB	Inhibitor of nuclear factor kappa-B kinase subunit beta	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q14164	IKBKE	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q14164	IKBKE	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	GO:0008384; F:IkappaB kinase activity; IEA:UniProtKB-EC
Q14164	IKBKE	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	GO:0004704; F:NF-kappaB-inducing kinase activity; IDA:UniProtKB
Q14164	IKBKE	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	GO:0005515; F:protein binding; IPI:UniProtKB
Q14164	IKBKE	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	GO:0006955; P:immune response; NAS:UniProtKB
Q14164	IKBKE	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	GO:0045087; P:innate immune response; TAS:Reactome
Q14164	IKBKE	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IMP:UniProtKB
Q14164	IKBKE	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q14164	IKBKE	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
Q14164	IKBKE	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	GO:0038061; P:NIK/NF-kappaB signaling; IDA:GOC
Q14164	IKBKE	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
Q14164	IKBKE	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q14164	IKBKE	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q14164	IKBKE	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q14164	IKBKE	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q14164	IKBKE	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0003677; F:DNA binding; TAS:ProtInc
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0030183; P:B cell differentiation; IEA:Ensembl
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0030900; P:forebrain development; IEA:Ensembl
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0048732; P:gland development; IEA:Ensembl
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0048535; P:lymph node development; IEA:Ensembl
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0007498; P:mesoderm development; TAS:ProtInc
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0001779; P:natural killer cell differentiation; IEA:Ensembl
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0048541; P:Peyer's patch development; IEA:Ensembl
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0045660; P:positive regulation of neutrophil differentiation; IEA:Ensembl
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0051138; P:positive regulation of NK T cell differentiation; IEA:Ensembl
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0030217; P:T cell differentiation; IEA:Ensembl
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0048538; P:thymus development; IEA:Ensembl
Q13422	IKZF1	DNA-binding protein Ikaros	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UKS7	IKZF2	Zinc finger protein Helios	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UKS7	IKZF2	Zinc finger protein Helios	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UKS7	IKZF2	Zinc finger protein Helios	GO:0005515; F:protein binding; IPI:IntAct
Q9UKS7	IKZF2	Zinc finger protein Helios	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UKS7	IKZF2	Zinc finger protein Helios	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UKT9	IKZF3	Zinc finger protein Aiolos	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UKT9	IKZF3	Zinc finger protein Aiolos	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKT9	IKZF3	Zinc finger protein Aiolos	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
Q9UKT9	IKZF3	Zinc finger protein Aiolos	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q9UKT9	IKZF3	Zinc finger protein Aiolos	GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB
Q9UKT9	IKZF3	Zinc finger protein Aiolos	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9UKT9	IKZF3	Zinc finger protein Aiolos	GO:0042113; P:B cell activation; IEA:UniProtKB-KW
Q9UKT9	IKZF3	Zinc finger protein Aiolos	GO:0007498; P:mesoderm development; TAS:ProtInc
Q9UKT9	IKZF3	Zinc finger protein Aiolos	GO:0042981; P:regulation of apoptotic process; IMP:UniProtKB
Q9UKT9	IKZF3	Zinc finger protein Aiolos	GO:0045577; P:regulation of B cell differentiation; ISS:UniProtKB
Q9UKT9	IKZF3	Zinc finger protein Aiolos	GO:0030888; P:regulation of B cell proliferation; ISS:UniProtKB
Q9UKT9	IKZF3	Zinc finger protein Aiolos	GO:0045619; P:regulation of lymphocyte differentiation; ISS:UniProtKB
Q9UKT9	IKZF3	Zinc finger protein Aiolos	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9UKT9	IKZF3	Zinc finger protein Aiolos	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H2S9	IKZF4	Zinc finger protein Eos	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H2S9	IKZF4	Zinc finger protein Eos	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H2S9	IKZF4	Zinc finger protein Eos	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:UniProtKB
Q9H2S9	IKZF4	Zinc finger protein Eos	GO:0045892; P:negative regulation of transcription, DNA-templated; TAS:UniProtKB
Q9H2S9	IKZF4	Zinc finger protein Eos	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H5V7	IKZF5	Zinc finger protein Pegasus	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H5V7	IKZF5	Zinc finger protein Pegasus	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H5V7	IKZF5	Zinc finger protein Pegasus	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H5V7	IKZF5	Zinc finger protein Pegasus	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P22301	IL10	Interleukin-10	GO:0005125; F:cytokine activity; NAS:BHF-UCL
P22301	IL10	Interleukin-10	GO:0008083; F:growth factor activity; NAS:UniProtKB
P22301	IL10	Interleukin-10	GO:0005141; F:interleukin-10 receptor binding; NAS:UniProtKB
P22301	IL10	Interleukin-10	GO:0030183; P:B cell differentiation; NAS:UniProtKB
P22301	IL10	Interleukin-10	GO:0042100; P:B cell proliferation; NAS:UniProtKB
P22301	IL10	Interleukin-10	GO:0060670; P:branching involved in labyrinthine layer morphogenesis; IEA:Ensembl
P22301	IL10	Interleukin-10	GO:0007267; P:cell-cell signaling; IC:UniProtKB
P22301	IL10	Interleukin-10	GO:0071392; P:cellular response to estradiol stimulus; IEA:Ensembl
P22301	IL10	Interleukin-10	GO:0071222; P:cellular response to lipopolysaccharide; NAS:BHF-UCL
P22301	IL10	Interleukin-10	GO:0007253; P:cytoplasmic sequestering of NF-kappaB; NAS:UniProtKB
P22301	IL10	Interleukin-10	GO:0042742; P:defense response to bacterium; IEA:Ensembl
P22301	IL10	Interleukin-10	GO:0030097; P:hemopoiesis; TAS:UniProtKB
P22301	IL10	Interleukin-10	GO:0006954; P:inflammatory response; IDA:BHF-UCL
P22301	IL10	Interleukin-10	GO:0030595; P:leukocyte chemotaxis; TAS:ProtInc
P22301	IL10	Interleukin-10	GO:0043066; P:negative regulation of apoptotic process; NAS:UniProtKB
P22301	IL10	Interleukin-10	GO:0030889; P:negative regulation of B cell proliferation; IDA:MGI
P22301	IL10	Interleukin-10	GO:0002875; P:negative regulation of chronic inflammatory response to antigenic stimulus; IEA:Ensembl
P22301	IL10	Interleukin-10	GO:0002740; P:negative regulation of cytokine secretion involved in immune response; IDA:BHF-UCL
P22301	IL10	Interleukin-10	GO:0044130; P:negative regulation of growth of symbiont in host; IEA:Ensembl
P22301	IL10	Interleukin-10	GO:0045355; P:negative regulation of interferon-alpha biosynthetic process; NAS:UniProtKB
P22301	IL10	Interleukin-10	GO:0032689; P:negative regulation of interferon-gamma production; IEA:Ensembl
P22301	IL10	Interleukin-10	GO:0032695; P:negative regulation of interleukin-12 production; IEA:Ensembl
P22301	IL10	Interleukin-10	GO:0032715; P:negative regulation of interleukin-6 production; IDA:BHF-UCL
P22301	IL10	Interleukin-10	GO:0051045; P:negative regulation of membrane protein ectodomain proteolysis; IDA:BHF-UCL
P22301	IL10	Interleukin-10	GO:0045347; P:negative regulation of MHC class II biosynthetic process; TAS:UniProtKB
P22301	IL10	Interleukin-10	GO:0030886; P:negative regulation of myeloid dendritic cell activation; IEA:Ensembl
P22301	IL10	Interleukin-10	GO:0045019; P:negative regulation of nitric oxide biosynthetic process; IEA:Ensembl
P22301	IL10	Interleukin-10	GO:0042130; P:negative regulation of T cell proliferation; NAS:UniProtKB
P22301	IL10	Interleukin-10	GO:0042536; P:negative regulation of tumor necrosis factor biosynthetic process; IEA:Ensembl
P22301	IL10	Interleukin-10	GO:0032720; P:negative regulation of tumor necrosis factor production; IEA:Ensembl
P22301	IL10	Interleukin-10	GO:0002904; P:positive regulation of B cell apoptotic process; IDA:MGI
P22301	IL10	Interleukin-10	GO:0050715; P:positive regulation of cytokine secretion; IDA:BHF-UCL
P22301	IL10	Interleukin-10	GO:0045348; P:positive regulation of MHC class II biosynthetic process; IEA:Ensembl
P22301	IL10	Interleukin-10	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P22301	IL10	Interleukin-10	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P22301	IL10	Interleukin-10	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
P22301	IL10	Interleukin-10	GO:0032800; P:receptor biosynthetic process; IDA:BHF-UCL
P22301	IL10	Interleukin-10	GO:0010468; P:regulation of gene expression; IDA:MGI
P22301	IL10	Interleukin-10	GO:0045191; P:regulation of isotype switching; NAS:UniProtKB
P22301	IL10	Interleukin-10	GO:0051930; P:regulation of sensory perception of pain; IEA:Ensembl
P22301	IL10	Interleukin-10	GO:0014823; P:response to activity; IEA:Ensembl
P22301	IL10	Interleukin-10	GO:0034465; P:response to carbon monoxide; IEA:Ensembl
P22301	IL10	Interleukin-10	GO:0042493; P:response to drug; IEA:Ensembl
P22301	IL10	Interleukin-10	GO:0051384; P:response to glucocorticoid; IDA:BHF-UCL
P22301	IL10	Interleukin-10	GO:0014854; P:response to inactivity; IEA:Ensembl
P22301	IL10	Interleukin-10	GO:0032868; P:response to insulin; IEA:Ensembl
P22301	IL10	Interleukin-10	GO:0002237; P:response to molecule of bacterial origin; IDA:UniProtKB
P22301	IL10	Interleukin-10	GO:0042092; P:type 2 immune response; TAS:UniProtKB
P20809	IL11	Interleukin-11	GO:0008083; F:growth factor activity; IDA:UniProtKB
P20809	IL11	Interleukin-11	GO:0005142; F:interleukin-11 receptor binding; NAS:UniProtKB
P20809	IL11	Interleukin-11	GO:0030183; P:B cell differentiation; NAS:UniProtKB
P20809	IL11	Interleukin-11	GO:0007267; P:cell-cell signaling; IC:UniProtKB
P20809	IL11	Interleukin-11	GO:0045444; P:fat cell differentiation; NAS:UniProtKB
P20809	IL11	Interleukin-11	GO:0030219; P:megakaryocyte differentiation; NAS:UniProtKB
P20809	IL11	Interleukin-11	GO:0046888; P:negative regulation of hormone secretion; IDA:MGI
P20809	IL11	Interleukin-11	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P20809	IL11	Interleukin-11	GO:0043410; P:positive regulation of MAPK cascade; IDA:MGI
P20809	IL11	Interleukin-11	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:MGI
P20809	IL11	Interleukin-11	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:MGI
P20809	IL11	Interleukin-11	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
P29459	IL12A	Interleukin-12 subunit alpha	GO:0005143; F:interleukin-12 receptor binding; NAS:UniProtKB
P29459	IL12A	Interleukin-12 subunit alpha	GO:0045513; F:interleukin-27 binding; IPI:UniProtKB
P29459	IL12A	Interleukin-12 subunit alpha	GO:0005515; F:protein binding; IPI:IntAct
P29459	IL12A	Interleukin-12 subunit alpha	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
P29459	IL12A	Interleukin-12 subunit alpha	GO:0007050; P:cell cycle arrest; IDA:BHF-UCL
P29459	IL12A	Interleukin-12 subunit alpha	GO:0016477; P:cell migration; IDA:UniProtKB
P29459	IL12A	Interleukin-12 subunit alpha	GO:0050830; P:defense response to Gram-positive bacterium; IEP:UniProtKB
P29459	IL12A	Interleukin-12 subunit alpha	GO:0042832; P:defense response to protozoan; IEA:Ensembl
P29459	IL12A	Interleukin-12 subunit alpha	GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:BHF-UCL
P29459	IL12A	Interleukin-12 subunit alpha	GO:0006955; P:immune response; TAS:UniProtKB
P29459	IL12A	Interleukin-12 subunit alpha	GO:0032700; P:negative regulation of interleukin-17 production; IDA:BHF-UCL
P29459	IL12A	Interleukin-12 subunit alpha	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IDA:BHF-UCL
P29459	IL12A	Interleukin-12 subunit alpha	GO:0045785; P:positive regulation of cell adhesion; IDA:UniProtKB
P29459	IL12A	Interleukin-12 subunit alpha	GO:0032729; P:positive regulation of interferon-gamma production; IDA:UniProtKB
P29459	IL12A	Interleukin-12 subunit alpha	GO:0050671; P:positive regulation of lymphocyte proliferation; IDA:UniProtKB
P29459	IL12A	Interleukin-12 subunit alpha	GO:0032816; P:positive regulation of natural killer cell activation; IDA:UniProtKB
P29459	IL12A	Interleukin-12 subunit alpha	GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; IDA:UniProtKB
P29459	IL12A	Interleukin-12 subunit alpha	GO:0002860; P:positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; IDA:UniProtKB
P29459	IL12A	Interleukin-12 subunit alpha	GO:0051135; P:positive regulation of NK T cell activation; IDA:BHF-UCL
P29459	IL12A	Interleukin-12 subunit alpha	GO:0034393; P:positive regulation of smooth muscle cell apoptotic process; IDA:BHF-UCL
P29459	IL12A	Interleukin-12 subunit alpha	GO:0045582; P:positive regulation of T cell differentiation; IEA:Ensembl
P29459	IL12A	Interleukin-12 subunit alpha	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IDA:UniProtKB
P29459	IL12A	Interleukin-12 subunit alpha	GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl
P29459	IL12A	Interleukin-12 subunit alpha	GO:0042520; P:positive regulation of tyrosine phosphorylation of Stat4 protein; IDA:UniProtKB
P29459	IL12A	Interleukin-12 subunit alpha	GO:0032496; P:response to lipopolysaccharide; IDA:UniProtKB
P29459	IL12A	Interleukin-12 subunit alpha	GO:0010224; P:response to UV-B; IDA:UniProtKB
P29459	IL12A	Interleukin-12 subunit alpha	GO:0009615; P:response to virus; IEP:UniProtKB
P29460	IL12B	Interleukin-12 subunit beta	GO:0004896; F:cytokine receptor activity; IEA:InterPro
P29460	IL12B	Interleukin-12 subunit beta	GO:0042802; F:identical protein binding; IPI:IntAct
P29460	IL12B	Interleukin-12 subunit beta	GO:0005143; F:interleukin-12 receptor binding; TAS:UniProtKB
P29460	IL12B	Interleukin-12 subunit beta	GO:0005515; F:protein binding; IPI:IntAct
P29460	IL12B	Interleukin-12 subunit beta	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
P29460	IL12B	Interleukin-12 subunit beta	GO:0007050; P:cell cycle arrest; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0016477; P:cell migration; IDA:UniProtKB
P29460	IL12B	Interleukin-12 subunit beta	GO:0071346; P:cellular response to interferon-gamma; IEA:Ensembl
P29460	IL12B	Interleukin-12 subunit beta	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
P29460	IL12B	Interleukin-12 subunit beta	GO:0050829; P:defense response to Gram-negative bacterium; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0042832; P:defense response to protozoan; IEA:Ensembl
P29460	IL12B	Interleukin-12 subunit beta	GO:0051607; P:defense response to virus; IEA:Ensembl
P29460	IL12B	Interleukin-12 subunit beta	GO:0042095; P:interferon-gamma biosynthetic process; TAS:UniProtKB
P29460	IL12B	Interleukin-12 subunit beta	GO:0030101; P:natural killer cell activation; IDA:UniProtKB
P29460	IL12B	Interleukin-12 subunit beta	GO:0002323; P:natural killer cell activation involved in immune response; IEA:Ensembl
P29460	IL12B	Interleukin-12 subunit beta	GO:0044130; P:negative regulation of growth of symbiont in host; IEA:Ensembl
P29460	IL12B	Interleukin-12 subunit beta	GO:0002862; P:negative regulation of inflammatory response to antigenic stimulus; IEA:Ensembl
P29460	IL12B	Interleukin-12 subunit beta	GO:0032693; P:negative regulation of interleukin-10 production; IMP:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0032700; P:negative regulation of interleukin-17 production; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0042104; P:positive regulation of activated T cell proliferation; IDA:UniProtKB
P29460	IL12B	Interleukin-12 subunit beta	GO:0010535; P:positive regulation of activation of JAK2 kinase activity; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0045785; P:positive regulation of cell adhesion; IDA:UniProtKB
P29460	IL12B	Interleukin-12 subunit beta	GO:0002230; P:positive regulation of defense response to virus by host; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0032725; P:positive regulation of granulocyte macrophage colony-stimulating factor production; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0050729; P:positive regulation of inflammatory response; IC:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0045078; P:positive regulation of interferon-gamma biosynthetic process; TAS:UniProtKB
P29460	IL12B	Interleukin-12 subunit beta	GO:0032729; P:positive regulation of interferon-gamma production; IDA:UniProtKB
P29460	IL12B	Interleukin-12 subunit beta	GO:0032733; P:positive regulation of interleukin-10 production; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0032735; P:positive regulation of interleukin-12 production; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0032740; P:positive regulation of interleukin-17 production; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0050671; P:positive regulation of lymphocyte proliferation; IDA:UniProtKB
P29460	IL12B	Interleukin-12 subunit beta	GO:0043382; P:positive regulation of memory T cell differentiation; ISS:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0032816; P:positive regulation of natural killer cell activation; IDA:UniProtKB
P29460	IL12B	Interleukin-12 subunit beta	GO:0002860; P:positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; IDA:UniProtKB
P29460	IL12B	Interleukin-12 subunit beta	GO:0032819; P:positive regulation of natural killer cell proliferation; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0042346; P:positive regulation of NF-kappaB import into nucleus; TAS:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0051135; P:positive regulation of NK T cell activation; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0051142; P:positive regulation of NK T cell proliferation; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0045672; P:positive regulation of osteoclast differentiation; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0034393; P:positive regulation of smooth muscle cell apoptotic process; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; ISS:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0042102; P:positive regulation of T cell proliferation; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0002827; P:positive regulation of T-helper 1 type immune response; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:2000330; P:positive regulation of T-helper 17 cell lineage commitment; ISS:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:2000318; P:positive regulation of T-helper 17 type immune response; ISS:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0034105; P:positive regulation of tissue remodeling; IC:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0032760; P:positive regulation of tumor necrosis factor production; IMP:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0042520; P:positive regulation of tyrosine phosphorylation of Stat4 protein; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0042523; P:positive regulation of tyrosine phosphorylation of Stat5 protein; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0042035; P:regulation of cytokine biosynthetic process; TAS:UniProtKB
P29460	IL12B	Interleukin-12 subunit beta	GO:0042510; P:regulation of tyrosine phosphorylation of Stat1 protein; IDA:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0010224; P:response to UV-B; IDA:UniProtKB
P29460	IL12B	Interleukin-12 subunit beta	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P29460	IL12B	Interleukin-12 subunit beta	GO:0019953; P:sexual reproduction; TAS:BHF-UCL
P29460	IL12B	Interleukin-12 subunit beta	GO:0042088; P:T-helper 1 type immune response; TAS:UniProtKB
P29460	IL12B	Interleukin-12 subunit beta	GO:0042093; P:T-helper cell differentiation; IDA:UniProtKB
P35225	IL13	Interleukin-13	GO:0005125; F:cytokine activity; TAS:ProtInc
P35225	IL13	Interleukin-13	GO:0005515; F:protein binding; IPI:IntAct
P35225	IL13	Interleukin-13	GO:0007267; P:cell-cell signaling; IC:UniProtKB
P35225	IL13	Interleukin-13	GO:0006928; P:cellular component movement; TAS:ProtInc
P35225	IL13	Interleukin-13	GO:0071345; P:cellular response to cytokine stimulus; IEA:Ensembl
P35225	IL13	Interleukin-13	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P35225	IL13	Interleukin-13	GO:0006955; P:immune response; IEA:InterPro
P35225	IL13	Interleukin-13	GO:0006954; P:inflammatory response; TAS:ProtInc
P35225	IL13	Interleukin-13	GO:1901247; P:negative regulation of lung ciliated cell differentiation; NAS:BHF-UCL
P35225	IL13	Interleukin-13	GO:0071635; P:negative regulation of transforming growth factor beta production; IEA:Ensembl
P35225	IL13	Interleukin-13	GO:0030890; P:positive regulation of B cell proliferation; IEA:Ensembl
P35225	IL13	Interleukin-13	GO:0032723; P:positive regulation of connective tissue growth factor production; IEA:Ensembl
P35225	IL13	Interleukin-13	GO:0002639; P:positive regulation of immunoglobulin production; IEA:Ensembl
P35225	IL13	Interleukin-13	GO:1901251; P:positive regulation of lung goblet cell differentiation; NAS:BHF-UCL
P35225	IL13	Interleukin-13	GO:0043032; P:positive regulation of macrophage activation; IEA:Ensembl
P35225	IL13	Interleukin-13	GO:2000231; P:positive regulation of pancreatic stellate cell proliferation; IEA:Ensembl
P35225	IL13	Interleukin-13	GO:0050714; P:positive regulation of protein secretion; IEA:Ensembl
P35225	IL13	Interleukin-13	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IEA:Ensembl
P35225	IL13	Interleukin-13	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
P35225	IL13	Interleukin-13	GO:0042526; P:positive regulation of tyrosine phosphorylation of Stat6 protein; IEA:Ensembl
P35225	IL13	Interleukin-13	GO:0010155; P:regulation of proton transport; IEA:Ensembl
P35225	IL13	Interleukin-13	GO:0045471; P:response to ethanol; IEA:Ensembl
P35225	IL13	Interleukin-13	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P35225	IL13	Interleukin-13	GO:0035094; P:response to nicotine; IEA:Ensembl
P35225	IL13	Interleukin-13	GO:0007165; P:signal transduction; NAS:ProtInc
P40933	IL15	Interleukin-15	GO:0005515; F:protein binding; IPI:IntAct
P40933	IL15	Interleukin-15	GO:0007568; P:aging; IEA:Ensembl
P40933	IL15	Interleukin-15	GO:0048469; P:cell maturation; IEA:Ensembl
P40933	IL15	Interleukin-15	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P40933	IL15	Interleukin-15	GO:0071305; P:cellular response to vitamin D; IEA:Ensembl
P40933	IL15	Interleukin-15	GO:0045062; P:extrathymic T cell selection; IEA:Ensembl
P40933	IL15	Interleukin-15	GO:0030212; P:hyaluronan metabolic process; IEA:Ensembl
P40933	IL15	Interleukin-15	GO:0006955; P:immune response; TAS:ProtInc
P40933	IL15	Interleukin-15	GO:0006954; P:inflammatory response; IEA:Ensembl
P40933	IL15	Interleukin-15	GO:0048535; P:lymph node development; IEA:Ensembl
P40933	IL15	Interleukin-15	GO:0001779; P:natural killer cell differentiation; IEA:Ensembl
P40933	IL15	Interleukin-15	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IEA:Ensembl
P40933	IL15	Interleukin-15	GO:0001866; P:NK T cell proliferation; IEA:Ensembl
P40933	IL15	Interleukin-15	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P40933	IL15	Interleukin-15	GO:0050778; P:positive regulation of immune response; IEA:Ensembl
P40933	IL15	Interleukin-15	GO:0050729; P:positive regulation of inflammatory response; IC:BHF-UCL
P40933	IL15	Interleukin-15	GO:0032740; P:positive regulation of interleukin-17 production; IDA:BHF-UCL
P40933	IL15	Interleukin-15	GO:0032825; P:positive regulation of natural killer cell differentiation; IEA:Ensembl
P40933	IL15	Interleukin-15	GO:0032819; P:positive regulation of natural killer cell proliferation; IEA:Ensembl
P40933	IL15	Interleukin-15	GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl
P40933	IL15	Interleukin-15	GO:0034105; P:positive regulation of tissue remodeling; IC:BHF-UCL
P40933	IL15	Interleukin-15	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IEA:Ensembl
P40933	IL15	Interleukin-15	GO:0050691; P:regulation of defense response to virus by host; IEA:Ensembl
P40933	IL15	Interleukin-15	GO:0045580; P:regulation of T cell differentiation; IEA:Ensembl
P40933	IL15	Interleukin-15	GO:0007165; P:signal transduction; TAS:ProtInc
P40933	IL15	Interleukin-15	GO:0014732; P:skeletal muscle atrophy; IEA:Ensembl
Q14005	IL16	Pro-interleukin-16	GO:0006955; P:immune response; TAS:ProtInc
Q14005	IL16	Pro-interleukin-16	GO:0050930; P:induction of positive chemotaxis; IEA:Ensembl
Q14005	IL16	Pro-interleukin-16	GO:0030595; P:leukocyte chemotaxis; IEA:Ensembl
Q14005	IL16	Pro-interleukin-16	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q14005	IL16	Pro-interleukin-16	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14005	IL16	Pro-interleukin-16	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9UHF5	IL17B	Interleukin-17B	GO:0005125; F:cytokine activity; TAS:ProtInc
Q9UHF5	IL17B	Interleukin-17B	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9UHF5	IL17B	Interleukin-17B	GO:0006955; P:immune response; TAS:ProtInc
Q9UHF5	IL17B	Interleukin-17B	GO:0006954; P:inflammatory response; IEA:InterPro
Q9UHF5	IL17B	Interleukin-17B	GO:1900017; P:positive regulation of cytokine production involved in inflammatory response; IEA:Ensembl
Q9P0M4	IL17C	Interleukin-17C	GO:0005125; F:cytokine activity; TAS:ProtInc
Q9P0M4	IL17C	Interleukin-17C	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q9P0M4	IL17C	Interleukin-17C	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9P0M4	IL17C	Interleukin-17C	GO:0006954; P:inflammatory response; TAS:ProtInc
Q9P0M4	IL17C	Interleukin-17C	GO:0030223; P:neutrophil differentiation; IEA:Ensembl
Q9P0M4	IL17C	Interleukin-17C	GO:1900017; P:positive regulation of cytokine production involved in inflammatory response; IEA:Ensembl
Q8TAD2	IL17D	Interleukin-17D	GO:0006954; P:inflammatory response; IEA:InterPro
Q96PD4	IL17F	Interleukin-17F	GO:0005125; F:cytokine activity; IDA:UniProtKB
Q96PD4	IL17F	Interleukin-17F	GO:0019955; F:cytokine binding; IDA:UniProtKB
Q96PD4	IL17F	Interleukin-17F	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q96PD4	IL17F	Interleukin-17F	GO:0051216; P:cartilage development; IDA:UniProtKB
Q96PD4	IL17F	Interleukin-17F	GO:0042089; P:cytokine biosynthetic process; IDA:UniProtKB
Q96PD4	IL17F	Interleukin-17F	GO:0006954; P:inflammatory response; IEA:InterPro
Q96PD4	IL17F	Interleukin-17F	GO:0042109; P:lymphotoxin A biosynthetic process; IDA:UniProtKB
Q96PD4	IL17F	Interleukin-17F	GO:0016525; P:negative regulation of angiogenesis; IDA:UniProtKB
Q96PD4	IL17F	Interleukin-17F	GO:1900017; P:positive regulation of cytokine production involved in inflammatory response; IEA:Ensembl
Q96PD4	IL17F	Interleukin-17F	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q96PD4	IL17F	Interleukin-17F	GO:0006029; P:proteoglycan metabolic process; IDA:UniProtKB
Q96PD4	IL17F	Interleukin-17F	GO:0045423; P:regulation of granulocyte macrophage colony-stimulating factor biosynthetic process; IDA:UniProtKB
Q96PD4	IL17F	Interleukin-17F	GO:0045076; P:regulation of interleukin-2 biosynthetic process; IDA:UniProtKB
Q96PD4	IL17F	Interleukin-17F	GO:0045408; P:regulation of interleukin-6 biosynthetic process; IDA:UniProtKB
Q96PD4	IL17F	Interleukin-17F	GO:0045414; P:regulation of interleukin-8 biosynthetic process; IDA:UniProtKB
Q96PD4	IL17F	Interleukin-17F	GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
Q16552	IL17A	Interleukin-17A	GO:0005125; F:cytokine activity; TAS:ProtInc
Q16552	IL17A	Interleukin-17A	GO:0006915; P:apoptotic process; TAS:ProtInc
Q16552	IL17A	Interleukin-17A	GO:0008219; P:cell death; TAS:ProtInc
Q16552	IL17A	Interleukin-17A	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q16552	IL17A	Interleukin-17A	GO:0071347; P:cellular response to interleukin-1; IEA:Ensembl
Q16552	IL17A	Interleukin-17A	GO:0072537; P:fibroblast activation; IDA:BHF-UCL
Q16552	IL17A	Interleukin-17A	GO:0006955; P:immune response; TAS:ProtInc
Q16552	IL17A	Interleukin-17A	GO:0006954; P:inflammatory response; IEA:InterPro
Q16552	IL17A	Interleukin-17A	GO:1900017; P:positive regulation of cytokine production involved in inflammatory response; IEA:Ensembl
Q16552	IL17A	Interleukin-17A	GO:0032747; P:positive regulation of interleukin-23 production; IDA:BHF-UCL
Q16552	IL17A	Interleukin-17A	GO:0045672; P:positive regulation of osteoclast differentiation; IDA:BHF-UCL
Q16552	IL17A	Interleukin-17A	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q16552	IL17A	Interleukin-17A	GO:0006486; P:protein glycosylation; TAS:ProtInc
Q13478	IL18R1	Interleukin-18 receptor 1	GO:0004908; F:interleukin-1 receptor activity; IEA:InterPro
Q13478	IL18R1	Interleukin-18 receptor 1	GO:0042008; F:interleukin-18 receptor activity; IEA:Ensembl
Q13478	IL18R1	Interleukin-18 receptor 1	GO:0004872; F:receptor activity; TAS:ProtInc
Q13478	IL18R1	Interleukin-18 receptor 1	GO:0006955; P:immune response; TAS:ProtInc
Q13478	IL18R1	Interleukin-18 receptor 1	GO:0030101; P:natural killer cell activation; IEA:Ensembl
Q13478	IL18R1	Interleukin-18 receptor 1	GO:0032729; P:positive regulation of interferon-gamma production; IEA:Ensembl
Q13478	IL18R1	Interleukin-18 receptor 1	GO:0042346; P:positive regulation of NF-kappaB import into nucleus; IEA:Ensembl
Q13478	IL18R1	Interleukin-18 receptor 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q13478	IL18R1	Interleukin-18 receptor 1	GO:0045063; P:T-helper 1 cell differentiation; IEA:Ensembl
Q14116	IL18	Interleukin-18	GO:0005125; F:cytokine activity; TAS:UniProtKB
Q14116	IL18	Interleukin-18	GO:0001525; P:angiogenesis; IDA:UniProtKB
Q14116	IL18	Interleukin-18	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q14116	IL18	Interleukin-18	GO:0071407; P:cellular response to organic cyclic compound; IDA:UniProtKB
Q14116	IL18	Interleukin-18	GO:0042033; P:chemokine biosynthetic process; TAS:UniProtKB
Q14116	IL18	Interleukin-18	GO:0042253; P:granulocyte macrophage colony-stimulating factor biosynthetic process; TAS:UniProtKB
Q14116	IL18	Interleukin-18	GO:0006955; P:immune response; TAS:ProtInc
Q14116	IL18	Interleukin-18	GO:0006954; P:inflammatory response; IDA:UniProtKB
Q14116	IL18	Interleukin-18	GO:0042095; P:interferon-gamma biosynthetic process; TAS:UniProtKB
Q14116	IL18	Interleukin-18	GO:0042231; P:interleukin-13 biosynthetic process; TAS:UniProtKB
Q14116	IL18	Interleukin-18	GO:0042094; P:interleukin-2 biosynthetic process; TAS:UniProtKB
Q14116	IL18	Interleukin-18	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IDA:UniProtKB
Q14116	IL18	Interleukin-18	GO:0000165; P:MAPK cascade; IMP:UniProtKB
Q14116	IL18	Interleukin-18	GO:0030101; P:natural killer cell activation; IEA:Ensembl
Q14116	IL18	Interleukin-18	GO:0042104; P:positive regulation of activated T cell proliferation; IDA:UniProtKB
Q14116	IL18	Interleukin-18	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
Q14116	IL18	Interleukin-18	GO:0032725; P:positive regulation of granulocyte macrophage colony-stimulating factor production; IDA:BHF-UCL
Q14116	IL18	Interleukin-18	GO:0050729; P:positive regulation of inflammatory response; IC:BHF-UCL
Q14116	IL18	Interleukin-18	GO:0032729; P:positive regulation of interferon-gamma production; IDA:BHF-UCL
Q14116	IL18	Interleukin-18	GO:0032740; P:positive regulation of interleukin-17 production; IDA:BHF-UCL
Q14116	IL18	Interleukin-18	GO:0032819; P:positive regulation of natural killer cell proliferation; IDA:BHF-UCL
Q14116	IL18	Interleukin-18	GO:0042346; P:positive regulation of NF-kappaB import into nucleus; IEA:Ensembl
Q14116	IL18	Interleukin-18	GO:0051142; P:positive regulation of NK T cell proliferation; IDA:BHF-UCL
Q14116	IL18	Interleukin-18	GO:0034105; P:positive regulation of tissue remodeling; IC:BHF-UCL
Q14116	IL18	Interleukin-18	GO:0030155; P:regulation of cell adhesion; IDA:UniProtKB
Q14116	IL18	Interleukin-18	GO:0030431; P:sleep; ISS:UniProtKB
Q14116	IL18	Interleukin-18	GO:0042088; P:T-helper 1 type immune response; IDA:UniProtKB
Q14116	IL18	Interleukin-18	GO:0042092; P:type 2 immune response; TAS:UniProtKB
Q9NPH3	IL1RAP	Interleukin-1 receptor accessory protein	GO:0004908; F:interleukin-1 receptor activity; IEA:Ensembl
Q9NPH3	IL1RAP	Interleukin-1 receptor accessory protein	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q9NPH3	IL1RAP	Interleukin-1 receptor accessory protein	GO:0006955; P:immune response; TAS:ProtInc
Q9NPH3	IL1RAP	Interleukin-1 receptor accessory protein	GO:0006954; P:inflammatory response; TAS:ProtInc
Q9NPH3	IL1RAP	Interleukin-1 receptor accessory protein	GO:0042094; P:interleukin-2 biosynthetic process; IEA:Ensembl
Q9NPH3	IL1RAP	Interleukin-1 receptor accessory protein	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q9UHD0	IL19	Interleukin-19	GO:0005125; F:cytokine activity; TAS:UniProtKB
Q9UHD0	IL19	Interleukin-19	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9UHD0	IL19	Interleukin-19	GO:0006955; P:immune response; NAS:UniProtKB
Q9UHD0	IL19	Interleukin-19	GO:0042226; P:interleukin-6 biosynthetic process; IEA:Ensembl
Q9UHD0	IL19	Interleukin-19	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl
Q9UHD0	IL19	Interleukin-19	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl
Q9UHD0	IL19	Interleukin-19	GO:0072593; P:reactive oxygen species metabolic process; IEA:Ensembl
Q9UHD0	IL19	Interleukin-19	GO:0007165; P:signal transduction; NAS:UniProtKB
P01583	IL1A	Interleukin-1 alpha	GO:0005507; F:copper ion binding; IDA:UniProtKB
P01583	IL1A	Interleukin-1 alpha	GO:0005125; F:cytokine activity; IMP:BHF-UCL
P01583	IL1A	Interleukin-1 alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P01583	IL1A	Interleukin-1 alpha	GO:0006915; P:apoptotic process; TAS:ProtInc
P01583	IL1A	Interleukin-1 alpha	GO:0008283; P:cell proliferation; TAS:ProtInc
P01583	IL1A	Interleukin-1 alpha	GO:0034605; P:cellular response to heat; IDA:UniProtKB
P01583	IL1A	Interleukin-1 alpha	GO:0019221; P:cytokine-mediated signaling pathway; IMP:BHF-UCL
P01583	IL1A	Interleukin-1 alpha	GO:0035234; P:ectopic germ cell programmed cell death; IEA:Ensembl
P01583	IL1A	Interleukin-1 alpha	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P01583	IL1A	Interleukin-1 alpha	GO:0001660; P:fever generation; IEA:UniProtKB-KW
P01583	IL1A	Interleukin-1 alpha	GO:0006955; P:immune response; IEA:InterPro
P01583	IL1A	Interleukin-1 alpha	GO:0006954; P:inflammatory response; TAS:ProtInc
P01583	IL1A	Interleukin-1 alpha	GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL
P01583	IL1A	Interleukin-1 alpha	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; TAS:BHF-UCL
P01583	IL1A	Interleukin-1 alpha	GO:0045766; P:positive regulation of angiogenesis; ISS:BHF-UCL
P01583	IL1A	Interleukin-1 alpha	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P01583	IL1A	Interleukin-1 alpha	GO:0050715; P:positive regulation of cytokine secretion; IDA:BHF-UCL
P01583	IL1A	Interleukin-1 alpha	GO:0045086; P:positive regulation of interleukin-2 biosynthetic process; IMP:BHF-UCL
P01583	IL1A	Interleukin-1 alpha	GO:0045840; P:positive regulation of mitosis; IMP:BHF-UCL
P01583	IL1A	Interleukin-1 alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P01583	IL1A	Interleukin-1 alpha	GO:0010575; P:positive regulation vascular endothelial growth factor production; ISS:BHF-UCL
P01583	IL1A	Interleukin-1 alpha	GO:0046688; P:response to copper ion; IDA:UniProtKB
P01584	IL1B	Interleukin-1 beta	GO:0005125; F:cytokine activity; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0005149; F:interleukin-1 receptor binding; NAS:UniProtKB
P01584	IL1B	Interleukin-1 beta	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P01584	IL1B	Interleukin-1 beta	GO:0000187; P:activation of MAPK activity; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0006915; P:apoptotic process; TAS:ProtInc
P01584	IL1B	Interleukin-1 beta	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P01584	IL1B	Interleukin-1 beta	GO:0035690; P:cellular response to drug; IDA:MGI
P01584	IL1B	Interleukin-1 beta	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
P01584	IL1B	Interleukin-1 beta	GO:0071407; P:cellular response to organic cyclic compound; IDA:UniProtKB
P01584	IL1B	Interleukin-1 beta	GO:0071310; P:cellular response to organic substance; IDA:MGI
P01584	IL1B	Interleukin-1 beta	GO:0019221; P:cytokine-mediated signaling pathway; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0035234; P:ectopic germ cell programmed cell death; IEA:Ensembl
P01584	IL1B	Interleukin-1 beta	GO:0007566; P:embryo implantation; TAS:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P01584	IL1B	Interleukin-1 beta	GO:0001660; P:fever generation; IEA:UniProtKB-KW
P01584	IL1B	Interleukin-1 beta	GO:0030213; P:hyaluronan biosynthetic process; IDA:UniProtKB
P01584	IL1B	Interleukin-1 beta	GO:0006955; P:immune response; IEA:InterPro
P01584	IL1B	Interleukin-1 beta	GO:0006954; P:inflammatory response; IDA:UniProtKB
P01584	IL1B	Interleukin-1 beta	GO:0032611; P:interleukin-1 beta production; IEA:Ensembl
P01584	IL1B	Interleukin-1 beta	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IDA:UniProtKB
P01584	IL1B	Interleukin-1 beta	GO:0000165; P:MAPK cascade; IMP:UniProtKB
P01584	IL1B	Interleukin-1 beta	GO:0070487; P:monocyte aggregation; IDA:UniProtKB
P01584	IL1B	Interleukin-1 beta	GO:0070164; P:negative regulation of adiponectin secretion; ISS:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0010829; P:negative regulation of glucose transport; ISS:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0046627; P:negative regulation of insulin receptor signaling pathway; ISS:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0050995; P:negative regulation of lipid catabolic process; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0045833; P:negative regulation of lipid metabolic process; ISS:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0043407; P:negative regulation of MAP kinase activity; ISS:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0030593; P:neutrophil chemotaxis; IEA:Ensembl
P01584	IL1B	Interleukin-1 beta	GO:0045766; P:positive regulation of angiogenesis; ISS:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0060559; P:positive regulation of calcidiol 1-monooxygenase activity; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0060355; P:positive regulation of cell adhesion molecule production; NAS:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P01584	IL1B	Interleukin-1 beta	GO:0045080; P:positive regulation of chemokine biosynthetic process; IEA:Ensembl
P01584	IL1B	Interleukin-1 beta	GO:0031622; P:positive regulation of fever generation; ISS:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0032725; P:positive regulation of granulocyte macrophage colony-stimulating factor production; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0034116; P:positive regulation of heterotypic cell-cell adhesion; IDA:UniProtKB
P01584	IL1B	Interleukin-1 beta	GO:0035066; P:positive regulation of histone acetylation; NAS:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0033129; P:positive regulation of histone phosphorylation; NAS:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
P01584	IL1B	Interleukin-1 beta	GO:0032729; P:positive regulation of interferon-gamma production; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0045086; P:positive regulation of interleukin-2 biosynthetic process; IMP:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0045410; P:positive regulation of interleukin-6 biosynthetic process; IEA:Ensembl
P01584	IL1B	Interleukin-1 beta	GO:0032755; P:positive regulation of interleukin-6 production; TAS:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0032757; P:positive regulation of interleukin-8 production; IDA:UniProtKB
P01584	IL1B	Interleukin-1 beta	GO:0046330; P:positive regulation of JNK cascade; IEA:Ensembl
P01584	IL1B	Interleukin-1 beta	GO:0050996; P:positive regulation of lipid catabolic process; ISS:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0051044; P:positive regulation of membrane protein ectodomain proteolysis; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0045840; P:positive regulation of mitosis; IMP:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0071639; P:positive regulation of monocyte chemotactic protein-1 production; IDA:UniProtKB
P01584	IL1B	Interleukin-1 beta	GO:0035505; P:positive regulation of myosin light chain kinase activity; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0042346; P:positive regulation of NF-kappaB import into nucleus; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0032308; P:positive regulation of prostaglandin secretion; ISS:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0046827; P:positive regulation of protein export from nucleus; NAS:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0001934; P:positive regulation of protein phosphorylation; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0002711; P:positive regulation of T cell mediated immunity; IC:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0042102; P:positive regulation of T cell proliferation; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P01584	IL1B	Interleukin-1 beta	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P01584	IL1B	Interleukin-1 beta	GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; IC:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0010575; P:positive regulation vascular endothelial growth factor production; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0043491; P:protein kinase B signaling; IMP:UniProtKB
P01584	IL1B	Interleukin-1 beta	GO:0043122; P:regulation of I-kappaB kinase/NF-kappaB signaling; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0050796; P:regulation of insulin secretion; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0033198; P:response to ATP; IEA:Ensembl
P01584	IL1B	Interleukin-1 beta	GO:0009743; P:response to carbohydrate; IEA:Ensembl
P01584	IL1B	Interleukin-1 beta	GO:0030730; P:sequestering of triglyceride; IDA:BHF-UCL
P01584	IL1B	Interleukin-1 beta	GO:0007165; P:signal transduction; TAS:ProtInc
P01584	IL1B	Interleukin-1 beta	GO:0014805; P:smooth muscle adaptation; NAS:BHF-UCL
P14778	IL1R1	Interleukin-1 receptor type 1	GO:0004908; F:interleukin-1 receptor activity; IDA:BHF-UCL
P14778	IL1R1	Interleukin-1 receptor type 1	GO:0004909; F:interleukin-1, Type I, activating receptor activity; TAS:ProtInc
P14778	IL1R1	Interleukin-1 receptor type 1	GO:0005161; F:platelet-derived growth factor receptor binding; IPI:BHF-UCL
P14778	IL1R1	Interleukin-1 receptor type 1	GO:0005515; F:protein binding; IPI:IntAct
P14778	IL1R1	Interleukin-1 receptor type 1	GO:0004871; F:signal transducer activity; TAS:ProtInc
P14778	IL1R1	Interleukin-1 receptor type 1	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
P14778	IL1R1	Interleukin-1 receptor type 1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P14778	IL1R1	Interleukin-1 receptor type 1	GO:0006955; P:immune response; TAS:ProtInc
P14778	IL1R1	Interleukin-1 receptor type 1	GO:0070498; P:interleukin-1-mediated signaling pathway; IDA:BHF-UCL
P14778	IL1R1	Interleukin-1 receptor type 1	GO:0050727; P:regulation of inflammatory response; IEA:Ensembl
P14778	IL1R1	Interleukin-1 receptor type 1	GO:0070555; P:response to interleukin-1; IDA:BHF-UCL
P27930	IL1R2	Interleukin-1 receptor type 2	GO:0004908; F:interleukin-1 receptor activity; TAS:ProtInc
P27930	IL1R2	Interleukin-1 receptor type 2	GO:0004910; F:interleukin-1, Type II, blocking receptor activity; IEA:InterPro
P27930	IL1R2	Interleukin-1 receptor type 2	GO:0005515; F:protein binding; IPI:BHF-UCL
P27930	IL1R2	Interleukin-1 receptor type 2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:GOC
P27930	IL1R2	Interleukin-1 receptor type 2	GO:0006955; P:immune response; TAS:ProtInc
Q9NYY1	IL20	Interleukin-20	GO:0045517; F:interleukin-20 receptor binding; TAS:UniProtKB
Q9NYY1	IL20	Interleukin-20	GO:0045606; P:positive regulation of epidermal cell differentiation; TAS:UniProtKB
Q9NYY1	IL20	Interleukin-20	GO:0045618; P:positive regulation of keratinocyte differentiation; TAS:UniProtKB
Q9NYY1	IL20	Interleukin-20	GO:0045672; P:positive regulation of osteoclast differentiation; IEA:Ensembl
Q9NYY1	IL20	Interleukin-20	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; TAS:UniProtKB
Q9NYY1	IL20	Interleukin-20	GO:0050727; P:regulation of inflammatory response; TAS:UniProtKB
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0005152; F:interleukin-1 receptor antagonist activity; IDA:BHF-UCL
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0005149; F:interleukin-1 receptor binding; IDA:BHF-UCL
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0045352; F:interleukin-1 Type I receptor antagonist activity; IDA:BHF-UCL
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0045353; F:interleukin-1 Type II receptor antagonist activity; IDA:BHF-UCL
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0005150; F:interleukin-1, Type I receptor binding; IPI:BHF-UCL
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0005151; F:interleukin-1, Type II receptor binding; IPI:BHF-UCL
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0006953; P:acute-phase response; IDA:BHF-UCL
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0019752; P:carboxylic acid metabolic process; IEA:Ensembl
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0002439; P:chronic inflammatory response to antigenic stimulus; IEA:Ensembl
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0007565; P:female pregnancy; IEA:Ensembl
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0001660; P:fever generation; IEA:Ensembl
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0006955; P:immune response; NAS:UniProtKB
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0030073; P:insulin secretion; IEA:Ensembl
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0006629; P:lipid metabolic process; IEA:Ensembl
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0007613; P:memory; IEA:Ensembl
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0001960; P:negative regulation of cytokine-mediated signaling pathway; IDA:GOC
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0014050; P:negative regulation of glutamate secretion; IEA:Ensembl
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0034115; P:negative regulation of heterotypic cell-cell adhesion; IDA:BHF-UCL
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:2000660; P:negative regulation of interleukin-1-mediated signaling pathway; IDA:BHF-UCL
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0045837; P:negative regulation of membrane potential; IEA:Ensembl
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0043507; P:positive regulation of JUN kinase activity; IEA:Ensembl
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0042493; P:response to drug; IEA:Ensembl
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0051384; P:response to glucocorticoid; IDA:BHF-UCL
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0070670; P:response to interleukin-4; IEA:Ensembl
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P18510	IL1RN	Interleukin-1 receptor antagonist protein	GO:0010243; P:response to organonitrogen compound; IEA:Ensembl
Q9HBE5	IL21R	Interleukin-21 receptor	GO:0001532; F:interleukin-21 receptor activity; NAS:UniProtKB
Q9HBE5	IL21R	Interleukin-21 receptor	GO:0038114; P:interleukin-21-mediated signaling pathway; NAS:GOC
Q9HBE5	IL21R	Interleukin-21 receptor	GO:0030101; P:natural killer cell activation; NAS:UniProtKB
Q9HBE4	IL21	Interleukin-21	GO:0005126; F:cytokine receptor binding; TAS:UniProtKB
Q9HBE4	IL21	Interleukin-21	GO:0005134; F:interleukin-2 receptor binding; IPI:UniProtKB
Q9HBE4	IL21	Interleukin-21	GO:0048469; P:cell maturation; IDA:UniProtKB
Q9HBE4	IL21	Interleukin-21	GO:0006955; P:immune response; IEA:InterPro
Q9HBE4	IL21	Interleukin-21	GO:0030890; P:positive regulation of B cell proliferation; IDA:MGI
Q9HBE4	IL21	Interleukin-21	GO:0008284; P:positive regulation of cell proliferation; IDA:MGI
Q9HBE4	IL21	Interleukin-21	GO:0050729; P:positive regulation of inflammatory response; IC:BHF-UCL
Q9HBE4	IL21	Interleukin-21	GO:0045078; P:positive regulation of interferon-gamma biosynthetic process; NAS:UniProtKB
Q9HBE4	IL21	Interleukin-21	GO:0032733; P:positive regulation of interleukin-10 production; IEA:Ensembl
Q9HBE4	IL21	Interleukin-21	GO:0032740; P:positive regulation of interleukin-17 production; IDA:BHF-UCL
Q9HBE4	IL21	Interleukin-21	GO:0002729; P:positive regulation of natural killer cell cytokine production; IEA:Ensembl
Q9HBE4	IL21	Interleukin-21	GO:0032825; P:positive regulation of natural killer cell differentiation; IEA:Ensembl
Q9HBE4	IL21	Interleukin-21	GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; IEA:Ensembl
Q9HBE4	IL21	Interleukin-21	GO:0042102; P:positive regulation of T cell proliferation; IDA:UniProtKB
Q9HBE4	IL21	Interleukin-21	GO:0034105; P:positive regulation of tissue remodeling; IC:BHF-UCL
Q9HBE4	IL21	Interleukin-21	GO:0042511; P:positive regulation of tyrosine phosphorylation of Stat1 protein; IDA:MGI
Q9HBE4	IL21	Interleukin-21	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IDA:MGI
Q9HBE4	IL21	Interleukin-21	GO:0007165; P:signal transduction; NAS:UniProtKB
Q9GZX6	IL22	Interleukin-22	GO:0045518; F:interleukin-22 receptor binding; NAS:UniProtKB
Q9GZX6	IL22	Interleukin-22	GO:0006953; P:acute-phase response; NAS:UniProtKB
Q9GZX6	IL22	Interleukin-22	GO:0007267; P:cell-cell signaling; IC:UniProtKB
Q9GZX6	IL22	Interleukin-22	GO:0006954; P:inflammatory response; NAS:UniProtKB
Q9GZX6	IL22	Interleukin-22	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0050829; P:defense response to Gram-negative bacterium; IDA:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0032693; P:negative regulation of interleukin-10 production; IMP:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0042104; P:positive regulation of activated T cell proliferation; IDA:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0010535; P:positive regulation of activation of JAK2 kinase activity; IDA:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0002230; P:positive regulation of defense response to virus by host; IDA:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0032725; P:positive regulation of granulocyte macrophage colony-stimulating factor production; IDA:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0050729; P:positive regulation of inflammatory response; IC:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0032729; P:positive regulation of interferon-gamma production; IDA:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0032733; P:positive regulation of interleukin-10 production; IDA:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0032735; P:positive regulation of interleukin-12 production; IDA:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0032740; P:positive regulation of interleukin-17 production; IDA:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0043382; P:positive regulation of memory T cell differentiation; ISS:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0032816; P:positive regulation of natural killer cell activation; IC:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0032819; P:positive regulation of natural killer cell proliferation; IDA:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0090023; P:positive regulation of neutrophil chemotaxis; IEA:Ensembl
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0042346; P:positive regulation of NF-kappaB import into nucleus; TAS:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0051135; P:positive regulation of NK T cell activation; IDA:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0051142; P:positive regulation of NK T cell proliferation; IDA:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0045672; P:positive regulation of osteoclast differentiation; IDA:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; ISS:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0042102; P:positive regulation of T cell proliferation; IDA:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0002827; P:positive regulation of T-helper 1 type immune response; IDA:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:2000330; P:positive regulation of T-helper 17 cell lineage commitment; ISS:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:2000318; P:positive regulation of T-helper 17 type immune response; ISS:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0034105; P:positive regulation of tissue remodeling; IC:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0032760; P:positive regulation of tumor necrosis factor production; IMP:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IDA:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0042520; P:positive regulation of tyrosine phosphorylation of Stat4 protein; IDA:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0042523; P:positive regulation of tyrosine phosphorylation of Stat5 protein; IDA:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0042510; P:regulation of tyrosine phosphorylation of Stat1 protein; IDA:BHF-UCL
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0042098; P:T cell proliferation; IEA:Ensembl
Q9NPF7	IL23A	Interleukin-23 subunit alpha	GO:0048771; P:tissue remodeling; IEA:UniProtKB-KW
Q13007	IL24	Interleukin-24	GO:0006915; P:apoptotic process; TAS:ProtInc
Q13007	IL24	Interleukin-24	GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl
Q13007	IL24	Interleukin-24	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
Q13007	IL24	Interleukin-24	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q13007	IL24	Interleukin-24	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
Q13007	IL24	Interleukin-24	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q13007	IL24	Interleukin-24	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
Q13007	IL24	Interleukin-24	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q13007	IL24	Interleukin-24	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q13007	IL24	Interleukin-24	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
Q13007	IL24	Interleukin-24	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IEA:Ensembl
Q13007	IL24	Interleukin-24	GO:0033136; P:serine phosphorylation of STAT3 protein; IEA:Ensembl
Q13007	IL24	Interleukin-24	GO:0042060; P:wound healing; IEA:Ensembl
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0050829; P:defense response to Gram-negative bacterium; IC:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0038155; P:interleukin-23-mediated signaling pathway; IDA:GOC
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0032693; P:negative regulation of interleukin-10 production; IMP:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0042104; P:positive regulation of activated T cell proliferation; IC:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0010535; P:positive regulation of activation of JAK2 kinase activity; IC:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0002230; P:positive regulation of defense response to virus by host; IDA:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0032725; P:positive regulation of granulocyte macrophage colony-stimulating factor production; IC:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0032729; P:positive regulation of interferon-gamma production; IDA:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0032735; P:positive regulation of interleukin-12 production; IDA:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0032740; P:positive regulation of interleukin-17 production; IC:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0043382; P:positive regulation of memory T cell differentiation; ISS:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0032819; P:positive regulation of natural killer cell proliferation; IC:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0051135; P:positive regulation of NK T cell activation; IC:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0045672; P:positive regulation of osteoclast differentiation; IC:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; ISS:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0042102; P:positive regulation of T cell proliferation; IC:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0002827; P:positive regulation of T-helper 1 type immune response; IDA:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:2000330; P:positive regulation of T-helper 17 cell lineage commitment; ISS:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:2000318; P:positive regulation of T-helper 17 type immune response; ISS:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IC:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0042520; P:positive regulation of tyrosine phosphorylation of Stat4 protein; IC:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0042523; P:positive regulation of tyrosine phosphorylation of Stat5 protein; IC:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0042510; P:regulation of tyrosine phosphorylation of Stat1 protein; IC:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0034341; P:response to interferon-gamma; IDA:BHF-UCL
Q5VWK5	IL23R	Interleukin-23 receptor	GO:0032496; P:response to lipopolysaccharide; IDA:BHF-UCL
Q9H293	IL25	Interleukin-25	GO:0030380; F:interleukin-17E receptor binding; TAS:UniProtKB
Q9H293	IL25	Interleukin-25	GO:0030222; P:eosinophil differentiation; IEA:Ensembl
Q9H293	IL25	Interleukin-25	GO:0002437; P:inflammatory response to antigenic stimulus; IEA:Ensembl
Q9H293	IL25	Interleukin-25	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9H293	IL25	Interleukin-25	GO:0009620; P:response to fungus; IEA:Ensembl
Q9H293	IL25	Interleukin-25	GO:0009624; P:response to nematode; IEA:Ensembl
Q8NEV9	IL27	Interleukin-27 subunit alpha	GO:0045523; F:interleukin-27 receptor binding; ISS:UniProtKB
Q8NEV9	IL27	Interleukin-27 subunit alpha	GO:0005102; F:receptor binding; ISS:UniProtKB
Q8NEV9	IL27	Interleukin-27 subunit alpha	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q8NEV9	IL27	Interleukin-27 subunit alpha	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q8NEV9	IL27	Interleukin-27 subunit alpha	GO:0045078; P:positive regulation of interferon-gamma biosynthetic process; IDA:UniProtKB
Q8NEV9	IL27	Interleukin-27 subunit alpha	GO:0050688; P:regulation of defense response to virus; IEA:UniProtKB-KW
Q8NEV9	IL27	Interleukin-27 subunit alpha	GO:0042129; P:regulation of T cell proliferation; ISS:UniProtKB
Q8NEV9	IL27	Interleukin-27 subunit alpha	GO:0045625; P:regulation of T-helper 1 cell differentiation; IDA:UniProtKB
Q8NEV9	IL27	Interleukin-27 subunit alpha	GO:0009617; P:response to bacterium; IEA:Ensembl
Q9NPH9	IL26	Interleukin-26	GO:0005125; F:cytokine activity; IDA:UniProtKB
Q9NPH9	IL26	Interleukin-26	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9NPH9	IL26	Interleukin-26	GO:0050680; P:negative regulation of epithelial cell proliferation; IDA:UniProtKB
Q9NPH9	IL26	Interleukin-26	GO:0050715; P:positive regulation of cytokine secretion; IDA:UniProtKB
Q9NPH9	IL26	Interleukin-26	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
Q9NPH9	IL26	Interleukin-26	GO:0046427; P:positive regulation of JAK-STAT cascade; IDA:UniProtKB
Q9NPH9	IL26	Interleukin-26	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:UniProtKB
Q9NPH9	IL26	Interleukin-26	GO:0032874; P:positive regulation of stress-activated MAPK cascade; IDA:UniProtKB
Q9NPH9	IL26	Interleukin-26	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q14213	EBI3	Interleukin-27 subunit beta	GO:0004896; F:cytokine receptor activity; IPI:UniProtKB
Q14213	EBI3	Interleukin-27 subunit beta	GO:0005515; F:protein binding; IPI:UniProtKB
Q14213	EBI3	Interleukin-27 subunit beta	GO:0019221; P:cytokine-mediated signaling pathway; IPI:GOC
Q14213	EBI3	Interleukin-27 subunit beta	GO:0006959; P:humoral immune response; TAS:ProtInc
Q14213	EBI3	Interleukin-27 subunit beta	GO:0046641; P:positive regulation of alpha-beta T cell proliferation; TAS:UniProtKB
Q14213	EBI3	Interleukin-27 subunit beta	GO:0045078; P:positive regulation of interferon-gamma biosynthetic process; TAS:UniProtKB
Q14213	EBI3	Interleukin-27 subunit beta	GO:0042088; P:T-helper 1 type immune response; TAS:UniProtKB
P01589	IL2RA	Interleukin-2 receptor subunit alpha	GO:0008144; F:drug binding; IEA:Ensembl
P01589	IL2RA	Interleukin-2 receptor subunit alpha	GO:0004911; F:interleukin-2 receptor activity; TAS:ProtInc
P01589	IL2RA	Interleukin-2 receptor subunit alpha	GO:0006924; P:activation-induced cell death of T cells; IEA:Ensembl
P01589	IL2RA	Interleukin-2 receptor subunit alpha	GO:0006915; P:apoptotic process; TAS:ProtInc
P01589	IL2RA	Interleukin-2 receptor subunit alpha	GO:0008283; P:cell proliferation; TAS:ProtInc
P01589	IL2RA	Interleukin-2 receptor subunit alpha	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P01589	IL2RA	Interleukin-2 receptor subunit alpha	GO:0006955; P:immune response; TAS:ProtInc
P01589	IL2RA	Interleukin-2 receptor subunit alpha	GO:0002437; P:inflammatory response to antigenic stimulus; IEA:Ensembl
P01589	IL2RA	Interleukin-2 receptor subunit alpha	GO:0050687; P:negative regulation of defense response to virus; IEA:Ensembl
P01589	IL2RA	Interleukin-2 receptor subunit alpha	GO:0050777; P:negative regulation of immune response; IEA:Ensembl
P01589	IL2RA	Interleukin-2 receptor subunit alpha	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
P01589	IL2RA	Interleukin-2 receptor subunit alpha	GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl
P01589	IL2RA	Interleukin-2 receptor subunit alpha	GO:0007219; P:Notch signaling pathway; IEA:Ensembl
P01589	IL2RA	Interleukin-2 receptor subunit alpha	GO:0042104; P:positive regulation of activated T cell proliferation; IEA:Ensembl
P01589	IL2RA	Interleukin-2 receptor subunit alpha	GO:0045582; P:positive regulation of T cell differentiation; IEA:Ensembl
P01589	IL2RA	Interleukin-2 receptor subunit alpha	GO:0046013; P:regulation of T cell homeostatic proliferation; IEA:Ensembl
P14784	IL2RB	Interleukin-2 receptor subunit beta	GO:0019976; F:interleukin-2 binding; ISS:UniProtKB
P14784	IL2RB	Interleukin-2 receptor subunit beta	GO:0004911; F:interleukin-2 receptor activity; IDA:MGI
P14784	IL2RB	Interleukin-2 receptor subunit beta	GO:0019221; P:cytokine-mediated signaling pathway; IDA:MGI
P14784	IL2RB	Interleukin-2 receptor subunit beta	GO:0038110; P:interleukin-2-mediated signaling pathway; IDA:GOC
P14784	IL2RB	Interleukin-2 receptor subunit beta	GO:0043066; P:negative regulation of apoptotic process; IDA:MGI
P14784	IL2RB	Interleukin-2 receptor subunit beta	GO:0006461; P:protein complex assembly; TAS:ProtInc
P14784	IL2RB	Interleukin-2 receptor subunit beta	GO:0007165; P:signal transduction; TAS:ProtInc
P14784	IL2RB	Interleukin-2 receptor subunit beta	GO:0016032; P:viral process; IEA:UniProtKB-KW
P31785	IL2RG	Cytokine receptor common subunit gamma	GO:0004896; F:cytokine receptor activity; IEA:InterPro
P31785	IL2RG	Cytokine receptor common subunit gamma	GO:0019976; F:interleukin-2 binding; ISS:UniProtKB
P31785	IL2RG	Cytokine receptor common subunit gamma	GO:0005515; F:protein binding; IPI:UniProtKB
P31785	IL2RG	Cytokine receptor common subunit gamma	GO:0006955; P:immune response; TAS:ProtInc
P31785	IL2RG	Cytokine receptor common subunit gamma	GO:0038110; P:interleukin-2-mediated signaling pathway; TAS:GOC
P31785	IL2RG	Cytokine receptor common subunit gamma	GO:0035771; P:interleukin-4-mediated signaling pathway; TAS:GOC
P31785	IL2RG	Cytokine receptor common subunit gamma	GO:0038111; P:interleukin-7-mediated signaling pathway; TAS:GOC
P31785	IL2RG	Cytokine receptor common subunit gamma	GO:0007165; P:signal transduction; NAS:ProtInc
P31785	IL2RG	Cytokine receptor common subunit gamma	GO:0016032; P:viral process; IEA:UniProtKB-KW
P60568	IL2	Interleukin-2	GO:0030246; F:carbohydrate binding; IEA:Ensembl
P60568	IL2	Interleukin-2	GO:0005125; F:cytokine activity; IDA:MGI
P60568	IL2	Interleukin-2	GO:0043208; F:glycosphingolipid binding; IEA:Ensembl
P60568	IL2	Interleukin-2	GO:0008083; F:growth factor activity; TAS:UniProtKB
P60568	IL2	Interleukin-2	GO:0005134; F:interleukin-2 receptor binding; TAS:UniProtKB
P60568	IL2	Interleukin-2	GO:0019209; F:kinase activator activity; TAS:UniProtKB
P60568	IL2	Interleukin-2	GO:0007155; P:cell adhesion; TAS:UniProtKB
P60568	IL2	Interleukin-2	GO:0007267; P:cell-cell signaling; TAS:UniProtKB
P60568	IL2	Interleukin-2	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P60568	IL2	Interleukin-2	GO:0006955; P:immune response; TAS:UniProtKB
P60568	IL2	Interleukin-2	GO:0030101; P:natural killer cell activation; TAS:UniProtKB
P60568	IL2	Interleukin-2	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
P60568	IL2	Interleukin-2	GO:0002903; P:negative regulation of B cell apoptotic process; IDA:MGI
P60568	IL2	Interleukin-2	GO:0045822; P:negative regulation of heart contraction; IEA:Ensembl
P60568	IL2	Interleukin-2	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
P60568	IL2	Interleukin-2	GO:0050672; P:negative regulation of lymphocyte proliferation; IEA:Ensembl
P60568	IL2	Interleukin-2	GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl
P60568	IL2	Interleukin-2	GO:0042104; P:positive regulation of activated T cell proliferation; IDA:MGI
P60568	IL2	Interleukin-2	GO:0030890; P:positive regulation of B cell proliferation; IDA:MGI
P60568	IL2	Interleukin-2	GO:0030307; P:positive regulation of cell growth; TAS:UniProtKB
P60568	IL2	Interleukin-2	GO:0008284; P:positive regulation of cell proliferation; TAS:UniProtKB
P60568	IL2	Interleukin-2	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P60568	IL2	Interleukin-2	GO:0060999; P:positive regulation of dendritic spine development; IEA:Ensembl
P60568	IL2	Interleukin-2	GO:0051024; P:positive regulation of immunoglobulin secretion; IEA:Ensembl
P60568	IL2	Interleukin-2	GO:0050729; P:positive regulation of inflammatory response; IC:BHF-UCL
P60568	IL2	Interleukin-2	GO:0032729; P:positive regulation of interferon-gamma production; IEA:Ensembl
P60568	IL2	Interleukin-2	GO:0032740; P:positive regulation of interleukin-17 production; IDA:BHF-UCL
P60568	IL2	Interleukin-2	GO:0048304; P:positive regulation of isotype switching to IgG isotypes; IEA:Ensembl
P60568	IL2	Interleukin-2	GO:0045591; P:positive regulation of regulatory T cell differentiation; IEA:Ensembl
P60568	IL2	Interleukin-2	GO:0034105; P:positive regulation of tissue remodeling; IC:BHF-UCL
P60568	IL2	Interleukin-2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P60568	IL2	Interleukin-2	GO:0042523; P:positive regulation of tyrosine phosphorylation of Stat5 protein; IDA:BHF-UCL
P60568	IL2	Interleukin-2	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P60568	IL2	Interleukin-2	GO:0046013; P:regulation of T cell homeostatic proliferation; IEA:Ensembl
P60568	IL2	Interleukin-2	GO:0030217; P:T cell differentiation; TAS:UniProtKB
Q8NI17	IL31RA	Interleukin-31 receptor subunit alpha	GO:0019955; F:cytokine binding; NAS:UniProtKB
Q8NI17	IL31RA	Interleukin-31 receptor subunit alpha	GO:0004896; F:cytokine receptor activity; TAS:UniProtKB
Q8NI17	IL31RA	Interleukin-31 receptor subunit alpha	GO:0019901; F:protein kinase binding; NAS:UniProtKB
Q8NI17	IL31RA	Interleukin-31 receptor subunit alpha	GO:0003713; F:transcription coactivator activity; NAS:UniProtKB
Q8NI17	IL31RA	Interleukin-31 receptor subunit alpha	GO:0019221; P:cytokine-mediated signaling pathway; TAS:UniProtKB
Q8NI17	IL31RA	Interleukin-31 receptor subunit alpha	GO:0006952; P:defense response; NAS:UniProtKB
Q8NI17	IL31RA	Interleukin-31 receptor subunit alpha	GO:0042592; P:homeostatic process; NAS:UniProtKB
Q8NI17	IL31RA	Interleukin-31 receptor subunit alpha	GO:0007259; P:JAK-STAT cascade; IEP:UniProtKB
Q8NI17	IL31RA	Interleukin-31 receptor subunit alpha	GO:0030225; P:macrophage differentiation; NAS:UniProtKB
Q8NI17	IL31RA	Interleukin-31 receptor subunit alpha	GO:0000165; P:MAPK cascade; NAS:UniProtKB
Q8NI17	IL31RA	Interleukin-31 receptor subunit alpha	GO:0030224; P:monocyte differentiation; IEP:UniProtKB
Q8NI17	IL31RA	Interleukin-31 receptor subunit alpha	GO:0043066; P:negative regulation of apoptotic process; NAS:UniProtKB
Q8NI17	IL31RA	Interleukin-31 receptor subunit alpha	GO:0043031; P:negative regulation of macrophage activation; NAS:UniProtKB
Q8NI17	IL31RA	Interleukin-31 receptor subunit alpha	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q8NI17	IL31RA	Interleukin-31 receptor subunit alpha	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
Q8NI17	IL31RA	Interleukin-31 receptor subunit alpha	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IEP:UniProtKB
Q8NI17	IL31RA	Interleukin-31 receptor subunit alpha	GO:0042523; P:positive regulation of tyrosine phosphorylation of Stat5 protein; IEP:UniProtKB
Q8NI17	IL31RA	Interleukin-31 receptor subunit alpha	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; NAS:UniProtKB
Q6EBC2	IL31	Interleukin-31	GO:0002376; P:immune system process; IEA:UniProtKB-KW
P24001	IL32	Interleukin-32	GO:0005515; F:protein binding; IPI:IntAct
P24001	IL32	Interleukin-32	GO:0007155; P:cell adhesion; TAS:ProtInc
P24001	IL32	Interleukin-32	GO:0006952; P:defense response; TAS:ProtInc
P24001	IL32	Interleukin-32	GO:0006955; P:immune response; TAS:ProtInc
O95760	IL33	Interleukin-33	GO:0005125; F:cytokine activity; IDA:BHF-UCL
O95760	IL33	Interleukin-33	GO:0005515; F:protein binding; IPI:IntAct
O95760	IL33	Interleukin-33	GO:0051025; P:negative regulation of immunoglobulin secretion; IEA:Ensembl
O95760	IL33	Interleukin-33	GO:0032689; P:negative regulation of interferon-gamma production; IEA:Ensembl
O95760	IL33	Interleukin-33	GO:0002686; P:negative regulation of leukocyte migration; IEA:Ensembl
O95760	IL33	Interleukin-33	GO:0002826; P:negative regulation of T-helper 1 type immune response; IEA:Ensembl
O95760	IL33	Interleukin-33	GO:0090197; P:positive regulation of chemokine secretion; IDA:BHF-UCL
O95760	IL33	Interleukin-33	GO:0051024; P:positive regulation of immunoglobulin secretion; IEA:Ensembl
O95760	IL33	Interleukin-33	GO:0050729; P:positive regulation of inflammatory response; ISS:BHF-UCL
O95760	IL33	Interleukin-33	GO:0032736; P:positive regulation of interleukin-13 production; IEA:Ensembl
O95760	IL33	Interleukin-33	GO:0032753; P:positive regulation of interleukin-4 production; IEA:Ensembl
O95760	IL33	Interleukin-33	GO:0032754; P:positive regulation of interleukin-5 production; IEA:Ensembl
O95760	IL33	Interleukin-33	GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl
O95760	IL33	Interleukin-33	GO:0043032; P:positive regulation of macrophage activation; IDA:BHF-UCL
O95760	IL33	Interleukin-33	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
O95760	IL33	Interleukin-33	GO:0002830; P:positive regulation of type 2 immune response; IEA:Ensembl
O95760	IL33	Interleukin-33	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZMJ4	IL34	Interleukin-34	GO:0005157; F:macrophage colony-stimulating factor receptor binding; IDA:UniProtKB
Q6ZMJ4	IL34	Interleukin-34	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q6ZMJ4	IL34	Interleukin-34	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q6ZMJ4	IL34	Interleukin-34	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q6ZMJ4	IL34	Interleukin-34	GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB
Q9UHA7	IL36A	Interleukin-36 alpha	GO:0005149; F:interleukin-1 receptor binding; NAS:UniProtKB
Q9UHA7	IL36A	Interleukin-36 alpha	GO:0006955; P:immune response; NAS:UniProtKB
Q9UHA7	IL36A	Interleukin-36 alpha	GO:0006954; P:inflammatory response; IEA:InterPro
Q9UHA7	IL36A	Interleukin-36 alpha	GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl
Q9NZH7	IL36B	Interleukin-36 beta	GO:0005149; F:interleukin-1 receptor binding; NAS:UniProtKB
Q9NZH7	IL36B	Interleukin-36 beta	GO:0006955; P:immune response; NAS:UniProtKB
Q9NZH7	IL36B	Interleukin-36 beta	GO:0006954; P:inflammatory response; IEA:InterPro
Q9NZH7	IL36B	Interleukin-36 beta	GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl
Q9NZH7	IL36B	Interleukin-36 beta	GO:0045582; P:positive regulation of T cell differentiation; IEA:Ensembl
Q9NZH8	IL36G	Interleukin-36 gamma	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9NZH8	IL36G	Interleukin-36 gamma	GO:0006955; P:immune response; IEA:InterPro
Q9NZH8	IL36G	Interleukin-36 gamma	GO:0006954; P:inflammatory response; IEA:InterPro
Q9NZH8	IL36G	Interleukin-36 gamma	GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl
Q9NZH6	IL37	Interleukin-37	GO:0005149; F:interleukin-1 receptor binding; NAS:UniProtKB
Q9NZH6	IL37	Interleukin-37	GO:0006955; P:immune response; NAS:UniProtKB
Q9NZH6	IL37	Interleukin-37	GO:0006954; P:inflammatory response; IEA:InterPro
P26951	IL3RA	Interleukin-3 receptor subunit alpha	GO:0004912; F:interleukin-3 receptor activity; TAS:ProtInc
P26951	IL3RA	Interleukin-3 receptor subunit alpha	GO:0036016; P:cellular response to interleukin-3; TAS:GOC
P26951	IL3RA	Interleukin-3 receptor subunit alpha	GO:0038156; P:interleukin-3-mediated signaling pathway; TAS:GOC
P32927	CSF2RB	Cytokine receptor common subunit beta	GO:0004896; F:cytokine receptor activity; IEA:InterPro
P32927	CSF2RB	Cytokine receptor common subunit beta	GO:0005515; F:protein binding; IPI:UniProtKB
P32927	CSF2RB	Cytokine receptor common subunit beta	GO:0004872; F:receptor activity; TAS:ProtInc
P32927	CSF2RB	Cytokine receptor common subunit beta	GO:0036016; P:cellular response to interleukin-3; TAS:GOC
P32927	CSF2RB	Cytokine receptor common subunit beta	GO:0038156; P:interleukin-3-mediated signaling pathway; TAS:GOC
P32927	CSF2RB	Cytokine receptor common subunit beta	GO:0038043; P:interleukin-5-mediated signaling pathway; TAS:GOC
P32927	CSF2RB	Cytokine receptor common subunit beta	GO:0007585; P:respiratory gaseous exchange; TAS:ProtInc
P32927	CSF2RB	Cytokine receptor common subunit beta	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P32927	CSF2RB	Cytokine receptor common subunit beta	GO:0007165; P:signal transduction; NAS:UniProtKB
P08700	IL3	Interleukin-3	GO:0005135; F:interleukin-3 receptor binding; TAS:UniProtKB
P08700	IL3	Interleukin-3	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P08700	IL3	Interleukin-3	GO:0035162; P:embryonic hemopoiesis; IDA:DFLAT
P08700	IL3	Interleukin-3	GO:0006955; P:immune response; IEA:InterPro
P08700	IL3	Interleukin-3	GO:0007399; P:nervous system development; TAS:ProtInc
P08700	IL3	Interleukin-3	GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB
P08700	IL3	Interleukin-3	GO:0045740; P:positive regulation of DNA replication; IDA:BHF-UCL
P08700	IL3	Interleukin-3	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISS:UniProtKB
P08700	IL3	Interleukin-3	GO:0042523; P:positive regulation of tyrosine phosphorylation of Stat5 protein; IDA:BHF-UCL
P24394	IL4R	Interleukin-4 receptor subunit alpha	GO:0004913; F:interleukin-4 receptor activity; TAS:ProtInc
P24394	IL4R	Interleukin-4 receptor subunit alpha	GO:0005515; F:protein binding; IPI:IntAct
P24394	IL4R	Interleukin-4 receptor subunit alpha	GO:0005057; F:receptor signaling protein activity; TAS:ProtInc
P24394	IL4R	Interleukin-4 receptor subunit alpha	GO:0042832; P:defense response to protozoan; IEA:Ensembl
P24394	IL4R	Interleukin-4 receptor subunit alpha	GO:0006955; P:immune response; TAS:ProtInc
P24394	IL4R	Interleukin-4 receptor subunit alpha	GO:0035771; P:interleukin-4-mediated signaling pathway; TAS:GOC
P24394	IL4R	Interleukin-4 receptor subunit alpha	GO:0035556; P:intracellular signal transduction; TAS:GOC
P24394	IL4R	Interleukin-4 receptor subunit alpha	GO:0045626; P:negative regulation of T-helper 1 cell differentiation; IEA:Ensembl
P24394	IL4R	Interleukin-4 receptor subunit alpha	GO:0030728; P:ovulation; IEA:Ensembl
P24394	IL4R	Interleukin-4 receptor subunit alpha	GO:0090197; P:positive regulation of chemokine secretion; IEA:Ensembl
P24394	IL4R	Interleukin-4 receptor subunit alpha	GO:0043032; P:positive regulation of macrophage activation; IEA:Ensembl
P24394	IL4R	Interleukin-4 receptor subunit alpha	GO:0045630; P:positive regulation of T-helper 2 cell differentiation; IEA:Ensembl
P24394	IL4R	Interleukin-4 receptor subunit alpha	GO:0002532; P:production of molecular mediator involved in inflammatory response; IEA:InterPro
P24394	IL4R	Interleukin-4 receptor subunit alpha	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P24394	IL4R	Interleukin-4 receptor subunit alpha	GO:0043627; P:response to estrogen; IEA:Ensembl
P24394	IL4R	Interleukin-4 receptor subunit alpha	GO:0007165; P:signal transduction; TAS:ProtInc
P05112	IL4	Interleukin-4	GO:0008083; F:growth factor activity; NAS:UniProtKB
P05112	IL4	Interleukin-4	GO:0005136; F:interleukin-4 receptor binding; TAS:UniProtKB
P05112	IL4	Interleukin-4	GO:0005515; F:protein binding; IPI:IntAct
P05112	IL4	Interleukin-4	GO:0031296; P:B cell costimulation; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0030183; P:B cell differentiation; TAS:UniProtKB
P05112	IL4	Interleukin-4	GO:0006968; P:cellular defense response; TAS:ProtInc
P05112	IL4	Interleukin-4	GO:0071288; P:cellular response to mercury ion; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0006935; P:chemotaxis; TAS:ProtInc
P05112	IL4	Interleukin-4	GO:0008203; P:cholesterol metabolic process; ISS:UniProtKB
P05112	IL4	Interleukin-4	GO:0045189; P:connective tissue growth factor biosynthetic process; TAS:UniProtKB
P05112	IL4	Interleukin-4	GO:0042832; P:defense response to protozoan; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0097028; P:dendritic cell differentiation; IDA:DFLAT
P05112	IL4	Interleukin-4	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0007565; P:female pregnancy; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0006955; P:immune response; TAS:ProtInc
P05112	IL4	Interleukin-4	GO:0002227; P:innate immune response in mucosa; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0002674; P:negative regulation of acute inflammatory response; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB
P05112	IL4	Interleukin-4	GO:0002677; P:negative regulation of chronic inflammatory response; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0043031; P:negative regulation of macrophage activation; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0045019; P:negative regulation of nitric oxide biosynthetic process; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0045671; P:negative regulation of osteoclast differentiation; ISS:UniProtKB
P05112	IL4	Interleukin-4	GO:2000320; P:negative regulation of T-helper 17 cell differentiation; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P05112	IL4	Interleukin-4	GO:0042104; P:positive regulation of activated T cell proliferation; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0030890; P:positive regulation of B cell proliferation; ISS:UniProtKB
P05112	IL4	Interleukin-4	GO:0045080; P:positive regulation of chemokine biosynthetic process; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0032733; P:positive regulation of interleukin-10 production; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0032736; P:positive regulation of interleukin-13 production; IDA:UniProtKB
P05112	IL4	Interleukin-4	GO:0048295; P:positive regulation of isotype switching to IgE isotypes; ISS:UniProtKB
P05112	IL4	Interleukin-4	GO:0048304; P:positive regulation of isotype switching to IgG isotypes; ISS:UniProtKB
P05112	IL4	Interleukin-4	GO:0045348; P:positive regulation of MHC class II biosynthetic process; ISS:UniProtKB
P05112	IL4	Interleukin-4	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0045582; P:positive regulation of T cell differentiation; IDA:UniProtKB
P05112	IL4	Interleukin-4	GO:0042102; P:positive regulation of T cell proliferation; ISS:UniProtKB
P05112	IL4	Interleukin-4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
P05112	IL4	Interleukin-4	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P05112	IL4	Interleukin-4	GO:0042523; P:positive regulation of tyrosine phosphorylation of Stat5 protein; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0050776; P:regulation of immune response; ISS:UniProtKB
P05112	IL4	Interleukin-4	GO:0045191; P:regulation of isotype switching; TAS:UniProtKB
P05112	IL4	Interleukin-4	GO:0042325; P:regulation of phosphorylation; ISS:UniProtKB
P05112	IL4	Interleukin-4	GO:0010155; P:regulation of proton transport; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0034097; P:response to cytokine; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0042493; P:response to drug; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0045471; P:response to ethanol; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0007584; P:response to nutrient; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0002296; P:T-helper 1 cell lineage commitment; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0035745; P:T-helper 2 cell cytokine production; IDA:UniProtKB
P05112	IL4	Interleukin-4	GO:0045064; P:T-helper 2 cell differentiation; IEA:Ensembl
P05112	IL4	Interleukin-4	GO:0042092; P:type 2 immune response; TAS:UniProtKB
Q01344	IL5RA	Interleukin-5 receptor subunit alpha	GO:0004914; F:interleukin-5 receptor activity; TAS:ProtInc
Q01344	IL5RA	Interleukin-5 receptor subunit alpha	GO:0005515; F:protein binding; IPI:IntAct
Q01344	IL5RA	Interleukin-5 receptor subunit alpha	GO:0008283; P:cell proliferation; TAS:ProtInc
Q01344	IL5RA	Interleukin-5 receptor subunit alpha	GO:0002437; P:inflammatory response to antigenic stimulus; IEA:Ensembl
Q01344	IL5RA	Interleukin-5 receptor subunit alpha	GO:0038043; P:interleukin-5-mediated signaling pathway; TAS:GOC
Q01344	IL5RA	Interleukin-5 receptor subunit alpha	GO:0032674; P:regulation of interleukin-5 production; IEA:Ensembl
Q01344	IL5RA	Interleukin-5 receptor subunit alpha	GO:0007165; P:signal transduction; TAS:ProtInc
P05113	IL5	Interleukin-5	GO:0005137; F:interleukin-5 receptor binding; TAS:ProtInc
P05113	IL5	Interleukin-5	GO:0005515; F:protein binding; IPI:IntAct
P05113	IL5	Interleukin-5	GO:0019221; P:cytokine-mediated signaling pathway; IEA:Ensembl
P05113	IL5	Interleukin-5	GO:0006955; P:immune response; IEA:InterPro
P05113	IL5	Interleukin-5	GO:0006954; P:inflammatory response; TAS:ProtInc
P05113	IL5	Interleukin-5	GO:0030890; P:positive regulation of B cell proliferation; IEA:Ensembl
P05113	IL5	Interleukin-5	GO:0045645; P:positive regulation of eosinophil differentiation; IEA:Ensembl
P05113	IL5	Interleukin-5	GO:0051024; P:positive regulation of immunoglobulin secretion; IEA:Ensembl
P05113	IL5	Interleukin-5	GO:0046427; P:positive regulation of JAK-STAT cascade; IEA:Ensembl
P05113	IL5	Interleukin-5	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISS:UniProtKB
P05113	IL5	Interleukin-5	GO:0071803; P:positive regulation of podosome assembly; IDA:BHF-UCL
P05113	IL5	Interleukin-5	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P05113	IL5	Interleukin-5	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0070119; F:ciliary neurotrophic factor binding; IPI:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0019899; F:enzyme binding; IPI:UniProtKB
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0019981; F:interleukin-6 binding; IPI:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0004915; F:interleukin-6 receptor activity; IEA:Ensembl
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0005515; F:protein binding; IPI:IntAct
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0006953; P:acute-phase response; TAS:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0070120; P:ciliary neurotrophic factor-mediated signaling pathway; IMP:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0019221; P:cytokine-mediated signaling pathway; IDA:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0050829; P:defense response to Gram-negative bacterium; IEP:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0050830; P:defense response to Gram-positive bacterium; IEP:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0031018; P:endocrine pancreas development; IMP:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0097191; P:extrinsic apoptotic signaling pathway; TAS:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0002384; P:hepatic immune response; TAS:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0070102; P:interleukin-6-mediated signaling pathway; IMP:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0002548; P:monocyte chemotaxis; IC:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0032966; P:negative regulation of collagen biosynthetic process; IDA:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0032717; P:negative regulation of interleukin-8 production; IEP:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0002446; P:neutrophil mediated immunity; IC:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0010536; P:positive regulation of activation of Janus kinase activity; IDA:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0032722; P:positive regulation of chemokine production; IDA:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0032755; P:positive regulation of interleukin-6 production; IDA:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0002690; P:positive regulation of leukocyte chemotaxis; IC:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0043410; P:positive regulation of MAPK cascade; IDA:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0045669; P:positive regulation of osteoblast differentiation; TAS:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IDA:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IMP:BHF-UCL
P08887	IL6R	Interleukin-6 receptor subunit alpha	GO:0034097; P:response to cytokine; IDA:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0004897; F:ciliary neurotrophic factor receptor activity; IDA:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0005127; F:ciliary neurotrophic factor receptor binding; IPI:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0019838; F:growth factor binding; IPI:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0004921; F:interleukin-11 receptor activity; IEA:Ensembl
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0045509; F:interleukin-27 receptor activity; IC:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0005515; F:protein binding; IPI:IntAct
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0042803; F:protein homodimerization activity; TAS:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0070120; P:ciliary neurotrophic factor-mediated signaling pathway; IDA:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0019221; P:cytokine-mediated signaling pathway; IDA:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0005977; P:glycogen metabolic process; IEA:Ensembl
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0070106; P:interleukin-27-mediated signaling pathway; IMP:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0070102; P:interleukin-6-mediated signaling pathway; IMP:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0048861; P:leukemia inhibitory factor signaling pathway; IGI:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0043066; P:negative regulation of apoptotic process; TAS:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0070104; P:negative regulation of interleukin-6-mediated signaling pathway; IDA:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0038165; P:oncostatin-M-mediated signaling pathway; IMP:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0002675; P:positive regulation of acute inflammatory response; IC:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0002821; P:positive regulation of adaptive immune response; IC:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0048711; P:positive regulation of astrocyte differentiation; IEA:Ensembl
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0010613; P:positive regulation of cardiac muscle hypertrophy; TAS:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0045669; P:positive regulation of osteoblast differentiation; IMP:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0042102; P:positive regulation of T cell proliferation; IMP:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0042511; P:positive regulation of tyrosine phosphorylation of Stat1 protein; IMP:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IMP:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0010575; P:positive regulation vascular endothelial growth factor production; TAS:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0008593; P:regulation of Notch signaling pathway; IEA:Ensembl
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0034097; P:response to cytokine; IDA:BHF-UCL
P40189	IL6ST	Interleukin-6 receptor subunit beta	GO:0016032; P:viral process; IEA:UniProtKB-KW
P05231	IL6	Interleukin-6	GO:0005125; F:cytokine activity; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0008083; F:growth factor activity; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0005138; F:interleukin-6 receptor binding; NAS:UniProtKB
P05231	IL6	Interleukin-6	GO:0005515; F:protein binding; IPI:IntAct
P05231	IL6	Interleukin-6	GO:0006953; P:acute-phase response; TAS:BHF-UCL
P05231	IL6	Interleukin-6	GO:0007568; P:aging; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0046849; P:bone remodeling; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0060445; P:branching involved in salivary gland morphogenesis; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0016049; P:cell growth; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0045454; P:cell redox homeostasis; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0070301; P:cellular response to hydrogen peroxide; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0071222; P:cellular response to lipopolysaccharide; IMP:MGI
P05231	IL6	Interleukin-6	GO:0019221; P:cytokine-mediated signaling pathway; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0050829; P:defense response to Gram-negative bacterium; IEP:BHF-UCL
P05231	IL6	Interleukin-6	GO:0050830; P:defense response to Gram-positive bacterium; IEP:BHF-UCL
P05231	IL6	Interleukin-6	GO:0042832; P:defense response to protozoan; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0051607; P:defense response to virus; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0031018; P:endocrine pancreas development; ISS:BHF-UCL
P05231	IL6	Interleukin-6	GO:0060664; P:epithelial cell proliferation involved in salivary gland morphogenesis; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0070091; P:glucagon secretion; ISS:BHF-UCL
P05231	IL6	Interleukin-6	GO:0002384; P:hepatic immune response; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0006959; P:humoral immune response; IC:BHF-UCL
P05231	IL6	Interleukin-6	GO:0006954; P:inflammatory response; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0070102; P:interleukin-6-mediated signaling pathway; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0002548; P:monocyte chemotaxis; IC:BHF-UCL
P05231	IL6	Interleukin-6	GO:0046716; P:muscle cell cellular homeostasis; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P05231	IL6	Interleukin-6	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P05231	IL6	Interleukin-6	GO:0045079; P:negative regulation of chemokine biosynthetic process; ISS:UniProtKB
P05231	IL6	Interleukin-6	GO:0032966; P:negative regulation of collagen biosynthetic process; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0050710; P:negative regulation of cytokine secretion; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0045599; P:negative regulation of fat cell differentiation; NAS:BHF-UCL
P05231	IL6	Interleukin-6	GO:0045721; P:negative regulation of gluconeogenesis; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0046888; P:negative regulation of hormone secretion; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0010888; P:negative regulation of lipid storage; NAS:BHF-UCL
P05231	IL6	Interleukin-6	GO:0048635; P:negative regulation of muscle organ development; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:1901215; P:negative regulation of neuron death; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0031175; P:neuron projection development; IMP:BHF-UCL
P05231	IL6	Interleukin-6	GO:0001781; P:neutrophil apoptotic process; IDA:UniProtKB
P05231	IL6	Interleukin-6	GO:0002446; P:neutrophil mediated immunity; IC:BHF-UCL
P05231	IL6	Interleukin-6	GO:0030168; P:platelet activation; TAS:BHF-UCL
P05231	IL6	Interleukin-6	GO:0002675; P:positive regulation of acute inflammatory response; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P05231	IL6	Interleukin-6	GO:0050871; P:positive regulation of B cell activation; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0032722; P:positive regulation of chemokine production; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0045740; P:positive regulation of DNA replication; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0051024; P:positive regulation of immunoglobulin secretion; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0032755; P:positive regulation of interleukin-6 production; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0046427; P:positive regulation of JAK-STAT cascade; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0002690; P:positive regulation of leukocyte chemotaxis; IC:BHF-UCL
P05231	IL6	Interleukin-6	GO:0043410; P:positive regulation of MAPK cascade; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0045669; P:positive regulation of osteoblast differentiation; TAS:BHF-UCL
P05231	IL6	Interleukin-6	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:MGI
P05231	IL6	Interleukin-6	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:MGI
P05231	IL6	Interleukin-6	GO:0033160; P:positive regulation of protein import into nucleus, translocation; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:2000366; P:positive regulation of STAT protein import into nucleus; IC:BHF-UCL
P05231	IL6	Interleukin-6	GO:0042102; P:positive regulation of T cell proliferation; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0045630; P:positive regulation of T-helper 2 cell differentiation; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0045727; P:positive regulation of translation; IDA:UniProtKB
P05231	IL6	Interleukin-6	GO:0051971; P:positive regulation of transmission of nerve impulse; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:2000676; P:positive regulation of type B pancreatic cell apoptotic process; TAS:BHF-UCL
P05231	IL6	Interleukin-6	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0045765; P:regulation of angiogenesis; IC:BHF-UCL
P05231	IL6	Interleukin-6	GO:0008360; P:regulation of cell shape; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0045188; P:regulation of circadian sleep/wake cycle, non-REM sleep; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0010574; P:regulation of vascular endothelial growth factor production; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0043200; P:response to amino acid; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0046677; P:response to antibiotic; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0031000; P:response to caffeine; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0051592; P:response to calcium ion; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0009409; P:response to cold; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0042493; P:response to drug; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0051602; P:response to electrical stimulus; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0051384; P:response to glucocorticoid; IDA:BHF-UCL
P05231	IL6	Interleukin-6	GO:0009408; P:response to heat; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0032868; P:response to insulin; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0031667; P:response to nutrient levels; IEA:Ensembl
P05231	IL6	Interleukin-6	GO:0032494; P:response to peptidoglycan; IEP:BHF-UCL
P05231	IL6	Interleukin-6	GO:0072540; P:T-helper 17 cell lineage commitment; ISS:UniProtKB
P16871	IL7R	Interleukin-7 receptor subunit alpha	GO:0003823; F:antigen binding; TAS:ProtInc
P16871	IL7R	Interleukin-7 receptor subunit alpha	GO:0004917; F:interleukin-7 receptor activity; TAS:ProtInc
P16871	IL7R	Interleukin-7 receptor subunit alpha	GO:0005515; F:protein binding; IPI:IntAct
P16871	IL7R	Interleukin-7 receptor subunit alpha	GO:0042100; P:B cell proliferation; IEA:Ensembl
P16871	IL7R	Interleukin-7 receptor subunit alpha	GO:0016049; P:cell growth; IEA:Ensembl
P16871	IL7R	Interleukin-7 receptor subunit alpha	GO:0000902; P:cell morphogenesis; IEA:Ensembl
P16871	IL7R	Interleukin-7 receptor subunit alpha	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P16871	IL7R	Interleukin-7 receptor subunit alpha	GO:0048872; P:homeostasis of number of cells; IEA:Ensembl
P16871	IL7R	Interleukin-7 receptor subunit alpha	GO:0006955; P:immune response; TAS:ProtInc
P16871	IL7R	Interleukin-7 receptor subunit alpha	GO:0002377; P:immunoglobulin production; IEA:Ensembl
P16871	IL7R	Interleukin-7 receptor subunit alpha	GO:0038111; P:interleukin-7-mediated signaling pathway; TAS:GOC
P16871	IL7R	Interleukin-7 receptor subunit alpha	GO:0048535; P:lymph node development; IEA:Ensembl
P16871	IL7R	Interleukin-7 receptor subunit alpha	GO:0001915; P:negative regulation of T cell mediated cytotoxicity; IEA:Ensembl
P16871	IL7R	Interleukin-7 receptor subunit alpha	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P16871	IL7R	Interleukin-7 receptor subunit alpha	GO:0033089; P:positive regulation of T cell differentiation in thymus; IEA:Ensembl
P16871	IL7R	Interleukin-7 receptor subunit alpha	GO:0008361; P:regulation of cell size; IEA:Ensembl
P16871	IL7R	Interleukin-7 receptor subunit alpha	GO:0000018; P:regulation of DNA recombination; TAS:ProtInc
P16871	IL7R	Interleukin-7 receptor subunit alpha	GO:0007165; P:signal transduction; TAS:ProtInc
P16871	IL7R	Interleukin-7 receptor subunit alpha	GO:0030217; P:T cell differentiation; IEA:Ensembl
P13232	IL7	Interleukin-7	GO:0008083; F:growth factor activity; ISS:UniProtKB
P13232	IL7	Interleukin-7	GO:0005139; F:interleukin-7 receptor binding; TAS:ProtInc
P13232	IL7	Interleukin-7	GO:0005515; F:protein binding; IPI:IntAct
P13232	IL7	Interleukin-7	GO:0045453; P:bone resorption; ISS:UniProtKB
P13232	IL7	Interleukin-7	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P13232	IL7	Interleukin-7	GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl
P13232	IL7	Interleukin-7	GO:0006959; P:humoral immune response; TAS:ProtInc
P13232	IL7	Interleukin-7	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB
P13232	IL7	Interleukin-7	GO:0043086; P:negative regulation of catalytic activity; IEA:Ensembl
P13232	IL7	Interleukin-7	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P13232	IL7	Interleukin-7	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P13232	IL7	Interleukin-7	GO:0030890; P:positive regulation of B cell proliferation; ISS:UniProtKB
P13232	IL7	Interleukin-7	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P13232	IL7	Interleukin-7	GO:0046622; P:positive regulation of organ growth; IEA:Ensembl
P13232	IL7	Interleukin-7	GO:0045582; P:positive regulation of T cell differentiation; ISS:UniProtKB
P13232	IL7	Interleukin-7	GO:0010468; P:regulation of gene expression; IEA:Ensembl
P13232	IL7	Interleukin-7	GO:0002360; P:T cell lineage commitment; IEA:Ensembl
P10145	CXCL8	Interleukin-8	GO:0008009; F:chemokine activity; TAS:UniProtKB
P10145	CXCL8	Interleukin-8	GO:0005153; F:interleukin-8 receptor binding; IPI:UniProtKB
P10145	CXCL8	Interleukin-8	GO:0005515; F:protein binding; IPI:UniProtKB
P10145	CXCL8	Interleukin-8	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P10145	CXCL8	Interleukin-8	GO:0001525; P:angiogenesis; TAS:UniProtKB
P10145	CXCL8	Interleukin-8	GO:0019722; P:calcium-mediated signaling; TAS:UniProtKB
P10145	CXCL8	Interleukin-8	GO:0007050; P:cell cycle arrest; IDA:UniProtKB
P10145	CXCL8	Interleukin-8	GO:0006928; P:cellular component movement; TAS:ProtInc
P10145	CXCL8	Interleukin-8	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P10145	CXCL8	Interleukin-8	GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEP:UniProtKB
P10145	CXCL8	Interleukin-8	GO:0071347; P:cellular response to interleukin-1; IEP:UniProtKB
P10145	CXCL8	Interleukin-8	GO:0071222; P:cellular response to lipopolysaccharide; IDA:BHF-UCL
P10145	CXCL8	Interleukin-8	GO:0071356; P:cellular response to tumor necrosis factor; IEP:UniProtKB
P10145	CXCL8	Interleukin-8	GO:0006935; P:chemotaxis; TAS:UniProtKB
P10145	CXCL8	Interleukin-8	GO:0048566; P:embryonic digestive tract development; IEP:DFLAT
P10145	CXCL8	Interleukin-8	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P10145	CXCL8	Interleukin-8	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P10145	CXCL8	Interleukin-8	GO:0006955; P:immune response; IEA:InterPro
P10145	CXCL8	Interleukin-8	GO:0050930; P:induction of positive chemotaxis; IGI:UniProtKB
P10145	CXCL8	Interleukin-8	GO:0006954; P:inflammatory response; TAS:UniProtKB
P10145	CXCL8	Interleukin-8	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
P10145	CXCL8	Interleukin-8	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P10145	CXCL8	Interleukin-8	GO:0045744; P:negative regulation of G-protein coupled receptor protein signaling pathway; IDA:UniProtKB
P10145	CXCL8	Interleukin-8	GO:0042119; P:neutrophil activation; TAS:UniProtKB
P10145	CXCL8	Interleukin-8	GO:0030593; P:neutrophil chemotaxis; IGI:UniProtKB
P10145	CXCL8	Interleukin-8	GO:0090023; P:positive regulation of neutrophil chemotaxis; TAS:BHF-UCL
P10145	CXCL8	Interleukin-8	GO:0031623; P:receptor internalization; IDA:UniProtKB
P10145	CXCL8	Interleukin-8	GO:0030155; P:regulation of cell adhesion; IDA:UniProtKB
P10145	CXCL8	Interleukin-8	GO:0045091; P:regulation of single stranded viral RNA replication via double stranded DNA intermediate; IDA:UniProtKB
P10145	CXCL8	Interleukin-8	GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB
P10145	CXCL8	Interleukin-8	GO:0002237; P:response to molecule of bacterial origin; IDA:BHF-UCL
P10145	CXCL8	Interleukin-8	GO:0007165; P:signal transduction; TAS:ProtInc
Q01113	IL9R	Interleukin-9 receptor	GO:0004919; F:interleukin-9 receptor activity; TAS:ProtInc
Q01113	IL9R	Interleukin-9 receptor	GO:0008283; P:cell proliferation; TAS:ProtInc
Q01113	IL9R	Interleukin-9 receptor	GO:0030307; P:positive regulation of cell growth; IEA:Ensembl
Q01113	IL9R	Interleukin-9 receptor	GO:0007165; P:signal transduction; TAS:ProtInc
P15248	IL9	Interleukin-9	GO:0006955; P:immune response; IEA:InterPro
P15248	IL9	Interleukin-9	GO:0006954; P:inflammatory response; TAS:ProtInc
P15248	IL9	Interleukin-9	GO:0030307; P:positive regulation of cell growth; IEA:Ensembl
P15248	IL9	Interleukin-9	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P15248	IL9	Interleukin-9	GO:0045407; P:positive regulation of interleukin-5 biosynthetic process; ISS:UniProtKB
Q71H61	ILDR2	Immunoglobulin-like domain-containing receptor 2	GO:0030154; P:cell differentiation; IEA:Ensembl
Q71H61	ILDR2	Immunoglobulin-like domain-containing receptor 2	GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl
Q71H61	ILDR2	Immunoglobulin-like domain-containing receptor 2	GO:0030073; P:insulin secretion; IEA:Ensembl
Q71H61	ILDR2	Immunoglobulin-like domain-containing receptor 2	GO:0031016; P:pancreas development; IEA:Ensembl
Q71H61	ILDR2	Immunoglobulin-like domain-containing receptor 2	GO:0009749; P:response to glucose; IEA:Ensembl
P30740	SERPINB1	Leukocyte elastase inhibitor	GO:0004867; F:serine-type endopeptidase inhibitor activity; NAS:UniProtKB
P30740	SERPINB1	Leukocyte elastase inhibitor	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P30740	SERPINB1	Leukocyte elastase inhibitor	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
Q12905	ILF2	Interleukin enhancer-binding factor 2	GO:0005524; F:ATP binding; IEA:InterPro
Q12905	ILF2	Interleukin enhancer-binding factor 2	GO:0003677; F:DNA binding; IDA:UniProtKB
Q12905	ILF2	Interleukin enhancer-binding factor 2	GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB
Q12905	ILF2	Interleukin enhancer-binding factor 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q12905	ILF2	Interleukin enhancer-binding factor 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q12905	ILF2	Interleukin enhancer-binding factor 2	GO:0016740; F:transferase activity; IEA:InterPro
Q12905	ILF2	Interleukin enhancer-binding factor 2	GO:0006955; P:immune response; IEA:InterPro
Q12905	ILF2	Interleukin enhancer-binding factor 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q12905	ILF2	Interleukin enhancer-binding factor 2	GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB
Q12906	ILF3	Interleukin enhancer-binding factor 3	GO:0003677; F:DNA binding; IDA:UniProtKB
Q12906	ILF3	Interleukin enhancer-binding factor 3	GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB
Q12906	ILF3	Interleukin enhancer-binding factor 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q12906	ILF3	Interleukin enhancer-binding factor 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q12906	ILF3	Interleukin enhancer-binding factor 3	GO:0003723; F:RNA binding; NAS:UniProtKB
Q12906	ILF3	Interleukin enhancer-binding factor 3	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q12906	ILF3	Interleukin enhancer-binding factor 3	GO:0000279; P:M phase; NAS:UniProtKB
Q12906	ILF3	Interleukin enhancer-binding factor 3	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q12906	ILF3	Interleukin enhancer-binding factor 3	GO:0017148; P:negative regulation of translation; ISS:UniProtKB
Q12906	ILF3	Interleukin enhancer-binding factor 3	GO:0045071; P:negative regulation of viral genome replication; ISS:UniProtKB
Q12906	ILF3	Interleukin enhancer-binding factor 3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q12906	ILF3	Interleukin enhancer-binding factor 3	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q12906	ILF3	Interleukin enhancer-binding factor 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N9Z9	IFLTD1	Intermediate filament tail domain-containing protein 1	GO:0005198; F:structural molecule activity; IEA:InterPro
Q8N9Z9	IFLTD1	Intermediate filament tail domain-containing protein 1	GO:0008283; P:cell proliferation; IEA:Ensembl
Q9H0C8	ILKAP	Integrin-linked kinase-associated serine/threonine phosphatase 2C	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H0C8	ILKAP	Integrin-linked kinase-associated serine/threonine phosphatase 2C	GO:0005515; F:protein binding; IPI:IntAct
Q9H0C8	ILKAP	Integrin-linked kinase-associated serine/threonine phosphatase 2C	GO:0004722; F:protein serine/threonine phosphatase activity; IEA:Ensembl
Q9H0C8	ILKAP	Integrin-linked kinase-associated serine/threonine phosphatase 2C	GO:0006470; P:protein dephosphorylation; IEA:Ensembl
Q9H0C8	ILKAP	Integrin-linked kinase-associated serine/threonine phosphatase 2C	GO:0033262; P:regulation of nuclear cell cycle DNA replication; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13418	ILK	Integrin-linked protein kinase	GO:0005515; F:protein binding; IPI:UniProtKB
Q13418	ILK	Integrin-linked protein kinase	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q13418	ILK	Integrin-linked protein kinase	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q13418	ILK	Integrin-linked protein kinase	GO:0004871; F:signal transducer activity; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0007569; P:cell aging; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0007050; P:cell cycle arrest; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0034329; P:cell junction assembly; TAS:Reactome
Q13418	ILK	Integrin-linked protein kinase	GO:0008283; P:cell proliferation; NAS:UniProtKB
Q13418	ILK	Integrin-linked protein kinase	GO:0007160; P:cell-matrix adhesion; TAS:ProtInc
Q13418	ILK	Integrin-linked protein kinase	GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0043206; P:extracellular fibril organization; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0007229; P:integrin-mediated signaling pathway; IDA:MGI
Q13418	ILK	Integrin-linked protein kinase	GO:0032288; P:myelin assembly; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0022011; P:myelination in peripheral nervous system; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0014912; P:negative regulation of smooth muscle cell migration; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0021675; P:nerve development; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0048812; P:neuron projection morphogenesis; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0045773; P:positive regulation of axon extension; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0030513; P:positive regulation of BMP signaling pathway; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:UniProtKB
Q13418	ILK	Integrin-linked protein kinase	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0001954; P:positive regulation of cell-matrix adhesion; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0050775; P:positive regulation of dendrite morphogenesis; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0043406; P:positive regulation of MAP kinase activity; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0045663; P:positive regulation of myoblast differentiation; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0042327; P:positive regulation of phosphorylation; IMP:UniProtKB
Q13418	ILK	Integrin-linked protein kinase	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q13418	ILK	Integrin-linked protein kinase	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0043491; P:protein kinase B signaling; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q13418	ILK	Integrin-linked protein kinase	GO:0032956; P:regulation of actin cytoskeleton organization; IEA:Ensembl
Q13418	ILK	Integrin-linked protein kinase	GO:0034446; P:substrate adhesion-dependent cell spreading; IMP:UniProtKB
Q01638	IL1RL1	Interleukin-1 receptor-like 1	GO:0004896; F:cytokine receptor activity; TAS:UniProtKB
Q01638	IL1RL1	Interleukin-1 receptor-like 1	GO:0004908; F:interleukin-1 receptor activity; IEA:InterPro
Q01638	IL1RL1	Interleukin-1 receptor-like 1	GO:0002114; F:interleukin-33 receptor activity; IEA:Ensembl
Q01638	IL1RL1	Interleukin-1 receptor-like 1	GO:0005515; F:protein binding; IPI:IntAct
Q01638	IL1RL1	Interleukin-1 receptor-like 1	GO:0005057; F:receptor signaling protein activity; TAS:ProtInc
Q01638	IL1RL1	Interleukin-1 receptor-like 1	GO:0006955; P:immune response; NAS:UniProtKB
Q01638	IL1RL1	Interleukin-1 receptor-like 1	GO:0035556; P:intracellular signal transduction; TAS:GOC
Q01638	IL1RL1	Interleukin-1 receptor-like 1	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
Q01638	IL1RL1	Interleukin-1 receptor-like 1	GO:0032689; P:negative regulation of interferon-gamma production; IEA:Ensembl
Q01638	IL1RL1	Interleukin-1 receptor-like 1	GO:0002826; P:negative regulation of T-helper 1 type immune response; IEA:Ensembl
Q01638	IL1RL1	Interleukin-1 receptor-like 1	GO:0090197; P:positive regulation of chemokine secretion; IEA:Ensembl
Q01638	IL1RL1	Interleukin-1 receptor-like 1	GO:0050729; P:positive regulation of inflammatory response; IEA:Ensembl
Q01638	IL1RL1	Interleukin-1 receptor-like 1	GO:0032754; P:positive regulation of interleukin-5 production; IEA:Ensembl
Q01638	IL1RL1	Interleukin-1 receptor-like 1	GO:0043032; P:positive regulation of macrophage activation; IEA:Ensembl
Q01638	IL1RL1	Interleukin-1 receptor-like 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q9HB29	IL1RL2	Interleukin-1 receptor-like 2	GO:0004908; F:interleukin-1 receptor activity; TAS:ProtInc
Q9HB29	IL1RL2	Interleukin-1 receptor-like 2	GO:0004909; F:interleukin-1, Type I, activating receptor activity; IEA:InterPro
Q9HB29	IL1RL2	Interleukin-1 receptor-like 2	GO:0006968; P:cellular defense response; TAS:ProtInc
Q9HB29	IL1RL2	Interleukin-1 receptor-like 2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:GOC
Q9HB29	IL1RL2	Interleukin-1 receptor-like 2	GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl
Q9HB29	IL1RL2	Interleukin-1 receptor-like 2	GO:0045582; P:positive regulation of T cell differentiation; IEA:Ensembl
Q9HB29	IL1RL2	Interleukin-1 receptor-like 2	GO:0050727; P:regulation of inflammatory response; IEA:Ensembl
Q9HB29	IL1RL2	Interleukin-1 receptor-like 2	GO:0007165; P:signal transduction; TAS:ProtInc
A1L0T0	ILVBL	Acetolactate synthase-like protein	GO:0000287; F:magnesium ion binding; IEA:InterPro
A1L0T0	ILVBL	Acetolactate synthase-like protein	GO:0030976; F:thiamine pyrophosphate binding; IEA:InterPro
A1L0T0	ILVBL	Acetolactate synthase-like protein	GO:0016740; F:transferase activity; IEA:UniProtKB-KW
P52292	KPNA2	Importin subunit alpha-1	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
P52292	KPNA2	Importin subunit alpha-1	GO:0008139; F:nuclear localization sequence binding; IDA:UniProtKB
P52292	KPNA2	Importin subunit alpha-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P52292	KPNA2	Importin subunit alpha-1	GO:0005515; F:protein binding; IPI:UniProtKB
P52292	KPNA2	Importin subunit alpha-1	GO:0008565; F:protein transporter activity; IEA:InterPro
P52292	KPNA2	Importin subunit alpha-1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P52292	KPNA2	Importin subunit alpha-1	GO:0006259; P:DNA metabolic process; TAS:ProtInc
P52292	KPNA2	Importin subunit alpha-1	GO:0000085; P:mitotic G2 phase; TAS:ProtInc
P52292	KPNA2	Importin subunit alpha-1	GO:0006607; P:NLS-bearing protein import into nucleus; IDA:UniProtKB
P52292	KPNA2	Importin subunit alpha-1	GO:0000018; P:regulation of DNA recombination; TAS:ProtInc
P52292	KPNA2	Importin subunit alpha-1	GO:0016032; P:viral process; IEA:UniProtKB-KW
O00629	KPNA4	Importin subunit alpha-3	GO:0005515; F:protein binding; IPI:IntAct
O00629	KPNA4	Importin subunit alpha-3	GO:0008565; F:protein transporter activity; IEA:Ensembl
O00629	KPNA4	Importin subunit alpha-3	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
O00629	KPNA4	Importin subunit alpha-3	GO:0006607; P:NLS-bearing protein import into nucleus; TAS:ProtInc
O00505	KPNA3	Importin subunit alpha-4	GO:0008139; F:nuclear localization sequence binding; TAS:ProtInc
O00505	KPNA3	Importin subunit alpha-4	GO:0005515; F:protein binding; IPI:IntAct
O00505	KPNA3	Importin subunit alpha-4	GO:0008565; F:protein transporter activity; IEA:InterPro
O00505	KPNA3	Importin subunit alpha-4	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
O00505	KPNA3	Importin subunit alpha-4	GO:0006607; P:NLS-bearing protein import into nucleus; TAS:ProtInc
O00505	KPNA3	Importin subunit alpha-4	GO:0006461; P:protein complex assembly; TAS:ProtInc
O00505	KPNA3	Importin subunit alpha-4	GO:0046718; P:viral entry into host cell; IEA:UniProtKB-KW
O00505	KPNA3	Importin subunit alpha-4	GO:0075732; P:viral penetration into host nucleus; IEA:UniProtKB-KW
P52294	KPNA1	Importin subunit alpha-5	GO:0008139; F:nuclear localization sequence binding; TAS:ProtInc
P52294	KPNA1	Importin subunit alpha-5	GO:0005515; F:protein binding; IPI:UniProtKB
P52294	KPNA1	Importin subunit alpha-5	GO:0008565; F:protein transporter activity; IEA:InterPro
P52294	KPNA1	Importin subunit alpha-5	GO:0006309; P:apoptotic DNA fragmentation; TAS:Reactome
P52294	KPNA1	Importin subunit alpha-5	GO:0006915; P:apoptotic process; TAS:Reactome
P52294	KPNA1	Importin subunit alpha-5	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
P52294	KPNA1	Importin subunit alpha-5	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P52294	KPNA1	Importin subunit alpha-5	GO:0075733; P:intracellular transport of virus; TAS:Reactome
P52294	KPNA1	Importin subunit alpha-5	GO:0006607; P:NLS-bearing protein import into nucleus; TAS:ProtInc
P52294	KPNA1	Importin subunit alpha-5	GO:0042307; P:positive regulation of protein import into nucleus; ISS:UniProtKB
P52294	KPNA1	Importin subunit alpha-5	GO:0000018; P:regulation of DNA recombination; TAS:ProtInc
P52294	KPNA1	Importin subunit alpha-5	GO:0019058; P:viral life cycle; TAS:Reactome
P52294	KPNA1	Importin subunit alpha-5	GO:0016032; P:viral process; TAS:Reactome
O15131	KPNA5	Importin subunit alpha-6	GO:0005515; F:protein binding; IPI:IntAct
O15131	KPNA5	Importin subunit alpha-6	GO:0008565; F:protein transporter activity; IEA:InterPro
O15131	KPNA5	Importin subunit alpha-6	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
O15131	KPNA5	Importin subunit alpha-6	GO:0006607; P:NLS-bearing protein import into nucleus; TAS:ProtInc
O60684	KPNA6	Importin subunit alpha-7	GO:0008565; F:protein transporter activity; IEA:Ensembl
O60684	KPNA6	Importin subunit alpha-7	GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
O60684	KPNA6	Importin subunit alpha-7	GO:0006607; P:NLS-bearing protein import into nucleus; TAS:ProtInc
O60684	KPNA6	Importin subunit alpha-7	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
A9QM74	KPNA7	Importin subunit alpha-8	GO:0008565; F:protein transporter activity; IEA:InterPro
A9QM74	KPNA7	Importin subunit alpha-8	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
A9QM74	KPNA7	Importin subunit alpha-8	GO:0006606; P:protein import into nucleus; IEA:InterPro
Q14974	KPNB1	Importin subunit beta-1	GO:0019899; F:enzyme binding; IPI:UniProt
Q14974	KPNB1	Importin subunit beta-1	GO:0008139; F:nuclear localization sequence binding; TAS:ProtInc
Q14974	KPNB1	Importin subunit beta-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14974	KPNB1	Importin subunit beta-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q14974	KPNB1	Importin subunit beta-1	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q14974	KPNB1	Importin subunit beta-1	GO:0008565; F:protein transporter activity; IEA:Ensembl
Q14974	KPNB1	Importin subunit beta-1	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q14974	KPNB1	Importin subunit beta-1	GO:0006309; P:apoptotic DNA fragmentation; TAS:Reactome
Q14974	KPNB1	Importin subunit beta-1	GO:0006915; P:apoptotic process; TAS:Reactome
Q14974	KPNB1	Importin subunit beta-1	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q14974	KPNB1	Importin subunit beta-1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q14974	KPNB1	Importin subunit beta-1	GO:0075733; P:intracellular transport of virus; TAS:Reactome
Q14974	KPNB1	Importin subunit beta-1	GO:0006607; P:NLS-bearing protein import into nucleus; TAS:ProtInc
Q14974	KPNB1	Importin subunit beta-1	GO:0006606; P:protein import into nucleus; IDA:MGI
Q14974	KPNB1	Importin subunit beta-1	GO:0000060; P:protein import into nucleus, translocation; TAS:ProtInc
Q14974	KPNB1	Importin subunit beta-1	GO:0006610; P:ribosomal protein import into nucleus; IDA:UniProtKB
Q14974	KPNB1	Importin subunit beta-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14974	KPNB1	Importin subunit beta-1	GO:0019058; P:viral life cycle; TAS:Reactome
Q14974	KPNB1	Importin subunit beta-1	GO:0016032; P:viral process; TAS:Reactome
P20839	IMPDH1	Inosine-5'-monophosphate dehydrogenase 1	GO:0030554; F:adenyl nucleotide binding; IEA:InterPro
P20839	IMPDH1	Inosine-5'-monophosphate dehydrogenase 1	GO:0003677; F:DNA binding; IDA:UniProtKB
P20839	IMPDH1	Inosine-5'-monophosphate dehydrogenase 1	GO:0003938; F:IMP dehydrogenase activity; TAS:ProtInc
P20839	IMPDH1	Inosine-5'-monophosphate dehydrogenase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-HAMAP
P20839	IMPDH1	Inosine-5'-monophosphate dehydrogenase 1	GO:0003676; F:nucleic acid binding; IDA:UniProtKB
P20839	IMPDH1	Inosine-5'-monophosphate dehydrogenase 1	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
P20839	IMPDH1	Inosine-5'-monophosphate dehydrogenase 1	GO:0006177; P:GMP biosynthetic process; IEA:UniProtKB-HAMAP
P20839	IMPDH1	Inosine-5'-monophosphate dehydrogenase 1	GO:0046651; P:lymphocyte proliferation; IEA:Ensembl
P20839	IMPDH1	Inosine-5'-monophosphate dehydrogenase 1	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P20839	IMPDH1	Inosine-5'-monophosphate dehydrogenase 1	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P20839	IMPDH1	Inosine-5'-monophosphate dehydrogenase 1	GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome
P20839	IMPDH1	Inosine-5'-monophosphate dehydrogenase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P12268	IMPDH2	Inosine-5'-monophosphate dehydrogenase 2	GO:0030554; F:adenyl nucleotide binding; IEA:InterPro
P12268	IMPDH2	Inosine-5'-monophosphate dehydrogenase 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P12268	IMPDH2	Inosine-5'-monophosphate dehydrogenase 2	GO:0003938; F:IMP dehydrogenase activity; TAS:ProtInc
P12268	IMPDH2	Inosine-5'-monophosphate dehydrogenase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-HAMAP
P12268	IMPDH2	Inosine-5'-monophosphate dehydrogenase 2	GO:0000166; F:nucleotide binding; IDA:UniProtKB
P12268	IMPDH2	Inosine-5'-monophosphate dehydrogenase 2	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
P12268	IMPDH2	Inosine-5'-monophosphate dehydrogenase 2	GO:0006177; P:GMP biosynthetic process; IEA:UniProtKB-HAMAP
P12268	IMPDH2	Inosine-5'-monophosphate dehydrogenase 2	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P12268	IMPDH2	Inosine-5'-monophosphate dehydrogenase 2	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P12268	IMPDH2	Inosine-5'-monophosphate dehydrogenase 2	GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome
P12268	IMPDH2	Inosine-5'-monophosphate dehydrogenase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16891	IMMT	Mitochondrial inner membrane protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q16891	IMMT	Mitochondrial inner membrane protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q16891	IMMT	Mitochondrial inner membrane protein	GO:0051560; P:mitochondrial calcium ion homeostasis; IEA:Ensembl
Q16891	IMMT	Mitochondrial inner membrane protein	GO:0009409; P:response to cold; IEA:Ensembl
Q96LU5	IMMP1L	Mitochondrial inner membrane protease subunit 1	GO:0008236; F:serine-type peptidase activity; IEA:InterPro
Q96T52	IMMP2L	Mitochondrial inner membrane protease subunit 2	GO:0008233; F:peptidase activity; ISS:UniProtKB
Q96T52	IMMP2L	Mitochondrial inner membrane protease subunit 2	GO:0008236; F:serine-type peptidase activity; IEA:InterPro
Q96T52	IMMP2L	Mitochondrial inner membrane protease subunit 2	GO:0001541; P:ovarian follicle development; IEA:Ensembl
Q96T52	IMMP2L	Mitochondrial inner membrane protease subunit 2	GO:0030728; P:ovulation; IEA:Ensembl
Q96T52	IMMP2L	Mitochondrial inner membrane protease subunit 2	GO:0006627; P:protein processing involved in protein targeting to mitochondrion; ISS:UniProtKB
Q96T52	IMMP2L	Mitochondrial inner membrane protease subunit 2	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q9NV31	IMP3	U3 small nucleolar ribonucleoprotein protein IMP3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NV31	IMP3	U3 small nucleolar ribonucleoprotein protein IMP3	GO:0005515; F:protein binding; IPI:HGNC
Q9NV31	IMP3	U3 small nucleolar ribonucleoprotein protein IMP3	GO:0019843; F:rRNA binding; IEA:UniProtKB-KW
Q9NV31	IMP3	U3 small nucleolar ribonucleoprotein protein IMP3	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q96G21	IMP4	U3 small nucleolar ribonucleoprotein protein IMP4	GO:0005515; F:protein binding; IPI:HGNC
Q96G21	IMP4	U3 small nucleolar ribonucleoprotein protein IMP4	GO:0006364; P:rRNA processing; NAS:HGNC
P29218	IMPA1	Inositol monophosphatase 1	GO:0042802; F:identical protein binding; IPI:IntAct
P29218	IMPA1	Inositol monophosphatase 1	GO:0008934; F:inositol monophosphate 1-phosphatase activity; IMP:UniProtKB
P29218	IMPA1	Inositol monophosphatase 1	GO:0052832; F:inositol monophosphate 3-phosphatase activity; IEA:UniProtKB-EC
P29218	IMPA1	Inositol monophosphatase 1	GO:0052833; F:inositol monophosphate 4-phosphatase activity; IEA:UniProtKB-EC
P29218	IMPA1	Inositol monophosphatase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P29218	IMPA1	Inositol monophosphatase 1	GO:0042803; F:protein homodimerization activity; IPI:MGI
P29218	IMPA1	Inositol monophosphatase 1	GO:0006021; P:inositol biosynthetic process; IEA:UniProtKB-UniPathway
P29218	IMPA1	Inositol monophosphatase 1	GO:0046855; P:inositol phosphate dephosphorylation; IDA:MGI
P29218	IMPA1	Inositol monophosphatase 1	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
P29218	IMPA1	Inositol monophosphatase 1	GO:0006796; P:phosphate-containing compound metabolic process; IMP:UniProtKB
P29218	IMPA1	Inositol monophosphatase 1	GO:0006661; P:phosphatidylinositol biosynthetic process; IMP:UniProtKB
P29218	IMPA1	Inositol monophosphatase 1	GO:0046854; P:phosphatidylinositol phosphorylation; IEA:InterPro
P29218	IMPA1	Inositol monophosphatase 1	GO:0007165; P:signal transduction; IMP:UniProtKB
P29218	IMPA1	Inositol monophosphatase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O14732	IMPA2	Inositol monophosphatase 2	GO:0008934; F:inositol monophosphate 1-phosphatase activity; IDA:MGI
O14732	IMPA2	Inositol monophosphatase 2	GO:0052832; F:inositol monophosphate 3-phosphatase activity; IEA:UniProtKB-EC
O14732	IMPA2	Inositol monophosphatase 2	GO:0052833; F:inositol monophosphate 4-phosphatase activity; IEA:UniProtKB-EC
O14732	IMPA2	Inositol monophosphatase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14732	IMPA2	Inositol monophosphatase 2	GO:0042803; F:protein homodimerization activity; IPI:MGI
O14732	IMPA2	Inositol monophosphatase 2	GO:0006021; P:inositol biosynthetic process; IEA:UniProtKB-UniPathway
O14732	IMPA2	Inositol monophosphatase 2	GO:0046855; P:inositol phosphate dephosphorylation; IDA:MGI
O14732	IMPA2	Inositol monophosphatase 2	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
O14732	IMPA2	Inositol monophosphatase 2	GO:0006796; P:phosphate-containing compound metabolic process; TAS:ProtInc
O14732	IMPA2	Inositol monophosphatase 2	GO:0046854; P:phosphatidylinositol phosphorylation; IEA:InterPro
O14732	IMPA2	Inositol monophosphatase 2	GO:0007165; P:signal transduction; TAS:ProtInc
O14732	IMPA2	Inositol monophosphatase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NX62	IMPAD1	Inositol monophosphatase 3	GO:0008441; F:3'(2'),5'-bisphosphate nucleotidase activity; IEA:UniProtKB-EC
Q9NX62	IMPAD1	Inositol monophosphatase 3	GO:0008254; F:3'-nucleotidase activity; IEA:Ensembl
Q9NX62	IMPAD1	Inositol monophosphatase 3	GO:0008934; F:inositol monophosphate 1-phosphatase activity; IEA:UniProtKB-EC
Q9NX62	IMPAD1	Inositol monophosphatase 3	GO:0052832; F:inositol monophosphate 3-phosphatase activity; IEA:UniProtKB-EC
Q9NX62	IMPAD1	Inositol monophosphatase 3	GO:0052833; F:inositol monophosphate 4-phosphatase activity; IEA:UniProtKB-EC
Q9NX62	IMPAD1	Inositol monophosphatase 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NX62	IMPAD1	Inositol monophosphatase 3	GO:0002063; P:chondrocyte development; IEA:Ensembl
Q9NX62	IMPAD1	Inositol monophosphatase 3	GO:0030204; P:chondroitin sulfate metabolic process; IEA:Ensembl
Q9NX62	IMPAD1	Inositol monophosphatase 3	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
Q9NX62	IMPAD1	Inositol monophosphatase 3	GO:0001958; P:endochondral ossification; IEA:Ensembl
Q9NX62	IMPAD1	Inositol monophosphatase 3	GO:0006021; P:inositol biosynthetic process; IEA:UniProtKB-UniPathway
Q9NX62	IMPAD1	Inositol monophosphatase 3	GO:0046854; P:phosphatidylinositol phosphorylation; IEA:InterPro
Q9NX62	IMPAD1	Inositol monophosphatase 3	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q9P2X3	IMPACT	Protein IMPACT	GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl
Q9P2X3	IMPACT	Protein IMPACT	GO:0006446; P:regulation of translational initiation; IEA:Ensembl
Q17R60	IMPG1	Interphotoreceptor matrix proteoglycan 1	GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc
Q17R60	IMPG1	Interphotoreceptor matrix proteoglycan 1	GO:0007601; P:visual perception; TAS:ProtInc
Q9BZV3	IMPG2	Interphotoreceptor matrix proteoglycan 2	GO:0005201; F:extracellular matrix structural constituent; TAS:UniProtKB
Q9BZV3	IMPG2	Interphotoreceptor matrix proteoglycan 2	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
Q9BZV3	IMPG2	Interphotoreceptor matrix proteoglycan 2	GO:0005540; F:hyaluronic acid binding; TAS:UniProtKB
Q9BZV3	IMPG2	Interphotoreceptor matrix proteoglycan 2	GO:0007601; P:visual perception; TAS:UniProtKB
Q9C086	INO80B	INO80 complex subunit B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9C086	INO80B	INO80 complex subunit B	GO:0005515; F:protein binding; IPI:IntAct
Q9C086	INO80B	INO80 complex subunit B	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q9C086	INO80B	INO80 complex subunit B	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q9C086	INO80B	INO80 complex subunit B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9C086	INO80B	INO80 complex subunit B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P80217	IFI35	Interferon-induced 35 kDa protein	GO:0005515; F:protein binding; IPI:UniProtKB
P80217	IFI35	Interferon-induced 35 kDa protein	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P80217	IFI35	Interferon-induced 35 kDa protein	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q53TQ3	INO80D	INO80 complex subunit D	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q53TQ3	INO80D	INO80 complex subunit D	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q53TQ3	INO80D	INO80 complex subunit D	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q53TQ3	INO80D	INO80 complex subunit D	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6PI98	INO80C	INO80 complex subunit C	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q6PI98	INO80C	INO80 complex subunit C	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q6PI98	INO80C	INO80 complex subunit C	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6PI98	INO80C	INO80 complex subunit C	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NBZ0	INO80E	INO80 complex subunit E	GO:0005515; F:protein binding; IPI:IntAct
Q8NBZ0	INO80E	INO80 complex subunit E	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q8NBZ0	INO80E	INO80 complex subunit E	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q8NBZ0	INO80E	INO80 complex subunit E	GO:0006260; P:DNA replication; IEA:InterPro
Q8NBZ0	INO80E	INO80 complex subunit E	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NBZ0	INO80E	INO80 complex subunit E	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NI35	INADL	InaD-like protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NI35	INADL	InaD-like protein	GO:0034329; P:cell junction assembly; TAS:Reactome
Q8NI35	INADL	InaD-like protein	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q8NI35	INADL	InaD-like protein	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
Q8NI35	INADL	InaD-like protein	GO:0070830; P:tight junction assembly; TAS:Reactome
P17181	IFNAR1	Interferon alpha/beta receptor 1	GO:0005515; F:protein binding; IPI:IntAct
P17181	IFNAR1	Interferon alpha/beta receptor 1	GO:0004905; F:type I interferon receptor activity; TAS:ProtInc
P17181	IFNAR1	Interferon alpha/beta receptor 1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P17181	IFNAR1	Interferon alpha/beta receptor 1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P17181	IFNAR1	Interferon alpha/beta receptor 1	GO:0051607; P:defense response to virus; IEA:Ensembl
P17181	IFNAR1	Interferon alpha/beta receptor 1	GO:0007259; P:JAK-STAT cascade; TAS:ProtInc
P17181	IFNAR1	Interferon alpha/beta receptor 1	GO:0032729; P:positive regulation of interferon-gamma production; IEA:Ensembl
P17181	IFNAR1	Interferon alpha/beta receptor 1	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P17181	IFNAR1	Interferon alpha/beta receptor 1	GO:0009615; P:response to virus; TAS:ProtInc
P17181	IFNAR1	Interferon alpha/beta receptor 1	GO:0042110; P:T cell activation; IEA:Ensembl
P17181	IFNAR1	Interferon alpha/beta receptor 1	GO:0045351; P:type I interferon biosynthetic process; IEA:Ensembl
P17181	IFNAR1	Interferon alpha/beta receptor 1	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P48551	IFNAR2	Interferon alpha/beta receptor 2	GO:0005515; F:protein binding; IPI:IntAct
P48551	IFNAR2	Interferon alpha/beta receptor 2	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P48551	IFNAR2	Interferon alpha/beta receptor 2	GO:0019962; F:type I interferon binding; IPI:UniProtKB
P48551	IFNAR2	Interferon alpha/beta receptor 2	GO:0004905; F:type I interferon receptor activity; IDA:UniProtKB
P48551	IFNAR2	Interferon alpha/beta receptor 2	GO:0008283; P:cell proliferation; IEA:Ensembl
P48551	IFNAR2	Interferon alpha/beta receptor 2	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P48551	IFNAR2	Interferon alpha/beta receptor 2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P48551	IFNAR2	Interferon alpha/beta receptor 2	GO:0007259; P:JAK-STAT cascade; TAS:ProtInc
P48551	IFNAR2	Interferon alpha/beta receptor 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P48551	IFNAR2	Interferon alpha/beta receptor 2	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P48551	IFNAR2	Interferon alpha/beta receptor 2	GO:0035455; P:response to interferon-alpha; IDA:UniProtKB
P48551	IFNAR2	Interferon alpha/beta receptor 2	GO:0009615; P:response to virus; TAS:ProtInc
P48551	IFNAR2	Interferon alpha/beta receptor 2	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q0VD86	INCA1	Protein INCA1	GO:0030332; F:cyclin binding; IDA:MGI
Q0VD86	INCA1	Protein INCA1	GO:0004861; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; IDA:MGI
Q0VD86	INCA1	Protein INCA1	GO:0005515; F:protein binding; IPI:IntAct
Q0VD86	INCA1	Protein INCA1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q0VD86	INCA1	Protein INCA1	GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:MGI
Q0VD86	INCA1	Protein INCA1	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
Q9NQS7	INCENP	Inner centromere protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NQS7	INCENP	Inner centromere protein	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q9NQS7	INCENP	Inner centromere protein	GO:0000910; P:cytokinesis; IMP:UniProtKB
Q9NQS7	INCENP	Inner centromere protein	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9NQS7	INCENP	Inner centromere protein	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q27J81	INF2	Inverted formin-2	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
Q27J81	INF2	Inverted formin-2	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q27J81	INF2	Inverted formin-2	GO:0032535; P:regulation of cellular component size; IEA:Ensembl
Q27J81	INF2	Inverted formin-2	GO:0090140; P:regulation of mitochondrial fission; IMP:MGI
Q9UK53	ING1	Inhibitor of growth protein 1	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q9UK53	ING1	Inhibitor of growth protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9UK53	ING1	Inhibitor of growth protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UK53	ING1	Inhibitor of growth protein 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9UK53	ING1	Inhibitor of growth protein 1	GO:0016568; P:chromatin modification; IEA:InterPro
Q9UK53	ING1	Inhibitor of growth protein 1	GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB
Q9UK53	ING1	Inhibitor of growth protein 1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q9UK53	ING1	Inhibitor of growth protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q9UK53	ING1	Inhibitor of growth protein 1	GO:0006606; P:protein import into nucleus; IEA:Ensembl
Q9UK53	ING1	Inhibitor of growth protein 1	GO:0010941; P:regulation of cell death; IEA:Ensembl
Q9H160	ING2	Inhibitor of growth protein 2	GO:0003682; F:chromatin binding; TAS:ProtInc
Q9H160	ING2	Inhibitor of growth protein 2	GO:0003677; F:DNA binding; IDA:UniProtKB
Q9H160	ING2	Inhibitor of growth protein 2	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q9H160	ING2	Inhibitor of growth protein 2	GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB
Q9H160	ING2	Inhibitor of growth protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H160	ING2	Inhibitor of growth protein 2	GO:0032403; F:protein complex binding; IDA:UniProtKB
Q9H160	ING2	Inhibitor of growth protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H160	ING2	Inhibitor of growth protein 2	GO:0016568; P:chromatin modification; ISS:BHF-UCL
Q9H160	ING2	Inhibitor of growth protein 2	GO:0048133; P:male germ-line stem cell division; ISS:BHF-UCL
Q9H160	ING2	Inhibitor of growth protein 2	GO:0007141; P:male meiosis I; ISS:BHF-UCL
Q9H160	ING2	Inhibitor of growth protein 2	GO:0008285; P:negative regulation of cell proliferation; IEA:InterPro
Q9H160	ING2	Inhibitor of growth protein 2	GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; TAS:BHF-UCL
Q9H160	ING2	Inhibitor of growth protein 2	GO:0043065; P:positive regulation of apoptotic process; IEA:InterPro
Q9H160	ING2	Inhibitor of growth protein 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9H160	ING2	Inhibitor of growth protein 2	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
Q9H160	ING2	Inhibitor of growth protein 2	GO:2000772; P:regulation of cellular senescence; NAS:BHF-UCL
Q9H160	ING2	Inhibitor of growth protein 2	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q9H160	ING2	Inhibitor of growth protein 2	GO:2001020; P:regulation of response to DNA damage stimulus; NAS:BHF-UCL
Q9H160	ING2	Inhibitor of growth protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q9H160	ING2	Inhibitor of growth protein 2	GO:0072520; P:seminiferous tubule development; ISS:BHF-UCL
Q9H160	ING2	Inhibitor of growth protein 2	GO:0007165; P:signal transduction; TAS:ProtInc
Q9H160	ING2	Inhibitor of growth protein 2	GO:0030317; P:sperm motility; ISS:BHF-UCL
Q9H160	ING2	Inhibitor of growth protein 2	GO:0007286; P:spermatid development; ISS:BHF-UCL
Q9H160	ING2	Inhibitor of growth protein 2	GO:0007283; P:spermatogenesis; ISS:BHF-UCL
Q9H160	ING2	Inhibitor of growth protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NXR8	ING3	Inhibitor of growth protein 3	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q9NXR8	ING3	Inhibitor of growth protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NXR8	ING3	Inhibitor of growth protein 3	GO:0006325; P:chromatin organization; TAS:Reactome
Q9NXR8	ING3	Inhibitor of growth protein 3	GO:0043968; P:histone H2A acetylation; IDA:UniProtKB
Q9NXR8	ING3	Inhibitor of growth protein 3	GO:0043967; P:histone H4 acetylation; IDA:UniProtKB
Q9NXR8	ING3	Inhibitor of growth protein 3	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q9NXR8	ING3	Inhibitor of growth protein 3	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q9NXR8	ING3	Inhibitor of growth protein 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NXR8	ING3	Inhibitor of growth protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UNL4	ING4	Inhibitor of growth protein 4	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q9UNL4	ING4	Inhibitor of growth protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UNL4	ING4	Inhibitor of growth protein 4	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q9UNL4	ING4	Inhibitor of growth protein 4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UNL4	ING4	Inhibitor of growth protein 4	GO:0006915; P:apoptotic process; IDA:UniProtKB
Q9UNL4	ING4	Inhibitor of growth protein 4	GO:0007050; P:cell cycle arrest; IDA:UniProtKB
Q9UNL4	ING4	Inhibitor of growth protein 4	GO:0006325; P:chromatin organization; TAS:Reactome
Q9UNL4	ING4	Inhibitor of growth protein 4	GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IDA:UniProtKB
Q9UNL4	ING4	Inhibitor of growth protein 4	GO:0006260; P:DNA replication; IDA:UniProtKB
Q9UNL4	ING4	Inhibitor of growth protein 4	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
Q9UNL4	ING4	Inhibitor of growth protein 4	GO:0043983; P:histone H4-K12 acetylation; IDA:UniProtKB
Q9UNL4	ING4	Inhibitor of growth protein 4	GO:0043981; P:histone H4-K5 acetylation; IDA:UniProtKB
Q9UNL4	ING4	Inhibitor of growth protein 4	GO:0043982; P:histone H4-K8 acetylation; IDA:UniProtKB
Q9UNL4	ING4	Inhibitor of growth protein 4	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q9UNL4	ING4	Inhibitor of growth protein 4	GO:0045926; P:negative regulation of growth; IDA:UniProtKB
Q9UNL4	ING4	Inhibitor of growth protein 4	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UNL4	ING4	Inhibitor of growth protein 4	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q9UNL4	ING4	Inhibitor of growth protein 4	GO:0006473; P:protein acetylation; IDA:UniProtKB
Q8WYH8	ING5	Inhibitor of growth protein 5	GO:0003682; F:chromatin binding; IEA:Ensembl
Q8WYH8	ING5	Inhibitor of growth protein 5	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q8WYH8	ING5	Inhibitor of growth protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WYH8	ING5	Inhibitor of growth protein 5	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WYH8	ING5	Inhibitor of growth protein 5	GO:0006325; P:chromatin organization; TAS:Reactome
Q8WYH8	ING5	Inhibitor of growth protein 5	GO:0006260; P:DNA replication; IDA:UniProtKB
Q8WYH8	ING5	Inhibitor of growth protein 5	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
Q8WYH8	ING5	Inhibitor of growth protein 5	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q8WYH8	ING5	Inhibitor of growth protein 5	GO:0045926; P:negative regulation of growth; IDA:UniProtKB
Q8WYH8	ING5	Inhibitor of growth protein 5	GO:0043065; P:positive regulation of apoptotic process; IGI:MGI
Q8WYH8	ING5	Inhibitor of growth protein 5	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
Q8WYH8	ING5	Inhibitor of growth protein 5	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q8WYH8	ING5	Inhibitor of growth protein 5	GO:0006473; P:protein acetylation; IDA:UniProtKB
Q8WYH8	ING5	Inhibitor of growth protein 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P15260	IFNGR1	Interferon gamma receptor 1	GO:0004906; F:interferon-gamma receptor activity; TAS:ProtInc
P15260	IFNGR1	Interferon gamma receptor 1	GO:0005515; F:protein binding; IPI:IntAct
P15260	IFNGR1	Interferon gamma receptor 1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P15260	IFNGR1	Interferon gamma receptor 1	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P15260	IFNGR1	Interferon gamma receptor 1	GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; TAS:Reactome
P15260	IFNGR1	Interferon gamma receptor 1	GO:0009615; P:response to virus; TAS:ProtInc
P15260	IFNGR1	Interferon gamma receptor 1	GO:0007165; P:signal transduction; TAS:ProtInc
P38484	IFNGR2	Interferon gamma receptor 2	GO:0004906; F:interferon-gamma receptor activity; TAS:ProtInc
P38484	IFNGR2	Interferon gamma receptor 2	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P38484	IFNGR2	Interferon gamma receptor 2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P38484	IFNGR2	Interferon gamma receptor 2	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P38484	IFNGR2	Interferon gamma receptor 2	GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; TAS:Reactome
P38484	IFNGR2	Interferon gamma receptor 2	GO:0009615; P:response to virus; TAS:ProtInc
P05111	INHA	Inhibin alpha chain	GO:0005125; F:cytokine activity; TAS:UniProtKB
P05111	INHA	Inhibin alpha chain	GO:0008083; F:growth factor activity; TAS:UniProtKB
P05111	INHA	Inhibin alpha chain	GO:0005179; F:hormone activity; TAS:UniProtKB
P05111	INHA	Inhibin alpha chain	GO:0005515; F:protein binding; IPI:UniProtKB
P05111	INHA	Inhibin alpha chain	GO:0005102; F:receptor binding; IPI:HGNC
P05111	INHA	Inhibin alpha chain	GO:0007050; P:cell cycle arrest; TAS:UniProtKB
P05111	INHA	Inhibin alpha chain	GO:0030154; P:cell differentiation; TAS:UniProtKB
P05111	INHA	Inhibin alpha chain	GO:0007166; P:cell surface receptor signaling pathway; TAS:UniProtKB
P05111	INHA	Inhibin alpha chain	GO:0007267; P:cell-cell signaling; TAS:UniProtKB
P05111	INHA	Inhibin alpha chain	GO:0030218; P:erythrocyte differentiation; NAS:UniProtKB
P05111	INHA	Inhibin alpha chain	GO:0042541; P:hemoglobin biosynthetic process; IDA:UniProtKB
P05111	INHA	Inhibin alpha chain	GO:0008584; P:male gonad development; IEA:Ensembl
P05111	INHA	Inhibin alpha chain	GO:0045578; P:negative regulation of B cell differentiation; TAS:UniProtKB
P05111	INHA	Inhibin alpha chain	GO:0045786; P:negative regulation of cell cycle; TAS:UniProtKB
P05111	INHA	Inhibin alpha chain	GO:0046882; P:negative regulation of follicle-stimulating hormone secretion; NAS:UniProtKB
P05111	INHA	Inhibin alpha chain	GO:0045077; P:negative regulation of interferon-gamma biosynthetic process; TAS:UniProtKB
P05111	INHA	Inhibin alpha chain	GO:0045650; P:negative regulation of macrophage differentiation; TAS:UniProtKB
P05111	INHA	Inhibin alpha chain	GO:0042326; P:negative regulation of phosphorylation; TAS:UniProtKB
P05111	INHA	Inhibin alpha chain	GO:0007399; P:nervous system development; NAS:UniProtKB
P05111	INHA	Inhibin alpha chain	GO:0001541; P:ovarian follicle development; NAS:UniProtKB
P05111	INHA	Inhibin alpha chain	GO:0046881; P:positive regulation of follicle-stimulating hormone secretion; TAS:UniProtKB
P05111	INHA	Inhibin alpha chain	GO:0051726; P:regulation of cell cycle; IDA:HGNC
P05111	INHA	Inhibin alpha chain	GO:0042127; P:regulation of cell proliferation; IDA:HGNC
P05111	INHA	Inhibin alpha chain	GO:0009605; P:response to external stimulus; TAS:UniProtKB
P05111	INHA	Inhibin alpha chain	GO:0007165; P:signal transduction; TAS:ProtInc
P05111	INHA	Inhibin alpha chain	GO:0001501; P:skeletal system development; TAS:ProtInc
P08476	INHBA	Inhibin beta A chain	GO:0005125; F:cytokine activity; IDA:HGNC
P08476	INHBA	Inhibin beta A chain	GO:0008083; F:growth factor activity; TAS:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0005179; F:hormone activity; TAS:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0042802; F:identical protein binding; IPI:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0017046; F:peptide hormone binding; IPI:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0005515; F:protein binding; IPI:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0070699; F:type II activin receptor binding; IPI:BHF-UCL
P08476	INHBA	Inhibin beta A chain	GO:0032924; P:activin receptor signaling pathway; IDA:BHF-UCL
P08476	INHBA	Inhibin beta A chain	GO:0007050; P:cell cycle arrest; IDA:HGNC
P08476	INHBA	Inhibin beta A chain	GO:0030154; P:cell differentiation; TAS:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0007166; P:cell surface receptor signaling pathway; TAS:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0007267; P:cell-cell signaling; TAS:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0071397; P:cellular response to cholesterol; IEA:Ensembl
P08476	INHBA	Inhibin beta A chain	GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; IEA:Ensembl
P08476	INHBA	Inhibin beta A chain	GO:0006952; P:defense response; TAS:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0030218; P:erythrocyte differentiation; NAS:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:BHF-UCL
P08476	INHBA	Inhibin beta A chain	GO:0061029; P:eyelid development in camera-type eye; ISS:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0000082; P:G1/S transition of mitotic cell cycle; IDA:HGNC
P08476	INHBA	Inhibin beta A chain	GO:0040007; P:growth; IEA:InterPro
P08476	INHBA	Inhibin beta A chain	GO:0001942; P:hair follicle development; IGI:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0002244; P:hematopoietic progenitor cell differentiation; IDA:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0042541; P:hemoglobin biosynthetic process; IDA:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0008584; P:male gonad development; IGI:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0048333; P:mesodermal cell differentiation; IEA:Ensembl
P08476	INHBA	Inhibin beta A chain	GO:0045578; P:negative regulation of B cell differentiation; TAS:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0045786; P:negative regulation of cell cycle; IDA:HGNC
P08476	INHBA	Inhibin beta A chain	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0046882; P:negative regulation of follicle-stimulating hormone secretion; NAS:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0045077; P:negative regulation of interferon-gamma biosynthetic process; TAS:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0045650; P:negative regulation of macrophage differentiation; TAS:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0042326; P:negative regulation of phosphorylation; TAS:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0007399; P:nervous system development; NAS:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0042476; P:odontogenesis; IGI:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0001541; P:ovarian follicle development; IGI:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0060021; P:palate development; IGI:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0045648; P:positive regulation of erythrocyte differentiation; IDA:HGNC
P08476	INHBA	Inhibin beta A chain	GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IDA:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0046881; P:positive regulation of follicle-stimulating hormone secretion; TAS:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0060279; P:positive regulation of ovulation; ISS:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
P08476	INHBA	Inhibin beta A chain	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0042701; P:progesterone secretion; IGI:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0046880; P:regulation of follicle-stimulating hormone secretion; IGI:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P08476	INHBA	Inhibin beta A chain	GO:0042493; P:response to drug; IDA:UniProtKB
P09529	INHBB	Inhibin beta B chain	GO:0005125; F:cytokine activity; TAS:UniProtKB
P09529	INHBB	Inhibin beta B chain	GO:0005179; F:hormone activity; TAS:UniProtKB
P09529	INHBB	Inhibin beta B chain	GO:0046789; F:host cell surface receptor binding; TAS:UniProtKB
P09529	INHBB	Inhibin beta B chain	GO:0005515; F:protein binding; IPI:UniProtKB
P09529	INHBB	Inhibin beta B chain	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P09529	INHBB	Inhibin beta B chain	GO:0032924; P:activin receptor signaling pathway; IDA:UniProtKB
P09529	INHBB	Inhibin beta B chain	GO:0030154; P:cell differentiation; NAS:UniProtKB
P09529	INHBB	Inhibin beta B chain	GO:0032869; P:cellular response to insulin stimulus; ISS:UniProtKB
P09529	INHBB	Inhibin beta B chain	GO:0044320; P:cellular response to leptin stimulus; IEA:Ensembl
P09529	INHBB	Inhibin beta B chain	GO:0009267; P:cellular response to starvation; ISS:UniProtKB
P09529	INHBB	Inhibin beta B chain	GO:0006952; P:defense response; TAS:UniProtKB
P09529	INHBB	Inhibin beta B chain	GO:0045444; P:fat cell differentiation; ISS:UniProtKB
P09529	INHBB	Inhibin beta B chain	GO:0040007; P:growth; IEA:InterPro
P09529	INHBB	Inhibin beta B chain	GO:0046882; P:negative regulation of follicle-stimulating hormone secretion; IPI:UniProtKB
P09529	INHBB	Inhibin beta B chain	GO:0048178; P:negative regulation of hepatocyte growth factor biosynthetic process; IDA:UniProtKB
P09529	INHBB	Inhibin beta B chain	GO:0046676; P:negative regulation of insulin secretion; ISS:UniProtKB
P09529	INHBB	Inhibin beta B chain	GO:0048599; P:oocyte development; IEA:Ensembl
P09529	INHBB	Inhibin beta B chain	GO:0001541; P:ovarian follicle development; NAS:UniProtKB
P09529	INHBB	Inhibin beta B chain	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
P09529	INHBB	Inhibin beta B chain	GO:0046881; P:positive regulation of follicle-stimulating hormone secretion; IPI:UniProtKB
P09529	INHBB	Inhibin beta B chain	GO:0060279; P:positive regulation of ovulation; ISS:UniProtKB
P09529	INHBB	Inhibin beta B chain	GO:0009612; P:response to mechanical stimulus; IDA:UniProtKB
P55103	INHBC	Inhibin beta C chain	GO:0005160; F:transforming growth factor beta receptor binding; TAS:ProtInc
P55103	INHBC	Inhibin beta C chain	GO:0040007; P:growth; IEA:InterPro
P58166	INHBE	Inhibin beta E chain	GO:0040007; P:growth; IEA:InterPro
Q8IU57	IFNLR1	Interferon lambda receptor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IU57	IFNLR1	Interferon lambda receptor 1	GO:0019221; P:cytokine-mediated signaling pathway; NAS:GOC
Q8IU57	IFNLR1	Interferon lambda receptor 1	GO:0051607; P:defense response to virus; ISS:UniProtKB
Q8IU57	IFNLR1	Interferon lambda receptor 1	GO:0002385; P:mucosal immune response; ISS:UniProtKB
Q8IU57	IFNLR1	Interferon lambda receptor 1	GO:0008285; P:negative regulation of cell proliferation; NAS:UniProtKB
Q8IU57	IFNLR1	Interferon lambda receptor 1	GO:0050691; P:regulation of defense response to virus by host; IDA:UniProtKB
O95050	INMT	Indolethylamine N-methyltransferase	GO:0030748; F:amine N-methyltransferase activity; IDA:UniProtKB
O95050	INMT	Indolethylamine N-methyltransferase	GO:0004790; F:thioether S-methyltransferase activity; IEA:UniProtKB-EC
O95050	INMT	Indolethylamine N-methyltransferase	GO:0009308; P:amine metabolic process; IDA:UniProtKB
O95050	INMT	Indolethylamine N-methyltransferase	GO:0032259; P:methylation; IDA:UniProtKB
O95050	INMT	Indolethylamine N-methyltransferase	GO:0009636; P:response to toxic substance; IEA:UniProtKB-KW
Q9NPH2	ISYNA1	Inositol-3-phosphate synthase 1	GO:0004512; F:inositol-3-phosphate synthase activity; TAS:Reactome
Q9NPH2	ISYNA1	Inositol-3-phosphate synthase 1	GO:0006021; P:inositol biosynthetic process; IEA:UniProtKB-UniPathway
Q9NPH2	ISYNA1	Inositol-3-phosphate synthase 1	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q9NPH2	ISYNA1	Inositol-3-phosphate synthase 1	GO:0008654; P:phospholipid biosynthetic process; IEA:UniProtKB-KW
Q9NPH2	ISYNA1	Inositol-3-phosphate synthase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9ULG1	INO80	DNA helicase INO80	GO:0043014; F:alpha-tubulin binding; IMP:UniProtKB
Q9ULG1	INO80	DNA helicase INO80	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9ULG1	INO80	DNA helicase INO80	GO:0016887; F:ATPase activity; IDA:UniProtKB
Q9ULG1	INO80	DNA helicase INO80	GO:0003677; F:DNA binding; IDA:UniProtKB
Q9ULG1	INO80	DNA helicase INO80	GO:0003678; F:DNA helicase activity; IDA:UniProtKB
Q9ULG1	INO80	DNA helicase INO80	GO:0005515; F:protein binding; IPI:IntAct
Q9ULG1	INO80	DNA helicase INO80	GO:0006200; P:ATP catabolic process; IDA:GOC
Q9ULG1	INO80	DNA helicase INO80	GO:0071479; P:cellular response to ionizing radiation; IMP:UniProtKB
Q9ULG1	INO80	DNA helicase INO80	GO:0034644; P:cellular response to UV; IMP:UniProtKB
Q9ULG1	INO80	DNA helicase INO80	GO:0006338; P:chromatin remodeling; IDA:UniProtKB
Q9ULG1	INO80	DNA helicase INO80	GO:0032508; P:DNA duplex unwinding; IDA:GOC
Q9ULG1	INO80	DNA helicase INO80	GO:0006302; P:double-strand break repair; IMP:UniProtKB
Q9ULG1	INO80	DNA helicase INO80	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
Q9ULG1	INO80	DNA helicase INO80	GO:0000070; P:mitotic sister chromatid segregation; IMP:UniProtKB
Q9ULG1	INO80	DNA helicase INO80	GO:0030307; P:positive regulation of cell growth; IMP:UniProtKB
Q9ULG1	INO80	DNA helicase INO80	GO:0010571; P:positive regulation of nuclear cell cycle DNA replication; IMP:UniProtKB
Q9ULG1	INO80	DNA helicase INO80	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q9ULG1	INO80	DNA helicase INO80	GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; IMP:UniProtKB
Q9ULG1	INO80	DNA helicase INO80	GO:0051225; P:spindle assembly; IMP:UniProtKB
Q9ULG1	INO80	DNA helicase INO80	GO:0070914; P:UV-damage excision repair; IMP:UniProtKB
Q96PE3	INPP4A	Type I inositol 3,4-bisphosphate 4-phosphatase	GO:0016316; F:phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity; IEA:UniProtKB-EC
Q96PE3	INPP4A	Type I inositol 3,4-bisphosphate 4-phosphatase	GO:0034597; F:phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity; IEA:UniProtKB-EC
Q96PE3	INPP4A	Type I inositol 3,4-bisphosphate 4-phosphatase	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q96PE3	INPP4A	Type I inositol 3,4-bisphosphate 4-phosphatase	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q96PE3	INPP4A	Type I inositol 3,4-bisphosphate 4-phosphatase	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q96PE3	INPP4A	Type I inositol 3,4-bisphosphate 4-phosphatase	GO:0007165; P:signal transduction; TAS:ProtInc
Q96PE3	INPP4A	Type I inositol 3,4-bisphosphate 4-phosphatase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15327	INPP4B	Type II inositol 3,4-bisphosphate 4-phosphatase	GO:0008289; F:lipid binding; IEA:Ensembl
O15327	INPP4B	Type II inositol 3,4-bisphosphate 4-phosphatase	GO:0034594; F:phosphatidylinositol trisphosphate phosphatase activity; IEA:Ensembl
O15327	INPP4B	Type II inositol 3,4-bisphosphate 4-phosphatase	GO:0016316; F:phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity; TAS:ProtInc
O15327	INPP4B	Type II inositol 3,4-bisphosphate 4-phosphatase	GO:0034597; F:phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity; IEA:UniProtKB-EC
O15327	INPP4B	Type II inositol 3,4-bisphosphate 4-phosphatase	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
O15327	INPP4B	Type II inositol 3,4-bisphosphate 4-phosphatase	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
O15327	INPP4B	Type II inositol 3,4-bisphosphate 4-phosphatase	GO:0045671; P:negative regulation of osteoclast differentiation; IEA:Ensembl
O15327	INPP4B	Type II inositol 3,4-bisphosphate 4-phosphatase	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
O15327	INPP4B	Type II inositol 3,4-bisphosphate 4-phosphatase	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
O15327	INPP4B	Type II inositol 3,4-bisphosphate 4-phosphatase	GO:0046850; P:regulation of bone remodeling; IEA:Ensembl
O15327	INPP4B	Type II inositol 3,4-bisphosphate 4-phosphatase	GO:0046822; P:regulation of nucleocytoplasmic transport; IEA:Ensembl
O15327	INPP4B	Type II inositol 3,4-bisphosphate 4-phosphatase	GO:0051896; P:regulation of protein kinase B signaling; IEA:Ensembl
O15327	INPP4B	Type II inositol 3,4-bisphosphate 4-phosphatase	GO:0007165; P:signal transduction; TAS:ProtInc
O15327	INPP4B	Type II inositol 3,4-bisphosphate 4-phosphatase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NRR6	INPP5E	72 kDa inositol polyphosphate 5-phosphatase	GO:0004445; F:inositol-polyphosphate 5-phosphatase activity; TAS:UniProtKB
Q9NRR6	INPP5E	72 kDa inositol polyphosphate 5-phosphatase	GO:0004439; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; IEA:UniProtKB-EC
Q9NRR6	INPP5E	72 kDa inositol polyphosphate 5-phosphatase	GO:0046855; P:inositol phosphate dephosphorylation; IEA:Ensembl
Q9NRR6	INPP5E	72 kDa inositol polyphosphate 5-phosphatase	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q9NRR6	INPP5E	72 kDa inositol polyphosphate 5-phosphatase	GO:0046856; P:phosphatidylinositol dephosphorylation; IEA:Ensembl
Q9NRR6	INPP5E	72 kDa inositol polyphosphate 5-phosphatase	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9NRR6	INPP5E	72 kDa inositol polyphosphate 5-phosphatase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0016312; F:inositol bisphosphate phosphatase activity; IDA:MGI
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0046030; F:inositol trisphosphate phosphatase activity; IDA:MGI
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0052659; F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; IEA:UniProtKB-EC
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0052658; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; IEA:UniProtKB-EC
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0004445; F:inositol-polyphosphate 5-phosphatase activity; IEA:UniProtKB-EC
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0042577; F:lipid phosphatase activity; NAS:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0034595; F:phosphatidylinositol phosphate 5-phosphatase activity; IMP:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0034594; F:phosphatidylinositol trisphosphate phosphatase activity; IDA:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0034485; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; IDA:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0005000; F:vasopressin receptor activity; ISS:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0030036; P:actin cytoskeleton organization; NAS:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0071320; P:cellular response to cAMP; ISS:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0071364; P:cellular response to epidermal growth factor stimulus; IDA:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0032870; P:cellular response to hormone stimulus; ISS:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0032869; P:cellular response to insulin stimulus; IDA:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0071356; P:cellular response to tumor necrosis factor; IDA:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0016311; P:dephosphorylation; IDA:GOC
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0007186; P:G-protein coupled receptor signaling pathway; ISS:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0042593; P:glucose homeostasis; ISS:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0046855; P:inositol phosphate dephosphorylation; IDA:MGI
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0043922; P:negative regulation by host of viral transcription; IDA:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0051926; P:negative regulation of calcium ion transport; IDA:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0035305; P:negative regulation of dephosphorylation; ISS:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0010829; P:negative regulation of glucose transport; IDA:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:2000466; P:negative regulation of glycogen (starch) synthase activity; ISS:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0045719; P:negative regulation of glycogen biosynthetic process; IDA:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0046627; P:negative regulation of insulin receptor signaling pathway; IDA:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0043407; P:negative regulation of MAP kinase activity; IDA:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; IDA:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0010801; P:negative regulation of peptidyl-threonine phosphorylation; IDA:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0006469; P:negative regulation of protein kinase activity; IDA:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0051898; P:negative regulation of protein kinase B signaling; IDA:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0001933; P:negative regulation of protein phosphorylation; ISS:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0090315; P:negative regulation of protein targeting to membrane; IDA:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0045869; P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate; IDA:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0051497; P:negative regulation of stress fiber assembly; IDA:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0046856; P:phosphatidylinositol dephosphorylation; IDA:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:2001153; P:positive regulation of renal water transport; ISS:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0035810; P:positive regulation of urine volume; ISS:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0072661; P:protein targeting to plasma membrane; ISS:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0005979; P:regulation of glycogen biosynthetic process; ISS:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0097178; P:ruffle assembly; IDA:UniProtKB
Q9BT40	INPP5K	Inositol polyphosphate 5-phosphatase K	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P49441	INPP1	Inositol polyphosphate 1-phosphatase	GO:0052829; F:inositol-1,3,4-trisphosphate 1-phosphatase activity; TAS:Reactome
P49441	INPP1	Inositol polyphosphate 1-phosphatase	GO:0004441; F:inositol-1,4-bisphosphate 1-phosphatase activity; TAS:Reactome
P49441	INPP1	Inositol polyphosphate 1-phosphatase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P49441	INPP1	Inositol polyphosphate 1-phosphatase	GO:0016311; P:dephosphorylation; TAS:GOC
P49441	INPP1	Inositol polyphosphate 1-phosphatase	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
P49441	INPP1	Inositol polyphosphate 1-phosphatase	GO:0006796; P:phosphate-containing compound metabolic process; TAS:ProtInc
P49441	INPP1	Inositol polyphosphate 1-phosphatase	GO:0046854; P:phosphatidylinositol phosphorylation; IEA:InterPro
P49441	INPP1	Inositol polyphosphate 1-phosphatase	GO:0007165; P:signal transduction; TAS:ProtInc
P49441	INPP1	Inositol polyphosphate 1-phosphatase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q1MX18	INSC	Protein inscuteable homolog	GO:0000132; P:establishment of mitotic spindle orientation; IEA:Ensembl
Q1MX18	INSC	Protein inscuteable homolog	GO:0060487; P:lung epithelial cell differentiation; IEA:Ensembl
Q1MX18	INSC	Protein inscuteable homolog	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
O15503	INSIG1	Insulin-induced gene 1 protein	GO:0005515; F:protein binding; IPI:UniProtKB
O15503	INSIG1	Insulin-induced gene 1 protein	GO:0008283; P:cell proliferation; TAS:ProtInc
O15503	INSIG1	Insulin-induced gene 1 protein	GO:0006695; P:cholesterol biosynthetic process; IEA:Ensembl
O15503	INSIG1	Insulin-induced gene 1 protein	GO:0060363; P:cranial suture morphogenesis; IEA:Ensembl
O15503	INSIG1	Insulin-induced gene 1 protein	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
O15503	INSIG1	Insulin-induced gene 1 protein	GO:0008152; P:metabolic process; TAS:ProtInc
O15503	INSIG1	Insulin-induced gene 1 protein	GO:0042474; P:middle ear morphogenesis; IEA:Ensembl
O15503	INSIG1	Insulin-induced gene 1 protein	GO:1901303; P:negative regulation of cargo loading into COPII-coated vesicle; IMP:UniProtKB
O15503	INSIG1	Insulin-induced gene 1 protein	GO:0045599; P:negative regulation of fat cell differentiation; IEA:Ensembl
O15503	INSIG1	Insulin-induced gene 1 protein	GO:0045717; P:negative regulation of fatty acid biosynthetic process; IEA:Ensembl
O15503	INSIG1	Insulin-induced gene 1 protein	GO:0010894; P:negative regulation of steroid biosynthetic process; IEA:Ensembl
O15503	INSIG1	Insulin-induced gene 1 protein	GO:0060021; P:palate development; IEA:Ensembl
O15503	INSIG1	Insulin-induced gene 1 protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15503	INSIG1	Insulin-induced gene 1 protein	GO:0032933; P:SREBP signaling pathway; IDA:UniProtKB
O15503	INSIG1	Insulin-induced gene 1 protein	GO:0006641; P:triglyceride metabolic process; IEA:Ensembl
Q9Y5U4	INSIG2	Insulin-induced gene 2 protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y5U4	INSIG2	Insulin-induced gene 2 protein	GO:0006695; P:cholesterol biosynthetic process; IEA:Ensembl
Q9Y5U4	INSIG2	Insulin-induced gene 2 protein	GO:0060363; P:cranial suture morphogenesis; IEA:Ensembl
Q9Y5U4	INSIG2	Insulin-induced gene 2 protein	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q9Y5U4	INSIG2	Insulin-induced gene 2 protein	GO:0042474; P:middle ear morphogenesis; IEA:Ensembl
Q9Y5U4	INSIG2	Insulin-induced gene 2 protein	GO:0045717; P:negative regulation of fatty acid biosynthetic process; IEA:Ensembl
Q9Y5U4	INSIG2	Insulin-induced gene 2 protein	GO:0010894; P:negative regulation of steroid biosynthetic process; IEA:Ensembl
Q9Y5U4	INSIG2	Insulin-induced gene 2 protein	GO:0060021; P:palate development; IEA:Ensembl
Q9Y5U4	INSIG2	Insulin-induced gene 2 protein	GO:0070542; P:response to fatty acid; IEA:Ensembl
Q9Y5U4	INSIG2	Insulin-induced gene 2 protein	GO:0032868; P:response to insulin; IEA:Ensembl
Q9Y5U4	INSIG2	Insulin-induced gene 2 protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y5U4	INSIG2	Insulin-induced gene 2 protein	GO:0032933; P:SREBP signaling pathway; IDA:UniProtKB
Q9Y5U4	INSIG2	Insulin-induced gene 2 protein	GO:0006641; P:triglyceride metabolic process; IEA:Ensembl
P51460	INSL3	Insulin-like 3	GO:0005158; F:insulin receptor binding; TAS:ProtInc
P51460	INSL3	Insulin-like 3	GO:0002020; F:protease binding; IPI:UniProtKB
P51460	INSL3	Insulin-like 3	GO:0005102; F:receptor binding; TAS:ProtInc
P51460	INSL3	Insulin-like 3	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IEA:Ensembl
P51460	INSL3	Insulin-like 3	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P51460	INSL3	Insulin-like 3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P51460	INSL3	Insulin-like 3	GO:0008584; P:male gonad development; IEA:Ensembl
P51460	INSL3	Insulin-like 3	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P51460	INSL3	Insulin-like 3	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P51460	INSL3	Insulin-like 3	GO:0001556; P:oocyte maturation; IEA:Ensembl
P51460	INSL3	Insulin-like 3	GO:0030819; P:positive regulation of cAMP biosynthetic process; IEA:Ensembl
P51460	INSL3	Insulin-like 3	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P51460	INSL3	Insulin-like 3	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q14641	INSL4	Early placenta insulin-like peptide	GO:0005159; F:insulin-like growth factor receptor binding; TAS:ProtInc
Q14641	INSL4	Early placenta insulin-like peptide	GO:0005102; F:receptor binding; TAS:ProtInc
Q14641	INSL4	Early placenta insulin-like peptide	GO:0008283; P:cell proliferation; TAS:ProtInc
Q14641	INSL4	Early placenta insulin-like peptide	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q14641	INSL4	Early placenta insulin-like peptide	GO:0007565; P:female pregnancy; TAS:ProtInc
Q14641	INSL4	Early placenta insulin-like peptide	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q14641	INSL4	Early placenta insulin-like peptide	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y581	INSL6	Insulin-like peptide INSL6	GO:0005179; F:hormone activity; NAS:UniProtKB
Q9Y581	INSL6	Insulin-like peptide INSL6	GO:0009566; P:fertilization; IEA:Ensembl
Q9Y581	INSL6	Insulin-like peptide INSL6	GO:0008584; P:male gonad development; IEA:Ensembl
Q9Y581	INSL6	Insulin-like peptide INSL6	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q9Y581	INSL6	Insulin-like peptide INSL6	GO:0030317; P:sperm motility; IEA:Ensembl
Q9Y581	INSL6	Insulin-like peptide INSL6	GO:0007286; P:spermatid development; IEA:Ensembl
Q01101	INSM1	Insulinoma-associated protein 1	GO:0031490; F:chromatin DNA binding; IDA:UniProtKB
Q01101	INSM1	Insulinoma-associated protein 1	GO:0001047; F:core promoter binding; IDA:UniProtKB
Q01101	INSM1	Insulinoma-associated protein 1	GO:0030332; F:cyclin binding; IPI:UniProtKB
Q01101	INSM1	Insulinoma-associated protein 1	GO:0042826; F:histone deacetylase binding; IPI:UniProtKB
Q01101	INSM1	Insulinoma-associated protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q01101	INSM1	Insulinoma-associated protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q01101	INSM1	Insulinoma-associated protein 1	GO:0061104; P:adrenal chromaffin cell differentiation; ISS:UniProtKB
Q01101	INSM1	Insulinoma-associated protein 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q01101	INSM1	Insulinoma-associated protein 1	GO:0031018; P:endocrine pancreas development; TAS:Reactome
Q01101	INSM1	Insulinoma-associated protein 1	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q01101	INSM1	Insulinoma-associated protein 1	GO:0001933; P:negative regulation of protein phosphorylation; IDA:UniProtKB
Q01101	INSM1	Insulinoma-associated protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q01101	INSM1	Insulinoma-associated protein 1	GO:0003358; P:noradrenergic neuron development; ISS:UniProtKB
Q01101	INSM1	Insulinoma-associated protein 1	GO:0042421; P:norepinephrine biosynthetic process; ISS:UniProtKB
Q01101	INSM1	Insulinoma-associated protein 1	GO:0003310; P:pancreatic A cell differentiation; ISS:UniProtKB
Q01101	INSM1	Insulinoma-associated protein 1	GO:0071158; P:positive regulation of cell cycle arrest; IDA:UniProtKB
Q01101	INSM1	Insulinoma-associated protein 1	GO:0045597; P:positive regulation of cell differentiation; ISS:UniProtKB
Q01101	INSM1	Insulinoma-associated protein 1	GO:2000179; P:positive regulation of neural precursor cell proliferation; ISS:UniProtKB
Q01101	INSM1	Insulinoma-associated protein 1	GO:0010468; P:regulation of gene expression; ISS:UniProtKB
Q01101	INSM1	Insulinoma-associated protein 1	GO:0043254; P:regulation of protein complex assembly; IDA:UniProtKB
Q01101	INSM1	Insulinoma-associated protein 1	GO:0061549; P:sympathetic ganglion development; ISS:UniProtKB
Q01101	INSM1	Insulinoma-associated protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q01101	INSM1	Insulinoma-associated protein 1	GO:0060290; P:transdifferentiation; IDA:UniProtKB
Q01101	INSM1	Insulinoma-associated protein 1	GO:0003323; P:type B pancreatic cell development; IEA:Ensembl
Q01101	INSM1	Insulinoma-associated protein 1	GO:0003309; P:type B pancreatic cell differentiation; ISS:UniProtKB
Q96T92	INSM2	Insulinoma-associated protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96T92	INSM2	Insulinoma-associated protein 2	GO:0046872; F:metal ion binding; IEA:InterPro
Q96T92	INSM2	Insulinoma-associated protein 2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q96T92	INSM2	Insulinoma-associated protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96T92	INSM2	Insulinoma-associated protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P14616	INSRR	Insulin receptor-related protein	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P14616	INSRR	Insulin receptor-related protein	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IDA:UniProtKB
P14616	INSRR	Insulin receptor-related protein	GO:0031532; P:actin cytoskeleton reorganization; IDA:UniProtKB
P14616	INSRR	Insulin receptor-related protein	GO:0071469; P:cellular response to alkalinity; IDA:UniProtKB
P14616	INSRR	Insulin receptor-related protein	GO:0030238; P:male sex determination; IEA:Ensembl
P14616	INSRR	Insulin receptor-related protein	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:GOC
P14616	INSRR	Insulin receptor-related protein	GO:0046777; P:protein autophosphorylation; IMP:UniProtKB
P14616	INSRR	Insulin receptor-related protein	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; NAS:UniProtKB
P06213	INSR	Insulin receptor	GO:0005524; F:ATP binding; IDA:BHF-UCL
P06213	INSR	Insulin receptor	GO:0005525; F:GTP binding; IDA:BHF-UCL
P06213	INSR	Insulin receptor	GO:0043559; F:insulin binding; IDA:UniProtKB
P06213	INSR	Insulin receptor	GO:0043560; F:insulin receptor substrate binding; IPI:UniProtKB
P06213	INSR	Insulin receptor	GO:0005009; F:insulin-activated receptor activity; IDA:UniProtKB
P06213	INSR	Insulin receptor	GO:0031994; F:insulin-like growth factor I binding; IPI:BHF-UCL
P06213	INSR	Insulin receptor	GO:0031995; F:insulin-like growth factor II binding; IPI:BHF-UCL
P06213	INSR	Insulin receptor	GO:0005159; F:insulin-like growth factor receptor binding; IDA:BHF-UCL
P06213	INSR	Insulin receptor	GO:0043548; F:phosphatidylinositol 3-kinase binding; IPI:UniProtKB
P06213	INSR	Insulin receptor	GO:0005515; F:protein binding; IPI:BHF-UCL
P06213	INSR	Insulin receptor	GO:0004713; F:protein tyrosine kinase activity; IMP:UniProtKB
P06213	INSR	Insulin receptor	GO:0051425; F:PTB domain binding; IPI:UniProtKB
P06213	INSR	Insulin receptor	GO:0004716; F:receptor signaling protein tyrosine kinase activity; IDA:BHF-UCL
P06213	INSR	Insulin receptor	GO:0042169; F:SH2 domain binding; IPI:UniProtKB
P06213	INSR	Insulin receptor	GO:0000187; P:activation of MAPK activity; IMP:BHF-UCL
P06213	INSR	Insulin receptor	GO:0032147; P:activation of protein kinase activity; IMP:BHF-UCL
P06213	INSR	Insulin receptor	GO:0032148; P:activation of protein kinase B activity; IDA:BHF-UCL
P06213	INSR	Insulin receptor	GO:0005975; P:carbohydrate metabolic process; IEA:UniProtKB-KW
P06213	INSR	Insulin receptor	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P06213	INSR	Insulin receptor	GO:0032869; P:cellular response to insulin stimulus; IDA:BHF-UCL
P06213	INSR	Insulin receptor	GO:0031017; P:exocrine pancreas development; IEA:Ensembl
P06213	INSR	Insulin receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:BHF-UCL
P06213	INSR	Insulin receptor	GO:0042593; P:glucose homeostasis; IMP:BHF-UCL
P06213	INSR	Insulin receptor	GO:0003007; P:heart morphogenesis; IMP:BHF-UCL
P06213	INSR	Insulin receptor	GO:0008286; P:insulin receptor signaling pathway; IDA:UniProtKB
P06213	INSR	Insulin receptor	GO:0030238; P:male sex determination; IEA:Ensembl
P06213	INSR	Insulin receptor	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:BHF-UCL
P06213	INSR	Insulin receptor	GO:0030335; P:positive regulation of cell migration; IMP:BHF-UCL
P06213	INSR	Insulin receptor	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P06213	INSR	Insulin receptor	GO:0048639; P:positive regulation of developmental growth; IMP:BHF-UCL
P06213	INSR	Insulin receptor	GO:0045740; P:positive regulation of DNA replication; IMP:BHF-UCL
P06213	INSR	Insulin receptor	GO:0046326; P:positive regulation of glucose import; IDA:BHF-UCL
P06213	INSR	Insulin receptor	GO:0045725; P:positive regulation of glycogen biosynthetic process; IDA:BHF-UCL
P06213	INSR	Insulin receptor	GO:0045821; P:positive regulation of glycolytic process; IMP:BHF-UCL
P06213	INSR	Insulin receptor	GO:0043410; P:positive regulation of MAPK cascade; IMP:BHF-UCL
P06213	INSR	Insulin receptor	GO:0045840; P:positive regulation of mitosis; IMP:BHF-UCL
P06213	INSR	Insulin receptor	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IMP:BHF-UCL
P06213	INSR	Insulin receptor	GO:0051897; P:positive regulation of protein kinase B signaling; IMP:BHF-UCL
P06213	INSR	Insulin receptor	GO:0001934; P:positive regulation of protein phosphorylation; IDA:BHF-UCL
P06213	INSR	Insulin receptor	GO:0060267; P:positive regulation of respiratory burst; IDA:BHF-UCL
P06213	INSR	Insulin receptor	GO:0046777; P:protein autophosphorylation; IMP:UniProtKB
P06213	INSR	Insulin receptor	GO:0051290; P:protein heterotetramerization; IDA:UniProtKB
P06213	INSR	Insulin receptor	GO:0045995; P:regulation of embryonic development; IMP:BHF-UCL
P06213	INSR	Insulin receptor	GO:0006355; P:regulation of transcription, DNA-templated; IMP:BHF-UCL
P06213	INSR	Insulin receptor	GO:0023014; P:signal transduction by phosphorylation; IDA:GOC
P06213	INSR	Insulin receptor	GO:0019087; P:transformation of host cell by virus; IMP:BHF-UCL
P01308	INS	Insulin	GO:0005179; F:hormone activity; NAS:UniProtKB
P01308	INS	Insulin	GO:0042802; F:identical protein binding; IPI:IntAct
P01308	INS	Insulin	GO:0005158; F:insulin receptor binding; IDA:UniProtKB
P01308	INS	Insulin	GO:0005159; F:insulin-like growth factor receptor binding; IPI:BHF-UCL
P01308	INS	Insulin	GO:0002020; F:protease binding; IPI:UniProtKB
P01308	INS	Insulin	GO:0005515; F:protein binding; IPI:UniProtKB
P01308	INS	Insulin	GO:0032148; P:activation of protein kinase B activity; IDA:BHF-UCL
P01308	INS	Insulin	GO:0006953; P:acute-phase response; IDA:BHF-UCL
P01308	INS	Insulin	GO:0046631; P:alpha-beta T cell activation; IDA:UniProtKB
P01308	INS	Insulin	GO:0007267; P:cell-cell signaling; IC:UniProtKB
P01308	INS	Insulin	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P01308	INS	Insulin	GO:0031018; P:endocrine pancreas development; TAS:Reactome
P01308	INS	Insulin	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P01308	INS	Insulin	GO:0055089; P:fatty acid homeostasis; IMP:BHF-UCL
P01308	INS	Insulin	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:BHF-UCL
P01308	INS	Insulin	GO:0042593; P:glucose homeostasis; IMP:BHF-UCL
P01308	INS	Insulin	GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW
P01308	INS	Insulin	GO:0015758; P:glucose transport; IDA:UniProtKB
P01308	INS	Insulin	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P01308	INS	Insulin	GO:0000165; P:MAPK cascade; IDA:BHF-UCL
P01308	INS	Insulin	GO:0002674; P:negative regulation of acute inflammatory response; IDA:BHF-UCL
P01308	INS	Insulin	GO:0045922; P:negative regulation of fatty acid metabolic process; IMP:BHF-UCL
P01308	INS	Insulin	GO:2000252; P:negative regulation of feeding behavior; IDA:DFLAT
P01308	INS	Insulin	GO:0045721; P:negative regulation of gluconeogenesis; NAS:BHF-UCL
P01308	INS	Insulin	GO:0045818; P:negative regulation of glycogen catabolic process; IMP:BHF-UCL
P01308	INS	Insulin	GO:1902176; P:negative regulation of intrinsic apoptotic signaling pathway in response to oxidative stress; NAS:BHF-UCL
P01308	INS	Insulin	GO:0050995; P:negative regulation of lipid catabolic process; NAS:BHF-UCL
P01308	INS	Insulin	GO:0033861; P:negative regulation of NAD(P)H oxidase activity; IDA:BHF-UCL
P01308	INS	Insulin	GO:0042177; P:negative regulation of protein catabolic process; IDA:UniProtKB
P01308	INS	Insulin	GO:0032460; P:negative regulation of protein oligomerization; IDA:UniProtKB
P01308	INS	Insulin	GO:0050709; P:negative regulation of protein secretion; IDA:BHF-UCL
P01308	INS	Insulin	GO:0045861; P:negative regulation of proteolysis; IMP:BHF-UCL
P01308	INS	Insulin	GO:0060266; P:negative regulation of respiratory burst involved in inflammatory response; IDA:BHF-UCL
P01308	INS	Insulin	GO:0045908; P:negative regulation of vasodilation; NAS:UniProtKB
P01308	INS	Insulin	GO:0090336; P:positive regulation of brown fat cell differentiation; TAS:BHF-UCL
P01308	INS	Insulin	GO:0045597; P:positive regulation of cell differentiation; NAS:BHF-UCL
P01308	INS	Insulin	GO:0030307; P:positive regulation of cell growth; NAS:BHF-UCL
P01308	INS	Insulin	GO:0030335; P:positive regulation of cell migration; ISS:BHF-UCL
P01308	INS	Insulin	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P01308	INS	Insulin	GO:0032270; P:positive regulation of cellular protein metabolic process; IMP:BHF-UCL
P01308	INS	Insulin	GO:0050715; P:positive regulation of cytokine secretion; IDA:UniProtKB
P01308	INS	Insulin	GO:0045740; P:positive regulation of DNA replication; IDA:BHF-UCL
P01308	INS	Insulin	GO:0046326; P:positive regulation of glucose import; IDA:BHF-UCL
P01308	INS	Insulin	GO:0045725; P:positive regulation of glycogen biosynthetic process; IDA:BHF-UCL
P01308	INS	Insulin	GO:0045821; P:positive regulation of glycolytic process; IDA:BHF-UCL
P01308	INS	Insulin	GO:0046628; P:positive regulation of insulin receptor signaling pathway; IDA:BHF-UCL
P01308	INS	Insulin	GO:0046889; P:positive regulation of lipid biosynthetic process; NAS:BHF-UCL
P01308	INS	Insulin	GO:0043410; P:positive regulation of MAPK cascade; IDA:BHF-UCL
P01308	INS	Insulin	GO:0045840; P:positive regulation of mitosis; IDA:UniProtKB
P01308	INS	Insulin	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:BHF-UCL
P01308	INS	Insulin	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; NAS:UniProtKB
P01308	INS	Insulin	GO:0051000; P:positive regulation of nitric-oxide synthase activity; NAS:UniProtKB
P01308	INS	Insulin	GO:0090277; P:positive regulation of peptide hormone secretion; TAS:BHF-UCL
P01308	INS	Insulin	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL
P01308	INS	Insulin	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IDA:BHF-UCL
P01308	INS	Insulin	GO:0031954; P:positive regulation of protein autophosphorylation; ISS:BHF-UCL
P01308	INS	Insulin	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:BHF-UCL
P01308	INS	Insulin	GO:0060267; P:positive regulation of respiratory burst; IDA:BHF-UCL
P01308	INS	Insulin	GO:0045909; P:positive regulation of vasodilation; NAS:UniProtKB
P01308	INS	Insulin	GO:0006521; P:regulation of cellular amino acid metabolic process; IMP:BHF-UCL
P01308	INS	Insulin	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P01308	INS	Insulin	GO:0032880; P:regulation of protein localization; IDA:BHF-UCL
P01308	INS	Insulin	GO:0050708; P:regulation of protein secretion; IDA:UniProtKB
P01308	INS	Insulin	GO:0006355; P:regulation of transcription, DNA-templated; NAS:BHF-UCL
P01308	INS	Insulin	GO:0022898; P:regulation of transmembrane transporter activity; IDA:BHF-UCL
P01308	INS	Insulin	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P01308	INS	Insulin	GO:0042060; P:wound healing; IDA:BHF-UCL
Q9NVR2	INTS10	Integrator complex subunit 10	GO:0005515; F:protein binding; IPI:HGNC
Q9NVR2	INTS10	Integrator complex subunit 10	GO:0016180; P:snRNA processing; IDA:HGNC
Q5TA45	CPSF3L	Integrator complex subunit 11	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q96CB8	INTS12	Integrator complex subunit 12	GO:0005515; F:protein binding; IPI:UniProtKB
Q96CB8	INTS12	Integrator complex subunit 12	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96CB8	INTS12	Integrator complex subunit 12	GO:0016180; P:snRNA processing; IDA:HGNC
Q8N201	INTS1	Integrator complex subunit 1	GO:0001833; P:inner cell mass cell proliferation; IEA:Ensembl
Q8N201	INTS1	Integrator complex subunit 1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q8N201	INTS1	Integrator complex subunit 1	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
Q8N201	INTS1	Integrator complex subunit 1	GO:0016180; P:snRNA processing; IDA:HGNC
Q8N201	INTS1	Integrator complex subunit 1	GO:0034474; P:U2 snRNA 3'-end processing; IEA:Ensembl
Q9H0H0	INTS2	Integrator complex subunit 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H0H0	INTS2	Integrator complex subunit 2	GO:0016180; P:snRNA processing; IDA:HGNC
Q68E01	INTS3	Integrator complex subunit 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q68E01	INTS3	Integrator complex subunit 3	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
Q68E01	INTS3	Integrator complex subunit 3	GO:0006281; P:DNA repair; IMP:UniProtKB
Q68E01	INTS3	Integrator complex subunit 3	GO:0007093; P:mitotic cell cycle checkpoint; IMP:UniProtKB
Q68E01	INTS3	Integrator complex subunit 3	GO:0010212; P:response to ionizing radiation; IMP:UniProtKB
Q68E01	INTS3	Integrator complex subunit 3	GO:0016180; P:snRNA processing; IDA:HGNC
Q96HW7	INTS4	Integrator complex subunit 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q96HW7	INTS4	Integrator complex subunit 4	GO:0016180; P:snRNA processing; IDA:HGNC
Q6P9B9	INTS5	Integrator complex subunit 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q6P9B9	INTS5	Integrator complex subunit 5	GO:0016180; P:snRNA processing; IDA:HGNC
Q9UL03	INTS6	Integrator complex subunit 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UL03	INTS6	Integrator complex subunit 6	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q9UL03	INTS6	Integrator complex subunit 6	GO:0007165; P:signal transduction; TAS:GOC
Q9UL03	INTS6	Integrator complex subunit 6	GO:0016180; P:snRNA processing; IDA:HGNC
Q9NVH2	INTS7	Integrator complex subunit 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NVH2	INTS7	Integrator complex subunit 7	GO:0071479; P:cellular response to ionizing radiation; IDA:UniProtKB
Q9NVH2	INTS7	Integrator complex subunit 7	GO:0000077; P:DNA damage checkpoint; IMP:UniProtKB
Q9NVH2	INTS7	Integrator complex subunit 7	GO:0016180; P:snRNA processing; IDA:HGNC
Q75QN2	INTS8	Integrator complex subunit 8	GO:0005515; F:protein binding; IPI:UniProtKB
Q75QN2	INTS8	Integrator complex subunit 8	GO:0016180; P:snRNA processing; IDA:HGNC
Q9NV88	INTS9	Integrator complex subunit 9	GO:0016787; F:hydrolase activity; IEA:InterPro
Q9NV88	INTS9	Integrator complex subunit 9	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NV88	INTS9	Integrator complex subunit 9	GO:0016180; P:snRNA processing; IDA:HGNC
Q9ULD6	INTU	Protein inturned	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q9ULD6	INTU	Protein inturned	GO:0060173; P:limb development; ISS:UniProtKB
Q9ULD6	INTU	Protein inturned	GO:0007399; P:nervous system development; ISS:UniProtKB
Q9ULD6	INTU	Protein inturned	GO:0008589; P:regulation of smoothened signaling pathway; ISS:UniProtKB
Q9ULD6	INTU	Protein inturned	GO:0021513; P:spinal cord dorsal/ventral patterning; IEA:Ensembl
P07476	IVL	Involucrin	GO:0030674; F:protein binding, bridging; IDA:UniProtKB
P07476	IVL	Involucrin	GO:0005198; F:structural molecule activity; IDA:UniProtKB
P07476	IVL	Involucrin	GO:0018153; P:isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine; TAS:UniProtKB
P07476	IVL	Involucrin	GO:0031424; P:keratinization; IEA:UniProtKB-KW
P07476	IVL	Involucrin	GO:0030216; P:keratinocyte differentiation; IDA:UniProtKB
P07476	IVL	Involucrin	GO:0018149; P:peptide cross-linking; IDA:UniProtKB
P07476	IVL	Involucrin	GO:0010224; P:response to UV-B; IDA:UniProtKB
Q9Y283	INVS	Inversin	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y283	INVS	Inversin	GO:0060971; P:embryonic heart tube left/right pattern formation; IEA:Ensembl
Q9Y283	INVS	Inversin	GO:0001822; P:kidney development; IEA:Ensembl
Q9Y283	INVS	Inversin	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:UniProtKB
Q9Y283	INVS	Inversin	GO:0031016; P:pancreas development; IEA:Ensembl
Q9Y283	INVS	Inversin	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q9Y283	INVS	Inversin	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P49895	DIO1	Type I iodothyronine deiodinase	GO:0008430; F:selenium binding; TAS:ProtInc
P49895	DIO1	Type I iodothyronine deiodinase	GO:0004800; F:thyroxine 5'-deiodinase activity; TAS:ProtInc
P49895	DIO1	Type I iodothyronine deiodinase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P49895	DIO1	Type I iodothyronine deiodinase	GO:0042446; P:hormone biosynthetic process; IEA:UniProtKB-KW
P49895	DIO1	Type I iodothyronine deiodinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P49895	DIO1	Type I iodothyronine deiodinase	GO:0006590; P:thyroid hormone generation; TAS:Reactome
Q92813	DIO2	Type II iodothyronine deiodinase	GO:0008430; F:selenium binding; IC:UniProtKB
Q92813	DIO2	Type II iodothyronine deiodinase	GO:0004800; F:thyroxine 5'-deiodinase activity; IDA:UniProtKB
Q92813	DIO2	Type II iodothyronine deiodinase	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q92813	DIO2	Type II iodothyronine deiodinase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q92813	DIO2	Type II iodothyronine deiodinase	GO:0042446; P:hormone biosynthetic process; IEA:UniProtKB-KW
Q92813	DIO2	Type II iodothyronine deiodinase	GO:0001514; P:selenocysteine incorporation; NAS:UniProtKB
Q92813	DIO2	Type II iodothyronine deiodinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q92813	DIO2	Type II iodothyronine deiodinase	GO:0006590; P:thyroid hormone generation; TAS:UniProtKB
Q92813	DIO2	Type II iodothyronine deiodinase	GO:0042403; P:thyroid hormone metabolic process; IDA:UniProtKB
P55073	DIO3	Type III iodothyronine deiodinase	GO:0004800; F:thyroxine 5'-deiodinase activity; IEA:InterPro
P55073	DIO3	Type III iodothyronine deiodinase	GO:0033798; F:thyroxine 5-deiodinase activity; IEA:UniProtKB-EC
P55073	DIO3	Type III iodothyronine deiodinase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P55073	DIO3	Type III iodothyronine deiodinase	GO:0042446; P:hormone biosynthetic process; IEA:UniProtKB-KW
P55073	DIO3	Type III iodothyronine deiodinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P55073	DIO3	Type III iodothyronine deiodinase	GO:0006590; P:thyroid hormone generation; TAS:Reactome
P23677	ITPKA	Inositol-trisphosphate 3-kinase A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P23677	ITPKA	Inositol-trisphosphate 3-kinase A	GO:0004683; F:calmodulin-dependent protein kinase activity; IEA:Ensembl
P23677	ITPKA	Inositol-trisphosphate 3-kinase A	GO:0008440; F:inositol-1,4,5-trisphosphate 3-kinase activity; TAS:ProtInc
P23677	ITPKA	Inositol-trisphosphate 3-kinase A	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
P23677	ITPKA	Inositol-trisphosphate 3-kinase A	GO:0097062; P:dendritic spine maintenance; IEA:Ensembl
P23677	ITPKA	Inositol-trisphosphate 3-kinase A	GO:0006020; P:inositol metabolic process; IEA:Ensembl
P23677	ITPKA	Inositol-trisphosphate 3-kinase A	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
P23677	ITPKA	Inositol-trisphosphate 3-kinase A	GO:0061003; P:positive regulation of dendritic spine morphogenesis; IEA:Ensembl
P23677	ITPKA	Inositol-trisphosphate 3-kinase A	GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl
P23677	ITPKA	Inositol-trisphosphate 3-kinase A	GO:0007165; P:signal transduction; TAS:ProtInc
P23677	ITPKA	Inositol-trisphosphate 3-kinase A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96DU7	ITPKC	Inositol-trisphosphate 3-kinase C	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96DU7	ITPKC	Inositol-trisphosphate 3-kinase C	GO:0008440; F:inositol-1,4,5-trisphosphate 3-kinase activity; IEA:UniProtKB-EC
Q96DU7	ITPKC	Inositol-trisphosphate 3-kinase C	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q96DU7	ITPKC	Inositol-trisphosphate 3-kinase C	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P27987	ITPKB	Inositol-trisphosphate 3-kinase B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P27987	ITPKB	Inositol-trisphosphate 3-kinase B	GO:0008440; F:inositol-1,4,5-trisphosphate 3-kinase activity; TAS:ProtInc
P27987	ITPKB	Inositol-trisphosphate 3-kinase B	GO:0005515; F:protein binding; IPI:UniProtKB
P27987	ITPKB	Inositol-trisphosphate 3-kinase B	GO:0007166; P:cell surface receptor signaling pathway; IEA:Ensembl
P27987	ITPKB	Inositol-trisphosphate 3-kinase B	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
P27987	ITPKB	Inositol-trisphosphate 3-kinase B	GO:0000165; P:MAPK cascade; IEA:Ensembl
P27987	ITPKB	Inositol-trisphosphate 3-kinase B	GO:0046638; P:positive regulation of alpha-beta T cell differentiation; IEA:Ensembl
P27987	ITPKB	Inositol-trisphosphate 3-kinase B	GO:0046579; P:positive regulation of Ras protein signal transduction; IEA:Ensembl
P27987	ITPKB	Inositol-trisphosphate 3-kinase B	GO:0045059; P:positive thymic T cell selection; IEA:Ensembl
P27987	ITPKB	Inositol-trisphosphate 3-kinase B	GO:0007165; P:signal transduction; TAS:ProtInc
P27987	ITPKB	Inositol-trisphosphate 3-kinase B	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q92551	IP6K1	Inositol hexakisphosphate kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q92551	IP6K1	Inositol hexakisphosphate kinase 1	GO:0052723; F:inositol hexakisphosphate 1-kinase activity; IEA:UniProtKB-EC
Q92551	IP6K1	Inositol hexakisphosphate kinase 1	GO:0052724; F:inositol hexakisphosphate 3-kinase activity; IEA:UniProtKB-EC
Q92551	IP6K1	Inositol hexakisphosphate kinase 1	GO:0000832; F:inositol hexakisphosphate 5-kinase activity; IEA:UniProtKB-EC
Q92551	IP6K1	Inositol hexakisphosphate kinase 1	GO:0008440; F:inositol-1,4,5-trisphosphate 3-kinase activity; IEA:InterPro
Q92551	IP6K1	Inositol hexakisphosphate kinase 1	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q92551	IP6K1	Inositol hexakisphosphate kinase 1	GO:0046854; P:phosphatidylinositol phosphorylation; IDA:UniProtKB
Q92551	IP6K1	Inositol hexakisphosphate kinase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UHH9	IP6K2	Inositol hexakisphosphate kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UHH9	IP6K2	Inositol hexakisphosphate kinase 2	GO:0052723; F:inositol hexakisphosphate 1-kinase activity; IEA:UniProtKB-EC
Q9UHH9	IP6K2	Inositol hexakisphosphate kinase 2	GO:0052724; F:inositol hexakisphosphate 3-kinase activity; IEA:UniProtKB-EC
Q9UHH9	IP6K2	Inositol hexakisphosphate kinase 2	GO:0000832; F:inositol hexakisphosphate 5-kinase activity; IEA:UniProtKB-EC
Q9UHH9	IP6K2	Inositol hexakisphosphate kinase 2	GO:0008440; F:inositol-1,4,5-trisphosphate 3-kinase activity; IEA:InterPro
Q9UHH9	IP6K2	Inositol hexakisphosphate kinase 2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q9UHH9	IP6K2	Inositol hexakisphosphate kinase 2	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q9UHH9	IP6K2	Inositol hexakisphosphate kinase 2	GO:0030308; P:negative regulation of cell growth; IMP:UniProtKB
Q9UHH9	IP6K2	Inositol hexakisphosphate kinase 2	GO:0006817; P:phosphate ion transport; IEA:Ensembl
Q9UHH9	IP6K2	Inositol hexakisphosphate kinase 2	GO:0046854; P:phosphatidylinositol phosphorylation; IDA:UniProtKB
Q9UHH9	IP6K2	Inositol hexakisphosphate kinase 2	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q9UHH9	IP6K2	Inositol hexakisphosphate kinase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UHH9	IP6K2	Inositol hexakisphosphate kinase 2	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q96PC2	IP6K3	Inositol hexakisphosphate kinase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96PC2	IP6K3	Inositol hexakisphosphate kinase 3	GO:0052723; F:inositol hexakisphosphate 1-kinase activity; IEA:UniProtKB-EC
Q96PC2	IP6K3	Inositol hexakisphosphate kinase 3	GO:0052724; F:inositol hexakisphosphate 3-kinase activity; IEA:UniProtKB-EC
Q96PC2	IP6K3	Inositol hexakisphosphate kinase 3	GO:0000832; F:inositol hexakisphosphate 5-kinase activity; IEA:UniProtKB-EC
Q96PC2	IP6K3	Inositol hexakisphosphate kinase 3	GO:0000831; F:inositol hexakisphosphate 6-kinase activity; IDA:MGI
Q96PC2	IP6K3	Inositol hexakisphosphate kinase 3	GO:0008440; F:inositol-1,4,5-trisphosphate 3-kinase activity; IEA:InterPro
Q96PC2	IP6K3	Inositol hexakisphosphate kinase 3	GO:0032958; P:inositol phosphate biosynthetic process; IDA:MGI
Q96PC2	IP6K3	Inositol hexakisphosphate kinase 3	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q96PC2	IP6K3	Inositol hexakisphosphate kinase 3	GO:0046488; P:phosphatidylinositol metabolic process; IDA:UniProtKB
Q96PC2	IP6K3	Inositol hexakisphosphate kinase 3	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q96PC2	IP6K3	Inositol hexakisphosphate kinase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P61925	PKIA	cAMP-dependent protein kinase inhibitor alpha	GO:0004862; F:cAMP-dependent protein kinase inhibitor activity; TAS:UniProtKB
P61925	PKIA	cAMP-dependent protein kinase inhibitor alpha	GO:0005515; F:protein binding; IPI:IntAct
P61925	PKIA	cAMP-dependent protein kinase inhibitor alpha	GO:0034236; F:protein kinase A catalytic subunit binding; IPI:BHF-UCL
P61925	PKIA	cAMP-dependent protein kinase inhibitor alpha	GO:2000480; P:negative regulation of cAMP-dependent protein kinase activity; IDA:BHF-UCL
P61925	PKIA	cAMP-dependent protein kinase inhibitor alpha	GO:0042308; P:negative regulation of protein import into nucleus; IEA:Ensembl
P61925	PKIA	cAMP-dependent protein kinase inhibitor alpha	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P61925	PKIA	cAMP-dependent protein kinase inhibitor alpha	GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; IEA:Ensembl
Q9C010	PKIB	cAMP-dependent protein kinase inhibitor beta	GO:0004862; F:cAMP-dependent protein kinase inhibitor activity; IEA:InterPro
Q9Y2B9	PKIG	cAMP-dependent protein kinase inhibitor gamma	GO:0004862; F:cAMP-dependent protein kinase inhibitor activity; TAS:ProtInc
Q9Y2B9	PKIG	cAMP-dependent protein kinase inhibitor gamma	GO:0042308; P:negative regulation of protein import into nucleus; IEA:Ensembl
Q9Y2B9	PKIG	cAMP-dependent protein kinase inhibitor gamma	GO:0071901; P:negative regulation of protein serine/threonine kinase activity; TAS:GOC
Q9Y2B9	PKIG	cAMP-dependent protein kinase inhibitor gamma	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9Y2B9	PKIG	cAMP-dependent protein kinase inhibitor gamma	GO:0007165; P:signal transduction; IEA:Ensembl
Q8NFU5	IPMK	Inositol polyphosphate multikinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NFU5	IPMK	Inositol polyphosphate multikinase	GO:0000824; F:inositol tetrakisphosphate 3-kinase activity; IEA:Ensembl
Q8NFU5	IPMK	Inositol polyphosphate multikinase	GO:0008440; F:inositol-1,4,5-trisphosphate 3-kinase activity; IEA:Ensembl
Q8NFU5	IPMK	Inositol polyphosphate multikinase	GO:0000823; F:inositol-1,4,5-trisphosphate 6-kinase activity; IEA:UniProtKB-EC
Q8NFU5	IPMK	Inositol polyphosphate multikinase	GO:0032958; P:inositol phosphate biosynthetic process; IEA:Ensembl
Q8NFU5	IPMK	Inositol polyphosphate multikinase	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q8NFU5	IPMK	Inositol polyphosphate multikinase	GO:0001841; P:neural tube formation; IEA:Ensembl
Q8NFU5	IPMK	Inositol polyphosphate multikinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UI26	IPO11	Importin-11	GO:0008565; F:protein transporter activity; IEA:Ensembl
Q9UI26	IPO11	Importin-11	GO:0006610; P:ribosomal protein import into nucleus; IEA:Ensembl
O94829	IPO13	Importin-13	GO:0005515; F:protein binding; IPI:IntAct
O94829	IPO13	Importin-13	GO:0006606; P:protein import into nucleus; IDA:MGI
Q8TEX9	IPO4	Importin-4	GO:0006335; P:DNA replication-dependent nucleosome assembly; IDA:UniProt
Q8TEX9	IPO4	Importin-4	GO:0006336; P:DNA replication-independent nucleosome assembly; IDA:UniProt
Q8TEX9	IPO4	Importin-4	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q8TEX9	IPO4	Importin-4	GO:0015031; P:protein transport; NAS:UniProtKB
O00410	IPO5	Importin-5	GO:0005095; F:GTPase inhibitor activity; TAS:ProtInc
O00410	IPO5	Importin-5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O00410	IPO5	Importin-5	GO:0005515; F:protein binding; IPI:UniProtKB
O00410	IPO5	Importin-5	GO:0008565; F:protein transporter activity; ISS:UniProtKB
O00410	IPO5	Importin-5	GO:0008536; F:Ran GTPase binding; TAS:ProtInc
O00410	IPO5	Importin-5	GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB
O00410	IPO5	Importin-5	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
O00410	IPO5	Importin-5	GO:0006607; P:NLS-bearing protein import into nucleus; ISS:UniProtKB
O00410	IPO5	Importin-5	GO:0042307; P:positive regulation of protein import into nucleus; ISS:UniProtKB
O00410	IPO5	Importin-5	GO:0006610; P:ribosomal protein import into nucleus; IDA:UniProtKB
O00410	IPO5	Importin-5	GO:0016032; P:viral process; IEA:UniProtKB-KW
O95373	IPO7	Importin-7	GO:0005515; F:protein binding; IPI:UniProtKB
O95373	IPO7	Importin-7	GO:0008536; F:Ran GTPase binding; TAS:ProtInc
O95373	IPO7	Importin-7	GO:0005083; F:small GTPase regulator activity; TAS:ProtInc
O95373	IPO7	Importin-7	GO:0005215; F:transporter activity; TAS:ProtInc
O95373	IPO7	Importin-7	GO:0006606; P:protein import into nucleus; IEA:Ensembl
O95373	IPO7	Importin-7	GO:0050790; P:regulation of catalytic activity; TAS:GOC
O95373	IPO7	Importin-7	GO:0007165; P:signal transduction; TAS:ProtInc
O95373	IPO7	Importin-7	GO:0016032; P:viral process; IEA:UniProtKB-KW
O15397	IPO8	Importin-8	GO:0005515; F:protein binding; IPI:IntAct
O15397	IPO8	Importin-8	GO:0008536; F:Ran GTPase binding; TAS:ProtInc
O15397	IPO8	Importin-8	GO:0006886; P:intracellular protein transport; IEA:InterPro
O15397	IPO8	Importin-8	GO:0007165; P:signal transduction; TAS:ProtInc
Q96P70	IPO9	Importin-9	GO:0042393; F:histone binding; ISS:UniProtKB
Q96P70	IPO9	Importin-9	GO:0005515; F:protein binding; IPI:UniProtKB
Q96P70	IPO9	Importin-9	GO:0008565; F:protein transporter activity; IDA:UniProtKB
Q96P70	IPO9	Importin-9	GO:0006606; P:protein import into nucleus; NAS:UniProtKB
Q96PQ5	PPP1R2P1	Putative protein phosphatase inhibitor 2-like protein 1	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
Q96PQ5	PPP1R2P1	Putative protein phosphatase inhibitor 2-like protein 1	GO:0005977; P:glycogen metabolic process; IEA:UniProtKB-KW
Q96PQ5	PPP1R2P1	Putative protein phosphatase inhibitor 2-like protein 1	GO:0043666; P:regulation of phosphoprotein phosphatase activity; IEA:InterPro
Q96PQ5	PPP1R2P1	Putative protein phosphatase inhibitor 2-like protein 1	GO:0009966; P:regulation of signal transduction; IEA:InterPro
Q6NXS1	PPP1R2P3	Protein phosphatase inhibitor 2-like protein 3	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
Q6NXS1	PPP1R2P3	Protein phosphatase inhibitor 2-like protein 3	GO:0005977; P:glycogen metabolic process; IEA:UniProtKB-KW
Q6NXS1	PPP1R2P3	Protein phosphatase inhibitor 2-like protein 3	GO:0043666; P:regulation of phosphoprotein phosphatase activity; IEA:InterPro
Q6NXS1	PPP1R2P3	Protein phosphatase inhibitor 2-like protein 3	GO:0009966; P:regulation of signal transduction; IEA:InterPro
P41236	PPP1R2	Protein phosphatase inhibitor 2	GO:0005515; F:protein binding; IPI:UniProtKB
P41236	PPP1R2	Protein phosphatase inhibitor 2	GO:0004865; F:protein serine/threonine phosphatase inhibitor activity; TAS:ProtInc
P41236	PPP1R2	Protein phosphatase inhibitor 2	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P41236	PPP1R2	Protein phosphatase inhibitor 2	GO:0005977; P:glycogen metabolic process; IEA:UniProtKB-KW
P41236	PPP1R2	Protein phosphatase inhibitor 2	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
P41236	PPP1R2	Protein phosphatase inhibitor 2	GO:0043666; P:regulation of phosphoprotein phosphatase activity; IEA:InterPro
P41236	PPP1R2	Protein phosphatase inhibitor 2	GO:0009966; P:regulation of signal transduction; IEA:InterPro
O14990	PPP1R2P9	Putative type-1 protein phosphatase inhibitor 4	GO:0004864; F:protein phosphatase inhibitor activity; NAS:UniProtKB
O14990	PPP1R2P9	Putative type-1 protein phosphatase inhibitor 4	GO:0043086; P:negative regulation of catalytic activity; NAS:GOC
O14990	PPP1R2P9	Putative type-1 protein phosphatase inhibitor 4	GO:0043666; P:regulation of phosphoprotein phosphatase activity; IEA:InterPro
O14990	PPP1R2P9	Putative type-1 protein phosphatase inhibitor 4	GO:0009966; P:regulation of signal transduction; IEA:InterPro
Q9H8X2	IPPK	Inositol-pentakisphosphate 2-kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H8X2	IPPK	Inositol-pentakisphosphate 2-kinase	GO:0035299; F:inositol pentakisphosphate 2-kinase activity; IDA:HGNC
Q9H8X2	IPPK	Inositol-pentakisphosphate 2-kinase	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q9H8X2	IPPK	Inositol-pentakisphosphate 2-kinase	GO:0052746; P:inositol phosphorylation; IDA:BHF-UCL
Q9H8X2	IPPK	Inositol-pentakisphosphate 2-kinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y573	IPP	Actin-binding protein IPP	GO:0003779; F:actin binding; TAS:ProtInc
Q8IWB1	ITPRIP	Inositol 1,4,5-trisphosphate receptor-interacting protein	GO:0004860; F:protein kinase inhibitor activity; IEA:Ensembl
Q8IWB1	ITPRIP	Inositol 1,4,5-trisphosphate receptor-interacting protein	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
P05154	SERPINA5	Plasma serine protease inhibitor	GO:0032190; F:acrosin binding; IPI:UniProtKB
P05154	SERPINA5	Plasma serine protease inhibitor	GO:0005539; F:glycosaminoglycan binding; TAS:UniProtKB
P05154	SERPINA5	Plasma serine protease inhibitor	GO:0008201; F:heparin binding; TAS:UniProtKB
P05154	SERPINA5	Plasma serine protease inhibitor	GO:0031210; F:phosphatidylcholine binding; IDA:UniProtKB
P05154	SERPINA5	Plasma serine protease inhibitor	GO:0002020; F:protease binding; IPI:UniProtKB
P05154	SERPINA5	Plasma serine protease inhibitor	GO:0001972; F:retinoic acid binding; IDA:UniProtKB
P05154	SERPINA5	Plasma serine protease inhibitor	GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:UniProtKB
P05154	SERPINA5	Plasma serine protease inhibitor	GO:0007342; P:fusion of sperm to egg plasma membrane; NAS:UniProtKB
P05154	SERPINA5	Plasma serine protease inhibitor	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
P05154	SERPINA5	Plasma serine protease inhibitor	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P05154	SERPINA5	Plasma serine protease inhibitor	GO:0045861; P:negative regulation of proteolysis; IEA:Ensembl
P05154	SERPINA5	Plasma serine protease inhibitor	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
P05154	SERPINA5	Plasma serine protease inhibitor	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q9H2U2	PPA2	Inorganic pyrophosphatase 2, mitochondrial	GO:0004427; F:inorganic diphosphatase activity; TAS:Reactome
Q9H2U2	PPA2	Inorganic pyrophosphatase 2, mitochondrial	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q9H2U2	PPA2	Inorganic pyrophosphatase 2, mitochondrial	GO:0004722; F:protein serine/threonine phosphatase activity; IEA:Ensembl
Q9H2U2	PPA2	Inorganic pyrophosphatase 2, mitochondrial	GO:0071344; P:diphosphate metabolic process; TAS:Reactome
Q9H2U2	PPA2	Inorganic pyrophosphatase 2, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
Q9H2U2	PPA2	Inorganic pyrophosphatase 2, mitochondrial	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q15181	PPA1	Inorganic pyrophosphatase	GO:0004427; F:inorganic diphosphatase activity; EXP:Reactome
Q15181	PPA1	Inorganic pyrophosphatase	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q15181	PPA1	Inorganic pyrophosphatase	GO:0071344; P:diphosphate metabolic process; TAS:Reactome
Q15181	PPA1	Inorganic pyrophosphatase	GO:0010467; P:gene expression; TAS:Reactome
Q15181	PPA1	Inorganic pyrophosphatase	GO:0006796; P:phosphate-containing compound metabolic process; TAS:ProtInc
Q15181	PPA1	Inorganic pyrophosphatase	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q86XH1	IQCA1	IQ and AAA domain-containing protein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
A6NCM1	IQCA1P1	Putative IQ and AAA domain-containing protein 1-like	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q15051	IQCB1	IQ calmodulin-binding motif-containing protein 1	GO:0005516; F:calmodulin binding; IDA:HGNC
Q15051	IQCB1	IQ calmodulin-binding motif-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15051	IQCB1	IQ calmodulin-binding motif-containing protein 1	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q15051	IQCB1	IQ calmodulin-binding motif-containing protein 1	GO:0048496; P:maintenance of organ identity; IMP:HGNC
Q15051	IQCB1	IQ calmodulin-binding motif-containing protein 1	GO:0045494; P:photoreceptor cell maintenance; IMP:HGNC
Q6DN90	IQSEC1	IQ motif and SEC7 domain-containing protein 1	GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; IBA:RefGenome
Q6DN90	IQSEC1	IQ motif and SEC7 domain-containing protein 1	GO:0030036; P:actin cytoskeleton organization; IBA:RefGenome
Q6DN90	IQSEC1	IQ motif and SEC7 domain-containing protein 1	GO:0032012; P:regulation of ARF protein signal transduction; IEA:InterPro
Q6DN90	IQSEC1	IQ motif and SEC7 domain-containing protein 1	GO:0043087; P:regulation of GTPase activity; IBA:GOC
Q5JU85	IQSEC2	IQ motif and SEC7 domain-containing protein 2	GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; IBA:RefGenome
Q5JU85	IQSEC2	IQ motif and SEC7 domain-containing protein 2	GO:0030036; P:actin cytoskeleton organization; IBA:RefGenome
Q5JU85	IQSEC2	IQ motif and SEC7 domain-containing protein 2	GO:0032012; P:regulation of ARF protein signal transduction; IEA:InterPro
Q5JU85	IQSEC2	IQ motif and SEC7 domain-containing protein 2	GO:0043087; P:regulation of GTPase activity; IBA:GOC
Q9UPP2	IQSEC3	IQ motif and SEC7 domain-containing protein 3	GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; IBA:RefGenome
Q9UPP2	IQSEC3	IQ motif and SEC7 domain-containing protein 3	GO:0030036; P:actin cytoskeleton organization; IBA:RefGenome
Q9UPP2	IQSEC3	IQ motif and SEC7 domain-containing protein 3	GO:0032012; P:regulation of ARF protein signal transduction; IEA:InterPro
Q9UPP2	IQSEC3	IQ motif and SEC7 domain-containing protein 3	GO:0043087; P:regulation of GTPase activity; IBA:GOC
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0005509; F:calcium ion binding; TAS:BHF-UCL
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0005516; F:calmodulin binding; IPI:BHF-UCL
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0005096; F:GTPase activator activity; TAS:ProtInc
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0005095; F:GTPase inhibitor activity; TAS:ProtInc
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0005515; F:protein binding; IPI:UniProtKB
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0005099; F:Ras GTPase activator activity; IEA:InterPro
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0071277; P:cellular response to calcium ion; IDA:BHF-UCL
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0072015; P:glomerular visceral epithelial cell development; ISS:UniProtKB
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0035305; P:negative regulation of dephosphorylation; IEA:Ensembl
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0043547; P:positive regulation of GTPase activity; TAS:GOC
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0045860; P:positive regulation of protein kinase activity; IMP:BHF-UCL
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0001817; P:regulation of cytokine production; IEA:Ensembl
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0007165; P:signal transduction; TAS:ProtInc
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P46940	IQGAP1	Ras GTPase-activating-like protein IQGAP1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q13576	IQGAP2	Ras GTPase-activating-like protein IQGAP2	GO:0003779; F:actin binding; TAS:ProtInc
Q13576	IQGAP2	Ras GTPase-activating-like protein IQGAP2	GO:0005095; F:GTPase inhibitor activity; TAS:ProtInc
Q13576	IQGAP2	Ras GTPase-activating-like protein IQGAP2	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB
Q13576	IQGAP2	Ras GTPase-activating-like protein IQGAP2	GO:0005099; F:Ras GTPase activator activity; IEA:InterPro
Q13576	IQGAP2	Ras GTPase-activating-like protein IQGAP2	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
Q13576	IQGAP2	Ras GTPase-activating-like protein IQGAP2	GO:0007165; P:signal transduction; TAS:ProtInc
Q13576	IQGAP2	Ras GTPase-activating-like protein IQGAP2	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q86VI3	IQGAP3	Ras GTPase-activating-like protein IQGAP3	GO:0005099; F:Ras GTPase activator activity; IEA:InterPro
Q86VI3	IQGAP3	Ras GTPase-activating-like protein IQGAP3	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
Q86VI3	IQGAP3	Ras GTPase-activating-like protein IQGAP3	GO:0071310; P:cellular response to organic substance; IEA:Ensembl
Q86VI3	IQGAP3	Ras GTPase-activating-like protein IQGAP3	GO:0070371; P:ERK1 and ERK2 cascade; IEA:Ensembl
Q86VI3	IQGAP3	Ras GTPase-activating-like protein IQGAP3	GO:0000082; P:G1/S transition of mitotic cell cycle; IEA:Ensembl
Q86VI3	IQGAP3	Ras GTPase-activating-like protein IQGAP3	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
Q86VI3	IQGAP3	Ras GTPase-activating-like protein IQGAP3	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
Q86VI3	IQGAP3	Ras GTPase-activating-like protein IQGAP3	GO:0033601; P:positive regulation of mammary gland epithelial cell proliferation; IEA:Ensembl
Q86VI3	IQGAP3	Ras GTPase-activating-like protein IQGAP3	GO:0007265; P:Ras protein signal transduction; IEA:Ensembl
Q86VI3	IQGAP3	Ras GTPase-activating-like protein IQGAP3	GO:0008361; P:regulation of cell size; IEA:Ensembl
Q8NA54	IQUB	IQ and ubiquitin-like domain-containing protein	GO:0060271; P:cilium morphogenesis; IEA:Ensembl
Q9Y5U9	IER3IP1	Immediate early response 3-interacting protein 1	GO:2000269; P:regulation of fibroblast apoptotic process; IMP:UniProtKB
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0016301; F:kinase activity; IDA:MGI
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0004704; F:NF-kappaB-inducing kinase activity; TAS:ProtInc
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0005515; F:protein binding; IPI:UniProtKB
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0042803; F:protein homodimerization activity; NAS:UniProtKB
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0004672; F:protein kinase activity; IDA:MGI
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0004674; F:protein serine/threonine kinase activity; NAS:UniProtKB
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0004842; F:ubiquitin-protein ligase activity; TAS:Reactome
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0000187; P:activation of MAPK activity; TAS:Reactome
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0007250; P:activation of NF-kappaB-inducing kinase activity; IDA:UniProtKB
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0045087; P:innate immune response; TAS:Reactome
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0070498; P:interleukin-1-mediated signaling pathway; IMP:BHF-UCL
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0007254; P:JNK cascade; TAS:Reactome
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IMP:BHF-UCL
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:BHF-UCL
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IMP:BHF-UCL
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:BHF-UCL
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0046777; P:protein autophosphorylation; NAS:UniProtKB
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0051259; P:protein oligomerization; IMP:UniProtKB
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0016567; P:protein ubiquitination; TAS:GOC
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0001959; P:regulation of cytokine-mediated signaling pathway; IMP:BHF-UCL
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0070555; P:response to interleukin-1; IMP:BHF-UCL
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0032496; P:response to lipopolysaccharide; IMP:BHF-UCL
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0032494; P:response to peptidoglycan; IEA:Ensembl
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0007165; P:signal transduction; NAS:UniProtKB
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0034134; P:toll-like receptor 2 signaling pathway; IMP:BHF-UCL
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0007178; P:transmembrane receptor protein serine/threonine kinase signaling pathway; NAS:UniProtKB
P51617	IRAK1	Interleukin-1 receptor-associated kinase 1	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0005515; F:protein binding; IPI:IntAct
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0004672; F:protein kinase activity; IEA:InterPro
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0000187; P:activation of MAPK activity; TAS:Reactome
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:ProtInc
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0006954; P:inflammatory response; TAS:ProtInc
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0045087; P:innate immune response; TAS:Reactome
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0070498; P:interleukin-1-mediated signaling pathway; IMP:BHF-UCL
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0007254; P:JNK cascade; TAS:Reactome
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IEA:Ensembl
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:BHF-UCL
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IMP:BHF-UCL
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:BHF-UCL
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0006468; P:protein phosphorylation; TAS:ProtInc
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0001959; P:regulation of cytokine-mediated signaling pathway; IMP:BHF-UCL
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0070555; P:response to interleukin-1; IMP:BHF-UCL
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
O43187	IRAK2	Interleukin-1 receptor-associated kinase-like 2	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0019221; P:cytokine-mediated signaling pathway; ISS:UniProtKB
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0070498; P:interleukin-1-mediated signaling pathway; IMP:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0001960; P:negative regulation of cytokine-mediated signaling pathway; IC:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0045824; P:negative regulation of innate immune response; ISS:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0032695; P:negative regulation of interleukin-12 production; IMP:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0032715; P:negative regulation of interleukin-6 production; IMP:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0010936; P:negative regulation of macrophage cytokine production; ISS:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0043407; P:negative regulation of MAP kinase activity; IMP:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IMP:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0042177; P:negative regulation of protein catabolic process; IMP:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0043242; P:negative regulation of protein complex disassembly; IMP:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0034122; P:negative regulation of toll-like receptor signaling pathway; ISS:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0032720; P:negative regulation of tumor necrosis factor production; IMP:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0010933; P:positive regulation of macrophage tolerance induction; ISS:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0043244; P:regulation of protein complex disassembly; ISS:UniProtKB
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0043330; P:response to exogenous dsRNA; ISS:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0070555; P:response to interleukin-1; IMP:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0032496; P:response to lipopolysaccharide; ISS:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0032494; P:response to peptidoglycan; ISS:BHF-UCL
Q9Y616	IRAK3	Interleukin-1 receptor-associated kinase 3	GO:0009615; P:response to virus; IC:BHF-UCL
Q9NWZ3	IRAK4	Interleukin-1 receptor-associated kinase 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NWZ3	IRAK4	Interleukin-1 receptor-associated kinase 4	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q9NWZ3	IRAK4	Interleukin-1 receptor-associated kinase 4	GO:0005515; F:protein binding; IPI:IntAct
Q9NWZ3	IRAK4	Interleukin-1 receptor-associated kinase 4	GO:0004672; F:protein kinase activity; EXP:Reactome
Q9NWZ3	IRAK4	Interleukin-1 receptor-associated kinase 4	GO:0004674; F:protein serine/threonine kinase activity; EXP:Reactome
Q9NWZ3	IRAK4	Interleukin-1 receptor-associated kinase 4	GO:0001816; P:cytokine production; IEA:Ensembl
Q9NWZ3	IRAK4	Interleukin-1 receptor-associated kinase 4	GO:0019221; P:cytokine-mediated signaling pathway; IEA:Ensembl
Q9NWZ3	IRAK4	Interleukin-1 receptor-associated kinase 4	GO:0045087; P:innate immune response; TAS:UniProtKB
Q9NWZ3	IRAK4	Interleukin-1 receptor-associated kinase 4	GO:0007254; P:JNK cascade; IEA:Ensembl
Q9NWZ3	IRAK4	Interleukin-1 receptor-associated kinase 4	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:UniProtKB
Q9NWZ3	IRAK4	Interleukin-1 receptor-associated kinase 4	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
Q9NWZ3	IRAK4	Interleukin-1 receptor-associated kinase 4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9NWZ3	IRAK4	Interleukin-1 receptor-associated kinase 4	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q9NWZ3	IRAK4	Interleukin-1 receptor-associated kinase 4	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q9NWZ3	IRAK4	Interleukin-1 receptor-associated kinase 4	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q9NWZ3	IRAK4	Interleukin-1 receptor-associated kinase 4	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q9NWZ3	IRAK4	Interleukin-1 receptor-associated kinase 4	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q9NWZ3	IRAK4	Interleukin-1 receptor-associated kinase 4	GO:0002224; P:toll-like receptor signaling pathway; TAS:UniProtKB
Q9NWZ3	IRAK4	Interleukin-1 receptor-associated kinase 4	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q9NWZ3	IRAK4	Interleukin-1 receptor-associated kinase 4	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P48200	IREB2	Iron-responsive element-binding protein 2	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
P48200	IREB2	Iron-responsive element-binding protein 2	GO:0030350; F:iron-responsive element binding; TAS:UniProtKB
P48200	IREB2	Iron-responsive element-binding protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P48200	IREB2	Iron-responsive element-binding protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
P48200	IREB2	Iron-responsive element-binding protein 2	GO:0003723; F:RNA binding; IDA:UniProtKB
P48200	IREB2	Iron-responsive element-binding protein 2	GO:0007568; P:aging; IEA:Ensembl
P48200	IREB2	Iron-responsive element-binding protein 2	GO:0006879; P:cellular iron ion homeostasis; IEA:Ensembl
P48200	IREB2	Iron-responsive element-binding protein 2	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
P48200	IREB2	Iron-responsive element-binding protein 2	GO:0034101; P:erythrocyte homeostasis; IEA:Ensembl
P48200	IREB2	Iron-responsive element-binding protein 2	GO:0050892; P:intestinal absorption; IEA:Ensembl
P48200	IREB2	Iron-responsive element-binding protein 2	GO:0006826; P:iron ion transport; TAS:UniProtKB
P48200	IREB2	Iron-responsive element-binding protein 2	GO:0030316; P:osteoclast differentiation; IEA:Ensembl
P48200	IREB2	Iron-responsive element-binding protein 2	GO:0009791; P:post-embryonic development; IEA:Ensembl
P48200	IREB2	Iron-responsive element-binding protein 2	GO:0006782; P:protoporphyrinogen IX biosynthetic process; IEA:Ensembl
P48200	IREB2	Iron-responsive element-binding protein 2	GO:0006417; P:regulation of translation; IEA:Ensembl
P48200	IREB2	Iron-responsive element-binding protein 2	GO:0010040; P:response to iron(II) ion; IEA:Ensembl
P48200	IREB2	Iron-responsive element-binding protein 2	GO:0032526; P:response to retinoic acid; IEA:Ensembl
P10914	IRF1	Interferon regulatory factor 1	GO:0003677; F:DNA binding; TAS:UniProtKB
P10914	IRF1	Interferon regulatory factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
P10914	IRF1	Interferon regulatory factor 1	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:BHF-UCL
P10914	IRF1	Interferon regulatory factor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P10914	IRF1	Interferon regulatory factor 1	GO:0006915; P:apoptotic process; IDA:UniProtKB
P10914	IRF1	Interferon regulatory factor 1	GO:0007596; P:blood coagulation; TAS:Reactome
P10914	IRF1	Interferon regulatory factor 1	GO:0043374; P:CD8-positive, alpha-beta T cell differentiation; IEA:Ensembl
P10914	IRF1	Interferon regulatory factor 1	GO:0007050; P:cell cycle arrest; IDA:UniProtKB
P10914	IRF1	Interferon regulatory factor 1	GO:0035458; P:cellular response to interferon-beta; IDA:BHF-UCL
P10914	IRF1	Interferon regulatory factor 1	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
P10914	IRF1	Interferon regulatory factor 1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P10914	IRF1	Interferon regulatory factor 1	GO:0051607; P:defense response to virus; IDA:UniProtKB
P10914	IRF1	Interferon regulatory factor 1	GO:0060333; P:interferon-gamma-mediated signaling pathway; ISS:UniProtKB
P10914	IRF1	Interferon regulatory factor 1	GO:0008285; P:negative regulation of cell proliferation; TAS:UniProtKB
P10914	IRF1	Interferon regulatory factor 1	GO:0045590; P:negative regulation of regulatory T cell differentiation; ISS:UniProtKB
P10914	IRF1	Interferon regulatory factor 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
P10914	IRF1	Interferon regulatory factor 1	GO:0032728; P:positive regulation of interferon-beta production; IMP:UniProtKB
P10914	IRF1	Interferon regulatory factor 1	GO:0045084; P:positive regulation of interleukin-12 biosynthetic process; IEA:Ensembl
P10914	IRF1	Interferon regulatory factor 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P10914	IRF1	Interferon regulatory factor 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P10914	IRF1	Interferon regulatory factor 1	GO:0032481; P:positive regulation of type I interferon production; ISS:UniProtKB
P10914	IRF1	Interferon regulatory factor 1	GO:0002819; P:regulation of adaptive immune response; TAS:UniProtKB
P10914	IRF1	Interferon regulatory factor 1	GO:2000564; P:regulation of CD8-positive, alpha-beta T cell proliferation; ISS:UniProtKB
P10914	IRF1	Interferon regulatory factor 1	GO:0051726; P:regulation of cell cycle; TAS:UniProtKB
P10914	IRF1	Interferon regulatory factor 1	GO:0045088; P:regulation of innate immune response; TAS:UniProtKB
P10914	IRF1	Interferon regulatory factor 1	GO:0034124; P:regulation of MyD88-dependent toll-like receptor signaling pathway; ISS:UniProtKB
P10914	IRF1	Interferon regulatory factor 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P10914	IRF1	Interferon regulatory factor 1	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P14316	IRF2	Interferon regulatory factor 2	GO:0003677; F:DNA binding; IDA:UniProtKB
P14316	IRF2	Interferon regulatory factor 2	GO:0005515; F:protein binding; IPI:UniProtKB
P14316	IRF2	Interferon regulatory factor 2	GO:0000975; F:regulatory region DNA binding; IEA:InterPro
P14316	IRF2	Interferon regulatory factor 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IMP:UniProtKB
P14316	IRF2	Interferon regulatory factor 2	GO:0007596; P:blood coagulation; TAS:Reactome
P14316	IRF2	Interferon regulatory factor 2	GO:0008283; P:cell proliferation; TAS:ProtInc
P14316	IRF2	Interferon regulatory factor 2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P14316	IRF2	Interferon regulatory factor 2	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P14316	IRF2	Interferon regulatory factor 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P14316	IRF2	Interferon regulatory factor 2	GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB
P14316	IRF2	Interferon regulatory factor 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P14316	IRF2	Interferon regulatory factor 2	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q14653	IRF3	Interferon regulatory factor 3	GO:0003677; F:DNA binding; NAS:BHF-UCL
Q14653	IRF3	Interferon regulatory factor 3	GO:0042802; F:identical protein binding; IPI:IntAct
Q14653	IRF3	Interferon regulatory factor 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q14653	IRF3	Interferon regulatory factor 3	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q14653	IRF3	Interferon regulatory factor 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q14653	IRF3	Interferon regulatory factor 3	GO:0003712; F:transcription cofactor activity; TAS:ProtInc
Q14653	IRF3	Interferon regulatory factor 3	GO:0044212; F:transcription regulatory region DNA binding; IEA:Ensembl
Q14653	IRF3	Interferon regulatory factor 3	GO:0006915; P:apoptotic process; TAS:UniProtKB
Q14653	IRF3	Interferon regulatory factor 3	GO:0006974; P:cellular response to DNA damage stimulus; TAS:UniProtKB
Q14653	IRF3	Interferon regulatory factor 3	GO:0071359; P:cellular response to dsRNA; IEA:Ensembl
Q14653	IRF3	Interferon regulatory factor 3	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q14653	IRF3	Interferon regulatory factor 3	GO:0051607; P:defense response to virus; ISS:UniProtKB
Q14653	IRF3	Interferon regulatory factor 3	GO:0045087; P:innate immune response; TAS:Reactome
Q14653	IRF3	Interferon regulatory factor 3	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q14653	IRF3	Interferon regulatory factor 3	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IEA:Ensembl
Q14653	IRF3	Interferon regulatory factor 3	GO:0071888; P:macrophage apoptotic process; TAS:UniProtKB
Q14653	IRF3	Interferon regulatory factor 3	GO:0039530; P:MDA-5 signaling pathway; TAS:UniProtKB
Q14653	IRF3	Interferon regulatory factor 3	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q14653	IRF3	Interferon regulatory factor 3	GO:0050689; P:negative regulation of defense response to virus by host; IEA:Ensembl
Q14653	IRF3	Interferon regulatory factor 3	GO:0045358; P:negative regulation of interferon-beta biosynthetic process; IEA:Ensembl
Q14653	IRF3	Interferon regulatory factor 3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q14653	IRF3	Interferon regulatory factor 3	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
Q14653	IRF3	Interferon regulatory factor 3	GO:0050715; P:positive regulation of cytokine secretion; IEA:Ensembl
Q14653	IRF3	Interferon regulatory factor 3	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
Q14653	IRF3	Interferon regulatory factor 3	GO:0032727; P:positive regulation of interferon-alpha production; ISS:UniProtKB
Q14653	IRF3	Interferon regulatory factor 3	GO:0032728; P:positive regulation of interferon-beta production; ISS:UniProtKB
Q14653	IRF3	Interferon regulatory factor 3	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q14653	IRF3	Interferon regulatory factor 3	GO:0060340; P:positive regulation of type I interferon-mediated signaling pathway; IEA:Ensembl
Q14653	IRF3	Interferon regulatory factor 3	GO:0043330; P:response to exogenous dsRNA; IEA:Ensembl
Q14653	IRF3	Interferon regulatory factor 3	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q14653	IRF3	Interferon regulatory factor 3	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q14653	IRF3	Interferon regulatory factor 3	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q14653	IRF3	Interferon regulatory factor 3	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q14653	IRF3	Interferon regulatory factor 3	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q14653	IRF3	Interferon regulatory factor 3	GO:0045351; P:type I interferon biosynthetic process; IEA:Ensembl
Q14653	IRF3	Interferon regulatory factor 3	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q14653	IRF3	Interferon regulatory factor 3	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q15306	IRF4	Interferon regulatory factor 4	GO:0005515; F:protein binding; IPI:IntAct
Q15306	IRF4	Interferon regulatory factor 4	GO:0016279; F:protein-lysine N-methyltransferase activity; IEA:Ensembl
Q15306	IRF4	Interferon regulatory factor 4	GO:0000975; F:regulatory region DNA binding; IEA:InterPro
Q15306	IRF4	Interferon regulatory factor 4	GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB
Q15306	IRF4	Interferon regulatory factor 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q15306	IRF4	Interferon regulatory factor 4	GO:0008134; F:transcription factor binding; NAS:UniProtKB
Q15306	IRF4	Interferon regulatory factor 4	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q15306	IRF4	Interferon regulatory factor 4	GO:0042832; P:defense response to protozoan; ISS:UniProtKB
Q15306	IRF4	Interferon regulatory factor 4	GO:0043966; P:histone H3 acetylation; IEA:Ensembl
Q15306	IRF4	Interferon regulatory factor 4	GO:0043967; P:histone H4 acetylation; IEA:Ensembl
Q15306	IRF4	Interferon regulatory factor 4	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q15306	IRF4	Interferon regulatory factor 4	GO:0043011; P:myeloid dendritic cell differentiation; IEA:Ensembl
Q15306	IRF4	Interferon regulatory factor 4	GO:0034122; P:negative regulation of toll-like receptor signaling pathway; IEA:Ensembl
Q15306	IRF4	Interferon regulatory factor 4	GO:0043388; P:positive regulation of DNA binding; IEA:Ensembl
Q15306	IRF4	Interferon regulatory factor 4	GO:0045082; P:positive regulation of interleukin-10 biosynthetic process; IDA:UniProtKB
Q15306	IRF4	Interferon regulatory factor 4	GO:0045368; P:positive regulation of interleukin-13 biosynthetic process; IDA:UniProtKB
Q15306	IRF4	Interferon regulatory factor 4	GO:0045086; P:positive regulation of interleukin-2 biosynthetic process; IDA:UniProtKB
Q15306	IRF4	Interferon regulatory factor 4	GO:0045404; P:positive regulation of interleukin-4 biosynthetic process; IDA:UniProtKB
Q15306	IRF4	Interferon regulatory factor 4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q15306	IRF4	Interferon regulatory factor 4	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q15306	IRF4	Interferon regulatory factor 4	GO:0045622; P:regulation of T-helper cell differentiation; NAS:UniProtKB
Q15306	IRF4	Interferon regulatory factor 4	GO:0042110; P:T cell activation; NAS:UniProtKB
Q15306	IRF4	Interferon regulatory factor 4	GO:0072540; P:T-helper 17 cell lineage commitment; ISS:UniProtKB
Q15306	IRF4	Interferon regulatory factor 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15306	IRF4	Interferon regulatory factor 4	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q13568	IRF5	Interferon regulatory factor 5	GO:0005515; F:protein binding; IPI:IntAct
Q13568	IRF5	Interferon regulatory factor 5	GO:0000975; F:regulatory region DNA binding; IEA:InterPro
Q13568	IRF5	Interferon regulatory factor 5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q13568	IRF5	Interferon regulatory factor 5	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q13568	IRF5	Interferon regulatory factor 5	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q13568	IRF5	Interferon regulatory factor 5	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q13568	IRF5	Interferon regulatory factor 5	GO:0043065; P:positive regulation of apoptotic process; IMP:BHF-UCL
Q13568	IRF5	Interferon regulatory factor 5	GO:0032727; P:positive regulation of interferon-alpha production; IC:BHF-UCL
Q13568	IRF5	Interferon regulatory factor 5	GO:0032728; P:positive regulation of interferon-beta production; IC:BHF-UCL
Q13568	IRF5	Interferon regulatory factor 5	GO:0032735; P:positive regulation of interleukin-12 production; IC:BHF-UCL
Q13568	IRF5	Interferon regulatory factor 5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q13568	IRF5	Interferon regulatory factor 5	GO:0032495; P:response to muramyl dipeptide; IDA:BHF-UCL
Q13568	IRF5	Interferon regulatory factor 5	GO:0032494; P:response to peptidoglycan; IDA:BHF-UCL
Q13568	IRF5	Interferon regulatory factor 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13568	IRF5	Interferon regulatory factor 5	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
O14896	IRF6	Interferon regulatory factor 6	GO:0003677; F:DNA binding; ISS:UniProtKB
O14896	IRF6	Interferon regulatory factor 6	GO:0005515; F:protein binding; IPI:UniProtKB
O14896	IRF6	Interferon regulatory factor 6	GO:0000975; F:regulatory region DNA binding; IEA:InterPro
O14896	IRF6	Interferon regulatory factor 6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
O14896	IRF6	Interferon regulatory factor 6	GO:0007050; P:cell cycle arrest; IDA:UniProtKB
O14896	IRF6	Interferon regulatory factor 6	GO:0048468; P:cell development; IEA:Ensembl
O14896	IRF6	Interferon regulatory factor 6	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
O14896	IRF6	Interferon regulatory factor 6	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
O14896	IRF6	Interferon regulatory factor 6	GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
O14896	IRF6	Interferon regulatory factor 6	GO:0043616; P:keratinocyte proliferation; IEA:Ensembl
O14896	IRF6	Interferon regulatory factor 6	GO:0060644; P:mammary gland epithelial cell differentiation; ISS:UniProtKB
O14896	IRF6	Interferon regulatory factor 6	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
O14896	IRF6	Interferon regulatory factor 6	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
O14896	IRF6	Interferon regulatory factor 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O14896	IRF6	Interferon regulatory factor 6	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q92985	IRF7	Interferon regulatory factor 7	GO:0003677; F:DNA binding; IMP:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0005515; F:protein binding; IPI:IntAct
Q92985	IRF7	Interferon regulatory factor 7	GO:0000982; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IDA:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0006974; P:cellular response to DNA damage stimulus; TAS:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q92985	IRF7	Interferon regulatory factor 7	GO:0019043; P:establishment of viral latency; TAS:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0016064; P:immunoglobulin mediated immune response; IEA:Ensembl
Q92985	IRF7	Interferon regulatory factor 7	GO:0045087; P:innate immune response; TAS:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0032607; P:interferon-alpha production; ISS:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0032608; P:interferon-beta production; ISS:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q92985	IRF7	Interferon regulatory factor 7	GO:0039530; P:MDA-5 signaling pathway; TAS:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q92985	IRF7	Interferon regulatory factor 7	GO:2000110; P:negative regulation of macrophage apoptotic process; TAS:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q92985	IRF7	Interferon regulatory factor 7	GO:0032727; P:positive regulation of interferon-alpha production; TAS:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0032728; P:positive regulation of interferon-beta production; TAS:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q92985	IRF7	Interferon regulatory factor 7	GO:0060340; P:positive regulation of type I interferon-mediated signaling pathway; IEA:Ensembl
Q92985	IRF7	Interferon regulatory factor 7	GO:0002819; P:regulation of adaptive immune response; IDA:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0050776; P:regulation of immune response; TAS:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0045655; P:regulation of monocyte differentiation; TAS:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0034124; P:regulation of MyD88-dependent toll-like receptor signaling pathway; ISS:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0034127; P:regulation of MyD88-independent toll-like receptor signaling pathway; ISS:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0032479; P:regulation of type I interferon production; TAS:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0009615; P:response to virus; TAS:UniProtKB
Q92985	IRF7	Interferon regulatory factor 7	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q92985	IRF7	Interferon regulatory factor 7	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q92985	IRF7	Interferon regulatory factor 7	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q92985	IRF7	Interferon regulatory factor 7	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q92985	IRF7	Interferon regulatory factor 7	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q92985	IRF7	Interferon regulatory factor 7	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q92985	IRF7	Interferon regulatory factor 7	GO:0045351; P:type I interferon biosynthetic process; IEA:Ensembl
Q92985	IRF7	Interferon regulatory factor 7	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q00978	IRF9	Interferon regulatory factor 9	GO:0005515; F:protein binding; IPI:IntAct
Q00978	IRF9	Interferon regulatory factor 9	GO:0000975; F:regulatory region DNA binding; IEA:InterPro
Q00978	IRF9	Interferon regulatory factor 9	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q00978	IRF9	Interferon regulatory factor 9	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q00978	IRF9	Interferon regulatory factor 9	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q00978	IRF9	Interferon regulatory factor 9	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q00978	IRF9	Interferon regulatory factor 9	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q00978	IRF9	Interferon regulatory factor 9	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q00978	IRF9	Interferon regulatory factor 9	GO:0045351; P:type I interferon biosynthetic process; IEA:Ensembl
Q00978	IRF9	Interferon regulatory factor 9	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q02556	IRF8	Interferon regulatory factor 8	GO:0005515; F:protein binding; IPI:IntAct
Q02556	IRF8	Interferon regulatory factor 8	GO:0000975; F:regulatory region DNA binding; IEA:InterPro
Q02556	IRF8	Interferon regulatory factor 8	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q02556	IRF8	Interferon regulatory factor 8	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
Q02556	IRF8	Interferon regulatory factor 8	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q02556	IRF8	Interferon regulatory factor 8	GO:0042742; P:defense response to bacterium; IEA:Ensembl
Q02556	IRF8	Interferon regulatory factor 8	GO:0042832; P:defense response to protozoan; IEA:Ensembl
Q02556	IRF8	Interferon regulatory factor 8	GO:0006955; P:immune response; TAS:ProtInc
Q02556	IRF8	Interferon regulatory factor 8	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q02556	IRF8	Interferon regulatory factor 8	GO:0030099; P:myeloid cell differentiation; IEA:Ensembl
Q02556	IRF8	Interferon regulatory factor 8	GO:0044130; P:negative regulation of growth of symbiont in host; IEA:Ensembl
Q02556	IRF8	Interferon regulatory factor 8	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q02556	IRF8	Interferon regulatory factor 8	GO:0006909; P:phagocytosis; IEA:Ensembl
Q02556	IRF8	Interferon regulatory factor 8	GO:0032729; P:positive regulation of interferon-gamma production; IEA:Ensembl
Q02556	IRF8	Interferon regulatory factor 8	GO:0032735; P:positive regulation of interleukin-12 production; IEA:Ensembl
Q02556	IRF8	Interferon regulatory factor 8	GO:0060261; P:positive regulation of transcription initiation from RNA polymerase II promoter; IEA:Ensembl
Q02556	IRF8	Interferon regulatory factor 8	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:GOC
Q02556	IRF8	Interferon regulatory factor 8	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0047547; F:2-methylcitrate dehydratase activity; IEA:InterPro
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0047613; F:aconitate decarboxylase activity; IDA:UniProtKB
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0035458; P:cellular response to interferon-beta; ISS:UniProtKB
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0071346; P:cellular response to interferon-gamma; ISS:UniProtKB
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0071347; P:cellular response to interleukin-1; ISS:UniProtKB
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0071222; P:cellular response to lipopolysaccharide; IDA:UniProtKB
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0071219; P:cellular response to molecule of bacterial origin; ISS:UniProtKB
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0071393; P:cellular response to progesterone stimulus; ISS:UniProtKB
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0071356; P:cellular response to tumor necrosis factor; ISS:UniProtKB
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0006952; P:defense response; IDA:UniProtKB
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0007566; P:embryo implantation; ISS:UniProtKB
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0008152; P:metabolic process; IDA:UniProtKB
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0050728; P:negative regulation of inflammatory response; ISS:UniProtKB
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0045824; P:negative regulation of innate immune response; ISS:UniProtKB
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; ISS:UniProtKB
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0034136; P:negative regulation of toll-like receptor 2 signaling pathway; ISS:UniProtKB
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0034144; P:negative regulation of toll-like receptor 4 signaling pathway; ISS:UniProtKB
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0032480; P:negative regulation of type I interferon production; ISS:UniProtKB
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0002760; P:positive regulation of antimicrobial humoral response; IDA:UniProtKB
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; ISS:UniProtKB
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0019543; P:propionate catabolic process; IEA:InterPro
A6NK06	IRG1	Cis-aconitate decarboxylase	GO:0072573; P:tolerance induction to lipopolysaccharide; IDA:UniProtKB
A1A4Y4	IRGM	Immunity-related GTPase family M protein	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
A1A4Y4	IRGM	Immunity-related GTPase family M protein	GO:0016817; F:hydrolase activity, acting on acid anhydrides; IEA:InterPro
A1A4Y4	IRGM	Immunity-related GTPase family M protein	GO:0006914; P:autophagy; IEA:UniProtKB-KW
A1A4Y4	IRGM	Immunity-related GTPase family M protein	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
A1A4Y4	IRGM	Immunity-related GTPase family M protein	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q9NZN1	IL1RAPL1	Interleukin-1 receptor accessory protein-like 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NZN1	IL1RAPL1	Interleukin-1 receptor accessory protein-like 1	GO:0005102; F:receptor binding; ISS:BHF-UCL
Q9NZN1	IL1RAPL1	Interleukin-1 receptor accessory protein-like 1	GO:0005245; F:voltage-gated calcium channel activity; ISS:UniProtKB
Q9NZN1	IL1RAPL1	Interleukin-1 receptor accessory protein-like 1	GO:0070588; P:calcium ion transmembrane transport; ISS:GOC
Q9NZN1	IL1RAPL1	Interleukin-1 receptor accessory protein-like 1	GO:0007157; P:heterophilic cell-cell adhesion; ISS:BHF-UCL
Q9NZN1	IL1RAPL1	Interleukin-1 receptor accessory protein-like 1	GO:0045920; P:negative regulation of exocytosis; IDA:UniProtKB
Q9NZN1	IL1RAPL1	Interleukin-1 receptor accessory protein-like 1	GO:0030182; P:neuron differentiation; ISS:BHF-UCL
Q9NZN1	IL1RAPL1	Interleukin-1 receptor accessory protein-like 1	GO:0050775; P:positive regulation of dendrite morphogenesis; ISS:BHF-UCL
Q9NZN1	IL1RAPL1	Interleukin-1 receptor accessory protein-like 1	GO:0097105; P:presynaptic membrane assembly; ISS:BHF-UCL
Q9NZN1	IL1RAPL1	Interleukin-1 receptor accessory protein-like 1	GO:0010975; P:regulation of neuron projection development; ISS:UniProtKB
Q9NZN1	IL1RAPL1	Interleukin-1 receptor accessory protein-like 1	GO:0007165; P:signal transduction; IEA:InterPro
Q9NP60	IL1RAPL2	X-linked interleukin-1 receptor accessory protein-like 2	GO:0004908; F:interleukin-1 receptor activity; TAS:ProtInc
Q9NP60	IL1RAPL2	X-linked interleukin-1 receptor accessory protein-like 2	GO:0004910; F:interleukin-1, Type II, blocking receptor activity; IEA:InterPro
Q9NP60	IL1RAPL2	X-linked interleukin-1 receptor accessory protein-like 2	GO:0007417; P:central nervous system development; TAS:ProtInc
Q9NP60	IL1RAPL2	X-linked interleukin-1 receptor accessory protein-like 2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:GOC
P35568	IRS1	Insulin receptor substrate 1	GO:0005158; F:insulin receptor binding; IPI:UniProtKB
P35568	IRS1	Insulin receptor substrate 1	GO:0005159; F:insulin-like growth factor receptor binding; IPI:UniProtKB
P35568	IRS1	Insulin receptor substrate 1	GO:0043548; F:phosphatidylinositol 3-kinase binding; IPI:UniProtKB
P35568	IRS1	Insulin receptor substrate 1	GO:0005515; F:protein binding; IPI:UniProtKB
P35568	IRS1	Insulin receptor substrate 1	GO:0005080; F:protein kinase C binding; ISS:BHF-UCL
P35568	IRS1	Insulin receptor substrate 1	GO:0042169; F:SH2 domain binding; ISS:UniProtKB
P35568	IRS1	Insulin receptor substrate 1	GO:0004871; F:signal transducer activity; TAS:ProtInc
P35568	IRS1	Insulin receptor substrate 1	GO:0005068; F:transmembrane receptor protein tyrosine kinase adaptor activity; ISS:BHF-UCL
P35568	IRS1	Insulin receptor substrate 1	GO:0032869; P:cellular response to insulin stimulus; IMP:BHF-UCL
P35568	IRS1	Insulin receptor substrate 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P35568	IRS1	Insulin receptor substrate 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P35568	IRS1	Insulin receptor substrate 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P35568	IRS1	Insulin receptor substrate 1	GO:0042593; P:glucose homeostasis; TAS:BHF-UCL
P35568	IRS1	Insulin receptor substrate 1	GO:0045087; P:innate immune response; TAS:Reactome
P35568	IRS1	Insulin receptor substrate 1	GO:0008286; P:insulin receptor signaling pathway; IPI:UniProtKB
P35568	IRS1	Insulin receptor substrate 1	GO:0048009; P:insulin-like growth factor receptor signaling pathway; IPI:UniProtKB
P35568	IRS1	Insulin receptor substrate 1	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome
P35568	IRS1	Insulin receptor substrate 1	GO:0016042; P:lipid catabolic process; IEA:Ensembl
P35568	IRS1	Insulin receptor substrate 1	GO:0030879; P:mammary gland development; IEA:Ensembl
P35568	IRS1	Insulin receptor substrate 1	GO:0046627; P:negative regulation of insulin receptor signaling pathway; ISS:BHF-UCL
P35568	IRS1	Insulin receptor substrate 1	GO:0046676; P:negative regulation of insulin secretion; IDA:BHF-UCL
P35568	IRS1	Insulin receptor substrate 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P35568	IRS1	Insulin receptor substrate 1	GO:0014065; P:phosphatidylinositol 3-kinase signaling; IDA:BHF-UCL
P35568	IRS1	Insulin receptor substrate 1	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P35568	IRS1	Insulin receptor substrate 1	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
P35568	IRS1	Insulin receptor substrate 1	GO:0008284; P:positive regulation of cell proliferation; NAS:BHF-UCL
P35568	IRS1	Insulin receptor substrate 1	GO:0032000; P:positive regulation of fatty acid beta-oxidation; IMP:BHF-UCL
P35568	IRS1	Insulin receptor substrate 1	GO:0046326; P:positive regulation of glucose import; IMP:BHF-UCL
P35568	IRS1	Insulin receptor substrate 1	GO:2001275; P:positive regulation of glucose import in response to insulin stimulus; IDA:BHF-UCL
P35568	IRS1	Insulin receptor substrate 1	GO:0010907; P:positive regulation of glucose metabolic process; IMP:BHF-UCL
P35568	IRS1	Insulin receptor substrate 1	GO:0045725; P:positive regulation of glycogen biosynthetic process; IMP:BHF-UCL
P35568	IRS1	Insulin receptor substrate 1	GO:0046628; P:positive regulation of insulin receptor signaling pathway; ISS:BHF-UCL
P35568	IRS1	Insulin receptor substrate 1	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl
P35568	IRS1	Insulin receptor substrate 1	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; ISS:BHF-UCL
P35568	IRS1	Insulin receptor substrate 1	GO:0043491; P:protein kinase B signaling; IEA:Ensembl
P35568	IRS1	Insulin receptor substrate 1	GO:0034504; P:protein localization to nucleus; IEA:Ensembl
P35568	IRS1	Insulin receptor substrate 1	GO:0010468; P:regulation of gene expression; IEA:Ensembl
P35568	IRS1	Insulin receptor substrate 1	GO:0032868; P:response to insulin; IDA:BHF-UCL
P35568	IRS1	Insulin receptor substrate 1	GO:0043434; P:response to peptide hormone; ISS:BHF-UCL
P35568	IRS1	Insulin receptor substrate 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0005515; F:protein binding; IPI:IntAct
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0007420; P:brain development; IEA:Ensembl
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0008283; P:cell proliferation; IEA:Ensembl
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0032869; P:cellular response to insulin stimulus; IMP:BHF-UCL
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0006006; P:glucose metabolic process; TAS:ProtInc
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0045087; P:innate immune response; TAS:Reactome
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0008286; P:insulin receptor signaling pathway; ISS:BHF-UCL
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0055088; P:lipid homeostasis; TAS:BHF-UCL
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0030879; P:mammary gland development; IEA:Ensembl
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0002903; P:negative regulation of B cell apoptotic process; ISS:BHF-UCL
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0033673; P:negative regulation of kinase activity; ISS:BHF-UCL
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0010748; P:negative regulation of plasma membrane long-chain fatty acid transport; IMP:BHF-UCL
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0030890; P:positive regulation of B cell proliferation; ISS:BHF-UCL
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0008284; P:positive regulation of cell proliferation; NAS:BHF-UCL
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0032000; P:positive regulation of fatty acid beta-oxidation; IMP:BHF-UCL
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0046326; P:positive regulation of glucose import; IMP:BHF-UCL
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0010907; P:positive regulation of glucose metabolic process; IMP:BHF-UCL
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0045725; P:positive regulation of glycogen biosynthetic process; IMP:BHF-UCL
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0032024; P:positive regulation of insulin secretion; ISS:BHF-UCL
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0019216; P:regulation of lipid metabolic process; TAS:BHF-UCL
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0009749; P:response to glucose; ISS:BHF-UCL
Q9Y4H2	IRS2	Insulin receptor substrate 2	GO:0007165; P:signal transduction; TAS:ProtInc
O14654	IRS4	Insulin receptor substrate 4	GO:0005515; F:protein binding; IPI:IntAct
O14654	IRS4	Insulin receptor substrate 4	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
O14654	IRS4	Insulin receptor substrate 4	GO:0004871; F:signal transducer activity; TAS:ProtInc
O14654	IRS4	Insulin receptor substrate 4	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
O14654	IRS4	Insulin receptor substrate 4	GO:0007165; P:signal transduction; TAS:ProtInc
P78414	IRX1	Iroquois-class homeodomain protein IRX-1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P78414	IRX1	Iroquois-class homeodomain protein IRX-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P78414	IRX1	Iroquois-class homeodomain protein IRX-1	GO:0072272; P:proximal/distal pattern formation involved in metanephric nephron development; IEA:Ensembl
P78414	IRX1	Iroquois-class homeodomain protein IRX-1	GO:0072086; P:specification of loop of Henle identity; IEA:Ensembl
Q9BZI1	IRX2	Iroquois-class homeodomain protein IRX-2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9BZI1	IRX2	Iroquois-class homeodomain protein IRX-2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9BZI1	IRX2	Iroquois-class homeodomain protein IRX-2	GO:0072272; P:proximal/distal pattern formation involved in metanephric nephron development; IEA:Ensembl
Q9BZI1	IRX2	Iroquois-class homeodomain protein IRX-2	GO:0072086; P:specification of loop of Henle identity; IEA:Ensembl
P78415	IRX3	Iroquois-class homeodomain protein IRX-3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P78415	IRX3	Iroquois-class homeodomain protein IRX-3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P78415	IRX3	Iroquois-class homeodomain protein IRX-3	GO:0007498; P:mesoderm development; IEA:Ensembl
P78415	IRX3	Iroquois-class homeodomain protein IRX-3	GO:0001656; P:metanephros development; IEA:Ensembl
P78415	IRX3	Iroquois-class homeodomain protein IRX-3	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
P78415	IRX3	Iroquois-class homeodomain protein IRX-3	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P78415	IRX3	Iroquois-class homeodomain protein IRX-3	GO:0072086; P:specification of loop of Henle identity; IEA:Ensembl
P78415	IRX3	Iroquois-class homeodomain protein IRX-3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P78413	IRX4	Iroquois-class homeodomain protein IRX-4	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P78413	IRX4	Iroquois-class homeodomain protein IRX-4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P78413	IRX4	Iroquois-class homeodomain protein IRX-4	GO:0048561; P:establishment of organ orientation; IEA:Ensembl
P78413	IRX4	Iroquois-class homeodomain protein IRX-4	GO:0007507; P:heart development; TAS:ProtInc
P78411	IRX5	Iroquois-class homeodomain protein IRX-5	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P78411	IRX5	Iroquois-class homeodomain protein IRX-5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P78411	IRX5	Iroquois-class homeodomain protein IRX-5	GO:0005499; F:vitamin D binding; IEA:UniProtKB-KW
P78411	IRX5	Iroquois-class homeodomain protein IRX-5	GO:0048701; P:embryonic cranial skeleton morphogenesis; IMP:UniProtKB
P78411	IRX5	Iroquois-class homeodomain protein IRX-5	GO:0008406; P:gonad development; IMP:UniProtKB
P78411	IRX5	Iroquois-class homeodomain protein IRX-5	GO:0042551; P:neuron maturation; IEA:Ensembl
P78411	IRX5	Iroquois-class homeodomain protein IRX-5	GO:0002027; P:regulation of heart rate; IEA:Ensembl
P78411	IRX5	Iroquois-class homeodomain protein IRX-5	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
P78411	IRX5	Iroquois-class homeodomain protein IRX-5	GO:0060040; P:retinal bipolar neuron differentiation; IEA:Ensembl
P78411	IRX5	Iroquois-class homeodomain protein IRX-5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P78411	IRX5	Iroquois-class homeodomain protein IRX-5	GO:0007601; P:visual perception; IEA:UniProtKB-KW
P78412	IRX6	Iroquois-class homeodomain protein IRX-6	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P78412	IRX6	Iroquois-class homeodomain protein IRX-6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9BUE6	ISCA1	Iron-sulfur cluster assembly 1 homolog, mitochondrial	GO:0051536; F:iron-sulfur cluster binding; IEA:UniProtKB-KW
Q9BUE6	ISCA1	Iron-sulfur cluster assembly 1 homolog, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BUE6	ISCA1	Iron-sulfur cluster assembly 1 homolog, mitochondrial	GO:0005198; F:structural molecule activity; IEA:InterPro
Q9BUE6	ISCA1	Iron-sulfur cluster assembly 1 homolog, mitochondrial	GO:0016226; P:iron-sulfur cluster assembly; IEA:InterPro
Q86U28	ISCA2	Iron-sulfur cluster assembly 2 homolog, mitochondrial	GO:0051536; F:iron-sulfur cluster binding; IEA:UniProtKB-KW
Q86U28	ISCA2	Iron-sulfur cluster assembly 2 homolog, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86U28	ISCA2	Iron-sulfur cluster assembly 2 homolog, mitochondrial	GO:0005198; F:structural molecule activity; IEA:InterPro
Q86U28	ISCA2	Iron-sulfur cluster assembly 2 homolog, mitochondrial	GO:0016226; P:iron-sulfur cluster assembly; IEA:InterPro
Q9H1K1	ISCU	Iron-sulfur cluster assembly enzyme ISCU, mitochondrial	GO:0005506; F:iron ion binding; TAS:UniProtKB
Q9H1K1	ISCU	Iron-sulfur cluster assembly enzyme ISCU, mitochondrial	GO:0051536; F:iron-sulfur cluster binding; IEA:InterPro
Q9H1K1	ISCU	Iron-sulfur cluster assembly enzyme ISCU, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H1K1	ISCU	Iron-sulfur cluster assembly enzyme ISCU, mitochondrial	GO:0032947; F:protein complex scaffold; IDA:HGNC
Q9H1K1	ISCU	Iron-sulfur cluster assembly enzyme ISCU, mitochondrial	GO:0016226; P:iron-sulfur cluster assembly; TAS:UniProtKB
Q9H1K1	ISCU	Iron-sulfur cluster assembly enzyme ISCU, mitochondrial	GO:0009399; P:nitrogen fixation; TAS:UniProtKB
Q9H1K1	ISCU	Iron-sulfur cluster assembly enzyme ISCU, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P05161	ISG15	Ubiquitin-like protein ISG15	GO:0005515; F:protein binding; IPI:UniProtKB
P05161	ISG15	Ubiquitin-like protein ISG15	GO:0031386; F:protein tag; IEA:Ensembl
P05161	ISG15	Ubiquitin-like protein ISG15	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P05161	ISG15	Ubiquitin-like protein ISG15	GO:0042742; P:defense response to bacterium; IMP:UniProtKB
P05161	ISG15	Ubiquitin-like protein ISG15	GO:0051607; P:defense response to virus; IMP:UniProtKB
P05161	ISG15	Ubiquitin-like protein ISG15	GO:0045087; P:innate immune response; TAS:Reactome
P05161	ISG15	Ubiquitin-like protein ISG15	GO:0032020; P:ISG15-protein conjugation; IDA:UniProtKB
P05161	ISG15	Ubiquitin-like protein ISG15	GO:0019941; P:modification-dependent protein catabolic process; IEA:Ensembl
P05161	ISG15	Ubiquitin-like protein ISG15	GO:0031397; P:negative regulation of protein ubiquitination; IDA:UniProtKB
P05161	ISG15	Ubiquitin-like protein ISG15	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
P05161	ISG15	Ubiquitin-like protein ISG15	GO:0045071; P:negative regulation of viral genome replication; IMP:UniProtKB
P05161	ISG15	Ubiquitin-like protein ISG15	GO:0045648; P:positive regulation of erythrocyte differentiation; IEA:Ensembl
P05161	ISG15	Ubiquitin-like protein ISG15	GO:0032649; P:regulation of interferon-gamma production; IMP:UniProtKB
P05161	ISG15	Ubiquitin-like protein ISG15	GO:0034340; P:response to type I interferon; IDA:UniProtKB
P05161	ISG15	Ubiquitin-like protein ISG15	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P05161	ISG15	Ubiquitin-like protein ISG15	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q96AZ6	ISG20	Interferon-stimulated gene 20 kDa protein	GO:0000175; F:3'-5'-exoribonuclease activity; IDA:UniProtKB
Q96AZ6	ISG20	Interferon-stimulated gene 20 kDa protein	GO:0004527; F:exonuclease activity; IMP:UniProtKB
Q96AZ6	ISG20	Interferon-stimulated gene 20 kDa protein	GO:0008859; F:exoribonuclease II activity; IEA:UniProtKB-EC
Q96AZ6	ISG20	Interferon-stimulated gene 20 kDa protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96AZ6	ISG20	Interferon-stimulated gene 20 kDa protein	GO:0008310; F:single-stranded DNA 3'-5' exodeoxyribonuclease activity; IDA:UniProtKB
Q96AZ6	ISG20	Interferon-stimulated gene 20 kDa protein	GO:0030619; F:U1 snRNA binding; IDA:UniProtKB
Q96AZ6	ISG20	Interferon-stimulated gene 20 kDa protein	GO:0030620; F:U2 snRNA binding; IDA:UniProtKB
Q96AZ6	ISG20	Interferon-stimulated gene 20 kDa protein	GO:0034511; F:U3 snoRNA binding; IDA:UniProtKB
Q96AZ6	ISG20	Interferon-stimulated gene 20 kDa protein	GO:0008283; P:cell proliferation; TAS:ProtInc
Q96AZ6	ISG20	Interferon-stimulated gene 20 kDa protein	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q96AZ6	ISG20	Interferon-stimulated gene 20 kDa protein	GO:0051607; P:defense response to virus; IMP:UniProtKB
Q96AZ6	ISG20	Interferon-stimulated gene 20 kDa protein	GO:0000738; P:DNA catabolic process, exonucleolytic; IDA:UniProtKB
Q96AZ6	ISG20	Interferon-stimulated gene 20 kDa protein	GO:0045071; P:negative regulation of viral genome replication; IMP:UniProtKB
Q96AZ6	ISG20	Interferon-stimulated gene 20 kDa protein	GO:0009615; P:response to virus; IDA:UniProtKB
Q96AZ6	ISG20	Interferon-stimulated gene 20 kDa protein	GO:0006401; P:RNA catabolic process; IDA:UniProtKB
Q96AZ6	ISG20	Interferon-stimulated gene 20 kDa protein	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; IDA:GOC
Q96AZ6	ISG20	Interferon-stimulated gene 20 kDa protein	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q96AZ6	ISG20	Interferon-stimulated gene 20 kDa protein	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q1W4C9	SPINK13	Serine protease inhibitor Kazal-type 13	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q1W4C9	SPINK13	Serine protease inhibitor Kazal-type 13	GO:1902225; P:negative regulation of acrosome reaction; ISS:UniProtKB
Q6IE38	SPINK14	Serine protease inhibitor Kazal-type 14	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
P00995	SPINK1	Pancreatic secretory trypsin inhibitor	GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc
P00995	SPINK1	Pancreatic secretory trypsin inhibitor	GO:0005515; F:protein binding; IPI:UniProtKB
P00995	SPINK1	Pancreatic secretory trypsin inhibitor	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
P00995	SPINK1	Pancreatic secretory trypsin inhibitor	GO:0090281; P:negative regulation of calcium ion import; IEA:Ensembl
P00995	SPINK1	Pancreatic secretory trypsin inhibitor	GO:0010751; P:negative regulation of nitric oxide mediated signal transduction; IEA:Ensembl
P00995	SPINK1	Pancreatic secretory trypsin inhibitor	GO:0050732; P:negative regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
P00995	SPINK1	Pancreatic secretory trypsin inhibitor	GO:1900004; P:negative regulation of serine-type endopeptidase activity; IEA:Ensembl
P00995	SPINK1	Pancreatic secretory trypsin inhibitor	GO:0060046; P:regulation of acrosome reaction; IEA:Ensembl
P00995	SPINK1	Pancreatic secretory trypsin inhibitor	GO:2001256; P:regulation of store-operated calcium entry; IEA:Ensembl
P20155	SPINK2	Serine protease inhibitor Kazal-type 2	GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc
P20155	SPINK2	Serine protease inhibitor Kazal-type 2	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
P20155	SPINK2	Serine protease inhibitor Kazal-type 2	GO:0009566; P:fertilization; IEA:Ensembl
P20155	SPINK2	Serine protease inhibitor Kazal-type 2	GO:0002176; P:male germ cell proliferation; IEA:Ensembl
P20155	SPINK2	Serine protease inhibitor Kazal-type 2	GO:1900004; P:negative regulation of serine-type endopeptidase activity; IEA:Ensembl
P20155	SPINK2	Serine protease inhibitor Kazal-type 2	GO:0072520; P:seminiferous tubule development; IEA:Ensembl
P20155	SPINK2	Serine protease inhibitor Kazal-type 2	GO:0007286; P:spermatid development; IEA:Ensembl
O60575	SPINK4	Serine protease inhibitor Kazal-type 4	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
O60575	SPINK4	Serine protease inhibitor Kazal-type 4	GO:0042493; P:response to drug; IEA:Ensembl
Q9NQ38	SPINK5	Serine protease inhibitor Kazal-type 5	GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:UniProtKB
Q9NQ38	SPINK5	Serine protease inhibitor Kazal-type 5	GO:0042640; P:anagen; TAS:UniProtKB
Q9NQ38	SPINK5	Serine protease inhibitor Kazal-type 5	GO:0009913; P:epidermal cell differentiation; IDA:UniProtKB
Q9NQ38	SPINK5	Serine protease inhibitor Kazal-type 5	GO:0030855; P:epithelial cell differentiation; TAS:UniProtKB
Q9NQ38	SPINK5	Serine protease inhibitor Kazal-type 5	GO:0030198; P:extracellular matrix organization; TAS:UniProtKB
Q9NQ38	SPINK5	Serine protease inhibitor Kazal-type 5	GO:0035315; P:hair cell differentiation; TAS:UniProtKB
Q9NQ38	SPINK5	Serine protease inhibitor Kazal-type 5	GO:0016525; P:negative regulation of angiogenesis; TAS:UniProtKB
Q9NQ38	SPINK5	Serine protease inhibitor Kazal-type 5	GO:0010951; P:negative regulation of endopeptidase activity; IDA:GOC
Q9NQ38	SPINK5	Serine protease inhibitor Kazal-type 5	GO:0050777; P:negative regulation of immune response; TAS:UniProtKB
Q9NQ38	SPINK5	Serine protease inhibitor Kazal-type 5	GO:0045861; P:negative regulation of proteolysis; IEA:Ensembl
Q9NQ38	SPINK5	Serine protease inhibitor Kazal-type 5	GO:0030155; P:regulation of cell adhesion; IEA:Ensembl
Q9NQ38	SPINK5	Serine protease inhibitor Kazal-type 5	GO:0045580; P:regulation of T cell differentiation; TAS:UniProtKB
Q6UWN8	SPINK6	Serine protease inhibitor Kazal-type 6	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
P0C7L1	SPINK8	Serine protease inhibitor Kazal-type 8	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
P58062	SPINK7	Serine protease inhibitor Kazal-type 7	GO:0005515; F:protein binding; IPI:IntAct
P58062	SPINK7	Serine protease inhibitor Kazal-type 7	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q5DT21	SPINK9	Serine protease inhibitor Kazal-type 9	GO:0005515; F:protein binding; IPI:UniProtKB
Q5DT21	SPINK9	Serine protease inhibitor Kazal-type 9	GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:UniProtKB
Q5DT21	SPINK9	Serine protease inhibitor Kazal-type 9	GO:0010951; P:negative regulation of endopeptidase activity; IDA:GOC
Q96A47	ISL2	Insulin gene enhancer protein ISL-2	GO:0003677; F:DNA binding; ISS:BHF-UCL
Q96A47	ISL2	Insulin gene enhancer protein ISL-2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q96A47	ISL2	Insulin gene enhancer protein ISL-2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q96A47	ISL2	Insulin gene enhancer protein ISL-2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96A47	ISL2	Insulin gene enhancer protein ISL-2	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
Q96A47	ISL2	Insulin gene enhancer protein ISL-2	GO:0048666; P:neuron development; TAS:BHF-UCL
Q96A47	ISL2	Insulin gene enhancer protein ISL-2	GO:0048935; P:peripheral nervous system neuron development; TAS:BHF-UCL
Q96A47	ISL2	Insulin gene enhancer protein ISL-2	GO:0031290; P:retinal ganglion cell axon guidance; IEA:Ensembl
Q96A47	ISL2	Insulin gene enhancer protein ISL-2	GO:0021520; P:spinal cord motor neuron cell fate specification; IEA:Ensembl
Q96A47	ISL2	Insulin gene enhancer protein ISL-2	GO:0021524; P:visceral motor neuron differentiation; IEA:Ensembl
Q6UXK2	ISLR2	Immunoglobulin superfamily containing leucine-rich repeat protein 2	GO:0045773; P:positive regulation of axon extension; ISS:UniProtKB
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0043425; F:bHLH transcription factor binding; IPI:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0003682; F:chromatin binding; IEA:Ensembl
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0001158; F:enhancer sequence-specific DNA binding; IDA:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0030331; F:estrogen receptor binding; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0016922; F:ligand-dependent nuclear receptor binding; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0001105; F:RNA polymerase II transcription coactivator activity; IDA:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0008270; F:zinc ion binding; IEA:InterPro
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0060413; P:atrial septum morphogenesis; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0031103; P:axon regeneration; IEA:Ensembl
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0060913; P:cardiac cell fate determination; IDA:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0060379; P:cardiac muscle cell myoblast differentiation; IEA:Ensembl
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0003215; P:cardiac right ventricle morphogenesis; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0071385; P:cellular response to glucocorticoid stimulus; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0003203; P:endocardial cushion morphogenesis; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0060384; P:innervation; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0048762; P:mesenchymal cell differentiation; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEA:Ensembl
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0050728; P:negative regulation of inflammatory response; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0033147; P:negative regulation of intracellular estrogen receptor signaling pathway; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0090074; P:negative regulation of protein homodimerization activity; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0001755; P:neural crest cell migration; IEA:Ensembl
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0048665; P:neuron fate specification; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0003151; P:outflow tract morphogenesis; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0003148; P:outflow tract septum morphogenesis; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0031016; P:pancreas development; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0048936; P:peripheral nervous system neuron axonogenesis; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0060037; P:pharyngeal system development; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0021983; P:pituitary gland development; IEA:Ensembl
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0045766; P:positive regulation of angiogenesis; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0043388; P:positive regulation of DNA binding; IEA:Ensembl
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0071657; P:positive regulation of granulocyte colony-stimulating factor production; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0032725; P:positive regulation of granulocyte macrophage colony-stimulating factor production; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0032024; P:positive regulation of insulin secretion; IC:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0032729; P:positive regulation of interferon-gamma production; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0032730; P:positive regulation of interleukin-1 alpha production; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0032731; P:positive regulation of interleukin-1 beta production; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0032735; P:positive regulation of interleukin-12 production; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0032755; P:positive regulation of interleukin-6 production; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:1901258; P:positive regulation of macrophage colony-stimulating factor production; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0032760; P:positive regulation of tumor necrosis factor production; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IEA:Ensembl
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0010575; P:positive regulation vascular endothelial growth factor production; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0003266; P:regulation of secondary heart field cardioblast proliferation; IEA:Ensembl
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0031290; P:retinal ganglion cell axon guidance; IEA:Ensembl
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0003139; P:secondary heart field specification; IMP:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0048880; P:sensory system development; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0021520; P:spinal cord motor neuron cell fate specification; IEA:Ensembl
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0021522; P:spinal cord motor neuron differentiation; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0021559; P:trigeminal nerve development; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; ISS:BHF-UCL
P61371	ISL1	Insulin gene enhancer protein ISL-1	GO:0021524; P:visceral motor neuron differentiation; IEA:Ensembl
O14498	ISLR	Immunoglobulin superfamily containing leucine-rich repeat protein	GO:0007155; P:cell adhesion; TAS:ProtInc
Q96CN7	ISOC1	Isochorismatase domain-containing protein 1	GO:0003824; F:catalytic activity; IEA:InterPro
Q96AB3	ISOC2	Isochorismatase domain-containing protein 2, mitochondrial	GO:0003824; F:catalytic activity; IEA:InterPro
Q96AB3	ISOC2	Isochorismatase domain-containing protein 2, mitochondrial	GO:0005515; F:protein binding; IPI:BHF-UCL
Q96AB3	ISOC2	Isochorismatase domain-containing protein 2, mitochondrial	GO:0031648; P:protein destabilization; IMP:BHF-UCL
A4D126	ISPD	Isoprenoid synthase domain-containing protein	GO:0016779; F:nucleotidyltransferase activity; IEA:UniProtKB-KW
A4D126	ISPD	Isoprenoid synthase domain-containing protein	GO:0007411; P:axon guidance; IEA:Ensembl
A4D126	ISPD	Isoprenoid synthase domain-containing protein	GO:0008299; P:isoprenoid biosynthetic process; IEA:InterPro
A4D126	ISPD	Isoprenoid synthase domain-containing protein	GO:0035269; P:protein O-linked mannosylation; IMP:UniProtKB
P53990	IST1	IST1 homolog	GO:0090541; F:MIT domain binding; IPI:UniProtKB
P53990	IST1	IST1 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
P53990	IST1	IST1 homolog	GO:0032403; F:protein complex binding; IDA:UniProtKB
P53990	IST1	IST1 homolog	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P53990	IST1	IST1 homolog	GO:0009838; P:abscission; IDA:UniProtKB
P53990	IST1	IST1 homolog	GO:0051301; P:cell division; IMP:UniProtKB
P53990	IST1	IST1 homolog	GO:0000910; P:cytokinesis; IMP:UniProtKB
P53990	IST1	IST1 homolog	GO:0045184; P:establishment of protein localization; IMP:UniProt
P53990	IST1	IST1 homolog	GO:0048672; P:positive regulation of collateral sprouting; IEA:Ensembl
P53990	IST1	IST1 homolog	GO:0045862; P:positive regulation of proteolysis; IDA:UniProtKB
P53990	IST1	IST1 homolog	GO:0008104; P:protein localization; IMP:UniProtKB
P53990	IST1	IST1 homolog	GO:0046745; P:viral capsid secondary envelopment; IDA:UniProtKB
P53990	IST1	IST1 homolog	GO:0019076; P:viral release from host cell; IDA:UniProtKB
Q2M1V0	ISX	Intestine-specific homeobox	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q2M1V0	ISX	Intestine-specific homeobox	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q2M1V0	ISX	Intestine-specific homeobox	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q2M1V0	ISX	Intestine-specific homeobox	GO:1901738; P:regulation of vitamin A metabolic process; IEA:Ensembl
Q2M1V0	ISX	Intestine-specific homeobox	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9ULR0	ISY1	Pre-mRNA-splicing factor ISY1 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9ULR0	ISY1	Pre-mRNA-splicing factor ISY1 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q9ULR0	ISY1	Pre-mRNA-splicing factor ISY1 homolog	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
O75578	ITGA10	Integrin alpha-10	GO:0005518; F:collagen binding; TAS:ProtInc
O75578	ITGA10	Integrin alpha-10	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75578	ITGA10	Integrin alpha-10	GO:0007411; P:axon guidance; TAS:Reactome
O75578	ITGA10	Integrin alpha-10	GO:0007596; P:blood coagulation; TAS:Reactome
O75578	ITGA10	Integrin alpha-10	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
O75578	ITGA10	Integrin alpha-10	GO:0007160; P:cell-matrix adhesion; TAS:ProtInc
O75578	ITGA10	Integrin alpha-10	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O75578	ITGA10	Integrin alpha-10	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
Q9UKX5	ITGA11	Integrin alpha-11	GO:0005518; F:collagen binding; TAS:ProtInc
Q9UKX5	ITGA11	Integrin alpha-11	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UKX5	ITGA11	Integrin alpha-11	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9UKX5	ITGA11	Integrin alpha-11	GO:0007160; P:cell-matrix adhesion; TAS:ProtInc
Q9UKX5	ITGA11	Integrin alpha-11	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q9UKX5	ITGA11	Integrin alpha-11	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
Q9UKX5	ITGA11	Integrin alpha-11	GO:0007517; P:muscle organ development; TAS:ProtInc
P56199	ITGA1	Integrin alpha-1	GO:0005518; F:collagen binding; TAS:UniProtKB
P56199	ITGA1	Integrin alpha-1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P56199	ITGA1	Integrin alpha-1	GO:0005515; F:protein binding; IPI:UniProtKB
P56199	ITGA1	Integrin alpha-1	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
P56199	ITGA1	Integrin alpha-1	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
P56199	ITGA1	Integrin alpha-1	GO:0007411; P:axon guidance; TAS:Reactome
P56199	ITGA1	Integrin alpha-1	GO:0007596; P:blood coagulation; TAS:Reactome
P56199	ITGA1	Integrin alpha-1	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P56199	ITGA1	Integrin alpha-1	GO:0045123; P:cellular extravasation; IEA:Ensembl
P56199	ITGA1	Integrin alpha-1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P56199	ITGA1	Integrin alpha-1	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P56199	ITGA1	Integrin alpha-1	GO:0006936; P:muscle contraction; TAS:Reactome
P56199	ITGA1	Integrin alpha-1	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
P56199	ITGA1	Integrin alpha-1	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; ISS:UniProtKB
P56199	ITGA1	Integrin alpha-1	GO:0030593; P:neutrophil chemotaxis; IEA:Ensembl
P56199	ITGA1	Integrin alpha-1	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
P56199	ITGA1	Integrin alpha-1	GO:0032516; P:positive regulation of phosphoprotein phosphatase activity; IDA:UniProtKB
P56199	ITGA1	Integrin alpha-1	GO:0042311; P:vasodilation; IEA:Ensembl
P08514	ITGA2B	Integrin alpha-IIb	GO:0050840; F:extracellular matrix binding; IEA:Ensembl
P08514	ITGA2B	Integrin alpha-IIb	GO:0042802; F:identical protein binding; IPI:IntAct
P08514	ITGA2B	Integrin alpha-IIb	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P08514	ITGA2B	Integrin alpha-IIb	GO:0005515; F:protein binding; IPI:IntAct
P08514	ITGA2B	Integrin alpha-IIb	GO:0007411; P:axon guidance; TAS:Reactome
P08514	ITGA2B	Integrin alpha-IIb	GO:0007596; P:blood coagulation; TAS:Reactome
P08514	ITGA2B	Integrin alpha-IIb	GO:0007155; P:cell adhesion; TAS:ProtInc
P08514	ITGA2B	Integrin alpha-IIb	GO:0007160; P:cell-matrix adhesion; IEA:Ensembl
P08514	ITGA2B	Integrin alpha-IIb	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P08514	ITGA2B	Integrin alpha-IIb	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P08514	ITGA2B	Integrin alpha-IIb	GO:0030168; P:platelet activation; TAS:Reactome
P08514	ITGA2B	Integrin alpha-IIb	GO:0070527; P:platelet aggregation; IEA:Ensembl
P08514	ITGA2B	Integrin alpha-IIb	GO:0002576; P:platelet degranulation; TAS:Reactome
P08514	ITGA2B	Integrin alpha-IIb	GO:0002687; P:positive regulation of leukocyte migration; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0005518; F:collagen binding; TAS:ProtInc
P17301	ITGA2	Integrin alpha-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17301	ITGA2	Integrin alpha-2	GO:0005515; F:protein binding; IPI:UniProtKB
P17301	ITGA2	Integrin alpha-2	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
P17301	ITGA2	Integrin alpha-2	GO:0007411; P:axon guidance; TAS:Reactome
P17301	ITGA2	Integrin alpha-2	GO:0007596; P:blood coagulation; TAS:Reactome
P17301	ITGA2	Integrin alpha-2	GO:0007155; P:cell adhesion; TAS:ProtInc
P17301	ITGA2	Integrin alpha-2	GO:0008283; P:cell proliferation; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0007160; P:cell-matrix adhesion; TAS:ProtInc
P17301	ITGA2	Integrin alpha-2	GO:0032870; P:cellular response to hormone stimulus; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0045184; P:establishment of protein localization; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P17301	ITGA2	Integrin alpha-2	GO:0070365; P:hepatocyte differentiation; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0006971; P:hypotonic response; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P17301	ITGA2	Integrin alpha-2	GO:0030879; P:mammary gland development; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P17301	ITGA2	Integrin alpha-2	GO:0010694; P:positive regulation of alkaline phosphatase activity; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0045785; P:positive regulation of cell adhesion; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0031346; P:positive regulation of cell projection organization; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0033343; P:positive regulation of collagen binding; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0032967; P:positive regulation of collagen biosynthetic process; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0043388; P:positive regulation of DNA binding; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0010634; P:positive regulation of epithelial cell migration; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0050729; P:positive regulation of inflammatory response; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0002687; P:positive regulation of leukocyte migration; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0060100; P:positive regulation of phagocytosis, engulfment; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0050927; P:positive regulation of positive chemotaxis; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0014911; P:positive regulation of smooth muscle cell migration; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0045987; P:positive regulation of smooth muscle contraction; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0045727; P:positive regulation of translation; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0051971; P:positive regulation of transmission of nerve impulse; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0014075; P:response to amine; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0042493; P:response to drug; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0001666; P:response to hypoxia; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0033591; P:response to L-ascorbic acid; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0014850; P:response to muscle activity; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0043589; P:skin morphogenesis; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0001894; P:tissue homeostasis; IEA:Ensembl
P17301	ITGA2	Integrin alpha-2	GO:0016032; P:viral process; IEA:UniProtKB-KW
P26006	ITGA3	Integrin alpha-3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P26006	ITGA3	Integrin alpha-3	GO:0005515; F:protein binding; IPI:UniProtKB
P26006	ITGA3	Integrin alpha-3	GO:0007596; P:blood coagulation; TAS:Reactome
P26006	ITGA3	Integrin alpha-3	GO:0007160; P:cell-matrix adhesion; TAS:ProtInc
P26006	ITGA3	Integrin alpha-3	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P26006	ITGA3	Integrin alpha-3	GO:0007507; P:heart development; IEA:Ensembl
P26006	ITGA3	Integrin alpha-3	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P26006	ITGA3	Integrin alpha-3	GO:0050900; P:leukocyte migration; TAS:Reactome
P26006	ITGA3	Integrin alpha-3	GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
P26006	ITGA3	Integrin alpha-3	GO:0007613; P:memory; IEA:Ensembl
P26006	ITGA3	Integrin alpha-3	GO:0031345; P:negative regulation of cell projection organization; IEA:Ensembl
P26006	ITGA3	Integrin alpha-3	GO:0001764; P:neuron migration; IEA:Ensembl
P26006	ITGA3	Integrin alpha-3	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
P26006	ITGA3	Integrin alpha-3	GO:0010634; P:positive regulation of epithelial cell migration; IEA:Ensembl
P26006	ITGA3	Integrin alpha-3	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P26006	ITGA3	Integrin alpha-3	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
P26006	ITGA3	Integrin alpha-3	GO:0042493; P:response to drug; IEA:Ensembl
P26006	ITGA3	Integrin alpha-3	GO:0034698; P:response to gonadotropin; IEA:Ensembl
P13612	ITGA4	Integrin alpha-4	GO:0050839; F:cell adhesion molecule binding; IPI:UniProtKB
P13612	ITGA4	Integrin alpha-4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P13612	ITGA4	Integrin alpha-4	GO:0005515; F:protein binding; IPI:UniProtKB
P13612	ITGA4	Integrin alpha-4	GO:0030183; P:B cell differentiation; IC:BHF-UCL
P13612	ITGA4	Integrin alpha-4	GO:0007596; P:blood coagulation; TAS:Reactome
P13612	ITGA4	Integrin alpha-4	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
P13612	ITGA4	Integrin alpha-4	GO:0060710; P:chorio-allantoic fusion; IEA:Ensembl
P13612	ITGA4	Integrin alpha-4	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P13612	ITGA4	Integrin alpha-4	GO:0060324; P:face development; IEA:Ensembl
P13612	ITGA4	Integrin alpha-4	GO:0007507; P:heart development; IEA:Ensembl
P13612	ITGA4	Integrin alpha-4	GO:0007157; P:heterophilic cell-cell adhesion; IEA:Ensembl
P13612	ITGA4	Integrin alpha-4	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P13612	ITGA4	Integrin alpha-4	GO:0007159; P:leukocyte cell-cell adhesion; IDA:BHF-UCL
P13612	ITGA4	Integrin alpha-4	GO:0050900; P:leukocyte migration; TAS:Reactome
P13612	ITGA4	Integrin alpha-4	GO:0090074; P:negative regulation of protein homodimerization activity; IDA:UniProtKB
P13612	ITGA4	Integrin alpha-4	GO:0050776; P:regulation of immune response; TAS:Reactome
P08648	ITGA5	Integrin alpha-5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P08648	ITGA5	Integrin alpha-5	GO:0005161; F:platelet-derived growth factor receptor binding; TAS:BHF-UCL
P08648	ITGA5	Integrin alpha-5	GO:0005515; F:protein binding; IPI:UniProtKB
P08648	ITGA5	Integrin alpha-5	GO:0043184; F:vascular endothelial growth factor receptor 2 binding; TAS:BHF-UCL
P08648	ITGA5	Integrin alpha-5	GO:0001525; P:angiogenesis; TAS:BHF-UCL
P08648	ITGA5	Integrin alpha-5	GO:0007411; P:axon guidance; TAS:Reactome
P08648	ITGA5	Integrin alpha-5	GO:0007596; P:blood coagulation; TAS:Reactome
P08648	ITGA5	Integrin alpha-5	GO:0007155; P:cell adhesion; TAS:ProtInc
P08648	ITGA5	Integrin alpha-5	GO:0033631; P:cell-cell adhesion mediated by integrin; IEA:Ensembl
P08648	ITGA5	Integrin alpha-5	GO:0007044; P:cell-substrate junction assembly; IEA:Ensembl
P08648	ITGA5	Integrin alpha-5	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P08648	ITGA5	Integrin alpha-5	GO:0007157; P:heterophilic cell-cell adhesion; IEA:Ensembl
P08648	ITGA5	Integrin alpha-5	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P08648	ITGA5	Integrin alpha-5	GO:0007159; P:leukocyte cell-cell adhesion; IEA:Ensembl
P08648	ITGA5	Integrin alpha-5	GO:0050900; P:leukocyte migration; TAS:Reactome
P08648	ITGA5	Integrin alpha-5	GO:0007613; P:memory; IEA:Ensembl
P08648	ITGA5	Integrin alpha-5	GO:2000811; P:negative regulation of anoikis; IMP:UniProtKB
P08648	ITGA5	Integrin alpha-5	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
P08648	ITGA5	Integrin alpha-5	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
P08648	ITGA5	Integrin alpha-5	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IMP:BHF-UCL
P08648	ITGA5	Integrin alpha-5	GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; TAS:BHF-UCL
P08648	ITGA5	Integrin alpha-5	GO:0016032; P:viral process; IEA:UniProtKB-KW
P08648	ITGA5	Integrin alpha-5	GO:0035313; P:wound healing, spreading of epidermal cells; IEP:BHF-UCL
P23229	ITGA6	Integrin alpha-6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P23229	ITGA6	Integrin alpha-6	GO:0005515; F:protein binding; IPI:IntAct
P23229	ITGA6	Integrin alpha-6	GO:0007596; P:blood coagulation; TAS:Reactome
P23229	ITGA6	Integrin alpha-6	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
P23229	ITGA6	Integrin alpha-6	GO:0033627; P:cell adhesion mediated by integrin; IEA:Ensembl
P23229	ITGA6	Integrin alpha-6	GO:0034329; P:cell junction assembly; TAS:Reactome
P23229	ITGA6	Integrin alpha-6	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
P23229	ITGA6	Integrin alpha-6	GO:0007160; P:cell-matrix adhesion; IEA:Ensembl
P23229	ITGA6	Integrin alpha-6	GO:0007044; P:cell-substrate junction assembly; TAS:ProtInc
P23229	ITGA6	Integrin alpha-6	GO:0031668; P:cellular response to extracellular stimulus; IEA:Ensembl
P23229	ITGA6	Integrin alpha-6	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
P23229	ITGA6	Integrin alpha-6	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P23229	ITGA6	Integrin alpha-6	GO:0046847; P:filopodium assembly; IEA:Ensembl
P23229	ITGA6	Integrin alpha-6	GO:0031581; P:hemidesmosome assembly; TAS:Reactome
P23229	ITGA6	Integrin alpha-6	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P23229	ITGA6	Integrin alpha-6	GO:0050900; P:leukocyte migration; TAS:Reactome
P23229	ITGA6	Integrin alpha-6	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:BHF-UCL
P23229	ITGA6	Integrin alpha-6	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
P23229	ITGA6	Integrin alpha-6	GO:0043065; P:positive regulation of apoptotic process; IGI:MGI
P23229	ITGA6	Integrin alpha-6	GO:0022409; P:positive regulation of cell-cell adhesion; IEA:Ensembl
P23229	ITGA6	Integrin alpha-6	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
P23229	ITGA6	Integrin alpha-6	GO:0042327; P:positive regulation of phosphorylation; IMP:BHF-UCL
P23229	ITGA6	Integrin alpha-6	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q13683	ITGA7	Integrin alpha-7	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13683	ITGA7	Integrin alpha-7	GO:0048514; P:blood vessel morphogenesis; IEA:Ensembl
Q13683	ITGA7	Integrin alpha-7	GO:0016477; P:cell migration; IEA:Ensembl
Q13683	ITGA7	Integrin alpha-7	GO:0007160; P:cell-matrix adhesion; TAS:ProtInc
Q13683	ITGA7	Integrin alpha-7	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q13683	ITGA7	Integrin alpha-7	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
Q13683	ITGA7	Integrin alpha-7	GO:0007517; P:muscle organ development; TAS:ProtInc
Q13683	ITGA7	Integrin alpha-7	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
Q13683	ITGA7	Integrin alpha-7	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
P53708	ITGA8	Integrin alpha-8	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P53708	ITGA8	Integrin alpha-8	GO:0007420; P:brain development; IEA:Ensembl
P53708	ITGA8	Integrin alpha-8	GO:0030030; P:cell projection organization; IEA:Ensembl
P53708	ITGA8	Integrin alpha-8	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
P53708	ITGA8	Integrin alpha-8	GO:0007160; P:cell-matrix adhesion; NAS:UniProtKB
P53708	ITGA8	Integrin alpha-8	GO:0045184; P:establishment of protein localization; IEA:Ensembl
P53708	ITGA8	Integrin alpha-8	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P53708	ITGA8	Integrin alpha-8	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
P53708	ITGA8	Integrin alpha-8	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P53708	ITGA8	Integrin alpha-8	GO:0007613; P:memory; IEA:Ensembl
P53708	ITGA8	Integrin alpha-8	GO:0001656; P:metanephros development; IEA:Ensembl
P53708	ITGA8	Integrin alpha-8	GO:2000721; P:positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation; IEA:Ensembl
P53708	ITGA8	Integrin alpha-8	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl
P53708	ITGA8	Integrin alpha-8	GO:0048745; P:smooth muscle tissue development; IEA:Ensembl
Q13797	ITGA9	Integrin alpha-9	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13797	ITGA9	Integrin alpha-9	GO:0007411; P:axon guidance; TAS:Reactome
Q13797	ITGA9	Integrin alpha-9	GO:0007155; P:cell adhesion; IGI:MGI
Q13797	ITGA9	Integrin alpha-9	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q13797	ITGA9	Integrin alpha-9	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
Q13797	ITGA9	Integrin alpha-9	GO:0030593; P:neutrophil chemotaxis; IEA:Ensembl
Q13797	ITGA9	Integrin alpha-9	GO:0042060; P:wound healing; IEA:Ensembl
Q13349	ITGAD	Integrin alpha-D	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13349	ITGAD	Integrin alpha-D	GO:0050798; P:activated T cell proliferation; IEA:Ensembl
Q13349	ITGAD	Integrin alpha-D	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q13349	ITGAD	Integrin alpha-D	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q13349	ITGAD	Integrin alpha-D	GO:0006955; P:immune response; NAS:UniProtKB
Q13349	ITGAD	Integrin alpha-D	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P38570	ITGAE	Integrin alpha-E	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P38570	ITGAE	Integrin alpha-E	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P38570	ITGAE	Integrin alpha-E	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P38570	ITGAE	Integrin alpha-E	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P20701	ITGAL	Integrin alpha-L	GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL
P20701	ITGAL	Integrin alpha-L	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P20701	ITGAL	Integrin alpha-L	GO:0005515; F:protein binding; IPI:IntAct
P20701	ITGAL	Integrin alpha-L	GO:0050798; P:activated T cell proliferation; IEA:Ensembl
P20701	ITGAL	Integrin alpha-L	GO:0007596; P:blood coagulation; TAS:Reactome
P20701	ITGAL	Integrin alpha-L	GO:0007155; P:cell adhesion; NAS:UniProtKB
P20701	ITGAL	Integrin alpha-L	GO:0006928; P:cellular component movement; TAS:ProtInc
P20701	ITGAL	Integrin alpha-L	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P20701	ITGAL	Integrin alpha-L	GO:0007157; P:heterophilic cell-cell adhesion; IMP:BHF-UCL
P20701	ITGAL	Integrin alpha-L	GO:0006954; P:inflammatory response; NAS:UniProtKB
P20701	ITGAL	Integrin alpha-L	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P20701	ITGAL	Integrin alpha-L	GO:0007159; P:leukocyte cell-cell adhesion; IMP:BHF-UCL
P20701	ITGAL	Integrin alpha-L	GO:0050900; P:leukocyte migration; TAS:Reactome
P20701	ITGAL	Integrin alpha-L	GO:0050850; P:positive regulation of calcium-mediated signaling; IEA:Ensembl
P20701	ITGAL	Integrin alpha-L	GO:0022409; P:positive regulation of cell-cell adhesion; IEA:Ensembl
P20701	ITGAL	Integrin alpha-L	GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl
P20701	ITGAL	Integrin alpha-L	GO:0050776; P:regulation of immune response; TAS:Reactome
P20701	ITGAL	Integrin alpha-L	GO:0007165; P:signal transduction; NAS:UniProtKB
P20701	ITGAL	Integrin alpha-L	GO:0002291; P:T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; IMP:BHF-UCL
P11215	ITGAM	Integrin alpha-M	GO:0001948; F:glycoprotein binding; IPI:UniProtKB
P11215	ITGAM	Integrin alpha-M	GO:0008201; F:heparin binding; IEA:Ensembl
P11215	ITGAM	Integrin alpha-M	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P11215	ITGAM	Integrin alpha-M	GO:0005515; F:protein binding; IPI:UniProtKB
P11215	ITGAM	Integrin alpha-M	GO:0050798; P:activated T cell proliferation; IEA:Ensembl
P11215	ITGAM	Integrin alpha-M	GO:0007596; P:blood coagulation; TAS:Reactome
P11215	ITGAM	Integrin alpha-M	GO:0007155; P:cell adhesion; TAS:ProtInc
P11215	ITGAM	Integrin alpha-M	GO:0045123; P:cellular extravasation; IEA:Ensembl
P11215	ITGAM	Integrin alpha-M	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P11215	ITGAM	Integrin alpha-M	GO:0045087; P:innate immune response; TAS:Reactome
P11215	ITGAM	Integrin alpha-M	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P11215	ITGAM	Integrin alpha-M	GO:0007159; P:leukocyte cell-cell adhesion; IEA:Ensembl
P11215	ITGAM	Integrin alpha-M	GO:0050900; P:leukocyte migration; TAS:Reactome
P11215	ITGAM	Integrin alpha-M	GO:0014005; P:microglia development; IEA:Ensembl
P11215	ITGAM	Integrin alpha-M	GO:0030593; P:neutrophil chemotaxis; IEA:Ensembl
P11215	ITGAM	Integrin alpha-M	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P11215	ITGAM	Integrin alpha-M	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P06756	ITGAV	Integrin alpha-V	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P06756	ITGAV	Integrin alpha-V	GO:0005515; F:protein binding; IPI:UniProtKB
P06756	ITGAV	Integrin alpha-V	GO:0050431; F:transforming growth factor beta binding; ISS:BHF-UCL
P06756	ITGAV	Integrin alpha-V	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
P06756	ITGAV	Integrin alpha-V	GO:0005245; F:voltage-gated calcium channel activity; IDA:UniProtKB
P06756	ITGAV	Integrin alpha-V	GO:0001525; P:angiogenesis; IEP:UniProtKB
P06756	ITGAV	Integrin alpha-V	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P06756	ITGAV	Integrin alpha-V	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P06756	ITGAV	Integrin alpha-V	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P06756	ITGAV	Integrin alpha-V	GO:0043277; P:apoptotic cell clearance; IEA:Ensembl
P06756	ITGAV	Integrin alpha-V	GO:0007411; P:axon guidance; TAS:Reactome
P06756	ITGAV	Integrin alpha-V	GO:0007596; P:blood coagulation; TAS:Reactome
P06756	ITGAV	Integrin alpha-V	GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB
P06756	ITGAV	Integrin alpha-V	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P06756	ITGAV	Integrin alpha-V	GO:0007160; P:cell-matrix adhesion; NAS:UniProtKB
P06756	ITGAV	Integrin alpha-V	GO:0052066; P:entry of symbiont into host cell by promotion of host phagocytosis; NAS:BHF-UCL
P06756	ITGAV	Integrin alpha-V	GO:0070371; P:ERK1 and ERK2 cascade; ISS:BHF-UCL
P06756	ITGAV	Integrin alpha-V	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P06756	ITGAV	Integrin alpha-V	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; ISS:BHF-UCL
P06756	ITGAV	Integrin alpha-V	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P06756	ITGAV	Integrin alpha-V	GO:0050900; P:leukocyte migration; TAS:Reactome
P06756	ITGAV	Integrin alpha-V	GO:2000536; P:negative regulation of entry of bacterium into host cell; IDA:BHF-UCL
P06756	ITGAV	Integrin alpha-V	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:BHF-UCL
P06756	ITGAV	Integrin alpha-V	GO:0010888; P:negative regulation of lipid storage; IMP:BHF-UCL
P06756	ITGAV	Integrin alpha-V	GO:0032369; P:negative regulation of lipid transport; IMP:BHF-UCL
P06756	ITGAV	Integrin alpha-V	GO:0050748; P:negative regulation of lipoprotein metabolic process; IMP:BHF-UCL
P06756	ITGAV	Integrin alpha-V	GO:0045715; P:negative regulation of low-density lipoprotein particle receptor biosynthetic process; IMP:BHF-UCL
P06756	ITGAV	Integrin alpha-V	GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; IMP:BHF-UCL
P06756	ITGAV	Integrin alpha-V	GO:0045785; P:positive regulation of cell adhesion; IDA:BHF-UCL
P06756	ITGAV	Integrin alpha-V	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
P06756	ITGAV	Integrin alpha-V	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P06756	ITGAV	Integrin alpha-V	GO:0033690; P:positive regulation of osteoblast proliferation; IEA:Ensembl
P06756	ITGAV	Integrin alpha-V	GO:2000425; P:regulation of apoptotic cell clearance; ISS:BHF-UCL
P06756	ITGAV	Integrin alpha-V	GO:0050764; P:regulation of phagocytosis; IDA:BHF-UCL
P06756	ITGAV	Integrin alpha-V	GO:0046718; P:viral entry into host cell; TAS:BHF-UCL
P20702	ITGAX	Integrin alpha-X	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P20702	ITGAX	Integrin alpha-X	GO:0005515; F:protein binding; IPI:BHF-UCL
P20702	ITGAX	Integrin alpha-X	GO:0004872; F:receptor activity; TAS:ProtInc
P20702	ITGAX	Integrin alpha-X	GO:0007596; P:blood coagulation; TAS:Reactome
P20702	ITGAX	Integrin alpha-X	GO:0007155; P:cell adhesion; TAS:ProtInc
P20702	ITGAX	Integrin alpha-X	GO:0051607; P:defense response to virus; IEA:Ensembl
P20702	ITGAX	Integrin alpha-X	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P20702	ITGAX	Integrin alpha-X	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P20702	ITGAX	Integrin alpha-X	GO:0050900; P:leukocyte migration; TAS:Reactome
P20702	ITGAX	Integrin alpha-X	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P05556	ITGB1	Integrin beta-1	GO:0003779; F:actin binding; IDA:BHF-UCL
P05556	ITGB1	Integrin beta-1	GO:0050839; F:cell adhesion molecule binding; IPI:UniProtKB
P05556	ITGB1	Integrin beta-1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P05556	ITGB1	Integrin beta-1	GO:0042277; F:peptide binding; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0005515; F:protein binding; IPI:IntAct
P05556	ITGB1	Integrin beta-1	GO:0046982; F:protein heterodimerization activity; NAS:UniProtKB
P05556	ITGB1	Integrin beta-1	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
P05556	ITGB1	Integrin beta-1	GO:0007411; P:axon guidance; TAS:Reactome
P05556	ITGB1	Integrin beta-1	GO:0030183; P:B cell differentiation; IC:BHF-UCL
P05556	ITGB1	Integrin beta-1	GO:0007596; P:blood coagulation; TAS:Reactome
P05556	ITGB1	Integrin beta-1	GO:0007161; P:calcium-independent cell-matrix adhesion; IGI:MGI
P05556	ITGB1	Integrin beta-1	GO:0055007; P:cardiac muscle cell differentiation; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0001708; P:cell fate specification; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0034329; P:cell junction assembly; TAS:Reactome
P05556	ITGB1	Integrin beta-1	GO:0016477; P:cell migration; TAS:HGNC
P05556	ITGB1	Integrin beta-1	GO:0002042; P:cell migration involved in sprouting angiogenesis; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0033631; P:cell-cell adhesion mediated by integrin; IEP:BHF-UCL
P05556	ITGB1	Integrin beta-1	GO:0007160; P:cell-matrix adhesion; IMP:BHF-UCL
P05556	ITGB1	Integrin beta-1	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0006968; P:cellular defense response; TAS:ProtInc
P05556	ITGB1	Integrin beta-1	GO:0071479; P:cellular response to ionizing radiation; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0071305; P:cellular response to vitamin D; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P05556	ITGB1	Integrin beta-1	GO:0021943; P:formation of radial glial scaffolds; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0000082; P:G1/S transition of mitotic cell cycle; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0008354; P:germ cell migration; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0007156; P:homophilic cell adhesion; TAS:ProtInc
P05556	ITGB1	Integrin beta-1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P05556	ITGB1	Integrin beta-1	GO:0007159; P:leukocyte cell-cell adhesion; IDA:BHF-UCL
P05556	ITGB1	Integrin beta-1	GO:0050900; P:leukocyte migration; TAS:Reactome
P05556	ITGB1	Integrin beta-1	GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:2000811; P:negative regulation of anoikis; IMP:UniProtKB
P05556	ITGB1	Integrin beta-1	GO:0031345; P:negative regulation of cell projection organization; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0043065; P:positive regulation of apoptotic process; IGI:MGI
P05556	ITGB1	Integrin beta-1	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0045807; P:positive regulation of endocytosis; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0032594; P:protein transport within lipid bilayer; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0050776; P:regulation of immune response; TAS:Reactome
P05556	ITGB1	Integrin beta-1	GO:0014823; P:response to activity; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0042493; P:response to drug; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0034698; P:response to gonadotropin; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0071559; P:response to transforming growth factor beta; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0045214; P:sarcomere organization; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0070830; P:tight junction assembly; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0001894; P:tissue homeostasis; IEA:Ensembl
P05556	ITGB1	Integrin beta-1	GO:0016032; P:viral process; IEA:UniProtKB-KW
P05107	ITGB2	Integrin beta-2	GO:0001948; F:glycoprotein binding; IPI:BHF-UCL
P05107	ITGB2	Integrin beta-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P05107	ITGB2	Integrin beta-2	GO:0005515; F:protein binding; IPI:IntAct
P05107	ITGB2	Integrin beta-2	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P05107	ITGB2	Integrin beta-2	GO:0004872; F:receptor activity; IEA:InterPro
P05107	ITGB2	Integrin beta-2	GO:0006915; P:apoptotic process; NAS:UniProtKB
P05107	ITGB2	Integrin beta-2	GO:0007596; P:blood coagulation; TAS:Reactome
P05107	ITGB2	Integrin beta-2	GO:0007155; P:cell adhesion; TAS:ProtInc
P05107	ITGB2	Integrin beta-2	GO:0007267; P:cell-cell signaling; NAS:UniProtKB
P05107	ITGB2	Integrin beta-2	GO:0007160; P:cell-matrix adhesion; IEA:InterPro
P05107	ITGB2	Integrin beta-2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P05107	ITGB2	Integrin beta-2	GO:0006954; P:inflammatory response; NAS:UniProtKB
P05107	ITGB2	Integrin beta-2	GO:0045087; P:innate immune response; TAS:Reactome
P05107	ITGB2	Integrin beta-2	GO:0007229; P:integrin-mediated signaling pathway; NAS:UniProtKB
P05107	ITGB2	Integrin beta-2	GO:0007159; P:leukocyte cell-cell adhesion; IDA:UniProtKB
P05107	ITGB2	Integrin beta-2	GO:0050900; P:leukocyte migration; TAS:Reactome
P05107	ITGB2	Integrin beta-2	GO:0007275; P:multicellular organismal development; IEA:InterPro
P05107	ITGB2	Integrin beta-2	GO:0030593; P:neutrophil chemotaxis; IDA:UniProtKB
P05107	ITGB2	Integrin beta-2	GO:0008360; P:regulation of cell shape; NAS:UniProtKB
P05107	ITGB2	Integrin beta-2	GO:0050776; P:regulation of immune response; TAS:Reactome
P05107	ITGB2	Integrin beta-2	GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P05107	ITGB2	Integrin beta-2	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P05107	ITGB2	Integrin beta-2	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P05106	ITGB3	Integrin beta-3	GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL
P05106	ITGB3	Integrin beta-3	GO:0042802; F:identical protein binding; IPI:IntAct
P05106	ITGB3	Integrin beta-3	GO:0005161; F:platelet-derived growth factor receptor binding; TAS:BHF-UCL
P05106	ITGB3	Integrin beta-3	GO:0005515; F:protein binding; IPI:UniProtKB
P05106	ITGB3	Integrin beta-3	GO:0003756; F:protein disulfide isomerase activity; IDA:UniProtKB
P05106	ITGB3	Integrin beta-3	GO:0004872; F:receptor activity; IEA:InterPro
P05106	ITGB3	Integrin beta-3	GO:0043184; F:vascular endothelial growth factor receptor 2 binding; IPI:BHF-UCL
P05106	ITGB3	Integrin beta-3	GO:0032147; P:activation of protein kinase activity; IMP:BHF-UCL
P05106	ITGB3	Integrin beta-3	GO:0060055; P:angiogenesis involved in wound healing; TAS:BHF-UCL
P05106	ITGB3	Integrin beta-3	GO:0007411; P:axon guidance; TAS:Reactome
P05106	ITGB3	Integrin beta-3	GO:0007596; P:blood coagulation; TAS:Reactome
P05106	ITGB3	Integrin beta-3	GO:0007155; P:cell adhesion; TAS:ProtInc
P05106	ITGB3	Integrin beta-3	GO:0007160; P:cell-matrix adhesion; IEA:InterPro
P05106	ITGB3	Integrin beta-3	GO:0007044; P:cell-substrate junction assembly; IEA:InterPro
P05106	ITGB3	Integrin beta-3	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P05106	ITGB3	Integrin beta-3	GO:0007229; P:integrin-mediated signaling pathway; TAS:BHF-UCL
P05106	ITGB3	Integrin beta-3	GO:0050900; P:leukocyte migration; TAS:Reactome
P05106	ITGB3	Integrin beta-3	GO:0010888; P:negative regulation of lipid storage; IMP:BHF-UCL
P05106	ITGB3	Integrin beta-3	GO:0032369; P:negative regulation of lipid transport; IMP:BHF-UCL
P05106	ITGB3	Integrin beta-3	GO:0050748; P:negative regulation of lipoprotein metabolic process; IMP:BHF-UCL
P05106	ITGB3	Integrin beta-3	GO:0045715; P:negative regulation of low-density lipoprotein particle receptor biosynthetic process; IMP:BHF-UCL
P05106	ITGB3	Integrin beta-3	GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; IMP:BHF-UCL
P05106	ITGB3	Integrin beta-3	GO:0030168; P:platelet activation; IMP:UniProtKB
P05106	ITGB3	Integrin beta-3	GO:0070527; P:platelet aggregation; IMP:UniProtKB
P05106	ITGB3	Integrin beta-3	GO:0002576; P:platelet degranulation; TAS:Reactome
P05106	ITGB3	Integrin beta-3	GO:0010595; P:positive regulation of endothelial cell migration; IMP:BHF-UCL
P05106	ITGB3	Integrin beta-3	GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:BHF-UCL
P05106	ITGB3	Integrin beta-3	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IMP:BHF-UCL
P05106	ITGB3	Integrin beta-3	GO:0001934; P:positive regulation of protein phosphorylation; TAS:BHF-UCL
P05106	ITGB3	Integrin beta-3	GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; TAS:BHF-UCL
P05106	ITGB3	Integrin beta-3	GO:0006457; P:protein folding; IDA:GOC
P05106	ITGB3	Integrin beta-3	GO:0045124; P:regulation of bone resorption; TAS:BHF-UCL
P05106	ITGB3	Integrin beta-3	GO:0014909; P:smooth muscle cell migration; IMP:BHF-UCL
P05106	ITGB3	Integrin beta-3	GO:0035295; P:tube development; TAS:BHF-UCL
P05106	ITGB3	Integrin beta-3	GO:0016032; P:viral process; IEA:UniProtKB-KW
P05106	ITGB3	Integrin beta-3	GO:0042060; P:wound healing; IC:BHF-UCL
P16144	ITGB4	Integrin beta-4	GO:0005515; F:protein binding; IPI:UniProtKB
P16144	ITGB4	Integrin beta-4	GO:0004872; F:receptor activity; IEA:InterPro
P16144	ITGB4	Integrin beta-4	GO:0007155; P:cell adhesion; NAS:ProtInc
P16144	ITGB4	Integrin beta-4	GO:0034329; P:cell junction assembly; TAS:Reactome
P16144	ITGB4	Integrin beta-4	GO:0048870; P:cell motility; IMP:UniProtKB
P16144	ITGB4	Integrin beta-4	GO:0007160; P:cell-matrix adhesion; IEA:InterPro
P16144	ITGB4	Integrin beta-4	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P16144	ITGB4	Integrin beta-4	GO:0046847; P:filopodium assembly; IEA:Ensembl
P16144	ITGB4	Integrin beta-4	GO:0031581; P:hemidesmosome assembly; IDA:UniProtKB
P16144	ITGB4	Integrin beta-4	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P16144	ITGB4	Integrin beta-4	GO:0007275; P:multicellular organismal development; IEA:InterPro
P16144	ITGB4	Integrin beta-4	GO:0009611; P:response to wounding; IDA:UniProtKB
P18084	ITGB5	Integrin beta-5	GO:0005515; F:protein binding; IPI:IntAct
P18084	ITGB5	Integrin beta-5	GO:0004872; F:receptor activity; IEA:InterPro
P18084	ITGB5	Integrin beta-5	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P18084	ITGB5	Integrin beta-5	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P18084	ITGB5	Integrin beta-5	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P18084	ITGB5	Integrin beta-5	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P18084	ITGB5	Integrin beta-5	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P18084	ITGB5	Integrin beta-5	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P18084	ITGB5	Integrin beta-5	GO:0007275; P:multicellular organismal development; IEA:InterPro
P18084	ITGB5	Integrin beta-5	GO:0006936; P:muscle contraction; TAS:Reactome
P18564	ITGB6	Integrin beta-6	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
P18564	ITGB6	Integrin beta-6	GO:0007155; P:cell adhesion; TAS:ProtInc
P18564	ITGB6	Integrin beta-6	GO:0007160; P:cell-matrix adhesion; IEA:InterPro
P18564	ITGB6	Integrin beta-6	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P18564	ITGB6	Integrin beta-6	GO:0006954; P:inflammatory response; IEA:Ensembl
P18564	ITGB6	Integrin beta-6	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P18564	ITGB6	Integrin beta-6	GO:0007275; P:multicellular organismal development; IEA:InterPro
P18564	ITGB6	Integrin beta-6	GO:0016032; P:viral process; IEA:UniProtKB-KW
P26010	ITGB7	Integrin beta-7	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P26010	ITGB7	Integrin beta-7	GO:0005515; F:protein binding; IPI:IntAct
P26010	ITGB7	Integrin beta-7	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
P26010	ITGB7	Integrin beta-7	GO:0007155; P:cell adhesion; TAS:ProtInc
P26010	ITGB7	Integrin beta-7	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P26010	ITGB7	Integrin beta-7	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P26010	ITGB7	Integrin beta-7	GO:0050900; P:leukocyte migration; IEA:Ensembl
P26010	ITGB7	Integrin beta-7	GO:0007275; P:multicellular organismal development; IEA:InterPro
P26010	ITGB7	Integrin beta-7	GO:0050776; P:regulation of immune response; TAS:Reactome
P26012	ITGB8	Integrin beta-8	GO:0004872; F:receptor activity; IEA:InterPro
P26012	ITGB8	Integrin beta-8	GO:0007155; P:cell adhesion; TAS:ProtInc
P26012	ITGB8	Integrin beta-8	GO:0007160; P:cell-matrix adhesion; IEA:InterPro
P26012	ITGB8	Integrin beta-8	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P26012	ITGB8	Integrin beta-8	GO:0001573; P:ganglioside metabolic process; IEA:Ensembl
P26012	ITGB8	Integrin beta-8	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P26012	ITGB8	Integrin beta-8	GO:0060674; P:placenta blood vessel development; TAS:BHF-UCL
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0005092; F:GDP-dissociation inhibitor activity; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0005178; F:integrin binding; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0032403; F:protein complex binding; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0008565; F:protein transporter activity; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0032148; P:activation of protein kinase B activity; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0002043; P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0016477; P:cell migration; TAS:HGNC
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0007160; P:cell-matrix adhesion; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0044344; P:cellular response to fibroblast growth factor stimulus; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0033622; P:integrin activation; ISS:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0007229; P:integrin-mediated signaling pathway; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0051451; P:myoblast migration; ISS:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0006933; P:negative regulation of cell adhesion involved in substrate-bound cell migration; ISS:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0090051; P:negative regulation of cell migration involved in sprouting angiogenesis; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0010764; P:negative regulation of fibroblast migration; ISS:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0051895; P:negative regulation of focal adhesion assembly; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0032091; P:negative regulation of protein binding; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0006469; P:negative regulation of protein kinase activity; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0090315; P:negative regulation of protein targeting to membrane; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:1900025; P:negative regulation of substrate adhesion-dependent cell spreading; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0010595; P:positive regulation of endothelial cell migration; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0051894; P:positive regulation of focal adhesion assembly; IEA:Ensembl
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0045747; P:positive regulation of Notch signaling pathway; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0090314; P:positive regulation of protein targeting to membrane; ISS:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0051496; P:positive regulation of stress fiber assembly; ISS:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0015031; P:protein transport; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0043113; P:receptor clustering; ISS:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0050880; P:regulation of blood vessel size; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0043088; P:regulation of Cdc42 GTPase activity; IDA:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0033628; P:regulation of cell adhesion mediated by integrin; ISS:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:2001044; P:regulation of integrin-mediated signaling pathway; ISS:UniProtKB
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O14713	ITGB1BP1	Integrin beta-1-binding protein 1	GO:0035148; P:tube formation; IDA:UniProtKB
Q9UKP3	ITGB1BP2	Integrin beta-1-binding protein 2	GO:0005509; F:calcium ion binding; IEA:Ensembl
Q9UKP3	ITGB1BP2	Integrin beta-1-binding protein 2	GO:0008270; F:zinc ion binding; IEA:Ensembl
Q9UKP3	ITGB1BP2	Integrin beta-1-binding protein 2	GO:0007517; P:muscle organ development; TAS:ProtInc
Q9UKP3	ITGB1BP2	Integrin beta-1-binding protein 2	GO:0007165; P:signal transduction; TAS:ProtInc
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0045236; F:CXCR chemokine receptor binding; IPI:UniProtKB
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0005515; F:protein binding; IPI:IntAct
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0043021; F:ribonucleoprotein complex binding; IPI:UniProtKB
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0006954; P:inflammatory response; NAS:UniProtKB
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0045087; P:innate immune response; TAS:Reactome
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0046642; P:negative regulation of alpha-beta T cell proliferation; IEA:Ensembl
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0050687; P:negative regulation of defense response to virus; IMP:UniProtKB
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0046329; P:negative regulation of JNK cascade; ISS:BHF-UCL
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; ISS:BHF-UCL
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0002669; P:positive regulation of T cell anergy; IEA:Ensembl
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0035519; P:protein K29-linked ubiquitination; IDA:UniProtKB
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:RefGenome
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0090085; P:regulation of protein deubiquitination; ISS:BHF-UCL
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0006511; P:ubiquitin-dependent protein catabolic process; NAS:UniProtKB
Q96J02	ITCH	E3 ubiquitin-protein ligase Itchy homolog	GO:0046718; P:viral entry into host cell; TAS:UniProtKB
P15884	TCF4	Transcription factor 4	GO:0003677; F:DNA binding; IDA:UniProtKB
P15884	TCF4	Transcription factor 4	GO:0070888; F:E-box binding; ISS:UniProtKB
P15884	TCF4	Transcription factor 4	GO:0005515; F:protein binding; IPI:IntAct
P15884	TCF4	Transcription factor 4	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P15884	TCF4	Transcription factor 4	GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB
P15884	TCF4	Transcription factor 4	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; ISS:BHF-UCL
P15884	TCF4	Transcription factor 4	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; ISS:BHF-UCL
P15884	TCF4	Transcription factor 4	GO:0001011; F:sequence-specific DNA binding RNA polymerase recruiting transcription factor activity; ISS:BHF-UCL
P15884	TCF4	Transcription factor 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P15884	TCF4	Transcription factor 4	GO:0001087; F:TFIIB-class binding transcription factor activity; ISS:BHF-UCL
P15884	TCF4	Transcription factor 4	GO:0001093; F:TFIIB-class transcription factor binding; ISS:BHF-UCL
P15884	TCF4	Transcription factor 4	GO:0006352; P:DNA-templated transcription, initiation; ISS:BHF-UCL
P15884	TCF4	Transcription factor 4	GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB
P15884	TCF4	Transcription factor 4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P15884	TCF4	Transcription factor 4	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P15884	TCF4	Transcription factor 4	GO:0065004; P:protein-DNA complex assembly; ISS:BHF-UCL
P15884	TCF4	Transcription factor 4	GO:0006367; P:transcription initiation from RNA polymerase II promoter; ISS:BHF-UCL
O95965	ITGBL1	Integrin beta-like protein 1	GO:0007155; P:cell adhesion; TAS:ProtInc
O95965	ITGBL1	Integrin beta-like protein 1	GO:0007229; P:integrin-mediated signaling pathway; IEA:UniProtKB-KW
P19827	ITIH1	Inter-alpha-trypsin inhibitor heavy chain H1	GO:0005509; F:calcium ion binding; TAS:ProtInc
P19827	ITIH1	Inter-alpha-trypsin inhibitor heavy chain H1	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
P19827	ITIH1	Inter-alpha-trypsin inhibitor heavy chain H1	GO:0030212; P:hyaluronan metabolic process; IEA:InterPro
P19823	ITIH2	Inter-alpha-trypsin inhibitor heavy chain H2	GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc
P19823	ITIH2	Inter-alpha-trypsin inhibitor heavy chain H2	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
P19823	ITIH2	Inter-alpha-trypsin inhibitor heavy chain H2	GO:0030212; P:hyaluronan metabolic process; IEA:InterPro
P19823	ITIH2	Inter-alpha-trypsin inhibitor heavy chain H2	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
Q06033	ITIH3	Inter-alpha-trypsin inhibitor heavy chain H3	GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc
Q06033	ITIH3	Inter-alpha-trypsin inhibitor heavy chain H3	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q06033	ITIH3	Inter-alpha-trypsin inhibitor heavy chain H3	GO:0030212; P:hyaluronan metabolic process; IEA:InterPro
Q06033	ITIH3	Inter-alpha-trypsin inhibitor heavy chain H3	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
Q14624	ITIH4	Inter-alpha-trypsin inhibitor heavy chain H4	GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc
Q14624	ITIH4	Inter-alpha-trypsin inhibitor heavy chain H4	GO:0005515; F:protein binding; IPI:UniProtKB
Q14624	ITIH4	Inter-alpha-trypsin inhibitor heavy chain H4	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q14624	ITIH4	Inter-alpha-trypsin inhibitor heavy chain H4	GO:0006953; P:acute-phase response; IEP:UniProtKB
Q14624	ITIH4	Inter-alpha-trypsin inhibitor heavy chain H4	GO:0030212; P:hyaluronan metabolic process; IEA:InterPro
Q14624	ITIH4	Inter-alpha-trypsin inhibitor heavy chain H4	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
Q14624	ITIH4	Inter-alpha-trypsin inhibitor heavy chain H4	GO:0034097; P:response to cytokine; IEP:UniProtKB
Q86UX2	ITIH5	Inter-alpha-trypsin inhibitor heavy chain H5	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q86UX2	ITIH5	Inter-alpha-trypsin inhibitor heavy chain H5	GO:0030212; P:hyaluronan metabolic process; IEA:InterPro
Q6UXX5	ITIH6	Inter-alpha-trypsin inhibitor heavy chain H6	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q6UXX5	ITIH6	Inter-alpha-trypsin inhibitor heavy chain H6	GO:0030212; P:hyaluronan metabolic process; IEA:InterPro
Q08881	ITK	Tyrosine-protein kinase ITK/TSK	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q08881	ITK	Tyrosine-protein kinase ITK/TSK	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q08881	ITK	Tyrosine-protein kinase ITK/TSK	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB
Q08881	ITK	Tyrosine-protein kinase ITK/TSK	GO:0005515; F:protein binding; IPI:UniProtKB
Q08881	ITK	Tyrosine-protein kinase ITK/TSK	GO:0007202; P:activation of phospholipase C activity; ISS:UniProtKB
Q08881	ITK	Tyrosine-protein kinase ITK/TSK	GO:0002250; P:adaptive immune response; ISS:UniProtKB
Q08881	ITK	Tyrosine-protein kinase ITK/TSK	GO:0006968; P:cellular defense response; TAS:ProtInc
Q08881	ITK	Tyrosine-protein kinase ITK/TSK	GO:0001816; P:cytokine production; ISS:UniProtKB
Q08881	ITK	Tyrosine-protein kinase ITK/TSK	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q08881	ITK	Tyrosine-protein kinase ITK/TSK	GO:0045087; P:innate immune response; TAS:Reactome
Q08881	ITK	Tyrosine-protein kinase ITK/TSK	GO:0032609; P:interferon-gamma production; IEA:Ensembl
Q08881	ITK	Tyrosine-protein kinase ITK/TSK	GO:0032633; P:interleukin-4 production; IEA:Ensembl
Q08881	ITK	Tyrosine-protein kinase ITK/TSK	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q08881	ITK	Tyrosine-protein kinase ITK/TSK	GO:0001865; P:NK T cell differentiation; IEA:Ensembl
Q08881	ITK	Tyrosine-protein kinase ITK/TSK	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:GOC
Q08881	ITK	Tyrosine-protein kinase ITK/TSK	GO:0007165; P:signal transduction; TAS:ProtInc
Q08881	ITK	Tyrosine-protein kinase ITK/TSK	GO:0042110; P:T cell activation; TAS:UniProtKB
Q08881	ITK	Tyrosine-protein kinase ITK/TSK	GO:0050852; P:T cell receptor signaling pathway; ISS:UniProtKB
O43736	ITM2A	Integral membrane protein 2A	GO:0005515; F:protein binding; IPI:IntAct
Q9Y287	ITM2B	Integral membrane protein 2B	GO:0005524; F:ATP binding; IEA:Ensembl
Q9Y287	ITM2B	Integral membrane protein 2B	GO:0001540; F:beta-amyloid binding; IPI:BHF-UCL
Q9Y287	ITM2B	Integral membrane protein 2B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y287	ITM2B	Integral membrane protein 2B	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
Q9Y287	ITM2B	Integral membrane protein 2B	GO:0042985; P:negative regulation of amyloid precursor protein biosynthetic process; IDA:UniProtKB
Q9Y287	ITM2B	Integral membrane protein 2B	GO:0007399; P:nervous system development; TAS:ProtInc
Q8WWA0	ITLN1	Intelectin-1	GO:0046326; P:positive regulation of glucose import; IDA:UniProtKB
Q8WWA0	ITLN1	Intelectin-1	GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB
Q8WWA0	ITLN1	Intelectin-1	GO:0009624; P:response to nematode; ISS:UniProtKB
Q9NQX7	ITM2C	Integral membrane protein 2C	GO:0005524; F:ATP binding; IEA:Ensembl
Q9NQX7	ITM2C	Integral membrane protein 2C	GO:0001540; F:beta-amyloid binding; IPI:BHF-UCL
Q9NQX7	ITM2C	Integral membrane protein 2C	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NQX7	ITM2C	Integral membrane protein 2C	GO:0010977; P:negative regulation of neuron projection development; IDA:UniProtKB
Q9NQX7	ITM2C	Integral membrane protein 2C	GO:0030182; P:neuron differentiation; IDA:UniProtKB
Q9NQX7	ITM2C	Integral membrane protein 2C	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl
Q9BY32	ITPA	Inosine triphosphate pyrophosphatase	GO:0035870; F:dITP diphosphatase activity; EXP:Reactome
Q9BY32	ITPA	Inosine triphosphate pyrophosphatase	GO:0036220; F:ITP diphosphatase activity; EXP:Reactome
Q9BY32	ITPA	Inosine triphosphate pyrophosphatase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BY32	ITPA	Inosine triphosphate pyrophosphatase	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
Q9BY32	ITPA	Inosine triphosphate pyrophosphatase	GO:0036222; F:XTP diphosphatase activity; EXP:Reactome
Q9BY32	ITPA	Inosine triphosphate pyrophosphatase	GO:0051276; P:chromosome organization; IEA:Ensembl
Q9BY32	ITPA	Inosine triphosphate pyrophosphatase	GO:0009204; P:deoxyribonucleoside triphosphate catabolic process; IEA:UniProtKB-HAMAP
Q9BY32	ITPA	Inosine triphosphate pyrophosphatase	GO:0006193; P:ITP catabolic process; IEA:Ensembl
Q9BY32	ITPA	Inosine triphosphate pyrophosphatase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q9BY32	ITPA	Inosine triphosphate pyrophosphatase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q13572	ITPK1	Inositol-tetrakisphosphate 1-kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13572	ITPK1	Inositol-tetrakisphosphate 1-kinase	GO:0003824; F:catalytic activity; TAS:ProtInc
Q13572	ITPK1	Inositol-tetrakisphosphate 1-kinase	GO:0047325; F:inositol tetrakisphosphate 1-kinase activity; TAS:Reactome
Q13572	ITPK1	Inositol-tetrakisphosphate 1-kinase	GO:0052825; F:inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity; TAS:Reactome
Q13572	ITPK1	Inositol-tetrakisphosphate 1-kinase	GO:0052831; F:inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity; TAS:Reactome
Q13572	ITPK1	Inositol-tetrakisphosphate 1-kinase	GO:0052830; F:inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity; TAS:Reactome
Q13572	ITPK1	Inositol-tetrakisphosphate 1-kinase	GO:0052726; F:inositol-1,3,4-trisphosphate 5-kinase activity; TAS:Reactome
Q13572	ITPK1	Inositol-tetrakisphosphate 1-kinase	GO:0052725; F:inositol-1,3,4-trisphosphate 6-kinase activity; TAS:Reactome
Q13572	ITPK1	Inositol-tetrakisphosphate 1-kinase	GO:0052835; F:inositol-3,4,6-trisphosphate 1-kinase activity; TAS:Reactome
Q13572	ITPK1	Inositol-tetrakisphosphate 1-kinase	GO:0016853; F:isomerase activity; IEA:UniProtKB-KW
Q13572	ITPK1	Inositol-tetrakisphosphate 1-kinase	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q13572	ITPK1	Inositol-tetrakisphosphate 1-kinase	GO:0007596; P:blood coagulation; TAS:Reactome
Q13572	ITPK1	Inositol-tetrakisphosphate 1-kinase	GO:0016311; P:dephosphorylation; TAS:GOC
Q13572	ITPK1	Inositol-tetrakisphosphate 1-kinase	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q13572	ITPK1	Inositol-tetrakisphosphate 1-kinase	GO:0032957; P:inositol trisphosphate metabolic process; IEA:InterPro
Q13572	ITPK1	Inositol-tetrakisphosphate 1-kinase	GO:0007165; P:signal transduction; TAS:ProtInc
Q13572	ITPK1	Inositol-tetrakisphosphate 1-kinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0015085; F:calcium ion transmembrane transporter activity; TAS:ProtInc
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0005220; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; ISS:UniProtKB
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0005218; F:intracellular ligand-gated calcium channel activity; ISS:UniProtKB
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0035091; F:phosphatidylinositol binding; ISS:UniProtKB
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0006816; P:calcium ion transport; NAS:UniProtKB
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; IEA:Ensembl
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0045087; P:innate immune response; TAS:Reactome
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0048016; P:inositol phosphate-mediated signaling; ISS:GOC
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISS:UniProtKB
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0030168; P:platelet activation; TAS:Reactome
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0051209; P:release of sequestered calcium ion into cytosol; ISS:UniProtKB
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0001666; P:response to hypoxia; IDA:BHF-UCL
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0007165; P:signal transduction; NAS:UniProtKB
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14643	ITPR1	Inositol 1,4,5-trisphosphate receptor type 1	GO:0050882; P:voluntary musculoskeletal movement; IEA:Ensembl
Q14571	ITPR2	Inositol 1,4,5-trisphosphate receptor type 2	GO:0015085; F:calcium ion transmembrane transporter activity; TAS:ProtInc
Q14571	ITPR2	Inositol 1,4,5-trisphosphate receptor type 2	GO:0005220; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; TAS:ProtInc
Q14571	ITPR2	Inositol 1,4,5-trisphosphate receptor type 2	GO:0035091; F:phosphatidylinositol binding; IEA:Ensembl
Q14571	ITPR2	Inositol 1,4,5-trisphosphate receptor type 2	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
Q14571	ITPR2	Inositol 1,4,5-trisphosphate receptor type 2	GO:0007596; P:blood coagulation; TAS:Reactome
Q14571	ITPR2	Inositol 1,4,5-trisphosphate receptor type 2	GO:0071320; P:cellular response to cAMP; IEA:Ensembl
Q14571	ITPR2	Inositol 1,4,5-trisphosphate receptor type 2	GO:0071361; P:cellular response to ethanol; IEA:Ensembl
Q14571	ITPR2	Inositol 1,4,5-trisphosphate receptor type 2	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q14571	ITPR2	Inositol 1,4,5-trisphosphate receptor type 2	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q14571	ITPR2	Inositol 1,4,5-trisphosphate receptor type 2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q14571	ITPR2	Inositol 1,4,5-trisphosphate receptor type 2	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q14571	ITPR2	Inositol 1,4,5-trisphosphate receptor type 2	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q14571	ITPR2	Inositol 1,4,5-trisphosphate receptor type 2	GO:0045087; P:innate immune response; TAS:Reactome
Q14571	ITPR2	Inositol 1,4,5-trisphosphate receptor type 2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q14571	ITPR2	Inositol 1,4,5-trisphosphate receptor type 2	GO:0030168; P:platelet activation; TAS:Reactome
Q14571	ITPR2	Inositol 1,4,5-trisphosphate receptor type 2	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
Q14571	ITPR2	Inositol 1,4,5-trisphosphate receptor type 2	GO:0001666; P:response to hypoxia; IDA:BHF-UCL
Q14571	ITPR2	Inositol 1,4,5-trisphosphate receptor type 2	GO:0007165; P:signal transduction; TAS:Reactome
Q14571	ITPR2	Inositol 1,4,5-trisphosphate receptor type 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14571	ITPR2	Inositol 1,4,5-trisphosphate receptor type 2	GO:0006810; P:transport; TAS:ProtInc
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0043533; F:inositol 1,3,4,5 tetrakisphosphate binding; ISS:BHF-UCL
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0070679; F:inositol 1,4,5 trisphosphate binding; IDA:BHF-UCL
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0005220; F:inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; ISS:UniProtKB
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0000822; F:inositol hexakisphosphate binding; ISS:BHF-UCL
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0005218; F:intracellular ligand-gated calcium channel activity; ISS:UniProtKB
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0035091; F:phosphatidylinositol binding; IEA:Ensembl
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0007596; P:blood coagulation; TAS:Reactome
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0060402; P:calcium ion transport into cytosol; ISS:UniProtKB
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0007186; P:G-protein coupled receptor signaling pathway; ISS:BHF-UCL
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0045087; P:innate immune response; TAS:Reactome
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0007613; P:memory; IEA:Ensembl
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0030168; P:platelet activation; TAS:Reactome
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISS:BHF-UCL
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0051291; P:protein heterooligomerization; ISS:BHF-UCL
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0051260; P:protein homooligomerization; ISS:BHF-UCL
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0051592; P:response to calcium ion; IDA:BHF-UCL
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0050913; P:sensory perception of bitter taste; IEA:Ensembl
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0050916; P:sensory perception of sweet taste; IEA:Ensembl
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0050917; P:sensory perception of umami taste; IEA:Ensembl
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0007165; P:signal transduction; TAS:Reactome
Q14573	ITPR3	Inositol 1,4,5-trisphosphate receptor type 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15811	ITSN1	Intersectin-1	GO:0005509; F:calcium ion binding; NAS:UniProtKB
Q15811	ITSN1	Intersectin-1	GO:0005085; F:guanyl-nucleotide exchange factor activity; NAS:UniProtKB
Q15811	ITSN1	Intersectin-1	GO:0019209; F:kinase activator activity; IEA:Ensembl
Q15811	ITSN1	Intersectin-1	GO:0070064; F:proline-rich region binding; IPI:UniProtKB
Q15811	ITSN1	Intersectin-1	GO:0005515; F:protein binding; IPI:IntAct
Q15811	ITSN1	Intersectin-1	GO:0032947; F:protein complex scaffold; IDA:UniProtKB
Q15811	ITSN1	Intersectin-1	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q15811	ITSN1	Intersectin-1	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q15811	ITSN1	Intersectin-1	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q15811	ITSN1	Intersectin-1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q15811	ITSN1	Intersectin-1	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q15811	ITSN1	Intersectin-1	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
Q15811	ITSN1	Intersectin-1	GO:0043087; P:regulation of GTPase activity; NAS:GOC
Q15811	ITSN1	Intersectin-1	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q15811	ITSN1	Intersectin-1	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q15811	ITSN1	Intersectin-1	GO:0048488; P:synaptic vesicle endocytosis; TAS:ProtInc
Q9NZM3	ITSN2	Intersectin-2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NZM3	ITSN2	Intersectin-2	GO:0005515; F:protein binding; IPI:IntAct
Q9NZM3	ITSN2	Intersectin-2	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q9NZM3	ITSN2	Intersectin-2	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
Q9NZM3	ITSN2	Intersectin-2	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q9NZM3	ITSN2	Intersectin-2	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
P26440	IVD	Isovaleryl-CoA dehydrogenase, mitochondrial	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
P26440	IVD	Isovaleryl-CoA dehydrogenase, mitochondrial	GO:0008470; F:isovaleryl-CoA dehydrogenase activity; ISS:BHF-UCL
P26440	IVD	Isovaleryl-CoA dehydrogenase, mitochondrial	GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome
P26440	IVD	Isovaleryl-CoA dehydrogenase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P26440	IVD	Isovaleryl-CoA dehydrogenase, mitochondrial	GO:0006552; P:leucine catabolic process; ISS:BHF-UCL
P26440	IVD	Isovaleryl-CoA dehydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96ST2	IWS1	Protein IWS1 homolog	GO:0003677; F:DNA binding; IEA:InterPro
Q96ST2	IWS1	Protein IWS1 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q96ST2	IWS1	Protein IWS1 homolog	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q96ST2	IWS1	Protein IWS1 homolog	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q96ST2	IWS1	Protein IWS1 homolog	GO:2001253; P:regulation of histone H3-K36 trimethylation; IMP:UniProtKB
Q96ST2	IWS1	Protein IWS1 homolog	GO:0090239; P:regulation of histone H4 acetylation; IMP:UniProtKB
Q96ST2	IWS1	Protein IWS1 homolog	GO:0010793; P:regulation of mRNA export from nucleus; IMP:UniProtKB
Q96ST2	IWS1	Protein IWS1 homolog	GO:0050684; P:regulation of mRNA processing; IMP:UniProtKB
Q96ST2	IWS1	Protein IWS1 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96ST2	IWS1	Protein IWS1 homolog	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q96ST2	IWS1	Protein IWS1 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6PHW0	IYD	Iodotyrosine dehalogenase 1	GO:0004447; F:iodide peroxidase activity; IEA:Ensembl
Q6PHW0	IYD	Iodotyrosine dehalogenase 1	GO:0016491; F:oxidoreductase activity; TAS:Reactome
Q6PHW0	IYD	Iodotyrosine dehalogenase 1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q6PHW0	IYD	Iodotyrosine dehalogenase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6PHW0	IYD	Iodotyrosine dehalogenase 1	GO:0006590; P:thyroid hormone generation; TAS:Reactome
Q8IYV9	IZUMO1	Izumo sperm-egg fusion protein 1	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q8IYV9	IZUMO1	Izumo sperm-egg fusion protein 1	GO:0007155; P:cell adhesion; IC:HGNC
Q8IYV9	IZUMO1	Izumo sperm-egg fusion protein 1	GO:0007342; P:fusion of sperm to egg plasma membrane; IDA:HGNC
Q8IYV9	IZUMO1	Izumo sperm-egg fusion protein 1	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
Q8IYV9	IZUMO1	Izumo sperm-egg fusion protein 1	GO:0007338; P:single fertilization; TAS:Reactome
Q5VZ72	IZUMO3	Izumo sperm-egg fusion protein 3	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q6IE81	JADE1	Protein Jade-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q6IE81	JADE1	Protein Jade-1	GO:0001105; F:RNA polymerase II transcription coactivator activity; IDA:MGI
Q6IE81	JADE1	Protein Jade-1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6IE81	JADE1	Protein Jade-1	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q6IE81	JADE1	Protein Jade-1	GO:0006325; P:chromatin organization; TAS:Reactome
Q6IE81	JADE1	Protein Jade-1	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
Q6IE81	JADE1	Protein Jade-1	GO:0043983; P:histone H4-K12 acetylation; IDA:UniProtKB
Q6IE81	JADE1	Protein Jade-1	GO:0043981; P:histone H4-K5 acetylation; IDA:UniProtKB
Q6IE81	JADE1	Protein Jade-1	GO:0043982; P:histone H4-K8 acetylation; IDA:UniProtKB
Q6IE81	JADE1	Protein Jade-1	GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB
Q6IE81	JADE1	Protein Jade-1	GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IDA:MGI
Q6IE81	JADE1	Protein Jade-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:GOC
Q6IE81	JADE1	Protein Jade-1	GO:0006950; P:response to stress; NAS:UniProtKB
Q92613	JADE3	Protein Jade-3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q92613	JADE3	Protein Jade-3	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
Q92613	JADE3	Protein Jade-3	GO:0043983; P:histone H4-K12 acetylation; IDA:UniProtKB
Q92613	JADE3	Protein Jade-3	GO:0043981; P:histone H4-K5 acetylation; IDA:UniProtKB
Q92613	JADE3	Protein Jade-3	GO:0043982; P:histone H4-K8 acetylation; IDA:UniProtKB
Q9NQC1	JADE2	Protein Jade-2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NQC1	JADE2	Protein Jade-2	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
Q9NQC1	JADE2	Protein Jade-2	GO:0043983; P:histone H4-K12 acetylation; IDA:UniProtKB
Q9NQC1	JADE2	Protein Jade-2	GO:0043981; P:histone H4-K5 acetylation; IDA:UniProtKB
Q9NQC1	JADE2	Protein Jade-2	GO:0043982; P:histone H4-K8 acetylation; IDA:UniProtKB
P78504	JAG1	Protein jagged-1	GO:0005509; F:calcium ion binding; IEA:InterPro
P78504	JAG1	Protein jagged-1	GO:0008083; F:growth factor activity; NAS:UniProtKB
P78504	JAG1	Protein jagged-1	GO:0005112; F:Notch binding; NAS:UniProtKB
P78504	JAG1	Protein jagged-1	GO:0005515; F:protein binding; IPI:IntAct
P78504	JAG1	Protein jagged-1	GO:0005198; F:structural molecule activity; NAS:UniProtKB
P78504	JAG1	Protein jagged-1	GO:0001525; P:angiogenesis; NAS:UniProtKB
P78504	JAG1	Protein jagged-1	GO:0035909; P:aorta morphogenesis; ISS:BHF-UCL
P78504	JAG1	Protein jagged-1	GO:0042491; P:auditory receptor cell differentiation; IEA:Ensembl
P78504	JAG1	Protein jagged-1	GO:0061309; P:cardiac neural crest cell development involved in outflow tract morphogenesis; ISS:BHF-UCL
P78504	JAG1	Protein jagged-1	GO:0003215; P:cardiac right ventricle morphogenesis; ISS:BHF-UCL
P78504	JAG1	Protein jagged-1	GO:0060411; P:cardiac septum morphogenesis; ISS:BHF-UCL
P78504	JAG1	Protein jagged-1	GO:0001709; P:cell fate determination; NAS:UniProtKB
P78504	JAG1	Protein jagged-1	GO:0072017; P:distal tubule development; IEA:Ensembl
P78504	JAG1	Protein jagged-1	GO:0061444; P:endocardial cushion cell development; ISS:BHF-UCL
P78504	JAG1	Protein jagged-1	GO:0045446; P:endothelial cell differentiation; NAS:UniProtKB
P78504	JAG1	Protein jagged-1	GO:0030097; P:hemopoiesis; NAS:UniProtKB
P78504	JAG1	Protein jagged-1	GO:0030216; P:keratinocyte differentiation; NAS:UniProtKB
P78504	JAG1	Protein jagged-1	GO:0072070; P:loop of Henle development; IEA:Ensembl
P78504	JAG1	Protein jagged-1	GO:0002011; P:morphogenesis of an epithelial sheet; IEA:Ensembl
P78504	JAG1	Protein jagged-1	GO:0045445; P:myoblast differentiation; NAS:UniProtKB
P78504	JAG1	Protein jagged-1	GO:0045599; P:negative regulation of fat cell differentiation; IEA:Ensembl
P78504	JAG1	Protein jagged-1	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
P78504	JAG1	Protein jagged-1	GO:2000737; P:negative regulation of stem cell differentiation; IMP:UniProtKB
P78504	JAG1	Protein jagged-1	GO:0007399; P:nervous system development; NAS:UniProtKB
P78504	JAG1	Protein jagged-1	GO:0097150; P:neuronal stem cell maintenance; IEP:UniProtKB
P78504	JAG1	Protein jagged-1	GO:0007220; P:Notch receptor processing; TAS:Reactome
P78504	JAG1	Protein jagged-1	GO:0061314; P:Notch signaling involved in heart development; IMP:BHF-UCL
P78504	JAG1	Protein jagged-1	GO:0007219; P:Notch signaling pathway; IMP:UniProtKB
P78504	JAG1	Protein jagged-1	GO:0045639; P:positive regulation of myeloid cell differentiation; IEA:Ensembl
P78504	JAG1	Protein jagged-1	GO:0045747; P:positive regulation of Notch signaling pathway; IEA:Ensembl
P78504	JAG1	Protein jagged-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P78504	JAG1	Protein jagged-1	GO:0061156; P:pulmonary artery morphogenesis; IMP:BHF-UCL
P78504	JAG1	Protein jagged-1	GO:0003184; P:pulmonary valve morphogenesis; IMP:BHF-UCL
P78504	JAG1	Protein jagged-1	GO:0030334; P:regulation of cell migration; NAS:UniProtKB
P78504	JAG1	Protein jagged-1	GO:0042127; P:regulation of cell proliferation; NAS:UniProtKB
P78504	JAG1	Protein jagged-1	GO:0032495; P:response to muramyl dipeptide; IEA:Ensembl
P78504	JAG1	Protein jagged-1	GO:0002456; P:T cell mediated immunity; IMP:UniProt
Q9Y219	JAG2	Protein jagged-2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y219	JAG2	Protein jagged-2	GO:0008083; F:growth factor activity; IDA:UniProtKB
Q9Y219	JAG2	Protein jagged-2	GO:0005112; F:Notch binding; IPI:UniProtKB
Q9Y219	JAG2	Protein jagged-2	GO:0005515; F:protein binding; IPI:IntAct
Q9Y219	JAG2	Protein jagged-2	GO:0009912; P:auditory receptor cell fate commitment; ISS:UniProtKB
Q9Y219	JAG2	Protein jagged-2	GO:0007049; P:cell cycle; NAS:UniProtKB
Q9Y219	JAG2	Protein jagged-2	GO:0030154; P:cell differentiation; IDA:UniProtKB
Q9Y219	JAG2	Protein jagged-2	GO:1990134; P:epithelial cell apoptotic process involved in palatal shelf morphogenesis; IEA:Ensembl
Q9Y219	JAG2	Protein jagged-2	GO:0042492; P:gamma-delta T cell differentiation; IEA:Ensembl
Q9Y219	JAG2	Protein jagged-2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9Y219	JAG2	Protein jagged-2	GO:0016331; P:morphogenesis of embryonic epithelium; IEA:Ensembl
Q9Y219	JAG2	Protein jagged-2	GO:0007220; P:Notch receptor processing; TAS:Reactome
Q9Y219	JAG2	Protein jagged-2	GO:0007219; P:Notch signaling pathway; NAS:UniProtKB
Q9Y219	JAG2	Protein jagged-2	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
Q9Y219	JAG2	Protein jagged-2	GO:0030155; P:regulation of cell adhesion; IEA:Ensembl
Q9Y219	JAG2	Protein jagged-2	GO:0030334; P:regulation of cell migration; NAS:UniProtKB
Q9Y219	JAG2	Protein jagged-2	GO:0042127; P:regulation of cell proliferation; IDA:UniProtKB
Q9Y219	JAG2	Protein jagged-2	GO:0003016; P:respiratory system process; IEA:Ensembl
Q9Y219	JAG2	Protein jagged-2	GO:0001501; P:skeletal system development; IEA:Ensembl
Q9Y219	JAG2	Protein jagged-2	GO:0007283; P:spermatogenesis; IEP:UniProtKB
Q9Y219	JAG2	Protein jagged-2	GO:0030217; P:T cell differentiation; IDA:UniProtKB
Q9Y219	JAG2	Protein jagged-2	GO:0045061; P:thymic T cell selection; IDA:UniProtKB
Q8N5M9	JAGN1	Protein jagunal homolog 1	GO:0007029; P:endoplasmic reticulum organization; IEA:InterPro
P23458	JAK1	Tyrosine-protein kinase JAK1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P23458	JAK1	Tyrosine-protein kinase JAK1	GO:0005131; F:growth hormone receptor binding; ISS:BHF-UCL
P23458	JAK1	Tyrosine-protein kinase JAK1	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC
P23458	JAK1	Tyrosine-protein kinase JAK1	GO:0005515; F:protein binding; IPI:UniProtKB
P23458	JAK1	Tyrosine-protein kinase JAK1	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
P23458	JAK1	Tyrosine-protein kinase JAK1	GO:0004713; F:protein tyrosine kinase activity; EXP:Reactome
P23458	JAK1	Tyrosine-protein kinase JAK1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P23458	JAK1	Tyrosine-protein kinase JAK1	GO:0007167; P:enzyme linked receptor protein signaling pathway; IEA:Ensembl
P23458	JAK1	Tyrosine-protein kinase JAK1	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P23458	JAK1	Tyrosine-protein kinase JAK1	GO:0038110; P:interleukin-2-mediated signaling pathway; IDA:UniProtKB
P23458	JAK1	Tyrosine-protein kinase JAK1	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
P23458	JAK1	Tyrosine-protein kinase JAK1	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
P23458	JAK1	Tyrosine-protein kinase JAK1	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P23458	JAK1	Tyrosine-protein kinase JAK1	GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; TAS:Reactome
P23458	JAK1	Tyrosine-protein kinase JAK1	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P23458	JAK1	Tyrosine-protein kinase JAK1	GO:0046677; P:response to antibiotic; IDA:MGI
P23458	JAK1	Tyrosine-protein kinase JAK1	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0005131; F:growth hormone receptor binding; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0020037; F:heme binding; IDA:UniProtKB
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0042393; F:histone binding; IDA:UniProtKB
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0035401; F:histone kinase activity (H3-Y41 specific); IDA:UniProtKB
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0005143; F:interleukin-12 receptor binding; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0005515; F:protein binding; IPI:UniProtKB
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0004672; F:protein kinase activity; NAS:ProtInc
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0019901; F:protein kinase binding; IDA:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0004713; F:protein tyrosine kinase activity; ISS:UniProtKB
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0005102; F:receptor binding; IPI:UniProtKB
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0042169; F:SH2 domain binding; IPI:UniProtKB
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0030041; P:actin filament polymerization; NAS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0097296; P:activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0042977; P:activation of JAK2 kinase activity; ISS:UniProtKB
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0000186; P:activation of MAPKK activity; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0006915; P:apoptotic process; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0031103; P:axon regeneration; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0007596; P:blood coagulation; TAS:Reactome
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0030154; P:cell differentiation; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0006928; P:cellular component movement; TAS:ProtInc
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0019221; P:cytokine-mediated signaling pathway; ISS:UniProtKB
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0007167; P:enzyme linked receptor protein signaling pathway; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0030218; P:erythrocyte differentiation; ISS:UniProtKB
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0097191; P:extrinsic apoptotic signaling pathway; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0060396; P:growth hormone receptor signaling pathway; IDA:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0035409; P:histone H3-Y41 phosphorylation; IDA:UniProtKB
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0009755; P:hormone-mediated signaling pathway; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0034050; P:host programmed cell death induced by symbiont; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0035722; P:interleukin-12-mediated signaling pathway; IDA:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0035556; P:intracellular signal transduction; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0007259; P:JAK-STAT cascade; TAS:ProtInc
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; ISS:UniProtKB
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0061180; P:mammary gland epithelium development; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0007498; P:mesoderm development; TAS:ProtInc
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0031959; P:mineralocorticoid receptor signaling pathway; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0008285; P:negative regulation of cell proliferation; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0022408; P:negative regulation of cell-cell adhesion; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0043392; P:negative regulation of DNA binding; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0045822; P:negative regulation of heart contraction; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0018108; P:peptidyl-tyrosine phosphorylation; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0050867; P:positive regulation of cell activation; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0045597; P:positive regulation of cell differentiation; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0010811; P:positive regulation of cell-substrate adhesion; IDA:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0043388; P:positive regulation of DNA binding; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0060399; P:positive regulation of growth hormone receptor signaling pathway; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0050729; P:positive regulation of inflammatory response; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0032731; P:positive regulation of interleukin-1 beta production; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0032516; P:positive regulation of phosphoprotein phosphatase activity; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0033160; P:positive regulation of protein import into nucleus, translocation; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0032760; P:positive regulation of tumor necrosis factor production; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; ISS:UniProtKB
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0042523; P:positive regulation of tyrosine phosphorylation of Stat5 protein; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0046777; P:protein autophosphorylation; ISS:UniProtKB
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0006468; P:protein phosphorylation; TAS:ProtInc
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0050727; P:regulation of inflammatory response; IDA:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; TAS:Reactome
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0046677; P:response to antibiotic; IDA:MGI
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0033194; P:response to hydroperoxide; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0070671; P:response to interleukin-12; IDA:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0032496; P:response to lipopolysaccharide; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0034612; P:response to tumor necrosis factor; IDA:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0007165; P:signal transduction; ISS:UniProtKB
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0007262; P:STAT protein import into nucleus; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IDA:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0007260; P:tyrosine phosphorylation of STAT protein; ISS:BHF-UCL
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0042508; P:tyrosine phosphorylation of Stat1 protein; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0042503; P:tyrosine phosphorylation of Stat3 protein; IEA:Ensembl
O60674	JAK2	Tyrosine-protein kinase JAK2	GO:0042506; P:tyrosine phosphorylation of Stat5 protein; IEA:Ensembl
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0005515; F:protein binding; IPI:IntAct
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0004713; F:protein tyrosine kinase activity; ISS:BHF-UCL
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0030183; P:B cell differentiation; ISS:BHF-UCL
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0007167; P:enzyme linked receptor protein signaling pathway; ISS:BHF-UCL
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0035771; P:interleukin-4-mediated signaling pathway; IDA:BHF-UCL
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0035556; P:intracellular signal transduction; ISS:BHF-UCL
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:UniProtKB
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0002731; P:negative regulation of dendritic cell cytokine production; ISS:BHF-UCL
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0045221; P:negative regulation of FasL biosynthetic process; ISS:BHF-UCL
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0032693; P:negative regulation of interleukin-10 production; ISS:BHF-UCL
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0032695; P:negative regulation of interleukin-12 production; ISS:BHF-UCL
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0050868; P:negative regulation of T cell activation; ISS:BHF-UCL
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0045626; P:negative regulation of T-helper 1 cell differentiation; ISS:BHF-UCL
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0070244; P:negative regulation of thymocyte apoptotic process; ISS:BHF-UCL
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0018108; P:peptidyl-tyrosine phosphorylation; ISS:BHF-UCL
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:2000670; P:positive regulation of dendritic cell apoptotic process; IEA:Ensembl
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0070232; P:regulation of T cell apoptotic process; ISS:BHF-UCL
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0070672; P:response to interleukin-15; TAS:BHF-UCL
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0070669; P:response to interleukin-2; TAS:BHF-UCL
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0070670; P:response to interleukin-4; IDA:BHF-UCL
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0071104; P:response to interleukin-9; TAS:BHF-UCL
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0007262; P:STAT protein import into nucleus; TAS:UniProtKB
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0043029; P:T cell homeostasis; TAS:UniProtKB
P52333	JAK3	Tyrosine-protein kinase JAK3	GO:0007260; P:tyrosine phosphorylation of STAT protein; TAS:UniProtKB
Q9Y624	F11R	Junctional adhesion molecule A	GO:0005515; F:protein binding; IPI:IntAct
Q9Y624	F11R	Junctional adhesion molecule A	GO:0007596; P:blood coagulation; TAS:Reactome
Q9Y624	F11R	Junctional adhesion molecule A	GO:0007155; P:cell adhesion; IEA:Ensembl
Q9Y624	F11R	Junctional adhesion molecule A	GO:0034329; P:cell junction assembly; TAS:Reactome
Q9Y624	F11R	Junctional adhesion molecule A	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q9Y624	F11R	Junctional adhesion molecule A	GO:0030855; P:epithelial cell differentiation; IEA:Ensembl
Q9Y624	F11R	Junctional adhesion molecule A	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q9Y624	F11R	Junctional adhesion molecule A	GO:0006954; P:inflammatory response; TAS:ProtInc
Q9Y624	F11R	Junctional adhesion molecule A	GO:0050900; P:leukocyte migration; TAS:Reactome
Q9Y624	F11R	Junctional adhesion molecule A	GO:0070830; P:tight junction assembly; TAS:Reactome
Q9Y624	F11R	Junctional adhesion molecule A	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q9Y624	F11R	Junctional adhesion molecule A	GO:0016032; P:viral process; IEA:UniProtKB-KW
P57087	JAM2	Junctional adhesion molecule B	GO:0005515; F:protein binding; IPI:IntAct
P57087	JAM2	Junctional adhesion molecule B	GO:0007596; P:blood coagulation; TAS:Reactome
P57087	JAM2	Junctional adhesion molecule B	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
P57087	JAM2	Junctional adhesion molecule B	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P57087	JAM2	Junctional adhesion molecule B	GO:0050900; P:leukocyte migration; TAS:Reactome
P57087	JAM2	Junctional adhesion molecule B	GO:0007162; P:negative regulation of cell adhesion; IEA:Ensembl
Q9BX67	JAM3	Junctional adhesion molecule C	GO:0005178; F:integrin binding; IPI:UniProtKB
Q9BX67	JAM3	Junctional adhesion molecule C	GO:0005515; F:protein binding; IPI:IntAct
Q9BX67	JAM3	Junctional adhesion molecule C	GO:0002250; P:adaptive immune response; IEA:Ensembl
Q9BX67	JAM3	Junctional adhesion molecule C	GO:0001525; P:angiogenesis; IDA:UniProtKB
Q9BX67	JAM3	Junctional adhesion molecule C	GO:0007596; P:blood coagulation; TAS:Reactome
Q9BX67	JAM3	Junctional adhesion molecule C	GO:0007160; P:cell-matrix adhesion; IEA:Ensembl
Q9BX67	JAM3	Junctional adhesion molecule C	GO:0030010; P:establishment of cell polarity; IEA:Ensembl
Q9BX67	JAM3	Junctional adhesion molecule C	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q9BX67	JAM3	Junctional adhesion molecule C	GO:0050900; P:leukocyte migration; TAS:Reactome
Q9BX67	JAM3	Junctional adhesion molecule C	GO:0002523; P:leukocyte migration involved in inflammatory response; IEA:Ensembl
Q9BX67	JAM3	Junctional adhesion molecule C	GO:0042552; P:myelination; IEA:Ensembl
Q9BX67	JAM3	Junctional adhesion molecule C	GO:0002318; P:myeloid progenitor cell differentiation; IEA:Ensembl
Q9BX67	JAM3	Junctional adhesion molecule C	GO:0001780; P:neutrophil homeostasis; IEA:Ensembl
Q9BX67	JAM3	Junctional adhesion molecule C	GO:0090138; P:regulation of actin cytoskeleton organization by cell-cell adhesion; IEA:Ensembl
Q9BX67	JAM3	Junctional adhesion molecule C	GO:0090022; P:regulation of neutrophil chemotaxis; IDA:UniProtKB
Q9BX67	JAM3	Junctional adhesion molecule C	GO:0007286; P:spermatid development; IEA:Ensembl
Q9BX67	JAM3	Junctional adhesion molecule C	GO:0019226; P:transmission of nerve impulse; IEA:Ensembl
Q86YT9	AMICA1	Junctional adhesion molecule-like	GO:0050839; F:cell adhesion molecule binding; IPI:UniProtKB
Q86YT9	AMICA1	Junctional adhesion molecule-like	GO:0005178; F:integrin binding; IPI:UniProtKB
Q86YT9	AMICA1	Junctional adhesion molecule-like	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q86YT9	AMICA1	Junctional adhesion molecule-like	GO:0007596; P:blood coagulation; TAS:Reactome
Q86YT9	AMICA1	Junctional adhesion molecule-like	GO:0046629; P:gamma-delta T cell activation; ISS:UniProtKB
Q86YT9	AMICA1	Junctional adhesion molecule-like	GO:0007157; P:heterophilic cell-cell adhesion; IDA:UniProtKB
Q86YT9	AMICA1	Junctional adhesion molecule-like	GO:0050900; P:leukocyte migration; TAS:Reactome
Q86YT9	AMICA1	Junctional adhesion molecule-like	GO:0035696; P:monocyte extravasation; IMP:UniProtKB
Q86YT9	AMICA1	Junctional adhesion molecule-like	GO:0030593; P:neutrophil chemotaxis; IMP:UniProtKB
Q86YT9	AMICA1	Junctional adhesion molecule-like	GO:0072672; P:neutrophil extravasation; IMP:UniProtKB
Q86YT9	AMICA1	Junctional adhesion molecule-like	GO:0060054; P:positive regulation of epithelial cell proliferation involved in wound healing; ISS:UniProtKB
Q86YT9	AMICA1	Junctional adhesion molecule-like	GO:0050776; P:regulation of immune response; TAS:Reactome
Q86VZ6	JAZF1	Juxtaposed with another zinc finger protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86VZ6	JAZF1	Juxtaposed with another zinc finger protein 1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q86VZ6	JAZF1	Juxtaposed with another zinc finger protein 1	GO:0003714; F:transcription corepressor activity; IDA:MGI
Q86VZ6	JAZF1	Juxtaposed with another zinc finger protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q86VZ6	JAZF1	Juxtaposed with another zinc finger protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q92833	JARID2	Protein Jumonji	GO:0003682; F:chromatin binding; ISS:UniProtKB
Q92833	JARID2	Protein Jumonji	GO:0003677; F:DNA binding; IEA:Ensembl
Q92833	JARID2	Protein Jumonji	GO:0007417; P:central nervous system development; TAS:ProtInc
Q92833	JARID2	Protein Jumonji	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q92833	JARID2	Protein Jumonji	GO:0001889; P:liver development; IEA:Ensembl
Q92833	JARID2	Protein Jumonji	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q92833	JARID2	Protein Jumonji	GO:0031061; P:negative regulation of histone methylation; ISS:UniProtKB
Q92833	JARID2	Protein Jumonji	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q92833	JARID2	Protein Jumonji	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q92833	JARID2	Protein Jumonji	GO:0051574; P:positive regulation of histone H3-K9 methylation; ISS:UniProtKB
Q92833	JARID2	Protein Jumonji	GO:0048536; P:spleen development; IEA:Ensembl
Q92833	JARID2	Protein Jumonji	GO:0048863; P:stem cell differentiation; ISS:UniProtKB
Q92833	JARID2	Protein Jumonji	GO:0048538; P:thymus development; IEA:Ensembl
Q92833	JARID2	Protein Jumonji	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9P266	KIAA1462	Junctional protein associated with coronary artery disease	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q8WYK2	JDP2	Jun dimerization protein 2	GO:0003682; F:chromatin binding; IEA:Ensembl
Q8WYK2	JDP2	Jun dimerization protein 2	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
Q8WYK2	JDP2	Jun dimerization protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q8WYK2	JDP2	Jun dimerization protein 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q8WYK2	JDP2	Jun dimerization protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q8WYK2	JDP2	Jun dimerization protein 2	GO:0045599; P:negative regulation of fat cell differentiation; IEA:Ensembl
Q8WYK2	JDP2	Jun dimerization protein 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8WYK2	JDP2	Jun dimerization protein 2	GO:0031065; P:positive regulation of histone deacetylation; IEA:Ensembl
Q8WYK2	JDP2	Jun dimerization protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y4A0	JRKL	Jerky protein homolog-like	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y4A0	JRKL	Jerky protein homolog-like	GO:0007417; P:central nervous system development; TAS:ProtInc
O75564	JRK	Jerky protein homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O75564	JRK	Jerky protein homolog	GO:0005515; F:protein binding; IPI:IntAct
Q15652	JMJD1C	Probable JmjC domain-containing histone demethylation protein 2C	GO:0051213; F:dioxygenase activity; IEA:UniProtKB-KW
Q15652	JMJD1C	Probable JmjC domain-containing histone demethylation protein 2C	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15652	JMJD1C	Probable JmjC domain-containing histone demethylation protein 2C	GO:0005515; F:protein binding; IPI:IntAct
Q15652	JMJD1C	Probable JmjC domain-containing histone demethylation protein 2C	GO:0046966; F:thyroid hormone receptor binding; TAS:UniProtKB
Q15652	JMJD1C	Probable JmjC domain-containing histone demethylation protein 2C	GO:0007596; P:blood coagulation; TAS:Reactome
Q15652	JMJD1C	Probable JmjC domain-containing histone demethylation protein 2C	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q15652	JMJD1C	Probable JmjC domain-containing histone demethylation protein 2C	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q15652	JMJD1C	Probable JmjC domain-containing histone demethylation protein 2C	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UQF2	MAPK8IP1	C-Jun-amino-terminal kinase-interacting protein 1	GO:0019894; F:kinesin binding; IPI:UniProtKB
Q9UQF2	MAPK8IP1	C-Jun-amino-terminal kinase-interacting protein 1	GO:0005078; F:MAP-kinase scaffold activity; IPI:UniProtKB
Q9UQF2	MAPK8IP1	C-Jun-amino-terminal kinase-interacting protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UQF2	MAPK8IP1	C-Jun-amino-terminal kinase-interacting protein 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q9UQF2	MAPK8IP1	C-Jun-amino-terminal kinase-interacting protein 1	GO:0004860; F:protein kinase inhibitor activity; TAS:ProtInc
Q9UQF2	MAPK8IP1	C-Jun-amino-terminal kinase-interacting protein 1	GO:0007258; P:JUN phosphorylation; IEA:Ensembl
Q9UQF2	MAPK8IP1	C-Jun-amino-terminal kinase-interacting protein 1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q9UQF2	MAPK8IP1	C-Jun-amino-terminal kinase-interacting protein 1	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl
Q9UQF2	MAPK8IP1	C-Jun-amino-terminal kinase-interacting protein 1	GO:0046329; P:negative regulation of JNK cascade; IEA:Ensembl
Q9UQF2	MAPK8IP1	C-Jun-amino-terminal kinase-interacting protein 1	GO:0043508; P:negative regulation of JUN kinase activity; IEA:Ensembl
Q9UQF2	MAPK8IP1	C-Jun-amino-terminal kinase-interacting protein 1	GO:0009967; P:positive regulation of signal transduction; IPI:GOC
Q9UQF2	MAPK8IP1	C-Jun-amino-terminal kinase-interacting protein 1	GO:0046328; P:regulation of JNK cascade; ISS:UniProtKB
Q9UQF2	MAPK8IP1	C-Jun-amino-terminal kinase-interacting protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:Ensembl
Q9UQF2	MAPK8IP1	C-Jun-amino-terminal kinase-interacting protein 1	GO:0016192; P:vesicle-mediated transport; ISS:UniProtKB
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:0001540; F:beta-amyloid binding; NAS:UniProtKB
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:0019894; F:kinesin binding; ISS:UniProtKB
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:0005078; F:MAP-kinase scaffold activity; NAS:UniProtKB
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:0030295; F:protein kinase activator activity; IDA:MGI
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:0005198; F:structural molecule activity; TAS:ProtInc
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:0001662; P:behavioral fear response; ISS:BHF-UCL
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:0048813; P:dendrite morphogenesis; ISS:BHF-UCL
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:0000165; P:MAPK cascade; IDA:MGI
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:0046958; P:nonassociative learning; ISS:BHF-UCL
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:0045860; P:positive regulation of protein kinase activity; IDA:GOC
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:0009967; P:positive regulation of signal transduction; NAS:GOC
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:2000311; P:regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; ISS:BHF-UCL
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; ISS:BHF-UCL
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:0046328; P:regulation of JNK cascade; IDA:UniProtKB
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:2000310; P:regulation of N-methyl-D-aspartate selective glutamate receptor activity; ISS:BHF-UCL
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:0010469; P:regulation of receptor activity; ISS:BHF-UCL
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:0051966; P:regulation of synaptic transmission, glutamatergic; ISS:BHF-UCL
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:0007172; P:signal complex assembly; TAS:ProtInc
Q13387	MAPK8IP2	C-Jun-amino-terminal kinase-interacting protein 2	GO:0035176; P:social behavior; ISS:BHF-UCL
Q9UPT6	MAPK8IP3	C-Jun-amino-terminal kinase-interacting protein 3	GO:0019894; F:kinesin binding; ISS:UniProtKB
Q9UPT6	MAPK8IP3	C-Jun-amino-terminal kinase-interacting protein 3	GO:0005078; F:MAP-kinase scaffold activity; ISS:UniProtKB
Q9UPT6	MAPK8IP3	C-Jun-amino-terminal kinase-interacting protein 3	GO:0019901; F:protein kinase binding; ISS:UniProtKB
Q9UPT6	MAPK8IP3	C-Jun-amino-terminal kinase-interacting protein 3	GO:0007257; P:activation of JUN kinase activity; IEA:Ensembl
Q9UPT6	MAPK8IP3	C-Jun-amino-terminal kinase-interacting protein 3	GO:0007411; P:axon guidance; IEA:Ensembl
Q9UPT6	MAPK8IP3	C-Jun-amino-terminal kinase-interacting protein 3	GO:0030900; P:forebrain development; IEA:Ensembl
Q9UPT6	MAPK8IP3	C-Jun-amino-terminal kinase-interacting protein 3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9UPT6	MAPK8IP3	C-Jun-amino-terminal kinase-interacting protein 3	GO:0048286; P:lung alveolus development; IEA:Ensembl
Q9UPT6	MAPK8IP3	C-Jun-amino-terminal kinase-interacting protein 3	GO:0060425; P:lung morphogenesis; IEA:Ensembl
Q9UPT6	MAPK8IP3	C-Jun-amino-terminal kinase-interacting protein 3	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
Q9UPT6	MAPK8IP3	C-Jun-amino-terminal kinase-interacting protein 3	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q9UPT6	MAPK8IP3	C-Jun-amino-terminal kinase-interacting protein 3	GO:0008104; P:protein localization; IEA:Ensembl
Q9UPT6	MAPK8IP3	C-Jun-amino-terminal kinase-interacting protein 3	GO:0010468; P:regulation of gene expression; IEA:Ensembl
Q9UPT6	MAPK8IP3	C-Jun-amino-terminal kinase-interacting protein 3	GO:0046328; P:regulation of JNK cascade; ISS:UniProtKB
Q9UPT6	MAPK8IP3	C-Jun-amino-terminal kinase-interacting protein 3	GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl
Q9UPT6	MAPK8IP3	C-Jun-amino-terminal kinase-interacting protein 3	GO:0016192; P:vesicle-mediated transport; ISS:UniProtKB
O60271	SPAG9	C-Jun-amino-terminal kinase-interacting protein 4	GO:0005515; F:protein binding; IPI:IntAct
O60271	SPAG9	C-Jun-amino-terminal kinase-interacting protein 4	GO:0007257; P:activation of JUN kinase activity; IEA:Ensembl
O60271	SPAG9	C-Jun-amino-terminal kinase-interacting protein 4	GO:0042692; P:muscle cell differentiation; TAS:Reactome
O60271	SPAG9	C-Jun-amino-terminal kinase-interacting protein 4	GO:0090074; P:negative regulation of protein homodimerization activity; IEA:Ensembl
O60271	SPAG9	C-Jun-amino-terminal kinase-interacting protein 4	GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB
O60271	SPAG9	C-Jun-amino-terminal kinase-interacting protein 4	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
O60271	SPAG9	C-Jun-amino-terminal kinase-interacting protein 4	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
O60271	SPAG9	C-Jun-amino-terminal kinase-interacting protein 4	GO:0051260; P:protein homooligomerization; IEA:Ensembl
O60271	SPAG9	C-Jun-amino-terminal kinase-interacting protein 4	GO:0042147; P:retrograde transport, endosome to Golgi; IDA:MGI
O60271	SPAG9	C-Jun-amino-terminal kinase-interacting protein 4	GO:0007283; P:spermatogenesis; TAS:ProtInc
O60271	SPAG9	C-Jun-amino-terminal kinase-interacting protein 4	GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl
Q9P055	JKAMP	JNK1/MAPK8-associated membrane protein	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q9P055	JKAMP	JNK1/MAPK8-associated membrane protein	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9P055	JKAMP	JNK1/MAPK8-associated membrane protein	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
Q96N16	JAKMIP1	Janus kinase and microtubule-interacting protein 1	GO:0050811; F:GABA receptor binding; IDA:MGI
Q96N16	JAKMIP1	Janus kinase and microtubule-interacting protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q96N16	JAKMIP1	Janus kinase and microtubule-interacting protein 1	GO:0003723; F:RNA binding; IDA:MGI
Q96N16	JAKMIP1	Janus kinase and microtubule-interacting protein 1	GO:0050890; P:cognition; IMP:UniProt
Q96N16	JAKMIP1	Janus kinase and microtubule-interacting protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9H9V9	JMJD4	JmjC domain-containing protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0033746; F:histone demethylase activity (H3-R2 specific); IDA:UniProtKB
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0033749; F:histone demethylase activity (H4-R3 specific); IDA:UniProtKB
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0042802; F:identical protein binding; IPI:IntAct
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0005506; F:iron ion binding; IDA:UniProtKB
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0070815; F:peptidyl-lysine 5-dioxygenase activity; IDA:UniProtKB
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0005515; F:protein binding; IPI:UniProtKB
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0004872; F:receptor activity; IEA:Ensembl
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0003723; F:RNA binding; TAS:UniProtKB
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0003727; F:single-stranded RNA binding; IDA:UniProtKB
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0007166; P:cell surface receptor signaling pathway; IEA:Ensembl
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0048821; P:erythrocyte development; IEA:Ensembl
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0007507; P:heart development; IEA:Ensembl
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0070078; P:histone H3-R2 demethylation; IDA:BHF-UCL
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0070079; P:histone H4-R3 demethylation; IDA:BHF-UCL
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0001822; P:kidney development; IEA:Ensembl
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0030324; P:lung development; IEA:Ensembl
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0042116; P:macrophage activation; IEA:Ensembl
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0018395; P:peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine; IDA:UniProtKB
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0070782; P:phosphatidylserine exposure on apoptotic cell surface; IEA:Ensembl
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0043654; P:recognition of apoptotic cell; IEA:Ensembl
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0048024; P:regulation of mRNA splicing, via spliceosome; IMP:UniProtKB
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0002040; P:sprouting angiogenesis; ISS:UniProtKB
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
Q6NYC1	JMJD6	Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N9B5	JMY	Junction-mediating and -regulatory protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N9B5	JMY	Junction-mediating and -regulatory protein	GO:0003713; F:transcription coactivator activity; ISS:HGNC
Q8N9B5	JMY	Junction-mediating and -regulatory protein	GO:0070060; P:'de novo' actin filament nucleation; ISS:UniProtKB
Q8N9B5	JMY	Junction-mediating and -regulatory protein	GO:0070358; P:actin polymerization-dependent cell motility; ISS:UniProtKB
Q8N9B5	JMY	Junction-mediating and -regulatory protein	GO:0034314; P:Arp2/3 complex-mediated actin nucleation; ISS:UniProtKB
Q8N9B5	JMY	Junction-mediating and -regulatory protein	GO:0007050; P:cell cycle arrest; ISS:UniProtKB
Q8N9B5	JMY	Junction-mediating and -regulatory protein	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q8N9B5	JMY	Junction-mediating and -regulatory protein	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IEA:Ensembl
Q8N9B5	JMY	Junction-mediating and -regulatory protein	GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB
Q8N9B5	JMY	Junction-mediating and -regulatory protein	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q8N9B5	JMY	Junction-mediating and -regulatory protein	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; ISS:HGNC
Q15040	JOSD1	Josephin-1	GO:0008242; F:omega peptidase activity; IEA:InterPro
Q8TAC2	JOSD2	Josephin-2	GO:0008242; F:omega peptidase activity; IEA:InterPro
Q8TAC2	JOSD2	Josephin-2	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q8TAC2	JOSD2	Josephin-2	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
Q9HDC5	JPH1	Junctophilin-1	GO:0008307; F:structural constituent of muscle; IEA:Ensembl
Q9HDC5	JPH1	Junctophilin-1	GO:0060402; P:calcium ion transport into cytosol; TAS:BHF-UCL
Q9HDC5	JPH1	Junctophilin-1	GO:0007517; P:muscle organ development; IEA:Ensembl
Q9HDC5	JPH1	Junctophilin-1	GO:0060314; P:regulation of ryanodine-sensitive calcium-release channel activity; TAS:BHF-UCL
Q9BR39	JPH2	Junctophilin-2	GO:0015278; F:calcium-release channel activity; IDA:UniProtKB
Q9BR39	JPH2	Junctophilin-2	GO:0070300; F:phosphatidic acid binding; IDA:UniProtKB
Q9BR39	JPH2	Junctophilin-2	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB
Q9BR39	JPH2	Junctophilin-2	GO:0080025; F:phosphatidylinositol-3,5-bisphosphate binding; IDA:UniProtKB
Q9BR39	JPH2	Junctophilin-2	GO:0032266; F:phosphatidylinositol-3-phosphate binding; IDA:UniProtKB
Q9BR39	JPH2	Junctophilin-2	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProtKB
Q9BR39	JPH2	Junctophilin-2	GO:0070273; F:phosphatidylinositol-4-phosphate binding; IDA:UniProtKB
Q9BR39	JPH2	Junctophilin-2	GO:0010314; F:phosphatidylinositol-5-phosphate binding; IDA:UniProtKB
Q9BR39	JPH2	Junctophilin-2	GO:0001786; F:phosphatidylserine binding; IDA:UniProtKB
Q9BR39	JPH2	Junctophilin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BR39	JPH2	Junctophilin-2	GO:0055074; P:calcium ion homeostasis; IDA:UniProtKB
Q9BR39	JPH2	Junctophilin-2	GO:0070588; P:calcium ion transmembrane transport; IDA:GOC
Q9BR39	JPH2	Junctophilin-2	GO:0060402; P:calcium ion transport into cytosol; TAS:BHF-UCL
Q9BR39	JPH2	Junctophilin-2	GO:0060316; P:positive regulation of ryanodine-sensitive calcium-release channel activity; IDA:UniProtKB
Q9BR39	JPH2	Junctophilin-2	GO:0055024; P:regulation of cardiac muscle tissue development; IEA:Ensembl
Q9BR39	JPH2	Junctophilin-2	GO:0060314; P:regulation of ryanodine-sensitive calcium-release channel activity; TAS:BHF-UCL
Q8WXH2	JPH3	Junctophilin-3	GO:0015278; F:calcium-release channel activity; IEA:Ensembl
Q8WXH2	JPH3	Junctophilin-3	GO:0060402; P:calcium ion transport into cytosol; TAS:BHF-UCL
Q8WXH2	JPH3	Junctophilin-3	GO:0035640; P:exploration behavior; IEA:Ensembl
Q8WXH2	JPH3	Junctophilin-3	GO:0007612; P:learning; IEA:Ensembl
Q8WXH2	JPH3	Junctophilin-3	GO:0040011; P:locomotion; IEA:Ensembl
Q8WXH2	JPH3	Junctophilin-3	GO:0007613; P:memory; IEA:Ensembl
Q8WXH2	JPH3	Junctophilin-3	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q8WXH2	JPH3	Junctophilin-3	GO:0048168; P:regulation of neuronal synaptic plasticity; IEA:Ensembl
Q8WXH2	JPH3	Junctophilin-3	GO:0060314; P:regulation of ryanodine-sensitive calcium-release channel activity; TAS:BHF-UCL
Q96JJ6	JPH4	Junctophilin-4	GO:0060402; P:calcium ion transport into cytosol; TAS:BHF-UCL
Q96JJ6	JPH4	Junctophilin-4	GO:0007612; P:learning; IEA:Ensembl
Q96JJ6	JPH4	Junctophilin-4	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q96JJ6	JPH4	Junctophilin-4	GO:0060314; P:regulation of ryanodine-sensitive calcium-release channel activity; TAS:BHF-UCL
Q96JJ6	JPH4	Junctophilin-4	GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl
Q96MG2	JSRP1	Junctional sarcoplasmic reticulum protein 1	GO:0072657; P:protein localization to membrane; IEA:Ensembl
Q96MG2	JSRP1	Junctional sarcoplasmic reticulum protein 1	GO:0060314; P:regulation of ryanodine-sensitive calcium-release channel activity; IEA:Ensembl
Q96MG2	JSRP1	Junctional sarcoplasmic reticulum protein 1	GO:0003009; P:skeletal muscle contraction; IDA:UniProtKB
P17275	JUNB	Transcription factor jun-B	GO:0003677; F:DNA binding; TAS:ProtInc
P17275	JUNB	Transcription factor jun-B	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0005515; F:protein binding; IPI:IntAct
P17275	JUNB	Transcription factor jun-B	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P17275	JUNB	Transcription factor jun-B	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
P17275	JUNB	Transcription factor jun-B	GO:0071277; P:cellular response to calcium ion; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0032870; P:cellular response to hormone stimulus; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0046697; P:decidualization; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0060136; P:embryonic process involved in female pregnancy; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0010467; P:gene expression; TAS:Reactome
P17275	JUNB	Transcription factor jun-B	GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0033687; P:osteoblast proliferation; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0030316; P:osteoclast differentiation; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0045597; P:positive regulation of cell differentiation; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
P17275	JUNB	Transcription factor jun-B	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P17275	JUNB	Transcription factor jun-B	GO:0051591; P:response to cAMP; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0051412; P:response to corticosterone; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0034097; P:response to cytokine; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0042493; P:response to drug; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0009416; P:response to light stimulus; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0032570; P:response to progesterone; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P17275	JUNB	Transcription factor jun-B	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
P17275	JUNB	Transcription factor jun-B	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P17275	JUNB	Transcription factor jun-B	GO:0001829; P:trophectodermal cell differentiation; IEA:Ensembl
P17275	JUNB	Transcription factor jun-B	GO:0001570; P:vasculogenesis; IEA:Ensembl
P17535	JUND	Transcription factor jun-D	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
P17535	JUND	Transcription factor jun-D	GO:0005515; F:protein binding; IPI:UniProtKB
P17535	JUND	Transcription factor jun-D	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P17535	JUND	Transcription factor jun-D	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P17535	JUND	Transcription factor jun-D	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P17535	JUND	Transcription factor jun-D	GO:0007568; P:aging; IEA:Ensembl
P17535	JUND	Transcription factor jun-D	GO:0071277; P:cellular response to calcium ion; IEA:Ensembl
P17535	JUND	Transcription factor jun-D	GO:0007623; P:circadian rhythm; IEA:Ensembl
P17535	JUND	Transcription factor jun-D	GO:0002076; P:osteoblast development; IEA:Ensembl
P17535	JUND	Transcription factor jun-D	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
P17535	JUND	Transcription factor jun-D	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P17535	JUND	Transcription factor jun-D	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P17535	JUND	Transcription factor jun-D	GO:0009416; P:response to light stimulus; IEA:Ensembl
P17535	JUND	Transcription factor jun-D	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P17535	JUND	Transcription factor jun-D	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P17535	JUND	Transcription factor jun-D	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P17535	JUND	Transcription factor jun-D	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P17535	JUND	Transcription factor jun-D	GO:0006366; P:transcription from RNA polymerase II promoter; IEA:Ensembl
A6ND01	FOLR4	Sperm-egg fusion protein Juno	GO:0005542; F:folic acid binding; IEA:UniProtKB-KW
O76095	JTB	Protein JTB	GO:0019901; F:protein kinase binding; IDA:UniProtKB
O76095	JTB	Protein JTB	GO:0008637; P:apoptotic mitochondrial changes; IEA:Ensembl
O76095	JTB	Protein JTB	GO:0000910; P:cytokinesis; IMP:UniProtKB
O76095	JTB	Protein JTB	GO:0007067; P:mitosis; IMP:UniProtKB
O76095	JTB	Protein JTB	GO:0045860; P:positive regulation of protein kinase activity; IMP:UniProtKB
O76095	JTB	Protein JTB	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0035497; F:cAMP response element binding; IDA:BHF-UCL
P05412	JUN	Transcription factor AP-1	GO:0003677; F:DNA binding; TAS:ProtInc
P05412	JUN	Transcription factor AP-1	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P05412	JUN	Transcription factor AP-1	GO:0005515; F:protein binding; IPI:UniProtKB
P05412	JUN	Transcription factor AP-1	GO:0070412; F:R-SMAD binding; IPI:BHF-UCL
P05412	JUN	Transcription factor AP-1	GO:0005100; F:Rho GTPase activator activity; IDA:UniProtKB
P05412	JUN	Transcription factor AP-1	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
P05412	JUN	Transcription factor AP-1	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IDA:BHF-UCL
P05412	JUN	Transcription factor AP-1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P05412	JUN	Transcription factor AP-1	GO:0001190; F:RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription; IC:BHF-UCL
P05412	JUN	Transcription factor AP-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P05412	JUN	Transcription factor AP-1	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
P05412	JUN	Transcription factor AP-1	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P05412	JUN	Transcription factor AP-1	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P05412	JUN	Transcription factor AP-1	GO:0007568; P:aging; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0001525; P:angiogenesis; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0031103; P:axon regeneration; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0071277; P:cellular response to calcium ion; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0051365; P:cellular response to potassium ion starvation; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0007623; P:circadian rhythm; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P05412	JUN	Transcription factor AP-1	GO:0045087; P:innate immune response; TAS:Reactome
P05412	JUN	Transcription factor AP-1	GO:0035026; P:leading edge cell differentiation; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0007612; P:learning; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0001889; P:liver development; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0051899; P:membrane depolarization; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0001774; P:microglial cell activation; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0030224; P:monocyte differentiation; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P05412	JUN	Transcription factor AP-1	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P05412	JUN	Transcription factor AP-1	GO:0043922; P:negative regulation by host of viral transcription; IDA:UniProtKB
P05412	JUN	Transcription factor AP-1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0043392; P:negative regulation of DNA binding; IDA:UniProtKB
P05412	JUN	Transcription factor AP-1	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0031953; P:negative regulation of protein autophosphorylation; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P05412	JUN	Transcription factor AP-1	GO:0003151; P:outflow tract morphogenesis; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0043923; P:positive regulation by host of viral transcription; IDA:UniProtKB
P05412	JUN	Transcription factor AP-1	GO:0045740; P:positive regulation of DNA replication; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0045657; P:positive regulation of monocyte differentiation; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0032321; P:positive regulation of Rho GTPase activity; IDA:GOC
P05412	JUN	Transcription factor AP-1	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P05412	JUN	Transcription factor AP-1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P05412	JUN	Transcription factor AP-1	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; TAS:Reactome
P05412	JUN	Transcription factor AP-1	GO:0001836; P:release of cytochrome c from mitochondria; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0051591; P:response to cAMP; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0034097; P:response to cytokine; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0042493; P:response to drug; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0009314; P:response to radiation; IEA:Ensembl
P05412	JUN	Transcription factor AP-1	GO:0007184; P:SMAD protein import into nucleus; IDA:BHF-UCL
P05412	JUN	Transcription factor AP-1	GO:0060395; P:SMAD protein signal transduction; IDA:BHF-UCL
P05412	JUN	Transcription factor AP-1	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P05412	JUN	Transcription factor AP-1	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P05412	JUN	Transcription factor AP-1	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P05412	JUN	Transcription factor AP-1	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P05412	JUN	Transcription factor AP-1	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P05412	JUN	Transcription factor AP-1	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P05412	JUN	Transcription factor AP-1	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P05412	JUN	Transcription factor AP-1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P05412	JUN	Transcription factor AP-1	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P05412	JUN	Transcription factor AP-1	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P05412	JUN	Transcription factor AP-1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
P05412	JUN	Transcription factor AP-1	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q15397	KIAA0020	Pumilio domain-containing protein KIAA0020	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q92628	KIAA0232	Uncharacterized protein KIAA0232	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5VV43	KIAA0319	Dyslexia-associated protein KIAA0319	GO:0005515; F:protein binding; IPI:UniProtKB
Q5VV43	KIAA0319	Dyslexia-associated protein KIAA0319	GO:2000171; P:negative regulation of dendrite development; IGI:UniProtKB
Q5VV43	KIAA0319	Dyslexia-associated protein KIAA0319	GO:0001764; P:neuron migration; IGI:UniProtKB
Q6ZU52	KIAA0408	Uncharacterized protein KIAA0408	GO:0005515; F:protein binding; IPI:IntAct
Q7Z7F0	KIAA0907	UPF0469 protein KIAA0907	GO:0003723; F:RNA binding; IEA:Ensembl
Q9UPV7	KIAA1045	Protein KIAA1045	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q2LD37	KIAA1109	Uncharacterized protein KIAA1109	GO:0005515; F:protein binding; IPI:IntAct
Q2LD37	KIAA1109	Uncharacterized protein KIAA1109	GO:0001558; P:regulation of cell growth; NAS:BHF-UCL
Q2LD37	KIAA1109	Uncharacterized protein KIAA1109	GO:0030856; P:regulation of epithelial cell differentiation; NAS:BHF-UCL
Q6NSJ0	KIAA1161	Uncharacterized family 31 glucosidase KIAA1161	GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro
Q6NSJ0	KIAA1161	Uncharacterized family 31 glucosidase KIAA1161	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q6NSJ0	KIAA1161	Uncharacterized family 31 glucosidase KIAA1161	GO:0043568; P:positive regulation of insulin-like growth factor receptor signaling pathway; IEA:Ensembl
Q6NSJ0	KIAA1161	Uncharacterized family 31 glucosidase KIAA1161	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
Q6NSJ0	KIAA1161	Uncharacterized family 31 glucosidase KIAA1161	GO:0048741; P:skeletal muscle fiber development; IEA:Ensembl
Q6UXG2	KIAA1324	UPF0577 protein KIAA1324	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6UXG2	KIAA1324	UPF0577 protein KIAA1324	GO:0009267; P:cellular response to starvation; IMP:BHF-UCL
Q6UXG2	KIAA1324	UPF0577 protein KIAA1324	GO:0016236; P:macroautophagy; IMP:BHF-UCL
Q6UXG2	KIAA1324	UPF0577 protein KIAA1324	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IMP:BHF-UCL
Q6UXG2	KIAA1324	UPF0577 protein KIAA1324	GO:2000786; P:positive regulation of autophagic vacuole assembly; IMP:BHF-UCL
Q6UXG2	KIAA1324	UPF0577 protein KIAA1324	GO:0044090; P:positive regulation of vacuole organization; IMP:BHF-UCL
Q9P2H0	KIAA1377	Uncharacterized protein KIAA1377	GO:0005515; F:protein binding; IPI:IntAct
Q9P272	KIAA1456	Putative methyltransferase KIAA1456	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q9HCI6	KIAA1586	Uncharacterized protein KIAA1586	GO:0003676; F:nucleic acid binding; IEA:InterPro
P13645	KRT10	Keratin, type I cytoskeletal 10	GO:0030280; F:structural constituent of epidermis; NAS:UniProtKB
P13645	KRT10	Keratin, type I cytoskeletal 10	GO:0071277; P:cellular response to calcium ion; IEA:Ensembl
P13645	KRT10	Keratin, type I cytoskeletal 10	GO:0030216; P:keratinocyte differentiation; IEP:UniProtKB
Q99456	KRT12	Keratin, type I cytoskeletal 12	GO:0005198; F:structural molecule activity; NAS:ProtInc
Q99456	KRT12	Keratin, type I cytoskeletal 12	GO:0007601; P:visual perception; TAS:ProtInc
P13646	KRT13	Keratin, type I cytoskeletal 13	GO:0005198; F:structural molecule activity; IEA:InterPro
P13646	KRT13	Keratin, type I cytoskeletal 13	GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl
P13646	KRT13	Keratin, type I cytoskeletal 13	GO:0009314; P:response to radiation; IEA:Ensembl
P13646	KRT13	Keratin, type I cytoskeletal 13	GO:0043587; P:tongue morphogenesis; IEA:Ensembl
P02533	KRT14	Keratin, type I cytoskeletal 14	GO:0005515; F:protein binding; IPI:UniProtKB
P02533	KRT14	Keratin, type I cytoskeletal 14	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P02533	KRT14	Keratin, type I cytoskeletal 14	GO:0034329; P:cell junction assembly; TAS:Reactome
P02533	KRT14	Keratin, type I cytoskeletal 14	GO:0008544; P:epidermis development; TAS:ProtInc
P02533	KRT14	Keratin, type I cytoskeletal 14	GO:0030855; P:epithelial cell differentiation; IEA:Ensembl
P02533	KRT14	Keratin, type I cytoskeletal 14	GO:0031581; P:hemidesmosome assembly; TAS:Reactome
P02533	KRT14	Keratin, type I cytoskeletal 14	GO:0045110; P:intermediate filament bundle assembly; IMP:UniProtKB
P02533	KRT14	Keratin, type I cytoskeletal 14	GO:0010212; P:response to ionizing radiation; IEA:Ensembl
P02533	KRT14	Keratin, type I cytoskeletal 14	GO:0010043; P:response to zinc ion; IEA:Ensembl
P19012	KRT15	Keratin, type I cytoskeletal 15	GO:0005515; F:protein binding; IPI:IntAct
P19012	KRT15	Keratin, type I cytoskeletal 15	GO:0097110; F:scaffold protein binding; IPI:BHF-UCL
P19012	KRT15	Keratin, type I cytoskeletal 15	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P19012	KRT15	Keratin, type I cytoskeletal 15	GO:0008544; P:epidermis development; TAS:ProtInc
P08779	KRT16	Keratin, type I cytoskeletal 16	GO:0005515; F:protein binding; IPI:HGNC
P08779	KRT16	Keratin, type I cytoskeletal 16	GO:0005200; F:structural constituent of cytoskeleton; NAS:UniProtKB
P08779	KRT16	Keratin, type I cytoskeletal 16	GO:0008283; P:cell proliferation; TAS:ProtInc
P08779	KRT16	Keratin, type I cytoskeletal 16	GO:0007010; P:cytoskeleton organization; NAS:UniProtKB
P08779	KRT16	Keratin, type I cytoskeletal 16	GO:0008544; P:epidermis development; TAS:ProtInc
P08779	KRT16	Keratin, type I cytoskeletal 16	GO:0045104; P:intermediate filament cytoskeleton organization; IEA:Ensembl
Q04695	KRT17	Keratin, type I cytoskeletal 17	GO:0042289; F:MHC class II protein binding; IPI:UniProtKB
Q04695	KRT17	Keratin, type I cytoskeletal 17	GO:0032395; F:MHC class II receptor activity; IDA:UniProtKB
Q04695	KRT17	Keratin, type I cytoskeletal 17	GO:0005515; F:protein binding; IPI:IntAct
Q04695	KRT17	Keratin, type I cytoskeletal 17	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
Q04695	KRT17	Keratin, type I cytoskeletal 17	GO:0008544; P:epidermis development; TAS:ProtInc
Q04695	KRT17	Keratin, type I cytoskeletal 17	GO:0045109; P:intermediate filament organization; IEA:Ensembl
Q04695	KRT17	Keratin, type I cytoskeletal 17	GO:0031424; P:keratinization; IEA:Ensembl
Q04695	KRT17	Keratin, type I cytoskeletal 17	GO:0002009; P:morphogenesis of an epithelium; IEA:Ensembl
Q04695	KRT17	Keratin, type I cytoskeletal 17	GO:0030307; P:positive regulation of cell growth; IEA:Ensembl
Q04695	KRT17	Keratin, type I cytoskeletal 17	GO:0051798; P:positive regulation of hair follicle development; IEA:Ensembl
Q04695	KRT17	Keratin, type I cytoskeletal 17	GO:0045727; P:positive regulation of translation; IEA:Ensembl
Q04695	KRT17	Keratin, type I cytoskeletal 17	GO:0007165; P:signal transduction; IMP:UniProtKB
P05783	KRT18	Keratin, type I cytoskeletal 18	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P05783	KRT18	Keratin, type I cytoskeletal 18	GO:0005515; F:protein binding; IPI:UniProtKB
P05783	KRT18	Keratin, type I cytoskeletal 18	GO:0097110; F:scaffold protein binding; IPI:BHF-UCL
P05783	KRT18	Keratin, type I cytoskeletal 18	GO:0005198; F:structural molecule activity; IEA:InterPro
P05783	KRT18	Keratin, type I cytoskeletal 18	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P05783	KRT18	Keratin, type I cytoskeletal 18	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P05783	KRT18	Keratin, type I cytoskeletal 18	GO:0097191; P:extrinsic apoptotic signaling pathway; IEA:Ensembl
P05783	KRT18	Keratin, type I cytoskeletal 18	GO:0043000; P:Golgi to plasma membrane CFTR protein transport; IDA:UniProtKB
P05783	KRT18	Keratin, type I cytoskeletal 18	GO:0097284; P:hepatocyte apoptotic process; IEA:Ensembl
P05783	KRT18	Keratin, type I cytoskeletal 18	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P05783	KRT18	Keratin, type I cytoskeletal 18	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IEA:Ensembl
P05783	KRT18	Keratin, type I cytoskeletal 18	GO:0016032; P:viral process; IEA:UniProtKB-KW
P08727	KRT19	Keratin, type I cytoskeletal 19	GO:0005515; F:protein binding; IPI:UniProtKB
P08727	KRT19	Keratin, type I cytoskeletal 19	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P08727	KRT19	Keratin, type I cytoskeletal 19	GO:0008307; F:structural constituent of muscle; IDA:UniProtKB
P08727	KRT19	Keratin, type I cytoskeletal 19	GO:0060706; P:cell differentiation involved in embryonic placenta development; IEA:Ensembl
P08727	KRT19	Keratin, type I cytoskeletal 19	GO:0043627; P:response to estrogen; IEP:UniProtKB
P08727	KRT19	Keratin, type I cytoskeletal 19	GO:0045214; P:sarcomere organization; IDA:UniProtKB
P08727	KRT19	Keratin, type I cytoskeletal 19	GO:0016032; P:viral process; IEA:UniProtKB-KW
P35900	KRT20	Keratin, type I cytoskeletal 20	GO:0005515; F:protein binding; IPI:UniProtKB
P35900	KRT20	Keratin, type I cytoskeletal 20	GO:0005200; F:structural constituent of cytoskeleton; NAS:UniProtKB
P35900	KRT20	Keratin, type I cytoskeletal 20	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P35900	KRT20	Keratin, type I cytoskeletal 20	GO:0033554; P:cellular response to stress; IEA:Ensembl
P35900	KRT20	Keratin, type I cytoskeletal 20	GO:0045109; P:intermediate filament organization; IMP:UniProtKB
P35900	KRT20	Keratin, type I cytoskeletal 20	GO:0050708; P:regulation of protein secretion; IEA:Ensembl
Q9C075	KRT23	Keratin, type I cytoskeletal 23	GO:0005198; F:structural molecule activity; IEA:InterPro
Q2M2I5	KRT24	Keratin, type I cytoskeletal 24	GO:0005198; F:structural molecule activity; IEA:InterPro
Q7Z3Z0	KRT25	Keratin, type I cytoskeletal 25	GO:0005198; F:structural molecule activity; IEA:InterPro
Q7Z3Z0	KRT25	Keratin, type I cytoskeletal 25	GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl
Q7Z3Z0	KRT25	Keratin, type I cytoskeletal 25	GO:0045109; P:intermediate filament organization; IEA:Ensembl
Q7Z3Y9	KRT26	Keratin, type I cytoskeletal 26	GO:0005198; F:structural molecule activity; IEA:InterPro
Q7Z3Y8	KRT27	Keratin, type I cytoskeletal 27	GO:0005198; F:structural molecule activity; IEA:InterPro
Q7Z3Y8	KRT27	Keratin, type I cytoskeletal 27	GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl
Q7Z3Y7	KRT28	Keratin, type I cytoskeletal 28	GO:0005198; F:structural molecule activity; IEA:InterPro
Q6A163	KRT39	Keratin, type I cytoskeletal 39	GO:0005198; F:structural molecule activity; IEA:InterPro
Q6A162	KRT40	Keratin, type I cytoskeletal 40	GO:0005198; F:structural molecule activity; IEA:InterPro
P35527	KRT9	Keratin, type I cytoskeletal 9	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P35527	KRT9	Keratin, type I cytoskeletal 9	GO:0008544; P:epidermis development; TAS:ProtInc
P35527	KRT9	Keratin, type I cytoskeletal 9	GO:0045109; P:intermediate filament organization; IMP:UniProtKB
P35527	KRT9	Keratin, type I cytoskeletal 9	GO:0043588; P:skin development; IDA:UniProtKB
Q15323	KRT31	Keratin, type I cuticular Ha1	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
Q15323	KRT31	Keratin, type I cuticular Ha1	GO:0008544; P:epidermis development; TAS:ProtInc
Q14532	KRT32	Keratin, type I cuticular Ha2	GO:0005198; F:structural molecule activity; IEA:InterPro
Q14532	KRT32	Keratin, type I cuticular Ha2	GO:0008544; P:epidermis development; TAS:ProtInc
Q68DE3	KIAA2018	Basic helix-loop-helix domain-containing protein KIAA2018	GO:0005509; F:calcium ion binding; IEA:InterPro
Q68DE3	KIAA2018	Basic helix-loop-helix domain-containing protein KIAA2018	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q68DE3	KIAA2018	Basic helix-loop-helix domain-containing protein KIAA2018	GO:0004571; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; IEA:InterPro
Q5QGS0	KIAA2022	Protein KIAA2022	GO:0008408; F:3'-5' exonuclease activity; IBA:RefGenome
Q5QGS0	KIAA2022	Protein KIAA2022	GO:0003887; F:DNA-directed DNA polymerase activity; IBA:RefGenome
Q5QGS0	KIAA2022	Protein KIAA2022	GO:0006287; P:base-excision repair, gap-filling; IBA:RefGenome
Q5QGS0	KIAA2022	Protein KIAA2022	GO:0045004; P:DNA replication proofreading; IBA:RefGenome
Q5QGS0	KIAA2022	Protein KIAA2022	GO:0043137; P:DNA replication, removal of RNA primer; IBA:RefGenome
Q5QGS0	KIAA2022	Protein KIAA2022	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q5QGS0	KIAA2022	Protein KIAA2022	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IBA:GOC
Q5QGS0	KIAA2022	Protein KIAA2022	GO:0006297; P:nucleotide-excision repair, DNA gap filling; IBA:RefGenome
Q5QGS0	KIAA2022	Protein KIAA2022	GO:0007346; P:regulation of mitotic cell cycle; IBA:RefGenome
P35908	KRT2	Keratin, type II cytoskeletal 2 epidermal	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P35908	KRT2	Keratin, type II cytoskeletal 2 epidermal	GO:0008544; P:epidermis development; TAS:ProtInc
P35908	KRT2	Keratin, type II cytoskeletal 2 epidermal	GO:0031424; P:keratinization; IDA:UniProtKB
P35908	KRT2	Keratin, type II cytoskeletal 2 epidermal	GO:0032980; P:keratinocyte activation; IDA:UniProtKB
P35908	KRT2	Keratin, type II cytoskeletal 2 epidermal	GO:0051546; P:keratinocyte migration; IDA:UniProtKB
P35908	KRT2	Keratin, type II cytoskeletal 2 epidermal	GO:0043616; P:keratinocyte proliferation; IDA:UniProtKB
Q01546	KRT76	Keratin, type II cytoskeletal 2 oral	GO:0005198; F:structural molecule activity; IEA:InterPro
Q01546	KRT76	Keratin, type II cytoskeletal 2 oral	GO:0007010; P:cytoskeleton organization; NAS:UniProtKB
Q7Z794	KRT77	Keratin, type II cytoskeletal 1b	GO:0005198; F:structural molecule activity; IEA:InterPro
P04264	KRT1	Keratin, type II cytoskeletal 1	GO:0030246; F:carbohydrate binding; IPI:UniProtKB
P04264	KRT1	Keratin, type II cytoskeletal 1	GO:0005515; F:protein binding; IPI:UniProtKB
P04264	KRT1	Keratin, type II cytoskeletal 1	GO:0004872; F:receptor activity; NAS:UniProtKB
P04264	KRT1	Keratin, type II cytoskeletal 1	GO:0005198; F:structural molecule activity; IEA:InterPro
P04264	KRT1	Keratin, type II cytoskeletal 1	GO:0001867; P:complement activation, lectin pathway; IPI:UniProtKB
P04264	KRT1	Keratin, type II cytoskeletal 1	GO:0042730; P:fibrinolysis; NAS:UniProtKB
P04264	KRT1	Keratin, type II cytoskeletal 1	GO:0045765; P:regulation of angiogenesis; NAS:UniProtKB
P04264	KRT1	Keratin, type II cytoskeletal 1	GO:0006979; P:response to oxidative stress; NAS:UniProtKB
P04264	KRT1	Keratin, type II cytoskeletal 1	GO:0001895; P:retina homeostasis; IEP:UniProt
P12035	KRT3	Keratin, type II cytoskeletal 3	GO:0005198; F:structural molecule activity; IMP:UniProtKB
P12035	KRT3	Keratin, type II cytoskeletal 3	GO:0030855; P:epithelial cell differentiation; ISS:UniProtKB
P12035	KRT3	Keratin, type II cytoskeletal 3	GO:0045104; P:intermediate filament cytoskeleton organization; IMP:UniProtKB
P19013	KRT4	Keratin, type II cytoskeletal 4	GO:0005198; F:structural molecule activity; IEA:InterPro
P19013	KRT4	Keratin, type II cytoskeletal 4	GO:0007010; P:cytoskeleton organization; NAS:UniProtKB
P19013	KRT4	Keratin, type II cytoskeletal 4	GO:0030855; P:epithelial cell differentiation; ISS:UniProtKB
P19013	KRT4	Keratin, type II cytoskeletal 4	GO:0050680; P:negative regulation of epithelial cell proliferation; ISS:UniProtKB
P13647	KRT5	Keratin, type II cytoskeletal 5	GO:0005515; F:protein binding; IPI:IntAct
P13647	KRT5	Keratin, type II cytoskeletal 5	GO:0097110; F:scaffold protein binding; IPI:BHF-UCL
P13647	KRT5	Keratin, type II cytoskeletal 5	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P13647	KRT5	Keratin, type II cytoskeletal 5	GO:0034329; P:cell junction assembly; TAS:Reactome
P13647	KRT5	Keratin, type II cytoskeletal 5	GO:0008544; P:epidermis development; TAS:ProtInc
P13647	KRT5	Keratin, type II cytoskeletal 5	GO:0031581; P:hemidesmosome assembly; TAS:Reactome
P02538	KRT6A	Keratin, type II cytoskeletal 6A	GO:0005515; F:protein binding; IPI:IntAct
P02538	KRT6A	Keratin, type II cytoskeletal 6A	GO:0005200; F:structural constituent of cytoskeleton; NAS:UniProtKB
P02538	KRT6A	Keratin, type II cytoskeletal 6A	GO:0030154; P:cell differentiation; NAS:UniProtKB
P02538	KRT6A	Keratin, type II cytoskeletal 6A	GO:0007398; P:ectoderm development; TAS:ProtInc
P02538	KRT6A	Keratin, type II cytoskeletal 6A	GO:0008284; P:positive regulation of cell proliferation; NAS:UniProtKB
P04259	KRT6B	Keratin, type II cytoskeletal 6B	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P04259	KRT6B	Keratin, type II cytoskeletal 6B	GO:0007398; P:ectoderm development; TAS:ProtInc
P48668	KRT6C	Keratin, type II cytoskeletal 6C	GO:0005198; F:structural molecule activity; IEA:InterPro
Q3SY84	KRT71	Keratin, type II cytoskeletal 71	GO:0005198; F:structural molecule activity; IEA:InterPro
Q3SY84	KRT71	Keratin, type II cytoskeletal 71	GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl
Q14CN4	KRT72	Keratin, type II cytoskeletal 72	GO:0005198; F:structural molecule activity; IEA:InterPro
Q86Y46	KRT73	Keratin, type II cytoskeletal 73	GO:0005198; F:structural molecule activity; IEA:InterPro
Q7RTS7	KRT74	Keratin, type II cytoskeletal 74	GO:0005198; F:structural molecule activity; IEA:InterPro
O95678	KRT75	Keratin, type II cytoskeletal 75	GO:0005198; F:structural molecule activity; TAS:ProtInc
Q8N1N4	KRT78	Keratin, type II cytoskeletal 78	GO:0005198; F:structural molecule activity; IEA:InterPro
Q5XKE5	KRT79	Keratin, type II cytoskeletal 79	GO:0005198; F:structural molecule activity; IEA:InterPro
P08729	KRT7	Keratin, type II cytoskeletal 7	GO:0005515; F:protein binding; IPI:UniProtKB
P08729	KRT7	Keratin, type II cytoskeletal 7	GO:0005198; F:structural molecule activity; IEA:InterPro
P08729	KRT7	Keratin, type II cytoskeletal 7	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q6KB66	KRT80	Keratin, type II cytoskeletal 80	GO:0005198; F:structural molecule activity; IEA:InterPro
P05787	KRT8	Keratin, type II cytoskeletal 8	GO:0005515; F:protein binding; IPI:UniProtKB
P05787	KRT8	Keratin, type II cytoskeletal 8	GO:0097110; F:scaffold protein binding; IPI:BHF-UCL
P05787	KRT8	Keratin, type II cytoskeletal 8	GO:0005198; F:structural molecule activity; IEA:InterPro
P05787	KRT8	Keratin, type II cytoskeletal 8	GO:0060706; P:cell differentiation involved in embryonic placenta development; IEA:Ensembl
P05787	KRT8	Keratin, type II cytoskeletal 8	GO:0097191; P:extrinsic apoptotic signaling pathway; IEA:Ensembl
P05787	KRT8	Keratin, type II cytoskeletal 8	GO:0097284; P:hepatocyte apoptotic process; IEA:Ensembl
P05787	KRT8	Keratin, type II cytoskeletal 8	GO:0051599; P:response to hydrostatic pressure; IEA:Ensembl
P05787	KRT8	Keratin, type II cytoskeletal 8	GO:0051707; P:response to other organism; IEA:Ensembl
P05787	KRT8	Keratin, type II cytoskeletal 8	GO:0045214; P:sarcomere organization; IEA:Ensembl
P05787	KRT8	Keratin, type II cytoskeletal 8	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IEA:Ensembl
P05787	KRT8	Keratin, type II cytoskeletal 8	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q8IZA0	KIAA0319L	Dyslexia-associated protein KIAA0319-like protein	GO:0005515; F:protein binding; IPI:UniProtKB
P08237	PFKM	6-phosphofructokinase, muscle type	GO:0003872; F:6-phosphofructokinase activity; IDA:UniProtKB
P08237	PFKM	6-phosphofructokinase, muscle type	GO:0005524; F:ATP binding; IDA:BHF-UCL
P08237	PFKM	6-phosphofructokinase, muscle type	GO:0070061; F:fructose binding; IDA:BHF-UCL
P08237	PFKM	6-phosphofructokinase, muscle type	GO:0042802; F:identical protein binding; IPI:IntAct
P08237	PFKM	6-phosphofructokinase, muscle type	GO:0019900; F:kinase binding; IPI:BHF-UCL
P08237	PFKM	6-phosphofructokinase, muscle type	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P08237	PFKM	6-phosphofructokinase, muscle type	GO:0005515; F:protein binding; IPI:IntAct
P08237	PFKM	6-phosphofructokinase, muscle type	GO:0008022; F:protein C-terminus binding; IPI:HGNC
P08237	PFKM	6-phosphofructokinase, muscle type	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P08237	PFKM	6-phosphofructokinase, muscle type	GO:0046835; P:carbohydrate phosphorylation; IDA:GOC
P08237	PFKM	6-phosphofructokinase, muscle type	GO:0006002; P:fructose 6-phosphate metabolic process; IDA:BHF-UCL
P08237	PFKM	6-phosphofructokinase, muscle type	GO:0042593; P:glucose homeostasis; IEA:Ensembl
P08237	PFKM	6-phosphofructokinase, muscle type	GO:0006006; P:glucose metabolic process; TAS:Reactome
P08237	PFKM	6-phosphofructokinase, muscle type	GO:0006096; P:glycolytic process; IMP:UniProtKB
P08237	PFKM	6-phosphofructokinase, muscle type	GO:0046716; P:muscle cell cellular homeostasis; IMP:BHF-UCL
P08237	PFKM	6-phosphofructokinase, muscle type	GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl
P08237	PFKM	6-phosphofructokinase, muscle type	GO:0051259; P:protein oligomerization; IDA:BHF-UCL
P08237	PFKM	6-phosphofructokinase, muscle type	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P17858	PFKL	6-phosphofructokinase, liver type	GO:0003872; F:6-phosphofructokinase activity; IDA:UniProtKB
P17858	PFKL	6-phosphofructokinase, liver type	GO:0005524; F:ATP binding; IDA:UniProtKB
P17858	PFKL	6-phosphofructokinase, liver type	GO:0070061; F:fructose binding; IDA:BHF-UCL
P17858	PFKL	6-phosphofructokinase, liver type	GO:0070095; F:fructose-6-phosphate binding; IDA:BHF-UCL
P17858	PFKL	6-phosphofructokinase, liver type	GO:0042802; F:identical protein binding; IPI:IntAct
P17858	PFKL	6-phosphofructokinase, liver type	GO:0019900; F:kinase binding; IPI:BHF-UCL
P17858	PFKL	6-phosphofructokinase, liver type	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17858	PFKL	6-phosphofructokinase, liver type	GO:0005515; F:protein binding; IPI:UniProtKB
P17858	PFKL	6-phosphofructokinase, liver type	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P17858	PFKL	6-phosphofructokinase, liver type	GO:0046835; P:carbohydrate phosphorylation; IDA:GOC
P17858	PFKL	6-phosphofructokinase, liver type	GO:0030388; P:fructose 1,6-bisphosphate metabolic process; IDA:UniProtKB
P17858	PFKL	6-phosphofructokinase, liver type	GO:0006002; P:fructose 6-phosphate metabolic process; IDA:UniProtKB
P17858	PFKL	6-phosphofructokinase, liver type	GO:0006006; P:glucose metabolic process; TAS:Reactome
P17858	PFKL	6-phosphofructokinase, liver type	GO:0006096; P:glycolytic process; IDA:UniProtKB
P17858	PFKL	6-phosphofructokinase, liver type	GO:0046676; P:negative regulation of insulin secretion; IEA:Ensembl
P17858	PFKL	6-phosphofructokinase, liver type	GO:0051289; P:protein homotetramerization; IEA:Ensembl
P17858	PFKL	6-phosphofructokinase, liver type	GO:0051259; P:protein oligomerization; IDA:BHF-UCL
P17858	PFKL	6-phosphofructokinase, liver type	GO:0009749; P:response to glucose; IDA:UniProtKB
P17858	PFKL	6-phosphofructokinase, liver type	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q01813	PFKP	6-phosphofructokinase type C	GO:0003872; F:6-phosphofructokinase activity; ISS:UniProtKB
Q01813	PFKP	6-phosphofructokinase type C	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q01813	PFKP	6-phosphofructokinase type C	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q01813	PFKP	6-phosphofructokinase type C	GO:0032403; F:protein complex binding; IDA:MGI
Q01813	PFKP	6-phosphofructokinase type C	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q01813	PFKP	6-phosphofructokinase type C	GO:0046835; P:carbohydrate phosphorylation; ISS:GOC
Q01813	PFKP	6-phosphofructokinase type C	GO:0006002; P:fructose 6-phosphate metabolic process; IEA:InterPro
Q01813	PFKP	6-phosphofructokinase type C	GO:0006006; P:glucose metabolic process; TAS:Reactome
Q01813	PFKP	6-phosphofructokinase type C	GO:0006096; P:glycolytic process; TAS:Reactome
Q01813	PFKP	6-phosphofructokinase type C	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UBP8	KAAG1	Kidney-associated antigen 1	GO:0006955; P:immune response; NAS:UniProtKB
P00568	AK1	Adenylate kinase isoenzyme 1	GO:0004017; F:adenylate kinase activity; TAS:ProtInc
P00568	AK1	Adenylate kinase isoenzyme 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P00568	AK1	Adenylate kinase isoenzyme 1	GO:0004550; F:nucleoside diphosphate kinase activity; IDA:UniProtKB
P00568	AK1	Adenylate kinase isoenzyme 1	GO:0046034; P:ATP metabolic process; IEA:InterPro
P00568	AK1	Adenylate kinase isoenzyme 1	GO:0007050; P:cell cycle arrest; IEA:Ensembl
P00568	AK1	Adenylate kinase isoenzyme 1	GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome
P00568	AK1	Adenylate kinase isoenzyme 1	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P00568	AK1	Adenylate kinase isoenzyme 1	GO:0006165; P:nucleoside diphosphate phosphorylation; IDA:UniProtKB
P00568	AK1	Adenylate kinase isoenzyme 1	GO:0009142; P:nucleoside triphosphate biosynthetic process; IDA:UniProtKB
P00568	AK1	Adenylate kinase isoenzyme 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P54819	AK2	Adenylate kinase 2, mitochondrial	GO:0004017; F:adenylate kinase activity; TAS:ProtInc
P54819	AK2	Adenylate kinase 2, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P54819	AK2	Adenylate kinase 2, mitochondrial	GO:0006172; P:ADP biosynthetic process; IEA:Ensembl
P54819	AK2	Adenylate kinase 2, mitochondrial	GO:0046033; P:AMP metabolic process; IEA:Ensembl
P54819	AK2	Adenylate kinase 2, mitochondrial	GO:0046034; P:ATP metabolic process; IEA:Ensembl
P54819	AK2	Adenylate kinase 2, mitochondrial	GO:0007420; P:brain development; IEA:Ensembl
P54819	AK2	Adenylate kinase 2, mitochondrial	GO:0046060; P:dATP metabolic process; IEA:Ensembl
P54819	AK2	Adenylate kinase 2, mitochondrial	GO:0001889; P:liver development; IEA:Ensembl
P54819	AK2	Adenylate kinase 2, mitochondrial	GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome
P54819	AK2	Adenylate kinase 2, mitochondrial	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P54819	AK2	Adenylate kinase 2, mitochondrial	GO:0046939; P:nucleotide phosphorylation; TAS:GOC
P54819	AK2	Adenylate kinase 2, mitochondrial	GO:0006119; P:oxidative phosphorylation; IEA:Ensembl
P54819	AK2	Adenylate kinase 2, mitochondrial	GO:0097066; P:response to thyroid hormone; IEA:Ensembl
P54819	AK2	Adenylate kinase 2, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UIJ7	AK3	GTP:AMP phosphotransferase AK3, mitochondrial	GO:0005524; F:ATP binding; IEA:InterPro
Q9UIJ7	AK3	GTP:AMP phosphotransferase AK3, mitochondrial	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9UIJ7	AK3	GTP:AMP phosphotransferase AK3, mitochondrial	GO:0046899; F:nucleoside triphosphate adenylate kinase activity; IDA:BHF-UCL
Q9UIJ7	AK3	GTP:AMP phosphotransferase AK3, mitochondrial	GO:0046033; P:AMP metabolic process; IDA:BHF-UCL
Q9UIJ7	AK3	GTP:AMP phosphotransferase AK3, mitochondrial	GO:0007596; P:blood coagulation; TAS:Reactome
Q9UIJ7	AK3	GTP:AMP phosphotransferase AK3, mitochondrial	GO:0046039; P:GTP metabolic process; IDA:BHF-UCL
Q9UIJ7	AK3	GTP:AMP phosphotransferase AK3, mitochondrial	GO:0046041; P:ITP metabolic process; IDA:BHF-UCL
Q9UIJ7	AK3	GTP:AMP phosphotransferase AK3, mitochondrial	GO:0046051; P:UTP metabolic process; IDA:BHF-UCL
P27144	AK4	Adenylate kinase 4, mitochondrial	GO:0004017; F:adenylate kinase activity; IDA:BHF-UCL
P27144	AK4	Adenylate kinase 4, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P27144	AK4	Adenylate kinase 4, mitochondrial	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P27144	AK4	Adenylate kinase 4, mitochondrial	GO:0004550; F:nucleoside diphosphate kinase activity; IDA:UniProtKB
P27144	AK4	Adenylate kinase 4, mitochondrial	GO:0046899; F:nucleoside triphosphate adenylate kinase activity; IDA:BHF-UCL
P27144	AK4	Adenylate kinase 4, mitochondrial	GO:0046033; P:AMP metabolic process; IDA:BHF-UCL
P27144	AK4	Adenylate kinase 4, mitochondrial	GO:0046034; P:ATP metabolic process; IDA:BHF-UCL
P27144	AK4	Adenylate kinase 4, mitochondrial	GO:0007420; P:brain development; IEA:Ensembl
P27144	AK4	Adenylate kinase 4, mitochondrial	GO:0046039; P:GTP metabolic process; IDA:BHF-UCL
P27144	AK4	Adenylate kinase 4, mitochondrial	GO:0001889; P:liver development; IEA:Ensembl
P27144	AK4	Adenylate kinase 4, mitochondrial	GO:0006165; P:nucleoside diphosphate phosphorylation; IDA:UniProtKB
P27144	AK4	Adenylate kinase 4, mitochondrial	GO:0009142; P:nucleoside triphosphate biosynthetic process; IDA:UniProtKB
P27144	AK4	Adenylate kinase 4, mitochondrial	GO:0042493; P:response to drug; IEA:Ensembl
Q9Y6K8	AK5	Adenylate kinase isoenzyme 5	GO:0004017; F:adenylate kinase activity; TAS:ProtInc
Q9Y6K8	AK5	Adenylate kinase isoenzyme 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y6K8	AK5	Adenylate kinase isoenzyme 5	GO:0004550; F:nucleoside diphosphate kinase activity; IDA:UniProtKB
Q9Y6K8	AK5	Adenylate kinase isoenzyme 5	GO:0019206; F:nucleoside kinase activity; EXP:Reactome
Q9Y6K8	AK5	Adenylate kinase isoenzyme 5	GO:0006172; P:ADP biosynthetic process; TAS:ProtInc
Q9Y6K8	AK5	Adenylate kinase isoenzyme 5	GO:0046034; P:ATP metabolic process; IEA:InterPro
Q9Y6K8	AK5	Adenylate kinase isoenzyme 5	GO:0006173; P:dADP biosynthetic process; TAS:ProtInc
Q9Y6K8	AK5	Adenylate kinase isoenzyme 5	GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome
Q9Y6K8	AK5	Adenylate kinase isoenzyme 5	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q9Y6K8	AK5	Adenylate kinase isoenzyme 5	GO:0006165; P:nucleoside diphosphate phosphorylation; IDA:UniProtKB
Q9Y6K8	AK5	Adenylate kinase isoenzyme 5	GO:0009142; P:nucleoside triphosphate biosynthetic process; IDA:UniProtKB
Q9Y6K8	AK5	Adenylate kinase isoenzyme 5	GO:0009220; P:pyrimidine ribonucleotide biosynthetic process; TAS:ProtInc
Q9Y6K8	AK5	Adenylate kinase isoenzyme 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y3D8	AK6	Adenylate kinase isoenzyme 6	GO:0004017; F:adenylate kinase activity; IDA:UniProtKB
Q9Y3D8	AK6	Adenylate kinase isoenzyme 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y3D8	AK6	Adenylate kinase isoenzyme 6	GO:0016887; F:ATPase activity; IEA:UniProtKB-HAMAP
Q9Y3D8	AK6	Adenylate kinase isoenzyme 6	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3D8	AK6	Adenylate kinase isoenzyme 6	GO:0046939; P:nucleotide phosphorylation; IDA:GOC
Q96M32	AK7	Adenylate kinase 7	GO:0004017; F:adenylate kinase activity; IDA:UniProtKB
Q96M32	AK7	Adenylate kinase 7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96M32	AK7	Adenylate kinase 7	GO:0004127; F:cytidylate kinase activity; IDA:UniProtKB
Q96M32	AK7	Adenylate kinase 7	GO:0004550; F:nucleoside diphosphate kinase activity; IDA:UniProtKB
Q96M32	AK7	Adenylate kinase 7	GO:0007420; P:brain development; IEA:Ensembl
Q96M32	AK7	Adenylate kinase 7	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
Q96M32	AK7	Adenylate kinase 7	GO:0003351; P:epithelial cilium movement; IEA:Ensembl
Q96M32	AK7	Adenylate kinase 7	GO:0002437; P:inflammatory response to antigenic stimulus; IEA:Ensembl
Q96M32	AK7	Adenylate kinase 7	GO:0006165; P:nucleoside diphosphate phosphorylation; IDA:UniProtKB
Q96M32	AK7	Adenylate kinase 7	GO:0009142; P:nucleoside triphosphate biosynthetic process; IDA:UniProtKB
Q96M32	AK7	Adenylate kinase 7	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q96MA6	AK8	Adenylate kinase 8	GO:0004017; F:adenylate kinase activity; IDA:UniProtKB
Q96MA6	AK8	Adenylate kinase 8	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96MA6	AK8	Adenylate kinase 8	GO:0004127; F:cytidylate kinase activity; IDA:UniProtKB
Q96MA6	AK8	Adenylate kinase 8	GO:0004550; F:nucleoside diphosphate kinase activity; IDA:UniProtKB
Q96MA6	AK8	Adenylate kinase 8	GO:0006165; P:nucleoside diphosphate phosphorylation; IDA:UniProtKB
Q96MA6	AK8	Adenylate kinase 8	GO:0009142; P:nucleoside triphosphate biosynthetic process; IDA:UniProtKB
Q96MA6	AK8	Adenylate kinase 8	GO:0021591; P:ventricular system development; IEA:Ensembl
Q5TCS8	AK9	Adenylate kinase 9	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5TCS8	AK9	Adenylate kinase 9	GO:0004550; F:nucleoside diphosphate kinase activity; IDA:UniProtKB
Q5TCS8	AK9	Adenylate kinase 9	GO:0050145; F:nucleoside phosphate kinase activity; IDA:UniProtKB
Q5TCS8	AK9	Adenylate kinase 9	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q5TCS8	AK9	Adenylate kinase 9	GO:0006757; P:ADP phosphorylation; IDA:UniProtKB
Q5TCS8	AK9	Adenylate kinase 9	GO:0006756; P:AMP phosphorylation; IDA:UniProtKB
Q5TCS8	AK9	Adenylate kinase 9	GO:0061508; P:CDP phosphorylation; IDA:UniProtKB
Q5TCS8	AK9	Adenylate kinase 9	GO:0061566; P:CMP phosphorylation; IDA:UniProtKB
Q5TCS8	AK9	Adenylate kinase 9	GO:0006174; P:dADP phosphorylation; IDA:UniProtKB
Q5TCS8	AK9	Adenylate kinase 9	GO:0061565; P:dAMP phosphorylation; IDA:UniProtKB
Q5TCS8	AK9	Adenylate kinase 9	GO:0061570; P:dCDP phosphorylation; IDA:UniProtKB
Q5TCS8	AK9	Adenylate kinase 9	GO:0061567; P:dCMP phosphorylation; IDA:UniProtKB
Q5TCS8	AK9	Adenylate kinase 9	GO:0006186; P:dGDP phosphorylation; IDA:UniProtKB
Q5TCS8	AK9	Adenylate kinase 9	GO:0061568; P:GDP phosphorylation; IDA:UniProtKB
Q5TCS8	AK9	Adenylate kinase 9	GO:0061571; P:TDP phosphorylation; IDA:UniProtKB
Q5TCS8	AK9	Adenylate kinase 9	GO:0061569; P:UDP phosphorylation; IDA:UniProtKB
P29622	SERPINA4	Kallistatin	GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome
P29622	SERPINA4	Kallistatin	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P29622	SERPINA4	Kallistatin	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
Q86T24	ZBTB33	Transcriptional regulator Kaiso	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86T24	ZBTB33	Transcriptional regulator Kaiso	GO:0008327; F:methyl-CpG binding; IDA:UniProt
Q86T24	ZBTB33	Transcriptional regulator Kaiso	GO:0005515; F:protein binding; IPI:UniProt
Q86T24	ZBTB33	Transcriptional regulator Kaiso	GO:0043565; F:sequence-specific DNA binding; IDA:UniProt
Q86T24	ZBTB33	Transcriptional regulator Kaiso	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
Q86T24	ZBTB33	Transcriptional regulator Kaiso	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProt
Q86T24	ZBTB33	Transcriptional regulator Kaiso	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86T24	ZBTB33	Transcriptional regulator Kaiso	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P23352	KAL1	Anosmin-1	GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc
P23352	KAL1	Anosmin-1	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P23352	KAL1	Anosmin-1	GO:0005515; F:protein binding; IPI:IntAct
P23352	KAL1	Anosmin-1	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
P23352	KAL1	Anosmin-1	GO:0007411; P:axon guidance; TAS:ProtInc
P23352	KAL1	Anosmin-1	GO:0007155; P:cell adhesion; TAS:ProtInc
P23352	KAL1	Anosmin-1	GO:0006928; P:cellular component movement; TAS:ProtInc
P23352	KAL1	Anosmin-1	GO:0006935; P:chemotaxis; TAS:ProtInc
O60229	KALRN	Kalirin	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O60229	KALRN	Kalirin	GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:ProtInc
O60229	KALRN	Kalirin	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60229	KALRN	Kalirin	GO:0005515; F:protein binding; IPI:IntAct
O60229	KALRN	Kalirin	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
O60229	KALRN	Kalirin	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
O60229	KALRN	Kalirin	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
O60229	KALRN	Kalirin	GO:0035556; P:intracellular signal transduction; ISS:HGNC
O60229	KALRN	Kalirin	GO:0007399; P:nervous system development; ISS:HGNC
O60229	KALRN	Kalirin	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O60229	KALRN	Kalirin	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
O60229	KALRN	Kalirin	GO:0006468; P:protein phosphorylation; TAS:ProtInc
O60229	KALRN	Kalirin	GO:0043087; P:regulation of GTPase activity; TAS:GOC
O60229	KALRN	Kalirin	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
O60229	KALRN	Kalirin	GO:0007165; P:signal transduction; TAS:ProtInc
O60229	KALRN	Kalirin	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
O60229	KALRN	Kalirin	GO:0016192; P:vesicle-mediated transport; TAS:ProtInc
Q14678	KANK1	KN motif and ankyrin repeat domain-containing protein 1	GO:0008013; F:beta-catenin binding; IDA:UniProtKB
Q14678	KANK1	KN motif and ankyrin repeat domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q14678	KANK1	KN motif and ankyrin repeat domain-containing protein 1	GO:0030837; P:negative regulation of actin filament polymerization; IDA:UniProtKB
Q14678	KANK1	KN motif and ankyrin repeat domain-containing protein 1	GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB
Q14678	KANK1	KN motif and ankyrin repeat domain-containing protein 1	GO:0046627; P:negative regulation of insulin receptor signaling pathway; IMP:UniProtKB
Q14678	KANK1	KN motif and ankyrin repeat domain-containing protein 1	GO:2000393; P:negative regulation of lamellipodium morphogenesis; IDA:UniProtKB
Q14678	KANK1	KN motif and ankyrin repeat domain-containing protein 1	GO:0010977; P:negative regulation of neuron projection development; IDA:UniProtKB
Q14678	KANK1	KN motif and ankyrin repeat domain-containing protein 1	GO:0035024; P:negative regulation of Rho protein signal transduction; IMP:UniProtKB
Q14678	KANK1	KN motif and ankyrin repeat domain-containing protein 1	GO:1900028; P:negative regulation of ruffle assembly; IDA:UniProtKB
Q14678	KANK1	KN motif and ankyrin repeat domain-containing protein 1	GO:1900025; P:negative regulation of substrate adhesion-dependent cell spreading; IDA:UniProtKB
Q14678	KANK1	KN motif and ankyrin repeat domain-containing protein 1	GO:0035413; P:positive regulation of catenin import into nucleus; IMP:UniProtKB
Q14678	KANK1	KN motif and ankyrin repeat domain-containing protein 1	GO:0030177; P:positive regulation of Wnt signaling pathway; IDA:UniProtKB
Q14678	KANK1	KN motif and ankyrin repeat domain-containing protein 1	GO:0090303; P:positive regulation of wound healing; IMP:UniProtKB
Q14678	KANK1	KN motif and ankyrin repeat domain-containing protein 1	GO:2000114; P:regulation of establishment of cell polarity; IMP:UniProtKB
Q14678	KANK1	KN motif and ankyrin repeat domain-containing protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q14678	KANK1	KN motif and ankyrin repeat domain-containing protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q63ZY3	KANK2	KN motif and ankyrin repeat domain-containing protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q63ZY3	KANK2	KN motif and ankyrin repeat domain-containing protein 2	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q63ZY3	KANK2	KN motif and ankyrin repeat domain-containing protein 2	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q63ZY3	KANK2	KN motif and ankyrin repeat domain-containing protein 2	GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IDA:UniProtKB
Q63ZY3	KANK2	KN motif and ankyrin repeat domain-containing protein 2	GO:0033147; P:negative regulation of intracellular estrogen receptor signaling pathway; IDA:UniProtKB
Q63ZY3	KANK2	KN motif and ankyrin repeat domain-containing protein 2	GO:0043069; P:negative regulation of programmed cell death; IDA:UniProtKB
Q63ZY3	KANK2	KN motif and ankyrin repeat domain-containing protein 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q63ZY3	KANK2	KN motif and ankyrin repeat domain-containing protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z3B3	KANSL1	KAT8 regulatory NSL complex subunit 1	GO:0005515; F:protein binding; IPI:IntAct
Q7Z3B3	KANSL1	KAT8 regulatory NSL complex subunit 1	GO:0006325; P:chromatin organization; TAS:Reactome
Q7Z3B3	KANSL1	KAT8 regulatory NSL complex subunit 1	GO:0043984; P:histone H4-K16 acetylation; IDA:UniProtKB
Q7Z3B3	KANSL1	KAT8 regulatory NSL complex subunit 1	GO:0043981; P:histone H4-K5 acetylation; IDA:UniProtKB
Q7Z3B3	KANSL1	KAT8 regulatory NSL complex subunit 1	GO:0043982; P:histone H4-K8 acetylation; IDA:UniProtKB
Q9P2N6	KANSL3	KAT8 regulatory NSL complex subunit 3	GO:0006325; P:chromatin organization; TAS:Reactome
Q9P2N6	KANSL3	KAT8 regulatory NSL complex subunit 3	GO:0043984; P:histone H4-K16 acetylation; IDA:UniProtKB
Q9P2N6	KANSL3	KAT8 regulatory NSL complex subunit 3	GO:0043981; P:histone H4-K5 acetylation; IDA:UniProtKB
Q9P2N6	KANSL3	KAT8 regulatory NSL complex subunit 3	GO:0043982; P:histone H4-K8 acetylation; IDA:UniProtKB
Q9H9L4	KANSL2	KAT8 regulatory NSL complex subunit 2	GO:0006325; P:chromatin organization; TAS:Reactome
Q9H9L4	KANSL2	KAT8 regulatory NSL complex subunit 2	GO:0043984; P:histone H4-K16 acetylation; IDA:UniProtKB
Q9H9L4	KANSL2	KAT8 regulatory NSL complex subunit 2	GO:0043981; P:histone H4-K5 acetylation; IDA:UniProtKB
Q9H9L4	KANSL2	KAT8 regulatory NSL complex subunit 2	GO:0043982; P:histone H4-K8 acetylation; IDA:UniProtKB
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0030552; F:cAMP binding; IEA:UniProtKB-KW
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0004862; F:cAMP-dependent protein kinase inhibitor activity; IDA:BHF-UCL
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0008603; F:cAMP-dependent protein kinase regulator activity; IEA:InterPro
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0005515; F:protein binding; IPI:IntAct
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0034236; F:protein kinase A catalytic subunit binding; IPI:BHF-UCL
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0031625; F:ubiquitin protein ligase binding; IDA:UniProtKB
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0034199; P:activation of protein kinase A activity; TAS:Reactome
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0007596; P:blood coagulation; TAS:Reactome
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0060038; P:cardiac muscle cell proliferation; IEA:Ensembl
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0007143; P:female meiotic division; IEA:Ensembl
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0045087; P:innate immune response; TAS:Reactome
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0001707; P:mesoderm formation; IEA:Ensembl
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:2000480; P:negative regulation of cAMP-dependent protein kinase activity; IDA:BHF-UCL
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0045835; P:negative regulation of meiosis; IEA:Ensembl
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0045214; P:sarcomere organization; IEA:Ensembl
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0007165; P:signal transduction; TAS:Reactome
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0055085; P:transmembrane transport; TAS:Reactome
P10644	PRKAR1A	cAMP-dependent protein kinase type I-alpha regulatory subunit	GO:0006833; P:water transport; TAS:Reactome
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:0030552; F:cAMP binding; IEA:UniProtKB-KW
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:0004862; F:cAMP-dependent protein kinase inhibitor activity; IDA:BHF-UCL
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:0008603; F:cAMP-dependent protein kinase regulator activity; NAS:UniProtKB
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:0034236; F:protein kinase A catalytic subunit binding; IPI:BHF-UCL
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:0034199; P:activation of protein kinase A activity; TAS:Reactome
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:0007596; P:blood coagulation; TAS:Reactome
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:0045087; P:innate immune response; TAS:Reactome
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:0007611; P:learning or memory; IEA:Ensembl
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:2000480; P:negative regulation of cAMP-dependent protein kinase activity; IDA:BHF-UCL
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:0006468; P:protein phosphorylation; NAS:UniProtKB
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:0007165; P:signal transduction; TAS:Reactome
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:0055085; P:transmembrane transport; TAS:Reactome
P31321	PRKAR1B	cAMP-dependent protein kinase type I-beta regulatory subunit	GO:0006833; P:water transport; TAS:Reactome
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0030552; F:cAMP binding; IEA:UniProtKB-KW
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0004862; F:cAMP-dependent protein kinase inhibitor activity; IDA:BHF-UCL
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0008603; F:cAMP-dependent protein kinase regulator activity; NAS:UniProtKB
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0005515; F:protein binding; IPI:IntAct
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0034236; F:protein kinase A catalytic subunit binding; IPI:BHF-UCL
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0031625; F:ubiquitin protein ligase binding; IDA:UniProtKB
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0034199; P:activation of protein kinase A activity; TAS:Reactome
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0007596; P:blood coagulation; TAS:Reactome
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0045087; P:innate immune response; TAS:Reactome
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:2000480; P:negative regulation of cAMP-dependent protein kinase activity; IDA:BHF-UCL
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0007165; P:signal transduction; TAS:Reactome
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0055085; P:transmembrane transport; TAS:Reactome
P13861	PRKAR2A	cAMP-dependent protein kinase type II-alpha regulatory subunit	GO:0006833; P:water transport; TAS:Reactome
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0030552; F:cAMP binding; IEA:UniProtKB-KW
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0004862; F:cAMP-dependent protein kinase inhibitor activity; IDA:BHF-UCL
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0008603; F:cAMP-dependent protein kinase regulator activity; IDA:BHF-UCL
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0034236; F:protein kinase A catalytic subunit binding; IPI:BHF-UCL
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0031625; F:ubiquitin protein ligase binding; IDA:UniProtKB
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0034199; P:activation of protein kinase A activity; TAS:Reactome
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0007596; P:blood coagulation; TAS:Reactome
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0006631; P:fatty acid metabolic process; IEA:Ensembl
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0045087; P:innate immune response; TAS:Reactome
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0007612; P:learning; IEA:Ensembl
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:2000480; P:negative regulation of cAMP-dependent protein kinase activity; IDA:BHF-UCL
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0007165; P:signal transduction; TAS:Reactome
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0055085; P:transmembrane transport; TAS:Reactome
P31323	PRKAR2B	cAMP-dependent protein kinase type II-beta regulatory subunit	GO:0006833; P:water transport; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0004691; F:cAMP-dependent protein kinase activity; IDA:BHF-UCL
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0005515; F:protein binding; IPI:BHF-UCL
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0034237; F:protein kinase A regulatory subunit binding; IPI:BHF-UCL
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0031625; F:ubiquitin protein ligase binding; IDA:UniProtKB
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0034199; P:activation of protein kinase A activity; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0007596; P:blood coagulation; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0035584; P:calcium-mediated signaling using intracellular calcium source; TAS:BHF-UCL
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0086064; P:cell communication by electrical coupling involved in cardiac conduction; TAS:BHF-UCL
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0071872; P:cellular response to epinephrine stimulus; TAS:BHF-UCL
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0071333; P:cellular response to glucose stimulus; IDA:UniProtKB
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0071374; P:cellular response to parathyroid hormone stimulus; IEA:Ensembl
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0051480; P:cytosolic calcium ion homeostasis; TAS:BHF-UCL
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0006094; P:gluconeogenesis; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0006006; P:glucose metabolic process; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0045087; P:innate immune response; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0035556; P:intracellular signal transduction; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0001707; P:mesoderm formation; IEA:Ensembl
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0071158; P:positive regulation of cell cycle arrest; ISS:UniProtKB
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0046827; P:positive regulation of protein export from nucleus; IEA:Ensembl
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0006468; P:protein phosphorylation; NAS:UniProtKB
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0055117; P:regulation of cardiac muscle contraction; TAS:BHF-UCL
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; TAS:BHF-UCL
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0002027; P:regulation of heart rate; TAS:BHF-UCL
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0045667; P:regulation of osteoblast differentiation; IDA:UniProtKB
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0061136; P:regulation of proteasomal protein catabolic process; IDA:UniProtKB
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0043393; P:regulation of protein binding; TAS:BHF-UCL
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0060314; P:regulation of ryanodine-sensitive calcium-release channel activity; TAS:BHF-UCL
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0050804; P:regulation of synaptic transmission; IEA:Ensembl
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:2000810; P:regulation of tight junction assembly; IDA:UniProtKB
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0007165; P:signal transduction; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0048240; P:sperm capacitation; ISS:UniProtKB
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0055085; P:transmembrane transport; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0019433; P:triglyceride catabolic process; TAS:Reactome
P17612	PRKACA	cAMP-dependent protein kinase catalytic subunit alpha	GO:0006833; P:water transport; TAS:Reactome
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0005524; F:ATP binding; IDA:UniProtKB
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0004691; F:cAMP-dependent protein kinase activity; IDA:UniProtKB
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0005515; F:protein binding; IPI:IntAct
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0031625; F:ubiquitin protein ligase binding; IDA:UniProtKB
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0034199; P:activation of protein kinase A activity; TAS:Reactome
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; TAS:UniProtKB
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0007596; P:blood coagulation; TAS:Reactome
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0006094; P:gluconeogenesis; TAS:Reactome
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0006006; P:glucose metabolic process; TAS:Reactome
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0045087; P:innate immune response; TAS:Reactome
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0035556; P:intracellular signal transduction; TAS:Reactome
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0051447; P:negative regulation of meiotic cell cycle; IEA:Ensembl
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0097338; P:response to clozapine; IEA:Ensembl
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0007165; P:signal transduction; TAS:Reactome
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0007268; P:synaptic transmission; TAS:Reactome
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0055085; P:transmembrane transport; TAS:Reactome
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0019433; P:triglyceride catabolic process; TAS:Reactome
P22694	PRKACB	cAMP-dependent protein kinase catalytic subunit beta	GO:0006833; P:water transport; TAS:Reactome
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0004691; F:cAMP-dependent protein kinase activity; TAS:ProtInc
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0034199; P:activation of protein kinase A activity; TAS:Reactome
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0007596; P:blood coagulation; TAS:Reactome
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0006094; P:gluconeogenesis; TAS:Reactome
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0006006; P:glucose metabolic process; TAS:Reactome
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0045087; P:innate immune response; TAS:Reactome
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0035556; P:intracellular signal transduction; TAS:Reactome
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0008584; P:male gonad development; TAS:ProtInc
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0007165; P:signal transduction; TAS:Reactome
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0007283; P:spermatogenesis; TAS:ProtInc
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0055085; P:transmembrane transport; TAS:Reactome
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0019433; P:triglyceride catabolic process; TAS:Reactome
P22612	PRKACG	cAMP-dependent protein kinase catalytic subunit gamma	GO:0006833; P:water transport; TAS:Reactome
Q8N6L0	CCDC155	Protein KASH5	GO:0005509; F:calcium ion binding; IEA:InterPro
Q16773	CCBL1	Kynurenine--oxoglutarate transaminase 1	GO:0047804; F:cysteine-S-conjugate beta-lyase activity; IEA:UniProtKB-EC
Q16773	CCBL1	Kynurenine--oxoglutarate transaminase 1	GO:0047316; F:glutamine-phenylpyruvate transaminase activity; IEA:UniProtKB-EC
Q16773	CCBL1	Kynurenine--oxoglutarate transaminase 1	GO:0016212; F:kynurenine-oxoglutarate transaminase activity; IDA:UniProtKB
Q16773	CCBL1	Kynurenine--oxoglutarate transaminase 1	GO:0047945; F:L-glutamine:pyruvate aminotransferase activity; EXP:Reactome
Q16773	CCBL1	Kynurenine--oxoglutarate transaminase 1	GO:0036141; F:L-phenylalanine-oxaloacetate transaminase activity; TAS:Reactome
Q16773	CCBL1	Kynurenine--oxoglutarate transaminase 1	GO:0047312; F:L-phenylalanine:pyruvate aminotransferase activity; EXP:Reactome
Q16773	CCBL1	Kynurenine--oxoglutarate transaminase 1	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q16773	CCBL1	Kynurenine--oxoglutarate transaminase 1	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q16773	CCBL1	Kynurenine--oxoglutarate transaminase 1	GO:0008483; F:transaminase activity; TAS:ProtInc
Q16773	CCBL1	Kynurenine--oxoglutarate transaminase 1	GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome
Q16773	CCBL1	Kynurenine--oxoglutarate transaminase 1	GO:0006575; P:cellular modified amino acid metabolic process; TAS:ProtInc
Q16773	CCBL1	Kynurenine--oxoglutarate transaminase 1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q16773	CCBL1	Kynurenine--oxoglutarate transaminase 1	GO:0070189; P:kynurenine metabolic process; IDA:UniProtKB
Q16773	CCBL1	Kynurenine--oxoglutarate transaminase 1	GO:0097053; P:L-kynurenine catabolic process; IEA:UniProtKB-UniPathway
Q16773	CCBL1	Kynurenine--oxoglutarate transaminase 1	GO:0006559; P:L-phenylalanine catabolic process; TAS:Reactome
Q16773	CCBL1	Kynurenine--oxoglutarate transaminase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16773	CCBL1	Kynurenine--oxoglutarate transaminase 1	GO:0006569; P:tryptophan catabolic process; TAS:Reactome
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0003682; F:chromatin binding; IEA:Ensembl
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0010484; F:H3 histone acetyltransferase activity; IDA:BHF-UCL
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0004402; F:histone acetyltransferase activity; IDA:UniProtKB
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0043997; F:histone acetyltransferase activity (H4-K12 specific); IEA:Ensembl
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0042826; F:histone deacetylase binding; IPI:UniProtKB
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0005515; F:protein binding; IPI:UniProtKB
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0008283; P:cell proliferation; IEA:Ensembl
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0006325; P:chromatin organization; TAS:Reactome
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0006338; P:chromatin remodeling; TAS:ProtInc
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0016578; P:histone deubiquitination; IDA:UniProtKB
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0044154; P:histone H3-K14 acetylation; IEA:Ensembl
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0022037; P:metencephalon development; IEA:Ensembl
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0030901; P:midbrain development; IEA:Ensembl
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0001843; P:neural tube closure; IEA:Ensembl
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0031647; P:regulation of protein stability; IMP:MGI
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0001756; P:somitogenesis; IEA:Ensembl
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0021537; P:telencephalon development; IEA:Ensembl
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q92830	KAT2A	Histone acetyltransferase KAT2A	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0016407; F:acetyltransferase activity; IDA:UniProtKB
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0004861; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; ISS:UniProtKB
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0004402; F:histone acetyltransferase activity; IDA:UniProtKB
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0042826; F:histone deacetylase binding; IPI:UniProtKB
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0004468; F:lysine N-acetyltransferase activity; IDA:UniProtKB
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0005515; F:protein binding; IPI:UniProtKB
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0032403; F:protein complex binding; IDA:UniProtKB
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0019901; F:protein kinase binding; ISS:UniProtKB
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0003712; F:transcription cofactor activity; IPI:UniProtKB
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0007050; P:cell cycle arrest; TAS:ProtInc
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0032869; P:cellular response to insulin stimulus; IDA:BHF-UCL
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0006325; P:chromatin organization; TAS:Reactome
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0006338; P:chromatin remodeling; IDA:UniProtKB
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0010467; P:gene expression; TAS:Reactome
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0043966; P:histone H3 acetylation; IDA:BHF-UCL
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0018393; P:internal peptidyl-lysine acetylation; IDA:UniProtKB
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0018076; P:N-terminal peptidyl-lysine acetylation; IDA:UniProtKB
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:Ensembl
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0018394; P:peptidyl-lysine acetylation; IDA:BHF-UCL
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0006473; P:protein acetylation; TAS:ProtInc
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0010835; P:regulation of protein ADP-ribosylation; IDA:BHF-UCL
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q92831	KAT2B	Histone acetyltransferase KAT2B	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q6YP21	CCBL2	Kynurenine--oxoglutarate transaminase 3	GO:0047804; F:cysteine-S-conjugate beta-lyase activity; IEA:UniProtKB-EC
Q6YP21	CCBL2	Kynurenine--oxoglutarate transaminase 3	GO:0047315; F:kynurenine-glyoxylate transaminase activity; ISS:UniProtKB
Q6YP21	CCBL2	Kynurenine--oxoglutarate transaminase 3	GO:0016212; F:kynurenine-oxoglutarate transaminase activity; ISS:UniProtKB
Q6YP21	CCBL2	Kynurenine--oxoglutarate transaminase 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6YP21	CCBL2	Kynurenine--oxoglutarate transaminase 3	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q6YP21	CCBL2	Kynurenine--oxoglutarate transaminase 3	GO:0006103; P:2-oxoglutarate metabolic process; IEA:Ensembl
Q6YP21	CCBL2	Kynurenine--oxoglutarate transaminase 3	GO:0009058; P:biosynthetic process; IEA:InterPro
Q6YP21	CCBL2	Kynurenine--oxoglutarate transaminase 3	GO:0006520; P:cellular amino acid metabolic process; ISS:UniProtKB
Q6YP21	CCBL2	Kynurenine--oxoglutarate transaminase 3	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q6YP21	CCBL2	Kynurenine--oxoglutarate transaminase 3	GO:0070189; P:kynurenine metabolic process; ISS:UniProtKB
Q6YP21	CCBL2	Kynurenine--oxoglutarate transaminase 3	GO:0097052; P:L-kynurenine metabolic process; ISS:GOC
Q6YP21	CCBL2	Kynurenine--oxoglutarate transaminase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6YP21	CCBL2	Kynurenine--oxoglutarate transaminase 3	GO:0006569; P:tryptophan catabolic process; TAS:Reactome
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0050681; F:androgen receptor binding; NAS:UniProtKB
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0004402; F:histone acetyltransferase activity; IDA:UniProtKB
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0005515; F:protein binding; IPI:UniProtKB
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0070491; F:repressing transcription factor binding; IPI:BHF-UCL
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0071392; P:cellular response to estradiol stimulus; IDA:UniProt
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0006325; P:chromatin organization; TAS:Reactome
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IDA:UniProtKB
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0006302; P:double-strand break repair; IMP:UniProtKB
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0016573; P:histone acetylation; IDA:UniProtKB
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0032703; P:negative regulation of interleukin-2 production; IDA:BHF-UCL
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProt
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0010212; P:response to ionizing radiation; IDA:UniProtKB
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q92993	KAT5	Histone acetyltransferase KAT5	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0016407; F:acetyltransferase activity; IDA:UniProtKB
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0003682; F:chromatin binding; IEA:Ensembl
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0003677; F:DNA binding; IDA:UniProtKB
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0004402; F:histone acetyltransferase activity; IDA:UniProtKB
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0005515; F:protein binding; IPI:UniProtKB
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0003713; F:transcription coactivator activity; TAS:UniProtKB
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0008134; F:transcription factor binding; IDA:UniProtKB
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0035909; P:aorta morphogenesis; IEA:Ensembl
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0090398; P:cellular senescence; IMP:UniProtKB
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0006325; P:chromatin organization; TAS:Reactome
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0006323; P:DNA packaging; TAS:ProtInc
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0035162; P:embryonic hemopoiesis; IEA:Ensembl
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0060325; P:face morphogenesis; IEA:Ensembl
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0003007; P:heart morphogenesis; IEA:Ensembl
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0016573; P:histone acetylation; IDA:UniProtKB
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0030099; P:myeloid cell differentiation; IDA:UniProtKB
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0006473; P:protein acetylation; IDA:UniProtKB
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
Q92794	KAT6A	Histone acetyltransferase KAT6A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WYB5	KAT6B	Histone acetyltransferase KAT6B	GO:0016407; F:acetyltransferase activity; IDA:UniProtKB
Q8WYB5	KAT6B	Histone acetyltransferase KAT6B	GO:0003677; F:DNA binding; IEA:InterPro
Q8WYB5	KAT6B	Histone acetyltransferase KAT6B	GO:0004402; F:histone acetyltransferase activity; IDA:UniProtKB
Q8WYB5	KAT6B	Histone acetyltransferase KAT6B	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WYB5	KAT6B	Histone acetyltransferase KAT6B	GO:0008134; F:transcription factor binding; IDA:UniProtKB
Q8WYB5	KAT6B	Histone acetyltransferase KAT6B	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WYB5	KAT6B	Histone acetyltransferase KAT6B	GO:0006325; P:chromatin organization; TAS:Reactome
Q8WYB5	KAT6B	Histone acetyltransferase KAT6B	GO:0016573; P:histone acetylation; IDA:UniProtKB
Q8WYB5	KAT6B	Histone acetyltransferase KAT6B	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
Q8WYB5	KAT6B	Histone acetyltransferase KAT6B	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q8WYB5	KAT6B	Histone acetyltransferase KAT6B	GO:0006334; P:nucleosome assembly; NAS:UniProtKB
Q8WYB5	KAT6B	Histone acetyltransferase KAT6B	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q8WYB5	KAT6B	Histone acetyltransferase KAT6B	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q8WYB5	KAT6B	Histone acetyltransferase KAT6B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95251	KAT7	Histone acetyltransferase KAT7	GO:0004402; F:histone acetyltransferase activity; IEA:UniProtKB-EC
O95251	KAT7	Histone acetyltransferase KAT7	GO:0005515; F:protein binding; IPI:UniProtKB
O95251	KAT7	Histone acetyltransferase KAT7	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O95251	KAT7	Histone acetyltransferase KAT7	GO:0008270; F:zinc ion binding; IEA:InterPro
O95251	KAT7	Histone acetyltransferase KAT7	GO:0006325; P:chromatin organization; TAS:Reactome
O95251	KAT7	Histone acetyltransferase KAT7	GO:0006260; P:DNA replication; IDA:UniProtKB
O95251	KAT7	Histone acetyltransferase KAT7	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
O95251	KAT7	Histone acetyltransferase KAT7	GO:0043983; P:histone H4-K12 acetylation; IDA:UniProtKB
O95251	KAT7	Histone acetyltransferase KAT7	GO:0043981; P:histone H4-K5 acetylation; IDA:UniProtKB
O95251	KAT7	Histone acetyltransferase KAT7	GO:0043982; P:histone H4-K8 acetylation; IDA:UniProtKB
O95251	KAT7	Histone acetyltransferase KAT7	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
O95251	KAT7	Histone acetyltransferase KAT7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H7Z6	KAT8	Histone acetyltransferase KAT8	GO:0016407; F:acetyltransferase activity; IDA:UniProtKB
Q9H7Z6	KAT8	Histone acetyltransferase KAT8	GO:0004402; F:histone acetyltransferase activity; IDA:UniProtKB
Q9H7Z6	KAT8	Histone acetyltransferase KAT8	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H7Z6	KAT8	Histone acetyltransferase KAT8	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q9H7Z6	KAT8	Histone acetyltransferase KAT8	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H7Z6	KAT8	Histone acetyltransferase KAT8	GO:0008134; F:transcription factor binding; IDA:UniProtKB
Q9H7Z6	KAT8	Histone acetyltransferase KAT8	GO:0006325; P:chromatin organization; TAS:Reactome
Q9H7Z6	KAT8	Histone acetyltransferase KAT8	GO:0016573; P:histone acetylation; IDA:UniProtKB
Q9H7Z6	KAT8	Histone acetyltransferase KAT8	GO:0043984; P:histone H4-K16 acetylation; IDA:UniProtKB
Q9H7Z6	KAT8	Histone acetyltransferase KAT8	GO:0043981; P:histone H4-K5 acetylation; IDA:UniProtKB
Q9H7Z6	KAT8	Histone acetyltransferase KAT8	GO:0043982; P:histone H4-K8 acetylation; IDA:UniProtKB
Q9H7Z6	KAT8	Histone acetyltransferase KAT8	GO:0030099; P:myeloid cell differentiation; IDA:UniProtKB
Q9H7Z6	KAT8	Histone acetyltransferase KAT8	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9H7Z6	KAT8	Histone acetyltransferase KAT8	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9H7Z6	KAT8	Histone acetyltransferase KAT8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BW62	KATNAL1	Katanin p60 ATPase-containing subunit A-like 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BW62	KATNAL1	Katanin p60 ATPase-containing subunit A-like 1	GO:0008568; F:microtubule-severing ATPase activity; IEA:UniProtKB-EC
Q9BW62	KATNAL1	Katanin p60 ATPase-containing subunit A-like 1	GO:0051013; P:microtubule severing; IEA:Ensembl
Q9BW62	KATNAL1	Katanin p60 ATPase-containing subunit A-like 1	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q8IYT4	KATNAL2	Katanin p60 ATPase-containing subunit A-like 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IYT4	KATNAL2	Katanin p60 ATPase-containing subunit A-like 2	GO:0008568; F:microtubule-severing ATPase activity; IEA:UniProtKB-EC
Q8IYT4	KATNAL2	Katanin p60 ATPase-containing subunit A-like 2	GO:0051013; P:microtubule severing; IEA:UniProtKB-HAMAP
Q96I82	KAZALD1	Kazal-type serine protease inhibitor domain-containing protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96I82	KAZALD1	Kazal-type serine protease inhibitor domain-containing protein 1	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q96I82	KAZALD1	Kazal-type serine protease inhibitor domain-containing protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q96I82	KAZALD1	Kazal-type serine protease inhibitor domain-containing protein 1	GO:0001503; P:ossification; IEA:UniProtKB-KW
Q96I82	KAZALD1	Kazal-type serine protease inhibitor domain-containing protein 1	GO:0001558; P:regulation of cell growth; IEA:InterPro
Q674X7	KAZN	Kazrin	GO:0031424; P:keratinization; IEA:UniProtKB-KW
O75600	GCAT	2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial	GO:0008890; F:glycine C-acetyltransferase activity; NAS:UniProtKB
O75600	GCAT	2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
O75600	GCAT	2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial	GO:0009058; P:biosynthetic process; IEA:InterPro
O75600	GCAT	2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial	GO:0006520; P:cellular amino acid metabolic process; NAS:UniProtKB
O75600	GCAT	2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial	GO:0019518; P:L-threonine catabolic process to glycine; IEA:UniProtKB-UniPathway
Q96EK5	KIAA1279	KIF1-binding protein	GO:0019894; F:kinesin binding; IPI:UniProtKB
Q96EK5	KIAA1279	KIF1-binding protein	GO:0005515; F:protein binding; IPI:IntAct
Q96EK5	KIAA1279	KIF1-binding protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96EK5	KIAA1279	KIF1-binding protein	GO:0006839; P:mitochondrial transport; IMP:UniProtKB
Q96EK5	KIAA1279	KIF1-binding protein	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q9NYS0	NKIRAS1	NF-kappa-B inhibitor-interacting Ras-like protein 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9NYS0	NKIRAS1	NF-kappa-B inhibitor-interacting Ras-like protein 1	GO:0003924; F:GTPase activity; NAS:UniProtKB
Q9NYS0	NKIRAS1	NF-kappa-B inhibitor-interacting Ras-like protein 1	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; NAS:UniProtKB
Q9NYS0	NKIRAS1	NF-kappa-B inhibitor-interacting Ras-like protein 1	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9NYR9	NKIRAS2	NF-kappa-B inhibitor-interacting Ras-like protein 2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9NYR9	NKIRAS2	NF-kappa-B inhibitor-interacting Ras-like protein 2	GO:0003924; F:GTPase activity; NAS:UniProtKB
Q9NYR9	NKIRAS2	NF-kappa-B inhibitor-interacting Ras-like protein 2	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; NAS:UniProtKB
Q9NYR9	NKIRAS2	NF-kappa-B inhibitor-interacting Ras-like protein 2	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q86V97	KBTBD6	Kelch repeat and BTB domain-containing protein 6	GO:0005515; F:protein binding; IPI:IntAct
Q8WVZ9	KBTBD7	Kelch repeat and BTB domain-containing protein 7	GO:0005515; F:protein binding; IPI:IntAct
C9JR72	KBTBD13	Kelch repeat and BTB domain-containing protein 13	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8N752	CSNK1A1L	Casein kinase I isoform alpha-like	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8N752	CSNK1A1L	Casein kinase I isoform alpha-like	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q8N752	CSNK1A1L	Casein kinase I isoform alpha-like	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P48729	CSNK1A1	Casein kinase I isoform alpha	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P48729	CSNK1A1	Casein kinase I isoform alpha	GO:0005515; F:protein binding; IPI:IntAct
P48729	CSNK1A1	Casein kinase I isoform alpha	GO:0004672; F:protein kinase activity; TAS:UniProtKB
P48729	CSNK1A1	Casein kinase I isoform alpha	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P48729	CSNK1A1	Casein kinase I isoform alpha	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P48729	CSNK1A1	Casein kinase I isoform alpha	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P48729	CSNK1A1	Casein kinase I isoform alpha	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P48729	CSNK1A1	Casein kinase I isoform alpha	GO:0007165; P:signal transduction; NAS:ProtInc
P48729	CSNK1A1	Casein kinase I isoform alpha	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P48730	CSNK1D	Casein kinase I isoform delta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P48730	CSNK1D	Casein kinase I isoform delta	GO:0042277; F:peptide binding; IEA:Ensembl
P48730	CSNK1D	Casein kinase I isoform delta	GO:0005515; F:protein binding; IPI:UniProtKB
P48730	CSNK1D	Casein kinase I isoform delta	GO:0004672; F:protein kinase activity; IDA:UniProtKB
P48730	CSNK1D	Casein kinase I isoform delta	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
P48730	CSNK1D	Casein kinase I isoform delta	GO:0050321; F:tau-protein kinase activity; IEA:UniProtKB-EC
P48730	CSNK1D	Casein kinase I isoform delta	GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB
P48730	CSNK1D	Casein kinase I isoform delta	GO:0006281; P:DNA repair; TAS:ProtInc
P48730	CSNK1D	Casein kinase I isoform delta	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P48730	CSNK1D	Casein kinase I isoform delta	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P48730	CSNK1D	Casein kinase I isoform delta	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
P48730	CSNK1D	Casein kinase I isoform delta	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; ISS:UniProtKB
P48730	CSNK1D	Casein kinase I isoform delta	GO:0001934; P:positive regulation of protein phosphorylation; IMP:BHF-UCL
P48730	CSNK1D	Casein kinase I isoform delta	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P48730	CSNK1D	Casein kinase I isoform delta	GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB
P48730	CSNK1D	Casein kinase I isoform delta	GO:0007165; P:signal transduction; TAS:ProtInc
P48730	CSNK1D	Casein kinase I isoform delta	GO:0051225; P:spindle assembly; IDA:UniProtKB
P48730	CSNK1D	Casein kinase I isoform delta	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P49674	CSNK1E	Casein kinase I isoform epsilon	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49674	CSNK1E	Casein kinase I isoform epsilon	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P49674	CSNK1E	Casein kinase I isoform epsilon	GO:0005515; F:protein binding; IPI:UniProtKB
P49674	CSNK1E	Casein kinase I isoform epsilon	GO:0004672; F:protein kinase activity; ISS:UniProtKB
P49674	CSNK1E	Casein kinase I isoform epsilon	GO:0004674; F:protein serine/threonine kinase activity; TAS:UniProtKB
P49674	CSNK1E	Casein kinase I isoform epsilon	GO:0034613; P:cellular protein localization; IEA:Ensembl
P49674	CSNK1E	Casein kinase I isoform epsilon	GO:0006281; P:DNA repair; TAS:ProtInc
P49674	CSNK1E	Casein kinase I isoform epsilon	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P49674	CSNK1E	Casein kinase I isoform epsilon	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P49674	CSNK1E	Casein kinase I isoform epsilon	GO:0030178; P:negative regulation of Wnt signaling pathway; IEA:Ensembl
P49674	CSNK1E	Casein kinase I isoform epsilon	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl
P49674	CSNK1E	Casein kinase I isoform epsilon	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; ISS:UniProtKB
P49674	CSNK1E	Casein kinase I isoform epsilon	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
P49674	CSNK1E	Casein kinase I isoform epsilon	GO:0007165; P:signal transduction; TAS:ProtInc
Q9HCP0	CSNK1G1	Casein kinase I isoform gamma-1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9HCP0	CSNK1G1	Casein kinase I isoform gamma-1	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q9HCP0	CSNK1G1	Casein kinase I isoform gamma-1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P78368	CSNK1G2	Casein kinase I isoform gamma-2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P78368	CSNK1G2	Casein kinase I isoform gamma-2	GO:0000287; F:magnesium ion binding; IEA:Ensembl
P78368	CSNK1G2	Casein kinase I isoform gamma-2	GO:0042277; F:peptide binding; IEA:Ensembl
P78368	CSNK1G2	Casein kinase I isoform gamma-2	GO:0004674; F:protein serine/threonine kinase activity; TAS:UniProtKB
P78368	CSNK1G2	Casein kinase I isoform gamma-2	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
P78368	CSNK1G2	Casein kinase I isoform gamma-2	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P78368	CSNK1G2	Casein kinase I isoform gamma-2	GO:0007165; P:signal transduction; TAS:ProtInc
P78368	CSNK1G2	Casein kinase I isoform gamma-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P78368	CSNK1G2	Casein kinase I isoform gamma-2	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
P78368	CSNK1G2	Casein kinase I isoform gamma-2	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
P78368	CSNK1G2	Casein kinase I isoform gamma-2	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9Y6M4	CSNK1G3	Casein kinase I isoform gamma-3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y6M4	CSNK1G3	Casein kinase I isoform gamma-3	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q9Y6M4	CSNK1G3	Casein kinase I isoform gamma-3	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q9Y6M4	CSNK1G3	Casein kinase I isoform gamma-3	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q9Y6M4	CSNK1G3	Casein kinase I isoform gamma-3	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y6M4	CSNK1G3	Casein kinase I isoform gamma-3	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q16322	KCNA10	Potassium voltage-gated channel subfamily A member 10	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
Q16322	KCNA10	Potassium voltage-gated channel subfamily A member 10	GO:0005221; F:intracellular cyclic nucleotide activated cation channel activity; TAS:ProtInc
Q16322	KCNA10	Potassium voltage-gated channel subfamily A member 10	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q16322	KCNA10	Potassium voltage-gated channel subfamily A member 10	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q16322	KCNA10	Potassium voltage-gated channel subfamily A member 10	GO:0007268; P:synaptic transmission; TAS:Reactome
Q14722	KCNAB1	Voltage-gated potassium channel subunit beta-1	GO:0015459; F:potassium channel regulator activity; TAS:ProtInc
Q14722	KCNAB1	Voltage-gated potassium channel subunit beta-1	GO:0005249; F:voltage-gated potassium channel activity; IEA:InterPro
Q14722	KCNAB1	Voltage-gated potassium channel subunit beta-1	GO:0007611; P:learning or memory; IEA:Ensembl
Q14722	KCNAB1	Voltage-gated potassium channel subunit beta-1	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q14722	KCNAB1	Voltage-gated potassium channel subunit beta-1	GO:1901016; P:regulation of potassium ion transmembrane transporter activity; IEA:Ensembl
Q14722	KCNAB1	Voltage-gated potassium channel subunit beta-1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q13303	KCNAB2	Voltage-gated potassium channel subunit beta-2	GO:0015459; F:potassium channel regulator activity; TAS:ProtInc
Q13303	KCNAB2	Voltage-gated potassium channel subunit beta-2	GO:0005249; F:voltage-gated potassium channel activity; IEA:InterPro
Q13303	KCNAB2	Voltage-gated potassium channel subunit beta-2	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q13303	KCNAB2	Voltage-gated potassium channel subunit beta-2	GO:0007268; P:synaptic transmission; TAS:Reactome
O43448	KCNAB3	Voltage-gated potassium channel subunit beta-3	GO:0015459; F:potassium channel regulator activity; TAS:ProtInc
O43448	KCNAB3	Voltage-gated potassium channel subunit beta-3	GO:0005249; F:voltage-gated potassium channel activity; IEA:InterPro
O43448	KCNAB3	Voltage-gated potassium channel subunit beta-3	GO:0006813; P:potassium ion transport; TAS:ProtInc
O43448	KCNAB3	Voltage-gated potassium channel subunit beta-3	GO:0007268; P:synaptic transmission; TAS:Reactome
Q14012	CAMK1	Calcium/calmodulin-dependent protein kinase type 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q14012	CAMK1	Calcium/calmodulin-dependent protein kinase type 1	GO:0004683; F:calmodulin-dependent protein kinase activity; ISS:UniProtKB
Q14012	CAMK1	Calcium/calmodulin-dependent protein kinase type 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q14012	CAMK1	Calcium/calmodulin-dependent protein kinase type 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q14012	CAMK1	Calcium/calmodulin-dependent protein kinase type 1	GO:0006913; P:nucleocytoplasmic transport; IEA:Ensembl
Q14012	CAMK1	Calcium/calmodulin-dependent protein kinase type 1	GO:0060999; P:positive regulation of dendritic spine development; IMP:UniProtKB
Q14012	CAMK1	Calcium/calmodulin-dependent protein kinase type 1	GO:0051149; P:positive regulation of muscle cell differentiation; IMP:BHF-UCL
Q14012	CAMK1	Calcium/calmodulin-dependent protein kinase type 1	GO:0010976; P:positive regulation of neuron projection development; IDA:UniProtKB
Q14012	CAMK1	Calcium/calmodulin-dependent protein kinase type 1	GO:0046827; P:positive regulation of protein export from nucleus; IEA:Ensembl
Q14012	CAMK1	Calcium/calmodulin-dependent protein kinase type 1	GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IDA:UniProtKB
Q14012	CAMK1	Calcium/calmodulin-dependent protein kinase type 1	GO:0051835; P:positive regulation of synapse structural plasticity; IMP:UniProtKB
Q14012	CAMK1	Calcium/calmodulin-dependent protein kinase type 1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q14012	CAMK1	Calcium/calmodulin-dependent protein kinase type 1	GO:0051147; P:regulation of muscle cell differentiation; IDA:UniProtKB
Q14012	CAMK1	Calcium/calmodulin-dependent protein kinase type 1	GO:0043393; P:regulation of protein binding; IDA:UniProtKB
Q14012	CAMK1	Calcium/calmodulin-dependent protein kinase type 1	GO:0032880; P:regulation of protein localization; IDA:UniProtKB
Q14012	CAMK1	Calcium/calmodulin-dependent protein kinase type 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q6P2M8	PNCK	Calcium/calmodulin-dependent protein kinase type 1B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6P2M8	PNCK	Calcium/calmodulin-dependent protein kinase type 1B	GO:0004683; F:calmodulin-dependent protein kinase activity; IEA:UniProtKB-EC
Q8IU85	CAMK1D	Calcium/calmodulin-dependent protein kinase type 1D	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IU85	CAMK1D	Calcium/calmodulin-dependent protein kinase type 1D	GO:0004683; F:calmodulin-dependent protein kinase activity; IEA:UniProtKB-EC
Q8IU85	CAMK1D	Calcium/calmodulin-dependent protein kinase type 1D	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q8IU85	CAMK1D	Calcium/calmodulin-dependent protein kinase type 1D	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q8IU85	CAMK1D	Calcium/calmodulin-dependent protein kinase type 1D	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q8IU85	CAMK1D	Calcium/calmodulin-dependent protein kinase type 1D	GO:0032793; P:positive regulation of CREB transcription factor activity; IDA:UniProtKB
Q8IU85	CAMK1D	Calcium/calmodulin-dependent protein kinase type 1D	GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB
Q8IU85	CAMK1D	Calcium/calmodulin-dependent protein kinase type 1D	GO:0090023; P:positive regulation of neutrophil chemotaxis; ISS:UniProtKB
Q8IU85	CAMK1D	Calcium/calmodulin-dependent protein kinase type 1D	GO:0050766; P:positive regulation of phagocytosis; IMP:UniProtKB
Q8IU85	CAMK1D	Calcium/calmodulin-dependent protein kinase type 1D	GO:0060267; P:positive regulation of respiratory burst; IMP:UniProtKB
Q8IU85	CAMK1D	Calcium/calmodulin-dependent protein kinase type 1D	GO:0050773; P:regulation of dendrite development; IMP:UniProtKB
Q8IU85	CAMK1D	Calcium/calmodulin-dependent protein kinase type 1D	GO:0071622; P:regulation of granulocyte chemotaxis; IMP:UniProtKB
Q96NX5	CAMK1G	Calcium/calmodulin-dependent protein kinase type 1G	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96NX5	CAMK1G	Calcium/calmodulin-dependent protein kinase type 1G	GO:0004683; F:calmodulin-dependent protein kinase activity; IEA:UniProtKB-EC
Q9UQM7	CAMK2A	Calcium/calmodulin-dependent protein kinase type II subunit alpha	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UQM7	CAMK2A	Calcium/calmodulin-dependent protein kinase type II subunit alpha	GO:0004683; F:calmodulin-dependent protein kinase activity; IEA:UniProtKB-EC
Q9UQM7	CAMK2A	Calcium/calmodulin-dependent protein kinase type II subunit alpha	GO:0016301; F:kinase activity; IDA:UniProtKB
Q9UQM7	CAMK2A	Calcium/calmodulin-dependent protein kinase type II subunit alpha	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UQM7	CAMK2A	Calcium/calmodulin-dependent protein kinase type II subunit alpha	GO:0006816; P:calcium ion transport; IEA:Ensembl
Q9UQM7	CAMK2A	Calcium/calmodulin-dependent protein kinase type II subunit alpha	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q9UQM7	CAMK2A	Calcium/calmodulin-dependent protein kinase type II subunit alpha	GO:0000082; P:G1/S transition of mitotic cell cycle; IEA:Ensembl
Q9UQM7	CAMK2A	Calcium/calmodulin-dependent protein kinase type II subunit alpha	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q9UQM7	CAMK2A	Calcium/calmodulin-dependent protein kinase type II subunit alpha	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
Q9UQM7	CAMK2A	Calcium/calmodulin-dependent protein kinase type II subunit alpha	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
Q9UQM7	CAMK2A	Calcium/calmodulin-dependent protein kinase type II subunit alpha	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9UQM7	CAMK2A	Calcium/calmodulin-dependent protein kinase type II subunit alpha	GO:0048168; P:regulation of neuronal synaptic plasticity; IEA:Ensembl
Q9UQM7	CAMK2A	Calcium/calmodulin-dependent protein kinase type II subunit alpha	GO:0046928; P:regulation of neurotransmitter secretion; IEA:Ensembl
Q9UQM7	CAMK2A	Calcium/calmodulin-dependent protein kinase type II subunit alpha	GO:0007268; P:synaptic transmission; TAS:Reactome
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0004683; F:calmodulin-dependent protein kinase activity; IEA:UniProtKB-EC
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0060466; P:activation of meiosis involved in egg activation; IEA:Ensembl
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0006816; P:calcium ion transport; IEA:Ensembl
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0000082; P:G1/S transition of mitotic cell cycle; IEA:Ensembl
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0002030; P:inhibitory G-protein coupled receptor phosphorylation; IEA:Ensembl
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0061003; P:positive regulation of dendritic spine morphogenesis; ISS:UniProtKB
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0090129; P:positive regulation of synapse maturation; ISS:UniProtKB
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0051924; P:regulation of calcium ion transport; TAS:UniProtKB
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0060998; P:regulation of dendritic spine development; TAS:UniProtKB
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0048169; P:regulation of long-term neuronal synaptic plasticity; TAS:UniProtKB
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0014733; P:regulation of skeletal muscle adaptation; TAS:UniProtKB
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0051823; P:regulation of synapse structural plasticity; TAS:UniProtKB
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0032222; P:regulation of synaptic transmission, cholinergic; IEA:Ensembl
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0046686; P:response to cadmium ion; IEA:Ensembl
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0007165; P:signal transduction; TAS:ProtInc
Q13554	CAMK2B	Calcium/calmodulin-dependent protein kinase type II subunit beta	GO:0007268; P:synaptic transmission; TAS:Reactome
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0004683; F:calmodulin-dependent protein kinase activity; IDA:BHF-UCL
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0044325; F:ion channel binding; ISS:BHF-UCL
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0031432; F:titin binding; IPI:BHF-UCL
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0006816; P:calcium ion transport; IEA:Ensembl
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0086003; P:cardiac muscle cell contraction; ISS:BHF-UCL
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0071277; P:cellular response to calcium ion; TAS:BHF-UCL
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0000082; P:G1/S transition of mitotic cell cycle; IEA:Ensembl
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0018107; P:peptidyl-threonine phosphorylation; IDA:BHF-UCL
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0010613; P:positive regulation of cardiac muscle hypertrophy; IMP:UniProtKB
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; TAS:UniProtKB
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0060341; P:regulation of cellular localization; IMP:UniProtKB
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0008016; P:regulation of heart contraction; TAS:UniProtKB
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:1901725; P:regulation of histone deacetylase activity; TAS:BHF-UCL
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:1901897; P:regulation of relaxation of cardiac muscle; IDA:BHF-UCL
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0060314; P:regulation of ryanodine-sensitive calcium-release channel activity; TAS:UniProtKB
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0002028; P:regulation of sodium ion transport; IEA:Ensembl
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0002026; P:regulation of the force of heart contraction; TAS:BHF-UCL
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:BHF-UCL
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0055119; P:relaxation of cardiac muscle; ISS:BHF-UCL
Q13557	CAMK2D	Calcium/calmodulin-dependent protein kinase type II subunit delta	GO:0007268; P:synaptic transmission; TAS:Reactome
Q13555	CAMK2G	Calcium/calmodulin-dependent protein kinase type II subunit gamma	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13555	CAMK2G	Calcium/calmodulin-dependent protein kinase type II subunit gamma	GO:0004723; F:calcium-dependent protein serine/threonine phosphatase activity; NAS:UniProtKB
Q13555	CAMK2G	Calcium/calmodulin-dependent protein kinase type II subunit gamma	GO:0005516; F:calmodulin binding; NAS:UniProtKB
Q13555	CAMK2G	Calcium/calmodulin-dependent protein kinase type II subunit gamma	GO:0004683; F:calmodulin-dependent protein kinase activity; IEA:UniProtKB-EC
Q13555	CAMK2G	Calcium/calmodulin-dependent protein kinase type II subunit gamma	GO:0005515; F:protein binding; IPI:IntAct
Q13555	CAMK2G	Calcium/calmodulin-dependent protein kinase type II subunit gamma	GO:0006816; P:calcium ion transport; IEA:Ensembl
Q13555	CAMK2G	Calcium/calmodulin-dependent protein kinase type II subunit gamma	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q13555	CAMK2G	Calcium/calmodulin-dependent protein kinase type II subunit gamma	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q13555	CAMK2G	Calcium/calmodulin-dependent protein kinase type II subunit gamma	GO:0016311; P:dephosphorylation; NAS:GOC
Q13555	CAMK2G	Calcium/calmodulin-dependent protein kinase type II subunit gamma	GO:0000082; P:G1/S transition of mitotic cell cycle; IEA:Ensembl
Q13555	CAMK2G	Calcium/calmodulin-dependent protein kinase type II subunit gamma	GO:0030073; P:insulin secretion; NAS:UniProtKB
Q13555	CAMK2G	Calcium/calmodulin-dependent protein kinase type II subunit gamma	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q13555	CAMK2G	Calcium/calmodulin-dependent protein kinase type II subunit gamma	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q13555	CAMK2G	Calcium/calmodulin-dependent protein kinase type II subunit gamma	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
Q13555	CAMK2G	Calcium/calmodulin-dependent protein kinase type II subunit gamma	GO:0051924; P:regulation of calcium ion transport; TAS:UniProtKB
Q13555	CAMK2G	Calcium/calmodulin-dependent protein kinase type II subunit gamma	GO:1901897; P:regulation of relaxation of cardiac muscle; IEA:Ensembl
Q13555	CAMK2G	Calcium/calmodulin-dependent protein kinase type II subunit gamma	GO:0014733; P:regulation of skeletal muscle adaptation; TAS:UniProtKB
Q13555	CAMK2G	Calcium/calmodulin-dependent protein kinase type II subunit gamma	GO:0007268; P:synaptic transmission; TAS:Reactome
Q16566	CAMK4	Calcium/calmodulin-dependent protein kinase type IV	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q16566	CAMK4	Calcium/calmodulin-dependent protein kinase type IV	GO:0004683; F:calmodulin-dependent protein kinase activity; IEA:UniProtKB-EC
Q16566	CAMK4	Calcium/calmodulin-dependent protein kinase type IV	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
Q16566	CAMK4	Calcium/calmodulin-dependent protein kinase type IV	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q16566	CAMK4	Calcium/calmodulin-dependent protein kinase type IV	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q16566	CAMK4	Calcium/calmodulin-dependent protein kinase type IV	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q16566	CAMK4	Calcium/calmodulin-dependent protein kinase type IV	GO:0045087; P:innate immune response; TAS:Reactome
Q16566	CAMK4	Calcium/calmodulin-dependent protein kinase type IV	GO:0007616; P:long-term memory; IGI:UniProtKB
Q16566	CAMK4	Calcium/calmodulin-dependent protein kinase type IV	GO:0043011; P:myeloid dendritic cell differentiation; IMP:UniProtKB
Q16566	CAMK4	Calcium/calmodulin-dependent protein kinase type IV	GO:0007270; P:neuron-neuron synaptic transmission; IEA:Ensembl
Q16566	CAMK4	Calcium/calmodulin-dependent protein kinase type IV	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q16566	CAMK4	Calcium/calmodulin-dependent protein kinase type IV	GO:0006913; P:nucleocytoplasmic transport; IEA:Ensembl
Q16566	CAMK4	Calcium/calmodulin-dependent protein kinase type IV	GO:0046827; P:positive regulation of protein export from nucleus; IEA:Ensembl
Q16566	CAMK4	Calcium/calmodulin-dependent protein kinase type IV	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q16566	CAMK4	Calcium/calmodulin-dependent protein kinase type IV	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q16566	CAMK4	Calcium/calmodulin-dependent protein kinase type IV	GO:0045670; P:regulation of osteoclast differentiation; TAS:UniProtKB
Q16566	CAMK4	Calcium/calmodulin-dependent protein kinase type IV	GO:0033081; P:regulation of T cell differentiation in thymus; TAS:UniProtKB
Q16566	CAMK4	Calcium/calmodulin-dependent protein kinase type IV	GO:0007165; P:signal transduction; TAS:Reactome
Q16566	CAMK4	Calcium/calmodulin-dependent protein kinase type IV	GO:0007268; P:synaptic transmission; TAS:Reactome
Q96CX2	KCTD12	BTB/POZ domain-containing protein KCTD12	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96CX2	KCTD12	BTB/POZ domain-containing protein KCTD12	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q96SI1	KCTD15	BTB/POZ domain-containing protein KCTD15	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q96SI1	KCTD15	BTB/POZ domain-containing protein KCTD15	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q693B1	KCTD11	BTB/POZ domain-containing protein KCTD11	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q693B1	KCTD11	BTB/POZ domain-containing protein KCTD11	GO:0007406; P:negative regulation of neuroblast proliferation; IEA:Ensembl
Q693B1	KCTD11	BTB/POZ domain-containing protein KCTD11	GO:0045879; P:negative regulation of smoothened signaling pathway; IEA:Ensembl
Q693B1	KCTD11	BTB/POZ domain-containing protein KCTD11	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
Q693B1	KCTD11	BTB/POZ domain-containing protein KCTD11	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q693B1	KCTD11	BTB/POZ domain-containing protein KCTD11	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q693B1	KCTD11	BTB/POZ domain-containing protein KCTD11	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q9BQ13	KCTD14	BTB/POZ domain-containing protein KCTD14	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q68DU8	KCTD16	BTB/POZ domain-containing protein KCTD16	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q68DU8	KCTD16	BTB/POZ domain-containing protein KCTD16	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; IEA:Ensembl
Q8N5Z5	KCTD17	BTB/POZ domain-containing protein KCTD17	GO:0042802; F:identical protein binding; IPI:IntAct
Q8N5Z5	KCTD17	BTB/POZ domain-containing protein KCTD17	GO:0005515; F:protein binding; IPI:IntAct
Q8N5Z5	KCTD17	BTB/POZ domain-containing protein KCTD17	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q17RG1	KCTD19	BTB/POZ domain-containing protein KCTD19	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q6PI47	KCTD18	BTB/POZ domain-containing protein KCTD18	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q7Z5Y7	KCTD20	BTB/POZ domain-containing protein KCTD20	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q4G0X4	KCTD21	BTB/POZ domain-containing protein KCTD21	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q9UJ90	KCNE1L	Potassium voltage-gated channel subfamily E member 1-like protein	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q9UJ90	KCNE1L	Potassium voltage-gated channel subfamily E member 1-like protein	GO:0015459; F:potassium channel regulator activity; IDA:BHF-UCL
Q9UJ90	KCNE1L	Potassium voltage-gated channel subfamily E member 1-like protein	GO:0086014; P:atrial cardiac muscle cell action potential; IMP:BHF-UCL
Q9UJ90	KCNE1L	Potassium voltage-gated channel subfamily E member 1-like protein	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
Q9UJ90	KCNE1L	Potassium voltage-gated channel subfamily E member 1-like protein	GO:0086013; P:membrane repolarization during cardiac muscle cell action potential; IMP:GOC
Q9UJ90	KCNE1L	Potassium voltage-gated channel subfamily E member 1-like protein	GO:1901380; P:negative regulation of potassium ion transmembrane transport; IDA:BHF-UCL
Q9UJ90	KCNE1L	Potassium voltage-gated channel subfamily E member 1-like protein	GO:1901381; P:positive regulation of potassium ion transmembrane transport; IDA:BHF-UCL
Q9UJ90	KCNE1L	Potassium voltage-gated channel subfamily E member 1-like protein	GO:0071435; P:potassium ion export; IDA:BHF-UCL
Q9UJ90	KCNE1L	Potassium voltage-gated channel subfamily E member 1-like protein	GO:0071805; P:potassium ion transmembrane transport; IDA:BHF-UCL
Q9UJ90	KCNE1L	Potassium voltage-gated channel subfamily E member 1-like protein	GO:0060372; P:regulation of atrial cardiac muscle cell membrane repolarization; IMP:BHF-UCL
Q9UJ90	KCNE1L	Potassium voltage-gated channel subfamily E member 1-like protein	GO:2001257; P:regulation of cation channel activity; IDA:BHF-UCL
Q9UJ90	KCNE1L	Potassium voltage-gated channel subfamily E member 1-like protein	GO:0008016; P:regulation of heart contraction; IMP:BHF-UCL
Q9UJ90	KCNE1L	Potassium voltage-gated channel subfamily E member 1-like protein	GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL
Q9UJ90	KCNE1L	Potassium voltage-gated channel subfamily E member 1-like protein	GO:0060306; P:regulation of membrane repolarization; IDA:BHF-UCL
Q9UJ90	KCNE1L	Potassium voltage-gated channel subfamily E member 1-like protein	GO:1901379; P:regulation of potassium ion transmembrane transport; IDA:BHF-UCL
Q9UJ90	KCNE1L	Potassium voltage-gated channel subfamily E member 1-like protein	GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL
Q9UJ90	KCNE1L	Potassium voltage-gated channel subfamily E member 1-like protein	GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL
Q9NZI2	KCNIP1	Kv channel-interacting protein 1	GO:0005509; F:calcium ion binding; IEA:Ensembl
Q9NZI2	KCNIP1	Kv channel-interacting protein 1	GO:0005267; F:potassium channel activity; IEA:UniProtKB-KW
Q9NZI2	KCNIP1	Kv channel-interacting protein 1	GO:0015459; F:potassium channel regulator activity; IEA:Ensembl
Q9NZI2	KCNIP1	Kv channel-interacting protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NZI2	KCNIP1	Kv channel-interacting protein 1	GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW
Q9NZI2	KCNIP1	Kv channel-interacting protein 1	GO:0005513; P:detection of calcium ion; TAS:ProtInc
Q9NZI2	KCNIP1	Kv channel-interacting protein 1	GO:0045760; P:positive regulation of action potential; IEA:Ensembl
Q9NZI2	KCNIP1	Kv channel-interacting protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q9NZI2	KCNIP1	Kv channel-interacting protein 1	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q9NS61	KCNIP2	Kv channel-interacting protein 2	GO:0005250; F:A-type (transient outward) potassium channel activity; TAS:UniProtKB
Q9NS61	KCNIP2	Kv channel-interacting protein 2	GO:0005509; F:calcium ion binding; TAS:UniProtKB
Q9NS61	KCNIP2	Kv channel-interacting protein 2	GO:0046923; F:ER retention sequence binding; NAS:UniProtKB
Q9NS61	KCNIP2	Kv channel-interacting protein 2	GO:0042802; F:identical protein binding; IPI:IntAct
Q9NS61	KCNIP2	Kv channel-interacting protein 2	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q9NS61	KCNIP2	Kv channel-interacting protein 2	GO:0015459; F:potassium channel regulator activity; IDA:BHF-UCL
Q9NS61	KCNIP2	Kv channel-interacting protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q9NS61	KCNIP2	Kv channel-interacting protein 2	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q9NS61	KCNIP2	Kv channel-interacting protein 2	GO:0045163; P:clustering of voltage-gated potassium channels; IDA:UniProtKB
Q9NS61	KCNIP2	Kv channel-interacting protein 2	GO:0005513; P:detection of calcium ion; TAS:ProtInc
Q9NS61	KCNIP2	Kv channel-interacting protein 2	GO:0086009; P:membrane repolarization; IDA:BHF-UCL
Q9NS61	KCNIP2	Kv channel-interacting protein 2	GO:0006936; P:muscle contraction; NAS:UniProtKB
Q9NS61	KCNIP2	Kv channel-interacting protein 2	GO:0071435; P:potassium ion export; IDA:BHF-UCL
Q9NS61	KCNIP2	Kv channel-interacting protein 2	GO:0071805; P:potassium ion transmembrane transport; IDA:BHF-UCL
Q9NS61	KCNIP2	Kv channel-interacting protein 2	GO:0006813; P:potassium ion transport; TAS:UniProtKB
Q9NS61	KCNIP2	Kv channel-interacting protein 2	GO:2001257; P:regulation of cation channel activity; TAS:BHF-UCL
Q9NS61	KCNIP2	Kv channel-interacting protein 2	GO:0008016; P:regulation of heart contraction; TAS:UniProtKB
Q9NS61	KCNIP2	Kv channel-interacting protein 2	GO:0007165; P:signal transduction; TAS:ProtInc
Q9NS61	KCNIP2	Kv channel-interacting protein 2	GO:0007268; P:synaptic transmission; NAS:UniProtKB
Q6PIL6	KCNIP4	Kv channel-interacting protein 4	GO:0005509; F:calcium ion binding; IEA:InterPro
Q6PIL6	KCNIP4	Kv channel-interacting protein 4	GO:0005267; F:potassium channel activity; IEA:UniProtKB-KW
Q6PIL6	KCNIP4	Kv channel-interacting protein 4	GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0015272; F:ATP-activated inward rectifier potassium channel activity; TAS:ProtInc
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0005515; F:protein binding; IPI:UniProtKB
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0007628; P:adult walking behavior; IEA:Ensembl
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0022010; P:central nervous system myelination; IEA:Ensembl
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0006954; P:inflammatory response; IEA:Ensembl
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0051935; P:L-glutamate uptake involved in synaptic transmission; IEA:Ensembl
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0060081; P:membrane hyperpolarization; IEA:Ensembl
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0021554; P:optic nerve development; IEA:Ensembl
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0055075; P:potassium ion homeostasis; IEA:Ensembl
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0010107; P:potassium ion import; IEA:Ensembl
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0006813; P:potassium ion transport; TAS:ProtInc
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0051289; P:protein homotetramerization; IEA:Ensembl
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IEA:Ensembl
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0060075; P:regulation of resting membrane potential; IEA:Ensembl
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0051930; P:regulation of sensory perception of pain; IEA:Ensembl
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0009637; P:response to blue light; IEA:Ensembl
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0051385; P:response to mineralocorticoid; IEA:Ensembl
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0007268; P:synaptic transmission; TAS:Reactome
P78508	KCNJ10	ATP-sensitive inward rectifier potassium channel 10	GO:0007601; P:visual perception; IEA:Ensembl
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0030506; F:ankyrin binding; IPI:BHF-UCL
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0005524; F:ATP binding; ISS:BHF-UCL
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0015272; F:ATP-activated inward rectifier potassium channel activity; ISS:BHF-UCL
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0030955; F:potassium ion binding; TAS:BHF-UCL
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0005249; F:voltage-gated potassium channel activity; IDA:BHF-UCL
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0071316; P:cellular response to nicotine; IEA:Ensembl
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0006006; P:glucose metabolic process; IMP:BHF-UCL
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0046676; P:negative regulation of insulin secretion; IMP:BHF-UCL
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0050877; P:neurological system process; IMP:BHF-UCL
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:2001259; P:positive regulation of cation channel activity; IEA:Ensembl
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0010107; P:potassium ion import; ISS:BHF-UCL
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0071805; P:potassium ion transmembrane transport; IDA:BHF-UCL
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0050796; P:regulation of insulin secretion; IMP:BHF-UCL
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0042391; P:regulation of membrane potential; IDA:BHF-UCL
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0033198; P:response to ATP; IDA:BHF-UCL
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0042493; P:response to drug; IMP:BHF-UCL
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0032355; P:response to estradiol; IEA:Ensembl
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0002931; P:response to ischemia; IEA:Ensembl
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0033574; P:response to testosterone; IEA:Ensembl
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14654	KCNJ11	ATP-sensitive inward rectifier potassium channel 11	GO:0007268; P:synaptic transmission; TAS:Reactome
Q14500	KCNJ12	ATP-sensitive inward rectifier potassium channel 12	GO:0005242; F:inward rectifier potassium channel activity; IDA:UniProtKB
Q14500	KCNJ12	ATP-sensitive inward rectifier potassium channel 12	GO:0006936; P:muscle contraction; TAS:ProtInc
Q14500	KCNJ12	ATP-sensitive inward rectifier potassium channel 12	GO:0071805; P:potassium ion transmembrane transport; IDA:GOC
Q14500	KCNJ12	ATP-sensitive inward rectifier potassium channel 12	GO:0006813; P:potassium ion transport; IDA:UniProtKB
Q14500	KCNJ12	ATP-sensitive inward rectifier potassium channel 12	GO:0051289; P:protein homotetramerization; IDA:UniProtKB
Q14500	KCNJ12	ATP-sensitive inward rectifier potassium channel 12	GO:0008016; P:regulation of heart contraction; TAS:ProtInc
Q14500	KCNJ12	ATP-sensitive inward rectifier potassium channel 12	GO:0007268; P:synaptic transmission; TAS:Reactome
O60928	KCNJ13	Inward rectifier potassium channel 13	GO:0005242; F:inward rectifier potassium channel activity; NAS:UniProtKB
O60928	KCNJ13	Inward rectifier potassium channel 13	GO:0071805; P:potassium ion transmembrane transport; NAS:GOC
O60928	KCNJ13	Inward rectifier potassium channel 13	GO:0006813; P:potassium ion transport; NAS:UniProtKB
Q9UNX9	KCNJ14	ATP-sensitive inward rectifier potassium channel 14	GO:0005242; F:inward rectifier potassium channel activity; TAS:ProtInc
Q9UNX9	KCNJ14	ATP-sensitive inward rectifier potassium channel 14	GO:0071805; P:potassium ion transmembrane transport; TAS:GOC
Q9UNX9	KCNJ14	ATP-sensitive inward rectifier potassium channel 14	GO:0007268; P:synaptic transmission; TAS:Reactome
Q99712	KCNJ15	ATP-sensitive inward rectifier potassium channel 15	GO:0005242; F:inward rectifier potassium channel activity; TAS:ProtInc
Q99712	KCNJ15	ATP-sensitive inward rectifier potassium channel 15	GO:0005515; F:protein binding; IPI:IntAct
Q99712	KCNJ15	ATP-sensitive inward rectifier potassium channel 15	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q99712	KCNJ15	ATP-sensitive inward rectifier potassium channel 15	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9NPI9	KCNJ16	Inward rectifier potassium channel 16	GO:0005242; F:inward rectifier potassium channel activity; NAS:UniProtKB
Q9NPI9	KCNJ16	Inward rectifier potassium channel 16	GO:0071805; P:potassium ion transmembrane transport; NAS:GOC
Q9NPI9	KCNJ16	Inward rectifier potassium channel 16	GO:0006813; P:potassium ion transport; NAS:UniProtKB
Q9NPI9	KCNJ16	Inward rectifier potassium channel 16	GO:0007268; P:synaptic transmission; TAS:Reactome
B7U540	KCNJ18	Inward rectifier potassium channel 18	GO:0005242; F:inward rectifier potassium channel activity; IDA:UniProtKB
B7U540	KCNJ18	Inward rectifier potassium channel 18	GO:0071805; P:potassium ion transmembrane transport; IDA:GOC
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0003779; F:actin binding; IDA:BHF-UCL
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0015269; F:calcium-activated potassium channel activity; IDA:UniProtKB
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0060072; F:large conductance calcium-activated potassium channel activity; IDA:UniProtKB
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0007628; P:adult walking behavior; IEA:Ensembl
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0042491; P:auditory receptor cell differentiation; IEA:Ensembl
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0007596; P:blood coagulation; TAS:Reactome
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0048469; P:cell maturation; IEA:Ensembl
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0030007; P:cellular potassium ion homeostasis; IDA:UniProtKB
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0060082; P:eye blink reflex; IEA:Ensembl
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0045475; P:locomotor rhythm; IEA:Ensembl
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0060073; P:micturition; IDA:UniProtKB
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0045794; P:negative regulation of cell volume; IDA:UniProtKB
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0019228; P:neuronal action potential; IEA:Ensembl
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0071805; P:potassium ion transmembrane transport; IBA:RefGenome
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0006813; P:potassium ion transport; IDA:UniProtKB
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0051260; P:protein homooligomerization; IEA:Ensembl
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0032344; P:regulation of aldosterone metabolic process; IEA:Ensembl
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0042391; P:regulation of membrane potential; IDA:UniProtKB
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0060087; P:relaxation of vascular smooth muscle; IEA:Ensembl
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0051592; P:response to calcium ion; IDA:UniProtKB
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0034465; P:response to carbon monoxide; IDA:UniProtKB
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0001666; P:response to hypoxia; IDA:UniProtKB
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0006970; P:response to osmotic stress; IDA:UniProtKB
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0046541; P:saliva secretion; IEA:Ensembl
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0007605; P:sensory perception of sound; IEA:Ensembl
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0060083; P:smooth muscle contraction involved in micturition; IDA:UniProtKB
Q12791	KCNMA1	Calcium-activated potassium channel subunit alpha-1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q16558	KCNMB1	Calcium-activated potassium channel subunit beta-1	GO:0015269; F:calcium-activated potassium channel activity; TAS:ProtInc
Q16558	KCNMB1	Calcium-activated potassium channel subunit beta-1	GO:0015459; F:potassium channel regulator activity; TAS:ProtInc
Q16558	KCNMB1	Calcium-activated potassium channel subunit beta-1	GO:0007596; P:blood coagulation; TAS:Reactome
Q16558	KCNMB1	Calcium-activated potassium channel subunit beta-1	GO:0071805; P:potassium ion transmembrane transport; TAS:GOC
Q16558	KCNMB1	Calcium-activated potassium channel subunit beta-1	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q16558	KCNMB1	Calcium-activated potassium channel subunit beta-1	GO:0051592; P:response to calcium ion; IEA:Ensembl
Q16558	KCNMB1	Calcium-activated potassium channel subunit beta-1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9NPA1	KCNMB3	Calcium-activated potassium channel subunit beta-3	GO:0015269; F:calcium-activated potassium channel activity; IDA:UniProtKB
Q9NPA1	KCNMB3	Calcium-activated potassium channel subunit beta-3	GO:0015459; F:potassium channel regulator activity; NAS:UniProtKB
Q9NPA1	KCNMB3	Calcium-activated potassium channel subunit beta-3	GO:0001508; P:action potential; IDA:UniProtKB
Q9NPA1	KCNMB3	Calcium-activated potassium channel subunit beta-3	GO:0007596; P:blood coagulation; TAS:Reactome
Q9NPA1	KCNMB3	Calcium-activated potassium channel subunit beta-3	GO:0005513; P:detection of calcium ion; IDA:UniProtKB
Q9NPA1	KCNMB3	Calcium-activated potassium channel subunit beta-3	GO:0019228; P:neuronal action potential; IDA:UniProtKB
Q9NPA1	KCNMB3	Calcium-activated potassium channel subunit beta-3	GO:0071805; P:potassium ion transmembrane transport; IDA:GOC
Q9NPA1	KCNMB3	Calcium-activated potassium channel subunit beta-3	GO:0006813; P:potassium ion transport; IDA:UniProtKB
Q9NPA1	KCNMB3	Calcium-activated potassium channel subunit beta-3	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9Y691	KCNMB2	Calcium-activated potassium channel subunit beta-2	GO:0015269; F:calcium-activated potassium channel activity; IDA:UniProtKB
Q9Y691	KCNMB2	Calcium-activated potassium channel subunit beta-2	GO:0008200; F:ion channel inhibitor activity; TAS:ProtInc
Q9Y691	KCNMB2	Calcium-activated potassium channel subunit beta-2	GO:0015459; F:potassium channel regulator activity; TAS:ProtInc
Q9Y691	KCNMB2	Calcium-activated potassium channel subunit beta-2	GO:0001508; P:action potential; IDA:UniProtKB
Q9Y691	KCNMB2	Calcium-activated potassium channel subunit beta-2	GO:0007596; P:blood coagulation; TAS:Reactome
Q9Y691	KCNMB2	Calcium-activated potassium channel subunit beta-2	GO:0005513; P:detection of calcium ion; IDA:UniProtKB
Q9Y691	KCNMB2	Calcium-activated potassium channel subunit beta-2	GO:0019228; P:neuronal action potential; IDA:UniProtKB
Q9Y691	KCNMB2	Calcium-activated potassium channel subunit beta-2	GO:0071805; P:potassium ion transmembrane transport; IDA:GOC
Q9Y691	KCNMB2	Calcium-activated potassium channel subunit beta-2	GO:0006813; P:potassium ion transport; IDA:UniProtKB
Q9Y691	KCNMB2	Calcium-activated potassium channel subunit beta-2	GO:0019229; P:regulation of vasoconstriction; TAS:UniProtKB
Q9Y691	KCNMB2	Calcium-activated potassium channel subunit beta-2	GO:0007268; P:synaptic transmission; TAS:Reactome
Q86W47	KCNMB4	Calcium-activated potassium channel subunit beta-4	GO:0015269; F:calcium-activated potassium channel activity; IDA:UniProtKB
Q86W47	KCNMB4	Calcium-activated potassium channel subunit beta-4	GO:0005515; F:protein binding; IPI:UniProtKB
Q86W47	KCNMB4	Calcium-activated potassium channel subunit beta-4	GO:0001508; P:action potential; IDA:UniProtKB
Q86W47	KCNMB4	Calcium-activated potassium channel subunit beta-4	GO:0007596; P:blood coagulation; TAS:Reactome
Q86W47	KCNMB4	Calcium-activated potassium channel subunit beta-4	GO:0005513; P:detection of calcium ion; IDA:UniProtKB
Q86W47	KCNMB4	Calcium-activated potassium channel subunit beta-4	GO:0019228; P:neuronal action potential; IDA:UniProtKB
Q86W47	KCNMB4	Calcium-activated potassium channel subunit beta-4	GO:0071805; P:potassium ion transmembrane transport; IDA:GOC
Q86W47	KCNMB4	Calcium-activated potassium channel subunit beta-4	GO:0006813; P:potassium ion transport; IDA:UniProtKB
Q86W47	KCNMB4	Calcium-activated potassium channel subunit beta-4	GO:0046928; P:regulation of neurotransmitter secretion; TAS:UniProtKB
Q86W47	KCNMB4	Calcium-activated potassium channel subunit beta-4	GO:0019229; P:regulation of vasoconstriction; TAS:UniProtKB
Q86W47	KCNMB4	Calcium-activated potassium channel subunit beta-4	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9P0J7	KCMF1	E3 ubiquitin-protein ligase KCMF1	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9P0J7	KCMF1	E3 ubiquitin-protein ligase KCMF1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q09470	KCNA1	Potassium voltage-gated channel subfamily A member 1	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
Q09470	KCNA1	Potassium voltage-gated channel subfamily A member 1	GO:0005267; F:potassium channel activity; TAS:ProtInc
Q09470	KCNA1	Potassium voltage-gated channel subfamily A member 1	GO:0015079; F:potassium ion transmembrane transporter activity; TAS:ProtInc
Q09470	KCNA1	Potassium voltage-gated channel subfamily A member 1	GO:0005515; F:protein binding; IPI:IntAct
Q09470	KCNA1	Potassium voltage-gated channel subfamily A member 1	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q09470	KCNA1	Potassium voltage-gated channel subfamily A member 1	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q09470	KCNA1	Potassium voltage-gated channel subfamily A member 1	GO:0007268; P:synaptic transmission; TAS:Reactome
P16389	KCNA2	Potassium voltage-gated channel subfamily A member 2	GO:0005251; F:delayed rectifier potassium channel activity; TAS:ProtInc
P16389	KCNA2	Potassium voltage-gated channel subfamily A member 2	GO:0015271; F:outward rectifier potassium channel activity; IEA:Ensembl
P16389	KCNA2	Potassium voltage-gated channel subfamily A member 2	GO:0005267; F:potassium channel activity; TAS:ProtInc
P16389	KCNA2	Potassium voltage-gated channel subfamily A member 2	GO:0005249; F:voltage-gated potassium channel activity; TAS:ProtInc
P16389	KCNA2	Potassium voltage-gated channel subfamily A member 2	GO:0021633; P:optic nerve structural organization; IEA:Ensembl
P16389	KCNA2	Potassium voltage-gated channel subfamily A member 2	GO:0006813; P:potassium ion transport; TAS:ProtInc
P16389	KCNA2	Potassium voltage-gated channel subfamily A member 2	GO:0051260; P:protein homooligomerization; IEA:InterPro
P16389	KCNA2	Potassium voltage-gated channel subfamily A member 2	GO:0007268; P:synaptic transmission; TAS:Reactome
P22001	KCNA3	Potassium voltage-gated channel subfamily A member 3	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
P22001	KCNA3	Potassium voltage-gated channel subfamily A member 3	GO:0015271; F:outward rectifier potassium channel activity; IEA:Ensembl
P22001	KCNA3	Potassium voltage-gated channel subfamily A member 3	GO:0005244; F:voltage-gated ion channel activity; TAS:ProtInc
P22001	KCNA3	Potassium voltage-gated channel subfamily A member 3	GO:0006813; P:potassium ion transport; TAS:ProtInc
P22001	KCNA3	Potassium voltage-gated channel subfamily A member 3	GO:0051260; P:protein homooligomerization; IEA:InterPro
P22001	KCNA3	Potassium voltage-gated channel subfamily A member 3	GO:0007268; P:synaptic transmission; TAS:Reactome
P22459	KCNA4	Potassium voltage-gated channel subfamily A member 4	GO:0030955; F:potassium ion binding; IEA:InterPro
P22459	KCNA4	Potassium voltage-gated channel subfamily A member 4	GO:0005515; F:protein binding; IPI:UniProtKB
P22459	KCNA4	Potassium voltage-gated channel subfamily A member 4	GO:0005249; F:voltage-gated potassium channel activity; TAS:ProtInc
P22459	KCNA4	Potassium voltage-gated channel subfamily A member 4	GO:0006813; P:potassium ion transport; TAS:ProtInc
P22459	KCNA4	Potassium voltage-gated channel subfamily A member 4	GO:0051260; P:protein homooligomerization; IEA:InterPro
P22459	KCNA4	Potassium voltage-gated channel subfamily A member 4	GO:0007268; P:synaptic transmission; TAS:Reactome
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0051393; F:alpha-actinin binding; IPI:BHF-UCL
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0005251; F:delayed rectifier potassium channel activity; IDA:BHF-UCL
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0015271; F:outward rectifier potassium channel activity; IDA:BHF-UCL
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0019870; F:potassium channel inhibitor activity; IEA:Ensembl
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0005515; F:protein binding; IPI:IntAct
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0097110; F:scaffold protein binding; IPI:BHF-UCL
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0086089; F:voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization; IMP:BHF-UCL
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0086014; P:atrial cardiac muscle cell action potential; IMP:BHF-UCL
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0060081; P:membrane hyperpolarization; IMP:BHF-UCL
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0051481; P:negative regulation of cytosolic calcium ion concentration; IEA:Ensembl
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0043267; P:negative regulation of potassium ion transport; IEA:Ensembl
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:2000288; P:positive regulation of myoblast proliferation; IEA:Ensembl
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0071435; P:potassium ion export; IDA:BHF-UCL
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0055075; P:potassium ion homeostasis; IEA:Ensembl
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0006813; P:potassium ion transport; IDA:MGI
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0051260; P:protein homooligomerization; IEA:InterPro
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0060372; P:regulation of atrial cardiac muscle cell membrane repolarization; IMP:BHF-UCL
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0050796; P:regulation of insulin secretion; TAS:BHF-UCL
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0042391; P:regulation of membrane potential; IDA:BHF-UCL
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0043266; P:regulation of potassium ion transport; IMP:BHF-UCL
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0019229; P:regulation of vasoconstriction; IEA:Ensembl
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0001666; P:response to hypoxia; IEA:Ensembl
P22460	KCNA5	Potassium voltage-gated channel subfamily A member 5	GO:0007268; P:synaptic transmission; TAS:Reactome
P17658	KCNA6	Potassium voltage-gated channel subfamily A member 6	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
P17658	KCNA6	Potassium voltage-gated channel subfamily A member 6	GO:0005249; F:voltage-gated potassium channel activity; TAS:ProtInc
P17658	KCNA6	Potassium voltage-gated channel subfamily A member 6	GO:0006813; P:potassium ion transport; TAS:ProtInc
P17658	KCNA6	Potassium voltage-gated channel subfamily A member 6	GO:0051260; P:protein homooligomerization; IEA:InterPro
P17658	KCNA6	Potassium voltage-gated channel subfamily A member 6	GO:0007268; P:synaptic transmission; TAS:Reactome
Q96RP8	KCNA7	Potassium voltage-gated channel subfamily A member 7	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
Q96RP8	KCNA7	Potassium voltage-gated channel subfamily A member 7	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q96RP8	KCNA7	Potassium voltage-gated channel subfamily A member 7	GO:0007268; P:synaptic transmission; TAS:Reactome
Q14721	KCNB1	Potassium voltage-gated channel subfamily B member 1	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
Q14721	KCNB1	Potassium voltage-gated channel subfamily B member 1	GO:0015271; F:outward rectifier potassium channel activity; IEA:Ensembl
Q14721	KCNB1	Potassium voltage-gated channel subfamily B member 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q14721	KCNB1	Potassium voltage-gated channel subfamily B member 1	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q14721	KCNB1	Potassium voltage-gated channel subfamily B member 1	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q14721	KCNB1	Potassium voltage-gated channel subfamily B member 1	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
Q14721	KCNB1	Potassium voltage-gated channel subfamily B member 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14721	KCNB1	Potassium voltage-gated channel subfamily B member 1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q92953	KCNB2	Potassium voltage-gated channel subfamily B member 2	GO:0005251; F:delayed rectifier potassium channel activity; TAS:ProtInc
Q92953	KCNB2	Potassium voltage-gated channel subfamily B member 2	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q92953	KCNB2	Potassium voltage-gated channel subfamily B member 2	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q92953	KCNB2	Potassium voltage-gated channel subfamily B member 2	GO:0006940; P:regulation of smooth muscle contraction; TAS:ProtInc
Q92953	KCNB2	Potassium voltage-gated channel subfamily B member 2	GO:0007268; P:synaptic transmission; TAS:Reactome
P48547	KCNC1	Potassium voltage-gated channel subfamily C member 1	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
P48547	KCNC1	Potassium voltage-gated channel subfamily C member 1	GO:0005249; F:voltage-gated potassium channel activity; TAS:ProtInc
P48547	KCNC1	Potassium voltage-gated channel subfamily C member 1	GO:0006813; P:potassium ion transport; TAS:ProtInc
P48547	KCNC1	Potassium voltage-gated channel subfamily C member 1	GO:0051260; P:protein homooligomerization; IEA:InterPro
P48547	KCNC1	Potassium voltage-gated channel subfamily C member 1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q96PR1	KCNC2	Potassium voltage-gated channel subfamily C member 2	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
Q96PR1	KCNC2	Potassium voltage-gated channel subfamily C member 2	GO:0001508; P:action potential; IEA:Ensembl
Q96PR1	KCNC2	Potassium voltage-gated channel subfamily C member 2	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q96PR1	KCNC2	Potassium voltage-gated channel subfamily C member 2	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q96PR1	KCNC2	Potassium voltage-gated channel subfamily C member 2	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
Q96PR1	KCNC2	Potassium voltage-gated channel subfamily C member 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96PR1	KCNC2	Potassium voltage-gated channel subfamily C member 2	GO:0007268; P:synaptic transmission; TAS:Reactome
Q14003	KCNC3	Potassium voltage-gated channel subfamily C member 3	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
Q14003	KCNC3	Potassium voltage-gated channel subfamily C member 3	GO:0005249; F:voltage-gated potassium channel activity; TAS:ProtInc
Q14003	KCNC3	Potassium voltage-gated channel subfamily C member 3	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q14003	KCNC3	Potassium voltage-gated channel subfamily C member 3	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q14003	KCNC3	Potassium voltage-gated channel subfamily C member 3	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q14003	KCNC3	Potassium voltage-gated channel subfamily C member 3	GO:0046928; P:regulation of neurotransmitter secretion; IEA:Ensembl
Q14003	KCNC3	Potassium voltage-gated channel subfamily C member 3	GO:0007268; P:synaptic transmission; TAS:Reactome
Q03721	KCNC4	Potassium voltage-gated channel subfamily C member 4	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
Q03721	KCNC4	Potassium voltage-gated channel subfamily C member 4	GO:0005267; F:potassium channel activity; TAS:ProtInc
Q03721	KCNC4	Potassium voltage-gated channel subfamily C member 4	GO:0005249; F:voltage-gated potassium channel activity; TAS:ProtInc
Q03721	KCNC4	Potassium voltage-gated channel subfamily C member 4	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q03721	KCNC4	Potassium voltage-gated channel subfamily C member 4	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q03721	KCNC4	Potassium voltage-gated channel subfamily C member 4	GO:0046928; P:regulation of neurotransmitter secretion; IEA:Ensembl
Q03721	KCNC4	Potassium voltage-gated channel subfamily C member 4	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9NSA2	KCND1	Potassium voltage-gated channel subfamily D member 1	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
Q9NSA2	KCND1	Potassium voltage-gated channel subfamily D member 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NSA2	KCND1	Potassium voltage-gated channel subfamily D member 1	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q9NSA2	KCND1	Potassium voltage-gated channel subfamily D member 1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9NZV8	KCND2	Potassium voltage-gated channel subfamily D member 2	GO:0005250; F:A-type (transient outward) potassium channel activity; IBA:RefGenome
Q9NZV8	KCND2	Potassium voltage-gated channel subfamily D member 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NZV8	KCND2	Potassium voltage-gated channel subfamily D member 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NZV8	KCND2	Potassium voltage-gated channel subfamily D member 2	GO:0005249; F:voltage-gated potassium channel activity; NAS:UniProtKB
Q9NZV8	KCND2	Potassium voltage-gated channel subfamily D member 2	GO:0001508; P:action potential; TAS:UniProtKB
Q9NZV8	KCND2	Potassium voltage-gated channel subfamily D member 2	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q9NZV8	KCND2	Potassium voltage-gated channel subfamily D member 2	GO:0007268; P:synaptic transmission; TAS:UniProtKB
Q9UK17	KCND3	Potassium voltage-gated channel subfamily D member 3	GO:0005250; F:A-type (transient outward) potassium channel activity; IBA:RefGenome
Q9UK17	KCND3	Potassium voltage-gated channel subfamily D member 3	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q9UK17	KCND3	Potassium voltage-gated channel subfamily D member 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UK17	KCND3	Potassium voltage-gated channel subfamily D member 3	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9UK17	KCND3	Potassium voltage-gated channel subfamily D member 3	GO:0086009; P:membrane repolarization; IDA:BHF-UCL
Q9UK17	KCND3	Potassium voltage-gated channel subfamily D member 3	GO:0071435; P:potassium ion export; IDA:BHF-UCL
Q9UK17	KCND3	Potassium voltage-gated channel subfamily D member 3	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q9UK17	KCND3	Potassium voltage-gated channel subfamily D member 3	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q9UK17	KCND3	Potassium voltage-gated channel subfamily D member 3	GO:0007268; P:synaptic transmission; TAS:Reactome
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0005251; F:delayed rectifier potassium channel activity; IEA:Ensembl
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0015459; F:potassium channel regulator activity; IDA:BHF-UCL
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0005515; F:protein binding; IPI:IntAct
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0031433; F:telethonin binding; IPI:BHF-UCL
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0086002; P:cardiac muscle cell action potential involved in contraction; IMP:BHF-UCL
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0071468; P:cellular response to acidity; IEA:Ensembl
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0071320; P:cellular response to cAMP; IDA:BHF-UCL
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0002070; P:epithelial cell maturation; IEA:Ensembl
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0060047; P:heart contraction; IEA:Ensembl
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0008584; P:male gonad development; IEA:Ensembl
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0086009; P:membrane repolarization; IDA:BHF-UCL
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0086011; P:membrane repolarization during action potential; IDA:BHF-UCL
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0086013; P:membrane repolarization during cardiac muscle cell action potential; IDA:BHF-UCL
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0090315; P:negative regulation of protein targeting to membrane; IEA:Ensembl
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:1901381; P:positive regulation of potassium ion transmembrane transport; IDA:BHF-UCL
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0071435; P:potassium ion export; IDA:BHF-UCL
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0071805; P:potassium ion transmembrane transport; IDA:BHF-UCL
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0006487; P:protein N-linked glycosylation; IDA:UniProtKB
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0006493; P:protein O-linked glycosylation; IDA:UniProtKB
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:1902259; P:regulation of delayed rectifier potassium channel activity; IDA:BHF-UCL
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:1901379; P:regulation of potassium ion transmembrane transport; IDA:BHF-UCL
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0007605; P:sensory perception of sound; TAS:ProtInc
P15382	KCNE1	Potassium voltage-gated channel subfamily E member 1	GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:0005251; F:delayed rectifier potassium channel activity; IEA:Ensembl
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:0005242; F:inward rectifier potassium channel activity; IEA:Ensembl
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:0044325; F:ion channel binding; IDA:BHF-UCL
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:0015459; F:potassium channel regulator activity; IDA:BHF-UCL
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:1902282; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; IMP:BHF-UCL
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:0007568; P:aging; IEA:Ensembl
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:0086002; P:cardiac muscle cell action potential involved in contraction; IMP:BHF-UCL
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:0034613; P:cellular protein localization; IEA:Ensembl
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:0035690; P:cellular response to drug; IDA:BHF-UCL
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:0086009; P:membrane repolarization; IDA:BHF-UCL
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:0086011; P:membrane repolarization during action potential; IMP:BHF-UCL
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:1901800; P:positive regulation of proteasomal protein catabolic process; IDA:BHF-UCL
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:0071435; P:potassium ion export; IDA:BHF-UCL
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:0010107; P:potassium ion import; IMP:BHF-UCL
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:0071805; P:potassium ion transmembrane transport; IDA:BHF-UCL
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:1902159; P:regulation of cyclic nucleotide-gated ion channel activity; IEA:Ensembl
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:1902259; P:regulation of delayed rectifier potassium channel activity; IDA:BHF-UCL
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:1901979; P:regulation of inward rectifier potassium channel activity; IDA:BHF-UCL
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:0060306; P:regulation of membrane repolarization; IDA:BHF-UCL
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:1901379; P:regulation of potassium ion transmembrane transport; IDA:BHF-UCL
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:0043586; P:tongue development; IEA:Ensembl
Q9Y6J6	KCNE2	Potassium voltage-gated channel subfamily E member 2	GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL
Q9Y6H6	KCNE3	Potassium voltage-gated channel subfamily E member 3	GO:0015459; F:potassium channel regulator activity; IEA:Ensembl
Q9Y6H6	KCNE3	Potassium voltage-gated channel subfamily E member 3	GO:0005249; F:voltage-gated potassium channel activity; IEA:InterPro
Q9Y6H6	KCNE3	Potassium voltage-gated channel subfamily E member 3	GO:0043266; P:regulation of potassium ion transport; IEA:Ensembl
Q8WWG9	KCNE4	Potassium voltage-gated channel subfamily E member 4	GO:0005249; F:voltage-gated potassium channel activity; IEA:InterPro
Q9H3M0	KCNF1	Potassium voltage-gated channel subfamily F member 1	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
Q9H3M0	KCNF1	Potassium voltage-gated channel subfamily F member 1	GO:0005267; F:potassium channel activity; TAS:ProtInc
Q9H3M0	KCNF1	Potassium voltage-gated channel subfamily F member 1	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q9H3M0	KCNF1	Potassium voltage-gated channel subfamily F member 1	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q9H3M0	KCNF1	Potassium voltage-gated channel subfamily F member 1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9UIX4	KCNG1	Potassium voltage-gated channel subfamily G member 1	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
Q9UIX4	KCNG1	Potassium voltage-gated channel subfamily G member 1	GO:0005267; F:potassium channel activity; NAS:UniProtKB
Q9UIX4	KCNG1	Potassium voltage-gated channel subfamily G member 1	GO:0006813; P:potassium ion transport; NAS:UniProtKB
Q9UIX4	KCNG1	Potassium voltage-gated channel subfamily G member 1	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q9UIX4	KCNG1	Potassium voltage-gated channel subfamily G member 1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q8TAE7	KCNG3	Potassium voltage-gated channel subfamily G member 3	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
Q8TAE7	KCNG3	Potassium voltage-gated channel subfamily G member 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TAE7	KCNG3	Potassium voltage-gated channel subfamily G member 3	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q8TAE7	KCNG3	Potassium voltage-gated channel subfamily G member 3	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9UJ96	KCNG2	Potassium voltage-gated channel subfamily G member 2	GO:0005251; F:delayed rectifier potassium channel activity; TAS:ProtInc
Q9UJ96	KCNG2	Potassium voltage-gated channel subfamily G member 2	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q9UJ96	KCNG2	Potassium voltage-gated channel subfamily G member 2	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q9UJ96	KCNG2	Potassium voltage-gated channel subfamily G member 2	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q9UJ96	KCNG2	Potassium voltage-gated channel subfamily G member 2	GO:0008016; P:regulation of heart contraction; TAS:ProtInc
Q9UJ96	KCNG2	Potassium voltage-gated channel subfamily G member 2	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
Q9UJ96	KCNG2	Potassium voltage-gated channel subfamily G member 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UJ96	KCNG2	Potassium voltage-gated channel subfamily G member 2	GO:0007268; P:synaptic transmission; TAS:Reactome
Q8TDN1	KCNG4	Potassium voltage-gated channel subfamily G member 4	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
Q8TDN1	KCNG4	Potassium voltage-gated channel subfamily G member 4	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q8TDN1	KCNG4	Potassium voltage-gated channel subfamily G member 4	GO:0007268; P:synaptic transmission; TAS:Reactome
O95259	KCNH1	Potassium voltage-gated channel subfamily H member 1	GO:0005251; F:delayed rectifier potassium channel activity; TAS:ProtInc
O95259	KCNH1	Potassium voltage-gated channel subfamily H member 1	GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro
O95259	KCNH1	Potassium voltage-gated channel subfamily H member 1	GO:0005515; F:protein binding; IPI:IntAct
O95259	KCNH1	Potassium voltage-gated channel subfamily H member 1	GO:0007520; P:myoblast fusion; TAS:ProtInc
O95259	KCNH1	Potassium voltage-gated channel subfamily H member 1	GO:0071805; P:potassium ion transmembrane transport; IBA:RefGenome
O95259	KCNH1	Potassium voltage-gated channel subfamily H member 1	GO:0006813; P:potassium ion transport; TAS:ProtInc
O95259	KCNH1	Potassium voltage-gated channel subfamily H member 1	GO:0042391; P:regulation of membrane potential; IBA:RefGenome
O95259	KCNH1	Potassium voltage-gated channel subfamily H member 1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0005251; F:delayed rectifier potassium channel activity; IDA:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0042802; F:identical protein binding; IPI:IntAct
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0005242; F:inward rectifier potassium channel activity; IDA:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0031625; F:ubiquitin protein ligase binding; IPI:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0005249; F:voltage-gated potassium channel activity; IDA:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:1902282; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; IMP:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0035690; P:cellular response to drug; IDA:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0086010; P:membrane depolarization during action potential; IDA:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0086011; P:membrane repolarization during action potential; IDA:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0086013; P:membrane repolarization during cardiac muscle cell action potential; IMP:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:1902303; P:negative regulation of potassium ion export; IDA:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:1901380; P:negative regulation of potassium ion transmembrane transport; IDA:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:1901381; P:positive regulation of potassium ion transmembrane transport; IDA:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0071435; P:potassium ion export; IDA:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0055075; P:potassium ion homeostasis; IDA:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0071805; P:potassium ion transmembrane transport; IDA:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0003064; P:regulation of heart rate by hormone; TAS:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0042391; P:regulation of membrane potential; IDA:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0060306; P:regulation of membrane repolarization; IDA:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:1901379; P:regulation of potassium ion transmembrane transport; IDA:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0007268; P:synaptic transmission; TAS:Reactome
Q12809	KCNH2	Potassium voltage-gated channel subfamily H member 2	GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL
Q9ULD8	KCNH3	Potassium voltage-gated channel subfamily H member 3	GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro
Q9ULD8	KCNH3	Potassium voltage-gated channel subfamily H member 3	GO:0005515; F:protein binding; IPI:IntAct
Q9ULD8	KCNH3	Potassium voltage-gated channel subfamily H member 3	GO:0005249; F:voltage-gated potassium channel activity; TAS:UniProtKB
Q9ULD8	KCNH3	Potassium voltage-gated channel subfamily H member 3	GO:0071805; P:potassium ion transmembrane transport; IBA:RefGenome
Q9ULD8	KCNH3	Potassium voltage-gated channel subfamily H member 3	GO:0006813; P:potassium ion transport; TAS:UniProtKB
Q9ULD8	KCNH3	Potassium voltage-gated channel subfamily H member 3	GO:0042391; P:regulation of membrane potential; IBA:RefGenome
Q9ULD8	KCNH3	Potassium voltage-gated channel subfamily H member 3	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9UQ05	KCNH4	Potassium voltage-gated channel subfamily H member 4	GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro
Q9UQ05	KCNH4	Potassium voltage-gated channel subfamily H member 4	GO:0005249; F:voltage-gated potassium channel activity; IBA:RefGenome
Q9UQ05	KCNH4	Potassium voltage-gated channel subfamily H member 4	GO:0071805; P:potassium ion transmembrane transport; IBA:RefGenome
Q9UQ05	KCNH4	Potassium voltage-gated channel subfamily H member 4	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q9UQ05	KCNH4	Potassium voltage-gated channel subfamily H member 4	GO:0042391; P:regulation of membrane potential; IBA:RefGenome
Q9UQ05	KCNH4	Potassium voltage-gated channel subfamily H member 4	GO:0007268; P:synaptic transmission; TAS:Reactome
Q8NCM2	KCNH5	Potassium voltage-gated channel subfamily H member 5	GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro
Q8NCM2	KCNH5	Potassium voltage-gated channel subfamily H member 5	GO:0005249; F:voltage-gated potassium channel activity; IBA:RefGenome
Q8NCM2	KCNH5	Potassium voltage-gated channel subfamily H member 5	GO:0071805; P:potassium ion transmembrane transport; IBA:RefGenome
Q8NCM2	KCNH5	Potassium voltage-gated channel subfamily H member 5	GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; IDA:MGI
Q8NCM2	KCNH5	Potassium voltage-gated channel subfamily H member 5	GO:0042391; P:regulation of membrane potential; IBA:RefGenome
Q8NCM2	KCNH5	Potassium voltage-gated channel subfamily H member 5	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9H252	KCNH6	Potassium voltage-gated channel subfamily H member 6	GO:0004871; F:signal transducer activity; IEA:InterPro
Q9H252	KCNH6	Potassium voltage-gated channel subfamily H member 6	GO:0005249; F:voltage-gated potassium channel activity; IBA:RefGenome
Q9H252	KCNH6	Potassium voltage-gated channel subfamily H member 6	GO:0071805; P:potassium ion transmembrane transport; IBA:RefGenome
Q9H252	KCNH6	Potassium voltage-gated channel subfamily H member 6	GO:0042391; P:regulation of membrane potential; IBA:RefGenome
Q9H252	KCNH6	Potassium voltage-gated channel subfamily H member 6	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9NS40	KCNH7	Potassium voltage-gated channel subfamily H member 7	GO:0005242; F:inward rectifier potassium channel activity; IEA:Ensembl
Q9NS40	KCNH7	Potassium voltage-gated channel subfamily H member 7	GO:0004871; F:signal transducer activity; IEA:InterPro
Q9NS40	KCNH7	Potassium voltage-gated channel subfamily H member 7	GO:0005249; F:voltage-gated potassium channel activity; IBA:RefGenome
Q9NS40	KCNH7	Potassium voltage-gated channel subfamily H member 7	GO:0007623; P:circadian rhythm; IEA:Ensembl
Q9NS40	KCNH7	Potassium voltage-gated channel subfamily H member 7	GO:0071805; P:potassium ion transmembrane transport; IBA:RefGenome
Q9NS40	KCNH7	Potassium voltage-gated channel subfamily H member 7	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q9NS40	KCNH7	Potassium voltage-gated channel subfamily H member 7	GO:0042391; P:regulation of membrane potential; IBA:RefGenome
Q9NS40	KCNH7	Potassium voltage-gated channel subfamily H member 7	GO:0007268; P:synaptic transmission; TAS:Reactome
Q96L42	KCNH8	Potassium voltage-gated channel subfamily H member 8	GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro
Q96L42	KCNH8	Potassium voltage-gated channel subfamily H member 8	GO:0005249; F:voltage-gated potassium channel activity; IBA:RefGenome
Q96L42	KCNH8	Potassium voltage-gated channel subfamily H member 8	GO:0071805; P:potassium ion transmembrane transport; IBA:RefGenome
Q96L42	KCNH8	Potassium voltage-gated channel subfamily H member 8	GO:0042391; P:regulation of membrane potential; IBA:RefGenome
Q96L42	KCNH8	Potassium voltage-gated channel subfamily H member 8	GO:0007268; P:synaptic transmission; TAS:Reactome
P48048	KCNJ1	ATP-sensitive inward rectifier potassium channel 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P48048	KCNJ1	ATP-sensitive inward rectifier potassium channel 1	GO:0005242; F:inward rectifier potassium channel activity; TAS:ProtInc
P48048	KCNJ1	ATP-sensitive inward rectifier potassium channel 1	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:BHF-UCL
P48048	KCNJ1	ATP-sensitive inward rectifier potassium channel 1	GO:0072358; P:cardiovascular system development; IEA:Ensembl
P48048	KCNJ1	ATP-sensitive inward rectifier potassium channel 1	GO:0007588; P:excretion; TAS:ProtInc
P48048	KCNJ1	ATP-sensitive inward rectifier potassium channel 1	GO:0001822; P:kidney development; IEA:Ensembl
P48048	KCNJ1	ATP-sensitive inward rectifier potassium channel 1	GO:0009791; P:post-embryonic development; IEA:Ensembl
P48048	KCNJ1	ATP-sensitive inward rectifier potassium channel 1	GO:0071805; P:potassium ion transmembrane transport; TAS:GOC
P48048	KCNJ1	ATP-sensitive inward rectifier potassium channel 1	GO:0006813; P:potassium ion transport; TAS:ProtInc
P48048	KCNJ1	ATP-sensitive inward rectifier potassium channel 1	GO:1900128; P:regulation of G-protein activated inward rectifier potassium channel activity; IEA:Ensembl
P48048	KCNJ1	ATP-sensitive inward rectifier potassium channel 1	GO:0070294; P:renal sodium ion absorption; IEA:Ensembl
P48048	KCNJ1	ATP-sensitive inward rectifier potassium channel 1	GO:0007268; P:synaptic transmission; TAS:Reactome
P48048	KCNJ1	ATP-sensitive inward rectifier potassium channel 1	GO:0001894; P:tissue homeostasis; IEA:Ensembl
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0005242; F:inward rectifier potassium channel activity; IDA:UniProtKB
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:BHF-UCL
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0086008; F:voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization; IMP:BHF-UCL
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0086002; P:cardiac muscle cell action potential involved in contraction; IMP:BHF-UCL
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0030007; P:cellular potassium ion homeostasis; TAS:BHF-UCL
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0015693; P:magnesium ion transport; IEA:Ensembl
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0086012; P:membrane depolarization during cardiac muscle cell action potential; TAS:BHF-UCL
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0086011; P:membrane repolarization during action potential; IMP:BHF-UCL
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0086013; P:membrane repolarization during cardiac muscle cell action potential; IMP:BHF-UCL
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:1901381; P:positive regulation of potassium ion transmembrane transport; IEA:Ensembl
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0010107; P:potassium ion import; IDA:BHF-UCL
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0071805; P:potassium ion transmembrane transport; IDA:BHF-UCL
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0006813; P:potassium ion transport; IDA:UniProtKB
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0051289; P:protein homotetramerization; IDA:UniProtKB
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0060306; P:regulation of membrane repolarization; IDA:BHF-UCL
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0060075; P:regulation of resting membrane potential; TAS:BHF-UCL
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0014861; P:regulation of skeletal muscle contraction via regulation of action potential; IMP:BHF-UCL
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0055119; P:relaxation of cardiac muscle; IMP:BHF-UCL
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0090076; P:relaxation of skeletal muscle; IMP:BHF-UCL
P63252	KCNJ2	Inward rectifier potassium channel 2	GO:0007268; P:synaptic transmission; TAS:Reactome
P48549	KCNJ3	G protein-activated inward rectifier potassium channel 1	GO:0015467; F:G-protein activated inward rectifier potassium channel activity; TAS:ProtInc
P48549	KCNJ3	G protein-activated inward rectifier potassium channel 1	GO:0005515; F:protein binding; IPI:BHF-UCL
P48549	KCNJ3	G protein-activated inward rectifier potassium channel 1	GO:0071805; P:potassium ion transmembrane transport; IDA:GOC
P48549	KCNJ3	G protein-activated inward rectifier potassium channel 1	GO:0006813; P:potassium ion transport; TAS:ProtInc
P48549	KCNJ3	G protein-activated inward rectifier potassium channel 1	GO:0051602; P:response to electrical stimulus; IEA:Ensembl
P48549	KCNJ3	G protein-activated inward rectifier potassium channel 1	GO:0007268; P:synaptic transmission; TAS:Reactome
P48050	KCNJ4	Inward rectifier potassium channel 4	GO:0005242; F:inward rectifier potassium channel activity; TAS:ProtInc
P48050	KCNJ4	Inward rectifier potassium channel 4	GO:0030165; F:PDZ domain binding; IPI:UniProtKB
P48050	KCNJ4	Inward rectifier potassium channel 4	GO:0005515; F:protein binding; IPI:UniProtKB
P48050	KCNJ4	Inward rectifier potassium channel 4	GO:0071805; P:potassium ion transmembrane transport; TAS:GOC
P48050	KCNJ4	Inward rectifier potassium channel 4	GO:0006813; P:potassium ion transport; TAS:ProtInc
P48050	KCNJ4	Inward rectifier potassium channel 4	GO:0007268; P:synaptic transmission; TAS:Reactome
P48544	KCNJ5	G protein-activated inward rectifier potassium channel 4	GO:0015467; F:G-protein activated inward rectifier potassium channel activity; TAS:UniProtKB
P48544	KCNJ5	G protein-activated inward rectifier potassium channel 4	GO:0005515; F:protein binding; IPI:BHF-UCL
P48544	KCNJ5	G protein-activated inward rectifier potassium channel 4	GO:0071805; P:potassium ion transmembrane transport; IDA:GOC
P48544	KCNJ5	G protein-activated inward rectifier potassium channel 4	GO:0006813; P:potassium ion transport; TAS:ProtInc
P48544	KCNJ5	G protein-activated inward rectifier potassium channel 4	GO:0007268; P:synaptic transmission; TAS:Reactome
P48051	KCNJ6	G protein-activated inward rectifier potassium channel 2	GO:0015467; F:G-protein activated inward rectifier potassium channel activity; TAS:ProtInc
P48051	KCNJ6	G protein-activated inward rectifier potassium channel 2	GO:0005242; F:inward rectifier potassium channel activity; TAS:ProtInc
P48051	KCNJ6	G protein-activated inward rectifier potassium channel 2	GO:0005515; F:protein binding; IPI:BHF-UCL
P48051	KCNJ6	G protein-activated inward rectifier potassium channel 2	GO:0071805; P:potassium ion transmembrane transport; TAS:GOC
P48051	KCNJ6	G protein-activated inward rectifier potassium channel 2	GO:0006813; P:potassium ion transport; TAS:ProtInc
P48051	KCNJ6	G protein-activated inward rectifier potassium channel 2	GO:0007268; P:synaptic transmission; TAS:Reactome
Q15842	KCNJ8	ATP-sensitive inward rectifier potassium channel 8	GO:0005524; F:ATP binding; IEA:Ensembl
Q15842	KCNJ8	ATP-sensitive inward rectifier potassium channel 8	GO:0015272; F:ATP-activated inward rectifier potassium channel activity; IEA:Ensembl
Q15842	KCNJ8	ATP-sensitive inward rectifier potassium channel 8	GO:0005242; F:inward rectifier potassium channel activity; TAS:ProtInc
Q15842	KCNJ8	ATP-sensitive inward rectifier potassium channel 8	GO:0051607; P:defense response to virus; IEA:Ensembl
Q15842	KCNJ8	ATP-sensitive inward rectifier potassium channel 8	GO:0007507; P:heart development; IEA:Ensembl
Q15842	KCNJ8	ATP-sensitive inward rectifier potassium channel 8	GO:0001822; P:kidney development; IEA:Ensembl
Q15842	KCNJ8	ATP-sensitive inward rectifier potassium channel 8	GO:0010107; P:potassium ion import; IEA:Ensembl
Q15842	KCNJ8	ATP-sensitive inward rectifier potassium channel 8	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q15842	KCNJ8	ATP-sensitive inward rectifier potassium channel 8	GO:0043330; P:response to exogenous dsRNA; IEA:Ensembl
Q15842	KCNJ8	ATP-sensitive inward rectifier potassium channel 8	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
Q15842	KCNJ8	ATP-sensitive inward rectifier potassium channel 8	GO:0009268; P:response to pH; IEA:Ensembl
Q15842	KCNJ8	ATP-sensitive inward rectifier potassium channel 8	GO:0007268; P:synaptic transmission; TAS:Reactome
Q15842	KCNJ8	ATP-sensitive inward rectifier potassium channel 8	GO:0042311; P:vasodilation; IEA:Ensembl
Q92806	KCNJ9	G protein-activated inward rectifier potassium channel 3	GO:0015467; F:G-protein activated inward rectifier potassium channel activity; IEA:InterPro
Q92806	KCNJ9	G protein-activated inward rectifier potassium channel 3	GO:0005515; F:protein binding; IPI:BHF-UCL
Q92806	KCNJ9	G protein-activated inward rectifier potassium channel 3	GO:0007268; P:synaptic transmission; TAS:Reactome
O00180	KCNK1	Potassium channel subfamily K member 1	GO:0005242; F:inward rectifier potassium channel activity; TAS:ProtInc
O00180	KCNK1	Potassium channel subfamily K member 1	GO:0006813; P:potassium ion transport; TAS:ProtInc
O00180	KCNK1	Potassium channel subfamily K member 1	GO:0035094; P:response to nicotine; IEA:Ensembl
O00180	KCNK1	Potassium channel subfamily K member 1	GO:0007268; P:synaptic transmission; TAS:Reactome
O95069	KCNK2	Potassium channel subfamily K member 2	GO:0005249; F:voltage-gated potassium channel activity; IEA:Ensembl
O95069	KCNK2	Potassium channel subfamily K member 2	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:Ensembl
O95069	KCNK2	Potassium channel subfamily K member 2	GO:0007268; P:synaptic transmission; TAS:Reactome
O14649	KCNK3	Potassium channel subfamily K member 3	GO:0005216; F:ion channel activity; IMP:UniProt
O14649	KCNK3	Potassium channel subfamily K member 3	GO:0005252; F:open rectifier potassium channel activity; IEA:Ensembl
O14649	KCNK3	Potassium channel subfamily K member 3	GO:0005267; F:potassium channel activity; TAS:ProtInc
O14649	KCNK3	Potassium channel subfamily K member 3	GO:0022841; F:potassium ion leak channel activity; IDA:UniProtKB
O14649	KCNK3	Potassium channel subfamily K member 3	GO:0044548; F:S100 protein binding; IPI:UniProt
O14649	KCNK3	Potassium channel subfamily K member 3	GO:0007420; P:brain development; IEA:Ensembl
O14649	KCNK3	Potassium channel subfamily K member 3	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
O14649	KCNK3	Potassium channel subfamily K member 3	GO:0071294; P:cellular response to zinc ion; IEA:Ensembl
O14649	KCNK3	Potassium channel subfamily K member 3	GO:0090102; P:cochlea development; IEA:Ensembl
O14649	KCNK3	Potassium channel subfamily K member 3	GO:0034220; P:ion transmembrane transport; IMP:UniProt
O14649	KCNK3	Potassium channel subfamily K member 3	GO:0051481; P:negative regulation of cytosolic calcium ion concentration; IEA:Ensembl
O14649	KCNK3	Potassium channel subfamily K member 3	GO:0006813; P:potassium ion transport; TAS:ProtInc
O14649	KCNK3	Potassium channel subfamily K member 3	GO:0042493; P:response to drug; IEA:Ensembl
O14649	KCNK3	Potassium channel subfamily K member 3	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9NYG8	KCNK4	Potassium channel subfamily K member 4	GO:0005267; F:potassium channel activity; TAS:ProtInc
Q9NYG8	KCNK4	Potassium channel subfamily K member 4	GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW
Q9NYG8	KCNK4	Potassium channel subfamily K member 4	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q9NYG8	KCNK4	Potassium channel subfamily K member 4	GO:0007268; P:synaptic transmission; TAS:Reactome
O95279	KCNK5	Potassium channel subfamily K member 5	GO:0005267; F:potassium channel activity; TAS:ProtInc
O95279	KCNK5	Potassium channel subfamily K member 5	GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW
O95279	KCNK5	Potassium channel subfamily K member 5	GO:0007588; P:excretion; TAS:ProtInc
O95279	KCNK5	Potassium channel subfamily K member 5	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q9Y2U2	KCNK7	Potassium channel subfamily K member 7	GO:0005267; F:potassium channel activity; TAS:ProtInc
Q9Y2U2	KCNK7	Potassium channel subfamily K member 7	GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW
Q9Y2U2	KCNK7	Potassium channel subfamily K member 7	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q9Y2U2	KCNK7	Potassium channel subfamily K member 7	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9Y257	KCNK6	Potassium channel subfamily K member 6	GO:0005242; F:inward rectifier potassium channel activity; TAS:ProtInc
Q9Y257	KCNK6	Potassium channel subfamily K member 6	GO:0003085; P:negative regulation of systemic arterial blood pressure; IEA:Ensembl
Q9Y257	KCNK6	Potassium channel subfamily K member 6	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q9Y257	KCNK6	Potassium channel subfamily K member 6	GO:0060075; P:regulation of resting membrane potential; IEA:Ensembl
Q9Y257	KCNK6	Potassium channel subfamily K member 6	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9NPC2	KCNK9	Potassium channel subfamily K member 9	GO:0005267; F:potassium channel activity; IEA:UniProtKB-KW
Q9NPC2	KCNK9	Potassium channel subfamily K member 9	GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW
Q9NPC2	KCNK9	Potassium channel subfamily K member 9	GO:0090102; P:cochlea development; IEA:Ensembl
Q9NPC2	KCNK9	Potassium channel subfamily K member 9	GO:0006813; P:potassium ion transport; NAS:UniProtKB
Q9NPC2	KCNK9	Potassium channel subfamily K member 9	GO:0007268; P:synaptic transmission; TAS:Reactome
P57789	KCNK10	Potassium channel subfamily K member 10	GO:0005267; F:potassium channel activity; TAS:ProtInc
P57789	KCNK10	Potassium channel subfamily K member 10	GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW
P57789	KCNK10	Potassium channel subfamily K member 10	GO:0007165; P:signal transduction; NAS:ProtInc
P57789	KCNK10	Potassium channel subfamily K member 10	GO:0007268; P:synaptic transmission; TAS:Reactome
P57789	KCNK10	Potassium channel subfamily K member 10	GO:0006810; P:transport; TAS:ProtInc
Q9HB15	KCNK12	Potassium channel subfamily K member 12	GO:0005267; F:potassium channel activity; IEA:UniProtKB-KW
Q9HB15	KCNK12	Potassium channel subfamily K member 12	GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW
Q9HB14	KCNK13	Potassium channel subfamily K member 13	GO:0005267; F:potassium channel activity; TAS:Reactome
Q9HB14	KCNK13	Potassium channel subfamily K member 13	GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW
Q9HB14	KCNK13	Potassium channel subfamily K member 13	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9H427	KCNK15	Potassium channel subfamily K member 15	GO:0005267; F:potassium channel activity; IEA:UniProtKB-KW
Q9H427	KCNK15	Potassium channel subfamily K member 15	GO:0034765; P:regulation of ion transmembrane transport; IEA:UniProtKB-KW
Q96T55	KCNK16	Potassium channel subfamily K member 16	GO:0005267; F:potassium channel activity; IDA:MGI
Q96T55	KCNK16	Potassium channel subfamily K member 16	GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW
Q96T55	KCNK16	Potassium channel subfamily K member 16	GO:0006813; P:potassium ion transport; IDA:MGI
Q96T55	KCNK16	Potassium channel subfamily K member 16	GO:0007268; P:synaptic transmission; TAS:Reactome
Q96T54	KCNK17	Potassium channel subfamily K member 17	GO:0005267; F:potassium channel activity; IDA:UniProtKB
Q96T54	KCNK17	Potassium channel subfamily K member 17	GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW
Q96T54	KCNK17	Potassium channel subfamily K member 17	GO:0006813; P:potassium ion transport; IDA:UniProtKB
Q96T54	KCNK17	Potassium channel subfamily K member 17	GO:0007268; P:synaptic transmission; TAS:Reactome
Q7Z418	KCNK18	Potassium channel subfamily K member 18	GO:0015269; F:calcium-activated potassium channel activity; IEA:Ensembl
Q7Z418	KCNK18	Potassium channel subfamily K member 18	GO:0015271; F:outward rectifier potassium channel activity; IDA:BHF-UCL
Q7Z418	KCNK18	Potassium channel subfamily K member 18	GO:0005267; F:potassium channel activity; TAS:Reactome
Q7Z418	KCNK18	Potassium channel subfamily K member 18	GO:0071467; P:cellular response to pH; IDA:BHF-UCL
Q7Z418	KCNK18	Potassium channel subfamily K member 18	GO:0071435; P:potassium ion export; IDA:BHF-UCL
Q7Z418	KCNK18	Potassium channel subfamily K member 18	GO:0006813; P:potassium ion transport; IDA:UniProtKB
Q7Z418	KCNK18	Potassium channel subfamily K member 18	GO:0007268; P:synaptic transmission; TAS:Reactome
Q92952	KCNN1	Small conductance calcium-activated potassium channel protein 1	GO:0015269; F:calcium-activated potassium channel activity; TAS:ProtInc
Q92952	KCNN1	Small conductance calcium-activated potassium channel protein 1	GO:0005516; F:calmodulin binding; IBA:RefGenome
Q92952	KCNN1	Small conductance calcium-activated potassium channel protein 1	GO:0016286; F:small conductance calcium-activated potassium channel activity; IBA:RefGenome
Q92952	KCNN1	Small conductance calcium-activated potassium channel protein 1	GO:0071805; P:potassium ion transmembrane transport; IBA:RefGenome
Q92952	KCNN1	Small conductance calcium-activated potassium channel protein 1	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q92952	KCNN1	Small conductance calcium-activated potassium channel protein 1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9H2S1	KCNN2	Small conductance calcium-activated potassium channel protein 2	GO:0051393; F:alpha-actinin binding; IPI:BHF-UCL
Q9H2S1	KCNN2	Small conductance calcium-activated potassium channel protein 2	GO:0015269; F:calcium-activated potassium channel activity; IDA:BHF-UCL
Q9H2S1	KCNN2	Small conductance calcium-activated potassium channel protein 2	GO:0005516; F:calmodulin binding; IBA:RefGenome
Q9H2S1	KCNN2	Small conductance calcium-activated potassium channel protein 2	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q9H2S1	KCNN2	Small conductance calcium-activated potassium channel protein 2	GO:0016286; F:small conductance calcium-activated potassium channel activity; TAS:UniProtKB
Q9H2S1	KCNN2	Small conductance calcium-activated potassium channel protein 2	GO:0071805; P:potassium ion transmembrane transport; IDA:BHF-UCL
Q9H2S1	KCNN2	Small conductance calcium-activated potassium channel protein 2	GO:0006813; P:potassium ion transport; NAS:UniProtKB
Q9H2S1	KCNN2	Small conductance calcium-activated potassium channel protein 2	GO:1901379; P:regulation of potassium ion transmembrane transport; IDA:BHF-UCL
Q9H2S1	KCNN2	Small conductance calcium-activated potassium channel protein 2	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9UGI6	KCNN3	Small conductance calcium-activated potassium channel protein 3	GO:0005516; F:calmodulin binding; IBA:RefGenome
Q9UGI6	KCNN3	Small conductance calcium-activated potassium channel protein 3	GO:0016286; F:small conductance calcium-activated potassium channel activity; IBA:RefGenome
Q9UGI6	KCNN3	Small conductance calcium-activated potassium channel protein 3	GO:0071805; P:potassium ion transmembrane transport; IBA:RefGenome
Q9UGI6	KCNN3	Small conductance calcium-activated potassium channel protein 3	GO:0007268; P:synaptic transmission; TAS:Reactome
O15554	KCNN4	Intermediate conductance calcium-activated potassium channel protein 4	GO:0015269; F:calcium-activated potassium channel activity; IDA:BHF-UCL
O15554	KCNN4	Intermediate conductance calcium-activated potassium channel protein 4	GO:0005516; F:calmodulin binding; IBA:RefGenome
O15554	KCNN4	Intermediate conductance calcium-activated potassium channel protein 4	GO:0022894; F:Intermediate conductance calcium-activated potassium channel activity; IBA:RefGenome
O15554	KCNN4	Intermediate conductance calcium-activated potassium channel protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
O15554	KCNN4	Intermediate conductance calcium-activated potassium channel protein 4	GO:0019903; F:protein phosphatase binding; IPI:BHF-UCL
O15554	KCNN4	Intermediate conductance calcium-activated potassium channel protein 4	GO:0006816; P:calcium ion transport; IDA:BHF-UCL
O15554	KCNN4	Intermediate conductance calcium-activated potassium channel protein 4	GO:0006884; P:cell volume homeostasis; IEA:Ensembl
O15554	KCNN4	Intermediate conductance calcium-activated potassium channel protein 4	GO:0006952; P:defense response; TAS:ProtInc
O15554	KCNN4	Intermediate conductance calcium-activated potassium channel protein 4	GO:0002376; P:immune system process; IEA:UniProtKB-KW
O15554	KCNN4	Intermediate conductance calcium-activated potassium channel protein 4	GO:0045332; P:phospholipid translocation; IEA:Ensembl
O15554	KCNN4	Intermediate conductance calcium-activated potassium channel protein 4	GO:0050714; P:positive regulation of protein secretion; IEA:Ensembl
O15554	KCNN4	Intermediate conductance calcium-activated potassium channel protein 4	GO:0050862; P:positive regulation of T cell receptor signaling pathway; IDA:BHF-UCL
O15554	KCNN4	Intermediate conductance calcium-activated potassium channel protein 4	GO:0071435; P:potassium ion export; IEA:Ensembl
O15554	KCNN4	Intermediate conductance calcium-activated potassium channel protein 4	GO:0071805; P:potassium ion transmembrane transport; IBA:RefGenome
O15554	KCNN4	Intermediate conductance calcium-activated potassium channel protein 4	GO:0006813; P:potassium ion transport; TAS:ProtInc
O15554	KCNN4	Intermediate conductance calcium-activated potassium channel protein 4	GO:0046541; P:saliva secretion; IEA:Ensembl
O15554	KCNN4	Intermediate conductance calcium-activated potassium channel protein 4	GO:0030322; P:stabilization of membrane potential; IDA:BHF-UCL
O15554	KCNN4	Intermediate conductance calcium-activated potassium channel protein 4	GO:0007268; P:synaptic transmission; TAS:Reactome
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0005516; F:calmodulin binding; IDA:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0005251; F:delayed rectifier potassium channel activity; IDA:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0044325; F:ion channel binding; IPI:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0015271; F:outward rectifier potassium channel activity; IEA:Ensembl
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0005515; F:protein binding; IPI:IntAct
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0034236; F:protein kinase A catalytic subunit binding; IDA:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0034237; F:protein kinase A regulatory subunit binding; IDA:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0008157; F:protein phosphatase 1 binding; IDA:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0097110; F:scaffold protein binding; IPI:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0005249; F:voltage-gated potassium channel activity; IDA:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0086089; F:voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization; IMP:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0086008; F:voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization; IMP:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:1902282; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; IMP:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0086014; P:atrial cardiac muscle cell action potential; IMP:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0072358; P:cardiovascular system development; IEA:Ensembl
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0071320; P:cellular response to cAMP; IDA:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0035690; P:cellular response to drug; IDA:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0071872; P:cellular response to epinephrine stimulus; TAS:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0016458; P:gene silencing; IEA:Ensembl
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0008584; P:male gonad development; IEA:Ensembl
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0086011; P:membrane repolarization during action potential; IDA:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0086013; P:membrane repolarization during cardiac muscle cell action potential; IMP:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0046676; P:negative regulation of insulin secretion; IEA:Ensembl
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0060454; P:positive regulation of gastric acid secretion; IEA:Ensembl
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:1901381; P:positive regulation of potassium ion transmembrane transport; IDA:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0071435; P:potassium ion export; IDA:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0071805; P:potassium ion transmembrane transport; IDA:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0060372; P:regulation of atrial cardiac muscle cell membrane repolarization; IMP:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0006349; P:regulation of gene expression by genetic imprinting; IEA:Ensembl
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0008016; P:regulation of heart contraction; IC:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0060306; P:regulation of membrane repolarization; IDA:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0007605; P:sensory perception of sound; TAS:ProtInc
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0007268; P:synaptic transmission; TAS:Reactome
P51787	KCNQ1	Potassium voltage-gated channel subfamily KQT member 1	GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL
O43526	KCNQ2	Potassium voltage-gated channel subfamily KQT member 2	GO:0030506; F:ankyrin binding; IPI:BHF-UCL
O43526	KCNQ2	Potassium voltage-gated channel subfamily KQT member 2	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
O43526	KCNQ2	Potassium voltage-gated channel subfamily KQT member 2	GO:0005267; F:potassium channel activity; TAS:ProtInc
O43526	KCNQ2	Potassium voltage-gated channel subfamily KQT member 2	GO:0005249; F:voltage-gated potassium channel activity; TAS:ProtInc
O43526	KCNQ2	Potassium voltage-gated channel subfamily KQT member 2	GO:0007411; P:axon guidance; TAS:Reactome
O43526	KCNQ2	Potassium voltage-gated channel subfamily KQT member 2	GO:0007399; P:nervous system development; TAS:ProtInc
O43526	KCNQ2	Potassium voltage-gated channel subfamily KQT member 2	GO:0006813; P:potassium ion transport; TAS:ProtInc
O43526	KCNQ2	Potassium voltage-gated channel subfamily KQT member 2	GO:0007268; P:synaptic transmission; TAS:Reactome
O43526	KCNQ2	Potassium voltage-gated channel subfamily KQT member 2	GO:0019226; P:transmission of nerve impulse; IEA:Ensembl
O43525	KCNQ3	Potassium voltage-gated channel subfamily KQT member 3	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
O43525	KCNQ3	Potassium voltage-gated channel subfamily KQT member 3	GO:0005267; F:potassium channel activity; TAS:ProtInc
O43525	KCNQ3	Potassium voltage-gated channel subfamily KQT member 3	GO:0005249; F:voltage-gated potassium channel activity; TAS:ProtInc
O43525	KCNQ3	Potassium voltage-gated channel subfamily KQT member 3	GO:0007411; P:axon guidance; TAS:Reactome
O43525	KCNQ3	Potassium voltage-gated channel subfamily KQT member 3	GO:0060081; P:membrane hyperpolarization; IEA:Ensembl
O43525	KCNQ3	Potassium voltage-gated channel subfamily KQT member 3	GO:0006813; P:potassium ion transport; TAS:ProtInc
O43525	KCNQ3	Potassium voltage-gated channel subfamily KQT member 3	GO:0007268; P:synaptic transmission; TAS:Reactome
P56696	KCNQ4	Potassium voltage-gated channel subfamily KQT member 4	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
P56696	KCNQ4	Potassium voltage-gated channel subfamily KQT member 4	GO:0005267; F:potassium channel activity; TAS:ProtInc
P56696	KCNQ4	Potassium voltage-gated channel subfamily KQT member 4	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
P56696	KCNQ4	Potassium voltage-gated channel subfamily KQT member 4	GO:0006813; P:potassium ion transport; TAS:ProtInc
P56696	KCNQ4	Potassium voltage-gated channel subfamily KQT member 4	GO:0007605; P:sensory perception of sound; TAS:ProtInc
P56696	KCNQ4	Potassium voltage-gated channel subfamily KQT member 4	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9NR82	KCNQ5	Potassium voltage-gated channel subfamily KQT member 5	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
Q9NR82	KCNQ5	Potassium voltage-gated channel subfamily KQT member 5	GO:0005242; F:inward rectifier potassium channel activity; TAS:ProtInc
Q9NR82	KCNQ5	Potassium voltage-gated channel subfamily KQT member 5	GO:0006461; P:protein complex assembly; NAS:ProtInc
Q9NR82	KCNQ5	Potassium voltage-gated channel subfamily KQT member 5	GO:0007268; P:synaptic transmission; TAS:Reactome
Q8N5I3	KCNRG	Potassium channel regulatory protein	GO:0042802; F:identical protein binding; IPI:IntAct
Q8N5I3	KCNRG	Potassium channel regulatory protein	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q96KK3	KCNS1	Potassium voltage-gated channel subfamily S member 1	GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB
Q96KK3	KCNS1	Potassium voltage-gated channel subfamily S member 1	GO:0015459; F:potassium channel regulator activity; IDA:UniProtKB
Q96KK3	KCNS1	Potassium voltage-gated channel subfamily S member 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96KK3	KCNS1	Potassium voltage-gated channel subfamily S member 1	GO:0006813; P:potassium ion transport; TAS:UniProtKB
Q96KK3	KCNS1	Potassium voltage-gated channel subfamily S member 1	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q96KK3	KCNS1	Potassium voltage-gated channel subfamily S member 1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9ULS6	KCNS2	Potassium voltage-gated channel subfamily S member 2	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
Q9ULS6	KCNS2	Potassium voltage-gated channel subfamily S member 2	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q9ULS6	KCNS2	Potassium voltage-gated channel subfamily S member 2	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9BQ31	KCNS3	Potassium voltage-gated channel subfamily S member 3	GO:0005251; F:delayed rectifier potassium channel activity; TAS:ProtInc
Q9BQ31	KCNS3	Potassium voltage-gated channel subfamily S member 3	GO:0015459; F:potassium channel regulator activity; TAS:ProtInc
Q9BQ31	KCNS3	Potassium voltage-gated channel subfamily S member 3	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q9BQ31	KCNS3	Potassium voltage-gated channel subfamily S member 3	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q9BQ31	KCNS3	Potassium voltage-gated channel subfamily S member 3	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q9BQ31	KCNS3	Potassium voltage-gated channel subfamily S member 3	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
Q9BQ31	KCNS3	Potassium voltage-gated channel subfamily S member 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BQ31	KCNS3	Potassium voltage-gated channel subfamily S member 3	GO:0007268; P:synaptic transmission; TAS:Reactome
Q5JUK3	KCNT1	Potassium channel subfamily T member 1	GO:0015269; F:calcium-activated potassium channel activity; IBA:RefGenome
Q5JUK3	KCNT1	Potassium channel subfamily T member 1	GO:0005249; F:voltage-gated potassium channel activity; IBA:RefGenome
Q5JUK3	KCNT1	Potassium channel subfamily T member 1	GO:0071805; P:potassium ion transmembrane transport; IBA:RefGenome
Q6UVM3	KCNT2	Potassium channel subfamily T member 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6UVM3	KCNT2	Potassium channel subfamily T member 2	GO:0015269; F:calcium-activated potassium channel activity; IBA:RefGenome
Q6UVM3	KCNT2	Potassium channel subfamily T member 2	GO:0005249; F:voltage-gated potassium channel activity; IBA:RefGenome
Q6UVM3	KCNT2	Potassium channel subfamily T member 2	GO:0071805; P:potassium ion transmembrane transport; IBA:RefGenome
A8MYU2	KCNU1	Potassium channel subfamily U member 1	GO:0060072; F:large conductance calcium-activated potassium channel activity; IBA:RefGenome
A8MYU2	KCNU1	Potassium channel subfamily U member 1	GO:0005267; F:potassium channel activity; TAS:Reactome
A8MYU2	KCNU1	Potassium channel subfamily U member 1	GO:0005249; F:voltage-gated potassium channel activity; IBA:RefGenome
A8MYU2	KCNU1	Potassium channel subfamily U member 1	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
A8MYU2	KCNU1	Potassium channel subfamily U member 1	GO:0071805; P:potassium ion transmembrane transport; IBA:RefGenome
A8MYU2	KCNU1	Potassium channel subfamily U member 1	GO:0007338; P:single fertilization; TAS:Reactome
A8MYU2	KCNU1	Potassium channel subfamily U member 1	GO:0035036; P:sperm-egg recognition; TAS:Reactome
Q6PIU1	KCNV1	Potassium voltage-gated channel subfamily V member 1	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
Q6PIU1	KCNV1	Potassium voltage-gated channel subfamily V member 1	GO:0008200; F:ion channel inhibitor activity; TAS:ProtInc
Q6PIU1	KCNV1	Potassium voltage-gated channel subfamily V member 1	GO:0015459; F:potassium channel regulator activity; TAS:ProtInc
Q6PIU1	KCNV1	Potassium voltage-gated channel subfamily V member 1	GO:0006813; P:potassium ion transport; TAS:ProtInc
Q6PIU1	KCNV1	Potassium voltage-gated channel subfamily V member 1	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q6PIU1	KCNV1	Potassium voltage-gated channel subfamily V member 1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q8TDN2	KCNV2	Potassium voltage-gated channel subfamily V member 2	GO:0005251; F:delayed rectifier potassium channel activity; IBA:RefGenome
Q8TDN2	KCNV2	Potassium voltage-gated channel subfamily V member 2	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q8TDN2	KCNV2	Potassium voltage-gated channel subfamily V member 2	GO:0007268; P:synaptic transmission; TAS:Reactome
P12277	CKB	Creatine kinase B-type	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P12277	CKB	Creatine kinase B-type	GO:0004111; F:creatine kinase activity; TAS:ProtInc
P12277	CKB	Creatine kinase B-type	GO:0005515; F:protein binding; IPI:IntAct
P12277	CKB	Creatine kinase B-type	GO:0030644; P:cellular chloride ion homeostasis; IEA:Ensembl
P12277	CKB	Creatine kinase B-type	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P12277	CKB	Creatine kinase B-type	GO:0006600; P:creatine metabolic process; TAS:Reactome
P12277	CKB	Creatine kinase B-type	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P12277	CKB	Creatine kinase B-type	GO:0021762; P:substantia nigra development; IEP:UniProt
P06732	CKM	Creatine kinase M-type	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P06732	CKM	Creatine kinase M-type	GO:0004111; F:creatine kinase activity; TAS:ProtInc
P06732	CKM	Creatine kinase M-type	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P06732	CKM	Creatine kinase M-type	GO:0006600; P:creatine metabolic process; TAS:Reactome
P06732	CKM	Creatine kinase M-type	GO:0046314; P:phosphocreatine biosynthetic process; IEA:Ensembl
P06732	CKM	Creatine kinase M-type	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P17540	CKMT2	Creatine kinase S-type, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P17540	CKMT2	Creatine kinase S-type, mitochondrial	GO:0004111; F:creatine kinase activity; TAS:ProtInc
P17540	CKMT2	Creatine kinase S-type, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P17540	CKMT2	Creatine kinase S-type, mitochondrial	GO:0006600; P:creatine metabolic process; TAS:Reactome
P17540	CKMT2	Creatine kinase S-type, mitochondrial	GO:0006936; P:muscle contraction; TAS:ProtInc
P17540	CKMT2	Creatine kinase S-type, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P12532	CKMT1A	Creatine kinase U-type, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P12532	CKMT1A	Creatine kinase U-type, mitochondrial	GO:0004111; F:creatine kinase activity; TAS:ProtInc
P12532	CKMT1A	Creatine kinase U-type, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P12532	CKMT1A	Creatine kinase U-type, mitochondrial	GO:0006600; P:creatine metabolic process; TAS:Reactome
P12532	CKMT1A	Creatine kinase U-type, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q719H9	KCTD1	BTB/POZ domain-containing protein KCTD1	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q719H9	KCTD1	BTB/POZ domain-containing protein KCTD1	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q719H9	KCTD1	BTB/POZ domain-containing protein KCTD1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q719H9	KCTD1	BTB/POZ domain-containing protein KCTD1	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q719H9	KCTD1	BTB/POZ domain-containing protein KCTD1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y597	KCTD3	BTB/POZ domain-containing protein KCTD3	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q14681	KCTD2	BTB/POZ domain-containing protein KCTD2	GO:0032403; F:protein complex binding; IDA:MGI
Q14681	KCTD2	BTB/POZ domain-containing protein KCTD2	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q8WVF5	KCTD4	BTB/POZ domain-containing protein KCTD4	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q9NXV2	KCTD5	BTB/POZ domain-containing protein KCTD5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NXV2	KCTD5	BTB/POZ domain-containing protein KCTD5	GO:0032403; F:protein complex binding; IDA:MGI
Q9NXV2	KCTD5	BTB/POZ domain-containing protein KCTD5	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q9NXV2	KCTD5	BTB/POZ domain-containing protein KCTD5	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q8NC69	KCTD6	BTB/POZ domain-containing protein KCTD6	GO:0030506; F:ankyrin binding; IDA:MGI
Q8NC69	KCTD6	BTB/POZ domain-containing protein KCTD6	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q96MP8	KCTD7	BTB/POZ domain-containing protein KCTD7	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q96MP8	KCTD7	BTB/POZ domain-containing protein KCTD7	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q6ZWB6	KCTD8	BTB/POZ domain-containing protein KCTD8	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q6ZWB6	KCTD8	BTB/POZ domain-containing protein KCTD8	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; IEA:Ensembl
Q7L273	KCTD9	BTB/POZ domain-containing protein KCTD9	GO:0051260; P:protein homooligomerization; IEA:InterPro
P30085	CMPK1	UMP-CMP kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P30085	CMPK1	UMP-CMP kinase	GO:0004127; F:cytidylate kinase activity; IEA:UniProtKB-EC
P30085	CMPK1	UMP-CMP kinase	GO:0004550; F:nucleoside diphosphate kinase activity; IDA:UniProtKB
P30085	CMPK1	UMP-CMP kinase	GO:0033862; F:UMP kinase activity; IEA:Ensembl
P30085	CMPK1	UMP-CMP kinase	GO:0004849; F:uridine kinase activity; TAS:ProtInc
P30085	CMPK1	UMP-CMP kinase	GO:0046705; P:CDP biosynthetic process; IEA:Ensembl
P30085	CMPK1	UMP-CMP kinase	GO:0006240; P:dCDP biosynthetic process; IEA:Ensembl
P30085	CMPK1	UMP-CMP kinase	GO:0006227; P:dUDP biosynthetic process; IEA:Ensembl
P30085	CMPK1	UMP-CMP kinase	GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome
P30085	CMPK1	UMP-CMP kinase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P30085	CMPK1	UMP-CMP kinase	GO:0006165; P:nucleoside diphosphate phosphorylation; IDA:UniProtKB
P30085	CMPK1	UMP-CMP kinase	GO:0009142; P:nucleoside triphosphate biosynthetic process; IDA:UniProtKB
P30085	CMPK1	UMP-CMP kinase	GO:0022602; P:ovulation cycle process; IEA:Ensembl
P30085	CMPK1	UMP-CMP kinase	GO:0018963; P:phthalate metabolic process; IEA:Ensembl
P30085	CMPK1	UMP-CMP kinase	GO:0009220; P:pyrimidine ribonucleotide biosynthetic process; TAS:ProtInc
P30085	CMPK1	UMP-CMP kinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P30085	CMPK1	UMP-CMP kinase	GO:0006225; P:UDP biosynthetic process; IEA:Ensembl
P30085	CMPK1	UMP-CMP kinase	GO:0006222; P:UMP biosynthetic process; TAS:GOC
Q9ULH0	KIDINS220	Kinase D-interacting substrate of 220 kDa	GO:0030165; F:PDZ domain binding; ISS:UniProtKB
Q9ULH0	KIDINS220	Kinase D-interacting substrate of 220 kDa	GO:0000186; P:activation of MAPKK activity; TAS:Reactome
Q9ULH0	KIDINS220	Kinase D-interacting substrate of 220 kDa	GO:1990090; P:cellular response to nerve growth factor stimulus; ISS:UniProtKB
Q9ULH0	KIDINS220	Kinase D-interacting substrate of 220 kDa	GO:0016482; P:cytoplasmic transport; ISS:UniProtKB
Q9ULH0	KIDINS220	Kinase D-interacting substrate of 220 kDa	GO:0048813; P:dendrite morphogenesis; IEA:Ensembl
Q9ULH0	KIDINS220	Kinase D-interacting substrate of 220 kDa	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9ULH0	KIDINS220	Kinase D-interacting substrate of 220 kDa	GO:0038180; P:nerve growth factor signaling pathway; ISS:UniProtKB
Q9ULH0	KIDINS220	Kinase D-interacting substrate of 220 kDa	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9ULH0	KIDINS220	Kinase D-interacting substrate of 220 kDa	GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0050681; F:androgen receptor binding; IDA:UniProtKB
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0003682; F:chromatin binding; IDA:UniProtKB
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0032451; F:demethylase activity; IMP:BHF-UCL
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0019899; F:enzyme binding; IPI:BHF-UCL
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0032452; F:histone demethylase activity; IDA:BHF-UCL
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0034648; F:histone demethylase activity (H3-dimethyl-K4 specific); IDA:UniProtKB
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0032453; F:histone demethylase activity (H3-K4 specific); IDA:UniProtKB
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0032454; F:histone demethylase activity (H3-K9 specific); IDA:UniProtKB
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IMP:UniProtKB
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0043426; F:MRF binding; IDA:BHF-UCL
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0016491; F:oxidoreductase activity; IDA:UniProtKB
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0002039; F:p53 binding; IPI:BHF-UCL
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0005515; F:protein binding; IPI:UniProtKB
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0008134; F:transcription factor binding; IDA:BHF-UCL
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0044212; F:transcription regulatory region DNA binding; ISS:BHF-UCL
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0007596; P:blood coagulation; TAS:Reactome
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0008283; P:cell proliferation; IEA:Ensembl
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0030851; P:granulocyte differentiation; IEA:Ensembl
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0034720; P:histone H3-K4 demethylation; IDA:UniProtKB
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0033169; P:histone H3-K9 demethylation; IDA:UniProtKB
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0055001; P:muscle cell development; ISS:BHF-UCL
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0043392; P:negative regulation of DNA binding; IC:BHF-UCL
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0043518; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; IMP:BHF-UCL
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0051572; P:negative regulation of histone H3-K4 methylation; IEA:Ensembl
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0051573; P:negative regulation of histone H3-K9 methylation; IEA:Ensembl
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IMP:BHF-UCL
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0032091; P:negative regulation of protein binding; IMP:BHF-UCL
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0021983; P:pituitary gland development; IEA:Ensembl
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0045648; P:positive regulation of erythrocyte differentiation; IEA:Ensembl
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0046886; P:positive regulation of hormone biosynthetic process; IEA:Ensembl
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0045654; P:positive regulation of megakaryocyte differentiation; IEA:Ensembl
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:2000179; P:positive regulation of neural precursor cell proliferation; IEA:Ensembl
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:2000648; P:positive regulation of stem cell proliferation; IEA:Ensembl
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0006482; P:protein demethylation; IMP:BHF-UCL
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0010725; P:regulation of primitive erythrocyte differentiation; IEA:Ensembl
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
O60341	KDM1A	Lysine-specific histone demethylase 1A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NB78	KDM1B	Lysine-specific histone demethylase 1B	GO:0003677; F:DNA binding; IEA:InterPro
Q8NB78	KDM1B	Lysine-specific histone demethylase 1B	GO:0050660; F:flavin adenine dinucleotide binding; IEA:Ensembl
Q8NB78	KDM1B	Lysine-specific histone demethylase 1B	GO:0034648; F:histone demethylase activity (H3-dimethyl-K4 specific); ISS:UniProtKB
Q8NB78	KDM1B	Lysine-specific histone demethylase 1B	GO:0034649; F:histone demethylase activity (H3-monomethyl-K4 specific); ISS:UniProtKB
Q8NB78	KDM1B	Lysine-specific histone demethylase 1B	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q8NB78	KDM1B	Lysine-specific histone demethylase 1B	GO:0008270; F:zinc ion binding; IEA:Ensembl
Q8NB78	KDM1B	Lysine-specific histone demethylase 1B	GO:0043046; P:DNA methylation involved in gamete generation; IEA:Ensembl
Q8NB78	KDM1B	Lysine-specific histone demethylase 1B	GO:0034720; P:histone H3-K4 demethylation; ISS:UniProtKB
Q8NB78	KDM1B	Lysine-specific histone demethylase 1B	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8NB78	KDM1B	Lysine-specific histone demethylase 1B	GO:0044030; P:regulation of DNA methylation; ISS:UniProtKB
Q8NB78	KDM1B	Lysine-specific histone demethylase 1B	GO:0006349; P:regulation of gene expression by genetic imprinting; ISS:UniProtKB
Q8NB78	KDM1B	Lysine-specific histone demethylase 1B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NB78	KDM1B	Lysine-specific histone demethylase 1B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2K7	KDM2A	Lysine-specific demethylase 2A	GO:0051864; F:histone demethylase activity (H3-K36 specific); IEA:UniProtKB-EC
Q9Y2K7	KDM2A	Lysine-specific demethylase 2A	GO:0045322; F:unmethylated CpG binding; IEA:Ensembl
Q9Y2K7	KDM2A	Lysine-specific demethylase 2A	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y2K7	KDM2A	Lysine-specific demethylase 2A	GO:0070544; P:histone H3-K36 demethylation; IMP:MGI
Q9Y2K7	KDM2A	Lysine-specific demethylase 2A	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2K7	KDM2A	Lysine-specific demethylase 2A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0003677; F:DNA binding; NAS:UniProtKB
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0032452; F:histone demethylase activity; TAS:BHF-UCL
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0051864; F:histone demethylase activity (H3-K36 specific); IEA:UniProtKB-EC
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0019843; F:rRNA binding; IEA:UniProtKB-KW
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0048596; P:embryonic camera-type eye morphogenesis; ISS:BHF-UCL
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0030900; P:forebrain development; ISS:BHF-UCL
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0021592; P:fourth ventricle development; ISS:BHF-UCL
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0030902; P:hindbrain development; ISS:BHF-UCL
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0016577; P:histone demethylation; TAS:GOC
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0035518; P:histone H2A monoubiquitination; IDA:UniProtKB
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0021993; P:initiation of neural tube closure; ISS:BHF-UCL
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0021670; P:lateral ventricle development; ISS:BHF-UCL
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0030901; P:midbrain development; ISS:BHF-UCL
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0021555; P:midbrain-hindbrain boundary morphogenesis; ISS:BHF-UCL
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:2000178; P:negative regulation of neural precursor cell proliferation; ISS:BHF-UCL
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:BHF-UCL
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0007283; P:spermatogenesis; ISS:BHF-UCL
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0021678; P:third ventricle development; ISS:BHF-UCL
Q8NHM5	KDM2B	Lysine-specific demethylase 2B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y4C1	KDM3A	Lysine-specific demethylase 3A	GO:0050681; F:androgen receptor binding; IDA:UniProtKB
Q9Y4C1	KDM3A	Lysine-specific demethylase 3A	GO:0001047; F:core promoter binding; IEA:Ensembl
Q9Y4C1	KDM3A	Lysine-specific demethylase 3A	GO:0051213; F:dioxygenase activity; IEA:UniProtKB-KW
Q9Y4C1	KDM3A	Lysine-specific demethylase 3A	GO:0005506; F:iron ion binding; IMP:UniProtKB
Q9Y4C1	KDM3A	Lysine-specific demethylase 3A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q9Y4C1	KDM3A	Lysine-specific demethylase 3A	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:Ensembl
Q9Y4C1	KDM3A	Lysine-specific demethylase 3A	GO:0030521; P:androgen receptor signaling pathway; IDA:UniProtKB
Q9Y4C1	KDM3A	Lysine-specific demethylase 3A	GO:0046293; P:formaldehyde biosynthetic process; IDA:UniProtKB
Q9Y4C1	KDM3A	Lysine-specific demethylase 3A	GO:0033169; P:histone H3-K9 demethylation; IDA:UniProtKB
Q9Y4C1	KDM3A	Lysine-specific demethylase 3A	GO:0036123; P:histone H3-K9 dimethylation; IEA:Ensembl
Q9Y4C1	KDM3A	Lysine-specific demethylase 3A	GO:0009755; P:hormone-mediated signaling pathway; IDA:UniProtKB
Q9Y4C1	KDM3A	Lysine-specific demethylase 3A	GO:0051573; P:negative regulation of histone H3-K9 methylation; IEA:Ensembl
Q9Y4C1	KDM3A	Lysine-specific demethylase 3A	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9Y4C1	KDM3A	Lysine-specific demethylase 3A	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q9Y4C1	KDM3A	Lysine-specific demethylase 3A	GO:0007290; P:spermatid nucleus elongation; IEA:Ensembl
Q9Y4C1	KDM3A	Lysine-specific demethylase 3A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7LBC6	KDM3B	Lysine-specific demethylase 3B	GO:0051213; F:dioxygenase activity; IEA:UniProtKB-KW
Q7LBC6	KDM3B	Lysine-specific demethylase 3B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7LBC6	KDM3B	Lysine-specific demethylase 3B	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q7LBC6	KDM3B	Lysine-specific demethylase 3B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7LBC6	KDM3B	Lysine-specific demethylase 3B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75164	KDM4A	Lysine-specific demethylase 4A	GO:0051864; F:histone demethylase activity (H3-K36 specific); IDA:UniProtKB
O75164	KDM4A	Lysine-specific demethylase 4A	GO:0035064; F:methylated histone binding; IDA:UniProtKB
O75164	KDM4A	Lysine-specific demethylase 4A	GO:0005515; F:protein binding; IPI:IntAct
O75164	KDM4A	Lysine-specific demethylase 4A	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
O75164	KDM4A	Lysine-specific demethylase 4A	GO:0008270; F:zinc ion binding; IEA:InterPro
O75164	KDM4A	Lysine-specific demethylase 4A	GO:0014898; P:cardiac muscle hypertrophy in response to stress; IEA:Ensembl
O75164	KDM4A	Lysine-specific demethylase 4A	GO:0016577; P:histone demethylation; IDA:UniProtKB
O75164	KDM4A	Lysine-specific demethylase 4A	GO:0070544; P:histone H3-K36 demethylation; IDA:GOC
O75164	KDM4A	Lysine-specific demethylase 4A	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
O75164	KDM4A	Lysine-specific demethylase 4A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75164	KDM4A	Lysine-specific demethylase 4A	GO:0016032; P:viral process; IEA:UniProtKB-KW
O94953	KDM4B	Lysine-specific demethylase 4B	GO:0051213; F:dioxygenase activity; IEA:UniProtKB-KW
O94953	KDM4B	Lysine-specific demethylase 4B	GO:0008270; F:zinc ion binding; IEA:InterPro
O94953	KDM4B	Lysine-specific demethylase 4B	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
O94953	KDM4B	Lysine-specific demethylase 4B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O94953	KDM4B	Lysine-specific demethylase 4B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H3R0	KDM4C	Lysine-specific demethylase 4C	GO:0050681; F:androgen receptor binding; IPI:BHF-UCL
Q9H3R0	KDM4C	Lysine-specific demethylase 4C	GO:0051213; F:dioxygenase activity; IEA:UniProtKB-KW
Q9H3R0	KDM4C	Lysine-specific demethylase 4C	GO:0019899; F:enzyme binding; IPI:BHF-UCL
Q9H3R0	KDM4C	Lysine-specific demethylase 4C	GO:0032454; F:histone demethylase activity (H3-K9 specific); IDA:UniProtKB
Q9H3R0	KDM4C	Lysine-specific demethylase 4C	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H3R0	KDM4C	Lysine-specific demethylase 4C	GO:0033169; P:histone H3-K9 demethylation; IDA:UniProtKB
Q9H3R0	KDM4C	Lysine-specific demethylase 4C	GO:0008284; P:positive regulation of cell proliferation; IMP:BHF-UCL
Q9H3R0	KDM4C	Lysine-specific demethylase 4C	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9H3R0	KDM4C	Lysine-specific demethylase 4C	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6B0I6	KDM4D	Lysine-specific demethylase 4D	GO:0051213; F:dioxygenase activity; IEA:UniProtKB-KW
Q6B0I6	KDM4D	Lysine-specific demethylase 4D	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6B0I6	KDM4D	Lysine-specific demethylase 4D	GO:0033169; P:histone H3-K9 demethylation; IEA:Ensembl
Q6B0I6	KDM4D	Lysine-specific demethylase 4D	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6B0I6	KDM4D	Lysine-specific demethylase 4D	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
B2RXH2	KDM4E	Lysine-specific demethylase 4E	GO:0051213; F:dioxygenase activity; IEA:UniProtKB-KW
B2RXH2	KDM4E	Lysine-specific demethylase 4E	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
B2RXH2	KDM4E	Lysine-specific demethylase 4E	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
B2RXH2	KDM4E	Lysine-specific demethylase 4E	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
B2RXH2	KDM4E	Lysine-specific demethylase 4E	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P29375	KDM5A	Lysine-specific demethylase 5A	GO:0003682; F:chromatin binding; IEA:Ensembl
P29375	KDM5A	Lysine-specific demethylase 5A	GO:0003677; F:DNA binding; IDA:GDB
P29375	KDM5A	Lysine-specific demethylase 5A	GO:0016706; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; IEA:InterPro
P29375	KDM5A	Lysine-specific demethylase 5A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P29375	KDM5A	Lysine-specific demethylase 5A	GO:0008270; F:zinc ion binding; IEA:InterPro
P29375	KDM5A	Lysine-specific demethylase 5A	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
P29375	KDM5A	Lysine-specific demethylase 5A	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P29375	KDM5A	Lysine-specific demethylase 5A	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P29375	KDM5A	Lysine-specific demethylase 5A	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9UGL1	KDM5B	Lysine-specific demethylase 5B	GO:0003677; F:DNA binding; IDA:GDB
Q9UGL1	KDM5B	Lysine-specific demethylase 5B	GO:0034648; F:histone demethylase activity (H3-dimethyl-K4 specific); IDA:UniProtKB
Q9UGL1	KDM5B	Lysine-specific demethylase 5B	GO:0034647; F:histone demethylase activity (H3-trimethyl-K4 specific); IDA:UniProtKB
Q9UGL1	KDM5B	Lysine-specific demethylase 5B	GO:0016706; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; IEA:InterPro
Q9UGL1	KDM5B	Lysine-specific demethylase 5B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UGL1	KDM5B	Lysine-specific demethylase 5B	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9UGL1	KDM5B	Lysine-specific demethylase 5B	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q9UGL1	KDM5B	Lysine-specific demethylase 5B	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UGL1	KDM5B	Lysine-specific demethylase 5B	GO:0034720; P:histone H3-K4 demethylation; IDA:UniProtKB
Q9UGL1	KDM5B	Lysine-specific demethylase 5B	GO:0034721; P:histone H3-K4 demethylation, trimethyl-H3-K4-specific; IDA:GOC
Q9UGL1	KDM5B	Lysine-specific demethylase 5B	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:GDB
Q9UGL1	KDM5B	Lysine-specific demethylase 5B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P41229	KDM5C	Lysine-specific demethylase 5C	GO:0003677; F:DNA binding; IEA:InterPro
P41229	KDM5C	Lysine-specific demethylase 5C	GO:0032453; F:histone demethylase activity (H3-K4 specific); IDA:MGI
P41229	KDM5C	Lysine-specific demethylase 5C	GO:0016706; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; IEA:InterPro
P41229	KDM5C	Lysine-specific demethylase 5C	GO:0008270; F:zinc ion binding; IEA:InterPro
P41229	KDM5C	Lysine-specific demethylase 5C	GO:0034720; P:histone H3-K4 demethylation; IDA:MGI
P41229	KDM5C	Lysine-specific demethylase 5C	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P41229	KDM5C	Lysine-specific demethylase 5C	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N371	KDM8	Lysine-specific demethylase 8	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q8N371	KDM8	Lysine-specific demethylase 8	GO:0051864; F:histone demethylase activity (H3-K36 specific); IDA:UniProtKB
Q8N371	KDM8	Lysine-specific demethylase 8	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N371	KDM8	Lysine-specific demethylase 8	GO:0000086; P:G2/M transition of mitotic cell cycle; IMP:UniProtKB
Q8N371	KDM8	Lysine-specific demethylase 8	GO:0070544; P:histone H3-K36 demethylation; IDA:UniProtKB
Q8N371	KDM8	Lysine-specific demethylase 8	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q8N371	KDM8	Lysine-specific demethylase 8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BY66	KDM5D	Lysine-specific demethylase 5D	GO:0003677; F:DNA binding; IEA:InterPro
Q9BY66	KDM5D	Lysine-specific demethylase 5D	GO:0032453; F:histone demethylase activity (H3-K4 specific); IDA:MGI
Q9BY66	KDM5D	Lysine-specific demethylase 5D	GO:0016706; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; IEA:InterPro
Q9BY66	KDM5D	Lysine-specific demethylase 5D	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BY66	KDM5D	Lysine-specific demethylase 5D	GO:0034720; P:histone H3-K4 demethylation; IDA:MGI
O15054	KDM6B	Lysine-specific demethylase 6B	GO:0051213; F:dioxygenase activity; IEA:UniProtKB-KW
O15054	KDM6B	Lysine-specific demethylase 6B	GO:0071558; F:histone demethylase activity (H3-K27 specific); EXP:Reactome
O15054	KDM6B	Lysine-specific demethylase 6B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15054	KDM6B	Lysine-specific demethylase 6B	GO:0005515; F:protein binding; IPI:IntAct
O15054	KDM6B	Lysine-specific demethylase 6B	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
O15054	KDM6B	Lysine-specific demethylase 6B	GO:0071557; P:histone H3-K27 demethylation; EXP:GOC
O15054	KDM6B	Lysine-specific demethylase 6B	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
O15054	KDM6B	Lysine-specific demethylase 6B	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O15550	KDM6A	Lysine-specific demethylase 6A	GO:0051213; F:dioxygenase activity; IEA:UniProtKB-KW
O15550	KDM6A	Lysine-specific demethylase 6A	GO:0071558; F:histone demethylase activity (H3-K27 specific); IEA:Ensembl
O15550	KDM6A	Lysine-specific demethylase 6A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15550	KDM6A	Lysine-specific demethylase 6A	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl
O15550	KDM6A	Lysine-specific demethylase 6A	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
O15550	KDM6A	Lysine-specific demethylase 6A	GO:0007507; P:heart development; IEA:Ensembl
O15550	KDM6A	Lysine-specific demethylase 6A	GO:0051568; P:histone H3-K4 methylation; ISS:UniProtKB
O15550	KDM6A	Lysine-specific demethylase 6A	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O15550	KDM6A	Lysine-specific demethylase 6A	GO:0048333; P:mesodermal cell differentiation; IEA:Ensembl
O15550	KDM6A	Lysine-specific demethylase 6A	GO:0001843; P:neural tube closure; IEA:Ensembl
O15550	KDM6A	Lysine-specific demethylase 6A	GO:0048570; P:notochord morphogenesis; IEA:Ensembl
O15550	KDM6A	Lysine-specific demethylase 6A	GO:0003016; P:respiratory system process; IEA:Ensembl
O15550	KDM6A	Lysine-specific demethylase 6A	GO:0032525; P:somite rostral/caudal axis specification; IEA:Ensembl
Q6ZMT4	KDM7A	Lysine-specific demethylase 7A	GO:0071558; F:histone demethylase activity (H3-K27 specific); IDA:UniProtKB
Q6ZMT4	KDM7A	Lysine-specific demethylase 7A	GO:0051864; F:histone demethylase activity (H3-K36 specific); IDA:UniProtKB
Q6ZMT4	KDM7A	Lysine-specific demethylase 7A	GO:0032454; F:histone demethylase activity (H3-K9 specific); IDA:UniProtKB
Q6ZMT4	KDM7A	Lysine-specific demethylase 7A	GO:0035575; F:histone demethylase activity (H4-K20 specific); IDA:UniProtKB
Q6ZMT4	KDM7A	Lysine-specific demethylase 7A	GO:0005506; F:iron ion binding; IDA:UniProtKB
Q6ZMT4	KDM7A	Lysine-specific demethylase 7A	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q6ZMT4	KDM7A	Lysine-specific demethylase 7A	GO:0016706; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; IDA:UniProtKB
Q6ZMT4	KDM7A	Lysine-specific demethylase 7A	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q6ZMT4	KDM7A	Lysine-specific demethylase 7A	GO:0071557; P:histone H3-K27 demethylation; IDA:UniProtKB
Q6ZMT4	KDM7A	Lysine-specific demethylase 7A	GO:0070544; P:histone H3-K36 demethylation; IDA:UniProtKB
Q6ZMT4	KDM7A	Lysine-specific demethylase 7A	GO:0033169; P:histone H3-K9 demethylation; IDA:UniProtKB
Q6ZMT4	KDM7A	Lysine-specific demethylase 7A	GO:0035574; P:histone H4-K20 demethylation; IDA:UniProtKB
Q6ZMT4	KDM7A	Lysine-specific demethylase 7A	GO:0030901; P:midbrain development; ISS:UniProtKB
Q6ZMT4	KDM7A	Lysine-specific demethylase 7A	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q6ZMT4	KDM7A	Lysine-specific demethylase 7A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q06136	KDSR	3-ketodihydrosphingosine reductase	GO:0047560; F:3-dehydrosphinganine reductase activity; IDA:MGI
Q06136	KDSR	3-ketodihydrosphingosine reductase	GO:0006666; P:3-keto-sphinganine metabolic process; IDA:MGI
Q06136	KDSR	3-ketodihydrosphingosine reductase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q06136	KDSR	3-ketodihydrosphingosine reductase	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
Q06136	KDSR	3-ketodihydrosphingosine reductase	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q14145	KEAP1	Kelch-like ECH-associated protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q14145	KEAP1	Kelch-like ECH-associated protein 1	GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl
Q14145	KEAP1	Kelch-like ECH-associated protein 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q14145	KEAP1	Kelch-like ECH-associated protein 1	GO:0010499; P:proteasomal ubiquitin-independent protein catabolic process; IDA:UniProtKB
Q14145	KEAP1	Kelch-like ECH-associated protein 1	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q14145	KEAP1	Kelch-like ECH-associated protein 1	GO:0045604; P:regulation of epidermal cell differentiation; IEA:Ensembl
Q14145	KEAP1	Kelch-like ECH-associated protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q14145	KEAP1	Kelch-like ECH-associated protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P23276	KEL	Kell blood group glycoprotein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P23276	KEL	Kell blood group glycoprotein	GO:0004222; F:metalloendopeptidase activity; IDA:HGNC
P23276	KEL	Kell blood group glycoprotein	GO:0005515; F:protein binding; IPI:HGNC
P23276	KEL	Kell blood group glycoprotein	GO:0042310; P:vasoconstriction; TAS:HGNC
O60938	KERA	Keratocan	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O60938	KERA	Keratocan	GO:0061303; P:cornea development in camera-type eye; IEA:Ensembl
O60938	KERA	Keratocan	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O60938	KERA	Keratocan	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
O60938	KERA	Keratocan	GO:0042340; P:keratan sulfate catabolic process; TAS:Reactome
O60938	KERA	Keratocan	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
O60938	KERA	Keratocan	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
O60938	KERA	Keratocan	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60938	KERA	Keratocan	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q63HM1	AFMID	Kynurenine formamidase	GO:0004061; F:arylformamidase activity; IEA:UniProtKB-HAMAP
Q63HM1	AFMID	Kynurenine formamidase	GO:0034354; P:'de novo' NAD biosynthetic process from tryptophan; IEA:UniProtKB-HAMAP
Q63HM1	AFMID	Kynurenine formamidase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q63HM1	AFMID	Kynurenine formamidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q63HM1	AFMID	Kynurenine formamidase	GO:0006569; P:tryptophan catabolic process; TAS:Reactome
Q63HM1	AFMID	Kynurenine formamidase	GO:0019441; P:tryptophan catabolic process to kynurenine; IEA:UniProtKB-UniPathway
Q2TVT4	KGFLP1	Putative keratinocyte growth factor-like protein 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IEA:InterPro
Q2TVT3	KGFLP2	Putative keratinocyte growth factor-like protein 2	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IEA:InterPro
Q13976	PRKG1	cGMP-dependent protein kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13976	PRKG1	cGMP-dependent protein kinase 1	GO:0005246; F:calcium channel regulator activity; IDA:UniProtKB
Q13976	PRKG1	cGMP-dependent protein kinase 1	GO:0030553; F:cGMP binding; IEA:UniProtKB-KW
Q13976	PRKG1	cGMP-dependent protein kinase 1	GO:0004692; F:cGMP-dependent protein kinase activity; IDA:UniProtKB
Q13976	PRKG1	cGMP-dependent protein kinase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13976	PRKG1	cGMP-dependent protein kinase 1	GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc
Q13976	PRKG1	cGMP-dependent protein kinase 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q13976	PRKG1	cGMP-dependent protein kinase 1	GO:0016358; P:dendrite development; IEA:Ensembl
Q13976	PRKG1	cGMP-dependent protein kinase 1	GO:0030900; P:forebrain development; IEA:Ensembl
Q13976	PRKG1	cGMP-dependent protein kinase 1	GO:0090331; P:negative regulation of platelet aggregation; IMP:UniProtKB
Q13976	PRKG1	cGMP-dependent protein kinase 1	GO:0001764; P:neuron migration; IEA:Ensembl
Q13976	PRKG1	cGMP-dependent protein kinase 1	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q13976	PRKG1	cGMP-dependent protein kinase 1	GO:0043087; P:regulation of GTPase activity; IMP:UniProtKB
Q13976	PRKG1	cGMP-dependent protein kinase 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q13237	PRKG2	cGMP-dependent protein kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13237	PRKG2	cGMP-dependent protein kinase 2	GO:0030553; F:cGMP binding; IEA:UniProtKB-KW
Q13237	PRKG2	cGMP-dependent protein kinase 2	GO:0004692; F:cGMP-dependent protein kinase activity; IEA:UniProtKB-EC
Q13237	PRKG2	cGMP-dependent protein kinase 2	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q13237	PRKG2	cGMP-dependent protein kinase 2	GO:0007596; P:blood coagulation; TAS:Reactome
Q13237	PRKG2	cGMP-dependent protein kinase 2	GO:0032922; P:circadian regulation of gene expression; IEA:Ensembl
Q13237	PRKG2	cGMP-dependent protein kinase 2	GO:0046209; P:nitric oxide metabolic process; TAS:Reactome
Q13237	PRKG2	cGMP-dependent protein kinase 2	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q13237	PRKG2	cGMP-dependent protein kinase 2	GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome
Q13237	PRKG2	cGMP-dependent protein kinase 2	GO:0007165; P:signal transduction; TAS:ProtInc
Q13237	PRKG2	cGMP-dependent protein kinase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16774	GUK1	Guanylate kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q16774	GUK1	Guanylate kinase	GO:0004385; F:guanylate kinase activity; IDA:UniProtKB
Q16774	GUK1	Guanylate kinase	GO:0046034; P:ATP metabolic process; IEA:Ensembl
Q16774	GUK1	Guanylate kinase	GO:0046060; P:dATP metabolic process; IEA:Ensembl
Q16774	GUK1	Guanylate kinase	GO:0006185; P:dGDP biosynthetic process; IEA:Ensembl
Q16774	GUK1	Guanylate kinase	GO:0046054; P:dGMP metabolic process; IEA:Ensembl
Q16774	GUK1	Guanylate kinase	GO:0017144; P:drug metabolic process; TAS:Reactome
Q16774	GUK1	Guanylate kinase	GO:0046711; P:GDP biosynthetic process; IEA:Ensembl
Q16774	GUK1	Guanylate kinase	GO:0019673; P:GDP-mannose metabolic process; IEA:Ensembl
Q16774	GUK1	Guanylate kinase	GO:0034436; P:glycoprotein transport; IEA:Ensembl
Q16774	GUK1	Guanylate kinase	GO:0046037; P:GMP metabolic process; IEA:Ensembl
Q16774	GUK1	Guanylate kinase	GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome
Q16774	GUK1	Guanylate kinase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q16774	GUK1	Guanylate kinase	GO:0006163; P:purine nucleotide metabolic process; IDA:UniProtKB
Q16774	GUK1	Guanylate kinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q4VXA5	KHDC1	KH homology domain-containing protein 1	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q07666	KHDRBS1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	GO:0003677; F:DNA binding; TAS:ProtInc
Q07666	KHDRBS1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	GO:0008143; F:poly(A) binding; IDA:MGI
Q07666	KHDRBS1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q07666	KHDRBS1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	GO:0008266; F:poly(U) RNA binding; IDA:MGI
Q07666	KHDRBS1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q07666	KHDRBS1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	GO:0003723; F:RNA binding; IDA:UniProtKB
Q07666	KHDRBS1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	GO:0005070; F:SH3/SH2 adaptor activity; IPI:UniProtKB
Q07666	KHDRBS1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	GO:0007050; P:cell cycle arrest; TAS:ProtInc
Q07666	KHDRBS1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	GO:0008283; P:cell proliferation; TAS:ProtInc
Q07666	KHDRBS1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	GO:0007166; P:cell surface receptor signaling pathway; IDA:UniProtKB
Q07666	KHDRBS1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	GO:0000086; P:G2/M transition of mitotic cell cycle; ISS:UniProtKB
Q07666	KHDRBS1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	GO:0006397; P:mRNA processing; TAS:ProtInc
Q07666	KHDRBS1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q07666	KHDRBS1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	GO:0046833; P:positive regulation of RNA export from nucleus; IDA:UniProtKB
Q07666	KHDRBS1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	GO:0009967; P:positive regulation of signal transduction; IPI:GOC
Q07666	KHDRBS1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	GO:0045948; P:positive regulation of translational initiation; IDA:UniProtKB
Q07666	KHDRBS1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	GO:0046831; P:regulation of RNA export from nucleus; ISS:UniProtKB
Q07666	KHDRBS1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q07666	KHDRBS1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5VWX1	KHDRBS2	KH domain-containing, RNA-binding, signal transduction-associated protein 2	GO:0008143; F:poly(A) binding; IEA:Ensembl
Q5VWX1	KHDRBS2	KH domain-containing, RNA-binding, signal transduction-associated protein 2	GO:0008266; F:poly(U) RNA binding; IEA:Ensembl
Q5VWX1	KHDRBS2	KH domain-containing, RNA-binding, signal transduction-associated protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q5VWX1	KHDRBS2	KH domain-containing, RNA-binding, signal transduction-associated protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5VWX1	KHDRBS2	KH domain-containing, RNA-binding, signal transduction-associated protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75525	KHDRBS3	KH domain-containing, RNA-binding, signal transduction-associated protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75525	KHDRBS3	KH domain-containing, RNA-binding, signal transduction-associated protein 3	GO:0005515; F:protein binding; IPI:IntAct
O75525	KHDRBS3	KH domain-containing, RNA-binding, signal transduction-associated protein 3	GO:0003723; F:RNA binding; IDA:UniProtKB
O75525	KHDRBS3	KH domain-containing, RNA-binding, signal transduction-associated protein 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O75525	KHDRBS3	KH domain-containing, RNA-binding, signal transduction-associated protein 3	GO:0007283; P:spermatogenesis; TAS:ProtInc
O75525	KHDRBS3	KH domain-containing, RNA-binding, signal transduction-associated protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P50053	KHK	Ketohexokinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P50053	KHK	Ketohexokinase	GO:0004454; F:ketohexokinase activity; EXP:Reactome
P50053	KHK	Ketohexokinase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P50053	KHK	Ketohexokinase	GO:0046835; P:carbohydrate phosphorylation; EXP:GOC
P50053	KHK	Ketohexokinase	GO:0006001; P:fructose catabolic process; TAS:Reactome
P50053	KHK	Ketohexokinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H1H9	KIF13A	Kinesin-like protein KIF13A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H1H9	KIF13A	Kinesin-like protein KIF13A	GO:0003777; F:microtubule motor activity; ISS:UniProtKB
Q9H1H9	KIF13A	Kinesin-like protein KIF13A	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H1H9	KIF13A	Kinesin-like protein KIF13A	GO:0035459; P:cargo loading into vesicle; IMP:UniProtKB
Q9H1H9	KIF13A	Kinesin-like protein KIF13A	GO:0000910; P:cytokinesis; IMP:UniProtKB
Q9H1H9	KIF13A	Kinesin-like protein KIF13A	GO:0008333; P:endosome to lysosome transport; IMP:UniProtKB
Q9H1H9	KIF13A	Kinesin-like protein KIF13A	GO:0043001; P:Golgi to plasma membrane protein transport; ISS:UniProtKB
Q9H1H9	KIF13A	Kinesin-like protein KIF13A	GO:0006886; P:intracellular protein transport; IMP:UniProtKB
Q9H1H9	KIF13A	Kinesin-like protein KIF13A	GO:0032438; P:melanosome organization; IMP:UniProtKB
Q9H1H9	KIF13A	Kinesin-like protein KIF13A	GO:0008152; P:metabolic process; ISS:GOC
Q9H1H9	KIF13A	Kinesin-like protein KIF13A	GO:0072383; P:plus-end-directed vesicle transport along microtubule; ISS:UniProtKB
Q9NQT8	KIF13B	Kinesin-like protein KIF13B	GO:0071889; F:14-3-3 protein binding; IDA:UniProtKB
Q9NQT8	KIF13B	Kinesin-like protein KIF13B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NQT8	KIF13B	Kinesin-like protein KIF13B	GO:0003777; F:microtubule motor activity; NAS:UniProtKB
Q9NQT8	KIF13B	Kinesin-like protein KIF13B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NQT8	KIF13B	Kinesin-like protein KIF13B	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q9NQT8	KIF13B	Kinesin-like protein KIF13B	GO:0008152; P:metabolic process; NAS:GOC
Q9NQT8	KIF13B	Kinesin-like protein KIF13B	GO:0007018; P:microtubule-based movement; TAS:UniProtKB
Q9NQT8	KIF13B	Kinesin-like protein KIF13B	GO:0006605; P:protein targeting; TAS:UniProtKB
Q9NQT8	KIF13B	Kinesin-like protein KIF13B	GO:0050770; P:regulation of axonogenesis; IDA:UniProtKB
Q9NQT8	KIF13B	Kinesin-like protein KIF13B	GO:0007165; P:signal transduction; NAS:UniProtKB
Q9NQT8	KIF13B	Kinesin-like protein KIF13B	GO:0042110; P:T cell activation; NAS:UniProtKB
Q96L93	KIF16B	Kinesin-like protein KIF16B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96L93	KIF16B	Kinesin-like protein KIF16B	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB
Q96L93	KIF16B	Kinesin-like protein KIF16B	GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; IDA:UniProtKB
Q96L93	KIF16B	Kinesin-like protein KIF16B	GO:0080025; F:phosphatidylinositol-3,5-bisphosphate binding; IDA:UniProtKB
Q96L93	KIF16B	Kinesin-like protein KIF16B	GO:0032266; F:phosphatidylinositol-3-phosphate binding; IDA:UniProtKB
Q96L93	KIF16B	Kinesin-like protein KIF16B	GO:0008574; F:plus-end-directed microtubule motor activity; IDA:UniProtKB
Q96L93	KIF16B	Kinesin-like protein KIF16B	GO:0045022; P:early endosome to late endosome transport; IMP:UniProtKB
Q96L93	KIF16B	Kinesin-like protein KIF16B	GO:0007492; P:endoderm development; ISS:UniProtKB
Q96L93	KIF16B	Kinesin-like protein KIF16B	GO:0007173; P:epidermal growth factor receptor signaling pathway; IMP:UniProtKB
Q96L93	KIF16B	Kinesin-like protein KIF16B	GO:0008543; P:fibroblast growth factor receptor signaling pathway; ISS:UniProtKB
Q96L93	KIF16B	Kinesin-like protein KIF16B	GO:0001704; P:formation of primary germ layer; ISS:UniProtKB
Q96L93	KIF16B	Kinesin-like protein KIF16B	GO:0006895; P:Golgi to endosome transport; ISS:UniProtKB
Q96L93	KIF16B	Kinesin-like protein KIF16B	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q96L93	KIF16B	Kinesin-like protein KIF16B	GO:0032801; P:receptor catabolic process; IMP:UniProtKB
Q96L93	KIF16B	Kinesin-like protein KIF16B	GO:0001919; P:regulation of receptor recycling; IMP:UniProtKB
Q8NI77	KIF18A	Kinesin-like protein KIF18A	GO:0003779; F:actin binding; IPI:UniProtKB
Q8NI77	KIF18A	Kinesin-like protein KIF18A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NI77	KIF18A	Kinesin-like protein KIF18A	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q8NI77	KIF18A	Kinesin-like protein KIF18A	GO:0051010; F:microtubule plus-end binding; IDA:UniProtKB
Q8NI77	KIF18A	Kinesin-like protein KIF18A	GO:0008574; F:plus-end-directed microtubule motor activity; IDA:UniProtKB
Q8NI77	KIF18A	Kinesin-like protein KIF18A	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NI77	KIF18A	Kinesin-like protein KIF18A	GO:0070463; F:tubulin-dependent ATPase activity; IDA:UniProtKB
Q8NI77	KIF18A	Kinesin-like protein KIF18A	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
Q8NI77	KIF18A	Kinesin-like protein KIF18A	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q8NI77	KIF18A	Kinesin-like protein KIF18A	GO:0006200; P:ATP catabolic process; IDA:GOC
Q8NI77	KIF18A	Kinesin-like protein KIF18A	GO:0007596; P:blood coagulation; TAS:Reactome
Q8NI77	KIF18A	Kinesin-like protein KIF18A	GO:0008152; P:metabolic process; IDA:GOC
Q8NI77	KIF18A	Kinesin-like protein KIF18A	GO:0007019; P:microtubule depolymerization; IDA:UniProtKB
Q8NI77	KIF18A	Kinesin-like protein KIF18A	GO:0007018; P:microtubule-based movement; TAS:Reactome
Q8NI77	KIF18A	Kinesin-like protein KIF18A	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8NI77	KIF18A	Kinesin-like protein KIF18A	GO:0007080; P:mitotic metaphase plate congression; IDA:UniProtKB
Q8NI77	KIF18A	Kinesin-like protein KIF18A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q86Y91	KIF18B	Kinesin-like protein KIF18B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86Y91	KIF18B	Kinesin-like protein KIF18B	GO:0019894; F:kinesin binding; IPI:UniProt
Q86Y91	KIF18B	Kinesin-like protein KIF18B	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q86Y91	KIF18B	Kinesin-like protein KIF18B	GO:0003774; F:motor activity; IDA:UniProt
Q86Y91	KIF18B	Kinesin-like protein KIF18B	GO:0005515; F:protein binding; IPI:UniProt
Q86Y91	KIF18B	Kinesin-like protein KIF18B	GO:0008152; P:metabolic process; IDA:GOC
Q86Y91	KIF18B	Kinesin-like protein KIF18B	GO:0007019; P:microtubule depolymerization; IDA:UniProt
Q86Y91	KIF18B	Kinesin-like protein KIF18B	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q86Y91	KIF18B	Kinesin-like protein KIF18B	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q86Y91	KIF18B	Kinesin-like protein KIF18B	GO:0000278; P:mitotic cell cycle; IDA:UniProtKB
Q86Y91	KIF18B	Kinesin-like protein KIF18B	GO:0051302; P:regulation of cell division; IDA:UniProtKB
O95235	KIF20A	Kinesin-like protein KIF20A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O95235	KIF20A	Kinesin-like protein KIF20A	GO:0003777; F:microtubule motor activity; IEA:InterPro
O95235	KIF20A	Kinesin-like protein KIF20A	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O95235	KIF20A	Kinesin-like protein KIF20A	GO:0005215; F:transporter activity; TAS:ProtInc
O95235	KIF20A	Kinesin-like protein KIF20A	GO:0000910; P:cytokinesis; IDA:UniProtKB
O95235	KIF20A	Kinesin-like protein KIF20A	GO:0001578; P:microtubule bundle formation; IDA:UniProtKB
O95235	KIF20A	Kinesin-like protein KIF20A	GO:0007018; P:microtubule-based movement; IEA:InterPro
O95235	KIF20A	Kinesin-like protein KIF20A	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O95235	KIF20A	Kinesin-like protein KIF20A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O95235	KIF20A	Kinesin-like protein KIF20A	GO:0016192; P:vesicle-mediated transport; TAS:ProtInc
Q96Q89	KIF20B	Kinesin-like protein KIF20B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96Q89	KIF20B	Kinesin-like protein KIF20B	GO:0016887; F:ATPase activity; IDA:UniProtKB
Q96Q89	KIF20B	Kinesin-like protein KIF20B	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q96Q89	KIF20B	Kinesin-like protein KIF20B	GO:0050699; F:WW domain binding; IPI:UniProtKB
Q96Q89	KIF20B	Kinesin-like protein KIF20B	GO:0006200; P:ATP catabolic process; IDA:GOC
Q96Q89	KIF20B	Kinesin-like protein KIF20B	GO:0007050; P:cell cycle arrest; NAS:UniProtKB
Q96Q89	KIF20B	Kinesin-like protein KIF20B	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q96Q89	KIF20B	Kinesin-like protein KIF20B	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q96Q89	KIF20B	Kinesin-like protein KIF20B	GO:0000087; P:mitotic M phase; TAS:ProtInc
Q96Q89	KIF20B	Kinesin-like protein KIF20B	GO:0007088; P:regulation of mitosis; NAS:UniProtKB
Q7Z4S6	KIF21A	Kinesin-like protein KIF21A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q7Z4S6	KIF21A	Kinesin-like protein KIF21A	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q7Z4S6	KIF21A	Kinesin-like protein KIF21A	GO:0005515; F:protein binding; IPI:IntAct
Q7Z4S6	KIF21A	Kinesin-like protein KIF21A	GO:0007018; P:microtubule-based movement; IEA:InterPro
O75037	KIF21B	Kinesin-like protein KIF21B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75037	KIF21B	Kinesin-like protein KIF21B	GO:0003777; F:microtubule motor activity; IEA:InterPro
O75037	KIF21B	Kinesin-like protein KIF21B	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q9ULI4	KIF26A	Kinesin-like protein KIF26A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9ULI4	KIF26A	Kinesin-like protein KIF26A	GO:0008017; F:microtubule binding; ISS:UniProtKB
Q9ULI4	KIF26A	Kinesin-like protein KIF26A	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q9ULI4	KIF26A	Kinesin-like protein KIF26A	GO:0007596; P:blood coagulation; TAS:Reactome
Q9ULI4	KIF26A	Kinesin-like protein KIF26A	GO:0048484; P:enteric nervous system development; ISS:UniProtKB
Q9ULI4	KIF26A	Kinesin-like protein KIF26A	GO:0007018; P:microtubule-based movement; TAS:Reactome
Q9ULI4	KIF26A	Kinesin-like protein KIF26A	GO:0009968; P:negative regulation of signal transduction; ISS:UniProtKB
Q9ULI4	KIF26A	Kinesin-like protein KIF26A	GO:0001560; P:regulation of cell growth by extracellular stimulus; ISS:UniProtKB
Q2KJY2	KIF26B	Kinesin-like protein KIF26B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q2KJY2	KIF26B	Kinesin-like protein KIF26B	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q2KJY2	KIF26B	Kinesin-like protein KIF26B	GO:0030010; P:establishment of cell polarity; IEA:Ensembl
Q2KJY2	KIF26B	Kinesin-like protein KIF26B	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q2KJY2	KIF26B	Kinesin-like protein KIF26B	GO:0022409; P:positive regulation of cell-cell adhesion; IEA:Ensembl
Q2KJY2	KIF26B	Kinesin-like protein KIF26B	GO:0072092; P:ureteric bud invasion; IEA:Ensembl
P43626	KIR2DL1	Killer cell immunoglobulin-like receptor 2DL1	GO:0005515; F:protein binding; IPI:UniProtKB
P43626	KIR2DL1	Killer cell immunoglobulin-like receptor 2DL1	GO:0004872; F:receptor activity; TAS:ProtInc
P43626	KIR2DL1	Killer cell immunoglobulin-like receptor 2DL1	GO:0006955; P:immune response; TAS:ProtInc
P43626	KIR2DL1	Killer cell immunoglobulin-like receptor 2DL1	GO:0002769; P:natural killer cell inhibitory signaling pathway; IDA:UniProtKB
P43626	KIR2DL1	Killer cell immunoglobulin-like receptor 2DL1	GO:0050776; P:regulation of immune response; TAS:Reactome
P43627	KIR2DL2	Killer cell immunoglobulin-like receptor 2DL2	GO:0050776; P:regulation of immune response; TAS:Reactome
P43628	KIR2DL3	Killer cell immunoglobulin-like receptor 2DL3	GO:0003823; F:antigen binding; TAS:ProtInc
P43628	KIR2DL3	Killer cell immunoglobulin-like receptor 2DL3	GO:0005515; F:protein binding; IPI:UniProtKB
P43628	KIR2DL3	Killer cell immunoglobulin-like receptor 2DL3	GO:0004872; F:receptor activity; TAS:ProtInc
P43628	KIR2DL3	Killer cell immunoglobulin-like receptor 2DL3	GO:0006955; P:immune response; TAS:ProtInc
P43628	KIR2DL3	Killer cell immunoglobulin-like receptor 2DL3	GO:0050776; P:regulation of immune response; TAS:Reactome
Q99706	KIR2DL4	Killer cell immunoglobulin-like receptor 2DL4	GO:0005515; F:protein binding; IPI:UniProtKB
Q99706	KIR2DL4	Killer cell immunoglobulin-like receptor 2DL4	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q99706	KIR2DL4	Killer cell immunoglobulin-like receptor 2DL4	GO:0006968; P:cellular defense response; TAS:ProtInc
Q99706	KIR2DL4	Killer cell immunoglobulin-like receptor 2DL4	GO:0050776; P:regulation of immune response; TAS:Reactome
Q99706	KIR2DL4	Killer cell immunoglobulin-like receptor 2DL4	GO:0007165; P:signal transduction; TAS:ProtInc
Q14954	KIR2DS1	Killer cell immunoglobulin-like receptor 2DS1	GO:0004888; F:transmembrane signaling receptor activity; NAS:UniProtKB
Q14954	KIR2DS1	Killer cell immunoglobulin-like receptor 2DS1	GO:0006955; P:immune response; NAS:UniProtKB
Q14954	KIR2DS1	Killer cell immunoglobulin-like receptor 2DS1	GO:0045087; P:innate immune response; TAS:Reactome
Q14954	KIR2DS1	Killer cell immunoglobulin-like receptor 2DS1	GO:0050776; P:regulation of immune response; TAS:Reactome
Q14954	KIR2DS1	Killer cell immunoglobulin-like receptor 2DS1	GO:0007165; P:signal transduction; NAS:GOC
P43631	KIR2DS2	Killer cell immunoglobulin-like receptor 2DS2	GO:0004888; F:transmembrane signaling receptor activity; NAS:UniProtKB
P43631	KIR2DS2	Killer cell immunoglobulin-like receptor 2DS2	GO:0006955; P:immune response; NAS:UniProtKB
P43631	KIR2DS2	Killer cell immunoglobulin-like receptor 2DS2	GO:0045087; P:innate immune response; TAS:Reactome
P43631	KIR2DS2	Killer cell immunoglobulin-like receptor 2DS2	GO:0050776; P:regulation of immune response; TAS:Reactome
P43631	KIR2DS2	Killer cell immunoglobulin-like receptor 2DS2	GO:0007165; P:signal transduction; NAS:GOC
Q14952	KIR2DS3	Killer cell immunoglobulin-like receptor 2DS3	GO:0006968; P:cellular defense response; TAS:ProtInc
P43632	KIR2DS4	Killer cell immunoglobulin-like receptor 2DS4	GO:0045087; P:innate immune response; TAS:Reactome
Q14953	KIR2DS5	Killer cell immunoglobulin-like receptor 2DS5	GO:0030110; F:HLA-C specific inhibitory MHC class I receptor activity; NAS:UniProtKB
Q14953	KIR2DS5	Killer cell immunoglobulin-like receptor 2DS5	GO:0006955; P:immune response; NAS:UniProtKB
Q14953	KIR2DS5	Killer cell immunoglobulin-like receptor 2DS5	GO:0045087; P:innate immune response; TAS:Reactome
Q14953	KIR2DS5	Killer cell immunoglobulin-like receptor 2DS5	GO:0007165; P:signal transduction; NAS:GOC
P43629	KIR3DL1	Killer cell immunoglobulin-like receptor 3DL1	GO:0030109; F:HLA-B specific inhibitory MHC class I receptor activity; NAS:UniProtKB
P43629	KIR3DL1	Killer cell immunoglobulin-like receptor 3DL1	GO:0006955; P:immune response; NAS:UniProtKB
P43629	KIR3DL1	Killer cell immunoglobulin-like receptor 3DL1	GO:0050776; P:regulation of immune response; TAS:Reactome
P43629	KIR3DL1	Killer cell immunoglobulin-like receptor 3DL1	GO:0007165; P:signal transduction; NAS:GOC
P43630	KIR3DL2	Killer cell immunoglobulin-like receptor 3DL2	GO:0006968; P:cellular defense response; TAS:ProtInc
P43630	KIR3DL2	Killer cell immunoglobulin-like receptor 3DL2	GO:0050776; P:regulation of immune response; TAS:Reactome
Q14943	KIR3DS1	Killer cell immunoglobulin-like receptor 3DS1	GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB
Q14943	KIR3DS1	Killer cell immunoglobulin-like receptor 3DS1	GO:0006955; P:immune response; NAS:UniProtKB
Q14943	KIR3DS1	Killer cell immunoglobulin-like receptor 3DS1	GO:0045087; P:innate immune response; TAS:Reactome
Q14943	KIR3DS1	Killer cell immunoglobulin-like receptor 3DS1	GO:0030101; P:natural killer cell activation; NAS:UniProtKB
Q14943	KIR3DS1	Killer cell immunoglobulin-like receptor 3DS1	GO:0007165; P:signal transduction; NAS:GOC
P46013	MKI67	Antigen KI-67	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P46013	MKI67	Antigen KI-67	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P46013	MKI67	Antigen KI-67	GO:0005515; F:protein binding; IPI:UniProtKB
P46013	MKI67	Antigen KI-67	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P46013	MKI67	Antigen KI-67	GO:0008283; P:cell proliferation; TAS:UniProtKB
P46013	MKI67	Antigen KI-67	GO:0034605; P:cellular response to heat; IEA:Ensembl
P46013	MKI67	Antigen KI-67	GO:0006259; P:DNA metabolic process; IEA:Ensembl
P46013	MKI67	Antigen KI-67	GO:0030212; P:hyaluronan metabolic process; IEA:Ensembl
P46013	MKI67	Antigen KI-67	GO:0007126; P:meiotic nuclear division; IEA:Ensembl
P46013	MKI67	Antigen KI-67	GO:0031100; P:organ regeneration; IEA:Ensembl
P46013	MKI67	Antigen KI-67	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
Q8IX03	WWC1	Protein KIBRA	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IX03	WWC1	Protein KIBRA	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q8IX03	WWC1	Protein KIBRA	GO:0016477; P:cell migration; IDA:UniProtKB
Q8IX03	WWC1	Protein KIBRA	GO:0035329; P:hippo signaling; TAS:Reactome
Q8IX03	WWC1	Protein KIBRA	GO:0043410; P:positive regulation of MAPK cascade; IDA:UniProtKB
Q8IX03	WWC1	Protein KIBRA	GO:0035330; P:regulation of hippo signaling; IMP:UniProtKB
Q8IX03	WWC1	Protein KIBRA	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8IX03	WWC1	Protein KIBRA	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P52732	KIF11	Kinesin-like protein KIF11	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P52732	KIF11	Kinesin-like protein KIF11	GO:0003777; F:microtubule motor activity; TAS:ProtInc
P52732	KIF11	Kinesin-like protein KIF11	GO:0032403; F:protein complex binding; IDA:UniProtKB
P52732	KIF11	Kinesin-like protein KIF11	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P52732	KIF11	Kinesin-like protein KIF11	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P52732	KIF11	Kinesin-like protein KIF11	GO:0007596; P:blood coagulation; TAS:Reactome
P52732	KIF11	Kinesin-like protein KIF11	GO:0008152; P:metabolic process; TAS:GOC
P52732	KIF11	Kinesin-like protein KIF11	GO:0007018; P:microtubule-based movement; TAS:Reactome
P52732	KIF11	Kinesin-like protein KIF11	GO:0007067; P:mitosis; TAS:ProtInc
P52732	KIF11	Kinesin-like protein KIF11	GO:0007100; P:mitotic centrosome separation; IEA:Ensembl
P52732	KIF11	Kinesin-like protein KIF11	GO:0007052; P:mitotic spindle organization; TAS:ProtInc
P52732	KIF11	Kinesin-like protein KIF11	GO:0090307; P:spindle assembly involved in mitosis; IDA:UniProtKB
P52732	KIF11	Kinesin-like protein KIF11	GO:0007051; P:spindle organization; IMP:UniProtKB
Q96FN5	KIF12	Kinesin-like protein KIF12	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96FN5	KIF12	Kinesin-like protein KIF12	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q96FN5	KIF12	Kinesin-like protein KIF12	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q9NS87	KIF15	Kinesin-like protein KIF15	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NS87	KIF15	Kinesin-like protein KIF15	GO:0003677; F:DNA binding; TAS:ProtInc
Q9NS87	KIF15	Kinesin-like protein KIF15	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q9NS87	KIF15	Kinesin-like protein KIF15	GO:0003774; F:motor activity; TAS:ProtInc
Q9NS87	KIF15	Kinesin-like protein KIF15	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q9NS87	KIF15	Kinesin-like protein KIF15	GO:0007596; P:blood coagulation; TAS:Reactome
Q9NS87	KIF15	Kinesin-like protein KIF15	GO:0008283; P:cell proliferation; TAS:ProtInc
Q9NS87	KIF15	Kinesin-like protein KIF15	GO:0008152; P:metabolic process; TAS:GOC
Q9NS87	KIF15	Kinesin-like protein KIF15	GO:0007018; P:microtubule-based movement; TAS:Reactome
Q9NS87	KIF15	Kinesin-like protein KIF15	GO:0007067; P:mitosis; TAS:ProtInc
Q15058	KIF14	Kinesin-like protein KIF14	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q15058	KIF14	Kinesin-like protein KIF14	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q15058	KIF14	Kinesin-like protein KIF14	GO:0030165; F:PDZ domain binding; IDA:MGI
Q15058	KIF14	Kinesin-like protein KIF14	GO:0005515; F:protein binding; IPI:UniProtKB
Q15058	KIF14	Kinesin-like protein KIF14	GO:0045184; P:establishment of protein localization; IDA:MGI
Q15058	KIF14	Kinesin-like protein KIF14	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q15058	KIF14	Kinesin-like protein KIF14	GO:0033624; P:negative regulation of integrin activation; IMP:MGI
Q15058	KIF14	Kinesin-like protein KIF14	GO:0030155; P:regulation of cell adhesion; IMP:MGI
Q15058	KIF14	Kinesin-like protein KIF14	GO:0030334; P:regulation of cell migration; IMP:MGI
Q15058	KIF14	Kinesin-like protein KIF14	GO:0032487; P:regulation of Rap protein signal transduction; IMP:MGI
Q15058	KIF14	Kinesin-like protein KIF14	GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:MGI
Q9P2E2	KIF17	Kinesin-like protein KIF17	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9P2E2	KIF17	Kinesin-like protein KIF17	GO:0003777; F:microtubule motor activity; IEA:Ensembl
Q9P2E2	KIF17	Kinesin-like protein KIF17	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q9P2E2	KIF17	Kinesin-like protein KIF17	GO:0031503; P:protein complex localization; IEA:Ensembl
Q9P2E2	KIF17	Kinesin-like protein KIF17	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9P2E2	KIF17	Kinesin-like protein KIF17	GO:0016192; P:vesicle-mediated transport; IEA:Ensembl
Q2TAC6	KIF19	Kinesin-like protein KIF19	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q2TAC6	KIF19	Kinesin-like protein KIF19	GO:0008574; F:plus-end-directed microtubule motor activity; ISS:UniProtKB
Q2TAC6	KIF19	Kinesin-like protein KIF19	GO:0060404; P:axonemal microtubule depolymerization; ISS:UniProtKB
Q2TAC6	KIF19	Kinesin-like protein KIF19	GO:0008152; P:metabolic process; ISS:GOC
Q2TAC6	KIF19	Kinesin-like protein KIF19	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q2TAC6	KIF19	Kinesin-like protein KIF19	GO:0070462; P:plus-end specific microtubule depolymerization; ISS:UniProtKB
Q12756	KIF1A	Kinesin-like protein KIF1A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q12756	KIF1A	Kinesin-like protein KIF1A	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q12756	KIF1A	Kinesin-like protein KIF1A	GO:0003774; F:motor activity; TAS:ProtInc
Q12756	KIF1A	Kinesin-like protein KIF1A	GO:0008089; P:anterograde axon cargo transport; TAS:ProtInc
Q12756	KIF1A	Kinesin-like protein KIF1A	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q12756	KIF1A	Kinesin-like protein KIF1A	GO:0008152; P:metabolic process; TAS:GOC
O60333	KIF1B	Kinesin-like protein KIF1B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O60333	KIF1B	Kinesin-like protein KIF1B	GO:0016887; F:ATPase activity; ISS:UniProtKB
O60333	KIF1B	Kinesin-like protein KIF1B	GO:0019894; F:kinesin binding; TAS:UniProtKB
O60333	KIF1B	Kinesin-like protein KIF1B	GO:0003777; F:microtubule motor activity; ISS:UniProtKB
O60333	KIF1B	Kinesin-like protein KIF1B	GO:0005515; F:protein binding; IPI:IntAct
O60333	KIF1B	Kinesin-like protein KIF1B	GO:0008089; P:anterograde axon cargo transport; ISS:UniProtKB
O60333	KIF1B	Kinesin-like protein KIF1B	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O60333	KIF1B	Kinesin-like protein KIF1B	GO:0030705; P:cytoskeleton-dependent intracellular transport; ISS:UniProtKB
O60333	KIF1B	Kinesin-like protein KIF1B	GO:0007018; P:microtubule-based movement; ISS:UniProtKB
O60333	KIF1B	Kinesin-like protein KIF1B	GO:0047497; P:mitochondrion transport along microtubule; IEA:Ensembl
O60333	KIF1B	Kinesin-like protein KIF1B	GO:0007274; P:neuromuscular synaptic transmission; ISS:UniProtKB
O60333	KIF1B	Kinesin-like protein KIF1B	GO:0007270; P:neuron-neuron synaptic transmission; ISS:UniProtKB
O43896	KIF1C	Kinesin-like protein KIF1C	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43896	KIF1C	Kinesin-like protein KIF1C	GO:0003777; F:microtubule motor activity; IEA:InterPro
O43896	KIF1C	Kinesin-like protein KIF1C	GO:0003774; F:motor activity; TAS:ProtInc
O43896	KIF1C	Kinesin-like protein KIF1C	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O43896	KIF1C	Kinesin-like protein KIF1C	GO:0005515; F:protein binding; IPI:IntAct
O43896	KIF1C	Kinesin-like protein KIF1C	GO:0008152; P:metabolic process; TAS:GOC
O43896	KIF1C	Kinesin-like protein KIF1C	GO:0007018; P:microtubule-based movement; IEA:InterPro
O43896	KIF1C	Kinesin-like protein KIF1C	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; TAS:ProtInc
Q14807	KIF22	Kinesin-like protein KIF22	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q14807	KIF22	Kinesin-like protein KIF22	GO:0003677; F:DNA binding; TAS:ProtInc
Q14807	KIF22	Kinesin-like protein KIF22	GO:0003777; F:microtubule motor activity; TAS:ProtInc
Q14807	KIF22	Kinesin-like protein KIF22	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q14807	KIF22	Kinesin-like protein KIF22	GO:0007596; P:blood coagulation; TAS:Reactome
Q14807	KIF22	Kinesin-like protein KIF22	GO:0006281; P:DNA repair; IEA:InterPro
Q14807	KIF22	Kinesin-like protein KIF22	GO:0007018; P:microtubule-based movement; TAS:Reactome
Q14807	KIF22	Kinesin-like protein KIF22	GO:0007067; P:mitosis; TAS:ProtInc
Q02241	KIF23	Kinesin-like protein KIF23	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q02241	KIF23	Kinesin-like protein KIF23	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q02241	KIF23	Kinesin-like protein KIF23	GO:0003777; F:microtubule motor activity; TAS:ProtInc
Q02241	KIF23	Kinesin-like protein KIF23	GO:0005515; F:protein binding; IPI:UniProtKB
Q02241	KIF23	Kinesin-like protein KIF23	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q02241	KIF23	Kinesin-like protein KIF23	GO:0007596; P:blood coagulation; TAS:Reactome
Q02241	KIF23	Kinesin-like protein KIF23	GO:0000910; P:cytokinesis; IMP:UniProtKB
Q02241	KIF23	Kinesin-like protein KIF23	GO:0008152; P:metabolic process; TAS:GOC
Q02241	KIF23	Kinesin-like protein KIF23	GO:0007018; P:microtubule-based movement; TAS:Reactome
Q02241	KIF23	Kinesin-like protein KIF23	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q02241	KIF23	Kinesin-like protein KIF23	GO:0000022; P:mitotic spindle elongation; TAS:ProtInc
Q02241	KIF23	Kinesin-like protein KIF23	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB
Q02241	KIF23	Kinesin-like protein KIF23	GO:0051256; P:spindle midzone assembly involved in mitosis; IMP:UniProtKB
Q5T7B8	KIF24	Kinesin-like protein KIF24	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5T7B8	KIF24	Kinesin-like protein KIF24	GO:0003777; F:microtubule motor activity; IDA:UniProtKB
Q5T7B8	KIF24	Kinesin-like protein KIF24	GO:0005515; F:protein binding; IPI:IntAct
Q5T7B8	KIF24	Kinesin-like protein KIF24	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q5T7B8	KIF24	Kinesin-like protein KIF24	GO:0008152; P:metabolic process; IDA:GOC
Q5T7B8	KIF24	Kinesin-like protein KIF24	GO:0007019; P:microtubule depolymerization; IDA:UniProtKB
Q5T7B8	KIF24	Kinesin-like protein KIF24	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q9UIL4	KIF25	Kinesin-like protein KIF25	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UIL4	KIF25	Kinesin-like protein KIF25	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q9UIL4	KIF25	Kinesin-like protein KIF25	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q9UIL4	KIF25	Kinesin-like protein KIF25	GO:0000070; P:mitotic sister chromatid segregation; TAS:ProtInc
Q9UIL4	KIF25	Kinesin-like protein KIF25	GO:0010507; P:negative regulation of autophagy; IMP:BHF-UCL
Q9UIL4	KIF25	Kinesin-like protein KIF25	GO:0006996; P:organelle organization; TAS:ProtInc
Q86VH2	KIF27	Kinesin-like protein KIF27	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86VH2	KIF27	Kinesin-like protein KIF27	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q86VH2	KIF27	Kinesin-like protein KIF27	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q86VH2	KIF27	Kinesin-like protein KIF27	GO:0003351; P:epithelial cilium movement; IEA:Ensembl
Q86VH2	KIF27	Kinesin-like protein KIF27	GO:0021591; P:ventricular system development; IEA:Ensembl
B7ZC32	KIF28P	Kinesin-like protein KIF28P	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
B7ZC32	KIF28P	Kinesin-like protein KIF28P	GO:0003777; F:microtubule motor activity; IEA:InterPro
B7ZC32	KIF28P	Kinesin-like protein KIF28P	GO:0007005; P:mitochondrion organization; ISS:UniProtKB
B7ZC32	KIF28P	Kinesin-like protein KIF28P	GO:0072384; P:organelle transport along microtubule; ISS:UniProtKB
O00139	KIF2A	Kinesin-like protein KIF2A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O00139	KIF2A	Kinesin-like protein KIF2A	GO:0003777; F:microtubule motor activity; IEA:InterPro
O00139	KIF2A	Kinesin-like protein KIF2A	GO:0003774; F:motor activity; TAS:ProtInc
O00139	KIF2A	Kinesin-like protein KIF2A	GO:0005515; F:protein binding; IPI:UniProtKB
O00139	KIF2A	Kinesin-like protein KIF2A	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
O00139	KIF2A	Kinesin-like protein KIF2A	GO:0007596; P:blood coagulation; TAS:Reactome
O00139	KIF2A	Kinesin-like protein KIF2A	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O00139	KIF2A	Kinesin-like protein KIF2A	GO:0008152; P:metabolic process; TAS:GOC
O00139	KIF2A	Kinesin-like protein KIF2A	GO:0007018; P:microtubule-based movement; TAS:Reactome
O00139	KIF2A	Kinesin-like protein KIF2A	GO:0007067; P:mitosis; IEA:UniProtKB-KW
O00139	KIF2A	Kinesin-like protein KIF2A	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O00139	KIF2A	Kinesin-like protein KIF2A	GO:0007052; P:mitotic spindle organization; IDA:UniProtKB
O00139	KIF2A	Kinesin-like protein KIF2A	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q8N4N8	KIF2B	Kinesin-like protein KIF2B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8N4N8	KIF2B	Kinesin-like protein KIF2B	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q8N4N8	KIF2B	Kinesin-like protein KIF2B	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q8N4N8	KIF2B	Kinesin-like protein KIF2B	GO:0007596; P:blood coagulation; TAS:Reactome
Q8N4N8	KIF2B	Kinesin-like protein KIF2B	GO:0007019; P:microtubule depolymerization; IMP:UniProtKB
Q8N4N8	KIF2B	Kinesin-like protein KIF2B	GO:0007018; P:microtubule-based movement; TAS:Reactome
Q8N4N8	KIF2B	Kinesin-like protein KIF2B	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q8N4N8	KIF2B	Kinesin-like protein KIF2B	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8N4N8	KIF2B	Kinesin-like protein KIF2B	GO:0051983; P:regulation of chromosome segregation; IMP:UniProtKB
Q99661	KIF2C	Kinesin-like protein KIF2C	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q99661	KIF2C	Kinesin-like protein KIF2C	GO:0019237; F:centromeric DNA binding; TAS:ProtInc
Q99661	KIF2C	Kinesin-like protein KIF2C	GO:0003777; F:microtubule motor activity; TAS:ProtInc
Q99661	KIF2C	Kinesin-like protein KIF2C	GO:0051010; F:microtubule plus-end binding; IDA:UniProtKB
Q99661	KIF2C	Kinesin-like protein KIF2C	GO:0005515; F:protein binding; IPI:UniProtKB
Q99661	KIF2C	Kinesin-like protein KIF2C	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q99661	KIF2C	Kinesin-like protein KIF2C	GO:0007596; P:blood coagulation; TAS:Reactome
Q99661	KIF2C	Kinesin-like protein KIF2C	GO:0008283; P:cell proliferation; TAS:ProtInc
Q99661	KIF2C	Kinesin-like protein KIF2C	GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW
Q99661	KIF2C	Kinesin-like protein KIF2C	GO:0030951; P:establishment or maintenance of microtubule cytoskeleton polarity; IMP:HGNC
Q99661	KIF2C	Kinesin-like protein KIF2C	GO:0008152; P:metabolic process; TAS:GOC
Q99661	KIF2C	Kinesin-like protein KIF2C	GO:0007019; P:microtubule depolymerization; IDA:UniProtKB
Q99661	KIF2C	Kinesin-like protein KIF2C	GO:0007018; P:microtubule-based movement; TAS:Reactome
Q99661	KIF2C	Kinesin-like protein KIF2C	GO:0007067; P:mitosis; TAS:ProtInc
Q99661	KIF2C	Kinesin-like protein KIF2C	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q99661	KIF2C	Kinesin-like protein KIF2C	GO:0051983; P:regulation of chromosome segregation; IMP:UniProtKB
O15066	KIF3B	Kinesin-like protein KIF3B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O15066	KIF3B	Kinesin-like protein KIF3B	GO:0003777; F:microtubule motor activity; TAS:ProtInc
O15066	KIF3B	Kinesin-like protein KIF3B	GO:0008574; F:plus-end-directed microtubule motor activity; TAS:ProtInc
O15066	KIF3B	Kinesin-like protein KIF3B	GO:0005515; F:protein binding; IPI:IntAct
O15066	KIF3B	Kinesin-like protein KIF3B	GO:0017048; F:Rho GTPase binding; IPI:BHF-UCL
O15066	KIF3B	Kinesin-like protein KIF3B	GO:0008089; P:anterograde axon cargo transport; TAS:ProtInc
O15066	KIF3B	Kinesin-like protein KIF3B	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
O15066	KIF3B	Kinesin-like protein KIF3B	GO:0007596; P:blood coagulation; TAS:Reactome
O15066	KIF3B	Kinesin-like protein KIF3B	GO:0007368; P:determination of left/right symmetry; TAS:ProtInc
O15066	KIF3B	Kinesin-like protein KIF3B	GO:0061024; P:membrane organization; TAS:Reactome
O15066	KIF3B	Kinesin-like protein KIF3B	GO:0008152; P:metabolic process; TAS:GOC
O15066	KIF3B	Kinesin-like protein KIF3B	GO:0007018; P:microtubule-based movement; TAS:Reactome
O15066	KIF3B	Kinesin-like protein KIF3B	GO:0007100; P:mitotic centrosome separation; TAS:BHF-UCL
O15066	KIF3B	Kinesin-like protein KIF3B	GO:0007052; P:mitotic spindle organization; TAS:BHF-UCL
O15066	KIF3B	Kinesin-like protein KIF3B	GO:0072383; P:plus-end-directed vesicle transport along microtubule; TAS:BHF-UCL
O15066	KIF3B	Kinesin-like protein KIF3B	GO:0090307; P:spindle assembly involved in mitosis; IMP:BHF-UCL
Q9Y496	KIF3A	Kinesin-like protein KIF3A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y496	KIF3A	Kinesin-like protein KIF3A	GO:0008574; F:plus-end-directed microtubule motor activity; TAS:BHF-UCL
Q9Y496	KIF3A	Kinesin-like protein KIF3A	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y496	KIF3A	Kinesin-like protein KIF3A	GO:0030507; F:spectrin binding; IDA:MGI
Q9Y496	KIF3A	Kinesin-like protein KIF3A	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q9Y496	KIF3A	Kinesin-like protein KIF3A	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q9Y496	KIF3A	Kinesin-like protein KIF3A	GO:0007596; P:blood coagulation; TAS:Reactome
Q9Y496	KIF3A	Kinesin-like protein KIF3A	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q9Y496	KIF3A	Kinesin-like protein KIF3A	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
Q9Y496	KIF3A	Kinesin-like protein KIF3A	GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl
Q9Y496	KIF3A	Kinesin-like protein KIF3A	GO:0007507; P:heart development; IEA:Ensembl
Q9Y496	KIF3A	Kinesin-like protein KIF3A	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9Y496	KIF3A	Kinesin-like protein KIF3A	GO:0001822; P:kidney development; IEA:Ensembl
Q9Y496	KIF3A	Kinesin-like protein KIF3A	GO:0061024; P:membrane organization; TAS:Reactome
Q9Y496	KIF3A	Kinesin-like protein KIF3A	GO:0008152; P:metabolic process; TAS:GOC
Q9Y496	KIF3A	Kinesin-like protein KIF3A	GO:0007018; P:microtubule-based movement; TAS:Reactome
Q9Y496	KIF3A	Kinesin-like protein KIF3A	GO:0006996; P:organelle organization; TAS:ProtInc
Q9Y496	KIF3A	Kinesin-like protein KIF3A	GO:0072383; P:plus-end-directed vesicle transport along microtubule; TAS:BHF-UCL
Q9Y496	KIF3A	Kinesin-like protein KIF3A	GO:0048260; P:positive regulation of receptor-mediated endocytosis; IEA:Ensembl
Q9Y496	KIF3A	Kinesin-like protein KIF3A	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
O14782	KIF3C	Kinesin-like protein KIF3C	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O14782	KIF3C	Kinesin-like protein KIF3C	GO:0003777; F:microtubule motor activity; IEA:InterPro
O14782	KIF3C	Kinesin-like protein KIF3C	GO:0003774; F:motor activity; TAS:ProtInc
O14782	KIF3C	Kinesin-like protein KIF3C	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
O14782	KIF3C	Kinesin-like protein KIF3C	GO:0007596; P:blood coagulation; TAS:Reactome
O14782	KIF3C	Kinesin-like protein KIF3C	GO:0008152; P:metabolic process; TAS:GOC
O14782	KIF3C	Kinesin-like protein KIF3C	GO:0007018; P:microtubule-based movement; TAS:Reactome
O95239	KIF4A	Chromosome-associated kinesin KIF4A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O95239	KIF4A	Chromosome-associated kinesin KIF4A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O95239	KIF4A	Chromosome-associated kinesin KIF4A	GO:0003777; F:microtubule motor activity; TAS:ProtInc
O95239	KIF4A	Chromosome-associated kinesin KIF4A	GO:0008089; P:anterograde axon cargo transport; TAS:ProtInc
O95239	KIF4A	Chromosome-associated kinesin KIF4A	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
O95239	KIF4A	Chromosome-associated kinesin KIF4A	GO:0007411; P:axon guidance; TAS:Reactome
O95239	KIF4A	Chromosome-associated kinesin KIF4A	GO:0007596; P:blood coagulation; TAS:Reactome
O95239	KIF4A	Chromosome-associated kinesin KIF4A	GO:0008152; P:metabolic process; TAS:GOC
O95239	KIF4A	Chromosome-associated kinesin KIF4A	GO:0007018; P:microtubule-based movement; TAS:Reactome
O95239	KIF4A	Chromosome-associated kinesin KIF4A	GO:0006996; P:organelle organization; TAS:ProtInc
Q2VIQ3	KIF4B	Chromosome-associated kinesin KIF4B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q2VIQ3	KIF4B	Chromosome-associated kinesin KIF4B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q2VIQ3	KIF4B	Chromosome-associated kinesin KIF4B	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q2VIQ3	KIF4B	Chromosome-associated kinesin KIF4B	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q2VIQ3	KIF4B	Chromosome-associated kinesin KIF4B	GO:0007411; P:axon guidance; TAS:Reactome
Q2VIQ3	KIF4B	Chromosome-associated kinesin KIF4B	GO:0007596; P:blood coagulation; TAS:Reactome
Q2VIQ3	KIF4B	Chromosome-associated kinesin KIF4B	GO:0007018; P:microtubule-based movement; TAS:Reactome
Q12840	KIF5A	Kinesin heavy chain isoform 5A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q12840	KIF5A	Kinesin heavy chain isoform 5A	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q12840	KIF5A	Kinesin heavy chain isoform 5A	GO:0003774; F:motor activity; TAS:ProtInc
Q12840	KIF5A	Kinesin heavy chain isoform 5A	GO:0005515; F:protein binding; IPI:IntAct
Q12840	KIF5A	Kinesin heavy chain isoform 5A	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q12840	KIF5A	Kinesin heavy chain isoform 5A	GO:0007596; P:blood coagulation; TAS:Reactome
Q12840	KIF5A	Kinesin heavy chain isoform 5A	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q12840	KIF5A	Kinesin heavy chain isoform 5A	GO:0008152; P:metabolic process; TAS:GOC
Q12840	KIF5A	Kinesin heavy chain isoform 5A	GO:0007018; P:microtubule-based movement; TAS:Reactome
Q12840	KIF5A	Kinesin heavy chain isoform 5A	GO:0007268; P:synaptic transmission; TAS:ProtInc
O60282	KIF5C	Kinesin heavy chain isoform 5C	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O60282	KIF5C	Kinesin heavy chain isoform 5C	GO:0003777; F:microtubule motor activity; TAS:ProtInc
O60282	KIF5C	Kinesin heavy chain isoform 5C	GO:0005515; F:protein binding; IPI:IntAct
O60282	KIF5C	Kinesin heavy chain isoform 5C	GO:0008152; P:metabolic process; TAS:GOC
O60282	KIF5C	Kinesin heavy chain isoform 5C	GO:0007018; P:microtubule-based movement; IEA:InterPro
O60282	KIF5C	Kinesin heavy chain isoform 5C	GO:0051028; P:mRNA transport; ISS:UniProtKB
O60282	KIF5C	Kinesin heavy chain isoform 5C	GO:0006996; P:organelle organization; TAS:ProtInc
Q6ZMV9	KIF6	Kinesin-like protein KIF6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6ZMV9	KIF6	Kinesin-like protein KIF6	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q6ZMV9	KIF6	Kinesin-like protein KIF6	GO:0005515; F:protein binding; IPI:IntAct
Q6ZMV9	KIF6	Kinesin-like protein KIF6	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q2M1P5	KIF7	Kinesin-like protein KIF7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q2M1P5	KIF7	Kinesin-like protein KIF7	GO:0003777; F:microtubule motor activity; IDA:UniProtKB
Q2M1P5	KIF7	Kinesin-like protein KIF7	GO:0005515; F:protein binding; IPI:UniProtKB
Q2M1P5	KIF7	Kinesin-like protein KIF7	GO:0008152; P:metabolic process; IDA:GOC
Q2M1P5	KIF7	Kinesin-like protein KIF7	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q2M1P5	KIF7	Kinesin-like protein KIF7	GO:0045879; P:negative regulation of smoothened signaling pathway; ISS:UniProtKB
Q2M1P5	KIF7	Kinesin-like protein KIF7	GO:0045880; P:positive regulation of smoothened signaling pathway; ISS:UniProtKB
Q9HAQ2	KIF9	Kinesin-like protein KIF9	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9HAQ2	KIF9	Kinesin-like protein KIF9	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q9HAQ2	KIF9	Kinesin-like protein KIF9	GO:0005515; F:protein binding; IPI:IntAct
Q9HAQ2	KIF9	Kinesin-like protein KIF9	GO:0046983; F:protein dimerization activity; IDA:UniProt
Q9HAQ2	KIF9	Kinesin-like protein KIF9	GO:0007596; P:blood coagulation; TAS:Reactome
Q9HAQ2	KIF9	Kinesin-like protein KIF9	GO:0007018; P:microtubule-based movement; TAS:Reactome
Q92845	KIFAP3	Kinesin-associated protein 3	GO:0019894; F:kinesin binding; IPI:BHF-UCL
Q92845	KIFAP3	Kinesin-associated protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q92845	KIFAP3	Kinesin-associated protein 3	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q92845	KIFAP3	Kinesin-associated protein 3	GO:0007596; P:blood coagulation; TAS:Reactome
Q92845	KIFAP3	Kinesin-associated protein 3	GO:0061024; P:membrane organization; TAS:Reactome
Q92845	KIFAP3	Kinesin-associated protein 3	GO:0007018; P:microtubule-based movement; TAS:Reactome
Q92845	KIFAP3	Kinesin-associated protein 3	GO:0007017; P:microtubule-based process; ISS:UniProtKB
Q92845	KIFAP3	Kinesin-associated protein 3	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q92845	KIFAP3	Kinesin-associated protein 3	GO:0072383; P:plus-end-directed vesicle transport along microtubule; TAS:BHF-UCL
Q92845	KIFAP3	Kinesin-associated protein 3	GO:0046587; P:positive regulation of calcium-dependent cell-cell adhesion; IEA:Ensembl
Q92845	KIFAP3	Kinesin-associated protein 3	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q92845	KIFAP3	Kinesin-associated protein 3	GO:0008104; P:protein localization; IEA:Ensembl
Q92845	KIFAP3	Kinesin-associated protein 3	GO:0007165; P:signal transduction; TAS:ProtInc
Q9BW19	KIFC1	Kinesin-like protein KIFC1	GO:0005524; F:ATP binding; NAS:UniProtKB
Q9BW19	KIFC1	Kinesin-like protein KIFC1	GO:0003777; F:microtubule motor activity; NAS:UniProtKB
Q9BW19	KIFC1	Kinesin-like protein KIFC1	GO:0007596; P:blood coagulation; TAS:Reactome
Q9BW19	KIFC1	Kinesin-like protein KIFC1	GO:0008152; P:metabolic process; NAS:GOC
Q9BW19	KIFC1	Kinesin-like protein KIFC1	GO:0007018; P:microtubule-based movement; TAS:Reactome
Q9BW19	KIFC1	Kinesin-like protein KIFC1	GO:0000070; P:mitotic sister chromatid segregation; NAS:UniProtKB
Q9BVG8	KIFC3	Kinesin-like protein KIFC3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BVG8	KIFC3	Kinesin-like protein KIFC3	GO:0003777; F:microtubule motor activity; TAS:ProtInc
Q9BVG8	KIFC3	Kinesin-like protein KIFC3	GO:0090136; P:epithelial cell-cell adhesion; IMP:UniProtKB
Q9BVG8	KIFC3	Kinesin-like protein KIFC3	GO:0007030; P:Golgi organization; IEA:Ensembl
Q9BVG8	KIFC3	Kinesin-like protein KIFC3	GO:0008152; P:metabolic process; TAS:GOC
Q9BVG8	KIFC3	Kinesin-like protein KIFC3	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q9BVG8	KIFC3	Kinesin-like protein KIFC3	GO:0007601; P:visual perception; TAS:ProtInc
Q9BVG8	KIFC3	Kinesin-like protein KIFC3	GO:0045218; P:zonula adherens maintenance; IMP:UniProtKB
Q96AC6	KIFC2	Kinesin-like protein KIFC2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96AC6	KIFC2	Kinesin-like protein KIFC2	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q96AC6	KIFC2	Kinesin-like protein KIFC2	GO:0007018; P:microtubule-based movement; IEA:InterPro
B2CW77	KLLN	Killin	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
B2CW77	KLLN	Killin	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
B2CW77	KLLN	Killin	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q03426	MVK	Mevalonate kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q03426	MVK	Mevalonate kinase	GO:0042802; F:identical protein binding; IPI:IntAct
Q03426	MVK	Mevalonate kinase	GO:0004496; F:mevalonate kinase activity; IDA:UniProtKB
Q03426	MVK	Mevalonate kinase	GO:0006695; P:cholesterol biosynthetic process; IDA:UniProtKB
Q03426	MVK	Mevalonate kinase	GO:0019287; P:isopentenyl diphosphate biosynthetic process, mevalonate pathway; IEA:UniProtKB-UniPathway
Q03426	MVK	Mevalonate kinase	GO:0008299; P:isoprenoid biosynthetic process; IDA:UniProtKB
Q03426	MVK	Mevalonate kinase	GO:0050728; P:negative regulation of inflammatory response; IMP:BHF-UCL
Q03426	MVK	Mevalonate kinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60870	KIN	DNA/RNA-binding protein KIN17	GO:0003677; F:DNA binding; TAS:ProtInc
O60870	KIN	DNA/RNA-binding protein KIN17	GO:0003690; F:double-stranded DNA binding; ISS:UniProtKB
O60870	KIN	DNA/RNA-binding protein KIN17	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60870	KIN	DNA/RNA-binding protein KIN17	GO:0003723; F:RNA binding; IDA:UniProtKB
O60870	KIN	DNA/RNA-binding protein KIN17	GO:0006974; P:cellular response to DNA damage stimulus; IEP:UniProtKB
O60870	KIN	DNA/RNA-binding protein KIN17	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
O60870	KIN	DNA/RNA-binding protein KIN17	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
O60870	KIN	DNA/RNA-binding protein KIN17	GO:0006260; P:DNA replication; IDA:UniProtKB
O60870	KIN	DNA/RNA-binding protein KIN17	GO:0006397; P:mRNA processing; TAS:UniProtKB
O60870	KIN	DNA/RNA-binding protein KIN17	GO:0016032; P:viral process; IEA:UniProtKB-KW
P33176	KIF5B	Kinesin-1 heavy chain	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P33176	KIF5B	Kinesin-1 heavy chain	GO:0008017; F:microtubule binding; ISS:HGNC
P33176	KIF5B	Kinesin-1 heavy chain	GO:0003777; F:microtubule motor activity; ISS:HGNC
P33176	KIF5B	Kinesin-1 heavy chain	GO:0005515; F:protein binding; IPI:UniProtKB
P33176	KIF5B	Kinesin-1 heavy chain	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P33176	KIF5B	Kinesin-1 heavy chain	GO:0007028; P:cytoplasm organization; IEA:Ensembl
P33176	KIF5B	Kinesin-1 heavy chain	GO:0007018; P:microtubule-based movement; TAS:ProtInc
P33176	KIF5B	Kinesin-1 heavy chain	GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; IDA:BHF-UCL
P33176	KIF5B	Kinesin-1 heavy chain	GO:0043268; P:positive regulation of potassium ion transport; IDA:BHF-UCL
P33176	KIF5B	Kinesin-1 heavy chain	GO:0042391; P:regulation of membrane potential; IDA:BHF-UCL
P33176	KIF5B	Kinesin-1 heavy chain	GO:0035617; P:stress granule disassembly; ISS:BHF-UCL
P33176	KIF5B	Kinesin-1 heavy chain	GO:0047496; P:vesicle transport along microtubule; ISS:HGNC
Q96J84	KIRREL	Kin of IRRE-like protein 1	GO:0017022; F:myosin binding; IPI:UniProtKB
Q96J84	KIRREL	Kin of IRRE-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96J84	KIRREL	Kin of IRRE-like protein 1	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
Q96J84	KIRREL	Kin of IRRE-like protein 1	GO:0007588; P:excretion; IEA:Ensembl
Q96J84	KIRREL	Kin of IRRE-like protein 1	GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl
Q96J84	KIRREL	Kin of IRRE-like protein 1	GO:0030838; P:positive regulation of actin filament polymerization; IEA:Ensembl
Q6UWL6	KIRREL2	Kin of IRRE-like protein 2	GO:0007155; P:cell adhesion; NAS:UniProtKB
Q6UWL6	KIRREL2	Kin of IRRE-like protein 2	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
Q6UWL6	KIRREL2	Kin of IRRE-like protein 2	GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl
Q8IZU9	KIRREL3	Kin of IRRE-like protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IZU9	KIRREL3	Kin of IRRE-like protein 3	GO:0030097; P:hemopoiesis; ISS:UniProtKB
Q8IZU9	KIRREL3	Kin of IRRE-like protein 3	GO:0001764; P:neuron migration; IEA:Ensembl
Q8IZU9	KIRREL3	Kin of IRRE-like protein 3	GO:0021740; P:principal sensory nucleus of trigeminal nerve development; IEA:Ensembl
Q15726	KISS1	Metastasis-suppressor KiSS-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15726	KISS1	Metastasis-suppressor KiSS-1	GO:0007010; P:cytoskeleton organization; TAS:ProtInc
Q15726	KISS1	Metastasis-suppressor KiSS-1	GO:0060112; P:generation of ovulation cycle rhythm; IEA:Ensembl
Q15726	KISS1	Metastasis-suppressor KiSS-1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q15726	KISS1	Metastasis-suppressor KiSS-1	GO:0051482; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway; IEA:Ensembl
Q15726	KISS1	Metastasis-suppressor KiSS-1	GO:0060124; P:positive regulation of growth hormone secretion; IEA:Ensembl
Q15726	KISS1	Metastasis-suppressor KiSS-1	GO:0033686; P:positive regulation of luteinizing hormone secretion; IEA:Ensembl
Q15726	KISS1	Metastasis-suppressor KiSS-1	GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl
Q15726	KISS1	Metastasis-suppressor KiSS-1	GO:0050806; P:positive regulation of synaptic transmission; IEA:Ensembl
Q969F8	KISS1R	KiSS-1 receptor	GO:0042923; F:neuropeptide binding; IEA:Ensembl
Q969F8	KISS1R	KiSS-1 receptor	GO:0008188; F:neuropeptide receptor activity; IDA:UniProtKB
Q969F8	KISS1R	KiSS-1 receptor	GO:0005515; F:protein binding; IPI:UniProtKB
Q969F8	KISS1R	KiSS-1 receptor	GO:0000186; P:activation of MAPKK activity; IEA:Ensembl
Q969F8	KISS1R	KiSS-1 receptor	GO:0050482; P:arachidonic acid secretion; IEA:Ensembl
Q969F8	KISS1R	KiSS-1 receptor	GO:0019722; P:calcium-mediated signaling; IEA:Ensembl
Q969F8	KISS1R	KiSS-1 receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
Q969F8	KISS1R	KiSS-1 receptor	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q969F8	KISS1R	KiSS-1 receptor	GO:0007218; P:neuropeptide signaling pathway; IDA:GOC
Q969F8	KISS1R	KiSS-1 receptor	GO:0046887; P:positive regulation of hormone secretion; IEA:Ensembl
Q969F8	KISS1R	KiSS-1 receptor	GO:0051496; P:positive regulation of stress fiber assembly; IEA:Ensembl
Q969F8	KISS1R	KiSS-1 receptor	GO:0050806; P:positive regulation of synaptic transmission; IEA:Ensembl
P04183	TK1	Thymidine kinase, cytosolic	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P04183	TK1	Thymidine kinase, cytosolic	GO:0042802; F:identical protein binding; IPI:IntAct
P04183	TK1	Thymidine kinase, cytosolic	GO:0019206; F:nucleoside kinase activity; EXP:Reactome
P04183	TK1	Thymidine kinase, cytosolic	GO:0004797; F:thymidine kinase activity; TAS:ProtInc
P04183	TK1	Thymidine kinase, cytosolic	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P04183	TK1	Thymidine kinase, cytosolic	GO:0009157; P:deoxyribonucleoside monophosphate biosynthetic process; TAS:GOC
P04183	TK1	Thymidine kinase, cytosolic	GO:0048565; P:digestive tract development; IEA:Ensembl
P04183	TK1	Thymidine kinase, cytosolic	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
P04183	TK1	Thymidine kinase, cytosolic	GO:0060138; P:fetal process involved in parturition; IEA:Ensembl
P04183	TK1	Thymidine kinase, cytosolic	GO:0001889; P:liver development; IEA:Ensembl
P04183	TK1	Thymidine kinase, cytosolic	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
P04183	TK1	Thymidine kinase, cytosolic	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P04183	TK1	Thymidine kinase, cytosolic	GO:0009165; P:nucleotide biosynthetic process; EXP:GOC
P04183	TK1	Thymidine kinase, cytosolic	GO:0051289; P:protein homotetramerization; IPI:UniProtKB
P04183	TK1	Thymidine kinase, cytosolic	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
P04183	TK1	Thymidine kinase, cytosolic	GO:0043097; P:pyrimidine nucleoside salvage; TAS:Reactome
P04183	TK1	Thymidine kinase, cytosolic	GO:0046688; P:response to copper ion; IEA:Ensembl
P04183	TK1	Thymidine kinase, cytosolic	GO:0051414; P:response to cortisol; IEA:Ensembl
P04183	TK1	Thymidine kinase, cytosolic	GO:0031667; P:response to nutrient levels; IEA:Ensembl
P04183	TK1	Thymidine kinase, cytosolic	GO:0009636; P:response to toxic substance; IEA:Ensembl
P04183	TK1	Thymidine kinase, cytosolic	GO:0014856; P:skeletal muscle cell proliferation; IEA:Ensembl
P04183	TK1	Thymidine kinase, cytosolic	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P04183	TK1	Thymidine kinase, cytosolic	GO:0046104; P:thymidine metabolic process; IEA:Ensembl
O00142	TK2	Thymidine kinase 2, mitochondrial	GO:0005524; F:ATP binding; IEA:InterPro
O00142	TK2	Thymidine kinase 2, mitochondrial	GO:0004137; F:deoxycytidine kinase activity; IEA:Ensembl
O00142	TK2	Thymidine kinase 2, mitochondrial	GO:0016773; F:phosphotransferase activity, alcohol group as acceptor; IEA:InterPro
O00142	TK2	Thymidine kinase 2, mitochondrial	GO:0004797; F:thymidine kinase activity; IEA:Ensembl
O00142	TK2	Thymidine kinase 2, mitochondrial	GO:0046092; P:deoxycytidine metabolic process; IEA:Ensembl
O00142	TK2	Thymidine kinase 2, mitochondrial	GO:0009157; P:deoxyribonucleoside monophosphate biosynthetic process; TAS:GOC
O00142	TK2	Thymidine kinase 2, mitochondrial	GO:0009262; P:deoxyribonucleotide metabolic process; IEA:Ensembl
O00142	TK2	Thymidine kinase 2, mitochondrial	GO:0006264; P:mitochondrial DNA replication; IEA:Ensembl
O00142	TK2	Thymidine kinase 2, mitochondrial	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
O00142	TK2	Thymidine kinase 2, mitochondrial	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
O00142	TK2	Thymidine kinase 2, mitochondrial	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
O00142	TK2	Thymidine kinase 2, mitochondrial	GO:0043097; P:pyrimidine nucleoside salvage; TAS:Reactome
O00142	TK2	Thymidine kinase 2, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00142	TK2	Thymidine kinase 2, mitochondrial	GO:0046104; P:thymidine metabolic process; IEA:Ensembl
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0019955; F:cytokine binding; IDA:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0005515; F:protein binding; IPI:IntAct
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0004713; F:protein tyrosine kinase activity; TAS:ProtInc
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0004716; F:receptor signaling protein tyrosine kinase activity; TAS:ProtInc
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0005020; F:stem cell factor receptor activity; IEA:Ensembl
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IDA:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0031532; P:actin cytoskeleton reorganization; IDA:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0000187; P:activation of MAPK activity; IDA:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0060326; P:cell chemotaxis; IDA:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0097067; P:cellular response to thyroid hormone stimulus; IEA:Ensembl
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0019221; P:cytokine-mediated signaling pathway; IDA:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0002371; P:dendritic cell cytokine production; ISS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; ISS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0048565; P:digestive tract development; ISS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0035234; P:ectopic germ cell programmed cell death; IEA:Ensembl
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0035162; P:embryonic hemopoiesis; ISS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0050673; P:epithelial cell proliferation; IEA:Ensembl
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0030218; P:erythrocyte differentiation; ISS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0038162; P:erythropoietin-mediated signaling pathway; ISS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0038093; P:Fc receptor signaling pathway; IDA:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0008354; P:germ cell migration; IEA:Ensembl
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0006687; P:glycosphingolipid metabolic process; IEA:Ensembl
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0030097; P:hemopoiesis; TAS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0002327; P:immature B cell differentiation; ISS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0006954; P:inflammatory response; ISS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0045087; P:innate immune response; TAS:Reactome
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0038109; P:Kit signaling pathway; IDA:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0030032; P:lamellipodium assembly; ISS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0002320; P:lymphoid progenitor cell differentiation; IEA:Ensembl
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0008584; P:male gonad development; IEP:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0002551; P:mast cell chemotaxis; IDA:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0032762; P:mast cell cytokine production; IDA:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0043303; P:mast cell degranulation; IMP:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0060374; P:mast cell differentiation; ISS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0070662; P:mast cell proliferation; TAS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0035855; P:megakaryocyte development; ISS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0097326; P:melanocyte adhesion; ISS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0030318; P:melanocyte differentiation; ISS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0097324; P:melanocyte migration; ISS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0002318; P:myeloid progenitor cell differentiation; IEA:Ensembl
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0043069; P:negative regulation of programmed cell death; IEA:Ensembl
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0001541; P:ovarian follicle development; ISS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0043473; P:pigmentation; ISS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0046427; P:positive regulation of JAK-STAT cascade; IMP:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0048170; P:positive regulation of long-term neuronal synaptic plasticity; IEA:Ensembl
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0043410; P:positive regulation of MAPK cascade; IMP:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0045747; P:positive regulation of Notch signaling pathway; IEA:Ensembl
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; TAS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; TAS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0010863; P:positive regulation of phospholipase C activity; TAS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0031274; P:positive regulation of pseudopodium assembly; IEA:Ensembl
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0042511; P:positive regulation of tyrosine phosphorylation of Stat1 protein; IMP:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IMP:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0042523; P:positive regulation of tyrosine phosphorylation of Stat5 protein; IMP:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0042127; P:regulation of cell proliferation; TAS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0008360; P:regulation of cell shape; ISS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0048070; P:regulation of developmental pigmentation; IEA:Ensembl
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0007165; P:signal transduction; TAS:ProtInc
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0023014; P:signal transduction by phosphorylation; TAS:GOC
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0048103; P:somatic stem cell division; IEA:Ensembl
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0007286; P:spermatid development; IEA:Ensembl
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0007283; P:spermatogenesis; ISS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0048863; P:stem cell differentiation; ISS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0019827; P:stem cell maintenance; TAS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0030217; P:T cell differentiation; ISS:UniProtKB
P10721	KIT	Mast/stem cell growth factor receptor Kit	GO:0008542; P:visual learning; IEA:Ensembl
Q2M2Z5	KIZ	Centrosomal protein kizuna	GO:0005515; F:protein binding; IPI:UniProtKB
Q2M2Z5	KIZ	Centrosomal protein kizuna	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q2M2Z5	KIZ	Centrosomal protein kizuna	GO:0007051; P:spindle organization; IMP:UniProtKB
Q8N5S9	CAMKK1	Calcium/calmodulin-dependent protein kinase kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8N5S9	CAMKK1	Calcium/calmodulin-dependent protein kinase kinase 1	GO:0004683; F:calmodulin-dependent protein kinase activity; IEA:UniProtKB-EC
Q8N5S9	CAMKK1	Calcium/calmodulin-dependent protein kinase kinase 1	GO:0005515; F:protein binding; IPI:IntAct
Q8N5S9	CAMKK1	Calcium/calmodulin-dependent protein kinase kinase 1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q96RR4	CAMKK2	Calcium/calmodulin-dependent protein kinase kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96RR4	CAMKK2	Calcium/calmodulin-dependent protein kinase kinase 2	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q96RR4	CAMKK2	Calcium/calmodulin-dependent protein kinase kinase 2	GO:0005516; F:calmodulin binding; TAS:UniProtKB
Q96RR4	CAMKK2	Calcium/calmodulin-dependent protein kinase kinase 2	GO:0004683; F:calmodulin-dependent protein kinase activity; IEA:UniProtKB-EC
Q96RR4	CAMKK2	Calcium/calmodulin-dependent protein kinase kinase 2	GO:0004713; F:protein tyrosine kinase activity; TAS:UniProtKB
Q96RR4	CAMKK2	Calcium/calmodulin-dependent protein kinase kinase 2	GO:0019722; P:calcium-mediated signaling; TAS:UniProtKB
Q96RR4	CAMKK2	Calcium/calmodulin-dependent protein kinase kinase 2	GO:0000165; P:MAPK cascade; TAS:UniProtKB
Q96RR4	CAMKK2	Calcium/calmodulin-dependent protein kinase kinase 2	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:GOC
Q96RR4	CAMKK2	Calcium/calmodulin-dependent protein kinase kinase 2	GO:0045893; P:positive regulation of transcription, DNA-templated; TAS:UniProtKB
Q96RR4	CAMKK2	Calcium/calmodulin-dependent protein kinase kinase 2	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q96RR4	CAMKK2	Calcium/calmodulin-dependent protein kinase kinase 2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q96RR4	CAMKK2	Calcium/calmodulin-dependent protein kinase kinase 2	GO:0045859; P:regulation of protein kinase activity; TAS:UniProtKB
Q07866	KLC1	Kinesin light chain 1	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q07866	KLC1	Kinesin light chain 1	GO:0003774; F:motor activity; TAS:ProtInc
Q07866	KLC1	Kinesin light chain 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q07866	KLC1	Kinesin light chain 1	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q07866	KLC1	Kinesin light chain 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q07866	KLC1	Kinesin light chain 1	GO:0008152; P:metabolic process; TAS:GOC
Q07866	KLC1	Kinesin light chain 1	GO:0007018; P:microtubule-based movement; TAS:Reactome
Q07866	KLC1	Kinesin light chain 1	GO:0035617; P:stress granule disassembly; ISS:BHF-UCL
Q07866	KLC1	Kinesin light chain 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9H0B6	KLC2	Kinesin light chain 2	GO:0019894; F:kinesin binding; ISS:BHF-UCL
Q9H0B6	KLC2	Kinesin light chain 2	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q9H0B6	KLC2	Kinesin light chain 2	GO:0005515; F:protein binding; IPI:HGNC
Q9H0B6	KLC2	Kinesin light chain 2	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q9H0B6	KLC2	Kinesin light chain 2	GO:0008088; P:axon cargo transport; IEA:Ensembl
Q9H0B6	KLC2	Kinesin light chain 2	GO:0007596; P:blood coagulation; TAS:Reactome
Q9H0B6	KLC2	Kinesin light chain 2	GO:0007018; P:microtubule-based movement; TAS:Reactome
Q6P597	KLC3	Kinesin light chain 3	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q6P597	KLC3	Kinesin light chain 3	GO:0008088; P:axon cargo transport; IEA:Ensembl
Q9NSK0	KLC4	Kinesin light chain 4	GO:0003777; F:microtubule motor activity; IEA:InterPro
Q8TBB5	KLHDC4	Kelch domain-containing protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q9BQ90	KLHDC3	Kelch domain-containing protein 3	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q9BQ90	KLHDC3	Kelch domain-containing protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BQ90	KLHDC3	Kelch domain-containing protein 3	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q9BQ90	KLHDC3	Kelch domain-containing protein 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9BQ90	KLHDC3	Kelch domain-containing protein 3	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q9BQ90	KLHDC3	Kelch domain-containing protein 3	GO:0007131; P:reciprocal meiotic recombination; NAS:UniProtKB
Q13118	KLF10	Krueppel-like factor 10	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q13118	KLF10	Krueppel-like factor 10	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13118	KLF10	Krueppel-like factor 10	GO:0005515; F:protein binding; IPI:IntAct
Q13118	KLF10	Krueppel-like factor 10	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q13118	KLF10	Krueppel-like factor 10	GO:0030282; P:bone mineralization; IEA:Ensembl
Q13118	KLF10	Krueppel-like factor 10	GO:0008283; P:cell proliferation; TAS:ProtInc
Q13118	KLF10	Krueppel-like factor 10	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q13118	KLF10	Krueppel-like factor 10	GO:1901653; P:cellular response to peptide; IEA:Ensembl
Q13118	KLF10	Krueppel-like factor 10	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q13118	KLF10	Krueppel-like factor 10	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q13118	KLF10	Krueppel-like factor 10	GO:0045672; P:positive regulation of osteoclast differentiation; IEA:Ensembl
Q13118	KLF10	Krueppel-like factor 10	GO:0001501; P:skeletal system development; TAS:ProtInc
Q13118	KLF10	Krueppel-like factor 10	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
Q13118	KLF10	Krueppel-like factor 10	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13118	KLF10	Krueppel-like factor 10	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:ProtInc
O14901	KLF11	Krueppel-like factor 11	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14901	KLF11	Krueppel-like factor 11	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:BHF-UCL
O14901	KLF11	Krueppel-like factor 11	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O14901	KLF11	Krueppel-like factor 11	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
O14901	KLF11	Krueppel-like factor 11	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O14901	KLF11	Krueppel-like factor 11	GO:1901653; P:cellular response to peptide; IEA:Ensembl
O14901	KLF11	Krueppel-like factor 11	GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL
O14901	KLF11	Krueppel-like factor 11	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
O14901	KLF11	Krueppel-like factor 11	GO:0043065; P:positive regulation of apoptotic process; IDA:BHF-UCL
O14901	KLF11	Krueppel-like factor 11	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; IDA:BHF-UCL
O14901	KLF11	Krueppel-like factor 11	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9Y4X4	KLF12	Krueppel-like factor 12	GO:0003677; F:DNA binding; IDA:MGI
Q9Y4X4	KLF12	Krueppel-like factor 12	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y4X4	KLF12	Krueppel-like factor 12	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl
Q9Y4X4	KLF12	Krueppel-like factor 12	GO:0001227; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IEA:Ensembl
Q9Y4X4	KLF12	Krueppel-like factor 12	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:MGI
Q9Y4X4	KLF12	Krueppel-like factor 12	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q9Y4X4	KLF12	Krueppel-like factor 12	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q9Y4X4	KLF12	Krueppel-like factor 12	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9Y4X4	KLF12	Krueppel-like factor 12	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9Y2Y9	KLF13	Krueppel-like factor 13	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y2Y9	KLF13	Krueppel-like factor 13	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y2Y9	KLF13	Krueppel-like factor 13	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2Y9	KLF13	Krueppel-like factor 13	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q9Y2Y9	KLF13	Krueppel-like factor 13	GO:0045647; P:negative regulation of erythrocyte differentiation; IEA:Ensembl
Q9Y2Y9	KLF13	Krueppel-like factor 13	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9Y2Y9	KLF13	Krueppel-like factor 13	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q8TD94	KLF14	Krueppel-like factor 14	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TD94	KLF14	Krueppel-like factor 14	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TD94	KLF14	Krueppel-like factor 14	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8TD94	KLF14	Krueppel-like factor 14	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UIH9	KLF15	Krueppel-like factor 15	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UIH9	KLF15	Krueppel-like factor 15	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UIH9	KLF15	Krueppel-like factor 15	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IC:BHF-UCL
Q9UIH9	KLF15	Krueppel-like factor 15	GO:0044212; F:transcription regulatory region DNA binding; ISS:UniProtKB
Q9UIH9	KLF15	Krueppel-like factor 15	GO:1901653; P:cellular response to peptide; IEA:Ensembl
Q9UIH9	KLF15	Krueppel-like factor 15	GO:0010001; P:glial cell differentiation; IEA:Ensembl
Q9UIH9	KLF15	Krueppel-like factor 15	GO:0072112; P:glomerular visceral epithelial cell differentiation; ISS:UniProtKB
Q9UIH9	KLF15	Krueppel-like factor 15	GO:0015758; P:glucose transport; IEA:Ensembl
Q9UIH9	KLF15	Krueppel-like factor 15	GO:2000757; P:negative regulation of peptidyl-lysine acetylation; IMP:UniProtKB
Q9UIH9	KLF15	Krueppel-like factor 15	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q9BXK1	KLF16	Krueppel-like factor 16	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BXK1	KLF16	Krueppel-like factor 16	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BXK1	KLF16	Krueppel-like factor 16	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q9BXK1	KLF16	Krueppel-like factor 16	GO:0007212; P:dopamine receptor signaling pathway; IEA:Ensembl
Q9BXK1	KLF16	Krueppel-like factor 16	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9BXK1	KLF16	Krueppel-like factor 16	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5JT82	KLF17	Krueppel-like factor 17	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5JT82	KLF17	Krueppel-like factor 17	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q5JT82	KLF17	Krueppel-like factor 17	GO:0044212; F:transcription regulatory region DNA binding; ISS:UniProtKB
Q5JT82	KLF17	Krueppel-like factor 17	GO:0007276; P:gamete generation; IEA:Ensembl
Q5JT82	KLF17	Krueppel-like factor 17	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q5JT82	KLF17	Krueppel-like factor 17	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13351	KLF1	Krueppel-like factor 1	GO:0000987; F:core promoter proximal region sequence-specific DNA binding; IDA:BHF-UCL
Q13351	KLF1	Krueppel-like factor 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13351	KLF1	Krueppel-like factor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q13351	KLF1	Krueppel-like factor 1	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q13351	KLF1	Krueppel-like factor 1	GO:1901653; P:cellular response to peptide; IEA:Ensembl
Q13351	KLF1	Krueppel-like factor 1	GO:0006338; P:chromatin remodeling; IEA:Ensembl
Q13351	KLF1	Krueppel-like factor 1	GO:0035162; P:embryonic hemopoiesis; IEA:Ensembl
Q13351	KLF1	Krueppel-like factor 1	GO:0030218; P:erythrocyte differentiation; IMP:UniProtKB
Q13351	KLF1	Krueppel-like factor 1	GO:0043249; P:erythrocyte maturation; IEA:Ensembl
Q13351	KLF1	Krueppel-like factor 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q13351	KLF1	Krueppel-like factor 1	GO:0001889; P:liver development; IEA:Ensembl
Q13351	KLF1	Krueppel-like factor 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q13351	KLF1	Krueppel-like factor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y5W3	KLF2	Krueppel-like factor 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y5W3	KLF2	Krueppel-like factor 2	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q9Y5W3	KLF2	Krueppel-like factor 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q9Y5W3	KLF2	Krueppel-like factor 2	GO:0000902; P:cell morphogenesis; IEA:Ensembl
Q9Y5W3	KLF2	Krueppel-like factor 2	GO:0071409; P:cellular response to cycloheximide; IEA:Ensembl
Q9Y5W3	KLF2	Krueppel-like factor 2	GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl
Q9Y5W3	KLF2	Krueppel-like factor 2	GO:0071347; P:cellular response to interleukin-1; IEA:Ensembl
Q9Y5W3	KLF2	Krueppel-like factor 2	GO:0071499; P:cellular response to laminar fluid shear stress; IMP:BHF-UCL
Q9Y5W3	KLF2	Krueppel-like factor 2	GO:1901653; P:cellular response to peptide; IEA:Ensembl
Q9Y5W3	KLF2	Krueppel-like factor 2	GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl
Q9Y5W3	KLF2	Krueppel-like factor 2	GO:0043249; P:erythrocyte maturation; IEA:Ensembl
Q9Y5W3	KLF2	Krueppel-like factor 2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9Y5W3	KLF2	Krueppel-like factor 2	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q9Y5W3	KLF2	Krueppel-like factor 2	GO:0032715; P:negative regulation of interleukin-6 production; IEA:Ensembl
Q9Y5W3	KLF2	Krueppel-like factor 2	GO:0051247; P:positive regulation of protein metabolic process; IGI:BHF-UCL
Q9Y5W3	KLF2	Krueppel-like factor 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IGI:BHF-UCL
Q9Y5W3	KLF2	Krueppel-like factor 2	GO:0036003; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; IMP:BHF-UCL
Q9Y5W3	KLF2	Krueppel-like factor 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y5W3	KLF2	Krueppel-like factor 2	GO:0060509; P:Type I pneumocyte differentiation; IEA:Ensembl
P57682	KLF3	Krueppel-like factor 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P57682	KLF3	Krueppel-like factor 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P57682	KLF3	Krueppel-like factor 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
P57682	KLF3	Krueppel-like factor 3	GO:1901653; P:cellular response to peptide; IEA:Ensembl
P57682	KLF3	Krueppel-like factor 3	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P57682	KLF3	Krueppel-like factor 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13887	KLF5	Krueppel-like factor 5	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q13887	KLF5	Krueppel-like factor 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13887	KLF5	Krueppel-like factor 5	GO:0005515; F:protein binding; IPI:IntAct
Q13887	KLF5	Krueppel-like factor 5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q13887	KLF5	Krueppel-like factor 5	GO:0001525; P:angiogenesis; IEA:Ensembl
Q13887	KLF5	Krueppel-like factor 5	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
Q13887	KLF5	Krueppel-like factor 5	GO:1901653; P:cellular response to peptide; IEA:Ensembl
Q13887	KLF5	Krueppel-like factor 5	GO:0030033; P:microvillus assembly; IEA:Ensembl
Q13887	KLF5	Krueppel-like factor 5	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q13887	KLF5	Krueppel-like factor 5	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q13887	KLF5	Krueppel-like factor 5	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q13887	KLF5	Krueppel-like factor 5	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
O43474	KLF4	Krueppel-like factor 4	GO:0000987; F:core promoter proximal region sequence-specific DNA binding; IDA:BHF-UCL
O43474	KLF4	Krueppel-like factor 4	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
O43474	KLF4	Krueppel-like factor 4	GO:0035014; F:phosphatidylinositol 3-kinase regulator activity; IEA:Ensembl
O43474	KLF4	Krueppel-like factor 4	GO:0005515; F:protein binding; IPI:IntAct
O43474	KLF4	Krueppel-like factor 4	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IMP:BHF-UCL
O43474	KLF4	Krueppel-like factor 4	GO:0001085; F:RNA polymerase II transcription factor binding; IPI:BHF-UCL
O43474	KLF4	Krueppel-like factor 4	GO:0001190; F:RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription; IDA:BHF-UCL
O43474	KLF4	Krueppel-like factor 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
O43474	KLF4	Krueppel-like factor 4	GO:0001010; F:sequence-specific DNA binding transcription factor recruiting transcription factor activity; ISS:BHF-UCL
O43474	KLF4	Krueppel-like factor 4	GO:0044212; F:transcription regulatory region DNA binding; ISS:UniProtKB
O43474	KLF4	Krueppel-like factor 4	GO:0008270; F:zinc ion binding; NAS:UniProtKB
O43474	KLF4	Krueppel-like factor 4	GO:0071409; P:cellular response to cycloheximide; IEA:Ensembl
O43474	KLF4	Krueppel-like factor 4	GO:0071363; P:cellular response to growth factor stimulus; IDA:BHF-UCL
O43474	KLF4	Krueppel-like factor 4	GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl
O43474	KLF4	Krueppel-like factor 4	GO:1901653; P:cellular response to peptide; IEA:Ensembl
O43474	KLF4	Krueppel-like factor 4	GO:0009913; P:epidermal cell differentiation; IEA:Ensembl
O43474	KLF4	Krueppel-like factor 4	GO:0048730; P:epidermis morphogenesis; IEA:Ensembl
O43474	KLF4	Krueppel-like factor 4	GO:0045444; P:fat cell differentiation; ISS:BHF-UCL
O43474	KLF4	Krueppel-like factor 4	GO:0007500; P:mesodermal cell fate determination; TAS:ProtInc
O43474	KLF4	Krueppel-like factor 4	GO:0090051; P:negative regulation of cell migration involved in sprouting angiogenesis; IDA:BHF-UCL
O43474	KLF4	Krueppel-like factor 4	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
O43474	KLF4	Krueppel-like factor 4	GO:2000342; P:negative regulation of chemokine (C-X-C motif) ligand 2 production; IDA:BHF-UCL
O43474	KLF4	Krueppel-like factor 4	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:BHF-UCL
O43474	KLF4	Krueppel-like factor 4	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IEA:Ensembl
O43474	KLF4	Krueppel-like factor 4	GO:0034115; P:negative regulation of heterotypic cell-cell adhesion; IDA:BHF-UCL
O43474	KLF4	Krueppel-like factor 4	GO:0050728; P:negative regulation of inflammatory response; TAS:BHF-UCL
O43474	KLF4	Krueppel-like factor 4	GO:0045415; P:negative regulation of interleukin-8 biosynthetic process; IDA:BHF-UCL
O43474	KLF4	Krueppel-like factor 4	GO:0014740; P:negative regulation of muscle hyperplasia; IEA:Ensembl
O43474	KLF4	Krueppel-like factor 4	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:BHF-UCL
O43474	KLF4	Krueppel-like factor 4	GO:0014067; P:negative regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl
O43474	KLF4	Krueppel-like factor 4	GO:0051898; P:negative regulation of protein kinase B signaling; IEA:Ensembl
O43474	KLF4	Krueppel-like factor 4	GO:0060761; P:negative regulation of response to cytokine stimulus; IDA:BHF-UCL
O43474	KLF4	Krueppel-like factor 4	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IEA:Ensembl
O43474	KLF4	Krueppel-like factor 4	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
O43474	KLF4	Krueppel-like factor 4	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
O43474	KLF4	Krueppel-like factor 4	GO:0046985; P:positive regulation of hemoglobin biosynthetic process; IMP:BHF-UCL
O43474	KLF4	Krueppel-like factor 4	GO:0051247; P:positive regulation of protein metabolic process; IGI:BHF-UCL
O43474	KLF4	Krueppel-like factor 4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IGI:BHF-UCL
O43474	KLF4	Krueppel-like factor 4	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
O43474	KLF4	Krueppel-like factor 4	GO:0031077; P:post-embryonic camera-type eye development; IEA:Ensembl
O43474	KLF4	Krueppel-like factor 4	GO:0035166; P:post-embryonic hemopoiesis; IMP:BHF-UCL
O43474	KLF4	Krueppel-like factor 4	GO:0045595; P:regulation of cell differentiation; ISS:UniProtKB
O43474	KLF4	Krueppel-like factor 4	GO:0032526; P:response to retinoic acid; IEA:Ensembl
O43474	KLF4	Krueppel-like factor 4	GO:0019827; P:stem cell maintenance; ISS:UniProtKB
O43474	KLF4	Krueppel-like factor 4	GO:0006366; P:transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q99612	KLF6	Krueppel-like factor 6	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q99612	KLF6	Krueppel-like factor 6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q99612	KLF6	Krueppel-like factor 6	GO:0030183; P:B cell differentiation; NAS:UniProtKB
Q99612	KLF6	Krueppel-like factor 6	GO:0019221; P:cytokine-mediated signaling pathway; IEA:Ensembl
Q99612	KLF6	Krueppel-like factor 6	GO:0045893; P:positive regulation of transcription, DNA-templated; TAS:UniProtKB
Q99612	KLF6	Krueppel-like factor 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75840	KLF7	Krueppel-like factor 7	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O75840	KLF7	Krueppel-like factor 7	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O75840	KLF7	Krueppel-like factor 7	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
O75840	KLF7	Krueppel-like factor 7	GO:0008270; F:zinc ion binding; TAS:ProtInc
O75840	KLF7	Krueppel-like factor 7	GO:0007411; P:axon guidance; IEA:Ensembl
O75840	KLF7	Krueppel-like factor 7	GO:0048813; P:dendrite morphogenesis; IEA:Ensembl
O75840	KLF7	Krueppel-like factor 7	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
O75840	KLF7	Krueppel-like factor 7	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O75840	KLF7	Krueppel-like factor 7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95600	KLF8	Krueppel-like factor 8	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O95600	KLF8	Krueppel-like factor 8	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95600	KLF8	Krueppel-like factor 8	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O95600	KLF8	Krueppel-like factor 8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13886	KLF9	Krueppel-like factor 9	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q13886	KLF9	Krueppel-like factor 9	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13886	KLF9	Krueppel-like factor 9	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q13886	KLF9	Krueppel-like factor 9	GO:0097067; P:cellular response to thyroid hormone stimulus; IDA:UniProtKB
Q13886	KLF9	Krueppel-like factor 9	GO:0007566; P:embryo implantation; IEA:Ensembl
Q13886	KLF9	Krueppel-like factor 9	GO:0050847; P:progesterone receptor signaling pathway; IEA:Ensembl
Q13886	KLF9	Krueppel-like factor 9	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q13886	KLF9	Krueppel-like factor 9	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6JEL2	KLHL10	Kelch-like protein 10	GO:0000902; P:cell morphogenesis; IEA:Ensembl
Q6JEL2	KLHL10	Kelch-like protein 10	GO:0009566; P:fertilization; IEA:Ensembl
Q6JEL2	KLHL10	Kelch-like protein 10	GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl
Q6JEL2	KLHL10	Kelch-like protein 10	GO:0048808; P:male genitalia morphogenesis; IEA:Ensembl
Q6JEL2	KLHL10	Kelch-like protein 10	GO:0008584; P:male gonad development; IEA:Ensembl
Q6JEL2	KLHL10	Kelch-like protein 10	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q6JEL2	KLHL10	Kelch-like protein 10	GO:0007286; P:spermatid development; IEA:Ensembl
Q53G59	KLHL12	Kelch-like protein 12	GO:0005515; F:protein binding; IPI:IntAct
Q53G59	KLHL12	Kelch-like protein 12	GO:0048208; P:COPII vesicle coating; IMP:UniProtKB
Q53G59	KLHL12	Kelch-like protein 12	GO:0006888; P:ER to Golgi vesicle-mediated transport; IDA:UniProtKB
Q53G59	KLHL12	Kelch-like protein 12	GO:0006513; P:protein monoubiquitination; IDA:UniProtKB
Q53G59	KLHL12	Kelch-like protein 12	GO:0016055; P:Wnt signaling pathway; IMP:UniProtKB
Q9P2N7	KLHL13	Kelch-like protein 13	GO:0000910; P:cytokinesis; IMP:UniProtKB
Q9P2N7	KLHL13	Kelch-like protein 13	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9P2N7	KLHL13	Kelch-like protein 13	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q96M94	KLHL15	Kelch-like protein 15	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q6TDP4	KLHL17	Kelch-like protein 17	GO:0032947; F:protein complex scaffold; ISS:UniProtKB
Q6TDP4	KLHL17	Kelch-like protein 17	GO:0030036; P:actin cytoskeleton organization; ISS:UniProtKB
Q6TDP4	KLHL17	Kelch-like protein 17	GO:0007420; P:brain development; IEA:Ensembl
Q6TDP4	KLHL17	Kelch-like protein 17	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9Y2M5	KLHL20	Kelch-like protein 20	GO:0019964; F:interferon-gamma binding; IDA:UniProtKB
Q9Y2M5	KLHL20	Kelch-like protein 20	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y2M5	KLHL20	Kelch-like protein 20	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9Y2M5	KLHL20	Kelch-like protein 20	GO:0007010; P:cytoskeleton organization; TAS:ProtInc
Q9Y2M5	KLHL20	Kelch-like protein 20	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q9Y2M5	KLHL20	Kelch-like protein 20	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9Y2M5	KLHL20	Kelch-like protein 20	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q9Y2M5	KLHL20	Kelch-like protein 20	GO:0035455; P:response to interferon-alpha; TAS:UniProtKB
Q9UJP4	KLHL21	Kelch-like protein 21	GO:0035853; P:chromosome passenger complex localization to spindle midzone; IMP:UniProtKB
Q9UJP4	KLHL21	Kelch-like protein 21	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9UJP4	KLHL21	Kelch-like protein 21	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q9UJP4	KLHL21	Kelch-like protein 21	GO:0032465; P:regulation of cytokinesis; IMP:UniProtKB
Q53GT1	KLHL22	Kelch-like protein 22	GO:0005515; F:protein binding; IPI:UniProtKB
Q53GT1	KLHL22	Kelch-like protein 22	GO:0051301; P:cell division; IMP:UniProtKB
Q53GT1	KLHL22	Kelch-like protein 22	GO:0000070; P:mitotic sister chromatid segregation; IMP:UniProtKB
Q53GT1	KLHL22	Kelch-like protein 22	GO:0007094; P:mitotic spindle assembly checkpoint; IMP:UniProtKB
Q53GT1	KLHL22	Kelch-like protein 22	GO:0006513; P:protein monoubiquitination; IDA:UniProtKB
Q9H0H3	KLHL25	Kelch-like protein 25	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q9H0H3	KLHL25	Kelch-like protein 25	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9H0H3	KLHL25	Kelch-like protein 25	GO:0006446; P:regulation of translational initiation; IDA:UniProtKB
Q9H511	KLHL31	Kelch-like protein 31	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H511	KLHL31	Kelch-like protein 31	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N4N3	KLHL36	Kelch-like protein 36	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q2WGJ6	KLHL38	Kelch-like protein 38	GO:0005515; F:protein binding; IPI:IntAct
Q2TBA0	KLHL40	Kelch-like protein 40	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
O60662	KLHL41	Kelch-like protein 41	GO:0005515; F:protein binding; IPI:IntAct
O60662	KLHL41	Kelch-like protein 41	GO:0030239; P:myofibril assembly; ISS:UniProtKB
O60662	KLHL41	Kelch-like protein 41	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
O60662	KLHL41	Kelch-like protein 41	GO:0031275; P:regulation of lateral pseudopodium assembly; IEA:Ensembl
O60662	KLHL41	Kelch-like protein 41	GO:0045661; P:regulation of myoblast differentiation; ISS:UniProtKB
O60662	KLHL41	Kelch-like protein 41	GO:2000291; P:regulation of myoblast proliferation; ISS:UniProtKB
O60662	KLHL41	Kelch-like protein 41	GO:2001014; P:regulation of skeletal muscle cell differentiation; IEA:Ensembl
O60662	KLHL41	Kelch-like protein 41	GO:0035914; P:skeletal muscle cell differentiation; ISS:UniProtKB
O60662	KLHL41	Kelch-like protein 41	GO:0006941; P:striated muscle contraction; TAS:ProtInc
Q9P2K6	KLHL42	Kelch-like protein 42	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P2K6	KLHL42	Kelch-like protein 42	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9P2K6	KLHL42	Kelch-like protein 42	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9P2K6	KLHL42	Kelch-like protein 42	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q9P2K6	KLHL42	Kelch-like protein 42	GO:0032886; P:regulation of microtubule-based process; IMP:UniProtKB
Q9NR64	KLHL1	Kelch-like protein 1	GO:0003779; F:actin binding; NAS:UniProtKB
Q9NR64	KLHL1	Kelch-like protein 1	GO:0030036; P:actin cytoskeleton organization; NAS:UniProtKB
Q9NR64	KLHL1	Kelch-like protein 1	GO:0007628; P:adult walking behavior; IEA:Ensembl
Q9NR64	KLHL1	Kelch-like protein 1	GO:0021680; P:cerebellar Purkinje cell layer development; IEA:Ensembl
Q9NR64	KLHL1	Kelch-like protein 1	GO:0016358; P:dendrite development; IEA:Ensembl
O95198	KLHL2	Kelch-like protein 2	GO:0003779; F:actin binding; IDA:UniProtKB
O95198	KLHL2	Kelch-like protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
O95198	KLHL2	Kelch-like protein 2	GO:0016567; P:protein ubiquitination; ISS:UniProtKB
Q9UH77	KLHL3	Kelch-like protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UH77	KLHL3	Kelch-like protein 3	GO:0005198; F:structural molecule activity; TAS:ProtInc
Q9UH77	KLHL3	Kelch-like protein 3	GO:0072156; P:distal tubule morphogenesis; IMP:UniProtKB
Q9UH77	KLHL3	Kelch-like protein 3	GO:0050801; P:ion homeostasis; IMP:UniProtKB
Q9UH77	KLHL3	Kelch-like protein 3	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
Q9UH77	KLHL3	Kelch-like protein 3	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q9UH77	KLHL3	Kelch-like protein 3	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9UH77	KLHL3	Kelch-like protein 3	GO:0070294; P:renal sodium ion absorption; IMP:UniProtKB
Q8WZ60	KLHL6	Kelch-like protein 6	GO:0050853; P:B cell receptor signaling pathway; IEA:Ensembl
Q8WZ60	KLHL6	Kelch-like protein 6	GO:0002467; P:germinal center formation; IEA:Ensembl
Q8IXQ5	KLHL7	Kelch-like protein 7	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q8IXQ5	KLHL7	Kelch-like protein 7	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q9P2G9	KLHL8	Kelch-like protein 8	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q9P2G9	KLHL8	Kelch-like protein 8	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9P2J3	KLHL9	Kelch-like protein 9	GO:0000910; P:cytokinesis; IMP:UniProtKB
Q9P2J3	KLHL9	Kelch-like protein 9	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9P2J3	KLHL9	Kelch-like protein 9	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
O43240	KLK10	Kallikrein-10	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
O43240	KLK10	Kallikrein-10	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
O43240	KLK10	Kallikrein-10	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9UBX7	KLK11	Kallikrein-11	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q9UBX7	KLK11	Kallikrein-11	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
Q9UKR0	KLK12	Kallikrein-12	GO:0008233; F:peptidase activity; IDA:UniProtKB
Q9UKR0	KLK12	Kallikrein-12	GO:0004252; F:serine-type endopeptidase activity; NAS:UniProtKB
Q9UKR0	KLK12	Kallikrein-12	GO:0008236; F:serine-type peptidase activity; IDA:UniProtKB
Q9UKR0	KLK12	Kallikrein-12	GO:0006508; P:proteolysis; IDA:UniProtKB
Q9UKR3	KLK13	Kallikrein-13	GO:0016787; F:hydrolase activity; IDA:UniProtKB
Q9UKR3	KLK13	Kallikrein-13	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKR3	KLK13	Kallikrein-13	GO:0004252; F:serine-type endopeptidase activity; NAS:UniProtKB
Q9UKR3	KLK13	Kallikrein-13	GO:0006508; P:proteolysis; NAS:UniProtKB
Q9P0G3	KLK14	Kallikrein-14	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
Q9P0G3	KLK14	Kallikrein-14	GO:0048730; P:epidermis morphogenesis; IDA:UniProtKB
Q9P0G3	KLK14	Kallikrein-14	GO:0009566; P:fertilization; IDA:UniProtKB
Q9P0G3	KLK14	Kallikrein-14	GO:0045744; P:negative regulation of G-protein coupled receptor protein signaling pathway; IDA:UniProtKB
Q9P0G3	KLK14	Kallikrein-14	GO:0045745; P:positive regulation of G-protein coupled receptor protein signaling pathway; IDA:UniProtKB
Q9P0G3	KLK14	Kallikrein-14	GO:0006508; P:proteolysis; IDA:UniProtKB
Q9P0G3	KLK14	Kallikrein-14	GO:0070684; P:seminal clot liquefaction; IDA:UniProtKB
Q9H2R5	KLK15	Kallikrein-15	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q9H2R5	KLK15	Kallikrein-15	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
P06870	KLK1	Kallikrein-1	GO:0004252; F:serine-type endopeptidase activity; NAS:UniProtKB
P20151	KLK2	Kallikrein-2	GO:0004252; F:serine-type endopeptidase activity; IDA:BHF-UCL
P20151	KLK2	Kallikrein-2	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P20151	KLK2	Kallikrein-2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P07288	KLK3	Prostate-specific antigen	GO:0005515; F:protein binding; IPI:UniProtKB
P07288	KLK3	Prostate-specific antigen	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
P07288	KLK3	Prostate-specific antigen	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
P07288	KLK3	Prostate-specific antigen	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P07288	KLK3	Prostate-specific antigen	GO:0016525; P:negative regulation of angiogenesis; NAS:UniProtKB
Q9Y5K2	KLK4	Kallikrein-4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y5K2	KLK4	Kallikrein-4	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q9Y5K2	KLK4	Kallikrein-4	GO:0008236; F:serine-type peptidase activity; NAS:UniProtKB
Q9Y5K2	KLK4	Kallikrein-4	GO:0097186; P:amelogenesis; IMP:UniProtKB
Q9Y5K2	KLK4	Kallikrein-4	GO:0006508; P:proteolysis; NAS:UniProtKB
Q9Y337	KLK5	Kallikrein-5	GO:0008233; F:peptidase activity; TAS:ProtInc
Q9Y337	KLK5	Kallikrein-5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y337	KLK5	Kallikrein-5	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
Q9Y337	KLK5	Kallikrein-5	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
Q9Y337	KLK5	Kallikrein-5	GO:0008544; P:epidermis development; TAS:ProtInc
Q9Y337	KLK5	Kallikrein-5	GO:0045745; P:positive regulation of G-protein coupled receptor protein signaling pathway; IDA:UniProtKB
P49862	KLK7	Kallikrein-7	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
P49862	KLK7	Kallikrein-7	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
P49862	KLK7	Kallikrein-7	GO:0008544; P:epidermis development; TAS:ProtInc
P49862	KLK7	Kallikrein-7	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P49862	KLK7	Kallikrein-7	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q92876	KLK6	Kallikrein-6	GO:0005515; F:protein binding; IPI:UniProtKB
Q92876	KLK6	Kallikrein-6	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
Q92876	KLK6	Kallikrein-6	GO:0042982; P:amyloid precursor protein metabolic process; NAS:UniProtKB
Q92876	KLK6	Kallikrein-6	GO:0007417; P:central nervous system development; NAS:UniProtKB
Q92876	KLK6	Kallikrein-6	GO:0030574; P:collagen catabolic process; NAS:UniProtKB
Q92876	KLK6	Kallikrein-6	GO:0042445; P:hormone metabolic process; NAS:UniProtKB
Q92876	KLK6	Kallikrein-6	GO:0042552; P:myelination; NAS:UniProtKB
Q92876	KLK6	Kallikrein-6	GO:0070997; P:neuron death; IMP:UniProt
Q92876	KLK6	Kallikrein-6	GO:0045745; P:positive regulation of G-protein coupled receptor protein signaling pathway; IDA:UniProtKB
Q92876	KLK6	Kallikrein-6	GO:0016540; P:protein autoprocessing; NAS:UniProtKB
Q92876	KLK6	Kallikrein-6	GO:0006508; P:proteolysis; IBA:RefGenome
Q92876	KLK6	Kallikrein-6	GO:0045595; P:regulation of cell differentiation; NAS:UniProtKB
Q92876	KLK6	Kallikrein-6	GO:0010975; P:regulation of neuron projection development; IEA:Ensembl
Q92876	KLK6	Kallikrein-6	GO:0009611; P:response to wounding; NAS:UniProtKB
Q92876	KLK6	Kallikrein-6	GO:0042246; P:tissue regeneration; NAS:UniProtKB
O60259	KLK8	Kallikrein-8	GO:0005515; F:protein binding; IPI:UniProtKB
O60259	KLK8	Kallikrein-8	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
O60259	KLK8	Kallikrein-8	GO:0008219; P:cell death; ISS:UniProtKB
O60259	KLK8	Kallikrein-8	GO:0043616; P:keratinocyte proliferation; ISS:UniProtKB
O60259	KLK8	Kallikrein-8	GO:0007613; P:memory; ISS:UniProtKB
O60259	KLK8	Kallikrein-8	GO:0048681; P:negative regulation of axon regeneration; ISS:UniProtKB
O60259	KLK8	Kallikrein-8	GO:0031642; P:negative regulation of myelination; ISS:UniProtKB
O60259	KLK8	Kallikrein-8	GO:0048812; P:neuron projection morphogenesis; ISS:UniProtKB
O60259	KLK8	Kallikrein-8	GO:0050807; P:regulation of synapse organization; ISS:UniProtKB
O60259	KLK8	Kallikrein-8	GO:0009611; P:response to wounding; ISS:UniProtKB
O60259	KLK8	Kallikrein-8	GO:0050808; P:synapse organization; IEA:Ensembl
Q9UKQ9	KLK9	Kallikrein-9	GO:0004252; F:serine-type endopeptidase activity; NAS:UniProtKB
P03952	KLKB1	Plasma kallikrein	GO:0005515; F:protein binding; IPI:UniProtKB
P03952	KLKB1	Plasma kallikrein	GO:0004252; F:serine-type endopeptidase activity; TAS:ProtInc
P03952	KLKB1	Plasma kallikrein	GO:0007596; P:blood coagulation; TAS:Reactome
P03952	KLKB1	Plasma kallikrein	GO:0007597; P:blood coagulation, intrinsic pathway; TAS:Reactome
P03952	KLKB1	Plasma kallikrein	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P03952	KLKB1	Plasma kallikrein	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P03952	KLKB1	Plasma kallikrein	GO:0002542; P:Factor XII activation; TAS:BHF-UCL
P03952	KLKB1	Plasma kallikrein	GO:0042730; P:fibrinolysis; IEA:UniProtKB-KW
P03952	KLKB1	Plasma kallikrein	GO:0031639; P:plasminogen activation; IDA:BHF-UCL
P03952	KLKB1	Plasma kallikrein	GO:0051919; P:positive regulation of fibrinolysis; IDA:BHF-UCL
P03952	KLKB1	Plasma kallikrein	GO:0006508; P:proteolysis; TAS:ProtInc
P03952	KLKB1	Plasma kallikrein	GO:0031638; P:zymogen activation; TAS:BHF-UCL
Q86Z14	KLB	Beta-klotho	GO:0017134; F:fibroblast growth factor binding; IPI:UniProtKB
Q86Z14	KLB	Beta-klotho	GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro
Q86Z14	KLB	Beta-klotho	GO:0005515; F:protein binding; IPI:IntAct
Q86Z14	KLB	Beta-klotho	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q86Z14	KLB	Beta-klotho	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q86Z14	KLB	Beta-klotho	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q86Z14	KLB	Beta-klotho	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q86Z14	KLB	Beta-klotho	GO:0045087; P:innate immune response; TAS:Reactome
Q86Z14	KLB	Beta-klotho	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q86Z14	KLB	Beta-klotho	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q86Z14	KLB	Beta-klotho	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q86Z14	KLB	Beta-klotho	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q86Z14	KLB	Beta-klotho	GO:0090080; P:positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway; IEA:Ensembl
Q9UEF7	KL	Klotho	GO:0008422; F:beta-glucosidase activity; TAS:ProtInc
Q9UEF7	KL	Klotho	GO:0004566; F:beta-glucuronidase activity; IEA:UniProtKB-EC
Q9UEF7	KL	Klotho	GO:0017134; F:fibroblast growth factor binding; IPI:UniProtKB
Q9UEF7	KL	Klotho	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q9UEF7	KL	Klotho	GO:0005499; F:vitamin D binding; IEA:UniProtKB-KW
Q9UEF7	KL	Klotho	GO:0002526; P:acute inflammatory response; IEA:Ensembl
Q9UEF7	KL	Klotho	GO:0007568; P:aging; IMP:UniProtKB
Q9UEF7	KL	Klotho	GO:0055074; P:calcium ion homeostasis; IEA:Ensembl
Q9UEF7	KL	Klotho	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q9UEF7	KL	Klotho	GO:0006112; P:energy reserve metabolic process; IEA:Ensembl
Q9UEF7	KL	Klotho	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q9UEF7	KL	Klotho	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9UEF7	KL	Klotho	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q9UEF7	KL	Klotho	GO:0045087; P:innate immune response; TAS:Reactome
Q9UEF7	KL	Klotho	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q9UEF7	KL	Klotho	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9UEF7	KL	Klotho	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q9UEF7	KL	Klotho	GO:0030501; P:positive regulation of bone mineralization; IMP:UniProtKB
Q9UEF7	KL	Klotho	GO:0090080; P:positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway; IEA:Ensembl
Q12918	KLRB1	Killer cell lectin-like receptor subfamily B member 1	GO:0030246; F:carbohydrate binding; TAS:ProtInc
Q12918	KLRB1	Killer cell lectin-like receptor subfamily B member 1	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q12918	KLRB1	Killer cell lectin-like receptor subfamily B member 1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q13241	KLRD1	Natural killer cells antigen CD94	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q13241	KLRD1	Natural killer cells antigen CD94	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q13241	KLRD1	Natural killer cells antigen CD94	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q13241	KLRD1	Natural killer cells antigen CD94	GO:0045087; P:innate immune response; TAS:Reactome
Q13241	KLRD1	Natural killer cells antigen CD94	GO:0050776; P:regulation of immune response; TAS:Reactome
Q9NZS2	KLRF1	Killer cell lectin-like receptor subfamily F member 1	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q9NZS2	KLRF1	Killer cell lectin-like receptor subfamily F member 1	GO:0032393; F:MHC class I receptor activity; TAS:UniProtKB
Q9NZS2	KLRF1	Killer cell lectin-like receptor subfamily F member 1	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q9NZS2	KLRF1	Killer cell lectin-like receptor subfamily F member 1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
D3W0D1	KLRF2	Killer cell lectin-like receptor subfamily F member 2	GO:0030246; F:carbohydrate binding; IEA:InterPro
D3W0D1	KLRF2	Killer cell lectin-like receptor subfamily F member 2	GO:0005515; F:protein binding; IPI:UniProtKB
D3W0D1	KLRF2	Killer cell lectin-like receptor subfamily F member 2	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
D3W0D1	KLRF2	Killer cell lectin-like receptor subfamily F member 2	GO:0050663; P:cytokine secretion; TAS:UniProtKB
D3W0D1	KLRF2	Killer cell lectin-like receptor subfamily F member 2	GO:0043320; P:natural killer cell degranulation; TAS:UniProtKB
Q96E93	KLRG1	Killer cell lectin-like receptor subfamily G member 1	GO:0030246; F:carbohydrate binding; TAS:ProtInc
Q96E93	KLRG1	Killer cell lectin-like receptor subfamily G member 1	GO:0004872; F:receptor activity; TAS:ProtInc
Q96E93	KLRG1	Killer cell lectin-like receptor subfamily G member 1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q96E93	KLRG1	Killer cell lectin-like receptor subfamily G member 1	GO:0006968; P:cellular defense response; TAS:ProtInc
Q96E93	KLRG1	Killer cell lectin-like receptor subfamily G member 1	GO:0006954; P:inflammatory response; TAS:ProtInc
Q96E93	KLRG1	Killer cell lectin-like receptor subfamily G member 1	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q96E93	KLRG1	Killer cell lectin-like receptor subfamily G member 1	GO:0050776; P:regulation of immune response; TAS:Reactome
A4D1S0	KLRG2	Killer cell lectin-like receptor subfamily G member 2	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q5SVS4	SLC25A30	Kidney mitochondrial carrier protein 1	GO:0006839; P:mitochondrial transport; IEA:InterPro
O15229	KMO	Kynurenine 3-monooxygenase	GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB
O15229	KMO	Kynurenine 3-monooxygenase	GO:0004502; F:kynurenine 3-monooxygenase activity; IDA:UniProtKB
O15229	KMO	Kynurenine 3-monooxygenase	GO:0016174; F:NAD(P)H oxidase activity; IDA:UniProtKB
O15229	KMO	Kynurenine 3-monooxygenase	GO:0034354; P:'de novo' NAD biosynthetic process from tryptophan; IEA:UniProtKB-HAMAP
O15229	KMO	Kynurenine 3-monooxygenase	GO:0043420; P:anthranilate metabolic process; IEA:UniProtKB-HAMAP
O15229	KMO	Kynurenine 3-monooxygenase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
O15229	KMO	Kynurenine 3-monooxygenase	GO:0070189; P:kynurenine metabolic process; IDA:UniProtKB
O15229	KMO	Kynurenine 3-monooxygenase	GO:0019805; P:quinolinate biosynthetic process; IEA:UniProtKB-HAMAP
O15229	KMO	Kynurenine 3-monooxygenase	GO:0009651; P:response to salt stress; IDA:UniProtKB
O15229	KMO	Kynurenine 3-monooxygenase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15229	KMO	Kynurenine 3-monooxygenase	GO:0006569; P:tryptophan catabolic process; TAS:Reactome
O15229	KMO	Kynurenine 3-monooxygenase	GO:0019441; P:tryptophan catabolic process to kynurenine; IEA:Ensembl
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0003680; F:AT DNA binding; NAS:UniProtKB
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0003682; F:chromatin binding; IEA:Ensembl
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0070577; F:lysine-acetylated histone binding; IDA:UniProtKB
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0042800; F:histone methyltransferase activity (H3-K4 specific); IDA:UniProtKB
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0042802; F:identical protein binding; IPI:IntAct
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0005515; F:protein binding; IPI:IntAct
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0045322; F:unmethylated CpG binding; IDA:UniProtKB
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0006306; P:DNA methylation; IEA:Ensembl
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0035162; P:embryonic hemopoiesis; TAS:UniProtKB
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0051568; P:histone H3-K4 methylation; IDA:UniProtKB
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0080182; P:histone H3-K4 trimethylation; IDA:BHF-UCL
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0043984; P:histone H4-K16 acetylation; IMP:UniProtKB
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:2001040; P:positive regulation of cellular response to drug; IMP:BHF-UCL
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0032411; P:positive regulation of transporter activity; IMP:BHF-UCL
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0006461; P:protein complex assembly; IDA:UniProtKB
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0051569; P:regulation of histone H3-K4 methylation; IEA:Ensembl
Q03164	KMT2A	Histone-lysine N-methyltransferase 2A	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9UMN6	KMT2B	Histone-lysine N-methyltransferase 2B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UMN6	KMT2B	Histone-lysine N-methyltransferase 2B	GO:0042800; F:histone methyltransferase activity (H3-K4 specific); IDA:MGI
Q9UMN6	KMT2B	Histone-lysine N-methyltransferase 2B	GO:0005515; F:protein binding; IPI:IntAct
Q9UMN6	KMT2B	Histone-lysine N-methyltransferase 2B	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9UMN6	KMT2B	Histone-lysine N-methyltransferase 2B	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UMN6	KMT2B	Histone-lysine N-methyltransferase 2B	GO:0048096; P:chromatin-mediated maintenance of transcription; NAS:UniProtKB
Q9UMN6	KMT2B	Histone-lysine N-methyltransferase 2B	GO:0016458; P:gene silencing; IEA:Ensembl
Q9UMN6	KMT2B	Histone-lysine N-methyltransferase 2B	GO:0051568; P:histone H3-K4 methylation; IMP:UniProtKB
Q9UMN6	KMT2B	Histone-lysine N-methyltransferase 2B	GO:0080182; P:histone H3-K4 trimethylation; IEA:Ensembl
Q9UMN6	KMT2B	Histone-lysine N-methyltransferase 2B	GO:0009994; P:oocyte differentiation; IEA:Ensembl
Q9UMN6	KMT2B	Histone-lysine N-methyltransferase 2B	GO:0001541; P:ovarian follicle development; IEA:Ensembl
Q9UMN6	KMT2B	Histone-lysine N-methyltransferase 2B	GO:0030728; P:ovulation; IEA:Ensembl
Q9UMN6	KMT2B	Histone-lysine N-methyltransferase 2B	GO:0051569; P:regulation of histone H3-K4 methylation; IEA:Ensembl
Q9UMN6	KMT2B	Histone-lysine N-methyltransferase 2B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NEZ4	KMT2C	Histone-lysine N-methyltransferase 2C	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NEZ4	KMT2C	Histone-lysine N-methyltransferase 2C	GO:0042800; F:histone methyltransferase activity (H3-K4 specific); IDA:MGI
Q8NEZ4	KMT2C	Histone-lysine N-methyltransferase 2C	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8NEZ4	KMT2C	Histone-lysine N-methyltransferase 2C	GO:0005515; F:protein binding; IPI:IntAct
Q8NEZ4	KMT2C	Histone-lysine N-methyltransferase 2C	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8NEZ4	KMT2C	Histone-lysine N-methyltransferase 2C	GO:0051568; P:histone H3-K4 methylation; IDA:GOC
Q8NEZ4	KMT2C	Histone-lysine N-methyltransferase 2C	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8NEZ4	KMT2C	Histone-lysine N-methyltransferase 2C	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NEZ4	KMT2C	Histone-lysine N-methyltransferase 2C	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O14686	KMT2D	Histone-lysine N-methyltransferase 2D	GO:0003677; F:DNA binding; NAS:UniProtKB
O14686	KMT2D	Histone-lysine N-methyltransferase 2D	GO:0018024; F:histone-lysine N-methyltransferase activity; IEA:UniProtKB-EC
O14686	KMT2D	Histone-lysine N-methyltransferase 2D	GO:0005515; F:protein binding; IPI:IntAct
O14686	KMT2D	Histone-lysine N-methyltransferase 2D	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
O14686	KMT2D	Histone-lysine N-methyltransferase 2D	GO:0008270; F:zinc ion binding; IEA:InterPro
O14686	KMT2D	Histone-lysine N-methyltransferase 2D	GO:0006342; P:chromatin silencing; ISS:UniProtKB
O14686	KMT2D	Histone-lysine N-methyltransferase 2D	GO:0051568; P:histone H3-K4 methylation; ISS:UniProtKB
O14686	KMT2D	Histone-lysine N-methyltransferase 2D	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O14686	KMT2D	Histone-lysine N-methyltransferase 2D	GO:0001555; P:oocyte growth; ISS:UniProtKB
O14686	KMT2D	Histone-lysine N-methyltransferase 2D	GO:0048477; P:oogenesis; ISS:UniProtKB
O14686	KMT2D	Histone-lysine N-methyltransferase 2D	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
O14686	KMT2D	Histone-lysine N-methyltransferase 2D	GO:0033148; P:positive regulation of intracellular estrogen receptor signaling pathway; IMP:UniProtKB
O14686	KMT2D	Histone-lysine N-methyltransferase 2D	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
O14686	KMT2D	Histone-lysine N-methyltransferase 2D	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
O14686	KMT2D	Histone-lysine N-methyltransferase 2D	GO:0043627; P:response to estrogen; IDA:UniProtKB
O14686	KMT2D	Histone-lysine N-methyltransferase 2D	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IZD2	KMT2E	Histone-lysine N-methyltransferase 2E	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q8IZD2	KMT2E	Histone-lysine N-methyltransferase 2E	GO:0042800; F:histone methyltransferase activity (H3-K4 specific); IDA:UniProtKB
Q8IZD2	KMT2E	Histone-lysine N-methyltransferase 2E	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IZD2	KMT2E	Histone-lysine N-methyltransferase 2E	GO:0003713; F:transcription coactivator activity; IMP:UniProtKB
Q8IZD2	KMT2E	Histone-lysine N-methyltransferase 2E	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IZD2	KMT2E	Histone-lysine N-methyltransferase 2E	GO:0007050; P:cell cycle arrest; IEA:UniProtKB-KW
Q8IZD2	KMT2E	Histone-lysine N-methyltransferase 2E	GO:0071300; P:cellular response to retinoic acid; IDA:BHF-UCL
Q8IZD2	KMT2E	Histone-lysine N-methyltransferase 2E	GO:0006306; P:DNA methylation; ISS:UniProtKB
Q8IZD2	KMT2E	Histone-lysine N-methyltransferase 2E	GO:0030218; P:erythrocyte differentiation; ISS:UniProtKB
Q8IZD2	KMT2E	Histone-lysine N-methyltransferase 2E	GO:0051568; P:histone H3-K4 methylation; IDA:BHF-UCL
Q8IZD2	KMT2E	Histone-lysine N-methyltransferase 2E	GO:0042119; P:neutrophil activation; ISS:UniProtKB
Q8IZD2	KMT2E	Histone-lysine N-methyltransferase 2E	GO:0002446; P:neutrophil mediated immunity; ISS:UniProtKB
Q8IZD2	KMT2E	Histone-lysine N-methyltransferase 2E	GO:0030854; P:positive regulation of granulocyte differentiation; IMP:BHF-UCL
Q8IZD2	KMT2E	Histone-lysine N-methyltransferase 2E	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q8IZD2	KMT2E	Histone-lysine N-methyltransferase 2E	GO:0048384; P:retinoic acid receptor signaling pathway; IMP:UniProtKB
Q8IZD2	KMT2E	Histone-lysine N-methyltransferase 2E	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P01042	KNG1	Kininogen-1	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IDA:UniProt
P01042	KNG1	Kininogen-1	GO:0008201; F:heparin binding; NAS:UniProtKB
P01042	KNG1	Kininogen-1	GO:0005515; F:protein binding; IPI:IntAct
P01042	KNG1	Kininogen-1	GO:0005102; F:receptor binding; IPI:UniProtKB
P01042	KNG1	Kininogen-1	GO:0008270; F:zinc ion binding; NAS:UniProtKB
P01042	KNG1	Kininogen-1	GO:0007596; P:blood coagulation; TAS:Reactome
P01042	KNG1	Kininogen-1	GO:0007597; P:blood coagulation, intrinsic pathway; TAS:Reactome
P01042	KNG1	Kininogen-1	GO:0006954; P:inflammatory response; TAS:UniProtKB
P01042	KNG1	Kininogen-1	GO:0030195; P:negative regulation of blood coagulation; IDA:UniProtKB
P01042	KNG1	Kininogen-1	GO:0007162; P:negative regulation of cell adhesion; IDA:UniProtKB
P01042	KNG1	Kininogen-1	GO:0010951; P:negative regulation of endopeptidase activity; IDA:GOC
P01042	KNG1	Kininogen-1	GO:0045861; P:negative regulation of proteolysis; IDA:UniProt
P01042	KNG1	Kininogen-1	GO:0030168; P:platelet activation; TAS:Reactome
P01042	KNG1	Kininogen-1	GO:0002576; P:platelet degranulation; TAS:Reactome
P01042	KNG1	Kininogen-1	GO:0043065; P:positive regulation of apoptotic process; NAS:UniProtKB
P01042	KNG1	Kininogen-1	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB
P01042	KNG1	Kininogen-1	GO:0035815; P:positive regulation of renal sodium excretion; TAS:UniProtKB
P01042	KNG1	Kininogen-1	GO:0035810; P:positive regulation of urine volume; TAS:UniProtKB
P01042	KNG1	Kininogen-1	GO:0006939; P:smooth muscle contraction; TAS:UniProtKB
P01042	KNG1	Kininogen-1	GO:0042311; P:vasodilation; IEA:UniProtKB-KW
Q1ED39	KNOP1	Lysine-rich nucleolar protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P50748	KNTC1	Kinetochore-associated protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P50748	KNTC1	Kinetochore-associated protein 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P50748	KNTC1	Kinetochore-associated protein 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P50748	KNTC1	Kinetochore-associated protein 1	GO:0007093; P:mitotic cell cycle checkpoint; IDA:UniProtKB
P50748	KNTC1	Kinetochore-associated protein 1	GO:0006461; P:protein complex assembly; NAS:UniProtKB
P50748	KNTC1	Kinetochore-associated protein 1	GO:0007096; P:regulation of exit from mitosis; NAS:UniProtKB
P46020	PHKA1	Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform	GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro
P46020	PHKA1	Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform	GO:0004689; F:phosphorylase kinase activity; TAS:ProtInc
P46020	PHKA1	Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P46020	PHKA1	Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P46020	PHKA1	Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform	GO:0006006; P:glucose metabolic process; TAS:Reactome
P46020	PHKA1	Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform	GO:0005980; P:glycogen catabolic process; TAS:Reactome
P46020	PHKA1	Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform	GO:0005977; P:glycogen metabolic process; TAS:ProtInc
P46020	PHKA1	Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform	GO:0006468; P:protein phosphorylation; TAS:GOC
P46020	PHKA1	Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P46019	PHKA2	Phosphorylase b kinase regulatory subunit alpha, liver isoform	GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro
P46019	PHKA2	Phosphorylase b kinase regulatory subunit alpha, liver isoform	GO:0004689; F:phosphorylase kinase activity; TAS:ProtInc
P46019	PHKA2	Phosphorylase b kinase regulatory subunit alpha, liver isoform	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P46019	PHKA2	Phosphorylase b kinase regulatory subunit alpha, liver isoform	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P46019	PHKA2	Phosphorylase b kinase regulatory subunit alpha, liver isoform	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P46019	PHKA2	Phosphorylase b kinase regulatory subunit alpha, liver isoform	GO:0006006; P:glucose metabolic process; TAS:Reactome
P46019	PHKA2	Phosphorylase b kinase regulatory subunit alpha, liver isoform	GO:0005980; P:glycogen catabolic process; TAS:Reactome
P46019	PHKA2	Phosphorylase b kinase regulatory subunit alpha, liver isoform	GO:0006468; P:protein phosphorylation; TAS:GOC
P46019	PHKA2	Phosphorylase b kinase regulatory subunit alpha, liver isoform	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q93100	PHKB	Phosphorylase b kinase regulatory subunit beta	GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro
Q93100	PHKB	Phosphorylase b kinase regulatory subunit beta	GO:0004689; F:phosphorylase kinase activity; IEA:Ensembl
Q93100	PHKB	Phosphorylase b kinase regulatory subunit beta	GO:0005515; F:protein binding; IPI:IntAct
Q93100	PHKB	Phosphorylase b kinase regulatory subunit beta	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q93100	PHKB	Phosphorylase b kinase regulatory subunit beta	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
Q93100	PHKB	Phosphorylase b kinase regulatory subunit beta	GO:0006006; P:glucose metabolic process; TAS:Reactome
Q93100	PHKB	Phosphorylase b kinase regulatory subunit beta	GO:0005980; P:glycogen catabolic process; TAS:Reactome
Q93100	PHKB	Phosphorylase b kinase regulatory subunit beta	GO:0005977; P:glycogen metabolic process; TAS:ProtInc
Q93100	PHKB	Phosphorylase b kinase regulatory subunit beta	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P17252	PRKCA	Protein kinase C alpha type	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P17252	PRKCA	Protein kinase C alpha type	GO:0004698; F:calcium-dependent protein kinase C activity; IEA:Ensembl
P17252	PRKCA	Protein kinase C alpha type	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P17252	PRKCA	Protein kinase C alpha type	GO:0035403; F:histone kinase activity (H3-T6 specific); IDA:UniProtKB
P17252	PRKCA	Protein kinase C alpha type	GO:0005515; F:protein binding; IPI:UniProtKB
P17252	PRKCA	Protein kinase C alpha type	GO:0004672; F:protein kinase activity; IDA:UniProtKB
P17252	PRKCA	Protein kinase C alpha type	GO:0004697; F:protein kinase C activity; ISS:BHF-UCL
P17252	PRKCA	Protein kinase C alpha type	GO:0008270; F:zinc ion binding; IEA:InterPro
P17252	PRKCA	Protein kinase C alpha type	GO:0007190; P:activation of adenylate cyclase activity; ISS:BHF-UCL
P17252	PRKCA	Protein kinase C alpha type	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
P17252	PRKCA	Protein kinase C alpha type	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P17252	PRKCA	Protein kinase C alpha type	GO:0097190; P:apoptotic signaling pathway; TAS:ProtInc
P17252	PRKCA	Protein kinase C alpha type	GO:0007596; P:blood coagulation; TAS:Reactome
P17252	PRKCA	Protein kinase C alpha type	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P17252	PRKCA	Protein kinase C alpha type	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
P17252	PRKCA	Protein kinase C alpha type	GO:0071322; P:cellular response to carbohydrate stimulus; IEA:Ensembl
P17252	PRKCA	Protein kinase C alpha type	GO:0002062; P:chondrocyte differentiation; IEA:Ensembl
P17252	PRKCA	Protein kinase C alpha type	GO:0002159; P:desmosome assembly; IMP:BHF-UCL
P17252	PRKCA	Protein kinase C alpha type	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P17252	PRKCA	Protein kinase C alpha type	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P17252	PRKCA	Protein kinase C alpha type	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P17252	PRKCA	Protein kinase C alpha type	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P17252	PRKCA	Protein kinase C alpha type	GO:0010467; P:gene expression; TAS:Reactome
P17252	PRKCA	Protein kinase C alpha type	GO:0035408; P:histone H3-T6 phosphorylation; IDA:UniProtKB
P17252	PRKCA	Protein kinase C alpha type	GO:0000188; P:inactivation of MAPK activity; IEA:Ensembl
P17252	PRKCA	Protein kinase C alpha type	GO:0050930; P:induction of positive chemotaxis; IEA:Ensembl
P17252	PRKCA	Protein kinase C alpha type	GO:0045087; P:innate immune response; TAS:Reactome
P17252	PRKCA	Protein kinase C alpha type	GO:0097193; P:intrinsic apoptotic signaling pathway; IEA:Ensembl
P17252	PRKCA	Protein kinase C alpha type	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P17252	PRKCA	Protein kinase C alpha type	GO:0007194; P:negative regulation of adenylate cyclase activity; ISS:BHF-UCL
P17252	PRKCA	Protein kinase C alpha type	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P17252	PRKCA	Protein kinase C alpha type	GO:0034351; P:negative regulation of glial cell apoptotic process; IMP:UniProtKB
P17252	PRKCA	Protein kinase C alpha type	GO:0046325; P:negative regulation of glucose import; IEA:Ensembl
P17252	PRKCA	Protein kinase C alpha type	GO:0046627; P:negative regulation of insulin receptor signaling pathway; IEA:Ensembl
P17252	PRKCA	Protein kinase C alpha type	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P17252	PRKCA	Protein kinase C alpha type	GO:0030593; P:neutrophil chemotaxis; IEA:Ensembl
P17252	PRKCA	Protein kinase C alpha type	GO:0036289; P:peptidyl-serine autophosphorylation; IEA:Ensembl
P17252	PRKCA	Protein kinase C alpha type	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P17252	PRKCA	Protein kinase C alpha type	GO:0030168; P:platelet activation; TAS:Reactome
P17252	PRKCA	Protein kinase C alpha type	GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB
P17252	PRKCA	Protein kinase C alpha type	GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IDA:DFLAT
P17252	PRKCA	Protein kinase C alpha type	GO:0010613; P:positive regulation of cardiac muscle hypertrophy; ISS:UniProtKB
P17252	PRKCA	Protein kinase C alpha type	GO:0045785; P:positive regulation of cell adhesion; IMP:UniProtKB
P17252	PRKCA	Protein kinase C alpha type	GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB
P17252	PRKCA	Protein kinase C alpha type	GO:2000707; P:positive regulation of dense core granule biogenesis; ISS:UniProtKB
P17252	PRKCA	Protein kinase C alpha type	GO:0010595; P:positive regulation of endothelial cell migration; IMP:UniProtKB
P17252	PRKCA	Protein kinase C alpha type	GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:UniProtKB
P17252	PRKCA	Protein kinase C alpha type	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
P17252	PRKCA	Protein kinase C alpha type	GO:0050729; P:positive regulation of inflammatory response; IEA:Ensembl
P17252	PRKCA	Protein kinase C alpha type	GO:0031666; P:positive regulation of lipopolysaccharide-mediated signaling pathway; IMP:UniProtKB
P17252	PRKCA	Protein kinase C alpha type	GO:0045651; P:positive regulation of macrophage differentiation; ISS:UniProtKB
P17252	PRKCA	Protein kinase C alpha type	GO:0045931; P:positive regulation of mitotic cell cycle; IMP:UniProtKB
P17252	PRKCA	Protein kinase C alpha type	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
P17252	PRKCA	Protein kinase C alpha type	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P17252	PRKCA	Protein kinase C alpha type	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P17252	PRKCA	Protein kinase C alpha type	GO:0006937; P:regulation of muscle contraction; IEA:Ensembl
P17252	PRKCA	Protein kinase C alpha type	GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
P17252	PRKCA	Protein kinase C alpha type	GO:0090330; P:regulation of platelet aggregation; IDA:UniProtKB
P17252	PRKCA	Protein kinase C alpha type	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
P17252	PRKCA	Protein kinase C alpha type	GO:0002026; P:regulation of the force of heart contraction; IEA:Ensembl
P17252	PRKCA	Protein kinase C alpha type	GO:0070555; P:response to interleukin-1; IMP:BHF-UCL
P17252	PRKCA	Protein kinase C alpha type	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
P17252	PRKCA	Protein kinase C alpha type	GO:0016070; P:RNA metabolic process; TAS:Reactome
P17252	PRKCA	Protein kinase C alpha type	GO:0007165; P:signal transduction; TAS:Reactome
P17252	PRKCA	Protein kinase C alpha type	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P17252	PRKCA	Protein kinase C alpha type	GO:0007268; P:synaptic transmission; TAS:Reactome
P05771	PRKCB	Protein kinase C beta type	GO:0050681; F:androgen receptor binding; IDA:UniProtKB
P05771	PRKCB	Protein kinase C beta type	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P05771	PRKCB	Protein kinase C beta type	GO:0005246; F:calcium channel regulator activity; IEA:Ensembl
P05771	PRKCB	Protein kinase C beta type	GO:0003682; F:chromatin binding; IDA:UniProtKB
P05771	PRKCB	Protein kinase C beta type	GO:0042393; F:histone binding; IDA:UniProtKB
P05771	PRKCB	Protein kinase C beta type	GO:0035403; F:histone kinase activity (H3-T6 specific); IDA:UniProtKB
P05771	PRKCB	Protein kinase C beta type	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IMP:UniProtKB
P05771	PRKCB	Protein kinase C beta type	GO:0005515; F:protein binding; IPI:IntAct
P05771	PRKCB	Protein kinase C beta type	GO:0004697; F:protein kinase C activity; TAS:ProtInc
P05771	PRKCB	Protein kinase C beta type	GO:0005080; F:protein kinase C binding; IPI:UniProtKB
P05771	PRKCB	Protein kinase C beta type	GO:0004674; F:protein serine/threonine kinase activity; TAS:Reactome
P05771	PRKCB	Protein kinase C beta type	GO:0008270; F:zinc ion binding; IEA:InterPro
P05771	PRKCB	Protein kinase C beta type	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P05771	PRKCB	Protein kinase C beta type	GO:0042113; P:B cell activation; ISS:UniProtKB
P05771	PRKCB	Protein kinase C beta type	GO:0050853; P:B cell receptor signaling pathway; ISS:UniProtKB
P05771	PRKCB	Protein kinase C beta type	GO:0007596; P:blood coagulation; TAS:Reactome
P05771	PRKCB	Protein kinase C beta type	GO:0006816; P:calcium ion transport; IEA:Ensembl
P05771	PRKCB	Protein kinase C beta type	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
P05771	PRKCB	Protein kinase C beta type	GO:0071322; P:cellular response to carbohydrate stimulus; IEA:Ensembl
P05771	PRKCB	Protein kinase C beta type	GO:0035408; P:histone H3-T6 phosphorylation; IDA:UniProtKB
P05771	PRKCB	Protein kinase C beta type	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P05771	PRKCB	Protein kinase C beta type	GO:0042953; P:lipoprotein transport; TAS:BHF-UCL
P05771	PRKCB	Protein kinase C beta type	GO:0010829; P:negative regulation of glucose transport; ISS:UniProtKB
P05771	PRKCB	Protein kinase C beta type	GO:0046627; P:negative regulation of insulin receptor signaling pathway; ISS:UniProtKB
P05771	PRKCB	Protein kinase C beta type	GO:0030168; P:platelet activation; TAS:Reactome
P05771	PRKCB	Protein kinase C beta type	GO:0045766; P:positive regulation of angiogenesis; ISS:UniProtKB
P05771	PRKCB	Protein kinase C beta type	GO:0050861; P:positive regulation of B cell receptor signaling pathway; ISS:UniProtKB
P05771	PRKCB	Protein kinase C beta type	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; ISS:UniProtKB
P05771	PRKCB	Protein kinase C beta type	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB
P05771	PRKCB	Protein kinase C beta type	GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; ISS:UniProtKB
P05771	PRKCB	Protein kinase C beta type	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P05771	PRKCB	Protein kinase C beta type	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
P05771	PRKCB	Protein kinase C beta type	GO:0007165; P:signal transduction; NAS:ProtInc
P05771	PRKCB	Protein kinase C beta type	GO:0007268; P:synaptic transmission; TAS:Reactome
P05771	PRKCB	Protein kinase C beta type	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0042802; F:identical protein binding; IPI:IntAct
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0004697; F:protein kinase C activity; IEA:UniProtKB-EC
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0004674; F:protein serine/threonine kinase activity; TAS:UniProtKB
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0008283; P:cell proliferation; TAS:ProtInc
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0034599; P:cellular response to oxidative stress; IDA:UniProtKB
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IMP:UniProtKB
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0007030; P:Golgi organization; IMP:UniProtKB
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0048193; P:Golgi vesicle transport; ISS:UniProtKB
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0007229; P:integrin-mediated signaling pathway; TAS:BHF-UCL
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0035556; P:intracellular signal transduction; IMP:BHF-UCL
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0060548; P:negative regulation of cell death; IMP:UniProtKB
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0045806; P:negative regulation of endocytosis; TAS:BHF-UCL
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IMP:BHF-UCL
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0032793; P:positive regulation of CREB transcription factor activity; IGI:BHF-UCL
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:2001028; P:positive regulation of endothelial cell chemotaxis; IMP:BHF-UCL
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0038033; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; IMP:BHF-UCL
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0010595; P:positive regulation of endothelial cell migration; IMP:UniProtKB
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0001938; P:positive regulation of endothelial cell proliferation; IGI:BHF-UCL
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:1901727; P:positive regulation of histone deacetylase activity; IGI:BHF-UCL
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0010976; P:positive regulation of neuron projection development; IMP:UniProtKB
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0045669; P:positive regulation of osteoblast differentiation; ISS:UniProtKB
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IGI:BHF-UCL
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0046777; P:protein autophosphorylation; TAS:BHF-UCL
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:2001044; P:regulation of integrin-mediated signaling pathway; TAS:BHF-UCL
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0010837; P:regulation of keratinocyte proliferation; ISS:UniProtKB
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0007165; P:signal transduction; TAS:ProtInc
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q15139	PRKD1	Serine/threonine-protein kinase D1	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IMP:BHF-UCL
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0004672; F:protein kinase activity; IDA:BHF-UCL
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0004697; F:protein kinase C activity; IEA:UniProtKB-EC
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0004674; F:protein serine/threonine kinase activity; NAS:UniProtKB
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0008219; P:cell death; IMP:BHF-UCL
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IMP:BHF-UCL
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0061154; P:endothelial tube morphogenesis; TAS:BHF-UCL
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0035556; P:intracellular signal transduction; IMP:BHF-UCL
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IMP:BHF-UCL
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0045785; P:positive regulation of cell adhesion; IMP:UniProtKB
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0032793; P:positive regulation of CREB transcription factor activity; IGI:BHF-UCL
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:2000573; P:positive regulation of DNA biosynthetic process; ISS:UniProtKB
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:2001028; P:positive regulation of endothelial cell chemotaxis; IMP:BHF-UCL
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0038033; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; IMP:BHF-UCL
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0010595; P:positive regulation of endothelial cell migration; IMP:UniProtKB
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:UniProtKB
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0045743; P:positive regulation of fibroblast growth factor receptor signaling pathway; IMP:UniProtKB
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:1901727; P:positive regulation of histone deacetylase activity; IGI:BHF-UCL
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0032743; P:positive regulation of interleukin-2 production; ISS:UniProtKB
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0032757; P:positive regulation of interleukin-8 production; IMP:UniProtKB
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:1902533; P:positive regulation of intracellular signal transduction; IMP:BHF-UCL
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IGI:BHF-UCL
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:UniProtKB
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0050862; P:positive regulation of T cell receptor signaling pathway; ISS:UniProtKB
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; IMP:UniProtKB
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0046777; P:protein autophosphorylation; IDA:BHF-UCL
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0006468; P:protein phosphorylation; NAS:UniProtKB
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0050852; P:T cell receptor signaling pathway; IDA:BHF-UCL
Q9BZL6	PRKD2	Serine/threonine-protein kinase D2	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IMP:BHF-UCL
O94806	PRKD3	Serine/threonine-protein kinase D3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O94806	PRKD3	Serine/threonine-protein kinase D3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O94806	PRKD3	Serine/threonine-protein kinase D3	GO:0005515; F:protein binding; IPI:IntAct
O94806	PRKD3	Serine/threonine-protein kinase D3	GO:0004697; F:protein kinase C activity; TAS:ProtInc
O94806	PRKD3	Serine/threonine-protein kinase D3	GO:0035556; P:intracellular signal transduction; IEA:InterPro
O94806	PRKD3	Serine/threonine-protein kinase D3	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; TAS:ProtInc
O94806	PRKD3	Serine/threonine-protein kinase D3	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q05655	PRKCD	Protein kinase C delta type	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q05655	PRKCD	Protein kinase C delta type	GO:0004699; F:calcium-independent protein kinase C activity; TAS:BHF-UCL
Q05655	PRKCD	Protein kinase C delta type	GO:0008047; F:enzyme activator activity; IDA:UniProtKB
Q05655	PRKCD	Protein kinase C delta type	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q05655	PRKCD	Protein kinase C delta type	GO:0043560; F:insulin receptor substrate binding; ISS:BHF-UCL
Q05655	PRKCD	Protein kinase C delta type	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q05655	PRKCD	Protein kinase C delta type	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC
Q05655	PRKCD	Protein kinase C delta type	GO:0005515; F:protein binding; IPI:UniProtKB
Q05655	PRKCD	Protein kinase C delta type	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q05655	PRKCD	Protein kinase C delta type	GO:0004697; F:protein kinase C activity; ISS:UniProtKB
Q05655	PRKCD	Protein kinase C delta type	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q05655	PRKCD	Protein kinase C delta type	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
Q05655	PRKCD	Protein kinase C delta type	GO:0006915; P:apoptotic process; IDA:UniProtKB
Q05655	PRKCD	Protein kinase C delta type	GO:0042100; P:B cell proliferation; IEA:Ensembl
Q05655	PRKCD	Protein kinase C delta type	GO:0007596; P:blood coagulation; TAS:Reactome
Q05655	PRKCD	Protein kinase C delta type	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q05655	PRKCD	Protein kinase C delta type	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q05655	PRKCD	Protein kinase C delta type	GO:0090398; P:cellular senescence; IMP:BHF-UCL
Q05655	PRKCD	Protein kinase C delta type	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q05655	PRKCD	Protein kinase C delta type	GO:0042742; P:defense response to bacterium; ISS:UniProtKB
Q05655	PRKCD	Protein kinase C delta type	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q05655	PRKCD	Protein kinase C delta type	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q05655	PRKCD	Protein kinase C delta type	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q05655	PRKCD	Protein kinase C delta type	GO:0010467; P:gene expression; TAS:Reactome
Q05655	PRKCD	Protein kinase C delta type	GO:0016064; P:immunoglobulin mediated immune response; IEA:Ensembl
Q05655	PRKCD	Protein kinase C delta type	GO:0045087; P:innate immune response; TAS:Reactome
Q05655	PRKCD	Protein kinase C delta type	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q05655	PRKCD	Protein kinase C delta type	GO:0032613; P:interleukin-10 production; IEA:Ensembl
Q05655	PRKCD	Protein kinase C delta type	GO:0032615; P:interleukin-12 production; IEA:Ensembl
Q05655	PRKCD	Protein kinase C delta type	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q05655	PRKCD	Protein kinase C delta type	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q05655	PRKCD	Protein kinase C delta type	GO:0030837; P:negative regulation of actin filament polymerization; ISS:UniProtKB
Q05655	PRKCD	Protein kinase C delta type	GO:0051490; P:negative regulation of filopodium assembly; ISS:UniProtKB
Q05655	PRKCD	Protein kinase C delta type	GO:0034351; P:negative regulation of glial cell apoptotic process; IMP:UniProtKB
Q05655	PRKCD	Protein kinase C delta type	GO:0050728; P:negative regulation of inflammatory response; IC:BHF-UCL
Q05655	PRKCD	Protein kinase C delta type	GO:0046627; P:negative regulation of insulin receptor signaling pathway; ISS:BHF-UCL
Q05655	PRKCD	Protein kinase C delta type	GO:0043407; P:negative regulation of MAP kinase activity; IMP:BHF-UCL
Q05655	PRKCD	Protein kinase C delta type	GO:0050732; P:negative regulation of peptidyl-tyrosine phosphorylation; ISS:BHF-UCL
Q05655	PRKCD	Protein kinase C delta type	GO:0090331; P:negative regulation of platelet aggregation; ISS:UniProtKB
Q05655	PRKCD	Protein kinase C delta type	GO:0032091; P:negative regulation of protein binding; TAS:BHF-UCL
Q05655	PRKCD	Protein kinase C delta type	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q05655	PRKCD	Protein kinase C delta type	GO:0042119; P:neutrophil activation; IDA:UniProtKB
Q05655	PRKCD	Protein kinase C delta type	GO:0018107; P:peptidyl-threonine phosphorylation; IDA:UniProtKB
Q05655	PRKCD	Protein kinase C delta type	GO:0030168; P:platelet activation; TAS:Reactome
Q05655	PRKCD	Protein kinase C delta type	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
Q05655	PRKCD	Protein kinase C delta type	GO:2000304; P:positive regulation of ceramide biosynthetic process; IMP:BHF-UCL
Q05655	PRKCD	Protein kinase C delta type	GO:2000753; P:positive regulation of glucosylceramide catabolic process; IMP:BHF-UCL
Q05655	PRKCD	Protein kinase C delta type	GO:1900163; P:positive regulation of phospholipid scramblase activity; IMP:UniProtKB
Q05655	PRKCD	Protein kinase C delta type	GO:0035307; P:positive regulation of protein dephosphorylation; IMP:BHF-UCL
Q05655	PRKCD	Protein kinase C delta type	GO:2001022; P:positive regulation of response to DNA damage stimulus; IMP:UniProtKB
Q05655	PRKCD	Protein kinase C delta type	GO:2000755; P:positive regulation of sphingomyelin catabolic process; IMP:BHF-UCL
Q05655	PRKCD	Protein kinase C delta type	GO:0032930; P:positive regulation of superoxide anion generation; IMP:UniProtKB
Q05655	PRKCD	Protein kinase C delta type	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q05655	PRKCD	Protein kinase C delta type	GO:0050821; P:protein stabilization; NAS:UniProtKB
Q05655	PRKCD	Protein kinase C delta type	GO:0010469; P:regulation of receptor activity; TAS:BHF-UCL
Q05655	PRKCD	Protein kinase C delta type	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q05655	PRKCD	Protein kinase C delta type	GO:0007165; P:signal transduction; TAS:Reactome
Q05655	PRKCD	Protein kinase C delta type	GO:0023021; P:termination of signal transduction; IMP:BHF-UCL
Q02156	PRKCE	Protein kinase C epsilon type	GO:0003785; F:actin monomer binding; ISS:UniProtKB
Q02156	PRKCE	Protein kinase C epsilon type	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q02156	PRKCE	Protein kinase C epsilon type	GO:0004699; F:calcium-independent protein kinase C activity; IEA:Ensembl
Q02156	PRKCE	Protein kinase C epsilon type	GO:0008047; F:enzyme activator activity; IMP:BHF-UCL
Q02156	PRKCE	Protein kinase C epsilon type	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q02156	PRKCE	Protein kinase C epsilon type	GO:0035276; F:ethanol binding; IEA:Ensembl
Q02156	PRKCE	Protein kinase C epsilon type	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q02156	PRKCE	Protein kinase C epsilon type	GO:0005515; F:protein binding; IPI:IntAct
Q02156	PRKCE	Protein kinase C epsilon type	GO:0004697; F:protein kinase C activity; IDA:BHF-UCL
Q02156	PRKCE	Protein kinase C epsilon type	GO:0030546; F:receptor activator activity; IEA:Ensembl
Q02156	PRKCE	Protein kinase C epsilon type	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q02156	PRKCE	Protein kinase C epsilon type	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
Q02156	PRKCE	Protein kinase C epsilon type	GO:0006915; P:apoptotic process; TAS:ProtInc
Q02156	PRKCE	Protein kinase C epsilon type	GO:0007596; P:blood coagulation; TAS:Reactome
Q02156	PRKCE	Protein kinase C epsilon type	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q02156	PRKCE	Protein kinase C epsilon type	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q02156	PRKCE	Protein kinase C epsilon type	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q02156	PRKCE	Protein kinase C epsilon type	GO:0071361; P:cellular response to ethanol; IEA:Ensembl
Q02156	PRKCE	Protein kinase C epsilon type	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
Q02156	PRKCE	Protein kinase C epsilon type	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q02156	PRKCE	Protein kinase C epsilon type	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q02156	PRKCE	Protein kinase C epsilon type	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q02156	PRKCE	Protein kinase C epsilon type	GO:0045087; P:innate immune response; TAS:Reactome
Q02156	PRKCE	Protein kinase C epsilon type	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q02156	PRKCE	Protein kinase C epsilon type	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; ISS:UniProtKB
Q02156	PRKCE	Protein kinase C epsilon type	GO:0035641; P:locomotory exploration behavior; IEA:Ensembl
Q02156	PRKCE	Protein kinase C epsilon type	GO:0002281; P:macrophage activation involved in immune response; IEA:Ensembl
Q02156	PRKCE	Protein kinase C epsilon type	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q02156	PRKCE	Protein kinase C epsilon type	GO:0030168; P:platelet activation; TAS:Reactome
Q02156	PRKCE	Protein kinase C epsilon type	GO:0030838; P:positive regulation of actin filament polymerization; ISS:UniProtKB
Q02156	PRKCE	Protein kinase C epsilon type	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
Q02156	PRKCE	Protein kinase C epsilon type	GO:2001031; P:positive regulation of cellular glucuronidation; IMP:BHF-UCL
Q02156	PRKCE	Protein kinase C epsilon type	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB
Q02156	PRKCE	Protein kinase C epsilon type	GO:0010634; P:positive regulation of epithelial cell migration; IMP:UniProtKB
Q02156	PRKCE	Protein kinase C epsilon type	GO:0010763; P:positive regulation of fibroblast migration; ISS:UniProtKB
Q02156	PRKCE	Protein kinase C epsilon type	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
Q02156	PRKCE	Protein kinase C epsilon type	GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl
Q02156	PRKCE	Protein kinase C epsilon type	GO:0050996; P:positive regulation of lipid catabolic process; IEA:Ensembl
Q02156	PRKCE	Protein kinase C epsilon type	GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl
Q02156	PRKCE	Protein kinase C epsilon type	GO:0070257; P:positive regulation of mucus secretion; IEA:Ensembl
Q02156	PRKCE	Protein kinase C epsilon type	GO:0032230; P:positive regulation of synaptic transmission, GABAergic; IEA:Ensembl
Q02156	PRKCE	Protein kinase C epsilon type	GO:0090303; P:positive regulation of wound healing; IMP:UniProtKB
Q02156	PRKCE	Protein kinase C epsilon type	GO:0006468; P:protein phosphorylation; IDA:BHF-UCL
Q02156	PRKCE	Protein kinase C epsilon type	GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl
Q02156	PRKCE	Protein kinase C epsilon type	GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
Q02156	PRKCE	Protein kinase C epsilon type	GO:0051209; P:release of sequestered calcium ion into cytosol; IEA:Ensembl
Q02156	PRKCE	Protein kinase C epsilon type	GO:0043278; P:response to morphine; IEA:Ensembl
Q02156	PRKCE	Protein kinase C epsilon type	GO:0007165; P:signal transduction; TAS:Reactome
Q02156	PRKCE	Protein kinase C epsilon type	GO:0035669; P:TRAM-dependent toll-like receptor 4 signaling pathway; ISS:UniProtKB
P05129	PRKCG	Protein kinase C gamma type	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P05129	PRKCG	Protein kinase C gamma type	GO:0004698; F:calcium-dependent protein kinase C activity; IEA:Ensembl
P05129	PRKCG	Protein kinase C gamma type	GO:0004672; F:protein kinase activity; IDA:HGNC
P05129	PRKCG	Protein kinase C gamma type	GO:0004697; F:protein kinase C activity; TAS:ProtInc
P05129	PRKCG	Protein kinase C gamma type	GO:0008270; F:zinc ion binding; IEA:InterPro
P05129	PRKCG	Protein kinase C gamma type	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
P05129	PRKCG	Protein kinase C gamma type	GO:0007596; P:blood coagulation; TAS:Reactome
P05129	PRKCG	Protein kinase C gamma type	GO:0008219; P:cell death; IEA:UniProtKB-KW
P05129	PRKCG	Protein kinase C gamma type	GO:0007635; P:chemosensory behavior; IEA:Ensembl
P05129	PRKCG	Protein kinase C gamma type	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P05129	PRKCG	Protein kinase C gamma type	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P05129	PRKCG	Protein kinase C gamma type	GO:0045087; P:innate immune response; TAS:Reactome
P05129	PRKCG	Protein kinase C gamma type	GO:0060384; P:innervation; IEA:Ensembl
P05129	PRKCG	Protein kinase C gamma type	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P05129	PRKCG	Protein kinase C gamma type	GO:0007611; P:learning or memory; IEA:Ensembl
P05129	PRKCG	Protein kinase C gamma type	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB
P05129	PRKCG	Protein kinase C gamma type	GO:0042177; P:negative regulation of protein catabolic process; IDA:HGNC
P05129	PRKCG	Protein kinase C gamma type	GO:0031397; P:negative regulation of protein ubiquitination; IDA:HGNC
P05129	PRKCG	Protein kinase C gamma type	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P05129	PRKCG	Protein kinase C gamma type	GO:0016310; P:phosphorylation; IDA:HGNC
P05129	PRKCG	Protein kinase C gamma type	GO:0030168; P:platelet activation; TAS:Reactome
P05129	PRKCG	Protein kinase C gamma type	GO:0032425; P:positive regulation of mismatch repair; IDA:HGNC
P05129	PRKCG	Protein kinase C gamma type	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
P05129	PRKCG	Protein kinase C gamma type	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P05129	PRKCG	Protein kinase C gamma type	GO:0043278; P:response to morphine; ISS:UniProtKB
P05129	PRKCG	Protein kinase C gamma type	GO:0048265; P:response to pain; ISS:UniProtKB
P05129	PRKCG	Protein kinase C gamma type	GO:0007165; P:signal transduction; TAS:Reactome
P05129	PRKCG	Protein kinase C gamma type	GO:0007268; P:synaptic transmission; TAS:Reactome
P41743	PRKCI	Protein kinase C iota type	GO:0005524; F:ATP binding; TAS:UniProtKB
P41743	PRKCI	Protein kinase C iota type	GO:0005543; F:phospholipid binding; IDA:UniProtKB
P41743	PRKCI	Protein kinase C iota type	GO:0005515; F:protein binding; IPI:UniProtKB
P41743	PRKCI	Protein kinase C iota type	GO:0004672; F:protein kinase activity; IDA:UniProtKB
P41743	PRKCI	Protein kinase C iota type	GO:0004697; F:protein kinase C activity; ISS:BHF-UCL
P41743	PRKCI	Protein kinase C iota type	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P41743	PRKCI	Protein kinase C iota type	GO:0008270; F:zinc ion binding; IEA:InterPro
P41743	PRKCI	Protein kinase C iota type	GO:0007015; P:actin filament organization; IEA:Ensembl
P41743	PRKCI	Protein kinase C iota type	GO:0034329; P:cell junction assembly; TAS:Reactome
P41743	PRKCI	Protein kinase C iota type	GO:0016477; P:cell migration; IEA:Ensembl
P41743	PRKCI	Protein kinase C iota type	GO:0045216; P:cell-cell junction organization; IMP:UniProtKB
P41743	PRKCI	Protein kinase C iota type	GO:0032869; P:cellular response to insulin stimulus; ISS:BHF-UCL
P41743	PRKCI	Protein kinase C iota type	GO:0007010; P:cytoskeleton organization; NAS:UniProtKB
P41743	PRKCI	Protein kinase C iota type	GO:0035089; P:establishment of apical/basal cell polarity; IEA:Ensembl
P41743	PRKCI	Protein kinase C iota type	GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; TAS:UniProtKB
P41743	PRKCI	Protein kinase C iota type	GO:0042462; P:eye photoreceptor cell development; IEA:Ensembl
P41743	PRKCI	Protein kinase C iota type	GO:0048194; P:Golgi vesicle budding; IEA:Ensembl
P41743	PRKCI	Protein kinase C iota type	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P41743	PRKCI	Protein kinase C iota type	GO:0061024; P:membrane organization; NAS:UniProtKB
P41743	PRKCI	Protein kinase C iota type	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P41743	PRKCI	Protein kinase C iota type	GO:0034351; P:negative regulation of glial cell apoptotic process; IMP:UniProtKB
P41743	PRKCI	Protein kinase C iota type	GO:0043524; P:negative regulation of neuron apoptotic process; IDA:UniProtKB
P41743	PRKCI	Protein kinase C iota type	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P41743	PRKCI	Protein kinase C iota type	GO:2000353; P:positive regulation of endothelial cell apoptotic process; IMP:UniProtKB
P41743	PRKCI	Protein kinase C iota type	GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; ISS:BHF-UCL
P41743	PRKCI	Protein kinase C iota type	GO:0060252; P:positive regulation of glial cell proliferation; IMP:UniProtKB
P41743	PRKCI	Protein kinase C iota type	GO:0046326; P:positive regulation of glucose import; ISS:BHF-UCL
P41743	PRKCI	Protein kinase C iota type	GO:0010976; P:positive regulation of neuron projection development; IMP:UniProtKB
P41743	PRKCI	Protein kinase C iota type	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
P41743	PRKCI	Protein kinase C iota type	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P41743	PRKCI	Protein kinase C iota type	GO:0006612; P:protein targeting to membrane; NAS:UniProtKB
P41743	PRKCI	Protein kinase C iota type	GO:0070555; P:response to interleukin-1; IEA:Ensembl
P41743	PRKCI	Protein kinase C iota type	GO:0046903; P:secretion; NAS:UniProtKB
P41743	PRKCI	Protein kinase C iota type	GO:0070830; P:tight junction assembly; TAS:Reactome
P41743	PRKCI	Protein kinase C iota type	GO:0016192; P:vesicle-mediated transport; TAS:UniProtKB
P24723	PRKCH	Protein kinase C eta type	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P24723	PRKCH	Protein kinase C eta type	GO:0004699; F:calcium-independent protein kinase C activity; IEA:Ensembl
P24723	PRKCH	Protein kinase C eta type	GO:0019899; F:enzyme binding; IPI:UniProtKB
P24723	PRKCH	Protein kinase C eta type	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P24723	PRKCH	Protein kinase C eta type	GO:0004697; F:protein kinase C activity; TAS:ProtInc
P24723	PRKCH	Protein kinase C eta type	GO:0007596; P:blood coagulation; TAS:Reactome
P24723	PRKCH	Protein kinase C eta type	GO:0034351; P:negative regulation of glial cell apoptotic process; IMP:UniProtKB
P24723	PRKCH	Protein kinase C eta type	GO:0030168; P:platelet activation; TAS:Reactome
P24723	PRKCH	Protein kinase C eta type	GO:0050861; P:positive regulation of B cell receptor signaling pathway; IMP:UniProtKB
P24723	PRKCH	Protein kinase C eta type	GO:0060252; P:positive regulation of glial cell proliferation; IMP:UniProtKB
P24723	PRKCH	Protein kinase C eta type	GO:0045618; P:positive regulation of keratinocyte differentiation; ISS:UniProtKB
P24723	PRKCH	Protein kinase C eta type	GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; ISS:UniProtKB
P24723	PRKCH	Protein kinase C eta type	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
P24723	PRKCH	Protein kinase C eta type	GO:0070528; P:protein kinase C signaling; IEA:Ensembl
P24723	PRKCH	Protein kinase C eta type	GO:0006468; P:protein phosphorylation; IMP:UniProtKB
P24723	PRKCH	Protein kinase C eta type	GO:2000810; P:regulation of tight junction assembly; IMP:UniProtKB
P24723	PRKCH	Protein kinase C eta type	GO:0007165; P:signal transduction; TAS:ProtInc
Q04759	PRKCQ	Protein kinase C theta type	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q04759	PRKCQ	Protein kinase C theta type	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q04759	PRKCQ	Protein kinase C theta type	GO:0005515; F:protein binding; IPI:UniProtKB
Q04759	PRKCQ	Protein kinase C theta type	GO:0004697; F:protein kinase C activity; IEA:UniProtKB-EC
Q04759	PRKCQ	Protein kinase C theta type	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q04759	PRKCQ	Protein kinase C theta type	GO:0004842; F:ubiquitin-protein ligase activity; TAS:Reactome
Q04759	PRKCQ	Protein kinase C theta type	GO:0006915; P:apoptotic process; TAS:Reactome
Q04759	PRKCQ	Protein kinase C theta type	GO:0007411; P:axon guidance; TAS:Reactome
Q04759	PRKCQ	Protein kinase C theta type	GO:0007596; P:blood coagulation; TAS:Reactome
Q04759	PRKCQ	Protein kinase C theta type	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q04759	PRKCQ	Protein kinase C theta type	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q04759	PRKCQ	Protein kinase C theta type	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q04759	PRKCQ	Protein kinase C theta type	GO:0045087; P:innate immune response; TAS:Reactome
Q04759	PRKCQ	Protein kinase C theta type	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q04759	PRKCQ	Protein kinase C theta type	GO:0006509; P:membrane protein ectodomain proteolysis; ISS:BHF-UCL
Q04759	PRKCQ	Protein kinase C theta type	GO:0046627; P:negative regulation of insulin receptor signaling pathway; IMP:UniProtKB
Q04759	PRKCQ	Protein kinase C theta type	GO:0070233; P:negative regulation of T cell apoptotic process; IMP:UniProtKB
Q04759	PRKCQ	Protein kinase C theta type	GO:0007603; P:phototransduction, visible light; TAS:Reactome
Q04759	PRKCQ	Protein kinase C theta type	GO:0030168; P:platelet activation; TAS:Reactome
Q04759	PRKCQ	Protein kinase C theta type	GO:0032740; P:positive regulation of interleukin-17 production; ISS:UniProtKB
Q04759	PRKCQ	Protein kinase C theta type	GO:0045086; P:positive regulation of interleukin-2 biosynthetic process; IEA:Ensembl
Q04759	PRKCQ	Protein kinase C theta type	GO:0032753; P:positive regulation of interleukin-4 production; ISS:UniProtKB
Q04759	PRKCQ	Protein kinase C theta type	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q04759	PRKCQ	Protein kinase C theta type	GO:0050870; P:positive regulation of T cell activation; ISS:UniProtKB
Q04759	PRKCQ	Protein kinase C theta type	GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl
Q04759	PRKCQ	Protein kinase C theta type	GO:2000318; P:positive regulation of T-helper 17 type immune response; ISS:UniProtKB
Q04759	PRKCQ	Protein kinase C theta type	GO:2000570; P:positive regulation of T-helper 2 cell activation; ISS:UniProtKB
Q04759	PRKCQ	Protein kinase C theta type	GO:0016567; P:protein ubiquitination; TAS:GOC
Q04759	PRKCQ	Protein kinase C theta type	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
Q04759	PRKCQ	Protein kinase C theta type	GO:0090330; P:regulation of platelet aggregation; ISS:UniProtKB
Q04759	PRKCQ	Protein kinase C theta type	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
Q04759	PRKCQ	Protein kinase C theta type	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
Q04759	PRKCQ	Protein kinase C theta type	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
Q04759	PRKCQ	Protein kinase C theta type	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q05513	PRKCZ	Protein kinase C zeta type	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q05513	PRKCZ	Protein kinase C zeta type	GO:0043560; F:insulin receptor substrate binding; IC:BHF-UCL
Q05513	PRKCZ	Protein kinase C zeta type	GO:0015459; F:potassium channel regulator activity; IEA:Ensembl
Q05513	PRKCZ	Protein kinase C zeta type	GO:0005515; F:protein binding; IPI:UniProtKB
Q05513	PRKCZ	Protein kinase C zeta type	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q05513	PRKCZ	Protein kinase C zeta type	GO:0004697; F:protein kinase C activity; IEA:UniProtKB-EC
Q05513	PRKCZ	Protein kinase C zeta type	GO:0004674; F:protein serine/threonine kinase activity; IDA:BHF-UCL
Q05513	PRKCZ	Protein kinase C zeta type	GO:0008270; F:zinc ion binding; IEA:InterPro
Q05513	PRKCZ	Protein kinase C zeta type	GO:0031532; P:actin cytoskeleton reorganization; IEA:Ensembl
Q05513	PRKCZ	Protein kinase C zeta type	GO:0031584; P:activation of phospholipase D activity; IEA:Ensembl
Q05513	PRKCZ	Protein kinase C zeta type	GO:0032148; P:activation of protein kinase B activity; IEA:Ensembl
Q05513	PRKCZ	Protein kinase C zeta type	GO:0007596; P:blood coagulation; TAS:Reactome
Q05513	PRKCZ	Protein kinase C zeta type	GO:0016477; P:cell migration; IEA:Ensembl
Q05513	PRKCZ	Protein kinase C zeta type	GO:0030010; P:establishment of cell polarity; ISS:UniProtKB
Q05513	PRKCZ	Protein kinase C zeta type	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q05513	PRKCZ	Protein kinase C zeta type	GO:0008286; P:insulin receptor signaling pathway; IEA:Ensembl
Q05513	PRKCZ	Protein kinase C zeta type	GO:0007616; P:long-term memory; IEA:Ensembl
Q05513	PRKCZ	Protein kinase C zeta type	GO:0060291; P:long-term synaptic potentiation; ISS:UniProtKB
Q05513	PRKCZ	Protein kinase C zeta type	GO:0060081; P:membrane hyperpolarization; IEA:Ensembl
Q05513	PRKCZ	Protein kinase C zeta type	GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl
Q05513	PRKCZ	Protein kinase C zeta type	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
Q05513	PRKCZ	Protein kinase C zeta type	GO:0051346; P:negative regulation of hydrolase activity; IEA:Ensembl
Q05513	PRKCZ	Protein kinase C zeta type	GO:0046627; P:negative regulation of insulin receptor signaling pathway; IMP:BHF-UCL
Q05513	PRKCZ	Protein kinase C zeta type	GO:0050732; P:negative regulation of peptidyl-tyrosine phosphorylation; IMP:BHF-UCL
Q05513	PRKCZ	Protein kinase C zeta type	GO:0031333; P:negative regulation of protein complex assembly; IMP:BHF-UCL
Q05513	PRKCZ	Protein kinase C zeta type	GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL
Q05513	PRKCZ	Protein kinase C zeta type	GO:0030168; P:platelet activation; TAS:Reactome
Q05513	PRKCZ	Protein kinase C zeta type	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q05513	PRKCZ	Protein kinase C zeta type	GO:0001954; P:positive regulation of cell-matrix adhesion; IEA:Ensembl
Q05513	PRKCZ	Protein kinase C zeta type	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB
Q05513	PRKCZ	Protein kinase C zeta type	GO:2000463; P:positive regulation of excitatory postsynaptic membrane potential; ISS:UniProtKB
Q05513	PRKCZ	Protein kinase C zeta type	GO:0046326; P:positive regulation of glucose import; IEA:Ensembl
Q05513	PRKCZ	Protein kinase C zeta type	GO:0046628; P:positive regulation of insulin receptor signaling pathway; ISS:UniProtKB
Q05513	PRKCZ	Protein kinase C zeta type	GO:2001181; P:positive regulation of interleukin-10 secretion; ISS:UniProtKB
Q05513	PRKCZ	Protein kinase C zeta type	GO:2000667; P:positive regulation of interleukin-13 secretion; ISS:UniProtKB
Q05513	PRKCZ	Protein kinase C zeta type	GO:0032753; P:positive regulation of interleukin-4 production; ISS:UniProtKB
Q05513	PRKCZ	Protein kinase C zeta type	GO:2000664; P:positive regulation of interleukin-5 secretion; ISS:UniProtKB
Q05513	PRKCZ	Protein kinase C zeta type	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB
Q05513	PRKCZ	Protein kinase C zeta type	GO:2000553; P:positive regulation of T-helper 2 cell cytokine production; ISS:UniProtKB
Q05513	PRKCZ	Protein kinase C zeta type	GO:0045630; P:positive regulation of T-helper 2 cell differentiation; ISS:UniProtKB
Q05513	PRKCZ	Protein kinase C zeta type	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q05513	PRKCZ	Protein kinase C zeta type	GO:0070528; P:protein kinase C signaling; IEA:Ensembl
Q05513	PRKCZ	Protein kinase C zeta type	GO:0072659; P:protein localization to plasma membrane; IEA:Ensembl
Q05513	PRKCZ	Protein kinase C zeta type	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q05513	PRKCZ	Protein kinase C zeta type	GO:0007165; P:signal transduction; TAS:ProtInc
Q05513	PRKCZ	Protein kinase C zeta type	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q05513	PRKCZ	Protein kinase C zeta type	GO:0047496; P:vesicle transport along microtubule; IEA:Ensembl
Q14558	PRPSAP1	Phosphoribosyl pyrophosphate synthase-associated protein 1	GO:0004857; F:enzyme inhibitor activity; TAS:ProtInc
Q14558	PRPSAP1	Phosphoribosyl pyrophosphate synthase-associated protein 1	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q14558	PRPSAP1	Phosphoribosyl pyrophosphate synthase-associated protein 1	GO:0004749; F:ribose phosphate diphosphokinase activity; IEA:InterPro
Q14558	PRPSAP1	Phosphoribosyl pyrophosphate synthase-associated protein 1	GO:0033673; P:negative regulation of kinase activity; IEA:Ensembl
Q14558	PRPSAP1	Phosphoribosyl pyrophosphate synthase-associated protein 1	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
Q14558	PRPSAP1	Phosphoribosyl pyrophosphate synthase-associated protein 1	GO:0009165; P:nucleotide biosynthetic process; IEA:UniProtKB-KW
O60256	PRPSAP2	Phosphoribosyl pyrophosphate synthase-associated protein 2	GO:0004857; F:enzyme inhibitor activity; TAS:ProtInc
O60256	PRPSAP2	Phosphoribosyl pyrophosphate synthase-associated protein 2	GO:0000287; F:magnesium ion binding; IEA:InterPro
O60256	PRPSAP2	Phosphoribosyl pyrophosphate synthase-associated protein 2	GO:0004749; F:ribose phosphate diphosphokinase activity; IEA:InterPro
O60256	PRPSAP2	Phosphoribosyl pyrophosphate synthase-associated protein 2	GO:0060348; P:bone development; IEA:Ensembl
O60256	PRPSAP2	Phosphoribosyl pyrophosphate synthase-associated protein 2	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
O60256	PRPSAP2	Phosphoribosyl pyrophosphate synthase-associated protein 2	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
O60256	PRPSAP2	Phosphoribosyl pyrophosphate synthase-associated protein 2	GO:0009165; P:nucleotide biosynthetic process; IEA:InterPro
P11801	PSKH1	Serine/threonine-protein kinase H1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P11801	PSKH1	Serine/threonine-protein kinase H1	GO:0005515; F:protein binding; IPI:IntAct
P11801	PSKH1	Serine/threonine-protein kinase H1	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q96QS6	PSKH2	Serine/threonine-protein kinase H2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96QS6	PSKH2	Serine/threonine-protein kinase H2	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q9Y664	KPTN	Kaptin	GO:0003779; F:actin binding; TAS:ProtInc
Q9Y664	KPTN	Kaptin	GO:0007015; P:actin filament organization; TAS:ProtInc
Q9Y664	KPTN	Kaptin	GO:0006928; P:cellular component movement; TAS:ProtInc
Q9Y664	KPTN	Kaptin	GO:0007605; P:sensory perception of sound; NAS:ProtInc
P14618	PKM	Pyruvate kinase PKM	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P14618	PKM	Pyruvate kinase PKM	GO:0000287; F:magnesium ion binding; IEA:InterPro
P14618	PKM	Pyruvate kinase PKM	GO:0023026; F:MHC class II protein complex binding; IDA:UniProt
P14618	PKM	Pyruvate kinase PKM	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P14618	PKM	Pyruvate kinase PKM	GO:0030955; F:potassium ion binding; IEA:InterPro
P14618	PKM	Pyruvate kinase PKM	GO:0005515; F:protein binding; IPI:IntAct
P14618	PKM	Pyruvate kinase PKM	GO:0004743; F:pyruvate kinase activity; TAS:UniProtKB
P14618	PKM	Pyruvate kinase PKM	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P14618	PKM	Pyruvate kinase PKM	GO:0006006; P:glucose metabolic process; TAS:Reactome
P14618	PKM	Pyruvate kinase PKM	GO:0006096; P:glycolytic process; TAS:Reactome
P14618	PKM	Pyruvate kinase PKM	GO:0012501; P:programmed cell death; IDA:UniProtKB
P14618	PKM	Pyruvate kinase PKM	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P30613	PKLR	Pyruvate kinase PKLR	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P30613	PKLR	Pyruvate kinase PKLR	GO:0000287; F:magnesium ion binding; IEA:InterPro
P30613	PKLR	Pyruvate kinase PKLR	GO:0030955; F:potassium ion binding; IEA:InterPro
P30613	PKLR	Pyruvate kinase PKLR	GO:0004743; F:pyruvate kinase activity; TAS:ProtInc
P30613	PKLR	Pyruvate kinase PKLR	GO:0006754; P:ATP biosynthetic process; IEA:Ensembl
P30613	PKLR	Pyruvate kinase PKLR	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P30613	PKLR	Pyruvate kinase PKLR	GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl
P30613	PKLR	Pyruvate kinase PKLR	GO:0031018; P:endocrine pancreas development; TAS:Reactome
P30613	PKLR	Pyruvate kinase PKLR	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P30613	PKLR	Pyruvate kinase PKLR	GO:0006006; P:glucose metabolic process; TAS:Reactome
P30613	PKLR	Pyruvate kinase PKLR	GO:0006096; P:glycolytic process; TAS:Reactome
P30613	PKLR	Pyruvate kinase PKLR	GO:0031325; P:positive regulation of cellular metabolic process; TAS:Reactome
P30613	PKLR	Pyruvate kinase PKLR	GO:0042866; P:pyruvate biosynthetic process; IEA:Ensembl
P30613	PKLR	Pyruvate kinase PKLR	GO:0033198; P:response to ATP; IEA:Ensembl
P30613	PKLR	Pyruvate kinase PKLR	GO:0051591; P:response to cAMP; IEA:Ensembl
P30613	PKLR	Pyruvate kinase PKLR	GO:0009749; P:response to glucose; IEA:Ensembl
P30613	PKLR	Pyruvate kinase PKLR	GO:0009408; P:response to heat; IEA:Ensembl
P30613	PKLR	Pyruvate kinase PKLR	GO:0001666; P:response to hypoxia; IEA:Ensembl
P30613	PKLR	Pyruvate kinase PKLR	GO:0010226; P:response to lithium ion; IEA:Ensembl
P30613	PKLR	Pyruvate kinase PKLR	GO:0007584; P:response to nutrient; IEA:Ensembl
P30613	PKLR	Pyruvate kinase PKLR	GO:0051707; P:response to other organism; IEA:Ensembl
P30613	PKLR	Pyruvate kinase PKLR	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8IUC1	KRTAP11-1	Keratin-associated protein 11-1	GO:0005198; F:structural molecule activity; IEA:InterPro
Q3LI83	KRTAP24-1	Keratin-associated protein 24-1	GO:0005198; F:structural molecule activity; IEA:InterPro
Q6PEX3	KRTAP26-1	Keratin-associated protein 26-1	GO:0005515; F:protein binding; IPI:IntAct
Q9BQ66	KRTAP4-12	Keratin-associated protein 4-12	GO:0005515; F:protein binding; IPI:IntAct
A6NCN2	KRT87P	Putative keratin-87 protein	GO:0005198; F:structural molecule activity; IEA:InterPro
Q8IUG1	KRTAP1-3	Keratin-associated protein 1-3	GO:0030280; F:structural constituent of epidermis; NAS:UniProtKB
Q9BYR8	KRTAP3-1	Keratin-associated protein 3-1	GO:0005198; F:structural molecule activity; IEA:InterPro
Q9BYR7	KRTAP3-2	Keratin-associated protein 3-2	GO:0005515; F:protein binding; IPI:IntAct
Q9BYR7	KRTAP3-2	Keratin-associated protein 3-2	GO:0005198; F:structural molecule activity; IEA:InterPro
Q9BYR6	KRTAP3-3	Keratin-associated protein 3-3	GO:0005198; F:structural molecule activity; IEA:InterPro
O75690	KRTAP5-8	Keratin-associated protein 5-8	GO:0030280; F:structural constituent of epidermis; NAS:UniProtKB
P26371	KRTAP5-9	Keratin-associated protein 5-9	GO:0005515; F:protein binding; IPI:IntAct
P26371	KRTAP5-9	Keratin-associated protein 5-9	GO:0008544; P:epidermis development; TAS:ProtInc
Q6ZNG9	KRBA2	KRAB-A domain-containing protein 2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q6ZNG9	KRBA2	KRAB-A domain-containing protein 2	GO:0015074; P:DNA integration; IEA:InterPro
Q6ZNG9	KRBA2	KRAB-A domain-containing protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
C9JBD0	KRBOX1	KRAB domain-containing protein 1	GO:0003676; F:nucleic acid binding; IEA:InterPro
C9JBD0	KRBOX1	KRAB domain-containing protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q5JUW0	KRBOX4	KRAB domain-containing protein 4	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q5JUW0	KRBOX4	KRAB domain-containing protein 4	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q96MU8	KREMEN1	Kremen protein 1	GO:0005515; F:protein binding; IPI:BHF-UCL
Q96MU8	KREMEN1	Kremen protein 1	GO:0007154; P:cell communication; TAS:UniProtKB
Q96MU8	KREMEN1	Kremen protein 1	GO:0060828; P:regulation of canonical Wnt signaling pathway; NAS:BHF-UCL
Q96MU8	KREMEN1	Kremen protein 1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q8NCW0	KREMEN2	Kremen protein 2	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q8N9T8	KRI1	Protein KRI1 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O00522	KRIT1	Krev interaction trapped protein 1	GO:0008017; F:microtubule binding; IDA:UniProtKB
O00522	KRIT1	Krev interaction trapped protein 1	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProtKB
O00522	KRIT1	Krev interaction trapped protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
O00522	KRIT1	Krev interaction trapped protein 1	GO:0032403; F:protein complex binding; IDA:UniProtKB
O00522	KRIT1	Krev interaction trapped protein 1	GO:0005083; F:small GTPase regulator activity; TAS:ProtInc
O00522	KRIT1	Krev interaction trapped protein 1	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
O00522	KRIT1	Krev interaction trapped protein 1	GO:0045454; P:cell redox homeostasis; IMP:UniProtKB
O00522	KRIT1	Krev interaction trapped protein 1	GO:0016525; P:negative regulation of angiogenesis; IMP:UniProtKB
O00522	KRIT1	Krev interaction trapped protein 1	GO:2000352; P:negative regulation of endothelial cell apoptotic process; IMP:UniProtKB
O00522	KRIT1	Krev interaction trapped protein 1	GO:0010596; P:negative regulation of endothelial cell migration; IMP:UniProtKB
O00522	KRIT1	Krev interaction trapped protein 1	GO:0001937; P:negative regulation of endothelial cell proliferation; IMP:UniProtKB
O00522	KRIT1	Krev interaction trapped protein 1	GO:0032092; P:positive regulation of protein binding; IEA:Ensembl
O00522	KRIT1	Krev interaction trapped protein 1	GO:0050790; P:regulation of catalytic activity; TAS:GOC
O00522	KRIT1	Krev interaction trapped protein 1	GO:2000114; P:regulation of establishment of cell polarity; IMP:UniProtKB
O00522	KRIT1	Krev interaction trapped protein 1	GO:0007264; P:small GTPase mediated signal transduction; TAS:ProtInc
Q13601	KRR1	KRR1 small subunit processome component homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13601	KRR1	KRR1 small subunit processome component homolog	GO:0005515; F:protein binding; IPI:IntAct
Q13601	KRR1	KRR1 small subunit processome component homolog	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
O76011	KRT34	Keratin, type I cuticular Ha4	GO:0005198; F:structural molecule activity; NAS:ProtInc
O76011	KRT34	Keratin, type I cuticular Ha4	GO:0008544; P:epidermis development; TAS:ProtInc
Q92764	KRT35	Keratin, type I cuticular Ha5	GO:0005198; F:structural molecule activity; IEA:InterPro
Q92764	KRT35	Keratin, type I cuticular Ha5	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
O76013	KRT36	Keratin, type I cuticular Ha6	GO:0030280; F:structural constituent of epidermis; NAS:UniProtKB
O76013	KRT36	Keratin, type I cuticular Ha6	GO:0045616; P:regulation of keratinocyte differentiation; IEA:Ensembl
O76015	KRT38	Keratin, type I cuticular Ha8	GO:0005198; F:structural molecule activity; TAS:ProtInc
O76014	KRT37	Keratin, type I cuticular Ha7	GO:0005198; F:structural molecule activity; TAS:ProtInc
Q14533	KRT81	Keratin, type II cuticular Hb1	GO:0005515; F:protein binding; IPI:IntAct
Q14533	KRT81	Keratin, type II cuticular Hb1	GO:0005198; F:structural molecule activity; IEA:InterPro
Q9NSB4	KRT82	Keratin, type II cuticular Hb2	GO:0030280; F:structural constituent of epidermis; NAS:UniProtKB
P78385	KRT83	Keratin, type II cuticular Hb3	GO:0005198; F:structural molecule activity; IEA:InterPro
P78385	KRT83	Keratin, type II cuticular Hb3	GO:0008544; P:epidermis development; TAS:ProtInc
Q9NSB2	KRT84	Keratin, type II cuticular Hb4	GO:0005200; F:structural constituent of cytoskeleton; NAS:UniProtKB
Q9NSB2	KRT84	Keratin, type II cuticular Hb4	GO:0030280; F:structural constituent of epidermis; IEA:Ensembl
Q9NSB2	KRT84	Keratin, type II cuticular Hb4	GO:0001942; P:hair follicle development; NAS:UniProtKB
Q9NSB2	KRT84	Keratin, type II cuticular Hb4	GO:0035878; P:nail development; NAS:UniProtKB
Q9NSB2	KRT84	Keratin, type II cuticular Hb4	GO:0045616; P:regulation of keratinocyte differentiation; IEA:Ensembl
P78386	KRT85	Keratin, type II cuticular Hb5	GO:0005198; F:structural molecule activity; TAS:ProtInc
P78386	KRT85	Keratin, type II cuticular Hb5	GO:0008544; P:epidermis development; TAS:ProtInc
O43790	KRT86	Keratin, type II cuticular Hb6	GO:0005198; F:structural molecule activity; IEA:InterPro
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IDA:UniProtKB
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0005515; F:protein binding; IPI:IntAct
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0007411; P:axon guidance; TAS:Reactome
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0045087; P:innate immune response; TAS:Reactome
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0045597; P:positive regulation of cell differentiation; TAS:UniProtKB
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0030307; P:positive regulation of cell growth; TAS:UniProtKB
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:2000491; P:positive regulation of hepatic stellate cell activation; IMP:UniProtKB
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0043620; P:regulation of DNA-templated transcription in response to stress; TAS:UniProtKB
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0043555; P:regulation of translation in response to stress; TAS:UniProtKB
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0007165; P:signal transduction; TAS:ProtInc
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q15418	RPS6KA1	Ribosomal protein S6 kinase alpha-1	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0005515; F:protein binding; IPI:IntAct
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0004711; F:ribosomal protein S6 kinase activity; IEA:Ensembl
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0007411; P:axon guidance; TAS:Reactome
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0002035; P:brain renin-angiotensin system; IEA:Ensembl
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0010659; P:cardiac muscle cell apoptotic process; IEA:Ensembl
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0071322; P:cellular response to carbohydrate stimulus; IEA:Ensembl
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0060047; P:heart contraction; IEA:Ensembl
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0007507; P:heart development; IEA:Ensembl
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0045087; P:innate immune response; TAS:Reactome
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0045786; P:negative regulation of cell cycle; IDA:UniProtKB
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0045835; P:negative regulation of meiosis; IEA:Ensembl
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0001556; P:oocyte maturation; IEA:Ensembl
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0070613; P:regulation of protein processing; IEA:Ensembl
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0007165; P:signal transduction; NAS:ProtInc
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0007268; P:synaptic transmission; TAS:Reactome
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q15349	RPS6KA2	Ribosomal protein S6 kinase alpha-2	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IDA:UniProtKB
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0000287; F:magnesium ion binding; IEA:InterPro
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0004672; F:protein kinase activity; TAS:ProtInc
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0007411; P:axon guidance; TAS:Reactome
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0007417; P:central nervous system development; TAS:ProtInc
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0045087; P:innate immune response; TAS:Reactome
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0045597; P:positive regulation of cell differentiation; TAS:UniProtKB
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0030307; P:positive regulation of cell growth; TAS:UniProtKB
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0043620; P:regulation of DNA-templated transcription in response to stress; TAS:UniProtKB
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0043555; P:regulation of translation in response to stress; TAS:UniProtKB
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0032496; P:response to lipopolysaccharide; ISS:UniProtKB
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0007165; P:signal transduction; TAS:ProtInc
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0001501; P:skeletal system development; TAS:ProtInc
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0007268; P:synaptic transmission; TAS:Reactome
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0002224; P:toll-like receptor signaling pathway; ISS:UniProtKB
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P51812	RPS6KA3	Ribosomal protein S6 kinase alpha-3	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0005524; F:ATP binding; IDA:UniProtKB
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0000287; F:magnesium ion binding; IEA:InterPro
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0048273; F:mitogen-activated protein kinase p38 binding; IGI:UniProtKB
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0005515; F:protein binding; IPI:IntAct
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0004711; F:ribosomal protein S6 kinase activity; NAS:UniProtKB
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0007411; P:axon guidance; TAS:Reactome
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0043987; P:histone H3-S10 phosphorylation; IMP:UniProtKB
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0043988; P:histone H3-S28 phosphorylation; IMP:UniProtKB
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0016572; P:histone phosphorylation; TAS:BHF-UCL
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0070498; P:interleukin-1-mediated signaling pathway; IMP:BHF-UCL
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0001818; P:negative regulation of cytokine production; TAS:UniProtKB
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0032793; P:positive regulation of CREB transcription factor activity; TAS:UniProtKB
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0035066; P:positive regulation of histone acetylation; IMP:BHF-UCL
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0033129; P:positive regulation of histone phosphorylation; IMP:BHF-UCL
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:UniProtKB
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
O75676	RPS6KA4	Ribosomal protein S6 kinase alpha-4	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0005524; F:ATP binding; IDA:UniProtKB
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0000287; F:magnesium ion binding; IEA:InterPro
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0005515; F:protein binding; IPI:IntAct
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0004672; F:protein kinase activity; IDA:UniProtKB
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0007411; P:axon guidance; TAS:Reactome
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:UniProtKB
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0043990; P:histone H2A-S1 phosphorylation; IDA:UniProtKB
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0043987; P:histone H3-S10 phosphorylation; IMP:UniProtKB
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0043988; P:histone H3-S28 phosphorylation; IMP:UniProtKB
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0016572; P:histone phosphorylation; IDA:UniProtKB
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0045087; P:innate immune response; TAS:Reactome
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0070498; P:interleukin-1-mediated signaling pathway; IMP:BHF-UCL
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0001818; P:negative regulation of cytokine production; TAS:UniProtKB
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0032793; P:positive regulation of CREB transcription factor activity; TAS:UniProtKB
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0035066; P:positive regulation of histone acetylation; IMP:BHF-UCL
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0033129; P:positive regulation of histone phosphorylation; IMP:BHF-UCL
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
O75582	RPS6KA5	Ribosomal protein S6 kinase alpha-5	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q9UK32	RPS6KA6	Ribosomal protein S6 kinase alpha-6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UK32	RPS6KA6	Ribosomal protein S6 kinase alpha-6	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q9UK32	RPS6KA6	Ribosomal protein S6 kinase alpha-6	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q9UK32	RPS6KA6	Ribosomal protein S6 kinase alpha-6	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q9UK32	RPS6KA6	Ribosomal protein S6 kinase alpha-6	GO:0007411; P:axon guidance; TAS:Reactome
Q9UK32	RPS6KA6	Ribosomal protein S6 kinase alpha-6	GO:0007417; P:central nervous system development; TAS:ProtInc
Q9UK32	RPS6KA6	Ribosomal protein S6 kinase alpha-6	GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IMP:UniProtKB
Q9UK32	RPS6KA6	Ribosomal protein S6 kinase alpha-6	GO:0045992; P:negative regulation of embryonic development; ISS:UniProtKB
Q9UK32	RPS6KA6	Ribosomal protein S6 kinase alpha-6	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
Q9UK32	RPS6KA6	Ribosomal protein S6 kinase alpha-6	GO:2000381; P:negative regulation of mesoderm development; ISS:UniProtKB
Q9UK32	RPS6KA6	Ribosomal protein S6 kinase alpha-6	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UK32	RPS6KA6	Ribosomal protein S6 kinase alpha-6	GO:0007268; P:synaptic transmission; TAS:Reactome
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0042277; F:peptide binding; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0005515; F:protein binding; IPI:IntAct
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0004672; F:protein kinase activity; IDA:UniProtKB
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0004711; F:ribosomal protein S6 kinase activity; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0007568; P:aging; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0016477; P:cell migration; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0071363; P:cellular response to growth factor stimulus; IDA:UniProtKB
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0032870; P:cellular response to hormone stimulus; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:UniProtKB
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0007281; P:germ cell development; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0007616; P:long-term memory; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0046627; P:negative regulation of insulin receptor signaling pathway; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:UniProtKB
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0045931; P:positive regulation of mitotic cell cycle; IMP:UniProtKB
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0048633; P:positive regulation of skeletal muscle tissue growth; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0014911; P:positive regulation of smooth muscle cell migration; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0045727; P:positive regulation of translation; IMP:UniProtKB
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0045948; P:positive regulation of translational initiation; IMP:UniProtKB
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0043491; P:protein kinase B signaling; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0006468; P:protein phosphorylation; IDA:GOC
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0046324; P:regulation of glucose import; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0042493; P:response to drug; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0014878; P:response to electrical stimulus involved in regulation of muscle adaptation; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0045471; P:response to ethanol; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0033762; P:response to glucagon; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0009749; P:response to glucose; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0009408; P:response to heat; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0032868; P:response to insulin; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0043201; P:response to leucine; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0007584; P:response to nutrient; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0033574; P:response to testosterone; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0009636; P:response to toxic substance; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0034612; P:response to tumor necrosis factor; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0009611; P:response to wounding; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0007165; P:signal transduction; IEA:InterPro
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0014732; P:skeletal muscle atrophy; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0003009; P:skeletal muscle contraction; IEA:Ensembl
P23443	RPS6KB1	Ribosomal protein S6 kinase beta-1	GO:0031929; P:TOR signaling; IDA:UniProtKB
Q9UBS0	RPS6KB2	Ribosomal protein S6 kinase beta-2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UBS0	RPS6KB2	Ribosomal protein S6 kinase beta-2	GO:0042277; F:peptide binding; IEA:Ensembl
Q9UBS0	RPS6KB2	Ribosomal protein S6 kinase beta-2	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q9UBS0	RPS6KB2	Ribosomal protein S6 kinase beta-2	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
Q9UBS0	RPS6KB2	Ribosomal protein S6 kinase beta-2	GO:0004711; F:ribosomal protein S6 kinase activity; IEA:Ensembl
Q9UBS0	RPS6KB2	Ribosomal protein S6 kinase beta-2	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q9UBS0	RPS6KB2	Ribosomal protein S6 kinase beta-2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9UBS0	RPS6KB2	Ribosomal protein S6 kinase beta-2	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q9UBS0	RPS6KB2	Ribosomal protein S6 kinase beta-2	GO:0045087; P:innate immune response; TAS:Reactome
Q9UBS0	RPS6KB2	Ribosomal protein S6 kinase beta-2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9UBS0	RPS6KB2	Ribosomal protein S6 kinase beta-2	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q9UBS0	RPS6KB2	Ribosomal protein S6 kinase beta-2	GO:0045948; P:positive regulation of translational initiation; IMP:UniProtKB
Q9UBS0	RPS6KB2	Ribosomal protein S6 kinase beta-2	GO:0043491; P:protein kinase B signaling; IEA:Ensembl
Q9UBS0	RPS6KB2	Ribosomal protein S6 kinase beta-2	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UBS0	RPS6KB2	Ribosomal protein S6 kinase beta-2	GO:0006412; P:translation; TAS:ProtInc
Q96S38	RPS6KC1	Ribosomal protein S6 kinase delta-1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96S38	RPS6KC1	Ribosomal protein S6 kinase delta-1	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
Q96S38	RPS6KC1	Ribosomal protein S6 kinase delta-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96S38	RPS6KC1	Ribosomal protein S6 kinase delta-1	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
Q96S38	RPS6KC1	Ribosomal protein S6 kinase delta-1	GO:0007165; P:signal transduction; TAS:ProtInc
Q8IVT5	KSR1	Kinase suppressor of Ras 1	GO:0005524; F:ATP binding; IEA:InterPro
Q8IVT5	KSR1	Kinase suppressor of Ras 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IVT5	KSR1	Kinase suppressor of Ras 1	GO:0005515; F:protein binding; IPI:IntAct
Q8IVT5	KSR1	Kinase suppressor of Ras 1	GO:0004672; F:protein kinase activity; NAS:UniProtKB
Q8IVT5	KSR1	Kinase suppressor of Ras 1	GO:0004674; F:protein serine/threonine kinase activity; IEA:InterPro
Q8IVT5	KSR1	Kinase suppressor of Ras 1	GO:0007265; P:Ras protein signal transduction; NAS:UniProtKB
Q6VAB6	KSR2	Kinase suppressor of Ras 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6VAB6	KSR2	Kinase suppressor of Ras 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6VAB6	KSR2	Kinase suppressor of Ras 2	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q6VAB6	KSR2	Kinase suppressor of Ras 2	GO:0019722; P:calcium-mediated signaling; IEA:Ensembl
Q6VAB6	KSR2	Kinase suppressor of Ras 2	GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl
P43405	SYK	Tyrosine-protein kinase SYK	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P43405	SYK	Tyrosine-protein kinase SYK	GO:0005178; F:integrin binding; IPI:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0005515; F:protein binding; IPI:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0004672; F:protein kinase activity; NAS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0004713; F:protein tyrosine kinase activity; EXP:Reactome
P43405	SYK	Tyrosine-protein kinase SYK	GO:0004716; F:receptor signaling protein tyrosine kinase activity; IEA:Ensembl
P43405	SYK	Tyrosine-protein kinase SYK	GO:0007257; P:activation of JUN kinase activity; IEA:Ensembl
P43405	SYK	Tyrosine-protein kinase SYK	GO:0002250; P:adaptive immune response; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P43405	SYK	Tyrosine-protein kinase SYK	GO:0050853; P:B cell receptor signaling pathway; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0043366; P:beta selection; IEA:Ensembl
P43405	SYK	Tyrosine-protein kinase SYK	GO:0007596; P:blood coagulation; TAS:Reactome
P43405	SYK	Tyrosine-protein kinase SYK	GO:0048514; P:blood vessel morphogenesis; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0008283; P:cell proliferation; TAS:ProtInc
P43405	SYK	Tyrosine-protein kinase SYK	GO:0071226; P:cellular response to molecule of fungal origin; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0042742; P:defense response to bacterium; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0007167; P:enzyme linked receptor protein signaling pathway; IEA:Ensembl
P43405	SYK	Tyrosine-protein kinase SYK	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P43405	SYK	Tyrosine-protein kinase SYK	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P43405	SYK	Tyrosine-protein kinase SYK	GO:0045087; P:innate immune response; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0007229; P:integrin-mediated signaling pathway; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0002366; P:leukocyte activation involved in immune response; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0007159; P:leukocyte cell-cell adhesion; IDA:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0019370; P:leukotriene biosynthetic process; IEA:Ensembl
P43405	SYK	Tyrosine-protein kinase SYK	GO:0001945; P:lymph vessel development; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0002281; P:macrophage activation involved in immune response; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0002283; P:neutrophil activation involved in immune response; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0030593; P:neutrophil chemotaxis; IDA:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P43405	SYK	Tyrosine-protein kinase SYK	GO:0030168; P:platelet activation; TAS:Reactome
P43405	SYK	Tyrosine-protein kinase SYK	GO:0046638; P:positive regulation of alpha-beta T cell differentiation; IEA:Ensembl
P43405	SYK	Tyrosine-protein kinase SYK	GO:0046641; P:positive regulation of alpha-beta T cell proliferation; IEA:Ensembl
P43405	SYK	Tyrosine-protein kinase SYK	GO:0045579; P:positive regulation of B cell differentiation; IEA:Ensembl
P43405	SYK	Tyrosine-protein kinase SYK	GO:0045780; P:positive regulation of bone resorption; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0050850; P:positive regulation of calcium-mediated signaling; IEA:Ensembl
P43405	SYK	Tyrosine-protein kinase SYK	GO:0033630; P:positive regulation of cell adhesion mediated by integrin; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0050715; P:positive regulation of cytokine secretion; IEA:Ensembl
P43405	SYK	Tyrosine-protein kinase SYK	GO:0045588; P:positive regulation of gamma-delta T cell differentiation; IEA:Ensembl
P43405	SYK	Tyrosine-protein kinase SYK	GO:0045425; P:positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process; IEA:Ensembl
P43405	SYK	Tyrosine-protein kinase SYK	GO:0045401; P:positive regulation of interleukin-3 biosynthetic process; IEA:Ensembl
P43405	SYK	Tyrosine-protein kinase SYK	GO:0043306; P:positive regulation of mast cell degranulation; IEA:Ensembl
P43405	SYK	Tyrosine-protein kinase SYK	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
P43405	SYK	Tyrosine-protein kinase SYK	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
P43405	SYK	Tyrosine-protein kinase SYK	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0090237; P:regulation of arachidonic acid secretion; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0070372; P:regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0043313; P:regulation of neutrophil degranulation; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0050764; P:regulation of phagocytosis; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0010543; P:regulation of platelet activation; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0090330; P:regulation of platelet aggregation; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0032928; P:regulation of superoxide anion generation; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0002554; P:serotonin secretion by platelet; ISS:UniProtKB
P43405	SYK	Tyrosine-protein kinase SYK	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q8N1A0	KRT222	Keratin-like protein KRT222	GO:0005198; F:structural molecule activity; IEA:InterPro
O76009	KRT33A	Keratin, type I cuticular Ha3-I	GO:0005198; F:structural molecule activity; IEA:InterPro
Q9HA64	FN3KRP	Ketosamine-3-kinase	GO:0016301; F:kinase activity; IEA:UniProtKB-KW
Q14525	KRT33B	Keratin, type I cuticular Ha3-II	GO:0005198; F:structural molecule activity; IEA:InterPro
P60985	KRTDAP	Keratinocyte differentiation-associated protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P23919	DTYMK	Thymidylate kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P23919	DTYMK	Thymidylate kinase	GO:0050145; F:nucleoside phosphate kinase activity; EXP:Reactome
P23919	DTYMK	Thymidylate kinase	GO:0004798; F:thymidylate kinase activity; IDA:MGI
P23919	DTYMK	Thymidylate kinase	GO:0007049; P:cell cycle; TAS:ProtInc
P23919	DTYMK	Thymidylate kinase	GO:0008283; P:cell proliferation; TAS:ProtInc
P23919	DTYMK	Thymidylate kinase	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P23919	DTYMK	Thymidylate kinase	GO:0006233; P:dTDP biosynthetic process; IEA:Ensembl
P23919	DTYMK	Thymidylate kinase	GO:0006235; P:dTTP biosynthetic process; IEA:UniProtKB-UniPathway
P23919	DTYMK	Thymidylate kinase	GO:0045445; P:myoblast differentiation; IEA:Ensembl
P23919	DTYMK	Thymidylate kinase	GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome
P23919	DTYMK	Thymidylate kinase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P23919	DTYMK	Thymidylate kinase	GO:0046940; P:nucleoside monophosphate phosphorylation; EXP:GOC
P23919	DTYMK	Thymidylate kinase	GO:0046939; P:nucleotide phosphorylation; IDA:GOC
P23919	DTYMK	Thymidylate kinase	GO:0046686; P:response to cadmium ion; IEA:Ensembl
P23919	DTYMK	Thymidylate kinase	GO:0043627; P:response to estrogen; IEA:Ensembl
P23919	DTYMK	Thymidylate kinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96EK9	KTI12	Protein KTI12 homolog	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86UP2	KTN1	Kinectin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q86UP2	KTN1	Kinectin	GO:0007018; P:microtubule-based movement; NAS:ProtInc
O75449	KATNA1	Katanin p60 ATPase-containing subunit A1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75449	KATNA1	Katanin p60 ATPase-containing subunit A1	GO:0008017; F:microtubule binding; IDA:UniProtKB
O75449	KATNA1	Katanin p60 ATPase-containing subunit A1	GO:0008568; F:microtubule-severing ATPase activity; IEA:UniProtKB-EC
O75449	KATNA1	Katanin p60 ATPase-containing subunit A1	GO:0005515; F:protein binding; IPI:UniProtKB
O75449	KATNA1	Katanin p60 ATPase-containing subunit A1	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
O75449	KATNA1	Katanin p60 ATPase-containing subunit A1	GO:0031122; P:cytoplasmic microtubule organization; IEA:Ensembl
O75449	KATNA1	Katanin p60 ATPase-containing subunit A1	GO:0001578; P:microtubule bundle formation; IEA:Ensembl
O75449	KATNA1	Katanin p60 ATPase-containing subunit A1	GO:0051013; P:microtubule severing; IEA:UniProtKB-HAMAP
O75449	KATNA1	Katanin p60 ATPase-containing subunit A1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
O75449	KATNA1	Katanin p60 ATPase-containing subunit A1	GO:0051329; P:mitotic interphase; IMP:UniProtKB
O75449	KATNA1	Katanin p60 ATPase-containing subunit A1	GO:0010977; P:negative regulation of neuron projection development; IEA:Ensembl
O75449	KATNA1	Katanin p60 ATPase-containing subunit A1	GO:0001764; P:neuron migration; IEA:Ensembl
O75449	KATNA1	Katanin p60 ATPase-containing subunit A1	GO:0008104; P:protein localization; IEA:Ensembl
Q9BVA0	KATNB1	Katanin p80 WD40 repeat-containing subunit B1	GO:0008017; F:microtubule binding; NAS:UniProtKB
Q9BVA0	KATNB1	Katanin p80 WD40 repeat-containing subunit B1	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q9BVA0	KATNB1	Katanin p80 WD40 repeat-containing subunit B1	GO:0006200; P:ATP catabolic process; IDA:GOC
Q9BVA0	KATNB1	Katanin p80 WD40 repeat-containing subunit B1	GO:0051013; P:microtubule severing; IEA:UniProtKB-HAMAP
Q9BVA0	KATNB1	Katanin p80 WD40 repeat-containing subunit B1	GO:0007079; P:mitotic chromosome movement towards spindle pole; IEA:UniProtKB-HAMAP
Q9BVA0	KATNB1	Katanin p80 WD40 repeat-containing subunit B1	GO:0007026; P:negative regulation of microtubule depolymerization; IMP:UniProtKB
Q9BVA0	KATNB1	Katanin p80 WD40 repeat-containing subunit B1	GO:0010942; P:positive regulation of cell death; IEA:Ensembl
Q9BVA0	KATNB1	Katanin p80 WD40 repeat-containing subunit B1	GO:0031117; P:positive regulation of microtubule depolymerization; IMP:UniProtKB
Q9BVA0	KATNB1	Katanin p80 WD40 repeat-containing subunit B1	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
Q9BVA0	KATNB1	Katanin p80 WD40 repeat-containing subunit B1	GO:0006605; P:protein targeting; NAS:UniProtKB
Q9NVR5	DNAAF2	Protein kintoun	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NVR5	DNAAF2	Protein kintoun	GO:0070286; P:axonemal dynein complex assembly; IMP:UniProtKB
Q9NVR5	DNAAF2	Protein kintoun	GO:0071973; P:bacterial-type flagellum-dependent cell motility; IMP:UniProtKB
Q9NVR5	DNAAF2	Protein kintoun	GO:0060285; P:cilium-dependent cell motility; IMP:UniProtKB
Q9NVR5	DNAAF2	Protein kintoun	GO:0032526; P:response to retinoic acid; IEA:Ensembl
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
P01602	IGKV1-5	Ig kappa chain V-I region HK102	GO:0003823; F:antigen binding; NAS:UniProtKB
P01602	IGKV1-5	Ig kappa chain V-I region HK102	GO:0006956; P:complement activation; TAS:Reactome
P01602	IGKV1-5	Ig kappa chain V-I region HK102	GO:0006958; P:complement activation, classical pathway; TAS:Reactome
P01602	IGKV1-5	Ig kappa chain V-I region HK102	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P01602	IGKV1-5	Ig kappa chain V-I region HK102	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P01602	IGKV1-5	Ig kappa chain V-I region HK102	GO:0006955; P:immune response; NAS:UniProtKB
P01602	IGKV1-5	Ig kappa chain V-I region HK102	GO:0045087; P:innate immune response; TAS:Reactome
P01602	IGKV1-5	Ig kappa chain V-I region HK102	GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; IEA:UniProtKB-KW
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; IEA:UniProtKB-KW
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0019731; P:antibacterial humoral response; IDA:UniProt
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0003094; P:glomerular filtration; IMP:UniProt
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; IEA:UniProtKB-KW
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
P06312	IGKV4-1	Ig kappa chain V-IV region	GO:0003823; F:antigen binding; NAS:UniProtKB
P06312	IGKV4-1	Ig kappa chain V-IV region	GO:0006956; P:complement activation; TAS:Reactome
P06312	IGKV4-1	Ig kappa chain V-IV region	GO:0006958; P:complement activation, classical pathway; TAS:Reactome
P06312	IGKV4-1	Ig kappa chain V-IV region	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P06312	IGKV4-1	Ig kappa chain V-IV region	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P06312	IGKV4-1	Ig kappa chain V-IV region	GO:0006955; P:immune response; NAS:UniProtKB
P06312	IGKV4-1	Ig kappa chain V-IV region	GO:0045087; P:innate immune response; TAS:Reactome
P06312	IGKV4-1	Ig kappa chain V-IV region	GO:0050776; P:regulation of immune response; TAS:Reactome
Q9BQD3	KXD1	KxDL motif-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9BQD3	KXD1	KxDL motif-containing protein 1	GO:0016192; P:vesicle-mediated transport; ISS:UniProtKB
Q16719	KYNU	Kynureninase	GO:0030429; F:kynureninase activity; IDA:UniProtKB
Q16719	KYNU	Kynureninase	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q16719	KYNU	Kynureninase	GO:0030170; F:pyridoxal phosphate binding; IEA:UniProtKB-HAMAP
Q16719	KYNU	Kynureninase	GO:0034354; P:'de novo' NAD biosynthetic process from tryptophan; IEA:UniProtKB-HAMAP
Q16719	KYNU	Kynureninase	GO:0043420; P:anthranilate metabolic process; IDA:UniProtKB
Q16719	KYNU	Kynureninase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q16719	KYNU	Kynureninase	GO:0097053; P:L-kynurenine catabolic process; IEA:UniProtKB-UniPathway
Q16719	KYNU	Kynureninase	GO:0019805; P:quinolinate biosynthetic process; IDA:UniProtKB
Q16719	KYNU	Kynureninase	GO:0034341; P:response to interferon-gamma; IDA:UniProtKB
Q16719	KYNU	Kynureninase	GO:0034516; P:response to vitamin B6; IMP:UniProtKB
Q16719	KYNU	Kynureninase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16719	KYNU	Kynureninase	GO:0006569; P:tryptophan catabolic process; IMP:UniProtKB
Q16719	KYNU	Kynureninase	GO:0019442; P:tryptophan catabolic process to acetyl-CoA; IEA:Ensembl
Q16719	KYNU	Kynureninase	GO:0019441; P:tryptophan catabolic process to kynurenine; IEA:Ensembl
Q8NBH2	KY	Kyphoscoliosis peptidase	GO:0008233; F:peptidase activity; IEA:UniProtKB-KW
Q8NBH2	KY	Kyphoscoliosis peptidase	GO:0007517; P:muscle organ development; IEA:Ensembl
Q8NBH2	KY	Kyphoscoliosis peptidase	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
P32004	L1CAM	Neural cell adhesion molecule L1	GO:0033691; F:sialic acid binding; IEA:Ensembl
P32004	L1CAM	Neural cell adhesion molecule L1	GO:0007411; P:axon guidance; TAS:Reactome
P32004	L1CAM	Neural cell adhesion molecule L1	GO:0007596; P:blood coagulation; TAS:Reactome
P32004	L1CAM	Neural cell adhesion molecule L1	GO:0007155; P:cell adhesion; NAS:ProtInc
P32004	L1CAM	Neural cell adhesion molecule L1	GO:0008219; P:cell death; IEA:UniProtKB-KW
P32004	L1CAM	Neural cell adhesion molecule L1	GO:0007166; P:cell surface receptor signaling pathway; IEA:Ensembl
P32004	L1CAM	Neural cell adhesion molecule L1	GO:0033631; P:cell-cell adhesion mediated by integrin; IEA:Ensembl
P32004	L1CAM	Neural cell adhesion molecule L1	GO:0006935; P:chemotaxis; TAS:BHF-UCL
P32004	L1CAM	Neural cell adhesion molecule L1	GO:0007157; P:heterophilic cell-cell adhesion; IEA:Ensembl
P32004	L1CAM	Neural cell adhesion molecule L1	GO:0007156; P:homophilic cell adhesion; IEA:Ensembl
P32004	L1CAM	Neural cell adhesion molecule L1	GO:0034109; P:homotypic cell-cell adhesion; IEA:Ensembl
P32004	L1CAM	Neural cell adhesion molecule L1	GO:0007159; P:leukocyte cell-cell adhesion; IEA:Ensembl
P32004	L1CAM	Neural cell adhesion molecule L1	GO:0050900; P:leukocyte migration; TAS:Reactome
P32004	L1CAM	Neural cell adhesion molecule L1	GO:0007399; P:nervous system development; TAS:ProtInc
P32004	L1CAM	Neural cell adhesion molecule L1	GO:0050850; P:positive regulation of calcium-mediated signaling; IEA:Ensembl
P32004	L1CAM	Neural cell adhesion molecule L1	GO:0022409; P:positive regulation of cell-cell adhesion; IEA:Ensembl
Q15334	LLGL1	Lethal(2) giant larvae protein homolog 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15334	LLGL1	Lethal(2) giant larvae protein homolog 1	GO:0019901; F:protein kinase binding; IDA:UniProtKB
Q15334	LLGL1	Lethal(2) giant larvae protein homolog 1	GO:0005097; F:Rab GTPase activator activity; ISS:UniProtKB
Q15334	LLGL1	Lethal(2) giant larvae protein homolog 1	GO:0005198; F:structural molecule activity; TAS:ProtInc
Q15334	LLGL1	Lethal(2) giant larvae protein homolog 1	GO:0007409; P:axonogenesis; ISS:UniProtKB
Q15334	LLGL1	Lethal(2) giant larvae protein homolog 1	GO:0030866; P:cortical actin cytoskeleton organization; IDA:UniProtKB
Q15334	LLGL1	Lethal(2) giant larvae protein homolog 1	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q15334	LLGL1	Lethal(2) giant larvae protein homolog 1	GO:0006893; P:Golgi to plasma membrane transport; ISS:UniProtKB
Q15334	LLGL1	Lethal(2) giant larvae protein homolog 1	GO:0035090; P:maintenance of apical/basal cell polarity; IEA:Ensembl
Q15334	LLGL1	Lethal(2) giant larvae protein homolog 1	GO:0032851; P:positive regulation of Rab GTPase activity; ISS:GOC
Q15334	LLGL1	Lethal(2) giant larvae protein homolog 1	GO:0006461; P:protein complex assembly; IDA:UniProtKB
Q6P1M3	LLGL2	Lethal(2) giant larvae protein homolog 2	GO:0030165; F:PDZ domain binding; IPI:UniProtKB
Q6P1M3	LLGL2	Lethal(2) giant larvae protein homolog 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q6P1M3	LLGL2	Lethal(2) giant larvae protein homolog 2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q6P1M3	LLGL2	Lethal(2) giant larvae protein homolog 2	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q6P1M3	LLGL2	Lethal(2) giant larvae protein homolog 2	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q6P1M3	LLGL2	Lethal(2) giant larvae protein homolog 2	GO:0032878; P:regulation of establishment or maintenance of cell polarity; IDA:UniProtKB
Q9H9P8	L2HGDH	L-2-hydroxyglutarate dehydrogenase, mitochondrial	GO:0047545; F:2-hydroxyglutarate dehydrogenase activity; IDA:HGNC
Q9H9P8	L2HGDH	L-2-hydroxyglutarate dehydrogenase, mitochondrial	GO:0006103; P:2-oxoglutarate metabolic process; TAS:Reactome
Q9H9P8	L2HGDH	L-2-hydroxyglutarate dehydrogenase, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q9H9P8	L2HGDH	L-2-hydroxyglutarate dehydrogenase, mitochondrial	GO:0044267; P:cellular protein metabolic process; IDA:HGNC
Q9H9P8	L2HGDH	L-2-hydroxyglutarate dehydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6ZP29	PQLC2	Lysosomal amino acid transporter 1 homolog	GO:0015181; F:arginine transmembrane transporter activity; IDA:UniProtKB
Q6ZP29	PQLC2	Lysosomal amino acid transporter 1 homolog	GO:0015326; F:cationic amino acid transmembrane transporter activity; ISS:UniProtKB
Q6ZP29	PQLC2	Lysosomal amino acid transporter 1 homolog	GO:0015189; F:L-lysine transmembrane transporter activity; IDA:UniProtKB
Q6ZP29	PQLC2	Lysosomal amino acid transporter 1 homolog	GO:0080144; P:amino acid homeostasis; IDA:UniProtKB
Q6ZP29	PQLC2	Lysosomal amino acid transporter 1 homolog	GO:0003333; P:amino acid transmembrane transport; ISS:GOC
Q6ZP29	PQLC2	Lysosomal amino acid transporter 1 homolog	GO:0015809; P:arginine transport; IDA:UniProtKB
Q6ZP29	PQLC2	Lysosomal amino acid transporter 1 homolog	GO:0015819; P:lysine transport; IDA:UniProtKB
P0CG04	IGLC1	Ig lambda-1 chain C regions	GO:0003823; F:antigen binding; NAS:UniProtKB
P0CG04	IGLC1	Ig lambda-1 chain C regions	GO:0006956; P:complement activation; TAS:Reactome
P0CG04	IGLC1	Ig lambda-1 chain C regions	GO:0006958; P:complement activation, classical pathway; TAS:Reactome
P0CG04	IGLC1	Ig lambda-1 chain C regions	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P0CG04	IGLC1	Ig lambda-1 chain C regions	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P0CG04	IGLC1	Ig lambda-1 chain C regions	GO:0006955; P:immune response; NAS:UniProtKB
P0CG04	IGLC1	Ig lambda-1 chain C regions	GO:0045087; P:innate immune response; TAS:Reactome
P0CG04	IGLC1	Ig lambda-1 chain C regions	GO:0050776; P:regulation of immune response; TAS:Reactome
P0CG05	IGLC2	Ig lambda-2 chain C regions	GO:0003823; F:antigen binding; IEA:UniProtKB-KW
P0CG05	IGLC2	Ig lambda-2 chain C regions	GO:0006956; P:complement activation; TAS:Reactome
P0CG05	IGLC2	Ig lambda-2 chain C regions	GO:0006958; P:complement activation, classical pathway; TAS:Reactome
P0CG05	IGLC2	Ig lambda-2 chain C regions	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P0CG05	IGLC2	Ig lambda-2 chain C regions	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P0CG05	IGLC2	Ig lambda-2 chain C regions	GO:0045087; P:innate immune response; TAS:Reactome
P0CG05	IGLC2	Ig lambda-2 chain C regions	GO:0050776; P:regulation of immune response; TAS:Reactome
P0CG06	IGLC3	Ig lambda-3 chain C regions	GO:0003823; F:antigen binding; IEA:UniProtKB-KW
P0CG06	IGLC3	Ig lambda-3 chain C regions	GO:0006956; P:complement activation; TAS:Reactome
P0CG06	IGLC3	Ig lambda-3 chain C regions	GO:0006958; P:complement activation, classical pathway; TAS:Reactome
P0CG06	IGLC3	Ig lambda-3 chain C regions	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P0CG06	IGLC3	Ig lambda-3 chain C regions	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P0CG06	IGLC3	Ig lambda-3 chain C regions	GO:0045087; P:innate immune response; TAS:Reactome
P0CG06	IGLC3	Ig lambda-3 chain C regions	GO:0050776; P:regulation of immune response; TAS:Reactome
P0CF74	IGLC6	Ig lambda-6 chain C region	GO:0003823; F:antigen binding; IEA:UniProtKB-KW
P0CF74	IGLC6	Ig lambda-6 chain C region	GO:0006956; P:complement activation; TAS:Reactome
P0CF74	IGLC6	Ig lambda-6 chain C region	GO:0006958; P:complement activation, classical pathway; TAS:Reactome
P0CF74	IGLC6	Ig lambda-6 chain C region	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P0CF74	IGLC6	Ig lambda-6 chain C region	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P0CF74	IGLC6	Ig lambda-6 chain C region	GO:0045087; P:innate immune response; TAS:Reactome
P0CF74	IGLC6	Ig lambda-6 chain C region	GO:0050776; P:regulation of immune response; TAS:Reactome
A0M8Q6	IGLC7	Ig lambda-7 chain C region	GO:0003823; F:antigen binding; IEA:UniProtKB-KW
A0M8Q6	IGLC7	Ig lambda-7 chain C region	GO:0006956; P:complement activation; TAS:Reactome
A0M8Q6	IGLC7	Ig lambda-7 chain C region	GO:0006958; P:complement activation, classical pathway; TAS:Reactome
A0M8Q6	IGLC7	Ig lambda-7 chain C region	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
A0M8Q6	IGLC7	Ig lambda-7 chain C region	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
A0M8Q6	IGLC7	Ig lambda-7 chain C region	GO:0045087; P:innate immune response; TAS:Reactome
A0M8Q6	IGLC7	Ig lambda-7 chain C region	GO:0050776; P:regulation of immune response; TAS:Reactome
Q53H82	LACTB2	Beta-lactamase-like protein 2	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q53H82	LACTB2	Beta-lactamase-like protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8WV93	LACE1	Lactation elevated protein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9GZZ8	LACRT	Extracellular glycoprotein lacritin	GO:0005518; F:collagen binding; IDA:UniProtKB
Q9GZZ8	LACRT	Extracellular glycoprotein lacritin	GO:0001968; F:fibronectin binding; IDA:UniProtKB
Q9GZZ8	LACRT	Extracellular glycoprotein lacritin	GO:0001948; F:glycoprotein binding; IDA:UniProtKB
Q9GZZ8	LACRT	Extracellular glycoprotein lacritin	GO:0008083; F:growth factor activity; IDA:UniProtKB
Q9GZZ8	LACRT	Extracellular glycoprotein lacritin	GO:0043237; F:laminin-1 binding; IDA:UniProtKB
Q9GZZ8	LACRT	Extracellular glycoprotein lacritin	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q9GZZ8	LACRT	Extracellular glycoprotein lacritin	GO:0033173; P:calcineurin-NFAT signaling cascade; IDA:UniProtKB
Q9GZZ8	LACRT	Extracellular glycoprotein lacritin	GO:0019722; P:calcium-mediated signaling; IDA:UniProtKB
Q9GZZ8	LACRT	Extracellular glycoprotein lacritin	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q9GZZ8	LACRT	Extracellular glycoprotein lacritin	GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:UniProtKB
Q9GZZ8	LACRT	Extracellular glycoprotein lacritin	GO:0051533; P:positive regulation of NFAT protein import into nucleus; IDA:UniProtKB
Q9GZZ8	LACRT	Extracellular glycoprotein lacritin	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
Q9GZZ8	LACRT	Extracellular glycoprotein lacritin	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IDA:UniProtKB
Q9GZZ8	LACRT	Extracellular glycoprotein lacritin	GO:0051047; P:positive regulation of secretion; IDA:UniProtKB
Q9GZZ8	LACRT	Extracellular glycoprotein lacritin	GO:0034067; P:protein localization to Golgi apparatus; IDA:UniProtKB
Q9GZZ8	LACRT	Extracellular glycoprotein lacritin	GO:0070075; P:tear secretion; NAS:UniProtKB
P83111	LACTB	Serine beta-lactamase-like protein LACTB, mitochondrial	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
O00515	LAD1	Ladinin-1	GO:0005198; F:structural molecule activity; TAS:ProtInc
P18627	LAG3	Lymphocyte activation gene 3 protein	GO:0003823; F:antigen binding; TAS:ProtInc
P18627	LAG3	Lymphocyte activation gene 3 protein	GO:0042289; F:MHC class II protein binding; IDA:MGI
P18627	LAG3	Lymphocyte activation gene 3 protein	GO:0004888; F:transmembrane signaling receptor activity; IEA:Ensembl
P18627	LAG3	Lymphocyte activation gene 3 protein	GO:0007166; P:cell surface receptor signaling pathway; IEA:Ensembl
P18627	LAG3	Lymphocyte activation gene 3 protein	GO:0045085; P:negative regulation of interleukin-2 biosynthetic process; IEA:Ensembl
P18627	LAG3	Lymphocyte activation gene 3 protein	GO:0050868; P:negative regulation of T cell activation; IEA:Ensembl
P18627	LAG3	Lymphocyte activation gene 3 protein	GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; IEA:Ensembl
Q14657	LAGE3	EKC/KEOPS complex subunit LAGE3	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q6GTX8	LAIR1	Leukocyte-associated immunoglobulin-like receptor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q6GTX8	LAIR1	Leukocyte-associated immunoglobulin-like receptor 1	GO:0002376; P:immune system process; IEA:UniProtKB-KW
P00709	LALBA	Alpha-lactalbumin	GO:0005509; F:calcium ion binding; IEA:InterPro
P00709	LALBA	Alpha-lactalbumin	GO:0004461; F:lactose synthase activity; IEA:InterPro
P00709	LALBA	Alpha-lactalbumin	GO:0006915; P:apoptotic process; TAS:ProtInc
P00709	LALBA	Alpha-lactalbumin	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P00709	LALBA	Alpha-lactalbumin	GO:0042742; P:defense response to bacterium; TAS:ProtInc
P00709	LALBA	Alpha-lactalbumin	GO:0005989; P:lactose biosynthetic process; TAS:ProtInc
P00709	LALBA	Alpha-lactalbumin	GO:0007165; P:signal transduction; TAS:ProtInc
P25391	LAMA1	Laminin subunit alpha-1	GO:0005201; F:extracellular matrix structural constituent; ISS:UniProtKB
P25391	LAMA1	Laminin subunit alpha-1	GO:0043208; F:glycosphingolipid binding; IEA:Ensembl
P25391	LAMA1	Laminin subunit alpha-1	GO:0005515; F:protein binding; IPI:IntAct
P25391	LAMA1	Laminin subunit alpha-1	GO:0007411; P:axon guidance; TAS:Reactome
P25391	LAMA1	Laminin subunit alpha-1	GO:0060445; P:branching involved in salivary gland morphogenesis; IEA:Ensembl
P25391	LAMA1	Laminin subunit alpha-1	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P25391	LAMA1	Laminin subunit alpha-1	GO:0007166; P:cell surface receptor signaling pathway; ISS:UniProtKB
P25391	LAMA1	Laminin subunit alpha-1	GO:0060441; P:epithelial tube branching involved in lung morphogenesis; IEA:Ensembl
P25391	LAMA1	Laminin subunit alpha-1	GO:0045198; P:establishment of epithelial cell apical/basal polarity; IEA:Ensembl
P25391	LAMA1	Laminin subunit alpha-1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P25391	LAMA1	Laminin subunit alpha-1	GO:0002011; P:morphogenesis of an epithelial sheet; IEA:Ensembl
P25391	LAMA1	Laminin subunit alpha-1	GO:0030155; P:regulation of cell adhesion; IEA:InterPro
P25391	LAMA1	Laminin subunit alpha-1	GO:0030334; P:regulation of cell migration; IEA:InterPro
P25391	LAMA1	Laminin subunit alpha-1	GO:0045995; P:regulation of embryonic development; IEA:InterPro
P25391	LAMA1	Laminin subunit alpha-1	GO:0061304; P:retinal blood vessel morphogenesis; IEA:Ensembl
P24043	LAMA2	Laminin subunit alpha-2	GO:0005198; F:structural molecule activity; TAS:ProtInc
P24043	LAMA2	Laminin subunit alpha-2	GO:0007411; P:axon guidance; IEA:Ensembl
P24043	LAMA2	Laminin subunit alpha-2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P24043	LAMA2	Laminin subunit alpha-2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P24043	LAMA2	Laminin subunit alpha-2	GO:0007517; P:muscle organ development; TAS:ProtInc
P24043	LAMA2	Laminin subunit alpha-2	GO:0022011; P:myelination in peripheral nervous system; IEA:Ensembl
P24043	LAMA2	Laminin subunit alpha-2	GO:0032224; P:positive regulation of synaptic transmission, cholinergic; IEA:Ensembl
P24043	LAMA2	Laminin subunit alpha-2	GO:0030155; P:regulation of cell adhesion; IEA:InterPro
P24043	LAMA2	Laminin subunit alpha-2	GO:0030334; P:regulation of cell migration; IEA:InterPro
P24043	LAMA2	Laminin subunit alpha-2	GO:0045995; P:regulation of embryonic development; IEA:InterPro
Q16787	LAMA3	Laminin subunit alpha-3	GO:0005198; F:structural molecule activity; NAS:ProtInc
Q16787	LAMA3	Laminin subunit alpha-3	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q16787	LAMA3	Laminin subunit alpha-3	GO:0034329; P:cell junction assembly; TAS:Reactome
Q16787	LAMA3	Laminin subunit alpha-3	GO:0008544; P:epidermis development; TAS:ProtInc
Q16787	LAMA3	Laminin subunit alpha-3	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q16787	LAMA3	Laminin subunit alpha-3	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q16787	LAMA3	Laminin subunit alpha-3	GO:0031581; P:hemidesmosome assembly; TAS:Reactome
Q16787	LAMA3	Laminin subunit alpha-3	GO:0030155; P:regulation of cell adhesion; IEA:InterPro
Q16787	LAMA3	Laminin subunit alpha-3	GO:0030334; P:regulation of cell migration; IEA:InterPro
Q16787	LAMA3	Laminin subunit alpha-3	GO:0045995; P:regulation of embryonic development; IEA:InterPro
Q16363	LAMA4	Laminin subunit alpha-4	GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc
Q16363	LAMA4	Laminin subunit alpha-4	GO:0001568; P:blood vessel development; IEA:Ensembl
Q16363	LAMA4	Laminin subunit alpha-4	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
Q16363	LAMA4	Laminin subunit alpha-4	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q16363	LAMA4	Laminin subunit alpha-4	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q16363	LAMA4	Laminin subunit alpha-4	GO:0030155; P:regulation of cell adhesion; IEA:InterPro
Q16363	LAMA4	Laminin subunit alpha-4	GO:0030334; P:regulation of cell migration; IEA:InterPro
Q16363	LAMA4	Laminin subunit alpha-4	GO:0045995; P:regulation of embryonic development; IEA:InterPro
O15230	LAMA5	Laminin subunit alpha-5	GO:0005178; F:integrin binding; IDA:UniProtKB
O15230	LAMA5	Laminin subunit alpha-5	GO:0005198; F:structural molecule activity; IC:UniProtKB
O15230	LAMA5	Laminin subunit alpha-5	GO:0001525; P:angiogenesis; NAS:UniProtKB
O15230	LAMA5	Laminin subunit alpha-5	GO:0060445; P:branching involved in salivary gland morphogenesis; IEA:Ensembl
O15230	LAMA5	Laminin subunit alpha-5	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
O15230	LAMA5	Laminin subunit alpha-5	GO:0030154; P:cell differentiation; NAS:UniProtKB
O15230	LAMA5	Laminin subunit alpha-5	GO:0016477; P:cell migration; IDA:UniProtKB
O15230	LAMA5	Laminin subunit alpha-5	GO:0008283; P:cell proliferation; NAS:UniProtKB
O15230	LAMA5	Laminin subunit alpha-5	GO:0008037; P:cell recognition; NAS:UniProtKB
O15230	LAMA5	Laminin subunit alpha-5	GO:0042384; P:cilium assembly; IEA:Ensembl
O15230	LAMA5	Laminin subunit alpha-5	GO:0007010; P:cytoskeleton organization; NAS:UniProtKB
O15230	LAMA5	Laminin subunit alpha-5	GO:0009790; P:embryo development; NAS:UniProtKB
O15230	LAMA5	Laminin subunit alpha-5	GO:0045446; P:endothelial cell differentiation; NAS:UniProtKB
O15230	LAMA5	Laminin subunit alpha-5	GO:0090002; P:establishment of protein localization to plasma membrane; IEA:Ensembl
O15230	LAMA5	Laminin subunit alpha-5	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
O15230	LAMA5	Laminin subunit alpha-5	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O15230	LAMA5	Laminin subunit alpha-5	GO:0048041; P:focal adhesion assembly; NAS:UniProtKB
O15230	LAMA5	Laminin subunit alpha-5	GO:0001942; P:hair follicle development; IEA:Ensembl
O15230	LAMA5	Laminin subunit alpha-5	GO:0007229; P:integrin-mediated signaling pathway; IMP:UniProtKB
O15230	LAMA5	Laminin subunit alpha-5	GO:0030324; P:lung development; IEA:Ensembl
O15230	LAMA5	Laminin subunit alpha-5	GO:0001738; P:morphogenesis of a polarized epithelium; IEA:Ensembl
O15230	LAMA5	Laminin subunit alpha-5	GO:0016331; P:morphogenesis of embryonic epithelium; IEA:Ensembl
O15230	LAMA5	Laminin subunit alpha-5	GO:0007517; P:muscle organ development; IEA:Ensembl
O15230	LAMA5	Laminin subunit alpha-5	GO:0001755; P:neural crest cell migration; IEA:Ensembl
O15230	LAMA5	Laminin subunit alpha-5	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
O15230	LAMA5	Laminin subunit alpha-5	GO:0030155; P:regulation of cell adhesion; IEA:InterPro
O15230	LAMA5	Laminin subunit alpha-5	GO:0030334; P:regulation of cell migration; IEA:InterPro
O15230	LAMA5	Laminin subunit alpha-5	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
O15230	LAMA5	Laminin subunit alpha-5	GO:0045995; P:regulation of embryonic development; IEA:InterPro
O15230	LAMA5	Laminin subunit alpha-5	GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:BHF-UCL
P07942	LAMB1	Laminin subunit beta-1	GO:0005201; F:extracellular matrix structural constituent; IDA:HGNC
P07942	LAMB1	Laminin subunit beta-1	GO:0043208; F:glycosphingolipid binding; IEA:Ensembl
P07942	LAMB1	Laminin subunit beta-1	GO:0005198; F:structural molecule activity; NAS:UniProtKB
P07942	LAMB1	Laminin subunit beta-1	GO:0007411; P:axon guidance; TAS:Reactome
P07942	LAMB1	Laminin subunit beta-1	GO:0007155; P:cell adhesion; TAS:HGNC
P07942	LAMB1	Laminin subunit beta-1	GO:0007566; P:embryo implantation; IEA:Ensembl
P07942	LAMB1	Laminin subunit beta-1	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P07942	LAMB1	Laminin subunit beta-1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P07942	LAMB1	Laminin subunit beta-1	GO:0007162; P:negative regulation of cell adhesion; IEA:Ensembl
P07942	LAMB1	Laminin subunit beta-1	GO:0031175; P:neuron projection development; IDA:UniProtKB
P07942	LAMB1	Laminin subunit beta-1	GO:0021812; P:neuronal-glial interaction involved in cerebral cortex radial glia guided migration; IMP:UniProtKB
P07942	LAMB1	Laminin subunit beta-1	GO:0042476; P:odontogenesis; IDA:UniProtKB
P07942	LAMB1	Laminin subunit beta-1	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
P07942	LAMB1	Laminin subunit beta-1	GO:0050679; P:positive regulation of epithelial cell proliferation; TAS:HGNC
P07942	LAMB1	Laminin subunit beta-1	GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:BHF-UCL
P55268	LAMB2	Laminin subunit beta-2	GO:0005198; F:structural molecule activity; NAS:ProtInc
P55268	LAMB2	Laminin subunit beta-2	GO:0014002; P:astrocyte development; IEA:Ensembl
P55268	LAMB2	Laminin subunit beta-2	GO:0048677; P:axon extension involved in regeneration; IEA:Ensembl
P55268	LAMB2	Laminin subunit beta-2	GO:0007411; P:axon guidance; IEA:Ensembl
P55268	LAMB2	Laminin subunit beta-2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P55268	LAMB2	Laminin subunit beta-2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P55268	LAMB2	Laminin subunit beta-2	GO:0072274; P:metanephric glomerular basement membrane development; IEA:Ensembl
P55268	LAMB2	Laminin subunit beta-2	GO:0072249; P:metanephric glomerular visceral epithelial cell development; IEA:Ensembl
P55268	LAMB2	Laminin subunit beta-2	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
P55268	LAMB2	Laminin subunit beta-2	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
P55268	LAMB2	Laminin subunit beta-2	GO:0014044; P:Schwann cell development; IEA:Ensembl
P55268	LAMB2	Laminin subunit beta-2	GO:0007601; P:visual perception; IEA:Ensembl
Q13751	LAMB3	Laminin subunit beta-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q13751	LAMB3	Laminin subunit beta-3	GO:0005198; F:structural molecule activity; NAS:ProtInc
Q13751	LAMB3	Laminin subunit beta-3	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
Q13751	LAMB3	Laminin subunit beta-3	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q13751	LAMB3	Laminin subunit beta-3	GO:0034329; P:cell junction assembly; TAS:Reactome
Q13751	LAMB3	Laminin subunit beta-3	GO:0008544; P:epidermis development; TAS:ProtInc
Q13751	LAMB3	Laminin subunit beta-3	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q13751	LAMB3	Laminin subunit beta-3	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q13751	LAMB3	Laminin subunit beta-3	GO:0031581; P:hemidesmosome assembly; TAS:Reactome
A4D0S4	LAMB4	Laminin subunit beta-4	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P11047	LAMC1	Laminin subunit gamma-1	GO:0005201; F:extracellular matrix structural constituent; IMP:HGNC
P11047	LAMC1	Laminin subunit gamma-1	GO:0043208; F:glycosphingolipid binding; IEA:Ensembl
P11047	LAMC1	Laminin subunit gamma-1	GO:0007411; P:axon guidance; TAS:Reactome
P11047	LAMC1	Laminin subunit gamma-1	GO:0007155; P:cell adhesion; IDA:HGNC
P11047	LAMC1	Laminin subunit gamma-1	GO:0016477; P:cell migration; IMP:HGNC
P11047	LAMC1	Laminin subunit gamma-1	GO:0007492; P:endoderm development; TAS:ProtInc
P11047	LAMC1	Laminin subunit gamma-1	GO:0022617; P:extracellular matrix disassembly; IMP:HGNC
P11047	LAMC1	Laminin subunit gamma-1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P11047	LAMC1	Laminin subunit gamma-1	GO:0031581; P:hemidesmosome assembly; IMP:HGNC
P11047	LAMC1	Laminin subunit gamma-1	GO:0050679; P:positive regulation of epithelial cell proliferation; TAS:HGNC
P11047	LAMC1	Laminin subunit gamma-1	GO:0006461; P:protein complex assembly; IDA:HGNC
P11047	LAMC1	Laminin subunit gamma-1	GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:BHF-UCL
Q13753	LAMC2	Laminin subunit gamma-2	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
Q13753	LAMC2	Laminin subunit gamma-2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q13753	LAMC2	Laminin subunit gamma-2	GO:0034329; P:cell junction assembly; TAS:Reactome
Q13753	LAMC2	Laminin subunit gamma-2	GO:0008544; P:epidermis development; TAS:ProtInc
Q13753	LAMC2	Laminin subunit gamma-2	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q13753	LAMC2	Laminin subunit gamma-2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q13753	LAMC2	Laminin subunit gamma-2	GO:0031581; P:hemidesmosome assembly; TAS:Reactome
Q9Y6N6	LAMC3	Laminin subunit gamma-3	GO:0005198; F:structural molecule activity; TAS:ProtInc
Q9Y6N6	LAMC3	Laminin subunit gamma-3	GO:0014002; P:astrocyte development; IEA:Ensembl
Q9Y6N6	LAMC3	Laminin subunit gamma-3	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9Y6N6	LAMC3	Laminin subunit gamma-3	GO:0000904; P:cell morphogenesis involved in differentiation; IEA:Ensembl
Q9Y6N6	LAMC3	Laminin subunit gamma-3	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q9Y6N6	LAMC3	Laminin subunit gamma-3	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
Q9Y6N6	LAMC3	Laminin subunit gamma-3	GO:0007601; P:visual perception; IEA:Ensembl
P11279	LAMP1	Lysosome-associated membrane glycoprotein 1	GO:0019899; F:enzyme binding; IPI:UniProt
P11279	LAMP1	Lysosome-associated membrane glycoprotein 1	GO:0005515; F:protein binding; IPI:IntAct
P11279	LAMP1	Lysosome-associated membrane glycoprotein 1	GO:0048102; P:autophagic cell death; IEA:Ensembl
P11279	LAMP1	Lysosome-associated membrane glycoprotein 1	GO:0006914; P:autophagy; IEA:Ensembl
P11279	LAMP1	Lysosome-associated membrane glycoprotein 1	GO:0072594; P:establishment of protein localization to organelle; IMP:UniProt
P11279	LAMP1	Lysosome-associated membrane glycoprotein 1	GO:0090160; P:Golgi to lysosome transport; IMP:UniProt
P11279	LAMP1	Lysosome-associated membrane glycoprotein 1	GO:0008626; P:granzyme-mediated apoptotic signaling pathway; IMP:UniProt
P11279	LAMP1	Lysosome-associated membrane glycoprotein 1	GO:0043323; P:positive regulation of natural killer cell degranulation; IMP:UniProt
P11279	LAMP1	Lysosome-associated membrane glycoprotein 1	GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; IMP:UniProt
P11279	LAMP1	Lysosome-associated membrane glycoprotein 1	GO:0050821; P:protein stabilization; ISS:UniProt
P11279	LAMP1	Lysosome-associated membrane glycoprotein 1	GO:1902513; P:regulation of organelle transport along microtubule; IMP:UniProt
P13473	LAMP2	Lysosome-associated membrane glycoprotein 2	GO:0019899; F:enzyme binding; IPI:UniProt
P13473	LAMP2	Lysosome-associated membrane glycoprotein 2	GO:0007596; P:blood coagulation; TAS:Reactome
P13473	LAMP2	Lysosome-associated membrane glycoprotein 2	GO:0030168; P:platelet activation; TAS:Reactome
P13473	LAMP2	Lysosome-associated membrane glycoprotein 2	GO:0002576; P:platelet degranulation; TAS:Reactome
P13473	LAMP2	Lysosome-associated membrane glycoprotein 2	GO:0050821; P:protein stabilization; ISS:UniProt
Q9UQV4	LAMP3	Lysosome-associated membrane glycoprotein 3	GO:0008283; P:cell proliferation; TAS:ProtInc
Q9UQV4	LAMP3	Lysosome-associated membrane glycoprotein 3	GO:0002376; P:immune system process; IEA:UniProtKB-KW
O43813	LANCL1	LanC-like protein 1	GO:0003824; F:catalytic activity; IEA:InterPro
O43813	LANCL1	LanC-like protein 1	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O43813	LANCL1	LanC-like protein 1	GO:0043295; F:glutathione binding; IDA:UniProtKB
O43813	LANCL1	LanC-like protein 1	GO:0050750; F:low-density lipoprotein particle receptor binding; IDA:MGI
O43813	LANCL1	LanC-like protein 1	GO:0005515; F:protein binding; IPI:IntAct
O43813	LANCL1	LanC-like protein 1	GO:0017124; F:SH3 domain binding; IPI:UniProtKB
O43813	LANCL1	LanC-like protein 1	GO:0008270; F:zinc ion binding; IDA:UniProtKB
O43813	LANCL1	LanC-like protein 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q9NS86	LANCL2	LanC-like protein 2	GO:0005524; F:ATP binding; NAS:UniProtKB
Q9NS86	LANCL2	LanC-like protein 2	GO:0003824; F:catalytic activity; IEA:InterPro
Q9NS86	LANCL2	LanC-like protein 2	GO:0005525; F:GTP binding; NAS:UniProtKB
Q9NS86	LANCL2	LanC-like protein 2	GO:0032266; F:phosphatidylinositol-3-phosphate binding; IDA:UniProtKB
Q9NS86	LANCL2	LanC-like protein 2	GO:0070273; F:phosphatidylinositol-4-phosphate binding; IDA:UniProtKB
Q9NS86	LANCL2	LanC-like protein 2	GO:0010314; F:phosphatidylinositol-5-phosphate binding; IDA:UniProtKB
Q9NS86	LANCL2	LanC-like protein 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9NS86	LANCL2	LanC-like protein 2	GO:0009789; P:positive regulation of abscisic acid-activated signaling pathway; IDA:UniProtKB
Q6ZV70	LANCL3	LanC-like protein 3	GO:0003824; F:catalytic activity; IEA:InterPro
P42166	TMPO	Lamina-associated polypeptide 2, isoform alpha	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P42166	TMPO	Lamina-associated polypeptide 2, isoform alpha	GO:0005521; F:lamin binding; TAS:ProtInc
P42166	TMPO	Lamina-associated polypeptide 2, isoform alpha	GO:0006355; P:regulation of transcription, DNA-templated; IEA:Ensembl
P42167	TMPO	Lamina-associated polypeptide 2, isoforms beta/gamma	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P42167	TMPO	Lamina-associated polypeptide 2, isoforms beta/gamma	GO:0005521; F:lamin binding; TAS:ProtInc
P42167	TMPO	Lamina-associated polypeptide 2, isoforms beta/gamma	GO:0005515; F:protein binding; IPI:IntAct
Q96RT1	ERBB2IP	Protein LAP2	GO:0005176; F:ErbB-2 class receptor binding; TAS:UniProtKB
Q96RT1	ERBB2IP	Protein LAP2	GO:0005178; F:integrin binding; IPI:UniProtKB
Q96RT1	ERBB2IP	Protein LAP2	GO:0005515; F:protein binding; IPI:IntAct
Q96RT1	ERBB2IP	Protein LAP2	GO:0005200; F:structural constituent of cytoskeleton; NAS:UniProtKB
Q96RT1	ERBB2IP	Protein LAP2	GO:0045175; P:basal protein localization; NAS:UniProtKB
Q96RT1	ERBB2IP	Protein LAP2	GO:0007155; P:cell adhesion; NAS:UniProtKB
Q96RT1	ERBB2IP	Protein LAP2	GO:0007049; P:cell cycle; NAS:UniProtKB
Q96RT1	ERBB2IP	Protein LAP2	GO:0016049; P:cell growth; NAS:UniProtKB
Q96RT1	ERBB2IP	Protein LAP2	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:UniProtKB
Q96RT1	ERBB2IP	Protein LAP2	GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; NAS:UniProtKB
Q96RT1	ERBB2IP	Protein LAP2	GO:0007229; P:integrin-mediated signaling pathway; NAS:UniProtKB
Q96RT1	ERBB2IP	Protein LAP2	GO:0045104; P:intermediate filament cytoskeleton organization; NAS:UniProtKB
Q96RT1	ERBB2IP	Protein LAP2	GO:0006605; P:protein targeting; IEA:Ensembl
Q96RT1	ERBB2IP	Protein LAP2	GO:0007165; P:signal transduction; TAS:ProtInc
Q15012	LAPTM4A	Lysosomal-associated transmembrane protein 4A	GO:0006810; P:transport; IEA:UniProtKB-KW
Q86VI4	LAPTM4B	Lysosomal-associated transmembrane protein 4B	GO:0005515; F:protein binding; IPI:IntAct
Q86VI4	LAPTM4B	Lysosomal-associated transmembrane protein 4B	GO:0006810; P:transport; IEA:UniProtKB-KW
Q13571	LAPTM5	Lysosomal-associated transmembrane protein 5	GO:0006810; P:transport; IEA:UniProtKB-KW
Q659C4	LARP1B	La-related protein 1B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8N3Y3	GYLTL1B	Glycosyltransferase-like protein LARGE2	GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW
Q8N3Y3	GYLTL1B	Glycosyltransferase-like protein LARGE2	GO:0046716; P:muscle cell cellular homeostasis; ISS:UniProtKB
Q92615	LARP4B	La-related protein 4B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q92615	LARP4B	La-related protein 4B	GO:0045727; P:positive regulation of translation; IMP:UniProtKB
O95461	LARGE	Glycosyltransferase-like protein LARGE1	GO:0008375; F:acetylglucosaminyltransferase activity; TAS:ProtInc
O95461	LARGE	Glycosyltransferase-like protein LARGE1	GO:0016757; F:transferase activity, transferring glycosyl groups; TAS:UniProtKB
O95461	LARGE	Glycosyltransferase-like protein LARGE1	GO:0009101; P:glycoprotein biosynthetic process; TAS:UniProtKB
O95461	LARGE	Glycosyltransferase-like protein LARGE1	GO:0006688; P:glycosphingolipid biosynthetic process; TAS:UniProtKB
O95461	LARGE	Glycosyltransferase-like protein LARGE1	GO:0046716; P:muscle cell cellular homeostasis; ISS:UniProtKB
O95461	LARGE	Glycosyltransferase-like protein LARGE1	GO:0006044; P:N-acetylglucosamine metabolic process; TAS:ProtInc
O95461	LARGE	Glycosyltransferase-like protein LARGE1	GO:0006486; P:protein glycosylation; TAS:ProtInc
Q6PKG0	LARP1	La-related protein 1	GO:0008190; F:eukaryotic initiation factor 4E binding; IPI:UniProtKB
Q6PKG0	LARP1	La-related protein 1	GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB
Q6PKG0	LARP1	La-related protein 1	GO:0048027; F:mRNA 5'-UTR binding; IDA:UniProtKB
Q6PKG0	LARP1	La-related protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6PKG0	LARP1	La-related protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q6PKG0	LARP1	La-related protein 1	GO:0000339; F:RNA cap binding; IDA:UniProtKB
Q6PKG0	LARP1	La-related protein 1	GO:0008494; F:translation activator activity; IMP:UniProtKB
Q6PKG0	LARP1	La-related protein 1	GO:0031369; F:translation initiation factor binding; IDA:UniProtKB
Q6PKG0	LARP1	La-related protein 1	GO:0008283; P:cell proliferation; IMP:UniProtKB
Q6PKG0	LARP1	La-related protein 1	GO:0016239; P:positive regulation of macroautophagy; IMP:BHF-UCL
Q6PKG0	LARP1	La-related protein 1	GO:0045727; P:positive regulation of translation; IMP:GOC
Q6PKG0	LARP1	La-related protein 1	GO:0031929; P:TOR signaling; IMP:UniProtKB
Q6PKG0	LARP1	La-related protein 1	GO:0006413; P:translational initiation; IMP:UniProtKB
Q71RC2	LARP4	La-related protein 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q71RC2	LARP4	La-related protein 4	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q71RC2	LARP4	La-related protein 4	GO:0022604; P:regulation of cell morphogenesis; IMP:UniProtKB
Q9BRS8	LARP6	La-related protein 6	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9BRS8	LARP6	La-related protein 6	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9BRS8	LARP6	La-related protein 6	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q9BRS8	LARP6	La-related protein 6	GO:0006396; P:RNA processing; IEA:InterPro
Q4G0J3	LARP7	La-related protein 7	GO:0000166; F:nucleotide binding; IEA:InterPro
Q4G0J3	LARP7	La-related protein 7	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q4G0J3	LARP7	La-related protein 7	GO:0005515; F:protein binding; IPI:IntAct
Q4G0J3	LARP7	La-related protein 7	GO:0006396; P:RNA processing; IEA:InterPro
Q9Y4W2	LAS1L	Ribosomal biogenesis protein LAS1L	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y4W2	LAS1L	Ribosomal biogenesis protein LAS1L	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q14847	LASP1	LIM and SH3 domain protein 1	GO:0015075; F:ion transmembrane transporter activity; ISS:UniProtKB
Q14847	LASP1	LIM and SH3 domain protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q14847	LASP1	LIM and SH3 domain protein 1	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
Q14847	LASP1	LIM and SH3 domain protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q14847	LASP1	LIM and SH3 domain protein 1	GO:0006811; P:ion transport; ISS:UniProtKB
Q14847	LASP1	LIM and SH3 domain protein 1	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
Q9GIP4	SLC7A5P2	Putative L-type amino acid transporter 1-like protein IMAA	GO:0015171; F:amino acid transmembrane transporter activity; IEA:InterPro
Q8MH63	SLC7A5P1	Putative L-type amino acid transporter 1-like protein MLAS	GO:0015171; F:amino acid transmembrane transporter activity; IEA:InterPro
Q01650	SLC7A5	Large neutral amino acids transporter small subunit 1	GO:0015171; F:amino acid transmembrane transporter activity; ISS:UniProtKB
Q01650	SLC7A5	Large neutral amino acids transporter small subunit 1	GO:0015179; F:L-amino acid transmembrane transporter activity; IEA:Ensembl
Q01650	SLC7A5	Large neutral amino acids transporter small subunit 1	GO:0015175; F:neutral amino acid transmembrane transporter activity; TAS:ProtInc
Q01650	SLC7A5	Large neutral amino acids transporter small subunit 1	GO:0042605; F:peptide antigen binding; ISS:UniProtKB
Q01650	SLC7A5	Large neutral amino acids transporter small subunit 1	GO:0006865; P:amino acid transport; TAS:Reactome
Q01650	SLC7A5	Large neutral amino acids transporter small subunit 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q01650	SLC7A5	Large neutral amino acids transporter small subunit 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q01650	SLC7A5	Large neutral amino acids transporter small subunit 1	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
Q01650	SLC7A5	Large neutral amino acids transporter small subunit 1	GO:0006811; P:ion transport; TAS:Reactome
Q01650	SLC7A5	Large neutral amino acids transporter small subunit 1	GO:0050900; P:leukocyte migration; TAS:Reactome
Q01650	SLC7A5	Large neutral amino acids transporter small subunit 1	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q01650	SLC7A5	Large neutral amino acids transporter small subunit 1	GO:0015804; P:neutral amino acid transport; ISS:UniProtKB
Q01650	SLC7A5	Large neutral amino acids transporter small subunit 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q01650	SLC7A5	Large neutral amino acids transporter small subunit 1	GO:0006810; P:transport; TAS:ProtInc
Q9UHI5	SLC7A8	Large neutral amino acids transporter small subunit 2	GO:0015171; F:amino acid transmembrane transporter activity; IDA:UniProtKB
Q9UHI5	SLC7A8	Large neutral amino acids transporter small subunit 2	GO:0015179; F:L-amino acid transmembrane transporter activity; IEA:Ensembl
Q9UHI5	SLC7A8	Large neutral amino acids transporter small subunit 2	GO:0015175; F:neutral amino acid transmembrane transporter activity; TAS:ProtInc
Q9UHI5	SLC7A8	Large neutral amino acids transporter small subunit 2	GO:0015101; F:organic cation transmembrane transporter activity; IDA:UniProtKB
Q9UHI5	SLC7A8	Large neutral amino acids transporter small subunit 2	GO:0042605; F:peptide antigen binding; ISS:UniProtKB
Q9UHI5	SLC7A8	Large neutral amino acids transporter small subunit 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UHI5	SLC7A8	Large neutral amino acids transporter small subunit 2	GO:0019534; F:toxin transporter activity; IDA:UniProtKB
Q9UHI5	SLC7A8	Large neutral amino acids transporter small subunit 2	GO:0006865; P:amino acid transport; IDA:UniProtKB
Q9UHI5	SLC7A8	Large neutral amino acids transporter small subunit 2	GO:0007596; P:blood coagulation; TAS:Reactome
Q9UHI5	SLC7A8	Large neutral amino acids transporter small subunit 2	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
Q9UHI5	SLC7A8	Large neutral amino acids transporter small subunit 2	GO:0006811; P:ion transport; TAS:Reactome
Q9UHI5	SLC7A8	Large neutral amino acids transporter small subunit 2	GO:0050900; P:leukocyte migration; TAS:Reactome
Q9UHI5	SLC7A8	Large neutral amino acids transporter small subunit 2	GO:0055065; P:metal ion homeostasis; NAS:UniProtKB
Q9UHI5	SLC7A8	Large neutral amino acids transporter small subunit 2	GO:0015804; P:neutral amino acid transport; ISS:UniProtKB
Q9UHI5	SLC7A8	Large neutral amino acids transporter small subunit 2	GO:0015695; P:organic cation transport; IDA:GOC
Q9UHI5	SLC7A8	Large neutral amino acids transporter small subunit 2	GO:0009636; P:response to toxic substance; NAS:UniProtKB
Q9UHI5	SLC7A8	Large neutral amino acids transporter small subunit 2	GO:1901998; P:toxin transport; IDA:GOC
Q9UHI5	SLC7A8	Large neutral amino acids transporter small subunit 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UHI5	SLC7A8	Large neutral amino acids transporter small subunit 2	GO:0006810; P:transport; TAS:ProtInc
O75387	SLC43A1	Large neutral amino acids transporter small subunit 3	GO:0015179; F:L-amino acid transmembrane transporter activity; IEA:Ensembl
O75387	SLC43A1	Large neutral amino acids transporter small subunit 3	GO:0015175; F:neutral amino acid transmembrane transporter activity; IDA:UniProtKB
O75387	SLC43A1	Large neutral amino acids transporter small subunit 3	GO:0006865; P:amino acid transport; TAS:Reactome
O75387	SLC43A1	Large neutral amino acids transporter small subunit 3	GO:0006811; P:ion transport; TAS:Reactome
O75387	SLC43A1	Large neutral amino acids transporter small subunit 3	GO:0015804; P:neutral amino acid transport; IDA:UniProtKB
O75387	SLC43A1	Large neutral amino acids transporter small subunit 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8N370	SLC43A2	Large neutral amino acids transporter small subunit 4	GO:0015179; F:L-amino acid transmembrane transporter activity; IEA:Ensembl
Q8N370	SLC43A2	Large neutral amino acids transporter small subunit 4	GO:0006865; P:amino acid transport; TAS:Reactome
Q8N370	SLC43A2	Large neutral amino acids transporter small subunit 4	GO:0006811; P:ion transport; TAS:Reactome
Q8N370	SLC43A2	Large neutral amino acids transporter small subunit 4	GO:0055085; P:transmembrane transport; TAS:Reactome
Q86YQ2	LATH	Putative latherin	GO:0008289; F:lipid binding; IEA:InterPro
Q9NRM7	LATS2	Serine/threonine-protein kinase LATS2	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9NRM7	LATS2	Serine/threonine-protein kinase LATS2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NRM7	LATS2	Serine/threonine-protein kinase LATS2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NRM7	LATS2	Serine/threonine-protein kinase LATS2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9NRM7	LATS2	Serine/threonine-protein kinase LATS2	GO:0034613; P:cellular protein localization; IEA:Ensembl
Q9NRM7	LATS2	Serine/threonine-protein kinase LATS2	GO:0000082; P:G1/S transition of mitotic cell cycle; IDA:UniProtKB
Q9NRM7	LATS2	Serine/threonine-protein kinase LATS2	GO:0035329; P:hippo signaling; IDA:BHF-UCL
Q9NRM7	LATS2	Serine/threonine-protein kinase LATS2	GO:0009755; P:hormone-mediated signaling pathway; IDA:UniProtKB
Q9NRM7	LATS2	Serine/threonine-protein kinase LATS2	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q9NRM7	LATS2	Serine/threonine-protein kinase LATS2	GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
Q9NRM7	LATS2	Serine/threonine-protein kinase LATS2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9NRM7	LATS2	Serine/threonine-protein kinase LATS2	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
Q9NRM7	LATS2	Serine/threonine-protein kinase LATS2	GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:UniProtKB
Q9NRM7	LATS2	Serine/threonine-protein kinase LATS2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9NRM7	LATS2	Serine/threonine-protein kinase LATS2	GO:0046620; P:regulation of organ growth; IEA:Ensembl
O95835	LATS1	Serine/threonine-protein kinase LATS1	GO:0005524; F:ATP binding; IDA:UniProtKB
O95835	LATS1	Serine/threonine-protein kinase LATS1	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
O95835	LATS1	Serine/threonine-protein kinase LATS1	GO:0005515; F:protein binding; IPI:UniProtKB
O95835	LATS1	Serine/threonine-protein kinase LATS1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O95835	LATS1	Serine/threonine-protein kinase LATS1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
O95835	LATS1	Serine/threonine-protein kinase LATS1	GO:0051220; P:cytoplasmic sequestering of protein; IMP:BHF-UCL
O95835	LATS1	Serine/threonine-protein kinase LATS1	GO:0000086; P:G2/M transition of mitotic cell cycle; IDA:UniProtKB
O95835	LATS1	Serine/threonine-protein kinase LATS1	GO:0035329; P:hippo signaling; IDA:BHF-UCL
O95835	LATS1	Serine/threonine-protein kinase LATS1	GO:0009755; P:hormone-mediated signaling pathway; ISS:UniProtKB
O95835	LATS1	Serine/threonine-protein kinase LATS1	GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
O95835	LATS1	Serine/threonine-protein kinase LATS1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
O95835	LATS1	Serine/threonine-protein kinase LATS1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
O95835	LATS1	Serine/threonine-protein kinase LATS1	GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:UniProtKB
O95835	LATS1	Serine/threonine-protein kinase LATS1	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:BHF-UCL
O95835	LATS1	Serine/threonine-protein kinase LATS1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
O95835	LATS1	Serine/threonine-protein kinase LATS1	GO:0030833; P:regulation of actin filament polymerization; IDA:UniProtKB
O95835	LATS1	Serine/threonine-protein kinase LATS1	GO:0043254; P:regulation of protein complex assembly; IMP:BHF-UCL
O95835	LATS1	Serine/threonine-protein kinase LATS1	GO:0000819; P:sister chromatid segregation; IDA:UniProtKB
O43561	LAT	Linker for activation of T-cells family member 1	GO:0005515; F:protein binding; IPI:IntAct
O43561	LAT	Linker for activation of T-cells family member 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O43561	LAT	Linker for activation of T-cells family member 1	GO:0005070; F:SH3/SH2 adaptor activity; IDA:HGNC
O43561	LAT	Linker for activation of T-cells family member 1	GO:0007596; P:blood coagulation; TAS:Reactome
O43561	LAT	Linker for activation of T-cells family member 1	GO:0019722; P:calcium-mediated signaling; IMP:HGNC
O43561	LAT	Linker for activation of T-cells family member 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O43561	LAT	Linker for activation of T-cells family member 1	GO:0010467; P:gene expression; IEA:Ensembl
O43561	LAT	Linker for activation of T-cells family member 1	GO:0006955; P:immune response; IDA:HGNC
O43561	LAT	Linker for activation of T-cells family member 1	GO:0006954; P:inflammatory response; IEA:Ensembl
O43561	LAT	Linker for activation of T-cells family member 1	GO:0045087; P:innate immune response; TAS:Reactome
O43561	LAT	Linker for activation of T-cells family member 1	GO:0007229; P:integrin-mediated signaling pathway; IDA:HGNC
O43561	LAT	Linker for activation of T-cells family member 1	GO:0035556; P:intracellular signal transduction; IDA:HGNC
O43561	LAT	Linker for activation of T-cells family member 1	GO:0043303; P:mast cell degranulation; IEA:UniProtKB-KW
O43561	LAT	Linker for activation of T-cells family member 1	GO:0030168; P:platelet activation; TAS:Reactome
O43561	LAT	Linker for activation of T-cells family member 1	GO:0009967; P:positive regulation of signal transduction; IDA:GOC
O43561	LAT	Linker for activation of T-cells family member 1	GO:0007265; P:Ras protein signal transduction; IMP:HGNC
O43561	LAT	Linker for activation of T-cells family member 1	GO:0050863; P:regulation of T cell activation; IMP:HGNC
O43561	LAT	Linker for activation of T-cells family member 1	GO:0007165; P:signal transduction; IEA:InterPro
O43561	LAT	Linker for activation of T-cells family member 1	GO:0042110; P:T cell activation; TAS:UniProtKB
O43561	LAT	Linker for activation of T-cells family member 1	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q8IWV1	LAX1	Lymphocyte transmembrane adapter 1	GO:0005515; F:protein binding; IPI:HGNC
Q8IWV1	LAX1	Lymphocyte transmembrane adapter 1	GO:0019901; F:protein kinase binding; IDA:HGNC
Q8IWV1	LAX1	Lymphocyte transmembrane adapter 1	GO:0042169; F:SH2 domain binding; IDA:HGNC
Q8IWV1	LAX1	Lymphocyte transmembrane adapter 1	GO:0050851; P:antigen receptor-mediated signaling pathway; IEA:Ensembl
Q8IWV1	LAX1	Lymphocyte transmembrane adapter 1	GO:0042113; P:B cell activation; IDA:HGNC
Q8IWV1	LAX1	Lymphocyte transmembrane adapter 1	GO:0006955; P:immune response; IDA:HGNC
Q8IWV1	LAX1	Lymphocyte transmembrane adapter 1	GO:0048305; P:immunoglobulin secretion; IEA:Ensembl
Q8IWV1	LAX1	Lymphocyte transmembrane adapter 1	GO:0000188; P:inactivation of MAPK activity; IMP:HGNC
Q8IWV1	LAX1	Lymphocyte transmembrane adapter 1	GO:0035556; P:intracellular signal transduction; IDA:HGNC
Q8IWV1	LAX1	Lymphocyte transmembrane adapter 1	GO:0050868; P:negative regulation of T cell activation; IDA:HGNC
Q6UX15	LAYN	Layilin	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q6UX15	LAYN	Layilin	GO:0005540; F:hyaluronic acid binding; IDA:HGNC
P05455	SSB	Lupus La protein	GO:0003729; F:mRNA binding; TAS:ProtInc
P05455	SSB	Lupus La protein	GO:0000166; F:nucleotide binding; IEA:InterPro
P05455	SSB	Lupus La protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P05455	SSB	Lupus La protein	GO:0005515; F:protein binding; IPI:IntAct
P05455	SSB	Lupus La protein	GO:0000049; F:tRNA binding; TAS:ProtInc
P05455	SSB	Lupus La protein	GO:0008334; P:histone mRNA metabolic process; TAS:ProtInc
P05455	SSB	Lupus La protein	GO:0006400; P:tRNA modification; TAS:ProtInc
Q53QV2	LBH	Protein LBH	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q53QV2	LBH	Protein LBH	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q53QV2	LBH	Protein LBH	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86UK5	EVC2	Limbin	GO:0007224; P:smoothened signaling pathway; ISS:UniProtKB
P18428	LBP	Lipopolysaccharide-binding protein	GO:0001530; F:lipopolysaccharide binding; ISS:BHF-UCL
P18428	LBP	Lipopolysaccharide-binding protein	GO:0070891; F:lipoteichoic acid binding; IDA:MGI
P18428	LBP	Lipopolysaccharide-binding protein	GO:0005515; F:protein binding; IPI:IntAct
P18428	LBP	Lipopolysaccharide-binding protein	GO:0005102; F:receptor binding; ISS:BHF-UCL
P18428	LBP	Lipopolysaccharide-binding protein	GO:0006953; P:acute-phase response; IEP:BHF-UCL
P18428	LBP	Lipopolysaccharide-binding protein	GO:0006968; P:cellular defense response; ISS:BHF-UCL
P18428	LBP	Lipopolysaccharide-binding protein	GO:0071222; P:cellular response to lipopolysaccharide; IDA:MGI
P18428	LBP	Lipopolysaccharide-binding protein	GO:0071223; P:cellular response to lipoteichoic acid; IDA:MGI
P18428	LBP	Lipopolysaccharide-binding protein	GO:0050829; P:defense response to Gram-negative bacterium; IDA:BHF-UCL
P18428	LBP	Lipopolysaccharide-binding protein	GO:0050830; P:defense response to Gram-positive bacterium; IDA:BHF-UCL
P18428	LBP	Lipopolysaccharide-binding protein	GO:0032490; P:detection of molecule of bacterial origin; IDA:BHF-UCL
P18428	LBP	Lipopolysaccharide-binding protein	GO:0045087; P:innate immune response; ISS:BHF-UCL
P18428	LBP	Lipopolysaccharide-binding protein	GO:0002232; P:leukocyte chemotaxis involved in inflammatory response; IEA:Ensembl
P18428	LBP	Lipopolysaccharide-binding protein	GO:0015920; P:lipopolysaccharide transport; IDA:BHF-UCL
P18428	LBP	Lipopolysaccharide-binding protein	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IDA:BHF-UCL
P18428	LBP	Lipopolysaccharide-binding protein	GO:0002281; P:macrophage activation involved in immune response; ISS:BHF-UCL
P18428	LBP	Lipopolysaccharide-binding protein	GO:0044130; P:negative regulation of growth of symbiont in host; IEA:Ensembl
P18428	LBP	Lipopolysaccharide-binding protein	GO:0032720; P:negative regulation of tumor necrosis factor production; IDA:BHF-UCL
P18428	LBP	Lipopolysaccharide-binding protein	GO:0008228; P:opsonization; ISS:BHF-UCL
P18428	LBP	Lipopolysaccharide-binding protein	GO:0032722; P:positive regulation of chemokine production; IEA:Ensembl
P18428	LBP	Lipopolysaccharide-binding protein	GO:0032755; P:positive regulation of interleukin-6 production; IDA:BHF-UCL
P18428	LBP	Lipopolysaccharide-binding protein	GO:0032757; P:positive regulation of interleukin-8 production; IDA:BHF-UCL
P18428	LBP	Lipopolysaccharide-binding protein	GO:0043032; P:positive regulation of macrophage activation; IDA:BHF-UCL
P18428	LBP	Lipopolysaccharide-binding protein	GO:0090023; P:positive regulation of neutrophil chemotaxis; IEA:Ensembl
P18428	LBP	Lipopolysaccharide-binding protein	GO:0060265; P:positive regulation of respiratory burst involved in inflammatory response; ISS:BHF-UCL
P18428	LBP	Lipopolysaccharide-binding protein	GO:0034145; P:positive regulation of toll-like receptor 4 signaling pathway; IDA:BHF-UCL
P18428	LBP	Lipopolysaccharide-binding protein	GO:0042535; P:positive regulation of tumor necrosis factor biosynthetic process; IEA:Ensembl
P18428	LBP	Lipopolysaccharide-binding protein	GO:0032760; P:positive regulation of tumor necrosis factor production; IDA:BHF-UCL
P18428	LBP	Lipopolysaccharide-binding protein	GO:0032496; P:response to lipopolysaccharide; IDA:BHF-UCL
P18428	LBP	Lipopolysaccharide-binding protein	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P18428	LBP	Lipopolysaccharide-binding protein	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q14739	LBR	Lamin-B receptor	GO:0070087; F:chromo shadow domain binding; IPI:BHF-UCL
Q14739	LBR	Lamin-B receptor	GO:0003677; F:DNA binding; TAS:ProtInc
Q14739	LBR	Lamin-B receptor	GO:0005521; F:lamin binding; TAS:ProtInc
Q14739	LBR	Lamin-B receptor	GO:0016628; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; IEA:InterPro
Q14739	LBR	Lamin-B receptor	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14739	LBR	Lamin-B receptor	GO:0005515; F:protein binding; IPI:UniProtKB
Q14739	LBR	Lamin-B receptor	GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome
Q14739	LBR	Lamin-B receptor	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P52954	LBX1	Transcription factor LBX1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P52954	LBX1	Transcription factor LBX1	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
P52954	LBX1	Transcription factor LBX1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P52954	LBX1	Transcription factor LBX1	GO:0001947; P:heart looping; IEA:Ensembl
P52954	LBX1	Transcription factor LBX1	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
P52954	LBX1	Transcription factor LBX1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P52954	LBX1	Transcription factor LBX1	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
P52954	LBX1	Transcription factor LBX1	GO:0048664; P:neuron fate determination; IEA:Ensembl
P52954	LBX1	Transcription factor LBX1	GO:0021920; P:regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification; IEA:Ensembl
P52954	LBX1	Transcription factor LBX1	GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl
P52954	LBX1	Transcription factor LBX1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6XYB7	LBX2	Transcription factor LBX2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q6XYB7	LBX2	Transcription factor LBX2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q6XYB7	LBX2	Transcription factor LBX2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y383	LUC7L2	Putative RNA-binding protein Luc7-like 2	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9Y383	LUC7L2	Putative RNA-binding protein Luc7-like 2	GO:0003729; F:mRNA binding; IEA:InterPro
Q9Y383	LUC7L2	Putative RNA-binding protein Luc7-like 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y383	LUC7L2	Putative RNA-binding protein Luc7-like 2	GO:0005515; F:protein binding; IPI:IntAct
Q9Y383	LUC7L2	Putative RNA-binding protein Luc7-like 2	GO:0006376; P:mRNA splice site selection; IEA:InterPro
O95232	LUC7L3	Luc7-like protein 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O95232	LUC7L3	Luc7-like protein 3	GO:0003729; F:mRNA binding; IMP:UniProtKB
O95232	LUC7L3	Luc7-like protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O95232	LUC7L3	Luc7-like protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
O95232	LUC7L3	Luc7-like protein 3	GO:0006376; P:mRNA splice site selection; IEA:InterPro
O95232	LUC7L3	Luc7-like protein 3	GO:0008380; P:RNA splicing; IMP:UniProtKB
Q86VQ0	LCA5	Lebercilin	GO:0005515; F:protein binding; IPI:UniProtKB
Q86VQ0	LCA5	Lebercilin	GO:0032403; F:protein complex binding; IDA:MGI
Q86VQ0	LCA5	Lebercilin	GO:0042073; P:intraciliary transport; IEA:Ensembl
Q86VQ0	LCA5	Lebercilin	GO:0045494; P:photoreceptor cell maintenance; IEA:Ensembl
Q86VQ0	LCA5	Lebercilin	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9UIQ6	LNPEP	Leucyl-cystinyl aminopeptidase	GO:0004177; F:aminopeptidase activity; TAS:HGNC
Q9UIQ6	LNPEP	Leucyl-cystinyl aminopeptidase	GO:0008237; F:metallopeptidase activity; TAS:ProtInc
Q9UIQ6	LNPEP	Leucyl-cystinyl aminopeptidase	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q9UIQ6	LNPEP	Leucyl-cystinyl aminopeptidase	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q9UIQ6	LNPEP	Leucyl-cystinyl aminopeptidase	GO:0002480; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent; TAS:Reactome
Q9UIQ6	LNPEP	Leucyl-cystinyl aminopeptidase	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q9UIQ6	LNPEP	Leucyl-cystinyl aminopeptidase	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9UIQ6	LNPEP	Leucyl-cystinyl aminopeptidase	GO:0007565; P:female pregnancy; TAS:ProtInc
Q9UIQ6	LNPEP	Leucyl-cystinyl aminopeptidase	GO:0061024; P:membrane organization; TAS:Reactome
Q9UIQ6	LNPEP	Leucyl-cystinyl aminopeptidase	GO:0030163; P:protein catabolic process; IEA:Ensembl
Q9UIQ6	LNPEP	Leucyl-cystinyl aminopeptidase	GO:0000209; P:protein polyubiquitination; TAS:Reactome
Q9UIQ6	LNPEP	Leucyl-cystinyl aminopeptidase	GO:0006508; P:proteolysis; TAS:ProtInc
P04180	LCAT	Phosphatidylcholine-sterol acyltransferase	GO:0034186; F:apolipoprotein A-I binding; IPI:BHF-UCL
P04180	LCAT	Phosphatidylcholine-sterol acyltransferase	GO:0004607; F:phosphatidylcholine-sterol O-acyltransferase activity; NAS:UniProtKB
P04180	LCAT	Phosphatidylcholine-sterol acyltransferase	GO:0005515; F:protein binding; IPI:UniProtKB
P04180	LCAT	Phosphatidylcholine-sterol acyltransferase	GO:0034435; P:cholesterol esterification; IDA:BHF-UCL
P04180	LCAT	Phosphatidylcholine-sterol acyltransferase	GO:0042632; P:cholesterol homeostasis; IDA:BHF-UCL
P04180	LCAT	Phosphatidylcholine-sterol acyltransferase	GO:0008203; P:cholesterol metabolic process; IDA:BHF-UCL
P04180	LCAT	Phosphatidylcholine-sterol acyltransferase	GO:0030301; P:cholesterol transport; IDA:MGI
P04180	LCAT	Phosphatidylcholine-sterol acyltransferase	GO:0034375; P:high-density lipoprotein particle remodeling; IDA:UniProtKB
P04180	LCAT	Phosphatidylcholine-sterol acyltransferase	GO:0042158; P:lipoprotein biosynthetic process; IEA:Ensembl
P04180	LCAT	Phosphatidylcholine-sterol acyltransferase	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
P04180	LCAT	Phosphatidylcholine-sterol acyltransferase	GO:0006656; P:phosphatidylcholine biosynthetic process; IDA:BHF-UCL
P04180	LCAT	Phosphatidylcholine-sterol acyltransferase	GO:0006644; P:phospholipid metabolic process; IDA:BHF-UCL
P04180	LCAT	Phosphatidylcholine-sterol acyltransferase	GO:0090107; P:regulation of high-density lipoprotein particle assembly; IEA:Ensembl
P04180	LCAT	Phosphatidylcholine-sterol acyltransferase	GO:0043691; P:reverse cholesterol transport; IDA:BHF-UCL
P04180	LCAT	Phosphatidylcholine-sterol acyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P04180	LCAT	Phosphatidylcholine-sterol acyltransferase	GO:0034372; P:very-low-density lipoprotein particle remodeling; IDA:BHF-UCL
Q5T7P2	LCE1A	Late cornified envelope protein 1A	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q5T7P3	LCE1B	Late cornified envelope protein 1B	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q5T751	LCE1C	Late cornified envelope protein 1C	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q5T752	LCE1D	Late cornified envelope protein 1D	GO:0071277; P:cellular response to calcium ion; IDA:MGI
Q5T752	LCE1D	Late cornified envelope protein 1D	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q5T753	LCE1E	Late cornified envelope protein 1E	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q5TA79	LCE2A	Late cornified envelope protein 2A	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q5T754	LCE1F	Late cornified envelope protein 1F	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q5TA81	LCE2C	Late cornified envelope protein 2C	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q5TA82	LCE2D	Late cornified envelope protein 2D	GO:0031424; P:keratinization; IEA:UniProtKB-KW
O14633	LCE2B	Late cornified envelope protein 2B	GO:0008544; P:epidermis development; NAS:UniProtKB
O14633	LCE2B	Late cornified envelope protein 2B	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q5TA77	LCE3B	Late cornified envelope protein 3B	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q5T5A8	LCE3C	Late cornified envelope protein 3C	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q9BYE3	LCE3D	Late cornified envelope protein 3D	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q5T5B0	LCE3E	Late cornified envelope protein 3E	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q5TA76	LCE3A	Late cornified envelope protein 3A	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q5TA78	LCE4A	Late cornified envelope protein 4A	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q5TCM9	LCE5A	Late cornified envelope protein 5A	GO:0031424; P:keratinization; IEA:UniProtKB-KW
A0A183	LCE6A	Late cornified envelope protein 6A	GO:0031424; P:keratinization; IEA:UniProtKB-KW
P06239	LCK	Tyrosine-protein kinase Lck	GO:0003823; F:antigen binding; IEA:Ensembl
P06239	LCK	Tyrosine-protein kinase Lck	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P06239	LCK	Tyrosine-protein kinase Lck	GO:0051117; F:ATPase binding; IPI:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0042609; F:CD4 receptor binding; IPI:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0042610; F:CD8 receptor binding; IPI:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0001948; F:glycoprotein binding; IPI:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0042802; F:identical protein binding; IPI:IntAct
P06239	LCK	Tyrosine-protein kinase Lck	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC
P06239	LCK	Tyrosine-protein kinase Lck	GO:0043548; F:phosphatidylinositol 3-kinase binding; IPI:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0005515; F:protein binding; IPI:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0004722; F:protein serine/threonine phosphatase activity; IDA:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0042169; F:SH2 domain binding; IPI:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0007568; P:aging; IEA:Ensembl
P06239	LCK	Tyrosine-protein kinase Lck	GO:0050853; P:B cell receptor signaling pathway; IEA:Ensembl
P06239	LCK	Tyrosine-protein kinase Lck	GO:0007596; P:blood coagulation; TAS:Reactome
P06239	LCK	Tyrosine-protein kinase Lck	GO:0006882; P:cellular zinc ion homeostasis; IEP:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0016311; P:dephosphorylation; IDA:GOC
P06239	LCK	Tyrosine-protein kinase Lck	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P06239	LCK	Tyrosine-protein kinase Lck	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P06239	LCK	Tyrosine-protein kinase Lck	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P06239	LCK	Tyrosine-protein kinase Lck	GO:0030097; P:hemopoiesis; NAS:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0045087; P:innate immune response; TAS:Reactome
P06239	LCK	Tyrosine-protein kinase Lck	GO:0050900; P:leukocyte migration; TAS:Reactome
P06239	LCK	Tyrosine-protein kinase Lck	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P06239	LCK	Tyrosine-protein kinase Lck	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P06239	LCK	Tyrosine-protein kinase Lck	GO:0030168; P:platelet activation; TAS:Reactome
P06239	LCK	Tyrosine-protein kinase Lck	GO:0045588; P:positive regulation of gamma-delta T cell differentiation; IEA:Ensembl
P06239	LCK	Tyrosine-protein kinase Lck	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P06239	LCK	Tyrosine-protein kinase Lck	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0050870; P:positive regulation of T cell activation; IDA:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0050862; P:positive regulation of T cell receptor signaling pathway; NAS:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0042523; P:positive regulation of tyrosine phosphorylation of Stat5 protein; IEA:Ensembl
P06239	LCK	Tyrosine-protein kinase Lck	GO:0070474; P:positive regulation of uterine smooth muscle contraction; IEA:Ensembl
P06239	LCK	Tyrosine-protein kinase Lck	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
P06239	LCK	Tyrosine-protein kinase Lck	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
P06239	LCK	Tyrosine-protein kinase Lck	GO:0051249; P:regulation of lymphocyte activation; NAS:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0051209; P:release of sequestered calcium ion into cytosol; ISS:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0042493; P:response to drug; IDA:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
P06239	LCK	Tyrosine-protein kinase Lck	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P06239	LCK	Tyrosine-protein kinase Lck	GO:0010043; P:response to zinc ion; IEA:Ensembl
P06239	LCK	Tyrosine-protein kinase Lck	GO:0031295; P:T cell costimulation; TAS:Reactome
P06239	LCK	Tyrosine-protein kinase Lck	GO:0030217; P:T cell differentiation; IMP:UniProtKB
P06239	LCK	Tyrosine-protein kinase Lck	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P06239	LCK	Tyrosine-protein kinase Lck	GO:0016032; P:viral process; TAS:Reactome
Q6UWP7	LCLAT1	Lysocardiolipin acyltransferase 1	GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; IEA:UniProtKB-EC
Q6UWP7	LCLAT1	Lysocardiolipin acyltransferase 1	GO:0035965; P:cardiolipin acyl-chain remodeling; TAS:Reactome
Q6UWP7	LCLAT1	Lysocardiolipin acyltransferase 1	GO:0016024; P:CDP-diacylglycerol biosynthetic process; IEA:UniProtKB-UniPathway
Q6UWP7	LCLAT1	Lysocardiolipin acyltransferase 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q6UWP7	LCLAT1	Lysocardiolipin acyltransferase 1	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q6UWP7	LCLAT1	Lysocardiolipin acyltransferase 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q6UWP7	LCLAT1	Lysocardiolipin acyltransferase 1	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
Q6UWP7	LCLAT1	Lysocardiolipin acyltransferase 1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q6UWP7	LCLAT1	Lysocardiolipin acyltransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6UWP7	LCLAT1	Lysocardiolipin acyltransferase 1	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
Q9UIC8	LCMT1	Leucine carboxyl methyltransferase 1	GO:0005515; F:protein binding; IPI:IntAct
Q9UIC8	LCMT1	Leucine carboxyl methyltransferase 1	GO:0003880; F:protein C-terminal carboxyl O-methyltransferase activity; IDA:MGI
Q9UIC8	LCMT1	Leucine carboxyl methyltransferase 1	GO:0008757; F:S-adenosylmethionine-dependent methyltransferase activity; TAS:ProtInc
Q9UIC8	LCMT1	Leucine carboxyl methyltransferase 1	GO:0006481; P:C-terminal protein methylation; IDA:MGI
Q9UIC8	LCMT1	Leucine carboxyl methyltransferase 1	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q9UIC8	LCMT1	Leucine carboxyl methyltransferase 1	GO:0031333; P:negative regulation of protein complex assembly; IMP:MGI
Q9UIC8	LCMT1	Leucine carboxyl methyltransferase 1	GO:0006479; P:protein methylation; IMP:MGI
Q9UIC8	LCMT1	Leucine carboxyl methyltransferase 1	GO:0042981; P:regulation of apoptotic process; IMP:MGI
Q9UIC8	LCMT1	Leucine carboxyl methyltransferase 1	GO:0090266; P:regulation of mitotic cell cycle spindle assembly checkpoint; IMP:MGI
Q6JVE6	LCN10	Epididymal-specific lipocalin-10	GO:0006810; P:transport; IEA:UniProtKB-KW
Q6JVE5	LCN12	Epididymal-specific lipocalin-12	GO:0001972; F:retinoic acid binding; ISS:UniProtKB
Q6JVE5	LCN12	Epididymal-specific lipocalin-12	GO:0005215; F:transporter activity; IEA:InterPro
Q6JVE5	LCN12	Epididymal-specific lipocalin-12	GO:0006629; P:lipid metabolic process; IEA:InterPro
Q6UWW0	LCN15	Lipocalin-15	GO:0036094; F:small molecule binding; IEA:InterPro
Q6UWW0	LCN15	Lipocalin-15	GO:0005215; F:transporter activity; IEA:InterPro
Q6UWW0	LCN15	Lipocalin-15	GO:0006629; P:lipid metabolic process; IEA:InterPro
P31025	LCN1	Lipocalin-1	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; TAS:ProtInc
P31025	LCN1	Lipocalin-1	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
P31025	LCN1	Lipocalin-1	GO:0006508; P:proteolysis; TAS:ProtInc
P31025	LCN1	Lipocalin-1	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
P31025	LCN1	Lipocalin-1	GO:0001895; P:retina homeostasis; IEP:UniProt
P31025	LCN1	Lipocalin-1	GO:0050909; P:sensory perception of taste; IEA:UniProtKB-KW
P31025	LCN1	Lipocalin-1	GO:0006810; P:transport; IEA:UniProtKB-KW
P62502	LCN6	Epididymal-specific lipocalin-6	GO:0007338; P:single fertilization; IEA:UniProtKB-KW
Q6JVE9	LCN8	Epididymal-specific lipocalin-8	GO:0009725; P:response to hormone; IEA:Ensembl
Q6JVE9	LCN8	Epididymal-specific lipocalin-8	GO:0006810; P:transport; IEA:UniProtKB-KW
Q8WX39	LCN9	Epididymal-specific lipocalin-9	GO:0005550; F:pheromone binding; IEA:InterPro
Q8WX39	LCN9	Epididymal-specific lipocalin-9	GO:0005215; F:transporter activity; IEA:InterPro
Q8N3X6	LCORL	Ligand-dependent nuclear receptor corepressor-like protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N3X6	LCORL	Ligand-dependent nuclear receptor corepressor-like protein	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8N3X6	LCORL	Ligand-dependent nuclear receptor corepressor-like protein	GO:0006366; P:transcription from RNA polymerase II promoter; IEA:Ensembl
Q96JN0	LCOR	Ligand-dependent corepressor	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96JN0	LCOR	Ligand-dependent corepressor	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q96JN0	LCOR	Ligand-dependent corepressor	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q96JN0	LCOR	Ligand-dependent corepressor	GO:0006366; P:transcription from RNA polymerase II promoter; IEA:Ensembl
Q13094	LCP2	Lymphocyte cytosolic protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q13094	LCP2	Lymphocyte cytosolic protein 2	GO:0007596; P:blood coagulation; TAS:Reactome
Q13094	LCP2	Lymphocyte cytosolic protein 2	GO:0050663; P:cytokine secretion; IEA:Ensembl
Q13094	LCP2	Lymphocyte cytosolic protein 2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q13094	LCP2	Lymphocyte cytosolic protein 2	GO:0006955; P:immune response; TAS:ProtInc
Q13094	LCP2	Lymphocyte cytosolic protein 2	GO:0045087; P:innate immune response; TAS:Reactome
Q13094	LCP2	Lymphocyte cytosolic protein 2	GO:0045576; P:mast cell activation; IEA:Ensembl
Q13094	LCP2	Lymphocyte cytosolic protein 2	GO:0030168; P:platelet activation; TAS:Reactome
Q13094	LCP2	Lymphocyte cytosolic protein 2	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q13094	LCP2	Lymphocyte cytosolic protein 2	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc
Q6UWM7	LCTL	Lactase-like protein	GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro
Q6UWM7	LCTL	Lactase-like protein	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q86U70	LDB1	LIM domain-binding protein 1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q86U70	LDB1	LIM domain-binding protein 1	GO:0001158; F:enhancer sequence-specific DNA binding; IEA:Ensembl
Q86U70	LDB1	LIM domain-binding protein 1	GO:0030274; F:LIM domain binding; IPI:UniProtKB
Q86U70	LDB1	LIM domain-binding protein 1	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q86U70	LDB1	LIM domain-binding protein 1	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
Q86U70	LDB1	LIM domain-binding protein 1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q86U70	LDB1	LIM domain-binding protein 1	GO:0009948; P:anterior/posterior axis specification; IEA:Ensembl
Q86U70	LDB1	LIM domain-binding protein 1	GO:0022607; P:cellular component assembly; IEA:Ensembl
Q86U70	LDB1	LIM domain-binding protein 1	GO:0021702; P:cerebellar Purkinje cell differentiation; IEA:Ensembl
Q86U70	LDB1	LIM domain-binding protein 1	GO:0010669; P:epithelial structure maintenance; IEA:Ensembl
Q86U70	LDB1	LIM domain-binding protein 1	GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl
Q86U70	LDB1	LIM domain-binding protein 1	GO:0001942; P:hair follicle development; IEA:Ensembl
Q86U70	LDB1	LIM domain-binding protein 1	GO:0060322; P:head development; IEA:Ensembl
Q86U70	LDB1	LIM domain-binding protein 1	GO:0043973; P:histone H3-K4 acetylation; ISS:BHF-UCL
Q86U70	LDB1	LIM domain-binding protein 1	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
Q86U70	LDB1	LIM domain-binding protein 1	GO:0045647; P:negative regulation of erythrocyte differentiation; ISS:UniProtKB
Q86U70	LDB1	LIM domain-binding protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q86U70	LDB1	LIM domain-binding protein 1	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q86U70	LDB1	LIM domain-binding protein 1	GO:0045785; P:positive regulation of cell adhesion; IEA:Ensembl
Q86U70	LDB1	LIM domain-binding protein 1	GO:0046985; P:positive regulation of hemoglobin biosynthetic process; ISS:BHF-UCL
Q86U70	LDB1	LIM domain-binding protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q86U70	LDB1	LIM domain-binding protein 1	GO:0032784; P:regulation of DNA-templated transcription, elongation; ISS:BHF-UCL
Q86U70	LDB1	LIM domain-binding protein 1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:ProtInc
Q86U70	LDB1	LIM domain-binding protein 1	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
Q86U70	LDB1	LIM domain-binding protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; IEA:Ensembl
Q86U70	LDB1	LIM domain-binding protein 1	GO:0006351; P:transcription, DNA-templated; NAS:UniProtKB
Q86U70	LDB1	LIM domain-binding protein 1	GO:0000972; P:transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery; ISS:BHF-UCL
Q86U70	LDB1	LIM domain-binding protein 1	GO:0016055; P:Wnt signaling pathway; IEA:Ensembl
O43679	LDB2	LIM domain-binding protein 2	GO:0030274; F:LIM domain binding; ISS:UniProtKB
O43679	LDB2	LIM domain-binding protein 2	GO:0003712; F:transcription cofactor activity; TAS:ProtInc
O43679	LDB2	LIM domain-binding protein 2	GO:0010669; P:epithelial structure maintenance; IEA:Ensembl
O43679	LDB2	LIM domain-binding protein 2	GO:0001942; P:hair follicle development; IEA:Ensembl
O43679	LDB2	LIM domain-binding protein 2	GO:0044089; P:positive regulation of cellular component biogenesis; IEA:Ensembl
O43679	LDB2	LIM domain-binding protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O43679	LDB2	LIM domain-binding protein 2	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
O75112	LDB3	LIM domain-binding protein 3	GO:0008092; F:cytoskeletal protein binding; IPI:UniProtKB
O75112	LDB3	LIM domain-binding protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
O75112	LDB3	LIM domain-binding protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
O75112	LDB3	LIM domain-binding protein 3	GO:0045214; P:sarcomere organization; IEA:Ensembl
Q6ZMR3	LDHAL6A	L-lactate dehydrogenase A-like 6A	GO:0004459; F:L-lactate dehydrogenase activity; IEA:UniProtKB-EC
Q6ZMR3	LDHAL6A	L-lactate dehydrogenase A-like 6A	GO:0006096; P:glycolytic process; IEA:UniProtKB-KW
Q9BYZ2	LDHAL6B	L-lactate dehydrogenase A-like 6B	GO:0004459; F:L-lactate dehydrogenase activity; IEA:UniProtKB-EC
Q9BYZ2	LDHAL6B	L-lactate dehydrogenase A-like 6B	GO:0005515; F:protein binding; IPI:IntAct
Q9BYZ2	LDHAL6B	L-lactate dehydrogenase A-like 6B	GO:0006096; P:glycolytic process; IEA:UniProtKB-KW
P00338	LDHA	L-lactate dehydrogenase A chain	GO:0004459; F:L-lactate dehydrogenase activity; NAS:UniProtKB
P00338	LDHA	L-lactate dehydrogenase A chain	GO:0005515; F:protein binding; IPI:IntAct
P00338	LDHA	L-lactate dehydrogenase A chain	GO:0044237; P:cellular metabolic process; TAS:Reactome
P00338	LDHA	L-lactate dehydrogenase A chain	GO:0031668; P:cellular response to extracellular stimulus; IEA:Ensembl
P00338	LDHA	L-lactate dehydrogenase A chain	GO:0006096; P:glycolytic process; NAS:UniProtKB
P00338	LDHA	L-lactate dehydrogenase A chain	GO:0006090; P:pyruvate metabolic process; TAS:Reactome
P00338	LDHA	L-lactate dehydrogenase A chain	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P00338	LDHA	L-lactate dehydrogenase A chain	GO:0021762; P:substantia nigra development; IEP:UniProtKB
P07195	LDHB	L-lactate dehydrogenase B chain	GO:0004459; F:L-lactate dehydrogenase activity; TAS:ProtInc
P07195	LDHB	L-lactate dehydrogenase B chain	GO:0051287; F:NAD binding; IEA:Ensembl
P07195	LDHB	L-lactate dehydrogenase B chain	GO:0044237; P:cellular metabolic process; TAS:Reactome
P07195	LDHB	L-lactate dehydrogenase B chain	GO:0006096; P:glycolytic process; IEA:UniProtKB-KW
P07195	LDHB	L-lactate dehydrogenase B chain	GO:0006089; P:lactate metabolic process; IEA:Ensembl
P07195	LDHB	L-lactate dehydrogenase B chain	GO:0019674; P:NAD metabolic process; IEA:Ensembl
P07195	LDHB	L-lactate dehydrogenase B chain	GO:0006090; P:pyruvate metabolic process; TAS:Reactome
P07195	LDHB	L-lactate dehydrogenase B chain	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P07864	LDHC	L-lactate dehydrogenase C chain	GO:0004459; F:L-lactate dehydrogenase activity; TAS:ProtInc
P07864	LDHC	L-lactate dehydrogenase C chain	GO:0006754; P:ATP biosynthetic process; IEA:Ensembl
P07864	LDHC	L-lactate dehydrogenase C chain	GO:0006096; P:glycolytic process; IEA:UniProtKB-KW
P07864	LDHC	L-lactate dehydrogenase C chain	GO:0019244; P:lactate biosynthetic process from pyruvate; IEA:Ensembl
P07864	LDHC	L-lactate dehydrogenase C chain	GO:0019516; P:lactate oxidation; IEA:Ensembl
P07864	LDHC	L-lactate dehydrogenase C chain	GO:0030317; P:sperm motility; IEA:Ensembl
Q86WU2	LDHD	Probable D-lactate dehydrogenase, mitochondrial	GO:0004458; F:D-lactate dehydrogenase (cytochrome) activity; IEA:UniProtKB-EC
Q86WU2	LDHD	Probable D-lactate dehydrogenase, mitochondrial	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q86WU2	LDHD	Probable D-lactate dehydrogenase, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q86WU2	LDHD	Probable D-lactate dehydrogenase, mitochondrial	GO:0008762; F:UDP-N-acetylmuramate dehydrogenase activity; IEA:InterPro
P01130	LDLR	Low-density lipoprotein receptor	GO:0005509; F:calcium ion binding; IEA:InterPro
P01130	LDLR	Low-density lipoprotein receptor	GO:0001948; F:glycoprotein binding; IPI:BHF-UCL
P01130	LDLR	Low-density lipoprotein receptor	GO:0030169; F:low-density lipoprotein particle binding; IEA:Ensembl
P01130	LDLR	Low-density lipoprotein receptor	GO:0005041; F:low-density lipoprotein receptor activity; IDA:BHF-UCL
P01130	LDLR	Low-density lipoprotein receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P01130	LDLR	Low-density lipoprotein receptor	GO:0030229; F:very-low-density lipoprotein particle receptor activity; IDA:BHF-UCL
P01130	LDLR	Low-density lipoprotein receptor	GO:0042632; P:cholesterol homeostasis; IMP:BHF-UCL
P01130	LDLR	Low-density lipoprotein receptor	GO:0070508; P:cholesterol import; ISS:BHF-UCL
P01130	LDLR	Low-density lipoprotein receptor	GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW
P01130	LDLR	Low-density lipoprotein receptor	GO:0030301; P:cholesterol transport; IMP:HGNC
P01130	LDLR	Low-density lipoprotein receptor	GO:0006897; P:endocytosis; TAS:ProtInc
P01130	LDLR	Low-density lipoprotein receptor	GO:0030299; P:intestinal cholesterol absorption; IMP:HGNC
P01130	LDLR	Low-density lipoprotein receptor	GO:0006629; P:lipid metabolic process; TAS:ProtInc
P01130	LDLR	Low-density lipoprotein receptor	GO:0042159; P:lipoprotein catabolic process; IEA:Ensembl
P01130	LDLR	Low-density lipoprotein receptor	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
P01130	LDLR	Low-density lipoprotein receptor	GO:0034383; P:low-density lipoprotein particle clearance; IMP:BHF-UCL
P01130	LDLR	Low-density lipoprotein receptor	GO:0015914; P:phospholipid transport; ISS:BHF-UCL
P01130	LDLR	Low-density lipoprotein receptor	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P01130	LDLR	Low-density lipoprotein receptor	GO:0010867; P:positive regulation of triglyceride biosynthetic process; ISS:BHF-UCL
P01130	LDLR	Low-density lipoprotein receptor	GO:0006898; P:receptor-mediated endocytosis; TAS:Reactome
P01130	LDLR	Low-density lipoprotein receptor	GO:0010899; P:regulation of phosphatidylcholine catabolic process; ISS:BHF-UCL
P01130	LDLR	Low-density lipoprotein receptor	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P01130	LDLR	Low-density lipoprotein receptor	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P01130	LDLR	Low-density lipoprotein receptor	GO:0016032; P:viral process; IEA:UniProtKB-KW
O95751	LDOC1	Protein LDOC1	GO:0005515; F:protein binding; IPI:IntAct
O95751	LDOC1	Protein LDOC1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q969E1	LEAP2	Liver-expressed antimicrobial peptide 2	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
O75829	LECT1	Leukocyte cell-derived chemotaxin 1	GO:0051216; P:cartilage development; IEA:UniProtKB-KW
O75829	LECT1	Leukocyte cell-derived chemotaxin 1	GO:0001886; P:endothelial cell morphogenesis; IEA:Ensembl
O75829	LECT1	Leukocyte cell-derived chemotaxin 1	GO:0016525; P:negative regulation of angiogenesis; IDA:UniProtKB
O75829	LECT1	Leukocyte cell-derived chemotaxin 1	GO:0001937; P:negative regulation of endothelial cell proliferation; IEA:Ensembl
O75829	LECT1	Leukocyte cell-derived chemotaxin 1	GO:0030948; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; IEA:Ensembl
O75829	LECT1	Leukocyte cell-derived chemotaxin 1	GO:0006029; P:proteoglycan metabolic process; TAS:ProtInc
O75829	LECT1	Leukocyte cell-derived chemotaxin 1	GO:0001501; P:skeletal system development; TAS:ProtInc
O14960	LECT2	Leukocyte cell-derived chemotaxin-2	GO:0042802; F:identical protein binding; IPI:IntAct
O14960	LECT2	Leukocyte cell-derived chemotaxin-2	GO:0006935; P:chemotaxis; TAS:ProtInc
O14960	LECT2	Leukocyte cell-derived chemotaxin-2	GO:0030178; P:negative regulation of Wnt signaling pathway; IEA:Ensembl
O14960	LECT2	Leukocyte cell-derived chemotaxin-2	GO:0001501; P:skeletal system development; TAS:ProtInc
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0070016; F:armadillo repeat domain binding; IPI:BHF-UCL
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0008013; F:beta-catenin binding; IPI:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0070742; F:C2H2 zinc finger domain binding; IPI:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0003682; F:chromatin binding; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IMP:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0003677; F:DNA binding; ISS:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0008301; F:DNA binding, bending; ISS:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0035326; F:enhancer binding; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0030284; F:estrogen receptor activity; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0030331; F:estrogen receptor binding; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0045295; F:gamma-catenin binding; IPI:BHF-UCL
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0042393; F:histone binding; IPI:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:BHF-UCL
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0001228; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IMP:BHF-UCL
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0046632; P:alpha-beta T cell differentiation; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0060033; P:anatomical structure regression; IEA:Ensembl
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0060561; P:apoptotic process involved in morphogenesis; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:1902262; P:apoptotic process involved in patterning of blood vessels; IEA:Ensembl
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0042100; P:B cell proliferation; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0030509; P:BMP signaling pathway; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0060070; P:canonical Wnt signaling pathway; IMP:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0060326; P:cell chemotaxis; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0071345; P:cellular response to cytokine stimulus; IMP:BHF-UCL
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0071353; P:cellular response to interleukin-4; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0060710; P:chorio-allantoic fusion; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0021542; P:dentate gyrus development; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0030326; P:embryonic limb morphogenesis; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0001837; P:epithelial to mesenchymal transition; ISS:BHF-UCL
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0048069; P:eye pigmentation; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0060325; P:face morphogenesis; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0021873; P:forebrain neuroblast division; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0021879; P:forebrain neuron differentiation; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0021861; P:forebrain radial glial cell differentiation; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0021943; P:formation of radial glial scaffolds; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0043966; P:histone H3 acetylation; IMP:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0043967; P:histone H4 acetylation; IMP:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0021854; P:hypothalamus development; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0030879; P:mammary gland development; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0048747; P:muscle fiber development; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0071866; P:negative regulation of apoptotic process in bone marrow; IMP:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0022408; P:negative regulation of cell-cell adhesion; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0043392; P:negative regulation of DNA binding; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0071899; P:negative regulation of estrogen receptor binding; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0032696; P:negative regulation of interleukin-13 production; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0032713; P:negative regulation of interleukin-4 production; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0032714; P:negative regulation of interleukin-5 production; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0045843; P:negative regulation of striated muscle tissue development; IEA:Ensembl
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0001755; P:neural crest cell migration; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0030223; P:neutrophil differentiation; IMP:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0071895; P:odontoblast differentiation; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0001649; P:osteoblast differentiation; IEP:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0060021; P:palate development; ISS:BHF-UCL
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0048341; P:paraxial mesoderm formation; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0001569; P:patterning of blood vessels; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0043923; P:positive regulation by host of viral transcription; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0090068; P:positive regulation of cell cycle process; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0030307; P:positive regulation of cell growth; IMP:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0071864; P:positive regulation of cell proliferation in bone marrow; IMP:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0022409; P:positive regulation of cell-cell adhesion; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IMP:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0010628; P:positive regulation of gene expression; IDA:AgBase
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0030854; P:positive regulation of granulocyte differentiation; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0022407; P:regulation of cell-cell adhesion; IEA:Ensembl
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0016202; P:regulation of striated muscle tissue development; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0050909; P:sensory perception of taste; IEA:Ensembl
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0001756; P:somitogenesis; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0002040; P:sprouting angiogenesis; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0043401; P:steroid hormone mediated signaling pathway; IDA:GOC
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0033153; P:T cell receptor V(D)J recombination; IEA:Ensembl
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0045063; P:T-helper 1 cell differentiation; ISS:UniProtKB
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0043586; P:tongue development; IEA:Ensembl
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0061153; P:trachea gland development; IBA:RefGenome
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9UJU2	LEF1	Lymphoid enhancer-binding factor 1	GO:0016055; P:Wnt signaling pathway; IDA:BHF-UCL
Q05315	CLC	Galectin-10	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q05315	CLC	Galectin-10	GO:0097153; F:cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
Q05315	CLC	Galectin-10	GO:0005515; F:protein binding; IPI:UniProtKB
Q05315	CLC	Galectin-10	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q05315	CLC	Galectin-10	GO:0046006; P:regulation of activated T cell proliferation; IMP:UniProtKB
Q05315	CLC	Galectin-10	GO:0002667; P:regulation of T cell anergy; IMP:UniProtKB
Q05315	CLC	Galectin-10	GO:0002724; P:regulation of T cell cytokine production; IMP:UniProtKB
Q05315	CLC	Galectin-10	GO:0070231; P:T cell apoptotic process; IDA:UniProtKB
Q96DT0	LGALS12	Galectin-12	GO:0030395; F:lactose binding; IDA:MGI
Q96DT0	LGALS12	Galectin-12	GO:0097193; P:intrinsic apoptotic signaling pathway; IDA:MGI
A8MUM7	LGALS16	Galectin-16	GO:0030395; F:lactose binding; IDA:UniProtKB
A8MUM7	LGALS16	Galectin-16	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
A8MUM7	LGALS16	Galectin-16	GO:0070234; P:positive regulation of T cell apoptotic process; IDA:UniProtKB
P09382	LGALS1	Galectin-1	GO:0016936; F:galactoside binding; IEA:InterPro
P09382	LGALS1	Galectin-1	GO:0030395; F:lactose binding; IEA:Ensembl
P09382	LGALS1	Galectin-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P09382	LGALS1	Galectin-1	GO:0005515; F:protein binding; IPI:IntAct
P09382	LGALS1	Galectin-1	GO:0004871; F:signal transducer activity; IMP:UniProtKB
P09382	LGALS1	Galectin-1	GO:0006915; P:apoptotic process; TAS:ProtInc
P09382	LGALS1	Galectin-1	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
P09382	LGALS1	Galectin-1	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
P09382	LGALS1	Galectin-1	GO:0033555; P:multicellular organismal response to stress; IEA:Ensembl
P09382	LGALS1	Galectin-1	GO:0045445; P:myoblast differentiation; IEA:Ensembl
P09382	LGALS1	Galectin-1	GO:0010812; P:negative regulation of cell-substrate adhesion; IEA:Ensembl
P09382	LGALS1	Galectin-1	GO:0010977; P:negative regulation of neuron projection development; IEA:Ensembl
P09382	LGALS1	Galectin-1	GO:0002317; P:plasma cell differentiation; IEA:Ensembl
P09382	LGALS1	Galectin-1	GO:0034120; P:positive regulation of erythrocyte aggregation; IEA:Ensembl
P09382	LGALS1	Galectin-1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
P09382	LGALS1	Galectin-1	GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB
P09382	LGALS1	Galectin-1	GO:0048678; P:response to axon injury; IEA:Ensembl
P09382	LGALS1	Galectin-1	GO:0042493; P:response to drug; IEA:Ensembl
P09382	LGALS1	Galectin-1	GO:0007165; P:signal transduction; IMP:GOC
P09382	LGALS1	Galectin-1	GO:0031295; P:T cell costimulation; IEA:Ensembl
P05162	LGALS2	Galectin-2	GO:0030246; F:carbohydrate binding; IEA:InterPro
P05162	LGALS2	Galectin-2	GO:0016936; F:galactoside binding; IEA:Ensembl
P17931	LGALS3	Galectin-3	GO:0030246; F:carbohydrate binding; TAS:ProtInc
P17931	LGALS3	Galectin-3	GO:0042056; F:chemoattractant activity; IDA:BHF-UCL
P17931	LGALS3	Galectin-3	GO:0019863; F:IgE binding; IDA:BHF-UCL
P17931	LGALS3	Galectin-3	GO:0043236; F:laminin binding; IDA:BHF-UCL
P17931	LGALS3	Galectin-3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P17931	LGALS3	Galectin-3	GO:0005515; F:protein binding; IPI:UniProtKB
P17931	LGALS3	Galectin-3	GO:0048245; P:eosinophil chemotaxis; IDA:BHF-UCL
P17931	LGALS3	Galectin-3	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
P17931	LGALS3	Galectin-3	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
P17931	LGALS3	Galectin-3	GO:0045087; P:innate immune response; TAS:Reactome
P17931	LGALS3	Galectin-3	GO:0048246; P:macrophage chemotaxis; IDA:BHF-UCL
P17931	LGALS3	Galectin-3	GO:0002548; P:monocyte chemotaxis; IDA:BHF-UCL
P17931	LGALS3	Galectin-3	GO:0071674; P:mononuclear cell migration; IDA:BHF-UCL
P17931	LGALS3	Galectin-3	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
P17931	LGALS3	Galectin-3	GO:0045806; P:negative regulation of endocytosis; IDA:BHF-UCL
P17931	LGALS3	Galectin-3	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IDA:BHF-UCL
P17931	LGALS3	Galectin-3	GO:2000521; P:negative regulation of immunological synapse formation; ISS:BHF-UCL
P17931	LGALS3	Galectin-3	GO:2001189; P:negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; ISS:BHF-UCL
P17931	LGALS3	Galectin-3	GO:0050860; P:negative regulation of T cell receptor signaling pathway; ISS:BHF-UCL
P17931	LGALS3	Galectin-3	GO:0030593; P:neutrophil chemotaxis; IDA:BHF-UCL
P17931	LGALS3	Galectin-3	GO:0050918; P:positive chemotaxis; IDA:BHF-UCL
P17931	LGALS3	Galectin-3	GO:0090280; P:positive regulation of calcium ion import; IDA:BHF-UCL
P17931	LGALS3	Galectin-3	GO:0071677; P:positive regulation of mononuclear cell migration; IDA:BHF-UCL
P17931	LGALS3	Galectin-3	GO:1902041; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; IMP:BHF-UCL
P17931	LGALS3	Galectin-3	GO:0070232; P:regulation of T cell apoptotic process; IDA:BHF-UCL
P17931	LGALS3	Galectin-3	GO:0042129; P:regulation of T cell proliferation; IMP:BHF-UCL
P17931	LGALS3	Galectin-3	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
P17931	LGALS3	Galectin-3	GO:0001501; P:skeletal system development; IEA:Ensembl
P56470	LGALS4	Galectin-4	GO:0030246; F:carbohydrate binding; TAS:ProtInc
P56470	LGALS4	Galectin-4	GO:0007155; P:cell adhesion; TAS:ProtInc
O00214	LGALS8	Galectin-8	GO:0030246; F:carbohydrate binding; TAS:ProtInc
O00214	LGALS8	Galectin-8	GO:0005515; F:protein binding; IPI:IntAct
O00214	LGALS8	Galectin-8	GO:0002317; P:plasma cell differentiation; IEA:Ensembl
O00214	LGALS8	Galectin-8	GO:0031295; P:T cell costimulation; IEA:Ensembl
P47929	LGALS7	Galectin-7	GO:0030246; F:carbohydrate binding; TAS:ProtInc
P47929	LGALS7	Galectin-7	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P47929	LGALS7	Galectin-7	GO:0007157; P:heterophilic cell-cell adhesion; TAS:ProtInc
Q3B8N2	LGALS9B	Galectin-9B	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q6DKI2	LGALS9C	Galectin-9C	GO:0030246; F:carbohydrate binding; IEA:InterPro
O00182	LGALS9	Galectin-9	GO:0030246; F:carbohydrate binding; IDA:UniProtKB
O00182	LGALS9	Galectin-9	GO:0005534; F:galactose binding; TAS:ProtInc
O00182	LGALS9	Galectin-9	GO:0004871; F:signal transducer activity; IMP:UniProtKB
O00182	LGALS9	Galectin-9	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
O00182	LGALS9	Galectin-9	GO:0007165; P:signal transduction; IMP:GOC
Q3ZCW2	LGALSL	Galectin-related protein	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q8NC56	LEMD2	LEM domain-containing protein 2	GO:0043409; P:negative regulation of MAPK cascade; IEA:Ensembl
Q8NC56	LEMD2	LEM domain-containing protein 2	GO:0035914; P:skeletal muscle cell differentiation; IGI:MGI
Q9Y5L5	LENEP	Lens epithelial cell protein LEP503	GO:0003677; F:DNA binding; TAS:ProtInc
Q9Y5L5	LENEP	Lens epithelial cell protein LEP503	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q96PV6	LENG8	Leukocyte receptor cluster member 8	GO:0005515; F:protein binding; IPI:UniProtKB
Q96B70	LENG9	Leukocyte receptor cluster member 9	GO:0003824; F:catalytic activity; IEA:InterPro
Q96B70	LENG9	Leukocyte receptor cluster member 9	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8WVC0	LEO1	RNA polymerase-associated protein LEO1	GO:0005515; F:protein binding; IPI:IntAct
Q8WVC0	LEO1	RNA polymerase-associated protein LEO1	GO:0001711; P:endodermal cell fate commitment; ISS:UniProtKB
Q8WVC0	LEO1	RNA polymerase-associated protein LEO1	GO:0033523; P:histone H2B ubiquitination; IDA:UniProtKB
Q8WVC0	LEO1	RNA polymerase-associated protein LEO1	GO:0010390; P:histone monoubiquitination; IDA:UniProtKB
Q8WVC0	LEO1	RNA polymerase-associated protein LEO1	GO:0006378; P:mRNA polyadenylation; IMP:UniProtKB
Q8WVC0	LEO1	RNA polymerase-associated protein LEO1	GO:0045638; P:negative regulation of myeloid cell differentiation; IDA:UniProtKB
Q8WVC0	LEO1	RNA polymerase-associated protein LEO1	GO:0031442; P:positive regulation of mRNA 3'-end processing; IMP:UniProtKB
Q8WVC0	LEO1	RNA polymerase-associated protein LEO1	GO:0032968; P:positive regulation of transcription elongation from RNA polymerase II promoter; IDA:UniProtKB
Q8WVC0	LEO1	RNA polymerase-associated protein LEO1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q8WVC0	LEO1	RNA polymerase-associated protein LEO1	GO:0019827; P:stem cell maintenance; IDA:UniProtKB
Q8WVC0	LEO1	RNA polymerase-associated protein LEO1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WVC0	LEO1	RNA polymerase-associated protein LEO1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P48357	LEPR	Leptin receptor	GO:0004896; F:cytokine receptor activity; IEA:InterPro
P48357	LEPR	Leptin receptor	GO:0042802; F:identical protein binding; IPI:IntAct
P48357	LEPR	Leptin receptor	GO:0005515; F:protein binding; IPI:IntAct
P48357	LEPR	Leptin receptor	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
P48357	LEPR	Leptin receptor	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P48357	LEPR	Leptin receptor	GO:0008203; P:cholesterol metabolic process; IEA:Ensembl
P48357	LEPR	Leptin receptor	GO:0006112; P:energy reserve metabolic process; TAS:ProtInc
P48357	LEPR	Leptin receptor	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P48357	LEPR	Leptin receptor	GO:0051346; P:negative regulation of hydrolase activity; IEA:Ensembl
P41159	LEP	Leptin	GO:0060612; P:adipose tissue development; IEA:Ensembl
P41159	LEP	Leptin	GO:0008343; P:adult feeding behavior; ISS:HGNC
P41159	LEP	Leptin	GO:0008206; P:bile acid metabolic process; IEA:Ensembl
P41159	LEP	Leptin	GO:0035630; P:bone mineralization involved in bone maturation; IEA:Ensembl
P41159	LEP	Leptin	GO:0071298; P:cellular response to L-ascorbic acid; IEA:Ensembl
P41159	LEP	Leptin	GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl
P41159	LEP	Leptin	GO:0021954; P:central nervous system neuron development; IEA:Ensembl
P41159	LEP	Leptin	GO:0008203; P:cholesterol metabolic process; IEA:Ensembl
P41159	LEP	Leptin	GO:0007623; P:circadian rhythm; IEA:Ensembl
P41159	LEP	Leptin	GO:0042755; P:eating behavior; IEA:Ensembl
P41159	LEP	Leptin	GO:0006112; P:energy reserve metabolic process; TAS:ProtInc
P41159	LEP	Leptin	GO:0009062; P:fatty acid catabolic process; IEA:Ensembl
P41159	LEP	Leptin	GO:0007565; P:female pregnancy; IEA:Ensembl
P41159	LEP	Leptin	GO:0006006; P:glucose metabolic process; IEA:Ensembl
P41159	LEP	Leptin	GO:0006114; P:glycerol biosynthetic process; IEA:Ensembl
P41159	LEP	Leptin	GO:0042445; P:hormone metabolic process; IEA:Ensembl
P41159	LEP	Leptin	GO:0030073; P:insulin secretion; IEA:Ensembl
P41159	LEP	Leptin	GO:0033210; P:leptin-mediated signaling pathway; IEA:Ensembl
P41159	LEP	Leptin	GO:0050901; P:leukocyte tethering or rolling; IEA:Ensembl
P41159	LEP	Leptin	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P41159	LEP	Leptin	GO:0032099; P:negative regulation of appetite; ISS:HGNC
P41159	LEP	Leptin	GO:0061037; P:negative regulation of cartilage development; IEA:Ensembl
P41159	LEP	Leptin	GO:0070093; P:negative regulation of glucagon secretion; IEA:Ensembl
P41159	LEP	Leptin	GO:2000486; P:negative regulation of glutamine transport; IEA:Ensembl
P41159	LEP	Leptin	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P41159	LEP	Leptin	GO:0045906; P:negative regulation of vasoconstriction; IEA:Ensembl
P41159	LEP	Leptin	GO:0001542; P:ovulation from ovarian follicle; IEA:Ensembl
P41159	LEP	Leptin	GO:0001890; P:placenta development; IDA:DFLAT
P41159	LEP	Leptin	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P41159	LEP	Leptin	GO:0001819; P:positive regulation of cytokine production; IEA:Ensembl
P41159	LEP	Leptin	GO:0048639; P:positive regulation of developmental growth; IDA:DFLAT
P41159	LEP	Leptin	GO:0046881; P:positive regulation of follicle-stimulating hormone secretion; IEA:Ensembl
P41159	LEP	Leptin	GO:2000491; P:positive regulation of hepatic stellate cell activation; IEA:Ensembl
P41159	LEP	Leptin	GO:0046628; P:positive regulation of insulin receptor signaling pathway; IEA:Ensembl
P41159	LEP	Leptin	GO:0043270; P:positive regulation of ion transport; IEA:Ensembl
P41159	LEP	Leptin	GO:0033686; P:positive regulation of luteinizing hormone secretion; IEA:Ensembl
P41159	LEP	Leptin	GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl
P41159	LEP	Leptin	GO:0045639; P:positive regulation of myeloid cell differentiation; IEA:Ensembl
P41159	LEP	Leptin	GO:2000366; P:positive regulation of STAT protein import into nucleus; IEA:Ensembl
P41159	LEP	Leptin	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IEA:Ensembl
P41159	LEP	Leptin	GO:0008217; P:regulation of blood pressure; IEA:Ensembl
P41159	LEP	Leptin	GO:0045598; P:regulation of fat cell differentiation; IEA:Ensembl
P41159	LEP	Leptin	GO:0006111; P:regulation of gluconeogenesis; IEA:Ensembl
P41159	LEP	Leptin	GO:0050796; P:regulation of insulin secretion; IEA:Ensembl
P41159	LEP	Leptin	GO:0030300; P:regulation of intestinal cholesterol absorption; IEA:Ensembl
P41159	LEP	Leptin	GO:0060587; P:regulation of lipoprotein lipid oxidation; IEA:Ensembl
P41159	LEP	Leptin	GO:0050810; P:regulation of steroid biosynthetic process; IEA:Ensembl
P41159	LEP	Leptin	GO:0002021; P:response to dietary excess; IEA:Ensembl
P41159	LEP	Leptin	GO:0001666; P:response to hypoxia; IEA:Ensembl
P41159	LEP	Leptin	GO:0032868; P:response to insulin; IEA:Ensembl
P41159	LEP	Leptin	GO:0033197; P:response to vitamin E; IEA:Ensembl
P41159	LEP	Leptin	GO:0007260; P:tyrosine phosphorylation of STAT protein; IEA:Ensembl
O95202	LETM1	LETM1 and EF-hand domain-containing protein 1, mitochondrial	GO:0005509; F:calcium ion binding; TAS:ProtInc
O95202	LETM1	LETM1 and EF-hand domain-containing protein 1, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
O95202	LETM1	LETM1 and EF-hand domain-containing protein 1, mitochondrial	GO:0042407; P:cristae formation; IMP:UniProtKB
O43261	DLEU1	Leukemia-associated protein 1	GO:0005515; F:protein binding; IPI:IntAct
P16150	SPN	Leukosialin	GO:0005515; F:protein binding; IPI:MTBBASE
P16150	SPN	Leukosialin	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
P16150	SPN	Leukosialin	GO:0097190; P:apoptotic signaling pathway; IEA:Ensembl
P16150	SPN	Leukosialin	GO:0007596; P:blood coagulation; TAS:Reactome
P16150	SPN	Leukosialin	GO:0007166; P:cell surface receptor signaling pathway; IEA:Ensembl
P16150	SPN	Leukosialin	GO:0006968; P:cellular defense response; TAS:ProtInc
P16150	SPN	Leukosialin	GO:0006935; P:chemotaxis; TAS:ProtInc
P16150	SPN	Leukosialin	GO:0042742; P:defense response to bacterium; IDA:MGI
P16150	SPN	Leukosialin	GO:0007163; P:establishment or maintenance of cell polarity; TAS:ProtInc
P16150	SPN	Leukosialin	GO:0006955; P:immune response; TAS:ProtInc
P16150	SPN	Leukosialin	GO:0050900; P:leukocyte migration; TAS:Reactome
P16150	SPN	Leukosialin	GO:0007162; P:negative regulation of cell adhesion; TAS:ProtInc
P16150	SPN	Leukosialin	GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl
P16150	SPN	Leukosialin	GO:0001808; P:negative regulation of type IV hypersensitivity; IEA:Ensembl
P16150	SPN	Leukosialin	GO:0045060; P:negative thymic T cell selection; IEA:Ensembl
P16150	SPN	Leukosialin	GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl
P16150	SPN	Leukosialin	GO:0042535; P:positive regulation of tumor necrosis factor biosynthetic process; IDA:MGI
P16150	SPN	Leukosialin	GO:0050688; P:regulation of defense response to virus; IEA:Ensembl
P16150	SPN	Leukosialin	GO:0001562; P:response to protozoan; IEA:Ensembl
P16150	SPN	Leukosialin	GO:0007165; P:signal transduction; TAS:ProtInc
P16150	SPN	Leukosialin	GO:0031295; P:T cell costimulation; IEA:Ensembl
A8MZ59	LEUTX	Leucine-twenty homeobox	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
A8MZ59	LEUTX	Leucine-twenty homeobox	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P19256	CD58	Lymphocyte function-associated antigen 3	GO:0005515; F:protein binding; IPI:UniProtKB
P19256	CD58	Lymphocyte function-associated antigen 3	GO:0005102; F:receptor binding; IPI:UniProt
P19256	CD58	Lymphocyte function-associated antigen 3	GO:0007596; P:blood coagulation; TAS:Reactome
P19256	CD58	Lymphocyte function-associated antigen 3	GO:0007155; P:cell adhesion; NAS:ProtInc
P19256	CD58	Lymphocyte function-associated antigen 3	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
P19256	CD58	Lymphocyte function-associated antigen 3	GO:0071346; P:cellular response to interferon-gamma; IDA:UniProt
P19256	CD58	Lymphocyte function-associated antigen 3	GO:0071356; P:cellular response to tumor necrosis factor; IDA:UniProt
P19256	CD58	Lymphocyte function-associated antigen 3	GO:0034113; P:heterotypic cell-cell adhesion; IDA:UniProt
P19256	CD58	Lymphocyte function-associated antigen 3	GO:0050900; P:leukocyte migration; TAS:Reactome
P19256	CD58	Lymphocyte function-associated antigen 3	GO:2000484; P:positive regulation of interleukin-8 secretion; IMP:UniProt
Q9BWQ8	FAIM2	Protein lifeguard 2	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9BWQ8	FAIM2	Protein lifeguard 2	GO:0021681; P:cerebellar granular layer development; ISS:UniProtKB
Q9BWQ8	FAIM2	Protein lifeguard 2	GO:0021702; P:cerebellar Purkinje cell differentiation; ISS:UniProtKB
Q9BWQ8	FAIM2	Protein lifeguard 2	GO:0021680; P:cerebellar Purkinje cell layer development; ISS:UniProtKB
Q9BWQ8	FAIM2	Protein lifeguard 2	GO:0021549; P:cerebellum development; ISS:UniProtKB
Q9BWQ8	FAIM2	Protein lifeguard 2	GO:0043066; P:negative regulation of apoptotic process; NAS:UniProtKB
Q9BWQ8	FAIM2	Protein lifeguard 2	GO:0043523; P:regulation of neuron apoptotic process; IMP:UniProtKB
Q9HC24	TMBIM4	Protein lifeguard 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HC24	TMBIM4	Protein lifeguard 4	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9HC24	TMBIM4	Protein lifeguard 4	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q9HC24	TMBIM4	Protein lifeguard 4	GO:0050848; P:regulation of calcium-mediated signaling; IDA:UniProtKB
Q8NES3	LFNG	Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NES3	LFNG	Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe	GO:0033829; F:O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity; ISS:UniProt
Q8NES3	LFNG	Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe	GO:0007386; P:compartment pattern specification; IEA:Ensembl
Q8NES3	LFNG	Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe	GO:0007143; P:female meiotic division; IEA:Ensembl
Q8NES3	LFNG	Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe	GO:0008152; P:metabolic process; ISS:GOC
Q8NES3	LFNG	Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q8NES3	LFNG	Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe	GO:0009887; P:organ morphogenesis; NAS:UniProtKB
Q8NES3	LFNG	Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe	GO:0001541; P:ovarian follicle development; IEA:Ensembl
Q8NES3	LFNG	Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe	GO:0045747; P:positive regulation of Notch signaling pathway; IEA:Ensembl
Q8NES3	LFNG	Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe	GO:0032092; P:positive regulation of protein binding; IEA:Ensembl
Q8NES3	LFNG	Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe	GO:0008593; P:regulation of Notch signaling pathway; ISS:UniProt
Q8NES3	LFNG	Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe	GO:0014807; P:regulation of somitogenesis; IMP:UniProt
Q8NES3	LFNG	Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe	GO:0001756; P:somitogenesis; IEA:Ensembl
O00292	LEFTY2	Left-right determination factor 2	GO:0007596; P:blood coagulation; TAS:Reactome
O00292	LEFTY2	Left-right determination factor 2	GO:0016049; P:cell growth; IEA:InterPro
O00292	LEFTY2	Left-right determination factor 2	GO:0007275; P:multicellular organismal development; TAS:ProtInc
O00292	LEFTY2	Left-right determination factor 2	GO:0030168; P:platelet activation; TAS:Reactome
O00292	LEFTY2	Left-right determination factor 2	GO:0002576; P:platelet degranulation; TAS:Reactome
O00292	LEFTY2	Left-right determination factor 2	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:ProtInc
O75610	LEFTY1	Left-right determination factor 1	GO:0016049; P:cell growth; IEA:InterPro
O75610	LEFTY1	Left-right determination factor 1	GO:0007368; P:determination of left/right symmetry; ISS:BHF-UCL
O75610	LEFTY1	Left-right determination factor 1	GO:0003007; P:heart morphogenesis; ISS:BHF-UCL
O75610	LEFTY1	Left-right determination factor 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
O75610	LEFTY1	Left-right determination factor 1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:ProtInc
Q08380	LGALS3BP	Galectin-3-binding protein	GO:0005044; F:scavenger receptor activity; TAS:ProtInc
Q08380	LGALS3BP	Galectin-3-binding protein	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q08380	LGALS3BP	Galectin-3-binding protein	GO:0006968; P:cellular defense response; TAS:ProtInc
Q08380	LGALS3BP	Galectin-3-binding protein	GO:0006898; P:receptor-mediated endocytosis; TAS:GOC
Q08380	LGALS3BP	Galectin-3-binding protein	GO:0007165; P:signal transduction; TAS:ProtInc
Q92604	LPGAT1	Acyl-CoA:lysophosphatidylglycerol acyltransferase 1	GO:0016746; F:transferase activity, transferring acyl groups; IEA:UniProtKB-KW
Q92604	LPGAT1	Acyl-CoA:lysophosphatidylglycerol acyltransferase 1	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q92604	LPGAT1	Acyl-CoA:lysophosphatidylglycerol acyltransferase 1	GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome
Q92604	LPGAT1	Acyl-CoA:lysophosphatidylglycerol acyltransferase 1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q92604	LPGAT1	Acyl-CoA:lysophosphatidylglycerol acyltransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95970	LGI1	Leucine-rich glioma-inactivated protein 1	GO:0005515; F:protein binding; IPI:DFLAT
O95970	LGI1	Leucine-rich glioma-inactivated protein 1	GO:0005102; F:receptor binding; IPI:DFLAT
O95970	LGI1	Leucine-rich glioma-inactivated protein 1	GO:0007411; P:axon guidance; IMP:DFLAT
O95970	LGI1	Leucine-rich glioma-inactivated protein 1	GO:0008283; P:cell proliferation; TAS:ProtInc
O95970	LGI1	Leucine-rich glioma-inactivated protein 1	GO:0007399; P:nervous system development; TAS:ProtInc
O95970	LGI1	Leucine-rich glioma-inactivated protein 1	GO:0031175; P:neuron projection development; IMP:DFLAT
O95970	LGI1	Leucine-rich glioma-inactivated protein 1	GO:0030307; P:positive regulation of cell growth; IMP:DFLAT
O95970	LGI1	Leucine-rich glioma-inactivated protein 1	GO:0050806; P:positive regulation of synaptic transmission; ISS:UniProtKB
O95970	LGI1	Leucine-rich glioma-inactivated protein 1	GO:0051260; P:protein homooligomerization; IEA:Ensembl
Q8N145	LGI3	Leucine-rich repeat LGI family member 3	GO:0003824; F:catalytic activity; IEA:InterPro
Q8N145	LGI3	Leucine-rich repeat LGI family member 3	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q8N145	LGI3	Leucine-rich repeat LGI family member 3	GO:0017157; P:regulation of exocytosis; IEA:Ensembl
Q8N135	LGI4	Leucine-rich repeat LGI family member 4	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
Q8N135	LGI4	Leucine-rich repeat LGI family member 4	GO:0014009; P:glial cell proliferation; IEA:Ensembl
Q8N135	LGI4	Leucine-rich repeat LGI family member 4	GO:0022011; P:myelination in peripheral nervous system; IEA:Ensembl
Q8N135	LGI4	Leucine-rich repeat LGI family member 4	GO:0042551; P:neuron maturation; IEA:Ensembl
Q99538	LGMN	Legumain	GO:0004197; F:cysteine-type endopeptidase activity; ISS:UniProtKB
Q99538	LGMN	Legumain	GO:0008233; F:peptidase activity; IDA:MGI
Q99538	LGMN	Legumain	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q99538	LGMN	Legumain	GO:0045087; P:innate immune response; TAS:Reactome
Q99538	LGMN	Legumain	GO:1901185; P:negative regulation of ERBB signaling pathway; ISS:UniProtKB
Q99538	LGMN	Legumain	GO:0040015; P:negative regulation of multicellular organism growth; IEA:Ensembl
Q99538	LGMN	Legumain	GO:0043524; P:negative regulation of neuron apoptotic process; IGI:MGI
Q99538	LGMN	Legumain	GO:0006508; P:proteolysis; ISS:UniProtKB
Q99538	LGMN	Legumain	GO:0051603; P:proteolysis involved in cellular protein catabolic process; ISS:UniProtKB
Q99538	LGMN	Legumain	GO:0032801; P:receptor catabolic process; ISS:UniProtKB
Q99538	LGMN	Legumain	GO:0003014; P:renal system process; ISS:UniProtKB
Q99538	LGMN	Legumain	GO:0001101; P:response to acid; IEA:Ensembl
Q99538	LGMN	Legumain	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99538	LGMN	Legumain	GO:0008202; P:steroid metabolic process; TAS:Reactome
Q99538	LGMN	Legumain	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q99538	LGMN	Legumain	GO:0042359; P:vitamin D metabolic process; TAS:Reactome
Q9BXB1	LGR4	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q9BXB1	LGR4	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BXB1	LGR4	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0004888; F:transmembrane signaling receptor activity; IDA:UniProtKB
Q9BXB1	LGR4	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0030282; P:bone mineralization; ISS:UniProtKB
Q9BXB1	LGR4	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0046849; P:bone remodeling; ISS:UniProtKB
Q9BXB1	LGR4	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0061290; P:canonical Wnt signaling pathway involved in metanephric kidney development; IEA:Ensembl
Q9BXB1	LGR4	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0072202; P:cell differentiation involved in metanephros development; IEA:Ensembl
Q9BXB1	LGR4	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0050673; P:epithelial cell proliferation; IEA:Ensembl
Q9BXB1	LGR4	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q9BXB1	LGR4	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0030539; P:male genitalia development; IEA:Ensembl
Q9BXB1	LGR4	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0072224; P:metanephric glomerulus development; IEA:Ensembl
Q9BXB1	LGR4	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0072282; P:metanephric nephron tubule morphogenesis; IEA:Ensembl
Q9BXB1	LGR4	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0050710; P:negative regulation of cytokine secretion; ISS:UniProtKB
Q9BXB1	LGR4	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0034122; P:negative regulation of toll-like receptor signaling pathway; ISS:UniProtKB
Q9BXB1	LGR4	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q9BXB1	LGR4	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0001649; P:osteoblast differentiation; ISS:UniProtKB
Q9BXB1	LGR4	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; IEA:Ensembl
Q9BXB1	LGR4	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:UniProtKB
Q9BXB1	LGR4	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q9BXB1	LGR4	Leucine-rich repeat-containing G-protein coupled receptor 4	GO:0007283; P:spermatogenesis; ISS:UniProtKB
O75473	LGR5	Leucine-rich repeat-containing G-protein coupled receptor 5	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O75473	LGR5	Leucine-rich repeat-containing G-protein coupled receptor 5	GO:0005515; F:protein binding; IPI:UniProtKB
O75473	LGR5	Leucine-rich repeat-containing G-protein coupled receptor 5	GO:0016500; F:protein-hormone receptor activity; IEA:InterPro
O75473	LGR5	Leucine-rich repeat-containing G-protein coupled receptor 5	GO:0004888; F:transmembrane signaling receptor activity; IDA:UniProtKB
O75473	LGR5	Leucine-rich repeat-containing G-protein coupled receptor 5	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
O75473	LGR5	Leucine-rich repeat-containing G-protein coupled receptor 5	GO:0048839; P:inner ear development; IEA:Ensembl
O75473	LGR5	Leucine-rich repeat-containing G-protein coupled receptor 5	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:UniProtKB
Q9HBX8	LGR6	Leucine-rich repeat-containing G-protein coupled receptor 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HBX8	LGR6	Leucine-rich repeat-containing G-protein coupled receptor 6	GO:0004888; F:transmembrane signaling receptor activity; ISS:UniProtKB
Q9HBX8	LGR6	Leucine-rich repeat-containing G-protein coupled receptor 6	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:UniProtKB-KW
Q9HBX8	LGR6	Leucine-rich repeat-containing G-protein coupled receptor 6	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; ISS:UniProtKB
Q9HBX8	LGR6	Leucine-rich repeat-containing G-protein coupled receptor 6	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q5TDP6	LGSN	Lengsin	GO:0004356; F:glutamate-ammonia ligase activity; IEA:InterPro
Q5TDP6	LGSN	Lengsin	GO:0006542; P:glutamine biosynthetic process; IEA:InterPro
Q04760	GLO1	Lactoylglutathione lyase	GO:0004462; F:lactoylglutathione lyase activity; IDA:UniProtKB
Q04760	GLO1	Lactoylglutathione lyase	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q04760	GLO1	Lactoylglutathione lyase	GO:0005975; P:carbohydrate metabolic process; NAS:ProtInc
Q04760	GLO1	Lactoylglutathione lyase	GO:0006749; P:glutathione metabolic process; IEA:Ensembl
Q04760	GLO1	Lactoylglutathione lyase	GO:0009438; P:methylglyoxal metabolic process; IEA:Ensembl
Q04760	GLO1	Lactoylglutathione lyase	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q04760	GLO1	Lactoylglutathione lyase	GO:0030316; P:osteoclast differentiation; ISS:UniProtKB
Q04760	GLO1	Lactoylglutathione lyase	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9Y693	LHFP	Lipoma HMGIC fusion partner	GO:0003677; F:DNA binding; TAS:ProtInc
Q9H008	LHPP	Phospholysine phosphohistidine inorganic pyrophosphate phosphatase	GO:0004427; F:inorganic diphosphatase activity; IDA:UniProtKB
Q9H008	LHPP	Phospholysine phosphohistidine inorganic pyrophosphate phosphatase	GO:0000287; F:magnesium ion binding; ISS:UniProtKB
Q9H008	LHPP	Phospholysine phosphohistidine inorganic pyrophosphate phosphatase	GO:0008969; F:phosphohistidine phosphatase activity; ISS:UniProtKB
Q9H008	LHPP	Phospholysine phosphohistidine inorganic pyrophosphate phosphatase	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q9H008	LHPP	Phospholysine phosphohistidine inorganic pyrophosphate phosphatase	GO:0006796; P:phosphate-containing compound metabolic process; IDA:UniProtKB
Q9H008	LHPP	Phospholysine phosphohistidine inorganic pyrophosphate phosphatase	GO:0006470; P:protein dephosphorylation; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0003714; F:transcription corepressor activity; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0008270; F:zinc ion binding; IEA:InterPro
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0048646; P:anatomical structure formation involved in morphogenesis; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0009653; P:anatomical structure morphogenesis; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0009948; P:anterior/posterior axis specification; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0009952; P:anterior/posterior pattern specification; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0007267; P:cell-cell signaling; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEA:Ensembl
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0021702; P:cerebellar Purkinje cell differentiation; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0021937; P:cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0021549; P:cerebellum development; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0060067; P:cervix development; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0072049; P:comma-shaped body morphogenesis; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0009953; P:dorsal/ventral pattern formation; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0001705; P:ectoderm formation; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0009880; P:embryonic pattern specification; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0060059; P:embryonic retina morphogenesis in camera-type eye; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0048703; P:embryonic viscerocranium morphogenesis; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0001706; P:endoderm formation; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0060429; P:epithelium development; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0021871; P:forebrain regionalization; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0001702; P:gastrulation with mouth forming second; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0060322; P:head development; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0035852; P:horizontal cell localization; IEA:Ensembl
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0001822; P:kidney development; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0097477; P:lateral motor column neuron migration; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0072177; P:mesonephric duct development; IEA:Ensembl
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0072278; P:metanephric comma-shaped body morphogenesis; IEA:Ensembl
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0072224; P:metanephric glomerulus development; IEA:Ensembl
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0035502; P:metanephric part of ureteric bud development; IEA:Ensembl
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0072283; P:metanephric renal vesicle morphogenesis; IEA:Ensembl
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0072284; P:metanephric S-shaped body morphogenesis; IEA:Ensembl
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0008045; P:motor neuron axon guidance; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0035849; P:nephric duct elongation; IEA:Ensembl
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0072178; P:nephric duct morphogenesis; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0007399; P:nervous system development; TAS:ProtInc
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0060066; P:oviduct development; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0035846; P:oviduct epithelium development; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0061205; P:paramesonephric duct development; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0007389; P:pattern specification process; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:2000744; P:positive regulation of anterior head development; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0040019; P:positive regulation of embryonic development; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:2000543; P:positive regulation of gastrulation; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:2000768; P:positive regulation of nephron tubule epithelial cell differentiation; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0009791; P:post-embryonic development; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0090009; P:primitive streak formation; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0048793; P:pronephros development; IEA:Ensembl
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0010468; P:regulation of gene expression; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0072077; P:renal vesicle morphogenesis; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0010842; P:retina layer formation; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0072050; P:S-shaped body morphogenesis; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0032525; P:somite rostral/caudal axis specification; IEA:Ensembl
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0021527; P:spinal cord association neuron differentiation; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0021537; P:telencephalon development; IEA:Ensembl
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0006366; P:transcription from RNA polymerase II promoter; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0001657; P:ureteric bud development; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0001655; P:urogenital system development; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0035847; P:uterine epithelium development; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0060065; P:uterus development; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0060068; P:vagina development; ISS:UniProtKB
P48742	LHX1	LIM/homeobox protein Lhx1	GO:0021517; P:ventral spinal cord development; IEA:Ensembl
P50458	LHX2	LIM/homeobox protein Lhx2	GO:0001076; F:RNA polymerase II transcription factor binding transcription factor activity; IEA:Ensembl
P50458	LHX2	LIM/homeobox protein Lhx2	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P50458	LHX2	LIM/homeobox protein Lhx2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P50458	LHX2	LIM/homeobox protein Lhx2	GO:0008270; F:zinc ion binding; IEA:InterPro
P50458	LHX2	LIM/homeobox protein Lhx2	GO:0007411; P:axon guidance; IEA:Ensembl
P50458	LHX2	LIM/homeobox protein Lhx2	GO:0021987; P:cerebral cortex development; IEA:Ensembl
P50458	LHX2	LIM/homeobox protein Lhx2	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
P50458	LHX2	LIM/homeobox protein Lhx2	GO:0007498; P:mesoderm development; IEA:Ensembl
P50458	LHX2	LIM/homeobox protein Lhx2	GO:2000678; P:negative regulation of transcription regulatory region DNA binding; IEA:Ensembl
P50458	LHX2	LIM/homeobox protein Lhx2	GO:0001843; P:neural tube closure; IEA:Ensembl
P50458	LHX2	LIM/homeobox protein Lhx2	GO:0021772; P:olfactory bulb development; IEA:Ensembl
P50458	LHX2	LIM/homeobox protein Lhx2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P50458	LHX2	LIM/homeobox protein Lhx2	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
P50458	LHX2	LIM/homeobox protein Lhx2	GO:0021978; P:telencephalon regionalization; IEA:Ensembl
Q9UBR4	LHX3	LIM/homeobox protein Lhx3	GO:0001076; F:RNA polymerase II transcription factor binding transcription factor activity; IEA:Ensembl
Q9UBR4	LHX3	LIM/homeobox protein Lhx3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9UBR4	LHX3	LIM/homeobox protein Lhx3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9UBR4	LHX3	LIM/homeobox protein Lhx3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UBR4	LHX3	LIM/homeobox protein Lhx3	GO:0048839; P:inner ear development; IEP:UniProtKB
Q9UBR4	LHX3	LIM/homeobox protein Lhx3	GO:0030324; P:lung development; IEA:Ensembl
Q9UBR4	LHX3	LIM/homeobox protein Lhx3	GO:0021526; P:medial motor column neuron differentiation; IEA:Ensembl
Q9UBR4	LHX3	LIM/homeobox protein Lhx3	GO:0008045; P:motor neuron axon guidance; IEA:Ensembl
Q9UBR4	LHX3	LIM/homeobox protein Lhx3	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q9UBR4	LHX3	LIM/homeobox protein Lhx3	GO:0009887; P:organ morphogenesis; TAS:ProtInc
Q9UBR4	LHX3	LIM/homeobox protein Lhx3	GO:0021983; P:pituitary gland development; IEA:Ensembl
Q9UBR4	LHX3	LIM/homeobox protein Lhx3	GO:0001890; P:placenta development; IEA:Ensembl
Q9UBR4	LHX3	LIM/homeobox protein Lhx3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UBR4	LHX3	LIM/homeobox protein Lhx3	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q9UBR4	LHX3	LIM/homeobox protein Lhx3	GO:0021527; P:spinal cord association neuron differentiation; IEA:Ensembl
Q9UBR4	LHX3	LIM/homeobox protein Lhx3	GO:0021520; P:spinal cord motor neuron cell fate specification; IEA:Ensembl
Q9UBR4	LHX3	LIM/homeobox protein Lhx3	GO:0021521; P:ventral spinal cord interneuron specification; IEA:Ensembl
Q9NQ69	LHX9	LIM/homeobox protein Lhx9	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9NQ69	LHX9	LIM/homeobox protein Lhx9	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9NQ69	LHX9	LIM/homeobox protein Lhx9	GO:0003714; F:transcription corepressor activity; ISS:UniProtKB
Q9NQ69	LHX9	LIM/homeobox protein Lhx9	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NQ69	LHX9	LIM/homeobox protein Lhx9	GO:0008283; P:cell proliferation; IEA:Ensembl
Q9NQ69	LHX9	LIM/homeobox protein Lhx9	GO:0008585; P:female gonad development; IEA:Ensembl
Q9NQ69	LHX9	LIM/homeobox protein Lhx9	GO:0035262; P:gonad morphogenesis; IEA:Ensembl
Q9NQ69	LHX9	LIM/homeobox protein Lhx9	GO:0008584; P:male gonad development; IEA:Ensembl
Q9NQ69	LHX9	LIM/homeobox protein Lhx9	GO:0008045; P:motor neuron axon guidance; ISS:UniProtKB
Q9NQ69	LHX9	LIM/homeobox protein Lhx9	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q9H2C1	LHX5	LIM/homeobox protein Lhx5	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9H2C1	LHX5	LIM/homeobox protein Lhx5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9H2C1	LHX5	LIM/homeobox protein Lhx5	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H2C1	LHX5	LIM/homeobox protein Lhx5	GO:0021846; P:cell proliferation in forebrain; IEA:Ensembl
Q9H2C1	LHX5	LIM/homeobox protein Lhx5	GO:0021702; P:cerebellar Purkinje cell differentiation; IEA:Ensembl
Q9H2C1	LHX5	LIM/homeobox protein Lhx5	GO:0021937; P:cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation; IEA:Ensembl
Q9H2C1	LHX5	LIM/homeobox protein Lhx5	GO:0021879; P:forebrain neuron differentiation; IEA:Ensembl
Q9H2C1	LHX5	LIM/homeobox protein Lhx5	GO:0021766; P:hippocampus development; IEA:Ensembl
Q9H2C1	LHX5	LIM/homeobox protein Lhx5	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q9H2C1	LHX5	LIM/homeobox protein Lhx5	GO:0021527; P:spinal cord association neuron differentiation; IEA:Ensembl
Q9H2C1	LHX5	LIM/homeobox protein Lhx5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q969G2	LHX4	LIM/homeobox protein Lhx4	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q969G2	LHX4	LIM/homeobox protein Lhx4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q969G2	LHX4	LIM/homeobox protein Lhx4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q969G2	LHX4	LIM/homeobox protein Lhx4	GO:0021526; P:medial motor column neuron differentiation; IEA:Ensembl
Q969G2	LHX4	LIM/homeobox protein Lhx4	GO:0008045; P:motor neuron axon guidance; IEA:Ensembl
Q969G2	LHX4	LIM/homeobox protein Lhx4	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q969G2	LHX4	LIM/homeobox protein Lhx4	GO:0009887; P:organ morphogenesis; IEA:Ensembl
Q969G2	LHX4	LIM/homeobox protein Lhx4	GO:0001890; P:placenta development; IEA:Ensembl
Q969G2	LHX4	LIM/homeobox protein Lhx4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UPM6	LHX6	LIM/homeobox protein Lhx6	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9UPM6	LHX6	LIM/homeobox protein Lhx6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9UPM6	LHX6	LIM/homeobox protein Lhx6	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UPM6	LHX6	LIM/homeobox protein Lhx6	GO:0048469; P:cell maturation; ISS:UniProtKB
Q9UPM6	LHX6	LIM/homeobox protein Lhx6	GO:0021853; P:cerebral cortex GABAergic interneuron migration; ISS:UniProtKB
Q9UPM6	LHX6	LIM/homeobox protein Lhx6	GO:0021799; P:cerebral cortex radially oriented cell migration; ISS:UniProtKB
Q9UPM6	LHX6	LIM/homeobox protein Lhx6	GO:0021800; P:cerebral cortex tangential migration; ISS:UniProtKB
Q9UPM6	LHX6	LIM/homeobox protein Lhx6	GO:0021884; P:forebrain neuron development; IEA:Ensembl
Q9UPM6	LHX6	LIM/homeobox protein Lhx6	GO:0021877; P:forebrain neuron fate commitment; IEA:Ensembl
Q9UPM6	LHX6	LIM/homeobox protein Lhx6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q68G74	LHX8	LIM/homeobox protein Lhx8	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q68G74	LHX8	LIM/homeobox protein Lhx8	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q68G74	LHX8	LIM/homeobox protein Lhx8	GO:0008270; F:zinc ion binding; IEA:InterPro
Q68G74	LHX8	LIM/homeobox protein Lhx8	GO:0008585; P:female gonad development; IEA:Ensembl
Q68G74	LHX8	LIM/homeobox protein Lhx8	GO:0021884; P:forebrain neuron development; IEA:Ensembl
Q68G74	LHX8	LIM/homeobox protein Lhx8	GO:0007611; P:learning or memory; IEA:Ensembl
Q68G74	LHX8	LIM/homeobox protein Lhx8	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
Q68G74	LHX8	LIM/homeobox protein Lhx8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43766	LIAS	Lipoyl synthase, mitochondrial	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-HAMAP
O43766	LIAS	Lipoyl synthase, mitochondrial	GO:0016992; F:lipoate synthase activity; IEA:UniProtKB-HAMAP
O43766	LIAS	Lipoyl synthase, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43766	LIAS	Lipoyl synthase, mitochondrial	GO:0006954; P:inflammatory response; ISS:UniProtKB
O43766	LIAS	Lipoyl synthase, mitochondrial	GO:0009107; P:lipoate biosynthetic process; ISS:UniProtKB
O43766	LIAS	Lipoyl synthase, mitochondrial	GO:0001843; P:neural tube closure; IEA:Ensembl
O43766	LIAS	Lipoyl synthase, mitochondrial	GO:0009249; P:protein lipoylation; IEA:UniProtKB-HAMAP
O43766	LIAS	Lipoyl synthase, mitochondrial	GO:0032496; P:response to lipopolysaccharide; ISS:UniProtKB
O43766	LIAS	Lipoyl synthase, mitochondrial	GO:0006979; P:response to oxidative stress; ISS:UniProtKB
P38571	LIPA	Lysosomal acid lipase/cholesteryl ester hydrolase	GO:0016298; F:lipase activity; IDA:UniProtKB
P38571	LIPA	Lysosomal acid lipase/cholesteryl ester hydrolase	GO:0004771; F:sterol esterase activity; IDA:UniProtKB
P38571	LIPA	Lysosomal acid lipase/cholesteryl ester hydrolase	GO:0000902; P:cell morphogenesis; IEA:Ensembl
P38571	LIPA	Lysosomal acid lipase/cholesteryl ester hydrolase	GO:0008283; P:cell proliferation; IEA:Ensembl
P38571	LIPA	Lysosomal acid lipase/cholesteryl ester hydrolase	GO:0001816; P:cytokine production; IEA:Ensembl
P38571	LIPA	Lysosomal acid lipase/cholesteryl ester hydrolase	GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl
P38571	LIPA	Lysosomal acid lipase/cholesteryl ester hydrolase	GO:0006954; P:inflammatory response; IEA:Ensembl
P38571	LIPA	Lysosomal acid lipase/cholesteryl ester hydrolase	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
P38571	LIPA	Lysosomal acid lipase/cholesteryl ester hydrolase	GO:0030324; P:lung development; IEA:Ensembl
P38571	LIPA	Lysosomal acid lipase/cholesteryl ester hydrolase	GO:0048771; P:tissue remodeling; IEA:Ensembl
P42702	LIFR	Leukemia inhibitory factor receptor	GO:0005127; F:ciliary neurotrophic factor receptor binding; IPI:BHF-UCL
P42702	LIFR	Leukemia inhibitory factor receptor	GO:0019838; F:growth factor binding; IPI:BHF-UCL
P42702	LIFR	Leukemia inhibitory factor receptor	GO:0004923; F:leukemia inhibitory factor receptor activity; IDA:MGI
P42702	LIFR	Leukemia inhibitory factor receptor	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P42702	LIFR	Leukemia inhibitory factor receptor	GO:0070120; P:ciliary neurotrophic factor-mediated signaling pathway; IDA:BHF-UCL
P42702	LIFR	Leukemia inhibitory factor receptor	GO:0019221; P:cytokine-mediated signaling pathway; IDA:MGI
P42702	LIFR	Leukemia inhibitory factor receptor	GO:0048861; P:leukemia inhibitory factor signaling pathway; IDA:BHF-UCL
P42702	LIFR	Leukemia inhibitory factor receptor	GO:0038165; P:oncostatin-M-mediated signaling pathway; IDA:GOC
P42702	LIFR	Leukemia inhibitory factor receptor	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P42702	LIFR	Leukemia inhibitory factor receptor	GO:0034097; P:response to cytokine; IDA:BHF-UCL
P15018	LIF	Leukemia inhibitory factor	GO:0005125; F:cytokine activity; IDA:MGI
P15018	LIF	Leukemia inhibitory factor	GO:0008083; F:growth factor activity; IDA:BHF-UCL
P15018	LIF	Leukemia inhibitory factor	GO:0005146; F:leukemia inhibitory factor receptor binding; IPI:BHF-UCL
P15018	LIF	Leukemia inhibitory factor	GO:0005102; F:receptor binding; IPI:BHF-UCL
P15018	LIF	Leukemia inhibitory factor	GO:0001135; F:RNA polymerase II transcription factor recruiting transcription factor activity; IDA:BHF-UCL
P15018	LIF	Leukemia inhibitory factor	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
P15018	LIF	Leukemia inhibitory factor	GO:0046697; P:decidualization; IEA:Ensembl
P15018	LIF	Leukemia inhibitory factor	GO:0007566; P:embryo implantation; IEA:Ensembl
P15018	LIF	Leukemia inhibitory factor	GO:0006955; P:immune response; IEA:InterPro
P15018	LIF	Leukemia inhibitory factor	GO:0048861; P:leukemia inhibitory factor signaling pathway; IDA:BHF-UCL
P15018	LIF	Leukemia inhibitory factor	GO:0048286; P:lung alveolus development; IEA:Ensembl
P15018	LIF	Leukemia inhibitory factor	GO:0060463; P:lung lobe morphogenesis; IEA:Ensembl
P15018	LIF	Leukemia inhibitory factor	GO:0060426; P:lung vasculature development; IEA:Ensembl
P15018	LIF	Leukemia inhibitory factor	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P15018	LIF	Leukemia inhibitory factor	GO:0048644; P:muscle organ morphogenesis; IEA:Ensembl
P15018	LIF	Leukemia inhibitory factor	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P15018	LIF	Leukemia inhibitory factor	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IEA:Ensembl
P15018	LIF	Leukemia inhibitory factor	GO:0046888; P:negative regulation of hormone secretion; IDA:MGI
P15018	LIF	Leukemia inhibitory factor	GO:0045835; P:negative regulation of meiosis; IEA:Ensembl
P15018	LIF	Leukemia inhibitory factor	GO:0048666; P:neuron development; IEA:Ensembl
P15018	LIF	Leukemia inhibitory factor	GO:0048711; P:positive regulation of astrocyte differentiation; IEA:Ensembl
P15018	LIF	Leukemia inhibitory factor	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P15018	LIF	Leukemia inhibitory factor	GO:1901676; P:positive regulation of histone H3-K27 acetylation; IDA:BHF-UCL
P15018	LIF	Leukemia inhibitory factor	GO:0045651; P:positive regulation of macrophage differentiation; IDA:MGI
P15018	LIF	Leukemia inhibitory factor	GO:0043410; P:positive regulation of MAPK cascade; IDA:MGI
P15018	LIF	Leukemia inhibitory factor	GO:0072108; P:positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; IDA:BHF-UCL
P15018	LIF	Leukemia inhibitory factor	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:MGI
P15018	LIF	Leukemia inhibitory factor	GO:0033141; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; IDA:BHF-UCL
P15018	LIF	Leukemia inhibitory factor	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:MGI
P15018	LIF	Leukemia inhibitory factor	GO:1900182; P:positive regulation of protein localization to nucleus; IDA:BHF-UCL
P15018	LIF	Leukemia inhibitory factor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P15018	LIF	Leukemia inhibitory factor	GO:0042511; P:positive regulation of tyrosine phosphorylation of Stat1 protein; IDA:BHF-UCL
P15018	LIF	Leukemia inhibitory factor	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IDA:BHF-UCL
P15018	LIF	Leukemia inhibitory factor	GO:0072307; P:regulation of metanephric nephron tubule epithelial cell differentiation; IDA:BHF-UCL
P15018	LIF	Leukemia inhibitory factor	GO:0060708; P:spongiotrophoblast differentiation; IEA:Ensembl
P15018	LIF	Leukemia inhibitory factor	GO:0019827; P:stem cell maintenance; IEA:Ensembl
P15018	LIF	Leukemia inhibitory factor	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:GOC
P15018	LIF	Leukemia inhibitory factor	GO:0060707; P:trophoblast giant cell differentiation; IEA:Ensembl
P15018	LIF	Leukemia inhibitory factor	GO:0042503; P:tyrosine phosphorylation of Stat3 protein; IEA:Ensembl
Q96FE5	LINGO1	Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1	GO:0021954; P:central nervous system neuron development; IEA:Ensembl
Q96FE5	LINGO1	Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1	GO:0050771; P:negative regulation of axonogenesis; TAS:Reactome
Q96FE5	LINGO1	Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1	GO:0048715; P:negative regulation of oligodendrocyte differentiation; IEA:Ensembl
Q96FE5	LINGO1	Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1	GO:0031175; P:neuron projection development; IEA:Ensembl
Q96FE5	LINGO1	Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q96FE5	LINGO1	Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1	GO:0043491; P:protein kinase B signaling; IEA:Ensembl
Q96FE5	LINGO1	Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1	GO:0050770; P:regulation of axonogenesis; TAS:Reactome
P0CW20	LIMS3L	LIM and senescent cell antigen-like-containing domain protein 3-like	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UHB6	LIMA1	LIM domain and actin-binding protein 1	GO:0051015; F:actin filament binding; IDA:UniProtKB
Q9UHB6	LIMA1	LIM domain and actin-binding protein 1	GO:0003785; F:actin monomer binding; IDA:UniProtKB
Q9UHB6	LIMA1	LIM domain and actin-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9UHB6	LIMA1	LIM domain and actin-binding protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UHB6	LIMA1	LIM domain and actin-binding protein 1	GO:0051017; P:actin filament bundle assembly; IDA:UniProtKB
Q9UHB6	LIMA1	LIM domain and actin-binding protein 1	GO:0030835; P:negative regulation of actin filament depolymerization; IDA:UniProtKB
Q9UHB6	LIMA1	LIM domain and actin-binding protein 1	GO:0031529; P:ruffle organization; IDA:UniProtKB
Q9UPQ0	LIMCH1	LIM and calponin homology domains-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UPQ0	LIMCH1	LIM and calponin homology domains-containing protein 1	GO:0031032; P:actomyosin structure organization; IEA:InterPro
Q9UGP4	LIMD1	LIM domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UGP4	LIMD1	LIM domain-containing protein 1	GO:0003714; F:transcription corepressor activity; ISS:UniProtKB
Q9UGP4	LIMD1	LIM domain-containing protein 1	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q9UGP4	LIMD1	LIM domain-containing protein 1	GO:0016477; P:cell migration; IMP:UniProtKB
Q9UGP4	LIMD1	LIM domain-containing protein 1	GO:0033962; P:cytoplasmic mRNA processing body assembly; IMP:MGI
Q9UGP4	LIMD1	LIM domain-containing protein 1	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q9UGP4	LIMD1	LIM domain-containing protein 1	GO:0035195; P:gene silencing by miRNA; IMP:MGI
Q9UGP4	LIMD1	LIM domain-containing protein 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q9UGP4	LIMD1	LIM domain-containing protein 1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISS:UniProtKB
Q9UGP4	LIMD1	LIM domain-containing protein 1	GO:0035331; P:negative regulation of hippo signaling; IDA:UniProtKB
Q9UGP4	LIMD1	LIM domain-containing protein 1	GO:0045668; P:negative regulation of osteoblast differentiation; ISS:UniProtKB
Q9UGP4	LIMD1	LIM domain-containing protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UGP4	LIMD1	LIM domain-containing protein 1	GO:0002076; P:osteoblast development; ISS:UniProtKB
Q9UGP4	LIMD1	LIM domain-containing protein 1	GO:0016310; P:phosphorylation; IDA:UniProtKB
Q9UGP4	LIMD1	LIM domain-containing protein 1	GO:2000637; P:positive regulation of gene silencing by miRNA; IMP:UniProtKB
Q9UGP4	LIMD1	LIM domain-containing protein 1	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
Q9UGP4	LIMD1	LIM domain-containing protein 1	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
Q9UGP4	LIMD1	LIM domain-containing protein 1	GO:0001666; P:response to hypoxia; IDA:UniProtKB
Q9UGP4	LIMD1	LIM domain-containing protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UGP4	LIMD1	LIM domain-containing protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H400	LIME1	Lck-interacting transmembrane adapter 1	GO:0050853; P:B cell receptor signaling pathway; IEA:InterPro
Q9H400	LIME1	Lck-interacting transmembrane adapter 1	GO:0050852; P:T cell receptor signaling pathway; IEA:InterPro
Q9BT23	LIMD2	LIM domain-containing protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
P53671	LIMK2	LIM domain kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P53671	LIMK2	LIM domain kinase 2	GO:0005515; F:protein binding; IPI:IntAct
P53671	LIMK2	LIM domain kinase 2	GO:0004674; F:protein serine/threonine kinase activity; TAS:UniProtKB
P53671	LIMK2	LIM domain kinase 2	GO:0008270; F:zinc ion binding; IEA:InterPro
P53671	LIMK2	LIM domain kinase 2	GO:0016310; P:phosphorylation; TAS:UniProtKB
P53671	LIMK2	LIM domain kinase 2	GO:0007283; P:spermatogenesis; IEA:Ensembl
P48059	LIMS1	LIM and senescent cell antigen-like-containing domain protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P48059	LIMS1	LIM and senescent cell antigen-like-containing domain protein 1	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P48059	LIMS1	LIM and senescent cell antigen-like-containing domain protein 1	GO:0007569; P:cell aging; TAS:ProtInc
P48059	LIMS1	LIM and senescent cell antigen-like-containing domain protein 1	GO:0034329; P:cell junction assembly; TAS:Reactome
P48059	LIMS1	LIM and senescent cell antigen-like-containing domain protein 1	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:UniProtKB
P48059	LIMS1	LIM and senescent cell antigen-like-containing domain protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q7Z4I7	LIMS2	LIM and senescent cell antigen-like-containing domain protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q7Z4I7	LIMS2	LIM and senescent cell antigen-like-containing domain protein 2	GO:0034329; P:cell junction assembly; TAS:Reactome
Q7Z4I7	LIMS2	LIM and senescent cell antigen-like-containing domain protein 2	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
Q7Z4I7	LIMS2	LIM and senescent cell antigen-like-containing domain protein 2	GO:0045216; P:cell-cell junction organization; IEA:Ensembl
Q7Z4I7	LIMS2	LIM and senescent cell antigen-like-containing domain protein 2	GO:2001046; P:positive regulation of integrin-mediated signaling pathway; IEA:Ensembl
P53667	LIMK1	LIM domain kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P53667	LIMK1	LIM domain kinase 1	GO:0031072; F:heat shock protein binding; IDA:BHF-UCL
P53667	LIMK1	LIM domain kinase 1	GO:0005515; F:protein binding; IPI:UniProtKB
P53667	LIMK1	LIM domain kinase 1	GO:0004672; F:protein kinase activity; NAS:ProtInc
P53667	LIMK1	LIM domain kinase 1	GO:0004674; F:protein serine/threonine kinase activity; TAS:Reactome
P53667	LIMK1	LIM domain kinase 1	GO:0008270; F:zinc ion binding; IEA:InterPro
P53667	LIMK1	LIM domain kinase 1	GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc
P53667	LIMK1	LIM domain kinase 1	GO:0007411; P:axon guidance; TAS:Reactome
P53667	LIMK1	LIM domain kinase 1	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P53667	LIMK1	LIM domain kinase 1	GO:0045087; P:innate immune response; TAS:Reactome
P53667	LIMK1	LIM domain kinase 1	GO:0051444; P:negative regulation of ubiquitin-protein ligase activity; IDA:BHF-UCL
P53667	LIMK1	LIM domain kinase 1	GO:0007399; P:nervous system development; TAS:ProtInc
P53667	LIMK1	LIM domain kinase 1	GO:0032233; P:positive regulation of actin filament bundle assembly; IDA:BHF-UCL
P53667	LIMK1	LIM domain kinase 1	GO:0045773; P:positive regulation of axon extension; ISS:UniProtKB
P53667	LIMK1	LIM domain kinase 1	GO:0006468; P:protein phosphorylation; IMP:UniProtKB
P53667	LIMK1	LIM domain kinase 1	GO:0007266; P:Rho protein signal transduction; TAS:ProtInc
P53667	LIMK1	LIM domain kinase 1	GO:0007165; P:signal transduction; TAS:ProtInc
P0CW19	LIMS3	LIM and senescent cell antigen-like-containing domain protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96GY3	LIN37	Protein lin-37 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q96GY3	LIN37	Protein lin-37 homolog	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q96GY3	LIN37	Protein lin-37 homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q96GY3	LIN37	Protein lin-37 homolog	GO:0051726; P:regulation of cell cycle; TAS:Reactome
Q2Q1W2	TRIM71	E3 ubiquitin-protein ligase TRIM71	GO:0035198; F:miRNA binding; ISS:UniProtKB
Q2Q1W2	TRIM71	E3 ubiquitin-protein ligase TRIM71	GO:0004842; F:ubiquitin-protein ligase activity; ISS:UniProtKB
Q2Q1W2	TRIM71	E3 ubiquitin-protein ligase TRIM71	GO:0008270; F:zinc ion binding; IEA:InterPro
Q2Q1W2	TRIM71	E3 ubiquitin-protein ligase TRIM71	GO:0008543; P:fibroblast growth factor receptor signaling pathway; ISS:UniProtKB
Q2Q1W2	TRIM71	E3 ubiquitin-protein ligase TRIM71	GO:0000082; P:G1/S transition of mitotic cell cycle; ISS:UniProtKB
Q2Q1W2	TRIM71	E3 ubiquitin-protein ligase TRIM71	GO:0010586; P:miRNA metabolic process; ISS:UniProtKB
Q2Q1W2	TRIM71	E3 ubiquitin-protein ligase TRIM71	GO:0035278; P:negative regulation of translation involved in gene silencing by miRNA; ISS:UniProtKB
Q2Q1W2	TRIM71	E3 ubiquitin-protein ligase TRIM71	GO:0001843; P:neural tube closure; IEA:Ensembl
Q2Q1W2	TRIM71	E3 ubiquitin-protein ligase TRIM71	GO:0021915; P:neural tube development; ISS:UniProtKB
Q2Q1W2	TRIM71	E3 ubiquitin-protein ligase TRIM71	GO:2000637; P:positive regulation of gene silencing by miRNA; IEA:Ensembl
Q2Q1W2	TRIM71	E3 ubiquitin-protein ligase TRIM71	GO:0051865; P:protein autoubiquitination; ISS:UniProtKB
Q2Q1W2	TRIM71	E3 ubiquitin-protein ligase TRIM71	GO:0060964; P:regulation of gene silencing by miRNA; ISS:UniProtKB
Q2Q1W2	TRIM71	E3 ubiquitin-protein ligase TRIM71	GO:2000177; P:regulation of neural precursor cell proliferation; ISS:UniProtKB
Q2Q1W2	TRIM71	E3 ubiquitin-protein ligase TRIM71	GO:0072089; P:stem cell proliferation; ISS:UniProtKB
Q52LA3	LIN52	Protein lin-52 homolog	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q52LA3	LIN52	Protein lin-52 homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q52LA3	LIN52	Protein lin-52 homolog	GO:0051726; P:regulation of cell cycle; TAS:Reactome
Q52LA3	LIN52	Protein lin-52 homolog	GO:0006351; P:transcription, DNA-templated; IEA:InterPro
Q6MZP7	LIN54	Protein lin-54 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6MZP7	LIN54	Protein lin-54 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q6MZP7	LIN54	Protein lin-54 homolog	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q6MZP7	LIN54	Protein lin-54 homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q6MZP7	LIN54	Protein lin-54 homolog	GO:0051726; P:regulation of cell cycle; TAS:Reactome
Q6MZP7	LIN54	Protein lin-54 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6MZP7	LIN54	Protein lin-54 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O14910	LIN7A	Protein lin-7 homolog A	GO:0097016; F:L27 domain binding; IPI:BHF-UCL
O14910	LIN7A	Protein lin-7 homolog A	GO:0005515; F:protein binding; IPI:UniProtKB
O14910	LIN7A	Protein lin-7 homolog A	GO:0006887; P:exocytosis; TAS:ProtInc
O14910	LIN7A	Protein lin-7 homolog A	GO:0048839; P:inner ear development; IEA:Ensembl
O14910	LIN7A	Protein lin-7 homolog A	GO:0007269; P:neurotransmitter secretion; IEA:Ensembl
O14910	LIN7A	Protein lin-7 homolog A	GO:0006461; P:protein complex assembly; TAS:ProtInc
O14910	LIN7A	Protein lin-7 homolog A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O14910	LIN7A	Protein lin-7 homolog A	GO:0048489; P:synaptic vesicle transport; IEA:Ensembl
Q9HAP6	LIN7B	Protein lin-7 homolog B	GO:0019904; F:protein domain specific binding; IPI:BHF-UCL
Q9HAP6	LIN7B	Protein lin-7 homolog B	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q9HAP6	LIN7B	Protein lin-7 homolog B	GO:0007269; P:neurotransmitter secretion; IEA:Ensembl
Q9HAP6	LIN7B	Protein lin-7 homolog B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9NUP9	LIN7C	Protein lin-7 homolog C	GO:0008092; F:cytoskeletal protein binding; IPI:UniProtKB
Q9NUP9	LIN7C	Protein lin-7 homolog C	GO:0097016; F:L27 domain binding; IDA:UniProt
Q9NUP9	LIN7C	Protein lin-7 homolog C	GO:0019904; F:protein domain specific binding; IPI:BHF-UCL
Q9NUP9	LIN7C	Protein lin-7 homolog C	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q9NUP9	LIN7C	Protein lin-7 homolog C	GO:0002011; P:morphogenesis of an epithelial sheet; IMP:UniProt
Q9NUP9	LIN7C	Protein lin-7 homolog C	GO:0007269; P:neurotransmitter secretion; IEA:Ensembl
Q9NUP9	LIN7C	Protein lin-7 homolog C	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q5TKA1	LIN9	Protein lin-9 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q5TKA1	LIN9	Protein lin-9 homolog	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q5TKA1	LIN9	Protein lin-9 homolog	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q5TKA1	LIN9	Protein lin-9 homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q5TKA1	LIN9	Protein lin-9 homolog	GO:0051726; P:regulation of cell cycle; TAS:Reactome
Q5TKA1	LIN9	Protein lin-9 homolog	GO:0006351; P:transcription, DNA-templated; IEA:InterPro
Q13136	PPFIA1	Liprin-alpha-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13136	PPFIA1	Liprin-alpha-1	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q13136	PPFIA1	Liprin-alpha-1	GO:0007160; P:cell-matrix adhesion; TAS:ProtInc
Q13136	PPFIA1	Liprin-alpha-1	GO:0090005; P:negative regulation of establishment of protein localization to plasma membrane; IMP:MGI
Q13136	PPFIA1	Liprin-alpha-1	GO:0051497; P:negative regulation of stress fiber assembly; IMP:MGI
Q13136	PPFIA1	Liprin-alpha-1	GO:0007165; P:signal transduction; TAS:ProtInc
O75334	PPFIA2	Liprin-alpha-2	GO:0005515; F:protein binding; IPI:UniProtKB
O75334	PPFIA2	Liprin-alpha-2	GO:0007160; P:cell-matrix adhesion; TAS:ProtInc
O75145	PPFIA3	Liprin-alpha-3	GO:0005515; F:protein binding; IPI:UniProtKB
O75335	PPFIA4	Liprin-alpha-4	GO:0005515; F:protein binding; IPI:UniProtKB
Q86W92	PPFIBP1	Liprin-beta-1	GO:0007155; P:cell adhesion; TAS:ProtInc
Q8ND30	PPFIBP2	Liprin-beta-2	GO:0003677; F:DNA binding; IEA:InterPro
Q8ND30	PPFIBP2	Liprin-beta-2	GO:0008907; F:integrase activity; IEA:InterPro
P11150	LIPC	Hepatic triacylglycerol lipase	GO:0034185; F:apolipoprotein binding; ISS:BHF-UCL
P11150	LIPC	Hepatic triacylglycerol lipase	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P11150	LIPC	Hepatic triacylglycerol lipase	GO:0030169; F:low-density lipoprotein particle binding; ISS:BHF-UCL
P11150	LIPC	Hepatic triacylglycerol lipase	GO:0004620; F:phospholipase activity; TAS:BHF-UCL
P11150	LIPC	Hepatic triacylglycerol lipase	GO:0004806; F:triglyceride lipase activity; IDA:BHF-UCL
P11150	LIPC	Hepatic triacylglycerol lipase	GO:0042632; P:cholesterol homeostasis; IMP:BHF-UCL
P11150	LIPC	Hepatic triacylglycerol lipase	GO:0008203; P:cholesterol metabolic process; IEA:Ensembl
P11150	LIPC	Hepatic triacylglycerol lipase	GO:0034382; P:chylomicron remnant clearance; TAS:BHF-UCL
P11150	LIPC	Hepatic triacylglycerol lipase	GO:0006633; P:fatty acid biosynthetic process; IDA:BHF-UCL
P11150	LIPC	Hepatic triacylglycerol lipase	GO:0034375; P:high-density lipoprotein particle remodeling; IMP:BHF-UCL
P11150	LIPC	Hepatic triacylglycerol lipase	GO:0034373; P:intermediate-density lipoprotein particle remodeling; TAS:BHF-UCL
P11150	LIPC	Hepatic triacylglycerol lipase	GO:0034374; P:low-density lipoprotein particle remodeling; IMP:BHF-UCL
P11150	LIPC	Hepatic triacylglycerol lipase	GO:0034638; P:phosphatidylcholine catabolic process; TAS:BHF-UCL
P11150	LIPC	Hepatic triacylglycerol lipase	GO:0043691; P:reverse cholesterol transport; IC:BHF-UCL
P11150	LIPC	Hepatic triacylglycerol lipase	GO:0019433; P:triglyceride catabolic process; IDA:BHF-UCL
P11150	LIPC	Hepatic triacylglycerol lipase	GO:0070328; P:triglyceride homeostasis; IMP:BHF-UCL
P11150	LIPC	Hepatic triacylglycerol lipase	GO:0034372; P:very-low-density lipoprotein particle remodeling; IDA:BHF-UCL
Q9Y5X9	LIPG	Endothelial lipase	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
Q9Y5X9	LIPG	Endothelial lipase	GO:0004465; F:lipoprotein lipase activity; IEA:InterPro
Q9Y5X9	LIPG	Endothelial lipase	GO:0008970; F:phosphatidylcholine 1-acylhydrolase activity; IDA:MGI
Q9Y5X9	LIPG	Endothelial lipase	GO:0004620; F:phospholipase activity; IDA:BHF-UCL
Q9Y5X9	LIPG	Endothelial lipase	GO:0008283; P:cell proliferation; IEA:Ensembl
Q9Y5X9	LIPG	Endothelial lipase	GO:0042632; P:cholesterol homeostasis; IMP:BHF-UCL
Q9Y5X9	LIPG	Endothelial lipase	GO:0034375; P:high-density lipoprotein particle remodeling; IMP:BHF-UCL
Q9Y5X9	LIPG	Endothelial lipase	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q9Y5X9	LIPG	Endothelial lipase	GO:0009395; P:phospholipid catabolic process; NAS:BHF-UCL
Q9Y5X9	LIPG	Endothelial lipase	GO:0055091; P:phospholipid homeostasis; IMP:BHF-UCL
Q9Y5X9	LIPG	Endothelial lipase	GO:0032376; P:positive regulation of cholesterol transport; IDA:BHF-UCL
Q9Y5X9	LIPG	Endothelial lipase	GO:0010983; P:positive regulation of high-density lipoprotein particle clearance; IMP:BHF-UCL
Q9Y5X9	LIPG	Endothelial lipase	GO:0050746; P:regulation of lipoprotein metabolic process; IEA:Ensembl
Q9Y5X9	LIPG	Endothelial lipase	GO:0007584; P:response to nutrient; IEA:Ensembl
Q9Y5X9	LIPG	Endothelial lipase	GO:0043691; P:reverse cholesterol transport; IMP:BHF-UCL
P07098	LIPF	Gastric triacylglycerol lipase	GO:0016788; F:hydrolase activity, acting on ester bonds; IEA:InterPro
P07098	LIPF	Gastric triacylglycerol lipase	GO:0008289; F:lipid binding; NAS:UniProtKB
P07098	LIPF	Gastric triacylglycerol lipase	GO:0016615; F:malate dehydrogenase activity; IEA:Ensembl
P07098	LIPF	Gastric triacylglycerol lipase	GO:0004806; F:triglyceride lipase activity; TAS:UniProtKB
P07098	LIPF	Gastric triacylglycerol lipase	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
P07098	LIPF	Gastric triacylglycerol lipase	GO:0006108; P:malate metabolic process; IEA:Ensembl
P07098	LIPF	Gastric triacylglycerol lipase	GO:0006641; P:triglyceride metabolic process; NAS:UniProtKB
Q8WWY8	LIPH	Lipase member H	GO:0008201; F:heparin binding; IDA:UniProtKB
Q8WWY8	LIPH	Lipase member H	GO:0004620; F:phospholipase activity; IDA:UniProtKB
Q8WWY8	LIPH	Lipase member H	GO:0016042; P:lipid catabolic process; IDA:UniProtKB
Q5W064	LIPJ	Lipase member J	GO:0016788; F:hydrolase activity, acting on ester bonds; IEA:InterPro
Q5W064	LIPJ	Lipase member J	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q5VXJ0	LIPK	Lipase member K	GO:0016788; F:hydrolase activity, acting on ester bonds; IEA:InterPro
Q5VXJ0	LIPK	Lipase member K	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q6XZB0	LIPI	Lipase member I	GO:0008201; F:heparin binding; IDA:UniProtKB
Q6XZB0	LIPI	Lipase member I	GO:0004620; F:phospholipase activity; IDA:UniProtKB
Q6XZB0	LIPI	Lipase member I	GO:0016042; P:lipid catabolic process; IDA:UniProtKB
P06858	LPL	Lipoprotein lipase	GO:0034185; F:apolipoprotein binding; IPI:BHF-UCL
P06858	LPL	Lipoprotein lipase	GO:0008201; F:heparin binding; IDA:BHF-UCL
P06858	LPL	Lipoprotein lipase	GO:0004465; F:lipoprotein lipase activity; IDA:BHF-UCL
P06858	LPL	Lipoprotein lipase	GO:0004620; F:phospholipase activity; ISS:BHF-UCL
P06858	LPL	Lipoprotein lipase	GO:0005515; F:protein binding; IPI:BHF-UCL
P06858	LPL	Lipoprotein lipase	GO:0005102; F:receptor binding; IPI:BHF-UCL
P06858	LPL	Lipoprotein lipase	GO:0017129; F:triglyceride binding; IEA:Ensembl
P06858	LPL	Lipoprotein lipase	GO:0004806; F:triglyceride lipase activity; IDA:BHF-UCL
P06858	LPL	Lipoprotein lipase	GO:0034371; P:chylomicron remodeling; IC:BHF-UCL
P06858	LPL	Lipoprotein lipase	GO:0006633; P:fatty acid biosynthetic process; IDA:BHF-UCL
P06858	LPL	Lipoprotein lipase	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
P06858	LPL	Lipoprotein lipase	GO:0006644; P:phospholipid metabolic process; ISS:BHF-UCL
P06858	LPL	Lipoprotein lipase	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P06858	LPL	Lipoprotein lipase	GO:0010886; P:positive regulation of cholesterol storage; IMP:BHF-UCL
P06858	LPL	Lipoprotein lipase	GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; IC:BHF-UCL
P06858	LPL	Lipoprotein lipase	GO:0010890; P:positive regulation of sequestering of triglyceride; IMP:BHF-UCL
P06858	LPL	Lipoprotein lipase	GO:0009409; P:response to cold; IEA:Ensembl
P06858	LPL	Lipoprotein lipase	GO:0042493; P:response to drug; IEA:Ensembl
P06858	LPL	Lipoprotein lipase	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P06858	LPL	Lipoprotein lipase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P06858	LPL	Lipoprotein lipase	GO:0019432; P:triglyceride biosynthetic process; IEA:Ensembl
P06858	LPL	Lipoprotein lipase	GO:0019433; P:triglyceride catabolic process; IDA:BHF-UCL
P06858	LPL	Lipoprotein lipase	GO:0070328; P:triglyceride homeostasis; IGI:BHF-UCL
P06858	LPL	Lipoprotein lipase	GO:0006641; P:triglyceride metabolic process; ISS:BHF-UCL
P06858	LPL	Lipoprotein lipase	GO:0034372; P:very-low-density lipoprotein particle remodeling; IDA:BHF-UCL
Q5VYY2	LIPM	Lipase member M	GO:0016788; F:hydrolase activity, acting on ester bonds; IEA:InterPro
Q5VYY2	LIPM	Lipase member M	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q5VXI9	LIPN	Lipase member N	GO:0016788; F:hydrolase activity, acting on ester bonds; IEA:InterPro
Q5VXI9	LIPN	Lipase member N	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
P16233	PNLIP	Pancreatic triacylglycerol lipase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P16233	PNLIP	Pancreatic triacylglycerol lipase	GO:0004806; F:triglyceride lipase activity; TAS:ProtInc
P16233	PNLIP	Pancreatic triacylglycerol lipase	GO:0030299; P:intestinal cholesterol absorption; IEA:Ensembl
P16233	PNLIP	Pancreatic triacylglycerol lipase	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
P16233	PNLIP	Pancreatic triacylglycerol lipase	GO:0044241; P:lipid digestion; TAS:Reactome
P16233	PNLIP	Pancreatic triacylglycerol lipase	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P16233	PNLIP	Pancreatic triacylglycerol lipase	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P16233	PNLIP	Pancreatic triacylglycerol lipase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P54315	PNLIPRP1	Inactive pancreatic lipase-related protein 1	GO:0005509; F:calcium ion binding; ISS:UniProtKB
P54315	PNLIPRP1	Inactive pancreatic lipase-related protein 1	GO:0004806; F:triglyceride lipase activity; TAS:ProtInc
P54315	PNLIPRP1	Inactive pancreatic lipase-related protein 1	GO:0006629; P:lipid metabolic process; IEA:InterPro
P54317	PNLIPRP2	Pancreatic lipase-related protein 2	GO:0047372; F:acylglycerol lipase activity; IDA:UniProtKB
P54317	PNLIPRP2	Pancreatic lipase-related protein 2	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P54317	PNLIPRP2	Pancreatic lipase-related protein 2	GO:0047714; F:galactolipase activity; IDA:UniProtKB
P54317	PNLIPRP2	Pancreatic lipase-related protein 2	GO:0004620; F:phospholipase activity; IDA:UniProtKB
P54317	PNLIPRP2	Pancreatic lipase-related protein 2	GO:0004806; F:triglyceride lipase activity; TAS:ProtInc
P54317	PNLIPRP2	Pancreatic lipase-related protein 2	GO:0019376; P:galactolipid catabolic process; IDA:UniProtKB
P54317	PNLIPRP2	Pancreatic lipase-related protein 2	GO:0044241; P:lipid digestion; TAS:Reactome
P54317	PNLIPRP2	Pancreatic lipase-related protein 2	GO:0009395; P:phospholipid catabolic process; IDA:UniProtKB
P54317	PNLIPRP2	Pancreatic lipase-related protein 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P54317	PNLIPRP2	Pancreatic lipase-related protein 2	GO:0006641; P:triglyceride metabolic process; TAS:ProtInc
Q17RR3	PNLIPRP3	Pancreatic lipase-related protein 3	GO:0004806; F:triglyceride lipase activity; IEA:UniProtKB-EC
Q17RR3	PNLIPRP3	Pancreatic lipase-related protein 3	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q05469	LIPE	Hormone-sensitive lipase	GO:0033878; F:hormone-sensitive lipase activity; IEA:UniProtKB-EC
Q05469	LIPE	Hormone-sensitive lipase	GO:0005515; F:protein binding; IPI:UniProtKB
Q05469	LIPE	Hormone-sensitive lipase	GO:0004806; F:triglyceride lipase activity; IEA:Ensembl
Q05469	LIPE	Hormone-sensitive lipase	GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW
Q05469	LIPE	Hormone-sensitive lipase	GO:0046340; P:diacylglycerol catabolic process; IEA:Ensembl
Q05469	LIPE	Hormone-sensitive lipase	GO:0016042; P:lipid catabolic process; ISS:UniProtKB
Q05469	LIPE	Hormone-sensitive lipase	GO:0042758; P:long-chain fatty acid catabolic process; IEA:Ensembl
Q05469	LIPE	Hormone-sensitive lipase	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q05469	LIPE	Hormone-sensitive lipase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q05469	LIPE	Hormone-sensitive lipase	GO:0019433; P:triglyceride catabolic process; TAS:Reactome
A6NK58	LIPT2	Putative lipoyltransferase 2, mitochondrial	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
A6NK58	LIPT2	Putative lipoyltransferase 2, mitochondrial	GO:0033819; F:lipoyl(octanoyl) transferase activity; IEA:UniProtKB-EC
A6NK58	LIPT2	Putative lipoyltransferase 2, mitochondrial	GO:0016415; F:octanoyltransferase activity; IEA:InterPro
A6NK58	LIPT2	Putative lipoyltransferase 2, mitochondrial	GO:0006464; P:cellular protein modification process; IEA:InterPro
A6NK58	LIPT2	Putative lipoyltransferase 2, mitochondrial	GO:0009107; P:lipoate biosynthetic process; IEA:InterPro
Q9Y234	LIPT1	Lipoyltransferase 1, mitochondrial	GO:0016746; F:transferase activity, transferring acyl groups; IEA:UniProtKB-KW
Q9Y234	LIPT1	Lipoyltransferase 1, mitochondrial	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q9Y234	LIPT1	Lipoyltransferase 1, mitochondrial	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q9Y234	LIPT1	Lipoyltransferase 1, mitochondrial	GO:0009249; P:protein lipoylation; IEA:InterPro
O75019	LILRA1	Leukocyte immunoglobulin-like receptor subfamily A member 1	GO:0003823; F:antigen binding; TAS:ProtInc
O75019	LILRA1	Leukocyte immunoglobulin-like receptor subfamily A member 1	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
O75019	LILRA1	Leukocyte immunoglobulin-like receptor subfamily A member 1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
O75019	LILRA1	Leukocyte immunoglobulin-like receptor subfamily A member 1	GO:0006952; P:defense response; TAS:ProtInc
O75019	LILRA1	Leukocyte immunoglobulin-like receptor subfamily A member 1	GO:0002376; P:immune system process; IEA:UniProtKB-KW
O75019	LILRA1	Leukocyte immunoglobulin-like receptor subfamily A member 1	GO:0050776; P:regulation of immune response; TAS:Reactome
Q8N149	LILRA2	Leukocyte immunoglobulin-like receptor subfamily A member 2	GO:0003823; F:antigen binding; TAS:ProtInc
Q8N149	LILRA2	Leukocyte immunoglobulin-like receptor subfamily A member 2	GO:0004872; F:receptor activity; TAS:ProtInc
Q8N149	LILRA2	Leukocyte immunoglobulin-like receptor subfamily A member 2	GO:0006952; P:defense response; TAS:ProtInc
Q8N149	LILRA2	Leukocyte immunoglobulin-like receptor subfamily A member 2	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q8N149	LILRA2	Leukocyte immunoglobulin-like receptor subfamily A member 2	GO:0007165; P:signal transduction; TAS:ProtInc
Q8N6C8	LILRA3	Leukocyte immunoglobulin-like receptor subfamily A member 3	GO:0003823; F:antigen binding; TAS:ProtInc
Q8N6C8	LILRA3	Leukocyte immunoglobulin-like receptor subfamily A member 3	GO:0004872; F:receptor activity; TAS:ProtInc
Q8N6C8	LILRA3	Leukocyte immunoglobulin-like receptor subfamily A member 3	GO:0006952; P:defense response; TAS:ProtInc
Q8N6C8	LILRA3	Leukocyte immunoglobulin-like receptor subfamily A member 3	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q8N6C8	LILRA3	Leukocyte immunoglobulin-like receptor subfamily A member 3	GO:0007165; P:signal transduction; TAS:ProtInc
A6NI73	LILRA5	Leukocyte immunoglobulin-like receptor subfamily A member 5	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
P59901	LILRA4	Leukocyte immunoglobulin-like receptor subfamily A member 4	GO:0005515; F:protein binding; IPI:UniProtKB
P59901	LILRA4	Leukocyte immunoglobulin-like receptor subfamily A member 4	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q6PI73	LILRA6	Leukocyte immunoglobulin-like receptor subfamily A member 6	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0030107; F:HLA-A specific inhibitory MHC class I receptor activity; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0030109; F:HLA-B specific inhibitory MHC class I receptor activity; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0042288; F:MHC class I protein binding; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0032393; F:MHC class I receptor activity; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0008157; F:protein phosphatase 1 binding; IPI:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0042169; F:SH2 domain binding; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0071222; P:cellular response to lipopolysaccharide; IEP:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0051607; P:defense response to virus; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0097028; P:dendritic cell differentiation; IEP:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0002774; P:Fc receptor mediated inhibitory signaling pathway; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0002767; P:immune response-inhibiting cell surface receptor signaling pathway; NAS:BHF-UCL
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0032609; P:interferon-gamma production; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0072643; P:interferon-gamma secretion; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0046636; P:negative regulation of alpha-beta T cell activation; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0051926; P:negative regulation of calcium ion transport; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:2001186; P:negative regulation of CD8-positive, alpha-beta T cell activation; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0045786; P:negative regulation of cell cycle; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0002740; P:negative regulation of cytokine secretion involved in immune response; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:2000669; P:negative regulation of dendritic cell apoptotic process; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:2001199; P:negative regulation of dendritic cell differentiation; IMP:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0045806; P:negative regulation of endocytosis; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0035548; P:negative regulation of interferon-beta secretion; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0045077; P:negative regulation of interferon-gamma biosynthetic process; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0032689; P:negative regulation of interferon-gamma production; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:2001180; P:negative regulation of interleukin-10 secretion; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:2001183; P:negative regulation of interleukin-12 secretion; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0032945; P:negative regulation of mononuclear cell proliferation; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0045953; P:negative regulation of natural killer cell mediated cytotoxicity; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:2001205; P:negative regulation of osteoclast development; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0014063; P:negative regulation of serotonin secretion; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:2001189; P:negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0001915; P:negative regulation of T cell mediated cytotoxicity; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0042130; P:negative regulation of T cell proliferation; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:2001202; P:negative regulation of transforming growth factor-beta secretion; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0042536; P:negative regulation of tumor necrosis factor biosynthetic process; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0045919; P:positive regulation of cytolysis; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0002230; P:positive regulation of defense response to virus by host; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:2001193; P:positive regulation of gamma-delta T cell activation involved in immune response; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; NAS:BHF-UCL
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0031623; P:receptor internalization; TAS:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0050776; P:regulation of immune response; TAS:Reactome
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0009615; P:response to virus; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0007165; P:signal transduction; IDA:UniProtKB
Q8NHL6	LILRB1	Leukocyte immunoglobulin-like receptor subfamily B member 1	GO:0002309; P:T cell proliferation involved in immune response; IDA:UniProtKB
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0032396; F:inhibitory MHC class I receptor activity; IDA:BHF-UCL
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0042288; F:MHC class I protein binding; IDA:UniProtKB
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0023029; F:MHC class Ib protein binding; IPI:BHF-UCL
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0008157; F:protein phosphatase 1 binding; IPI:UniProtKB
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0004872; F:receptor activity; TAS:ProtInc
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0006968; P:cellular defense response; TAS:ProtInc
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0071222; P:cellular response to lipopolysaccharide; IMP:BHF-UCL
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0002774; P:Fc receptor mediated inhibitory signaling pathway; IDA:UniProtKB
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0034113; P:heterotypic cell-cell adhesion; IDA:BHF-UCL
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0006955; P:immune response; TAS:ProtInc
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0002767; P:immune response-inhibiting cell surface receptor signaling pathway; IDA:BHF-UCL
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0002578; P:negative regulation of antigen processing and presentation; IDA:BHF-UCL
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0051926; P:negative regulation of calcium ion transport; IDA:UniProtKB
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0042130; P:negative regulation of T cell proliferation; IDA:BHF-UCL
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0032755; P:positive regulation of interleukin-6 production; NAS:BHF-UCL
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0045591; P:positive regulation of regulatory T cell differentiation; IMP:BHF-UCL
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0042102; P:positive regulation of T cell proliferation; IDA:BHF-UCL
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0002666; P:positive regulation of T cell tolerance induction; IMP:BHF-UCL
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:2001198; P:regulation of dendritic cell differentiation; IC:BHF-UCL
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0050776; P:regulation of immune response; TAS:Reactome
Q8N423	LILRB2	Leukocyte immunoglobulin-like receptor subfamily B member 2	GO:0007165; P:signal transduction; IDA:BHF-UCL
O75022	LILRB3	Leukocyte immunoglobulin-like receptor subfamily B member 3	GO:0005515; F:protein binding; IPI:UniProtKB
O75022	LILRB3	Leukocyte immunoglobulin-like receptor subfamily B member 3	GO:0004872; F:receptor activity; TAS:ProtInc
O75022	LILRB3	Leukocyte immunoglobulin-like receptor subfamily B member 3	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
O75022	LILRB3	Leukocyte immunoglobulin-like receptor subfamily B member 3	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
O75022	LILRB3	Leukocyte immunoglobulin-like receptor subfamily B member 3	GO:0006952; P:defense response; TAS:ProtInc
O75022	LILRB3	Leukocyte immunoglobulin-like receptor subfamily B member 3	GO:0002376; P:immune system process; IEA:UniProtKB-KW
O75022	LILRB3	Leukocyte immunoglobulin-like receptor subfamily B member 3	GO:0045671; P:negative regulation of osteoclast differentiation; IDA:UniProtKB
Q8NHJ6	LILRB4	Leukocyte immunoglobulin-like receptor subfamily B member 4	GO:0003823; F:antigen binding; TAS:ProtInc
Q8NHJ6	LILRB4	Leukocyte immunoglobulin-like receptor subfamily B member 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NHJ6	LILRB4	Leukocyte immunoglobulin-like receptor subfamily B member 4	GO:0004872; F:receptor activity; TAS:ProtInc
Q8NHJ6	LILRB4	Leukocyte immunoglobulin-like receptor subfamily B member 4	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q8NHJ6	LILRB4	Leukocyte immunoglobulin-like receptor subfamily B member 4	GO:0045671; P:negative regulation of osteoclast differentiation; IDA:UniProtKB
Q8NHJ6	LILRB4	Leukocyte immunoglobulin-like receptor subfamily B member 4	GO:0007165; P:signal transduction; TAS:ProtInc
O75023	LILRB5	Leukocyte immunoglobulin-like receptor subfamily B member 5	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
O75023	LILRB5	Leukocyte immunoglobulin-like receptor subfamily B member 5	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
O75023	LILRB5	Leukocyte immunoglobulin-like receptor subfamily B member 5	GO:0006952; P:defense response; TAS:ProtInc
O75023	LILRB5	Leukocyte immunoglobulin-like receptor subfamily B member 5	GO:0002376; P:immune system process; IEA:UniProtKB-KW
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0034452; F:dynactin binding; ISS:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0045502; F:dynein binding; IDA:UniProtKB
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0008201; F:heparin binding; ISS:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0008017; F:microtubule binding; ISS:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0043274; F:phospholipase binding; ISS:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0051219; F:phosphoprotein binding; ISS:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0001675; P:acrosome assembly; ISS:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0030036; P:actin cytoskeleton organization; ISS:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0008344; P:adult locomotory behavior; IMP:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0001667; P:ameboidal cell migration; IEA:Ensembl
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0048854; P:brain morphogenesis; IMP:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0021987; P:cerebral cortex development; IMP:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0021895; P:cerebral cortex neuron differentiation; IEA:Ensembl
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0021540; P:corpus callosum morphogenesis; IMP:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0051660; P:establishment of centrosome localization; IEA:Ensembl
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0000132; P:establishment of mitotic spindle orientation; IMP:UniProtKB
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0021766; P:hippocampus development; ISS:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0021819; P:layer formation in cerebral cortex; ISS:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0007611; P:learning or memory; ISS:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0000226; P:microtubule cytoskeleton organization; ISS:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0031023; P:microtubule organizing center organization; IMP:UniProtKB
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0007017; P:microtubule-based process; IDA:UniProtKB
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0046329; P:negative regulation of JNK cascade; IEA:Ensembl
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0010977; P:negative regulation of neuron projection development; IEA:Ensembl
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0007405; P:neuroblast proliferation; ISS:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0050885; P:neuromuscular process controlling balance; IMP:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0001764; P:neuron migration; IMP:UniProtKB
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0051081; P:nuclear envelope disassembly; IEA:Ensembl
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0007097; P:nuclear migration; IEA:Ensembl
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0036035; P:osteoclast development; IEA:Ensembl
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0046469; P:platelet activating factor metabolic process; ISS:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0045773; P:positive regulation of axon extension; IEA:Ensembl
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0001961; P:positive regulation of cytokine-mediated signaling pathway; IEA:Ensembl
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0045931; P:positive regulation of mitotic cell cycle; IEA:Ensembl
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0009306; P:protein secretion; IEA:Ensembl
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0032319; P:regulation of Rho GTPase activity; ISS:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0008090; P:retrograde axon cargo transport; ISS:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0017145; P:stem cell division; IEA:Ensembl
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0007268; P:synaptic transmission; ISS:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0019226; P:transmission of nerve impulse; ISS:BHF-UCL
P43034	PAFAH1B1	Platelet-activating factor acetylhydrolase IB subunit alpha	GO:0047496; P:vesicle transport along microtubule; ISS:BHF-UCL
Q99732	LITAF	Lipopolysaccharide-induced tumor necrosis factor-alpha factor	GO:0005515; F:protein binding; IPI:IntAct
Q99732	LITAF	Lipopolysaccharide-induced tumor necrosis factor-alpha factor	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q99732	LITAF	Lipopolysaccharide-induced tumor necrosis factor-alpha factor	GO:0050699; F:WW domain binding; IPI:UniProtKB
Q99732	LITAF	Lipopolysaccharide-induced tumor necrosis factor-alpha factor	GO:0007568; P:aging; IEA:Ensembl
Q99732	LITAF	Lipopolysaccharide-induced tumor necrosis factor-alpha factor	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q99732	LITAF	Lipopolysaccharide-induced tumor necrosis factor-alpha factor	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
Q99732	LITAF	Lipopolysaccharide-induced tumor necrosis factor-alpha factor	GO:0042347; P:negative regulation of NF-kappaB import into nucleus; IEA:Ensembl
Q99732	LITAF	Lipopolysaccharide-induced tumor necrosis factor-alpha factor	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q99732	LITAF	Lipopolysaccharide-induced tumor necrosis factor-alpha factor	GO:0001817; P:regulation of cytokine production; IEA:Ensembl
Q99732	LITAF	Lipopolysaccharide-induced tumor necrosis factor-alpha factor	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q99732	LITAF	Lipopolysaccharide-induced tumor necrosis factor-alpha factor	GO:0007165; P:signal transduction; IMP:GOC
Q99732	LITAF	Lipopolysaccharide-induced tumor necrosis factor-alpha factor	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P09960	LTA4H	Leukotriene A-4 hydrolase	GO:0004177; F:aminopeptidase activity; IDA:UniProtKB
P09960	LTA4H	Leukotriene A-4 hydrolase	GO:0004301; F:epoxide hydrolase activity; IDA:UniProtKB
P09960	LTA4H	Leukotriene A-4 hydrolase	GO:0004463; F:leukotriene-A4 hydrolase activity; IDA:UniProtKB
P09960	LTA4H	Leukotriene A-4 hydrolase	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
P09960	LTA4H	Leukotriene A-4 hydrolase	GO:0008233; F:peptidase activity; TAS:ProtInc
P09960	LTA4H	Leukotriene A-4 hydrolase	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P09960	LTA4H	Leukotriene A-4 hydrolase	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P09960	LTA4H	Leukotriene A-4 hydrolase	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P09960	LTA4H	Leukotriene A-4 hydrolase	GO:0006954; P:inflammatory response; NAS:ProtInc
P09960	LTA4H	Leukotriene A-4 hydrolase	GO:0019370; P:leukotriene biosynthetic process; IDA:UniProtKB
P09960	LTA4H	Leukotriene A-4 hydrolase	GO:0006691; P:leukotriene metabolic process; TAS:Reactome
P09960	LTA4H	Leukotriene A-4 hydrolase	GO:0043171; P:peptide catabolic process; IDA:UniProtKB
P09960	LTA4H	Leukotriene A-4 hydrolase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BRT6	LLPH	Protein LLP homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96L50	LRR1	Leucine-rich repeat protein 1	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9H0V9	LMAN2L	VIP36-like protein	GO:0005537; F:mannose binding; TAS:UniProtKB
Q9H0V9	LMAN2L	VIP36-like protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H0V9	LMAN2L	VIP36-like protein	GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:UniProtKB
Q9H0V9	LMAN2L	VIP36-like protein	GO:0006457; P:protein folding; NAS:UniProtKB
Q9H0V9	LMAN2L	VIP36-like protein	GO:0015031; P:protein transport; IMP:UniProtKB
P49257	LMAN1	Protein ERGIC-53	GO:0005537; F:mannose binding; TAS:ProtInc
P49257	LMAN1	Protein ERGIC-53	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P49257	LMAN1	Protein ERGIC-53	GO:0005515; F:protein binding; IPI:UniProtKB
P49257	LMAN1	Protein ERGIC-53	GO:0051082; F:unfolded protein binding; TAS:ProtInc
P49257	LMAN1	Protein ERGIC-53	GO:0007596; P:blood coagulation; TAS:ProtInc
P49257	LMAN1	Protein ERGIC-53	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P49257	LMAN1	Protein ERGIC-53	GO:0007029; P:endoplasmic reticulum organization; IEA:Ensembl
P49257	LMAN1	Protein ERGIC-53	GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:ProtInc
P49257	LMAN1	Protein ERGIC-53	GO:0007030; P:Golgi organization; IMP:UniProtKB
P49257	LMAN1	Protein ERGIC-53	GO:0010638; P:positive regulation of organelle organization; IMP:UniProtKB
P49257	LMAN1	Protein ERGIC-53	GO:0043687; P:post-translational protein modification; TAS:Reactome
P49257	LMAN1	Protein ERGIC-53	GO:0006457; P:protein folding; TAS:ProtInc
P49257	LMAN1	Protein ERGIC-53	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
P49257	LMAN1	Protein ERGIC-53	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q12907	LMAN2	Vesicular integral-membrane protein VIP36	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q12907	LMAN2	Vesicular integral-membrane protein VIP36	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9NUN5	LMBRD1	Probable lysosomal cobalamin transporter	GO:0031419; F:cobalamin binding; IEA:UniProtKB-KW
Q9NUN5	LMBRD1	Probable lysosomal cobalamin transporter	GO:0009235; P:cobalamin metabolic process; TAS:Reactome
Q9NUN5	LMBRD1	Probable lysosomal cobalamin transporter	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NUN5	LMBRD1	Probable lysosomal cobalamin transporter	GO:0006810; P:transport; IEA:UniProtKB-KW
Q9NUN5	LMBRD1	Probable lysosomal cobalamin transporter	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9NUN5	LMBRD1	Probable lysosomal cobalamin transporter	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9NUN5	LMBRD1	Probable lysosomal cobalamin transporter	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9Y468	L3MBTL1	Lethal(3)malignant brain tumor-like protein 1	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q9Y468	L3MBTL1	Lethal(3)malignant brain tumor-like protein 1	GO:0042393; F:histone binding; IPI:UniProtKB
Q9Y468	L3MBTL1	Lethal(3)malignant brain tumor-like protein 1	GO:0042802; F:identical protein binding; IPI:UniProtKB
Q9Y468	L3MBTL1	Lethal(3)malignant brain tumor-like protein 1	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q9Y468	L3MBTL1	Lethal(3)malignant brain tumor-like protein 1	GO:0031493; F:nucleosomal histone binding; IDA:UniProtKB
Q9Y468	L3MBTL1	Lethal(3)malignant brain tumor-like protein 1	GO:0031491; F:nucleosome binding; IDA:UniProtKB
Q9Y468	L3MBTL1	Lethal(3)malignant brain tumor-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y468	L3MBTL1	Lethal(3)malignant brain tumor-like protein 1	GO:0032093; F:SAM domain binding; IPI:UniProtKB
Q9Y468	L3MBTL1	Lethal(3)malignant brain tumor-like protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9Y468	L3MBTL1	Lethal(3)malignant brain tumor-like protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y468	L3MBTL1	Lethal(3)malignant brain tumor-like protein 1	GO:0016568; P:chromatin modification; IDA:UniProtKB
Q9Y468	L3MBTL1	Lethal(3)malignant brain tumor-like protein 1	GO:0030097; P:hemopoiesis; IEP:UniProtKB
Q9Y468	L3MBTL1	Lethal(3)malignant brain tumor-like protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9Y468	L3MBTL1	Lethal(3)malignant brain tumor-like protein 1	GO:0051726; P:regulation of cell cycle; NAS:UniProtKB
Q9Y468	L3MBTL1	Lethal(3)malignant brain tumor-like protein 1	GO:0045652; P:regulation of megakaryocyte differentiation; IDA:UniProtKB
Q9Y468	L3MBTL1	Lethal(3)malignant brain tumor-like protein 1	GO:0007088; P:regulation of mitosis; IMP:UniProtKB
Q9Y468	L3MBTL1	Lethal(3)malignant brain tumor-like protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q969R5	L3MBTL2	Lethal(3)malignant brain tumor-like protein 2	GO:0042393; F:histone binding; IPI:UniProtKB
Q969R5	L3MBTL2	Lethal(3)malignant brain tumor-like protein 2	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q969R5	L3MBTL2	Lethal(3)malignant brain tumor-like protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q969R5	L3MBTL2	Lethal(3)malignant brain tumor-like protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q969R5	L3MBTL2	Lethal(3)malignant brain tumor-like protein 2	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q969R5	L3MBTL2	Lethal(3)malignant brain tumor-like protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q969R5	L3MBTL2	Lethal(3)malignant brain tumor-like protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96JM7	L3MBTL3	Lethal(3)malignant brain tumor-like protein 3	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q96JM7	L3MBTL3	Lethal(3)malignant brain tumor-like protein 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96JM7	L3MBTL3	Lethal(3)malignant brain tumor-like protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NA19	L3MBTL4	Lethal(3)malignant brain tumor-like protein 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8NA19	L3MBTL4	Lethal(3)malignant brain tumor-like protein 4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8NA19	L3MBTL4	Lethal(3)malignant brain tumor-like protein 4	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q8NA19	L3MBTL4	Lethal(3)malignant brain tumor-like protein 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WVP7	LMBR1	Limb region 1 protein homolog	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
Q6UX01	LMBR1L	Protein LMBR1L	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q9NZU5	LMCD1	LIM and cysteine-rich domains protein 1	GO:0003714; F:transcription corepressor activity; ISS:UniProtKB
Q9NZU5	LMCD1	LIM and cysteine-rich domains protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NZU5	LMCD1	LIM and cysteine-rich domains protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9NZU5	LMCD1	LIM and cysteine-rich domains protein 1	GO:0070886; P:positive regulation of calcineurin-NFAT signaling cascade; IMP:UniProtKB
Q9NZU5	LMCD1	LIM and cysteine-rich domains protein 1	GO:0010611; P:regulation of cardiac muscle hypertrophy; IMP:UniProtKB
Q9NZU5	LMCD1	LIM and cysteine-rich domains protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96S06	LMF1	Lipase maturation factor 1	GO:0034382; P:chylomicron remnant clearance; IEA:Ensembl
Q96S06	LMF1	Lipase maturation factor 1	GO:0006888; P:ER to Golgi vesicle-mediated transport; IEA:Ensembl
Q96S06	LMF1	Lipase maturation factor 1	GO:0051006; P:positive regulation of lipoprotein lipase activity; IEA:Ensembl
Q96S06	LMF1	Lipase maturation factor 1	GO:0033578; P:protein glycosylation in Golgi; IEA:Ensembl
Q96S06	LMF1	Lipase maturation factor 1	GO:0051604; P:protein maturation; IEA:Ensembl
Q96S06	LMF1	Lipase maturation factor 1	GO:0009306; P:protein secretion; IEA:Ensembl
Q96S06	LMF1	Lipase maturation factor 1	GO:0090181; P:regulation of cholesterol metabolic process; IEA:Ensembl
Q96S06	LMF1	Lipase maturation factor 1	GO:0090207; P:regulation of triglyceride metabolic process; IEA:Ensembl
P55344	LIM2	Lens fiber membrane intrinsic protein	GO:0005212; F:structural constituent of eye lens; IEA:UniProtKB-KW
P55344	LIM2	Lens fiber membrane intrinsic protein	GO:0007043; P:cell-cell junction assembly; NAS:UniProtKB
P55344	LIM2	Lens fiber membrane intrinsic protein	GO:0002088; P:lens development in camera-type eye; IEA:Ensembl
Q96KR4	LMLN	Leishmanolysin-like peptidase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96KR4	LMLN	Leishmanolysin-like peptidase	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q96KR4	LMLN	Leishmanolysin-like peptidase	GO:0007155; P:cell adhesion; IEA:InterPro
Q96KR4	LMLN	Leishmanolysin-like peptidase	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P02545	LMNA	Prelamin-A/C	GO:0005515; F:protein binding; IPI:IntAct
P02545	LMNA	Prelamin-A/C	GO:0005198; F:structural molecule activity; IEA:InterPro
P02545	LMNA	Prelamin-A/C	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P02545	LMNA	Prelamin-A/C	GO:0006915; P:apoptotic process; TAS:Reactome
P02545	LMNA	Prelamin-A/C	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
P02545	LMNA	Prelamin-A/C	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P02545	LMNA	Prelamin-A/C	GO:0071456; P:cellular response to hypoxia; IEP:UniProtKB
P02545	LMNA	Prelamin-A/C	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P02545	LMNA	Prelamin-A/C	GO:0030951; P:establishment or maintenance of microtubule cytoskeleton polarity; ISS:BHF-UCL
P02545	LMNA	Prelamin-A/C	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P02545	LMNA	Prelamin-A/C	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
P02545	LMNA	Prelamin-A/C	GO:0007084; P:mitotic nuclear envelope reassembly; TAS:Reactome
P02545	LMNA	Prelamin-A/C	GO:0007517; P:muscle organ development; IMP:UniProtKB
P02545	LMNA	Prelamin-A/C	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl
P02545	LMNA	Prelamin-A/C	GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; IEA:Ensembl
P02545	LMNA	Prelamin-A/C	GO:0090343; P:positive regulation of cell aging; IDA:UniProtKB
P02545	LMNA	Prelamin-A/C	GO:0034504; P:protein localization to nucleus; ISS:UniProtKB
P02545	LMNA	Prelamin-A/C	GO:0030334; P:regulation of cell migration; ISS:BHF-UCL
P02545	LMNA	Prelamin-A/C	GO:0035105; P:sterol regulatory element binding protein import into nucleus; IEA:Ensembl
P02545	LMNA	Prelamin-A/C	GO:0055015; P:ventricular cardiac muscle cell development; IEA:Ensembl
P20700	LMNB1	Lamin-B1	GO:0005198; F:structural molecule activity; TAS:ProtInc
P20700	LMNB1	Lamin-B1	GO:0006915; P:apoptotic process; TAS:Reactome
P20700	LMNB1	Lamin-B1	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q03252	LMNB2	Lamin-B2	GO:0005198; F:structural molecule activity; IEA:InterPro
Q8TAP4	LMO3	LIM domain only protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TAP4	LMO3	LIM domain only protein 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8TAP4	LMO3	LIM domain only protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P61968	LMO4	LIM domain transcription factor LMO4	GO:0001158; F:enhancer sequence-specific DNA binding; IEA:Ensembl
P61968	LMO4	LIM domain transcription factor LMO4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:UniProtKB
P61968	LMO4	LIM domain transcription factor LMO4	GO:0008134; F:transcription factor binding; ISS:UniProtKB
P61968	LMO4	LIM domain transcription factor LMO4	GO:0008270; F:zinc ion binding; IEA:InterPro
P61968	LMO4	LIM domain transcription factor LMO4	GO:0031333; P:negative regulation of protein complex assembly; IEA:Ensembl
P61968	LMO4	LIM domain transcription factor LMO4	GO:0001843; P:neural tube closure; ISS:UniProtKB
P61968	LMO4	LIM domain transcription factor LMO4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P61968	LMO4	LIM domain transcription factor LMO4	GO:0050865; P:regulation of cell activation; IEA:Ensembl
P61968	LMO4	LIM domain transcription factor LMO4	GO:0042659; P:regulation of cell fate specification; IEA:Ensembl
P61968	LMO4	LIM domain transcription factor LMO4	GO:0021527; P:spinal cord association neuron differentiation; IEA:Ensembl
P61968	LMO4	LIM domain transcription factor LMO4	GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl
P61968	LMO4	LIM domain transcription factor LMO4	GO:0048538; P:thymus development; IEA:Ensembl
P61968	LMO4	LIM domain transcription factor LMO4	GO:0006366; P:transcription from RNA polymerase II promoter; ISS:UniProtKB
P61968	LMO4	LIM domain transcription factor LMO4	GO:0021514; P:ventral spinal cord interneuron differentiation; IEA:Ensembl
P61968	LMO4	LIM domain transcription factor LMO4	GO:0003281; P:ventricular septum development; IEA:Ensembl
Q8WWI1	LMO7	LIM domain only protein 7	GO:0004842; F:ubiquitin-protein ligase activity; NAS:UniProtKB
Q8WWI1	LMO7	LIM domain only protein 7	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WWI1	LMO7	LIM domain only protein 7	GO:0016567; P:protein ubiquitination; NAS:UniProtKB
P29536	LMOD1	Leiomodin-1	GO:0006936; P:muscle contraction; TAS:Reactome
Q6ZMQ8	AATK	Serine/threonine-protein kinase LMTK1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6ZMQ8	AATK	Serine/threonine-protein kinase LMTK1	GO:0005515; F:protein binding; IPI:IntAct
Q6ZMQ8	AATK	Serine/threonine-protein kinase LMTK1	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q6ZMQ8	AATK	Serine/threonine-protein kinase LMTK1	GO:0004713; F:protein tyrosine kinase activity; IEA:Ensembl
Q6ZMQ8	AATK	Serine/threonine-protein kinase LMTK1	GO:0007420; P:brain development; IEA:Ensembl
Q6ZMQ8	AATK	Serine/threonine-protein kinase LMTK1	GO:0030517; P:negative regulation of axon extension; IEA:Ensembl
Q6ZMQ8	AATK	Serine/threonine-protein kinase LMTK1	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
Q6ZMQ8	AATK	Serine/threonine-protein kinase LMTK1	GO:0038083; P:peptidyl-tyrosine autophosphorylation; IEA:Ensembl
Q6ZMQ8	AATK	Serine/threonine-protein kinase LMTK1	GO:0032482; P:Rab protein signal transduction; IEA:Ensembl
Q8IWU2	LMTK2	Serine/threonine-protein kinase LMTK2	GO:0005524; F:ATP binding; NAS:UniProtKB
Q8IWU2	LMTK2	Serine/threonine-protein kinase LMTK2	GO:0070853; F:myosin VI binding; IPI:UniProtKB
Q8IWU2	LMTK2	Serine/threonine-protein kinase LMTK2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IWU2	LMTK2	Serine/threonine-protein kinase LMTK2	GO:0004864; F:protein phosphatase inhibitor activity; IDA:UniProtKB
Q8IWU2	LMTK2	Serine/threonine-protein kinase LMTK2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q8IWU2	LMTK2	Serine/threonine-protein kinase LMTK2	GO:0004713; F:protein tyrosine kinase activity; IEA:InterPro
Q8IWU2	LMTK2	Serine/threonine-protein kinase LMTK2	GO:0045022; P:early endosome to late endosome transport; IMP:UniProtKB
Q8IWU2	LMTK2	Serine/threonine-protein kinase LMTK2	GO:0032456; P:endocytic recycling; IMP:UniProtKB
Q8IWU2	LMTK2	Serine/threonine-protein kinase LMTK2	GO:0043086; P:negative regulation of catalytic activity; IDA:GOC
Q8IWU2	LMTK2	Serine/threonine-protein kinase LMTK2	GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB
Q8IWU2	LMTK2	Serine/threonine-protein kinase LMTK2	GO:0018107; P:peptidyl-threonine phosphorylation; IDA:UniProtKB
Q8IWU2	LMTK2	Serine/threonine-protein kinase LMTK2	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q8IWU2	LMTK2	Serine/threonine-protein kinase LMTK2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q8IWU2	LMTK2	Serine/threonine-protein kinase LMTK2	GO:0001881; P:receptor recycling; IMP:UniProtKB
Q8IWU2	LMTK2	Serine/threonine-protein kinase LMTK2	GO:0033572; P:transferrin transport; IMP:UniProtKB
Q96Q04	LMTK3	Serine/threonine-protein kinase LMTK3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96Q04	LMTK3	Serine/threonine-protein kinase LMTK3	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q96Q04	LMTK3	Serine/threonine-protein kinase LMTK3	GO:0004713; F:protein tyrosine kinase activity; IEA:InterPro
Q96Q04	LMTK3	Serine/threonine-protein kinase LMTK3	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q8TE12	LMX1A	LIM homeobox transcription factor 1-alpha	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q8TE12	LMX1A	LIM homeobox transcription factor 1-alpha	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8TE12	LMX1A	LIM homeobox transcription factor 1-alpha	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TE12	LMX1A	LIM homeobox transcription factor 1-alpha	GO:0007411; P:axon guidance; IEA:Ensembl
Q8TE12	LMX1A	LIM homeobox transcription factor 1-alpha	GO:0021953; P:central nervous system neuron differentiation; IEA:Ensembl
Q8TE12	LMX1A	LIM homeobox transcription factor 1-alpha	GO:0021549; P:cerebellum development; IEA:Ensembl
Q8TE12	LMX1A	LIM homeobox transcription factor 1-alpha	GO:0021542; P:dentate gyrus development; IEA:Ensembl
Q8TE12	LMX1A	LIM homeobox transcription factor 1-alpha	GO:0071542; P:dopaminergic neuron differentiation; IEA:Ensembl
Q8TE12	LMX1A	LIM homeobox transcription factor 1-alpha	GO:0030901; P:midbrain development; IEA:Ensembl
Q8TE12	LMX1A	LIM homeobox transcription factor 1-alpha	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
Q8TE12	LMX1A	LIM homeobox transcription factor 1-alpha	GO:0001558; P:regulation of cell growth; IEA:Ensembl
Q8TE12	LMX1A	LIM homeobox transcription factor 1-alpha	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0005515; F:protein binding; IPI:UniProtKB
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0008270; F:zinc ion binding; IEA:InterPro
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0008219; P:cell death; IEA:Ensembl
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0008283; P:cell proliferation; IEA:Ensembl
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0021954; P:central nervous system neuron development; IEA:Ensembl
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0021587; P:cerebellum morphogenesis; IEA:Ensembl
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0030199; P:collagen fibril organization; IEA:Ensembl
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0071542; P:dopaminergic neuron differentiation; IEA:Ensembl
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0009953; P:dorsal/ventral pattern formation; ISS:UniProtKB
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0001701; P:in utero embryonic development; NAS:UniProtKB
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0035108; P:limb morphogenesis; IEA:Ensembl
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0030901; P:midbrain development; IEA:Ensembl
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0030182; P:neuron differentiation; ISS:UniProtKB
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0001764; P:neuron migration; IEA:Ensembl
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0035265; P:organ growth; IEA:Ensembl
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0002930; P:trabecular meshwork development; IEA:Ensembl
O60663	LMX1B	LIM homeobox transcription factor 1-beta	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H9Z2	LIN28A	Protein lin-28 homolog A	GO:0003677; F:DNA binding; IEA:InterPro
Q9H9Z2	LIN28A	Protein lin-28 homolog A	GO:0035198; F:miRNA binding; IEA:Ensembl
Q9H9Z2	LIN28A	Protein lin-28 homolog A	GO:0003729; F:mRNA binding; IEA:Ensembl
Q9H9Z2	LIN28A	Protein lin-28 homolog A	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H9Z2	LIN28A	Protein lin-28 homolog A	GO:0003723; F:RNA binding; IDA:UniProtKB
Q9H9Z2	LIN28A	Protein lin-28 homolog A	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H9Z2	LIN28A	Protein lin-28 homolog A	GO:0007281; P:germ cell development; IEA:Ensembl
Q9H9Z2	LIN28A	Protein lin-28 homolog A	GO:0010587; P:miRNA catabolic process; IMP:UniProtKB
Q9H9Z2	LIN28A	Protein lin-28 homolog A	GO:0045686; P:negative regulation of glial cell differentiation; IEA:Ensembl
Q9H9Z2	LIN28A	Protein lin-28 homolog A	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
Q9H9Z2	LIN28A	Protein lin-28 homolog A	GO:0045727; P:positive regulation of translation; IEA:Ensembl
Q9H9Z2	LIN28A	Protein lin-28 homolog A	GO:0031054; P:pre-miRNA processing; IMP:UniProtKB
Q9H9Z2	LIN28A	Protein lin-28 homolog A	GO:0060964; P:regulation of gene silencing by miRNA; IEA:Ensembl
Q9H9Z2	LIN28A	Protein lin-28 homolog A	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q9H9Z2	LIN28A	Protein lin-28 homolog A	GO:0031123; P:RNA 3'-end processing; IMP:UniProtKB
Q9H9Z2	LIN28A	Protein lin-28 homolog A	GO:0019827; P:stem cell maintenance; IMP:UniProtKB
Q6ZN17	LIN28B	Protein lin-28 homolog B	GO:0003677; F:DNA binding; IEA:InterPro
Q6ZN17	LIN28B	Protein lin-28 homolog B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6ZN17	LIN28B	Protein lin-28 homolog B	GO:0005515; F:protein binding; IPI:UniProtKB
Q6ZN17	LIN28B	Protein lin-28 homolog B	GO:0003723; F:RNA binding; IDA:UniProtKB
Q6ZN17	LIN28B	Protein lin-28 homolog B	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6ZN17	LIN28B	Protein lin-28 homolog B	GO:0010587; P:miRNA catabolic process; IMP:UniProtKB
Q6ZN17	LIN28B	Protein lin-28 homolog B	GO:0031054; P:pre-miRNA processing; IMP:UniProtKB
Q6ZN17	LIN28B	Protein lin-28 homolog B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q6ZN17	LIN28B	Protein lin-28 homolog B	GO:0031123; P:RNA 3'-end processing; IMP:UniProtKB
Q9C0E8	LNP	Protein lunapark	GO:0007596; P:blood coagulation; IEA:Ensembl
Q9C0E8	LNP	Protein lunapark	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
Q9C0E8	LNP	Protein lunapark	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
Q9C0E8	LNP	Protein lunapark	GO:0060173; P:limb development; NAS:UniProtKB
Q9C0E8	LNP	Protein lunapark	GO:0032330; P:regulation of chondrocyte differentiation; IEA:Ensembl
Q8TBB1	LNX1	E3 ubiquitin-protein ligase LNX	GO:0005515; F:protein binding; IPI:IntAct
Q8TBB1	LNX1	E3 ubiquitin-protein ligase LNX	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q8TBB1	LNX1	E3 ubiquitin-protein ligase LNX	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TBB1	LNX1	E3 ubiquitin-protein ligase LNX	GO:0051260; P:protein homooligomerization; IEA:Ensembl
Q8TBB1	LNX1	E3 ubiquitin-protein ligase LNX	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q8N448	LNX2	Ligand of Numb protein X 2	GO:0005515; F:protein binding; IPI:IntAct
Q8N448	LNX2	Ligand of Numb protein X 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N448	LNX2	Ligand of Numb protein X 2	GO:0051260; P:protein homooligomerization; IEA:Ensembl
Q17RB8	LONRF1	LON peptidase N-terminal domain and RING finger protein 1	GO:0004176; F:ATP-dependent peptidase activity; IEA:InterPro
Q17RB8	LONRF1	LON peptidase N-terminal domain and RING finger protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q1L5Z9	LONRF2	LON peptidase N-terminal domain and RING finger protein 2	GO:0004176; F:ATP-dependent peptidase activity; IEA:InterPro
Q1L5Z9	LONRF2	LON peptidase N-terminal domain and RING finger protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q496Y0	LONRF3	LON peptidase N-terminal domain and RING finger protein 3	GO:0004176; F:ATP-dependent peptidase activity; IEA:InterPro
Q496Y0	LONRF3	LON peptidase N-terminal domain and RING finger protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q496Y0	LONRF3	LON peptidase N-terminal domain and RING finger protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0043531; F:ADP binding; IDA:UniProtKB
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-HAMAP
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0004176; F:ATP-dependent peptidase activity; IEA:UniProtKB-HAMAP
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0070182; F:DNA polymerase binding; IPI:UniProtKB
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0051880; F:G-quadruplex DNA binding; IDA:UniProtKB
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0070362; F:mitochondrial heavy strand promoter anti-sense binding; IDA:UniProtKB
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0070361; F:mitochondrial light strand promoter anti-sense binding; IDA:UniProtKB
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0043565; F:sequence-specific DNA binding; IEA:UniProtKB-HAMAP
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0004252; F:serine-type endopeptidase activity; IEA:UniProtKB-HAMAP
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0003697; F:single-stranded DNA binding; IBA:RefGenome
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0003727; F:single-stranded RNA binding; IDA:UniProtKB
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0007568; P:aging; IEA:Ensembl
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0034599; P:cellular response to oxidative stress; IEA:UniProtKB-HAMAP
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0051131; P:chaperone-mediated protein complex assembly; IEA:UniProtKB-HAMAP
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0006515; P:misfolded or incompletely synthesized protein catabolic process; IEA:UniProtKB-HAMAP
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0032042; P:mitochondrial DNA metabolic process; NAS:UniProtKB
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0000002; P:mitochondrial genome maintenance; NAS:UniProtKB
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0007005; P:mitochondrion organization; IMP:UniProtKB
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0070407; P:oxidation-dependent protein catabolic process; IEA:UniProtKB-HAMAP
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0051603; P:proteolysis involved in cellular protein catabolic process; IDA:UniProtKB
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0090296; P:regulation of mitochondrial DNA replication; IEA:UniProtKB-HAMAP
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0010044; P:response to aluminum ion; IEA:Ensembl
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0009725; P:response to hormone; IEA:Ensembl
P36776	LONP1	Lon protease homolog, mitochondrial	GO:0001666; P:response to hypoxia; IEP:UniProtKB
Q86WA8	LONP2	Lon protease homolog 2, peroxisomal	GO:0005524; F:ATP binding; IBA:RefGenome
Q86WA8	LONP2	Lon protease homolog 2, peroxisomal	GO:0004176; F:ATP-dependent peptidase activity; IBA:RefGenome
Q86WA8	LONP2	Lon protease homolog 2, peroxisomal	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q86WA8	LONP2	Lon protease homolog 2, peroxisomal	GO:0008233; F:peptidase activity; IDA:UniProtKB
Q86WA8	LONP2	Lon protease homolog 2, peroxisomal	GO:0002020; F:protease binding; IPI:UniProtKB
Q86WA8	LONP2	Lon protease homolog 2, peroxisomal	GO:0005515; F:protein binding; IPI:UniProtKB
Q86WA8	LONP2	Lon protease homolog 2, peroxisomal	GO:0005102; F:receptor binding; IPI:UniProtKB
Q86WA8	LONP2	Lon protease homolog 2, peroxisomal	GO:0043565; F:sequence-specific DNA binding; IBA:RefGenome
Q86WA8	LONP2	Lon protease homolog 2, peroxisomal	GO:0004252; F:serine-type endopeptidase activity; IBA:RefGenome
Q86WA8	LONP2	Lon protease homolog 2, peroxisomal	GO:0006200; P:ATP catabolic process; IBA:GOC
Q86WA8	LONP2	Lon protease homolog 2, peroxisomal	GO:0006515; P:misfolded or incompletely synthesized protein catabolic process; IBA:RefGenome
Q86WA8	LONP2	Lon protease homolog 2, peroxisomal	GO:0007031; P:peroxisome organization; NAS:UniProtKB
Q86WA8	LONP2	Lon protease homolog 2, peroxisomal	GO:0016558; P:protein import into peroxisome matrix; IEA:UniProtKB-HAMAP
Q86WA8	LONP2	Lon protease homolog 2, peroxisomal	GO:0006625; P:protein targeting to peroxisome; NAS:UniProtKB
Q86WA8	LONP2	Lon protease homolog 2, peroxisomal	GO:0031998; P:regulation of fatty acid beta-oxidation; IMP:UniProtKB
Q86WA8	LONP2	Lon protease homolog 2, peroxisomal	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
Q86WA8	LONP2	Lon protease homolog 2, peroxisomal	GO:0006465; P:signal peptide processing; IMP:UniProtKB
Q9UN81	L1RE1	LINE-1 retrotransposable element ORF1 protein	GO:0042802; F:identical protein binding; IDA:UniProtKB
Q9UN81	L1RE1	LINE-1 retrotransposable element ORF1 protein	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
Q9UN81	L1RE1	LINE-1 retrotransposable element ORF1 protein	GO:0005515; F:protein binding; IPI:IntAct
Q9UN81	L1RE1	LINE-1 retrotransposable element ORF1 protein	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
Q9UN81	L1RE1	LINE-1 retrotransposable element ORF1 protein	GO:0003727; F:single-stranded RNA binding; IDA:UniProtKB
Q9UN81	L1RE1	LINE-1 retrotransposable element ORF1 protein	GO:0032197; P:transposition, RNA-mediated; IMP:UniProtKB
DR   GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
DR   GO:0003723; F:RNA binding; IEA:InterPro
DR   GO:0003964; F:RNA-directed DNA polymerase activity; IDA:UniProtKB
DR   GO:0009036; F:Type II site-specific deoxyribonuclease activity; IDA:UniProtKB
DR   GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
DR   GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
DR   GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:UniProtKB
DR   GO:0032199; P:reverse transcription involved in RNA-mediated transposition; IDA:UniProtKB
DR   GO:0032197; P:transposition, RNA-mediated; IMP:UniProtKB
P23490	LOR	Loricrin	GO:0005515; F:protein binding; IPI:UniProtKB
P23490	LOR	Loricrin	GO:0030674; F:protein binding, bridging; IDA:UniProtKB
P23490	LOR	Loricrin	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P23490	LOR	Loricrin	GO:0005198; F:structural molecule activity; IDA:UniProtKB
P23490	LOR	Loricrin	GO:0031424; P:keratinization; IEA:UniProtKB-KW
P23490	LOR	Loricrin	GO:0030216; P:keratinocyte differentiation; IDA:UniProtKB
P23490	LOR	Loricrin	GO:0018149; P:peptide cross-linking; IDA:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0004052; F:arachidonate 12-lipoxygenase activity; IDA:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0050473; F:arachidonate 15-lipoxygenase activity; IDA:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0097260; F:eoxin A4 synthase activity; TAS:Reactome
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0005506; F:iron ion binding; ISS:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0005515; F:protein binding; IPI:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0043277; P:apoptotic cell clearance; ISS:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0019369; P:arachidonic acid metabolic process; IDA:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0030282; P:bone mineralization; ISS:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0071277; P:cellular response to calcium ion; IDA:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0035963; P:cellular response to interleukin-13; IMP:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0051122; P:hepoxilin biosynthetic process; ISS:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0006954; P:inflammatory response; TAS:ProtInc
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0006691; P:leukotriene metabolic process; TAS:Reactome
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:2001303; P:lipoxin A4 biosynthetic process; ISS:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0019372; P:lipoxygenase pathway; IDA:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0002820; P:negative regulation of adaptive immune response; ISS:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0001503; P:ossification; ISS:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0006646; P:phosphatidylethanolamine biosynthetic process; ISS:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0030838; P:positive regulation of actin filament polymerization; ISS:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0010811; P:positive regulation of cell-substrate adhesion; IDA:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:1901074; P:regulation of engulfment of apoptotic cell; ISS:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0035358; P:regulation of peroxisome proliferator activated receptor signaling pathway; ISS:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0034976; P:response to endoplasmic reticulum stress; ISS:UniProtKB
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P16050	ALOX15	Arachidonate 15-lipoxygenase	GO:0042060; P:wound healing; ISS:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0004052; F:arachidonate 12-lipoxygenase activity; IDA:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0051120; F:hepoxilin A3 synthase activity; TAS:Reactome
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0047977; F:hepoxilin-epoxide hydrolase activity; ISS:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0005506; F:iron ion binding; IEA:InterPro
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0016165; F:linoleate 13S-lipoxygenase activity; IDA:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0016702; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; TAS:Reactome
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0005515; F:protein binding; IPI:IntAct
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0007568; P:aging; IEA:Ensembl
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0019369; P:arachidonic acid metabolic process; IDA:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0006928; P:cellular component movement; IMP:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0071396; P:cellular response to lipid; IEA:Ensembl
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0061436; P:establishment of skin barrier; ISS:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0019395; P:fatty acid oxidation; IMP:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0051122; P:hepoxilin biosynthetic process; ISS:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0051121; P:hepoxilin metabolic process; TAS:Reactome
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:1901751; P:leukotriene A4 metabolic process; IDA:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0043651; P:linoleic acid metabolic process; IDA:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:2001303; P:lipoxin A4 biosynthetic process; IDA:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:2001306; P:lipoxin B4 biosynthetic process; IDA:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:2001300; P:lipoxin metabolic process; TAS:Reactome
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0019372; P:lipoxygenase pathway; IDA:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0010656; P:negative regulation of muscle cell apoptotic process; IMP:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0090331; P:negative regulation of platelet aggregation; ISS:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0045785; P:positive regulation of cell adhesion; IMP:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0030307; P:positive regulation of cell growth; IMP:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0045603; P:positive regulation of endothelial cell differentiation; IEA:Ensembl
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0010595; P:positive regulation of endothelial cell migration; IEA:Ensembl
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0051901; P:positive regulation of mitochondrial depolarization; IEA:Ensembl
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0045909; P:positive regulation of vasodilation; IEA:Ensembl
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0072593; P:reactive oxygen species metabolic process; NAS:UniProtKB
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P18054	ALOX12	Arachidonate 12-lipoxygenase, 12S-type	GO:0042554; P:superoxide anion generation; NAS:UniProtKB
P09917	ALOX5	Arachidonate 5-lipoxygenase	GO:0004051; F:arachidonate 5-lipoxygenase activity; IDA:UniProtKB
P09917	ALOX5	Arachidonate 5-lipoxygenase	GO:0005506; F:iron ion binding; IDA:UniProtKB
P09917	ALOX5	Arachidonate 5-lipoxygenase	GO:0005515; F:protein binding; IPI:UniProtKB
P09917	ALOX5	Arachidonate 5-lipoxygenase	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P09917	ALOX5	Arachidonate 5-lipoxygenase	GO:0019370; P:leukotriene biosynthetic process; IDA:UniProtKB
P09917	ALOX5	Arachidonate 5-lipoxygenase	GO:0006691; P:leukotriene metabolic process; TAS:Reactome
P09917	ALOX5	Arachidonate 5-lipoxygenase	GO:0002540; P:leukotriene production involved in inflammatory response; IEA:Ensembl
P09917	ALOX5	Arachidonate 5-lipoxygenase	GO:2001300; P:lipoxin metabolic process; TAS:Reactome
P09917	ALOX5	Arachidonate 5-lipoxygenase	GO:0019372; P:lipoxygenase pathway; TAS:Reactome
P09917	ALOX5	Arachidonate 5-lipoxygenase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BYJ1	ALOXE3	Hydroperoxide isomerase ALOXE3	GO:0051120; F:hepoxilin A3 synthase activity; IDA:UniProtKB
Q9BYJ1	ALOXE3	Hydroperoxide isomerase ALOXE3	GO:0005506; F:iron ion binding; IEA:InterPro
Q9BYJ1	ALOXE3	Hydroperoxide isomerase ALOXE3	GO:0016702; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; IDA:UniProtKB
Q9BYJ1	ALOXE3	Hydroperoxide isomerase ALOXE3	GO:0005515; F:protein binding; IPI:IntAct
Q9BYJ1	ALOXE3	Hydroperoxide isomerase ALOXE3	GO:0019369; P:arachidonic acid metabolic process; IDA:UniProtKB
Q9BYJ1	ALOXE3	Hydroperoxide isomerase ALOXE3	GO:0046513; P:ceramide biosynthetic process; ISS:UniProtKB
Q9BYJ1	ALOXE3	Hydroperoxide isomerase ALOXE3	GO:0061436; P:establishment of skin barrier; ISS:UniProtKB
Q9BYJ1	ALOXE3	Hydroperoxide isomerase ALOXE3	GO:0045444; P:fat cell differentiation; ISS:UniProtKB
Q9BYJ1	ALOXE3	Hydroperoxide isomerase ALOXE3	GO:0051122; P:hepoxilin biosynthetic process; IDA:UniProtKB
Q9BYJ1	ALOXE3	Hydroperoxide isomerase ALOXE3	GO:0043651; P:linoleic acid metabolic process; IDA:UniProtKB
Q9BYJ1	ALOXE3	Hydroperoxide isomerase ALOXE3	GO:0019372; P:lipoxygenase pathway; IDA:UniProtKB
Q9BYJ1	ALOXE3	Hydroperoxide isomerase ALOXE3	GO:0035357; P:peroxisome proliferator activated receptor signaling pathway; ISS:UniProtKB
Q9BYJ1	ALOXE3	Hydroperoxide isomerase ALOXE3	GO:0019233; P:sensory perception of pain; ISS:UniProtKB
Q9BYJ1	ALOXE3	Hydroperoxide isomerase ALOXE3	GO:0006665; P:sphingolipid metabolic process; IDA:UniProtKB
Q8IVV2	LOXHD1	Lipoxygenase homology domain-containing protein 1	GO:0005262; F:calcium channel activity; IBA:RefGenome
Q8IVV2	LOXHD1	Lipoxygenase homology domain-containing protein 1	GO:0070588; P:calcium ion transmembrane transport; IBA:GOC
Q8IVV2	LOXHD1	Lipoxygenase homology domain-containing protein 1	GO:0050982; P:detection of mechanical stimulus; IBA:RefGenome
Q8IVV2	LOXHD1	Lipoxygenase homology domain-containing protein 1	GO:0007605; P:sensory perception of sound; IMP:UniProtKB
Q08397	LOXL1	Lysyl oxidase homolog 1	GO:0005507; F:copper ion binding; IEA:InterPro
Q08397	LOXL1	Lysyl oxidase homolog 1	GO:0016641; F:oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor; IEA:Ensembl
Q08397	LOXL1	Lysyl oxidase homolog 1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q08397	LOXL1	Lysyl oxidase homolog 1	GO:0055114; P:oxidation-reduction process; TAS:UniProtKB
Q08397	LOXL1	Lysyl oxidase homolog 1	GO:0018277; P:protein deamination; TAS:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0005507; F:copper ion binding; IEA:InterPro
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0009055; F:electron carrier activity; TAS:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0070492; F:oligosaccharide binding; IDA:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0004720; F:protein-lysine 6-oxidase activity; IDA:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0005044; F:scavenger receptor activity; IEA:InterPro
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0007568; P:aging; TAS:ProtInc
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0006464; P:cellular protein modification process; IDA:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0030199; P:collagen fibril organization; IMP:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0043542; P:endothelial cell migration; IMP:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0001935; P:endothelial cell proliferation; IMP:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0001837; P:epithelial to mesenchymal transition; IDA:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0016570; P:histone modification; IDA:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0032332; P:positive regulation of chondrocyte differentiation; ISS:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0018277; P:protein deamination; IDA:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0046688; P:response to copper ion; IDA:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0001666; P:response to hypoxia; ISS:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0002040; P:sprouting angiogenesis; IMP:UniProtKB
Q9Y4K0	LOXL2	Lysyl oxidase homolog 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P58215	LOXL3	Lysyl oxidase homolog 3	GO:0005507; F:copper ion binding; IEA:InterPro
P58215	LOXL3	Lysyl oxidase homolog 3	GO:0016641; F:oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor; IEA:InterPro
P58215	LOXL3	Lysyl oxidase homolog 3	GO:0005515; F:protein binding; IPI:UniProtKB
P58215	LOXL3	Lysyl oxidase homolog 3	GO:0004720; F:protein-lysine 6-oxidase activity; NAS:UniProtKB
P58215	LOXL3	Lysyl oxidase homolog 3	GO:0005044; F:scavenger receptor activity; IEA:InterPro
P58215	LOXL3	Lysyl oxidase homolog 3	GO:0001837; P:epithelial to mesenchymal transition; IDA:UniProtKB
P58215	LOXL3	Lysyl oxidase homolog 3	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q96JB6	LOXL4	Lysyl oxidase homolog 4	GO:0005507; F:copper ion binding; IEA:InterPro
Q96JB6	LOXL4	Lysyl oxidase homolog 4	GO:0005515; F:protein binding; IPI:IntAct
Q96JB6	LOXL4	Lysyl oxidase homolog 4	GO:0004720; F:protein-lysine 6-oxidase activity; IEA:Ensembl
Q96JB6	LOXL4	Lysyl oxidase homolog 4	GO:0005044; F:scavenger receptor activity; IEA:InterPro
Q92633	LPAR1	Lysophosphatidic acid receptor 1	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q92633	LPAR1	Lysophosphatidic acid receptor 1	GO:0070915; F:lysophosphatidic acid receptor activity; IEA:InterPro
Q92633	LPAR1	Lysophosphatidic acid receptor 1	GO:0005543; F:phospholipid binding; IEA:Ensembl
Q92633	LPAR1	Lysophosphatidic acid receptor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q92633	LPAR1	Lysophosphatidic acid receptor 1	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
Q92633	LPAR1	Lysophosphatidic acid receptor 1	GO:0007202; P:activation of phospholipase C activity; TAS:ProtInc
Q92633	LPAR1	Lysophosphatidic acid receptor 1	GO:0032060; P:bleb assembly; IEA:Ensembl
Q92633	LPAR1	Lysophosphatidic acid receptor 1	GO:0071453; P:cellular response to oxygen levels; IEA:Ensembl
Q92633	LPAR1	Lysophosphatidic acid receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q92633	LPAR1	Lysophosphatidic acid receptor 1	GO:0042552; P:myelination; IEA:Ensembl
Q92633	LPAR1	Lysophosphatidic acid receptor 1	GO:0010977; P:negative regulation of neuron projection development; IEA:Ensembl
Q92633	LPAR1	Lysophosphatidic acid receptor 1	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q92633	LPAR1	Lysophosphatidic acid receptor 1	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
Q92633	LPAR1	Lysophosphatidic acid receptor 1	GO:0051482; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway; IEA:Ensembl
Q92633	LPAR1	Lysophosphatidic acid receptor 1	GO:0060999; P:positive regulation of dendritic spine development; IEA:Ensembl
Q92633	LPAR1	Lysophosphatidic acid receptor 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
Q92633	LPAR1	Lysophosphatidic acid receptor 1	GO:0035025; P:positive regulation of Rho protein signal transduction; IEA:Ensembl
Q92633	LPAR1	Lysophosphatidic acid receptor 1	GO:0071673; P:positive regulation of smooth muscle cell chemotaxis; IEA:Ensembl
Q9HBW0	LPAR2	Lysophosphatidic acid receptor 2	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q9HBW0	LPAR2	Lysophosphatidic acid receptor 2	GO:0008289; F:lipid binding; TAS:ProtInc
Q9HBW0	LPAR2	Lysophosphatidic acid receptor 2	GO:0070915; F:lysophosphatidic acid receptor activity; IEA:InterPro
Q9HBW0	LPAR2	Lysophosphatidic acid receptor 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HBW0	LPAR2	Lysophosphatidic acid receptor 2	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
Q9HBW0	LPAR2	Lysophosphatidic acid receptor 2	GO:0007202; P:activation of phospholipase C activity; TAS:ProtInc
Q9HBW0	LPAR2	Lysophosphatidic acid receptor 2	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q9HBW0	LPAR2	Lysophosphatidic acid receptor 2	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
Q9HBW0	LPAR2	Lysophosphatidic acid receptor 2	GO:0035025; P:positive regulation of Rho protein signal transduction; IEA:Ensembl
Q9UBY5	LPAR3	Lysophosphatidic acid receptor 3	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q9UBY5	LPAR3	Lysophosphatidic acid receptor 3	GO:0008289; F:lipid binding; TAS:ProtInc
Q9UBY5	LPAR3	Lysophosphatidic acid receptor 3	GO:0070915; F:lysophosphatidic acid receptor activity; IEA:InterPro
Q9UBY5	LPAR3	Lysophosphatidic acid receptor 3	GO:0005543; F:phospholipid binding; IEA:Ensembl
Q9UBY5	LPAR3	Lysophosphatidic acid receptor 3	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
Q9UBY5	LPAR3	Lysophosphatidic acid receptor 3	GO:0032060; P:bleb assembly; IEA:Ensembl
Q9UBY5	LPAR3	Lysophosphatidic acid receptor 3	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
Q9UBY5	LPAR3	Lysophosphatidic acid receptor 3	GO:0051928; P:positive regulation of calcium ion transport; IEA:Ensembl
Q9UBY5	LPAR3	Lysophosphatidic acid receptor 3	GO:0048672; P:positive regulation of collateral sprouting; IEA:Ensembl
Q9UBY5	LPAR3	Lysophosphatidic acid receptor 3	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
Q9UBY5	LPAR3	Lysophosphatidic acid receptor 3	GO:0051482; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway; IEA:Ensembl
Q9UBY5	LPAR3	Lysophosphatidic acid receptor 3	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q99677	LPAR4	Lysophosphatidic acid receptor 4	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q99677	LPAR4	Lysophosphatidic acid receptor 4	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q99677	LPAR4	Lysophosphatidic acid receptor 4	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q9H1C0	LPAR5	Lysophosphatidic acid receptor 5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P43657	LPAR6	Lysophosphatidic acid receptor 6	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q643R3	LPCAT4	Lysophospholipid acyltransferase LPCAT4	GO:0047184; F:1-acylglycerophosphocholine O-acyltransferase activity; IEA:UniProtKB-EC
Q643R3	LPCAT4	Lysophospholipid acyltransferase LPCAT4	GO:0047166; F:1-alkenylglycerophosphoethanolamine O-acyltransferase activity; IEA:UniProtKB-EC
Q643R3	LPCAT4	Lysophospholipid acyltransferase LPCAT4	GO:0047192; F:1-alkylglycerophosphocholine O-acetyltransferase activity; IEA:UniProtKB-EC
Q643R3	LPCAT4	Lysophospholipid acyltransferase LPCAT4	GO:0005509; F:calcium ion binding; IEA:InterPro
Q643R3	LPCAT4	Lysophospholipid acyltransferase LPCAT4	GO:0071617; F:lysophospholipid acyltransferase activity; IDA:MGI
Q643R3	LPCAT4	Lysophospholipid acyltransferase LPCAT4	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q643R3	LPCAT4	Lysophospholipid acyltransferase LPCAT4	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q643R3	LPCAT4	Lysophospholipid acyltransferase LPCAT4	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
Q643R3	LPCAT4	Lysophospholipid acyltransferase LPCAT4	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
Q643R3	LPCAT4	Lysophospholipid acyltransferase LPCAT4	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
Q643R3	LPCAT4	Lysophospholipid acyltransferase LPCAT4	GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome
Q643R3	LPCAT4	Lysophospholipid acyltransferase LPCAT4	GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome
Q643R3	LPCAT4	Lysophospholipid acyltransferase LPCAT4	GO:0006644; P:phospholipid metabolic process; IDA:MGI
Q643R3	LPCAT4	Lysophospholipid acyltransferase LPCAT4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q643R3	LPCAT4	Lysophospholipid acyltransferase LPCAT4	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
O94910	LPHN1	Latrophilin-1	GO:0030246; F:carbohydrate binding; IEA:InterPro
O94910	LPHN1	Latrophilin-1	GO:0050839; F:cell adhesion molecule binding; ISS:UniProtKB
O94910	LPHN1	Latrophilin-1	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
O94910	LPHN1	Latrophilin-1	GO:0016524; F:latrotoxin receptor activity; ISS:UniProtKB
O94910	LPHN1	Latrophilin-1	GO:0005515; F:protein binding; IPI:IntAct
O94910	LPHN1	Latrophilin-1	GO:0035584; P:calcium-mediated signaling using intracellular calcium source; ISS:UniProtKB
O94910	LPHN1	Latrophilin-1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
O94910	LPHN1	Latrophilin-1	GO:0007157; P:heterophilic cell-cell adhesion; ISS:UniProtKB
O94910	LPHN1	Latrophilin-1	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
O94910	LPHN1	Latrophilin-1	GO:0090129; P:positive regulation of synapse maturation; ISS:UniProtKB
O95490	LPHN2	Latrophilin-2	GO:0030246; F:carbohydrate binding; IEA:InterPro
O95490	LPHN2	Latrophilin-2	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
O95490	LPHN2	Latrophilin-2	GO:0016524; F:latrotoxin receptor activity; NAS:UniProtKB
O95490	LPHN2	Latrophilin-2	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
O95490	LPHN2	Latrophilin-2	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q9HAR2	LPHN3	Latrophilin-3	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q9HAR2	LPHN3	Latrophilin-3	GO:0004930; F:G-protein coupled receptor activity; NAS:UniProtKB
Q9HAR2	LPHN3	Latrophilin-3	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
Q9HAR2	LPHN3	Latrophilin-3	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
P09848	LCT	Lactase-phlorizin hydrolase	GO:0017042; F:glycosylceramidase activity; IEA:UniProtKB-EC
P09848	LCT	Lactase-phlorizin hydrolase	GO:0000016; F:lactase activity; TAS:Reactome
P09848	LCT	Lactase-phlorizin hydrolase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P09848	LCT	Lactase-phlorizin hydrolase	GO:0044245; P:polysaccharide digestion; TAS:Reactome
P09848	LCT	Lactase-phlorizin hydrolase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14693	LPIN1	Phosphatidate phosphatase LPIN1	GO:0008195; F:phosphatidate phosphatase activity; IEA:UniProtKB-EC
Q14693	LPIN1	Phosphatidate phosphatase LPIN1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q14693	LPIN1	Phosphatidate phosphatase LPIN1	GO:0009062; P:fatty acid catabolic process; ISS:UniProtKB
Q14693	LPIN1	Phosphatidate phosphatase LPIN1	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q14693	LPIN1	Phosphatidate phosphatase LPIN1	GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome
Q14693	LPIN1	Phosphatidate phosphatase LPIN1	GO:0006646; P:phosphatidylethanolamine biosynthetic process; TAS:Reactome
Q14693	LPIN1	Phosphatidate phosphatase LPIN1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q14693	LPIN1	Phosphatidate phosphatase LPIN1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:InterPro
Q14693	LPIN1	Phosphatidate phosphatase LPIN1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14693	LPIN1	Phosphatidate phosphatase LPIN1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14693	LPIN1	Phosphatidate phosphatase LPIN1	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
Q14693	LPIN1	Phosphatidate phosphatase LPIN1	GO:0006642; P:triglyceride mobilization; ISS:UniProtKB
Q92539	LPIN2	Phosphatidate phosphatase LPIN2	GO:0008195; F:phosphatidate phosphatase activity; ISS:UniProtKB
Q92539	LPIN2	Phosphatidate phosphatase LPIN2	GO:0003713; F:transcription coactivator activity; ISS:UniProtKB
Q92539	LPIN2	Phosphatidate phosphatase LPIN2	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q92539	LPIN2	Phosphatidate phosphatase LPIN2	GO:0016311; P:dephosphorylation; ISS:GOC
Q92539	LPIN2	Phosphatidate phosphatase LPIN2	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW
Q92539	LPIN2	Phosphatidate phosphatase LPIN2	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q92539	LPIN2	Phosphatidate phosphatase LPIN2	GO:0006629; P:lipid metabolic process; ISS:UniProtKB
Q92539	LPIN2	Phosphatidate phosphatase LPIN2	GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome
Q92539	LPIN2	Phosphatidate phosphatase LPIN2	GO:0006646; P:phosphatidylethanolamine biosynthetic process; TAS:Reactome
Q92539	LPIN2	Phosphatidate phosphatase LPIN2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q92539	LPIN2	Phosphatidate phosphatase LPIN2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q92539	LPIN2	Phosphatidate phosphatase LPIN2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q92539	LPIN2	Phosphatidate phosphatase LPIN2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q92539	LPIN2	Phosphatidate phosphatase LPIN2	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
Q9BQK8	LPIN3	Phosphatidate phosphatase LPIN3	GO:0008195; F:phosphatidate phosphatase activity; IEA:UniProtKB-EC
Q9BQK8	LPIN3	Phosphatidate phosphatase LPIN3	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW
Q9BQK8	LPIN3	Phosphatidate phosphatase LPIN3	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9BQK8	LPIN3	Phosphatidate phosphatase LPIN3	GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome
Q9BQK8	LPIN3	Phosphatidate phosphatase LPIN3	GO:0006646; P:phosphatidylethanolamine biosynthetic process; TAS:Reactome
Q9BQK8	LPIN3	Phosphatidate phosphatase LPIN3	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9BQK8	LPIN3	Phosphatidate phosphatase LPIN3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O14494	PPAP2A	Lipid phosphate phosphohydrolase 1	GO:0008195; F:phosphatidate phosphatase activity; IDA:UniProtKB
O14494	PPAP2A	Lipid phosphate phosphohydrolase 1	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
O14494	PPAP2A	Lipid phosphate phosphohydrolase 1	GO:0008354; P:germ cell migration; TAS:ProtInc
O14494	PPAP2A	Lipid phosphate phosphohydrolase 1	GO:0030518; P:intracellular steroid hormone receptor signaling pathway; TAS:UniProtKB
O14494	PPAP2A	Lipid phosphate phosphohydrolase 1	GO:0006629; P:lipid metabolic process; NAS:ProtInc
O14494	PPAP2A	Lipid phosphate phosphohydrolase 1	GO:0008285; P:negative regulation of cell proliferation; NAS:UniProtKB
O14494	PPAP2A	Lipid phosphate phosphohydrolase 1	GO:0046839; P:phospholipid dephosphorylation; TAS:UniProtKB
O14494	PPAP2A	Lipid phosphate phosphohydrolase 1	GO:0006470; P:protein dephosphorylation; IEA:Ensembl
O14494	PPAP2A	Lipid phosphate phosphohydrolase 1	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; TAS:UniProtKB
O14494	PPAP2A	Lipid phosphate phosphohydrolase 1	GO:0019216; P:regulation of lipid metabolic process; NAS:UniProtKB
O14494	PPAP2A	Lipid phosphate phosphohydrolase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O14494	PPAP2A	Lipid phosphate phosphohydrolase 1	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
O14494	PPAP2A	Lipid phosphate phosphohydrolase 1	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
O43688	PPAP2C	Lipid phosphate phosphohydrolase 2	GO:0008195; F:phosphatidate phosphatase activity; IEA:UniProtKB-EC
O43688	PPAP2C	Lipid phosphate phosphohydrolase 2	GO:0004721; F:phosphoprotein phosphatase activity; TAS:ProtInc
O43688	PPAP2C	Lipid phosphate phosphohydrolase 2	GO:0016311; P:dephosphorylation; TAS:GOC
O43688	PPAP2C	Lipid phosphate phosphohydrolase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43688	PPAP2C	Lipid phosphate phosphohydrolase 2	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
O43688	PPAP2C	Lipid phosphate phosphohydrolase 2	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0042577; F:lipid phosphatase activity; IEA:Ensembl
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0008195; F:phosphatidate phosphatase activity; IEA:UniProtKB-EC
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0004721; F:phosphoprotein phosphatase activity; TAS:ProtInc
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0005515; F:protein binding; IPI:IntAct
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0001568; P:blood vessel development; IEA:Ensembl
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0044329; P:canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion; IMP:BHF-UCL
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0044328; P:canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration; IMP:BHF-UCL
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0044330; P:canonical Wnt signaling pathway involved in positive regulation of wound healing; IMP:BHF-UCL
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0016311; P:dephosphorylation; TAS:GOC
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0008354; P:germ cell migration; TAS:ProtInc
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0034109; P:homotypic cell-cell adhesion; IDA:BHF-UCL
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0006629; P:lipid metabolic process; NAS:ProtInc
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0001933; P:negative regulation of protein phosphorylation; IDA:BHF-UCL
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0006644; P:phospholipid metabolic process; IEA:Ensembl
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0050821; P:protein stabilization; IDA:BHF-UCL
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0030111; P:regulation of Wnt signaling pathway; IEA:Ensembl
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
O14495	PPAP2B	Lipid phosphate phosphohydrolase 3	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q86U10	ASPG	60 kDa lysophospholipase	GO:0003847; F:1-alkyl-2-acetylglycerophosphocholine esterase activity; IEA:UniProtKB-EC
Q86U10	ASPG	60 kDa lysophospholipase	GO:0004067; F:asparaginase activity; IEA:UniProtKB-EC
Q86U10	ASPG	60 kDa lysophospholipase	GO:0004622; F:lysophospholipase activity; IEA:UniProtKB-EC
Q86U10	ASPG	60 kDa lysophospholipase	GO:0006528; P:asparagine metabolic process; IEA:Ensembl
Q86U10	ASPG	60 kDa lysophospholipase	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q86U10	ASPG	60 kDa lysophospholipase	GO:0006644; P:phospholipid metabolic process; IEA:Ensembl
Q8TBJ4	LPPR1	Lipid phosphate phosphatase-related protein type 1	GO:0003824; F:catalytic activity; IEA:InterPro
Q8TBJ4	LPPR1	Lipid phosphate phosphatase-related protein type 1	GO:0007399; P:nervous system development; IEA:InterPro
Q96GM1	LPPR2	Lipid phosphate phosphatase-related protein type 2	GO:0008195; F:phosphatidate phosphatase activity; IEA:UniProtKB-EC
Q6T4P5	LPPR3	Lipid phosphate phosphatase-related protein type 3	GO:0008195; F:phosphatidate phosphatase activity; IEA:UniProtKB-EC
Q7Z2D5	LPPR4	Lipid phosphate phosphatase-related protein type 4	GO:0042577; F:lipid phosphatase activity; IEA:InterPro
Q7Z2D5	LPPR4	Lipid phosphate phosphatase-related protein type 4	GO:0008195; F:phosphatidate phosphatase activity; IEA:UniProtKB-EC
Q7Z2D5	LPPR4	Lipid phosphate phosphatase-related protein type 4	GO:0007409; P:axonogenesis; IEA:InterPro
Q7Z2D5	LPPR4	Lipid phosphate phosphatase-related protein type 4	GO:0048839; P:inner ear development; IEA:Ensembl
Q7Z2D5	LPPR4	Lipid phosphate phosphatase-related protein type 4	GO:0046839; P:phospholipid dephosphorylation; IEA:InterPro
P42704	LRPPRC	Leucine-rich PPR motif-containing protein, mitochondrial	GO:0048487; F:beta-tubulin binding; IDA:HGNC
P42704	LRPPRC	Leucine-rich PPR motif-containing protein, mitochondrial	GO:0008017; F:microtubule binding; TAS:HGNC
P42704	LRPPRC	Leucine-rich PPR motif-containing protein, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P42704	LRPPRC	Leucine-rich PPR motif-containing protein, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
P42704	LRPPRC	Leucine-rich PPR motif-containing protein, mitochondrial	GO:0003723; F:RNA binding; NAS:UniProtKB
P42704	LRPPRC	Leucine-rich PPR motif-containing protein, mitochondrial	GO:0003697; F:single-stranded DNA binding; IEA:Ensembl
P42704	LRPPRC	Leucine-rich PPR motif-containing protein, mitochondrial	GO:0047497; P:mitochondrion transport along microtubule; TAS:HGNC
P42704	LRPPRC	Leucine-rich PPR motif-containing protein, mitochondrial	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
P42704	LRPPRC	Leucine-rich PPR motif-containing protein, mitochondrial	GO:0000961; P:negative regulation of mitochondrial RNA catabolic process; IEA:Ensembl
P42704	LRPPRC	Leucine-rich PPR motif-containing protein, mitochondrial	GO:0070129; P:regulation of mitochondrial translation; IEA:Ensembl
P42704	LRPPRC	Leucine-rich PPR motif-containing protein, mitochondrial	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P42704	LRPPRC	Leucine-rich PPR motif-containing protein, mitochondrial	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q32ZL2	LPPR5	Lipid phosphate phosphatase-related protein type 5	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q93052	LPP	Lipoma-preferred partner	GO:0005515; F:protein binding; IPI:UniProtKB
Q93052	LPP	Lipoma-preferred partner	GO:0008270; F:zinc ion binding; IEA:InterPro
Q93052	LPP	Lipoma-preferred partner	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
O60711	LPXN	Leupaxin	GO:0005515; F:protein binding; IPI:UniProtKB
O60711	LPXN	Leupaxin	GO:0003712; F:transcription cofactor activity; IDA:UniProtKB
O60711	LPXN	Leupaxin	GO:0008270; F:zinc ion binding; IEA:InterPro
O60711	LPXN	Leupaxin	GO:0007155; P:cell adhesion; NAS:ProtInc
O60711	LPXN	Leupaxin	GO:0050859; P:negative regulation of B cell receptor signaling pathway; IDA:UniProtKB
O60711	LPXN	Leupaxin	GO:0007162; P:negative regulation of cell adhesion; IDA:UniProtKB
O60711	LPXN	Leupaxin	GO:0006461; P:protein complex assembly; TAS:ProtInc
O60711	LPXN	Leupaxin	GO:0033628; P:regulation of cell adhesion mediated by integrin; IEA:Ensembl
O60711	LPXN	Leupaxin	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O60711	LPXN	Leupaxin	GO:0007165; P:signal transduction; TAS:ProtInc
O60711	LPXN	Leupaxin	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5VZK9	LRRC16A	Leucine-rich repeat-containing protein 16A	GO:0032403; F:protein complex binding; IDA:UniProt
Q5VZK9	LRRC16A	Leucine-rich repeat-containing protein 16A	GO:0007015; P:actin filament organization; NAS:BHF-UCL
Q5VZK9	LRRC16A	Leucine-rich repeat-containing protein 16A	GO:0051638; P:barbed-end actin filament uncapping; ISS:UniProt
Q5VZK9	LRRC16A	Leucine-rich repeat-containing protein 16A	GO:0007596; P:blood coagulation; TAS:Reactome
Q5VZK9	LRRC16A	Leucine-rich repeat-containing protein 16A	GO:0016477; P:cell migration; IMP:BHF-UCL
Q5VZK9	LRRC16A	Leucine-rich repeat-containing protein 16A	GO:0030032; P:lamellipodium assembly; IMP:BHF-UCL
Q5VZK9	LRRC16A	Leucine-rich repeat-containing protein 16A	GO:2000813; P:negative regulation of barbed-end actin filament capping; ISS:UniProt
Q5VZK9	LRRC16A	Leucine-rich repeat-containing protein 16A	GO:0030838; P:positive regulation of actin filament polymerization; ISS:UniProt
Q5VZK9	LRRC16A	Leucine-rich repeat-containing protein 16A	GO:0030335; P:positive regulation of cell migration; IMP:UniProt
Q5VZK9	LRRC16A	Leucine-rich repeat-containing protein 16A	GO:1902745; P:positive regulation of lamellipodium organization; IDA:UniProt
Q5VZK9	LRRC16A	Leucine-rich repeat-containing protein 16A	GO:0051496; P:positive regulation of stress fiber assembly; IMP:UniProt
Q5VZK9	LRRC16A	Leucine-rich repeat-containing protein 16A	GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IMP:UniProt
Q5VZK9	LRRC16A	Leucine-rich repeat-containing protein 16A	GO:0031529; P:ruffle organization; IMP:BHF-UCL
Q5VZK9	LRRC16A	Leucine-rich repeat-containing protein 16A	GO:0046415; P:urate metabolic process; IMP:BHF-UCL
Q9P2M1	LRP2BP	LRP2-binding protein	GO:0005515; F:protein binding; IPI:HGNC
Q86YD5	LDLRAD3	Low-density lipoprotein receptor class A domain-containing protein 3	GO:0001540; F:beta-amyloid binding; IEA:Ensembl
Q86YD5	LDLRAD3	Low-density lipoprotein receptor class A domain-containing protein 3	GO:0006898; P:receptor-mediated endocytosis; IEA:Ensembl
Q86YD5	LDLRAD3	Low-density lipoprotein receptor class A domain-containing protein 3	GO:0070613; P:regulation of protein processing; IEA:Ensembl
O95237	LRAT	Lecithin retinol acyltransferase	GO:0047173; F:phosphatidylcholine-retinol O-acyltransferase activity; IEA:UniProtKB-EC
O95237	LRAT	Lecithin retinol acyltransferase	GO:0001972; F:retinoic acid binding; IEA:Ensembl
O95237	LRAT	Lecithin retinol acyltransferase	GO:0019841; F:retinol binding; IEA:Ensembl
O95237	LRAT	Lecithin retinol acyltransferase	GO:0016746; F:transferase activity, transferring acyl groups; TAS:ProtInc
O95237	LRAT	Lecithin retinol acyltransferase	GO:0009790; P:embryo development; IEA:Ensembl
O95237	LRAT	Lecithin retinol acyltransferase	GO:0007603; P:phototransduction, visible light; TAS:Reactome
O95237	LRAT	Lecithin retinol acyltransferase	GO:0042573; P:retinoic acid metabolic process; IEA:Ensembl
O95237	LRAT	Lecithin retinol acyltransferase	GO:0001523; P:retinoid metabolic process; TAS:Reactome
O95237	LRAT	Lecithin retinol acyltransferase	GO:0042572; P:retinol metabolic process; IEA:UniProtKB-UniPathway
O95237	LRAT	Lecithin retinol acyltransferase	GO:0007601; P:visual perception; IEA:UniProtKB-KW
O95237	LRAT	Lecithin retinol acyltransferase	GO:0006776; P:vitamin A metabolic process; IEA:Ensembl
Q5BKY1	LRRC10	Leucine-rich repeat-containing protein 10	GO:0055013; P:cardiac muscle cell development; IEA:Ensembl
Q8TF66	LRRC15	Leucine-rich repeat-containing protein 15	GO:0005518; F:collagen binding; IDA:UniProt
Q8TF66	LRRC15	Leucine-rich repeat-containing protein 15	GO:0001968; F:fibronectin binding; IDA:UniProt
Q8TF66	LRRC15	Leucine-rich repeat-containing protein 15	GO:0043236; F:laminin binding; IDA:UniProt
Q8TF66	LRRC15	Leucine-rich repeat-containing protein 15	GO:0090005; P:negative regulation of establishment of protein localization to plasma membrane; IMP:UniProt
Q8TF66	LRRC15	Leucine-rich repeat-containing protein 15	GO:0030335; P:positive regulation of cell migration; IMP:UniProt
Q8TF66	LRRC15	Leucine-rich repeat-containing protein 15	GO:0046813; P:receptor-mediated virion attachment to host cell; IMP:UniProt
Q8N6Y2	LRRC17	Leucine-rich repeat-containing protein 17	GO:0048539; P:bone marrow development; ISS:UniProtKB
Q8N6Y2	LRRC17	Leucine-rich repeat-containing protein 17	GO:0045671; P:negative regulation of osteoclast differentiation; ISS:UniProtKB
Q8N6Y2	LRRC17	Leucine-rich repeat-containing protein 17	GO:0001503; P:ossification; IEA:UniProtKB-KW
Q2I0M4	LRRC26	Leucine-rich repeat-containing protein 26	GO:0015459; F:potassium channel regulator activity; IDA:UniProtKB
Q2I0M4	LRRC26	Leucine-rich repeat-containing protein 26	GO:0005515; F:protein binding; IPI:UniProtKB
Q2I0M4	LRRC26	Leucine-rich repeat-containing protein 26	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q14392	LRRC32	Leucine-rich repeat-containing protein 32	GO:0046007; P:negative regulation of activated T cell proliferation; IEA:Ensembl
Q14392	LRRC32	Leucine-rich repeat-containing protein 32	GO:0050710; P:negative regulation of cytokine secretion; IEA:Ensembl
Q14392	LRRC32	Leucine-rich repeat-containing protein 32	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
Q5VT99	LRRC38	Leucine-rich repeat-containing protein 38	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q15345	LRRC41	Leucine-rich repeat-containing protein 41	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8N1G4	LRRC47	Leucine-rich repeat-containing protein 47	GO:0004826; F:phenylalanine-tRNA ligase activity; IEA:InterPro
Q8N1G4	LRRC47	Leucine-rich repeat-containing protein 47	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8N1G4	LRRC47	Leucine-rich repeat-containing protein 47	GO:0005515; F:protein binding; IPI:IntAct
Q9NT99	LRRC4B	Leucine-rich repeat-containing protein 4B	GO:0051965; P:positive regulation of synapse assembly; ISS:BHF-UCL
Q9HCJ2	LRRC4C	Leucine-rich repeat-containing protein 4C	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HCJ2	LRRC4C	Leucine-rich repeat-containing protein 4C	GO:0050770; P:regulation of axonogenesis; IDA:UniProtKB
Q8N7C0	LRRC52	Leucine-rich repeat-containing protein 52	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q6ZSA7	LRRC55	Leucine-rich repeat-containing protein 55	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q96AG4	LRRC59	Leucine-rich repeat-containing protein 59	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IWT6	LRRC8A	Leucine-rich repeat-containing protein 8A	GO:0002329; P:pre-B cell differentiation; ISS:UniProtKB
Q9C099	LRRCC1	Leucine-rich repeat and coiled-coil domain-containing protein 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
O75427	LRCH4	Leucine-rich repeat and calponin homology domain-containing protein 4	GO:0005515; F:protein binding; IPI:IntAct
O75427	LRCH4	Leucine-rich repeat and calponin homology domain-containing protein 4	GO:0007399; P:nervous system development; TAS:ProtInc
A6NCL2	LRCOL1	Leucine-rich colipase-like protein 1	GO:0008047; F:enzyme activator activity; IEA:InterPro
A6NCL2	LRCOL1	Leucine-rich colipase-like protein 1	GO:0007586; P:digestion; IEA:InterPro
A6NCL2	LRCOL1	Leucine-rich colipase-like protein 1	GO:0016042; P:lipid catabolic process; IEA:InterPro
Q9BTN0	LRFN3	Leucine-rich repeat and fibronectin type-III domain-containing protein 3	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q96M69	LRGUK	Leucine-rich repeat and guanylate kinase domain-containing protein	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96M69	LRGUK	Leucine-rich repeat and guanylate kinase domain-containing protein	GO:0016301; F:kinase activity; IEA:UniProtKB-KW
Q5T3J3	LRIF1	Ligand-dependent nuclear receptor-interacting factor 1	GO:0005515; F:protein binding; IPI:IntAct
Q5T3J3	LRIF1	Ligand-dependent nuclear receptor-interacting factor 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5T3J3	LRIF1	Ligand-dependent nuclear receptor-interacting factor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6UXM1	LRIG3	Leucine-rich repeats and immunoglobulin-like domains protein 3	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q3SXY7	LRIT3	Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3	GO:0040036; P:regulation of fibroblast growth factor receptor signaling pathway; IDA:UniProtKB
Q12912	LRMP	Lymphoid-restricted membrane protein	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q12912	LRMP	Lymphoid-restricted membrane protein	GO:0007338; P:single fertilization; IEA:UniProtKB-KW
Q12912	LRMP	Lymphoid-restricted membrane protein	GO:0006906; P:vesicle fusion; TAS:ProtInc
Q12912	LRMP	Lymphoid-restricted membrane protein	GO:0006903; P:vesicle targeting; TAS:ProtInc
Q7Z4F1	LRP10	Low-density lipoprotein receptor-related protein 10	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q9Y561	LRP12	Low-density lipoprotein receptor-related protein 12	GO:0005041; F:low-density lipoprotein receptor activity; NAS:UniProtKB
Q9Y561	LRP12	Low-density lipoprotein receptor-related protein 12	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y561	LRP12	Low-density lipoprotein receptor-related protein 12	GO:0006897; P:endocytosis; NAS:UniProtKB
Q9Y561	LRP12	Low-density lipoprotein receptor-related protein 12	GO:0006898; P:receptor-mediated endocytosis; NAS:GOC
Q9Y561	LRP12	Low-density lipoprotein receptor-related protein 12	GO:0040008; P:regulation of growth; NAS:UniProtKB
Q9Y561	LRP12	Low-density lipoprotein receptor-related protein 12	GO:0007165; P:signal transduction; NAS:UniProtKB
Q9NZR2	LRP1B	Low-density lipoprotein receptor-related protein 1B	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NZR2	LRP1B	Low-density lipoprotein receptor-related protein 1B	GO:0005041; F:low-density lipoprotein receptor activity; IEA:Ensembl
Q9NZR2	LRP1B	Low-density lipoprotein receptor-related protein 1B	GO:0015031; P:protein transport; TAS:ProtInc
Q9NZR2	LRP1B	Low-density lipoprotein receptor-related protein 1B	GO:0006898; P:receptor-mediated endocytosis; TAS:ProtInc
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0034185; F:apolipoprotein binding; IDA:UniProtKB
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0005509; F:calcium ion binding; ISS:UniProtKB
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0070325; F:lipoprotein particle receptor binding; IC:BHF-UCL
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0042954; F:lipoprotein transporter activity; NAS:UniProtKB
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0032403; F:protein complex binding; IDA:BHF-UCL
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0004872; F:receptor activity; TAS:ProtInc
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0007568; P:aging; IEA:Ensembl
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0035909; P:aorta morphogenesis; ISS:BHF-UCL
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0043277; P:apoptotic cell clearance; ISS:BHF-UCL
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0097242; P:beta-amyloid clearance; TAS:BHF-UCL
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0008283; P:cell proliferation; IEA:Ensembl
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0008203; P:cholesterol metabolic process; IEA:Ensembl
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0042157; P:lipoprotein metabolic process; IEA:Ensembl
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0042953; P:lipoprotein transport; NAS:UniProtKB
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:2000587; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; ISS:BHF-UCL
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0014912; P:negative regulation of smooth muscle cell migration; ISS:BHF-UCL
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0030178; P:negative regulation of Wnt signaling pathway; ISS:BHF-UCL
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0007603; P:phototransduction, visible light; TAS:Reactome
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0010875; P:positive regulation of cholesterol efflux; ISS:BHF-UCL
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0032370; P:positive regulation of lipid transport; ISS:BHF-UCL
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0051222; P:positive regulation of protein transport; IEA:Ensembl
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0006898; P:receptor-mediated endocytosis; IEA:Ensembl
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0032956; P:regulation of actin cytoskeleton organization; ISS:BHF-UCL
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0032374; P:regulation of cholesterol transport; ISS:BHF-UCL
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0032429; P:regulation of phospholipase A2 activity; ISS:BHF-UCL
Q07954	LRP1	Prolow-density lipoprotein receptor-related protein 1	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P98164	LRP2	Low-density lipoprotein receptor-related protein 2	GO:0005509; F:calcium ion binding; IEA:InterPro
P98164	LRP2	Low-density lipoprotein receptor-related protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
P98164	LRP2	Low-density lipoprotein receptor-related protein 2	GO:0008283; P:cell proliferation; IEA:Ensembl
P98164	LRP2	Low-density lipoprotein receptor-related protein 2	GO:0006897; P:endocytosis; TAS:ProtInc
P98164	LRP2	Low-density lipoprotein receptor-related protein 2	GO:0030900; P:forebrain development; IEA:Ensembl
P98164	LRP2	Low-density lipoprotein receptor-related protein 2	GO:0006629; P:lipid metabolic process; TAS:ProtInc
P98164	LRP2	Low-density lipoprotein receptor-related protein 2	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P98164	LRP2	Low-density lipoprotein receptor-related protein 2	GO:0006486; P:protein glycosylation; TAS:ProtInc
P98164	LRP2	Low-density lipoprotein receptor-related protein 2	GO:0006898; P:receptor-mediated endocytosis; TAS:ProtInc
P98164	LRP2	Low-density lipoprotein receptor-related protein 2	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P98164	LRP2	Low-density lipoprotein receptor-related protein 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P98164	LRP2	Low-density lipoprotein receptor-related protein 2	GO:0008202; P:steroid metabolic process; TAS:Reactome
P98164	LRP2	Low-density lipoprotein receptor-related protein 2	GO:0042359; P:vitamin D metabolic process; TAS:Reactome
O75074	LRP3	Low-density lipoprotein receptor-related protein 3	GO:0006898; P:receptor-mediated endocytosis; TAS:ProtInc
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0005509; F:calcium ion binding; IEA:InterPro
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0030971; F:receptor tyrosine kinase binding; ISS:UniProt
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0097110; F:scaffold protein binding; ISS:UniProt
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0048813; P:dendrite morphogenesis; ISS:UniProt
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0001942; P:hair follicle development; IEA:Ensembl
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0001822; P:kidney development; IDA:UniProt
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0060173; P:limb development; IDA:UniProt
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0050771; P:negative regulation of axonogenesis; ISS:UniProt
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:UniProtKB
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0030279; P:negative regulation of ossification; IMP:UniProtKB
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:1901631; P:positive regulation of presynaptic membrane organization; ISS:UniProt
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0097104; P:postsynaptic membrane assembly; ISS:UniProt
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0097105; P:presynaptic membrane assembly; ISS:UniProt
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0051290; P:protein heterotetramerization; ISS:UniProt
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0001932; P:regulation of protein phosphorylation; IEA:Ensembl
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0071340; P:skeletal muscle acetylcholine-gated channel clustering; ISS:UniProt
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0050808; P:synapse organization; ISS:UniProt
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0051124; P:synaptic growth at neuromuscular junction; ISS:UniProt
O75096	LRP4	Low-density lipoprotein receptor-related protein 4	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
A4QPB2	LRP5L	Low-density lipoprotein receptor-related protein 5-like protein	GO:0042813; F:Wnt-activated receptor activity; IBA:RefGenome
A4QPB2	LRP5L	Low-density lipoprotein receptor-related protein 5-like protein	GO:0017147; F:Wnt-protein binding; IBA:RefGenome
A4QPB2	LRP5L	Low-density lipoprotein receptor-related protein 5-like protein	GO:0060070; P:canonical Wnt signaling pathway; IBA:RefGenome
A4QPB2	LRP5L	Low-density lipoprotein receptor-related protein 5-like protein	GO:0044332; P:Wnt signaling pathway involved in dorsal/ventral axis specification; IBA:RefGenome
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0015026; F:coreceptor activity; IBA:RefGenome
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0005515; F:protein binding; IPI:IntAct
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0042813; F:Wnt-activated receptor activity; IBA:RefGenome
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0017147; F:Wnt-protein binding; IBA:RefGenome
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0060612; P:adipose tissue development; IMP:BHF-UCL
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0060033; P:anatomical structure regression; IEA:Ensembl
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0009952; P:anterior/posterior pattern specification; IBA:RefGenome
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:1902262; P:apoptotic process involved in patterning of blood vessels; IEA:Ensembl
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0048539; P:bone marrow development; IMP:BHF-UCL
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0060349; P:bone morphogenesis; IMP:BHF-UCL
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0046849; P:bone remodeling; IBA:RefGenome
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0060444; P:branching involved in mammary gland duct morphogenesis; IBA:RefGenome
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0060070; P:canonical Wnt signaling pathway; IDA:BHF-UCL
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0042074; P:cell migration involved in gastrulation; IEA:Ensembl
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0060764; P:cell-cell signaling involved in mammary gland development; IEA:Ensembl
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0042632; P:cholesterol homeostasis; IMP:BHF-UCL
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0008203; P:cholesterol metabolic process; IEA:Ensembl
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0048596; P:embryonic camera-type eye morphogenesis; IBA:RefGenome
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0030326; P:embryonic limb morphogenesis; IBA:RefGenome
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0060059; P:embryonic retina morphogenesis in camera-type eye; IBA:RefGenome
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0035426; P:extracellular matrix-cell signaling; IEA:Ensembl
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0001702; P:gastrulation with mouth forming second; IBA:RefGenome
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0006007; P:glucose catabolic process; IMP:BHF-UCL
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0045668; P:negative regulation of osteoblast differentiation; IMP:BHF-UCL
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0071901; P:negative regulation of protein serine/threonine kinase activity; IMP:BHF-UCL
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0002076; P:osteoblast development; IBA:RefGenome
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0045600; P:positive regulation of fat cell differentiation; IMP:BHF-UCL
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IMP:BHF-UCL
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0045840; P:positive regulation of mitosis; IDA:BHF-UCL
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0033690; P:positive regulation of osteoblast proliferation; IEA:Ensembl
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0042981; P:regulation of apoptotic process; IEA:Ensembl
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0008217; P:regulation of blood pressure; IMP:BHF-UCL
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0046850; P:regulation of bone remodeling; IEA:Ensembl
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0060828; P:regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; IBA:RefGenome
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0043434; P:response to peptide hormone; IEA:Ensembl
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0060042; P:retina morphogenesis in camera-type eye; IMP:BHF-UCL
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0061304; P:retinal blood vessel morphogenesis; IMP:BHF-UCL
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0016055; P:Wnt signaling pathway; IDA:BHF-UCL
O75197	LRP5	Low-density lipoprotein receptor-related protein 5	GO:0044332; P:Wnt signaling pathway involved in dorsal/ventral axis specification; IDA:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0034185; F:apolipoprotein binding; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0071936; F:coreceptor activity involved in Wnt signaling pathway; IDA:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0005109; F:frizzled binding; IPI:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0019210; F:kinase inhibitor activity; IMP:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0005041; F:low-density lipoprotein receptor activity; IDA:MGI
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0005515; F:protein binding; IPI:UniProtKB
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0005102; F:receptor binding; IPI:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0019534; F:toxin transporter activity; IMP:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0042813; F:Wnt-activated receptor activity; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0017147; F:Wnt-protein binding; IPI:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0009952; P:anterior/posterior pattern specification; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0090245; P:axis elongation involved in somitogenesis; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0060349; P:bone morphogenesis; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0046849; P:bone remodeling; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0060444; P:branching involved in mammary gland duct morphogenesis; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0060070; P:canonical Wnt signaling pathway; IDA:UniProtKB
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0061310; P:canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0044335; P:canonical Wnt signaling pathway involved in neural crest cell differentiation; IC:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0061324; P:canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0044340; P:canonical Wnt signaling pathway involved in regulation of cell proliferation; IC:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0042074; P:cell migration involved in gastrulation; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0071397; P:cellular response to cholesterol; IMP:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0021587; P:cerebellum morphogenesis; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0021795; P:cerebral cortex cell migration; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0021987; P:cerebral cortex development; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0060026; P:convergent extension; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0071542; P:dopaminergic neuron differentiation; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0048596; P:embryonic camera-type eye morphogenesis; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0030326; P:embryonic limb morphogenesis; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0009880; P:embryonic pattern specification; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0060059; P:embryonic retina morphogenesis in camera-type eye; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0035261; P:external genitalia morphogenesis; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0060325; P:face morphogenesis; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0021861; P:forebrain radial glial cell differentiation; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0021943; P:formation of radial glial scaffolds; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0001702; P:gastrulation with mouth forming second; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0001947; P:heart looping; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0060596; P:mammary placode formation; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0030901; P:midbrain development; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0030917; P:midbrain-hindbrain boundary development; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0045599; P:negative regulation of fat cell differentiation; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:2000151; P:negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:2000162; P:negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:2000168; P:negative regulation of planar cell polarity pathway involved in neural tube closure; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:2000164; P:negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:2000166; P:negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:2000149; P:negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0006469; P:negative regulation of protein kinase activity; IMP:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0001933; P:negative regulation of protein phosphorylation; IMP:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0071901; P:negative regulation of protein serine/threonine kinase activity; IDA:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0034392; P:negative regulation of smooth muscle cell apoptotic process; IMP:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0014033; P:neural crest cell differentiation; IDA:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0014029; P:neural crest formation; IDA:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0001843; P:neural tube closure; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0042475; P:odontogenesis of dentin-containing tooth; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0060021; P:palate development; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0003344; P:pericardium morphogenesis; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0045780; P:positive regulation of bone resorption; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0045787; P:positive regulation of cell cycle; IMP:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0045778; P:positive regulation of ossification; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:2000055; P:positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification; IDA:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0090009; P:primitive streak formation; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0090118; P:receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0060284; P:regulation of cell development; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0045598; P:regulation of fat cell differentiation; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0030278; P:regulation of ossification; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0051593; P:response to folic acid; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0043434; P:response to peptide hormone; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0007268; P:synaptic transmission; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0021794; P:thalamus development; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:1901998; P:toxin transport; IMP:GOC
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0060535; P:trachea cartilage morphogenesis; IBA:RefGenome
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0016055; P:Wnt signaling pathway; IMP:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0044332; P:Wnt signaling pathway involved in dorsal/ventral axis specification; IDA:BHF-UCL
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0021874; P:Wnt signaling pathway involved in forebrain neuroblast division; IEA:Ensembl
O75581	LRP6	Low-density lipoprotein receptor-related protein 6	GO:0090244; P:Wnt signaling pathway involved in somitogenesis; IBA:RefGenome
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0034185; F:apolipoprotein binding; IC:BHF-UCL
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0005509; F:calcium ion binding; IEA:InterPro
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0008035; F:high-density lipoprotein particle binding; IEA:Ensembl
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0005515; F:protein binding; IPI:IntAct
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0038025; F:reelin receptor activity; ISS:BHF-UCL
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0030229; F:very-low-density lipoprotein particle receptor activity; IDA:BHF-UCL
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0021541; P:ammon gyrus development; ISS:BHF-UCL
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0007596; P:blood coagulation; TAS:Reactome
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0071397; P:cellular response to cholesterol; IEA:Ensembl
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0019221; P:cytokine-mediated signaling pathway; NAS:UniProtKB
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0006897; P:endocytosis; IDA:UniProtKB
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0021819; P:layer formation in cerebral cortex; IEA:Ensembl
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0006629; P:lipid metabolic process; NAS:UniProtKB
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0007603; P:phototransduction, visible light; TAS:Reactome
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0032793; P:positive regulation of CREB transcription factor activity; ISS:BHF-UCL
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:1900006; P:positive regulation of dendrite development; ISS:BHF-UCL
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0061003; P:positive regulation of dendritic spine morphogenesis; ISS:BHF-UCL
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISS:BHF-UCL
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0061098; P:positive regulation of protein tyrosine kinase activity; ISS:BHF-UCL
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0006508; P:proteolysis; NAS:UniProtKB
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0006898; P:receptor-mediated endocytosis; IDA:GOC
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0038026; P:reelin-mediated signaling pathway; ISS:BHF-UCL
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0050804; P:regulation of synaptic transmission; ISS:BHF-UCL
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0042493; P:response to drug; IEA:Ensembl
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0001523; P:retinoid metabolic process; TAS:Reactome
Q14114	LRP8	Low-density lipoprotein receptor-related protein 8	GO:0007165; P:signal transduction; TAS:ProtInc
Q9BY71	LRRC3	Leucine-rich repeat-containing protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q9HBW1	LRRC4	Leucine-rich repeat-containing protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q96NW7	LRRC7	Leucine-rich repeat-containing protein 7	GO:0005515; F:protein binding; IPI:IntAct
A4D1F6	LRRD1	Leucine-rich repeat and death domain-containing protein 1	GO:0007165; P:signal transduction; IEA:InterPro
Q32MZ4	LRRFIP1	Leucine-rich repeat flightless-interacting protein 1	GO:0003677; F:DNA binding; IDA:UniProtKB
Q32MZ4	LRRFIP1	Leucine-rich repeat flightless-interacting protein 1	GO:0003725; F:double-stranded RNA binding; TAS:ProtInc
Q32MZ4	LRRFIP1	Leucine-rich repeat flightless-interacting protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q32MZ4	LRRFIP1	Leucine-rich repeat flightless-interacting protein 1	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q32MZ4	LRRFIP1	Leucine-rich repeat flightless-interacting protein 1	GO:0045087; P:innate immune response; TAS:Reactome
Q32MZ4	LRRFIP1	Leucine-rich repeat flightless-interacting protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB
Q32MZ4	LRRFIP1	Leucine-rich repeat flightless-interacting protein 1	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q32MZ4	LRRFIP1	Leucine-rich repeat flightless-interacting protein 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q32MZ4	LRRFIP1	Leucine-rich repeat flightless-interacting protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q38SD2	LRRK1	Leucine-rich repeat serine/threonine-protein kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q38SD2	LRRK1	Leucine-rich repeat serine/threonine-protein kinase 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q38SD2	LRRK1	Leucine-rich repeat serine/threonine-protein kinase 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q38SD2	LRRK1	Leucine-rich repeat serine/threonine-protein kinase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q38SD2	LRRK1	Leucine-rich repeat serine/threonine-protein kinase 1	GO:0005515; F:protein binding; IPI:IntAct
Q38SD2	LRRK1	Leucine-rich repeat serine/threonine-protein kinase 1	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q38SD2	LRRK1	Leucine-rich repeat serine/threonine-protein kinase 1	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9Y608	LRRFIP2	Leucine-rich repeat flightless-interacting protein 2	GO:0030275; F:LRR domain binding; IPI:UniProtKB
Q9Y608	LRRFIP2	Leucine-rich repeat flightless-interacting protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q9Y608	LRRFIP2	Leucine-rich repeat flightless-interacting protein 2	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0005525; F:GTP binding; IDA:UniProtKB
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0034211; F:GTP-dependent protein kinase activity; IMP:UniProtKB
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0005096; F:GTPase activator activity; IDA:UniProtKB
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0003924; F:GTPase activity; IDA:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0042802; F:identical protein binding; IPI:IntAct
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0044325; F:ion channel binding; IPI:UniProtKB
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0004708; F:MAP kinase kinase activity; IDA:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0051018; F:protein kinase A binding; IPI:ParkinsonsUK-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0017048; F:Rho GTPase binding; IPI:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0015631; F:tubulin binding; IDA:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0000187; P:activation of MAPK activity; IDA:GOC
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0000186; P:activation of MAPKK activity; IDA:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0008340; P:determination of adult lifespan; IMP:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0035640; P:exploration behavior; IMP:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0006184; P:GTP catabolic process; IDA:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0048312; P:intracellular distribution of mitochondria; IMP:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0000165; P:MAPK cascade; IDA:UniProtKB
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0034260; P:negative regulation of GTPase activity; IDA:MGI
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:1902823; P:negative regulation of late endosome to lysosome transport; TAS:ParkinsonsUK-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0032091; P:negative regulation of protein binding; IMP:ParkinsonsUK-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0007528; P:neuromuscular junction development; IMP:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0070997; P:neuron death; IMP:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0021772; P:olfactory bulb development; IMP:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0018107; P:peptidyl-threonine phosphorylation; IDA:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0010508; P:positive regulation of autophagy; IMP:UniProtKB
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0060161; P:positive regulation of dopamine receptor signaling pathway; IMP:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0043547; P:positive regulation of GTPase activity; IDA:GOC
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0043068; P:positive regulation of programmed cell death; IDA:UniProtKB
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; ISS:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0001934; P:positive regulation of protein phosphorylation; IMP:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:2000172; P:regulation of branching morphogenesis of a nerve; IMP:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0061001; P:regulation of dendritic spine morphogenesis; IMP:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0035564; P:regulation of kidney size; ISS:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0040012; P:regulation of locomotion; IMP:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0042391; P:regulation of membrane potential; IMP:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0051900; P:regulation of mitochondrial depolarization; IMP:ParkinsonsUK-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:1902692; P:regulation of neuroblast proliferation; IMP:ParkinsonsUK-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:1901214; P:regulation of neuron death; IMP:ParkinsonsUK-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0014041; P:regulation of neuron maturation; IMP:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:2000300; P:regulation of synaptic vesicle exocytosis; IMP:ParkinsonsUK-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0006979; P:response to oxidative stress; IMP:BHF-UCL
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q5S007	LRRK2	Leucine-rich repeat serine/threonine-protein kinase 2	GO:0022028; P:tangential migration from the subventricular zone to the olfactory bulb; IMP:BHF-UCL
O75325	LRRN2	Leucine-rich repeat neuronal protein 2	GO:0004872; F:receptor activity; TAS:ProtInc
O75325	LRRN2	Leucine-rich repeat neuronal protein 2	GO:0007155; P:cell adhesion; TAS:ProtInc
O75325	LRRN2	Leucine-rich repeat neuronal protein 2	GO:0007165; P:signal transduction; TAS:ProtInc
Q9H3W5	LRRN3	Leucine-rich repeat neuronal protein 3	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
Q8WUT4	LRRN4	Leucine-rich repeat neuronal protein 4	GO:0007616; P:long-term memory; IEA:Ensembl
Q8WUT4	LRRN4	Leucine-rich repeat neuronal protein 4	GO:0008542; P:visual learning; IEA:Ensembl
Q86UE6	LRRTM1	Leucine-rich repeat transmembrane neuronal protein 1	GO:0035640; P:exploration behavior; IEA:Ensembl
Q86UE6	LRRTM1	Leucine-rich repeat transmembrane neuronal protein 1	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q86UE6	LRRTM1	Leucine-rich repeat transmembrane neuronal protein 1	GO:0035418; P:protein localization to synapse; IEA:Ensembl
Q86UE6	LRRTM1	Leucine-rich repeat transmembrane neuronal protein 1	GO:0050808; P:synapse organization; IEA:Ensembl
O43300	LRRTM2	Leucine-rich repeat transmembrane neuronal protein 2	GO:0050808; P:synapse organization; IEA:Ensembl
Q86VH5	LRRTM3	Leucine-rich repeat transmembrane neuronal protein 3	GO:1902004; P:positive regulation of beta-amyloid formation; IMP:MGI
Q6UWE0	LRSAM1	E3 ubiquitin-protein ligase LRSAM1	GO:0005515; F:protein binding; IPI:UniProtKB
Q6UWE0	LRSAM1	E3 ubiquitin-protein ligase LRSAM1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q6UWE0	LRSAM1	E3 ubiquitin-protein ligase LRSAM1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6UWE0	LRSAM1	E3 ubiquitin-protein ligase LRSAM1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q6UWE0	LRSAM1	E3 ubiquitin-protein ligase LRSAM1	GO:0045806; P:negative regulation of endocytosis; IMP:UniProtKB
Q6UWE0	LRSAM1	E3 ubiquitin-protein ligase LRSAM1	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
Q6UWE0	LRSAM1	E3 ubiquitin-protein ligase LRSAM1	GO:0030163; P:protein catabolic process; IMP:UniProtKB
Q6UWE0	LRSAM1	E3 ubiquitin-protein ligase LRSAM1	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q6UWE0	LRSAM1	E3 ubiquitin-protein ligase LRSAM1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q6UWE0	LRSAM1	E3 ubiquitin-protein ligase LRSAM1	GO:0070086; P:ubiquitin-dependent endocytosis; IDA:UniProtKB
Q6UWE0	LRSAM1	E3 ubiquitin-protein ligase LRSAM1	GO:0046755; P:viral budding; IMP:UniProtKB
Q9UFC0	LRWD1	Leucine-rich repeat and WD repeat-containing protein 1	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q9UFC0	LRWD1	Leucine-rich repeat and WD repeat-containing protein 1	GO:0008327; F:methyl-CpG binding; IDA:UniProtKB
Q9UFC0	LRWD1	Leucine-rich repeat and WD repeat-containing protein 1	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q9UFC0	LRWD1	Leucine-rich repeat and WD repeat-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UFC0	LRWD1	Leucine-rich repeat and WD repeat-containing protein 1	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q9UFC0	LRWD1	Leucine-rich repeat and WD repeat-containing protein 1	GO:0006325; P:chromatin organization; IMP:UniProtKB
Q9UFC0	LRWD1	Leucine-rich repeat and WD repeat-containing protein 1	GO:0006270; P:DNA replication initiation; TAS:UniProtKB
Q9UFC0	LRWD1	Leucine-rich repeat and WD repeat-containing protein 1	GO:0071169; P:establishment of protein localization to chromatin; IDA:UniProtKB
Q8ND56	LSM14A	Protein LSM14 homolog A	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
Q8ND56	LSM14A	Protein LSM14 homolog A	GO:0003725; F:double-stranded RNA binding; IEA:Ensembl
Q8ND56	LSM14A	Protein LSM14 homolog A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8ND56	LSM14A	Protein LSM14 homolog A	GO:0003727; F:single-stranded RNA binding; IEA:Ensembl
Q8ND56	LSM14A	Protein LSM14 homolog A	GO:0033962; P:cytoplasmic mRNA processing body assembly; IDA:UniProtKB
Q8ND56	LSM14A	Protein LSM14 homolog A	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8ND56	LSM14A	Protein LSM14 homolog A	GO:0060340; P:positive regulation of type I interferon-mediated signaling pathway; IEA:Ensembl
Q8ND56	LSM14A	Protein LSM14 homolog A	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q8ND56	LSM14A	Protein LSM14 homolog A	GO:0039529; P:RIG-I signaling pathway; IEA:Ensembl
Q9BX40	LSM14B	Protein LSM14 homolog B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BX40	LSM14B	Protein LSM14 homolog B	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9BX40	LSM14B	Protein LSM14 homolog B	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q13449	LSAMP	Limbic system-associated membrane protein	GO:0005515; F:protein binding; IPI:IntAct
Q13449	LSAMP	Limbic system-associated membrane protein	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q13449	LSAMP	Limbic system-associated membrane protein	GO:0007399; P:nervous system development; TAS:ProtInc
Q9H089	LSG1	Large subunit GTPase 1 homolog	GO:0005525; F:GTP binding; IDA:UniProtKB
Q9H089	LSG1	Large subunit GTPase 1 homolog	GO:0003924; F:GTPase activity; IDA:UniProtKB
Q9H089	LSG1	Large subunit GTPase 1 homolog	GO:0006184; P:GTP catabolic process; IDA:GOC
Q9H089	LSG1	Large subunit GTPase 1 homolog	GO:0051168; P:nuclear export; IDA:UniProtKB
Q9H089	LSG1	Large subunit GTPase 1 homolog	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9H089	LSG1	Large subunit GTPase 1 homolog	GO:0042254; P:ribosome biogenesis; IBA:RefGenome
P01229	LHB	Lutropin subunit beta	GO:0005102; F:receptor binding; TAS:ProtInc
P01229	LHB	Lutropin subunit beta	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P01229	LHB	Lutropin subunit beta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P01229	LHB	Lutropin subunit beta	GO:0008584; P:male gonad development; TAS:ProtInc
P01229	LHB	Lutropin subunit beta	GO:0016486; P:peptide hormone processing; TAS:Reactome
P01229	LHB	Lutropin subunit beta	GO:0006701; P:progesterone biosynthetic process; TAS:BHF-UCL
P01229	LHB	Lutropin subunit beta	GO:0007165; P:signal transduction; TAS:ProtInc
P22888	LHCGR	Lutropin-choriogonadotropic hormone receptor	GO:0038106; F:choriogonadotropin hormone binding; ISS:BHF-UCL
P22888	LHCGR	Lutropin-choriogonadotropic hormone receptor	GO:0035472; F:choriogonadotropin hormone receptor activity; ISS:BHF-UCL
P22888	LHCGR	Lutropin-choriogonadotropic hormone receptor	GO:0004964; F:luteinizing hormone receptor activity; IEA:InterPro
P22888	LHCGR	Lutropin-choriogonadotropic hormone receptor	GO:0007190; P:activation of adenylate cyclase activity; ISS:BHF-UCL
P22888	LHCGR	Lutropin-choriogonadotropic hormone receptor	GO:0071371; P:cellular response to gonadotropin stimulus; ISS:BHF-UCL
P22888	LHCGR	Lutropin-choriogonadotropic hormone receptor	GO:0046544; P:development of secondary male sexual characteristics; IEA:Ensembl
P22888	LHCGR	Lutropin-choriogonadotropic hormone receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P22888	LHCGR	Lutropin-choriogonadotropic hormone receptor	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P22888	LHCGR	Lutropin-choriogonadotropic hormone receptor	GO:0030539; P:male genitalia development; TAS:ProtInc
P22888	LHCGR	Lutropin-choriogonadotropic hormone receptor	GO:0008584; P:male gonad development; TAS:ProtInc
P22888	LHCGR	Lutropin-choriogonadotropic hormone receptor	GO:0001541; P:ovarian follicle development; IEA:Ensembl
P22888	LHCGR	Lutropin-choriogonadotropic hormone receptor	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; ISS:BHF-UCL
P22888	LHCGR	Lutropin-choriogonadotropic hormone receptor	GO:0043950; P:positive regulation of cAMP-mediated signaling; ISS:BHF-UCL
P22888	LHCGR	Lutropin-choriogonadotropic hormone receptor	GO:0032962; P:positive regulation of inositol trisphosphate biosynthetic process; ISS:BHF-UCL
P22888	LHCGR	Lutropin-choriogonadotropic hormone receptor	GO:0090030; P:regulation of steroid hormone biosynthetic process; IEA:Ensembl
P22888	LHCGR	Lutropin-choriogonadotropic hormone receptor	GO:0072520; P:seminiferous tubule development; IEA:Ensembl
P22888	LHCGR	Lutropin-choriogonadotropic hormone receptor	GO:0007283; P:spermatogenesis; IEA:Ensembl
P22888	LHCGR	Lutropin-choriogonadotropic hormone receptor	GO:0060065; P:uterus development; IEA:Ensembl
P83369	LSM11	U7 snRNA-associated Sm-like protein LSm11	GO:0005515; F:protein binding; IPI:UniProtKB
P83369	LSM11	U7 snRNA-associated Sm-like protein LSm11	GO:0071209; F:U7 snRNA binding; IDA:UniProtKB
P83369	LSM11	U7 snRNA-associated Sm-like protein LSm11	GO:0010467; P:gene expression; TAS:Reactome
P83369	LSM11	U7 snRNA-associated Sm-like protein LSm11	GO:0006398; P:histone mRNA 3'-end processing; ISS:UniProtKB
P83369	LSM11	U7 snRNA-associated Sm-like protein LSm11	GO:0008334; P:histone mRNA metabolic process; TAS:Reactome
P83369	LSM11	U7 snRNA-associated Sm-like protein LSm11	GO:0000084; P:mitotic S phase; IMP:UniProtKB
P83369	LSM11	U7 snRNA-associated Sm-like protein LSm11	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
P83369	LSM11	U7 snRNA-associated Sm-like protein LSm11	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
P83369	LSM11	U7 snRNA-associated Sm-like protein LSm11	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q969L4	LSM10	U7 snRNA-associated Sm-like protein LSm10	GO:0071208; F:histone pre-mRNA DCP binding; ISS:UniProtKB
Q969L4	LSM10	U7 snRNA-associated Sm-like protein LSm10	GO:0005515; F:protein binding; IPI:UniProtKB
Q969L4	LSM10	U7 snRNA-associated Sm-like protein LSm10	GO:0010467; P:gene expression; TAS:Reactome
Q969L4	LSM10	U7 snRNA-associated Sm-like protein LSm10	GO:0008334; P:histone mRNA metabolic process; TAS:Reactome
Q969L4	LSM10	U7 snRNA-associated Sm-like protein LSm10	GO:0000084; P:mitotic S phase; IMP:UniProtKB
Q969L4	LSM10	U7 snRNA-associated Sm-like protein LSm10	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q969L4	LSM10	U7 snRNA-associated Sm-like protein LSm10	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q969L4	LSM10	U7 snRNA-associated Sm-like protein LSm10	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q969L4	LSM10	U7 snRNA-associated Sm-like protein LSm10	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q9Y333	LSM2	U6 snRNA-associated Sm-like protein LSm2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y333	LSM2	U6 snRNA-associated Sm-like protein LSm2	GO:0005515; F:protein binding; IPI:IntAct
Q9Y333	LSM2	U6 snRNA-associated Sm-like protein LSm2	GO:0017070; F:U6 snRNA binding; NAS:UniProtKB
Q9Y333	LSM2	U6 snRNA-associated Sm-like protein LSm2	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
Q9Y333	LSM2	U6 snRNA-associated Sm-like protein LSm2	GO:0010467; P:gene expression; TAS:Reactome
Q9Y333	LSM2	U6 snRNA-associated Sm-like protein LSm2	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9Y333	LSM2	U6 snRNA-associated Sm-like protein LSm2	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q9Y333	LSM2	U6 snRNA-associated Sm-like protein LSm2	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q9Y333	LSM2	U6 snRNA-associated Sm-like protein LSm2	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9Y333	LSM2	U6 snRNA-associated Sm-like protein LSm2	GO:0008380; P:RNA splicing; TAS:Reactome
P62310	LSM3	U6 snRNA-associated Sm-like protein LSm3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62310	LSM3	U6 snRNA-associated Sm-like protein LSm3	GO:0005515; F:protein binding; IPI:IntAct
P62310	LSM3	U6 snRNA-associated Sm-like protein LSm3	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
P62310	LSM3	U6 snRNA-associated Sm-like protein LSm3	GO:0010467; P:gene expression; TAS:Reactome
P62310	LSM3	U6 snRNA-associated Sm-like protein LSm3	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62310	LSM3	U6 snRNA-associated Sm-like protein LSm3	GO:0006397; P:mRNA processing; TAS:UniProtKB
P62310	LSM3	U6 snRNA-associated Sm-like protein LSm3	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P62310	LSM3	U6 snRNA-associated Sm-like protein LSm3	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
P62310	LSM3	U6 snRNA-associated Sm-like protein LSm3	GO:0016070; P:RNA metabolic process; TAS:Reactome
O15116	LSM1	U6 snRNA-associated Sm-like protein LSm1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O15116	LSM1	U6 snRNA-associated Sm-like protein LSm1	GO:0005515; F:protein binding; IPI:UniProtKB
O15116	LSM1	U6 snRNA-associated Sm-like protein LSm1	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
O15116	LSM1	U6 snRNA-associated Sm-like protein LSm1	GO:0010467; P:gene expression; TAS:Reactome
O15116	LSM1	U6 snRNA-associated Sm-like protein LSm1	GO:0071044; P:histone mRNA catabolic process; IMP:UniProtKB
O15116	LSM1	U6 snRNA-associated Sm-like protein LSm1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
O15116	LSM1	U6 snRNA-associated Sm-like protein LSm1	GO:0006397; P:mRNA processing; TAS:ProtInc
O15116	LSM1	U6 snRNA-associated Sm-like protein LSm1	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
O15116	LSM1	U6 snRNA-associated Sm-like protein LSm1	GO:0016070; P:RNA metabolic process; TAS:Reactome
O15116	LSM1	U6 snRNA-associated Sm-like protein LSm1	GO:0008380; P:RNA splicing; TAS:ProtInc
O15116	LSM1	U6 snRNA-associated Sm-like protein LSm1	GO:0000375; P:RNA splicing, via transesterification reactions; TAS:UniProtKB
Q9Y4Z0	LSM4	U6 snRNA-associated Sm-like protein LSm4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y4Z0	LSM4	U6 snRNA-associated Sm-like protein LSm4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y4Z0	LSM4	U6 snRNA-associated Sm-like protein LSm4	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
Q9Y4Z0	LSM4	U6 snRNA-associated Sm-like protein LSm4	GO:0010467; P:gene expression; TAS:Reactome
Q9Y4Z0	LSM4	U6 snRNA-associated Sm-like protein LSm4	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9Y4Z0	LSM4	U6 snRNA-associated Sm-like protein LSm4	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9Y4Z0	LSM4	U6 snRNA-associated Sm-like protein LSm4	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q9Y4Z0	LSM4	U6 snRNA-associated Sm-like protein LSm4	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9Y4Z0	LSM4	U6 snRNA-associated Sm-like protein LSm4	GO:0008380; P:RNA splicing; TAS:ProtInc
Q9Y4Y9	LSM5	U6 snRNA-associated Sm-like protein LSm5	GO:0005515; F:protein binding; IPI:IntAct
Q9Y4Y9	LSM5	U6 snRNA-associated Sm-like protein LSm5	GO:0003723; F:RNA binding; TAS:ProtInc
Q9Y4Y9	LSM5	U6 snRNA-associated Sm-like protein LSm5	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
Q9Y4Y9	LSM5	U6 snRNA-associated Sm-like protein LSm5	GO:0010467; P:gene expression; TAS:Reactome
Q9Y4Y9	LSM5	U6 snRNA-associated Sm-like protein LSm5	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9Y4Y9	LSM5	U6 snRNA-associated Sm-like protein LSm5	GO:0006397; P:mRNA processing; TAS:ProtInc
Q9Y4Y9	LSM5	U6 snRNA-associated Sm-like protein LSm5	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q9Y4Y9	LSM5	U6 snRNA-associated Sm-like protein LSm5	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9Y4Y9	LSM5	U6 snRNA-associated Sm-like protein LSm5	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
P62312	LSM6	U6 snRNA-associated Sm-like protein LSm6	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62312	LSM6	U6 snRNA-associated Sm-like protein LSm6	GO:0005515; F:protein binding; IPI:IntAct
P62312	LSM6	U6 snRNA-associated Sm-like protein LSm6	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
P62312	LSM6	U6 snRNA-associated Sm-like protein LSm6	GO:0010467; P:gene expression; TAS:Reactome
P62312	LSM6	U6 snRNA-associated Sm-like protein LSm6	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62312	LSM6	U6 snRNA-associated Sm-like protein LSm6	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
P62312	LSM6	U6 snRNA-associated Sm-like protein LSm6	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
P62312	LSM6	U6 snRNA-associated Sm-like protein LSm6	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62312	LSM6	U6 snRNA-associated Sm-like protein LSm6	GO:0008380; P:RNA splicing; TAS:UniProtKB
P62312	LSM6	U6 snRNA-associated Sm-like protein LSm6	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
P62312	LSM6	U6 snRNA-associated Sm-like protein LSm6	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q9UK45	LSM7	U6 snRNA-associated Sm-like protein LSm7	GO:0005515; F:protein binding; IPI:IntAct
Q9UK45	LSM7	U6 snRNA-associated Sm-like protein LSm7	GO:0017070; F:U6 snRNA binding; NAS:UniProtKB
Q9UK45	LSM7	U6 snRNA-associated Sm-like protein LSm7	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
Q9UK45	LSM7	U6 snRNA-associated Sm-like protein LSm7	GO:0010467; P:gene expression; TAS:Reactome
Q9UK45	LSM7	U6 snRNA-associated Sm-like protein LSm7	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9UK45	LSM7	U6 snRNA-associated Sm-like protein LSm7	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9UK45	LSM7	U6 snRNA-associated Sm-like protein LSm7	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q9UK45	LSM7	U6 snRNA-associated Sm-like protein LSm7	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9UK45	LSM7	U6 snRNA-associated Sm-like protein LSm7	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
O95777	LSM8	U6 snRNA-associated Sm-like protein LSm8	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O95777	LSM8	U6 snRNA-associated Sm-like protein LSm8	GO:0005515; F:protein binding; IPI:IntAct
O95777	LSM8	U6 snRNA-associated Sm-like protein LSm8	GO:0017070; F:U6 snRNA binding; NAS:UniProtKB
O95777	LSM8	U6 snRNA-associated Sm-like protein LSm8	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
O95777	LSM8	U6 snRNA-associated Sm-like protein LSm8	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q9BRA0	NAA38	N-alpha-acetyltransferase 38, NatC auxiliary subunit	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P33241	LSP1	Lymphocyte-specific protein 1	GO:0003779; F:actin binding; TAS:ProtInc
P33241	LSP1	Lymphocyte-specific protein 1	GO:0004871; F:signal transducer activity; IEA:InterPro
P33241	LSP1	Lymphocyte-specific protein 1	GO:0006928; P:cellular component movement; TAS:ProtInc
P33241	LSP1	Lymphocyte-specific protein 1	GO:0006968; P:cellular defense response; TAS:ProtInc
Q86X29	LSR	Lipolysis-stimulated lipoprotein receptor	GO:0009790; P:embryo development; ISS:HGNC
Q86X29	LSR	Lipolysis-stimulated lipoprotein receptor	GO:0001889; P:liver development; ISS:HGNC
Q86X29	LSR	Lipolysis-stimulated lipoprotein receptor	GO:0019216; P:regulation of lipid metabolic process; IEA:Ensembl
O00453	LST1	Leukocyte-specific transcript 1 protein	GO:0009653; P:anatomical structure morphogenesis; NAS:UniProtKB
O00453	LST1	Leukocyte-specific transcript 1 protein	GO:0000902; P:cell morphogenesis; IEA:InterPro
O00453	LST1	Leukocyte-specific transcript 1 protein	GO:0016358; P:dendrite development; IDA:UniProtKB
O00453	LST1	Leukocyte-specific transcript 1 protein	GO:0006955; P:immune response; NAS:UniProtKB
O00453	LST1	Leukocyte-specific transcript 1 protein	GO:0050672; P:negative regulation of lymphocyte proliferation; IDA:UniProtKB
O00453	LST1	Leukocyte-specific transcript 1 protein	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
Q9HCC9	ZFYVE28	Lateral signaling target protein 2 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HCC9	ZFYVE28	Lateral signaling target protein 2 homolog	GO:0032266; F:phosphatidylinositol-3-phosphate binding; IDA:UniProtKB
Q9HCC9	ZFYVE28	Lateral signaling target protein 2 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HCC9	ZFYVE28	Lateral signaling target protein 2 homolog	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; IMP:UniProtKB
Q9HCC9	ZFYVE28	Lateral signaling target protein 2 homolog	GO:0007175; P:negative regulation of epidermal growth factor-activated receptor activity; IMP:UniProtKB
Q9BVC4	MLST8	Target of rapamycin complex subunit LST8	GO:0005515; F:protein binding; IPI:IntAct
Q9BVC4	MLST8	Target of rapamycin complex subunit LST8	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q9BVC4	MLST8	Target of rapamycin complex subunit LST8	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9BVC4	MLST8	Target of rapamycin complex subunit LST8	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q9BVC4	MLST8	Target of rapamycin complex subunit LST8	GO:0045087; P:innate immune response; TAS:Reactome
Q9BVC4	MLST8	Target of rapamycin complex subunit LST8	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q9BVC4	MLST8	Target of rapamycin complex subunit LST8	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9BVC4	MLST8	Target of rapamycin complex subunit LST8	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q9BVC4	MLST8	Target of rapamycin complex subunit LST8	GO:0030838; P:positive regulation of actin filament polymerization; IEA:Ensembl
Q9BVC4	MLST8	Target of rapamycin complex subunit LST8	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
Q9BVC4	MLST8	Target of rapamycin complex subunit LST8	GO:0032008; P:positive regulation of TOR signaling; IMP:UniProtKB
Q9BVC4	MLST8	Target of rapamycin complex subunit LST8	GO:0032956; P:regulation of actin cytoskeleton organization; IMP:UniProtKB
Q9BVC4	MLST8	Target of rapamycin complex subunit LST8	GO:0032314; P:regulation of Rac GTPase activity; IEA:Ensembl
Q9BVC4	MLST8	Target of rapamycin complex subunit LST8	GO:0031295; P:T cell costimulation; TAS:Reactome
Q15722	LTB4R	Leukotriene B4 receptor 1	GO:0001632; F:leukotriene B4 receptor activity; IEA:Ensembl
Q15722	LTB4R	Leukotriene B4 receptor 1	GO:0004974; F:leukotriene receptor activity; TAS:ProtInc
Q15722	LTB4R	Leukotriene B4 receptor 1	GO:0000166; F:nucleotide binding; TAS:ProtInc
Q15722	LTB4R	Leukotriene B4 receptor 1	GO:0006928; P:cellular component movement; TAS:ProtInc
Q15722	LTB4R	Leukotriene B4 receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q15722	LTB4R	Leukotriene B4 receptor 1	GO:0006955; P:immune response; TAS:ProtInc
Q15722	LTB4R	Leukotriene B4 receptor 1	GO:0006954; P:inflammatory response; TAS:ProtInc
Q15722	LTB4R	Leukotriene B4 receptor 1	GO:0006936; P:muscle contraction; TAS:ProtInc
Q15722	LTB4R	Leukotriene B4 receptor 1	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; TAS:ProtInc
Q9NPC1	LTB4R2	Leukotriene B4 receptor 2	GO:0004974; F:leukotriene receptor activity; TAS:ProtInc
Q9NPC1	LTB4R2	Leukotriene B4 receptor 2	GO:0006935; P:chemotaxis; TAS:ProtInc
Q9NPC1	LTB4R2	Leukotriene B4 receptor 2	GO:0007194; P:negative regulation of adenylate cyclase activity; TAS:ProtInc
Q14766	LTBP1	Latent-transforming growth factor beta-binding protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q14766	LTBP1	Latent-transforming growth factor beta-binding protein 1	GO:0005515; F:protein binding; IPI:BHF-UCL
Q14766	LTBP1	Latent-transforming growth factor beta-binding protein 1	GO:0050431; F:transforming growth factor beta binding; IPI:UniProt
Q14766	LTBP1	Latent-transforming growth factor beta-binding protein 1	GO:0005024; F:transforming growth factor beta-activated receptor activity; NAS:UniProtKB
Q14766	LTBP1	Latent-transforming growth factor beta-binding protein 1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q14766	LTBP1	Latent-transforming growth factor beta-binding protein 1	GO:0035583; P:sequestering of TGFbeta in extracellular matrix; TAS:BHF-UCL
Q14766	LTBP1	Latent-transforming growth factor beta-binding protein 1	GO:0007178; P:transmembrane receptor protein serine/threonine kinase signaling pathway; NAS:GOC
Q14767	LTBP2	Latent-transforming growth factor beta-binding protein 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q14767	LTBP2	Latent-transforming growth factor beta-binding protein 2	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
Q14767	LTBP2	Latent-transforming growth factor beta-binding protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q14767	LTBP2	Latent-transforming growth factor beta-binding protein 2	GO:0009306; P:protein secretion; TAS:ProtInc
Q14767	LTBP2	Latent-transforming growth factor beta-binding protein 2	GO:0006605; P:protein targeting; TAS:ProtInc
Q14767	LTBP2	Latent-transforming growth factor beta-binding protein 2	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:ProtInc
Q9NS15	LTBP3	Latent-transforming growth factor beta-binding protein 3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NS15	LTBP3	Latent-transforming growth factor beta-binding protein 3	GO:0050431; F:transforming growth factor beta binding; IPI:UniProt
Q9NS15	LTBP3	Latent-transforming growth factor beta-binding protein 3	GO:0060349; P:bone morphogenesis; IEA:Ensembl
Q9NS15	LTBP3	Latent-transforming growth factor beta-binding protein 3	GO:0046849; P:bone remodeling; IEA:Ensembl
Q9NS15	LTBP3	Latent-transforming growth factor beta-binding protein 3	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q9NS15	LTBP3	Latent-transforming growth factor beta-binding protein 3	GO:0060430; P:lung saccule development; IEA:Ensembl
Q9NS15	LTBP3	Latent-transforming growth factor beta-binding protein 3	GO:0030502; P:negative regulation of bone mineralization; IEA:Ensembl
Q9NS15	LTBP3	Latent-transforming growth factor beta-binding protein 3	GO:0032331; P:negative regulation of chondrocyte differentiation; IEA:Ensembl
Q9NS15	LTBP3	Latent-transforming growth factor beta-binding protein 3	GO:0045780; P:positive regulation of bone resorption; IEA:Ensembl
Q9NS15	LTBP3	Latent-transforming growth factor beta-binding protein 3	GO:2000741; P:positive regulation of mesenchymal stem cell differentiation; IMP:UniProt
Q9NS15	LTBP3	Latent-transforming growth factor beta-binding protein 3	GO:1902462; P:positive regulation of mesenchymal stem cell proliferation; IMP:UniProt
Q9NS15	LTBP3	Latent-transforming growth factor beta-binding protein 3	GO:0036363; P:transforming growth factor beta activation; IMP:UniProt
Q9NS15	LTBP3	Latent-transforming growth factor beta-binding protein 3	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl
Q8N2S1	LTBP4	Latent-transforming growth factor beta-binding protein 4	GO:0005509; F:calcium ion binding; NAS:UniProtKB
Q8N2S1	LTBP4	Latent-transforming growth factor beta-binding protein 4	GO:0005539; F:glycosaminoglycan binding; NAS:UniProtKB
Q8N2S1	LTBP4	Latent-transforming growth factor beta-binding protein 4	GO:0005178; F:integrin binding; NAS:UniProtKB
Q8N2S1	LTBP4	Latent-transforming growth factor beta-binding protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q8N2S1	LTBP4	Latent-transforming growth factor beta-binding protein 4	GO:0050431; F:transforming growth factor beta binding; IDA:UniProtKB
Q8N2S1	LTBP4	Latent-transforming growth factor beta-binding protein 4	GO:0005024; F:transforming growth factor beta-activated receptor activity; NAS:UniProtKB
Q8N2S1	LTBP4	Latent-transforming growth factor beta-binding protein 4	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q8N2S1	LTBP4	Latent-transforming growth factor beta-binding protein 4	GO:0030252; P:growth hormone secretion; TAS:UniProtKB
Q8N2S1	LTBP4	Latent-transforming growth factor beta-binding protein 4	GO:0007275; P:multicellular organismal development; TAS:UniProtKB
Q8N2S1	LTBP4	Latent-transforming growth factor beta-binding protein 4	GO:0006457; P:protein folding; TAS:UniProtKB
Q8N2S1	LTBP4	Latent-transforming growth factor beta-binding protein 4	GO:0045595; P:regulation of cell differentiation; TAS:UniProtKB
Q8N2S1	LTBP4	Latent-transforming growth factor beta-binding protein 4	GO:0001558; P:regulation of cell growth; TAS:UniProtKB
Q8N2S1	LTBP4	Latent-transforming growth factor beta-binding protein 4	GO:0030162; P:regulation of proteolysis; IDA:UniProtKB
Q8N2S1	LTBP4	Latent-transforming growth factor beta-binding protein 4	GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; TAS:UniProtKB
Q8N2S1	LTBP4	Latent-transforming growth factor beta-binding protein 4	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl
Q16873	LTC4S	Leukotriene C4 synthase	GO:0008047; F:enzyme activator activity; IEA:InterPro
Q16873	LTC4S	Leukotriene C4 synthase	GO:0004602; F:glutathione peroxidase activity; IBA:RefGenome
Q16873	LTC4S	Leukotriene C4 synthase	GO:0004364; F:glutathione transferase activity; IBA:RefGenome
Q16873	LTC4S	Leukotriene C4 synthase	GO:0004464; F:leukotriene-C4 synthase activity; IDA:MGI
Q16873	LTC4S	Leukotriene C4 synthase	GO:0008289; F:lipid binding; IDA:MGI
Q16873	LTC4S	Leukotriene C4 synthase	GO:0005515; F:protein binding; IPI:UniProtKB
Q16873	LTC4S	Leukotriene C4 synthase	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
Q16873	LTC4S	Leukotriene C4 synthase	GO:0019370; P:leukotriene biosynthetic process; IBA:RefGenome
Q16873	LTC4S	Leukotriene C4 synthase	GO:0006691; P:leukotriene metabolic process; IDA:MGI
Q16873	LTC4S	Leukotriene C4 synthase	GO:2001300; P:lipoxin metabolic process; TAS:Reactome
Q16873	LTC4S	Leukotriene C4 synthase	GO:0019372; P:lipoxygenase pathway; TAS:Reactome
Q16873	LTC4S	Leukotriene C4 synthase	GO:0055114; P:oxidation-reduction process; IBA:GOC
Q16873	LTC4S	Leukotriene C4 synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6P1Q0	LETMD1	LETM1 domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
P29376	LTK	Leukocyte tyrosine kinase receptor	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P29376	LTK	Leukocyte tyrosine kinase receptor	GO:0004672; F:protein kinase activity; IDA:UniProtKB
P29376	LTK	Leukocyte tyrosine kinase receptor	GO:0004713; F:protein tyrosine kinase activity; TAS:ProtInc
P29376	LTK	Leukocyte tyrosine kinase receptor	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; TAS:ProtInc
P29376	LTK	Leukocyte tyrosine kinase receptor	GO:0008283; P:cell proliferation; IDA:UniProtKB
P29376	LTK	Leukocyte tyrosine kinase receptor	GO:0071300; P:cellular response to retinoic acid; IMP:BHF-UCL
P29376	LTK	Leukocyte tyrosine kinase receptor	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P29376	LTK	Leukocyte tyrosine kinase receptor	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:GOC
P29376	LTK	Leukocyte tyrosine kinase receptor	GO:0014065; P:phosphatidylinositol 3-kinase signaling; IMP:UniProtKB
P29376	LTK	Leukocyte tyrosine kinase receptor	GO:0010666; P:positive regulation of cardiac muscle cell apoptotic process; IDA:UniProtKB
P29376	LTK	Leukocyte tyrosine kinase receptor	GO:0010976; P:positive regulation of neuron projection development; IMP:BHF-UCL
P29376	LTK	Leukocyte tyrosine kinase receptor	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P29376	LTK	Leukocyte tyrosine kinase receptor	GO:0007165; P:signal transduction; TAS:ProtInc
P29376	LTK	Leukocyte tyrosine kinase receptor	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:InterPro
O94822	LTN1	E3 ubiquitin-protein ligase listerin	GO:0005515; F:protein binding; IPI:IntAct
O94822	LTN1	E3 ubiquitin-protein ligase listerin	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
O94822	LTN1	E3 ubiquitin-protein ligase listerin	GO:0008270; F:zinc ion binding; IEA:InterPro
O94822	LTN1	E3 ubiquitin-protein ligase listerin	GO:0051865; P:protein autoubiquitination; IEA:Ensembl
Q9Y2Q5	LAMTOR2	Ragulator complex protein LAMTOR2	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2Q5	LAMTOR2	Ragulator complex protein LAMTOR2	GO:0000186; P:activation of MAPKK activity; IEA:Ensembl
Q9Y2Q5	LAMTOR2	Ragulator complex protein LAMTOR2	GO:0016049; P:cell growth; IMP:UniProtKB
Q9Y2Q5	LAMTOR2	Ragulator complex protein LAMTOR2	GO:0034613; P:cellular protein localization; IMP:UniProtKB
Q9Y2Q5	LAMTOR2	Ragulator complex protein LAMTOR2	GO:0071230; P:cellular response to amino acid stimulus; IMP:UniProtKB
Q9Y2Q5	LAMTOR2	Ragulator complex protein LAMTOR2	GO:0032008; P:positive regulation of TOR signaling; IMP:UniProtKB
Q9Y2Q5	LAMTOR2	Ragulator complex protein LAMTOR2	GO:0043087; P:regulation of GTPase activity; IDA:GOC
Q6IAA8	LAMTOR1	Ragulator complex protein LAMTOR1	GO:0005515; F:protein binding; IPI:UniProtKB
Q6IAA8	LAMTOR1	Ragulator complex protein LAMTOR1	GO:0016049; P:cell growth; IMP:UniProtKB
Q6IAA8	LAMTOR1	Ragulator complex protein LAMTOR1	GO:0034613; P:cellular protein localization; IMP:UniProtKB
Q6IAA8	LAMTOR1	Ragulator complex protein LAMTOR1	GO:0071230; P:cellular response to amino acid stimulus; IMP:UniProtKB
Q6IAA8	LAMTOR1	Ragulator complex protein LAMTOR1	GO:0042632; P:cholesterol homeostasis; IMP:UniProtKB
Q6IAA8	LAMTOR1	Ragulator complex protein LAMTOR1	GO:0032439; P:endosome localization; ISS:UniProtKB
Q6IAA8	LAMTOR1	Ragulator complex protein LAMTOR1	GO:0007032; P:endosome organization; ISS:UniProtKB
Q6IAA8	LAMTOR1	Ragulator complex protein LAMTOR1	GO:0032418; P:lysosome localization; ISS:UniProtKB
Q6IAA8	LAMTOR1	Ragulator complex protein LAMTOR1	GO:0007040; P:lysosome organization; ISS:UniProtKB
Q6IAA8	LAMTOR1	Ragulator complex protein LAMTOR1	GO:0043410; P:positive regulation of MAPK cascade; ISS:UniProtKB
Q6IAA8	LAMTOR1	Ragulator complex protein LAMTOR1	GO:0032008; P:positive regulation of TOR signaling; IMP:UniProtKB
Q6IAA8	LAMTOR1	Ragulator complex protein LAMTOR1	GO:0010874; P:regulation of cholesterol efflux; IMP:UniProtKB
Q6IAA8	LAMTOR1	Ragulator complex protein LAMTOR1	GO:0010872; P:regulation of cholesterol esterification; IMP:UniProtKB
Q6IAA8	LAMTOR1	Ragulator complex protein LAMTOR1	GO:0060620; P:regulation of cholesterol import; IMP:UniProtKB
Q6IAA8	LAMTOR1	Ragulator complex protein LAMTOR1	GO:0043087; P:regulation of GTPase activity; IDA:GOC
Q6IAA8	LAMTOR1	Ragulator complex protein LAMTOR1	GO:0001919; P:regulation of receptor recycling; ISS:UniProtKB
Q9UHA4	LAMTOR3	Ragulator complex protein LAMTOR3	GO:0005515; F:protein binding; IPI:IntAct
Q9UHA4	LAMTOR3	Ragulator complex protein LAMTOR3	GO:0034613; P:cellular protein localization; IMP:UniProtKB
Q9UHA4	LAMTOR3	Ragulator complex protein LAMTOR3	GO:0071230; P:cellular response to amino acid stimulus; IMP:UniProtKB
Q9UHA4	LAMTOR3	Ragulator complex protein LAMTOR3	GO:0032008; P:positive regulation of TOR signaling; IMP:UniProtKB
Q9UHA4	LAMTOR3	Ragulator complex protein LAMTOR3	GO:0043087; P:regulation of GTPase activity; IDA:GOC
O43504	LAMTOR5	Ragulator complex protein LAMTOR5	GO:0005515; F:protein binding; IPI:UniProtKB
O43504	LAMTOR5	Ragulator complex protein LAMTOR5	GO:0071230; P:cellular response to amino acid stimulus; IMP:UniProtKB
O43504	LAMTOR5	Ragulator complex protein LAMTOR5	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
O43504	LAMTOR5	Ragulator complex protein LAMTOR5	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
O43504	LAMTOR5	Ragulator complex protein LAMTOR5	GO:0032008; P:positive regulation of TOR signaling; IMP:UniProtKB
O43504	LAMTOR5	Ragulator complex protein LAMTOR5	GO:0061462; P:protein localization to lysosome; IMP:UniProtKB
O43504	LAMTOR5	Ragulator complex protein LAMTOR5	GO:0008361; P:regulation of cell size; IMP:UniProtKB
O43504	LAMTOR5	Ragulator complex protein LAMTOR5	GO:0043087; P:regulation of GTPase activity; IDA:GOC
O43504	LAMTOR5	Ragulator complex protein LAMTOR5	GO:0009615; P:response to virus; TAS:ProtInc
O43504	LAMTOR5	Ragulator complex protein LAMTOR5	GO:0019079; P:viral genome replication; TAS:ProtInc
Q0VGL1	LAMTOR4	Ragulator complex protein LAMTOR4	GO:0071230; P:cellular response to amino acid stimulus; IMP:UniProtKB
Q0VGL1	LAMTOR4	Ragulator complex protein LAMTOR4	GO:0032008; P:positive regulation of TOR signaling; IMP:UniProtKB
Q0VGL1	LAMTOR4	Ragulator complex protein LAMTOR4	GO:0061462; P:protein localization to lysosome; IMP:UniProtKB
Q0VGL1	LAMTOR4	Ragulator complex protein LAMTOR4	GO:0008361; P:regulation of cell size; IMP:UniProtKB
Q0VGL1	LAMTOR4	Ragulator complex protein LAMTOR4	GO:0043087; P:regulation of GTPase activity; IDA:GOC
Q9NQ29	LUC7L	Putative RNA-binding protein Luc7-like 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q9NQ29	LUC7L	Putative RNA-binding protein Luc7-like 1	GO:0003729; F:mRNA binding; IEA:InterPro
Q9NQ29	LUC7L	Putative RNA-binding protein Luc7-like 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NQ29	LUC7L	Putative RNA-binding protein Luc7-like 1	GO:0006376; P:mRNA splice site selection; IEA:InterPro
Q9NQ29	LUC7L	Putative RNA-binding protein Luc7-like 1	GO:0045843; P:negative regulation of striated muscle tissue development; IEA:Ensembl
P51884	LUM	Lumican	GO:0005518; F:collagen binding; IDA:UniProtKB
P51884	LUM	Lumican	GO:0005201; F:extracellular matrix structural constituent; NAS:UniProtKB
P51884	LUM	Lumican	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P51884	LUM	Lumican	GO:0051216; P:cartilage development; IEA:Ensembl
P51884	LUM	Lumican	GO:0030199; P:collagen fibril organization; NAS:UniProtKB
P51884	LUM	Lumican	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P51884	LUM	Lumican	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P51884	LUM	Lumican	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
P51884	LUM	Lumican	GO:0042340; P:keratan sulfate catabolic process; TAS:Reactome
P51884	LUM	Lumican	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
P51884	LUM	Lumican	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P51884	LUM	Lumican	GO:0070848; P:response to growth factor; IEA:Ensembl
P51884	LUM	Lumican	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P51884	LUM	Lumican	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P51884	LUM	Lumican	GO:0007601; P:visual perception; TAS:ProtInc
Q96LR2	LURAP1	Leucine rich adaptor protein 1	GO:0031032; P:actomyosin structure organization; IEA:Ensembl
Q96LR2	LURAP1	Leucine rich adaptor protein 1	GO:0016477; P:cell migration; IEA:Ensembl
Q96LR2	LURAP1	Leucine rich adaptor protein 1	GO:0001819; P:positive regulation of cytokine production; IDA:UniProtKB
Q96LR2	LURAP1	Leucine rich adaptor protein 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q86V48	LUZP1	Leucine zipper protein 1	GO:0060840; P:artery development; IEA:Ensembl
Q86V48	LUZP1	Leucine zipper protein 1	GO:0021503; P:neural fold bending; IEA:Ensembl
Q86V48	LUZP1	Leucine zipper protein 1	GO:0003281; P:ventricular septum development; IEA:Ensembl
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; IEA:UniProtKB-KW
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0003823; F:antigen binding; NAS:UniProtKB
DR   GO:0006956; P:complement activation; TAS:Reactome
DR   GO:0006958; P:complement activation, classical pathway; TAS:Reactome
DR   GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
DR   GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0045087; P:innate immune response; TAS:Reactome
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
O75342	ALOX12B	Arachidonate 12-lipoxygenase, 12R-type	GO:0004052; F:arachidonate 12-lipoxygenase activity; IMP:UniProtKB
O75342	ALOX12B	Arachidonate 12-lipoxygenase, 12R-type	GO:0005506; F:iron ion binding; IEA:InterPro
O75342	ALOX12B	Arachidonate 12-lipoxygenase, 12R-type	GO:1990136; F:linoleate 9S-lipoxygenase activity; ISS:UniProtKB
O75342	ALOX12B	Arachidonate 12-lipoxygenase, 12R-type	GO:0016702; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; IDA:UniProtKB
O75342	ALOX12B	Arachidonate 12-lipoxygenase, 12R-type	GO:0005515; F:protein binding; IPI:IntAct
O75342	ALOX12B	Arachidonate 12-lipoxygenase, 12R-type	GO:0019369; P:arachidonic acid metabolic process; IMP:UniProtKB
O75342	ALOX12B	Arachidonate 12-lipoxygenase, 12R-type	GO:0046513; P:ceramide biosynthetic process; ISS:UniProtKB
O75342	ALOX12B	Arachidonate 12-lipoxygenase, 12R-type	GO:0061436; P:establishment of skin barrier; ISS:UniProtKB
O75342	ALOX12B	Arachidonate 12-lipoxygenase, 12R-type	GO:0051122; P:hepoxilin biosynthetic process; ISS:UniProtKB
O75342	ALOX12B	Arachidonate 12-lipoxygenase, 12R-type	GO:0043651; P:linoleic acid metabolic process; ISS:UniProtKB
O75342	ALOX12B	Arachidonate 12-lipoxygenase, 12R-type	GO:0019372; P:lipoxygenase pathway; IDA:UniProtKB
O75342	ALOX12B	Arachidonate 12-lipoxygenase, 12R-type	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
O75342	ALOX12B	Arachidonate 12-lipoxygenase, 12R-type	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
O75342	ALOX12B	Arachidonate 12-lipoxygenase, 12R-type	GO:0043410; P:positive regulation of MAPK cascade; IDA:UniProtKB
O75342	ALOX12B	Arachidonate 12-lipoxygenase, 12R-type	GO:0070257; P:positive regulation of mucus secretion; IMP:UniProtKB
O75342	ALOX12B	Arachidonate 12-lipoxygenase, 12R-type	GO:0006497; P:protein lipidation; ISS:UniProtKB
O75342	ALOX12B	Arachidonate 12-lipoxygenase, 12R-type	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75342	ALOX12B	Arachidonate 12-lipoxygenase, 12R-type	GO:0006665; P:sphingolipid metabolic process; IDA:UniProtKB
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0050473; F:arachidonate 15-lipoxygenase activity; IDA:UniProtKB
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0036403; F:arachidonate 8(S)-lipoxygenase activity; IEA:Ensembl
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0005509; F:calcium ion binding; IDA:UniProtKB
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0005506; F:iron ion binding; IDA:UniProtKB
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0016165; F:linoleate 13S-lipoxygenase activity; IDA:UniProtKB
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0006915; P:apoptotic process; TAS:UniProtKB
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0019369; P:arachidonic acid metabolic process; IDA:UniProtKB
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0051122; P:hepoxilin biosynthetic process; ISS:UniProtKB
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0043651; P:linoleic acid metabolic process; IEA:Ensembl
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0006629; P:lipid metabolic process; TAS:UniProtKB
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0019372; P:lipoxygenase pathway; TAS:Reactome
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0045786; P:negative regulation of cell cycle; IDA:UniProtKB
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0030336; P:negative regulation of cell migration; TAS:UniProtKB
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0045926; P:negative regulation of growth; IDA:UniProtKB
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0090197; P:positive regulation of chemokine secretion; IMP:UniProtKB
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0045618; P:positive regulation of keratinocyte differentiation; IEA:Ensembl
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; IMP:UniProtKB
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0035360; P:positive regulation of peroxisome proliferator activated receptor signaling pathway; IEA:Ensembl
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0030850; P:prostate gland development; NAS:UniProtKB
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0030856; P:regulation of epithelial cell differentiation; NAS:UniProtKB
O15296	ALOX15B	Arachidonate 15-lipoxygenase B	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BS40	LXN	Latexin	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
Q9BS40	LXN	Latexin	GO:0008191; F:metalloendopeptidase inhibitor activity; IEA:UniProtKB-KW
Q9BS40	LXN	Latexin	GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; IEA:Ensembl
Q9BS40	LXN	Latexin	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q14210	LY6D	Lymphocyte antigen 6D	GO:0007155; P:cell adhesion; TAS:ProtInc
Q14210	LY6D	Lymphocyte antigen 6D	GO:0030098; P:lymphocyte differentiation; IEA:Ensembl
Q14210	LY6D	Lymphocyte antigen 6D	GO:0035634; P:response to stilbenoid; IEA:Ensembl
Q16553	LY6E	Lymphocyte antigen 6E	GO:0030325; P:adrenal gland development; IEA:Ensembl
Q16553	LY6E	Lymphocyte antigen 6E	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q16553	LY6E	Lymphocyte antigen 6E	GO:0048242; P:epinephrine secretion; IEA:Ensembl
Q16553	LY6E	Lymphocyte antigen 6E	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q16553	LY6E	Lymphocyte antigen 6E	GO:0042415; P:norepinephrine metabolic process; IEA:Ensembl
Q16553	LY6E	Lymphocyte antigen 6E	GO:0035265; P:organ growth; IEA:Ensembl
Q16553	LY6E	Lymphocyte antigen 6E	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IEA:Ensembl
O94772	LY6H	Lymphocyte antigen 6H	GO:0007399; P:nervous system development; TAS:ProtInc
O94772	LY6H	Lymphocyte antigen 6H	GO:0009887; P:organ morphogenesis; TAS:ProtInc
O60449	LY75	Lymphocyte antigen 75	GO:0030246; F:carbohydrate binding; IEA:InterPro
O60449	LY75	Lymphocyte antigen 75	GO:0004872; F:receptor activity; TAS:ProtInc
O60449	LY75	Lymphocyte antigen 75	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
O60449	LY75	Lymphocyte antigen 75	GO:0006955; P:immune response; TAS:ProtInc
O60449	LY75	Lymphocyte antigen 75	GO:0006954; P:inflammatory response; TAS:ProtInc
O95711	LY86	Lymphocyte antigen 86	GO:0006915; P:apoptotic process; TAS:ProtInc
O95711	LY86	Lymphocyte antigen 86	GO:0008283; P:cell proliferation; TAS:ProtInc
O95711	LY86	Lymphocyte antigen 86	GO:0006959; P:humoral immune response; TAS:ProtInc
O95711	LY86	Lymphocyte antigen 86	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
O95711	LY86	Lymphocyte antigen 86	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
O95711	LY86	Lymphocyte antigen 86	GO:0031666; P:positive regulation of lipopolysaccharide-mediated signaling pathway; IGI:MGI
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0015026; F:coreceptor activity; TAS:ProtInc
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0001875; F:lipopolysaccharide receptor activity; IDA:UniProtKB
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0006968; P:cellular defense response; TAS:ProtInc
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0032497; P:detection of lipopolysaccharide; IDA:UniProtKB
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0045087; P:innate immune response; TAS:Reactome
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IDA:GOC
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0031666; P:positive regulation of lipopolysaccharide-mediated signaling pathway; IEA:Ensembl
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0032496; P:response to lipopolysaccharide; IDA:MGI
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q9Y6Y9	LY96	Lymphocyte antigen 96	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q9HBG7	LY9	T-lymphocyte surface antigen Ly-9	GO:0004872; F:receptor activity; IEA:InterPro
Q9HBG7	LY9	T-lymphocyte surface antigen Ly-9	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P10253	GAA	Lysosomal alpha-glucosidase	GO:0004558; F:alpha-glucosidase activity; IDA:BHF-UCL
P10253	GAA	Lysosomal alpha-glucosidase	GO:0030246; F:carbohydrate binding; IEA:InterPro
P10253	GAA	Lysosomal alpha-glucosidase	GO:0032450; F:maltose alpha-glucosidase activity; IEA:UniProtKB-EC
P10253	GAA	Lysosomal alpha-glucosidase	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
P10253	GAA	Lysosomal alpha-glucosidase	GO:0002086; P:diaphragm contraction; IMP:BHF-UCL
P10253	GAA	Lysosomal alpha-glucosidase	GO:0006006; P:glucose metabolic process; IC:BHF-UCL
P10253	GAA	Lysosomal alpha-glucosidase	GO:0005980; P:glycogen catabolic process; IDA:BHF-UCL
P10253	GAA	Lysosomal alpha-glucosidase	GO:0007626; P:locomotory behavior; IEA:Ensembl
P10253	GAA	Lysosomal alpha-glucosidase	GO:0007040; P:lysosome organization; IMP:BHF-UCL
P10253	GAA	Lysosomal alpha-glucosidase	GO:0000023; P:maltose metabolic process; IC:BHF-UCL
P10253	GAA	Lysosomal alpha-glucosidase	GO:0046716; P:muscle cell cellular homeostasis; IEA:Ensembl
P10253	GAA	Lysosomal alpha-glucosidase	GO:0007517; P:muscle organ development; IMP:BHF-UCL
P10253	GAA	Lysosomal alpha-glucosidase	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
P10253	GAA	Lysosomal alpha-glucosidase	GO:0050884; P:neuromuscular process controlling posture; IEA:Ensembl
P10253	GAA	Lysosomal alpha-glucosidase	GO:0002026; P:regulation of the force of heart contraction; IEA:Ensembl
P10253	GAA	Lysosomal alpha-glucosidase	GO:0005985; P:sucrose metabolic process; IC:BHF-UCL
P10253	GAA	Lysosomal alpha-glucosidase	GO:0043587; P:tongue morphogenesis; IMP:BHF-UCL
P10253	GAA	Lysosomal alpha-glucosidase	GO:0043181; P:vacuolar sequestering; IMP:BHF-UCL
P10253	GAA	Lysosomal alpha-glucosidase	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IMP:BHF-UCL
P14151	SELL	L-selectin	GO:0030246; F:carbohydrate binding; TAS:ProtInc
P14151	SELL	L-selectin	GO:0043208; F:glycosphingolipid binding; TAS:BHF-UCL
P14151	SELL	L-selectin	GO:0008201; F:heparin binding; TAS:BHF-UCL
P14151	SELL	L-selectin	GO:0002020; F:protease binding; IPI:BHF-UCL
P14151	SELL	L-selectin	GO:0005515; F:protein binding; IPI:UniProtKB
P14151	SELL	L-selectin	GO:0007596; P:blood coagulation; TAS:Reactome
P14151	SELL	L-selectin	GO:0007155; P:cell adhesion; TAS:ProtInc
P14151	SELL	L-selectin	GO:0050900; P:leukocyte migration; TAS:Reactome
P14151	SELL	L-selectin	GO:0050776; P:regulation of immune response; TAS:Reactome
P14151	SELL	L-selectin	GO:0033198; P:response to ATP; IEA:Ensembl
P16581	SELE	E-selectin	GO:0070492; F:oligosaccharide binding; IDA:BHF-UCL
P16581	SELE	E-selectin	GO:0043274; F:phospholipase binding; IDA:BHF-UCL
P16581	SELE	E-selectin	GO:0005515; F:protein binding; IPI:UniProtKB
P16581	SELE	E-selectin	GO:0033691; F:sialic acid binding; IDA:BHF-UCL
P16581	SELE	E-selectin	GO:0004888; F:transmembrane signaling receptor activity; IMP:BHF-UCL
P16581	SELE	E-selectin	GO:0030029; P:actin filament-based process; IDA:BHF-UCL
P16581	SELE	E-selectin	GO:0007202; P:activation of phospholipase C activity; IMP:BHF-UCL
P16581	SELE	E-selectin	GO:0007596; P:blood coagulation; TAS:Reactome
P16581	SELE	E-selectin	GO:0019722; P:calcium-mediated signaling; TAS:BHF-UCL
P16581	SELE	E-selectin	GO:0007157; P:heterophilic cell-cell adhesion; IMP:BHF-UCL
P16581	SELE	E-selectin	GO:0006954; P:inflammatory response; TAS:ProtInc
P16581	SELE	E-selectin	GO:0007159; P:leukocyte cell-cell adhesion; IDA:BHF-UCL
P16581	SELE	E-selectin	GO:0050900; P:leukocyte migration; TAS:Reactome
P16581	SELE	E-selectin	GO:0002523; P:leukocyte migration involved in inflammatory response; TAS:BHF-UCL
P16581	SELE	E-selectin	GO:0050901; P:leukocyte tethering or rolling; IMP:BHF-UCL
P16581	SELE	E-selectin	GO:0002687; P:positive regulation of leukocyte migration; IEA:Ensembl
P16581	SELE	E-selectin	GO:0002092; P:positive regulation of receptor internalization; IDA:BHF-UCL
P16581	SELE	E-selectin	GO:0050727; P:regulation of inflammatory response; TAS:BHF-UCL
P16581	SELE	E-selectin	GO:0070555; P:response to interleukin-1; IDA:BHF-UCL
P16581	SELE	E-selectin	GO:0032496; P:response to lipopolysaccharide; TAS:BHF-UCL
P16581	SELE	E-selectin	GO:0034612; P:response to tumor necrosis factor; TAS:BHF-UCL
P16109	SELP	P-selectin	GO:0042806; F:fucose binding; IDA:BHF-UCL
P16109	SELP	P-selectin	GO:0043208; F:glycosphingolipid binding; TAS:BHF-UCL
P16109	SELP	P-selectin	GO:0008201; F:heparin binding; IDA:BHF-UCL
P16109	SELP	P-selectin	GO:0001530; F:lipopolysaccharide binding; IMP:BHF-UCL
P16109	SELP	P-selectin	GO:0070492; F:oligosaccharide binding; IDA:BHF-UCL
P16109	SELP	P-selectin	GO:0005515; F:protein binding; IPI:UniProtKB
P16109	SELP	P-selectin	GO:0033691; F:sialic acid binding; IDA:BHF-UCL
P16109	SELP	P-selectin	GO:0007596; P:blood coagulation; TAS:Reactome
P16109	SELP	P-selectin	GO:0007155; P:cell adhesion; TAS:ProtInc
P16109	SELP	P-selectin	GO:0050829; P:defense response to Gram-negative bacterium; IC:BHF-UCL
P16109	SELP	P-selectin	GO:0007157; P:heterophilic cell-cell adhesion; IEA:Ensembl
P16109	SELP	P-selectin	GO:0006954; P:inflammatory response; IEA:Ensembl
P16109	SELP	P-selectin	GO:0007159; P:leukocyte cell-cell adhesion; IDA:BHF-UCL
P16109	SELP	P-selectin	GO:0050900; P:leukocyte migration; TAS:Reactome
P16109	SELP	P-selectin	GO:0050901; P:leukocyte tethering or rolling; IEA:Ensembl
P16109	SELP	P-selectin	GO:0030168; P:platelet activation; TAS:Reactome
P16109	SELP	P-selectin	GO:0002576; P:platelet degranulation; TAS:Reactome
P16109	SELP	P-selectin	GO:0002687; P:positive regulation of leukocyte migration; IEA:Ensembl
P16109	SELP	P-selectin	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IDA:UniProtKB
P16109	SELP	P-selectin	GO:0010572; P:positive regulation of platelet activation; ISS:BHF-UCL
P16109	SELP	P-selectin	GO:0033623; P:regulation of integrin activation; IMP:UniProtKB
P16109	SELP	P-selectin	GO:0032496; P:response to lipopolysaccharide; IC:BHF-UCL
Q9NX58	LYAR	Cell growth-regulating nucleolar protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NX58	LYAR	Cell growth-regulating nucleolar protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NX58	LYAR	Cell growth-regulating nucleolar protein	GO:0005515; F:protein binding; IPI:UniProt
Q86SG7	LYG2	Lysozyme g-like protein 2	GO:0003796; F:lysozyme activity; IEA:InterPro
Q86SG7	LYG2	Lysozyme g-like protein 2	GO:0016998; P:cell wall macromolecule catabolic process; IEA:InterPro
Q86SG7	LYG2	Lysozyme g-like protein 2	GO:0009253; P:peptidoglycan catabolic process; IEA:InterPro
Q8N1E2	LYG1	Lysozyme g-like protein 1	GO:0003796; F:lysozyme activity; IEA:InterPro
Q8N1E2	LYG1	Lysozyme g-like protein 1	GO:0016998; P:cell wall macromolecule catabolic process; IEA:InterPro
Q8N1E2	LYG1	Lysozyme g-like protein 1	GO:0009253; P:peptidoglycan catabolic process; IEA:InterPro
P12980	LYL1	Protein lyl-1	GO:0003677; F:DNA binding; IDA:UniProtKB
P12980	LYL1	Protein lyl-1	GO:0005515; F:protein binding; IPI:UniProtKB
P12980	LYL1	Protein lyl-1	GO:0030183; P:B cell differentiation; ISS:UniProtKB
P12980	LYL1	Protein lyl-1	GO:0001955; P:blood vessel maturation; IMP:UniProtKB
P12980	LYL1	Protein lyl-1	GO:0060216; P:definitive hemopoiesis; ISS:UniProtKB
P12980	LYL1	Protein lyl-1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P12980	LYL1	Protein lyl-1	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
P12980	LYL1	Protein lyl-1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P28300	LOX	Protein-lysine 6-oxidase	GO:0005507; F:copper ion binding; TAS:ProtInc
P28300	LOX	Protein-lysine 6-oxidase	GO:0005515; F:protein binding; IPI:IntAct
P28300	LOX	Protein-lysine 6-oxidase	GO:0004720; F:protein-lysine 6-oxidase activity; TAS:ProtInc
P28300	LOX	Protein-lysine 6-oxidase	GO:0001568; P:blood vessel development; IEA:Ensembl
P28300	LOX	Protein-lysine 6-oxidase	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P28300	LOX	Protein-lysine 6-oxidase	GO:0030199; P:collagen fibril organization; IEA:Ensembl
P28300	LOX	Protein-lysine 6-oxidase	GO:0048251; P:elastic fiber assembly; IEA:Ensembl
P28300	LOX	Protein-lysine 6-oxidase	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P28300	LOX	Protein-lysine 6-oxidase	GO:0030324; P:lung development; IEA:Ensembl
P28300	LOX	Protein-lysine 6-oxidase	GO:0042493; P:response to drug; IEA:Ensembl
P28300	LOX	Protein-lysine 6-oxidase	GO:0048545; P:response to steroid hormone; IEA:Ensembl
P28300	LOX	Protein-lysine 6-oxidase	GO:0042060; P:wound healing; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0019899; F:enzyme binding; IPI:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0043208; F:glycosphingolipid binding; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0044325; F:ion channel binding; IPI:BHF-UCL
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; TAS:Reactome
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0005515; F:protein binding; IPI:IntAct
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0004716; F:receptor signaling protein tyrosine kinase activity; TAS:ProtInc
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0001782; P:B cell homeostasis; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0050853; P:B cell receptor signaling pathway; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0007596; P:blood coagulation; TAS:Reactome
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0031668; P:cellular response to extracellular stimulus; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0034605; P:cellular response to heat; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0071300; P:cellular response to retinoic acid; IMP:BHF-UCL
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0050663; P:cytokine secretion; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0097028; P:dendritic cell differentiation; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0030218; P:erythrocyte differentiation; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0002774; P:Fc receptor mediated inhibitory signaling pathway; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0002431; P:Fc receptor mediated stimulatory signaling pathway; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0002553; P:histamine secretion by mast cell; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0002768; P:immune response-regulating cell surface receptor signaling pathway; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0045087; P:innate immune response; TAS:Reactome
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IC:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0050900; P:leukocyte migration; TAS:Reactome
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0030889; P:negative regulation of B cell proliferation; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0050777; P:negative regulation of immune response; TAS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:1902532; P:negative regulation of intracellular signal transduction; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0043407; P:negative regulation of MAP kinase activity; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0070667; P:negative regulation of mast cell proliferation; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0002762; P:negative regulation of myeloid leukocyte differentiation; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0001933; P:negative regulation of protein phosphorylation; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0034136; P:negative regulation of toll-like receptor 2 signaling pathway; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0034144; P:negative regulation of toll-like receptor 4 signaling pathway; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0031175; P:neuron projection development; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0014003; P:oligodendrocyte development; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0030168; P:platelet activation; TAS:Reactome
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0002576; P:platelet degranulation; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0051272; P:positive regulation of cellular component movement; IDA:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:2000670; P:positive regulation of dendritic cell apoptotic process; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0060369; P:positive regulation of Fc receptor mediated stimulatory signaling pathway; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0060252; P:positive regulation of glial cell proliferation; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0070668; P:positive regulation of mast cell proliferation; IMP:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0010976; P:positive regulation of neuron projection development; IMP:BHF-UCL
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0070447; P:positive regulation of oligodendrocyte progenitor proliferation; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0070304; P:positive regulation of stress-activated protein kinase signaling cascade; IDA:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0002902; P:regulation of B cell apoptotic process; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0050855; P:regulation of B cell receptor signaling pathway; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0033628; P:regulation of cell adhesion mediated by integrin; IMP:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0001817; P:regulation of cytokine production; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0050707; P:regulation of cytokine secretion; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0070372; P:regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0045646; P:regulation of erythrocyte differentiation; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0050727; P:regulation of inflammatory response; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0033003; P:regulation of mast cell activation; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0043304; P:regulation of mast cell degranulation; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0090025; P:regulation of monocyte chemotaxis; IMP:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0090330; P:regulation of platelet aggregation; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0001932; P:regulation of protein phosphorylation; TAS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0051279; P:regulation of release of sequestered calcium ion into cytosol; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0043200; P:response to amino acid; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0048678; P:response to axon injury; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0009743; P:response to carbohydrate; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0042493; P:response to drug; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0009725; P:response to hormone; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0032868; P:response to insulin; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0006991; P:response to sterol depletion; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0009636; P:response to toxic substance; IEA:Ensembl
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0007165; P:signal transduction; TAS:ProtInc
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0023014; P:signal transduction by phosphorylation; TAS:GOC
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0031295; P:T cell costimulation; TAS:Reactome
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0002513; P:tolerance induction to self antigen; ISS:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IMP:UniProtKB
P07948	LYN	Tyrosine-protein kinase Lyn	GO:0016032; P:viral process; IEA:UniProtKB-KW
O75608	LYPLA1	Acyl-protein thioesterase 1	GO:0004622; F:lysophospholipase activity; TAS:ProtInc
O75608	LYPLA1	Acyl-protein thioesterase 1	GO:0008474; F:palmitoyl-(protein) hydrolase activity; IMP:UniProtKB
O75608	LYPLA1	Acyl-protein thioesterase 1	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW
O75608	LYPLA1	Acyl-protein thioesterase 1	GO:0042997; P:negative regulation of Golgi to plasma membrane protein transport; IEA:Ensembl
O75608	LYPLA1	Acyl-protein thioesterase 1	GO:0046209; P:nitric oxide metabolic process; TAS:Reactome
O75608	LYPLA1	Acyl-protein thioesterase 1	GO:0002084; P:protein depalmitoylation; IEA:Ensembl
O75608	LYPLA1	Acyl-protein thioesterase 1	GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome
O75608	LYPLA1	Acyl-protein thioesterase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95372	LYPLA2	Acyl-protein thioesterase 2	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
O95372	LYPLA2	Acyl-protein thioesterase 2	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW
O95274	LYPD3	Ly6/PLAUR domain-containing protein 3	GO:0007160; P:cell-matrix adhesion; IEA:Ensembl
O95274	LYPD3	Ly6/PLAUR domain-containing protein 3	GO:0006928; P:cellular component movement; IEA:Ensembl
Q5VWZ2	LYPLAL1	Lysophospholipase-like protein 1	GO:0004622; F:lysophospholipase activity; NAS:UniProtKB
Q5VWZ2	LYPLAL1	Lysophospholipase-like protein 1	GO:0042997; P:negative regulation of Golgi to plasma membrane protein transport; IEA:Ensembl
Q5VWZ2	LYPLAL1	Lysophospholipase-like protein 1	GO:0002084; P:protein depalmitoylation; IEA:Ensembl
Q86UE4	MTDH	Protein LYRIC	GO:0003725; F:double-stranded RNA binding; IDA:MGI
Q86UE4	MTDH	Protein LYRIC	GO:0051059; F:NF-kappaB binding; IPI:UniProtKB
Q86UE4	MTDH	Protein LYRIC	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q86UE4	MTDH	Protein LYRIC	GO:0005515; F:protein binding; IPI:UniProtKB
Q86UE4	MTDH	Protein LYRIC	GO:0001085; F:RNA polymerase II transcription factor binding; IPI:UniProtKB
Q86UE4	MTDH	Protein LYRIC	GO:0003713; F:transcription coactivator activity; IMP:UniProtKB
Q86UE4	MTDH	Protein LYRIC	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IMP:UniProtKB
Q86UE4	MTDH	Protein LYRIC	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q86UE4	MTDH	Protein LYRIC	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q86UE4	MTDH	Protein LYRIC	GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB
Q86UE4	MTDH	Protein LYRIC	GO:0010508; P:positive regulation of autophagy; IDA:UniProtKB
Q86UE4	MTDH	Protein LYRIC	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q86UE4	MTDH	Protein LYRIC	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q86UE4	MTDH	Protein LYRIC	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:UniProtKB
Q86UE4	MTDH	Protein LYRIC	GO:0070830; P:tight junction assembly; IEA:Ensembl
Q9HD34	LYRM4	LYR motif-containing protein 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P61626	LYZ	Lysozyme C	GO:0042802; F:identical protein binding; IPI:IntAct
P61626	LYZ	Lysozyme C	GO:0003796; F:lysozyme activity; TAS:UniProtKB
P61626	LYZ	Lysozyme C	GO:0016998; P:cell wall macromolecule catabolic process; IEA:InterPro
P61626	LYZ	Lysozyme C	GO:0019835; P:cytolysis; IEA:UniProtKB-KW
P61626	LYZ	Lysozyme C	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
P61626	LYZ	Lysozyme C	GO:0006954; P:inflammatory response; TAS:UniProtKB
P61626	LYZ	Lysozyme C	GO:0001895; P:retina homeostasis; IEP:UniProt
Q96S90	LYSMD1	LysM and putative peptidoglycan-binding domain-containing protein 1	GO:0016998; P:cell wall macromolecule catabolic process; IEA:InterPro
Q8IV50	LYSMD2	LysM and putative peptidoglycan-binding domain-containing protein 2	GO:0016998; P:cell wall macromolecule catabolic process; IEA:InterPro
Q7Z3D4	LYSMD3	LysM and putative peptidoglycan-binding domain-containing protein 3	GO:0016998; P:cell wall macromolecule catabolic process; IEA:InterPro
Q5XG99	LYSMD4	LysM and putative peptidoglycan-binding domain-containing protein 4	GO:0016998; P:cell wall macromolecule catabolic process; IEA:InterPro
Q99698	LYST	Lysosomal-trafficking regulator	GO:0005515; F:protein binding; IPI:UniProtKB
Q99698	LYST	Lysosomal-trafficking regulator	GO:0007596; P:blood coagulation; IEA:Ensembl
Q99698	LYST	Lysosomal-trafficking regulator	GO:0042742; P:defense response to bacterium; ISS:UniProtKB
Q99698	LYST	Lysosomal-trafficking regulator	GO:0042832; P:defense response to protozoan; ISS:UniProtKB
Q99698	LYST	Lysosomal-trafficking regulator	GO:0051607; P:defense response to virus; ISS:UniProtKB
Q99698	LYST	Lysosomal-trafficking regulator	GO:0032510; P:endosome to lysosome transport via multivesicular body sorting pathway; IMP:UniProtKB
Q99698	LYST	Lysosomal-trafficking regulator	GO:0030595; P:leukocyte chemotaxis; ISS:UniProtKB
Q99698	LYST	Lysosomal-trafficking regulator	GO:0007040; P:lysosome organization; IEA:Ensembl
Q99698	LYST	Lysosomal-trafficking regulator	GO:0033364; P:mast cell secretory granule organization; ISS:UniProtKB
Q99698	LYST	Lysosomal-trafficking regulator	GO:0032438; P:melanosome organization; ISS:UniProtKB
Q99698	LYST	Lysosomal-trafficking regulator	GO:0007017; P:microtubule-based process; IEA:Ensembl
Q99698	LYST	Lysosomal-trafficking regulator	GO:0042267; P:natural killer cell mediated cytotoxicity; IMP:UniProtKB
Q99698	LYST	Lysosomal-trafficking regulator	GO:0002446; P:neutrophil mediated immunity; IEA:Ensembl
Q99698	LYST	Lysosomal-trafficking regulator	GO:0055091; P:phospholipid homeostasis; IEA:Ensembl
Q99698	LYST	Lysosomal-trafficking regulator	GO:0006644; P:phospholipid metabolic process; IEA:Ensembl
Q99698	LYST	Lysosomal-trafficking regulator	GO:0043473; P:pigmentation; IMP:UniProtKB
Q99698	LYST	Lysosomal-trafficking regulator	GO:0032816; P:positive regulation of natural killer cell activation; IEA:Ensembl
Q99698	LYST	Lysosomal-trafficking regulator	GO:0042493; P:response to drug; IEA:Ensembl
Q99698	LYST	Lysosomal-trafficking regulator	GO:0033299; P:secretion of lysosomal enzymes; IEA:Ensembl
Q99698	LYST	Lysosomal-trafficking regulator	GO:0002456; P:T cell mediated immunity; IEA:Ensembl
Q9Y5Y7	LYVE1	Lymphatic vessel endothelial hyaluronic acid receptor 1	GO:0005540; F:hyaluronic acid binding; IEA:Ensembl
Q9Y5Y7	LYVE1	Lymphatic vessel endothelial hyaluronic acid receptor 1	GO:0004872; F:receptor activity; TAS:ProtInc
Q9Y5Y7	LYVE1	Lymphatic vessel endothelial hyaluronic acid receptor 1	GO:0004888; F:transmembrane signaling receptor activity; IEA:Ensembl
Q9Y5Y7	LYVE1	Lymphatic vessel endothelial hyaluronic acid receptor 1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q9Y5Y7	LYVE1	Lymphatic vessel endothelial hyaluronic acid receptor 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9Y5Y7	LYVE1	Lymphatic vessel endothelial hyaluronic acid receptor 1	GO:0007160; P:cell-matrix adhesion; TAS:ProtInc
Q9Y5Y7	LYVE1	Lymphatic vessel endothelial hyaluronic acid receptor 1	GO:0006928; P:cellular component movement; TAS:ProtInc
Q9Y5Y7	LYVE1	Lymphatic vessel endothelial hyaluronic acid receptor 1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9Y5Y7	LYVE1	Lymphatic vessel endothelial hyaluronic acid receptor 1	GO:0030214; P:hyaluronan catabolic process; TAS:Reactome
Q9Y5Y7	LYVE1	Lymphatic vessel endothelial hyaluronic acid receptor 1	GO:0030212; P:hyaluronan metabolic process; TAS:Reactome
Q9Y5Y7	LYVE1	Lymphatic vessel endothelial hyaluronic acid receptor 1	GO:0009611; P:response to wounding; TAS:ProtInc
Q9Y5Y7	LYVE1	Lymphatic vessel endothelial hyaluronic acid receptor 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y5Y7	LYVE1	Lymphatic vessel endothelial hyaluronic acid receptor 1	GO:0006810; P:transport; IEA:UniProtKB-KW
Q6UWQ5	LYZL1	Lysozyme-like protein 1	GO:0003796; F:lysozyme activity; IEA:UniProtKB-EC
Q6UWQ5	LYZL1	Lysozyme-like protein 1	GO:0016998; P:cell wall macromolecule catabolic process; IEA:InterPro
Q7Z4W2	LYZL2	Lysozyme-like protein 2	GO:0003796; F:lysozyme activity; IEA:UniProtKB-EC
Q7Z4W2	LYZL2	Lysozyme-like protein 2	GO:0016998; P:cell wall macromolecule catabolic process; IEA:InterPro
Q96QH8	SPACA5	Sperm acrosome-associated protein 5	GO:0003796; F:lysozyme activity; IEA:UniProtKB-EC
Q96QH8	SPACA5	Sperm acrosome-associated protein 5	GO:0016998; P:cell wall macromolecule catabolic process; IEA:InterPro
Q96KX0	LYZL4	Lysozyme-like protein 4	GO:0003796; F:lysozyme activity; IEA:InterPro
Q96KX0	LYZL4	Lysozyme-like protein 4	GO:0016998; P:cell wall macromolecule catabolic process; IEA:InterPro
O75951	LYZL6	Lysozyme-like protein 6	GO:0003796; F:lysozyme activity; IEA:UniProtKB-EC
O75951	LYZL6	Lysozyme-like protein 6	GO:0016998; P:cell wall macromolecule catabolic process; IEA:InterPro
Q8WZA0	LZIC	Protein LZIC	GO:0007417; P:central nervous system development; IBA:RefGenome
Q8WZA0	LZIC	Protein LZIC	GO:0010212; P:response to ionizing radiation; IEA:Ensembl
Q9NQ48	LZTFL1	Leucine zipper transcription factor-like protein 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q9NQ48	LZTFL1	Leucine zipper transcription factor-like protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NQ48	LZTFL1	Leucine zipper transcription factor-like protein 1	GO:0072594; P:establishment of protein localization to organelle; IEA:Ensembl
Q8N653	LZTR1	Leucine-zipper-like transcriptional regulator 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q8N653	LZTR1	Leucine-zipper-like transcriptional regulator 1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q8N653	LZTR1	Leucine-zipper-like transcriptional regulator 1	GO:0006355; P:regulation of transcription, DNA-templated; TAS:GOC
Q9Y250	LZTS1	Leucine zipper putative tumor suppressor 1	GO:0003677; F:DNA binding; NAS:UniProtKB
Q9Y250	LZTS1	Leucine zipper putative tumor suppressor 1	GO:0005515; F:protein binding; IPI:IntAct
Q9Y250	LZTS1	Leucine zipper putative tumor suppressor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9Y250	LZTS1	Leucine zipper putative tumor suppressor 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9Y250	LZTS1	Leucine zipper putative tumor suppressor 1	GO:0010467; P:gene expression; TAS:Reactome
Q9Y250	LZTS1	Leucine zipper putative tumor suppressor 1	GO:0045087; P:innate immune response; TAS:Reactome
Q9Y250	LZTS1	Leucine zipper putative tumor suppressor 1	GO:0016242; P:negative regulation of macroautophagy; IMP:BHF-UCL
Q9Y250	LZTS1	Leucine zipper putative tumor suppressor 1	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q9Y250	LZTS1	Leucine zipper putative tumor suppressor 1	GO:0048814; P:regulation of dendrite morphogenesis; IEA:Ensembl
Q9Y250	LZTS1	Leucine zipper putative tumor suppressor 1	GO:0006355; P:regulation of transcription, DNA-templated; TAS:GOC
Q9Y250	LZTS1	Leucine zipper putative tumor suppressor 1	GO:0006386; P:termination of RNA polymerase III transcription; TAS:Reactome
Q9Y250	LZTS1	Leucine zipper putative tumor suppressor 1	GO:0006385; P:transcription elongation from RNA polymerase III promoter; TAS:Reactome
Q9Y250	LZTS1	Leucine zipper putative tumor suppressor 1	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
Q9Y250	LZTS1	Leucine zipper putative tumor suppressor 1	GO:0006351; P:transcription, DNA-templated; NAS:UniProtKB
Q9BRK4	LZTS2	Leucine zipper putative tumor suppressor 2	GO:0005515; F:protein binding; IPI:IntAct
Q9BRK4	LZTS2	Leucine zipper putative tumor suppressor 2	GO:0000910; P:cytokinesis; IEA:UniProtKB-HAMAP
Q9BRK4	LZTS2	Leucine zipper putative tumor suppressor 2	GO:0051013; P:microtubule severing; IEA:UniProtKB-HAMAP
Q9BRK4	LZTS2	Leucine zipper putative tumor suppressor 2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9BRK4	LZTS2	Leucine zipper putative tumor suppressor 2	GO:0030178; P:negative regulation of Wnt signaling pathway; IEA:UniProtKB-HAMAP
Q9BRK4	LZTS2	Leucine zipper putative tumor suppressor 2	GO:0051168; P:nuclear export; IEA:UniProtKB-HAMAP
Q9BRK4	LZTS2	Leucine zipper putative tumor suppressor 2	GO:0051255; P:spindle midzone assembly; IEA:UniProtKB-HAMAP
Q9BRK4	LZTS2	Leucine zipper putative tumor suppressor 2	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9BXT6	MOV10L1	Putative helicase Mov10l1	GO:0005524; F:ATP binding; TAS:UniProtKB
Q9BXT6	MOV10L1	Putative helicase Mov10l1	GO:0004004; F:ATP-dependent RNA helicase activity; NAS:UniProtKB
Q9BXT6	MOV10L1	Putative helicase Mov10l1	GO:0000287; F:magnesium ion binding; TAS:UniProtKB
Q9BXT6	MOV10L1	Putative helicase Mov10l1	GO:0003723; F:RNA binding; TAS:UniProtKB
Q9BXT6	MOV10L1	Putative helicase Mov10l1	GO:0006200; P:ATP catabolic process; NAS:GOC
Q9BXT6	MOV10L1	Putative helicase Mov10l1	GO:0007281; P:germ cell development; IEP:UniProtKB
Q9BXT6	MOV10L1	Putative helicase Mov10l1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9BXT6	MOV10L1	Putative helicase Mov10l1	GO:0007283; P:spermatogenesis; IEP:UniProtKB
Q6P0N0	MIS18BP1	Mis18-binding protein 1	GO:0003682; F:chromatin binding; IEA:InterPro
Q6P0N0	MIS18BP1	Mis18-binding protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6P0N0	MIS18BP1	Mis18-binding protein 1	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
Q6P0N0	MIS18BP1	Mis18-binding protein 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q6P0N0	MIS18BP1	Mis18-binding protein 1	GO:0006334; P:nucleosome assembly; TAS:Reactome
Q8TC57	M1AP	Meiosis 1 arrest protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8TC57	M1AP	Meiosis 1 arrest protein	GO:0031497; P:chromatin assembly; NAS:UniProtKB
Q8TC57	M1AP	Meiosis 1 arrest protein	GO:0007292; P:female gamete generation; ISS:UniProtKB
Q8TC57	M1AP	Meiosis 1 arrest protein	GO:0051308; P:male meiosis chromosome separation; ISS:UniProtKB
Q8TC57	M1AP	Meiosis 1 arrest protein	GO:0006396; P:RNA processing; NAS:UniProtKB
Q8TC57	M1AP	Meiosis 1 arrest protein	GO:0007283; P:spermatogenesis; ISS:UniProtKB
P0DM35	MT1HL1	Metallothionein 1H-like protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NPA3	MID1IP1	Mid1-interacting protein 1	GO:0006629; P:lipid metabolic process; IEA:UniProtKB-KW
Q9NPA3	MID1IP1	Mid1-interacting protein 1	GO:0007026; P:negative regulation of microtubule depolymerization; ISS:UniProtKB
Q9NPA3	MID1IP1	Mid1-interacting protein 1	GO:0045723; P:positive regulation of fatty acid biosynthetic process; ISS:UniProtKB
Q9NPA3	MID1IP1	Mid1-interacting protein 1	GO:0051351; P:positive regulation of ligase activity; ISS:UniProtKB
Q9NPA3	MID1IP1	Mid1-interacting protein 1	GO:0051258; P:protein polymerization; ISS:UniProtKB
Q9NPA3	MID1IP1	Mid1-interacting protein 1	GO:0046890; P:regulation of lipid biosynthetic process; ISS:UniProtKB
Q8IYB1	MB21D2	Protein MB21D2	GO:0032403; F:protein complex binding; IDA:MGI
Q9UI17	DMGDH	Dimethylglycine dehydrogenase, mitochondrial	GO:0004047; F:aminomethyltransferase activity; IEA:InterPro
Q9UI17	DMGDH	Dimethylglycine dehydrogenase, mitochondrial	GO:0047865; F:dimethylglycine dehydrogenase activity; IMP:UniProtKB
Q9UI17	DMGDH	Dimethylglycine dehydrogenase, mitochondrial	GO:0009055; F:electron carrier activity; NAS:UniProtKB
Q9UI17	DMGDH	Dimethylglycine dehydrogenase, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UI17	DMGDH	Dimethylglycine dehydrogenase, mitochondrial	GO:0006579; P:amino-acid betaine catabolic process; IEA:UniProtKB-UniPathway
Q9UI17	DMGDH	Dimethylglycine dehydrogenase, mitochondrial	GO:0019695; P:choline metabolic process; NAS:UniProtKB
Q9UI17	DMGDH	Dimethylglycine dehydrogenase, mitochondrial	GO:0006546; P:glycine catabolic process; IEA:InterPro
Q9UI17	DMGDH	Dimethylglycine dehydrogenase, mitochondrial	GO:0006544; P:glycine metabolic process; IMP:UniProtKB
Q02978	SLC25A11	Mitochondrial 2-oxoglutarate/malate carrier protein	GO:0015367; F:oxoglutarate:malate antiporter activity; TAS:Reactome
Q02978	SLC25A11	Mitochondrial 2-oxoglutarate/malate carrier protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q02978	SLC25A11	Mitochondrial 2-oxoglutarate/malate carrier protein	GO:0015742; P:alpha-ketoglutarate transport; TAS:GOC
Q02978	SLC25A11	Mitochondrial 2-oxoglutarate/malate carrier protein	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q02978	SLC25A11	Mitochondrial 2-oxoglutarate/malate carrier protein	GO:0006094; P:gluconeogenesis; TAS:Reactome
Q02978	SLC25A11	Mitochondrial 2-oxoglutarate/malate carrier protein	GO:0006006; P:glucose metabolic process; TAS:Reactome
Q02978	SLC25A11	Mitochondrial 2-oxoglutarate/malate carrier protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q02978	SLC25A11	Mitochondrial 2-oxoglutarate/malate carrier protein	GO:0006810; P:transport; TAS:ProtInc
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0043425; F:bHLH transcription factor binding; IPI:UniProtKB
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0004706; F:JUN kinase kinase kinase activity; ISS:UniProtKB
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0003714; F:transcription corepressor activity; ISS:UniProtKB
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0007256; P:activation of JNKK activity; ISS:GOC
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0007257; P:activation of JUN kinase activity; ISS:UniProtKB
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0006915; P:apoptotic process; TAS:ProtInc
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0007254; P:JNK cascade; TAS:ProtInc
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IMP:UniProtKB
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0018107; P:peptidyl-threonine phosphorylation; IDA:UniProtKB
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0046330; P:positive regulation of JNK cascade; IMP:UniProtKB
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0043507; P:positive regulation of JUN kinase activity; IMP:UniProtKB
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0046777; P:protein autophosphorylation; ISS:UniProtKB
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0007165; P:signal transduction; TAS:ProtInc
Q02779	MAP3K10	Mitogen-activated protein kinase kinase kinase 10	GO:0007224; P:smoothened signaling pathway; IMP:UniProtKB
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0042802; F:identical protein binding; IPI:UniProtKB
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0004706; F:JUN kinase kinase kinase activity; ISS:UniProtKB
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0031435; F:mitogen-activated protein kinase kinase kinase binding; IPI:UniProtKB
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0005515; F:protein binding; IPI:IntAct
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0004713; F:protein tyrosine kinase activity; IEA:InterPro
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0007257; P:activation of JUN kinase activity; IMP:UniProtKB
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0000187; P:activation of MAPK activity; IMP:UniProtKB
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0008219; P:cell death; IEA:Ensembl
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0008283; P:cell proliferation; IMP:UniProtKB
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0007254; P:JNK cascade; TAS:ProtInc
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0007017; P:microtubule-based process; IMP:UniProtKB
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0000080; P:mitotic G1 phase; IMP:UniProtKB
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0046330; P:positive regulation of JNK cascade; IMP:UniProtKB
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0043507; P:positive regulation of JUN kinase activity; IMP:UniProtKB
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q16584	MAP3K11	Mitogen-activated protein kinase kinase kinase 11	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q12852	MAP3K12	Mitogen-activated protein kinase kinase kinase 12	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q12852	MAP3K12	Mitogen-activated protein kinase kinase kinase 12	GO:0004709; F:MAP kinase kinase kinase activity; IEA:UniProtKB-EC
Q12852	MAP3K12	Mitogen-activated protein kinase kinase kinase 12	GO:0005515; F:protein binding; IPI:IntAct
Q12852	MAP3K12	Mitogen-activated protein kinase kinase kinase 12	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q12852	MAP3K12	Mitogen-activated protein kinase kinase kinase 12	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q12852	MAP3K12	Mitogen-activated protein kinase kinase kinase 12	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q12852	MAP3K12	Mitogen-activated protein kinase kinase kinase 12	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB
Q12852	MAP3K12	Mitogen-activated protein kinase kinase kinase 12	GO:0016572; P:histone phosphorylation; ISS:UniProtKB
Q12852	MAP3K12	Mitogen-activated protein kinase kinase kinase 12	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
Q12852	MAP3K12	Mitogen-activated protein kinase kinase kinase 12	GO:0007254; P:JNK cascade; ISS:UniProtKB
Q12852	MAP3K12	Mitogen-activated protein kinase kinase kinase 12	GO:0018105; P:peptidyl-serine phosphorylation; ISS:UniProtKB
Q12852	MAP3K12	Mitogen-activated protein kinase kinase kinase 12	GO:0018107; P:peptidyl-threonine phosphorylation; ISS:UniProtKB
Q12852	MAP3K12	Mitogen-activated protein kinase kinase kinase 12	GO:0046777; P:protein autophosphorylation; ISS:UniProtKB
Q12852	MAP3K12	Mitogen-activated protein kinase kinase kinase 12	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
O43283	MAP3K13	Mitogen-activated protein kinase kinase kinase 13	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43283	MAP3K13	Mitogen-activated protein kinase kinase kinase 13	GO:0042802; F:identical protein binding; IPI:IntAct
O43283	MAP3K13	Mitogen-activated protein kinase kinase kinase 13	GO:0004709; F:MAP kinase kinase kinase activity; IDA:UniProtKB
O43283	MAP3K13	Mitogen-activated protein kinase kinase kinase 13	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43283	MAP3K13	Mitogen-activated protein kinase kinase kinase 13	GO:0005515; F:protein binding; IPI:UniProtKB
O43283	MAP3K13	Mitogen-activated protein kinase kinase kinase 13	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O43283	MAP3K13	Mitogen-activated protein kinase kinase kinase 13	GO:0019901; F:protein kinase binding; ISS:UniProtKB
O43283	MAP3K13	Mitogen-activated protein kinase kinase kinase 13	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
O43283	MAP3K13	Mitogen-activated protein kinase kinase kinase 13	GO:0000186; P:activation of MAPKK activity; IDA:UniProtKB
O43283	MAP3K13	Mitogen-activated protein kinase kinase kinase 13	GO:0007254; P:JNK cascade; IDA:UniProtKB
O43283	MAP3K13	Mitogen-activated protein kinase kinase kinase 13	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
O43283	MAP3K13	Mitogen-activated protein kinase kinase kinase 13	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
O43283	MAP3K13	Mitogen-activated protein kinase kinase kinase 13	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q99558	MAP3K14	Mitogen-activated protein kinase kinase kinase 14	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q99558	MAP3K14	Mitogen-activated protein kinase kinase kinase 14	GO:0004709; F:MAP kinase kinase kinase activity; IEA:UniProtKB-EC
Q99558	MAP3K14	Mitogen-activated protein kinase kinase kinase 14	GO:0004704; F:NF-kappaB-inducing kinase activity; ISS:UniProtKB
Q99558	MAP3K14	Mitogen-activated protein kinase kinase kinase 14	GO:0005515; F:protein binding; IPI:UniProtKB
Q99558	MAP3K14	Mitogen-activated protein kinase kinase kinase 14	GO:0004672; F:protein kinase activity; IDA:MGI
Q99558	MAP3K14	Mitogen-activated protein kinase kinase kinase 14	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
Q99558	MAP3K14	Mitogen-activated protein kinase kinase kinase 14	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; ISS:UniProtKB
Q99558	MAP3K14	Mitogen-activated protein kinase kinase kinase 14	GO:0006955; P:immune response; ISS:UniProtKB
Q99558	MAP3K14	Mitogen-activated protein kinase kinase kinase 14	GO:0038061; P:NIK/NF-kappaB signaling; ISS:GOC
Q99558	MAP3K14	Mitogen-activated protein kinase kinase kinase 14	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q99558	MAP3K14	Mitogen-activated protein kinase kinase kinase 14	GO:0031295; P:T cell costimulation; TAS:Reactome
Q6ZN16	MAP3K15	Mitogen-activated protein kinase kinase kinase 15	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6ZN16	MAP3K15	Mitogen-activated protein kinase kinase kinase 15	GO:0004709; F:MAP kinase kinase kinase activity; IBA:RefGenome
Q6ZN16	MAP3K15	Mitogen-activated protein kinase kinase kinase 15	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZN16	MAP3K15	Mitogen-activated protein kinase kinase kinase 15	GO:0000186; P:activation of MAPKK activity; IBA:GOC
Q6ZN16	MAP3K15	Mitogen-activated protein kinase kinase kinase 15	GO:0000165; P:MAPK cascade; IBA:GOC
Q56UN5	MAP3K19	Mitogen-activated protein kinase kinase kinase 19	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q56UN5	MAP3K19	Mitogen-activated protein kinase kinase kinase 19	GO:0004709; F:MAP kinase kinase kinase activity; IBA:RefGenome
Q56UN5	MAP3K19	Mitogen-activated protein kinase kinase kinase 19	GO:0030036; P:actin cytoskeleton organization; IBA:RefGenome
Q56UN5	MAP3K19	Mitogen-activated protein kinase kinase kinase 19	GO:0000186; P:activation of MAPKK activity; IBA:GOC
Q56UN5	MAP3K19	Mitogen-activated protein kinase kinase kinase 19	GO:0000165; P:MAPK cascade; IBA:GOC
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0008545; F:JUN kinase kinase activity; IEA:Ensembl
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0004709; F:MAP kinase kinase kinase activity; NAS:UniProtKB
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0005515; F:protein binding; IPI:IntAct
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0004672; F:protein kinase activity; IDA:MGI
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0030036; P:actin cytoskeleton organization; IBA:RefGenome
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0000186; P:activation of MAPKK activity; NAS:GOC
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0008637; P:apoptotic mitochondrial changes; IEA:Ensembl
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0006915; P:apoptotic process; IBA:RefGenome
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0003382; P:epithelial cell morphogenesis; IEA:Ensembl
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0061029; P:eyelid development in camera-type eye; IEA:Ensembl
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0045087; P:innate immune response; TAS:Reactome
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0030838; P:positive regulation of actin filament polymerization; IEA:Ensembl
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0006468; P:protein phosphorylation; NAS:UniProtKB
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0030334; P:regulation of cell migration; IEA:Ensembl
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl
Q13233	MAP3K1	Mitogen-activated protein kinase kinase kinase 1	GO:0042060; P:wound healing; IEA:Ensembl
Q9Y2U5	MAP3K2	Mitogen-activated protein kinase kinase kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y2U5	MAP3K2	Mitogen-activated protein kinase kinase kinase 2	GO:0004709; F:MAP kinase kinase kinase activity; IEA:UniProtKB-EC
Q9Y2U5	MAP3K2	Mitogen-activated protein kinase kinase kinase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y2U5	MAP3K2	Mitogen-activated protein kinase kinase kinase 2	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2U5	MAP3K2	Mitogen-activated protein kinase kinase kinase 2	GO:0004672; F:protein kinase activity; IDA:MGI
Q9Y2U5	MAP3K2	Mitogen-activated protein kinase kinase kinase 2	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q9Y2U5	MAP3K2	Mitogen-activated protein kinase kinase kinase 2	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
Q9Y2U5	MAP3K2	Mitogen-activated protein kinase kinase kinase 2	GO:0007257; P:activation of JUN kinase activity; TAS:ProtInc
Q9Y2U5	MAP3K2	Mitogen-activated protein kinase kinase kinase 2	GO:0000187; P:activation of MAPK activity; TAS:ProtInc
Q9Y2U5	MAP3K2	Mitogen-activated protein kinase kinase kinase 2	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
Q9Y2U5	MAP3K2	Mitogen-activated protein kinase kinase kinase 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9Y2U5	MAP3K2	Mitogen-activated protein kinase kinase kinase 2	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q99759	MAP3K3	Mitogen-activated protein kinase kinase kinase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q99759	MAP3K3	Mitogen-activated protein kinase kinase kinase 3	GO:0004709; F:MAP kinase kinase kinase activity; TAS:ProtInc
Q99759	MAP3K3	Mitogen-activated protein kinase kinase kinase 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q99759	MAP3K3	Mitogen-activated protein kinase kinase kinase 3	GO:0005515; F:protein binding; IPI:IntAct
Q99759	MAP3K3	Mitogen-activated protein kinase kinase kinase 3	GO:0004672; F:protein kinase activity; IDA:MGI
Q99759	MAP3K3	Mitogen-activated protein kinase kinase kinase 3	GO:0000186; P:activation of MAPKK activity; TAS:GOC
Q99759	MAP3K3	Mitogen-activated protein kinase kinase kinase 3	GO:0035556; P:intracellular signal transduction; IDA:MGI
Q99759	MAP3K3	Mitogen-activated protein kinase kinase kinase 3	GO:0000165; P:MAPK cascade; TAS:ProtInc
Q99759	MAP3K3	Mitogen-activated protein kinase kinase kinase 3	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
Q99759	MAP3K3	Mitogen-activated protein kinase kinase kinase 3	GO:0046777; P:protein autophosphorylation; IDA:MGI
Q9Y6R4	MAP3K4	Mitogen-activated protein kinase kinase kinase 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y6R4	MAP3K4	Mitogen-activated protein kinase kinase kinase 4	GO:0004709; F:MAP kinase kinase kinase activity; IDA:UniProtKB
Q9Y6R4	MAP3K4	Mitogen-activated protein kinase kinase kinase 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y6R4	MAP3K4	Mitogen-activated protein kinase kinase kinase 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6R4	MAP3K4	Mitogen-activated protein kinase kinase kinase 4	GO:0000186; P:activation of MAPKK activity; IDA:UniProtKB
Q9Y6R4	MAP3K4	Mitogen-activated protein kinase kinase kinase 4	GO:0060718; P:chorionic trophoblast cell differentiation; IEA:Ensembl
Q9Y6R4	MAP3K4	Mitogen-activated protein kinase kinase kinase 4	GO:0035556; P:intracellular signal transduction; ISS:UniProtKB
Q9Y6R4	MAP3K4	Mitogen-activated protein kinase kinase kinase 4	GO:0019100; P:male germ-line sex determination; IEA:Ensembl
Q9Y6R4	MAP3K4	Mitogen-activated protein kinase kinase kinase 4	GO:0000165; P:MAPK cascade; IDA:GOC
Q9Y6R4	MAP3K4	Mitogen-activated protein kinase kinase kinase 4	GO:0001890; P:placenta development; IEA:Ensembl
Q9Y6R4	MAP3K4	Mitogen-activated protein kinase kinase kinase 4	GO:0043507; P:positive regulation of JUN kinase activity; IDA:UniProtKB
Q9Y6R4	MAP3K4	Mitogen-activated protein kinase kinase kinase 4	GO:1900745; P:positive regulation of p38MAPK cascade; IDA:UniProtKB
Q9Y6R4	MAP3K4	Mitogen-activated protein kinase kinase kinase 4	GO:0010468; P:regulation of gene expression; IEA:Ensembl
Q9Y6R4	MAP3K4	Mitogen-activated protein kinase kinase kinase 4	GO:0010225; P:response to UV-C; IMP:UniProtKB
O95382	MAP3K6	Mitogen-activated protein kinase kinase kinase 6	GO:0005524; F:ATP binding; IDA:UniProtKB
O95382	MAP3K6	Mitogen-activated protein kinase kinase kinase 6	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
O95382	MAP3K6	Mitogen-activated protein kinase kinase kinase 6	GO:0004709; F:MAP kinase kinase kinase activity; IDA:UniProtKB
O95382	MAP3K6	Mitogen-activated protein kinase kinase kinase 6	GO:0007257; P:activation of JUN kinase activity; TAS:ProtInc
O95382	MAP3K6	Mitogen-activated protein kinase kinase kinase 6	GO:0000186; P:activation of MAPKK activity; IDA:GOC
O95382	MAP3K6	Mitogen-activated protein kinase kinase kinase 6	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
O95382	MAP3K6	Mitogen-activated protein kinase kinase kinase 6	GO:0007165; P:signal transduction; TAS:ProtInc
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0005524; F:ATP binding; IDA:UniProtKB
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; IDA:UniProtKB
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0004709; F:MAP kinase kinase kinase activity; IDA:UniProtKB
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0019903; F:protein phosphatase binding; IPI:BHF-UCL
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:GOC
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0007257; P:activation of JUN kinase activity; TAS:ProtInc
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0000186; P:activation of MAPKK activity; IDA:BHF-UCL
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0097190; P:apoptotic signaling pathway; TAS:ProtInc
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0070301; P:cellular response to hydrogen peroxide; IDA:BHF-UCL
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IDA:UniProtKB
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0007254; P:JNK cascade; IDA:UniProtKB
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0000165; P:MAPK cascade; IDA:UniProtKB
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:BHF-UCL
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0002931; P:response to ischemia; IEA:Ensembl
Q99683	MAP3K5	Mitogen-activated protein kinase kinase kinase 5	GO:0016032; P:viral process; IEA:UniProtKB-KW
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0000287; F:magnesium ion binding; IEA:InterPro
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0004708; F:MAP kinase kinase activity; IEA:Ensembl
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0004709; F:MAP kinase kinase kinase activity; IDA:UniProtKB
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0005515; F:protein binding; IPI:IntAct
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0004672; F:protein kinase activity; IDA:UniProtKB
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0004674; F:protein serine/threonine kinase activity; EXP:Reactome
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0097110; F:scaffold protein binding; IDA:MGI
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0000187; P:activation of MAPK activity; IDA:UniProtKB
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0000186; P:activation of MAPKK activity; IDA:UniProtKB
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0007250; P:activation of NF-kappaB-inducing kinase activity; IMP:UniProtKB
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0001525; P:angiogenesis; IEA:Ensembl
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0043966; P:histone H3 acetylation; IDA:BHF-UCL
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0007252; P:I-kappaB phosphorylation; IDA:UniProtKB
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0045087; P:innate immune response; TAS:Reactome
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0007254; P:JNK cascade; IDA:UniProtKB
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0001841; P:neural tube formation; IEA:Ensembl
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0032743; P:positive regulation of interleukin-2 production; IMP:UniProtKB
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0046330; P:positive regulation of JNK cascade; IEA:Ensembl
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0043507; P:positive regulation of JUN kinase activity; IDA:UniProtKB
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:Reactome
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0050870; P:positive regulation of T cell activation; IC:UniProtKB
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0002726; P:positive regulation of T cell cytokine production; IMP:UniProtKB
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0051403; P:stress-activated MAPK cascade; IDA:UniProtKB
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0050852; P:T cell receptor signaling pathway; NAS:UniProtKB
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:ProtInc
O43318	MAP3K7	Mitogen-activated protein kinase kinase kinase 7	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P41279	MAP3K8	Mitogen-activated protein kinase kinase kinase 8	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P41279	MAP3K8	Mitogen-activated protein kinase kinase kinase 8	GO:0000287; F:magnesium ion binding; IEA:InterPro
P41279	MAP3K8	Mitogen-activated protein kinase kinase kinase 8	GO:0004709; F:MAP kinase kinase kinase activity; IBA:RefGenome
P41279	MAP3K8	Mitogen-activated protein kinase kinase kinase 8	GO:0005515; F:protein binding; IPI:IntAct
P41279	MAP3K8	Mitogen-activated protein kinase kinase kinase 8	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
P41279	MAP3K8	Mitogen-activated protein kinase kinase kinase 8	GO:0000186; P:activation of MAPKK activity; IBA:GOC
P41279	MAP3K8	Mitogen-activated protein kinase kinase kinase 8	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P41279	MAP3K8	Mitogen-activated protein kinase kinase kinase 8	GO:0000165; P:MAPK cascade; IBA:GOC
P41279	MAP3K8	Mitogen-activated protein kinase kinase kinase 8	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P41279	MAP3K8	Mitogen-activated protein kinase kinase kinase 8	GO:0031295; P:T cell costimulation; TAS:Reactome
P80192	MAP3K9	Mitogen-activated protein kinase kinase kinase 9	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P80192	MAP3K9	Mitogen-activated protein kinase kinase kinase 9	GO:0004706; F:JUN kinase kinase kinase activity; ISS:UniProtKB
P80192	MAP3K9	Mitogen-activated protein kinase kinase kinase 9	GO:0004708; F:MAP kinase kinase activity; NAS:UniProtKB
P80192	MAP3K9	Mitogen-activated protein kinase kinase kinase 9	GO:0005515; F:protein binding; IPI:IntAct
P80192	MAP3K9	Mitogen-activated protein kinase kinase kinase 9	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
P80192	MAP3K9	Mitogen-activated protein kinase kinase kinase 9	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P80192	MAP3K9	Mitogen-activated protein kinase kinase kinase 9	GO:0004713; F:protein tyrosine kinase activity; IEA:InterPro
P80192	MAP3K9	Mitogen-activated protein kinase kinase kinase 9	GO:0007256; P:activation of JNKK activity; ISS:GOC
P80192	MAP3K9	Mitogen-activated protein kinase kinase kinase 9	GO:0007257; P:activation of JUN kinase activity; ISS:UniProtKB
P80192	MAP3K9	Mitogen-activated protein kinase kinase kinase 9	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P80192	MAP3K9	Mitogen-activated protein kinase kinase kinase 9	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P80192	MAP3K9	Mitogen-activated protein kinase kinase kinase 9	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P80192	MAP3K9	Mitogen-activated protein kinase kinase kinase 9	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P80192	MAP3K9	Mitogen-activated protein kinase kinase kinase 9	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P80192	MAP3K9	Mitogen-activated protein kinase kinase kinase 9	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P57077	MAP3K7CL	MAP3K7 C-terminal-like protein	GO:0005515; F:protein binding; IPI:IntAct
Q5TCX8	MLK4	Mitogen-activated protein kinase kinase kinase MLK4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5TCX8	MLK4	Mitogen-activated protein kinase kinase kinase MLK4	GO:0004709; F:MAP kinase kinase kinase activity; IEA:UniProtKB-EC
Q5TCX8	MLK4	Mitogen-activated protein kinase kinase kinase MLK4	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q5TCX8	MLK4	Mitogen-activated protein kinase kinase kinase MLK4	GO:0004713; F:protein tyrosine kinase activity; IEA:InterPro
Q5TCX8	MLK4	Mitogen-activated protein kinase kinase kinase MLK4	GO:0007257; P:activation of JUN kinase activity; ISS:UniProtKB
Q5TCX8	MLK4	Mitogen-activated protein kinase kinase kinase MLK4	GO:0046777; P:protein autophosphorylation; ISS:UniProtKB
Q5TCX8	MLK4	Mitogen-activated protein kinase kinase kinase MLK4	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
Q92918	MAP4K1	Mitogen-activated protein kinase kinase kinase kinase 1	GO:0005524; F:ATP binding; IDA:UniProtKB
Q92918	MAP4K1	Mitogen-activated protein kinase kinase kinase kinase 1	GO:0008349; F:MAP kinase kinase kinase kinase activity; IDA:UniProtKB
Q92918	MAP4K1	Mitogen-activated protein kinase kinase kinase kinase 1	GO:0005515; F:protein binding; IPI:IntAct
Q92918	MAP4K1	Mitogen-activated protein kinase kinase kinase kinase 1	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q92918	MAP4K1	Mitogen-activated protein kinase kinase kinase kinase 1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q92918	MAP4K1	Mitogen-activated protein kinase kinase kinase kinase 1	GO:0005083; F:small GTPase regulator activity; IEA:InterPro
Q92918	MAP4K1	Mitogen-activated protein kinase kinase kinase kinase 1	GO:0007257; P:activation of JUN kinase activity; TAS:ProtInc
Q92918	MAP4K1	Mitogen-activated protein kinase kinase kinase kinase 1	GO:0000185; P:activation of MAPKKK activity; IC:UniProtKB
Q92918	MAP4K1	Mitogen-activated protein kinase kinase kinase kinase 1	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q92918	MAP4K1	Mitogen-activated protein kinase kinase kinase kinase 1	GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB
Q92918	MAP4K1	Mitogen-activated protein kinase kinase kinase kinase 1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q92918	MAP4K1	Mitogen-activated protein kinase kinase kinase kinase 1	GO:0006950; P:response to stress; IDA:UniProtKB
Q12851	MAP4K2	Mitogen-activated protein kinase kinase kinase kinase 2	GO:0005524; F:ATP binding; IDA:UniProtKB
Q12851	MAP4K2	Mitogen-activated protein kinase kinase kinase kinase 2	GO:0008349; F:MAP kinase kinase kinase kinase activity; IBA:RefGenome
Q12851	MAP4K2	Mitogen-activated protein kinase kinase kinase kinase 2	GO:0031435; F:mitogen-activated protein kinase kinase kinase binding; IPI:UniProtKB
Q12851	MAP4K2	Mitogen-activated protein kinase kinase kinase kinase 2	GO:0005515; F:protein binding; IPI:IntAct
Q12851	MAP4K2	Mitogen-activated protein kinase kinase kinase kinase 2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q12851	MAP4K2	Mitogen-activated protein kinase kinase kinase kinase 2	GO:0005083; F:small GTPase regulator activity; IEA:InterPro
Q12851	MAP4K2	Mitogen-activated protein kinase kinase kinase kinase 2	GO:0007257; P:activation of JUN kinase activity; IDA:UniProtKB
Q12851	MAP4K2	Mitogen-activated protein kinase kinase kinase kinase 2	GO:0000185; P:activation of MAPKKK activity; IBA:GOC
Q12851	MAP4K2	Mitogen-activated protein kinase kinase kinase kinase 2	GO:0006955; P:immune response; TAS:ProtInc
Q12851	MAP4K2	Mitogen-activated protein kinase kinase kinase kinase 2	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q12851	MAP4K2	Mitogen-activated protein kinase kinase kinase kinase 2	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q12851	MAP4K2	Mitogen-activated protein kinase kinase kinase kinase 2	GO:0007254; P:JNK cascade; TAS:ProtInc
Q12851	MAP4K2	Mitogen-activated protein kinase kinase kinase kinase 2	GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB
Q12851	MAP4K2	Mitogen-activated protein kinase kinase kinase kinase 2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q12851	MAP4K2	Mitogen-activated protein kinase kinase kinase kinase 2	GO:0006903; P:vesicle targeting; IEA:Ensembl
Q8IVH8	MAP4K3	Mitogen-activated protein kinase kinase kinase kinase 3	GO:0005524; F:ATP binding; IDA:UniProtKB
Q8IVH8	MAP4K3	Mitogen-activated protein kinase kinase kinase kinase 3	GO:0008349; F:MAP kinase kinase kinase kinase activity; IBA:RefGenome
Q8IVH8	MAP4K3	Mitogen-activated protein kinase kinase kinase kinase 3	GO:0005515; F:protein binding; IPI:IntAct
Q8IVH8	MAP4K3	Mitogen-activated protein kinase kinase kinase kinase 3	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q8IVH8	MAP4K3	Mitogen-activated protein kinase kinase kinase kinase 3	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q8IVH8	MAP4K3	Mitogen-activated protein kinase kinase kinase kinase 3	GO:0005083; F:small GTPase regulator activity; IEA:InterPro
Q8IVH8	MAP4K3	Mitogen-activated protein kinase kinase kinase kinase 3	GO:0000185; P:activation of MAPKKK activity; IBA:GOC
Q8IVH8	MAP4K3	Mitogen-activated protein kinase kinase kinase kinase 3	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q8IVH8	MAP4K3	Mitogen-activated protein kinase kinase kinase kinase 3	GO:0007254; P:JNK cascade; TAS:ProtInc
Q8IVH8	MAP4K3	Mitogen-activated protein kinase kinase kinase kinase 3	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q8IVH8	MAP4K3	Mitogen-activated protein kinase kinase kinase kinase 3	GO:0034612; P:response to tumor necrosis factor; IDA:UniProtKB
Q8IVH8	MAP4K3	Mitogen-activated protein kinase kinase kinase kinase 3	GO:0009411; P:response to UV; IDA:UniProtKB
O95819	MAP4K4	Mitogen-activated protein kinase kinase kinase kinase 4	GO:0005524; F:ATP binding; IDA:UniProtKB
O95819	MAP4K4	Mitogen-activated protein kinase kinase kinase kinase 4	GO:0005515; F:protein binding; IPI:UniProtKB
O95819	MAP4K4	Mitogen-activated protein kinase kinase kinase kinase 4	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
O95819	MAP4K4	Mitogen-activated protein kinase kinase kinase kinase 4	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
O95819	MAP4K4	Mitogen-activated protein kinase kinase kinase kinase 4	GO:0005083; F:small GTPase regulator activity; IEA:InterPro
O95819	MAP4K4	Mitogen-activated protein kinase kinase kinase kinase 4	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
O95819	MAP4K4	Mitogen-activated protein kinase kinase kinase kinase 4	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
O95819	MAP4K4	Mitogen-activated protein kinase kinase kinase kinase 4	GO:0046328; P:regulation of JNK cascade; IDA:UniProtKB
O95819	MAP4K4	Mitogen-activated protein kinase kinase kinase kinase 4	GO:0023014; P:signal transduction by phosphorylation; IBA:GOC
Q9Y4K4	MAP4K5	Mitogen-activated protein kinase kinase kinase kinase 5	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9Y4K4	MAP4K5	Mitogen-activated protein kinase kinase kinase kinase 5	GO:0005515; F:protein binding; IPI:IntAct
Q9Y4K4	MAP4K5	Mitogen-activated protein kinase kinase kinase kinase 5	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q9Y4K4	MAP4K5	Mitogen-activated protein kinase kinase kinase kinase 5	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9Y4K4	MAP4K5	Mitogen-activated protein kinase kinase kinase kinase 5	GO:0005083; F:small GTPase regulator activity; IEA:InterPro
Q9Y4K4	MAP4K5	Mitogen-activated protein kinase kinase kinase kinase 5	GO:0007257; P:activation of JUN kinase activity; TAS:ProtInc
Q9Y4K4	MAP4K5	Mitogen-activated protein kinase kinase kinase kinase 5	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q9Y4K4	MAP4K5	Mitogen-activated protein kinase kinase kinase kinase 5	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P33908	MAN1A1	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA	GO:0005509; F:calcium ion binding; TAS:ProtInc
P33908	MAN1A1	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA	GO:0015923; F:mannosidase activity; TAS:ProtInc
P33908	MAN1A1	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA	GO:0004571; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; TAS:ProtInc
P33908	MAN1A1	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P33908	MAN1A1	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA	GO:0043687; P:post-translational protein modification; TAS:Reactome
P33908	MAN1A1	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
O60476	MAN1A2	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	GO:0005509; F:calcium ion binding; IEA:InterPro
O60476	MAN1A2	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	GO:0004571; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; TAS:ProtInc
O60476	MAN1A2	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O60476	MAN1A2	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	GO:0048286; P:lung alveolus development; IEA:Ensembl
O60476	MAN1A2	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	GO:0006491; P:N-glycan processing; TAS:ProtInc
O60476	MAN1A2	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	GO:0043687; P:post-translational protein modification; TAS:Reactome
O60476	MAN1A2	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
O60476	MAN1A2	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl
Q9UKM7	MAN1B1	Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase	GO:0005509; F:calcium ion binding; TAS:UniProtKB
Q9UKM7	MAN1B1	Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase	GO:0004571; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; IDA:UniProtKB
Q9UKM7	MAN1B1	Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UKM7	MAN1B1	Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q9UKM7	MAN1B1	Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase	GO:0009311; P:oligosaccharide metabolic process; TAS:ProtInc
Q9UKM7	MAN1B1	Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9UKM7	MAN1B1	Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase	GO:0006457; P:protein folding; TAS:Reactome
Q9UKM7	MAN1B1	Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase	GO:0006487; P:protein N-linked glycosylation; NAS:UniProtKB
Q9UKM7	MAN1B1	Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9NR34	MAN1C1	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC	GO:0005509; F:calcium ion binding; TAS:UniProtKB
Q9NR34	MAN1C1	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC	GO:0004571; F:mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; TAS:UniProtKB
Q9NR34	MAN1C1	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9NR34	MAN1C1	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9NR34	MAN1C1	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC	GO:0006487; P:protein N-linked glycosylation; TAS:UniProtKB
Q9NR34	MAN1C1	Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q16706	MAN2A1	Alpha-mannosidase 2	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q16706	MAN2A1	Alpha-mannosidase 2	GO:0016799; F:hydrolase activity, hydrolyzing N-glycosyl compounds; IEA:Ensembl
Q16706	MAN2A1	Alpha-mannosidase 2	GO:0004572; F:mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; TAS:ProtInc
Q16706	MAN2A1	Alpha-mannosidase 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q16706	MAN2A1	Alpha-mannosidase 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q16706	MAN2A1	Alpha-mannosidase 2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q16706	MAN2A1	Alpha-mannosidase 2	GO:0001889; P:liver development; IEA:Ensembl
Q16706	MAN2A1	Alpha-mannosidase 2	GO:0048286; P:lung alveolus development; IEA:Ensembl
Q16706	MAN2A1	Alpha-mannosidase 2	GO:0006013; P:mannose metabolic process; IEA:InterPro
Q16706	MAN2A1	Alpha-mannosidase 2	GO:0007005; P:mitochondrion organization; IEA:Ensembl
Q16706	MAN2A1	Alpha-mannosidase 2	GO:0006491; P:N-glycan processing; IEA:Ensembl
Q16706	MAN2A1	Alpha-mannosidase 2	GO:0050769; P:positive regulation of neurogenesis; IEA:Ensembl
Q16706	MAN2A1	Alpha-mannosidase 2	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q16706	MAN2A1	Alpha-mannosidase 2	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q16706	MAN2A1	Alpha-mannosidase 2	GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl
Q16706	MAN2A1	Alpha-mannosidase 2	GO:0060042; P:retina morphogenesis in camera-type eye; IEA:Ensembl
Q16706	MAN2A1	Alpha-mannosidase 2	GO:0007033; P:vacuole organization; IEA:Ensembl
P49641	MAN2A2	Alpha-mannosidase 2x	GO:0030246; F:carbohydrate binding; IEA:InterPro
P49641	MAN2A2	Alpha-mannosidase 2x	GO:0016799; F:hydrolase activity, hydrolyzing N-glycosyl compounds; IEA:Ensembl
P49641	MAN2A2	Alpha-mannosidase 2x	GO:0004572; F:mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; IEA:UniProtKB-EC
P49641	MAN2A2	Alpha-mannosidase 2x	GO:0008270; F:zinc ion binding; IEA:InterPro
P49641	MAN2A2	Alpha-mannosidase 2x	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P49641	MAN2A2	Alpha-mannosidase 2x	GO:0006013; P:mannose metabolic process; IEA:InterPro
P49641	MAN2A2	Alpha-mannosidase 2x	GO:0043687; P:post-translational protein modification; TAS:Reactome
P49641	MAN2A2	Alpha-mannosidase 2x	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
O00754	MAN2B1	Lysosomal alpha-mannosidase	GO:0004559; F:alpha-mannosidase activity; TAS:ProtInc
O00754	MAN2B1	Lysosomal alpha-mannosidase	GO:0030246; F:carbohydrate binding; IEA:InterPro
O00754	MAN2B1	Lysosomal alpha-mannosidase	GO:0008270; F:zinc ion binding; IEA:InterPro
O00754	MAN2B1	Lysosomal alpha-mannosidase	GO:0006464; P:cellular protein modification process; IDA:UniProtKB
O00754	MAN2B1	Lysosomal alpha-mannosidase	GO:0006013; P:mannose metabolic process; IEA:InterPro
O00754	MAN2B1	Lysosomal alpha-mannosidase	GO:0006517; P:protein deglycosylation; TAS:ProtInc
Q9Y2E5	MAN2B2	Epididymis-specific alpha-mannosidase	GO:0004559; F:alpha-mannosidase activity; IEA:UniProtKB-EC
Q9Y2E5	MAN2B2	Epididymis-specific alpha-mannosidase	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q9Y2E5	MAN2B2	Epididymis-specific alpha-mannosidase	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y2E5	MAN2B2	Epididymis-specific alpha-mannosidase	GO:0006013; P:mannose metabolic process; IEA:Ensembl
Q9NTJ4	MAN2C1	Alpha-mannosidase 2C1	GO:0004559; F:alpha-mannosidase activity; IEA:UniProtKB-EC
Q9NTJ4	MAN2C1	Alpha-mannosidase 2C1	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q9NTJ4	MAN2C1	Alpha-mannosidase 2C1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NTJ4	MAN2C1	Alpha-mannosidase 2C1	GO:0006013; P:mannose metabolic process; IEA:InterPro
Q9H9H5	MAP6D1	MAP6 domain-containing protein 1	GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro
Q9H9H5	MAP6D1	MAP6 domain-containing protein 1	GO:0018009; P:N-terminal peptidyl-L-cysteine N-palmitoylation; IEA:Ensembl
Q9H9H5	MAP6D1	MAP6 domain-containing protein 1	GO:0007026; P:negative regulation of microtubule depolymerization; IEA:Ensembl
Q96T17	MAP7D2	MAP7 domain-containing protein 2	GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro
Q3KQU3	MAP7D1	MAP7 domain-containing protein 1	GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro
Q8IWC1	MAP7D3	MAP7 domain-containing protein 3	GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro
O43708	GSTZ1	Maleylacetoacetate isomerase	GO:0004602; F:glutathione peroxidase activity; TAS:ProtInc
O43708	GSTZ1	Maleylacetoacetate isomerase	GO:0004364; F:glutathione transferase activity; IDA:UniProtKB
O43708	GSTZ1	Maleylacetoacetate isomerase	GO:0016034; F:maleylacetoacetate isomerase activity; IDA:UniProtKB
O43708	GSTZ1	Maleylacetoacetate isomerase	GO:0005515; F:protein binding; IPI:IntAct
O43708	GSTZ1	Maleylacetoacetate isomerase	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
O43708	GSTZ1	Maleylacetoacetate isomerase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
O43708	GSTZ1	Maleylacetoacetate isomerase	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
O43708	GSTZ1	Maleylacetoacetate isomerase	GO:0006749; P:glutathione metabolic process; IDA:UniProtKB
O43708	GSTZ1	Maleylacetoacetate isomerase	GO:0006559; P:L-phenylalanine catabolic process; TAS:Reactome
O43708	GSTZ1	Maleylacetoacetate isomerase	GO:0055114; P:oxidation-reduction process; TAS:GOC
O43708	GSTZ1	Maleylacetoacetate isomerase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43708	GSTZ1	Maleylacetoacetate isomerase	GO:0006572; P:tyrosine catabolic process; IEA:UniProtKB-KW
O43708	GSTZ1	Maleylacetoacetate isomerase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q7Z4T9	MAATS1	Protein MAATS1	GO:0005515; F:protein binding; IPI:IntAct
Q6ZN28	MACC1	Metastasis-associated in colon cancer protein 1	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
Q6ZN28	MACC1	Metastasis-associated in colon cancer protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZN28	MACC1	Metastasis-associated in colon cancer protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A1Z1Q3	MACROD2	O-acetyl-ADP-ribose deacetylase MACROD2	GO:0019213; F:deacetylase activity; IDA:UniProtKB
A1Z1Q3	MACROD2	O-acetyl-ADP-ribose deacetylase MACROD2	GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IDA:UniProtKB
A1Z1Q3	MACROD2	O-acetyl-ADP-ribose deacetylase MACROD2	GO:0007420; P:brain development; IEA:Ensembl
A1Z1Q3	MACROD2	O-acetyl-ADP-ribose deacetylase MACROD2	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
A1Z1Q3	MACROD2	O-acetyl-ADP-ribose deacetylase MACROD2	GO:0051725; P:protein de-ADP-ribosylation; IDA:UniProtKB
A1Z1Q3	MACROD2	O-acetyl-ADP-ribose deacetylase MACROD2	GO:0042278; P:purine nucleoside metabolic process; IDA:UniProtKB
Q9UPN3	MACF1	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5	GO:0003779; F:actin binding; IDA:UniProtKB
Q9UPN3	MACF1	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5	GO:0051015; F:actin filament binding; NAS:UniProtKB
Q9UPN3	MACF1	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5	GO:0016887; F:ATPase activity; ISS:UniProtKB
Q9UPN3	MACF1	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UPN3	MACF1	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UPN3	MACF1	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UPN3	MACF1	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5	GO:0006200; P:ATP catabolic process; ISS:GOC
Q9UPN3	MACF1	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5	GO:0007050; P:cell cycle arrest; IEA:InterPro
Q9UPN3	MACF1	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5	GO:0006928; P:cellular component movement; IEA:Ensembl
Q9UPN3	MACF1	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5	GO:0007163; P:establishment or maintenance of cell polarity; IEA:Ensembl
Q9UPN3	MACF1	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5	GO:0043001; P:Golgi to plasma membrane protein transport; IDA:UniProtKB
Q9UPN3	MACF1	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5	GO:0001707; P:mesoderm formation; IEA:Ensembl
Q9UPN3	MACF1	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5	GO:0030177; P:positive regulation of Wnt signaling pathway; ISS:UniProtKB
Q9UPN3	MACF1	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5	GO:0006620; P:posttranslational protein targeting to membrane; IEA:Ensembl
Q9UPN3	MACF1	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5	GO:0010632; P:regulation of epithelial cell migration; ISS:UniProtKB
Q9UPN3	MACF1	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5	GO:0051893; P:regulation of focal adhesion assembly; ISS:UniProtKB
Q9UPN3	MACF1	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5	GO:0032886; P:regulation of microtubule-based process; IMP:UniProtKB
Q9UPN3	MACF1	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9UPN3	MACF1	Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5	GO:0042060; P:wound healing; ISS:UniProtKB
Q9BQ69	MACROD1	O-acetyl-ADP-ribose deacetylase MACROD1	GO:0019213; F:deacetylase activity; IDA:UniProtKB
Q9BQ69	MACROD1	O-acetyl-ADP-ribose deacetylase MACROD1	GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IDA:UniProtKB
Q9BQ69	MACROD1	O-acetyl-ADP-ribose deacetylase MACROD1	GO:0005515; F:protein binding; IPI:IntAct
Q9BQ69	MACROD1	O-acetyl-ADP-ribose deacetylase MACROD1	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
Q9BQ69	MACROD1	O-acetyl-ADP-ribose deacetylase MACROD1	GO:0051725; P:protein de-ADP-ribosylation; IDA:UniProtKB
Q9BQ69	MACROD1	O-acetyl-ADP-ribose deacetylase MACROD1	GO:0042278; P:purine nucleoside metabolic process; IDA:UniProtKB
Q8N5G2	TMEM57	Macoilin	GO:0007420; P:brain development; IEA:Ensembl
Q05195	MXD1	Max dimerization protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q05195	MXD1	Max dimerization protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q05195	MXD1	Max dimerization protein 1	GO:0003712; F:transcription cofactor activity; TAS:ProtInc
Q05195	MXD1	Max dimerization protein 1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q05195	MXD1	Max dimerization protein 1	GO:0008283; P:cell proliferation; TAS:ProtInc
Q05195	MXD1	Max dimerization protein 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q05195	MXD1	Max dimerization protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BW11	MXD3	Max dimerization protein 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BW11	MXD3	Max dimerization protein 3	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q9BW11	MXD3	Max dimerization protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13477	MADCAM1	Mucosal addressin cell adhesion molecule 1	GO:0007568; P:aging; IEA:Ensembl
Q13477	MADCAM1	Mucosal addressin cell adhesion molecule 1	GO:0007155; P:cell adhesion; TAS:ProtInc
Q13477	MADCAM1	Mucosal addressin cell adhesion molecule 1	GO:0009790; P:embryo development; IEA:Ensembl
Q13477	MADCAM1	Mucosal addressin cell adhesion molecule 1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q13477	MADCAM1	Mucosal addressin cell adhesion molecule 1	GO:0006955; P:immune response; TAS:ProtInc
Q13477	MADCAM1	Mucosal addressin cell adhesion molecule 1	GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
Q13477	MADCAM1	Mucosal addressin cell adhesion molecule 1	GO:0050900; P:leukocyte migration; IEA:Ensembl
Q13477	MADCAM1	Mucosal addressin cell adhesion molecule 1	GO:0002687; P:positive regulation of leukocyte migration; IEA:Ensembl
Q13477	MADCAM1	Mucosal addressin cell adhesion molecule 1	GO:0050776; P:regulation of immune response; TAS:Reactome
Q13477	MADCAM1	Mucosal addressin cell adhesion molecule 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q14582	MXD4	Max dimerization protein 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q14582	MXD4	Max dimerization protein 4	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q14582	MXD4	Max dimerization protein 4	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q14582	MXD4	Max dimerization protein 4	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q14582	MXD4	Max dimerization protein 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WXG6	MADD	MAP kinase-activating death domain protein	GO:0005123; F:death receptor binding; TAS:ProtInc
Q8WXG6	MADD	MAP kinase-activating death domain protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WXG6	MADD	MAP kinase-activating death domain protein	GO:0030295; F:protein kinase activator activity; TAS:UniProtKB
Q8WXG6	MADD	MAP kinase-activating death domain protein	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q8WXG6	MADD	MAP kinase-activating death domain protein	GO:0000187; P:activation of MAPK activity; IMP:UniProtKB
Q8WXG6	MADD	MAP kinase-activating death domain protein	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q8WXG6	MADD	MAP kinase-activating death domain protein	GO:0097194; P:execution phase of apoptosis; IMP:UniProtKB
Q8WXG6	MADD	MAP kinase-activating death domain protein	GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl
Q8WXG6	MADD	MAP kinase-activating death domain protein	GO:0042981; P:regulation of apoptotic process; IMP:UniProtKB
Q8WXG6	MADD	MAP kinase-activating death domain protein	GO:0051726; P:regulation of cell cycle; IMP:UniProtKB
Q8WXG6	MADD	MAP kinase-activating death domain protein	GO:2001236; P:regulation of extrinsic apoptotic signaling pathway; IDA:UniProtKB
Q8WXG6	MADD	MAP kinase-activating death domain protein	GO:1902041; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; IMP:UniProtKB
Q8WXG6	MADD	MAP kinase-activating death domain protein	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
Q8WXG6	MADD	MAP kinase-activating death domain protein	GO:0032483; P:regulation of Rab protein signal transduction; IDA:FlyBase
Q7L5Y9	MAEA	Macrophage erythroblast attacher	GO:0003779; F:actin binding; IDA:UniProtKB
Q7L5Y9	MAEA	Macrophage erythroblast attacher	GO:0007155; P:cell adhesion; IDA:UniProtKB
Q7L5Y9	MAEA	Macrophage erythroblast attacher	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q7L5Y9	MAEA	Macrophage erythroblast attacher	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q7L5Y9	MAEA	Macrophage erythroblast attacher	GO:0007010; P:cytoskeleton organization; IEA:Ensembl
Q7L5Y9	MAEA	Macrophage erythroblast attacher	GO:0048822; P:enucleate erythrocyte development; IEA:Ensembl
Q7L5Y9	MAEA	Macrophage erythroblast attacher	GO:0043249; P:erythrocyte maturation; IEA:UniProtKB-KW
Q7L5Y9	MAEA	Macrophage erythroblast attacher	GO:0033033; P:negative regulation of myeloid cell apoptotic process; IDA:UniProtKB
Q7L5Y9	MAEA	Macrophage erythroblast attacher	GO:0007346; P:regulation of mitotic cell cycle; NAS:UniProtKB
Q96JY0	MAEL	Protein maelstrom homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96JY0	MAEL	Protein maelstrom homolog	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96JY0	MAEL	Protein maelstrom homolog	GO:0000902; P:cell morphogenesis; IEA:Ensembl
Q96JY0	MAEL	Protein maelstrom homolog	GO:0043046; P:DNA methylation involved in gamete generation; ISS:UniProtKB
Q96JY0	MAEL	Protein maelstrom homolog	GO:0009566; P:fertilization; IEA:Ensembl
Q96JY0	MAEL	Protein maelstrom homolog	GO:0031047; P:gene silencing by RNA; ISS:UniProtKB
Q96JY0	MAEL	Protein maelstrom homolog	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
Q96JY0	MAEL	Protein maelstrom homolog	GO:0007140; P:male meiosis; IEA:Ensembl
Q96JY0	MAEL	Protein maelstrom homolog	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q96JY0	MAEL	Protein maelstrom homolog	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q96JY0	MAEL	Protein maelstrom homolog	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q96JY0	MAEL	Protein maelstrom homolog	GO:0034587; P:piRNA metabolic process; ISS:UniProtKB
Q96JY0	MAEL	Protein maelstrom homolog	GO:0046620; P:regulation of organ growth; IEA:Ensembl
Q96JY0	MAEL	Protein maelstrom homolog	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q96JY0	MAEL	Protein maelstrom homolog	GO:0007129; P:synapsis; IEA:Ensembl
Q9H063	MAF1	Repressor of RNA polymerase III transcription MAF1 homolog	GO:0001030; F:RNA polymerase III type 1 promoter DNA binding; IDA:UniProtKB
Q9H063	MAF1	Repressor of RNA polymerase III transcription MAF1 homolog	GO:0001031; F:RNA polymerase III type 2 promoter DNA binding; IDA:UniProtKB
Q9H063	MAF1	Repressor of RNA polymerase III transcription MAF1 homolog	GO:0001032; F:RNA polymerase III type 3 promoter DNA binding; IDA:UniProtKB
Q9H063	MAF1	Repressor of RNA polymerase III transcription MAF1 homolog	GO:0016480; P:negative regulation of transcription from RNA polymerase III promoter; IDA:UniProtKB
Q9H063	MAF1	Repressor of RNA polymerase III transcription MAF1 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NHW3	MAFA	Transcription factor MafA	GO:0003677; F:DNA binding; IDA:UniProtKB
Q8NHW3	MAFA	Transcription factor MafA	GO:0046982; F:protein heterodimerization activity; NAS:UniProtKB
Q8NHW3	MAFA	Transcription factor MafA	GO:0042803; F:protein homodimerization activity; TAS:UniProtKB
Q8NHW3	MAFA	Transcription factor MafA	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q8NHW3	MAFA	Transcription factor MafA	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:UniProtKB
Q8NHW3	MAFA	Transcription factor MafA	GO:0030073; P:insulin secretion; IDA:BHF-UCL
Q8NHW3	MAFA	Transcription factor MafA	GO:0007263; P:nitric oxide mediated signal transduction; IDA:BHF-UCL
Q8NHW3	MAFA	Transcription factor MafA	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8NHW3	MAFA	Transcription factor MafA	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q8NHW3	MAFA	Transcription factor MafA	GO:0009749; P:response to glucose; IDA:UniProtKB
Q8NHW3	MAFA	Transcription factor MafA	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y5Q3	MAFB	Transcription factor MafB	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y5Q3	MAFB	Transcription factor MafB	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9Y5Q3	MAFB	Transcription factor MafB	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9Y5Q3	MAFB	Transcription factor MafB	GO:0008134; F:transcription factor binding; IDA:UniProtKB
Q9Y5Q3	MAFB	Transcription factor MafB	GO:0035284; P:brain segmentation; IEA:Ensembl
Q9Y5Q3	MAFB	Transcription factor MafB	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q9Y5Q3	MAFB	Transcription factor MafB	GO:0045647; P:negative regulation of erythrocyte differentiation; IDA:UniProtKB
Q9Y5Q3	MAFB	Transcription factor MafB	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9Y5Q3	MAFB	Transcription factor MafB	GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl
Q9Y5Q3	MAFB	Transcription factor MafB	GO:0021571; P:rhombomere 5 development; IEA:Ensembl
Q9Y5Q3	MAFB	Transcription factor MafB	GO:0021572; P:rhombomere 6 development; IEA:Ensembl
Q9Y5Q3	MAFB	Transcription factor MafB	GO:0007379; P:segment specification; IEA:Ensembl
Q9Y5Q3	MAFB	Transcription factor MafB	GO:0007423; P:sensory organ development; TAS:ProtInc
Q9Y5Q3	MAFB	Transcription factor MafB	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
Q9Y5Q3	MAFB	Transcription factor MafB	GO:0048538; P:thymus development; IEA:Ensembl
Q9Y5Q3	MAFB	Transcription factor MafB	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9ULX9	MAFF	Transcription factor MafF	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9ULX9	MAFF	Transcription factor MafF	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9ULX9	MAFF	Transcription factor MafF	GO:0007596; P:blood coagulation; TAS:Reactome
Q9ULX9	MAFF	Transcription factor MafF	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9ULX9	MAFF	Transcription factor MafF	GO:0007567; P:parturition; TAS:ProtInc
Q9ULX9	MAFF	Transcription factor MafF	GO:0045604; P:regulation of epidermal cell differentiation; IEA:Ensembl
Q9ULX9	MAFF	Transcription factor MafF	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q9ULX9	MAFF	Transcription factor MafF	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
O15525	MAFG	Transcription factor MafG	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O15525	MAFG	Transcription factor MafG	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
O15525	MAFG	Transcription factor MafG	GO:0030534; P:adult behavior; IEA:Ensembl
O15525	MAFG	Transcription factor MafG	GO:0007596; P:blood coagulation; TAS:Reactome
O15525	MAFG	Transcription factor MafG	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O15525	MAFG	Transcription factor MafG	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
O15525	MAFG	Transcription factor MafG	GO:0030641; P:regulation of cellular pH; IEA:Ensembl
O15525	MAFG	Transcription factor MafG	GO:0045604; P:regulation of epidermal cell differentiation; IEA:Ensembl
O15525	MAFG	Transcription factor MafG	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WZ33	MAFIP	MaFF-interacting protein	GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro
Q8WZ33	MAFIP	MaFF-interacting protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8WZ33	MAFIP	MaFF-interacting protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60675	MAFK	Transcription factor MafK	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O60675	MAFK	Transcription factor MafK	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
O60675	MAFK	Transcription factor MafK	GO:0007596; P:blood coagulation; TAS:Reactome
O60675	MAFK	Transcription factor MafK	GO:0007399; P:nervous system development; IEA:Ensembl
O60675	MAFK	Transcription factor MafK	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75444	MAF	Transcription factor Maf	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
O75444	MAF	Transcription factor Maf	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
O75444	MAF	Transcription factor Maf	GO:0048468; P:cell development; IEA:Ensembl
O75444	MAF	Transcription factor Maf	GO:0001816; P:cytokine production; IEA:Ensembl
O75444	MAF	Transcription factor Maf	GO:0048839; P:inner ear development; IEA:Ensembl
O75444	MAF	Transcription factor Maf	GO:0070306; P:lens fiber cell differentiation; IEA:Ensembl
O75444	MAF	Transcription factor Maf	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O75444	MAF	Transcription factor Maf	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O75444	MAF	Transcription factor Maf	GO:0032330; P:regulation of chondrocyte differentiation; IEA:Ensembl
O75444	MAF	Transcription factor Maf	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P43357	MAGEA3	Melanoma-associated antigen 3	GO:0005515; F:protein binding; IPI:IntAct
P43356	MAGEA2	Melanoma-associated antigen 2	GO:0042826; F:histone deacetylase binding; IDA:UniProtKB
P43356	MAGEA2	Melanoma-associated antigen 2	GO:0005515; F:protein binding; IPI:UniProtKB
P43356	MAGEA2	Melanoma-associated antigen 2	GO:0070491; F:repressing transcription factor binding; IDA:UniProtKB
P43356	MAGEA2	Melanoma-associated antigen 2	GO:0031625; F:ubiquitin protein ligase binding; IDA:UniProtKB
P43356	MAGEA2	Melanoma-associated antigen 2	GO:0044257; P:cellular protein catabolic process; IMP:UniProtKB
P43356	MAGEA2	Melanoma-associated antigen 2	GO:0090398; P:cellular senescence; IDA:UniProtKB
P43356	MAGEA2	Melanoma-associated antigen 2	GO:1901984; P:negative regulation of protein acetylation; IDA:UniProtKB
P43356	MAGEA2	Melanoma-associated antigen 2	GO:0033234; P:negative regulation of protein sumoylation; IDA:UniProtKB
P43356	MAGEA2	Melanoma-associated antigen 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P43356	MAGEA2	Melanoma-associated antigen 2	GO:0051443; P:positive regulation of ubiquitin-protein ligase activity; IMP:UniProtKB
P43356	MAGEA2	Melanoma-associated antigen 2	GO:0072331; P:signal transduction by p53 class mediator; IDA:UniProtKB
P43356	MAGEA2	Melanoma-associated antigen 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P43358	MAGEA4	Melanoma-associated antigen 4	GO:0005515; F:protein binding; IPI:IntAct
P43360	MAGEA6	Melanoma-associated antigen 6	GO:0005515; F:protein binding; IPI:IntAct
P43355	MAGEA1	Melanoma-associated antigen 1	GO:0042826; F:histone deacetylase binding; IDA:UniProtKB
P43355	MAGEA1	Melanoma-associated antigen 1	GO:0005515; F:protein binding; IPI:IntAct
P43355	MAGEA1	Melanoma-associated antigen 1	GO:0045746; P:negative regulation of Notch signaling pathway; IDA:UniProtKB
P43355	MAGEA1	Melanoma-associated antigen 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P43355	MAGEA1	Melanoma-associated antigen 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P43364	MAGEA11	Melanoma-associated antigen 11	GO:0005515; F:protein binding; IPI:IntAct
Q8N7X4	MAGEB6	Melanoma-associated antigen B6	GO:0005515; F:protein binding; IPI:IntAct
O60732	MAGEC1	Melanoma-associated antigen C1	GO:0005515; F:protein binding; IPI:IntAct
Q9UBF1	MAGEC2	Melanoma-associated antigen C2	GO:0005515; F:protein binding; IPI:IntAct
Q9UBF1	MAGEC2	Melanoma-associated antigen C2	GO:0031625; F:ubiquitin protein ligase binding; IDA:UniProtKB
Q9UBF1	MAGEC2	Melanoma-associated antigen C2	GO:0044257; P:cellular protein catabolic process; IMP:UniProtKB
Q9UBF1	MAGEC2	Melanoma-associated antigen C2	GO:0051443; P:positive regulation of ubiquitin-protein ligase activity; IMP:UniProtKB
Q96M61	MAGEB18	Melanoma-associated antigen B18	GO:0005515; F:protein binding; IPI:IntAct
Q9Y5V3	MAGED1	Melanoma-associated antigen D1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y5V3	MAGED1	Melanoma-associated antigen D1	GO:0003713; F:transcription coactivator activity; IEA:Ensembl
Q9Y5V3	MAGED1	Melanoma-associated antigen D1	GO:0006915; P:apoptotic process; TAS:Reactome
Q9Y5V3	MAGED1	Melanoma-associated antigen D1	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q9Y5V3	MAGED1	Melanoma-associated antigen D1	GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB
Q9Y5V3	MAGED1	Melanoma-associated antigen D1	GO:0050680; P:negative regulation of epithelial cell proliferation; IDA:UniProtKB
Q9Y5V3	MAGED1	Melanoma-associated antigen D1	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q9Y5V3	MAGED1	Melanoma-associated antigen D1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9Y5V3	MAGED1	Melanoma-associated antigen D1	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q9Y5V3	MAGED1	Melanoma-associated antigen D1	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
Q9Y5V3	MAGED1	Melanoma-associated antigen D1	GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; IEA:Ensembl
Q9Y5V3	MAGED1	Melanoma-associated antigen D1	GO:0043406; P:positive regulation of MAP kinase activity; IEA:Ensembl
Q9Y5V3	MAGED1	Melanoma-associated antigen D1	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q9Y5V3	MAGED1	Melanoma-associated antigen D1	GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB
Q9Y5V3	MAGED1	Melanoma-associated antigen D1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9Y5V3	MAGED1	Melanoma-associated antigen D1	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q9HCI5	MAGEE1	Melanoma-associated antigen E1	GO:0005515; F:protein binding; IPI:IntAct
Q9H213	MAGEH1	Melanoma-associated antigen H1	GO:0006915; P:apoptotic process; TAS:ProtInc
Q96QZ7	MAGI1	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1	GO:0051393; F:alpha-actinin binding; IPI:UniProtKB
Q96QZ7	MAGI1	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96QZ7	MAGI1	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96QZ7	MAGI1	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1	GO:0008022; F:protein C-terminus binding; TAS:ProtInc
Q96QZ7	MAGI1	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1	GO:0007155; P:cell adhesion; TAS:ProtInc
Q96QZ7	MAGI1	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q96QZ7	MAGI1	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1	GO:0070997; P:neuron death; IMP:UniProt
Q96QZ7	MAGI1	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1	GO:0006461; P:protein complex assembly; NAS:ProtInc
Q96MG7	NDNL2	Melanoma-associated antigen G1	GO:0005515; F:protein binding; IPI:IntAct
Q96MG7	NDNL2	Melanoma-associated antigen G1	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q96MG7	NDNL2	Melanoma-associated antigen G1	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q96MG7	NDNL2	Melanoma-associated antigen G1	GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB
Q96MG7	NDNL2	Melanoma-associated antigen G1	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q96MG7	NDNL2	Melanoma-associated antigen G1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:Ensembl
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0031697; F:beta-1 adrenergic receptor binding; IPI:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0019902; F:phosphatase binding; IPI:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0030159; F:receptor signaling complex scaffold activity; IDA:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0004871; F:signal transducer activity; IEA:Ensembl
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0046332; F:SMAD binding; ISS:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0070699; F:type II activin receptor binding; ISS:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:1990090; P:cellular response to nerve growth factor stimulus; ISS:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0016482; P:cytoplasmic transport; ISS:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0072015; P:glomerular visceral epithelial cell development; ISS:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0071850; P:mitotic cell cycle arrest; ISS:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0032926; P:negative regulation of activin receptor signaling pathway; ISS:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0030336; P:negative regulation of cell migration; ISS:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0008285; P:negative regulation of cell proliferation; ISS:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0051898; P:negative regulation of protein kinase B signaling; IDA:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0038180; P:nerve growth factor signaling pathway; ISS:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0003402; P:planar cell polarity pathway involved in axis elongation; NAS:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0032516; P:positive regulation of phosphoprotein phosphatase activity; IDA:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0002092; P:positive regulation of receptor internalization; IDA:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0051291; P:protein heterooligomerization; ISS:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0043113; P:receptor clustering; ISS:UniProtKB
Q86UL8	MAGI2	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2	GO:0060395; P:SMAD protein signal transduction; ISS:UniProtKB
Q5TCQ9	MAGI3	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5TCQ9	MAGI3	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3	GO:0004385; F:guanylate kinase activity; NAS:UniProtKB
Q5TCQ9	MAGI3	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q5TCQ9	MAGI3	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q5TCQ9	MAGI3	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
Q5TCQ9	MAGI3	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3	GO:0046939; P:nucleotide phosphorylation; NAS:GOC
Q5TCQ9	MAGI3	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3	GO:0043507; P:positive regulation of JUN kinase activity; IEA:Ensembl
Q5TCQ9	MAGI3	Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9H0U3	MAGT1	Magnesium transporter protein 1	GO:0015095; F:magnesium ion transmembrane transporter activity; IMP:UniProtKB
Q9H0U3	MAGT1	Magnesium transporter protein 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9H0U3	MAGT1	Magnesium transporter protein 1	GO:0050890; P:cognition; IMP:UniProtKB
Q9H0U3	MAGT1	Magnesium transporter protein 1	GO:0015693; P:magnesium ion transport; IMP:UniProtKB
Q9H0U3	MAGT1	Magnesium transporter protein 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9H0U3	MAGT1	Magnesium transporter protein 1	GO:0006487; P:protein N-linked glycosylation; NAS:UniProtKB
Q9H0U3	MAGT1	Magnesium transporter protein 1	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
P20916	MAG	Myelin-associated glycoprotein	GO:0007596; P:blood coagulation; TAS:Reactome
P20916	MAG	Myelin-associated glycoprotein	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P20916	MAG	Myelin-associated glycoprotein	GO:0050900; P:leukocyte migration; TAS:Reactome
P20916	MAG	Myelin-associated glycoprotein	GO:0050771; P:negative regulation of axonogenesis; TAS:Reactome
P20916	MAG	Myelin-associated glycoprotein	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P20916	MAG	Myelin-associated glycoprotein	GO:0050770; P:regulation of axonogenesis; TAS:Reactome
P20916	MAG	Myelin-associated glycoprotein	GO:0021762; P:substantia nigra development; IEP:UniProtKB
Q9BXY0	MAK16	Protein MAK16 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P20794	MAK	Serine/threonine-protein kinase MAK	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P20794	MAK	Serine/threonine-protein kinase MAK	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC
P20794	MAK	Serine/threonine-protein kinase MAK	GO:0005515; F:protein binding; IPI:UniProtKB
P20794	MAK	Serine/threonine-protein kinase MAK	GO:0004672; F:protein kinase activity; NAS:UniProtKB
P20794	MAK	Serine/threonine-protein kinase MAK	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
P20794	MAK	Serine/threonine-protein kinase MAK	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P20794	MAK	Serine/threonine-protein kinase MAK	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P20794	MAK	Serine/threonine-protein kinase MAK	GO:0045494; P:photoreceptor cell maintenance; ISS:UniProtKB
P20794	MAK	Serine/threonine-protein kinase MAK	GO:0046777; P:protein autophosphorylation; IMP:UniProtKB
P20794	MAK	Serine/threonine-protein kinase MAK	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P20794	MAK	Serine/threonine-protein kinase MAK	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P20794	MAK	Serine/threonine-protein kinase MAK	GO:0007283; P:spermatogenesis; NAS:UniProtKB
P20794	MAK	Serine/threonine-protein kinase MAK	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q969L2	MAL2	Protein MAL2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BSK0	MARVELD1	MARVEL domain-containing protein 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8N4S9	MARVELD2	MARVEL domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProt
Q8N4S9	MARVELD2	MARVEL domain-containing protein 2	GO:0045216; P:cell-cell junction organization; IMP:MGI
Q8N4S9	MARVELD2	MARVEL domain-containing protein 2	GO:0061028; P:establishment of endothelial barrier; IMP:UniProt
Q8N4S9	MARVELD2	MARVEL domain-containing protein 2	GO:0007605; P:sensory perception of sound; IMP:MGI
Q8N4S9	MARVELD2	MARVEL domain-containing protein 2	GO:0070830; P:tight junction assembly; IMP:UniProt
Q96A59	MARVELD3	MARVEL domain-containing protein 3	GO:0005515; F:protein binding; IPI:UniProt
Q96A59	MARVELD3	MARVEL domain-containing protein 3	GO:0045216; P:cell-cell junction organization; IMP:MGI
Q96A59	MARVELD3	MARVEL domain-containing protein 3	GO:0070830; P:tight junction assembly; IMP:UniProt
Q13021	MALL	MAL-like protein	GO:0005515; F:protein binding; IPI:HGNC
Q13021	MALL	MAL-like protein	GO:0042632; P:cholesterol homeostasis; NAS:HGNC
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0004197; F:cysteine-type endopeptidase activity; NAS:UniProtKB
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0008233; F:peptidase activity; IDA:BHF-UCL
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0043621; F:protein self-association; IPI:UniProtKB
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0007250; P:activation of NF-kappaB-inducing kinase activity; IMP:UniProtKB
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0001923; P:B-1 B cell differentiation; IEA:Ensembl
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0006952; P:defense response; NAS:UniProtKB
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0045087; P:innate immune response; TAS:Reactome
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0043066; P:negative regulation of apoptotic process; NAS:UniProtKB
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0051168; P:nuclear export; IDA:UniProtKB
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0032743; P:positive regulation of interleukin-2 production; IMP:UniProtKB
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:BHF-UCL
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0031398; P:positive regulation of protein ubiquitination; NAS:BHF-UCL
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0050870; P:positive regulation of T cell activation; IC:UniProtKB
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0002726; P:positive regulation of T cell cytokine production; IMP:UniProtKB
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0051259; P:protein oligomerization; IDA:UniProtKB
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0016567; P:protein ubiquitination; IDA:GOC
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0006508; P:proteolysis; IDA:BHF-UCL
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0042981; P:regulation of apoptotic process; IDA:MGI
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0050856; P:regulation of T cell receptor signaling pathway; IEA:Ensembl
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0009620; P:response to fungus; IEA:Ensembl
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0002237; P:response to molecule of bacterial origin; IEA:Ensembl
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0042098; P:T cell proliferation; IEA:Ensembl
Q9UDY8	MALT1	Mucosa-associated lymphoid tissue lymphoma translocation protein 1	GO:0050852; P:T cell receptor signaling pathway; IDA:UniProtKB
P21145	MAL	Myelin and lymphocyte protein	GO:0015267; F:channel activity; TAS:ProtInc
P21145	MAL	Myelin and lymphocyte protein	GO:0008289; F:lipid binding; TAS:UniProtKB
P21145	MAL	Myelin and lymphocyte protein	GO:0016505; F:peptidase activator activity involved in apoptotic process; NAS:UniProtKB
P21145	MAL	Myelin and lymphocyte protein	GO:0005515; F:protein binding; IPI:IntAct
P21145	MAL	Myelin and lymphocyte protein	GO:0019911; F:structural constituent of myelin sheath; IDA:UniProtKB
P21145	MAL	Myelin and lymphocyte protein	GO:0045176; P:apical protein localization; TAS:UniProtKB
P21145	MAL	Myelin and lymphocyte protein	GO:0006915; P:apoptotic process; NAS:UniProtKB
P21145	MAL	Myelin and lymphocyte protein	GO:0030154; P:cell differentiation; TAS:UniProtKB
P21145	MAL	Myelin and lymphocyte protein	GO:0007417; P:central nervous system development; TAS:UniProtKB
P21145	MAL	Myelin and lymphocyte protein	GO:0001766; P:membrane raft polarization; TAS:UniProtKB
P21145	MAL	Myelin and lymphocyte protein	GO:0042552; P:myelination; NAS:UniProtKB
P21145	MAL	Myelin and lymphocyte protein	GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
P21145	MAL	Myelin and lymphocyte protein	GO:0055085; P:transmembrane transport; TAS:GOC
Q13495	MAMLD1	Mastermind-like domain-containing protein 1	GO:0008584; P:male gonad development; IEP:UniProtKB
Q13495	MAMLD1	Mastermind-like domain-containing protein 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q13495	MAMLD1	Mastermind-like domain-containing protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z304	MAMDC2	MAM domain-containing protein 2	GO:0005539; F:glycosaminoglycan binding; IEA:Ensembl
Q7Z304	MAMDC2	MAM domain-containing protein 2	GO:0019800; P:peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan; IEA:Ensembl
Q96JK9	MAML3	Mastermind-like protein 3	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q96JK9	MAML3	Mastermind-like protein 3	GO:0010467; P:gene expression; TAS:Reactome
Q96JK9	MAML3	Mastermind-like protein 3	GO:0007219; P:Notch signaling pathway; IDA:UniProtKB
Q96JK9	MAML3	Mastermind-like protein 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q96JK9	MAML3	Mastermind-like protein 3	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q8IZL2	MAML2	Mastermind-like protein 2	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q8IZL2	MAML2	Mastermind-like protein 2	GO:0010467; P:gene expression; TAS:Reactome
Q8IZL2	MAML2	Mastermind-like protein 2	GO:0007219; P:Notch signaling pathway; IDA:UniProtKB
Q8IZL2	MAML2	Mastermind-like protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q8IZL2	MAML2	Mastermind-like protein 2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q9Y2U8	LEMD3	Inner nuclear membrane protein Man1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y2U8	LEMD3	Inner nuclear membrane protein Man1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9Y2U8	LEMD3	Inner nuclear membrane protein Man1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y2U8	LEMD3	Inner nuclear membrane protein Man1	GO:0032926; P:negative regulation of activin receptor signaling pathway; IDA:UniProtKB
Q9Y2U8	LEMD3	Inner nuclear membrane protein Man1	GO:0030514; P:negative regulation of BMP signaling pathway; IDA:UniProtKB
Q9Y2U8	LEMD3	Inner nuclear membrane protein Man1	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
Q9Y2U8	LEMD3	Inner nuclear membrane protein Man1	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
Q9Y2U8	LEMD3	Inner nuclear membrane protein Man1	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q92585	MAML1	Mastermind-like protein 1	GO:0042605; F:peptide antigen binding; IPI:UniProtKB
Q92585	MAML1	Mastermind-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q92585	MAML1	Mastermind-like protein 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q92585	MAML1	Mastermind-like protein 1	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q92585	MAML1	Mastermind-like protein 1	GO:0060928; P:atrioventricular node cell development; ISS:BHF-UCL
Q92585	MAML1	Mastermind-like protein 1	GO:0003162; P:atrioventricular node development; ISS:BHF-UCL
Q92585	MAML1	Mastermind-like protein 1	GO:0010467; P:gene expression; TAS:Reactome
Q92585	MAML1	Mastermind-like protein 1	GO:0045445; P:myoblast differentiation; IEA:Ensembl
Q92585	MAML1	Mastermind-like protein 1	GO:0007219; P:Notch signaling pathway; IDA:UniProtKB
Q92585	MAML1	Mastermind-like protein 1	GO:0010831; P:positive regulation of myotube differentiation; IGI:UniProtKB
Q92585	MAML1	Mastermind-like protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q92585	MAML1	Mastermind-like protein 1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q92585	MAML1	Mastermind-like protein 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
O00462	MANBA	Beta-mannosidase	GO:0004567; F:beta-mannosidase activity; TAS:ProtInc
O00462	MANBA	Beta-mannosidase	GO:0005537; F:mannose binding; IEA:Ensembl
O00462	MANBA	Beta-mannosidase	GO:0006464; P:cellular protein modification process; NAS:UniProtKB
O00462	MANBA	Beta-mannosidase	GO:0006516; P:glycoprotein catabolic process; IEA:Ensembl
O00462	MANBA	Beta-mannosidase	GO:0046355; P:mannan catabolic process; IEA:InterPro
Q5SRI9	MANEA	Glycoprotein endo-alpha-1,2-mannosidase	GO:0004569; F:glycoprotein endo-alpha-1,2-mannosidase activity; IEA:UniProtKB-EC
Q5SRI9	MANEA	Glycoprotein endo-alpha-1,2-mannosidase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q5SRI9	MANEA	Glycoprotein endo-alpha-1,2-mannosidase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q5SRI9	MANEA	Glycoprotein endo-alpha-1,2-mannosidase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q5VSG8	MANEAL	Glycoprotein endo-alpha-1,2-mannosidase-like protein	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
P55145	MANF	Mesencephalic astrocyte-derived neurotrophic factor	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P55145	MANF	Mesencephalic astrocyte-derived neurotrophic factor	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
P55145	MANF	Mesencephalic astrocyte-derived neurotrophic factor	GO:0002014; P:vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure; IEA:Ensembl
P23368	ME2	NAD-dependent malic enzyme, mitochondrial	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P23368	ME2	NAD-dependent malic enzyme, mitochondrial	GO:0004471; F:malate dehydrogenase (decarboxylating) (NAD+) activity; TAS:ProtInc
P23368	ME2	NAD-dependent malic enzyme, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P23368	ME2	NAD-dependent malic enzyme, mitochondrial	GO:0051287; F:NAD binding; IEA:InterPro
P23368	ME2	NAD-dependent malic enzyme, mitochondrial	GO:0008948; F:oxaloacetate decarboxylase activity; IEA:UniProtKB-EC
P23368	ME2	NAD-dependent malic enzyme, mitochondrial	GO:0006108; P:malate metabolic process; IEA:InterPro
Q16798	ME3	NADP-dependent malic enzyme, mitochondrial	GO:0048037; F:cofactor binding; TAS:UniProtKB
Q16798	ME3	NADP-dependent malic enzyme, mitochondrial	GO:0004471; F:malate dehydrogenase (decarboxylating) (NAD+) activity; IEA:InterPro
Q16798	ME3	NADP-dependent malic enzyme, mitochondrial	GO:0004473; F:malate dehydrogenase (decarboxylating) (NADP+) activity; IDA:UniProtKB
Q16798	ME3	NADP-dependent malic enzyme, mitochondrial	GO:0004470; F:malic enzyme activity; IDA:UniProtKB
Q16798	ME3	NADP-dependent malic enzyme, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q16798	ME3	NADP-dependent malic enzyme, mitochondrial	GO:0051287; F:NAD binding; IEA:InterPro
Q16798	ME3	NADP-dependent malic enzyme, mitochondrial	GO:0008948; F:oxaloacetate decarboxylase activity; IEA:UniProtKB-EC
Q16798	ME3	NADP-dependent malic enzyme, mitochondrial	GO:0009060; P:aerobic respiration; TAS:UniProtKB
Q16798	ME3	NADP-dependent malic enzyme, mitochondrial	GO:0006108; P:malate metabolic process; IDA:UniProtKB
Q16798	ME3	NADP-dependent malic enzyme, mitochondrial	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q16798	ME3	NADP-dependent malic enzyme, mitochondrial	GO:0072592; P:oxygen metabolic process; TAS:UniProtKB
Q16798	ME3	NADP-dependent malic enzyme, mitochondrial	GO:0006090; P:pyruvate metabolic process; IDA:UniProtKB
P48163	ME1	NADP-dependent malic enzyme	GO:0043531; F:ADP binding; TAS:UniProtKB
P48163	ME1	NADP-dependent malic enzyme	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P48163	ME1	NADP-dependent malic enzyme	GO:0004471; F:malate dehydrogenase (decarboxylating) (NAD+) activity; IEA:InterPro
P48163	ME1	NADP-dependent malic enzyme	GO:0004473; F:malate dehydrogenase (decarboxylating) (NADP+) activity; IDA:UniProtKB
P48163	ME1	NADP-dependent malic enzyme	GO:0004470; F:malic enzyme activity; IDA:UniProtKB
P48163	ME1	NADP-dependent malic enzyme	GO:0030145; F:manganese ion binding; IDA:UniProtKB
P48163	ME1	NADP-dependent malic enzyme	GO:0051287; F:NAD binding; TAS:UniProtKB
P48163	ME1	NADP-dependent malic enzyme	GO:0050661; F:NADP binding; TAS:UniProtKB
P48163	ME1	NADP-dependent malic enzyme	GO:0008948; F:oxaloacetate decarboxylase activity; IEA:UniProtKB-EC
P48163	ME1	NADP-dependent malic enzyme	GO:0005975; P:carbohydrate metabolic process; NAS:ProtInc
P48163	ME1	NADP-dependent malic enzyme	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P48163	ME1	NADP-dependent malic enzyme	GO:0006108; P:malate metabolic process; IDA:UniProtKB
P48163	ME1	NADP-dependent malic enzyme	GO:0006741; P:NADP biosynthetic process; TAS:UniProtKB
P48163	ME1	NADP-dependent malic enzyme	GO:0051262; P:protein tetramerization; IEA:Ensembl
P48163	ME1	NADP-dependent malic enzyme	GO:0009743; P:response to carbohydrate; TAS:UniProtKB
P48163	ME1	NADP-dependent malic enzyme	GO:0009725; P:response to hormone; ISS:UniProtKB
P48163	ME1	NADP-dependent malic enzyme	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9P2G4	MAP10	Microtubule-associated protein 10	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q9P2G4	MAP10	Microtubule-associated protein 10	GO:0031122; P:cytoplasmic microtubule organization; IMP:UniProtKB
Q9P2G4	MAP10	Microtubule-associated protein 10	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB
Q9P2G4	MAP10	Microtubule-associated protein 10	GO:0032886; P:regulation of microtubule-based process; IMP:UniProtKB
Q9P2G4	MAP10	Microtubule-associated protein 10	GO:0051256; P:spindle midzone assembly involved in mitosis; IMP:UniProtKB
P53582	METAP1	Methionine aminopeptidase 1	GO:0004177; F:aminopeptidase activity; TAS:UniProtKB
P53582	METAP1	Methionine aminopeptidase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-HAMAP
P53582	METAP1	Methionine aminopeptidase 1	GO:0070006; F:metalloaminopeptidase activity; IEA:UniProtKB-HAMAP
P53582	METAP1	Methionine aminopeptidase 1	GO:0008235; F:metalloexopeptidase activity; TAS:UniProtKB
P53582	METAP1	Methionine aminopeptidase 1	GO:0031365; P:N-terminal protein amino acid modification; TAS:HGNC
P53582	METAP1	Methionine aminopeptidase 1	GO:0018206; P:peptidyl-methionine modification; TAS:HGNC
P53582	METAP1	Methionine aminopeptidase 1	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P53582	METAP1	Methionine aminopeptidase 1	GO:0070084; P:protein initiator methionine removal; IEA:UniProtKB-HAMAP
P53582	METAP1	Methionine aminopeptidase 1	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
P53582	METAP1	Methionine aminopeptidase 1	GO:0006417; P:regulation of translation; TAS:HGNC
P53582	METAP1	Methionine aminopeptidase 1	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
Q6UB28	METAP1D	Methionine aminopeptidase 1D, mitochondrial	GO:0004177; F:aminopeptidase activity; TAS:UniProtKB
Q6UB28	METAP1D	Methionine aminopeptidase 1D, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-HAMAP
Q6UB28	METAP1D	Methionine aminopeptidase 1D, mitochondrial	GO:0070006; F:metalloaminopeptidase activity; IEA:UniProtKB-HAMAP
Q6UB28	METAP1D	Methionine aminopeptidase 1D, mitochondrial	GO:0008235; F:metalloexopeptidase activity; TAS:UniProtKB
Q6UB28	METAP1D	Methionine aminopeptidase 1D, mitochondrial	GO:0031365; P:N-terminal protein amino acid modification; TAS:HGNC
Q6UB28	METAP1D	Methionine aminopeptidase 1D, mitochondrial	GO:0018206; P:peptidyl-methionine modification; TAS:HGNC
Q6UB28	METAP1D	Methionine aminopeptidase 1D, mitochondrial	GO:0070084; P:protein initiator methionine removal; IEA:UniProtKB-HAMAP
P78559	MAP1A	Microtubule-associated protein 1A	GO:0016787; F:hydrolase activity; IEA:InterPro
P78559	MAP1A	Microtubule-associated protein 1A	GO:0005515; F:protein binding; IPI:UniProtKB
P78559	MAP1A	Microtubule-associated protein 1A	GO:0005198; F:structural molecule activity; NAS:ProtInc
P78559	MAP1A	Microtubule-associated protein 1A	GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro
P78559	MAP1A	Microtubule-associated protein 1A	GO:0007605; P:sensory perception of sound; IEA:Ensembl
P46821	MAP1B	Microtubule-associated protein 1B	GO:0016787; F:hydrolase activity; IEA:InterPro
P46821	MAP1B	Microtubule-associated protein 1B	GO:0005515; F:protein binding; IPI:UniProtKB
P46821	MAP1B	Microtubule-associated protein 1B	GO:0005198; F:structural molecule activity; NAS:ProtInc
P46821	MAP1B	Microtubule-associated protein 1B	GO:0048675; P:axon extension; IEA:Ensembl
P46821	MAP1B	Microtubule-associated protein 1B	GO:0009987; P:cellular process; IDA:DFLAT
P46821	MAP1B	Microtubule-associated protein 1B	GO:0016358; P:dendrite development; IEA:Ensembl
P46821	MAP1B	Microtubule-associated protein 1B	GO:0061162; P:establishment of monopolar cell polarity; IEA:Ensembl
P46821	MAP1B	Microtubule-associated protein 1B	GO:0001578; P:microtubule bundle formation; IEA:Ensembl
P46821	MAP1B	Microtubule-associated protein 1B	GO:0047497; P:mitochondrion transport along microtubule; IEA:Ensembl
P46821	MAP1B	Microtubule-associated protein 1B	GO:0032387; P:negative regulation of intracellular transport; IEA:Ensembl
P46821	MAP1B	Microtubule-associated protein 1B	GO:0045773; P:positive regulation of axon extension; IEA:Ensembl
Q66K74	MAP1S	Microtubule-associated protein 1S	GO:0051015; F:actin filament binding; IDA:HGNC
Q66K74	MAP1S	Microtubule-associated protein 1S	GO:0048487; F:beta-tubulin binding; IDA:HGNC
Q66K74	MAP1S	Microtubule-associated protein 1S	GO:0003677; F:DNA binding; IDA:HGNC
Q66K74	MAP1S	Microtubule-associated protein 1S	GO:0016787; F:hydrolase activity; IEA:InterPro
Q66K74	MAP1S	Microtubule-associated protein 1S	GO:0008017; F:microtubule binding; IDA:HGNC
Q66K74	MAP1S	Microtubule-associated protein 1S	GO:0005515; F:protein binding; IPI:UniProtKB
Q66K74	MAP1S	Microtubule-associated protein 1S	GO:0015631; F:tubulin binding; IDA:HGNC
Q66K74	MAP1S	Microtubule-associated protein 1S	GO:0006309; P:apoptotic DNA fragmentation; TAS:BHF-UCL
Q66K74	MAP1S	Microtubule-associated protein 1S	GO:0007420; P:brain development; ISS:HGNC
Q66K74	MAP1S	Microtubule-associated protein 1S	GO:0097194; P:execution phase of apoptosis; IDA:BHF-UCL
Q66K74	MAP1S	Microtubule-associated protein 1S	GO:0001578; P:microtubule bundle formation; IMP:HGNC
Q66K74	MAP1S	Microtubule-associated protein 1S	GO:0047497; P:mitochondrion transport along microtubule; TAS:HGNC
Q66K74	MAP1S	Microtubule-associated protein 1S	GO:0007399; P:nervous system development; ISS:HGNC
Q66K74	MAP1S	Microtubule-associated protein 1S	GO:0048812; P:neuron projection morphogenesis; IEP:HGNC
P50579	METAP2	Methionine aminopeptidase 2	GO:0004177; F:aminopeptidase activity; IDA:UniProtKB
P50579	METAP2	Methionine aminopeptidase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-HAMAP
P50579	METAP2	Methionine aminopeptidase 2	GO:0070006; F:metalloaminopeptidase activity; IEA:UniProtKB-HAMAP
P50579	METAP2	Methionine aminopeptidase 2	GO:0008235; F:metalloexopeptidase activity; IDA:UniProtKB
P50579	METAP2	Methionine aminopeptidase 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P50579	METAP2	Methionine aminopeptidase 2	GO:0031365; P:N-terminal protein amino acid modification; IDA:HGNC
P50579	METAP2	Methionine aminopeptidase 2	GO:0018206; P:peptidyl-methionine modification; IDA:HGNC
P50579	METAP2	Methionine aminopeptidase 2	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P50579	METAP2	Methionine aminopeptidase 2	GO:0070084; P:protein initiator methionine removal; IEA:UniProtKB-HAMAP
P50579	METAP2	Methionine aminopeptidase 2	GO:0016485; P:protein processing; IDA:HGNC
P50579	METAP2	Methionine aminopeptidase 2	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
P50579	METAP2	Methionine aminopeptidase 2	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
P27816	MAP4	Microtubule-associated protein 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P27816	MAP4	Microtubule-associated protein 4	GO:0005515; F:protein binding; IPI:IntAct
P27816	MAP4	Microtubule-associated protein 4	GO:0005198; F:structural molecule activity; TAS:ProtInc
P27816	MAP4	Microtubule-associated protein 4	GO:0051301; P:cell division; IMP:MGI
P27816	MAP4	Microtubule-associated protein 4	GO:0051294; P:establishment of spindle orientation; IMP:MGI
P27816	MAP4	Microtubule-associated protein 4	GO:0051012; P:microtubule sliding; IMP:MGI
P27816	MAP4	Microtubule-associated protein 4	GO:0007052; P:mitotic spindle organization; IMP:MGI
Q96JE9	MAP6	Microtubule-associated protein 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q96JE9	MAP6	Microtubule-associated protein 6	GO:0048813; P:dendrite morphogenesis; IMP:UniProtKB
Q96JE9	MAP6	Microtubule-associated protein 6	GO:0032418; P:lysosome localization; IMP:UniProtKB
Q96JE9	MAP6	Microtubule-associated protein 6	GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro
Q96JE9	MAP6	Microtubule-associated protein 6	GO:0006810; P:transport; IEA:UniProtKB-KW
Q14244	MAP7	Ensconsin	GO:0005102; F:receptor binding; ISS:BHF-UCL
Q14244	MAP7	Ensconsin	GO:0005198; F:structural molecule activity; TAS:ProtInc
Q14244	MAP7	Ensconsin	GO:0000902; P:cell morphogenesis; IEA:Ensembl
Q14244	MAP7	Ensconsin	GO:0008283; P:cell proliferation; IEA:Ensembl
Q14244	MAP7	Ensconsin	GO:0007163; P:establishment or maintenance of cell polarity; TAS:ProtInc
Q14244	MAP7	Ensconsin	GO:0009566; P:fertilization; IEA:Ensembl
Q14244	MAP7	Ensconsin	GO:0007281; P:germ cell development; IEA:Ensembl
Q14244	MAP7	Ensconsin	GO:0006687; P:glycosphingolipid metabolic process; IEA:Ensembl
Q14244	MAP7	Ensconsin	GO:0048872; P:homeostasis of number of cells; IEA:Ensembl
Q14244	MAP7	Ensconsin	GO:0033327; P:Leydig cell differentiation; IEA:Ensembl
Q14244	MAP7	Ensconsin	GO:0001578; P:microtubule bundle formation; IEA:Ensembl
Q14244	MAP7	Ensconsin	GO:0000226; P:microtubule cytoskeleton organization; TAS:ProtInc
Q14244	MAP7	Ensconsin	GO:0006997; P:nucleus organization; IEA:Ensembl
Q14244	MAP7	Ensconsin	GO:0035265; P:organ growth; IEA:Ensembl
Q14244	MAP7	Ensconsin	GO:0072659; P:protein localization to plasma membrane; ISS:BHF-UCL
Q14244	MAP7	Ensconsin	GO:0006970; P:response to osmotic stress; ISS:BHF-UCL
Q14244	MAP7	Ensconsin	GO:0032526; P:response to retinoic acid; IEA:Ensembl
Q14244	MAP7	Ensconsin	GO:0060009; P:Sertoli cell development; IEA:Ensembl
Q14244	MAP7	Ensconsin	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q49MG5	MAP9	Microtubule-associated protein 9	GO:0000910; P:cytokinesis; IEA:InterPro
Q49MG5	MAP9	Microtubule-associated protein 9	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q49MG5	MAP9	Microtubule-associated protein 9	GO:0007088; P:regulation of mitosis; IEA:InterPro
Q49MG5	MAP9	Microtubule-associated protein 9	GO:0051225; P:spindle assembly; IEA:InterPro
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0005515; F:protein binding; IPI:UniProtKB
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0004672; F:protein kinase activity; TAS:ProtInc
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0004871; F:signal transducer activity; TAS:ProtInc
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0070935; P:3'-UTR-mediated mRNA stabilization; IDA:UniProtKB
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0000187; P:activation of MAPK activity; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IMP:BHF-UCL
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0031572; P:G2 DNA damage checkpoint; IMP:UniProtKB
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0010467; P:gene expression; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0006954; P:inflammatory response; ISS:UniProtKB
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0045087; P:innate immune response; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0048839; P:inner ear development; IEA:Ensembl
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0006691; P:leukotriene metabolic process; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0044351; P:macropinocytosis; ISS:UniProtKB
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0000165; P:MAPK cascade; TAS:ProtInc
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0032675; P:regulation of interleukin-6 production; ISS:UniProtKB
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0032680; P:regulation of tumor necrosis factor production; IDA:UniProtKB
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0034097; P:response to cytokine; IDA:UniProtKB
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0032496; P:response to lipopolysaccharide; ISS:UniProtKB
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0006950; P:response to stress; IDA:UniProtKB
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0016070; P:RNA metabolic process; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0002224; P:toll-like receptor signaling pathway; ISS:UniProtKB
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P49137	MAPKAPK2	MAP kinase-activated protein kinase 2	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IMP:BHF-UCL
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0004708; F:MAP kinase kinase activity; TAS:ProtInc
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0000187; P:activation of MAPK activity; TAS:Reactome
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0045087; P:innate immune response; TAS:Reactome
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0044351; P:macropinocytosis; ISS:UniProtKB
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0034097; P:response to cytokine; IDA:UniProtKB
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0032496; P:response to lipopolysaccharide; ISS:UniProtKB
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0006950; P:response to stress; TAS:ProtInc
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0007165; P:signal transduction; TAS:ProtInc
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0002224; P:toll-like receptor signaling pathway; ISS:UniProtKB
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q16644	MAPKAPK3	MAP kinase-activated protein kinase 3	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q8IW41	MAPKAPK5	MAP kinase-activated protein kinase 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IW41	MAPKAPK5	MAP kinase-activated protein kinase 5	GO:0004708; F:MAP kinase kinase activity; TAS:ProtInc
Q8IW41	MAPKAPK5	MAP kinase-activated protein kinase 5	GO:0002039; F:p53 binding; IDA:UniProtKB
Q8IW41	MAPKAPK5	MAP kinase-activated protein kinase 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IW41	MAPKAPK5	MAP kinase-activated protein kinase 5	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q8IW41	MAPKAPK5	MAP kinase-activated protein kinase 5	GO:0000187; P:activation of MAPK activity; TAS:GOC
Q8IW41	MAPKAPK5	MAP kinase-activated protein kinase 5	GO:0000165; P:MAPK cascade; TAS:GOC
Q8IW41	MAPKAPK5	MAP kinase-activated protein kinase 5	GO:0032007; P:negative regulation of TOR signaling; ISS:UniProtKB
Q8IW41	MAPKAPK5	MAP kinase-activated protein kinase 5	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q8IW41	MAPKAPK5	MAP kinase-activated protein kinase 5	GO:0007265; P:Ras protein signal transduction; IDA:UniProtKB
Q8IW41	MAPKAPK5	MAP kinase-activated protein kinase 5	GO:0006417; P:regulation of translation; IDA:UniProtKB
Q8IW41	MAPKAPK5	MAP kinase-activated protein kinase 5	GO:0007165; P:signal transduction; TAS:ProtInc
Q8IW41	MAPKAPK5	MAP kinase-activated protein kinase 5	GO:0090400; P:stress-induced premature senescence; IDA:UniProtKB
Q16655	MLANA	Melanoma antigen recognized by T-cells 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q5VT66	MARC1	Mitochondrial amidoxime-reducing component 1	GO:0030151; F:molybdenum ion binding; IDA:UniProtKB
Q5VT66	MARC1	Mitochondrial amidoxime-reducing component 1	GO:0043546; F:molybdopterin cofactor binding; IDA:UniProtKB
Q5VT66	MARC1	Mitochondrial amidoxime-reducing component 1	GO:0008940; F:nitrate reductase activity; IDA:UniProtKB
Q5VT66	MARC1	Mitochondrial amidoxime-reducing component 1	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q5VT66	MARC1	Mitochondrial amidoxime-reducing component 1	GO:0051410; P:detoxification of nitrogen compound; NAS:UniProtKB
Q5VT66	MARC1	Mitochondrial amidoxime-reducing component 1	GO:0042126; P:nitrate metabolic process; IDA:UniProtKB
Q5VT66	MARC1	Mitochondrial amidoxime-reducing component 1	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q969Z3	MARC2	Mitochondrial amidoxime reducing component 2	GO:0030151; F:molybdenum ion binding; IDA:UniProtKB
Q969Z3	MARC2	Mitochondrial amidoxime reducing component 2	GO:0043546; F:molybdopterin cofactor binding; IDA:UniProtKB
Q969Z3	MARC2	Mitochondrial amidoxime reducing component 2	GO:0008940; F:nitrate reductase activity; IDA:UniProtKB
Q969Z3	MARC2	Mitochondrial amidoxime reducing component 2	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q969Z3	MARC2	Mitochondrial amidoxime reducing component 2	GO:0051410; P:detoxification of nitrogen compound; NAS:UniProtKB
Q969Z3	MARC2	Mitochondrial amidoxime reducing component 2	GO:0042126; P:nitrate metabolic process; IDA:UniProtKB
Q969Z3	MARC2	Mitochondrial amidoxime reducing component 2	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q9UEW3	MARCO	Macrophage receptor MARCO	GO:0005044; F:scavenger receptor activity; IEA:InterPro
Q9UEW3	MARCO	Macrophage receptor MARCO	GO:0008329; F:signaling pattern recognition receptor activity; TAS:ProtInc
Q9UEW3	MARCO	Macrophage receptor MARCO	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q9UEW3	MARCO	Macrophage receptor MARCO	GO:0043277; P:apoptotic cell clearance; IEA:Ensembl
Q9UEW3	MARCO	Macrophage receptor MARCO	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q9UEW3	MARCO	Macrophage receptor MARCO	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q9UEW3	MARCO	Macrophage receptor MARCO	GO:0002221; P:pattern recognition receptor signaling pathway; TAS:GOC
P29966	MARCKS	Myristoylated alanine-rich C-kinase substrate	GO:0051015; F:actin filament binding; TAS:ProtInc
P29966	MARCKS	Myristoylated alanine-rich C-kinase substrate	GO:0005516; F:calmodulin binding; TAS:ProtInc
P29966	MARCKS	Myristoylated alanine-rich C-kinase substrate	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P29966	MARCKS	Myristoylated alanine-rich C-kinase substrate	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P29966	MARCKS	Myristoylated alanine-rich C-kinase substrate	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15691	MAPRE1	Microtubule-associated protein RP/EB family member 1	GO:0051010; F:microtubule plus-end binding; IDA:UniProtKB
Q15691	MAPRE1	Microtubule-associated protein RP/EB family member 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15691	MAPRE1	Microtubule-associated protein RP/EB family member 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15691	MAPRE1	Microtubule-associated protein RP/EB family member 1	GO:0008022; F:protein C-terminus binding; TAS:ProtInc
Q15691	MAPRE1	Microtubule-associated protein RP/EB family member 1	GO:0008283; P:cell proliferation; TAS:ProtInc
Q15691	MAPRE1	Microtubule-associated protein RP/EB family member 1	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q15691	MAPRE1	Microtubule-associated protein RP/EB family member 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q15691	MAPRE1	Microtubule-associated protein RP/EB family member 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q15691	MAPRE1	Microtubule-associated protein RP/EB family member 1	GO:0031115; P:negative regulation of microtubule polymerization; IDA:UniProtKB
Q15691	MAPRE1	Microtubule-associated protein RP/EB family member 1	GO:0035372; P:protein localization to microtubule; IDA:UniProtKB
Q15555	MAPRE2	Microtubule-associated protein RP/EB family member 2	GO:0008283; P:cell proliferation; TAS:ProtInc
Q15555	MAPRE2	Microtubule-associated protein RP/EB family member 2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q15555	MAPRE2	Microtubule-associated protein RP/EB family member 2	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UPY8	MAPRE3	Microtubule-associated protein RP/EB family member 3	GO:0008017; F:microtubule binding; ISS:BHF-UCL
Q9UPY8	MAPRE3	Microtubule-associated protein RP/EB family member 3	GO:0005515; F:protein binding; IPI:BHF-UCL
Q9UPY8	MAPRE3	Microtubule-associated protein RP/EB family member 3	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9UPY8	MAPRE3	Microtubule-associated protein RP/EB family member 3	GO:0045737; P:positive regulation of cyclin-dependent protein kinase activity; ISS:BHF-UCL
Q9UPY8	MAPRE3	Microtubule-associated protein RP/EB family member 3	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:BHF-UCL
Q9Y4F3	KIAA0430	Meiosis arrest female protein 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9Y4F3	KIAA0430	Meiosis arrest female protein 1	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9Y4F3	KIAA0430	Meiosis arrest female protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9Y4F3	KIAA0430	Meiosis arrest female protein 1	GO:0006302; P:double-strand break repair; IEA:Ensembl
Q9Y4F3	KIAA0430	Meiosis arrest female protein 1	GO:0007143; P:female meiotic division; ISS:UniProtKB
Q9Y4F3	KIAA0430	Meiosis arrest female protein 1	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q9Y4F3	KIAA0430	Meiosis arrest female protein 1	GO:0048477; P:oogenesis; ISS:UniProtKB
Q9Y4F3	KIAA0430	Meiosis arrest female protein 1	GO:0010468; P:regulation of gene expression; ISS:UniProtKB
Q8TCQ1	MARCH1	E3 ubiquitin-protein ligase MARCH1	GO:0042287; F:MHC protein binding; IDA:UniProtKB
Q8TCQ1	MARCH1	E3 ubiquitin-protein ligase MARCH1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q8TCQ1	MARCH1	E3 ubiquitin-protein ligase MARCH1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TCQ1	MARCH1	E3 ubiquitin-protein ligase MARCH1	GO:0002495; P:antigen processing and presentation of peptide antigen via MHC class II; IDA:UniProtKB
Q8TCQ1	MARCH1	E3 ubiquitin-protein ligase MARCH1	GO:0006955; P:immune response; IDA:UniProtKB
Q8TCQ1	MARCH1	E3 ubiquitin-protein ligase MARCH1	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q9P0N8	MARCH2	E3 ubiquitin-protein ligase MARCH2	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9P0N8	MARCH2	E3 ubiquitin-protein ligase MARCH2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9P0N8	MARCH2	E3 ubiquitin-protein ligase MARCH2	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q9P0N8	MARCH2	E3 ubiquitin-protein ligase MARCH2	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q86UD3	MARCH3	E3 ubiquitin-protein ligase MARCH3	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q86UD3	MARCH3	E3 ubiquitin-protein ligase MARCH3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86UD3	MARCH3	E3 ubiquitin-protein ligase MARCH3	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q86UD3	MARCH3	E3 ubiquitin-protein ligase MARCH3	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9P2E8	MARCH4	E3 ubiquitin-protein ligase MARCH4	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9P2E8	MARCH4	E3 ubiquitin-protein ligase MARCH4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NX47	MARCH5	E3 ubiquitin-protein ligase MARCH5	GO:0051020; F:GTPase binding; IPI:UniProtKB
Q9NX47	MARCH5	E3 ubiquitin-protein ligase MARCH5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NX47	MARCH5	E3 ubiquitin-protein ligase MARCH5	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9NX47	MARCH5	E3 ubiquitin-protein ligase MARCH5	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NX47	MARCH5	E3 ubiquitin-protein ligase MARCH5	GO:0090344; P:negative regulation of cell aging; IMP:UniProtKB
Q9NX47	MARCH5	E3 ubiquitin-protein ligase MARCH5	GO:0090141; P:positive regulation of mitochondrial fission; IMP:UniProtKB
Q9NX47	MARCH5	E3 ubiquitin-protein ligase MARCH5	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
Q9NX47	MARCH5	E3 ubiquitin-protein ligase MARCH5	GO:0070585; P:protein localization to mitochondrion; IMP:UniProtKB
Q9NX47	MARCH5	E3 ubiquitin-protein ligase MARCH5	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q9NX47	MARCH5	E3 ubiquitin-protein ligase MARCH5	GO:0090140; P:regulation of mitochondrial fission; IMP:UniProtKB
O60337	MARCH6	E3 ubiquitin-protein ligase MARCH6	GO:0019899; F:enzyme binding; IPI:UniProtKB
O60337	MARCH6	E3 ubiquitin-protein ligase MARCH6	GO:0031624; F:ubiquitin conjugating enzyme binding; IPI:UniProtKB
O60337	MARCH6	E3 ubiquitin-protein ligase MARCH6	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
O60337	MARCH6	E3 ubiquitin-protein ligase MARCH6	GO:0008270; F:zinc ion binding; IEA:InterPro
O60337	MARCH6	E3 ubiquitin-protein ligase MARCH6	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
Q9H992	MARCH7	E3 ubiquitin-protein ligase MARCH7	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9H992	MARCH7	E3 ubiquitin-protein ligase MARCH7	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H992	MARCH7	E3 ubiquitin-protein ligase MARCH7	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q5T0T0	MARCH8	E3 ubiquitin-protein ligase MARCH8	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q5T0T0	MARCH8	E3 ubiquitin-protein ligase MARCH8	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5T0T0	MARCH8	E3 ubiquitin-protein ligase MARCH8	GO:0002495; P:antigen processing and presentation of peptide antigen via MHC class II; IEA:Ensembl
Q5T0T0	MARCH8	E3 ubiquitin-protein ligase MARCH8	GO:0045347; P:negative regulation of MHC class II biosynthetic process; IEA:Ensembl
Q5T0T0	MARCH8	E3 ubiquitin-protein ligase MARCH8	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q86YJ5	MARCH9	E3 ubiquitin-protein ligase MARCH9	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q86YJ5	MARCH9	E3 ubiquitin-protein ligase MARCH9	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86YJ5	MARCH9	E3 ubiquitin-protein ligase MARCH9	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
A6NNE9	MARCH11	E3 ubiquitin-protein ligase MARCH11	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
A6NNE9	MARCH11	E3 ubiquitin-protein ligase MARCH11	GO:0008270; F:zinc ion binding; IEA:InterPro
A6NNE9	MARCH11	E3 ubiquitin-protein ligase MARCH11	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8NA82	MARCH10	Probable E3 ubiquitin-protein ligase MARCH10	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q8NA82	MARCH10	Probable E3 ubiquitin-protein ligase MARCH10	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8NA82	MARCH10	Probable E3 ubiquitin-protein ligase MARCH10	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9P0L2	MARK1	Serine/threonine-protein kinase MARK1	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9P0L2	MARK1	Serine/threonine-protein kinase MARK1	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q9P0L2	MARK1	Serine/threonine-protein kinase MARK1	GO:0070300; F:phosphatidic acid binding; IDA:UniProtKB
Q9P0L2	MARK1	Serine/threonine-protein kinase MARK1	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProtKB
Q9P0L2	MARK1	Serine/threonine-protein kinase MARK1	GO:0001786; F:phosphatidylserine binding; IDA:UniProtKB
Q9P0L2	MARK1	Serine/threonine-protein kinase MARK1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9P0L2	MARK1	Serine/threonine-protein kinase MARK1	GO:0050321; F:tau-protein kinase activity; ISS:UniProtKB
Q9P0L2	MARK1	Serine/threonine-protein kinase MARK1	GO:0007010; P:cytoskeleton organization; ISS:UniProtKB
Q9P0L2	MARK1	Serine/threonine-protein kinase MARK1	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q9P0L2	MARK1	Serine/threonine-protein kinase MARK1	GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl
Q9P0L2	MARK1	Serine/threonine-protein kinase MARK1	GO:0001764; P:neuron migration; ISS:UniProtKB
Q9P0L2	MARK1	Serine/threonine-protein kinase MARK1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9P0L2	MARK1	Serine/threonine-protein kinase MARK1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q7KZI7	MARK2	Serine/threonine-protein kinase MARK2	GO:0005524; F:ATP binding; IDA:UniProtKB
Q7KZI7	MARK2	Serine/threonine-protein kinase MARK2	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q7KZI7	MARK2	Serine/threonine-protein kinase MARK2	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q7KZI7	MARK2	Serine/threonine-protein kinase MARK2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7KZI7	MARK2	Serine/threonine-protein kinase MARK2	GO:0005515; F:protein binding; IPI:UniProtKB
Q7KZI7	MARK2	Serine/threonine-protein kinase MARK2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q7KZI7	MARK2	Serine/threonine-protein kinase MARK2	GO:0050321; F:tau-protein kinase activity; ISS:UniProtKB
Q7KZI7	MARK2	Serine/threonine-protein kinase MARK2	GO:0030010; P:establishment of cell polarity; IDA:UniProtKB
Q7KZI7	MARK2	Serine/threonine-protein kinase MARK2	GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; IDA:UniProtKB
Q7KZI7	MARK2	Serine/threonine-protein kinase MARK2	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q7KZI7	MARK2	Serine/threonine-protein kinase MARK2	GO:0001764; P:neuron migration; ISS:UniProtKB
Q7KZI7	MARK2	Serine/threonine-protein kinase MARK2	GO:0010976; P:positive regulation of neuron projection development; IDA:UniProtKB
Q7KZI7	MARK2	Serine/threonine-protein kinase MARK2	GO:0046777; P:protein autophosphorylation; ISS:UniProtKB
Q7KZI7	MARK2	Serine/threonine-protein kinase MARK2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q7KZI7	MARK2	Serine/threonine-protein kinase MARK2	GO:0050770; P:regulation of axonogenesis; IMP:UniProtKB
Q7KZI7	MARK2	Serine/threonine-protein kinase MARK2	GO:0051493; P:regulation of cytoskeleton organization; ISS:UniProtKB
Q7KZI7	MARK2	Serine/threonine-protein kinase MARK2	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P27448	MARK3	MAP/microtubule affinity-regulating kinase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P27448	MARK3	MAP/microtubule affinity-regulating kinase 3	GO:0005515; F:protein binding; IPI:UniProtKB
P27448	MARK3	MAP/microtubule affinity-regulating kinase 3	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q96L34	MARK4	MAP/microtubule affinity-regulating kinase 4	GO:0005524; F:ATP binding; NAS:UniProtKB
Q96L34	MARK4	MAP/microtubule affinity-regulating kinase 4	GO:0043015; F:gamma-tubulin binding; IDA:UniProtKB
Q96L34	MARK4	MAP/microtubule affinity-regulating kinase 4	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q96L34	MARK4	MAP/microtubule affinity-regulating kinase 4	GO:0005515; F:protein binding; IPI:IntAct
Q96L34	MARK4	MAP/microtubule affinity-regulating kinase 4	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q96L34	MARK4	MAP/microtubule affinity-regulating kinase 4	GO:0050321; F:tau-protein kinase activity; IDA:UniProtKB
Q96L34	MARK4	MAP/microtubule affinity-regulating kinase 4	GO:0043130; F:ubiquitin binding; NAS:UniProtKB
Q96L34	MARK4	MAP/microtubule affinity-regulating kinase 4	GO:0001578; P:microtubule bundle formation; IEP:UniProtKB
Q96L34	MARK4	MAP/microtubule affinity-regulating kinase 4	GO:0000226; P:microtubule cytoskeleton organization; IMP:UniProtKB
Q96L34	MARK4	MAP/microtubule affinity-regulating kinase 4	GO:0007399; P:nervous system development; IDA:UniProtKB
Q96L34	MARK4	MAP/microtubule affinity-regulating kinase 4	GO:0043068; P:positive regulation of programmed cell death; NAS:UniProtKB
Q96L34	MARK4	MAP/microtubule affinity-regulating kinase 4	GO:0006468; P:protein phosphorylation; TAS:UniProtKB
P35410	MAS1L	Mas-related G-protein coupled receptor MRG	GO:0004930; F:G-protein coupled receptor activity; NAS:UniProtKB
P35410	MAS1L	Mas-related G-protein coupled receptor MRG	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
P48740	MASP1	Mannan-binding lectin serine protease 1	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P48740	MASP1	Mannan-binding lectin serine protease 1	GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB
P48740	MASP1	Mannan-binding lectin serine protease 1	GO:0008233; F:peptidase activity; IDA:UniProtKB
P48740	MASP1	Mannan-binding lectin serine protease 1	GO:0005515; F:protein binding; IPI:UniProtKB
P48740	MASP1	Mannan-binding lectin serine protease 1	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P48740	MASP1	Mannan-binding lectin serine protease 1	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
P48740	MASP1	Mannan-binding lectin serine protease 1	GO:0006956; P:complement activation; TAS:Reactome
P48740	MASP1	Mannan-binding lectin serine protease 1	GO:0001867; P:complement activation, lectin pathway; IMP:UniProtKB
P48740	MASP1	Mannan-binding lectin serine protease 1	GO:0045087; P:innate immune response; TAS:Reactome
P48740	MASP1	Mannan-binding lectin serine protease 1	GO:0045916; P:negative regulation of complement activation; IDA:UniProtKB
O00187	MASP2	Mannan-binding lectin serine protease 2	GO:0005509; F:calcium ion binding; IEA:InterPro
O00187	MASP2	Mannan-binding lectin serine protease 2	GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB
O00187	MASP2	Mannan-binding lectin serine protease 2	GO:0008233; F:peptidase activity; IDA:UniProtKB
O00187	MASP2	Mannan-binding lectin serine protease 2	GO:0005515; F:protein binding; IPI:UniProtKB
O00187	MASP2	Mannan-binding lectin serine protease 2	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
O00187	MASP2	Mannan-binding lectin serine protease 2	GO:0006956; P:complement activation; TAS:Reactome
O00187	MASP2	Mannan-binding lectin serine protease 2	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
O00187	MASP2	Mannan-binding lectin serine protease 2	GO:0001867; P:complement activation, lectin pathway; IDA:UniProtKB
O00187	MASP2	Mannan-binding lectin serine protease 2	GO:0045087; P:innate immune response; TAS:Reactome
Q9Y2H9	MAST1	Microtubule-associated serine/threonine-protein kinase 1	GO:0005524; F:ATP binding; ISS:UniProtKB
Q9Y2H9	MAST1	Microtubule-associated serine/threonine-protein kinase 1	GO:0000287; F:magnesium ion binding; ISS:UniProtKB
Q9Y2H9	MAST1	Microtubule-associated serine/threonine-protein kinase 1	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2H9	MAST1	Microtubule-associated serine/threonine-protein kinase 1	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB
Q9Y2H9	MAST1	Microtubule-associated serine/threonine-protein kinase 1	GO:0007010; P:cytoskeleton organization; ISS:UniProtKB
Q9Y2H9	MAST1	Microtubule-associated serine/threonine-protein kinase 1	GO:0035556; P:intracellular signal transduction; ISS:UniProtKB
Q9Y2H9	MAST1	Microtubule-associated serine/threonine-protein kinase 1	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
Q6P0Q8	MAST2	Microtubule-associated serine/threonine-protein kinase 2	GO:0005524; F:ATP binding; ISS:UniProtKB
Q6P0Q8	MAST2	Microtubule-associated serine/threonine-protein kinase 2	GO:0000287; F:magnesium ion binding; ISS:UniProtKB
Q6P0Q8	MAST2	Microtubule-associated serine/threonine-protein kinase 2	GO:0019902; F:phosphatase binding; IPI:UniProtKB
Q6P0Q8	MAST2	Microtubule-associated serine/threonine-protein kinase 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q6P0Q8	MAST2	Microtubule-associated serine/threonine-protein kinase 2	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q6P0Q8	MAST2	Microtubule-associated serine/threonine-protein kinase 2	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
Q6P0Q8	MAST2	Microtubule-associated serine/threonine-protein kinase 2	GO:0045075; P:regulation of interleukin-12 biosynthetic process; ISS:UniProtKB
Q6P0Q8	MAST2	Microtubule-associated serine/threonine-protein kinase 2	GO:0048515; P:spermatid differentiation; ISS:UniProtKB
O60307	MAST3	Microtubule-associated serine/threonine-protein kinase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O60307	MAST3	Microtubule-associated serine/threonine-protein kinase 3	GO:0000287; F:magnesium ion binding; IEA:InterPro
O60307	MAST3	Microtubule-associated serine/threonine-protein kinase 3	GO:0005515; F:protein binding; IPI:IntAct
O60307	MAST3	Microtubule-associated serine/threonine-protein kinase 3	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
O15021	MAST4	Microtubule-associated serine/threonine-protein kinase 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O15021	MAST4	Microtubule-associated serine/threonine-protein kinase 4	GO:0000287; F:magnesium ion binding; IEA:InterPro
O15021	MAST4	Microtubule-associated serine/threonine-protein kinase 4	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q6ZN01	MAMSTR	MEF2-activating motif and SAP domain-containing transcriptional regulator	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q6ZN01	MAMSTR	MEF2-activating motif and SAP domain-containing transcriptional regulator	GO:0001076; F:RNA polymerase II transcription factor binding transcription factor activity; IEA:Ensembl
Q6ZN01	MAMSTR	MEF2-activating motif and SAP domain-containing transcriptional regulator	GO:0010831; P:positive regulation of myotube differentiation; IEA:Ensembl
Q6ZN01	MAMSTR	MEF2-activating motif and SAP domain-containing transcriptional regulator	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q96EH3	MALSU1	Mitochondrial assembly of ribosomal large subunit protein 1	GO:0070130; P:negative regulation of mitochondrial translation; IDA:UniProtKB
Q96EH3	MALSU1	Mitochondrial assembly of ribosomal large subunit protein 1	GO:0042273; P:ribosomal large subunit biogenesis; IMP:UniProtKB
P04201	MAS1	Proto-oncogene Mas	GO:0001595; F:angiotensin receptor activity; ISS:UniProtKB
P04201	MAS1	Proto-oncogene Mas	GO:0004945; F:angiotensin type II receptor activity; TAS:ProtInc
P04201	MAS1	Proto-oncogene Mas	GO:0004930; F:G-protein coupled receptor activity; IDA:UniProtKB
P04201	MAS1	Proto-oncogene Mas	GO:0042277; F:peptide binding; ISS:UniProtKB
P04201	MAS1	Proto-oncogene Mas	GO:0017046; F:peptide hormone binding; IEA:Ensembl
P04201	MAS1	Proto-oncogene Mas	GO:0007250; P:activation of NF-kappaB-inducing kinase activity; IEA:Ensembl
P04201	MAS1	Proto-oncogene Mas	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P04201	MAS1	Proto-oncogene Mas	GO:0008283; P:cell proliferation; TAS:ProtInc
P04201	MAS1	Proto-oncogene Mas	GO:0071375; P:cellular response to peptide hormone stimulus; IEA:Ensembl
P04201	MAS1	Proto-oncogene Mas	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P04201	MAS1	Proto-oncogene Mas	GO:0021766; P:hippocampus development; IEA:Ensembl
P04201	MAS1	Proto-oncogene Mas	GO:0008584; P:male gonad development; IEA:Ensembl
P04201	MAS1	Proto-oncogene Mas	GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl
P04201	MAS1	Proto-oncogene Mas	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P04201	MAS1	Proto-oncogene Mas	GO:0045740; P:positive regulation of DNA replication; IEA:Ensembl
P04201	MAS1	Proto-oncogene Mas	GO:0060732; P:positive regulation of inositol phosphate biosynthetic process; IEA:Ensembl
P04201	MAS1	Proto-oncogene Mas	GO:0070528; P:protein kinase C signaling; IMP:UniProtKB
P04201	MAS1	Proto-oncogene Mas	GO:0050727; P:regulation of inflammatory response; IEA:Ensembl
P04201	MAS1	Proto-oncogene Mas	GO:0014823; P:response to activity; IEA:Ensembl
P04201	MAS1	Proto-oncogene Mas	GO:0042493; P:response to drug; IEA:Ensembl
P04201	MAS1	Proto-oncogene Mas	GO:0034698; P:response to gonadotropin; IEA:Ensembl
P04201	MAS1	Proto-oncogene Mas	GO:0007283; P:spermatogenesis; IEA:Ensembl
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0005515; F:protein binding; IPI:UniProtKB
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0008270; F:zinc ion binding; TAS:ProtInc
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0007512; P:adult heart development; IEA:Ensembl
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0006200; P:ATP catabolic process; IDA:GOC
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0008283; P:cell proliferation; TAS:ProtInc
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0006281; P:DNA repair; TAS:Reactome
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0010467; P:gene expression; TAS:Reactome
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0000718; P:nucleotide-excision repair, DNA damage removal; TAS:Reactome
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0006461; P:protein complex assembly; TAS:ProtInc
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0006468; P:protein phosphorylation; IDA:GOC
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0051592; P:response to calcium ion; IEA:Ensembl
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0021591; P:ventricular system development; IEA:Ensembl
P51948	MNAT1	CDK-activating kinase assembly factor MAT1	GO:0016032; P:viral process; TAS:Reactome
Q9NZL9	MAT2B	Methionine adenosyltransferase 2 subunit beta	GO:0008831; F:dTDP-4-dehydrorhamnose reductase activity; IEA:InterPro
Q9NZL9	MAT2B	Methionine adenosyltransferase 2 subunit beta	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9NZL9	MAT2B	Methionine adenosyltransferase 2 subunit beta	GO:0048270; F:methionine adenosyltransferase regulator activity; IDA:UniProtKB
Q9NZL9	MAT2B	Methionine adenosyltransferase 2 subunit beta	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9NZL9	MAT2B	Methionine adenosyltransferase 2 subunit beta	GO:0045226; P:extracellular polysaccharide biosynthetic process; IEA:InterPro
Q9NZL9	MAT2B	Methionine adenosyltransferase 2 subunit beta	GO:0032259; P:methylation; TAS:Reactome
Q9NZL9	MAT2B	Methionine adenosyltransferase 2 subunit beta	GO:0006730; P:one-carbon metabolic process; IEA:UniProtKB-KW
Q9NZL9	MAT2B	Methionine adenosyltransferase 2 subunit beta	GO:0050790; P:regulation of catalytic activity; IDA:GOC
Q9NZL9	MAT2B	Methionine adenosyltransferase 2 subunit beta	GO:0006556; P:S-adenosylmethionine biosynthetic process; IDA:UniProtKB
Q9NZL9	MAT2B	Methionine adenosyltransferase 2 subunit beta	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NZL9	MAT2B	Methionine adenosyltransferase 2 subunit beta	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
Q9NZL9	MAT2B	Methionine adenosyltransferase 2 subunit beta	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P42679	MATK	Megakaryocyte-associated tyrosine-protein kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P42679	MATK	Megakaryocyte-associated tyrosine-protein kinase	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC
P42679	MATK	Megakaryocyte-associated tyrosine-protein kinase	GO:0005515; F:protein binding; IPI:IntAct
P42679	MATK	Megakaryocyte-associated tyrosine-protein kinase	GO:0004713; F:protein tyrosine kinase activity; TAS:ProtInc
P42679	MATK	Megakaryocyte-associated tyrosine-protein kinase	GO:0008283; P:cell proliferation; TAS:ProtInc
P42679	MATK	Megakaryocyte-associated tyrosine-protein kinase	GO:0007498; P:mesoderm development; TAS:ProtInc
P42679	MATK	Megakaryocyte-associated tyrosine-protein kinase	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:GOC
P42679	MATK	Megakaryocyte-associated tyrosine-protein kinase	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P42679	MATK	Megakaryocyte-associated tyrosine-protein kinase	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P21941	MATN1	Cartilage matrix protein	GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc
P21941	MATN1	Cartilage matrix protein	GO:0005515; F:protein binding; IPI:UniProtKB
P21941	MATN1	Cartilage matrix protein	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P21941	MATN1	Cartilage matrix protein	GO:0003429; P:growth plate cartilage chondrocyte morphogenesis; IEA:Ensembl
P21941	MATN1	Cartilage matrix protein	GO:0006461; P:protein complex assembly; TAS:ProtInc
P21941	MATN1	Cartilage matrix protein	GO:0030500; P:regulation of bone mineralization; IEA:Ensembl
O00339	MATN2	Matrilin-2	GO:0005509; F:calcium ion binding; IEA:InterPro
O00339	MATN2	Matrilin-2	GO:0005515; F:protein binding; IPI:IntAct
O00339	MATN2	Matrilin-2	GO:0007411; P:axon guidance; IEA:Ensembl
O00339	MATN2	Matrilin-2	GO:0031104; P:dendrite regeneration; IEA:Ensembl
O00339	MATN2	Matrilin-2	GO:0008347; P:glial cell migration; IEA:Ensembl
O00339	MATN2	Matrilin-2	GO:0001764; P:neuron migration; IEA:Ensembl
O00339	MATN2	Matrilin-2	GO:0048678; P:response to axon injury; IEA:Ensembl
O15232	MATN3	Matrilin-3	GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc
O15232	MATN3	Matrilin-3	GO:0005515; F:protein binding; IPI:UniProtKB
O15232	MATN3	Matrilin-3	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O15232	MATN3	Matrilin-3	GO:0001501; P:skeletal system development; TAS:ProtInc
O95460	MATN4	Matrilin-4	GO:0005515; F:protein binding; IPI:UniProtKB
O95460	MATN4	Matrilin-4	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O95460	MATN4	Matrilin-4	GO:0048678; P:response to axon injury; IEA:Ensembl
P43243	MATR3	Matrin-3	GO:0000166; F:nucleotide binding; IEA:InterPro
P43243	MATR3	Matrin-3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P43243	MATR3	Matrin-3	GO:0005515; F:protein binding; IPI:UniProtKB
P43243	MATR3	Matrin-3	GO:0005198; F:structural molecule activity; TAS:ProtInc
P43243	MATR3	Matrin-3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0050700; F:CARD domain binding; IPI:BHF-UCL
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0002218; P:activation of innate immune response; IMP:BHF-UCL
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0071360; P:cellular response to exogenous dsRNA; IMP:BHF-UCL
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0042742; P:defense response to bacterium; IMP:UniProtKB
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0051607; P:defense response to virus; IDA:UniProtKB
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0045087; P:innate immune response; IMP:UniProtKB
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0071651; P:positive regulation of chemokine (C-C motif) ligand 5 production; IDA:BHF-UCL
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0002230; P:positive regulation of defense response to virus by host; IMP:UniProtKB
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0032727; P:positive regulation of interferon-alpha production; IMP:UniProtKB
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0032728; P:positive regulation of interferon-beta production; IMP:UniProtKB
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0032757; P:positive regulation of interleukin-8 production; IDA:BHF-UCL
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0071660; P:positive regulation of IP-10 production; IDA:BHF-UCL
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0033160; P:positive regulation of protein import into nucleus, translocation; IDA:BHF-UCL
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0001934; P:positive regulation of protein phosphorylation; IDA:BHF-UCL
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0042993; P:positive regulation of transcription factor import into nucleus; IDA:BHF-UCL
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0032760; P:positive regulation of tumor necrosis factor production; IDA:BHF-UCL
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0060340; P:positive regulation of type I interferon-mediated signaling pathway; IDA:UniProtKB
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:1900063; P:regulation of peroxisome organization; IMP:UniProtKB
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0039529; P:RIG-I signaling pathway; IEA:Ensembl
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0007165; P:signal transduction; IMP:UniProtKB
Q7Z434	MAVS	Mitochondrial antiviral-signaling protein	GO:0016032; P:viral process; IEA:UniProtKB-KW
P61244	MAX	Protein max	GO:0005515; F:protein binding; IPI:UniProtKB
P61244	MAX	Protein max	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P61244	MAX	Protein max	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P61244	MAX	Protein max	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P61244	MAX	Protein max	GO:0003712; F:transcription cofactor activity; TAS:ProtInc
P61244	MAX	Protein max	GO:0071375; P:cellular response to peptide hormone stimulus; IEA:Ensembl
P61244	MAX	Protein max	GO:0009267; P:cellular response to starvation; IEA:Ensembl
P61244	MAX	Protein max	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
P61244	MAX	Protein max	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
P61244	MAX	Protein max	GO:0006461; P:protein complex assembly; IEA:Ensembl
P61244	MAX	Protein max	GO:0048678; P:response to axon injury; IEA:Ensembl
P61244	MAX	Protein max	GO:0032868; P:response to insulin; IEA:Ensembl
P61244	MAX	Protein max	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
P61244	MAX	Protein max	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P56270	MAZ	Myc-associated zinc finger protein	GO:0003682; F:chromatin binding; IEA:Ensembl
P56270	MAZ	Myc-associated zinc finger protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P56270	MAZ	Myc-associated zinc finger protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P56270	MAZ	Myc-associated zinc finger protein	GO:0005515; F:protein binding; IPI:IntAct
P56270	MAZ	Myc-associated zinc finger protein	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IDA:UniProtKB
P56270	MAZ	Myc-associated zinc finger protein	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IEA:Ensembl
P56270	MAZ	Myc-associated zinc finger protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P56270	MAZ	Myc-associated zinc finger protein	GO:0006369; P:termination of RNA polymerase II transcription; IDA:UniProtKB
P56270	MAZ	Myc-associated zinc finger protein	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB
Q96EY5	MVB12A	Multivesicular body subunit 12A	GO:0008289; F:lipid binding; IMP:UniProt
Q96EY5	MVB12A	Multivesicular body subunit 12A	GO:0005515; F:protein binding; IPI:UniProt
Q96EY5	MVB12A	Multivesicular body subunit 12A	GO:0043130; F:ubiquitin binding; IMP:UniProt
Q96EY5	MVB12A	Multivesicular body subunit 12A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96EY5	MVB12A	Multivesicular body subunit 12A	GO:0042058; P:regulation of epidermal growth factor receptor signaling pathway; IMP:UniProt
Q96EY5	MVB12A	Multivesicular body subunit 12A	GO:0043162; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; IC:UniProt
Q13394	MAB21L1	Protein mab-21-like 1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q13394	MAB21L1	Protein mab-21-like 1	GO:0043010; P:camera-type eye development; IEA:Ensembl
Q13394	MAB21L1	Protein mab-21-like 1	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q9H7P6	MVB12B	Multivesicular body subunit 12B	GO:0008289; F:lipid binding; IMP:UniProt
Q9H7P6	MVB12B	Multivesicular body subunit 12B	GO:0005515; F:protein binding; IPI:UniProt
Q9H7P6	MVB12B	Multivesicular body subunit 12B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9H7P6	MVB12B	Multivesicular body subunit 12B	GO:0042058; P:regulation of epidermal growth factor receptor signaling pathway; IMP:UniProt
Q9H7P6	MVB12B	Multivesicular body subunit 12B	GO:0043162; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; IC:UniProt
Q9Y586	MAB21L2	Protein mab-21-like 2	GO:0043010; P:camera-type eye development; IEA:Ensembl
Q9Y586	MAB21L2	Protein mab-21-like 2	GO:0010172; P:embryonic body morphogenesis; IEA:Ensembl
Q9Y586	MAB21L2	Protein mab-21-like 2	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y586	MAB21L2	Protein mab-21-like 2	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q8WWY6	MBD3L1	Methyl-CpG-binding domain protein 3-like 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8WWY6	MBD3L1	Methyl-CpG-binding domain protein 3-like 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A6NE82	MBD3L3	Putative methyl-CpG-binding domain protein 3-like 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A6NE82	MBD3L3	Putative methyl-CpG-binding domain protein 3-like 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A6NDZ8	MBD3L4	Putative methyl-CpG-binding domain protein 3-like 4	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A6NDZ8	MBD3L4	Putative methyl-CpG-binding domain protein 3-like 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BQG0	MYBBP1A	Myb-binding protein 1A	GO:0003887; F:DNA-directed DNA polymerase activity; IEA:InterPro
Q9BQG0	MYBBP1A	Myb-binding protein 1A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BQG0	MYBBP1A	Myb-binding protein 1A	GO:0005515; F:protein binding; IPI:IntAct
Q9BQG0	MYBBP1A	Myb-binding protein 1A	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q9BQG0	MYBBP1A	Myb-binding protein 1A	GO:0008134; F:transcription factor binding; TAS:ProtInc
Q9BQG0	MYBBP1A	Myb-binding protein 1A	GO:0042149; P:cellular response to glucose starvation; IDA:UniProtKB
Q9BQG0	MYBBP1A	Myb-binding protein 1A	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IMP:UniProtKB
Q9BQG0	MYBBP1A	Myb-binding protein 1A	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q9BQG0	MYBBP1A	Myb-binding protein 1A	GO:0006913; P:nucleocytoplasmic transport; ISS:UniProtKB
Q9BQG0	MYBBP1A	Myb-binding protein 1A	GO:0071158; P:positive regulation of cell cycle arrest; IMP:UniProtKB
Q9BQG0	MYBBP1A	Myb-binding protein 1A	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
Q9BQG0	MYBBP1A	Myb-binding protein 1A	GO:0022904; P:respiratory electron transport chain; IEA:Ensembl
Q9BQG0	MYBBP1A	Myb-binding protein 1A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UBB5	MBD2	Methyl-CpG-binding domain protein 2	GO:0070742; F:C2H2 zinc finger domain binding; IPI:UniProtKB
Q9UBB5	MBD2	Methyl-CpG-binding domain protein 2	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9UBB5	MBD2	Methyl-CpG-binding domain protein 2	GO:0008327; F:methyl-CpG binding; IDA:UniProtKB
Q9UBB5	MBD2	Methyl-CpG-binding domain protein 2	GO:0003729; F:mRNA binding; IEA:Ensembl
Q9UBB5	MBD2	Methyl-CpG-binding domain protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBB5	MBD2	Methyl-CpG-binding domain protein 2	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q9UBB5	MBD2	Methyl-CpG-binding domain protein 2	GO:0003696; F:satellite DNA binding; TAS:ProtInc
Q9UBB5	MBD2	Methyl-CpG-binding domain protein 2	GO:0035197; F:siRNA binding; IEA:Ensembl
Q9UBB5	MBD2	Methyl-CpG-binding domain protein 2	GO:0043044; P:ATP-dependent chromatin remodeling; IDA:UniProt
Q9UBB5	MBD2	Methyl-CpG-binding domain protein 2	GO:0043623; P:cellular protein complex assembly; IEA:Ensembl
Q9UBB5	MBD2	Methyl-CpG-binding domain protein 2	GO:0042711; P:maternal behavior; IEA:Ensembl
Q9UBB5	MBD2	Methyl-CpG-binding domain protein 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UBB5	MBD2	Methyl-CpG-binding domain protein 2	GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB
Q9UBB5	MBD2	Methyl-CpG-binding domain protein 2	GO:0030177; P:positive regulation of Wnt signaling pathway; IEA:Ensembl
Q9UBB5	MBD2	Methyl-CpG-binding domain protein 2	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q9UBB5	MBD2	Methyl-CpG-binding domain protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UIS9	MBD1	Methyl-CpG-binding domain protein 1	GO:0003677; F:DNA binding; TAS:ProtInc
Q9UIS9	MBD1	Methyl-CpG-binding domain protein 1	GO:0008327; F:methyl-CpG binding; NAS:UniProtKB
Q9UIS9	MBD1	Methyl-CpG-binding domain protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UIS9	MBD1	Methyl-CpG-binding domain protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9UIS9	MBD1	Methyl-CpG-binding domain protein 1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q9UIS9	MBD1	Methyl-CpG-binding domain protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UIS9	MBD1	Methyl-CpG-binding domain protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB
Q9UIS9	MBD1	Methyl-CpG-binding domain protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
O95243	MBD4	Methyl-CpG-binding domain protein 4	GO:0003824; F:catalytic activity; IEA:InterPro
O95243	MBD4	Methyl-CpG-binding domain protein 4	GO:0003677; F:DNA binding; IEA:InterPro
O95243	MBD4	Methyl-CpG-binding domain protein 4	GO:0004520; F:endodeoxyribonuclease activity; TAS:ProtInc
O95243	MBD4	Methyl-CpG-binding domain protein 4	GO:0005515; F:protein binding; IPI:IntAct
O95243	MBD4	Methyl-CpG-binding domain protein 4	GO:0008263; F:pyrimidine-specific mismatch base pair DNA N-glycosylase activity; IDA:MGI
O95243	MBD4	Methyl-CpG-binding domain protein 4	GO:0003696; F:satellite DNA binding; TAS:ProtInc
O95243	MBD4	Methyl-CpG-binding domain protein 4	GO:0006284; P:base-excision repair; IEA:InterPro
O95243	MBD4	Methyl-CpG-binding domain protein 4	GO:0006285; P:base-excision repair, AP site formation; TAS:Reactome
O95243	MBD4	Methyl-CpG-binding domain protein 4	GO:0045008; P:depyrimidination; TAS:Reactome
O95243	MBD4	Methyl-CpG-binding domain protein 4	GO:0000737; P:DNA catabolic process, endonucleolytic; TAS:GOC
O95243	MBD4	Methyl-CpG-binding domain protein 4	GO:0006281; P:DNA repair; TAS:Reactome
O95243	MBD4	Methyl-CpG-binding domain protein 4	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
O95243	MBD4	Methyl-CpG-binding domain protein 4	GO:0007095; P:mitotic G2 DNA damage checkpoint; IEA:Ensembl
O95243	MBD4	Methyl-CpG-binding domain protein 4	GO:0009314; P:response to radiation; IEA:Ensembl
Q9P267	MBD5	Methyl-CpG-binding domain protein 5	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q9P267	MBD5	Methyl-CpG-binding domain protein 5	GO:0042593; P:glucose homeostasis; ISS:UniProt
Q9P267	MBD5	Methyl-CpG-binding domain protein 5	GO:0007399; P:nervous system development; IMP:UniProt
Q9P267	MBD5	Methyl-CpG-binding domain protein 5	GO:0060399; P:positive regulation of growth hormone receptor signaling pathway; ISS:UniProt
Q9P267	MBD5	Methyl-CpG-binding domain protein 5	GO:0040014; P:regulation of multicellular organism growth; ISS:UniProt
Q9P267	MBD5	Methyl-CpG-binding domain protein 5	GO:0044708; P:single-organism behavior; IMP:UniProt
Q96DN6	MBD6	Methyl-CpG-binding domain protein 6	GO:0003682; F:chromatin binding; IDA:UniProtKB
O95983	MBD3	Methyl-CpG-binding domain protein 3	GO:0003682; F:chromatin binding; IEA:Ensembl
O95983	MBD3	Methyl-CpG-binding domain protein 3	GO:0003677; F:DNA binding; TAS:ProtInc
O95983	MBD3	Methyl-CpG-binding domain protein 3	GO:0008327; F:methyl-CpG binding; IDA:UniProtKB
O95983	MBD3	Methyl-CpG-binding domain protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
O95983	MBD3	Methyl-CpG-binding domain protein 3	GO:0043044; P:ATP-dependent chromatin remodeling; IDA:UniProt
O95983	MBD3	Methyl-CpG-binding domain protein 3	GO:0016573; P:histone acetylation; IEA:Ensembl
O95983	MBD3	Methyl-CpG-binding domain protein 3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O95983	MBD3	Methyl-CpG-binding domain protein 3	GO:0006346; P:methylation-dependent chromatin silencing; IEA:Ensembl
O95983	MBD3	Methyl-CpG-binding domain protein 3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O95983	MBD3	Methyl-CpG-binding domain protein 3	GO:0009888; P:tissue development; IEA:Ensembl
O95983	MBD3	Methyl-CpG-binding domain protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NS73	MBIP	MAP3K12-binding inhibitory protein 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q9NS73	MBIP	MAP3K12-binding inhibitory protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NS73	MBIP	MAP3K12-binding inhibitory protein 1	GO:0004860; F:protein kinase inhibitor activity; TAS:ProtInc
Q9NS73	MBIP	MAP3K12-binding inhibitory protein 1	GO:0006325; P:chromatin organization; TAS:Reactome
Q9NS73	MBIP	MAP3K12-binding inhibitory protein 1	GO:0043966; P:histone H3 acetylation; IDA:BHF-UCL
Q9NS73	MBIP	MAP3K12-binding inhibitory protein 1	GO:0000173; P:inactivation of MAPK activity involved in osmosensory signaling pathway; TAS:ProtInc
P11226	MBL2	Mannose-binding protein C	GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB
P11226	MBL2	Mannose-binding protein C	GO:0005537; F:mannose binding; NAS:UniProtKB
P11226	MBL2	Mannose-binding protein C	GO:0005515; F:protein binding; IPI:UniProtKB
P11226	MBL2	Mannose-binding protein C	GO:0005102; F:receptor binding; IPI:UniProtKB
P11226	MBL2	Mannose-binding protein C	GO:0006953; P:acute-phase response; TAS:BHF-UCL
P11226	MBL2	Mannose-binding protein C	GO:0006956; P:complement activation; TAS:Reactome
P11226	MBL2	Mannose-binding protein C	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
P11226	MBL2	Mannose-binding protein C	GO:0001867; P:complement activation, lectin pathway; IPI:UniProtKB
P11226	MBL2	Mannose-binding protein C	GO:0042742; P:defense response to bacterium; TAS:BHF-UCL
P11226	MBL2	Mannose-binding protein C	GO:0050830; P:defense response to Gram-positive bacterium; IDA:MGI
P11226	MBL2	Mannose-binding protein C	GO:0045087; P:innate immune response; TAS:Reactome
P11226	MBL2	Mannose-binding protein C	GO:0051873; P:killing by host of symbiont cells; IEA:Ensembl
P11226	MBL2	Mannose-binding protein C	GO:0044130; P:negative regulation of growth of symbiont in host; IDA:MGI
P11226	MBL2	Mannose-binding protein C	GO:0008228; P:opsonization; TAS:BHF-UCL
P11226	MBL2	Mannose-binding protein C	GO:0050766; P:positive regulation of phagocytosis; IEA:Ensembl
P11226	MBL2	Mannose-binding protein C	GO:0006979; P:response to oxidative stress; NAS:UniProtKB
A4D2B0	MBLAC1	Metallo-beta-lactamase domain-containing protein 1	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
A4D2B0	MBLAC1	Metallo-beta-lactamase domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q68D91	MBLAC2	Metallo-beta-lactamase domain-containing protein 2	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q68D91	MBLAC2	Metallo-beta-lactamase domain-containing protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NR56	MBNL1	Muscleblind-like protein 1	GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB
Q9NR56	MBNL1	Muscleblind-like protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NR56	MBNL1	Muscleblind-like protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NR56	MBNL1	Muscleblind-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NR56	MBNL1	Muscleblind-like protein 1	GO:0003723; F:RNA binding; IDA:UniProtKB
Q9NR56	MBNL1	Muscleblind-like protein 1	GO:0000380; P:alternative mRNA splicing, via spliceosome; IEA:Ensembl
Q9NR56	MBNL1	Muscleblind-like protein 1	GO:0030326; P:embryonic limb morphogenesis; ISS:UniProtKB
Q9NR56	MBNL1	Muscleblind-like protein 1	GO:0001701; P:in utero embryonic development; ISS:UniProtKB
Q9NR56	MBNL1	Muscleblind-like protein 1	GO:0006376; P:mRNA splice site selection; IEA:Ensembl
Q9NR56	MBNL1	Muscleblind-like protein 1	GO:0045445; P:myoblast differentiation; ISS:UniProtKB
Q9NR56	MBNL1	Muscleblind-like protein 1	GO:0007399; P:nervous system development; ISS:UniProtKB
Q9NR56	MBNL1	Muscleblind-like protein 1	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IEA:Ensembl
Q9NR56	MBNL1	Muscleblind-like protein 1	GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB
Q9NR56	MBNL1	Muscleblind-like protein 1	GO:0008380; P:RNA splicing; IDA:UniProtKB
Q9NR56	MBNL1	Muscleblind-like protein 1	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
Q5VZF2	MBNL2	Muscleblind-like protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5VZF2	MBNL2	Muscleblind-like protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q5VZF2	MBNL2	Muscleblind-like protein 2	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q5VZF2	MBNL2	Muscleblind-like protein 2	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IEA:Ensembl
Q5VZF2	MBNL2	Muscleblind-like protein 2	GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB
Q5VZF2	MBNL2	Muscleblind-like protein 2	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q9NUK0	MBNL3	Muscleblind-like protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NUK0	MBNL3	Muscleblind-like protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NUK0	MBNL3	Muscleblind-like protein 3	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9NUK0	MBNL3	Muscleblind-like protein 3	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9NUK0	MBNL3	Muscleblind-like protein 3	GO:0045662; P:negative regulation of myoblast differentiation; IEA:Ensembl
Q9NUK0	MBNL3	Muscleblind-like protein 3	GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB
Q9NUK0	MBNL3	Muscleblind-like protein 3	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q6ZNC8	MBOAT1	Lysophospholipid acyltransferase 1	GO:0016747; F:transferase activity, transferring acyl groups other than amino-acyl groups; IEA:UniProtKB-EC
Q6ZNC8	MBOAT1	Lysophospholipid acyltransferase 1	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q6ZNC8	MBOAT1	Lysophospholipid acyltransferase 1	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
Q6ZNC8	MBOAT1	Lysophospholipid acyltransferase 1	GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome
Q6ZNC8	MBOAT1	Lysophospholipid acyltransferase 1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q6ZNC8	MBOAT1	Lysophospholipid acyltransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6ZWT7	MBOAT2	Lysophospholipid acyltransferase 2	GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; IEA:UniProtKB-EC
Q6ZWT7	MBOAT2	Lysophospholipid acyltransferase 2	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q6ZWT7	MBOAT2	Lysophospholipid acyltransferase 2	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
Q6ZWT7	MBOAT2	Lysophospholipid acyltransferase 2	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
Q6ZWT7	MBOAT2	Lysophospholipid acyltransferase 2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q6ZWT7	MBOAT2	Lysophospholipid acyltransferase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6P1A2	LPCAT3	Lysophospholipid acyltransferase 5	GO:0047184; F:1-acylglycerophosphocholine O-acyltransferase activity; IMP:MGI
Q6P1A2	LPCAT3	Lysophospholipid acyltransferase 5	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q6P1A2	LPCAT3	Lysophospholipid acyltransferase 5	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
Q6P1A2	LPCAT3	Lysophospholipid acyltransferase 5	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
Q6P1A2	LPCAT3	Lysophospholipid acyltransferase 5	GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome
Q6P1A2	LPCAT3	Lysophospholipid acyltransferase 5	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q6P1A2	LPCAT3	Lysophospholipid acyltransferase 5	GO:0097006; P:regulation of plasma lipoprotein particle levels; IEA:Ensembl
Q6P1A2	LPCAT3	Lysophospholipid acyltransferase 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96T53	MBOAT4	Ghrelin O-acyltransferase	GO:0016412; F:serine O-acyltransferase activity; IDA:UniProtKB
Q96T53	MBOAT4	Ghrelin O-acyltransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q96T53	MBOAT4	Ghrelin O-acyltransferase	GO:0018191; P:peptidyl-serine octanoylation; IDA:UniProtKB
Q96N66	MBOAT7	Lysophospholipid acyltransferase 7	GO:0005515; F:protein binding; IPI:IntAct
Q96N66	MBOAT7	Lysophospholipid acyltransferase 7	GO:0016747; F:transferase activity, transferring acyl groups other than amino-acyl groups; IEA:UniProtKB-EC
Q96N66	MBOAT7	Lysophospholipid acyltransferase 7	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q96N66	MBOAT7	Lysophospholipid acyltransferase 7	GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome
Q96N66	MBOAT7	Lysophospholipid acyltransferase 7	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q96N66	MBOAT7	Lysophospholipid acyltransferase 7	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96N66	MBOAT7	Lysophospholipid acyltransferase 7	GO:0021591; P:ventricular system development; IEA:Ensembl
P02686	MBP	Myelin basic protein	GO:0005515; F:protein binding; IPI:IntAct
P02686	MBP	Myelin basic protein	GO:0019911; F:structural constituent of myelin sheath; IEA:Ensembl
P02686	MBP	Myelin basic protein	GO:0008366; P:axon ensheathment; TAS:ProtInc
P02686	MBP	Myelin basic protein	GO:0007417; P:central nervous system development; TAS:ProtInc
P02686	MBP	Myelin basic protein	GO:0006955; P:immune response; TAS:ProtInc
P02686	MBP	Myelin basic protein	GO:0061024; P:membrane organization; IEA:Ensembl
P02686	MBP	Myelin basic protein	GO:0042552; P:myelination; IEA:Ensembl
P02686	MBP	Myelin basic protein	GO:0050771; P:negative regulation of axonogenesis; IEA:Ensembl
P02686	MBP	Myelin basic protein	GO:0009636; P:response to toxic substance; IEA:Ensembl
P02686	MBP	Myelin basic protein	GO:0021762; P:substantia nigra development; IEP:UniProt
P02686	MBP	Myelin basic protein	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q05BQ5	MBTD1	MBT domain-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q05BQ5	MBTD1	MBT domain-containing protein 1	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q05BQ5	MBTD1	MBT domain-containing protein 1	GO:0048706; P:embryonic skeletal system development; IEA:Ensembl
Q05BQ5	MBTD1	MBT domain-containing protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q05BQ5	MBTD1	MBT domain-containing protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14703	MBTPS1	Membrane-bound transcription factor site-1 protease	GO:0004252; F:serine-type endopeptidase activity; IMP:UniProtKB
Q14703	MBTPS1	Membrane-bound transcription factor site-1 protease	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q14703	MBTPS1	Membrane-bound transcription factor site-1 protease	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q14703	MBTPS1	Membrane-bound transcription factor site-1 protease	GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW
Q14703	MBTPS1	Membrane-bound transcription factor site-1 protease	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q14703	MBTPS1	Membrane-bound transcription factor site-1 protease	GO:0006629; P:lipid metabolic process; IBA:RefGenome
Q14703	MBTPS1	Membrane-bound transcription factor site-1 protease	GO:0007040; P:lysosome organization; IMP:UniProtKB
Q14703	MBTPS1	Membrane-bound transcription factor site-1 protease	GO:0006508; P:proteolysis; IMP:UniProtKB
Q14703	MBTPS1	Membrane-bound transcription factor site-1 protease	GO:0042990; P:regulation of transcription factor import into nucleus; IEA:Ensembl
Q14703	MBTPS1	Membrane-bound transcription factor site-1 protease	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43462	MBTPS2	Membrane-bound transcription factor site-2 protease	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43462	MBTPS2	Membrane-bound transcription factor site-2 protease	GO:0004222; F:metalloendopeptidase activity; TAS:ProtInc
O43462	MBTPS2	Membrane-bound transcription factor site-2 protease	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
O43462	MBTPS2	Membrane-bound transcription factor site-2 protease	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O43462	MBTPS2	Membrane-bound transcription factor site-2 protease	GO:0008203; P:cholesterol metabolic process; TAS:ProtInc
O43462	MBTPS2	Membrane-bound transcription factor site-2 protease	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
O43462	MBTPS2	Membrane-bound transcription factor site-2 protease	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P41968	MC3R	Melanocortin receptor 3	GO:0004977; F:melanocortin receptor activity; TAS:ProtInc
P41968	MC3R	Melanocortin receptor 3	GO:0004980; F:melanocyte-stimulating hormone receptor activity; IPI:BHF-UCL
P41968	MC3R	Melanocortin receptor 3	GO:0042923; F:neuropeptide binding; IPI:UniProtKB
P41968	MC3R	Melanocortin receptor 3	GO:0017046; F:peptide hormone binding; IEA:Ensembl
P41968	MC3R	Melanocortin receptor 3	GO:0005515; F:protein binding; IPI:BHF-UCL
P41968	MC3R	Melanocortin receptor 3	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IEA:Ensembl
P41968	MC3R	Melanocortin receptor 3	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P41968	MC3R	Melanocortin receptor 3	GO:0042309; P:homoiothermy; IEA:Ensembl
P41968	MC3R	Melanocortin receptor 3	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; TAS:ProtInc
P41968	MC3R	Melanocortin receptor 3	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:BHF-UCL
P41968	MC3R	Melanocortin receptor 3	GO:0008217; P:regulation of blood pressure; IEA:Ensembl
P41968	MC3R	Melanocortin receptor 3	GO:0002027; P:regulation of heart rate; IEA:Ensembl
P41968	MC3R	Melanocortin receptor 3	GO:0055078; P:sodium ion homeostasis; IEA:Ensembl
P32245	MC4R	Melanocortin receptor 4	GO:0004977; F:melanocortin receptor activity; TAS:ProtInc
P32245	MC4R	Melanocortin receptor 4	GO:0004980; F:melanocyte-stimulating hormone receptor activity; IPI:BHF-UCL
P32245	MC4R	Melanocortin receptor 4	GO:0042923; F:neuropeptide binding; IPI:UniProtKB
P32245	MC4R	Melanocortin receptor 4	GO:0017046; F:peptide hormone binding; IEA:Ensembl
P32245	MC4R	Melanocortin receptor 4	GO:0005515; F:protein binding; IPI:BHF-UCL
P32245	MC4R	Melanocortin receptor 4	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P32245	MC4R	Melanocortin receptor 4	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; TAS:ProtInc
P32245	MC4R	Melanocortin receptor 4	GO:0002024; P:diet induced thermogenesis; IEA:Ensembl
P32245	MC4R	Melanocortin receptor 4	GO:0006112; P:energy reserve metabolic process; IEA:Ensembl
P32245	MC4R	Melanocortin receptor 4	GO:0007631; P:feeding behavior; TAS:ProtInc
P32245	MC4R	Melanocortin receptor 4	GO:0030073; P:insulin secretion; IEA:Ensembl
P32245	MC4R	Melanocortin receptor 4	GO:2000252; P:negative regulation of feeding behavior; IEA:Ensembl
P32245	MC4R	Melanocortin receptor 4	GO:0045780; P:positive regulation of bone resorption; IMP:HGNC
P32245	MC4R	Melanocortin receptor 4	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:BHF-UCL
P32245	MC4R	Melanocortin receptor 4	GO:2000821; P:regulation of grooming behavior; IEA:Ensembl
P32245	MC4R	Melanocortin receptor 4	GO:0032868; P:response to insulin; IEA:Ensembl
P33032	MC5R	Melanocortin receptor 5	GO:0042562; F:hormone binding; IEA:Ensembl
P33032	MC5R	Melanocortin receptor 5	GO:0004977; F:melanocortin receptor activity; TAS:ProtInc
P33032	MC5R	Melanocortin receptor 5	GO:0005515; F:protein binding; IPI:BHF-UCL
P33032	MC5R	Melanocortin receptor 5	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P33032	MC5R	Melanocortin receptor 5	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:BHF-UCL
O43324	EEF1E1	Eukaryotic translation elongation factor 1 epsilon-1	GO:0005515; F:protein binding; IPI:IntAct
O43324	EEF1E1	Eukaryotic translation elongation factor 1 epsilon-1	GO:0010467; P:gene expression; TAS:Reactome
O43324	EEF1E1	Eukaryotic translation elongation factor 1 epsilon-1	GO:0008285; P:negative regulation of cell proliferation; ISS:UniProtKB
O43324	EEF1E1	Eukaryotic translation elongation factor 1 epsilon-1	GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB
O43324	EEF1E1	Eukaryotic translation elongation factor 1 epsilon-1	GO:0043517; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; ISS:UniProtKB
O43324	EEF1E1	Eukaryotic translation elongation factor 1 epsilon-1	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q6VMQ6	ATF7IP	Activating transcription factor 7-interacting protein 1	GO:0016887; F:ATPase activity; IEA:Ensembl
Q6VMQ6	ATF7IP	Activating transcription factor 7-interacting protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q6VMQ6	ATF7IP	Activating transcription factor 7-interacting protein 1	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
Q6VMQ6	ATF7IP	Activating transcription factor 7-interacting protein 1	GO:0006306; P:DNA methylation; IDA:UniProtKB
Q6VMQ6	ATF7IP	Activating transcription factor 7-interacting protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q6VMQ6	ATF7IP	Activating transcription factor 7-interacting protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q6VMQ6	ATF7IP	Activating transcription factor 7-interacting protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q6VMQ6	ATF7IP	Activating transcription factor 7-interacting protein 1	GO:0045898; P:regulation of RNA polymerase II transcriptional preinitiation complex assembly; IDA:UniProtKB
Q6VMQ6	ATF7IP	Activating transcription factor 7-interacting protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6VMQ6	ATF7IP	Activating transcription factor 7-interacting protein 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q5U623	ATF7IP2	Activating transcription factor 7-interacting protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5U623	ATF7IP2	Activating transcription factor 7-interacting protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N8R3	SLC25A29	Mitochondrial carnitine/acylcarnitine carrier protein CACL	GO:0015227; F:acyl carnitine transmembrane transporter activity; IEA:Ensembl
O43772	SLC25A20	Mitochondrial carnitine/acylcarnitine carrier protein	GO:0006853; P:carnitine shuttle; TAS:Reactome
O43772	SLC25A20	Mitochondrial carnitine/acylcarnitine carrier protein	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O43772	SLC25A20	Mitochondrial carnitine/acylcarnitine carrier protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96RQ3	MCCC1	Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96RQ3	MCCC1	Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial	GO:0009374; F:biotin binding; NAS:UniProtKB
Q96RQ3	MCCC1	Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial	GO:0004075; F:biotin carboxylase activity; IEA:InterPro
Q96RQ3	MCCC1	Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial	GO:0046872; F:metal ion binding; IEA:InterPro
Q96RQ3	MCCC1	Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial	GO:0004485; F:methylcrotonoyl-CoA carboxylase activity; IDA:UniProtKB
Q96RQ3	MCCC1	Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q96RQ3	MCCC1	Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial	GO:0006768; P:biotin metabolic process; NAS:UniProtKB
Q96RQ3	MCCC1	Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial	GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome
Q96RQ3	MCCC1	Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q96RQ3	MCCC1	Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial	GO:0006552; P:leucine catabolic process; NAS:UniProtKB
Q96RQ3	MCCC1	Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96RQ3	MCCC1	Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q96RQ3	MCCC1	Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9HCC0	MCCC2	Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9HCC0	MCCC2	Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial	GO:0004485; F:methylcrotonoyl-CoA carboxylase activity; IDA:UniProtKB
Q9HCC0	MCCC2	Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HCC0	MCCC2	Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial	GO:0006768; P:biotin metabolic process; TAS:Reactome
Q9HCC0	MCCC2	Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial	GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome
Q9HCC0	MCCC2	Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9HCC0	MCCC2	Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial	GO:0015936; P:coenzyme A metabolic process; IEA:Ensembl
Q9HCC0	MCCC2	Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial	GO:0006552; P:leucine catabolic process; TAS:UniProtKB
Q9HCC0	MCCC2	Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9HCC0	MCCC2	Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9HCC0	MCCC2	Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
O60942	RNGTT	mRNA-capping enzyme	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
O60942	RNGTT	mRNA-capping enzyme	GO:0004484; F:mRNA guanylyltransferase activity; IDA:UniProtKB
O60942	RNGTT	mRNA-capping enzyme	GO:0004651; F:polynucleotide 5'-phosphatase activity; IEA:UniProtKB-EC
O60942	RNGTT	mRNA-capping enzyme	GO:0004725; F:protein tyrosine phosphatase activity; IEA:InterPro
O60942	RNGTT	mRNA-capping enzyme	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro
O60942	RNGTT	mRNA-capping enzyme	GO:0008192; F:RNA guanylyltransferase activity; IDA:UniProtKB
O60942	RNGTT	mRNA-capping enzyme	GO:0050355; F:triphosphatase activity; IDA:UniProtKB
O60942	RNGTT	mRNA-capping enzyme	GO:0006370; P:7-methylguanosine mRNA capping; IDA:UniProtKB
O60942	RNGTT	mRNA-capping enzyme	GO:0010467; P:gene expression; TAS:Reactome
O60942	RNGTT	mRNA-capping enzyme	GO:0006396; P:RNA processing; IDA:UniProtKB
O60942	RNGTT	mRNA-capping enzyme	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
O60942	RNGTT	mRNA-capping enzyme	GO:0016032; P:viral process; TAS:Reactome
Q96PE7	MCEE	Methylmalonyl-CoA epimerase, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96PE7	MCEE	Methylmalonyl-CoA epimerase, mitochondrial	GO:0004493; F:methylmalonyl-CoA epimerase activity; IDA:UniProtKB
Q96PE7	MCEE	Methylmalonyl-CoA epimerase, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q96PE7	MCEE	Methylmalonyl-CoA epimerase, mitochondrial	GO:0006635; P:fatty acid beta-oxidation; TAS:Reactome
Q96PE7	MCEE	Methylmalonyl-CoA epimerase, mitochondrial	GO:0046491; P:L-methylmalonyl-CoA metabolic process; IDA:UniProtKB
Q96PE7	MCEE	Methylmalonyl-CoA epimerase, mitochondrial	GO:0019626; P:short-chain fatty acid catabolic process; TAS:Reactome
Q96PE7	MCEE	Methylmalonyl-CoA epimerase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43148	RNMT	mRNA cap guanine-N7 methyltransferase	GO:0004482; F:mRNA (guanine-N7-)-methyltransferase activity; IDA:UniProtKB
O43148	RNMT	mRNA cap guanine-N7 methyltransferase	GO:0005515; F:protein binding; IPI:UniProtKB
O43148	RNMT	mRNA cap guanine-N7 methyltransferase	GO:0003723; F:RNA binding; IMP:UniProtKB
O43148	RNMT	mRNA cap guanine-N7 methyltransferase	GO:0006370; P:7-methylguanosine mRNA capping; IMP:UniProtKB
O43148	RNMT	mRNA cap guanine-N7 methyltransferase	GO:0010467; P:gene expression; TAS:Reactome
O43148	RNMT	mRNA cap guanine-N7 methyltransferase	GO:0036265; P:RNA (guanine-N7)-methylation; IDA:GOC
O43148	RNMT	mRNA cap guanine-N7 methyltransferase	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
O43148	RNMT	mRNA cap guanine-N7 methyltransferase	GO:0016032; P:viral process; TAS:Reactome
O15068	MCF2L	Guanine nucleotide exchange factor DBS	GO:0005545; F:1-phosphatidylinositol binding; IEA:Ensembl
O15068	MCF2L	Guanine nucleotide exchange factor DBS	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:Ensembl
O15068	MCF2L	Guanine nucleotide exchange factor DBS	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
O15068	MCF2L	Guanine nucleotide exchange factor DBS	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O15068	MCF2L	Guanine nucleotide exchange factor DBS	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
O15068	MCF2L	Guanine nucleotide exchange factor DBS	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O15068	MCF2L	Guanine nucleotide exchange factor DBS	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
O15068	MCF2L	Guanine nucleotide exchange factor DBS	GO:0007266; P:Rho protein signal transduction; IEA:Ensembl
O15068	MCF2L	Guanine nucleotide exchange factor DBS	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P10911	MCF2	Proto-oncogene DBL	GO:0005515; F:protein binding; IPI:IntAct
P10911	MCF2	Proto-oncogene DBL	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
P10911	MCF2	Proto-oncogene DBL	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
P10911	MCF2	Proto-oncogene DBL	GO:0016358; P:dendrite development; IEA:Ensembl
P10911	MCF2	Proto-oncogene DBL	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P10911	MCF2	Proto-oncogene DBL	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
P10911	MCF2	Proto-oncogene DBL	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P10911	MCF2	Proto-oncogene DBL	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q8NI22	MCFD2	Multiple coagulation factor deficiency protein 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8NI22	MCFD2	Multiple coagulation factor deficiency protein 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8NI22	MCFD2	Multiple coagulation factor deficiency protein 2	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q8NI22	MCFD2	Multiple coagulation factor deficiency protein 2	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q8NI22	MCFD2	Multiple coagulation factor deficiency protein 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8NI22	MCFD2	Multiple coagulation factor deficiency protein 2	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q9BQD1	PMCHL2	Putative pro-MCH-like protein 2	GO:0007268; P:synaptic transmission; IEA:InterPro
Q99705	MCHR1	Melanin-concentrating hormone receptor 1	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q99705	MCHR1	Melanin-concentrating hormone receptor 1	GO:0042562; F:hormone binding; IEA:Ensembl
Q99705	MCHR1	Melanin-concentrating hormone receptor 1	GO:0030273; F:melanin-concentrating hormone receptor activity; IEA:Ensembl
Q99705	MCHR1	Melanin-concentrating hormone receptor 1	GO:0008188; F:neuropeptide receptor activity; TAS:ProtInc
Q99705	MCHR1	Melanin-concentrating hormone receptor 1	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:ProtInc
Q99705	MCHR1	Melanin-concentrating hormone receptor 1	GO:0007631; P:feeding behavior; TAS:ProtInc
Q99705	MCHR1	Melanin-concentrating hormone receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q99705	MCHR1	Melanin-concentrating hormone receptor 1	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
Q99705	MCHR1	Melanin-concentrating hormone receptor 1	GO:0051928; P:positive regulation of calcium ion transport; IEA:Ensembl
Q99705	MCHR1	Melanin-concentrating hormone receptor 1	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
Q16048	PMCHL1	Putative pro-MCH-like protein 1	GO:0007268; P:synaptic transmission; IEA:InterPro
Q969V1	MCHR2	Melanin-concentrating hormone receptor 2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P20382	PMCH	Pro-MCH	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P20382	PMCH	Pro-MCH	GO:0007631; P:feeding behavior; ISS:UniProtKB
P20382	PMCH	Pro-MCH	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P20382	PMCH	Pro-MCH	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
P20382	PMCH	Pro-MCH	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
P20382	PMCH	Pro-MCH	GO:0007268; P:synaptic transmission; IEA:InterPro
D6RGH6	MCIDAS	Multicilin	GO:0042802; F:identical protein binding; IPI:IntAct
D6RGH6	MCIDAS	Multicilin	GO:0005515; F:protein binding; IPI:IntAct
D6RGH6	MCIDAS	Multicilin	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
D6RGH6	MCIDAS	Multicilin	GO:0042384; P:cilium assembly; ISS:UniProtKB
D6RGH6	MCIDAS	Multicilin	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
D6RGH6	MCIDAS	Multicilin	GO:0006275; P:regulation of DNA replication; IEA:InterPro
D6RGH6	MCIDAS	Multicilin	GO:0007346; P:regulation of mitotic cell cycle; IMP:UniProtKB
D6RGH6	MCIDAS	Multicilin	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q07820	MCL1	Induced myeloid leukemia cell differentiation protein Mcl-1	GO:0051434; F:BH3 domain binding; IPI:BHF-UCL
Q07820	MCL1	Induced myeloid leukemia cell differentiation protein Mcl-1	GO:0005515; F:protein binding; IPI:IntAct
Q07820	MCL1	Induced myeloid leukemia cell differentiation protein Mcl-1	GO:0015266; F:protein channel activity; TAS:UniProtKB
Q07820	MCL1	Induced myeloid leukemia cell differentiation protein Mcl-1	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q07820	MCL1	Induced myeloid leukemia cell differentiation protein Mcl-1	GO:0042803; F:protein homodimerization activity; IBA:RefGenome
Q07820	MCL1	Induced myeloid leukemia cell differentiation protein Mcl-1	GO:0008637; P:apoptotic mitochondrial changes; IEA:Ensembl
Q07820	MCL1	Induced myeloid leukemia cell differentiation protein Mcl-1	GO:0001709; P:cell fate determination; NAS:UniProtKB
Q07820	MCL1	Induced myeloid leukemia cell differentiation protein Mcl-1	GO:0019725; P:cellular homeostasis; NAS:UniProtKB
Q07820	MCL1	Induced myeloid leukemia cell differentiation protein Mcl-1	GO:0097194; P:execution phase of apoptosis; IDA:UniProtKB
Q07820	MCL1	Induced myeloid leukemia cell differentiation protein Mcl-1	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IMP:UniProtKB
Q07820	MCL1	Induced myeloid leukemia cell differentiation protein Mcl-1	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IBA:RefGenome
Q07820	MCL1	Induced myeloid leukemia cell differentiation protein Mcl-1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q07820	MCL1	Induced myeloid leukemia cell differentiation protein Mcl-1	GO:2000811; P:negative regulation of anoikis; IMP:UniProtKB
Q07820	MCL1	Induced myeloid leukemia cell differentiation protein Mcl-1	GO:1900118; P:negative regulation of execution phase of apoptosis; TAS:UniProtKB
Q07820	MCL1	Induced myeloid leukemia cell differentiation protein Mcl-1	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IMP:UniProtKB
Q07820	MCL1	Induced myeloid leukemia cell differentiation protein Mcl-1	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IBA:RefGenome
Q07820	MCL1	Induced myeloid leukemia cell differentiation protein Mcl-1	GO:0071806; P:protein transmembrane transport; TAS:GOC
Q07820	MCL1	Induced myeloid leukemia cell differentiation protein Mcl-1	GO:2001020; P:regulation of response to DNA damage stimulus; IMP:MGI
Q07820	MCL1	Induced myeloid leukemia cell differentiation protein Mcl-1	GO:0034097; P:response to cytokine; IDA:MGI
Q9GZU1	MCOLN1	Mucolipin-1	GO:0005261; F:cation channel activity; NAS:UniProtKB
Q9GZU1	MCOLN1	Mucolipin-1	GO:0072345; F:NAADP-sensitive calcium-release channel activity; IEA:Ensembl
Q9GZU1	MCOLN1	Mucolipin-1	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
Q9GZU1	MCOLN1	Mucolipin-1	GO:0006812; P:cation transport; NAS:UniProtKB
Q9GZU1	MCOLN1	Mucolipin-1	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
Q9GZU1	MCOLN1	Mucolipin-1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9GZU1	MCOLN1	Mucolipin-1	GO:0051209; P:release of sequestered calcium ion into cytosol; IEA:Ensembl
Q9GZU1	MCOLN1	Mucolipin-1	GO:0033572; P:transferrin transport; TAS:Reactome
Q9GZU1	MCOLN1	Mucolipin-1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8IZK6	MCOLN2	Mucolipin-2	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
Q8IZK6	MCOLN2	Mucolipin-2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q8IZK6	MCOLN2	Mucolipin-2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8TDD5	MCOLN3	Mucolipin-3	GO:0042491; P:auditory receptor cell differentiation; IEA:Ensembl
Q8TDD5	MCOLN3	Mucolipin-3	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
Q8TDD5	MCOLN3	Mucolipin-3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q8TDD5	MCOLN3	Mucolipin-3	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q8TDD5	MCOLN3	Mucolipin-3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q7L590	MCM10	Protein MCM10 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7L590	MCM10	Protein MCM10 homolog	GO:0042802; F:identical protein binding; IPI:IntAct
Q7L590	MCM10	Protein MCM10 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7L590	MCM10	Protein MCM10 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q7L590	MCM10	Protein MCM10 homolog	GO:0008283; P:cell proliferation; IEA:Ensembl
Q7L590	MCM10	Protein MCM10 homolog	GO:0006260; P:DNA replication; TAS:Reactome
Q7L590	MCM10	Protein MCM10 homolog	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q7L590	MCM10	Protein MCM10 homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P49736	MCM2	DNA replication licensing factor MCM2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49736	MCM2	DNA replication licensing factor MCM2	GO:0003677; F:DNA binding; TAS:ProtInc
P49736	MCM2	DNA replication licensing factor MCM2	GO:0003678; F:DNA helicase activity; IEA:InterPro
P49736	MCM2	DNA replication licensing factor MCM2	GO:0003688; F:DNA replication origin binding; IEA:Ensembl
P49736	MCM2	DNA replication licensing factor MCM2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P49736	MCM2	DNA replication licensing factor MCM2	GO:0005515; F:protein binding; IPI:UniProtKB
P49736	MCM2	DNA replication licensing factor MCM2	GO:0007049; P:cell cycle; TAS:ProtInc
P49736	MCM2	DNA replication licensing factor MCM2	GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl
P49736	MCM2	DNA replication licensing factor MCM2	GO:0006260; P:DNA replication; TAS:Reactome
P49736	MCM2	DNA replication licensing factor MCM2	GO:0006270; P:DNA replication initiation; IMP:UniProtKB
P49736	MCM2	DNA replication licensing factor MCM2	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P49736	MCM2	DNA replication licensing factor MCM2	GO:0006268; P:DNA unwinding involved in DNA replication; IEA:Ensembl
P49736	MCM2	DNA replication licensing factor MCM2	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P49736	MCM2	DNA replication licensing factor MCM2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P49736	MCM2	DNA replication licensing factor MCM2	GO:0006334; P:nucleosome assembly; IEA:Ensembl
P25205	MCM3	DNA replication licensing factor MCM3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P25205	MCM3	DNA replication licensing factor MCM3	GO:0003677; F:DNA binding; TAS:ProtInc
P25205	MCM3	DNA replication licensing factor MCM3	GO:0003678; F:DNA helicase activity; IEA:InterPro
P25205	MCM3	DNA replication licensing factor MCM3	GO:0005515; F:protein binding; IPI:IntAct
P25205	MCM3	DNA replication licensing factor MCM3	GO:0006260; P:DNA replication; TAS:Reactome
P25205	MCM3	DNA replication licensing factor MCM3	GO:0006270; P:DNA replication initiation; TAS:ProtInc
P25205	MCM3	DNA replication licensing factor MCM3	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P25205	MCM3	DNA replication licensing factor MCM3	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P25205	MCM3	DNA replication licensing factor MCM3	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P33991	MCM4	DNA replication licensing factor MCM4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P33991	MCM4	DNA replication licensing factor MCM4	GO:0003678; F:DNA helicase activity; IEA:Ensembl
P33991	MCM4	DNA replication licensing factor MCM4	GO:0005515; F:protein binding; IPI:IntAct
P33991	MCM4	DNA replication licensing factor MCM4	GO:0003697; F:single-stranded DNA binding; IEA:Ensembl
P33991	MCM4	DNA replication licensing factor MCM4	GO:0006260; P:DNA replication; NAS:UniProtKB
P33991	MCM4	DNA replication licensing factor MCM4	GO:0006270; P:DNA replication initiation; IEA:InterPro
P33991	MCM4	DNA replication licensing factor MCM4	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P33991	MCM4	DNA replication licensing factor MCM4	GO:0006268; P:DNA unwinding involved in DNA replication; IEA:Ensembl
P33991	MCM4	DNA replication licensing factor MCM4	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P33991	MCM4	DNA replication licensing factor MCM4	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P33992	MCM5	DNA replication licensing factor MCM5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P33992	MCM5	DNA replication licensing factor MCM5	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P33992	MCM5	DNA replication licensing factor MCM5	GO:0003678; F:DNA helicase activity; IEA:InterPro
P33992	MCM5	DNA replication licensing factor MCM5	GO:0005515; F:protein binding; IPI:IntAct
P33992	MCM5	DNA replication licensing factor MCM5	GO:0006260; P:DNA replication; TAS:Reactome
P33992	MCM5	DNA replication licensing factor MCM5	GO:0006270; P:DNA replication initiation; IEA:InterPro
P33992	MCM5	DNA replication licensing factor MCM5	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P33992	MCM5	DNA replication licensing factor MCM5	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P33992	MCM5	DNA replication licensing factor MCM5	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q14566	MCM6	DNA replication licensing factor MCM6	GO:0005524; F:ATP binding; NAS:UniProtKB
Q14566	MCM6	DNA replication licensing factor MCM6	GO:0003678; F:DNA helicase activity; IEA:Ensembl
Q14566	MCM6	DNA replication licensing factor MCM6	GO:0042802; F:identical protein binding; IPI:IntAct
Q14566	MCM6	DNA replication licensing factor MCM6	GO:0005515; F:protein binding; IPI:UniProtKB
Q14566	MCM6	DNA replication licensing factor MCM6	GO:0003697; F:single-stranded DNA binding; IEA:Ensembl
Q14566	MCM6	DNA replication licensing factor MCM6	GO:0006260; P:DNA replication; NAS:UniProtKB
Q14566	MCM6	DNA replication licensing factor MCM6	GO:0006270; P:DNA replication initiation; IEA:InterPro
Q14566	MCM6	DNA replication licensing factor MCM6	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
Q14566	MCM6	DNA replication licensing factor MCM6	GO:0006268; P:DNA unwinding involved in DNA replication; IEA:Ensembl
Q14566	MCM6	DNA replication licensing factor MCM6	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q14566	MCM6	DNA replication licensing factor MCM6	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P33993	MCM7	DNA replication licensing factor MCM7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P33993	MCM7	DNA replication licensing factor MCM7	GO:0003678; F:DNA helicase activity; IEA:Ensembl
P33993	MCM7	DNA replication licensing factor MCM7	GO:0005515; F:protein binding; IPI:UniProtKB
P33993	MCM7	DNA replication licensing factor MCM7	GO:0003697; F:single-stranded DNA binding; IEA:Ensembl
P33993	MCM7	DNA replication licensing factor MCM7	GO:0008283; P:cell proliferation; IEA:Ensembl
P33993	MCM7	DNA replication licensing factor MCM7	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
P33993	MCM7	DNA replication licensing factor MCM7	GO:0071364; P:cellular response to epidermal growth factor stimulus; IEA:Ensembl
P33993	MCM7	DNA replication licensing factor MCM7	GO:0006260; P:DNA replication; TAS:Reactome
P33993	MCM7	DNA replication licensing factor MCM7	GO:0006270; P:DNA replication initiation; IEA:InterPro
P33993	MCM7	DNA replication licensing factor MCM7	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P33993	MCM7	DNA replication licensing factor MCM7	GO:0006268; P:DNA unwinding involved in DNA replication; IEA:Ensembl
P33993	MCM7	DNA replication licensing factor MCM7	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P33993	MCM7	DNA replication licensing factor MCM7	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P33993	MCM7	DNA replication licensing factor MCM7	GO:0042325; P:regulation of phosphorylation; IMP:UniProtKB
P33993	MCM7	DNA replication licensing factor MCM7	GO:0042493; P:response to drug; IEA:Ensembl
Q9UJA3	MCM8	DNA helicase MCM8	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UJA3	MCM8	DNA helicase MCM8	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UJA3	MCM8	DNA helicase MCM8	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q9UJA3	MCM8	DNA helicase MCM8	GO:0005515; F:protein binding; IPI:IntAct
Q9UJA3	MCM8	DNA helicase MCM8	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q9UJA3	MCM8	DNA helicase MCM8	GO:0006260; P:DNA replication; TAS:Reactome
Q9UJA3	MCM8	DNA helicase MCM8	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
Q9UJA3	MCM8	DNA helicase MCM8	GO:0000724; P:double-strand break repair via homologous recombination; IEA:Ensembl
Q9UJA3	MCM8	DNA helicase MCM8	GO:0007292; P:female gamete generation; ISS:UniProtKB
Q9UJA3	MCM8	DNA helicase MCM8	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q9UJA3	MCM8	DNA helicase MCM8	GO:0048232; P:male gamete generation; ISS:UniProtKB
Q9UJA3	MCM8	DNA helicase MCM8	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9NXL9	MCM9	DNA helicase MCM9	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NXL9	MCM9	DNA helicase MCM9	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NXL9	MCM9	DNA helicase MCM9	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q9NXL9	MCM9	DNA helicase MCM9	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q9NXL9	MCM9	DNA helicase MCM9	GO:0006260; P:DNA replication; IEA:InterPro
Q9NXL9	MCM9	DNA helicase MCM9	GO:0000724; P:double-strand break repair via homologous recombination; IDA:UniProtKB
Q9NXL9	MCM9	DNA helicase MCM9	GO:0007292; P:female gamete generation; ISS:UniProtKB
Q9BTE3	MCMBP	Mini-chromosome maintenance complex-binding protein	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q9BTE3	MCMBP	Mini-chromosome maintenance complex-binding protein	GO:0005515; F:protein binding; IPI:IntAct
Q9BTE3	MCMBP	Mini-chromosome maintenance complex-binding protein	GO:0006261; P:DNA-dependent DNA replication; IMP:UniProtKB
Q9BTE3	MCMBP	Mini-chromosome maintenance complex-binding protein	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9BTE3	MCMBP	Mini-chromosome maintenance complex-binding protein	GO:0000084; P:mitotic S phase; IMP:UniProtKB
Q9BTE3	MCMBP	Mini-chromosome maintenance complex-binding protein	GO:0007062; P:sister chromatid cohesion; IMP:UniProtKB
Q4G0Z9	MCMDC2	MCM domain-containing protein 2	GO:0005524; F:ATP binding; IEA:InterPro
Q4G0Z9	MCMDC2	MCM domain-containing protein 2	GO:0003677; F:DNA binding; IEA:InterPro
Q4G0Z9	MCMDC2	MCM domain-containing protein 2	GO:0006260; P:DNA replication; IEA:InterPro
P0CW71	HSMCR30	Putative metaphase chromosome protein 1	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
P0CW71	HSMCR30	Putative metaphase chromosome protein 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q8NEM0	MCPH1	Microcephalin	GO:0042802; F:identical protein binding; IPI:IntAct
Q8NEM0	MCPH1	Microcephalin	GO:0005515; F:protein binding; IPI:IntAct
Q8NEM0	MCPH1	Microcephalin	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P15529	CD46	Membrane cofactor protein	GO:0045296; F:cadherin binding; IPI:UniProt
P15529	CD46	Membrane cofactor protein	GO:0005515; F:protein binding; IPI:IntAct
P15529	CD46	Membrane cofactor protein	GO:0004872; F:receptor activity; TAS:ProtInc
P15529	CD46	Membrane cofactor protein	GO:0002250; P:adaptive immune response; IC:UniProt
P15529	CD46	Membrane cofactor protein	GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW
P15529	CD46	Membrane cofactor protein	GO:0045087; P:innate immune response; TAS:Reactome
P15529	CD46	Membrane cofactor protein	GO:0032613; P:interleukin-10 production; IDA:UniProt
P15529	CD46	Membrane cofactor protein	GO:0045916; P:negative regulation of complement activation; IEA:Ensembl
P15529	CD46	Membrane cofactor protein	GO:0010629; P:negative regulation of gene expression; IDA:UniProt
P15529	CD46	Membrane cofactor protein	GO:0010628; P:positive regulation of gene expression; IMP:UniProt
P15529	CD46	Membrane cofactor protein	GO:0032733; P:positive regulation of interleukin-10 production; IDA:UniProt
P15529	CD46	Membrane cofactor protein	GO:0043382; P:positive regulation of memory T cell differentiation; IDA:UniProt
P15529	CD46	Membrane cofactor protein	GO:0045591; P:positive regulation of regulatory T cell differentiation; IDA:UniProt
P15529	CD46	Membrane cofactor protein	GO:0042102; P:positive regulation of T cell proliferation; IDA:UniProt
P15529	CD46	Membrane cofactor protein	GO:0071636; P:positive regulation of transforming growth factor beta production; IDA:UniProt
P15529	CD46	Membrane cofactor protein	GO:0006508; P:proteolysis; IEA:Ensembl
P15529	CD46	Membrane cofactor protein	GO:0030449; P:regulation of complement activation; TAS:Reactome
P15529	CD46	Membrane cofactor protein	GO:0008593; P:regulation of Notch signaling pathway; IDA:UniProt
P15529	CD46	Membrane cofactor protein	GO:0035581; P:sequestering of extracellular ligand from receptor; IDA:UniProt
P15529	CD46	Membrane cofactor protein	GO:0007338; P:single fertilization; IEA:UniProtKB-KW
P15529	CD46	Membrane cofactor protein	GO:0002456; P:T cell mediated immunity; IMP:UniProt
P15529	CD46	Membrane cofactor protein	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q96EZ8	MCRS1	Microspherule protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96EZ8	MCRS1	Microspherule protein 1	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q96EZ8	MCRS1	Microspherule protein 1	GO:0006325; P:chromatin organization; TAS:Reactome
Q96EZ8	MCRS1	Microspherule protein 1	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q96EZ8	MCRS1	Microspherule protein 1	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q96EZ8	MCRS1	Microspherule protein 1	GO:0043984; P:histone H4-K16 acetylation; IDA:UniProtKB
Q96EZ8	MCRS1	Microspherule protein 1	GO:0043981; P:histone H4-K5 acetylation; IDA:UniProtKB
Q96EZ8	MCRS1	Microspherule protein 1	GO:0043982; P:histone H4-K8 acetylation; IDA:UniProtKB
Q96EZ8	MCRS1	Microspherule protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96EZ8	MCRS1	Microspherule protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P08235	NR3C2	Mineralocorticoid receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P08235	NR3C2	Mineralocorticoid receptor	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P08235	NR3C2	Mineralocorticoid receptor	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P08235	NR3C2	Mineralocorticoid receptor	GO:0005496; F:steroid binding; IEA:UniProtKB-KW
P08235	NR3C2	Mineralocorticoid receptor	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P08235	NR3C2	Mineralocorticoid receptor	GO:0008270; F:zinc ion binding; IEA:InterPro
P08235	NR3C2	Mineralocorticoid receptor	GO:0010467; P:gene expression; TAS:Reactome
P08235	NR3C2	Mineralocorticoid receptor	GO:0007165; P:signal transduction; TAS:ProtInc
P08235	NR3C2	Mineralocorticoid receptor	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P08235	NR3C2	Mineralocorticoid receptor	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P49901	SMCP	Sperm mitochondrial-associated cysteine-rich protein	GO:0007341; P:penetration of zona pellucida; ISS:UniProtKB
P49901	SMCP	Sperm mitochondrial-associated cysteine-rich protein	GO:0030317; P:sperm motility; ISS:UniProtKB
Q6DN12	MCTP2	Multiple C2 and transmembrane domain-containing protein 2	GO:0005509; F:calcium ion binding; IDA:HGNC
Q6DN12	MCTP2	Multiple C2 and transmembrane domain-containing protein 2	GO:0019722; P:calcium-mediated signaling; NAS:HGNC
Q6DN14	MCTP1	Multiple C2 and transmembrane domain-containing protein 1	GO:0005509; F:calcium ion binding; IDA:HGNC
Q6DN14	MCTP1	Multiple C2 and transmembrane domain-containing protein 1	GO:0019722; P:calcium-mediated signaling; NAS:HGNC
Q9ULC4	MCTS1	Malignant T-cell-amplified sequence 1	GO:0003723; F:RNA binding; IEA:InterPro
Q9ULC4	MCTS1	Malignant T-cell-amplified sequence 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9ULC4	MCTS1	Malignant T-cell-amplified sequence 1	GO:0006974; P:cellular response to DNA damage stimulus; IEA:UniProtKB-KW
Q9ULC4	MCTS1	Malignant T-cell-amplified sequence 1	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q9ULC4	MCTS1	Malignant T-cell-amplified sequence 1	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q9ULC4	MCTS1	Malignant T-cell-amplified sequence 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9ULC4	MCTS1	Malignant T-cell-amplified sequence 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96AQ8	MCUR1	Mitochondrial calcium uniporter regulator 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96AQ8	MCUR1	Mitochondrial calcium uniporter regulator 1	GO:0070509; P:calcium ion import; IMP:UniProtKB
Q96AQ8	MCUR1	Mitochondrial calcium uniporter regulator 1	GO:0006851; P:mitochondrial calcium ion transport; IMP:UniProtKB
Q96AQ8	MCUR1	Mitochondrial calcium uniporter regulator 1	GO:0051561; P:positive regulation of mitochondrial calcium ion concentration; IMP:UniProtKB
Q9NWR8	CCDC109B	Mitochondrial calcium uniporter regulatory subunit MCUb	GO:0019855; F:calcium channel inhibitor activity; ISS:UniProtKB
Q9NWR8	CCDC109B	Mitochondrial calcium uniporter regulatory subunit MCUb	GO:0051560; P:mitochondrial calcium ion homeostasis; ISS:UniProtKB
Q9NWR8	CCDC109B	Mitochondrial calcium uniporter regulatory subunit MCUb	GO:0006851; P:mitochondrial calcium ion transport; ISS:UniProtKB
Q8NE86	MCU	Calcium uniporter protein, mitochondrial	GO:0005262; F:calcium channel activity; IDA:UniProtKB
Q8NE86	MCU	Calcium uniporter protein, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NE86	MCU	Calcium uniporter protein, mitochondrial	GO:0015292; F:uniporter activity; IDA:UniProtKB
Q8NE86	MCU	Calcium uniporter protein, mitochondrial	GO:0019722; P:calcium-mediated signaling; IDA:UniProtKB
Q8NE86	MCU	Calcium uniporter protein, mitochondrial	GO:0042593; P:glucose homeostasis; IMP:UniProtKB
Q8NE86	MCU	Calcium uniporter protein, mitochondrial	GO:0006851; P:mitochondrial calcium ion transport; IDA:UniProtKB
Q8NE86	MCU	Calcium uniporter protein, mitochondrial	GO:0032024; P:positive regulation of insulin secretion; IMP:UniProtKB
Q8NE86	MCU	Calcium uniporter protein, mitochondrial	GO:0051561; P:positive regulation of mitochondrial calcium ion concentration; IDA:UniProtKB
Q8NE86	MCU	Calcium uniporter protein, mitochondrial	GO:0035786; P:protein complex oligomerization; IDA:UniProtKB
Q86YW9	MED12L	Mediator of RNA polymerase II transcription subunit 12-like protein	GO:0001104; F:RNA polymerase II transcription cofactor activity; IEA:InterPro
Q71F56	MED13L	Mediator of RNA polymerase II transcription subunit 13-like	GO:0001104; F:RNA polymerase II transcription cofactor activity; IEA:InterPro
Q9Y6D9	MAD1L1	Mitotic spindle assembly checkpoint protein MAD1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6D9	MAD1L1	Mitotic spindle assembly checkpoint protein MAD1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9Y6D9	MAD1L1	Mitotic spindle assembly checkpoint protein MAD1	GO:0000090; P:mitotic anaphase; NAS:UniProtKB
Q9Y6D9	MAD1L1	Mitotic spindle assembly checkpoint protein MAD1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9Y6D9	MAD1L1	Mitotic spindle assembly checkpoint protein MAD1	GO:0007093; P:mitotic cell cycle checkpoint; NAS:UniProtKB
Q9Y6D9	MAD1L1	Mitotic spindle assembly checkpoint protein MAD1	GO:0000089; P:mitotic metaphase; NAS:UniProtKB
Q9Y6D9	MAD1L1	Mitotic spindle assembly checkpoint protein MAD1	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:Reactome
Q9Y6D9	MAD1L1	Mitotic spindle assembly checkpoint protein MAD1	GO:0000093; P:mitotic telophase; NAS:UniProtKB
Q9Y6D9	MAD1L1	Mitotic spindle assembly checkpoint protein MAD1	GO:0090235; P:regulation of metaphase plate congression; IDA:UniProtKB
Q15013	MAD2L1BP	MAD2L1-binding protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q15013	MAD2L1BP	MAD2L1-binding protein	GO:0007093; P:mitotic cell cycle checkpoint; IMP:UniProtKB
Q15013	MAD2L1BP	MAD2L1-binding protein	GO:0007096; P:regulation of exit from mitosis; IMP:UniProtKB
Q13257	MAD2L1	Mitotic spindle assembly checkpoint protein MAD2A	GO:0042802; F:identical protein binding; IPI:IntAct
Q13257	MAD2L1	Mitotic spindle assembly checkpoint protein MAD2A	GO:0005515; F:protein binding; IPI:UniProtKB
Q13257	MAD2L1	Mitotic spindle assembly checkpoint protein MAD2A	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q13257	MAD2L1	Mitotic spindle assembly checkpoint protein MAD2A	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q13257	MAD2L1	Mitotic spindle assembly checkpoint protein MAD2A	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q13257	MAD2L1	Mitotic spindle assembly checkpoint protein MAD2A	GO:0007093; P:mitotic cell cycle checkpoint; IDA:UniProtKB
Q13257	MAD2L1	Mitotic spindle assembly checkpoint protein MAD2A	GO:0000070; P:mitotic sister chromatid segregation; IEA:Ensembl
Q13257	MAD2L1	Mitotic spindle assembly checkpoint protein MAD2A	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:Reactome
Q13257	MAD2L1	Mitotic spindle assembly checkpoint protein MAD2A	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q13257	MAD2L1	Mitotic spindle assembly checkpoint protein MAD2A	GO:0060564; P:negative regulation of mitotic anaphase-promoting complex activity; IDA:UniProtKB
Q13257	MAD2L1	Mitotic spindle assembly checkpoint protein MAD2A	GO:0042177; P:negative regulation of protein catabolic process; IDA:UniProtKB
Q13257	MAD2L1	Mitotic spindle assembly checkpoint protein MAD2A	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q13257	MAD2L1	Mitotic spindle assembly checkpoint protein MAD2A	GO:0090267; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; IMP:UniProtKB
Q13257	MAD2L1	Mitotic spindle assembly checkpoint protein MAD2A	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:0008432; F:JUN kinase binding; IDA:UniProtKB
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:0007015; P:actin filament organization; IMP:BHF-UCL
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:0042772; P:DNA damage response, signal transduction resulting in transcription; IDA:UniProtKB
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:0006281; P:DNA repair; TAS:Reactome
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:0006302; P:double-strand break repair; IGI:UniProtKB
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:ProtInc
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:2000048; P:negative regulation of cell-cell adhesion mediated by cadherin; IMP:BHF-UCL
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:0010719; P:negative regulation of epithelial to mesenchymal transition; IMP:BHF-UCL
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:0060564; P:negative regulation of mitotic anaphase-promoting complex activity; IDA:UniProtKB
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:0042177; P:negative regulation of protein catabolic process; IDA:UniProtKB
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:0010944; P:negative regulation of transcription by competitive promoter binding; IMP:BHF-UCL
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:2000678; P:negative regulation of transcription regulatory region DNA binding; IMP:BHF-UCL
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:UniProtKB
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:0001558; P:regulation of cell growth; IGI:UniProtKB
Q9UI95	MAD2L2	Mitotic spindle assembly checkpoint protein MAD2B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14676	MDC1	Mediator of DNA damage checkpoint protein 1	GO:0070975; F:FHA domain binding; IPI:UniProtKB
Q14676	MDC1	Mediator of DNA damage checkpoint protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q14676	MDC1	Mediator of DNA damage checkpoint protein 1	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q14676	MDC1	Mediator of DNA damage checkpoint protein 1	GO:0006281; P:DNA repair; TAS:Reactome
Q14676	MDC1	Mediator of DNA damage checkpoint protein 1	GO:0006302; P:double-strand break repair; TAS:Reactome
Q14676	MDC1	Mediator of DNA damage checkpoint protein 1	GO:0000724; P:double-strand break repair via homologous recombination; TAS:Reactome
Q14676	MDC1	Mediator of DNA damage checkpoint protein 1	GO:0031573; P:intra-S DNA damage checkpoint; TAS:UniProtKB
Q9P1T7	MDFIC	MyoD family inhibitor domain-containing protein	GO:0030332; F:cyclin binding; IPI:UniProtKB
Q9P1T7	MDFIC	MyoD family inhibitor domain-containing protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P1T7	MDFIC	MyoD family inhibitor domain-containing protein	GO:0030957; F:Tat protein binding; IDA:UniProtKB
Q9P1T7	MDFIC	MyoD family inhibitor domain-containing protein	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q9P1T7	MDFIC	MyoD family inhibitor domain-containing protein	GO:0007257; P:activation of JUN kinase activity; IDA:UniProtKB
Q9P1T7	MDFIC	MyoD family inhibitor domain-containing protein	GO:0042308; P:negative regulation of protein import into nucleus; ISS:UniProtKB
Q9P1T7	MDFIC	MyoD family inhibitor domain-containing protein	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q9P1T7	MDFIC	MyoD family inhibitor domain-containing protein	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9P1T7	MDFIC	MyoD family inhibitor domain-containing protein	GO:0050434; P:positive regulation of viral transcription; IDA:UniProtKB
Q9P1T7	MDFIC	MyoD family inhibitor domain-containing protein	GO:0030111; P:regulation of Wnt signaling pathway; IDA:UniProtKB
Q9P1T7	MDFIC	MyoD family inhibitor domain-containing protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9P1T7	MDFIC	MyoD family inhibitor domain-containing protein	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q99750	MDFI	MyoD family inhibitor	GO:0005515; F:protein binding; IPI:IntAct
Q99750	MDFI	MyoD family inhibitor	GO:0007257; P:activation of JUN kinase activity; IEA:Ensembl
Q99750	MDFI	MyoD family inhibitor	GO:0042994; P:cytoplasmic sequestering of transcription factor; TAS:ProtInc
Q99750	MDFI	MyoD family inhibitor	GO:0009950; P:dorsal/ventral axis specification; ISS:UniProtKB
Q99750	MDFI	MyoD family inhibitor	GO:0009790; P:embryo development; TAS:ProtInc
Q99750	MDFI	MyoD family inhibitor	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
Q99750	MDFI	MyoD family inhibitor	GO:0043392; P:negative regulation of DNA binding; ISS:UniProtKB
Q99750	MDFI	MyoD family inhibitor	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q99750	MDFI	MyoD family inhibitor	GO:0030178; P:negative regulation of Wnt signaling pathway; ISS:UniProtKB
Q99750	MDFI	MyoD family inhibitor	GO:0060707; P:trophoblast giant cell differentiation; IEA:Ensembl
Q8NFP4	MDGA1	MAM domain-containing glycosylphosphatidylinositol anchor protein 1	GO:0007420; P:brain development; ISS:HGNC
Q8NFP4	MDGA1	MAM domain-containing glycosylphosphatidylinositol anchor protein 1	GO:0021799; P:cerebral cortex radially oriented cell migration; IEA:Ensembl
Q8NFP4	MDGA1	MAM domain-containing glycosylphosphatidylinositol anchor protein 1	GO:0001764; P:neuron migration; ISS:UniProtKB
Q8NFP4	MDGA1	MAM domain-containing glycosylphosphatidylinositol anchor protein 1	GO:0021527; P:spinal cord association neuron differentiation; ISS:HGNC
Q7Z553	MDGA2	MAM domain-containing glycosylphosphatidylinositol anchor protein 2	GO:0021522; P:spinal cord motor neuron differentiation; ISS:HGNC
Q5I0G3	MDH1B	Putative malate dehydrogenase 1B	GO:0016615; F:malate dehydrogenase activity; IEA:InterPro
Q5I0G3	MDH1B	Putative malate dehydrogenase 1B	GO:0016616; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; IEA:InterPro
Q5I0G3	MDH1B	Putative malate dehydrogenase 1B	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q5I0G3	MDH1B	Putative malate dehydrogenase 1B	GO:0006108; P:malate metabolic process; IEA:InterPro
Q5I0G3	MDH1B	Putative malate dehydrogenase 1B	GO:0006099; P:tricarboxylic acid cycle; IEA:UniProtKB-KW
P40925	MDH1	Malate dehydrogenase, cytoplasmic	GO:0047860; F:diiodophenylpyruvate reductase activity; IEA:UniProtKB-EC
P40925	MDH1	Malate dehydrogenase, cytoplasmic	GO:0030060; F:L-malate dehydrogenase activity; TAS:Reactome
P40925	MDH1	Malate dehydrogenase, cytoplasmic	GO:0004470; F:malic enzyme activity; TAS:ProtInc
P40925	MDH1	Malate dehydrogenase, cytoplasmic	GO:0051287; F:NAD binding; IEA:Ensembl
P40925	MDH1	Malate dehydrogenase, cytoplasmic	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P40925	MDH1	Malate dehydrogenase, cytoplasmic	GO:0044262; P:cellular carbohydrate metabolic process; IEA:InterPro
P40925	MDH1	Malate dehydrogenase, cytoplasmic	GO:0006094; P:gluconeogenesis; TAS:Reactome
P40925	MDH1	Malate dehydrogenase, cytoplasmic	GO:0006006; P:glucose metabolic process; TAS:Reactome
P40925	MDH1	Malate dehydrogenase, cytoplasmic	GO:0006108; P:malate metabolic process; IEA:Ensembl
P40925	MDH1	Malate dehydrogenase, cytoplasmic	GO:0006734; P:NADH metabolic process; IEA:Ensembl
P40925	MDH1	Malate dehydrogenase, cytoplasmic	GO:0006107; P:oxaloacetate metabolic process; IEA:Ensembl
P40925	MDH1	Malate dehydrogenase, cytoplasmic	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P40925	MDH1	Malate dehydrogenase, cytoplasmic	GO:0006099; P:tricarboxylic acid cycle; IEA:UniProtKB-KW
P40926	MDH2	Malate dehydrogenase, mitochondrial	GO:0030060; F:L-malate dehydrogenase activity; IDA:UniProtKB
P40926	MDH2	Malate dehydrogenase, mitochondrial	GO:0046554; F:malate dehydrogenase (NADP+) activity; IEA:Ensembl
P40926	MDH2	Malate dehydrogenase, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P40926	MDH2	Malate dehydrogenase, mitochondrial	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P40926	MDH2	Malate dehydrogenase, mitochondrial	GO:0044262; P:cellular carbohydrate metabolic process; IEA:InterPro
P40926	MDH2	Malate dehydrogenase, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P40926	MDH2	Malate dehydrogenase, mitochondrial	GO:0006094; P:gluconeogenesis; TAS:Reactome
P40926	MDH2	Malate dehydrogenase, mitochondrial	GO:0006006; P:glucose metabolic process; TAS:Reactome
P40926	MDH2	Malate dehydrogenase, mitochondrial	GO:0006475; P:internal protein amino acid acetylation; IDA:UniProtKB
P40926	MDH2	Malate dehydrogenase, mitochondrial	GO:0006108; P:malate metabolic process; IDA:UniProtKB
P40926	MDH2	Malate dehydrogenase, mitochondrial	GO:0006734; P:NADH metabolic process; IEA:Ensembl
P40926	MDH2	Malate dehydrogenase, mitochondrial	GO:0006107; P:oxaloacetate metabolic process; IEA:Ensembl
P40926	MDH2	Malate dehydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P40926	MDH2	Malate dehydrogenase, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; TAS:Reactome
Q8TC05	MDM1	Nuclear protein MDM1	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0042802; F:identical protein binding; IPI:IntAct
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0002039; F:p53 binding; IPI:UniProtKB
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0005515; F:protein binding; IPI:UniProtKB
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0071229; P:cellular response to acid; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0071312; P:cellular response to alkaloid; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0071236; P:cellular response to antibiotic; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0071391; P:cellular response to estrogen stimulus; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0071456; P:cellular response to hypoxia; IEP:UniProtKB
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0071375; P:cellular response to peptide hormone stimulus; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0071494; P:cellular response to UV-C; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0071301; P:cellular response to vitamin B1; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; IMP:UniProtKB
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0045184; P:establishment of protein localization; IDA:BHF-UCL
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0045087; P:innate immune response; TAS:Reactome
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0071157; P:negative regulation of cell cycle arrest; IDA:BHF-UCL
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0043518; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; IDA:BHF-UCL
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0010955; P:negative regulation of protein processing; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0018205; P:peptidyl-lysine modification; IMP:BHF-UCL
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0008284; P:positive regulation of cell proliferation; TAS:BHF-UCL
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0045931; P:positive regulation of mitotic cell cycle; IMP:UniProtKB
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:BHF-UCL
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0046827; P:positive regulation of protein export from nucleus; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0006461; P:protein complex assembly; IDA:UniProtKB
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0031648; P:protein destabilization; IDA:BHF-UCL
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0034504; P:protein localization to nucleus; IDA:BHF-UCL
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:BHF-UCL
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0042176; P:regulation of protein catabolic process; IDA:UniProtKB
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0046677; P:response to antibiotic; IEP:UniProtKB
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0009743; P:response to carbohydrate; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0042220; P:response to cocaine; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0042493; P:response to drug; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0045472; P:response to ether; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0010039; P:response to iron ion; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0032026; P:response to magnesium ion; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0043278; P:response to morphine; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0007268; P:synaptic transmission; TAS:Reactome
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0007089; P:traversing start control point of mitotic cell cycle; IEA:Ensembl
Q00987	MDM2	E3 ubiquitin-protein ligase Mdm2	GO:0016032; P:viral process; IEA:UniProtKB-KW
O15151	MDM4	Protein Mdm4	GO:0019899; F:enzyme binding; IPI:UniProtKB
O15151	MDM4	Protein Mdm4	GO:0005515; F:protein binding; IPI:UniProtKB
O15151	MDM4	Protein Mdm4	GO:0008270; F:zinc ion binding; TAS:UniProtKB
O15151	MDM4	Protein Mdm4	GO:0008283; P:cell proliferation; IEP:UniProtKB
O15151	MDM4	Protein Mdm4	GO:0071456; P:cellular response to hypoxia; IEP:UniProtKB
O15151	MDM4	Protein Mdm4	GO:0030330; P:DNA damage response, signal transduction by p53 class mediator; IEP:UniProtKB
O15151	MDM4	Protein Mdm4	GO:0045023; P:G0 to G1 transition; IEP:UniProtKB
O15151	MDM4	Protein Mdm4	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
O15151	MDM4	Protein Mdm4	GO:0071157; P:negative regulation of cell cycle arrest; IEA:InterPro
O15151	MDM4	Protein Mdm4	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
O15151	MDM4	Protein Mdm4	GO:0042177; P:negative regulation of protein catabolic process; IMP:UniProtKB
O15151	MDM4	Protein Mdm4	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O15151	MDM4	Protein Mdm4	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
O15151	MDM4	Protein Mdm4	GO:0006461; P:protein complex assembly; IDA:UniProtKB
O15151	MDM4	Protein Mdm4	GO:0050821; P:protein stabilization; IEP:UniProtKB
Q9NU22	MDN1	Midasin	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NU22	MDN1	Midasin	GO:0016887; F:ATPase activity; NAS:UniProtKB
Q9NU22	MDN1	Midasin	GO:0005515; F:protein binding; IPI:IntAct
Q9NU22	MDN1	Midasin	GO:0051082; F:unfolded protein binding; NAS:UniProtKB
Q9NU22	MDN1	Midasin	GO:0006200; P:ATP catabolic process; NAS:GOC
Q9NU22	MDN1	Midasin	GO:0006461; P:protein complex assembly; NAS:UniProtKB
P08183	ABCB1	Multidrug resistance protein 1	GO:0005524; F:ATP binding; TAS:ProtInc
P08183	ABCB1	Multidrug resistance protein 1	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IBA:RefGenome
P08183	ABCB1	Multidrug resistance protein 1	GO:0005515; F:protein binding; IPI:IntAct
P08183	ABCB1	Multidrug resistance protein 1	GO:0005215; F:transporter activity; TAS:ProtInc
P08183	ABCB1	Multidrug resistance protein 1	GO:0008559; F:xenobiotic-transporting ATPase activity; IEA:UniProtKB-EC
P08183	ABCB1	Multidrug resistance protein 1	GO:0006855; P:drug transmembrane transport; TAS:Reactome
P08183	ABCB1	Multidrug resistance protein 1	GO:0000086; P:G2/M transition of mitotic cell cycle; IDA:DFLAT
P08183	ABCB1	Multidrug resistance protein 1	GO:0042493; P:response to drug; TAS:ProtInc
P08183	ABCB1	Multidrug resistance protein 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P08183	ABCB1	Multidrug resistance protein 1	GO:0072089; P:stem cell proliferation; IMP:DFLAT
P08183	ABCB1	Multidrug resistance protein 1	GO:0055085; P:transmembrane transport; IBA:RefGenome
P08183	ABCB1	Multidrug resistance protein 1	GO:0006810; P:transport; TAS:ProtInc
P21439	ABCB4	Multidrug resistance protein 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P21439	ABCB4	Multidrug resistance protein 3	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IBA:RefGenome
P21439	ABCB4	Multidrug resistance protein 3	GO:0008559; F:xenobiotic-transporting ATPase activity; IEA:UniProtKB-EC
P21439	ABCB4	Multidrug resistance protein 3	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P21439	ABCB4	Multidrug resistance protein 3	GO:0006629; P:lipid metabolic process; TAS:ProtInc
P21439	ABCB4	Multidrug resistance protein 3	GO:0042493; P:response to drug; TAS:ProtInc
P21439	ABCB4	Multidrug resistance protein 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P21439	ABCB4	Multidrug resistance protein 3	GO:0055085; P:transmembrane transport; IBA:RefGenome
P21439	ABCB4	Multidrug resistance protein 3	GO:0006810; P:transport; TAS:ProtInc
Q13465	MECOM	MDS1 and EVI1 complex locus protein MDS1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q13465	MECOM	MDS1 and EVI1 complex locus protein MDS1	GO:0006355; P:regulation of transcription, DNA-templated; TAS:GOC
A6NDR6	MEIS3P1	Putative homeobox protein Meis3-like 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
A6NDR6	MEIS3P1	Putative homeobox protein Meis3-like 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
A8K0S8	MEIS3P2	Putative homeobox protein Meis3-like 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
A8K0S8	MEIS3P2	Putative homeobox protein Meis3-like 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q16626	MEA1	Male-enhanced antigen 1	GO:0005515; F:protein binding; IPI:IntAct
Q16626	MEA1	Male-enhanced antigen 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q16626	MEA1	Male-enhanced antigen 1	GO:0008584; P:male gonad development; TAS:ProtInc
Q16626	MEA1	Male-enhanced antigen 1	GO:0007283; P:spermatogenesis; TAS:ProtInc
P0C7V9	METTL15P1	Putative methyltransferase-like protein 15P1	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0003682; F:chromatin binding; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0003677; F:DNA binding; TAS:ProtInc
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0010385; F:double-stranded methylated DNA binding; IMP:MGI
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0008327; F:methyl-CpG binding; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0003729; F:mRNA binding; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0005515; F:protein binding; IPI:IntAct
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0035197; F:siRNA binding; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0001662; P:behavioral fear response; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0032048; P:cardiolipin metabolic process; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0050432; P:catecholamine secretion; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0021549; P:cerebellum development; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0006342; P:chromatin silencing; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0016358; P:dendrite development; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0009790; P:embryo development; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0008211; P:glucocorticoid metabolic process; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0006541; P:glutamine metabolic process; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0016573; P:histone acetylation; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0016571; P:histone methylation; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0006020; P:inositol metabolic process; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0007616; P:long-term memory; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0006122; P:mitochondrial electron transport, ubiquinol to cytochrome c; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0035067; P:negative regulation of histone acetylation; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0031061; P:negative regulation of histone methylation; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0001976; P:neurological system process involved in regulation of systemic arterial blood pressure; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0042551; P:neuron maturation; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0009405; P:pathogenesis; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0046470; P:phosphatidylcholine metabolic process; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0051965; P:positive regulation of synapse assembly; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0009791; P:post-embryonic development; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0019230; P:proprioception; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0008104; P:protein localization; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0006349; P:regulation of gene expression by genetic imprinting; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0002087; P:regulation of respiratory gaseous exchange by neurological system process; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0001666; P:response to hypoxia; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0035176; P:social behavior; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0001964; P:startle response; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0007416; P:synapse assembly; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0021591; P:ventricular system development; IEA:Ensembl
P51608	MECP2	Methyl-CpG-binding protein 2	GO:0008542; P:visual learning; IEA:Ensembl
Q9BV79	MECR	Trans-2-enoyl-CoA reductase, mitochondrial	GO:0019166; F:trans-2-enoyl-CoA reductase (NADPH) activity; IDA:UniProtKB
Q9BV79	MECR	Trans-2-enoyl-CoA reductase, mitochondrial	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BV79	MECR	Trans-2-enoyl-CoA reductase, mitochondrial	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
Q9BV79	MECR	Trans-2-enoyl-CoA reductase, mitochondrial	GO:0006631; P:fatty acid metabolic process; IDA:UniProtKB
Q9BTT4	MED10	Mediator of RNA polymerase II transcription subunit 10	GO:0001104; F:RNA polymerase II transcription cofactor activity; IEA:InterPro
Q9BTT4	MED10	Mediator of RNA polymerase II transcription subunit 10	GO:0010467; P:gene expression; TAS:Reactome
Q9BTT4	MED10	Mediator of RNA polymerase II transcription subunit 10	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9BTT4	MED10	Mediator of RNA polymerase II transcription subunit 10	GO:0019827; P:stem cell maintenance; IEA:Ensembl
Q9BTT4	MED10	Mediator of RNA polymerase II transcription subunit 10	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q9P086	MED11	Mediator of RNA polymerase II transcription subunit 11	GO:0005515; F:protein binding; IPI:IntAct
Q9P086	MED11	Mediator of RNA polymerase II transcription subunit 11	GO:0001104; F:RNA polymerase II transcription cofactor activity; IEA:InterPro
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0003682; F:chromatin binding; IEA:Ensembl
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; NAS:UniProtKB
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0005515; F:protein binding; IPI:IntAct
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0004872; F:receptor activity; IDA:UniProtKB
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IEA:Ensembl
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0001104; F:RNA polymerase II transcription cofactor activity; IDA:UniProtKB
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0001190; F:RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0046966; F:thyroid hormone receptor binding; IDA:UniProtKB
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0003713; F:transcription coactivator activity; IDA:MGI
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0003712; F:transcription cofactor activity; IDA:UniProtKB
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0042809; F:vitamin D receptor binding; NAS:UniProtKB
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0030521; P:androgen receptor signaling pathway; IDA:UniProtKB
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0090245; P:axis elongation involved in somitogenesis; IEA:Ensembl
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0010467; P:gene expression; TAS:Reactome
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0007507; P:heart development; IEA:Ensembl
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0030518; P:intracellular steroid hormone receptor signaling pathway; IDA:UniProtKB
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0030178; P:negative regulation of Wnt signaling pathway; IMP:UniProtKB
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0001843; P:neural tube closure; IEA:Ensembl
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0014003; P:oligodendrocyte development; IEA:Ensembl
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0014044; P:Schwann cell development; IEA:Ensembl
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0019827; P:stem cell maintenance; IEA:Ensembl
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB
Q93074	MED12	Mediator of RNA polymerase II transcription subunit 12	GO:0060071; P:Wnt signaling pathway, planar cell polarity pathway; IEA:Ensembl
Q9UHV7	MED13	Mediator of RNA polymerase II transcription subunit 13	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; NAS:UniProtKB
Q9UHV7	MED13	Mediator of RNA polymerase II transcription subunit 13	GO:0004872; F:receptor activity; IDA:UniProtKB
Q9UHV7	MED13	Mediator of RNA polymerase II transcription subunit 13	GO:0001104; F:RNA polymerase II transcription cofactor activity; IDA:UniProtKB
Q9UHV7	MED13	Mediator of RNA polymerase II transcription subunit 13	GO:0046966; F:thyroid hormone receptor binding; IDA:UniProtKB
Q9UHV7	MED13	Mediator of RNA polymerase II transcription subunit 13	GO:0003713; F:transcription coactivator activity; IDA:MGI
Q9UHV7	MED13	Mediator of RNA polymerase II transcription subunit 13	GO:0003712; F:transcription cofactor activity; IDA:UniProtKB
Q9UHV7	MED13	Mediator of RNA polymerase II transcription subunit 13	GO:0042809; F:vitamin D receptor binding; NAS:UniProtKB
Q9UHV7	MED13	Mediator of RNA polymerase II transcription subunit 13	GO:0030521; P:androgen receptor signaling pathway; IDA:UniProtKB
Q9UHV7	MED13	Mediator of RNA polymerase II transcription subunit 13	GO:0010467; P:gene expression; TAS:Reactome
Q9UHV7	MED13	Mediator of RNA polymerase II transcription subunit 13	GO:0030518; P:intracellular steroid hormone receptor signaling pathway; IDA:UniProtKB
Q9UHV7	MED13	Mediator of RNA polymerase II transcription subunit 13	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q9UHV7	MED13	Mediator of RNA polymerase II transcription subunit 13	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UHV7	MED13	Mediator of RNA polymerase II transcription subunit 13	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB
O60244	MED14	Mediator of RNA polymerase II transcription subunit 14	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; NAS:UniProtKB
O60244	MED14	Mediator of RNA polymerase II transcription subunit 14	GO:0004872; F:receptor activity; IDA:UniProtKB
O60244	MED14	Mediator of RNA polymerase II transcription subunit 14	GO:0001104; F:RNA polymerase II transcription cofactor activity; IDA:UniProtKB
O60244	MED14	Mediator of RNA polymerase II transcription subunit 14	GO:0046966; F:thyroid hormone receptor binding; IDA:UniProtKB
O60244	MED14	Mediator of RNA polymerase II transcription subunit 14	GO:0003713; F:transcription coactivator activity; IDA:MGI
O60244	MED14	Mediator of RNA polymerase II transcription subunit 14	GO:0003712; F:transcription cofactor activity; IDA:UniProtKB
O60244	MED14	Mediator of RNA polymerase II transcription subunit 14	GO:0042809; F:vitamin D receptor binding; NAS:UniProtKB
O60244	MED14	Mediator of RNA polymerase II transcription subunit 14	GO:0030521; P:androgen receptor signaling pathway; IDA:UniProtKB
O60244	MED14	Mediator of RNA polymerase II transcription subunit 14	GO:0010467; P:gene expression; TAS:Reactome
O60244	MED14	Mediator of RNA polymerase II transcription subunit 14	GO:0030518; P:intracellular steroid hormone receptor signaling pathway; IDA:UniProtKB
O60244	MED14	Mediator of RNA polymerase II transcription subunit 14	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
O60244	MED14	Mediator of RNA polymerase II transcription subunit 14	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O60244	MED14	Mediator of RNA polymerase II transcription subunit 14	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O60244	MED14	Mediator of RNA polymerase II transcription subunit 14	GO:0019827; P:stem cell maintenance; IEA:Ensembl
O60244	MED14	Mediator of RNA polymerase II transcription subunit 14	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB
Q96RN5	MED15	Mediator of RNA polymerase II transcription subunit 15	GO:0005515; F:protein binding; IPI:UniProtKB
Q96RN5	MED15	Mediator of RNA polymerase II transcription subunit 15	GO:0001104; F:RNA polymerase II transcription cofactor activity; IEA:InterPro
Q96RN5	MED15	Mediator of RNA polymerase II transcription subunit 15	GO:0010467; P:gene expression; TAS:Reactome
Q96RN5	MED15	Mediator of RNA polymerase II transcription subunit 15	GO:0019827; P:stem cell maintenance; IEA:Ensembl
Q96RN5	MED15	Mediator of RNA polymerase II transcription subunit 15	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q9Y2X0	MED16	Mediator of RNA polymerase II transcription subunit 16	GO:0003824; F:catalytic activity; IEA:InterPro
Q9Y2X0	MED16	Mediator of RNA polymerase II transcription subunit 16	GO:0004872; F:receptor activity; IDA:UniProtKB
Q9Y2X0	MED16	Mediator of RNA polymerase II transcription subunit 16	GO:0046966; F:thyroid hormone receptor binding; IDA:UniProtKB
Q9Y2X0	MED16	Mediator of RNA polymerase II transcription subunit 16	GO:0030375; F:thyroid hormone receptor coactivator activity; IDA:UniProtKB
Q9Y2X0	MED16	Mediator of RNA polymerase II transcription subunit 16	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q9Y2X0	MED16	Mediator of RNA polymerase II transcription subunit 16	GO:0003712; F:transcription cofactor activity; IDA:UniProtKB
Q9Y2X0	MED16	Mediator of RNA polymerase II transcription subunit 16	GO:0042809; F:vitamin D receptor binding; NAS:UniProtKB
Q9Y2X0	MED16	Mediator of RNA polymerase II transcription subunit 16	GO:0030521; P:androgen receptor signaling pathway; IDA:UniProtKB
Q9Y2X0	MED16	Mediator of RNA polymerase II transcription subunit 16	GO:0010467; P:gene expression; TAS:Reactome
Q9Y2X0	MED16	Mediator of RNA polymerase II transcription subunit 16	GO:0030518; P:intracellular steroid hormone receptor signaling pathway; IDA:UniProtKB
Q9Y2X0	MED16	Mediator of RNA polymerase II transcription subunit 16	GO:2000273; P:positive regulation of receptor activity; IDA:GOC
Q9Y2X0	MED16	Mediator of RNA polymerase II transcription subunit 16	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9Y2X0	MED16	Mediator of RNA polymerase II transcription subunit 16	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; NAS:UniProtKB
Q9Y2X0	MED16	Mediator of RNA polymerase II transcription subunit 16	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9Y2X0	MED16	Mediator of RNA polymerase II transcription subunit 16	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB
Q9NVC6	MED17	Mediator of RNA polymerase II transcription subunit 17	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; NAS:UniProtKB
Q9NVC6	MED17	Mediator of RNA polymerase II transcription subunit 17	GO:0004872; F:receptor activity; IDA:UniProtKB
Q9NVC6	MED17	Mediator of RNA polymerase II transcription subunit 17	GO:0001104; F:RNA polymerase II transcription cofactor activity; IDA:UniProtKB
Q9NVC6	MED17	Mediator of RNA polymerase II transcription subunit 17	GO:0046966; F:thyroid hormone receptor binding; IDA:UniProtKB
Q9NVC6	MED17	Mediator of RNA polymerase II transcription subunit 17	GO:0003713; F:transcription coactivator activity; IDA:MGI
Q9NVC6	MED17	Mediator of RNA polymerase II transcription subunit 17	GO:0003712; F:transcription cofactor activity; IDA:UniProtKB
Q9NVC6	MED17	Mediator of RNA polymerase II transcription subunit 17	GO:0042809; F:vitamin D receptor binding; NAS:UniProtKB
Q9NVC6	MED17	Mediator of RNA polymerase II transcription subunit 17	GO:0030521; P:androgen receptor signaling pathway; IDA:UniProtKB
Q9NVC6	MED17	Mediator of RNA polymerase II transcription subunit 17	GO:0010467; P:gene expression; TAS:Reactome
Q9NVC6	MED17	Mediator of RNA polymerase II transcription subunit 17	GO:0030518; P:intracellular steroid hormone receptor signaling pathway; IDA:UniProtKB
Q9NVC6	MED17	Mediator of RNA polymerase II transcription subunit 17	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q9NVC6	MED17	Mediator of RNA polymerase II transcription subunit 17	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9NVC6	MED17	Mediator of RNA polymerase II transcription subunit 17	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q9NVC6	MED17	Mediator of RNA polymerase II transcription subunit 17	GO:0019827; P:stem cell maintenance; IEA:Ensembl
Q9NVC6	MED17	Mediator of RNA polymerase II transcription subunit 17	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB
Q9BUE0	MED18	Mediator of RNA polymerase II transcription subunit 18	GO:0005515; F:protein binding; IPI:IntAct
Q9BUE0	MED18	Mediator of RNA polymerase II transcription subunit 18	GO:0001104; F:RNA polymerase II transcription cofactor activity; IEA:InterPro
A0JLT2	MED19	Mediator of RNA polymerase II transcription subunit 19	GO:0001104; F:RNA polymerase II transcription cofactor activity; IEA:InterPro
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0003682; F:chromatin binding; IMP:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0031490; F:chromatin DNA binding; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0001047; F:core promoter binding; IDA:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0030331; F:estrogen receptor binding; IPI:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0050693; F:LBD domain binding; IPI:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0016922; F:ligand-dependent nuclear receptor binding; IDA:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IMP:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0036033; F:mediator complex binding; IDA:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0035257; F:nuclear hormone receptor binding; IPI:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0042975; F:peroxisome proliferator activated receptor binding; IPI:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0004872; F:receptor activity; IDA:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0042974; F:retinoic acid receptor binding; IPI:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0001104; F:RNA polymerase II transcription cofactor activity; IDA:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; ISS:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0046966; F:thyroid hormone receptor binding; IDA:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0030375; F:thyroid hormone receptor coactivator activity; IMP:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0003712; F:transcription cofactor activity; IDA:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0042809; F:vitamin D receptor binding; IPI:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0006702; P:androgen biosynthetic process; IMP:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0030521; P:androgen receptor signaling pathway; IDA:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0001525; P:angiogenesis; ISS:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0007420; P:brain development; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0000902; P:cell morphogenesis; IMP:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0071364; P:cellular response to epidermal growth factor stimulus; IDA:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0035729; P:cellular response to hepatocyte growth factor stimulus; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0071383; P:cellular response to steroid hormone stimulus; IDA:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0097067; P:cellular response to thyroid hormone stimulus; IDA:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0006260; P:DNA replication; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0035050; P:embryonic heart tube development; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0035162; P:embryonic hemopoiesis; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0001892; P:embryonic placenta development; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0048822; P:enucleate erythrocyte development; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0060750; P:epithelial cell proliferation involved in mammary gland duct elongation; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0070371; P:ERK1 and ERK2 cascade; IDA:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0048821; P:erythrocyte development; ISS:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0045444; P:fat cell differentiation; IDA:MGI
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0010467; P:gene expression; TAS:Reactome
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0030518; P:intracellular steroid hormone receptor signaling pathway; IDA:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0030216; P:keratinocyte differentiation; IMP:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0007595; P:lactation; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0002088; P:lens development in camera-type eye; ISS:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0001889; P:liver development; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0060745; P:mammary gland branching involved in pregnancy; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0060744; P:mammary gland branching involved in thelarche; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0035855; P:megakaryocyte development; ISS:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0030224; P:monocyte differentiation; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0042789; P:mRNA transcription from RNA polymerase II promoter; ISS:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0010839; P:negative regulation of keratinocyte proliferation; IMP:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0045665; P:negative regulation of neuron differentiation; ISS:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0031100; P:organ regeneration; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0035357; P:peroxisome proliferator activated receptor signaling pathway; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0070318; P:positive regulation of G0 to G1 transition; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:2000347; P:positive regulation of hepatocyte proliferation; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0060335; P:positive regulation of interferon-gamma-mediated signaling pathway; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0033148; P:positive regulation of intracellular estrogen receptor signaling pathway; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0045618; P:positive regulation of keratinocyte differentiation; IMP:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0033601; P:positive regulation of mammary gland epithelial cell proliferation; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0033160; P:positive regulation of protein import into nucleus, translocation; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:2000273; P:positive regulation of receptor activity; IMP:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0051726; P:regulation of cell cycle; NAS:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:2001141; P:regulation of RNA biosynthetic process; IMP:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0006356; P:regulation of transcription from RNA polymerase I promoter; IDA:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0070562; P:regulation of vitamin D receptor signaling pathway; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0003406; P:retinal pigment epithelium development; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0006590; P:thyroid hormone generation; IEA:Ensembl
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0002154; P:thyroid hormone mediated signaling pathway; IMP:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB
Q15648	MED1	Mediator of RNA polymerase II transcription subunit 1	GO:0003222; P:ventricular trabecula myocardium morphogenesis; IEA:Ensembl
Q9H944	MED20	Mediator of RNA polymerase II transcription subunit 20	GO:0003899; F:DNA-directed RNA polymerase activity; NAS:UniProtKB
Q9H944	MED20	Mediator of RNA polymerase II transcription subunit 20	GO:0005515; F:protein binding; IPI:IntAct
Q9H944	MED20	Mediator of RNA polymerase II transcription subunit 20	GO:0001104; F:RNA polymerase II transcription cofactor activity; IEA:InterPro
Q9H944	MED20	Mediator of RNA polymerase II transcription subunit 20	GO:0010467; P:gene expression; TAS:Reactome
Q9H944	MED20	Mediator of RNA polymerase II transcription subunit 20	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9H944	MED20	Mediator of RNA polymerase II transcription subunit 20	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9H944	MED20	Mediator of RNA polymerase II transcription subunit 20	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q9H944	MED20	Mediator of RNA polymerase II transcription subunit 20	GO:0006351; P:transcription, DNA-templated; NAS:UniProtKB
Q13503	MED21	Mediator of RNA polymerase II transcription subunit 21	GO:0003899; F:DNA-directed RNA polymerase activity; TAS:ProtInc
Q13503	MED21	Mediator of RNA polymerase II transcription subunit 21	GO:0003713; F:transcription coactivator activity; IDA:MGI
Q13503	MED21	Mediator of RNA polymerase II transcription subunit 21	GO:0001824; P:blastocyst development; IEA:Ensembl
Q13503	MED21	Mediator of RNA polymerase II transcription subunit 21	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q13503	MED21	Mediator of RNA polymerase II transcription subunit 21	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q13503	MED21	Mediator of RNA polymerase II transcription subunit 21	GO:0019827; P:stem cell maintenance; IEA:Ensembl
Q13503	MED21	Mediator of RNA polymerase II transcription subunit 21	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15528	MED22	Mediator of RNA polymerase II transcription subunit 22	GO:0005515; F:protein binding; IPI:IntAct
Q15528	MED22	Mediator of RNA polymerase II transcription subunit 22	GO:0001104; F:RNA polymerase II transcription cofactor activity; IEA:InterPro
Q9ULK4	MED23	Mediator of RNA polymerase II transcription subunit 23	GO:0005515; F:protein binding; IPI:UniProtKB
Q9ULK4	MED23	Mediator of RNA polymerase II transcription subunit 23	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q9ULK4	MED23	Mediator of RNA polymerase II transcription subunit 23	GO:0010467; P:gene expression; TAS:Reactome
Q9ULK4	MED23	Mediator of RNA polymerase II transcription subunit 23	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9ULK4	MED23	Mediator of RNA polymerase II transcription subunit 23	GO:0006355; P:regulation of transcription, DNA-templated; IDA:MGI
Q9ULK4	MED23	Mediator of RNA polymerase II transcription subunit 23	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
O75448	MED24	Mediator of RNA polymerase II transcription subunit 24	GO:0004402; F:histone acetyltransferase activity; IEA:Ensembl
O75448	MED24	Mediator of RNA polymerase II transcription subunit 24	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; NAS:UniProtKB
O75448	MED24	Mediator of RNA polymerase II transcription subunit 24	GO:0004872; F:receptor activity; IDA:UniProtKB
O75448	MED24	Mediator of RNA polymerase II transcription subunit 24	GO:0001104; F:RNA polymerase II transcription cofactor activity; IDA:UniProtKB
O75448	MED24	Mediator of RNA polymerase II transcription subunit 24	GO:0046966; F:thyroid hormone receptor binding; IDA:UniProtKB
O75448	MED24	Mediator of RNA polymerase II transcription subunit 24	GO:0003712; F:transcription cofactor activity; IDA:UniProtKB
O75448	MED24	Mediator of RNA polymerase II transcription subunit 24	GO:0042809; F:vitamin D receptor binding; NAS:UniProtKB
O75448	MED24	Mediator of RNA polymerase II transcription subunit 24	GO:0030521; P:androgen receptor signaling pathway; IDA:UniProtKB
O75448	MED24	Mediator of RNA polymerase II transcription subunit 24	GO:0010467; P:gene expression; TAS:Reactome
O75448	MED24	Mediator of RNA polymerase II transcription subunit 24	GO:0030518; P:intracellular steroid hormone receptor signaling pathway; IDA:UniProtKB
O75448	MED24	Mediator of RNA polymerase II transcription subunit 24	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O75448	MED24	Mediator of RNA polymerase II transcription subunit 24	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
O75448	MED24	Mediator of RNA polymerase II transcription subunit 24	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:GOC
O75448	MED24	Mediator of RNA polymerase II transcription subunit 24	GO:0019827; P:stem cell maintenance; IEA:Ensembl
O75448	MED24	Mediator of RNA polymerase II transcription subunit 24	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB
Q71SY5	MED25	Mediator of RNA polymerase II transcription subunit 25	GO:0005515; F:protein binding; IPI:UniProtKB
Q71SY5	MED25	Mediator of RNA polymerase II transcription subunit 25	GO:0042974; F:retinoic acid receptor binding; IPI:UniProtKB
Q71SY5	MED25	Mediator of RNA polymerase II transcription subunit 25	GO:0046965; F:retinoid X receptor binding; IPI:UniProtKB
Q71SY5	MED25	Mediator of RNA polymerase II transcription subunit 25	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q71SY5	MED25	Mediator of RNA polymerase II transcription subunit 25	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q71SY5	MED25	Mediator of RNA polymerase II transcription subunit 25	GO:0010467; P:gene expression; TAS:Reactome
Q71SY5	MED25	Mediator of RNA polymerase II transcription subunit 25	GO:0048147; P:negative regulation of fibroblast proliferation; IMP:UniProtKB
Q71SY5	MED25	Mediator of RNA polymerase II transcription subunit 25	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q71SY5	MED25	Mediator of RNA polymerase II transcription subunit 25	GO:0071158; P:positive regulation of cell cycle arrest; IMP:UniProtKB
Q71SY5	MED25	Mediator of RNA polymerase II transcription subunit 25	GO:0035563; P:positive regulation of chromatin binding; IMP:UniProtKB
Q71SY5	MED25	Mediator of RNA polymerase II transcription subunit 25	GO:2001178; P:positive regulation of mediator complex assembly; IMP:UniProtKB
Q71SY5	MED25	Mediator of RNA polymerase II transcription subunit 25	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q71SY5	MED25	Mediator of RNA polymerase II transcription subunit 25	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
O95402	MED26	Mediator of RNA polymerase II transcription subunit 26	GO:0003677; F:DNA binding; IEA:InterPro
O95402	MED26	Mediator of RNA polymerase II transcription subunit 26	GO:0005515; F:protein binding; IPI:IntAct
O95402	MED26	Mediator of RNA polymerase II transcription subunit 26	GO:0001104; F:RNA polymerase II transcription cofactor activity; IDA:UniProtKB
O95402	MED26	Mediator of RNA polymerase II transcription subunit 26	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
O95402	MED26	Mediator of RNA polymerase II transcription subunit 26	GO:0010467; P:gene expression; TAS:Reactome
O95402	MED26	Mediator of RNA polymerase II transcription subunit 26	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O95402	MED26	Mediator of RNA polymerase II transcription subunit 26	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q6P2C8	MED27	Mediator of RNA polymerase II transcription subunit 27	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q6P2C8	MED27	Mediator of RNA polymerase II transcription subunit 27	GO:0010467; P:gene expression; TAS:Reactome
Q6P2C8	MED27	Mediator of RNA polymerase II transcription subunit 27	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q6P2C8	MED27	Mediator of RNA polymerase II transcription subunit 27	GO:0019827; P:stem cell maintenance; IEA:Ensembl
Q6P2C8	MED27	Mediator of RNA polymerase II transcription subunit 27	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q9H204	MED28	Mediator of RNA polymerase II transcription subunit 28	GO:0005515; F:protein binding; IPI:IntAct
Q9H204	MED28	Mediator of RNA polymerase II transcription subunit 28	GO:0051151; P:negative regulation of smooth muscle cell differentiation; IEA:Ensembl
Q9H204	MED28	Mediator of RNA polymerase II transcription subunit 28	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H204	MED28	Mediator of RNA polymerase II transcription subunit 28	GO:0019827; P:stem cell maintenance; IEA:Ensembl
Q9H204	MED28	Mediator of RNA polymerase II transcription subunit 28	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NX70	MED29	Mediator of RNA polymerase II transcription subunit 29	GO:0005515; F:protein binding; IPI:IntAct
Q9NX70	MED29	Mediator of RNA polymerase II transcription subunit 29	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NX70	MED29	Mediator of RNA polymerase II transcription subunit 29	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96HR3	MED30	Mediator of RNA polymerase II transcription subunit 30	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; NAS:UniProtKB
Q96HR3	MED30	Mediator of RNA polymerase II transcription subunit 30	GO:0005515; F:protein binding; IPI:UniProtKB
Q96HR3	MED30	Mediator of RNA polymerase II transcription subunit 30	GO:0004872; F:receptor activity; IDA:UniProtKB
Q96HR3	MED30	Mediator of RNA polymerase II transcription subunit 30	GO:0001104; F:RNA polymerase II transcription cofactor activity; IDA:UniProtKB
Q96HR3	MED30	Mediator of RNA polymerase II transcription subunit 30	GO:0046966; F:thyroid hormone receptor binding; IDA:UniProtKB
Q96HR3	MED30	Mediator of RNA polymerase II transcription subunit 30	GO:0003712; F:transcription cofactor activity; IDA:UniProtKB
Q96HR3	MED30	Mediator of RNA polymerase II transcription subunit 30	GO:0042809; F:vitamin D receptor binding; NAS:UniProtKB
Q96HR3	MED30	Mediator of RNA polymerase II transcription subunit 30	GO:0030521; P:androgen receptor signaling pathway; IDA:UniProtKB
Q96HR3	MED30	Mediator of RNA polymerase II transcription subunit 30	GO:0010467; P:gene expression; TAS:Reactome
Q96HR3	MED30	Mediator of RNA polymerase II transcription subunit 30	GO:0030518; P:intracellular steroid hormone receptor signaling pathway; IDA:UniProtKB
Q96HR3	MED30	Mediator of RNA polymerase II transcription subunit 30	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q96HR3	MED30	Mediator of RNA polymerase II transcription subunit 30	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:GOC
Q96HR3	MED30	Mediator of RNA polymerase II transcription subunit 30	GO:0019827; P:stem cell maintenance; IEA:Ensembl
Q96HR3	MED30	Mediator of RNA polymerase II transcription subunit 30	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB
Q9Y3C7	MED31	Mediator of RNA polymerase II transcription subunit 31	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3C7	MED31	Mediator of RNA polymerase II transcription subunit 31	GO:0001104; F:RNA polymerase II transcription cofactor activity; IEA:InterPro
Q9Y3C7	MED31	Mediator of RNA polymerase II transcription subunit 31	GO:0010467; P:gene expression; TAS:Reactome
Q9Y3C7	MED31	Mediator of RNA polymerase II transcription subunit 31	GO:0060173; P:limb development; IEA:Ensembl
Q9Y3C7	MED31	Mediator of RNA polymerase II transcription subunit 31	GO:0048147; P:negative regulation of fibroblast proliferation; IEA:Ensembl
Q9Y3C7	MED31	Mediator of RNA polymerase II transcription subunit 31	GO:0006461; P:protein complex assembly; IEA:Ensembl
Q9Y3C7	MED31	Mediator of RNA polymerase II transcription subunit 31	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q9NPJ6	MED4	Mediator of RNA polymerase II transcription subunit 4	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; NAS:UniProtKB
Q9NPJ6	MED4	Mediator of RNA polymerase II transcription subunit 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NPJ6	MED4	Mediator of RNA polymerase II transcription subunit 4	GO:0004872; F:receptor activity; IDA:UniProtKB
Q9NPJ6	MED4	Mediator of RNA polymerase II transcription subunit 4	GO:0001104; F:RNA polymerase II transcription cofactor activity; IDA:UniProtKB
Q9NPJ6	MED4	Mediator of RNA polymerase II transcription subunit 4	GO:0046966; F:thyroid hormone receptor binding; IDA:UniProtKB
Q9NPJ6	MED4	Mediator of RNA polymerase II transcription subunit 4	GO:0003712; F:transcription cofactor activity; IDA:UniProtKB
Q9NPJ6	MED4	Mediator of RNA polymerase II transcription subunit 4	GO:0042809; F:vitamin D receptor binding; NAS:UniProtKB
Q9NPJ6	MED4	Mediator of RNA polymerase II transcription subunit 4	GO:0030521; P:androgen receptor signaling pathway; IDA:UniProtKB
Q9NPJ6	MED4	Mediator of RNA polymerase II transcription subunit 4	GO:0010467; P:gene expression; TAS:Reactome
Q9NPJ6	MED4	Mediator of RNA polymerase II transcription subunit 4	GO:0030518; P:intracellular steroid hormone receptor signaling pathway; IDA:UniProtKB
Q9NPJ6	MED4	Mediator of RNA polymerase II transcription subunit 4	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9NPJ6	MED4	Mediator of RNA polymerase II transcription subunit 4	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9NPJ6	MED4	Mediator of RNA polymerase II transcription subunit 4	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB
O75586	MED6	Mediator of RNA polymerase II transcription subunit 6	GO:0003677; F:DNA binding; IEA:Ensembl
O75586	MED6	Mediator of RNA polymerase II transcription subunit 6	GO:0001104; F:RNA polymerase II transcription cofactor activity; IEA:InterPro
O75586	MED6	Mediator of RNA polymerase II transcription subunit 6	GO:0003713; F:transcription coactivator activity; IDA:MGI
O75586	MED6	Mediator of RNA polymerase II transcription subunit 6	GO:0008134; F:transcription factor binding; IPI:UniProtKB
O75586	MED6	Mediator of RNA polymerase II transcription subunit 6	GO:0010467; P:gene expression; TAS:Reactome
O75586	MED6	Mediator of RNA polymerase II transcription subunit 6	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
O75586	MED6	Mediator of RNA polymerase II transcription subunit 6	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O75586	MED6	Mediator of RNA polymerase II transcription subunit 6	GO:0019827; P:stem cell maintenance; IEA:Ensembl
O75586	MED6	Mediator of RNA polymerase II transcription subunit 6	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
O43513	MED7	Mediator of RNA polymerase II transcription subunit 7	GO:0005515; F:protein binding; IPI:UniProtKB
O43513	MED7	Mediator of RNA polymerase II transcription subunit 7	GO:0001104; F:RNA polymerase II transcription cofactor activity; IEA:InterPro
O43513	MED7	Mediator of RNA polymerase II transcription subunit 7	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
O43513	MED7	Mediator of RNA polymerase II transcription subunit 7	GO:0010467; P:gene expression; TAS:Reactome
O43513	MED7	Mediator of RNA polymerase II transcription subunit 7	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:MGI
O43513	MED7	Mediator of RNA polymerase II transcription subunit 7	GO:0019827; P:stem cell maintenance; IEA:Ensembl
O43513	MED7	Mediator of RNA polymerase II transcription subunit 7	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q96G25	MED8	Mediator of RNA polymerase II transcription subunit 8	GO:0005515; F:protein binding; IPI:IntAct
Q96G25	MED8	Mediator of RNA polymerase II transcription subunit 8	GO:0001104; F:RNA polymerase II transcription cofactor activity; IEA:InterPro
Q96G25	MED8	Mediator of RNA polymerase II transcription subunit 8	GO:0010467; P:gene expression; TAS:Reactome
Q96G25	MED8	Mediator of RNA polymerase II transcription subunit 8	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q96G25	MED8	Mediator of RNA polymerase II transcription subunit 8	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q9NWA0	MED9	Mediator of RNA polymerase II transcription subunit 9	GO:0005515; F:protein binding; IPI:IntAct
Q9NWA0	MED9	Mediator of RNA polymerase II transcription subunit 9	GO:0001104; F:RNA polymerase II transcription cofactor activity; IEA:InterPro
Q5VYS4	MEDAG	Mesenteric estrogen-dependent adipogenesis protein	GO:0045600; P:positive regulation of fat cell differentiation; ISS:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0033613; F:activating transcription factor binding; IPI:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0035035; F:histone acetyltransferase binding; IPI:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0042826; F:histone deacetylase binding; IPI:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0005515; F:protein binding; IPI:BHF-UCL
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0001105; F:RNA polymerase II transcription coactivator activity; IDA:BHF-UCL
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0001085; F:RNA polymerase II transcription factor binding; IPI:BHF-UCL
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0046332; F:SMAD binding; IPI:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0061337; P:cardiac conduction; ISS:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0071277; P:cellular response to calcium ion; IDA:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0048813; P:dendrite morphogenesis; ISS:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0070375; P:ERK5 cascade; IMP:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0007507; P:heart development; IEP:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0045087; P:innate immune response; TAS:Reactome
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0000165; P:MAPK cascade; IDA:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0000002; P:mitochondrial genome maintenance; ISS:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0048311; P:mitochondrion distribution; ISS:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0042692; P:muscle cell differentiation; TAS:Reactome
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0007517; P:muscle organ development; NAS:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:GOC
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q02078	MEF2A	Myocyte-specific enhancer factor 2A	GO:0055005; P:ventricular cardiac myofibril assembly; ISS:UniProtKB
Q02080	MEF2B	Myocyte-specific enhancer factor 2B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q02080	MEF2B	Myocyte-specific enhancer factor 2B	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
Q02080	MEF2B	Myocyte-specific enhancer factor 2B	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
Q02080	MEF2B	Myocyte-specific enhancer factor 2B	GO:0007517; P:muscle organ development; TAS:ProtInc
Q02080	MEF2B	Myocyte-specific enhancer factor 2B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0033613; F:activating transcription factor binding; IPI:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0003680; F:AT DNA binding; IDA:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0003682; F:chromatin binding; IEA:Ensembl
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0000987; F:core promoter proximal region sequence-specific DNA binding; IEA:Ensembl
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0001046; F:core promoter sequence-specific DNA binding; IEA:Ensembl
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0003677; F:DNA binding; IDA:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0035198; F:miRNA binding; IDA:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0005515; F:protein binding; IPI:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0000983; F:RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0044212; F:transcription regulatory region DNA binding; ISS:BHF-UCL
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0001782; P:B cell homeostasis; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0042100; P:B cell proliferation; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0050853; P:B cell receptor signaling pathway; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0001568; P:blood vessel development; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0001974; P:blood vessel remodeling; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0014898; P:cardiac muscle hypertrophy in response to stress; IEA:Ensembl
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0003211; P:cardiac ventricle formation; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0060536; P:cartilage morphogenesis; IEA:Ensembl
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0035690; P:cellular response to drug; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0071498; P:cellular response to fluid shear stress; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0071222; P:cellular response to lipopolysaccharide; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0071374; P:cellular response to parathyroid hormone stimulus; IDA:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IDA:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0035984; P:cellular response to trichostatin A; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0002062; P:chondrocyte differentiation; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0021542; P:dentate gyrus development; IEA:Ensembl
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0048703; P:embryonic viscerocranium morphogenesis; IEA:Ensembl
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0001958; P:endochondral ossification; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:2001013; P:epithelial cell proliferation involved in renal tubule morphogenesis; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0002467; P:germinal center formation; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0072102; P:glomerulus morphogenesis; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0007507; P:heart development; IEP:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0001947; P:heart looping; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0006959; P:humoral immune response; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0045087; P:innate immune response; TAS:Reactome
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0007611; P:learning or memory; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0000165; P:MAPK cascade; IDA:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0030318; P:melanocyte differentiation; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0030224; P:monocyte differentiation; IEA:Ensembl
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0042692; P:muscle cell differentiation; TAS:Reactome
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0007521; P:muscle cell fate determination; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0007517; P:muscle organ development; TAS:ProtInc
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0014902; P:myotube differentiation; IEP:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0010629; P:negative regulation of gene expression; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0030279; P:negative regulation of ossification; IDA:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0072160; P:nephron tubule epithelial cell differentiation; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0007399; P:nervous system development; TAS:ProtInc
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0014033; P:neural crest cell differentiation; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0048666; P:neuron development; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0030182; P:neuron differentiation; IEP:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0001649; P:osteoblast differentiation; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0003151; P:outflow tract morphogenesis; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0060021; P:palate development; IEA:Ensembl
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0030220; P:platelet formation; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0010694; P:positive regulation of alkaline phosphatase activity; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0030890; P:positive regulation of B cell proliferation; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:2000987; P:positive regulation of behavioral fear response; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0030501; P:positive regulation of bone mineralization; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:2000727; P:positive regulation of cardiac muscle cell differentiation; IDA:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0060045; P:positive regulation of cardiac muscle cell proliferation; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0010613; P:positive regulation of cardiac muscle hypertrophy; IEA:Ensembl
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0071864; P:positive regulation of cell proliferation in bone marrow; IEA:Ensembl
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:2000111; P:positive regulation of macrophage apoptotic process; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0045663; P:positive regulation of myoblast differentiation; IMP:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0045669; P:positive regulation of osteoblast differentiation; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0090073; P:positive regulation of protein homodimerization activity; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:2001016; P:positive regulation of skeletal muscle cell differentiation; IDA:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0048643; P:positive regulation of skeletal muscle tissue development; IMP:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0003138; P:primary heart field specification; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0002634; P:regulation of germinal center formation; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0045652; P:regulation of megakaryocyte differentiation; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0060297; P:regulation of sarcomere organization; IEA:Ensembl
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0060025; P:regulation of synaptic activity; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0006355; P:regulation of transcription, DNA-templated; IDA:Alzheimers_University_of_Toronto
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0061333; P:renal tubule morphogenesis; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0009615; P:response to virus; IEP:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0033197; P:response to vitamin E; IEA:Ensembl
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0003139; P:secondary heart field specification; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0003185; P:sinoatrial valve morphogenesis; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0007519; P:skeletal muscle tissue development; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0051145; P:smooth muscle cell differentiation; ISS:UniProtKB
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q06413	MEF2C	Myocyte-specific enhancer factor 2C	GO:0055012; P:ventricular cardiac muscle cell differentiation; ISS:UniProtKB
Q14814	MEF2D	Myocyte-specific enhancer factor 2D	GO:0033613; F:activating transcription factor binding; IPI:UniProtKB
Q14814	MEF2D	Myocyte-specific enhancer factor 2D	GO:0042826; F:histone deacetylase binding; IPI:UniProtKB
Q14814	MEF2D	Myocyte-specific enhancer factor 2D	GO:0005515; F:protein binding; IPI:BHF-UCL
Q14814	MEF2D	Myocyte-specific enhancer factor 2D	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:UniProtKB
Q14814	MEF2D	Myocyte-specific enhancer factor 2D	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:UniProtKB
Q14814	MEF2D	Myocyte-specific enhancer factor 2D	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
Q14814	MEF2D	Myocyte-specific enhancer factor 2D	GO:0007512; P:adult heart development; IEP:UniProtKB
Q14814	MEF2D	Myocyte-specific enhancer factor 2D	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q14814	MEF2D	Myocyte-specific enhancer factor 2D	GO:0002062; P:chondrocyte differentiation; IEA:Ensembl
Q14814	MEF2D	Myocyte-specific enhancer factor 2D	GO:0001958; P:endochondral ossification; IEA:Ensembl
Q14814	MEF2D	Myocyte-specific enhancer factor 2D	GO:0007517; P:muscle organ development; TAS:ProtInc
Q14814	MEF2D	Myocyte-specific enhancer factor 2D	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q14814	MEF2D	Myocyte-specific enhancer factor 2D	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
Q14814	MEF2D	Myocyte-specific enhancer factor 2D	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q14814	MEF2D	Myocyte-specific enhancer factor 2D	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q14814	MEF2D	Myocyte-specific enhancer factor 2D	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:GOC
O15553	MEFV	Pyrin	GO:0003779; F:actin binding; IDA:UniProtKB
O15553	MEFV	Pyrin	GO:0008270; F:zinc ion binding; NAS:UniProtKB
O15553	MEFV	Pyrin	GO:0006954; P:inflammatory response; IDA:UniProtKB
O15553	MEFV	Pyrin	GO:0045087; P:innate immune response; TAS:Reactome
O15553	MEFV	Pyrin	GO:0050728; P:negative regulation of inflammatory response; IMP:BHF-UCL
O15553	MEFV	Pyrin	GO:0032691; P:negative regulation of interleukin-1 beta production; IMP:BHF-UCL
O15553	MEFV	Pyrin	GO:0032695; P:negative regulation of interleukin-12 production; IMP:BHF-UCL
O15553	MEFV	Pyrin	GO:0071641; P:negative regulation of macrophage inflammatory protein 1 alpha production; IMP:BHF-UCL
O15553	MEFV	Pyrin	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
O15553	MEFV	Pyrin	GO:2001056; P:positive regulation of cysteine-type endopeptidase activity; IDA:UniProtKB
Q96KG7	MEGF10	Multiple epidermal growth factor-like domains protein 10	GO:0034109; P:homotypic cell-cell adhesion; IDA:UniProtKB
Q96KG7	MEGF10	Multiple epidermal growth factor-like domains protein 10	GO:0055001; P:muscle cell development; IMP:UniProtKB
Q96KG7	MEGF10	Multiple epidermal growth factor-like domains protein 10	GO:0043654; P:recognition of apoptotic cell; IEA:Ensembl
Q96KG7	MEGF10	Multiple epidermal growth factor-like domains protein 10	GO:0051147; P:regulation of muscle cell differentiation; IMP:UniProtKB
Q96KG7	MEGF10	Multiple epidermal growth factor-like domains protein 10	GO:0048641; P:regulation of skeletal muscle tissue development; IMP:UniProtKB
Q96KG7	MEGF10	Multiple epidermal growth factor-like domains protein 10	GO:0014719; P:satellite cell activation; ISS:UniProtKB
Q96KG7	MEGF10	Multiple epidermal growth factor-like domains protein 10	GO:0014816; P:satellite cell differentiation; IMP:UniProtKB
Q96KG7	MEGF10	Multiple epidermal growth factor-like domains protein 10	GO:0014841; P:satellite cell proliferation; ISS:UniProtKB
A6BM72	MEGF11	Multiple epidermal growth factor-like domains protein 11	GO:0034109; P:homotypic cell-cell adhesion; ISS:UniProtKB
A6BM72	MEGF11	Multiple epidermal growth factor-like domains protein 11	GO:0010842; P:retina layer formation; ISS:UniProtKB
O75095	MEGF6	Multiple epidermal growth factor-like domains protein 6	GO:0005509; F:calcium ion binding; IEA:InterPro
O75095	MEGF6	Multiple epidermal growth factor-like domains protein 6	GO:0005515; F:protein binding; IPI:IntAct
A8MW99	MEI4	Meiosis-specific protein MEI4-like	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
A8MW99	MEI4	Meiosis-specific protein MEI4-like	GO:0042138; P:meiotic DNA double-strand break formation; ISS:UniProtKB
A8MW99	MEI4	Meiosis-specific protein MEI4-like	GO:0048477; P:oogenesis; ISS:UniProtKB
A8MW99	MEI4	Meiosis-specific protein MEI4-like	GO:0007283; P:spermatogenesis; ISS:UniProtKB
A8MW99	MEI4	Meiosis-specific protein MEI4-like	GO:0007129; P:synapsis; ISS:UniProtKB
Q7Z7M0	MEGF8	Multiple epidermal growth factor-like domains protein 8	GO:0005509; F:calcium ion binding; IEA:InterPro
Q7Z7M0	MEGF8	Multiple epidermal growth factor-like domains protein 8	GO:0005515; F:protein binding; IPI:IntAct
Q7Z7M0	MEGF8	Multiple epidermal growth factor-like domains protein 8	GO:0004872; F:receptor activity; IEA:InterPro
Q7Z7M0	MEGF8	Multiple epidermal growth factor-like domains protein 8	GO:0030509; P:BMP signaling pathway; ISS:UniProt
Q7Z7M0	MEGF8	Multiple epidermal growth factor-like domains protein 8	GO:0042074; P:cell migration involved in gastrulation; IMP:UniProt
Q7Z7M0	MEGF8	Multiple epidermal growth factor-like domains protein 8	GO:0097094; P:craniofacial suture morphogenesis; IMP:UniProt
Q7Z7M0	MEGF8	Multiple epidermal growth factor-like domains protein 8	GO:0071907; P:determination of digestive tract left/right asymmetry; ISS:UniProt
Q7Z7M0	MEGF8	Multiple epidermal growth factor-like domains protein 8	GO:0061371; P:determination of heart left/right asymmetry; IMP:UniProt
Q7Z7M0	MEGF8	Multiple epidermal growth factor-like domains protein 8	GO:0060971; P:embryonic heart tube left/right pattern formation; ISS:UniProt
Q7Z7M0	MEGF8	Multiple epidermal growth factor-like domains protein 8	GO:0003143; P:embryonic heart tube morphogenesis; ISS:UniProt
Q7Z7M0	MEGF8	Multiple epidermal growth factor-like domains protein 8	GO:0030326; P:embryonic limb morphogenesis; ISS:UniProt
Q7Z7M0	MEGF8	Multiple epidermal growth factor-like domains protein 8	GO:0048704; P:embryonic skeletal system morphogenesis; ISS:UniProt
Q7Z7M0	MEGF8	Multiple epidermal growth factor-like domains protein 8	GO:0055113; P:epiboly involved in gastrulation with mouth forming second; IMP:UniProt
Q7Z7M0	MEGF8	Multiple epidermal growth factor-like domains protein 8	GO:0097155; P:fasciculation of sensory neuron axon; ISS:UniProt
Q7Z7M0	MEGF8	Multiple epidermal growth factor-like domains protein 8	GO:0060972; P:left/right pattern formation; IMP:UniProt
Q7Z7M0	MEGF8	Multiple epidermal growth factor-like domains protein 8	GO:0035108; P:limb morphogenesis; IMP:UniProt
Q7Z7M0	MEGF8	Multiple epidermal growth factor-like domains protein 8	GO:0048842; P:positive regulation of axon extension involved in axon guidance; ISS:UniProt
Q7Z7M0	MEGF8	Multiple epidermal growth factor-like domains protein 8	GO:0010468; P:regulation of gene expression; ISS:UniProt
Q5TIA1	MEI1	Meiosis inhibitor protein 1	GO:0007141; P:male meiosis I; IEA:Ensembl
Q5TIA1	MEI1	Meiosis inhibitor protein 1	GO:0007286; P:spermatid development; IEA:Ensembl
Q5JSS6	MEIG1	Meiosis expressed gene 1 protein homolog	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q5JSS6	MEIG1	Meiosis expressed gene 1 protein homolog	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q8N635	MEIOB	Meiosis-specific with OB domain-containing protein	GO:0003682; F:chromatin binding; ISS:UniProtKB
Q8N635	MEIOB	Meiosis-specific with OB domain-containing protein	GO:0008310; F:single-stranded DNA 3'-5' exodeoxyribonuclease activity; ISS:UniProtKB
Q8N635	MEIOB	Meiosis-specific with OB domain-containing protein	GO:0003697; F:single-stranded DNA binding; ISS:UniProtKB
Q8N635	MEIOB	Meiosis-specific with OB domain-containing protein	GO:0000738; P:DNA catabolic process, exonucleolytic; ISS:GOC
Q8N635	MEIOB	Meiosis-specific with OB domain-containing protein	GO:0000724; P:double-strand break repair via homologous recombination; ISS:UniProtKB
Q8N635	MEIOB	Meiosis-specific with OB domain-containing protein	GO:0007144; P:female meiosis I; ISS:UniProtKB
Q8N635	MEIOB	Meiosis-specific with OB domain-containing protein	GO:0009566; P:fertilization; ISS:UniProtKB
Q8N635	MEIOB	Meiosis-specific with OB domain-containing protein	GO:0007140; P:male meiosis; ISS:UniProtKB
Q8N635	MEIOB	Meiosis-specific with OB domain-containing protein	GO:0000712; P:resolution of meiotic recombination intermediates; ISS:UniProtKB
Q8N635	MEIOB	Meiosis-specific with OB domain-containing protein	GO:0007129; P:synapsis; ISS:UniProtKB
O00470	MEIS1	Homeobox protein Meis1	GO:0005515; F:protein binding; IPI:IntAct
O00470	MEIS1	Homeobox protein Meis1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O00470	MEIS1	Homeobox protein Meis1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O00470	MEIS1	Homeobox protein Meis1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
O00470	MEIS1	Homeobox protein Meis1	GO:0045638; P:negative regulation of myeloid cell differentiation; ISS:UniProtKB
O00470	MEIS1	Homeobox protein Meis1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O14770	MEIS2	Homeobox protein Meis2	GO:0005515; F:protein binding; IPI:IntAct
O14770	MEIS2	Homeobox protein Meis2	GO:0043565; F:sequence-specific DNA binding; IDA:MGI
O14770	MEIS2	Homeobox protein Meis2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
O14770	MEIS2	Homeobox protein Meis2	GO:0003712; F:transcription cofactor activity; ISS:UniProtKB
O14770	MEIS2	Homeobox protein Meis2	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
O14770	MEIS2	Homeobox protein Meis2	GO:0008134; F:transcription factor binding; ISS:UniProtKB
O14770	MEIS2	Homeobox protein Meis2	GO:0001654; P:eye development; IEA:Ensembl
O14770	MEIS2	Homeobox protein Meis2	GO:0045638; P:negative regulation of myeloid cell differentiation; ISS:UniProtKB
O14770	MEIS2	Homeobox protein Meis2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O14770	MEIS2	Homeobox protein Meis2	GO:0031016; P:pancreas development; IEA:Ensembl
O14770	MEIS2	Homeobox protein Meis2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O14770	MEIS2	Homeobox protein Meis2	GO:0070848; P:response to growth factor; IEA:Ensembl
O14770	MEIS2	Homeobox protein Meis2	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
O14770	MEIS2	Homeobox protein Meis2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q99687	MEIS3	Homeobox protein Meis3	GO:0003682; F:chromatin binding; IEA:Ensembl
Q99687	MEIS3	Homeobox protein Meis3	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q99687	MEIS3	Homeobox protein Meis3	GO:0043565; F:sequence-specific DNA binding; IDA:MGI
Q99687	MEIS3	Homeobox protein Meis3	GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl
Q99687	MEIS3	Homeobox protein Meis3	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
Q14680	MELK	Maternal embryonic leucine zipper kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q14680	MELK	Maternal embryonic leucine zipper kinase	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q14680	MELK	Maternal embryonic leucine zipper kinase	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q14680	MELK	Maternal embryonic leucine zipper kinase	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB
Q14680	MELK	Maternal embryonic leucine zipper kinase	GO:0005515; F:protein binding; IPI:UniProtKB
Q14680	MELK	Maternal embryonic leucine zipper kinase	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q14680	MELK	Maternal embryonic leucine zipper kinase	GO:0006915; P:apoptotic process; IDA:UniProtKB
Q14680	MELK	Maternal embryonic leucine zipper kinase	GO:0008283; P:cell proliferation; IDA:UniProtKB
Q14680	MELK	Maternal embryonic leucine zipper kinase	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:UniProtKB
Q14680	MELK	Maternal embryonic leucine zipper kinase	GO:0030097; P:hemopoiesis; ISS:UniProtKB
Q14680	MELK	Maternal embryonic leucine zipper kinase	GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IEA:Ensembl
Q14680	MELK	Maternal embryonic leucine zipper kinase	GO:0061351; P:neural precursor cell proliferation; ISS:UniProtKB
Q14680	MELK	Maternal embryonic leucine zipper kinase	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:GOC
Q14680	MELK	Maternal embryonic leucine zipper kinase	GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB
Q14680	MELK	Maternal embryonic leucine zipper kinase	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q9BV36	MLPH	Melanophilin	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BV36	MLPH	Melanophilin	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9BV36	MLPH	Melanophilin	GO:0030318; P:melanocyte differentiation; IEA:Ensembl
Q9BV36	MLPH	Melanophilin	GO:0032400; P:melanosome localization; IEA:Ensembl
Q9BV36	MLPH	Melanophilin	GO:0006605; P:protein targeting; IEA:Ensembl
Q9Y316	MEMO1	Protein MEMO1	GO:0005515; F:protein binding; IPI:IntAct
Q9Y316	MEMO1	Protein MEMO1	GO:0032886; P:regulation of microtubule-based process; IMP:UniProtKB
O00255	MEN1	Menin	GO:0003682; F:chromatin binding; IEA:Ensembl
O00255	MEN1	Menin	GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB
O00255	MEN1	Menin	GO:0000400; F:four-way junction DNA binding; IDA:UniProtKB
O00255	MEN1	Menin	GO:0005515; F:protein binding; IPI:UniProtKB
O00255	MEN1	Menin	GO:0030674; F:protein binding, bridging; IDA:UniProtKB
O00255	MEN1	Menin	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
O00255	MEN1	Menin	GO:0070412; F:R-SMAD binding; IPI:BHF-UCL
O00255	MEN1	Menin	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
O00255	MEN1	Menin	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
O00255	MEN1	Menin	GO:0000403; F:Y-form DNA binding; IDA:UniProtKB
O00255	MEN1	Menin	GO:0007420; P:brain development; IEA:Ensembl
O00255	MEN1	Menin	GO:0007050; P:cell cycle arrest; IEA:Ensembl
O00255	MEN1	Menin	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
O00255	MEN1	Menin	GO:0006338; P:chromatin remodeling; IEA:Ensembl
O00255	MEN1	Menin	GO:0006281; P:DNA repair; NAS:UniProtKB
O00255	MEN1	Menin	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
O00255	MEN1	Menin	GO:0010467; P:gene expression; TAS:Reactome
O00255	MEN1	Menin	GO:0030097; P:hemopoiesis; IEA:Ensembl
O00255	MEN1	Menin	GO:0034968; P:histone lysine methylation; IDA:GOC
O00255	MEN1	Menin	GO:0001776; P:leukocyte homeostasis; IEA:Ensembl
O00255	MEN1	Menin	GO:0000165; P:MAPK cascade; IDA:UniProtKB
O00255	MEN1	Menin	GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
O00255	MEN1	Menin	GO:0045786; P:negative regulation of cell cycle; IDA:UniProtKB
O00255	MEN1	Menin	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
O00255	MEN1	Menin	GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IMP:UniProtKB
O00255	MEN1	Menin	GO:0046329; P:negative regulation of JNK cascade; IDA:UniProtKB
O00255	MEN1	Menin	GO:0046621; P:negative regulation of organ growth; IEA:Ensembl
O00255	MEN1	Menin	GO:0045668; P:negative regulation of osteoblast differentiation; IGI:MGI
O00255	MEN1	Menin	GO:0001933; P:negative regulation of protein phosphorylation; IDA:UniProtKB
O00255	MEN1	Menin	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
O00255	MEN1	Menin	GO:0051974; P:negative regulation of telomerase activity; IMP:UniProtKB
O00255	MEN1	Menin	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O00255	MEN1	Menin	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
O00255	MEN1	Menin	GO:0002076; P:osteoblast development; IGI:MGI
O00255	MEN1	Menin	GO:0002051; P:osteoblast fate commitment; IEA:Ensembl
O00255	MEN1	Menin	GO:0060021; P:palate development; IEA:Ensembl
O00255	MEN1	Menin	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
O00255	MEN1	Menin	GO:0051781; P:positive regulation of cell division; IEA:Ensembl
O00255	MEN1	Menin	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
O00255	MEN1	Menin	GO:0031062; P:positive regulation of histone methylation; IEA:Ensembl
O00255	MEN1	Menin	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
O00255	MEN1	Menin	GO:0032092; P:positive regulation of protein binding; IDA:UniProtKB
O00255	MEN1	Menin	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
O00255	MEN1	Menin	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IMP:UniProtKB
O00255	MEN1	Menin	GO:0032925; P:regulation of activin receptor signaling pathway; IEA:Ensembl
O00255	MEN1	Menin	GO:0010332; P:response to gamma radiation; IDA:UniProtKB
O00255	MEN1	Menin	GO:0009411; P:response to UV; IDA:UniProtKB
O00255	MEN1	Menin	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
O00255	MEN1	Menin	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
O00255	MEN1	Menin	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P50221	MEOX1	Homeobox protein MOX-1	GO:0003682; F:chromatin binding; IEA:Ensembl
P50221	MEOX1	Homeobox protein MOX-1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P50221	MEOX1	Homeobox protein MOX-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P50221	MEOX1	Homeobox protein MOX-1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P50221	MEOX1	Homeobox protein MOX-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P50221	MEOX1	Homeobox protein MOX-1	GO:0001757; P:somite specification; IEA:Ensembl
P50222	MEOX2	Homeobox protein MOX-2	GO:0005515; F:protein binding; IPI:UniProtKB
P50222	MEOX2	Homeobox protein MOX-2	GO:0043565; F:sequence-specific DNA binding; IDA:MGI
P50222	MEOX2	Homeobox protein MOX-2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P50222	MEOX2	Homeobox protein MOX-2	GO:0001525; P:angiogenesis; IEA:Ensembl
P50222	MEOX2	Homeobox protein MOX-2	GO:0008015; P:blood circulation; TAS:ProtInc
P50222	MEOX2	Homeobox protein MOX-2	GO:0060173; P:limb development; IEA:Ensembl
P50222	MEOX2	Homeobox protein MOX-2	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P50222	MEOX2	Homeobox protein MOX-2	GO:0070997; P:neuron death; IMP:UniProt
P50222	MEOX2	Homeobox protein MOX-2	GO:0060021; P:palate development; IEA:Ensembl
P50222	MEOX2	Homeobox protein MOX-2	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
P50222	MEOX2	Homeobox protein MOX-2	GO:0001757; P:somite specification; IEA:Ensembl
Q16819	MEP1A	Meprin A subunit alpha	GO:0004222; F:metalloendopeptidase activity; TAS:ProtInc
Q16819	MEP1A	Meprin A subunit alpha	GO:0005515; F:protein binding; IPI:IntAct
Q16819	MEP1A	Meprin A subunit alpha	GO:0008270; F:zinc ion binding; IEA:InterPro
Q16819	MEP1A	Meprin A subunit alpha	GO:0007586; P:digestion; TAS:ProtInc
Q16820	MEP1B	Meprin A subunit beta	GO:0004222; F:metalloendopeptidase activity; IEA:Ensembl
Q16820	MEP1B	Meprin A subunit beta	GO:0005515; F:protein binding; IPI:IntAct
Q16820	MEP1B	Meprin A subunit beta	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q16820	MEP1B	Meprin A subunit beta	GO:0007586; P:digestion; TAS:ProtInc
Q16820	MEP1B	Meprin A subunit beta	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q9BQA1	WDR77	Methylosome protein 50	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IGI:MGI
Q9BQA1	WDR77	Methylosome protein 50	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BQA1	WDR77	Methylosome protein 50	GO:0010467; P:gene expression; TAS:Reactome
Q9BQA1	WDR77	Methylosome protein 50	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
Q9BQA1	WDR77	Methylosome protein 50	GO:0060770; P:negative regulation of epithelial cell proliferation involved in prostate gland development; IEA:Ensembl
Q9BQA1	WDR77	Methylosome protein 50	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q9BQA1	WDR77	Methylosome protein 50	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9BQA1	WDR77	Methylosome protein 50	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9BQA1	WDR77	Methylosome protein 50	GO:0060528; P:secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development; IEA:Ensembl
Q9BQA1	WDR77	Methylosome protein 50	GO:0000387; P:spliceosomal snRNP assembly; TAS:Reactome
Q9NQ76	MEPE	Matrix extracellular phosphoglycoprotein	GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc
Q9NQ76	MEPE	Matrix extracellular phosphoglycoprotein	GO:0005515; F:protein binding; IPI:IntAct
Q9NQ76	MEPE	Matrix extracellular phosphoglycoprotein	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
Q9NQ76	MEPE	Matrix extracellular phosphoglycoprotein	GO:0030502; P:negative regulation of bone mineralization; IEA:Ensembl
Q9NQ76	MEPE	Matrix extracellular phosphoglycoprotein	GO:0046850; P:regulation of bone remodeling; IEA:Ensembl
Q9NQ76	MEPE	Matrix extracellular phosphoglycoprotein	GO:0001501; P:skeletal system development; TAS:ProtInc
Q7L2J0	MEPCE	7SK snRNA methylphosphate capping enzyme	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7L2J0	MEPCE	7SK snRNA methylphosphate capping enzyme	GO:0008173; F:RNA methyltransferase activity; IDA:UniProtKB
Q7L2J0	MEPCE	7SK snRNA methylphosphate capping enzyme	GO:0008757; F:S-adenosylmethionine-dependent methyltransferase activity; IDA:UniProtKB
Q7L2J0	MEPCE	7SK snRNA methylphosphate capping enzyme	GO:0035562; P:negative regulation of chromatin binding; IEA:Ensembl
Q7L2J0	MEPCE	7SK snRNA methylphosphate capping enzyme	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q7L2J0	MEPCE	7SK snRNA methylphosphate capping enzyme	GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl
Q7L2J0	MEPCE	7SK snRNA methylphosphate capping enzyme	GO:0001510; P:RNA methylation; IDA:UniProtKB
Q7L2J0	MEPCE	7SK snRNA methylphosphate capping enzyme	GO:0016073; P:snRNA metabolic process; IDA:UniProtKB
Q7L2J0	MEPCE	7SK snRNA methylphosphate capping enzyme	GO:0040031; P:snRNA modification; IDA:UniProtKB
P35240	NF2	Merlin	GO:0005515; F:protein binding; IPI:IntAct
P35240	NF2	Merlin	GO:0030036; P:actin cytoskeleton organization; IMP:HGNC
P35240	NF2	Merlin	GO:0045216; P:cell-cell junction organization; IEA:Ensembl
P35240	NF2	Merlin	GO:0007398; P:ectoderm development; IEA:Ensembl
P35240	NF2	Merlin	GO:0070306; P:lens fiber cell differentiation; IEA:Ensembl
P35240	NF2	Merlin	GO:0001707; P:mesoderm formation; IEA:Ensembl
P35240	NF2	Merlin	GO:0030336; P:negative regulation of cell migration; TAS:HGNC
P35240	NF2	Merlin	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
P35240	NF2	Merlin	GO:0022408; P:negative regulation of cell-cell adhesion; IDA:HGNC
P35240	NF2	Merlin	GO:0001953; P:negative regulation of cell-matrix adhesion; TAS:HGNC
P35240	NF2	Merlin	GO:0008156; P:negative regulation of DNA replication; IMP:HGNC
P35240	NF2	Merlin	GO:0046426; P:negative regulation of JAK-STAT cascade; IDA:HGNC
P35240	NF2	Merlin	GO:0043409; P:negative regulation of MAPK cascade; IEA:Ensembl
P35240	NF2	Merlin	GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl
P35240	NF2	Merlin	GO:0042518; P:negative regulation of tyrosine phosphorylation of Stat3 protein; IDA:HGNC
P35240	NF2	Merlin	GO:0042524; P:negative regulation of tyrosine phosphorylation of Stat5 protein; IDA:HGNC
P35240	NF2	Merlin	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
P35240	NF2	Merlin	GO:0051496; P:positive regulation of stress fiber assembly; IMP:HGNC
P35240	NF2	Merlin	GO:0035330; P:regulation of hippo signaling; IMP:UniProtKB
P35240	NF2	Merlin	GO:0014010; P:Schwann cell proliferation; IMP:HGNC
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0005515; F:protein binding; IPI:UniProtKB
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; TAS:ProtInc
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0043277; P:apoptotic cell clearance; IEA:Ensembl
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0007596; P:blood coagulation; TAS:Reactome
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0050900; P:leukocyte migration; TAS:Reactome
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0001779; P:natural killer cell differentiation; IEA:Ensembl
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0051250; P:negative regulation of lymphocyte activation; IEA:Ensembl
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:GOC
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0006909; P:phagocytosis; IMP:BHF-UCL
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0030168; P:platelet activation; IEA:Ensembl
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0050766; P:positive regulation of phagocytosis; IDA:UniProtKB
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0043491; P:protein kinase B signaling; IEA:Ensembl
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0032940; P:secretion by cell; IEA:Ensembl
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0034446; P:substrate adhesion-dependent cell spreading; IEA:Ensembl
Q12866	MERTK	Tyrosine-protein kinase Mer	GO:0060068; P:vagina development; IEA:Ensembl
Q8N4P3	HDDC3	Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1	GO:0008893; F:guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity; IEA:UniProtKB-EC
Q8N4P3	HDDC3	Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14696	MESDC2	LDLR chaperone MESD	GO:0007498; P:mesoderm development; NAS:UniProtKB
Q14696	MESDC2	LDLR chaperone MESD	GO:0006457; P:protein folding; ISS:UniProtKB
Q14696	MESDC2	LDLR chaperone MESD	GO:0034394; P:protein localization to cell surface; IEA:Ensembl
Q14696	MESDC2	LDLR chaperone MESD	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q0VG99	MESP2	Mesoderm posterior protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q0VG99	MESP2	Mesoderm posterior protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q0VG99	MESP2	Mesoderm posterior protein 2	GO:0008078; P:mesodermal cell migration; IEA:Ensembl
Q0VG99	MESP2	Mesoderm posterior protein 2	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
Q0VG99	MESP2	Mesoderm posterior protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q0VG99	MESP2	Mesoderm posterior protein 2	GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl
Q0VG99	MESP2	Mesoderm posterior protein 2	GO:0001756; P:somitogenesis; IEA:Ensembl
Q0VG99	MESP2	Mesoderm posterior protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0035326; F:enhancer binding; IEA:Ensembl
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0003210; P:cardiac atrium formation; IMP:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0060913; P:cardiac cell fate determination; ISS:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0055007; P:cardiac muscle cell differentiation; IMP:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0060947; P:cardiac vascular smooth muscle cell differentiation; IMP:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0003211; P:cardiac ventricle formation; IMP:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0003259; P:cardioblast anterior-lateral migration; ISS:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0060975; P:cardioblast migration to the midline involved in heart field formation; ISS:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0003143; P:embryonic heart tube morphogenesis; ISS:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0045446; P:endothelial cell differentiation; IMP:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0007369; P:gastrulation; ISS:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0003241; P:growth involved in heart morphogenesis; ISS:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0001947; P:heart looping; ISS:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0048368; P:lateral mesoderm development; ISS:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0008078; P:mesodermal cell migration; IEA:Ensembl
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0042664; P:negative regulation of endodermal cell fate specification; ISS:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0042662; P:negative regulation of mesodermal cell fate specification; ISS:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0022008; P:neurogenesis; IMP:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0090082; P:positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway; ISS:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0070368; P:positive regulation of hepatocyte differentiation; ISS:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0045747; P:positive regulation of Notch signaling pathway; ISS:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0035481; P:positive regulation of Notch signaling pathway involved in heart induction; IEA:Ensembl
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0051155; P:positive regulation of striated muscle cell differentiation; ISS:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0003139; P:secondary heart field specification; ISS:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0060921; P:sinoatrial node cell differentiation; IMP:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0003236; P:sinus venosus morphogenesis; ISS:BHF-UCL
Q9BRJ9	MESP1	Mesoderm posterior protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5EB52	MEST	Mesoderm-specific transcript homolog protein	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q5EB52	MEST	Mesoderm-specific transcript homolog protein	GO:0007498; P:mesoderm development; TAS:ProtInc
Q5EB52	MEST	Mesoderm-specific transcript homolog protein	GO:0010883; P:regulation of lipid storage; IEA:Ensembl
Q5EB52	MEST	Mesoderm-specific transcript homolog protein	GO:0032526; P:response to retinoic acid; IEA:Ensembl
Q5JPI9	METTL10	Methyltransferase-like protein 10	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q8N6R0	METTL13	Methyltransferase-like protein 13	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
A8MUP2	METTL12	Methyltransferase-like protein 12, mitochondrial	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q9HCE5	METTL14	N6-adenosine-methyltransferase subunit METTL14	GO:0016422; F:mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; IDA:UniProtKB
Q9HCE5	METTL14	N6-adenosine-methyltransferase subunit METTL14	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9HCE5	METTL14	N6-adenosine-methyltransferase subunit METTL14	GO:0061157; P:mRNA destabilization; ISS:UniProtKB
Q9HCE5	METTL14	N6-adenosine-methyltransferase subunit METTL14	GO:0080009; P:mRNA methylation; IMP:UniProtKB
Q9HCE5	METTL14	N6-adenosine-methyltransferase subunit METTL14	GO:0019827; P:stem cell maintenance; ISS:UniProtKB
A6NJ78	METTL15	Probable methyltransferase-like protein 15	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q86W50	METTL16	Methyltransferase-like protein 16	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q86W50	METTL16	Methyltransferase-like protein 16	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H7H0	METTL17	Methyltransferase-like protein 17, mitochondrial	GO:0005507; F:copper ion binding; IEA:InterPro
Q9H7H0	METTL17	Methyltransferase-like protein 17, mitochondrial	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q9H7H0	METTL17	Methyltransferase-like protein 17, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q9H7H0	METTL17	Methyltransferase-like protein 17, mitochondrial	GO:0006412; P:translation; IEA:InterPro
O95568	METTL18	Histidine protein methyltransferase 1 homolog	GO:0008276; F:protein methyltransferase activity; IEA:InterPro
Q8IXQ9	METTL20	Methyltransferase-like protein 20	GO:0008276; F:protein methyltransferase activity; IEA:InterPro
Q86XA0	METTL23	Methyltransferase-like protein 23	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q9BUU2	METTL22	Methyltransferase-like protein 22	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q5JXM2	METTL24	Methyltransferase-like protein 24	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q8N6Q8	METTL25	Methyltransferase-like protein 25	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q96IZ6	METTL2A	Methyltransferase-like protein 2A	GO:0016427; F:tRNA (cytosine) methyltransferase activity; ISS:UniProtKB
Q96IZ6	METTL2A	Methyltransferase-like protein 2A	GO:0030488; P:tRNA methylation; ISS:UniProtKB
Q6P1Q9	METTL2B	Methyltransferase-like protein 2B	GO:0016427; F:tRNA (cytosine) methyltransferase activity; IMP:UniProtKB
Q6P1Q9	METTL2B	Methyltransferase-like protein 2B	GO:0030488; P:tRNA methylation; IMP:UniProtKB
Q9H8H3	METTL7A	Methyltransferase-like protein 7A	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q6UX53	METTL7B	Methyltransferase-like protein 7B	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q99707	MTR	Methionine synthase	GO:0031419; F:cobalamin binding; IEA:UniProtKB-KW
Q99707	MTR	Methionine synthase	GO:0008898; F:S-adenosylmethionine-homocysteine S-methyltransferase activity; IEA:InterPro
Q99707	MTR	Methionine synthase	GO:0008705; F:methionine synthase activity; IEA:UniProtKB-EC
Q99707	MTR	Methionine synthase	GO:0008270; F:zinc ion binding; IEA:InterPro
Q99707	MTR	Methionine synthase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q99707	MTR	Methionine synthase	GO:0009235; P:cobalamin metabolic process; TAS:Reactome
Q99707	MTR	Methionine synthase	GO:0032259; P:methylation; TAS:Reactome
Q99707	MTR	Methionine synthase	GO:0007399; P:nervous system development; TAS:ProtInc
Q99707	MTR	Methionine synthase	GO:0042558; P:pteridine-containing compound metabolic process; IEA:InterPro
Q99707	MTR	Methionine synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99707	MTR	Methionine synthase	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
Q99707	MTR	Methionine synthase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q99707	MTR	Methionine synthase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q99707	MTR	Methionine synthase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q00266	MAT1A	S-adenosylmethionine synthase isoform type-1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q00266	MAT1A	S-adenosylmethionine synthase isoform type-1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q00266	MAT1A	S-adenosylmethionine synthase isoform type-1	GO:0004478; F:methionine adenosyltransferase activity; TAS:ProtInc
Q00266	MAT1A	S-adenosylmethionine synthase isoform type-1	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
Q00266	MAT1A	S-adenosylmethionine synthase isoform type-1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q00266	MAT1A	S-adenosylmethionine synthase isoform type-1	GO:0032259; P:methylation; TAS:Reactome
Q00266	MAT1A	S-adenosylmethionine synthase isoform type-1	GO:0006730; P:one-carbon metabolic process; IEA:UniProtKB-KW
Q00266	MAT1A	S-adenosylmethionine synthase isoform type-1	GO:0006556; P:S-adenosylmethionine biosynthetic process; IEA:UniProtKB-UniPathway
Q00266	MAT1A	S-adenosylmethionine synthase isoform type-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q00266	MAT1A	S-adenosylmethionine synthase isoform type-1	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
Q00266	MAT1A	S-adenosylmethionine synthase isoform type-1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P31153	MAT2A	S-adenosylmethionine synthase isoform type-2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P31153	MAT2A	S-adenosylmethionine synthase isoform type-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P31153	MAT2A	S-adenosylmethionine synthase isoform type-2	GO:0004478; F:methionine adenosyltransferase activity; IDA:UniProt
P31153	MAT2A	S-adenosylmethionine synthase isoform type-2	GO:0005515; F:protein binding; IPI:UniProtKB
P31153	MAT2A	S-adenosylmethionine synthase isoform type-2	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P31153	MAT2A	S-adenosylmethionine synthase isoform type-2	GO:0032259; P:methylation; TAS:Reactome
P31153	MAT2A	S-adenosylmethionine synthase isoform type-2	GO:0006730; P:one-carbon metabolic process; IEA:UniProtKB-KW
P31153	MAT2A	S-adenosylmethionine synthase isoform type-2	GO:0006556; P:S-adenosylmethionine biosynthetic process; IDA:UniProt
P31153	MAT2A	S-adenosylmethionine synthase isoform type-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P31153	MAT2A	S-adenosylmethionine synthase isoform type-2	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
P31153	MAT2A	S-adenosylmethionine synthase isoform type-2	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9NRN9	METTL5	Methyltransferase-like protein 5	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q9NRN9	METTL5	Methyltransferase-like protein 5	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8N3J2	METTL4	Methyltransferase-like protein 4	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q8N3J2	METTL4	Methyltransferase-like protein 4	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8N3J2	METTL4	Methyltransferase-like protein 4	GO:0006139; P:nucleobase-containing compound metabolic process; IEA:InterPro
Q9H825	METTL8	Methyltransferase-like protein 8	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q8TCB7	METTL6	Methyltransferase-like protein 6	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q9H1A3	METTL9	Methyltransferase-like protein 9	GO:0005515; F:protein binding; IPI:UniProtKB
Q641Q3	METRNL	Meteorin-like protein	GO:0045444; P:fat cell differentiation; ISS:UniProt
Q9UJH8	METRN	Meteorin	GO:0010001; P:glial cell differentiation; IEA:Ensembl
Q9UJH8	METRN	Meteorin	GO:0050772; P:positive regulation of axonogenesis; IEA:Ensembl
P08581	MET	Hepatocyte growth factor receptor	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P08581	MET	Hepatocyte growth factor receptor	GO:0005008; F:hepatocyte growth factor-activated receptor activity; TAS:ProtInc
P08581	MET	Hepatocyte growth factor receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P08581	MET	Hepatocyte growth factor receptor	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
P08581	MET	Hepatocyte growth factor receptor	GO:0004713; F:protein tyrosine kinase activity; NAS:UniProtKB
P08581	MET	Hepatocyte growth factor receptor	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
P08581	MET	Hepatocyte growth factor receptor	GO:0030534; P:adult behavior; IEA:Ensembl
P08581	MET	Hepatocyte growth factor receptor	GO:0007411; P:axon guidance; TAS:Reactome
P08581	MET	Hepatocyte growth factor receptor	GO:0007420; P:brain development; IEA:Ensembl
P08581	MET	Hepatocyte growth factor receptor	GO:0048754; P:branching morphogenesis of an epithelial tube; IMP:UniProtKB
P08581	MET	Hepatocyte growth factor receptor	GO:0008283; P:cell proliferation; TAS:ProtInc
P08581	MET	Hepatocyte growth factor receptor	GO:0007166; P:cell surface receptor signaling pathway; NAS:UniProtKB
P08581	MET	Hepatocyte growth factor receptor	GO:0042593; P:glucose homeostasis; IEA:Ensembl
P08581	MET	Hepatocyte growth factor receptor	GO:0001889; P:liver development; IEA:Ensembl
P08581	MET	Hepatocyte growth factor receptor	GO:0014812; P:muscle cell migration; IEA:Ensembl
P08581	MET	Hepatocyte growth factor receptor	GO:0051450; P:myoblast proliferation; IEA:Ensembl
P08581	MET	Hepatocyte growth factor receptor	GO:0014902; P:myotube differentiation; IEA:Ensembl
P08581	MET	Hepatocyte growth factor receptor	GO:1901299; P:negative regulation of hydrogen peroxide-mediated programmed cell death; IMP:BHF-UCL
P08581	MET	Hepatocyte growth factor receptor	GO:0018108; P:peptidyl-tyrosine phosphorylation; NAS:GOC
P08581	MET	Hepatocyte growth factor receptor	GO:0001890; P:placenta development; IEA:Ensembl
P08581	MET	Hepatocyte growth factor receptor	GO:0050918; P:positive chemotaxis; IDA:UniProtKB
P08581	MET	Hepatocyte growth factor receptor	GO:2001028; P:positive regulation of endothelial cell chemotaxis; IMP:UniProtKB
P08581	MET	Hepatocyte growth factor receptor	GO:0010828; P:positive regulation of glucose transport; IEA:Ensembl
P08581	MET	Hepatocyte growth factor receptor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P08581	MET	Hepatocyte growth factor receptor	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
P08581	MET	Hepatocyte growth factor receptor	GO:0060665; P:regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling; IEA:Ensembl
P08581	MET	Hepatocyte growth factor receptor	GO:0071526; P:semaphorin-plexin signaling pathway; IDA:UniProtKB
P08581	MET	Hepatocyte growth factor receptor	GO:0007165; P:signal transduction; TAS:ProtInc
P08581	MET	Hepatocyte growth factor receptor	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
A1L020	MEX3A	RNA-binding protein MEX3A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
A1L020	MEX3A	RNA-binding protein MEX3A	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6ZN04	MEX3B	RNA-binding protein MEX3B	GO:0005509; F:calcium ion binding; ISS:UniProtKB
Q6ZN04	MEX3B	RNA-binding protein MEX3B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6ZN04	MEX3B	RNA-binding protein MEX3B	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6ZN04	MEX3B	RNA-binding protein MEX3B	GO:0046777; P:protein autophosphorylation; ISS:UniProtKB
Q6ZN04	MEX3B	RNA-binding protein MEX3B	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
Q5U5Q3	MEX3C	RNA-binding E3 ubiquitin-protein ligase MEX3C	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q5U5Q3	MEX3C	RNA-binding E3 ubiquitin-protein ligase MEX3C	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q5U5Q3	MEX3C	RNA-binding E3 ubiquitin-protein ligase MEX3C	GO:0005515; F:protein binding; IPI:IntAct
Q5U5Q3	MEX3C	RNA-binding E3 ubiquitin-protein ligase MEX3C	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5U5Q3	MEX3C	RNA-binding E3 ubiquitin-protein ligase MEX3C	GO:0003415; P:chondrocyte hypertrophy; IEA:Ensembl
Q5U5Q3	MEX3C	RNA-binding E3 ubiquitin-protein ligase MEX3C	GO:0097009; P:energy homeostasis; IEA:Ensembl
Q5U5Q3	MEX3C	RNA-binding E3 ubiquitin-protein ligase MEX3C	GO:0045598; P:regulation of fat cell differentiation; IEA:Ensembl
Q86XN8	MEX3D	RNA-binding protein MEX3D	GO:0017091; F:AU-rich element binding; IDA:BHF-UCL
Q86XN8	MEX3D	RNA-binding protein MEX3D	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q86XN8	MEX3D	RNA-binding protein MEX3D	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86XN8	MEX3D	RNA-binding protein MEX3D	GO:0061157; P:mRNA destabilization; NAS:BHF-UCL
Q86XN8	MEX3D	RNA-binding protein MEX3D	GO:0010609; P:mRNA localization resulting in posttranscriptional regulation of gene expression; NAS:BHF-UCL
Q86YR7	MCF2L2	Probable guanine nucleotide exchange factor MCF2L2	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q96FH0	MEF2BNB	Protein MEF2BNB	GO:0005515; F:protein binding; IPI:IntAct
Q96FH0	MEF2BNB	Protein MEF2BNB	GO:0007507; P:heart development; IEP:UniProtKB
P55081	MFAP1	Microfibrillar-associated protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P55081	MFAP1	Microfibrillar-associated protein 1	GO:0005515; F:protein binding; IPI:IntAct
P55081	MFAP1	Microfibrillar-associated protein 1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P55001	MFAP2	Microfibrillar-associated protein 2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P55001	MFAP2	Microfibrillar-associated protein 2	GO:0030220; P:platelet formation; IEA:Ensembl
P55082	MFAP3	Microfibril-associated glycoprotein 3	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P55083	MFAP4	Microfibril-associated glycoprotein 4	GO:0005515; F:protein binding; IPI:BHF-UCL
P55083	MFAP4	Microfibril-associated glycoprotein 4	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P55083	MFAP4	Microfibril-associated glycoprotein 4	GO:0071493; P:cellular response to UV-B; IDA:BHF-UCL
P55083	MFAP4	Microfibril-associated glycoprotein 4	GO:0048251; P:elastic fiber assembly; IDA:BHF-UCL
P55083	MFAP4	Microfibril-associated glycoprotein 4	GO:0043206; P:extracellular fibril organization; IDA:BHF-UCL
P55083	MFAP4	Microfibril-associated glycoprotein 4	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P55083	MFAP4	Microfibril-associated glycoprotein 4	GO:0010712; P:regulation of collagen metabolic process; IDA:BHF-UCL
P55083	MFAP4	Microfibril-associated glycoprotein 4	GO:0009650; P:UV protection; IDA:BHF-UCL
Q13361	MFAP5	Microfibrillar-associated protein 5	GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc
Q13361	MFAP5	Microfibrillar-associated protein 5	GO:0043206; P:extracellular fibril organization; IEA:Ensembl
Q13361	MFAP5	Microfibrillar-associated protein 5	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q08431	MFGE8	Lactadherin	GO:0008429; F:phosphatidylethanolamine binding; IEA:Ensembl
Q08431	MFGE8	Lactadherin	GO:0001786; F:phosphatidylserine binding; IEA:Ensembl
Q08431	MFGE8	Lactadherin	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q08431	MFGE8	Lactadherin	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q08431	MFGE8	Lactadherin	GO:0006911; P:phagocytosis, engulfment; IEA:Ensembl
Q08431	MFGE8	Lactadherin	GO:0006910; P:phagocytosis, recognition; IEA:Ensembl
Q08431	MFGE8	Lactadherin	GO:2000427; P:positive regulation of apoptotic cell clearance; IEA:Ensembl
Q08431	MFGE8	Lactadherin	GO:0007338; P:single fertilization; IEA:UniProtKB-KW
Q08431	MFGE8	Lactadherin	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9GZY8	MFF	Mitochondrial fission factor	GO:0005515; F:protein binding; IPI:UniProtKB
Q9GZY8	MFF	Mitochondrial fission factor	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q9GZY8	MFF	Mitochondrial fission factor	GO:0000266; P:mitochondrial fission; ISS:UniProtKB
Q9GZY8	MFF	Mitochondrial fission factor	GO:0043653; P:mitochondrial fragmentation involved in apoptotic process; IMP:UniProtKB
Q9GZY8	MFF	Mitochondrial fission factor	GO:0008053; P:mitochondrial fusion; IMP:UniProtKB
Q9GZY8	MFF	Mitochondrial fission factor	GO:0070584; P:mitochondrion morphogenesis; IMP:MGI
Q9GZY8	MFF	Mitochondrial fission factor	GO:0016559; P:peroxisome fission; IMP:UniProtKB
Q9GZY8	MFF	Mitochondrial fission factor	GO:0090141; P:positive regulation of mitochondrial fission; IDA:UniProtKB
Q9GZY8	MFF	Mitochondrial fission factor	GO:0090314; P:positive regulation of protein targeting to membrane; IDA:UniProtKB
Q9GZY8	MFF	Mitochondrial fission factor	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IMP:UniProtKB
Q9GZY8	MFF	Mitochondrial fission factor	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
Q9GZY8	MFF	Mitochondrial fission factor	GO:0006626; P:protein targeting to mitochondrion; IMP:UniProtKB
Q9GZY8	MFF	Mitochondrial fission factor	GO:0010821; P:regulation of mitochondrion organization; IMP:UniProtKB
Q9GZY8	MFF	Mitochondrial fission factor	GO:1900063; P:regulation of peroxisome organization; IMP:UniProtKB
Q9GZY8	MFF	Mitochondrial fission factor	GO:0001836; P:release of cytochrome c from mitochondria; IMP:UniProtKB
Q9Y4C4	MFHAS1	Malignant fibrous histiocytoma-amplified sequence 1	GO:0005515; F:protein binding; IPI:IntAct
Q8IWA4	MFN1	Mitofusin-1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q8IWA4	MFN1	Mitofusin-1	GO:0003924; F:GTPase activity; IEA:InterPro
Q8IWA4	MFN1	Mitofusin-1	GO:0005515; F:protein binding; IPI:IntAct
Q8IWA4	MFN1	Mitofusin-1	GO:0008053; P:mitochondrial fusion; IMP:UniProtKB
O95140	MFN2	Mitofusin-2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
O95140	MFN2	Mitofusin-2	GO:0003924; F:GTPase activity; IEA:InterPro
O95140	MFN2	Mitofusin-2	GO:0005515; F:protein binding; IPI:UniProtKB
O95140	MFN2	Mitofusin-2	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
O95140	MFN2	Mitofusin-2	GO:0001825; P:blastocyst formation; IEA:Ensembl
O95140	MFN2	Mitofusin-2	GO:0007596; P:blood coagulation; TAS:Reactome
O95140	MFN2	Mitofusin-2	GO:0048593; P:camera-type eye morphogenesis; IEA:Ensembl
O95140	MFN2	Mitofusin-2	GO:0008219; P:cell death; IEA:UniProtKB-KW
O95140	MFN2	Mitofusin-2	GO:0008053; P:mitochondrial fusion; IMP:UniProtKB
O95140	MFN2	Mitofusin-2	GO:0007006; P:mitochondrial membrane organization; IDA:UniProtKB
O95140	MFN2	Mitofusin-2	GO:0051646; P:mitochondrion localization; IDA:UniProtKB
O95140	MFN2	Mitofusin-2	GO:0046580; P:negative regulation of Ras protein signal transduction; IDA:UniProtKB
O95140	MFN2	Mitofusin-2	GO:0048662; P:negative regulation of smooth muscle cell proliferation; ISS:UniProtKB
O95140	MFN2	Mitofusin-2	GO:0006626; P:protein targeting to mitochondrion; IDA:UniProtKB
O00587	MFNG	Beta-1,3-N-acetylglucosaminyltransferase manic fringe	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O00587	MFNG	Beta-1,3-N-acetylglucosaminyltransferase manic fringe	GO:0033829; F:O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity; IEA:UniProtKB-EC
O00587	MFNG	Beta-1,3-N-acetylglucosaminyltransferase manic fringe	GO:0007389; P:pattern specification process; TAS:ProtInc
O00587	MFNG	Beta-1,3-N-acetylglucosaminyltransferase manic fringe	GO:0045747; P:positive regulation of Notch signaling pathway; IEA:Ensembl
O00587	MFNG	Beta-1,3-N-acetylglucosaminyltransferase manic fringe	GO:0032092; P:positive regulation of protein binding; IEA:Ensembl
Q9NYZ2	SLC25A37	Mitoferrin-1	GO:0005381; F:iron ion transmembrane transporter activity; IEA:Ensembl
Q9NYZ2	SLC25A37	Mitoferrin-1	GO:0055072; P:iron ion homeostasis; IEA:UniProtKB-KW
Q9NYZ2	SLC25A37	Mitoferrin-1	GO:0048250; P:mitochondrial iron ion transport; IEA:Ensembl
Q9NYZ2	SLC25A37	Mitoferrin-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96A46	SLC25A28	Mitoferrin-2	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q96A46	SLC25A28	Mitoferrin-2	GO:0055072; P:iron ion homeostasis; IEA:UniProtKB-KW
Q96A46	SLC25A28	Mitoferrin-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BY79	MFRP	Membrane frizzled-related protein	GO:0009790; P:embryo development; NAS:UniProtKB
Q14728	MFSD10	Major facilitator superfamily domain-containing protein 10	GO:0008493; F:tetracycline transporter activity; TAS:ProtInc
Q14728	MFSD10	Major facilitator superfamily domain-containing protein 10	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q14728	MFSD10	Major facilitator superfamily domain-containing protein 10	GO:0015904; P:tetracycline transport; TAS:GOC
Q14728	MFSD10	Major facilitator superfamily domain-containing protein 10	GO:0055085; P:transmembrane transport; IEA:InterPro
Q14728	MFSD10	Major facilitator superfamily domain-containing protein 10	GO:0006810; P:transport; TAS:ProtInc
Q6NUT3	MFSD12	Major facilitator superfamily domain-containing protein 12	GO:0006810; P:transport; IEA:UniProtKB-KW
Q8NA29	MFSD2A	Major facilitator superfamily domain-containing protein 2A	GO:0006810; P:transport; IEA:UniProtKB-KW
A6NFX1	MFSD2B	Major facilitator superfamily domain-containing protein 2B	GO:0006810; P:transport; IEA:UniProtKB-KW
Q9H3U5	MFSD1	Major facilitator superfamily domain-containing protein 1	GO:0055085; P:transmembrane transport; IEA:InterPro
Q96ES6	MFSD3	Major facilitator superfamily domain-containing protein 3	GO:0055085; P:transmembrane transport; IEA:InterPro
Q8N468	MFSD4	Major facilitator superfamily domain-containing protein 4	GO:0055085; P:transmembrane transport; IEA:InterPro
Q6N075	MFSD5	Molybdate-anion transporter	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q6ZSS7	MFSD6	Major facilitator superfamily domain-containing protein 6	GO:0055085; P:transmembrane transport; IEA:InterPro
Q6UXD7	MFSD7	Major facilitator superfamily domain-containing protein 7	GO:0055085; P:transmembrane transport; IEA:InterPro
Q8NHS3	MFSD8	Major facilitator superfamily domain-containing protein 8	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q8NHS3	MFSD8	Major facilitator superfamily domain-containing protein 8	GO:0055085; P:transmembrane transport; IEA:InterPro
Q8NBP5	MFSD9	Major facilitator superfamily domain-containing protein 9	GO:0005215; F:transporter activity; IEA:InterPro
Q8NBP5	MFSD9	Major facilitator superfamily domain-containing protein 9	GO:0055085; P:transmembrane transport; IEA:InterPro
Q9H2D1	SLC25A32	Mitochondrial folate transporter/carrier	GO:0008517; F:folic acid transporter activity; NAS:UniProtKB
Q9H2D1	SLC25A32	Mitochondrial folate transporter/carrier	GO:0046655; P:folic acid metabolic process; TAS:Reactome
Q9H2D1	SLC25A32	Mitochondrial folate transporter/carrier	GO:0015884; P:folic acid transport; NAS:UniProtKB
Q9H2D1	SLC25A32	Mitochondrial folate transporter/carrier	GO:0006839; P:mitochondrial transport; IEA:InterPro
Q9H2D1	SLC25A32	Mitochondrial folate transporter/carrier	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H2D1	SLC25A32	Mitochondrial folate transporter/carrier	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9H2D1	SLC25A32	Mitochondrial folate transporter/carrier	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
DR   GO:0030246; F:carbohydrate binding; IEA:InterPro
DR   GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro
DR   GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q8IWI9	MGA	MAX gene-associated protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IWI9	MGA	MAX gene-associated protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8IWI9	MGA	MAX gene-associated protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
DR   GO:0030246; F:carbohydrate binding; IEA:InterPro
DR   GO:0004553; F:hydrolase activity, hydrolyzing O-glycosyl compounds; IEA:InterPro
DR   GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
P26572	MGAT1	Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GO:0008375; F:acetylglucosaminyltransferase activity; TAS:ProtInc
P26572	MGAT1	Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GO:0003827; F:alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; IEA:UniProtKB-EC
P26572	MGAT1	Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P26572	MGAT1	Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
P26572	MGAT1	Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P26572	MGAT1	Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P26572	MGAT1	Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GO:0043687; P:post-translational protein modification; TAS:Reactome
P26572	MGAT1	Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GO:0006486; P:protein glycosylation; TAS:ProtInc
P26572	MGAT1	Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
P26572	MGAT1	Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GO:0006049; P:UDP-N-acetylglucosamine catabolic process; IEA:Ensembl
Q10469	MGAT2	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GO:0008455; F:alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; TAS:ProtInc
Q10469	MGAT2	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GO:0030246; F:carbohydrate binding; IEA:Ensembl
Q10469	MGAT2	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q10469	MGAT2	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GO:0009312; P:oligosaccharide biosynthetic process; IEA:InterPro
Q10469	MGAT2	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GO:0009311; P:oligosaccharide metabolic process; TAS:ProtInc
Q10469	MGAT2	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q10469	MGAT2	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GO:0006487; P:protein N-linked glycosylation; TAS:ProtInc
Q10469	MGAT2	Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q09327	MGAT3	Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase	GO:0003830; F:beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; IEA:UniProtKB-EC
Q09327	MGAT3	Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q09327	MGAT3	Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q09327	MGAT3	Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
O43451	MGAM	Maltase-glucoamylase, intestinal	GO:0004558; F:alpha-glucosidase activity; TAS:Reactome
O43451	MGAM	Maltase-glucoamylase, intestinal	GO:0016160; F:amylase activity; IEA:Ensembl
O43451	MGAM	Maltase-glucoamylase, intestinal	GO:0030246; F:carbohydrate binding; IEA:InterPro
O43451	MGAM	Maltase-glucoamylase, intestinal	GO:0003824; F:catalytic activity; TAS:ProtInc
O43451	MGAM	Maltase-glucoamylase, intestinal	GO:0004339; F:glucan 1,4-alpha-glucosidase activity; IEA:UniProtKB-EC
O43451	MGAM	Maltase-glucoamylase, intestinal	GO:0032450; F:maltose alpha-glucosidase activity; IEA:UniProtKB-EC
O43451	MGAM	Maltase-glucoamylase, intestinal	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O43451	MGAM	Maltase-glucoamylase, intestinal	GO:0044245; P:polysaccharide digestion; TAS:Reactome
O43451	MGAM	Maltase-glucoamylase, intestinal	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43451	MGAM	Maltase-glucoamylase, intestinal	GO:0005983; P:starch catabolic process; TAS:ProtInc
Q86V88	MDP1	Magnesium-dependent phosphatase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86V88	MDP1	Magnesium-dependent phosphatase 1	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q99685	MGLL	Monoglyceride lipase	GO:0047372; F:acylglycerol lipase activity; ISS:UniProtKB
Q99685	MGLL	Monoglyceride lipase	GO:0008289; F:lipid binding; IEA:Ensembl
Q99685	MGLL	Monoglyceride lipase	GO:0004622; F:lysophospholipase activity; TAS:ProtInc
Q99685	MGLL	Monoglyceride lipase	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q99685	MGLL	Monoglyceride lipase	GO:0036155; P:acylglycerol acyl-chain remodeling; TAS:Reactome
Q99685	MGLL	Monoglyceride lipase	GO:0046464; P:acylglycerol catabolic process; ISS:UniProtKB
Q99685	MGLL	Monoglyceride lipase	GO:0019369; P:arachidonic acid metabolic process; ISS:UniProtKB
Q99685	MGLL	Monoglyceride lipase	GO:0007596; P:blood coagulation; TAS:Reactome
Q99685	MGLL	Monoglyceride lipase	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
Q99685	MGLL	Monoglyceride lipase	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q99685	MGLL	Monoglyceride lipase	GO:0006954; P:inflammatory response; TAS:ProtInc
Q99685	MGLL	Monoglyceride lipase	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q99685	MGLL	Monoglyceride lipase	GO:0060292; P:long term synaptic depression; IEA:Ensembl
Q99685	MGLL	Monoglyceride lipase	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q99685	MGLL	Monoglyceride lipase	GO:0030168; P:platelet activation; TAS:Reactome
Q99685	MGLL	Monoglyceride lipase	GO:2000124; P:regulation of endocannabinoid signaling pathway; ISS:UniProtKB
Q99685	MGLL	Monoglyceride lipase	GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB
Q99685	MGLL	Monoglyceride lipase	GO:0051930; P:regulation of sensory perception of pain; ISS:UniProtKB
Q99685	MGLL	Monoglyceride lipase	GO:0009966; P:regulation of signal transduction; ISS:UniProtKB
Q99685	MGLL	Monoglyceride lipase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99685	MGLL	Monoglyceride lipase	GO:0019433; P:triglyceride catabolic process; TAS:Reactome
Q9BQP7	MGME1	Mitochondrial genome maintenance exonuclease 1	GO:0008297; F:single-stranded DNA exodeoxyribonuclease activity; IDA:UniProtKB
Q9BQP7	MGME1	Mitochondrial genome maintenance exonuclease 1	GO:0000738; P:DNA catabolic process, exonucleolytic; IDA:GOC
Q9BQP7	MGME1	Mitochondrial genome maintenance exonuclease 1	GO:0043504; P:mitochondrial DNA repair; TAS:UniProtKB
Q9BQP7	MGME1	Mitochondrial genome maintenance exonuclease 1	GO:0006264; P:mitochondrial DNA replication; IMP:UniProtKB
Q9BQP7	MGME1	Mitochondrial genome maintenance exonuclease 1	GO:0000002; P:mitochondrial genome maintenance; IMP:UniProtKB
P16455	MGMT	Methylated-DNA--protein-cysteine methyltransferase	GO:0005509; F:calcium ion binding; IEA:Ensembl
P16455	MGMT	Methylated-DNA--protein-cysteine methyltransferase	GO:0003677; F:DNA binding; TAS:ProtInc
P16455	MGMT	Methylated-DNA--protein-cysteine methyltransferase	GO:0009008; F:DNA-methyltransferase activity; TAS:ProtInc
P16455	MGMT	Methylated-DNA--protein-cysteine methyltransferase	GO:0003908; F:methylated-DNA-[protein]-cysteine S-methyltransferase activity; IEA:UniProtKB-EC
P16455	MGMT	Methylated-DNA--protein-cysteine methyltransferase	GO:0008168; F:methyltransferase activity; TAS:ProtInc
P16455	MGMT	Methylated-DNA--protein-cysteine methyltransferase	GO:0071479; P:cellular response to ionizing radiation; IEA:Ensembl
P16455	MGMT	Methylated-DNA--protein-cysteine methyltransferase	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
P16455	MGMT	Methylated-DNA--protein-cysteine methyltransferase	GO:0034599; P:cellular response to oxidative stress; IEA:Ensembl
P16455	MGMT	Methylated-DNA--protein-cysteine methyltransferase	GO:0006307; P:DNA dealkylation involved in DNA repair; IEA:Ensembl
P16455	MGMT	Methylated-DNA--protein-cysteine methyltransferase	GO:0006266; P:DNA ligation; TAS:ProtInc
P16455	MGMT	Methylated-DNA--protein-cysteine methyltransferase	GO:0006306; P:DNA methylation; TAS:GOC
P16455	MGMT	Methylated-DNA--protein-cysteine methyltransferase	GO:0006281; P:DNA repair; TAS:Reactome
P16455	MGMT	Methylated-DNA--protein-cysteine methyltransferase	GO:0060644; P:mammary gland epithelial cell differentiation; IEA:Ensembl
P16455	MGMT	Methylated-DNA--protein-cysteine methyltransferase	GO:0060548; P:negative regulation of cell death; IEA:Ensembl
P16455	MGMT	Methylated-DNA--protein-cysteine methyltransferase	GO:0045739; P:positive regulation of DNA repair; IEA:Ensembl
P16455	MGMT	Methylated-DNA--protein-cysteine methyltransferase	GO:0043281; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
P16455	MGMT	Methylated-DNA--protein-cysteine methyltransferase	GO:0042493; P:response to drug; IEA:Ensembl
P16455	MGMT	Methylated-DNA--protein-cysteine methyltransferase	GO:0045471; P:response to ethanol; IEA:Ensembl
P16455	MGMT	Methylated-DNA--protein-cysteine methyltransferase	GO:0051593; P:response to folic acid; IEA:Ensembl
P16455	MGMT	Methylated-DNA--protein-cysteine methyltransferase	GO:0009636; P:response to toxic substance; IEA:Ensembl
Q96A72	MAGOHB	Protein mago nashi homolog 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96A72	MAGOHB	Protein mago nashi homolog 2	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q96A72	MAGOHB	Protein mago nashi homolog 2	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q96A72	MAGOHB	Protein mago nashi homolog 2	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
P61326	MAGOH	Protein mago nashi homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P61326	MAGOH	Protein mago nashi homolog	GO:0005515; F:protein binding; IPI:UniProtKB
P61326	MAGOH	Protein mago nashi homolog	GO:0010467; P:gene expression; TAS:Reactome
P61326	MAGOH	Protein mago nashi homolog	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
P61326	MAGOH	Protein mago nashi homolog	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
P61326	MAGOH	Protein mago nashi homolog	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P61326	MAGOH	Protein mago nashi homolog	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P61326	MAGOH	Protein mago nashi homolog	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IMP:UniProtKB
P61326	MAGOH	Protein mago nashi homolog	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IMP:UniProtKB
P61326	MAGOH	Protein mago nashi homolog	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
P61326	MAGOH	Protein mago nashi homolog	GO:0016070; P:RNA metabolic process; TAS:Reactome
P61326	MAGOH	Protein mago nashi homolog	GO:0008380; P:RNA splicing; TAS:Reactome
P61326	MAGOH	Protein mago nashi homolog	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
P61326	MAGOH	Protein mago nashi homolog	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
P08493	MGP	Matrix Gla protein	GO:0005509; F:calcium ion binding; IEA:InterPro
P08493	MGP	Matrix Gla protein	GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc
P08493	MGP	Matrix Gla protein	GO:0008147; F:structural constituent of bone; TAS:ProtInc
P08493	MGP	Matrix Gla protein	GO:0001502; P:cartilage condensation; TAS:ProtInc
P08493	MGP	Matrix Gla protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P08493	MGP	Matrix Gla protein	GO:0001503; P:ossification; TAS:ProtInc
P08493	MGP	Matrix Gla protein	GO:0030500; P:regulation of bone mineralization; IEA:InterPro
O60291	MGRN1	E3 ubiquitin-protein ligase MGRN1	GO:0005515; F:protein binding; IPI:UniProtKB
O60291	MGRN1	E3 ubiquitin-protein ligase MGRN1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
O60291	MGRN1	E3 ubiquitin-protein ligase MGRN1	GO:0008270; F:zinc ion binding; IEA:InterPro
O60291	MGRN1	E3 ubiquitin-protein ligase MGRN1	GO:0008333; P:endosome to lysosome transport; IMP:UniProtKB
O60291	MGRN1	E3 ubiquitin-protein ligase MGRN1	GO:0043951; P:negative regulation of cAMP-mediated signaling; IDA:UniProtKB
O60291	MGRN1	E3 ubiquitin-protein ligase MGRN1	GO:0045744; P:negative regulation of G-protein coupled receptor protein signaling pathway; IDA:UniProtKB
O60291	MGRN1	E3 ubiquitin-protein ligase MGRN1	GO:0006513; P:protein monoubiquitination; IMP:UniProtKB
O60291	MGRN1	E3 ubiquitin-protein ligase MGRN1	GO:0000209; P:protein polyubiquitination; IEA:Ensembl
P10620	MGST1	Microsomal glutathione S-transferase 1	GO:0043295; F:glutathione binding; IEA:Ensembl
P10620	MGST1	Microsomal glutathione S-transferase 1	GO:0004602; F:glutathione peroxidase activity; IDA:UniProtKB
P10620	MGST1	Microsomal glutathione S-transferase 1	GO:0004364; F:glutathione transferase activity; IDA:UniProtKB
P10620	MGST1	Microsomal glutathione S-transferase 1	GO:0005515; F:protein binding; IPI:IntAct
P10620	MGST1	Microsomal glutathione S-transferase 1	GO:0071449; P:cellular response to lipid hydroperoxide; IDA:UniProtKB
P10620	MGST1	Microsomal glutathione S-transferase 1	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
P10620	MGST1	Microsomal glutathione S-transferase 1	GO:0006749; P:glutathione metabolic process; IEA:Ensembl
P10620	MGST1	Microsomal glutathione S-transferase 1	GO:0033327; P:Leydig cell differentiation; IEA:Ensembl
P10620	MGST1	Microsomal glutathione S-transferase 1	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
P10620	MGST1	Microsomal glutathione S-transferase 1	GO:0070207; P:protein homotrimerization; ISS:UniProtKB
P10620	MGST1	Microsomal glutathione S-transferase 1	GO:0042493; P:response to drug; IEA:Ensembl
P10620	MGST1	Microsomal glutathione S-transferase 1	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P10620	MGST1	Microsomal glutathione S-transferase 1	GO:0010243; P:response to organonitrogen compound; IEA:Ensembl
P10620	MGST1	Microsomal glutathione S-transferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P10620	MGST1	Microsomal glutathione S-transferase 1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q99735	MGST2	Microsomal glutathione S-transferase 2	GO:0008047; F:enzyme activator activity; IEA:InterPro
Q99735	MGST2	Microsomal glutathione S-transferase 2	GO:0004602; F:glutathione peroxidase activity; IBA:RefGenome
Q99735	MGST2	Microsomal glutathione S-transferase 2	GO:0004364; F:glutathione transferase activity; IDA:UniProtKB
Q99735	MGST2	Microsomal glutathione S-transferase 2	GO:0004464; F:leukotriene-C4 synthase activity; IDA:UniProtKB
Q99735	MGST2	Microsomal glutathione S-transferase 2	GO:0006750; P:glutathione biosynthetic process; IDA:UniProtKB
Q99735	MGST2	Microsomal glutathione S-transferase 2	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
Q99735	MGST2	Microsomal glutathione S-transferase 2	GO:0019370; P:leukotriene biosynthetic process; IDA:UniProtKB
Q99735	MGST2	Microsomal glutathione S-transferase 2	GO:0055114; P:oxidation-reduction process; IBA:GOC
Q99735	MGST2	Microsomal glutathione S-transferase 2	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
Q99735	MGST2	Microsomal glutathione S-transferase 2	GO:0010243; P:response to organonitrogen compound; IEA:Ensembl
Q99735	MGST2	Microsomal glutathione S-transferase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99735	MGST2	Microsomal glutathione S-transferase 2	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
O14880	MGST3	Microsomal glutathione S-transferase 3	GO:0004602; F:glutathione peroxidase activity; IBA:RefGenome
O14880	MGST3	Microsomal glutathione S-transferase 3	GO:0004364; F:glutathione transferase activity; IBA:RefGenome
O14880	MGST3	Microsomal glutathione S-transferase 3	GO:0004601; F:peroxidase activity; TAS:ProtInc
O14880	MGST3	Microsomal glutathione S-transferase 3	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
O14880	MGST3	Microsomal glutathione S-transferase 3	GO:0006629; P:lipid metabolic process; TAS:ProtInc
O14880	MGST3	Microsomal glutathione S-transferase 3	GO:0055114; P:oxidation-reduction process; IBA:GOC
O14880	MGST3	Microsomal glutathione S-transferase 3	GO:0007165; P:signal transduction; TAS:ProtInc
O14880	MGST3	Microsomal glutathione S-transferase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O14880	MGST3	Microsomal glutathione S-transferase 3	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9UM21	MGAT4A	Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	GO:0008454; F:alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; TAS:ProtInc
Q9UM21	MGAT4A	Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UM21	MGAT4A	Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UM21	MGAT4A	Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	GO:0006491; P:N-glycan processing; TAS:ProtInc
Q9UM21	MGAT4A	Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9UM21	MGAT4A	Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9UQ53	MGAT4B	Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B	GO:0008454; F:alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; TAS:ProtInc
Q9UQ53	MGAT4B	Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UQ53	MGAT4B	Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UQ53	MGAT4B	Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B	GO:0006491; P:N-glycan processing; TAS:ProtInc
Q9UQ53	MGAT4B	Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9UQ53	MGAT4B	Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9UBM8	MGAT4C	Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C	GO:0008454; F:alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; IEA:UniProtKB-EC
Q9UBM8	MGAT4C	Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UBM8	MGAT4C	Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UBM8	MGAT4C	Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9UBM8	MGAT4C	Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
DR   GO:0016758; F:transferase activity, transferring hexosyl groups; IEA:InterPro
DR   GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q09328	MGAT5	Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A	GO:0030144; F:alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity; NAS:UniProtKB
Q09328	MGAT5	Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q09328	MGAT5	Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q09328	MGAT5	Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q3V5L5	MGAT5B	Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	GO:0030144; F:alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity; IEA:UniProtKB-EC
Q3V5L5	MGAT5B	Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q3V5L5	MGAT5B	Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	GO:0005515; F:protein binding; IPI:IntAct
Q3V5L5	MGAT5B	Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	GO:0006487; P:protein N-linked glycosylation; IEA:InterPro
A9UHW6	MIF4GD	MIF4G domain-containing protein	GO:0005515; F:protein binding; IPI:IntAct
A9UHW6	MIF4GD	MIF4G domain-containing protein	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
A9UHW6	MIF4GD	MIF4G domain-containing protein	GO:0003723; F:RNA binding; IEA:InterPro
A9UHW6	MIF4GD	MIF4G domain-containing protein	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q96PC5	MIA2	Melanoma inhibitory activity protein 2	GO:0042632; P:cholesterol homeostasis; IEA:Ensembl
Q96PC5	MIA2	Melanoma inhibitory activity protein 2	GO:0070328; P:triglyceride homeostasis; IEA:Ensembl
Q5JRA6	MIA3	Melanoma inhibitory activity protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q5JRA6	MIA3	Melanoma inhibitory activity protein 3	GO:0002063; P:chondrocyte development; IEA:Ensembl
Q5JRA6	MIA3	Melanoma inhibitory activity protein 3	GO:0030199; P:collagen fibril organization; IEA:Ensembl
Q5JRA6	MIA3	Melanoma inhibitory activity protein 3	GO:0006887; P:exocytosis; IMP:UniProtKB
Q5JRA6	MIA3	Melanoma inhibitory activity protein 3	GO:0007162; P:negative regulation of cell adhesion; IDA:BHF-UCL
Q5JRA6	MIA3	Melanoma inhibitory activity protein 3	GO:0030336; P:negative regulation of cell migration; IDA:BHF-UCL
Q5JRA6	MIA3	Melanoma inhibitory activity protein 3	GO:0030501; P:positive regulation of bone mineralization; IEA:Ensembl
Q5JRA6	MIA3	Melanoma inhibitory activity protein 3	GO:0002687; P:positive regulation of leukocyte migration; IDA:BHF-UCL
Q5JRA6	MIA3	Melanoma inhibitory activity protein 3	GO:0015031; P:protein transport; IMP:UniProtKB
Q5JRA6	MIA3	Melanoma inhibitory activity protein 3	GO:0042060; P:wound healing; IDA:BHF-UCL
Q8N4Q1	CHCHD4	Mitochondrial intermembrane space import and assembly protein 40	GO:0015035; F:protein disulfide oxidoreductase activity; IMP:UniProtKB
Q8N4Q1	CHCHD4	Mitochondrial intermembrane space import and assembly protein 40	GO:0051084; P:'de novo' posttranslational protein folding; IMP:UniProtKB
Q8N4Q1	CHCHD4	Mitochondrial intermembrane space import and assembly protein 40	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8N4Q1	CHCHD4	Mitochondrial intermembrane space import and assembly protein 40	GO:0045041; P:protein import into mitochondrial intermembrane space; IMP:UniProtKB
Q8N4Q1	CHCHD4	Mitochondrial intermembrane space import and assembly protein 40	GO:0022417; P:protein maturation by protein folding; IMP:UniProtKB
Q8N4Q1	CHCHD4	Mitochondrial intermembrane space import and assembly protein 40	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
Q16674	MIA	Melanoma-derived growth regulatory protein	GO:0008283; P:cell proliferation; TAS:ProtInc
Q86YT6	MIB1	E3 ubiquitin-protein ligase MIB1	GO:0005515; F:protein binding; IPI:IntAct
Q86YT6	MIB1	E3 ubiquitin-protein ligase MIB1	GO:0004842; F:ubiquitin-protein ligase activity; IEA:InterPro
Q86YT6	MIB1	E3 ubiquitin-protein ligase MIB1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86YT6	MIB1	E3 ubiquitin-protein ligase MIB1	GO:0001568; P:blood vessel development; IEA:Ensembl
Q86YT6	MIB1	E3 ubiquitin-protein ligase MIB1	GO:0001947; P:heart looping; IEA:Ensembl
Q86YT6	MIB1	E3 ubiquitin-protein ligase MIB1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q86YT6	MIB1	E3 ubiquitin-protein ligase MIB1	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
Q86YT6	MIB1	E3 ubiquitin-protein ligase MIB1	GO:0001841; P:neural tube formation; IEA:Ensembl
Q86YT6	MIB1	E3 ubiquitin-protein ligase MIB1	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q86YT6	MIB1	E3 ubiquitin-protein ligase MIB1	GO:0045807; P:positive regulation of endocytosis; IEA:Ensembl
Q86YT6	MIB1	E3 ubiquitin-protein ligase MIB1	GO:0001756; P:somitogenesis; IEA:Ensembl
Q96AX9	MIB2	E3 ubiquitin-protein ligase MIB2	GO:0005515; F:protein binding; IPI:IntAct
Q96AX9	MIB2	E3 ubiquitin-protein ligase MIB2	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q96AX9	MIB2	E3 ubiquitin-protein ligase MIB2	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q96AX9	MIB2	E3 ubiquitin-protein ligase MIB2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96AX9	MIB2	E3 ubiquitin-protein ligase MIB2	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
Q96AX9	MIB2	E3 ubiquitin-protein ligase MIB2	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q8TDZ2	MICAL1	Protein-methionine sulfoxide oxidase MICAL1	GO:0003779; F:actin binding; IDA:UniProtKB
Q8TDZ2	MICAL1	Protein-methionine sulfoxide oxidase MICAL1	GO:0071949; F:FAD binding; IDA:UniProtKB
Q8TDZ2	MICAL1	Protein-methionine sulfoxide oxidase MICAL1	GO:0016709; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; IDA:UniProtKB
Q8TDZ2	MICAL1	Protein-methionine sulfoxide oxidase MICAL1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TDZ2	MICAL1	Protein-methionine sulfoxide oxidase MICAL1	GO:0017124; F:SH3 domain binding; IPI:UniProtKB
Q8TDZ2	MICAL1	Protein-methionine sulfoxide oxidase MICAL1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TDZ2	MICAL1	Protein-methionine sulfoxide oxidase MICAL1	GO:0030042; P:actin filament depolymerization; IDA:UniProtKB
Q8TDZ2	MICAL1	Protein-methionine sulfoxide oxidase MICAL1	GO:0007010; P:cytoskeleton organization; NAS:UniProtKB
Q8TDZ2	MICAL1	Protein-methionine sulfoxide oxidase MICAL1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q8TDZ2	MICAL1	Protein-methionine sulfoxide oxidase MICAL1	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
Q8TDZ2	MICAL1	Protein-methionine sulfoxide oxidase MICAL1	GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl
Q8TDZ2	MICAL1	Protein-methionine sulfoxide oxidase MICAL1	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q8TDZ2	MICAL1	Protein-methionine sulfoxide oxidase MICAL1	GO:0007165; P:signal transduction; NAS:UniProtKB
Q8TDZ2	MICAL1	Protein-methionine sulfoxide oxidase MICAL1	GO:0019417; P:sulfur oxidation; ISS:UniProtKB
O94851	MICAL2	Protein-methionine sulfoxide oxidase MICAL2	GO:0003779; F:actin binding; ISS:UniProtKB
O94851	MICAL2	Protein-methionine sulfoxide oxidase MICAL2	GO:0071949; F:FAD binding; ISS:UniProtKB
O94851	MICAL2	Protein-methionine sulfoxide oxidase MICAL2	GO:0016709; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; ISS:UniProtKB
O94851	MICAL2	Protein-methionine sulfoxide oxidase MICAL2	GO:0008270; F:zinc ion binding; IEA:InterPro
O94851	MICAL2	Protein-methionine sulfoxide oxidase MICAL2	GO:0030042; P:actin filament depolymerization; ISS:UniProtKB
O94851	MICAL2	Protein-methionine sulfoxide oxidase MICAL2	GO:0055114; P:oxidation-reduction process; ISS:UniProtKB
O94851	MICAL2	Protein-methionine sulfoxide oxidase MICAL2	GO:0019417; P:sulfur oxidation; ISS:UniProtKB
Q7RTP6	MICAL3	Protein-methionine sulfoxide oxidase MICAL3	GO:0003779; F:actin binding; ISS:UniProtKB
Q7RTP6	MICAL3	Protein-methionine sulfoxide oxidase MICAL3	GO:0071949; F:FAD binding; ISS:UniProtKB
Q7RTP6	MICAL3	Protein-methionine sulfoxide oxidase MICAL3	GO:0016709; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; ISS:UniProtKB
Q7RTP6	MICAL3	Protein-methionine sulfoxide oxidase MICAL3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q7RTP6	MICAL3	Protein-methionine sulfoxide oxidase MICAL3	GO:0030042; P:actin filament depolymerization; ISS:UniProtKB
Q7RTP6	MICAL3	Protein-methionine sulfoxide oxidase MICAL3	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q7RTP6	MICAL3	Protein-methionine sulfoxide oxidase MICAL3	GO:0055114; P:oxidation-reduction process; ISS:UniProtKB
Q29983	MICA	MHC class I polypeptide-related sequence A	GO:0003823; F:antigen binding; IBA:RefGenome
Q29983	MICA	MHC class I polypeptide-related sequence A	GO:0046703; F:natural killer cell lectin-like receptor binding; IDA:UniProtKB
Q29983	MICA	MHC class I polypeptide-related sequence A	GO:0005515; F:protein binding; IPI:IntAct
Q29983	MICA	MHC class I polypeptide-related sequence A	GO:0019882; P:antigen processing and presentation; IBA:RefGenome
Q29983	MICA	MHC class I polypeptide-related sequence A	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q29983	MICA	MHC class I polypeptide-related sequence A	GO:0019835; P:cytolysis; IEA:UniProtKB-KW
Q29983	MICA	MHC class I polypeptide-related sequence A	GO:0042742; P:defense response to bacterium; IDA:UniProtKB
Q29983	MICA	MHC class I polypeptide-related sequence A	GO:0051607; P:defense response to virus; IDA:UniProtKB
Q29983	MICA	MHC class I polypeptide-related sequence A	GO:0046629; P:gamma-delta T cell activation; IDA:UniProtKB
Q29983	MICA	MHC class I polypeptide-related sequence A	GO:0002418; P:immune response to tumor cell; IDA:UniProtKB
Q29983	MICA	MHC class I polypeptide-related sequence A	GO:0042267; P:natural killer cell mediated cytotoxicity; IDA:UniProtKB
Q29983	MICA	MHC class I polypeptide-related sequence A	GO:0009408; P:response to heat; IDA:UniProtKB
Q29983	MICA	MHC class I polypeptide-related sequence A	GO:0001913; P:T cell mediated cytotoxicity; IDA:UniProtKB
Q29983	MICA	MHC class I polypeptide-related sequence A	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q29980	MICB	MHC class I polypeptide-related sequence B	GO:0003823; F:antigen binding; IBA:RefGenome
Q29980	MICB	MHC class I polypeptide-related sequence B	GO:0046703; F:natural killer cell lectin-like receptor binding; IDA:UniProtKB
Q29980	MICB	MHC class I polypeptide-related sequence B	GO:0019882; P:antigen processing and presentation; IBA:RefGenome
Q29980	MICB	MHC class I polypeptide-related sequence B	GO:0019835; P:cytolysis; IEA:UniProtKB-KW
Q29980	MICB	MHC class I polypeptide-related sequence B	GO:0046629; P:gamma-delta T cell activation; IDA:UniProtKB
Q29980	MICB	MHC class I polypeptide-related sequence B	GO:0002429; P:immune response-activating cell surface receptor signaling pathway; IDA:UniProtKB
Q29980	MICB	MHC class I polypeptide-related sequence B	GO:0042267; P:natural killer cell mediated cytotoxicity; IBA:RefGenome
Q29980	MICB	MHC class I polypeptide-related sequence B	GO:0050689; P:negative regulation of defense response to virus by host; IDA:UniProtKB
Q29980	MICB	MHC class I polypeptide-related sequence B	GO:0050776; P:regulation of immune response; TAS:Reactome
Q29980	MICB	MHC class I polypeptide-related sequence B	GO:0009408; P:response to heat; IDA:UniProtKB
Q29980	MICB	MHC class I polypeptide-related sequence B	GO:0006979; P:response to oxidative stress; IDA:UniProtKB
Q29980	MICB	MHC class I polypeptide-related sequence B	GO:0032526; P:response to retinoic acid; IDA:UniProtKB
Q29980	MICB	MHC class I polypeptide-related sequence B	GO:0001913; P:T cell mediated cytotoxicity; IBA:RefGenome
Q29980	MICB	MHC class I polypeptide-related sequence B	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q6ZW33	MICALCL	MICAL C-terminal-like protein	GO:0051019; F:mitogen-activated protein kinase binding; ISS:UniProtKB
Q6ZW33	MICALCL	MICAL C-terminal-like protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q6ZW33	MICALCL	MICAL C-terminal-like protein	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q6ZW33	MICALCL	MICAL C-terminal-like protein	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q9BPX6	MICU1	Calcium uptake protein 1, mitochondrial	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q9BPX6	MICU1	Calcium uptake protein 1, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BPX6	MICU1	Calcium uptake protein 1, mitochondrial	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q9BPX6	MICU1	Calcium uptake protein 1, mitochondrial	GO:0070509; P:calcium ion import; IDA:UniProtKB
Q9BPX6	MICU1	Calcium uptake protein 1, mitochondrial	GO:0006952; P:defense response; TAS:ProtInc
Q9BPX6	MICU1	Calcium uptake protein 1, mitochondrial	GO:0051560; P:mitochondrial calcium ion homeostasis; IMP:UniProtKB
Q9BPX6	MICU1	Calcium uptake protein 1, mitochondrial	GO:0006851; P:mitochondrial calcium ion transport; IDA:UniProtKB
Q9BPX6	MICU1	Calcium uptake protein 1, mitochondrial	GO:0051561; P:positive regulation of mitochondrial calcium ion concentration; IDA:UniProtKB
Q9BPX6	MICU1	Calcium uptake protein 1, mitochondrial	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
Q8IYU8	MICU2	Calcium uptake protein 2, mitochondrial	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8IYU8	MICU2	Calcium uptake protein 2, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IYU8	MICU2	Calcium uptake protein 2, mitochondrial	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q8IYU8	MICU2	Calcium uptake protein 2, mitochondrial	GO:0006851; P:mitochondrial calcium ion transport; IDA:UniProtKB
Q8IYU8	MICU2	Calcium uptake protein 2, mitochondrial	GO:0051562; P:negative regulation of mitochondrial calcium ion concentration; IDA:UniProtKB
Q8IYU8	MICU2	Calcium uptake protein 2, mitochondrial	GO:0051561; P:positive regulation of mitochondrial calcium ion concentration; IEA:Ensembl
Q86XE3	MICU3	Calcium uptake protein 3, mitochondrial	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96C03	MIEF2	Mitochondrial dynamics protein MID49	GO:0005515; F:protein binding; IPI:UniProtKB
Q96C03	MIEF2	Mitochondrial dynamics protein MID49	GO:0007005; P:mitochondrion organization; IDA:UniProtKB
Q96C03	MIEF2	Mitochondrial dynamics protein MID49	GO:0090141; P:positive regulation of mitochondrial fission; IDA:UniProtKB
Q96C03	MIEF2	Mitochondrial dynamics protein MID49	GO:0032464; P:positive regulation of protein homooligomerization; IDA:UniProtKB
Q96C03	MIEF2	Mitochondrial dynamics protein MID49	GO:0090314; P:positive regulation of protein targeting to membrane; IDA:UniProtKB
Q9NQG6	MIEF1	Mitochondrial dynamics protein MID51	GO:0042802; F:identical protein binding; IPI:IntAct
Q9NQG6	MIEF1	Mitochondrial dynamics protein MID51	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
Q9NQG6	MIEF1	Mitochondrial dynamics protein MID51	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NQG6	MIEF1	Mitochondrial dynamics protein MID51	GO:0000266; P:mitochondrial fission; IMP:UniProtKB
Q9NQG6	MIEF1	Mitochondrial dynamics protein MID51	GO:0090141; P:positive regulation of mitochondrial fission; IDA:UniProtKB
Q9NQG6	MIEF1	Mitochondrial dynamics protein MID51	GO:0090314; P:positive regulation of protein targeting to membrane; IDA:UniProtKB
Q8TC71	SPATA18	Mitochondria-eating protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TC71	SPATA18	Mitochondria-eating protein	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q8TC71	SPATA18	Mitochondria-eating protein	GO:0035694; P:mitochondrial protein catabolic process; IMP:UniProtKB
Q8TC71	SPATA18	Mitochondria-eating protein	GO:0035695; P:mitochondrion degradation by induced vacuole formation; IMP:UniProtKB
Q9BRT3	MIEN1	Migration and invasion enhancer 1	GO:0008430; F:selenium binding; IEA:InterPro
Q9BRT3	MIEN1	Migration and invasion enhancer 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9BRT3	MIEN1	Migration and invasion enhancer 1	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q9BRT3	MIEN1	Migration and invasion enhancer 1	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q9BRT3	MIEN1	Migration and invasion enhancer 1	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
Q9BRT3	MIEN1	Migration and invasion enhancer 1	GO:0051491; P:positive regulation of filopodium assembly; IDA:UniProtKB
Q8N108	MIER1	Mesoderm induction early response protein 1	GO:0003682; F:chromatin binding; IEA:InterPro
Q8N108	MIER1	Mesoderm induction early response protein 1	GO:0003677; F:DNA binding; IEA:InterPro
Q8N108	MIER1	Mesoderm induction early response protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q8N108	MIER1	Mesoderm induction early response protein 1	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q8N108	MIER1	Mesoderm induction early response protein 1	GO:0031937; P:positive regulation of chromatin silencing; IDA:UniProtKB
Q8N108	MIER1	Mesoderm induction early response protein 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q8N108	MIER1	Mesoderm induction early response protein 1	GO:0007165; P:signal transduction; IMP:GOC
Q8N108	MIER1	Mesoderm induction early response protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N344	MIER2	Mesoderm induction early response protein 2	GO:0003682; F:chromatin binding; IEA:InterPro
Q8N344	MIER2	Mesoderm induction early response protein 2	GO:0003677; F:DNA binding; IEA:InterPro
Q8N344	MIER2	Mesoderm induction early response protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N344	MIER2	Mesoderm induction early response protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z3K6	MIER3	Mesoderm induction early response protein 3	GO:0003682; F:chromatin binding; IEA:InterPro
Q7Z3K6	MIER3	Mesoderm induction early response protein 3	GO:0003677; F:DNA binding; IEA:InterPro
Q7Z3K6	MIER3	Mesoderm induction early response protein 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z3K6	MIER3	Mesoderm induction early response protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P14174	MIF	Macrophage migration inhibitory factor	GO:0042056; F:chemoattractant activity; IDA:BHF-UCL
P14174	MIF	Macrophage migration inhibitory factor	GO:0005125; F:cytokine activity; IDA:UniProtKB
P14174	MIF	Macrophage migration inhibitory factor	GO:0005126; F:cytokine receptor binding; IPI:BHF-UCL
P14174	MIF	Macrophage migration inhibitory factor	GO:0004167; F:dopachrome isomerase activity; IDA:UniProtKB
P14174	MIF	Macrophage migration inhibitory factor	GO:0050178; F:phenylpyruvate tautomerase activity; IDA:MGI
P14174	MIF	Macrophage migration inhibitory factor	GO:0005515; F:protein binding; IPI:UniProtKB
P14174	MIF	Macrophage migration inhibitory factor	GO:0005102; F:receptor binding; IPI:BHF-UCL
P14174	MIF	Macrophage migration inhibitory factor	GO:0019752; P:carboxylic acid metabolic process; IDA:BHF-UCL
P14174	MIF	Macrophage migration inhibitory factor	GO:0007569; P:cell aging; IEA:Ensembl
P14174	MIF	Macrophage migration inhibitory factor	GO:0008283; P:cell proliferation; IDA:UniProtKB
P14174	MIF	Macrophage migration inhibitory factor	GO:0007166; P:cell surface receptor signaling pathway; IDA:UniProtKB
P14174	MIF	Macrophage migration inhibitory factor	GO:0030330; P:DNA damage response, signal transduction by p53 class mediator; IEA:Ensembl
P14174	MIF	Macrophage migration inhibitory factor	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
P14174	MIF	Macrophage migration inhibitory factor	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
P14174	MIF	Macrophage migration inhibitory factor	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P14174	MIF	Macrophage migration inhibitory factor	GO:0090344; P:negative regulation of cell aging; IDA:BHF-UCL
P14174	MIF	Macrophage migration inhibitory factor	GO:0071157; P:negative regulation of cell cycle arrest; IDA:BHF-UCL
P14174	MIF	Macrophage migration inhibitory factor	GO:0032269; P:negative regulation of cellular protein metabolic process; IEA:Ensembl
P14174	MIF	Macrophage migration inhibitory factor	GO:0043518; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; IDA:BHF-UCL
P14174	MIF	Macrophage migration inhibitory factor	GO:0010629; P:negative regulation of gene expression; IDA:BHF-UCL
P14174	MIF	Macrophage migration inhibitory factor	GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IDA:BHF-UCL
P14174	MIF	Macrophage migration inhibitory factor	GO:0002906; P:negative regulation of mature B cell apoptotic process; IEA:Ensembl
P14174	MIF	Macrophage migration inhibitory factor	GO:0033033; P:negative regulation of myeloid cell apoptotic process; IEA:Ensembl
P14174	MIF	Macrophage migration inhibitory factor	GO:0050918; P:positive chemotaxis; IDA:GOC
P14174	MIF	Macrophage migration inhibitory factor	GO:0090238; P:positive regulation of arachidonic acid secretion; IEA:Ensembl
P14174	MIF	Macrophage migration inhibitory factor	GO:0030890; P:positive regulation of B cell proliferation; IDA:BHF-UCL
P14174	MIF	Macrophage migration inhibitory factor	GO:2000343; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; IEA:Ensembl
P14174	MIF	Macrophage migration inhibitory factor	GO:0050715; P:positive regulation of cytokine secretion; IDA:BHF-UCL
P14174	MIF	Macrophage migration inhibitory factor	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL
P14174	MIF	Macrophage migration inhibitory factor	GO:0048146; P:positive regulation of fibroblast proliferation; IDA:BHF-UCL
P14174	MIF	Macrophage migration inhibitory factor	GO:0031666; P:positive regulation of lipopolysaccharide-mediated signaling pathway; IEA:Ensembl
P14174	MIF	Macrophage migration inhibitory factor	GO:0043406; P:positive regulation of MAP kinase activity; IEA:Ensembl
P14174	MIF	Macrophage migration inhibitory factor	GO:0061081; P:positive regulation of myeloid leukocyte cytokine production involved in immune response; IEA:Ensembl
P14174	MIF	Macrophage migration inhibitory factor	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:BHF-UCL
P14174	MIF	Macrophage migration inhibitory factor	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL
P14174	MIF	Macrophage migration inhibitory factor	GO:0042327; P:positive regulation of phosphorylation; IDA:BHF-UCL
P14174	MIF	Macrophage migration inhibitory factor	GO:0061078; P:positive regulation of prostaglandin secretion involved in immune response; IEA:Ensembl
P14174	MIF	Macrophage migration inhibitory factor	GO:0010739; P:positive regulation of protein kinase A signaling; IDA:BHF-UCL
P14174	MIF	Macrophage migration inhibitory factor	GO:0001516; P:prostaglandin biosynthetic process; IDA:UniProtKB
P14174	MIF	Macrophage migration inhibitory factor	GO:0070207; P:protein homotrimerization; IPI:UniProtKB
P14174	MIF	Macrophage migration inhibitory factor	GO:0043030; P:regulation of macrophage activation; NAS:UniProtKB
Q8N3F8	MICALL1	MICAL-like protein 1	GO:0042802; F:identical protein binding; IPI:UniProtKB
Q8N3F8	MICALL1	MICAL-like protein 1	GO:0070300; F:phosphatidic acid binding; IDA:UniProtKB
Q8N3F8	MICALL1	MICAL-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N3F8	MICALL1	MICAL-like protein 1	GO:0017137; F:Rab GTPase binding; IPI:UniProtKB
Q8N3F8	MICALL1	MICAL-like protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N3F8	MICALL1	MICAL-like protein 1	GO:0006897; P:endocytosis; IMP:UniProtKB
Q8N3F8	MICALL1	MICAL-like protein 1	GO:0097320; P:membrane tubulation; IDA:UniProtKB
Q8N3F8	MICALL1	MICAL-like protein 1	GO:0031175; P:neuron projection development; ISS:UniProtKB
Q8N3F8	MICALL1	MICAL-like protein 1	GO:0036010; P:protein localization to endosome; IMP:UniProtKB
Q8N3F8	MICALL1	MICAL-like protein 1	GO:0006612; P:protein targeting to membrane; IMP:UniProtKB
Q8N3F8	MICALL1	MICAL-like protein 1	GO:0006898; P:receptor-mediated endocytosis; IMP:UniProtKB
Q8N3F8	MICALL1	MICAL-like protein 1	GO:1990126; P:retrograde transport, endosome to plasma membrane; IMP:UniProtKB
Q8N3F8	MICALL1	MICAL-like protein 1	GO:0032458; P:slow endocytic recycling; IMP:UniProtKB
Q8IY33	MICALL2	MICAL-like protein 2	GO:0051015; F:actin filament binding; ISS:UniProtKB
Q8IY33	MICALL2	MICAL-like protein 2	GO:0031005; F:filamin binding; IDA:UniProtKB
Q8IY33	MICALL2	MICAL-like protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IY33	MICALL2	MICAL-like protein 2	GO:0031532; P:actin cytoskeleton reorganization; ISS:UniProtKB
Q8IY33	MICALL2	MICAL-like protein 2	GO:0030041; P:actin filament polymerization; ISS:UniProtKB
Q8IY33	MICALL2	MICAL-like protein 2	GO:0032456; P:endocytic recycling; ISS:UniProtKB
Q8IY33	MICALL2	MICAL-like protein 2	GO:0031175; P:neuron projection development; ISS:UniProtKB
Q8IY33	MICALL2	MICAL-like protein 2	GO:0034446; P:substrate adhesion-dependent cell spreading; ISS:UniProtKB
Q8IY33	MICALL2	MICAL-like protein 2	GO:0070830; P:tight junction assembly; ISS:UniProtKB
Q7Z6M3	MILR1	Allergin-1	GO:0043303; P:mast cell degranulation; ISS:UniProtKB
Q7Z6M3	MILR1	Allergin-1	GO:0033004; P:negative regulation of mast cell activation; ISS:UniProtKB
P20774	OGN	Mimecan	GO:0005515; F:protein binding; IPI:IntAct
P20774	OGN	Mimecan	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P20774	OGN	Mimecan	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P20774	OGN	Mimecan	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
P20774	OGN	Mimecan	GO:0042340; P:keratan sulfate catabolic process; TAS:Reactome
P20774	OGN	Mimecan	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
P20774	OGN	Mimecan	GO:0048662; P:negative regulation of smooth muscle cell proliferation; ISS:UniProtKB
P20774	OGN	Mimecan	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8N183	NDUFAF2	Mimitin, mitochondrial	GO:0061179; P:negative regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl
Q8IUF8	MINA	Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA	GO:0051213; F:dioxygenase activity; IEA:UniProtKB-KW
Q8IUF8	MINA	Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IUF8	MINA	Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA	GO:0001191; F:RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription; IEA:Ensembl
Q8IUF8	MINA	Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA	GO:0042254; P:ribosome biogenesis; IEA:UniProtKB-KW
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:0005524; F:ATP binding; ISS:UniProtKB
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:0005083; F:small GTPase regulator activity; IEA:InterPro
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:0031532; P:actin cytoskeleton reorganization; IMP:UniProtKB
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:0048813; P:dendrite morphogenesis; ISS:UniProtKB
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:0035556; P:intracellular signal transduction; ISS:UniProtKB
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:0007254; P:JNK cascade; TAS:ProtInc
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:0007275; P:multicellular organismal development; ISS:UniProtKB
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:0045060; P:negative thymic T cell selection; IEA:Ensembl
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:0046330; P:positive regulation of JNK cascade; IMP:UniProtKB
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:2000311; P:regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; ISS:UniProtKB
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:0030334; P:regulation of cell migration; IMP:UniProtKB
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:0022407; P:regulation of cell-cell adhesion; IMP:UniProtKB
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:0001952; P:regulation of cell-matrix adhesion; IMP:UniProtKB
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:0006950; P:response to stress; ISS:UniProtKB
Q8N4C8	MINK1	Misshapen-like kinase 1	GO:0007268; P:synaptic transmission; ISS:UniProtKB
Q9UNW1	MINPP1	Multiple inositol polyphosphate phosphatase 1	GO:0003993; F:acid phosphatase activity; IEA:InterPro
Q9UNW1	MINPP1	Multiple inositol polyphosphate phosphatase 1	GO:0034417; F:bisphosphoglycerate 3-phosphatase activity; IDA:BHF-UCL
Q9UNW1	MINPP1	Multiple inositol polyphosphate phosphatase 1	GO:0052826; F:inositol hexakisphosphate 2-phosphatase activity; IEA:UniProtKB-EC
Q9UNW1	MINPP1	Multiple inositol polyphosphate phosphatase 1	GO:0008969; F:phosphohistidine phosphatase activity; TAS:ProtInc
Q9UNW1	MINPP1	Multiple inositol polyphosphate phosphatase 1	GO:0030282; P:bone mineralization; NAS:UniProtKB
Q9UNW1	MINPP1	Multiple inositol polyphosphate phosphatase 1	GO:0016311; P:dephosphorylation; IDA:GOC
Q9UNW1	MINPP1	Multiple inositol polyphosphate phosphatase 1	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q9UNW1	MINPP1	Multiple inositol polyphosphate phosphatase 1	GO:0001503; P:ossification; NAS:UniProtKB
Q9UNW1	MINPP1	Multiple inositol polyphosphate phosphatase 1	GO:0006797; P:polyphosphate metabolic process; TAS:ProtInc
Q9UNW1	MINPP1	Multiple inositol polyphosphate phosphatase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96T58	SPEN	Msx2-interacting protein	GO:0000166; F:nucleotide binding; IEA:InterPro
Q96T58	SPEN	Msx2-interacting protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96T58	SPEN	Msx2-interacting protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q96T58	SPEN	Msx2-interacting protein	GO:0001085; F:RNA polymerase II transcription factor binding; IPI:BHF-UCL
Q96T58	SPEN	Msx2-interacting protein	GO:0001191; F:RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription; IDA:BHF-UCL
Q96T58	SPEN	Msx2-interacting protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q96T58	SPEN	Msx2-interacting protein	GO:0003697; F:single-stranded DNA binding; IEA:Ensembl
Q96T58	SPEN	Msx2-interacting protein	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
Q96T58	SPEN	Msx2-interacting protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q96T58	SPEN	Msx2-interacting protein	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q96T58	SPEN	Msx2-interacting protein	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
Q96T58	SPEN	Msx2-interacting protein	GO:0050769; P:positive regulation of neurogenesis; IMP:BHF-UCL
Q96T58	SPEN	Msx2-interacting protein	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q96T58	SPEN	Msx2-interacting protein	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9UGB7	MIOX	Inositol oxygenase	GO:0004033; F:aldo-keto reductase (NADP) activity; ISS:UniProtKB
Q9UGB7	MIOX	Inositol oxygenase	GO:0008199; F:ferric iron binding; IDA:UniProtKB
Q9UGB7	MIOX	Inositol oxygenase	GO:0050113; F:inositol oxygenase activity; IDA:UniProtKB
Q9UGB7	MIOX	Inositol oxygenase	GO:0050661; F:NADP binding; IEA:Ensembl
Q9UGB7	MIOX	Inositol oxygenase	GO:0016651; F:oxidoreductase activity, acting on NAD(P)H; IEA:Ensembl
Q9UGB7	MIOX	Inositol oxygenase	GO:0016701; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen; ISS:UniProtKB
Q9UGB7	MIOX	Inositol oxygenase	GO:0019310; P:inositol catabolic process; IDA:UniProtKB
Q9Y3D0	FAM96B	Mitotic spindle-associated MMXD complex subunit MIP18	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y3D0	FAM96B	Mitotic spindle-associated MMXD complex subunit MIP18	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q9Y3D0	FAM96B	Mitotic spindle-associated MMXD complex subunit MIP18	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99797	MIPEP	Mitochondrial intermediate peptidase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q99797	MIPEP	Mitochondrial intermediate peptidase	GO:0004222; F:metalloendopeptidase activity; TAS:ProtInc
Q99797	MIPEP	Mitochondrial intermediate peptidase	GO:0006627; P:protein processing involved in protein targeting to mitochondrion; TAS:ProtInc
Q8TDR0	TRAF3IP1	TRAF3-interacting protein 1	GO:0005515; F:protein binding; IPI:IntAct
P30301	MIP	Lens fiber major intrinsic protein	GO:0005516; F:calmodulin binding; ISS:UniProtKB
P30301	MIP	Lens fiber major intrinsic protein	GO:0005212; F:structural constituent of eye lens; IEA:UniProtKB-KW
P30301	MIP	Lens fiber major intrinsic protein	GO:0005215; F:transporter activity; TAS:ProtInc
P30301	MIP	Lens fiber major intrinsic protein	GO:0015250; F:water channel activity; ISS:UniProtKB
P30301	MIP	Lens fiber major intrinsic protein	GO:0015722; P:canalicular bile acid transport; IEA:Ensembl
P30301	MIP	Lens fiber major intrinsic protein	GO:0002088; P:lens development in camera-type eye; IEA:Ensembl
P30301	MIP	Lens fiber major intrinsic protein	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
P30301	MIP	Lens fiber major intrinsic protein	GO:0055085; P:transmembrane transport; TAS:Reactome
P30301	MIP	Lens fiber major intrinsic protein	GO:0007601; P:visual perception; IEA:UniProtKB-KW
P30301	MIP	Lens fiber major intrinsic protein	GO:0006833; P:water transport; ISS:UniProtKB
Q8IXI2	RHOT1	Mitochondrial Rho GTPase 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8IXI2	RHOT1	Mitochondrial Rho GTPase 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q8IXI2	RHOT1	Mitochondrial Rho GTPase 1	GO:0003924; F:GTPase activity; IEA:InterPro
Q8IXI2	RHOT1	Mitochondrial Rho GTPase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IXI2	RHOT1	Mitochondrial Rho GTPase 1	GO:0019725; P:cellular homeostasis; IMP:UniProtKB
Q8IXI2	RHOT1	Mitochondrial Rho GTPase 1	GO:0097345; P:mitochondrial outer membrane permeabilization; IMP:UniProtKB
Q8IXI2	RHOT1	Mitochondrial Rho GTPase 1	GO:0047497; P:mitochondrion transport along microtubule; IMP:UniProtKB
Q8IXI2	RHOT1	Mitochondrial Rho GTPase 1	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q8IXI2	RHOT1	Mitochondrial Rho GTPase 1	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q8IXI1	RHOT2	Mitochondrial Rho GTPase 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8IXI1	RHOT2	Mitochondrial Rho GTPase 2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q8IXI1	RHOT2	Mitochondrial Rho GTPase 2	GO:0003924; F:GTPase activity; IEA:InterPro
Q8IXI1	RHOT2	Mitochondrial Rho GTPase 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IXI1	RHOT2	Mitochondrial Rho GTPase 2	GO:0019725; P:cellular homeostasis; IMP:UniProtKB
Q8IXI1	RHOT2	Mitochondrial Rho GTPase 2	GO:0097345; P:mitochondrial outer membrane permeabilization; IMP:UniProtKB
Q8IXI1	RHOT2	Mitochondrial Rho GTPase 2	GO:0047497; P:mitochondrion transport along microtubule; IMP:UniProtKB
Q8IXI1	RHOT2	Mitochondrial Rho GTPase 2	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q8IXI1	RHOT2	Mitochondrial Rho GTPase 2	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9H081	MIS12	Protein MIS12 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H081	MIS12	Protein MIS12 homolog	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q9H081	MIS12	Protein MIS12 homolog	GO:0051382; P:kinetochore assembly; IDA:UniProtKB
Q9H081	MIS12	Protein MIS12 homolog	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9H081	MIS12	Protein MIS12 homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8IVT2	MISP	Mitotic interactor and substrate of PLK1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P03971	AMH	Muellerian-inhibiting factor	GO:0005179; F:hormone activity; TAS:ProtInc
P03971	AMH	Muellerian-inhibiting factor	GO:0005102; F:receptor binding; IPI:UniProtKB
P03971	AMH	Muellerian-inhibiting factor	GO:0007568; P:aging; IEA:Ensembl
P03971	AMH	Muellerian-inhibiting factor	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P03971	AMH	Muellerian-inhibiting factor	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P03971	AMH	Muellerian-inhibiting factor	GO:0007506; P:gonadal mesoderm development; IEA:UniProtKB-KW
P03971	AMH	Muellerian-inhibiting factor	GO:0001880; P:Mullerian duct regression; IDA:UniProtKB
P03971	AMH	Muellerian-inhibiting factor	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
P03971	AMH	Muellerian-inhibiting factor	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:Ensembl
P03971	AMH	Muellerian-inhibiting factor	GO:0001546; P:preantral ovarian follicle growth; IEA:Ensembl
P03971	AMH	Muellerian-inhibiting factor	GO:0042493; P:response to drug; IEA:Ensembl
P03971	AMH	Muellerian-inhibiting factor	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P03971	AMH	Muellerian-inhibiting factor	GO:0007530; P:sex determination; TAS:ProtInc
P03971	AMH	Muellerian-inhibiting factor	GO:0007548; P:sex differentiation; TAS:UniProtKB
P03971	AMH	Muellerian-inhibiting factor	GO:0001655; P:urogenital system development; IEA:Ensembl
Q8WV92	MITD1	MIT domain-containing protein 1	GO:0035091; F:phosphatidylinositol binding; IMP:UniProt
Q8WV92	MITD1	MIT domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q8WV92	MITD1	MIT domain-containing protein 1	GO:0019904; F:protein domain specific binding; IPI:UniProt
Q8WV92	MITD1	MIT domain-containing protein 1	GO:0042803; F:protein homodimerization activity; IMP:UniProt
Q8WV92	MITD1	MIT domain-containing protein 1	GO:0000920; P:cytokinetic cell separation; IMP:UniProtKB
Q8WV92	MITD1	MIT domain-containing protein 1	GO:0000281; P:mitotic cytokinesis; IMP:UniProtKB
Q8WV92	MITD1	MIT domain-containing protein 1	GO:1902409; P:mitotic cytokinetic cell separation; IMP:UniProt
Q8WV92	MITD1	MIT domain-containing protein 1	GO:0032091; P:negative regulation of protein binding; IMP:UniProt
Q8WV92	MITD1	MIT domain-containing protein 1	GO:0006810; P:transport; IEA:UniProtKB-KW
O75030	MITF	Microphthalmia-associated transcription factor	GO:0003682; F:chromatin binding; IEA:Ensembl
O75030	MITF	Microphthalmia-associated transcription factor	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O75030	MITF	Microphthalmia-associated transcription factor	GO:0005515; F:protein binding; IPI:UniProtKB
O75030	MITF	Microphthalmia-associated transcription factor	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:UniProtKB
O75030	MITF	Microphthalmia-associated transcription factor	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
O75030	MITF	Microphthalmia-associated transcription factor	GO:0046849; P:bone remodeling; IEA:Ensembl
O75030	MITF	Microphthalmia-associated transcription factor	GO:0043010; P:camera-type eye development; IEA:Ensembl
O75030	MITF	Microphthalmia-associated transcription factor	GO:0044336; P:canonical Wnt signaling pathway involved in negative regulation of apoptotic process; IEA:Ensembl
O75030	MITF	Microphthalmia-associated transcription factor	GO:0045165; P:cell fate commitment; IEA:Ensembl
O75030	MITF	Microphthalmia-associated transcription factor	GO:0030318; P:melanocyte differentiation; NAS:UniProtKB
O75030	MITF	Microphthalmia-associated transcription factor	GO:0030316; P:osteoclast differentiation; IEA:Ensembl
O75030	MITF	Microphthalmia-associated transcription factor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O75030	MITF	Microphthalmia-associated transcription factor	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O75030	MITF	Microphthalmia-associated transcription factor	GO:0006461; P:protein complex assembly; IDA:UniProtKB
O75030	MITF	Microphthalmia-associated transcription factor	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
O75030	MITF	Microphthalmia-associated transcription factor	GO:0045670; P:regulation of osteoclast differentiation; IEA:Ensembl
O75030	MITF	Microphthalmia-associated transcription factor	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9H2W2	MIXL1	Homeobox protein MIXL1	GO:0000987; F:core promoter proximal region sequence-specific DNA binding; ISS:BHF-UCL
Q9H2W2	MIXL1	Homeobox protein MIXL1	GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
Q9H2W2	MIXL1	Homeobox protein MIXL1	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; ISS:BHF-UCL
Q9H2W2	MIXL1	Homeobox protein MIXL1	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; ISS:BHF-UCL
Q9H2W2	MIXL1	Homeobox protein MIXL1	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; ISS:BHF-UCL
Q9H2W2	MIXL1	Homeobox protein MIXL1	GO:0001205; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; ISS:BHF-UCL
Q9H2W2	MIXL1	Homeobox protein MIXL1	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:BHF-UCL
Q9H2W2	MIXL1	Homeobox protein MIXL1	GO:0001085; F:RNA polymerase II transcription factor binding; ISS:BHF-UCL
Q9H2W2	MIXL1	Homeobox protein MIXL1	GO:0001190; F:RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription; ISS:BHF-UCL
Q9H2W2	MIXL1	Homeobox protein MIXL1	GO:0042074; P:cell migration involved in gastrulation; IEA:Ensembl
Q9H2W2	MIXL1	Homeobox protein MIXL1	GO:0048565; P:digestive tract development; ISS:BHF-UCL
Q9H2W2	MIXL1	Homeobox protein MIXL1	GO:0007492; P:endoderm development; ISS:BHF-UCL
Q9H2W2	MIXL1	Homeobox protein MIXL1	GO:0035987; P:endodermal cell differentiation; ISS:BHF-UCL
Q9H2W2	MIXL1	Homeobox protein MIXL1	GO:0007369; P:gastrulation; ISS:BHF-UCL
Q9H2W2	MIXL1	Homeobox protein MIXL1	GO:0007507; P:heart development; ISS:BHF-UCL
Q9H2W2	MIXL1	Homeobox protein MIXL1	GO:0002244; P:hematopoietic progenitor cell differentiation; ISS:BHF-UCL
Q9H2W2	MIXL1	Homeobox protein MIXL1	GO:1901533; P:negative regulation of hematopoietic progenitor cell differentiation; ISS:BHF-UCL
Q9H2W2	MIXL1	Homeobox protein MIXL1	GO:2000382; P:positive regulation of mesoderm development; ISS:BHF-UCL
Q9H2W2	MIXL1	Homeobox protein MIXL1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0004707; F:MAP kinase activity; TAS:ProtInc
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0019902; F:phosphatase binding; IPI:UniProtKB
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0005515; F:protein binding; IPI:UniProtKB
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0008353; F:RNA polymerase II carboxy-terminal domain kinase activity; ISS:UniProtKB
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0000187; P:activation of MAPK activity; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0000186; P:activation of MAPKK activity; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0006915; P:apoptotic process; TAS:ProtInc
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0007411; P:axon guidance; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0050853; P:B cell receptor signaling pathway; IEA:Ensembl
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0007596; P:blood coagulation; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0072584; P:caveolin-mediated endocytosis; TAS:UniProtKB
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0006974; P:cellular response to DNA damage stimulus; IEA:Ensembl
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0006935; P:chemotaxis; TAS:ProtInc
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0019858; P:cytosine metabolic process; IEA:Ensembl
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0038127; P:ERBB signaling pathway; IDA:UniProtKB
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0070371; P:ERK1 and ERK2 cascade; IDA:UniProtKB
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0045087; P:innate immune response; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IEA:Ensembl
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0033598; P:mammary gland epithelial cell proliferation; IEA:Ensembl
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0000165; P:MAPK cascade; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0000189; P:MAPK import into nucleus; IEA:Ensembl
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0045596; P:negative regulation of cell differentiation; IEA:Ensembl
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0009887; P:organ morphogenesis; IEA:Ensembl
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0018107; P:peptidyl-threonine phosphorylation; ISS:UniProtKB
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0030168; P:platelet activation; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IDA:UniProtKB
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0045727; P:positive regulation of translation; IEA:Ensembl
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0051493; P:regulation of cytoskeleton organization; TAS:UniProtKB
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:2000641; P:regulation of early endosome to late endosome transport; TAS:UniProtKB
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0090170; P:regulation of Golgi inheritance; TAS:UniProtKB
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0031647; P:regulation of protein stability; ISS:UniProtKB
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0032872; P:regulation of stress-activated MAPK cascade; TAS:UniProtKB
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0070849; P:response to epidermal growth factor; IDA:UniProtKB
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0043627; P:response to estrogen; IEA:Ensembl
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0043330; P:response to exogenous dsRNA; IEA:Ensembl
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0006950; P:response to stress; TAS:ProtInc
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0009636; P:response to toxic substance; IEA:Ensembl
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0007165; P:signal transduction; TAS:ProtInc
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0007268; P:synaptic transmission; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0050852; P:T cell receptor signaling pathway; IEA:Ensembl
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P28482	MAPK1	Mitogen-activated protein kinase 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0004707; F:MAP kinase activity; IDA:UniProtKB
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0019902; F:phosphatase binding; IPI:UniProtKB
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0005515; F:protein binding; IPI:UniProtKB
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0000187; P:activation of MAPK activity; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0000186; P:activation of MAPKK activity; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0007411; P:axon guidance; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0007596; P:blood coagulation; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0030509; P:BMP signaling pathway; IMP:BHF-UCL
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0051216; P:cartilage development; IEA:Ensembl
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0072584; P:caveolin-mediated endocytosis; TAS:UniProtKB
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0006975; P:DNA damage induced protein phosphorylation; IDA:UniProtKB
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0010467; P:gene expression; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0045087; P:innate immune response; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0070498; P:interleukin-1-mediated signaling pathway; IMP:BHF-UCL
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IEA:Ensembl
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0000165; P:MAPK cascade; NAS:BHF-UCL
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:2000657; P:negative regulation of apolipoprotein binding; IEA:Ensembl
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0009887; P:organ morphogenesis; IEA:Ensembl
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0038083; P:peptidyl-tyrosine autophosphorylation; IDA:UniProtKB
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0016310; P:phosphorylation; IDA:UniProtKB
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0030168; P:platelet activation; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:BHF-UCL
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0035066; P:positive regulation of histone acetylation; IMP:BHF-UCL
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0033129; P:positive regulation of histone phosphorylation; IMP:BHF-UCL
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0001934; P:positive regulation of protein phosphorylation; IMP:BHF-UCL
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0051493; P:regulation of cytoskeleton organization; TAS:UniProtKB
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:2000641; P:regulation of early endosome to late endosome transport; TAS:UniProtKB
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0090170; P:regulation of Golgi inheritance; TAS:UniProtKB
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0032872; P:regulation of stress-activated MAPK cascade; TAS:UniProtKB
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0070849; P:response to epidermal growth factor; IDA:UniProtKB
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0043330; P:response to exogenous dsRNA; IEA:Ensembl
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P27361	MAPK3	Mitogen-activated protein kinase 3	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q16659	MAPK6	Mitogen-activated protein kinase 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q16659	MAPK6	Mitogen-activated protein kinase 6	GO:0004707; F:MAP kinase activity; ISS:UniProtKB
Q16659	MAPK6	Mitogen-activated protein kinase 6	GO:0005515; F:protein binding; IPI:IntAct
Q16659	MAPK6	Mitogen-activated protein kinase 6	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
Q16659	MAPK6	Mitogen-activated protein kinase 6	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q16659	MAPK6	Mitogen-activated protein kinase 6	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
Q16659	MAPK6	Mitogen-activated protein kinase 6	GO:0007165; P:signal transduction; TAS:ProtInc
P31152	MAPK4	Mitogen-activated protein kinase 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P31152	MAPK4	Mitogen-activated protein kinase 4	GO:0004707; F:MAP kinase activity; TAS:ProtInc
P31152	MAPK4	Mitogen-activated protein kinase 4	GO:0005515; F:protein binding; IPI:IntAct
P31152	MAPK4	Mitogen-activated protein kinase 4	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
P31152	MAPK4	Mitogen-activated protein kinase 4	GO:0019901; F:protein kinase binding; ISS:UniProtKB
P31152	MAPK4	Mitogen-activated protein kinase 4	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P31152	MAPK4	Mitogen-activated protein kinase 4	GO:0000165; P:MAPK cascade; TAS:GOC
P31152	MAPK4	Mitogen-activated protein kinase 4	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0004707; F:MAP kinase activity; TAS:ProtInc
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0051019; F:mitogen-activated protein kinase binding; IPI:BHF-UCL
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0019933; P:cAMP-mediated signaling; NAS:BHF-UCL
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0071363; P:cellular response to growth factor stimulus; IGI:BHF-UCL
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0070301; P:cellular response to hydrogen peroxide; IMP:BHF-UCL
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0071499; P:cellular response to laminar fluid shear stress; IMP:BHF-UCL
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IDA:UniProtKB
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0045087; P:innate immune response; TAS:Reactome
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0030821; P:negative regulation of cAMP catabolic process; NAS:BHF-UCL
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0051344; P:negative regulation of cyclic-nucleotide phosphodiesterase activity; NAS:BHF-UCL
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:2000352; P:negative regulation of endothelial cell apoptotic process; IMP:BHF-UCL
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IGI:BHF-UCL
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0034115; P:negative regulation of heterotypic cell-cell adhesion; IGI:BHF-UCL
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0050728; P:negative regulation of inflammatory response; TAS:BHF-UCL
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:1902176; P:negative regulation of intrinsic apoptotic signaling pathway in response to oxidative stress; IMP:BHF-UCL
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0051534; P:negative regulation of NFAT protein import into nucleus; IEA:Ensembl
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0060761; P:negative regulation of response to cytokine stimulus; IGI:BHF-UCL
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0051247; P:positive regulation of protein metabolic process; IGI:BHF-UCL
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IGI:BHF-UCL
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0036003; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; IMP:BHF-UCL
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0045765; P:regulation of angiogenesis; IEA:Ensembl
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0007165; P:signal transduction; TAS:ProtInc
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q13164	MAPK7	Mitogen-activated protein kinase 7	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0035033; F:histone deacetylase regulator activity; IMP:BHF-UCL
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0004705; F:JUN kinase activity; IDA:UniProtKB
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0004707; F:MAP kinase activity; IEA:InterPro
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0005515; F:protein binding; IPI:IntAct
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0006915; P:apoptotic process; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0071222; P:cellular response to lipopolysaccharide; IDA:MGI
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0045087; P:innate immune response; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0007254; P:JNK cascade; IDA:UniProtKB
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0007258; P:JUN phosphorylation; IDA:UniProtKB
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0032091; P:negative regulation of protein binding; IDA:UniProtKB
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0001503; P:ossification; IEA:Ensembl
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0018107; P:peptidyl-threonine phosphorylation; IDA:UniProtKB
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0090045; P:positive regulation of deacetylase activity; IMP:BHF-UCL
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:2000017; P:positive regulation of determination of dorsal identity; IEA:Ensembl
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0031063; P:regulation of histone deacetylation; IMP:GOC
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0032880; P:regulation of protein localization; IDA:BHF-UCL
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0046686; P:response to cadmium ion; IEA:Ensembl
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0006950; P:response to stress; TAS:ProtInc
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0009411; P:response to UV; IDA:MGI
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P45983	MAPK8	Mitogen-activated protein kinase 8	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0004705; F:JUN kinase activity; IDA:UniProtKB
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0005515; F:protein binding; IPI:IntAct
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0008134; F:transcription factor binding; IDA:UniProtKB
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0071347; P:cellular response to interleukin-1; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0034644; P:cellular response to UV; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0007417; P:central nervous system development; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0045087; P:innate immune response; TAS:Reactome
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0007254; P:JNK cascade; IDA:UniProtKB
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0031175; P:neuron projection development; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0010770; P:positive regulation of cell morphogenesis involved in differentiation; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0032722; P:positive regulation of chemokine production; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; IMP:BHF-UCL
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0031394; P:positive regulation of prostaglandin biosynthetic process; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0032308; P:positive regulation of prostaglandin secretion; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0006626; P:protein targeting to mitochondrion; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0046328; P:regulation of JNK cascade; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0031396; P:regulation of protein ubiquitination; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; TAS:Reactome
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0001836; P:release of cytochrome c from mitochondria; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0014075; P:response to amine; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0046686; P:response to cadmium ion; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0042493; P:response to drug; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0006950; P:response to stress; TAS:ProtInc
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0009636; P:response to toxic substance; IEA:Ensembl
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P45984	MAPK9	Mitogen-activated protein kinase 9	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0004707; F:MAP kinase activity; IDA:UniProtKB
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0005515; F:protein binding; IPI:IntAct
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0004674; F:protein serine/threonine kinase activity; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0000187; P:activation of MAPK activity; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0010467; P:gene expression; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0045087; P:innate immune response; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0042692; P:muscle cell differentiation; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0006950; P:response to stress; IDA:UniProtKB
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0007165; P:signal transduction; TAS:ProtInc
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15759	MAPK11	Mitogen-activated protein kinase 11	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P53778	MAPK12	Mitogen-activated protein kinase 12	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P53778	MAPK12	Mitogen-activated protein kinase 12	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
P53778	MAPK12	Mitogen-activated protein kinase 12	GO:0004707; F:MAP kinase activity; TAS:ProtInc
P53778	MAPK12	Mitogen-activated protein kinase 12	GO:0005515; F:protein binding; IPI:UniProtKB
P53778	MAPK12	Mitogen-activated protein kinase 12	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P53778	MAPK12	Mitogen-activated protein kinase 12	GO:0007050; P:cell cycle arrest; TAS:ProtInc
P53778	MAPK12	Mitogen-activated protein kinase 12	GO:0006975; P:DNA damage induced protein phosphorylation; TAS:ProtInc
P53778	MAPK12	Mitogen-activated protein kinase 12	GO:0042692; P:muscle cell differentiation; TAS:Reactome
P53778	MAPK12	Mitogen-activated protein kinase 12	GO:0007517; P:muscle organ development; TAS:ProtInc
P53778	MAPK12	Mitogen-activated protein kinase 12	GO:0045445; P:myoblast differentiation; IDA:UniProtKB
P53778	MAPK12	Mitogen-activated protein kinase 12	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P53778	MAPK12	Mitogen-activated protein kinase 12	GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL
P53778	MAPK12	Mitogen-activated protein kinase 12	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
P53778	MAPK12	Mitogen-activated protein kinase 12	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
P53778	MAPK12	Mitogen-activated protein kinase 12	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P53778	MAPK12	Mitogen-activated protein kinase 12	GO:0007165; P:signal transduction; TAS:ProtInc
P53778	MAPK12	Mitogen-activated protein kinase 12	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0004705; F:JUN kinase activity; ISS:UniProtKB
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0004708; F:MAP kinase kinase activity; TAS:ProtInc
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0005515; F:protein binding; IPI:IntAct
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0000187; P:activation of MAPK activity; TAS:GOC
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0045087; P:innate immune response; TAS:Reactome
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0007254; P:JNK cascade; ISS:UniProtKB
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0007258; P:JUN phosphorylation; ISS:GOC
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; TAS:Reactome
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0007165; P:signal transduction; TAS:ProtInc
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P53779	MAPK10	Mitogen-activated protein kinase 10	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
O15264	MAPK13	Mitogen-activated protein kinase 13	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O15264	MAPK13	Mitogen-activated protein kinase 13	GO:0004707; F:MAP kinase activity; IDA:UniProtKB
O15264	MAPK13	Mitogen-activated protein kinase 13	GO:0005515; F:protein binding; IPI:IntAct
O15264	MAPK13	Mitogen-activated protein kinase 13	GO:0004674; F:protein serine/threonine kinase activity; IDA:BHF-UCL
O15264	MAPK13	Mitogen-activated protein kinase 13	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
O15264	MAPK13	Mitogen-activated protein kinase 13	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
O15264	MAPK13	Mitogen-activated protein kinase 13	GO:0000165; P:MAPK cascade; IDA:GOC
O15264	MAPK13	Mitogen-activated protein kinase 13	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O15264	MAPK13	Mitogen-activated protein kinase 13	GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL
O15264	MAPK13	Mitogen-activated protein kinase 13	GO:0050729; P:positive regulation of inflammatory response; IC:BHF-UCL
O15264	MAPK13	Mitogen-activated protein kinase 13	GO:0032755; P:positive regulation of interleukin-6 production; IMP:BHF-UCL
O15264	MAPK13	Mitogen-activated protein kinase 13	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
O15264	MAPK13	Mitogen-activated protein kinase 13	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O15264	MAPK13	Mitogen-activated protein kinase 13	GO:0006970; P:response to osmotic stress; IDA:UniProtKB
O15264	MAPK13	Mitogen-activated protein kinase 13	GO:0006950; P:response to stress; IDA:UniProtKB
O15264	MAPK13	Mitogen-activated protein kinase 13	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0004707; F:MAP kinase activity; IDA:UniProtKB
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0004708; F:MAP kinase kinase activity; TAS:ProtInc
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0051525; F:NFAT protein binding; ISS:BHF-UCL
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0005515; F:protein binding; IPI:IntAct
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0004674; F:protein serine/threonine kinase activity; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0070935; P:3'-UTR-mediated mRNA stabilization; TAS:UniProtKB
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0000187; P:activation of MAPK activity; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0001525; P:angiogenesis; IEA:Ensembl
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0007596; P:blood coagulation; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0001502; P:cartilage condensation; IEA:Ensembl
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0000902; P:cell morphogenesis; IEA:Ensembl
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0006928; P:cellular component movement; TAS:ProtInc
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0071479; P:cellular response to ionizing radiation; IMP:BHF-UCL
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0071222; P:cellular response to lipopolysaccharide; IDA:MGI
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IMP:BHF-UCL
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0006935; P:chemotaxis; TAS:ProtInc
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0002062; P:chondrocyte differentiation; IEA:Ensembl
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0000077; P:DNA damage checkpoint; IEA:Ensembl
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0019395; P:fatty acid oxidation; IEA:Ensembl
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0010467; P:gene expression; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0006006; P:glucose metabolic process; IEA:Ensembl
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0045087; P:innate immune response; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IEA:Ensembl
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0042692; P:muscle cell differentiation; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEA:Ensembl
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0030316; P:osteoclast differentiation; ISS:BHF-UCL
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0038066; P:p38MAPK cascade; ISS:UniProtKB
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0018105; P:peptidyl-serine phosphorylation; ISS:BHF-UCL
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0030168; P:platelet activation; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0045648; P:positive regulation of erythrocyte differentiation; IEA:Ensembl
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0045663; P:positive regulation of myoblast differentiation; ISS:UniProtKB
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:1901741; P:positive regulation of myoblast fusion; ISS:UniProtKB
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0010831; P:positive regulation of myotube differentiation; ISS:UniProtKB
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0042307; P:positive regulation of protein import into nucleus; IEA:Ensembl
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IMP:BHF-UCL
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0032495; P:response to muramyl dipeptide; IEA:Ensembl
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0007165; P:signal transduction; TAS:ProtInc
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0042770; P:signal transduction in response to DNA damage; IMP:BHF-UCL
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0090400; P:stress-induced premature senescence; IMP:BHF-UCL
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0007178; P:transmembrane receptor protein serine/threonine kinase signaling pathway; IEA:Ensembl
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q16539	MAPK14	Mitogen-activated protein kinase 14	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IMP:BHF-UCL
Q8TD08	MAPK15	Mitogen-activated protein kinase 15	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8TD08	MAPK15	Mitogen-activated protein kinase 15	GO:0004707; F:MAP kinase activity; IDA:UniProtKB
Q8TD08	MAPK15	Mitogen-activated protein kinase 15	GO:0017124; F:SH3 domain binding; NAS:UniProtKB
Q8TD08	MAPK15	Mitogen-activated protein kinase 15	GO:0000165; P:MAPK cascade; IDA:GOC
Q8TD08	MAPK15	Mitogen-activated protein kinase 15	GO:0008156; P:negative regulation of DNA replication; IEA:Ensembl
Q8TD08	MAPK15	Mitogen-activated protein kinase 15	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8TD08	MAPK15	Mitogen-activated protein kinase 15	GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl
Q8TD08	MAPK15	Mitogen-activated protein kinase 15	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
Q8TD08	MAPK15	Mitogen-activated protein kinase 15	GO:0031398; P:positive regulation of protein ubiquitination; IEA:Ensembl
Q8TD08	MAPK15	Mitogen-activated protein kinase 15	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q8TD08	MAPK15	Mitogen-activated protein kinase 15	GO:0032355; P:response to estradiol; IEA:Ensembl
Q9BYG3	NIFK	MKI67 FHA domain-interacting nucleolar phosphoprotein	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9BYG3	NIFK	MKI67 FHA domain-interacting nucleolar phosphoprotein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BYG3	NIFK	MKI67 FHA domain-interacting nucleolar phosphoprotein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BYG3	NIFK	MKI67 FHA domain-interacting nucleolar phosphoprotein	GO:0003723; F:RNA binding; IDA:UniProtKB
Q9BYG3	NIFK	MKI67 FHA domain-interacting nucleolar phosphoprotein	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q9BYG3	NIFK	MKI67 FHA domain-interacting nucleolar phosphoprotein	GO:0006461; P:protein complex assembly; NAS:UniProtKB
Q9BYG3	NIFK	MKI67 FHA domain-interacting nucleolar phosphoprotein	GO:0016072; P:rRNA metabolic process; NAS:UniProtKB
Q9BYG3	NIFK	MKI67 FHA domain-interacting nucleolar phosphoprotein	GO:0009303; P:rRNA transcription; NAS:UniProtKB
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:MGI
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0051082; F:unfolded protein binding; TAS:ProtInc
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0014824; P:artery smooth muscle contraction; IEA:Ensembl
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0048854; P:brain morphogenesis; ISS:BHF-UCL
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0051216; P:cartilage development; IEA:Ensembl
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0021987; P:cerebral cortex development; ISS:BHF-UCL
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0051131; P:chaperone-mediated protein complex assembly; IEA:Ensembl
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0042384; P:cilium assembly; ISS:BHF-UCL
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0060271; P:cilium morphogenesis; ISS:BHF-UCL
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0060027; P:convergent extension involved in gastrulation; ISS:BHF-UCL
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; ISS:BHF-UCL
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0007368; P:determination of left/right symmetry; ISS:BHF-UCL
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0045444; P:fat cell differentiation; ISS:BHF-UCL
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0008406; P:gonad development; TAS:ProtInc
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0007507; P:heart development; TAS:ProtInc
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0001947; P:heart looping; ISS:BHF-UCL
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0021766; P:hippocampus development; ISS:BHF-UCL
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0046907; P:intracellular transport; ISS:BHF-UCL
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0032402; P:melanosome transport; ISS:BHF-UCL
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0038108; P:negative regulation of appetite by leptin-mediated signaling pathway; ISS:BHF-UCL
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0035058; P:nonmotile primary cilium assembly; IEA:Ensembl
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0045494; P:photoreceptor cell maintenance; ISS:BHF-UCL
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0051877; P:pigment granule aggregation in cell center; ISS:BHF-UCL
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0006457; P:protein folding; TAS:ProtInc
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0060296; P:regulation of cilium beat frequency involved in ciliary motility; ISS:BHF-UCL
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0007608; P:sensory perception of smell; ISS:BHF-UCL
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0035176; P:social behavior; ISS:BHF-UCL
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0007286; P:spermatid development; ISS:BHF-UCL
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0021756; P:striatum development; ISS:BHF-UCL
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0042311; P:vasodilation; IEA:Ensembl
Q9NPJ1	MKKS	McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q969V6	MKL1	MKL/myocardin-like protein 1	GO:0003785; F:actin monomer binding; ISS:UniProtKB
Q969V6	MKL1	MKL/myocardin-like protein 1	GO:0043522; F:leucine zipper domain binding; IPI:BHF-UCL
Q969V6	MKL1	MKL/myocardin-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q969V6	MKL1	MKL/myocardin-like protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q969V6	MKL1	MKL/myocardin-like protein 1	GO:0003713; F:transcription coactivator activity; ISS:UniProtKB
Q969V6	MKL1	MKL/myocardin-like protein 1	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:Ensembl
Q969V6	MKL1	MKL/myocardin-like protein 1	GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl
Q969V6	MKL1	MKL/myocardin-like protein 1	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
Q969V6	MKL1	MKL/myocardin-like protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q969V6	MKL1	MKL/myocardin-like protein 1	GO:0051145; P:smooth muscle cell differentiation; IMP:BHF-UCL
Q969V6	MKL1	MKL/myocardin-like protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UL63	MKLN1	Muskelin	GO:0007165; P:signal transduction; NAS:ProtInc
Q9ULH7	MKL2	MKL/myocardin-like protein 2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9ULH7	MKL2	MKL/myocardin-like protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9ULH7	MKL2	MKL/myocardin-like protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q9ULH7	MKL2	MKL/myocardin-like protein 2	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q9ULH7	MKL2	MKL/myocardin-like protein 2	GO:0048514; P:blood vessel morphogenesis; IEA:Ensembl
Q9ULH7	MKL2	MKL/myocardin-like protein 2	GO:0048738; P:cardiac muscle tissue development; IEA:Ensembl
Q9ULH7	MKL2	MKL/myocardin-like protein 2	GO:0048568; P:embryonic organ development; IEA:Ensembl
Q9ULH7	MKL2	MKL/myocardin-like protein 2	GO:0003007; P:heart morphogenesis; IEA:Ensembl
Q9ULH7	MKL2	MKL/myocardin-like protein 2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9ULH7	MKL2	MKL/myocardin-like protein 2	GO:0001889; P:liver development; IEA:Ensembl
Q9ULH7	MKL2	MKL/myocardin-like protein 2	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
Q9ULH7	MKL2	MKL/myocardin-like protein 2	GO:0045844; P:positive regulation of striated muscle tissue development; IDA:UniProtKB
Q9ULH7	MKL2	MKL/myocardin-like protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9ULH7	MKL2	MKL/myocardin-like protein 2	GO:0051145; P:smooth muscle cell differentiation; IEA:Ensembl
Q9ULH7	MKL2	MKL/myocardin-like protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BUB5	MKNK1	MAP kinase-interacting serine/threonine-protein kinase 1	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9BUB5	MKNK1	MAP kinase-interacting serine/threonine-protein kinase 1	GO:0005515; F:protein binding; IPI:IntAct
Q9BUB5	MKNK1	MAP kinase-interacting serine/threonine-protein kinase 1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9BUB5	MKNK1	MAP kinase-interacting serine/threonine-protein kinase 1	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
Q9BUB5	MKNK1	MAP kinase-interacting serine/threonine-protein kinase 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q9BUB5	MKNK1	MAP kinase-interacting serine/threonine-protein kinase 1	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q9BUB5	MKNK1	MAP kinase-interacting serine/threonine-protein kinase 1	GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL
Q9BUB5	MKNK1	MAP kinase-interacting serine/threonine-protein kinase 1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9BUB5	MKNK1	MAP kinase-interacting serine/threonine-protein kinase 1	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q9BUB5	MKNK1	MAP kinase-interacting serine/threonine-protein kinase 1	GO:0009651; P:response to salt stress; IEA:Ensembl
Q9HBH9	MKNK2	MAP kinase-interacting serine/threonine-protein kinase 2	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9HBH9	MKNK2	MAP kinase-interacting serine/threonine-protein kinase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HBH9	MKNK2	MAP kinase-interacting serine/threonine-protein kinase 2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9HBH9	MKNK2	MAP kinase-interacting serine/threonine-protein kinase 2	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q9HBH9	MKNK2	MAP kinase-interacting serine/threonine-protein kinase 2	GO:0071243; P:cellular response to arsenic-containing substance; IDA:UniProtKB
Q9HBH9	MKNK2	MAP kinase-interacting serine/threonine-protein kinase 2	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
Q9HBH9	MKNK2	MAP kinase-interacting serine/threonine-protein kinase 2	GO:0030097; P:hemopoiesis; IDA:UniProtKB
Q9HBH9	MKNK2	MAP kinase-interacting serine/threonine-protein kinase 2	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q9HBH9	MKNK2	MAP kinase-interacting serine/threonine-protein kinase 2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9HBH9	MKNK2	MAP kinase-interacting serine/threonine-protein kinase 2	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q9UHC7	MKRN1	E3 ubiquitin-protein ligase makorin-1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9UHC7	MKRN1	E3 ubiquitin-protein ligase makorin-1	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9UHC7	MKRN1	E3 ubiquitin-protein ligase makorin-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UHC7	MKRN1	E3 ubiquitin-protein ligase makorin-1	GO:0005515; F:protein binding; IPI:IntAct
Q9UHC7	MKRN1	E3 ubiquitin-protein ligase makorin-1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UHC7	MKRN1	E3 ubiquitin-protein ligase makorin-1	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9H000	MKRN2	Probable E3 ubiquitin-protein ligase makorin-2	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9H000	MKRN2	Probable E3 ubiquitin-protein ligase makorin-2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H000	MKRN2	Probable E3 ubiquitin-protein ligase makorin-2	GO:0005515; F:protein binding; IPI:IntAct
Q9H000	MKRN2	Probable E3 ubiquitin-protein ligase makorin-2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H000	MKRN2	Probable E3 ubiquitin-protein ligase makorin-2	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q13064	MKRN3	Probable E3 ubiquitin-protein ligase makorin-3	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q13064	MKRN3	Probable E3 ubiquitin-protein ligase makorin-3	GO:0005515; F:protein binding; IPI:IntAct
Q13064	MKRN3	Probable E3 ubiquitin-protein ligase makorin-3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13064	MKRN3	Probable E3 ubiquitin-protein ligase makorin-3	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q13434	MKRN4P	Putative E3 ubiquitin-protein ligase makorin-4	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q13434	MKRN4P	Putative E3 ubiquitin-protein ligase makorin-4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13434	MKRN4P	Putative E3 ubiquitin-protein ligase makorin-4	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9NXB0	MKS1	Meckel syndrome type 1 protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NXB0	MKS1	Meckel syndrome type 1 protein	GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl
Q9NXB0	MKS1	Meckel syndrome type 1 protein	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q9NXB0	MKS1	Meckel syndrome type 1 protein	GO:0060271; P:cilium morphogenesis; ISS:UniProtKB
Q5HYA8	TMEM67	Meckelin	GO:0031005; F:filamin binding; IPI:UniProtKB
Q5HYA8	TMEM67	Meckelin	GO:0005515; F:protein binding; IPI:UniProtKB
Q5HYA8	TMEM67	Meckelin	GO:0051082; F:unfolded protein binding; IPI:UniProtKB
Q5HYA8	TMEM67	Meckelin	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q5HYA8	TMEM67	Meckelin	GO:0060271; P:cilium morphogenesis; ISS:UniProtKB
Q5HYA8	TMEM67	Meckelin	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q5HYA8	TMEM67	Meckelin	GO:0010826; P:negative regulation of centrosome duplication; IMP:UniProtKB
P21741	MDK	Midkine	GO:0008083; F:growth factor activity; NAS:UniProtKB
P21741	MDK	Midkine	GO:0008201; F:heparin binding; IDA:UniProtKB
P21741	MDK	Midkine	GO:0030325; P:adrenal gland development; ISS:UniProtKB
P21741	MDK	Midkine	GO:0001662; P:behavioral fear response; IEA:Ensembl
P21741	MDK	Midkine	GO:0030154; P:cell differentiation; NAS:UniProtKB
P21741	MDK	Midkine	GO:0016477; P:cell migration; IEA:Ensembl
P21741	MDK	Midkine	GO:0021681; P:cerebellar granular layer development; IEA:Ensembl
P21741	MDK	Midkine	GO:0021987; P:cerebral cortex development; IEA:Ensembl
P21741	MDK	Midkine	GO:0030421; P:defecation; IEA:Ensembl
P21741	MDK	Midkine	GO:0021542; P:dentate gyrus development; IEA:Ensembl
P21741	MDK	Midkine	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P21741	MDK	Midkine	GO:0007399; P:nervous system development; NAS:UniProtKB
P21741	MDK	Midkine	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P21741	MDK	Midkine	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P21741	MDK	Midkine	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P21741	MDK	Midkine	GO:0050795; P:regulation of behavior; IEA:Ensembl
P21741	MDK	Midkine	GO:0042493; P:response to drug; IEA:Ensembl
P21741	MDK	Midkine	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P21741	MDK	Midkine	GO:0009611; P:response to wounding; ISS:UniProtKB
P21741	MDK	Midkine	GO:0007614; P:short-term memory; IEA:Ensembl
P21741	MDK	Midkine	GO:0007165; P:signal transduction; NAS:ProtInc
P19105	MYL12A	Myosin regulatory light chain 12A	GO:0005509; F:calcium ion binding; IEA:InterPro
P19105	MYL12A	Myosin regulatory light chain 12A	GO:0005515; F:protein binding; IPI:IntAct
P19105	MYL12A	Myosin regulatory light chain 12A	GO:0072661; P:protein targeting to plasma membrane; IEA:Ensembl
P19105	MYL12A	Myosin regulatory light chain 12A	GO:0008360; P:regulation of cell shape; IEA:Ensembl
O14950	MYL12B	Myosin regulatory light chain 12B	GO:0005509; F:calcium ion binding; IEA:InterPro
O14950	MYL12B	Myosin regulatory light chain 12B	GO:0005515; F:protein binding; IPI:IntAct
O14950	MYL12B	Myosin regulatory light chain 12B	GO:0007411; P:axon guidance; TAS:Reactome
O14950	MYL12B	Myosin regulatory light chain 12B	GO:0006936; P:muscle contraction; TAS:Reactome
O14950	MYL12B	Myosin regulatory light chain 12B	GO:0008360; P:regulation of cell shape; IEA:Ensembl
Q8IYA7	MKX	Homeobox protein Mohawk	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q8IYA7	MKX	Homeobox protein Mohawk	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IEA:Ensembl
Q8IYA7	MKX	Homeobox protein Mohawk	GO:0030199; P:collagen fibril organization; IEA:Ensembl
Q8IYA7	MKX	Homeobox protein Mohawk	GO:0007517; P:muscle organ development; ISS:HGNC
Q8IYA7	MKX	Homeobox protein Mohawk	GO:0045662; P:negative regulation of myoblast differentiation; IEA:Ensembl
Q8IYA7	MKX	Homeobox protein Mohawk	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8IYA7	MKX	Homeobox protein Mohawk	GO:0032967; P:positive regulation of collagen biosynthetic process; IEA:Ensembl
Q8IYA7	MKX	Homeobox protein Mohawk	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
Q8IYA7	MKX	Homeobox protein Mohawk	GO:0035990; P:tendon cell differentiation; IEA:Ensembl
Q8IYA7	MKX	Homeobox protein Mohawk	GO:0002932; P:tendon sheath development; IEA:Ensembl
Q15049	MLC1	Membrane protein MLC1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15049	MLC1	Membrane protein MLC1	GO:0032403; F:protein complex binding; IDA:UniProtKB
Q15049	MLC1	Membrane protein MLC1	GO:0008565; F:protein transporter activity; ISS:UniProtKB
Q15049	MLC1	Membrane protein MLC1	GO:0005215; F:transporter activity; NAS:UniProtKB
Q15049	MLC1	Membrane protein MLC1	GO:0072584; P:caveolin-mediated endocytosis; ISS:UniProtKB
Q15049	MLC1	Membrane protein MLC1	GO:0071397; P:cellular response to cholesterol; ISS:UniProtKB
Q15049	MLC1	Membrane protein MLC1	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q15049	MLC1	Membrane protein MLC1	GO:0032388; P:positive regulation of intracellular transport; IDA:UniProtKB
Q15049	MLC1	Membrane protein MLC1	GO:0051259; P:protein oligomerization; IDA:UniProtKB
Q15049	MLC1	Membrane protein MLC1	GO:0047484; P:regulation of response to osmotic stress; IMP:UniProtKB
Q15049	MLC1	Membrane protein MLC1	GO:0006810; P:transport; NAS:UniProtKB
Q15049	MLC1	Membrane protein MLC1	GO:0016192; P:vesicle-mediated transport; ISS:UniProtKB
Q14165	MLEC	Malectin	GO:0030246; F:carbohydrate binding; ISS:UniProtKB
Q14165	MLEC	Malectin	GO:0019899; F:enzyme binding; IPI:UniProt
Q14165	MLEC	Malectin	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q14165	MLEC	Malectin	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q14165	MLEC	Malectin	GO:0006457; P:protein folding; TAS:Reactome
Q14165	MLEC	Malectin	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
P58340	MLF1	Myeloid leukemia factor 1	GO:0003677; F:DNA binding; ISS:UniProtKB
P58340	MLF1	Myeloid leukemia factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
P58340	MLF1	Myeloid leukemia factor 1	GO:0019904; F:protein domain specific binding; IDA:UniProtKB
P58340	MLF1	Myeloid leukemia factor 1	GO:0007050; P:cell cycle arrest; IDA:UniProtKB
P58340	MLF1	Myeloid leukemia factor 1	GO:0002318; P:myeloid progenitor cell differentiation; ISS:UniProtKB
P58340	MLF1	Myeloid leukemia factor 1	GO:0006351; P:transcription, DNA-templated; ISS:UniProtKB
Q15773	MLF2	Myeloid leukemia factor 2	GO:0006952; P:defense response; IMP:UniProtKB
P40692	MLH1	DNA mismatch repair protein Mlh1	GO:0005524; F:ATP binding; IEA:InterPro
P40692	MLH1	DNA mismatch repair protein Mlh1	GO:0016887; F:ATPase activity; IBA:RefGenome
P40692	MLH1	DNA mismatch repair protein Mlh1	GO:0032137; F:guanine/thymine mispair binding; IEA:Ensembl
P40692	MLH1	DNA mismatch repair protein Mlh1	GO:0005515; F:protein binding; IPI:UniProtKB
P40692	MLH1	DNA mismatch repair protein Mlh1	GO:0006200; P:ATP catabolic process; IBA:GOC
P40692	MLH1	DNA mismatch repair protein Mlh1	GO:0006303; P:double-strand break repair via nonhomologous end joining; IEA:Ensembl
P40692	MLH1	DNA mismatch repair protein Mlh1	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
P40692	MLH1	DNA mismatch repair protein Mlh1	GO:0045190; P:isotype switching; IEA:Ensembl
P40692	MLH1	DNA mismatch repair protein Mlh1	GO:0007060; P:male meiosis chromosome segregation; IEA:Ensembl
P40692	MLH1	DNA mismatch repair protein Mlh1	GO:0043060; P:meiotic metaphase I plate congression; IEA:Ensembl
P40692	MLH1	DNA mismatch repair protein Mlh1	GO:0006298; P:mismatch repair; IGI:MGI
P40692	MLH1	DNA mismatch repair protein Mlh1	GO:0045950; P:negative regulation of mitotic recombination; IEA:Ensembl
P40692	MLH1	DNA mismatch repair protein Mlh1	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; IEA:Ensembl
P40692	MLH1	DNA mismatch repair protein Mlh1	GO:0048477; P:oogenesis; IEA:Ensembl
P40692	MLH1	DNA mismatch repair protein Mlh1	GO:0007131; P:reciprocal meiotic recombination; IBA:RefGenome
P40692	MLH1	DNA mismatch repair protein Mlh1	GO:0000712; P:resolution of meiotic recombination intermediates; IEA:Ensembl
P40692	MLH1	DNA mismatch repair protein Mlh1	GO:0016446; P:somatic hypermutation of immunoglobulin genes; IBA:RefGenome
P40692	MLH1	DNA mismatch repair protein Mlh1	GO:0007283; P:spermatogenesis; IEA:Ensembl
P40692	MLH1	DNA mismatch repair protein Mlh1	GO:0051257; P:spindle midzone assembly involved in meiosis; IEA:Ensembl
P40692	MLH1	DNA mismatch repair protein Mlh1	GO:0007129; P:synapsis; IEA:Ensembl
Q8NB16	MLKL	Mixed lineage kinase domain-like protein	GO:0005524; F:ATP binding; IDA:UniProtKB
Q8NB16	MLKL	Mixed lineage kinase domain-like protein	GO:0005515; F:protein binding; IPI:IntAct
Q8NB16	MLKL	Mixed lineage kinase domain-like protein	GO:0032403; F:protein complex binding; IDA:UniProtKB
Q8NB16	MLKL	Mixed lineage kinase domain-like protein	GO:0016772; F:transferase activity, transferring phosphorus-containing groups; IEA:InterPro
Q8NB16	MLKL	Mixed lineage kinase domain-like protein	GO:0070266; P:necroptotic process; IMP:UniProtKB
Q8NB16	MLKL	Mixed lineage kinase domain-like protein	GO:0070207; P:protein homotrimerization; IDA:UniProtKB
Q8NB16	MLKL	Mixed lineage kinase domain-like protein	GO:0006468; P:protein phosphorylation; IEA:InterPro
Q9UHC1	MLH3	DNA mismatch repair protein Mlh3	GO:0005524; F:ATP binding; IEA:InterPro
Q9UHC1	MLH3	DNA mismatch repair protein Mlh3	GO:0016887; F:ATPase activity; IBA:RefGenome
Q9UHC1	MLH3	DNA mismatch repair protein Mlh3	GO:0019237; F:centromeric DNA binding; IEA:Ensembl
Q9UHC1	MLH3	DNA mismatch repair protein Mlh3	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9UHC1	MLH3	DNA mismatch repair protein Mlh3	GO:0030983; F:mismatched DNA binding; IEA:InterPro
Q9UHC1	MLH3	DNA mismatch repair protein Mlh3	GO:0032407; F:MutSalpha complex binding; IBA:RefGenome
Q9UHC1	MLH3	DNA mismatch repair protein Mlh3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UHC1	MLH3	DNA mismatch repair protein Mlh3	GO:0003696; F:satellite DNA binding; TAS:ProtInc
Q9UHC1	MLH3	DNA mismatch repair protein Mlh3	GO:0003697; F:single-stranded DNA binding; IBA:RefGenome
Q9UHC1	MLH3	DNA mismatch repair protein Mlh3	GO:0006200; P:ATP catabolic process; IBA:GOC
Q9UHC1	MLH3	DNA mismatch repair protein Mlh3	GO:0007144; P:female meiosis I; IEA:Ensembl
Q9UHC1	MLH3	DNA mismatch repair protein Mlh3	GO:0007140; P:male meiosis; IEA:Ensembl
Q9UHC1	MLH3	DNA mismatch repair protein Mlh3	GO:0006298; P:mismatch repair; NAS:UniProtKB
Q9UHC1	MLH3	DNA mismatch repair protein Mlh3	GO:0008104; P:protein localization; IEA:Ensembl
Q9UHC1	MLH3	DNA mismatch repair protein Mlh3	GO:0007131; P:reciprocal meiotic recombination; NAS:UniProtKB
Q9UHC1	MLH3	DNA mismatch repair protein Mlh3	GO:0007130; P:synaptonemal complex assembly; IEA:Ensembl
Q9H492	MAP1LC3A	Microtubule-associated proteins 1A/1B light chain 3A	GO:0008429; F:phosphatidylethanolamine binding; IDA:UniProtKB
Q9H492	MAP1LC3A	Microtubule-associated proteins 1A/1B light chain 3A	GO:0005543; F:phospholipid binding; IDA:UniProtKB
Q9H492	MAP1LC3A	Microtubule-associated proteins 1A/1B light chain 3A	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H492	MAP1LC3A	Microtubule-associated proteins 1A/1B light chain 3A	GO:0000045; P:autophagic vacuole assembly; ISS:UniProtKB
Q9H492	MAP1LC3A	Microtubule-associated proteins 1A/1B light chain 3A	GO:0000422; P:mitochondrion degradation; IGI:MGI
Q9GZQ8	MAP1LC3B	Microtubule-associated proteins 1A/1B light chain 3B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9GZQ8	MAP1LC3B	Microtubule-associated proteins 1A/1B light chain 3B	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q9BXW4	MAP1LC3C	Microtubule-associated proteins 1A/1B light chain 3C	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BXW4	MAP1LC3C	Microtubule-associated proteins 1A/1B light chain 3C	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q01449	MYL7	Myosin regulatory light chain 2, atrial isoform	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96A32	MYLPF	Myosin regulatory light chain 2, skeletal muscle isoform	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96A32	MYLPF	Myosin regulatory light chain 2, skeletal muscle isoform	GO:0008307; F:structural constituent of muscle; ISS:BHF-UCL
Q96A32	MYLPF	Myosin regulatory light chain 2, skeletal muscle isoform	GO:0006955; P:immune response; IEA:Ensembl
Q96A32	MYLPF	Myosin regulatory light chain 2, skeletal muscle isoform	GO:0007519; P:skeletal muscle tissue development; ISS:BHF-UCL
P10916	MYL2	Myosin regulatory light chain 2, ventricular/cardiac muscle isoform	GO:0003785; F:actin monomer binding; IDA:BHF-UCL
P10916	MYL2	Myosin regulatory light chain 2, ventricular/cardiac muscle isoform	GO:0005509; F:calcium ion binding; IDA:MGI
P10916	MYL2	Myosin regulatory light chain 2, ventricular/cardiac muscle isoform	GO:0032036; F:myosin heavy chain binding; NAS:BHF-UCL
P10916	MYL2	Myosin regulatory light chain 2, ventricular/cardiac muscle isoform	GO:0005515; F:protein binding; IPI:UniProtKB
P10916	MYL2	Myosin regulatory light chain 2, ventricular/cardiac muscle isoform	GO:0008307; F:structural constituent of muscle; NAS:BHF-UCL
P10916	MYL2	Myosin regulatory light chain 2, ventricular/cardiac muscle isoform	GO:0060048; P:cardiac muscle contraction; IEA:Ensembl
P10916	MYL2	Myosin regulatory light chain 2, ventricular/cardiac muscle isoform	GO:0055003; P:cardiac myofibril assembly; ISS:BHF-UCL
P10916	MYL2	Myosin regulatory light chain 2, ventricular/cardiac muscle isoform	GO:0060047; P:heart contraction; ISS:BHF-UCL
P10916	MYL2	Myosin regulatory light chain 2, ventricular/cardiac muscle isoform	GO:0042694; P:muscle cell fate specification; IEA:Ensembl
P10916	MYL2	Myosin regulatory light chain 2, ventricular/cardiac muscle isoform	GO:0048747; P:muscle fiber development; IEA:Ensembl
P10916	MYL2	Myosin regulatory light chain 2, ventricular/cardiac muscle isoform	GO:0030049; P:muscle filament sliding; TAS:Reactome
P10916	MYL2	Myosin regulatory light chain 2, ventricular/cardiac muscle isoform	GO:0030308; P:negative regulation of cell growth; IMP:BHF-UCL
P10916	MYL2	Myosin regulatory light chain 2, ventricular/cardiac muscle isoform	GO:0009791; P:post-embryonic development; IEA:Ensembl
P10916	MYL2	Myosin regulatory light chain 2, ventricular/cardiac muscle isoform	GO:0006942; P:regulation of striated muscle contraction; TAS:ProtInc
P10916	MYL2	Myosin regulatory light chain 2, ventricular/cardiac muscle isoform	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IMP:BHF-UCL
Q9NYL2	ZAK	Mitogen-activated protein kinase kinase kinase MLT	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9NYL2	ZAK	Mitogen-activated protein kinase kinase kinase MLT	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q9NYL2	ZAK	Mitogen-activated protein kinase kinase kinase MLT	GO:0004709; F:MAP kinase kinase kinase activity; IDA:UniProtKB
Q9NYL2	ZAK	Mitogen-activated protein kinase kinase kinase MLT	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NYL2	ZAK	Mitogen-activated protein kinase kinase kinase MLT	GO:0005515; F:protein binding; IPI:IntAct
Q9NYL2	ZAK	Mitogen-activated protein kinase kinase kinase MLT	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9NYL2	ZAK	Mitogen-activated protein kinase kinase kinase MLT	GO:0007257; P:activation of JUN kinase activity; IDA:UniProtKB
Q9NYL2	ZAK	Mitogen-activated protein kinase kinase kinase MLT	GO:0000186; P:activation of MAPKK activity; TAS:UniProtKB
Q9NYL2	ZAK	Mitogen-activated protein kinase kinase kinase MLT	GO:0007050; P:cell cycle arrest; IMP:UniProtKB
Q9NYL2	ZAK	Mitogen-activated protein kinase kinase kinase MLT	GO:0000075; P:cell cycle checkpoint; IDA:UniProtKB
Q9NYL2	ZAK	Mitogen-activated protein kinase kinase kinase MLT	GO:0008219; P:cell death; NAS:UniProtKB
Q9NYL2	ZAK	Mitogen-activated protein kinase kinase kinase MLT	GO:0030154; P:cell differentiation; NAS:UniProtKB
Q9NYL2	ZAK	Mitogen-activated protein kinase kinase kinase MLT	GO:0008283; P:cell proliferation; NAS:UniProtKB
Q9NYL2	ZAK	Mitogen-activated protein kinase kinase kinase MLT	GO:0007010; P:cytoskeleton organization; IEA:Ensembl
Q9NYL2	ZAK	Mitogen-activated protein kinase kinase kinase MLT	GO:0000077; P:DNA damage checkpoint; IMP:UniProtKB
Q9NYL2	ZAK	Mitogen-activated protein kinase kinase kinase MLT	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q9NYL2	ZAK	Mitogen-activated protein kinase kinase kinase MLT	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q9NYL2	ZAK	Mitogen-activated protein kinase kinase kinase MLT	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9NYL2	ZAK	Mitogen-activated protein kinase kinase kinase MLT	GO:0009314; P:response to radiation; IDA:UniProtKB
Q9NYL2	ZAK	Mitogen-activated protein kinase kinase kinase MLT	GO:0006950; P:response to stress; NAS:UniProtKB
Q9HAP2	MLXIP	MLX-interacting protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9HAP2	MLXIP	MLX-interacting protein	GO:0006913; P:nucleocytoplasmic transport; IEA:Ensembl
Q9HAP2	MLXIP	MLX-interacting protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9HAP2	MLXIP	MLX-interacting protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0035538; F:carbohydrate response element binding; TAS:BHF-UCL
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0003677; F:DNA binding; NAS:BHF-UCL
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:BHF-UCL
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0055089; P:fatty acid homeostasis; ISS:UniProtKB
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0042593; P:glucose homeostasis; ISS:BHF-UCL
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0010255; P:glucose mediated signaling pathway; ISS:BHF-UCL
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0035556; P:intracellular signal transduction; TAS:Reactome
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0071157; P:negative regulation of cell cycle arrest; IMP:BHF-UCL
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0090324; P:negative regulation of oxidative phosphorylation; IMP:BHF-UCL
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; IMP:BHF-UCL
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:BHF-UCL
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0008284; P:positive regulation of cell proliferation; IMP:BHF-UCL
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0031325; P:positive regulation of cellular metabolic process; TAS:Reactome
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0045723; P:positive regulation of fatty acid biosynthetic process; ISS:BHF-UCL
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0045821; P:positive regulation of glycolytic process; IMP:BHF-UCL
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0046889; P:positive regulation of lipid biosynthetic process; IMP:BHF-UCL
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:BHF-UCL
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:2000505; P:regulation of energy homeostasis; ISS:UniProtKB
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0042304; P:regulation of fatty acid biosynthetic process; TAS:Reactome
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0006355; P:regulation of transcription, DNA-templated; NAS:BHF-UCL
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NP71	MLXIPL	Carbohydrate-responsive element-binding protein	GO:0070328; P:triglyceride homeostasis; NAS:BHF-UCL
Q9UH92	MLX	Max-like protein X	GO:0003677; F:DNA binding; IDA:BHF-UCL
Q9UH92	MLX	Max-like protein X	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
Q9UH92	MLX	Max-like protein X	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q9UH92	MLX	Max-like protein X	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9UH92	MLX	Max-like protein X	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
Q9UH92	MLX	Max-like protein X	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q9UH92	MLX	Max-like protein X	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
Q9UH92	MLX	Max-like protein X	GO:0006913; P:nucleocytoplasmic transport; IEA:Ensembl
Q9UH92	MLX	Max-like protein X	GO:0031325; P:positive regulation of cellular metabolic process; TAS:Reactome
Q9UH92	MLX	Max-like protein X	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9UH92	MLX	Max-like protein X	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UH92	MLX	Max-like protein X	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IVH4	MMAA	Methylmalonic aciduria type A protein, mitochondrial	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q8IVH4	MMAA	Methylmalonic aciduria type A protein, mitochondrial	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q8IVH4	MMAA	Methylmalonic aciduria type A protein, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q8IVH4	MMAA	Methylmalonic aciduria type A protein, mitochondrial	GO:0009236; P:cobalamin biosynthetic process; IEA:UniProtKB-UniPathway
Q8IVH4	MMAA	Methylmalonic aciduria type A protein, mitochondrial	GO:0009235; P:cobalamin metabolic process; TAS:Reactome
Q8IVH4	MMAA	Methylmalonic aciduria type A protein, mitochondrial	GO:0006635; P:fatty acid beta-oxidation; TAS:Reactome
Q8IVH4	MMAA	Methylmalonic aciduria type A protein, mitochondrial	GO:0019626; P:short-chain fatty acid catabolic process; TAS:Reactome
Q8IVH4	MMAA	Methylmalonic aciduria type A protein, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8IVH4	MMAA	Methylmalonic aciduria type A protein, mitochondrial	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q8IVH4	MMAA	Methylmalonic aciduria type A protein, mitochondrial	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q96EY8	MMAB	Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96EY8	MMAB	Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial	GO:0008817; F:cob(I)yrinic acid a,c-diamide adenosyltransferase activity; TAS:Reactome
Q96EY8	MMAB	Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial	GO:0009236; P:cobalamin biosynthetic process; IEA:UniProtKB-UniPathway
Q96EY8	MMAB	Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial	GO:0009235; P:cobalamin metabolic process; TAS:Reactome
Q96EY8	MMAB	Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96EY8	MMAB	Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q96EY8	MMAB	Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9Y4U1	MMACHC	Methylmalonic aciduria and homocystinuria type C protein	GO:0031419; F:cobalamin binding; IEA:UniProtKB-KW
Q9Y4U1	MMACHC	Methylmalonic aciduria and homocystinuria type C protein	GO:0009236; P:cobalamin biosynthetic process; IEA:UniProtKB-UniPathway
Q9Y4U1	MMACHC	Methylmalonic aciduria and homocystinuria type C protein	GO:0009235; P:cobalamin metabolic process; TAS:Reactome
Q9Y4U1	MMACHC	Methylmalonic aciduria and homocystinuria type C protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y4U1	MMACHC	Methylmalonic aciduria and homocystinuria type C protein	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9Y4U1	MMACHC	Methylmalonic aciduria and homocystinuria type C protein	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9H3L0	MMADHC	Methylmalonic aciduria and homocystinuria type D protein, mitochondrial	GO:0009235; P:cobalamin metabolic process; TAS:Reactome
Q9H3L0	MMADHC	Methylmalonic aciduria and homocystinuria type D protein, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H3L0	MMADHC	Methylmalonic aciduria and homocystinuria type D protein, mitochondrial	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9H3L0	MMADHC	Methylmalonic aciduria and homocystinuria type D protein, mitochondrial	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q495T6	MMEL1	Membrane metallo-endopeptidase-like 1	GO:0004222; F:metalloendopeptidase activity; IEA:Ensembl
Q495T6	MMEL1	Membrane metallo-endopeptidase-like 1	GO:0008270; F:zinc ion binding; IEA:Ensembl
Q8N4V1	MMGT1	Membrane magnesium transporter 1	GO:0015095; F:magnesium ion transmembrane transporter activity; ISS:UniProtKB
Q8N4V1	MMGT1	Membrane magnesium transporter 1	GO:0015693; P:magnesium ion transport; ISS:UniProtKB
P09238	MMP10	Stromelysin-2	GO:0005509; F:calcium ion binding; IEA:InterPro
P09238	MMP10	Stromelysin-2	GO:0004222; F:metalloendopeptidase activity; TAS:ProtInc
P09238	MMP10	Stromelysin-2	GO:0008270; F:zinc ion binding; TAS:ProtInc
P09238	MMP10	Stromelysin-2	GO:0030574; P:collagen catabolic process; TAS:Reactome
P09238	MMP10	Stromelysin-2	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P09238	MMP10	Stromelysin-2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P09238	MMP10	Stromelysin-2	GO:0006508; P:proteolysis; TAS:ProtInc
P09238	MMP10	Stromelysin-2	GO:0030334; P:regulation of cell migration; IEA:Ensembl
P24347	MMP11	Stromelysin-3	GO:0005509; F:calcium ion binding; IEA:InterPro
P24347	MMP11	Stromelysin-3	GO:0004222; F:metalloendopeptidase activity; TAS:ProtInc
P24347	MMP11	Stromelysin-3	GO:0008270; F:zinc ion binding; IEA:InterPro
P24347	MMP11	Stromelysin-3	GO:0071711; P:basement membrane organization; IEA:Ensembl
P24347	MMP11	Stromelysin-3	GO:0030574; P:collagen catabolic process; TAS:Reactome
P24347	MMP11	Stromelysin-3	GO:0030199; P:collagen fibril organization; IEA:Ensembl
P24347	MMP11	Stromelysin-3	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P24347	MMP11	Stromelysin-3	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P24347	MMP11	Stromelysin-3	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P24347	MMP11	Stromelysin-3	GO:0045599; P:negative regulation of fat cell differentiation; IEA:Ensembl
P24347	MMP11	Stromelysin-3	GO:0006508; P:proteolysis; TAS:ProtInc
P39900	MMP12	Macrophage metalloelastase	GO:0005509; F:calcium ion binding; IEA:InterPro
P39900	MMP12	Macrophage metalloelastase	GO:0004175; F:endopeptidase activity; TAS:UniProtKB
P39900	MMP12	Macrophage metalloelastase	GO:0004222; F:metalloendopeptidase activity; TAS:UniProtKB
P39900	MMP12	Macrophage metalloelastase	GO:0008270; F:zinc ion binding; TAS:ProtInc
P39900	MMP12	Macrophage metalloelastase	GO:0030574; P:collagen catabolic process; TAS:Reactome
P39900	MMP12	Macrophage metalloelastase	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P39900	MMP12	Macrophage metalloelastase	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P39900	MMP12	Macrophage metalloelastase	GO:0060054; P:positive regulation of epithelial cell proliferation involved in wound healing; IDA:BHF-UCL
P39900	MMP12	Macrophage metalloelastase	GO:0006508; P:proteolysis; TAS:ProtInc
P39900	MMP12	Macrophage metalloelastase	GO:0035313; P:wound healing, spreading of epidermal cells; IDA:BHF-UCL
P45452	MMP13	Collagenase 3	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P45452	MMP13	Collagenase 3	GO:0005518; F:collagen binding; IDA:UniProtKB
P45452	MMP13	Collagenase 3	GO:0004222; F:metalloendopeptidase activity; IDA:UniProtKB
P45452	MMP13	Collagenase 3	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P45452	MMP13	Collagenase 3	GO:0030282; P:bone mineralization; IEA:Ensembl
P45452	MMP13	Collagenase 3	GO:0060349; P:bone morphogenesis; IDA:UniProtKB
P45452	MMP13	Collagenase 3	GO:0051216; P:cartilage development; IEA:Ensembl
P45452	MMP13	Collagenase 3	GO:0044267; P:cellular protein metabolic process; IEA:Ensembl
P45452	MMP13	Collagenase 3	GO:0030574; P:collagen catabolic process; IDA:UniProtKB
P45452	MMP13	Collagenase 3	GO:0022617; P:extracellular matrix disassembly; IMP:UniProtKB
P45452	MMP13	Collagenase 3	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P45452	MMP13	Collagenase 3	GO:0006508; P:proteolysis; TAS:ProtInc
P50281	MMP14	Matrix metalloproteinase-14	GO:0005509; F:calcium ion binding; IEA:InterPro
P50281	MMP14	Matrix metalloproteinase-14	GO:0004222; F:metalloendopeptidase activity; TAS:ProtInc
P50281	MMP14	Matrix metalloproteinase-14	GO:0016504; F:peptidase activator activity; IEA:Ensembl
P50281	MMP14	Matrix metalloproteinase-14	GO:0005515; F:protein binding; IPI:UniProtKB
P50281	MMP14	Matrix metalloproteinase-14	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P50281	MMP14	Matrix metalloproteinase-14	GO:0008270; F:zinc ion binding; TAS:ProtInc
P50281	MMP14	Matrix metalloproteinase-14	GO:0001525; P:angiogenesis; IEA:Ensembl
P50281	MMP14	Matrix metalloproteinase-14	GO:0043615; P:astrocyte cell migration; IEA:Ensembl
P50281	MMP14	Matrix metalloproteinase-14	GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl
P50281	MMP14	Matrix metalloproteinase-14	GO:0030574; P:collagen catabolic process; TAS:Reactome
P50281	MMP14	Matrix metalloproteinase-14	GO:0001935; P:endothelial cell proliferation; IEA:Ensembl
P50281	MMP14	Matrix metalloproteinase-14	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P50281	MMP14	Matrix metalloproteinase-14	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P50281	MMP14	Matrix metalloproteinase-14	GO:0030324; P:lung development; IEA:Ensembl
P50281	MMP14	Matrix metalloproteinase-14	GO:0008584; P:male gonad development; IEA:Ensembl
P50281	MMP14	Matrix metalloproteinase-14	GO:0051895; P:negative regulation of focal adhesion assembly; IEA:Ensembl
P50281	MMP14	Matrix metalloproteinase-14	GO:0001503; P:ossification; IEA:Ensembl
P50281	MMP14	Matrix metalloproteinase-14	GO:0001541; P:ovarian follicle development; IEA:Ensembl
P50281	MMP14	Matrix metalloproteinase-14	GO:0030307; P:positive regulation of cell growth; IDA:UniProtKB
P50281	MMP14	Matrix metalloproteinase-14	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
P50281	MMP14	Matrix metalloproteinase-14	GO:0006508; P:proteolysis; TAS:ProtInc
P50281	MMP14	Matrix metalloproteinase-14	GO:0043627; P:response to estrogen; IEA:Ensembl
P50281	MMP14	Matrix metalloproteinase-14	GO:0001666; P:response to hypoxia; IEA:Ensembl
P50281	MMP14	Matrix metalloproteinase-14	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P50281	MMP14	Matrix metalloproteinase-14	GO:0006979; P:response to oxidative stress; IEA:Ensembl
P50281	MMP14	Matrix metalloproteinase-14	GO:0048771; P:tissue remodeling; IEA:Ensembl
P50281	MMP14	Matrix metalloproteinase-14	GO:0031638; P:zymogen activation; IEA:Ensembl
P51512	MMP16	Matrix metalloproteinase-16	GO:0005509; F:calcium ion binding; IEA:InterPro
P51512	MMP16	Matrix metalloproteinase-16	GO:0008047; F:enzyme activator activity; TAS:ProtInc
P51512	MMP16	Matrix metalloproteinase-16	GO:0004222; F:metalloendopeptidase activity; TAS:ProtInc
P51512	MMP16	Matrix metalloproteinase-16	GO:0008270; F:zinc ion binding; TAS:ProtInc
P51512	MMP16	Matrix metalloproteinase-16	GO:0030574; P:collagen catabolic process; IEA:UniProtKB-KW
P51512	MMP16	Matrix metalloproteinase-16	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P51512	MMP16	Matrix metalloproteinase-16	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P51512	MMP16	Matrix metalloproteinase-16	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
P51511	MMP15	Matrix metalloproteinase-15	GO:0005509; F:calcium ion binding; IEA:InterPro
P51511	MMP15	Matrix metalloproteinase-15	GO:0008047; F:enzyme activator activity; TAS:ProtInc
P51511	MMP15	Matrix metalloproteinase-15	GO:0004222; F:metalloendopeptidase activity; TAS:ProtInc
P51511	MMP15	Matrix metalloproteinase-15	GO:0005515; F:protein binding; IPI:IntAct
P51511	MMP15	Matrix metalloproteinase-15	GO:0008270; F:zinc ion binding; TAS:ProtInc
P51511	MMP15	Matrix metalloproteinase-15	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P51511	MMP15	Matrix metalloproteinase-15	GO:0030574; P:collagen catabolic process; TAS:Reactome
P51511	MMP15	Matrix metalloproteinase-15	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P51511	MMP15	Matrix metalloproteinase-15	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P51511	MMP15	Matrix metalloproteinase-15	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
P51511	MMP15	Matrix metalloproteinase-15	GO:0032355; P:response to estradiol; IEA:Ensembl
Q9ULZ9	MMP17	Matrix metalloproteinase-17	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9ULZ9	MMP17	Matrix metalloproteinase-17	GO:0008047; F:enzyme activator activity; TAS:ProtInc
Q9ULZ9	MMP17	Matrix metalloproteinase-17	GO:0004222; F:metalloendopeptidase activity; TAS:ProtInc
Q9ULZ9	MMP17	Matrix metalloproteinase-17	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q9ULZ9	MMP17	Matrix metalloproteinase-17	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
Q99542	MMP19	Matrix metalloproteinase-19	GO:0005509; F:calcium ion binding; IEA:InterPro
Q99542	MMP19	Matrix metalloproteinase-19	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q99542	MMP19	Matrix metalloproteinase-19	GO:0008270; F:zinc ion binding; IEA:InterPro
Q99542	MMP19	Matrix metalloproteinase-19	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q99542	MMP19	Matrix metalloproteinase-19	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q99542	MMP19	Matrix metalloproteinase-19	GO:0030574; P:collagen catabolic process; TAS:Reactome
Q99542	MMP19	Matrix metalloproteinase-19	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q99542	MMP19	Matrix metalloproteinase-19	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q99542	MMP19	Matrix metalloproteinase-19	GO:0001554; P:luteolysis; IEA:Ensembl
Q99542	MMP19	Matrix metalloproteinase-19	GO:0001541; P:ovarian follicle development; IEA:Ensembl
Q99542	MMP19	Matrix metalloproteinase-19	GO:0001542; P:ovulation from ovarian follicle; IEA:Ensembl
Q99542	MMP19	Matrix metalloproteinase-19	GO:0006508; P:proteolysis; NAS:UniProtKB
Q99542	MMP19	Matrix metalloproteinase-19	GO:0051591; P:response to cAMP; IEA:Ensembl
Q99542	MMP19	Matrix metalloproteinase-19	GO:0009725; P:response to hormone; IEA:Ensembl
P03956	MMP1	Interstitial collagenase	GO:0005509; F:calcium ion binding; IEA:InterPro
P03956	MMP1	Interstitial collagenase	GO:0004222; F:metalloendopeptidase activity; IDA:BHF-UCL
P03956	MMP1	Interstitial collagenase	GO:0008270; F:zinc ion binding; TAS:ProtInc
P03956	MMP1	Interstitial collagenase	GO:0007596; P:blood coagulation; TAS:Reactome
P03956	MMP1	Interstitial collagenase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P03956	MMP1	Interstitial collagenase	GO:0030574; P:collagen catabolic process; TAS:Reactome
P03956	MMP1	Interstitial collagenase	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P03956	MMP1	Interstitial collagenase	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P03956	MMP1	Interstitial collagenase	GO:0050900; P:leukocyte migration; TAS:Reactome
P03956	MMP1	Interstitial collagenase	GO:0006508; P:proteolysis; TAS:ProtInc
P03956	MMP1	Interstitial collagenase	GO:0016032; P:viral process; IEA:UniProtKB-KW
O60882	MMP20	Matrix metalloproteinase-20	GO:0005509; F:calcium ion binding; IEA:InterPro
O60882	MMP20	Matrix metalloproteinase-20	GO:0004222; F:metalloendopeptidase activity; TAS:ProtInc
O60882	MMP20	Matrix metalloproteinase-20	GO:0005515; F:protein binding; IPI:BHF-UCL
O60882	MMP20	Matrix metalloproteinase-20	GO:0008270; F:zinc ion binding; TAS:ProtInc
O60882	MMP20	Matrix metalloproteinase-20	GO:0097186; P:amelogenesis; IEA:Ensembl
O60882	MMP20	Matrix metalloproteinase-20	GO:0030574; P:collagen catabolic process; TAS:Reactome
O60882	MMP20	Matrix metalloproteinase-20	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
O60882	MMP20	Matrix metalloproteinase-20	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O60882	MMP20	Matrix metalloproteinase-20	GO:0006508; P:proteolysis; TAS:ProtInc
O60882	MMP20	Matrix metalloproteinase-20	GO:0070173; P:regulation of enamel mineralization; TAS:BHF-UCL
Q8N119	MMP21	Matrix metalloproteinase-21	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8N119	MMP21	Matrix metalloproteinase-21	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q8N119	MMP21	Matrix metalloproteinase-21	GO:0008270; F:zinc ion binding; IEA:InterPro
O75900	MMP23A	Matrix metalloproteinase-23	GO:0004222; F:metalloendopeptidase activity; IDA:UniProtKB
O75900	MMP23A	Matrix metalloproteinase-23	GO:0008237; F:metallopeptidase activity; NAS:UniProtKB
O75900	MMP23A	Matrix metalloproteinase-23	GO:0008270; F:zinc ion binding; NAS:UniProtKB
O75900	MMP23A	Matrix metalloproteinase-23	GO:0006508; P:proteolysis; IDA:UniProtKB
O75900	MMP23A	Matrix metalloproteinase-23	GO:0000003; P:reproduction; IEP:UniProtKB
Q9Y5R2	MMP24	Matrix metalloproteinase-24	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5R2	MMP24	Matrix metalloproteinase-24	GO:0008047; F:enzyme activator activity; TAS:ProtInc
Q9Y5R2	MMP24	Matrix metalloproteinase-24	GO:0004222; F:metalloendopeptidase activity; TAS:ProtInc
Q9Y5R2	MMP24	Matrix metalloproteinase-24	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y5R2	MMP24	Matrix metalloproteinase-24	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
Q9Y5R2	MMP24	Matrix metalloproteinase-24	GO:0006508; P:proteolysis; TAS:ProtInc
Q9NPA2	MMP25	Matrix metalloproteinase-25	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NPA2	MMP25	Matrix metalloproteinase-25	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q9NPA2	MMP25	Matrix metalloproteinase-25	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NPA2	MMP25	Matrix metalloproteinase-25	GO:0060022; P:hard palate development; IEA:Ensembl
Q9NPA2	MMP25	Matrix metalloproteinase-25	GO:0006954; P:inflammatory response; NAS:UniProtKB
Q9NPA2	MMP25	Matrix metalloproteinase-25	GO:0006508; P:proteolysis; NAS:UniProtKB
Q9NRE1	MMP26	Matrix metalloproteinase-26	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q9NRE1	MMP26	Matrix metalloproteinase-26	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NRE1	MMP26	Matrix metalloproteinase-26	GO:0030574; P:collagen catabolic process; IEA:UniProtKB-KW
Q9NRE1	MMP26	Matrix metalloproteinase-26	GO:0006508; P:proteolysis; NAS:UniProtKB
Q9H306	MMP27	Matrix metalloproteinase-27	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9H306	MMP27	Matrix metalloproteinase-27	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q9H306	MMP27	Matrix metalloproteinase-27	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H306	MMP27	Matrix metalloproteinase-27	GO:0030574; P:collagen catabolic process; IEA:UniProtKB-KW
P08253	MMP2	72 kDa type IV collagenase	GO:0004222; F:metalloendopeptidase activity; TAS:ProtInc
P08253	MMP2	72 kDa type IV collagenase	GO:0005515; F:protein binding; IPI:IntAct
P08253	MMP2	72 kDa type IV collagenase	GO:0004252; F:serine-type endopeptidase activity; TAS:Reactome
P08253	MMP2	72 kDa type IV collagenase	GO:0008270; F:zinc ion binding; TAS:ProtInc
P08253	MMP2	72 kDa type IV collagenase	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P08253	MMP2	72 kDa type IV collagenase	GO:0001955; P:blood vessel maturation; IEA:Ensembl
P08253	MMP2	72 kDa type IV collagenase	GO:0060346; P:bone trabecula formation; IEA:Ensembl
P08253	MMP2	72 kDa type IV collagenase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P08253	MMP2	72 kDa type IV collagenase	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
P08253	MMP2	72 kDa type IV collagenase	GO:0030574; P:collagen catabolic process; TAS:Reactome
P08253	MMP2	72 kDa type IV collagenase	GO:0007566; P:embryo implantation; IEA:Ensembl
P08253	MMP2	72 kDa type IV collagenase	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P08253	MMP2	72 kDa type IV collagenase	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P08253	MMP2	72 kDa type IV collagenase	GO:0060325; P:face morphogenesis; IEA:Ensembl
P08253	MMP2	72 kDa type IV collagenase	GO:0001957; P:intramembranous ossification; IEA:Ensembl
P08253	MMP2	72 kDa type IV collagenase	GO:0006508; P:proteolysis; TAS:ProtInc
P08253	MMP2	72 kDa type IV collagenase	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q9H239	MMP28	Matrix metalloproteinase-28	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9H239	MMP28	Matrix metalloproteinase-28	GO:0004222; F:metalloendopeptidase activity; TAS:UniProtKB
Q9H239	MMP28	Matrix metalloproteinase-28	GO:0008270; F:zinc ion binding; IEA:InterPro
P08254	MMP3	Stromelysin-1	GO:0005509; F:calcium ion binding; IEA:InterPro
P08254	MMP3	Stromelysin-1	GO:0004222; F:metalloendopeptidase activity; TAS:ProtInc
P08254	MMP3	Stromelysin-1	GO:0008270; F:zinc ion binding; IEA:InterPro
P08254	MMP3	Stromelysin-1	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
P08254	MMP3	Stromelysin-1	GO:0030574; P:collagen catabolic process; TAS:Reactome
P08254	MMP3	Stromelysin-1	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P08254	MMP3	Stromelysin-1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P08254	MMP3	Stromelysin-1	GO:0006508; P:proteolysis; TAS:ProtInc
P08254	MMP3	Stromelysin-1	GO:0030334; P:regulation of cell migration; IEA:Ensembl
P09237	MMP7	Matrilysin	GO:0004222; F:metalloendopeptidase activity; TAS:ProtInc
P09237	MMP7	Matrilysin	GO:0008270; F:zinc ion binding; IEA:InterPro
P09237	MMP7	Matrilysin	GO:0002779; P:antibacterial peptide secretion; IEA:Ensembl
P09237	MMP7	Matrilysin	GO:0030574; P:collagen catabolic process; TAS:Reactome
P09237	MMP7	Matrilysin	GO:0050829; P:defense response to Gram-negative bacterium; IEA:Ensembl
P09237	MMP7	Matrilysin	GO:0050830; P:defense response to Gram-positive bacterium; IEA:Ensembl
P09237	MMP7	Matrilysin	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P09237	MMP7	Matrilysin	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P09237	MMP7	Matrilysin	GO:0006508; P:proteolysis; TAS:ProtInc
P09237	MMP7	Matrilysin	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P09237	MMP7	Matrilysin	GO:0042493; P:response to drug; IEA:Ensembl
P22894	MMP8	Neutrophil collagenase	GO:0005509; F:calcium ion binding; IEA:InterPro
P22894	MMP8	Neutrophil collagenase	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
P22894	MMP8	Neutrophil collagenase	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
P22894	MMP8	Neutrophil collagenase	GO:0008270; F:zinc ion binding; TAS:UniProtKB
P22894	MMP8	Neutrophil collagenase	GO:0030574; P:collagen catabolic process; TAS:Reactome
P22894	MMP8	Neutrophil collagenase	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P22894	MMP8	Neutrophil collagenase	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P22894	MMP8	Neutrophil collagenase	GO:0006508; P:proteolysis; IDA:UniProtKB
P14780	MMP9	Matrix metalloproteinase-9	GO:0005518; F:collagen binding; TAS:UniProtKB
P14780	MMP9	Matrix metalloproteinase-9	GO:0042802; F:identical protein binding; IPI:IntAct
P14780	MMP9	Matrix metalloproteinase-9	GO:0004222; F:metalloendopeptidase activity; IDA:UniProtKB
P14780	MMP9	Matrix metalloproteinase-9	GO:0005515; F:protein binding; IPI:UniProtKB
P14780	MMP9	Matrix metalloproteinase-9	GO:0008270; F:zinc ion binding; TAS:UniProtKB
P14780	MMP9	Matrix metalloproteinase-9	GO:0030574; P:collagen catabolic process; TAS:Reactome
P14780	MMP9	Matrix metalloproteinase-9	GO:0007566; P:embryo implantation; IEA:Ensembl
P14780	MMP9	Matrix metalloproteinase-9	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P14780	MMP9	Matrix metalloproteinase-9	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P14780	MMP9	Matrix metalloproteinase-9	GO:0050900; P:leukocyte migration; IEA:InterPro
P14780	MMP9	Matrix metalloproteinase-9	GO:0030225; P:macrophage differentiation; TAS:UniProtKB
P14780	MMP9	Matrix metalloproteinase-9	GO:2001258; P:negative regulation of cation channel activity; IDA:UniProt
P14780	MMP9	Matrix metalloproteinase-9	GO:0001503; P:ossification; IEA:InterPro
P14780	MMP9	Matrix metalloproteinase-9	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P14780	MMP9	Matrix metalloproteinase-9	GO:0051549; P:positive regulation of keratinocyte migration; IMP:BHF-UCL
P14780	MMP9	Matrix metalloproteinase-9	GO:1900122; P:positive regulation of receptor binding; IDA:UniProt
P14780	MMP9	Matrix metalloproteinase-9	GO:0006508; P:proteolysis; IDA:UniProtKB
P14780	MMP9	Matrix metalloproteinase-9	GO:0001501; P:skeletal system development; IEA:Ensembl
Q13201	MMRN1	Multimerin-1	GO:0007596; P:blood coagulation; TAS:Reactome
Q13201	MMRN1	Multimerin-1	GO:0007155; P:cell adhesion; TAS:ProtInc
Q13201	MMRN1	Multimerin-1	GO:0030168; P:platelet activation; TAS:Reactome
Q13201	MMRN1	Multimerin-1	GO:0002576; P:platelet degranulation; TAS:Reactome
Q9H8L6	MMRN2	Multimerin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H8L6	MMRN2	Multimerin-2	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q9H8L6	MMRN2	Multimerin-2	GO:0090051; P:negative regulation of cell migration involved in sprouting angiogenesis; IDA:UniProtKB
Q9H8L6	MMRN2	Multimerin-2	GO:0030948; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; IDA:UniProtKB
Q96T76	MMS19	MMS19 nucleotide excision repair protein homolog	GO:0030331; F:estrogen receptor binding; IPI:UniProtKB
Q96T76	MMS19	MMS19 nucleotide excision repair protein homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q96T76	MMS19	MMS19 nucleotide excision repair protein homolog	GO:0030674; F:protein binding, bridging; NAS:UniProtKB
Q96T76	MMS19	MMS19 nucleotide excision repair protein homolog	GO:0030159; F:receptor signaling complex scaffold activity; NAS:UniProtKB
Q96T76	MMS19	MMS19 nucleotide excision repair protein homolog	GO:0003713; F:transcription coactivator activity; IMP:UniProtKB
Q96T76	MMS19	MMS19 nucleotide excision repair protein homolog	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
Q96T76	MMS19	MMS19 nucleotide excision repair protein homolog	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q96T76	MMS19	MMS19 nucleotide excision repair protein homolog	GO:0006259; P:DNA metabolic process; IMP:UniProtKB
Q96T76	MMS19	MMS19 nucleotide excision repair protein homolog	GO:0006281; P:DNA repair; IMP:UniProtKB
Q96T76	MMS19	MMS19 nucleotide excision repair protein homolog	GO:0016226; P:iron-sulfur cluster assembly; IMP:UniProtKB
Q96T76	MMS19	MMS19 nucleotide excision repair protein homolog	GO:0006289; P:nucleotide-excision repair; NAS:UniProtKB
Q96T76	MMS19	MMS19 nucleotide excision repair protein homolog	GO:0000160; P:phosphorelay signal transduction system; NAS:UniProtKB
Q96T76	MMS19	MMS19 nucleotide excision repair protein homolog	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q96T76	MMS19	MMS19 nucleotide excision repair protein homolog	GO:0009725; P:response to hormone; NAS:UniProtKB
Q96T76	MMS19	MMS19 nucleotide excision repair protein homolog	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96T76	MMS19	MMS19 nucleotide excision repair protein homolog	GO:0006351; P:transcription, DNA-templated; NAS:UniProtKB
Q6ZRQ5	MMS22L	Protein MMS22-like	GO:0005515; F:protein binding; IPI:UniProtKB
Q6ZRQ5	MMS22L	Protein MMS22-like	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
Q6ZRQ5	MMS22L	Protein MMS22-like	GO:0031297; P:replication fork processing; IMP:UniProtKB
Q02252	ALDH6A1	Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial	GO:0000062; F:fatty-acyl-CoA binding; ISS:UniProtKB
Q02252	ALDH6A1	Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial	GO:0018478; F:malonate-semialdehyde dehydrogenase (acetylating) activity; ISS:UniProtKB
Q02252	ALDH6A1	Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial	GO:0004491; F:methylmalonate-semialdehyde dehydrogenase (acylating) activity; ISS:UniProtKB
Q02252	ALDH6A1	Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q02252	ALDH6A1	Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial	GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome
Q02252	ALDH6A1	Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
Q02252	ALDH6A1	Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q02252	ALDH6A1	Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q02252	ALDH6A1	Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial	GO:0006210; P:thymine catabolic process; IMP:BHF-UCL
Q02252	ALDH6A1	Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial	GO:0019859; P:thymine metabolic process; ISS:UniProtKB
Q02252	ALDH6A1	Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial	GO:0006574; P:valine catabolic process; IMP:BHF-UCL
Q02252	ALDH6A1	Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial	GO:0006573; P:valine metabolic process; ISS:UniProtKB
Q9BU76	MMTAG2	Multiple myeloma tumor-associated protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BU76	MMTAG2	Multiple myeloma tumor-associated protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q10571	MN1	Probable tumor suppressor protein MN1	GO:0001957; P:intramembranous ossification; IEA:Ensembl
Q9BWT6	MND1	Meiotic nuclear division protein 1 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BWT6	MND1	Meiotic nuclear division protein 1 homolog	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q9BWT6	MND1	Meiotic nuclear division protein 1 homolog	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
P41218	MNDA	Myeloid cell nuclear differentiation antigen	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P41218	MNDA	Myeloid cell nuclear differentiation antigen	GO:0005515; F:protein binding; IPI:IntAct
P41218	MNDA	Myeloid cell nuclear differentiation antigen	GO:0050853; P:B cell receptor signaling pathway; IMP:UniProtKB
P41218	MNDA	Myeloid cell nuclear differentiation antigen	GO:0006968; P:cellular defense response; TAS:ProtInc
P41218	MNDA	Myeloid cell nuclear differentiation antigen	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
P41218	MNDA	Myeloid cell nuclear differentiation antigen	GO:0030889; P:negative regulation of B cell proliferation; IMP:UniProtKB
P41218	MNDA	Myeloid cell nuclear differentiation antigen	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
P41218	MNDA	Myeloid cell nuclear differentiation antigen	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P41218	MNDA	Myeloid cell nuclear differentiation antigen	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NEH6	MNS1	Meiosis-specific nuclear structural protein 1	GO:0042802; F:identical protein binding; IDA:MGI
Q8NEH6	MNS1	Meiosis-specific nuclear structural protein 1	GO:0044782; P:cilium organization; IEA:Ensembl
Q8NEH6	MNS1	Meiosis-specific nuclear structural protein 1	GO:0070986; P:left/right axis specification; IEA:Ensembl
Q8NEH6	MNS1	Meiosis-specific nuclear structural protein 1	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q99583	MNT	Max-binding protein MNT	GO:0003682; F:chromatin binding; IEA:Ensembl
Q99583	MNT	Max-binding protein MNT	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q99583	MNT	Max-binding protein MNT	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q99583	MNT	Max-binding protein MNT	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q99583	MNT	Max-binding protein MNT	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q99583	MNT	Max-binding protein MNT	GO:0007569; P:cell aging; IEA:Ensembl
Q99583	MNT	Max-binding protein MNT	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q99583	MNT	Max-binding protein MNT	GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl
Q99583	MNT	Max-binding protein MNT	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q99583	MNT	Max-binding protein MNT	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
Q99583	MNT	Max-binding protein MNT	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P50219	MNX1	Motor neuron and pancreas homeobox protein 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P50219	MNX1	Motor neuron and pancreas homeobox protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P50219	MNX1	Motor neuron and pancreas homeobox protein 1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P50219	MNX1	Motor neuron and pancreas homeobox protein 1	GO:0060539; P:diaphragm development; IEA:Ensembl
P50219	MNX1	Motor neuron and pancreas homeobox protein 1	GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl
P50219	MNX1	Motor neuron and pancreas homeobox protein 1	GO:0031018; P:endocrine pancreas development; IEA:Ensembl
P50219	MNX1	Motor neuron and pancreas homeobox protein 1	GO:0006959; P:humoral immune response; TAS:ProtInc
P50219	MNX1	Motor neuron and pancreas homeobox protein 1	GO:0008045; P:motor neuron axon guidance; IEA:Ensembl
P50219	MNX1	Motor neuron and pancreas homeobox protein 1	GO:0021675; P:nerve development; IEA:Ensembl
P50219	MNX1	Motor neuron and pancreas homeobox protein 1	GO:0001764; P:neuron migration; IEA:Ensembl
P50219	MNX1	Motor neuron and pancreas homeobox protein 1	GO:0009791; P:post-embryonic development; IEA:Ensembl
P50219	MNX1	Motor neuron and pancreas homeobox protein 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P50219	MNX1	Motor neuron and pancreas homeobox protein 1	GO:0021520; P:spinal cord motor neuron cell fate specification; IEA:Ensembl
P50219	MNX1	Motor neuron and pancreas homeobox protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TD46	CD200R1	Cell surface glycoprotein CD200 receptor 1	GO:0005515; F:protein binding; IPI:IntAct
Q8TD46	CD200R1	Cell surface glycoprotein CD200 receptor 1	GO:0050776; P:regulation of immune response; TAS:Reactome
Q8TD46	CD200R1	Cell surface glycoprotein CD200 receptor 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9UBU8	MORF4L1	Mortality factor 4-like protein 1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9UBU8	MORF4L1	Mortality factor 4-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBU8	MORF4L1	Mortality factor 4-like protein 1	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q9UBU8	MORF4L1	Mortality factor 4-like protein 1	GO:0008283; P:cell proliferation; IEA:Ensembl
Q9UBU8	MORF4L1	Mortality factor 4-like protein 1	GO:0006325; P:chromatin organization; TAS:Reactome
Q9UBU8	MORF4L1	Mortality factor 4-like protein 1	GO:0000724; P:double-strand break repair via homologous recombination; IDA:UniProtKB
Q9UBU8	MORF4L1	Mortality factor 4-like protein 1	GO:0016575; P:histone deacetylation; IDA:UniProtKB
Q9UBU8	MORF4L1	Mortality factor 4-like protein 1	GO:0043968; P:histone H2A acetylation; IDA:UniProtKB
Q9UBU8	MORF4L1	Mortality factor 4-like protein 1	GO:0043967; P:histone H4 acetylation; IDA:UniProtKB
Q9UBU8	MORF4L1	Mortality factor 4-like protein 1	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q9UBU8	MORF4L1	Mortality factor 4-like protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UBU8	MORF4L1	Mortality factor 4-like protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15014	MORF4L2	Mortality factor 4-like protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q15014	MORF4L2	Mortality factor 4-like protein 2	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q15014	MORF4L2	Mortality factor 4-like protein 2	GO:0006325; P:chromatin organization; TAS:Reactome
Q15014	MORF4L2	Mortality factor 4-like protein 2	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q15014	MORF4L2	Mortality factor 4-like protein 2	GO:0051155; P:positive regulation of striated muscle cell differentiation; IEA:Ensembl
Q15014	MORF4L2	Mortality factor 4-like protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q15014	MORF4L2	Mortality factor 4-like protein 2	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q15014	MORF4L2	Mortality factor 4-like protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96BY2	MOAP1	Modulator of apoptosis 1	GO:0005515; F:protein binding; IPI:HGNC
Q96BY2	MOAP1	Modulator of apoptosis 1	GO:0031625; F:ubiquitin protein ligase binding; IPI:BHF-UCL
Q96BY2	MOAP1	Modulator of apoptosis 1	GO:0097190; P:apoptotic signaling pathway; IDA:BHF-UCL
Q96BY2	MOAP1	Modulator of apoptosis 1	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IMP:BHF-UCL
Q96BY2	MOAP1	Modulator of apoptosis 1	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IMP:BHF-UCL
Q96BY2	MOAP1	Modulator of apoptosis 1	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IMP:BHF-UCL
Q96BY2	MOAP1	Modulator of apoptosis 1	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q96BY2	MOAP1	Modulator of apoptosis 1	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IMP:BHF-UCL
Q96BY2	MOAP1	Modulator of apoptosis 1	GO:0001844; P:protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; IMP:BHF-UCL
Q9H8S9	MOB1A	MOB kinase activator 1A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H8S9	MOB1A	MOB kinase activator 1A	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H8S9	MOB1A	MOB kinase activator 1A	GO:0035329; P:hippo signaling; IDA:UniProtKB
Q7L9L4	MOB1B	MOB kinase activator 1B	GO:0019209; F:kinase activator activity; IDA:UniProtKB
Q7L9L4	MOB1B	MOB kinase activator 1B	GO:0019900; F:kinase binding; IPI:UniProtKB
Q7L9L4	MOB1B	MOB kinase activator 1B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7L9L4	MOB1B	MOB kinase activator 1B	GO:0005515; F:protein binding; IPI:UniProtKB
Q7L9L4	MOB1B	MOB kinase activator 1B	GO:0035329; P:hippo signaling; IDA:UniProtKB
Q7L9L4	MOB1B	MOB kinase activator 1B	GO:0042327; P:positive regulation of phosphorylation; IDA:GOC
Q7L9L4	MOB1B	MOB kinase activator 1B	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q70IA6	MOB2	MOB kinase activator 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q70IA6	MOB2	MOB kinase activator 2	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
Q70IA6	MOB2	MOB kinase activator 2	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
Q70IA6	MOB2	MOB kinase activator 2	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
Q96BX8	MOB3A	MOB kinase activator 3A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86TA1	MOB3B	MOB kinase activator 3B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86TA1	MOB3B	MOB kinase activator 3B	GO:0005515; F:protein binding; IPI:IntAct
Q70IA8	MOB3C	MOB kinase activator 3C	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13875	MOBP	Myelin-associated oligodendrocyte basic protein	GO:0019911; F:structural constituent of myelin sheath; IEA:Ensembl
Q13875	MOBP	Myelin-associated oligodendrocyte basic protein	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q13875	MOBP	Myelin-associated oligodendrocyte basic protein	GO:0007399; P:nervous system development; TAS:ProtInc
O96033	MOCS2	Molybdopterin synthase sulfur carrier subunit	GO:0030366; F:molybdopterin synthase activity; IEA:UniProtKB-HAMAP
O96033	MOCS2	Molybdopterin synthase sulfur carrier subunit	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
O96033	MOCS2	Molybdopterin synthase sulfur carrier subunit	GO:0006777; P:Mo-molybdopterin cofactor biosynthetic process; IDA:UniProtKB
O96033	MOCS2	Molybdopterin synthase sulfur carrier subunit	GO:0032324; P:molybdopterin cofactor biosynthetic process; TAS:Reactome
O96033	MOCS2	Molybdopterin synthase sulfur carrier subunit	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O96033	MOCS2	Molybdopterin synthase sulfur carrier subunit	GO:0006766; P:vitamin metabolic process; TAS:Reactome
O96033	MOCS2	Molybdopterin synthase sulfur carrier subunit	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
O96007	MOCS2	Molybdopterin synthase catalytic subunit	GO:0030366; F:molybdopterin synthase activity; IDA:UniProtKB
O96007	MOCS2	Molybdopterin synthase catalytic subunit	GO:0006777; P:Mo-molybdopterin cofactor biosynthetic process; IDA:UniProtKB
O96007	MOCS2	Molybdopterin synthase catalytic subunit	GO:0032324; P:molybdopterin cofactor biosynthetic process; TAS:Reactome
O96007	MOCS2	Molybdopterin synthase catalytic subunit	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O96007	MOCS2	Molybdopterin synthase catalytic subunit	GO:0006766; P:vitamin metabolic process; TAS:Reactome
O96007	MOCS2	Molybdopterin synthase catalytic subunit	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q96EN8	MOCOS	Molybdenum cofactor sulfurase	GO:0016829; F:lyase activity; IEA:UniProtKB-HAMAP
Q96EN8	MOCOS	Molybdenum cofactor sulfurase	GO:0008265; F:Mo-molybdopterin cofactor sulfurase activity; IMP:UniProtKB
Q96EN8	MOCOS	Molybdenum cofactor sulfurase	GO:0030151; F:molybdenum ion binding; IEA:UniProtKB-HAMAP
Q96EN8	MOCOS	Molybdenum cofactor sulfurase	GO:0030170; F:pyridoxal phosphate binding; IEA:UniProtKB-HAMAP
Q96EN8	MOCOS	Molybdenum cofactor sulfurase	GO:0016740; F:transferase activity; IEA:UniProtKB-KW
Q96EN8	MOCOS	Molybdenum cofactor sulfurase	GO:0006777; P:Mo-molybdopterin cofactor biosynthetic process; IEA:UniProtKB-HAMAP
Q96EN8	MOCOS	Molybdenum cofactor sulfurase	GO:0032324; P:molybdopterin cofactor biosynthetic process; TAS:Reactome
Q96EN8	MOCOS	Molybdenum cofactor sulfurase	GO:0043545; P:molybdopterin cofactor metabolic process; IMP:UniProtKB
Q96EN8	MOCOS	Molybdenum cofactor sulfurase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96EN8	MOCOS	Molybdenum cofactor sulfurase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q96EN8	MOCOS	Molybdenum cofactor sulfurase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9NZB8	MOCS1	Molybdenum cofactor biosynthesis protein 1	GO:0051539; F:4 iron, 4 sulfur cluster binding; IDA:UniProtKB
Q9NZB8	MOCS1	Molybdenum cofactor biosynthesis protein 1	GO:0061597; F:cyclic pyranopterin monophosphate synthase activity; IEA:UniProtKB-EC
Q9NZB8	MOCS1	Molybdenum cofactor biosynthesis protein 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9NZB8	MOCS1	Molybdenum cofactor biosynthesis protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NZB8	MOCS1	Molybdenum cofactor biosynthesis protein 1	GO:0006777; P:Mo-molybdopterin cofactor biosynthetic process; IDA:UniProtKB
Q9NZB8	MOCS1	Molybdenum cofactor biosynthesis protein 1	GO:0032324; P:molybdopterin cofactor biosynthetic process; TAS:Reactome
Q9NZB8	MOCS1	Molybdenum cofactor biosynthesis protein 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NZB8	MOCS1	Molybdenum cofactor biosynthesis protein 1	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9NZB8	MOCS1	Molybdenum cofactor biosynthesis protein 1	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
O95396	MOCS3	Adenylyltransferase and sulfurtransferase MOCS3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O95396	MOCS3	Adenylyltransferase and sulfurtransferase MOCS3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95396	MOCS3	Adenylyltransferase and sulfurtransferase MOCS3	GO:0061605; F:molybdopterin-synthase adenylyltransferase activity; IEA:UniProtKB-EC
O95396	MOCS3	Adenylyltransferase and sulfurtransferase MOCS3	GO:0061604; F:molybdopterin-synthase sulfurtransferase activity; IEA:UniProtKB-EC
O95396	MOCS3	Adenylyltransferase and sulfurtransferase MOCS3	GO:0016779; F:nucleotidyltransferase activity; IDA:UniProtKB
O95396	MOCS3	Adenylyltransferase and sulfurtransferase MOCS3	GO:0005515; F:protein binding; IPI:UniProtKB
O95396	MOCS3	Adenylyltransferase and sulfurtransferase MOCS3	GO:0016783; F:sulfurtransferase activity; IDA:UniProtKB
O95396	MOCS3	Adenylyltransferase and sulfurtransferase MOCS3	GO:0004792; F:thiosulfate sulfurtransferase activity; IMP:UniProtKB
O95396	MOCS3	Adenylyltransferase and sulfurtransferase MOCS3	GO:0042292; F:URM1 activating enzyme activity; IDA:UniProtKB
O95396	MOCS3	Adenylyltransferase and sulfurtransferase MOCS3	GO:0018192; P:enzyme active site formation via L-cysteine persulfide; IDA:UniProtKB
O95396	MOCS3	Adenylyltransferase and sulfurtransferase MOCS3	GO:0006777; P:Mo-molybdopterin cofactor biosynthetic process; IDA:UniProtKB
O95396	MOCS3	Adenylyltransferase and sulfurtransferase MOCS3	GO:0032324; P:molybdopterin cofactor biosynthetic process; TAS:Reactome
O95396	MOCS3	Adenylyltransferase and sulfurtransferase MOCS3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95396	MOCS3	Adenylyltransferase and sulfurtransferase MOCS3	GO:0034227; P:tRNA thio-modification; IDA:UniProtKB
O95396	MOCS3	Adenylyltransferase and sulfurtransferase MOCS3	GO:0002143; P:tRNA wobble position uridine thiolation; IEA:InterPro
O95396	MOCS3	Adenylyltransferase and sulfurtransferase MOCS3	GO:0002098; P:tRNA wobble uridine modification; IDA:UniProtKB
O95396	MOCS3	Adenylyltransferase and sulfurtransferase MOCS3	GO:0006766; P:vitamin metabolic process; TAS:Reactome
O95396	MOCS3	Adenylyltransferase and sulfurtransferase MOCS3	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9H3H1	TRIT1	tRNA dimethylallyltransferase, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H3H1	TRIT1	tRNA dimethylallyltransferase, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H3H1	TRIT1	tRNA dimethylallyltransferase, mitochondrial	GO:0052381; F:tRNA dimethylallyltransferase activity; TAS:UniProtKB
Q9H3H1	TRIT1	tRNA dimethylallyltransferase, mitochondrial	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
P26038	MSN	Moesin	GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL
P26038	MSN	Moesin	GO:0003725; F:double-stranded RNA binding; IDA:MGI
P26038	MSN	Moesin	GO:0005515; F:protein binding; IPI:UniProtKB
P26038	MSN	Moesin	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P26038	MSN	Moesin	GO:0005102; F:receptor binding; IPI:UniProtKB
P26038	MSN	Moesin	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P26038	MSN	Moesin	GO:0006928; P:cellular component movement; TAS:UniProtKB
P26038	MSN	Moesin	GO:0061028; P:establishment of endothelial barrier; IGI:UniProt
P26038	MSN	Moesin	GO:0007159; P:leukocyte cell-cell adhesion; IEP:BHF-UCL
P26038	MSN	Moesin	GO:0050900; P:leukocyte migration; IEP:BHF-UCL
P26038	MSN	Moesin	GO:0022614; P:membrane to membrane docking; IEP:BHF-UCL
P26038	MSN	Moesin	GO:0010628; P:positive regulation of gene expression; IGI:UniProt
P26038	MSN	Moesin	GO:2000401; P:regulation of lymphocyte migration; IMP:UniProtKB
Q9Y605	MRFAP1	MORF4 family-associated protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HD47	RANGRF	Ran guanine nucleotide release factor	GO:0005085; F:guanyl-nucleotide exchange factor activity; ISS:BHF-UCL
Q9HD47	RANGRF	Ran guanine nucleotide release factor	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q9HD47	RANGRF	Ran guanine nucleotide release factor	GO:0008565; F:protein transporter activity; IMP:BHF-UCL
Q9HD47	RANGRF	Ran guanine nucleotide release factor	GO:0008536; F:Ran GTPase binding; IPI:BHF-UCL
Q9HD47	RANGRF	Ran guanine nucleotide release factor	GO:0017080; F:sodium channel regulator activity; IDA:BHF-UCL
Q9HD47	RANGRF	Ran guanine nucleotide release factor	GO:0006888; P:ER to Golgi vesicle-mediated transport; IMP:BHF-UCL
Q9HD47	RANGRF	Ran guanine nucleotide release factor	GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; IMP:BHF-UCL
Q9HD47	RANGRF	Ran guanine nucleotide release factor	GO:2000010; P:positive regulation of protein localization to cell surface; IDA:BHF-UCL
Q9HD47	RANGRF	Ran guanine nucleotide release factor	GO:0032527; P:protein exit from endoplasmic reticulum; IMP:BHF-UCL
Q9HD47	RANGRF	Ran guanine nucleotide release factor	GO:0043087; P:regulation of GTPase activity; ISS:GOC
Q9HD47	RANGRF	Ran guanine nucleotide release factor	GO:0002027; P:regulation of heart rate; TAS:BHF-UCL
Q9HD47	RANGRF	Ran guanine nucleotide release factor	GO:0003254; P:regulation of membrane depolarization; IDA:BHF-UCL
Q9HD47	RANGRF	Ran guanine nucleotide release factor	GO:1900825; P:regulation of membrane depolarization during cardiac muscle cell action potential; TAS:BHF-UCL
Q9HD47	RANGRF	Ran guanine nucleotide release factor	GO:0042391; P:regulation of membrane potential; IDA:BHF-UCL
Q9HD47	RANGRF	Ran guanine nucleotide release factor	GO:1902305; P:regulation of sodium ion transmembrane transport; IDA:BHF-UCL
Q9HD47	RANGRF	Ran guanine nucleotide release factor	GO:2000649; P:regulation of sodium ion transmembrane transporter activity; IDA:BHF-UCL
Q13724	MOGS	Mannosyl-oligosaccharide glucosidase	GO:0015926; F:glucosidase activity; TAS:ProtInc
Q13724	MOGS	Mannosyl-oligosaccharide glucosidase	GO:0004573; F:mannosyl-oligosaccharide glucosidase activity; IEA:UniProtKB-EC
Q13724	MOGS	Mannosyl-oligosaccharide glucosidase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q13724	MOGS	Mannosyl-oligosaccharide glucosidase	GO:0009311; P:oligosaccharide metabolic process; IEA:InterPro
Q13724	MOGS	Mannosyl-oligosaccharide glucosidase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q13724	MOGS	Mannosyl-oligosaccharide glucosidase	GO:0006457; P:protein folding; TAS:Reactome
Q13724	MOGS	Mannosyl-oligosaccharide glucosidase	GO:0006487; P:protein N-linked glycosylation; TAS:ProtInc
Q13724	MOGS	Mannosyl-oligosaccharide glucosidase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q96PD6	MOGAT1	2-acylglycerol O-acyltransferase 1	GO:0003846; F:2-acylglycerol O-acyltransferase activity; IEA:UniProtKB-EC
Q96PD6	MOGAT1	2-acylglycerol O-acyltransferase 1	GO:0004144; F:diacylglycerol O-acyltransferase activity; IEA:Ensembl
Q96PD6	MOGAT1	2-acylglycerol O-acyltransferase 1	GO:0006651; P:diacylglycerol biosynthetic process; IEA:Ensembl
Q96PD6	MOGAT1	2-acylglycerol O-acyltransferase 1	GO:0006071; P:glycerol metabolic process; IEA:UniProtKB-KW
Q96PD6	MOGAT1	2-acylglycerol O-acyltransferase 1	GO:0019432; P:triglyceride biosynthetic process; IEA:UniProtKB-UniPathway
Q3SYC2	MOGAT2	2-acylglycerol O-acyltransferase 2	GO:0003846; F:2-acylglycerol O-acyltransferase activity; IEA:UniProtKB-EC
Q3SYC2	MOGAT2	2-acylglycerol O-acyltransferase 2	GO:0016407; F:acetyltransferase activity; IEA:Ensembl
Q3SYC2	MOGAT2	2-acylglycerol O-acyltransferase 2	GO:0006651; P:diacylglycerol biosynthetic process; IEA:Ensembl
Q3SYC2	MOGAT2	2-acylglycerol O-acyltransferase 2	GO:0006071; P:glycerol metabolic process; IEA:UniProtKB-KW
Q3SYC2	MOGAT2	2-acylglycerol O-acyltransferase 2	GO:0050892; P:intestinal absorption; IEA:Ensembl
Q3SYC2	MOGAT2	2-acylglycerol O-acyltransferase 2	GO:0019432; P:triglyceride biosynthetic process; IEA:UniProtKB-UniPathway
Q86VF5	MOGAT3	2-acylglycerol O-acyltransferase 3	GO:0003846; F:2-acylglycerol O-acyltransferase activity; IEA:UniProtKB-EC
Q86VF5	MOGAT3	2-acylglycerol O-acyltransferase 3	GO:0004144; F:diacylglycerol O-acyltransferase activity; IEA:UniProtKB-EC
Q86VF5	MOGAT3	2-acylglycerol O-acyltransferase 3	GO:0006071; P:glycerol metabolic process; IEA:UniProtKB-KW
Q86VF5	MOGAT3	2-acylglycerol O-acyltransferase 3	GO:0019432; P:triglyceride biosynthetic process; IEA:UniProtKB-UniPathway
Q16653	MOG	Myelin-oligodendrocyte glycoprotein	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q16653	MOG	Myelin-oligodendrocyte glycoprotein	GO:0007417; P:central nervous system development; TAS:ProtInc
Q16653	MOG	Myelin-oligodendrocyte glycoprotein	GO:0034126; P:positive regulation of MyD88-dependent toll-like receptor signaling pathway; ISS:BHF-UCL
Q9UQ07	MOK	MAPK/MAK/MRK overlapping kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UQ07	MOK	MAPK/MAK/MRK overlapping kinase	GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC
Q9UQ07	MOK	MAPK/MAK/MRK overlapping kinase	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q9UQ07	MOK	MAPK/MAK/MRK overlapping kinase	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q9UQ07	MOK	MAPK/MAK/MRK overlapping kinase	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q9UQ07	MOK	MAPK/MAK/MRK overlapping kinase	GO:0007165; P:signal transduction; TAS:ProtInc
Q7L1V2	MON1B	Vacuolar fusion protein MON1 homolog B	GO:0005515; F:protein binding; IPI:IntAct
Q7Z3U7	MON2	Protein MON2 homolog	GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; IBA:RefGenome
Q7Z3U7	MON2	Protein MON2 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q7Z3U7	MON2	Protein MON2 homolog	GO:0030036; P:actin cytoskeleton organization; IBA:RefGenome
Q7Z3U7	MON2	Protein MON2 homolog	GO:0006895; P:Golgi to endosome transport; ISS:HGNC
Q7Z3U7	MON2	Protein MON2 homolog	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q7Z3U7	MON2	Protein MON2 homolog	GO:0043087; P:regulation of GTPase activity; IBA:GOC
Q7Z3U7	MON2	Protein MON2 homolog	GO:0016192; P:vesicle-mediated transport; IBA:RefGenome
Q86VD1	MORC1	MORC family CW-type zinc finger protein 1	GO:0005524; F:ATP binding; IEA:InterPro
Q86VD1	MORC1	MORC family CW-type zinc finger protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86VD1	MORC1	MORC family CW-type zinc finger protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q86VD1	MORC1	MORC family CW-type zinc finger protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q86VD1	MORC1	MORC family CW-type zinc finger protein 1	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q9Y6X9	MORC2	MORC family CW-type zinc finger protein 2	GO:0005524; F:ATP binding; IEA:InterPro
Q9Y6X9	MORC2	MORC family CW-type zinc finger protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q14149	MORC3	MORC family CW-type zinc finger protein 3	GO:0005524; F:ATP binding; IEA:InterPro
Q14149	MORC3	MORC family CW-type zinc finger protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q14149	MORC3	MORC family CW-type zinc finger protein 3	GO:0007569; P:cell aging; IDA:MGI
Q14149	MORC3	MORC family CW-type zinc finger protein 3	GO:0051457; P:maintenance of protein location in nucleus; IDA:MGI
Q14149	MORC3	MORC family CW-type zinc finger protein 3	GO:0048147; P:negative regulation of fibroblast proliferation; IDA:MGI
Q14149	MORC3	MORC family CW-type zinc finger protein 3	GO:0018105; P:peptidyl-serine phosphorylation; IDA:MGI
Q14149	MORC3	MORC family CW-type zinc finger protein 3	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q14149	MORC3	MORC family CW-type zinc finger protein 3	GO:0006468; P:protein phosphorylation; IDA:MGI
Q14149	MORC3	MORC family CW-type zinc finger protein 3	GO:0050821; P:protein stabilization; IDA:MGI
Q8TE76	MORC4	MORC family CW-type zinc finger protein 4	GO:0005524; F:ATP binding; IEA:InterPro
Q8TE76	MORC4	MORC family CW-type zinc finger protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q8TE76	MORC4	MORC family CW-type zinc finger protein 4	GO:0008270; F:zinc ion binding; IEA:InterPro
DR   GO:0007067; P:mitosis; IEA:UniProtKB-KW
P00540	MOS	Proto-oncogene serine/threonine-protein kinase mos	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P00540	MOS	Proto-oncogene serine/threonine-protein kinase mos	GO:0004709; F:MAP kinase kinase kinase activity; ISS:UniProt
P00540	MOS	Proto-oncogene serine/threonine-protein kinase mos	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProt
P00540	MOS	Proto-oncogene serine/threonine-protein kinase mos	GO:0000187; P:activation of MAPK activity; ISS:UniProt
P00540	MOS	Proto-oncogene serine/threonine-protein kinase mos	GO:0000186; P:activation of MAPKK activity; ISS:UniProt
P00540	MOS	Proto-oncogene serine/threonine-protein kinase mos	GO:0006325; P:chromatin organization; ISS:UniProt
P00540	MOS	Proto-oncogene serine/threonine-protein kinase mos	GO:0051296; P:establishment of meiotic spindle orientation; ISS:UniProt
P00540	MOS	Proto-oncogene serine/threonine-protein kinase mos	GO:0000165; P:MAPK cascade; ISS:GOC
P00540	MOS	Proto-oncogene serine/threonine-protein kinase mos	GO:0000212; P:meiotic spindle organization; ISS:UniProt
P00540	MOS	Proto-oncogene serine/threonine-protein kinase mos	GO:1902103; P:negative regulation of metaphase/anaphase transition of meiotic cell cycle; ISS:UniProt
P00540	MOS	Proto-oncogene serine/threonine-protein kinase mos	GO:0046777; P:protein autophosphorylation; ISS:UniProt
P00540	MOS	Proto-oncogene serine/threonine-protein kinase mos	GO:0040020; P:regulation of meiosis; IEA:Ensembl
Q8TF71	SLC16A10	Monocarboxylate transporter 10	GO:0006865; P:amino acid transport; TAS:Reactome
Q8TF71	SLC16A10	Monocarboxylate transporter 10	GO:0015801; P:aromatic amino acid transport; TAS:HGNC
Q8TF71	SLC16A10	Monocarboxylate transporter 10	GO:0006811; P:ion transport; TAS:Reactome
Q8TF71	SLC16A10	Monocarboxylate transporter 10	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8NCK7	SLC16A11	Monocarboxylate transporter 11	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q8NCK7	SLC16A11	Monocarboxylate transporter 11	GO:0006629; P:lipid metabolic process; IDA:UniProtKB
Q6ZSM3	SLC16A12	Monocarboxylate transporter 12	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q7RTY0	SLC16A13	Monocarboxylate transporter 13	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q7RTX9	SLC16A14	Monocarboxylate transporter 14	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
P53985	SLC16A1	Monocarboxylate transporter 1	GO:0015130; F:mevalonate transmembrane transporter activity; TAS:ProtInc
P53985	SLC16A1	Monocarboxylate transporter 1	GO:0008028; F:monocarboxylic acid transmembrane transporter activity; TAS:ProtInc
P53985	SLC16A1	Monocarboxylate transporter 1	GO:0097159; F:organic cyclic compound binding; IEA:Ensembl
P53985	SLC16A1	Monocarboxylate transporter 1	GO:0015355; F:secondary active monocarboxylate transmembrane transporter activity; IEA:InterPro
P53985	SLC16A1	Monocarboxylate transporter 1	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
P53985	SLC16A1	Monocarboxylate transporter 1	GO:0007596; P:blood coagulation; TAS:Reactome
P53985	SLC16A1	Monocarboxylate transporter 1	GO:0044237; P:cellular metabolic process; TAS:Reactome
P53985	SLC16A1	Monocarboxylate transporter 1	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
P53985	SLC16A1	Monocarboxylate transporter 1	GO:0051297; P:centrosome organization; IMP:UniProtKB
P53985	SLC16A1	Monocarboxylate transporter 1	GO:0050900; P:leukocyte migration; TAS:Reactome
P53985	SLC16A1	Monocarboxylate transporter 1	GO:0015728; P:mevalonate transport; TAS:ProtInc
P53985	SLC16A1	Monocarboxylate transporter 1	GO:0015718; P:monocarboxylic acid transport; TAS:ProtInc
P53985	SLC16A1	Monocarboxylate transporter 1	GO:0035879; P:plasma membrane lactate transport; ISS:UniProtKB
P53985	SLC16A1	Monocarboxylate transporter 1	GO:0006090; P:pyruvate metabolic process; TAS:Reactome
P53985	SLC16A1	Monocarboxylate transporter 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P53985	SLC16A1	Monocarboxylate transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
O60669	SLC16A7	Monocarboxylate transporter 2	GO:0015129; F:lactate transmembrane transporter activity; IDA:UniProtKB
O60669	SLC16A7	Monocarboxylate transporter 2	GO:0005477; F:pyruvate secondary active transmembrane transporter activity; TAS:ProtInc
O60669	SLC16A7	Monocarboxylate transporter 2	GO:0050833; F:pyruvate transmembrane transporter activity; IDA:UniProtKB
O60669	SLC16A7	Monocarboxylate transporter 2	GO:0015355; F:secondary active monocarboxylate transmembrane transporter activity; IEA:InterPro
O60669	SLC16A7	Monocarboxylate transporter 2	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
O60669	SLC16A7	Monocarboxylate transporter 2	GO:0035873; P:lactate transmembrane transport; IMP:UniProtKB
O60669	SLC16A7	Monocarboxylate transporter 2	GO:1901475; P:pyruvate transmembrane transport; IDA:UniProtKB
O60669	SLC16A7	Monocarboxylate transporter 2	GO:0055085; P:transmembrane transport; TAS:Reactome
O95907	SLC16A8	Monocarboxylate transporter 3	GO:0015129; F:lactate transmembrane transporter activity; TAS:ProtInc
O95907	SLC16A8	Monocarboxylate transporter 3	GO:0015355; F:secondary active monocarboxylate transmembrane transporter activity; IEA:InterPro
O95907	SLC16A8	Monocarboxylate transporter 3	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
O95907	SLC16A8	Monocarboxylate transporter 3	GO:0007596; P:blood coagulation; TAS:Reactome
O95907	SLC16A8	Monocarboxylate transporter 3	GO:0044237; P:cellular metabolic process; TAS:Reactome
O95907	SLC16A8	Monocarboxylate transporter 3	GO:0035873; P:lactate transmembrane transport; TAS:GOC
O95907	SLC16A8	Monocarboxylate transporter 3	GO:0015727; P:lactate transport; TAS:ProtInc
O95907	SLC16A8	Monocarboxylate transporter 3	GO:0050900; P:leukocyte migration; TAS:Reactome
O95907	SLC16A8	Monocarboxylate transporter 3	GO:0006090; P:pyruvate metabolic process; TAS:Reactome
O95907	SLC16A8	Monocarboxylate transporter 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95907	SLC16A8	Monocarboxylate transporter 3	GO:0055085; P:transmembrane transport; TAS:Reactome
O15427	SLC16A3	Monocarboxylate transporter 4	GO:0008028; F:monocarboxylic acid transmembrane transporter activity; TAS:ProtInc
O15427	SLC16A3	Monocarboxylate transporter 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O15427	SLC16A3	Monocarboxylate transporter 4	GO:0015355; F:secondary active monocarboxylate transmembrane transporter activity; IEA:InterPro
O15427	SLC16A3	Monocarboxylate transporter 4	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
O15427	SLC16A3	Monocarboxylate transporter 4	GO:0007596; P:blood coagulation; TAS:Reactome
O15427	SLC16A3	Monocarboxylate transporter 4	GO:0044237; P:cellular metabolic process; TAS:Reactome
O15427	SLC16A3	Monocarboxylate transporter 4	GO:0050900; P:leukocyte migration; TAS:Reactome
O15427	SLC16A3	Monocarboxylate transporter 4	GO:0015718; P:monocarboxylic acid transport; TAS:ProtInc
O15427	SLC16A3	Monocarboxylate transporter 4	GO:0006090; P:pyruvate metabolic process; TAS:Reactome
O15427	SLC16A3	Monocarboxylate transporter 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15427	SLC16A3	Monocarboxylate transporter 4	GO:0055085; P:transmembrane transport; TAS:Reactome
O15374	SLC16A4	Monocarboxylate transporter 5	GO:0008028; F:monocarboxylic acid transmembrane transporter activity; TAS:ProtInc
O15374	SLC16A4	Monocarboxylate transporter 5	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
O15374	SLC16A4	Monocarboxylate transporter 5	GO:0015718; P:monocarboxylic acid transport; TAS:ProtInc
O15375	SLC16A5	Monocarboxylate transporter 6	GO:0008028; F:monocarboxylic acid transmembrane transporter activity; TAS:ProtInc
O15375	SLC16A5	Monocarboxylate transporter 6	GO:0015355; F:secondary active monocarboxylate transmembrane transporter activity; IEA:InterPro
O15375	SLC16A5	Monocarboxylate transporter 6	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
O15375	SLC16A5	Monocarboxylate transporter 6	GO:0015718; P:monocarboxylic acid transport; TAS:ProtInc
O15403	SLC16A6	Monocarboxylate transporter 7	GO:0008028; F:monocarboxylic acid transmembrane transporter activity; TAS:ProtInc
O15403	SLC16A6	Monocarboxylate transporter 7	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
O15403	SLC16A6	Monocarboxylate transporter 7	GO:0015718; P:monocarboxylic acid transport; TAS:ProtInc
P36021	SLC16A2	Monocarboxylate transporter 8	GO:0008028; F:monocarboxylic acid transmembrane transporter activity; TAS:ProtInc
P36021	SLC16A2	Monocarboxylate transporter 8	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
P36021	SLC16A2	Monocarboxylate transporter 8	GO:0005215; F:transporter activity; TAS:ProtInc
P36021	SLC16A2	Monocarboxylate transporter 8	GO:0015718; P:monocarboxylic acid transport; TAS:ProtInc
P36021	SLC16A2	Monocarboxylate transporter 8	GO:0006810; P:transport; TAS:ProtInc
Q7RTY1	SLC16A9	Monocarboxylate transporter 9	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q7RTY1	SLC16A9	Monocarboxylate transporter 9	GO:0046415; P:urate metabolic process; IMP:BHF-UCL
P12872	MLN	Promotilin	GO:0005102; F:receptor binding; TAS:ProtInc
P12872	MLN	Promotilin	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P12872	MLN	Promotilin	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q9HCE1	MOV10	Putative helicase MOV-10	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9HCE1	MOV10	Putative helicase MOV-10	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q9HCE1	MOV10	Putative helicase MOV-10	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9HCE1	MOV10	Putative helicase MOV-10	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HCE1	MOV10	Putative helicase MOV-10	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q9HCE1	MOV10	Putative helicase MOV-10	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9HCE1	MOV10	Putative helicase MOV-10	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q9HCE1	MOV10	Putative helicase MOV-10	GO:0045087; P:innate immune response; TAS:Reactome
Q9HCE1	MOV10	Putative helicase MOV-10	GO:0035279; P:mRNA cleavage involved in gene silencing by miRNA; IDA:UniProtKB
Q9HCE1	MOV10	Putative helicase MOV-10	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9HCE1	MOV10	Putative helicase MOV-10	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q9HCE1	MOV10	Putative helicase MOV-10	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q9HCE1	MOV10	Putative helicase MOV-10	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9HCE1	MOV10	Putative helicase MOV-10	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6UVY6	MOXD1	DBH-like monooxygenase protein 1	GO:0005507; F:copper ion binding; IEA:InterPro
Q6UVY6	MOXD1	DBH-like monooxygenase protein 1	GO:0016715; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen; IEA:InterPro
A6NHM9	MOXD2P	Putative DBH-like monooxygenase protein 2	GO:0005507; F:copper ion binding; IEA:InterPro
A6NHM9	MOXD2P	Putative DBH-like monooxygenase protein 2	GO:0016715; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen; IEA:InterPro
Q2QL34	MPV17L	Mpv17-like protein	GO:0005102; F:receptor binding; IPI:UniProtKB
Q2QL34	MPV17L	Mpv17-like protein	GO:0010730; P:negative regulation of hydrogen peroxide biosynthetic process; IDA:BHF-UCL
Q2QL34	MPV17L	Mpv17-like protein	GO:1901029; P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; IDA:BHF-UCL
Q2QL34	MPV17L	Mpv17-like protein	GO:0072593; P:reactive oxygen species metabolic process; IDA:UniProtKB
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0004708; F:MAP kinase kinase activity; IDA:UniProtKB
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0043539; F:protein serine/threonine kinase activator activity; IDA:UniProtKB
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0004674; F:protein serine/threonine kinase activity; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; TAS:UniProtKB
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0004728; F:receptor signaling protein tyrosine phosphatase activity; IEA:Ensembl
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0000187; P:activation of MAPK activity; TAS:UniProtKB
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0000186; P:activation of MAPKK activity; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0007411; P:axon guidance; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0007050; P:cell cycle arrest; IMP:BHF-UCL
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0048870; P:cell motility; IEA:Ensembl
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0008283; P:cell proliferation; IEA:Ensembl
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0006928; P:cellular component movement; TAS:ProtInc
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0090398; P:cellular senescence; IMP:BHF-UCL
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0006935; P:chemotaxis; TAS:ProtInc
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0048313; P:Golgi inheritance; IEA:Ensembl
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0045087; P:innate immune response; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0060711; P:labyrinthine layer development; IEA:Ensembl
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0000165; P:MAPK cascade; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0032402; P:melanosome transport; IEA:Ensembl
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0007067; P:mitosis; IEA:Ensembl
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0034111; P:negative regulation of homotypic cell-cell adhesion; IEA:Ensembl
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0060674; P:placenta blood vessel development; IEA:Ensembl
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0045597; P:positive regulation of cell differentiation; IEA:Ensembl
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0010628; P:positive regulation of gene expression; IMP:UniProt
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IDA:UniProtKB
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0032320; P:positive regulation of Ras GTPase activity; IEA:Ensembl
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0046579; P:positive regulation of Ras protein signal transduction; IEA:Ensembl
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0032968; P:positive regulation of transcription elongation from RNA polymerase II promoter; IEA:Ensembl
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:2000641; P:regulation of early endosome to late endosome transport; TAS:UniProtKB
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0090170; P:regulation of Golgi inheritance; TAS:UniProtKB
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0032872; P:regulation of stress-activated MAPK cascade; TAS:UniProtKB
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0003056; P:regulation of vascular smooth muscle contraction; IEA:Ensembl
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0048678; P:response to axon injury; IEA:Ensembl
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0006979; P:response to oxidative stress; IEA:Ensembl
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q02750	MAP2K1	Dual specificity mitogen-activated protein kinase kinase 1	GO:0047496; P:vesicle transport along microtubule; IEA:Ensembl
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0004708; F:MAP kinase kinase activity; IDA:UniProtKB
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0030165; F:PDZ domain binding; IDA:UniProtKB
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0005515; F:protein binding; IPI:IntAct
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0043539; F:protein serine/threonine kinase activator activity; IDA:UniProtKB
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0004674; F:protein serine/threonine kinase activity; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; TAS:UniProtKB
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0097110; F:scaffold protein binding; IPI:UniProtKB
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0000187; P:activation of MAPK activity; TAS:UniProtKB
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0000186; P:activation of MAPKK activity; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0007411; P:axon guidance; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0070371; P:ERK1 and ERK2 cascade; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0045087; P:innate immune response; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0000165; P:MAPK cascade; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0036289; P:peptidyl-serine autophosphorylation; IDA:UniProtKB
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:2000147; P:positive regulation of cell motility; IEA:Ensembl
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IDA:UniProtKB
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:2000641; P:regulation of early endosome to late endosome transport; TAS:UniProtKB
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0090170; P:regulation of Golgi inheritance; TAS:UniProtKB
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0032872; P:regulation of stress-activated MAPK cascade; TAS:UniProtKB
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P36507	MAP2K2	Dual specificity mitogen-activated protein kinase kinase 2	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0004708; F:MAP kinase kinase activity; IBA:RefGenome
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0005515; F:protein binding; IPI:UniProtKB
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0000187; P:activation of MAPK activity; TAS:Reactome
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0060048; P:cardiac muscle contraction; IEA:Ensembl
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0006954; P:inflammatory response; IEA:Ensembl
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0045087; P:innate immune response; TAS:Reactome
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0045860; P:positive regulation of protein kinase activity; IDA:UniProtKB
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0042035; P:regulation of cytokine biosynthetic process; IEA:Ensembl
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0007165; P:signal transduction; TAS:ProtInc
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P46734	MAP2K3	Dual specificity mitogen-activated protein kinase kinase 3	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0008545; F:JUN kinase kinase activity; IEA:Ensembl
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0005515; F:protein binding; IPI:IntAct
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0004672; F:protein kinase activity; TAS:ProtInc
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0072709; P:cellular response to sorbitol; IEA:Ensembl
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0045087; P:innate immune response; TAS:Reactome
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0007254; P:JNK cascade; TAS:Reactome
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0045740; P:positive regulation of DNA replication; IEA:Ensembl
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0007165; P:signal transduction; TAS:ProtInc
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P45985	MAP2K4	Dual specificity mitogen-activated protein kinase kinase 4	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0000187; P:activation of MAPK activity; ISS:BHF-UCL
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0071363; P:cellular response to growth factor stimulus; ISS:BHF-UCL
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0071499; P:cellular response to laminar fluid shear stress; TAS:BHF-UCL
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0070375; P:ERK5 cascade; IEA:Ensembl
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0007507; P:heart development; IEA:Ensembl
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0090051; P:negative regulation of cell migration involved in sprouting angiogenesis; ISS:BHF-UCL
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:2000342; P:negative regulation of chemokine (C-X-C motif) ligand 2 production; ISS:BHF-UCL
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; ISS:BHF-UCL
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; ISS:BHF-UCL
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0034115; P:negative regulation of heterotypic cell-cell adhesion; ISS:BHF-UCL
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0045415; P:negative regulation of interleukin-8 biosynthetic process; ISS:BHF-UCL
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; ISS:BHF-UCL
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0060761; P:negative regulation of response to cytokine stimulus; ISS:BHF-UCL
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0030307; P:positive regulation of cell growth; IEA:Ensembl
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0051247; P:positive regulation of protein metabolic process; ISS:BHF-UCL
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q13163	MAP2K5	Dual specificity mitogen-activated protein kinase kinase 5	GO:0007165; P:signal transduction; TAS:ProtInc
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0004708; F:MAP kinase kinase activity; IBA:RefGenome
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0005515; F:protein binding; IPI:UniProtKB
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0000187; P:activation of MAPK activity; TAS:Reactome
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0060048; P:cardiac muscle contraction; IEA:Ensembl
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0007050; P:cell cycle arrest; TAS:ProtInc
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0072709; P:cellular response to sorbitol; IEA:Ensembl
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0006975; P:DNA damage induced protein phosphorylation; TAS:ProtInc
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0045087; P:innate immune response; TAS:Reactome
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0042692; P:muscle cell differentiation; TAS:Reactome
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0042493; P:response to drug; IEA:Ensembl
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0002931; P:response to ischemia; IEA:Ensembl
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0007165; P:signal transduction; TAS:ProtInc
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P52564	MAP2K6	Dual specificity mitogen-activated protein kinase kinase 6	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0008545; F:JUN kinase kinase activity; IEA:Ensembl
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0004708; F:MAP kinase kinase activity; IDA:UniProtKB
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0005515; F:protein binding; IPI:IntAct
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0019903; F:protein phosphatase binding; ISS:BHF-UCL
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0007257; P:activation of JUN kinase activity; ISS:BHF-UCL
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0072709; P:cellular response to sorbitol; IEA:Ensembl
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0045087; P:innate immune response; TAS:Reactome
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0007254; P:JNK cascade; TAS:Reactome
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0006950; P:response to stress; IDA:UniProtKB
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0007165; P:signal transduction; TAS:ProtInc
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0051403; P:stress-activated MAPK cascade; IDA:UniProtKB
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
O14733	MAP2K7	Dual specificity mitogen-activated protein kinase kinase 7	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
A6NCE7	MAP1LC3B2	Microtubule-associated proteins 1A/1B light chain 3 beta 2	GO:0006914; P:autophagy; IEA:UniProtKB-KW
P0DKB6	MPC1L	Mitochondrial pyruvate carrier 1-like protein	GO:0006850; P:mitochondrial pyruvate transport; IEA:InterPro
Q9Y5U8	MPC1	Mitochondrial pyruvate carrier 1	GO:0050833; F:pyruvate transmembrane transporter activity; IEA:Ensembl
Q9Y5U8	MPC1	Mitochondrial pyruvate carrier 1	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q9Y5U8	MPC1	Mitochondrial pyruvate carrier 1	GO:0006850; P:mitochondrial pyruvate transport; IEA:Ensembl
Q9Y5U8	MPC1	Mitochondrial pyruvate carrier 1	GO:0006090; P:pyruvate metabolic process; TAS:Reactome
Q9Y5U8	MPC1	Mitochondrial pyruvate carrier 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95563	MPC2	Mitochondrial pyruvate carrier 2	GO:0050833; F:pyruvate transmembrane transporter activity; IEA:Ensembl
O95563	MPC2	Mitochondrial pyruvate carrier 2	GO:0044237; P:cellular metabolic process; TAS:Reactome
O95563	MPC2	Mitochondrial pyruvate carrier 2	GO:0006850; P:mitochondrial pyruvate transport; IEA:Ensembl
O95563	MPC2	Mitochondrial pyruvate carrier 2	GO:0006090; P:pyruvate metabolic process; TAS:Reactome
O95563	MPC2	Mitochondrial pyruvate carrier 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q00325	SLC25A3	Phosphate carrier protein, mitochondrial	GO:0015320; F:phosphate ion carrier activity; TAS:ProtInc
Q00325	SLC25A3	Phosphate carrier protein, mitochondrial	GO:0032403; F:protein complex binding; IDA:MGI
Q00325	SLC25A3	Phosphate carrier protein, mitochondrial	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q00325	SLC25A3	Phosphate carrier protein, mitochondrial	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
Q00325	SLC25A3	Phosphate carrier protein, mitochondrial	GO:0035435; P:phosphate ion transmembrane transport; TAS:GOC
Q00325	SLC25A3	Phosphate carrier protein, mitochondrial	GO:0006810; P:transport; TAS:ProtInc
O75970	MPDZ	Multiple PDZ domain protein	GO:0005515; F:protein binding; IPI:UniProtKB
O75970	MPDZ	Multiple PDZ domain protein	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
O75970	MPDZ	Multiple PDZ domain protein	GO:0007155; P:cell adhesion; IEA:Ensembl
O75970	MPDZ	Multiple PDZ domain protein	GO:0042552; P:myelination; IEA:Ensembl
O75970	MPDZ	Multiple PDZ domain protein	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q99547	MPHOSPH6	M-phase phosphoprotein 6	GO:0005515; F:protein binding; IPI:IntAct
Q99547	MPHOSPH6	M-phase phosphoprotein 6	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q99547	MPHOSPH6	M-phase phosphoprotein 6	GO:0000460; P:maturation of 5.8S rRNA; IMP:UniProtKB
Q99547	MPHOSPH6	M-phase phosphoprotein 6	GO:0000087; P:mitotic M phase; TAS:ProtInc
P30304	CDC25A	M-phase inducer phosphatase 1	GO:0005515; F:protein binding; IPI:UniProtKB
P30304	CDC25A	M-phase inducer phosphatase 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P30304	CDC25A	M-phase inducer phosphatase 1	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
P30304	CDC25A	M-phase inducer phosphatase 1	GO:0008283; P:cell proliferation; TAS:UniProtKB
P30304	CDC25A	M-phase inducer phosphatase 1	GO:0034644; P:cellular response to UV; IDA:UniProtKB
P30304	CDC25A	M-phase inducer phosphatase 1	GO:0006260; P:DNA replication; TAS:Reactome
P30304	CDC25A	M-phase inducer phosphatase 1	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P30304	CDC25A	M-phase inducer phosphatase 1	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P30304	CDC25A	M-phase inducer phosphatase 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P30304	CDC25A	M-phase inducer phosphatase 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P30304	CDC25A	M-phase inducer phosphatase 1	GO:0051726; P:regulation of cell cycle; TAS:Reactome
P30304	CDC25A	M-phase inducer phosphatase 1	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:UniProtKB
P30304	CDC25A	M-phase inducer phosphatase 1	GO:0009314; P:response to radiation; IDA:UniProtKB
P30305	CDC25B	M-phase inducer phosphatase 2	GO:0005515; F:protein binding; IPI:IntAct
P30305	CDC25B	M-phase inducer phosphatase 2	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P30305	CDC25B	M-phase inducer phosphatase 2	GO:0004725; F:protein tyrosine phosphatase activity; TAS:UniProtKB
P30305	CDC25B	M-phase inducer phosphatase 2	GO:0007144; P:female meiosis I; IEA:Ensembl
P30305	CDC25B	M-phase inducer phosphatase 2	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:UniProtKB
P30305	CDC25B	M-phase inducer phosphatase 2	GO:0007067; P:mitosis; TAS:ProtInc
P30305	CDC25B	M-phase inducer phosphatase 2	GO:0000278; P:mitotic cell cycle; TAS:UniProtKB
P30305	CDC25B	M-phase inducer phosphatase 2	GO:0001556; P:oocyte maturation; IEA:Ensembl
P30305	CDC25B	M-phase inducer phosphatase 2	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
P30305	CDC25B	M-phase inducer phosphatase 2	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P30305	CDC25B	M-phase inducer phosphatase 2	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB
P30305	CDC25B	M-phase inducer phosphatase 2	GO:0045931; P:positive regulation of mitotic cell cycle; IMP:UniProtKB
P30305	CDC25B	M-phase inducer phosphatase 2	GO:0045860; P:positive regulation of protein kinase activity; IEA:Ensembl
P30305	CDC25B	M-phase inducer phosphatase 2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P30307	CDC25C	M-phase inducer phosphatase 3	GO:0005515; F:protein binding; IPI:IntAct
P30307	CDC25C	M-phase inducer phosphatase 3	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P30307	CDC25C	M-phase inducer phosphatase 3	GO:0004725; F:protein tyrosine phosphatase activity; NAS:UniProtKB
P30307	CDC25C	M-phase inducer phosphatase 3	GO:0050699; F:WW domain binding; IPI:BHF-UCL
P30307	CDC25C	M-phase inducer phosphatase 3	GO:0008283; P:cell proliferation; TAS:UniProtKB
P30307	CDC25C	M-phase inducer phosphatase 3	GO:0006260; P:DNA replication; TAS:Reactome
P30307	CDC25C	M-phase inducer phosphatase 3	GO:0000086; P:G2/M transition of mitotic cell cycle; IGI:UniProtKB
P30307	CDC25C	M-phase inducer phosphatase 3	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P30307	CDC25C	M-phase inducer phosphatase 3	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P30307	CDC25C	M-phase inducer phosphatase 3	GO:0035335; P:peptidyl-tyrosine dephosphorylation; NAS:GOC
P30307	CDC25C	M-phase inducer phosphatase 3	GO:0051726; P:regulation of cell cycle; TAS:Reactome
P30307	CDC25C	M-phase inducer phosphatase 3	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:UniProtKB
P30307	CDC25C	M-phase inducer phosphatase 3	GO:0007088; P:regulation of mitosis; TAS:ProtInc
P30307	CDC25C	M-phase inducer phosphatase 3	GO:0007283; P:spermatogenesis; IEA:Ensembl
P30307	CDC25C	M-phase inducer phosphatase 3	GO:0016032; P:viral process; IEA:UniProtKB-KW
P34949	MPI	Mannose-6-phosphate isomerase	GO:0004476; F:mannose-6-phosphate isomerase activity; TAS:ProtInc
P34949	MPI	Mannose-6-phosphate isomerase	GO:0008270; F:zinc ion binding; IEA:InterPro
P34949	MPI	Mannose-6-phosphate isomerase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P34949	MPI	Mannose-6-phosphate isomerase	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
P34949	MPI	Mannose-6-phosphate isomerase	GO:0009298; P:GDP-mannose biosynthetic process; TAS:Reactome
P34949	MPI	Mannose-6-phosphate isomerase	GO:0043687; P:post-translational protein modification; TAS:Reactome
P34949	MPI	Mannose-6-phosphate isomerase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q8TAP9	MPLKIP	M-phase-specific PLK1-interacting protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TAP9	MPLKIP	M-phase-specific PLK1-interacting protein	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q8N594	MPND	MPN domain-containing protein	GO:0008233; F:peptidase activity; IEA:UniProtKB-KW
O00566	MPHOSPH10	U3 small nucleolar ribonucleoprotein protein MPP10	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O00566	MPHOSPH10	U3 small nucleolar ribonucleoprotein protein MPP10	GO:0005515; F:protein binding; IPI:IntAct
O00566	MPHOSPH10	U3 small nucleolar ribonucleoprotein protein MPP10	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
O00566	MPHOSPH10	U3 small nucleolar ribonucleoprotein protein MPP10	GO:0006396; P:RNA processing; NAS:UniProtKB
O00566	MPHOSPH10	U3 small nucleolar ribonucleoprotein protein MPP10	GO:0008380; P:RNA splicing; NAS:UniProtKB
O00566	MPHOSPH10	U3 small nucleolar ribonucleoprotein protein MPP10	GO:0000375; P:RNA splicing, via transesterification reactions; NAS:UniProtKB
O00566	MPHOSPH10	U3 small nucleolar ribonucleoprotein protein MPP10	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q14168	MPP2	MAGUK p55 subfamily member 2	GO:0004385; F:guanylate kinase activity; TAS:ProtInc
Q14168	MPP2	MAGUK p55 subfamily member 2	GO:0046939; P:nucleotide phosphorylation; TAS:GOC
Q14168	MPP2	MAGUK p55 subfamily member 2	GO:0007165; P:signal transduction; TAS:ProtInc
Q13368	MPP3	MAGUK p55 subfamily member 3	GO:0004385; F:guanylate kinase activity; TAS:ProtInc
Q13368	MPP3	MAGUK p55 subfamily member 3	GO:0046939; P:nucleotide phosphorylation; TAS:GOC
Q13368	MPP3	MAGUK p55 subfamily member 3	GO:0007165; P:signal transduction; TAS:ProtInc
Q96JB8	MPP4	MAGUK p55 subfamily member 4	GO:0035418; P:protein localization to synapse; IEA:Ensembl
Q8N3R9	MPP5	MAGUK p55 subfamily member 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N3R9	MPP5	MAGUK p55 subfamily member 5	GO:0019904; F:protein domain specific binding; IPI:BHF-UCL
Q8N3R9	MPP5	MAGUK p55 subfamily member 5	GO:0034329; P:cell junction assembly; TAS:Reactome
Q8N3R9	MPP5	MAGUK p55 subfamily member 5	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q8N3R9	MPP5	MAGUK p55 subfamily member 5	GO:0090002; P:establishment of protein localization to plasma membrane; IEA:Ensembl
Q8N3R9	MPP5	MAGUK p55 subfamily member 5	GO:0032288; P:myelin assembly; IEA:Ensembl
Q8N3R9	MPP5	MAGUK p55 subfamily member 5	GO:0032287; P:peripheral nervous system myelin maintenance; IEA:Ensembl
Q8N3R9	MPP5	MAGUK p55 subfamily member 5	GO:0035750; P:protein localization to myelin sheath abaxonal region; IEA:Ensembl
Q8N3R9	MPP5	MAGUK p55 subfamily member 5	GO:0070830; P:tight junction assembly; TAS:Reactome
Q9NZW5	MPP6	MAGUK p55 subfamily member 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NZW5	MPP6	MAGUK p55 subfamily member 6	GO:0006461; P:protein complex assembly; NAS:UniProtKB
Q5T2T1	MPP7	MAGUK p55 subfamily member 7	GO:0005515; F:protein binding; IPI:BHF-UCL
Q5T2T1	MPP7	MAGUK p55 subfamily member 7	GO:0032947; F:protein complex scaffold; IDA:BHF-UCL
Q5T2T1	MPP7	MAGUK p55 subfamily member 7	GO:0019904; F:protein domain specific binding; IPI:BHF-UCL
Q5T2T1	MPP7	MAGUK p55 subfamily member 7	GO:0046982; F:protein heterodimerization activity; IDA:BHF-UCL
Q5T2T1	MPP7	MAGUK p55 subfamily member 7	GO:0035591; F:signaling adaptor activity; NAS:BHF-UCL
Q5T2T1	MPP7	MAGUK p55 subfamily member 7	GO:0030010; P:establishment of cell polarity; TAS:BHF-UCL
Q5T2T1	MPP7	MAGUK p55 subfamily member 7	GO:0031334; P:positive regulation of protein complex assembly; IDA:BHF-UCL
Q5T2T1	MPP7	MAGUK p55 subfamily member 7	GO:0009967; P:positive regulation of signal transduction; NAS:GOC
Q5T2T1	MPP7	MAGUK p55 subfamily member 7	GO:0071896; P:protein localization to adherens junction; IMP:BHF-UCL
Q5T2T1	MPP7	MAGUK p55 subfamily member 7	GO:0070830; P:tight junction assembly; IDA:BHF-UCL
Q99550	MPHOSPH9	M-phase phosphoprotein 9	GO:0000087; P:mitotic M phase; TAS:ProtInc
Q99549	MPHOSPH8	M-phase phosphoprotein 8	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q99549	MPHOSPH8	M-phase phosphoprotein 8	GO:0005515; F:protein binding; IPI:IntAct
Q99549	MPHOSPH8	M-phase phosphoprotein 8	GO:0007049; P:cell cycle; NAS:UniProtKB
Q99549	MPHOSPH8	M-phase phosphoprotein 8	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q99549	MPHOSPH8	M-phase phosphoprotein 8	GO:0044030; P:regulation of DNA methylation; IMP:UniProtKB
Q99549	MPHOSPH8	M-phase phosphoprotein 8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q10713	PMPCA	Mitochondrial-processing peptidase subunit alpha	GO:0046872; F:metal ion binding; IEA:InterPro
Q10713	PMPCA	Mitochondrial-processing peptidase subunit alpha	GO:0004222; F:metalloendopeptidase activity; TAS:UniProtKB
Q10713	PMPCA	Mitochondrial-processing peptidase subunit alpha	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q10713	PMPCA	Mitochondrial-processing peptidase subunit alpha	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
Q10713	PMPCA	Mitochondrial-processing peptidase subunit alpha	GO:0006508; P:proteolysis; TAS:UniProtKB
O15442	MPPED1	Metallophosphoesterase domain-containing protein 1	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
O75439	PMPCB	Mitochondrial-processing peptidase subunit beta	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75439	PMPCB	Mitochondrial-processing peptidase subunit beta	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
O75439	PMPCB	Mitochondrial-processing peptidase subunit beta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O75439	PMPCB	Mitochondrial-processing peptidase subunit beta	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
Q15777	MPPED2	Metallophosphoesterase MPPED2	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q15777	MPPED2	Metallophosphoesterase MPPED2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15777	MPPED2	Metallophosphoesterase MPPED2	GO:0007399; P:nervous system development; TAS:ProtInc
Q53F39	MPPE1	Metallophosphoesterase 1	GO:0034235; F:GPI anchor binding; ISS:UniProtKB
Q53F39	MPPE1	Metallophosphoesterase 1	GO:0030145; F:manganese ion binding; ISS:UniProtKB
Q53F39	MPPE1	Metallophosphoesterase 1	GO:0008081; F:phosphoric diester hydrolase activity; ISS:UniProtKB
Q53F39	MPPE1	Metallophosphoesterase 1	GO:0006888; P:ER to Golgi vesicle-mediated transport; ISS:UniProtKB
Q53F39	MPPE1	Metallophosphoesterase 1	GO:0006506; P:GPI anchor biosynthetic process; ISS:UniProtKB
Q86WK9	PAQR7	Membrane progestin receptor alpha	GO:0005496; F:steroid binding; IBA:RefGenome
Q86WK9	PAQR7	Membrane progestin receptor alpha	GO:0003707; F:steroid hormone receptor activity; IBA:RefGenome
Q86WK9	PAQR7	Membrane progestin receptor alpha	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q86WK9	PAQR7	Membrane progestin receptor alpha	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q86WK9	PAQR7	Membrane progestin receptor alpha	GO:0048477; P:oogenesis; IEA:UniProtKB-KW
Q86WK9	PAQR7	Membrane progestin receptor alpha	GO:0048545; P:response to steroid hormone; IBA:RefGenome
Q86WK9	PAQR7	Membrane progestin receptor alpha	GO:0043401; P:steroid hormone mediated signaling pathway; IBA:GOC
Q8TEZ7	PAQR8	Membrane progestin receptor beta	GO:0005496; F:steroid binding; IBA:RefGenome
Q8TEZ7	PAQR8	Membrane progestin receptor beta	GO:0003707; F:steroid hormone receptor activity; IBA:RefGenome
Q8TEZ7	PAQR8	Membrane progestin receptor beta	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8TEZ7	PAQR8	Membrane progestin receptor beta	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8TEZ7	PAQR8	Membrane progestin receptor beta	GO:0048477; P:oogenesis; IEA:UniProtKB-KW
Q8TEZ7	PAQR8	Membrane progestin receptor beta	GO:0048545; P:response to steroid hormone; IBA:RefGenome
Q8TEZ7	PAQR8	Membrane progestin receptor beta	GO:0043401; P:steroid hormone mediated signaling pathway; IBA:GOC
P20645	M6PR	Cation-dependent mannose-6-phosphate receptor	GO:0005537; F:mannose binding; IEA:InterPro
P20645	M6PR	Cation-dependent mannose-6-phosphate receptor	GO:0015578; F:mannose transmembrane transporter activity; IEA:InterPro
P20645	M6PR	Cation-dependent mannose-6-phosphate receptor	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
P20645	M6PR	Cation-dependent mannose-6-phosphate receptor	GO:0008333; P:endosome to lysosome transport; TAS:ProtInc
P20645	M6PR	Cation-dependent mannose-6-phosphate receptor	GO:0006898; P:receptor-mediated endocytosis; TAS:ProtInc
P20645	M6PR	Cation-dependent mannose-6-phosphate receptor	GO:0007165; P:signal transduction; TAS:GOC
Q9NXK6	PAQR5	Membrane progestin receptor gamma	GO:0004872; F:receptor activity; IBA:RefGenome
Q9NXK6	PAQR5	Membrane progestin receptor gamma	GO:0005496; F:steroid binding; IEA:UniProtKB-KW
Q9NXK6	PAQR5	Membrane progestin receptor gamma	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9NXK6	PAQR5	Membrane progestin receptor gamma	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9NXK6	PAQR5	Membrane progestin receptor gamma	GO:0048477; P:oogenesis; IEA:UniProtKB-KW
Q6WCQ1	MPRIP	Myosin phosphatase Rho-interacting protein	GO:0005515; F:protein binding; IPI:IntAct
P11717	IGF2R	Cation-independent mannose-6-phosphate receptor	GO:0004930; F:G-protein coupled receptor activity; IEA:Ensembl
P11717	IGF2R	Cation-independent mannose-6-phosphate receptor	GO:0001948; F:glycoprotein binding; IDA:UniProtKB
P11717	IGF2R	Cation-independent mannose-6-phosphate receptor	GO:0042802; F:identical protein binding; IPI:IntAct
P11717	IGF2R	Cation-independent mannose-6-phosphate receptor	GO:0005010; F:insulin-like growth factor-activated receptor activity; TAS:ProtInc
P11717	IGF2R	Cation-independent mannose-6-phosphate receptor	GO:0005537; F:mannose binding; IEA:Ensembl
P11717	IGF2R	Cation-independent mannose-6-phosphate receptor	GO:0051219; F:phosphoprotein binding; IDA:UniProtKB
P11717	IGF2R	Cation-independent mannose-6-phosphate receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P11717	IGF2R	Cation-independent mannose-6-phosphate receptor	GO:0004872; F:receptor activity; TAS:ProtInc
P11717	IGF2R	Cation-independent mannose-6-phosphate receptor	GO:0001972; F:retinoic acid binding; IEA:Ensembl
P11717	IGF2R	Cation-independent mannose-6-phosphate receptor	GO:0005215; F:transporter activity; IEA:InterPro
P11717	IGF2R	Cation-independent mannose-6-phosphate receptor	GO:0048009; P:insulin-like growth factor receptor signaling pathway; TAS:GOC
P11717	IGF2R	Cation-independent mannose-6-phosphate receptor	GO:0001889; P:liver development; IEA:Ensembl
P11717	IGF2R	Cation-independent mannose-6-phosphate receptor	GO:0031100; P:organ regeneration; IEA:Ensembl
P11717	IGF2R	Cation-independent mannose-6-phosphate receptor	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P11717	IGF2R	Cation-independent mannose-6-phosphate receptor	GO:0009791; P:post-embryonic development; IEA:Ensembl
P11717	IGF2R	Cation-independent mannose-6-phosphate receptor	GO:0006898; P:receptor-mediated endocytosis; TAS:ProtInc
P11717	IGF2R	Cation-independent mannose-6-phosphate receptor	GO:0032526; P:response to retinoic acid; IEA:Ensembl
P11717	IGF2R	Cation-independent mannose-6-phosphate receptor	GO:0007165; P:signal transduction; TAS:ProtInc
P11717	IGF2R	Cation-independent mannose-6-phosphate receptor	GO:0007283; P:spermatogenesis; IEA:Ensembl
O75352	MPDU1	Mannose-P-dolichol utilization defect 1 protein	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:UniProtKB
O75352	MPDU1	Mannose-P-dolichol utilization defect 1 protein	GO:0009312; P:oligosaccharide biosynthetic process; IDA:UniProtKB
O75352	MPDU1	Mannose-P-dolichol utilization defect 1 protein	GO:0006457; P:protein folding; NAS:UniProtKB
O75352	MPDU1	Mannose-P-dolichol utilization defect 1 protein	GO:0006810; P:transport; IEA:UniProtKB-KW
O95297	MPZL1	Myelin protein zero-like protein 1	GO:0005515; F:protein binding; IPI:IntAct
O95297	MPZL1	Myelin protein zero-like protein 1	GO:0005198; F:structural molecule activity; TAS:ProtInc
O95297	MPZL1	Myelin protein zero-like protein 1	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O95297	MPZL1	Myelin protein zero-like protein 1	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc
P39210	MPV17	Protein Mpv17	GO:0034614; P:cellular response to reactive oxygen species; ISS:UniProtKB
P39210	MPV17	Protein Mpv17	GO:0032836; P:glomerular basement membrane development; ISS:UniProtKB
P39210	MPV17	Protein Mpv17	GO:0042592; P:homeostatic process; IMP:UniProtKB
P39210	MPV17	Protein Mpv17	GO:0048839; P:inner ear development; ISS:UniProtKB
P39210	MPV17	Protein Mpv17	GO:0000002; P:mitochondrial genome maintenance; IMP:UniProtKB
P39210	MPV17	Protein Mpv17	GO:0072593; P:reactive oxygen species metabolic process; IEA:Ensembl
P39210	MPV17	Protein Mpv17	GO:2000377; P:regulation of reactive oxygen species metabolic process; ISS:UniProtKB
Q6UWV2	MPZL3	Myelin protein zero-like protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q6UWV2	MPZL3	Myelin protein zero-like protein 3	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q6UWV2	MPZL3	Myelin protein zero-like protein 3	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q6UWV2	MPZL3	Myelin protein zero-like protein 3	GO:0042633; P:hair cycle; IEA:Ensembl
O60487	MPZL2	Myelin protein zero-like protein 2	GO:0005515; F:protein binding; IPI:IntAct
O60487	MPZL2	Myelin protein zero-like protein 2	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
O60487	MPZL2	Myelin protein zero-like protein 2	GO:0007156; P:homophilic cell adhesion; TAS:ProtInc
O60487	MPZL2	Myelin protein zero-like protein 2	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
Q96HT8	MRFAP1L1	MORF4 family-associated protein 1-like 1	GO:0005515; F:protein binding; IPI:IntAct
Q8TCY5	MRAP	Melanocortin-2 receptor accessory protein	GO:0031780; F:corticotropin hormone receptor binding; IPI:BHF-UCL
Q8TCY5	MRAP	Melanocortin-2 receptor accessory protein	GO:0070996; F:type 1 melanocortin receptor binding; IPI:BHF-UCL
Q8TCY5	MRAP	Melanocortin-2 receptor accessory protein	GO:0031781; F:type 3 melanocortin receptor binding; IPI:BHF-UCL
Q8TCY5	MRAP	Melanocortin-2 receptor accessory protein	GO:0031782; F:type 4 melanocortin receptor binding; IPI:BHF-UCL
Q8TCY5	MRAP	Melanocortin-2 receptor accessory protein	GO:0031783; F:type 5 melanocortin receptor binding; IPI:BHF-UCL
Q8TCY5	MRAP	Melanocortin-2 receptor accessory protein	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
Q8TCY5	MRAP	Melanocortin-2 receptor accessory protein	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:BHF-UCL
Q8TCY5	MRAP	Melanocortin-2 receptor accessory protein	GO:0034394; P:protein localization to cell surface; IDA:BHF-UCL
Q96G30	MRAP2	Melanocortin-2 receptor accessory protein 2	GO:0031780; F:corticotropin hormone receptor binding; IPI:BHF-UCL
Q96G30	MRAP2	Melanocortin-2 receptor accessory protein 2	GO:0070996; F:type 1 melanocortin receptor binding; IPI:BHF-UCL
Q96G30	MRAP2	Melanocortin-2 receptor accessory protein 2	GO:0031781; F:type 3 melanocortin receptor binding; IPI:BHF-UCL
Q96G30	MRAP2	Melanocortin-2 receptor accessory protein 2	GO:0031782; F:type 4 melanocortin receptor binding; IPI:BHF-UCL
Q96G30	MRAP2	Melanocortin-2 receptor accessory protein 2	GO:0031783; F:type 5 melanocortin receptor binding; IPI:BHF-UCL
Q96G30	MRAP2	Melanocortin-2 receptor accessory protein 2	GO:0097009; P:energy homeostasis; ISS:UniProtKB
Q96G30	MRAP2	Melanocortin-2 receptor accessory protein 2	GO:0006112; P:energy reserve metabolic process; ISS:UniProtKB
Q96G30	MRAP2	Melanocortin-2 receptor accessory protein 2	GO:0007631; P:feeding behavior; ISS:UniProtKB
Q96G30	MRAP2	Melanocortin-2 receptor accessory protein 2	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:BHF-UCL
Q96G30	MRAP2	Melanocortin-2 receptor accessory protein 2	GO:0034394; P:protein localization to cell surface; IDA:BHF-UCL
P22897	MRC1	Macrophage mannose receptor 1	GO:0005537; F:mannose binding; TAS:ProtInc
P22897	MRC1	Macrophage mannose receptor 1	GO:0005515; F:protein binding; IPI:MTBBASE
P22897	MRC1	Macrophage mannose receptor 1	GO:0004872; F:receptor activity; IDA:UniProtKB
P22897	MRC1	Macrophage mannose receptor 1	GO:0006898; P:receptor-mediated endocytosis; IDA:UniProtKB
Q9UBG0	MRC2	C-type mannose receptor 2	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q9UBG0	MRC2	C-type mannose receptor 2	GO:0005518; F:collagen binding; IDA:UniProt
Q9UBG0	MRC2	C-type mannose receptor 2	GO:0005515; F:protein binding; IPI:UniProt
Q9UBG0	MRC2	C-type mannose receptor 2	GO:0030574; P:collagen catabolic process; IDA:UniProt
Q9UBG0	MRC2	C-type mannose receptor 2	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q5VT25	CDC42BPA	Serine/threonine-protein kinase MRCK alpha	GO:0005524; F:ATP binding; IDA:UniProtKB
Q5VT25	CDC42BPA	Serine/threonine-protein kinase MRCK alpha	GO:0042802; F:identical protein binding; IPI:IntAct
Q5VT25	CDC42BPA	Serine/threonine-protein kinase MRCK alpha	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q5VT25	CDC42BPA	Serine/threonine-protein kinase MRCK alpha	GO:0005515; F:protein binding; IPI:IntAct
Q5VT25	CDC42BPA	Serine/threonine-protein kinase MRCK alpha	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q5VT25	CDC42BPA	Serine/threonine-protein kinase MRCK alpha	GO:0005083; F:small GTPase regulator activity; IEA:InterPro
Q5VT25	CDC42BPA	Serine/threonine-protein kinase MRCK alpha	GO:0031532; P:actin cytoskeleton reorganization; IDA:UniProtKB
Q5VT25	CDC42BPA	Serine/threonine-protein kinase MRCK alpha	GO:0031032; P:actomyosin structure organization; IMP:UniProtKB
Q5VT25	CDC42BPA	Serine/threonine-protein kinase MRCK alpha	GO:0016477; P:cell migration; IMP:UniProtKB
Q5VT25	CDC42BPA	Serine/threonine-protein kinase MRCK alpha	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q5VT25	CDC42BPA	Serine/threonine-protein kinase MRCK alpha	GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl
Q5VT25	CDC42BPA	Serine/threonine-protein kinase MRCK alpha	GO:0007097; P:nuclear migration; IEA:Ensembl
Q5VT25	CDC42BPA	Serine/threonine-protein kinase MRCK alpha	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9Y5S2	CDC42BPB	Serine/threonine-protein kinase MRCK beta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y5S2	CDC42BPB	Serine/threonine-protein kinase MRCK beta	GO:0000287; F:magnesium ion binding; ISS:UniProtKB
Q9Y5S2	CDC42BPB	Serine/threonine-protein kinase MRCK beta	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y5S2	CDC42BPB	Serine/threonine-protein kinase MRCK beta	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q9Y5S2	CDC42BPB	Serine/threonine-protein kinase MRCK beta	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q9Y5S2	CDC42BPB	Serine/threonine-protein kinase MRCK beta	GO:0005083; F:small GTPase regulator activity; IEA:InterPro
Q9Y5S2	CDC42BPB	Serine/threonine-protein kinase MRCK beta	GO:0031532; P:actin cytoskeleton reorganization; ISS:UniProtKB
Q9Y5S2	CDC42BPB	Serine/threonine-protein kinase MRCK beta	GO:0031032; P:actomyosin structure organization; IMP:UniProtKB
Q9Y5S2	CDC42BPB	Serine/threonine-protein kinase MRCK beta	GO:0016477; P:cell migration; IMP:UniProtKB
Q9Y5S2	CDC42BPB	Serine/threonine-protein kinase MRCK beta	GO:0007010; P:cytoskeleton organization; TAS:ProtInc
Q9Y5S2	CDC42BPB	Serine/threonine-protein kinase MRCK beta	GO:0007163; P:establishment or maintenance of cell polarity; TAS:ProtInc
Q9Y5S2	CDC42BPB	Serine/threonine-protein kinase MRCK beta	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9Y5S2	CDC42BPB	Serine/threonine-protein kinase MRCK beta	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9Y5S2	CDC42BPB	Serine/threonine-protein kinase MRCK beta	GO:0007165; P:signal transduction; TAS:ProtInc
Q6DT37	CDC42BPG	Serine/threonine-protein kinase MRCK gamma	GO:0005524; F:ATP binding; IDA:UniProtKB
Q6DT37	CDC42BPG	Serine/threonine-protein kinase MRCK gamma	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q6DT37	CDC42BPG	Serine/threonine-protein kinase MRCK gamma	GO:0005515; F:protein binding; IPI:IntAct
Q6DT37	CDC42BPG	Serine/threonine-protein kinase MRCK gamma	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q6DT37	CDC42BPG	Serine/threonine-protein kinase MRCK gamma	GO:0005083; F:small GTPase regulator activity; IEA:InterPro
Q6DT37	CDC42BPG	Serine/threonine-protein kinase MRCK gamma	GO:0031532; P:actin cytoskeleton reorganization; ISS:UniProtKB
Q6DT37	CDC42BPG	Serine/threonine-protein kinase MRCK gamma	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q6DT37	CDC42BPG	Serine/threonine-protein kinase MRCK gamma	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0008408; F:3'-5' exonuclease activity; TAS:ProtInc
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0003690; F:double-stranded DNA binding; TAS:ProtInc
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0004520; F:endodeoxyribonuclease activity; TAS:ProtInc
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0030145; F:manganese ion binding; IEA:InterPro
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0004518; F:nuclease activity; TAS:BHF-UCL
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0005515; F:protein binding; IPI:UniProtKB
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0000014; F:single-stranded DNA endodeoxyribonuclease activity; TAS:ProtInc
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0008283; P:cell proliferation; IEA:Ensembl
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0006974; P:cellular response to DNA damage stimulus; IDA:MGI
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0000737; P:DNA catabolic process, endonucleolytic; TAS:GOC
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0032508; P:DNA duplex unwinding; IMP:BHF-UCL
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0006310; P:DNA recombination; TAS:ProtInc
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0006281; P:DNA repair; TAS:Reactome
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0006302; P:double-strand break repair; TAS:Reactome
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0000724; P:double-strand break repair via homologous recombination; TAS:Reactome
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0006303; P:double-strand break repair via nonhomologous end joining; TAS:ProtInc
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0045087; P:innate immune response; TAS:Reactome
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0031573; P:intra-S DNA damage checkpoint; IEA:Ensembl
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0007095; P:mitotic G2 DNA damage checkpoint; IEA:Ensembl
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0032876; P:negative regulation of DNA endoreduplication; IMP:BHF-UCL
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; TAS:GOC
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0033674; P:positive regulation of kinase activity; IDA:BHF-UCL
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0031954; P:positive regulation of protein autophosphorylation; IDA:BHF-UCL
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0007131; P:reciprocal meiotic recombination; TAS:ProtInc
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0000019; P:regulation of mitotic recombination; TAS:ProtInc
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0007062; P:sister chromatid cohesion; IMP:BHF-UCL
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0007129; P:synapsis; IEA:Ensembl
P49959	MRE11A	Double-strand break repair protein MRE11A	GO:0007004; P:telomere maintenance via telomerase; TAS:ProtInc
Q8N565	MREG	Melanoregulin	GO:0042640; P:anagen; IEA:Ensembl
Q8N565	MREG	Melanoregulin	GO:0030318; P:melanocyte differentiation; IEA:Ensembl
Q96LU7	MYRFL	Myelin regulatory factor-like protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96LU7	MYRFL	Myelin regulatory factor-like protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9Y2G1	MYRF	Myelin regulatory factor	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y2G1	MYRF	Myelin regulatory factor	GO:0008233; F:peptidase activity; IEA:UniProtKB-KW
Q9Y2G1	MYRF	Myelin regulatory factor	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9Y2G1	MYRF	Myelin regulatory factor	GO:0032286; P:central nervous system myelin maintenance; ISS:UniProtKB
Q9Y2G1	MYRF	Myelin regulatory factor	GO:0022010; P:central nervous system myelination; ISS:UniProtKB
Q9Y2G1	MYRF	Myelin regulatory factor	GO:0014003; P:oligodendrocyte development; ISS:UniProtKB
Q9Y2G1	MYRF	Myelin regulatory factor	GO:0048709; P:oligodendrocyte differentiation; ISS:UniProtKB
Q9Y2G1	MYRF	Myelin regulatory factor	GO:0031643; P:positive regulation of myelination; ISS:UniProtKB
Q9Y2G1	MYRF	Myelin regulatory factor	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q9Y2G1	MYRF	Myelin regulatory factor	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NV56	MRGBP	MRG/MORF4L-binding protein	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q9NV56	MRGBP	MRG/MORF4L-binding protein	GO:0006325; P:chromatin organization; TAS:Reactome
Q9NV56	MRGBP	MRG/MORF4L-binding protein	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q9NV56	MRGBP	MRG/MORF4L-binding protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NV56	MRGBP	MRG/MORF4L-binding protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TDS7	MRGPRD	Mas-related G-protein coupled receptor member D	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q86SM8	MRGPRE	Mas-related G-protein coupled receptor member E	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q86SM5	MRGPRG	Mas-related G-protein coupled receptor member G	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96AM1	MRGPRF	Mas-related G-protein coupled receptor member F	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96LB2	MRGPRX1	Mas-related G-protein coupled receptor member X1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96LB2	MRGPRX1	Mas-related G-protein coupled receptor member X1	GO:0006953; P:acute-phase response; IEA:UniProtKB-KW
Q96LB1	MRGPRX2	Mas-related G-protein coupled receptor member X2	GO:0004930; F:G-protein coupled receptor activity; IDA:UniProtKB
Q96LB1	MRGPRX2	Mas-related G-protein coupled receptor member X2	GO:0042923; F:neuropeptide binding; IPI:UniProtKB
Q96LB1	MRGPRX2	Mas-related G-protein coupled receptor member X2	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProt
Q96LB1	MRGPRX2	Mas-related G-protein coupled receptor member X2	GO:0019233; P:sensory perception of pain; NAS:UniProtKB
Q96LB1	MRGPRX2	Mas-related G-protein coupled receptor member X2	GO:0030431; P:sleep; NAS:UniProtKB
Q96LB0	MRGPRX3	Mas-related G-protein coupled receptor member X3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96LA9	MRGPRX4	Mas-related G-protein coupled receptor member X4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q6IN84	MRM1	rRNA methyltransferase 1, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6IN84	MRM1	rRNA methyltransferase 1, mitochondrial	GO:0008173; F:RNA methyltransferase activity; IEA:InterPro
Q6IN84	MRM1	rRNA methyltransferase 1, mitochondrial	GO:0006396; P:RNA processing; IEA:InterPro
P33527	ABCC1	Multidrug resistance-associated protein 1	GO:0005524; F:ATP binding; TAS:ProtInc
P33527	ABCC1	Multidrug resistance-associated protein 1	GO:0016887; F:ATPase activity; IDA:UniProtKB
P33527	ABCC1	Multidrug resistance-associated protein 1	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; TAS:ProtInc
P33527	ABCC1	Multidrug resistance-associated protein 1	GO:0005215; F:transporter activity; TAS:ProtInc
P33527	ABCC1	Multidrug resistance-associated protein 1	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P33527	ABCC1	Multidrug resistance-associated protein 1	GO:0006200; P:ATP catabolic process; IDA:GOC
P33527	ABCC1	Multidrug resistance-associated protein 1	GO:0009235; P:cobalamin metabolic process; TAS:Reactome
P33527	ABCC1	Multidrug resistance-associated protein 1	GO:0006691; P:leukotriene metabolic process; TAS:Reactome
P33527	ABCC1	Multidrug resistance-associated protein 1	GO:0042493; P:response to drug; TAS:ProtInc
P33527	ABCC1	Multidrug resistance-associated protein 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P33527	ABCC1	Multidrug resistance-associated protein 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P33527	ABCC1	Multidrug resistance-associated protein 1	GO:0006810; P:transport; TAS:ProtInc
P33527	ABCC1	Multidrug resistance-associated protein 1	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P33527	ABCC1	Multidrug resistance-associated protein 1	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q92887	ABCC2	Canalicular multispecific organic anion transporter 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q92887	ABCC2	Canalicular multispecific organic anion transporter 1	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; TAS:ProtInc
Q92887	ABCC2	Canalicular multispecific organic anion transporter 1	GO:0008514; F:organic anion transmembrane transporter activity; TAS:ProtInc
Q92887	ABCC2	Canalicular multispecific organic anion transporter 1	GO:0005515; F:protein binding; IPI:IntAct
Q92887	ABCC2	Canalicular multispecific organic anion transporter 1	GO:0030644; P:cellular chloride ion homeostasis; IEA:Ensembl
Q92887	ABCC2	Canalicular multispecific organic anion transporter 1	GO:0006855; P:drug transmembrane transport; IEA:Ensembl
Q92887	ABCC2	Canalicular multispecific organic anion transporter 1	GO:0015732; P:prostaglandin transport; IEA:Ensembl
Q92887	ABCC2	Canalicular multispecific organic anion transporter 1	GO:0046685; P:response to arsenic-containing substance; IEA:Ensembl
Q92887	ABCC2	Canalicular multispecific organic anion transporter 1	GO:0043627; P:response to estrogen; IEA:Ensembl
Q92887	ABCC2	Canalicular multispecific organic anion transporter 1	GO:0009408; P:response to heat; IEA:Ensembl
Q92887	ABCC2	Canalicular multispecific organic anion transporter 1	GO:0031427; P:response to methotrexate; IEA:Ensembl
Q92887	ABCC2	Canalicular multispecific organic anion transporter 1	GO:0006979; P:response to oxidative stress; IEA:Ensembl
Q92887	ABCC2	Canalicular multispecific organic anion transporter 1	GO:0070327; P:thyroid hormone transport; IEA:Ensembl
Q92887	ABCC2	Canalicular multispecific organic anion transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q92887	ABCC2	Canalicular multispecific organic anion transporter 1	GO:0006810; P:transport; TAS:ProtInc
O15438	ABCC3	Canalicular multispecific organic anion transporter 2	GO:0005524; F:ATP binding; TAS:ProtInc
O15438	ABCC3	Canalicular multispecific organic anion transporter 2	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; TAS:ProtInc
O15438	ABCC3	Canalicular multispecific organic anion transporter 2	GO:0008514; F:organic anion transmembrane transporter activity; TAS:ProtInc
O15438	ABCC3	Canalicular multispecific organic anion transporter 2	GO:0015721; P:bile acid and bile salt transport; TAS:Reactome
O15438	ABCC3	Canalicular multispecific organic anion transporter 2	GO:0008206; P:bile acid metabolic process; TAS:Reactome
O15438	ABCC3	Canalicular multispecific organic anion transporter 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15438	ABCC3	Canalicular multispecific organic anion transporter 2	GO:0055085; P:transmembrane transport; TAS:Reactome
O15438	ABCC3	Canalicular multispecific organic anion transporter 2	GO:0006810; P:transport; TAS:ProtInc
O15440	ABCC5	Multidrug resistance-associated protein 5	GO:0005524; F:ATP binding; TAS:ProtInc
O15440	ABCC5	Multidrug resistance-associated protein 5	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IEA:InterPro
O15440	ABCC5	Multidrug resistance-associated protein 5	GO:0008514; F:organic anion transmembrane transporter activity; TAS:ProtInc
O15440	ABCC5	Multidrug resistance-associated protein 5	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O15440	ABCC5	Multidrug resistance-associated protein 5	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O15440	ABCC5	Multidrug resistance-associated protein 5	GO:0030213; P:hyaluronan biosynthetic process; TAS:Reactome
O15440	ABCC5	Multidrug resistance-associated protein 5	GO:0030212; P:hyaluronan metabolic process; TAS:Reactome
O15440	ABCC5	Multidrug resistance-associated protein 5	GO:0015711; P:organic anion transport; TAS:GOC
O15440	ABCC5	Multidrug resistance-associated protein 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15440	ABCC5	Multidrug resistance-associated protein 5	GO:0055085; P:transmembrane transport; TAS:Reactome
O15440	ABCC5	Multidrug resistance-associated protein 5	GO:0006810; P:transport; TAS:ProtInc
O15439	ABCC4	Multidrug resistance-associated protein 4	GO:0016404; F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; NAS:UniProtKB
O15439	ABCC4	Multidrug resistance-associated protein 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O15439	ABCC4	Multidrug resistance-associated protein 4	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IEA:InterPro
O15439	ABCC4	Multidrug resistance-associated protein 4	GO:0007596; P:blood coagulation; TAS:Reactome
O15439	ABCC4	Multidrug resistance-associated protein 4	GO:0055114; P:oxidation-reduction process; NAS:GOC
O15439	ABCC4	Multidrug resistance-associated protein 4	GO:0030168; P:platelet activation; TAS:Reactome
O15439	ABCC4	Multidrug resistance-associated protein 4	GO:0002576; P:platelet degranulation; TAS:Reactome
O15439	ABCC4	Multidrug resistance-associated protein 4	GO:0055085; P:transmembrane transport; TAS:Reactome
O95255	ABCC6	Multidrug resistance-associated protein 6	GO:0005524; F:ATP binding; TAS:ProtInc
O95255	ABCC6	Multidrug resistance-associated protein 6	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; TAS:ProtInc
O95255	ABCC6	Multidrug resistance-associated protein 6	GO:0005215; F:transporter activity; TAS:ProtInc
O95255	ABCC6	Multidrug resistance-associated protein 6	GO:0042493; P:response to drug; TAS:ProtInc
O95255	ABCC6	Multidrug resistance-associated protein 6	GO:0055085; P:transmembrane transport; TAS:Reactome
O95255	ABCC6	Multidrug resistance-associated protein 6	GO:0006810; P:transport; TAS:ProtInc
O95255	ABCC6	Multidrug resistance-associated protein 6	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q5T3U5	ABCC10	Multidrug resistance-associated protein 7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5T3U5	ABCC10	Multidrug resistance-associated protein 7	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IEA:InterPro
Q5T3U5	ABCC10	Multidrug resistance-associated protein 7	GO:0055085; P:transmembrane transport; TAS:Reactome
Q96J65	ABCC12	Multidrug resistance-associated protein 9	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96J65	ABCC12	Multidrug resistance-associated protein 9	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IEA:InterPro
P49006	MARCKSL1	MARCKS-related protein	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q7L0Y3	TRMT10C	Mitochondrial ribonuclease P protein 1	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q7L0Y3	TRMT10C	Mitochondrial ribonuclease P protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7L0Y3	TRMT10C	Mitochondrial ribonuclease P protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q7L0Y3	TRMT10C	Mitochondrial ribonuclease P protein 1	GO:0000964; P:mitochondrial RNA 5'-end processing; IMP:UniProtKB
Q7L0Y3	TRMT10C	Mitochondrial ribonuclease P protein 1	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
O15091	KIAA0391	Mitochondrial ribonuclease P protein 3	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q9HD23	MRS2	Magnesium transporter MRS2 homolog, mitochondrial	GO:0015095; F:magnesium ion transmembrane transporter activity; IEA:InterPro
Q9UKD2	MRTO4	mRNA turnover protein 4 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UKD2	MRTO4	mRNA turnover protein 4 homolog	GO:0042254; P:ribosome biogenesis; IEA:UniProtKB-KW
Q9Y6F6	MRVI1	Protein MRVI1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6F6	MRVI1	Protein MRVI1	GO:0007596; P:blood coagulation; TAS:Reactome
O43482	OIP5	Protein Mis18-beta	GO:0005515; F:protein binding; IPI:IntAct
O43482	OIP5	Protein Mis18-beta	GO:0007154; P:cell communication; NAS:UniProtKB
O43482	OIP5	Protein Mis18-beta	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
O43482	OIP5	Protein Mis18-beta	GO:0007067; P:mitosis; IEA:UniProtKB-KW
O43482	OIP5	Protein Mis18-beta	GO:0006334; P:nucleosome assembly; TAS:Reactome
Q9NYP9	MIS18A	Protein Mis18-alpha	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
Q9NYP9	MIS18A	Protein Mis18-alpha	GO:0007059; P:chromosome segregation; IEA:Ensembl
Q9NYP9	MIS18A	Protein Mis18-alpha	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9NYP9	MIS18A	Protein Mis18-alpha	GO:0006334; P:nucleosome assembly; TAS:Reactome
Q9NYP9	MIS18A	Protein Mis18-alpha	GO:0044030; P:regulation of DNA methylation; IEA:Ensembl
Q8N5Y2	MSL3	Male-specific lethal 3 homolog	GO:0003677; F:DNA binding; IDA:UniProtKB
Q8N5Y2	MSL3	Male-specific lethal 3 homolog	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q8N5Y2	MSL3	Male-specific lethal 3 homolog	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q8N5Y2	MSL3	Male-specific lethal 3 homolog	GO:0006325; P:chromatin organization; TAS:Reactome
Q8N5Y2	MSL3	Male-specific lethal 3 homolog	GO:0043984; P:histone H4-K16 acetylation; IDA:UniProtKB
Q8N5Y2	MSL3	Male-specific lethal 3 homolog	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q8N5Y2	MSL3	Male-specific lethal 3 homolog	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P0C860	MSL3P1	Putative male-specific lethal-3 protein-like 2	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
P0C860	MSL3P1	Putative male-specific lethal-3 protein-like 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P0C860	MSL3P1	Putative male-specific lethal-3 protein-like 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96HJ5	MS4A3	Membrane-spanning 4-domains subfamily A member 3	GO:0005515; F:protein binding; IPI:UniProtKB
A6NI15	MSGN1	Mesogenin-1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A6NI15	MSGN1	Mesogenin-1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
A6NI15	MSGN1	Mesogenin-1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A6NI15	MSGN1	Mesogenin-1	GO:0007379; P:segment specification; IEA:Ensembl
A6NI15	MSGN1	Mesogenin-1	GO:0001756; P:somitogenesis; IEA:Ensembl
A6NI15	MSGN1	Mesogenin-1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0019237; F:centromeric DNA binding; IEA:Ensembl
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0003684; F:damaged DNA binding; IEA:Ensembl
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0003677; F:DNA binding; IDA:UniProtKB
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0008094; F:DNA-dependent ATPase activity; IBA:RefGenome
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0000406; F:double-strand/single-strand DNA junction binding; IBA:RefGenome
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0019899; F:enzyme binding; IPI:UniProtKB
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0032137; F:guanine/thymine mispair binding; IMP:MGI
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0000404; F:heteroduplex DNA loop binding; IBA:RefGenome
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0005515; F:protein binding; IPI:UniProtKB
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0042803; F:protein homodimerization activity; IDA:HGNC
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0000403; F:Y-form DNA binding; IBA:RefGenome
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0006200; P:ATP catabolic process; IDA:GOC
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0030183; P:B cell differentiation; ISS:BHF-UCL
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0019724; P:B cell mediated immunity; ISS:BHF-UCL
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0007050; P:cell cycle arrest; IEA:Ensembl
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0008340; P:determination of adult lifespan; IEA:Ensembl
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0006281; P:DNA repair; IDA:BHF-UCL
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0006302; P:double-strand break repair; IBA:RefGenome
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0007281; P:germ cell development; IEA:Ensembl
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0031573; P:intra-S DNA damage checkpoint; IBA:RefGenome
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IBA:RefGenome
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0045190; P:isotype switching; ISS:BHF-UCL
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0043570; P:maintenance of DNA repeat elements; IMP:HGNC
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0008584; P:male gonad development; ISS:BHF-UCL
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0006311; P:meiotic gene conversion; IBA:RefGenome
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0000710; P:meiotic mismatch repair; IBA:RefGenome
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0006298; P:mismatch repair; IDA:UniProtKB
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0045910; P:negative regulation of DNA recombination; IDA:BHF-UCL
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:BHF-UCL
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0045128; P:negative regulation of reciprocal meiotic recombination; IBA:RefGenome
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0006119; P:oxidative phosphorylation; IEA:Ensembl
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0051096; P:positive regulation of helicase activity; IDA:BHF-UCL
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0006301; P:postreplication repair; IDA:UniProtKB
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0010224; P:response to UV-B; ISS:BHF-UCL
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0010165; P:response to X-ray; ISS:BHF-UCL
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0016446; P:somatic hypermutation of immunoglobulin genes; IBA:RefGenome
P43246	MSH2	DNA mismatch repair protein Msh2	GO:0016447; P:somatic recombination of immunoglobulin gene segments; ISS:BHF-UCL
P20585	MSH3	DNA mismatch repair protein Msh3	GO:0005524; F:ATP binding; IEA:InterPro
P20585	MSH3	DNA mismatch repair protein Msh3	GO:0019237; F:centromeric DNA binding; IEA:Ensembl
P20585	MSH3	DNA mismatch repair protein Msh3	GO:0003684; F:damaged DNA binding; IEA:Ensembl
P20585	MSH3	DNA mismatch repair protein Msh3	GO:0008094; F:DNA-dependent ATPase activity; IBA:RefGenome
P20585	MSH3	DNA mismatch repair protein Msh3	GO:0000406; F:double-strand/single-strand DNA junction binding; IBA:RefGenome
P20585	MSH3	DNA mismatch repair protein Msh3	GO:0019899; F:enzyme binding; IPI:UniProtKB
P20585	MSH3	DNA mismatch repair protein Msh3	GO:0000404; F:heteroduplex DNA loop binding; IBA:RefGenome
P20585	MSH3	DNA mismatch repair protein Msh3	GO:0030983; F:mismatched DNA binding; IEA:InterPro
P20585	MSH3	DNA mismatch repair protein Msh3	GO:0005515; F:protein binding; IPI:UniProtKB
P20585	MSH3	DNA mismatch repair protein Msh3	GO:0000403; F:Y-form DNA binding; IBA:RefGenome
P20585	MSH3	DNA mismatch repair protein Msh3	GO:0006200; P:ATP catabolic process; IBA:GOC
P20585	MSH3	DNA mismatch repair protein Msh3	GO:0006281; P:DNA repair; IDA:BHF-UCL
P20585	MSH3	DNA mismatch repair protein Msh3	GO:0043570; P:maintenance of DNA repeat elements; IMP:HGNC
P20585	MSH3	DNA mismatch repair protein Msh3	GO:0000710; P:meiotic mismatch repair; IBA:RefGenome
P20585	MSH3	DNA mismatch repair protein Msh3	GO:0006298; P:mismatch repair; IEA:InterPro
P20585	MSH3	DNA mismatch repair protein Msh3	GO:0045910; P:negative regulation of DNA recombination; IDA:BHF-UCL
P20585	MSH3	DNA mismatch repair protein Msh3	GO:0051096; P:positive regulation of helicase activity; IDA:BHF-UCL
P20585	MSH3	DNA mismatch repair protein Msh3	GO:0007131; P:reciprocal meiotic recombination; IBA:RefGenome
P20585	MSH3	DNA mismatch repair protein Msh3	GO:0016447; P:somatic recombination of immunoglobulin gene segments; IBA:RefGenome
O15457	MSH4	MutS protein homolog 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O15457	MSH4	MutS protein homolog 4	GO:0003677; F:DNA binding; TAS:ProtInc
O15457	MSH4	MutS protein homolog 4	GO:0008094; F:DNA-dependent ATPase activity; IBA:RefGenome
O15457	MSH4	MutS protein homolog 4	GO:0030983; F:mismatched DNA binding; IBA:RefGenome
O15457	MSH4	MutS protein homolog 4	GO:0005515; F:protein binding; IPI:IntAct
O15457	MSH4	MutS protein homolog 4	GO:0006200; P:ATP catabolic process; IBA:GOC
O15457	MSH4	MutS protein homolog 4	GO:0051026; P:chiasma assembly; IBA:RefGenome
O15457	MSH4	MutS protein homolog 4	GO:0007292; P:female gamete generation; IEA:Ensembl
O15457	MSH4	MutS protein homolog 4	GO:0045143; P:homologous chromosome segregation; IBA:RefGenome
O15457	MSH4	MutS protein homolog 4	GO:0006298; P:mismatch repair; IEA:InterPro
O15457	MSH4	MutS protein homolog 4	GO:0001541; P:ovarian follicle development; IEA:Ensembl
O15457	MSH4	MutS protein homolog 4	GO:0007131; P:reciprocal meiotic recombination; IBA:RefGenome
O15457	MSH4	MutS protein homolog 4	GO:0007283; P:spermatogenesis; IEA:Ensembl
O43196	MSH5	MutS protein homolog 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43196	MSH5	MutS protein homolog 5	GO:0008094; F:DNA-dependent ATPase activity; IBA:RefGenome
O43196	MSH5	MutS protein homolog 5	GO:0030983; F:mismatched DNA binding; IBA:RefGenome
O43196	MSH5	MutS protein homolog 5	GO:0005515; F:protein binding; IPI:IntAct
O43196	MSH5	MutS protein homolog 5	GO:0006200; P:ATP catabolic process; IBA:GOC
O43196	MSH5	MutS protein homolog 5	GO:0051026; P:chiasma assembly; IBA:RefGenome
O43196	MSH5	MutS protein homolog 5	GO:0045143; P:homologous chromosome segregation; IBA:RefGenome
O43196	MSH5	MutS protein homolog 5	GO:0007126; P:meiotic nuclear division; TAS:ProtInc
O43196	MSH5	MutS protein homolog 5	GO:0007136; P:meiotic prophase II; TAS:ProtInc
O43196	MSH5	MutS protein homolog 5	GO:0006298; P:mismatch repair; TAS:ProtInc
O43196	MSH5	MutS protein homolog 5	GO:0007131; P:reciprocal meiotic recombination; IBA:RefGenome
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0005524; F:ATP binding; IEA:InterPro
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0003682; F:chromatin binding; IEA:Ensembl
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0003684; F:damaged DNA binding; IEA:Ensembl
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0008094; F:DNA-dependent ATPase activity; IBA:RefGenome
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0032137; F:guanine/thymine mispair binding; IEA:Ensembl
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0035064; F:methylated histone binding; IDA:UniProtKB
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0030983; F:mismatched DNA binding; IEA:InterPro
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0005515; F:protein binding; IPI:UniProtKB
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0006200; P:ATP catabolic process; IDA:GOC
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0008340; P:determination of adult lifespan; ISS:BHF-UCL
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0006281; P:DNA repair; IDA:BHF-UCL
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0097193; P:intrinsic apoptotic signaling pathway; ISS:BHF-UCL
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; ISS:BHF-UCL
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0045190; P:isotype switching; ISS:BHF-UCL
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0000710; P:meiotic mismatch repair; ISS:BHF-UCL
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0006298; P:mismatch repair; IEA:InterPro
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0045910; P:negative regulation of DNA recombination; IDA:BHF-UCL
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0051096; P:positive regulation of helicase activity; IDA:BHF-UCL
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0007131; P:reciprocal meiotic recombination; IBA:RefGenome
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0009411; P:response to UV; ISS:BHF-UCL
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0016446; P:somatic hypermutation of immunoglobulin genes; ISS:BHF-UCL
P52701	MSH6	DNA mismatch repair protein Msh6	GO:0016447; P:somatic recombination of immunoglobulin gene segments; ISS:BHF-UCL
Q01726	MC1R	Melanocyte-stimulating hormone receptor	GO:0008528; F:G-protein coupled peptide receptor activity; TAS:BHF-UCL
Q01726	MC1R	Melanocyte-stimulating hormone receptor	GO:0004977; F:melanocortin receptor activity; TAS:ProtInc
Q01726	MC1R	Melanocyte-stimulating hormone receptor	GO:0004980; F:melanocyte-stimulating hormone receptor activity; IPI:BHF-UCL
Q01726	MC1R	Melanocyte-stimulating hormone receptor	GO:0005515; F:protein binding; IPI:BHF-UCL
Q01726	MC1R	Melanocyte-stimulating hormone receptor	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q01726	MC1R	Melanocyte-stimulating hormone receptor	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
Q01726	MC1R	Melanocyte-stimulating hormone receptor	GO:0035556; P:intracellular signal transduction; ISS:BHF-UCL
Q01726	MC1R	Melanocyte-stimulating hormone receptor	GO:0042438; P:melanin biosynthetic process; IEA:Ensembl
Q01726	MC1R	Melanocyte-stimulating hormone receptor	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q01726	MC1R	Melanocyte-stimulating hormone receptor	GO:0032720; P:negative regulation of tumor necrosis factor production; IMP:BHF-UCL
Q01726	MC1R	Melanocyte-stimulating hormone receptor	GO:0043473; P:pigmentation; TAS:BHF-UCL
Q01726	MC1R	Melanocyte-stimulating hormone receptor	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:BHF-UCL
Q01726	MC1R	Melanocyte-stimulating hormone receptor	GO:0010739; P:positive regulation of protein kinase A signaling; ISS:BHF-UCL
Q01726	MC1R	Melanocyte-stimulating hormone receptor	GO:0051897; P:positive regulation of protein kinase B signaling; ISS:BHF-UCL
Q01726	MC1R	Melanocyte-stimulating hormone receptor	GO:0090037; P:positive regulation of protein kinase C signaling; ISS:BHF-UCL
Q01726	MC1R	Melanocyte-stimulating hormone receptor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q01726	MC1R	Melanocyte-stimulating hormone receptor	GO:0019233; P:sensory perception of pain; IEA:Ensembl
Q01726	MC1R	Melanocyte-stimulating hormone receptor	GO:0009650; P:UV protection; TAS:ProtInc
Q01726	MC1R	Melanocyte-stimulating hormone receptor	GO:0070914; P:UV-damage excision repair; IDA:BHF-UCL
O43347	MSI1	RNA-binding protein Musashi homolog 1	GO:0000166; F:nucleotide binding; IEA:InterPro
O43347	MSI1	RNA-binding protein Musashi homolog 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O43347	MSI1	RNA-binding protein Musashi homolog 1	GO:0008266; F:poly(U) RNA binding; IEA:Ensembl
O43347	MSI1	RNA-binding protein Musashi homolog 1	GO:0003723; F:RNA binding; TAS:ProtInc
O43347	MSI1	RNA-binding protein Musashi homolog 1	GO:0030855; P:epithelial cell differentiation; IEA:Ensembl
O43347	MSI1	RNA-binding protein Musashi homolog 1	GO:0007399; P:nervous system development; TAS:ProtInc
O43347	MSI1	RNA-binding protein Musashi homolog 1	GO:0009725; P:response to hormone; IEA:Ensembl
Q96DH6	MSI2	RNA-binding protein Musashi homolog 2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q96DH6	MSI2	RNA-binding protein Musashi homolog 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96DH6	MSI2	RNA-binding protein Musashi homolog 2	GO:0008266; F:poly(U) RNA binding; IEA:Ensembl
Q96DH6	MSI2	RNA-binding protein Musashi homolog 2	GO:0048864; P:stem cell development; IEA:Ensembl
Q68DK7	MSL1	Male-specific lethal 1 homolog	GO:0006325; P:chromatin organization; TAS:Reactome
Q68DK7	MSL1	Male-specific lethal 1 homolog	GO:0043984; P:histone H4-K16 acetylation; IDA:UniProtKB
Q9HCI7	MSL2	E3 ubiquitin-protein ligase MSL2	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9HCI7	MSL2	E3 ubiquitin-protein ligase MSL2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9HCI7	MSL2	E3 ubiquitin-protein ligase MSL2	GO:0006325; P:chromatin organization; TAS:Reactome
Q9HCI7	MSL2	E3 ubiquitin-protein ligase MSL2	GO:0043984; P:histone H4-K16 acetylation; IDA:UniProtKB
Q96KJ4	MSLNL	Mesothelin-like protein	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q13421	MSLN	Mesothelin	GO:0005515; F:protein binding; IPI:UniProtKB
Q13421	MSLN	Mesothelin	GO:0007155; P:cell adhesion; NAS:UniProtKB
Q13421	MSLN	Mesothelin	GO:0031016; P:pancreas development; IEA:Ensembl
Q15800	MSMO1	Methylsterol monooxygenase 1	GO:0000254; F:C-4 methylsterol oxidase activity; TAS:ProtInc
Q15800	MSMO1	Methylsterol monooxygenase 1	GO:0005506; F:iron ion binding; IEA:InterPro
Q15800	MSMO1	Methylsterol monooxygenase 1	GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome
Q15800	MSMO1	Methylsterol monooxygenase 1	GO:0006633; P:fatty acid biosynthetic process; IEA:InterPro
Q15800	MSMO1	Methylsterol monooxygenase 1	GO:0006631; P:fatty acid metabolic process; TAS:ProtInc
Q15800	MSMO1	Methylsterol monooxygenase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15800	MSMO1	Methylsterol monooxygenase 1	GO:0008202; P:steroid metabolic process; TAS:ProtInc
Q9UJG1	MOSPD1	Motile sperm domain-containing protein 1	GO:0005198; F:structural molecule activity; IEA:InterPro
Q9UJG1	MOSPD1	Motile sperm domain-containing protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q9UJG1	MOSPD1	Motile sperm domain-containing protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q8NHP6	MOSPD2	Motile sperm domain-containing protein 2	GO:0005198; F:structural molecule activity; IEA:InterPro
O75425	MOSPD3	Motile sperm domain-containing protein 3	GO:0005198; F:structural molecule activity; IEA:InterPro
O75425	MOSPD3	Motile sperm domain-containing protein 3	GO:0007507; P:heart development; IEA:Ensembl
Q9UJ68	MSRA	Mitochondrial peptide methionine sulfoxide reductase	GO:0008113; F:peptide-methionine (S)-S-oxide reductase activity; TAS:ProtInc
Q9UJ68	MSRA	Mitochondrial peptide methionine sulfoxide reductase	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q9UJ68	MSRA	Mitochondrial peptide methionine sulfoxide reductase	GO:0006555; P:methionine metabolic process; TAS:ProtInc
Q9UJ68	MSRA	Mitochondrial peptide methionine sulfoxide reductase	GO:0030091; P:protein repair; IEA:InterPro
Q9UJ68	MSRA	Mitochondrial peptide methionine sulfoxide reductase	GO:0006979; P:response to oxidative stress; TAS:ProtInc
Q9NZV6	MSRB1	Methionine-R-sulfoxide reductase B1	GO:0003779; F:actin binding; ISS:UniProtKB
Q9NZV6	MSRB1	Methionine-R-sulfoxide reductase B1	GO:0070191; F:methionine-R-sulfoxide reductase activity; IEA:Ensembl
Q9NZV6	MSRB1	Methionine-R-sulfoxide reductase B1	GO:0033743; F:peptide-methionine (R)-S-oxide reductase activity; ISS:UniProtKB
Q9NZV6	MSRB1	Methionine-R-sulfoxide reductase B1	GO:0008270; F:zinc ion binding; ISS:HGNC
Q9NZV6	MSRB1	Methionine-R-sulfoxide reductase B1	GO:0030041; P:actin filament polymerization; ISS:UniProtKB
Q9NZV6	MSRB1	Methionine-R-sulfoxide reductase B1	GO:0045087; P:innate immune response; ISS:UniProtKB
Q9NZV6	MSRB1	Methionine-R-sulfoxide reductase B1	GO:0030091; P:protein repair; ISS:HGNC
Q9NZV6	MSRB1	Methionine-R-sulfoxide reductase B1	GO:0006979; P:response to oxidative stress; IEA:InterPro
Q9Y3D2	MSRB2	Methionine-R-sulfoxide reductase B2, mitochondrial	GO:0003779; F:actin binding; ISS:UniProtKB
Q9Y3D2	MSRB2	Methionine-R-sulfoxide reductase B2, mitochondrial	GO:0033743; F:peptide-methionine (R)-S-oxide reductase activity; ISS:UniProtKB
Q9Y3D2	MSRB2	Methionine-R-sulfoxide reductase B2, mitochondrial	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9Y3D2	MSRB2	Methionine-R-sulfoxide reductase B2, mitochondrial	GO:0008270; F:zinc ion binding; ISS:HGNC
Q9Y3D2	MSRB2	Methionine-R-sulfoxide reductase B2, mitochondrial	GO:0030041; P:actin filament polymerization; ISS:UniProtKB
Q9Y3D2	MSRB2	Methionine-R-sulfoxide reductase B2, mitochondrial	GO:0030091; P:protein repair; ISS:HGNC
Q9Y3D2	MSRB2	Methionine-R-sulfoxide reductase B2, mitochondrial	GO:0006355; P:regulation of transcription, DNA-templated; TAS:GOC
Q9Y3D2	MSRB2	Methionine-R-sulfoxide reductase B2, mitochondrial	GO:0006979; P:response to oxidative stress; IEA:InterPro
Q8IXL7	MSRB3	Methionine-R-sulfoxide reductase B3	GO:0033743; F:peptide-methionine (R)-S-oxide reductase activity; IDA:HGNC
Q8IXL7	MSRB3	Methionine-R-sulfoxide reductase B3	GO:0008270; F:zinc ion binding; IDA:HGNC
Q8IXL7	MSRB3	Methionine-R-sulfoxide reductase B3	GO:0030091; P:protein repair; IDA:HGNC
Q8IXL7	MSRB3	Methionine-R-sulfoxide reductase B3	GO:0006979; P:response to oxidative stress; IEA:InterPro
P21757	MSR1	Macrophage scavenger receptor types I and II	GO:0030169; F:low-density lipoprotein particle binding; ISS:BHF-UCL
P21757	MSR1	Macrophage scavenger receptor types I and II	GO:0005515; F:protein binding; IPI:IntAct
P21757	MSR1	Macrophage scavenger receptor types I and II	GO:0005044; F:scavenger receptor activity; TAS:ProtInc
P21757	MSR1	Macrophage scavenger receptor types I and II	GO:0030301; P:cholesterol transport; ISS:BHF-UCL
P21757	MSR1	Macrophage scavenger receptor types I and II	GO:0042953; P:lipoprotein transport; IEA:Ensembl
P21757	MSR1	Macrophage scavenger receptor types I and II	GO:0034381; P:plasma lipoprotein particle clearance; ISS:BHF-UCL
P21757	MSR1	Macrophage scavenger receptor types I and II	GO:0010886; P:positive regulation of cholesterol storage; ISS:BHF-UCL
P21757	MSR1	Macrophage scavenger receptor types I and II	GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; ISS:BHF-UCL
P21757	MSR1	Macrophage scavenger receptor types I and II	GO:0006898; P:receptor-mediated endocytosis; TAS:ProtInc
P47224	RABIF	Guanine nucleotide exchange factor MSS4	GO:0005085; F:guanyl-nucleotide exchange factor activity; NAS:UniProtKB
P47224	RABIF	Guanine nucleotide exchange factor MSS4	GO:0005515; F:protein binding; IPI:IntAct
P47224	RABIF	Guanine nucleotide exchange factor MSS4	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P47224	RABIF	Guanine nucleotide exchange factor MSS4	GO:0061025; P:membrane fusion; TAS:ProtInc
P47224	RABIF	Guanine nucleotide exchange factor MSS4	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P47224	RABIF	Guanine nucleotide exchange factor MSS4	GO:0043087; P:regulation of GTPase activity; NAS:GOC
P47224	RABIF	Guanine nucleotide exchange factor MSS4	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q4VC12	MSS51	Putative protein MSS51 homolog, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q4VC12	MSS51	Putative protein MSS51 homolog, mitochondrial	GO:0035176; P:social behavior; IEP:UniProtKB
Q2TV78	MST1L	Putative macrophage stimulating 1-like protein	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q9P289	MST4	Serine/threonine-protein kinase MST4	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9P289	MST4	Serine/threonine-protein kinase MST4	GO:0042802; F:identical protein binding; IPI:IntAct
Q9P289	MST4	Serine/threonine-protein kinase MST4	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q9P289	MST4	Serine/threonine-protein kinase MST4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P289	MST4	Serine/threonine-protein kinase MST4	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q9P289	MST4	Serine/threonine-protein kinase MST4	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
Q9P289	MST4	Serine/threonine-protein kinase MST4	GO:0006915; P:apoptotic process; TAS:Reactome
Q9P289	MST4	Serine/threonine-protein kinase MST4	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q9P289	MST4	Serine/threonine-protein kinase MST4	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9P289	MST4	Serine/threonine-protein kinase MST4	GO:0042981; P:regulation of apoptotic process; IDA:UniProtKB
Q9P289	MST4	Serine/threonine-protein kinase MST4	GO:0045595; P:regulation of cell differentiation; IBA:RefGenome
Q9P289	MST4	Serine/threonine-protein kinase MST4	GO:0023014; P:signal transduction by phosphorylation; IBA:GOC
Q9BUK6	MSTO1	Protein misato homolog 1	GO:0048311; P:mitochondrion distribution; IMP:UniProtKB
Q9BUK6	MSTO1	Protein misato homolog 1	GO:0007005; P:mitochondrion organization; IMP:UniProtKB
P28360	MSX1	Homeobox protein MSX-1	GO:0002039; F:p53 binding; IPI:BHF-UCL
P28360	MSX1	Homeobox protein MSX-1	GO:0000982; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0001228; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0090427; P:activation of meiosis; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0061312; P:BMP signaling pathway involved in heart development; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0060349; P:bone morphogenesis; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0060536; P:cartilage morphogenesis; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0000902; P:cell morphogenesis; IDA:BHF-UCL
P28360	MSX1	Homeobox protein MSX-1	GO:0071316; P:cellular response to nicotine; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0035880; P:embryonic nail plate morphogenesis; IMP:BHF-UCL
P28360	MSX1	Homeobox protein MSX-1	GO:0003198; P:epithelial to mesenchymal transition involved in endocardial cushion formation; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0060325; P:face morphogenesis; IMP:BHF-UCL
P28360	MSX1	Homeobox protein MSX-1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0061180; P:mammary gland epithelium development; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0010463; P:mesenchymal cell proliferation; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0030901; P:midbrain development; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0042474; P:middle ear morphogenesis; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0007517; P:muscle organ development; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0030308; P:negative regulation of cell growth; IDA:BHF-UCL
P28360	MSX1	Homeobox protein MSX-1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0051154; P:negative regulation of striated muscle cell differentiation; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:2000678; P:negative regulation of transcription regulatory region DNA binding; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0042475; P:odontogenesis of dentin-containing tooth; IMP:BHF-UCL
P28360	MSX1	Homeobox protein MSX-1	GO:0060021; P:palate development; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0021983; P:pituitary gland development; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0030513; P:positive regulation of BMP signaling pathway; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0043517; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; IC:BHF-UCL
P28360	MSX1	Homeobox protein MSX-1	GO:1902255; P:positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator; IDA:BHF-UCL
P28360	MSX1	Homeobox protein MSX-1	GO:2001055; P:positive regulation of mesenchymal cell apoptotic process; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0034504; P:protein localization to nucleus; IDA:BHF-UCL
P28360	MSX1	Homeobox protein MSX-1	GO:0050821; P:protein stabilization; IDA:BHF-UCL
P28360	MSX1	Homeobox protein MSX-1	GO:0042481; P:regulation of odontogenesis; IEA:Ensembl
P28360	MSX1	Homeobox protein MSX-1	GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0005515; F:protein binding; IPI:UniProtKB
P35548	MSX2	Homeobox protein MSX-2	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0000982; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0043565; F:sequence-specific DNA binding; IDA:MGI
P35548	MSX2	Homeobox protein MSX-2	GO:0003712; F:transcription cofactor activity; ISS:BHF-UCL
P35548	MSX2	Homeobox protein MSX-2	GO:0044212; F:transcription regulatory region DNA binding; ISS:UniProtKB
P35548	MSX2	Homeobox protein MSX-2	GO:0090427; P:activation of meiosis; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0042640; P:anagen; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0061312; P:BMP signaling pathway involved in heart development; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0060346; P:bone trabecula formation; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0060444; P:branching involved in mammary gland duct morphogenesis; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0071392; P:cellular response to estradiol stimulus; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0002063; P:chondrocyte development; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0060363; P:cranial suture morphogenesis; TAS:BHF-UCL
P35548	MSX2	Homeobox protein MSX-2	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0035880; P:embryonic nail plate morphogenesis; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0070166; P:enamel mineralization; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0003416; P:endochondral bone growth; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0003198; P:epithelial to mesenchymal transition involved in endocardial cushion formation; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0060364; P:frontal suture morphogenesis; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0032792; P:negative regulation of CREB transcription factor activity; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0045599; P:negative regulation of fat cell differentiation; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0045617; P:negative regulation of keratinocyte differentiation; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P35548	MSX2	Homeobox protein MSX-2	GO:2000678; P:negative regulation of transcription regulatory region DNA binding; ISS:BHF-UCL
P35548	MSX2	Homeobox protein MSX-2	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
P35548	MSX2	Homeobox protein MSX-2	GO:0002076; P:osteoblast development; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0001649; P:osteoblast differentiation; ISS:UniProtKB
P35548	MSX2	Homeobox protein MSX-2	GO:0003148; P:outflow tract septum morphogenesis; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0030513; P:positive regulation of BMP signaling pathway; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0051795; P:positive regulation of catagen; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:2001055; P:positive regulation of mesenchymal cell apoptotic process; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl
P35548	MSX2	Homeobox protein MSX-2	GO:0035313; P:wound healing, spreading of epidermal cells; IEA:Ensembl
P04731	MT1A	Metallothionein-1A	GO:0005515; F:protein binding; IPI:IntAct
P04731	MT1A	Metallothionein-1A	GO:0008270; F:zinc ion binding; ISS:UniProtKB
P04731	MT1A	Metallothionein-1A	GO:0071276; P:cellular response to cadmium ion; IEP:UniProtKB
P04731	MT1A	Metallothionein-1A	GO:0071294; P:cellular response to zinc ion; IEP:UniProtKB
P04731	MT1A	Metallothionein-1A	GO:0045926; P:negative regulation of growth; ISS:UniProtKB
P07438	MT1B	Metallothionein-1B	GO:0008270; F:zinc ion binding; ISS:UniProtKB
P07438	MT1B	Metallothionein-1B	GO:0071294; P:cellular response to zinc ion; IEP:UniProtKB
P07438	MT1B	Metallothionein-1B	GO:0045926; P:negative regulation of growth; ISS:UniProtKB
A1L3X4	MT1DP	Putative metallothionein MT1DP	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P04732	MT1E	Metallothionein-1E	GO:0008270; F:zinc ion binding; ISS:UniProtKB
P04732	MT1E	Metallothionein-1E	GO:0071276; P:cellular response to cadmium ion; IEP:UniProtKB
P04732	MT1E	Metallothionein-1E	GO:0071294; P:cellular response to zinc ion; IEP:UniProtKB
P04732	MT1E	Metallothionein-1E	GO:0045926; P:negative regulation of growth; ISS:UniProtKB
P04733	MT1F	Metallothionein-1F	GO:0008270; F:zinc ion binding; ISS:UniProtKB
P04733	MT1F	Metallothionein-1F	GO:0071276; P:cellular response to cadmium ion; IEP:UniProtKB
P04733	MT1F	Metallothionein-1F	GO:0071294; P:cellular response to zinc ion; ISS:UniProtKB
P04733	MT1F	Metallothionein-1F	GO:0045926; P:negative regulation of growth; ISS:UniProtKB
P13640	MT1G	Metallothionein-1G	GO:0005515; F:protein binding; IPI:IntAct
P13640	MT1G	Metallothionein-1G	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P13640	MT1G	Metallothionein-1G	GO:0071276; P:cellular response to cadmium ion; IEP:UniProtKB
P13640	MT1G	Metallothionein-1G	GO:0071280; P:cellular response to copper ion; IEP:UniProtKB
P13640	MT1G	Metallothionein-1G	GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IEP:UniProtKB
P13640	MT1G	Metallothionein-1G	GO:0071294; P:cellular response to zinc ion; IDA:UniProtKB
P13640	MT1G	Metallothionein-1G	GO:0042117; P:monocyte activation; NAS:UniProtKB
P13640	MT1G	Metallothionein-1G	GO:0030224; P:monocyte differentiation; NAS:UniProtKB
P13640	MT1G	Metallothionein-1G	GO:0045926; P:negative regulation of growth; IDA:UniProtKB
P80294	MT1H	Metallothionein-1H	GO:0005515; F:protein binding; IPI:UniProtKB
P80294	MT1H	Metallothionein-1H	GO:0008270; F:zinc ion binding; ISS:UniProtKB
P80294	MT1H	Metallothionein-1H	GO:0071276; P:cellular response to cadmium ion; IEP:UniProtKB
P80294	MT1H	Metallothionein-1H	GO:0071294; P:cellular response to zinc ion; IEP:UniProtKB
P80294	MT1H	Metallothionein-1H	GO:0045926; P:negative regulation of growth; ISS:UniProtKB
Q93083	MT1L	Metallothionein-1L	GO:0008270; F:zinc ion binding; ISS:UniProtKB
Q93083	MT1L	Metallothionein-1L	GO:0071294; P:cellular response to zinc ion; IEP:UniProtKB
Q93083	MT1L	Metallothionein-1L	GO:0045926; P:negative regulation of growth; ISS:UniProtKB
Q8N339	MT1M	Metallothionein-1M	GO:0008270; F:zinc ion binding; ISS:UniProtKB
Q8N339	MT1M	Metallothionein-1M	GO:0071294; P:cellular response to zinc ion; ISS:UniProtKB
Q8N339	MT1M	Metallothionein-1M	GO:0045926; P:negative regulation of growth; ISS:UniProtKB
P80297	MT1X	Metallothionein-1X	GO:0046872; F:metal ion binding; TAS:ProtInc
P80297	MT1X	Metallothionein-1X	GO:0008270; F:zinc ion binding; ISS:UniProtKB
P80297	MT1X	Metallothionein-1X	GO:0071276; P:cellular response to cadmium ion; IEP:UniProtKB
P80297	MT1X	Metallothionein-1X	GO:0036018; P:cellular response to erythropoietin; IEP:UniProtKB
P80297	MT1X	Metallothionein-1X	GO:0071294; P:cellular response to zinc ion; IEP:UniProtKB
P80297	MT1X	Metallothionein-1X	GO:0045926; P:negative regulation of growth; ISS:UniProtKB
P80297	MT1X	Metallothionein-1X	GO:0010038; P:response to metal ion; TAS:ProtInc
Q8WXB1	METTL21A	Protein N-lysine methyltransferase METTL21A	GO:0051117; F:ATPase binding; IPI:BHF-UCL
Q8WXB1	METTL21A	Protein N-lysine methyltransferase METTL21A	GO:0030544; F:Hsp70 protein binding; IPI:BHF-UCL
Q8WXB1	METTL21A	Protein N-lysine methyltransferase METTL21A	GO:0005515; F:protein binding; IPI:BHF-UCL
Q8WXB1	METTL21A	Protein N-lysine methyltransferase METTL21A	GO:0016279; F:protein-lysine N-methyltransferase activity; IDA:UniProtKB
Q8WXB1	METTL21A	Protein N-lysine methyltransferase METTL21A	GO:0018022; P:peptidyl-lysine methylation; IDA:BHF-UCL
Q8WXB1	METTL21A	Protein N-lysine methyltransferase METTL21A	GO:0006479; P:protein methylation; IDA:UniProtKB
Q96AZ1	METTL21B	Protein-lysine methyltransferase METTL21B	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q5VZV1	METTL21C	Protein-lysine methyltransferase METTL21C	GO:0016279; F:protein-lysine N-methyltransferase activity; IDA:UniProtKB
Q5VZV1	METTL21C	Protein-lysine methyltransferase METTL21C	GO:0018022; P:peptidyl-lysine methylation; IDA:GOC
Q5VZV1	METTL21C	Protein-lysine methyltransferase METTL21C	GO:0006479; P:protein methylation; IDA:UniProtKB
Q9H867	VCPKMT	Protein-lysine methyltransferase METTL21D	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H867	VCPKMT	Protein-lysine methyltransferase METTL21D	GO:0016279; F:protein-lysine N-methyltransferase activity; IDA:UniProtKB
Q9H867	VCPKMT	Protein-lysine methyltransferase METTL21D	GO:0018023; P:peptidyl-lysine trimethylation; IDA:UniProtKB
A6NDL7	METTL21EP	Putative methyltransferase-like protein 21E pseudogene	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
P02795	MT2A	Metallothionein-2	GO:0008144; F:drug binding; IDA:UniProtKB
P02795	MT2A	Metallothionein-2	GO:0005515; F:protein binding; IPI:IntAct
P02795	MT2A	Metallothionein-2	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P02795	MT2A	Metallothionein-2	GO:0006878; P:cellular copper ion homeostasis; TAS:ProtInc
P02795	MT2A	Metallothionein-2	GO:0035690; P:cellular response to drug; IDA:UniProtKB
P02795	MT2A	Metallothionein-2	GO:0036018; P:cellular response to erythropoietin; IEP:UniProtKB
P02795	MT2A	Metallothionein-2	GO:0036016; P:cellular response to interleukin-3; IEP:UniProtKB
P02795	MT2A	Metallothionein-2	GO:0071294; P:cellular response to zinc ion; IEP:UniProtKB
P02795	MT2A	Metallothionein-2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P02795	MT2A	Metallothionein-2	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P02795	MT2A	Metallothionein-2	GO:0045926; P:negative regulation of growth; ISS:UniProtKB
P25713	MT3	Metallothionein-3	GO:0016209; F:antioxidant activity; NAS:UniProtKB
P25713	MT3	Metallothionein-3	GO:0046870; F:cadmium ion binding; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0005507; F:copper ion binding; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0008144; F:drug binding; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0005515; F:protein binding; IPI:UniProtKB
P25713	MT3	Metallothionein-3	GO:0030295; F:protein kinase activator activity; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0032148; P:activation of protein kinase B activity; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0014002; P:astrocyte development; ISS:UniProtKB
P25713	MT3	Metallothionein-3	GO:0055073; P:cadmium ion homeostasis; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0008283; P:cell proliferation; TAS:ProtInc
P25713	MT3	Metallothionein-3	GO:0044242; P:cellular lipid catabolic process; ISS:UniProtKB
P25713	MT3	Metallothionein-3	GO:0006875; P:cellular metal ion homeostasis; NAS:UniProtKB
P25713	MT3	Metallothionein-3	GO:0071276; P:cellular response to cadmium ion; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0035690; P:cellular response to drug; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0071456; P:cellular response to hypoxia; IEP:UniProtKB
P25713	MT3	Metallothionein-3	GO:0071732; P:cellular response to nitric oxide; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0034599; P:cellular response to oxidative stress; IEP:UniProtKB
P25713	MT3	Metallothionein-3	GO:0006882; P:cellular zinc ion homeostasis; ISS:UniProtKB
P25713	MT3	Metallothionein-3	GO:0006707; P:cholesterol catabolic process; ISS:UniProtKB
P25713	MT3	Metallothionein-3	GO:0006112; P:energy reserve metabolic process; ISS:UniProtKB
P25713	MT3	Metallothionein-3	GO:0070371; P:ERK1 and ERK2 cascade; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0016570; P:histone modification; IMP:UniProtKB
P25713	MT3	Metallothionein-3	GO:0033210; P:leptin-mediated signaling pathway; ISS:UniProtKB
P25713	MT3	Metallothionein-3	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0010507; P:negative regulation of autophagy; ISS:UniProtKB
P25713	MT3	Metallothionein-3	GO:0030517; P:negative regulation of axon extension; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:2000117; P:negative regulation of cysteine-type endopeptidase activity; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0060547; P:negative regulation of necrotic cell death; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB
P25713	MT3	Metallothionein-3	GO:0051354; P:negative regulation of oxidoreductase activity; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:2000378; P:negative regulation of reactive oxygen species metabolic process; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
P25713	MT3	Metallothionein-3	GO:0043085; P:positive regulation of catalytic activity; ISS:UniProtKB
P25713	MT3	Metallothionein-3	GO:0010942; P:positive regulation of cell death; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0097214; P:positive regulation of lysosomal membrane permeability; ISS:UniProtKB
P25713	MT3	Metallothionein-3	GO:0010940; P:positive regulation of necrotic cell death; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:2000376; P:positive regulation of oxygen metabolic process; ISS:UniProtKB
P25713	MT3	Metallothionein-3	GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0036091; P:positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0000060; P:protein import into nucleus, translocation; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0043491; P:protein kinase B signaling; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0050821; P:protein stabilization; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0060049; P:regulation of protein glycosylation; ISS:UniProtKB
P25713	MT3	Metallothionein-3	GO:0032095; P:regulation of response to food; ISS:UniProtKB
P25713	MT3	Metallothionein-3	GO:0019430; P:removal of superoxide radicals; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0001666; P:response to hypoxia; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0055069; P:zinc ion homeostasis; IDA:UniProtKB
P25713	MT3	Metallothionein-3	GO:0006829; P:zinc ion transport; ISS:UniProtKB
P47944	MT4	Metallothionein-4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P47944	MT4	Metallothionein-4	GO:0006875; P:cellular metal ion homeostasis; IEA:Ensembl
Q13330	MTA1	Metastasis-associated protein MTA1	GO:0003682; F:chromatin binding; IEA:InterPro
Q13330	MTA1	Metastasis-associated protein MTA1	GO:0005515; F:protein binding; IPI:IntAct
Q13330	MTA1	Metastasis-associated protein MTA1	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:BHF-UCL
Q13330	MTA1	Metastasis-associated protein MTA1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q13330	MTA1	Metastasis-associated protein MTA1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q13330	MTA1	Metastasis-associated protein MTA1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13330	MTA1	Metastasis-associated protein MTA1	GO:0033363; P:secretory granule organization; IEA:Ensembl
Q13330	MTA1	Metastasis-associated protein MTA1	GO:0007165; P:signal transduction; TAS:ProtInc
O94776	MTA2	Metastasis-associated protein MTA2	GO:0003682; F:chromatin binding; IEA:InterPro
O94776	MTA2	Metastasis-associated protein MTA2	GO:0004407; F:histone deacetylase activity; IEA:Ensembl
O94776	MTA2	Metastasis-associated protein MTA2	GO:0005515; F:protein binding; IPI:IntAct
O94776	MTA2	Metastasis-associated protein MTA2	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:BHF-UCL
O94776	MTA2	Metastasis-associated protein MTA2	GO:0001085; F:RNA polymerase II transcription factor binding; IPI:BHF-UCL
O94776	MTA2	Metastasis-associated protein MTA2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O94776	MTA2	Metastasis-associated protein MTA2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O94776	MTA2	Metastasis-associated protein MTA2	GO:0000989; F:transcription factor binding transcription factor activity; IEA:Ensembl
O94776	MTA2	Metastasis-associated protein MTA2	GO:0044212; F:transcription regulatory region DNA binding; IEA:Ensembl
O94776	MTA2	Metastasis-associated protein MTA2	GO:0008270; F:zinc ion binding; IEA:InterPro
O94776	MTA2	Metastasis-associated protein MTA2	GO:0043044; P:ATP-dependent chromatin remodeling; IDA:UniProt
O94776	MTA2	Metastasis-associated protein MTA2	GO:0006333; P:chromatin assembly or disassembly; TAS:ProtInc
O94776	MTA2	Metastasis-associated protein MTA2	GO:0006306; P:DNA methylation; IEA:Ensembl
O94776	MTA2	Metastasis-associated protein MTA2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O94776	MTA2	Metastasis-associated protein MTA2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9BTC8	MTA3	Metastasis-associated protein MTA3	GO:0003682; F:chromatin binding; IEA:InterPro
Q9BTC8	MTA3	Metastasis-associated protein MTA3	GO:0005515; F:protein binding; IPI:IntAct
Q9BTC8	MTA3	Metastasis-associated protein MTA3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9BTC8	MTA3	Metastasis-associated protein MTA3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9BTC8	MTA3	Metastasis-associated protein MTA3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BTC8	MTA3	Metastasis-associated protein MTA3	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q9BTC8	MTA3	Metastasis-associated protein MTA3	GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IEA:Ensembl
Q86U44	METTL3	N6-adenosine-methyltransferase 70 kDa subunit	GO:0016422; F:mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; IDA:UniProtKB
Q86U44	METTL3	N6-adenosine-methyltransferase 70 kDa subunit	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q86U44	METTL3	N6-adenosine-methyltransferase 70 kDa subunit	GO:0007623; P:circadian rhythm; ISS:UniProtKB
Q86U44	METTL3	N6-adenosine-methyltransferase 70 kDa subunit	GO:0010467; P:gene expression; TAS:Reactome
Q86U44	METTL3	N6-adenosine-methyltransferase 70 kDa subunit	GO:0061157; P:mRNA destabilization; ISS:UniProtKB
Q86U44	METTL3	N6-adenosine-methyltransferase 70 kDa subunit	GO:0080009; P:mRNA methylation; IDA:UniProtKB
Q86U44	METTL3	N6-adenosine-methyltransferase 70 kDa subunit	GO:0006397; P:mRNA processing; ISS:UniProtKB
Q86U44	METTL3	N6-adenosine-methyltransferase 70 kDa subunit	GO:0001510; P:RNA methylation; IMP:UniProtKB
Q86U44	METTL3	N6-adenosine-methyltransferase 70 kDa subunit	GO:0019827; P:stem cell maintenance; ISS:UniProtKB
P11137	MAP2	Microtubule-associated protein 2	GO:0002162; F:dystroglycan binding; IPI:UniProtKB
P11137	MAP2	Microtubule-associated protein 2	GO:0005515; F:protein binding; IPI:IntAct
P11137	MAP2	Microtubule-associated protein 2	GO:0005198; F:structural molecule activity; NAS:ProtInc
P11137	MAP2	Microtubule-associated protein 2	GO:0007409; P:axonogenesis; IEA:Ensembl
P11137	MAP2	Microtubule-associated protein 2	GO:0071310; P:cellular response to organic substance; IEA:Ensembl
P11137	MAP2	Microtubule-associated protein 2	GO:0021954; P:central nervous system neuron development; IEP:DFLAT
P11137	MAP2	Microtubule-associated protein 2	GO:0048813; P:dendrite morphogenesis; IEP:DFLAT
P11137	MAP2	Microtubule-associated protein 2	GO:0001578; P:microtubule bundle formation; IEA:Ensembl
P11137	MAP2	Microtubule-associated protein 2	GO:0031175; P:neuron projection development; IEP:DFLAT
P11137	MAP2	Microtubule-associated protein 2	GO:0018107; P:peptidyl-threonine phosphorylation; IEA:Ensembl
Q13126	MTAP	S-methyl-5'-thioadenosine phosphorylase	GO:0004645; F:phosphorylase activity; TAS:ProtInc
Q13126	MTAP	S-methyl-5'-thioadenosine phosphorylase	GO:0017061; F:S-methyl-5-thioadenosine phosphorylase activity; TAS:Reactome
Q13126	MTAP	S-methyl-5'-thioadenosine phosphorylase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q13126	MTAP	S-methyl-5'-thioadenosine phosphorylase	GO:0019509; P:L-methionine salvage from methylthioadenosine; TAS:Reactome
Q13126	MTAP	S-methyl-5'-thioadenosine phosphorylase	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
Q13126	MTAP	S-methyl-5'-thioadenosine phosphorylase	GO:0006595; P:polyamine metabolic process; TAS:Reactome
Q13126	MTAP	S-methyl-5'-thioadenosine phosphorylase	GO:0006166; P:purine ribonucleoside salvage; IEA:UniProtKB-KW
Q13126	MTAP	S-methyl-5'-thioadenosine phosphorylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q13126	MTAP	S-methyl-5'-thioadenosine phosphorylase	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
Q96DY7	MTBP	Mdm2-binding protein	GO:0007050; P:cell cycle arrest; IEA:UniProtKB-KW
Q96DY7	MTBP	Mdm2-binding protein	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q96DY7	MTBP	Mdm2-binding protein	GO:0007089; P:traversing start control point of mitotic cell cycle; IEA:Ensembl
Q9NZJ7	MTCH1	Mitochondrial carrier homolog 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NZJ7	MTCH1	Mitochondrial carrier homolog 1	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
Q9NZJ7	MTCH1	Mitochondrial carrier homolog 1	GO:0045161; P:neuronal ion channel clustering; NAS:UniProtKB
Q9NZJ7	MTCH1	Mitochondrial carrier homolog 1	GO:0043065; P:positive regulation of apoptotic process; IEP:UniProtKB
Q9NZJ7	MTCH1	Mitochondrial carrier homolog 1	GO:0009966; P:regulation of signal transduction; NAS:UniProtKB
Q9NZJ7	MTCH1	Mitochondrial carrier homolog 1	GO:0006810; P:transport; IEA:UniProtKB-KW
Q9Y6C9	MTCH2	Mitochondrial carrier homolog 2	GO:0006810; P:transport; IEA:UniProtKB-KW
Q9Y4B5	MTCL1	Microtubule cross-linking factor 1	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q9Y4B5	MTCL1	Microtubule cross-linking factor 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y4B5	MTCL1	Microtubule cross-linking factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y4B5	MTCL1	Microtubule cross-linking factor 1	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q9Y4B5	MTCL1	Microtubule cross-linking factor 1	GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; ISS:UniProtKB
Q9Y4B5	MTCL1	Microtubule cross-linking factor 1	GO:0001578; P:microtubule bundle formation; ISS:UniProtKB
Q9Y4B5	MTCL1	Microtubule cross-linking factor 1	GO:2000576; P:positive regulation of microtubule motor activity; ISS:UniProtKB
Q9Y4B5	MTCL1	Microtubule cross-linking factor 1	GO:0090314; P:positive regulation of protein targeting to membrane; ISS:UniProtKB
Q9Y4B5	MTCL1	Microtubule cross-linking factor 1	GO:0010506; P:regulation of autophagy; IEA:InterPro
P56278	MTCP1	Protein p13 MTCP-1	GO:0008283; P:cell proliferation; TAS:ProtInc
Q9H903	MTHFD2L	Probable bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2	GO:0004477; F:methenyltetrahydrofolate cyclohydrolase activity; IBA:RefGenome
Q9H903	MTHFD2L	Probable bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2	GO:0004487; F:methylenetetrahydrofolate dehydrogenase (NAD+) activity; IBA:RefGenome
Q9H903	MTHFD2L	Probable bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2	GO:0004488; F:methylenetetrahydrofolate dehydrogenase (NADP+) activity; IBA:RefGenome
Q9H903	MTHFD2L	Probable bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2	GO:0009396; P:folic acid-containing compound biosynthetic process; IEA:InterPro
Q9H903	MTHFD2L	Probable bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2	GO:0000105; P:histidine biosynthetic process; IEA:UniProtKB-KW
Q9H903	MTHFD2L	Probable bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2	GO:0009086; P:methionine biosynthetic process; IEA:UniProtKB-KW
Q9H903	MTHFD2L	Probable bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2	GO:0006730; P:one-carbon metabolic process; IBA:RefGenome
Q9H903	MTHFD2L	Probable bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2	GO:0006164; P:purine nucleotide biosynthetic process; IEA:UniProtKB-KW
Q9H903	MTHFD2L	Probable bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2	GO:0035999; P:tetrahydrofolate interconversion; IEA:UniProtKB-UniPathway
P13995	MTHFD2	Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
P13995	MTHFD2	Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial	GO:0004477; F:methenyltetrahydrofolate cyclohydrolase activity; ISS:UniProtKB
P13995	MTHFD2	Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial	GO:0004487; F:methylenetetrahydrofolate dehydrogenase (NAD+) activity; IDA:UniProtKB
P13995	MTHFD2	Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial	GO:0004488; F:methylenetetrahydrofolate dehydrogenase (NADP+) activity; IDA:UniProtKB
P13995	MTHFD2	Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial	GO:0042301; F:phosphate ion binding; IDA:UniProtKB
P13995	MTHFD2	Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial	GO:0009396; P:folic acid-containing compound biosynthetic process; IEA:InterPro
P13995	MTHFD2	Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial	GO:0006730; P:one-carbon metabolic process; IBA:RefGenome
P13995	MTHFD2	Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial	GO:0046653; P:tetrahydrofolate metabolic process; IDA:UniProtKB
Q96E29	MTERFD1	mTERF domain-containing protein 1, mitochondrial	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q96E29	MTERFD1	mTERF domain-containing protein 1, mitochondrial	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q96E29	MTERFD1	mTERF domain-containing protein 1, mitochondrial	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z6M4	MTERFD2	mTERF domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z6M4	MTERFD2	mTERF domain-containing protein 2	GO:0019843; F:rRNA binding; IDA:MGI
Q7Z6M4	MTERFD2	mTERF domain-containing protein 2	GO:0043010; P:camera-type eye development; IEA:Ensembl
Q7Z6M4	MTERFD2	mTERF domain-containing protein 2	GO:0007507; P:heart development; IEA:Ensembl
Q7Z6M4	MTERFD2	mTERF domain-containing protein 2	GO:0006626; P:protein targeting to mitochondrion; IEA:Ensembl
Q7Z6M4	MTERFD2	mTERF domain-containing protein 2	GO:0042255; P:ribosome assembly; IEA:Ensembl
Q7Z6M4	MTERFD2	mTERF domain-containing protein 2	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q7Z6M4	MTERFD2	mTERF domain-containing protein 2	GO:0006390; P:transcription from mitochondrial promoter; IEA:Ensembl
Q49AM1	MTERFD3	mTERF domain-containing protein 3, mitochondrial	GO:0044212; F:transcription regulatory region DNA binding; ISS:UniProtKB
Q49AM1	MTERFD3	mTERF domain-containing protein 3, mitochondrial	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
Q49AM1	MTERFD3	mTERF domain-containing protein 3, mitochondrial	GO:0006351; P:transcription, DNA-templated; ISS:UniProtKB
Q99551	MTERF	Transcription termination factor, mitochondrial	GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB
Q99551	MTERF	Transcription termination factor, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q99551	MTERF	Transcription termination factor, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q99551	MTERF	Transcription termination factor, mitochondrial	GO:0032392; P:DNA geometric change; IDA:UniProtKB
Q99551	MTERF	Transcription termination factor, mitochondrial	GO:0006353; P:DNA-templated transcription, termination; IDA:UniProtKB
Q99551	MTERF	Transcription termination factor, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
Q99551	MTERF	Transcription termination factor, mitochondrial	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q99551	MTERF	Transcription termination factor, mitochondrial	GO:0006393; P:termination of mitochondrial transcription; IDA:UniProtKB
Q99551	MTERF	Transcription termination factor, mitochondrial	GO:0006390; P:transcription from mitochondrial promoter; TAS:Reactome
Q14872	MTF1	Metal regulatory transcription factor 1	GO:0001047; F:core promoter binding; IDA:UniProtKB
Q14872	MTF1	Metal regulatory transcription factor 1	GO:0003677; F:DNA binding; TAS:ProtInc
Q14872	MTF1	Metal regulatory transcription factor 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14872	MTF1	Metal regulatory transcription factor 1	GO:0005515; F:protein binding; IPI:IntAct
Q14872	MTF1	Metal regulatory transcription factor 1	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl
Q14872	MTF1	Metal regulatory transcription factor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q14872	MTF1	Metal regulatory transcription factor 1	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q14872	MTF1	Metal regulatory transcription factor 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q14872	MTF1	Metal regulatory transcription factor 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q14872	MTF1	Metal regulatory transcription factor 1	GO:0046686; P:response to cadmium ion; IEA:Ensembl
Q14872	MTF1	Metal regulatory transcription factor 1	GO:0010038; P:response to metal ion; TAS:ProtInc
Q14872	MTF1	Metal regulatory transcription factor 1	GO:0006979; P:response to oxidative stress; IEA:Ensembl
Q14872	MTF1	Metal regulatory transcription factor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y483	MTF2	Metal-response element-binding transcription factor 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y483	MTF2	Metal-response element-binding transcription factor 2	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q9Y483	MTF2	Metal-response element-binding transcription factor 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y483	MTF2	Metal-response element-binding transcription factor 2	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q9Y483	MTF2	Metal-response element-binding transcription factor 2	GO:0061086; P:negative regulation of histone H3-K27 methylation; ISS:UniProtKB
Q9Y483	MTF2	Metal-response element-binding transcription factor 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q9Y483	MTF2	Metal-response element-binding transcription factor 2	GO:0061087; P:positive regulation of histone H3-K27 methylation; ISS:UniProtKB
Q9Y483	MTF2	Metal-response element-binding transcription factor 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q9Y483	MTF2	Metal-response element-binding transcription factor 2	GO:0007379; P:segment specification; ISS:UniProtKB
Q9Y483	MTF2	Metal-response element-binding transcription factor 2	GO:0048863; P:stem cell differentiation; ISS:UniProtKB
Q9Y483	MTF2	Metal-response element-binding transcription factor 2	GO:0019827; P:stem cell maintenance; ISS:UniProtKB
Q9UDX5	MTFP1	Mitochondrial fission process protein 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9UDX5	MTFP1	Mitochondrial fission process protein 1	GO:0000266; P:mitochondrial fission; IMP:UniProtKB
Q15390	MTFR1	Mitochondrial fission regulator 1	GO:0009060; P:aerobic respiration; ISS:UniProtKB
Q15390	MTFR1	Mitochondrial fission regulator 1	GO:0000266; P:mitochondrial fission; ISS:UniProtKB
Q15390	MTFR1	Mitochondrial fission regulator 1	GO:0007005; P:mitochondrion organization; ISS:UniProtKB
Q6P444	MTFR2	Mitochondrial fission regulator 2	GO:0009060; P:aerobic respiration; ISS:UniProtKB
Q6P444	MTFR2	Mitochondrial fission regulator 2	GO:0000266; P:mitochondrial fission; ISS:UniProtKB
Q6P444	MTFR2	Mitochondrial fission regulator 2	GO:0007005; P:mitochondrion organization; ISS:UniProtKB
O75081	CBFA2T3	Protein CBFA2T3	GO:0003682; F:chromatin binding; IEA:Ensembl
O75081	CBFA2T3	Protein CBFA2T3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75081	CBFA2T3	Protein CBFA2T3	GO:0005515; F:protein binding; IPI:IntAct
O75081	CBFA2T3	Protein CBFA2T3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O75081	CBFA2T3	Protein CBFA2T3	GO:0008283; P:cell proliferation; TAS:ProtInc
O75081	CBFA2T3	Protein CBFA2T3	GO:0030851; P:granulocyte differentiation; IDA:MGI
O75081	CBFA2T3	Protein CBFA2T3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O75081	CBFA2T3	Protein CBFA2T3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BT17	MTG1	Mitochondrial ribosome-associated GTPase 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9BT17	MTG1	Mitochondrial ribosome-associated GTPase 1	GO:0003924; F:GTPase activity; IDA:UniProtKB
Q9BT17	MTG1	Mitochondrial ribosome-associated GTPase 1	GO:0006184; P:GTP catabolic process; IDA:UniProtKB
Q9BT17	MTG1	Mitochondrial ribosome-associated GTPase 1	GO:0070129; P:regulation of mitochondrial translation; IMP:UniProtKB
Q9BT17	MTG1	Mitochondrial ribosome-associated GTPase 1	GO:0044065; P:regulation of respiratory system process; IMP:UniProtKB
Q9BT17	MTG1	Mitochondrial ribosome-associated GTPase 1	GO:0042254; P:ribosome biogenesis; IBA:RefGenome
Q9H4K7	MTG2	Mitochondrial ribosome-associated GTPase 2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9H4K7	MTG2	Mitochondrial ribosome-associated GTPase 2	GO:0003924; F:GTPase activity; IDA:UniProtKB
Q9H4K7	MTG2	Mitochondrial ribosome-associated GTPase 2	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q9H4K7	MTG2	Mitochondrial ribosome-associated GTPase 2	GO:0006184; P:GTP catabolic process; IDA:UniProtKB
Q9H4K7	MTG2	Mitochondrial ribosome-associated GTPase 2	GO:0070129; P:regulation of mitochondrial translation; IMP:UniProtKB
Q9H4K7	MTG2	Mitochondrial ribosome-associated GTPase 2	GO:0044065; P:regulation of respiratory system process; IMP:UniProtKB
Q9H4K7	MTG2	Mitochondrial ribosome-associated GTPase 2	GO:0042254; P:ribosome biogenesis; IEA:UniProtKB-KW
Q06455	RUNX1T1	Protein CBFA2T1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q06455	RUNX1T1	Protein CBFA2T1	GO:0042802; F:identical protein binding; IPI:IntAct
Q06455	RUNX1T1	Protein CBFA2T1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q06455	RUNX1T1	Protein CBFA2T1	GO:0005515; F:protein binding; IPI:UniProtKB
Q06455	RUNX1T1	Protein CBFA2T1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q06455	RUNX1T1	Protein CBFA2T1	GO:0045444; P:fat cell differentiation; IEA:Ensembl
Q06455	RUNX1T1	Protein CBFA2T1	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
Q06455	RUNX1T1	Protein CBFA2T1	GO:0051101; P:regulation of DNA binding; IEA:Ensembl
Q06455	RUNX1T1	Protein CBFA2T1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43439	CBFA2T2	Protein CBFA2T2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43439	CBFA2T2	Protein CBFA2T2	GO:0005515; F:protein binding; IPI:IntAct
O43439	CBFA2T2	Protein CBFA2T2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O43439	CBFA2T2	Protein CBFA2T2	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
O43439	CBFA2T2	Protein CBFA2T2	GO:0030855; P:epithelial cell differentiation; IEA:Ensembl
O43439	CBFA2T2	Protein CBFA2T2	GO:0010977; P:negative regulation of neuron projection development; ISS:UniProtKB
O43439	CBFA2T2	Protein CBFA2T2	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
O43439	CBFA2T2	Protein CBFA2T2	GO:0010976; P:positive regulation of neuron projection development; IDA:UniProtKB
O43439	CBFA2T2	Protein CBFA2T2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P49914	MTHFS	5-formyltetrahydrofolate cyclo-ligase	GO:0030272; F:5-formyltetrahydrofolate cyclo-ligase activity; IDA:UniProtKB
P49914	MTHFS	5-formyltetrahydrofolate cyclo-ligase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49914	MTHFS	5-formyltetrahydrofolate cyclo-ligase	GO:0005542; F:folic acid binding; IEA:UniProtKB-KW
P49914	MTHFS	5-formyltetrahydrofolate cyclo-ligase	GO:0009396; P:folic acid-containing compound biosynthetic process; IEA:InterPro
P49914	MTHFS	5-formyltetrahydrofolate cyclo-ligase	GO:0015942; P:formate metabolic process; NAS:UniProtKB
P49914	MTHFS	5-formyltetrahydrofolate cyclo-ligase	GO:0046653; P:tetrahydrofolate metabolic process; IDA:UniProtKB
P42898	MTHFR	Methylenetetrahydrofolate reductase	GO:0050660; F:flavin adenine dinucleotide binding; IEA:Ensembl
P42898	MTHFR	Methylenetetrahydrofolate reductase	GO:0004489; F:methylenetetrahydrofolate reductase (NAD(P)H) activity; TAS:Reactome
P42898	MTHFR	Methylenetetrahydrofolate reductase	GO:0072341; F:modified amino acid binding; IDA:UniProtKB
P42898	MTHFR	Methylenetetrahydrofolate reductase	GO:0050661; F:NADP binding; IEA:Ensembl
P42898	MTHFR	Methylenetetrahydrofolate reductase	GO:0008015; P:blood circulation; TAS:ProtInc
P42898	MTHFR	Methylenetetrahydrofolate reductase	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
P42898	MTHFR	Methylenetetrahydrofolate reductase	GO:0046655; P:folic acid metabolic process; TAS:Reactome
P42898	MTHFR	Methylenetetrahydrofolate reductase	GO:0050667; P:homocysteine metabolic process; IDA:UniProtKB
P42898	MTHFR	Methylenetetrahydrofolate reductase	GO:0009086; P:methionine biosynthetic process; IEA:Ensembl
P42898	MTHFR	Methylenetetrahydrofolate reductase	GO:0042493; P:response to drug; IEA:Ensembl
P42898	MTHFR	Methylenetetrahydrofolate reductase	GO:0051593; P:response to folic acid; IEA:Ensembl
P42898	MTHFR	Methylenetetrahydrofolate reductase	GO:0001666; P:response to hypoxia; IEA:Ensembl
P42898	MTHFR	Methylenetetrahydrofolate reductase	GO:0070555; P:response to interleukin-1; IEA:Ensembl
P42898	MTHFR	Methylenetetrahydrofolate reductase	GO:0033274; P:response to vitamin B2; IEA:Ensembl
P42898	MTHFR	Methylenetetrahydrofolate reductase	GO:0046500; P:S-adenosylmethionine metabolic process; IEA:Ensembl
P42898	MTHFR	Methylenetetrahydrofolate reductase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P42898	MTHFR	Methylenetetrahydrofolate reductase	GO:0035999; P:tetrahydrofolate interconversion; IEA:UniProtKB-UniPathway
P42898	MTHFR	Methylenetetrahydrofolate reductase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P42898	MTHFR	Methylenetetrahydrofolate reductase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q2M296	MTHFSD	Methenyltetrahydrofolate synthase domain-containing protein	GO:0030272; F:5-formyltetrahydrofolate cyclo-ligase activity; IEA:InterPro
Q2M296	MTHFSD	Methenyltetrahydrofolate synthase domain-containing protein	GO:0005524; F:ATP binding; IEA:InterPro
Q2M296	MTHFSD	Methenyltetrahydrofolate synthase domain-containing protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q2M296	MTHFSD	Methenyltetrahydrofolate synthase domain-containing protein	GO:0009396; P:folic acid-containing compound biosynthetic process; IEA:InterPro
Q9Y4I5	MTL5	Tesmin	GO:0046872; F:metal ion binding; NAS:UniProtKB
Q9Y4I5	MTL5	Tesmin	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9Y4I5	MTL5	Tesmin	GO:0006875; P:cellular metal ion homeostasis; NAS:UniProtKB
Q9Y4I5	MTL5	Tesmin	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9Y4I5	MTL5	Tesmin	GO:0010038; P:response to metal ion; NAS:UniProtKB
Q9Y4I5	MTL5	Tesmin	GO:0007283; P:spermatogenesis; NAS:UniProtKB
O43193	MLNR	Motilin receptor	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O43193	MLNR	Motilin receptor	GO:0016520; F:growth hormone-releasing hormone receptor activity; IEA:InterPro
O43193	MLNR	Motilin receptor	GO:0007586; P:digestion; TAS:ProtInc
O43193	MLNR	Motilin receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q13496	MTM1	Myotubularin	GO:0019215; F:intermediate filament binding; IDA:UniProtKB
Q13496	MTM1	Myotubularin	GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB
Q13496	MTM1	Myotubularin	GO:0052629; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; IDA:UniProtKB
Q13496	MTM1	Myotubularin	GO:0004438; F:phosphatidylinositol-3-phosphatase activity; IDA:UniProtKB
Q13496	MTM1	Myotubularin	GO:0004721; F:phosphoprotein phosphatase activity; IDA:UniProtKB
Q13496	MTM1	Myotubularin	GO:0005515; F:protein binding; IPI:IntAct
Q13496	MTM1	Myotubularin	GO:0004725; F:protein tyrosine phosphatase activity; IEA:InterPro
Q13496	MTM1	Myotubularin	GO:0008333; P:endosome to lysosome transport; IDA:UniProtKB
Q13496	MTM1	Myotubularin	GO:0045109; P:intermediate filament organization; IMP:UniProtKB
Q13496	MTM1	Myotubularin	GO:0048311; P:mitochondrion distribution; IMP:UniProtKB
Q13496	MTM1	Myotubularin	GO:0070584; P:mitochondrion morphogenesis; IDA:UniProtKB
Q13496	MTM1	Myotubularin	GO:0046716; P:muscle cell cellular homeostasis; IEA:Ensembl
Q13496	MTM1	Myotubularin	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q13496	MTM1	Myotubularin	GO:0046856; P:phosphatidylinositol dephosphorylation; IDA:UniProtKB
Q13496	MTM1	Myotubularin	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q13496	MTM1	Myotubularin	GO:0006470; P:protein dephosphorylation; IDA:UniProtKB
Q13496	MTM1	Myotubularin	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q13496	MTM1	Myotubularin	GO:0044088; P:regulation of vacuole organization; IDA:UniProtKB
Q13496	MTM1	Myotubularin	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q13613	MTMR1	Myotubularin-related protein 1	GO:0004438; F:phosphatidylinositol-3-phosphatase activity; ISS:UniProtKB
Q13613	MTMR1	Myotubularin-related protein 1	GO:0004725; F:protein tyrosine phosphatase activity; IEA:InterPro
Q13613	MTMR1	Myotubularin-related protein 1	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q13613	MTMR1	Myotubularin-related protein 1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q13613	MTMR1	Myotubularin-related protein 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q13614	MTMR2	Myotubularin-related protein 2	GO:0052866; F:phosphatidylinositol phosphate phosphatase activity; IEA:Ensembl
Q13614	MTMR2	Myotubularin-related protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q13614	MTMR2	Myotubularin-related protein 2	GO:0004725; F:protein tyrosine phosphatase activity; IEA:InterPro
Q13614	MTMR2	Myotubularin-related protein 2	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; NAS:UniProtKB
Q13614	MTMR2	Myotubularin-related protein 2	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q13614	MTMR2	Myotubularin-related protein 2	GO:0097062; P:dendritic spine maintenance; ISS:BHF-UCL
Q13614	MTMR2	Myotubularin-related protein 2	GO:0046855; P:inositol phosphate dephosphorylation; IEA:Ensembl
Q13614	MTMR2	Myotubularin-related protein 2	GO:0032288; P:myelin assembly; IEA:Ensembl
Q13614	MTMR2	Myotubularin-related protein 2	GO:0045806; P:negative regulation of endocytosis; ISS:BHF-UCL
Q13614	MTMR2	Myotubularin-related protein 2	GO:0090394; P:negative regulation of excitatory postsynaptic membrane potential; ISS:BHF-UCL
Q13614	MTMR2	Myotubularin-related protein 2	GO:0031642; P:negative regulation of myelination; IEA:Ensembl
Q13614	MTMR2	Myotubularin-related protein 2	GO:2000645; P:negative regulation of receptor catabolic process; ISS:BHF-UCL
Q13614	MTMR2	Myotubularin-related protein 2	GO:0002091; P:negative regulation of receptor internalization; ISS:BHF-UCL
Q13614	MTMR2	Myotubularin-related protein 2	GO:0048666; P:neuron development; IEA:Ensembl
Q13614	MTMR2	Myotubularin-related protein 2	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q13614	MTMR2	Myotubularin-related protein 2	GO:0046856; P:phosphatidylinositol dephosphorylation; IEA:Ensembl
Q13614	MTMR2	Myotubularin-related protein 2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q13614	MTMR2	Myotubularin-related protein 2	GO:2000643; P:positive regulation of early endosome to late endosome transport; ISS:BHF-UCL
Q13614	MTMR2	Myotubularin-related protein 2	GO:0006470; P:protein dephosphorylation; NAS:UniProtKB
Q13614	MTMR2	Myotubularin-related protein 2	GO:0051262; P:protein tetramerization; IEA:Ensembl
Q13614	MTMR2	Myotubularin-related protein 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q13615	MTMR3	Myotubularin-related protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13615	MTMR3	Myotubularin-related protein 3	GO:0004438; F:phosphatidylinositol-3-phosphatase activity; IDA:UniProtKB
Q13615	MTMR3	Myotubularin-related protein 3	GO:0004722; F:protein serine/threonine phosphatase activity; IDA:UniProtKB
Q13615	MTMR3	Myotubularin-related protein 3	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
Q13615	MTMR3	Myotubularin-related protein 3	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:GOC
Q13615	MTMR3	Myotubularin-related protein 3	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q13615	MTMR3	Myotubularin-related protein 3	GO:0046856; P:phosphatidylinositol dephosphorylation; IDA:UniProtKB
Q13615	MTMR3	Myotubularin-related protein 3	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q13615	MTMR3	Myotubularin-related protein 3	GO:0006470; P:protein dephosphorylation; IDA:UniProtKB
Q13615	MTMR3	Myotubularin-related protein 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NYA4	MTMR4	Myotubularin-related protein 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NYA4	MTMR4	Myotubularin-related protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q9NYA4	MTMR4	Myotubularin-related protein 4	GO:0004722; F:protein serine/threonine phosphatase activity; TAS:Reactome
Q9NYA4	MTMR4	Myotubularin-related protein 4	GO:0004725; F:protein tyrosine phosphatase activity; TAS:ProtInc
Q9NYA4	MTMR4	Myotubularin-related protein 4	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q9NYA4	MTMR4	Myotubularin-related protein 4	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
Q9NYA4	MTMR4	Myotubularin-related protein 4	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q9NYA4	MTMR4	Myotubularin-related protein 4	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9NYA4	MTMR4	Myotubularin-related protein 4	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
Q9NYA4	MTMR4	Myotubularin-related protein 4	GO:0014894; P:response to denervation involved in regulation of muscle adaptation; IEA:Ensembl
Q9NYA4	MTMR4	Myotubularin-related protein 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NYA4	MTMR4	Myotubularin-related protein 4	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
O95248	SBF1	Myotubularin-related protein 5	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; TAS:UniProtKB
O95248	SBF1	Myotubularin-related protein 5	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
O95248	SBF1	Myotubularin-related protein 5	GO:0008219; P:cell death; IEA:UniProtKB-KW
O95248	SBF1	Myotubularin-related protein 5	GO:0006470; P:protein dephosphorylation; TAS:UniProtKB
O95248	SBF1	Myotubularin-related protein 5	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
O95248	SBF1	Myotubularin-related protein 5	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q9Y217	MTMR6	Myotubularin-related protein 6	GO:0015269; F:calcium-activated potassium channel activity; IDA:UniProtKB
Q9Y217	MTMR6	Myotubularin-related protein 6	GO:0004722; F:protein serine/threonine phosphatase activity; NAS:UniProtKB
Q9Y217	MTMR6	Myotubularin-related protein 6	GO:0004725; F:protein tyrosine phosphatase activity; NAS:UniProtKB
Q9Y217	MTMR6	Myotubularin-related protein 6	GO:0035335; P:peptidyl-tyrosine dephosphorylation; NAS:GOC
Q9Y217	MTMR6	Myotubularin-related protein 6	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q9Y217	MTMR6	Myotubularin-related protein 6	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9Y217	MTMR6	Myotubularin-related protein 6	GO:0071805; P:potassium ion transmembrane transport; IDA:GOC
Q9Y217	MTMR6	Myotubularin-related protein 6	GO:0006470; P:protein dephosphorylation; NAS:UniProtKB
Q9Y217	MTMR6	Myotubularin-related protein 6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y216	MTMR7	Myotubularin-related protein 7	GO:0004725; F:protein tyrosine phosphatase activity; TAS:ProtInc
Q9Y216	MTMR7	Myotubularin-related protein 7	GO:0046855; P:inositol phosphate dephosphorylation; IEA:Ensembl
Q9Y216	MTMR7	Myotubularin-related protein 7	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
Q9Y216	MTMR7	Myotubularin-related protein 7	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q9Y216	MTMR7	Myotubularin-related protein 7	GO:0046856; P:phosphatidylinositol dephosphorylation; IEA:Ensembl
Q9Y216	MTMR7	Myotubularin-related protein 7	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9Y216	MTMR7	Myotubularin-related protein 7	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
Q9Y216	MTMR7	Myotubularin-related protein 7	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96EF0	MTMR8	Myotubularin-related protein 8	GO:0004725; F:protein tyrosine phosphatase activity; IEA:InterPro
Q96QG7	MTMR9	Myotubularin-related protein 9	GO:0030234; F:enzyme regulator activity; IEA:Ensembl
Q96QG7	MTMR9	Myotubularin-related protein 9	GO:0016791; F:phosphatase activity; IEA:InterPro
Q96QG7	MTMR9	Myotubularin-related protein 9	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NXD2	MTMR10	Myotubularin-related protein 10	GO:0016791; F:phosphatase activity; IEA:InterPro
A4FU01	MTMR11	Myotubularin-related protein 11	GO:0016791; F:phosphatase activity; IEA:InterPro
Q9C0I1	MTMR12	Myotubularin-related protein 12	GO:0016791; F:phosphatase activity; IEA:InterPro
Q9C0I1	MTMR12	Myotubularin-related protein 12	GO:0005515; F:protein binding; IPI:IntAct
Q86WG5	SBF2	Myotubularin-related protein 13	GO:0016791; F:phosphatase activity; IEA:InterPro
Q86WG5	SBF2	Myotubularin-related protein 13	GO:0019208; F:phosphatase regulator activity; IEA:Ensembl
Q86WG5	SBF2	Myotubularin-related protein 13	GO:0035091; F:phosphatidylinositol binding; IEA:Ensembl
Q86WG5	SBF2	Myotubularin-related protein 13	GO:0005515; F:protein binding; IPI:UniProtKB
Q86WG5	SBF2	Myotubularin-related protein 13	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q86WG5	SBF2	Myotubularin-related protein 13	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q86WG5	SBF2	Myotubularin-related protein 13	GO:0042552; P:myelination; NAS:UniProtKB
Q86WG5	SBF2	Myotubularin-related protein 13	GO:0051262; P:protein tetramerization; IEA:Ensembl
Q86WG5	SBF2	Myotubularin-related protein 13	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
Q8NCE2	MTMR14	Myotubularin-related protein 14	GO:0004438; F:phosphatidylinositol-3-phosphatase activity; IDA:UniProtKB
Q8NCE2	MTMR14	Myotubularin-related protein 14	GO:0004725; F:protein tyrosine phosphatase activity; IEA:InterPro
Q8NCE2	MTMR14	Myotubularin-related protein 14	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q8NCE2	MTMR14	Myotubularin-related protein 14	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q8NCE2	MTMR14	Myotubularin-related protein 14	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BV20	MRI1	Methylthioribose-1-phosphate isomerase	GO:0042802; F:identical protein binding; IPI:IntAct
Q9BV20	MRI1	Methylthioribose-1-phosphate isomerase	GO:0046523; F:S-methyl-5-thioribose-1-phosphate isomerase activity; IBA:RefGenome
Q9BV20	MRI1	Methylthioribose-1-phosphate isomerase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9BV20	MRI1	Methylthioribose-1-phosphate isomerase	GO:0019284; P:L-methionine biosynthetic process from S-adenosylmethionine; IEA:UniProtKB-HAMAP
Q9BV20	MRI1	Methylthioribose-1-phosphate isomerase	GO:0019509; P:L-methionine salvage from methylthioadenosine; IBA:RefGenome
Q9BV20	MRI1	Methylthioribose-1-phosphate isomerase	GO:0006595; P:polyamine metabolic process; TAS:Reactome
Q9BV20	MRI1	Methylthioribose-1-phosphate isomerase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BV20	MRI1	Methylthioribose-1-phosphate isomerase	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
Q96GX9	APIP	Methylthioribulose-1-phosphate dehydratase	GO:0042802; F:identical protein binding; IPI:IntAct
Q96GX9	APIP	Methylthioribulose-1-phosphate dehydratase	GO:0046570; F:methylthioribulose 1-phosphate dehydratase activity; TAS:Reactome
Q96GX9	APIP	Methylthioribulose-1-phosphate dehydratase	GO:0005515; F:protein binding; IPI:IntAct
Q96GX9	APIP	Methylthioribulose-1-phosphate dehydratase	GO:0008270; F:zinc ion binding; IEA:UniProtKB-HAMAP
Q96GX9	APIP	Methylthioribulose-1-phosphate dehydratase	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q96GX9	APIP	Methylthioribulose-1-phosphate dehydratase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q96GX9	APIP	Methylthioribulose-1-phosphate dehydratase	GO:0019284; P:L-methionine biosynthetic process from S-adenosylmethionine; IEA:UniProtKB-HAMAP
Q96GX9	APIP	Methylthioribulose-1-phosphate dehydratase	GO:0019509; P:L-methionine salvage from methylthioadenosine; IMP:UniProtKB
Q96GX9	APIP	Methylthioribulose-1-phosphate dehydratase	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q96GX9	APIP	Methylthioribulose-1-phosphate dehydratase	GO:0006595; P:polyamine metabolic process; TAS:Reactome
Q96GX9	APIP	Methylthioribulose-1-phosphate dehydratase	GO:0070372; P:regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
Q96GX9	APIP	Methylthioribulose-1-phosphate dehydratase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96GX9	APIP	Methylthioribulose-1-phosphate dehydratase	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
Q9BV57	ADI1	1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase	GO:0010309; F:acireductone dioxygenase [iron(II)-requiring] activity; TAS:Reactome
Q9BV57	ADI1	1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase	GO:0005506; F:iron ion binding; IEA:UniProtKB-HAMAP
Q9BV57	ADI1	1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase	GO:0016491; F:oxidoreductase activity; IDA:UniProtKB
Q9BV57	ADI1	1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BV57	ADI1	1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9BV57	ADI1	1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase	GO:0019509; P:L-methionine salvage from methylthioadenosine; IDA:UniProtKB
Q9BV57	ADI1	1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase	GO:0006595; P:polyamine metabolic process; TAS:Reactome
Q9BV57	ADI1	1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BV57	ADI1	1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
Q9Y2Z2	MTO1	Protein MTO1 homolog, mitochondrial	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q9Y2Z2	MTO1	Protein MTO1 homolog, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y2Z2	MTO1	Protein MTO1 homolog, mitochondrial	GO:0070899; P:mitochondrial tRNA wobble uridine modification; IEA:Ensembl
Q9Y2Z2	MTO1	Protein MTO1 homolog, mitochondrial	GO:0055114; P:oxidation-reduction process; IEA:InterPro
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0008144; F:drug binding; IEA:InterPro
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0016301; F:kinase activity; TAS:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0051219; F:phosphoprotein binding; IPI:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0005515; F:protein binding; IPI:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0043022; F:ribosome binding; IEA:Ensembl
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0001030; F:RNA polymerase III type 1 promoter DNA binding; IDA:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0001031; F:RNA polymerase III type 2 promoter DNA binding; IDA:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0001032; F:RNA polymerase III type 3 promoter DNA binding; IDA:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0001156; F:TFIIIC-class transcription factor binding; IDA:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0016049; P:cell growth; IDA:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0071456; P:cellular response to hypoxia; ISS:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0031669; P:cellular response to nutrient levels; ISS:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0007281; P:germ cell development; IEA:Ensembl
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0040007; P:growth; NAS:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0045087; P:innate immune response; TAS:Reactome
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0010507; P:negative regulation of autophagy; ISS:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0045792; P:negative regulation of cell size; IEA:Ensembl
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0016242; P:negative regulation of macroautophagy; IEA:Ensembl
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0051534; P:negative regulation of NFAT protein import into nucleus; IEA:Ensembl
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0018105; P:peptidyl-serine phosphorylation; IMP:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0018107; P:peptidyl-threonine phosphorylation; IEA:Ensembl
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0016310; P:phosphorylation; IDA:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0030838; P:positive regulation of actin filament polymerization; IEA:Ensembl
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0010592; P:positive regulation of lamellipodium assembly; IEA:Ensembl
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0046889; P:positive regulation of lipid biosynthetic process; IMP:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0010831; P:positive regulation of myotube differentiation; IEA:Ensembl
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0051496; P:positive regulation of stress fiber assembly; IEA:Ensembl
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0045945; P:positive regulation of transcription from RNA polymerase III promoter; IMP:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0045727; P:positive regulation of translation; IDA:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0046777; P:protein autophosphorylation; IDA:MGI
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0030163; P:protein catabolic process; TAS:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0032956; P:regulation of actin cytoskeleton organization; IMP:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0043610; P:regulation of carbohydrate utilization; IEA:Ensembl
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0031998; P:regulation of fatty acid beta-oxidation; IEA:Ensembl
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0005979; P:regulation of glycogen biosynthetic process; IEA:Ensembl
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0045859; P:regulation of protein kinase activity; IEA:Ensembl
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0032314; P:regulation of Rac GTPase activity; IEA:Ensembl
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0032095; P:regulation of response to food; IEA:Ensembl
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0043200; P:response to amino acid; IDA:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0007584; P:response to nutrient; NAS:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0006950; P:response to stress; IMP:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0031529; P:ruffle organization; IEA:Ensembl
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0007165; P:signal transduction; NAS:UniProtKB
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0031295; P:T cell costimulation; TAS:Reactome
P42345	MTOR	Serine/threonine-protein kinase mTOR	GO:0031929; P:TOR signaling; IMP:UniProtKB
P58546	MTPN	Myotrophin	GO:0006584; P:catecholamine metabolic process; IEA:Ensembl
P58546	MTPN	Myotrophin	GO:0016049; P:cell growth; IDA:UniProtKB
P58546	MTPN	Myotrophin	GO:0021707; P:cerebellar granule cell differentiation; IEA:Ensembl
P58546	MTPN	Myotrophin	GO:0030182; P:neuron differentiation; NAS:UniProtKB
P58546	MTPN	Myotrophin	GO:0010613; P:positive regulation of cardiac muscle hypertrophy; IMP:UniProtKB
P58546	MTPN	Myotrophin	GO:0030307; P:positive regulation of cell growth; ISS:UniProtKB
P58546	MTPN	Myotrophin	GO:0010557; P:positive regulation of macromolecule biosynthetic process; ISS:UniProtKB
P58546	MTPN	Myotrophin	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB
P58546	MTPN	Myotrophin	GO:0051247; P:positive regulation of protein metabolic process; ISS:UniProtKB
P58546	MTPN	Myotrophin	GO:2000812; P:regulation of barbed-end actin filament capping; IDA:UniProtKB
P58546	MTPN	Myotrophin	GO:0016202; P:regulation of striated muscle tissue development; NAS:UniProtKB
P58546	MTPN	Myotrophin	GO:0006417; P:regulation of translation; NAS:UniProtKB
P58546	MTPN	Myotrophin	GO:0043403; P:skeletal muscle tissue regeneration; IEA:Ensembl
P58546	MTPN	Myotrophin	GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl
P55157	MTTP	Microsomal triglyceride transfer protein large subunit	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
P55157	MTTP	Microsomal triglyceride transfer protein large subunit	GO:0005319; F:lipid transporter activity; TAS:Reactome
P55157	MTTP	Microsomal triglyceride transfer protein large subunit	GO:0042632; P:cholesterol homeostasis; IEA:Ensembl
P55157	MTTP	Microsomal triglyceride transfer protein large subunit	GO:0006629; P:lipid metabolic process; TAS:ProtInc
P55157	MTTP	Microsomal triglyceride transfer protein large subunit	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
P55157	MTTP	Microsomal triglyceride transfer protein large subunit	GO:0042953; P:lipoprotein transport; IEA:Ensembl
P55157	MTTP	Microsomal triglyceride transfer protein large subunit	GO:0006497; P:protein lipidation; IEA:Ensembl
P55157	MTTP	Microsomal triglyceride transfer protein large subunit	GO:0051592; P:response to calcium ion; IEA:Ensembl
P55157	MTTP	Microsomal triglyceride transfer protein large subunit	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P55157	MTTP	Microsomal triglyceride transfer protein large subunit	GO:0006641; P:triglyceride metabolic process; IEA:Ensembl
P48039	MTNR1A	Melatonin receptor type 1A	GO:0042562; F:hormone binding; IPI:BHF-UCL
P48039	MTNR1A	Melatonin receptor type 1A	GO:0008502; F:melatonin receptor activity; TAS:ProtInc
P48039	MTNR1A	Melatonin receptor type 1A	GO:0097159; F:organic cyclic compound binding; IPI:BHF-UCL
P48039	MTNR1A	Melatonin receptor type 1A	GO:0005515; F:protein binding; IPI:IntAct
P48039	MTNR1A	Melatonin receptor type 1A	GO:0007623; P:circadian rhythm; TAS:ProtInc
P48039	MTNR1A	Melatonin receptor type 1A	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P48039	MTNR1A	Melatonin receptor type 1A	GO:0007617; P:mating behavior; TAS:ProtInc
P48039	MTNR1A	Melatonin receptor type 1A	GO:0030828; P:positive regulation of cGMP biosynthetic process; IDA:BHF-UCL
P49286	MTNR1B	Melatonin receptor type 1B	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P49286	MTNR1B	Melatonin receptor type 1B	GO:0008502; F:melatonin receptor activity; TAS:ProtInc
P49286	MTNR1B	Melatonin receptor type 1B	GO:0005515; F:protein binding; IPI:IntAct
P49286	MTNR1B	Melatonin receptor type 1B	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P49286	MTNR1B	Melatonin receptor type 1B	GO:0042593; P:glucose homeostasis; IMP:BHF-UCL
P49286	MTNR1B	Melatonin receptor type 1B	GO:0050796; P:regulation of insulin secretion; IMP:BHF-UCL
P49286	MTNR1B	Melatonin receptor type 1B	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q13585	GPR50	Melatonin-related receptor	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q13585	GPR50	Melatonin-related receptor	GO:0042802; F:identical protein binding; IPI:IntAct
Q13585	GPR50	Melatonin-related receptor	GO:0008502; F:melatonin receptor activity; IEA:InterPro
Q13585	GPR50	Melatonin-related receptor	GO:0005515; F:protein binding; IPI:IntAct
Q13585	GPR50	Melatonin-related receptor	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q13585	GPR50	Melatonin-related receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q9UBK8	MTRR	Methionine synthase reductase	GO:0030586; F:[methionine synthase] reductase activity; TAS:UniProtKB
Q9UBK8	MTRR	Methionine synthase reductase	GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB
Q9UBK8	MTRR	Methionine synthase reductase	GO:0010181; F:FMN binding; TAS:UniProtKB
Q9UBK8	MTRR	Methionine synthase reductase	GO:0005506; F:iron ion binding; IEA:InterPro
Q9UBK8	MTRR	Methionine synthase reductase	GO:0050661; F:NADP binding; TAS:UniProtKB
Q9UBK8	MTRR	Methionine synthase reductase	GO:0016709; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; IBA:RefGenome
Q9UBK8	MTRR	Methionine synthase reductase	GO:0016723; F:oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor; IDA:UniProtKB
Q9UBK8	MTRR	Methionine synthase reductase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9UBK8	MTRR	Methionine synthase reductase	GO:0009235; P:cobalamin metabolic process; TAS:Reactome
Q9UBK8	MTRR	Methionine synthase reductase	GO:0006306; P:DNA methylation; ISS:UniProtKB
Q9UBK8	MTRR	Methionine synthase reductase	GO:0046655; P:folic acid metabolic process; ISS:UniProtKB
Q9UBK8	MTRR	Methionine synthase reductase	GO:0009086; P:methionine biosynthetic process; IEA:UniProtKB-KW
Q9UBK8	MTRR	Methionine synthase reductase	GO:0006555; P:methionine metabolic process; TAS:UniProtKB
Q9UBK8	MTRR	Methionine synthase reductase	GO:0032259; P:methylation; TAS:Reactome
Q9UBK8	MTRR	Methionine synthase reductase	GO:0055114; P:oxidation-reduction process; TAS:UniProtKB
Q9UBK8	MTRR	Methionine synthase reductase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UBK8	MTRR	Methionine synthase reductase	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
Q9UBK8	MTRR	Methionine synthase reductase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9UBK8	MTRR	Methionine synthase reductase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9UBK8	MTRR	Methionine synthase reductase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
O43312	MTSS1	Metastasis suppressor protein 1	GO:0003785; F:actin monomer binding; IDA:UniProtKB
O43312	MTSS1	Metastasis suppressor protein 1	GO:0042802; F:identical protein binding; IPI:IntAct
O43312	MTSS1	Metastasis suppressor protein 1	GO:0005515; F:protein binding; IPI:IntAct
O43312	MTSS1	Metastasis suppressor protein 1	GO:0005102; F:receptor binding; IPI:UniProtKB
O43312	MTSS1	Metastasis suppressor protein 1	GO:0030036; P:actin cytoskeleton organization; TAS:UniProtKB
O43312	MTSS1	Metastasis suppressor protein 1	GO:0030041; P:actin filament polymerization; IEA:Ensembl
O43312	MTSS1	Metastasis suppressor protein 1	GO:0007155; P:cell adhesion; NAS:UniProtKB
O43312	MTSS1	Metastasis suppressor protein 1	GO:0006928; P:cellular component movement; NAS:UniProtKB
O43312	MTSS1	Metastasis suppressor protein 1	GO:0071498; P:cellular response to fluid shear stress; ISS:UniProtKB
O43312	MTSS1	Metastasis suppressor protein 1	GO:2001013; P:epithelial cell proliferation involved in renal tubule morphogenesis; ISS:UniProtKB
O43312	MTSS1	Metastasis suppressor protein 1	GO:0046847; P:filopodium assembly; IEA:InterPro
O43312	MTSS1	Metastasis suppressor protein 1	GO:0072102; P:glomerulus morphogenesis; ISS:UniProtKB
O43312	MTSS1	Metastasis suppressor protein 1	GO:0030035; P:microspike assembly; NAS:UniProtKB
O43312	MTSS1	Metastasis suppressor protein 1	GO:0050680; P:negative regulation of epithelial cell proliferation; ISS:UniProtKB
O43312	MTSS1	Metastasis suppressor protein 1	GO:0072160; P:nephron tubule epithelial cell differentiation; ISS:UniProtKB
O43312	MTSS1	Metastasis suppressor protein 1	GO:0061333; P:renal tubule morphogenesis; ISS:UniProtKB
O43312	MTSS1	Metastasis suppressor protein 1	GO:0007165; P:signal transduction; IEA:InterPro
O43312	MTSS1	Metastasis suppressor protein 1	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:UniProtKB
Q765P7	MTSS1L	MTSS1-like protein	GO:0046847; P:filopodium assembly; IEA:InterPro
Q765P7	MTSS1L	MTSS1-like protein	GO:0007165; P:signal transduction; IEA:InterPro
O75648	TRMU	Mitochondrial tRNA-specific 2-thiouridylase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75648	TRMU	Mitochondrial tRNA-specific 2-thiouridylase 1	GO:0016783; F:sulfurtransferase activity; IEA:InterPro
O75648	TRMU	Mitochondrial tRNA-specific 2-thiouridylase 1	GO:0000049; F:tRNA binding; IEA:UniProtKB-KW
O75648	TRMU	Mitochondrial tRNA-specific 2-thiouridylase 1	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q8N3F0	MTURN	Maturin	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9ULD2	MTUS1	Microtubule-associated tumor suppressor 1	GO:0071375; P:cellular response to peptide hormone stimulus; IEA:Ensembl
Q5JR59	MTUS2	Microtubule-associated tumor suppressor candidate 2	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q5JR59	MTUS2	Microtubule-associated tumor suppressor candidate 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q5JR59	MTUS2	Microtubule-associated tumor suppressor candidate 2	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q13505	MTX1	Metaxin-1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q13505	MTX1	Metaxin-1	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
Q5HYI7	MTX3	Metaxin-3	GO:0006626; P:protein targeting to mitochondrion; IEA:InterPro
O75431	MTX2	Metaxin-2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O75431	MTX2	Metaxin-2	GO:0006839; P:mitochondrial transport; TAS:ProtInc
O75431	MTX2	Metaxin-2	GO:0006626; P:protein targeting to mitochondrion; IEA:InterPro
Q9UKN1	MUC12	Mucin-12	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UKN1	MUC12	Mucin-12	GO:0016266; P:O-glycan processing; TAS:Reactome
Q9UKN1	MUC12	Mucin-12	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9UKN1	MUC12	Mucin-12	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
Q9H3R2	MUC13	Mucin-13	GO:0042803; F:protein homodimerization activity; IDA:UniProt
Q9H3R2	MUC13	Mucin-13	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9H3R2	MUC13	Mucin-13	GO:0030277; P:maintenance of gastrointestinal epithelium; IMP:UniProt
Q9H3R2	MUC13	Mucin-13	GO:0016266; P:O-glycan processing; TAS:Reactome
Q9H3R2	MUC13	Mucin-13	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q8N387	MUC15	Mucin-15	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8N387	MUC15	Mucin-15	GO:0016266; P:O-glycan processing; TAS:Reactome
Q8N387	MUC15	Mucin-15	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q8WXI7	MUC16	Mucin-16	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WXI7	MUC16	Mucin-16	GO:0007155; P:cell adhesion; NAS:UniProtKB
Q8WXI7	MUC16	Mucin-16	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8WXI7	MUC16	Mucin-16	GO:0016266; P:O-glycan processing; TAS:Reactome
Q8WXI7	MUC16	Mucin-16	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q685J3	MUC17	Mucin-17	GO:0030197; F:extracellular matrix constituent, lubricant activity; NAS:UniProtKB
Q685J3	MUC17	Mucin-17	GO:0030165; F:PDZ domain binding; IPI:UniProtKB
Q685J3	MUC17	Mucin-17	GO:0005515; F:protein binding; IPI:UniProtKB
Q685J3	MUC17	Mucin-17	GO:0019725; P:cellular homeostasis; TAS:UniProtKB
Q685J3	MUC17	Mucin-17	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q685J3	MUC17	Mucin-17	GO:0016266; P:O-glycan processing; TAS:Reactome
Q685J3	MUC17	Mucin-17	GO:0043687; P:post-translational protein modification; TAS:Reactome
P43121	MCAM	Cell surface glycoprotein MUC18	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P43121	MCAM	Cell surface glycoprotein MUC18	GO:0007155; P:cell adhesion; TAS:ProtInc
P43121	MCAM	Cell surface glycoprotein MUC18	GO:0003094; P:glomerular filtration; IEP:UniProtKB
P43121	MCAM	Cell surface glycoprotein MUC18	GO:0061042; P:vascular wound healing; IEP:UniProtKB
Q7Z5P9	MUC19	Mucin-19	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q7Z5P9	MUC19	Mucin-19	GO:0016266; P:O-glycan processing; TAS:Reactome
Q7Z5P9	MUC19	Mucin-19	GO:0043687; P:post-translational protein modification; TAS:Reactome
P15941	MUC1	Mucin-1	GO:0002039; F:p53 binding; IPI:BHF-UCL
P15941	MUC1	Mucin-1	GO:0005515; F:protein binding; IPI:IntAct
P15941	MUC1	Mucin-1	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:BHF-UCL
P15941	MUC1	Mucin-1	GO:0003712; F:transcription cofactor activity; IDA:BHF-UCL
P15941	MUC1	Mucin-1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P15941	MUC1	Mucin-1	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; IDA:BHF-UCL
P15941	MUC1	Mucin-1	GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IDA:BHF-UCL
P15941	MUC1	Mucin-1	GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IDA:BHF-UCL
P15941	MUC1	Mucin-1	GO:0010944; P:negative regulation of transcription by competitive promoter binding; IDA:BHF-UCL
P15941	MUC1	Mucin-1	GO:0016266; P:O-glycan processing; TAS:Reactome
P15941	MUC1	Mucin-1	GO:0090240; P:positive regulation of histone H4 acetylation; IDA:BHF-UCL
P15941	MUC1	Mucin-1	GO:0036003; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; IDA:BHF-UCL
P15941	MUC1	Mucin-1	GO:0043687; P:post-translational protein modification; TAS:Reactome
P15941	MUC1	Mucin-1	GO:0043618; P:regulation of transcription from RNA polymerase II promoter in response to stress; IDA:BHF-UCL
Q8N307	MUC20	Mucin-20	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
Q8N307	MUC20	Mucin-20	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8N307	MUC20	Mucin-20	GO:0048012; P:hepatocyte growth factor receptor signaling pathway; IEA:Ensembl
Q8N307	MUC20	Mucin-20	GO:0016266; P:O-glycan processing; TAS:Reactome
Q8N307	MUC20	Mucin-20	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q8N307	MUC20	Mucin-20	GO:0051260; P:protein homooligomerization; IDA:MGI
Q5SSG8	MUC21	Mucin-21	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q5SSG8	MUC21	Mucin-21	GO:0016266; P:O-glycan processing; TAS:Reactome
Q5SSG8	MUC21	Mucin-21	GO:0043687; P:post-translational protein modification; TAS:Reactome
E2RYF6	MUC22	Mucin-22	GO:0022408; P:negative regulation of cell-cell adhesion; IEA:Ensembl
E2RYF6	MUC22	Mucin-22	GO:0010812; P:negative regulation of cell-substrate adhesion; IEA:Ensembl
Q04900	CD164	Sialomucin core protein 24	GO:0005515; F:protein binding; IPI:UniProtKB
Q04900	CD164	Sialomucin core protein 24	GO:0007155; P:cell adhesion; IDA:MGI
Q04900	CD164	Sialomucin core protein 24	GO:0030097; P:hemopoiesis; NAS:UniProtKB
Q04900	CD164	Sialomucin core protein 24	GO:0007157; P:heterophilic cell-cell adhesion; IDA:MGI
Q04900	CD164	Sialomucin core protein 24	GO:0006955; P:immune response; TAS:ProtInc
Q04900	CD164	Sialomucin core protein 24	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q04900	CD164	Sialomucin core protein 24	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
Q04900	CD164	Sialomucin core protein 24	GO:0007162; P:negative regulation of cell adhesion; NAS:UniProtKB
Q04900	CD164	Sialomucin core protein 24	GO:0008285; P:negative regulation of cell proliferation; NAS:UniProtKB
Q04900	CD164	Sialomucin core protein 24	GO:0007165; P:signal transduction; TAS:ProtInc
Q02817	MUC2	Mucin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q02817	MUC2	Mucin-2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q02817	MUC2	Mucin-2	GO:0030277; P:maintenance of gastrointestinal epithelium; IMP:UniProt
Q02817	MUC2	Mucin-2	GO:0016266; P:O-glycan processing; TAS:Reactome
Q02817	MUC2	Mucin-2	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q02505	MUC3A	Mucin-3A	GO:0030197; F:extracellular matrix constituent, lubricant activity; NAS:UniProtKB
Q02505	MUC3A	Mucin-3A	GO:0005201; F:extracellular matrix structural constituent; NAS:UniProtKB
Q02505	MUC3A	Mucin-3A	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q02505	MUC3A	Mucin-3A	GO:0016266; P:O-glycan processing; TAS:Reactome
Q02505	MUC3A	Mucin-3A	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9H195	MUC3B	Mucin-3B	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9H195	MUC3B	Mucin-3B	GO:0016266; P:O-glycan processing; TAS:Reactome
Q9H195	MUC3B	Mucin-3B	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q99102	MUC4	Mucin-4	GO:0005176; F:ErbB-2 class receptor binding; TAS:ProtInc
Q99102	MUC4	Mucin-4	GO:0030197; F:extracellular matrix constituent, lubricant activity; NAS:UniProtKB
Q99102	MUC4	Mucin-4	GO:0007160; P:cell-matrix adhesion; IEA:InterPro
Q99102	MUC4	Mucin-4	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q99102	MUC4	Mucin-4	GO:0030277; P:maintenance of gastrointestinal epithelium; IMP:UniProt
Q99102	MUC4	Mucin-4	GO:0016266; P:O-glycan processing; TAS:Reactome
Q99102	MUC4	Mucin-4	GO:0043687; P:post-translational protein modification; TAS:Reactome
P98088	MUC5AC	Mucin-5AC	GO:0005201; F:extracellular matrix structural constituent; TAS:UniProtKB
P98088	MUC5AC	Mucin-5AC	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P98088	MUC5AC	Mucin-5AC	GO:0043206; P:extracellular fibril organization; IDA:MGI
P98088	MUC5AC	Mucin-5AC	GO:0016266; P:O-glycan processing; TAS:Reactome
P98088	MUC5AC	Mucin-5AC	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9HC84	MUC5B	Mucin-5B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HC84	MUC5B	Mucin-5B	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9HC84	MUC5B	Mucin-5B	GO:0016266; P:O-glycan processing; TAS:Reactome
Q9HC84	MUC5B	Mucin-5B	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q6W4X9	MUC6	Mucin-6	GO:0005201; F:extracellular matrix structural constituent; NAS:UniProtKB
Q6W4X9	MUC6	Mucin-6	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q6W4X9	MUC6	Mucin-6	GO:0030277; P:maintenance of gastrointestinal epithelium; NAS:UniProtKB
Q6W4X9	MUC6	Mucin-6	GO:0016266; P:O-glycan processing; TAS:Reactome
Q6W4X9	MUC6	Mucin-6	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q8TAX7	MUC7	Mucin-7	GO:0005515; F:protein binding; IPI:IntAct
Q8TAX7	MUC7	Mucin-7	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8TAX7	MUC7	Mucin-7	GO:0016266; P:O-glycan processing; TAS:Reactome
Q8TAX7	MUC7	Mucin-7	GO:0043687; P:post-translational protein modification; TAS:Reactome
DR   GO:0003823; F:antigen binding; TAS:UniProtKB
Q96DR8	MUCL1	Mucin-like protein 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q96DR8	MUCL1	Mucin-like protein 1	GO:0016266; P:O-glycan processing; TAS:Reactome
Q96DR8	MUCL1	Mucin-like protein 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0042802; F:identical protein binding; IPI:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0019789; F:SUMO ligase activity; IDA:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0007257; P:activation of JUN kinase activity; IDA:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0071360; P:cellular response to exogenous dsRNA; IDA:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0000266; P:mitochondrial fission; IMP:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0051646; P:mitochondrion localization; IMP:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0071650; P:negative regulation of chemokine (C-C motif) ligand 5 production; IMP:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0050689; P:negative regulation of defense response to virus by host; IMP:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0045824; P:negative regulation of innate immune response; IMP:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0010637; P:negative regulation of mitochondrial fusion; IDA:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0051898; P:negative regulation of protein kinase B signaling; IDA:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0060339; P:negative regulation of type I interferon-mediated signaling pathway; IMP:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0090141; P:positive regulation of mitochondrial fission; IDA:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0033235; P:positive regulation of protein sumoylation; IDA:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0050821; P:protein stabilization; IMP:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0016925; P:protein sumoylation; IEA:UniProtKB-UniPathway
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q969V5	MUL1	Mitochondrial ubiquitin ligase activator of NFKB 1	GO:1901028; P:regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; IDA:UniProtKB
Q2TAK8	MUM1	PWWP domain-containing protein MUM1	GO:0031491; F:nucleosome binding; IDA:UniProtKB
Q2TAK8	MUM1	PWWP domain-containing protein MUM1	GO:0005515; F:protein binding; IPI:UniProtKB
Q2TAK8	MUM1	PWWP domain-containing protein MUM1	GO:0006325; P:chromatin organization; IMP:UniProtKB
Q2TAK8	MUM1	PWWP domain-containing protein MUM1	GO:0006281; P:DNA repair; IMP:UniProtKB
Q5BKX8	MURC	Muscle-related coiled-coil protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q5BKX8	MURC	Muscle-related coiled-coil protein	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
Q5BKX8	MURC	Muscle-related coiled-coil protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q5BKX8	MURC	Muscle-related coiled-coil protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96NY9	MUS81	Crossover junction endonuclease MUS81	GO:0048257; F:3'-flap endonuclease activity; IMP:UniProtKB
Q96NY9	MUS81	Crossover junction endonuclease MUS81	GO:0003677; F:DNA binding; IEA:InterPro
Q96NY9	MUS81	Crossover junction endonuclease MUS81	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96NY9	MUS81	Crossover junction endonuclease MUS81	GO:0005515; F:protein binding; IPI:UniProtKB
Q96NY9	MUS81	Crossover junction endonuclease MUS81	GO:0000737; P:DNA catabolic process, endonucleolytic; IMP:GOC
Q96NY9	MUS81	Crossover junction endonuclease MUS81	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q96NY9	MUS81	Crossover junction endonuclease MUS81	GO:0006281; P:DNA repair; IMP:UniProtKB
O60682	MSC	Musculin	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O60682	MSC	Musculin	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O60682	MSC	Musculin	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
O60682	MSC	Musculin	GO:0014707; P:branchiomeric skeletal muscle development; IEA:Ensembl
O60682	MSC	Musculin	GO:0060539; P:diaphragm development; IEA:Ensembl
O60682	MSC	Musculin	GO:0060021; P:palate development; IEA:Ensembl
O60682	MSC	Musculin	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
O15146	MUSK	Muscle, skeletal receptor tyrosine-protein kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O15146	MUSK	Muscle, skeletal receptor tyrosine-protein kinase	GO:0005515; F:protein binding; IPI:IntAct
O15146	MUSK	Muscle, skeletal receptor tyrosine-protein kinase	GO:0004713; F:protein tyrosine kinase activity; ISS:UniProtKB
O15146	MUSK	Muscle, skeletal receptor tyrosine-protein kinase	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IEA:UniProtKB-EC
O15146	MUSK	Muscle, skeletal receptor tyrosine-protein kinase	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O15146	MUSK	Muscle, skeletal receptor tyrosine-protein kinase	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O15146	MUSK	Muscle, skeletal receptor tyrosine-protein kinase	GO:0007613; P:memory; ISS:UniProtKB
O15146	MUSK	Muscle, skeletal receptor tyrosine-protein kinase	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
O15146	MUSK	Muscle, skeletal receptor tyrosine-protein kinase	GO:0007528; P:neuromuscular junction development; ISS:UniProtKB
O15146	MUSK	Muscle, skeletal receptor tyrosine-protein kinase	GO:0018108; P:peptidyl-tyrosine phosphorylation; ISS:GOC
O15146	MUSK	Muscle, skeletal receptor tyrosine-protein kinase	GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB
O15146	MUSK	Muscle, skeletal receptor tyrosine-protein kinase	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
O15146	MUSK	Muscle, skeletal receptor tyrosine-protein kinase	GO:2000541; P:positive regulation of protein geranylgeranylation; ISS:UniProtKB
O15146	MUSK	Muscle, skeletal receptor tyrosine-protein kinase	GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB
O15146	MUSK	Muscle, skeletal receptor tyrosine-protein kinase	GO:0046777; P:protein autophosphorylation; ISS:UniProtKB
O15146	MUSK	Muscle, skeletal receptor tyrosine-protein kinase	GO:0008582; P:regulation of synaptic growth at neuromuscular junction; ISS:UniProtKB
O15146	MUSK	Muscle, skeletal receptor tyrosine-protein kinase	GO:0006355; P:regulation of transcription, DNA-templated; IEA:Ensembl
O15146	MUSK	Muscle, skeletal receptor tyrosine-protein kinase	GO:0071340; P:skeletal muscle acetylcholine-gated channel clustering; ISS:UniProtKB
O15146	MUSK	Muscle, skeletal receptor tyrosine-protein kinase	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc
Q8N9H8	EXD3	Exonuclease mut-7 homolog	GO:0008408; F:3'-5' exonuclease activity; IEA:InterPro
Q8N9H8	EXD3	Exonuclease mut-7 homolog	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9NX53	EXD3	Exonuclease mut-7 homolog, isoform 5	GO:0005515; F:protein binding; IPI:IntAct
P22033	MUT	Methylmalonyl-CoA mutase, mitochondrial	GO:0031419; F:cobalamin binding; IEA:UniProtKB-KW
P22033	MUT	Methylmalonyl-CoA mutase, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P22033	MUT	Methylmalonyl-CoA mutase, mitochondrial	GO:0004494; F:methylmalonyl-CoA mutase activity; TAS:ProtInc
P22033	MUT	Methylmalonyl-CoA mutase, mitochondrial	GO:0072341; F:modified amino acid binding; IDA:UniProtKB
P22033	MUT	Methylmalonyl-CoA mutase, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P22033	MUT	Methylmalonyl-CoA mutase, mitochondrial	GO:0009235; P:cobalamin metabolic process; TAS:Reactome
P22033	MUT	Methylmalonyl-CoA mutase, mitochondrial	GO:0006635; P:fatty acid beta-oxidation; TAS:Reactome
P22033	MUT	Methylmalonyl-CoA mutase, mitochondrial	GO:0050667; P:homocysteine metabolic process; IDA:UniProtKB
P22033	MUT	Methylmalonyl-CoA mutase, mitochondrial	GO:0009791; P:post-embryonic development; IEA:Ensembl
P22033	MUT	Methylmalonyl-CoA mutase, mitochondrial	GO:0019626; P:short-chain fatty acid catabolic process; TAS:Reactome
P22033	MUT	Methylmalonyl-CoA mutase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P22033	MUT	Methylmalonyl-CoA mutase, mitochondrial	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P22033	MUT	Methylmalonyl-CoA mutase, mitochondrial	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9UIF7	MUTYH	A/G-specific adenine DNA glycosylase	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
Q9UIF7	MUTYH	A/G-specific adenine DNA glycosylase	GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IEA:UniProtKB-KW
Q9UIF7	MUTYH	A/G-specific adenine DNA glycosylase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UIF7	MUTYH	A/G-specific adenine DNA glycosylase	GO:0032407; F:MutSalpha complex binding; IDA:HGNC
Q9UIF7	MUTYH	A/G-specific adenine DNA glycosylase	GO:0005515; F:protein binding; IPI:HGNC
Q9UIF7	MUTYH	A/G-specific adenine DNA glycosylase	GO:0006284; P:base-excision repair; TAS:Reactome
Q9UIF7	MUTYH	A/G-specific adenine DNA glycosylase	GO:0006285; P:base-excision repair, AP site formation; TAS:Reactome
Q9UIF7	MUTYH	A/G-specific adenine DNA glycosylase	GO:0045007; P:depurination; TAS:Reactome
Q9UIF7	MUTYH	A/G-specific adenine DNA glycosylase	GO:0006281; P:DNA repair; TAS:Reactome
Q9UIF7	MUTYH	A/G-specific adenine DNA glycosylase	GO:0006298; P:mismatch repair; TAS:ProtInc
P53602	MVD	Diphosphomevalonate decarboxylase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P53602	MVD	Diphosphomevalonate decarboxylase	GO:0004163; F:diphosphomevalonate decarboxylase activity; IDA:UniProtKB
P53602	MVD	Diphosphomevalonate decarboxylase	GO:0030544; F:Hsp70 protein binding; IPI:UniProtKB
P53602	MVD	Diphosphomevalonate decarboxylase	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P53602	MVD	Diphosphomevalonate decarboxylase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P53602	MVD	Diphosphomevalonate decarboxylase	GO:0006695; P:cholesterol biosynthetic process; NAS:UniProtKB
P53602	MVD	Diphosphomevalonate decarboxylase	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
P53602	MVD	Diphosphomevalonate decarboxylase	GO:0006489; P:dolichyl diphosphate biosynthetic process; TAS:Reactome
P53602	MVD	Diphosphomevalonate decarboxylase	GO:0008299; P:isoprenoid biosynthetic process; IDA:UniProtKB
P53602	MVD	Diphosphomevalonate decarboxylase	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
P53602	MVD	Diphosphomevalonate decarboxylase	GO:0043687; P:post-translational protein modification; TAS:Reactome
P53602	MVD	Diphosphomevalonate decarboxylase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
P53602	MVD	Diphosphomevalonate decarboxylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14764	MVP	Major vault protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q14764	MVP	Major vault protein	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q14764	MVP	Major vault protein	GO:0019903; F:protein phosphatase binding; IDA:UniProtKB
Q14764	MVP	Major vault protein	GO:0008283; P:cell proliferation; IEA:Ensembl
Q14764	MVP	Major vault protein	GO:0038127; P:ERBB signaling pathway; IDA:UniProtKB
Q14764	MVP	Major vault protein	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q14764	MVP	Major vault protein	GO:0031953; P:negative regulation of protein autophosphorylation; IDA:UniProtKB
Q14764	MVP	Major vault protein	GO:0061099; P:negative regulation of protein tyrosine kinase activity; IDA:UniProtKB
Q14764	MVP	Major vault protein	GO:0023057; P:negative regulation of signaling; IDA:UniProtKB
Q14764	MVP	Major vault protein	GO:0072376; P:protein activation cascade; IEA:Ensembl
Q14764	MVP	Major vault protein	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P20591	MX1	Interferon-induced GTP-binding protein Mx1	GO:0005525; F:GTP binding; TAS:ProtInc
P20591	MX1	Interferon-induced GTP-binding protein Mx1	GO:0003924; F:GTPase activity; IEA:InterPro
P20591	MX1	Interferon-induced GTP-binding protein Mx1	GO:0005515; F:protein binding; IPI:UniProtKB
P20591	MX1	Interferon-induced GTP-binding protein Mx1	GO:0006915; P:apoptotic process; TAS:ProtInc
P20591	MX1	Interferon-induced GTP-binding protein Mx1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P20591	MX1	Interferon-induced GTP-binding protein Mx1	GO:0006952; P:defense response; TAS:ProtInc
P20591	MX1	Interferon-induced GTP-binding protein Mx1	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P20591	MX1	Interferon-induced GTP-binding protein Mx1	GO:0045087; P:innate immune response; TAS:UniProtKB
P20591	MX1	Interferon-induced GTP-binding protein Mx1	GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB
P20591	MX1	Interferon-induced GTP-binding protein Mx1	GO:0034340; P:response to type I interferon; TAS:UniProtKB
P20591	MX1	Interferon-induced GTP-binding protein Mx1	GO:0009615; P:response to virus; IMP:UniProtKB
P20591	MX1	Interferon-induced GTP-binding protein Mx1	GO:0007165; P:signal transduction; TAS:ProtInc
P20591	MX1	Interferon-induced GTP-binding protein Mx1	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P20592	MX2	Interferon-induced GTP-binding protein Mx2	GO:0005525; F:GTP binding; IMP:UniProtKB
P20592	MX2	Interferon-induced GTP-binding protein Mx2	GO:0003924; F:GTPase activity; TAS:ProtInc
P20592	MX2	Interferon-induced GTP-binding protein Mx2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P20592	MX2	Interferon-induced GTP-binding protein Mx2	GO:0006952; P:defense response; TAS:ProtInc
P20592	MX2	Interferon-induced GTP-binding protein Mx2	GO:0051607; P:defense response to virus; IMP:UniProtKB
P20592	MX2	Interferon-induced GTP-binding protein Mx2	GO:0006184; P:GTP catabolic process; TAS:GOC
P20592	MX2	Interferon-induced GTP-binding protein Mx2	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
P20592	MX2	Interferon-induced GTP-binding protein Mx2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P20592	MX2	Interferon-induced GTP-binding protein Mx2	GO:0051726; P:regulation of cell cycle; IMP:UniProtKB
P20592	MX2	Interferon-induced GTP-binding protein Mx2	GO:0046822; P:regulation of nucleocytoplasmic transport; IMP:UniProtKB
P20592	MX2	Interferon-induced GTP-binding protein Mx2	GO:0035455; P:response to interferon-alpha; IDA:UniProtKB
P20592	MX2	Interferon-induced GTP-binding protein Mx2	GO:0009615; P:response to virus; IDA:UniProtKB
P20592	MX2	Interferon-induced GTP-binding protein Mx2	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P50539	MXI1	Max-interacting protein 1	GO:0003677; F:DNA binding; TAS:ProtInc
P50539	MXI1	Max-interacting protein 1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
P50539	MXI1	Max-interacting protein 1	GO:0042994; P:cytoplasmic sequestering of transcription factor; TAS:ProtInc
P50539	MXI1	Max-interacting protein 1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P50539	MXI1	Max-interacting protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P50539	MXI1	Max-interacting protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BRK3	MXRA8	Matrix-remodeling-associated protein 8	GO:0060857; P:establishment of glial blood-brain barrier; ISS:UniProt
Q96JP2	MYO15B	Unconventional myosin-XVB	GO:0005524; F:ATP binding; IEA:InterPro
Q96JP2	MYO15B	Unconventional myosin-XVB	GO:0003774; F:motor activity; IEA:InterPro
Q92614	MYO18A	Unconventional myosin-XVIIIa	GO:0051015; F:actin filament binding; IDA:UniProtKB
Q92614	MYO18A	Unconventional myosin-XVIIIa	GO:0043531; F:ADP binding; IDA:UniProtKB
Q92614	MYO18A	Unconventional myosin-XVIIIa	GO:0005524; F:ATP binding; IDA:UniProtKB
Q92614	MYO18A	Unconventional myosin-XVIIIa	GO:0003677; F:DNA binding; IEA:InterPro
Q92614	MYO18A	Unconventional myosin-XVIIIa	GO:0003774; F:motor activity; IEA:InterPro
Q92614	MYO18A	Unconventional myosin-XVIIIa	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q92614	MYO18A	Unconventional myosin-XVIIIa	GO:0005515; F:protein binding; IPI:IntAct
Q92614	MYO18A	Unconventional myosin-XVIIIa	GO:0031032; P:actomyosin structure organization; IMP:UniProtKB
Q92614	MYO18A	Unconventional myosin-XVIIIa	GO:0016477; P:cell migration; IMP:UniProtKB
Q92614	MYO18A	Unconventional myosin-XVIIIa	GO:0006259; P:DNA metabolic process; IEA:InterPro
Q92614	MYO18A	Unconventional myosin-XVIIIa	GO:0007030; P:Golgi organization; IMP:UniProtKB
Q92614	MYO18A	Unconventional myosin-XVIIIa	GO:0048194; P:Golgi vesicle budding; IMP:UniProtKB
Q92614	MYO18A	Unconventional myosin-XVIIIa	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
Q92614	MYO18A	Unconventional myosin-XVIIIa	GO:0050714; P:positive regulation of protein secretion; IMP:UniProtKB
Q8IUG5	MYO18B	Unconventional myosin-XVIIIb	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IUG5	MYO18B	Unconventional myosin-XVIIIb	GO:0003774; F:motor activity; IEA:InterPro
Q96S97	MYADM	Myeloid-associated differentiation marker	GO:0061028; P:establishment of endothelial barrier; IMP:UniProt
Q96S97	MYADM	Myeloid-associated differentiation marker	GO:0031579; P:membrane raft organization; IMP:UniProt
Q96S97	MYADM	Myeloid-associated differentiation marker	GO:0030837; P:negative regulation of actin filament polymerization; IMP:UniProt
Q96S97	MYADM	Myeloid-associated differentiation marker	GO:0010629; P:negative regulation of gene expression; IMP:UniProt
Q96S97	MYADM	Myeloid-associated differentiation marker	GO:0034115; P:negative regulation of heterotypic cell-cell adhesion; IDA:UniProt
Q96S97	MYADM	Myeloid-associated differentiation marker	GO:0090038; P:negative regulation of protein kinase C signaling; IMP:UniProt
Q96S97	MYADM	Myeloid-associated differentiation marker	GO:0001933; P:negative regulation of protein phosphorylation; IMP:UniProt
Q96S97	MYADM	Myeloid-associated differentiation marker	GO:0030335; P:positive regulation of cell migration; IMP:UniProt
Q96S97	MYADM	Myeloid-associated differentiation marker	GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IMP:UniProt
Q96S97	MYADM	Myeloid-associated differentiation marker	GO:0072661; P:protein targeting to plasma membrane; IMP:UniProt
P10243	MYBL1	Myb-related protein A	GO:0003682; F:chromatin binding; IEA:InterPro
P10243	MYBL1	Myb-related protein A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P10243	MYBL1	Myb-related protein A	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
P10243	MYBL1	Myb-related protein A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P10244	MYBL2	Myb-related protein B	GO:0003682; F:chromatin binding; IEA:InterPro
P10244	MYBL2	Myb-related protein B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P10244	MYBL2	Myb-related protein B	GO:0005515; F:protein binding; IPI:IntAct
P10244	MYBL2	Myb-related protein B	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P10244	MYBL2	Myb-related protein B	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P10244	MYBL2	Myb-related protein B	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P10244	MYBL2	Myb-related protein B	GO:0051726; P:regulation of cell cycle; TAS:Reactome
P10244	MYBL2	Myb-related protein B	GO:0090307; P:spindle assembly involved in mitosis; IEA:Ensembl
P10244	MYBL2	Myb-related protein B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13203	MYBPH	Myosin-binding protein H	GO:0005515; F:protein binding; IPI:IntAct
Q13203	MYBPH	Myosin-binding protein H	GO:0008307; F:structural constituent of muscle; TAS:ProtInc
Q13203	MYBPH	Myosin-binding protein H	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q13203	MYBPH	Myosin-binding protein H	GO:0006942; P:regulation of striated muscle contraction; TAS:ProtInc
Q8TBZ2	MYCBPAP	MYCBP-associated protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TBZ2	MYCBPAP	MYCBP-associated protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8TBZ2	MYCBPAP	MYCBP-associated protein	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8TBZ2	MYCBPAP	MYCBP-associated protein	GO:0007283; P:spermatogenesis; IEP:UniProtKB
Q8TBZ2	MYCBPAP	MYCBP-associated protein	GO:0007268; P:synaptic transmission; ISS:UniProtKB
P10242	MYB	Transcriptional activator Myb	GO:0003682; F:chromatin binding; IEA:InterPro
P10242	MYB	Transcriptional activator Myb	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P10242	MYB	Transcriptional activator Myb	GO:0005515; F:protein binding; IPI:UniProtKB
P10242	MYB	Transcriptional activator Myb	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P10242	MYB	Transcriptional activator Myb	GO:0030183; P:B cell differentiation; IEA:Ensembl
P10242	MYB	Transcriptional activator Myb	GO:0007596; P:blood coagulation; TAS:Reactome
P10242	MYB	Transcriptional activator Myb	GO:0006816; P:calcium ion transport; IEA:Ensembl
P10242	MYB	Transcriptional activator Myb	GO:0006338; P:chromatin remodeling; IMP:UniProtKB
P10242	MYB	Transcriptional activator Myb	GO:0048566; P:embryonic digestive tract development; IEA:Ensembl
P10242	MYB	Transcriptional activator Myb	GO:0000082; P:G1/S transition of mitotic cell cycle; IEA:Ensembl
P10242	MYB	Transcriptional activator Myb	GO:0048872; P:homeostasis of number of cells; IEA:Ensembl
P10242	MYB	Transcriptional activator Myb	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P10242	MYB	Transcriptional activator Myb	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P10242	MYB	Transcriptional activator Myb	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:BHF-UCL
P10242	MYB	Transcriptional activator Myb	GO:0051571; P:positive regulation of histone H3-K4 methylation; IMP:UniProtKB
P10242	MYB	Transcriptional activator Myb	GO:0051574; P:positive regulation of histone H3-K9 methylation; IMP:UniProtKB
P10242	MYB	Transcriptional activator Myb	GO:0045624; P:positive regulation of T-helper cell differentiation; IMP:UniProtKB
P10242	MYB	Transcriptional activator Myb	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P10242	MYB	Transcriptional activator Myb	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
P10242	MYB	Transcriptional activator Myb	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P10242	MYB	Transcriptional activator Myb	GO:0048538; P:thymus development; IEA:Ensembl
P10242	MYB	Transcriptional activator Myb	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75592	MYCBP2	E3 ubiquitin-protein ligase MYCBP2	GO:0005515; F:protein binding; IPI:IntAct
O75592	MYCBP2	E3 ubiquitin-protein ligase MYCBP2	GO:0004842; F:ubiquitin-protein ligase activity; IEA:InterPro
O75592	MYCBP2	E3 ubiquitin-protein ligase MYCBP2	GO:0008270; F:zinc ion binding; IEA:InterPro
O75592	MYCBP2	E3 ubiquitin-protein ligase MYCBP2	GO:0021785; P:branchiomotor neuron axon guidance; IEA:Ensembl
O75592	MYCBP2	E3 ubiquitin-protein ligase MYCBP2	GO:0021952; P:central nervous system projection neuron axonogenesis; IEA:Ensembl
O75592	MYCBP2	E3 ubiquitin-protein ligase MYCBP2	GO:0051493; P:regulation of cytoskeleton organization; IEA:Ensembl
O75592	MYCBP2	E3 ubiquitin-protein ligase MYCBP2	GO:0032880; P:regulation of protein localization; IEA:Ensembl
O75592	MYCBP2	E3 ubiquitin-protein ligase MYCBP2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O75592	MYCBP2	E3 ubiquitin-protein ligase MYCBP2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q99417	MYCBP	C-Myc-binding protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q99417	MYCBP	C-Myc-binding protein	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q99417	MYCBP	C-Myc-binding protein	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q99417	MYCBP	C-Myc-binding protein	GO:0007283; P:spermatogenesis; IEP:UniProtKB
Q99417	MYCBP	C-Myc-binding protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IZQ8	MYOCD	Myocardin	GO:0001046; F:core promoter sequence-specific DNA binding; IDA:UniProtKB
Q8IZQ8	MYOCD	Myocardin	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IZQ8	MYOCD	Myocardin	GO:0019904; F:protein domain specific binding; IDA:UniProtKB
Q8IZQ8	MYOCD	Myocardin	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:MGI
Q8IZQ8	MYOCD	Myocardin	GO:0001076; F:RNA polymerase II transcription factor binding transcription factor activity; ISS:BHF-UCL
Q8IZQ8	MYOCD	Myocardin	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q8IZQ8	MYOCD	Myocardin	GO:0055007; P:cardiac muscle cell differentiation; ISS:BHF-UCL
Q8IZQ8	MYOCD	Myocardin	GO:0035051; P:cardiocyte differentiation; NAS:UniProtKB
Q8IZQ8	MYOCD	Myocardin	GO:1900222; P:negative regulation of beta-amyloid clearance; IMP:BHF-UCL
Q8IZQ8	MYOCD	Myocardin	GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL
Q8IZQ8	MYOCD	Myocardin	GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:BHF-UCL
Q8IZQ8	MYOCD	Myocardin	GO:2001015; P:negative regulation of skeletal muscle cell differentiation; IDA:BHF-UCL
Q8IZQ8	MYOCD	Myocardin	GO:2000727; P:positive regulation of cardiac muscle cell differentiation; IDA:BHF-UCL
Q8IZQ8	MYOCD	Myocardin	GO:2000724; P:positive regulation of cardiac vascular smooth muscle cell differentiation; ISS:BHF-UCL
Q8IZQ8	MYOCD	Myocardin	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q8IZQ8	MYOCD	Myocardin	GO:0051152; P:positive regulation of smooth muscle cell differentiation; IDA:BHF-UCL
Q8IZQ8	MYOCD	Myocardin	GO:0045987; P:positive regulation of smooth muscle contraction; IDA:BHF-UCL
Q8IZQ8	MYOCD	Myocardin	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q8IZQ8	MYOCD	Myocardin	GO:0003257; P:positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; IDA:BHF-UCL
Q8IZQ8	MYOCD	Myocardin	GO:2000721; P:positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation; IDA:BHF-UCL
Q8IZQ8	MYOCD	Myocardin	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q8IZQ8	MYOCD	Myocardin	GO:0035065; P:regulation of histone acetylation; ISS:UniProtKB
Q8IZQ8	MYOCD	Myocardin	GO:0051150; P:regulation of smooth muscle cell differentiation; TAS:BHF-UCL
Q8IZQ8	MYOCD	Myocardin	GO:0001666; P:response to hypoxia; IEP:BHF-UCL
Q8IZQ8	MYOCD	Myocardin	GO:0051145; P:smooth muscle cell differentiation; IMP:BHF-UCL
Q8IZQ8	MYOCD	Myocardin	GO:0006366; P:transcription from RNA polymerase II promoter; ISS:GOC
P12524	MYCL	Protein L-Myc	GO:0003677; F:DNA binding; NAS:UniProtKB
P12524	MYCL	Protein L-Myc	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P04198	MYCN	N-myc proto-oncogene protein	GO:0003677; F:DNA binding; TAS:UniProtKB
P04198	MYCN	N-myc proto-oncogene protein	GO:0005515; F:protein binding; IPI:UniProtKB
P04198	MYCN	N-myc proto-oncogene protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P04198	MYCN	N-myc proto-oncogene protein	GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl
P04198	MYCN	N-myc proto-oncogene protein	GO:0001502; P:cartilage condensation; IEA:Ensembl
P04198	MYCN	N-myc proto-oncogene protein	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
P04198	MYCN	N-myc proto-oncogene protein	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P04198	MYCN	N-myc proto-oncogene protein	GO:0030324; P:lung development; IEA:Ensembl
P04198	MYCN	N-myc proto-oncogene protein	GO:0048712; P:negative regulation of astrocyte differentiation; IEA:Ensembl
P04198	MYCN	N-myc proto-oncogene protein	GO:2000378; P:negative regulation of reactive oxygen species metabolic process; IEA:Ensembl
P04198	MYCN	N-myc proto-oncogene protein	GO:0010942; P:positive regulation of cell death; IEA:Ensembl
P04198	MYCN	N-myc proto-oncogene protein	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl
P04198	MYCN	N-myc proto-oncogene protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P04198	MYCN	N-myc proto-oncogene protein	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P12525	MYCLP1	Putative myc-like protein MYCLP1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P12525	MYCLP1	Putative myc-like protein MYCLP1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q7Z401	DENND4A	C-myc promoter-binding protein	GO:0003677; F:DNA binding; NAS:UniProtKB
Q7Z401	DENND4A	C-myc promoter-binding protein	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q7Z401	DENND4A	C-myc promoter-binding protein	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
Q7Z401	DENND4A	C-myc promoter-binding protein	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q7Z401	DENND4A	C-myc promoter-binding protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96QE2	SLC2A13	Proton myo-inositol cotransporter	GO:0022891; F:substrate-specific transmembrane transporter activity; IEA:InterPro
Q96QE2	SLC2A13	Proton myo-inositol cotransporter	GO:0055085; P:transmembrane transport; TAS:Reactome
P01106	MYC	Myc proto-oncogene protein	GO:0003677; F:DNA binding; ISS:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0070888; F:E-box binding; IDA:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0005515; F:protein binding; IPI:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0032403; F:protein complex binding; IDA:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0070491; F:repressing transcription factor binding; IPI:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0001658; P:branching involved in ureteric bud morphogenesis; ISS:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0060070; P:canonical Wnt signaling pathway; IDA:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0007050; P:cell cycle arrest; IDA:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0006879; P:cellular iron ion homeostasis; IDA:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0035690; P:cellular response to drug; IDA:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0034644; P:cellular response to UV; IEP:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0006338; P:chromatin remodeling; IDA:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0051276; P:chromosome organization; IDA:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0006112; P:energy reserve metabolic process; NAS:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0044346; P:fibroblast apoptotic process; TAS:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0010467; P:gene expression; TAS:Reactome
P01106	MYC	Myc proto-oncogene protein	GO:0000165; P:MAPK cascade; IMP:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0051782; P:negative regulation of cell division; IDA:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0048147; P:negative regulation of fibroblast proliferation; IDA:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0045656; P:negative regulation of monocyte differentiation; IMP:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0032873; P:negative regulation of stress-activated MAPK cascade; ISS:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P01106	MYC	Myc proto-oncogene protein	GO:0015671; P:oxygen transport; NAS:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0008284; P:positive regulation of cell proliferation; IDA:MGI
P01106	MYC	Myc proto-oncogene protein	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:2000573; P:positive regulation of DNA biosynthetic process; IMP:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0048146; P:positive regulation of fibroblast proliferation; IDA:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0002053; P:positive regulation of mesenchymal cell proliferation; ISS:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0090096; P:positive regulation of metanephric cap mesenchymal cell proliferation; ISS:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:2001022; P:positive regulation of response to DNA damage stimulus; IDA:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0010468; P:regulation of gene expression; IDA:MGI
P01106	MYC	Myc proto-oncogene protein	GO:0032204; P:regulation of telomere maintenance; IMP:BHF-UCL
P01106	MYC	Myc proto-oncogene protein	GO:0042493; P:response to drug; IEP:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0010332; P:response to gamma radiation; IDA:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0070848; P:response to growth factor; TAS:UniProtKB
P01106	MYC	Myc proto-oncogene protein	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P01106	MYC	Myc proto-oncogene protein	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
P01106	MYC	Myc proto-oncogene protein	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0005123; F:death receptor binding; TAS:ProtInc
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0042802; F:identical protein binding; IPI:IntAct
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0005515; F:protein binding; IPI:UniProtKB
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0070976; F:TIR domain binding; IPI:BHF-UCL
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0070935; P:3'-UTR-mediated mRNA stabilization; IDA:BHF-UCL
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0050830; P:defense response to Gram-positive bacterium; ISS:UniProtKB
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0045087; P:innate immune response; TAS:Reactome
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0032740; P:positive regulation of interleukin-17 production; ISS:BHF-UCL
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0032747; P:positive regulation of interleukin-23 production; ISS:BHF-UCL
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0032755; P:positive regulation of interleukin-6 production; ISS:BHF-UCL
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0050727; P:regulation of inflammatory response; ISS:BHF-UCL
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0070555; P:response to interleukin-1; IMP:BHF-UCL
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0007165; P:signal transduction; NAS:ProtInc
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q99836	MYD88	Myeloid differentiation primary response protein MyD88	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q9P2K5	MYEF2	Myelin expression factor 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9P2K5	MYEF2	Myelin expression factor 2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9P2K5	MYEF2	Myelin expression factor 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9P2K5	MYEF2	Myelin expression factor 2	GO:0014902; P:myotube differentiation; IEP:UniProtKB
Q9P2K5	MYEF2	Myelin expression factor 2	GO:0030182; P:neuron differentiation; IEP:UniProtKB
Q9P2K5	MYEF2	Myelin expression factor 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P13349	MYF5	Myogenic factor 5	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P13349	MYF5	Myogenic factor 5	GO:0005515; F:protein binding; IPI:UniProtKB
P13349	MYF5	Myogenic factor 5	GO:0046982; F:protein heterodimerization activity; ISS:BHF-UCL
P13349	MYF5	Myogenic factor 5	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P13349	MYF5	Myogenic factor 5	GO:0043010; P:camera-type eye development; IEA:Ensembl
P13349	MYF5	Myogenic factor 5	GO:0001502; P:cartilage condensation; IEA:Ensembl
P13349	MYF5	Myogenic factor 5	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P13349	MYF5	Myogenic factor 5	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
P13349	MYF5	Myogenic factor 5	GO:0042692; P:muscle cell differentiation; TAS:Reactome
P13349	MYF5	Myogenic factor 5	GO:0042693; P:muscle cell fate commitment; ISS:BHF-UCL
P13349	MYF5	Myogenic factor 5	GO:0007517; P:muscle organ development; TAS:ProtInc
P13349	MYF5	Myogenic factor 5	GO:0060415; P:muscle tissue morphogenesis; IEA:Ensembl
P13349	MYF5	Myogenic factor 5	GO:0001503; P:ossification; IEA:Ensembl
P13349	MYF5	Myogenic factor 5	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
P13349	MYF5	Myogenic factor 5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P13349	MYF5	Myogenic factor 5	GO:0001952; P:regulation of cell-matrix adhesion; IEA:Ensembl
P13349	MYF5	Myogenic factor 5	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P13349	MYF5	Myogenic factor 5	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
P13349	MYF5	Myogenic factor 5	GO:0007519; P:skeletal muscle tissue development; TAS:ProtInc
P13349	MYF5	Myogenic factor 5	GO:0001756; P:somitogenesis; IEA:Ensembl
P13349	MYF5	Myogenic factor 5	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:GOC
Q9HB07	C12orf10	UPF0160 protein MYG1, mitochondrial	GO:0035641; P:locomotory exploration behavior; IEA:Ensembl
Q9HB07	C12orf10	UPF0160 protein MYG1, mitochondrial	GO:0043473; P:pigmentation; NAS:UniProtKB
P23409	MYF6	Myogenic factor 6	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P23409	MYF6	Myogenic factor 6	GO:0046982; F:protein heterodimerization activity; ISS:BHF-UCL
P23409	MYF6	Myogenic factor 6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P23409	MYF6	Myogenic factor 6	GO:0042692; P:muscle cell differentiation; TAS:Reactome
P23409	MYF6	Myogenic factor 6	GO:0042693; P:muscle cell fate commitment; ISS:BHF-UCL
P23409	MYF6	Myogenic factor 6	GO:0060415; P:muscle tissue morphogenesis; IEA:Ensembl
P23409	MYF6	Myogenic factor 6	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
P23409	MYF6	Myogenic factor 6	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
P23409	MYF6	Myogenic factor 6	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P23409	MYF6	Myogenic factor 6	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P23409	MYF6	Myogenic factor 6	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
P23409	MYF6	Myogenic factor 6	GO:0007519; P:skeletal muscle tissue development; TAS:ProtInc
P23409	MYF6	Myogenic factor 6	GO:0043403; P:skeletal muscle tissue regeneration; IEA:Ensembl
P23409	MYF6	Myogenic factor 6	GO:0001756; P:somitogenesis; IEA:Ensembl
P02144	MB	Myoglobin	GO:0020037; F:heme binding; IEA:InterPro
P02144	MB	Myoglobin	GO:0005506; F:iron ion binding; IEA:InterPro
P02144	MB	Myoglobin	GO:0019825; F:oxygen binding; IEA:Ensembl
P02144	MB	Myoglobin	GO:0005344; F:oxygen transporter activity; IEA:UniProtKB-KW
P02144	MB	Myoglobin	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
P02144	MB	Myoglobin	GO:0043353; P:enucleate erythrocyte differentiation; IEA:Ensembl
P02144	MB	Myoglobin	GO:0007507; P:heart development; IEA:Ensembl
P02144	MB	Myoglobin	GO:0009725; P:response to hormone; IEA:Ensembl
P02144	MB	Myoglobin	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
P02144	MB	Myoglobin	GO:0001666; P:response to hypoxia; IEA:Ensembl
P02144	MB	Myoglobin	GO:0031444; P:slow-twitch skeletal muscle fiber contraction; IEA:Ensembl
P35580	MYH10	Myosin-10	GO:0003779; F:actin binding; NAS:UniProtKB
P35580	MYH10	Myosin-10	GO:0051015; F:actin filament binding; IDA:MGI
P35580	MYH10	Myosin-10	GO:0030898; F:actin-dependent ATPase activity; IDA:MGI
P35580	MYH10	Myosin-10	GO:0043531; F:ADP binding; IDA:MGI
P35580	MYH10	Myosin-10	GO:0005524; F:ATP binding; NAS:UniProtKB
P35580	MYH10	Myosin-10	GO:0000146; F:microfilament motor activity; IDA:MGI
P35580	MYH10	Myosin-10	GO:0005515; F:protein binding; IPI:UniProtKB
P35580	MYH10	Myosin-10	GO:0030048; P:actin filament-based movement; IDA:MGI
P35580	MYH10	Myosin-10	GO:0031032; P:actomyosin structure organization; IMP:UniProt
P35580	MYH10	Myosin-10	GO:0007512; P:adult heart development; IEA:Ensembl
P35580	MYH10	Myosin-10	GO:0006200; P:ATP catabolic process; IMP:UniProt
P35580	MYH10	Myosin-10	GO:0007411; P:axon guidance; TAS:Reactome
P35580	MYH10	Myosin-10	GO:0055003; P:cardiac myofibril assembly; IEA:Ensembl
P35580	MYH10	Myosin-10	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P35580	MYH10	Myosin-10	GO:0008283; P:cell proliferation; IEA:Ensembl
P35580	MYH10	Myosin-10	GO:0021680; P:cerebellar Purkinje cell layer development; IEA:Ensembl
P35580	MYH10	Myosin-10	GO:0006887; P:exocytosis; IEA:Ensembl
P35580	MYH10	Myosin-10	GO:0021592; P:fourth ventricle development; IEA:Ensembl
P35580	MYH10	Myosin-10	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P35580	MYH10	Myosin-10	GO:0021670; P:lateral ventricle development; IEA:Ensembl
P35580	MYH10	Myosin-10	GO:0000281; P:mitotic cytokinesis; IDA:MGI
P35580	MYH10	Myosin-10	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
P35580	MYH10	Myosin-10	GO:0001764; P:neuron migration; IEA:Ensembl
P35580	MYH10	Myosin-10	GO:0007097; P:nuclear migration; IEA:Ensembl
P35580	MYH10	Myosin-10	GO:0001778; P:plasma membrane repair; IEA:Ensembl
P35580	MYH10	Myosin-10	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
P35580	MYH10	Myosin-10	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
P35580	MYH10	Myosin-10	GO:0006930; P:substrate-dependent cell migration, cell extension; IEA:Ensembl
P35580	MYH10	Myosin-10	GO:0021678; P:third ventricle development; IEA:Ensembl
P35580	MYH10	Myosin-10	GO:0055015; P:ventricular cardiac muscle cell development; IEA:Ensembl
Q9UKX3	MYH13	Myosin-13	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UKX3	MYH13	Myosin-13	GO:0000146; F:microfilament motor activity; TAS:UniProtKB
Q9UKX3	MYH13	Myosin-13	GO:0009267; P:cellular response to starvation; IEA:Ensembl
Q9UKX3	MYH13	Myosin-13	GO:0008152; P:metabolic process; TAS:GOC
Q9UKX3	MYH13	Myosin-13	GO:0006936; P:muscle contraction; TAS:UniProtKB
P35749	MYH11	Myosin-11	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P35749	MYH11	Myosin-11	GO:0003774; F:motor activity; IEA:Ensembl
P35749	MYH11	Myosin-11	GO:0005515; F:protein binding; IPI:IntAct
P35749	MYH11	Myosin-11	GO:0008307; F:structural constituent of muscle; IMP:UniProtKB
P35749	MYH11	Myosin-11	GO:0007411; P:axon guidance; TAS:Reactome
P35749	MYH11	Myosin-11	GO:0048739; P:cardiac muscle fiber development; IMP:UniProtKB
P35749	MYH11	Myosin-11	GO:0048251; P:elastic fiber assembly; IMP:UniProtKB
P35749	MYH11	Myosin-11	GO:0006936; P:muscle contraction; TAS:Reactome
P35749	MYH11	Myosin-11	GO:0030241; P:skeletal muscle myosin thick filament assembly; ISS:UniProtKB
P35749	MYH11	Myosin-11	GO:0006939; P:smooth muscle contraction; ISS:UniProtKB
Q7Z406	MYH14	Myosin-14	GO:0030898; F:actin-dependent ATPase activity; IEA:Ensembl
Q7Z406	MYH14	Myosin-14	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q7Z406	MYH14	Myosin-14	GO:0000146; F:microfilament motor activity; IEA:Ensembl
Q7Z406	MYH14	Myosin-14	GO:0030048; P:actin filament-based movement; IEA:Ensembl
Q7Z406	MYH14	Myosin-14	GO:0031032; P:actomyosin structure organization; IDA:UniProt
Q7Z406	MYH14	Myosin-14	GO:0006200; P:ATP catabolic process; IDA:UniProt
Q7Z406	MYH14	Myosin-14	GO:0007411; P:axon guidance; TAS:Reactome
Q7Z406	MYH14	Myosin-14	GO:0070584; P:mitochondrion morphogenesis; IMP:UniProt
Q7Z406	MYH14	Myosin-14	GO:0019228; P:neuronal action potential; IMP:UniProt
Q7Z406	MYH14	Myosin-14	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
Q7Z406	MYH14	Myosin-14	GO:0007605; P:sensory perception of sound; IMP:UniProt
Q7Z406	MYH14	Myosin-14	GO:0014732; P:skeletal muscle atrophy; IMP:UniProt
Q7Z406	MYH14	Myosin-14	GO:0003009; P:skeletal muscle contraction; IMP:UniProt
Q7Z406	MYH14	Myosin-14	GO:0007519; P:skeletal muscle tissue development; IMP:UniProt
Q7Z406	MYH14	Myosin-14	GO:0071625; P:vocalization behavior; IMP:UniProt
Q9Y2K3	MYH15	Myosin-15	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y2K3	MYH15	Myosin-15	GO:0003774; F:motor activity; IEA:InterPro
P12882	MYH1	Myosin-1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P12882	MYH1	Myosin-1	GO:0003774; F:motor activity; IEA:InterPro
P12882	MYH1	Myosin-1	GO:0006936; P:muscle contraction; IEA:Ensembl
Q9UKX2	MYH2	Myosin-2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UKX2	MYH2	Myosin-2	GO:0000146; F:microfilament motor activity; TAS:UniProtKB
Q9UKX2	MYH2	Myosin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKX2	MYH2	Myosin-2	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q9UKX2	MYH2	Myosin-2	GO:0045087; P:innate immune response; TAS:Reactome
Q9UKX2	MYH2	Myosin-2	GO:0061024; P:membrane organization; TAS:Reactome
Q9UKX2	MYH2	Myosin-2	GO:0008152; P:metabolic process; TAS:GOC
Q9UKX2	MYH2	Myosin-2	GO:0006936; P:muscle contraction; TAS:UniProtKB
Q9UKX2	MYH2	Myosin-2	GO:0030049; P:muscle filament sliding; NAS:BHF-UCL
Q9UKX2	MYH2	Myosin-2	GO:0001778; P:plasma membrane repair; IEA:Ensembl
Q9UKX2	MYH2	Myosin-2	GO:0014823; P:response to activity; IEA:Ensembl
P11055	MYH3	Myosin-3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P11055	MYH3	Myosin-3	GO:0042623; F:ATPase activity, coupled; NAS:BHF-UCL
P11055	MYH3	Myosin-3	GO:0005516; F:calmodulin binding; NAS:BHF-UCL
P11055	MYH3	Myosin-3	GO:0000146; F:microfilament motor activity; NAS:UniProtKB
P11055	MYH3	Myosin-3	GO:0030048; P:actin filament-based movement; NAS:UniProtKB
P11055	MYH3	Myosin-3	GO:0006200; P:ATP catabolic process; IMP:BHF-UCL
P11055	MYH3	Myosin-3	GO:0030326; P:embryonic limb morphogenesis; IC:BHF-UCL
P11055	MYH3	Myosin-3	GO:0060325; P:face morphogenesis; IC:BHF-UCL
P11055	MYH3	Myosin-3	GO:0030049; P:muscle filament sliding; TAS:Reactome
P11055	MYH3	Myosin-3	GO:0007517; P:muscle organ development; TAS:ProtInc
P11055	MYH3	Myosin-3	GO:0045214; P:sarcomere organization; NAS:BHF-UCL
P11055	MYH3	Myosin-3	GO:0003009; P:skeletal muscle contraction; IMP:BHF-UCL
Q9Y623	MYH4	Myosin-4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y623	MYH4	Myosin-4	GO:0003725; F:double-stranded RNA binding; IDA:MGI
Q9Y623	MYH4	Myosin-4	GO:0000146; F:microfilament motor activity; NAS:UniProtKB
Q9Y623	MYH4	Myosin-4	GO:0030048; P:actin filament-based movement; NAS:UniProtKB
Q9Y623	MYH4	Myosin-4	GO:0006200; P:ATP catabolic process; NAS:BHF-UCL
Q9Y623	MYH4	Myosin-4	GO:0061024; P:membrane organization; TAS:Reactome
Q9Y623	MYH4	Myosin-4	GO:0006936; P:muscle contraction; IDA:BHF-UCL
Q9Y623	MYH4	Myosin-4	GO:0030049; P:muscle filament sliding; NAS:BHF-UCL
Q9Y623	MYH4	Myosin-4	GO:0014823; P:response to activity; IEA:Ensembl
A7E2Y1	MYH7B	Myosin-7B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
A7E2Y1	MYH7B	Myosin-7B	GO:0003774; F:motor activity; IEA:InterPro
A7E2Y1	MYH7B	Myosin-7B	GO:0005515; F:protein binding; IPI:IntAct
P13533	MYH6	Myosin-6	GO:0030898; F:actin-dependent ATPase activity; IMP:HGNC
P13533	MYH6	Myosin-6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P13533	MYH6	Myosin-6	GO:0016887; F:ATPase activity; IDA:HGNC
P13533	MYH6	Myosin-6	GO:0000146; F:microfilament motor activity; IDA:BHF-UCL
P13533	MYH6	Myosin-6	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P13533	MYH6	Myosin-6	GO:0007512; P:adult heart development; IMP:HGNC
P13533	MYH6	Myosin-6	GO:0006200; P:ATP catabolic process; IMP:BHF-UCL
P13533	MYH6	Myosin-6	GO:0055009; P:atrial cardiac muscle tissue morphogenesis; IMP:HGNC
P13533	MYH6	Myosin-6	GO:0030509; P:BMP signaling pathway; IEA:Ensembl
P13533	MYH6	Myosin-6	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
P13533	MYH6	Myosin-6	GO:0048739; P:cardiac muscle fiber development; ISS:BHF-UCL
P13533	MYH6	Myosin-6	GO:0001701; P:in utero embryonic development; ISS:BHF-UCL
P13533	MYH6	Myosin-6	GO:0006936; P:muscle contraction; IDA:HGNC
P13533	MYH6	Myosin-6	GO:0030049; P:muscle filament sliding; IMP:HGNC
P13533	MYH6	Myosin-6	GO:0030239; P:myofibril assembly; ISS:BHF-UCL
P13533	MYH6	Myosin-6	GO:0043462; P:regulation of ATPase activity; ISS:BHF-UCL
P13533	MYH6	Myosin-6	GO:0008217; P:regulation of blood pressure; ISS:BHF-UCL
P13533	MYH6	Myosin-6	GO:0008016; P:regulation of heart contraction; ISS:BHF-UCL
P13533	MYH6	Myosin-6	GO:0060420; P:regulation of heart growth; IEA:Ensembl
P13533	MYH6	Myosin-6	GO:0002027; P:regulation of heart rate; IDA:HGNC
P13533	MYH6	Myosin-6	GO:0002026; P:regulation of the force of heart contraction; IDA:BHF-UCL
P13533	MYH6	Myosin-6	GO:0045214; P:sarcomere organization; ISS:BHF-UCL
P13533	MYH6	Myosin-6	GO:0006941; P:striated muscle contraction; IMP:BHF-UCL
P13533	MYH6	Myosin-6	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IMP:HGNC
P13533	MYH6	Myosin-6	GO:0007522; P:visceral muscle development; ISS:BHF-UCL
P12883	MYH7	Myosin-7	GO:0030898; F:actin-dependent ATPase activity; IMP:HGNC
P12883	MYH7	Myosin-7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P12883	MYH7	Myosin-7	GO:0016887; F:ATPase activity; IDA:HGNC
P12883	MYH7	Myosin-7	GO:0000146; F:microfilament motor activity; NAS:UniProtKB
P12883	MYH7	Myosin-7	GO:0005515; F:protein binding; IPI:BHF-UCL
P12883	MYH7	Myosin-7	GO:0007512; P:adult heart development; IMP:HGNC
P12883	MYH7	Myosin-7	GO:0006200; P:ATP catabolic process; IDA:BHF-UCL
P12883	MYH7	Myosin-7	GO:0006936; P:muscle contraction; IDA:HGNC
P12883	MYH7	Myosin-7	GO:0030049; P:muscle filament sliding; IMP:HGNC
P12883	MYH7	Myosin-7	GO:0002027; P:regulation of heart rate; IDA:HGNC
P12883	MYH7	Myosin-7	GO:0002026; P:regulation of the force of heart contraction; IDA:BHF-UCL
P12883	MYH7	Myosin-7	GO:0006941; P:striated muscle contraction; IDA:BHF-UCL
P12883	MYH7	Myosin-7	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IMP:BHF-UCL
P13535	MYH8	Myosin-8	GO:0051015; F:actin filament binding; TAS:BHF-UCL
P13535	MYH8	Myosin-8	GO:0005524; F:ATP binding; IMP:BHF-UCL
P13535	MYH8	Myosin-8	GO:0016887; F:ATPase activity; IMP:BHF-UCL
P13535	MYH8	Myosin-8	GO:0000146; F:microfilament motor activity; IMP:BHF-UCL
P13535	MYH8	Myosin-8	GO:0032027; F:myosin light chain binding; TAS:BHF-UCL
P13535	MYH8	Myosin-8	GO:0008307; F:structural constituent of muscle; NAS:UniProtKB
P13535	MYH8	Myosin-8	GO:0006200; P:ATP catabolic process; IMP:BHF-UCL
P13535	MYH8	Myosin-8	GO:0006936; P:muscle contraction; NAS:UniProtKB
P13535	MYH8	Myosin-8	GO:0030049; P:muscle filament sliding; IMP:BHF-UCL
P13535	MYH8	Myosin-8	GO:0003009; P:skeletal muscle contraction; IMP:BHF-UCL
P35579	MYH9	Myosin-9	GO:0003779; F:actin binding; IDA:MGI
P35579	MYH9	Myosin-9	GO:0051015; F:actin filament binding; IDA:UniProtKB
P35579	MYH9	Myosin-9	GO:0030898; F:actin-dependent ATPase activity; IDA:MGI
P35579	MYH9	Myosin-9	GO:0043531; F:ADP binding; IDA:MGI
P35579	MYH9	Myosin-9	GO:0005524; F:ATP binding; IDA:MGI
P35579	MYH9	Myosin-9	GO:0016887; F:ATPase activity; IDA:UniProtKB
P35579	MYH9	Myosin-9	GO:0000146; F:microfilament motor activity; IDA:UniProtKB
P35579	MYH9	Myosin-9	GO:0003774; F:motor activity; NAS:UniProtKB
P35579	MYH9	Myosin-9	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P35579	MYH9	Myosin-9	GO:0043495; F:protein anchor; IMP:UniProtKB
P35579	MYH9	Myosin-9	GO:0005515; F:protein binding; IPI:UniProtKB
P35579	MYH9	Myosin-9	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P35579	MYH9	Myosin-9	GO:0031532; P:actin cytoskeleton reorganization; IMP:UniProtKB
P35579	MYH9	Myosin-9	GO:0030048; P:actin filament-based movement; IDA:UniProtKB
P35579	MYH9	Myosin-9	GO:0031032; P:actomyosin structure organization; IDA:UniProt
P35579	MYH9	Myosin-9	GO:0001525; P:angiogenesis; IDA:UniProtKB
P35579	MYH9	Myosin-9	GO:0006200; P:ATP catabolic process; IDA:UniProt
P35579	MYH9	Myosin-9	GO:0007411; P:axon guidance; TAS:Reactome
P35579	MYH9	Myosin-9	GO:0043534; P:blood vessel endothelial cell migration; IMP:UniProtKB
P35579	MYH9	Myosin-9	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
P35579	MYH9	Myosin-9	GO:0000910; P:cytokinesis; IMP:UniProtKB
P35579	MYH9	Myosin-9	GO:0051295; P:establishment of meiotic spindle localization; IEA:Ensembl
P35579	MYH9	Myosin-9	GO:0001768; P:establishment of T cell polarity; IEA:Ensembl
P35579	MYH9	Myosin-9	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P35579	MYH9	Myosin-9	GO:0007229; P:integrin-mediated signaling pathway; NAS:UniProtKB
P35579	MYH9	Myosin-9	GO:0050900; P:leukocyte migration; NAS:UniProtKB
P35579	MYH9	Myosin-9	GO:0000212; P:meiotic spindle organization; IEA:Ensembl
P35579	MYH9	Myosin-9	GO:0006509; P:membrane protein ectodomain proteolysis; IDA:UniProtKB
P35579	MYH9	Myosin-9	GO:0030224; P:monocyte differentiation; IEP:UniProtKB
P35579	MYH9	Myosin-9	GO:0007520; P:myoblast fusion; IEA:Ensembl
P35579	MYH9	Myosin-9	GO:0030220; P:platelet formation; IMP:UniProtKB
P35579	MYH9	Myosin-9	GO:0015031; P:protein transport; IMP:UniProtKB
P35579	MYH9	Myosin-9	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
P35579	MYH9	Myosin-9	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
P35579	MYH9	Myosin-9	GO:0032796; P:uropod organization; IEA:Ensembl
Q9BUA6	MYL10	Myosin regulatory light chain 10	GO:0005509; F:calcium ion binding; IEA:InterPro
P05976	MYL1	Myosin light chain 1/3, skeletal muscle isoform	GO:0005509; F:calcium ion binding; IEA:InterPro
P05976	MYL1	Myosin light chain 1/3, skeletal muscle isoform	GO:0008307; F:structural constituent of muscle; NAS:BHF-UCL
P05976	MYL1	Myosin light chain 1/3, skeletal muscle isoform	GO:0060048; P:cardiac muscle contraction; IEA:Ensembl
P05976	MYL1	Myosin light chain 1/3, skeletal muscle isoform	GO:0006936; P:muscle contraction; IDA:BHF-UCL
P05976	MYL1	Myosin light chain 1/3, skeletal muscle isoform	GO:0030049; P:muscle filament sliding; NAS:BHF-UCL
P08590	MYL3	Myosin light chain 3	GO:0003785; F:actin monomer binding; IDA:BHF-UCL
P08590	MYL3	Myosin light chain 3	GO:0005509; F:calcium ion binding; IEA:InterPro
P08590	MYL3	Myosin light chain 3	GO:0003774; F:motor activity; IEA:Ensembl
P08590	MYL3	Myosin light chain 3	GO:0032038; F:myosin II heavy chain binding; NAS:BHF-UCL
P08590	MYL3	Myosin light chain 3	GO:0008307; F:structural constituent of muscle; TAS:ProtInc
P08590	MYL3	Myosin light chain 3	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
P08590	MYL3	Myosin light chain 3	GO:0030049; P:muscle filament sliding; TAS:Reactome
P08590	MYL3	Myosin light chain 3	GO:0032781; P:positive regulation of ATPase activity; ISS:BHF-UCL
P08590	MYL3	Myosin light chain 3	GO:0006942; P:regulation of striated muscle contraction; IMP:BHF-UCL
P08590	MYL3	Myosin light chain 3	GO:0002026; P:regulation of the force of heart contraction; IMP:BHF-UCL
P08590	MYL3	Myosin light chain 3	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
P08590	MYL3	Myosin light chain 3	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IMP:BHF-UCL
P12829	MYL4	Myosin light chain 4	GO:0051015; F:actin filament binding; IMP:BHF-UCL
P12829	MYL4	Myosin light chain 4	GO:0003785; F:actin monomer binding; IDA:BHF-UCL
P12829	MYL4	Myosin light chain 4	GO:0005509; F:calcium ion binding; IEA:InterPro
P12829	MYL4	Myosin light chain 4	GO:0032038; F:myosin II heavy chain binding; NAS:BHF-UCL
P12829	MYL4	Myosin light chain 4	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
P12829	MYL4	Myosin light chain 4	GO:0030049; P:muscle filament sliding; TAS:Reactome
P12829	MYL4	Myosin light chain 4	GO:0032781; P:positive regulation of ATPase activity; IMP:BHF-UCL
P12829	MYL4	Myosin light chain 4	GO:0002026; P:regulation of the force of heart contraction; IMP:BHF-UCL
Q02045	MYL5	Myosin light chain 5	GO:0005509; F:calcium ion binding; IEA:InterPro
Q02045	MYL5	Myosin light chain 5	GO:0008307; F:structural constituent of muscle; TAS:ProtInc
Q02045	MYL5	Myosin light chain 5	GO:0006937; P:regulation of muscle contraction; TAS:ProtInc
P14649	MYL6B	Myosin light chain 6B	GO:0005509; F:calcium ion binding; IEA:InterPro
P14649	MYL6B	Myosin light chain 6B	GO:0003774; F:motor activity; TAS:HGNC
P14649	MYL6B	Myosin light chain 6B	GO:0005515; F:protein binding; IPI:IntAct
P14649	MYL6B	Myosin light chain 6B	GO:0008307; F:structural constituent of muscle; TAS:HGNC
P14649	MYL6B	Myosin light chain 6B	GO:0008152; P:metabolic process; TAS:GOC
P14649	MYL6B	Myosin light chain 6B	GO:0006936; P:muscle contraction; TAS:HGNC
P14649	MYL6B	Myosin light chain 6B	GO:0030049; P:muscle filament sliding; TAS:HGNC
P14649	MYL6B	Myosin light chain 6B	GO:0007519; P:skeletal muscle tissue development; TAS:HGNC
P24844	MYL9	Myosin regulatory light polypeptide 9	GO:0005509; F:calcium ion binding; IEA:InterPro
P24844	MYL9	Myosin regulatory light polypeptide 9	GO:0008307; F:structural constituent of muscle; TAS:ProtInc
P24844	MYL9	Myosin regulatory light polypeptide 9	GO:0007411; P:axon guidance; TAS:Reactome
P24844	MYL9	Myosin regulatory light polypeptide 9	GO:0006936; P:muscle contraction; TAS:Reactome
P24844	MYL9	Myosin regulatory light polypeptide 9	GO:0006937; P:regulation of muscle contraction; TAS:ProtInc
P60660	MYL6	Myosin light polypeptide 6	GO:0030898; F:actin-dependent ATPase activity; ISS:HGNC
P60660	MYL6	Myosin light polypeptide 6	GO:0005509; F:calcium ion binding; IEA:InterPro
P60660	MYL6	Myosin light polypeptide 6	GO:0003774; F:motor activity; TAS:HGNC
P60660	MYL6	Myosin light polypeptide 6	GO:0005515; F:protein binding; IPI:IntAct
P60660	MYL6	Myosin light polypeptide 6	GO:0008307; F:structural constituent of muscle; IDA:HGNC
P60660	MYL6	Myosin light polypeptide 6	GO:0006200; P:ATP catabolic process; ISS:GOC
P60660	MYL6	Myosin light polypeptide 6	GO:0007411; P:axon guidance; TAS:Reactome
P60660	MYL6	Myosin light polypeptide 6	GO:0008152; P:metabolic process; TAS:GOC
P60660	MYL6	Myosin light polypeptide 6	GO:0006936; P:muscle contraction; TAS:HGNC
P60660	MYL6	Myosin light polypeptide 6	GO:0030049; P:muscle filament sliding; TAS:HGNC
P60660	MYL6	Myosin light polypeptide 6	GO:0007519; P:skeletal muscle tissue development; TAS:UniProtKB
Q8WY64	MYLIP	E3 ubiquitin-protein ligase MYLIP	GO:0008092; F:cytoskeletal protein binding; IDA:UniProtKB
Q8WY64	MYLIP	E3 ubiquitin-protein ligase MYLIP	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WY64	MYLIP	E3 ubiquitin-protein ligase MYLIP	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q8WY64	MYLIP	E3 ubiquitin-protein ligase MYLIP	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WY64	MYLIP	E3 ubiquitin-protein ligase MYLIP	GO:0006928; P:cellular component movement; IMP:UniProtKB
Q8WY64	MYLIP	E3 ubiquitin-protein ligase MYLIP	GO:0042632; P:cholesterol homeostasis; IEA:Ensembl
Q8WY64	MYLIP	E3 ubiquitin-protein ligase MYLIP	GO:0010989; P:negative regulation of low-density lipoprotein particle clearance; IEA:Ensembl
Q8WY64	MYLIP	E3 ubiquitin-protein ligase MYLIP	GO:0007399; P:nervous system development; IMP:UniProtKB
Q8WY64	MYLIP	E3 ubiquitin-protein ligase MYLIP	GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl
Q8WY64	MYLIP	E3 ubiquitin-protein ligase MYLIP	GO:0031648; P:protein destabilization; IEA:Ensembl
Q8WY64	MYLIP	E3 ubiquitin-protein ligase MYLIP	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q8WY64	MYLIP	E3 ubiquitin-protein ligase MYLIP	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q8WY64	MYLIP	E3 ubiquitin-protein ligase MYLIP	GO:0032803; P:regulation of low-density lipoprotein particle receptor catabolic process; IEA:Ensembl
Q9H1R3	MYLK2	Myosin light chain kinase 2, skeletal/cardiac muscle	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H1R3	MYLK2	Myosin light chain kinase 2, skeletal/cardiac muscle	GO:0005516; F:calmodulin binding; ISS:BHF-UCL
Q9H1R3	MYLK2	Myosin light chain kinase 2, skeletal/cardiac muscle	GO:0004683; F:calmodulin-dependent protein kinase activity; ISS:BHF-UCL
Q9H1R3	MYLK2	Myosin light chain kinase 2, skeletal/cardiac muscle	GO:0004687; F:myosin light chain kinase activity; IDA:BHF-UCL
Q9H1R3	MYLK2	Myosin light chain kinase 2, skeletal/cardiac muscle	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H1R3	MYLK2	Myosin light chain kinase 2, skeletal/cardiac muscle	GO:0060048; P:cardiac muscle contraction; IC:BHF-UCL
Q9H1R3	MYLK2	Myosin light chain kinase 2, skeletal/cardiac muscle	GO:0055008; P:cardiac muscle tissue morphogenesis; IMP:BHF-UCL
Q9H1R3	MYLK2	Myosin light chain kinase 2, skeletal/cardiac muscle	GO:0007274; P:neuromuscular synaptic transmission; IEA:Ensembl
Q9H1R3	MYLK2	Myosin light chain kinase 2, skeletal/cardiac muscle	GO:0018107; P:peptidyl-threonine phosphorylation; IDA:UniProtKB
Q9H1R3	MYLK2	Myosin light chain kinase 2, skeletal/cardiac muscle	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
Q9H1R3	MYLK2	Myosin light chain kinase 2, skeletal/cardiac muscle	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q9H1R3	MYLK2	Myosin light chain kinase 2, skeletal/cardiac muscle	GO:0032971; P:regulation of muscle filament sliding; IDA:BHF-UCL
Q9H1R3	MYLK2	Myosin light chain kinase 2, skeletal/cardiac muscle	GO:0014816; P:satellite cell differentiation; IEA:Ensembl
Q9H1R3	MYLK2	Myosin light chain kinase 2, skeletal/cardiac muscle	GO:0035914; P:skeletal muscle cell differentiation; IDA:UniProtKB
Q9H1R3	MYLK2	Myosin light chain kinase 2, skeletal/cardiac muscle	GO:0006941; P:striated muscle contraction; IDA:BHF-UCL
Q32MK0	MYLK3	Myosin light chain kinase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q32MK0	MYLK3	Myosin light chain kinase 3	GO:0004683; F:calmodulin-dependent protein kinase activity; ISS:BHF-UCL
Q32MK0	MYLK3	Myosin light chain kinase 3	GO:0004687; F:myosin light chain kinase activity; ISS:BHF-UCL
Q32MK0	MYLK3	Myosin light chain kinase 3	GO:0055003; P:cardiac myofibril assembly; ISS:BHF-UCL
Q32MK0	MYLK3	Myosin light chain kinase 3	GO:0071347; P:cellular response to interleukin-1; IMP:BHF-UCL
Q32MK0	MYLK3	Myosin light chain kinase 3	GO:0060298; P:positive regulation of sarcomere organization; ISS:BHF-UCL
Q32MK0	MYLK3	Myosin light chain kinase 3	GO:0006468; P:protein phosphorylation; ISS:BHF-UCL
Q32MK0	MYLK3	Myosin light chain kinase 3	GO:0002528; P:regulation of vascular permeability involved in acute inflammatory response; IMP:BHF-UCL
Q32MK0	MYLK3	Myosin light chain kinase 3	GO:0045214; P:sarcomere organization; ISS:BHF-UCL
Q32MK0	MYLK3	Myosin light chain kinase 3	GO:0048769; P:sarcomerogenesis; ISS:BHF-UCL
Q86YV6	MYLK4	Myosin light chain kinase family member 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86YV6	MYLK4	Myosin light chain kinase family member 4	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q15746	MYLK	Myosin light chain kinase, smooth muscle	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q15746	MYLK	Myosin light chain kinase, smooth muscle	GO:0004683; F:calmodulin-dependent protein kinase activity; IBA:RefGenome
Q15746	MYLK	Myosin light chain kinase, smooth muscle	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15746	MYLK	Myosin light chain kinase, smooth muscle	GO:0004687; F:myosin light chain kinase activity; IDA:UniProtKB
Q15746	MYLK	Myosin light chain kinase, smooth muscle	GO:0005515; F:protein binding; IPI:IntAct
Q15746	MYLK	Myosin light chain kinase, smooth muscle	GO:0007015; P:actin filament organization; IBA:RefGenome
Q15746	MYLK	Myosin light chain kinase, smooth muscle	GO:0060414; P:aorta smooth muscle tissue morphogenesis; IMP:BHF-UCL
Q15746	MYLK	Myosin light chain kinase, smooth muscle	GO:0032060; P:bleb assembly; IMP:UniProtKB
Q15746	MYLK	Myosin light chain kinase, smooth muscle	GO:0071476; P:cellular hypotonic response; IDA:UniProtKB
Q15746	MYLK	Myosin light chain kinase, smooth muscle	GO:0006936; P:muscle contraction; TAS:Reactome
Q15746	MYLK	Myosin light chain kinase, smooth muscle	GO:0051928; P:positive regulation of calcium ion transport; IDA:UniProtKB
Q15746	MYLK	Myosin light chain kinase, smooth muscle	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
Q15746	MYLK	Myosin light chain kinase, smooth muscle	GO:0090303; P:positive regulation of wound healing; IDA:UniProtKB
Q15746	MYLK	Myosin light chain kinase, smooth muscle	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q15746	MYLK	Myosin light chain kinase, smooth muscle	GO:0006939; P:smooth muscle contraction; ISS:UniProtKB
Q15746	MYLK	Myosin light chain kinase, smooth muscle	GO:0014820; P:tonic smooth muscle contraction; ISS:UniProtKB
Q9NPC7	MYNN	Myoneurin	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NPC7	MYNN	Myoneurin	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9NPC7	MYNN	Myoneurin	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q9NPC7	MYNN	Myoneurin	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9NPC7	MYNN	Myoneurin	GO:0006351; P:transcription, DNA-templated; TAS:ProtInc
Q9HD67	MYO10	Unconventional myosin-X	GO:0051015; F:actin filament binding; ISS:UniProtKB
Q9HD67	MYO10	Unconventional myosin-X	GO:0030898; F:actin-dependent ATPase activity; ISS:UniProtKB
Q9HD67	MYO10	Unconventional myosin-X	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9HD67	MYO10	Unconventional myosin-X	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; ISS:UniProtKB
Q9HD67	MYO10	Unconventional myosin-X	GO:0060002; F:plus-end directed microfilament motor activity; ISS:UniProtKB
Q9HD67	MYO10	Unconventional myosin-X	GO:0005515; F:protein binding; IPI:IntAct
Q9HD67	MYO10	Unconventional myosin-X	GO:0030507; F:spectrin binding; IDA:MGI
Q9HD67	MYO10	Unconventional myosin-X	GO:0006200; P:ATP catabolic process; ISS:GOC
Q9HD67	MYO10	Unconventional myosin-X	GO:0007411; P:axon guidance; TAS:Reactome
Q9HD67	MYO10	Unconventional myosin-X	GO:0030705; P:cytoskeleton-dependent intracellular transport; ISS:UniProtKB
Q9HD67	MYO10	Unconventional myosin-X	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q9HD67	MYO10	Unconventional myosin-X	GO:0045087; P:innate immune response; TAS:Reactome
Q9HD67	MYO10	Unconventional myosin-X	GO:0008152; P:metabolic process; ISS:GOC
Q9HD67	MYO10	Unconventional myosin-X	GO:0022409; P:positive regulation of cell-cell adhesion; IEA:Ensembl
Q9HD67	MYO10	Unconventional myosin-X	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
Q9HD67	MYO10	Unconventional myosin-X	GO:0051489; P:regulation of filopodium assembly; IMP:UniProtKB
Q9UKN7	MYO15A	Unconventional myosin-XV	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UKN7	MYO15A	Unconventional myosin-XV	GO:0003774; F:motor activity; IEA:InterPro
Q9UKN7	MYO15A	Unconventional myosin-XV	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q9UKN7	MYO15A	Unconventional myosin-XV	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q9UKN7	MYO15A	Unconventional myosin-XV	GO:0007605; P:sensory perception of sound; TAS:ProtInc
Q9Y6X6	MYO16	Unconventional myosin-XVI	GO:0051015; F:actin filament binding; ISS:HGNC
Q9Y6X6	MYO16	Unconventional myosin-XVI	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y6X6	MYO16	Unconventional myosin-XVI	GO:0003774; F:motor activity; IEA:InterPro
Q9Y6X6	MYO16	Unconventional myosin-XVI	GO:0021549; P:cerebellum development; ISS:HGNC
Q9Y6X6	MYO16	Unconventional myosin-XVI	GO:0008285; P:negative regulation of cell proliferation; ISS:HGNC
Q9Y6X6	MYO16	Unconventional myosin-XVI	GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; ISS:BHF-UCL
Q9Y6X6	MYO16	Unconventional myosin-XVI	GO:0048812; P:neuron projection morphogenesis; IEA:Ensembl
Q9Y6X6	MYO16	Unconventional myosin-XVI	GO:0014065; P:phosphatidylinositol 3-kinase signaling; IEA:Ensembl
Q96H55	MYO19	Unconventional myosin-XIX	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96H55	MYO19	Unconventional myosin-XIX	GO:0003774; F:motor activity; IEA:InterPro
Q9UBC5	MYO1A	Unconventional myosin-Ia	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UBC5	MYO1A	Unconventional myosin-Ia	GO:0003774; F:motor activity; IEA:InterPro
Q9UBC5	MYO1A	Unconventional myosin-Ia	GO:0030033; P:microvillus assembly; IEA:Ensembl
Q9UBC5	MYO1A	Unconventional myosin-Ia	GO:0007605; P:sensory perception of sound; IMP:UniProtKB
Q9UBC5	MYO1A	Unconventional myosin-Ia	GO:0051648; P:vesicle localization; IMP:UniProtKB
O43795	MYO1B	Unconventional myosin-Ib	GO:0005524; F:ATP binding; ISS:UniProtKB
O43795	MYO1B	Unconventional myosin-Ib	GO:0000146; F:microfilament motor activity; ISS:UniProtKB
O43795	MYO1B	Unconventional myosin-Ib	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; ISS:UniProtKB
O43795	MYO1B	Unconventional myosin-Ib	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISS:UniProtKB
O43795	MYO1B	Unconventional myosin-Ib	GO:0051017; P:actin filament bundle assembly; ISS:UniProtKB
O43795	MYO1B	Unconventional myosin-Ib	GO:0030048; P:actin filament-based movement; ISS:UniProtKB
O43795	MYO1B	Unconventional myosin-Ib	GO:0008152; P:metabolic process; ISS:GOC
O00159	MYO1C	Unconventional myosin-Ic	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O00159	MYO1C	Unconventional myosin-Ic	GO:0003774; F:motor activity; IEA:InterPro
O00159	MYO1C	Unconventional myosin-Ic	GO:0005515; F:protein binding; IPI:UniProtKB
O00159	MYO1C	Unconventional myosin-Ic	GO:0005102; F:receptor binding; IPI:UniProtKB
O00159	MYO1C	Unconventional myosin-Ic	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
O00159	MYO1C	Unconventional myosin-Ic	GO:0045087; P:innate immune response; TAS:Reactome
O00159	MYO1C	Unconventional myosin-Ic	GO:0061024; P:membrane organization; TAS:Reactome
O00159	MYO1C	Unconventional myosin-Ic	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
O00159	MYO1C	Unconventional myosin-Ic	GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB
O00159	MYO1C	Unconventional myosin-Ic	GO:0038089; P:positive regulation of cell migration by vascular endothelial growth factor signaling pathway; IMP:UniProtKB
O00159	MYO1C	Unconventional myosin-Ic	GO:0090314; P:positive regulation of protein targeting to membrane; IMP:UniProtKB
O00159	MYO1C	Unconventional myosin-Ic	GO:1900748; P:positive regulation of vascular endothelial growth factor signaling pathway; IMP:UniProtKB
O00159	MYO1C	Unconventional myosin-Ic	GO:0006605; P:protein targeting; IDA:UniProtKB
O00159	MYO1C	Unconventional myosin-Ic	GO:0006612; P:protein targeting to membrane; IDA:UniProtKB
O00159	MYO1C	Unconventional myosin-Ic	GO:2000810; P:regulation of tight junction assembly; IMP:UniProtKB
O94832	MYO1D	Unconventional myosin-Id	GO:0030898; F:actin-dependent ATPase activity; IEA:Ensembl
O94832	MYO1D	Unconventional myosin-Id	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O94832	MYO1D	Unconventional myosin-Id	GO:0000146; F:microfilament motor activity; IEA:Ensembl
O94832	MYO1D	Unconventional myosin-Id	GO:0061502; P:early endosome to recycling endosome transport; ISS:UniProt
O94832	MYO1D	Unconventional myosin-Id	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
O00160	MYO1F	Unconventional myosin-If	GO:0003779; F:actin binding; NAS:UniProtKB
O00160	MYO1F	Unconventional myosin-If	GO:0005524; F:ATP binding; NAS:UniProtKB
O00160	MYO1F	Unconventional myosin-If	GO:0003774; F:motor activity; IEA:InterPro
O00160	MYO1F	Unconventional myosin-If	GO:0050830; P:defense response to Gram-positive bacterium; IEA:Ensembl
O00160	MYO1F	Unconventional myosin-If	GO:0007162; P:negative regulation of cell adhesion; IEA:Ensembl
O00160	MYO1F	Unconventional myosin-If	GO:0043312; P:neutrophil degranulation; IEA:Ensembl
O00160	MYO1F	Unconventional myosin-If	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
O00160	MYO1F	Unconventional myosin-If	GO:0032956; P:regulation of actin cytoskeleton organization; IEA:Ensembl
O00160	MYO1F	Unconventional myosin-If	GO:0045088; P:regulation of innate immune response; IEA:Ensembl
B0I1T2	MYO1G	Unconventional myosin-Ig	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
B0I1T2	MYO1G	Unconventional myosin-Ig	GO:0003774; F:motor activity; IEA:InterPro
Q8N1T3	MYO1H	Unconventional myosin-Ih	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8N1T3	MYO1H	Unconventional myosin-Ih	GO:0003774; F:motor activity; IEA:InterPro
Q12965	MYO1E	Unconventional myosin-Ie	GO:0051015; F:actin filament binding; IDA:UniProtKB
Q12965	MYO1E	Unconventional myosin-Ie	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q12965	MYO1E	Unconventional myosin-Ie	GO:0042623; F:ATPase activity, coupled; IDA:UniProtKB
Q12965	MYO1E	Unconventional myosin-Ie	GO:0005516; F:calmodulin binding; IDA:UniProtKB
Q12965	MYO1E	Unconventional myosin-Ie	GO:0000146; F:microfilament motor activity; TAS:UniProtKB
Q12965	MYO1E	Unconventional myosin-Ie	GO:0003774; F:motor activity; TAS:ProtInc
Q12965	MYO1E	Unconventional myosin-Ie	GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB
Q12965	MYO1E	Unconventional myosin-Ie	GO:0005515; F:protein binding; IPI:IntAct
Q12965	MYO1E	Unconventional myosin-Ie	GO:0030048; P:actin filament-based movement; TAS:UniProtKB
Q12965	MYO1E	Unconventional myosin-Ie	GO:0006200; P:ATP catabolic process; IDA:GOC
Q12965	MYO1E	Unconventional myosin-Ie	GO:0006897; P:endocytosis; IMP:UniProtKB
Q12965	MYO1E	Unconventional myosin-Ie	GO:0032836; P:glomerular basement membrane development; ISS:UniProtKB
Q12965	MYO1E	Unconventional myosin-Ie	GO:0003094; P:glomerular filtration; ISS:UniProtKB
Q12965	MYO1E	Unconventional myosin-Ie	GO:0072015; P:glomerular visceral epithelial cell development; ISS:UniProtKB
Q12965	MYO1E	Unconventional myosin-Ie	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q12965	MYO1E	Unconventional myosin-Ie	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IEA:Ensembl
Q12965	MYO1E	Unconventional myosin-Ie	GO:0035166; P:post-embryonic hemopoiesis; IEA:Ensembl
Q12965	MYO1E	Unconventional myosin-Ie	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q8NEV4	MYO3A	Myosin-IIIa	GO:0030898; F:actin-dependent ATPase activity; IDA:UniProtKB
Q8NEV4	MYO3A	Myosin-IIIa	GO:0043531; F:ADP binding; IDA:UniProtKB
Q8NEV4	MYO3A	Myosin-IIIa	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NEV4	MYO3A	Myosin-IIIa	GO:0005516; F:calmodulin binding; IDA:UniProtKB
Q8NEV4	MYO3A	Myosin-IIIa	GO:0000146; F:microfilament motor activity; IDA:UniProtKB
Q8NEV4	MYO3A	Myosin-IIIa	GO:0060002; F:plus-end directed microfilament motor activity; IDA:UniProtKB
Q8NEV4	MYO3A	Myosin-IIIa	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q8NEV4	MYO3A	Myosin-IIIa	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q8NEV4	MYO3A	Myosin-IIIa	GO:0006200; P:ATP catabolic process; IDA:GOC
Q8NEV4	MYO3A	Myosin-IIIa	GO:0048839; P:inner ear development; IEA:Ensembl
Q8NEV4	MYO3A	Myosin-IIIa	GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl
Q8NEV4	MYO3A	Myosin-IIIa	GO:0018107; P:peptidyl-threonine phosphorylation; IEA:Ensembl
Q8NEV4	MYO3A	Myosin-IIIa	GO:0051491; P:positive regulation of filopodium assembly; IEA:Ensembl
Q8NEV4	MYO3A	Myosin-IIIa	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q8NEV4	MYO3A	Myosin-IIIa	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q8NEV4	MYO3A	Myosin-IIIa	GO:0007605; P:sensory perception of sound; IMP:UniProtKB
Q8NEV4	MYO3A	Myosin-IIIa	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q8WXR4	MYO3B	Myosin-IIIb	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8WXR4	MYO3B	Myosin-IIIb	GO:0000146; F:microfilament motor activity; IEA:Ensembl
Q8WXR4	MYO3B	Myosin-IIIb	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q8WXR4	MYO3B	Myosin-IIIb	GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl
Q8WXR4	MYO3B	Myosin-IIIb	GO:0018107; P:peptidyl-threonine phosphorylation; IEA:Ensembl
Q8WXR4	MYO3B	Myosin-IIIb	GO:0051491; P:positive regulation of filopodium assembly; IEA:Ensembl
Q8WXR4	MYO3B	Myosin-IIIb	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
Q8WXR4	MYO3B	Myosin-IIIb	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q8WXR4	MYO3B	Myosin-IIIb	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0005509; F:calcium ion binding; IEA:Ensembl
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0000146; F:microfilament motor activity; NAS:UniProtKB
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0030048; P:actin filament-based movement; NAS:UniProtKB
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0042640; P:anagen; IEA:Ensembl
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0032869; P:cellular response to insulin stimulus; ISS:UniProtKB
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0051643; P:endoplasmic reticulum localization; IEA:Ensembl
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0006887; P:exocytosis; IEA:Ensembl
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0030073; P:insulin secretion; IEA:Ensembl
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0031987; P:locomotion involved in locomotory behavior; IEA:Ensembl
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0042759; P:long-chain fatty acid biosynthetic process; IEA:Ensembl
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0042438; P:melanin biosynthetic process; IEA:Ensembl
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0030318; P:melanocyte differentiation; IEA:Ensembl
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0032402; P:melanosome transport; IEA:Ensembl
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0061024; P:membrane organization; TAS:Reactome
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0042552; P:myelination; IEA:Ensembl
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0042476; P:odontogenesis; IEA:Ensembl
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0072659; P:protein localization to plasma membrane; ISS:UniProtKB
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0031585; P:regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; IEA:Ensembl
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0032252; P:secretory granule localization; IEA:Ensembl
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0050808; P:synapse organization; IEA:Ensembl
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0007268; P:synaptic transmission; IEA:Ensembl
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0006810; P:transport; NAS:UniProtKB
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0016192; P:vesicle-mediated transport; ISS:UniProtKB
Q9Y4I1	MYO5A	Unconventional myosin-Va	GO:0007601; P:visual perception; IEA:Ensembl
Q9ULV0	MYO5B	Unconventional myosin-Vb	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9ULV0	MYO5B	Unconventional myosin-Vb	GO:0000146; F:microfilament motor activity; TAS:Reactome
Q9ULV0	MYO5B	Unconventional myosin-Vb	GO:0005515; F:protein binding; IPI:UniProtKB
Q9ULV0	MYO5B	Unconventional myosin-Vb	GO:0017137; F:Rab GTPase binding; IPI:UniProtKB
Q9ULV0	MYO5B	Unconventional myosin-Vb	GO:0008152; P:metabolic process; TAS:GOC
Q9ULV0	MYO5B	Unconventional myosin-Vb	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9ULV0	MYO5B	Unconventional myosin-Vb	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9ULV0	MYO5B	Unconventional myosin-Vb	GO:0016192; P:vesicle-mediated transport; IMP:UniProtKB
Q9ULV0	MYO5B	Unconventional myosin-Vb	GO:0006833; P:water transport; TAS:Reactome
Q9NQX4	MYO5C	Unconventional myosin-Vc	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NQX4	MYO5C	Unconventional myosin-Vc	GO:0003774; F:motor activity; IEA:InterPro
Q9UM54	MYO6	Unconventional myosin-VI	GO:0003779; F:actin binding; TAS:UniProtKB
Q9UM54	MYO6	Unconventional myosin-VI	GO:0051015; F:actin filament binding; IDA:UniProtKB
Q9UM54	MYO6	Unconventional myosin-VI	GO:0043531; F:ADP binding; ISS:UniProtKB
Q9UM54	MYO6	Unconventional myosin-VI	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UM54	MYO6	Unconventional myosin-VI	GO:0005516; F:calmodulin binding; ISS:UniProtKB
Q9UM54	MYO6	Unconventional myosin-VI	GO:0060001; F:minus-end directed microfilament motor activity; NAS:UniProtKB
Q9UM54	MYO6	Unconventional myosin-VI	GO:0003774; F:motor activity; ISS:UniProtKB
Q9UM54	MYO6	Unconventional myosin-VI	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UM54	MYO6	Unconventional myosin-VI	GO:0030048; P:actin filament-based movement; ISS:UniProtKB
Q9UM54	MYO6	Unconventional myosin-VI	GO:0042491; P:auditory receptor cell differentiation; IEA:Ensembl
Q9UM54	MYO6	Unconventional myosin-VI	GO:0071257; P:cellular response to electrical stimulus; IEA:Ensembl
Q9UM54	MYO6	Unconventional myosin-VI	GO:0016358; P:dendrite development; IEA:Ensembl
Q9UM54	MYO6	Unconventional myosin-VI	GO:0030330; P:DNA damage response, signal transduction by p53 class mediator; IDA:UniProtKB
Q9UM54	MYO6	Unconventional myosin-VI	GO:0006897; P:endocytosis; IMP:UniProtKB
Q9UM54	MYO6	Unconventional myosin-VI	GO:0014047; P:glutamate secretion; IEA:Ensembl
Q9UM54	MYO6	Unconventional myosin-VI	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q9UM54	MYO6	Unconventional myosin-VI	GO:0006886; P:intracellular protein transport; ISS:UniProtKB
Q9UM54	MYO6	Unconventional myosin-VI	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q9UM54	MYO6	Unconventional myosin-VI	GO:0061024; P:membrane organization; TAS:Reactome
Q9UM54	MYO6	Unconventional myosin-VI	GO:0008152; P:metabolic process; ISS:GOC
Q9UM54	MYO6	Unconventional myosin-VI	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q9UM54	MYO6	Unconventional myosin-VI	GO:0006605; P:protein targeting; IEA:Ensembl
Q9UM54	MYO6	Unconventional myosin-VI	GO:0051046; P:regulation of secretion; IMP:UniProtKB
Q9UM54	MYO6	Unconventional myosin-VI	GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl
Q9UM54	MYO6	Unconventional myosin-VI	GO:0042493; P:response to drug; IEA:Ensembl
Q9UM54	MYO6	Unconventional myosin-VI	GO:0007605; P:sensory perception of sound; IEA:UniProtKB-KW
Q9UM54	MYO6	Unconventional myosin-VI	GO:0007416; P:synapse assembly; IEA:Ensembl
Q9UM54	MYO6	Unconventional myosin-VI	GO:0007268; P:synaptic transmission; TAS:Reactome
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0051015; F:actin filament binding; IDA:UniProtKB
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0030898; F:actin-dependent ATPase activity; IEA:Ensembl
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0043531; F:ADP binding; IEA:Ensembl
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0005516; F:calmodulin binding; IMP:UniProtKB
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0000146; F:microfilament motor activity; IDA:UniProtKB
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0005515; F:protein binding; IPI:UniProtKB
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0030507; F:spectrin binding; IDA:MGI
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0030048; P:actin filament-based movement; IDA:UniProtKB
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0060088; P:auditory receptor cell stereocilium organization; IEA:Ensembl
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0050957; P:equilibrioception; IMP:HGNC
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0042462; P:eye photoreceptor cell development; IC:UniProtKB
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0006886; P:intracellular protein transport; IEA:Ensembl
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0007040; P:lysosome organization; IDA:UniProtKB
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0008152; P:metabolic process; IDA:GOC
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0001845; P:phagolysosome assembly; IEA:Ensembl
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0051904; P:pigment granule transport; IEA:Ensembl
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0048563; P:post-embryonic organ morphogenesis; IEA:Ensembl
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0050953; P:sensory perception of light stimulus; IMP:HGNC
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0007605; P:sensory perception of sound; IMP:UniProtKB
Q13402	MYO7A	Unconventional myosin-VIIa	GO:0007601; P:visual perception; IMP:UniProtKB
Q6PIF6	MYO7B	Unconventional myosin-VIIb	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6PIF6	MYO7B	Unconventional myosin-VIIb	GO:0003774; F:motor activity; IEA:InterPro
B2RTY4	MYO9A	Unconventional myosin-IXa	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
B2RTY4	MYO9A	Unconventional myosin-IXa	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
B2RTY4	MYO9A	Unconventional myosin-IXa	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
B2RTY4	MYO9A	Unconventional myosin-IXa	GO:0003774; F:motor activity; IEA:InterPro
B2RTY4	MYO9A	Unconventional myosin-IXa	GO:0005515; F:protein binding; IPI:UniProtKB
B2RTY4	MYO9A	Unconventional myosin-IXa	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
B2RTY4	MYO9A	Unconventional myosin-IXa	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
B2RTY4	MYO9A	Unconventional myosin-IXa	GO:0007601; P:visual perception; TAS:ProtInc
Q13459	MYO9B	Unconventional myosin-IXb	GO:0003779; F:actin binding; IDA:UniProtKB
Q13459	MYO9B	Unconventional myosin-IXb	GO:0030898; F:actin-dependent ATPase activity; IEA:Ensembl
Q13459	MYO9B	Unconventional myosin-IXb	GO:0043531; F:ADP binding; IDA:UniProtKB
Q13459	MYO9B	Unconventional myosin-IXb	GO:0005524; F:ATP binding; IDA:UniProtKB
Q13459	MYO9B	Unconventional myosin-IXb	GO:0016887; F:ATPase activity; IDA:UniProtKB
Q13459	MYO9B	Unconventional myosin-IXb	GO:0005516; F:calmodulin binding; IDA:UniProtKB
Q13459	MYO9B	Unconventional myosin-IXb	GO:0000146; F:microfilament motor activity; IDA:UniProtKB
Q13459	MYO9B	Unconventional myosin-IXb	GO:0005515; F:protein binding; IPI:IntAct
Q13459	MYO9B	Unconventional myosin-IXb	GO:0005100; F:Rho GTPase activator activity; IDA:UniProtKB
Q13459	MYO9B	Unconventional myosin-IXb	GO:0008270; F:zinc ion binding; IEA:Ensembl
Q13459	MYO9B	Unconventional myosin-IXb	GO:0030048; P:actin filament-based movement; TAS:UniProtKB
Q13459	MYO9B	Unconventional myosin-IXb	GO:0030010; P:establishment of cell polarity; IEA:Ensembl
Q13459	MYO9B	Unconventional myosin-IXb	GO:0072673; P:lamellipodium morphogenesis; IEA:Ensembl
Q13459	MYO9B	Unconventional myosin-IXb	GO:0048246; P:macrophage chemotaxis; IEA:Ensembl
Q13459	MYO9B	Unconventional myosin-IXb	GO:0002548; P:monocyte chemotaxis; IEA:Ensembl
Q13459	MYO9B	Unconventional myosin-IXb	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q13459	MYO9B	Unconventional myosin-IXb	GO:0007266; P:Rho protein signal transduction; IC:UniProtKB
Q13459	MYO9B	Unconventional myosin-IXb	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q99972	MYOC	Myocilin	GO:0001968; F:fibronectin binding; IPI:UniProtKB
Q99972	MYOC	Myocilin	GO:0005109; F:frizzled binding; IPI:UniProtKB
Q99972	MYOC	Myocilin	GO:0032027; F:myosin light chain binding; IPI:UniProtKB
Q99972	MYOC	Myocilin	GO:0005515; F:protein binding; IPI:UniProtKB
Q99972	MYOC	Myocilin	GO:0060348; P:bone development; ISS:UniProtKB
Q99972	MYOC	Myocilin	GO:0045162; P:clustering of voltage-gated sodium channels; ISS:UniProtKB
Q99972	MYOC	Myocilin	GO:0038133; P:ERBB2-ERBB3 signaling pathway; ISS:UniProtKB
Q99972	MYOC	Myocilin	GO:0022011; P:myelination in peripheral nervous system; ISS:UniProtKB
Q99972	MYOC	Myocilin	GO:0001953; P:negative regulation of cell-matrix adhesion; IDA:UniProtKB
Q99972	MYOC	Myocilin	GO:0035024; P:negative regulation of Rho protein signal transduction; IDA:UniProtKB
Q99972	MYOC	Myocilin	GO:0051497; P:negative regulation of stress fiber assembly; IDA:UniProtKB
Q99972	MYOC	Myocilin	GO:0031175; P:neuron projection development; IMP:UniProtKB
Q99972	MYOC	Myocilin	GO:0038031; P:non-canonical Wnt signaling pathway via JNK cascade; IMP:UniProtKB
Q99972	MYOC	Myocilin	GO:0001649; P:osteoblast differentiation; IDA:UniProtKB
Q99972	MYOC	Myocilin	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
Q99972	MYOC	Myocilin	GO:0051894; P:positive regulation of focal adhesion assembly; IDA:UniProtKB
Q99972	MYOC	Myocilin	GO:0051901; P:positive regulation of mitochondrial depolarization; IDA:UniProtKB
Q99972	MYOC	Myocilin	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IDA:UniProtKB
Q99972	MYOC	Myocilin	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:UniProtKB
Q99972	MYOC	Myocilin	GO:0051496; P:positive regulation of stress fiber assembly; IDA:UniProtKB
Q99972	MYOC	Myocilin	GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IDA:UniProtKB
Q99972	MYOC	Myocilin	GO:0043408; P:regulation of MAPK cascade; IDA:UniProtKB
Q99972	MYOC	Myocilin	GO:0014734; P:skeletal muscle hypertrophy; ISS:UniProtKB
P15172	MYOD1	Myoblast determination protein 1	GO:0031490; F:chromatin DNA binding; ISS:UniProtKB
P15172	MYOD1	Myoblast determination protein 1	GO:0001047; F:core promoter binding; ISS:UniProtKB
P15172	MYOD1	Myoblast determination protein 1	GO:0070888; F:E-box binding; ISS:BHF-UCL
P15172	MYOD1	Myoblast determination protein 1	GO:0035257; F:nuclear hormone receptor binding; IPI:UniProtKB
P15172	MYOD1	Myoblast determination protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P15172	MYOD1	Myoblast determination protein 1	GO:0046982; F:protein heterodimerization activity; ISS:BHF-UCL
P15172	MYOD1	Myoblast determination protein 1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P15172	MYOD1	Myoblast determination protein 1	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P15172	MYOD1	Myoblast determination protein 1	GO:0071392; P:cellular response to estradiol stimulus; ISS:UniProtKB
P15172	MYOD1	Myoblast determination protein 1	GO:0071385; P:cellular response to glucocorticoid stimulus; IEA:Ensembl
P15172	MYOD1	Myoblast determination protein 1	GO:0071453; P:cellular response to oxygen levels; IEA:Ensembl
P15172	MYOD1	Myoblast determination protein 1	GO:0009267; P:cellular response to starvation; IEA:Ensembl
P15172	MYOD1	Myoblast determination protein 1	GO:0043966; P:histone H3 acetylation; ISS:UniProtKB
P15172	MYOD1	Myoblast determination protein 1	GO:0043967; P:histone H4 acetylation; ISS:UniProtKB
P15172	MYOD1	Myoblast determination protein 1	GO:0042692; P:muscle cell differentiation; TAS:Reactome
P15172	MYOD1	Myoblast determination protein 1	GO:0042693; P:muscle cell fate commitment; ISS:BHF-UCL
P15172	MYOD1	Myoblast determination protein 1	GO:0007517; P:muscle organ development; TAS:ProtInc
P15172	MYOD1	Myoblast determination protein 1	GO:0007518; P:myoblast fate determination; IEA:Ensembl
P15172	MYOD1	Myoblast determination protein 1	GO:0014904; P:myotube cell development; IDA:BHF-UCL
P15172	MYOD1	Myoblast determination protein 1	GO:0014908; P:myotube differentiation involved in skeletal muscle regeneration; IEA:Ensembl
P15172	MYOD1	Myoblast determination protein 1	GO:0051149; P:positive regulation of muscle cell differentiation; IDA:BHF-UCL
P15172	MYOD1	Myoblast determination protein 1	GO:1901741; P:positive regulation of myoblast fusion; IDA:BHF-UCL
P15172	MYOD1	Myoblast determination protein 1	GO:0043415; P:positive regulation of skeletal muscle tissue regeneration; IEA:Ensembl
P15172	MYOD1	Myoblast determination protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
P15172	MYOD1	Myoblast determination protein 1	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P15172	MYOD1	Myoblast determination protein 1	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IEA:Ensembl
P15172	MYOD1	Myoblast determination protein 1	GO:0043484; P:regulation of RNA splicing; IDA:BHF-UCL
P15172	MYOD1	Myoblast determination protein 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P15172	MYOD1	Myoblast determination protein 1	GO:0043503; P:skeletal muscle fiber adaptation; IEA:Ensembl
P15172	MYOD1	Myoblast determination protein 1	GO:0048741; P:skeletal muscle fiber development; IEA:Ensembl
P15172	MYOD1	Myoblast determination protein 1	GO:0007519; P:skeletal muscle tissue development; TAS:ProtInc
P15172	MYOD1	Myoblast determination protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:GOC
Q9NZM1	MYOF	Myoferlin	GO:0005543; F:phospholipid binding; IDA:UniProtKB
Q9NZM1	MYOF	Myoferlin	GO:0005515; F:protein binding; IPI:UniProt
Q9NZM1	MYOF	Myoferlin	GO:0008015; P:blood circulation; TAS:ProtInc
Q9NZM1	MYOF	Myoferlin	GO:0034605; P:cellular response to heat; IEA:Ensembl
Q9NZM1	MYOF	Myoferlin	GO:0006936; P:muscle contraction; TAS:ProtInc
Q9NZM1	MYOF	Myoferlin	GO:0001778; P:plasma membrane repair; ISS:UniProtKB
Q9NZM1	MYOF	Myoferlin	GO:0030947; P:regulation of vascular endothelial growth factor receptor signaling pathway; IEA:Ensembl
P15173	MYOG	Myogenin	GO:0031490; F:chromatin DNA binding; ISS:UniProtKB
P15173	MYOG	Myogenin	GO:0001047; F:core promoter binding; ISS:UniProtKB
P15173	MYOG	Myogenin	GO:0000987; F:core promoter proximal region sequence-specific DNA binding; IEA:Ensembl
P15173	MYOG	Myogenin	GO:0070888; F:E-box binding; ISS:BHF-UCL
P15173	MYOG	Myogenin	GO:0046982; F:protein heterodimerization activity; ISS:BHF-UCL
P15173	MYOG	Myogenin	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; ISS:BHF-UCL
P15173	MYOG	Myogenin	GO:0001228; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; TAS:BHF-UCL
P15173	MYOG	Myogenin	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
P15173	MYOG	Myogenin	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P15173	MYOG	Myogenin	GO:0071392; P:cellular response to estradiol stimulus; ISS:UniProtKB
P15173	MYOG	Myogenin	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P15173	MYOG	Myogenin	GO:0071285; P:cellular response to lithium ion; IEA:Ensembl
P15173	MYOG	Myogenin	GO:0042789; P:mRNA transcription from RNA polymerase II promoter; TAS:BHF-UCL
P15173	MYOG	Myogenin	GO:0042692; P:muscle cell differentiation; TAS:Reactome
P15173	MYOG	Myogenin	GO:0042693; P:muscle cell fate commitment; ISS:BHF-UCL
P15173	MYOG	Myogenin	GO:0008285; P:negative regulation of cell proliferation; ISS:UniProtKB
P15173	MYOG	Myogenin	GO:0001503; P:ossification; IEA:Ensembl
P15173	MYOG	Myogenin	GO:0071158; P:positive regulation of cell cycle arrest; ISS:UniProtKB
P15173	MYOG	Myogenin	GO:0014737; P:positive regulation of muscle atrophy; ISS:UniProtKB
P15173	MYOG	Myogenin	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
P15173	MYOG	Myogenin	GO:0045663; P:positive regulation of myoblast differentiation; ISS:UniProtKB
P15173	MYOG	Myogenin	GO:0010831; P:positive regulation of myotube differentiation; ISS:UniProtKB
P15173	MYOG	Myogenin	GO:0048743; P:positive regulation of skeletal muscle fiber development; ISS:UniProtKB
P15173	MYOG	Myogenin	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
P15173	MYOG	Myogenin	GO:1901739; P:regulation of myoblast fusion; ISS:UniProtKB
P15173	MYOG	Myogenin	GO:0014842; P:regulation of satellite cell proliferation; ISS:UniProtKB
P15173	MYOG	Myogenin	GO:0014894; P:response to denervation involved in regulation of muscle adaptation; ISS:UniProtKB
P15173	MYOG	Myogenin	GO:0014878; P:response to electrical stimulus involved in regulation of muscle adaptation; ISS:UniProtKB
P15173	MYOG	Myogenin	GO:0014873; P:response to muscle activity involved in regulation of muscle adaptation; ISS:UniProtKB
P15173	MYOG	Myogenin	GO:0048741; P:skeletal muscle fiber development; IEA:Ensembl
P15173	MYOG	Myogenin	GO:0007519; P:skeletal muscle tissue development; TAS:ProtInc
P15173	MYOG	Myogenin	GO:0014891; P:striated muscle atrophy; ISS:UniProtKB
P52179	MYOM1	Myomesin-1	GO:0042802; F:identical protein binding; IPI:IntAct
P52179	MYOM1	Myomesin-1	GO:0005515; F:protein binding; IPI:IntAct
P52179	MYOM1	Myomesin-1	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
P52179	MYOM1	Myomesin-1	GO:0008307; F:structural constituent of muscle; TAS:ProtInc
P52179	MYOM1	Myomesin-1	GO:0006936; P:muscle contraction; IEA:Ensembl
P54296	MYOM2	Myomesin-2	GO:0005515; F:protein binding; IPI:IntAct
P54296	MYOM2	Myomesin-2	GO:0008307; F:structural constituent of muscle; TAS:ProtInc
P54296	MYOM2	Myomesin-2	GO:0006936; P:muscle contraction; TAS:ProtInc
Q5VTT5	MYOM3	Myomesin-3	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q5VU43	PDE4DIP	Myomegalin	GO:0019899; F:enzyme binding; ISS:UniProtKB
Q5VU43	PDE4DIP	Myomegalin	GO:0005515; F:protein binding; IPI:UniProtKB
Q5VU43	PDE4DIP	Myomegalin	GO:0043623; P:cellular protein complex assembly; ISS:UniProtKB
Q9UBF9	MYOT	Myotilin	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBF9	MYOT	Myotilin	GO:0008307; F:structural constituent of muscle; TAS:ProtInc
Q9UBF9	MYOT	Myotilin	GO:0006936; P:muscle contraction; TAS:ProtInc
Q9NP98	MYOZ1	Myozenin-1	GO:0051373; F:FATZ binding; IDA:UniProtKB
Q9NP98	MYOZ1	Myozenin-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NP98	MYOZ1	Myozenin-1	GO:0030239; P:myofibril assembly; TAS:UniProtKB
Q9NPC6	MYOZ2	Myozenin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NPC6	MYOZ2	Myozenin-2	GO:0030346; F:protein phosphatase 2B binding; NAS:UniProtKB
Q9NPC6	MYOZ2	Myozenin-2	GO:0031433; F:telethonin binding; IPI:BHF-UCL
Q8TDC0	MYOZ3	Myozenin-3	GO:0005515; F:protein binding; IPI:UniProtKB
P25189	MPZ	Myelin protein P0	GO:0005198; F:structural molecule activity; NAS:ProtInc
P25189	MPZ	Myelin protein P0	GO:0008219; P:cell death; IEA:UniProtKB-KW
P25189	MPZ	Myelin protein P0	GO:0045217; P:cell-cell junction maintenance; IEA:Ensembl
P25189	MPZ	Myelin protein P0	GO:0007268; P:synaptic transmission; TAS:ProtInc
P02689	PMP2	Myelin P2 protein	GO:0015485; F:cholesterol binding; IDA:UniProtKB
P02689	PMP2	Myelin P2 protein	GO:0005504; F:fatty acid binding; IDA:UniProtKB
P02689	PMP2	Myelin P2 protein	GO:0005215; F:transporter activity; IEA:InterPro
P02689	PMP2	Myelin P2 protein	GO:0061024; P:membrane organization; IEA:Ensembl
Q00872	MYBPC1	Myosin-binding protein C, slow-type	GO:0005515; F:protein binding; IPI:IntAct
Q00872	MYBPC1	Myosin-binding protein C, slow-type	GO:0008307; F:structural constituent of muscle; TAS:ProtInc
Q00872	MYBPC1	Myosin-binding protein C, slow-type	GO:0031432; F:titin binding; ISS:BHF-UCL
Q00872	MYBPC1	Myosin-binding protein C, slow-type	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q00872	MYBPC1	Myosin-binding protein C, slow-type	GO:0030049; P:muscle filament sliding; TAS:Reactome
Q14324	MYBPC2	Myosin-binding protein C, fast-type	GO:0005515; F:protein binding; IPI:IntAct
Q14324	MYBPC2	Myosin-binding protein C, fast-type	GO:0008307; F:structural constituent of muscle; TAS:ProtInc
Q14324	MYBPC2	Myosin-binding protein C, fast-type	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q14324	MYBPC2	Myosin-binding protein C, fast-type	GO:0030049; P:muscle filament sliding; TAS:Reactome
Q14896	MYBPC3	Myosin-binding protein C, cardiac-type	GO:0001671; F:ATPase activator activity; ISS:BHF-UCL
Q14896	MYBPC3	Myosin-binding protein C, cardiac-type	GO:0042802; F:identical protein binding; IPI:IntAct
Q14896	MYBPC3	Myosin-binding protein C, cardiac-type	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14896	MYBPC3	Myosin-binding protein C, cardiac-type	GO:0017022; F:myosin binding; IDA:BHF-UCL
Q14896	MYBPC3	Myosin-binding protein C, cardiac-type	GO:0032036; F:myosin heavy chain binding; IPI:BHF-UCL
Q14896	MYBPC3	Myosin-binding protein C, cardiac-type	GO:0008307; F:structural constituent of muscle; IMP:BHF-UCL
Q14896	MYBPC3	Myosin-binding protein C, cardiac-type	GO:0031432; F:titin binding; NAS:BHF-UCL
Q14896	MYBPC3	Myosin-binding protein C, cardiac-type	GO:0060048; P:cardiac muscle contraction; ISS:BHF-UCL
Q14896	MYBPC3	Myosin-binding protein C, cardiac-type	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q14896	MYBPC3	Myosin-binding protein C, cardiac-type	GO:0003007; P:heart morphogenesis; IMP:BHF-UCL
Q14896	MYBPC3	Myosin-binding protein C, cardiac-type	GO:0030049; P:muscle filament sliding; TAS:Reactome
Q14896	MYBPC3	Myosin-binding protein C, cardiac-type	GO:0031034; P:myosin filament assembly; IEA:Ensembl
Q14896	MYBPC3	Myosin-binding protein C, cardiac-type	GO:0032781; P:positive regulation of ATPase activity; ISS:BHF-UCL
Q14896	MYBPC3	Myosin-binding protein C, cardiac-type	GO:0002027; P:regulation of heart rate; IEA:Ensembl
Q14896	MYBPC3	Myosin-binding protein C, cardiac-type	GO:0032971; P:regulation of muscle filament sliding; ISS:BHF-UCL
Q14896	MYBPC3	Myosin-binding protein C, cardiac-type	GO:0006942; P:regulation of striated muscle contraction; ISS:BHF-UCL
Q14896	MYBPC3	Myosin-binding protein C, cardiac-type	GO:0045214; P:sarcomere organization; IEA:Ensembl
Q14896	MYBPC3	Myosin-binding protein C, cardiac-type	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IMP:BHF-UCL
Q86TC9	MYPN	Myopalladin	GO:0008092; F:cytoskeletal protein binding; IPI:BHF-UCL
Q86TC9	MYPN	Myopalladin	GO:0051371; F:muscle alpha-actinin binding; IPI:BHF-UCL
Q86TC9	MYPN	Myopalladin	GO:0005515; F:protein binding; IPI:IntAct
Q86TC9	MYPN	Myopalladin	GO:0017124; F:SH3 domain binding; IPI:BHF-UCL
Q86TC9	MYPN	Myopalladin	GO:0045214; P:sarcomere organization; IMP:BHF-UCL
Q86VE0	MYPOP	Myb-related transcription factor, partner of profilin	GO:0003682; F:chromatin binding; IEA:InterPro
Q86VE0	MYPOP	Myb-related transcription factor, partner of profilin	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86VE0	MYPOP	Myb-related transcription factor, partner of profilin	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q86VE0	MYPOP	Myb-related transcription factor, partner of profilin	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q86VE0	MYPOP	Myb-related transcription factor, partner of profilin	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P60201	PLP1	Myelin proteolipid protein	GO:0019911; F:structural constituent of myelin sheath; IEA:Ensembl
P60201	PLP1	Myelin proteolipid protein	GO:0005198; F:structural molecule activity; TAS:ProtInc
P60201	PLP1	Myelin proteolipid protein	GO:0008366; P:axon ensheathment; TAS:ProtInc
P60201	PLP1	Myelin proteolipid protein	GO:0008219; P:cell death; IEA:UniProtKB-KW
P60201	PLP1	Myelin proteolipid protein	GO:0048469; P:cell maturation; IEA:Ensembl
P60201	PLP1	Myelin proteolipid protein	GO:0022010; P:central nervous system myelination; IEA:Ensembl
P60201	PLP1	Myelin proteolipid protein	GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl
P60201	PLP1	Myelin proteolipid protein	GO:0042759; P:long-chain fatty acid biosynthetic process; IEA:Ensembl
P60201	PLP1	Myelin proteolipid protein	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P60201	PLP1	Myelin proteolipid protein	GO:0021762; P:substantia nigra development; IEP:UniProt
P60201	PLP1	Myelin proteolipid protein	GO:0007268; P:synaptic transmission; TAS:ProtInc
O14974	PPP1R12A	Protein phosphatase 1 regulatory subunit 12A	GO:0071889; F:14-3-3 protein binding; IDA:UniProtKB
O14974	PPP1R12A	Protein phosphatase 1 regulatory subunit 12A	GO:0004857; F:enzyme inhibitor activity; IDA:UniProtKB
O14974	PPP1R12A	Protein phosphatase 1 regulatory subunit 12A	GO:0019208; F:phosphatase regulator activity; IDA:UniProtKB
O14974	PPP1R12A	Protein phosphatase 1 regulatory subunit 12A	GO:0005515; F:protein binding; IPI:UniProtKB
O14974	PPP1R12A	Protein phosphatase 1 regulatory subunit 12A	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O14974	PPP1R12A	Protein phosphatase 1 regulatory subunit 12A	GO:0004871; F:signal transducer activity; NAS:ProtInc
O14974	PPP1R12A	Protein phosphatase 1 regulatory subunit 12A	GO:0051297; P:centrosome organization; IMP:UniProtKB
O14974	PPP1R12A	Protein phosphatase 1 regulatory subunit 12A	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
O14974	PPP1R12A	Protein phosphatase 1 regulatory subunit 12A	GO:0007067; P:mitosis; IMP:UniProtKB
O14974	PPP1R12A	Protein phosphatase 1 regulatory subunit 12A	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O14974	PPP1R12A	Protein phosphatase 1 regulatory subunit 12A	GO:0043086; P:negative regulation of catalytic activity; IDA:UniProtKB
O14974	PPP1R12A	Protein phosphatase 1 regulatory subunit 12A	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O14974	PPP1R12A	Protein phosphatase 1 regulatory subunit 12A	GO:0006470; P:protein dephosphorylation; IMP:UniProtKB
O14974	PPP1R12A	Protein phosphatase 1 regulatory subunit 12A	GO:0030155; P:regulation of cell adhesion; IDA:UniProtKB
O14974	PPP1R12A	Protein phosphatase 1 regulatory subunit 12A	GO:0035507; P:regulation of myosin-light-chain-phosphatase activity; IDA:UniProtKB
O14974	PPP1R12A	Protein phosphatase 1 regulatory subunit 12A	GO:0046822; P:regulation of nucleocytoplasmic transport; IEA:Ensembl
O14974	PPP1R12A	Protein phosphatase 1 regulatory subunit 12A	GO:0007165; P:signal transduction; NAS:GOC
O60237	PPP1R12B	Protein phosphatase 1 regulatory subunit 12B	GO:0008047; F:enzyme activator activity; TAS:ProtInc
O60237	PPP1R12B	Protein phosphatase 1 regulatory subunit 12B	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
O60237	PPP1R12B	Protein phosphatase 1 regulatory subunit 12B	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O60237	PPP1R12B	Protein phosphatase 1 regulatory subunit 12B	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
O60237	PPP1R12B	Protein phosphatase 1 regulatory subunit 12B	GO:0006937; P:regulation of muscle contraction; TAS:ProtInc
O60237	PPP1R12B	Protein phosphatase 1 regulatory subunit 12B	GO:0007165; P:signal transduction; TAS:ProtInc
Q8NFW9	MYRIP	Rab effector MyRIP	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NFW9	MYRIP	Rab effector MyRIP	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q8NFW9	MYRIP	Rab effector MyRIP	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q8NFW9	MYRIP	Rab effector MyRIP	GO:0032024; P:positive regulation of insulin secretion; ISS:UniProtKB
Q5VVJ2	MYSM1	Histone H2A deubiquitinase MYSM1	GO:0003682; F:chromatin binding; IEA:InterPro
Q5VVJ2	MYSM1	Histone H2A deubiquitinase MYSM1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5VVJ2	MYSM1	Histone H2A deubiquitinase MYSM1	GO:0042393; F:histone binding; IDA:UniProtKB
Q5VVJ2	MYSM1	Histone H2A deubiquitinase MYSM1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5VVJ2	MYSM1	Histone H2A deubiquitinase MYSM1	GO:0008237; F:metallopeptidase activity; IMP:UniProtKB
Q5VVJ2	MYSM1	Histone H2A deubiquitinase MYSM1	GO:0032403; F:protein complex binding; IDA:UniProtKB
Q5VVJ2	MYSM1	Histone H2A deubiquitinase MYSM1	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q5VVJ2	MYSM1	Histone H2A deubiquitinase MYSM1	GO:0004221; F:ubiquitin thiolesterase activity; IDA:UniProtKB
Q5VVJ2	MYSM1	Histone H2A deubiquitinase MYSM1	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q5VVJ2	MYSM1	Histone H2A deubiquitinase MYSM1	GO:0006338; P:chromatin remodeling; IMP:UniProtKB
Q5VVJ2	MYSM1	Histone H2A deubiquitinase MYSM1	GO:0035522; P:monoubiquitinated histone H2A deubiquitination; IMP:UniProtKB
Q5VVJ2	MYSM1	Histone H2A deubiquitinase MYSM1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q5VVJ2	MYSM1	Histone H2A deubiquitinase MYSM1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UL68	MYT1L	Myelin transcription factor 1-like protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UL68	MYT1L	Myelin transcription factor 1-like protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9UL68	MYT1L	Myelin transcription factor 1-like protein	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UL68	MYT1L	Myelin transcription factor 1-like protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9UL68	MYT1L	Myelin transcription factor 1-like protein	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q9UL68	MYT1L	Myelin transcription factor 1-like protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q01538	MYT1	Myelin transcription factor 1	GO:0001158; F:enhancer sequence-specific DNA binding; IEA:Ensembl
Q01538	MYT1	Myelin transcription factor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q01538	MYT1	Myelin transcription factor 1	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q01538	MYT1	Myelin transcription factor 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q01538	MYT1	Myelin transcription factor 1	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q01538	MYT1	Myelin transcription factor 1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q01538	MYT1	Myelin transcription factor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P0CAP1	MYZAP	Myocardial zonula adherens protein	GO:0005515; F:protein binding; IPI:IntAct
P0CAP1	MYZAP	Myocardial zonula adherens protein	GO:0035556; P:intracellular signal transduction; ISS:UniProtKB
Q8WU39	MZB1	Marginal zone B- and B1-cell-specific protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WU39	MZB1	Marginal zone B- and B1-cell-specific protein	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8WU39	MZB1	Marginal zone B- and B1-cell-specific protein	GO:0033622; P:integrin activation; ISS:UniProtKB
Q8WU39	MZB1	Marginal zone B- and B1-cell-specific protein	GO:2001274; P:negative regulation of glucose import in response to insulin stimulus; ISS:UniProtKB
Q8WU39	MZB1	Marginal zone B- and B1-cell-specific protein	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q8WU39	MZB1	Marginal zone B- and B1-cell-specific protein	GO:0002642; P:positive regulation of immunoglobulin biosynthetic process; ISS:UniProtKB
Q8WU39	MZB1	Marginal zone B- and B1-cell-specific protein	GO:0030888; P:regulation of B cell proliferation; ISS:UniProtKB
Q8WU39	MZB1	Marginal zone B- and B1-cell-specific protein	GO:0042127; P:regulation of cell proliferation; ISS:UniProtKB
P28698	MZF1	Myeloid zinc finger 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P28698	MZF1	Myeloid zinc finger 1	GO:0005515; F:protein binding; IPI:UniProtKB
P28698	MZF1	Myeloid zinc finger 1	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P28698	MZF1	Myeloid zinc finger 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
P28698	MZF1	Myeloid zinc finger 1	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P28698	MZF1	Myeloid zinc finger 1	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
P28698	MZF1	Myeloid zinc finger 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q08AG7	MZT1	Mitotic-spindle organizing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q08AG7	MZT1	Mitotic-spindle organizing protein 1	GO:0033566; P:gamma-tubulin complex localization; IMP:UniProtKB
Q6NZ67	MZT2B	Mitotic-spindle organizing protein 2B	GO:0005515; F:protein binding; IPI:IntAct
Q9BZM5	ULBP2	NKG2D ligand 2	GO:0003823; F:antigen binding; IBA:RefGenome
Q9BZM5	ULBP2	NKG2D ligand 2	GO:0046703; F:natural killer cell lectin-like receptor binding; IDA:UniProtKB
Q9BZM5	ULBP2	NKG2D ligand 2	GO:0019882; P:antigen processing and presentation; IBA:RefGenome
Q9BZM5	ULBP2	NKG2D ligand 2	GO:0030101; P:natural killer cell activation; IDA:UniProtKB
Q9BZM5	ULBP2	NKG2D ligand 2	GO:0042267; P:natural killer cell mediated cytotoxicity; IDA:UniProtKB
Q9BZM6	ULBP1	NKG2D ligand 1	GO:0003823; F:antigen binding; IBA:RefGenome
Q9BZM6	ULBP1	NKG2D ligand 1	GO:0046703; F:natural killer cell lectin-like receptor binding; IDA:UniProtKB
Q9BZM6	ULBP1	NKG2D ligand 1	GO:0019882; P:antigen processing and presentation; IBA:RefGenome
Q9BZM6	ULBP1	NKG2D ligand 1	GO:0030101; P:natural killer cell activation; IDA:UniProtKB
Q9BZM6	ULBP1	NKG2D ligand 1	GO:0042267; P:natural killer cell mediated cytotoxicity; IDA:UniProtKB
Q9BZM6	ULBP1	NKG2D ligand 1	GO:0050776; P:regulation of immune response; TAS:Reactome
Q9BZM4	ULBP3	NKG2D ligand 3	GO:0003823; F:antigen binding; IBA:RefGenome
Q9BZM4	ULBP3	NKG2D ligand 3	GO:0046703; F:natural killer cell lectin-like receptor binding; IDA:UniProtKB
Q9BZM4	ULBP3	NKG2D ligand 3	GO:0019882; P:antigen processing and presentation; IBA:RefGenome
Q9BZM4	ULBP3	NKG2D ligand 3	GO:0030101; P:natural killer cell activation; IDA:UniProtKB
Q9BZM4	ULBP3	NKG2D ligand 3	GO:0042267; P:natural killer cell mediated cytotoxicity; IDA:UniProtKB
Q9BZM4	ULBP3	NKG2D ligand 3	GO:0050776; P:regulation of immune response; TAS:Reactome
Q9BZM4	ULBP3	NKG2D ligand 3	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q8TD07	RAET1E	NKG2D ligand 4	GO:0003823; F:antigen binding; IBA:RefGenome
Q8TD07	RAET1E	NKG2D ligand 4	GO:0046703; F:natural killer cell lectin-like receptor binding; IPI:UniProtKB
Q8TD07	RAET1E	NKG2D ligand 4	GO:0019882; P:antigen processing and presentation; IBA:RefGenome
Q8TD07	RAET1E	NKG2D ligand 4	GO:0042267; P:natural killer cell mediated cytotoxicity; IDA:UniProtKB
Q8TD07	RAET1E	NKG2D ligand 4	GO:0050776; P:regulation of immune response; TAS:Reactome
Q8TD07	RAET1E	NKG2D ligand 4	GO:0001913; P:T cell mediated cytotoxicity; IBA:RefGenome
Q92802	N4BP2L2	NEDD4-binding protein 2-like 2	GO:0019899; F:enzyme binding; IPI:UniProt
Q92802	N4BP2L2	NEDD4-binding protein 2-like 2	GO:0005515; F:protein binding; IPI:IntAct
Q92802	N4BP2L2	NEDD4-binding protein 2-like 2	GO:0001106; F:RNA polymerase II transcription corepressor activity; ISS:UniProt
Q92802	N4BP2L2	NEDD4-binding protein 2-like 2	GO:1902037; P:negative regulation of hematopoietic stem cell differentiation; IMP:UniProt
Q92802	N4BP2L2	NEDD4-binding protein 2-like 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProt
Q92802	N4BP2L2	NEDD4-binding protein 2-like 2	GO:1902035; P:positive regulation of hematopoietic stem cell proliferation; IMP:UniProt
O75113	N4BP1	NEDD4-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
O75113	N4BP1	NEDD4-binding protein 1	GO:0034644; P:cellular response to UV; IMP:BHF-UCL
O75113	N4BP1	NEDD4-binding protein 1	GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; ISS:UniProtKB
O75113	N4BP1	NEDD4-binding protein 1	GO:0031397; P:negative regulation of protein ubiquitination; ISS:UniProtKB
Q86UW6	N4BP2	NEDD4-binding protein 2	GO:0005524; F:ATP binding; IDA:MGI
Q86UW6	N4BP2	NEDD4-binding protein 2	GO:0046404; F:ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity; IDA:MGI
Q86UW6	N4BP2	NEDD4-binding protein 2	GO:0004519; F:endonuclease activity; IDA:MGI
Q86UW6	N4BP2	NEDD4-binding protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q86UW6	N4BP2	NEDD4-binding protein 2	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:GOC
Q86UW6	N4BP2	NEDD4-binding protein 2	GO:0016310; P:phosphorylation; IDA:GOC
Q9H1M0	NUP62CL	Nucleoporin-62 C-terminal-like protein	GO:0017056; F:structural constituent of nuclear pore; IEA:InterPro
Q9H1M0	NUP62CL	Nucleoporin-62 C-terminal-like protein	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8WVE0	N6AMT2	N(6)-adenine-specific DNA methyltransferase 2	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q8WVE0	N6AMT2	N(6)-adenine-specific DNA methyltransferase 2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9BSU3	NAA11	N-alpha-acetyltransferase 11	GO:0004596; F:peptide alpha-N-acetyltransferase activity; IDA:UniProtKB
Q9BSU3	NAA11	N-alpha-acetyltransferase 11	GO:0005515; F:protein binding; IPI:UniProt
Q9BSU3	NAA11	N-alpha-acetyltransferase 11	GO:0006474; P:N-terminal protein amino acid acetylation; IDA:UniProtKB
P41227	NAA10	N-alpha-acetyltransferase 10	GO:0008080; F:N-acetyltransferase activity; TAS:ProtInc
P41227	NAA10	N-alpha-acetyltransferase 10	GO:0004596; F:peptide alpha-N-acetyltransferase activity; IEA:UniProtKB-EC
P41227	NAA10	N-alpha-acetyltransferase 10	GO:0005515; F:protein binding; IPI:UniProtKB
P41227	NAA10	N-alpha-acetyltransferase 10	GO:0006323; P:DNA packaging; TAS:ProtInc
P41227	NAA10	N-alpha-acetyltransferase 10	GO:0006475; P:internal protein amino acid acetylation; TAS:ProtInc
P41227	NAA10	N-alpha-acetyltransferase 10	GO:0006474; P:N-terminal protein amino acid acetylation; IDA:UniProtKB
Q9BXJ9	NAA15	N-alpha-acetyltransferase 15, NatA auxiliary subunit	GO:0008080; F:N-acetyltransferase activity; IEA:Ensembl
Q9BXJ9	NAA15	N-alpha-acetyltransferase 15, NatA auxiliary subunit	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BXJ9	NAA15	N-alpha-acetyltransferase 15, NatA auxiliary subunit	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BXJ9	NAA15	N-alpha-acetyltransferase 15, NatA auxiliary subunit	GO:0043022; F:ribosome binding; IDA:UniProt
Q9BXJ9	NAA15	N-alpha-acetyltransferase 15, NatA auxiliary subunit	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q9BXJ9	NAA15	N-alpha-acetyltransferase 15, NatA auxiliary subunit	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9BXJ9	NAA15	N-alpha-acetyltransferase 15, NatA auxiliary subunit	GO:0006474; P:N-terminal protein amino acid acetylation; IDA:UniProtKB
Q9BXJ9	NAA15	N-alpha-acetyltransferase 15, NatA auxiliary subunit	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProt
Q9BXJ9	NAA15	N-alpha-acetyltransferase 15, NatA auxiliary subunit	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9BXJ9	NAA15	N-alpha-acetyltransferase 15, NatA auxiliary subunit	GO:0050821; P:protein stabilization; IMP:UniProt
Q9BXJ9	NAA15	N-alpha-acetyltransferase 15, NatA auxiliary subunit	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6N069	NAA16	N-alpha-acetyltransferase 16, NatA auxiliary subunit	GO:0005515; F:protein binding; IPI:UniProt
Q6N069	NAA16	N-alpha-acetyltransferase 16, NatA auxiliary subunit	GO:0043022; F:ribosome binding; IDA:UniProt
Q6N069	NAA16	N-alpha-acetyltransferase 16, NatA auxiliary subunit	GO:0006474; P:N-terminal protein amino acid acetylation; ISS:UniProtKB
Q6N069	NAA16	N-alpha-acetyltransferase 16, NatA auxiliary subunit	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProt
Q6N069	NAA16	N-alpha-acetyltransferase 16, NatA auxiliary subunit	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q6N069	NAA16	N-alpha-acetyltransferase 16, NatA auxiliary subunit	GO:0050821; P:protein stabilization; IMP:UniProt
P61599	NAA20	N-alpha-acetyltransferase 20	GO:0004596; F:peptide alpha-N-acetyltransferase activity; IEA:UniProtKB-EC
Q147X3	NAA30	N-alpha-acetyltransferase 30	GO:0004596; F:peptide alpha-N-acetyltransferase activity; IDA:UniProtKB
Q147X3	NAA30	N-alpha-acetyltransferase 30	GO:0005515; F:protein binding; IPI:IntAct
Q147X3	NAA30	N-alpha-acetyltransferase 30	GO:0008152; P:metabolic process; IDA:GOC
Q5VZE5	NAA35	N-alpha-acetyltransferase 35, NatC auxiliary subunit	GO:0005515; F:protein binding; IPI:IntAct
Q5VZE5	NAA35	N-alpha-acetyltransferase 35, NatC auxiliary subunit	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q5VZE5	NAA35	N-alpha-acetyltransferase 35, NatC auxiliary subunit	GO:0048659; P:smooth muscle cell proliferation; ISS:UniProtKB
Q9GZZ1	NAA50	N-alpha-acetyltransferase 50	GO:0010485; F:H4 histone acetyltransferase activity; IDA:UniProtKB
Q9GZZ1	NAA50	N-alpha-acetyltransferase 50	GO:0004596; F:peptide alpha-N-acetyltransferase activity; IDA:UniProtKB
Q9GZZ1	NAA50	N-alpha-acetyltransferase 50	GO:0052858; F:peptidyl-lysine N-acetyltransferase activity; IDA:UniProtKB
Q9GZZ1	NAA50	N-alpha-acetyltransferase 50	GO:0005515; F:protein binding; IPI:IntAct
Q9GZZ1	NAA50	N-alpha-acetyltransferase 50	GO:0043967; P:histone H4 acetylation; IDA:GOC
Q9GZZ1	NAA50	N-alpha-acetyltransferase 50	GO:0071962; P:mitotic sister chromatid cohesion, centromeric; IDA:UniProtKB
Q9GZZ1	NAA50	N-alpha-acetyltransferase 50	GO:0006474; P:N-terminal protein amino acid acetylation; TAS:HGNC
Q86UY6	NAA40	N-alpha-acetyltransferase 40	GO:0008080; F:N-acetyltransferase activity; IEA:InterPro
Q86UY6	NAA40	N-alpha-acetyltransferase 40	GO:0006629; P:lipid metabolic process; IEA:Ensembl
Q9H7X0	NAA60	N-alpha-acetyltransferase 60	GO:0010485; F:H4 histone acetyltransferase activity; IDA:UniProtKB
Q9H7X0	NAA60	N-alpha-acetyltransferase 60	GO:0004596; F:peptide alpha-N-acetyltransferase activity; IDA:UniProtKB
Q9H7X0	NAA60	N-alpha-acetyltransferase 60	GO:0008283; P:cell proliferation; IMP:UniProtKB
Q9H7X0	NAA60	N-alpha-acetyltransferase 60	GO:0007059; P:chromosome segregation; ISS:UniProtKB
Q9H7X0	NAA60	N-alpha-acetyltransferase 60	GO:0043967; P:histone H4 acetylation; IDA:UniProtKB
Q9H7X0	NAA60	N-alpha-acetyltransferase 60	GO:0017196; P:N-terminal peptidyl-methionine acetylation; IDA:UniProtKB
Q9H7X0	NAA60	N-alpha-acetyltransferase 60	GO:0006334; P:nucleosome assembly; IDA:UniProtKB
Q02083	NAAA	N-acylethanolamine-hydrolyzing acid amidase	GO:0016810; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; IDA:MGI
Q02083	NAAA	N-acylethanolamine-hydrolyzing acid amidase	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q02083	NAAA	N-acylethanolamine-hydrolyzing acid amidase	GO:0006629; P:lipid metabolic process; IEA:InterPro
Q13506	NAB1	NGFI-A-binding protein 1	GO:0001958; P:endochondral ossification; IEA:Ensembl
Q13506	NAB1	NGFI-A-binding protein 1	GO:0042552; P:myelination; IEA:Ensembl
Q13506	NAB1	NGFI-A-binding protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB
Q13506	NAB1	NGFI-A-binding protein 1	GO:0045682; P:regulation of epidermis development; IEA:Ensembl
Q13506	NAB1	NGFI-A-binding protein 1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q13506	NAB1	NGFI-A-binding protein 1	GO:0014037; P:Schwann cell differentiation; IEA:Ensembl
Q13506	NAB1	NGFI-A-binding protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15742	NAB2	NGFI-A-binding protein 2	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q15742	NAB2	NGFI-A-binding protein 2	GO:0008283; P:cell proliferation; TAS:ProtInc
Q15742	NAB2	NGFI-A-binding protein 2	GO:0001958; P:endochondral ossification; IEA:Ensembl
Q15742	NAB2	NGFI-A-binding protein 2	GO:0042552; P:myelination; IEA:Ensembl
Q15742	NAB2	NGFI-A-binding protein 2	GO:0016480; P:negative regulation of transcription from RNA polymerase III promoter; IDA:MGI
Q15742	NAB2	NGFI-A-binding protein 2	GO:0007399; P:nervous system development; TAS:ProtInc
Q15742	NAB2	NGFI-A-binding protein 2	GO:0045682; P:regulation of epidermis development; IEA:Ensembl
Q15742	NAB2	NGFI-A-binding protein 2	GO:0014037; P:Schwann cell differentiation; IEA:Ensembl
Q15742	NAB2	NGFI-A-binding protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0030506; F:ankyrin binding; IPI:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0005432; F:calcium:sodium antiporter activity; IDA:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0008092; F:cytoskeletal protein binding; IDA:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0044325; F:ion channel binding; ISS:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0007596; P:blood coagulation; TAS:Reactome
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:1901660; P:calcium ion export; IDA:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0055074; P:calcium ion homeostasis; ISS:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0070509; P:calcium ion import; IDA:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0060402; P:calcium ion transport into cytosol; ISS:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0055013; P:cardiac muscle cell development; ISS:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0060048; P:cardiac muscle contraction; IEA:Ensembl
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0086064; P:cell communication by electrical coupling involved in cardiac conduction; ISS:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0071313; P:cellular response to caffeine; ISS:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0034614; P:cellular response to reactive oxygen species; IDA:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0060401; P:cytosolic calcium ion transport; TAS:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0035050; P:embryonic heart tube development; IEA:Ensembl
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0001892; P:embryonic placenta development; IEA:Ensembl
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0003007; P:heart morphogenesis; IEA:Ensembl
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0006811; P:ion transport; TAS:Reactome
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0006936; P:muscle contraction; TAS:ProtInc
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0048747; P:muscle fiber development; IEA:Ensembl
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0051481; P:negative regulation of cytosolic calcium ion concentration; ISS:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0009791; P:post-embryonic development; IEA:Ensembl
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; ISS:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0002027; P:regulation of heart rate; ISS:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0002026; P:regulation of the force of heart contraction; ISS:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0055119; P:relaxation of cardiac muscle; IC:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0044557; P:relaxation of smooth muscle; ISS:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0071436; P:sodium ion export; IDA:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0097369; P:sodium ion import; IDA:BHF-UCL
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P32418	SLC8A1	Sodium/calcium exchanger 1	GO:0014829; P:vascular smooth muscle contraction; ISS:BHF-UCL
Q9UPR5	SLC8A2	Sodium/calcium exchanger 2	GO:0005432; F:calcium:sodium antiporter activity; IEA:InterPro
Q9UPR5	SLC8A2	Sodium/calcium exchanger 2	GO:0007596; P:blood coagulation; TAS:Reactome
Q9UPR5	SLC8A2	Sodium/calcium exchanger 2	GO:0007154; P:cell communication; IEA:InterPro
Q9UPR5	SLC8A2	Sodium/calcium exchanger 2	GO:0006811; P:ion transport; TAS:Reactome
Q9UPR5	SLC8A2	Sodium/calcium exchanger 2	GO:0055085; P:transmembrane transport; TAS:Reactome
P57103	SLC8A3	Sodium/calcium exchanger 3	GO:0005432; F:calcium:sodium antiporter activity; IEA:Ensembl
P57103	SLC8A3	Sodium/calcium exchanger 3	GO:0007596; P:blood coagulation; TAS:Reactome
P57103	SLC8A3	Sodium/calcium exchanger 3	GO:1990034; P:calcium ion export from cell; IEA:Ensembl
P57103	SLC8A3	Sodium/calcium exchanger 3	GO:1990035; P:calcium ion import into cell; IEA:Ensembl
P57103	SLC8A3	Sodium/calcium exchanger 3	GO:0060402; P:calcium ion transport into cytosol; IEA:Ensembl
P57103	SLC8A3	Sodium/calcium exchanger 3	GO:0007154; P:cell communication; IEA:InterPro
P57103	SLC8A3	Sodium/calcium exchanger 3	GO:0071320; P:cellular response to cAMP; IEA:Ensembl
P57103	SLC8A3	Sodium/calcium exchanger 3	GO:0006811; P:ion transport; TAS:Reactome
P57103	SLC8A3	Sodium/calcium exchanger 3	GO:0021537; P:telencephalon development; IEA:Ensembl
P57103	SLC8A3	Sodium/calcium exchanger 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9H009	NACA2	Nascent polypeptide-associated complex subunit alpha-2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O15069	NACAD	NAC-alpha domain-containing protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
E9PAV3	NACA	Nascent polypeptide-associated complex subunit alpha, muscle-specific form	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
E9PAV3	NACA	Nascent polypeptide-associated complex subunit alpha, muscle-specific form	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
E9PAV3	NACA	Nascent polypeptide-associated complex subunit alpha, muscle-specific form	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13765	NACA	Nascent polypeptide-associated complex subunit alpha	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q13765	NACA	Nascent polypeptide-associated complex subunit alpha	GO:0005515; F:protein binding; IPI:IntAct
Q13765	NACA	Nascent polypeptide-associated complex subunit alpha	GO:0017025; F:TBP-class protein binding; ISS:BHF-UCL
Q13765	NACA	Nascent polypeptide-associated complex subunit alpha	GO:0003713; F:transcription coactivator activity; ISS:BHF-UCL
Q13765	NACA	Nascent polypeptide-associated complex subunit alpha	GO:0003231; P:cardiac ventricle development; ISS:BHF-UCL
Q13765	NACA	Nascent polypeptide-associated complex subunit alpha	GO:0061384; P:heart trabecula morphogenesis; ISS:BHF-UCL
Q13765	NACA	Nascent polypeptide-associated complex subunit alpha	GO:0010664; P:negative regulation of striated muscle cell apoptotic process; ISS:BHF-UCL
Q13765	NACA	Nascent polypeptide-associated complex subunit alpha	GO:1901227; P:negative regulation of transcription from RNA polymerase II promoter involved in heart development; ISS:BHF-UCL
Q13765	NACA	Nascent polypeptide-associated complex subunit alpha	GO:2000138; P:positive regulation of cell proliferation involved in heart morphogenesis; ISS:BHF-UCL
Q13765	NACA	Nascent polypeptide-associated complex subunit alpha	GO:0048633; P:positive regulation of skeletal muscle tissue growth; ISS:BHF-UCL
Q13765	NACA	Nascent polypeptide-associated complex subunit alpha	GO:1901228; P:positive regulation of transcription from RNA polymerase II promoter involved in heart development; ISS:BHF-UCL
Q13765	NACA	Nascent polypeptide-associated complex subunit alpha	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q13765	NACA	Nascent polypeptide-associated complex subunit alpha	GO:0048742; P:regulation of skeletal muscle fiber development; ISS:BHF-UCL
Q13765	NACA	Nascent polypeptide-associated complex subunit alpha	GO:0043403; P:skeletal muscle tissue regeneration; ISS:BHF-UCL
Q13765	NACA	Nascent polypeptide-associated complex subunit alpha	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13765	NACA	Nascent polypeptide-associated complex subunit alpha	GO:0006412; P:translation; TAS:ProtInc
Q13765	NACA	Nascent polypeptide-associated complex subunit alpha	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q96RE7	NACC1	Nucleus accumbens-associated protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q96RE7	NACC1	Nucleus accumbens-associated protein 1	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
Q96RE7	NACC1	Nucleus accumbens-associated protein 1	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
Q96RE7	NACC1	Nucleus accumbens-associated protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96BF6	NACC2	Nucleus accumbens-associated protein 2	GO:0004407; F:histone deacetylase activity; IDA:BHF-UCL
Q96BF6	NACC2	Nucleus accumbens-associated protein 2	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
Q96BF6	NACC2	Nucleus accumbens-associated protein 2	GO:0005515; F:protein binding; IPI:BHF-UCL
Q96BF6	NACC2	Nucleus accumbens-associated protein 2	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
Q96BF6	NACC2	Nucleus accumbens-associated protein 2	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:BHF-UCL
Q96BF6	NACC2	Nucleus accumbens-associated protein 2	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IDA:BHF-UCL
Q96BF6	NACC2	Nucleus accumbens-associated protein 2	GO:0001076; F:RNA polymerase II transcription factor binding transcription factor activity; IDA:BHF-UCL
Q96BF6	NACC2	Nucleus accumbens-associated protein 2	GO:0034629; P:cellular protein complex localization; IDA:BHF-UCL
Q96BF6	NACC2	Nucleus accumbens-associated protein 2	GO:0016575; P:histone deacetylation; IDA:GOC
Q96BF6	NACC2	Nucleus accumbens-associated protein 2	GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL
Q96BF6	NACC2	Nucleus accumbens-associated protein 2	GO:1900477; P:negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q96BF6	NACC2	Nucleus accumbens-associated protein 2	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q96BF6	NACC2	Nucleus accumbens-associated protein 2	GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB
Q96BF6	NACC2	Nucleus accumbens-associated protein 2	GO:1902231; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; IDA:BHF-UCL
Q96BF6	NACC2	Nucleus accumbens-associated protein 2	GO:0010608; P:posttranscriptional regulation of gene expression; IMP:BHF-UCL
Q96BF6	NACC2	Nucleus accumbens-associated protein 2	GO:0051260; P:protein homooligomerization; ISS:UniProtKB
Q96BF6	NACC2	Nucleus accumbens-associated protein 2	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:GOC
Q9BWU0	SLC4A1AP	Kanadaptin	GO:0005515; F:protein binding; IPI:IntAct
Q15274	QPRT	Nicotinate-nucleotide pyrophosphorylase [carboxylating]	GO:0004514; F:nicotinate-nucleotide diphosphorylase (carboxylating) activity; IDA:UniProtKB
Q15274	QPRT	Nicotinate-nucleotide pyrophosphorylase [carboxylating]	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q15274	QPRT	Nicotinate-nucleotide pyrophosphorylase [carboxylating]	GO:0009435; P:NAD biosynthetic process; IEA:UniProtKB-UniPathway
Q15274	QPRT	Nicotinate-nucleotide pyrophosphorylase [carboxylating]	GO:0019674; P:NAD metabolic process; TAS:Reactome
Q15274	QPRT	Nicotinate-nucleotide pyrophosphorylase [carboxylating]	GO:0051259; P:protein oligomerization; IDA:UniProtKB
Q15274	QPRT	Nicotinate-nucleotide pyrophosphorylase [carboxylating]	GO:0034213; P:quinolinate catabolic process; IDA:UniProtKB
Q15274	QPRT	Nicotinate-nucleotide pyrophosphorylase [carboxylating]	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15274	QPRT	Nicotinate-nucleotide pyrophosphorylase [carboxylating]	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q15274	QPRT	Nicotinate-nucleotide pyrophosphorylase [carboxylating]	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q6IA69	NADSYN1	Glutamine-dependent NAD(+) synthetase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6IA69	NADSYN1	Glutamine-dependent NAD(+) synthetase	GO:0016810; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; IEA:InterPro
Q6IA69	NADSYN1	Glutamine-dependent NAD(+) synthetase	GO:0003952; F:NAD+ synthase (glutamine-hydrolyzing) activity; TAS:Reactome
Q6IA69	NADSYN1	Glutamine-dependent NAD(+) synthetase	GO:0009435; P:NAD biosynthetic process; IEA:UniProtKB-UniPathway
Q6IA69	NADSYN1	Glutamine-dependent NAD(+) synthetase	GO:0019674; P:NAD metabolic process; TAS:Reactome
Q6IA69	NADSYN1	Glutamine-dependent NAD(+) synthetase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6IA69	NADSYN1	Glutamine-dependent NAD(+) synthetase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q6IA69	NADSYN1	Glutamine-dependent NAD(+) synthetase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
O95544	NADK	NAD kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O95544	NADK	NAD kinase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95544	NADK	NAD kinase	GO:0003951; F:NAD+ kinase activity; IDA:UniProtKB
O95544	NADK	NAD kinase	GO:0046034; P:ATP metabolic process; NAS:UniProtKB
O95544	NADK	NAD kinase	GO:0019674; P:NAD metabolic process; TAS:Reactome
O95544	NADK	NAD kinase	GO:0006741; P:NADP biosynthetic process; IEA:InterPro
O95544	NADK	NAD kinase	GO:0016310; P:phosphorylation; NAS:UniProtKB
O95544	NADK	NAD kinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95544	NADK	NAD kinase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
O95544	NADK	NAD kinase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q58DX5	NAALADL2	Inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2	GO:0008233; F:peptidase activity; IEA:InterPro
Q96HR8	NAF1	H/ACA ribonucleoprotein complex non-core subunit NAF1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96HR8	NAF1	H/ACA ribonucleoprotein complex non-core subunit NAF1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96HR8	NAF1	H/ACA ribonucleoprotein complex non-core subunit NAF1	GO:0003723; F:RNA binding; IDA:UniProtKB
Q96HR8	NAF1	H/ACA ribonucleoprotein complex non-core subunit NAF1	GO:0001522; P:pseudouridine synthesis; IEA:InterPro
Q96HR8	NAF1	H/ACA ribonucleoprotein complex non-core subunit NAF1	GO:0042254; P:ribosome biogenesis; IDA:UniProtKB
Q96HR8	NAF1	H/ACA ribonucleoprotein complex non-core subunit NAF1	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
P17050	NAGA	Alpha-N-acetylgalactosaminidase	GO:0004557; F:alpha-galactosidase activity; IBA:RefGenome
P17050	NAGA	Alpha-N-acetylgalactosaminidase	GO:0008456; F:alpha-N-acetylgalactosaminidase activity; IDA:UniProtKB
P17050	NAGA	Alpha-N-acetylgalactosaminidase	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P17050	NAGA	Alpha-N-acetylgalactosaminidase	GO:0016052; P:carbohydrate catabolic process; IDA:UniProtKB
P17050	NAGA	Alpha-N-acetylgalactosaminidase	GO:0019377; P:glycolipid catabolic process; IMP:UniProtKB
P17050	NAGA	Alpha-N-acetylgalactosaminidase	GO:0016139; P:glycoside catabolic process; IBA:RefGenome
P17050	NAGA	Alpha-N-acetylgalactosaminidase	GO:0046477; P:glycosylceramide catabolic process; IBA:RefGenome
P17050	NAGA	Alpha-N-acetylgalactosaminidase	GO:0009311; P:oligosaccharide metabolic process; IBA:RefGenome
Q9Y303	AMDHD2	Putative N-acetylglucosamine-6-phosphate deacetylase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y303	AMDHD2	Putative N-acetylglucosamine-6-phosphate deacetylase	GO:0008448; F:N-acetylglucosamine-6-phosphate deacetylase activity; IDA:UniProtKB
Q9Y303	AMDHD2	Putative N-acetylglucosamine-6-phosphate deacetylase	GO:0005975; P:carbohydrate metabolic process; IEA:UniProtKB-KW
Q9Y303	AMDHD2	Putative N-acetylglucosamine-6-phosphate deacetylase	GO:0006044; P:N-acetylglucosamine metabolic process; IEA:InterPro
Q9Y303	AMDHD2	Putative N-acetylglucosamine-6-phosphate deacetylase	GO:0019262; P:N-acetylneuraminate catabolic process; TAS:UniProtKB
Q9UJ70	NAGK	N-acetyl-D-glucosamine kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UJ70	NAGK	N-acetyl-D-glucosamine kinase	GO:0045127; F:N-acetylglucosamine kinase activity; IDA:UniProtKB
Q9UJ70	NAGK	N-acetyl-D-glucosamine kinase	GO:0009384; F:N-acylmannosamine kinase activity; IEA:Ensembl
Q9UJ70	NAGK	N-acetyl-D-glucosamine kinase	GO:0005515; F:protein binding; IPI:IntAct
Q9UJ70	NAGK	N-acetyl-D-glucosamine kinase	GO:0046835; P:carbohydrate phosphorylation; IDA:GOC
Q9UJ70	NAGK	N-acetyl-D-glucosamine kinase	GO:0006044; P:N-acetylglucosamine metabolic process; TAS:ProtInc
Q9UJ70	NAGK	N-acetyl-D-glucosamine kinase	GO:0006051; P:N-acetylmannosamine metabolic process; TAS:ProtInc
Q9UJ70	NAGK	N-acetyl-D-glucosamine kinase	GO:0019262; P:N-acetylneuraminate catabolic process; TAS:UniProtKB
Q9UK23	NAGPA	N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase	GO:0003944; F:N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity; TAS:ProtInc
Q9UK23	NAGPA	N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
Q9UK23	NAGPA	N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q9UK23	NAGPA	N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase	GO:0007040; P:lysosome organization; TAS:ProtInc
Q9UK23	NAGPA	N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q9UK23	NAGPA	N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase	GO:0006622; P:protein targeting to lysosome; TAS:ProtInc
Q8N159	NAGS	N-acetylglutamate synthase, mitochondrial	GO:0004042; F:acetyl-CoA:L-glutamate N-acetyltransferase activity; TAS:BHF-UCL
Q8N159	NAGS	N-acetylglutamate synthase, mitochondrial	GO:0006526; P:arginine biosynthetic process; IEA:UniProtKB-UniPathway
Q8N159	NAGS	N-acetylglutamate synthase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q8N159	NAGS	N-acetylglutamate synthase, mitochondrial	GO:0006536; P:glutamate metabolic process; TAS:BHF-UCL
Q8N159	NAGS	N-acetylglutamate synthase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8N159	NAGS	N-acetylglutamate synthase, mitochondrial	GO:0000050; P:urea cycle; TAS:Reactome
Q5TF39	NAGLT1	Sodium-dependent glucose transporter 1	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q5TF39	NAGLT1	Sodium-dependent glucose transporter 1	GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW
Q5TF39	NAGLT1	Sodium-dependent glucose transporter 1	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q69YI7	NAIF1	Nuclear apoptosis-inducing factor 1	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q69YI7	NAIF1	Nuclear apoptosis-inducing factor 1	GO:1902108; P:regulation of mitochondrial membrane permeability involved in apoptotic process; IDA:UniProtKB
Q4G0N4	NADK2	NAD kinase 2, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q4G0N4	NADK2	NAD kinase 2, mitochondrial	GO:0003951; F:NAD+ kinase activity; IDA:UniProtKB
Q4G0N4	NADK2	NAD kinase 2, mitochondrial	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q4G0N4	NADK2	NAD kinase 2, mitochondrial	GO:0019674; P:NAD metabolic process; IDA:UniProtKB
Q4G0N4	NADK2	NAD kinase 2, mitochondrial	GO:0006741; P:NADP biosynthetic process; IEA:InterPro
Q86W26	NLRP10	NACHT, LRR and PYD domains-containing protein 10	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86W26	NLRP10	NACHT, LRR and PYD domains-containing protein 10	GO:0050832; P:defense response to fungus; ISS:UniProtKB
Q86W26	NLRP10	NACHT, LRR and PYD domains-containing protein 10	GO:0050829; P:defense response to Gram-negative bacterium; IMP:UniProtKB
Q86W26	NLRP10	NACHT, LRR and PYD domains-containing protein 10	GO:0036336; P:dendritic cell migration; ISS:UniProtKB
Q86W26	NLRP10	NACHT, LRR and PYD domains-containing protein 10	GO:0035397; P:helper T cell enhancement of adaptive immune response; ISS:UniProtKB
Q86W26	NLRP10	NACHT, LRR and PYD domains-containing protein 10	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q86W26	NLRP10	NACHT, LRR and PYD domains-containing protein 10	GO:2000778; P:positive regulation of interleukin-6 secretion; IMP:UniProtKB
Q86W26	NLRP10	NACHT, LRR and PYD domains-containing protein 10	GO:2000484; P:positive regulation of interleukin-8 secretion; IMP:UniProtKB
Q86W26	NLRP10	NACHT, LRR and PYD domains-containing protein 10	GO:0002827; P:positive regulation of T-helper 1 type immune response; ISS:UniProtKB
Q86W26	NLRP10	NACHT, LRR and PYD domains-containing protein 10	GO:2000318; P:positive regulation of T-helper 17 type immune response; ISS:UniProtKB
P59045	NLRP11	NACHT, LRR and PYD domains-containing protein 11	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P59045	NLRP11	NACHT, LRR and PYD domains-containing protein 11	GO:0016715; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen; IEA:InterPro
P59045	NLRP11	NACHT, LRR and PYD domains-containing protein 11	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; NAS:UniProtKB
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0005515; F:protein binding; IPI:UniProtKB
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; NAS:UniProtKB
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0071345; P:cellular response to cytokine stimulus; IEA:Ensembl
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0036336; P:dendritic cell migration; IEA:Ensembl
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0050710; P:negative regulation of cytokine secretion; IDA:HGNC
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IEA:Ensembl
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:HGNC
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0050728; P:negative regulation of inflammatory response; IMP:BHF-UCL
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0050711; P:negative regulation of interleukin-1 secretion; IDA:HGNC
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0045409; P:negative regulation of interleukin-6 biosynthetic process; IDA:HGNC
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:BHF-UCL
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:1901223; P:negative regulation of NIK/NF-kappaB signaling; IEA:Ensembl
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0031953; P:negative regulation of protein autophosphorylation; IDA:HGNC
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0009968; P:negative regulation of signal transduction; IDA:HGNC
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0045751; P:negative regulation of Toll signaling pathway; IDA:HGNC
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0050729; P:positive regulation of inflammatory response; NAS:UniProtKB
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0050718; P:positive regulation of interleukin-1 beta secretion; NAS:UniProtKB
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0045381; P:regulation of interleukin-18 biosynthetic process; NAS:UniProtKB
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0008588; P:release of cytoplasmic sequestered NF-kappaB; IDA:UniProtKB
P59046	NLRP12	NACHT, LRR and PYD domains-containing protein 12	GO:0007165; P:signal transduction; NAS:UniProtKB
Q86W24	NLRP14	NACHT, LRR and PYD domains-containing protein 14	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86W24	NLRP14	NACHT, LRR and PYD domains-containing protein 14	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q86W24	NLRP14	NACHT, LRR and PYD domains-containing protein 14	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q86W24	NLRP14	NACHT, LRR and PYD domains-containing protein 14	GO:0007283; P:spermatogenesis; IMP:UniProtKB
Q86W25	NLRP13	NACHT, LRR and PYD domains-containing protein 13	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IZF0	NALCN	Sodium leak channel non-selective protein	GO:0005515; F:protein binding; IPI:IntAct
Q8IZF0	NALCN	Sodium leak channel non-selective protein	GO:0005272; F:sodium channel activity; TAS:Reactome
Q8IZF0	NALCN	Sodium leak channel non-selective protein	GO:0005245; F:voltage-gated calcium channel activity; IBA:RefGenome
Q8IZF0	NALCN	Sodium leak channel non-selective protein	GO:0070509; P:calcium ion import; IBA:RefGenome
Q8IZF0	NALCN	Sodium leak channel non-selective protein	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q8IZF0	NALCN	Sodium leak channel non-selective protein	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q8IZF0	NALCN	Sodium leak channel non-selective protein	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q8IZF0	NALCN	Sodium leak channel non-selective protein	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
Q8IZF0	NALCN	Sodium leak channel non-selective protein	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9Y3Q0	NAALAD2	N-acetylated-alpha-linked acidic dipeptidase 2	GO:0004180; F:carboxypeptidase activity; NAS:UniProtKB
Q9Y3Q0	NAALAD2	N-acetylated-alpha-linked acidic dipeptidase 2	GO:0016805; F:dipeptidase activity; NAS:UniProtKB
Q9Y3Q0	NAALAD2	N-acetylated-alpha-linked acidic dipeptidase 2	GO:0008239; F:dipeptidyl-peptidase activity; NAS:UniProtKB
Q9Y3Q0	NAALAD2	N-acetylated-alpha-linked acidic dipeptidase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y3Q0	NAALAD2	N-acetylated-alpha-linked acidic dipeptidase 2	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
Q9Y3Q0	NAALAD2	N-acetylated-alpha-linked acidic dipeptidase 2	GO:0050129; F:N-formylglutamate deformylase activity; IEA:Ensembl
Q9Y3Q0	NAALAD2	N-acetylated-alpha-linked acidic dipeptidase 2	GO:0008236; F:serine-type peptidase activity; NAS:UniProtKB
Q9Y3Q0	NAALAD2	N-acetylated-alpha-linked acidic dipeptidase 2	GO:0042135; P:neurotransmitter catabolic process; IEA:Ensembl
Q9Y3Q0	NAALAD2	N-acetylated-alpha-linked acidic dipeptidase 2	GO:0006508; P:proteolysis; NAS:UniProtKB
Q9UQQ1	NAALADL1	N-acetylated-alpha-linked acidic dipeptidase-like protein	GO:0004180; F:carboxypeptidase activity; IEA:UniProtKB-KW
Q9UQQ1	NAALADL1	N-acetylated-alpha-linked acidic dipeptidase-like protein	GO:0016805; F:dipeptidase activity; IEA:UniProtKB-KW
Q9UQQ1	NAALADL1	N-acetylated-alpha-linked acidic dipeptidase-like protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UQQ1	NAALADL1	N-acetylated-alpha-linked acidic dipeptidase-like protein	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
Q9UQQ1	NAALADL1	N-acetylated-alpha-linked acidic dipeptidase-like protein	GO:0008233; F:peptidase activity; NAS:UniProtKB
Q9NX02	NLRP2	NACHT, LRR and PYD domains-containing protein 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NX02	NLRP2	NACHT, LRR and PYD domains-containing protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q9NX02	NLRP2	NACHT, LRR and PYD domains-containing protein 2	GO:0032090; F:Pyrin domain binding; IPI:HGNC
Q9NX02	NLRP2	NACHT, LRR and PYD domains-containing protein 2	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:HGNC
Q9NX02	NLRP2	NACHT, LRR and PYD domains-containing protein 2	GO:0050718; P:positive regulation of interleukin-1 beta secretion; IDA:HGNC
Q9C000	NLRP1	NACHT, LRR and PYD domains-containing protein 1	GO:0005524; F:ATP binding; IDA:HGNC
Q9C000	NLRP1	NACHT, LRR and PYD domains-containing protein 1	GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; NAS:UniProtKB
Q9C000	NLRP1	NACHT, LRR and PYD domains-containing protein 1	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9C000	NLRP1	NACHT, LRR and PYD domains-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9C000	NLRP1	NACHT, LRR and PYD domains-containing protein 1	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q9C000	NLRP1	NACHT, LRR and PYD domains-containing protein 1	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; NAS:UniProtKB
Q9C000	NLRP1	NACHT, LRR and PYD domains-containing protein 1	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q9C000	NLRP1	NACHT, LRR and PYD domains-containing protein 1	GO:0042742; P:defense response to bacterium; ISS:BHF-UCL
Q9C000	NLRP1	NACHT, LRR and PYD domains-containing protein 1	GO:0045087; P:innate immune response; TAS:Reactome
Q9C000	NLRP1	NACHT, LRR and PYD domains-containing protein 1	GO:0051402; P:neuron apoptotic process; IDA:HGNC
Q9C000	NLRP1	NACHT, LRR and PYD domains-containing protein 1	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q9C000	NLRP1	NACHT, LRR and PYD domains-containing protein 1	GO:0050718; P:positive regulation of interleukin-1 beta secretion; ISS:BHF-UCL
Q9C000	NLRP1	NACHT, LRR and PYD domains-containing protein 1	GO:0050727; P:regulation of inflammatory response; IC:BHF-UCL
Q9C000	NLRP1	NACHT, LRR and PYD domains-containing protein 1	GO:0032495; P:response to muramyl dipeptide; ISS:BHF-UCL
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0042834; F:peptidoglycan binding; TAS:HGNC
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0071222; P:cellular response to lipopolysaccharide; IMP:BHF-UCL
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0006952; P:defense response; TAS:HGNC
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0051607; P:defense response to virus; IEA:Ensembl
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0009595; P:detection of biotic stimulus; TAS:HGNC
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0006954; P:inflammatory response; IMP:UniProtKB
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0045087; P:innate immune response; TAS:Reactome
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0032611; P:interleukin-1 beta production; IEA:Ensembl
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0050701; P:interleukin-1 secretion; IEA:Ensembl
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0032621; P:interleukin-18 production; IEA:Ensembl
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0002674; P:negative regulation of acute inflammatory response; IMP:BHF-UCL
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0050728; P:negative regulation of inflammatory response; IMP:BHF-UCL
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0050713; P:negative regulation of interleukin-1 beta secretion; IMP:BHF-UCL
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0042347; P:negative regulation of NF-kappaB import into nucleus; IDA:HGNC
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:HGNC
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0044546; P:NLRP3 inflammasome complex assembly; IEA:Ensembl
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:HGNC
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0050718; P:positive regulation of interleukin-1 beta secretion; IDA:HGNC
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0051259; P:protein oligomerization; TAS:HGNC
Q96P20	NLRP3	NACHT, LRR and PYD domains-containing protein 3	GO:0007165; P:signal transduction; NAS:UniProtKB
Q96MN2	NLRP4	NACHT, LRR and PYD domains-containing protein 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96MN2	NLRP4	NACHT, LRR and PYD domains-containing protein 4	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q96MN2	NLRP4	NACHT, LRR and PYD domains-containing protein 4	GO:0045087; P:innate immune response; TAS:Reactome
Q96MN2	NLRP4	NACHT, LRR and PYD domains-containing protein 4	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q96MN2	NLRP4	NACHT, LRR and PYD domains-containing protein 4	GO:0032479; P:regulation of type I interferon production; TAS:Reactome
P59047	NLRP5	NACHT, LRR and PYD domains-containing protein 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P59047	NLRP5	NACHT, LRR and PYD domains-containing protein 5	GO:0043623; P:cellular protein complex assembly; IEA:Ensembl
P59047	NLRP5	NACHT, LRR and PYD domains-containing protein 5	GO:0007566; P:embryo implantation; IEA:Ensembl
P59047	NLRP5	NACHT, LRR and PYD domains-containing protein 5	GO:0009566; P:fertilization; IEA:Ensembl
P59047	NLRP5	NACHT, LRR and PYD domains-containing protein 5	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P59047	NLRP5	NACHT, LRR and PYD domains-containing protein 5	GO:0070997; P:neuron death; IMP:UniProt
P59047	NLRP5	NACHT, LRR and PYD domains-containing protein 5	GO:0009887; P:organ morphogenesis; IEA:Ensembl
P59047	NLRP5	NACHT, LRR and PYD domains-containing protein 5	GO:0031647; P:regulation of protein stability; IEA:Ensembl
P59047	NLRP5	NACHT, LRR and PYD domains-containing protein 5	GO:0043487; P:regulation of RNA stability; IEA:Ensembl
P59044	NLRP6	NACHT, LRR and PYD domains-containing protein 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P59044	NLRP6	NACHT, LRR and PYD domains-containing protein 6	GO:0005000; F:vasopressin receptor activity; ISS:UniProtKB
P59044	NLRP6	NACHT, LRR and PYD domains-containing protein 6	GO:0007186; P:G-protein coupled receptor signaling pathway; ISS:GOC
P59044	NLRP6	NACHT, LRR and PYD domains-containing protein 6	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
P59044	NLRP6	NACHT, LRR and PYD domains-containing protein 6	GO:0050777; P:negative regulation of immune response; IEA:Ensembl
P59044	NLRP6	NACHT, LRR and PYD domains-containing protein 6	GO:0043409; P:negative regulation of MAPK cascade; IEA:Ensembl
P59044	NLRP6	NACHT, LRR and PYD domains-containing protein 6	GO:0034122; P:negative regulation of toll-like receptor signaling pathway; IEA:Ensembl
P59044	NLRP6	NACHT, LRR and PYD domains-containing protein 6	GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB
P59044	NLRP6	NACHT, LRR and PYD domains-containing protein 6	GO:0009617; P:response to bacterium; IEA:Ensembl
P59044	NLRP6	NACHT, LRR and PYD domains-containing protein 6	GO:0042060; P:wound healing; IEA:Ensembl
Q8WX94	NLRP7	NACHT, LRR and PYD domains-containing protein 7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86W28	NLRP8	NACHT, LRR and PYD domains-containing protein 8	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86W28	NLRP8	NACHT, LRR and PYD domains-containing protein 8	GO:0070997; P:neuron death; IMP:UniProt
Q7RTR0	NLRP9	NACHT, LRR and PYD domains-containing protein 9	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P43490	NAMPT	Nicotinamide phosphoribosyltransferase	GO:0005125; F:cytokine activity; TAS:ProtInc
P43490	NAMPT	Nicotinamide phosphoribosyltransferase	GO:0047280; F:nicotinamide phosphoribosyltransferase activity; IEA:UniProtKB-EC
P43490	NAMPT	Nicotinamide phosphoribosyltransferase	GO:0004514; F:nicotinate-nucleotide diphosphorylase (carboxylating) activity; IEA:InterPro
P43490	NAMPT	Nicotinamide phosphoribosyltransferase	GO:0005515; F:protein binding; IPI:IntAct
P43490	NAMPT	Nicotinamide phosphoribosyltransferase	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P43490	NAMPT	Nicotinamide phosphoribosyltransferase	GO:0009435; P:NAD biosynthetic process; IEA:UniProtKB-UniPathway
P43490	NAMPT	Nicotinamide phosphoribosyltransferase	GO:0019674; P:NAD metabolic process; TAS:Reactome
P43490	NAMPT	Nicotinamide phosphoribosyltransferase	GO:0006769; P:nicotinamide metabolic process; TAS:Reactome
P43490	NAMPT	Nicotinamide phosphoribosyltransferase	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P43490	NAMPT	Nicotinamide phosphoribosyltransferase	GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; IDA:BHF-UCL
P43490	NAMPT	Nicotinamide phosphoribosyltransferase	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P43490	NAMPT	Nicotinamide phosphoribosyltransferase	GO:0007165; P:signal transduction; TAS:ProtInc
P43490	NAMPT	Nicotinamide phosphoribosyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P43490	NAMPT	Nicotinamide phosphoribosyltransferase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P43490	NAMPT	Nicotinamide phosphoribosyltransferase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q8N7R0	NANOGP1	Putative homeobox protein NANOG2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q8N7R0	NANOGP1	Putative homeobox protein NANOG2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8N7R0	NANOGP1	Putative homeobox protein NANOG2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z5D8	NANOGNB	NANOG neighbor homeobox	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q7Z5D8	NANOGNB	NANOG neighbor homeobox	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8WY41	NANOS1	Nanos homolog 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WY41	NANOS1	Nanos homolog 1	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q8WY41	NANOS1	Nanos homolog 1	GO:0030371; F:translation repressor activity; ISS:UniProtKB
Q8WY41	NANOS1	Nanos homolog 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WY41	NANOS1	Nanos homolog 1	GO:0016477; P:cell migration; IDA:UniProtKB
Q8WY41	NANOS1	Nanos homolog 1	GO:0010631; P:epithelial cell migration; IDA:UniProtKB
Q8WY41	NANOS1	Nanos homolog 1	GO:0017148; P:negative regulation of translation; ISS:GOC
P60321	NANOS2	Nanos homolog 2	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
P60321	NANOS2	Nanos homolog 2	GO:0008270; F:zinc ion binding; IEA:InterPro
P60321	NANOS2	Nanos homolog 2	GO:0030718; P:germ-line stem cell maintenance; ISS:UniProtKB
P60321	NANOS2	Nanos homolog 2	GO:0006402; P:mRNA catabolic process; ISS:UniProtKB
P60321	NANOS2	Nanos homolog 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P60321	NANOS2	Nanos homolog 2	GO:0045835; P:negative regulation of meiosis; ISS:UniProtKB
P60321	NANOS2	Nanos homolog 2	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
P60321	NANOS2	Nanos homolog 2	GO:0007283; P:spermatogenesis; ISS:UniProtKB
P60323	NANOS3	Nanos homolog 3	GO:0003723; F:RNA binding; ISS:UniProtKB
P60323	NANOS3	Nanos homolog 3	GO:0008270; F:zinc ion binding; IEA:InterPro
P60323	NANOS3	Nanos homolog 3	GO:0007281; P:germ cell development; IMP:UniProtKB
P60323	NANOS3	Nanos homolog 3	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P60323	NANOS3	Nanos homolog 3	GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl
P60323	NANOS3	Nanos homolog 3	GO:0048477; P:oogenesis; IEA:UniProtKB-KW
P60323	NANOS3	Nanos homolog 3	GO:0051726; P:regulation of cell cycle; ISS:UniProtKB
P60323	NANOS3	Nanos homolog 3	GO:0006417; P:regulation of translation; ISS:UniProtKB
P60323	NANOS3	Nanos homolog 3	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0003677; F:DNA binding; IDA:UniProtKB
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0001158; F:enhancer sequence-specific DNA binding; IEA:Ensembl
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:HGNC
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0003714; F:transcription corepressor activity; ISS:UniProtKB
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0030154; P:cell differentiation; IEP:HGNC
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0008283; P:cell proliferation; IMP:HGNC
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0009790; P:embryo development; IEP:HGNC
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0009880; P:embryonic pattern specification; IEA:Ensembl
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0001714; P:endodermal cell fate specification; IDA:MGI
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0008406; P:gonad development; IEA:Ensembl
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0001710; P:mesodermal cell fate commitment; IEA:Ensembl
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0030514; P:negative regulation of BMP signaling pathway; IEA:Ensembl
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0010454; P:negative regulation of cell fate commitment; IEA:Ensembl
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0045931; P:positive regulation of mitotic cell cycle; IEA:Ensembl
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0045595; P:regulation of cell differentiation; IMP:HGNC
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0010468; P:regulation of gene expression; IMP:UniProtKB
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0006355; P:regulation of transcription, DNA-templated; IDA:HGNC
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0032526; P:response to retinoic acid; IEA:Ensembl
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0035019; P:somatic stem cell maintenance; IMP:UniProtKB
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0017145; P:stem cell division; IEA:Ensembl
Q9H9S0	NANOG	Homeobox protein NANOG	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TBE9	NANP	N-acylneuraminate-9-phosphatase	GO:0050124; F:N-acylneuraminate-9-phosphatase activity; IDA:UniProtKB
Q8TBE9	NANP	N-acylneuraminate-9-phosphatase	GO:0005975; P:carbohydrate metabolic process; IEA:UniProtKB-KW
Q8TBE9	NANP	N-acylneuraminate-9-phosphatase	GO:0016311; P:dephosphorylation; IDA:GOC
Q8TBE9	NANP	N-acylneuraminate-9-phosphatase	GO:0006045; P:N-acetylglucosamine biosynthetic process; IEA:UniProtKB-UniPathway
Q8TBE9	NANP	N-acylneuraminate-9-phosphatase	GO:0046380; P:N-acetylneuraminate biosynthetic process; IDA:UniProtKB
Q6NSW7	NANOGP8	Putative homeobox protein NANOGP8	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q6NSW7	NANOGP8	Putative homeobox protein NANOGP8	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q6NSW7	NANOGP8	Putative homeobox protein NANOGP8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BU70	C9orf156	Nef-associated protein 1	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q9BU70	C9orf156	Nef-associated protein 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q6IQ20	NAPEPLD	N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D	GO:0070290; F:NAPE-specific phospholipase D activity; IEA:InterPro
Q6IQ20	NAPEPLD	N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6IQ20	NAPEPLD	N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D	GO:0009395; P:phospholipid catabolic process; IEA:UniProtKB-KW
O96009	NAPSA	Napsin-A	GO:0004190; F:aspartic-type endopeptidase activity; NAS:UniProtKB
O96009	NAPSA	Napsin-A	GO:0004175; F:endopeptidase activity; IDA:UniProtKB
O96009	NAPSA	Napsin-A	GO:0008233; F:peptidase activity; IDA:UniProtKB
O96009	NAPSA	Napsin-A	GO:0033619; P:membrane protein proteolysis; IDA:UniProtKB
O96009	NAPSA	Napsin-A	GO:0006508; P:proteolysis; NAS:UniProtKB
O96009	NAPSA	Napsin-A	GO:0043129; P:surfactant homeostasis; IDA:UniProtKB
P52961	ART1	GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1	GO:0003956; F:NAD(P)+-protein-arginine ADP-ribosyltransferase activity; IEA:UniProtKB-EC
P52961	ART1	GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; TAS:ProtInc
P52961	ART1	GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1	GO:0045087; P:innate immune response; TAS:Reactome
P52961	ART1	GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1	GO:0006471; P:protein ADP-ribosylation; TAS:ProtInc
Q13508	ART3	Ecto-ADP-ribosyltransferase 3	GO:0003956; F:NAD(P)+-protein-arginine ADP-ribosyltransferase activity; IEA:UniProtKB-EC
Q13508	ART3	Ecto-ADP-ribosyltransferase 3	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; TAS:ProtInc
Q13508	ART3	Ecto-ADP-ribosyltransferase 3	GO:0006471; P:protein ADP-ribosylation; TAS:ProtInc
Q93070	ART4	Ecto-ADP-ribosyltransferase 4	GO:0003956; F:NAD(P)+-protein-arginine ADP-ribosyltransferase activity; NAS:UniProtKB
Q93070	ART4	Ecto-ADP-ribosyltransferase 4	GO:0006525; P:arginine metabolic process; NAS:UniProtKB
Q93070	ART4	Ecto-ADP-ribosyltransferase 4	GO:0006471; P:protein ADP-ribosylation; NAS:UniProtKB
Q96L15	ART5	Ecto-ADP-ribosyltransferase 5	GO:0003956; F:NAD(P)+-protein-arginine ADP-ribosyltransferase activity; IEA:UniProtKB-EC
Q96L15	ART5	Ecto-ADP-ribosyltransferase 5	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IEA:Ensembl
Q96L15	ART5	Ecto-ADP-ribosyltransferase 5	GO:0003953; F:NAD+ nucleosidase activity; IEA:Ensembl
Q96L15	ART5	Ecto-ADP-ribosyltransferase 5	GO:0006471; P:protein ADP-ribosylation; IEA:Ensembl
Q9H6Q4	NARFL	Cytosolic Fe-S cluster assembly factor NARFL	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
Q9H6Q4	NARFL	Cytosolic Fe-S cluster assembly factor NARFL	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H6Q4	NARFL	Cytosolic Fe-S cluster assembly factor NARFL	GO:0016226; P:iron-sulfur cluster assembly; IMP:UniProtKB
Q9H6Q4	NARFL	Cytosolic Fe-S cluster assembly factor NARFL	GO:0032364; P:oxygen homeostasis; IDA:HGNC
Q9H6Q4	NARFL	Cytosolic Fe-S cluster assembly factor NARFL	GO:0006355; P:regulation of transcription, DNA-templated; IDA:HGNC
Q9H6Q4	NARFL	Cytosolic Fe-S cluster assembly factor NARFL	GO:0001666; P:response to hypoxia; IDA:HGNC
Q9H6Q4	NARFL	Cytosolic Fe-S cluster assembly factor NARFL	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UHQ1	NARF	Nuclear prelamin A recognition factor	GO:0005521; F:lamin binding; IPI:HGNC
P49321	NASP	Nuclear autoantigenic sperm protein	GO:0051879; F:Hsp90 protein binding; ISS:UniProtKB
P49321	NASP	Nuclear autoantigenic sperm protein	GO:0001824; P:blastocyst development; ISS:UniProtKB
P49321	NASP	Nuclear autoantigenic sperm protein	GO:0007049; P:cell cycle; ISS:UniProtKB
P49321	NASP	Nuclear autoantigenic sperm protein	GO:0008283; P:cell proliferation; ISS:UniProtKB
P49321	NASP	Nuclear autoantigenic sperm protein	GO:0006260; P:DNA replication; ISS:UniProtKB
P49321	NASP	Nuclear autoantigenic sperm protein	GO:0006335; P:DNA replication-dependent nucleosome assembly; IDA:UniProt
P49321	NASP	Nuclear autoantigenic sperm protein	GO:0006336; P:DNA replication-independent nucleosome assembly; IDA:UniProt
P49321	NASP	Nuclear autoantigenic sperm protein	GO:0043486; P:histone exchange; ISS:UniProtKB
P49321	NASP	Nuclear autoantigenic sperm protein	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9H0A0	NAT10	N-acetyltransferase 10	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H0A0	NAT10	N-acetyltransferase 10	GO:0008080; F:N-acetyltransferase activity; IEA:InterPro
Q9H0A0	NAT10	N-acetyltransferase 10	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8WUY8	NAT14	N-acetyltransferase 14	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8WUY8	NAT14	N-acetyltransferase 14	GO:0008080; F:N-acetyltransferase activity; IEA:InterPro
Q8WUY8	NAT14	N-acetyltransferase 14	GO:0006352; P:DNA-templated transcription, initiation; NAS:UniProtKB
Q8WUY8	NAT14	N-acetyltransferase 14	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
Q8N8M0	NAT16	Putative N-acetyltransferase 16	GO:0008080; F:N-acetyltransferase activity; IEA:InterPro
Q93015	NAT6	N-acetyltransferase 6	GO:0008080; F:N-acetyltransferase activity; IEA:InterPro
Q9UHF3	NAT8B	Probable N-acetyltransferase 8B	GO:0008080; F:N-acetyltransferase activity; NAS:UniProtKB
Q9UHF3	NAT8B	Probable N-acetyltransferase 8B	GO:0001702; P:gastrulation with mouth forming second; NAS:UniProtKB
Q9UHF3	NAT8B	Probable N-acetyltransferase 8B	GO:0008152; P:metabolic process; NAS:GOC
Q8N9F0	NAT8L	N-acetylaspartate synthetase	GO:0017188; F:aspartate N-acetyltransferase activity; IDA:UniProtKB
Q8N9F0	NAT8L	N-acetylaspartate synthetase	GO:0008152; P:metabolic process; IDA:GOC
Q8N9F0	NAT8L	N-acetylaspartate synthetase	GO:0051586; P:positive regulation of dopamine uptake involved in synaptic transmission; IEA:Ensembl
Q9UHE5	NAT8	Probable N-acetyltransferase 8	GO:0008080; F:N-acetyltransferase activity; NAS:UniProtKB
Q9UHE5	NAT8	Probable N-acetyltransferase 8	GO:0001702; P:gastrulation with mouth forming second; IMP:UniProtKB
Q9UHE5	NAT8	Probable N-acetyltransferase 8	GO:0008152; P:metabolic process; NAS:GOC
Q9UHE5	NAT8	Probable N-acetyltransferase 8	GO:0042493; P:response to drug; TAS:ProtInc
Q9BTE0	NAT9	N-acetyltransferase 9	GO:0008080; F:N-acetyltransferase activity; IEA:InterPro
Q8NEY1	NAV1	Neuron navigator 1	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q8NEY1	NAV1	Neuron navigator 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8NEY1	NAV1	Neuron navigator 1	GO:0001578; P:microtubule bundle formation; IEA:Ensembl
Q8NEY1	NAV1	Neuron navigator 1	GO:0001764; P:neuron migration; IEA:Ensembl
Q8IVL1	NAV2	Neuron navigator 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IVL1	NAV2	Neuron navigator 2	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q8IVL1	NAV2	Neuron navigator 2	GO:0008201; F:heparin binding; IEA:Ensembl
Q8IVL1	NAV2	Neuron navigator 2	GO:0021563; P:glossopharyngeal nerve development; IEA:Ensembl
Q8IVL1	NAV2	Neuron navigator 2	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q8IVL1	NAV2	Neuron navigator 2	GO:0021554; P:optic nerve development; IEA:Ensembl
Q8IVL1	NAV2	Neuron navigator 2	GO:0003025; P:regulation of systemic arterial blood pressure by baroreceptor feedback; IEA:Ensembl
Q8IVL1	NAV2	Neuron navigator 2	GO:0007608; P:sensory perception of smell; IEA:Ensembl
Q8IVL1	NAV2	Neuron navigator 2	GO:0007605; P:sensory perception of sound; IEA:Ensembl
Q8IVL1	NAV2	Neuron navigator 2	GO:0021564; P:vagus nerve development; IEA:Ensembl
Q8IVL0	NAV3	Neuron navigator 3	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q8IVL0	NAV3	Neuron navigator 3	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9UHQ9	CYB5R1	NADH-cytochrome b5 reductase 1	GO:0004128; F:cytochrome-b5 reductase activity, acting on NAD(P)H; IEA:UniProtKB-EC
Q9UHQ9	CYB5R1	NADH-cytochrome b5 reductase 1	GO:0016126; P:sterol biosynthetic process; IEA:UniProtKB-KW
Q6BCY4	CYB5R2	NADH-cytochrome b5 reductase 2	GO:0004128; F:cytochrome-b5 reductase activity, acting on NAD(P)H; IDA:UniProtKB
Q6BCY4	CYB5R2	NADH-cytochrome b5 reductase 2	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q6BCY4	CYB5R2	NADH-cytochrome b5 reductase 2	GO:0016126; P:sterol biosynthetic process; IEA:UniProtKB-KW
P00387	CYB5R3	NADH-cytochrome b5 reductase 3	GO:0043531; F:ADP binding; IEA:Ensembl
P00387	CYB5R3	NADH-cytochrome b5 reductase 3	GO:0016208; F:AMP binding; IEA:Ensembl
P00387	CYB5R3	NADH-cytochrome b5 reductase 3	GO:0004128; F:cytochrome-b5 reductase activity, acting on NAD(P)H; TAS:Reactome
P00387	CYB5R3	NADH-cytochrome b5 reductase 3	GO:0071949; F:FAD binding; IDA:UniProtKB
P00387	CYB5R3	NADH-cytochrome b5 reductase 3	GO:0050660; F:flavin adenine dinucleotide binding; IEA:Ensembl
P00387	CYB5R3	NADH-cytochrome b5 reductase 3	GO:0051287; F:NAD binding; IEA:Ensembl
P00387	CYB5R3	NADH-cytochrome b5 reductase 3	GO:0008015; P:blood circulation; TAS:ProtInc
P00387	CYB5R3	NADH-cytochrome b5 reductase 3	GO:0006695; P:cholesterol biosynthetic process; IEA:UniProtKB-KW
P00387	CYB5R3	NADH-cytochrome b5 reductase 3	GO:0019852; P:L-ascorbic acid metabolic process; TAS:Reactome
P00387	CYB5R3	NADH-cytochrome b5 reductase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P00387	CYB5R3	NADH-cytochrome b5 reductase 3	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P00387	CYB5R3	NADH-cytochrome b5 reductase 3	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q7L1T6	CYB5R4	Cytochrome b5 reductase 4	GO:0004128; F:cytochrome-b5 reductase activity, acting on NAD(P)H; IDA:UniProtKB
Q7L1T6	CYB5R4	Cytochrome b5 reductase 4	GO:0050660; F:flavin adenine dinucleotide binding; IEA:Ensembl
Q7L1T6	CYB5R4	Cytochrome b5 reductase 4	GO:0020037; F:heme binding; IEA:Ensembl
Q7L1T6	CYB5R4	Cytochrome b5 reductase 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7L1T6	CYB5R4	Cytochrome b5 reductase 4	GO:0016174; F:NAD(P)H oxidase activity; IDA:UniProtKB
Q7L1T6	CYB5R4	Cytochrome b5 reductase 4	GO:0003958; F:NADPH-hemoprotein reductase activity; IEA:Ensembl
Q7L1T6	CYB5R4	Cytochrome b5 reductase 4	GO:0016653; F:oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor; IDA:UniProtKB
Q7L1T6	CYB5R4	Cytochrome b5 reductase 4	GO:0048468; P:cell development; ISS:UniProtKB
Q7L1T6	CYB5R4	Cytochrome b5 reductase 4	GO:0003032; P:detection of oxygen; NAS:UniProtKB
Q7L1T6	CYB5R4	Cytochrome b5 reductase 4	GO:0006091; P:generation of precursor metabolites and energy; IDA:UniProtKB
Q7L1T6	CYB5R4	Cytochrome b5 reductase 4	GO:0042593; P:glucose homeostasis; ISS:UniProtKB
Q7L1T6	CYB5R4	Cytochrome b5 reductase 4	GO:0030073; P:insulin secretion; ISS:UniProtKB
Q7L1T6	CYB5R4	Cytochrome b5 reductase 4	GO:0006739; P:NADP metabolic process; IEA:Ensembl
Q7L1T6	CYB5R4	Cytochrome b5 reductase 4	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q7L1T6	CYB5R4	Cytochrome b5 reductase 4	GO:0046677; P:response to antibiotic; ISS:UniProtKB
Q7L1T6	CYB5R4	Cytochrome b5 reductase 4	GO:0006801; P:superoxide metabolic process; IDA:UniProtKB
Q6IPT4	CYB5RL	NADH-cytochrome b5 reductase-like	GO:0004128; F:cytochrome-b5 reductase activity, acting on NAD(P)H; IEA:UniProtKB-EC
A2RRP1	NBAS	Neuroblastoma-amplified sequence	GO:2000623; P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IMP:UniProt
A2RRP1	NBAS	Neuroblastoma-amplified sequence	GO:0000956; P:nuclear-transcribed mRNA catabolic process; IMP:UniProt
Q8NFP9	NBEA	Neurobeachin	GO:0008104; P:protein localization; IEA:Ensembl
Q6ZNJ1	NBEAL2	Neurobeachin-like protein 2	GO:0030220; P:platelet formation; IMP:UniProtKB
P41271	NBL1	Neuroblastoma suppressor of tumorigenicity 1	GO:0036122; F:BMP binding; ISS:BHF-UCL
P41271	NBL1	Neuroblastoma suppressor of tumorigenicity 1	GO:0016015; F:morphogen activity; ISS:BHF-UCL
P41271	NBL1	Neuroblastoma suppressor of tumorigenicity 1	GO:0042803; F:protein homodimerization activity; IMP:UniProt
P41271	NBL1	Neuroblastoma suppressor of tumorigenicity 1	GO:0048263; P:determination of dorsal identity; ISS:BHF-UCL
P41271	NBL1	Neuroblastoma suppressor of tumorigenicity 1	GO:0030514; P:negative regulation of BMP signaling pathway; IDA:UniProt
P41271	NBL1	Neuroblastoma suppressor of tumorigenicity 1	GO:0090027; P:negative regulation of monocyte chemotaxis; ISS:BHF-UCL
P41271	NBL1	Neuroblastoma suppressor of tumorigenicity 1	GO:0007399; P:nervous system development; ISS:BHF-UCL
P41271	NBL1	Neuroblastoma suppressor of tumorigenicity 1	GO:0048812; P:neuron projection morphogenesis; ISS:BHF-UCL
P41271	NBL1	Neuroblastoma suppressor of tumorigenicity 1	GO:0045666; P:positive regulation of neuron differentiation; ISS:BHF-UCL
P41271	NBL1	Neuroblastoma suppressor of tumorigenicity 1	GO:0038098; P:sequestering of BMP from receptor via BMP binding; IDA:UniProt
P41271	NBL1	Neuroblastoma suppressor of tumorigenicity 1	GO:0035582; P:sequestering of BMP in extracellular matrix; ISS:BHF-UCL
O60934	NBN	Nibrin	GO:0003684; F:damaged DNA binding; IEA:Ensembl
O60934	NBN	Nibrin	GO:0005515; F:protein binding; IPI:UniProtKB
O60934	NBN	Nibrin	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
O60934	NBN	Nibrin	GO:0008134; F:transcription factor binding; IPI:UniProtKB
O60934	NBN	Nibrin	GO:0001832; P:blastocyst growth; IEA:Ensembl
O60934	NBN	Nibrin	GO:0007050; P:cell cycle arrest; TAS:UniProtKB
O60934	NBN	Nibrin	GO:0008283; P:cell proliferation; IEA:Ensembl
O60934	NBN	Nibrin	GO:0000077; P:DNA damage checkpoint; IDA:MGI
O60934	NBN	Nibrin	GO:0030330; P:DNA damage response, signal transduction by p53 class mediator; TAS:UniProtKB
O60934	NBN	Nibrin	GO:0032508; P:DNA duplex unwinding; IMP:BHF-UCL
O60934	NBN	Nibrin	GO:0006281; P:DNA repair; TAS:Reactome
O60934	NBN	Nibrin	GO:0006302; P:double-strand break repair; IDA:UniProtKB
O60934	NBN	Nibrin	GO:0000724; P:double-strand break repair via homologous recombination; TAS:Reactome
O60934	NBN	Nibrin	GO:0097193; P:intrinsic apoptotic signaling pathway; IEA:Ensembl
O60934	NBN	Nibrin	GO:0045190; P:isotype switching; IEA:Ensembl
O60934	NBN	Nibrin	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
O60934	NBN	Nibrin	GO:0007093; P:mitotic cell cycle checkpoint; IDA:UniProtKB
O60934	NBN	Nibrin	GO:0007095; P:mitotic G2 DNA damage checkpoint; IDA:UniProtKB
O60934	NBN	Nibrin	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
O60934	NBN	Nibrin	GO:0033674; P:positive regulation of kinase activity; IDA:BHF-UCL
O60934	NBN	Nibrin	GO:0031954; P:positive regulation of protein autophosphorylation; IDA:BHF-UCL
O60934	NBN	Nibrin	GO:0030174; P:regulation of DNA-dependent DNA replication initiation; TAS:UniProtKB
O60934	NBN	Nibrin	GO:0000723; P:telomere maintenance; IMP:UniProtKB
Q6P3W6	NBPF10	Neuroblastoma breakpoint family member 10	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14596	NBR1	Next to BRCA1 gene 1 protein	GO:0051019; F:mitogen-activated protein kinase binding; ISS:BHF-UCL
Q14596	NBR1	Next to BRCA1 gene 1 protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q14596	NBR1	Next to BRCA1 gene 1 protein	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
Q14596	NBR1	Next to BRCA1 gene 1 protein	GO:0008270; F:zinc ion binding; IEA:InterPro
Q14596	NBR1	Next to BRCA1 gene 1 protein	GO:0016236; P:macroautophagy; IDA:UniProtKB
Q14596	NBR1	Next to BRCA1 gene 1 protein	GO:0045668; P:negative regulation of osteoblast differentiation; ISS:BHF-UCL
Q14596	NBR1	Next to BRCA1 gene 1 protein	GO:0051259; P:protein oligomerization; IDA:UniProtKB
Q14596	NBR1	Next to BRCA1 gene 1 protein	GO:0030500; P:regulation of bone mineralization; ISS:BHF-UCL
Q14596	NBR1	Next to BRCA1 gene 1 protein	GO:0032872; P:regulation of stress-activated MAPK cascade; ISS:BHF-UCL
Q14919	DRAP1	Dr1-associated corepressor	GO:0003677; F:DNA binding; TAS:ProtInc
Q14919	DRAP1	Dr1-associated corepressor	GO:0005515; F:protein binding; IPI:IntAct
Q14919	DRAP1	Dr1-associated corepressor	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q14919	DRAP1	Dr1-associated corepressor	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q14919	DRAP1	Dr1-associated corepressor	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q14919	DRAP1	Dr1-associated corepressor	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q14919	DRAP1	Dr1-associated corepressor	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q01658	DR1	Protein Dr1	GO:0003677; F:DNA binding; TAS:ProtInc
Q01658	DR1	Protein Dr1	GO:0005515; F:protein binding; IPI:BHF-UCL
Q01658	DR1	Protein Dr1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q01658	DR1	Protein Dr1	GO:0017025; F:TBP-class protein binding; IDA:BHF-UCL
Q01658	DR1	Protein Dr1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q01658	DR1	Protein Dr1	GO:0008134; F:transcription factor binding; TAS:ProtInc
Q01658	DR1	Protein Dr1	GO:0006325; P:chromatin organization; TAS:Reactome
Q01658	DR1	Protein Dr1	GO:0043966; P:histone H3 acetylation; IDA:BHF-UCL
Q01658	DR1	Protein Dr1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q01658	DR1	Protein Dr1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P61601	NCALD	Neurocalcin-delta	GO:0003779; F:actin binding; IDA:UniProtKB
P61601	NCALD	Neurocalcin-delta	GO:0005509; F:calcium ion binding; IEA:InterPro
P61601	NCALD	Neurocalcin-delta	GO:0030276; F:clathrin binding; IDA:UniProtKB
P61601	NCALD	Neurocalcin-delta	GO:0015631; F:tubulin binding; IDA:UniProtKB
P61601	NCALD	Neurocalcin-delta	GO:0019722; P:calcium-mediated signaling; IEA:Ensembl
P61601	NCALD	Neurocalcin-delta	GO:0003073; P:regulation of systemic arterial blood pressure; IEA:Ensembl
P61601	NCALD	Neurocalcin-delta	GO:0007268; P:synaptic transmission; TAS:Reactome
P61601	NCALD	Neurocalcin-delta	GO:0016192; P:vesicle-mediated transport; NAS:UniProtKB
P13591	NCAM1	Neural cell adhesion molecule 1	GO:0042802; F:identical protein binding; IPI:IntAct
P13591	NCAM1	Neural cell adhesion molecule 1	GO:0007411; P:axon guidance; TAS:Reactome
P13591	NCAM1	Neural cell adhesion molecule 1	GO:0007155; P:cell adhesion; NAS:ProtInc
P13591	NCAM1	Neural cell adhesion molecule 1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P13591	NCAM1	Neural cell adhesion molecule 1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P13591	NCAM1	Neural cell adhesion molecule 1	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
O15394	NCAM2	Neural cell adhesion molecule 2	GO:0007413; P:axonal fasciculation; IEA:Ensembl
O15394	NCAM2	Neural cell adhesion molecule 2	GO:0007158; P:neuron cell-cell adhesion; TAS:ProtInc
O15394	NCAM2	Neural cell adhesion molecule 2	GO:0007608; P:sensory perception of smell; IEA:Ensembl
O14594	NCAN	Neurocan core protein	GO:0005509; F:calcium ion binding; IEA:InterPro
O14594	NCAN	Neurocan core protein	GO:0030246; F:carbohydrate binding; IEA:InterPro
O14594	NCAN	Neurocan core protein	GO:0005540; F:hyaluronic acid binding; IEA:UniProtKB-KW
O14594	NCAN	Neurocan core protein	GO:0007411; P:axon guidance; TAS:Reactome
O14594	NCAN	Neurocan core protein	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O14594	NCAN	Neurocan core protein	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
O14594	NCAN	Neurocan core protein	GO:0030206; P:chondroitin sulfate biosynthetic process; TAS:Reactome
O14594	NCAN	Neurocan core protein	GO:0030207; P:chondroitin sulfate catabolic process; TAS:Reactome
O14594	NCAN	Neurocan core protein	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
O14594	NCAN	Neurocan core protein	GO:0030208; P:dermatan sulfate biosynthetic process; TAS:Reactome
O14594	NCAN	Neurocan core protein	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O14594	NCAN	Neurocan core protein	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O14594	NCAN	Neurocan core protein	GO:0051823; P:regulation of synapse structural plasticity; IEA:Ensembl
O14594	NCAN	Neurocan core protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
A6PVI3	NCBP2L	Nuclear cap-binding protein subunit 2-like	GO:0000166; F:nucleotide binding; IEA:InterPro
A6PVI3	NCBP2L	Nuclear cap-binding protein subunit 2-like	GO:0000339; F:RNA cap binding; IEA:InterPro
A6PVI3	NCBP2L	Nuclear cap-binding protein subunit 2-like	GO:0045292; P:mRNA cis splicing, via spliceosome; IEA:InterPro
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0003723; F:RNA binding; TAS:ProtInc
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0000339; F:RNA cap binding; TAS:ProtInc
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0006370; P:7-methylguanosine mRNA capping; IDA:UniProtKB
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0010467; P:gene expression; TAS:Reactome
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0008334; P:histone mRNA metabolic process; TAS:Reactome
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0045292; P:mRNA cis splicing, via spliceosome; IEA:InterPro
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0006379; P:mRNA cleavage; IDA:UniProtKB
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0006406; P:mRNA export from nucleus; IMP:UniProtKB
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IDA:UniProtKB
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0031442; P:positive regulation of mRNA 3'-end processing; IDA:UniProtKB
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0006446; P:regulation of translational initiation; IDA:UniProtKB
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0008380; P:RNA splicing; TAS:Reactome
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0000387; P:spliceosomal snRNP assembly; TAS:Reactome
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q09161	NCBP1	Nuclear cap-binding protein subunit 1	GO:0016032; P:viral process; TAS:Reactome
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0000166; F:nucleotide binding; IEA:InterPro
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0005515; F:protein binding; IPI:UniProtKB
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0000340; F:RNA 7-methylguanosine cap binding; IDA:UniProtKB
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0000339; F:RNA cap binding; NAS:UniProtKB
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0006370; P:7-methylguanosine mRNA capping; IDA:UniProtKB
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0010467; P:gene expression; TAS:Reactome
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0008334; P:histone mRNA metabolic process; TAS:Reactome
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0045292; P:mRNA cis splicing, via spliceosome; IDA:UniProtKB
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IDA:UniProtKB
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0046833; P:positive regulation of RNA export from nucleus; ISS:UniProtKB
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0006446; P:regulation of translational initiation; IDA:UniProtKB
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0016070; P:RNA metabolic process; TAS:Reactome
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0008380; P:RNA splicing; ISS:UniProtKB
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0006408; P:snRNA export from nucleus; ISS:UniProtKB
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0000387; P:spliceosomal snRNP assembly; TAS:Reactome
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
P52298	NCBP2	Nuclear cap-binding protein subunit 2	GO:0016032; P:viral process; TAS:Reactome
Q9UBB6	NCDN	Neurochondrin	GO:0045453; P:bone resorption; IEA:Ensembl
Q9UBB6	NCDN	Neurochondrin	GO:0031175; P:neuron projection development; ISS:UniProtKB
Q9UBB6	NCDN	Neurochondrin	GO:0048168; P:regulation of neuronal synaptic plasticity; IEA:Ensembl
Q6PIU2	NCEH1	Neutral cholesterol ester hydrolase 1	GO:0052689; F:carboxylic ester hydrolase activity; IEA:InterPro
Q6PIU2	NCEH1	Neutral cholesterol ester hydrolase 1	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
A8MVU1	NCF1C	Putative neutrophil cytosol factor 1C	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
A8MVU1	NCF1C	Putative neutrophil cytosol factor 1C	GO:0016175; F:superoxide-generating NADPH oxidase activity; IEA:InterPro
P14598	NCF1	Neutrophil cytosol factor 1	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P14598	NCF1	Neutrophil cytosol factor 1	GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB
P14598	NCF1	Neutrophil cytosol factor 1	GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; IDA:UniProtKB
P14598	NCF1	Neutrophil cytosol factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
P14598	NCF1	Neutrophil cytosol factor 1	GO:0017124; F:SH3 domain binding; IPI:BHF-UCL
P14598	NCF1	Neutrophil cytosol factor 1	GO:0016175; F:superoxide-generating NADPH oxidase activity; IMP:UniProtKB
P14598	NCF1	Neutrophil cytosol factor 1	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P14598	NCF1	Neutrophil cytosol factor 1	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P14598	NCF1	Neutrophil cytosol factor 1	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P14598	NCF1	Neutrophil cytosol factor 1	GO:0006915; P:apoptotic process; IEA:Ensembl
P14598	NCF1	Neutrophil cytosol factor 1	GO:0008283; P:cell proliferation; IEA:Ensembl
P14598	NCF1	Neutrophil cytosol factor 1	GO:0006968; P:cellular defense response; TAS:ProtInc
P14598	NCF1	Neutrophil cytosol factor 1	GO:0050665; P:hydrogen peroxide biosynthetic process; IEA:Ensembl
P14598	NCF1	Neutrophil cytosol factor 1	GO:0006954; P:inflammatory response; IEA:Ensembl
P14598	NCF1	Neutrophil cytosol factor 1	GO:0045087; P:innate immune response; TAS:BHF-UCL
P14598	NCF1	Neutrophil cytosol factor 1	GO:0051701; P:interaction with host; TAS:Reactome
P14598	NCF1	Neutrophil cytosol factor 1	GO:0006691; P:leukotriene metabolic process; IEA:Ensembl
P14598	NCF1	Neutrophil cytosol factor 1	GO:0045986; P:negative regulation of smooth muscle contraction; IEA:Ensembl
P14598	NCF1	Neutrophil cytosol factor 1	GO:0070947; P:neutrophil mediated killing of fungus; IEA:Ensembl
P14598	NCF1	Neutrophil cytosol factor 1	GO:0070946; P:neutrophil mediated killing of gram-positive bacterium; IEA:Ensembl
P14598	NCF1	Neutrophil cytosol factor 1	GO:0055114; P:oxidation-reduction process; IMP:GOC
P14598	NCF1	Neutrophil cytosol factor 1	GO:0090382; P:phagosome maturation; TAS:Reactome
P14598	NCF1	Neutrophil cytosol factor 1	GO:0006612; P:protein targeting to membrane; IDA:UniProtKB
P14598	NCF1	Neutrophil cytosol factor 1	GO:0045730; P:respiratory burst; TAS:BHF-UCL
P14598	NCF1	Neutrophil cytosol factor 1	GO:0002679; P:respiratory burst involved in defense response; IEA:Ensembl
P14598	NCF1	Neutrophil cytosol factor 1	GO:0001878; P:response to yeast; IEA:Ensembl
P14598	NCF1	Neutrophil cytosol factor 1	GO:0042554; P:superoxide anion generation; IMP:UniProtKB
P14598	NCF1	Neutrophil cytosol factor 1	GO:0006801; P:superoxide metabolic process; TAS:BHF-UCL
A6NI72	NCF1B	Putative neutrophil cytosol factor 1B	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
A6NI72	NCF1B	Putative neutrophil cytosol factor 1B	GO:0016175; F:superoxide-generating NADPH oxidase activity; IEA:InterPro
P19878	NCF2	Neutrophil cytosol factor 2	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P19878	NCF2	Neutrophil cytosol factor 2	GO:0005515; F:protein binding; IPI:IntAct
P19878	NCF2	Neutrophil cytosol factor 2	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P19878	NCF2	Neutrophil cytosol factor 2	GO:0007568; P:aging; IEA:Ensembl
P19878	NCF2	Neutrophil cytosol factor 2	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P19878	NCF2	Neutrophil cytosol factor 2	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P19878	NCF2	Neutrophil cytosol factor 2	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P19878	NCF2	Neutrophil cytosol factor 2	GO:0006968; P:cellular defense response; TAS:ProtInc
P19878	NCF2	Neutrophil cytosol factor 2	GO:0032870; P:cellular response to hormone stimulus; IEA:Ensembl
P19878	NCF2	Neutrophil cytosol factor 2	GO:0045087; P:innate immune response; TAS:BHF-UCL
P19878	NCF2	Neutrophil cytosol factor 2	GO:0051701; P:interaction with host; TAS:Reactome
P19878	NCF2	Neutrophil cytosol factor 2	GO:0090382; P:phagosome maturation; TAS:Reactome
P19878	NCF2	Neutrophil cytosol factor 2	GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl
P19878	NCF2	Neutrophil cytosol factor 2	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
P19878	NCF2	Neutrophil cytosol factor 2	GO:0045730; P:respiratory burst; TAS:BHF-UCL
P19878	NCF2	Neutrophil cytosol factor 2	GO:0014823; P:response to activity; IEA:Ensembl
P19878	NCF2	Neutrophil cytosol factor 2	GO:0042493; P:response to drug; IEA:Ensembl
P19878	NCF2	Neutrophil cytosol factor 2	GO:0009749; P:response to glucose; IEA:Ensembl
P19878	NCF2	Neutrophil cytosol factor 2	GO:0055093; P:response to hyperoxia; IEA:Ensembl
P19878	NCF2	Neutrophil cytosol factor 2	GO:0034616; P:response to laminar fluid shear stress; IEA:Ensembl
P19878	NCF2	Neutrophil cytosol factor 2	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P19878	NCF2	Neutrophil cytosol factor 2	GO:0032570; P:response to progesterone; IEA:Ensembl
P19878	NCF2	Neutrophil cytosol factor 2	GO:0042554; P:superoxide anion generation; TAS:BHF-UCL
P19878	NCF2	Neutrophil cytosol factor 2	GO:0006801; P:superoxide metabolic process; TAS:BHF-UCL
Q15080	NCF4	Neutrophil cytosol factor 4	GO:0032266; F:phosphatidylinositol-3-phosphate binding; IDA:UniProtKB
Q15080	NCF4	Neutrophil cytosol factor 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q15080	NCF4	Neutrophil cytosol factor 4	GO:0046983; F:protein dimerization activity; TAS:UniProtKB
Q15080	NCF4	Neutrophil cytosol factor 4	GO:0016176; F:superoxide-generating NADPH oxidase activator activity; IMP:UniProtKB
Q15080	NCF4	Neutrophil cytosol factor 4	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q15080	NCF4	Neutrophil cytosol factor 4	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q15080	NCF4	Neutrophil cytosol factor 4	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q15080	NCF4	Neutrophil cytosol factor 4	GO:0006955; P:immune response; TAS:UniProtKB
Q15080	NCF4	Neutrophil cytosol factor 4	GO:0051701; P:interaction with host; TAS:Reactome
Q15080	NCF4	Neutrophil cytosol factor 4	GO:0055114; P:oxidation-reduction process; TAS:UniProtKB
Q15080	NCF4	Neutrophil cytosol factor 4	GO:0090382; P:phagosome maturation; TAS:Reactome
Q15080	NCF4	Neutrophil cytosol factor 4	GO:0043085; P:positive regulation of catalytic activity; IMP:GOC
P16333	NCK1	Cytoplasmic protein NCK1	GO:0008093; F:cytoskeletal adaptor activity; NAS:UniProtKB
P16333	NCK1	Cytoplasmic protein NCK1	GO:0005515; F:protein binding; IPI:UniProtKB
P16333	NCK1	Cytoplasmic protein NCK1	GO:0004860; F:protein kinase inhibitor activity; IDA:UniProtKB
P16333	NCK1	Cytoplasmic protein NCK1	GO:0005102; F:receptor binding; IPI:UniProtKB
P16333	NCK1	Cytoplasmic protein NCK1	GO:0030159; F:receptor signaling complex scaffold activity; NAS:UniProtKB
P16333	NCK1	Cytoplasmic protein NCK1	GO:0007015; P:actin filament organization; IEA:Ensembl
P16333	NCK1	Cytoplasmic protein NCK1	GO:0007411; P:axon guidance; TAS:Reactome
P16333	NCK1	Cytoplasmic protein NCK1	GO:0016477; P:cell migration; IEA:Ensembl
P16333	NCK1	Cytoplasmic protein NCK1	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P16333	NCK1	Cytoplasmic protein NCK1	GO:0045087; P:innate immune response; TAS:Reactome
P16333	NCK1	Cytoplasmic protein NCK1	GO:0030032; P:lamellipodium assembly; IEA:Ensembl
P16333	NCK1	Cytoplasmic protein NCK1	GO:0060548; P:negative regulation of cell death; IDA:UniProtKB
P16333	NCK1	Cytoplasmic protein NCK1	GO:0006469; P:negative regulation of protein kinase activity; IDA:GOC
P16333	NCK1	Cytoplasmic protein NCK1	GO:0030838; P:positive regulation of actin filament polymerization; IMP:UniProtKB
P16333	NCK1	Cytoplasmic protein NCK1	GO:0042102; P:positive regulation of T cell proliferation; IMP:UniProtKB
P16333	NCK1	Cytoplasmic protein NCK1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P16333	NCK1	Cytoplasmic protein NCK1	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
P16333	NCK1	Cytoplasmic protein NCK1	GO:0051707; P:response to other organism; IEA:Ensembl
P16333	NCK1	Cytoplasmic protein NCK1	GO:0007172; P:signal complex assembly; NAS:UniProtKB
P16333	NCK1	Cytoplasmic protein NCK1	GO:0042110; P:T cell activation; IMP:UniProtKB
P16333	NCK1	Cytoplasmic protein NCK1	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
O43639	NCK2	Cytoplasmic protein NCK2	GO:0008093; F:cytoskeletal adaptor activity; NAS:UniProtKB
O43639	NCK2	Cytoplasmic protein NCK2	GO:0005515; F:protein binding; IPI:UniProtKB
O43639	NCK2	Cytoplasmic protein NCK2	GO:0030159; F:receptor signaling complex scaffold activity; NAS:UniProtKB
O43639	NCK2	Cytoplasmic protein NCK2	GO:0007015; P:actin filament organization; IEA:Ensembl
O43639	NCK2	Cytoplasmic protein NCK2	GO:0007411; P:axon guidance; TAS:Reactome
O43639	NCK2	Cytoplasmic protein NCK2	GO:0016477; P:cell migration; IEA:Ensembl
O43639	NCK2	Cytoplasmic protein NCK2	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:ProtInc
O43639	NCK2	Cytoplasmic protein NCK2	GO:0030032; P:lamellipodium assembly; IEA:Ensembl
O43639	NCK2	Cytoplasmic protein NCK2	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
O43639	NCK2	Cytoplasmic protein NCK2	GO:0030838; P:positive regulation of actin filament polymerization; IMP:UniProtKB
O43639	NCK2	Cytoplasmic protein NCK2	GO:0042102; P:positive regulation of T cell proliferation; IMP:UniProtKB
O43639	NCK2	Cytoplasmic protein NCK2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O43639	NCK2	Cytoplasmic protein NCK2	GO:0007176; P:regulation of epidermal growth factor-activated receptor activity; TAS:ProtInc
O43639	NCK2	Cytoplasmic protein NCK2	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
O43639	NCK2	Cytoplasmic protein NCK2	GO:0007172; P:signal complex assembly; NAS:UniProtKB
O43639	NCK2	Cytoplasmic protein NCK2	GO:0007165; P:signal transduction; TAS:ProtInc
O43639	NCK2	Cytoplasmic protein NCK2	GO:0042110; P:T cell activation; NAS:UniProtKB
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0032403; F:protein complex binding; IDA:UniProt
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0045176; P:apical protein localization; IEA:Ensembl
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0006915; P:apoptotic process; TAS:ProtInc
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0045175; P:basal protein localization; IEA:Ensembl
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0007417; P:central nervous system development; TAS:ProtInc
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0010172; P:embryonic body morphogenesis; IEA:Ensembl
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0048617; P:embryonic foregut morphogenesis; IEA:Ensembl
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0035050; P:embryonic heart tube development; IEA:Ensembl
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0007492; P:endoderm development; IEA:Ensembl
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0030950; P:establishment or maintenance of actin cytoskeleton polarity; IEA:Ensembl
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0045087; P:innate immune response; TAS:Reactome
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0030032; P:lamellipodium assembly; IEA:Ensembl
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0008078; P:mesodermal cell migration; IEA:Ensembl
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0001843; P:neural tube closure; IEA:Ensembl
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0048570; P:notochord morphogenesis; IEA:Ensembl
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0048340; P:paraxial mesoderm morphogenesis; IEA:Ensembl
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:2000601; P:positive regulation of Arp2/3 complex-mediated actin nucleation; IDA:UniProt
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0010592; P:positive regulation of lamellipodium assembly; IMP:UniProt
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0050821; P:protein stabilization; IEA:Ensembl
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0016601; P:Rac protein signal transduction; IDA:UniProt
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0032880; P:regulation of protein localization; IEA:Ensembl
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0001756; P:somitogenesis; IEA:Ensembl
Q9Y2A7	NCKAP1	Nck-associated protein 1	GO:0007354; P:zygotic determination of anterior/posterior axis, embryo; IEA:Ensembl
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0005515; F:protein binding; IPI:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0032403; F:protein complex binding; IDA:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0030295; F:protein kinase activator activity; IMP:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0030675; F:Rac GTPase activator activity; IMP:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0070358; P:actin polymerization-dependent cell motility; IMP:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0001782; P:B cell homeostasis; ISS:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0050853; P:B cell receptor signaling pathway; IMP:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0006935; P:chemotaxis; IDA:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0030866; P:cortical actin cytoskeleton organization; IMP:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0048821; P:erythrocyte development; IEP:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0030011; P:maintenance of cell polarity; IMP:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0002262; P:myeloid cell homeostasis; ISS:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0032700; P:negative regulation of interleukin-17 production; ISS:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0032715; P:negative regulation of interleukin-6 production; ISS:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0035509; P:negative regulation of myosin-light-chain-phosphatase activity; IMP:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0030593; P:neutrophil chemotaxis; IDA:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0030838; P:positive regulation of actin filament polymerization; IMP:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0045579; P:positive regulation of B cell differentiation; ISS:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0030890; P:positive regulation of B cell proliferation; IMP:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0043372; P:positive regulation of CD4-positive, alpha-beta T cell differentiation; ISS:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0043378; P:positive regulation of CD8-positive, alpha-beta T cell differentiation; ISS:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0033630; P:positive regulation of cell adhesion mediated by integrin; ISS:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0045648; P:positive regulation of erythrocyte differentiation; ISS:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0045588; P:positive regulation of gamma-delta T cell differentiation; ISS:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0045621; P:positive regulation of lymphocyte differentiation; ISS:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0090023; P:positive regulation of neutrophil chemotaxis; ISS:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0060100; P:positive regulation of phagocytosis, engulfment; ISS:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0042327; P:positive regulation of phosphorylation; IMP:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0045860; P:positive regulation of protein kinase activity; IMP:GOC
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0032855; P:positive regulation of Rac GTPase activity; IMP:GOC
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0042102; P:positive regulation of T cell proliferation; ISS:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0006461; P:protein complex assembly; ISS:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0042493; P:response to drug; IMP:UniProtKB
P55160	NCKAP1L	Nck-associated protein 1-like	GO:0043029; P:T cell homeostasis; ISS:UniProtKB
O60721	SLC24A1	Sodium/potassium/calcium exchanger 1	GO:0008273; F:calcium, potassium:sodium antiporter activity; IEA:InterPro
O60721	SLC24A1	Sodium/potassium/calcium exchanger 1	GO:0005515; F:protein binding; IPI:IntAct
O60721	SLC24A1	Sodium/potassium/calcium exchanger 1	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
O60721	SLC24A1	Sodium/potassium/calcium exchanger 1	GO:0006816; P:calcium ion transport; NAS:UniProtKB
O60721	SLC24A1	Sodium/potassium/calcium exchanger 1	GO:0006811; P:ion transport; TAS:Reactome
O60721	SLC24A1	Sodium/potassium/calcium exchanger 1	GO:0007603; P:phototransduction, visible light; TAS:Reactome
O60721	SLC24A1	Sodium/potassium/calcium exchanger 1	GO:0009642; P:response to light intensity; NAS:UniProtKB
O60721	SLC24A1	Sodium/potassium/calcium exchanger 1	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
O60721	SLC24A1	Sodium/potassium/calcium exchanger 1	GO:0035725; P:sodium ion transmembrane transport; NAS:GOC
O60721	SLC24A1	Sodium/potassium/calcium exchanger 1	GO:0055085; P:transmembrane transport; TAS:Reactome
O60721	SLC24A1	Sodium/potassium/calcium exchanger 1	GO:0006810; P:transport; TAS:ProtInc
O60721	SLC24A1	Sodium/potassium/calcium exchanger 1	GO:0007601; P:visual perception; IEA:InterPro
Q9UI40	SLC24A2	Sodium/potassium/calcium exchanger 2	GO:0046870; F:cadmium ion binding; IEA:Ensembl
Q9UI40	SLC24A2	Sodium/potassium/calcium exchanger 2	GO:0005262; F:calcium channel activity; IEA:Ensembl
Q9UI40	SLC24A2	Sodium/potassium/calcium exchanger 2	GO:0005509; F:calcium ion binding; IEA:Ensembl
Q9UI40	SLC24A2	Sodium/potassium/calcium exchanger 2	GO:0008273; F:calcium, potassium:sodium antiporter activity; IDA:MGI
Q9UI40	SLC24A2	Sodium/potassium/calcium exchanger 2	GO:0030145; F:manganese ion binding; IEA:Ensembl
Q9UI40	SLC24A2	Sodium/potassium/calcium exchanger 2	GO:0016151; F:nickel cation binding; IEA:Ensembl
Q9UI40	SLC24A2	Sodium/potassium/calcium exchanger 2	GO:0030955; F:potassium ion binding; IEA:Ensembl
Q9UI40	SLC24A2	Sodium/potassium/calcium exchanger 2	GO:0031402; F:sodium ion binding; IEA:Ensembl
Q9UI40	SLC24A2	Sodium/potassium/calcium exchanger 2	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q9UI40	SLC24A2	Sodium/potassium/calcium exchanger 2	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
Q9UI40	SLC24A2	Sodium/potassium/calcium exchanger 2	GO:0034220; P:ion transmembrane transport; IDA:MGI
Q9UI40	SLC24A2	Sodium/potassium/calcium exchanger 2	GO:0006811; P:ion transport; TAS:Reactome
Q9UI40	SLC24A2	Sodium/potassium/calcium exchanger 2	GO:0007612; P:learning; IEA:Ensembl
Q9UI40	SLC24A2	Sodium/potassium/calcium exchanger 2	GO:0060292; P:long term synaptic depression; IEA:Ensembl
Q9UI40	SLC24A2	Sodium/potassium/calcium exchanger 2	GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl
Q9UI40	SLC24A2	Sodium/potassium/calcium exchanger 2	GO:0007613; P:memory; IEA:Ensembl
Q9UI40	SLC24A2	Sodium/potassium/calcium exchanger 2	GO:0035725; P:sodium ion transmembrane transport; IDA:GOC
Q9UI40	SLC24A2	Sodium/potassium/calcium exchanger 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UI40	SLC24A2	Sodium/potassium/calcium exchanger 2	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q9HC58	SLC24A3	Sodium/potassium/calcium exchanger 3	GO:0008273; F:calcium, potassium:sodium antiporter activity; IEA:Ensembl
Q9HC58	SLC24A3	Sodium/potassium/calcium exchanger 3	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q9HC58	SLC24A3	Sodium/potassium/calcium exchanger 3	GO:0006811; P:ion transport; TAS:Reactome
Q9HC58	SLC24A3	Sodium/potassium/calcium exchanger 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8NFF2	SLC24A4	Sodium/potassium/calcium exchanger 4	GO:0008273; F:calcium, potassium:sodium antiporter activity; IEA:Ensembl
Q8NFF2	SLC24A4	Sodium/potassium/calcium exchanger 4	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q8NFF2	SLC24A4	Sodium/potassium/calcium exchanger 4	GO:0097186; P:amelogenesis; ISS:UniProtKB
Q8NFF2	SLC24A4	Sodium/potassium/calcium exchanger 4	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
Q8NFF2	SLC24A4	Sodium/potassium/calcium exchanger 4	GO:0006811; P:ion transport; TAS:Reactome
Q8NFF2	SLC24A4	Sodium/potassium/calcium exchanger 4	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q8NFF2	SLC24A4	Sodium/potassium/calcium exchanger 4	GO:0007608; P:sensory perception of smell; ISS:UniProtKB
Q8NFF2	SLC24A4	Sodium/potassium/calcium exchanger 4	GO:0055085; P:transmembrane transport; TAS:Reactome
Q71RS6	SLC24A5	Sodium/potassium/calcium exchanger 5	GO:0008273; F:calcium, potassium:sodium antiporter activity; IDA:MGI
Q71RS6	SLC24A5	Sodium/potassium/calcium exchanger 5	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q71RS6	SLC24A5	Sodium/potassium/calcium exchanger 5	GO:0034220; P:ion transmembrane transport; IDA:MGI
Q71RS6	SLC24A5	Sodium/potassium/calcium exchanger 5	GO:0006811; P:ion transport; TAS:Reactome
Q71RS6	SLC24A5	Sodium/potassium/calcium exchanger 5	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q71RS6	SLC24A5	Sodium/potassium/calcium exchanger 5	GO:0035725; P:sodium ion transmembrane transport; IDA:GOC
Q71RS6	SLC24A5	Sodium/potassium/calcium exchanger 5	GO:0055085; P:transmembrane transport; TAS:Reactome
Q6J4K2	SLC8B1	Sodium/potassium/calcium exchanger 6, mitochondrial	GO:0005432; F:calcium:sodium antiporter activity; IDA:UniProtKB
Q6J4K2	SLC8B1	Sodium/potassium/calcium exchanger 6, mitochondrial	GO:0042593; P:glucose homeostasis; IDA:UniProtKB
Q6J4K2	SLC8B1	Sodium/potassium/calcium exchanger 6, mitochondrial	GO:0006811; P:ion transport; TAS:Reactome
Q6J4K2	SLC8B1	Sodium/potassium/calcium exchanger 6, mitochondrial	GO:0006851; P:mitochondrial calcium ion transport; IDA:UniProtKB
Q6J4K2	SLC8B1	Sodium/potassium/calcium exchanger 6, mitochondrial	GO:0050796; P:regulation of insulin secretion; IDA:UniProtKB
Q6J4K2	SLC8B1	Sodium/potassium/calcium exchanger 6, mitochondrial	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q6J4K2	SLC8B1	Sodium/potassium/calcium exchanger 6, mitochondrial	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9HCD5	NCOA5	Nuclear receptor coactivator 5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9HCD5	NCOA5	Nuclear receptor coactivator 5	GO:0005515; F:protein binding; IPI:IntAct
Q9HCD5	NCOA5	Nuclear receptor coactivator 5	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9HCD5	NCOA5	Nuclear receptor coactivator 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13772	NCOA4	Nuclear receptor coactivator 4	GO:0050681; F:androgen receptor binding; NAS:UniProtKB
Q13772	NCOA4	Nuclear receptor coactivator 4	GO:0003713; F:transcription coactivator activity; NAS:UniProtKB
Q13772	NCOA4	Nuclear receptor coactivator 4	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
Q13772	NCOA4	Nuclear receptor coactivator 4	GO:0008584; P:male gonad development; TAS:ProtInc
Q13772	NCOA4	Nuclear receptor coactivator 4	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
Q13772	NCOA4	Nuclear receptor coactivator 4	GO:0009725; P:response to hormone; IEA:Ensembl
Q13772	NCOA4	Nuclear receptor coactivator 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5T1S8	NCMAP	Noncompact myelin-associated protein	GO:0019911; F:structural constituent of myelin sheath; ISS:UniProtKB
Q5T1S8	NCMAP	Noncompact myelin-associated protein	GO:0032290; P:peripheral nervous system myelin formation; ISS:UniProtKB
Q5T1S8	NCMAP	Noncompact myelin-associated protein	GO:0031643; P:positive regulation of myelination; ISS:UniProtKB
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0050681; F:androgen receptor binding; NAS:UniProtKB
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0004402; F:histone acetyltransferase activity; IDA:UniProtKB
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0016922; F:ligand-dependent nuclear receptor binding; IPI:UniProtKB
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IEA:InterPro
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0035257; F:nuclear hormone receptor binding; IDA:UniProtKB
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0004871; F:signal transducer activity; IEA:InterPro
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0046966; F:thyroid hormone receptor binding; NAS:UniProtKB
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0048589; P:developmental growth; IEA:Ensembl
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0016573; P:histone acetylation; IDA:GOC
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0060713; P:labyrinthine layer morphogenesis; IEA:Ensembl
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0060744; P:mammary gland branching involved in thelarche; IEA:Ensembl
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0045618; P:positive regulation of keratinocyte differentiation; IMP:UniProtKB
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0035624; P:receptor transactivation; TAS:UniProtKB
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:2001141; P:regulation of RNA biosynthetic process; IMP:UniProtKB
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y6Q9	NCOA3	Nuclear receptor coactivator 3	GO:0060068; P:vagina development; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0050681; F:androgen receptor binding; NAS:UniProtKB
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0004402; F:histone acetyltransferase activity; IEA:UniProtKB-EC
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0016922; F:ligand-dependent nuclear receptor binding; IPI:UniProtKB
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IDA:UniProtKB
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0035257; F:nuclear hormone receptor binding; IDA:UniProtKB
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0001012; F:RNA polymerase II regulatory region DNA binding; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0001105; F:RNA polymerase II transcription coactivator activity; NAS:BHF-UCL
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0004871; F:signal transducer activity; IEA:InterPro
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0032870; P:cellular response to hormone stimulus; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0021549; P:cerebellum development; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0021987; P:cerebral cortex development; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0060206; P:estrous cycle phase; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0021766; P:hippocampus development; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0043967; P:histone H4 acetylation; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0021854; P:hypothalamus development; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0060713; P:labyrinthine layer morphogenesis; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0007595; P:lactation; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0008584; P:male gonad development; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0060179; P:male mating behavior; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0045925; P:positive regulation of female receptivity; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0000435; P:positive regulation of transcription from RNA polymerase II promoter by galactose; IDA:UniProtKB
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:2001038; P:regulation of cellular response to drug; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0032355; P:response to estradiol; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0032570; P:response to progesterone; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0032526; P:response to retinoic acid; IEA:Ensembl
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15788	NCOA1	Nuclear receptor coactivator 1	GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0003682; F:chromatin binding; ISS:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0030331; F:estrogen receptor binding; TAS:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IPI:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0046965; F:retinoid X receptor binding; TAS:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0046966; F:thyroid hormone receptor binding; IDA:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0007420; P:brain development; ISS:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0006974; P:cellular response to DNA damage stimulus; IDA:MGI
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0006310; P:DNA recombination; NAS:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0006281; P:DNA repair; NAS:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0006260; P:DNA replication; NAS:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0006352; P:DNA-templated transcription, initiation; IDA:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0042921; P:glucocorticoid receptor signaling pathway; NAS:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0007507; P:heart development; ISS:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0030520; P:intracellular estrogen receptor signaling pathway; NAS:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0030099; P:myeloid cell differentiation; IDA:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0045893; P:positive regulation of transcription, DNA-templated; TAS:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0009725; P:response to hormone; TAS:UniProtKB
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14686	NCOA6	Nuclear receptor coactivator 6	GO:0006367; P:transcription initiation from RNA polymerase II promoter; ISS:UniProtKB
Q15596	NCOA2	Nuclear receptor coactivator 2	GO:0003682; F:chromatin binding; IEA:Ensembl
Q15596	NCOA2	Nuclear receptor coactivator 2	GO:0004402; F:histone acetyltransferase activity; IEA:InterPro
Q15596	NCOA2	Nuclear receptor coactivator 2	GO:0016922; F:ligand-dependent nuclear receptor binding; IPI:UniProtKB
Q15596	NCOA2	Nuclear receptor coactivator 2	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IDA:BHF-UCL
Q15596	NCOA2	Nuclear receptor coactivator 2	GO:0035257; F:nuclear hormone receptor binding; IPI:UniProtKB
Q15596	NCOA2	Nuclear receptor coactivator 2	GO:0005515; F:protein binding; IPI:IntAct
Q15596	NCOA2	Nuclear receptor coactivator 2	GO:0004871; F:signal transducer activity; IEA:InterPro
Q15596	NCOA2	Nuclear receptor coactivator 2	GO:0030375; F:thyroid hormone receptor coactivator activity; IEA:Ensembl
Q15596	NCOA2	Nuclear receptor coactivator 2	GO:0003713; F:transcription coactivator activity; ISS:UniProtKB
Q15596	NCOA2	Nuclear receptor coactivator 2	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q15596	NCOA2	Nuclear receptor coactivator 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q15596	NCOA2	Nuclear receptor coactivator 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q15596	NCOA2	Nuclear receptor coactivator 2	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q15596	NCOA2	Nuclear receptor coactivator 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15596	NCOA2	Nuclear receptor coactivator 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NI08	NCOA7	Nuclear receptor coactivator 7	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IDA:UniProtKB
Q8NI08	NCOA7	Nuclear receptor coactivator 7	GO:0035257; F:nuclear hormone receptor binding; IDA:UniProtKB
Q8NI08	NCOA7	Nuclear receptor coactivator 7	GO:0005515; F:protein binding; IPI:IntAct
Q8NI08	NCOA7	Nuclear receptor coactivator 7	GO:0016998; P:cell wall macromolecule catabolic process; IEA:InterPro
Q8NI08	NCOA7	Nuclear receptor coactivator 7	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q8NI08	NCOA7	Nuclear receptor coactivator 7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q969V3	NCLN	Nicalin	GO:0008233; F:peptidase activity; IEA:InterPro
Q969V3	NCLN	Nicalin	GO:0005515; F:protein binding; IPI:UniProtKB
Q969V3	NCLN	Nicalin	GO:0009966; P:regulation of signal transduction; IEA:InterPro
O60502	MGEA5	Bifunctional protein NCOAT	GO:0004402; F:histone acetyltransferase activity; IEA:UniProtKB-EC
O60502	MGEA5	Bifunctional protein NCOAT	GO:0004415; F:hyalurononglucosaminidase activity; TAS:ProtInc
O60502	MGEA5	Bifunctional protein NCOAT	GO:0007568; P:aging; IEA:Ensembl
O60502	MGEA5	Bifunctional protein NCOAT	GO:0046060; P:dATP metabolic process; IEA:Ensembl
O60502	MGEA5	Bifunctional protein NCOAT	GO:0006516; P:glycoprotein catabolic process; TAS:ProtInc
O60502	MGEA5	Bifunctional protein NCOAT	GO:0006044; P:N-acetylglucosamine metabolic process; IEA:Ensembl
O60502	MGEA5	Bifunctional protein NCOAT	GO:0070265; P:necrotic cell death; IEA:Ensembl
O60502	MGEA5	Bifunctional protein NCOAT	GO:0010616; P:negative regulation of cardiac muscle adaptation; IEA:Ensembl
O60502	MGEA5	Bifunctional protein NCOAT	GO:0060051; P:negative regulation of protein glycosylation; IEA:Ensembl
O60502	MGEA5	Bifunctional protein NCOAT	GO:0010524; P:positive regulation of calcium ion transport into cytosol; IEA:Ensembl
O60502	MGEA5	Bifunctional protein NCOAT	GO:0031343; P:positive regulation of cell killing; IEA:Ensembl
O60502	MGEA5	Bifunctional protein NCOAT	GO:0051054; P:positive regulation of DNA metabolic process; IEA:Ensembl
O60502	MGEA5	Bifunctional protein NCOAT	GO:0046326; P:positive regulation of glucose import; IEA:Ensembl
O60502	MGEA5	Bifunctional protein NCOAT	GO:0060124; P:positive regulation of growth hormone secretion; IEA:Ensembl
O60502	MGEA5	Bifunctional protein NCOAT	GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl
O60502	MGEA5	Bifunctional protein NCOAT	GO:0051901; P:positive regulation of mitochondrial depolarization; IEA:Ensembl
O60502	MGEA5	Bifunctional protein NCOAT	GO:0043243; P:positive regulation of protein complex disassembly; IEA:Ensembl
O60502	MGEA5	Bifunctional protein NCOAT	GO:0045862; P:positive regulation of proteolysis; IEA:Ensembl
O60502	MGEA5	Bifunctional protein NCOAT	GO:0006612; P:protein targeting to membrane; IEA:Ensembl
O60502	MGEA5	Bifunctional protein NCOAT	GO:0048545; P:response to steroid hormone; IEA:Ensembl
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0003682; F:chromatin binding; IEA:InterPro
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0035033; F:histone deacetylase regulator activity; IEA:Ensembl
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0035257; F:nuclear hormone receptor binding; IPI:UniProtKB
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0005515; F:protein binding; IPI:UniProtKB
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0003714; F:transcription corepressor activity; IMP:UniProtKB
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0044212; F:transcription regulatory region DNA binding; ISS:BHF-UCL
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0002361; P:CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation; IEA:Ensembl
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0042632; P:cholesterol homeostasis; IEA:Ensembl
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0032922; P:circadian regulation of gene expression; IEA:Ensembl
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0060318; P:definitive erythrocyte differentiation; IEA:Ensembl
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0010467; P:gene expression; TAS:Reactome
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0046329; P:negative regulation of JNK cascade; IDA:UniProtKB
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0014067; P:negative regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0007219; P:Notch signaling pathway; TAS:Reactome
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0031065; P:positive regulation of histone deacetylation; IEA:Ensembl
O75376	NCOR1	Nuclear receptor corepressor 1	GO:2000191; P:regulation of fatty acid transport; IC:BHF-UCL
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0072362; P:regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0072368; P:regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0051225; P:spindle assembly; IMP:UniProtKB
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0021794; P:thalamus development; IEA:Ensembl
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
O75376	NCOR1	Nuclear receptor corepressor 1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q9Y618	NCOR2	Nuclear receptor corepressor 2	GO:0003682; F:chromatin binding; IEA:InterPro
Q9Y618	NCOR2	Nuclear receptor corepressor 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y618	NCOR2	Nuclear receptor corepressor 2	GO:0042826; F:histone deacetylase binding; IPI:UniProtKB
Q9Y618	NCOR2	Nuclear receptor corepressor 2	GO:0005112; F:Notch binding; IPI:UniProtKB
Q9Y618	NCOR2	Nuclear receptor corepressor 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y618	NCOR2	Nuclear receptor corepressor 2	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q9Y618	NCOR2	Nuclear receptor corepressor 2	GO:0003714; F:transcription corepressor activity; IMP:UniProtKB
Q9Y618	NCOR2	Nuclear receptor corepressor 2	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9Y618	NCOR2	Nuclear receptor corepressor 2	GO:0010467; P:gene expression; TAS:Reactome
Q9Y618	NCOR2	Nuclear receptor corepressor 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q9Y618	NCOR2	Nuclear receptor corepressor 2	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q9Y618	NCOR2	Nuclear receptor corepressor 2	GO:0072365; P:regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q9Y618	NCOR2	Nuclear receptor corepressor 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y618	NCOR2	Nuclear receptor corepressor 2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q9Y618	NCOR2	Nuclear receptor corepressor 2	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
Q9Y618	NCOR2	Nuclear receptor corepressor 2	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P16435	POR	NADPH--cytochrome P450 reductase	GO:0004128; F:cytochrome-b5 reductase activity, acting on NAD(P)H; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0009055; F:electron carrier activity; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0050660; F:flavin adenine dinucleotide binding; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0010181; F:FMN binding; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0016787; F:hydrolase activity; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0005506; F:iron ion binding; IEA:InterPro
P16435	POR	NADPH--cytochrome P450 reductase	GO:0047726; F:iron-cytochrome-c reductase activity; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0050661; F:NADP binding; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0003958; F:NADPH-hemoprotein reductase activity; TAS:UniProtKB
P16435	POR	NADPH--cytochrome P450 reductase	GO:0008941; F:nitric oxide dioxygenase activity; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0005515; F:protein binding; IPI:IntAct
P16435	POR	NADPH--cytochrome P450 reductase	GO:0009437; P:carnitine metabolic process; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0090346; P:cellular organofluorine metabolic process; IDA:BHF-UCL
P16435	POR	NADPH--cytochrome P450 reductase	GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0071375; P:cellular response to peptide hormone stimulus; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0070988; P:demethylation; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0019395; P:fatty acid oxidation; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0009812; P:flavonoid metabolic process; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0018393; P:internal peptidyl-lysine acetylation; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0060192; P:negative regulation of lipase activity; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0043602; P:nitrate catabolic process; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0046210; P:nitric oxide catabolic process; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0055114; P:oxidation-reduction process; TAS:UniProtKB
P16435	POR	NADPH--cytochrome P450 reductase	GO:0045542; P:positive regulation of cholesterol biosynthetic process; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0032332; P:positive regulation of chondrocyte differentiation; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0032770; P:positive regulation of monooxygenase activity; IDA:BHF-UCL
P16435	POR	NADPH--cytochrome P450 reductase	GO:0045880; P:positive regulation of smoothened signaling pathway; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0090031; P:positive regulation of steroid hormone biosynthetic process; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0003420; P:regulation of growth plate cartilage chondrocyte proliferation; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0042493; P:response to drug; IEA:Ensembl
P16435	POR	NADPH--cytochrome P450 reductase	GO:0007584; P:response to nutrient; IEA:Ensembl
P62166	NCS1	Neuronal calcium sensor 1	GO:0005509; F:calcium ion binding; TAS:UniProtKB
P62166	NCS1	Neuronal calcium sensor 1	GO:0000287; F:magnesium ion binding; IEA:Ensembl
P62166	NCS1	Neuronal calcium sensor 1	GO:0005515; F:protein binding; IPI:UniProtKB
P62166	NCS1	Neuronal calcium sensor 1	GO:0005245; F:voltage-gated calcium channel activity; ISS:UniProtKB
P62166	NCS1	Neuronal calcium sensor 1	GO:0070588; P:calcium ion transmembrane transport; ISS:GOC
P62166	NCS1	Neuronal calcium sensor 1	GO:0048015; P:phosphatidylinositol-mediated signaling; IEA:Ensembl
P62166	NCS1	Neuronal calcium sensor 1	GO:0045921; P:positive regulation of exocytosis; IEA:Ensembl
P62166	NCS1	Neuronal calcium sensor 1	GO:0010975; P:regulation of neuron projection development; ISS:UniProtKB
O76036	NCR1	Natural cytotoxicity triggering receptor 1	GO:0005057; F:receptor signaling protein activity; TAS:ProtInc
O76036	NCR1	Natural cytotoxicity triggering receptor 1	GO:0006968; P:cellular defense response; TAS:ProtInc
O76036	NCR1	Natural cytotoxicity triggering receptor 1	GO:0035556; P:intracellular signal transduction; TAS:GOC
O76036	NCR1	Natural cytotoxicity triggering receptor 1	GO:0030101; P:natural killer cell activation; NAS:UniProtKB
O76036	NCR1	Natural cytotoxicity triggering receptor 1	GO:0042269; P:regulation of natural killer cell mediated cytotoxicity; TAS:UniProtKB
O76036	NCR1	Natural cytotoxicity triggering receptor 1	GO:0007165; P:signal transduction; TAS:ProtInc
O95944	NCR2	Natural cytotoxicity triggering receptor 2	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
O95944	NCR2	Natural cytotoxicity triggering receptor 2	GO:0006968; P:cellular defense response; TAS:ProtInc
O95944	NCR2	Natural cytotoxicity triggering receptor 2	GO:0045087; P:innate immune response; TAS:Reactome
O95944	NCR2	Natural cytotoxicity triggering receptor 2	GO:0007165; P:signal transduction; TAS:ProtInc
O14931	NCR3	Natural cytotoxicity triggering receptor 3	GO:0008037; P:cell recognition; TAS:BHF-UCL
O14931	NCR3	Natural cytotoxicity triggering receptor 3	GO:0006955; P:immune response; NAS:UniProtKB
O14931	NCR3	Natural cytotoxicity triggering receptor 3	GO:0006954; P:inflammatory response; NAS:UniProtKB
O14931	NCR3	Natural cytotoxicity triggering receptor 3	GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; IMP:BHF-UCL
Q8WWB7	C1orf85	Lysosomal protein NCU-G1	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; IMP:BHF-UCL
Q8WWB7	C1orf85	Lysosomal protein NCU-G1	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IDA:BHF-UCL
Q8WWB7	C1orf85	Lysosomal protein NCU-G1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL
Q8WWB7	C1orf85	Lysosomal protein NCU-G1	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
Q8WWB7	C1orf85	Lysosomal protein NCU-G1	GO:0030522; P:intracellular receptor signaling pathway; IMP:GOC
Q8WWB7	C1orf85	Lysosomal protein NCU-G1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P40205	MYCNOS	N-cym protein	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q9BTX1	NDC1	Nucleoporin NDC1	GO:0017056; F:structural constituent of nuclear pore; IMP:UniProtKB
Q9BTX1	NDC1	Nucleoporin NDC1	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q9BTX1	NDC1	Nucleoporin NDC1	GO:0051292; P:nuclear pore complex assembly; IMP:UniProtKB
Q9BTX1	NDC1	Nucleoporin NDC1	GO:0031081; P:nuclear pore distribution; IMP:UniProtKB
Q9BTX1	NDC1	Nucleoporin NDC1	GO:0015031; P:protein transport; NAS:UniProtKB
O14777	NDC80	Kinetochore protein NDC80 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
O14777	NDC80	Kinetochore protein NDC80 homolog	GO:0008608; P:attachment of spindle microtubules to kinetochore; IMP:UniProtKB
O14777	NDC80	Kinetochore protein NDC80 homolog	GO:0007049; P:cell cycle; NAS:UniProtKB
O14777	NDC80	Kinetochore protein NDC80 homolog	GO:0007059; P:chromosome segregation; IMP:UniProtKB
O14777	NDC80	Kinetochore protein NDC80 homolog	GO:0000132; P:establishment of mitotic spindle orientation; IMP:UniProtKB
O14777	NDC80	Kinetochore protein NDC80 homolog	GO:0007067; P:mitosis; TAS:ProtInc
O14777	NDC80	Kinetochore protein NDC80 homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O14777	NDC80	Kinetochore protein NDC80 homolog	GO:0000070; P:mitotic sister chromatid segregation; TAS:ProtInc
O14777	NDC80	Kinetochore protein NDC80 homolog	GO:0007052; P:mitotic spindle organization; IMP:UniProtKB
O14777	NDC80	Kinetochore protein NDC80 homolog	GO:0048015; P:phosphatidylinositol-mediated signaling; NAS:UniProtKB
O14777	NDC80	Kinetochore protein NDC80 homolog	GO:0007051; P:spindle organization; NAS:UniProtKB
Q9NXR1	NDE1	Nuclear distribution protein nudE homolog 1	GO:0008017; F:microtubule binding; ISS:UniProtKB
Q9NXR1	NDE1	Nuclear distribution protein nudE homolog 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NXR1	NDE1	Nuclear distribution protein nudE homolog 1	GO:0051298; P:centrosome duplication; ISS:UniProtKB
Q9NXR1	NDE1	Nuclear distribution protein nudE homolog 1	GO:0021987; P:cerebral cortex development; IMP:UniProtKB
Q9NXR1	NDE1	Nuclear distribution protein nudE homolog 1	GO:0051303; P:establishment of chromosome localization; IMP:UniProtKB
Q9NXR1	NDE1	Nuclear distribution protein nudE homolog 1	GO:0000132; P:establishment of mitotic spindle orientation; IMP:UniProtKB
Q9NXR1	NDE1	Nuclear distribution protein nudE homolog 1	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q9NXR1	NDE1	Nuclear distribution protein nudE homolog 1	GO:0007020; P:microtubule nucleation; IEA:Ensembl
Q9NXR1	NDE1	Nuclear distribution protein nudE homolog 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9NXR1	NDE1	Nuclear distribution protein nudE homolog 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9NXR1	NDE1	Nuclear distribution protein nudE homolog 1	GO:0007405; P:neuroblast proliferation; IEA:Ensembl
Q9NXR1	NDE1	Nuclear distribution protein nudE homolog 1	GO:0001764; P:neuron migration; IEA:Ensembl
Q9NXR1	NDE1	Nuclear distribution protein nudE homolog 1	GO:0047496; P:vesicle transport along microtubule; IEA:Ensembl
Q9GZM8	NDEL1	Nuclear distribution protein nudE-like 1	GO:0070012; F:oligopeptidase activity; IEA:Ensembl
Q9GZM8	NDEL1	Nuclear distribution protein nudE-like 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9GZM8	NDEL1	Nuclear distribution protein nudE-like 1	GO:0032864; P:activation of Cdc42 GTPase activity; IEA:Ensembl
Q9GZM8	NDEL1	Nuclear distribution protein nudE-like 1	GO:0021955; P:central nervous system neuron axonogenesis; IEA:Ensembl
Q9GZM8	NDEL1	Nuclear distribution protein nudE-like 1	GO:0051642; P:centrosome localization; IEA:Ensembl
Q9GZM8	NDEL1	Nuclear distribution protein nudE-like 1	GO:0021799; P:cerebral cortex radially oriented cell migration; IEA:Ensembl
Q9GZM8	NDEL1	Nuclear distribution protein nudE-like 1	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q9GZM8	NDEL1	Nuclear distribution protein nudE-like 1	GO:0001833; P:inner cell mass cell proliferation; IEA:Ensembl
Q9GZM8	NDEL1	Nuclear distribution protein nudE-like 1	GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl
Q9GZM8	NDEL1	Nuclear distribution protein nudE-like 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9GZM8	NDEL1	Nuclear distribution protein nudE-like 1	GO:0060052; P:neurofilament cytoskeleton organization; IEA:Ensembl
Q9GZM8	NDEL1	Nuclear distribution protein nudE-like 1	GO:0001764; P:neuron migration; IEA:Ensembl
Q9GZM8	NDEL1	Nuclear distribution protein nudE-like 1	GO:0051081; P:nuclear envelope disassembly; IEA:Ensembl
Q9GZM8	NDEL1	Nuclear distribution protein nudE-like 1	GO:0045773; P:positive regulation of axon extension; IEA:Ensembl
Q9GZM8	NDEL1	Nuclear distribution protein nudE-like 1	GO:0048680; P:positive regulation of axon regeneration; IEA:Ensembl
Q9GZM8	NDEL1	Nuclear distribution protein nudE-like 1	GO:0008090; P:retrograde axon cargo transport; IEA:Ensembl
Q9GZM8	NDEL1	Nuclear distribution protein nudE-like 1	GO:0047496; P:vesicle transport along microtubule; IEA:Ensembl
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0003682; F:chromatin binding; ISS:UniProtKB
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0070888; F:E-box binding; IDA:UniProtKB
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0001105; F:RNA polymerase II transcription coactivator activity; IDA:BHF-UCL
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0035881; P:amacrine cell differentiation; ISS:UniProtKB
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0021549; P:cerebellum development; ISS:UniProtKB
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0021542; P:dentate gyrus development; ISS:UniProtKB
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0048562; P:embryonic organ morphogenesis; ISS:BHF-UCL
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0031018; P:endocrine pancreas development; ISS:UniProtKB
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0035883; P:enteroendocrine cell differentiation; ISS:UniProtKB
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0042593; P:glucose homeostasis; ISS:BHF-UCL
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0048839; P:inner ear development; ISS:UniProtKB
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0030073; P:insulin secretion; IDA:BHF-UCL
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0046426; P:negative regulation of JAK-STAT cascade; IEA:Ensembl
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:2000675; P:negative regulation of type B pancreatic cell apoptotic process; ISS:BHF-UCL
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0022008; P:neurogenesis; TAS:BHF-UCL
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0007263; P:nitric oxide mediated signal transduction; IDA:BHF-UCL
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0006913; P:nucleocytoplasmic transport; IEA:Ensembl
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0003326; P:pancreatic A cell fate commitment; IEA:Ensembl
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0003329; P:pancreatic PP cell fate commitment; IEA:Ensembl
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0045597; P:positive regulation of cell differentiation; ISS:UniProtKB
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:2000679; P:positive regulation of transcription regulatory region DNA binding; IDA:BHF-UCL
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0071156; P:regulation of cell cycle arrest; ISS:UniProtKB
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0050796; P:regulation of insulin secretion; IC:BHF-UCL
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0060730; P:regulation of intestinal epithelial structure maintenance; ISS:UniProtKB
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0042493; P:response to drug; IEA:Ensembl
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0009749; P:response to glucose; IMP:BHF-UCL
Q13562	NEUROD1	Neurogenic differentiation factor 1	GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl
Q15784	NEUROD2	Neurogenic differentiation factor 2	GO:0070888; F:E-box binding; ISS:UniProtKB
Q15784	NEUROD2	Neurogenic differentiation factor 2	GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB
Q15784	NEUROD2	Neurogenic differentiation factor 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q15784	NEUROD2	Neurogenic differentiation factor 2	GO:0003714; F:transcription corepressor activity; ISS:UniProtKB
Q15784	NEUROD2	Neurogenic differentiation factor 2	GO:0008306; P:associative learning; IEA:Ensembl
Q15784	NEUROD2	Neurogenic differentiation factor 2	GO:0001662; P:behavioral fear response; IEA:Ensembl
Q15784	NEUROD2	Neurogenic differentiation factor 2	GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB
Q15784	NEUROD2	Neurogenic differentiation factor 2	GO:0071257; P:cellular response to electrical stimulus; ISS:UniProtKB
Q15784	NEUROD2	Neurogenic differentiation factor 2	GO:0021695; P:cerebellar cortex development; ISS:UniProtKB
Q15784	NEUROD2	Neurogenic differentiation factor 2	GO:2000297; P:negative regulation of synapse maturation; ISS:UniProtKB
Q15784	NEUROD2	Neurogenic differentiation factor 2	GO:0007399; P:nervous system development; TAS:ProtInc
Q15784	NEUROD2	Neurogenic differentiation factor 2	GO:0048666; P:neuron development; IEA:Ensembl
Q15784	NEUROD2	Neurogenic differentiation factor 2	GO:0050850; P:positive regulation of calcium-mediated signaling; ISS:UniProtKB
Q15784	NEUROD2	Neurogenic differentiation factor 2	GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB
Q15784	NEUROD2	Neurogenic differentiation factor 2	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q15784	NEUROD2	Neurogenic differentiation factor 2	GO:0090129; P:positive regulation of synapse maturation; ISS:UniProtKB
Q15784	NEUROD2	Neurogenic differentiation factor 2	GO:0031915; P:positive regulation of synaptic plasticity; ISS:UniProtKB
Q15784	NEUROD2	Neurogenic differentiation factor 2	GO:0016567; P:protein ubiquitination; ISS:UniProtKB
Q15784	NEUROD2	Neurogenic differentiation factor 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q15784	NEUROD2	Neurogenic differentiation factor 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HD90	NEUROD4	Neurogenic differentiation factor 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9HD90	NEUROD4	Neurogenic differentiation factor 4	GO:0035881; P:amacrine cell differentiation; ISS:UniProtKB
Q9HD90	NEUROD4	Neurogenic differentiation factor 4	GO:0045165; P:cell fate commitment; IEA:Ensembl
Q9HD90	NEUROD4	Neurogenic differentiation factor 4	GO:0010001; P:glial cell differentiation; IEA:Ensembl
Q9HD90	NEUROD4	Neurogenic differentiation factor 4	GO:0007405; P:neuroblast proliferation; IEA:Ensembl
Q9HD90	NEUROD4	Neurogenic differentiation factor 4	GO:0048666; P:neuron development; IEA:Ensembl
Q9HD90	NEUROD4	Neurogenic differentiation factor 4	GO:0001764; P:neuron migration; IEA:Ensembl
Q9HD90	NEUROD4	Neurogenic differentiation factor 4	GO:0007219; P:Notch signaling pathway; IEA:Ensembl
Q9HD90	NEUROD4	Neurogenic differentiation factor 4	GO:0045597; P:positive regulation of cell differentiation; ISS:UniProtKB
Q9HD90	NEUROD4	Neurogenic differentiation factor 4	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9HD90	NEUROD4	Neurogenic differentiation factor 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96NK8	NEUROD6	Neurogenic differentiation factor 6	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96NK8	NEUROD6	Neurogenic differentiation factor 6	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96NK8	NEUROD6	Neurogenic differentiation factor 6	GO:0021542; P:dentate gyrus development; IEA:Ensembl
Q96NK8	NEUROD6	Neurogenic differentiation factor 6	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96NK8	NEUROD6	Neurogenic differentiation factor 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75414	NME6	Nucleoside diphosphate kinase 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75414	NME6	Nucleoside diphosphate kinase 6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75414	NME6	Nucleoside diphosphate kinase 6	GO:0004550; F:nucleoside diphosphate kinase activity; IDA:UniProtKB
O75414	NME6	Nucleoside diphosphate kinase 6	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O75414	NME6	Nucleoside diphosphate kinase 6	GO:0006241; P:CTP biosynthetic process; IEA:InterPro
O75414	NME6	Nucleoside diphosphate kinase 6	GO:0006183; P:GTP biosynthetic process; IEA:InterPro
O75414	NME6	Nucleoside diphosphate kinase 6	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
O75414	NME6	Nucleoside diphosphate kinase 6	GO:0045839; P:negative regulation of mitosis; IDA:UniProtKB
O75414	NME6	Nucleoside diphosphate kinase 6	GO:0006228; P:UTP biosynthetic process; IEA:InterPro
Q9Y5B8	NME7	Nucleoside diphosphate kinase 7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y5B8	NME7	Nucleoside diphosphate kinase 7	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y5B8	NME7	Nucleoside diphosphate kinase 7	GO:0004550; F:nucleoside diphosphate kinase activity; IEA:UniProtKB-EC
Q9Y5B8	NME7	Nucleoside diphosphate kinase 7	GO:0007420; P:brain development; IEA:Ensembl
Q9Y5B8	NME7	Nucleoside diphosphate kinase 7	GO:0060830; P:ciliary receptor clustering involved in smoothened signaling pathway; IEA:Ensembl
Q9Y5B8	NME7	Nucleoside diphosphate kinase 7	GO:0006241; P:CTP biosynthetic process; IEA:InterPro
Q9Y5B8	NME7	Nucleoside diphosphate kinase 7	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
Q9Y5B8	NME7	Nucleoside diphosphate kinase 7	GO:0003351; P:epithelial cilium movement; IEA:Ensembl
Q9Y5B8	NME7	Nucleoside diphosphate kinase 7	GO:0006183; P:GTP biosynthetic process; IEA:InterPro
Q9Y5B8	NME7	Nucleoside diphosphate kinase 7	GO:0042073; P:intraciliary transport; IEA:Ensembl
Q9Y5B8	NME7	Nucleoside diphosphate kinase 7	GO:0060972; P:left/right pattern formation; IEA:Ensembl
Q9Y5B8	NME7	Nucleoside diphosphate kinase 7	GO:0006228; P:UTP biosynthetic process; IEA:InterPro
Q13232	NME3	Nucleoside diphosphate kinase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13232	NME3	Nucleoside diphosphate kinase 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13232	NME3	Nucleoside diphosphate kinase 3	GO:0004550; F:nucleoside diphosphate kinase activity; IEA:UniProtKB-EC
Q13232	NME3	Nucleoside diphosphate kinase 3	GO:0006915; P:apoptotic process; TAS:ProtInc
Q13232	NME3	Nucleoside diphosphate kinase 3	GO:0006241; P:CTP biosynthetic process; IEA:InterPro
Q13232	NME3	Nucleoside diphosphate kinase 3	GO:0006183; P:GTP biosynthetic process; IEA:InterPro
Q13232	NME3	Nucleoside diphosphate kinase 3	GO:0006228; P:UTP biosynthetic process; IEA:InterPro
O60361	NME2P1	Putative nucleoside diphosphate kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O60361	NME2P1	Putative nucleoside diphosphate kinase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60361	NME2P1	Putative nucleoside diphosphate kinase	GO:0004550; F:nucleoside diphosphate kinase activity; IEA:UniProtKB-EC
O60361	NME2P1	Putative nucleoside diphosphate kinase	GO:0006241; P:CTP biosynthetic process; IEA:InterPro
O60361	NME2P1	Putative nucleoside diphosphate kinase	GO:0006183; P:GTP biosynthetic process; IEA:InterPro
O60361	NME2P1	Putative nucleoside diphosphate kinase	GO:0006228; P:UTP biosynthetic process; IEA:InterPro
P56597	NME5	Nucleoside diphosphate kinase homolog 5	GO:0005524; F:ATP binding; IEA:InterPro
P56597	NME5	Nucleoside diphosphate kinase homolog 5	GO:0004550; F:nucleoside diphosphate kinase activity; TAS:ProtInc
P56597	NME5	Nucleoside diphosphate kinase homolog 5	GO:0042384; P:cilium assembly; IEA:Ensembl
P56597	NME5	Nucleoside diphosphate kinase homolog 5	GO:0006241; P:CTP biosynthetic process; IEA:InterPro
P56597	NME5	Nucleoside diphosphate kinase homolog 5	GO:0003351; P:epithelial cilium movement; IEA:Ensembl
P56597	NME5	Nucleoside diphosphate kinase homolog 5	GO:0006183; P:GTP biosynthetic process; IEA:InterPro
P56597	NME5	Nucleoside diphosphate kinase homolog 5	GO:1902176; P:negative regulation of intrinsic apoptotic signaling pathway in response to oxidative stress; IEA:Ensembl
P56597	NME5	Nucleoside diphosphate kinase homolog 5	GO:0009116; P:nucleoside metabolic process; TAS:ProtInc
P56597	NME5	Nucleoside diphosphate kinase homolog 5	GO:0007286; P:spermatid development; ISS:UniProtKB
P56597	NME5	Nucleoside diphosphate kinase homolog 5	GO:0007283; P:spermatogenesis; TAS:ProtInc
P56597	NME5	Nucleoside diphosphate kinase homolog 5	GO:0006228; P:UTP biosynthetic process; IEA:InterPro
P56597	NME5	Nucleoside diphosphate kinase homolog 5	GO:0021591; P:ventricular system development; IEA:Ensembl
P15531	NME1	Nucleoside diphosphate kinase A	GO:0005524; F:ATP binding; IDA:UniProtKB
P15531	NME1	Nucleoside diphosphate kinase A	GO:0004536; F:deoxyribonuclease activity; IDA:UniProtKB
P15531	NME1	Nucleoside diphosphate kinase A	GO:0005525; F:GTP binding; IDA:UniProtKB
P15531	NME1	Nucleoside diphosphate kinase A	GO:0042802; F:identical protein binding; IPI:IntAct
P15531	NME1	Nucleoside diphosphate kinase A	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
P15531	NME1	Nucleoside diphosphate kinase A	GO:0004550; F:nucleoside diphosphate kinase activity; IDA:UniProtKB
P15531	NME1	Nucleoside diphosphate kinase A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P15531	NME1	Nucleoside diphosphate kinase A	GO:0005515; F:protein binding; IPI:UniProtKB
P15531	NME1	Nucleoside diphosphate kinase A	GO:0043024; F:ribosomal small subunit binding; IPI:UniProtKB
P15531	NME1	Nucleoside diphosphate kinase A	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl
P15531	NME1	Nucleoside diphosphate kinase A	GO:0003697; F:single-stranded DNA binding; IEA:Ensembl
P15531	NME1	Nucleoside diphosphate kinase A	GO:0035690; P:cellular response to drug; IEA:Ensembl
P15531	NME1	Nucleoside diphosphate kinase A	GO:0071398; P:cellular response to fatty acid; IEA:Ensembl
P15531	NME1	Nucleoside diphosphate kinase A	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
P15531	NME1	Nucleoside diphosphate kinase A	GO:0006241; P:CTP biosynthetic process; IEA:InterPro
P15531	NME1	Nucleoside diphosphate kinase A	GO:0006308; P:DNA catabolic process; IDA:GOC
P15531	NME1	Nucleoside diphosphate kinase A	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
P15531	NME1	Nucleoside diphosphate kinase A	GO:0006183; P:GTP biosynthetic process; IEA:InterPro
P15531	NME1	Nucleoside diphosphate kinase A	GO:0021766; P:hippocampus development; IEA:Ensembl
P15531	NME1	Nucleoside diphosphate kinase A	GO:0007595; P:lactation; IEA:Ensembl
P15531	NME1	Nucleoside diphosphate kinase A	GO:0008285; P:negative regulation of cell proliferation; TAS:UniProtKB
P15531	NME1	Nucleoside diphosphate kinase A	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
P15531	NME1	Nucleoside diphosphate kinase A	GO:0002762; P:negative regulation of myeloid leukocyte differentiation; IEA:Ensembl
P15531	NME1	Nucleoside diphosphate kinase A	GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome
P15531	NME1	Nucleoside diphosphate kinase A	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P15531	NME1	Nucleoside diphosphate kinase A	GO:0043388; P:positive regulation of DNA binding; IDA:UniProtKB
P15531	NME1	Nucleoside diphosphate kinase A	GO:0050679; P:positive regulation of epithelial cell proliferation; IMP:HGNC
P15531	NME1	Nucleoside diphosphate kinase A	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
P15531	NME1	Nucleoside diphosphate kinase A	GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB
P15531	NME1	Nucleoside diphosphate kinase A	GO:0014075; P:response to amine; IEA:Ensembl
P15531	NME1	Nucleoside diphosphate kinase A	GO:0051591; P:response to cAMP; IEA:Ensembl
P15531	NME1	Nucleoside diphosphate kinase A	GO:0033574; P:response to testosterone; IEA:Ensembl
P15531	NME1	Nucleoside diphosphate kinase A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P15531	NME1	Nucleoside diphosphate kinase A	GO:0006228; P:UTP biosynthetic process; IEA:InterPro
O00746	NME4	Nucleoside diphosphate kinase, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O00746	NME4	Nucleoside diphosphate kinase, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O00746	NME4	Nucleoside diphosphate kinase, mitochondrial	GO:0004550; F:nucleoside diphosphate kinase activity; IEA:UniProtKB-EC
O00746	NME4	Nucleoside diphosphate kinase, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
O00746	NME4	Nucleoside diphosphate kinase, mitochondrial	GO:0006241; P:CTP biosynthetic process; IEA:InterPro
O00746	NME4	Nucleoside diphosphate kinase, mitochondrial	GO:0006183; P:GTP biosynthetic process; IEA:InterPro
O00746	NME4	Nucleoside diphosphate kinase, mitochondrial	GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome
O00746	NME4	Nucleoside diphosphate kinase, mitochondrial	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
O00746	NME4	Nucleoside diphosphate kinase, mitochondrial	GO:0009116; P:nucleoside metabolic process; TAS:ProtInc
O00746	NME4	Nucleoside diphosphate kinase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00746	NME4	Nucleoside diphosphate kinase, mitochondrial	GO:0006228; P:UTP biosynthetic process; IEA:InterPro
P22392	NME2	Nucleoside diphosphate kinase B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P22392	NME2	Nucleoside diphosphate kinase B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P22392	NME2	Nucleoside diphosphate kinase B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P22392	NME2	Nucleoside diphosphate kinase B	GO:0004550; F:nucleoside diphosphate kinase activity; IDA:UniProtKB
P22392	NME2	Nucleoside diphosphate kinase B	GO:0005515; F:protein binding; IPI:UniProtKB
P22392	NME2	Nucleoside diphosphate kinase B	GO:0004673; F:protein histidine kinase activity; IEA:UniProtKB-EC
P22392	NME2	Nucleoside diphosphate kinase B	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:UniProtKB
P22392	NME2	Nucleoside diphosphate kinase B	GO:0007155; P:cell adhesion; TAS:HGNC
P22392	NME2	Nucleoside diphosphate kinase B	GO:0006241; P:CTP biosynthetic process; IEA:InterPro
P22392	NME2	Nucleoside diphosphate kinase B	GO:0006183; P:GTP biosynthetic process; IEA:InterPro
P22392	NME2	Nucleoside diphosphate kinase B	GO:0007229; P:integrin-mediated signaling pathway; IDA:UniProtKB
P22392	NME2	Nucleoside diphosphate kinase B	GO:0043066; P:negative regulation of apoptotic process; IMP:HGNC
P22392	NME2	Nucleoside diphosphate kinase B	GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome
P22392	NME2	Nucleoside diphosphate kinase B	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P22392	NME2	Nucleoside diphosphate kinase B	GO:0009142; P:nucleoside triphosphate biosynthetic process; IDA:UniProtKB
P22392	NME2	Nucleoside diphosphate kinase B	GO:0050679; P:positive regulation of epithelial cell proliferation; IMP:HGNC
P22392	NME2	Nucleoside diphosphate kinase B	GO:0045618; P:positive regulation of keratinocyte differentiation; IMP:HGNC
P22392	NME2	Nucleoside diphosphate kinase B	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P22392	NME2	Nucleoside diphosphate kinase B	GO:0045682; P:regulation of epidermis development; IMP:HGNC
P22392	NME2	Nucleoside diphosphate kinase B	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
P22392	NME2	Nucleoside diphosphate kinase B	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P22392	NME2	Nucleoside diphosphate kinase B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P22392	NME2	Nucleoside diphosphate kinase B	GO:0006228; P:UTP biosynthetic process; IEA:InterPro
Q8TB73	NDNF	Protein NDNF	GO:0005539; F:glycosaminoglycan binding; ISS:UniProtKB
Q8TB73	NDNF	Protein NDNF	GO:0008201; F:heparin binding; ISS:UniProtKB
Q8TB73	NDNF	Protein NDNF	GO:0016049; P:cell growth; IDA:UniProtKB
Q8TB73	NDNF	Protein NDNF	GO:0030198; P:extracellular matrix organization; ISS:UniProtKB
Q8TB73	NDNF	Protein NDNF	GO:0043524; P:negative regulation of neuron apoptotic process; IDA:UniProtKB
Q8TB73	NDNF	Protein NDNF	GO:0001764; P:neuron migration; IDA:UniProtKB
Q8TB73	NDNF	Protein NDNF	GO:0019800; P:peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan; ISS:UniProtKB
Q8TB73	NDNF	Protein NDNF	GO:0010811; P:positive regulation of cell-substrate adhesion; ISS:UniProtKB
Q8TB73	NDNF	Protein NDNF	GO:0010976; P:positive regulation of neuron projection development; IDA:UniProtKB
Q9UHB4	NDOR1	NADPH-dependent diflavin oxidoreductase 1	GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB
Q9UHB4	NDOR1	NADPH-dependent diflavin oxidoreductase 1	GO:0010181; F:FMN binding; IDA:UniProtKB
Q9UHB4	NDOR1	NADPH-dependent diflavin oxidoreductase 1	GO:0005506; F:iron ion binding; IEA:InterPro
Q9UHB4	NDOR1	NADPH-dependent diflavin oxidoreductase 1	GO:0050661; F:NADP binding; IDA:UniProtKB
Q9UHB4	NDOR1	NADPH-dependent diflavin oxidoreductase 1	GO:0003958; F:NADPH-hemoprotein reductase activity; IBA:RefGenome
Q9UHB4	NDOR1	NADPH-dependent diflavin oxidoreductase 1	GO:0016491; F:oxidoreductase activity; IDA:UniProtKB
Q9UHB4	NDOR1	NADPH-dependent diflavin oxidoreductase 1	GO:0016709; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; IBA:RefGenome
Q9UHB4	NDOR1	NADPH-dependent diflavin oxidoreductase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UHB4	NDOR1	NADPH-dependent diflavin oxidoreductase 1	GO:0008219; P:cell death; IDA:UniProtKB
Q9UHB4	NDOR1	NADPH-dependent diflavin oxidoreductase 1	GO:0036245; P:cellular response to menadione; IDA:UniProtKB
Q9UHB4	NDOR1	NADPH-dependent diflavin oxidoreductase 1	GO:0016226; P:iron-sulfur cluster assembly; IEA:UniProtKB-HAMAP
Q9UHB4	NDOR1	NADPH-dependent diflavin oxidoreductase 1	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q9UHB4	NDOR1	NADPH-dependent diflavin oxidoreductase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q00604	NDP	Norrin	GO:0005109; F:frizzled binding; IPI:BHF-UCL
Q00604	NDP	Norrin	GO:0008083; F:growth factor activity; TAS:ProtInc
Q00604	NDP	Norrin	GO:0005515; F:protein binding; IPI:IntAct
Q00604	NDP	Norrin	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q00604	NDP	Norrin	GO:0060070; P:canonical Wnt signaling pathway; IDA:BHF-UCL
Q00604	NDP	Norrin	GO:0008283; P:cell proliferation; TAS:ProtInc
Q00604	NDP	Norrin	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q00604	NDP	Norrin	GO:0035426; P:extracellular matrix-cell signaling; IEA:Ensembl
Q00604	NDP	Norrin	GO:0007399; P:nervous system development; TAS:ProtInc
Q00604	NDP	Norrin	GO:0001890; P:placenta development; IEA:Ensembl
Q00604	NDP	Norrin	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q00604	NDP	Norrin	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
Q00604	NDP	Norrin	GO:0061299; P:retina vasculature morphogenesis in camera-type eye; IEA:Ensembl
Q00604	NDP	Norrin	GO:0007605; P:sensory perception of sound; NAS:ProtInc
Q00604	NDP	Norrin	GO:0007165; P:signal transduction; TAS:ProtInc
Q00604	NDP	Norrin	GO:0007033; P:vacuole organization; TAS:ProtInc
Q00604	NDP	Norrin	GO:0007601; P:visual perception; TAS:ProtInc
Q00604	NDP	Norrin	GO:0016055; P:Wnt signaling pathway; IDA:BHF-UCL
Q92597	NDRG1	Protein NDRG1	GO:0045296; F:cadherin binding; IDA:UniProtKB
Q92597	NDRG1	Protein NDRG1	GO:0043015; F:gamma-tubulin binding; IDA:UniProtKB
Q92597	NDRG1	Protein NDRG1	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q92597	NDRG1	Protein NDRG1	GO:0005515; F:protein binding; IPI:UniProtKB
Q92597	NDRG1	Protein NDRG1	GO:0017137; F:Rab GTPase binding; IDA:UniProtKB
Q92597	NDRG1	Protein NDRG1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q92597	NDRG1	Protein NDRG1	GO:0071456; P:cellular response to hypoxia; IEP:UniProtKB
Q92597	NDRG1	Protein NDRG1	GO:0030330; P:DNA damage response, signal transduction by p53 class mediator; IEP:UniProtKB
Q92597	NDRG1	Protein NDRG1	GO:0045576; P:mast cell activation; IEA:Ensembl
Q92597	NDRG1	Protein NDRG1	GO:0032287; P:peripheral nervous system myelin maintenance; IEA:Ensembl
Q92597	NDRG1	Protein NDRG1	GO:0090232; P:positive regulation of spindle checkpoint; IDA:UniProtKB
Q92597	NDRG1	Protein NDRG1	GO:0010038; P:response to metal ion; TAS:ProtInc
Q9UN36	NDRG2	Protein NDRG2	GO:0005515; F:protein binding; IPI:IntAct
Q9UN36	NDRG2	Protein NDRG2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9UN36	NDRG2	Protein NDRG2	GO:0001818; P:negative regulation of cytokine production; IEA:Ensembl
Q9UN36	NDRG2	Protein NDRG2	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IEA:Ensembl
Q9UN36	NDRG2	Protein NDRG2	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IEA:Ensembl
Q9UN36	NDRG2	Protein NDRG2	GO:0090361; P:regulation of platelet-derived growth factor production; IEA:Ensembl
Q9UN36	NDRG2	Protein NDRG2	GO:0010574; P:regulation of vascular endothelial growth factor production; IEA:Ensembl
Q9UN36	NDRG2	Protein NDRG2	GO:0021762; P:substantia nigra development; IEP:UniProt
Q9UN36	NDRG2	Protein NDRG2	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9UGV2	NDRG3	Protein NDRG3	GO:0030154; P:cell differentiation; NAS:UniProtKB
Q9UGV2	NDRG3	Protein NDRG3	GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB
Q9UGV2	NDRG3	Protein NDRG3	GO:0007283; P:spermatogenesis; NAS:UniProtKB
Q9ULP0	NDRG4	Protein NDRG4	GO:0030154; P:cell differentiation; NAS:UniProtKB
Q9ULP0	NDRG4	Protein NDRG4	GO:0016049; P:cell growth; NAS:UniProtKB
Q9ULP0	NDRG4	Protein NDRG4	GO:0006950; P:response to stress; NAS:UniProtKB
P52848	NDST1	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1	GO:0015016; F:[heparan sulfate]-glucosamine N-sulfotransferase activity; IEA:UniProtKB-EC
P52848	NDST1	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1	GO:0019213; F:deacetylase activity; IEA:Ensembl
P52848	NDST1	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P52848	NDST1	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1	GO:0048702; P:embryonic neurocranium morphogenesis; IEA:Ensembl
P52848	NDST1	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1	GO:0048703; P:embryonic viscerocranium morphogenesis; IEA:Ensembl
P52848	NDST1	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; IEA:Ensembl
P52848	NDST1	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1	GO:0030900; P:forebrain development; IEA:Ensembl
P52848	NDST1	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
P52848	NDST1	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P52848	NDST1	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1	GO:0015012; P:heparan sulfate proteoglycan biosynthetic process; TAS:ProtInc
P52848	NDST1	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1	GO:0030210; P:heparin biosynthetic process; IEA:UniProtKB-UniPathway
P52848	NDST1	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
P52848	NDST1	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1	GO:0000165; P:MAPK cascade; IEA:Ensembl
P52848	NDST1	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1	GO:0030901; P:midbrain development; IEA:Ensembl
P52848	NDST1	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1	GO:0000271; P:polysaccharide biosynthetic process; IEA:Ensembl
P52848	NDST1	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1	GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl
P52848	NDST1	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P52848	NDST1	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
P52849	NDST2	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2	GO:0015016; F:[heparan sulfate]-glucosamine N-sulfotransferase activity; IEA:UniProtKB-EC
P52849	NDST2	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
P52849	NDST2	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P52849	NDST2	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
P52849	NDST2	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P52849	NDST2	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2	GO:0015012; P:heparan sulfate proteoglycan biosynthetic process; IEA:UniProtKB-UniPathway
P52849	NDST2	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2	GO:0030210; P:heparin biosynthetic process; IEA:UniProtKB-UniPathway
P52849	NDST2	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95803	NDST3	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3	GO:0015016; F:[heparan sulfate]-glucosamine N-sulfotransferase activity; IEA:InterPro
O95803	NDST3	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3	GO:0019213; F:deacetylase activity; IEA:Ensembl
O95803	NDST3	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3	GO:0016787; F:hydrolase activity; IEA:InterPro
O95803	NDST3	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3	GO:0015012; P:heparan sulfate proteoglycan biosynthetic process; IEA:UniProtKB-UniPathway
O95803	NDST3	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3	GO:0030210; P:heparin biosynthetic process; IEA:UniProtKB-UniPathway
Q9H3R1	NDST4	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4	GO:0015016; F:[heparan sulfate]-glucosamine N-sulfotransferase activity; IEA:UniProtKB-EC
Q9H3R1	NDST4	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4	GO:0019213; F:deacetylase activity; IEA:Ensembl
Q9H3R1	NDST4	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4	GO:0015012; P:heparan sulfate proteoglycan biosynthetic process; IEA:UniProtKB-UniPathway
Q9H3R1	NDST4	Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4	GO:0030210; P:heparin biosynthetic process; IEA:UniProtKB-UniPathway
O15239	NDUFA1	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O15239	NDUFA1	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1	GO:0044237; P:cellular metabolic process; TAS:Reactome
O15239	NDUFA1	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O15239	NDUFA1	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O15239	NDUFA1	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43678	NDUFA2	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O43678	NDUFA2	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2	GO:0044237; P:cellular metabolic process; TAS:Reactome
O43678	NDUFA2	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O43678	NDUFA2	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O43678	NDUFA2	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95167	NDUFA3	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O95167	NDUFA3	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3	GO:0044237; P:cellular metabolic process; TAS:Reactome
O95167	NDUFA3	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O95167	NDUFA3	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O95167	NDUFA3	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00483	NDUFA4	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O00483	NDUFA4	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4	GO:0032403; F:protein complex binding; IDA:MGI
O00483	NDUFA4	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4	GO:0044237; P:cellular metabolic process; TAS:Reactome
O00483	NDUFA4	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4	GO:1902600; P:hydrogen ion transmembrane transport; IMP:GOC
O00483	NDUFA4	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O00483	NDUFA4	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O00483	NDUFA4	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16718	NDUFA5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
Q16718	NDUFA5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q16718	NDUFA5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
Q16718	NDUFA5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
Q16718	NDUFA5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P56556	NDUFA6	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
P56556	NDUFA6	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6	GO:0044237; P:cellular metabolic process; TAS:Reactome
P56556	NDUFA6	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
P56556	NDUFA6	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P56556	NDUFA6	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6	GO:0006979; P:response to oxidative stress; IDA:UniProtKB
P56556	NDUFA6	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95182	NDUFA7	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O95182	NDUFA7	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7	GO:0044237; P:cellular metabolic process; TAS:Reactome
O95182	NDUFA7	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O95182	NDUFA7	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O95182	NDUFA7	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P51970	NDUFA8	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
P51970	NDUFA8	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8	GO:0032403; F:protein complex binding; IDA:MGI
P51970	NDUFA8	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8	GO:0044237; P:cellular metabolic process; TAS:Reactome
P51970	NDUFA8	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
P51970	NDUFA8	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P51970	NDUFA8	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16795	NDUFA9	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial	GO:0050662; F:coenzyme binding; IEA:InterPro
Q16795	NDUFA9	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
Q16795	NDUFA9	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial	GO:0003954; F:NADH dehydrogenase activity; IMP:UniProtKB
Q16795	NDUFA9	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q16795	NDUFA9	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial	GO:0032403; F:protein complex binding; IDA:MGI
Q16795	NDUFA9	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q16795	NDUFA9	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
Q16795	NDUFA9	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
Q16795	NDUFA9	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16795	NDUFA9	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial	GO:0006814; P:sodium ion transport; NAS:UniProtKB
O95299	NDUFA10	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial	GO:0005524; F:ATP binding; IEA:InterPro
O95299	NDUFA10	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O95299	NDUFA10	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial	GO:0016773; F:phosphotransferase activity, alcohol group as acceptor; IEA:InterPro
O95299	NDUFA10	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
O95299	NDUFA10	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O95299	NDUFA10	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial	GO:0006139; P:nucleobase-containing compound metabolic process; IEA:InterPro
O95299	NDUFA10	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O95299	NDUFA10	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial	GO:0042493; P:response to drug; IEA:Ensembl
O95299	NDUFA10	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q86Y39	NDUFA11	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q86Y39	NDUFA11	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
Q86Y39	NDUFA11	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UI09	NDUFA12	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12	GO:0009055; F:electron carrier activity; IEA:InterPro
Q9UI09	NDUFA12	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
Q9UI09	NDUFA12	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q9UI09	NDUFA12	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
Q9UI09	NDUFA12	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12	GO:0007585; P:respiratory gaseous exchange; NAS:UniProtKB
Q9UI09	NDUFA12	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12	GO:0006979; P:response to oxidative stress; IDA:UniProtKB
Q9UI09	NDUFA12	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9P0J0	NDUFA13	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	GO:0005524; F:ATP binding; NAS:UniProtKB
Q9P0J0	NDUFA13	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; IDA:UniProtKB
Q9P0J0	NDUFA13	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	GO:0003954; F:NADH dehydrogenase activity; IMP:UniProtKB
Q9P0J0	NDUFA13	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P0J0	NDUFA13	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	GO:0097190; P:apoptotic signaling pathway; IDA:UniProtKB
Q9P0J0	NDUFA13	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q9P0J0	NDUFA13	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	GO:0097191; P:extrinsic apoptotic signaling pathway; IEA:Ensembl
Q9P0J0	NDUFA13	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q9P0J0	NDUFA13	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
Q9P0J0	NDUFA13	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9P0J0	NDUFA13	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	GO:0045039; P:protein import into mitochondrial inner membrane; IDA:UniProtKB
Q9P0J0	NDUFA13	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	GO:0072593; P:reactive oxygen species metabolic process; IMP:UniProtKB
Q9P0J0	NDUFA13	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
Q9P0J0	NDUFA13	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75438	NDUFB1	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O75438	NDUFB1	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1	GO:0044237; P:cellular metabolic process; TAS:Reactome
O75438	NDUFB1	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O75438	NDUFB1	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O75438	NDUFB1	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95178	NDUFB2	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O95178	NDUFB2	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
O95178	NDUFB2	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O95178	NDUFB2	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O95178	NDUFB2	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43676	NDUFB3	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O43676	NDUFB3	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3	GO:0044237; P:cellular metabolic process; TAS:Reactome
O43676	NDUFB3	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O43676	NDUFB3	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O43676	NDUFB3	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95168	NDUFB4	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O95168	NDUFB4	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4	GO:0044237; P:cellular metabolic process; TAS:Reactome
O95168	NDUFB4	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O95168	NDUFB4	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O95168	NDUFB4	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4	GO:0006979; P:response to oxidative stress; IDA:UniProtKB
O95168	NDUFB4	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43674	NDUFB5	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O43674	NDUFB5	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
O43674	NDUFB5	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O43674	NDUFB5	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O43674	NDUFB5	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95139	NDUFB6	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O95139	NDUFB6	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6	GO:0044237; P:cellular metabolic process; TAS:Reactome
O95139	NDUFB6	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O95139	NDUFB6	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O95139	NDUFB6	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P17568	NDUFB7	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
P17568	NDUFB7	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7	GO:0044237; P:cellular metabolic process; TAS:Reactome
P17568	NDUFB7	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
P17568	NDUFB7	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P17568	NDUFB7	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95169	NDUFB8	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; IEA:InterPro
O95169	NDUFB8	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
O95169	NDUFB8	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O95169	NDUFB8	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O95169	NDUFB8	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y6M9	NDUFB9	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
Q9Y6M9	NDUFB9	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q9Y6M9	NDUFB9	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
Q9Y6M9	NDUFB9	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
Q9Y6M9	NDUFB9	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9	GO:0007605; P:sensory perception of sound; TAS:ProtInc
Q9Y6M9	NDUFB9	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O96000	NDUFB10	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O96000	NDUFB10	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10	GO:0005515; F:protein binding; IPI:HGNC
O96000	NDUFB10	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10	GO:0044237; P:cellular metabolic process; TAS:Reactome
O96000	NDUFB10	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O96000	NDUFB10	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O96000	NDUFB10	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NX14	NDUFB11	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q9NX14	NDUFB11	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
Q9NX14	NDUFB11	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43677	NDUFC1	NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O43677	NDUFC1	NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
O43677	NDUFC1	NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O43677	NDUFC1	NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O43677	NDUFC1	NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95298	NDUFC2	NADH dehydrogenase [ubiquinone] 1 subunit C2	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O95298	NDUFC2	NADH dehydrogenase [ubiquinone] 1 subunit C2	GO:0044237; P:cellular metabolic process; TAS:Reactome
O95298	NDUFC2	NADH dehydrogenase [ubiquinone] 1 subunit C2	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O95298	NDUFC2	NADH dehydrogenase [ubiquinone] 1 subunit C2	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O95298	NDUFC2	NADH dehydrogenase [ubiquinone] 1 subunit C2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
E9PQ53	NDUFC2-KCTD14	NADH dehydrogenase [ubiquinone] 1 subunit C2, isoform 2	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; IEA:InterPro
E9PQ53	NDUFC2-KCTD14	NADH dehydrogenase [ubiquinone] 1 subunit C2, isoform 2	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; IEA:InterPro
Q9BU61	NDUFAF3	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BU61	NDUFAF3	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3	GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:UniProtKB
Q9P032	NDUFAF4	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P032	NDUFAF4	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4	GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:UniProtKB
Q5TEU4	NDUFAF5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q5TEU4	NDUFAF5	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5	GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:UniProtKB
Q7L592	NDUFAF7	NADH dehydrogenase [ubiquinone] complex I, assembly factor 7	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q7L592	NDUFAF7	NADH dehydrogenase [ubiquinone] complex I, assembly factor 7	GO:0008168; F:methyltransferase activity; NAS:UniProtKB
Q7L592	NDUFAF7	NADH dehydrogenase [ubiquinone] complex I, assembly factor 7	GO:0032259; P:methylation; NAS:GOC
Q7L592	NDUFAF7	NADH dehydrogenase [ubiquinone] complex I, assembly factor 7	GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:UniProtKB
Q330K2	NDUFAF6	NADH dehydrogenase (ubiquinone) complex I, assembly factor 6	GO:0016740; F:transferase activity; IEA:InterPro
Q330K2	NDUFAF6	NADH dehydrogenase (ubiquinone) complex I, assembly factor 6	GO:0009058; P:biosynthetic process; IEA:InterPro
Q330K2	NDUFAF6	NADH dehydrogenase (ubiquinone) complex I, assembly factor 6	GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:UniProtKB
P28331	NDUFS1	NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial	GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:UniProtKB-KW
P28331	NDUFS1	NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
P28331	NDUFS1	NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial	GO:0009055; F:electron carrier activity; NAS:UniProtKB
P28331	NDUFS1	NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P28331	NDUFS1	NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
P28331	NDUFS1	NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
P28331	NDUFS1	NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial	GO:0008637; P:apoptotic mitochondrial changes; IDA:UniProtKB
P28331	NDUFS1	NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial	GO:0046034; P:ATP metabolic process; IMP:UniProtKB
P28331	NDUFS1	NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P28331	NDUFS1	NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial	GO:0045333; P:cellular respiration; IMP:UniProtKB
P28331	NDUFS1	NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
P28331	NDUFS1	NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial	GO:0072593; P:reactive oxygen species metabolic process; IMP:UniProtKB
P28331	NDUFS1	NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial	GO:0051881; P:regulation of mitochondrial membrane potential; IMP:UniProtKB
P28331	NDUFS1	NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P28331	NDUFS1	NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75306	NDUFS2	NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
O75306	NDUFS2	NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial	GO:0009055; F:electron carrier activity; NAS:UniProtKB
O75306	NDUFS2	NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75306	NDUFS2	NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial	GO:0051287; F:NAD binding; IEA:InterPro
O75306	NDUFS2	NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O75306	NDUFS2	NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
O75306	NDUFS2	NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial	GO:0048038; F:quinone binding; IEA:InterPro
O75306	NDUFS2	NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
O75306	NDUFS2	NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O75306	NDUFS2	NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O75306	NDUFS2	NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial	GO:0006979; P:response to oxidative stress; IDA:UniProtKB
O75306	NDUFS2	NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75489	NDUFS3	NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial	GO:0009055; F:electron carrier activity; NAS:UniProtKB
O75489	NDUFS3	NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O75489	NDUFS3	NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial	GO:0003954; F:NADH dehydrogenase activity; IMP:UniProtKB
O75489	NDUFS3	NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
O75489	NDUFS3	NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
O75489	NDUFS3	NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O75489	NDUFS3	NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial	GO:0030308; P:negative regulation of cell growth; IMP:UniProtKB
O75489	NDUFS3	NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
O75489	NDUFS3	NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial	GO:0072593; P:reactive oxygen species metabolic process; IMP:UniProtKB
O75489	NDUFS3	NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O75489	NDUFS3	NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75489	NDUFS3	NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial	GO:0021762; P:substantia nigra development; IEP:UniProt
O43181	NDUFS4	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; IMP:UniProtKB
O43181	NDUFS4	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial	GO:0007420; P:brain development; IMP:UniProtKB
O43181	NDUFS4	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial	GO:0019933; P:cAMP-mediated signaling; IMP:UniProtKB
O43181	NDUFS4	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
O43181	NDUFS4	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial	GO:0045333; P:cellular respiration; IMP:UniProtKB
O43181	NDUFS4	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O43181	NDUFS4	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial	GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:UniProtKB
O43181	NDUFS4	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial	GO:0048146; P:positive regulation of fibroblast proliferation; IMP:UniProtKB
O43181	NDUFS4	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial	GO:0072593; P:reactive oxygen species metabolic process; IMP:UniProtKB
O43181	NDUFS4	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial	GO:0001932; P:regulation of protein phosphorylation; IMP:MGI
O43181	NDUFS4	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O43181	NDUFS4	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial	GO:0051591; P:response to cAMP; IMP:UniProtKB
O43181	NDUFS4	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43920	NDUFS5	NADH dehydrogenase [ubiquinone] iron-sulfur protein 5	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O43920	NDUFS5	NADH dehydrogenase [ubiquinone] iron-sulfur protein 5	GO:0044237; P:cellular metabolic process; TAS:Reactome
O43920	NDUFS5	NADH dehydrogenase [ubiquinone] iron-sulfur protein 5	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O43920	NDUFS5	NADH dehydrogenase [ubiquinone] iron-sulfur protein 5	GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:UniProtKB
O43920	NDUFS5	NADH dehydrogenase [ubiquinone] iron-sulfur protein 5	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O43920	NDUFS5	NADH dehydrogenase [ubiquinone] iron-sulfur protein 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75380	NDUFS6	NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial	GO:0009055; F:electron carrier activity; NAS:UniProtKB
O75380	NDUFS6	NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O75380	NDUFS6	NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial	GO:0072358; P:cardiovascular system development; IEA:Ensembl
O75380	NDUFS6	NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
O75380	NDUFS6	NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial	GO:0006631; P:fatty acid metabolic process; IEA:Ensembl
O75380	NDUFS6	NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O75380	NDUFS6	NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial	GO:0070584; P:mitochondrion morphogenesis; IEA:Ensembl
O75380	NDUFS6	NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial	GO:0035264; P:multicellular organism growth; IEA:Ensembl
O75380	NDUFS6	NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial	GO:0010259; P:multicellular organismal aging; IEA:Ensembl
O75380	NDUFS6	NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial	GO:0006936; P:muscle contraction; IEA:Ensembl
O75380	NDUFS6	NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial	GO:0061458; P:reproductive system development; IEA:Ensembl
O75380	NDUFS6	NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O75380	NDUFS6	NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75251	NDUFS7	NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
O75251	NDUFS7	NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75251	NDUFS7	NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O75251	NDUFS7	NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial	GO:0016655; F:oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; NAS:UniProtKB
O75251	NDUFS7	NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
O75251	NDUFS7	NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial	GO:0048038; F:quinone binding; IEA:InterPro
O75251	NDUFS7	NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
O75251	NDUFS7	NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O75251	NDUFS7	NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial	GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:UniProtKB
O75251	NDUFS7	NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O75251	NDUFS7	NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00217	NDUFS8	NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
O00217	NDUFS8	NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O00217	NDUFS8	NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
O00217	NDUFS8	NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
O00217	NDUFS8	NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
O00217	NDUFS8	NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial	GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:UniProtKB
O00217	NDUFS8	NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O00217	NDUFS8	NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial	GO:0006979; P:response to oxidative stress; IDA:UniProtKB
O00217	NDUFS8	NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P49821	NDUFV1	NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
P49821	NDUFV1	NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial	GO:0010181; F:FMN binding; IEA:InterPro
P49821	NDUFV1	NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P49821	NDUFV1	NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial	GO:0051287; F:NAD binding; IEA:InterPro
P49821	NDUFV1	NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
P49821	NDUFV1	NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P49821	NDUFV1	NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
P49821	NDUFV1	NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P49821	NDUFV1	NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P19404	NDUFV2	NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial	GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:UniProtKB-KW
P19404	NDUFV2	NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial	GO:0009055; F:electron carrier activity; NAS:UniProtKB
P19404	NDUFV2	NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P19404	NDUFV2	NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; IMP:UniProtKB
P19404	NDUFV2	NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial	GO:0048738; P:cardiac muscle tissue development; IMP:UniProtKB
P19404	NDUFV2	NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P19404	NDUFV2	NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; IMP:UniProtKB
P19404	NDUFV2	NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial	GO:0007399; P:nervous system development; IMP:UniProtKB
P19404	NDUFV2	NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P19404	NDUFV2	NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P56181	NDUFV3	NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
P56181	NDUFV3	NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P56181	NDUFV3	NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P56181	NDUFV3	NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
P56181	NDUFV3	NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P56181	NDUFV3	NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9ULJ8	PPP1R9A	Neurabin-1	GO:0005515; F:protein binding; IPI:IntAct
Q9ULJ8	PPP1R9A	Neurabin-1	GO:0007015; P:actin filament organization; IEA:Ensembl
Q9ULJ8	PPP1R9A	Neurabin-1	GO:0019722; P:calcium-mediated signaling; IEA:Ensembl
Q9ULJ8	PPP1R9A	Neurabin-1	GO:0031175; P:neuron projection development; IEA:Ensembl
Q96SB3	PPP1R9B	Neurabin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q96SB3	PPP1R9B	Neurabin-2	GO:0008157; F:protein phosphatase 1 binding; NAS:UniProtKB
Q96SB3	PPP1R9B	Neurabin-2	GO:0004864; F:protein phosphatase inhibitor activity; NAS:UniProtKB
Q96SB3	PPP1R9B	Neurabin-2	GO:0007015; P:actin filament organization; IEA:Ensembl
Q96SB3	PPP1R9B	Neurabin-2	GO:0019722; P:calcium-mediated signaling; IEA:Ensembl
Q96SB3	PPP1R9B	Neurabin-2	GO:0007050; P:cell cycle arrest; TAS:UniProtKB
Q96SB3	PPP1R9B	Neurabin-2	GO:0016477; P:cell migration; IMP:UniProtKB
Q96SB3	PPP1R9B	Neurabin-2	GO:0071315; P:cellular response to morphine; ISS:UniProtKB
Q96SB3	PPP1R9B	Neurabin-2	GO:0016358; P:dendrite development; IEA:Ensembl
Q96SB3	PPP1R9B	Neurabin-2	GO:0046847; P:filopodium assembly; IMP:UniProtKB
Q96SB3	PPP1R9B	Neurabin-2	GO:0043086; P:negative regulation of catalytic activity; NAS:GOC
Q96SB3	PPP1R9B	Neurabin-2	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q96SB3	PPP1R9B	Neurabin-2	GO:0001560; P:regulation of cell growth by extracellular stimulus; TAS:UniProtKB
Q96SB3	PPP1R9B	Neurabin-2	GO:0042127; P:regulation of cell proliferation; NAS:UniProtKB
Q96SB3	PPP1R9B	Neurabin-2	GO:0007096; P:regulation of exit from mitosis; NAS:UniProtKB
Q96SB3	PPP1R9B	Neurabin-2	GO:2000474; P:regulation of opioid receptor signaling pathway; ISS:UniProtKB
Q96SB3	PPP1R9B	Neurabin-2	GO:0001932; P:regulation of protein phosphorylation; IEA:Ensembl
Q96SB3	PPP1R9B	Neurabin-2	GO:0008380; P:RNA splicing; NAS:UniProtKB
O76041	NEBL	Nebulette	GO:0051015; F:actin filament binding; IDA:UniProtKB
O76041	NEBL	Nebulette	GO:0008092; F:cytoskeletal protein binding; IDA:UniProtKB
O76041	NEBL	Nebulette	GO:0031005; F:filamin binding; IPI:UniProtKB
O76041	NEBL	Nebulette	GO:0005515; F:protein binding; IPI:UniProtKB
O76041	NEBL	Nebulette	GO:0008307; F:structural constituent of muscle; NAS:UniProtKB
O76041	NEBL	Nebulette	GO:0005523; F:tropomyosin binding; IPI:UniProtKB
O76041	NEBL	Nebulette	GO:0071691; P:cardiac muscle thin filament assembly; IMP:UniProtKB
P20929	NEB	Nebulin	GO:0005515; F:protein binding; IPI:IntAct
P20929	NEB	Nebulin	GO:0008307; F:structural constituent of muscle; TAS:ProtInc
P20929	NEB	Nebulin	GO:0030049; P:muscle filament sliding; TAS:Reactome
P20929	NEB	Nebulin	GO:0007517; P:muscle organ development; TAS:ProtInc
P20929	NEB	Nebulin	GO:0030832; P:regulation of actin filament length; NAS:UniProtKB
P20929	NEB	Nebulin	GO:0007525; P:somatic muscle development; NAS:UniProtKB
P29120	PCSK1	Neuroendocrine convertase 1	GO:0004252; F:serine-type endopeptidase activity; ISS:BHF-UCL
P29120	PCSK1	Neuroendocrine convertase 1	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P29120	PCSK1	Neuroendocrine convertase 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P29120	PCSK1	Neuroendocrine convertase 1	GO:0008152; P:metabolic process; TAS:ProtInc
P29120	PCSK1	Neuroendocrine convertase 1	GO:0043043; P:peptide biosynthetic process; ISS:BHF-UCL
P29120	PCSK1	Neuroendocrine convertase 1	GO:0016486; P:peptide hormone processing; TAS:Reactome
P29120	PCSK1	Neuroendocrine convertase 1	GO:0006508; P:proteolysis; TAS:ProtInc
P29120	PCSK1	Neuroendocrine convertase 1	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P16519	PCSK2	Neuroendocrine convertase 2	GO:0005515; F:protein binding; IPI:UniProtKB
P16519	PCSK2	Neuroendocrine convertase 2	GO:0004252; F:serine-type endopeptidase activity; IDA:BHF-UCL
P16519	PCSK2	Neuroendocrine convertase 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P16519	PCSK2	Neuroendocrine convertase 2	GO:0009790; P:embryo development; IEA:Ensembl
P16519	PCSK2	Neuroendocrine convertase 2	GO:0034230; P:enkephalin processing; ISS:BHF-UCL
P16519	PCSK2	Neuroendocrine convertase 2	GO:0030070; P:insulin processing; IDA:BHF-UCL
P16519	PCSK2	Neuroendocrine convertase 2	GO:0034231; P:islet amyloid polypeptide processing; ISS:BHF-UCL
P16519	PCSK2	Neuroendocrine convertase 2	GO:0007399; P:nervous system development; IEA:Ensembl
P16519	PCSK2	Neuroendocrine convertase 2	GO:0016540; P:protein autoprocessing; IEA:Ensembl
P16519	PCSK2	Neuroendocrine convertase 2	GO:0006508; P:proteolysis; IDA:BHF-UCL
Q7Z6G3	NECAB2	N-terminal EF-hand calcium-binding protein 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q7Z6G3	NECAB2	N-terminal EF-hand calcium-binding protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q8N987	NECAB1	N-terminal EF-hand calcium-binding protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96P71	NECAB3	N-terminal EF-hand calcium-binding protein 3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96P71	NECAB3	N-terminal EF-hand calcium-binding protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q96P71	NECAB3	N-terminal EF-hand calcium-binding protein 3	GO:0019538; P:protein metabolic process; IDA:UniProtKB
Q96P71	NECAB3	N-terminal EF-hand calcium-binding protein 3	GO:0009306; P:protein secretion; NAS:UniProtKB
Q96P71	NECAB3	N-terminal EF-hand calcium-binding protein 3	GO:0042984; P:regulation of amyloid precursor protein biosynthetic process; IDA:UniProtKB
Q99608	NDN	Necdin	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q99608	NDN	Necdin	GO:0048675; P:axon extension; IEA:Ensembl
Q99608	NDN	Necdin	GO:0007413; P:axonal fasciculation; IEA:Ensembl
Q99608	NDN	Necdin	GO:0007417; P:central nervous system development; IEA:Ensembl
Q99608	NDN	Necdin	GO:0071514; P:genetic imprinting; IEA:Ensembl
Q99608	NDN	Necdin	GO:0008347; P:glial cell migration; IEA:Ensembl
Q99608	NDN	Necdin	GO:0048871; P:multicellular organismal homeostasis; IEA:Ensembl
Q99608	NDN	Necdin	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q99608	NDN	Necdin	GO:0007399; P:nervous system development; TAS:ProtInc
Q99608	NDN	Necdin	GO:0001764; P:neuron migration; IEA:Ensembl
Q99608	NDN	Necdin	GO:0048011; P:neurotrophin TRK receptor signaling pathway; IEA:Ensembl
Q99608	NDN	Necdin	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q99608	NDN	Necdin	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q99608	NDN	Necdin	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q99608	NDN	Necdin	GO:0003016; P:respiratory system process; IEA:Ensembl
Q99608	NDN	Necdin	GO:0019233; P:sensory perception of pain; IEA:Ensembl
Q99608	NDN	Necdin	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NC96	NECAP1	Adaptin ear-binding coat-associated protein 1	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q8NC96	NECAP1	Adaptin ear-binding coat-associated protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9NVZ3	NECAP2	Adaptin ear-binding coat-associated protein 2	GO:0006897; P:endocytosis; ISS:UniProtKB
Q9NVZ3	NECAP2	Adaptin ear-binding coat-associated protein 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0019870; F:potassium channel inhibitor activity; IDA:BHF-UCL
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0015459; F:potassium channel regulator activity; IDA:BHF-UCL
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0005515; F:protein binding; IPI:UniProtKB
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0019871; F:sodium channel inhibitor activity; IDA:BHF-UCL
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0017080; F:sodium channel regulator activity; IDA:UniProtKB
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0004842; F:ubiquitin-protein ligase activity; NAS:UniProtKB
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0006883; P:cellular sodium ion homeostasis; NAS:UniProtKB
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0007588; P:excretion; NAS:UniProtKB
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0010467; P:gene expression; TAS:Reactome
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:1901380; P:negative regulation of potassium ion transmembrane transport; IDA:BHF-UCL
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:1901017; P:negative regulation of potassium ion transmembrane transporter activity; IDA:BHF-UCL
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:2000009; P:negative regulation of protein localization to cell surface; IDA:BHF-UCL
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:1902306; P:negative regulation of sodium ion transmembrane transport; IDA:BHF-UCL
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:2000650; P:negative regulation of sodium ion transmembrane transporter activity; IDA:BHF-UCL
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0003085; P:negative regulation of systemic arterial blood pressure; IEA:Ensembl
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:Reactome
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:2001259; P:positive regulation of cation channel activity; IEA:Ensembl
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:2001288; P:positive regulation of caveolin-mediated endocytosis; ISS:BHF-UCL
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0045807; P:positive regulation of endocytosis; NAS:UniProtKB
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0010765; P:positive regulation of sodium ion transport; IEA:Ensembl
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:BHF-UCL
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0070936; P:protein K48-linked ubiquitination; IDA:BHF-UCL
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0006513; P:protein monoubiquitination; IEA:Ensembl
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0016567; P:protein ubiquitination; NAS:UniProtKB
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:BHF-UCL
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0034765; P:regulation of ion transmembrane transport; IDA:BHF-UCL
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0003254; P:regulation of membrane depolarization; IDA:BHF-UCL
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0042391; P:regulation of membrane potential; IDA:BHF-UCL
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0060306; P:regulation of membrane repolarization; IDA:BHF-UCL
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:1901016; P:regulation of potassium ion transmembrane transporter activity; IDA:BHF-UCL
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0042176; P:regulation of protein catabolic process; NAS:UniProtKB
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:2000810; P:regulation of tight junction assembly; IEA:Ensembl
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0010038; P:response to metal ion; IDA:UniProtKB
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0009651; P:response to salt stress; IEA:Ensembl
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0006814; P:sodium ion transport; NAS:UniProtKB
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0055085; P:transmembrane transport; TAS:Reactome
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0043162; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; IEA:Ensembl
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0086005; P:ventricular cardiac muscle cell action potential; ISS:BHF-UCL
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0019058; P:viral life cycle; TAS:Reactome
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0016032; P:viral process; TAS:Reactome
Q96PU5	NEDD4L	E3 ubiquitin-protein ligase NEDD4-like	GO:0030104; P:water homeostasis; NAS:UniProtKB
Q8NHV4	NEDD1	Protein NEDD1	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q8NHV4	NEDD1	Protein NEDD1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q8NHV4	NEDD1	Protein NEDD1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0031698; F:beta-2 adrenergic receptor binding; IDA:UniProtKB
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0050815; F:phosphoserine binding; ISS:BHF-UCL
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0050816; F:phosphothreonine binding; ISS:BHF-UCL
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0070064; F:proline-rich region binding; IPI:UniProtKB
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0005515; F:protein binding; IPI:UniProtKB
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0070063; F:RNA polymerase binding; IPI:BHF-UCL
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0019871; F:sodium channel inhibitor activity; IDA:BHF-UCL
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0043130; F:ubiquitin binding; IDA:BHF-UCL
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0004842; F:ubiquitin-protein ligase activity; IDA:BHF-UCL
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0002250; P:adaptive immune response; IEA:Ensembl
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0048514; P:blood vessel morphogenesis; IEA:Ensembl
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0034644; P:cellular response to UV; IMP:BHF-UCL
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0044111; P:development involved in symbiotic interaction; IMP:UniProtKB
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0003197; P:endocardial cushion development; IEA:Ensembl
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0042921; P:glucocorticoid receptor signaling pathway; IDA:BHF-UCL
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0007041; P:lysosomal transport; IDA:UniProtKB
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0010766; P:negative regulation of sodium ion transport; IDA:UniProtKB
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0010768; P:negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage; IMP:BHF-UCL
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0030948; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; ISS:UniProtKB
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0031175; P:neuron projection development; IEP:BHF-UCL
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0003151; P:outflow tract morphogenesis; IEA:Ensembl
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0046824; P:positive regulation of nucleocytoplasmic transport; IDA:BHF-UCL
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IMP:BHF-UCL
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0045732; P:positive regulation of protein catabolic process; IDA:MGI
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0050847; P:progesterone receptor signaling pathway; IDA:BHF-UCL
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0070534; P:protein K63-linked ubiquitination; ISS:UniProtKB
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0006513; P:protein monoubiquitination; IEA:Ensembl
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0006622; P:protein targeting to lysosome; IDA:UniProtKB
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:BHF-UCL
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0032801; P:receptor catabolic process; IDA:UniProtKB
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0031623; P:receptor internalization; IDA:UniProtKB
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0048814; P:regulation of dendrite morphogenesis; ISS:UniProtKB
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0034765; P:regulation of ion transmembrane transport; IDA:BHF-UCL
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0042391; P:regulation of membrane potential; IDA:BHF-UCL
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:1901016; P:regulation of potassium ion transmembrane transporter activity; IDA:BHF-UCL
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0050807; P:regulation of synapse organization; IEA:Ensembl
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0051592; P:response to calcium ion; TAS:BHF-UCL
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0042110; P:T cell activation; IEA:Ensembl
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0019089; P:transmission of virus; IMP:BHF-UCL
P46934	NEDD4	E3 ubiquitin-protein ligase NEDD4	GO:0043162; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; IMP:BHF-UCL
Q15843	NEDD8	NEDD8	GO:0005515; F:protein binding; IPI:IntAct
Q15843	NEDD8	NEDD8	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q15843	NEDD8	NEDD8	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q15843	NEDD8	NEDD8	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q15843	NEDD8	NEDD8	GO:0008104; P:protein localization; IEA:Ensembl
Q15843	NEDD8	NEDD8	GO:0045116; P:protein neddylation; IDA:MGI
Q15843	NEDD8	NEDD8	GO:0006508; P:proteolysis; TAS:ProtInc
Q15843	NEDD8	NEDD8	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q15843	NEDD8	NEDD8	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
Q15843	NEDD8	NEDD8	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q15843	NEDD8	NEDD8	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
Q7Z3B1	NEGR1	Neuronal growth regulator 1	GO:0005515; F:protein binding; IPI:IntAct
Q7Z3B1	NEGR1	Neuronal growth regulator 1	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
Q7Z3B1	NEGR1	Neuronal growth regulator 1	GO:0007631; P:feeding behavior; IEA:Ensembl
Q7Z3B1	NEGR1	Neuronal growth regulator 1	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q7Z3B1	NEGR1	Neuronal growth regulator 1	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
Q96FI4	NEIL1	Endonuclease 8-like 1	GO:0003684; F:damaged DNA binding; IEA:InterPro
Q96FI4	NEIL1	Endonuclease 8-like 1	GO:0019104; F:DNA N-glycosylase activity; IEA:Ensembl
Q96FI4	NEIL1	Endonuclease 8-like 1	GO:0003906; F:DNA-(apurinic or apyrimidinic site) lyase activity; IEA:UniProtKB-EC
Q96FI4	NEIL1	Endonuclease 8-like 1	GO:0016798; F:hydrolase activity, acting on glycosyl bonds; IDA:UniProtKB
Q96FI4	NEIL1	Endonuclease 8-like 1	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q96FI4	NEIL1	Endonuclease 8-like 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96FI4	NEIL1	Endonuclease 8-like 1	GO:0006284; P:base-excision repair; IDA:UniProtKB
Q96FI4	NEIL1	Endonuclease 8-like 1	GO:0032074; P:negative regulation of nuclease activity; IDA:UniProtKB
Q96FI4	NEIL1	Endonuclease 8-like 1	GO:0006289; P:nucleotide-excision repair; IEA:InterPro
Q96FI4	NEIL1	Endonuclease 8-like 1	GO:0006979; P:response to oxidative stress; IDA:UniProtKB
Q969S2	NEIL2	Endonuclease 8-like 2	GO:0003684; F:damaged DNA binding; IEA:InterPro
Q969S2	NEIL2	Endonuclease 8-like 2	GO:0003906; F:DNA-(apurinic or apyrimidinic site) lyase activity; IEA:UniProtKB-EC
Q969S2	NEIL2	Endonuclease 8-like 2	GO:0016799; F:hydrolase activity, hydrolyzing N-glycosyl compounds; IEA:InterPro
Q969S2	NEIL2	Endonuclease 8-like 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q969S2	NEIL2	Endonuclease 8-like 2	GO:0006284; P:base-excision repair; IEA:InterPro
Q969S2	NEIL2	Endonuclease 8-like 2	GO:0006289; P:nucleotide-excision repair; IEA:InterPro
Q8TAT5	NEIL3	Endonuclease 8-like 3	GO:0000405; F:bubble DNA binding; ISS:UniProtKB
Q8TAT5	NEIL3	Endonuclease 8-like 3	GO:0003684; F:damaged DNA binding; IEA:InterPro
Q8TAT5	NEIL3	Endonuclease 8-like 3	GO:0019104; F:DNA N-glycosylase activity; ISS:UniProtKB
Q8TAT5	NEIL3	Endonuclease 8-like 3	GO:0003906; F:DNA-(apurinic or apyrimidinic site) lyase activity; IDA:UniProtKB
Q8TAT5	NEIL3	Endonuclease 8-like 3	GO:0003690; F:double-stranded DNA binding; ISS:UniProtKB
Q8TAT5	NEIL3	Endonuclease 8-like 3	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
Q8TAT5	NEIL3	Endonuclease 8-like 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TAT5	NEIL3	Endonuclease 8-like 3	GO:0006284; P:base-excision repair; ISS:UniProtKB
Q8TAT5	NEIL3	Endonuclease 8-like 3	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
Q8TAT5	NEIL3	Endonuclease 8-like 3	GO:0006289; P:nucleotide-excision repair; IEA:InterPro
Q6ZWH5	NEK10	Serine/threonine-protein kinase Nek10	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6ZWH5	NEK10	Serine/threonine-protein kinase Nek10	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZWH5	NEK10	Serine/threonine-protein kinase Nek10	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q6ZWH5	NEK10	Serine/threonine-protein kinase Nek10	GO:0004713; F:protein tyrosine kinase activity; IEA:InterPro
Q8NG66	NEK11	Serine/threonine-protein kinase Nek11	GO:0005524; F:ATP binding; IDA:UniProtKB
Q8NG66	NEK11	Serine/threonine-protein kinase Nek11	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NG66	NEK11	Serine/threonine-protein kinase Nek11	GO:0005515; F:protein binding; IPI:IntAct
Q8NG66	NEK11	Serine/threonine-protein kinase Nek11	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q8NG66	NEK11	Serine/threonine-protein kinase Nek11	GO:0031572; P:G2 DNA damage checkpoint; IMP:UniProtKB
Q8NG66	NEK11	Serine/threonine-protein kinase Nek11	GO:0031573; P:intra-S DNA damage checkpoint; IDA:UniProtKB
Q8NG66	NEK11	Serine/threonine-protein kinase Nek11	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q8NG66	NEK11	Serine/threonine-protein kinase Nek11	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q96PY6	NEK1	Serine/threonine-protein kinase Nek1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96PY6	NEK1	Serine/threonine-protein kinase Nek1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96PY6	NEK1	Serine/threonine-protein kinase Nek1	GO:0005515; F:protein binding; IPI:IntAct
Q96PY6	NEK1	Serine/threonine-protein kinase Nek1	GO:0004672; F:protein kinase activity; IDA:MGI
Q96PY6	NEK1	Serine/threonine-protein kinase Nek1	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q96PY6	NEK1	Serine/threonine-protein kinase Nek1	GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW
Q96PY6	NEK1	Serine/threonine-protein kinase Nek1	GO:0006974; P:cellular response to DNA damage stimulus; IEA:Ensembl
Q96PY6	NEK1	Serine/threonine-protein kinase Nek1	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q96PY6	NEK1	Serine/threonine-protein kinase Nek1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q96PY6	NEK1	Serine/threonine-protein kinase Nek1	GO:0010212; P:response to ionizing radiation; IEA:Ensembl
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0005515; F:protein binding; IPI:UniProtKB
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0004672; F:protein kinase activity; IDA:UniProtKB
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0004674; F:protein serine/threonine kinase activity; TAS:UniProtKB
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0001824; P:blastocyst development; IEA:Ensembl
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0051299; P:centrosome separation; IDA:UniProtKB
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0007059; P:chromosome segregation; IDA:UniProtKB
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0007067; P:mitosis; TAS:ProtInc
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0000070; P:mitotic sister chromatid segregation; IEA:Ensembl
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0043392; P:negative regulation of DNA binding; IEA:Ensembl
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0051988; P:regulation of attachment of spindle microtubules to kinetochore; IMP:UniProtKB
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0007088; P:regulation of mitosis; TAS:ProtInc
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0046602; P:regulation of mitotic centrosome separation; TAS:UniProtKB
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0051225; P:spindle assembly; TAS:UniProtKB
P51955	NEK2	Serine/threonine-protein kinase Nek2	GO:0090307; P:spindle assembly involved in mitosis; IEA:Ensembl
P51956	NEK3	Serine/threonine-protein kinase Nek3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P51956	NEK3	Serine/threonine-protein kinase Nek3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P51956	NEK3	Serine/threonine-protein kinase Nek3	GO:0005515; F:protein binding; IPI:IntAct
P51956	NEK3	Serine/threonine-protein kinase Nek3	GO:0004674; F:protein serine/threonine kinase activity; NAS:UniProtKB
P51956	NEK3	Serine/threonine-protein kinase Nek3	GO:0007067; P:mitosis; NAS:UniProtKB
P51956	NEK3	Serine/threonine-protein kinase Nek3	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
P51957	NEK4	Serine/threonine-protein kinase Nek4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P51957	NEK4	Serine/threonine-protein kinase Nek4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P51957	NEK4	Serine/threonine-protein kinase Nek4	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
P51957	NEK4	Serine/threonine-protein kinase Nek4	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
P51957	NEK4	Serine/threonine-protein kinase Nek4	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P51957	NEK4	Serine/threonine-protein kinase Nek4	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P51957	NEK4	Serine/threonine-protein kinase Nek4	GO:0023014; P:signal transduction by phosphorylation; IBA:GOC
Q6P3R8	NEK5	Serine/threonine-protein kinase Nek5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6P3R8	NEK5	Serine/threonine-protein kinase Nek5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6P3R8	NEK5	Serine/threonine-protein kinase Nek5	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0019894; F:kinesin binding; IPI:UniProtKB
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0005515; F:protein binding; IPI:IntAct
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0007059; P:chromosome segregation; IDA:UniProtKB
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0000910; P:cytokinesis; TAS:UniProtKB
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0031572; P:G2 DNA damage checkpoint; IMP:UniProtKB
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:2000772; P:regulation of cellular senescence; TAS:UniProtKB
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0007346; P:regulation of mitotic cell cycle; TAS:UniProtKB
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0030071; P:regulation of mitotic metaphase/anaphase transition; IDA:UniProtKB
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0007165; P:signal transduction; IMP:GOC
Q9HC98	NEK6	Serine/threonine-protein kinase Nek6	GO:0051225; P:spindle assembly; TAS:UniProtKB
Q8TDX7	NEK7	Serine/threonine-protein kinase Nek7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8TDX7	NEK7	Serine/threonine-protein kinase Nek7	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TDX7	NEK7	Serine/threonine-protein kinase Nek7	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB
Q8TDX7	NEK7	Serine/threonine-protein kinase Nek7	GO:0000910; P:cytokinesis; TAS:UniProtKB
Q8TDX7	NEK7	Serine/threonine-protein kinase Nek7	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q8TDX7	NEK7	Serine/threonine-protein kinase Nek7	GO:0007346; P:regulation of mitotic cell cycle; TAS:UniProtKB
Q8TDX7	NEK7	Serine/threonine-protein kinase Nek7	GO:0051225; P:spindle assembly; TAS:UniProtKB
Q86SG6	NEK8	Serine/threonine-protein kinase Nek8	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86SG6	NEK8	Serine/threonine-protein kinase Nek8	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86SG6	NEK8	Serine/threonine-protein kinase Nek8	GO:0005515; F:protein binding; IPI:UniProtKB
Q86SG6	NEK8	Serine/threonine-protein kinase Nek8	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q86SG6	NEK8	Serine/threonine-protein kinase Nek8	GO:0009887; P:organ morphogenesis; IMP:UniProtKB
Q86SG6	NEK8	Serine/threonine-protein kinase Nek8	GO:0035330; P:regulation of hippo signaling; IDA:UniProtKB
Q8TD19	NEK9	Serine/threonine-protein kinase Nek9	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8TD19	NEK9	Serine/threonine-protein kinase Nek9	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TD19	NEK9	Serine/threonine-protein kinase Nek9	GO:0005515; F:protein binding; IPI:IntAct
Q8TD19	NEK9	Serine/threonine-protein kinase Nek9	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q8TD19	NEK9	Serine/threonine-protein kinase Nek9	GO:0004674; F:protein serine/threonine kinase activity; EXP:Reactome
Q8TD19	NEK9	Serine/threonine-protein kinase Nek9	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q8TD19	NEK9	Serine/threonine-protein kinase Nek9	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8TD19	NEK9	Serine/threonine-protein kinase Nek9	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
Q9H3P2	NELFA	Negative elongation factor A	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9H3P2	NELFA	Negative elongation factor A	GO:0005515; F:protein binding; IPI:IntAct
Q9H3P2	NELFA	Negative elongation factor A	GO:0010467; P:gene expression; TAS:Reactome
Q9H3P2	NELFA	Negative elongation factor A	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q9H3P2	NELFA	Negative elongation factor A	GO:0034244; P:negative regulation of transcription elongation from RNA polymerase II promoter; IEA:Ensembl
Q9H3P2	NELFA	Negative elongation factor A	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
Q9H3P2	NELFA	Negative elongation factor A	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q9H3P2	NELFA	Negative elongation factor A	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q9H3P2	NELFA	Negative elongation factor A	GO:0016032; P:viral process; TAS:Reactome
Q8IXH7	NELFCD	Negative elongation factor C/D	GO:0005515; F:protein binding; IPI:IntAct
Q8IXH7	NELFCD	Negative elongation factor C/D	GO:0010467; P:gene expression; TAS:Reactome
Q8IXH7	NELFCD	Negative elongation factor C/D	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
Q8IXH7	NELFCD	Negative elongation factor C/D	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
Q8IXH7	NELFCD	Negative elongation factor C/D	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q8IXH7	NELFCD	Negative elongation factor C/D	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q8IXH7	NELFCD	Negative elongation factor C/D	GO:0016032; P:viral process; TAS:Reactome
Q8WX92	NELFB	Negative elongation factor B	GO:0005515; F:protein binding; IPI:IntAct
Q8WX92	NELFB	Negative elongation factor B	GO:0010467; P:gene expression; TAS:Reactome
Q8WX92	NELFB	Negative elongation factor B	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
Q8WX92	NELFB	Negative elongation factor B	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
Q8WX92	NELFB	Negative elongation factor B	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q8WX92	NELFB	Negative elongation factor B	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q8WX92	NELFB	Negative elongation factor B	GO:0016032; P:viral process; TAS:Reactome
P18615	NELFE	Negative elongation factor E	GO:0000166; F:nucleotide binding; IEA:InterPro
P18615	NELFE	Negative elongation factor E	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P18615	NELFE	Negative elongation factor E	GO:0005515; F:protein binding; IPI:IntAct
P18615	NELFE	Negative elongation factor E	GO:0003723; F:RNA binding; NAS:UniProtKB
P18615	NELFE	Negative elongation factor E	GO:0010467; P:gene expression; TAS:Reactome
P18615	NELFE	Negative elongation factor E	GO:0034244; P:negative regulation of transcription elongation from RNA polymerase II promoter; IEA:Ensembl
P18615	NELFE	Negative elongation factor E	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P18615	NELFE	Negative elongation factor E	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P18615	NELFE	Negative elongation factor E	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
P18615	NELFE	Negative elongation factor E	GO:0016032; P:viral process; TAS:Reactome
Q92832	NELL1	Protein kinase C-binding protein NELL1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q92832	NELL1	Protein kinase C-binding protein NELL1	GO:0005515; F:protein binding; IPI:UniProtKB
Q92832	NELL1	Protein kinase C-binding protein NELL1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q92832	NELL1	Protein kinase C-binding protein NELL1	GO:2000599; P:negative regulation of cyclin catabolic process; IDA:UniProtKB
Q92832	NELL1	Protein kinase C-binding protein NELL1	GO:0033689; P:negative regulation of osteoblast proliferation; IDA:UniProtKB
Q92832	NELL1	Protein kinase C-binding protein NELL1	GO:0007399; P:nervous system development; TAS:ProtInc
Q92832	NELL1	Protein kinase C-binding protein NELL1	GO:0030501; P:positive regulation of bone mineralization; IDA:UniProtKB
Q92832	NELL1	Protein kinase C-binding protein NELL1	GO:0045669; P:positive regulation of osteoblast differentiation; IDA:UniProtKB
Q92832	NELL1	Protein kinase C-binding protein NELL1	GO:0010468; P:regulation of gene expression; IDA:UniProtKB
Q99435	NELL2	Protein kinase C-binding protein NELL2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q99435	NELL2	Protein kinase C-binding protein NELL2	GO:0005515; F:protein binding; IPI:IntAct
O60524	NEMF	Nuclear export mediator factor NEMF	GO:0051168; P:nuclear export; IMP:UniProtKB
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0000187; P:activation of MAPK activity; TAS:Reactome
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0007250; P:activation of NF-kappaB-inducing kinase activity; IEA:Ensembl
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0006915; P:apoptotic process; TAS:ProtInc
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0001782; P:B cell homeostasis; IEA:Ensembl
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:UniProtKB
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0006955; P:immune response; TAS:ProtInc
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0006954; P:inflammatory response; TAS:UniProtKB
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0045087; P:innate immune response; TAS:UniProtKB
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0007254; P:JNK cascade; TAS:Reactome
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0009615; P:response to virus; TAS:UniProtKB
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0050852; P:T cell receptor signaling pathway; NAS:UniProtKB
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q9Y6K9	IKBKG	NF-kappa-B essential modulator	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9UMX5	NENF	Neudesin	GO:0020037; F:heme binding; IEA:InterPro
Q9UMX5	NENF	Neudesin	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UMX5	NENF	Neudesin	GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl
Q92859	NEO1	Neogenin	GO:0004872; F:receptor activity; IEA:Ensembl
Q92859	NEO1	Neogenin	GO:0007411; P:axon guidance; TAS:Reactome
Q92859	NEO1	Neogenin	GO:0007155; P:cell adhesion; NAS:ProtInc
Q92859	NEO1	Neogenin	GO:0055072; P:iron ion homeostasis; IGI:MGI
Q92859	NEO1	Neogenin	GO:0042692; P:muscle cell differentiation; TAS:Reactome
Q92859	NEO1	Neogenin	GO:0007520; P:myoblast fusion; IEA:Ensembl
Q92859	NEO1	Neogenin	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
Q92859	NEO1	Neogenin	GO:0006355; P:regulation of transcription, DNA-templated; IEA:Ensembl
Q92979	EMG1	Ribosomal RNA small subunit methyltransferase NEP1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q92979	EMG1	Ribosomal RNA small subunit methyltransferase NEP1	GO:0003723; F:RNA binding; ISS:UniProtKB
Q92979	EMG1	Ribosomal RNA small subunit methyltransferase NEP1	GO:0070037; F:rRNA (pseudouridine) methyltransferase activity; IDA:UniProtKB
Q92979	EMG1	Ribosomal RNA small subunit methyltransferase NEP1	GO:0019843; F:rRNA binding; IEA:UniProtKB-KW
Q92979	EMG1	Ribosomal RNA small subunit methyltransferase NEP1	GO:0042274; P:ribosomal small subunit biogenesis; ISS:UniProtKB
Q92979	EMG1	Ribosomal RNA small subunit methyltransferase NEP1	GO:0031167; P:rRNA methylation; IDA:GOC
Q92979	EMG1	Ribosomal RNA small subunit methyltransferase NEP1	GO:0006364; P:rRNA processing; ISS:UniProtKB
Q8N9A8	CNEP1R1	Nuclear envelope phosphatase-regulatory subunit 1	GO:0005515; F:protein binding; IPI:IntAct
Q8N9A8	CNEP1R1	Nuclear envelope phosphatase-regulatory subunit 1	GO:0006629; P:lipid metabolic process; IEA:UniProtKB-KW
Q8N9A8	CNEP1R1	Nuclear envelope phosphatase-regulatory subunit 1	GO:0035307; P:positive regulation of protein dephosphorylation; IDA:UniProtKB
Q8N9A8	CNEP1R1	Nuclear envelope phosphatase-regulatory subunit 1	GO:0010867; P:positive regulation of triglyceride biosynthetic process; IGI:UniProtKB
Q8N9A8	CNEP1R1	Nuclear envelope phosphatase-regulatory subunit 1	GO:0034504; P:protein localization to nucleus; IDA:UniProtKB
P08473	MME	Neprilysin	GO:0004175; F:endopeptidase activity; IDA:UniProtKB
P08473	MME	Neprilysin	GO:0004222; F:metalloendopeptidase activity; IMP:UniProtKB
P08473	MME	Neprilysin	GO:0042277; F:peptide binding; ISS:UniProtKB
P08473	MME	Neprilysin	GO:0005515; F:protein binding; IPI:IntAct
P08473	MME	Neprilysin	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P08473	MME	Neprilysin	GO:0002003; P:angiotensin maturation; TAS:Reactome
P08473	MME	Neprilysin	GO:0050435; P:beta-amyloid metabolic process; ISS:UniProtKB
P08473	MME	Neprilysin	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P08473	MME	Neprilysin	GO:0071345; P:cellular response to cytokine stimulus; IDA:UniProtKB
P08473	MME	Neprilysin	GO:0071492; P:cellular response to UV-A; IDA:UniProtKB
P08473	MME	Neprilysin	GO:0071493; P:cellular response to UV-B; IDA:UniProtKB
P08473	MME	Neprilysin	GO:0046449; P:creatinine metabolic process; IMP:UniProtKB
P08473	MME	Neprilysin	GO:0001822; P:kidney development; IEP:UniProtKB
P08473	MME	Neprilysin	GO:0006518; P:peptide metabolic process; ISS:UniProtKB
P08473	MME	Neprilysin	GO:0006508; P:proteolysis; IDA:UniProtKB
P08473	MME	Neprilysin	GO:0090399; P:replicative senescence; IEP:UniProtKB
P08473	MME	Neprilysin	GO:0019233; P:sensory perception of pain; ISS:UniProtKB
P48681	NES	Nestin	GO:0019215; F:intermediate filament binding; ISS:UniProtKB
P48681	NES	Nestin	GO:0005198; F:structural molecule activity; IEA:InterPro
P48681	NES	Nestin	GO:0007420; P:brain development; ISS:UniProtKB
P48681	NES	Nestin	GO:0048858; P:cell projection morphogenesis; IEA:Ensembl
P48681	NES	Nestin	GO:0007417; P:central nervous system development; NAS:UniProtKB
P48681	NES	Nestin	GO:0031076; P:embryonic camera-type eye development; ISS:UniProtKB
P48681	NES	Nestin	GO:0000086; P:G2/M transition of mitotic cell cycle; IDA:DFLAT
P48681	NES	Nestin	GO:0043086; P:negative regulation of catalytic activity; IDA:UniProtKB
P48681	NES	Nestin	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P48681	NES	Nestin	GO:0032091; P:negative regulation of protein binding; IDA:UniProtKB
P48681	NES	Nestin	GO:0030844; P:positive regulation of intermediate filament depolymerization; ISS:UniProtKB
P48681	NES	Nestin	GO:2000179; P:positive regulation of neural precursor cell proliferation; ISS:UniProtKB
P48681	NES	Nestin	GO:0072089; P:stem cell proliferation; IMP:DFLAT
O95631	NTN1	Netrin-1	GO:0005515; F:protein binding; IPI:UniProtKB
O95631	NTN1	Netrin-1	GO:0033564; P:anterior/posterior axon guidance; IEA:Ensembl
O95631	NTN1	Netrin-1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O95631	NTN1	Netrin-1	GO:0007411; P:axon guidance; TAS:Reactome
O95631	NTN1	Netrin-1	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
O95631	NTN1	Netrin-1	GO:0040023; P:establishment of nucleus localization; IEA:Ensembl
O95631	NTN1	Netrin-1	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
O95631	NTN1	Netrin-1	GO:0060603; P:mammary gland duct morphogenesis; IEA:Ensembl
O95631	NTN1	Netrin-1	GO:0030517; P:negative regulation of axon extension; IEA:Ensembl
O95631	NTN1	Netrin-1	GO:0001764; P:neuron migration; IEA:Ensembl
O95631	NTN1	Netrin-1	GO:0045773; P:positive regulation of axon extension; IEA:Ensembl
O95631	NTN1	Netrin-1	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
O95631	NTN1	Netrin-1	GO:0030334; P:regulation of cell migration; IEA:Ensembl
O00634	NTN3	Netrin-3	GO:0007411; P:axon guidance; NAS:UniProtKB
O00634	NTN3	Netrin-3	GO:0042692; P:muscle cell differentiation; TAS:Reactome
O00634	NTN3	Netrin-3	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
Q9HB63	NTN4	Netrin-4	GO:0007411; P:axon guidance; TAS:Reactome
Q9HB63	NTN4	Netrin-4	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q9HB63	NTN4	Netrin-4	GO:0016322; P:neuron remodeling; IEA:Ensembl
Q9HB63	NTN4	Netrin-4	GO:0060668; P:regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling; IEA:Ensembl
Q8TDF5	NETO1	Neuropilin and tolloid-like protein 1	GO:0007613; P:memory; ISS:UniProtKB
Q8TDF5	NETO1	Neuropilin and tolloid-like protein 1	GO:0048169; P:regulation of long-term neuronal synaptic plasticity; ISS:UniProtKB
Q8TDF5	NETO1	Neuropilin and tolloid-like protein 1	GO:0008542; P:visual learning; ISS:UniProtKB
Q8NC67	NETO2	Neuropilin and tolloid-like protein 2	GO:2000312; P:regulation of kainate selective glutamate receptor activity; IEA:InterPro
P56730	PRSS12	Neurotrypsin	GO:0005044; F:scavenger receptor activity; IEA:InterPro
P56730	PRSS12	Neurotrypsin	GO:0004252; F:serine-type endopeptidase activity; IEA:Ensembl
P56730	PRSS12	Neurotrypsin	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
P56730	PRSS12	Neurotrypsin	GO:0006887; P:exocytosis; ISS:UniProtKB
P56730	PRSS12	Neurotrypsin	GO:0031638; P:zymogen activation; IEA:Ensembl
A8MQ27	NEURL1B	E3 ubiquitin-protein ligase NEURL1B	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
A8MQ27	NEURL1B	E3 ubiquitin-protein ligase NEURL1B	GO:0008270; F:zinc ion binding; IEA:InterPro
A8MQ27	NEURL1B	E3 ubiquitin-protein ligase NEURL1B	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
A8MQ27	NEURL1B	E3 ubiquitin-protein ligase NEURL1B	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
P01178	OXT	Oxytocin-neurophysin 1	GO:0042756; P:drinking behavior; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0042755; P:eating behavior; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0007565; P:female pregnancy; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0007625; P:grooming behavior; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0007507; P:heart development; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0042538; P:hyperosmotic salinity response; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0060179; P:male mating behavior; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0002125; P:maternal aggressive behavior; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0042711; P:maternal behavior; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0007613; P:memory; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0060455; P:negative regulation of gastric acid secretion; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0035811; P:negative regulation of urine volume; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0045925; P:positive regulation of female receptivity; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0060450; P:positive regulation of hindgut contraction; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0010701; P:positive regulation of norepinephrine secretion; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0045778; P:positive regulation of ossification; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0060406; P:positive regulation of penile erection; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0032308; P:positive regulation of prostaglandin secretion; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0035815; P:positive regulation of renal sodium excretion; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0051965; P:positive regulation of synapse assembly; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0050806; P:positive regulation of synaptic transmission; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0070474; P:positive regulation of uterine smooth muscle contraction; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0002027; P:regulation of heart rate; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0051930; P:regulation of sensory perception of pain; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0014823; P:response to activity; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0001975; P:response to amphetamine; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0051591; P:response to cAMP; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0042220; P:response to cocaine; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0051602; P:response to electrical stimulus; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0032355; P:response to estradiol; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0045472; P:response to ether; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0032094; P:response to food; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0032570; P:response to progesterone; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0034695; P:response to prostaglandin E; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0032526; P:response to retinoic acid; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0009744; P:response to sucrose; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0007165; P:signal transduction; TAS:ProtInc
P01178	OXT	Oxytocin-neurophysin 1	GO:0030431; P:sleep; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0035176; P:social behavior; IEA:Ensembl
P01178	OXT	Oxytocin-neurophysin 1	GO:0042713; P:sperm ejaculation; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IDA:UniProtKB
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0005184; F:neuropeptide hormone activity; TAS:ProtInc
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0004672; F:protein kinase activity; IDA:UniProtKB
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0005102; F:receptor binding; TAS:ProtInc
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0004871; F:signal transducer activity; IDA:UniProtKB
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0031894; F:V1A vasopressin receptor binding; IPI:UniProtKB
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0070371; P:ERK1 and ERK2 cascade; IDA:UniProtKB
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0007625; P:grooming behavior; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0042538; P:hyperosmotic salinity response; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0007626; P:locomotory behavior; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0002125; P:maternal aggressive behavior; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0042711; P:maternal behavior; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0050891; P:multicellular organismal water homeostasis; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0007621; P:negative regulation of female receptivity; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; IDA:UniProtKB
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0051970; P:negative regulation of transmission of nerve impulse; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0043084; P:penile erection; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0030819; P:positive regulation of cAMP biosynthetic process; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0030307; P:positive regulation of cell growth; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0032849; P:positive regulation of cellular pH reduction; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0014049; P:positive regulation of glutamate secretion; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:UniProtKB
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0031394; P:positive regulation of prostaglandin biosynthetic process; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0003084; P:positive regulation of systemic arterial blood pressure; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0070528; P:protein kinase C signaling; IDA:UniProtKB
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0006468; P:protein phosphorylation; IDA:GOC
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0035813; P:regulation of renal sodium excretion; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0045471; P:response to ethanol; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0035094; P:response to nicotine; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0033574; P:response to testosterone; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0007165; P:signal transduction; IDA:UniProtKB
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0035176; P:social behavior; IEA:Ensembl
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0043252; P:sodium-independent organic anion transport; TAS:Reactome
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0055085; P:transmembrane transport; TAS:Reactome
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0042310; P:vasoconstriction; IEA:UniProtKB-KW
P01185	AVP	Vasopressin-neurophysin 2-copeptin	GO:0006833; P:water transport; TAS:Reactome
Q8NFW8	CMAS	N-acylneuraminate cytidylyltransferase	GO:0008781; F:N-acylneuraminate cytidylyltransferase activity; IEA:UniProtKB-EC
Q8NFW8	CMAS	N-acylneuraminate cytidylyltransferase	GO:0009103; P:lipopolysaccharide biosynthetic process; IEA:InterPro
Q8NFW8	CMAS	N-acylneuraminate cytidylyltransferase	GO:0006054; P:N-acetylneuraminate metabolic process; IEA:UniProtKB-UniPathway
Q92686	NRGN	Neurogranin	GO:0005516; F:calmodulin binding; TAS:ProtInc
Q92686	NRGN	Neurogranin	GO:0007399; P:nervous system development; TAS:ProtInc
Q92686	NRGN	Neurogranin	GO:0007165; P:signal transduction; TAS:ProtInc
Q8WUJ1	CYB5D2	Neuferricin	GO:0020037; F:heme binding; IEA:InterPro
Q8WUJ1	CYB5D2	Neuferricin	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
O76050	NEURL1	E3 ubiquitin-protein ligase NEURL1	GO:0045183; F:translation factor activity, non-nucleic acid binding; ISS:UniProtKB
O76050	NEURL1	E3 ubiquitin-protein ligase NEURL1	GO:0004842; F:ubiquitin-protein ligase activity; ISS:UniProtKB
O76050	NEURL1	E3 ubiquitin-protein ligase NEURL1	GO:0008270; F:zinc ion binding; IEA:InterPro
O76050	NEURL1	E3 ubiquitin-protein ligase NEURL1	GO:0007420; P:brain development; IEA:Ensembl
O76050	NEURL1	E3 ubiquitin-protein ligase NEURL1	GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB
O76050	NEURL1	E3 ubiquitin-protein ligase NEURL1	GO:0007595; P:lactation; IEA:Ensembl
O76050	NEURL1	E3 ubiquitin-protein ligase NEURL1	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
O76050	NEURL1	E3 ubiquitin-protein ligase NEURL1	GO:0045746; P:negative regulation of Notch signaling pathway; IDA:UniProtKB
O76050	NEURL1	E3 ubiquitin-protein ligase NEURL1	GO:0007399; P:nervous system development; TAS:ProtInc
O76050	NEURL1	E3 ubiquitin-protein ligase NEURL1	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
O76050	NEURL1	E3 ubiquitin-protein ligase NEURL1	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
O76050	NEURL1	E3 ubiquitin-protein ligase NEURL1	GO:0060999; P:positive regulation of dendritic spine development; ISS:UniProtKB
O76050	NEURL1	E3 ubiquitin-protein ligase NEURL1	GO:0045741; P:positive regulation of epidermal growth factor-activated receptor activity; IEA:Ensembl
O76050	NEURL1	E3 ubiquitin-protein ligase NEURL1	GO:0051491; P:positive regulation of filopodium assembly; ISS:UniProtKB
O76050	NEURL1	E3 ubiquitin-protein ligase NEURL1	GO:0048170; P:positive regulation of long-term neuronal synaptic plasticity; ISS:UniProtKB
O76050	NEURL1	E3 ubiquitin-protein ligase NEURL1	GO:0090129; P:positive regulation of synapse maturation; ISS:UniProtKB
O76050	NEURL1	E3 ubiquitin-protein ligase NEURL1	GO:0006513; P:protein monoubiquitination; ISS:UniProtKB
O76050	NEURL1	E3 ubiquitin-protein ligase NEURL1	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
O76050	NEURL1	E3 ubiquitin-protein ligase NEURL1	GO:0007288; P:sperm axoneme assembly; IEA:Ensembl
O76050	NEURL1	E3 ubiquitin-protein ligase NEURL1	GO:0030317; P:sperm motility; IEA:Ensembl
Q9BR09	NEURL2	Neuralized-like protein 2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9BR09	NEURL2	Neuralized-like protein 2	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9BR09	NEURL2	Neuralized-like protein 2	GO:0045214; P:sarcomere organization; IEA:Ensembl
Q96JN8	NEURL4	Neuralized-like protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q96EH8	NEURL3	E3 ubiquitin-protein ligase NEURL3	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q96EH8	NEURL3	E3 ubiquitin-protein ligase NEURL3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96EH8	NEURL3	E3 ubiquitin-protein ligase NEURL3	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9BYT8	NLN	Neurolysin, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BYT8	NLN	Neurolysin, mitochondrial	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q9BYT8	NLN	Neurolysin, mitochondrial	GO:0042277; F:peptide binding; IEA:Ensembl
P17677	GAP43	Neuromodulin	GO:0005515; F:protein binding; IPI:IntAct
P17677	GAP43	Neuromodulin	GO:0016198; P:axon choice point recognition; IEA:Ensembl
P17677	GAP43	Neuromodulin	GO:0045165; P:cell fate commitment; IEA:Ensembl
P17677	GAP43	Neuromodulin	GO:0010001; P:glial cell differentiation; IEA:Ensembl
P17677	GAP43	Neuromodulin	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; TAS:ProtInc
P17677	GAP43	Neuromodulin	GO:0051489; P:regulation of filopodium assembly; IDA:UniProtKB
P17677	GAP43	Neuromodulin	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
P17677	GAP43	Neuromodulin	GO:0009611; P:response to wounding; TAS:ProtInc
P17677	GAP43	Neuromodulin	GO:0042246; P:tissue regeneration; IEA:Ensembl
Q99519	NEU1	Sialidase-1	GO:0052794; F:exo-alpha-(2->3)-sialidase activity; IEA:UniProtKB-EC
Q99519	NEU1	Sialidase-1	GO:0052795; F:exo-alpha-(2->6)-sialidase activity; IEA:UniProtKB-EC
Q99519	NEU1	Sialidase-1	GO:0052796; F:exo-alpha-(2->8)-sialidase activity; IEA:UniProtKB-EC
Q99519	NEU1	Sialidase-1	GO:0004308; F:exo-alpha-sialidase activity; IDA:UniProtKB
Q99519	NEU1	Sialidase-1	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
Q99519	NEU1	Sialidase-1	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q99519	NEU1	Sialidase-1	GO:0009313; P:oligosaccharide catabolic process; IMP:UniProtKB
Q99519	NEU1	Sialidase-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99519	NEU1	Sialidase-1	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q9Y3R4	NEU2	Sialidase-2	GO:0052794; F:exo-alpha-(2->3)-sialidase activity; IDA:UniProtKB
Q9Y3R4	NEU2	Sialidase-2	GO:0052795; F:exo-alpha-(2->6)-sialidase activity; IEA:UniProtKB-EC
Q9Y3R4	NEU2	Sialidase-2	GO:0052796; F:exo-alpha-(2->8)-sialidase activity; IEA:UniProtKB-EC
Q9Y3R4	NEU2	Sialidase-2	GO:0006689; P:ganglioside catabolic process; IDA:UniProtKB
Q9Y3R4	NEU2	Sialidase-2	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
Q9Y3R4	NEU2	Sialidase-2	GO:0009313; P:oligosaccharide catabolic process; IDA:UniProtKB
Q9Y3R4	NEU2	Sialidase-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y3R4	NEU2	Sialidase-2	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q9UQ49	NEU3	Sialidase-3	GO:0016997; F:alpha-sialidase activity; IDA:MGI
Q9UQ49	NEU3	Sialidase-3	GO:0052794; F:exo-alpha-(2->3)-sialidase activity; ISS:UniProtKB
Q9UQ49	NEU3	Sialidase-3	GO:0052795; F:exo-alpha-(2->6)-sialidase activity; IEA:UniProtKB-EC
Q9UQ49	NEU3	Sialidase-3	GO:0052796; F:exo-alpha-(2->8)-sialidase activity; ISS:UniProtKB
Q9UQ49	NEU3	Sialidase-3	GO:0004308; F:exo-alpha-sialidase activity; IDA:UniProtKB
Q9UQ49	NEU3	Sialidase-3	GO:0005975; P:carbohydrate metabolic process; IDA:MGI
Q9UQ49	NEU3	Sialidase-3	GO:0006689; P:ganglioside catabolic process; IDA:UniProtKB
Q9UQ49	NEU3	Sialidase-3	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
Q9UQ49	NEU3	Sialidase-3	GO:0009313; P:oligosaccharide catabolic process; IDA:UniProtKB
Q9UQ49	NEU3	Sialidase-3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UQ49	NEU3	Sialidase-3	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q8WWR8	NEU4	Sialidase-4	GO:0052794; F:exo-alpha-(2->3)-sialidase activity; IEA:UniProtKB-EC
Q8WWR8	NEU4	Sialidase-4	GO:0052795; F:exo-alpha-(2->6)-sialidase activity; IEA:UniProtKB-EC
Q8WWR8	NEU4	Sialidase-4	GO:0052796; F:exo-alpha-(2->8)-sialidase activity; IEA:UniProtKB-EC
Q8WWR8	NEU4	Sialidase-4	GO:0004308; F:exo-alpha-sialidase activity; IDA:UniProtKB
Q8WWR8	NEU4	Sialidase-4	GO:0005515; F:protein binding; IPI:IntAct
Q8WWR8	NEU4	Sialidase-4	GO:0006689; P:ganglioside catabolic process; IDA:UniProtKB
Q8WWR8	NEU4	Sialidase-4	GO:0006516; P:glycoprotein catabolic process; IDA:UniProtKB
Q8WWR8	NEU4	Sialidase-4	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
Q8WWR8	NEU4	Sialidase-4	GO:0009313; P:oligosaccharide catabolic process; IDA:UniProtKB
Q8WWR8	NEU4	Sialidase-4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8WWR8	NEU4	Sialidase-4	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q99574	SERPINI1	Neuroserpin	GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome
Q99574	SERPINI1	Neuroserpin	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q99574	SERPINI1	Neuroserpin	GO:0007417; P:central nervous system development; TAS:ProtInc
Q99574	SERPINI1	Neuroserpin	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
Q99574	SERPINI1	Neuroserpin	GO:0007422; P:peripheral nervous system development; TAS:ProtInc
Q99574	SERPINI1	Neuroserpin	GO:0030155; P:regulation of cell adhesion; IEA:Ensembl
Q99574	SERPINI1	Neuroserpin	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
P30990	NTS	Neurotensin/neuromedin N	GO:0005515; F:protein binding; IPI:IntAct
P30990	NTS	Neurotensin/neuromedin N	GO:0050880; P:regulation of blood vessel size; IEA:UniProtKB-KW
P30990	NTS	Neurotensin/neuromedin N	GO:0007165; P:signal transduction; NAS:ProtInc
Q0ZGT2	NEXN	Nexilin	GO:0051015; F:actin filament binding; IDA:UniProtKB
Q0ZGT2	NEXN	Nexilin	GO:0004683; F:calmodulin-dependent protein kinase activity; IBA:RefGenome
Q0ZGT2	NEXN	Nexilin	GO:0008307; F:structural constituent of muscle; IMP:UniProtKB
Q0ZGT2	NEXN	Nexilin	GO:0048739; P:cardiac muscle fiber development; IBA:RefGenome
Q0ZGT2	NEXN	Nexilin	GO:0006468; P:protein phosphorylation; IBA:GOC
Q0ZGT2	NEXN	Nexilin	GO:0030334; P:regulation of cell migration; IDA:UniProtKB
Q0ZGT2	NEXN	Nexilin	GO:0051493; P:regulation of cytoskeleton organization; IEP:UniProtKB
P21359	NF1	Neurofibromin	GO:0031210; F:phosphatidylcholine binding; IDA:UniProtKB
P21359	NF1	Neurofibromin	GO:0008429; F:phosphatidylethanolamine binding; IDA:UniProtKB
P21359	NF1	Neurofibromin	GO:0005515; F:protein binding; IPI:IntAct
P21359	NF1	Neurofibromin	GO:0005099; F:Ras GTPase activator activity; IDA:UniProtKB
P21359	NF1	Neurofibromin	GO:0030036; P:actin cytoskeleton organization; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0030325; P:adrenal gland development; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0048844; P:artery morphogenesis; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0007420; P:brain development; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0048593; P:camera-type eye morphogenesis; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0007154; P:cell communication; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0021987; P:cerebral cortex development; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0050890; P:cognition; IMP:HGNC
P21359	NF1	Neurofibromin	GO:0030199; P:collagen fibril organization; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0030198; P:extracellular matrix organization; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
P21359	NF1	Neurofibromin	GO:0021897; P:forebrain astrocyte development; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0048853; P:forebrain morphogenesis; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0007507; P:heart development; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0001889; P:liver development; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0000165; P:MAPK cascade; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0001656; P:metanephros development; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0022011; P:myelination in peripheral nervous system; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl
P21359	NF1	Neurofibromin	GO:0048712; P:negative regulation of astrocyte differentiation; IEA:Ensembl
P21359	NF1	Neurofibromin	GO:0030336; P:negative regulation of cell migration; IMP:MGI
P21359	NF1	Neurofibromin	GO:0001953; P:negative regulation of cell-matrix adhesion; IEA:Ensembl
P21359	NF1	Neurofibromin	GO:0001937; P:negative regulation of endothelial cell proliferation; IMP:HGNC
P21359	NF1	Neurofibromin	GO:0048147; P:negative regulation of fibroblast proliferation; ISS:UniProtKB
P21359	NF1	Neurofibromin	GO:0043407; P:negative regulation of MAP kinase activity; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0043409; P:negative regulation of MAPK cascade; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0007406; P:negative regulation of neuroblast proliferation; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0046929; P:negative regulation of neurotransmitter secretion; IEA:Ensembl
P21359	NF1	Neurofibromin	GO:0048715; P:negative regulation of oligodendrocyte differentiation; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0045671; P:negative regulation of osteoclast differentiation; IEA:Ensembl
P21359	NF1	Neurofibromin	GO:0006469; P:negative regulation of protein kinase activity; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0035021; P:negative regulation of Rac protein signal transduction; IEA:Ensembl
P21359	NF1	Neurofibromin	GO:0046580; P:negative regulation of Ras protein signal transduction; IBA:RefGenome
P21359	NF1	Neurofibromin	GO:0042992; P:negative regulation of transcription factor import into nucleus; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0021915; P:neural tube development; IEA:Ensembl
P21359	NF1	Neurofibromin	GO:0001649; P:osteoblast differentiation; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0007422; P:peripheral nervous system development; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0014065; P:phosphatidylinositol 3-kinase signaling; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0043473; P:pigmentation; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0045762; P:positive regulation of adenylate cyclase activity; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0043065; P:positive regulation of apoptotic process; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl
P21359	NF1	Neurofibromin	GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P21359	NF1	Neurofibromin	GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
P21359	NF1	Neurofibromin	GO:0043525; P:positive regulation of neuron apoptotic process; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0032320; P:positive regulation of Ras GTPase activity; IDA:UniProtKB
P21359	NF1	Neurofibromin	GO:0007265; P:Ras protein signal transduction; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0045765; P:regulation of angiogenesis; IMP:HGNC
P21359	NF1	Neurofibromin	GO:0043535; P:regulation of blood vessel endothelial cell migration; IMP:HGNC
P21359	NF1	Neurofibromin	GO:0045124; P:regulation of bone resorption; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0001952; P:regulation of cell-matrix adhesion; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0045685; P:regulation of glial cell differentiation; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IEA:Ensembl
P21359	NF1	Neurofibromin	GO:0032318; P:regulation of Ras GTPase activity; IMP:HGNC
P21359	NF1	Neurofibromin	GO:0032228; P:regulation of synaptic transmission, GABAergic; IEA:Ensembl
P21359	NF1	Neurofibromin	GO:0001666; P:response to hypoxia; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0014044; P:Schwann cell development; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
P21359	NF1	Neurofibromin	GO:0048745; P:smooth muscle tissue development; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0021510; P:spinal cord development; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0048485; P:sympathetic nervous system development; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0008542; P:visual learning; ISS:HGNC
P21359	NF1	Neurofibromin	GO:0042060; P:wound healing; ISS:HGNC
Q8NCF5	NFATC2IP	NFATC2-interacting protein	GO:0001816; P:cytokine production; IEA:Ensembl
Q8NCF5	NFATC2IP	NFATC2-interacting protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:Ensembl
Q14494	NFE2L1	Nuclear factor erythroid 2-related factor 1	GO:0001190; F:RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q14494	NFE2L1	Nuclear factor erythroid 2-related factor 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q14494	NFE2L1	Nuclear factor erythroid 2-related factor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q14494	NFE2L1	Nuclear factor erythroid 2-related factor 1	GO:0003712; F:transcription cofactor activity; TAS:ProtInc
Q14494	NFE2L1	Nuclear factor erythroid 2-related factor 1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q14494	NFE2L1	Nuclear factor erythroid 2-related factor 1	GO:0030218; P:erythrocyte differentiation; IEA:Ensembl
Q14494	NFE2L1	Nuclear factor erythroid 2-related factor 1	GO:0006783; P:heme biosynthetic process; TAS:ProtInc
Q14494	NFE2L1	Nuclear factor erythroid 2-related factor 1	GO:0006954; P:inflammatory response; TAS:ProtInc
Q14494	NFE2L1	Nuclear factor erythroid 2-related factor 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:0003677; F:DNA binding; IDA:UniProtKB
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:0005515; F:protein binding; IPI:IntAct
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:0070301; P:cellular response to hydrogen peroxide; IMP:BHF-UCL
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:0071499; P:cellular response to laminar fluid shear stress; IMP:BHF-UCL
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:0071356; P:cellular response to tumor necrosis factor; IMP:BHF-UCL
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:0030968; P:endoplasmic reticulum unfolded protein response; IEA:Ensembl
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:2000352; P:negative regulation of endothelial cell apoptotic process; IMP:BHF-UCL
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:1902176; P:negative regulation of intrinsic apoptotic signaling pathway in response to oxidative stress; IMP:BHF-UCL
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:0030194; P:positive regulation of blood coagulation; IEA:Ensembl
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IEA:Ensembl
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:0036003; P:positive regulation of transcription from RNA polymerase II promoter in response to stress; IMP:BHF-UCL
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:0010499; P:proteasomal ubiquitin-independent protein catabolic process; IDA:UniProtKB
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:0045995; P:regulation of embryonic development; IEA:Ensembl
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:2000121; P:regulation of removal of superoxide radicals; IEA:Ensembl
Q16236	NFE2L2	Nuclear factor erythroid 2-related factor 2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9Y4A8	NFE2L3	Nuclear factor erythroid 2-related factor 3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9Y4A8	NFE2L3	Nuclear factor erythroid 2-related factor 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9Y4A8	NFE2L3	Nuclear factor erythroid 2-related factor 3	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q9Y4A8	NFE2L3	Nuclear factor erythroid 2-related factor 3	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
O95644	NFATC1	Nuclear factor of activated T-cells, cytoplasmic 1	GO:0005528; F:FK506 binding; TAS:ProtInc
O95644	NFATC1	Nuclear factor of activated T-cells, cytoplasmic 1	GO:0048273; F:mitogen-activated protein kinase p38 binding; ISS:BHF-UCL
O95644	NFATC1	Nuclear factor of activated T-cells, cytoplasmic 1	GO:0005515; F:protein binding; IPI:UniProtKB
O95644	NFATC1	Nuclear factor of activated T-cells, cytoplasmic 1	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; ISS:BHF-UCL
O95644	NFATC1	Nuclear factor of activated T-cells, cytoplasmic 1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
O95644	NFATC1	Nuclear factor of activated T-cells, cytoplasmic 1	GO:0001205; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; ISS:BHF-UCL
O95644	NFATC1	Nuclear factor of activated T-cells, cytoplasmic 1	GO:0001085; F:RNA polymerase II transcription factor binding; ISS:BHF-UCL
O95644	NFATC1	Nuclear factor of activated T-cells, cytoplasmic 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O95644	NFATC1	Nuclear factor of activated T-cells, cytoplasmic 1	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
O95644	NFATC1	Nuclear factor of activated T-cells, cytoplasmic 1	GO:0006816; P:calcium ion transport; IEA:Ensembl
O95644	NFATC1	Nuclear factor of activated T-cells, cytoplasmic 1	GO:0001837; P:epithelial to mesenchymal transition; IEA:Ensembl
O95644	NFATC1	Nuclear factor of activated T-cells, cytoplasmic 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O95644	NFATC1	Nuclear factor of activated T-cells, cytoplasmic 1	GO:0000082; P:G1/S transition of mitotic cell cycle; IEA:Ensembl
O95644	NFATC1	Nuclear factor of activated T-cells, cytoplasmic 1	GO:0007507; P:heart development; IEA:Ensembl
O95644	NFATC1	Nuclear factor of activated T-cells, cytoplasmic 1	GO:0045087; P:innate immune response; TAS:Reactome
O95644	NFATC1	Nuclear factor of activated T-cells, cytoplasmic 1	GO:0035556; P:intracellular signal transduction; IDA:MGI
O95644	NFATC1	Nuclear factor of activated T-cells, cytoplasmic 1	GO:0030316; P:osteoclast differentiation; IEA:Ensembl
O95644	NFATC1	Nuclear factor of activated T-cells, cytoplasmic 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
O95644	NFATC1	Nuclear factor of activated T-cells, cytoplasmic 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O95644	NFATC1	Nuclear factor of activated T-cells, cytoplasmic 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q13469	NFATC2	Nuclear factor of activated T-cells, cytoplasmic 2	GO:0003677; F:DNA binding; TAS:UniProtKB
Q13469	NFATC2	Nuclear factor of activated T-cells, cytoplasmic 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q13469	NFATC2	Nuclear factor of activated T-cells, cytoplasmic 2	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q13469	NFATC2	Nuclear factor of activated T-cells, cytoplasmic 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:UniProtKB
Q13469	NFATC2	Nuclear factor of activated T-cells, cytoplasmic 2	GO:0044212; F:transcription regulatory region DNA binding; IEA:Ensembl
Q13469	NFATC2	Nuclear factor of activated T-cells, cytoplasmic 2	GO:0050853; P:B cell receptor signaling pathway; IMP:UniProtKB
Q13469	NFATC2	Nuclear factor of activated T-cells, cytoplasmic 2	GO:0016477; P:cell migration; IDA:UniProtKB
Q13469	NFATC2	Nuclear factor of activated T-cells, cytoplasmic 2	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
Q13469	NFATC2	Nuclear factor of activated T-cells, cytoplasmic 2	GO:0001816; P:cytokine production; IEA:Ensembl
Q13469	NFATC2	Nuclear factor of activated T-cells, cytoplasmic 2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q13469	NFATC2	Nuclear factor of activated T-cells, cytoplasmic 2	GO:0045087; P:innate immune response; TAS:Reactome
Q13469	NFATC2	Nuclear factor of activated T-cells, cytoplasmic 2	GO:0030890; P:positive regulation of B cell proliferation; IMP:UniProtKB
Q13469	NFATC2	Nuclear factor of activated T-cells, cytoplasmic 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q13469	NFATC2	Nuclear factor of activated T-cells, cytoplasmic 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:MGI
Q13469	NFATC2	Nuclear factor of activated T-cells, cytoplasmic 2	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q13469	NFATC2	Nuclear factor of activated T-cells, cytoplasmic 2	GO:0042493; P:response to drug; IMP:UniProtKB
Q13469	NFATC2	Nuclear factor of activated T-cells, cytoplasmic 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q12968	NFATC3	Nuclear factor of activated T-cells, cytoplasmic 3	GO:0003682; F:chromatin binding; IEA:Ensembl
Q12968	NFATC3	Nuclear factor of activated T-cells, cytoplasmic 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q12968	NFATC3	Nuclear factor of activated T-cells, cytoplasmic 3	GO:0005515; F:protein binding; IPI:IntAct
Q12968	NFATC3	Nuclear factor of activated T-cells, cytoplasmic 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q12968	NFATC3	Nuclear factor of activated T-cells, cytoplasmic 3	GO:0045333; P:cellular respiration; IEA:Ensembl
Q12968	NFATC3	Nuclear factor of activated T-cells, cytoplasmic 3	GO:0071285; P:cellular response to lithium ion; IEA:Ensembl
Q12968	NFATC3	Nuclear factor of activated T-cells, cytoplasmic 3	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q12968	NFATC3	Nuclear factor of activated T-cells, cytoplasmic 3	GO:0007507; P:heart development; IEA:Ensembl
Q12968	NFATC3	Nuclear factor of activated T-cells, cytoplasmic 3	GO:0006954; P:inflammatory response; TAS:ProtInc
Q12968	NFATC3	Nuclear factor of activated T-cells, cytoplasmic 3	GO:0045087; P:innate immune response; TAS:Reactome
Q12968	NFATC3	Nuclear factor of activated T-cells, cytoplasmic 3	GO:0055001; P:muscle cell development; IEA:Ensembl
Q12968	NFATC3	Nuclear factor of activated T-cells, cytoplasmic 3	GO:0001569; P:patterning of blood vessels; IEA:Ensembl
Q12968	NFATC3	Nuclear factor of activated T-cells, cytoplasmic 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q12968	NFATC3	Nuclear factor of activated T-cells, cytoplasmic 3	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q12968	NFATC3	Nuclear factor of activated T-cells, cytoplasmic 3	GO:0051145; P:smooth muscle cell differentiation; IEA:Ensembl
Q12968	NFATC3	Nuclear factor of activated T-cells, cytoplasmic 3	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q14934	NFATC4	Nuclear factor of activated T-cells, cytoplasmic 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q14934	NFATC4	Nuclear factor of activated T-cells, cytoplasmic 4	GO:0005515; F:protein binding; IPI:IntAct
Q14934	NFATC4	Nuclear factor of activated T-cells, cytoplasmic 4	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IEA:Ensembl
Q14934	NFATC4	Nuclear factor of activated T-cells, cytoplasmic 4	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q14934	NFATC4	Nuclear factor of activated T-cells, cytoplasmic 4	GO:0045333; P:cellular respiration; IEA:Ensembl
Q14934	NFATC4	Nuclear factor of activated T-cells, cytoplasmic 4	GO:0071285; P:cellular response to lithium ion; IEA:Ensembl
Q14934	NFATC4	Nuclear factor of activated T-cells, cytoplasmic 4	GO:0034644; P:cellular response to UV; IEA:Ensembl
Q14934	NFATC4	Nuclear factor of activated T-cells, cytoplasmic 4	GO:0007507; P:heart development; IEA:Ensembl
Q14934	NFATC4	Nuclear factor of activated T-cells, cytoplasmic 4	GO:0006954; P:inflammatory response; TAS:ProtInc
Q14934	NFATC4	Nuclear factor of activated T-cells, cytoplasmic 4	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
Q14934	NFATC4	Nuclear factor of activated T-cells, cytoplasmic 4	GO:0055001; P:muscle cell development; IEA:Ensembl
Q14934	NFATC4	Nuclear factor of activated T-cells, cytoplasmic 4	GO:0001569; P:patterning of blood vessels; IEA:Ensembl
Q14934	NFATC4	Nuclear factor of activated T-cells, cytoplasmic 4	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q14934	NFATC4	Nuclear factor of activated T-cells, cytoplasmic 4	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
Q14934	NFATC4	Nuclear factor of activated T-cells, cytoplasmic 4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q14934	NFATC4	Nuclear factor of activated T-cells, cytoplasmic 4	GO:0032760; P:positive regulation of tumor necrosis factor production; IEA:Ensembl
Q14934	NFATC4	Nuclear factor of activated T-cells, cytoplasmic 4	GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl
Q14934	NFATC4	Nuclear factor of activated T-cells, cytoplasmic 4	GO:0051145; P:smooth muscle cell differentiation; IEA:Ensembl
Q14934	NFATC4	Nuclear factor of activated T-cells, cytoplasmic 4	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q8NET5	NFAM1	NFAT activation molecule 1	GO:0004888; F:transmembrane signaling receptor activity; IDA:HGNC
Q8NET5	NFAM1	NFAT activation molecule 1	GO:0030183; P:B cell differentiation; ISS:HGNC
Q8NET5	NFAM1	NFAT activation molecule 1	GO:0050853; P:B cell receptor signaling pathway; IEA:Ensembl
Q8NET5	NFAM1	NFAT activation molecule 1	GO:0006954; P:inflammatory response; NAS:HGNC
Q8NET5	NFAM1	NFAT activation molecule 1	GO:0035556; P:intracellular signal transduction; IDA:HGNC
Q8NET5	NFAM1	NFAT activation molecule 1	GO:0050861; P:positive regulation of B cell receptor signaling pathway; ISS:HGNC
Q8NET5	NFAM1	NFAT activation molecule 1	GO:0001819; P:positive regulation of cytokine production; NAS:HGNC
Q8NET5	NFAM1	NFAT activation molecule 1	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:HGNC
Q8NET5	NFAM1	NFAT activation molecule 1	GO:0045577; P:regulation of B cell differentiation; IEA:Ensembl
Q8NET5	NFAM1	NFAT activation molecule 1	GO:0007165; P:signal transduction; IDA:HGNC
O94856	NFASC	Neurofascin	GO:0005515; F:protein binding; IPI:UniProtKB
O94856	NFASC	Neurofascin	GO:0007411; P:axon guidance; TAS:Reactome
O94856	NFASC	Neurofascin	GO:0045162; P:clustering of voltage-gated sodium channels; IEA:Ensembl
O94856	NFASC	Neurofascin	GO:0034113; P:heterotypic cell-cell adhesion; IEA:Ensembl
O94856	NFASC	Neurofascin	GO:0042552; P:myelination; ISS:BHF-UCL
O94856	NFASC	Neurofascin	GO:0030913; P:paranodal junction assembly; IEA:Ensembl
O94856	NFASC	Neurofascin	GO:0007422; P:peripheral nervous system development; ISS:BHF-UCL
O94856	NFASC	Neurofascin	GO:0071205; P:protein localization to juxtaparanode region of axon; IEA:Ensembl
O94856	NFASC	Neurofascin	GO:0002175; P:protein localization to paranode region of axon; IEA:Ensembl
O94856	NFASC	Neurofascin	GO:0050808; P:synapse organization; IEA:Ensembl
O94856	NFASC	Neurofascin	GO:0019226; P:transmission of nerve impulse; IEA:Ensembl
P12036	NEFH	Neurofilament heavy polypeptide	GO:0045502; F:dynein binding; TAS:BHF-UCL
P12036	NEFH	Neurofilament heavy polypeptide	GO:0019894; F:kinesin binding; TAS:BHF-UCL
P12036	NEFH	Neurofilament heavy polypeptide	GO:0008017; F:microtubule binding; TAS:BHF-UCL
P12036	NEFH	Neurofilament heavy polypeptide	GO:0030674; F:protein binding, bridging; ISS:BHF-UCL
P12036	NEFH	Neurofilament heavy polypeptide	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
P12036	NEFH	Neurofilament heavy polypeptide	GO:0005200; F:structural constituent of cytoskeleton; ISS:BHF-UCL
P12036	NEFH	Neurofilament heavy polypeptide	GO:0005198; F:structural molecule activity; IMP:BHF-UCL
P12036	NEFH	Neurofilament heavy polypeptide	GO:0061564; P:axon development; IMP:BHF-UCL
P12036	NEFH	Neurofilament heavy polypeptide	GO:0007409; P:axonogenesis; TAS:BHF-UCL
P12036	NEFH	Neurofilament heavy polypeptide	GO:0008219; P:cell death; IEA:UniProtKB-KW
P12036	NEFH	Neurofilament heavy polypeptide	GO:0030031; P:cell projection assembly; TAS:BHF-UCL
P12036	NEFH	Neurofilament heavy polypeptide	GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl
P12036	NEFH	Neurofilament heavy polypeptide	GO:0033693; P:neurofilament bundle assembly; IMP:BHF-UCL
P12036	NEFH	Neurofilament heavy polypeptide	GO:0048936; P:peripheral nervous system neuron axonogenesis; IEA:Ensembl
P12036	NEFH	Neurofilament heavy polypeptide	GO:1902513; P:regulation of organelle transport along microtubule; IMP:BHF-UCL
Q86UQ8	NFE4	Transcription factor NF-E4	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q86UQ8	NFE4	Transcription factor NF-E4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O94916	NFAT5	Nuclear factor of activated T-cells 5	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O94916	NFAT5	Nuclear factor of activated T-cells 5	GO:0005515; F:protein binding; IPI:IntAct
O94916	NFAT5	Nuclear factor of activated T-cells 5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O94916	NFAT5	Nuclear factor of activated T-cells 5	GO:0001816; P:cytokine production; IEA:Ensembl
O94916	NFAT5	Nuclear factor of activated T-cells 5	GO:0007588; P:excretion; TAS:ProtInc
O94916	NFAT5	Nuclear factor of activated T-cells 5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O94916	NFAT5	Nuclear factor of activated T-cells 5	GO:0070884; P:regulation of calcineurin-NFAT signaling cascade; IEA:Ensembl
O94916	NFAT5	Nuclear factor of activated T-cells 5	GO:0007165; P:signal transduction; NAS:ProtInc
O94916	NFAT5	Nuclear factor of activated T-cells 5	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q16621	NFE2	Transcription factor NF-E2 45 kDa subunit	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q16621	NFE2	Transcription factor NF-E2 45 kDa subunit	GO:0043565; F:sequence-specific DNA binding; TAS:BHF-UCL
Q16621	NFE2	Transcription factor NF-E2 45 kDa subunit	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q16621	NFE2	Transcription factor NF-E2 45 kDa subunit	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q16621	NFE2	Transcription factor NF-E2 45 kDa subunit	GO:0050699; F:WW domain binding; IPI:BHF-UCL
Q16621	NFE2	Transcription factor NF-E2 45 kDa subunit	GO:0008015; P:blood circulation; TAS:ProtInc
Q16621	NFE2	Transcription factor NF-E2 45 kDa subunit	GO:0007596; P:blood coagulation; TAS:Reactome
Q16621	NFE2	Transcription factor NF-E2 45 kDa subunit	GO:0007267; P:cell-cell signaling; IEA:Ensembl
Q16621	NFE2	Transcription factor NF-E2 45 kDa subunit	GO:0007599; P:hemostasis; TAS:ProtInc
Q16621	NFE2	Transcription factor NF-E2 45 kDa subunit	GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl
Q16621	NFE2	Transcription factor NF-E2 45 kDa subunit	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q16621	NFE2	Transcription factor NF-E2 45 kDa subunit	GO:0030502; P:negative regulation of bone mineralization; IEA:Ensembl
Q16621	NFE2	Transcription factor NF-E2 45 kDa subunit	GO:0034242; P:negative regulation of syncytium formation by plasma membrane fusion; IEA:Ensembl
Q16621	NFE2	Transcription factor NF-E2 45 kDa subunit	GO:0006337; P:nucleosome disassembly; TAS:BHF-UCL
Q16621	NFE2	Transcription factor NF-E2 45 kDa subunit	GO:2000758; P:positive regulation of peptidyl-lysine acetylation; IEA:Ensembl
Q16621	NFE2	Transcription factor NF-E2 45 kDa subunit	GO:0045893; P:positive regulation of transcription, DNA-templated; TAS:BHF-UCL
Q16621	NFE2	Transcription factor NF-E2 45 kDa subunit	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q16621	NFE2	Transcription factor NF-E2 45 kDa subunit	GO:0006351; P:transcription, DNA-templated; TAS:BHF-UCL
Q12857	NFIA	Nuclear factor 1 A-type	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q12857	NFIA	Nuclear factor 1 A-type	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q12857	NFIA	Nuclear factor 1 A-type	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q12857	NFIA	Nuclear factor 1 A-type	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q12857	NFIA	Nuclear factor 1 A-type	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q12857	NFIA	Nuclear factor 1 A-type	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q12857	NFIA	Nuclear factor 1 A-type	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
Q12857	NFIA	Nuclear factor 1 A-type	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q12857	NFIA	Nuclear factor 1 A-type	GO:0019079; P:viral genome replication; NAS:UniProtKB
O00712	NFIB	Nuclear factor 1 B-type	GO:0003677; F:DNA binding; IDA:UniProtKB
O00712	NFIB	Nuclear factor 1 B-type	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
O00712	NFIB	Nuclear factor 1 B-type	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
O00712	NFIB	Nuclear factor 1 B-type	GO:0001106; F:RNA polymerase II transcription corepressor activity; IDA:UniProtKB
O00712	NFIB	Nuclear factor 1 B-type	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:UniProtKB
O00712	NFIB	Nuclear factor 1 B-type	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O00712	NFIB	Nuclear factor 1 B-type	GO:0021960; P:anterior commissure morphogenesis; ISS:UniProtKB
O00712	NFIB	Nuclear factor 1 B-type	GO:0002062; P:chondrocyte differentiation; ISS:UniProtKB
O00712	NFIB	Nuclear factor 1 B-type	GO:0060486; P:Clara cell differentiation; ISS:UniProtKB
O00712	NFIB	Nuclear factor 1 B-type	GO:0071679; P:commissural neuron axon guidance; ISS:UniProtKB
O00712	NFIB	Nuclear factor 1 B-type	GO:0006260; P:DNA replication; IEA:InterPro
O00712	NFIB	Nuclear factor 1 B-type	GO:0010001; P:glial cell differentiation; ISS:UniProtKB
O00712	NFIB	Nuclear factor 1 B-type	GO:0030902; P:hindbrain development; IEA:Ensembl
O00712	NFIB	Nuclear factor 1 B-type	GO:0061141; P:lung ciliated cell differentiation; ISS:UniProtKB
O00712	NFIB	Nuclear factor 1 B-type	GO:0043392; P:negative regulation of DNA binding; IDA:UniProtKB
O00712	NFIB	Nuclear factor 1 B-type	GO:2000795; P:negative regulation of epithelial cell proliferation involved in lung morphogenesis; ISS:UniProtKB
O00712	NFIB	Nuclear factor 1 B-type	GO:2000791; P:negative regulation of mesenchymal cell proliferation involved in lung development; ISS:UniProtKB
O00712	NFIB	Nuclear factor 1 B-type	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O00712	NFIB	Nuclear factor 1 B-type	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O00712	NFIB	Nuclear factor 1 B-type	GO:0021740; P:principal sensory nucleus of trigeminal nerve development; ISS:UniProtKB
O00712	NFIB	Nuclear factor 1 B-type	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:GOC
O00712	NFIB	Nuclear factor 1 B-type	GO:0060509; P:Type I pneumocyte differentiation; ISS:UniProtKB
O00712	NFIB	Nuclear factor 1 B-type	GO:0060510; P:Type II pneumocyte differentiation; ISS:UniProtKB
P08651	NFIC	Nuclear factor 1 C-type	GO:0001159; F:core promoter proximal region DNA binding; IEA:Ensembl
P08651	NFIC	Nuclear factor 1 C-type	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
P08651	NFIC	Nuclear factor 1 C-type	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:MGI
P08651	NFIC	Nuclear factor 1 C-type	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
P08651	NFIC	Nuclear factor 1 C-type	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P08651	NFIC	Nuclear factor 1 C-type	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
P08651	NFIC	Nuclear factor 1 C-type	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P08651	NFIC	Nuclear factor 1 C-type	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q16649	NFIL3	Nuclear factor interleukin-3-regulated protein	GO:0003677; F:DNA binding; TAS:ProtInc
Q16649	NFIL3	Nuclear factor interleukin-3-regulated protein	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IDA:BHF-UCL
Q16649	NFIL3	Nuclear factor interleukin-3-regulated protein	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl
Q16649	NFIL3	Nuclear factor interleukin-3-regulated protein	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:BHF-UCL
Q16649	NFIL3	Nuclear factor interleukin-3-regulated protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q16649	NFIL3	Nuclear factor interleukin-3-regulated protein	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q16649	NFIL3	Nuclear factor interleukin-3-regulated protein	GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl
Q16649	NFIL3	Nuclear factor interleukin-3-regulated protein	GO:0007623; P:circadian rhythm; IEA:InterPro
Q16649	NFIL3	Nuclear factor interleukin-3-regulated protein	GO:0006955; P:immune response; TAS:ProtInc
Q16649	NFIL3	Nuclear factor interleukin-3-regulated protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q16649	NFIL3	Nuclear factor interleukin-3-regulated protein	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
Q16649	NFIL3	Nuclear factor interleukin-3-regulated protein	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9BT67	NDFIP1	NEDD4 family-interacting protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BT67	NDFIP1	NEDD4 family-interacting protein 1	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q9BT67	NDFIP1	NEDD4 family-interacting protein 1	GO:0006879; P:cellular iron ion homeostasis; IMP:UniProtKB
Q9BT67	NDFIP1	NEDD4 family-interacting protein 1	GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB
Q9BT67	NDFIP1	NEDD4 family-interacting protein 1	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
Q9BT67	NDFIP1	NEDD4 family-interacting protein 1	GO:0032713; P:negative regulation of interleukin-4 production; IEA:Ensembl
Q9BT67	NDFIP1	NEDD4 family-interacting protein 1	GO:0048294; P:negative regulation of isotype switching to IgE isotypes; IEA:Ensembl
Q9BT67	NDFIP1	NEDD4 family-interacting protein 1	GO:0051224; P:negative regulation of protein transport; IMP:UniProtKB
Q9BT67	NDFIP1	NEDD4 family-interacting protein 1	GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl
Q9BT67	NDFIP1	NEDD4 family-interacting protein 1	GO:0032410; P:negative regulation of transporter activity; IMP:UniProtKB
Q9BT67	NDFIP1	NEDD4 family-interacting protein 1	GO:0002829; P:negative regulation of type 2 immune response; IEA:Ensembl
Q9BT67	NDFIP1	NEDD4 family-interacting protein 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q9BT67	NDFIP1	NEDD4 family-interacting protein 1	GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl
Q9BT67	NDFIP1	NEDD4 family-interacting protein 1	GO:0031398; P:positive regulation of protein ubiquitination; IMP:UniProtKB
Q9BT67	NDFIP1	NEDD4 family-interacting protein 1	GO:0048302; P:regulation of isotype switching to IgG isotypes; IEA:Ensembl
Q9BT67	NDFIP1	NEDD4 family-interacting protein 1	GO:0045619; P:regulation of lymphocyte differentiation; IEA:Ensembl
Q9BT67	NDFIP1	NEDD4 family-interacting protein 1	GO:0002761; P:regulation of myeloid leukocyte differentiation; IEA:Ensembl
Q9BT67	NDFIP1	NEDD4 family-interacting protein 1	GO:0007165; P:signal transduction; IMP:GOC
Q9BT67	NDFIP1	NEDD4 family-interacting protein 1	GO:0043162; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; IEA:Ensembl
Q9NV92	NDFIP2	NEDD4 family-interacting protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NV92	NDFIP2	NEDD4 family-interacting protein 2	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q9NV92	NDFIP2	NEDD4 family-interacting protein 2	GO:0050699; F:WW domain binding; IPI:BHF-UCL
Q9NV92	NDFIP2	NEDD4 family-interacting protein 2	GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB
Q9NV92	NDFIP2	NEDD4 family-interacting protein 2	GO:0051224; P:negative regulation of protein transport; IMP:UniProtKB
Q9NV92	NDFIP2	NEDD4 family-interacting protein 2	GO:0032410; P:negative regulation of transporter activity; IMP:UniProtKB
Q9NV92	NDFIP2	NEDD4 family-interacting protein 2	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q9NV92	NDFIP2	NEDD4 family-interacting protein 2	GO:0031398; P:positive regulation of protein ubiquitination; IMP:UniProtKB
Q9NV92	NDFIP2	NEDD4 family-interacting protein 2	GO:0007165; P:signal transduction; IMP:GOC
Q14938	NFIX	Nuclear factor 1 X-type	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q14938	NFIX	Nuclear factor 1 X-type	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q14938	NFIX	Nuclear factor 1 X-type	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q14938	NFIX	Nuclear factor 1 X-type	GO:0048708; P:astrocyte differentiation; IEA:Ensembl
Q14938	NFIX	Nuclear factor 1 X-type	GO:0021707; P:cerebellar granule cell differentiation; IEA:Ensembl
Q14938	NFIX	Nuclear factor 1 X-type	GO:0021680; P:cerebellar Purkinje cell layer development; IEA:Ensembl
Q14938	NFIX	Nuclear factor 1 X-type	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q14938	NFIX	Nuclear factor 1 X-type	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q14938	NFIX	Nuclear factor 1 X-type	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q14938	NFIX	Nuclear factor 1 X-type	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0001071; F:nucleic acid binding transcription factor activity; IDA:UniProtKB
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0005515; F:protein binding; IPI:IntAct
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0000975; F:regulatory region DNA binding; IDA:UniProtKB
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0008134; F:transcription factor binding; IDA:MGI
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IDA:UniProtKB
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0071347; P:cellular response to interleukin-1; IEP:BHF-UCL
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0071222; P:cellular response to lipopolysaccharide; IMP:MGI
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0006954; P:inflammatory response; TAS:UniProtKB
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0045087; P:innate immune response; TAS:Reactome
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0031293; P:membrane protein intracellular domain proteolysis; TAS:Reactome
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0010956; P:negative regulation of calcidiol 1-monooxygenase activity; IDA:BHF-UCL
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0032269; P:negative regulation of cellular protein metabolic process; IC:BHF-UCL
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0032375; P:negative regulation of cholesterol transport; IC:BHF-UCL
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0001818; P:negative regulation of cytokine production; IEA:Ensembl
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0045083; P:negative regulation of interleukin-12 biosynthetic process; IEA:Ensembl
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0010957; P:negative regulation of vitamin D biosynthetic process; IC:BHF-UCL
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:UniProtKB
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:1900127; P:positive regulation of hyaluronan biosynthetic process; IDA:UniProtKB
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0010884; P:positive regulation of lipid storage; IC:BHF-UCL
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; IC:BHF-UCL
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:Reactome
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0046688; P:response to copper ion; IEA:Ensembl
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0006979; P:response to oxidative stress; IEA:Ensembl
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:UniProtKB
P19838	NFKB1	Nuclear factor NF-kappa-B p105 subunit	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0005515; F:protein binding; IPI:BHF-UCL
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0002268; P:follicular dendritic cell differentiation; IEA:Ensembl
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0002467; P:germinal center formation; IEA:Ensembl
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0045087; P:innate immune response; TAS:Reactome
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:Reactome
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0048536; P:spleen development; IEA:Ensembl
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q00653	NFKB2	Nuclear factor NF-kappa-B p100 subunit	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P07196	NEFL	Neurofilament light polypeptide	GO:0042802; F:identical protein binding; IPI:UniProtKB
P07196	NEFL	Neurofilament light polypeptide	GO:0005515; F:protein binding; IPI:UniProtKB
P07196	NEFL	Neurofilament light polypeptide	GO:0030674; F:protein binding, bridging; ISS:BHF-UCL
P07196	NEFL	Neurofilament light polypeptide	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P07196	NEFL	Neurofilament light polypeptide	GO:0005200; F:structural constituent of cytoskeleton; IDA:UniProtKB
P07196	NEFL	Neurofilament light polypeptide	GO:0008089; P:anterograde axon cargo transport; IMP:UniProtKB
P07196	NEFL	Neurofilament light polypeptide	GO:0019896; P:axon transport of mitochondrion; IMP:UniProtKB
P07196	NEFL	Neurofilament light polypeptide	GO:0008219; P:cell death; IEA:UniProtKB-KW
P07196	NEFL	Neurofilament light polypeptide	GO:0045109; P:intermediate filament organization; IMP:UniProtKB
P07196	NEFL	Neurofilament light polypeptide	GO:0033693; P:neurofilament bundle assembly; IDA:UniProtKB
P07196	NEFL	Neurofilament light polypeptide	GO:0008090; P:retrograde axon cargo transport; IMP:UniProtKB
P07196	NEFL	Neurofilament light polypeptide	GO:0007268; P:synaptic transmission; TAS:Reactome
P07197	NEFM	Neurofilament medium polypeptide	GO:0008017; F:microtubule binding; TAS:BHF-UCL
P07197	NEFM	Neurofilament medium polypeptide	GO:0005515; F:protein binding; IPI:IntAct
P07197	NEFM	Neurofilament medium polypeptide	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P07197	NEFM	Neurofilament medium polypeptide	GO:0008088; P:axon cargo transport; IEA:Ensembl
P07197	NEFM	Neurofilament medium polypeptide	GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl
P07197	NEFM	Neurofilament medium polypeptide	GO:0033693; P:neurofilament bundle assembly; TAS:BHF-UCL
P07197	NEFM	Neurofilament medium polypeptide	GO:0031133; P:regulation of axon diameter; IEA:Ensembl
Q6P4R8	NFRKB	Nuclear factor related to kappa-B-binding protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6P4R8	NFRKB	Nuclear factor related to kappa-B-binding protein	GO:0002020; F:protease binding; IPI:UniProtKB
Q6P4R8	NFRKB	Nuclear factor related to kappa-B-binding protein	GO:0005515; F:protein binding; IPI:IntAct
Q6P4R8	NFRKB	Nuclear factor related to kappa-B-binding protein	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q6P4R8	NFRKB	Nuclear factor related to kappa-B-binding protein	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q6P4R8	NFRKB	Nuclear factor related to kappa-B-binding protein	GO:0006954; P:inflammatory response; TAS:ProtInc
Q6P4R8	NFRKB	Nuclear factor related to kappa-B-binding protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6P4R8	NFRKB	Nuclear factor related to kappa-B-binding protein	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9Y697	NFS1	Cysteine desulfurase, mitochondrial	GO:0031071; F:cysteine desulfurase activity; IDA:HGNC
Q9Y697	NFS1	Cysteine desulfurase, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y697	NFS1	Cysteine desulfurase, mitochondrial	GO:0042803; F:protein homodimerization activity; IDA:HGNC
Q9Y697	NFS1	Cysteine desulfurase, mitochondrial	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q9Y697	NFS1	Cysteine desulfurase, mitochondrial	GO:0006534; P:cysteine metabolic process; IEA:InterPro
Q9Y697	NFS1	Cysteine desulfurase, mitochondrial	GO:0018283; P:iron incorporation into metallo-sulfur cluster; IDA:HGNC
Q9Y697	NFS1	Cysteine desulfurase, mitochondrial	GO:0006777; P:Mo-molybdopterin cofactor biosynthetic process; IEA:UniProtKB-KW
Q9Y697	NFS1	Cysteine desulfurase, mitochondrial	GO:0032324; P:molybdopterin cofactor biosynthetic process; TAS:Reactome
Q9Y697	NFS1	Cysteine desulfurase, mitochondrial	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q9Y697	NFS1	Cysteine desulfurase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y697	NFS1	Cysteine desulfurase, mitochondrial	GO:0000096; P:sulfur amino acid metabolic process; TAS:ProtInc
Q9Y697	NFS1	Cysteine desulfurase, mitochondrial	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9Y697	NFS1	Cysteine desulfurase, mitochondrial	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9UMS0	NFU1	NFU1 iron-sulfur cluster scaffold homolog, mitochondrial	GO:0051539; F:4 iron, 4 sulfur cluster binding; IDA:UniProtKB
Q9UMS0	NFU1	NFU1 iron-sulfur cluster scaffold homolog, mitochondrial	GO:0005506; F:iron ion binding; IDA:UniProtKB
Q9UMS0	NFU1	NFU1 iron-sulfur cluster scaffold homolog, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q9UMS0	NFU1	NFU1 iron-sulfur cluster scaffold homolog, mitochondrial	GO:0016226; P:iron-sulfur cluster assembly; IDA:UniProtKB
Q12986	NFX1	Transcriptional repressor NF-X1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q12986	NFX1	Transcriptional repressor NF-X1	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q12986	NFX1	Transcriptional repressor NF-X1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q12986	NFX1	Transcriptional repressor NF-X1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q12986	NFX1	Transcriptional repressor NF-X1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q12986	NFX1	Transcriptional repressor NF-X1	GO:0006954; P:inflammatory response; TAS:ProtInc
Q12986	NFX1	Transcriptional repressor NF-X1	GO:0045347; P:negative regulation of MHC class II biosynthetic process; IEA:Ensembl
Q12986	NFX1	Transcriptional repressor NF-X1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q12986	NFX1	Transcriptional repressor NF-X1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q12986	NFX1	Transcriptional repressor NF-X1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q6ZNB6	NFXL1	NF-X1-type zinc finger protein NFXL1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q6ZNB6	NFXL1	NF-X1-type zinc finger protein NFXL1	GO:0008270; F:zinc ion binding; IEA:InterPro
P23511	NFYA	Nuclear transcription factor Y subunit alpha	GO:0003677; F:DNA binding; IDA:UniProtKB
P23511	NFYA	Nuclear transcription factor Y subunit alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P23511	NFYA	Nuclear transcription factor Y subunit alpha	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P23511	NFYA	Nuclear transcription factor Y subunit alpha	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P23511	NFYA	Nuclear transcription factor Y subunit alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P23511	NFYA	Nuclear transcription factor Y subunit alpha	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
P23511	NFYA	Nuclear transcription factor Y subunit alpha	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P23511	NFYA	Nuclear transcription factor Y subunit alpha	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P25208	NFYB	Nuclear transcription factor Y subunit beta	GO:0003677; F:DNA binding; IDA:UniProtKB
P25208	NFYB	Nuclear transcription factor Y subunit beta	GO:0005515; F:protein binding; IPI:UniProtKB
P25208	NFYB	Nuclear transcription factor Y subunit beta	GO:0070491; F:repressing transcription factor binding; IPI:UniProtKB
P25208	NFYB	Nuclear transcription factor Y subunit beta	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P25208	NFYB	Nuclear transcription factor Y subunit beta	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P25208	NFYB	Nuclear transcription factor Y subunit beta	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P25208	NFYB	Nuclear transcription factor Y subunit beta	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P25208	NFYB	Nuclear transcription factor Y subunit beta	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
P25208	NFYB	Nuclear transcription factor Y subunit beta	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P25208	NFYB	Nuclear transcription factor Y subunit beta	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13952	NFYC	Nuclear transcription factor Y subunit gamma	GO:0003677; F:DNA binding; IDA:UniProtKB
Q13952	NFYC	Nuclear transcription factor Y subunit gamma	GO:0005515; F:protein binding; IPI:IntAct
Q13952	NFYC	Nuclear transcription factor Y subunit gamma	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q13952	NFYC	Nuclear transcription factor Y subunit gamma	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q13952	NFYC	Nuclear transcription factor Y subunit gamma	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q13952	NFYC	Nuclear transcription factor Y subunit gamma	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q13952	NFYC	Nuclear transcription factor Y subunit gamma	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q13952	NFYC	Nuclear transcription factor Y subunit gamma	GO:0006457; P:protein folding; TAS:ProtInc
Q13952	NFYC	Nuclear transcription factor Y subunit gamma	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q13952	NFYC	Nuclear transcription factor Y subunit gamma	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q13952	NFYC	Nuclear transcription factor Y subunit gamma	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q13952	NFYC	Nuclear transcription factor Y subunit gamma	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P80188	LCN2	Neutrophil gelatinase-associated lipocalin	GO:0005506; F:iron ion binding; ISS:UniProtKB
P80188	LCN2	Neutrophil gelatinase-associated lipocalin	GO:0036094; F:small molecule binding; IEA:InterPro
P80188	LCN2	Neutrophil gelatinase-associated lipocalin	GO:0005215; F:transporter activity; IEA:InterPro
P80188	LCN2	Neutrophil gelatinase-associated lipocalin	GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl
P80188	LCN2	Neutrophil gelatinase-associated lipocalin	GO:0071347; P:cellular response to interleukin-1; IEA:Ensembl
P80188	LCN2	Neutrophil gelatinase-associated lipocalin	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
P80188	LCN2	Neutrophil gelatinase-associated lipocalin	GO:0031669; P:cellular response to nutrient levels; IEA:Ensembl
P80188	LCN2	Neutrophil gelatinase-associated lipocalin	GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl
P80188	LCN2	Neutrophil gelatinase-associated lipocalin	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P80188	LCN2	Neutrophil gelatinase-associated lipocalin	GO:0045087; P:innate immune response; ISS:UniProtKB
P80188	LCN2	Neutrophil gelatinase-associated lipocalin	GO:0006811; P:ion transport; IEA:UniProtKB-KW
P80188	LCN2	Neutrophil gelatinase-associated lipocalin	GO:0031346; P:positive regulation of cell projection organization; IEA:Ensembl
P80188	LCN2	Neutrophil gelatinase-associated lipocalin	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P80188	LCN2	Neutrophil gelatinase-associated lipocalin	GO:0070207; P:protein homotrimerization; IEA:Ensembl
P80188	LCN2	Neutrophil gelatinase-associated lipocalin	GO:0042493; P:response to drug; IEA:Ensembl
P80188	LCN2	Neutrophil gelatinase-associated lipocalin	GO:0009635; P:response to herbicide; IEA:Ensembl
P80188	LCN2	Neutrophil gelatinase-associated lipocalin	GO:0009615; P:response to virus; IEA:Ensembl
P80188	LCN2	Neutrophil gelatinase-associated lipocalin	GO:0015891; P:siderophore transport; ISS:UniProtKB
Q9UJF2	RASAL2	Ras GTPase-activating protein nGAP	GO:0005515; F:protein binding; IPI:IntAct
Q9UJF2	RASAL2	Ras GTPase-activating protein nGAP	GO:0005099; F:Ras GTPase activator activity; IBA:RefGenome
Q9UJF2	RASAL2	Ras GTPase-activating protein nGAP	GO:0046580; P:negative regulation of Ras protein signal transduction; IBA:RefGenome
Q9UJF2	RASAL2	Ras GTPase-activating protein nGAP	GO:0032320; P:positive regulation of Ras GTPase activity; IBA:RefGenome
Q9UJF2	RASAL2	Ras GTPase-activating protein nGAP	GO:0007165; P:signal transduction; TAS:ProtInc
Q96E22	NUS1	Nogo-B receptor	GO:0005515; F:protein binding; IPI:IntAct
Q96E22	NUS1	Nogo-B receptor	GO:0016765; F:transferase activity, transferring alkyl or aryl (other than methyl) groups; IEA:InterPro
Q96E22	NUS1	Nogo-B receptor	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q96E22	NUS1	Nogo-B receptor	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96E22	NUS1	Nogo-B receptor	GO:0032367; P:intracellular cholesterol transport; IGI:MGI
Q96E22	NUS1	Nogo-B receptor	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q96E22	NUS1	Nogo-B receptor	GO:0055092; P:sterol homeostasis; IEA:Ensembl
Q9NPG2	NGB	Neuroglobin	GO:0020037; F:heme binding; IEA:InterPro
Q9NPG2	NGB	Neuroglobin	GO:0005506; F:iron ion binding; IEA:InterPro
Q9NPG2	NGB	Neuroglobin	GO:0019825; F:oxygen binding; IEA:InterPro
Q9NPG2	NGB	Neuroglobin	GO:0005344; F:oxygen transporter activity; TAS:UniProtKB
Q9NPG2	NGB	Neuroglobin	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9NPG2	NGB	Neuroglobin	GO:0015671; P:oxygen transport; NAS:UniProtKB
Q8N5V2	NGEF	Ephexin-1	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q8N5V2	NGEF	Ephexin-1	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q8N5V2	NGEF	Ephexin-1	GO:0048013; P:ephrin receptor signaling pathway; ISS:UniProtKB
Q8N5V2	NGEF	Ephexin-1	GO:0061002; P:negative regulation of dendritic spine morphogenesis; ISS:UniProtKB
Q8N5V2	NGEF	Ephexin-1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q8N5V2	NGEF	Ephexin-1	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q8N5V2	NGEF	Ephexin-1	GO:0043087; P:regulation of GTPase activity; ISS:UniProtKB
Q8N5V2	NGEF	Ephexin-1	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q8N5V2	NGEF	Ephexin-1	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q8NEJ9	NGDN	Neuroguidin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8NEJ9	NGDN	Neuroguidin	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
P01138	NGF	Beta-nerve growth factor	GO:0005163; F:nerve growth factor receptor binding; IPI:BHF-UCL
P01138	NGF	Beta-nerve growth factor	GO:0005057; F:receptor signaling protein activity; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0000186; P:activation of MAPKK activity; TAS:Reactome
P01138	NGF	Beta-nerve growth factor	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
P01138	NGF	Beta-nerve growth factor	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
P01138	NGF	Beta-nerve growth factor	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IDA:BHF-UCL
P01138	NGF	Beta-nerve growth factor	GO:0006954; P:inflammatory response; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0007613; P:memory; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P01138	NGF	Beta-nerve growth factor	GO:0045786; P:negative regulation of cell cycle; TAS:Reactome
P01138	NGF	Beta-nerve growth factor	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:2000675; P:negative regulation of type B pancreatic cell apoptotic process; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0032455; P:nerve growth factor processing; TAS:Reactome
P01138	NGF	Beta-nerve growth factor	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0048812; P:neuron projection morphogenesis; IDA:MGI
P01138	NGF	Beta-nerve growth factor	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P01138	NGF	Beta-nerve growth factor	GO:0007422; P:peripheral nervous system development; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P01138	NGF	Beta-nerve growth factor	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
P01138	NGF	Beta-nerve growth factor	GO:0045773; P:positive regulation of axon extension; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0050772; P:positive regulation of axonogenesis; TAS:Reactome
P01138	NGF	Beta-nerve growth factor	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
P01138	NGF	Beta-nerve growth factor	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0051388; P:positive regulation of neurotrophin TRK receptor signaling pathway; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0031954; P:positive regulation of protein autophosphorylation; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:2000648; P:positive regulation of stem cell proliferation; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
P01138	NGF	Beta-nerve growth factor	GO:0050770; P:regulation of axonogenesis; TAS:Reactome
P01138	NGF	Beta-nerve growth factor	GO:0043281; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:Reactome
P01138	NGF	Beta-nerve growth factor	GO:0046928; P:regulation of neurotransmitter secretion; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0042493; P:response to drug; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0051602; P:response to electrical stimulus; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0035094; P:response to nicotine; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0010193; P:response to ozone; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0009314; P:response to radiation; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P01138	NGF	Beta-nerve growth factor	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P01138	NGF	Beta-nerve growth factor	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:Reactome
Q96IV0	NGLY1	Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96IV0	NGLY1	Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase	GO:0000224; F:peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity; IEA:UniProtKB-EC
Q96IV0	NGLY1	Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase	GO:0005515; F:protein binding; IPI:UniProtKB
Q96IV0	NGLY1	Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase	GO:0006516; P:glycoprotein catabolic process; IDA:UniProtKB
Q92886	NEUROG1	Neurogenin-1	GO:0003682; F:chromatin binding; ISS:UniProtKB
Q92886	NEUROG1	Neurogenin-1	GO:0003677; F:DNA binding; ISS:UniProtKB
Q92886	NEUROG1	Neurogenin-1	GO:0070888; F:E-box binding; ISS:UniProtKB
Q92886	NEUROG1	Neurogenin-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q92886	NEUROG1	Neurogenin-1	GO:0000989; F:transcription factor binding transcription factor activity; ISS:UniProtKB
Q92886	NEUROG1	Neurogenin-1	GO:0045165; P:cell fate commitment; IEA:Ensembl
Q92886	NEUROG1	Neurogenin-1	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q92886	NEUROG1	Neurogenin-1	GO:0007399; P:nervous system development; TAS:ProtInc
Q92886	NEUROG1	Neurogenin-1	GO:0030182; P:neuron differentiation; IEA:Ensembl
Q92886	NEUROG1	Neurogenin-1	GO:0031536; P:positive regulation of exit from mitosis; IEA:Ensembl
Q92886	NEUROG1	Neurogenin-1	GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB
Q92886	NEUROG1	Neurogenin-1	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q92886	NEUROG1	Neurogenin-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q92886	NEUROG1	Neurogenin-1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q92886	NEUROG1	Neurogenin-1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H2A3	NEUROG2	Neurogenin-2	GO:0070888; F:E-box binding; ISS:UniProtKB
Q9H2A3	NEUROG2	Neurogenin-2	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q9H2A3	NEUROG2	Neurogenin-2	GO:0007411; P:axon guidance; IEA:Ensembl
Q9H2A3	NEUROG2	Neurogenin-2	GO:0045165; P:cell fate commitment; IEA:Ensembl
Q9H2A3	NEUROG2	Neurogenin-2	GO:0021954; P:central nervous system neuron development; IEA:Ensembl
Q9H2A3	NEUROG2	Neurogenin-2	GO:0030900; P:forebrain development; IEA:Ensembl
Q9H2A3	NEUROG2	Neurogenin-2	GO:0001764; P:neuron migration; IEA:Ensembl
Q9H2A3	NEUROG2	Neurogenin-2	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
Q9H2A3	NEUROG2	Neurogenin-2	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q9H2A3	NEUROG2	Neurogenin-2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9H2A3	NEUROG2	Neurogenin-2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y4Z2	NEUROG3	Neurogenin-3	GO:0031490; F:chromatin DNA binding; ISS:UniProtKB
Q9Y4Z2	NEUROG3	Neurogenin-3	GO:0001047; F:core promoter binding; ISS:UniProtKB
Q9Y4Z2	NEUROG3	Neurogenin-3	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
Q9Y4Z2	NEUROG3	Neurogenin-3	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q9Y4Z2	NEUROG3	Neurogenin-3	GO:0003713; F:transcription coactivator activity; ISS:UniProtKB
Q9Y4Z2	NEUROG3	Neurogenin-3	GO:0007417; P:central nervous system development; TAS:ProtInc
Q9Y4Z2	NEUROG3	Neurogenin-3	GO:0031018; P:endocrine pancreas development; TAS:Reactome
Q9Y4Z2	NEUROG3	Neurogenin-3	GO:0030855; P:epithelial cell differentiation; IEA:Ensembl
Q9Y4Z2	NEUROG3	Neurogenin-3	GO:0030900; P:forebrain development; IEA:Ensembl
Q9Y4Z2	NEUROG3	Neurogenin-3	GO:0030902; P:hindbrain development; IEA:Ensembl
Q9Y4Z2	NEUROG3	Neurogenin-3	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y4Z2	NEUROG3	Neurogenin-3	GO:0007422; P:peripheral nervous system development; TAS:ProtInc
Q9Y4Z2	NEUROG3	Neurogenin-3	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
Q9Y4Z2	NEUROG3	Neurogenin-3	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q9Y4Z2	NEUROG3	Neurogenin-3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9Y4Z2	NEUROG3	Neurogenin-3	GO:0021510; P:spinal cord development; IEA:Ensembl
Q9Y4Z2	NEUROG3	Neurogenin-3	GO:0060290; P:transdifferentiation; ISS:UniProtKB
Q9NPE2	NGRN	Neugrin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NPE2	NGRN	Neugrin	GO:0030182; P:neuron differentiation; NAS:UniProtKB
P55769	NHP2L1	NHP2-like protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P55769	NHP2L1	NHP2-like protein 1	GO:0005515; F:protein binding; IPI:IntAct
P55769	NHP2L1	NHP2-like protein 1	GO:0003723; F:RNA binding; TAS:ProtInc
P55769	NHP2L1	NHP2-like protein 1	GO:0010467; P:gene expression; TAS:Reactome
P55769	NHP2L1	NHP2-like protein 1	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P55769	NHP2L1	NHP2-like protein 1	GO:0042254; P:ribosome biogenesis; IEA:InterPro
P55769	NHP2L1	NHP2-like protein 1	GO:0008380; P:RNA splicing; TAS:Reactome
Q9H9Q4	NHEJ1	Non-homologous end-joining factor 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H9Q4	NHEJ1	Non-homologous end-joining factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H9Q4	NHEJ1	Non-homologous end-joining factor 1	GO:0030183; P:B cell differentiation; IMP:UniProtKB
Q9H9Q4	NHEJ1	Non-homologous end-joining factor 1	GO:0007417; P:central nervous system development; NAS:UniProtKB
Q9H9Q4	NHEJ1	Non-homologous end-joining factor 1	GO:0006310; P:DNA recombination; IEA:InterPro
Q9H9Q4	NHEJ1	Non-homologous end-joining factor 1	GO:0006303; P:double-strand break repair via nonhomologous end joining; IMP:UniProtKB
Q9H9Q4	NHEJ1	Non-homologous end-joining factor 1	GO:0051351; P:positive regulation of ligase activity; NAS:UniProtKB
Q9H9Q4	NHEJ1	Non-homologous end-joining factor 1	GO:0010212; P:response to ionizing radiation; IDA:UniProtKB
Q9H9Q4	NHEJ1	Non-homologous end-joining factor 1	GO:0030217; P:T cell differentiation; IMP:UniProtKB
Q6VVB1	NHLRC1	E3 ubiquitin-protein ligase NHLRC1	GO:0005515; F:protein binding; IPI:UniProtKB
Q6VVB1	NHLRC1	E3 ubiquitin-protein ligase NHLRC1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q6VVB1	NHLRC1	E3 ubiquitin-protein ligase NHLRC1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6VVB1	NHLRC1	E3 ubiquitin-protein ligase NHLRC1	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q6VVB1	NHLRC1	E3 ubiquitin-protein ligase NHLRC1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q6VVB1	NHLRC1	E3 ubiquitin-protein ligase NHLRC1	GO:0006006; P:glucose metabolic process; TAS:Reactome
Q6VVB1	NHLRC1	E3 ubiquitin-protein ligase NHLRC1	GO:0005978; P:glycogen biosynthetic process; TAS:Reactome
Q6VVB1	NHLRC1	E3 ubiquitin-protein ligase NHLRC1	GO:0031398; P:positive regulation of protein ubiquitination; IEA:Ensembl
Q6VVB1	NHLRC1	E3 ubiquitin-protein ligase NHLRC1	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q6VVB1	NHLRC1	E3 ubiquitin-protein ligase NHLRC1	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q6VVB1	NHLRC1	E3 ubiquitin-protein ligase NHLRC1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NX24	NHP2	H/ACA ribonucleoprotein complex subunit 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NX24	NHP2	H/ACA ribonucleoprotein complex subunit 2	GO:0030515; F:snoRNA binding; ISS:UniProtKB
Q9NX24	NHP2	H/ACA ribonucleoprotein complex subunit 2	GO:0031118; P:rRNA pseudouridine synthesis; ISS:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0031698; F:beta-2 adrenergic receptor binding; IPI:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0008013; F:beta-catenin binding; IPI:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0017081; F:chloride channel regulator activity; IDA:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0070851; F:growth factor receptor binding; IPI:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0030165; F:PDZ domain binding; IPI:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0019902; F:phosphatase binding; IPI:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0005515; F:protein binding; IPI:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0043621; F:protein self-association; IDA:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0005102; F:receptor binding; IPI:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0007191; P:adenylate cyclase-activating dopamine receptor signaling pathway; IEA:Ensembl
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0032782; P:bile acid secretion; ISS:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0030643; P:cellular phosphate ion homeostasis; IEA:Ensembl
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0034613; P:cellular protein localization; IEA:Ensembl
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0034635; P:glutathione transport; ISS:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0030033; P:microvillus assembly; IMP:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0014067; P:negative regulation of phosphatidylinositol 3-kinase signaling; ISS:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0010642; P:negative regulation of platelet-derived growth factor receptor signaling pathway; ISS:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0051898; P:negative regulation of protein kinase B signaling; IMP:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0010766; P:negative regulation of sodium ion transport; IEA:Ensembl
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0032416; P:negative regulation of sodium:proton antiporter activity; IEA:Ensembl
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0060158; P:phospholipase C-activating dopamine receptor signaling pathway; IEA:Ensembl
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IDA:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0006461; P:protein complex assembly; TAS:ProtInc
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0044062; P:regulation of excretion; IEA:Ensembl
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0045859; P:regulation of protein kinase activity; ISS:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0032415; P:regulation of sodium:proton antiporter activity; NAS:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0070293; P:renal absorption; ISS:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0097291; P:renal phosphate ion absorption; IMP:UniProtKB
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0003096; P:renal sodium ion transport; IEA:Ensembl
O14745	SLC9A3R1	Na(+)/H(+) exchange regulatory cofactor NHE-RF1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q15599	SLC9A3R2	Na(+)/H(+) exchange regulatory cofactor NHE-RF2	GO:0008013; F:beta-catenin binding; IPI:UniProtKB
Q15599	SLC9A3R2	Na(+)/H(+) exchange regulatory cofactor NHE-RF2	GO:0019902; F:phosphatase binding; IPI:UniProtKB
Q15599	SLC9A3R2	Na(+)/H(+) exchange regulatory cofactor NHE-RF2	GO:0005515; F:protein binding; IPI:UniProtKB
Q15599	SLC9A3R2	Na(+)/H(+) exchange regulatory cofactor NHE-RF2	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q15599	SLC9A3R2	Na(+)/H(+) exchange regulatory cofactor NHE-RF2	GO:0005102; F:receptor binding; IPI:UniProtKB
Q15599	SLC9A3R2	Na(+)/H(+) exchange regulatory cofactor NHE-RF2	GO:0014067; P:negative regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl
Q15599	SLC9A3R2	Na(+)/H(+) exchange regulatory cofactor NHE-RF2	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q5T2W1	PDZK1	Na(+)/H(+) exchange regulatory cofactor NHE-RF3	GO:0030165; F:PDZ domain binding; IPI:UniProtKB
Q5T2W1	PDZK1	Na(+)/H(+) exchange regulatory cofactor NHE-RF3	GO:0005515; F:protein binding; IPI:UniProtKB
Q5T2W1	PDZK1	Na(+)/H(+) exchange regulatory cofactor NHE-RF3	GO:0005215; F:transporter activity; TAS:UniProtKB
Q5T2W1	PDZK1	Na(+)/H(+) exchange regulatory cofactor NHE-RF3	GO:0015879; P:carnitine transport; IDA:BHF-UCL
Q5T2W1	PDZK1	Na(+)/H(+) exchange regulatory cofactor NHE-RF3	GO:0008283; P:cell proliferation; TAS:UniProtKB
Q5T2W1	PDZK1	Na(+)/H(+) exchange regulatory cofactor NHE-RF3	GO:0015893; P:drug transport; NAS:UniProtKB
Q5T2W1	PDZK1	Na(+)/H(+) exchange regulatory cofactor NHE-RF3	GO:0090002; P:establishment of protein localization to plasma membrane; IEA:Ensembl
Q5T2W1	PDZK1	Na(+)/H(+) exchange regulatory cofactor NHE-RF3	GO:0034767; P:positive regulation of ion transmembrane transport; IDA:BHF-UCL
Q5T2W1	PDZK1	Na(+)/H(+) exchange regulatory cofactor NHE-RF3	GO:0090314; P:positive regulation of protein targeting to membrane; ISS:UniProtKB
Q5T2W1	PDZK1	Na(+)/H(+) exchange regulatory cofactor NHE-RF3	GO:0044070; P:regulation of anion transport; ISS:UniProtKB
Q5T2W1	PDZK1	Na(+)/H(+) exchange regulatory cofactor NHE-RF3	GO:0006810; P:transport; IDA:BHF-UCL
Q86UT5	PDZD3	Na(+)/H(+) exchange regulatory cofactor NHE-RF4	GO:0030251; F:guanylate cyclase inhibitor activity; IDA:UniProtKB
Q86UT5	PDZD3	Na(+)/H(+) exchange regulatory cofactor NHE-RF4	GO:0008200; F:ion channel inhibitor activity; TAS:UniProtKB
Q86UT5	PDZD3	Na(+)/H(+) exchange regulatory cofactor NHE-RF4	GO:0005515; F:protein binding; IPI:IntAct
Q86UT5	PDZD3	Na(+)/H(+) exchange regulatory cofactor NHE-RF4	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q86UT5	PDZD3	Na(+)/H(+) exchange regulatory cofactor NHE-RF4	GO:0019934; P:cGMP-mediated signaling; NAS:UniProtKB
Q86UT5	PDZD3	Na(+)/H(+) exchange regulatory cofactor NHE-RF4	GO:0006811; P:ion transport; NAS:UniProtKB
Q86UT5	PDZD3	Na(+)/H(+) exchange regulatory cofactor NHE-RF4	GO:0030827; P:negative regulation of cGMP biosynthetic process; TAS:UniProtKB
Q86UT5	PDZD3	Na(+)/H(+) exchange regulatory cofactor NHE-RF4	GO:0031283; P:negative regulation of guanylate cyclase activity; IDA:GOC
Q86UT5	PDZD3	Na(+)/H(+) exchange regulatory cofactor NHE-RF4	GO:0007168; P:receptor guanylyl cyclase signaling pathway; IC:UniProtKB
Q86UT5	PDZD3	Na(+)/H(+) exchange regulatory cofactor NHE-RF4	GO:0009636; P:response to toxic substance; TAS:UniProtKB
Q86UT5	PDZD3	Na(+)/H(+) exchange regulatory cofactor NHE-RF4	GO:0006833; P:water transport; NAS:UniProtKB
Q6T4R5	NHS	Nance-Horan syndrome protein	GO:0030154; P:cell differentiation; IEA:Ensembl
Q6T4R5	NHS	Nance-Horan syndrome protein	GO:0002088; P:lens development in camera-type eye; IEA:Ensembl
Q9BZQ8	FAM129A	Protein Niban	GO:0005515; F:protein binding; IPI:IntAct
Q9BZQ8	FAM129A	Protein Niban	GO:0001933; P:negative regulation of protein phosphorylation; ISS:UniProtKB
Q9BZQ8	FAM129A	Protein Niban	GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB
Q9BZQ8	FAM129A	Protein Niban	GO:0045727; P:positive regulation of translation; ISS:UniProtKB
Q9BZQ8	FAM129A	Protein Niban	GO:0034976; P:response to endoplasmic reticulum stress; ISS:UniProtKB
Q96TA1	FAM129B	Niban-like protein 1	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q92542	NCSTN	Nicastrin	GO:0004175; F:endopeptidase activity; IEA:Ensembl
Q92542	NCSTN	Nicastrin	GO:0005515; F:protein binding; IPI:UniProtKB
Q92542	NCSTN	Nicastrin	GO:0042987; P:amyloid precursor protein catabolic process; TAS:HGNC
Q92542	NCSTN	Nicastrin	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q92542	NCSTN	Nicastrin	GO:0050435; P:beta-amyloid metabolic process; IEA:Ensembl
Q92542	NCSTN	Nicastrin	GO:0050673; P:epithelial cell proliferation; IEA:Ensembl
Q92542	NCSTN	Nicastrin	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q92542	NCSTN	Nicastrin	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q92542	NCSTN	Nicastrin	GO:0006509; P:membrane protein ectodomain proteolysis; ISS:UniProtKB
Q92542	NCSTN	Nicastrin	GO:0031293; P:membrane protein intracellular domain proteolysis; TAS:Reactome
Q92542	NCSTN	Nicastrin	GO:0002262; P:myeloid cell homeostasis; IEA:Ensembl
Q92542	NCSTN	Nicastrin	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q92542	NCSTN	Nicastrin	GO:0007220; P:Notch receptor processing; TAS:HGNC
Q92542	NCSTN	Nicastrin	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q92542	NCSTN	Nicastrin	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q92542	NCSTN	Nicastrin	GO:0043085; P:positive regulation of catalytic activity; ISS:UniProtKB
Q92542	NCSTN	Nicastrin	GO:0016485; P:protein processing; ISS:UniProtKB
Q92542	NCSTN	Nicastrin	GO:0006508; P:proteolysis; NAS:UniProtKB
Q92542	NCSTN	Nicastrin	GO:0042098; P:T cell proliferation; IEA:Ensembl
P14543	NID1	Nidogen-1	GO:0005509; F:calcium ion binding; IEA:InterPro
P14543	NID1	Nidogen-1	GO:0005518; F:collagen binding; IDA:BHF-UCL
P14543	NID1	Nidogen-1	GO:0043236; F:laminin binding; IDA:BHF-UCL
P14543	NID1	Nidogen-1	GO:0043394; F:proteoglycan binding; IPI:BHF-UCL
P14543	NID1	Nidogen-1	GO:0071711; P:basement membrane organization; TAS:BHF-UCL
P14543	NID1	Nidogen-1	GO:0007160; P:cell-matrix adhesion; IEA:Ensembl
P14543	NID1	Nidogen-1	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P14543	NID1	Nidogen-1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P14543	NID1	Nidogen-1	GO:0032836; P:glomerular basement membrane development; IEA:Ensembl
P14543	NID1	Nidogen-1	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
Q14112	NID2	Nidogen-2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q14112	NID2	Nidogen-2	GO:0005518; F:collagen binding; TAS:ProtInc
Q14112	NID2	Nidogen-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q14112	NID2	Nidogen-2	GO:0071711; P:basement membrane organization; TAS:BHF-UCL
Q14112	NID2	Nidogen-2	GO:0007155; P:cell adhesion; TAS:ProtInc
Q14112	NID2	Nidogen-2	GO:0007160; P:cell-matrix adhesion; IEA:Ensembl
Q14112	NID2	Nidogen-2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q8IY84	NIM1K	Serine/threonine-protein kinase NIM1	GO:0005524; F:ATP binding; IDA:UniProtKB
Q8IY84	NIM1K	Serine/threonine-protein kinase NIM1	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q8IY84	NIM1K	Serine/threonine-protein kinase NIM1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q8IY84	NIM1K	Serine/threonine-protein kinase NIM1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q92982	NINJ1	Ninjurin-1	GO:0007155; P:cell adhesion; TAS:ProtInc
Q92982	NINJ1	Ninjurin-1	GO:0007399; P:nervous system development; TAS:ProtInc
Q92982	NINJ1	Ninjurin-1	GO:0042246; P:tissue regeneration; IEA:InterPro
Q9NZG7	NINJ2	Ninjurin-2	GO:0007399; P:nervous system development; TAS:ProtInc
Q9NZG7	NINJ2	Ninjurin-2	GO:0007158; P:neuron cell-cell adhesion; TAS:ProtInc
Q9NZG7	NINJ2	Ninjurin-2	GO:0042246; P:tissue regeneration; IEA:InterPro
Q9Y2I6	NINL	Ninein-like protein	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y2I6	NINL	Ninein-like protein	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q9Y2I6	NINL	Ninein-like protein	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8N4C6	NIN	Ninein	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8N4C6	NIN	Ninein	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q8N4C6	NIN	Ninein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N4C6	NIN	Ninein	GO:0051642; P:centrosome localization; TAS:HGNC
Q8N4C6	NIN	Ninein	GO:0090222; P:centrosome-templated microtubule nucleation; IEA:Ensembl
Q8N4C6	NIN	Ninein	GO:0034454; P:microtubule anchoring at centrosome; IEA:Ensembl
Q9Y221	NIP7	60S ribosome subunit biogenesis protein NIP7 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y221	NIP7	60S ribosome subunit biogenesis protein NIP7 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y221	NIP7	60S ribosome subunit biogenesis protein NIP7 homolog	GO:0042255; P:ribosome assembly; IEA:InterPro
Q7RTP0	NIPA1	Magnesium transporter NIPA1	GO:0015095; F:magnesium ion transmembrane transporter activity; IEA:InterPro
Q7RTP0	NIPA1	Magnesium transporter NIPA1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q8N8Q9	NIPA2	Magnesium transporter NIPA2	GO:0015095; F:magnesium ion transmembrane transporter activity; IEA:InterPro
Q6NVV3	NIPAL1	Magnesium transporter NIPA3	GO:0015095; F:magnesium ion transmembrane transporter activity; IEA:InterPro
Q0D2K0	NIPAL4	Magnesium transporter NIPA4	GO:0015095; F:magnesium ion transmembrane transporter activity; IEA:InterPro
Q86WB0	ZC3HC1	Nuclear-interacting partner of ALK	GO:0005515; F:protein binding; IPI:UniProtKB
Q86WB0	ZC3HC1	Nuclear-interacting partner of ALK	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q86WB0	ZC3HC1	Nuclear-interacting partner of ALK	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86WB0	ZC3HC1	Nuclear-interacting partner of ALK	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q86WB0	ZC3HC1	Nuclear-interacting partner of ALK	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
Q86WB0	ZC3HC1	Nuclear-interacting partner of ALK	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q6KC79	NIPBL	Nipped-B-like protein	GO:0003682; F:chromatin binding; IEA:Ensembl
Q6KC79	NIPBL	Nipped-B-like protein	GO:0070087; F:chromo shadow domain binding; IPI:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q6KC79	NIPBL	Nipped-B-like protein	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q6KC79	NIPBL	Nipped-B-like protein	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q6KC79	NIPBL	Nipped-B-like protein	GO:0007420; P:brain development; IMP:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0034613; P:cellular protein localization; IMP:UniProtKB
Q6KC79	NIPBL	Nipped-B-like protein	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
Q6KC79	NIPBL	Nipped-B-like protein	GO:0071481; P:cellular response to X-ray; IMP:UniProtKB
Q6KC79	NIPBL	Nipped-B-like protein	GO:0050890; P:cognition; IMP:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0048589; P:developmental growth; IMP:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0042471; P:ear morphogenesis; IMP:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0048557; P:embryonic digestive tract morphogenesis; IMP:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0035115; P:embryonic forelimb morphogenesis; IMP:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0048703; P:embryonic viscerocranium morphogenesis; IEA:Ensembl
Q6KC79	NIPBL	Nipped-B-like protein	GO:0035261; P:external genitalia morphogenesis; IMP:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0048592; P:eye morphogenesis; IMP:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0060325; P:face morphogenesis; IMP:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0045444; P:fat cell differentiation; IEA:Ensembl
Q6KC79	NIPBL	Nipped-B-like protein	GO:0035136; P:forelimb morphogenesis; IMP:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0061010; P:gall bladder development; IMP:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0003007; P:heart morphogenesis; IMP:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0034088; P:maintenance of mitotic sister chromatid cohesion; IMP:UniProtKB
Q6KC79	NIPBL	Nipped-B-like protein	GO:0001656; P:metanephros development; NAS:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q6KC79	NIPBL	Nipped-B-like protein	GO:0007064; P:mitotic sister chromatid cohesion; IMP:UniProtKB
Q6KC79	NIPBL	Nipped-B-like protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0003151; P:outflow tract morphogenesis; IMP:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0031065; P:positive regulation of histone deacetylation; IDA:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
Q6KC79	NIPBL	Nipped-B-like protein	GO:0045778; P:positive regulation of ossification; IEA:Ensembl
Q6KC79	NIPBL	Nipped-B-like protein	GO:0048638; P:regulation of developmental growth; IMP:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0045995; P:regulation of embryonic development; IMP:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0042634; P:regulation of hair cycle; IMP:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0007605; P:sensory perception of sound; IMP:BHF-UCL
Q6KC79	NIPBL	Nipped-B-like protein	GO:0019827; P:stem cell maintenance; IEA:Ensembl
Q6KC79	NIPBL	Nipped-B-like protein	GO:0061038; P:uterus morphogenesis; IMP:BHF-UCL
Q9BPW8	NIPSNAP1	Protein NipSnap homolog 1	GO:0042165; F:neurotransmitter binding; IEA:Ensembl
Q9BPW8	NIPSNAP1	Protein NipSnap homolog 1	GO:0019233; P:sensory perception of pain; IEA:Ensembl
O75323	GBAS	Protein NipSnap homolog 2	GO:0005515; F:protein binding; IPI:IntAct
O75323	GBAS	Protein NipSnap homolog 2	GO:0006754; P:ATP biosynthetic process; IMP:BHF-UCL
O75323	GBAS	Protein NipSnap homolog 2	GO:2000984; P:negative regulation of ATP citrate synthase activity; IMP:BHF-UCL
O75323	GBAS	Protein NipSnap homolog 2	GO:0006119; P:oxidative phosphorylation; IMP:BHF-UCL
Q9Y2I1	NISCH	Nischarin	GO:0008227; F:G-protein coupled amine receptor activity; IEA:Ensembl
Q9Y2I1	NISCH	Nischarin	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
Q9Y2I1	NISCH	Nischarin	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
Q9Y2I1	NISCH	Nischarin	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9Y2I1	NISCH	Nischarin	GO:0006006; P:glucose metabolic process; IEA:Ensembl
Q9Y2I1	NISCH	Nischarin	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
Q9Y2I1	NISCH	Nischarin	GO:0048243; P:norepinephrine secretion; IEA:Ensembl
Q9Y2I1	NISCH	Nischarin	GO:0016601; P:Rac protein signal transduction; IEA:Ensembl
Q9Y2I1	NISCH	Nischarin	GO:0008217; P:regulation of blood pressure; IEA:Ensembl
Q9Y2I1	NISCH	Nischarin	GO:0032228; P:regulation of synaptic transmission, GABAergic; IEA:Ensembl
Q86X76	NIT1	Nitrilase homolog 1	GO:0000257; F:nitrilase activity; TAS:ProtInc
Q86X76	NIT1	Nitrilase homolog 1	GO:0006807; P:nitrogen compound metabolic process; IEA:InterPro
Q9NQR4	NIT2	Omega-amidase NIT2	GO:0050152; F:omega-amidase activity; IEA:UniProtKB-EC
Q9NQR4	NIT2	Omega-amidase NIT2	GO:0006807; P:nitrogen compound metabolic process; IEA:InterPro
P25103	TACR1	Substance-P receptor	GO:0005515; F:protein binding; IPI:IntAct
P25103	TACR1	Substance-P receptor	GO:0016496; F:substance P receptor activity; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0004995; F:tachykinin receptor activity; TAS:ProtInc
P25103	TACR1	Substance-P receptor	GO:0002526; P:acute inflammatory response; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0002118; P:aggressive behavior; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0003051; P:angiotensin-mediated drinking behavior; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0008306; P:associative learning; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0048266; P:behavioral response to pain; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0009582; P:detection of abiotic stimulus; TAS:ProtInc
P25103	TACR1	Substance-P receptor	GO:0042755; P:eating behavior; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0006954; P:inflammatory response; TAS:ProtInc
P25103	TACR1	Substance-P receptor	GO:0007616; P:long-term memory; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0035106; P:operant conditioning; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; TAS:ProtInc
P25103	TACR1	Substance-P receptor	GO:0045760; P:positive regulation of action potential; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0010634; P:positive regulation of epithelial cell migration; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0046887; P:positive regulation of hormone secretion; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0002687; P:positive regulation of leukocyte migration; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0050671; P:positive regulation of lymphocyte proliferation; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0045778; P:positive regulation of ossification; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0035815; P:positive regulation of renal sodium excretion; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0046878; P:positive regulation of saliva secretion; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0051496; P:positive regulation of stress fiber assembly; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0032224; P:positive regulation of synaptic transmission, cholinergic; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0032230; P:positive regulation of synaptic transmission, GABAergic; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0070474; P:positive regulation of uterine smooth muscle contraction; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0043117; P:positive regulation of vascular permeability; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0014910; P:regulation of smooth muscle cell migration; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0048660; P:regulation of smooth muscle cell proliferation; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0010996; P:response to auditory stimulus; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0032355; P:response to estradiol; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0045471; P:response to ethanol; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0009408; P:response to heat; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0043278; P:response to morphine; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0035094; P:response to nicotine; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0010193; P:response to ozone; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0032570; P:response to progesterone; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0060083; P:smooth muscle contraction involved in micturition; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0042713; P:sperm ejaculation; IEA:Ensembl
P25103	TACR1	Substance-P receptor	GO:0007217; P:tachykinin receptor signaling pathway; IDA:BHF-UCL
P21452	TACR2	Substance-K receptor	GO:0005515; F:protein binding; IPI:IntAct
P21452	TACR2	Substance-K receptor	GO:0016497; F:substance K receptor activity; IEA:Ensembl
P21452	TACR2	Substance-K receptor	GO:0004995; F:tachykinin receptor activity; TAS:ProtInc
P21452	TACR2	Substance-K receptor	GO:0007588; P:excretion; TAS:ProtInc
P21452	TACR2	Substance-K receptor	GO:0014827; P:intestine smooth muscle contraction; IEA:Ensembl
P21452	TACR2	Substance-K receptor	GO:0006936; P:muscle contraction; TAS:ProtInc
P21452	TACR2	Substance-K receptor	GO:0033685; P:negative regulation of luteinizing hormone secretion; IEA:Ensembl
P21452	TACR2	Substance-K receptor	GO:0035106; P:operant conditioning; IEA:Ensembl
P21452	TACR2	Substance-K receptor	GO:0014057; P:positive regulation of acetylcholine secretion, neurotransmission; IEA:Ensembl
P21452	TACR2	Substance-K receptor	GO:0070474; P:positive regulation of uterine smooth muscle contraction; IEA:Ensembl
P21452	TACR2	Substance-K receptor	GO:0043117; P:positive regulation of vascular permeability; IEA:Ensembl
P21452	TACR2	Substance-K receptor	GO:0070459; P:prolactin secretion; IEA:Ensembl
P21452	TACR2	Substance-K receptor	GO:0007217; P:tachykinin receptor signaling pathway; TAS:ProtInc
P29371	TACR3	Neuromedin-K receptor	GO:0005515; F:protein binding; IPI:IntAct
P29371	TACR3	Neuromedin-K receptor	GO:0004995; F:tachykinin receptor activity; TAS:ProtInc
P29371	TACR3	Neuromedin-K receptor	GO:0007568; P:aging; IEA:Ensembl
P29371	TACR3	Neuromedin-K receptor	GO:0042538; P:hyperosmotic salinity response; IEA:Ensembl
P29371	TACR3	Neuromedin-K receptor	GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl
P29371	TACR3	Neuromedin-K receptor	GO:0010460; P:positive regulation of heart rate; IEA:Ensembl
P29371	TACR3	Neuromedin-K receptor	GO:0070474; P:positive regulation of uterine smooth muscle contraction; IEA:Ensembl
P29371	TACR3	Neuromedin-K receptor	GO:0042053; P:regulation of dopamine metabolic process; IEA:Ensembl
P29371	TACR3	Neuromedin-K receptor	GO:0060259; P:regulation of feeding behavior; IEA:Ensembl
P29371	TACR3	Neuromedin-K receptor	GO:0042220; P:response to cocaine; IEA:Ensembl
P29371	TACR3	Neuromedin-K receptor	GO:0032355; P:response to estradiol; IEA:Ensembl
P29371	TACR3	Neuromedin-K receptor	GO:0043278; P:response to morphine; IEA:Ensembl
P29371	TACR3	Neuromedin-K receptor	GO:0007217; P:tachykinin receptor signaling pathway; TAS:ProtInc
Q8N5F7	NKAP	NF-kappa-B-activating protein	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q8N5F7	NKAP	NF-kappa-B-activating protein	GO:0031490; F:chromatin DNA binding; IEA:Ensembl
Q8N5F7	NKAP	NF-kappa-B-activating protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8N5F7	NKAP	NF-kappa-B-activating protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N5F7	NKAP	NF-kappa-B-activating protein	GO:0030851; P:granulocyte differentiation; IEA:Ensembl
Q8N5F7	NKAP	NF-kappa-B-activating protein	GO:0071425; P:hematopoietic stem cell proliferation; IEA:Ensembl
Q8N5F7	NKAP	NF-kappa-B-activating protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8N5F7	NKAP	NF-kappa-B-activating protein	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q8N5F7	NKAP	NF-kappa-B-activating protein	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
Q8N5F7	NKAP	NF-kappa-B-activating protein	GO:0046638; P:positive regulation of alpha-beta T cell differentiation; IMP:UniProtKB
Q8N5F7	NKAP	NF-kappa-B-activating protein	GO:0019827; P:stem cell maintenance; IEA:Ensembl
Q8N5F7	NKAP	NF-kappa-B-activating protein	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
Q8N5F7	NKAP	NF-kappa-B-activating protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q969G9	NKD1	Protein naked cuticle homolog 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q969G9	NKD1	Protein naked cuticle homolog 1	GO:0005515; F:protein binding; IPI:IntAct
Q969G9	NKD1	Protein naked cuticle homolog 1	GO:0001754; P:eye photoreceptor cell differentiation; ISS:BHF-UCL
Q969G9	NKD1	Protein naked cuticle homolog 1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
Q969G9	NKD1	Protein naked cuticle homolog 1	GO:1901233; P:negative regulation of convergent extension involved in axis elongation; ISS:BHF-UCL
Q969G9	NKD1	Protein naked cuticle homolog 1	GO:1901231; P:positive regulation of non-canonical Wnt signaling pathway via JNK cascade; ISS:BHF-UCL
Q969G9	NKD1	Protein naked cuticle homolog 1	GO:0045732; P:positive regulation of protein catabolic process; IMP:BHF-UCL
Q969G9	NKD1	Protein naked cuticle homolog 1	GO:2000096; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; ISS:BHF-UCL
Q969G9	NKD1	Protein naked cuticle homolog 1	GO:0090249; P:regulation of cell motility involved in somitogenic axis elongation; ISS:BHF-UCL
Q969G9	NKD1	Protein naked cuticle homolog 1	GO:0007525; P:somatic muscle development; ISS:BHF-UCL
Q969G9	NKD1	Protein naked cuticle homolog 1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q969F2	NKD2	Protein naked cuticle homolog 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q969F2	NKD2	Protein naked cuticle homolog 2	GO:0019838; F:growth factor binding; IPI:BHF-UCL
Q969F2	NKD2	Protein naked cuticle homolog 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q969F2	NKD2	Protein naked cuticle homolog 2	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q969F2	NKD2	Protein naked cuticle homolog 2	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q969F2	NKD2	Protein naked cuticle homolog 2	GO:0048210; P:Golgi vesicle fusion to target membrane; IMP:BHF-UCL
Q969F2	NKD2	Protein naked cuticle homolog 2	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:BHF-UCL
Q969F2	NKD2	Protein naked cuticle homolog 2	GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; IDA:BHF-UCL
Q969F2	NKD2	Protein naked cuticle homolog 2	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:BHF-UCL
Q969F2	NKD2	Protein naked cuticle homolog 2	GO:0010954; P:positive regulation of protein processing; IDA:BHF-UCL
Q969F2	NKD2	Protein naked cuticle homolog 2	GO:0072661; P:protein targeting to plasma membrane; IMP:BHF-UCL
Q969F2	NKD2	Protein naked cuticle homolog 2	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P26715	KLRC1	NKG2-A/NKG2-B type II integral membrane protein	GO:0030246; F:carbohydrate binding; IEA:InterPro
P26715	KLRC1	NKG2-A/NKG2-B type II integral membrane protein	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
P26715	KLRC1	NKG2-A/NKG2-B type II integral membrane protein	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P26715	KLRC1	NKG2-A/NKG2-B type II integral membrane protein	GO:0050776; P:regulation of immune response; TAS:Reactome
P26718	KLRK1	NKG2-D type II integral membrane protein	GO:0030246; F:carbohydrate binding; IEA:InterPro
P26718	KLRK1	NKG2-D type II integral membrane protein	GO:0032394; F:MHC class Ib receptor activity; IEA:Ensembl
P26718	KLRK1	NKG2-D type II integral membrane protein	GO:0005515; F:protein binding; IPI:UniProtKB
P26718	KLRK1	NKG2-D type II integral membrane protein	GO:0004872; F:receptor activity; TAS:ProtInc
P26718	KLRK1	NKG2-D type II integral membrane protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P26718	KLRK1	NKG2-D type II integral membrane protein	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
P26718	KLRK1	NKG2-D type II integral membrane protein	GO:0050830; P:defense response to Gram-positive bacterium; IEA:Ensembl
P26718	KLRK1	NKG2-D type II integral membrane protein	GO:0045087; P:innate immune response; TAS:Reactome
P26718	KLRK1	NKG2-D type II integral membrane protein	GO:0030101; P:natural killer cell activation; TAS:BHF-UCL
P26718	KLRK1	NKG2-D type II integral membrane protein	GO:0032729; P:positive regulation of interferon-gamma production; IEA:Ensembl
P26718	KLRK1	NKG2-D type II integral membrane protein	GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; IDA:UniProtKB
P26718	KLRK1	NKG2-D type II integral membrane protein	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IEA:Ensembl
P26718	KLRK1	NKG2-D type II integral membrane protein	GO:0050776; P:regulation of immune response; TAS:Reactome
P26718	KLRK1	NKG2-D type II integral membrane protein	GO:0007165; P:signal transduction; TAS:ProtInc
P26718	KLRK1	NKG2-D type II integral membrane protein	GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; IEA:Ensembl
P26718	KLRK1	NKG2-D type II integral membrane protein	GO:0031295; P:T cell costimulation; TAS:BHF-UCL
P26717	KLRC2	NKG2-C type II integral membrane protein	GO:0030246; F:carbohydrate binding; IEA:InterPro
P26717	KLRC2	NKG2-C type II integral membrane protein	GO:0005515; F:protein binding; IPI:IntAct
P26717	KLRC2	NKG2-C type II integral membrane protein	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
P26717	KLRC2	NKG2-C type II integral membrane protein	GO:0006968; P:cellular defense response; TAS:ProtInc
P26717	KLRC2	NKG2-C type II integral membrane protein	GO:0045087; P:innate immune response; TAS:Reactome
P26717	KLRC2	NKG2-C type II integral membrane protein	GO:0007165; P:signal transduction; TAS:ProtInc
Q07444	KLRC3	NKG2-E type II integral membrane protein	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q07444	KLRC3	NKG2-E type II integral membrane protein	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q07444	KLRC3	NKG2-E type II integral membrane protein	GO:0006968; P:cellular defense response; TAS:ProtInc
Q07444	KLRC3	NKG2-E type II integral membrane protein	GO:0007165; P:signal transduction; TAS:GOC
O43908	KLRC4	NKG2-F type II integral membrane protein	GO:0006968; P:cellular defense response; TAS:ProtInc
P30414	NKTR	NK-tumor recognition protein	GO:0016018; F:cyclosporin A binding; TAS:ProtInc
P30414	NKTR	NK-tumor recognition protein	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW
P30414	NKTR	NK-tumor recognition protein	GO:0006457; P:protein folding; IEA:UniProtKB-KW
O15226	NKRF	NF-kappa-B-repressing factor	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O15226	NKRF	NF-kappa-B-repressing factor	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O15226	NKRF	NF-kappa-B-repressing factor	GO:0005515; F:protein binding; IPI:IntAct
O15226	NKRF	NF-kappa-B-repressing factor	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
O15226	NKRF	NF-kappa-B-repressing factor	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UD57	NKX1-2	NK1 transcription factor-related protein 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9UD57	NKX1-2	NK1 transcription factor-related protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9UD57	NKX1-2	NK1 transcription factor-related protein 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q15270	NKX1-1	NK1 transcription factor-related protein 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q15270	NKX1-1	NK1 transcription factor-related protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q15270	NKX1-1	NK1 transcription factor-related protein 1	GO:0006629; P:lipid metabolic process; IEA:Ensembl
Q15270	NKX1-1	NK1 transcription factor-related protein 1	GO:0050877; P:neurological system process; IEA:Ensembl
Q15270	NKX1-1	NK1 transcription factor-related protein 1	GO:0043467; P:regulation of generation of precursor metabolites and energy; IEA:Ensembl
Q15270	NKX1-1	NK1 transcription factor-related protein 1	GO:0010906; P:regulation of glucose metabolic process; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0003677; F:DNA binding; IMP:UniProtKB
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0005515; F:protein binding; IPI:UniProtKB
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0048646; P:anatomical structure formation involved in morphogenesis; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0007411; P:axon guidance; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0007420; P:brain development; IMP:UniProtKB
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0021795; P:cerebral cortex cell migration; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0021892; P:cerebral cortex GABAergic interneuron differentiation; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0060486; P:Clara cell differentiation; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0031128; P:developmental induction; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0007492; P:endoderm development; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0060441; P:epithelial tube branching involved in lung morphogenesis; IEP:UniProtKB
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0030900; P:forebrain development; IEP:UniProtKB
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0021798; P:forebrain dorsal/ventral pattern formation; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0021877; P:forebrain neuron fate commitment; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0021759; P:globus pallidus development; IMP:UniProtKB
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0021766; P:hippocampus development; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0033327; P:Leydig cell differentiation; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0007626; P:locomotory behavior; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0030324; P:lung development; IEP:UniProtKB
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0060430; P:lung saccule development; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0042696; P:menarche; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0010719; P:negative regulation of epithelial to mesenchymal transition; IDA:UniProtKB
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0001764; P:neuron migration; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0048709; P:oligodendrocyte differentiation; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0006644; P:phospholipid metabolic process; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0021983; P:pituitary gland development; IEA:Ensembl
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0009725; P:response to hormone; IEP:UniProtKB
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0030878; P:thyroid gland development; IMP:UniProtKB
P43699	NKX2-1	Homeobox protein Nkx-2.1	GO:0060510; P:Type II pneumocyte differentiation; IEA:Ensembl
Q8TAU0	NKX2-3	Homeobox protein Nkx-2.3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q8TAU0	NKX2-3	Homeobox protein Nkx-2.3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8TAU0	NKX2-3	Homeobox protein Nkx-2.3	GO:0043367; P:CD4-positive, alpha-beta T cell differentiation; IEA:Ensembl
Q8TAU0	NKX2-3	Homeobox protein Nkx-2.3	GO:0022612; P:gland morphogenesis; IEA:Ensembl
Q8TAU0	NKX2-3	Homeobox protein Nkx-2.3	GO:0001776; P:leukocyte homeostasis; IEA:Ensembl
Q8TAU0	NKX2-3	Homeobox protein Nkx-2.3	GO:0050900; P:leukocyte migration; IEA:Ensembl
Q8TAU0	NKX2-3	Homeobox protein Nkx-2.3	GO:0048535; P:lymph node development; IEA:Ensembl
Q8TAU0	NKX2-3	Homeobox protein Nkx-2.3	GO:0030225; P:macrophage differentiation; IEA:Ensembl
Q8TAU0	NKX2-3	Homeobox protein Nkx-2.3	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
Q8TAU0	NKX2-3	Homeobox protein Nkx-2.3	GO:0048541; P:Peyer's patch development; IEA:Ensembl
Q8TAU0	NKX2-3	Homeobox protein Nkx-2.3	GO:0002317; P:plasma cell differentiation; IEA:Ensembl
Q8TAU0	NKX2-3	Homeobox protein Nkx-2.3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8TAU0	NKX2-3	Homeobox protein Nkx-2.3	GO:0048621; P:post-embryonic digestive tract morphogenesis; IEA:Ensembl
Q8TAU0	NKX2-3	Homeobox protein Nkx-2.3	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q8TAU0	NKX2-3	Homeobox protein Nkx-2.3	GO:0048536; P:spleen development; IEA:Ensembl
Q8TAU0	NKX2-3	Homeobox protein Nkx-2.3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TAU0	NKX2-3	Homeobox protein Nkx-2.3	GO:0006641; P:triglyceride metabolic process; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0003682; F:chromatin binding; ISS:UniProtKB
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0001159; F:core promoter proximal region DNA binding; ISS:UniProtKB
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0003713; F:transcription coactivator activity; ISS:UniProtKB
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0048708; P:astrocyte differentiation; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0007420; P:brain development; TAS:ProtInc
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0048565; P:digestive tract development; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0031018; P:endocrine pancreas development; TAS:Reactome
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0048665; P:neuron fate specification; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0014003; P:oligodendrocyte development; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0021554; P:optic nerve development; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0003326; P:pancreatic A cell fate commitment; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0003329; P:pancreatic PP cell fate commitment; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0048714; P:positive regulation of oligodendrocyte differentiation; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0009749; P:response to glucose; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0032570; P:response to progesterone; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0021530; P:spinal cord oligodendrocyte cell fate specification; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0003323; P:type B pancreatic cell development; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0003327; P:type B pancreatic cell fate commitment; IEA:Ensembl
O95096	NKX2-2	Homeobox protein Nkx-2.2	GO:0060580; P:ventral spinal cord interneuron fate determination; IEA:Ensembl
Q9H2Z4	NKX2-4	Homeobox protein Nkx-2.4	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9H2Z4	NKX2-4	Homeobox protein Nkx-2.4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9H2Z4	NKX2-4	Homeobox protein Nkx-2.4	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0003682; F:chromatin binding; IDA:MGI
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0003677; F:DNA binding; IDA:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0005515; F:protein binding; IPI:UniProtKB
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0046982; F:protein heterodimerization activity; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0001104; F:RNA polymerase II transcription cofactor activity; IEA:Ensembl
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0001190; F:RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0043565; F:sequence-specific DNA binding; IDA:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0010736; F:serum response element binding; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0007512; P:adult heart development; IMP:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0003278; P:apoptotic process involved in heart morphogenesis; IEA:Ensembl
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0055014; P:atrial cardiac muscle cell development; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0060413; P:atrial septum morphogenesis; IMP:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0060928; P:atrioventricular node cell development; IEA:Ensembl
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0060929; P:atrioventricular node cell fate commitment; IEA:Ensembl
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0030509; P:BMP signaling pathway; IEA:Ensembl
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0003166; P:bundle of His development; IEA:Ensembl
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0003161; P:cardiac conduction system development; IMP:MGI
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0055007; P:cardiac muscle cell differentiation; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0060038; P:cardiac muscle cell proliferation; IEA:Ensembl
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0060048; P:cardiac muscle contraction; IEA:Ensembl
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0055008; P:cardiac muscle tissue morphogenesis; IMP:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0003211; P:cardiac ventricle formation; IEA:Ensembl
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0030154; P:cell differentiation; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0035050; P:embryonic heart tube development; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0060971; P:embryonic heart tube left/right pattern formation; IEA:Ensembl
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0001947; P:heart looping; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0003007; P:heart morphogenesis; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0060347; P:heart trabecula formation; IEA:Ensembl
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0030097; P:hemopoiesis; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0043066; P:negative regulation of apoptotic process; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IMP:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0010832; P:negative regulation of myotube differentiation; IMP:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0003148; P:outflow tract septum morphogenesis; IMP:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0060037; P:pharyngeal system development; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0051891; P:positive regulation of cardioblast differentiation; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0008284; P:positive regulation of cell proliferation; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0045823; P:positive regulation of heart contraction; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0045666; P:positive regulation of neuron differentiation; IMP:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0010765; P:positive regulation of sodium ion transport; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0060261; P:positive regulation of transcription initiation from RNA polymerase II promoter; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0010735; P:positive regulation of transcription via serum response element binding; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:1901387; P:positive regulation of voltage-gated calcium channel activity; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0003342; P:proepicardium development; IEA:Ensembl
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0003350; P:pulmonary myocardium development; IEA:Ensembl
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0003168; P:Purkinje myocyte differentiation; IEA:Ensembl
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0060043; P:regulation of cardiac muscle cell proliferation; IEA:Ensembl
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0055117; P:regulation of cardiac muscle contraction; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0003221; P:right ventricular cardiac muscle tissue morphogenesis; IMP:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0045214; P:sarcomere organization; IEA:Ensembl
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0003285; P:septum secundum development; IMP:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0048536; P:spleen development; IMP:UniProtKB
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0030878; P:thyroid gland development; IMP:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0001570; P:vasculogenesis; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0055015; P:ventricular cardiac muscle cell development; ISS:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0055005; P:ventricular cardiac myofibril assembly; IEA:Ensembl
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0060412; P:ventricular septum morphogenesis; IMP:BHF-UCL
P52952	NKX2-5	Homeobox protein Nkx-2.5	GO:0003222; P:ventricular trabecula myocardium morphogenesis; IEA:Ensembl
A6NCS4	NKX2-6	Homeobox protein Nkx-2.6	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
A6NCS4	NKX2-6	Homeobox protein Nkx-2.6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:HGNC
A6NCS4	NKX2-6	Homeobox protein Nkx-2.6	GO:0055014; P:atrial cardiac muscle cell development; ISS:BHF-UCL
A6NCS4	NKX2-6	Homeobox protein Nkx-2.6	GO:0030154; P:cell differentiation; ISS:BHF-UCL
A6NCS4	NKX2-6	Homeobox protein Nkx-2.6	GO:0048565; P:digestive tract development; ISS:BHF-UCL
A6NCS4	NKX2-6	Homeobox protein Nkx-2.6	GO:0035050; P:embryonic heart tube development; IMP:HGNC
A6NCS4	NKX2-6	Homeobox protein Nkx-2.6	GO:0021854; P:hypothalamus development; ISS:BHF-UCL
A6NCS4	NKX2-6	Homeobox protein Nkx-2.6	GO:0043066; P:negative regulation of apoptotic process; ISS:BHF-UCL
A6NCS4	NKX2-6	Homeobox protein Nkx-2.6	GO:0060039; P:pericardium development; ISS:BHF-UCL
A6NCS4	NKX2-6	Homeobox protein Nkx-2.6	GO:0060037; P:pharyngeal system development; ISS:BHF-UCL
A6NCS4	NKX2-6	Homeobox protein Nkx-2.6	GO:0008284; P:positive regulation of cell proliferation; ISS:BHF-UCL
A6NCS4	NKX2-6	Homeobox protein Nkx-2.6	GO:0043586; P:tongue development; ISS:BHF-UCL
A6NCS4	NKX2-6	Homeobox protein Nkx-2.6	GO:0006351; P:transcription, DNA-templated; IDA:HGNC
A6NCS4	NKX2-6	Homeobox protein Nkx-2.6	GO:0055015; P:ventricular cardiac muscle cell development; ISS:BHF-UCL
O15522	NKX2-8	Homeobox protein Nkx-2.8	GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB
O15522	NKX2-8	Homeobox protein Nkx-2.8	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
O15522	NKX2-8	Homeobox protein Nkx-2.8	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
O15522	NKX2-8	Homeobox protein Nkx-2.8	GO:0007409; P:axonogenesis; IEA:Ensembl
O15522	NKX2-8	Homeobox protein Nkx-2.8	GO:0001889; P:liver development; NAS:UniProtKB
O15522	NKX2-8	Homeobox protein Nkx-2.8	GO:0030324; P:lung development; IEA:Ensembl
O15522	NKX2-8	Homeobox protein Nkx-2.8	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
O15522	NKX2-8	Homeobox protein Nkx-2.8	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
O15522	NKX2-8	Homeobox protein Nkx-2.8	GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0004882; F:androgen receptor activity; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0001047; F:core promoter binding; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0030284; F:estrogen receptor activity; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0030331; F:estrogen receptor binding; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0042826; F:histone deacetylase binding; IPI:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0005515; F:protein binding; IPI:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0030295; F:protein kinase activator activity; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0043621; F:protein self-association; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0000983; F:RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IDA:BHF-UCL
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0030521; P:androgen receptor signaling pathway; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0060442; P:branching involved in prostate gland morphogenesis; ISS:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0048754; P:branching morphogenesis of an epithelial tube; ISS:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0035690; P:cellular response to drug; IEP:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0071456; P:cellular response to hypoxia; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0071347; P:cellular response to interleukin-1; IEP:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0071383; P:cellular response to steroid hormone stimulus; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0071356; P:cellular response to tumor necrosis factor; IEP:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0035907; P:dorsal aorta development; IEA:Ensembl
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0060664; P:epithelial cell proliferation involved in salivary gland morphogenesis; ISS:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0007507; P:heart development; IEA:Ensembl
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0008584; P:male gonad development; IEA:Ensembl
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0001656; P:metanephros development; IEA:Ensembl
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0071850; P:mitotic cell cycle arrest; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0050680; P:negative regulation of epithelial cell proliferation; ISS:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0060770; P:negative regulation of epithelial cell proliferation involved in prostate gland development; ISS:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0071899; P:negative regulation of estrogen receptor binding; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0043569; P:negative regulation of insulin-like growth factor receptor signaling pathway; ISS:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0045930; P:negative regulation of mitotic cell cycle; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0060037; P:pharyngeal system development; IEA:Ensembl
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:2000836; P:positive regulation of androgen secretion; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:2001235; P:positive regulation of apoptotic signaling pathway; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0010942; P:positive regulation of cell death; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0051781; P:positive regulation of cell division; IMP:BHF-UCL
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0045931; P:positive regulation of mitotic cell cycle; IMP:BHF-UCL
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0045860; P:positive regulation of protein kinase activity; IDA:GOC
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:2001022; P:positive regulation of response to DNA damage stimulus; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0043491; P:protein kinase B signaling; IMP:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0033574; P:response to testosterone; ISS:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0007431; P:salivary gland development; ISS:UniProtKB
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0001756; P:somitogenesis; IEA:Ensembl
Q99801	NKX3-1	Homeobox protein Nkx-3.1	GO:0043401; P:steroid hormone mediated signaling pathway; IDA:GOC
P78367	NKX3-2	Homeobox protein Nkx-3.2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P78367	NKX3-2	Homeobox protein Nkx-3.2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P78367	NKX3-2	Homeobox protein Nkx-3.2	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
P78367	NKX3-2	Homeobox protein Nkx-3.2	GO:0048706; P:embryonic skeletal system development; IEA:Ensembl
P78367	NKX3-2	Homeobox protein Nkx-3.2	GO:0060576; P:intestinal epithelial cell development; IEA:Ensembl
P78367	NKX3-2	Homeobox protein Nkx-3.2	GO:0042474; P:middle ear morphogenesis; IEA:Ensembl
P78367	NKX3-2	Homeobox protein Nkx-3.2	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P78367	NKX3-2	Homeobox protein Nkx-3.2	GO:0032331; P:negative regulation of chondrocyte differentiation; ISS:UniProtKB
P78367	NKX3-2	Homeobox protein Nkx-3.2	GO:0048645; P:organ formation; IEA:Ensembl
P78367	NKX3-2	Homeobox protein Nkx-3.2	GO:0031016; P:pancreas development; IEA:Ensembl
P78367	NKX3-2	Homeobox protein Nkx-3.2	GO:0001501; P:skeletal system development; TAS:ProtInc
P78367	NKX3-2	Homeobox protein Nkx-3.2	GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl
P78367	NKX3-2	Homeobox protein Nkx-3.2	GO:0048536; P:spleen development; IEA:Ensembl
P78367	NKX3-2	Homeobox protein Nkx-3.2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0003682; F:chromatin binding; IEA:Ensembl
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0008283; P:cell proliferation; IEA:Ensembl
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0071345; P:cellular response to cytokine stimulus; IEA:Ensembl
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0071375; P:cellular response to peptide hormone stimulus; IEA:Ensembl
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0051594; P:detection of glucose; ISS:BHF-UCL
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0031018; P:endocrine pancreas development; TAS:Reactome
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0045686; P:negative regulation of glial cell differentiation; IEA:Ensembl
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0048709; P:oligodendrocyte differentiation; IEA:Ensembl
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0031016; P:pancreas development; ISS:BHF-UCL
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0045687; P:positive regulation of glial cell differentiation; IEA:Ensembl
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:2000078; P:positive regulation of type B pancreatic cell development; ISS:BHF-UCL
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0021912; P:regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification; IEA:Ensembl
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0021913; P:regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification; IEA:Ensembl
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0042493; P:response to drug; IEA:Ensembl
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0035094; P:response to nicotine; IEA:Ensembl
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0006366; P:transcription from RNA polymerase II promoter; IEA:Ensembl
P78426	NKX6-1	Homeobox protein Nkx-6.1	GO:0072560; P:type B pancreatic cell maturation; ISS:BHF-UCL
Q9C056	NKX6-2	Homeobox protein Nkx-6.2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9C056	NKX6-2	Homeobox protein Nkx-6.2	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
Q9C056	NKX6-2	Homeobox protein Nkx-6.2	GO:0022010; P:central nervous system myelination; IEA:Ensembl
Q9C056	NKX6-2	Homeobox protein Nkx-6.2	GO:0031018; P:endocrine pancreas development; IEA:Ensembl
Q9C056	NKX6-2	Homeobox protein Nkx-6.2	GO:0010454; P:negative regulation of cell fate commitment; IEA:Ensembl
Q9C056	NKX6-2	Homeobox protein Nkx-6.2	GO:0045686; P:negative regulation of glial cell differentiation; IEA:Ensembl
Q9C056	NKX6-2	Homeobox protein Nkx-6.2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9C056	NKX6-2	Homeobox protein Nkx-6.2	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q9C056	NKX6-2	Homeobox protein Nkx-6.2	GO:0010455; P:positive regulation of cell fate commitment; IEA:Ensembl
Q9C056	NKX6-2	Homeobox protein Nkx-6.2	GO:0045687; P:positive regulation of glial cell differentiation; IEA:Ensembl
Q9C056	NKX6-2	Homeobox protein Nkx-6.2	GO:0021912; P:regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification; IEA:Ensembl
Q9C056	NKX6-2	Homeobox protein Nkx-6.2	GO:0021913; P:regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification; IEA:Ensembl
Q9C056	NKX6-2	Homeobox protein Nkx-6.2	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
A6NJ46	NKX6-3	Homeobox protein Nkx-6.3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
A6NJ46	NKX6-3	Homeobox protein Nkx-6.3	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
A6NJ46	NKX6-3	Homeobox protein Nkx-6.3	GO:0001709; P:cell fate determination; IEA:Ensembl
A6NJ46	NKX6-3	Homeobox protein Nkx-6.3	GO:0002067; P:glandular epithelial cell differentiation; IEA:Ensembl
A6NJ46	NKX6-3	Homeobox protein Nkx-6.3	GO:0030857; P:negative regulation of epithelial cell differentiation; IEA:Ensembl
A6NJ46	NKX6-3	Homeobox protein Nkx-6.3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NVX2	NLE1	Notchless protein homolog 1	GO:0001826; P:inner cell mass cell differentiation; IEA:Ensembl
Q9NVX2	NLE1	Notchless protein homolog 1	GO:2001268; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; IEA:Ensembl
Q9NVX2	NLE1	Notchless protein homolog 1	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
Q9NVX2	NLE1	Notchless protein homolog 1	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl
Q8N2Q7	NLGN1	Neuroligin-1	GO:0050839; F:cell adhesion molecule binding; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0042043; F:neurexin family protein binding; ISS:UniProtKB
Q8N2Q7	NLGN1	Neuroligin-1	GO:0030165; F:PDZ domain binding; IDA:UniProt
Q8N2Q7	NLGN1	Neuroligin-1	GO:0046983; F:protein dimerization activity; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0004872; F:receptor activity; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0097113; P:alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0016339; P:calcium-dependent cell-cell adhesion; ISS:UniProtKB
Q8N2Q7	NLGN1	Neuroligin-1	GO:0048789; P:cytoskeletal matrix organization at active zone; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0045184; P:establishment of protein localization; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0007157; P:heterophilic cell-cell adhesion; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0097114; P:N-methyl-D-aspartate receptor clustering; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0007399; P:nervous system development; ISS:UniProtKB
Q8N2Q7	NLGN1	Neuroligin-1	GO:0097115; P:neurexin clustering; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0007158; P:neuron cell-cell adhesion; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0023041; P:neuronal signal transduction; TAS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0060999; P:positive regulation of dendritic spine development; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:2000463; P:positive regulation of excitatory postsynaptic membrane potential; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0051491; P:positive regulation of filopodium assembly; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:1902533; P:positive regulation of intracellular signal transduction; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:1900029; P:positive regulation of ruffle assembly; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0051965; P:positive regulation of synapse assembly; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0032230; P:positive regulation of synaptic transmission, GABAergic; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:1900244; P:positive regulation of synaptic vesicle endocytosis; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:2000302; P:positive regulation of synaptic vesicle exocytosis; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0097119; P:postsynaptic density protein 95 clustering; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0097104; P:postsynaptic membrane assembly; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0097105; P:presynaptic membrane assembly; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0051290; P:protein heterotetramerization; IEA:Ensembl
Q8N2Q7	NLGN1	Neuroligin-1	GO:0051260; P:protein homooligomerization; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0035418; P:protein localization to synapse; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0006605; P:protein targeting; ISS:UniProtKB
Q8N2Q7	NLGN1	Neuroligin-1	GO:0097120; P:receptor localization to synapse; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:2000311; P:regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:2000310; P:regulation of N-methyl-D-aspartate selective glutamate receptor activity; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0045664; P:regulation of neuron differentiation; ISS:UniProtKB
Q8N2Q7	NLGN1	Neuroligin-1	GO:0002087; P:regulation of respiratory gaseous exchange by neurological system process; IEA:Ensembl
Q8N2Q7	NLGN1	Neuroligin-1	GO:0007416; P:synapse assembly; ISS:UniProtKB
Q8N2Q7	NLGN1	Neuroligin-1	GO:0097091; P:synaptic vesicle clustering; ISS:BHF-UCL
Q8N2Q7	NLGN1	Neuroligin-1	GO:0016080; P:synaptic vesicle targeting; ISS:UniProtKB
Q8N2Q7	NLGN1	Neuroligin-1	GO:0072553; P:terminal button organization; ISS:BHF-UCL
Q8NFZ4	NLGN2	Neuroligin-2	GO:0050839; F:cell adhesion molecule binding; ISS:BHF-UCL
Q8NFZ4	NLGN2	Neuroligin-2	GO:0042043; F:neurexin family protein binding; NAS:UniProtKB
Q8NFZ4	NLGN2	Neuroligin-2	GO:0004872; F:receptor activity; IBA:RefGenome
Q8NFZ4	NLGN2	Neuroligin-2	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
Q8NFZ4	NLGN2	Neuroligin-2	GO:0045217; P:cell-cell junction maintenance; NAS:UniProtKB
Q8NFZ4	NLGN2	Neuroligin-2	GO:0097116; P:gephyrin clustering; ISS:BHF-UCL
Q8NFZ4	NLGN2	Neuroligin-2	GO:0035641; P:locomotory exploration behavior; IEA:Ensembl
Q8NFZ4	NLGN2	Neuroligin-2	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q8NFZ4	NLGN2	Neuroligin-2	GO:0007158; P:neuron cell-cell adhesion; ISS:BHF-UCL
Q8NFZ4	NLGN2	Neuroligin-2	GO:2000463; P:positive regulation of excitatory postsynaptic membrane potential; ISS:BHF-UCL
Q8NFZ4	NLGN2	Neuroligin-2	GO:0097151; P:positive regulation of inhibitory postsynaptic membrane potential; ISS:BHF-UCL
Q8NFZ4	NLGN2	Neuroligin-2	GO:0051965; P:positive regulation of synapse assembly; ISS:BHF-UCL
Q8NFZ4	NLGN2	Neuroligin-2	GO:0032230; P:positive regulation of synaptic transmission, GABAergic; ISS:BHF-UCL
Q8NFZ4	NLGN2	Neuroligin-2	GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; ISS:BHF-UCL
Q8NFZ4	NLGN2	Neuroligin-2	GO:0097119; P:postsynaptic density protein 95 clustering; ISS:BHF-UCL
Q8NFZ4	NLGN2	Neuroligin-2	GO:0097104; P:postsynaptic membrane assembly; ISS:BHF-UCL
Q8NFZ4	NLGN2	Neuroligin-2	GO:0097105; P:presynaptic membrane assembly; ISS:BHF-UCL
Q8NFZ4	NLGN2	Neuroligin-2	GO:0035418; P:protein localization to synapse; ISS:BHF-UCL
Q8NFZ4	NLGN2	Neuroligin-2	GO:2000311; P:regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; ISS:BHF-UCL
Q8NFZ4	NLGN2	Neuroligin-2	GO:0002087; P:regulation of respiratory gaseous exchange by neurological system process; ISS:BHF-UCL
Q8NFZ4	NLGN2	Neuroligin-2	GO:0050804; P:regulation of synaptic transmission; ISS:BHF-UCL
Q8NFZ4	NLGN2	Neuroligin-2	GO:0019233; P:sensory perception of pain; IEA:Ensembl
Q8NFZ4	NLGN2	Neuroligin-2	GO:0007416; P:synapse assembly; NAS:UniProtKB
Q8NFZ4	NLGN2	Neuroligin-2	GO:0050808; P:synapse organization; ISS:BHF-UCL
Q8NFZ4	NLGN2	Neuroligin-2	GO:0072553; P:terminal button organization; ISS:BHF-UCL
Q9NZ94	NLGN3	Neuroligin-3	GO:0050839; F:cell adhesion molecule binding; ISS:BHF-UCL
Q9NZ94	NLGN3	Neuroligin-3	GO:0042043; F:neurexin family protein binding; ISS:BHF-UCL
Q9NZ94	NLGN3	Neuroligin-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NZ94	NLGN3	Neuroligin-3	GO:0004872; F:receptor activity; ISS:BHF-UCL
Q9NZ94	NLGN3	Neuroligin-3	GO:0030534; P:adult behavior; IMP:BHF-UCL
Q9NZ94	NLGN3	Neuroligin-3	GO:0048675; P:axon extension; ISS:BHF-UCL
Q9NZ94	NLGN3	Neuroligin-3	GO:0007612; P:learning; IMP:BHF-UCL
Q9NZ94	NLGN3	Neuroligin-3	GO:0007158; P:neuron cell-cell adhesion; ISS:BHF-UCL
Q9NZ94	NLGN3	Neuroligin-3	GO:2000969; P:positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; ISS:BHF-UCL
Q9NZ94	NLGN3	Neuroligin-3	GO:2000463; P:positive regulation of excitatory postsynaptic membrane potential; ISS:BHF-UCL
Q9NZ94	NLGN3	Neuroligin-3	GO:0051965; P:positive regulation of synapse assembly; ISS:BHF-UCL
Q9NZ94	NLGN3	Neuroligin-3	GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; ISS:BHF-UCL
Q9NZ94	NLGN3	Neuroligin-3	GO:0097104; P:postsynaptic membrane assembly; ISS:BHF-UCL
Q9NZ94	NLGN3	Neuroligin-3	GO:0097105; P:presynaptic membrane assembly; ISS:BHF-UCL
Q9NZ94	NLGN3	Neuroligin-3	GO:0006898; P:receptor-mediated endocytosis; ISS:BHF-UCL
Q9NZ94	NLGN3	Neuroligin-3	GO:0061001; P:regulation of dendritic spine morphogenesis; IEA:Ensembl
Q9NZ94	NLGN3	Neuroligin-3	GO:0060080; P:regulation of inhibitory postsynaptic membrane potential; ISS:BHF-UCL
Q9NZ94	NLGN3	Neuroligin-3	GO:1900271; P:regulation of long-term synaptic potentiation; IEA:Ensembl
Q9NZ94	NLGN3	Neuroligin-3	GO:2000310; P:regulation of N-methyl-D-aspartate selective glutamate receptor activity; IEA:Ensembl
Q9NZ94	NLGN3	Neuroligin-3	GO:0002087; P:regulation of respiratory gaseous exchange by neurological system process; ISS:BHF-UCL
Q9NZ94	NLGN3	Neuroligin-3	GO:0050804; P:regulation of synaptic transmission; ISS:BHF-UCL
Q9NZ94	NLGN3	Neuroligin-3	GO:2000331; P:regulation of terminal button organization; IEA:Ensembl
Q9NZ94	NLGN3	Neuroligin-3	GO:0060024; P:rhythmic synaptic transmission; ISS:BHF-UCL
Q9NZ94	NLGN3	Neuroligin-3	GO:0035176; P:social behavior; IMP:UniProtKB
Q9NZ94	NLGN3	Neuroligin-3	GO:0007416; P:synapse assembly; ISS:BHF-UCL
Q9NZ94	NLGN3	Neuroligin-3	GO:0050808; P:synapse organization; IMP:UniProtKB
Q9NZ94	NLGN3	Neuroligin-3	GO:0008542; P:visual learning; IEA:Ensembl
Q9NZ94	NLGN3	Neuroligin-3	GO:0071625; P:vocalization behavior; IMP:BHF-UCL
Q8NFZ3	NLGN4Y	Neuroligin-4, Y-linked	GO:0050839; F:cell adhesion molecule binding; TAS:BHF-UCL
Q8NFZ3	NLGN4Y	Neuroligin-4, Y-linked	GO:0042043; F:neurexin family protein binding; IBA:RefGenome
Q8NFZ3	NLGN4Y	Neuroligin-4, Y-linked	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NFZ3	NLGN4Y	Neuroligin-4, Y-linked	GO:0004872; F:receptor activity; IBA:RefGenome
Q8NFZ3	NLGN4Y	Neuroligin-4, Y-linked	GO:0007612; P:learning; IMP:BHF-UCL
Q8NFZ3	NLGN4Y	Neuroligin-4, Y-linked	GO:0007158; P:neuron cell-cell adhesion; TAS:BHF-UCL
Q8NFZ3	NLGN4Y	Neuroligin-4, Y-linked	GO:0035176; P:social behavior; IMP:BHF-UCL
Q8NFZ3	NLGN4Y	Neuroligin-4, Y-linked	GO:0007416; P:synapse assembly; IBA:RefGenome
Q8NFZ3	NLGN4Y	Neuroligin-4, Y-linked	GO:0071625; P:vocalization behavior; IMP:BHF-UCL
Q8N0W4	NLGN4X	Neuroligin-4, X-linked	GO:0050839; F:cell adhesion molecule binding; TAS:BHF-UCL
Q8N0W4	NLGN4X	Neuroligin-4, X-linked	GO:0031404; F:chloride ion binding; IDA:UniProtKB
Q8N0W4	NLGN4X	Neuroligin-4, X-linked	GO:0042043; F:neurexin family protein binding; IPI:UniProtKB
Q8N0W4	NLGN4X	Neuroligin-4, X-linked	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N0W4	NLGN4X	Neuroligin-4, X-linked	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q8N0W4	NLGN4X	Neuroligin-4, X-linked	GO:0004872; F:receptor activity; IBA:RefGenome
Q8N0W4	NLGN4X	Neuroligin-4, X-linked	GO:0030534; P:adult behavior; IMP:BHF-UCL
Q8N0W4	NLGN4X	Neuroligin-4, X-linked	GO:0003360; P:brainstem development; ISS:BHF-UCL
Q8N0W4	NLGN4X	Neuroligin-4, X-linked	GO:0045216; P:cell-cell junction organization; NAS:UniProtKB
Q8N0W4	NLGN4X	Neuroligin-4, X-linked	GO:0021549; P:cerebellum development; ISS:BHF-UCL
Q8N0W4	NLGN4X	Neuroligin-4, X-linked	GO:0007612; P:learning; IMP:BHF-UCL
Q8N0W4	NLGN4X	Neuroligin-4, X-linked	GO:0090394; P:negative regulation of excitatory postsynaptic membrane potential; IDA:BHF-UCL
Q8N0W4	NLGN4X	Neuroligin-4, X-linked	GO:0007158; P:neuron cell-cell adhesion; TAS:BHF-UCL
Q8N0W4	NLGN4X	Neuroligin-4, X-linked	GO:0030182; P:neuron differentiation; NAS:BHF-UCL
Q8N0W4	NLGN4X	Neuroligin-4, X-linked	GO:0035265; P:organ growth; ISS:BHF-UCL
Q8N0W4	NLGN4X	Neuroligin-4, X-linked	GO:0097105; P:presynaptic membrane assembly; IDA:BHF-UCL
Q8N0W4	NLGN4X	Neuroligin-4, X-linked	GO:0035176; P:social behavior; IMP:UniProtKB
Q8N0W4	NLGN4X	Neuroligin-4, X-linked	GO:0050808; P:synapse organization; IMP:UniProtKB
Q8N0W4	NLGN4X	Neuroligin-4, X-linked	GO:0071625; P:vocalization behavior; IMP:BHF-UCL
Q9UBE8	NLK	Serine/threonine-protein kinase NLK	GO:0005524; F:ATP binding; ISS:UniProtKB
Q9UBE8	NLK	Serine/threonine-protein kinase NLK	GO:0000287; F:magnesium ion binding; ISS:UniProtKB
Q9UBE8	NLK	Serine/threonine-protein kinase NLK	GO:0004707; F:MAP kinase activity; ISS:UniProtKB
Q9UBE8	NLK	Serine/threonine-protein kinase NLK	GO:0005515; F:protein binding; IPI:IntAct
Q9UBE8	NLK	Serine/threonine-protein kinase NLK	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q9UBE8	NLK	Serine/threonine-protein kinase NLK	GO:0004674; F:protein serine/threonine kinase activity; TAS:Reactome
Q9UBE8	NLK	Serine/threonine-protein kinase NLK	GO:0042169; F:SH2 domain binding; ISS:UniProtKB
Q9UBE8	NLK	Serine/threonine-protein kinase NLK	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q9UBE8	NLK	Serine/threonine-protein kinase NLK	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q9UBE8	NLK	Serine/threonine-protein kinase NLK	GO:0035556; P:intracellular signal transduction; ISS:UniProtKB
Q9UBE8	NLK	Serine/threonine-protein kinase NLK	GO:0030178; P:negative regulation of Wnt signaling pathway; ISS:UniProtKB
Q9UBE8	NLK	Serine/threonine-protein kinase NLK	GO:0018107; P:peptidyl-threonine phosphorylation; ISS:UniProtKB
Q9UBE8	NLK	Serine/threonine-protein kinase NLK	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
Q9UBE8	NLK	Serine/threonine-protein kinase NLK	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
Q9UBE8	NLK	Serine/threonine-protein kinase NLK	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
Q9UBE8	NLK	Serine/threonine-protein kinase NLK	GO:0033136; P:serine phosphorylation of STAT3 protein; ISS:UniProtKB
Q9UBE8	NLK	Serine/threonine-protein kinase NLK	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UBE8	NLK	Serine/threonine-protein kinase NLK	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IMP:UniProtKB
Q9UBE8	NLK	Serine/threonine-protein kinase NLK	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q7RTR2	NLRC3	Protein NLRC3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q7RTR2	NLRC3	Protein NLRC3	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q7RTR2	NLRC3	Protein NLRC3	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IMP:MGI
Q7RTR2	NLRC3	Protein NLRC3	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q7RTR2	NLRC3	Protein NLRC3	GO:0042110; P:T cell activation; IEP:UniProtKB
Q9NPP4	NLRC4	NLR family CARD domain-containing protein 4	GO:0005524; F:ATP binding; IDA:HGNC
Q9NPP4	NLRC4	NLR family CARD domain-containing protein 4	GO:0042802; F:identical protein binding; IPI:IntAct
Q9NPP4	NLRC4	NLR family CARD domain-containing protein 4	GO:0000287; F:magnesium ion binding; TAS:HGNC
Q9NPP4	NLRC4	NLR family CARD domain-containing protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NPP4	NLRC4	NLR family CARD domain-containing protein 4	GO:0042803; F:protein homodimerization activity; IDA:HGNC
Q9NPP4	NLRC4	NLR family CARD domain-containing protein 4	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:HGNC
Q9NPP4	NLRC4	NLR family CARD domain-containing protein 4	GO:0002218; P:activation of innate immune response; ISS:UniProtKB
Q9NPP4	NLRC4	NLR family CARD domain-containing protein 4	GO:0042742; P:defense response to bacterium; IDA:HGNC
Q9NPP4	NLRC4	NLR family CARD domain-containing protein 4	GO:0016045; P:detection of bacterium; IDA:HGNC
Q9NPP4	NLRC4	NLR family CARD domain-containing protein 4	GO:0006954; P:inflammatory response; ISS:UniProtKB
Q9NPP4	NLRC4	NLR family CARD domain-containing protein 4	GO:0045087; P:innate immune response; TAS:Reactome
Q9NPP4	NLRC4	NLR family CARD domain-containing protein 4	GO:0050702; P:interleukin-1 beta secretion; IDA:HGNC
Q9NPP4	NLRC4	NLR family CARD domain-containing protein 4	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q9NPP4	NLRC4	NLR family CARD domain-containing protein 4	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q9NPP4	NLRC4	NLR family CARD domain-containing protein 4	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q9NPP4	NLRC4	NLR family CARD domain-containing protein 4	GO:0051260; P:protein homooligomerization; ISS:UniProtKB
Q9NPP4	NLRC4	NLR family CARD domain-containing protein 4	GO:0070269; P:pyroptosis; ISS:UniProtKB
Q86WI3	NLRC5	Protein NLRC5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86WI3	NLRC5	Protein NLRC5	GO:0005515; F:protein binding; IPI:UniProtKB
Q86WI3	NLRC5	Protein NLRC5	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IDA:BHF-UCL
Q86WI3	NLRC5	Protein NLRC5	GO:0051607; P:defense response to virus; IEP:UniProtKB
Q86WI3	NLRC5	Protein NLRC5	GO:0045087; P:innate immune response; IMP:UniProtKB
Q86WI3	NLRC5	Protein NLRC5	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q86WI3	NLRC5	Protein NLRC5	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
Q86WI3	NLRC5	Protein NLRC5	GO:0060339; P:negative regulation of type I interferon-mediated signaling pathway; IDA:UniProtKB
Q86WI3	NLRC5	Protein NLRC5	GO:0060335; P:positive regulation of interferon-gamma-mediated signaling pathway; IDA:UniProtKB
Q86WI3	NLRC5	Protein NLRC5	GO:0045345; P:positive regulation of MHC class I biosynthetic process; IDA:BHF-UCL
Q86WI3	NLRC5	Protein NLRC5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q86WI3	NLRC5	Protein NLRC5	GO:0060340; P:positive regulation of type I interferon-mediated signaling pathway; IDA:UniProtKB
Q86WI3	NLRC5	Protein NLRC5	GO:0043549; P:regulation of kinase activity; IDA:UniProtKB
Q86UT6	NLRX1	NLR family member X1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86UT6	NLRX1	NLR family member X1	GO:0005515; F:protein binding; IPI:IntAct
Q86UT6	NLRX1	NLR family member X1	GO:0045087; P:innate immune response; TAS:Reactome
Q86UT6	NLRX1	NLR family member X1	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
Q86UT6	NLRX1	NLR family member X1	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
Q86UT6	NLRX1	NLR family member X1	GO:0045824; P:negative regulation of innate immune response; IEA:Ensembl
Q86UT6	NLRX1	NLR family member X1	GO:0032688; P:negative regulation of interferon-beta production; IEA:Ensembl
Q86UT6	NLRX1	NLR family member X1	GO:0032715; P:negative regulation of interleukin-6 production; IEA:Ensembl
Q86UT6	NLRX1	NLR family member X1	GO:0039536; P:negative regulation of RIG-I signaling pathway; IEA:Ensembl
Q86UT6	NLRX1	NLR family member X1	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
Q86UT6	NLRX1	NLR family member X1	GO:0016032; P:viral process; IEA:UniProtKB-KW
P22307	SCP2	Non-specific lipid-transfer protein	GO:0015485; F:cholesterol binding; IDA:UniProtKB
P22307	SCP2	Non-specific lipid-transfer protein	GO:0000062; F:fatty-acyl-CoA binding; IDA:UniProtKB
P22307	SCP2	Non-specific lipid-transfer protein	GO:0036042; F:long-chain fatty acyl-CoA binding; IDA:UniProtKB
P22307	SCP2	Non-specific lipid-transfer protein	GO:0070538; F:oleic acid binding; IDA:UniProtKB
P22307	SCP2	Non-specific lipid-transfer protein	GO:0008526; F:phosphatidylinositol transporter activity; IDA:UniProtKB
P22307	SCP2	Non-specific lipid-transfer protein	GO:0033814; F:propanoyl-CoA C-acyltransferase activity; IEA:UniProtKB-EC
P22307	SCP2	Non-specific lipid-transfer protein	GO:0005515; F:protein binding; IPI:UniProtKB
P22307	SCP2	Non-specific lipid-transfer protein	GO:0005102; F:receptor binding; IPI:UniProtKB
P22307	SCP2	Non-specific lipid-transfer protein	GO:0036109; P:alpha-linolenic acid metabolic process; TAS:Reactome
P22307	SCP2	Non-specific lipid-transfer protein	GO:0006699; P:bile acid biosynthetic process; TAS:Reactome
P22307	SCP2	Non-specific lipid-transfer protein	GO:0008206; P:bile acid metabolic process; TAS:Reactome
P22307	SCP2	Non-specific lipid-transfer protein	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P22307	SCP2	Non-specific lipid-transfer protein	GO:0033540; P:fatty acid beta-oxidation using acyl-CoA oxidase; TAS:Reactome
P22307	SCP2	Non-specific lipid-transfer protein	GO:0032959; P:inositol trisphosphate biosynthetic process; IDA:UniProtKB
P22307	SCP2	Non-specific lipid-transfer protein	GO:1901373; P:lipid hydroperoxide transport; IDA:UniProtKB
P22307	SCP2	Non-specific lipid-transfer protein	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
P22307	SCP2	Non-specific lipid-transfer protein	GO:0007031; P:peroxisome organization; IEA:Ensembl
P22307	SCP2	Non-specific lipid-transfer protein	GO:0015914; P:phospholipid transport; IDA:UniProtKB
P22307	SCP2	Non-specific lipid-transfer protein	GO:0032385; P:positive regulation of intracellular cholesterol transport; IDA:UniProtKB
P22307	SCP2	Non-specific lipid-transfer protein	GO:0045940; P:positive regulation of steroid metabolic process; IDA:UniProtKB
P22307	SCP2	Non-specific lipid-transfer protein	GO:0006701; P:progesterone biosynthetic process; IDA:UniProtKB
P22307	SCP2	Non-specific lipid-transfer protein	GO:0072659; P:protein localization to plasma membrane; IDA:UniProtKB
P22307	SCP2	Non-specific lipid-transfer protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P22307	SCP2	Non-specific lipid-transfer protein	GO:0006694; P:steroid biosynthetic process; IDA:UniProtKB
P22307	SCP2	Non-specific lipid-transfer protein	GO:0033559; P:unsaturated fatty acid metabolic process; TAS:Reactome
P28336	NMBR	Neuromedin-B receptor	GO:0004946; F:bombesin receptor activity; TAS:ProtInc
P28336	NMBR	Neuromedin-B receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P28336	NMBR	Neuromedin-B receptor	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; TAS:ProtInc
P08949	NMB	Neuromedin-B	GO:0005179; F:hormone activity; TAS:ProtInc
P08949	NMB	Neuromedin-B	GO:0050482; P:arachidonic acid secretion; IEA:Ensembl
P08949	NMB	Neuromedin-B	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P08949	NMB	Neuromedin-B	GO:0042593; P:glucose homeostasis; IEA:Ensembl
P08949	NMB	Neuromedin-B	GO:0046888; P:negative regulation of hormone secretion; IEA:Ensembl
P08949	NMB	Neuromedin-B	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
P08949	NMB	Neuromedin-B	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P08949	NMB	Neuromedin-B	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P08949	NMB	Neuromedin-B	GO:0046887; P:positive regulation of hormone secretion; IEA:Ensembl
P08949	NMB	Neuromedin-B	GO:0007165; P:signal transduction; TAS:ProtInc
Q8TCU5	GRIN3A	Glutamate receptor ionotropic, NMDA 3A	GO:0005262; F:calcium channel activity; IEA:Ensembl
Q8TCU5	GRIN3A	Glutamate receptor ionotropic, NMDA 3A	GO:0005234; F:extracellular-glutamate-gated ion channel activity; IBA:RefGenome
Q8TCU5	GRIN3A	Glutamate receptor ionotropic, NMDA 3A	GO:0016594; F:glycine binding; IDA:UniProtKB
Q8TCU5	GRIN3A	Glutamate receptor ionotropic, NMDA 3A	GO:0042802; F:identical protein binding; IPI:UniProtKB
Q8TCU5	GRIN3A	Glutamate receptor ionotropic, NMDA 3A	GO:0004972; F:N-methyl-D-aspartate selective glutamate receptor activity; IDA:UniProtKB
Q8TCU5	GRIN3A	Glutamate receptor ionotropic, NMDA 3A	GO:0042165; F:neurotransmitter binding; IEA:Ensembl
Q8TCU5	GRIN3A	Glutamate receptor ionotropic, NMDA 3A	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TCU5	GRIN3A	Glutamate receptor ionotropic, NMDA 3A	GO:0051721; F:protein phosphatase 2A binding; ISS:UniProtKB
Q8TCU5	GRIN3A	Glutamate receptor ionotropic, NMDA 3A	GO:0006816; P:calcium ion transport; ISS:UniProtKB
Q8TCU5	GRIN3A	Glutamate receptor ionotropic, NMDA 3A	GO:0016358; P:dendrite development; IEA:Ensembl
Q8TCU5	GRIN3A	Glutamate receptor ionotropic, NMDA 3A	GO:0034220; P:ion transmembrane transport; IBA:RefGenome
Q8TCU5	GRIN3A	Glutamate receptor ionotropic, NMDA 3A	GO:0035235; P:ionotropic glutamate receptor signaling pathway; IBA:RefGenome
Q8TCU5	GRIN3A	Glutamate receptor ionotropic, NMDA 3A	GO:0060134; P:prepulse inhibition; IEA:Ensembl
Q8TCU5	GRIN3A	Glutamate receptor ionotropic, NMDA 3A	GO:0045471; P:response to ethanol; IDA:UniProtKB
Q8TCU5	GRIN3A	Glutamate receptor ionotropic, NMDA 3A	GO:0048511; P:rhythmic process; IEA:Ensembl
Q8TCU5	GRIN3A	Glutamate receptor ionotropic, NMDA 3A	GO:0035249; P:synaptic transmission, glutamatergic; IBA:RefGenome
O60391	GRIN3B	Glutamate receptor ionotropic, NMDA 3B	GO:0005262; F:calcium channel activity; IEA:Ensembl
O60391	GRIN3B	Glutamate receptor ionotropic, NMDA 3B	GO:0005261; F:cation channel activity; ISS:UniProtKB
O60391	GRIN3B	Glutamate receptor ionotropic, NMDA 3B	GO:0005234; F:extracellular-glutamate-gated ion channel activity; IBA:RefGenome
O60391	GRIN3B	Glutamate receptor ionotropic, NMDA 3B	GO:0016594; F:glycine binding; ISS:UniProtKB
O60391	GRIN3B	Glutamate receptor ionotropic, NMDA 3B	GO:0004972; F:N-methyl-D-aspartate selective glutamate receptor activity; IBA:RefGenome
O60391	GRIN3B	Glutamate receptor ionotropic, NMDA 3B	GO:0042165; F:neurotransmitter binding; ISS:UniProtKB
O60391	GRIN3B	Glutamate receptor ionotropic, NMDA 3B	GO:0030594; F:neurotransmitter receptor activity; ISS:UniProtKB
O60391	GRIN3B	Glutamate receptor ionotropic, NMDA 3B	GO:0034220; P:ion transmembrane transport; IBA:RefGenome
O60391	GRIN3B	Glutamate receptor ionotropic, NMDA 3B	GO:0035235; P:ionotropic glutamate receptor signaling pathway; ISS:UniProtKB
O60391	GRIN3B	Glutamate receptor ionotropic, NMDA 3B	GO:0051205; P:protein insertion into membrane; ISS:UniProtKB
O60391	GRIN3B	Glutamate receptor ionotropic, NMDA 3B	GO:0051924; P:regulation of calcium ion transport; ISS:UniProtKB
O60391	GRIN3B	Glutamate receptor ionotropic, NMDA 3B	GO:0035249; P:synaptic transmission, glutamatergic; IBA:RefGenome
Q96D46	NMD3	60S ribosomal export protein NMD3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96D46	NMD3	60S ribosomal export protein NMD3	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0005262; F:calcium channel activity; IEA:Ensembl
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0005234; F:extracellular-glutamate-gated ion channel activity; IBA:RefGenome
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0004972; F:N-methyl-D-aspartate selective glutamate receptor activity; IBA:RefGenome
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0005515; F:protein binding; IPI:UniProtKB
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0008270; F:zinc ion binding; ISS:UniProtKB
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0033058; P:directional locomotion; IEA:Ensembl
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0042417; P:dopamine metabolic process; IEA:Ensembl
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0007215; P:glutamate receptor signaling pathway; TAS:ProtInc
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0034220; P:ion transmembrane transport; IBA:RefGenome
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0035235; P:ionotropic glutamate receptor signaling pathway; IBA:RefGenome
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0007611; P:learning or memory; TAS:ProtInc
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0007613; P:memory; IEA:Ensembl
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0042177; P:negative regulation of protein catabolic process; IEA:Ensembl
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0022008; P:neurogenesis; IEA:Ensembl
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0008104; P:protein localization; IEA:Ensembl
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0051930; P:regulation of sensory perception of pain; IEA:Ensembl
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0001975; P:response to amphetamine; IEA:Ensembl
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0042493; P:response to drug; IEA:Ensembl
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0045471; P:response to ethanol; IDA:UniProtKB
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0009611; P:response to wounding; IEA:Ensembl
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0019233; P:sensory perception of pain; IEA:Ensembl
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0042428; P:serotonin metabolic process; IEA:Ensembl
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0030431; P:sleep; IEA:Ensembl
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0001964; P:startle response; IEA:Ensembl
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0007268; P:synaptic transmission; TAS:Reactome
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0035249; P:synaptic transmission, glutamatergic; IBA:RefGenome
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0006810; P:transport; TAS:ProtInc
Q12879	GRIN2A	Glutamate receptor ionotropic, NMDA 2A	GO:0008542; P:visual learning; IEA:Ensembl
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0005262; F:calcium channel activity; IEA:Ensembl
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0005234; F:extracellular-glutamate-gated ion channel activity; IBA:RefGenome
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0016594; F:glycine binding; IDA:UniProtKB
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0004972; F:N-methyl-D-aspartate selective glutamate receptor activity; IBA:RefGenome
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0005515; F:protein binding; IPI:UniProtKB
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0008270; F:zinc ion binding; ISS:UniProtKB
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0001662; P:behavioral fear response; IEA:Ensembl
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0048266; P:behavioral response to pain; IEA:Ensembl
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; IEA:Ensembl
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0007215; P:glutamate receptor signaling pathway; TAS:ProtInc
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0034220; P:ion transmembrane transport; IBA:RefGenome
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0035235; P:ionotropic glutamate receptor signaling pathway; IBA:RefGenome
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0007612; P:learning; IEA:Ensembl
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0007611; P:learning or memory; TAS:ProtInc
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0007613; P:memory; IEA:Ensembl
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0045471; P:response to ethanol; IDA:UniProtKB
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0007423; P:sensory organ development; IEA:Ensembl
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0001964; P:startle response; IEA:Ensembl
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0001967; P:suckling behavior; IEA:Ensembl
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0007268; P:synaptic transmission; TAS:Reactome
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0035249; P:synaptic transmission, glutamatergic; IBA:RefGenome
Q13224	GRIN2B	Glutamate receptor ionotropic, NMDA 2B	GO:0006810; P:transport; TAS:ProtInc
Q14957	GRIN2C	Glutamate receptor ionotropic, NMDA 2C	GO:0005261; F:cation channel activity; IEA:Ensembl
Q14957	GRIN2C	Glutamate receptor ionotropic, NMDA 2C	GO:0005234; F:extracellular-glutamate-gated ion channel activity; IBA:RefGenome
Q14957	GRIN2C	Glutamate receptor ionotropic, NMDA 2C	GO:0004972; F:N-methyl-D-aspartate selective glutamate receptor activity; IBA:RefGenome
Q14957	GRIN2C	Glutamate receptor ionotropic, NMDA 2C	GO:0005515; F:protein binding; IPI:IntAct
Q14957	GRIN2C	Glutamate receptor ionotropic, NMDA 2C	GO:0033058; P:directional locomotion; IEA:Ensembl
Q14957	GRIN2C	Glutamate receptor ionotropic, NMDA 2C	GO:0007215; P:glutamate receptor signaling pathway; TAS:ProtInc
Q14957	GRIN2C	Glutamate receptor ionotropic, NMDA 2C	GO:0034220; P:ion transmembrane transport; IBA:RefGenome
Q14957	GRIN2C	Glutamate receptor ionotropic, NMDA 2C	GO:0035235; P:ionotropic glutamate receptor signaling pathway; IBA:RefGenome
Q14957	GRIN2C	Glutamate receptor ionotropic, NMDA 2C	GO:0042177; P:negative regulation of protein catabolic process; IEA:Ensembl
Q14957	GRIN2C	Glutamate receptor ionotropic, NMDA 2C	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q14957	GRIN2C	Glutamate receptor ionotropic, NMDA 2C	GO:0008104; P:protein localization; IEA:Ensembl
Q14957	GRIN2C	Glutamate receptor ionotropic, NMDA 2C	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
Q14957	GRIN2C	Glutamate receptor ionotropic, NMDA 2C	GO:0009611; P:response to wounding; IEA:Ensembl
Q14957	GRIN2C	Glutamate receptor ionotropic, NMDA 2C	GO:0007268; P:synaptic transmission; TAS:Reactome
Q14957	GRIN2C	Glutamate receptor ionotropic, NMDA 2C	GO:0035249; P:synaptic transmission, glutamatergic; IBA:RefGenome
Q14957	GRIN2C	Glutamate receptor ionotropic, NMDA 2C	GO:0006810; P:transport; TAS:ProtInc
O15399	GRIN2D	Glutamate receptor ionotropic, NMDA 2D	GO:0005234; F:extracellular-glutamate-gated ion channel activity; IBA:RefGenome
O15399	GRIN2D	Glutamate receptor ionotropic, NMDA 2D	GO:0004972; F:N-methyl-D-aspartate selective glutamate receptor activity; IBA:RefGenome
O15399	GRIN2D	Glutamate receptor ionotropic, NMDA 2D	GO:0005515; F:protein binding; IPI:IntAct
O15399	GRIN2D	Glutamate receptor ionotropic, NMDA 2D	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
O15399	GRIN2D	Glutamate receptor ionotropic, NMDA 2D	GO:0034220; P:ion transmembrane transport; IBA:RefGenome
O15399	GRIN2D	Glutamate receptor ionotropic, NMDA 2D	GO:0035235; P:ionotropic glutamate receptor signaling pathway; IBA:RefGenome
O15399	GRIN2D	Glutamate receptor ionotropic, NMDA 2D	GO:0051930; P:regulation of sensory perception of pain; IEA:Ensembl
O15399	GRIN2D	Glutamate receptor ionotropic, NMDA 2D	GO:0007165; P:signal transduction; NAS:ProtInc
O15399	GRIN2D	Glutamate receptor ionotropic, NMDA 2D	GO:0001964; P:startle response; IEA:Ensembl
O15399	GRIN2D	Glutamate receptor ionotropic, NMDA 2D	GO:0007268; P:synaptic transmission; TAS:Reactome
O15399	GRIN2D	Glutamate receptor ionotropic, NMDA 2D	GO:0035249; P:synaptic transmission, glutamatergic; IBA:RefGenome
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0005262; F:calcium channel activity; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0005509; F:calcium ion binding; ISS:UniProtKB
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0005516; F:calmodulin binding; ISS:UniProtKB
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0005234; F:extracellular-glutamate-gated ion channel activity; IBA:RefGenome
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0016595; F:glutamate binding; IDA:UniProtKB
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0016594; F:glycine binding; IDA:UniProtKB
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0004972; F:N-methyl-D-aspartate selective glutamate receptor activity; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0042165; F:neurotransmitter binding; ISS:BHF-UCL
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0005515; F:protein binding; IPI:IntAct
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0022843; F:voltage-gated cation channel activity; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0055074; P:calcium ion homeostasis; ISS:UniProtKB
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0006812; P:cation transport; IDA:UniProtKB
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0071287; P:cellular response to manganese ion; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0021987; P:cerebral cortex development; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0001661; P:conditioned taste aversion; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0034220; P:ion transmembrane transport; IBA:RefGenome
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0035235; P:ionotropic glutamate receptor signaling pathway; ISS:UniProtKB
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0007616; P:long-term memory; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0060179; P:male mating behavior; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0008355; P:olfactory learning; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0021586; P:pons maturation; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:2000463; P:positive regulation of excitatory postsynaptic membrane potential; ISS:BHF-UCL
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0060134; P:prepulse inhibition; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0018964; P:propylene metabolic process; ISS:BHF-UCL
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0051262; P:protein tetramerization; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0050770; P:regulation of axonogenesis; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0048814; P:regulation of dendrite morphogenesis; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; ISS:UniProtKB
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0042391; P:regulation of membrane potential; IDA:UniProtKB
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0043576; P:regulation of respiratory gaseous exchange; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0051963; P:regulation of synapse assembly; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0001975; P:response to amphetamine; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0051592; P:response to calcium ion; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0045471; P:response to ethanol; IDA:UniProtKB
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0060992; P:response to fungicide; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0043278; P:response to morphine; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0048511; P:rhythmic process; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0019233; P:sensory perception of pain; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0035176; P:social behavior; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0001967; P:suckling behavior; IEA:Ensembl
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0035249; P:synaptic transmission, glutamatergic; IBA:RefGenome
Q05586	GRIN1	Glutamate receptor ionotropic, NMDA 1	GO:0008542; P:visual learning; ISS:UniProtKB
Q13287	NMI	N-myc-interactor	GO:0005515; F:protein binding; IPI:UniProtKB
Q13287	NMI	N-myc-interactor	GO:0003712; F:transcription cofactor activity; TAS:ProtInc
Q13287	NMI	N-myc-interactor	GO:0006954; P:inflammatory response; TAS:ProtInc
Q13287	NMI	N-myc-interactor	GO:0007259; P:JAK-STAT cascade; TAS:UniProtKB
Q13287	NMI	N-myc-interactor	GO:2001141; P:regulation of RNA biosynthetic process; TAS:GOC
Q13287	NMI	N-myc-interactor	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9HAN9	NMNAT1	Nicotinamide mononucleotide adenylyltransferase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9HAN9	NMNAT1	Nicotinamide mononucleotide adenylyltransferase 1	GO:0000309; F:nicotinamide-nucleotide adenylyltransferase activity; IDA:UniProtKB
Q9HAN9	NMNAT1	Nicotinamide mononucleotide adenylyltransferase 1	GO:0004515; F:nicotinate-nucleotide adenylyltransferase activity; IDA:UniProtKB
Q9HAN9	NMNAT1	Nicotinamide mononucleotide adenylyltransferase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HAN9	NMNAT1	Nicotinamide mononucleotide adenylyltransferase 1	GO:0009435; P:NAD biosynthetic process; IC:UniProtKB
Q9HAN9	NMNAT1	Nicotinamide mononucleotide adenylyltransferase 1	GO:0019674; P:NAD metabolic process; TAS:Reactome
Q9HAN9	NMNAT1	Nicotinamide mononucleotide adenylyltransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9HAN9	NMNAT1	Nicotinamide mononucleotide adenylyltransferase 1	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9HAN9	NMNAT1	Nicotinamide mononucleotide adenylyltransferase 1	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9BZQ4	NMNAT2	Nicotinamide mononucleotide adenylyltransferase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BZQ4	NMNAT2	Nicotinamide mononucleotide adenylyltransferase 2	GO:0000309; F:nicotinamide-nucleotide adenylyltransferase activity; TAS:Reactome
Q9BZQ4	NMNAT2	Nicotinamide mononucleotide adenylyltransferase 2	GO:0004515; F:nicotinate-nucleotide adenylyltransferase activity; IDA:UniProtKB
Q9BZQ4	NMNAT2	Nicotinamide mononucleotide adenylyltransferase 2	GO:0009435; P:NAD biosynthetic process; IC:UniProtKB
Q9BZQ4	NMNAT2	Nicotinamide mononucleotide adenylyltransferase 2	GO:0019674; P:NAD metabolic process; TAS:Reactome
Q9BZQ4	NMNAT2	Nicotinamide mononucleotide adenylyltransferase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BZQ4	NMNAT2	Nicotinamide mononucleotide adenylyltransferase 2	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9BZQ4	NMNAT2	Nicotinamide mononucleotide adenylyltransferase 2	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q96T66	NMNAT3	Nicotinamide mononucleotide adenylyltransferase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96T66	NMNAT3	Nicotinamide mononucleotide adenylyltransferase 3	GO:0000309; F:nicotinamide-nucleotide adenylyltransferase activity; TAS:Reactome
Q96T66	NMNAT3	Nicotinamide mononucleotide adenylyltransferase 3	GO:0004515; F:nicotinate-nucleotide adenylyltransferase activity; IDA:UniProtKB
Q96T66	NMNAT3	Nicotinamide mononucleotide adenylyltransferase 3	GO:0009435; P:NAD biosynthetic process; IC:UniProtKB
Q96T66	NMNAT3	Nicotinamide mononucleotide adenylyltransferase 3	GO:0019674; P:NAD metabolic process; TAS:Reactome
Q96T66	NMNAT3	Nicotinamide mononucleotide adenylyltransferase 3	GO:0009611; P:response to wounding; IEA:Ensembl
Q96T66	NMNAT3	Nicotinamide mononucleotide adenylyltransferase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96T66	NMNAT3	Nicotinamide mononucleotide adenylyltransferase 3	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q96T66	NMNAT3	Nicotinamide mononucleotide adenylyltransferase 3	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q5H8A3	NMS	Neuromedin-S	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
P30419	NMT1	Glycylpeptide N-tetradecanoyltransferase 1	GO:0003824; F:catalytic activity; TAS:ProtInc
P30419	NMT1	Glycylpeptide N-tetradecanoyltransferase 1	GO:0004379; F:glycylpeptide N-tetradecanoyltransferase activity; IEA:UniProtKB-EC
P30419	NMT1	Glycylpeptide N-tetradecanoyltransferase 1	GO:0006915; P:apoptotic process; TAS:Reactome
P30419	NMT1	Glycylpeptide N-tetradecanoyltransferase 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P30419	NMT1	Glycylpeptide N-tetradecanoyltransferase 1	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
P30419	NMT1	Glycylpeptide N-tetradecanoyltransferase 1	GO:0006499; P:N-terminal protein myristoylation; IEA:Ensembl
P30419	NMT1	Glycylpeptide N-tetradecanoyltransferase 1	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P30419	NMT1	Glycylpeptide N-tetradecanoyltransferase 1	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
P30419	NMT1	Glycylpeptide N-tetradecanoyltransferase 1	GO:0009249; P:protein lipoylation; TAS:ProtInc
P30419	NMT1	Glycylpeptide N-tetradecanoyltransferase 1	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
P30419	NMT1	Glycylpeptide N-tetradecanoyltransferase 1	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
P30419	NMT1	Glycylpeptide N-tetradecanoyltransferase 1	GO:0016032; P:viral process; TAS:Reactome
O60551	NMT2	Glycylpeptide N-tetradecanoyltransferase 2	GO:0003824; F:catalytic activity; TAS:ProtInc
O60551	NMT2	Glycylpeptide N-tetradecanoyltransferase 2	GO:0004379; F:glycylpeptide N-tetradecanoyltransferase activity; IEA:UniProtKB-EC
O60551	NMT2	Glycylpeptide N-tetradecanoyltransferase 2	GO:0075733; P:intracellular transport of virus; TAS:Reactome
O60551	NMT2	Glycylpeptide N-tetradecanoyltransferase 2	GO:0006499; P:N-terminal protein myristoylation; IEA:InterPro
O60551	NMT2	Glycylpeptide N-tetradecanoyltransferase 2	GO:0007603; P:phototransduction, visible light; TAS:Reactome
O60551	NMT2	Glycylpeptide N-tetradecanoyltransferase 2	GO:0009249; P:protein lipoylation; TAS:ProtInc
O60551	NMT2	Glycylpeptide N-tetradecanoyltransferase 2	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
O60551	NMT2	Glycylpeptide N-tetradecanoyltransferase 2	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
O60551	NMT2	Glycylpeptide N-tetradecanoyltransferase 2	GO:0016032; P:viral process; TAS:Reactome
O60551	NMT2	Glycylpeptide N-tetradecanoyltransferase 2	GO:0019082; P:viral protein processing; TAS:Reactome
O60551	NMT2	Glycylpeptide N-tetradecanoyltransferase 2	GO:0019068; P:virion assembly; TAS:Reactome
Q9HB89	NMUR1	Neuromedin-U receptor 1	GO:0004930; F:G-protein coupled receptor activity; TAS:UniProtKB
Q9HB89	NMUR1	Neuromedin-U receptor 1	GO:0001607; F:neuromedin U receptor activity; IDA:UniProtKB
Q9HB89	NMUR1	Neuromedin-U receptor 1	GO:0008188; F:neuropeptide receptor activity; TAS:ProtInc
Q9HB89	NMUR1	Neuromedin-U receptor 1	GO:0007202; P:activation of phospholipase C activity; IDA:UniProtKB
Q9HB89	NMUR1	Neuromedin-U receptor 1	GO:0006816; P:calcium ion transport; IDA:UniProtKB
Q9HB89	NMUR1	Neuromedin-U receptor 1	GO:0019722; P:calcium-mediated signaling; IDA:UniProtKB
Q9HB89	NMUR1	Neuromedin-U receptor 1	GO:0006821; P:chloride transport; IDA:UniProtKB
Q9HB89	NMUR1	Neuromedin-U receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q9HB89	NMUR1	Neuromedin-U receptor 1	GO:0048016; P:inositol phosphate-mediated signaling; IDA:UniProtKB
Q9HB89	NMUR1	Neuromedin-U receptor 1	GO:0007218; P:neuropeptide signaling pathway; TAS:UniProtKB
Q9HB89	NMUR1	Neuromedin-U receptor 1	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; IDA:UniProtKB
Q9HB89	NMUR1	Neuromedin-U receptor 1	GO:0006939; P:smooth muscle contraction; IEP:UniProtKB
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0005525; F:GTP binding; IDA:UniProtKB
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0005229; F:intracellular calcium activated chloride channel activity; IDA:UniProtKB
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0042924; F:neuromedin U binding; IDA:UniProtKB
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0001607; F:neuromedin U receptor activity; IDA:UniProtKB
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0043006; P:activation of phospholipase A2 activity by calcium-mediated signaling; IDA:UniProtKB
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0050482; P:arachidonic acid secretion; IDA:UniProtKB
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0006816; P:calcium ion transport; IDA:UniProtKB
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0019722; P:calcium-mediated signaling; NAS:UniProtKB
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0007417; P:central nervous system development; IEP:UniProtKB
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:1902476; P:chloride transmembrane transport; IDA:GOC
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0006821; P:chloride transport; IDA:GOC
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0007631; P:feeding behavior; TAS:ProtInc
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0007625; P:grooming behavior; IEA:Ensembl
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0048016; P:inositol phosphate-mediated signaling; IDA:UniProtKB
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0007218; P:neuropeptide signaling pathway; TAS:ProtInc
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; IDA:UniProtKB
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0002023; P:reduction of food intake in response to dietary excess; IEA:Ensembl
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0006940; P:regulation of smooth muscle contraction; NAS:UniProtKB
Q9GZQ4	NMUR2	Neuromedin-U receptor 2	GO:0048265; P:response to pain; IEA:Ensembl
P48645	NMU	Neuromedin-U	GO:0005102; F:receptor binding; TAS:ProtInc
P48645	NMU	Neuromedin-U	GO:0007586; P:digestion; TAS:ProtInc
P48645	NMU	Neuromedin-U	GO:0042755; P:eating behavior; IEA:Ensembl
P48645	NMU	Neuromedin-U	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P48645	NMU	Neuromedin-U	GO:0001696; P:gastric acid secretion; IEA:Ensembl
P48645	NMU	Neuromedin-U	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
P48645	NMU	Neuromedin-U	GO:0009648; P:photoperiodism; IEA:Ensembl
P48645	NMU	Neuromedin-U	GO:0046887; P:positive regulation of hormone secretion; IEA:Ensembl
P48645	NMU	Neuromedin-U	GO:0045987; P:positive regulation of smooth muscle contraction; IEA:Ensembl
P48645	NMU	Neuromedin-U	GO:0050806; P:positive regulation of synaptic transmission; IEA:Ensembl
P48645	NMU	Neuromedin-U	GO:0006940; P:regulation of smooth muscle contraction; TAS:ProtInc
P48645	NMU	Neuromedin-U	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P48645	NMU	Neuromedin-U	GO:0007165; P:signal transduction; TAS:ProtInc
Q16517	NNAT	Neuronatin	GO:0007420; P:brain development; TAS:ProtInc
Q16517	NNAT	Neuronatin	GO:0030182; P:neuron differentiation; IEA:Ensembl
Q16517	NNAT	Neuronatin	GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl
Q16517	NNAT	Neuronatin	GO:0009249; P:protein lipoylation; TAS:ProtInc
Q16517	NNAT	Neuronatin	GO:0032880; P:regulation of protein localization; IEA:Ensembl
Q16517	NNAT	Neuronatin	GO:0009749; P:response to glucose; IEA:Ensembl
Q16517	NNAT	Neuronatin	GO:0006810; P:transport; TAS:ProtInc
P40261	NNMT	Nicotinamide N-methyltransferase	GO:0008112; F:nicotinamide N-methyltransferase activity; TAS:ProtInc
P40261	NNMT	Nicotinamide N-methyltransferase	GO:0032259; P:methylation; TAS:Reactome
P40261	NNMT	Nicotinamide N-methyltransferase	GO:0031100; P:organ regeneration; IEA:Ensembl
P40261	NNMT	Nicotinamide N-methyltransferase	GO:0042493; P:response to drug; IEA:Ensembl
P40261	NNMT	Nicotinamide N-methyltransferase	GO:0010243; P:response to organonitrogen compound; IEA:Ensembl
P40261	NNMT	Nicotinamide N-methyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P40261	NNMT	Nicotinamide N-methyltransferase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q8IW45	CARKD	ATP-dependent (S)-NAD(P)H-hydrate dehydratase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IW45	CARKD	ATP-dependent (S)-NAD(P)H-hydrate dehydratase	GO:0047453; F:ATP-dependent NAD(P)H-hydrate dehydratase activity; IEA:UniProtKB-HAMAP
Q8IW45	CARKD	ATP-dependent (S)-NAD(P)H-hydrate dehydratase	GO:0046496; P:nicotinamide nucleotide metabolic process; IEA:UniProtKB-HAMAP
Q8NCW5	APOA1BP	NAD(P)H-hydrate epimerase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NCW5	APOA1BP	NAD(P)H-hydrate epimerase	GO:0052856; F:NADHX epimerase activity; IEA:UniProtKB-HAMAP
Q8NCW5	APOA1BP	NAD(P)H-hydrate epimerase	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
Q8NCW5	APOA1BP	NAD(P)H-hydrate epimerase	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NCW5	APOA1BP	NAD(P)H-hydrate epimerase	GO:0051289; P:protein homotetramerization; IEA:Ensembl
Q13423	NNT	NAD(P) transhydrogenase, mitochondrial	GO:0051287; F:NAD binding; TAS:UniProtKB
Q13423	NNT	NAD(P) transhydrogenase, mitochondrial	GO:0008750; F:NAD(P)+ transhydrogenase (AB-specific) activity; IEA:UniProtKB-EC
Q13423	NNT	NAD(P) transhydrogenase, mitochondrial	GO:0003957; F:NAD(P)+ transhydrogenase (B-specific) activity; TAS:UniProtKB
Q13423	NNT	NAD(P) transhydrogenase, mitochondrial	GO:0008746; F:NAD(P)+ transhydrogenase activity; EXP:Reactome
Q13423	NNT	NAD(P) transhydrogenase, mitochondrial	GO:0050661; F:NADP binding; IDA:UniProtKB
Q13423	NNT	NAD(P) transhydrogenase, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q13423	NNT	NAD(P) transhydrogenase, mitochondrial	GO:1902600; P:hydrogen ion transmembrane transport; TAS:GOC
Q13423	NNT	NAD(P) transhydrogenase, mitochondrial	GO:0055114; P:oxidation-reduction process; TAS:UniProtKB
Q13423	NNT	NAD(P) transhydrogenase, mitochondrial	GO:0015992; P:proton transport; TAS:UniProtKB
Q13423	NNT	NAD(P) transhydrogenase, mitochondrial	GO:0072593; P:reactive oxygen species metabolic process; IMP:UniProtKB
Q13423	NNT	NAD(P) transhydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q13423	NNT	NAD(P) transhydrogenase, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; TAS:UniProtKB
Q9NP64	ZCCHC17	Nucleolar protein of 40 kDa	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NP64	ZCCHC17	Nucleolar protein of 40 kDa	GO:0005515; F:protein binding; IPI:IntAct
Q9NP64	ZCCHC17	Nucleolar protein of 40 kDa	GO:0003723; F:RNA binding; IEA:InterPro
Q9NP64	ZCCHC17	Nucleolar protein of 40 kDa	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H6W3	NO66	Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66	GO:0051864; F:histone demethylase activity (H3-K36 specific); ISS:UniProtKB
Q9H6W3	NO66	Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66	GO:0032453; F:histone demethylase activity (H3-K4 specific); ISS:UniProtKB
Q9H6W3	NO66	Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66	GO:0005506; F:iron ion binding; ISS:UniProtKB
Q9H6W3	NO66	Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66	GO:0016706; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; ISS:UniProtKB
Q9H6W3	NO66	Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H6W3	NO66	Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66	GO:0070544; P:histone H3-K36 demethylation; ISS:UniProtKB
Q9H6W3	NO66	Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66	GO:0034720; P:histone H3-K4 demethylation; ISS:UniProtKB
Q9H6W3	NO66	Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66	GO:0045668; P:negative regulation of osteoblast differentiation; ISS:UniProtKB
Q9H6W3	NO66	Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q9H6W3	NO66	Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9ULX3	NOB1	RNA-binding protein NOB1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9ULX3	NOB1	RNA-binding protein NOB1	GO:0007601; P:visual perception; IEA:Ensembl
O60393	NOBOX	Homeobox protein NOBOX	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O60393	NOBOX	Homeobox protein NOBOX	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
O60393	NOBOX	Homeobox protein NOBOX	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O60393	NOBOX	Homeobox protein NOBOX	GO:0048477; P:oogenesis; IEA:UniProtKB-KW
O60393	NOBOX	Homeobox protein NOBOX	GO:0001541; P:ovarian follicle development; IEA:Ensembl
O60393	NOBOX	Homeobox protein NOBOX	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O60393	NOBOX	Homeobox protein NOBOX	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NC60	NOA1	Nitric oxide-associated protein 1	GO:0005525; F:GTP binding; IDA:UniProtKB
Q8NC60	NOA1	Nitric oxide-associated protein 1	GO:0003924; F:GTPase activity; IBA:RefGenome
Q8NC60	NOA1	Nitric oxide-associated protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8NC60	NOA1	Nitric oxide-associated protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NC60	NOA1	Nitric oxide-associated protein 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8NC60	NOA1	Nitric oxide-associated protein 1	GO:0006184; P:GTP catabolic process; IBA:GOC
Q8NC60	NOA1	Nitric oxide-associated protein 1	GO:0032543; P:mitochondrial translation; ISS:UniProtKB
Q8NC60	NOA1	Nitric oxide-associated protein 1	GO:0010941; P:regulation of cell death; IMP:UniProtKB
Q8NC60	NOA1	Nitric oxide-associated protein 1	GO:0043457; P:regulation of cellular respiration; IMP:UniProtKB
Q8NC60	NOA1	Nitric oxide-associated protein 1	GO:0042254; P:ribosome biogenesis; IBA:RefGenome
Q9Y3T9	NOC2L	Nucleolar complex protein 2 homolog	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q9Y3T9	NOC2L	Nucleolar complex protein 2 homolog	GO:0042393; F:histone binding; IDA:UniProtKB
Q9Y3T9	NOC2L	Nucleolar complex protein 2 homolog	GO:0031491; F:nucleosome binding; IDA:UniProtKB
Q9Y3T9	NOC2L	Nucleolar complex protein 2 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y3T9	NOC2L	Nucleolar complex protein 2 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y3T9	NOC2L	Nucleolar complex protein 2 homolog	GO:0070491; F:repressing transcription factor binding; IDA:UniProtKB
Q9Y3T9	NOC2L	Nucleolar complex protein 2 homolog	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q9Y3T9	NOC2L	Nucleolar complex protein 2 homolog	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9Y3T9	NOC2L	Nucleolar complex protein 2 homolog	GO:0034644; P:cellular response to UV; IDA:UniProtKB
Q9Y3T9	NOC2L	Nucleolar complex protein 2 homolog	GO:0031497; P:chromatin assembly; IDA:UniProtKB
Q9Y3T9	NOC2L	Nucleolar complex protein 2 homolog	GO:0002903; P:negative regulation of B cell apoptotic process; IMP:UniProtKB
Q9Y3T9	NOC2L	Nucleolar complex protein 2 homolog	GO:0035067; P:negative regulation of histone acetylation; IDA:UniProtKB
Q9Y3T9	NOC2L	Nucleolar complex protein 2 homolog	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
Q9Y3T9	NOC2L	Nucleolar complex protein 2 homolog	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9Y3T9	NOC2L	Nucleolar complex protein 2 homolog	GO:0032066; P:nucleolus to nucleoplasm transport; IDA:UniProtKB
Q9Y3T9	NOC2L	Nucleolar complex protein 2 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WTT2	NOC3L	Nucleolar complex protein 3 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8WTT2	NOC3L	Nucleolar complex protein 3 homolog	GO:0045444; P:fat cell differentiation; IEA:Ensembl
Q9BVI4	NOC4L	Nucleolar complex protein 4 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BVI4	NOC4L	Nucleolar complex protein 4 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q9BVI4	NOC4L	Nucleolar complex protein 4 homolog	GO:0006364; P:rRNA processing; ISS:UniProtKB
Q9UK39	CCRN4L	Nocturnin	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UK39	CCRN4L	Nocturnin	GO:0004535; F:poly(A)-specific ribonuclease activity; IEA:UniProtKB-EC
Q9UK39	CCRN4L	Nocturnin	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9UK39	CCRN4L	Nocturnin	GO:0033962; P:cytoplasmic mRNA processing body assembly; IEA:Ensembl
Q9UK39	CCRN4L	Nocturnin	GO:0000290; P:deadenylation-dependent decapping of nuclear-transcribed mRNA; IEA:Ensembl
Q9UK39	CCRN4L	Nocturnin	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9UK39	CCRN4L	Nocturnin	GO:0006355; P:regulation of transcription, DNA-templated; TAS:GOC
Q9UK39	CCRN4L	Nocturnin	GO:0048511; P:rhythmic process; IEA:UniProtKB-KW
Q9UK39	CCRN4L	Nocturnin	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0050700; F:CARD domain binding; IDA:MGI
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; TAS:ProtInc
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0042834; F:peptidoglycan binding; TAS:HGNC
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:MGI
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0000187; P:activation of MAPK activity; TAS:Reactome
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0006915; P:apoptotic process; TAS:ProtInc
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0006952; P:defense response; TAS:HGNC
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0042742; P:defense response to bacterium; IDA:HGNC
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0050830; P:defense response to Gram-positive bacterium; IEA:Ensembl
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0016045; P:detection of bacterium; IDA:HGNC
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0009595; P:detection of biotic stimulus; TAS:HGNC
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0006954; P:inflammatory response; TAS:HGNC
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0045087; P:innate immune response; TAS:Reactome
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0042228; P:interleukin-8 biosynthetic process; IDA:HGNC
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0035556; P:intracellular signal transduction; IDA:HGNC
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0007254; P:JNK cascade; TAS:Reactome
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:MGI
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0002606; P:positive regulation of dendritic cell antigen processing and presentation; ISS:BHF-UCL
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:MGI
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0046330; P:positive regulation of JNK cascade; IEA:Ensembl
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0032760; P:positive regulation of tumor necrosis factor production; IEA:Ensembl
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0051259; P:protein oligomerization; TAS:HGNC
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0007165; P:signal transduction; TAS:HGNC
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q9Y239	NOD1	Nucleotide-binding oligomerization domain-containing protein 1	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0050700; F:CARD domain binding; IPI:UniProtKB
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0032500; F:muramyl dipeptide binding; IDA:HGNC
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0042834; F:peptidoglycan binding; IDA:HGNC
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0000187; P:activation of MAPK activity; TAS:Reactome
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0035419; P:activation of MAPK activity involved in innate immune response; ISS:BHF-UCL
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0071225; P:cellular response to muramyl dipeptide; IDA:UniProtKB
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0071224; P:cellular response to peptidoglycan; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0002367; P:cytokine production involved in immune response; IMP:UniProtKB
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0006952; P:defense response; TAS:HGNC
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0042742; P:defense response to bacterium; IDA:HGNC
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0050830; P:defense response to Gram-positive bacterium; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0016045; P:detection of bacterium; IDA:HGNC
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0009595; P:detection of biotic stimulus; TAS:HGNC
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0032498; P:detection of muramyl dipeptide; IDA:HGNC
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0002381; P:immunoglobulin production involved in immunoglobulin mediated immune response; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0045087; P:innate immune response; IDA:UniProtKB
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0002227; P:innate immune response in mucosa; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0035556; P:intracellular signal transduction; IDA:HGNC
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0007254; P:JNK cascade; TAS:Reactome
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0071608; P:macrophage inflammatory protein-1 alpha production; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0030277; P:maintenance of gastrointestinal epithelium; IMP:UniProt
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0002282; P:microglial cell activation involved in immune response; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0044130; P:negative regulation of growth of symbiont in host; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0002862; P:negative regulation of inflammatory response to antigenic stimulus; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0032689; P:negative regulation of interferon-gamma production; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0032695; P:negative regulation of interleukin-12 production; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0032701; P:negative regulation of interleukin-18 production; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0032703; P:negative regulation of interleukin-2 production; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:2000110; P:negative regulation of macrophage apoptotic process; ISS:BHF-UCL
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0002710; P:negative regulation of T cell mediated immunity; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0034136; P:negative regulation of toll-like receptor 2 signaling pathway; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0032720; P:negative regulation of tumor necrosis factor production; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0070431; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; IDA:UniProtKB
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0052033; P:pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0050871; P:positive regulation of B cell activation; IDA:BHF-UCL
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0006965; P:positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0002606; P:positive regulation of dendritic cell antigen processing and presentation; ISS:BHF-UCL
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0002732; P:positive regulation of dendritic cell cytokine production; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0050679; P:positive regulation of epithelial cell proliferation; ISS:BHF-UCL
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:BHF-UCL
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0046645; P:positive regulation of gamma-delta T cell activation; ISS:BHF-UCL
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0002925; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0032731; P:positive regulation of interleukin-1 beta production; IMP:BHF-UCL
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0050718; P:positive regulation of interleukin-1 beta secretion; IDA:HGNC
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0032733; P:positive regulation of interleukin-10 production; ISS:BHF-UCL
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0032735; P:positive regulation of interleukin-12 production; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0032740; P:positive regulation of interleukin-17 production; IMP:UniProtKB
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0032755; P:positive regulation of interleukin-6 production; IDA:BHF-UCL
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0046330; P:positive regulation of JNK cascade; IDA:MGI
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; ISS:BHF-UCL
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0045747; P:positive regulation of Notch signaling pathway; ISS:BHF-UCL
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0051353; P:positive regulation of oxidoreductase activity; ISS:BHF-UCL
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0050766; P:positive regulation of phagocytosis; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; ISS:BHF-UCL
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:2000363; P:positive regulation of prostaglandin-E synthase activity; ISS:BHF-UCL
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0060585; P:positive regulation of prostaglandin-endoperoxide synthase activity; ISS:BHF-UCL
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0032874; P:positive regulation of stress-activated MAPK cascade; IDA:MGI
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0032760; P:positive regulation of tumor necrosis factor production; IMP:BHF-UCL
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0002830; P:positive regulation of type 2 immune response; IMP:BHF-UCL
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0051259; P:protein oligomerization; TAS:HGNC
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0050727; P:regulation of inflammatory response; IC:BHF-UCL
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0090022; P:regulation of neutrophil chemotaxis; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0043330; P:response to exogenous dsRNA; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0032495; P:response to muramyl dipeptide; IDA:BHF-UCL
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0007584; P:response to nutrient; IEA:Ensembl
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q9HC29	NOD2	Nucleotide-binding oligomerization domain-containing protein 2	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q96S42	NODAL	Nodal homolog	GO:0016015; F:morphogen activity; NAS:BHF-UCL
Q96S42	NODAL	Nodal homolog	GO:0070698; F:type I activin receptor binding; IMP:BHF-UCL
Q96S42	NODAL	Nodal homolog	GO:0048327; P:axial mesodermal cell fate specification; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0007420; P:brain development; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0042074; P:cell migration involved in gastrulation; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0048546; P:digestive tract morphogenesis; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0009880; P:embryonic pattern specification; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0001892; P:embryonic placenta development; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0060136; P:embryonic process involved in female pregnancy; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0035987; P:endodermal cell differentiation; IMP:BHF-UCL
Q96S42	NODAL	Nodal homolog	GO:0060802; P:epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0033505; P:floor plate morphogenesis; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0048859; P:formation of anatomical boundary; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0040007; P:growth; IEA:InterPro
Q96S42	NODAL	Nodal homolog	GO:0001947; P:heart looping; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0002085; P:inhibition of neuroepithelial cell differentiation; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0060460; P:left lung morphogenesis; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0001889; P:liver development; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0001893; P:maternal placenta development; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0060137; P:maternal process involved in parturition; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0048382; P:mesendoderm development; IMP:BHF-UCL
Q96S42	NODAL	Nodal homolog	GO:0060766; P:negative regulation of androgen receptor signaling pathway; IDA:BHF-UCL
Q96S42	NODAL	Nodal homolog	GO:1901383; P:negative regulation of chorionic trophoblast cell proliferation; IDA:BHF-UCL
Q96S42	NODAL	Nodal homolog	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:1901164; P:negative regulation of trophoblast cell migration; IDA:BHF-UCL
Q96S42	NODAL	Nodal homolog	GO:0001842; P:neural fold formation; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:1900164; P:nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0001890; P:placenta development; IMP:BHF-UCL
Q96S42	NODAL	Nodal homolog	GO:0010085; P:polarity specification of proximal/distal axis; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0032927; P:positive regulation of activin receptor signaling pathway; IGI:BHF-UCL
Q96S42	NODAL	Nodal homolog	GO:0045766; P:positive regulation of angiogenesis; IMP:BHF-UCL
Q96S42	NODAL	Nodal homolog	GO:0022409; P:positive regulation of cell-cell adhesion; IMP:BHF-UCL
Q96S42	NODAL	Nodal homolog	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:BHF-UCL
Q96S42	NODAL	Nodal homolog	GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:BHF-UCL
Q96S42	NODAL	Nodal homolog	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:BHF-UCL
Q96S42	NODAL	Nodal homolog	GO:1900224; P:positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry; ISS:BHF-UCL
Q96S42	NODAL	Nodal homolog	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IMP:BHF-UCL
Q96S42	NODAL	Nodal homolog	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL
Q96S42	NODAL	Nodal homolog	GO:0060391; P:positive regulation of SMAD protein import into nucleus; IMP:BHF-UCL
Q96S42	NODAL	Nodal homolog	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0010575; P:positive regulation vascular endothelial growth factor production; IMP:BHF-UCL
Q96S42	NODAL	Nodal homolog	GO:0010470; P:regulation of gastrulation; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:2000036; P:regulation of stem cell maintenance; TAS:BHF-UCL
Q96S42	NODAL	Nodal homolog	GO:0060395; P:SMAD protein signal transduction; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0019827; P:stem cell maintenance; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0090010; P:transforming growth factor beta receptor signaling pathway involved in primitive streak formation; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0001831; P:trophectodermal cellular morphogenesis; IEA:Ensembl
Q96S42	NODAL	Nodal homolog	GO:0001944; P:vasculature development; IEA:Ensembl
Q99784	OLFM1	Noelin	GO:0005515; F:protein binding; IPI:IntAct
Q99784	OLFM1	Noelin	GO:0007399; P:nervous system development; TAS:ProtInc
Q99784	OLFM1	Noelin	GO:0051259; P:protein oligomerization; IEA:Ensembl
O95897	OLFM2	Noelin-2	GO:0009306; P:protein secretion; IDA:MGI
Q96PB7	OLFM3	Noelin-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q96PB7	OLFM3	Noelin-3	GO:0042462; P:eye photoreceptor cell development; IEA:Ensembl
Q9BZE4	GTPBP4	Nucleolar GTP-binding protein 1	GO:0005525; F:GTP binding; IDA:HGNC
Q9BZE4	GTPBP4	Nucleolar GTP-binding protein 1	GO:0003924; F:GTPase activity; IDA:HGNC
Q9BZE4	GTPBP4	Nucleolar GTP-binding protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BZE4	GTPBP4	Nucleolar GTP-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9BZE4	GTPBP4	Nucleolar GTP-binding protein 1	GO:0006184; P:GTP catabolic process; IDA:GOC
Q9BZE4	GTPBP4	Nucleolar GTP-binding protein 1	GO:0030336; P:negative regulation of cell migration; IDA:HGNC
Q9BZE4	GTPBP4	Nucleolar GTP-binding protein 1	GO:0008285; P:negative regulation of cell proliferation; IMP:HGNC
Q9BZE4	GTPBP4	Nucleolar GTP-binding protein 1	GO:0022408; P:negative regulation of cell-cell adhesion; IDA:HGNC
Q9BZE4	GTPBP4	Nucleolar GTP-binding protein 1	GO:0033342; P:negative regulation of collagen binding; IMP:HGNC
Q9BZE4	GTPBP4	Nucleolar GTP-binding protein 1	GO:0008156; P:negative regulation of DNA replication; IMP:HGNC
Q9BZE4	GTPBP4	Nucleolar GTP-binding protein 1	GO:0031397; P:negative regulation of protein ubiquitination; IDA:HGNC
Q9BZE4	GTPBP4	Nucleolar GTP-binding protein 1	GO:0050821; P:protein stabilization; IDA:HGNC
Q9BZE4	GTPBP4	Nucleolar GTP-binding protein 1	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:HGNC
Q9BZE4	GTPBP4	Nucleolar GTP-binding protein 1	GO:0042254; P:ribosome biogenesis; IEA:UniProtKB-KW
Q13823	GNL2	Nucleolar GTP-binding protein 2	GO:0005525; F:GTP binding; NAS:UniProtKB
Q13823	GNL2	Nucleolar GTP-binding protein 2	GO:0003924; F:GTPase activity; NAS:UniProtKB
Q13823	GNL2	Nucleolar GTP-binding protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13823	GNL2	Nucleolar GTP-binding protein 2	GO:0006184; P:GTP catabolic process; IBA:GOC
Q13823	GNL2	Nucleolar GTP-binding protein 2	GO:0042254; P:ribosome biogenesis; IBA:RefGenome
Q13253	NOG	Noggin	GO:0019955; F:cytokine binding; IPI:BHF-UCL
Q13253	NOG	Noggin	GO:0005515; F:protein binding; IPI:IntAct
Q13253	NOG	Noggin	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
Q13253	NOG	Noggin	GO:0048318; P:axial mesoderm development; IEA:Ensembl
Q13253	NOG	Noggin	GO:0030509; P:BMP signaling pathway; TAS:Reactome
Q13253	NOG	Noggin	GO:0051216; P:cartilage development; IEA:UniProtKB-KW
Q13253	NOG	Noggin	GO:0021533; P:cell differentiation in hindbrain; IMP:BHF-UCL
Q13253	NOG	Noggin	GO:0071773; P:cellular response to BMP stimulus; IEA:Ensembl
Q13253	NOG	Noggin	GO:0009953; P:dorsal/ventral pattern formation; IDA:BHF-UCL
Q13253	NOG	Noggin	GO:0042733; P:embryonic digit morphogenesis; IMP:BHF-UCL
Q13253	NOG	Noggin	GO:0060272; P:embryonic skeletal joint morphogenesis; IMP:BHF-UCL
Q13253	NOG	Noggin	GO:0048706; P:embryonic skeletal system development; IMP:BHF-UCL
Q13253	NOG	Noggin	GO:0001706; P:endoderm formation; IEA:Ensembl
Q13253	NOG	Noggin	GO:0001837; P:epithelial to mesenchymal transition; ISS:UniProtKB
Q13253	NOG	Noggin	GO:0060325; P:face morphogenesis; IEA:Ensembl
Q13253	NOG	Noggin	GO:0060825; P:fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation; IMP:BHF-UCL
Q13253	NOG	Noggin	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q13253	NOG	Noggin	GO:0060173; P:limb development; IMP:BHF-UCL
Q13253	NOG	Noggin	GO:0060425; P:lung morphogenesis; IEA:Ensembl
Q13253	NOG	Noggin	GO:0001707; P:mesoderm formation; IEA:Ensembl
Q13253	NOG	Noggin	GO:0042474; P:middle ear morphogenesis; IMP:BHF-UCL
Q13253	NOG	Noggin	GO:0008045; P:motor neuron axon guidance; IEA:Ensembl
Q13253	NOG	Noggin	GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl
Q13253	NOG	Noggin	GO:0048712; P:negative regulation of astrocyte differentiation; ISS:UniProtKB
Q13253	NOG	Noggin	GO:0030514; P:negative regulation of BMP signaling pathway; ISS:UniProtKB
Q13253	NOG	Noggin	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:BHF-UCL
Q13253	NOG	Noggin	GO:0060044; P:negative regulation of cardiac muscle cell proliferation; ISS:UniProtKB
Q13253	NOG	Noggin	GO:0061037; P:negative regulation of cartilage development; IEA:Ensembl
Q13253	NOG	Noggin	GO:0030336; P:negative regulation of cell migration; IDA:BHF-UCL
Q13253	NOG	Noggin	GO:0060302; P:negative regulation of cytokine activity; IPI:BHF-UCL
Q13253	NOG	Noggin	GO:0045668; P:negative regulation of osteoblast differentiation; IDA:BHF-UCL
Q13253	NOG	Noggin	GO:0060394; P:negative regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
Q13253	NOG	Noggin	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q13253	NOG	Noggin	GO:0007399; P:nervous system development; TAS:ProtInc
Q13253	NOG	Noggin	GO:0001839; P:neural plate morphogenesis; IEA:Ensembl
Q13253	NOG	Noggin	GO:0001843; P:neural tube closure; IEA:Ensembl
Q13253	NOG	Noggin	GO:0048570; P:notochord morphogenesis; IEA:Ensembl
Q13253	NOG	Noggin	GO:0001649; P:osteoblast differentiation; ISS:UniProtKB
Q13253	NOG	Noggin	GO:0021983; P:pituitary gland development; IEA:Ensembl
Q13253	NOG	Noggin	GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; ISS:UniProtKB
Q13253	NOG	Noggin	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
Q13253	NOG	Noggin	GO:0090193; P:positive regulation of glomerulus development; ISS:UniProtKB
Q13253	NOG	Noggin	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q13253	NOG	Noggin	GO:0060513; P:prostatic bud formation; IEA:Ensembl
Q13253	NOG	Noggin	GO:2000313; P:regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation; IMP:BHF-UCL
Q13253	NOG	Noggin	GO:0001501; P:skeletal system development; TAS:ProtInc
Q13253	NOG	Noggin	GO:0035019; P:somatic stem cell maintenance; IMP:BHF-UCL
Q13253	NOG	Noggin	GO:0061053; P:somite development; IEA:Ensembl
Q13253	NOG	Noggin	GO:0021510; P:spinal cord development; IEA:Ensembl
Q13253	NOG	Noggin	GO:0060676; P:ureteric bud formation; IEA:Ensembl
Q13253	NOG	Noggin	GO:0042060; P:wound healing; ISS:UniProtKB
Q9BSC4	NOL10	Nucleolar protein 10	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H8H0	NOL11	Nucleolar protein 11	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H8H0	NOL11	Nucleolar protein 11	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H8H0	NOL11	Nucleolar protein 11	GO:0030490; P:maturation of SSU-rRNA; IMP:UniProtKB
Q9H8H0	NOL11	Nucleolar protein 11	GO:1901838; P:positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter; IMP:UniProtKB
Q9H8H0	NOL11	Nucleolar protein 11	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UGY1	NOL12	Nucleolar protein 12	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UGY1	NOL12	Nucleolar protein 12	GO:0019843; F:rRNA binding; IEA:UniProtKB-KW
O60936	NOL3	Nucleolar protein 3	GO:0042802; F:identical protein binding; IPI:IntAct
O60936	NOL3	Nucleolar protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
O60936	NOL3	Nucleolar protein 3	GO:0003723; F:RNA binding; TAS:ProtInc
O60936	NOL3	Nucleolar protein 3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O60936	NOL3	Nucleolar protein 3	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
O60936	NOL3	Nucleolar protein 3	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
O60936	NOL3	Nucleolar protein 3	GO:0042981; P:regulation of apoptotic process; IEA:InterPro
O60936	NOL3	Nucleolar protein 3	GO:0008380; P:RNA splicing; TAS:ProtInc
O94818	NOL4	Nucleolar protein 4	GO:0003723; F:RNA binding; TAS:ProtInc
Q9UMY1	NOL7	Nucleolar protein 7	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q76FK4	NOL8	Nucleolar protein 8	GO:0000166; F:nucleotide binding; IEA:InterPro
Q76FK4	NOL8	Nucleolar protein 8	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q76FK4	NOL8	Nucleolar protein 8	GO:0005515; F:protein binding; IPI:UniProtKB
Q76FK4	NOL8	Nucleolar protein 8	GO:0006260; P:DNA replication; IMP:HGNC
Q76FK4	NOL8	Nucleolar protein 8	GO:0030307; P:positive regulation of cell growth; IMP:HGNC
Q76FK4	NOL8	Nucleolar protein 8	GO:0006364; P:rRNA processing; IMP:UniProtKB
Q9H6R4	NOL6	Nucleolar protein 6	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H6R4	NOL6	Nucleolar protein 6	GO:0003723; F:RNA binding; ISS:UniProtKB
Q9H6R4	NOL6	Nucleolar protein 6	GO:0006364; P:rRNA processing; ISS:UniProtKB
Q5SY16	NOL9	Polynucleotide 5'-hydroxyl-kinase NOL9	GO:0005524; F:ATP binding; TAS:UniProtKB
Q5SY16	NOL9	Polynucleotide 5'-hydroxyl-kinase NOL9	GO:0051731; F:polynucleotide 5'-hydroxyl-kinase activity; IDA:UniProtKB
Q5SY16	NOL9	Polynucleotide 5'-hydroxyl-kinase NOL9	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q5SY16	NOL9	Polynucleotide 5'-hydroxyl-kinase NOL9	GO:0000460; P:maturation of 5.8S rRNA; IMP:UniProtKB
Q14978	NOLC1	Nucleolar and coiled-body phosphoprotein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q14978	NOLC1	Nucleolar and coiled-body phosphoprotein 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q14978	NOLC1	Nucleolar and coiled-body phosphoprotein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14978	NOLC1	Nucleolar and coiled-body phosphoprotein 1	GO:0005515; F:protein binding; IPI:IntAct
Q14978	NOLC1	Nucleolar and coiled-body phosphoprotein 1	GO:0007049; P:cell cycle; TAS:ProtInc
Q14978	NOLC1	Nucleolar and coiled-body phosphoprotein 1	GO:0007067; P:mitosis; TAS:ProtInc
Q14978	NOLC1	Nucleolar and coiled-body phosphoprotein 1	GO:0007000; P:nucleolus organization; IEA:Ensembl
Q14978	NOLC1	Nucleolar and coiled-body phosphoprotein 1	GO:0006364; P:rRNA processing; TAS:ProtInc
Q5C9Z4	NOM1	Nucleolar MIF4G domain-containing protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q5C9Z4	NOM1	Nucleolar MIF4G domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15155	NOMO1	Nodal modulator 1	GO:0030246; F:carbohydrate binding; IEA:InterPro
P69849	NOMO3	Nodal modulator 3	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q5JPE7	NOMO2	Nodal modulator 2	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q5JPE7	NOMO2	Nodal modulator 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q15233	NONO	Non-POU domain-containing octamer-binding protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q15233	NONO	Non-POU domain-containing octamer-binding protein	GO:0042802; F:identical protein binding; IPI:IntAct
Q15233	NONO	Non-POU domain-containing octamer-binding protein	GO:0000166; F:nucleotide binding; IEA:InterPro
Q15233	NONO	Non-POU domain-containing octamer-binding protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15233	NONO	Non-POU domain-containing octamer-binding protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q15233	NONO	Non-POU domain-containing octamer-binding protein	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q15233	NONO	Non-POU domain-containing octamer-binding protein	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q15233	NONO	Non-POU domain-containing octamer-binding protein	GO:0006397; P:mRNA processing; TAS:ProtInc
Q15233	NONO	Non-POU domain-containing octamer-binding protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q15233	NONO	Non-POU domain-containing octamer-binding protein	GO:0008380; P:RNA splicing; TAS:ProtInc
Q15233	NONO	Non-POU domain-containing octamer-binding protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NPE3	NOP10	H/ACA ribonucleoprotein complex subunit 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NPE3	NOP10	H/ACA ribonucleoprotein complex subunit 3	GO:0030515; F:snoRNA binding; IEA:InterPro
Q9NPE3	NOP10	H/ACA ribonucleoprotein complex subunit 3	GO:0001522; P:pseudouridine synthesis; NAS:UniProtKB
Q9NPE3	NOP10	H/ACA ribonucleoprotein complex subunit 3	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
P78316	NOP14	Nucleolar protein 14	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P78316	NOP14	Nucleolar protein 14	GO:0030515; F:snoRNA binding; ISS:UniProtKB
P78316	NOP14	Nucleolar protein 14	GO:0000480; P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); ISS:UniProtKB
P78316	NOP14	Nucleolar protein 14	GO:0000447; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); ISS:UniProtKB
P78316	NOP14	Nucleolar protein 14	GO:0000472; P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); ISS:UniProtKB
P78316	NOP14	Nucleolar protein 14	GO:0000462; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); ISS:UniProtKB
P78316	NOP14	Nucleolar protein 14	GO:0042274; P:ribosomal small subunit biogenesis; ISS:UniProtKB
P78316	NOP14	Nucleolar protein 14	GO:0006364; P:rRNA processing; ISS:UniProtKB
Q9Y3C1	NOP16	Nucleolar protein 16	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P46087	NOP2	Putative ribosomal RNA methyltransferase NOP2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P46087	NOP2	Putative ribosomal RNA methyltransferase NOP2	GO:0005515; F:protein binding; IPI:UniProtKB
P46087	NOP2	Putative ribosomal RNA methyltransferase NOP2	GO:0008757; F:S-adenosylmethionine-dependent methyltransferase activity; IEA:InterPro
P46087	NOP2	Putative ribosomal RNA methyltransferase NOP2	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P46087	NOP2	Putative ribosomal RNA methyltransferase NOP2	GO:0006364; P:rRNA processing; IEA:InterPro
O00567	NOP56	Nucleolar protein 56	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O00567	NOP56	Nucleolar protein 56	GO:0005515; F:protein binding; IPI:BHF-UCL
O00567	NOP56	Nucleolar protein 56	GO:0003723; F:RNA binding; TAS:ProtInc
O00567	NOP56	Nucleolar protein 56	GO:0030515; F:snoRNA binding; IDA:BHF-UCL
O00567	NOP56	Nucleolar protein 56	GO:0008219; P:cell death; IEA:UniProtKB-KW
O00567	NOP56	Nucleolar protein 56	GO:0006364; P:rRNA processing; TAS:ProtInc
Q9Y2X3	NOP58	Nucleolar protein 58	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y2X3	NOP58	Nucleolar protein 58	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2X3	NOP58	Nucleolar protein 58	GO:0030515; F:snoRNA binding; IDA:BHF-UCL
Q9Y2X3	NOP58	Nucleolar protein 58	GO:0016049; P:cell growth; TAS:UniProtKB
Q9Y2X3	NOP58	Nucleolar protein 58	GO:0006364; P:rRNA processing; TAS:UniProtKB
Q9Y2X3	NOP58	Nucleolar protein 58	GO:0006608; P:snRNP protein import into nucleus; ISS:UniProtKB
Q86U38	NOP9	Nucleolar protein 9	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P29475	NOS1	Nitric oxide synthase, brain	GO:0034618; F:arginine binding; TAS:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0046870; F:cadmium ion binding; ISS:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0050660; F:flavin adenine dinucleotide binding; ISS:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0010181; F:FMN binding; ISS:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0020037; F:heme binding; ISS:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0044325; F:ion channel binding; ISS:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0005506; F:iron ion binding; IEA:InterPro
P29475	NOS1	Nitric oxide synthase, brain	GO:0050661; F:NADP binding; ISS:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0003958; F:NADPH-hemoprotein reductase activity; IBA:RefGenome
P29475	NOS1	Nitric oxide synthase, brain	GO:0004517; F:nitric-oxide synthase activity; ISS:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0016491; F:oxidoreductase activity; IBA:RefGenome
P29475	NOS1	Nitric oxide synthase, brain	GO:0005515; F:protein binding; IPI:UniProtKB
P29475	NOS1	Nitric oxide synthase, brain	GO:0097110; F:scaffold protein binding; ISS:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0017080; F:sodium channel regulator activity; ISS:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0034617; F:tetrahydrobiopterin binding; NAS:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0006527; P:arginine catabolic process; IC:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0007596; P:blood coagulation; TAS:Reactome
P29475	NOS1	Nitric oxide synthase, brain	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P29475	NOS1	Nitric oxide synthase, brain	GO:0042738; P:exogenous drug catabolic process; IEA:Ensembl
P29475	NOS1	Nitric oxide synthase, brain	GO:0051701; P:interaction with host; TAS:Reactome
P29475	NOS1	Nitric oxide synthase, brain	GO:0033555; P:multicellular organismal response to stress; IMP:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0007520; P:myoblast fusion; TAS:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0045776; P:negative regulation of blood pressure; IBA:RefGenome
P29475	NOS1	Nitric oxide synthase, brain	GO:0010523; P:negative regulation of calcium ion transport into cytosol; TAS:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0051346; P:negative regulation of hydrolase activity; IEA:Ensembl
P29475	NOS1	Nitric oxide synthase, brain	GO:0043267; P:negative regulation of potassium ion transport; IEA:Ensembl
P29475	NOS1	Nitric oxide synthase, brain	GO:0051612; P:negative regulation of serotonin uptake; IEA:Ensembl
P29475	NOS1	Nitric oxide synthase, brain	GO:0042136; P:neurotransmitter biosynthetic process; TAS:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0006809; P:nitric oxide biosynthetic process; ISS:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0007263; P:nitric oxide mediated signal transduction; IBA:RefGenome
P29475	NOS1	Nitric oxide synthase, brain	GO:0018119; P:peptidyl-cysteine S-nitrosylation; ISS:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0090382; P:phagosome maturation; TAS:Reactome
P29475	NOS1	Nitric oxide synthase, brain	GO:0031284; P:positive regulation of guanylate cyclase activity; IBA:RefGenome
P29475	NOS1	Nitric oxide synthase, brain	GO:0035066; P:positive regulation of histone acetylation; IEA:Ensembl
P29475	NOS1	Nitric oxide synthase, brain	GO:1902307; P:positive regulation of sodium ion transmembrane transport; ISS:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P29475	NOS1	Nitric oxide synthase, brain	GO:0045909; P:positive regulation of vasodilation; IDA:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0055117; P:regulation of cardiac muscle contraction; TAS:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0009408; P:response to heat; IDA:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0001666; P:response to hypoxia; IEP:BHF-UCL
P29475	NOS1	Nitric oxide synthase, brain	GO:0006941; P:striated muscle contraction; IEA:Ensembl
P35228	NOS2	Nitric oxide synthase, inducible	GO:0034618; F:arginine binding; ISS:BHF-UCL
P35228	NOS2	Nitric oxide synthase, inducible	GO:0050660; F:flavin adenine dinucleotide binding; ISS:BHF-UCL
P35228	NOS2	Nitric oxide synthase, inducible	GO:0010181; F:FMN binding; ISS:BHF-UCL
P35228	NOS2	Nitric oxide synthase, inducible	GO:0020037; F:heme binding; ISS:BHF-UCL
P35228	NOS2	Nitric oxide synthase, inducible	GO:0005506; F:iron ion binding; IEA:InterPro
P35228	NOS2	Nitric oxide synthase, inducible	GO:0050661; F:NADP binding; TAS:BHF-UCL
P35228	NOS2	Nitric oxide synthase, inducible	GO:0003958; F:NADPH-hemoprotein reductase activity; IBA:RefGenome
P35228	NOS2	Nitric oxide synthase, inducible	GO:0004517; F:nitric-oxide synthase activity; IDA:UniProtKB
P35228	NOS2	Nitric oxide synthase, inducible	GO:0005515; F:protein binding; IPI:UniProtKB
P35228	NOS2	Nitric oxide synthase, inducible	GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
P35228	NOS2	Nitric oxide synthase, inducible	GO:0005102; F:receptor binding; IPI:UniProtKB
P35228	NOS2	Nitric oxide synthase, inducible	GO:0034617; F:tetrahydrobiopterin binding; ISS:BHF-UCL
P35228	NOS2	Nitric oxide synthase, inducible	GO:0006527; P:arginine catabolic process; IDA:BHF-UCL
P35228	NOS2	Nitric oxide synthase, inducible	GO:0007596; P:blood coagulation; TAS:Reactome
P35228	NOS2	Nitric oxide synthase, inducible	GO:0071346; P:cellular response to interferon-gamma; IEA:Ensembl
P35228	NOS2	Nitric oxide synthase, inducible	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
P35228	NOS2	Nitric oxide synthase, inducible	GO:0042742; P:defense response to bacterium; ISS:UniProtKB
P35228	NOS2	Nitric oxide synthase, inducible	GO:0050829; P:defense response to Gram-negative bacterium; NAS:BHF-UCL
P35228	NOS2	Nitric oxide synthase, inducible	GO:0006954; P:inflammatory response; IBA:RefGenome
P35228	NOS2	Nitric oxide synthase, inducible	GO:0002227; P:innate immune response in mucosa; NAS:BHF-UCL
P35228	NOS2	Nitric oxide synthase, inducible	GO:0051701; P:interaction with host; TAS:Reactome
P35228	NOS2	Nitric oxide synthase, inducible	GO:0045776; P:negative regulation of blood pressure; IBA:RefGenome
P35228	NOS2	Nitric oxide synthase, inducible	GO:0010629; P:negative regulation of gene expression; IGI:UniProtKB
P35228	NOS2	Nitric oxide synthase, inducible	GO:0042177; P:negative regulation of protein catabolic process; IEA:Ensembl
P35228	NOS2	Nitric oxide synthase, inducible	GO:0006809; P:nitric oxide biosynthetic process; IDA:UniProtKB
P35228	NOS2	Nitric oxide synthase, inducible	GO:0007263; P:nitric oxide mediated signal transduction; IBA:RefGenome
P35228	NOS2	Nitric oxide synthase, inducible	GO:0018119; P:peptidyl-cysteine S-nitrosylation; ISS:UniProtKB
P35228	NOS2	Nitric oxide synthase, inducible	GO:0090382; P:phagosome maturation; TAS:Reactome
P35228	NOS2	Nitric oxide synthase, inducible	GO:0031284; P:positive regulation of guanylate cyclase activity; IBA:RefGenome
P35228	NOS2	Nitric oxide synthase, inducible	GO:0051712; P:positive regulation of killing of cells of other organism; IMP:BHF-UCL
P35228	NOS2	Nitric oxide synthase, inducible	GO:0001912; P:positive regulation of leukocyte mediated cytotoxicity; TAS:BHF-UCL
P35228	NOS2	Nitric oxide synthase, inducible	GO:0045909; P:positive regulation of vasodilation; IBA:RefGenome
P35228	NOS2	Nitric oxide synthase, inducible	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P35228	NOS2	Nitric oxide synthase, inducible	GO:0043457; P:regulation of cellular respiration; TAS:BHF-UCL
P35228	NOS2	Nitric oxide synthase, inducible	GO:0050796; P:regulation of insulin secretion; IMP:BHF-UCL
P35228	NOS2	Nitric oxide synthase, inducible	GO:0009617; P:response to bacterium; NAS:UniProtKB
P35228	NOS2	Nitric oxide synthase, inducible	GO:0001666; P:response to hypoxia; IEA:Ensembl
P35228	NOS2	Nitric oxide synthase, inducible	GO:0006801; P:superoxide metabolic process; ISS:UniProtKB
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0003785; F:actin monomer binding; IPI:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0034618; F:arginine binding; IDA:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0046870; F:cadmium ion binding; NAS:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0050660; F:flavin adenine dinucleotide binding; NAS:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0010181; F:FMN binding; NAS:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0020037; F:heme binding; IDA:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0005506; F:iron ion binding; IEA:InterPro
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0050661; F:NADP binding; NAS:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0003958; F:NADPH-hemoprotein reductase activity; IBA:RefGenome
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0004517; F:nitric-oxide synthase activity; IDA:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0005515; F:protein binding; IPI:UniProtKB
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0034617; F:tetrahydrobiopterin binding; IDA:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0001525; P:angiogenesis; IEA:Ensembl
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0006527; P:arginine catabolic process; IDA:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0007596; P:blood coagulation; TAS:Reactome
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0001974; P:blood vessel remodeling; ISS:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0043542; P:endothelial cell migration; IMP:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0051701; P:interaction with host; TAS:Reactome
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IEA:Ensembl
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0030324; P:lung development; IEA:Ensembl
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0007005; P:mitochondrion organization; ISS:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0045776; P:negative regulation of blood pressure; IBA:RefGenome
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0051926; P:negative regulation of calcium ion transport; IEA:Ensembl
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0008285; P:negative regulation of cell proliferation; ISS:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; ISS:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0051346; P:negative regulation of hydrolase activity; IEA:Ensembl
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0014740; P:negative regulation of muscle hyperplasia; ISS:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0010544; P:negative regulation of platelet activation; NAS:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0043267; P:negative regulation of potassium ion transport; IEA:Ensembl
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0006809; P:nitric oxide biosynthetic process; IDA:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0007263; P:nitric oxide mediated signal transduction; IBA:RefGenome
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0046209; P:nitric oxide metabolic process; TAS:Reactome
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0001542; P:ovulation from ovarian follicle; IEA:Ensembl
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0090382; P:phagosome maturation; TAS:Reactome
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0045766; P:positive regulation of angiogenesis; ISS:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0031284; P:positive regulation of guanylate cyclase activity; IMP:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0045909; P:positive regulation of vasodilation; NAS:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0008217; P:regulation of blood pressure; NAS:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0050880; P:regulation of blood vessel size; ISS:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0002028; P:regulation of sodium ion transport; IEA:Ensembl
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0003100; P:regulation of systemic arterial blood pressure by endothelin; IMP:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0003057; P:regulation of the force of heart contraction by chemical signal; IEA:Ensembl
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0034405; P:response to fluid shear stress; IEP:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0009408; P:response to heat; NAS:BHF-UCL
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P29474	NOS3	Nitric oxide synthase, endothelial	GO:0014806; P:smooth muscle hyperplasia; ISS:BHF-UCL
Q9Y314	NOSIP	Nitric oxide synthase-interacting protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y314	NOSIP	Nitric oxide synthase-interacting protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y314	NOSIP	Nitric oxide synthase-interacting protein	GO:0043086; P:negative regulation of catalytic activity; IDA:UniProtKB
Q9Y314	NOSIP	Nitric oxide synthase-interacting protein	GO:0051001; P:negative regulation of nitric-oxide synthase activity; IDA:UniProtKB
Q9Y314	NOSIP	Nitric oxide synthase-interacting protein	GO:0046209; P:nitric oxide metabolic process; TAS:Reactome
Q9Y314	NOSIP	Nitric oxide synthase-interacting protein	GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome
Q9Y314	NOSIP	Nitric oxide synthase-interacting protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8IVI9	NOSTRIN	Nostrin	GO:0003677; F:DNA binding; IEA:Ensembl
Q8IVI9	NOSTRIN	Nostrin	GO:0005515; F:protein binding; IPI:IntAct
Q8IVI9	NOSTRIN	Nostrin	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q8IVI9	NOSTRIN	Nostrin	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q8IVI9	NOSTRIN	Nostrin	GO:0046209; P:nitric oxide metabolic process; TAS:Reactome
Q8IVI9	NOSTRIN	Nostrin	GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome
Q8IVI9	NOSTRIN	Nostrin	GO:0007165; P:signal transduction; IEA:InterPro
Q8IVI9	NOSTRIN	Nostrin	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0031490; F:chromatin DNA binding; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0001047; F:core promoter binding; ISS:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0019899; F:enzyme binding; ISS:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0004857; F:enzyme inhibitor activity; ISS:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0004872; F:receptor activity; IEA:InterPro
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0001190; F:RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0042640; P:anagen; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003180; P:aortic valve morphogenesis; IMP:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:1902263; P:apoptotic process involved in embryonic digit morphogenesis; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0060842; P:arterial endothelial cell differentiation; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003162; P:atrioventricular node development; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003181; P:atrioventricular valve morphogenesis; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0009912; P:auditory receptor cell fate commitment; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0007409; P:axonogenesis; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003209; P:cardiac atrium morphogenesis; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003207; P:cardiac chamber formation; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0060317; P:cardiac epithelial to mesenchymal transition; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003214; P:cardiac left ventricle morphogenesis; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0060038; P:cardiac muscle cell proliferation; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0055008; P:cardiac muscle tissue morphogenesis; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003213; P:cardiac right atrium morphogenesis; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003219; P:cardiac right ventricle formation; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0060411; P:cardiac septum morphogenesis; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0060948; P:cardiac vascular smooth muscle cell development; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003208; P:cardiac ventricle morphogenesis; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0001708; P:cell fate specification; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003273; P:cell migration involved in endocardial cushion formation; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; IDA:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IDA:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0060271; P:cilium morphogenesis; ISS:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0072044; P:collecting duct development; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0007386; P:compartment pattern specification; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0060982; P:coronary artery morphogenesis; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003169; P:coronary vein morphogenesis; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0007368; P:determination of left/right symmetry; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0072017; P:distal tubule development; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0060956; P:endocardial cell differentiation; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003203; P:endocardial cushion morphogenesis; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003157; P:endocardium development; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003160; P:endocardium morphogenesis; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0007492; P:endoderm development; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0001837; P:epithelial to mesenchymal transition; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003198; P:epithelial to mesenchymal transition involved in endocardial cushion formation; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0030900; P:forebrain development; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0007440; P:foregut morphogenesis; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0010467; P:gene expression; TAS:Reactome
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0010001; P:glial cell differentiation; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0072144; P:glomerular mesangial cell development; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003241; P:growth involved in heart morphogenesis; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0007507; P:heart development; IMP:DFLAT
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0001947; P:heart looping; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0061384; P:heart trabecula morphogenesis; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0006959; P:humoral immune response; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0006955; P:immune response; NAS:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0002437; P:inflammatory response to antigenic stimulus; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0072602; P:interleukin-4 secretion; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0070986; P:left/right axis specification; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0001889; P:liver development; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0030324; P:lung development; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0014031; P:mesenchymal cell development; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003192; P:mitral valve formation; IMP:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:2000811; P:negative regulation of anoikis; IMP:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0030514; P:negative regulation of BMP signaling pathway; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0045955; P:negative regulation of calcium ion-dependent exocytosis; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0043086; P:negative regulation of catalytic activity; ISS:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0090051; P:negative regulation of cell migration involved in sprouting angiogenesis; IDA:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0010812; P:negative regulation of cell-substrate adhesion; IDA:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:2001027; P:negative regulation of endothelial cell chemotaxis; IDA:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0060253; P:negative regulation of glial cell proliferation; ISS:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0045662; P:negative regulation of myoblast differentiation; IMP:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0010832; P:negative regulation of myotube differentiation; ISS:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0050768; P:negative regulation of neurogenesis; ISS:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0048715; P:negative regulation of oligodendrocyte differentiation; ISS:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0030279; P:negative regulation of ossification; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0045668; P:negative regulation of osteoblast differentiation; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0046533; P:negative regulation of photoreceptor cell differentiation; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:2000974; P:negative regulation of pro-B cell differentiation; ISS:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:2000737; P:negative regulation of stem cell differentiation; IMP:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0021915; P:neural tube development; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0097150; P:neuronal stem cell maintenance; IEP:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0007220; P:Notch receptor processing; TAS:Reactome
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0061314; P:Notch signaling involved in heart development; IMP:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0007219; P:Notch signaling pathway; IMP:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003270; P:Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003344; P:pericardium morphogenesis; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0048711; P:positive regulation of astrocyte differentiation; ISS:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0030513; P:positive regulation of BMP signaling pathway; ISS:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0060045; P:positive regulation of cardiac muscle cell proliferation; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0030335; P:positive regulation of cell migration; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IMP:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0046427; P:positive regulation of JAK-STAT cascade; ISS:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0045618; P:positive regulation of keratinocyte differentiation; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0061419; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; ISS:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0007221; P:positive regulation of transcription of Notch receptor target; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0060740; P:prostate gland epithelium morphogenesis; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003184; P:pulmonary valve morphogenesis; IMP:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0060768; P:regulation of epithelial cell proliferation involved in prostate gland development; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:1901201; P:regulation of extracellular matrix assembly; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0014807; P:regulation of somitogenesis; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003256; P:regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0032495; P:response to muramyl dipeptide; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0060528; P:secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0048103; P:somatic stem cell division; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0002040; P:sprouting angiogenesis; IEA:Ensembl
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0035148; P:tube formation; IMP:UniProtKB
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0060979; P:vasculogenesis involved in coronary vascular morphogenesis; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0060843; P:venous endothelial cell differentiation; ISS:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0060412; P:ventricular septum morphogenesis; IMP:BHF-UCL
P46531	NOTCH1	Neurogenic locus notch homolog protein 1	GO:0003222; P:ventricular trabecula myocardium morphogenesis; ISS:BHF-UCL
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0038049; F:ligand-activated RNA polymerase II transcription factor binding transcription factor activity; TAS:UniProtKB
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0004872; F:receptor activity; NAS:UniProtKB
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0006915; P:apoptotic process; TAS:UniProtKB
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0060413; P:atrial septum morphogenesis; IMP:BHF-UCL
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0046849; P:bone remodeling; IMP:UniProtKB
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0007050; P:cell cycle arrest; IDA:UniProtKB
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0001709; P:cell fate determination; TAS:UniProtKB
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0016049; P:cell growth; IDA:UniProtKB
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0010467; P:gene expression; TAS:Reactome
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0030097; P:hemopoiesis; TAS:UniProtKB
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0006959; P:humoral immune response; IEA:Ensembl
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0002437; P:inflammatory response to antigenic stimulus; IEA:Ensembl
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0072602; P:interleukin-4 secretion; IEA:Ensembl
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0030522; P:intracellular receptor signaling pathway; TAS:GOC
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0002011; P:morphogenesis of an epithelial sheet; IEA:Ensembl
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0007399; P:nervous system development; NAS:UniProtKB
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0007220; P:Notch receptor processing; TAS:Reactome
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0061314; P:Notch signaling involved in heart development; IC:BHF-UCL
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0009887; P:organ morphogenesis; IEP:UniProtKB
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0060674; P:placenta blood vessel development; IEA:Ensembl
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0046579; P:positive regulation of Ras protein signal transduction; IDA:UniProtKB
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0003184; P:pulmonary valve morphogenesis; IMP:BHF-UCL
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0019827; P:stem cell maintenance; TAS:UniProtKB
Q04721	NOTCH2	Neurogenic locus notch homolog protein 2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q9UM47	NOTCH3	Neurogenic locus notch homolog protein 3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UM47	NOTCH3	Neurogenic locus notch homolog protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UM47	NOTCH3	Neurogenic locus notch homolog protein 3	GO:0030900; P:forebrain development; IEA:Ensembl
Q9UM47	NOTCH3	Neurogenic locus notch homolog protein 3	GO:0010467; P:gene expression; TAS:Reactome
Q9UM47	NOTCH3	Neurogenic locus notch homolog protein 3	GO:0072104; P:glomerular capillary formation; IEA:Ensembl
Q9UM47	NOTCH3	Neurogenic locus notch homolog protein 3	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
Q9UM47	NOTCH3	Neurogenic locus notch homolog protein 3	GO:0048663; P:neuron fate commitment; IEA:Ensembl
Q9UM47	NOTCH3	Neurogenic locus notch homolog protein 3	GO:0007220; P:Notch receptor processing; TAS:Reactome
Q9UM47	NOTCH3	Neurogenic locus notch homolog protein 3	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q9UM47	NOTCH3	Neurogenic locus notch homolog protein 3	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
Q9UM47	NOTCH3	Neurogenic locus notch homolog protein 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UM47	NOTCH3	Neurogenic locus notch homolog protein 3	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q99466	NOTCH4	Neurogenic locus notch homolog protein 4	GO:0005509; F:calcium ion binding; TAS:UniProtKB
Q99466	NOTCH4	Neurogenic locus notch homolog protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q99466	NOTCH4	Neurogenic locus notch homolog protein 4	GO:0046982; F:protein heterodimerization activity; TAS:UniProtKB
Q99466	NOTCH4	Neurogenic locus notch homolog protein 4	GO:0004872; F:receptor activity; TAS:UniProtKB
Q99466	NOTCH4	Neurogenic locus notch homolog protein 4	GO:0030154; P:cell differentiation; NAS:UniProtKB
Q99466	NOTCH4	Neurogenic locus notch homolog protein 4	GO:0001709; P:cell fate determination; TAS:UniProtKB
Q99466	NOTCH4	Neurogenic locus notch homolog protein 4	GO:0009790; P:embryo development; ISS:UniProtKB
Q99466	NOTCH4	Neurogenic locus notch homolog protein 4	GO:0001886; P:endothelial cell morphogenesis; IEA:Ensembl
Q99466	NOTCH4	Neurogenic locus notch homolog protein 4	GO:0010467; P:gene expression; TAS:Reactome
Q99466	NOTCH4	Neurogenic locus notch homolog protein 4	GO:0030097; P:hemopoiesis; TAS:UniProtKB
Q99466	NOTCH4	Neurogenic locus notch homolog protein 4	GO:0030879; P:mammary gland development; IDA:UniProtKB
Q99466	NOTCH4	Neurogenic locus notch homolog protein 4	GO:0001763; P:morphogenesis of a branching structure; ISS:UniProtKB
Q99466	NOTCH4	Neurogenic locus notch homolog protein 4	GO:0045596; P:negative regulation of cell differentiation; NAS:UniProtKB
Q99466	NOTCH4	Neurogenic locus notch homolog protein 4	GO:0045602; P:negative regulation of endothelial cell differentiation; ISS:UniProtKB
Q99466	NOTCH4	Neurogenic locus notch homolog protein 4	GO:0007220; P:Notch receptor processing; TAS:Reactome
Q99466	NOTCH4	Neurogenic locus notch homolog protein 4	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q99466	NOTCH4	Neurogenic locus notch homolog protein 4	GO:0001569; P:patterning of blood vessels; ISS:UniProtKB
Q99466	NOTCH4	Neurogenic locus notch homolog protein 4	GO:0007221; P:positive regulation of transcription of Notch receptor target; TAS:BHF-UCL
Q99466	NOTCH4	Neurogenic locus notch homolog protein 4	GO:0045893; P:positive regulation of transcription, DNA-templated; TAS:UniProtKB
Q99466	NOTCH4	Neurogenic locus notch homolog protein 4	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
A8MTQ0	NOTO	Homeobox protein notochord	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
A8MTQ0	NOTO	Homeobox protein notochord	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
A8MTQ0	NOTO	Homeobox protein notochord	GO:0060271; P:cilium morphogenesis; IEA:Ensembl
A8MTQ0	NOTO	Homeobox protein notochord	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
A8MTQ0	NOTO	Homeobox protein notochord	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
A8MTQ0	NOTO	Homeobox protein notochord	GO:0009880; P:embryonic pattern specification; IEA:Ensembl
A8MTQ0	NOTO	Homeobox protein notochord	GO:0030903; P:notochord development; IEA:Ensembl
A8MTQ0	NOTO	Homeobox protein notochord	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6P988	NOTUM	Protein notum homolog	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
P51513	NOVA1	RNA-binding protein Nova-1	GO:0003729; F:mRNA binding; IEA:Ensembl
P51513	NOVA1	RNA-binding protein Nova-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P51513	NOVA1	RNA-binding protein Nova-1	GO:0003723; F:RNA binding; TAS:ProtInc
P51513	NOVA1	RNA-binding protein Nova-1	GO:0007626; P:locomotory behavior; TAS:ProtInc
P51513	NOVA1	RNA-binding protein Nova-1	GO:0000398; P:mRNA splicing, via spliceosome; IEA:Ensembl
P51513	NOVA1	RNA-binding protein Nova-1	GO:0006396; P:RNA processing; TAS:ProtInc
P51513	NOVA1	RNA-binding protein Nova-1	GO:0008380; P:RNA splicing; TAS:ProtInc
P51513	NOVA1	RNA-binding protein Nova-1	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q9UNW9	NOVA2	RNA-binding protein Nova-2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UNW9	NOVA2	RNA-binding protein Nova-2	GO:0003723; F:RNA binding; NAS:UniProtKB
P48745	NOV	Protein NOV homolog	GO:0001558; P:regulation of cell growth; IEA:InterPro
P48745	NOV	Protein NOV homolog	GO:0010468; P:regulation of gene expression; IEA:Ensembl
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0050661; F:NADP binding; IC:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0005515; F:protein binding; IPI:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0048365; F:Rac GTPase binding; IPI:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0016175; F:superoxide-generating NADPH oxidase activity; TAS:UniProtKB
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0030171; F:voltage-gated proton channel activity; IDA:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0001525; P:angiogenesis; IMP:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0016477; P:cell migration; IMP:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0071468; P:cellular response to acidity; IDA:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0042743; P:hydrogen peroxide metabolic process; IDA:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0006954; P:inflammatory response; TAS:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0051454; P:intracellular pH elevation; IDA:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0006739; P:NADP metabolic process; IC:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0072592; P:oxygen metabolic process; IEA:Ensembl
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0045726; P:positive regulation of integrin biosynthetic process; IMP:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0048661; P:positive regulation of smooth muscle cell proliferation; ISS:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0010575; P:positive regulation vascular endothelial growth factor production; IEP:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0015992; P:proton transport; IDA:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0008217; P:regulation of blood pressure; TAS:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0003081; P:regulation of systemic arterial blood pressure by renin-angiotensin; IEA:Ensembl
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0045730; P:respiratory burst; TAS:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0007165; P:signal transduction; TAS:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0042554; P:superoxide anion generation; IDA:BHF-UCL
Q9Y5S8	NOX1	NADPH oxidase 1	GO:0006801; P:superoxide metabolic process; IMP:BHF-UCL
Q9HBY0	NOX3	NADPH oxidase 3	GO:0016175; F:superoxide-generating NADPH oxidase activity; IEA:Ensembl
Q9HBY0	NOX3	NADPH oxidase 3	GO:0009590; P:detection of gravity; IEA:Ensembl
Q9HBY0	NOX3	NADPH oxidase 3	GO:0048840; P:otolith development; IEA:Ensembl
Q9HBY0	NOX3	NADPH oxidase 3	GO:0042554; P:superoxide anion generation; IEA:Ensembl
Q9HBY0	NOX3	NADPH oxidase 3	GO:0001659; P:temperature homeostasis; IEA:Ensembl
Q9NPH5	NOX4	NADPH oxidase 4	GO:0009055; F:electron carrier activity; TAS:UniProtKB
Q9NPH5	NOX4	NADPH oxidase 4	GO:0050660; F:flavin adenine dinucleotide binding; TAS:UniProtKB
Q9NPH5	NOX4	NADPH oxidase 4	GO:0020037; F:heme binding; TAS:UniProtKB
Q9NPH5	NOX4	NADPH oxidase 4	GO:0072341; F:modified amino acid binding; IDA:UniProtKB
Q9NPH5	NOX4	NADPH oxidase 4	GO:0016174; F:NAD(P)H oxidase activity; TAS:UniProtKB
Q9NPH5	NOX4	NADPH oxidase 4	GO:0000166; F:nucleotide binding; TAS:UniProtKB
Q9NPH5	NOX4	NADPH oxidase 4	GO:0019826; F:oxygen sensor activity; TAS:UniProtKB
Q9NPH5	NOX4	NADPH oxidase 4	GO:0016175; F:superoxide-generating NADPH oxidase activity; IEA:Ensembl
Q9NPH5	NOX4	NADPH oxidase 4	GO:0045453; P:bone resorption; IEA:Ensembl
Q9NPH5	NOX4	NADPH oxidase 4	GO:0035051; P:cardiocyte differentiation; IEA:Ensembl
Q9NPH5	NOX4	NADPH oxidase 4	GO:0007569; P:cell aging; ISS:UniProtKB
Q9NPH5	NOX4	NADPH oxidase 4	GO:0000902; P:cell morphogenesis; ISS:UniProtKB
Q9NPH5	NOX4	NADPH oxidase 4	GO:0071320; P:cellular response to cAMP; IEA:Ensembl
Q9NPH5	NOX4	NADPH oxidase 4	GO:0071480; P:cellular response to gamma radiation; IEA:Ensembl
Q9NPH5	NOX4	NADPH oxidase 4	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
Q9NPH5	NOX4	NADPH oxidase 4	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEA:Ensembl
Q9NPH5	NOX4	NADPH oxidase 4	GO:0050667; P:homocysteine metabolic process; IDA:UniProtKB
Q9NPH5	NOX4	NADPH oxidase 4	GO:0006954; P:inflammatory response; TAS:UniProtKB
Q9NPH5	NOX4	NADPH oxidase 4	GO:0008285; P:negative regulation of cell proliferation; ISS:UniProtKB
Q9NPH5	NOX4	NADPH oxidase 4	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q9NPH5	NOX4	NADPH oxidase 4	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q9NPH5	NOX4	NADPH oxidase 4	GO:2000573; P:positive regulation of DNA biosynthetic process; IEA:Ensembl
Q9NPH5	NOX4	NADPH oxidase 4	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl
Q9NPH5	NOX4	NADPH oxidase 4	GO:0043406; P:positive regulation of MAP kinase activity; IEA:Ensembl
Q9NPH5	NOX4	NADPH oxidase 4	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
Q9NPH5	NOX4	NADPH oxidase 4	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IEA:Ensembl
Q9NPH5	NOX4	NADPH oxidase 4	GO:0014911; P:positive regulation of smooth muscle cell migration; IEA:Ensembl
Q9NPH5	NOX4	NADPH oxidase 4	GO:0051496; P:positive regulation of stress fiber assembly; IEA:Ensembl
Q9NPH5	NOX4	NADPH oxidase 4	GO:0072593; P:reactive oxygen species metabolic process; IDA:UniProtKB
Q9NPH5	NOX4	NADPH oxidase 4	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q9NPH5	NOX4	NADPH oxidase 4	GO:0042554; P:superoxide anion generation; ISS:UniProtKB
Q96PH1	NOX5	NADPH oxidase 5	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96PH1	NOX5	NADPH oxidase 5	GO:0050660; F:flavin adenine dinucleotide binding; NAS:UniProtKB
Q96PH1	NOX5	NADPH oxidase 5	GO:0020037; F:heme binding; NAS:UniProtKB
Q96PH1	NOX5	NADPH oxidase 5	GO:0015252; F:hydrogen ion channel activity; IDA:UniProtKB
Q96PH1	NOX5	NADPH oxidase 5	GO:0050661; F:NADP binding; NAS:UniProtKB
Q96PH1	NOX5	NADPH oxidase 5	GO:0005515; F:protein binding; IPI:IntAct
Q96PH1	NOX5	NADPH oxidase 5	GO:0016175; F:superoxide-generating NADPH oxidase activity; IDA:UniProtKB
Q96PH1	NOX5	NADPH oxidase 5	GO:0001525; P:angiogenesis; IDA:UniProtKB
Q96PH1	NOX5	NADPH oxidase 5	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q96PH1	NOX5	NADPH oxidase 5	GO:0008283; P:cell proliferation; NAS:UniProtKB
Q96PH1	NOX5	NADPH oxidase 5	GO:0050663; P:cytokine secretion; NAS:UniProtKB
Q96PH1	NOX5	NADPH oxidase 5	GO:0000910; P:cytokinesis; NAS:UniProtKB
Q96PH1	NOX5	NADPH oxidase 5	GO:0001935; P:endothelial cell proliferation; IDA:UniProtKB
Q96PH1	NOX5	NADPH oxidase 5	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q96PH1	NOX5	NADPH oxidase 5	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IDA:UniProtKB
Q96PH1	NOX5	NADPH oxidase 5	GO:0015992; P:proton transport; IDA:GOC
Q96PH1	NOX5	NADPH oxidase 5	GO:0043012; P:regulation of fusion of sperm to egg plasma membrane; NAS:UniProtKB
Q96PH1	NOX5	NADPH oxidase 5	GO:0010155; P:regulation of proton transport; NAS:UniProtKB
Q96PH1	NOX5	NADPH oxidase 5	GO:0042554; P:superoxide anion generation; IDA:UniProtKB
Q86UR1	NOXA1	NADPH oxidase activator 1	GO:0019899; F:enzyme binding; IPI:BHF-UCL
Q86UR1	NOXA1	NADPH oxidase activator 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q86UR1	NOXA1	NADPH oxidase activator 1	GO:0048365; F:Rac GTPase binding; IPI:BHF-UCL
Q86UR1	NOXA1	NADPH oxidase activator 1	GO:0017124; F:SH3 domain binding; IPI:UniProtKB
Q86UR1	NOXA1	NADPH oxidase activator 1	GO:0016176; F:superoxide-generating NADPH oxidase activator activity; IDA:UniProtKB
Q86UR1	NOXA1	NADPH oxidase activator 1	GO:0043085; P:positive regulation of catalytic activity; IDA:GOC
Q86UR1	NOXA1	NADPH oxidase activator 1	GO:0010310; P:regulation of hydrogen peroxide metabolic process; IMP:BHF-UCL
Q86UR1	NOXA1	NADPH oxidase activator 1	GO:0060263; P:regulation of respiratory burst; IMP:BHF-UCL
Q86UR1	NOXA1	NADPH oxidase activator 1	GO:0006801; P:superoxide metabolic process; IMP:UniProtKB
Q8NFA2	NOXO1	NADPH oxidase organizer 1	GO:0019899; F:enzyme binding; IPI:BHF-UCL
Q8NFA2	NOXO1	NADPH oxidase organizer 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q8NFA2	NOXO1	NADPH oxidase organizer 1	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
Q8NFA2	NOXO1	NADPH oxidase organizer 1	GO:0005543; F:phospholipid binding; TAS:BHF-UCL
Q8NFA2	NOXO1	NADPH oxidase organizer 1	GO:0005515; F:protein binding; IPI:IntAct
Q8NFA2	NOXO1	NADPH oxidase organizer 1	GO:0016176; F:superoxide-generating NADPH oxidase activator activity; TAS:BHF-UCL
Q8NFA2	NOXO1	NADPH oxidase organizer 1	GO:0022617; P:extracellular matrix disassembly; IMP:UniProtKB
Q8NFA2	NOXO1	NADPH oxidase organizer 1	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
Q8NFA2	NOXO1	NADPH oxidase organizer 1	GO:0010310; P:regulation of hydrogen peroxide metabolic process; TAS:BHF-UCL
Q8NFA2	NOXO1	NADPH oxidase organizer 1	GO:0060263; P:regulation of respiratory burst; TAS:BHF-UCL
Q8NFA2	NOXO1	NADPH oxidase organizer 1	GO:0006801; P:superoxide metabolic process; IEA:Ensembl
Q8IXT1	NOXIN	Nitric oxide-inducible gene protein	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8IXT1	NOXIN	Nitric oxide-inducible gene protein	GO:0071345; P:cellular response to cytokine stimulus; IEA:Ensembl
Q8IXT1	NOXIN	Nitric oxide-inducible gene protein	GO:0006974; P:cellular response to DNA damage stimulus; IEA:Ensembl
Q8IXT1	NOXIN	Nitric oxide-inducible gene protein	GO:0071480; P:cellular response to gamma radiation; IEA:Ensembl
Q8IXT1	NOXIN	Nitric oxide-inducible gene protein	GO:0071447; P:cellular response to hydroperoxide; IEA:Ensembl
Q8IXT1	NOXIN	Nitric oxide-inducible gene protein	GO:0034644; P:cellular response to UV; IEA:Ensembl
Q8IXT1	NOXIN	Nitric oxide-inducible gene protein	GO:0030097; P:hemopoiesis; IEA:Ensembl
Q8IXT1	NOXIN	Nitric oxide-inducible gene protein	GO:0071850; P:mitotic cell cycle arrest; IEA:Ensembl
Q8IXT1	NOXIN	Nitric oxide-inducible gene protein	GO:2000270; P:negative regulation of fibroblast apoptotic process; IEA:Ensembl
Q8IXT1	NOXIN	Nitric oxide-inducible gene protein	GO:0007286; P:spermatid development; IEA:Ensembl
P55209	NAP1L1	Nucleosome assembly protein 1-like 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P55209	NAP1L1	Nucleosome assembly protein 1-like 1	GO:0005515; F:protein binding; IPI:IntAct
P55209	NAP1L1	Nucleosome assembly protein 1-like 1	GO:0006260; P:DNA replication; TAS:ProtInc
P55209	NAP1L1	Nucleosome assembly protein 1-like 1	GO:0006334; P:nucleosome assembly; TAS:ProtInc
P55209	NAP1L1	Nucleosome assembly protein 1-like 1	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q9ULW6	NAP1L2	Nucleosome assembly protein 1-like 2	GO:0005515; F:protein binding; IPI:IntAct
Q9ULW6	NAP1L2	Nucleosome assembly protein 1-like 2	GO:0006334; P:nucleosome assembly; TAS:ProtInc
Q99457	NAP1L3	Nucleosome assembly protein 1-like 3	GO:0006334; P:nucleosome assembly; TAS:ProtInc
Q99733	NAP1L4	Nucleosome assembly protein 1-like 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q99733	NAP1L4	Nucleosome assembly protein 1-like 4	GO:0005515; F:protein binding; IPI:IntAct
Q99733	NAP1L4	Nucleosome assembly protein 1-like 4	GO:0051082; F:unfolded protein binding; TAS:ProtInc
Q99733	NAP1L4	Nucleosome assembly protein 1-like 4	GO:0006334; P:nucleosome assembly; TAS:ProtInc
Q96NT1	NAP1L5	Nucleosome assembly protein 1-like 5	GO:0006334; P:nucleosome assembly; IEA:InterPro
A6NFF2	NAP1L6	Putative nucleosome assembly protein 1-like 6	GO:0006334; P:nucleosome assembly; IEA:InterPro
O60287	URB1	Nucleolar pre-ribosomal-associated protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H841	NIPAL2	NIPA-like protein 2	GO:0015095; F:magnesium ion transmembrane transporter activity; IEA:InterPro
Q6P499	NIPAL3	NIPA-like protein 3	GO:0015095; F:magnesium ion transmembrane transporter activity; IEA:InterPro
Q9NZP6	NPAP1	Nuclear pore-associated protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9NZP6	NPAP1	Nuclear pore-associated protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9NZP6	NPAP1	Nuclear pore-associated protein 1	GO:0007283; P:spermatogenesis; NAS:UniProtKB
Q99742	NPAS1	Neuronal PAS domain-containing protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q99742	NPAS1	Neuronal PAS domain-containing protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q99742	NPAS1	Neuronal PAS domain-containing protein 1	GO:0004871; F:signal transducer activity; IEA:InterPro
Q99742	NPAS1	Neuronal PAS domain-containing protein 1	GO:0007417; P:central nervous system development; TAS:ProtInc
Q99742	NPAS1	Neuronal PAS domain-containing protein 1	GO:0042711; P:maternal behavior; IEA:Ensembl
Q99742	NPAS1	Neuronal PAS domain-containing protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q99742	NPAS1	Neuronal PAS domain-containing protein 1	GO:0001964; P:startle response; IEA:Ensembl
Q99742	NPAS1	Neuronal PAS domain-containing protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q99743	NPAS2	Neuronal PAS domain-containing protein 2	GO:0001047; F:core promoter binding; ISS:UniProtKB
Q99743	NPAS2	Neuronal PAS domain-containing protein 2	GO:0003677; F:DNA binding; IDA:UniProtKB
Q99743	NPAS2	Neuronal PAS domain-containing protein 2	GO:0051879; F:Hsp90 protein binding; IDA:BHF-UCL
Q99743	NPAS2	Neuronal PAS domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q99743	NPAS2	Neuronal PAS domain-containing protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q99743	NPAS2	Neuronal PAS domain-containing protein 2	GO:0004871; F:signal transducer activity; IEA:InterPro
Q99743	NPAS2	Neuronal PAS domain-containing protein 2	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q99743	NPAS2	Neuronal PAS domain-containing protein 2	GO:0007417; P:central nervous system development; TAS:ProtInc
Q99743	NPAS2	Neuronal PAS domain-containing protein 2	GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB
Q99743	NPAS2	Neuronal PAS domain-containing protein 2	GO:0042745; P:circadian sleep/wake cycle; IEA:Ensembl
Q99743	NPAS2	Neuronal PAS domain-containing protein 2	GO:0045475; P:locomotor rhythm; IEA:Ensembl
Q99743	NPAS2	Neuronal PAS domain-containing protein 2	GO:0060548; P:negative regulation of cell death; IMP:UniProtKB
Q99743	NPAS2	Neuronal PAS domain-containing protein 2	GO:0045739; P:positive regulation of DNA repair; IMP:UniProtKB
Q99743	NPAS2	Neuronal PAS domain-containing protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IGI:MGI
Q99743	NPAS2	Neuronal PAS domain-containing protein 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q99743	NPAS2	Neuronal PAS domain-containing protein 2	GO:2001020; P:regulation of response to DNA damage stimulus; IMP:UniProtKB
Q99743	NPAS2	Neuronal PAS domain-containing protein 2	GO:0051775; P:response to redox state; IDA:UniProtKB
Q99743	NPAS2	Neuronal PAS domain-containing protein 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99743	NPAS2	Neuronal PAS domain-containing protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IXF0	NPAS3	Neuronal PAS domain-containing protein 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IXF0	NPAS3	Neuronal PAS domain-containing protein 3	GO:0004871; F:signal transducer activity; IEA:InterPro
Q8IXF0	NPAS3	Neuronal PAS domain-containing protein 3	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q8IXF0	NPAS3	Neuronal PAS domain-containing protein 3	GO:0042711; P:maternal behavior; IEA:Ensembl
Q8IXF0	NPAS3	Neuronal PAS domain-containing protein 3	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q8IXF0	NPAS3	Neuronal PAS domain-containing protein 3	GO:0001964; P:startle response; IEA:Ensembl
Q8IXF0	NPAS3	Neuronal PAS domain-containing protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IUM7	NPAS4	Neuronal PAS domain-containing protein 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IUM7	NPAS4	Neuronal PAS domain-containing protein 4	GO:0004871; F:signal transducer activity; IEA:InterPro
Q8IUM7	NPAS4	Neuronal PAS domain-containing protein 4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8IUM7	NPAS4	Neuronal PAS domain-containing protein 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14207	NPAT	Protein NPAT	GO:0005515; F:protein binding; IPI:UniProtKB
Q14207	NPAT	Protein NPAT	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q14207	NPAT	Protein NPAT	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q14207	NPAT	Protein NPAT	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q14207	NPAT	Protein NPAT	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q14207	NPAT	Protein NPAT	GO:0003714; F:transcription corepressor activity; IMP:UniProtKB
Q14207	NPAT	Protein NPAT	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q14207	NPAT	Protein NPAT	GO:0010468; P:regulation of gene expression; IMP:UniProtKB
Q14207	NPAT	Protein NPAT	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; IMP:UniProtKB
Q14207	NPAT	Protein NPAT	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P48145	NPBWR1	Neuropeptides B/W receptor type 1	GO:0008188; F:neuropeptide receptor activity; IEA:InterPro
P48145	NPBWR1	Neuropeptides B/W receptor type 1	GO:0004985; F:opioid receptor activity; TAS:ProtInc
P48145	NPBWR1	Neuropeptides B/W receptor type 1	GO:0005515; F:protein binding; IPI:HGNC
P48145	NPBWR1	Neuropeptides B/W receptor type 1	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:HGNC
P48145	NPBWR1	Neuropeptides B/W receptor type 1	GO:0038003; P:opioid receptor signaling pathway; TAS:GOC
P48145	NPBWR1	Neuropeptides B/W receptor type 1	GO:0019222; P:regulation of metabolic process; IEA:Ensembl
P48145	NPBWR1	Neuropeptides B/W receptor type 1	GO:0007268; P:synaptic transmission; TAS:ProtInc
P48146	NPBWR2	Neuropeptides B/W receptor type 2	GO:0008188; F:neuropeptide receptor activity; IEA:InterPro
P48146	NPBWR2	Neuropeptides B/W receptor type 2	GO:0004985; F:opioid receptor activity; TAS:ProtInc
P48146	NPBWR2	Neuropeptides B/W receptor type 2	GO:0005515; F:protein binding; IPI:HGNC
P48146	NPBWR2	Neuropeptides B/W receptor type 2	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:HGNC
P48146	NPBWR2	Neuropeptides B/W receptor type 2	GO:0038003; P:opioid receptor signaling pathway; TAS:GOC
Q8NG41	NPB	Neuropeptide B	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NG41	NPB	Neuropeptide B	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:HGNC
Q8NG41	NPB	Neuropeptide B	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
O15118	NPC1	Niemann-Pick C1 protein	GO:0015485; F:cholesterol binding; IDA:UniProtKB
O15118	NPC1	Niemann-Pick C1 protein	GO:0008158; F:hedgehog receptor activity; IEA:InterPro
O15118	NPC1	Niemann-Pick C1 protein	GO:0005515; F:protein binding; IPI:UniProtKB
O15118	NPC1	Niemann-Pick C1 protein	GO:0004872; F:receptor activity; TAS:ProtInc
O15118	NPC1	Niemann-Pick C1 protein	GO:0015248; F:sterol transporter activity; TAS:ProtInc
O15118	NPC1	Niemann-Pick C1 protein	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
O15118	NPC1	Niemann-Pick C1 protein	GO:0007628; P:adult walking behavior; IEA:Ensembl
O15118	NPC1	Niemann-Pick C1 protein	GO:0006914; P:autophagy; IGI:MGI
O15118	NPC1	Niemann-Pick C1 protein	GO:0008206; P:bile acid metabolic process; ISS:UniProtKB
O15118	NPC1	Niemann-Pick C1 protein	GO:0071404; P:cellular response to low-density lipoprotein particle stimulus; IEA:Ensembl
O15118	NPC1	Niemann-Pick C1 protein	GO:0071383; P:cellular response to steroid hormone stimulus; IEA:Ensembl
O15118	NPC1	Niemann-Pick C1 protein	GO:0033344; P:cholesterol efflux; IDA:BHF-UCL
O15118	NPC1	Niemann-Pick C1 protein	GO:0042632; P:cholesterol homeostasis; IDA:UniProtKB
O15118	NPC1	Niemann-Pick C1 protein	GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW
O15118	NPC1	Niemann-Pick C1 protein	GO:0030301; P:cholesterol transport; IDA:UniProtKB
O15118	NPC1	Niemann-Pick C1 protein	GO:0006897; P:endocytosis; IEA:Ensembl
O15118	NPC1	Niemann-Pick C1 protein	GO:0007041; P:lysosomal transport; ISS:UniProtKB
O15118	NPC1	Niemann-Pick C1 protein	GO:0060548; P:negative regulation of cell death; IEA:Ensembl
O15118	NPC1	Niemann-Pick C1 protein	GO:0016242; P:negative regulation of macroautophagy; IEA:Ensembl
O15118	NPC1	Niemann-Pick C1 protein	GO:0006486; P:protein glycosylation; IDA:UniProtKB
O15118	NPC1	Niemann-Pick C1 protein	GO:0046686; P:response to cadmium ion; IEA:Ensembl
O15118	NPC1	Niemann-Pick C1 protein	GO:0042493; P:response to drug; IEA:Ensembl
O15118	NPC1	Niemann-Pick C1 protein	GO:0007165; P:signal transduction; TAS:GOC
P61916	NPC2	Epididymal secretory protein E1	GO:0015485; F:cholesterol binding; IDA:UniProtKB
P61916	NPC2	Epididymal secretory protein E1	GO:0019899; F:enzyme binding; IPI:UniProtKB
P61916	NPC2	Epididymal secretory protein E1	GO:0005515; F:protein binding; IPI:UniProtKB
P61916	NPC2	Epididymal secretory protein E1	GO:0033344; P:cholesterol efflux; IDA:BHF-UCL
P61916	NPC2	Epididymal secretory protein E1	GO:0042632; P:cholesterol homeostasis; IDA:UniProtKB
P61916	NPC2	Epididymal secretory protein E1	GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW
P61916	NPC2	Epididymal secretory protein E1	GO:0030301; P:cholesterol transport; IDA:UniProtKB
P61916	NPC2	Epididymal secretory protein E1	GO:0046836; P:glycolipid transport; TAS:HGNC
P61916	NPC2	Epididymal secretory protein E1	GO:0032367; P:intracellular cholesterol transport; IDA:UniProtKB
P61916	NPC2	Epididymal secretory protein E1	GO:0032366; P:intracellular sterol transport; IDA:HGNC
P61916	NPC2	Epididymal secretory protein E1	GO:0015914; P:phospholipid transport; TAS:HGNC
P61916	NPC2	Epididymal secretory protein E1	GO:0019747; P:regulation of isoprenoid metabolic process; TAS:UniProtKB
P61916	NPC2	Epididymal secretory protein E1	GO:0009615; P:response to virus; IEP:UniProtKB
Q9UHC9	NPC1L1	Niemann-Pick C1-like protein 1	GO:0008144; F:drug binding; IEA:Ensembl
Q9UHC9	NPC1L1	Niemann-Pick C1-like protein 1	GO:0008158; F:hedgehog receptor activity; IEA:InterPro
Q9UHC9	NPC1L1	Niemann-Pick C1-like protein 1	GO:0031489; F:myosin V binding; IPI:UniProtKB
Q9UHC9	NPC1L1	Niemann-Pick C1-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UHC9	NPC1L1	Niemann-Pick C1-like protein 1	GO:0017137; F:Rab GTPase binding; IPI:UniProtKB
Q9UHC9	NPC1L1	Niemann-Pick C1-like protein 1	GO:0006695; P:cholesterol biosynthetic process; IMP:HGNC
Q9UHC9	NPC1L1	Niemann-Pick C1-like protein 1	GO:0030301; P:cholesterol transport; IMP:HGNC
Q9UHC9	NPC1L1	Niemann-Pick C1-like protein 1	GO:0030299; P:intestinal cholesterol absorption; IMP:HGNC
Q9UHC9	NPC1L1	Niemann-Pick C1-like protein 1	GO:0042157; P:lipoprotein metabolic process; IMP:HGNC
Q9UHC9	NPC1L1	Niemann-Pick C1-like protein 1	GO:0042493; P:response to drug; IEA:Ensembl
Q9UHC9	NPC1L1	Niemann-Pick C1-like protein 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UHC9	NPC1L1	Niemann-Pick C1-like protein 1	GO:0015918; P:sterol transport; TAS:Reactome
Q9GZQ6	NPFFR1	Neuropeptide FF receptor 1	GO:0004930; F:G-protein coupled receptor activity; NAS:UniProtKB
Q9GZQ6	NPFFR1	Neuropeptide FF receptor 1	GO:0008188; F:neuropeptide receptor activity; NAS:UniProtKB
Q9GZQ6	NPFFR1	Neuropeptide FF receptor 1	GO:0007218; P:neuropeptide signaling pathway; NAS:GOC
Q9Y5X5	NPFFR2	Neuropeptide FF receptor 2	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q9Y5X5	NPFFR2	Neuropeptide FF receptor 2	GO:0008188; F:neuropeptide receptor activity; IEA:InterPro
Q9Y5X5	NPFFR2	Neuropeptide FF receptor 2	GO:0009582; P:detection of abiotic stimulus; TAS:ProtInc
Q9Y5X5	NPFFR2	Neuropeptide FF receptor 2	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q9Y5X5	NPFFR2	Neuropeptide FF receptor 2	GO:0045761; P:regulation of adenylate cyclase activity; IEA:InterPro
Q9Y5X5	NPFFR2	Neuropeptide FF receptor 2	GO:2000479; P:regulation of cAMP-dependent protein kinase activity; IEA:InterPro
Q9Y5X5	NPFFR2	Neuropeptide FF receptor 2	GO:0043408; P:regulation of MAPK cascade; IEA:InterPro
O15130	NPFF	Pro-FMRFamide-related neuropeptide FF	GO:0005102; F:receptor binding; TAS:ProtInc
O15130	NPFF	Pro-FMRFamide-related neuropeptide FF	GO:0002438; P:acute inflammatory response to antigenic stimulus; IEA:Ensembl
O15130	NPFF	Pro-FMRFamide-related neuropeptide FF	GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
O15130	NPFF	Pro-FMRFamide-related neuropeptide FF	GO:0032099; P:negative regulation of appetite; IEA:Ensembl
O15130	NPFF	Pro-FMRFamide-related neuropeptide FF	GO:0010459; P:negative regulation of heart rate; IEA:Ensembl
O15130	NPFF	Pro-FMRFamide-related neuropeptide FF	GO:0046676; P:negative regulation of insulin secretion; IEA:Ensembl
O15130	NPFF	Pro-FMRFamide-related neuropeptide FF	GO:0007218; P:neuropeptide signaling pathway; TAS:ProtInc
O15130	NPFF	Pro-FMRFamide-related neuropeptide FF	GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl
O15130	NPFF	Pro-FMRFamide-related neuropeptide FF	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
O15130	NPFF	Pro-FMRFamide-related neuropeptide FF	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
O15130	NPFF	Pro-FMRFamide-related neuropeptide FF	GO:0003254; P:regulation of membrane depolarization; IEA:Ensembl
O15130	NPFF	Pro-FMRFamide-related neuropeptide FF	GO:0051930; P:regulation of sensory perception of pain; IEA:Ensembl
O15130	NPFF	Pro-FMRFamide-related neuropeptide FF	GO:0042493; P:response to drug; IEA:Ensembl
O15130	NPFF	Pro-FMRFamide-related neuropeptide FF	GO:0043278; P:response to morphine; IEA:Ensembl
O15130	NPFF	Pro-FMRFamide-related neuropeptide FF	GO:0070253; P:somatostatin secretion; IEA:Ensembl
O15130	NPFF	Pro-FMRFamide-related neuropeptide FF	GO:0021510; P:spinal cord development; IEA:Ensembl
O15130	NPFF	Pro-FMRFamide-related neuropeptide FF	GO:0007268; P:synaptic transmission; TAS:ProtInc
O15130	NPFF	Pro-FMRFamide-related neuropeptide FF	GO:0030103; P:vasopressin secretion; IEA:Ensembl
O60500	NPHS1	Nephrin	GO:0017022; F:myosin binding; IPI:UniProtKB
O60500	NPHS1	Nephrin	GO:0005515; F:protein binding; IPI:IntAct
O60500	NPHS1	Nephrin	GO:0007155; P:cell adhesion; TAS:ProtInc
O60500	NPHS1	Nephrin	GO:0007588; P:excretion; TAS:ProtInc
O60500	NPHS1	Nephrin	GO:0032836; P:glomerular basement membrane development; IEP:UniProtKB
O60500	NPHS1	Nephrin	GO:0072015; P:glomerular visceral epithelial cell development; IEP:UniProtKB
O60500	NPHS1	Nephrin	GO:0007254; P:JNK cascade; IEA:Ensembl
O60500	NPHS1	Nephrin	GO:0007520; P:myoblast fusion; IEA:Ensembl
O60500	NPHS1	Nephrin	GO:0030838; P:positive regulation of actin filament polymerization; IEA:Ensembl
O60500	NPHS1	Nephrin	GO:0044062; P:regulation of excretion; IEA:Ensembl
O60500	NPHS1	Nephrin	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
O15259	NPHP1	Nephrocystin-1	GO:0005515; F:protein binding; IPI:UniProtKB
O15259	NPHP1	Nephrocystin-1	GO:0005198; F:structural molecule activity; NAS:UniProtKB
O15259	NPHP1	Nephrocystin-1	GO:0030036; P:actin cytoskeleton organization; NAS:UniProtKB
O15259	NPHP1	Nephrocystin-1	GO:0030030; P:cell projection organization; ISS:UniProtKB
O15259	NPHP1	Nephrocystin-1	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
O15259	NPHP1	Nephrocystin-1	GO:0034613; P:cellular protein localization; IEA:Ensembl
O15259	NPHP1	Nephrocystin-1	GO:0007588; P:excretion; TAS:ProtInc
O15259	NPHP1	Nephrocystin-1	GO:0035845; P:photoreceptor cell outer segment organization; IEA:Ensembl
O15259	NPHP1	Nephrocystin-1	GO:0060041; P:retina development in camera-type eye; ISS:UniProtKB
O15259	NPHP1	Nephrocystin-1	GO:0007165; P:signal transduction; NAS:UniProtKB
O15259	NPHP1	Nephrocystin-1	GO:0048515; P:spermatid differentiation; ISS:UniProtKB
O15259	NPHP1	Nephrocystin-1	GO:0007632; P:visual behavior; NAS:UniProtKB
Q7Z494	NPHP3	Nephrocystin-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z494	NPHP3	Nephrocystin-3	GO:0003283; P:atrial septum development; IMP:BHF-UCL
Q7Z494	NPHP3	Nephrocystin-3	GO:0060271; P:cilium morphogenesis; ISS:UniProtKB
Q7Z494	NPHP3	Nephrocystin-3	GO:0060027; P:convergent extension involved in gastrulation; IGI:BHF-UCL
Q7Z494	NPHP3	Nephrocystin-3	GO:0071908; P:determination of intestine left/right asymmetry; IMP:BHF-UCL
Q7Z494	NPHP3	Nephrocystin-3	GO:0007368; P:determination of left/right symmetry; IMP:BHF-UCL
Q7Z494	NPHP3	Nephrocystin-3	GO:0071910; P:determination of liver left/right asymmetry; IMP:BHF-UCL
Q7Z494	NPHP3	Nephrocystin-3	GO:0035469; P:determination of pancreatic left/right asymmetry; IMP:BHF-UCL
Q7Z494	NPHP3	Nephrocystin-3	GO:0071909; P:determination of stomach left/right asymmetry; IMP:BHF-UCL
Q7Z494	NPHP3	Nephrocystin-3	GO:0060287; P:epithelial cilium movement involved in determination of left/right asymmetry; IC:BHF-UCL
Q7Z494	NPHP3	Nephrocystin-3	GO:0007163; P:establishment or maintenance of cell polarity; IEA:Ensembl
Q7Z494	NPHP3	Nephrocystin-3	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q7Z494	NPHP3	Nephrocystin-3	GO:0001947; P:heart looping; IMP:BHF-UCL
Q7Z494	NPHP3	Nephrocystin-3	GO:0001822; P:kidney development; IMP:BHF-UCL
Q7Z494	NPHP3	Nephrocystin-3	GO:0060993; P:kidney morphogenesis; IMP:BHF-UCL
Q7Z494	NPHP3	Nephrocystin-3	GO:0006629; P:lipid metabolic process; IEA:Ensembl
Q7Z494	NPHP3	Nephrocystin-3	GO:0030324; P:lung development; IMP:BHF-UCL
Q7Z494	NPHP3	Nephrocystin-3	GO:0048496; P:maintenance of organ identity; IMP:HGNC
Q7Z494	NPHP3	Nephrocystin-3	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:UniProtKB
Q7Z494	NPHP3	Nephrocystin-3	GO:0045494; P:photoreceptor cell maintenance; IMP:HGNC
Q7Z494	NPHP3	Nephrocystin-3	GO:0030814; P:regulation of cAMP metabolic process; IEA:Ensembl
Q7Z494	NPHP3	Nephrocystin-3	GO:2000167; P:regulation of planar cell polarity pathway involved in neural tube closure; IC:BHF-UCL
Q7Z494	NPHP3	Nephrocystin-3	GO:2000095; P:regulation of Wnt signaling pathway, planar cell polarity pathway; ISS:UniProtKB
Q7Z494	NPHP3	Nephrocystin-3	GO:0072189; P:ureter development; IMP:BHF-UCL
Q7Z494	NPHP3	Nephrocystin-3	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
O75161	NPHP4	Nephrocystin-4	GO:0005515; F:protein binding; IPI:UniProtKB
O75161	NPHP4	Nephrocystin-4	GO:0005198; F:structural molecule activity; NAS:UniProtKB
O75161	NPHP4	Nephrocystin-4	GO:0030036; P:actin cytoskeleton organization; NAS:UniProtKB
O75161	NPHP4	Nephrocystin-4	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
O75161	NPHP4	Nephrocystin-4	GO:0035329; P:hippo signaling; TAS:Reactome
O75161	NPHP4	Nephrocystin-4	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
O75161	NPHP4	Nephrocystin-4	GO:0007165; P:signal transduction; NAS:UniProtKB
O75161	NPHP4	Nephrocystin-4	GO:0007632; P:visual behavior; NAS:UniProtKB
Q9UND3	NPIPA1	Nuclear pore complex-interacting protein family member A1	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q9UND3	NPIPA1	Nuclear pore complex-interacting protein family member A1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8TAT6	NPLOC4	Nuclear protein localization protein 4 homolog	GO:0005515; F:protein binding; IPI:HGNC
Q8TAT6	NPLOC4	Nuclear protein localization protein 4 homolog	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TAT6	NPLOC4	Nuclear protein localization protein 4 homolog	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; ISS:HGNC
Q8TAT6	NPLOC4	Nuclear protein localization protein 4 homolog	GO:0007030; P:Golgi organization; ISS:HGNC
Q8TAT6	NPLOC4	Nuclear protein localization protein 4 homolog	GO:0061025; P:membrane fusion; ISS:HGNC
Q9BXD5	NPL	N-acetylneuraminate lyase	GO:0008747; F:N-acetylneuraminate lyase activity; ISS:UniProtKB
Q9BXD5	NPL	N-acetylneuraminate lyase	GO:0005975; P:carbohydrate metabolic process; IEA:UniProtKB-KW
Q9BXD5	NPL	N-acetylneuraminate lyase	GO:0019262; P:N-acetylneuraminate catabolic process; TAS:UniProtKB
Q86SE8	NPM2	Nucleoplasmin-2	GO:0042393; F:histone binding; TAS:UniProtKB
Q86SE8	NPM2	Nucleoplasmin-2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q86SE8	NPM2	Nucleoplasmin-2	GO:0006338; P:chromatin remodeling; IDA:UniProtKB
Q86SE8	NPM2	Nucleoplasmin-2	GO:0009790; P:embryo development; IMP:UniProtKB
Q86SE8	NPM2	Nucleoplasmin-2	GO:0009994; P:oocyte differentiation; IEP:UniProtKB
Q86SE8	NPM2	Nucleoplasmin-2	GO:0043085; P:positive regulation of catalytic activity; IEA:Ensembl
Q86SE8	NPM2	Nucleoplasmin-2	GO:0045740; P:positive regulation of DNA replication; IEA:Ensembl
Q86SE8	NPM2	Nucleoplasmin-2	GO:0045836; P:positive regulation of meiosis; IMP:UniProtKB
Q86SE8	NPM2	Nucleoplasmin-2	GO:0051260; P:protein homooligomerization; IEA:Ensembl
Q86SE8	NPM2	Nucleoplasmin-2	GO:0007096; P:regulation of exit from mitosis; IMP:UniProtKB
Q86SE8	NPM2	Nucleoplasmin-2	GO:0007338; P:single fertilization; IMP:UniProtKB
O75607	NPM3	Nucleoplasmin-3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75607	NPM3	Nucleoplasmin-3	GO:0005515; F:protein binding; IPI:IntAct
O75607	NPM3	Nucleoplasmin-3	GO:0006364; P:rRNA processing; IEA:Ensembl
O75607	NPM3	Nucleoplasmin-3	GO:0009303; P:rRNA transcription; IEA:Ensembl
P06748	NPM1	Nucleophosmin	GO:0042393; F:histone binding; IDA:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0051059; F:NF-kappaB binding; IDA:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0005515; F:protein binding; IPI:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0046982; F:protein heterodimerization activity; IMP:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0004860; F:protein kinase inhibitor activity; IDA:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0043023; F:ribosomal large subunit binding; IDA:MGI
P06748	NPM1	Nucleophosmin	GO:0043024; F:ribosomal small subunit binding; IDA:MGI
P06748	NPM1	Nucleophosmin	GO:0003723; F:RNA binding; IDA:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0030957; F:Tat protein binding; IDA:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0051082; F:unfolded protein binding; IDA:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0007569; P:cell aging; IMP:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
P06748	NPM1	Nucleophosmin	GO:0007098; P:centrosome cycle; IMP:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0006281; P:DNA repair; IDA:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0006886; P:intracellular protein transport; TAS:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0010826; P:negative regulation of centrosome duplication; IMP:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0044387; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; IDA:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0006913; P:nucleocytoplasmic transport; IDA:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0006334; P:nucleosome assembly; IDA:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0045727; P:positive regulation of translation; IDA:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0008104; P:protein localization; IDA:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0051259; P:protein oligomerization; IDA:MGI
P06748	NPM1	Nucleophosmin	GO:0046599; P:regulation of centriole replication; IMP:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0060735; P:regulation of eIF2 alpha phosphorylation by dsRNA; IDA:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0032071; P:regulation of endodeoxyribonuclease activity; IDA:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0060699; P:regulation of endoribonuclease activity; IDA:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0006950; P:response to stress; IMP:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0042255; P:ribosome assembly; TAS:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0007165; P:signal transduction; NAS:UniProtKB
P06748	NPM1	Nucleophosmin	GO:0016032; P:viral process; TAS:Reactome
Q6UXI9	NPNT	Nephronectin	GO:0005509; F:calcium ion binding; IEA:InterPro
Q6UXI9	NPNT	Nephronectin	GO:0005178; F:integrin binding; ISS:BHF-UCL
Q6UXI9	NPNT	Nephronectin	GO:0001658; P:branching involved in ureteric bud morphogenesis; ISS:BHF-UCL
Q6UXI9	NPNT	Nephronectin	GO:0033631; P:cell-cell adhesion mediated by integrin; ISS:BHF-UCL
Q6UXI9	NPNT	Nephronectin	GO:0007160; P:cell-matrix adhesion; ISS:BHF-UCL
Q6UXI9	NPNT	Nephronectin	GO:0071356; P:cellular response to tumor necrosis factor; ISS:BHF-UCL
Q6UXI9	NPNT	Nephronectin	GO:0045184; P:establishment of protein localization; IEA:Ensembl
Q6UXI9	NPNT	Nephronectin	GO:0030198; P:extracellular matrix organization; ISS:BHF-UCL
Q6UXI9	NPNT	Nephronectin	GO:0097195; P:pilomotor reflex; IEA:Ensembl
Q6UXI9	NPNT	Nephronectin	GO:0010694; P:positive regulation of alkaline phosphatase activity; IEA:Ensembl
Q6UXI9	NPNT	Nephronectin	GO:0010811; P:positive regulation of cell-substrate adhesion; ISS:BHF-UCL
Q6UXI9	NPNT	Nephronectin	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:BHF-UCL
Q6UXI9	NPNT	Nephronectin	GO:0045669; P:positive regulation of osteoblast differentiation; ISS:BHF-UCL
Q6UXI9	NPNT	Nephronectin	GO:0045987; P:positive regulation of smooth muscle contraction; IEA:Ensembl
Q6UXI9	NPNT	Nephronectin	GO:2000721; P:positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation; IEA:Ensembl
Q6UXI9	NPNT	Nephronectin	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl
Q6UXI9	NPNT	Nephronectin	GO:0001657; P:ureteric bud development; ISS:BHF-UCL
Q8WTW4	NPRL2	Nitrogen permease regulator 2-like protein	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q8WTW4	NPRL2	Nitrogen permease regulator 2-like protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WTW4	NPRL2	Nitrogen permease regulator 2-like protein	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q8WTW4	NPRL2	Nitrogen permease regulator 2-like protein	GO:0033673; P:negative regulation of kinase activity; IDA:UniProtKB
Q8WTW4	NPRL2	Nitrogen permease regulator 2-like protein	GO:0006468; P:protein phosphorylation; IDA:GOC
Q12980	NPRL3	Nitrogen permease regulator 3-like protein	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q12980	NPRL3	Nitrogen permease regulator 3-like protein	GO:0035909; P:aorta morphogenesis; IEA:Ensembl
Q12980	NPRL3	Nitrogen permease regulator 3-like protein	GO:0048738; P:cardiac muscle tissue development; IEA:Ensembl
Q12980	NPRL3	Nitrogen permease regulator 3-like protein	GO:0060021; P:palate development; IEA:Ensembl
Q12980	NPRL3	Nitrogen permease regulator 3-like protein	GO:0003281; P:ventricular septum development; IEA:Ensembl
Q9UFN0	NIPSNAP3A	Protein NipSnap homolog 3A	GO:0005515; F:protein binding; IPI:IntAct
Q6W5P4	NPSR1	Neuropeptide S receptor	GO:0005000; F:vasopressin receptor activity; IEA:InterPro
P0C0P6	NPS	Neuropeptide S	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
P0C0P6	NPS	Neuropeptide S	GO:0045760; P:positive regulation of action potential; IEA:Ensembl
P0C0P6	NPS	Neuropeptide S	GO:0032230; P:positive regulation of synaptic transmission, GABAergic; IEA:Ensembl
P0C0P6	NPS	Neuropeptide S	GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IEA:Ensembl
P0C0P6	NPS	Neuropeptide S	GO:0008542; P:visual learning; IEA:Ensembl
Q14916	SLC17A1	Sodium-dependent phosphate transport protein 1	GO:0015321; F:sodium-dependent phosphate transmembrane transporter activity; TAS:ProtInc
Q14916	SLC17A1	Sodium-dependent phosphate transport protein 1	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q14916	SLC17A1	Sodium-dependent phosphate transport protein 1	GO:0006811; P:ion transport; TAS:Reactome
Q14916	SLC17A1	Sodium-dependent phosphate transport protein 1	GO:0006817; P:phosphate ion transport; TAS:ProtInc
Q14916	SLC17A1	Sodium-dependent phosphate transport protein 1	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q14916	SLC17A1	Sodium-dependent phosphate transport protein 1	GO:0044341; P:sodium-dependent phosphate transport; TAS:GOC
Q14916	SLC17A1	Sodium-dependent phosphate transport protein 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q14916	SLC17A1	Sodium-dependent phosphate transport protein 1	GO:0046415; P:urate metabolic process; IMP:BHF-UCL
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0005515; F:protein binding; IPI:UniProtKB
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0015321; F:sodium-dependent phosphate transmembrane transporter activity; IDA:UniProtKB
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:1901684; P:arsenate ion transmembrane transport; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0046849; P:bone remodeling; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0071248; P:cellular response to metal ion; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0071374; P:cellular response to parathyroid hormone stimulus; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0072734; P:cellular response to staurosporine; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0097187; P:dentinogenesis; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:1901128; P:gentamycin metabolic process; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0009100; P:glycoprotein metabolic process; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0042431; P:indole metabolic process; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0006811; P:ion transport; TAS:Reactome
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0001822; P:kidney development; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0001503; P:ossification; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0055062; P:phosphate ion homeostasis; IDA:UniProtKB
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0006817; P:phosphate ion transport; IDA:UniProtKB
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0045838; P:positive regulation of membrane potential; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:2000187; P:positive regulation of phosphate transmembrane transport; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:2000120; P:positive regulation of sodium-dependent phosphate transport; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0051260; P:protein homooligomerization; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0046686; P:response to cadmium ion; IDA:UniProtKB
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0042493; P:response to drug; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0032355; P:response to estradiol; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0060416; P:response to growth hormone; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0010288; P:response to lead ion; IDA:UniProtKB
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0032026; P:response to magnesium ion; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0046689; P:response to mercury ion; IDA:UniProtKB
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0035864; P:response to potassium ion; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0097066; P:response to thyroid hormone; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0033189; P:response to vitamin A; IEA:Ensembl
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0055085; P:transmembrane transport; TAS:Reactome
Q06495	SLC34A1	Sodium-dependent phosphate transport protein 2A	GO:0072350; P:tricarboxylic acid metabolic process; IEA:Ensembl
O95436	SLC34A2	Sodium-dependent phosphate transport protein 2B	GO:0042301; F:phosphate ion binding; IDA:UniProtKB
O95436	SLC34A2	Sodium-dependent phosphate transport protein 2B	GO:0031402; F:sodium ion binding; IDA:UniProtKB
O95436	SLC34A2	Sodium-dependent phosphate transport protein 2B	GO:0015321; F:sodium-dependent phosphate transmembrane transporter activity; IDA:UniProtKB
O95436	SLC34A2	Sodium-dependent phosphate transport protein 2B	GO:0005436; F:sodium:phosphate symporter activity; IDA:UniProtKB
O95436	SLC34A2	Sodium-dependent phosphate transport protein 2B	GO:0007568; P:aging; IEA:Ensembl
O95436	SLC34A2	Sodium-dependent phosphate transport protein 2B	GO:0030643; P:cellular phosphate ion homeostasis; IDA:UniProtKB
O95436	SLC34A2	Sodium-dependent phosphate transport protein 2B	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O95436	SLC34A2	Sodium-dependent phosphate transport protein 2B	GO:0006811; P:ion transport; TAS:Reactome
O95436	SLC34A2	Sodium-dependent phosphate transport protein 2B	GO:0035435; P:phosphate ion transmembrane transport; IDA:GOC
O95436	SLC34A2	Sodium-dependent phosphate transport protein 2B	GO:0006817; P:phosphate ion transport; IDA:UniProtKB
O95436	SLC34A2	Sodium-dependent phosphate transport protein 2B	GO:0032355; P:response to estradiol; IEA:Ensembl
O95436	SLC34A2	Sodium-dependent phosphate transport protein 2B	GO:0043627; P:response to estrogen; IEP:UniProtKB
O95436	SLC34A2	Sodium-dependent phosphate transport protein 2B	GO:0009750; P:response to fructose; IEA:Ensembl
O95436	SLC34A2	Sodium-dependent phosphate transport protein 2B	GO:0035725; P:sodium ion transmembrane transport; IDA:GOC
O95436	SLC34A2	Sodium-dependent phosphate transport protein 2B	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8N130	SLC34A3	Sodium-dependent phosphate transport protein 2C	GO:0015321; F:sodium-dependent phosphate transmembrane transporter activity; IDA:UniProtKB
Q8N130	SLC34A3	Sodium-dependent phosphate transport protein 2C	GO:0005436; F:sodium:phosphate symporter activity; IDA:UniProtKB
Q8N130	SLC34A3	Sodium-dependent phosphate transport protein 2C	GO:0030643; P:cellular phosphate ion homeostasis; IDA:UniProtKB
Q8N130	SLC34A3	Sodium-dependent phosphate transport protein 2C	GO:0006811; P:ion transport; TAS:Reactome
Q8N130	SLC34A3	Sodium-dependent phosphate transport protein 2C	GO:0035435; P:phosphate ion transmembrane transport; IDA:GOC
Q8N130	SLC34A3	Sodium-dependent phosphate transport protein 2C	GO:0006817; P:phosphate ion transport; IDA:UniProtKB
Q8N130	SLC34A3	Sodium-dependent phosphate transport protein 2C	GO:0035725; P:sodium ion transmembrane transport; IDA:GOC
Q8N130	SLC34A3	Sodium-dependent phosphate transport protein 2C	GO:0006814; P:sodium ion transport; IDA:UniProtKB
Q8N130	SLC34A3	Sodium-dependent phosphate transport protein 2C	GO:0055085; P:transmembrane transport; TAS:Reactome
O00624	SLC17A2	Sodium-dependent phosphate transport protein 3	GO:0005436; F:sodium:phosphate symporter activity; TAS:ProtInc
O00624	SLC17A2	Sodium-dependent phosphate transport protein 3	GO:0035435; P:phosphate ion transmembrane transport; TAS:GOC
O00624	SLC17A2	Sodium-dependent phosphate transport protein 3	GO:0006796; P:phosphate-containing compound metabolic process; TAS:ProtInc
O00624	SLC17A2	Sodium-dependent phosphate transport protein 3	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
O00624	SLC17A2	Sodium-dependent phosphate transport protein 3	GO:0006814; P:sodium ion transport; TAS:ProtInc
O00624	SLC17A2	Sodium-dependent phosphate transport protein 3	GO:0055085; P:transmembrane transport; IEA:InterPro
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0015238; F:drug transmembrane transporter activity; IDA:UniProtKB
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0015562; F:efflux transmembrane transporter activity; IDA:UniProtKB
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0008514; F:organic anion transmembrane transporter activity; IDA:UniProtKB
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0005436; F:sodium:phosphate symporter activity; ISS:UniProtKB
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0019534; F:toxin transporter activity; IDA:UniProtKB
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0015143; F:urate transmembrane transporter activity; IDA:UniProtKB
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0008308; F:voltage-gated anion channel activity; IDA:UniProtKB
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0006855; P:drug transmembrane transport; IDA:GOC
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0015893; P:drug transport; IDA:UniProtKB
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0015760; P:glucose-6-phosphate transport; TAS:UniProtKB
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0034220; P:ion transmembrane transport; TAS:Reactome
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0015849; P:organic acid transport; IDA:GOC
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0015711; P:organic anion transport; IDA:UniProtKB
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0035435; P:phosphate ion transmembrane transport; ISS:GOC
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0006817; P:phosphate ion transport; ISS:UniProtKB
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0044070; P:regulation of anion transport; IDA:GOC
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0035725; P:sodium ion transmembrane transport; ISS:GOC
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0006814; P:sodium ion transport; ISS:UniProtKB
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:1901998; P:toxin transport; IDA:GOC
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0055085; P:transmembrane transport; TAS:Reactome
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0046415; P:urate metabolic process; IMP:UniProtKB
O00476	SLC17A3	Sodium-dependent phosphate transport protein 4	GO:0015747; P:urate transport; IDA:UniProtKB
Q9Y639	NPTN	Neuroplastin	GO:0050839; F:cell adhesion molecule binding; ISS:HGNC
Q9Y639	NPTN	Neuroplastin	GO:0005105; F:type 1 fibroblast growth factor receptor binding; ISS:UniProtKB
Q9Y639	NPTN	Neuroplastin	GO:0007156; P:homophilic cell adhesion; ISS:HGNC
Q9Y639	NPTN	Neuroplastin	GO:0060291; P:long-term synaptic potentiation; ISS:UniProtKB
Q9Y639	NPTN	Neuroplastin	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISS:UniProtKB
Q9Y639	NPTN	Neuroplastin	GO:0045743; P:positive regulation of fibroblast growth factor receptor signaling pathway; ISS:UniProtKB
Q9Y639	NPTN	Neuroplastin	GO:0048170; P:positive regulation of long-term neuronal synaptic plasticity; ISS:HGNC
Q9Y639	NPTN	Neuroplastin	GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB
Q9Y639	NPTN	Neuroplastin	GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB
Q15818	NPTX1	Neuronal pentraxin-1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15818	NPTX1	Neuronal pentraxin-1	GO:0060385; P:axonogenesis involved in innervation; IEA:Ensembl
Q15818	NPTX1	Neuronal pentraxin-1	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
Q15818	NPTX1	Neuronal pentraxin-1	GO:0035865; P:cellular response to potassium ion; IEA:Ensembl
Q15818	NPTX1	Neuronal pentraxin-1	GO:0007417; P:central nervous system development; TAS:ProtInc
Q15818	NPTX1	Neuronal pentraxin-1	GO:0043653; P:mitochondrial fragmentation involved in apoptotic process; IEA:Ensembl
Q15818	NPTX1	Neuronal pentraxin-1	GO:0006839; P:mitochondrial transport; IEA:Ensembl
Q15818	NPTX1	Neuronal pentraxin-1	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q15818	NPTX1	Neuronal pentraxin-1	GO:0006810; P:transport; TAS:ProtInc
P47972	NPTX2	Neuronal pentraxin-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P47972	NPTX2	Neuronal pentraxin-2	GO:0007268; P:synaptic transmission; NAS:UniProtKB
O95502	NPTXR	Neuronal pentraxin receptor	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HCQ7	NPVF	Pro-FMRFamide-related neuropeptide VF	GO:0032277; P:negative regulation of gonadotropin secretion; IDA:UniProtKB
Q9HCQ7	NPVF	Pro-FMRFamide-related neuropeptide VF	GO:0007218; P:neuropeptide signaling pathway; NAS:UniProtKB
Q8N729	NPW	Neuropeptide W	GO:0005515; F:protein binding; IPI:HGNC
Q8N729	NPW	Neuropeptide W	GO:0007631; P:feeding behavior; IDA:HGNC
Q8N729	NPW	Neuropeptide W	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:HGNC
Q8N729	NPW	Neuropeptide W	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
P25929	NPY1R	Neuropeptide Y receptor type 1	GO:0004983; F:neuropeptide Y receptor activity; TAS:ProtInc
P25929	NPY1R	Neuropeptide Y receptor type 1	GO:0001602; F:pancreatic polypeptide receptor activity; IEA:Ensembl
P25929	NPY1R	Neuropeptide Y receptor type 1	GO:0001601; F:peptide YY receptor activity; IEA:Ensembl
P25929	NPY1R	Neuropeptide Y receptor type 1	GO:0005515; F:protein binding; IPI:IntAct
P25929	NPY1R	Neuropeptide Y receptor type 1	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:ProtInc
P25929	NPY1R	Neuropeptide Y receptor type 1	GO:0007631; P:feeding behavior; IEA:Ensembl
P25929	NPY1R	Neuropeptide Y receptor type 1	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P25929	NPY1R	Neuropeptide Y receptor type 1	GO:0006006; P:glucose metabolic process; IEA:Ensembl
P25929	NPY1R	Neuropeptide Y receptor type 1	GO:0007626; P:locomotory behavior; IEA:Ensembl
P25929	NPY1R	Neuropeptide Y receptor type 1	GO:0007218; P:neuropeptide signaling pathway; TAS:GOC
P25929	NPY1R	Neuropeptide Y receptor type 1	GO:0003151; P:outflow tract morphogenesis; IMP:BHF-UCL
P25929	NPY1R	Neuropeptide Y receptor type 1	GO:0008217; P:regulation of blood pressure; IEA:Ensembl
P25929	NPY1R	Neuropeptide Y receptor type 1	GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl
P25929	NPY1R	Neuropeptide Y receptor type 1	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0005246; F:calcium channel regulator activity; TAS:ProtInc
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0004983; F:neuropeptide Y receptor activity; TAS:ProtInc
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0001601; F:peptide YY receptor activity; IEA:Ensembl
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0005515; F:protein binding; IPI:IntAct
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0004872; F:receptor activity; TAS:ProtInc
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:ProtInc
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0001662; P:behavioral fear response; IEA:Ensembl
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0003214; P:cardiac left ventricle morphogenesis; IMP:BHF-UCL
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0007626; P:locomotory behavior; TAS:ProtInc
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0030818; P:negative regulation of cAMP biosynthetic process; IEA:Ensembl
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0090394; P:negative regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:2000252; P:negative regulation of feeding behavior; IEA:Ensembl
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0031645; P:negative regulation of neurological system process; IEA:Ensembl
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0051048; P:negative regulation of secretion; IEA:Ensembl
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0051967; P:negative regulation of synaptic transmission, glutamatergic; IEA:Ensembl
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0007218; P:neuropeptide signaling pathway; TAS:GOC
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0007263; P:nitric oxide mediated signal transduction; IEA:Ensembl
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0003151; P:outflow tract morphogenesis; IMP:BHF-UCL
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0045785; P:positive regulation of cell adhesion; IEA:Ensembl
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0046010; P:positive regulation of circadian sleep/wake cycle, non-REM sleep; IEA:Ensembl
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0033603; P:positive regulation of dopamine secretion; IEA:Ensembl
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0002793; P:positive regulation of peptide secretion; IEA:Ensembl
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0045987; P:positive regulation of smooth muscle contraction; IEA:Ensembl
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0051930; P:regulation of sensory perception of pain; IEA:Ensembl
P49146	NPY2R	Neuropeptide Y receptor type 2	GO:0046903; P:secretion; IEA:Ensembl
P50391	NPY4R	Neuropeptide Y receptor type 4	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P50391	NPY4R	Neuropeptide Y receptor type 4	GO:0001602; F:pancreatic polypeptide receptor activity; IEA:Ensembl
P50391	NPY4R	Neuropeptide Y receptor type 4	GO:0042277; F:peptide binding; IEA:Ensembl
P50391	NPY4R	Neuropeptide Y receptor type 4	GO:0001601; F:peptide YY receptor activity; IEA:Ensembl
P50391	NPY4R	Neuropeptide Y receptor type 4	GO:0008015; P:blood circulation; TAS:ProtInc
P50391	NPY4R	Neuropeptide Y receptor type 4	GO:0007586; P:digestion; TAS:ProtInc
P50391	NPY4R	Neuropeptide Y receptor type 4	GO:0007631; P:feeding behavior; TAS:ProtInc
P50391	NPY4R	Neuropeptide Y receptor type 4	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q15761	NPY5R	Neuropeptide Y receptor type 5	GO:0004983; F:neuropeptide Y receptor activity; TAS:ProtInc
Q15761	NPY5R	Neuropeptide Y receptor type 5	GO:0001602; F:pancreatic polypeptide receptor activity; IEA:Ensembl
Q15761	NPY5R	Neuropeptide Y receptor type 5	GO:0001601; F:peptide YY receptor activity; IEA:Ensembl
Q15761	NPY5R	Neuropeptide Y receptor type 5	GO:0003214; P:cardiac left ventricle morphogenesis; IMP:BHF-UCL
Q15761	NPY5R	Neuropeptide Y receptor type 5	GO:0042755; P:eating behavior; IEA:Ensembl
Q15761	NPY5R	Neuropeptide Y receptor type 5	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q15761	NPY5R	Neuropeptide Y receptor type 5	GO:0060112; P:generation of ovulation cycle rhythm; IEA:Ensembl
Q15761	NPY5R	Neuropeptide Y receptor type 5	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q15761	NPY5R	Neuropeptide Y receptor type 5	GO:0014050; P:negative regulation of glutamate secretion; IEA:Ensembl
Q15761	NPY5R	Neuropeptide Y receptor type 5	GO:0032229; P:negative regulation of synaptic transmission, GABAergic; IEA:Ensembl
Q15761	NPY5R	Neuropeptide Y receptor type 5	GO:0007218; P:neuropeptide signaling pathway; TAS:GOC
Q15761	NPY5R	Neuropeptide Y receptor type 5	GO:0003151; P:outflow tract morphogenesis; IMP:BHF-UCL
Q15761	NPY5R	Neuropeptide Y receptor type 5	GO:0002675; P:positive regulation of acute inflammatory response; IEA:Ensembl
Q15761	NPY5R	Neuropeptide Y receptor type 5	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
Q99463	NPY6R	Putative neuropeptide Y receptor type 6	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
P01303	NPY	Pro-neuropeptide Y	GO:0005246; F:calcium channel regulator activity; TAS:ProtInc
P01303	NPY	Pro-neuropeptide Y	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P01303	NPY	Pro-neuropeptide Y	GO:0005184; F:neuropeptide hormone activity; TAS:ProtInc
P01303	NPY	Pro-neuropeptide Y	GO:0005102; F:receptor binding; TAS:ProtInc
P01303	NPY	Pro-neuropeptide Y	GO:0008343; P:adult feeding behavior; ISS:HGNC
P01303	NPY	Pro-neuropeptide Y	GO:0007610; P:behavior; TAS:ProtInc
P01303	NPY	Pro-neuropeptide Y	GO:0008015; P:blood circulation; NAS:ProtInc
P01303	NPY	Pro-neuropeptide Y	GO:0006816; P:calcium ion transport; TAS:ProtInc
P01303	NPY	Pro-neuropeptide Y	GO:0008283; P:cell proliferation; TAS:ProtInc
P01303	NPY	Pro-neuropeptide Y	GO:0006928; P:cellular component movement; TAS:ProtInc
P01303	NPY	Pro-neuropeptide Y	GO:0021954; P:central nervous system neuron development; IEP:DFLAT
P01303	NPY	Pro-neuropeptide Y	GO:0021987; P:cerebral cortex development; IEP:DFLAT
P01303	NPY	Pro-neuropeptide Y	GO:0007586; P:digestion; NAS:ProtInc
P01303	NPY	Pro-neuropeptide Y	GO:0007631; P:feeding behavior; TAS:ProtInc
P01303	NPY	Pro-neuropeptide Y	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P01303	NPY	Pro-neuropeptide Y	GO:0031175; P:neuron projection development; IEP:DFLAT
P01303	NPY	Pro-neuropeptide Y	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
P01303	NPY	Pro-neuropeptide Y	GO:0032100; P:positive regulation of appetite; ISS:HGNC
P01303	NPY	Pro-neuropeptide Y	GO:0008217; P:regulation of blood pressure; IEA:Ensembl
P01303	NPY	Pro-neuropeptide Y	GO:0007268; P:synaptic transmission; TAS:ProtInc
P15559	NQO1	NAD(P)H dehydrogenase [quinone] 1	GO:0004128; F:cytochrome-b5 reductase activity, acting on NAD(P)H; TAS:ProtInc
P15559	NQO1	NAD(P)H dehydrogenase [quinone] 1	GO:0003955; F:NAD(P)H dehydrogenase (quinone) activity; TAS:ProtInc
P15559	NQO1	NAD(P)H dehydrogenase [quinone] 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P15559	NQO1	NAD(P)H dehydrogenase [quinone] 1	GO:0005515; F:protein binding; IPI:IntAct
P15559	NQO1	NAD(P)H dehydrogenase [quinone] 1	GO:0004784; F:superoxide dismutase activity; IEA:Ensembl
P15559	NQO1	NAD(P)H dehydrogenase [quinone] 1	GO:0007568; P:aging; IEA:Ensembl
P15559	NQO1	NAD(P)H dehydrogenase [quinone] 1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P15559	NQO1	NAD(P)H dehydrogenase [quinone] 1	GO:0043086; P:negative regulation of catalytic activity; IEA:Ensembl
P15559	NQO1	NAD(P)H dehydrogenase [quinone] 1	GO:0006809; P:nitric oxide biosynthetic process; TAS:ProtInc
P15559	NQO1	NAD(P)H dehydrogenase [quinone] 1	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
P15559	NQO1	NAD(P)H dehydrogenase [quinone] 1	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P15559	NQO1	NAD(P)H dehydrogenase [quinone] 1	GO:0032355; P:response to estradiol; IEA:Ensembl
P15559	NQO1	NAD(P)H dehydrogenase [quinone] 1	GO:0045471; P:response to ethanol; IEA:Ensembl
P15559	NQO1	NAD(P)H dehydrogenase [quinone] 1	GO:0007584; P:response to nutrient; IEA:Ensembl
P15559	NQO1	NAD(P)H dehydrogenase [quinone] 1	GO:0006979; P:response to oxidative stress; IEA:Ensembl
P15559	NQO1	NAD(P)H dehydrogenase [quinone] 1	GO:0009636; P:response to toxic substance; TAS:ProtInc
P15559	NQO1	NAD(P)H dehydrogenase [quinone] 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P15559	NQO1	NAD(P)H dehydrogenase [quinone] 1	GO:0006801; P:superoxide metabolic process; IEA:Ensembl
P15559	NQO1	NAD(P)H dehydrogenase [quinone] 1	GO:0007271; P:synaptic transmission, cholinergic; TAS:ProtInc
P15559	NQO1	NAD(P)H dehydrogenase [quinone] 1	GO:0006805; P:xenobiotic metabolic process; TAS:ProtInc
P16083	NQO2	Ribosyldihydronicotinamide dehydrogenase [quinone]	GO:0001512; F:dihydronicotinamide riboside quinone reductase activity; IEA:UniProtKB-EC
P16083	NQO2	Ribosyldihydronicotinamide dehydrogenase [quinone]	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P16083	NQO2	Ribosyldihydronicotinamide dehydrogenase [quinone]	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P16083	NQO2	Ribosyldihydronicotinamide dehydrogenase [quinone]	GO:0008753; F:NADPH dehydrogenase (quinone) activity; TAS:ProtInc
P16083	NQO2	Ribosyldihydronicotinamide dehydrogenase [quinone]	GO:0007613; P:memory; IEA:Ensembl
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0050682; F:AF-2 domain binding; IPI:UniProtKB
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0003677; F:DNA binding; IDA:HGNC
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0032448; F:DNA hairpin binding; IDA:HGNC
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; NAS:UniProtKB
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0005515; F:protein binding; IPI:UniProtKB
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0003723; F:RNA binding; IDA:HGNC
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0043565; F:sequence-specific DNA binding; IDA:HGNC
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0035258; F:steroid hormone receptor binding; IPI:UniProtKB
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0003714; F:transcription corepressor activity; IMP:BHF-UCL
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0030325; P:adrenal gland development; IMP:HGNC
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0010467; P:gene expression; TAS:Reactome
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0008406; P:gonad development; IMP:HGNC
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0021854; P:hypothalamus development; NAS:UniProtKB
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0030522; P:intracellular receptor signaling pathway; IDA:GOC
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0033327; P:Leydig cell differentiation; IEA:Ensembl
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0008584; P:male gonad development; IMP:UniProtKB
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0030238; P:male sex determination; IEA:Ensembl
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0045596; P:negative regulation of cell differentiation; IEA:Ensembl
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0033144; P:negative regulation of intracellular steroid hormone receptor signaling pathway; IDA:UniProtKB
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:HGNC
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0021983; P:pituitary gland development; NAS:UniProtKB
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0008104; P:protein localization; IDA:UniProtKB
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0035902; P:response to immobilization stress; IEA:Ensembl
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0060008; P:Sertoli cell differentiation; IEA:Ensembl
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0007283; P:spermatogenesis; IEA:Ensembl
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0006694; P:steroid biosynthetic process; IDA:HGNC
P51843	NR0B1	Nuclear receptor subfamily 0 group B member 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q15466	NR0B2	Nuclear receptor subfamily 0 group B member 2	GO:0003677; F:DNA binding; IEA:InterPro
Q15466	NR0B2	Nuclear receptor subfamily 0 group B member 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q15466	NR0B2	Nuclear receptor subfamily 0 group B member 2	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q15466	NR0B2	Nuclear receptor subfamily 0 group B member 2	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q15466	NR0B2	Nuclear receptor subfamily 0 group B member 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q15466	NR0B2	Nuclear receptor subfamily 0 group B member 2	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
Q15466	NR0B2	Nuclear receptor subfamily 0 group B member 2	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q15466	NR0B2	Nuclear receptor subfamily 0 group B member 2	GO:0008203; P:cholesterol metabolic process; TAS:ProtInc
Q15466	NR0B2	Nuclear receptor subfamily 0 group B member 2	GO:0010467; P:gene expression; TAS:Reactome
Q15466	NR0B2	Nuclear receptor subfamily 0 group B member 2	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q15466	NR0B2	Nuclear receptor subfamily 0 group B member 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q15466	NR0B2	Nuclear receptor subfamily 0 group B member 2	GO:0031100; P:organ regeneration; IEA:Ensembl
Q15466	NR0B2	Nuclear receptor subfamily 0 group B member 2	GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl
Q15466	NR0B2	Nuclear receptor subfamily 0 group B member 2	GO:0009749; P:response to glucose; IEA:Ensembl
Q15466	NR0B2	Nuclear receptor subfamily 0 group B member 2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0001046; F:core promoter sequence-specific DNA binding; IDA:UniProtKB
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0020037; F:heme binding; IDA:UniProtKB
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; TAS:ProtInc
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0005515; F:protein binding; IPI:UniProtKB
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0003707; F:steroid hormone receptor activity; TAS:ProtInc
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0001222; F:transcription corepressor binding; IDA:UniProtKB
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0008270; F:zinc ion binding; IEA:InterPro
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0071222; P:cellular response to lipopolysaccharide; IMP:BHF-UCL
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0060086; P:circadian temperature homeostasis; ISS:UniProtKB
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0010467; P:gene expression; TAS:Reactome
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0030522; P:intracellular receptor signaling pathway; TAS:GOC
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0010871; P:negative regulation of receptor biosynthetic process; IMP:BHF-UCL
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0034144; P:negative regulation of toll-like receptor 4 signaling pathway; IMP:BHF-UCL
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0070859; P:positive regulation of bile acid biosynthetic process; ISS:UniProtKB
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0010498; P:proteasomal protein catabolic process; ISS:UniProtKB
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:2000188; P:regulation of cholesterol homeostasis; ISS:UniProtKB
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0045598; P:regulation of fat cell differentiation; ISS:UniProtKB
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0035947; P:regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0019216; P:regulation of lipid metabolic process; ISS:UniProtKB
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0061469; P:regulation of type B pancreatic cell proliferation; ISS:UniProtKB
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0044321; P:response to leptin; ISS:UniProtKB
P20393	NR1D1	Nuclear receptor subfamily 1 group D member 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q14995	NR1D2	Nuclear receptor subfamily 1 group D member 2	GO:0001046; F:core promoter sequence-specific DNA binding; IDA:UniProtKB
Q14995	NR1D2	Nuclear receptor subfamily 1 group D member 2	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; TAS:UniProtKB
Q14995	NR1D2	Nuclear receptor subfamily 1 group D member 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q14995	NR1D2	Nuclear receptor subfamily 1 group D member 2	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
Q14995	NR1D2	Nuclear receptor subfamily 1 group D member 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q14995	NR1D2	Nuclear receptor subfamily 1 group D member 2	GO:0010467; P:gene expression; TAS:Reactome
Q14995	NR1D2	Nuclear receptor subfamily 1 group D member 2	GO:0030522; P:intracellular receptor signaling pathway; TAS:GOC
Q14995	NR1D2	Nuclear receptor subfamily 1 group D member 2	GO:0055088; P:lipid homeostasis; ISS:UniProtKB
Q14995	NR1D2	Nuclear receptor subfamily 1 group D member 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q14995	NR1D2	Nuclear receptor subfamily 1 group D member 2	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q14995	NR1D2	Nuclear receptor subfamily 1 group D member 2	GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB
Q14995	NR1D2	Nuclear receptor subfamily 1 group D member 2	GO:2000505; P:regulation of energy homeostasis; ISS:UniProtKB
Q14995	NR1D2	Nuclear receptor subfamily 1 group D member 2	GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB
Q14995	NR1D2	Nuclear receptor subfamily 1 group D member 2	GO:0019216; P:regulation of lipid metabolic process; ISS:UniProtKB
Q14995	NR1D2	Nuclear receptor subfamily 1 group D member 2	GO:2001014; P:regulation of skeletal muscle cell differentiation; ISS:UniProtKB
Q14995	NR1D2	Nuclear receptor subfamily 1 group D member 2	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q14995	NR1D2	Nuclear receptor subfamily 1 group D member 2	GO:0048511; P:rhythmic process; IEA:UniProtKB-KW
Q14995	NR1D2	Nuclear receptor subfamily 1 group D member 2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0003677; F:DNA binding; TAS:ProtInc
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; TAS:ProtInc
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0005515; F:protein binding; IPI:IntAct
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0001133; F:sequence-specific transcription regulatory region DNA binding RNA polymerase II transcription factor recruiting transcription factor activity; IEA:Ensembl
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0008270; F:zinc ion binding; IEA:InterPro
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0044255; P:cellular lipid metabolic process; IEA:Ensembl
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0042632; P:cholesterol homeostasis; IEA:Ensembl
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0010467; P:gene expression; TAS:Reactome
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0010887; P:negative regulation of cholesterol storage; IMP:BHF-UCL
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0060336; P:negative regulation of interferon-gamma-mediated signaling pathway; NAS:BHF-UCL
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0032369; P:negative regulation of lipid transport; IMP:BHF-UCL
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; IC:BHF-UCL
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0048550; P:negative regulation of pinocytosis; IMP:BHF-UCL
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0045861; P:negative regulation of proteolysis; IEA:Ensembl
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:HGNC
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0032270; P:positive regulation of cellular protein metabolic process; IMP:BHF-UCL
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0010875; P:positive regulation of cholesterol efflux; IMP:BHF-UCL
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0032376; P:positive regulation of cholesterol transport; IDA:BHF-UCL
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0045723; P:positive regulation of fatty acid biosynthetic process; IMP:BHF-UCL
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0090108; P:positive regulation of high-density lipoprotein particle assembly; IEA:Ensembl
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0010884; P:positive regulation of lipid storage; IEA:Ensembl
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0051006; P:positive regulation of lipoprotein lipase activity; IMP:BHF-UCL
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0090187; P:positive regulation of pancreatic juice secretion; IEA:Ensembl
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0090340; P:positive regulation of secretion of lysosomal enzymes; IEA:Ensembl
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0010867; P:positive regulation of triglyceride biosynthetic process; IMP:BHF-UCL
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:2000188; P:regulation of cholesterol homeostasis; ISS:UniProtKB
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0048384; P:retinoic acid receptor signaling pathway; IEA:Ensembl
P55055	NR1H2	Oxysterols receptor LXR-beta	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0015485; F:cholesterol binding; TAS:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0003677; F:DNA binding; TAS:ProtInc
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; TAS:ProtInc
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0005515; F:protein binding; IPI:UniProtKB
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0032810; F:sterol response element binding; IDA:UniProtKB
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0043277; P:apoptotic cell clearance; IMP:UniProtKB
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0044255; P:cellular lipid metabolic process; IEA:Ensembl
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0071222; P:cellular response to lipopolysaccharide; IDA:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0042632; P:cholesterol homeostasis; ISS:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0010467; P:gene expression; TAS:Reactome
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0055088; P:lipid homeostasis; ISS:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0010887; P:negative regulation of cholesterol storage; IMP:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0050728; P:negative regulation of inflammatory response; ISS:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0060336; P:negative regulation of interferon-gamma-mediated signaling pathway; NAS:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0032369; P:negative regulation of lipid transport; IMP:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0043031; P:negative regulation of macrophage activation; ISS:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; IC:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0090188; P:negative regulation of pancreatic juice secretion; ISS:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0048550; P:negative regulation of pinocytosis; IMP:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0045861; P:negative regulation of proteolysis; IEA:Ensembl
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0090341; P:negative regulation of secretion of lysosomal enzymes; ISS:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0032270; P:positive regulation of cellular protein metabolic process; IMP:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0010875; P:positive regulation of cholesterol efflux; IDA:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:2000189; P:positive regulation of cholesterol homeostasis; IDA:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0032376; P:positive regulation of cholesterol transport; IDA:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0045723; P:positive regulation of fatty acid biosynthetic process; IMP:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0051006; P:positive regulation of lipoprotein lipase activity; IMP:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0010870; P:positive regulation of receptor biosynthetic process; IDA:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0034145; P:positive regulation of toll-like receptor 4 signaling pathway; IDA:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0010867; P:positive regulation of triglyceride biosynthetic process; IMP:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:2000188; P:regulation of cholesterol homeostasis; ISS:UniProtKB
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0042752; P:regulation of circadian rhythm; TAS:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0032570; P:response to progesterone; IDA:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0055092; P:sterol homeostasis; ISS:BHF-UCL
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q13133	NR1H3	Oxysterols receptor LXR-alpha	GO:0070328; P:triglyceride homeostasis; ISS:BHF-UCL
O75469	NR1I2	Nuclear receptor subfamily 1 group I member 2	GO:0008144; F:drug binding; IDA:UniProtKB
O75469	NR1I2	Nuclear receptor subfamily 1 group I member 2	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:UniProtKB
O75469	NR1I2	Nuclear receptor subfamily 1 group I member 2	GO:0005515; F:protein binding; IPI:UniProtKB
O75469	NR1I2	Nuclear receptor subfamily 1 group I member 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O75469	NR1I2	Nuclear receptor subfamily 1 group I member 2	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
O75469	NR1I2	Nuclear receptor subfamily 1 group I member 2	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
O75469	NR1I2	Nuclear receptor subfamily 1 group I member 2	GO:0008270; F:zinc ion binding; IEA:InterPro
O75469	NR1I2	Nuclear receptor subfamily 1 group I member 2	GO:0046618; P:drug export; IDA:UniProtKB
O75469	NR1I2	Nuclear receptor subfamily 1 group I member 2	GO:0042738; P:exogenous drug catabolic process; IDA:UniProtKB
O75469	NR1I2	Nuclear receptor subfamily 1 group I member 2	GO:0010467; P:gene expression; TAS:Reactome
O75469	NR1I2	Nuclear receptor subfamily 1 group I member 2	GO:0030522; P:intracellular receptor signaling pathway; IDA:GOC
O75469	NR1I2	Nuclear receptor subfamily 1 group I member 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:MGI
O75469	NR1I2	Nuclear receptor subfamily 1 group I member 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O75469	NR1I2	Nuclear receptor subfamily 1 group I member 2	GO:0007165; P:signal transduction; TAS:ProtInc
O75469	NR1I2	Nuclear receptor subfamily 1 group I member 2	GO:0008202; P:steroid metabolic process; TAS:ProtInc
O75469	NR1I2	Nuclear receptor subfamily 1 group I member 2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
O75469	NR1I2	Nuclear receptor subfamily 1 group I member 2	GO:0006805; P:xenobiotic metabolic process; IDA:UniProtKB
O75469	NR1I2	Nuclear receptor subfamily 1 group I member 2	GO:0042908; P:xenobiotic transport; IDA:UniProtKB
Q96RI1	NR1H4	Bile acid receptor	GO:0032052; F:bile acid binding; ISS:BHF-UCL
Q96RI1	NR1H4	Bile acid receptor	GO:0038181; F:bile acid receptor activity; IDA:UniProtKB
Q96RI1	NR1H4	Bile acid receptor	GO:1902122; F:chenodeoxycholic acid binding; IDA:UniProtKB
Q96RI1	NR1H4	Bile acid receptor	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; ISS:BHF-UCL
Q96RI1	NR1H4	Bile acid receptor	GO:0016922; F:ligand-dependent nuclear receptor binding; TAS:BHF-UCL
Q96RI1	NR1H4	Bile acid receptor	GO:0042277; F:peptide binding; IEA:Ensembl
Q96RI1	NR1H4	Bile acid receptor	GO:0005515; F:protein binding; IPI:UniProtKB
Q96RI1	NR1H4	Bile acid receptor	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IDA:BHF-UCL
Q96RI1	NR1H4	Bile acid receptor	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q96RI1	NR1H4	Bile acid receptor	GO:0001190; F:RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription; IDA:BHF-UCL
Q96RI1	NR1H4	Bile acid receptor	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q96RI1	NR1H4	Bile acid receptor	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q96RI1	NR1H4	Bile acid receptor	GO:0003707; F:steroid hormone receptor activity; IEA:Ensembl
Q96RI1	NR1H4	Bile acid receptor	GO:0004887; F:thyroid hormone receptor activity; IEA:InterPro
Q96RI1	NR1H4	Bile acid receptor	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q96RI1	NR1H4	Bile acid receptor	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q96RI1	NR1H4	Bile acid receptor	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96RI1	NR1H4	Bile acid receptor	GO:0008206; P:bile acid metabolic process; IEA:Ensembl
Q96RI1	NR1H4	Bile acid receptor	GO:0071229; P:cellular response to acid; IDA:BHF-UCL
Q96RI1	NR1H4	Bile acid receptor	GO:0071417; P:cellular response to organonitrogen compound; ISS:BHF-UCL
Q96RI1	NR1H4	Bile acid receptor	GO:0048565; P:digestive tract development; IEA:Ensembl
Q96RI1	NR1H4	Bile acid receptor	GO:0010467; P:gene expression; TAS:Reactome
Q96RI1	NR1H4	Bile acid receptor	GO:0038185; P:intracellular bile acid receptor signaling pathway; IDA:UniProtKB
Q96RI1	NR1H4	Bile acid receptor	GO:0030522; P:intracellular receptor signaling pathway; ISS:BHF-UCL
Q96RI1	NR1H4	Bile acid receptor	GO:0070858; P:negative regulation of bile acid biosynthetic process; IDA:UniProtKB
Q96RI1	NR1H4	Bile acid receptor	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q96RI1	NR1H4	Bile acid receptor	GO:0001080; P:nitrogen catabolite activation of transcription from RNA polymerase II promoter; IC:BHF-UCL
Q96RI1	NR1H4	Bile acid receptor	GO:2001250; P:positive regulation of ammonia assimilation cycle; IEA:Ensembl
Q96RI1	NR1H4	Bile acid receptor	GO:2000213; P:positive regulation of glutamate metabolic process; ISS:BHF-UCL
Q96RI1	NR1H4	Bile acid receptor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q96RI1	NR1H4	Bile acid receptor	GO:0070857; P:regulation of bile acid biosynthetic process; TAS:BHF-UCL
Q96RI1	NR1H4	Bile acid receptor	GO:0006109; P:regulation of carbohydrate metabolic process; IEA:Ensembl
Q96RI1	NR1H4	Bile acid receptor	GO:0090181; P:regulation of cholesterol metabolic process; TAS:BHF-UCL
Q96RI1	NR1H4	Bile acid receptor	GO:0034255; P:regulation of urea metabolic process; ISS:BHF-UCL
Q96RI1	NR1H4	Bile acid receptor	GO:0009749; P:response to glucose; IEA:Ensembl
Q96RI1	NR1H4	Bile acid receptor	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
Q96RI1	NR1H4	Bile acid receptor	GO:0007165; P:signal transduction; TAS:ProtInc
Q96RI1	NR1H4	Bile acid receptor	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q14994	NR1I3	Nuclear receptor subfamily 1 group I member 3	GO:0004882; F:androgen receptor activity; TAS:ProtInc
Q14994	NR1I3	Nuclear receptor subfamily 1 group I member 3	GO:0003677; F:DNA binding; TAS:ProtInc
Q14994	NR1I3	Nuclear receptor subfamily 1 group I member 3	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; TAS:ProtInc
Q14994	NR1I3	Nuclear receptor subfamily 1 group I member 3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q14994	NR1I3	Nuclear receptor subfamily 1 group I member 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q14994	NR1I3	Nuclear receptor subfamily 1 group I member 3	GO:0004887; F:thyroid hormone receptor activity; IEA:InterPro
Q14994	NR1I3	Nuclear receptor subfamily 1 group I member 3	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q14994	NR1I3	Nuclear receptor subfamily 1 group I member 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q14994	NR1I3	Nuclear receptor subfamily 1 group I member 3	GO:0030521; P:androgen receptor signaling pathway; TAS:GOC
Q14994	NR1I3	Nuclear receptor subfamily 1 group I member 3	GO:0010467; P:gene expression; TAS:Reactome
Q14994	NR1I3	Nuclear receptor subfamily 1 group I member 3	GO:0030522; P:intracellular receptor signaling pathway; TAS:GOC
Q14994	NR1I3	Nuclear receptor subfamily 1 group I member 3	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q14994	NR1I3	Nuclear receptor subfamily 1 group I member 3	GO:0007165; P:signal transduction; TAS:ProtInc
Q14994	NR1I3	Nuclear receptor subfamily 1 group I member 3	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P13056	NR2C1	Nuclear receptor subfamily 2 group C member 1	GO:0003677; F:DNA binding; TAS:ProtInc
P13056	NR2C1	Nuclear receptor subfamily 2 group C member 1	GO:0005515; F:protein binding; IPI:UniProtKB
P13056	NR2C1	Nuclear receptor subfamily 2 group C member 1	GO:0004872; F:receptor activity; TAS:ProtInc
P13056	NR2C1	Nuclear receptor subfamily 2 group C member 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P13056	NR2C1	Nuclear receptor subfamily 2 group C member 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P13056	NR2C1	Nuclear receptor subfamily 2 group C member 1	GO:0003707; F:steroid hormone receptor activity; TAS:ProtInc
P13056	NR2C1	Nuclear receptor subfamily 2 group C member 1	GO:0008270; F:zinc ion binding; IEA:InterPro
P13056	NR2C1	Nuclear receptor subfamily 2 group C member 1	GO:0010467; P:gene expression; TAS:Reactome
P13056	NR2C1	Nuclear receptor subfamily 2 group C member 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P13056	NR2C1	Nuclear receptor subfamily 2 group C member 1	GO:0048386; P:positive regulation of retinoic acid receptor signaling pathway; IEA:Ensembl
P13056	NR2C1	Nuclear receptor subfamily 2 group C member 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P49116	NR2C2	Nuclear receptor subfamily 2 group C member 2	GO:0005515; F:protein binding; IPI:UniProtKB
P49116	NR2C2	Nuclear receptor subfamily 2 group C member 2	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
P49116	NR2C2	Nuclear receptor subfamily 2 group C member 2	GO:0004872; F:receptor activity; TAS:ProtInc
P49116	NR2C2	Nuclear receptor subfamily 2 group C member 2	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
P49116	NR2C2	Nuclear receptor subfamily 2 group C member 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P49116	NR2C2	Nuclear receptor subfamily 2 group C member 2	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P49116	NR2C2	Nuclear receptor subfamily 2 group C member 2	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P49116	NR2C2	Nuclear receptor subfamily 2 group C member 2	GO:0008270; F:zinc ion binding; IEA:InterPro
P49116	NR2C2	Nuclear receptor subfamily 2 group C member 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P49116	NR2C2	Nuclear receptor subfamily 2 group C member 2	GO:0021549; P:cerebellum development; IEA:Ensembl
P49116	NR2C2	Nuclear receptor subfamily 2 group C member 2	GO:0010467; P:gene expression; TAS:Reactome
P49116	NR2C2	Nuclear receptor subfamily 2 group C member 2	GO:0051321; P:meiotic cell cycle; IEA:Ensembl
P49116	NR2C2	Nuclear receptor subfamily 2 group C member 2	GO:0007399; P:nervous system development; TAS:ProtInc
P49116	NR2C2	Nuclear receptor subfamily 2 group C member 2	GO:0048520; P:positive regulation of behavior; IEA:Ensembl
P49116	NR2C2	Nuclear receptor subfamily 2 group C member 2	GO:0040019; P:positive regulation of embryonic development; IEA:Ensembl
P49116	NR2C2	Nuclear receptor subfamily 2 group C member 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P49116	NR2C2	Nuclear receptor subfamily 2 group C member 2	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
P49116	NR2C2	Nuclear receptor subfamily 2 group C member 2	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
P49116	NR2C2	Nuclear receptor subfamily 2 group C member 2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q86WQ0	NR2C2AP	Nuclear receptor 2C2-associated protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q86WQ0	NR2C2AP	Nuclear receptor 2C2-associated protein	GO:0007155; P:cell adhesion; IEA:InterPro
Q86WQ0	NR2C2AP	Nuclear receptor 2C2-associated protein	GO:0010467; P:gene expression; TAS:Reactome
Q86WQ0	NR2C2AP	Nuclear receptor 2C2-associated protein	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0002118; P:aggressive behavior; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0021764; P:amygdala development; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0021960; P:anterior commissure morphogenesis; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0001662; P:behavioral fear response; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0045165; P:cell fate commitment; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0021895; P:cerebral cortex neuron differentiation; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0021542; P:dentate gyrus development; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0021872; P:forebrain generation of neurons; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0010467; P:gene expression; TAS:Reactome
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0008347; P:glial cell migration; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0021819; P:layer formation in cerebral cortex; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0048712; P:negative regulation of astrocyte differentiation; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:2000178; P:negative regulation of neural precursor cell proliferation; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0021772; P:olfactory bulb development; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0045787; P:positive regulation of cell cycle; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:2000179; P:positive regulation of neural precursor cell proliferation; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:2000648; P:positive regulation of stem cell proliferation; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0090049; P:regulation of cell migration involved in sprouting angiogenesis; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0048814; P:regulation of dendrite morphogenesis; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0060164; P:regulation of timing of neuron differentiation; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0035176; P:social behavior; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y466	NR2E1	Nuclear receptor subfamily 2 group E member 1	GO:0007601; P:visual perception; IEA:Ensembl
Q9Y5X4	NR2E3	Photoreceptor-specific nuclear receptor	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; TAS:ProtInc
Q9Y5X4	NR2E3	Photoreceptor-specific nuclear receptor	GO:0005515; F:protein binding; IPI:IntAct
Q9Y5X4	NR2E3	Photoreceptor-specific nuclear receptor	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9Y5X4	NR2E3	Photoreceptor-specific nuclear receptor	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
Q9Y5X4	NR2E3	Photoreceptor-specific nuclear receptor	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y5X4	NR2E3	Photoreceptor-specific nuclear receptor	GO:0010467; P:gene expression; TAS:Reactome
Q9Y5X4	NR2E3	Photoreceptor-specific nuclear receptor	GO:0030522; P:intracellular receptor signaling pathway; TAS:GOC
Q9Y5X4	NR2E3	Photoreceptor-specific nuclear receptor	GO:0007602; P:phototransduction; TAS:ProtInc
Q9Y5X4	NR2E3	Photoreceptor-specific nuclear receptor	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y5X4	NR2E3	Photoreceptor-specific nuclear receptor	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9Y5X4	NR2E3	Photoreceptor-specific nuclear receptor	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q9Y5X4	NR2E3	Photoreceptor-specific nuclear receptor	GO:0007601; P:visual perception; TAS:ProtInc
P10588	NR2F6	Nuclear receptor subfamily 2 group F member 6	GO:0003677; F:DNA binding; TAS:ProtInc
P10588	NR2F6	Nuclear receptor subfamily 2 group F member 6	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; TAS:ProtInc
P10588	NR2F6	Nuclear receptor subfamily 2 group F member 6	GO:0005515; F:protein binding; IPI:IntAct
P10588	NR2F6	Nuclear receptor subfamily 2 group F member 6	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
P10588	NR2F6	Nuclear receptor subfamily 2 group F member 6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P10588	NR2F6	Nuclear receptor subfamily 2 group F member 6	GO:0003707; F:steroid hormone receptor activity; TAS:ProtInc
P10588	NR2F6	Nuclear receptor subfamily 2 group F member 6	GO:0004887; F:thyroid hormone receptor activity; TAS:ProtInc
P10588	NR2F6	Nuclear receptor subfamily 2 group F member 6	GO:0008270; F:zinc ion binding; IEA:InterPro
P10588	NR2F6	Nuclear receptor subfamily 2 group F member 6	GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; IEA:Ensembl
P10588	NR2F6	Nuclear receptor subfamily 2 group F member 6	GO:0043153; P:entrainment of circadian clock by photoperiod; IEA:Ensembl
P10588	NR2F6	Nuclear receptor subfamily 2 group F member 6	GO:0010467; P:gene expression; TAS:Reactome
P10588	NR2F6	Nuclear receptor subfamily 2 group F member 6	GO:0030522; P:intracellular receptor signaling pathway; TAS:GOC
P10588	NR2F6	Nuclear receptor subfamily 2 group F member 6	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P10588	NR2F6	Nuclear receptor subfamily 2 group F member 6	GO:0048666; P:neuron development; IEA:Ensembl
P10588	NR2F6	Nuclear receptor subfamily 2 group F member 6	GO:0007165; P:signal transduction; TAS:ProtInc
P10588	NR2F6	Nuclear receptor subfamily 2 group F member 6	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q68D85	NCR3LG1	Natural cytotoxicity triggering receptor 3 ligand 1	GO:0005198; F:structural molecule activity; IEA:InterPro
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0003677; F:DNA binding; ISS:BHF-UCL
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; TAS:ProtInc
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0005515; F:protein binding; IPI:IntAct
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0008270; F:zinc ion binding; IEA:InterPro
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0002042; P:cell migration involved in sprouting angiogenesis; IDA:BHF-UCL
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0044344; P:cellular response to fibroblast growth factor stimulus; IMP:BHF-UCL
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IMP:BHF-UCL
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0035767; P:endothelial cell chemotaxis; IMP:BHF-UCL
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0010467; P:gene expression; TAS:Reactome
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0045087; P:innate immune response; TAS:Reactome
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0030522; P:intracellular receptor signaling pathway; TAS:GOC
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:BHF-UCL
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0007165; P:signal transduction; TAS:ProtInc
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
P22736	NR4A1	Nuclear receptor subfamily 4 group A member 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; TAS:ProtInc
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0005515; F:protein binding; IPI:IntAct
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0008270; F:zinc ion binding; IEA:InterPro
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0031668; P:cellular response to extracellular stimulus; IDA:MGI
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0034599; P:cellular response to oxidative stress; IEA:Ensembl
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0021952; P:central nervous system projection neuron axonogenesis; IEA:Ensembl
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0016265; P:death; IEA:Ensembl
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0042416; P:dopamine biosynthetic process; IEA:Ensembl
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0071542; P:dopaminergic neuron differentiation; ISS:UniProtKB
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0010467; P:gene expression; TAS:Reactome
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0051866; P:general adaptation syndrome; IEA:Ensembl
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0021986; P:habenula development; IEA:Ensembl
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0030522; P:intracellular receptor signaling pathway; TAS:GOC
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0042551; P:neuron maturation; IEA:Ensembl
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0001764; P:neuron migration; IEA:Ensembl
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0043085; P:positive regulation of catalytic activity; IEA:Ensembl
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0009791; P:post-embryonic development; IEA:Ensembl
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0042053; P:regulation of dopamine metabolic process; IEA:Ensembl
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0043576; P:regulation of respiratory gaseous exchange; IEA:Ensembl
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0001975; P:response to amphetamine; IEA:Ensembl
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0001666; P:response to hypoxia; IEA:Ensembl
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0010035; P:response to inorganic substance; IEA:Ensembl
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0017085; P:response to insecticide; IEA:Ensembl
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0007165; P:signal transduction; NAS:ProtInc
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P43354	NR4A2	Nuclear receptor subfamily 4 group A member 2	GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0003677; F:DNA binding; NAS:UniProtKB
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0003707; F:steroid hormone receptor activity; TAS:ProtInc
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0004887; F:thyroid hormone receptor activity; TAS:ProtInc
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0030534; P:adult behavior; IEA:Ensembl
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0007411; P:axon guidance; IEA:Ensembl
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0010467; P:gene expression; TAS:Reactome
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0021766; P:hippocampus development; IEA:Ensembl
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0030522; P:intracellular receptor signaling pathway; TAS:GOC
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0001707; P:mesoderm formation; IEA:Ensembl
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0031100; P:organ regeneration; IEA:Ensembl
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0045787; P:positive regulation of cell cycle; IEA:Ensembl
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:2000108; P:positive regulation of leukocyte apoptotic process; IEA:Ensembl
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0043434; P:response to peptide hormone; IEA:Ensembl
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0048752; P:semicircular canal morphogenesis; IEA:Ensembl
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q92570	NR4A3	Nuclear receptor subfamily 4 group A member 3	GO:0060005; P:vestibular reflex; IEA:Ensembl
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0003677; F:DNA binding; IDA:UniProtKB
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; TAS:UniProtKB
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0005543; F:phospholipid binding; IDA:UniProtKB
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0005515; F:protein binding; IPI:UniProtKB
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0008270; F:zinc ion binding; IEA:InterPro
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0008206; P:bile acid metabolic process; IEA:Ensembl
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0042632; P:cholesterol homeostasis; IEA:Ensembl
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0009790; P:embryo development; TAS:UniProtKB
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0031018; P:endocrine pancreas development; TAS:Reactome
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0010467; P:gene expression; TAS:Reactome
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0042592; P:homeostatic process; NAS:UniProtKB
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0030522; P:intracellular receptor signaling pathway; TAS:GOC
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0045070; P:positive regulation of viral genome replication; IDA:BHF-UCL
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
O00482	NR5A2	Nuclear receptor subfamily 5 group A member 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15406	NR6A1	Nuclear receptor subfamily 6 group A member 1	GO:0003677; F:DNA binding; ISS:UniProtKB
Q15406	NR6A1	Nuclear receptor subfamily 6 group A member 1	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; TAS:ProtInc
Q15406	NR6A1	Nuclear receptor subfamily 6 group A member 1	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q15406	NR6A1	Nuclear receptor subfamily 6 group A member 1	GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB
Q15406	NR6A1	Nuclear receptor subfamily 6 group A member 1	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
Q15406	NR6A1	Nuclear receptor subfamily 6 group A member 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q15406	NR6A1	Nuclear receptor subfamily 6 group A member 1	GO:0008283; P:cell proliferation; TAS:ProtInc
Q15406	NR6A1	Nuclear receptor subfamily 6 group A member 1	GO:0007276; P:gamete generation; ISS:UniProtKB
Q15406	NR6A1	Nuclear receptor subfamily 6 group A member 1	GO:0010467; P:gene expression; TAS:Reactome
Q15406	NR6A1	Nuclear receptor subfamily 6 group A member 1	GO:0030522; P:intracellular receptor signaling pathway; TAS:GOC
Q15406	NR6A1	Nuclear receptor subfamily 6 group A member 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q15406	NR6A1	Nuclear receptor subfamily 6 group A member 1	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q15406	NR6A1	Nuclear receptor subfamily 6 group A member 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0005384; F:manganese ion transmembrane transporter activity; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0051139; F:metal ion:proton antiporter activity; IGI:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0046915; F:transition metal ion transmembrane transporter activity; IGI:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0032147; P:activation of protein kinase activity; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0048002; P:antigen processing and presentation of peptide antigen; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0070574; P:cadmium ion transmembrane transport; IGI:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0006876; P:cellular cadmium ion homeostasis; IGI:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0006879; P:cellular iron ion homeostasis; IMP:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0042742; P:defense response to bacterium; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0050829; P:defense response to Gram-negative bacterium; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0042832; P:defense response to protozoan; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0070839; P:divalent metal ion export; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0006954; P:inflammatory response; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0051701; P:interaction with host; TAS:Reactome
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0032623; P:interleukin-2 production; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0032632; P:interleukin-3 production; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0055072; P:iron ion homeostasis; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0006826; P:iron ion transport; IMP:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0043091; P:L-arginine import; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0042116; P:macrophage activation; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0006828; P:manganese ion transport; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0045342; P:MHC class II biosynthetic process; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0048255; P:mRNA stabilization; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0060586; P:multicellular organismal iron ion homeostasis; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0001818; P:negative regulation of cytokine production; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0015707; P:nitrite transport; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0006909; P:phagocytosis; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0090382; P:phagosome maturation; TAS:Reactome
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0001819; P:positive regulation of cytokine production; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0002606; P:positive regulation of dendritic cell antigen processing and presentation; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0010628; P:positive regulation of gene expression; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0032729; P:positive regulation of interferon-gamma production; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0050766; P:positive regulation of phagocytosis; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0002827; P:positive regulation of T-helper 1 type immune response; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0000060; P:protein import into nucleus, translocation; IEA:Ensembl
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0045730; P:respiratory burst; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0009617; P:response to bacterium; IDA:UniProtKB
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0034341; P:response to interferon-gamma; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0032496; P:response to lipopolysaccharide; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0002369; P:T cell cytokine production; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0002309; P:T cell proliferation involved in immune response; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0007035; P:vacuolar acidification; ISS:BHF-UCL
P49279	SLC11A1	Natural resistance-associated macrophage protein 1	GO:0042060; P:wound healing; ISS:BHF-UCL
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0046870; F:cadmium ion binding; IEA:Ensembl
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0015086; F:cadmium ion transmembrane transporter activity; IDA:BHF-UCL
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0050897; F:cobalt ion binding; IEA:Ensembl
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0015087; F:cobalt ion transmembrane transporter activity; IDA:UniProtKB
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0005507; F:copper ion binding; IEA:Ensembl
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0005375; F:copper ion transmembrane transporter activity; IDA:BHF-UCL
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0015093; F:ferrous iron transmembrane transporter activity; IDA:BHF-UCL
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0015078; F:hydrogen ion transmembrane transporter activity; IEA:Ensembl
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0022890; F:inorganic cation transmembrane transporter activity; IGI:UniProtKB
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0005506; F:iron ion binding; IEA:Ensembl
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0015094; F:lead ion transmembrane transporter activity; IDA:BHF-UCL
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0030145; F:manganese ion binding; IEA:Ensembl
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0005384; F:manganese ion transmembrane transporter activity; IDA:BHF-UCL
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0016151; F:nickel cation binding; IEA:Ensembl
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0015099; F:nickel cation transmembrane transporter activity; IDA:UniProtKB
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0015295; F:solute:proton symporter activity; IDA:UniProtKB
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0015100; F:vanadium ion transmembrane transporter activity; IDA:UniProtKB
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0008270; F:zinc ion binding; IEA:Ensembl
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0005385; F:zinc ion transmembrane transporter activity; IDA:UniProtKB
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0070574; P:cadmium ion transmembrane transport; IDA:BHF-UCL
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0071281; P:cellular response to iron ion; IEA:Ensembl
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0034599; P:cellular response to oxidative stress; IDA:UniProtKB
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0006824; P:cobalt ion transport; IDA:UniProtKB
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0006825; P:copper ion transport; IDA:BHF-UCL
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0048813; P:dendrite morphogenesis; IEA:Ensembl
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0003032; P:detection of oxygen; IEP:UniProtKB
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0048821; P:erythrocyte development; IEA:Ensembl
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0070627; P:ferrous iron import; IDA:UniProtKB
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0015684; P:ferrous iron transport; IDA:BHF-UCL
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0006783; P:heme biosynthetic process; IEA:Ensembl
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0015692; P:lead ion transport; IDA:BHF-UCL
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0007611; P:learning or memory; IEA:Ensembl
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0071421; P:manganese ion transmembrane transport; IDA:GOC
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0006828; P:manganese ion transport; IDA:BHF-UCL
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0060586; P:multicellular organismal iron ion homeostasis; IMP:BHF-UCL
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0035444; P:nickel cation transmembrane transport; IDA:GOC
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0015675; P:nickel cation transport; IDA:UniProtKB
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0046686; P:response to cadmium ion; IEA:Ensembl
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0001666; P:response to hypoxia; IEP:UniProtKB
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0010039; P:response to iron ion; IEP:UniProtKB
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0010288; P:response to lead ion; IEA:Ensembl
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0010042; P:response to manganese ion; IEA:Ensembl
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0055085; P:transmembrane transport; TAS:Reactome
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0015676; P:vanadium ion transport; IDA:GOC
P49281	SLC11A2	Natural resistance-associated macrophage protein 2	GO:0071577; P:zinc ion transmembrane transport; IDA:GOC
Q86VF7	NRAP	Nebulin-related-anchoring protein	GO:0003779; F:actin binding; ISS:UniProtKB
Q86VF7	NRAP	Nebulin-related-anchoring protein	GO:0051371; F:muscle alpha-actinin binding; ISS:UniProtKB
Q86VF7	NRAP	Nebulin-related-anchoring protein	GO:0008270; F:zinc ion binding; IEA:InterPro
Q7Z6K4	NRARP	Notch-regulated ankyrin repeat-containing protein	GO:0002043; P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis; IBA:RefGenome
Q7Z6K4	NRARP	Notch-regulated ankyrin repeat-containing protein	GO:0045746; P:negative regulation of Notch signaling pathway; IMP:MGI
Q7Z6K4	NRARP	Notch-regulated ankyrin repeat-containing protein	GO:1902367; P:negative regulation of Notch signaling pathway involved in somitogenesis; IEA:Ensembl
Q7Z6K4	NRARP	Notch-regulated ankyrin repeat-containing protein	GO:0045581; P:negative regulation of T cell differentiation; IEA:Ensembl
Q7Z6K4	NRARP	Notch-regulated ankyrin repeat-containing protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q7Z6K4	NRARP	Notch-regulated ankyrin repeat-containing protein	GO:0001569; P:patterning of blood vessels; IBA:RefGenome
Q7Z6K4	NRARP	Notch-regulated ankyrin repeat-containing protein	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:MGI
Q7Z6K4	NRARP	Notch-regulated ankyrin repeat-containing protein	GO:0001938; P:positive regulation of endothelial cell proliferation; IBA:RefGenome
Q7Z6K4	NRARP	Notch-regulated ankyrin repeat-containing protein	GO:0022407; P:regulation of cell-cell adhesion; IEA:Ensembl
Q7Z6K4	NRARP	Notch-regulated ankyrin repeat-containing protein	GO:0032525; P:somite rostral/caudal axis specification; IEA:Ensembl
Q96F24	NRBF2	Nuclear receptor-binding factor 2	GO:0010467; P:gene expression; TAS:Reactome
Q96F24	NRBF2	Nuclear receptor-binding factor 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96F24	NRBF2	Nuclear receptor-binding factor 2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q9NSY0	NRBP2	Nuclear receptor-binding protein 2	GO:0005524; F:ATP binding; IEA:InterPro
Q9NSY0	NRBP2	Nuclear receptor-binding protein 2	GO:0004672; F:protein kinase activity; IEA:InterPro
Q9NSY0	NRBP2	Nuclear receptor-binding protein 2	GO:0016242; P:negative regulation of macroautophagy; IMP:BHF-UCL
Q9NSY0	NRBP2	Nuclear receptor-binding protein 2	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB
Q9NSY0	NRBP2	Nuclear receptor-binding protein 2	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q9UHY1	NRBP1	Nuclear receptor-binding protein	GO:0005524; F:ATP binding; IEA:InterPro
Q9UHY1	NRBP1	Nuclear receptor-binding protein	GO:0005515; F:protein binding; IPI:IntAct
Q9UHY1	NRBP1	Nuclear receptor-binding protein	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q9UHY1	NRBP1	Nuclear receptor-binding protein	GO:0004672; F:protein kinase activity; IEA:InterPro
Q9UHY1	NRBP1	Nuclear receptor-binding protein	GO:0006888; P:ER to Golgi vesicle-mediated transport; IDA:UniProtKB
Q9UHY1	NRBP1	Nuclear receptor-binding protein	GO:0010467; P:gene expression; TAS:Reactome
Q9UHY1	NRBP1	Nuclear receptor-binding protein	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q92823	NRCAM	Neuronal cell adhesion molecule	GO:0030506; F:ankyrin binding; IDA:UniProtKB
Q92823	NRCAM	Neuronal cell adhesion molecule	GO:0005515; F:protein binding; IPI:UniProtKB
Q92823	NRCAM	Neuronal cell adhesion molecule	GO:0001525; P:angiogenesis; IEP:UniProtKB
Q92823	NRCAM	Neuronal cell adhesion molecule	GO:0007411; P:axon guidance; TAS:Reactome
Q92823	NRCAM	Neuronal cell adhesion molecule	GO:0007413; P:axonal fasciculation; NAS:UniProtKB
Q92823	NRCAM	Neuronal cell adhesion molecule	GO:0007409; P:axonogenesis; NAS:UniProtKB
Q92823	NRCAM	Neuronal cell adhesion molecule	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
Q92823	NRCAM	Neuronal cell adhesion molecule	GO:0007417; P:central nervous system development; NAS:UniProtKB
Q92823	NRCAM	Neuronal cell adhesion molecule	GO:0045162; P:clustering of voltage-gated sodium channels; IDA:UniProtKB
Q92823	NRCAM	Neuronal cell adhesion molecule	GO:0034113; P:heterotypic cell-cell adhesion; IEA:Ensembl
Q92823	NRCAM	Neuronal cell adhesion molecule	GO:0001764; P:neuron migration; NAS:UniProtKB
Q92823	NRCAM	Neuronal cell adhesion molecule	GO:0019227; P:neuronal action potential propagation; IEA:Ensembl
Q92823	NRCAM	Neuronal cell adhesion molecule	GO:0045666; P:positive regulation of neuron differentiation; NAS:UniProtKB
Q92823	NRCAM	Neuronal cell adhesion molecule	GO:0008104; P:protein localization; IEA:Ensembl
Q92823	NRCAM	Neuronal cell adhesion molecule	GO:0030516; P:regulation of axon extension; NAS:UniProtKB
Q92823	NRCAM	Neuronal cell adhesion molecule	GO:0031290; P:retinal ganglion cell axon guidance; IEA:Ensembl
Q92823	NRCAM	Neuronal cell adhesion molecule	GO:0007416; P:synapse assembly; TAS:UniProtKB
O43847	NRD1	Nardilysin	GO:0048408; F:epidermal growth factor binding; TAS:UniProtKB
O43847	NRD1	Nardilysin	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43847	NRD1	Nardilysin	GO:0004222; F:metalloendopeptidase activity; NAS:UniProtKB
O43847	NRD1	Nardilysin	GO:0005515; F:protein binding; IPI:IntAct
O43847	NRD1	Nardilysin	GO:0016477; P:cell migration; TAS:UniProtKB
O43847	NRD1	Nardilysin	GO:0008283; P:cell proliferation; TAS:UniProtKB
O43847	NRD1	Nardilysin	GO:0007528; P:neuromuscular junction development; TAS:ProtInc
O43847	NRD1	Nardilysin	GO:0051044; P:positive regulation of membrane protein ectodomain proteolysis; IDA:BHF-UCL
O43847	NRD1	Nardilysin	GO:0006508; P:proteolysis; NAS:UniProtKB
O43847	NRD1	Nardilysin	GO:0052548; P:regulation of endopeptidase activity; IDA:BHF-UCL
Q16612	NREP	Neuronal regeneration-related protein	GO:0005515; F:protein binding; IPI:IntAct
Q16612	NREP	Neuronal regeneration-related protein	GO:0031103; P:axon regeneration; IEA:Ensembl
Q16612	NREP	Neuronal regeneration-related protein	GO:0045664; P:regulation of neuron differentiation; IEA:Ensembl
Q16612	NREP	Neuronal regeneration-related protein	GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl
Q16656	NRF1	Nuclear respiratory factor 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q16656	NRF1	Nuclear respiratory factor 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q16656	NRF1	Nuclear respiratory factor 1	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
Q16656	NRF1	Nuclear respiratory factor 1	GO:0007005; P:mitochondrion organization; IEA:Ensembl
Q16656	NRF1	Nuclear respiratory factor 1	GO:0031100; P:organ regeneration; IEA:Ensembl
Q16656	NRF1	Nuclear respiratory factor 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q16656	NRF1	Nuclear respiratory factor 1	GO:0051602; P:response to electrical stimulus; IEA:Ensembl
Q16656	NRF1	Nuclear respiratory factor 1	GO:0032355; P:response to estradiol; IEA:Ensembl
Q16656	NRF1	Nuclear respiratory factor 1	GO:0051593; P:response to folic acid; IEA:Ensembl
Q16656	NRF1	Nuclear respiratory factor 1	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q16656	NRF1	Nuclear respiratory factor 1	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
Q16656	NRF1	Nuclear respiratory factor 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16656	NRF1	Nuclear respiratory factor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0005125; F:cytokine activity; TAS:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0043125; F:ErbB-3 class receptor binding; IDA:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0008083; F:growth factor activity; IDA:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0005515; F:protein binding; IPI:IntAct
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0030296; F:protein tyrosine kinase activator activity; IDA:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0005102; F:receptor binding; IPI:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0030971; F:receptor tyrosine kinase binding; NAS:UniProtKB
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0003712; F:transcription cofactor activity; IDA:MGI
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0030297; F:transmembrane receptor protein tyrosine kinase activator activity; IC:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0007171; P:activation of transmembrane receptor protein tyrosine kinase activity; IDA:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0003161; P:cardiac conduction system development; IEA:Ensembl
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0055007; P:cardiac muscle cell differentiation; ISS:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0060379; P:cardiac muscle cell myoblast differentiation; IDA:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0007154; P:cell communication; TAS:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0016477; P:cell migration; IEA:Ensembl
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0000902; P:cell morphogenesis; IEA:Ensembl
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0008283; P:cell proliferation; IDA:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0043624; P:cellular protein complex disassembly; IGI:MGI
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0009790; P:embryo development; IEA:InterPro
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0060956; P:endocardial cell differentiation; IDA:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0038127; P:ERBB signaling pathway; IDA:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0021781; P:glial cell fate commitment; IEA:Ensembl
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0045087; P:innate immune response; TAS:Reactome
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0030879; P:mammary gland development; TAS:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0000165; P:MAPK cascade; IEA:Ensembl
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IDA:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IDA:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0042177; P:negative regulation of protein catabolic process; IEA:Ensembl
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0051048; P:negative regulation of secretion; IDA:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:MGI
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0007399; P:nervous system development; TAS:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0014032; P:neural crest cell development; TAS:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0048663; P:neuron fate commitment; IEA:Ensembl
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0045213; P:neurotransmitter receptor metabolic process; IEA:Ensembl
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0007422; P:peripheral nervous system development; IEA:Ensembl
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0060045; P:positive regulation of cardiac muscle cell proliferation; IDA:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0045785; P:positive regulation of cell adhesion; IDA:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0030307; P:positive regulation of cell growth; IDA:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0061098; P:positive regulation of protein tyrosine kinase activity; IDA:GOC
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0046579; P:positive regulation of Ras protein signal transduction; IEA:Ensembl
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0051155; P:positive regulation of striated muscle cell differentiation; ISS:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0043497; P:regulation of protein heterodimerization activity; IDA:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0043496; P:regulation of protein homodimerization activity; TAS:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0007416; P:synapse assembly; IEA:Ensembl
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IDA:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0055012; P:ventricular cardiac muscle cell differentiation; IDA:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0003222; P:ventricular trabecula myocardium morphogenesis; IDA:BHF-UCL
Q02297	NRG1	Pro-neuregulin-1, membrane-bound isoform	GO:0042060; P:wound healing; IDA:BHF-UCL
O14511	NRG2	Pro-neuregulin-2, membrane-bound isoform	GO:0005102; F:receptor binding; TAS:ProtInc
O14511	NRG2	Pro-neuregulin-2, membrane-bound isoform	GO:0009790; P:embryo development; IEA:InterPro
O14511	NRG2	Pro-neuregulin-2, membrane-bound isoform	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O14511	NRG2	Pro-neuregulin-2, membrane-bound isoform	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O14511	NRG2	Pro-neuregulin-2, membrane-bound isoform	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
O14511	NRG2	Pro-neuregulin-2, membrane-bound isoform	GO:0045087; P:innate immune response; TAS:Reactome
O14511	NRG2	Pro-neuregulin-2, membrane-bound isoform	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O14511	NRG2	Pro-neuregulin-2, membrane-bound isoform	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
O14511	NRG2	Pro-neuregulin-2, membrane-bound isoform	GO:0007165; P:signal transduction; TAS:ProtInc
P56975	NRG3	Pro-neuregulin-3, membrane-bound isoform	GO:0008083; F:growth factor activity; NAS:UniProtKB
P56975	NRG3	Pro-neuregulin-3, membrane-bound isoform	GO:0030971; F:receptor tyrosine kinase binding; NAS:UniProtKB
P56975	NRG3	Pro-neuregulin-3, membrane-bound isoform	GO:0030297; F:transmembrane receptor protein tyrosine kinase activator activity; NAS:UniProtKB
P56975	NRG3	Pro-neuregulin-3, membrane-bound isoform	GO:0007171; P:activation of transmembrane receptor protein tyrosine kinase activity; NAS:GOC
P56975	NRG3	Pro-neuregulin-3, membrane-bound isoform	GO:0060596; P:mammary placode formation; IEA:Ensembl
P56975	NRG3	Pro-neuregulin-3, membrane-bound isoform	GO:0007389; P:pattern specification process; IEA:Ensembl
P56975	NRG3	Pro-neuregulin-3, membrane-bound isoform	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
Q8WWG1	NRG4	Pro-neuregulin-4, membrane-bound isoform	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q8WWG1	NRG4	Pro-neuregulin-4, membrane-bound isoform	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q8WWG1	NRG4	Pro-neuregulin-4, membrane-bound isoform	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q8WWG1	NRG4	Pro-neuregulin-4, membrane-bound isoform	GO:0045087; P:innate immune response; TAS:Reactome
Q8WWG1	NRG4	Pro-neuregulin-4, membrane-bound isoform	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q8WWG1	NRG4	Pro-neuregulin-4, membrane-bound isoform	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P48552	NRIP1	Nuclear receptor-interacting protein 1	GO:0050681; F:androgen receptor binding; NAS:UniProtKB
P48552	NRIP1	Nuclear receptor-interacting protein 1	GO:0030331; F:estrogen receptor binding; IPI:UniProtKB
P48552	NRIP1	Nuclear receptor-interacting protein 1	GO:0035259; F:glucocorticoid receptor binding; IPI:UniProtKB
P48552	NRIP1	Nuclear receptor-interacting protein 1	GO:0035257; F:nuclear hormone receptor binding; IPI:UniProtKB
P48552	NRIP1	Nuclear receptor-interacting protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P48552	NRIP1	Nuclear receptor-interacting protein 1	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
P48552	NRIP1	Nuclear receptor-interacting protein 1	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
P48552	NRIP1	Nuclear receptor-interacting protein 1	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
P48552	NRIP1	Nuclear receptor-interacting protein 1	GO:0019915; P:lipid storage; IEA:Ensembl
P48552	NRIP1	Nuclear receptor-interacting protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P48552	NRIP1	Nuclear receptor-interacting protein 1	GO:0001543; P:ovarian follicle rupture; IEA:Ensembl
P48552	NRIP1	Nuclear receptor-interacting protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P48552	NRIP1	Nuclear receptor-interacting protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
P48552	NRIP1	Nuclear receptor-interacting protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BQI9	NRIP2	Nuclear receptor-interacting protein 2	GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro
Q9BQI9	NRIP2	Nuclear receptor-interacting protein 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9BQI9	NRIP2	Nuclear receptor-interacting protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NQ35	NRIP3	Nuclear receptor-interacting protein 3	GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro
Q9NWW6	NMRK1	Nicotinamide riboside kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NWW6	NMRK1	Nicotinamide riboside kinase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NWW6	NMRK1	Nicotinamide riboside kinase 1	GO:0050262; F:ribosylnicotinamide kinase activity; IEA:UniProtKB-EC
Q9NWW6	NMRK1	Nicotinamide riboside kinase 1	GO:0004849; F:uridine kinase activity; IEA:InterPro
Q9NWW6	NMRK1	Nicotinamide riboside kinase 1	GO:0009435; P:NAD biosynthetic process; IEA:UniProtKB-UniPathway
Q9NPI5	NMRK2	Nicotinamide riboside kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NPI5	NMRK2	Nicotinamide riboside kinase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NPI5	NMRK2	Nicotinamide riboside kinase 2	GO:0005515; F:protein binding; IPI:IntAct
Q9NPI5	NMRK2	Nicotinamide riboside kinase 2	GO:0050262; F:ribosylnicotinamide kinase activity; IEA:UniProtKB-EC
Q9NPI5	NMRK2	Nicotinamide riboside kinase 2	GO:0009435; P:NAD biosynthetic process; IEA:UniProtKB-UniPathway
Q9NPI5	NMRK2	Nicotinamide riboside kinase 2	GO:0045662; P:negative regulation of myoblast differentiation; IEA:Ensembl
Q7Z2Y5	NRK	Nik-related protein kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q7Z2Y5	NRK	Nik-related protein kinase	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
Q7Z2Y5	NRK	Nik-related protein kinase	GO:0005083; F:small GTPase regulator activity; IEA:InterPro
Q7Z2Y5	NRK	Nik-related protein kinase	GO:0023014; P:signal transduction by phosphorylation; IBA:GOC
P54845	NRL	Neural retina-specific leucine zipper protein	GO:0003677; F:DNA binding; TAS:ProtInc
P54845	NRL	Neural retina-specific leucine zipper protein	GO:0043522; F:leucine zipper domain binding; IPI:UniProtKB
P54845	NRL	Neural retina-specific leucine zipper protein	GO:0005515; F:protein binding; IPI:IntAct
P54845	NRL	Neural retina-specific leucine zipper protein	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P54845	NRL	Neural retina-specific leucine zipper protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P54845	NRL	Neural retina-specific leucine zipper protein	GO:0045872; P:positive regulation of rhodopsin gene expression; IEA:Ensembl
P54845	NRL	Neural retina-specific leucine zipper protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P54845	NRL	Neural retina-specific leucine zipper protein	GO:0007468; P:regulation of rhodopsin gene expression; TAS:ProtInc
P54845	NRL	Neural retina-specific leucine zipper protein	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
P54845	NRL	Neural retina-specific leucine zipper protein	GO:0046548; P:retinal rod cell development; IEA:Ensembl
P54845	NRL	Neural retina-specific leucine zipper protein	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P54845	NRL	Neural retina-specific leucine zipper protein	GO:0007601; P:visual perception; TAS:ProtInc
Q496H8	NRN1L	Neuritin-like protein	GO:0007399; P:nervous system development; IEA:InterPro
Q9NPD7	NRN1	Neuritin	GO:0007399; P:nervous system development; IEA:InterPro
O14786	NRP1	Neuropilin-1	GO:0015026; F:coreceptor activity; TAS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0019955; F:cytokine binding; NAS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0019838; F:growth factor binding; IPI:UniProtKB
O14786	NRP1	Neuropilin-1	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
O14786	NRP1	Neuropilin-1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14786	NRP1	Neuropilin-1	GO:0005515; F:protein binding; IPI:IntAct
O14786	NRP1	Neuropilin-1	GO:0017154; F:semaphorin receptor activity; NAS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0005021; F:vascular endothelial growth factor-activated receptor activity; ISS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0048846; P:axon extension involved in axon guidance; ISS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0007411; P:axon guidance; NAS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0007413; P:axonal fasciculation; IEA:Ensembl
O14786	NRP1	Neuropilin-1	GO:0060385; P:axonogenesis involved in innervation; ISS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0007155; P:cell adhesion; IEA:InterPro
O14786	NRP1	Neuropilin-1	GO:0002042; P:cell migration involved in sprouting angiogenesis; ISS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O14786	NRP1	Neuropilin-1	GO:0035729; P:cellular response to hepatocyte growth factor stimulus; IMP:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0071679; P:commissural neuron axon guidance; ISS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0016358; P:dendrite development; IEA:Ensembl
O14786	NRP1	Neuropilin-1	GO:0060666; P:dichotomous subdivision of terminal units involved in salivary gland branching; IEA:Ensembl
O14786	NRP1	Neuropilin-1	GO:0035767; P:endothelial cell chemotaxis; IMP:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0097102; P:endothelial tip cell fate specification; ISS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0007507; P:heart development; IEA:Ensembl
O14786	NRP1	Neuropilin-1	GO:0048012; P:hepatocyte growth factor receptor signaling pathway; IMP:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0048843; P:negative regulation of axon extension involved in axon guidance; IEA:Ensembl
O14786	NRP1	Neuropilin-1	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl
O14786	NRP1	Neuropilin-1	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
O14786	NRP1	Neuropilin-1	GO:0021675; P:nerve development; ISS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0001764; P:neuron migration; ISS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0009887; P:organ morphogenesis; TAS:ProtInc
O14786	NRP1	Neuropilin-1	GO:0001569; P:patterning of blood vessels; ISS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IMP:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0050918; P:positive chemotaxis; ISS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0048842; P:positive regulation of axon extension involved in axon guidance; ISS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0060301; P:positive regulation of cytokine activity; TAS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0010595; P:positive regulation of endothelial cell migration; TAS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0001938; P:positive regulation of endothelial cell proliferation; TAS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IMP:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:1902336; P:positive regulation of retinal ganglion cell axon guidance; ISS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0014911; P:positive regulation of smooth muscle cell migration; TAS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0090259; P:regulation of retinal ganglion cell axon guidance; ISS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0060627; P:regulation of vesicle-mediated transport; TAS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0009611; P:response to wounding; IEA:Ensembl
O14786	NRP1	Neuropilin-1	GO:0031290; P:retinal ganglion cell axon guidance; ISS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0071526; P:semaphorin-plexin signaling pathway; NAS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:1902285; P:semaphorin-plexin signaling pathway involved in neuron projection guidance; ISS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0007165; P:signal transduction; TAS:ProtInc
O14786	NRP1	Neuropilin-1	GO:0061549; P:sympathetic ganglion development; ISS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0097490; P:sympathetic neuron projection extension; ISS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0097491; P:sympathetic neuron projection guidance; ISS:BHF-UCL
O14786	NRP1	Neuropilin-1	GO:0021636; P:trigeminal nerve morphogenesis; IEA:Ensembl
O14786	NRP1	Neuropilin-1	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IMP:BHF-UCL
O60462	NRP2	Neuropilin-2	GO:0019955; F:cytokine binding; NAS:BHF-UCL
O60462	NRP2	Neuropilin-2	GO:0019838; F:growth factor binding; TAS:BHF-UCL
O60462	NRP2	Neuropilin-2	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
O60462	NRP2	Neuropilin-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60462	NRP2	Neuropilin-2	GO:0004872; F:receptor activity; TAS:ProtInc
O60462	NRP2	Neuropilin-2	GO:0017154; F:semaphorin receptor activity; NAS:UniProtKB
O60462	NRP2	Neuropilin-2	GO:0005021; F:vascular endothelial growth factor-activated receptor activity; NAS:UniProtKB
O60462	NRP2	Neuropilin-2	GO:0001525; P:angiogenesis; NAS:UniProtKB
O60462	NRP2	Neuropilin-2	GO:0048846; P:axon extension involved in axon guidance; ISS:BHF-UCL
O60462	NRP2	Neuropilin-2	GO:0007411; P:axon guidance; NAS:BHF-UCL
O60462	NRP2	Neuropilin-2	GO:0007155; P:cell adhesion; NAS:UniProtKB
O60462	NRP2	Neuropilin-2	GO:0007507; P:heart development; IEA:Ensembl
O60462	NRP2	Neuropilin-2	GO:0050919; P:negative chemotaxis; IEA:Ensembl
O60462	NRP2	Neuropilin-2	GO:0021675; P:nerve development; ISS:BHF-UCL
O60462	NRP2	Neuropilin-2	GO:0001755; P:neural crest cell migration; IEA:Ensembl
O60462	NRP2	Neuropilin-2	GO:0010595; P:positive regulation of endothelial cell migration; TAS:BHF-UCL
O60462	NRP2	Neuropilin-2	GO:0001938; P:positive regulation of endothelial cell proliferation; TAS:BHF-UCL
O60462	NRP2	Neuropilin-2	GO:1902285; P:semaphorin-plexin signaling pathway involved in neuron projection guidance; ISS:BHF-UCL
O60462	NRP2	Neuropilin-2	GO:0061549; P:sympathetic ganglion development; ISS:BHF-UCL
O60462	NRP2	Neuropilin-2	GO:0097490; P:sympathetic neuron projection extension; ISS:BHF-UCL
O60462	NRP2	Neuropilin-2	GO:0097491; P:sympathetic neuron projection guidance; ISS:BHF-UCL
O60462	NRP2	Neuropilin-2	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; TAS:Reactome
Q86YC3	NRROS	Negative regulator of reactive oxygen species	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q8IZ57	NRSN1	Neurensin-1	GO:0007399; P:nervous system development; ISS:UniProtKB
Q99748	NRTN	Neurturin	GO:0005102; F:receptor binding; TAS:ProtInc
Q99748	NRTN	Neurturin	GO:0007411; P:axon guidance; TAS:Reactome
Q99748	NRTN	Neurturin	GO:0000165; P:MAPK cascade; TAS:ProtInc
Q99748	NRTN	Neurturin	GO:0021675; P:nerve development; IEA:Ensembl
Q99748	NRTN	Neurturin	GO:0007399; P:nervous system development; TAS:ProtInc
Q99748	NRTN	Neurturin	GO:0001755; P:neural crest cell migration; IDA:MGI
Q99748	NRTN	Neurturin	GO:0031175; P:neuron projection development; IDA:MGI
Q99748	NRTN	Neurturin	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc
Q9ULB1	NRXN1	Neurexin-1	GO:0033130; F:acetylcholine receptor binding; ISS:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0005246; F:calcium channel regulator activity; ISS:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0005509; F:calcium ion binding; ISS:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0050839; F:cell adhesion molecule binding; ISS:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0097109; F:neuroligin family protein binding; ISS:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9ULB1	NRXN1	Neurexin-1	GO:0004872; F:receptor activity; TAS:ProtInc
Q9ULB1	NRXN1	Neurexin-1	GO:0030534; P:adult behavior; IMP:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0007411; P:axon guidance; TAS:ProtInc
Q9ULB1	NRXN1	Neurexin-1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q9ULB1	NRXN1	Neurexin-1	GO:0097116; P:gephyrin clustering; ISS:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0007612; P:learning; IMP:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0097118; P:neuroligin clustering; ISS:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0050885; P:neuromuscular process controlling balance; ISS:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0007158; P:neuron cell-cell adhesion; TAS:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0007269; P:neurotransmitter secretion; ISS:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:2000463; P:positive regulation of excitatory postsynaptic membrane potential; ISS:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0051965; P:positive regulation of synapse assembly; ISS:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0090129; P:positive regulation of synapse maturation; ISS:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; ISS:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0097119; P:postsynaptic density protein 95 clustering; ISS:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0097104; P:postsynaptic membrane assembly; ISS:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0060134; P:prepulse inhibition; IEA:Ensembl
Q9ULB1	NRXN1	Neurexin-1	GO:2000821; P:regulation of grooming behavior; IEA:Ensembl
Q9ULB1	NRXN1	Neurexin-1	GO:0035176; P:social behavior; IMP:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0007416; P:synapse assembly; ISS:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0007268; P:synaptic transmission; ISS:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0042297; P:vocal learning; IMP:BHF-UCL
Q9ULB1	NRXN1	Neurexin-1	GO:0071625; P:vocalization behavior; IMP:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0005246; F:calcium channel regulator activity; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0048306; F:calcium-dependent protein binding; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0050839; F:cell adhesion molecule binding; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P58400	NRXN1	Neurexin-1-beta	GO:0097109; F:neuroligin family protein binding; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0005102; F:receptor binding; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0030534; P:adult behavior; IMP:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0001525; P:angiogenesis; ISS:UniProtKB
P58400	NRXN1	Neurexin-1-beta	GO:0016339; P:calcium-dependent cell-cell adhesion; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0021707; P:cerebellar granule cell differentiation; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0045184; P:establishment of protein localization; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0097112; P:gamma-aminobutyric acid receptor clustering; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0097116; P:gephyrin clustering; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0097117; P:guanylate kinase-associated protein clustering; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0007157; P:heterophilic cell-cell adhesion; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0007612; P:learning; IMP:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0097114; P:N-methyl-D-aspartate receptor clustering; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0051490; P:negative regulation of filopodium assembly; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0097118; P:neuroligin clustering; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0007158; P:neuron cell-cell adhesion; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0023041; P:neuronal signal transduction; TAS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0007269; P:neurotransmitter secretion; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:2000463; P:positive regulation of excitatory postsynaptic membrane potential; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0090129; P:positive regulation of synapse maturation; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0097119; P:postsynaptic density protein 95 clustering; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0097104; P:postsynaptic membrane assembly; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0097105; P:presynaptic membrane assembly; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0035418; P:protein localization to synapse; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0097120; P:receptor localization to synapse; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:2000311; P:regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:2000310; P:regulation of N-methyl-D-aspartate selective glutamate receptor activity; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0035176; P:social behavior; IMP:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0007416; P:synapse assembly; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0007268; P:synaptic transmission; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0097091; P:synaptic vesicle clustering; ISS:BHF-UCL
P58400	NRXN1	Neurexin-1-beta	GO:0071625; P:vocalization behavior; IMP:BHF-UCL
Q9P2S2	NRXN2	Neurexin-2	GO:0005246; F:calcium channel regulator activity; ISS:BHF-UCL
Q9P2S2	NRXN2	Neurexin-2	GO:0050839; F:cell adhesion molecule binding; ISS:BHF-UCL
Q9P2S2	NRXN2	Neurexin-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9P2S2	NRXN2	Neurexin-2	GO:0097109; F:neuroligin family protein binding; ISS:BHF-UCL
Q9P2S2	NRXN2	Neurexin-2	GO:0030534; P:adult behavior; IMP:BHF-UCL
Q9P2S2	NRXN2	Neurexin-2	GO:0097116; P:gephyrin clustering; ISS:BHF-UCL
Q9P2S2	NRXN2	Neurexin-2	GO:0097118; P:neuroligin clustering; ISS:BHF-UCL
Q9P2S2	NRXN2	Neurexin-2	GO:0007158; P:neuron cell-cell adhesion; TAS:BHF-UCL
Q9P2S2	NRXN2	Neurexin-2	GO:0007269; P:neurotransmitter secretion; ISS:BHF-UCL
Q9P2S2	NRXN2	Neurexin-2	GO:0097119; P:postsynaptic density protein 95 clustering; ISS:BHF-UCL
Q9P2S2	NRXN2	Neurexin-2	GO:0097104; P:postsynaptic membrane assembly; ISS:BHF-UCL
Q9P2S2	NRXN2	Neurexin-2	GO:0035176; P:social behavior; IMP:BHF-UCL
Q9P2S2	NRXN2	Neurexin-2	GO:0007416; P:synapse assembly; ISS:BHF-UCL
Q9P2S2	NRXN2	Neurexin-2	GO:0007268; P:synaptic transmission; ISS:BHF-UCL
Q9P2S2	NRXN2	Neurexin-2	GO:0042297; P:vocal learning; IMP:BHF-UCL
Q9P2S2	NRXN2	Neurexin-2	GO:0071625; P:vocalization behavior; IMP:BHF-UCL
P58401	NRXN2	Neurexin-2-beta	GO:0050839; F:cell adhesion molecule binding; TAS:BHF-UCL
P58401	NRXN2	Neurexin-2-beta	GO:0097109; F:neuroligin family protein binding; TAS:BHF-UCL
P58401	NRXN2	Neurexin-2-beta	GO:0007158; P:neuron cell-cell adhesion; TAS:BHF-UCL
Q9Y4C0	NRXN3	Neurexin-3	GO:0005246; F:calcium channel regulator activity; IEA:Ensembl
Q9Y4C0	NRXN3	Neurexin-3	GO:0050839; F:cell adhesion molecule binding; TAS:BHF-UCL
Q9Y4C0	NRXN3	Neurexin-3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y4C0	NRXN3	Neurexin-3	GO:0097109; F:neuroligin family protein binding; TAS:BHF-UCL
Q9Y4C0	NRXN3	Neurexin-3	GO:0004872; F:receptor activity; TAS:ProtInc
Q9Y4C0	NRXN3	Neurexin-3	GO:0030534; P:adult behavior; IGI:BHF-UCL
Q9Y4C0	NRXN3	Neurexin-3	GO:0007411; P:axon guidance; TAS:ProtInc
Q9Y4C0	NRXN3	Neurexin-3	GO:0007612; P:learning; IGI:BHF-UCL
Q9Y4C0	NRXN3	Neurexin-3	GO:0007158; P:neuron cell-cell adhesion; TAS:BHF-UCL
Q9Y4C0	NRXN3	Neurexin-3	GO:0007269; P:neurotransmitter secretion; IEA:Ensembl
Q9Y4C0	NRXN3	Neurexin-3	GO:0051965; P:positive regulation of synapse assembly; IEA:InterPro
Q9Y4C0	NRXN3	Neurexin-3	GO:0090129; P:positive regulation of synapse maturation; IEA:InterPro
Q9Y4C0	NRXN3	Neurexin-3	GO:0035176; P:social behavior; IGI:BHF-UCL
Q9Y4C0	NRXN3	Neurexin-3	GO:0007416; P:synapse assembly; IEA:Ensembl
Q9Y4C0	NRXN3	Neurexin-3	GO:0071625; P:vocalization behavior; IGI:BHF-UCL
Q9HDB5	NRXN3	Neurexin-3-beta	GO:0050839; F:cell adhesion molecule binding; TAS:BHF-UCL
Q9HDB5	NRXN3	Neurexin-3-beta	GO:0097109; F:neuroligin family protein binding; TAS:BHF-UCL
Q9HDB5	NRXN3	Neurexin-3-beta	GO:0030534; P:adult behavior; IGI:BHF-UCL
Q9HDB5	NRXN3	Neurexin-3-beta	GO:0001525; P:angiogenesis; ISS:UniProtKB
Q9HDB5	NRXN3	Neurexin-3-beta	GO:0007612; P:learning; IGI:BHF-UCL
Q9HDB5	NRXN3	Neurexin-3-beta	GO:0007158; P:neuron cell-cell adhesion; TAS:BHF-UCL
Q9HDB5	NRXN3	Neurexin-3-beta	GO:0007269; P:neurotransmitter secretion; IEA:InterPro
Q9HDB5	NRXN3	Neurexin-3-beta	GO:0051965; P:positive regulation of synapse assembly; IEA:InterPro
Q9HDB5	NRXN3	Neurexin-3-beta	GO:0090129; P:positive regulation of synapse maturation; IEA:InterPro
Q9HDB5	NRXN3	Neurexin-3-beta	GO:0035176; P:social behavior; IGI:BHF-UCL
Q9HDB5	NRXN3	Neurexin-3-beta	GO:0007416; P:synapse assembly; IEA:InterPro
Q9HDB5	NRXN3	Neurexin-3-beta	GO:0071625; P:vocalization behavior; IGI:BHF-UCL
Q9Y6Y0	IVNS1ABP	Influenza virus NS1A-binding protein	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl
Q9Y6Y0	IVNS1ABP	Influenza virus NS1A-binding protein	GO:0009615; P:response to virus; TAS:ProtInc
Q9Y6Y0	IVNS1ABP	Influenza virus NS1A-binding protein	GO:0008380; P:RNA splicing; TAS:ProtInc
Q9Y6Y0	IVNS1ABP	Influenza virus NS1A-binding protein	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:ProtInc
Q9Y6Y0	IVNS1ABP	Influenza virus NS1A-binding protein	GO:0016032; P:viral process; IEA:UniProtKB-KW
O95478	NSA2	Ribosome biogenesis protein NSA2 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O95478	NSA2	Ribosome biogenesis protein NSA2 homolog	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q96L73	NSD1	Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific	GO:0050681; F:androgen receptor binding; IDA:UniProtKB
Q96L73	NSD1	Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific	GO:0003682; F:chromatin binding; ISS:UniProtKB
Q96L73	NSD1	Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific	GO:0030331; F:estrogen receptor binding; ISS:UniProtKB
Q96L73	NSD1	Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific	GO:0046975; F:histone methyltransferase activity (H3-K36 specific); IDA:UniProtKB
Q96L73	NSD1	Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific	GO:0042799; F:histone methyltransferase activity (H4-K20 specific); ISS:UniProtKB
Q96L73	NSD1	Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific	GO:0016922; F:ligand-dependent nuclear receptor binding; ISS:UniProtKB
Q96L73	NSD1	Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific	GO:0042974; F:retinoic acid receptor binding; ISS:UniProtKB
Q96L73	NSD1	Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific	GO:0046965; F:retinoid X receptor binding; ISS:UniProtKB
Q96L73	NSD1	Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific	GO:0046966; F:thyroid hormone receptor binding; ISS:UniProtKB
Q96L73	NSD1	Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific	GO:0003712; F:transcription cofactor activity; IDA:UniProtKB
Q96L73	NSD1	Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific	GO:0003714; F:transcription corepressor activity; ISS:UniProtKB
Q96L73	NSD1	Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q96L73	NSD1	Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific	GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl
Q96L73	NSD1	Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific	GO:0010452; P:histone H3-K36 methylation; IDA:GOC
Q96L73	NSD1	Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific	GO:0034770; P:histone H4-K20 methylation; ISS:GOC
Q96L73	NSD1	Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific	GO:0016571; P:histone methylation; ISS:UniProtKB
Q96L73	NSD1	Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q96L73	NSD1	Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q96L73	NSD1	Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O96028	WHSC1	Histone-lysine N-methyltransferase NSD2	GO:0003682; F:chromatin binding; IEA:Ensembl
O96028	WHSC1	Histone-lysine N-methyltransferase NSD2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O96028	WHSC1	Histone-lysine N-methyltransferase NSD2	GO:0018024; F:histone-lysine N-methyltransferase activity; IEA:UniProtKB-EC
O96028	WHSC1	Histone-lysine N-methyltransferase NSD2	GO:0005515; F:protein binding; IPI:IntAct
O96028	WHSC1	Histone-lysine N-methyltransferase NSD2	GO:0008270; F:zinc ion binding; IEA:InterPro
O96028	WHSC1	Histone-lysine N-methyltransferase NSD2	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
O96028	WHSC1	Histone-lysine N-methyltransferase NSD2	GO:0003289; P:atrial septum primum morphogenesis; IEA:Ensembl
O96028	WHSC1	Histone-lysine N-methyltransferase NSD2	GO:0003290; P:atrial septum secundum morphogenesis; IEA:Ensembl
O96028	WHSC1	Histone-lysine N-methyltransferase NSD2	GO:0060348; P:bone development; IEA:Ensembl
O96028	WHSC1	Histone-lysine N-methyltransferase NSD2	GO:0003149; P:membranous septum morphogenesis; IEA:Ensembl
O96028	WHSC1	Histone-lysine N-methyltransferase NSD2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O96028	WHSC1	Histone-lysine N-methyltransferase NSD2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BZ95	WHSC1L1	Histone-lysine N-methyltransferase NSD3	GO:0018024; F:histone-lysine N-methyltransferase activity; IEA:InterPro
Q9BZ95	WHSC1L1	Histone-lysine N-methyltransferase NSD3	GO:0005515; F:protein binding; IPI:IntAct
Q9BZ95	WHSC1L1	Histone-lysine N-methyltransferase NSD3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BZ95	WHSC1L1	Histone-lysine N-methyltransferase NSD3	GO:0034968; P:histone lysine methylation; IDA:GOC
Q9BZ95	WHSC1L1	Histone-lysine N-methyltransferase NSD3	GO:0016571; P:histone methylation; IDA:UniProtKB
Q9BZ95	WHSC1L1	Histone-lysine N-methyltransferase NSD3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9BZ95	WHSC1L1	Histone-lysine N-methyltransferase NSD3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15738	NSDHL	Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating	GO:0003854; F:3-beta-hydroxy-delta5-steroid dehydrogenase activity; TAS:ProtInc
Q15738	NSDHL	Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating	GO:0047012; F:sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity; IEA:UniProtKB-EC
Q15738	NSDHL	Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating	GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome
Q15738	NSDHL	Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating	GO:0001942; P:hair follicle development; IEA:Ensembl
Q15738	NSDHL	Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating	GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl
Q15738	NSDHL	Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15738	NSDHL	Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
Q8WV22	NSMCE1	Non-structural maintenance of chromosomes element 1 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q8WV22	NSMCE1	Non-structural maintenance of chromosomes element 1 homolog	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q8WV22	NSMCE1	Non-structural maintenance of chromosomes element 1 homolog	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WV22	NSMCE1	Non-structural maintenance of chromosomes element 1 homolog	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q8WV22	NSMCE1	Non-structural maintenance of chromosomes element 1 homolog	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q8WV22	NSMCE1	Non-structural maintenance of chromosomes element 1 homolog	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8WV22	NSMCE1	Non-structural maintenance of chromosomes element 1 homolog	GO:2001022; P:positive regulation of response to DNA damage stimulus; IMP:UniProtKB
Q8WV22	NSMCE1	Non-structural maintenance of chromosomes element 1 homolog	GO:0016567; P:protein ubiquitination; IDA:GOC
Q96MF7	NSMCE2	E3 SUMO-protein ligase NSE2	GO:0005515; F:protein binding; IPI:IntAct
Q96MF7	NSMCE2	E3 SUMO-protein ligase NSE2	GO:0019789; F:SUMO ligase activity; IDA:UniProtKB
Q96MF7	NSMCE2	E3 SUMO-protein ligase NSE2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96MF7	NSMCE2	E3 SUMO-protein ligase NSE2	GO:0090398; P:cellular senescence; IMP:UniProtKB
Q96MF7	NSMCE2	E3 SUMO-protein ligase NSE2	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
Q96MF7	NSMCE2	E3 SUMO-protein ligase NSE2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q96MF7	NSMCE2	E3 SUMO-protein ligase NSE2	GO:0034184; P:positive regulation of maintenance of mitotic sister chromatid cohesion; IMP:UniProtKB
Q96MF7	NSMCE2	E3 SUMO-protein ligase NSE2	GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; IMP:UniProtKB
Q96MF7	NSMCE2	E3 SUMO-protein ligase NSE2	GO:0016925; P:protein sumoylation; IEA:UniProtKB-UniPathway
Q96MF7	NSMCE2	E3 SUMO-protein ligase NSE2	GO:0000722; P:telomere maintenance via recombination; IMP:UniProtKB
Q9NXX6	NSMCE4A	Non-structural maintenance of chromosomes element 4 homolog A	GO:0005515; F:protein binding; IPI:IntAct
Q9NXX6	NSMCE4A	Non-structural maintenance of chromosomes element 4 homolog A	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q9NXX6	NSMCE4A	Non-structural maintenance of chromosomes element 4 homolog A	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q9NXX6	NSMCE4A	Non-structural maintenance of chromosomes element 4 homolog A	GO:2001022; P:positive regulation of response to DNA damage stimulus; IMP:UniProtKB
Q9UNZ2	NSFL1C	NSFL1 cofactor p47	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q9UNZ2	NSFL1C	NSFL1 cofactor p47	GO:0005515; F:protein binding; IPI:IntAct
P46459	NSF	Vesicle-fusing ATPase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P46459	NSF	Vesicle-fusing ATPase	GO:0042623; F:ATPase activity, coupled; IEA:Ensembl
P46459	NSF	Vesicle-fusing ATPase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P46459	NSF	Vesicle-fusing ATPase	GO:0030165; F:PDZ domain binding; IPI:UniProtKB
P46459	NSF	Vesicle-fusing ATPase	GO:0005515; F:protein binding; IPI:UniProtKB
P46459	NSF	Vesicle-fusing ATPase	GO:0032403; F:protein complex binding; IDA:UniProtKB
P46459	NSF	Vesicle-fusing ATPase	GO:0006887; P:exocytosis; TAS:UniProtKB
P46459	NSF	Vesicle-fusing ATPase	GO:0045026; P:plasma membrane fusion; TAS:UniProtKB
P46459	NSF	Vesicle-fusing ATPase	GO:0001921; P:positive regulation of receptor recycling; IDA:UniProtKB
P46459	NSF	Vesicle-fusing ATPase	GO:0006813; P:potassium ion transport; IEA:Ensembl
P46459	NSF	Vesicle-fusing ATPase	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P46459	NSF	Vesicle-fusing ATPase	GO:0007268; P:synaptic transmission; TAS:Reactome
P42857	NSG1	Neuron-specific protein family member 1	GO:0048268; P:clathrin coat assembly; IEA:InterPro
P42857	NSG1	Neuron-specific protein family member 1	GO:0007212; P:dopamine receptor signaling pathway; IEA:InterPro
Q9Y328	NSG2	Neuron-specific protein family member 2	GO:0048268; P:clathrin coat assembly; IEA:InterPro
Q9Y328	NSG2	Neuron-specific protein family member 2	GO:0007212; P:dopamine receptor signaling pathway; IEA:InterPro
Q9NY59	SMPD3	Sphingomyelin phosphodiesterase 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NY59	SMPD3	Sphingomyelin phosphodiesterase 3	GO:0004767; F:sphingomyelin phosphodiesterase activity; IEA:UniProtKB-EC
Q9NY59	SMPD3	Sphingomyelin phosphodiesterase 3	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9NY59	SMPD3	Sphingomyelin phosphodiesterase 3	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
Q9NY59	SMPD3	Sphingomyelin phosphodiesterase 3	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9NY59	SMPD3	Sphingomyelin phosphodiesterase 3	GO:0030072; P:peptide hormone secretion; IEA:Ensembl
Q9NY59	SMPD3	Sphingomyelin phosphodiesterase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NY59	SMPD3	Sphingomyelin phosphodiesterase 3	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q9NY59	SMPD3	Sphingomyelin phosphodiesterase 3	GO:0006685; P:sphingomyelin catabolic process; TAS:ProtInc
Q96IY1	NSL1	Kinetochore-associated protein NSL1 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q96IY1	NSL1	Kinetochore-associated protein NSL1 homolog	GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW
Q96IY1	NSL1	Kinetochore-associated protein NSL1 homolog	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q96IY1	NSL1	Kinetochore-associated protein NSL1 homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9NXE4	SMPD4	Sphingomyelin phosphodiesterase 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NXE4	SMPD4	Sphingomyelin phosphodiesterase 4	GO:0004767; F:sphingomyelin phosphodiesterase activity; TAS:Reactome
Q9NXE4	SMPD4	Sphingomyelin phosphodiesterase 4	GO:0050290; F:sphingomyelin phosphodiesterase D activity; IEA:InterPro
Q9NXE4	SMPD4	Sphingomyelin phosphodiesterase 4	GO:0071356; P:cellular response to tumor necrosis factor; IDA:BHF-UCL
Q9NXE4	SMPD4	Sphingomyelin phosphodiesterase 4	GO:0046513; P:ceramide biosynthetic process; IDA:BHF-UCL
Q9NXE4	SMPD4	Sphingomyelin phosphodiesterase 4	GO:0046475; P:glycerophospholipid catabolic process; IDA:BHF-UCL
Q9NXE4	SMPD4	Sphingomyelin phosphodiesterase 4	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
Q9NXE4	SMPD4	Sphingomyelin phosphodiesterase 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NXE4	SMPD4	Sphingomyelin phosphodiesterase 4	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q9NXE4	SMPD4	Sphingomyelin phosphodiesterase 4	GO:0006685; P:sphingomyelin catabolic process; IDA:HGNC
O60906	SMPD2	Sphingomyelin phosphodiesterase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60906	SMPD2	Sphingomyelin phosphodiesterase 2	GO:0004767; F:sphingomyelin phosphodiesterase activity; TAS:ProtInc
O60906	SMPD2	Sphingomyelin phosphodiesterase 2	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
O60906	SMPD2	Sphingomyelin phosphodiesterase 2	GO:0046513; P:ceramide biosynthetic process; IEA:Ensembl
O60906	SMPD2	Sphingomyelin phosphodiesterase 2	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
O60906	SMPD2	Sphingomyelin phosphodiesterase 2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O60906	SMPD2	Sphingomyelin phosphodiesterase 2	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
O60906	SMPD2	Sphingomyelin phosphodiesterase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60906	SMPD2	Sphingomyelin phosphodiesterase 2	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
O60906	SMPD2	Sphingomyelin phosphodiesterase 2	GO:0006684; P:sphingomyelin metabolic process; TAS:ProtInc
Q63ZY6	NSUN5P2	Putative methyltransferase NSUN5C	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q63ZY6	NSUN5P2	Putative methyltransferase NSUN5C	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q6X4W1	NSMF	NMDA receptor synaptonuclear signaling and neuronal migration factor	GO:0048306; F:calcium-dependent protein binding; ISS:UniProtKB
Q6X4W1	NSMF	NMDA receptor synaptonuclear signaling and neuronal migration factor	GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB
Q6X4W1	NSMF	NMDA receptor synaptonuclear signaling and neuronal migration factor	GO:0071257; P:cellular response to electrical stimulus; ISS:UniProtKB
Q6X4W1	NSMF	NMDA receptor synaptonuclear signaling and neuronal migration factor	GO:0071371; P:cellular response to gonadotropin stimulus; ISS:UniProtKB
Q6X4W1	NSMF	NMDA receptor synaptonuclear signaling and neuronal migration factor	GO:2001224; P:positive regulation of neuron migration; IMP:UniProtKB
Q6X4W1	NSMF	NMDA receptor synaptonuclear signaling and neuronal migration factor	GO:0035307; P:positive regulation of protein dephosphorylation; ISS:UniProtKB
Q6X4W1	NSMF	NMDA receptor synaptonuclear signaling and neuronal migration factor	GO:0048814; P:regulation of dendrite morphogenesis; ISS:UniProtKB
Q6X4W1	NSMF	NMDA receptor synaptonuclear signaling and neuronal migration factor	GO:0043523; P:regulation of neuron apoptotic process; ISS:UniProtKB
Q6X4W1	NSMF	NMDA receptor synaptonuclear signaling and neuronal migration factor	GO:0048168; P:regulation of neuronal synaptic plasticity; ISS:UniProtKB
Q3KNT7	NSUN5P1	Putative NOL1/NOP2/Sun domain family member 5B	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q3KNT7	NSUN5P1	Putative NOL1/NOP2/Sun domain family member 5B	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9H0G5	NSRP1	Nuclear speckle splicing regulatory protein 1	GO:0003729; F:mRNA binding; IDA:UniProtKB
Q9H0G5	NSRP1	Nuclear speckle splicing regulatory protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H0G5	NSRP1	Nuclear speckle splicing regulatory protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H0G5	NSRP1	Nuclear speckle splicing regulatory protein 1	GO:0032502; P:developmental process; IMP:UniProtKB
Q9H0G5	NSRP1	Nuclear speckle splicing regulatory protein 1	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9H0G5	NSRP1	Nuclear speckle splicing regulatory protein 1	GO:0006913; P:nucleocytoplasmic transport; IDA:UniProtKB
Q9H0G5	NSRP1	Nuclear speckle splicing regulatory protein 1	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB
Q9H0G5	NSRP1	Nuclear speckle splicing regulatory protein 1	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q08J23	NSUN2	tRNA (cytosine(34)-C(5))-methyltransferase	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q08J23	NSUN2	tRNA (cytosine(34)-C(5))-methyltransferase	GO:0016428; F:tRNA (cytosine-5-)-methyltransferase activity; IDA:UniProtKB
Q08J23	NSUN2	tRNA (cytosine(34)-C(5))-methyltransferase	GO:0000049; F:tRNA binding; IEA:UniProtKB-KW
Q08J23	NSUN2	tRNA (cytosine(34)-C(5))-methyltransferase	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q08J23	NSUN2	tRNA (cytosine(34)-C(5))-methyltransferase	GO:0030488; P:tRNA methylation; IDA:UniProtKB
Q9H649	NSUN3	Putative methyltransferase NSUN3	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q9H649	NSUN3	Putative methyltransferase NSUN3	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q96CB9	NSUN4	5-methylcytosine rRNA methyltransferase NSUN4	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q96CB9	NSUN4	5-methylcytosine rRNA methyltransferase NSUN4	GO:0005515; F:protein binding; IPI:UniProtKB
Q96CB9	NSUN4	5-methylcytosine rRNA methyltransferase NSUN4	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q96CB9	NSUN4	5-methylcytosine rRNA methyltransferase NSUN4	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q96P11	NSUN5	Putative methyltransferase NSUN5	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q96P11	NSUN5	Putative methyltransferase NSUN5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8TEA1	NSUN6	Putative methyltransferase NSUN6	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q8TEA1	NSUN6	Putative methyltransferase NSUN6	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q8NE18	NSUN7	Putative methyltransferase NSUN7	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q8NE18	NSUN7	Putative methyltransferase NSUN7	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q7Z3S9	NOTCH2NL	Notch homolog 2 N-terminal-like protein	GO:0005509; F:calcium ion binding; IEA:InterPro
Q7Z3S9	NOTCH2NL	Notch homolog 2 N-terminal-like protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q7Z3S9	NOTCH2NL	Notch homolog 2 N-terminal-like protein	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q7Z3S9	NOTCH2NL	Notch homolog 2 N-terminal-like protein	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
Q8TCD5	NT5C	5'(3')-deoxyribonucleotidase, cytosolic type	GO:0008253; F:5'-nucleotidase activity; EXP:Reactome
Q8TCD5	NT5C	5'(3')-deoxyribonucleotidase, cytosolic type	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TCD5	NT5C	5'(3')-deoxyribonucleotidase, cytosolic type	GO:0008252; F:nucleotidase activity; IDA:UniProtKB
Q8TCD5	NT5C	5'(3')-deoxyribonucleotidase, cytosolic type	GO:0019103; F:pyrimidine nucleotide binding; IDA:UniProtKB
Q8TCD5	NT5C	5'(3')-deoxyribonucleotidase, cytosolic type	GO:0016311; P:dephosphorylation; IDA:UniProtKB
Q8TCD5	NT5C	5'(3')-deoxyribonucleotidase, cytosolic type	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q8TCD5	NT5C	5'(3')-deoxyribonucleotidase, cytosolic type	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
Q8TCD5	NT5C	5'(3')-deoxyribonucleotidase, cytosolic type	GO:0006195; P:purine nucleotide catabolic process; TAS:Reactome
Q8TCD5	NT5C	5'(3')-deoxyribonucleotidase, cytosolic type	GO:0009223; P:pyrimidine deoxyribonucleotide catabolic process; IDA:UniProtKB
Q8TCD5	NT5C	5'(3')-deoxyribonucleotidase, cytosolic type	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
Q8TCD5	NT5C	5'(3')-deoxyribonucleotidase, cytosolic type	GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome
Q8TCD5	NT5C	5'(3')-deoxyribonucleotidase, cytosolic type	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H857	NT5DC2	5'-nucleotidase domain-containing protein 2	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q9H857	NT5DC2	5'-nucleotidase domain-containing protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86UY8	NT5DC3	5'-nucleotidase domain-containing protein 3	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q86UY8	NT5DC3	5'-nucleotidase domain-containing protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5TFE4	NT5DC1	5'-nucleotidase domain-containing protein 1	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q5TFE4	NT5DC1	5'-nucleotidase domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86YG4	NT5DC4	5'-nucleotidase domain-containing protein 4	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q86YG4	NT5DC4	5'-nucleotidase domain-containing protein 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NPB1	NT5M	5'(3')-deoxyribonucleotidase, mitochondrial	GO:0008253; F:5'-nucleotidase activity; EXP:Reactome
Q9NPB1	NT5M	5'(3')-deoxyribonucleotidase, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NPB1	NT5M	5'(3')-deoxyribonucleotidase, mitochondrial	GO:0008252; F:nucleotidase activity; TAS:ProtInc
Q9NPB1	NT5M	5'(3')-deoxyribonucleotidase, mitochondrial	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
Q9NPB1	NT5M	5'(3')-deoxyribonucleotidase, mitochondrial	GO:0016311; P:dephosphorylation; EXP:GOC
Q9NPB1	NT5M	5'(3')-deoxyribonucleotidase, mitochondrial	GO:0006260; P:DNA replication; TAS:ProtInc
Q9NPB1	NT5M	5'(3')-deoxyribonucleotidase, mitochondrial	GO:0046079; P:dUMP catabolic process; IEA:Ensembl
Q9NPB1	NT5M	5'(3')-deoxyribonucleotidase, mitochondrial	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q9NPB1	NT5M	5'(3')-deoxyribonucleotidase, mitochondrial	GO:0009223; P:pyrimidine deoxyribonucleotide catabolic process; TAS:ProtInc
Q9NPB1	NT5M	5'(3')-deoxyribonucleotidase, mitochondrial	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
Q9NPB1	NT5M	5'(3')-deoxyribonucleotidase, mitochondrial	GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome
Q9NPB1	NT5M	5'(3')-deoxyribonucleotidase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9GZY6	LAT2	Linker for activation of T-cells family member 2	GO:0005515; F:protein binding; IPI:HGNC
Q9GZY6	LAT2	Linker for activation of T-cells family member 2	GO:0042169; F:SH2 domain binding; IMP:HGNC
Q9GZY6	LAT2	Linker for activation of T-cells family member 2	GO:0042113; P:B cell activation; IDA:HGNC
Q9GZY6	LAT2	Linker for activation of T-cells family member 2	GO:0050853; P:B cell receptor signaling pathway; IDA:HGNC
Q9GZY6	LAT2	Linker for activation of T-cells family member 2	GO:0019722; P:calcium-mediated signaling; IGI:HGNC
Q9GZY6	LAT2	Linker for activation of T-cells family member 2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9GZY6	LAT2	Linker for activation of T-cells family member 2	GO:0045087; P:innate immune response; TAS:Reactome
Q9GZY6	LAT2	Linker for activation of T-cells family member 2	GO:0035556; P:intracellular signal transduction; IGI:HGNC
Q9GZY6	LAT2	Linker for activation of T-cells family member 2	GO:0043303; P:mast cell degranulation; IEA:UniProtKB-KW
Q96AB6	NTAN1	Protein N-terminal asparagine amidohydrolase	GO:0008418; F:protein-N-terminal asparagine amidohydrolase activity; IEA:Ensembl
Q96AB6	NTAN1	Protein N-terminal asparagine amidohydrolase	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
Q96AB6	NTAN1	Protein N-terminal asparagine amidohydrolase	GO:0007613; P:memory; IEA:Ensembl
Q96HA8	WDYHV1	Protein N-terminal glutamine amidohydrolase	GO:0005515; F:protein binding; IPI:IntAct
Q96HA8	WDYHV1	Protein N-terminal glutamine amidohydrolase	GO:0070773; F:protein-N-terminal glutamine amidohydrolase activity; ISS:UniProtKB
Q96HA8	WDYHV1	Protein N-terminal glutamine amidohydrolase	GO:0006464; P:cellular protein modification process; ISS:UniProtKB
Q12908	SLC10A2	Ileal sodium/bile acid cotransporter	GO:0008508; F:bile acid:sodium symporter activity; TAS:ProtInc
Q12908	SLC10A2	Ileal sodium/bile acid cotransporter	GO:0015721; P:bile acid and bile salt transport; TAS:Reactome
Q12908	SLC10A2	Ileal sodium/bile acid cotransporter	GO:0008206; P:bile acid metabolic process; TAS:Reactome
Q12908	SLC10A2	Ileal sodium/bile acid cotransporter	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q12908	SLC10A2	Ileal sodium/bile acid cotransporter	GO:0006810; P:transport; TAS:ProtInc
Q96EP9	SLC10A4	Sodium/bile acid cotransporter 4	GO:0008508; F:bile acid:sodium symporter activity; IEA:InterPro
Q5PT55	SLC10A5	Sodium/bile acid cotransporter 5	GO:0008508; F:bile acid:sodium symporter activity; IEA:InterPro
Q0GE19	SLC10A7	Sodium/bile acid cotransporter 7	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q0GE19	SLC10A7	Sodium/bile acid cotransporter 7	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q14973	SLC10A1	Sodium/bile acid cotransporter	GO:0008508; F:bile acid:sodium symporter activity; TAS:ProtInc
Q14973	SLC10A1	Sodium/bile acid cotransporter	GO:0015721; P:bile acid and bile salt transport; TAS:Reactome
Q14973	SLC10A1	Sodium/bile acid cotransporter	GO:0008206; P:bile acid metabolic process; TAS:Reactome
Q14973	SLC10A1	Sodium/bile acid cotransporter	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14973	SLC10A1	Sodium/bile acid cotransporter	GO:0006810; P:transport; TAS:ProtInc
P61970	NUTF2	Nuclear transport factor 2	GO:0005515; F:protein binding; IPI:UniProtKB
P61970	NUTF2	Nuclear transport factor 2	GO:0005215; F:transporter activity; TAS:ProtInc
P61970	NUTF2	Nuclear transport factor 2	GO:0006611; P:protein export from nucleus; IDA:BHF-UCL
P20783	NTF3	Neurotrophin-3	GO:0042056; F:chemoattractant activity; IDA:BHF-UCL
P20783	NTF3	Neurotrophin-3	GO:0008083; F:growth factor activity; IDA:BHF-UCL
P20783	NTF3	Neurotrophin-3	GO:0005102; F:receptor binding; TAS:ProtInc
P20783	NTF3	Neurotrophin-3	GO:0000187; P:activation of MAPK activity; IDA:BHF-UCL
P20783	NTF3	Neurotrophin-3	GO:0032148; P:activation of protein kinase B activity; IDA:BHF-UCL
P20783	NTF3	Neurotrophin-3	GO:0032856; P:activation of Ras GTPase activity; IDA:BHF-UCL
P20783	NTF3	Neurotrophin-3	GO:0007411; P:axon guidance; IEA:Ensembl
P20783	NTF3	Neurotrophin-3	GO:0007420; P:brain development; IEA:Ensembl
P20783	NTF3	Neurotrophin-3	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P20783	NTF3	Neurotrophin-3	GO:0048484; P:enteric nervous system development; IEA:Ensembl
P20783	NTF3	Neurotrophin-3	GO:0008544; P:epidermis development; IEA:Ensembl
P20783	NTF3	Neurotrophin-3	GO:0007403; P:glial cell fate determination; IEA:Ensembl
P20783	NTF3	Neurotrophin-3	GO:0050930; P:induction of positive chemotaxis; IDA:BHF-UCL
P20783	NTF3	Neurotrophin-3	GO:0042490; P:mechanoreceptor differentiation; IEA:Ensembl
P20783	NTF3	Neurotrophin-3	GO:0042552; P:myelination; IEA:Ensembl
P20783	NTF3	Neurotrophin-3	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P20783	NTF3	Neurotrophin-3	GO:0050732; P:negative regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL
P20783	NTF3	Neurotrophin-3	GO:0021675; P:nerve development; IEA:Ensembl
P20783	NTF3	Neurotrophin-3	GO:0007399; P:nervous system development; TAS:ProtInc
P20783	NTF3	Neurotrophin-3	GO:0007274; P:neuromuscular synaptic transmission; IEA:Ensembl
P20783	NTF3	Neurotrophin-3	GO:0007422; P:peripheral nervous system development; IEA:Ensembl
P20783	NTF3	Neurotrophin-3	GO:0050918; P:positive chemotaxis; IDA:GOC
P20783	NTF3	Neurotrophin-3	GO:2000251; P:positive regulation of actin cytoskeleton reorganization; IDA:BHF-UCL
P20783	NTF3	Neurotrophin-3	GO:0030335; P:positive regulation of cell migration; IDA:BHF-UCL
P20783	NTF3	Neurotrophin-3	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P20783	NTF3	Neurotrophin-3	GO:0045687; P:positive regulation of glial cell differentiation; IEA:Ensembl
P20783	NTF3	Neurotrophin-3	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:BHF-UCL
P20783	NTF3	Neurotrophin-3	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL
P20783	NTF3	Neurotrophin-3	GO:0002092; P:positive regulation of receptor internalization; IDA:BHF-UCL
P20783	NTF3	Neurotrophin-3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P20783	NTF3	Neurotrophin-3	GO:0050804; P:regulation of synaptic transmission; IEA:Ensembl
P20783	NTF3	Neurotrophin-3	GO:0007165; P:signal transduction; TAS:ProtInc
P20783	NTF3	Neurotrophin-3	GO:0051145; P:smooth muscle cell differentiation; IEA:Ensembl
P20783	NTF3	Neurotrophin-3	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IDA:BHF-UCL
P34130	NTF4	Neurotrophin-4	GO:0008083; F:growth factor activity; TAS:ProtInc
P34130	NTF4	Neurotrophin-4	GO:0008344; P:adult locomotory behavior; ISS:UniProtKB
P34130	NTF4	Neurotrophin-4	GO:0008544; P:epidermis development; ISS:UniProtKB
P34130	NTF4	Neurotrophin-4	GO:0007402; P:ganglion mother cell fate determination; ISS:UniProtKB
P34130	NTF4	Neurotrophin-4	GO:0007616; P:long-term memory; ISS:UniProtKB
P34130	NTF4	Neurotrophin-4	GO:0042490; P:mechanoreceptor differentiation; IEA:Ensembl
P34130	NTF4	Neurotrophin-4	GO:0008052; P:sensory organ boundary specification; ISS:UniProtKB
P78549	NTHL1	Endonuclease III-like protein 1	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
P78549	NTHL1	Endonuclease III-like protein 1	GO:0019104; F:DNA N-glycosylase activity; IDA:UniProtKB
P78549	NTHL1	Endonuclease III-like protein 1	GO:0003906; F:DNA-(apurinic or apyrimidinic site) lyase activity; IDA:UniProtKB
P78549	NTHL1	Endonuclease III-like protein 1	GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB
P78549	NTHL1	Endonuclease III-like protein 1	GO:0004519; F:endonuclease activity; TAS:ProtInc
P78549	NTHL1	Endonuclease III-like protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P78549	NTHL1	Endonuclease III-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P78549	NTHL1	Endonuclease III-like protein 1	GO:0006284; P:base-excision repair; TAS:Reactome
P78549	NTHL1	Endonuclease III-like protein 1	GO:0006285; P:base-excision repair, AP site formation; IDA:UniProtKB
P78549	NTHL1	Endonuclease III-like protein 1	GO:0045008; P:depyrimidination; TAS:Reactome
P78549	NTHL1	Endonuclease III-like protein 1	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
P78549	NTHL1	Endonuclease III-like protein 1	GO:0006281; P:DNA repair; TAS:Reactome
P78549	NTHL1	Endonuclease III-like protein 1	GO:0006296; P:nucleotide-excision repair, DNA incision, 5'-to lesion; IDA:UniProtKB
Q96KG9	SCYL1	N-terminal kinase-like protein	GO:0005524; F:ATP binding; IEA:InterPro
Q96KG9	SCYL1	N-terminal kinase-like protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96KG9	SCYL1	N-terminal kinase-like protein	GO:0004713; F:protein tyrosine kinase activity; NAS:UniProtKB
Q96KG9	SCYL1	N-terminal kinase-like protein	GO:0018108; P:peptidyl-tyrosine phosphorylation; NAS:GOC
Q96KG9	SCYL1	N-terminal kinase-like protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96KG9	SCYL1	N-terminal kinase-like protein	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; IDA:UniProtKB
Q96KG9	SCYL1	N-terminal kinase-like protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BV86	NTMT1	N-terminal Xaa-Pro-Lys N-methyltransferase 1	GO:0008276; F:protein methyltransferase activity; IDA:UniProtKB
Q9BV86	NTMT1	N-terminal Xaa-Pro-Lys N-methyltransferase 1	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q9BV86	NTMT1	N-terminal Xaa-Pro-Lys N-methyltransferase 1	GO:0018012; P:N-terminal peptidyl-alanine trimethylation; IEA:Ensembl
Q9BV86	NTMT1	N-terminal Xaa-Pro-Lys N-methyltransferase 1	GO:0018016; P:N-terminal peptidyl-proline dimethylation; IDA:UniProtKB
Q9BV86	NTMT1	N-terminal Xaa-Pro-Lys N-methyltransferase 1	GO:0035572; P:N-terminal peptidyl-serine dimethylation; IDA:UniProtKB
Q9BV86	NTMT1	N-terminal Xaa-Pro-Lys N-methyltransferase 1	GO:0035573; P:N-terminal peptidyl-serine trimethylation; IDA:UniProtKB
Q9BV86	NTMT1	N-terminal Xaa-Pro-Lys N-methyltransferase 1	GO:0007051; P:spindle organization; IMP:UniProtKB
Q5VVY1	METTL11B	Alpha N-terminal protein methyltransferase 1B	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q9Y2I2	NTNG1	Netrin-G1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y2I2	NTNG1	Netrin-G1	GO:0007409; P:axonogenesis; ISS:UniProtKB
Q96CW9	NTNG2	Netrin-G2	GO:0005515; F:protein binding; IPI:IntAct
Q96CW9	NTNG2	Netrin-G2	GO:0007409; P:axonogenesis; ISS:UniProtKB
Q9BSD7	NTPCR	Cancer-related nucleoside-triphosphatase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BSD7	NTPCR	Cancer-related nucleoside-triphosphatase	GO:0017111; F:nucleoside-triphosphatase activity; IEA:UniProtKB-EC
Q9BSD7	NTPCR	Cancer-related nucleoside-triphosphatase	GO:0098519; F:nucleotide phosphatase activity, acting on free nucleotides; IEA:InterPro
Q9BSD7	NTPCR	Cancer-related nucleoside-triphosphatase	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P30989	NTSR1	Neurotensin receptor type 1	GO:0016492; F:G-protein coupled neurotensin receptor activity; IMP:UniProtKB
P30989	NTSR1	Neurotensin receptor type 1	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P30989	NTSR1	Neurotensin receptor type 1	GO:0005515; F:protein binding; IPI:IntAct
P30989	NTSR1	Neurotensin receptor type 1	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P30989	NTSR1	Neurotensin receptor type 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P30989	NTSR1	Neurotensin receptor type 1	GO:0007218; P:neuropeptide signaling pathway; IMP:GOC
P30989	NTSR1	Neurotensin receptor type 1	GO:0007268; P:synaptic transmission; TAS:ProtInc
O95665	NTSR2	Neurotensin receptor type 2	GO:0016492; F:G-protein coupled neurotensin receptor activity; IEA:Ensembl
O95665	NTSR2	Neurotensin receptor type 2	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O95665	NTSR2	Neurotensin receptor type 2	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
O95665	NTSR2	Neurotensin receptor type 2	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
O95665	NTSR2	Neurotensin receptor type 2	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
O95665	NTSR2	Neurotensin receptor type 2	GO:0007600; P:sensory perception; TAS:ProtInc
Q9P121	NTM	Neurotrimin	GO:0005515; F:protein binding; IPI:IntAct
Q9P121	NTM	Neurotrimin	GO:0007155; P:cell adhesion; NAS:ProtInc
Q9P121	NTM	Neurotrimin	GO:0008038; P:neuron recognition; TAS:ProtInc
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0048406; F:nerve growth factor binding; IDA:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0010465; F:nerve growth factor receptor activity; IDA:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0043121; F:neurotrophin binding; TAS:ProtInc
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IDA:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0007190; P:activation of adenylate cyclase activity; TAS:Reactome
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0000186; P:activation of MAPKK activity; TAS:Reactome
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0007568; P:aging; IEA:Ensembl
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0007411; P:axon guidance; IEA:Ensembl
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0060385; P:axonogenesis involved in innervation; ISS:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0030183; P:B cell differentiation; IEA:Ensembl
P04629	NTRK1	High affinity nerve growth factor receptor	GO:1990090; P:cellular response to nerve growth factor stimulus; ISS:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0071316; P:cellular response to nicotine; IEA:Ensembl
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; IEA:Ensembl
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; IEA:Ensembl
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0010623; P:developmental programmed cell death; ISS:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0007611; P:learning or memory; IEA:Ensembl
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0042490; P:mechanoreceptor differentiation; IEA:Ensembl
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0048011; P:neurotrophin TRK receptor signaling pathway; IDA:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0021553; P:olfactory nerve development; IEA:Ensembl
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:GOC
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0010976; P:positive regulation of neuron projection development; IDA:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0043068; P:positive regulation of programmed cell death; ISS:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0032320; P:positive regulation of Ras GTPase activity; IDA:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0046579; P:positive regulation of Ras protein signal transduction; IDA:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IEA:Ensembl
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0014823; P:response to activity; IEA:Ensembl
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0048678; P:response to axon injury; IEA:Ensembl
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0042493; P:response to drug; IEA:Ensembl
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0051602; P:response to electrical stimulus; IEA:Ensembl
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0045471; P:response to ethanol; IEA:Ensembl
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0051599; P:response to hydrostatic pressure; IEA:Ensembl
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0031667; P:response to nutrient levels; IEA:Ensembl
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0009314; P:response to radiation; IEA:Ensembl
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0060009; P:Sertoli cell development; IEA:Ensembl
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0048485; P:sympathetic nervous system development; ISS:UniProtKB
P04629	NTRK1	High affinity nerve growth factor receptor	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:Reactome
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0048403; F:brain-derived neurotrophic factor binding; ISS:UniProtKB
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0060175; F:brain-derived neurotrophic factor-activated receptor activity; IMP:UniProtKB
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0043121; F:neurotrophin binding; IDA:UniProtKB
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0007190; P:activation of adenylate cyclase activity; TAS:Reactome
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0007568; P:aging; IEA:Ensembl
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0031547; P:brain-derived neurotrophic factor receptor signaling pathway; IMP:UniProtKB
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0035584; P:calcium-mediated signaling using intracellular calcium source; IEA:Ensembl
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0021954; P:central nervous system neuron development; ISS:UniProtKB
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0021987; P:cerebral cortex development; ISS:UniProtKB
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0007631; P:feeding behavior; IEA:Ensembl
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0014047; P:glutamate secretion; IEA:Ensembl
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0007612; P:learning; ISS:UniProtKB
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0007616; P:long-term memory; IEA:Ensembl
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0042490; P:mechanoreceptor differentiation; IEA:Ensembl
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:2000811; P:negative regulation of anoikis; IEA:Ensembl
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0001764; P:neuron migration; ISS:UniProtKB
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0048709; P:oligodendrocyte differentiation; IEA:Ensembl
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0048935; P:peripheral nervous system neuron development; IEA:Ensembl
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0050772; P:positive regulation of axonogenesis; ISS:UniProtKB
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0043410; P:positive regulation of MAPK cascade; ISS:UniProtKB
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; ISS:UniProtKB
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IEA:Ensembl
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0046777; P:protein autophosphorylation; ISS:UniProtKB
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0050773; P:regulation of dendrite development; IEA:Ensembl
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0046928; P:regulation of neurotransmitter secretion; IEA:Ensembl
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0051896; P:regulation of protein kinase B signaling; IEA:Ensembl
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0032314; P:regulation of Rac GTPase activity; ISS:UniProtKB
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0010996; P:response to auditory stimulus; IEA:Ensembl
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0046548; P:retinal rod cell development; IEA:Ensembl
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:Reactome
Q16620	NTRK2	BDNF/NT-3 growth factors receptor	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q16288	NTRK3	NT-3 growth factor receptor	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q16288	NTRK3	NT-3 growth factor receptor	GO:0043121; F:neurotrophin binding; TAS:ProtInc
Q16288	NTRK3	NT-3 growth factor receptor	GO:0005030; F:neurotrophin receptor activity; IDA:BHF-UCL
Q16288	NTRK3	NT-3 growth factor receptor	GO:0002039; F:p53 binding; IPI:BHF-UCL
Q16288	NTRK3	NT-3 growth factor receptor	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IEA:UniProtKB-EC
Q16288	NTRK3	NT-3 growth factor receptor	GO:0000187; P:activation of MAPK activity; IDA:BHF-UCL
Q16288	NTRK3	NT-3 growth factor receptor	GO:0032148; P:activation of protein kinase B activity; IDA:BHF-UCL
Q16288	NTRK3	NT-3 growth factor receptor	GO:0032856; P:activation of Ras GTPase activity; IDA:BHF-UCL
Q16288	NTRK3	NT-3 growth factor receptor	GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl
Q16288	NTRK3	NT-3 growth factor receptor	GO:0090102; P:cochlea development; IEA:Ensembl
Q16288	NTRK3	NT-3 growth factor receptor	GO:0042490; P:mechanoreceptor differentiation; IEA:Ensembl
Q16288	NTRK3	NT-3 growth factor receptor	GO:0019056; P:modulation by virus of host transcription; IEA:Ensembl
Q16288	NTRK3	NT-3 growth factor receptor	GO:0048712; P:negative regulation of astrocyte differentiation; IEA:Ensembl
Q16288	NTRK3	NT-3 growth factor receptor	GO:0060548; P:negative regulation of cell death; IEA:Ensembl
Q16288	NTRK3	NT-3 growth factor receptor	GO:0001933; P:negative regulation of protein phosphorylation; IDA:BHF-UCL
Q16288	NTRK3	NT-3 growth factor receptor	GO:0048665; P:neuron fate specification; IEA:Ensembl
Q16288	NTRK3	NT-3 growth factor receptor	GO:0001764; P:neuron migration; IEA:Ensembl
Q16288	NTRK3	NT-3 growth factor receptor	GO:0038179; P:neurotrophin signaling pathway; IDA:GOC
Q16288	NTRK3	NT-3 growth factor receptor	GO:2000251; P:positive regulation of actin cytoskeleton reorganization; IDA:BHF-UCL
Q16288	NTRK3	NT-3 growth factor receptor	GO:0048691; P:positive regulation of axon extension involved in regeneration; IEA:Ensembl
Q16288	NTRK3	NT-3 growth factor receptor	GO:0030335; P:positive regulation of cell migration; IDA:BHF-UCL
Q16288	NTRK3	NT-3 growth factor receptor	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
Q16288	NTRK3	NT-3 growth factor receptor	GO:0010628; P:positive regulation of gene expression; IDA:BHF-UCL
Q16288	NTRK3	NT-3 growth factor receptor	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:BHF-UCL
Q16288	NTRK3	NT-3 growth factor receptor	GO:0050927; P:positive regulation of positive chemotaxis; IDA:BHF-UCL
Q16288	NTRK3	NT-3 growth factor receptor	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
Q16288	NTRK3	NT-3 growth factor receptor	GO:0048678; P:response to axon injury; IEA:Ensembl
Q16288	NTRK3	NT-3 growth factor receptor	GO:0051412; P:response to corticosterone; IEA:Ensembl
Q16288	NTRK3	NT-3 growth factor receptor	GO:0045471; P:response to ethanol; IEA:Ensembl
Q16288	NTRK3	NT-3 growth factor receptor	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IDA:BHF-UCL
P57740	NUP107	Nuclear pore complex protein Nup107	GO:0005487; F:nucleocytoplasmic transporter activity; IDA:UniProtKB
P57740	NUP107	Nuclear pore complex protein Nup107	GO:0005515; F:protein binding; IPI:UniProtKB
P57740	NUP107	Nuclear pore complex protein Nup107	GO:0017056; F:structural constituent of nuclear pore; IMP:UniProtKB
P57740	NUP107	Nuclear pore complex protein Nup107	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P57740	NUP107	Nuclear pore complex protein Nup107	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P57740	NUP107	Nuclear pore complex protein Nup107	GO:0015758; P:glucose transport; TAS:Reactome
P57740	NUP107	Nuclear pore complex protein Nup107	GO:0008645; P:hexose transport; TAS:Reactome
P57740	NUP107	Nuclear pore complex protein Nup107	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P57740	NUP107	Nuclear pore complex protein Nup107	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
P57740	NUP107	Nuclear pore complex protein Nup107	GO:0006406; P:mRNA export from nucleus; IDA:UniProtKB
P57740	NUP107	Nuclear pore complex protein Nup107	GO:0051292; P:nuclear pore complex assembly; IMP:UniProtKB
P57740	NUP107	Nuclear pore complex protein Nup107	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P57740	NUP107	Nuclear pore complex protein Nup107	GO:0010827; P:regulation of glucose transport; TAS:Reactome
P57740	NUP107	Nuclear pore complex protein Nup107	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P57740	NUP107	Nuclear pore complex protein Nup107	GO:0055085; P:transmembrane transport; TAS:Reactome
P57740	NUP107	Nuclear pore complex protein Nup107	GO:0016032; P:viral process; TAS:Reactome
Q8WUM0	NUP133	Nuclear pore complex protein Nup133	GO:0005487; F:nucleocytoplasmic transporter activity; IDA:UniProtKB
Q8WUM0	NUP133	Nuclear pore complex protein Nup133	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WUM0	NUP133	Nuclear pore complex protein Nup133	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q8WUM0	NUP133	Nuclear pore complex protein Nup133	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q8WUM0	NUP133	Nuclear pore complex protein Nup133	GO:0015758; P:glucose transport; TAS:Reactome
Q8WUM0	NUP133	Nuclear pore complex protein Nup133	GO:0008645; P:hexose transport; TAS:Reactome
Q8WUM0	NUP133	Nuclear pore complex protein Nup133	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8WUM0	NUP133	Nuclear pore complex protein Nup133	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
Q8WUM0	NUP133	Nuclear pore complex protein Nup133	GO:0006406; P:mRNA export from nucleus; IDA:UniProtKB
Q8WUM0	NUP133	Nuclear pore complex protein Nup133	GO:0006999; P:nuclear pore organization; IMP:UniProtKB
Q8WUM0	NUP133	Nuclear pore complex protein Nup133	GO:0048339; P:paraxial mesoderm development; IEA:Ensembl
Q8WUM0	NUP133	Nuclear pore complex protein Nup133	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8WUM0	NUP133	Nuclear pore complex protein Nup133	GO:0010827; P:regulation of glucose transport; TAS:Reactome
Q8WUM0	NUP133	Nuclear pore complex protein Nup133	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8WUM0	NUP133	Nuclear pore complex protein Nup133	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8WUM0	NUP133	Nuclear pore complex protein Nup133	GO:0016032; P:viral process; TAS:Reactome
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0042802; F:identical protein binding; IPI:IntAct
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0005487; F:nucleocytoplasmic transporter activity; IDA:UniProtKB
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0043495; F:protein anchor; IMP:UniProtKB
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0005515; F:protein binding; IPI:UniProtKB
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0017056; F:structural constituent of nuclear pore; IMP:UniProtKB
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0005215; F:transporter activity; TAS:ProtInc
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0008270; F:zinc ion binding; IEA:InterPro
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0015758; P:glucose transport; TAS:Reactome
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0008645; P:hexose transport; TAS:Reactome
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0046832; P:negative regulation of RNA export from nucleus; IDA:UniProtKB
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0051292; P:nuclear pore complex assembly; IMP:UniProtKB
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0010827; P:regulation of glucose transport; TAS:Reactome
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0055085; P:transmembrane transport; TAS:Reactome
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0046718; P:viral entry into host cell; IEA:UniProtKB-KW
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0075732; P:viral penetration into host nucleus; IEA:UniProtKB-KW
P49790	NUP153	Nuclear pore complex protein Nup153	GO:0016032; P:viral process; TAS:Reactome
O75694	NUP155	Nuclear pore complex protein Nup155	GO:0017056; F:structural constituent of nuclear pore; IEA:InterPro
O75694	NUP155	Nuclear pore complex protein Nup155	GO:0005215; F:transporter activity; TAS:ProtInc
O75694	NUP155	Nuclear pore complex protein Nup155	GO:0086014; P:atrial cardiac muscle cell action potential; IEA:Ensembl
O75694	NUP155	Nuclear pore complex protein Nup155	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O75694	NUP155	Nuclear pore complex protein Nup155	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
O75694	NUP155	Nuclear pore complex protein Nup155	GO:0015758; P:glucose transport; TAS:Reactome
O75694	NUP155	Nuclear pore complex protein Nup155	GO:0008645; P:hexose transport; TAS:Reactome
O75694	NUP155	Nuclear pore complex protein Nup155	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O75694	NUP155	Nuclear pore complex protein Nup155	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
O75694	NUP155	Nuclear pore complex protein Nup155	GO:0006406; P:mRNA export from nucleus; IEA:Ensembl
O75694	NUP155	Nuclear pore complex protein Nup155	GO:0006998; P:nuclear envelope organization; IDA:MGI
O75694	NUP155	Nuclear pore complex protein Nup155	GO:0006606; P:protein import into nucleus; IEA:Ensembl
O75694	NUP155	Nuclear pore complex protein Nup155	GO:0010827; P:regulation of glucose transport; TAS:Reactome
O75694	NUP155	Nuclear pore complex protein Nup155	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75694	NUP155	Nuclear pore complex protein Nup155	GO:0055085; P:transmembrane transport; TAS:Reactome
O75694	NUP155	Nuclear pore complex protein Nup155	GO:0016032; P:viral process; TAS:Reactome
Q12769	NUP160	Nuclear pore complex protein Nup160	GO:0005487; F:nucleocytoplasmic transporter activity; IDA:UniProtKB
Q12769	NUP160	Nuclear pore complex protein Nup160	GO:0005515; F:protein binding; IPI:UniProtKB
Q12769	NUP160	Nuclear pore complex protein Nup160	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q12769	NUP160	Nuclear pore complex protein Nup160	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q12769	NUP160	Nuclear pore complex protein Nup160	GO:0015758; P:glucose transport; TAS:Reactome
Q12769	NUP160	Nuclear pore complex protein Nup160	GO:0008645; P:hexose transport; TAS:Reactome
Q12769	NUP160	Nuclear pore complex protein Nup160	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q12769	NUP160	Nuclear pore complex protein Nup160	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
Q12769	NUP160	Nuclear pore complex protein Nup160	GO:0006406; P:mRNA export from nucleus; IDA:UniProtKB
Q12769	NUP160	Nuclear pore complex protein Nup160	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q12769	NUP160	Nuclear pore complex protein Nup160	GO:0010827; P:regulation of glucose transport; TAS:Reactome
Q12769	NUP160	Nuclear pore complex protein Nup160	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q12769	NUP160	Nuclear pore complex protein Nup160	GO:0055085; P:transmembrane transport; TAS:Reactome
Q12769	NUP160	Nuclear pore complex protein Nup160	GO:0016032; P:viral process; TAS:Reactome
Q5SRE5	NUP188	Nucleoporin NUP188 homolog	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q5SRE5	NUP188	Nucleoporin NUP188 homolog	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q5SRE5	NUP188	Nucleoporin NUP188 homolog	GO:0015758; P:glucose transport; TAS:Reactome
Q5SRE5	NUP188	Nucleoporin NUP188 homolog	GO:0008645; P:hexose transport; TAS:Reactome
Q5SRE5	NUP188	Nucleoporin NUP188 homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q5SRE5	NUP188	Nucleoporin NUP188 homolog	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
Q5SRE5	NUP188	Nucleoporin NUP188 homolog	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q5SRE5	NUP188	Nucleoporin NUP188 homolog	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q5SRE5	NUP188	Nucleoporin NUP188 homolog	GO:0010827; P:regulation of glucose transport; TAS:Reactome
Q5SRE5	NUP188	Nucleoporin NUP188 homolog	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5SRE5	NUP188	Nucleoporin NUP188 homolog	GO:0055085; P:transmembrane transport; TAS:Reactome
Q5SRE5	NUP188	Nucleoporin NUP188 homolog	GO:0016032; P:viral process; TAS:Reactome
P03886	MT-ND1	NADH-ubiquinone oxidoreductase chain 1	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
P03886	MT-ND1	NADH-ubiquinone oxidoreductase chain 1	GO:0005515; F:protein binding; IPI:IntAct
P03886	MT-ND1	NADH-ubiquinone oxidoreductase chain 1	GO:0044237; P:cellular metabolic process; TAS:Reactome
P03886	MT-ND1	NADH-ubiquinone oxidoreductase chain 1	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
P03886	MT-ND1	NADH-ubiquinone oxidoreductase chain 1	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P03886	MT-ND1	NADH-ubiquinone oxidoreductase chain 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q92621	NUP205	Nuclear pore complex protein Nup205	GO:0005515; F:protein binding; IPI:UniProtKB
Q92621	NUP205	Nuclear pore complex protein Nup205	GO:0017056; F:structural constituent of nuclear pore; IMP:UniProtKB
Q92621	NUP205	Nuclear pore complex protein Nup205	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q92621	NUP205	Nuclear pore complex protein Nup205	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q92621	NUP205	Nuclear pore complex protein Nup205	GO:0015758; P:glucose transport; TAS:Reactome
Q92621	NUP205	Nuclear pore complex protein Nup205	GO:0008645; P:hexose transport; TAS:Reactome
Q92621	NUP205	Nuclear pore complex protein Nup205	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q92621	NUP205	Nuclear pore complex protein Nup205	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
Q92621	NUP205	Nuclear pore complex protein Nup205	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q92621	NUP205	Nuclear pore complex protein Nup205	GO:0051292; P:nuclear pore complex assembly; IMP:UniProtKB
Q92621	NUP205	Nuclear pore complex protein Nup205	GO:0006913; P:nucleocytoplasmic transport; TAS:UniProtKB
Q92621	NUP205	Nuclear pore complex protein Nup205	GO:0000059; P:protein import into nucleus, docking; TAS:UniProtKB
Q92621	NUP205	Nuclear pore complex protein Nup205	GO:0010827; P:regulation of glucose transport; TAS:Reactome
Q92621	NUP205	Nuclear pore complex protein Nup205	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q92621	NUP205	Nuclear pore complex protein Nup205	GO:0055085; P:transmembrane transport; TAS:Reactome
Q92621	NUP205	Nuclear pore complex protein Nup205	GO:0016032; P:viral process; TAS:Reactome
P35658	NUP214	Nuclear pore complex protein Nup214	GO:0005487; F:nucleocytoplasmic transporter activity; IEA:Ensembl
P35658	NUP214	Nuclear pore complex protein Nup214	GO:0005515; F:protein binding; IPI:UniProtKB
P35658	NUP214	Nuclear pore complex protein Nup214	GO:0005215; F:transporter activity; TAS:ProtInc
P35658	NUP214	Nuclear pore complex protein Nup214	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P35658	NUP214	Nuclear pore complex protein Nup214	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P35658	NUP214	Nuclear pore complex protein Nup214	GO:0010467; P:gene expression; TAS:Reactome
P35658	NUP214	Nuclear pore complex protein Nup214	GO:0015758; P:glucose transport; TAS:Reactome
P35658	NUP214	Nuclear pore complex protein Nup214	GO:0008645; P:hexose transport; TAS:Reactome
P35658	NUP214	Nuclear pore complex protein Nup214	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P35658	NUP214	Nuclear pore complex protein Nup214	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
P35658	NUP214	Nuclear pore complex protein Nup214	GO:0006406; P:mRNA export from nucleus; IEA:Ensembl
P35658	NUP214	Nuclear pore complex protein Nup214	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P35658	NUP214	Nuclear pore complex protein Nup214	GO:0006611; P:protein export from nucleus; IMP:MGI
P35658	NUP214	Nuclear pore complex protein Nup214	GO:0006606; P:protein import into nucleus; IEA:Ensembl
P35658	NUP214	Nuclear pore complex protein Nup214	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
P35658	NUP214	Nuclear pore complex protein Nup214	GO:0010827; P:regulation of glucose transport; TAS:Reactome
P35658	NUP214	Nuclear pore complex protein Nup214	GO:0016070; P:RNA metabolic process; TAS:Reactome
P35658	NUP214	Nuclear pore complex protein Nup214	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P35658	NUP214	Nuclear pore complex protein Nup214	GO:0055085; P:transmembrane transport; TAS:Reactome
P35658	NUP214	Nuclear pore complex protein Nup214	GO:0016032; P:viral process; TAS:Reactome
P03891	MT-ND2	NADH-ubiquinone oxidoreductase chain 2	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
P03891	MT-ND2	NADH-ubiquinone oxidoreductase chain 2	GO:0044237; P:cellular metabolic process; TAS:Reactome
P03891	MT-ND2	NADH-ubiquinone oxidoreductase chain 2	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
P03891	MT-ND2	NADH-ubiquinone oxidoreductase chain 2	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P03891	MT-ND2	NADH-ubiquinone oxidoreductase chain 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P03897	MT-ND3	NADH-ubiquinone oxidoreductase chain 3	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
P03897	MT-ND3	NADH-ubiquinone oxidoreductase chain 3	GO:0005515; F:protein binding; IPI:IntAct
P03897	MT-ND3	NADH-ubiquinone oxidoreductase chain 3	GO:0044237; P:cellular metabolic process; TAS:Reactome
P03897	MT-ND3	NADH-ubiquinone oxidoreductase chain 3	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
P03897	MT-ND3	NADH-ubiquinone oxidoreductase chain 3	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P03897	MT-ND3	NADH-ubiquinone oxidoreductase chain 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P03901	MT-ND4L	NADH-ubiquinone oxidoreductase chain 4L	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
P03901	MT-ND4L	NADH-ubiquinone oxidoreductase chain 4L	GO:0044237; P:cellular metabolic process; TAS:Reactome
P03901	MT-ND4L	NADH-ubiquinone oxidoreductase chain 4L	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
P03901	MT-ND4L	NADH-ubiquinone oxidoreductase chain 4L	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P03901	MT-ND4L	NADH-ubiquinone oxidoreductase chain 4L	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P03905	MT-ND4	NADH-ubiquinone oxidoreductase chain 4	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
P03905	MT-ND4	NADH-ubiquinone oxidoreductase chain 4	GO:0044237; P:cellular metabolic process; TAS:Reactome
P03905	MT-ND4	NADH-ubiquinone oxidoreductase chain 4	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
P03905	MT-ND4	NADH-ubiquinone oxidoreductase chain 4	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P03905	MT-ND4	NADH-ubiquinone oxidoreductase chain 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P03915	MT-ND5	NADH-ubiquinone oxidoreductase chain 5	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; NAS:UniProtKB
P03915	MT-ND5	NADH-ubiquinone oxidoreductase chain 5	GO:0044237; P:cellular metabolic process; TAS:Reactome
P03915	MT-ND5	NADH-ubiquinone oxidoreductase chain 5	GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; NAS:UniProtKB
P03915	MT-ND5	NADH-ubiquinone oxidoreductase chain 5	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P03915	MT-ND5	NADH-ubiquinone oxidoreductase chain 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P03923	MT-ND6	NADH-ubiquinone oxidoreductase chain 6	GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; IEA:UniProtKB-EC
P03923	MT-ND6	NADH-ubiquinone oxidoreductase chain 6	GO:0044237; P:cellular metabolic process; TAS:Reactome
P03923	MT-ND6	NADH-ubiquinone oxidoreductase chain 6	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P03923	MT-ND6	NADH-ubiquinone oxidoreductase chain 6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60285	NUAK1	NUAK family SNF1-like kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O60285	NUAK1	NUAK family SNF1-like kinase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60285	NUAK1	NUAK family SNF1-like kinase 1	GO:0002039; F:p53 binding; IPI:UniProtKB
O60285	NUAK1	NUAK family SNF1-like kinase 1	GO:0005515; F:protein binding; IPI:UniProtKB
O60285	NUAK1	NUAK family SNF1-like kinase 1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
O60285	NUAK1	NUAK family SNF1-like kinase 1	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
O60285	NUAK1	NUAK family SNF1-like kinase 1	GO:0006974; P:cellular response to DNA damage stimulus; IEA:UniProtKB-KW
O60285	NUAK1	NUAK family SNF1-like kinase 1	GO:0030155; P:regulation of cell adhesion; IDA:UniProtKB
O60285	NUAK1	NUAK family SNF1-like kinase 1	GO:0042127; P:regulation of cell proliferation; TAS:UniProtKB
O60285	NUAK1	NUAK family SNF1-like kinase 1	GO:2000772; P:regulation of cellular senescence; IDA:UniProtKB
O60285	NUAK1	NUAK family SNF1-like kinase 1	GO:0035507; P:regulation of myosin-light-chain-phosphatase activity; IDA:UniProtKB
Q9H093	NUAK2	NUAK family SNF1-like kinase 2	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9H093	NUAK2	NUAK family SNF1-like kinase 2	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q9H093	NUAK2	NUAK family SNF1-like kinase 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H093	NUAK2	NUAK family SNF1-like kinase 2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9H093	NUAK2	NUAK family SNF1-like kinase 2	GO:0030036; P:actin cytoskeleton organization; IDA:UniProtKB
Q9H093	NUAK2	NUAK family SNF1-like kinase 2	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9H093	NUAK2	NUAK family SNF1-like kinase 2	GO:0042149; P:cellular response to glucose starvation; IDA:UniProtKB
Q9H093	NUAK2	NUAK family SNF1-like kinase 2	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q9H093	NUAK2	NUAK family SNF1-like kinase 2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9Y5A7	NUB1	NEDD8 ultimate buster 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y5A7	NUB1	NEDD8 ultimate buster 1	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q9Y5A7	NUB1	NEDD8 ultimate buster 1	GO:0016567; P:protein ubiquitination; IMP:UniProtKB
Q9Y5A7	NUB1	NEDD8 ultimate buster 1	GO:0034341; P:response to interferon-gamma; IEP:UniProtKB
Q9Y5A7	NUB1	NEDD8 ultimate buster 1	GO:0034612; P:response to tumor necrosis factor; IEP:UniProtKB
Q9Y5A7	NUB1	NEDD8 ultimate buster 1	GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB
P53384	NUBP1	Cytosolic Fe-S cluster assembly factor NUBP1	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-HAMAP
P53384	NUBP1	Cytosolic Fe-S cluster assembly factor NUBP1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P53384	NUBP1	Cytosolic Fe-S cluster assembly factor NUBP1	GO:0051536; F:iron-sulfur cluster binding; IDA:UniProtKB
P53384	NUBP1	Cytosolic Fe-S cluster assembly factor NUBP1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P53384	NUBP1	Cytosolic Fe-S cluster assembly factor NUBP1	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
P53384	NUBP1	Cytosolic Fe-S cluster assembly factor NUBP1	GO:0000166; F:nucleotide binding; TAS:ProtInc
P53384	NUBP1	Cytosolic Fe-S cluster assembly factor NUBP1	GO:0005515; F:protein binding; IPI:UniProtKB
P53384	NUBP1	Cytosolic Fe-S cluster assembly factor NUBP1	GO:0016049; P:cell growth; IMP:UniProtKB
P53384	NUBP1	Cytosolic Fe-S cluster assembly factor NUBP1	GO:0006879; P:cellular iron ion homeostasis; IMP:UniProtKB
P53384	NUBP1	Cytosolic Fe-S cluster assembly factor NUBP1	GO:0051642; P:centrosome localization; IEA:Ensembl
P53384	NUBP1	Cytosolic Fe-S cluster assembly factor NUBP1	GO:0016226; P:iron-sulfur cluster assembly; IMP:UniProtKB
P53384	NUBP1	Cytosolic Fe-S cluster assembly factor NUBP1	GO:0010826; P:negative regulation of centrosome duplication; IEA:Ensembl
P53384	NUBP1	Cytosolic Fe-S cluster assembly factor NUBP1	GO:0072697; P:protein localization to cell cortex; IEA:Ensembl
P53384	NUBP1	Cytosolic Fe-S cluster assembly factor NUBP1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y5Y2	NUBP2	Cytosolic Fe-S cluster assembly factor NUBP2	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-HAMAP
Q9Y5Y2	NUBP2	Cytosolic Fe-S cluster assembly factor NUBP2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y5Y2	NUBP2	Cytosolic Fe-S cluster assembly factor NUBP2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y5Y2	NUBP2	Cytosolic Fe-S cluster assembly factor NUBP2	GO:0000166; F:nucleotide binding; TAS:ProtInc
Q9Y5Y2	NUBP2	Cytosolic Fe-S cluster assembly factor NUBP2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y5Y2	NUBP2	Cytosolic Fe-S cluster assembly factor NUBP2	GO:0016226; P:iron-sulfur cluster assembly; IEA:UniProtKB-HAMAP
Q9Y5Y2	NUBP2	Cytosolic Fe-S cluster assembly factor NUBP2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8TB37	NUBPL	Iron-sulfur protein NUBPL	GO:0051539; F:4 iron, 4 sulfur cluster binding; IDA:UniProtKB
Q8TB37	NUBPL	Iron-sulfur protein NUBPL	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8TB37	NUBPL	Iron-sulfur protein NUBPL	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TB37	NUBPL	Iron-sulfur protein NUBPL	GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:UniProtKB
Q8TB37	NUBPL	Iron-sulfur protein NUBPL	GO:0070584; P:mitochondrion morphogenesis; IMP:UniProtKB
Q02818	NUCB1	Nucleobindin-1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q02818	NUCB1	Nucleobindin-1	GO:0003677; F:DNA binding; TAS:ProtInc
Q02818	NUCB1	Nucleobindin-1	GO:0005515; F:protein binding; IPI:IntAct
P80303	NUCB2	Nucleobindin-2	GO:0005509; F:calcium ion binding; TAS:ProtInc
P80303	NUCB2	Nucleobindin-2	GO:0003677; F:DNA binding; TAS:ProtInc
P80303	NUCB2	Nucleobindin-2	GO:0005515; F:protein binding; IPI:IntAct
Q14249	ENDOG	Endonuclease G, mitochondrial	GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW
Q14249	ENDOG	Endonuclease G, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14249	ENDOG	Endonuclease G, mitochondrial	GO:0004518; F:nuclease activity; IBA:RefGenome
Q14249	ENDOG	Endonuclease G, mitochondrial	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q14249	ENDOG	Endonuclease G, mitochondrial	GO:0006309; P:apoptotic DNA fragmentation; IBA:RefGenome
Q14249	ENDOG	Endonuclease G, mitochondrial	GO:0006310; P:DNA recombination; TAS:UniProtKB
Q14249	ENDOG	Endonuclease G, mitochondrial	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q14249	ENDOG	Endonuclease G, mitochondrial	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q14249	ENDOG	Endonuclease G, mitochondrial	GO:0046677; P:response to antibiotic; IEA:Ensembl
Q14249	ENDOG	Endonuclease G, mitochondrial	GO:0034612; P:response to tumor necrosis factor; IEA:Ensembl
Q9H1E3	NUCKS1	Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P19338	NCL	Nucleolin	GO:0042802; F:identical protein binding; IPI:IntAct
P19338	NCL	Nucleolin	GO:0000166; F:nucleotide binding; IEA:InterPro
P19338	NCL	Nucleolin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P19338	NCL	Nucleolin	GO:0005515; F:protein binding; IPI:UniProtKB
P19338	NCL	Nucleolin	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P19338	NCL	Nucleolin	GO:0003723; F:RNA binding; IDA:UniProtKB
P19338	NCL	Nucleolin	GO:0042162; F:telomeric DNA binding; IDA:UniProtKB
P19338	NCL	Nucleolin	GO:0001525; P:angiogenesis; IDA:UniProtKB
P19338	NCL	Nucleolin	GO:1901838; P:positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter; IMP:UniProt
Q8NFP7	NUDT10	Diphosphoinositol polyphosphate phosphohydrolase 3-alpha	GO:0008486; F:diphosphoinositol-polyphosphate diphosphatase activity; ISS:UniProtKB
Q8NFP7	NUDT10	Diphosphoinositol polyphosphate phosphohydrolase 3-alpha	GO:0052840; F:inositol diphosphate tetrakisphosphate diphosphatase activity; IEA:UniProtKB-EC
Q8NFP7	NUDT10	Diphosphoinositol polyphosphate phosphohydrolase 3-alpha	GO:0052846; F:inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity; IEA:UniProtKB-EC
Q8NFP7	NUDT10	Diphosphoinositol polyphosphate phosphohydrolase 3-alpha	GO:0052847; F:inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity; IEA:UniProtKB-EC
Q8NFP7	NUDT10	Diphosphoinositol polyphosphate phosphohydrolase 3-alpha	GO:0052843; F:inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity; IEA:UniProtKB-EC
Q8NFP7	NUDT10	Diphosphoinositol polyphosphate phosphohydrolase 3-alpha	GO:0052848; F:inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity; IEA:UniProtKB-EC
Q8NFP7	NUDT10	Diphosphoinositol polyphosphate phosphohydrolase 3-alpha	GO:0052844; F:inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity; IEA:UniProtKB-EC
Q8NFP7	NUDT10	Diphosphoinositol polyphosphate phosphohydrolase 3-alpha	GO:0052845; F:inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity; IEA:UniProtKB-EC
Q8NFP7	NUDT10	Diphosphoinositol polyphosphate phosphohydrolase 3-alpha	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NFP7	NUDT10	Diphosphoinositol polyphosphate phosphohydrolase 3-alpha	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q8NFP7	NUDT10	Diphosphoinositol polyphosphate phosphohydrolase 3-alpha	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96G61	NUDT11	Diphosphoinositol polyphosphate phosphohydrolase 3-beta	GO:0008486; F:diphosphoinositol-polyphosphate diphosphatase activity; ISS:UniProtKB
Q96G61	NUDT11	Diphosphoinositol polyphosphate phosphohydrolase 3-beta	GO:0052840; F:inositol diphosphate tetrakisphosphate diphosphatase activity; IEA:UniProtKB-EC
Q96G61	NUDT11	Diphosphoinositol polyphosphate phosphohydrolase 3-beta	GO:0052846; F:inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity; IEA:UniProtKB-EC
Q96G61	NUDT11	Diphosphoinositol polyphosphate phosphohydrolase 3-beta	GO:0052847; F:inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity; IEA:UniProtKB-EC
Q96G61	NUDT11	Diphosphoinositol polyphosphate phosphohydrolase 3-beta	GO:0052843; F:inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity; IEA:UniProtKB-EC
Q96G61	NUDT11	Diphosphoinositol polyphosphate phosphohydrolase 3-beta	GO:0052848; F:inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity; IEA:UniProtKB-EC
Q96G61	NUDT11	Diphosphoinositol polyphosphate phosphohydrolase 3-beta	GO:0052844; F:inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity; IEA:UniProtKB-EC
Q96G61	NUDT11	Diphosphoinositol polyphosphate phosphohydrolase 3-beta	GO:0052845; F:inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity; IEA:UniProtKB-EC
Q96G61	NUDT11	Diphosphoinositol polyphosphate phosphohydrolase 3-beta	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96G61	NUDT11	Diphosphoinositol polyphosphate phosphohydrolase 3-beta	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q96G61	NUDT11	Diphosphoinositol polyphosphate phosphohydrolase 3-beta	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q86X67	NUDT13	Nucleoside diphosphate-linked moiety X motif 13	GO:0016787; F:hydrolase activity; IEA:InterPro
Q86X67	NUDT13	Nucleoside diphosphate-linked moiety X motif 13	GO:0046872; F:metal ion binding; IEA:InterPro
Q9BQG2	NUDT12	Peroxisomal NADH pyrophosphatase NUDT12	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BQG2	NUDT12	Peroxisomal NADH pyrophosphatase NUDT12	GO:0000210; F:NAD+ diphosphatase activity; IDA:UniProtKB
Q9BQG2	NUDT12	Peroxisomal NADH pyrophosphatase NUDT12	GO:0035529; F:NADH pyrophosphatase activity; IDA:UniProtKB
Q9BQG2	NUDT12	Peroxisomal NADH pyrophosphatase NUDT12	GO:0019677; P:NAD catabolic process; IDA:UniProtKB
Q9BQG2	NUDT12	Peroxisomal NADH pyrophosphatase NUDT12	GO:0006742; P:NADP catabolic process; IDA:UniProtKB
O95848	NUDT14	Uridine diphosphate glucose pyrophosphatase	GO:0047631; F:ADP-ribose diphosphatase activity; IEA:Ensembl
O95848	NUDT14	Uridine diphosphate glucose pyrophosphatase	GO:0046872; F:metal ion binding; IEA:InterPro
O95848	NUDT14	Uridine diphosphate glucose pyrophosphatase	GO:0005515; F:protein binding; IPI:IntAct
O95848	NUDT14	Uridine diphosphate glucose pyrophosphatase	GO:0008768; F:UDP-sugar diphosphatase activity; IEA:UniProtKB-EC
Q9NV35	NUDT15	Probable 8-oxo-dGTP diphosphatase NUDT15	GO:0035539; F:8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity; IDA:UniProtKB
Q9NV35	NUDT15	Probable 8-oxo-dGTP diphosphatase NUDT15	GO:0008413; F:8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity; IDA:UniProtKB
Q9NV35	NUDT15	Probable 8-oxo-dGTP diphosphatase NUDT15	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NV35	NUDT15	Probable 8-oxo-dGTP diphosphatase NUDT15	GO:0006203; P:dGTP catabolic process; IDA:UniProtKB
Q9NV35	NUDT15	Probable 8-oxo-dGTP diphosphatase NUDT15	GO:0006184; P:GTP catabolic process; IDA:UniProtKB
Q9NV35	NUDT15	Probable 8-oxo-dGTP diphosphatase NUDT15	GO:0034656; P:nucleobase-containing small molecule catabolic process; TAS:Reactome
Q9NV35	NUDT15	Probable 8-oxo-dGTP diphosphatase NUDT15	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q9NV35	NUDT15	Probable 8-oxo-dGTP diphosphatase NUDT15	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0050897; F:cobalt ion binding; IDA:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0097383; F:dIDP diphosphatase activity; EXP:Reactome
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0035870; F:dITP diphosphatase activity; ISS:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0005525; F:GTP binding; IDA:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0090450; F:inosine-diphosphatase activity; EXP:Reactome
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:1901641; F:ITP binding; IDA:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0050072; F:m7G(5')pppN diphosphatase activity; IDA:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0030145; F:manganese ion binding; IDA:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0008235; F:metalloexopeptidase activity; IDA:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0003729; F:mRNA binding; IDA:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0098519; F:nucleotide phosphatase activity, acting on free nucleotides; IDA:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0030515; F:snoRNA binding; IDA:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:1901640; F:XTP binding; IDA:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0006382; P:adenosine to inosine editing; IMP:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0016311; P:dephosphorylation; IDA:GOC
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0035863; P:dITP catabolic process; ISS:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0046709; P:IDP catabolic process; IDA:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0006402; P:mRNA catabolic process; IDA:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:2000233; P:negative regulation of rRNA processing; ISS:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0034656; P:nucleobase-containing small molecule catabolic process; TAS:Reactome
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0090068; P:positive regulation of cell cycle process; IMP:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:2000781; P:positive regulation of double-strand break repair; IMP:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0006508; P:proteolysis; IDA:GOC
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:0016077; P:snoRNA catabolic process; IDA:UniProtKB
Q96DE0	NUDT16	U8 snoRNA-decapping enzyme	GO:1901639; P:XDP catabolic process; IDA:UniProtKB
P0C025	NUDT17	Nucleoside diphosphate-linked moiety X motif 17	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
P0C025	NUDT17	Nucleoside diphosphate-linked moiety X motif 17	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZVK8	NUDT18	8-oxo-dGDP phosphatase NUDT18	GO:0044717; F:8-hydroxy-dADP phosphatase activity; IDA:UniProtKB
Q6ZVK8	NUDT18	8-oxo-dGDP phosphatase NUDT18	GO:0044715; F:8-oxo-dGDP phosphatase activity; IDA:UniProtKB
Q6ZVK8	NUDT18	8-oxo-dGDP phosphatase NUDT18	GO:0044716; F:8-oxo-GDP phosphatase activity; IDA:UniProtKB
Q6ZVK8	NUDT18	8-oxo-dGDP phosphatase NUDT18	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q6ZVK8	NUDT18	8-oxo-dGDP phosphatase NUDT18	GO:0005515; F:protein binding; IPI:IntAct
Q6ZVK8	NUDT18	8-oxo-dGDP phosphatase NUDT18	GO:0046057; P:dADP catabolic process; IDA:UniProtKB
Q6ZVK8	NUDT18	8-oxo-dGDP phosphatase NUDT18	GO:0046067; P:dGDP catabolic process; IDA:UniProtKB
Q6ZVK8	NUDT18	8-oxo-dGDP phosphatase NUDT18	GO:0046712; P:GDP catabolic process; IDA:UniProtKB
Q6ZVK8	NUDT18	8-oxo-dGDP phosphatase NUDT18	GO:0034656; P:nucleobase-containing small molecule catabolic process; TAS:Reactome
Q6ZVK8	NUDT18	8-oxo-dGDP phosphatase NUDT18	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q6ZVK8	NUDT18	8-oxo-dGDP phosphatase NUDT18	GO:0044281; P:small molecule metabolic process; TAS:Reactome
A8MXV4	NUDT19	Nucleoside diphosphate-linked moiety X motif 19, mitochondrial	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
A8MXV4	NUDT19	Nucleoside diphosphate-linked moiety X motif 19, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A8MXV4	NUDT19	Nucleoside diphosphate-linked moiety X motif 19, mitochondrial	GO:0005102; F:receptor binding; IPI:UniProtKB
Q9BRQ3	NUDT22	Nucleoside diphosphate-linked moiety X motif 22	GO:0016787; F:hydrolase activity; IEA:InterPro
Q8WVJ2	NUDCD2	NudC domain-containing protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q96RS6	NUDCD1	NudC domain-containing protein 1	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q9Y266	NUDC	Nuclear migration protein nudC	GO:0008283; P:cell proliferation; TAS:ProtInc
Q9Y266	NUDC	Nuclear migration protein nudC	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9Y266	NUDC	Nuclear migration protein nudC	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9Y266	NUDC	Nuclear migration protein nudC	GO:0007275; P:multicellular organismal development; TAS:ProtInc
O95989	NUDT3	Diphosphoinositol polyphosphate phosphohydrolase 1	GO:0008486; F:diphosphoinositol-polyphosphate diphosphatase activity; IDA:UniProtKB
O95989	NUDT3	Diphosphoinositol polyphosphate phosphohydrolase 1	GO:0052840; F:inositol diphosphate tetrakisphosphate diphosphatase activity; IEA:UniProtKB-EC
O95989	NUDT3	Diphosphoinositol polyphosphate phosphohydrolase 1	GO:0052846; F:inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity; IEA:UniProtKB-EC
O95989	NUDT3	Diphosphoinositol polyphosphate phosphohydrolase 1	GO:0052847; F:inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity; IEA:UniProtKB-EC
O95989	NUDT3	Diphosphoinositol polyphosphate phosphohydrolase 1	GO:0052843; F:inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity; IEA:UniProtKB-EC
O95989	NUDT3	Diphosphoinositol polyphosphate phosphohydrolase 1	GO:0052848; F:inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity; IEA:UniProtKB-EC
O95989	NUDT3	Diphosphoinositol polyphosphate phosphohydrolase 1	GO:0052844; F:inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity; IEA:UniProtKB-EC
O95989	NUDT3	Diphosphoinositol polyphosphate phosphohydrolase 1	GO:0052845; F:inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity; IEA:UniProtKB-EC
O95989	NUDT3	Diphosphoinositol polyphosphate phosphohydrolase 1	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
O95989	NUDT3	Diphosphoinositol polyphosphate phosphohydrolase 1	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O95989	NUDT3	Diphosphoinositol polyphosphate phosphohydrolase 1	GO:0015961; P:diadenosine polyphosphate catabolic process; TAS:ProtInc
O95989	NUDT3	Diphosphoinositol polyphosphate phosphohydrolase 1	GO:0071544; P:diphosphoinositol polyphosphate catabolic process; IDA:UniProtKB
O95989	NUDT3	Diphosphoinositol polyphosphate phosphohydrolase 1	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
O95989	NUDT3	Diphosphoinositol polyphosphate phosphohydrolase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NZJ9	NUDT4	Diphosphoinositol polyphosphate phosphohydrolase 2	GO:0008486; F:diphosphoinositol-polyphosphate diphosphatase activity; IDA:UniProtKB
Q9NZJ9	NUDT4	Diphosphoinositol polyphosphate phosphohydrolase 2	GO:0052840; F:inositol diphosphate tetrakisphosphate diphosphatase activity; TAS:Reactome
Q9NZJ9	NUDT4	Diphosphoinositol polyphosphate phosphohydrolase 2	GO:0052846; F:inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity; IEA:UniProtKB-EC
Q9NZJ9	NUDT4	Diphosphoinositol polyphosphate phosphohydrolase 2	GO:0052847; F:inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity; IEA:UniProtKB-EC
Q9NZJ9	NUDT4	Diphosphoinositol polyphosphate phosphohydrolase 2	GO:0052843; F:inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity; IEA:UniProtKB-EC
Q9NZJ9	NUDT4	Diphosphoinositol polyphosphate phosphohydrolase 2	GO:0052848; F:inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity; IEA:UniProtKB-EC
Q9NZJ9	NUDT4	Diphosphoinositol polyphosphate phosphohydrolase 2	GO:0052844; F:inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity; IEA:UniProtKB-EC
Q9NZJ9	NUDT4	Diphosphoinositol polyphosphate phosphohydrolase 2	GO:0052845; F:inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity; IEA:UniProtKB-EC
Q9NZJ9	NUDT4	Diphosphoinositol polyphosphate phosphohydrolase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NZJ9	NUDT4	Diphosphoinositol polyphosphate phosphohydrolase 2	GO:0030515; F:snoRNA binding; ISS:UniProtKB
Q9NZJ9	NUDT4	Diphosphoinositol polyphosphate phosphohydrolase 2	GO:0019722; P:calcium-mediated signaling; TAS:UniProtKB
Q9NZJ9	NUDT4	Diphosphoinositol polyphosphate phosphohydrolase 2	GO:0009187; P:cyclic nucleotide metabolic process; TAS:ProtInc
Q9NZJ9	NUDT4	Diphosphoinositol polyphosphate phosphohydrolase 2	GO:0019935; P:cyclic-nucleotide-mediated signaling; TAS:UniProtKB
Q9NZJ9	NUDT4	Diphosphoinositol polyphosphate phosphohydrolase 2	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q9NZJ9	NUDT4	Diphosphoinositol polyphosphate phosphohydrolase 2	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
Q9NZJ9	NUDT4	Diphosphoinositol polyphosphate phosphohydrolase 2	GO:0046907; P:intracellular transport; TAS:UniProtKB
Q9NZJ9	NUDT4	Diphosphoinositol polyphosphate phosphohydrolase 2	GO:0046831; P:regulation of RNA export from nucleus; TAS:UniProtKB
Q9NZJ9	NUDT4	Diphosphoinositol polyphosphate phosphohydrolase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UKK9	NUDT5	ADP-sugar pyrophosphatase	GO:0047631; F:ADP-ribose diphosphatase activity; EXP:Reactome
Q9UKK9	NUDT5	ADP-sugar pyrophosphatase	GO:0019144; F:ADP-sugar diphosphatase activity; IDA:UniProtKB
Q9UKK9	NUDT5	ADP-sugar pyrophosphatase	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q9UKK9	NUDT5	ADP-sugar pyrophosphatase	GO:0017110; F:nucleoside-diphosphatase activity; IEA:Ensembl
Q9UKK9	NUDT5	ADP-sugar pyrophosphatase	GO:0030515; F:snoRNA binding; ISS:UniProtKB
Q9UKK9	NUDT5	ADP-sugar pyrophosphatase	GO:0019303; P:D-ribose catabolic process; NAS:UniProtKB
Q9UKK9	NUDT5	ADP-sugar pyrophosphatase	GO:0034656; P:nucleobase-containing small molecule catabolic process; TAS:Reactome
Q9UKK9	NUDT5	ADP-sugar pyrophosphatase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q9UKK9	NUDT5	ADP-sugar pyrophosphatase	GO:0009117; P:nucleotide metabolic process; NAS:ProtInc
Q9UKK9	NUDT5	ADP-sugar pyrophosphatase	GO:0009191; P:ribonucleoside diphosphate catabolic process; IDA:UniProtKB
Q9UKK9	NUDT5	ADP-sugar pyrophosphatase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P0C024	NUDT7	Peroxisomal coenzyme A diphosphatase NUDT7	GO:0003986; F:acetyl-CoA hydrolase activity; ISS:UniProtKB
P0C024	NUDT7	Peroxisomal coenzyme A diphosphatase NUDT7	GO:0016818; F:hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; IEA:InterPro
P0C024	NUDT7	Peroxisomal coenzyme A diphosphatase NUDT7	GO:0000287; F:magnesium ion binding; IEA:InterPro
P0C024	NUDT7	Peroxisomal coenzyme A diphosphatase NUDT7	GO:0030145; F:manganese ion binding; IEA:InterPro
P0C024	NUDT7	Peroxisomal coenzyme A diphosphatase NUDT7	GO:0005102; F:receptor binding; IPI:UniProtKB
P0C024	NUDT7	Peroxisomal coenzyme A diphosphatase NUDT7	GO:0030515; F:snoRNA binding; ISS:UniProtKB
P0C024	NUDT7	Peroxisomal coenzyme A diphosphatase NUDT7	GO:0046356; P:acetyl-CoA catabolic process; ISS:UniProtKB
P0C024	NUDT7	Peroxisomal coenzyme A diphosphatase NUDT7	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
P0C024	NUDT7	Peroxisomal coenzyme A diphosphatase NUDT7	GO:0015938; P:coenzyme A catabolic process; ISS:UniProtKB
P0C024	NUDT7	Peroxisomal coenzyme A diphosphatase NUDT7	GO:0009132; P:nucleoside diphosphate metabolic process; IEA:InterPro
P53370	NUDT6	Nucleoside diphosphate-linked moiety X motif 6	GO:0008083; F:growth factor activity; TAS:UniProtKB
P53370	NUDT6	Nucleoside diphosphate-linked moiety X motif 6	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q8WV74	NUDT8	Nucleoside diphosphate-linked moiety X motif 8, mitochondrial	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q8WV74	NUDT8	Nucleoside diphosphate-linked moiety X motif 8, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BW91	NUDT9	ADP-ribose pyrophosphatase, mitochondrial	GO:0043262; F:adenosine-diphosphatase activity; IEA:Ensembl
Q9BW91	NUDT9	ADP-ribose pyrophosphatase, mitochondrial	GO:0047631; F:ADP-ribose diphosphatase activity; EXP:Reactome
Q9BW91	NUDT9	ADP-ribose pyrophosphatase, mitochondrial	GO:0019144; F:ADP-sugar diphosphatase activity; NAS:UniProtKB
Q9BW91	NUDT9	ADP-ribose pyrophosphatase, mitochondrial	GO:0046032; P:ADP catabolic process; IEA:Ensembl
Q9BW91	NUDT9	ADP-ribose pyrophosphatase, mitochondrial	GO:0046709; P:IDP catabolic process; IEA:Ensembl
Q9BW91	NUDT9	ADP-ribose pyrophosphatase, mitochondrial	GO:0034656; P:nucleobase-containing small molecule catabolic process; TAS:Reactome
Q9BW91	NUDT9	ADP-ribose pyrophosphatase, mitochondrial	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q9BW91	NUDT9	ADP-ribose pyrophosphatase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BZD4	NUF2	Kinetochore protein Nuf2	GO:0005515; F:protein binding; IPI:IntAct
Q9BZD4	NUF2	Kinetochore protein Nuf2	GO:0007059; P:chromosome segregation; NAS:UniProtKB
Q9BZD4	NUF2	Kinetochore protein Nuf2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9BZD4	NUF2	Kinetochore protein Nuf2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q7Z417	NUFIP2	Nuclear fragile X mental retardation-interacting protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7Z417	NUFIP2	Nuclear fragile X mental retardation-interacting protein 2	GO:0005515; F:protein binding; IPI:HGNC
Q7Z417	NUFIP2	Nuclear fragile X mental retardation-interacting protein 2	GO:0003723; F:RNA binding; IDA:HGNC
Q9UHK0	NUFIP1	Nuclear fragile X mental retardation-interacting protein 1	GO:0003677; F:DNA binding; NAS:UniProtKB
Q9UHK0	NUFIP1	Nuclear fragile X mental retardation-interacting protein 1	GO:0042802; F:identical protein binding; IPI:BHF-UCL
Q9UHK0	NUFIP1	Nuclear fragile X mental retardation-interacting protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UHK0	NUFIP1	Nuclear fragile X mental retardation-interacting protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UHK0	NUFIP1	Nuclear fragile X mental retardation-interacting protein 1	GO:0030674; F:protein binding, bridging; IPI:BHF-UCL
Q9UHK0	NUFIP1	Nuclear fragile X mental retardation-interacting protein 1	GO:0003723; F:RNA binding; IDA:HGNC
Q9UHK0	NUFIP1	Nuclear fragile X mental retardation-interacting protein 1	GO:0000492; P:box C/D snoRNP assembly; IMP:BHF-UCL
Q9UHK0	NUFIP1	Nuclear fragile X mental retardation-interacting protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:HGNC
Q9UHK0	NUFIP1	Nuclear fragile X mental retardation-interacting protein 1	GO:0006396; P:RNA processing; TAS:ProtInc
Q14980	NUMA1	Nuclear mitotic apparatus protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q14980	NUMA1	Nuclear mitotic apparatus protein 1	GO:0005198; F:structural molecule activity; TAS:ProtInc
Q14980	NUMA1	Nuclear mitotic apparatus protein 1	GO:0000132; P:establishment of mitotic spindle orientation; IEA:Ensembl
Q14980	NUMA1	Nuclear mitotic apparatus protein 1	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q14980	NUMA1	Nuclear mitotic apparatus protein 1	GO:0060487; P:lung epithelial cell differentiation; IEA:Ensembl
Q14980	NUMA1	Nuclear mitotic apparatus protein 1	GO:0051321; P:meiotic cell cycle; IEA:Ensembl
Q14980	NUMA1	Nuclear mitotic apparatus protein 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q14980	NUMA1	Nuclear mitotic apparatus protein 1	GO:0000090; P:mitotic anaphase; TAS:ProtInc
Q14980	NUMA1	Nuclear mitotic apparatus protein 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q14980	NUMA1	Nuclear mitotic apparatus protein 1	GO:0006997; P:nucleus organization; TAS:ProtInc
Q9Y6R0	NUMBL	Numb-like protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6R0	NUMBL	Numb-like protein	GO:0034332; P:adherens junction organization; IEA:Ensembl
Q9Y6R0	NUMBL	Numb-like protein	GO:0007409; P:axonogenesis; IEA:Ensembl
Q9Y6R0	NUMBL	Numb-like protein	GO:0019221; P:cytokine-mediated signaling pathway; IDA:UniProtKB
Q9Y6R0	NUMBL	Numb-like protein	GO:0021670; P:lateral ventricle development; ISS:UniProtKB
Q9Y6R0	NUMBL	Numb-like protein	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y6R0	NUMBL	Numb-like protein	GO:0021849; P:neuroblast division in subventricular zone; ISS:UniProtKB
Q9Y6R0	NUMBL	Numb-like protein	GO:0050775; P:positive regulation of dendrite morphogenesis; IEA:Ensembl
Q9Y6R0	NUMBL	Numb-like protein	GO:0050769; P:positive regulation of neurogenesis; ISS:UniProtKB
Q9Y6R0	NUMBL	Numb-like protein	GO:0019538; P:protein metabolic process; IDA:UniProtKB
P49757	NUMB	Protein numb homolog	GO:0005515; F:protein binding; IPI:IntAct
P49757	NUMB	Protein numb homolog	GO:0034332; P:adherens junction organization; IEA:Ensembl
P49757	NUMB	Protein numb homolog	GO:0007411; P:axon guidance; TAS:Reactome
P49757	NUMB	Protein numb homolog	GO:0021670; P:lateral ventricle development; ISS:UniProtKB
P49757	NUMB	Protein numb homolog	GO:0060487; P:lung epithelial cell differentiation; IEA:Ensembl
P49757	NUMB	Protein numb homolog	GO:0045746; P:negative regulation of Notch signaling pathway; IEA:Ensembl
P49757	NUMB	Protein numb homolog	GO:0021849; P:neuroblast division in subventricular zone; ISS:UniProtKB
P49757	NUMB	Protein numb homolog	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P49757	NUMB	Protein numb homolog	GO:0050769; P:positive regulation of neurogenesis; ISS:UniProtKB
P49757	NUMB	Protein numb homolog	GO:0030862; P:positive regulation of polarized epithelial cell differentiation; IEA:Ensembl
Q8NFH4	NUP37	Nucleoporin Nup37	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NFH4	NUP37	Nucleoporin Nup37	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q8NFH4	NUP37	Nucleoporin Nup37	GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW
Q8NFH4	NUP37	Nucleoporin Nup37	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q8NFH4	NUP37	Nucleoporin Nup37	GO:0015758; P:glucose transport; TAS:Reactome
Q8NFH4	NUP37	Nucleoporin Nup37	GO:0008645; P:hexose transport; TAS:Reactome
Q8NFH4	NUP37	Nucleoporin Nup37	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q8NFH4	NUP37	Nucleoporin Nup37	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8NFH4	NUP37	Nucleoporin Nup37	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
Q8NFH4	NUP37	Nucleoporin Nup37	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q8NFH4	NUP37	Nucleoporin Nup37	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8NFH4	NUP37	Nucleoporin Nup37	GO:0010827; P:regulation of glucose transport; TAS:Reactome
Q8NFH4	NUP37	Nucleoporin Nup37	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8NFH4	NUP37	Nucleoporin Nup37	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8NFH4	NUP37	Nucleoporin Nup37	GO:0016032; P:viral process; TAS:Reactome
Q8NFH3	NUP43	Nucleoporin Nup43	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NFH3	NUP43	Nucleoporin Nup43	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q8NFH3	NUP43	Nucleoporin Nup43	GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW
Q8NFH3	NUP43	Nucleoporin Nup43	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q8NFH3	NUP43	Nucleoporin Nup43	GO:0015758; P:glucose transport; TAS:Reactome
Q8NFH3	NUP43	Nucleoporin Nup43	GO:0008645; P:hexose transport; TAS:Reactome
Q8NFH3	NUP43	Nucleoporin Nup43	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q8NFH3	NUP43	Nucleoporin Nup43	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8NFH3	NUP43	Nucleoporin Nup43	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
Q8NFH3	NUP43	Nucleoporin Nup43	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q8NFH3	NUP43	Nucleoporin Nup43	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8NFH3	NUP43	Nucleoporin Nup43	GO:0010827; P:regulation of glucose transport; TAS:Reactome
Q8NFH3	NUP43	Nucleoporin Nup43	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8NFH3	NUP43	Nucleoporin Nup43	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8NFH3	NUP43	Nucleoporin Nup43	GO:0016032; P:viral process; TAS:Reactome
Q9UKX7	NUP50	Nuclear pore complex protein Nup50	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKX7	NUP50	Nuclear pore complex protein Nup50	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9UKX7	NUP50	Nuclear pore complex protein Nup50	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q9UKX7	NUP50	Nuclear pore complex protein Nup50	GO:0015758; P:glucose transport; TAS:Reactome
Q9UKX7	NUP50	Nuclear pore complex protein Nup50	GO:0008645; P:hexose transport; TAS:Reactome
Q9UKX7	NUP50	Nuclear pore complex protein Nup50	GO:0046907; P:intracellular transport; IEA:InterPro
Q9UKX7	NUP50	Nuclear pore complex protein Nup50	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9UKX7	NUP50	Nuclear pore complex protein Nup50	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
Q9UKX7	NUP50	Nuclear pore complex protein Nup50	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q9UKX7	NUP50	Nuclear pore complex protein Nup50	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9UKX7	NUP50	Nuclear pore complex protein Nup50	GO:0010827; P:regulation of glucose transport; TAS:Reactome
Q9UKX7	NUP50	Nuclear pore complex protein Nup50	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UKX7	NUP50	Nuclear pore complex protein Nup50	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UKX7	NUP50	Nuclear pore complex protein Nup50	GO:0016032; P:viral process; TAS:Reactome
Q8NFH5	NUP35	Nucleoporin NUP53	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q8NFH5	NUP35	Nucleoporin NUP53	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q8NFH5	NUP35	Nucleoporin NUP53	GO:0015758; P:glucose transport; TAS:Reactome
Q8NFH5	NUP35	Nucleoporin NUP53	GO:0008645; P:hexose transport; TAS:Reactome
Q8NFH5	NUP35	Nucleoporin NUP53	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8NFH5	NUP35	Nucleoporin NUP53	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
Q8NFH5	NUP35	Nucleoporin NUP53	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q8NFH5	NUP35	Nucleoporin NUP53	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8NFH5	NUP35	Nucleoporin NUP53	GO:0010827; P:regulation of glucose transport; TAS:Reactome
Q8NFH5	NUP35	Nucleoporin NUP53	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8NFH5	NUP35	Nucleoporin NUP53	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8NFH5	NUP35	Nucleoporin NUP53	GO:0016032; P:viral process; TAS:Reactome
Q7Z3B4	NUP54	Nucleoporin p54	GO:0005487; F:nucleocytoplasmic transporter activity; IEA:Ensembl
Q7Z3B4	NUP54	Nucleoporin p54	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q7Z3B4	NUP54	Nucleoporin p54	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q7Z3B4	NUP54	Nucleoporin p54	GO:0015758; P:glucose transport; TAS:Reactome
Q7Z3B4	NUP54	Nucleoporin p54	GO:0008645; P:hexose transport; TAS:Reactome
Q7Z3B4	NUP54	Nucleoporin p54	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q7Z3B4	NUP54	Nucleoporin p54	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
Q7Z3B4	NUP54	Nucleoporin p54	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q7Z3B4	NUP54	Nucleoporin p54	GO:0006605; P:protein targeting; IEA:Ensembl
Q7Z3B4	NUP54	Nucleoporin p54	GO:0010827; P:regulation of glucose transport; TAS:Reactome
Q7Z3B4	NUP54	Nucleoporin p54	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q7Z3B4	NUP54	Nucleoporin p54	GO:0055085; P:transmembrane transport; TAS:Reactome
Q7Z3B4	NUP54	Nucleoporin p54	GO:0016032; P:viral process; TAS:Reactome
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0003682; F:chromatin binding; NAS:UniProtKB
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0005515; F:protein binding; IPI:UniProtKB
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0030159; F:receptor signaling complex scaffold activity; IDA:UniProtKB
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0042169; F:SH2 domain binding; IDA:UniProtKB
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0017056; F:structural constituent of nuclear pore; IEA:InterPro
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0046966; F:thyroid hormone receptor binding; IPI:UniProtKB
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0007569; P:cell aging; IEA:Ensembl
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0008219; P:cell death; IMP:UniProtKB
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0007166; P:cell surface receptor signaling pathway; IDA:UniProtKB
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0015758; P:glucose transport; TAS:Reactome
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0008645; P:hexose transport; TAS:Reactome
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0009755; P:hormone-mediated signaling pathway; NAS:UniProtKB
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; IEA:Ensembl
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0043407; P:negative regulation of MAP kinase activity; IEA:Ensembl
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0043069; P:negative regulation of programmed cell death; IDA:UniProtKB
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0046580; P:negative regulation of Ras protein signal transduction; IEA:Ensembl
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0006913; P:nucleocytoplasmic transport; NAS:GOC
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0045742; P:positive regulation of epidermal growth factor receptor signaling pathway; NAS:UniProtKB
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0010827; P:regulation of glucose transport; TAS:Reactome
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0046578; P:regulation of Ras protein signal transduction; NAS:UniProtKB
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0009966; P:regulation of signal transduction; NAS:UniProtKB
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0055085; P:transmembrane transport; TAS:Reactome
P37198	NUP62	Nuclear pore glycoprotein p62	GO:0016032; P:viral process; TAS:Reactome
Q9BW27	NUP85	Nuclear pore complex protein Nup85	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BW27	NUP85	Nuclear pore complex protein Nup85	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9BW27	NUP85	Nuclear pore complex protein Nup85	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q9BW27	NUP85	Nuclear pore complex protein Nup85	GO:0015758; P:glucose transport; TAS:Reactome
Q9BW27	NUP85	Nuclear pore complex protein Nup85	GO:0008645; P:hexose transport; TAS:Reactome
Q9BW27	NUP85	Nuclear pore complex protein Nup85	GO:0030032; P:lamellipodium assembly; IEA:Ensembl
Q9BW27	NUP85	Nuclear pore complex protein Nup85	GO:0048246; P:macrophage chemotaxis; IEA:Ensembl
Q9BW27	NUP85	Nuclear pore complex protein Nup85	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9BW27	NUP85	Nuclear pore complex protein Nup85	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
Q9BW27	NUP85	Nuclear pore complex protein Nup85	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q9BW27	NUP85	Nuclear pore complex protein Nup85	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9BW27	NUP85	Nuclear pore complex protein Nup85	GO:0010827; P:regulation of glucose transport; TAS:Reactome
Q9BW27	NUP85	Nuclear pore complex protein Nup85	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BW27	NUP85	Nuclear pore complex protein Nup85	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9BW27	NUP85	Nuclear pore complex protein Nup85	GO:0016032; P:viral process; TAS:Reactome
Q99567	NUP88	Nuclear pore complex protein Nup88	GO:0005215; F:transporter activity; TAS:ProtInc
Q99567	NUP88	Nuclear pore complex protein Nup88	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q99567	NUP88	Nuclear pore complex protein Nup88	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q99567	NUP88	Nuclear pore complex protein Nup88	GO:0015758; P:glucose transport; TAS:Reactome
Q99567	NUP88	Nuclear pore complex protein Nup88	GO:0008645; P:hexose transport; TAS:Reactome
Q99567	NUP88	Nuclear pore complex protein Nup88	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q99567	NUP88	Nuclear pore complex protein Nup88	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
Q99567	NUP88	Nuclear pore complex protein Nup88	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q99567	NUP88	Nuclear pore complex protein Nup88	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q99567	NUP88	Nuclear pore complex protein Nup88	GO:0010827; P:regulation of glucose transport; TAS:Reactome
Q99567	NUP88	Nuclear pore complex protein Nup88	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99567	NUP88	Nuclear pore complex protein Nup88	GO:0055085; P:transmembrane transport; TAS:Reactome
Q99567	NUP88	Nuclear pore complex protein Nup88	GO:0016032; P:viral process; TAS:Reactome
Q8N1F7	NUP93	Nuclear pore complex protein Nup93	GO:0017056; F:structural constituent of nuclear pore; IMP:UniProtKB
Q8N1F7	NUP93	Nuclear pore complex protein Nup93	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q8N1F7	NUP93	Nuclear pore complex protein Nup93	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q8N1F7	NUP93	Nuclear pore complex protein Nup93	GO:0015758; P:glucose transport; TAS:Reactome
Q8N1F7	NUP93	Nuclear pore complex protein Nup93	GO:0008645; P:hexose transport; TAS:Reactome
Q8N1F7	NUP93	Nuclear pore complex protein Nup93	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8N1F7	NUP93	Nuclear pore complex protein Nup93	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
Q8N1F7	NUP93	Nuclear pore complex protein Nup93	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q8N1F7	NUP93	Nuclear pore complex protein Nup93	GO:0051292; P:nuclear pore complex assembly; IMP:UniProtKB
Q8N1F7	NUP93	Nuclear pore complex protein Nup93	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8N1F7	NUP93	Nuclear pore complex protein Nup93	GO:0010827; P:regulation of glucose transport; TAS:Reactome
Q8N1F7	NUP93	Nuclear pore complex protein Nup93	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8N1F7	NUP93	Nuclear pore complex protein Nup93	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8N1F7	NUP93	Nuclear pore complex protein Nup93	GO:0016032; P:viral process; TAS:Reactome
P52948	NUP98	Nuclear pore complex protein Nup98-Nup96	GO:0042277; F:peptide binding; IEA:Ensembl
P52948	NUP98	Nuclear pore complex protein Nup98-Nup96	GO:0005515; F:protein binding; IPI:UniProtKB
P52948	NUP98	Nuclear pore complex protein Nup98-Nup96	GO:0017056; F:structural constituent of nuclear pore; IMP:UniProtKB
P52948	NUP98	Nuclear pore complex protein Nup98-Nup96	GO:0005215; F:transporter activity; TAS:ProtInc
P52948	NUP98	Nuclear pore complex protein Nup98-Nup96	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P52948	NUP98	Nuclear pore complex protein Nup98-Nup96	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P52948	NUP98	Nuclear pore complex protein Nup98-Nup96	GO:0006260; P:DNA replication; IMP:UniProtKB
P52948	NUP98	Nuclear pore complex protein Nup98-Nup96	GO:0015758; P:glucose transport; TAS:Reactome
P52948	NUP98	Nuclear pore complex protein Nup98-Nup96	GO:0008645; P:hexose transport; TAS:Reactome
P52948	NUP98	Nuclear pore complex protein Nup98-Nup96	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P52948	NUP98	Nuclear pore complex protein Nup98-Nup96	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
P52948	NUP98	Nuclear pore complex protein Nup98-Nup96	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
P52948	NUP98	Nuclear pore complex protein Nup98-Nup96	GO:0051292; P:nuclear pore complex assembly; IMP:UniProtKB
P52948	NUP98	Nuclear pore complex protein Nup98-Nup96	GO:0006999; P:nuclear pore organization; NAS:UniProtKB
P52948	NUP98	Nuclear pore complex protein Nup98-Nup96	GO:0006913; P:nucleocytoplasmic transport; TAS:UniProtKB
P52948	NUP98	Nuclear pore complex protein Nup98-Nup96	GO:0000059; P:protein import into nucleus, docking; NAS:UniProtKB
P52948	NUP98	Nuclear pore complex protein Nup98-Nup96	GO:0010827; P:regulation of glucose transport; TAS:Reactome
P52948	NUP98	Nuclear pore complex protein Nup98-Nup96	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P52948	NUP98	Nuclear pore complex protein Nup98-Nup96	GO:0055085; P:transmembrane transport; TAS:Reactome
P52948	NUP98	Nuclear pore complex protein Nup98-Nup96	GO:0016032; P:viral process; TAS:Reactome
Q9BVL2	NUPL1	Nucleoporin p58/p45	GO:0005487; F:nucleocytoplasmic transporter activity; IEA:Ensembl
Q9BVL2	NUPL1	Nucleoporin p58/p45	GO:0005515; F:protein binding; IPI:IntAct
Q9BVL2	NUPL1	Nucleoporin p58/p45	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9BVL2	NUPL1	Nucleoporin p58/p45	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q9BVL2	NUPL1	Nucleoporin p58/p45	GO:0015758; P:glucose transport; TAS:Reactome
Q9BVL2	NUPL1	Nucleoporin p58/p45	GO:0008645; P:hexose transport; TAS:Reactome
Q9BVL2	NUPL1	Nucleoporin p58/p45	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9BVL2	NUPL1	Nucleoporin p58/p45	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
Q9BVL2	NUPL1	Nucleoporin p58/p45	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q9BVL2	NUPL1	Nucleoporin p58/p45	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9BVL2	NUPL1	Nucleoporin p58/p45	GO:0010827; P:regulation of glucose transport; TAS:Reactome
Q9BVL2	NUPL1	Nucleoporin p58/p45	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BVL2	NUPL1	Nucleoporin p58/p45	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9BVL2	NUPL1	Nucleoporin p58/p45	GO:0016032; P:viral process; TAS:Reactome
O15504	NUPL2	Nucleoporin-like protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15504	NUPL2	Nucleoporin-like protein 2	GO:0005049; F:nuclear export signal receptor activity; TAS:ProtInc
O15504	NUPL2	Nucleoporin-like protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O15504	NUPL2	Nucleoporin-like protein 2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O15504	NUPL2	Nucleoporin-like protein 2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
O15504	NUPL2	Nucleoporin-like protein 2	GO:0015758; P:glucose transport; TAS:Reactome
O15504	NUPL2	Nucleoporin-like protein 2	GO:0008645; P:hexose transport; TAS:Reactome
O15504	NUPL2	Nucleoporin-like protein 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O15504	NUPL2	Nucleoporin-like protein 2	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
O15504	NUPL2	Nucleoporin-like protein 2	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
O15504	NUPL2	Nucleoporin-like protein 2	GO:0006611; P:protein export from nucleus; TAS:ProtInc
O15504	NUPL2	Nucleoporin-like protein 2	GO:0010827; P:regulation of glucose transport; TAS:Reactome
O15504	NUPL2	Nucleoporin-like protein 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15504	NUPL2	Nucleoporin-like protein 2	GO:0055085; P:transmembrane transport; TAS:Reactome
O15504	NUPL2	Nucleoporin-like protein 2	GO:0016032; P:viral process; TAS:Reactome
O60356	NUPR1	Nuclear protein 1	GO:0003682; F:chromatin binding; IEA:Ensembl
O60356	NUPR1	Nuclear protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O60356	NUPR1	Nuclear protein 1	GO:0002526; P:acute inflammatory response; IEA:Ensembl
O60356	NUPR1	Nuclear protein 1	GO:0016049; P:cell growth; IDA:UniProtKB
O60356	NUPR1	Nuclear protein 1	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IEA:Ensembl
O60356	NUPR1	Nuclear protein 1	GO:0008584; P:male gonad development; IEA:Ensembl
O60356	NUPR1	Nuclear protein 1	GO:0045786; P:negative regulation of cell cycle; IEA:Ensembl
O60356	NUPR1	Nuclear protein 1	GO:0048147; P:negative regulation of fibroblast proliferation; IEA:Ensembl
O60356	NUPR1	Nuclear protein 1	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
O60356	NUPR1	Nuclear protein 1	GO:0031401; P:positive regulation of protein modification process; IEA:Ensembl
O60356	NUPR1	Nuclear protein 1	GO:0006473; P:protein acetylation; IEA:Ensembl
O60356	NUPR1	Nuclear protein 1	GO:0006461; P:protein complex assembly; IEA:Ensembl
O60356	NUPR1	Nuclear protein 1	GO:2000194; P:regulation of female gonad development; IEA:Ensembl
O60356	NUPR1	Nuclear protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O60356	NUPR1	Nuclear protein 1	GO:0009636; P:response to toxic substance; IEA:Ensembl
O60356	NUPR1	Nuclear protein 1	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
O60356	NUPR1	Nuclear protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BXS6	NUSAP1	Nucleolar and spindle-associated protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BXS6	NUSAP1	Nucleolar and spindle-associated protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BXS6	NUSAP1	Nucleolar and spindle-associated protein 1	GO:0040001; P:establishment of mitotic spindle localization; IDA:MGI
Q9BXS6	NUSAP1	Nucleolar and spindle-associated protein 1	GO:0007076; P:mitotic chromosome condensation; IDA:MGI
Q9BXS6	NUSAP1	Nucleolar and spindle-associated protein 1	GO:0000281; P:mitotic cytokinesis; IDA:MGI
Q9BXS6	NUSAP1	Nucleolar and spindle-associated protein 1	GO:0000070; P:mitotic sister chromatid segregation; IDA:MGI
Q9BXS6	NUSAP1	Nucleolar and spindle-associated protein 1	GO:0045840; P:positive regulation of mitosis; IDA:MGI
O15381	NVL	Nuclear valosin-containing protein-like	GO:0005524; F:ATP binding; TAS:ProtInc
O15381	NVL	Nuclear valosin-containing protein-like	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
O15381	NVL	Nuclear valosin-containing protein-like	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q149M9	NWD1	NACHT and WD repeat domain-containing protein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UBU9	NXF1	Nuclear RNA export factor 1	GO:0003729; F:mRNA binding; IEA:Ensembl
Q9UBU9	NXF1	Nuclear RNA export factor 1	GO:0005487; F:nucleocytoplasmic transporter activity; IEA:Ensembl
Q9UBU9	NXF1	Nuclear RNA export factor 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9UBU9	NXF1	Nuclear RNA export factor 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UBU9	NXF1	Nuclear RNA export factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBU9	NXF1	Nuclear RNA export factor 1	GO:0010467; P:gene expression; TAS:Reactome
Q9UBU9	NXF1	Nuclear RNA export factor 1	GO:0006406; P:mRNA export from nucleus; IDA:UniProtKB
Q9UBU9	NXF1	Nuclear RNA export factor 1	GO:0016973; P:poly(A)+ mRNA export from nucleus; IEA:Ensembl
Q9UBU9	NXF1	Nuclear RNA export factor 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9GZY0	NXF2	Nuclear RNA export factor 2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9GZY0	NXF2	Nuclear RNA export factor 2	GO:0003723; F:RNA binding; NAS:UniProtKB
Q9GZY0	NXF2	Nuclear RNA export factor 2	GO:0006406; P:mRNA export from nucleus; NAS:UniProtKB
Q9GZY0	NXF2	Nuclear RNA export factor 2	GO:0007275; P:multicellular organismal development; ISS:UniProtKB
Q9GZY0	NXF2	Nuclear RNA export factor 2	GO:0050658; P:RNA transport; ISS:UniProtKB
Q9H1B4	NXF5	Nuclear RNA export factor 5	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9H1B4	NXF5	Nuclear RNA export factor 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H1B4	NXF5	Nuclear RNA export factor 5	GO:0003723; F:RNA binding; IDA:UniProtKB
Q9H1B4	NXF5	Nuclear RNA export factor 5	GO:0006406; P:mRNA export from nucleus; IDA:UniProtKB
Q9H1B4	NXF5	Nuclear RNA export factor 5	GO:0007275; P:multicellular organismal development; IEP:UniProtKB
Q9H1B4	NXF5	Nuclear RNA export factor 5	GO:0050658; P:RNA transport; IDA:UniProtKB
Q9H4D5	NXF3	Nuclear RNA export factor 3	GO:0003729; F:mRNA binding; IEA:Ensembl
Q9H4D5	NXF3	Nuclear RNA export factor 3	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9H4D5	NXF3	Nuclear RNA export factor 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H4D5	NXF3	Nuclear RNA export factor 3	GO:0006406; P:mRNA export from nucleus; IDA:UniProtKB
Q9H4D5	NXF3	Nuclear RNA export factor 3	GO:0016973; P:poly(A)+ mRNA export from nucleus; IEA:Ensembl
Q6DKJ4	NXN	Nucleoredoxin	GO:0047134; F:protein-disulfide reductase activity; IEA:UniProtKB-EC
Q6DKJ4	NXN	Nucleoredoxin	GO:0004791; F:thioredoxin-disulfide reductase activity; IEA:Ensembl
Q6DKJ4	NXN	Nucleoredoxin	GO:0072358; P:cardiovascular system development; ISS:UniProtKB
Q6DKJ4	NXN	Nucleoredoxin	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q6DKJ4	NXN	Nucleoredoxin	GO:0031397; P:negative regulation of protein ubiquitination; ISS:UniProtKB
Q6DKJ4	NXN	Nucleoredoxin	GO:0030178; P:negative regulation of Wnt signaling pathway; ISS:UniProtKB
Q6DKJ4	NXN	Nucleoredoxin	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q5VZ03	NXNL2	Nucleoredoxin-like protein 2	GO:0007608; P:sensory perception of smell; IEA:Ensembl
Q5VZ03	NXNL2	Nucleoredoxin-like protein 2	GO:0007601; P:visual perception; IEA:Ensembl
O95156	NXPH2	Neurexophilin-2	GO:0007218; P:neuropeptide signaling pathway; NAS:UniProtKB
O95157	NXPH3	Neurexophilin-3	GO:0007218; P:neuropeptide signaling pathway; NAS:UniProtKB
Q6NXP6	NOXRED1	NADP-dependent oxidoreductase domain-containing protein 1	GO:0004735; F:pyrroline-5-carboxylate reductase activity; IEA:InterPro
Q6NXP6	NOXRED1	NADP-dependent oxidoreductase domain-containing protein 1	GO:0006561; P:proline biosynthetic process; IEA:InterPro
O95158	NXPH4	Neurexophilin-4	GO:0007218; P:neuropeptide signaling pathway; NAS:UniProtKB
Q9UKK6	NXT1	NTF2-related export protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKK6	NXT1	NTF2-related export protein 1	GO:0006611; P:protein export from nucleus; IEA:Ensembl
Q9UKK6	NXT1	NTF2-related export protein 1	GO:0006405; P:RNA export from nucleus; IEA:Ensembl
Q9NPJ8	NXT2	NTF2-related export protein 2	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q9NPJ8	NXT2	NTF2-related export protein 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q6ZVC0	NYAP1	Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 1	GO:0048812; P:neuron projection morphogenesis; ISS:UniProtKB
Q6ZVC0	NYAP1	Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 1	GO:0014065; P:phosphatidylinositol 3-kinase signaling; ISS:UniProtKB
Q9P242	NYAP2	Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 2	GO:0048812; P:neuron projection morphogenesis; ISS:UniProtKB
Q9P242	NYAP2	Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 2	GO:0014065; P:phosphatidylinositol 3-kinase signaling; ISS:UniProtKB
Q9GZU5	NYX	Nyctalopin	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q9GZU5	NYX	Nyctalopin	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q9P2P1	NYNRIN	Protein NYNRIN	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9P2P1	NYNRIN	Protein NYNRIN	GO:0015074; P:DNA integration; IEA:InterPro
Q9H208	OR10A2	Olfactory receptor 10A2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9H208	OR10A2	Olfactory receptor 10A2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9H209	OR10A4	Olfactory receptor 10A4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9H209	OR10A4	Olfactory receptor 10A4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9H209	OR10A4	Olfactory receptor 10A4	GO:0007411; P:axon guidance; IEA:Ensembl
Q9H207	OR10A5	Olfactory receptor 10A5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9H207	OR10A5	Olfactory receptor 10A5	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q9H207	OR10A5	Olfactory receptor 10A5	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q9H207	OR10A5	Olfactory receptor 10A5	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
P58181	OR10A3	Olfactory receptor 10A3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P58181	OR10A3	Olfactory receptor 10A3	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
P58181	OR10A3	Olfactory receptor 10A3	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
P58181	OR10A3	Olfactory receptor 10A3	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q8NH08	OR10AC1P	Putative olfactory receptor 10AC1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH08	OR10AC1P	Putative olfactory receptor 10AC1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGE0	OR10AD1	Olfactory receptor 10AD1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGE0	OR10AD1	Olfactory receptor 10AD1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGE5	OR10A7	Olfactory receptor 10A7	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGE5	OR10A7	Olfactory receptor 10A7	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH74	OR10A6	Olfactory receptor 10A6	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH74	OR10A6	Olfactory receptor 10A6	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH19	OR10AG1	Olfactory receptor 10AG1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH19	OR10AG1	Olfactory receptor 10AG1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q96KK4	OR10C1	Olfactory receptor 10C1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96KK4	OR10C1	Olfactory receptor 10C1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH80	OR10D3	Putative olfactory receptor 10D3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH80	OR10D3	Putative olfactory receptor 10D3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGN7	OR10D4P	Putative olfactory receptor 10D4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGN7	OR10D4P	Putative olfactory receptor 10D4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGC3	OR10G2	Olfactory receptor 10G2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGC3	OR10G2	Olfactory receptor 10G2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGN3	OR10G4	Olfactory receptor 10G4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGN3	OR10G4	Olfactory receptor 10G4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGC4	OR10G3	Olfactory receptor 10G3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGC4	OR10G3	Olfactory receptor 10G3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH81	OR10G6	Olfactory receptor 10G6	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH81	OR10G6	Olfactory receptor 10G6	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGN6	OR10G7	Olfactory receptor 10G7	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGN6	OR10G7	Olfactory receptor 10G7	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGN5	OR10G8	Olfactory receptor 10G8	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGN5	OR10G8	Olfactory receptor 10G8	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9Y4A9	OR10H1	Olfactory receptor 10H1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9Y4A9	OR10H1	Olfactory receptor 10H1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGN4	OR10G9	Olfactory receptor 10G9	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGN4	OR10G9	Olfactory receptor 10G9	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGA5	OR10H4	Olfactory receptor 10H4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGA5	OR10H4	Olfactory receptor 10H4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
O60403	OR10H2	Olfactory receptor 10H2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O60403	OR10H2	Olfactory receptor 10H2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGA6	OR10H5	Olfactory receptor 10H5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGA6	OR10H5	Olfactory receptor 10H5	GO:0004984; F:olfactory receptor activity; IEA:InterPro
O60404	OR10H3	Olfactory receptor 10H3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O60404	OR10H3	Olfactory receptor 10H3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q5JRS4	OR10J3	Olfactory receptor 10J3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q5JRS4	OR10J3	Olfactory receptor 10J3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P0C629	OR10J4	Olfactory receptor 10J4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P0C629	OR10J4	Olfactory receptor 10J4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NHC4	OR10J5	Olfactory receptor 10J5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NHC4	OR10J5	Olfactory receptor 10J5	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGY7	OR10J6P	Putative olfactory receptor 10J6	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGY7	OR10J6P	Putative olfactory receptor 10J6	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P30954	OR10J1	Olfactory receptor 10J1	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P30954	OR10J1	Olfactory receptor 10J1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P30954	OR10J1	Olfactory receptor 10J1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P30954	OR10J1	Olfactory receptor 10J1	GO:0007606; P:sensory perception of chemical stimulus; TAS:ProtInc
P30954	OR10J1	Olfactory receptor 10J1	GO:0007338; P:single fertilization; TAS:ProtInc
Q8NGX5	OR10K1	Olfactory receptor 10K1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGX5	OR10K1	Olfactory receptor 10K1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q6IF99	OR10K2	Olfactory receptor 10K2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q6IF99	OR10K2	Olfactory receptor 10K2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGE3	OR10P1	Olfactory receptor 10P1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGE3	OR10P1	Olfactory receptor 10P1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGQ4	OR10Q1	Olfactory receptor 10Q1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGQ4	OR10Q1	Olfactory receptor 10Q1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGX6	OR10R2	Olfactory receptor 10R2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGX6	OR10R2	Olfactory receptor 10R2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGN2	OR10S1	Olfactory receptor 10S1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGN2	OR10S1	Olfactory receptor 10S1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGX3	OR10T2	Olfactory receptor 10T2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGX3	OR10T2	Olfactory receptor 10T2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGI7	OR10V1	Olfactory receptor 10V1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGI7	OR10V1	Olfactory receptor 10V1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGF6	OR10W1	Olfactory receptor 10W1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGF6	OR10W1	Olfactory receptor 10W1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGY0	OR10X1	Olfactory receptor 10X1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGY0	OR10X1	Olfactory receptor 10X1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGY1	OR10Z1	Olfactory receptor 10Z1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGY1	OR10Z1	Olfactory receptor 10Z1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9GZK7	OR11A1	Olfactory receptor 11A1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9GZK7	OR11A1	Olfactory receptor 11A1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NG94	OR11H1	Olfactory receptor 11H1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NG94	OR11H1	Olfactory receptor 11H1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH07	OR11H2	Olfactory receptor 11H2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH07	OR11H2	Olfactory receptor 11H2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGC1	OR11G2	Olfactory receptor 11G2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGC1	OR11G2	Olfactory receptor 11G2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGC9	OR11H4	Olfactory receptor 11H4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGC9	OR11H4	Olfactory receptor 11H4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGC7	OR11H6	Olfactory receptor 11H6	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGC7	OR11H6	Olfactory receptor 11H6	GO:0004984; F:olfactory receptor activity; IEA:InterPro
B2RN74	OR11H12	Olfactory receptor 11H12	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
B2RN74	OR11H12	Olfactory receptor 11H12	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGC8	OR11H7	Olfactory receptor 11H7	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGC8	OR11H7	Olfactory receptor 11H7	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P58182	OR12D2	Olfactory receptor 12D2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P58182	OR12D2	Olfactory receptor 12D2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9UGF7	OR12D3	Olfactory receptor 12D3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9UGF7	OR12D3	Olfactory receptor 12D3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGR1	OR13A1	Olfactory receptor 13A1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGR1	OR13A1	Olfactory receptor 13A1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGX0	OR11L1	Olfactory receptor 11L1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGX0	OR11L1	Olfactory receptor 11L1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGS9	OR13C2	Olfactory receptor 13C2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGS9	OR13C2	Olfactory receptor 13C2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGS6	OR13C3	Olfactory receptor 13C3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGS6	OR13C3	Olfactory receptor 13C3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGS5	OR13C4	Olfactory receptor 13C4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGS5	OR13C4	Olfactory receptor 13C4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGS8	OR13C5	Olfactory receptor 13C5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGS8	OR13C5	Olfactory receptor 13C5	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGS7	OR13C8	Olfactory receptor 13C8	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGS7	OR13C8	Olfactory receptor 13C8	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGT0	OR13C9	Olfactory receptor 13C9	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGT0	OR13C9	Olfactory receptor 13C9	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGV5	OR13D1	Olfactory receptor 13D1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGV5	OR13D1	Olfactory receptor 13D1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGS4	OR13F1	Olfactory receptor 13F1	GO:0004935; F:adrenergic receptor activity; IEA:InterPro
Q8NGS4	OR13F1	Olfactory receptor 13F1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGZ3	OR13G1	Olfactory receptor 13G1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGZ3	OR13G1	Olfactory receptor 13G1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NG92	OR13H1	Olfactory receptor 13H1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NG92	OR13H1	Olfactory receptor 13H1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGT2	OR13J1	Olfactory receptor 13J1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGT2	OR13J1	Olfactory receptor 13J1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q96R54	OR14A2	Olfactory receptor 14A2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96R54	OR14A2	Olfactory receptor 14A2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NHC5	OR14A16	Olfactory receptor 14A16	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NHC5	OR14A16	Olfactory receptor 14A16	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NHC7	OR14C36	Olfactory receptor 14C36	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NHC7	OR14C36	Olfactory receptor 14C36	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A6ND48	OR14I1	Olfactory receptor 14I1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6ND48	OR14I1	Olfactory receptor 14I1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9UGF5	OR14J1	Olfactory receptor 14J1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9UGF5	OR14J1	Olfactory receptor 14J1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGZ2	OR14K1	Olfactory receptor 14K1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGZ2	OR14K1	Olfactory receptor 14K1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NHC6	OR14L1P	Putative olfactory receptor 14L1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NHC6	OR14L1P	Putative olfactory receptor 14L1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGT7	OR2A12	Olfactory receptor 2A12	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGT7	OR2A12	Olfactory receptor 2A12	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q96R47	OR2A14	Olfactory receptor 2A14	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96R47	OR2A14	Olfactory receptor 2A14	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A4D2G3	OR2A25	Olfactory receptor 2A25	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A4D2G3	OR2A25	Olfactory receptor 2A25	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NHA4	OR2AE1	Olfactory receptor 2AE1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NHA4	OR2AE1	Olfactory receptor 2AE1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9H205	OR2AG1	Olfactory receptor 2AG1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9H205	OR2AG1	Olfactory receptor 2AG1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9H205	OR2AG1	Olfactory receptor 2AG1	GO:0005515; F:protein binding; IPI:IntAct
A6NM03	OR2AG2	Olfactory receptor 2AG2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NM03	OR2AG2	Olfactory receptor 2AG2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGZ0	OR2AJ1	Olfactory receptor 2AJ1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGZ0	OR2AJ1	Olfactory receptor 2AJ1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NG84	OR2AK2	Olfactory receptor 2AK2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NG84	OR2AK2	Olfactory receptor 2AK2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGE2	OR2AP1	Olfactory receptor 2AP1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGE2	OR2AP1	Olfactory receptor 2AP1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A6NND4	OR2AT4	Olfactory receptor 2AT4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NND4	OR2AT4	Olfactory receptor 2AT4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH01	OR2T11	Olfactory receptor 2T11	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH01	OR2T11	Olfactory receptor 2T11	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NG77	OR2T12	Olfactory receptor 2T12	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NG77	OR2T12	Olfactory receptor 2T12	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGZ9	OR2T10	Olfactory receptor 2T10	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGZ9	OR2T10	Olfactory receptor 2T10	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH02	OR2T29	Olfactory receptor 2T29	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH02	OR2T29	Olfactory receptor 2T29	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NG76	OR2T33	Olfactory receptor 2T33	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NG76	OR2T33	Olfactory receptor 2T33	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH04	OR2T27	Olfactory receptor 2T27	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH04	OR2T27	Olfactory receptor 2T27	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGX2	OR2T35	Olfactory receptor 2T35	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGX2	OR2T35	Olfactory receptor 2T35	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGX1	OR2T34	Olfactory receptor 2T34	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGX1	OR2T34	Olfactory receptor 2T34	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGL6	OR4A15	Olfactory receptor 4A15	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGL6	OR4A15	Olfactory receptor 4A15	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH70	OR4A16	Olfactory receptor 4A16	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH70	OR4A16	Olfactory receptor 4A16	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q6IF82	OR4A47	Olfactory receptor 4A47	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q6IF82	OR4A47	Olfactory receptor 4A47	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A6NMZ5	OR4C45	Olfactory receptor 4C45	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NMZ5	OR4C45	Olfactory receptor 4C45	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A6NHA9	OR4C46	Olfactory receptor 4C46	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NHA9	OR4C46	Olfactory receptor 4C46	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGB8	OR4F15	Olfactory receptor 4F15	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGB8	OR4F15	Olfactory receptor 4F15	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGA8	OR4F17	Olfactory receptor 4F17	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGA8	OR4F17	Olfactory receptor 4F17	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGJ7	OR51A2	Olfactory receptor 51A2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGJ7	OR51A2	Olfactory receptor 51A2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGJ6	OR51A4	Olfactory receptor 51A4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGJ6	OR51A4	Olfactory receptor 51A4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
O95013	OR4F21	Olfactory receptor 4F21	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O95013	OR4F21	Olfactory receptor 4F21	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH64	OR51A7	Olfactory receptor 51A7	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH64	OR51A7	Olfactory receptor 51A7	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9Y5P1	OR51B2	Olfactory receptor 51B2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9Y5P1	OR51B2	Olfactory receptor 51B2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9Y5P0	OR51B4	Olfactory receptor 51B4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9Y5P0	OR51B4	Olfactory receptor 51B4	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q9Y5P0	OR51B4	Olfactory receptor 51B4	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q9Y5P0	OR51B4	Olfactory receptor 51B4	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q9H339	OR51B5	Olfactory receptor 51B5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9H339	OR51B5	Olfactory receptor 51B5	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q9H339	OR51B5	Olfactory receptor 51B5	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q9H339	OR51B5	Olfactory receptor 51B5	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q8NGF3	OR51D1	Olfactory receptor 51D1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGF3	OR51D1	Olfactory receptor 51D1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9H340	OR51B6	Olfactory receptor 51B6	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9H340	OR51B6	Olfactory receptor 51B6	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q9H340	OR51B6	Olfactory receptor 51B6	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q9H340	OR51B6	Olfactory receptor 51B6	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q8TCB6	OR51E1	Olfactory receptor 51E1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8TCB6	OR51E1	Olfactory receptor 51E1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9H255	OR51E2	Olfactory receptor 51E2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9H255	OR51E2	Olfactory receptor 51E2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH61	OR51F2	Olfactory receptor 51F2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH61	OR51F2	Olfactory receptor 51F2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A6NGY5	OR51F1	Olfactory receptor 51F1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NGY5	OR51F1	Olfactory receptor 51F1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGK0	OR51G2	Olfactory receptor 51G2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGK0	OR51G2	Olfactory receptor 51G2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGK1	OR51G1	Olfactory receptor 51G1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGK1	OR51G1	Olfactory receptor 51G1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH63	OR51H1P	Putative olfactory receptor 51H1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH63	OR51H1P	Putative olfactory receptor 51H1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9H344	OR51I2	Olfactory receptor 51I2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9H344	OR51I2	Olfactory receptor 51I2	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q9H344	OR51I2	Olfactory receptor 51I2	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q9H344	OR51I2	Olfactory receptor 51I2	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q9H343	OR51I1	Olfactory receptor 51I1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9H343	OR51I1	Olfactory receptor 51I1	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q9H343	OR51I1	Olfactory receptor 51I1	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q9H343	OR51I1	Olfactory receptor 51I1	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q9H342	OR51J1	Olfactory receptor 51J1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9H342	OR51J1	Olfactory receptor 51J1	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q9H342	OR51J1	Olfactory receptor 51J1	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q9H342	OR51J1	Olfactory receptor 51J1	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q8NGJ5	OR51L1	Olfactory receptor 51L1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGJ5	OR51L1	Olfactory receptor 51L1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9H341	OR51M1	Olfactory receptor 51M1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9H341	OR51M1	Olfactory receptor 51M1	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q9H341	OR51M1	Olfactory receptor 51M1	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q9H341	OR51M1	Olfactory receptor 51M1	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q8NH59	OR51Q1	Olfactory receptor 51Q1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH59	OR51Q1	Olfactory receptor 51Q1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGJ8	OR51S1	Olfactory receptor 51S1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGJ8	OR51S1	Olfactory receptor 51S1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGJ9	OR51T1	Olfactory receptor 51T1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGJ9	OR51T1	Olfactory receptor 51T1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9UKL2	OR52A1	Olfactory receptor 52A1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9UKL2	OR52A1	Olfactory receptor 52A1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9UKL2	OR52A1	Olfactory receptor 52A1	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q9UKL2	OR52A1	Olfactory receptor 52A1	GO:0007608; P:sensory perception of smell; TAS:ProtInc
Q9UKL2	OR52A1	Olfactory receptor 52A1	GO:0007165; P:signal transduction; TAS:ProtInc
A6NMU1	OR52A4	Putative olfactory receptor 52A4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NMU1	OR52A4	Putative olfactory receptor 52A4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9H2C8	OR51V1	Olfactory receptor 51V1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9H2C8	OR51V1	Olfactory receptor 51V1	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q9H2C8	OR51V1	Olfactory receptor 51V1	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q9H2C8	OR51V1	Olfactory receptor 51V1	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q9H2C5	OR52A5	Olfactory receptor 52A5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9H2C5	OR52A5	Olfactory receptor 52A5	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q9H2C5	OR52A5	Olfactory receptor 52A5	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q9H2C5	OR52A5	Olfactory receptor 52A5	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q96RD2	OR52B2	Olfactory receptor 52B2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96RD2	OR52B2	Olfactory receptor 52B2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGJ3	OR52E1	Olfactory receptor 52E1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGJ3	OR52E1	Olfactory receptor 52E1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9H346	OR52D1	Olfactory receptor 52D1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9H346	OR52D1	Olfactory receptor 52D1	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q9H346	OR52D1	Olfactory receptor 52D1	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q9H346	OR52D1	Olfactory receptor 52D1	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q8NGJ4	OR52E2	Olfactory receptor 52E2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGJ4	OR52E2	Olfactory receptor 52E2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGF0	OR52B6	Olfactory receptor 52B6	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGF0	OR52B6	Olfactory receptor 52B6	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q96RD3	OR52E6	Olfactory receptor 52E6	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96RD3	OR52E6	Olfactory receptor 52E6	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH55	OR52E5	Olfactory receptor 52E5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH55	OR52E5	Olfactory receptor 52E5	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGH9	OR52E4	Olfactory receptor 52E4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGH9	OR52E4	Olfactory receptor 52E4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGK2	OR52B4	Olfactory receptor 52B4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGK2	OR52B4	Olfactory receptor 52B4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q6IFG1	OR52E8	Olfactory receptor 52E8	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q6IFG1	OR52E8	Olfactory receptor 52E8	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGK6	OR52I1	Olfactory receptor 52I1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGK6	OR52I1	Olfactory receptor 52I1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGJ2	OR52H1	Olfactory receptor 52H1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGJ2	OR52H1	Olfactory receptor 52H1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH67	OR52I2	Olfactory receptor 52I2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH67	OR52I2	Olfactory receptor 52I2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH60	OR52J3	Olfactory receptor 52J3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH60	OR52J3	Olfactory receptor 52J3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGK4	OR52K1	Olfactory receptor 52K1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGK4	OR52K1	Olfactory receptor 52K1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGK3	OR52K2	Olfactory receptor 52K2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGK3	OR52K2	Olfactory receptor 52K2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGH7	OR52L1	Olfactory receptor 52L1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGH7	OR52L1	Olfactory receptor 52L1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGK5	OR52M1	Olfactory receptor 52M1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGK5	OR52M1	Olfactory receptor 52M1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGH6	OR52L2P	Putative olfactory receptor 52L2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGH6	OR52L2P	Putative olfactory receptor 52L2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH53	OR52N1	Olfactory receptor 52N1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH53	OR52N1	Olfactory receptor 52N1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGI0	OR52N2	Olfactory receptor 52N2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGI0	OR52N2	Olfactory receptor 52N2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGI2	OR52N4	Olfactory receptor 52N4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGI2	OR52N4	Olfactory receptor 52N4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH56	OR52N5	Olfactory receptor 52N5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH56	OR52N5	Olfactory receptor 52N5	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH57	OR52P1P	Putative olfactory receptor 52P1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH57	OR52P1P	Putative olfactory receptor 52P1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P0C646	OR52Z1	Olfactory receptor 52Z1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P0C646	OR52Z1	Olfactory receptor 52Z1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGF1	OR52R1	Olfactory receptor 52R1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGF1	OR52R1	Olfactory receptor 52R1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q6IF63	OR52W1	Olfactory receptor 52W1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q6IF63	OR52W1	Olfactory receptor 52W1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGH5	OR56A1	Olfactory receptor 56A1	GO:0004935; F:adrenergic receptor activity; IEA:InterPro
Q8NGH5	OR56A1	Olfactory receptor 56A1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH54	OR56A3	Olfactory receptor 56A3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH54	OR56A3	Olfactory receptor 56A3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGH8	OR56A4	Olfactory receptor 56A4	GO:0004935; F:adrenergic receptor activity; IEA:InterPro
Q8NGH8	OR56A4	Olfactory receptor 56A4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P0C7T3	OR56A5	Olfactory receptor 56A5	GO:0004935; F:adrenergic receptor activity; IEA:InterPro
P0C7T3	OR56A5	Olfactory receptor 56A5	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGI3	OR56B1	Olfactory receptor 56B1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGI3	OR56B1	Olfactory receptor 56B1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH76	OR56B4	Olfactory receptor 56B4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH76	OR56B4	Olfactory receptor 56B4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P0C628	OR5AC1	Olfactory receptor 5AC1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P0C628	OR5AC1	Olfactory receptor 5AC1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH90	OR5AK2	Olfactory receptor 5AK2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH90	OR5AK2	Olfactory receptor 5AK2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGI1	OR56B2P	Putative olfactory receptor 56B2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGI1	OR56B2P	Putative olfactory receptor 56B2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH89	OR5AK3P	Putative olfactory receptor 5AK3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH89	OR5AK3P	Putative olfactory receptor 5AK3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P0C617	OR5AL1	Olfactory receptor 5AL1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P0C617	OR5AL1	Olfactory receptor 5AL1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9NZP5	OR5AC2	Olfactory receptor 5AC2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9NZP5	OR5AC2	Olfactory receptor 5AC2	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q9NZP5	OR5AC2	Olfactory receptor 5AC2	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q9NZP5	OR5AC2	Olfactory receptor 5AC2	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q8NGP9	OR5AR1	Olfactory receptor 5AR1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGP9	OR5AR1	Olfactory receptor 5AR1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGF4	OR5AP2	Olfactory receptor 5AP2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGF4	OR5AP2	Olfactory receptor 5AP2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGI8	OR5AN1	Olfactory receptor 5AN1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGI8	OR5AN1	Olfactory receptor 5AN1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8N127	OR5AS1	Olfactory receptor 5AS1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8N127	OR5AS1	Olfactory receptor 5AS1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGC0	OR5AU1	Olfactory receptor 5AU1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGC0	OR5AU1	Olfactory receptor 5AU1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A6NDH6	OR5H15	Olfactory receptor 5H15	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NDH6	OR5H15	Olfactory receptor 5H15	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A6NHG9	OR5H14	Olfactory receptor 5H14	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NHG9	OR5H14	Olfactory receptor 5H14	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A6NDL8	OR6C68	Olfactory receptor 6C68	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NDL8	OR6C68	Olfactory receptor 6C68	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A6NIJ9	OR6C70	Olfactory receptor 6C70	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NIJ9	OR6C70	Olfactory receptor 6C70	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A6NJZ3	OR6C65	Olfactory receptor 6C65	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NJZ3	OR6C65	Olfactory receptor 6C65	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A6NCV1	OR6C74	Olfactory receptor 6C74	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NCV1	OR6C74	Olfactory receptor 6C74	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A6NL08	OR6C75	Olfactory receptor 6C75	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NL08	OR6C75	Olfactory receptor 6C75	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q6IFN5	OR7E24	Olfactory receptor 7E24	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q6IFN5	OR7E24	Olfactory receptor 7E24	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A6NM76	OR6C76	Olfactory receptor 6C76	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NM76	OR6C76	Olfactory receptor 6C76	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9Y530	OARD1	O-acetyl-ADP-ribose deacetylase 1	GO:0019213; F:deacetylase activity; IDA:UniProtKB
Q9Y530	OARD1	O-acetyl-ADP-ribose deacetylase 1	GO:0005515; F:protein binding; IPI:IntAct
Q9Y530	OARD1	O-acetyl-ADP-ribose deacetylase 1	GO:0001883; F:purine nucleoside binding; IDA:UniProtKB
Q9Y530	OARD1	O-acetyl-ADP-ribose deacetylase 1	GO:0042278; P:purine nucleoside metabolic process; IDA:UniProtKB
P00973	OAS1	2'-5'-oligoadenylate synthase 1	GO:0001730; F:2'-5'-oligoadenylate synthetase activity; IDA:UniProtKB
P00973	OAS1	2'-5'-oligoadenylate synthase 1	GO:0005524; F:ATP binding; TAS:UniProtKB
P00973	OAS1	2'-5'-oligoadenylate synthase 1	GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB
P00973	OAS1	2'-5'-oligoadenylate synthase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P00973	OAS1	2'-5'-oligoadenylate synthase 1	GO:0005515; F:protein binding; IPI:IntAct
P00973	OAS1	2'-5'-oligoadenylate synthase 1	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P00973	OAS1	2'-5'-oligoadenylate synthase 1	GO:0035457; P:cellular response to interferon-alpha; IDA:UniProtKB
P00973	OAS1	2'-5'-oligoadenylate synthase 1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P00973	OAS1	2'-5'-oligoadenylate synthase 1	GO:0051607; P:defense response to virus; IDA:UniProtKB
P00973	OAS1	2'-5'-oligoadenylate synthase 1	GO:0042593; P:glucose homeostasis; IMP:UniProt
P00973	OAS1	2'-5'-oligoadenylate synthase 1	GO:0006006; P:glucose metabolic process; IMP:UniProt
P00973	OAS1	2'-5'-oligoadenylate synthase 1	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P00973	OAS1	2'-5'-oligoadenylate synthase 1	GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB
P00973	OAS1	2'-5'-oligoadenylate synthase 1	GO:0051259; P:protein oligomerization; IDA:UniProtKB
P00973	OAS1	2'-5'-oligoadenylate synthase 1	GO:0006164; P:purine nucleotide biosynthetic process; IDA:UniProtKB
P00973	OAS1	2'-5'-oligoadenylate synthase 1	GO:0060700; P:regulation of ribonuclease activity; IDA:UniProtKB
P00973	OAS1	2'-5'-oligoadenylate synthase 1	GO:0009615; P:response to virus; IDA:UniProtKB
P00973	OAS1	2'-5'-oligoadenylate synthase 1	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P29728	OAS2	2'-5'-oligoadenylate synthase 2	GO:0001730; F:2'-5'-oligoadenylate synthetase activity; IDA:UniProtKB
P29728	OAS2	2'-5'-oligoadenylate synthase 2	GO:0005524; F:ATP binding; IMP:UniProtKB
P29728	OAS2	2'-5'-oligoadenylate synthase 2	GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB
P29728	OAS2	2'-5'-oligoadenylate synthase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P29728	OAS2	2'-5'-oligoadenylate synthase 2	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P29728	OAS2	2'-5'-oligoadenylate synthase 2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P29728	OAS2	2'-5'-oligoadenylate synthase 2	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P29728	OAS2	2'-5'-oligoadenylate synthase 2	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P29728	OAS2	2'-5'-oligoadenylate synthase 2	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
P29728	OAS2	2'-5'-oligoadenylate synthase 2	GO:0006486; P:protein glycosylation; IDA:UniProtKB
P29728	OAS2	2'-5'-oligoadenylate synthase 2	GO:0018377; P:protein myristoylation; IMP:UniProtKB
P29728	OAS2	2'-5'-oligoadenylate synthase 2	GO:0006164; P:purine nucleotide biosynthetic process; IDA:UniProtKB
P29728	OAS2	2'-5'-oligoadenylate synthase 2	GO:0009615; P:response to virus; TAS:UniProtKB
P29728	OAS2	2'-5'-oligoadenylate synthase 2	GO:0006401; P:RNA catabolic process; IEA:Ensembl
P29728	OAS2	2'-5'-oligoadenylate synthase 2	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q9Y6K5	OAS3	2'-5'-oligoadenylate synthase 3	GO:0001730; F:2'-5'-oligoadenylate synthetase activity; IDA:UniProtKB
Q9Y6K5	OAS3	2'-5'-oligoadenylate synthase 3	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9Y6K5	OAS3	2'-5'-oligoadenylate synthase 3	GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB
Q9Y6K5	OAS3	2'-5'-oligoadenylate synthase 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y6K5	OAS3	2'-5'-oligoadenylate synthase 3	GO:0005515; F:protein binding; IPI:IntAct
Q9Y6K5	OAS3	2'-5'-oligoadenylate synthase 3	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q9Y6K5	OAS3	2'-5'-oligoadenylate synthase 3	GO:0051607; P:defense response to virus; IDA:UniProtKB
Q9Y6K5	OAS3	2'-5'-oligoadenylate synthase 3	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q9Y6K5	OAS3	2'-5'-oligoadenylate synthase 3	GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB
Q9Y6K5	OAS3	2'-5'-oligoadenylate synthase 3	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
Q9Y6K5	OAS3	2'-5'-oligoadenylate synthase 3	GO:0060700; P:regulation of ribonuclease activity; IDA:UniProtKB
Q9Y6K5	OAS3	2'-5'-oligoadenylate synthase 3	GO:0009615; P:response to virus; IDA:UniProtKB
Q9Y6K5	OAS3	2'-5'-oligoadenylate synthase 3	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q15646	OASL	2'-5'-oligoadenylate synthase-like protein	GO:0005524; F:ATP binding; IEA:InterPro
Q15646	OASL	2'-5'-oligoadenylate synthase-like protein	GO:0003677; F:DNA binding; IDA:UniProtKB
Q15646	OASL	2'-5'-oligoadenylate synthase-like protein	GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB
Q15646	OASL	2'-5'-oligoadenylate synthase-like protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15646	OASL	2'-5'-oligoadenylate synthase-like protein	GO:0046966; F:thyroid hormone receptor binding; TAS:UniProtKB
Q15646	OASL	2'-5'-oligoadenylate synthase-like protein	GO:0016740; F:transferase activity; IEA:InterPro
Q15646	OASL	2'-5'-oligoadenylate synthase-like protein	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q15646	OASL	2'-5'-oligoadenylate synthase-like protein	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q15646	OASL	2'-5'-oligoadenylate synthase-like protein	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q15646	OASL	2'-5'-oligoadenylate synthase-like protein	GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB
Q15646	OASL	2'-5'-oligoadenylate synthase-like protein	GO:0009615; P:response to virus; IDA:UniProtKB
Q15646	OASL	2'-5'-oligoadenylate synthase-like protein	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P04181	OAT	Ornithine aminotransferase, mitochondrial	GO:0004587; F:ornithine-oxo-acid transaminase activity; EXP:Reactome
P04181	OAT	Ornithine aminotransferase, mitochondrial	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
P04181	OAT	Ornithine aminotransferase, mitochondrial	GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome
P04181	OAT	Ornithine aminotransferase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P04181	OAT	Ornithine aminotransferase, mitochondrial	GO:0055129; P:L-proline biosynthetic process; IEA:UniProtKB-UniPathway
P04181	OAT	Ornithine aminotransferase, mitochondrial	GO:0034214; P:protein hexamerization; IDA:UniProtKB
P04181	OAT	Ornithine aminotransferase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P04181	OAT	Ornithine aminotransferase, mitochondrial	GO:0007601; P:visual perception; TAS:ProtInc
P54368	OAZ1	Ornithine decarboxylase antizyme 1	GO:0008073; F:ornithine decarboxylase inhibitor activity; TAS:ProtInc
P54368	OAZ1	Ornithine decarboxylase antizyme 1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P54368	OAZ1	Ornithine decarboxylase antizyme 1	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
P54368	OAZ1	Ornithine decarboxylase antizyme 1	GO:0006596; P:polyamine biosynthetic process; TAS:ProtInc
P54368	OAZ1	Ornithine decarboxylase antizyme 1	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P54368	OAZ1	Ornithine decarboxylase antizyme 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95190	OAZ2	Ornithine decarboxylase antizyme 2	GO:0008073; F:ornithine decarboxylase inhibitor activity; TAS:ProtInc
O95190	OAZ2	Ornithine decarboxylase antizyme 2	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
O95190	OAZ2	Ornithine decarboxylase antizyme 2	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
O95190	OAZ2	Ornithine decarboxylase antizyme 2	GO:0006595; P:polyamine metabolic process; TAS:ProtInc
O95190	OAZ2	Ornithine decarboxylase antizyme 2	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
O95190	OAZ2	Ornithine decarboxylase antizyme 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UMX2	OAZ3	Ornithine decarboxylase antizyme 3	GO:0008073; F:ornithine decarboxylase inhibitor activity; TAS:ProtInc
Q9UMX2	OAZ3	Ornithine decarboxylase antizyme 3	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9UMX2	OAZ3	Ornithine decarboxylase antizyme 3	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
Q9UMX2	OAZ3	Ornithine decarboxylase antizyme 3	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
Q9UMX2	OAZ3	Ornithine decarboxylase antizyme 3	GO:0043666; P:regulation of phosphoprotein phosphatase activity; IEA:Ensembl
Q9UMX2	OAZ3	Ornithine decarboxylase antizyme 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UMX2	OAZ3	Ornithine decarboxylase antizyme 3	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q16633	POU2AF1	POU domain class 2-associating factor 1	GO:0003677; F:DNA binding; IEA:Ensembl
Q16633	POU2AF1	POU domain class 2-associating factor 1	GO:0005515; F:protein binding; IPI:IntAct
Q16633	POU2AF1	POU domain class 2-associating factor 1	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q16633	POU2AF1	POU domain class 2-associating factor 1	GO:0003712; F:transcription cofactor activity; TAS:ProtInc
Q16633	POU2AF1	POU domain class 2-associating factor 1	GO:0006959; P:humoral immune response; TAS:ProtInc
Q16633	POU2AF1	POU domain class 2-associating factor 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q16633	POU2AF1	POU domain class 2-associating factor 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9NPH6	OBP2B	Odorant-binding protein 2b	GO:0005549; F:odorant binding; NAS:UniProtKB
Q9NPH6	OBP2B	Odorant-binding protein 2b	GO:0007635; P:chemosensory behavior; TAS:ProtInc
Q9NPH6	OBP2B	Odorant-binding protein 2b	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q9NPH6	OBP2B	Odorant-binding protein 2b	GO:0006810; P:transport; IEA:UniProtKB-KW
Q9NY56	OBP2A	Odorant-binding protein 2a	GO:0005549; F:odorant binding; NAS:UniProtKB
Q9NY56	OBP2A	Odorant-binding protein 2a	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q9NY56	OBP2A	Odorant-binding protein 2a	GO:0007606; P:sensory perception of chemical stimulus; TAS:ProtInc
Q9NY56	OBP2A	Odorant-binding protein 2a	GO:0007608; P:sensory perception of smell; IEA:UniProtKB-KW
Q9NY56	OBP2A	Odorant-binding protein 2a	GO:0006810; P:transport; IEA:UniProtKB-KW
O15243	LEPROT	Leptin receptor gene-related protein	GO:0005102; F:receptor binding; IDA:UniProtKB
O15243	LEPROT	Leptin receptor gene-related protein	GO:0060400; P:negative regulation of growth hormone receptor signaling pathway; IDA:UniProtKB
O15243	LEPROT	Leptin receptor gene-related protein	GO:0046426; P:negative regulation of JAK-STAT cascade; IDA:UniProtKB
O15243	LEPROT	Leptin receptor gene-related protein	GO:2000009; P:negative regulation of protein localization to cell surface; IDA:UniProtKB
Q5VST9	OBSCN	Obscurin	GO:0030506; F:ankyrin binding; IPI:BHF-UCL
Q5VST9	OBSCN	Obscurin	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5VST9	OBSCN	Obscurin	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5VST9	OBSCN	Obscurin	GO:0005515; F:protein binding; IPI:IntAct
Q5VST9	OBSCN	Obscurin	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q5VST9	OBSCN	Obscurin	GO:0004713; F:protein tyrosine kinase activity; IEA:InterPro
Q5VST9	OBSCN	Obscurin	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q5VST9	OBSCN	Obscurin	GO:0008307; F:structural constituent of muscle; NAS:BHF-UCL
Q5VST9	OBSCN	Obscurin	GO:0031432; F:titin binding; IPI:BHF-UCL
Q5VST9	OBSCN	Obscurin	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q5VST9	OBSCN	Obscurin	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q5VST9	OBSCN	Obscurin	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q5VST9	OBSCN	Obscurin	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q5VST9	OBSCN	Obscurin	GO:0036309; P:protein localization to M-band; ISS:BHF-UCL
Q5VST9	OBSCN	Obscurin	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q5VST9	OBSCN	Obscurin	GO:0045214; P:sarcomere organization; TAS:BHF-UCL
Q5VST9	OBSCN	Obscurin	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
O75147	OBSL1	Obscurin-like protein 1	GO:0008093; F:cytoskeletal adaptor activity; NAS:BHF-UCL
O75147	OBSL1	Obscurin-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
O75147	OBSL1	Obscurin-like protein 1	GO:0055003; P:cardiac myofibril assembly; NAS:BHF-UCL
O75147	OBSL1	Obscurin-like protein 1	GO:0007010; P:cytoskeleton organization; NAS:BHF-UCL
O75147	OBSL1	Obscurin-like protein 1	GO:0007030; P:Golgi organization; IMP:UniProtKB
O75147	OBSL1	Obscurin-like protein 1	GO:0050775; P:positive regulation of dendrite morphogenesis; IMP:UniProtKB
O75147	OBSL1	Obscurin-like protein 1	GO:0034067; P:protein localization to Golgi apparatus; IMP:UniProtKB
Q02509	OC90	Otoconin-90	GO:0005509; F:calcium ion binding; IEA:InterPro
Q02509	OC90	Otoconin-90	GO:0004623; F:phospholipase A2 activity; IEA:InterPro
Q02509	OC90	Otoconin-90	GO:0016042; P:lipid catabolic process; IEA:InterPro
Q02509	OC90	Otoconin-90	GO:0006644; P:phospholipid metabolic process; IEA:InterPro
Q9NX40	OCIAD1	OCIA domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q16625	OCLN	Occludin	GO:0005515; F:protein binding; IPI:UniProtKB
Q16625	OCLN	Occludin	GO:0019904; F:protein domain specific binding; IPI:UniProt
Q16625	OCLN	Occludin	GO:0005198; F:structural molecule activity; IEA:InterPro
Q16625	OCLN	Occludin	GO:0008119; F:thiopurine S-methyltransferase activity; IEA:Ensembl
Q16625	OCLN	Occludin	GO:0006915; P:apoptotic process; TAS:Reactome
Q16625	OCLN	Occludin	GO:0045216; P:cell-cell junction organization; IMP:MGI
Q16625	OCLN	Occludin	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q16625	OCLN	Occludin	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q16625	OCLN	Occludin	GO:0046498; P:S-adenosylhomocysteine metabolic process; IEA:Ensembl
Q16625	OCLN	Occludin	GO:0046500; P:S-adenosylmethionine metabolic process; IEA:Ensembl
Q16625	OCLN	Occludin	GO:0070830; P:tight junction assembly; IMP:UniProt
P0CE71	OCM2	Putative oncomodulin-2	GO:0005509; F:calcium ion binding; NAS:UniProtKB
Q01968	OCRL	Inositol polyphosphate 5-phosphatase OCRL-1	GO:0052745; F:inositol phosphate phosphatase activity; NAS:UniProtKB
Q01968	OCRL	Inositol polyphosphate 5-phosphatase OCRL-1	GO:0004439; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; TAS:ProtInc
Q01968	OCRL	Inositol polyphosphate 5-phosphatase OCRL-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q01968	OCRL	Inositol polyphosphate 5-phosphatase OCRL-1	GO:0030675; F:Rac GTPase activator activity; IDA:FlyBase
Q01968	OCRL	Inositol polyphosphate 5-phosphatase OCRL-1	GO:0048365; F:Rac GTPase binding; IPI:FlyBase
Q01968	OCRL	Inositol polyphosphate 5-phosphatase OCRL-1	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q01968	OCRL	Inositol polyphosphate 5-phosphatase OCRL-1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q01968	OCRL	Inositol polyphosphate 5-phosphatase OCRL-1	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q01968	OCRL	Inositol polyphosphate 5-phosphatase OCRL-1	GO:0006629; P:lipid metabolic process; NAS:UniProtKB
Q01968	OCRL	Inositol polyphosphate 5-phosphatase OCRL-1	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q01968	OCRL	Inositol polyphosphate 5-phosphatase OCRL-1	GO:0046856; P:phosphatidylinositol dephosphorylation; IEA:Ensembl
Q01968	OCRL	Inositol polyphosphate 5-phosphatase OCRL-1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q01968	OCRL	Inositol polyphosphate 5-phosphatase OCRL-1	GO:0032855; P:positive regulation of Rac GTPase activity; IDA:GOC
Q01968	OCRL	Inositol polyphosphate 5-phosphatase OCRL-1	GO:0032314; P:regulation of Rac GTPase activity; IDA:FlyBase
Q01968	OCRL	Inositol polyphosphate 5-phosphatase OCRL-1	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q01968	OCRL	Inositol polyphosphate 5-phosphatase OCRL-1	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q01968	OCRL	Inositol polyphosphate 5-phosphatase OCRL-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BR26	OCSTAMP	Osteoclast stimulatory transmembrane protein	GO:0071391; P:cellular response to estrogen stimulus; ISS:UniProtKB
Q9BR26	OCSTAMP	Osteoclast stimulatory transmembrane protein	GO:0071356; P:cellular response to tumor necrosis factor; ISS:UniProtKB
Q9BR26	OCSTAMP	Osteoclast stimulatory transmembrane protein	GO:0072674; P:multinuclear osteoclast differentiation; ISS:UniProtKB
Q9BR26	OCSTAMP	Osteoclast stimulatory transmembrane protein	GO:0034241; P:positive regulation of macrophage fusion; IEA:Ensembl
Q9BR26	OCSTAMP	Osteoclast stimulatory transmembrane protein	GO:0045672; P:positive regulation of osteoclast differentiation; ISS:UniProtKB
Q9BR26	OCSTAMP	Osteoclast stimulatory transmembrane protein	GO:0090290; P:positive regulation of osteoclast proliferation; ISS:UniProtKB
Q9UKG9	CROT	Peroxisomal carnitine O-octanoyltransferase	GO:0008458; F:carnitine O-octanoyltransferase activity; IDA:UniProtKB
Q9UKG9	CROT	Peroxisomal carnitine O-octanoyltransferase	GO:0005102; F:receptor binding; IPI:UniProtKB
Q9UKG9	CROT	Peroxisomal carnitine O-octanoyltransferase	GO:0009437; P:carnitine metabolic process; ISS:UniProtKB
Q9UKG9	CROT	Peroxisomal carnitine O-octanoyltransferase	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9UKG9	CROT	Peroxisomal carnitine O-octanoyltransferase	GO:0015936; P:coenzyme A metabolic process; ISS:UniProtKB
Q9UKG9	CROT	Peroxisomal carnitine O-octanoyltransferase	GO:0006635; P:fatty acid beta-oxidation; IDA:UniProtKB
Q9UKG9	CROT	Peroxisomal carnitine O-octanoyltransferase	GO:0033540; P:fatty acid beta-oxidation using acyl-CoA oxidase; TAS:Reactome
Q9UKG9	CROT	Peroxisomal carnitine O-octanoyltransferase	GO:0006631; P:fatty acid metabolic process; IMP:UniProtKB
Q9UKG9	CROT	Peroxisomal carnitine O-octanoyltransferase	GO:0015908; P:fatty acid transport; IEA:Ensembl
Q9UKG9	CROT	Peroxisomal carnitine O-octanoyltransferase	GO:0006091; P:generation of precursor metabolites and energy; IDA:UniProtKB
Q9UKG9	CROT	Peroxisomal carnitine O-octanoyltransferase	GO:0051791; P:medium-chain fatty acid metabolic process; IDA:UniProtKB
Q9UKG9	CROT	Peroxisomal carnitine O-octanoyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
A1E959	ODAM	Odontogenic ameloblast-associated protein	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
A1E959	ODAM	Odontogenic ameloblast-associated protein	GO:0042475; P:odontogenesis of dentin-containing tooth; IEP:HGNC
P11182	DBT	Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial	GO:0043754; F:dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity; IEA:UniProtKB-EC
P11182	DBT	Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial	GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome
P11182	DBT	Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P11182	DBT	Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P12694	BCKDHA	2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial	GO:0003863; F:3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity; TAS:ProtInc
P12694	BCKDHA	2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial	GO:0003826; F:alpha-ketoacid dehydrogenase activity; IDA:HGNC
P12694	BCKDHA	2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial	GO:0016831; F:carboxy-lyase activity; TAS:HGNC
P12694	BCKDHA	2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P12694	BCKDHA	2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
P12694	BCKDHA	2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial	GO:0009083; P:branched-chain amino acid catabolic process; IDA:HGNC
P12694	BCKDHA	2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P12694	BCKDHA	2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P21953	BCKDHB	2-oxoisovalerate dehydrogenase subunit beta, mitochondrial	GO:0003863; F:3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity; TAS:ProtInc
P21953	BCKDHB	2-oxoisovalerate dehydrogenase subunit beta, mitochondrial	GO:0003826; F:alpha-ketoacid dehydrogenase activity; IEA:Ensembl
P21953	BCKDHB	2-oxoisovalerate dehydrogenase subunit beta, mitochondrial	GO:0016831; F:carboxy-lyase activity; TAS:HGNC
P21953	BCKDHB	2-oxoisovalerate dehydrogenase subunit beta, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
P21953	BCKDHB	2-oxoisovalerate dehydrogenase subunit beta, mitochondrial	GO:0009083; P:branched-chain amino acid catabolic process; IMP:HGNC
P21953	BCKDHB	2-oxoisovalerate dehydrogenase subunit beta, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P21953	BCKDHB	2-oxoisovalerate dehydrogenase subunit beta, mitochondrial	GO:0051591; P:response to cAMP; IEA:Ensembl
P21953	BCKDHB	2-oxoisovalerate dehydrogenase subunit beta, mitochondrial	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P21953	BCKDHB	2-oxoisovalerate dehydrogenase subunit beta, mitochondrial	GO:0007584; P:response to nutrient; IEA:Ensembl
P21953	BCKDHB	2-oxoisovalerate dehydrogenase subunit beta, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BQT8	SLC25A21	Mitochondrial 2-oxodicarboxylate carrier	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9BQT8	SLC25A21	Mitochondrial 2-oxodicarboxylate carrier	GO:0006554; P:lysine catabolic process; TAS:Reactome
Q9BQT8	SLC25A21	Mitochondrial 2-oxodicarboxylate carrier	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BQT8	SLC25A21	Mitochondrial 2-oxodicarboxylate carrier	GO:0055085; P:transmembrane transport; IEA:InterPro
Q96PU9	ODF3	Outer dense fiber protein 3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96PU9	ODF3	Outer dense fiber protein 3	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q96PU9	ODF3	Outer dense fiber protein 3	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q14990	ODF1	Outer dense fiber protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q14990	ODF1	Outer dense fiber protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q14990	ODF1	Outer dense fiber protein 1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q5BJF6	ODF2	Outer dense fiber protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q5BJF6	ODF2	Outer dense fiber protein 2	GO:0005198; F:structural molecule activity; TAS:ProtInc
Q5BJF6	ODF2	Outer dense fiber protein 2	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q5BJF6	ODF2	Outer dense fiber protein 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q5BJF6	ODF2	Outer dense fiber protein 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q5BJF6	ODF2	Outer dense fiber protein 2	GO:0007286; P:spermatid development; IEA:Ensembl
Q2M2E3	ODF4	Outer dense fiber protein 4	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q2M2E3	ODF4	Outer dense fiber protein 4	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q2M2E3	ODF4	Outer dense fiber protein 4	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q02218	OGDH	2-oxoglutarate dehydrogenase, mitochondrial	GO:0034602; F:oxoglutarate dehydrogenase (NAD+) activity; IEA:Ensembl
Q02218	OGDH	2-oxoglutarate dehydrogenase, mitochondrial	GO:0004591; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; ISS:UniProtKB
Q02218	OGDH	2-oxoglutarate dehydrogenase, mitochondrial	GO:0030976; F:thiamine pyrophosphate binding; IEA:InterPro
Q02218	OGDH	2-oxoglutarate dehydrogenase, mitochondrial	GO:0006103; P:2-oxoglutarate metabolic process; IEA:Ensembl
Q02218	OGDH	2-oxoglutarate dehydrogenase, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q02218	OGDH	2-oxoglutarate dehydrogenase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q02218	OGDH	2-oxoglutarate dehydrogenase, mitochondrial	GO:0021695; P:cerebellar cortex development; IEA:Ensembl
Q02218	OGDH	2-oxoglutarate dehydrogenase, mitochondrial	GO:0006091; P:generation of precursor metabolites and energy; ISS:UniProtKB
Q02218	OGDH	2-oxoglutarate dehydrogenase, mitochondrial	GO:0006096; P:glycolytic process; IEA:UniProtKB-KW
Q02218	OGDH	2-oxoglutarate dehydrogenase, mitochondrial	GO:0021766; P:hippocampus development; IEA:Ensembl
Q02218	OGDH	2-oxoglutarate dehydrogenase, mitochondrial	GO:0006554; P:lysine catabolic process; TAS:Reactome
Q02218	OGDH	2-oxoglutarate dehydrogenase, mitochondrial	GO:0006734; P:NADH metabolic process; IEA:Ensembl
Q02218	OGDH	2-oxoglutarate dehydrogenase, mitochondrial	GO:0061034; P:olfactory bulb mitral cell layer development; IEA:Ensembl
Q02218	OGDH	2-oxoglutarate dehydrogenase, mitochondrial	GO:0021860; P:pyramidal neuron development; IEA:Ensembl
Q02218	OGDH	2-oxoglutarate dehydrogenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q02218	OGDH	2-oxoglutarate dehydrogenase, mitochondrial	GO:0021756; P:striatum development; IEA:Ensembl
Q02218	OGDH	2-oxoglutarate dehydrogenase, mitochondrial	GO:0006104; P:succinyl-CoA metabolic process; IEA:Ensembl
Q02218	OGDH	2-oxoglutarate dehydrogenase, mitochondrial	GO:0022028; P:tangential migration from the subventricular zone to the olfactory bulb; IEA:Ensembl
Q02218	OGDH	2-oxoglutarate dehydrogenase, mitochondrial	GO:0021794; P:thalamus development; IEA:Ensembl
Q02218	OGDH	2-oxoglutarate dehydrogenase, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; TAS:Reactome
P36957	DLST	Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial	GO:0004149; F:dihydrolipoyllysine-residue succinyltransferase activity; IEA:UniProtKB-EC
P36957	DLST	Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P36957	DLST	Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P36957	DLST	Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P36957	DLST	Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial	GO:0033512; P:L-lysine catabolic process to acetyl-CoA via saccharopine; IEA:UniProtKB-UniPathway
P36957	DLST	Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial	GO:0006554; P:lysine catabolic process; TAS:Reactome
P36957	DLST	Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P36957	DLST	Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; TAS:Reactome
P10515	DLAT	Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial	GO:0004742; F:dihydrolipoyllysine-residue acetyltransferase activity; NAS:UniProtKB
P10515	DLAT	Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
P10515	DLAT	Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P10515	DLAT	Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial	GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW
P10515	DLAT	Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial	GO:0006090; P:pyruvate metabolic process; TAS:Reactome
P10515	DLAT	Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial	GO:0010510; P:regulation of acetyl-CoA biosynthetic process from pyruvate; TAS:Reactome
P10515	DLAT	Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P10515	DLAT	Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; IEA:UniProtKB-KW
P29803	PDHA2	Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial	GO:0004739; F:pyruvate dehydrogenase (acetyl-transferring) activity; IDA:UniProtKB
P29803	PDHA2	Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial	GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW
P29803	PDHA2	Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial	GO:0006096; P:glycolytic process; IEA:InterPro
P29803	PDHA2	Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial	GO:0006090; P:pyruvate metabolic process; IDA:UniProtKB
P29803	PDHA2	Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; IEA:UniProtKB-KW
P08559	PDHA1	Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial	GO:0004739; F:pyruvate dehydrogenase (acetyl-transferring) activity; IEA:UniProtKB-EC
P08559	PDHA1	Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial	GO:0004738; F:pyruvate dehydrogenase activity; IDA:UniProtKB
P08559	PDHA1	Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial	GO:0006086; P:acetyl-CoA biosynthetic process from pyruvate; IDA:UniProtKB
P08559	PDHA1	Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P08559	PDHA1	Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial	GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW
P08559	PDHA1	Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial	GO:0006096; P:glycolytic process; IEA:InterPro
P08559	PDHA1	Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial	GO:0006090; P:pyruvate metabolic process; TAS:Reactome
P08559	PDHA1	Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial	GO:0010510; P:regulation of acetyl-CoA biosynthetic process from pyruvate; TAS:Reactome
P08559	PDHA1	Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P08559	PDHA1	Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; IDA:UniProtKB
P11177	PDHB	Pyruvate dehydrogenase E1 component subunit beta, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
P11177	PDHB	Pyruvate dehydrogenase E1 component subunit beta, mitochondrial	GO:0004739; F:pyruvate dehydrogenase (acetyl-transferring) activity; TAS:ProtInc
P11177	PDHB	Pyruvate dehydrogenase E1 component subunit beta, mitochondrial	GO:0004738; F:pyruvate dehydrogenase activity; IDA:UniProtKB
P11177	PDHB	Pyruvate dehydrogenase E1 component subunit beta, mitochondrial	GO:0006086; P:acetyl-CoA biosynthetic process from pyruvate; IDA:UniProtKB
P11177	PDHB	Pyruvate dehydrogenase E1 component subunit beta, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P11177	PDHB	Pyruvate dehydrogenase E1 component subunit beta, mitochondrial	GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW
P11177	PDHB	Pyruvate dehydrogenase E1 component subunit beta, mitochondrial	GO:0006090; P:pyruvate metabolic process; TAS:Reactome
P11177	PDHB	Pyruvate dehydrogenase E1 component subunit beta, mitochondrial	GO:0010510; P:regulation of acetyl-CoA biosynthetic process from pyruvate; TAS:Reactome
P11177	PDHB	Pyruvate dehydrogenase E1 component subunit beta, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P11177	PDHB	Pyruvate dehydrogenase E1 component subunit beta, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; IDA:UniProtKB
O00330	PDHX	Pyruvate dehydrogenase protein X component, mitochondrial	GO:0016746; F:transferase activity, transferring acyl groups; IEA:InterPro
O00330	PDHX	Pyruvate dehydrogenase protein X component, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
O00330	PDHX	Pyruvate dehydrogenase protein X component, mitochondrial	GO:0006090; P:pyruvate metabolic process; TAS:Reactome
O00330	PDHX	Pyruvate dehydrogenase protein X component, mitochondrial	GO:0010510; P:regulation of acetyl-CoA biosynthetic process from pyruvate; TAS:Reactome
O00330	PDHX	Pyruvate dehydrogenase protein X component, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5SWX8	ODR4	Protein odr-4 homolog	GO:0016491; F:oxidoreductase activity; IEA:InterPro
Q5SWX8	ODR4	Protein odr-4 homolog	GO:0008270; F:zinc ion binding; IEA:InterPro
O75665	OFD1	Oral-facial-digital syndrome 1 protein	GO:0043014; F:alpha-tubulin binding; ISS:UniProtKB
O75665	OFD1	Oral-facial-digital syndrome 1 protein	GO:0043015; F:gamma-tubulin binding; ISS:UniProtKB
O75665	OFD1	Oral-facial-digital syndrome 1 protein	GO:0005515; F:protein binding; IPI:UniProtKB
O75665	OFD1	Oral-facial-digital syndrome 1 protein	GO:0060271; P:cilium morphogenesis; ISS:UniProtKB
O75665	OFD1	Oral-facial-digital syndrome 1 protein	GO:0060287; P:epithelial cilium movement involved in determination of left/right asymmetry; ISS:UniProtKB
O75665	OFD1	Oral-facial-digital syndrome 1 protein	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
O75665	OFD1	Oral-facial-digital syndrome 1 protein	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8IZS5	OFCC1	Orofacial cleft 1 candidate gene 1 protein	GO:0005515; F:protein binding; IPI:IntAct
Q9H488	POFUT1	GDP-fucose protein O-fucosyltransferase 1	GO:0008417; F:fucosyltransferase activity; IDA:UniProtKB
Q9H488	POFUT1	GDP-fucose protein O-fucosyltransferase 1	GO:0046922; F:peptide-O-fucosyltransferase activity; IDA:UniProtKB
Q9H488	POFUT1	GDP-fucose protein O-fucosyltransferase 1	GO:0001525; P:angiogenesis; IEA:Ensembl
Q9H488	POFUT1	GDP-fucose protein O-fucosyltransferase 1	GO:0009790; P:embryo development; NAS:UniProtKB
Q9H488	POFUT1	GDP-fucose protein O-fucosyltransferase 1	GO:0006004; P:fucose metabolic process; IEA:UniProtKB-KW
Q9H488	POFUT1	GDP-fucose protein O-fucosyltransferase 1	GO:0007507; P:heart development; IEA:Ensembl
Q9H488	POFUT1	GDP-fucose protein O-fucosyltransferase 1	GO:0007399; P:nervous system development; IEA:Ensembl
Q9H488	POFUT1	GDP-fucose protein O-fucosyltransferase 1	GO:0007219; P:Notch signaling pathway; NAS:UniProtKB
Q9H488	POFUT1	GDP-fucose protein O-fucosyltransferase 1	GO:0016266; P:O-glycan processing; TAS:UniProtKB
Q9H488	POFUT1	GDP-fucose protein O-fucosyltransferase 1	GO:0036066; P:protein O-linked fucosylation; IDA:UniProtKB
Q9H488	POFUT1	GDP-fucose protein O-fucosyltransferase 1	GO:0006493; P:protein O-linked glycosylation; IDA:UniProtKB
Q9H488	POFUT1	GDP-fucose protein O-fucosyltransferase 1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9H488	POFUT1	GDP-fucose protein O-fucosyltransferase 1	GO:0001756; P:somitogenesis; IEA:Ensembl
Q9Y2G5	POFUT2	GDP-fucose protein O-fucosyltransferase 2	GO:0046922; F:peptide-O-fucosyltransferase activity; IDA:UniProtKB
Q9Y2G5	POFUT2	GDP-fucose protein O-fucosyltransferase 2	GO:0006004; P:fucose metabolic process; IEA:UniProtKB-KW
Q9Y2G5	POFUT2	GDP-fucose protein O-fucosyltransferase 2	GO:0001707; P:mesoderm formation; IEA:Ensembl
Q9Y2G5	POFUT2	GDP-fucose protein O-fucosyltransferase 2	GO:0036066; P:protein O-linked fucosylation; IDA:UniProtKB
Q9Y2G5	POFUT2	GDP-fucose protein O-fucosyltransferase 2	GO:0010717; P:regulation of epithelial to mesenchymal transition; IEA:Ensembl
Q9Y2G5	POFUT2	GDP-fucose protein O-fucosyltransferase 2	GO:0010468; P:regulation of gene expression; IEA:Ensembl
Q9Y2G5	POFUT2	GDP-fucose protein O-fucosyltransferase 2	GO:0051046; P:regulation of secretion; IDA:UniProtKB
Q9ULD0	OGDHL	2-oxoglutarate dehydrogenase-like, mitochondrial	GO:0004591; F:oxoglutarate dehydrogenase (succinyl-transferring) activity; IEA:InterPro
Q9ULD0	OGDHL	2-oxoglutarate dehydrogenase-like, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q9ULD0	OGDHL	2-oxoglutarate dehydrogenase-like, mitochondrial	GO:0030976; F:thiamine pyrophosphate binding; IEA:InterPro
Q9ULD0	OGDHL	2-oxoglutarate dehydrogenase-like, mitochondrial	GO:0006096; P:glycolytic process; IEA:UniProtKB-KW
Q9ULD0	OGDHL	2-oxoglutarate dehydrogenase-like, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; IEA:InterPro
Q8N543	OGFOD1	Prolyl 3-hydroxylase OGFOD1	GO:0005506; F:iron ion binding; IEA:InterPro
Q8N543	OGFOD1	Prolyl 3-hydroxylase OGFOD1	GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW
Q8N543	OGFOD1	Prolyl 3-hydroxylase OGFOD1	GO:0016706; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; IEA:InterPro
Q8N543	OGFOD1	Prolyl 3-hydroxylase OGFOD1	GO:0031544; F:peptidyl-proline 3-dioxygenase activity; IDA:UniProtKB
Q8N543	OGFOD1	Prolyl 3-hydroxylase OGFOD1	GO:0031543; F:peptidyl-proline dioxygenase activity; IDA:UniProtKB
Q8N543	OGFOD1	Prolyl 3-hydroxylase OGFOD1	GO:0008283; P:cell proliferation; IMP:UniProtKB
Q8N543	OGFOD1	Prolyl 3-hydroxylase OGFOD1	GO:0019511; P:peptidyl-proline hydroxylation; IDA:GOC
Q8N543	OGFOD1	Prolyl 3-hydroxylase OGFOD1	GO:0018126; P:protein hydroxylation; IDA:UniProtKB
Q8N543	OGFOD1	Prolyl 3-hydroxylase OGFOD1	GO:0006449; P:regulation of translational termination; IMP:UniProtKB
Q8N543	OGFOD1	Prolyl 3-hydroxylase OGFOD1	GO:0034063; P:stress granule assembly; IMP:UniProtKB
Q6N063	OGFOD2	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2	GO:0005506; F:iron ion binding; IEA:InterPro
Q6N063	OGFOD2	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2	GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW
Q6N063	OGFOD2	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2	GO:0016706; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; IEA:InterPro
Q6PK18	OGFOD3	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3	GO:0005506; F:iron ion binding; IEA:InterPro
Q6PK18	OGFOD3	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3	GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW
Q6PK18	OGFOD3	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3	GO:0016706; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; IEA:InterPro
Q9NZT2	OGFR	Opioid growth factor receptor	GO:0004985; F:opioid receptor activity; NAS:UniProtKB
Q9NZT2	OGFR	Opioid growth factor receptor	GO:0038003; P:opioid receptor signaling pathway; NAS:GOC
Q9NZT2	OGFR	Opioid growth factor receptor	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
O15527	OGG1	N-glycosylase/DNA lyase	GO:0034039; F:8-oxo-7,8-dihydroguanine DNA N-glycosylase activity; IEA:Ensembl
O15527	OGG1	N-glycosylase/DNA lyase	GO:0003684; F:damaged DNA binding; TAS:ProtInc
O15527	OGG1	N-glycosylase/DNA lyase	GO:0004519; F:endonuclease activity; TAS:ProtInc
O15527	OGG1	N-glycosylase/DNA lyase	GO:0008534; F:oxidized purine nucleobase lesion DNA N-glycosylase activity; TAS:ProtInc
O15527	OGG1	N-glycosylase/DNA lyase	GO:0005515; F:protein binding; IPI:UniProtKB
O15527	OGG1	N-glycosylase/DNA lyase	GO:0002526; P:acute inflammatory response; IEA:Ensembl
O15527	OGG1	N-glycosylase/DNA lyase	GO:0006284; P:base-excision repair; TAS:Reactome
O15527	OGG1	N-glycosylase/DNA lyase	GO:0006285; P:base-excision repair, AP site formation; TAS:Reactome
O15527	OGG1	N-glycosylase/DNA lyase	GO:0071276; P:cellular response to cadmium ion; IEA:Ensembl
O15527	OGG1	N-glycosylase/DNA lyase	GO:0045007; P:depurination; TAS:Reactome
O15527	OGG1	N-glycosylase/DNA lyase	GO:0000737; P:DNA catabolic process, endonucleolytic; TAS:GOC
O15527	OGG1	N-glycosylase/DNA lyase	GO:0006281; P:DNA repair; TAS:Reactome
O15527	OGG1	N-glycosylase/DNA lyase	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; TAS:GOC
O15527	OGG1	N-glycosylase/DNA lyase	GO:0006289; P:nucleotide-excision repair; IEA:InterPro
O15527	OGG1	N-glycosylase/DNA lyase	GO:0033158; P:regulation of protein import into nucleus, translocation; IDA:UniProtKB
O15527	OGG1	N-glycosylase/DNA lyase	GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB
O15527	OGG1	N-glycosylase/DNA lyase	GO:0042493; P:response to drug; IEA:Ensembl
O15527	OGG1	N-glycosylase/DNA lyase	GO:0032355; P:response to estradiol; IEA:Ensembl
O15527	OGG1	N-glycosylase/DNA lyase	GO:0045471; P:response to ethanol; IEA:Ensembl
O15527	OGG1	N-glycosylase/DNA lyase	GO:0051593; P:response to folic acid; IEA:Ensembl
O15527	OGG1	N-glycosylase/DNA lyase	GO:0006979; P:response to oxidative stress; IDA:UniProtKB
O15527	OGG1	N-glycosylase/DNA lyase	GO:0009314; P:response to radiation; IDA:UniProtKB
Q15743	GPR68	Ovarian cancer G-protein coupled receptor 1	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q15743	GPR68	Ovarian cancer G-protein coupled receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q15743	GPR68	Ovarian cancer G-protein coupled receptor 1	GO:0006954; P:inflammatory response; TAS:ProtInc
Q5TC84	OGFRL1	Opioid growth factor receptor-like protein 1	GO:0004872; F:receptor activity; IEA:InterPro
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0008375; F:acetylglucosaminyltransferase activity; TAS:ProtInc
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0008047; F:enzyme activator activity; IDA:BHF-UCL
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0005515; F:protein binding; IPI:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0016262; F:protein N-acetylglucosaminyltransferase activity; IDA:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0097363; F:protein O-GlcNAc transferase activity; ISS:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0006915; P:apoptotic process; IDA:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0071300; P:cellular response to retinoic acid; IMP:BHF-UCL
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0006325; P:chromatin organization; TAS:Reactome
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0080182; P:histone H3-K4 trimethylation; IMP:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0043984; P:histone H4-K16 acetylation; IDA:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0043981; P:histone H4-K5 acetylation; IDA:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0043982; P:histone H4-K8 acetylation; IDA:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0031397; P:negative regulation of protein ubiquitination; ISS:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0048015; P:phosphatidylinositol-mediated signaling; IDA:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0043085; P:positive regulation of catalytic activity; IDA:GOC
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0030854; P:positive regulation of granulocyte differentiation; IMP:BHF-UCL
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0061087; P:positive regulation of histone H3-K27 methylation; IMP:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0051571; P:positive regulation of histone H3-K4 methylation; IDA:BHF-UCL
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0045862; P:positive regulation of proteolysis; IDA:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0006493; P:protein O-linked glycosylation; IDA:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0090526; P:regulation of gluconeogenesis involved in cellular glucose homeostasis; ISS:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0006110; P:regulation of glycolytic process; IDA:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0046626; P:regulation of insulin receptor signaling pathway; IDA:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0035020; P:regulation of Rac protein signal transduction; IDA:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0032868; P:response to insulin; IDA:UniProtKB
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0007584; P:response to nutrient; TAS:ProtInc
O15294	OGT	UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit	GO:0007165; P:signal transduction; TAS:ProtInc
Q8WWZ8	OIT3	Oncoprotein-induced transcript 3 protein	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NTK5	OLA1	Obg-like ATPase 1	GO:0005524; F:ATP binding; IDA:HGNC
Q9NTK5	OLA1	Obg-like ATPase 1	GO:0016887; F:ATPase activity; IEA:UniProtKB-HAMAP
Q9NTK5	OLA1	Obg-like ATPase 1	GO:0005525; F:GTP binding; IEA:InterPro
Q9NTK5	OLA1	Obg-like ATPase 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NTK5	OLA1	Obg-like ATPase 1	GO:0043023; F:ribosomal large subunit binding; IEA:UniProtKB-HAMAP
Q9NTK5	OLA1	Obg-like ATPase 1	GO:0043022; F:ribosome binding; IEA:UniProtKB-HAMAP
Q9NTK5	OLA1	Obg-like ATPase 1	GO:0006200; P:ATP catabolic process; IDA:HGNC
Q9NRN5	OLFML3	Olfactomedin-like protein 3	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q6UX06	OLFM4	Olfactomedin-4	GO:0045296; F:cadherin binding; IMP:UniProt
Q6UX06	OLFM4	Olfactomedin-4	GO:0003824; F:catalytic activity; IEA:InterPro
Q6UX06	OLFM4	Olfactomedin-4	GO:0042803; F:protein homodimerization activity; IMP:UniProt
Q6UX06	OLFM4	Olfactomedin-4	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q6UX06	OLFM4	Olfactomedin-4	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
Q6UX06	OLFM4	Olfactomedin-4	GO:0050777; P:negative regulation of immune response; IEA:Ensembl
Q6UX06	OLFM4	Olfactomedin-4	GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IDA:UniProt
Q6UX06	OLFM4	Olfactomedin-4	GO:0051260; P:protein homooligomerization; IMP:UniProt
Q8TAK6	OLIG1	Oligodendrocyte transcription factor 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TAK6	OLIG1	Oligodendrocyte transcription factor 1	GO:0005515; F:protein binding; IPI:IntAct
Q8TAK6	OLIG1	Oligodendrocyte transcription factor 1	GO:0048663; P:neuron fate commitment; IEA:Ensembl
Q8TAK6	OLIG1	Oligodendrocyte transcription factor 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8TAK6	OLIG1	Oligodendrocyte transcription factor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q68BL7	OLFML2A	Olfactomedin-like protein 2A	GO:0050840; F:extracellular matrix binding; IEA:Ensembl
Q68BL7	OLFML2A	Olfactomedin-like protein 2A	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q7RTU3	OLIG3	Oligodendrocyte transcription factor 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7RTU3	OLIG3	Oligodendrocyte transcription factor 3	GO:0001106; F:RNA polymerase II transcription corepressor activity; IEA:Ensembl
Q7RTU3	OLIG3	Oligodendrocyte transcription factor 3	GO:0021520; P:spinal cord motor neuron cell fate specification; IEA:Ensembl
Q7RTU3	OLIG3	Oligodendrocyte transcription factor 3	GO:0097476; P:spinal cord motor neuron migration; IEA:Ensembl
Q13516	OLIG2	Oligodendrocyte transcription factor 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q13516	OLIG2	Oligodendrocyte transcription factor 2	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q13516	OLIG2	Oligodendrocyte transcription factor 2	GO:0042552; P:myelination; IEA:Ensembl
Q13516	OLIG2	Oligodendrocyte transcription factor 2	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
Q13516	OLIG2	Oligodendrocyte transcription factor 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q13516	OLIG2	Oligodendrocyte transcription factor 2	GO:0048663; P:neuron fate commitment; IEA:Ensembl
Q13516	OLIG2	Oligodendrocyte transcription factor 2	GO:0048714; P:positive regulation of oligodendrocyte differentiation; IEA:Ensembl
Q13516	OLIG2	Oligodendrocyte transcription factor 2	GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl
Q13516	OLIG2	Oligodendrocyte transcription factor 2	GO:0021530; P:spinal cord oligodendrocyte cell fate specification; IEA:Ensembl
Q13516	OLIG2	Oligodendrocyte transcription factor 2	GO:0021794; P:thalamus development; IEA:Ensembl
Q68BL8	OLFML2B	Olfactomedin-like protein 2B	GO:0050840; F:extracellular matrix binding; IEA:Ensembl
Q68BL8	OLFML2B	Olfactomedin-like protein 2B	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
P78380	OLR1	Oxidized low-density lipoprotein receptor 1	GO:0030246; F:carbohydrate binding; IEA:InterPro
P78380	OLR1	Oxidized low-density lipoprotein receptor 1	GO:0005041; F:low-density lipoprotein receptor activity; IEA:Ensembl
P78380	OLR1	Oxidized low-density lipoprotein receptor 1	GO:0008015; P:blood circulation; TAS:ProtInc
P78380	OLR1	Oxidized low-density lipoprotein receptor 1	GO:0007596; P:blood coagulation; TAS:Reactome
P78380	OLR1	Oxidized low-density lipoprotein receptor 1	GO:0008219; P:cell death; IEA:Ensembl
P78380	OLR1	Oxidized low-density lipoprotein receptor 1	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
P78380	OLR1	Oxidized low-density lipoprotein receptor 1	GO:0007159; P:leukocyte cell-cell adhesion; IEA:Ensembl
P78380	OLR1	Oxidized low-density lipoprotein receptor 1	GO:0050900; P:leukocyte migration; TAS:Reactome
P78380	OLR1	Oxidized low-density lipoprotein receptor 1	GO:0042157; P:lipoprotein metabolic process; IEA:Ensembl
P78380	OLR1	Oxidized low-density lipoprotein receptor 1	GO:0006508; P:proteolysis; TAS:ProtInc
P78380	OLR1	Oxidized low-density lipoprotein receptor 1	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
Q96E52	OMA1	Metalloendopeptidase OMA1, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96E52	OMA1	Metalloendopeptidase OMA1, mitochondrial	GO:0004222; F:metalloendopeptidase activity; IMP:UniProtKB
Q96E52	OMA1	Metalloendopeptidase OMA1, mitochondrial	GO:0042407; P:cristae formation; IEA:Ensembl
Q96E52	OMA1	Metalloendopeptidase OMA1, mitochondrial	GO:0002024; P:diet induced thermogenesis; IMP:UniProtKB
Q96E52	OMA1	Metalloendopeptidase OMA1, mitochondrial	GO:0097009; P:energy homeostasis; IMP:UniProtKB
Q96E52	OMA1	Metalloendopeptidase OMA1, mitochondrial	GO:0006006; P:glucose metabolic process; IMP:UniProtKB
Q96E52	OMA1	Metalloendopeptidase OMA1, mitochondrial	GO:0006629; P:lipid metabolic process; IMP:UniProtKB
Q96E52	OMA1	Metalloendopeptidase OMA1, mitochondrial	GO:0006515; P:misfolded or incompletely synthesized protein catabolic process; IMP:UniProtKB
Q96E52	OMA1	Metalloendopeptidase OMA1, mitochondrial	GO:0034982; P:mitochondrial protein processing; IEA:Ensembl
Q96E52	OMA1	Metalloendopeptidase OMA1, mitochondrial	GO:0010637; P:negative regulation of mitochondrial fusion; IMP:UniProtKB
Q96E52	OMA1	Metalloendopeptidase OMA1, mitochondrial	GO:0006950; P:response to stress; IDA:UniProtKB
Q99983	OMD	Osteomodulin	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q99983	OMD	Osteomodulin	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q99983	OMD	Osteomodulin	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q99983	OMD	Osteomodulin	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
Q99983	OMD	Osteomodulin	GO:0042340; P:keratan sulfate catabolic process; TAS:Reactome
Q99983	OMD	Osteomodulin	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
Q99983	OMD	Osteomodulin	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P23515	OMG	Oligodendrocyte-myelin glycoprotein	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P23515	OMG	Oligodendrocyte-myelin glycoprotein	GO:0050771; P:negative regulation of axonogenesis; TAS:Reactome
P23515	OMG	Oligodendrocyte-myelin glycoprotein	GO:0031102; P:neuron projection regeneration; IEA:Ensembl
P23515	OMG	Oligodendrocyte-myelin glycoprotein	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P23515	OMG	Oligodendrocyte-myelin glycoprotein	GO:0050770; P:regulation of axonogenesis; TAS:Reactome
P23515	OMG	Oligodendrocyte-myelin glycoprotein	GO:0048683; P:regulation of collateral sprouting of intact axon in response to injury; IEA:Ensembl
P47874	OMP	Olfactory marker protein	GO:0004871; F:signal transducer activity; IEA:Ensembl
P47874	OMP	Olfactory marker protein	GO:0022008; P:neurogenesis; IEA:Ensembl
P47874	OMP	Olfactory marker protein	GO:0007608; P:sensory perception of smell; TAS:ProtInc
P47874	OMP	Olfactory marker protein	GO:0007165; P:signal transduction; TAS:ProtInc
P47874	OMP	Olfactory marker protein	GO:0007268; P:synaptic transmission; TAS:ProtInc
P13725	OSM	Oncostatin-M	GO:0005125; F:cytokine activity; IDA:BHF-UCL
P13725	OSM	Oncostatin-M	GO:0008083; F:growth factor activity; IDA:BHF-UCL
P13725	OSM	Oncostatin-M	GO:0005147; F:oncostatin-M receptor binding; IPI:BHF-UCL
P13725	OSM	Oncostatin-M	GO:0048266; P:behavioral response to pain; IEA:Ensembl
P13725	OSM	Oncostatin-M	GO:0008283; P:cell proliferation; TAS:ProtInc
P13725	OSM	Oncostatin-M	GO:0006955; P:immune response; IEA:InterPro
P13725	OSM	Oncostatin-M	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P13725	OSM	Oncostatin-M	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P13725	OSM	Oncostatin-M	GO:0046888; P:negative regulation of hormone secretion; IDA:MGI
P13725	OSM	Oncostatin-M	GO:0045835; P:negative regulation of meiosis; IEA:Ensembl
P13725	OSM	Oncostatin-M	GO:0007422; P:peripheral nervous system development; IEA:Ensembl
P13725	OSM	Oncostatin-M	GO:0002675; P:positive regulation of acute inflammatory response; IC:BHF-UCL
P13725	OSM	Oncostatin-M	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
P13725	OSM	Oncostatin-M	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P13725	OSM	Oncostatin-M	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P13725	OSM	Oncostatin-M	GO:0043410; P:positive regulation of MAPK cascade; IDA:MGI
P13725	OSM	Oncostatin-M	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:MGI
P13725	OSM	Oncostatin-M	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL
P13725	OSM	Oncostatin-M	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
P13725	OSM	Oncostatin-M	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
P13725	OSM	Oncostatin-M	GO:0009408; P:response to heat; IEA:Ensembl
P13725	OSM	Oncostatin-M	GO:0042508; P:tyrosine phosphorylation of Stat1 protein; IEA:Ensembl
P13725	OSM	Oncostatin-M	GO:0042503; P:tyrosine phosphorylation of Stat3 protein; IEA:Ensembl
P13725	OSM	Oncostatin-M	GO:0042506; P:tyrosine phosphorylation of Stat5 protein; IEA:Ensembl
P0CE72	OCM	Oncomodulin-1	GO:0005509; F:calcium ion binding; NAS:UniProtKB
O95948	ONECUT2	One cut domain family member 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O95948	ONECUT2	One cut domain family member 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
O95948	ONECUT2	One cut domain family member 2	GO:0045165; P:cell fate commitment; IEA:Ensembl
O95948	ONECUT2	One cut domain family member 2	GO:0042384; P:cilium assembly; IEA:Ensembl
O95948	ONECUT2	One cut domain family member 2	GO:0031018; P:endocrine pancreas development; IEA:Ensembl
O95948	ONECUT2	One cut domain family member 2	GO:0002064; P:epithelial cell development; IEA:Ensembl
O95948	ONECUT2	One cut domain family member 2	GO:0001889; P:liver development; IEA:Ensembl
O95948	ONECUT2	One cut domain family member 2	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl
O95948	ONECUT2	One cut domain family member 2	GO:0009887; P:organ morphogenesis; TAS:ProtInc
O95948	ONECUT2	One cut domain family member 2	GO:0048935; P:peripheral nervous system neuron development; IEA:Ensembl
O95948	ONECUT2	One cut domain family member 2	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
O95948	ONECUT2	One cut domain family member 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O95948	ONECUT2	One cut domain family member 2	GO:0001952; P:regulation of cell-matrix adhesion; IEA:Ensembl
O95948	ONECUT2	One cut domain family member 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60422	ONECUT3	One cut domain family member 3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O60422	ONECUT3	One cut domain family member 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
O60422	ONECUT3	One cut domain family member 3	GO:0031018; P:endocrine pancreas development; TAS:Reactome
O60422	ONECUT3	One cut domain family member 3	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O60422	ONECUT3	One cut domain family member 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A6NGQ2	OOEP	Oocyte-expressed protein homolog	GO:0003723; F:RNA binding; IEA:Ensembl
A6NGQ2	OOEP	Oocyte-expressed protein homolog	GO:0043623; P:cellular protein complex assembly; IEA:Ensembl
A6NGQ2	OOEP	Oocyte-expressed protein homolog	GO:0007566; P:embryo implantation; IEA:Ensembl
A6NGQ2	OOEP	Oocyte-expressed protein homolog	GO:0009880; P:embryonic pattern specification; IEA:Ensembl
A6NGQ2	OOEP	Oocyte-expressed protein homolog	GO:0035088; P:establishment or maintenance of apical/basal cell polarity; IEA:Ensembl
A6NGQ2	OOEP	Oocyte-expressed protein homolog	GO:0009566; P:fertilization; IEA:Ensembl
A6NGQ2	OOEP	Oocyte-expressed protein homolog	GO:0001701; P:in utero embryonic development; IEA:Ensembl
A6NGQ2	OOEP	Oocyte-expressed protein homolog	GO:0006468; P:protein phosphorylation; IEA:Ensembl
O60313	OPA1	Dynamin-like 120 kDa protein, mitochondrial	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
O60313	OPA1	Dynamin-like 120 kDa protein, mitochondrial	GO:0003924; F:GTPase activity; TAS:UniProtKB
O60313	OPA1	Dynamin-like 120 kDa protein, mitochondrial	GO:0000287; F:magnesium ion binding; NAS:UniProtKB
O60313	OPA1	Dynamin-like 120 kDa protein, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
O60313	OPA1	Dynamin-like 120 kDa protein, mitochondrial	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O60313	OPA1	Dynamin-like 120 kDa protein, mitochondrial	GO:0019896; P:axon transport of mitochondrion; TAS:UniProtKB
O60313	OPA1	Dynamin-like 120 kDa protein, mitochondrial	GO:0090398; P:cellular senescence; IDA:UniProtKB
O60313	OPA1	Dynamin-like 120 kDa protein, mitochondrial	GO:0006184; P:GTP catabolic process; TAS:GOC
O60313	OPA1	Dynamin-like 120 kDa protein, mitochondrial	GO:0007007; P:inner mitochondrial membrane organization; IDA:UniProtKB
O60313	OPA1	Dynamin-like 120 kDa protein, mitochondrial	GO:0000266; P:mitochondrial fission; TAS:UniProtKB
O60313	OPA1	Dynamin-like 120 kDa protein, mitochondrial	GO:0008053; P:mitochondrial fusion; IDA:UniProtKB
O60313	OPA1	Dynamin-like 120 kDa protein, mitochondrial	GO:0007005; P:mitochondrion organization; NAS:UniProtKB
O60313	OPA1	Dynamin-like 120 kDa protein, mitochondrial	GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; IMP:UniProtKB
O60313	OPA1	Dynamin-like 120 kDa protein, mitochondrial	GO:0001843; P:neural tube closure; IEA:Ensembl
O60313	OPA1	Dynamin-like 120 kDa protein, mitochondrial	GO:0007601; P:visual perception; IMP:UniProtKB
Q9H6K4	OPA3	Optic atrophy 3 protein	GO:0040007; P:growth; IEA:Ensembl
Q9H6K4	OPA3	Optic atrophy 3 protein	GO:0070584; P:mitochondrion morphogenesis; IEA:Ensembl
Q9H6K4	OPA3	Optic atrophy 3 protein	GO:0050905; P:neuromuscular process; IEA:Ensembl
Q9H6K4	OPA3	Optic atrophy 3 protein	GO:0019216; P:regulation of lipid metabolic process; IEA:Ensembl
Q9H6K4	OPA3	Optic atrophy 3 protein	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q9H6K4	OPA3	Optic atrophy 3 protein	GO:0007601; P:visual perception; IMP:UniProtKB
Q14982	OPCML	Opioid-binding protein/cell adhesion molecule	GO:0004985; F:opioid receptor activity; TAS:ProtInc
Q14982	OPCML	Opioid-binding protein/cell adhesion molecule	GO:0007155; P:cell adhesion; TAS:ProtInc
Q14982	OPCML	Opioid-binding protein/cell adhesion molecule	GO:0008038; P:neuron recognition; TAS:ProtInc
Q14982	OPCML	Opioid-binding protein/cell adhesion molecule	GO:0038003; P:opioid receptor signaling pathway; TAS:GOC
O60890	OPHN1	Oligophrenin-1	GO:0005543; F:phospholipid binding; IDA:FlyBase
O60890	OPHN1	Oligophrenin-1	GO:0005100; F:Rho GTPase activator activity; TAS:ProtInc
O60890	OPHN1	Oligophrenin-1	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
O60890	OPHN1	Oligophrenin-1	GO:0007411; P:axon guidance; TAS:ProtInc
O60890	OPHN1	Oligophrenin-1	GO:0007399; P:nervous system development; TAS:ProtInc
O60890	OPHN1	Oligophrenin-1	GO:0030100; P:regulation of endocytosis; IEA:Ensembl
O60890	OPHN1	Oligophrenin-1	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
O60890	OPHN1	Oligophrenin-1	GO:0051966; P:regulation of synaptic transmission, glutamatergic; IEA:Ensembl
O60890	OPHN1	Oligophrenin-1	GO:0007165; P:signal transduction; TAS:ProtInc
O60890	OPHN1	Oligophrenin-1	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
O60890	OPHN1	Oligophrenin-1	GO:0006930; P:substrate-dependent cell migration, cell extension; TAS:ProtInc
O60890	OPHN1	Oligophrenin-1	GO:0048488; P:synaptic vesicle endocytosis; IEA:Ensembl
Q9H1Y3	OPN3	Opsin-3	GO:0008020; F:G-protein coupled photoreceptor activity; NAS:UniProtKB
Q9H1Y3	OPN3	Opsin-3	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q9H1Y3	OPN3	Opsin-3	GO:0009881; F:photoreceptor activity; NAS:UniProtKB
Q9H1Y3	OPN3	Opsin-3	GO:0009583; P:detection of light stimulus; NAS:UniProtKB
Q9H1Y3	OPN3	Opsin-3	GO:0009584; P:detection of visible light; NAS:GOC
Q9H1Y3	OPN3	Opsin-3	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q9H1Y3	OPN3	Opsin-3	GO:0007602; P:phototransduction; NAS:UniProtKB
Q9H1Y3	OPN3	Opsin-3	GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW
Q9H1Y3	OPN3	Opsin-3	GO:0042752; P:regulation of circadian rhythm; NAS:UniProtKB
O14841	OPLAH	5-oxoprolinase	GO:0017168; F:5-oxoprolinase (ATP-hydrolyzing) activity; TAS:Reactome
O14841	OPLAH	5-oxoprolinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O14841	OPLAH	5-oxoprolinase	GO:0006750; P:glutathione biosynthetic process; TAS:Reactome
O14841	OPLAH	5-oxoprolinase	GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome
O14841	OPLAH	5-oxoprolinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O14841	OPLAH	5-oxoprolinase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9UHM6	OPN4	Melanopsin	GO:0005502; F:11-cis retinal binding; IDA:UniProtKB
Q9UHM6	OPN4	Melanopsin	GO:0008020; F:G-protein coupled photoreceptor activity; IDA:UniProtKB
Q9UHM6	OPN4	Melanopsin	GO:0007602; P:phototransduction; IDA:UniProtKB
Q9UHM6	OPN4	Melanopsin	GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW
Q9UHM6	OPN4	Melanopsin	GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB
Q9UHM6	OPN4	Melanopsin	GO:0016056; P:rhodopsin mediated signaling pathway; IEA:Ensembl
Q9UHM6	OPN4	Melanopsin	GO:0048511; P:rhythmic process; IEA:UniProtKB-KW
Q9UHM6	OPN4	Melanopsin	GO:0007601; P:visual perception; IEA:InterPro
Q6U736	OPN5	Opsin-5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q6U736	OPN5	Opsin-5	GO:0009881; F:photoreceptor activity; IEA:UniProtKB-KW
Q6U736	OPN5	Opsin-5	GO:0007602; P:phototransduction; IEA:UniProtKB-KW
Q6U736	OPN5	Opsin-5	GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW
Q6U736	OPN5	Opsin-5	GO:0007601; P:visual perception; IEA:InterPro
P41143	OPRD1	Delta-type opioid receptor	GO:0038046; F:enkephalin receptor activity; IMP:UniProtKB
P41143	OPRD1	Delta-type opioid receptor	GO:0004985; F:opioid receptor activity; IDA:UniProtKB
P41143	OPRD1	Delta-type opioid receptor	GO:0005515; F:protein binding; IPI:IntAct
P41143	OPRD1	Delta-type opioid receptor	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IEA:Ensembl
P41143	OPRD1	Delta-type opioid receptor	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P41143	OPRD1	Delta-type opioid receptor	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P41143	OPRD1	Delta-type opioid receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:UniProtKB
P41143	OPRD1	Delta-type opioid receptor	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P41143	OPRD1	Delta-type opioid receptor	GO:0006955; P:immune response; TAS:ProtInc
P41143	OPRD1	Delta-type opioid receptor	GO:0007218; P:neuropeptide signaling pathway; IEA:Ensembl
P41143	OPRD1	Delta-type opioid receptor	GO:0038003; P:opioid receptor signaling pathway; IMP:UniProtKB
P41143	OPRD1	Delta-type opioid receptor	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; ISS:UniProtKB
P41143	OPRD1	Delta-type opioid receptor	GO:0000060; P:protein import into nucleus, translocation; IDA:UniProtKB
P41143	OPRD1	Delta-type opioid receptor	GO:0051924; P:regulation of calcium ion transport; IEA:Ensembl
P41143	OPRD1	Delta-type opioid receptor	GO:0051930; P:regulation of sensory perception of pain; IEA:Ensembl
P41145	OPRK1	Kappa-type opioid receptor	GO:0038048; F:dynorphin receptor activity; IDA:UniProtKB
P41145	OPRK1	Kappa-type opioid receptor	GO:0004985; F:opioid receptor activity; IDA:UniProtKB
P41145	OPRK1	Kappa-type opioid receptor	GO:0005515; F:protein binding; IPI:IntAct
P41145	OPRK1	Kappa-type opioid receptor	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:ProtInc
P41145	OPRK1	Kappa-type opioid receptor	GO:0031635; P:adenylate cyclase-inhibiting opioid receptor signaling pathway; IDA:UniProtKB
P41145	OPRK1	Kappa-type opioid receptor	GO:0007610; P:behavior; TAS:ProtInc
P41145	OPRK1	Kappa-type opioid receptor	GO:0051607; P:defense response to virus; IDA:UniProtKB
P41145	OPRK1	Kappa-type opioid receptor	GO:0006955; P:immune response; IDA:UniProtKB
P41145	OPRK1	Kappa-type opioid receptor	GO:0007626; P:locomotory behavior; ISS:UniProtKB
P41145	OPRK1	Kappa-type opioid receptor	GO:0038003; P:opioid receptor signaling pathway; IDA:UniProtKB
P41145	OPRK1	Kappa-type opioid receptor	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; ISS:UniProtKB
P41145	OPRK1	Kappa-type opioid receptor	GO:0046877; P:regulation of saliva secretion; ISS:UniProtKB
P41145	OPRK1	Kappa-type opioid receptor	GO:0007600; P:sensory perception; TAS:ProtInc
P41145	OPRK1	Kappa-type opioid receptor	GO:0019233; P:sensory perception of pain; ISS:UniProtKB
P41145	OPRK1	Kappa-type opioid receptor	GO:0007268; P:synaptic transmission; TAS:ProtInc
P35372	OPRM1	Mu-type opioid receptor	GO:0004979; F:beta-endorphin receptor activity; IMP:UniProtKB
P35372	OPRM1	Mu-type opioid receptor	GO:0001965; F:G-protein alpha-subunit binding; IDA:UniProtKB
P35372	OPRM1	Mu-type opioid receptor	GO:0004930; F:G-protein coupled receptor activity; ISS:UniProtKB
P35372	OPRM1	Mu-type opioid receptor	GO:0038047; F:morphine receptor activity; ISS:UniProtKB
P35372	OPRM1	Mu-type opioid receptor	GO:0005515; F:protein binding; IPI:IntAct
P35372	OPRM1	Mu-type opioid receptor	GO:0005245; F:voltage-gated calcium channel activity; ISS:UniProtKB
P35372	OPRM1	Mu-type opioid receptor	GO:0007191; P:adenylate cyclase-activating dopamine receptor signaling pathway; IEA:Ensembl
P35372	OPRM1	Mu-type opioid receptor	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IEA:Ensembl
P35372	OPRM1	Mu-type opioid receptor	GO:0048149; P:behavioral response to ethanol; IMP:UniProtKB
P35372	OPRM1	Mu-type opioid receptor	GO:0070588; P:calcium ion transmembrane transport; ISS:GOC
P35372	OPRM1	Mu-type opioid receptor	GO:0033554; P:cellular response to stress; IMP:UniProtKB
P35372	OPRM1	Mu-type opioid receptor	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P35372	OPRM1	Mu-type opioid receptor	GO:0007626; P:locomotory behavior; IEA:Ensembl
P35372	OPRM1	Mu-type opioid receptor	GO:0007194; P:negative regulation of adenylate cyclase activity; ISS:UniProtKB
P35372	OPRM1	Mu-type opioid receptor	GO:0043951; P:negative regulation of cAMP-mediated signaling; IDA:UniProtKB
P35372	OPRM1	Mu-type opioid receptor	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P35372	OPRM1	Mu-type opioid receptor	GO:0051481; P:negative regulation of cytosolic calcium ion concentration; IDA:UniProtKB
P35372	OPRM1	Mu-type opioid receptor	GO:0045019; P:negative regulation of nitric oxide biosynthetic process; IDA:UniProtKB
P35372	OPRM1	Mu-type opioid receptor	GO:0061358; P:negative regulation of Wnt protein secretion; IMP:UniProtKB
P35372	OPRM1	Mu-type opioid receptor	GO:0007218; P:neuropeptide signaling pathway; IMP:GOC
P35372	OPRM1	Mu-type opioid receptor	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; ISS:UniProtKB
P35372	OPRM1	Mu-type opioid receptor	GO:0043950; P:positive regulation of cAMP-mediated signaling; IDA:UniProtKB
P35372	OPRM1	Mu-type opioid receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB
P35372	OPRM1	Mu-type opioid receptor	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
P35372	OPRM1	Mu-type opioid receptor	GO:0050769; P:positive regulation of neurogenesis; ISS:UniProtKB
P35372	OPRM1	Mu-type opioid receptor	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IDA:UniProtKB
P35372	OPRM1	Mu-type opioid receptor	GO:2000310; P:regulation of N-methyl-D-aspartate selective glutamate receptor activity; ISS:UniProtKB
P35372	OPRM1	Mu-type opioid receptor	GO:0007600; P:sensory perception; NAS:UniProtKB
P35372	OPRM1	Mu-type opioid receptor	GO:0019233; P:sensory perception of pain; ISS:UniProtKB
P41146	OPRL1	Nociceptin receptor	GO:0004930; F:G-protein coupled receptor activity; IMP:UniProtKB
P41146	OPRL1	Nociceptin receptor	GO:0001626; F:nociceptin receptor activity; IDA:UniProtKB
P41146	OPRL1	Nociceptin receptor	GO:0005515; F:protein binding; IPI:IntAct
P41146	OPRL1	Nociceptin receptor	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IMP:UniProtKB
P41146	OPRL1	Nociceptin receptor	GO:0007610; P:behavior; IEA:UniProtKB-KW
P41146	OPRL1	Nociceptin receptor	GO:0038003; P:opioid receptor signaling pathway; IDA:GOC
P41146	OPRL1	Nociceptin receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IGI:UniProtKB
P41146	OPRL1	Nociceptin receptor	GO:0007600; P:sensory perception; TAS:ProtInc
P41146	OPRL1	Nociceptin receptor	GO:0019233; P:sensory perception of pain; ISS:UniProtKB
P03999	OPN1SW	Short-wave-sensitive opsin 1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P03999	OPN1SW	Short-wave-sensitive opsin 1	GO:0009881; F:photoreceptor activity; IEA:UniProtKB-KW
P03999	OPN1SW	Short-wave-sensitive opsin 1	GO:0004872; F:receptor activity; TAS:ProtInc
P03999	OPN1SW	Short-wave-sensitive opsin 1	GO:0007602; P:phototransduction; TAS:ProtInc
P03999	OPN1SW	Short-wave-sensitive opsin 1	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P03999	OPN1SW	Short-wave-sensitive opsin 1	GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW
P03999	OPN1SW	Short-wave-sensitive opsin 1	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P03999	OPN1SW	Short-wave-sensitive opsin 1	GO:0007165; P:signal transduction; TAS:ProtInc
P03999	OPN1SW	Short-wave-sensitive opsin 1	GO:0007601; P:visual perception; TAS:ProtInc
P08100	RHO	Rhodopsin	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P08100	RHO	Rhodopsin	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P08100	RHO	Rhodopsin	GO:0009881; F:photoreceptor activity; IEA:UniProtKB-KW
P08100	RHO	Rhodopsin	GO:0005515; F:protein binding; IPI:UniProtKB
P08100	RHO	Rhodopsin	GO:0016918; F:retinal binding; IEA:Ensembl
P08100	RHO	Rhodopsin	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P08100	RHO	Rhodopsin	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P08100	RHO	Rhodopsin	GO:0006468; P:protein phosphorylation; IEA:Ensembl
P08100	RHO	Rhodopsin	GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW
P08100	RHO	Rhodopsin	GO:0009585; P:red, far-red light phototransduction; IEA:Ensembl
P08100	RHO	Rhodopsin	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
P08100	RHO	Rhodopsin	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
P08100	RHO	Rhodopsin	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P08100	RHO	Rhodopsin	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
P08100	RHO	Rhodopsin	GO:0007601; P:visual perception; IEA:UniProtKB-KW
P04001	OPN1MW	Medium-wave-sensitive opsin 1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P04001	OPN1MW	Medium-wave-sensitive opsin 1	GO:0009881; F:photoreceptor activity; TAS:ProtInc
P04001	OPN1MW	Medium-wave-sensitive opsin 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P04001	OPN1MW	Medium-wave-sensitive opsin 1	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P04001	OPN1MW	Medium-wave-sensitive opsin 1	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProt
P04001	OPN1MW	Medium-wave-sensitive opsin 1	GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW
P04001	OPN1MW	Medium-wave-sensitive opsin 1	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P04001	OPN1MW	Medium-wave-sensitive opsin 1	GO:0007601; P:visual perception; TAS:ProtInc
P04000	OPN1LW	Long-wave-sensitive opsin 1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P04000	OPN1LW	Long-wave-sensitive opsin 1	GO:0009881; F:photoreceptor activity; TAS:ProtInc
P04000	OPN1LW	Long-wave-sensitive opsin 1	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P04000	OPN1LW	Long-wave-sensitive opsin 1	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProt
P04000	OPN1LW	Long-wave-sensitive opsin 1	GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW
P04000	OPN1LW	Long-wave-sensitive opsin 1	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P04000	OPN1LW	Long-wave-sensitive opsin 1	GO:0007165; P:signal transduction; TAS:ProtInc
P04000	OPN1LW	Long-wave-sensitive opsin 1	GO:0007601; P:visual perception; TAS:ProtInc
O14718	RRH	Visual pigment-like receptor peropsin	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O14718	RRH	Visual pigment-like receptor peropsin	GO:0009881; F:photoreceptor activity; IEA:UniProtKB-KW
O14718	RRH	Visual pigment-like receptor peropsin	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
O14718	RRH	Visual pigment-like receptor peropsin	GO:0007602; P:phototransduction; IEA:UniProtKB-KW
O14718	RRH	Visual pigment-like receptor peropsin	GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW
O14718	RRH	Visual pigment-like receptor peropsin	GO:0007601; P:visual perception; TAS:ProtInc
Q96CV9	OPTN	Optineurin	GO:0005515; F:protein binding; IPI:UniProtKB
Q96CV9	OPTN	Optineurin	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q96CV9	OPTN	Optineurin	GO:0008219; P:cell death; TAS:ProtInc
Q96CV9	OPTN	Optineurin	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q96CV9	OPTN	Optineurin	GO:0007030; P:Golgi organization; IMP:UniProtKB
Q96CV9	OPTN	Optineurin	GO:0090161; P:Golgi ribbon formation; IDA:UniProtKB
Q96CV9	OPTN	Optineurin	GO:0043001; P:Golgi to plasma membrane protein transport; IMP:UniProtKB
Q96CV9	OPTN	Optineurin	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q96CV9	OPTN	Optineurin	GO:0000042; P:protein targeting to Golgi; IMP:UniProtKB
Q96CV9	OPTN	Optineurin	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UBM4	OPTC	Opticin	GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc
Q9UBM4	OPTC	Opticin	GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl
Q9P1Q5	OR1A1	Olfactory receptor 1A1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9P1Q5	OR1A1	Olfactory receptor 1A1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9Y585	OR1A2	Olfactory receptor 1A2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9Y585	OR1A2	Olfactory receptor 1A2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9Y585	OR1A2	Olfactory receptor 1A2	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProt
Q8NGR6	OR1B1	Olfactory receptor 1B1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGR6	OR1B1	Olfactory receptor 1B1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q15619	OR1C1	Olfactory receptor 1C1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q15619	OR1C1	Olfactory receptor 1C1	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q15619	OR1C1	Olfactory receptor 1C1	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q15619	OR1C1	Olfactory receptor 1C1	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
P34982	OR1D2	Olfactory receptor 1D2	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P34982	OR1D2	Olfactory receptor 1D2	GO:0004984; F:olfactory receptor activity; IDA:UniProtKB
P34982	OR1D2	Olfactory receptor 1D2	GO:0006928; P:cellular component movement; TAS:ProtInc
P34982	OR1D2	Olfactory receptor 1D2	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
P34982	OR1D2	Olfactory receptor 1D2	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; IDA:GOC
P34982	OR1D2	Olfactory receptor 1D2	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:UniProtKB
P34982	OR1D2	Olfactory receptor 1D2	GO:0000060; P:protein import into nucleus, translocation; IMP:UniProtKB
P34982	OR1D2	Olfactory receptor 1D2	GO:0007608; P:sensory perception of smell; TAS:ProtInc
P34982	OR1D2	Olfactory receptor 1D2	GO:0007338; P:single fertilization; IEA:UniProtKB-KW
P47884	OR1D4	Olfactory receptor 1D4	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P47884	OR1D4	Olfactory receptor 1D4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P47884	OR1D4	Olfactory receptor 1D4	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P47884	OR1D4	Olfactory receptor 1D4	GO:0007606; P:sensory perception of chemical stimulus; TAS:ProtInc
P58170	OR1D5	Olfactory receptor 1D5	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P58170	OR1D5	Olfactory receptor 1D5	GO:0004984; F:olfactory receptor activity; TAS:ProtInc
P58170	OR1D5	Olfactory receptor 1D5	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; TAS:GOC
P58170	OR1D5	Olfactory receptor 1D5	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P58170	OR1D5	Olfactory receptor 1D5	GO:0007608; P:sensory perception of smell; TAS:ProtInc
P30953	OR1E1	Olfactory receptor 1E1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P30953	OR1E1	Olfactory receptor 1E1	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
P30953	OR1E1	Olfactory receptor 1E1	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
P30953	OR1E1	Olfactory receptor 1E1	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
P47887	OR1E2	Olfactory receptor 1E2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P47887	OR1E2	Olfactory receptor 1E2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P47887	OR1E2	Olfactory receptor 1E2	GO:0004872; F:receptor activity; TAS:ProtInc
P47887	OR1E2	Olfactory receptor 1E2	GO:0007606; P:sensory perception of chemical stimulus; TAS:ProtInc
P47887	OR1E2	Olfactory receptor 1E2	GO:0007165; P:signal transduction; TAS:ProtInc
Q8WZA6	OR1E3	Olfactory receptor 1E3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8WZA6	OR1E3	Olfactory receptor 1E3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
O43749	OR1F1	Olfactory receptor 1F1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O43749	OR1F1	Olfactory receptor 1F1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
O43749	OR1F1	Olfactory receptor 1F1	GO:0007165; P:signal transduction; NAS:ProtInc
Q96R84	OR1F2P	Putative olfactory receptor 1F2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96R84	OR1F2P	Putative olfactory receptor 1F2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NHA8	OR1F12	Olfactory receptor 1F12	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NHA8	OR1F12	Olfactory receptor 1F12	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P47890	OR1G1	Olfactory receptor 1G1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P47890	OR1G1	Olfactory receptor 1G1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P47890	OR1G1	Olfactory receptor 1G1	GO:0007165; P:signal transduction; NAS:ProtInc
O60431	OR1I1	Olfactory receptor 1I1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O60431	OR1I1	Olfactory receptor 1I1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGS3	OR1J1	Olfactory receptor 1J1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGS3	OR1J1	Olfactory receptor 1J1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGS2	OR1J2	Olfactory receptor 1J2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGS2	OR1J2	Olfactory receptor 1J2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGS1	OR1J4	Olfactory receptor 1J4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGS1	OR1J4	Olfactory receptor 1J4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGR3	OR1K1	Olfactory receptor 1K1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGR3	OR1K1	Olfactory receptor 1K1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH94	OR1L1	Olfactory receptor 1L1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH94	OR1L1	Olfactory receptor 1L1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH93	OR1L3	Olfactory receptor 1L3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH93	OR1L3	Olfactory receptor 1L3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGR2	OR1L6	Olfactory receptor 1L6	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGR2	OR1L6	Olfactory receptor 1L6	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGR8	OR1L8	Olfactory receptor 1L8	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGR8	OR1L8	Olfactory receptor 1L8	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGR5	OR1L4	Olfactory receptor 1L4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGR5	OR1L4	Olfactory receptor 1L4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGA1	OR1M1	Olfactory receptor 1M1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGA1	OR1M1	Olfactory receptor 1M1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGS0	OR1N1	Olfactory receptor 1N1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGS0	OR1N1	Olfactory receptor 1N1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH06	OR1P1	Olfactory receptor 1P1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH06	OR1P1	Olfactory receptor 1P1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGR9	OR1N2	Olfactory receptor 1N2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGR9	OR1N2	Olfactory receptor 1N2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q15612	OR1Q1	Olfactory receptor 1Q1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q15612	OR1Q1	Olfactory receptor 1Q1	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q15612	OR1Q1	Olfactory receptor 1Q1	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q15612	OR1Q1	Olfactory receptor 1Q1	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q8NH92	OR1S1	Olfactory receptor 1S1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH92	OR1S1	Olfactory receptor 1S1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGQ3	OR1S2	Olfactory receptor 1S2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGQ3	OR1S2	Olfactory receptor 1S2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
O95047	OR2A4	Olfactory receptor 2A4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O95047	OR2A4	Olfactory receptor 2A4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
O95047	OR2A4	Olfactory receptor 2A4	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProt
O95047	OR2A4	Olfactory receptor 2A4	GO:0032956; P:regulation of actin cytoskeleton organization; IMP:UniProt
Q96R45	OR2A7	Olfactory receptor 2A7	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96R45	OR2A7	Olfactory receptor 2A7	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q96R48	OR2A5	Olfactory receptor 2A5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96R48	OR2A5	Olfactory receptor 2A5	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q6IF42	OR2A2	Olfactory receptor 2A2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q6IF42	OR2A2	Olfactory receptor 2A2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9GZK3	OR2B2	Olfactory receptor 2B2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9GZK3	OR2B2	Olfactory receptor 2B2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGT9	OR2A1	Olfactory receptor 2A1/2A42	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGT9	OR2A1	Olfactory receptor 2A1/2A42	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P59922	OR2B8P	Putative olfactory receptor 2B8	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P59922	OR2B8P	Putative olfactory receptor 2B8	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P58173	OR2B6	Olfactory receptor 2B6	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P58173	OR2B6	Olfactory receptor 2B6	GO:0004984; F:olfactory receptor activity; IEA:InterPro
O76000	OR2B3	Putative olfactory receptor 2B3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O76000	OR2B3	Putative olfactory receptor 2B3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
O95371	OR2C1	Olfactory receptor 2C1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O95371	OR2C1	Olfactory receptor 2C1	GO:0004984; F:olfactory receptor activity; TAS:ProtInc
O95371	OR2C1	Olfactory receptor 2C1	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; TAS:GOC
Q5JQS5	OR2B11	Olfactory receptor 2B11	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q5JQS5	OR2B11	Olfactory receptor 2B11	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9H210	OR2D2	Olfactory receptor 2D2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9H210	OR2D2	Olfactory receptor 2D2	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q9H210	OR2D2	Olfactory receptor 2D2	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q9H210	OR2D2	Olfactory receptor 2D2	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q13607	OR2F1	Olfactory receptor 2F1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q13607	OR2F1	Olfactory receptor 2F1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q13607	OR2F1	Olfactory receptor 2F1	GO:0007165; P:signal transduction; NAS:ProtInc
O95006	OR2F2	Olfactory receptor 2F2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O95006	OR2F2	Olfactory receptor 2F2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGZ5	OR2G2	Olfactory receptor 2G2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGZ5	OR2G2	Olfactory receptor 2G2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGH3	OR2D3	Olfactory receptor 2D3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGH3	OR2D3	Olfactory receptor 2D3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGZ4	OR2G3	Olfactory receptor 2G3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGZ4	OR2G3	Olfactory receptor 2G3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q5TZ20	OR2G6	Olfactory receptor 2G6	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q5TZ20	OR2G6	Olfactory receptor 2G6	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9GZK4	OR2H1	Olfactory receptor 2H1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9GZK4	OR2H1	Olfactory receptor 2H1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8N628	OR2C3	Olfactory receptor 2C3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8N628	OR2C3	Olfactory receptor 2C3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9GZK6	OR2J1	Olfactory receptor 2J1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9GZK6	OR2J1	Olfactory receptor 2J1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
O76002	OR2J2	Olfactory receptor 2J2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O76002	OR2J2	Olfactory receptor 2J2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGT1	OR2K2	Olfactory receptor 2K2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGT1	OR2K2	Olfactory receptor 2K2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGU4	OR2I1P	Putative olfactory receptor 2I1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGU4	OR2I1P	Putative olfactory receptor 2I1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH16	OR2L2	Olfactory receptor 2L2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH16	OR2L2	Olfactory receptor 2L2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
O76001	OR2J3	Olfactory receptor 2J3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O76001	OR2J3	Olfactory receptor 2J3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NG85	OR2L3	Olfactory receptor 2L3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NG85	OR2L3	Olfactory receptor 2L3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGY9	OR2L8	Olfactory receptor 2L8	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGY9	OR2L8	Olfactory receptor 2L8	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8N349	OR2L13	Olfactory receptor 2L13	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8N349	OR2L13	Olfactory receptor 2L13	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8N349	OR2L13	Olfactory receptor 2L13	GO:0005515; F:protein binding; IPI:UniProtKB
O95918	OR2H2	Olfactory receptor 2H2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O95918	OR2H2	Olfactory receptor 2H2	GO:0004984; F:olfactory receptor activity; TAS:ProtInc
O95918	OR2H2	Olfactory receptor 2H2	GO:0006952; P:defense response; TAS:ProtInc
O95918	OR2H2	Olfactory receptor 2H2	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; TAS:GOC
O95918	OR2H2	Olfactory receptor 2H2	GO:0007618; P:mating; TAS:ProtInc
Q8NG80	OR2L5	Olfactory receptor 2L5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NG80	OR2L5	Olfactory receptor 2L5	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NG83	OR2M3	Olfactory receptor 2M3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NG83	OR2M3	Olfactory receptor 2M3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A3KFT3	OR2M5	Olfactory receptor 2M5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A3KFT3	OR2M5	Olfactory receptor 2M5	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q96R27	OR2M4	Olfactory receptor 2M4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96R27	OR2M4	Olfactory receptor 2M4	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q96R27	OR2M4	Olfactory receptor 2M4	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q96R27	OR2M4	Olfactory receptor 2M4	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q9NQN1	OR2S2	Olfactory receptor 2S2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9NQN1	OR2S2	Olfactory receptor 2S2	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q9NQN1	OR2S2	Olfactory receptor 2S2	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q9NQN1	OR2S2	Olfactory receptor 2S2	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q96R28	OR2M2	Olfactory receptor 2M2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96R28	OR2M2	Olfactory receptor 2M2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
O43869	OR2T1	Olfactory receptor 2T1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O43869	OR2T1	Olfactory receptor 2T1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q6IF00	OR2T2	Olfactory receptor 2T2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q6IF00	OR2T2	Olfactory receptor 2T2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NG81	OR2M7	Olfactory receptor 2M7	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NG81	OR2M7	Olfactory receptor 2M7	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH03	OR2T3	Olfactory receptor 2T3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH03	OR2T3	Olfactory receptor 2T3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH00	OR2T4	Olfactory receptor 2T4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH00	OR2T4	Olfactory receptor 2T4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q6IEZ7	OR2T5	Olfactory receptor 2T5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q6IEZ7	OR2T5	Olfactory receptor 2T5	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P0C7T2	OR2T7	Olfactory receptor 2T7	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P0C7T2	OR2T7	Olfactory receptor 2T7	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A6NH00	OR2T8	Olfactory receptor 2T8	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NH00	OR2T8	Olfactory receptor 2T8	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NHC8	OR2T6	Olfactory receptor 2T6	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NHC8	OR2T6	Olfactory receptor 2T6	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NHB1	OR2V1	Olfactory receptor 2V1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NHB1	OR2V1	Olfactory receptor 2V1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q96R30	OR2V2	Olfactory receptor 2V2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96R30	OR2V2	Olfactory receptor 2V2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9Y3N9	OR2W1	Olfactory receptor 2W1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9Y3N9	OR2W1	Olfactory receptor 2W1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A6NFC9	OR2W5	Putative olfactory receptor 2W5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NFC9	OR2W5	Putative olfactory receptor 2W5	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NHA6	OR2W6P	Putative olfactory receptor 2W6	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NHA6	OR2W6P	Putative olfactory receptor 2W6	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q7Z3T1	OR2W3	Olfactory receptor 2W3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q7Z3T1	OR2W3	Olfactory receptor 2W3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGV0	OR2Y1	Olfactory receptor 2Y1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGV0	OR2Y1	Olfactory receptor 2Y1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NG97	OR2Z1	Olfactory receptor 2Z1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NG97	OR2Z1	Olfactory receptor 2Z1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P47881	OR3A1	Olfactory receptor 3A1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P47881	OR3A1	Olfactory receptor 3A1	GO:0004984; F:olfactory receptor activity; TAS:ProtInc
P47881	OR3A1	Olfactory receptor 3A1	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; TAS:GOC
P47881	OR3A1	Olfactory receptor 3A1	GO:0007165; P:signal transduction; NAS:ProtInc
P47893	OR3A2	Olfactory receptor 3A2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P47893	OR3A2	Olfactory receptor 3A2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P47893	OR3A2	Olfactory receptor 3A2	GO:0004872; F:receptor activity; TAS:ProtInc
P47893	OR3A2	Olfactory receptor 3A2	GO:0007606; P:sensory perception of chemical stimulus; TAS:ProtInc
P47893	OR3A2	Olfactory receptor 3A2	GO:0007165; P:signal transduction; TAS:ProtInc
P47888	OR3A3	Olfactory receptor 3A3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P47888	OR3A3	Olfactory receptor 3A3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P47888	OR3A3	Olfactory receptor 3A3	GO:0007165; P:signal transduction; NAS:ProtInc
P47883	OR3A4P	Putative olfactory receptor 3A4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P47883	OR3A4P	Putative olfactory receptor 3A4	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
P47883	OR3A4P	Putative olfactory receptor 3A4	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
P47883	OR3A4P	Putative olfactory receptor 3A4	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q8NGN8	OR4A4P	Putative olfactory receptor 4A4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGN8	OR4A4P	Putative olfactory receptor 4A4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH83	OR4A5	Olfactory receptor 4A5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH83	OR4A5	Olfactory receptor 4A5	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P0C604	OR4A8P	Putative olfactory receptor 4A8	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P0C604	OR4A8P	Putative olfactory receptor 4A8	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGF8	OR4B1	Olfactory receptor 4B1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGF8	OR4B1	Olfactory receptor 4B1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH37	OR4C3	Olfactory receptor 4C3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH37	OR4C3	Olfactory receptor 4C3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGB2	OR4C5	Olfactory receptor 4C5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGB2	OR4C5	Olfactory receptor 4C5	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH72	OR4C6	Olfactory receptor 4C6	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH72	OR4C6	Olfactory receptor 4C6	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q6IEV9	OR4C11	Olfactory receptor 4C11	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q6IEV9	OR4C11	Olfactory receptor 4C11	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q96R67	OR4C12	Olfactory receptor 4C12	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96R67	OR4C12	Olfactory receptor 4C12	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGP0	OR4C13	Olfactory receptor 4C13	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGP0	OR4C13	Olfactory receptor 4C13	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGM1	OR4C15	Olfactory receptor 4C15	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGM1	OR4C15	Olfactory receptor 4C15	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q15615	OR4D1	Olfactory receptor 4D1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q15615	OR4D1	Olfactory receptor 4D1	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q15615	OR4D1	Olfactory receptor 4D1	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q15615	OR4D1	Olfactory receptor 4D1	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
P58180	OR4D2	Olfactory receptor 4D2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P58180	OR4D2	Olfactory receptor 4D2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGL9	OR4C16	Olfactory receptor 4C16	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGL9	OR4C16	Olfactory receptor 4C16	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGN0	OR4D5	Olfactory receptor 4D5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGN0	OR4D5	Olfactory receptor 4D5	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGE8	OR4D9	Olfactory receptor 4D9	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGE8	OR4D9	Olfactory receptor 4D9	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGJ1	OR4D6	Olfactory receptor 4D6	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGJ1	OR4D6	Olfactory receptor 4D6	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGI6	OR4D10	Olfactory receptor 4D10	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGI6	OR4D10	Olfactory receptor 4D10	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGI4	OR4D11	Olfactory receptor 4D11	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGI4	OR4D11	Olfactory receptor 4D11	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P0C645	OR4E1	Olfactory receptor 4E1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P0C645	OR4E1	Olfactory receptor 4E1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q6IEY1	OR4F3	Olfactory receptor 4F3/4F16/4F29	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q6IEY1	OR4F3	Olfactory receptor 4F3/4F16/4F29	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGC2	OR4E2	Olfactory receptor 4E2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGC2	OR4E2	Olfactory receptor 4E2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q96R69	OR4F4	Olfactory receptor 4F4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96R69	OR4F4	Olfactory receptor 4F4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGB9	OR4F6	Olfactory receptor 4F6	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGB9	OR4F6	Olfactory receptor 4F6	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH21	OR4F5	Olfactory receptor 4F5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH21	OR4F5	Olfactory receptor 4F5	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGD4	OR4K1	Olfactory receptor 4K1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGD4	OR4K1	Olfactory receptor 4K1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
DR   GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
DR   GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGD2	OR4K2	Olfactory receptor 4K2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGD2	OR4K2	Olfactory receptor 4K2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q96R72	OR4K3	Olfactory receptor 4K3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96R72	OR4K3	Olfactory receptor 4K3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGD3	OR4K5	Olfactory receptor 4K5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGD3	OR4K5	Olfactory receptor 4K5	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH42	OR4K13	Olfactory receptor 4K13	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH42	OR4K13	Olfactory receptor 4K13	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGD5	OR4K14	Olfactory receptor 4K14	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGD5	OR4K14	Olfactory receptor 4K14	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH41	OR4K15	Olfactory receptor 4K15	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH41	OR4K15	Olfactory receptor 4K15	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGC6	OR4K17	Olfactory receptor 4K17	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGC6	OR4K17	Olfactory receptor 4K17	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH43	OR4L1	Olfactory receptor 4L1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH43	OR4L1	Olfactory receptor 4L1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGD0	OR4M1	Olfactory receptor 4M1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGD0	OR4M1	Olfactory receptor 4M1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGB6	OR4M2	Olfactory receptor 4M2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGB6	OR4M2	Olfactory receptor 4M2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGD1	OR4N2	Olfactory receptor 4N2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGD1	OR4N2	Olfactory receptor 4N2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8N0Y3	OR4N4	Olfactory receptor 4N4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8N0Y3	OR4N4	Olfactory receptor 4N4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8IXE1	OR4N5	Olfactory receptor 4N5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8IXE1	OR4N5	Olfactory receptor 4N5	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGL7	OR4P4	Olfactory receptor 4P4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGL7	OR4P4	Olfactory receptor 4P4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH05	OR4Q3	Olfactory receptor 4Q3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH05	OR4Q3	Olfactory receptor 4Q3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGB4	OR4S1	Olfactory receptor 4S1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGB4	OR4S1	Olfactory receptor 4S1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH73	OR4S2	Olfactory receptor 4S2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH73	OR4S2	Olfactory receptor 4S2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P0C623	OR4Q2	Olfactory receptor 4Q2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P0C623	OR4Q2	Olfactory receptor 4Q2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH49	OR4X1	Olfactory receptor 4X1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH49	OR4X1	Olfactory receptor 4X1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGF9	OR4X2	Olfactory receptor 4X2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGF9	OR4X2	Olfactory receptor 4X2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGJ0	OR5A1	Olfactory receptor 5A1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGJ0	OR5A1	Olfactory receptor 5A1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGI9	OR5A2	Olfactory receptor 5A2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGI9	OR5A2	Olfactory receptor 5A2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH48	OR5B3	Olfactory receptor 5B3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH48	OR5B3	Olfactory receptor 5B3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q96R09	OR5B2	Olfactory receptor 5B2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96R09	OR5B2	Olfactory receptor 5B2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q96R08	OR5B12	Olfactory receptor 5B12	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96R08	OR5B12	Olfactory receptor 5B12	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGR4	OR5C1	Olfactory receptor 5C1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGR4	OR5C1	Olfactory receptor 5C1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A6NL26	OR5B21	Olfactory receptor 5B21	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NL26	OR5B21	Olfactory receptor 5B21	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGF7	OR5B17	Olfactory receptor 5B17	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGF7	OR5B17	Olfactory receptor 5B17	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGL4	OR5D13	Olfactory receptor 5D13	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGL4	OR5D13	Olfactory receptor 5D13	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGL1	OR5D18	Olfactory receptor 5D18	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGL1	OR5D18	Olfactory receptor 5D18	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGL3	OR5D14	Olfactory receptor 5D14	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGL3	OR5D14	Olfactory receptor 5D14	GO:0004984; F:olfactory receptor activity; IEA:InterPro
O95221	OR5F1	Olfactory receptor 5F1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O95221	OR5F1	Olfactory receptor 5F1	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
O95221	OR5F1	Olfactory receptor 5F1	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
O95221	OR5F1	Olfactory receptor 5F1	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q8NGK9	OR5D16	Olfactory receptor 5D16	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGK9	OR5D16	Olfactory receptor 5D16	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A6NKK0	OR5H1	Olfactory receptor 5H1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NKK0	OR5H1	Olfactory receptor 5H1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P0C626	OR5G3	Olfactory receptor 5G3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P0C626	OR5G3	Olfactory receptor 5G3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGV7	OR5H2	Olfactory receptor 5H2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGV7	OR5H2	Olfactory receptor 5H2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGV6	OR5H6	Olfactory receptor 5H6	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGV6	OR5H6	Olfactory receptor 5H6	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q13606	OR5I1	Olfactory receptor 5I1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q13606	OR5I1	Olfactory receptor 5I1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q13606	OR5I1	Olfactory receptor 5I1	GO:0007165; P:signal transduction; NAS:ProtInc
Q8NH18	OR5J2	Olfactory receptor 5J2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH18	OR5J2	Olfactory receptor 5J2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NHB8	OR5K2	Olfactory receptor 5K2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NHB8	OR5K2	Olfactory receptor 5K2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A6NET4	OR5K3	Olfactory receptor 5K3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NET4	OR5K3	Olfactory receptor 5K3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NHB7	OR5K1	Olfactory receptor 5K1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NHB7	OR5K1	Olfactory receptor 5K1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGL2	OR5L1	Olfactory receptor 5L1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGL2	OR5L1	Olfactory receptor 5L1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGP8	OR5M1	Olfactory receptor 5M1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGP8	OR5M1	Olfactory receptor 5M1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A6NMS3	OR5K4	Olfactory receptor 5K4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NMS3	OR5K4	Olfactory receptor 5K4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGP4	OR5M3	Olfactory receptor 5M3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGP4	OR5M3	Olfactory receptor 5M3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGL0	OR5L2	Olfactory receptor 5L2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGL0	OR5L2	Olfactory receptor 5L2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGP6	OR5M8	Olfactory receptor 5M8	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGP6	OR5M8	Olfactory receptor 5M8	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGP3	OR5M9	Olfactory receptor 5M9	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGP3	OR5M9	Olfactory receptor 5M9	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q96RB7	OR5M11	Olfactory receptor 5M11	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96RB7	OR5M11	Olfactory receptor 5M11	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q6IEU7	OR5M10	Olfactory receptor 5M10	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q6IEU7	OR5M10	Olfactory receptor 5M10	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8WZ94	OR5P3	Olfactory receptor 5P3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8WZ94	OR5P3	Olfactory receptor 5P3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8WZ92	OR5P2	Olfactory receptor 5P2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8WZ92	OR5P2	Olfactory receptor 5P2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH85	OR5R1	Olfactory receptor 5R1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH85	OR5R1	Olfactory receptor 5R1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NG75	OR5T1	Olfactory receptor 5T1	GO:0004935; F:adrenergic receptor activity; IEA:InterPro
Q8NG75	OR5T1	Olfactory receptor 5T1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGG2	OR5T2	Olfactory receptor 5T2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGG2	OR5T2	Olfactory receptor 5T2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGG3	OR5T3	Olfactory receptor 5T3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGG3	OR5T3	Olfactory receptor 5T3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH69	OR5W2	Olfactory receptor 5W2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH69	OR5W2	Olfactory receptor 5W2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9UGF6	OR5V1	Olfactory receptor 5V1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9UGF6	OR5V1	Olfactory receptor 5V1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
O95222	OR6A2	Olfactory receptor 6A2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O95222	OR6A2	Olfactory receptor 6A2	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
O95222	OR6A2	Olfactory receptor 6A2	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
O95222	OR6A2	Olfactory receptor 6A2	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
O95222	OR6A2	Olfactory receptor 6A2	GO:0007165; P:signal transduction; NAS:UniProtKB
O95007	OR6B1	Olfactory receptor 6B1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O95007	OR6B1	Olfactory receptor 6B1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q6IFH4	OR6B2	Olfactory receptor 6B2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q6IFH4	OR6B2	Olfactory receptor 6B2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGW1	OR6B3	Olfactory receptor 6B3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGW1	OR6B3	Olfactory receptor 6B3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q96RD1	OR6C1	Olfactory receptor 6C1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96RD1	OR6C1	Olfactory receptor 6C1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9NZP2	OR6C2	Olfactory receptor 6C2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9NZP2	OR6C2	Olfactory receptor 6C2	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q9NZP2	OR6C2	Olfactory receptor 6C2	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q9NZP2	OR6C2	Olfactory receptor 6C2	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q8NGE1	OR6C4	Olfactory receptor 6C4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGE1	OR6C4	Olfactory receptor 6C4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGZ6	OR6F1	Olfactory receptor 6F1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGZ6	OR6F1	Olfactory receptor 6F1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGC5	OR6J1	Olfactory receptor 6J1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGC5	OR6J1	Olfactory receptor 6J1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
A6NF89	OR6C6	Olfactory receptor 6C6	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
A6NF89	OR6C6	Olfactory receptor 6C6	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9NZP0	OR6C3	Olfactory receptor 6C3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9NZP0	OR6C3	Olfactory receptor 6C3	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q9NZP0	OR6C3	Olfactory receptor 6C3	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q9NZP0	OR6C3	Olfactory receptor 6C3	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q8NGY3	OR6K3	Olfactory receptor 6K3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGY3	OR6K3	Olfactory receptor 6K3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGY2	OR6K2	Olfactory receptor 6K2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGY2	OR6K2	Olfactory receptor 6K2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGW6	OR6K6	Olfactory receptor 6K6	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGW6	OR6K6	Olfactory receptor 6K6	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGM8	OR6M1	Olfactory receptor 6M1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGM8	OR6M1	Olfactory receptor 6M1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGY5	OR6N1	Olfactory receptor 6N1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGY5	OR6N1	Olfactory receptor 6N1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGY6	OR6N2	Olfactory receptor 6N2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGY6	OR6N2	Olfactory receptor 6N2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGQ2	OR6Q1	Olfactory receptor 6Q1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGQ2	OR6Q1	Olfactory receptor 6Q1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH40	OR6S1	Olfactory receptor 6S1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH40	OR6S1	Olfactory receptor 6S1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGN1	OR6T1	Olfactory receptor 6T1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGN1	OR6T1	Olfactory receptor 6T1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8N148	OR6V1	Olfactory receptor 6V1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8N148	OR6V1	Olfactory receptor 6V1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH79	OR6X1	Olfactory receptor 6X1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH79	OR6X1	Olfactory receptor 6X1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGX8	OR6Y1	Olfactory receptor 6Y1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGX8	OR6Y1	Olfactory receptor 6Y1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGX9	OR6P1	Olfactory receptor 6P1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGX9	OR6P1	Olfactory receptor 6P1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGA2	OR7A2P	Putative olfactory receptor 7A2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGA2	OR7A2P	Putative olfactory receptor 7A2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q15622	OR7A5	Olfactory receptor 7A5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q15622	OR7A5	Olfactory receptor 7A5	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q15622	OR7A5	Olfactory receptor 7A5	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q15622	OR7A5	Olfactory receptor 7A5	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
O14581	OR7A17	Olfactory receptor 7A17	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O14581	OR7A17	Olfactory receptor 7A17	GO:0004984; F:olfactory receptor activity; IEA:InterPro
O76100	OR7A10	Olfactory receptor 7A10	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O76100	OR7A10	Olfactory receptor 7A10	GO:0004984; F:olfactory receptor activity; IEA:InterPro
O76099	OR7C1	Olfactory receptor 7C1	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O76099	OR7C1	Olfactory receptor 7C1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
O76099	OR7C1	Olfactory receptor 7C1	GO:0007283; P:spermatogenesis; TAS:ProtInc
O60412	OR7C2	Olfactory receptor 7C2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
O60412	OR7C2	Olfactory receptor 7C2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q96RA2	OR7D2	Olfactory receptor 7D2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96RA2	OR7D2	Olfactory receptor 7D2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q96RA2	OR7D2	Olfactory receptor 7D2	GO:0006355; P:regulation of transcription, DNA-templated; IDA:MGI
Q8NG98	OR7D4	Olfactory receptor 7D4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NG98	OR7D4	Olfactory receptor 7D4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGA0	OR7G1	Olfactory receptor 7G1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGA0	OR7G1	Olfactory receptor 7G1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NG99	OR7G2	Olfactory receptor 7G2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NG99	OR7G2	Olfactory receptor 7G2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NG95	OR7G3	Olfactory receptor 7G3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NG95	OR7G3	Olfactory receptor 7G3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGG7	OR8A1	Olfactory receptor 8A1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGG7	OR8A1	Olfactory receptor 8A1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGG7	OR8A1	Olfactory receptor 8A1	GO:0007411; P:axon guidance; IEA:Ensembl
Q96RD0	OR8B2	Olfactory receptor 8B2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96RD0	OR8B2	Olfactory receptor 8B2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q96RC9	OR8B4	Olfactory receptor 8B4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96RC9	OR8B4	Olfactory receptor 8B4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGG8	OR8B3	Olfactory receptor 8B3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGG8	OR8B3	Olfactory receptor 8B3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q15620	OR8B8	Olfactory receptor 8B8	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q15620	OR8B8	Olfactory receptor 8B8	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q15620	OR8B8	Olfactory receptor 8B8	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q15620	OR8B8	Olfactory receptor 8B8	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q8NGG6	OR8B12	Olfactory receptor 8B12	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGG6	OR8B12	Olfactory receptor 8B12	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q9GZM6	OR8D2	Olfactory receptor 8D2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9GZM6	OR8D2	Olfactory receptor 8D2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8WZ84	OR8D1	Olfactory receptor 8D1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8WZ84	OR8D1	Olfactory receptor 8D1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGM9	OR8D4	Olfactory receptor 8D4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGM9	OR8D4	Olfactory receptor 8D4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q15614	OR8G2	Olfactory receptor 8G2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q15614	OR8G2	Olfactory receptor 8G2	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q15614	OR8G2	Olfactory receptor 8G2	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q15614	OR8G2	Olfactory receptor 8G2	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q15617	OR8G1	Olfactory receptor 8G1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q15617	OR8G1	Olfactory receptor 8G1	GO:0004984; F:olfactory receptor activity; NAS:UniProtKB
Q15617	OR8G1	Olfactory receptor 8G1	GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; NAS:GOC
Q15617	OR8G1	Olfactory receptor 8G1	GO:0007608; P:sensory perception of smell; NAS:UniProtKB
Q8NG78	OR8G5	Olfactory receptor 8G5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NG78	OR8G5	Olfactory receptor 8G5	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8N162	OR8H2	Olfactory receptor 8H2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8N162	OR8H2	Olfactory receptor 8H2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGG4	OR8H1	Olfactory receptor 8H1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGG4	OR8H1	Olfactory receptor 8H1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8N146	OR8H3	Olfactory receptor 8H3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8N146	OR8H3	Olfactory receptor 8H3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8N0Y5	OR8I2	Olfactory receptor 8I2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8N0Y5	OR8I2	Olfactory receptor 8I2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGP2	OR8J1	Olfactory receptor 8J1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGP2	OR8J1	Olfactory receptor 8J1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGG1	OR8J2	Olfactory receptor 8J2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGG1	OR8J2	Olfactory receptor 8J2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGG0	OR8J3	Olfactory receptor 8J3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGG0	OR8J3	Olfactory receptor 8J3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGG5	OR8K1	Olfactory receptor 8K1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGG5	OR8K1	Olfactory receptor 8K1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH51	OR8K3	Olfactory receptor 8K3	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH51	OR8K3	Olfactory receptor 8K3	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH50	OR8K5	Olfactory receptor 8K5	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH50	OR8K5	Olfactory receptor 8K5	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH09	OR8S1	Olfactory receptor 8S1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH09	OR8S1	Olfactory receptor 8S1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH10	OR8U1	Olfactory receptor 8U1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH10	OR8U1	Olfactory receptor 8U1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P0C7N1	OR8U8	Olfactory receptor 8U8	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P0C7N1	OR8U8	Olfactory receptor 8U8	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P0C7N5	OR8U9	Olfactory receptor 8U9	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P0C7N5	OR8U9	Olfactory receptor 8U9	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGU2	OR9A4	Olfactory receptor 9A4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGU2	OR9A4	Olfactory receptor 9A4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGU1	OR9A1P	Putative olfactory receptor 9A1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGU1	OR9A1P	Putative olfactory receptor 9A1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGT5	OR9A2	Olfactory receptor 9A2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGT5	OR9A2	Olfactory receptor 9A2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NH87	OR9G1	Olfactory receptor 9G1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NH87	OR9G1	Olfactory receptor 9G1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGQ1	OR9G4	Olfactory receptor 9G4	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGQ1	OR9G4	Olfactory receptor 9G4	GO:0004984; F:olfactory receptor activity; IEA:InterPro
P0C7N8	OR9G9	Olfactory receptor 9G9	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P0C7N8	OR9G9	Olfactory receptor 9G9	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGE7	OR9K2	Olfactory receptor 9K2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGE7	OR9K2	Olfactory receptor 9K2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGQ6	OR9I1	Olfactory receptor 9I1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGQ6	OR9I1	Olfactory receptor 9I1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGQ5	OR9Q1	Olfactory receptor 9Q1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGQ5	OR9Q1	Olfactory receptor 9Q1	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q8NGE9	OR9Q2	Olfactory receptor 9Q2	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q8NGE9	OR9Q2	Olfactory receptor 9Q2	GO:0004984; F:olfactory receptor activity; IEA:InterPro
Q96SN7	ORAI2	Protein orai-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BRQ5	ORAI3	Protein orai-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q13415	ORC1	Origin recognition complex subunit 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13415	ORC1	Origin recognition complex subunit 1	GO:0003682; F:chromatin binding; IEA:InterPro
Q13415	ORC1	Origin recognition complex subunit 1	GO:0003677; F:DNA binding; TAS:ProtInc
Q13415	ORC1	Origin recognition complex subunit 1	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q13415	ORC1	Origin recognition complex subunit 1	GO:0005515; F:protein binding; IPI:IntAct
Q13415	ORC1	Origin recognition complex subunit 1	GO:0006260; P:DNA replication; TAS:Reactome
Q13415	ORC1	Origin recognition complex subunit 1	GO:0006270; P:DNA replication initiation; TAS:ProtInc
Q13415	ORC1	Origin recognition complex subunit 1	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q13415	ORC1	Origin recognition complex subunit 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q13415	ORC1	Origin recognition complex subunit 1	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; TAS:Reactome
Q13416	ORC2	Origin recognition complex subunit 2	GO:0003688; F:DNA replication origin binding; TAS:ProtInc
Q13416	ORC2	Origin recognition complex subunit 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q13416	ORC2	Origin recognition complex subunit 2	GO:0006260; P:DNA replication; TAS:Reactome
Q13416	ORC2	Origin recognition complex subunit 2	GO:0006270; P:DNA replication initiation; TAS:ProtInc
Q13416	ORC2	Origin recognition complex subunit 2	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q13416	ORC2	Origin recognition complex subunit 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q13416	ORC2	Origin recognition complex subunit 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9UBD5	ORC3	Origin recognition complex subunit 3	GO:0003688; F:DNA replication origin binding; TAS:ProtInc
Q9UBD5	ORC3	Origin recognition complex subunit 3	GO:0005515; F:protein binding; IPI:IntAct
Q9UBD5	ORC3	Origin recognition complex subunit 3	GO:0006260; P:DNA replication; TAS:Reactome
Q9UBD5	ORC3	Origin recognition complex subunit 3	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q9UBD5	ORC3	Origin recognition complex subunit 3	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9UBD5	ORC3	Origin recognition complex subunit 3	GO:0061351; P:neural precursor cell proliferation; IEA:Ensembl
O43929	ORC4	Origin recognition complex subunit 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43929	ORC4	Origin recognition complex subunit 4	GO:0003688; F:DNA replication origin binding; IMP:UniProtKB
O43929	ORC4	Origin recognition complex subunit 4	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
O43929	ORC4	Origin recognition complex subunit 4	GO:0000166; F:nucleotide binding; IDA:UniProtKB
O43929	ORC4	Origin recognition complex subunit 4	GO:0005515; F:protein binding; IPI:IntAct
O43929	ORC4	Origin recognition complex subunit 4	GO:0006260; P:DNA replication; TAS:Reactome
O43929	ORC4	Origin recognition complex subunit 4	GO:0006270; P:DNA replication initiation; IMP:UniProtKB
O43929	ORC4	Origin recognition complex subunit 4	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
O43929	ORC4	Origin recognition complex subunit 4	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O43913	ORC5	Origin recognition complex subunit 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43913	ORC5	Origin recognition complex subunit 5	GO:0003688; F:DNA replication origin binding; TAS:ProtInc
O43913	ORC5	Origin recognition complex subunit 5	GO:0000166; F:nucleotide binding; TAS:ProtInc
O43913	ORC5	Origin recognition complex subunit 5	GO:0005515; F:protein binding; IPI:IntAct
O43913	ORC5	Origin recognition complex subunit 5	GO:0006260; P:DNA replication; NAS:UniProtKB
O43913	ORC5	Origin recognition complex subunit 5	GO:0006270; P:DNA replication initiation; TAS:ProtInc
O43913	ORC5	Origin recognition complex subunit 5	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
O43913	ORC5	Origin recognition complex subunit 5	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9Y5N6	ORC6	Origin recognition complex subunit 6	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y5N6	ORC6	Origin recognition complex subunit 6	GO:0005515; F:protein binding; IPI:IntAct
Q9Y5N6	ORC6	Origin recognition complex subunit 6	GO:0006260; P:DNA replication; TAS:Reactome
Q9Y5N6	ORC6	Origin recognition complex subunit 6	GO:0006261; P:DNA-dependent DNA replication; IEA:Ensembl
Q9Y5N6	ORC6	Origin recognition complex subunit 6	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q9Y5N6	ORC6	Origin recognition complex subunit 6	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O43612	HCRT	Orexin	GO:0042755; P:eating behavior; IEA:Ensembl
O43612	HCRT	Orexin	GO:0008156; P:negative regulation of DNA replication; IEA:Ensembl
O43612	HCRT	Orexin	GO:0043267; P:negative regulation of potassium ion transport; IEA:Ensembl
O43612	HCRT	Orexin	GO:0051970; P:negative regulation of transmission of nerve impulse; IEA:Ensembl
O43612	HCRT	Orexin	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
O43612	HCRT	Orexin	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
O43612	HCRT	Orexin	GO:0051928; P:positive regulation of calcium ion transport; IEA:Ensembl
O43612	HCRT	Orexin	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
O43612	HCRT	Orexin	GO:0051971; P:positive regulation of transmission of nerve impulse; IEA:Ensembl
O43612	HCRT	Orexin	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
O43612	HCRT	Orexin	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
O43612	HCRT	Orexin	GO:0046928; P:regulation of neurotransmitter secretion; IEA:Ensembl
O43612	HCRT	Orexin	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q9P0S3	ORMDL1	ORM1-like protein 1	GO:0006672; P:ceramide metabolic process; IMP:UniProtKB
Q53FV1	ORMDL2	ORM1-like protein 2	GO:0006672; P:ceramide metabolic process; IMP:UniProtKB
Q8N138	ORMDL3	ORM1-like protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N138	ORMDL3	ORM1-like protein 3	GO:0006672; P:ceramide metabolic process; IMP:UniProtKB
Q9Y619	SLC25A15	Mitochondrial ornithine transporter 1	GO:0000064; F:L-ornithine transmembrane transporter activity; TAS:ProtInc
Q9Y619	SLC25A15	Mitochondrial ornithine transporter 1	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
Q9Y619	SLC25A15	Mitochondrial ornithine transporter 1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9Y619	SLC25A15	Mitochondrial ornithine transporter 1	GO:0000066; P:mitochondrial ornithine transport; TAS:ProtInc
Q9Y619	SLC25A15	Mitochondrial ornithine transporter 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y619	SLC25A15	Mitochondrial ornithine transporter 1	GO:0000050; P:urea cycle; TAS:Reactome
Q9BXI2	SLC25A2	Mitochondrial ornithine transporter 2	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9BXI2	SLC25A2	Mitochondrial ornithine transporter 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BXI2	SLC25A2	Mitochondrial ornithine transporter 2	GO:0006810; P:transport; IEA:UniProtKB-KW
Q9BXI2	SLC25A2	Mitochondrial ornithine transporter 2	GO:0000050; P:urea cycle; TAS:Reactome
Q9Y3B8	REXO2	Oligoribonuclease, mitochondrial	GO:0008408; F:3'-5' exonuclease activity; IDA:MGI
Q9Y3B8	REXO2	Oligoribonuclease, mitochondrial	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9Y3B8	REXO2	Oligoribonuclease, mitochondrial	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:GOC
Q9Y3B8	REXO2	Oligoribonuclease, mitochondrial	GO:0006139; P:nucleobase-containing compound metabolic process; IDA:MGI
Q9Y3B8	REXO2	Oligoribonuclease, mitochondrial	GO:0009117; P:nucleotide metabolic process; TAS:ProtInc
Q13438	OS9	Protein OS-9	GO:0001948; F:glycoprotein binding; IDA:UniProtKB
Q13438	OS9	Protein OS-9	GO:0005515; F:protein binding; IPI:UniProtKB
Q13438	OS9	Protein OS-9	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q13438	OS9	Protein OS-9	GO:0006621; P:protein retention in ER lumen; IDA:UniProtKB
Q13438	OS9	Protein OS-9	GO:0006605; P:protein targeting; IEA:Ensembl
Q13438	OS9	Protein OS-9	GO:0016567; P:protein ubiquitination; IMP:UniProtKB
Q13438	OS9	Protein OS-9	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q13438	OS9	Protein OS-9	GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB
Q9BXB5	OSBPL10	Oxysterol-binding protein-related protein 10	GO:0015485; F:cholesterol binding; IDA:BHF-UCL
Q9BXB5	OSBPL10	Oxysterol-binding protein-related protein 10	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q9BXB4	OSBPL11	Oxysterol-binding protein-related protein 11	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q9BXB4	OSBPL11	Oxysterol-binding protein-related protein 11	GO:0045444; P:fat cell differentiation; IMP:BHF-UCL
Q9BXB4	OSBPL11	Oxysterol-binding protein-related protein 11	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q9BXB4	OSBPL11	Oxysterol-binding protein-related protein 11	GO:0010890; P:positive regulation of sequestering of triglyceride; IMP:BHF-UCL
Q9BXW6	OSBPL1A	Oxysterol-binding protein-related protein 1	GO:0015485; F:cholesterol binding; IDA:BHF-UCL
Q9BXW6	OSBPL1A	Oxysterol-binding protein-related protein 1	GO:0005543; F:phospholipid binding; NAS:UniProtKB
Q9BXW6	OSBPL1A	Oxysterol-binding protein-related protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BXW6	OSBPL1A	Oxysterol-binding protein-related protein 1	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q9BXW6	OSBPL1A	Oxysterol-binding protein-related protein 1	GO:0008203; P:cholesterol metabolic process; NAS:UniProtKB
Q9BXW6	OSBPL1A	Oxysterol-binding protein-related protein 1	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q9BXW6	OSBPL1A	Oxysterol-binding protein-related protein 1	GO:0016192; P:vesicle-mediated transport; NAS:UniProtKB
Q9H1P3	OSBPL2	Oxysterol-binding protein-related protein 2	GO:0015485; F:cholesterol binding; IDA:BHF-UCL
Q9H1P3	OSBPL2	Oxysterol-binding protein-related protein 2	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q9H4L5	OSBPL3	Oxysterol-binding protein-related protein 3	GO:0015485; F:cholesterol binding; IDA:BHF-UCL
Q9H4L5	OSBPL3	Oxysterol-binding protein-related protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q9H4L5	OSBPL3	Oxysterol-binding protein-related protein 3	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q9H0X9	OSBPL5	Oxysterol-binding protein-related protein 5	GO:0015485; F:cholesterol binding; IDA:BHF-UCL
Q9H0X9	OSBPL5	Oxysterol-binding protein-related protein 5	GO:0008142; F:oxysterol binding; NAS:UniProtKB
Q9H0X9	OSBPL5	Oxysterol-binding protein-related protein 5	GO:0008203; P:cholesterol metabolic process; NAS:UniProtKB
Q9H0X9	OSBPL5	Oxysterol-binding protein-related protein 5	GO:0030301; P:cholesterol transport; NAS:UniProtKB
Q9H0X9	OSBPL5	Oxysterol-binding protein-related protein 5	GO:0006893; P:Golgi to plasma membrane transport; NAS:UniProtKB
Q9BZF3	OSBPL6	Oxysterol-binding protein-related protein 6	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q9BZF3	OSBPL6	Oxysterol-binding protein-related protein 6	GO:0005515; F:protein binding; IPI:IntAct
Q9BZF3	OSBPL6	Oxysterol-binding protein-related protein 6	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q9BZF1	OSBPL8	Oxysterol-binding protein-related protein 8	GO:0015485; F:cholesterol binding; IDA:BHF-UCL
Q9BZF1	OSBPL8	Oxysterol-binding protein-related protein 8	GO:0045444; P:fat cell differentiation; IDA:BHF-UCL
Q9BZF1	OSBPL8	Oxysterol-binding protein-related protein 8	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q9BZF1	OSBPL8	Oxysterol-binding protein-related protein 8	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
Q9BZF1	OSBPL8	Oxysterol-binding protein-related protein 8	GO:0010891; P:negative regulation of sequestering of triglyceride; IDA:BHF-UCL
Q9BZF1	OSBPL8	Oxysterol-binding protein-related protein 8	GO:0046628; P:positive regulation of insulin receptor signaling pathway; IEA:Ensembl
Q9BZF1	OSBPL8	Oxysterol-binding protein-related protein 8	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
Q9BZF1	OSBPL8	Oxysterol-binding protein-related protein 8	GO:0090204; P:protein localization to nuclear pore; IEA:Ensembl
Q96SU4	OSBPL9	Oxysterol-binding protein-related protein 9	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q96SU4	OSBPL9	Oxysterol-binding protein-related protein 9	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
P22059	OSBP	Oxysterol-binding protein 1	GO:0008142; F:oxysterol binding; TAS:ProtInc
P22059	OSBP	Oxysterol-binding protein 1	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q8WVF1	OSCP1	Protein OSCP1	GO:0006810; P:transport; IEA:UniProtKB-KW
Q9BZF2	OSBPL7	Oxysterol-binding protein-related protein 7	GO:0015485; F:cholesterol binding; IDA:BHF-UCL
Q9BZF2	OSBPL7	Oxysterol-binding protein-related protein 7	GO:0005515; F:protein binding; IPI:BHF-UCL
Q9BZF2	OSBPL7	Oxysterol-binding protein-related protein 7	GO:0071397; P:cellular response to cholesterol; IMP:BHF-UCL
Q9BZF2	OSBPL7	Oxysterol-binding protein-related protein 7	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q9BZF2	OSBPL7	Oxysterol-binding protein-related protein 7	GO:1901800; P:positive regulation of proteasomal protein catabolic process; IMP:BHF-UCL
Q969R2	OSBP2	Oxysterol-binding protein 2	GO:0015485; F:cholesterol binding; IDA:BHF-UCL
Q969R2	OSBP2	Oxysterol-binding protein 2	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q9NX31	OSER1	Oxidative stress-responsive serine-rich protein 1	GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl
Q9NPF4	OSGEP	Probable tRNA N6-adenosine threonylcarbamoyltransferase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NPF4	OSGEP	Probable tRNA N6-adenosine threonylcarbamoyltransferase	GO:0016747; F:transferase activity, transferring acyl groups other than amino-acyl groups; IEA:UniProtKB-HAMAP
Q9NPF4	OSGEP	Probable tRNA N6-adenosine threonylcarbamoyltransferase	GO:0070526; P:threonylcarbamoyladenosine biosynthetic process; IEA:UniProtKB-HAMAP
Q9UJX0	OSGIN1	Oxidative stress-induced growth inhibitor 1	GO:0008083; F:growth factor activity; IDA:UniProtKB
Q9UJX0	OSGIN1	Oxidative stress-induced growth inhibitor 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9UJX0	OSGIN1	Oxidative stress-induced growth inhibitor 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9UJX0	OSGIN1	Oxidative stress-induced growth inhibitor 1	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q9Y236	OSGIN2	Oxidative stress-induced growth inhibitor 2	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q9H4B0	OSGEPL1	Probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H4B0	OSGEPL1	Probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial	GO:0016747; F:transferase activity, transferring acyl groups other than amino-acyl groups; IEA:UniProtKB-HAMAP
Q9H4B0	OSGEPL1	Probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial	GO:0070526; P:threonylcarbamoyladenosine biosynthetic process; IEA:UniProtKB-HAMAP
Q99650	OSMR	Oncostatin-M-specific receptor subunit beta	GO:0019838; F:growth factor binding; IPI:BHF-UCL
Q99650	OSMR	Oncostatin-M-specific receptor subunit beta	GO:0004924; F:oncostatin-M receptor activity; TAS:ProtInc
Q99650	OSMR	Oncostatin-M-specific receptor subunit beta	GO:0008283; P:cell proliferation; TAS:ProtInc
Q99650	OSMR	Oncostatin-M-specific receptor subunit beta	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q99650	OSMR	Oncostatin-M-specific receptor subunit beta	GO:0038165; P:oncostatin-M-mediated signaling pathway; IDA:GOC
Q99650	OSMR	Oncostatin-M-specific receptor subunit beta	GO:0002675; P:positive regulation of acute inflammatory response; IC:BHF-UCL
Q99650	OSMR	Oncostatin-M-specific receptor subunit beta	GO:0008284; P:positive regulation of cell proliferation; IGI:BHF-UCL
Q99650	OSMR	Oncostatin-M-specific receptor subunit beta	GO:0034097; P:response to cytokine; IDA:BHF-UCL
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0046872; F:metal ion binding; IEA:InterPro
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0060349; P:bone morphogenesis; ISS:UniProtKB
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0030154; P:cell differentiation; ISS:BHF-UCL
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0002062; P:chondrocyte differentiation; ISS:BHF-UCL
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0009790; P:embryo development; ISS:UniProtKB
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0042733; P:embryonic digit morphogenesis; ISS:BHF-UCL
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0035115; P:embryonic forelimb morphogenesis; ISS:BHF-UCL
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0035116; P:embryonic hindlimb morphogenesis; ISS:BHF-UCL
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0072498; P:embryonic skeletal joint development; ISS:BHF-UCL
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0060272; P:embryonic skeletal joint morphogenesis; ISS:BHF-UCL
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0036023; P:embryonic skeletal limb joint morphogenesis; ISS:BHF-UCL
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0048704; P:embryonic skeletal system morphogenesis; ISS:UniProtKB
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0061029; P:eyelid development in camera-type eye; ISS:UniProtKB
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0060322; P:head development; ISS:BHF-UCL
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0001823; P:mesonephros development; ISS:UniProtKB
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0001656; P:metanephros development; ISS:UniProtKB
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0042474; P:middle ear morphogenesis; ISS:UniProtKB
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0042476; P:odontogenesis; ISS:UniProtKB
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0033687; P:osteoblast proliferation; ISS:UniProtKB
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0060021; P:palate development; ISS:UniProtKB
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0030501; P:positive regulation of bone mineralization; ISS:BHF-UCL
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0050679; P:positive regulation of epithelial cell proliferation; ISS:UniProtKB
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:2000543; P:positive regulation of gastrulation; IEA:Ensembl
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q8N2R0	OSR2	Protein odd-skipped-related 2	GO:0048793; P:pronephros development; IEA:Ensembl
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0030154; P:cell differentiation; ISS:BHF-UCL
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0072111; P:cell proliferation involved in kidney development; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0002062; P:chondrocyte differentiation; ISS:BHF-UCL
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0042733; P:embryonic digit morphogenesis; ISS:BHF-UCL
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0035115; P:embryonic forelimb morphogenesis; ISS:BHF-UCL
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0035116; P:embryonic hindlimb morphogenesis; ISS:BHF-UCL
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0072498; P:embryonic skeletal joint development; ISS:BHF-UCL
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0060272; P:embryonic skeletal joint morphogenesis; ISS:BHF-UCL
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0036023; P:embryonic skeletal limb joint morphogenesis; ISS:BHF-UCL
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0008406; P:gonad development; IEA:Ensembl
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0007507; P:heart development; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0048389; P:intermediate mesoderm development; IEA:Ensembl
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0072143; P:mesangial cell development; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0072180; P:mesonephric duct morphogenesis; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0001823; P:mesonephros development; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0090094; P:metanephric cap mesenchymal cell proliferation involved in metanephros development; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0072207; P:metanephric epithelium development; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0072239; P:metanephric glomerulus vasculature development; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0072259; P:metanephric interstitial cell development; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0072162; P:metanephric mesenchymal cell differentiation; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0072075; P:metanephric mesenchyme development; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0072133; P:metanephric mesenchyme morphogenesis; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0072234; P:metanephric nephron tubule development; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0072208; P:metanephric smooth muscle tissue development; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0042474; P:middle ear morphogenesis; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0030857; P:negative regulation of epithelial cell differentiation; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0072183; P:negative regulation of nephron tubule epithelial cell differentiation; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0042476; P:odontogenesis; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0060021; P:palate development; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0072268; P:pattern specification involved in metanephros development; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0030501; P:positive regulation of bone mineralization; ISS:BHF-UCL
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0050679; P:positive regulation of epithelial cell proliferation; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:2000543; P:positive regulation of gastrulation; IMP:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0072166; P:posterior mesonephric tubule development; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0048793; P:pronephros development; IMP:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0072184; P:renal vesicle progenitor cell differentiation; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0072168; P:specification of anterior mesonephric tubule identity; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0072169; P:specification of posterior mesonephric tubule identity; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0048863; P:stem cell differentiation; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0072190; P:ureter urothelium development; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0001657; P:ureteric bud development; ISS:UniProtKB
Q8TAX0	OSR1	Protein odd-skipped-related 1	GO:0001655; P:urogenital system development; ISS:UniProtKB
P39656	DDOST	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit	GO:0004579; F:dolichyl-diphosphooligosaccharide-protein glycotransferase activity; IEA:InterPro
P39656	DDOST	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit	GO:0005515; F:protein binding; IPI:IntAct
P39656	DDOST	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P39656	DDOST	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit	GO:0010467; P:gene expression; TAS:Reactome
P39656	DDOST	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit	GO:0045087; P:innate immune response; TAS:Reactome
P39656	DDOST	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit	GO:0043687; P:post-translational protein modification; TAS:Reactome
P39656	DDOST	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit	GO:0006486; P:protein glycosylation; ISS:UniProtKB
P39656	DDOST	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit	GO:0006487; P:protein N-linked glycosylation; IDA:UniProtKB
P39656	DDOST	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit	GO:0018279; P:protein N-linked glycosylation via asparagine; IC:HGNC
P39656	DDOST	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit	GO:0034097; P:response to cytokine; IDA:UniProtKB
P39656	DDOST	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P39656	DDOST	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit	GO:0042110; P:T cell activation; IDA:UniProtKB
P39656	DDOST	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit	GO:0006412; P:translation; TAS:Reactome
Q86UW1	SLC51A	Organic solute transporter subunit alpha	GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB
Q86UW1	SLC51A	Organic solute transporter subunit alpha	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q86UW1	SLC51A	Organic solute transporter subunit alpha	GO:0005215; F:transporter activity; IDA:UniProtKB
Q86UW1	SLC51A	Organic solute transporter subunit alpha	GO:0015721; P:bile acid and bile salt transport; ISS:UniProtKB
Q86UW1	SLC51A	Organic solute transporter subunit alpha	GO:0006810; P:transport; IEP:UniProtKB
Q86UW2	SLC51B	Organic solute transporter subunit beta	GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB
Q86UW2	SLC51B	Organic solute transporter subunit beta	GO:0005215; F:transporter activity; IEA:Ensembl
Q86UW2	SLC51B	Organic solute transporter subunit beta	GO:0015721; P:bile acid and bile salt transport; ISS:UniProtKB
Q86UW2	SLC51B	Organic solute transporter subunit beta	GO:0070863; P:positive regulation of protein exit from endoplasmic reticulum; ISS:UniProtKB
Q86UW2	SLC51B	Organic solute transporter subunit beta	GO:0060050; P:positive regulation of protein glycosylation; ISS:UniProtKB
Q86UW2	SLC51B	Organic solute transporter subunit beta	GO:0090314; P:positive regulation of protein targeting to membrane; ISS:UniProtKB
Q86UW2	SLC51B	Organic solute transporter subunit beta	GO:0031647; P:regulation of protein stability; ISS:UniProtKB
P02818	BGLAP	Osteocalcin	GO:0005509; F:calcium ion binding; IEA:InterPro
P02818	BGLAP	Osteocalcin	GO:0046848; F:hydroxyapatite binding; NAS:UniProtKB
P02818	BGLAP	Osteocalcin	GO:0008147; F:structural constituent of bone; NAS:UniProtKB
P02818	BGLAP	Osteocalcin	GO:0005198; F:structural molecule activity; NAS:ProtInc
P02818	BGLAP	Osteocalcin	GO:0060348; P:bone development; IEA:Ensembl
P02818	BGLAP	Osteocalcin	GO:0030282; P:bone mineralization; NAS:UniProtKB
P02818	BGLAP	Osteocalcin	GO:0007155; P:cell adhesion; NAS:UniProtKB
P02818	BGLAP	Osteocalcin	GO:0007569; P:cell aging; IEA:Ensembl
P02818	BGLAP	Osteocalcin	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P02818	BGLAP	Osteocalcin	GO:0071305; P:cellular response to vitamin D; IEA:Ensembl
P02818	BGLAP	Osteocalcin	GO:0042476; P:odontogenesis; NAS:UniProtKB
P02818	BGLAP	Osteocalcin	GO:0002076; P:osteoblast development; IEA:Ensembl
P02818	BGLAP	Osteocalcin	GO:0001649; P:osteoblast differentiation; IEP:BHF-UCL
P02818	BGLAP	Osteocalcin	GO:0030500; P:regulation of bone mineralization; IEA:InterPro
P02818	BGLAP	Osteocalcin	GO:0045124; P:regulation of bone resorption; NAS:UniProtKB
P02818	BGLAP	Osteocalcin	GO:0045670; P:regulation of osteoclast differentiation; NAS:UniProtKB
P02818	BGLAP	Osteocalcin	GO:0014823; P:response to activity; IEA:Ensembl
P02818	BGLAP	Osteocalcin	GO:0042493; P:response to drug; IEA:Ensembl
P02818	BGLAP	Osteocalcin	GO:0043627; P:response to estrogen; IEA:Ensembl
P02818	BGLAP	Osteocalcin	GO:0045471; P:response to ethanol; IEA:Ensembl
P02818	BGLAP	Osteocalcin	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P02818	BGLAP	Osteocalcin	GO:0009629; P:response to gravity; IEA:Ensembl
P02818	BGLAP	Osteocalcin	GO:0033594; P:response to hydroxyisoflavone; IEA:Ensembl
P02818	BGLAP	Osteocalcin	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P02818	BGLAP	Osteocalcin	GO:0033574; P:response to testosterone; IEA:Ensembl
P02818	BGLAP	Osteocalcin	GO:0033280; P:response to vitamin D; IEP:BHF-UCL
P02818	BGLAP	Osteocalcin	GO:0032571; P:response to vitamin K; IEA:Ensembl
P02818	BGLAP	Osteocalcin	GO:0010043; P:response to zinc ion; IEA:Ensembl
P02818	BGLAP	Osteocalcin	GO:0001501; P:skeletal system development; TAS:ProtInc
Q9NRP0	OSTC	Oligosaccharyltransferase complex subunit OSTC	GO:0018279; P:protein N-linked glycosylation via asparagine; IC:HGNC
Q92882	OSTF1	Osteoclast-stimulating factor 1	GO:0005515; F:protein binding; IPI:IntAct
Q92882	OSTF1	Osteoclast-stimulating factor 1	GO:0001503; P:ossification; TAS:ProtInc
Q92882	OSTF1	Osteoclast-stimulating factor 1	GO:0007165; P:signal transduction; TAS:ProtInc
P61366	OSTN	Osteocrin	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P61366	OSTN	Osteocrin	GO:0007166; P:cell surface receptor signaling pathway; IEA:Ensembl
P61366	OSTN	Osteocrin	GO:0003416; P:endochondral bone growth; IEA:Ensembl
P61366	OSTN	Osteocrin	GO:0046325; P:negative regulation of glucose import; IEA:Ensembl
P61366	OSTN	Osteocrin	GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl
P61366	OSTN	Osteocrin	GO:0001503; P:ossification; IEA:UniProtKB-KW
P61366	OSTN	Osteocrin	GO:0030828; P:positive regulation of cGMP biosynthetic process; IEA:Ensembl
Q86WC4	OSTM1	Osteopetrosis-associated transmembrane protein 1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q86WC4	OSTM1	Osteopetrosis-associated transmembrane protein 1	GO:0030316; P:osteoclast differentiation; IEA:Ensembl
Q86WC4	OSTM1	Osteopetrosis-associated transmembrane protein 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P10451	SPP1	Osteopontin	GO:0050840; F:extracellular matrix binding; IEA:Ensembl
P10451	SPP1	Osteopontin	GO:0005515; F:protein binding; IPI:IntAct
P10451	SPP1	Osteopontin	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
P10451	SPP1	Osteopontin	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P10451	SPP1	Osteopontin	GO:0046697; P:decidualization; TAS:BHF-UCL
P10451	SPP1	Osteopontin	GO:0007566; P:embryo implantation; TAS:BHF-UCL
P10451	SPP1	Osteopontin	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P10451	SPP1	Osteopontin	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P10451	SPP1	Osteopontin	GO:0006954; P:inflammatory response; IEA:Ensembl
P10451	SPP1	Osteopontin	GO:0048685; P:negative regulation of collateral sprouting of intact axon in response to injury; IEA:Ensembl
P10451	SPP1	Osteopontin	GO:0030593; P:neutrophil chemotaxis; IEA:Ensembl
P10451	SPP1	Osteopontin	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
P10451	SPP1	Osteopontin	GO:0045780; P:positive regulation of bone resorption; IEA:Ensembl
P10451	SPP1	Osteopontin	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
P10451	SPP1	Osteopontin	GO:0048545; P:response to steroid hormone; IEA:Ensembl
P10451	SPP1	Osteopontin	GO:0033280; P:response to vitamin D; IDA:BHF-UCL
P00480	OTC	Ornithine carbamoyltransferase, mitochondrial	GO:0016597; F:amino acid binding; IEA:Ensembl
P00480	OTC	Ornithine carbamoyltransferase, mitochondrial	GO:0004585; F:ornithine carbamoyltransferase activity; IDA:BHF-UCL
P00480	OTC	Ornithine carbamoyltransferase, mitochondrial	GO:0042301; F:phosphate ion binding; IEA:Ensembl
P00480	OTC	Ornithine carbamoyltransferase, mitochondrial	GO:0005543; F:phospholipid binding; IEA:Ensembl
P00480	OTC	Ornithine carbamoyltransferase, mitochondrial	GO:0097272; P:ammonia homeostasis; IMP:BHF-UCL
P00480	OTC	Ornithine carbamoyltransferase, mitochondrial	GO:0006526; P:arginine biosynthetic process; IEA:UniProtKB-KW
P00480	OTC	Ornithine carbamoyltransferase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P00480	OTC	Ornithine carbamoyltransferase, mitochondrial	GO:0019240; P:citrulline biosynthetic process; IDA:BHF-UCL
P00480	OTC	Ornithine carbamoyltransferase, mitochondrial	GO:0001889; P:liver development; IEA:Ensembl
P00480	OTC	Ornithine carbamoyltransferase, mitochondrial	GO:0007494; P:midgut development; IEA:Ensembl
P00480	OTC	Ornithine carbamoyltransferase, mitochondrial	GO:0006593; P:ornithine catabolic process; IDA:BHF-UCL
P00480	OTC	Ornithine carbamoyltransferase, mitochondrial	GO:0070207; P:protein homotrimerization; IEA:Ensembl
P00480	OTC	Ornithine carbamoyltransferase, mitochondrial	GO:0070781; P:response to biotin; IEA:Ensembl
P00480	OTC	Ornithine carbamoyltransferase, mitochondrial	GO:0042493; P:response to drug; IEA:Ensembl
P00480	OTC	Ornithine carbamoyltransferase, mitochondrial	GO:0032868; P:response to insulin; IEA:Ensembl
P00480	OTC	Ornithine carbamoyltransferase, mitochondrial	GO:0010043; P:response to zinc ion; IEA:Ensembl
P00480	OTC	Ornithine carbamoyltransferase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P00480	OTC	Ornithine carbamoyltransferase, mitochondrial	GO:0000050; P:urea cycle; IDA:BHF-UCL
Q7RTW8	OTOA	Otoancorin	GO:0007160; P:cell-matrix adhesion; IEA:Ensembl
Q7RTW8	OTOA	Otoancorin	GO:0007605; P:sensory perception of sound; IEA:UniProtKB-KW
Q7RTW8	OTOA	Otoancorin	GO:0019226; P:transmission of nerve impulse; IEA:Ensembl
Q9HC10	OTOF	Otoferlin	GO:0005509; F:calcium ion binding; ISS:UniProtKB
Q9HC10	OTOF	Otoferlin	GO:0061025; P:membrane fusion; TAS:ProtInc
Q9HC10	OTOF	Otoferlin	GO:0007605; P:sensory perception of sound; TAS:ProtInc
Q9HC10	OTOF	Otoferlin	GO:0016079; P:synaptic vesicle exocytosis; ISS:UniProtKB
Q3ZCN5	OTOGL	Otogelin-like protein	GO:0046556; F:alpha-L-arabinofuranosidase activity; IEA:InterPro
Q3ZCN5	OTOGL	Otogelin-like protein	GO:0046373; P:L-arabinose metabolic process; IEA:InterPro
Q6ZRI0	OTOG	Otogelin	GO:0046556; F:alpha-L-arabinofuranosidase activity; IEA:InterPro
Q6ZRI0	OTOG	Otogelin	GO:0005198; F:structural molecule activity; IEA:Ensembl
Q6ZRI0	OTOG	Otogelin	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
Q6ZRI0	OTOG	Otogelin	GO:0046373; P:L-arabinose metabolic process; IEA:InterPro
Q6ZRI0	OTOG	Otogelin	GO:0007605; P:sensory perception of sound; IEA:Ensembl
Q7RTS5	OTOP3	Otopetrin-3	GO:0046872; F:metal ion binding; IEA:InterPro
Q9NRC9	OTOR	Otoraplin	GO:0001502; P:cartilage condensation; IEA:Ensembl
Q9NRC9	OTOR	Otoraplin	GO:0007605; P:sensory perception of sound; TAS:ProtInc
Q7RTM1	OTOP1	Otopetrin-1	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
Q7RTM1	OTOP1	Otopetrin-1	GO:0009590; P:detection of gravity; IEA:Ensembl
Q7RTM1	OTOP1	Otopetrin-1	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q8NHW6	OTOS	Otospiralin	GO:0007605; P:sensory perception of sound; IEA:Ensembl
Q5XKR4	OTP	Homeobox protein orthopedia	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q5XKR4	OTP	Homeobox protein orthopedia	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
Q5XKR4	OTP	Homeobox protein orthopedia	GO:0021879; P:forebrain neuron differentiation; IEA:Ensembl
Q5XKR4	OTP	Homeobox protein orthopedia	GO:0021979; P:hypothalamus cell differentiation; IEA:Ensembl
Q5XKR4	OTP	Homeobox protein orthopedia	GO:0021985; P:neurohypophysis development; IEA:Ensembl
Q5XKR4	OTP	Homeobox protein orthopedia	GO:0002052; P:positive regulation of neuroblast proliferation; IEA:Ensembl
Q5XKR4	OTP	Homeobox protein orthopedia	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5VVQ6	YOD1	Ubiquitin thioesterase OTU1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5VVQ6	YOD1	Ubiquitin thioesterase OTU1	GO:0005515; F:protein binding; IPI:UniProtKB
Q5VVQ6	YOD1	Ubiquitin thioesterase OTU1	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q5VVQ6	YOD1	Ubiquitin thioesterase OTU1	GO:0006520; P:cellular amino acid metabolic process; ISS:UniProtKB
Q5VVQ6	YOD1	Ubiquitin thioesterase OTU1	GO:0030968; P:endoplasmic reticulum unfolded protein response; IMP:UniProtKB
Q5VVQ6	YOD1	Ubiquitin thioesterase OTU1	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q5VVQ6	YOD1	Ubiquitin thioesterase OTU1	GO:0035871; P:protein K11-linked deubiquitination; IDA:UniProtKB
Q5VVQ6	YOD1	Ubiquitin thioesterase OTU1	GO:1990167; P:protein K27-linked deubiquitination; IDA:UniProtKB
Q5VVQ6	YOD1	Ubiquitin thioesterase OTU1	GO:0035523; P:protein K29-linked deubiquitination; IDA:UniProtKB
Q5VVQ6	YOD1	Ubiquitin thioesterase OTU1	GO:1990168; P:protein K33-linked deubiquitination; IDA:UniProtKB
Q5VVQ6	YOD1	Ubiquitin thioesterase OTU1	GO:0071108; P:protein K48-linked deubiquitination; IDA:UniProtKB
Q5VVQ6	YOD1	Ubiquitin thioesterase OTU1	GO:0070536; P:protein K63-linked deubiquitination; IDA:UniProtKB
Q7L8S5	OTUD6A	OTU domain-containing protein 6A	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q7L8S5	OTUD6A	OTU domain-containing protein 6A	GO:0035871; P:protein K11-linked deubiquitination; IDA:UniProtKB
Q7L8S5	OTUD6A	OTU domain-containing protein 6A	GO:1990167; P:protein K27-linked deubiquitination; IDA:UniProtKB
Q7L8S5	OTUD6A	OTU domain-containing protein 6A	GO:0035523; P:protein K29-linked deubiquitination; IDA:UniProtKB
Q7L8S5	OTUD6A	OTU domain-containing protein 6A	GO:1990168; P:protein K33-linked deubiquitination; IDA:UniProtKB
Q8N6M0	OTUD6B	OTU domain-containing protein 6B	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
Q8TE49	OTUD7A	OTU domain-containing protein 7A	GO:0003677; F:DNA binding; IEA:InterPro
Q8TE49	OTUD7A	OTU domain-containing protein 7A	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q8TE49	OTUD7A	OTU domain-containing protein 7A	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TE49	OTUD7A	OTU domain-containing protein 7A	GO:0035871; P:protein K11-linked deubiquitination; IDA:UniProtKB
Q6GQQ9	OTUD7B	OTU domain-containing protein 7B	GO:0008234; F:cysteine-type peptidase activity; ISS:UniProtKB
Q6GQQ9	OTUD7B	OTU domain-containing protein 7B	GO:0003677; F:DNA binding; IEA:InterPro
Q6GQQ9	OTUD7B	OTU domain-containing protein 7B	GO:0005515; F:protein binding; IPI:IntAct
Q6GQQ9	OTUD7B	OTU domain-containing protein 7B	GO:0004221; F:ubiquitin thiolesterase activity; ISS:UniProtKB
Q6GQQ9	OTUD7B	OTU domain-containing protein 7B	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q6GQQ9	OTUD7B	OTU domain-containing protein 7B	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6GQQ9	OTUD7B	OTU domain-containing protein 7B	GO:0002385; P:mucosal immune response; ISS:UniProtKB
Q6GQQ9	OTUD7B	OTU domain-containing protein 7B	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:HGNC
Q6GQQ9	OTUD7B	OTU domain-containing protein 7B	GO:0035871; P:protein K11-linked deubiquitination; IDA:UniProtKB
Q6GQQ9	OTUD7B	OTU domain-containing protein 7B	GO:0071108; P:protein K48-linked deubiquitination; ISS:UniProtKB
Q6GQQ9	OTUD7B	OTU domain-containing protein 7B	GO:0070536; P:protein K63-linked deubiquitination; IDA:UniProtKB
Q96FW1	OTUB1	Ubiquitin thioesterase OTUB1	GO:0019784; F:NEDD8-specific protease activity; IDA:UniProtKB
Q96FW1	OTUB1	Ubiquitin thioesterase OTUB1	GO:0008242; F:omega peptidase activity; IEA:InterPro
Q96FW1	OTUB1	Ubiquitin thioesterase OTUB1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96FW1	OTUB1	Ubiquitin thioesterase OTUB1	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
Q96FW1	OTUB1	Ubiquitin thioesterase OTUB1	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q96FW1	OTUB1	Ubiquitin thioesterase OTUB1	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q96FW1	OTUB1	Ubiquitin thioesterase OTUB1	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q96FW1	OTUB1	Ubiquitin thioesterase OTUB1	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q96FW1	OTUB1	Ubiquitin thioesterase OTUB1	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q96FW1	OTUB1	Ubiquitin thioesterase OTUB1	GO:2000780; P:negative regulation of double-strand break repair; IMP:UniProtKB
Q96FW1	OTUB1	Ubiquitin thioesterase OTUB1	GO:1901315; P:negative regulation of histone H2A K63-linked ubiquitination; IDA:UniProtKB
Q96FW1	OTUB1	Ubiquitin thioesterase OTUB1	GO:0071108; P:protein K48-linked deubiquitination; IDA:UniProtKB
Q96DC9	OTUB2	Ubiquitin thioesterase OTUB2	GO:0008242; F:omega peptidase activity; IEA:InterPro
Q96DC9	OTUB2	Ubiquitin thioesterase OTUB2	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q96DC9	OTUB2	Ubiquitin thioesterase OTUB2	GO:0006520; P:cellular amino acid metabolic process; IDA:UniProtKB
Q96DC9	OTUB2	Ubiquitin thioesterase OTUB2	GO:0016579; P:protein deubiquitination; IMP:UniProtKB
Q96DC9	OTUB2	Ubiquitin thioesterase OTUB2	GO:0035871; P:protein K11-linked deubiquitination; IDA:UniProtKB
Q96DC9	OTUB2	Ubiquitin thioesterase OTUB2	GO:0071108; P:protein K48-linked deubiquitination; IDA:UniProtKB
Q96DC9	OTUB2	Ubiquitin thioesterase OTUB2	GO:0070536; P:protein K63-linked deubiquitination; IDA:UniProtKB
Q5VV17	OTUD1	OTU domain-containing protein 1	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q5VV17	OTUD1	OTU domain-containing protein 1	GO:0070536; P:protein K63-linked deubiquitination; IDA:UniProtKB
Q5T2D3	OTUD3	OTU domain-containing protein 3	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q5T2D3	OTUD3	OTU domain-containing protein 3	GO:0035871; P:protein K11-linked deubiquitination; IDA:UniProtKB
Q5T2D3	OTUD3	OTU domain-containing protein 3	GO:0044313; P:protein K6-linked deubiquitination; IDA:UniProtKB
Q01804	OTUD4	OTU domain-containing protein 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q01804	OTUD4	OTU domain-containing protein 4	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q01804	OTUD4	OTU domain-containing protein 4	GO:0071108; P:protein K48-linked deubiquitination; IDA:UniProtKB
Q96G74	OTUD5	OTU domain-containing protein 5	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q96G74	OTUD5	OTU domain-containing protein 5	GO:0045087; P:innate immune response; TAS:Reactome
Q96G74	OTUD5	OTU domain-containing protein 5	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
Q96G74	OTUD5	OTU domain-containing protein 5	GO:0071108; P:protein K48-linked deubiquitination; IDA:UniProtKB
Q96G74	OTUD5	OTU domain-containing protein 5	GO:0070536; P:protein K63-linked deubiquitination; IDA:UniProtKB
Q96G74	OTUD5	OTU domain-containing protein 5	GO:0032496; P:response to lipopolysaccharide; IDA:UniProtKB
Q96BN8	OTULIN	Ubiquitin thioesterase otulin	GO:0008234; F:cysteine-type peptidase activity; IMP:UniProtKB
Q96BN8	OTULIN	Ubiquitin thioesterase otulin	GO:0005515; F:protein binding; IPI:UniProtKB
Q96BN8	OTULIN	Ubiquitin thioesterase otulin	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q96BN8	OTULIN	Ubiquitin thioesterase otulin	GO:0060070; P:canonical Wnt signaling pathway; ISS:UniProtKB
Q96BN8	OTULIN	Ubiquitin thioesterase otulin	GO:0045087; P:innate immune response; IMP:UniProtKB
Q96BN8	OTULIN	Ubiquitin thioesterase otulin	GO:0050728; P:negative regulation of inflammatory response; IMP:UniProtKB
Q96BN8	OTULIN	Ubiquitin thioesterase otulin	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q96BN8	OTULIN	Ubiquitin thioesterase otulin	GO:0070431; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; IMP:UniProtKB
Q96BN8	OTULIN	Ubiquitin thioesterase otulin	GO:1990108; P:protein linear deubiquitination; IDA:UniProtKB
Q96BN8	OTULIN	Ubiquitin thioesterase otulin	GO:0002040; P:sprouting angiogenesis; ISS:UniProtKB
P32242	OTX1	Homeobox protein OTX1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P32242	OTX1	Homeobox protein OTX1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P32242	OTX1	Homeobox protein OTX1	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P32242	OTX1	Homeobox protein OTX1	GO:0048852; P:diencephalon morphogenesis; IEA:Ensembl
P32242	OTX1	Homeobox protein OTX1	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
P32242	OTX1	Homeobox protein OTX1	GO:0022037; P:metencephalon development; IEA:Ensembl
P32242	OTX1	Homeobox protein OTX1	GO:0030901; P:midbrain development; IEA:Ensembl
P32242	OTX1	Homeobox protein OTX1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P32243	OTX2	Homeobox protein OTX2	GO:0008190; F:eukaryotic initiation factor 4E binding; TAS:UniProtKB
P32243	OTX2	Homeobox protein OTX2	GO:0005515; F:protein binding; IPI:UniProtKB
P32243	OTX2	Homeobox protein OTX2	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:UniProtKB
P32243	OTX2	Homeobox protein OTX2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P32243	OTX2	Homeobox protein OTX2	GO:0007411; P:axon guidance; IDA:UniProtKB
P32243	OTX2	Homeobox protein OTX2	GO:0001708; P:cell fate specification; IEA:Ensembl
P32243	OTX2	Homeobox protein OTX2	GO:0048852; P:diencephalon morphogenesis; IEA:Ensembl
P32243	OTX2	Homeobox protein OTX2	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
P32243	OTX2	Homeobox protein OTX2	GO:0007492; P:endoderm development; IEA:Ensembl
P32243	OTX2	Homeobox protein OTX2	GO:0042706; P:eye photoreceptor cell fate commitment; IEA:Ensembl
P32243	OTX2	Homeobox protein OTX2	GO:0030900; P:forebrain development; TAS:UniProtKB
P32243	OTX2	Homeobox protein OTX2	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
P32243	OTX2	Homeobox protein OTX2	GO:0022037; P:metencephalon development; IEA:Ensembl
P32243	OTX2	Homeobox protein OTX2	GO:0030901; P:midbrain development; TAS:UniProtKB
P32243	OTX2	Homeobox protein OTX2	GO:0040019; P:positive regulation of embryonic development; ISS:UniProtKB
P32243	OTX2	Homeobox protein OTX2	GO:2000543; P:positive regulation of gastrulation; ISS:UniProtKB
P32243	OTX2	Homeobox protein OTX2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P32243	OTX2	Homeobox protein OTX2	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
P32243	OTX2	Homeobox protein OTX2	GO:0090009; P:primitive streak formation; ISS:UniProtKB
P32243	OTX2	Homeobox protein OTX2	GO:0006461; P:protein complex assembly; IDA:UniProtKB
P32243	OTX2	Homeobox protein OTX2	GO:0040036; P:regulation of fibroblast growth factor receptor signaling pathway; TAS:UniProtKB
P32243	OTX2	Homeobox protein OTX2	GO:0008589; P:regulation of smoothened signaling pathway; TAS:UniProtKB
P32243	OTX2	Homeobox protein OTX2	GO:0032525; P:somite rostral/caudal axis specification; IEA:Ensembl
Q8WZ82	OVCA2	Ovarian cancer-associated gene 2 protein	GO:0016787; F:hydrolase activity; NAS:UniProtKB
Q8WZ82	OVCA2	Ovarian cancer-associated gene 2 protein	GO:0008152; P:metabolic process; NAS:GOC
Q8WZ82	OVCA2	Ovarian cancer-associated gene 2 protein	GO:0032526; P:response to retinoic acid; IDA:UniProtKB
Q7RTY7	OVCH1	Ovochymase-1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7RTY7	OVCH1	Ovochymase-1	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q7RTZ1	OVCH2	Ovochymase-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7RTZ1	OVCH2	Ovochymase-2	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q12889	OVGP1	Oviduct-specific glycoprotein	GO:0004568; F:chitinase activity; IEA:InterPro
Q12889	OVGP1	Oviduct-specific glycoprotein	GO:0007339; P:binding of sperm to zona pellucida; TAS:Reactome
Q12889	OVGP1	Oviduct-specific glycoprotein	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q12889	OVGP1	Oviduct-specific glycoprotein	GO:0006032; P:chitin catabolic process; IEA:InterPro
Q12889	OVGP1	Oviduct-specific glycoprotein	GO:0007565; P:female pregnancy; TAS:ProtInc
Q12889	OVGP1	Oviduct-specific glycoprotein	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
Q12889	OVGP1	Oviduct-specific glycoprotein	GO:0007338; P:single fertilization; TAS:Reactome
O14753	OVOL1	Putative transcription factor Ovo-like 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O14753	OVOL1	Putative transcription factor Ovo-like 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14753	OVOL1	Putative transcription factor Ovo-like 1	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IEA:Ensembl
O14753	OVOL1	Putative transcription factor Ovo-like 1	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
O14753	OVOL1	Putative transcription factor Ovo-like 1	GO:0008544; P:epidermis development; IEA:Ensembl
O14753	OVOL1	Putative transcription factor Ovo-like 1	GO:0051729; P:germline cell cycle switching, mitotic to meiotic cell cycle; IEA:Ensembl
O14753	OVOL1	Putative transcription factor Ovo-like 1	GO:0001822; P:kidney development; IEA:Ensembl
O14753	OVOL1	Putative transcription factor Ovo-like 1	GO:0007498; P:mesoderm development; IEA:Ensembl
O14753	OVOL1	Putative transcription factor Ovo-like 1	GO:1901994; P:negative regulation of meiotic cell cycle phase transition; IEA:Ensembl
O14753	OVOL1	Putative transcription factor Ovo-like 1	GO:0007283; P:spermatogenesis; IEA:Ensembl
O14753	OVOL1	Putative transcription factor Ovo-like 1	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q6IE37	OVOS1	Ovostatin homolog 1	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
O00110	OVOL3	Putative transcription factor ovo-like protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O00110	OVOL3	Putative transcription factor ovo-like protein 3	GO:0003676; F:nucleic acid binding; IEA:InterPro
O00110	OVOL3	Putative transcription factor ovo-like protein 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O00110	OVOL3	Putative transcription factor ovo-like protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6IE36	OVOS2	Ovostatin homolog 2	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0001525; P:angiogenesis; IEA:Ensembl
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0048557; P:embryonic digestive tract morphogenesis; IEA:Ensembl
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0060214; P:endocardium formation; IEA:Ensembl
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0001947; P:heart looping; IEA:Ensembl
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0060347; P:heart trabecula formation; IEA:Ensembl
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0045617; P:negative regulation of keratinocyte differentiation; IMP:BHF-UCL
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0045746; P:negative regulation of Notch signaling pathway; IDA:BHF-UCL
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0010944; P:negative regulation of transcription by competitive promoter binding; IDA:BHF-UCL
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0001755; P:neural crest cell migration; IEA:Ensembl
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0001842; P:neural fold formation; IEA:Ensembl
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0051726; P:regulation of cell cycle; IMP:BHF-UCL
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0010837; P:regulation of keratinocyte proliferation; IEA:Ensembl
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
Q9BRP0	OVOL2	Transcription factor Ovo-like 2	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
O43613	HCRTR1	Orexin receptor type 1	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O43613	HCRTR1	Orexin receptor type 1	GO:0016499; F:orexin receptor activity; IEA:InterPro
O43613	HCRTR1	Orexin receptor type 1	GO:0017046; F:peptide hormone binding; IEA:Ensembl
O43613	HCRTR1	Orexin receptor type 1	GO:0007631; P:feeding behavior; TAS:ProtInc
O43613	HCRTR1	Orexin receptor type 1	GO:0007218; P:neuropeptide signaling pathway; TAS:ProtInc
O43613	HCRTR1	Orexin receptor type 1	GO:0007268; P:synaptic transmission; TAS:ProtInc
P83859	QRFP	Orexigenic neuropeptide QRFP	GO:0005184; F:neuropeptide hormone activity; IDA:UniProtKB
P83859	QRFP	Orexigenic neuropeptide QRFP	GO:0031854; F:orexigenic neuropeptide QRFP receptor binding; ISS:UniProtKB
P83859	QRFP	Orexigenic neuropeptide QRFP	GO:0007625; P:grooming behavior; IEA:Ensembl
P83859	QRFP	Orexigenic neuropeptide QRFP	GO:0007626; P:locomotory behavior; ISS:UniProtKB
P83859	QRFP	Orexigenic neuropeptide QRFP	GO:0007218; P:neuropeptide signaling pathway; IDA:UniProtKB
P83859	QRFP	Orexigenic neuropeptide QRFP	GO:0045777; P:positive regulation of blood pressure; ISS:UniProtKB
P83859	QRFP	Orexigenic neuropeptide QRFP	GO:0060259; P:regulation of feeding behavior; ISS:UniProtKB
P41217	CD200	OX-2 membrane glycoprotein	GO:0005515; F:protein binding; IPI:IntAct
P41217	CD200	OX-2 membrane glycoprotein	GO:0050776; P:regulation of immune response; TAS:Reactome
O43614	HCRTR2	Orexin receptor type 2	GO:0008188; F:neuropeptide receptor activity; TAS:ProtInc
O43614	HCRTR2	Orexin receptor type 2	GO:0016499; F:orexin receptor activity; IEA:Ensembl
O43614	HCRTR2	Orexin receptor type 2	GO:0017046; F:peptide hormone binding; IEA:Ensembl
O43614	HCRTR2	Orexin receptor type 2	GO:0022410; P:circadian sleep/wake cycle process; IEA:InterPro
O43614	HCRTR2	Orexin receptor type 2	GO:0007631; P:feeding behavior; TAS:ProtInc
O43614	HCRTR2	Orexin receptor type 2	GO:0007218; P:neuropeptide signaling pathway; TAS:ProtInc
O43614	HCRTR2	Orexin receptor type 2	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
O43614	HCRTR2	Orexin receptor type 2	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q15070	OXA1L	Mitochondrial inner membrane protein OXA1L	GO:0097177; F:mitochondrial ribosome binding; IDA:UniProtKB
Q15070	OXA1L	Mitochondrial inner membrane protein OXA1L	GO:0005515; F:protein binding; IPI:UniProtKB
Q15070	OXA1L	Mitochondrial inner membrane protein OXA1L	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q15070	OXA1L	Mitochondrial inner membrane protein OXA1L	GO:0009060; P:aerobic respiration; IMP:UniProtKB
Q15070	OXA1L	Mitochondrial inner membrane protein OXA1L	GO:0033615; P:mitochondrial proton-transporting ATP synthase complex assembly; IMP:UniProtKB
Q15070	OXA1L	Mitochondrial inner membrane protein OXA1L	GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:UniProtKB
Q15070	OXA1L	Mitochondrial inner membrane protein OXA1L	GO:0097031; P:mitochondrial respiratory chain complex I biogenesis; IMP:UniProtKB
Q15070	OXA1L	Mitochondrial inner membrane protein OXA1L	GO:0032780; P:negative regulation of ATPase activity; IMP:UniProtKB
Q15070	OXA1L	Mitochondrial inner membrane protein OXA1L	GO:0051354; P:negative regulation of oxidoreductase activity; IMP:UniProtKB
Q15070	OXA1L	Mitochondrial inner membrane protein OXA1L	GO:0055114; P:oxidation-reduction process; NAS:UniProtKB
Q15070	OXA1L	Mitochondrial inner membrane protein OXA1L	GO:0006461; P:protein complex assembly; NAS:UniProtKB
Q15070	OXA1L	Mitochondrial inner membrane protein OXA1L	GO:0051205; P:protein insertion into membrane; IEA:InterPro
Q15070	OXA1L	Mitochondrial inner membrane protein OXA1L	GO:0051262; P:protein tetramerization; IDA:UniProtKB
P14920	DAO	D-amino-acid oxidase	GO:0048037; F:cofactor binding; IDA:UniProtKB
P14920	DAO	D-amino-acid oxidase	GO:0003884; F:D-amino-acid oxidase activity; IDA:UniProtKB
P14920	DAO	D-amino-acid oxidase	GO:0071949; F:FAD binding; IDA:UniProtKB
P14920	DAO	D-amino-acid oxidase	GO:0005515; F:protein binding; IPI:UniProtKB
P14920	DAO	D-amino-acid oxidase	GO:0046983; F:protein dimerization activity; IDA:UniProtKB
P14920	DAO	D-amino-acid oxidase	GO:0005102; F:receptor binding; IPI:UniProtKB
P14920	DAO	D-amino-acid oxidase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P14920	DAO	D-amino-acid oxidase	GO:0055130; P:D-alanine catabolic process; IDA:UniProtKB
P14920	DAO	D-amino-acid oxidase	GO:0036088; P:D-serine catabolic process; IDA:UniProtKB
P14920	DAO	D-amino-acid oxidase	GO:0070178; P:D-serine metabolic process; IDA:UniProtKB
P14920	DAO	D-amino-acid oxidase	GO:0042416; P:dopamine biosynthetic process; IDA:UniProtKB
P14920	DAO	D-amino-acid oxidase	GO:0046487; P:glyoxylate metabolic process; TAS:Reactome
P14920	DAO	D-amino-acid oxidase	GO:0006551; P:leucine metabolic process; IEA:Ensembl
P14920	DAO	D-amino-acid oxidase	GO:0006562; P:proline catabolic process; IDA:UniProtKB
P14920	DAO	D-amino-acid oxidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99489	DDO	D-aspartate oxidase	GO:0048037; F:cofactor binding; IDA:UniProtKB
Q99489	DDO	D-aspartate oxidase	GO:0008445; F:D-aspartate oxidase activity; IDA:UniProtKB
Q99489	DDO	D-aspartate oxidase	GO:0005515; F:protein binding; IPI:UniProtKB
Q99489	DDO	D-aspartate oxidase	GO:0005102; F:receptor binding; IPI:UniProtKB
Q99489	DDO	D-aspartate oxidase	GO:0006533; P:aspartate catabolic process; IDA:UniProtKB
Q99489	DDO	D-aspartate oxidase	GO:0006531; P:aspartate metabolic process; IEA:Ensembl
Q99489	DDO	D-aspartate oxidase	GO:0019478; P:D-amino acid catabolic process; IDA:UniProtKB
Q99489	DDO	D-aspartate oxidase	GO:0007625; P:grooming behavior; IEA:Ensembl
Q99489	DDO	D-aspartate oxidase	GO:0042445; P:hormone metabolic process; IEA:Ensembl
Q99489	DDO	D-aspartate oxidase	GO:0007320; P:insemination; IEA:Ensembl
Q99489	DDO	D-aspartate oxidase	GO:0055114; P:oxidation-reduction process; IDA:GOC
Q96P68	OXGR1	2-oxoglutarate receptor 1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q96P68	OXGR1	2-oxoglutarate receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:UniProtKB
Q8TDS5	OXER1	Oxoeicosanoid receptor 1	GO:0050648; F:5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding; NAS:UniProtKB
Q8TDS5	OXER1	Oxoeicosanoid receptor 1	GO:0050647; F:5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding; NAS:UniProtKB
Q8TDS5	OXER1	Oxoeicosanoid receptor 1	GO:0050646; F:5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding; NAS:UniProtKB
Q8TDS5	OXER1	Oxoeicosanoid receptor 1	GO:0004930; F:G-protein coupled receptor activity; NAS:UniProtKB
Q8TDS5	OXER1	Oxoeicosanoid receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
Q8TDS5	OXER1	Oxoeicosanoid receptor 1	GO:0030817; P:regulation of cAMP biosynthetic process; IDA:UniProtKB
Q96RQ9	IL4I1	L-amino-acid oxidase	GO:0001716; F:L-amino-acid oxidase activity; EXP:Reactome
Q96HP4	OXNAD1	Oxidoreductase NAD-binding domain-containing protein 1	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q8N573	OXR1	Oxidation resistance protein 1	GO:0016491; F:oxidoreductase activity; IEA:Ensembl
Q8N573	OXR1	Oxidation resistance protein 1	GO:0007628; P:adult walking behavior; IEA:Ensembl
Q8N573	OXR1	Oxidation resistance protein 1	GO:0016998; P:cell wall macromolecule catabolic process; IEA:InterPro
Q8N573	OXR1	Oxidation resistance protein 1	GO:0071447; P:cellular response to hydroperoxide; IEA:Ensembl
Q8N573	OXR1	Oxidation resistance protein 1	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q8N573	OXR1	Oxidation resistance protein 1	GO:0006979; P:response to oxidative stress; NAS:UniProtKB
Q9NWU1	OXSM	3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial	GO:0004315; F:3-oxoacyl-[acyl-carrier-protein] synthase activity; IDA:HGNC
Q9NWU1	OXSM	3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial	GO:0006637; P:acyl-CoA metabolic process; IDA:HGNC
Q9NWU1	OXSM	3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial	GO:0051792; P:medium-chain fatty acid biosynthetic process; IDA:HGNC
Q9NWU1	OXSM	3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial	GO:0051790; P:short-chain fatty acid biosynthetic process; IDA:HGNC
O95747	OXSR1	Serine/threonine-protein kinase OSR1	GO:0005524; F:ATP binding; IDA:UniProtKB
O95747	OXSR1	Serine/threonine-protein kinase OSR1	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
O95747	OXSR1	Serine/threonine-protein kinase OSR1	GO:0005515; F:protein binding; IPI:IntAct
O95747	OXSR1	Serine/threonine-protein kinase OSR1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
O95747	OXSR1	Serine/threonine-protein kinase OSR1	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
O95747	OXSR1	Serine/threonine-protein kinase OSR1	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
O95747	OXSR1	Serine/threonine-protein kinase OSR1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
O95747	OXSR1	Serine/threonine-protein kinase OSR1	GO:0006979; P:response to oxidative stress; TAS:ProtInc
O95747	OXSR1	Serine/threonine-protein kinase OSR1	GO:0023014; P:signal transduction by phosphorylation; IBA:GOC
P30559	OXTR	Oxytocin receptor	GO:0004990; F:oxytocin receptor activity; TAS:ProtInc
P30559	OXTR	Oxytocin receptor	GO:0017046; F:peptide hormone binding; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0005000; F:vasopressin receptor activity; IEA:InterPro
P30559	OXTR	Oxytocin receptor	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P30559	OXTR	Oxytocin receptor	GO:0048565; P:digestive tract development; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0042755; P:eating behavior; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0070371; P:ERK1 and ERK2 cascade; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0060206; P:estrous cycle phase; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0007565; P:female pregnancy; TAS:ProtInc
P30559	OXTR	Oxytocin receptor	GO:0007507; P:heart development; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0007595; P:lactation; TAS:ProtInc
P30559	OXTR	Oxytocin receptor	GO:0042711; P:maternal behavior; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0060137; P:maternal process involved in parturition; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0007613; P:memory; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0006936; P:muscle contraction; TAS:ProtInc
P30559	OXTR	Oxytocin receptor	GO:0060455; P:negative regulation of gastric acid secretion; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0010701; P:positive regulation of norepinephrine secretion; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0060406; P:positive regulation of penile erection; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0051965; P:positive regulation of synapse assembly; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0032230; P:positive regulation of synaptic transmission, GABAergic; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0070474; P:positive regulation of uterine smooth muscle contraction; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0001975; P:response to amphetamine; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0034059; P:response to anoxia; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0042220; P:response to cocaine; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0034097; P:response to cytokine; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0042493; P:response to drug; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0032355; P:response to estradiol; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0032570; P:response to progesterone; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0030431; P:sleep; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0035176; P:social behavior; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0042713; P:sperm ejaculation; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0001967; P:suckling behavior; IEA:Ensembl
P30559	OXTR	Oxytocin receptor	GO:0021537; P:telencephalon development; IEA:Ensembl
Q15072	ZNF146	Zinc finger protein OZF	GO:0003677; F:DNA binding; TAS:ProtInc
Q15072	ZNF146	Zinc finger protein OZF	GO:0008201; F:heparin binding; TAS:ProtInc
Q15072	ZNF146	Zinc finger protein OZF	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q15072	ZNF146	Zinc finger protein OZF	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q15072	ZNF146	Zinc finger protein OZF	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
A6NF01	POM121B	Putative nuclear envelope pore membrane protein POM 121B	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
A6NF01	POM121B	Putative nuclear envelope pore membrane protein POM 121B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
A8CG34	POM121C	Nuclear envelope pore membrane protein POM 121C	GO:0005515; F:protein binding; IPI:UniProtKB
A8CG34	POM121C	Nuclear envelope pore membrane protein POM 121C	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
A8CG34	POM121C	Nuclear envelope pore membrane protein POM 121C	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96HA1	POM121	Nuclear envelope pore membrane protein POM 121	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q96HA1	POM121	Nuclear envelope pore membrane protein POM 121	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q96HA1	POM121	Nuclear envelope pore membrane protein POM 121	GO:0015758; P:glucose transport; TAS:Reactome
Q96HA1	POM121	Nuclear envelope pore membrane protein POM 121	GO:0008645; P:hexose transport; TAS:Reactome
Q96HA1	POM121	Nuclear envelope pore membrane protein POM 121	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q96HA1	POM121	Nuclear envelope pore membrane protein POM 121	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
Q96HA1	POM121	Nuclear envelope pore membrane protein POM 121	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q96HA1	POM121	Nuclear envelope pore membrane protein POM 121	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96HA1	POM121	Nuclear envelope pore membrane protein POM 121	GO:0010827; P:regulation of glucose transport; TAS:Reactome
Q96HA1	POM121	Nuclear envelope pore membrane protein POM 121	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96HA1	POM121	Nuclear envelope pore membrane protein POM 121	GO:0055085; P:transmembrane transport; TAS:Reactome
Q96HA1	POM121	Nuclear envelope pore membrane protein POM 121	GO:0016032; P:viral process; TAS:Reactome
Q6GTS8	PM20D1	Probable carboxypeptidase PM20D1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6GTS8	PM20D1	Probable carboxypeptidase PM20D1	GO:0008233; F:peptidase activity; IEA:UniProtKB-KW
Q6GTS8	PM20D1	Probable carboxypeptidase PM20D1	GO:1901215; P:negative regulation of neuron death; IMP:UniProt
Q6GTS8	PM20D1	Probable carboxypeptidase PM20D1	GO:0050691; P:regulation of defense response to virus by host; IMP:UniProt
Q6GTS8	PM20D1	Probable carboxypeptidase PM20D1	GO:0050792; P:regulation of viral process; IMP:UniProt
Q8IYS1	PM20D2	Peptidase M20 domain-containing protein 2	GO:0016787; F:hydrolase activity; IEA:InterPro
A8MW92	PHF20L1	PHD finger protein 20-like protein 1	GO:0005515; F:protein binding; IPI:IntAct
A8MW92	PHF20L1	PHD finger protein 20-like protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5VU65	NUP210L	Nuclear pore membrane glycoprotein 210-like	GO:0060009; P:Sertoli cell development; IEA:Ensembl
Q5VU65	NUP210L	Nuclear pore membrane glycoprotein 210-like	GO:0007286; P:spermatid development; IEA:Ensembl
Q06190	PPP2R3A	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha	GO:0005509; F:calcium ion binding; IEA:InterPro
Q06190	PPP2R3A	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha	GO:0005515; F:protein binding; IPI:IntAct
Q06190	PPP2R3A	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha	GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:ProtInc
Q06190	PPP2R3A	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha	GO:0001754; P:eye photoreceptor cell differentiation; IGI:BHF-UCL
Q06190	PPP2R3A	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IGI:BHF-UCL
Q06190	PPP2R3A	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:BHF-UCL
Q06190	PPP2R3A	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha	GO:0045732; P:positive regulation of protein catabolic process; IMP:BHF-UCL
Q06190	PPP2R3A	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha	GO:0006470; P:protein dephosphorylation; ISS:UniProtKB
Q06190	PPP2R3A	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha	GO:0050790; P:regulation of catalytic activity; TAS:GOC
Q06190	PPP2R3A	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha	GO:0090249; P:regulation of cell motility involved in somitogenic axis elongation; IGI:BHF-UCL
Q06190	PPP2R3A	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha	GO:0007525; P:somatic muscle development; IGI:BHF-UCL
Q06190	PPP2R3A	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha	GO:0061053; P:somite development; ISS:BHF-UCL
Q06190	PPP2R3A	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha	GO:0090244; P:Wnt signaling pathway involved in somitogenesis; IC:BHF-UCL
Q9Y5P8	PPP2R3B	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5P8	PPP2R3B	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta	GO:0004721; F:phosphoprotein phosphatase activity; TAS:Reactome
Q9Y5P8	PPP2R3B	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y5P8	PPP2R3B	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta	GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:ProtInc
Q9Y5P8	PPP2R3B	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta	GO:0004722; F:protein serine/threonine phosphatase activity; ISS:UniProtKB
Q9Y5P8	PPP2R3B	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta	GO:0007050; P:cell cycle arrest; TAS:ProtInc
Q9Y5P8	PPP2R3B	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q9Y5P8	PPP2R3B	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9Y5P8	PPP2R3B	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta	GO:0006470; P:protein dephosphorylation; ISS:UniProtKB
Q9Y5P8	PPP2R3B	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta	GO:0050790; P:regulation of catalytic activity; TAS:GOC
Q969Q6	PPP2R3C	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma	GO:0005509; F:calcium ion binding; IEA:InterPro
Q969Q6	PPP2R3C	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma	GO:0032147; P:activation of protein kinase activity; IEA:Ensembl
Q969Q6	PPP2R3C	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma	GO:0001782; P:B cell homeostasis; IEA:Ensembl
Q969Q6	PPP2R3C	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma	GO:0045579; P:positive regulation of B cell differentiation; IEA:Ensembl
Q969Q6	PPP2R3C	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma	GO:0002759; P:regulation of antimicrobial humoral response; IEA:Ensembl
Q969Q6	PPP2R3C	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma	GO:0051900; P:regulation of mitochondrial depolarization; IEA:Ensembl
Q969Q6	PPP2R3C	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma	GO:0048536; P:spleen development; IEA:Ensembl
Q969Q6	PPP2R3C	Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma	GO:0043029; P:T cell homeostasis; IEA:Ensembl
P51575	P2RX1	P2X purinoceptor 1	GO:0005524; F:ATP binding; IEA:Ensembl
P51575	P2RX1	P2X purinoceptor 1	GO:0005262; F:calcium channel activity; TAS:Reactome
P51575	P2RX1	P2X purinoceptor 1	GO:0005261; F:cation channel activity; IDA:MGI
P51575	P2RX1	P2X purinoceptor 1	GO:0008144; F:drug binding; IEA:Ensembl
P51575	P2RX1	P2X purinoceptor 1	GO:0004931; F:extracellular ATP-gated cation channel activity; IBA:RefGenome
P51575	P2RX1	P2X purinoceptor 1	GO:0001614; F:purinergic nucleotide receptor activity; IDA:MGI
P51575	P2RX1	P2X purinoceptor 1	GO:0008270; F:zinc ion binding; IEA:Ensembl
P51575	P2RX1	P2X purinoceptor 1	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
P51575	P2RX1	P2X purinoceptor 1	GO:0007596; P:blood coagulation; TAS:Reactome
P51575	P2RX1	P2X purinoceptor 1	GO:0070588; P:calcium ion transmembrane transport; TAS:GOC
P51575	P2RX1	P2X purinoceptor 1	GO:0006812; P:cation transport; IBA:RefGenome
P51575	P2RX1	P2X purinoceptor 1	GO:0046513; P:ceramide biosynthetic process; IEA:Ensembl
P51575	P2RX1	P2X purinoceptor 1	GO:0007320; P:insemination; IEA:Ensembl
P51575	P2RX1	P2X purinoceptor 1	GO:0006811; P:ion transport; IDA:MGI
P51575	P2RX1	P2X purinoceptor 1	GO:0019228; P:neuronal action potential; IEA:Ensembl
P51575	P2RX1	P2X purinoceptor 1	GO:0030168; P:platelet activation; IEA:Ensembl
P51575	P2RX1	P2X purinoceptor 1	GO:0043270; P:positive regulation of ion transport; IEA:Ensembl
P51575	P2RX1	P2X purinoceptor 1	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P51575	P2RX1	P2X purinoceptor 1	GO:0051260; P:protein homooligomerization; IEA:Ensembl
P51575	P2RX1	P2X purinoceptor 1	GO:0035590; P:purinergic nucleotide receptor signaling pathway; IDA:GOC
P51575	P2RX1	P2X purinoceptor 1	GO:0008217; P:regulation of blood pressure; IEA:Ensembl
P51575	P2RX1	P2X purinoceptor 1	GO:0051924; P:regulation of calcium ion transport; IEA:Ensembl
P51575	P2RX1	P2X purinoceptor 1	GO:0003056; P:regulation of vascular smooth muscle contraction; IEA:Ensembl
P51575	P2RX1	P2X purinoceptor 1	GO:0033198; P:response to ATP; IEA:Ensembl
P51575	P2RX1	P2X purinoceptor 1	GO:0002554; P:serotonin secretion by platelet; IEA:Ensembl
P51575	P2RX1	P2X purinoceptor 1	GO:0007165; P:signal transduction; TAS:ProtInc
P51575	P2RX1	P2X purinoceptor 1	GO:0035249; P:synaptic transmission, glutamatergic; IEA:Ensembl
P51575	P2RX1	P2X purinoceptor 1	GO:0006810; P:transport; TAS:ProtInc
P51575	P2RX1	P2X purinoceptor 1	GO:0042310; P:vasoconstriction; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0005524; F:ATP binding; NAS:BHF-UCL
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0046870; F:cadmium ion binding; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0050897; F:cobalt ion binding; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0005507; F:copper ion binding; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0008144; F:drug binding; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0004931; F:extracellular ATP-gated cation channel activity; IDA:UniProtKB
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0042802; F:identical protein binding; IPI:BHF-UCL
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0015276; F:ligand-gated ion channel activity; TAS:ProtInc
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0045340; F:mercury ion binding; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0016151; F:nickel cation binding; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0035091; F:phosphatidylinositol binding; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0001614; F:purinergic nucleotide receptor activity; NAS:BHF-UCL
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0008270; F:zinc ion binding; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0048266; P:behavioral response to pain; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0006812; P:cation transport; IDA:GOC
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0003029; P:detection of hypoxic conditions in blood by carotid body chemoreceptor signaling; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0034220; P:ion transmembrane transport; TAS:GOC
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0007274; P:neuromuscular synaptic transmission; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0019228; P:neuronal action potential; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0030432; P:peristalsis; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0010524; P:positive regulation of calcium ion transport into cytosol; NAS:BHF-UCL
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0050850; P:positive regulation of calcium-mediated signaling; NAS:BHF-UCL
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0051260; P:protein homooligomerization; IPI:BHF-UCL
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0035590; P:purinergic nucleotide receptor signaling pathway; NAS:GOC
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0033198; P:response to ATP; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0009743; P:response to carbohydrate; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0007605; P:sensory perception of sound; IMP:UniProtKB
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0050909; P:sensory perception of taste; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0048741; P:skeletal muscle fiber development; IEA:Ensembl
Q9UBL9	P2RX2	P2X purinoceptor 2	GO:0014832; P:urinary bladder smooth muscle contraction; IEA:Ensembl
P56373	P2RX3	P2X purinoceptor 3	GO:0005524; F:ATP binding; NAS:BHF-UCL
P56373	P2RX3	P2X purinoceptor 3	GO:0004931; F:extracellular ATP-gated cation channel activity; NAS:BHF-UCL
P56373	P2RX3	P2X purinoceptor 3	GO:0001614; F:purinergic nucleotide receptor activity; NAS:BHF-UCL
P56373	P2RX3	P2X purinoceptor 3	GO:0048266; P:behavioral response to pain; IEA:Ensembl
P56373	P2RX3	P2X purinoceptor 3	GO:0007274; P:neuromuscular synaptic transmission; IEA:Ensembl
P56373	P2RX3	P2X purinoceptor 3	GO:0019228; P:neuronal action potential; IEA:Ensembl
P56373	P2RX3	P2X purinoceptor 3	GO:0030432; P:peristalsis; IEA:Ensembl
P56373	P2RX3	P2X purinoceptor 3	GO:0010524; P:positive regulation of calcium ion transport into cytosol; NAS:BHF-UCL
P56373	P2RX3	P2X purinoceptor 3	GO:0050850; P:positive regulation of calcium-mediated signaling; NAS:BHF-UCL
P56373	P2RX3	P2X purinoceptor 3	GO:0051260; P:protein homooligomerization; IEA:Ensembl
P56373	P2RX3	P2X purinoceptor 3	GO:0035590; P:purinergic nucleotide receptor signaling pathway; NAS:GOC
P56373	P2RX3	P2X purinoceptor 3	GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl
P56373	P2RX3	P2X purinoceptor 3	GO:0033198; P:response to ATP; IEA:Ensembl
P56373	P2RX3	P2X purinoceptor 3	GO:0009743; P:response to carbohydrate; IEA:Ensembl
P56373	P2RX3	P2X purinoceptor 3	GO:0009409; P:response to cold; IEA:Ensembl
P56373	P2RX3	P2X purinoceptor 3	GO:0009408; P:response to heat; IEA:Ensembl
P56373	P2RX3	P2X purinoceptor 3	GO:0001666; P:response to hypoxia; IEA:Ensembl
P56373	P2RX3	P2X purinoceptor 3	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P56373	P2RX3	P2X purinoceptor 3	GO:0050909; P:sensory perception of taste; IEA:Ensembl
P56373	P2RX3	P2X purinoceptor 3	GO:0007165; P:signal transduction; TAS:ProtInc
P56373	P2RX3	P2X purinoceptor 3	GO:0006810; P:transport; TAS:ProtInc
P56373	P2RX3	P2X purinoceptor 3	GO:0014832; P:urinary bladder smooth muscle contraction; IEA:Ensembl
Q99571	P2RX4	P2X purinoceptor 4	GO:0005524; F:ATP binding; IC:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0045296; F:cadherin binding; IPI:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0005507; F:copper ion binding; ISS:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0004931; F:extracellular ATP-gated cation channel activity; IDA:UniProtKB
Q99571	P2RX4	P2X purinoceptor 4	GO:0042803; F:protein homodimerization activity; NAS:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0001614; F:purinergic nucleotide receptor activity; IDA:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0005102; F:receptor binding; ISS:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0008270; F:zinc ion binding; ISS:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0097190; P:apoptotic signaling pathway; IDA:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0006812; P:cation transport; IDA:GOC
Q99571	P2RX4	P2X purinoceptor 4	GO:0071318; P:cellular response to ATP; IDA:UniProtKB
Q99571	P2RX4	P2X purinoceptor 4	GO:0042118; P:endothelial cell activation; TAS:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0034220; P:ion transmembrane transport; IDA:UniProtKB
Q99571	P2RX4	P2X purinoceptor 4	GO:0051899; P:membrane depolarization; IDA:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0010614; P:negative regulation of cardiac muscle hypertrophy; IMP:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0051928; P:positive regulation of calcium ion transport; NAS:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0010524; P:positive regulation of calcium ion transport into cytosol; IDA:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0050850; P:positive regulation of calcium-mediated signaling; IDA:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; NAS:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0032308; P:positive regulation of prostaglandin secretion; NAS:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0035590; P:purinergic nucleotide receptor signaling pathway; IMP:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0008217; P:regulation of blood pressure; IMP:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0055117; P:regulation of cardiac muscle contraction; IMP:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0002028; P:regulation of sodium ion transport; ISS:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0055119; P:relaxation of cardiac muscle; IMP:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0033198; P:response to ATP; IDA:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0034405; P:response to fluid shear stress; IDA:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0019233; P:sensory perception of pain; ISS:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0007165; P:signal transduction; IDA:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0001894; P:tissue homeostasis; NAS:BHF-UCL
Q99571	P2RX4	P2X purinoceptor 4	GO:0006810; P:transport; IDA:BHF-UCL
Q93086	P2RX5	P2X purinoceptor 5	GO:0005524; F:ATP binding; NAS:BHF-UCL
Q93086	P2RX5	P2X purinoceptor 5	GO:0004931; F:extracellular ATP-gated cation channel activity; NAS:BHF-UCL
Q93086	P2RX5	P2X purinoceptor 5	GO:0005216; F:ion channel activity; TAS:ProtInc
Q93086	P2RX5	P2X purinoceptor 5	GO:0001614; F:purinergic nucleotide receptor activity; NAS:BHF-UCL
Q93086	P2RX5	P2X purinoceptor 5	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q93086	P2RX5	P2X purinoceptor 5	GO:0006812; P:cation transport; NAS:GOC
Q93086	P2RX5	P2X purinoceptor 5	GO:0034220; P:ion transmembrane transport; TAS:GOC
Q93086	P2RX5	P2X purinoceptor 5	GO:0007399; P:nervous system development; TAS:ProtInc
Q93086	P2RX5	P2X purinoceptor 5	GO:0010524; P:positive regulation of calcium ion transport into cytosol; NAS:BHF-UCL
Q93086	P2RX5	P2X purinoceptor 5	GO:0050850; P:positive regulation of calcium-mediated signaling; NAS:BHF-UCL
Q93086	P2RX5	P2X purinoceptor 5	GO:0035590; P:purinergic nucleotide receptor signaling pathway; NAS:GOC
Q93086	P2RX5	P2X purinoceptor 5	GO:0007165; P:signal transduction; TAS:ProtInc
Q93086	P2RX5	P2X purinoceptor 5	GO:0006810; P:transport; TAS:ProtInc
O15547	P2RX6	P2X purinoceptor 6	GO:0005524; F:ATP binding; NAS:BHF-UCL
O15547	P2RX6	P2X purinoceptor 6	GO:0015267; F:channel activity; TAS:ProtInc
O15547	P2RX6	P2X purinoceptor 6	GO:0004931; F:extracellular ATP-gated cation channel activity; NAS:BHF-UCL
O15547	P2RX6	P2X purinoceptor 6	GO:0042802; F:identical protein binding; IPI:BHF-UCL
O15547	P2RX6	P2X purinoceptor 6	GO:0001614; F:purinergic nucleotide receptor activity; NAS:BHF-UCL
O15547	P2RX6	P2X purinoceptor 6	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
O15547	P2RX6	P2X purinoceptor 6	GO:0006812; P:cation transport; IBA:RefGenome
O15547	P2RX6	P2X purinoceptor 6	GO:0006936; P:muscle contraction; TAS:ProtInc
O15547	P2RX6	P2X purinoceptor 6	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
O15547	P2RX6	P2X purinoceptor 6	GO:0051260; P:protein homooligomerization; IPI:BHF-UCL
O15547	P2RX6	P2X purinoceptor 6	GO:0035590; P:purinergic nucleotide receptor signaling pathway; NAS:GOC
O15547	P2RX6	P2X purinoceptor 6	GO:0007165; P:signal transduction; TAS:ProtInc
O15547	P2RX6	P2X purinoceptor 6	GO:0055085; P:transmembrane transport; TAS:GOC
O15547	P2RX6	P2X purinoceptor 6	GO:0006810; P:transport; TAS:ProtInc
Q99572	P2RX7	P2X purinoceptor 7	GO:0005524; F:ATP binding; IC:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0004931; F:extracellular ATP-gated cation channel activity; IDA:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0001530; F:lipopolysaccharide binding; ISS:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0042803; F:protein homodimerization activity; NAS:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0001614; F:purinergic nucleotide receptor activity; IDA:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0005102; F:receptor binding; ISS:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0097190; P:apoptotic signaling pathway; ISS:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0032060; P:bleb assembly; ISS:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0006812; P:cation transport; IDA:GOC
Q99572	P2RX7	P2X purinoceptor 7	GO:0007166; P:cell surface receptor signaling pathway; ISS:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0045087; P:innate immune response; TAS:Reactome
Q99572	P2RX7	P2X purinoceptor 7	GO:0051899; P:membrane depolarization; IDA:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0045779; P:negative regulation of bone resorption; ISS:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0043409; P:negative regulation of MAPK cascade; ISS:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q99572	P2RX7	P2X purinoceptor 7	GO:0046931; P:pore complex assembly; IDA:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0030501; P:positive regulation of bone mineralization; ISS:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0010524; P:positive regulation of calcium ion transport into cytosol; IDA:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0045919; P:positive regulation of cytolysis; ISS:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0051495; P:positive regulation of cytoskeleton organization; ISS:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0050718; P:positive regulation of interleukin-1 beta secretion; IDA:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0035590; P:purinergic nucleotide receptor signaling pathway; IDA:GOC
Q99572	P2RX7	P2X purinoceptor 7	GO:0051709; P:regulation of killing of cells of other organism; NAS:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0002028; P:regulation of sodium ion transport; ISS:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0033198; P:response to ATP; IDA:BHF-UCL
Q99572	P2RX7	P2X purinoceptor 7	GO:0019233; P:sensory perception of pain; ISS:BHF-UCL
P47900	P2RY1	P2Y purinoceptor 1	GO:0043531; F:ADP binding; IEA:Ensembl
P47900	P2RY1	P2Y purinoceptor 1	GO:0045032; F:ADP-activated nucleotide receptor activity; IEA:Ensembl
P47900	P2RY1	P2Y purinoceptor 1	GO:0005524; F:ATP binding; IEA:Ensembl
P47900	P2RY1	P2Y purinoceptor 1	GO:0045031; F:ATP-activated nucleotide receptor activity; ISS:BHF-UCL
P47900	P2RY1	P2Y purinoceptor 1	GO:0045028; F:G-protein coupled purinergic nucleotide receptor activity; ISS:BHF-UCL
P47900	P2RY1	P2Y purinoceptor 1	GO:0005515; F:protein binding; IPI:IntAct
P47900	P2RY1	P2Y purinoceptor 1	GO:0004872; F:receptor activity; TAS:ProtInc
P47900	P2RY1	P2Y purinoceptor 1	GO:0097110; F:scaffold protein binding; ISS:BHF-UCL
P47900	P2RY1	P2Y purinoceptor 1	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IEA:Ensembl
P47900	P2RY1	P2Y purinoceptor 1	GO:0007568; P:aging; IEA:Ensembl
P47900	P2RY1	P2Y purinoceptor 1	GO:0007596; P:blood coagulation; TAS:Reactome
P47900	P2RY1	P2Y purinoceptor 1	GO:0007420; P:brain development; IEA:Ensembl
P47900	P2RY1	P2Y purinoceptor 1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P47900	P2RY1	P2Y purinoceptor 1	GO:0042755; P:eating behavior; IEA:Ensembl
P47900	P2RY1	P2Y purinoceptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; ISS:BHF-UCL
P47900	P2RY1	P2Y purinoceptor 1	GO:0051100; P:negative regulation of binding; IEA:Ensembl
P47900	P2RY1	P2Y purinoceptor 1	GO:0010700; P:negative regulation of norepinephrine secretion; IEA:Ensembl
P47900	P2RY1	P2Y purinoceptor 1	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; TAS:ProtInc
P47900	P2RY1	P2Y purinoceptor 1	GO:0030168; P:platelet activation; TAS:Reactome
P47900	P2RY1	P2Y purinoceptor 1	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISS:BHF-UCL
P47900	P2RY1	P2Y purinoceptor 1	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:BHF-UCL
P47900	P2RY1	P2Y purinoceptor 1	GO:0046887; P:positive regulation of hormone secretion; IEA:Ensembl
P47900	P2RY1	P2Y purinoceptor 1	GO:0032962; P:positive regulation of inositol trisphosphate biosynthetic process; IEA:Ensembl
P47900	P2RY1	P2Y purinoceptor 1	GO:0043270; P:positive regulation of ion transport; IEA:Ensembl
P47900	P2RY1	P2Y purinoceptor 1	GO:0060406; P:positive regulation of penile erection; IEA:Ensembl
P47900	P2RY1	P2Y purinoceptor 1	GO:0001934; P:positive regulation of protein phosphorylation; ISS:BHF-UCL
P47900	P2RY1	P2Y purinoceptor 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P47900	P2RY1	P2Y purinoceptor 1	GO:0072659; P:protein localization to plasma membrane; ISS:BHF-UCL
P47900	P2RY1	P2Y purinoceptor 1	GO:0010469; P:regulation of receptor activity; IEA:Ensembl
P47900	P2RY1	P2Y purinoceptor 1	GO:0042312; P:regulation of vasodilation; IEA:Ensembl
P47900	P2RY1	P2Y purinoceptor 1	GO:0090075; P:relaxation of muscle; IEA:InterPro
P47900	P2RY1	P2Y purinoceptor 1	GO:0070848; P:response to growth factor; IEA:Ensembl
P47900	P2RY1	P2Y purinoceptor 1	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P47900	P2RY1	P2Y purinoceptor 1	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P47900	P2RY1	P2Y purinoceptor 1	GO:0023019; P:signal transduction involved in regulation of gene expression; ISS:BHF-UCL
P41231	P2RY2	P2Y purinoceptor 2	GO:0045028; F:G-protein coupled purinergic nucleotide receptor activity; IEA:InterPro
P41231	P2RY2	P2Y purinoceptor 2	GO:0004872; F:receptor activity; TAS:ProtInc
P41231	P2RY2	P2Y purinoceptor 2	GO:0006873; P:cellular ion homeostasis; TAS:ProtInc
P41231	P2RY2	P2Y purinoceptor 2	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; TAS:ProtInc
P41231	P2RY2	P2Y purinoceptor 2	GO:0070257; P:positive regulation of mucus secretion; IEA:Ensembl
P41231	P2RY2	P2Y purinoceptor 2	GO:0042312; P:regulation of vasodilation; IEA:InterPro
P51582	P2RY4	P2Y purinoceptor 4	GO:0005524; F:ATP binding; IEA:Ensembl
P51582	P2RY4	P2Y purinoceptor 4	GO:0045028; F:G-protein coupled purinergic nucleotide receptor activity; IEA:InterPro
P51582	P2RY4	P2Y purinoceptor 4	GO:0015065; F:uridine nucleotide receptor activity; TAS:ProtInc
P51582	P2RY4	P2Y purinoceptor 4	GO:0045030; F:UTP-activated nucleotide receptor activity; IEA:Ensembl
P51582	P2RY4	P2Y purinoceptor 4	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; TAS:ProtInc
P51582	P2RY4	P2Y purinoceptor 4	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
P51582	P2RY4	P2Y purinoceptor 4	GO:0030321; P:transepithelial chloride transport; IEA:Ensembl
Q15077	P2RY6	P2Y purinoceptor 6	GO:0045028; F:G-protein coupled purinergic nucleotide receptor activity; IEA:InterPro
Q15077	P2RY6	P2Y purinoceptor 6	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q15077	P2RY6	P2Y purinoceptor 6	GO:0045029; F:UDP-activated nucleotide receptor activity; IEA:Ensembl
Q15077	P2RY6	P2Y purinoceptor 6	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; TAS:ProtInc
Q15077	P2RY6	P2Y purinoceptor 6	GO:0014911; P:positive regulation of smooth muscle cell migration; IEA:Ensembl
Q15077	P2RY6	P2Y purinoceptor 6	GO:0030321; P:transepithelial chloride transport; IEA:Ensembl
Q86VZ1	P2RY8	P2Y purinoceptor 8	GO:0045028; F:G-protein coupled purinergic nucleotide receptor activity; IEA:InterPro
O00398	P2RY10	Putative P2Y purinoceptor 10	GO:0045028; F:G-protein coupled purinergic nucleotide receptor activity; IEA:InterPro
Q96G91	P2RY11	P2Y purinoceptor 11	GO:0045031; F:ATP-activated nucleotide receptor activity; IDA:BHF-UCL
Q96G91	P2RY11	P2Y purinoceptor 11	GO:0045028; F:G-protein coupled purinergic nucleotide receptor activity; IEA:InterPro
Q96G91	P2RY11	P2Y purinoceptor 11	GO:0030594; F:neurotransmitter receptor activity; IDA:BHF-UCL
Q96G91	P2RY11	P2Y purinoceptor 11	GO:0004872; F:receptor activity; TAS:ProtInc
Q96G91	P2RY11	P2Y purinoceptor 11	GO:0007190; P:activation of adenylate cyclase activity; TAS:ProtInc
Q96G91	P2RY11	P2Y purinoceptor 11	GO:0001973; P:adenosine receptor signaling pathway; IDA:GOC
Q96G91	P2RY11	P2Y purinoceptor 11	GO:0019722; P:calcium-mediated signaling; IDA:BHF-UCL
Q96G91	P2RY11	P2Y purinoceptor 11	GO:0071318; P:cellular response to ATP; IDA:BHF-UCL
Q96G91	P2RY11	P2Y purinoceptor 11	GO:0006952; P:defense response; TAS:ProtInc
Q96G91	P2RY11	P2Y purinoceptor 11	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:BHF-UCL
Q96G91	P2RY11	P2Y purinoceptor 11	GO:0023041; P:neuronal signal transduction; IDA:BHF-UCL
Q96G91	P2RY11	P2Y purinoceptor 11	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; TAS:ProtInc
Q96G91	P2RY11	P2Y purinoceptor 11	GO:0007268; P:synaptic transmission; IDA:GOC
Q9H244	P2RY12	P2Y purinoceptor 12	GO:0001621; F:ADP receptor activity; IEA:Ensembl
Q9H244	P2RY12	P2Y purinoceptor 12	GO:0001609; F:G-protein coupled adenosine receptor activity; IEA:Ensembl
Q9H244	P2RY12	P2Y purinoceptor 12	GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:Reactome
Q9H244	P2RY12	P2Y purinoceptor 12	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IEA:Ensembl
Q9H244	P2RY12	P2Y purinoceptor 12	GO:0007596; P:blood coagulation; TAS:Reactome
Q9H244	P2RY12	P2Y purinoceptor 12	GO:0070588; P:calcium ion transmembrane transport; IEA:Ensembl
Q9H244	P2RY12	P2Y purinoceptor 12	GO:0030030; P:cell projection organization; IEA:Ensembl
Q9H244	P2RY12	P2Y purinoceptor 12	GO:0007599; P:hemostasis; NAS:UniProtKB
Q9H244	P2RY12	P2Y purinoceptor 12	GO:0045596; P:negative regulation of cell differentiation; IEA:Ensembl
Q9H244	P2RY12	P2Y purinoceptor 12	GO:0010700; P:negative regulation of norepinephrine secretion; IEA:Ensembl
Q9H244	P2RY12	P2Y purinoceptor 12	GO:0030168; P:platelet activation; TAS:Reactome
Q9H244	P2RY12	P2Y purinoceptor 12	GO:0070527; P:platelet aggregation; IEA:Ensembl
Q9H244	P2RY12	P2Y purinoceptor 12	GO:0043270; P:positive regulation of ion transport; IEA:Ensembl
Q9H244	P2RY12	P2Y purinoceptor 12	GO:0071805; P:potassium ion transmembrane transport; IEA:Ensembl
Q9H244	P2RY12	P2Y purinoceptor 12	GO:0043491; P:protein kinase B signaling; IEA:Ensembl
Q9H244	P2RY12	P2Y purinoceptor 12	GO:0051924; P:regulation of calcium ion transport; IEA:Ensembl
Q9H244	P2RY12	P2Y purinoceptor 12	GO:0043087; P:regulation of GTPase activity; TAS:GOC
Q15391	P2RY14	P2Y purinoceptor 14	GO:0045028; F:G-protein coupled purinergic nucleotide receptor activity; IEA:InterPro
Q15391	P2RY14	P2Y purinoceptor 14	GO:0045029; F:UDP-activated nucleotide receptor activity; NAS:UniProtKB
Q15391	P2RY14	P2Y purinoceptor 14	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
Q9BPV8	P2RY13	P2Y purinoceptor 13	GO:0045028; F:G-protein coupled purinergic nucleotide receptor activity; IEA:Ensembl
Q9BPV8	P2RY13	P2Y purinoceptor 13	GO:0007194; P:negative regulation of adenylate cyclase activity; IEA:InterPro
Q96A73	KIAA1191	Putative monooxygenase p33MONOX	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
O00443	PIK3C2A	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	GO:0016303; F:1-phosphatidylinositol-3-kinase activity; IBA:RefGenome
O00443	PIK3C2A	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	GO:0035005; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; TAS:Reactome
O00443	PIK3C2A	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O00443	PIK3C2A	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	GO:0035004; F:phosphatidylinositol 3-kinase activity; TAS:UniProtKB
O00443	PIK3C2A	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
O00443	PIK3C2A	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	GO:0048268; P:clathrin coat assembly; TAS:UniProtKB
O00443	PIK3C2A	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	GO:0006897; P:endocytosis; IMP:UniProtKB
O00443	PIK3C2A	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:UniProtKB
O00443	PIK3C2A	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	GO:0006887; P:exocytosis; TAS:UniProtKB
O00443	PIK3C2A	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	GO:0008286; P:insulin receptor signaling pathway; TAS:UniProtKB
O00443	PIK3C2A	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
O00443	PIK3C2A	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	GO:0048015; P:phosphatidylinositol-mediated signaling; IEA:InterPro
O00443	PIK3C2A	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
O00443	PIK3C2A	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; TAS:UniProtKB
O00443	PIK3C2A	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00443	PIK3C2A	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha	GO:0014829; P:vascular smooth muscle contraction; TAS:UniProtKB
O75747	PIK3C2G	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	GO:0016303; F:1-phosphatidylinositol-3-kinase activity; NAS:UniProtKB
O75747	PIK3C2G	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	GO:0035005; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; IBA:RefGenome
O75747	PIK3C2G	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75747	PIK3C2G	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
O75747	PIK3C2G	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	GO:0016307; F:phosphatidylinositol phosphate kinase activity; NAS:UniProtKB
O75747	PIK3C2G	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
O75747	PIK3C2G	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
O75747	PIK3C2G	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	GO:0036092; P:phosphatidylinositol-3-phosphate biosynthetic process; NAS:GOC
O75747	PIK3C2G	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	GO:0048015; P:phosphatidylinositol-mediated signaling; IEA:InterPro
O75747	PIK3C2G	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
O75747	PIK3C2G	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00750	PIK3C2B	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	GO:0016303; F:1-phosphatidylinositol-3-kinase activity; IBA:RefGenome
O00750	PIK3C2B	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	GO:0035005; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; NAS:UniProtKB
O00750	PIK3C2B	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O00750	PIK3C2B	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	GO:0001727; F:lipid kinase activity; IEA:Ensembl
O00750	PIK3C2B	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
O00750	PIK3C2B	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	GO:0005515; F:protein binding; IPI:IntAct
O00750	PIK3C2B	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
O00750	PIK3C2B	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	GO:0036092; P:phosphatidylinositol-3-phosphate biosynthetic process; IBA:GOC
O00750	PIK3C2B	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	GO:0048015; P:phosphatidylinositol-mediated signaling; IEA:InterPro
O00750	PIK3C2B	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
O00750	PIK3C2B	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	GO:0043491; P:protein kinase B signaling; IEA:Ensembl
O00750	PIK3C2B	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q32P28	LEPRE1	Prolyl 3-hydroxylase 1	GO:0005506; F:iron ion binding; IEA:InterPro
Q32P28	LEPRE1	Prolyl 3-hydroxylase 1	GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW
Q32P28	LEPRE1	Prolyl 3-hydroxylase 1	GO:0019797; F:procollagen-proline 3-dioxygenase activity; ISS:UniProt
Q32P28	LEPRE1	Prolyl 3-hydroxylase 1	GO:0032403; F:protein complex binding; ISS:UniProt
Q32P28	LEPRE1	Prolyl 3-hydroxylase 1	GO:0060348; P:bone development; IMP:UniProt
Q32P28	LEPRE1	Prolyl 3-hydroxylase 1	GO:0016049; P:cell growth; IEA:Ensembl
Q32P28	LEPRE1	Prolyl 3-hydroxylase 1	GO:0061077; P:chaperone-mediated protein folding; ISS:UniProt
Q32P28	LEPRE1	Prolyl 3-hydroxylase 1	GO:0030199; P:collagen fibril organization; IEA:Ensembl
Q32P28	LEPRE1	Prolyl 3-hydroxylase 1	GO:0032963; P:collagen metabolic process; ISS:UniProt
Q32P28	LEPRE1	Prolyl 3-hydroxylase 1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q32P28	LEPRE1	Prolyl 3-hydroxylase 1	GO:0008285; P:negative regulation of cell proliferation; NAS:UniProtKB
Q32P28	LEPRE1	Prolyl 3-hydroxylase 1	GO:1901874; P:negative regulation of post-translational protein modification; IMP:UniProt
Q32P28	LEPRE1	Prolyl 3-hydroxylase 1	GO:0019511; P:peptidyl-proline hydroxylation; ISS:GOC
Q32P28	LEPRE1	Prolyl 3-hydroxylase 1	GO:0006457; P:protein folding; IMP:UniProt
Q32P28	LEPRE1	Prolyl 3-hydroxylase 1	GO:0018126; P:protein hydroxylation; IMP:UniProt
Q32P28	LEPRE1	Prolyl 3-hydroxylase 1	GO:0050821; P:protein stabilization; IMP:UniProt
Q32P28	LEPRE1	Prolyl 3-hydroxylase 1	GO:0030278; P:regulation of ossification; IEA:Ensembl
Q32P28	LEPRE1	Prolyl 3-hydroxylase 1	GO:0050708; P:regulation of protein secretion; IMP:UniProt
Q8IVL5	LEPREL1	Prolyl 3-hydroxylase 2	GO:0005506; F:iron ion binding; IEA:InterPro
Q8IVL5	LEPREL1	Prolyl 3-hydroxylase 2	GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW
Q8IVL5	LEPREL1	Prolyl 3-hydroxylase 2	GO:0019797; F:procollagen-proline 3-dioxygenase activity; IDA:UniProtKB
Q8IVL5	LEPREL1	Prolyl 3-hydroxylase 2	GO:0032963; P:collagen metabolic process; IDA:UniProtKB
Q8IVL5	LEPREL1	Prolyl 3-hydroxylase 2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q8IVL5	LEPREL1	Prolyl 3-hydroxylase 2	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q8IVL5	LEPREL1	Prolyl 3-hydroxylase 2	GO:0019511; P:peptidyl-proline hydroxylation; IDA:UniProtKB
Q8IVL6	LEPREL2	Prolyl 3-hydroxylase 3	GO:0005506; F:iron ion binding; IEA:InterPro
Q8IVL6	LEPREL2	Prolyl 3-hydroxylase 3	GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW
Q8IVL6	LEPREL2	Prolyl 3-hydroxylase 3	GO:0019797; F:procollagen-proline 3-dioxygenase activity; IEA:UniProtKB-EC
Q8IVL6	LEPREL2	Prolyl 3-hydroxylase 3	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q8IVL6	LEPREL2	Prolyl 3-hydroxylase 3	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q96FE7	PIK3IP1	Phosphoinositide-3-kinase-interacting protein 1	GO:0036313; F:phosphatidylinositol 3-kinase catalytic subunit binding; IPI:UniProtKB
Q96FE7	PIK3IP1	Phosphoinositide-3-kinase-interacting protein 1	GO:0043553; P:negative regulation of phosphatidylinositol 3-kinase activity; IDA:UniProtKB
Q96FE7	PIK3IP1	Phosphoinositide-3-kinase-interacting protein 1	GO:0014067; P:negative regulation of phosphatidylinositol 3-kinase signaling; IDA:UniProtKB
P09131	SLC10A3	P3 protein	GO:0008508; F:bile acid:sodium symporter activity; IEA:InterPro
P09131	SLC10A3	P3 protein	GO:0032526; P:response to retinoic acid; IEA:Ensembl
P13674	P4HA1	Prolyl 4-hydroxylase subunit alpha-1	GO:0005506; F:iron ion binding; IEA:InterPro
P13674	P4HA1	Prolyl 4-hydroxylase subunit alpha-1	GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW
P13674	P4HA1	Prolyl 4-hydroxylase subunit alpha-1	GO:0016702; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; IEA:InterPro
P13674	P4HA1	Prolyl 4-hydroxylase subunit alpha-1	GO:0004656; F:procollagen-proline 4-dioxygenase activity; TAS:ProtInc
P13674	P4HA1	Prolyl 4-hydroxylase subunit alpha-1	GO:0005515; F:protein binding; IPI:IntAct
P13674	P4HA1	Prolyl 4-hydroxylase subunit alpha-1	GO:0030199; P:collagen fibril organization; IEA:Ensembl
P13674	P4HA1	Prolyl 4-hydroxylase subunit alpha-1	GO:0018401; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; IEA:Ensembl
O15460	P4HA2	Prolyl 4-hydroxylase subunit alpha-2	GO:0009055; F:electron carrier activity; TAS:UniProtKB
O15460	P4HA2	Prolyl 4-hydroxylase subunit alpha-2	GO:0005506; F:iron ion binding; IEA:InterPro
O15460	P4HA2	Prolyl 4-hydroxylase subunit alpha-2	GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW
O15460	P4HA2	Prolyl 4-hydroxylase subunit alpha-2	GO:0016702; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; IEA:InterPro
O15460	P4HA2	Prolyl 4-hydroxylase subunit alpha-2	GO:0004656; F:procollagen-proline 4-dioxygenase activity; TAS:ProtInc
O15460	P4HA2	Prolyl 4-hydroxylase subunit alpha-2	GO:0018401; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; IEA:Ensembl
Q7Z4N8	P4HA3	Prolyl 4-hydroxylase subunit alpha-3	GO:0005506; F:iron ion binding; IEA:InterPro
Q7Z4N8	P4HA3	Prolyl 4-hydroxylase subunit alpha-3	GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW
Q7Z4N8	P4HA3	Prolyl 4-hydroxylase subunit alpha-3	GO:0016702; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; IEA:InterPro
Q7Z4N8	P4HA3	Prolyl 4-hydroxylase subunit alpha-3	GO:0004656; F:procollagen-proline 4-dioxygenase activity; IEA:UniProtKB-EC
Q9NXG6	P4HTM	Transmembrane prolyl 4-hydroxylase	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NXG6	P4HTM	Transmembrane prolyl 4-hydroxylase	GO:0005506; F:iron ion binding; IEA:InterPro
Q9NXG6	P4HTM	Transmembrane prolyl 4-hydroxylase	GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW
Q9NXG6	P4HTM	Transmembrane prolyl 4-hydroxylase	GO:0016706; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; IEA:InterPro
Q9BTU6	PI4K2A	Phosphatidylinositol 4-kinase type 2-alpha	GO:0004430; F:1-phosphatidylinositol 4-kinase activity; IDA:UniProtKB
Q9BTU6	PI4K2A	Phosphatidylinositol 4-kinase type 2-alpha	GO:0035651; F:AP-3 adaptor complex binding; IDA:UniProtKB
Q9BTU6	PI4K2A	Phosphatidylinositol 4-kinase type 2-alpha	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BTU6	PI4K2A	Phosphatidylinositol 4-kinase type 2-alpha	GO:0000287; F:magnesium ion binding; NAS:UniProtKB
Q9BTU6	PI4K2A	Phosphatidylinositol 4-kinase type 2-alpha	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BTU6	PI4K2A	Phosphatidylinositol 4-kinase type 2-alpha	GO:0006661; P:phosphatidylinositol biosynthetic process; IDA:UniProtKB
Q9BTU6	PI4K2A	Phosphatidylinositol 4-kinase type 2-alpha	GO:0046854; P:phosphatidylinositol phosphorylation; IDA:GOC
Q9BTU6	PI4K2A	Phosphatidylinositol 4-kinase type 2-alpha	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9BTU6	PI4K2A	Phosphatidylinositol 4-kinase type 2-alpha	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8TCG2	PI4K2B	Phosphatidylinositol 4-kinase type 2-beta	GO:0004430; F:1-phosphatidylinositol 4-kinase activity; IEA:UniProtKB-EC
Q8TCG2	PI4K2B	Phosphatidylinositol 4-kinase type 2-beta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8TCG2	PI4K2B	Phosphatidylinositol 4-kinase type 2-beta	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q8TCG2	PI4K2B	Phosphatidylinositol 4-kinase type 2-beta	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q8TCG2	PI4K2B	Phosphatidylinositol 4-kinase type 2-beta	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5MIZ7	SMEK2	Serine/threonine-protein phosphatase 4 regulatory subunit 3B	GO:0045722; P:positive regulation of gluconeogenesis; IEA:Ensembl
Q5MIZ7	SMEK2	Serine/threonine-protein phosphatase 4 regulatory subunit 3B	GO:0006470; P:protein dephosphorylation; IEA:Ensembl
Q5MIZ7	SMEK2	Serine/threonine-protein phosphatase 4 regulatory subunit 3B	GO:0019216; P:regulation of lipid metabolic process; IEA:Ensembl
Q6IN85	SMEK1	Serine/threonine-protein phosphatase 4 regulatory subunit 3A	GO:0045722; P:positive regulation of gluconeogenesis; IEA:Ensembl
Q6IN85	SMEK1	Serine/threonine-protein phosphatase 4 regulatory subunit 3A	GO:0006470; P:protein dephosphorylation; IEA:Ensembl
O43422	PRKRIR	52 kDa repressor of the inhibitor of the protein kinase	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O43422	PRKRIR	52 kDa repressor of the inhibitor of the protein kinase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43422	PRKRIR	52 kDa repressor of the inhibitor of the protein kinase	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
O43422	PRKRIR	52 kDa repressor of the inhibitor of the protein kinase	GO:0006950; P:response to stress; TAS:ProtInc
O43422	PRKRIR	52 kDa repressor of the inhibitor of the protein kinase	GO:0007165; P:signal transduction; TAS:ProtInc
P04637	TP53	Cellular tumor antigen p53	GO:0005524; F:ATP binding; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0051087; F:chaperone binding; IPI:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0003682; F:chromatin binding; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0005507; F:copper ion binding; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0003684; F:damaged DNA binding; IBA:RefGenome
P04637	TP53	Cellular tumor antigen p53	GO:0003677; F:DNA binding; IMP:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0019899; F:enzyme binding; IPI:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0035035; F:histone acetyltransferase binding; IPI:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0035033; F:histone deacetylase regulator activity; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0042802; F:identical protein binding; IPI:IntAct
P04637	TP53	Cellular tumor antigen p53	GO:0002039; F:p53 binding; IBA:RefGenome
P04637	TP53	Cellular tumor antigen p53	GO:0002020; F:protease binding; IPI:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0005515; F:protein binding; IPI:IntAct
P04637	TP53	Cellular tumor antigen p53	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0051721; F:protein phosphatase 2A binding; IPI:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0019903; F:protein phosphatase binding; IPI:UniProt
P04637	TP53	Cellular tumor antigen p53	GO:0030971; F:receptor tyrosine kinase binding; IPI:BHF-UCL
P04637	TP53	Cellular tumor antigen p53	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0001085; F:RNA polymerase II transcription factor binding; IPI:BHF-UCL
P04637	TP53	Cellular tumor antigen p53	GO:0001228; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:BHF-UCL
P04637	TP53	Cellular tumor antigen p53	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
P04637	TP53	Cellular tumor antigen p53	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0008270; F:zinc ion binding; TAS:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0006915; P:apoptotic process; TAS:Reactome
P04637	TP53	Cellular tumor antigen p53	GO:0002326; P:B cell lineage commitment; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0006284; P:base-excision repair; TAS:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0007596; P:blood coagulation; TAS:Reactome
P04637	TP53	Cellular tumor antigen p53	GO:0007569; P:cell aging; IMP:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0007050; P:cell cycle arrest; IMP:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0030154; P:cell differentiation; TAS:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0008283; P:cell proliferation; TAS:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0034613; P:cellular protein localization; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0035690; P:cellular response to drug; IEP:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0042149; P:cellular response to glucose starvation; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0071456; P:cellular response to hypoxia; IEP:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0071479; P:cellular response to ionizing radiation; IMP:BHF-UCL
P04637	TP53	Cellular tumor antigen p53	GO:0034644; P:cellular response to UV; IBA:RefGenome
P04637	TP53	Cellular tumor antigen p53	GO:0007417; P:central nervous system development; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0031497; P:chromatin assembly; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0008340; P:determination of adult lifespan; ISS:BHF-UCL
P04637	TP53	Cellular tumor antigen p53	GO:0030330; P:DNA damage response, signal transduction by p53 class mediator; IDA:BHF-UCL
P04637	TP53	Cellular tumor antigen p53	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P04637	TP53	Cellular tumor antigen p53	GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IMP:BHF-UCL
P04637	TP53	Cellular tumor antigen p53	GO:0000733; P:DNA strand renaturation; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0006302; P:double-strand break repair; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0048568; P:embryonic organ development; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0006983; P:ER overload response; IDA:MGI
P04637	TP53	Cellular tumor antigen p53	GO:0007369; P:gastrulation; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:HGNC
P04637	TP53	Cellular tumor antigen p53	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IMP:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0071850; P:mitotic cell cycle arrest; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0031571; P:mitotic G1 DNA damage checkpoint; IMP:BHF-UCL
P04637	TP53	Cellular tumor antigen p53	GO:0035264; P:multicellular organism growth; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0007275; P:multicellular organismal development; IMP:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0030308; P:negative regulation of cell growth; IMP:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0008285; P:negative regulation of cell proliferation; ISS:BHF-UCL
P04637	TP53	Cellular tumor antigen p53	GO:0008156; P:negative regulation of DNA replication; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0048147; P:negative regulation of fibroblast proliferation; IMP:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0051097; P:negative regulation of helicase activity; TAS:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:1901525; P:negative regulation of macromitophagy; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0007406; P:negative regulation of neuroblast proliferation; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:2000378; P:negative regulation of reactive oxygen species metabolic process; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:BHF-UCL
P04637	TP53	Cellular tumor antigen p53	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P04637	TP53	Cellular tumor antigen p53	GO:0006289; P:nucleotide-excision repair; IMP:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0097252; P:oligodendrocyte apoptotic process; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0090403; P:oxidative stress-induced premature senescence; IMP:BHF-UCL
P04637	TP53	Cellular tumor antigen p53	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0010666; P:positive regulation of cardiac muscle cell apoptotic process; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0090343; P:positive regulation of cell aging; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0071158; P:positive regulation of cell cycle arrest; IMP:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0031065; P:positive regulation of histone deacetylation; IBA:RefGenome
P04637	TP53	Cellular tumor antigen p53	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0043525; P:positive regulation of neuron apoptotic process; IBA:RefGenome
P04637	TP53	Cellular tumor antigen p53	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISS:BHF-UCL
P04637	TP53	Cellular tumor antigen p53	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
P04637	TP53	Cellular tumor antigen p53	GO:0032461; P:positive regulation of protein oligomerization; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IMP:BHF-UCL
P04637	TP53	Cellular tumor antigen p53	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0070245; P:positive regulation of thymocyte apoptotic process; ISS:BHF-UCL
P04637	TP53	Cellular tumor antigen p53	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0006461; P:protein complex assembly; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0000060; P:protein import into nucleus, translocation; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0008104; P:protein localization; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0051262; P:protein tetramerization; TAS:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0007265; P:Ras protein signal transduction; IEP:BHF-UCL
P04637	TP53	Cellular tumor antigen p53	GO:0042981; P:regulation of apoptotic process; IDA:MGI
P04637	TP53	Cellular tumor antigen p53	GO:0046902; P:regulation of mitochondrial membrane permeability; TAS:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:1902108; P:regulation of mitochondrial membrane permeability involved in apoptotic process; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0034103; P:regulation of tissue remodeling; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0001836; P:release of cytochrome c from mitochondria; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0090399; P:replicative senescence; IMP:BHF-UCL
P04637	TP53	Cellular tumor antigen p53	GO:0046677; P:response to antibiotic; IEP:UniProtKB
P04637	TP53	Cellular tumor antigen p53	GO:0010332; P:response to gamma radiation; IMP:BHF-UCL
P04637	TP53	Cellular tumor antigen p53	GO:0002931; P:response to ischemia; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0009651; P:response to salt stress; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0010165; P:response to X-ray; IBA:RefGenome
P04637	TP53	Cellular tumor antigen p53	GO:0009303; P:rRNA transcription; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0001756; P:somitogenesis; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0002360; P:T cell lineage commitment; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0002309; P:T cell proliferation involved in immune response; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl
P04637	TP53	Cellular tumor antigen p53	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q92569	PIK3R3	Phosphatidylinositol 3-kinase regulatory subunit gamma	GO:0016303; F:1-phosphatidylinositol-3-kinase activity; TAS:ProtInc
Q92569	PIK3R3	Phosphatidylinositol 3-kinase regulatory subunit gamma	GO:0035014; F:phosphatidylinositol 3-kinase regulator activity; IEA:InterPro
Q92569	PIK3R3	Phosphatidylinositol 3-kinase regulatory subunit gamma	GO:0005515; F:protein binding; IPI:IntAct
Q92569	PIK3R3	Phosphatidylinositol 3-kinase regulatory subunit gamma	GO:0008286; P:insulin receptor signaling pathway; TAS:ProtInc
Q92569	PIK3R3	Phosphatidylinositol 3-kinase regulatory subunit gamma	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q92569	PIK3R3	Phosphatidylinositol 3-kinase regulatory subunit gamma	GO:0036092; P:phosphatidylinositol-3-phosphate biosynthetic process; TAS:GOC
Q92569	PIK3R3	Phosphatidylinositol 3-kinase regulatory subunit gamma	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q92569	PIK3R3	Phosphatidylinositol 3-kinase regulatory subunit gamma	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P32322	PYCR1	Pyrroline-5-carboxylate reductase 1, mitochondrial	GO:0042802; F:identical protein binding; IPI:IntAct
P32322	PYCR1	Pyrroline-5-carboxylate reductase 1, mitochondrial	GO:0004735; F:pyrroline-5-carboxylate reductase activity; IEA:UniProtKB-EC
P32322	PYCR1	Pyrroline-5-carboxylate reductase 1, mitochondrial	GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome
P32322	PYCR1	Pyrroline-5-carboxylate reductase 1, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P32322	PYCR1	Pyrroline-5-carboxylate reductase 1, mitochondrial	GO:0034599; P:cellular response to oxidative stress; IMP:UniProtKB
P32322	PYCR1	Pyrroline-5-carboxylate reductase 1, mitochondrial	GO:0055129; P:L-proline biosynthetic process; IEA:UniProtKB-UniPathway
P32322	PYCR1	Pyrroline-5-carboxylate reductase 1, mitochondrial	GO:0006561; P:proline biosynthetic process; IDA:UniProtKB
P32322	PYCR1	Pyrroline-5-carboxylate reductase 1, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96C36	PYCR2	Pyrroline-5-carboxylate reductase 2	GO:0004735; F:pyrroline-5-carboxylate reductase activity; IEA:UniProtKB-EC
Q96C36	PYCR2	Pyrroline-5-carboxylate reductase 2	GO:0055129; P:L-proline biosynthetic process; IEA:UniProtKB-UniPathway
Q53H96	PYCRL	Pyrroline-5-carboxylate reductase 3	GO:0004735; F:pyrroline-5-carboxylate reductase activity; IEA:UniProtKB-EC
Q53H96	PYCRL	Pyrroline-5-carboxylate reductase 3	GO:0055129; P:L-proline biosynthetic process; IEA:UniProtKB-UniPathway
P54886	ALDH18A1	Delta-1-pyrroline-5-carboxylate synthase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P54886	ALDH18A1	Delta-1-pyrroline-5-carboxylate synthase	GO:0004349; F:glutamate 5-kinase activity; IDA:UniProtKB
P54886	ALDH18A1	Delta-1-pyrroline-5-carboxylate synthase	GO:0004350; F:glutamate-5-semialdehyde dehydrogenase activity; IDA:UniProtKB
P54886	ALDH18A1	Delta-1-pyrroline-5-carboxylate synthase	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P54886	ALDH18A1	Delta-1-pyrroline-5-carboxylate synthase	GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome
P54886	ALDH18A1	Delta-1-pyrroline-5-carboxylate synthase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P54886	ALDH18A1	Delta-1-pyrroline-5-carboxylate synthase	GO:0019240; P:citrulline biosynthetic process; IMP:UniProtKB
P54886	ALDH18A1	Delta-1-pyrroline-5-carboxylate synthase	GO:0006536; P:glutamate metabolic process; IMP:UniProtKB
P54886	ALDH18A1	Delta-1-pyrroline-5-carboxylate synthase	GO:0055129; P:L-proline biosynthetic process; IEA:UniProtKB-UniPathway
P54886	ALDH18A1	Delta-1-pyrroline-5-carboxylate synthase	GO:0006592; P:ornithine biosynthetic process; IMP:UniProtKB
P54886	ALDH18A1	Delta-1-pyrroline-5-carboxylate synthase	GO:0006561; P:proline biosynthetic process; IMP:UniProtKB
P54886	ALDH18A1	Delta-1-pyrroline-5-carboxylate synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q06416	POU5F1B	Putative POU domain, class 5, transcription factor 1B	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q06416	POU5F1B	Putative POU domain, class 5, transcription factor 1B	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:UniProtKB
Q06416	POU5F1B	Putative POU domain, class 5, transcription factor 1B	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q06416	POU5F1B	Putative POU domain, class 5, transcription factor 1B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O14683	TP53I11	Tumor protein p53-inducible protein 11	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
O14683	TP53I11	Tumor protein p53-inducible protein 11	GO:0006950; P:response to stress; TAS:ProtInc
Q9H3D4	TP63	Tumor protein 63	GO:0003682; F:chromatin binding; IBA:RefGenome
Q9H3D4	TP63	Tumor protein 63	GO:0003684; F:damaged DNA binding; IBA:RefGenome
Q9H3D4	TP63	Tumor protein 63	GO:0003677; F:DNA binding; NAS:UniProtKB
Q9H3D4	TP63	Tumor protein 63	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
Q9H3D4	TP63	Tumor protein 63	GO:0042802; F:identical protein binding; IPI:UniProtKB
Q9H3D4	TP63	Tumor protein 63	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H3D4	TP63	Tumor protein 63	GO:0002039; F:p53 binding; IBA:RefGenome
Q9H3D4	TP63	Tumor protein 63	GO:0005515; F:protein binding; IPI:IntAct
Q9H3D4	TP63	Tumor protein 63	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0043565; F:sequence-specific DNA binding; IBA:RefGenome
Q9H3D4	TP63	Tumor protein 63	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9H3D4	TP63	Tumor protein 63	GO:0044212; F:transcription regulatory region DNA binding; IEA:InterPro
Q9H3D4	TP63	Tumor protein 63	GO:0006915; P:apoptotic process; TAS:ProtInc
Q9H3D4	TP63	Tumor protein 63	GO:0007569; P:cell aging; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0034644; P:cellular response to UV; IBA:RefGenome
Q9H3D4	TP63	Tumor protein 63	GO:0006338; P:chromatin remodeling; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0060197; P:cloacal septation; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IBA:RefGenome
Q9H3D4	TP63	Tumor protein 63	GO:0007499; P:ectoderm and mesoderm interaction; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0010481; P:epidermal cell division; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0002064; P:epithelial cell development; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0001736; P:establishment of planar polarity; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0048807; P:female genitalia morphogenesis; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IBA:RefGenome
Q9H3D4	TP63	Tumor protein 63	GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0043616; P:keratinocyte proliferation; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0031571; P:mitotic G1 DNA damage checkpoint; IBA:RefGenome
Q9H3D4	TP63	Tumor protein 63	GO:0010259; P:multicellular organismal aging; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0045617; P:negative regulation of keratinocyte differentiation; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:2000381; P:negative regulation of mesoderm development; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q9H3D4	TP63	Tumor protein 63	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9H3D4	TP63	Tumor protein 63	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
Q9H3D4	TP63	Tumor protein 63	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0030859; P:polarized epithelial cell differentiation; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:2000271; P:positive regulation of fibroblast apoptotic process; IDA:UniProtKB
Q9H3D4	TP63	Tumor protein 63	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0045747; P:positive regulation of Notch signaling pathway; IDA:UniProtKB
Q9H3D4	TP63	Tumor protein 63	GO:0045669; P:positive regulation of osteoblast differentiation; IMP:BHF-UCL
Q9H3D4	TP63	Tumor protein 63	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9H3D4	TP63	Tumor protein 63	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9H3D4	TP63	Tumor protein 63	GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0060513; P:prostatic bud formation; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0051289; P:protein homotetramerization; IPI:UniProtKB
Q9H3D4	TP63	Tumor protein 63	GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0043523; P:regulation of neuron apoptotic process; IBA:RefGenome
Q9H3D4	TP63	Tumor protein 63	GO:0010332; P:response to gamma radiation; IBA:RefGenome
Q9H3D4	TP63	Tumor protein 63	GO:0010165; P:response to X-ray; IBA:RefGenome
Q9H3D4	TP63	Tumor protein 63	GO:0001501; P:skeletal system development; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0048745; P:smooth muscle tissue development; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0060529; P:squamous basal epithelial stem cell differentiation involved in prostate gland acinus development; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0048485; P:sympathetic nervous system development; IEA:Ensembl
Q9H3D4	TP63	Tumor protein 63	GO:0060157; P:urinary bladder development; IEA:Ensembl
Q86YP4	GATAD2A	Transcriptional repressor p66-alpha	GO:0005515; F:protein binding; IPI:UniProtKB
Q86YP4	GATAD2A	Transcriptional repressor p66-alpha	GO:0030674; F:protein binding, bridging; IDA:UniProtKB
Q86YP4	GATAD2A	Transcriptional repressor p66-alpha	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q86YP4	GATAD2A	Transcriptional repressor p66-alpha	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q86YP4	GATAD2A	Transcriptional repressor p66-alpha	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86YP4	GATAD2A	Transcriptional repressor p66-alpha	GO:0021506; P:anterior neuropore closure; IEA:Ensembl
Q86YP4	GATAD2A	Transcriptional repressor p66-alpha	GO:0001568; P:blood vessel development; IEA:Ensembl
Q86YP4	GATAD2A	Transcriptional repressor p66-alpha	GO:0006306; P:DNA methylation; TAS:UniProtKB
Q86YP4	GATAD2A	Transcriptional repressor p66-alpha	GO:0010172; P:embryonic body morphogenesis; IEA:Ensembl
Q86YP4	GATAD2A	Transcriptional repressor p66-alpha	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q86YP4	GATAD2A	Transcriptional repressor p66-alpha	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q86YP4	GATAD2A	Transcriptional repressor p66-alpha	GO:0001842; P:neural fold formation; IEA:Ensembl
Q86YP4	GATAD2A	Transcriptional repressor p66-alpha	GO:0012501; P:programmed cell death; IEA:Ensembl
Q86YP4	GATAD2A	Transcriptional repressor p66-alpha	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WXI9	GATAD2B	Transcriptional repressor p66-beta	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q8WXI9	GATAD2B	Transcriptional repressor p66-beta	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8WXI9	GATAD2B	Transcriptional repressor p66-beta	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WXI9	GATAD2B	Transcriptional repressor p66-beta	GO:0043044; P:ATP-dependent chromatin remodeling; IDA:UniProt
Q8WXI9	GATAD2B	Transcriptional repressor p66-beta	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15350	TP73	Tumor protein p73	GO:0003682; F:chromatin binding; IBA:RefGenome
O15350	TP73	Tumor protein p73	GO:0003684; F:damaged DNA binding; IBA:RefGenome
O15350	TP73	Tumor protein p73	GO:0003690; F:double-stranded DNA binding; IBA:RefGenome
O15350	TP73	Tumor protein p73	GO:0042802; F:identical protein binding; IPI:IntAct
O15350	TP73	Tumor protein p73	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15350	TP73	Tumor protein p73	GO:0002039; F:p53 binding; IBA:RefGenome
O15350	TP73	Tumor protein p73	GO:0005515; F:protein binding; IPI:IntAct
O15350	TP73	Tumor protein p73	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O15350	TP73	Tumor protein p73	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
O15350	TP73	Tumor protein p73	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:MGI
O15350	TP73	Tumor protein p73	GO:0008134; F:transcription factor binding; IPI:UniProtKB
O15350	TP73	Tumor protein p73	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
O15350	TP73	Tumor protein p73	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
O15350	TP73	Tumor protein p73	GO:0007050; P:cell cycle arrest; IEA:Ensembl
O15350	TP73	Tumor protein p73	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
O15350	TP73	Tumor protein p73	GO:0034644; P:cellular response to UV; IBA:RefGenome
O15350	TP73	Tumor protein p73	GO:0033326; P:cerebrospinal fluid secretion; IEA:Ensembl
O15350	TP73	Tumor protein p73	GO:0048546; P:digestive tract morphogenesis; IEA:Ensembl
O15350	TP73	Tumor protein p73	GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IBA:RefGenome
O15350	TP73	Tumor protein p73	GO:0021766; P:hippocampus development; IEA:Ensembl
O15350	TP73	Tumor protein p73	GO:0006954; P:inflammatory response; IEA:Ensembl
O15350	TP73	Tumor protein p73	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; TAS:ProtInc
O15350	TP73	Tumor protein p73	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IDA:UniProtKB
O15350	TP73	Tumor protein p73	GO:0001822; P:kidney development; IEA:Ensembl
O15350	TP73	Tumor protein p73	GO:0006298; P:mismatch repair; TAS:ProtInc
O15350	TP73	Tumor protein p73	GO:0031571; P:mitotic G1 DNA damage checkpoint; IBA:RefGenome
O15350	TP73	Tumor protein p73	GO:0043508; P:negative regulation of JUN kinase activity; IBA:RefGenome
O15350	TP73	Tumor protein p73	GO:0043524; P:negative regulation of neuron apoptotic process; IBA:RefGenome
O15350	TP73	Tumor protein p73	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
O15350	TP73	Tumor protein p73	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
O15350	TP73	Tumor protein p73	GO:0048666; P:neuron development; IEA:Ensembl
O15350	TP73	Tumor protein p73	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
O15350	TP73	Tumor protein p73	GO:0045793; P:positive regulation of cell size; IEA:Ensembl
O15350	TP73	Tumor protein p73	GO:1902167; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IEA:Ensembl
O15350	TP73	Tumor protein p73	GO:0048714; P:positive regulation of oligodendrocyte differentiation; IEA:Ensembl
O15350	TP73	Tumor protein p73	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O15350	TP73	Tumor protein p73	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O15350	TP73	Tumor protein p73	GO:0009791; P:post-embryonic development; IEA:Ensembl
O15350	TP73	Tumor protein p73	GO:0051262; P:protein tetramerization; IEA:InterPro
O15350	TP73	Tumor protein p73	GO:0001836; P:release of cytochrome c from mitochondria; IEA:Ensembl
O15350	TP73	Tumor protein p73	GO:0010332; P:response to gamma radiation; IBA:RefGenome
O15350	TP73	Tumor protein p73	GO:0010243; P:response to organonitrogen compound; IEA:Ensembl
O15350	TP73	Tumor protein p73	GO:0010165; P:response to X-ray; IBA:RefGenome
O15350	TP73	Tumor protein p73	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0043125; F:ErbB-3 class receptor binding; IDA:UniProtKB
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0043559; F:insulin binding; IDA:UniProtKB
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0005158; F:insulin receptor binding; IPI:UniProtKB
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0043560; F:insulin receptor substrate binding; ISS:BHF-UCL
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0005159; F:insulin-like growth factor receptor binding; IPI:UniProtKB
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0005168; F:neurotrophin TRKA receptor binding; IPI:UniProtKB
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0043548; F:phosphatidylinositol 3-kinase binding; ISS:BHF-UCL
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0035014; F:phosphatidylinositol 3-kinase regulator activity; ISS:UniProtKB
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0005068; F:transmembrane receptor protein tyrosine kinase adaptor activity; ISS:BHF-UCL
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0030183; P:B cell differentiation; IEA:Ensembl
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0007596; P:blood coagulation; TAS:Reactome
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0034644; P:cellular response to UV; IEA:Ensembl
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0060396; P:growth hormone receptor signaling pathway; IDA:BHF-UCL
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0045087; P:innate immune response; TAS:Reactome
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0008286; P:insulin receptor signaling pathway; IPI:UniProtKB
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0048009; P:insulin-like growth factor receptor signaling pathway; IPI:UniProtKB
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0050900; P:leukocyte migration; TAS:Reactome
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0001953; P:negative regulation of cell-matrix adhesion; IEA:Ensembl
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0045671; P:negative regulation of osteoclast differentiation; IEA:Ensembl
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0051531; P:NFAT protein import into nucleus; IEA:Ensembl
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0014065; P:phosphatidylinositol 3-kinase signaling; IDA:BHF-UCL
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0046854; P:phosphatidylinositol phosphorylation; ISS:UniProtKB
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0030168; P:platelet activation; TAS:Reactome
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; ISS:BHF-UCL
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0046326; P:positive regulation of glucose import; ISS:BHF-UCL
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0032760; P:positive regulation of tumor necrosis factor production; IEA:Ensembl
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0006468; P:protein phosphorylation; IEA:Ensembl
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0043551; P:regulation of phosphatidylinositol 3-kinase activity; ISS:BHF-UCL
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0031295; P:T cell costimulation; TAS:Reactome
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P27986	PIK3R1	Phosphatidylinositol 3-kinase regulatory subunit alpha	GO:0016032; P:viral process; IEA:UniProtKB-KW
O00459	PIK3R2	Phosphatidylinositol 3-kinase regulatory subunit beta	GO:0035014; F:phosphatidylinositol 3-kinase regulator activity; IEA:InterPro
O00459	PIK3R2	Phosphatidylinositol 3-kinase regulatory subunit beta	GO:0005515; F:protein binding; IPI:IntAct
O00459	PIK3R2	Phosphatidylinositol 3-kinase regulatory subunit beta	GO:0030971; F:receptor tyrosine kinase binding; IPI:UniProtKB
O00459	PIK3R2	Phosphatidylinositol 3-kinase regulatory subunit beta	GO:0007596; P:blood coagulation; TAS:Reactome
O00459	PIK3R2	Phosphatidylinositol 3-kinase regulatory subunit beta	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O00459	PIK3R2	Phosphatidylinositol 3-kinase regulatory subunit beta	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O00459	PIK3R2	Phosphatidylinositol 3-kinase regulatory subunit beta	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
O00459	PIK3R2	Phosphatidylinositol 3-kinase regulatory subunit beta	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
O00459	PIK3R2	Phosphatidylinositol 3-kinase regulatory subunit beta	GO:0045087; P:innate immune response; TAS:Reactome
O00459	PIK3R2	Phosphatidylinositol 3-kinase regulatory subunit beta	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
O00459	PIK3R2	Phosphatidylinositol 3-kinase regulatory subunit beta	GO:0050900; P:leukocyte migration; TAS:Reactome
O00459	PIK3R2	Phosphatidylinositol 3-kinase regulatory subunit beta	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O00459	PIK3R2	Phosphatidylinositol 3-kinase regulatory subunit beta	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
O00459	PIK3R2	Phosphatidylinositol 3-kinase regulatory subunit beta	GO:0036092; P:phosphatidylinositol-3-phosphate biosynthetic process; ISS:GOC
O00459	PIK3R2	Phosphatidylinositol 3-kinase regulatory subunit beta	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
O00459	PIK3R2	Phosphatidylinositol 3-kinase regulatory subunit beta	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
O00459	PIK3R2	Phosphatidylinositol 3-kinase regulatory subunit beta	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
O00459	PIK3R2	Phosphatidylinositol 3-kinase regulatory subunit beta	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
O00459	PIK3R2	Phosphatidylinositol 3-kinase regulatory subunit beta	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00459	PIK3R2	Phosphatidylinositol 3-kinase regulatory subunit beta	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P68402	PAFAH1B2	Platelet-activating factor acetylhydrolase IB subunit beta	GO:0003847; F:1-alkyl-2-acetylglycerophosphocholine esterase activity; IEA:UniProtKB-EC
P68402	PAFAH1B2	Platelet-activating factor acetylhydrolase IB subunit beta	GO:0007420; P:brain development; IEA:Ensembl
P68402	PAFAH1B2	Platelet-activating factor acetylhydrolase IB subunit beta	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
P68402	PAFAH1B2	Platelet-activating factor acetylhydrolase IB subunit beta	GO:0006629; P:lipid metabolic process; TAS:ProtInc
P68402	PAFAH1B2	Platelet-activating factor acetylhydrolase IB subunit beta	GO:0016239; P:positive regulation of macroautophagy; IMP:BHF-UCL
P68402	PAFAH1B2	Platelet-activating factor acetylhydrolase IB subunit beta	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q15102	PAFAH1B3	Platelet-activating factor acetylhydrolase IB subunit gamma	GO:0003847; F:1-alkyl-2-acetylglycerophosphocholine esterase activity; IEA:UniProtKB-EC
Q15102	PAFAH1B3	Platelet-activating factor acetylhydrolase IB subunit gamma	GO:0005515; F:protein binding; IPI:IntAct
Q15102	PAFAH1B3	Platelet-activating factor acetylhydrolase IB subunit gamma	GO:0007420; P:brain development; IEA:Ensembl
Q15102	PAFAH1B3	Platelet-activating factor acetylhydrolase IB subunit gamma	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q15102	PAFAH1B3	Platelet-activating factor acetylhydrolase IB subunit gamma	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q15102	PAFAH1B3	Platelet-activating factor acetylhydrolase IB subunit gamma	GO:0007399; P:nervous system development; TAS:ProtInc
Q15102	PAFAH1B3	Platelet-activating factor acetylhydrolase IB subunit gamma	GO:0007283; P:spermatogenesis; IEA:Ensembl
P04054	PLA2G1B	Phospholipase A2	GO:0032052; F:bile acid binding; ISS:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0005509; F:calcium ion binding; IDA:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0047498; F:calcium-dependent phospholipase A2 activity; IDA:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0004623; F:phospholipase A2 activity; IDA:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0005102; F:receptor binding; IPI:UniProtKB
P04054	PLA2G1B	Phospholipase A2	GO:0007015; P:actin filament organization; TAS:ProtInc
P04054	PLA2G1B	Phospholipase A2	GO:0000187; P:activation of MAPK activity; ISS:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0032431; P:activation of phospholipase A2 activity; TAS:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0019731; P:antibacterial humoral response; IDA:UniProt
P04054	PLA2G1B	Phospholipase A2	GO:0050482; P:arachidonic acid secretion; TAS:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0032869; P:cellular response to insulin stimulus; ISS:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProt
P04054	PLA2G1B	Phospholipase A2	GO:0006633; P:fatty acid biosynthetic process; IDA:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0015758; P:glucose transport; ISS:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
P04054	PLA2G1B	Phospholipase A2	GO:0002227; P:innate immune response in mucosa; IDA:UniProt
P04054	PLA2G1B	Phospholipase A2	GO:0032637; P:interleukin-8 production; ISS:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0035556; P:intracellular signal transduction; ISS:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0019370; P:leukotriene biosynthetic process; ISS:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0044240; P:multicellular organismal lipid catabolic process; IDA:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0030593; P:neutrophil chemotaxis; ISS:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0002446; P:neutrophil mediated immunity; ISS:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
P04054	PLA2G1B	Phospholipase A2	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
P04054	PLA2G1B	Phospholipase A2	GO:0046470; P:phosphatidylcholine metabolic process; IDA:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
P04054	PLA2G1B	Phospholipase A2	GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome
P04054	PLA2G1B	Phospholipase A2	GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome
P04054	PLA2G1B	Phospholipase A2	GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome
P04054	PLA2G1B	Phospholipase A2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P04054	PLA2G1B	Phospholipase A2	GO:0010524; P:positive regulation of calcium ion transport into cytosol; ISS:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0045740; P:positive regulation of DNA replication; IDA:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0048146; P:positive regulation of fibroblast proliferation; IC:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0050778; P:positive regulation of immune response; ISS:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0050714; P:positive regulation of protein secretion; TAS:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P04054	PLA2G1B	Phospholipase A2	GO:0007165; P:signal transduction; TAS:ProtInc
P04054	PLA2G1B	Phospholipase A2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0047498; F:calcium-dependent phospholipase A2 activity; EXP:Reactome
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0005544; F:calcium-dependent phospholipid binding; IDA:UniProtKB
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0004622; F:lysophospholipase activity; IEA:UniProtKB-EC
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0004623; F:phospholipase A2 activity; IDA:UniProtKB
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0050482; P:arachidonic acid secretion; IEA:Ensembl
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0007596; P:blood coagulation; TAS:Reactome
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0035965; P:cardiolipin acyl-chain remodeling; TAS:Reactome
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0071236; P:cellular response to antibiotic; IEA:Ensembl
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0046456; P:icosanoid biosynthetic process; IEA:Ensembl
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0006690; P:icosanoid metabolic process; NAS:UniProtKB
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0009395; P:phospholipid catabolic process; IEA:InterPro
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0006663; P:platelet activating factor biosynthetic process; NAS:UniProtKB
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0030168; P:platelet activation; TAS:Reactome
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P47712	PLA2G4A	Cytosolic phospholipase A2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P0C869	PLA2G4B	Cytosolic phospholipase A2 beta	GO:0005509; F:calcium ion binding; NAS:UniProtKB
P0C869	PLA2G4B	Cytosolic phospholipase A2 beta	GO:0047498; F:calcium-dependent phospholipase A2 activity; IDA:UniProtKB
P0C869	PLA2G4B	Cytosolic phospholipase A2 beta	GO:0005544; F:calcium-dependent phospholipid binding; NAS:UniProtKB
P0C869	PLA2G4B	Cytosolic phospholipase A2 beta	GO:0004622; F:lysophospholipase activity; NAS:UniProtKB
P0C869	PLA2G4B	Cytosolic phospholipase A2 beta	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P0C869	PLA2G4B	Cytosolic phospholipase A2 beta	GO:0019369; P:arachidonic acid metabolic process; NAS:UniProtKB
P0C869	PLA2G4B	Cytosolic phospholipase A2 beta	GO:0019722; P:calcium-mediated signaling; NAS:UniProtKB
P0C869	PLA2G4B	Cytosolic phospholipase A2 beta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P0C869	PLA2G4B	Cytosolic phospholipase A2 beta	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P0C869	PLA2G4B	Cytosolic phospholipase A2 beta	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
P0C869	PLA2G4B	Cytosolic phospholipase A2 beta	GO:0046475; P:glycerophospholipid catabolic process; IDA:UniProtKB
P0C869	PLA2G4B	Cytosolic phospholipase A2 beta	GO:0006954; P:inflammatory response; NAS:UniProtKB
P0C869	PLA2G4B	Cytosolic phospholipase A2 beta	GO:0007567; P:parturition; NAS:UniProtKB
P0C869	PLA2G4B	Cytosolic phospholipase A2 beta	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
P0C869	PLA2G4B	Cytosolic phospholipase A2 beta	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
P0C869	PLA2G4B	Cytosolic phospholipase A2 beta	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
P0C869	PLA2G4B	Cytosolic phospholipase A2 beta	GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome
P0C869	PLA2G4B	Cytosolic phospholipase A2 beta	GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome
P0C869	PLA2G4B	Cytosolic phospholipase A2 beta	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P0C869	PLA2G4B	Cytosolic phospholipase A2 beta	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UP65	PLA2G4C	Cytosolic phospholipase A2 gamma	GO:0047499; F:calcium-independent phospholipase A2 activity; IDA:UniProtKB
Q9UP65	PLA2G4C	Cytosolic phospholipase A2 gamma	GO:0005543; F:phospholipid binding; NAS:UniProtKB
Q9UP65	PLA2G4C	Cytosolic phospholipase A2 gamma	GO:0019369; P:arachidonic acid metabolic process; NAS:UniProtKB
Q9UP65	PLA2G4C	Cytosolic phospholipase A2 gamma	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9UP65	PLA2G4C	Cytosolic phospholipase A2 gamma	GO:0046475; P:glycerophospholipid catabolic process; IDA:UniProtKB
Q9UP65	PLA2G4C	Cytosolic phospholipase A2 gamma	GO:0006954; P:inflammatory response; NAS:UniProtKB
Q9UP65	PLA2G4C	Cytosolic phospholipase A2 gamma	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
Q9UP65	PLA2G4C	Cytosolic phospholipase A2 gamma	GO:0007567; P:parturition; NAS:UniProtKB
Q9UP65	PLA2G4C	Cytosolic phospholipase A2 gamma	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
Q9UP65	PLA2G4C	Cytosolic phospholipase A2 gamma	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
Q9UP65	PLA2G4C	Cytosolic phospholipase A2 gamma	GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome
Q9UP65	PLA2G4C	Cytosolic phospholipase A2 gamma	GO:0006644; P:phospholipid metabolic process; TAS:UniProtKB
Q9UP65	PLA2G4C	Cytosolic phospholipase A2 gamma	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q86XP0	PLA2G4D	Cytosolic phospholipase A2 delta	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86XP0	PLA2G4D	Cytosolic phospholipase A2 delta	GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC
Q86XP0	PLA2G4D	Cytosolic phospholipase A2 delta	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q86XP0	PLA2G4D	Cytosolic phospholipase A2 delta	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
Q86XP0	PLA2G4D	Cytosolic phospholipase A2 delta	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
Q86XP0	PLA2G4D	Cytosolic phospholipase A2 delta	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
Q86XP0	PLA2G4D	Cytosolic phospholipase A2 delta	GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome
Q86XP0	PLA2G4D	Cytosolic phospholipase A2 delta	GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome
Q86XP0	PLA2G4D	Cytosolic phospholipase A2 delta	GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome
Q86XP0	PLA2G4D	Cytosolic phospholipase A2 delta	GO:0009395; P:phospholipid catabolic process; IEA:InterPro
Q86XP0	PLA2G4D	Cytosolic phospholipase A2 delta	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q86XP0	PLA2G4D	Cytosolic phospholipase A2 delta	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q3MJ16	PLA2G4E	Cytosolic phospholipase A2 epsilon	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q3MJ16	PLA2G4E	Cytosolic phospholipase A2 epsilon	GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC
Q3MJ16	PLA2G4E	Cytosolic phospholipase A2 epsilon	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q3MJ16	PLA2G4E	Cytosolic phospholipase A2 epsilon	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
Q3MJ16	PLA2G4E	Cytosolic phospholipase A2 epsilon	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
Q3MJ16	PLA2G4E	Cytosolic phospholipase A2 epsilon	GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome
Q3MJ16	PLA2G4E	Cytosolic phospholipase A2 epsilon	GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome
Q3MJ16	PLA2G4E	Cytosolic phospholipase A2 epsilon	GO:0009395; P:phospholipid catabolic process; IEA:InterPro
Q3MJ16	PLA2G4E	Cytosolic phospholipase A2 epsilon	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q3MJ16	PLA2G4E	Cytosolic phospholipase A2 epsilon	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q68DD2	PLA2G4F	Cytosolic phospholipase A2 zeta	GO:0047498; F:calcium-dependent phospholipase A2 activity; IEA:Ensembl
Q68DD2	PLA2G4F	Cytosolic phospholipase A2 zeta	GO:0004622; F:lysophospholipase activity; IEA:Ensembl
Q68DD2	PLA2G4F	Cytosolic phospholipase A2 zeta	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q68DD2	PLA2G4F	Cytosolic phospholipase A2 zeta	GO:0050482; P:arachidonic acid secretion; IEA:Ensembl
Q68DD2	PLA2G4F	Cytosolic phospholipase A2 zeta	GO:0071236; P:cellular response to antibiotic; IEA:Ensembl
Q68DD2	PLA2G4F	Cytosolic phospholipase A2 zeta	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
Q68DD2	PLA2G4F	Cytosolic phospholipase A2 zeta	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q68DD2	PLA2G4F	Cytosolic phospholipase A2 zeta	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
Q68DD2	PLA2G4F	Cytosolic phospholipase A2 zeta	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
Q68DD2	PLA2G4F	Cytosolic phospholipase A2 zeta	GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome
Q68DD2	PLA2G4F	Cytosolic phospholipase A2 zeta	GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome
Q68DD2	PLA2G4F	Cytosolic phospholipase A2 zeta	GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome
Q68DD2	PLA2G4F	Cytosolic phospholipase A2 zeta	GO:0009395; P:phospholipid catabolic process; IEA:InterPro
Q68DD2	PLA2G4F	Cytosolic phospholipase A2 zeta	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q68DD2	PLA2G4F	Cytosolic phospholipase A2 zeta	GO:0001516; P:prostaglandin biosynthetic process; IEA:Ensembl
Q68DD2	PLA2G4F	Cytosolic phospholipase A2 zeta	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NZ20	PLA2G3	Group 3 secretory phospholipase A2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NZ20	PLA2G3	Group 3 secretory phospholipase A2	GO:0047498; F:calcium-dependent phospholipase A2 activity; TAS:ProtInc
Q9NZ20	PLA2G3	Group 3 secretory phospholipase A2	GO:0060271; P:cilium morphogenesis; IMP:UniProtKB
Q9NZ20	PLA2G3	Group 3 secretory phospholipase A2	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9NZ20	PLA2G3	Group 3 secretory phospholipase A2	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q9NZ20	PLA2G3	Group 3 secretory phospholipase A2	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
Q9NZ20	PLA2G3	Group 3 secretory phospholipase A2	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
Q9NZ20	PLA2G3	Group 3 secretory phospholipase A2	GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome
Q9NZ20	PLA2G3	Group 3 secretory phospholipase A2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9NZ20	PLA2G3	Group 3 secretory phospholipase A2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UQ80	PA2G4	Proliferation-associated protein 2G4	GO:0003677; F:DNA binding; IDA:MGI
Q9UQ80	PA2G4	Proliferation-associated protein 2G4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UQ80	PA2G4	Proliferation-associated protein 2G4	GO:0005515; F:protein binding; IPI:IntAct
Q9UQ80	PA2G4	Proliferation-associated protein 2G4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:MGI
Q9UQ80	PA2G4	Proliferation-associated protein 2G4	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q9UQ80	PA2G4	Proliferation-associated protein 2G4	GO:0007050; P:cell cycle arrest; TAS:ProtInc
Q9UQ80	PA2G4	Proliferation-associated protein 2G4	GO:0008283; P:cell proliferation; TAS:ProtInc
Q9UQ80	PA2G4	Proliferation-associated protein 2G4	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:MGI
Q9UQ80	PA2G4	Proliferation-associated protein 2G4	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q9UQ80	PA2G4	Proliferation-associated protein 2G4	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q9UQ80	PA2G4	Proliferation-associated protein 2G4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P39877	PLA2G5	Calcium-dependent phospholipase A2	GO:0005509; F:calcium ion binding; IEA:InterPro
P39877	PLA2G5	Calcium-dependent phospholipase A2	GO:0047498; F:calcium-dependent phospholipase A2 activity; TAS:ProtInc
P39877	PLA2G5	Calcium-dependent phospholipase A2	GO:0008201; F:heparin binding; IEA:Ensembl
P39877	PLA2G5	Calcium-dependent phospholipase A2	GO:0050482; P:arachidonic acid secretion; IEA:Ensembl
P39877	PLA2G5	Calcium-dependent phospholipase A2	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
P39877	PLA2G5	Calcium-dependent phospholipase A2	GO:0019370; P:leukotriene biosynthetic process; IEA:Ensembl
P39877	PLA2G5	Calcium-dependent phospholipase A2	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
P39877	PLA2G5	Calcium-dependent phospholipase A2	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
P39877	PLA2G5	Calcium-dependent phospholipase A2	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
P39877	PLA2G5	Calcium-dependent phospholipase A2	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
P39877	PLA2G5	Calcium-dependent phospholipase A2	GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome
P39877	PLA2G5	Calcium-dependent phospholipase A2	GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome
P39877	PLA2G5	Calcium-dependent phospholipase A2	GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome
P39877	PLA2G5	Calcium-dependent phospholipase A2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P39877	PLA2G5	Calcium-dependent phospholipase A2	GO:0006663; P:platelet activating factor biosynthetic process; IEA:Ensembl
P39877	PLA2G5	Calcium-dependent phospholipase A2	GO:0051591; P:response to cAMP; IEA:Ensembl
P39877	PLA2G5	Calcium-dependent phospholipase A2	GO:0034097; P:response to cytokine; IEA:Ensembl
P39877	PLA2G5	Calcium-dependent phospholipase A2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P14555	PLA2G2A	Phospholipase A2, membrane associated	GO:0005509; F:calcium ion binding; IEA:InterPro
P14555	PLA2G2A	Phospholipase A2, membrane associated	GO:0047498; F:calcium-dependent phospholipase A2 activity; TAS:UniProtKB
P14555	PLA2G2A	Phospholipase A2, membrane associated	GO:0004623; F:phospholipase A2 activity; IDA:BHF-UCL
P14555	PLA2G2A	Phospholipase A2, membrane associated	GO:0005543; F:phospholipid binding; IDA:BHF-UCL
P14555	PLA2G2A	Phospholipase A2, membrane associated	GO:0050830; P:defense response to Gram-positive bacterium; TAS:BHF-UCL
P14555	PLA2G2A	Phospholipase A2, membrane associated	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
P14555	PLA2G2A	Phospholipase A2, membrane associated	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
P14555	PLA2G2A	Phospholipase A2, membrane associated	GO:0034374; P:low-density lipoprotein particle remodeling; TAS:BHF-UCL
P14555	PLA2G2A	Phospholipase A2, membrane associated	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
P14555	PLA2G2A	Phospholipase A2, membrane associated	GO:0046473; P:phosphatidic acid metabolic process; IDA:BHF-UCL
P14555	PLA2G2A	Phospholipase A2, membrane associated	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
P14555	PLA2G2A	Phospholipase A2, membrane associated	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
P14555	PLA2G2A	Phospholipase A2, membrane associated	GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome
P14555	PLA2G2A	Phospholipase A2, membrane associated	GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome
P14555	PLA2G2A	Phospholipase A2, membrane associated	GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome
P14555	PLA2G2A	Phospholipase A2, membrane associated	GO:0006644; P:phospholipid metabolic process; IDA:BHF-UCL
P14555	PLA2G2A	Phospholipase A2, membrane associated	GO:0050729; P:positive regulation of inflammatory response; TAS:BHF-UCL
P14555	PLA2G2A	Phospholipase A2, membrane associated	GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; TAS:BHF-UCL
P14555	PLA2G2A	Phospholipase A2, membrane associated	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5R387	PLA2G2C	Putative inactive group IIC secretory phospholipase A2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q5R387	PLA2G2C	Putative inactive group IIC secretory phospholipase A2	GO:0047498; F:calcium-dependent phospholipase A2 activity; IEA:Ensembl
Q5R387	PLA2G2C	Putative inactive group IIC secretory phospholipase A2	GO:0016042; P:lipid catabolic process; IEA:InterPro
Q5R387	PLA2G2C	Putative inactive group IIC secretory phospholipase A2	GO:0006644; P:phospholipid metabolic process; IEA:InterPro
Q9BZM2	PLA2G2F	Group IIF secretory phospholipase A2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9BZM2	PLA2G2F	Group IIF secretory phospholipase A2	GO:0004623; F:phospholipase A2 activity; NAS:UniProtKB
Q9BZM2	PLA2G2F	Group IIF secretory phospholipase A2	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9BZM2	PLA2G2F	Group IIF secretory phospholipase A2	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q9BZM2	PLA2G2F	Group IIF secretory phospholipase A2	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
Q9BZM2	PLA2G2F	Group IIF secretory phospholipase A2	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
Q9BZM2	PLA2G2F	Group IIF secretory phospholipase A2	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
Q9BZM2	PLA2G2F	Group IIF secretory phospholipase A2	GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome
Q9BZM2	PLA2G2F	Group IIF secretory phospholipase A2	GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome
Q9BZM2	PLA2G2F	Group IIF secretory phospholipase A2	GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome
Q9BZM2	PLA2G2F	Group IIF secretory phospholipase A2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9BZM2	PLA2G2F	Group IIF secretory phospholipase A2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NZK7	PLA2G2E	Group IIE secretory phospholipase A2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NZK7	PLA2G2E	Group IIE secretory phospholipase A2	GO:0004623; F:phospholipase A2 activity; TAS:ProtInc
Q9NZK7	PLA2G2E	Group IIE secretory phospholipase A2	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9NZK7	PLA2G2E	Group IIE secretory phospholipase A2	GO:0006954; P:inflammatory response; TAS:ProtInc
Q9NZK7	PLA2G2E	Group IIE secretory phospholipase A2	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q9NZK7	PLA2G2E	Group IIE secretory phospholipase A2	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
Q9NZK7	PLA2G2E	Group IIE secretory phospholipase A2	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
Q9NZK7	PLA2G2E	Group IIE secretory phospholipase A2	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
Q9NZK7	PLA2G2E	Group IIE secretory phospholipase A2	GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome
Q9NZK7	PLA2G2E	Group IIE secretory phospholipase A2	GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome
Q9NZK7	PLA2G2E	Group IIE secretory phospholipase A2	GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome
Q9NZK7	PLA2G2E	Group IIE secretory phospholipase A2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9NZK7	PLA2G2E	Group IIE secretory phospholipase A2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UNK4	PLA2G2D	Group IID secretory phospholipase A2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UNK4	PLA2G2D	Group IID secretory phospholipase A2	GO:0004623; F:phospholipase A2 activity; TAS:ProtInc
Q9UNK4	PLA2G2D	Group IID secretory phospholipase A2	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9UNK4	PLA2G2D	Group IID secretory phospholipase A2	GO:0006954; P:inflammatory response; TAS:ProtInc
Q9UNK4	PLA2G2D	Group IID secretory phospholipase A2	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q9UNK4	PLA2G2D	Group IID secretory phospholipase A2	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
Q9UNK4	PLA2G2D	Group IID secretory phospholipase A2	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
Q9UNK4	PLA2G2D	Group IID secretory phospholipase A2	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
Q9UNK4	PLA2G2D	Group IID secretory phospholipase A2	GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome
Q9UNK4	PLA2G2D	Group IID secretory phospholipase A2	GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome
Q9UNK4	PLA2G2D	Group IID secretory phospholipase A2	GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome
Q9UNK4	PLA2G2D	Group IID secretory phospholipase A2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9UNK4	PLA2G2D	Group IID secretory phospholipase A2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0005509; F:calcium ion binding; IEA:InterPro
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0004623; F:phospholipase A2 activity; TAS:ProtInc
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0004620; F:phospholipase activity; ISS:BHF-UCL
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0019369; P:arachidonic acid metabolic process; NAS:BHF-UCL
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0007411; P:axon guidance; IDA:MGI
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0042632; P:cholesterol homeostasis; ISS:BHF-UCL
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0051977; P:lysophospholipid transport; IDA:MGI
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0090370; P:negative regulation of cholesterol efflux; ISS:BHF-UCL
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0090238; P:positive regulation of arachidonic acid secretion; ISS:BHF-UCL
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0032270; P:positive regulation of cellular protein metabolic process; IMP:BHF-UCL
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0010884; P:positive regulation of lipid storage; IMP:BHF-UCL
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; IC:BHF-UCL
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0032308; P:positive regulation of prostaglandin secretion; IMP:BHF-UCL
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0043030; P:regulation of macrophage activation; IMP:BHF-UCL
O15496	PLA2G10	Group 10 secretory phospholipase A2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BRP4	PAAF1	Proteasomal ATPase-associated factor 1	GO:0005515; F:protein binding; IPI:IntAct
Q9BRP4	PAAF1	Proteasomal ATPase-associated factor 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
P0CB38	PABPC4L	Polyadenylate-binding protein 4-like	GO:0000166; F:nucleotide binding; IEA:InterPro
P0CB38	PABPC4L	Polyadenylate-binding protein 4-like	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0000166; F:nucleotide binding; IEA:InterPro
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0008143; F:poly(A) binding; TAS:UniProtKB
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0008266; F:poly(U) RNA binding; IDA:MGI
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0008494; F:translation activator activity; TAS:UniProtKB
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0010467; P:gene expression; TAS:Reactome
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0031047; P:gene silencing by RNA; ISS:UniProtKB
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0006378; P:mRNA polyadenylation; TAS:UniProtKB
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0048255; P:mRNA stabilization; TAS:UniProtKB
P11940	PABPC1	Polyadenylate-binding protein 1	GO:2000623; P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IDA:UniProtKB
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
P11940	PABPC1	Polyadenylate-binding protein 1	GO:1900153; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; ISS:UniProtKB
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; ISS:UniProtKB
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0045727; P:positive regulation of translation; TAS:GOC
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0016070; P:RNA metabolic process; TAS:Reactome
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0006412; P:translation; TAS:Reactome
P11940	PABPC1	Polyadenylate-binding protein 1	GO:0006413; P:translational initiation; TAS:Reactome
Q86U42	PABPN1	Polyadenylate-binding protein 2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q86U42	PABPN1	Polyadenylate-binding protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q86U42	PABPN1	Polyadenylate-binding protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q86U42	PABPN1	Polyadenylate-binding protein 2	GO:0003723; F:RNA binding; TAS:ProtInc
Q86U42	PABPN1	Polyadenylate-binding protein 2	GO:0010467; P:gene expression; TAS:Reactome
Q86U42	PABPN1	Polyadenylate-binding protein 2	GO:0046778; P:modification by virus of host mRNA processing; TAS:Reactome
Q86U42	PABPN1	Polyadenylate-binding protein 2	GO:0019048; P:modulation by virus of host morphology or physiology; TAS:Reactome
Q86U42	PABPN1	Polyadenylate-binding protein 2	GO:0019054; P:modulation by virus of host process; TAS:Reactome
Q86U42	PABPN1	Polyadenylate-binding protein 2	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q86U42	PABPN1	Polyadenylate-binding protein 2	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q86U42	PABPN1	Polyadenylate-binding protein 2	GO:0006936; P:muscle contraction; TAS:ProtInc
Q86U42	PABPN1	Polyadenylate-binding protein 2	GO:0016973; P:poly(A)+ mRNA export from nucleus; IMP:UniProtKB
Q86U42	PABPN1	Polyadenylate-binding protein 2	GO:0006396; P:RNA processing; TAS:ProtInc
Q86U42	PABPN1	Polyadenylate-binding protein 2	GO:0008380; P:RNA splicing; TAS:Reactome
Q86U42	PABPN1	Polyadenylate-binding protein 2	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q86U42	PABPN1	Polyadenylate-binding protein 2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q86U42	PABPN1	Polyadenylate-binding protein 2	GO:0019058; P:viral life cycle; TAS:Reactome
Q9H361	PABPC3	Polyadenylate-binding protein 3	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9H361	PABPC3	Polyadenylate-binding protein 3	GO:0008143; F:poly(A) binding; IDA:UniProtKB
Q9H361	PABPC3	Polyadenylate-binding protein 3	GO:0016071; P:mRNA metabolic process; NAS:UniProtKB
Q96DU9	PABPC5	Polyadenylate-binding protein 5	GO:0000166; F:nucleotide binding; IEA:InterPro
Q96DU9	PABPC5	Polyadenylate-binding protein 5	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q13310	PABPC4	Polyadenylate-binding protein 4	GO:0000166; F:nucleotide binding; IEA:InterPro
Q13310	PABPC4	Polyadenylate-binding protein 4	GO:0008143; F:poly(A) binding; IDA:MGI
Q13310	PABPC4	Polyadenylate-binding protein 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13310	PABPC4	Polyadenylate-binding protein 4	GO:0008266; F:poly(U) RNA binding; IDA:MGI
Q13310	PABPC4	Polyadenylate-binding protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q13310	PABPC4	Polyadenylate-binding protein 4	GO:0007596; P:blood coagulation; TAS:ProtInc
Q13310	PABPC4	Polyadenylate-binding protein 4	GO:0006401; P:RNA catabolic process; TAS:ProtInc
Q13310	PABPC4	Polyadenylate-binding protein 4	GO:0006396; P:RNA processing; TAS:ProtInc
Q13310	PABPC4	Polyadenylate-binding protein 4	GO:0006412; P:translation; TAS:ProtInc
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0005184; F:neuropeptide hormone activity; IDA:UniProtKB
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0051428; F:peptide hormone receptor binding; IDA:UniProtKB
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0016521; F:pituitary adenylate cyclase activating polypeptide activity; IDA:BHF-UCL
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0005102; F:receptor binding; IPI:BHF-UCL
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0005057; F:receptor signaling protein activity; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0007190; P:activation of adenylate cyclase activity; TAS:Reactome
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0046034; P:ATP metabolic process; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0001662; P:behavioral fear response; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0019933; P:cAMP-mediated signaling; IMP:UniProtKB
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0071385; P:cellular response to glucocorticoid stimulus; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0007565; P:female pregnancy; TAS:ProtInc
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0001821; P:histamine secretion; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0002865; P:negative regulation of acute inflammatory response to antigenic stimulus; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0002878; P:negative regulation of acute inflammatory response to non-antigenic stimulus; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0045786; P:negative regulation of cell cycle; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0060253; P:negative regulation of glial cell proliferation; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0010656; P:negative regulation of muscle cell apoptotic process; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0043267; P:negative regulation of potassium ion transport; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0034259; P:negative regulation of Rho GTPase activity; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0031175; P:neuron projection development; IDA:UniProtKB
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0007218; P:neuropeptide signaling pathway; IDA:UniProtKB
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0001541; P:ovarian follicle development; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0021983; P:pituitary gland development; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0010579; P:positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway; IDA:BHF-UCL
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0060124; P:positive regulation of growth hormone secretion; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0045860; P:positive regulation of protein kinase activity; IDA:UniProtKB
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0032854; P:positive regulation of Rap GTPase activity; IDA:UniProtKB
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0090274; P:positive regulation of somatostatin secretion; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0045909; P:positive regulation of vasodilation; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; IDA:UniProtKB
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0070445; P:regulation of oligodendrocyte progenitor proliferation; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0060078; P:regulation of postsynaptic membrane potential; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0032880; P:regulation of protein localization; IDA:BHF-UCL
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0045471; P:response to ethanol; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0042594; P:response to starvation; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:Reactome
Q8IZE3	SCYL3	Protein-associating with the carboxyl-terminal domain of ezrin	GO:0005524; F:ATP binding; IEA:InterPro
Q8IZE3	SCYL3	Protein-associating with the carboxyl-terminal domain of ezrin	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IZE3	SCYL3	Protein-associating with the carboxyl-terminal domain of ezrin	GO:0016772; F:transferase activity, transferring phosphorus-containing groups; IEA:InterPro
Q8IZE3	SCYL3	Protein-associating with the carboxyl-terminal domain of ezrin	GO:0016477; P:cell migration; NAS:UniProtKB
Q8IZE3	SCYL3	Protein-associating with the carboxyl-terminal domain of ezrin	GO:0006468; P:protein phosphorylation; IEA:InterPro
Q9BY11	PACSIN1	Protein kinase C and casein kinase substrate in neurons protein 1	GO:0005543; F:phospholipid binding; IDA:UniProtKB
Q9BY11	PACSIN1	Protein kinase C and casein kinase substrate in neurons protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9BY11	PACSIN1	Protein kinase C and casein kinase substrate in neurons protein 1	GO:0090002; P:establishment of protein localization to plasma membrane; ISS:BHF-UCL
Q9BY11	PACSIN1	Protein kinase C and casein kinase substrate in neurons protein 1	GO:0097320; P:membrane tubulation; IDA:UniProtKB
Q9BY11	PACSIN1	Protein kinase C and casein kinase substrate in neurons protein 1	GO:0045806; P:negative regulation of endocytosis; IEA:Ensembl
Q9BY11	PACSIN1	Protein kinase C and casein kinase substrate in neurons protein 1	GO:0048812; P:neuron projection morphogenesis; ISS:UniProtKB
Q9BY11	PACSIN1	Protein kinase C and casein kinase substrate in neurons protein 1	GO:1900006; P:positive regulation of dendrite development; ISS:BHF-UCL
Q9BY11	PACSIN1	Protein kinase C and casein kinase substrate in neurons protein 1	GO:0072657; P:protein localization to membrane; ISS:UniProtKB
Q9BY11	PACSIN1	Protein kinase C and casein kinase substrate in neurons protein 1	GO:0048488; P:synaptic vesicle endocytosis; ISS:UniProtKB
Q9UNF0	PACSIN2	Protein kinase C and casein kinase substrate in neurons protein 2	GO:0042802; F:identical protein binding; IPI:IntAct
Q9UNF0	PACSIN2	Protein kinase C and casein kinase substrate in neurons protein 2	GO:0070300; F:phosphatidic acid binding; IDA:UniProtKB
Q9UNF0	PACSIN2	Protein kinase C and casein kinase substrate in neurons protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UNF0	PACSIN2	Protein kinase C and casein kinase substrate in neurons protein 2	GO:0005215; F:transporter activity; TAS:ProtInc
Q9UNF0	PACSIN2	Protein kinase C and casein kinase substrate in neurons protein 2	GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc
Q9UNF0	PACSIN2	Protein kinase C and casein kinase substrate in neurons protein 2	GO:0070836; P:caveola assembly; IMP:UniProtKB
Q9UNF0	PACSIN2	Protein kinase C and casein kinase substrate in neurons protein 2	GO:0072584; P:caveolin-mediated endocytosis; IMP:UniProtKB
Q9UNF0	PACSIN2	Protein kinase C and casein kinase substrate in neurons protein 2	GO:0048858; P:cell projection morphogenesis; ISS:UniProtKB
Q9UNF0	PACSIN2	Protein kinase C and casein kinase substrate in neurons protein 2	GO:0097320; P:membrane tubulation; IDA:UniProtKB
Q9UNF0	PACSIN2	Protein kinase C and casein kinase substrate in neurons protein 2	GO:0045806; P:negative regulation of endocytosis; IEA:Ensembl
Q9UNF0	PACSIN2	Protein kinase C and casein kinase substrate in neurons protein 2	GO:0036010; P:protein localization to endosome; IMP:UniProtKB
Q9UKS6	PACSIN3	Protein kinase C and casein kinase substrate in neurons protein 3	GO:0019855; F:calcium channel inhibitor activity; ISS:UniProtKB
Q9UKS6	PACSIN3	Protein kinase C and casein kinase substrate in neurons protein 3	GO:0008092; F:cytoskeletal protein binding; ISS:UniProtKB
Q9UKS6	PACSIN3	Protein kinase C and casein kinase substrate in neurons protein 3	GO:0008289; F:lipid binding; IDA:UniProtKB
Q9UKS6	PACSIN3	Protein kinase C and casein kinase substrate in neurons protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q9UKS6	PACSIN3	Protein kinase C and casein kinase substrate in neurons protein 3	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q9UKS6	PACSIN3	Protein kinase C and casein kinase substrate in neurons protein 3	GO:0097320; P:membrane tubulation; IDA:UniProtKB
Q9UKS6	PACSIN3	Protein kinase C and casein kinase substrate in neurons protein 3	GO:0051926; P:negative regulation of calcium ion transport; ISS:UniProtKB
Q9UKS6	PACSIN3	Protein kinase C and casein kinase substrate in neurons protein 3	GO:0045806; P:negative regulation of endocytosis; ISS:UniProtKB
Q9UKS6	PACSIN3	Protein kinase C and casein kinase substrate in neurons protein 3	GO:0051044; P:positive regulation of membrane protein ectodomain proteolysis; IMP:BHF-UCL
Q96M98	PACRG	Parkin coregulated gene protein	GO:0007286; P:spermatid development; IEA:Ensembl
P41586	ADCYAP1R1	Pituitary adenylate cyclase-activating polypeptide type I receptor	GO:0042923; F:neuropeptide binding; IEA:Ensembl
P41586	ADCYAP1R1	Pituitary adenylate cyclase-activating polypeptide type I receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P41586	ADCYAP1R1	Pituitary adenylate cyclase-activating polypeptide type I receptor	GO:0004872; F:receptor activity; TAS:ProtInc
P41586	ADCYAP1R1	Pituitary adenylate cyclase-activating polypeptide type I receptor	GO:0004999; F:vasoactive intestinal polypeptide receptor activity; IEA:InterPro
P41586	ADCYAP1R1	Pituitary adenylate cyclase-activating polypeptide type I receptor	GO:0007190; P:activation of adenylate cyclase activity; TAS:Reactome
P41586	ADCYAP1R1	Pituitary adenylate cyclase-activating polypeptide type I receptor	GO:0007202; P:activation of phospholipase C activity; IEA:Ensembl
P41586	ADCYAP1R1	Pituitary adenylate cyclase-activating polypeptide type I receptor	GO:0019933; P:cAMP-mediated signaling; IEA:Ensembl
P41586	ADCYAP1R1	Pituitary adenylate cyclase-activating polypeptide type I receptor	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P41586	ADCYAP1R1	Pituitary adenylate cyclase-activating polypeptide type I receptor	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P41586	ADCYAP1R1	Pituitary adenylate cyclase-activating polypeptide type I receptor	GO:0046545; P:development of primary female sexual characteristics; IEA:Ensembl
P41586	ADCYAP1R1	Pituitary adenylate cyclase-activating polypeptide type I receptor	GO:0033555; P:multicellular organismal response to stress; IEA:Ensembl
P41586	ADCYAP1R1	Pituitary adenylate cyclase-activating polypeptide type I receptor	GO:0060548; P:negative regulation of cell death; IEA:Ensembl
P41586	ADCYAP1R1	Pituitary adenylate cyclase-activating polypeptide type I receptor	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P41586	ADCYAP1R1	Pituitary adenylate cyclase-activating polypeptide type I receptor	GO:0010524; P:positive regulation of calcium ion transport into cytosol; IEA:Ensembl
P41586	ADCYAP1R1	Pituitary adenylate cyclase-activating polypeptide type I receptor	GO:0060732; P:positive regulation of inositol phosphate biosynthetic process; IEA:Ensembl
P41586	ADCYAP1R1	Pituitary adenylate cyclase-activating polypeptide type I receptor	GO:0042493; P:response to drug; IEA:Ensembl
P41586	ADCYAP1R1	Pituitary adenylate cyclase-activating polypeptide type I receptor	GO:0032355; P:response to estradiol; IEA:Ensembl
P41586	ADCYAP1R1	Pituitary adenylate cyclase-activating polypeptide type I receptor	GO:0045471; P:response to ethanol; IEA:Ensembl
P41586	ADCYAP1R1	Pituitary adenylate cyclase-activating polypeptide type I receptor	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
P41586	ADCYAP1R1	Pituitary adenylate cyclase-activating polypeptide type I receptor	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:Reactome
Q6VY07	PACS1	Phosphofurin acidic cluster sorting protein 1	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q6VY07	PACS1	Phosphofurin acidic cluster sorting protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q6VY07	PACS1	Phosphofurin acidic cluster sorting protein 1	GO:0000042; P:protein targeting to Golgi; IEA:Ensembl
Q6VY07	PACS1	Phosphofurin acidic cluster sorting protein 1	GO:0072661; P:protein targeting to plasma membrane; IMP:BHF-UCL
Q6VY07	PACS1	Phosphofurin acidic cluster sorting protein 1	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
Q6VY07	PACS1	Phosphofurin acidic cluster sorting protein 1	GO:0016032; P:viral process; TAS:Reactome
Q86VP3	PACS2	Phosphofurin acidic cluster sorting protein 2	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q86VP3	PACS2	Phosphofurin acidic cluster sorting protein 2	GO:0072661; P:protein targeting to plasma membrane; IMP:BHF-UCL
Q86VP3	PACS2	Phosphofurin acidic cluster sorting protein 2	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9ULC6	PADI1	Protein-arginine deiminase type-1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9ULC6	PADI1	Protein-arginine deiminase type-1	GO:0004668; F:protein-arginine deiminase activity; IEA:UniProtKB-EC
Q9ULC6	PADI1	Protein-arginine deiminase type-1	GO:0018101; P:protein citrullination; IEA:InterPro
Q9ULW8	PADI3	Protein-arginine deiminase type-3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9ULW8	PADI3	Protein-arginine deiminase type-3	GO:0004668; F:protein-arginine deiminase activity; TAS:ProtInc
Q9ULW8	PADI3	Protein-arginine deiminase type-3	GO:0018101; P:protein citrullination; IEA:InterPro
Q9UM07	PADI4	Protein-arginine deiminase type-4	GO:0016990; F:arginine deiminase activity; IDA:UniProtKB
Q9UM07	PADI4	Protein-arginine deiminase type-4	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q9UM07	PADI4	Protein-arginine deiminase type-4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UM07	PADI4	Protein-arginine deiminase type-4	GO:0004668; F:protein-arginine deiminase activity; IDA:UniProtKB
Q9UM07	PADI4	Protein-arginine deiminase type-4	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q9UM07	PADI4	Protein-arginine deiminase type-4	GO:0016568; P:chromatin modification; ISS:UniProtKB
Q9UM07	PADI4	Protein-arginine deiminase type-4	GO:0006338; P:chromatin remodeling; ISS:UniProtKB
Q9UM07	PADI4	Protein-arginine deiminase type-4	GO:0036414; P:histone citrullination; IDA:UniProtKB
Q9UM07	PADI4	Protein-arginine deiminase type-4	GO:0036413; P:histone H3-R26 citrullination; IDA:UniProtKB
Q9UM07	PADI4	Protein-arginine deiminase type-4	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q9UM07	PADI4	Protein-arginine deiminase type-4	GO:0006334; P:nucleosome assembly; ISS:UniProtKB
Q9UM07	PADI4	Protein-arginine deiminase type-4	GO:0018101; P:protein citrullination; IDA:UniProtKB
Q9UM07	PADI4	Protein-arginine deiminase type-4	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UM07	PADI4	Protein-arginine deiminase type-4	GO:0019827; P:stem cell maintenance; ISS:UniProtKB
Q9UM07	PADI4	Protein-arginine deiminase type-4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2J8	PADI2	Protein-arginine deiminase type-2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y2J8	PADI2	Protein-arginine deiminase type-2	GO:0030331; F:estrogen receptor binding; IPI:UniProt
Q9Y2J8	PADI2	Protein-arginine deiminase type-2	GO:0004668; F:protein-arginine deiminase activity; IDA:UniProt
Q9Y2J8	PADI2	Protein-arginine deiminase type-2	GO:0048096; P:chromatin-mediated maintenance of transcription; IMP:UniProt
Q9Y2J8	PADI2	Protein-arginine deiminase type-2	GO:0036413; P:histone H3-R26 citrullination; IDA:UniProt
Q9Y2J8	PADI2	Protein-arginine deiminase type-2	GO:0030520; P:intracellular estrogen receptor signaling pathway; IMP:UniProt
Q9Y2J8	PADI2	Protein-arginine deiminase type-2	GO:0070100; P:negative regulation of chemokine-mediated signaling pathway; IDA:UniProt
Q9Y2J8	PADI2	Protein-arginine deiminase type-2	GO:1901624; P:negative regulation of lymphocyte chemotaxis; IDA:UniProt
Q9Y2J8	PADI2	Protein-arginine deiminase type-2	GO:0018101; P:protein citrullination; IDA:UniProt
Q9Y2J8	PADI2	Protein-arginine deiminase type-2	GO:0010848; P:regulation of chromatin disassembly; IDA:UniProt
Q9Y2J8	PADI2	Protein-arginine deiminase type-2	GO:0021762; P:substantia nigra development; IEP:UniProt
Q6TGC4	PADI6	Protein-arginine deiminase type-6	GO:0005509; F:calcium ion binding; IEA:InterPro
Q6TGC4	PADI6	Protein-arginine deiminase type-6	GO:0004668; F:protein-arginine deiminase activity; IEA:UniProtKB-EC
Q6TGC4	PADI6	Protein-arginine deiminase type-6	GO:0018101; P:protein citrullination; IEA:InterPro
P09466	PAEP	Glycodelin	GO:0036094; F:small molecule binding; IEA:InterPro
P09466	PAEP	Glycodelin	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P09466	PAEP	Glycodelin	GO:0006810; P:transport; IEA:InterPro
Q15004	KIAA0101	PCNA-associated factor	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q15004	KIAA0101	PCNA-associated factor	GO:0005515; F:protein binding; IPI:UniProtKB
Q15004	KIAA0101	PCNA-associated factor	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q15004	KIAA0101	PCNA-associated factor	GO:0051297; P:centrosome organization; IMP:UniProtKB
Q15004	KIAA0101	PCNA-associated factor	GO:0006260; P:DNA replication; IDA:UniProtKB
Q15004	KIAA0101	PCNA-associated factor	GO:0051726; P:regulation of cell cycle; IMP:UniProtKB
Q15004	KIAA0101	PCNA-associated factor	GO:0009411; P:response to UV; IDA:UniProtKB
Q15004	KIAA0101	PCNA-associated factor	GO:0019985; P:translesion synthesis; IMP:UniProtKB
Q8N7H5	PAF1	RNA polymerase II-associated factor 1 homolog	GO:0003682; F:chromatin binding; IEA:Ensembl
Q8N7H5	PAF1	RNA polymerase II-associated factor 1 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q8N7H5	PAF1	RNA polymerase II-associated factor 1 homolog	GO:0000993; F:RNA polymerase II core binding; IDA:UniProtKB
Q8N7H5	PAF1	RNA polymerase II-associated factor 1 homolog	GO:0071222; P:cellular response to lipopolysaccharide; ISS:UniProtKB
Q8N7H5	PAF1	RNA polymerase II-associated factor 1 homolog	GO:0001711; P:endodermal cell fate commitment; ISS:UniProtKB
Q8N7H5	PAF1	RNA polymerase II-associated factor 1 homolog	GO:0033523; P:histone H2B ubiquitination; IDA:UniProtKB
Q8N7H5	PAF1	RNA polymerase II-associated factor 1 homolog	GO:0010390; P:histone monoubiquitination; IDA:UniProtKB
Q8N7H5	PAF1	RNA polymerase II-associated factor 1 homolog	GO:0006378; P:mRNA polyadenylation; IMP:UniProtKB
Q8N7H5	PAF1	RNA polymerase II-associated factor 1 homolog	GO:0045638; P:negative regulation of myeloid cell differentiation; IDA:UniProtKB
Q8N7H5	PAF1	RNA polymerase II-associated factor 1 homolog	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q8N7H5	PAF1	RNA polymerase II-associated factor 1 homolog	GO:0031442; P:positive regulation of mRNA 3'-end processing; IMP:UniProtKB
Q8N7H5	PAF1	RNA polymerase II-associated factor 1 homolog	GO:0032968; P:positive regulation of transcription elongation from RNA polymerase II promoter; IDA:UniProtKB
Q8N7H5	PAF1	RNA polymerase II-associated factor 1 homolog	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q8N7H5	PAF1	RNA polymerase II-associated factor 1 homolog	GO:0019827; P:stem cell maintenance; IEA:Ensembl
Q8N7H5	PAF1	RNA polymerase II-associated factor 1 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N7H5	PAF1	RNA polymerase II-associated factor 1 homolog	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q99487	PAFAH2	Platelet-activating factor acetylhydrolase 2, cytoplasmic	GO:0003847; F:1-alkyl-2-acetylglycerophosphocholine esterase activity; IEA:UniProtKB-EC
Q99487	PAFAH2	Platelet-activating factor acetylhydrolase 2, cytoplasmic	GO:0005543; F:phospholipid binding; TAS:ProtInc
Q99487	PAFAH2	Platelet-activating factor acetylhydrolase 2, cytoplasmic	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q99487	PAFAH2	Platelet-activating factor acetylhydrolase 2, cytoplasmic	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q99487	PAFAH2	Platelet-activating factor acetylhydrolase 2, cytoplasmic	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q13093	PLA2G7	Platelet-activating factor acetylhydrolase	GO:0003847; F:1-alkyl-2-acetylglycerophosphocholine esterase activity; IEA:UniProtKB-EC
Q13093	PLA2G7	Platelet-activating factor acetylhydrolase	GO:0047499; F:calcium-independent phospholipase A2 activity; IDA:BHF-UCL
Q13093	PLA2G7	Platelet-activating factor acetylhydrolase	GO:0005543; F:phospholipid binding; IDA:BHF-UCL
Q13093	PLA2G7	Platelet-activating factor acetylhydrolase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q13093	PLA2G7	Platelet-activating factor acetylhydrolase	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q13093	PLA2G7	Platelet-activating factor acetylhydrolase	GO:0034440; P:lipid oxidation; IDA:BHF-UCL
Q13093	PLA2G7	Platelet-activating factor acetylhydrolase	GO:0034374; P:low-density lipoprotein particle remodeling; IDA:BHF-UCL
Q13093	PLA2G7	Platelet-activating factor acetylhydrolase	GO:0034441; P:plasma lipoprotein particle oxidation; IDA:BHF-UCL
Q13093	PLA2G7	Platelet-activating factor acetylhydrolase	GO:0050729; P:positive regulation of inflammatory response; TAS:BHF-UCL
Q13093	PLA2G7	Platelet-activating factor acetylhydrolase	GO:0090026; P:positive regulation of monocyte chemotaxis; IDA:BHF-UCL
Q8NCC3	PLA2G15	Group XV phospholipase A2	GO:0047499; F:calcium-independent phospholipase A2 activity; ISS:UniProtKB
Q8NCC3	PLA2G15	Group XV phospholipase A2	GO:0004622; F:lysophospholipase activity; TAS:ProtInc
Q8NCC3	PLA2G15	Group XV phospholipase A2	GO:0008374; F:O-acyltransferase activity; ISS:UniProtKB
Q8NCC3	PLA2G15	Group XV phospholipase A2	GO:0005543; F:phospholipid binding; TAS:ProtInc
Q8NCC3	PLA2G15	Group XV phospholipase A2	GO:0006672; P:ceramide metabolic process; IEA:Ensembl
Q8NCC3	PLA2G15	Group XV phospholipase A2	GO:0009062; P:fatty acid catabolic process; TAS:ProtInc
Q8NCC3	PLA2G15	Group XV phospholipase A2	GO:0046470; P:phosphatidylcholine metabolic process; IEA:Ensembl
O75459	PAGE1	P antigen family member 1	GO:0006968; P:cellular defense response; TAS:ProtInc
Q9BTK6	PAGR1	PAXIP1-associated glutamate-rich protein 1	GO:0005515; F:protein binding; IPI:IntAct
P01298	PPY	Pancreatic prohormone	GO:0005179; F:hormone activity; TAS:ProtInc
P01298	PPY	Pancreatic prohormone	GO:0005102; F:receptor binding; TAS:ProtInc
P01298	PPY	Pancreatic prohormone	GO:0007586; P:digestion; TAS:ProtInc
P01298	PPY	Pancreatic prohormone	GO:0009306; P:protein secretion; TAS:ProtInc
O14832	PHYH	Phytanoyl-CoA dioxygenase, peroxisomal	GO:0048037; F:cofactor binding; IDA:UniProtKB
O14832	PHYH	Phytanoyl-CoA dioxygenase, peroxisomal	GO:0009055; F:electron carrier activity; TAS:UniProtKB
O14832	PHYH	Phytanoyl-CoA dioxygenase, peroxisomal	GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW
O14832	PHYH	Phytanoyl-CoA dioxygenase, peroxisomal	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14832	PHYH	Phytanoyl-CoA dioxygenase, peroxisomal	GO:0048244; F:phytanoyl-CoA dioxygenase activity; IDA:UniProtKB
O14832	PHYH	Phytanoyl-CoA dioxygenase, peroxisomal	GO:0005515; F:protein binding; IPI:UniProtKB
O14832	PHYH	Phytanoyl-CoA dioxygenase, peroxisomal	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O14832	PHYH	Phytanoyl-CoA dioxygenase, peroxisomal	GO:0001561; P:fatty acid alpha-oxidation; IDA:UniProtKB
O14832	PHYH	Phytanoyl-CoA dioxygenase, peroxisomal	GO:0006720; P:isoprenoid metabolic process; IDA:UniProtKB
O14832	PHYH	Phytanoyl-CoA dioxygenase, peroxisomal	GO:0097089; P:methyl-branched fatty acid metabolic process; IDA:UniProtKB
O14832	PHYH	Phytanoyl-CoA dioxygenase, peroxisomal	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0002020; F:protease binding; IPI:UniProtKB
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0005515; F:protein binding; IPI:IntAct
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0001525; P:angiogenesis; IEP:UniProtKB
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0007596; P:blood coagulation; TAS:Reactome
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0071222; P:cellular response to lipopolysaccharide; IMP:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0001300; P:chronological cell aging; IEP:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0050829; P:defense response to Gram-negative bacterium; IGI:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0042730; P:fibrinolysis; TAS:Reactome
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0010467; P:gene expression; TAS:Reactome
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0030195; P:negative regulation of blood coagulation; IC:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0033629; P:negative regulation of cell adhesion mediated by integrin; IDA:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0030336; P:negative regulation of cell migration; IDA:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0010951; P:negative regulation of endopeptidase activity; IDA:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:2000352; P:negative regulation of endothelial cell apoptotic process; IMP:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IMP:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0051918; P:negative regulation of fibrinolysis; IDA:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0010757; P:negative regulation of plasminogen activation; IDA:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0014912; P:negative regulation of smooth muscle cell migration; IDA:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:2000098; P:negative regulation of smooth muscle cell-matrix adhesion; IDA:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0061044; P:negative regulation of vascular wound healing; IGI:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0061045; P:negative regulation of wound healing; IC:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0030168; P:platelet activation; TAS:Reactome
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0002576; P:platelet degranulation; TAS:Reactome
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0045766; P:positive regulation of angiogenesis; IMP:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0030194; P:positive regulation of blood coagulation; IMP:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0050729; P:positive regulation of inflammatory response; IGI:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0032757; P:positive regulation of interleukin-8 production; IMP:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0035491; P:positive regulation of leukotriene production involved in inflammatory response; IMP:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0090026; P:positive regulation of monocyte chemotaxis; IMP:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0048260; P:positive regulation of receptor-mediated endocytosis; IDA:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0010469; P:regulation of receptor activity; IDA:BHF-UCL
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
P05121	SERPINE1	Plasminogen activator inhibitor 1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P05120	SERPINB2	Plasminogen activator inhibitor 2	GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome
P05120	SERPINB2	Plasminogen activator inhibitor 2	GO:0007596; P:blood coagulation; TAS:Reactome
P05120	SERPINB2	Plasminogen activator inhibitor 2	GO:0042730; P:fibrinolysis; TAS:Reactome
P05120	SERPINB2	Plasminogen activator inhibitor 2	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
P05120	SERPINB2	Plasminogen activator inhibitor 2	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P05120	SERPINB2	Plasminogen activator inhibitor 2	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
Q9ULR5	PAIP2B	Polyadenylate-binding protein-interacting protein 2B	GO:0005515; F:protein binding; IPI:HGNC
Q9ULR5	PAIP2B	Polyadenylate-binding protein-interacting protein 2B	GO:0000900; F:translation repressor activity, nucleic acid binding; IDA:HGNC
Q9ULR5	PAIP2B	Polyadenylate-binding protein-interacting protein 2B	GO:0045947; P:negative regulation of translational initiation; IDA:HGNC
Q9H074	PAIP1	Polyadenylate-binding protein-interacting protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H074	PAIP1	Polyadenylate-binding protein-interacting protein 1	GO:0003723; F:RNA binding; TAS:ProtInc
Q9H074	PAIP1	Polyadenylate-binding protein-interacting protein 1	GO:0008494; F:translation activator activity; IDA:UniProtKB
Q9H074	PAIP1	Polyadenylate-binding protein-interacting protein 1	GO:0010467; P:gene expression; TAS:Reactome
Q9H074	PAIP1	Polyadenylate-binding protein-interacting protein 1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9H074	PAIP1	Polyadenylate-binding protein-interacting protein 1	GO:0048255; P:mRNA stabilization; TAS:UniProtKB
Q9H074	PAIP1	Polyadenylate-binding protein-interacting protein 1	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q9H074	PAIP1	Polyadenylate-binding protein-interacting protein 1	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
Q9H074	PAIP1	Polyadenylate-binding protein-interacting protein 1	GO:0045727; P:positive regulation of translation; IDA:GOC
Q9H074	PAIP1	Polyadenylate-binding protein-interacting protein 1	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9H074	PAIP1	Polyadenylate-binding protein-interacting protein 1	GO:0006413; P:translational initiation; TAS:ProtInc
Q9BPZ3	PAIP2	Polyadenylate-binding protein-interacting protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BPZ3	PAIP2	Polyadenylate-binding protein-interacting protein 2	GO:0030371; F:translation repressor activity; IDA:UniProtKB
Q9BPZ3	PAIP2	Polyadenylate-binding protein-interacting protein 2	GO:0045947; P:negative regulation of translational initiation; IDA:UniProtKB
Q8NC51	SERBP1	Plasminogen activator inhibitor 1 RNA-binding protein	GO:0003730; F:mRNA 3'-UTR binding; IDA:HGNC
Q8NC51	SERBP1	Plasminogen activator inhibitor 1 RNA-binding protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8NC51	SERBP1	Plasminogen activator inhibitor 1 RNA-binding protein	GO:0005515; F:protein binding; IPI:IntAct
Q8NC51	SERBP1	Plasminogen activator inhibitor 1 RNA-binding protein	GO:0042981; P:regulation of apoptotic process; IEA:Ensembl
Q8NC51	SERBP1	Plasminogen activator inhibitor 1 RNA-binding protein	GO:0043488; P:regulation of mRNA stability; NAS:HGNC
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0005518; F:collagen binding; IPI:UniProtKB
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0005515; F:protein binding; IPI:IntAct
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0031532; P:actin cytoskeleton reorganization; IDA:UniProtKB
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0007411; P:axon guidance; TAS:Reactome
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0007409; P:axonogenesis; IBA:RefGenome
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0048754; P:branching morphogenesis of an epithelial tube; IMP:UniProtKB
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0016358; P:dendrite development; IEA:Ensembl
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0045087; P:innate immune response; TAS:Reactome
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0060244; P:negative regulation of cell proliferation involved in contact inhibition; IMP:UniProtKB
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0048812; P:neuron projection morphogenesis; ISS:UniProtKB
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0033148; P:positive regulation of intracellular estrogen receptor signaling pathway; IDA:UniProtKB
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0043507; P:positive regulation of JUN kinase activity; IMP:UniProtKB
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:UniProtKB
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0001934; P:positive regulation of protein phosphorylation; IMP:UniProtKB
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0051496; P:positive regulation of stress fiber assembly; IMP:UniProtKB
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0043113; P:receptor clustering; IEA:Ensembl
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0023014; P:signal transduction by phosphorylation; IBA:GOC
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0031295; P:T cell costimulation; TAS:Reactome
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q13153	PAK1	Serine/threonine-protein kinase PAK 1	GO:0042060; P:wound healing; IMP:UniProtKB
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0042802; F:identical protein binding; IPI:IntAct
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0004674; F:protein serine/threonine kinase activity; IDA:BHF-UCL
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0030296; F:protein tyrosine kinase activator activity; IDA:BHF-UCL
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0030036; P:actin cytoskeleton organization; IBA:RefGenome
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0006915; P:apoptotic process; TAS:Reactome
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0007411; P:axon guidance; TAS:Reactome
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0007409; P:axonogenesis; IBA:RefGenome
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0045087; P:innate immune response; TAS:Reactome
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:2001271; P:negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis; IDA:UniProtKB
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0006469; P:negative regulation of protein kinase activity; TAS:ProtInc
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0016310; P:phosphorylation; IDA:UniProtKB
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0061098; P:positive regulation of protein tyrosine kinase activity; IDA:GOC
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0046777; P:protein autophosphorylation; IDA:MGI
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0006468; P:protein phosphorylation; IDA:MGI
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0007165; P:signal transduction; TAS:ProtInc
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0023014; P:signal transduction by phosphorylation; IBA:GOC
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0031295; P:T cell costimulation; TAS:Reactome
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q13177	PAK2	Serine/threonine-protein kinase PAK 2	GO:0016032; P:viral process; TAS:Reactome
O75914	PAK3	Serine/threonine-protein kinase PAK 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75914	PAK3	Serine/threonine-protein kinase PAK 3	GO:0004708; F:MAP kinase kinase activity; IDA:UniProtKB
O75914	PAK3	Serine/threonine-protein kinase PAK 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75914	PAK3	Serine/threonine-protein kinase PAK 3	GO:0005515; F:protein binding; IPI:IntAct
O75914	PAK3	Serine/threonine-protein kinase PAK 3	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
O75914	PAK3	Serine/threonine-protein kinase PAK 3	GO:0000187; P:activation of MAPK activity; IDA:GOC
O75914	PAK3	Serine/threonine-protein kinase PAK 3	GO:0007409; P:axonogenesis; ISS:UniProtKB
O75914	PAK3	Serine/threonine-protein kinase PAK 3	GO:0016358; P:dendrite development; ISS:UniProtKB
O75914	PAK3	Serine/threonine-protein kinase PAK 3	GO:0060997; P:dendritic spine morphogenesis; TAS:UniProtKB
O75914	PAK3	Serine/threonine-protein kinase PAK 3	GO:0000165; P:MAPK cascade; IDA:GOC
O75914	PAK3	Serine/threonine-protein kinase PAK 3	GO:0030833; P:regulation of actin filament polymerization; IDA:UniProtKB
O75914	PAK3	Serine/threonine-protein kinase PAK 3	GO:0023014; P:signal transduction by phosphorylation; IBA:GOC
O75914	PAK3	Serine/threonine-protein kinase PAK 3	GO:0050808; P:synapse organization; TAS:UniProtKB
O96013	PAK4	Serine/threonine-protein kinase PAK 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O96013	PAK4	Serine/threonine-protein kinase PAK 4	GO:0005515; F:protein binding; IPI:IntAct
O96013	PAK4	Serine/threonine-protein kinase PAK 4	GO:0004672; F:protein kinase activity; NAS:ProtInc
O96013	PAK4	Serine/threonine-protein kinase PAK 4	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
O96013	PAK4	Serine/threonine-protein kinase PAK 4	GO:0006915; P:apoptotic process; TAS:UniProtKB
O96013	PAK4	Serine/threonine-protein kinase PAK 4	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
O96013	PAK4	Serine/threonine-protein kinase PAK 4	GO:0016049; P:cell growth; TAS:UniProtKB
O96013	PAK4	Serine/threonine-protein kinase PAK 4	GO:0016477; P:cell migration; TAS:UniProtKB
O96013	PAK4	Serine/threonine-protein kinase PAK 4	GO:0008283; P:cell proliferation; TAS:UniProtKB
O96013	PAK4	Serine/threonine-protein kinase PAK 4	GO:0006928; P:cellular component movement; TAS:ProtInc
O96013	PAK4	Serine/threonine-protein kinase PAK 4	GO:0007010; P:cytoskeleton organization; TAS:UniProtKB
O96013	PAK4	Serine/threonine-protein kinase PAK 4	GO:0007165; P:signal transduction; TAS:UniProtKB
O96013	PAK4	Serine/threonine-protein kinase PAK 4	GO:0023014; P:signal transduction by phosphorylation; IBA:GOC
Q9NQU5	PAK6	Serine/threonine-protein kinase PAK 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NQU5	PAK6	Serine/threonine-protein kinase PAK 6	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
Q9NQU5	PAK6	Serine/threonine-protein kinase PAK 6	GO:0006915; P:apoptotic process; TAS:UniProtKB
Q9NQU5	PAK6	Serine/threonine-protein kinase PAK 6	GO:0007010; P:cytoskeleton organization; TAS:UniProtKB
Q9NQU5	PAK6	Serine/threonine-protein kinase PAK 6	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q9NQU5	PAK6	Serine/threonine-protein kinase PAK 6	GO:0023014; P:signal transduction by phosphorylation; IBA:GOC
Q9P286	PAK7	Serine/threonine-protein kinase PAK 7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9P286	PAK7	Serine/threonine-protein kinase PAK 7	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
Q9P286	PAK7	Serine/threonine-protein kinase PAK 7	GO:0006915; P:apoptotic process; TAS:UniProtKB
Q9P286	PAK7	Serine/threonine-protein kinase PAK 7	GO:0016049; P:cell growth; TAS:UniProtKB
Q9P286	PAK7	Serine/threonine-protein kinase PAK 7	GO:0016477; P:cell migration; TAS:UniProtKB
Q9P286	PAK7	Serine/threonine-protein kinase PAK 7	GO:0008283; P:cell proliferation; TAS:UniProtKB
Q9P286	PAK7	Serine/threonine-protein kinase PAK 7	GO:0007010; P:cytoskeleton organization; TAS:UniProtKB
Q9P286	PAK7	Serine/threonine-protein kinase PAK 7	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl
Q9P286	PAK7	Serine/threonine-protein kinase PAK 7	GO:0007165; P:signal transduction; TAS:UniProtKB
Q9P286	PAK7	Serine/threonine-protein kinase PAK 7	GO:0023014; P:signal transduction by phosphorylation; IBA:GOC
F5H284	PPIAL4D	Peptidyl-prolyl cis-trans isomerase A-like 4D	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW
F5H284	PPIAL4D	Peptidyl-prolyl cis-trans isomerase A-like 4D	GO:0006457; P:protein folding; IEA:UniProtKB-KW
Q9Y536	PPIAL4A	Peptidyl-prolyl cis-trans isomerase A-like 4A/B/C	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW
Q9Y536	PPIAL4A	Peptidyl-prolyl cis-trans isomerase A-like 4A/B/C	GO:0006457; P:protein folding; IEA:UniProtKB-KW
A2BFH1	PPIAL4G	Peptidyl-prolyl cis-trans isomerase A-like 4G	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW
A2BFH1	PPIAL4G	Peptidyl-prolyl cis-trans isomerase A-like 4G	GO:0006457; P:protein folding; IEA:UniProtKB-KW
Q86YC2	PALB2	Partner and localizer of BRCA2	GO:0003677; F:DNA binding; IDA:UniProtKB
Q86YC2	PALB2	Partner and localizer of BRCA2	GO:0005515; F:protein binding; IPI:UniProtKB
Q86YC2	PALB2	Partner and localizer of BRCA2	GO:0006281; P:DNA repair; TAS:Reactome
Q86YC2	PALB2	Partner and localizer of BRCA2	GO:0000724; P:double-strand break repair via homologous recombination; IDA:UniProtKB
Q86YC2	PALB2	Partner and localizer of BRCA2	GO:0001833; P:inner cell mass cell proliferation; IEA:Ensembl
Q86YC2	PALB2	Partner and localizer of BRCA2	GO:0007498; P:mesoderm development; IEA:Ensembl
Q86YC2	PALB2	Partner and localizer of BRCA2	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q86YC2	PALB2	Partner and localizer of BRCA2	GO:0009887; P:organ morphogenesis; IEA:Ensembl
Q86YC2	PALB2	Partner and localizer of BRCA2	GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl
Q86YC2	PALB2	Partner and localizer of BRCA2	GO:0001756; P:somitogenesis; IEA:Ensembl
Q9ULE6	PALD1	Paladin	GO:0005515; F:protein binding; IPI:IntAct
Q8WX93	PALLD	Palladin	GO:0051371; F:muscle alpha-actinin binding; TAS:HGNC
Q8WX93	PALLD	Palladin	GO:0005515; F:protein binding; IPI:IntAct
Q8WX93	PALLD	Palladin	GO:0007010; P:cytoskeleton organization; NAS:HGNC
Q8IXS6	PALM2	Paralemmin-2	GO:0008360; P:regulation of cell shape; IEA:InterPro
A6NDB9	PALM3	Paralemmin-3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
A6NDB9	PALM3	Paralemmin-3	GO:0005515; F:protein binding; IPI:UniProtKB
A6NDB9	PALM3	Paralemmin-3	GO:0001960; P:negative regulation of cytokine-mediated signaling pathway; IDA:UniProtKB
A6NDB9	PALM3	Paralemmin-3	GO:0032496; P:response to lipopolysaccharide; IDA:UniProtKB
A6NDB9	PALM3	Paralemmin-3	GO:0008063; P:Toll signaling pathway; IMP:UniProtKB
Q9NP74	PALMD	Palmdelphin	GO:0008360; P:regulation of cell shape; IEA:InterPro
O75781	PALM	Paralemmin-1	GO:0005515; F:protein binding; IPI:UniProtKB
O75781	PALM	Paralemmin-1	GO:0006928; P:cellular component movement; TAS:ProtInc
O75781	PALM	Paralemmin-1	GO:0071257; P:cellular response to electrical stimulus; IEA:Ensembl
O75781	PALM	Paralemmin-1	GO:0007010; P:cytoskeleton organization; IEA:Ensembl
O75781	PALM	Paralemmin-1	GO:0007194; P:negative regulation of adenylate cyclase activity; IDA:UniProtKB
O75781	PALM	Paralemmin-1	GO:0060160; P:negative regulation of dopamine receptor signaling pathway; IDA:UniProtKB
O75781	PALM	Paralemmin-1	GO:0060999; P:positive regulation of dendritic spine development; IEA:Ensembl
O75781	PALM	Paralemmin-1	GO:0051491; P:positive regulation of filopodium assembly; IDA:UniProtKB
O75781	PALM	Paralemmin-1	GO:0072661; P:protein targeting to plasma membrane; IEA:Ensembl
O75781	PALM	Paralemmin-1	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
O75781	PALM	Paralemmin-1	GO:0060074; P:synapse maturation; IEA:Ensembl
Q6UXH9	PAMR1	Inactive serine protease PAMR1	GO:0003824; F:catalytic activity; IEA:InterPro
Q504Q3	PAN2	PAB-dependent poly(A)-specific ribonuclease subunit PAN2	GO:0000175; F:3'-5'-exoribonuclease activity; IDA:UniProtKB
Q504Q3	PAN2	PAB-dependent poly(A)-specific ribonuclease subunit PAN2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q504Q3	PAN2	PAB-dependent poly(A)-specific ribonuclease subunit PAN2	GO:0004535; F:poly(A)-specific ribonuclease activity; IDA:UniProtKB
Q504Q3	PAN2	PAB-dependent poly(A)-specific ribonuclease subunit PAN2	GO:0005515; F:protein binding; IPI:IntAct
Q504Q3	PAN2	PAB-dependent poly(A)-specific ribonuclease subunit PAN2	GO:0010467; P:gene expression; TAS:Reactome
Q504Q3	PAN2	PAB-dependent poly(A)-specific ribonuclease subunit PAN2	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q504Q3	PAN2	PAB-dependent poly(A)-specific ribonuclease subunit PAN2	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q504Q3	PAN2	PAB-dependent poly(A)-specific ribonuclease subunit PAN2	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
Q504Q3	PAN2	PAB-dependent poly(A)-specific ribonuclease subunit PAN2	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q504Q3	PAN2	PAB-dependent poly(A)-specific ribonuclease subunit PAN2	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; IDA:GOC
Q58A45	PAN3	PAB-dependent poly(A)-specific ribonuclease subunit PAN3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q58A45	PAN3	PAB-dependent poly(A)-specific ribonuclease subunit PAN3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q58A45	PAN3	PAB-dependent poly(A)-specific ribonuclease subunit PAN3	GO:0005515; F:protein binding; IPI:IntAct
Q58A45	PAN3	PAB-dependent poly(A)-specific ribonuclease subunit PAN3	GO:0004672; F:protein kinase activity; IEA:InterPro
Q58A45	PAN3	PAB-dependent poly(A)-specific ribonuclease subunit PAN3	GO:0000290; P:deadenylation-dependent decapping of nuclear-transcribed mRNA; IEA:Ensembl
Q58A45	PAN3	PAB-dependent poly(A)-specific ribonuclease subunit PAN3	GO:0010467; P:gene expression; TAS:Reactome
Q58A45	PAN3	PAB-dependent poly(A)-specific ribonuclease subunit PAN3	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q58A45	PAN3	PAB-dependent poly(A)-specific ribonuclease subunit PAN3	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q58A45	PAN3	PAB-dependent poly(A)-specific ribonuclease subunit PAN3	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
Q58A45	PAN3	PAB-dependent poly(A)-specific ribonuclease subunit PAN3	GO:0010606; P:positive regulation of cytoplasmic mRNA processing body assembly; IEA:Ensembl
Q58A45	PAN3	PAB-dependent poly(A)-specific ribonuclease subunit PAN3	GO:0006605; P:protein targeting; IEA:Ensembl
Q58A45	PAN3	PAB-dependent poly(A)-specific ribonuclease subunit PAN3	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q58A45	PAN3	PAB-dependent poly(A)-specific ribonuclease subunit PAN3	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; IDA:GOC
Q8TE04	PANK1	Pantothenate kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8TE04	PANK1	Pantothenate kinase 1	GO:0004594; F:pantothenate kinase activity; IEA:UniProtKB-EC
Q8TE04	PANK1	Pantothenate kinase 1	GO:0015937; P:coenzyme A biosynthetic process; IEA:UniProtKB-UniPathway
Q8TE04	PANK1	Pantothenate kinase 1	GO:0009108; P:coenzyme biosynthetic process; TAS:Reactome
Q8TE04	PANK1	Pantothenate kinase 1	GO:0015939; P:pantothenate metabolic process; TAS:Reactome
Q8TE04	PANK1	Pantothenate kinase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8TE04	PANK1	Pantothenate kinase 1	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q8TE04	PANK1	Pantothenate kinase 1	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9BZ23	PANK2	Pantothenate kinase 2, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BZ23	PANK2	Pantothenate kinase 2, mitochondrial	GO:0004594; F:pantothenate kinase activity; IEA:UniProtKB-EC
Q9BZ23	PANK2	Pantothenate kinase 2, mitochondrial	GO:0009060; P:aerobic respiration; IEA:Ensembl
Q9BZ23	PANK2	Pantothenate kinase 2, mitochondrial	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9BZ23	PANK2	Pantothenate kinase 2, mitochondrial	GO:0015937; P:coenzyme A biosynthetic process; IEA:UniProtKB-UniPathway
Q9BZ23	PANK2	Pantothenate kinase 2, mitochondrial	GO:0009108; P:coenzyme biosynthetic process; TAS:Reactome
Q9BZ23	PANK2	Pantothenate kinase 2, mitochondrial	GO:0070584; P:mitochondrion morphogenesis; IEA:Ensembl
Q9BZ23	PANK2	Pantothenate kinase 2, mitochondrial	GO:0015939; P:pantothenate metabolic process; TAS:Reactome
Q9BZ23	PANK2	Pantothenate kinase 2, mitochondrial	GO:0051881; P:regulation of mitochondrial membrane potential; IEA:Ensembl
Q9BZ23	PANK2	Pantothenate kinase 2, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BZ23	PANK2	Pantothenate kinase 2, mitochondrial	GO:0007286; P:spermatid development; IEA:Ensembl
Q9BZ23	PANK2	Pantothenate kinase 2, mitochondrial	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9BZ23	PANK2	Pantothenate kinase 2, mitochondrial	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9H999	PANK3	Pantothenate kinase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H999	PANK3	Pantothenate kinase 3	GO:0004594; F:pantothenate kinase activity; IEA:UniProtKB-EC
Q9H999	PANK3	Pantothenate kinase 3	GO:0015937; P:coenzyme A biosynthetic process; IEA:UniProtKB-UniPathway
Q9NVE7	PANK4	Pantothenate kinase 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NVE7	PANK4	Pantothenate kinase 4	GO:0004594; F:pantothenate kinase activity; IEA:UniProtKB-EC
Q9NVE7	PANK4	Pantothenate kinase 4	GO:0015937; P:coenzyme A biosynthetic process; IEA:UniProtKB-UniPathway
Q96RD7	PANX1	Pannexin-1	GO:0005262; F:calcium channel activity; IMP:UniProtKB
Q96RD7	PANX1	Pannexin-1	GO:0055077; F:gap junction hemi-channel activity; IDA:UniProtKB
Q96RD7	PANX1	Pannexin-1	GO:0022840; F:leak channel activity; IMP:UniProtKB
Q96RD7	PANX1	Pannexin-1	GO:0005102; F:receptor binding; IPI:UniProtKB
Q96RD7	PANX1	Pannexin-1	GO:0006816; P:calcium ion transport; IMP:UniProtKB
Q96RD7	PANX1	Pannexin-1	GO:0006812; P:cation transport; IDA:BHF-UCL
Q96RD7	PANX1	Pannexin-1	GO:0045087; P:innate immune response; TAS:Reactome
Q96RD7	PANX1	Pannexin-1	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q96RD7	PANX1	Pannexin-1	GO:0050717; P:positive regulation of interleukin-1 alpha secretion; IEA:Ensembl
Q96RD7	PANX1	Pannexin-1	GO:0050718; P:positive regulation of interleukin-1 beta secretion; IDA:BHF-UCL
Q96RD7	PANX1	Pannexin-1	GO:0034214; P:protein hexamerization; IDA:UniProtKB
Q96RD7	PANX1	Pannexin-1	GO:0033198; P:response to ATP; IEA:Ensembl
Q96RD7	PANX1	Pannexin-1	GO:0002931; P:response to ischemia; IEA:Ensembl
Q96RD7	PANX1	Pannexin-1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q96RD6	PANX2	Pannexin-2	GO:0055077; F:gap junction hemi-channel activity; ISS:UniProtKB
Q96RD6	PANX2	Pannexin-2	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q96RD6	PANX2	Pannexin-2	GO:0034214; P:protein hexamerization; ISS:UniProtKB
Q96RD6	PANX2	Pannexin-2	GO:0002931; P:response to ischemia; IEA:Ensembl
Q96RD6	PANX2	Pannexin-2	GO:0007268; P:synaptic transmission; TAS:Reactome
Q96QZ0	PANX3	Pannexin-3	GO:0055077; F:gap junction hemi-channel activity; ISS:UniProtKB
Q96QZ0	PANX3	Pannexin-3	GO:0007267; P:cell-cell signaling; IEA:Ensembl
Q96QZ0	PANX3	Pannexin-3	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q96QZ0	PANX3	Pannexin-3	GO:0034214; P:protein hexamerization; ISS:UniProtKB
Q96QZ0	PANX3	Pannexin-3	GO:0055085; P:transmembrane transport; ISS:GOC
Q6QHF9	PAOX	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	GO:0052899; F:N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; IEA:UniProtKB-EC
Q6QHF9	PAOX	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	GO:0052904; F:N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; TAS:Reactome
Q6QHF9	PAOX	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	GO:0052903; F:N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity; IEA:UniProtKB-EC
Q6QHF9	PAOX	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	GO:0046592; F:polyamine oxidase activity; IDA:UniProtKB
Q6QHF9	PAOX	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	GO:0005102; F:receptor binding; IPI:UniProtKB
Q6QHF9	PAOX	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	GO:0052902; F:spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity; IEA:UniProtKB-EC
Q6QHF9	PAOX	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	GO:0052901; F:spermine:oxygen oxidoreductase (spermidine-forming) activity; IEA:UniProtKB-EC
Q6QHF9	PAOX	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q6QHF9	PAOX	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	GO:0055114; P:oxidation-reduction process; IDA:GOC
Q6QHF9	PAOX	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	GO:0006596; P:polyamine biosynthetic process; TAS:Reactome
Q6QHF9	PAOX	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	GO:0006598; P:polyamine catabolic process; IDA:UniProtKB
Q6QHF9	PAOX	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	GO:0006595; P:polyamine metabolic process; TAS:Reactome
Q6QHF9	PAOX	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	GO:1901307; P:positive regulation of spermidine biosynthetic process; IDA:UniProtKB
Q6QHF9	PAOX	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	GO:0009446; P:putrescine biosynthetic process; IDA:UniProtKB
Q6QHF9	PAOX	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	GO:0009447; P:putrescine catabolic process; IDA:UniProtKB
Q6QHF9	PAOX	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6QHF9	PAOX	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	GO:0046203; P:spermidine catabolic process; IDA:UniProtKB
Q6QHF9	PAOX	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	GO:0046208; P:spermine catabolic process; IDA:UniProtKB
Q6QHF9	PAOX	Peroxisomal N(1)-acetyl-spermine/spermidine oxidase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q4VXU2	PABPC1L	Polyadenylate-binding protein 1-like	GO:0000166; F:nucleotide binding; IEA:InterPro
Q4VXU2	PABPC1L	Polyadenylate-binding protein 1-like	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q5JQF8	PABPC1L2A	Polyadenylate-binding protein 1-like 2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q5JQF8	PABPC1L2A	Polyadenylate-binding protein 1-like 2	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9NVV4	MTPAP	Poly(A) RNA polymerase, mitochondrial	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9NVV4	MTPAP	Poly(A) RNA polymerase, mitochondrial	GO:0042802; F:identical protein binding; IPI:IntAct
Q9NVV4	MTPAP	Poly(A) RNA polymerase, mitochondrial	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q9NVV4	MTPAP	Poly(A) RNA polymerase, mitochondrial	GO:0030145; F:manganese ion binding; IDA:UniProtKB
Q9NVV4	MTPAP	Poly(A) RNA polymerase, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NVV4	MTPAP	Poly(A) RNA polymerase, mitochondrial	GO:0004652; F:polynucleotide adenylyltransferase activity; IDA:UniProtKB
Q9NVV4	MTPAP	Poly(A) RNA polymerase, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q9NVV4	MTPAP	Poly(A) RNA polymerase, mitochondrial	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q9NVV4	MTPAP	Poly(A) RNA polymerase, mitochondrial	GO:0002134; F:UTP binding; IDA:UniProtKB
Q9NVV4	MTPAP	Poly(A) RNA polymerase, mitochondrial	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9NVV4	MTPAP	Poly(A) RNA polymerase, mitochondrial	GO:0071044; P:histone mRNA catabolic process; IMP:UniProtKB
Q9NVV4	MTPAP	Poly(A) RNA polymerase, mitochondrial	GO:0006378; P:mRNA polyadenylation; IDA:UniProtKB
Q9NVV4	MTPAP	Poly(A) RNA polymerase, mitochondrial	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NDF8	PAPD5	Non-canonical poly(A) RNA polymerase PAPD5	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NDF8	PAPD5	Non-canonical poly(A) RNA polymerase PAPD5	GO:0003887; F:DNA-directed DNA polymerase activity; IEA:UniProtKB-KW
Q8NDF8	PAPD5	Non-canonical poly(A) RNA polymerase PAPD5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NDF8	PAPD5	Non-canonical poly(A) RNA polymerase PAPD5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8NDF8	PAPD5	Non-canonical poly(A) RNA polymerase PAPD5	GO:0004652; F:polynucleotide adenylyltransferase activity; IEA:UniProtKB-EC
Q8NDF8	PAPD5	Non-canonical poly(A) RNA polymerase PAPD5	GO:0071044; P:histone mRNA catabolic process; IMP:UniProtKB
Q8NDF8	PAPD5	Non-canonical poly(A) RNA polymerase PAPD5	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q8NDF8	PAPD5	Non-canonical poly(A) RNA polymerase PAPD5	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q8NDF8	PAPD5	Non-canonical poly(A) RNA polymerase PAPD5	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q5XG87	PAPD7	Non-canonical poly(A) RNA polymerase PAPD7	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5XG87	PAPD7	Non-canonical poly(A) RNA polymerase PAPD7	GO:0003887; F:DNA-directed DNA polymerase activity; IEA:UniProtKB-KW
Q5XG87	PAPD7	Non-canonical poly(A) RNA polymerase PAPD7	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5XG87	PAPD7	Non-canonical poly(A) RNA polymerase PAPD7	GO:0004652; F:polynucleotide adenylyltransferase activity; IEA:UniProtKB-EC
Q5XG87	PAPD7	Non-canonical poly(A) RNA polymerase PAPD7	GO:0043221; F:SMC family protein binding; TAS:UniProtKB
Q5XG87	PAPD7	Non-canonical poly(A) RNA polymerase PAPD7	GO:0006302; P:double-strand break repair; NAS:UniProtKB
Q5XG87	PAPD7	Non-canonical poly(A) RNA polymerase PAPD7	GO:0007076; P:mitotic chromosome condensation; NAS:UniProtKB
Q5XG87	PAPD7	Non-canonical poly(A) RNA polymerase PAPD7	GO:0042493; P:response to drug; IDA:UniProtKB
Q5XG87	PAPD7	Non-canonical poly(A) RNA polymerase PAPD7	GO:0007062; P:sister chromatid cohesion; TAS:UniProtKB
Q6ZNF0	PAPL	Iron/zinc purple acid phosphatase-like protein	GO:0003993; F:acid phosphatase activity; IEA:UniProtKB-EC
Q6ZNF0	PAPL	Iron/zinc purple acid phosphatase-like protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P51003	PAPOLA	Poly(A) polymerase alpha	GO:0005524; F:ATP binding; ISS:UniProtKB
P51003	PAPOLA	Poly(A) polymerase alpha	GO:0000287; F:magnesium ion binding; ISS:UniProtKB
P51003	PAPOLA	Poly(A) polymerase alpha	GO:0030145; F:manganese ion binding; ISS:UniProtKB
P51003	PAPOLA	Poly(A) polymerase alpha	GO:0004652; F:polynucleotide adenylyltransferase activity; ISS:UniProtKB
P51003	PAPOLA	Poly(A) polymerase alpha	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
P51003	PAPOLA	Poly(A) polymerase alpha	GO:0010467; P:gene expression; TAS:Reactome
P51003	PAPOLA	Poly(A) polymerase alpha	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
P51003	PAPOLA	Poly(A) polymerase alpha	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P51003	PAPOLA	Poly(A) polymerase alpha	GO:0043631; P:RNA polyadenylation; ISS:UniProtKB
P51003	PAPOLA	Poly(A) polymerase alpha	GO:0008380; P:RNA splicing; TAS:Reactome
P51003	PAPOLA	Poly(A) polymerase alpha	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
P51003	PAPOLA	Poly(A) polymerase alpha	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q9NRJ5	PAPOLB	Poly(A) polymerase beta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NRJ5	PAPOLB	Poly(A) polymerase beta	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NRJ5	PAPOLB	Poly(A) polymerase beta	GO:0004652; F:polynucleotide adenylyltransferase activity; IBA:RefGenome
Q9NRJ5	PAPOLB	Poly(A) polymerase beta	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9NRJ5	PAPOLB	Poly(A) polymerase beta	GO:0006378; P:mRNA polyadenylation; IBA:RefGenome
Q9NRJ5	PAPOLB	Poly(A) polymerase beta	GO:0000398; P:mRNA splicing, via spliceosome; IBA:RefGenome
Q9NRJ5	PAPOLB	Poly(A) polymerase beta	GO:0006369; P:termination of RNA polymerase II transcription; IBA:RefGenome
Q9BWT3	PAPOLG	Poly(A) polymerase gamma	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BWT3	PAPOLG	Poly(A) polymerase gamma	GO:0046872; F:metal ion binding; IDA:UniProtKB
Q9BWT3	PAPOLG	Poly(A) polymerase gamma	GO:0004652; F:polynucleotide adenylyltransferase activity; IEA:InterPro
Q9BWT3	PAPOLG	Poly(A) polymerase gamma	GO:0003723; F:RNA binding; IEA:InterPro
Q9BWT3	PAPOLG	Poly(A) polymerase gamma	GO:0006378; P:mRNA polyadenylation; IBA:RefGenome
Q9BWT3	PAPOLG	Poly(A) polymerase gamma	GO:0043631; P:RNA polyadenylation; IEA:InterPro
Q13219	PAPPA	Pappalysin-1	GO:0004175; F:endopeptidase activity; IEA:Ensembl
Q13219	PAPPA	Pappalysin-1	GO:0008237; F:metallopeptidase activity; IDA:UniProtKB
Q13219	PAPPA	Pappalysin-1	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q13219	PAPPA	Pappalysin-1	GO:0030154; P:cell differentiation; IEA:InterPro
Q13219	PAPPA	Pappalysin-1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q13219	PAPPA	Pappalysin-1	GO:0007565; P:female pregnancy; NAS:UniProtKB
Q13219	PAPPA	Pappalysin-1	GO:0032354; P:response to follicle-stimulating hormone; IEA:Ensembl
Q13219	PAPPA	Pappalysin-1	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
Q9BXP8	PAPPA2	Pappalysin-2	GO:0008237; F:metallopeptidase activity; IDA:UniProtKB
Q9BXP8	PAPPA2	Pappalysin-2	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9BXP8	PAPPA2	Pappalysin-2	GO:0030154; P:cell differentiation; IEA:InterPro
Q9BXP8	PAPPA2	Pappalysin-2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9BXP8	PAPPA2	Pappalysin-2	GO:0006508; P:proteolysis; IDA:UniProtKB
Q9BXP8	PAPPA2	Pappalysin-2	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
O43252	PAPSS1	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1	GO:0004020; F:adenylylsulfate kinase activity; IEA:UniProtKB-EC
O43252	PAPSS1	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43252	PAPSS1	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1	GO:0016779; F:nucleotidyltransferase activity; ISS:UniProtKB
O43252	PAPSS1	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1	GO:0004781; F:sulfate adenylyltransferase (ATP) activity; ISS:UniProtKB
O43252	PAPSS1	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1	GO:0050428; P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process; TAS:Reactome
O43252	PAPSS1	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1	GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; TAS:Reactome
O43252	PAPSS1	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O43252	PAPSS1	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O43252	PAPSS1	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1	GO:0001501; P:skeletal system development; TAS:ProtInc
O43252	PAPSS1	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43252	PAPSS1	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1	GO:0000103; P:sulfate assimilation; IEA:UniProtKB-UniPathway
O43252	PAPSS1	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
O95340	PAPSS2	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2	GO:0004020; F:adenylylsulfate kinase activity; IEA:UniProtKB-EC
O95340	PAPSS2	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O95340	PAPSS2	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2	GO:0016779; F:nucleotidyltransferase activity; ISS:UniProtKB
O95340	PAPSS2	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2	GO:0004781; F:sulfate adenylyltransferase (ATP) activity; ISS:UniProtKB
O95340	PAPSS2	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2	GO:0050428; P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process; TAS:Reactome
O95340	PAPSS2	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2	GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; TAS:Reactome
O95340	PAPSS2	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2	GO:0007596; P:blood coagulation; IEA:Ensembl
O95340	PAPSS2	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2	GO:0060348; P:bone development; IEA:Ensembl
O95340	PAPSS2	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O95340	PAPSS2	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O95340	PAPSS2	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2	GO:0001501; P:skeletal system development; TAS:ProtInc
O95340	PAPSS2	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95340	PAPSS2	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2	GO:0000103; P:sulfate assimilation; IEA:UniProtKB-UniPathway
O95340	PAPSS2	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q6TCH7	PAQR3	Progestin and adipoQ receptor family member 3	GO:0004872; F:receptor activity; IBA:RefGenome
Q6TCH7	PAQR3	Progestin and adipoQ receptor family member 3	GO:0043407; P:negative regulation of MAP kinase activity; IDA:MGI
Q6TCH7	PAQR3	Progestin and adipoQ receptor family member 3	GO:0010977; P:negative regulation of neuron projection development; IDA:MGI
Q6TCH7	PAQR3	Progestin and adipoQ receptor family member 3	GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; IDA:MGI
Q6TCH7	PAQR3	Progestin and adipoQ receptor family member 3	GO:0001933; P:negative regulation of protein phosphorylation; IDA:MGI
Q6TCH7	PAQR3	Progestin and adipoQ receptor family member 3	GO:0034067; P:protein localization to Golgi apparatus; IPI:MGI
Q6TCH4	PAQR6	Progestin and adipoQ receptor family member 6	GO:0004872; F:receptor activity; IBA:RefGenome
Q8N4S7	PAQR4	Progestin and adipoQ receptor family member 4	GO:0004872; F:receptor activity; IBA:RefGenome
Q6ZVX9	PAQR9	Progestin and adipoQ receptor family member 9	GO:0004872; F:receptor activity; IBA:RefGenome
Q53GL7	PARP10	Poly [ADP-ribose] polymerase 10	GO:0070530; F:K63-linked polyubiquitin binding; IMP:UniProt
Q53GL7	PARP10	Poly [ADP-ribose] polymerase 10	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IMP:UniProt
Q53GL7	PARP10	Poly [ADP-ribose] polymerase 10	GO:0005515; F:protein binding; IPI:UniProtKB
Q53GL7	PARP10	Poly [ADP-ribose] polymerase 10	GO:0048147; P:negative regulation of fibroblast proliferation; IDA:UniProtKB
Q53GL7	PARP10	Poly [ADP-ribose] polymerase 10	GO:0010629; P:negative regulation of gene expression; IMP:UniProt
Q53GL7	PARP10	Poly [ADP-ribose] polymerase 10	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IMP:UniProt
Q53GL7	PARP10	Poly [ADP-ribose] polymerase 10	GO:0033159; P:negative regulation of protein import into nucleus, translocation; IMP:UniProt
Q53GL7	PARP10	Poly [ADP-ribose] polymerase 10	GO:1900045; P:negative regulation of protein K63-linked ubiquitination; IMP:UniProt
Q53GL7	PARP10	Poly [ADP-ribose] polymerase 10	GO:0045071; P:negative regulation of viral genome replication; IMP:UniProt
Q53GL7	PARP10	Poly [ADP-ribose] polymerase 10	GO:0006471; P:protein ADP-ribosylation; IMP:UniProt
Q53GL7	PARP10	Poly [ADP-ribose] polymerase 10	GO:0070213; P:protein auto-ADP-ribosylation; IMP:UniProt
Q53GL7	PARP10	Poly [ADP-ribose] polymerase 10	GO:0070212; P:protein poly-ADP-ribosylation; IDA:UniProtKB
Q53GL7	PARP10	Poly [ADP-ribose] polymerase 10	GO:0010847; P:regulation of chromatin assembly; IDA:UniProtKB
Q9NR21	PARP11	Poly [ADP-ribose] polymerase 11	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IEA:UniProtKB-EC
Q460N5	PARP14	Poly [ADP-ribose] polymerase 14	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IEA:UniProtKB-EC
Q460N5	PARP14	Poly [ADP-ribose] polymerase 14	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q460N5	PARP14	Poly [ADP-ribose] polymerase 14	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15546	MMD	Monocyte to macrophage differentiation factor	GO:0004872; F:receptor activity; TAS:ProtInc
Q15546	MMD	Monocyte to macrophage differentiation factor	GO:0019835; P:cytolysis; IEA:InterPro
Q460N3	PARP15	Poly [ADP-ribose] polymerase 15	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IEA:UniProtKB-EC
Q460N3	PARP15	Poly [ADP-ribose] polymerase 15	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q460N3	PARP15	Poly [ADP-ribose] polymerase 15	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H0J9	PARP12	Poly [ADP-ribose] polymerase 12	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H0J9	PARP12	Poly [ADP-ribose] polymerase 12	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IEA:UniProtKB-EC
Q9H0J9	PARP12	Poly [ADP-ribose] polymerase 12	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8N5Y8	PARP16	Mono [ADP-ribose] polymerase PARP16	GO:0019900; F:kinase binding; IPI:UniProt
Q8N5Y8	PARP16	Mono [ADP-ribose] polymerase PARP16	GO:0003956; F:NAD(P)+-protein-arginine ADP-ribosyltransferase activity; IEA:UniProtKB-EC
Q8N5Y8	PARP16	Mono [ADP-ribose] polymerase PARP16	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IMP:UniProt
Q8N5Y8	PARP16	Mono [ADP-ribose] polymerase PARP16	GO:0005515; F:protein binding; IPI:UniProt
Q8N5Y8	PARP16	Mono [ADP-ribose] polymerase PARP16	GO:0043539; F:protein serine/threonine kinase activator activity; IMP:UniProt
Q8N5Y8	PARP16	Mono [ADP-ribose] polymerase PARP16	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; IMP:UniProt
Q8N5Y8	PARP16	Mono [ADP-ribose] polymerase PARP16	GO:0030968; P:endoplasmic reticulum unfolded protein response; IMP:UniProt
Q8N5Y8	PARP16	Mono [ADP-ribose] polymerase PARP16	GO:0060548; P:negative regulation of cell death; IMP:UniProt
Q8N5Y8	PARP16	Mono [ADP-ribose] polymerase PARP16	GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IMP:UniProt
Q8N5Y8	PARP16	Mono [ADP-ribose] polymerase PARP16	GO:0006471; P:protein ADP-ribosylation; IMP:UniProt
Q8N5Y8	PARP16	Mono [ADP-ribose] polymerase PARP16	GO:0070213; P:protein auto-ADP-ribosylation; IMP:UniProt
P25116	F2R	Proteinase-activated receptor 1	GO:0001965; F:G-protein alpha-subunit binding; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0031681; F:G-protein beta-subunit binding; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0004930; F:G-protein coupled receptor activity; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0005515; F:protein binding; IPI:IntAct
P25116	F2R	Proteinase-activated receptor 1	GO:0005102; F:receptor binding; IPI:BHF-UCL
P25116	F2R	Proteinase-activated receptor 1	GO:0015057; F:thrombin receptor activity; IDA:BHF-UCL
P25116	F2R	Proteinase-activated receptor 1	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:BHF-UCL
P25116	F2R	Proteinase-activated receptor 1	GO:0000186; P:activation of MAPKK activity; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P25116	F2R	Proteinase-activated receptor 1	GO:0007596; P:blood coagulation; TAS:Reactome
P25116	F2R	Proteinase-activated receptor 1	GO:0002248; P:connective tissue replacement involved in inflammatory response wound healing; IDA:BHF-UCL
P25116	F2R	Proteinase-activated receptor 1	GO:0007529; P:establishment of synaptic specificity at neuromuscular junction; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0048873; P:homeostasis of number of cells within a tissue; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0006954; P:inflammatory response; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL
P25116	F2R	Proteinase-activated receptor 1	GO:0003105; P:negative regulation of glomerular filtration; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:1900134; P:negative regulation of renin secretion into blood stream; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; IDA:BHF-UCL
P25116	F2R	Proteinase-activated receptor 1	GO:0030168; P:platelet activation; IDA:BHF-UCL
P25116	F2R	Proteinase-activated receptor 1	GO:0060155; P:platelet dense granule organization; IC:BHF-UCL
P25116	F2R	Proteinase-activated receptor 1	GO:0030194; P:positive regulation of blood coagulation; IDA:BHF-UCL
P25116	F2R	Proteinase-activated receptor 1	GO:0051928; P:positive regulation of calcium ion transport; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0030335; P:positive regulation of cell migration; IMP:BHF-UCL
P25116	F2R	Proteinase-activated receptor 1	GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0032967; P:positive regulation of collagen biosynthetic process; IDA:BHF-UCL
P25116	F2R	Proteinase-activated receptor 1	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:BHF-UCL
P25116	F2R	Proteinase-activated receptor 1	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0051482; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:2000778; P:positive regulation of interleukin-6 secretion; IDA:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:2000484; P:positive regulation of interleukin-8 secretion; IDA:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0046427; P:positive regulation of JAK-STAT cascade; IDA:BHF-UCL
P25116	F2R	Proteinase-activated receptor 1	GO:0043410; P:positive regulation of MAPK cascade; IDA:BHF-UCL
P25116	F2R	Proteinase-activated receptor 1	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IDA:BHF-UCL
P25116	F2R	Proteinase-activated receptor 1	GO:0035025; P:positive regulation of Rho protein signal transduction; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0045987; P:positive regulation of smooth muscle contraction; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
P25116	F2R	Proteinase-activated receptor 1	GO:0045907; P:positive regulation of vasoconstriction; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0030193; P:regulation of blood coagulation; IDA:BHF-UCL
P25116	F2R	Proteinase-activated receptor 1	GO:0032651; P:regulation of interleukin-1 beta production; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0051930; P:regulation of sensory perception of pain; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0051209; P:release of sequestered calcium ion into cytosol; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0032496; P:response to lipopolysaccharide; ISS:UniProtKB
P25116	F2R	Proteinase-activated receptor 1	GO:0009611; P:response to wounding; IDA:BHF-UCL
P25116	F2R	Proteinase-activated receptor 1	GO:0007262; P:STAT protein import into nucleus; IDA:BHF-UCL
P25116	F2R	Proteinase-activated receptor 1	GO:0007260; P:tyrosine phosphorylation of STAT protein; IDA:BHF-UCL
Q8TEW8	PARD3B	Partitioning defective 3 homolog B	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8TEW8	PARD3B	Partitioning defective 3 homolog B	GO:0051301; P:cell division; IEA:UniProtKB-KW
O00254	F2RL2	Proteinase-activated receptor 3	GO:0004435; F:phosphatidylinositol phospholipase C activity; TAS:ProtInc
O00254	F2RL2	Proteinase-activated receptor 3	GO:0005515; F:protein binding; IPI:IntAct
O00254	F2RL2	Proteinase-activated receptor 3	GO:0015057; F:thrombin receptor activity; TAS:ProtInc
O00254	F2RL2	Proteinase-activated receptor 3	GO:0007596; P:blood coagulation; TAS:Reactome
O00254	F2RL2	Proteinase-activated receptor 3	GO:0008152; P:metabolic process; TAS:GOC
O00254	F2RL2	Proteinase-activated receptor 3	GO:0030168; P:platelet activation; TAS:Reactome
O00254	F2RL2	Proteinase-activated receptor 3	GO:0009611; P:response to wounding; TAS:ProtInc
Q96RI0	F2RL3	Proteinase-activated receptor 4	GO:0015057; F:thrombin receptor activity; TAS:ProtInc
Q96RI0	F2RL3	Proteinase-activated receptor 4	GO:0007596; P:blood coagulation; TAS:Reactome
Q96RI0	F2RL3	Proteinase-activated receptor 4	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; TAS:ProtInc
Q96RI0	F2RL3	Proteinase-activated receptor 4	GO:0030168; P:platelet activation; TAS:Reactome
Q96RI0	F2RL3	Proteinase-activated receptor 4	GO:0060155; P:platelet dense granule organization; IC:BHF-UCL
Q96RI0	F2RL3	Proteinase-activated receptor 4	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IDA:BHF-UCL
Q96RI0	F2RL3	Proteinase-activated receptor 4	GO:0009611; P:response to wounding; TAS:ProtInc
Q96RI0	F2RL3	Proteinase-activated receptor 4	GO:0007165; P:signal transduction; TAS:ProtInc
P55085	F2RL1	Proteinase-activated receptor 2	GO:0001965; F:G-protein alpha-subunit binding; ISS:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0031681; F:G-protein beta-subunit binding; ISS:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0004930; F:G-protein coupled receptor activity; IMP:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0005515; F:protein binding; IPI:IntAct
P55085	F2RL1	Proteinase-activated receptor 2	GO:0004872; F:receptor activity; TAS:ProtInc
P55085	F2RL1	Proteinase-activated receptor 2	GO:0005102; F:receptor binding; TAS:ProtInc
P55085	F2RL1	Proteinase-activated receptor 2	GO:0015057; F:thrombin receptor activity; IEA:InterPro
P55085	F2RL1	Proteinase-activated receptor 2	GO:0007596; P:blood coagulation; IEA:InterPro
P55085	F2RL1	Proteinase-activated receptor 2	GO:0035926; P:chemokine (C-C motif) ligand 2 secretion; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0090195; P:chemokine secretion; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0051607; P:defense response to virus; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0061028; P:establishment of endothelial barrier; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P55085	F2RL1	Proteinase-activated receptor 2	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
P55085	F2RL1	Proteinase-activated receptor 2	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
P55085	F2RL1	Proteinase-activated receptor 2	GO:0072643; P:interferon-gamma secretion; ISS:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0050702; P:interleukin-1 beta secretion; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0072608; P:interleukin-10 secretion; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0050900; P:leukocyte migration; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0070661; P:leukocyte proliferation; ISS:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0097029; P:mature dendritic cell differentiation; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0090198; P:negative regulation of chemokine secretion; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0046329; P:negative regulation of JNK cascade; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0034140; P:negative regulation of toll-like receptor 3 signaling pathway; IMP:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0042119; P:neutrophil activation; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0030836; P:positive regulation of actin filament depolymerization; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0050921; P:positive regulation of chemotaxis; ISS:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0002741; P:positive regulation of cytokine secretion involved in immune response; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0043311; P:positive regulation of eosinophil degranulation; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0003104; P:positive regulation of glomerular filtration; ISS:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:2000778; P:positive regulation of interleukin-6 secretion; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:2000484; P:positive regulation of interleukin-8 secretion; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0002690; P:positive regulation of leukocyte chemotaxis; IDA:BHF-UCL
P55085	F2RL1	Proteinase-activated receptor 2	GO:0070963; P:positive regulation of neutrophil mediated killing of gram-negative bacterium; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0060100; P:positive regulation of phagocytosis, engulfment; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; ISS:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0050927; P:positive regulation of positive chemotaxis; IDA:BHF-UCL
P55085	F2RL1	Proteinase-activated receptor 2	GO:0031274; P:positive regulation of pseudopodium assembly; ISS:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:1900135; P:positive regulation of renin secretion into blood stream; ISS:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0035025; P:positive regulation of Rho protein signal transduction; IMP:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0032930; P:positive regulation of superoxide anion generation; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0034137; P:positive regulation of toll-like receptor 2 signaling pathway; IMP:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0034141; P:positive regulation of toll-like receptor 3 signaling pathway; IMP:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0034145; P:positive regulation of toll-like receptor 4 signaling pathway; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0045909; P:positive regulation of vasodilation; ISS:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0030193; P:regulation of blood coagulation; IDA:BHF-UCL
P55085	F2RL1	Proteinase-activated receptor 2	GO:0043122; P:regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0046328; P:regulation of JNK cascade; IDA:UniProtKB
P55085	F2RL1	Proteinase-activated receptor 2	GO:0002286; P:T cell activation involved in immune response; ISS:UniProtKB
Q9NPB6	PARD6A	Partitioning defective 6 homolog alpha	GO:0030742; F:GTP-dependent protein binding; ISS:UniProtKB
Q9NPB6	PARD6A	Partitioning defective 6 homolog alpha	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NPB6	PARD6A	Partitioning defective 6 homolog alpha	GO:0017048; F:Rho GTPase binding; ISS:UniProtKB
Q9NPB6	PARD6A	Partitioning defective 6 homolog alpha	GO:0008134; F:transcription factor binding; TAS:ProtInc
Q9NPB6	PARD6A	Partitioning defective 6 homolog alpha	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9NPB6	PARD6A	Partitioning defective 6 homolog alpha	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q9NPB6	PARD6A	Partitioning defective 6 homolog alpha	GO:0034329; P:cell junction assembly; TAS:Reactome
Q9NPB6	PARD6A	Partitioning defective 6 homolog alpha	GO:0045217; P:cell-cell junction maintenance; ISS:UniProtKB
Q9NPB6	PARD6A	Partitioning defective 6 homolog alpha	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q9NPB6	PARD6A	Partitioning defective 6 homolog alpha	GO:0070830; P:tight junction assembly; TAS:Reactome
Q9NPB6	PARD6A	Partitioning defective 6 homolog alpha	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q9NPB6	PARD6A	Partitioning defective 6 homolog alpha	GO:0016032; P:viral process; TAS:ProtInc
Q9BYG5	PARD6B	Partitioning defective 6 homolog beta	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BYG5	PARD6B	Partitioning defective 6 homolog beta	GO:0007409; P:axonogenesis; TAS:UniProtKB
Q9BYG5	PARD6B	Partitioning defective 6 homolog beta	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9BYG5	PARD6B	Partitioning defective 6 homolog beta	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q9BYG5	PARD6B	Partitioning defective 6 homolog beta	GO:0034329; P:cell junction assembly; TAS:Reactome
Q9BYG5	PARD6B	Partitioning defective 6 homolog beta	GO:0007043; P:cell-cell junction assembly; TAS:UniProtKB
Q9BYG5	PARD6B	Partitioning defective 6 homolog beta	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q9BYG5	PARD6B	Partitioning defective 6 homolog beta	GO:0007163; P:establishment or maintenance of cell polarity; TAS:UniProtKB
Q9BYG5	PARD6B	Partitioning defective 6 homolog beta	GO:0006461; P:protein complex assembly; IDA:UniProtKB
Q9BYG5	PARD6B	Partitioning defective 6 homolog beta	GO:0030334; P:regulation of cell migration; TAS:UniProtKB
Q9BYG5	PARD6B	Partitioning defective 6 homolog beta	GO:0070830; P:tight junction assembly; TAS:Reactome
Q9BYG4	PARD6G	Partitioning defective 6 homolog gamma	GO:0005515; F:protein binding; IPI:IntAct
Q9BYG4	PARD6G	Partitioning defective 6 homolog gamma	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9BYG4	PARD6G	Partitioning defective 6 homolog gamma	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q9BYG4	PARD6G	Partitioning defective 6 homolog gamma	GO:0034329; P:cell junction assembly; TAS:Reactome
Q9BYG4	PARD6G	Partitioning defective 6 homolog gamma	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q9BYG4	PARD6G	Partitioning defective 6 homolog gamma	GO:0070830; P:tight junction assembly; TAS:Reactome
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; ISS:UniProtKB
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0032266; F:phosphatidylinositol-3-phosphate binding; ISS:UniProtKB
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISS:UniProtKB
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0003383; P:apical constriction; IEA:Ensembl
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0008356; P:asymmetric cell division; TAS:ProtInc
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0007409; P:axonogenesis; TAS:UniProtKB
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0034329; P:cell junction assembly; TAS:Reactome
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0051642; P:centrosome localization; IEA:Ensembl
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0090162; P:establishment of epithelial cell polarity; ISS:UniProtKB
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0007163; P:establishment or maintenance of cell polarity; TAS:UniProtKB
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; TAS:UniProtKB
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0006612; P:protein targeting to membrane; ISS:UniProtKB
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0032970; P:regulation of actin filament-based process; IEA:Ensembl
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0060341; P:regulation of cellular localization; IEA:Ensembl
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0070830; P:tight junction assembly; ISS:UniProtKB
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q8TEW0	PARD3	Partitioning defective 3 homolog	GO:0044319; P:wound healing, spreading of cells; IEA:Ensembl
Q86W56	PARG	Poly(ADP-ribose) glycohydrolase	GO:0004649; F:poly(ADP-ribose) glycohydrolase activity; IDA:UniProtKB
Q86W56	PARG	Poly(ADP-ribose) glycohydrolase	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q86W56	PARG	Poly(ADP-ribose) glycohydrolase	GO:0006974; P:cellular response to DNA damage stimulus; IEA:Ensembl
Q86W56	PARG	Poly(ADP-ribose) glycohydrolase	GO:0016045; P:detection of bacterium; IEA:Ensembl
Q9NWS1	PARPBP	PCNA-interacting partner	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NWS1	PARPBP	PCNA-interacting partner	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NWS1	PARPBP	PCNA-interacting partner	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q9NWS1	PARPBP	PCNA-interacting partner	GO:2000042; P:negative regulation of double-strand break repair via homologous recombination; IMP:UniProtKB
Q99497	PARK7	Protein DJ-1	GO:0050681; F:androgen receptor binding; IPI:ParkinsonsUK-UCL
Q99497	PARK7	Protein DJ-1	GO:0003729; F:mRNA binding; IDA:UniProtKB
Q99497	PARK7	Protein DJ-1	GO:0008233; F:peptidase activity; IDA:UniProtKB
Q99497	PARK7	Protein DJ-1	GO:0004601; F:peroxidase activity; ISS:UniProtKB
Q99497	PARK7	Protein DJ-1	GO:0051920; F:peroxiredoxin activity; IEA:Ensembl
Q99497	PARK7	Protein DJ-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q99497	PARK7	Protein DJ-1	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q99497	PARK7	Protein DJ-1	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
Q99497	PARK7	Protein DJ-1	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q99497	PARK7	Protein DJ-1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q99497	PARK7	Protein DJ-1	GO:0070301; P:cellular response to hydrogen peroxide; IDA:UniProtKB
Q99497	PARK7	Protein DJ-1	GO:0051583; P:dopamine uptake involved in synaptic transmission; IEA:Ensembl
Q99497	PARK7	Protein DJ-1	GO:0042743; P:hydrogen peroxide metabolic process; IEA:Ensembl
Q99497	PARK7	Protein DJ-1	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q99497	PARK7	Protein DJ-1	GO:0051899; P:membrane depolarization; IEA:Ensembl
Q99497	PARK7	Protein DJ-1	GO:0060081; P:membrane hyperpolarization; IEA:Ensembl
Q99497	PARK7	Protein DJ-1	GO:0007005; P:mitochondrion organization; ISS:UniProtKB
Q99497	PARK7	Protein DJ-1	GO:0060548; P:negative regulation of cell death; IDA:UniProtKB
Q99497	PARK7	Protein DJ-1	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB
Q99497	PARK7	Protein DJ-1	GO:0043524; P:negative regulation of neuron apoptotic process; IDA:BHF-UCL
Q99497	PARK7	Protein DJ-1	GO:0032091; P:negative regulation of protein binding; IDA:UniProtKB
Q99497	PARK7	Protein DJ-1	GO:0055114; P:oxidation-reduction process; ISS:GOC
Q99497	PARK7	Protein DJ-1	GO:2000825; P:positive regulation of androgen receptor activity; IMP:ParkinsonsUK-UCL
Q99497	PARK7	Protein DJ-1	GO:2000277; P:positive regulation of oxidative phosphorylation uncoupler activity; IEA:Ensembl
Q99497	PARK7	Protein DJ-1	GO:0050821; P:protein stabilization; IMP:UniProtKB
Q99497	PARK7	Protein DJ-1	GO:0060765; P:regulation of androgen receptor signaling pathway; IDA:UniProtKB
Q99497	PARK7	Protein DJ-1	GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB
Q99497	PARK7	Protein DJ-1	GO:0043523; P:regulation of neuron apoptotic process; IDA:UniProtKB
Q99497	PARK7	Protein DJ-1	GO:0007338; P:single fertilization; IEA:UniProtKB-KW
Q9H300	PARL	Presenilins-associated rhomboid-like protein, mitochondrial	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q9H300	PARL	Presenilins-associated rhomboid-like protein, mitochondrial	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl
Q9H300	PARL	Presenilins-associated rhomboid-like protein, mitochondrial	GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; IEA:Ensembl
Q6UWI2	PARM1	Prostate androgen-regulated mucin-like protein 1	GO:0051973; P:positive regulation of telomerase activity; ISS:UniProtKB
O95453	PARN	Poly(A)-specific ribonuclease PARN	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95453	PARN	Poly(A)-specific ribonuclease PARN	GO:0003730; F:mRNA 3'-UTR binding; TAS:ProtInc
O95453	PARN	Poly(A)-specific ribonuclease PARN	GO:0004518; F:nuclease activity; TAS:ProtInc
O95453	PARN	Poly(A)-specific ribonuclease PARN	GO:0000166; F:nucleotide binding; IEA:InterPro
O95453	PARN	Poly(A)-specific ribonuclease PARN	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O95453	PARN	Poly(A)-specific ribonuclease PARN	GO:0004535; F:poly(A)-specific ribonuclease activity; TAS:Reactome
O95453	PARN	Poly(A)-specific ribonuclease PARN	GO:0005515; F:protein binding; IPI:UniProtKB
O95453	PARN	Poly(A)-specific ribonuclease PARN	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O95453	PARN	Poly(A)-specific ribonuclease PARN	GO:0007292; P:female gamete generation; TAS:ProtInc
O95453	PARN	Poly(A)-specific ribonuclease PARN	GO:0010467; P:gene expression; TAS:Reactome
O95453	PARN	Poly(A)-specific ribonuclease PARN	GO:0016071; P:mRNA metabolic process; TAS:Reactome
O95453	PARN	Poly(A)-specific ribonuclease PARN	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
O95453	PARN	Poly(A)-specific ribonuclease PARN	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IMP:UniProtKB
O95453	PARN	Poly(A)-specific ribonuclease PARN	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
O95453	PARN	Poly(A)-specific ribonuclease PARN	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; TAS:GOC
O95453	PARN	Poly(A)-specific ribonuclease PARN	GO:0016070; P:RNA metabolic process; TAS:Reactome
O95453	PARN	Poly(A)-specific ribonuclease PARN	GO:0009451; P:RNA modification; TAS:ProtInc
O95453	PARN	Poly(A)-specific ribonuclease PARN	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; TAS:GOC
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0003677; F:DNA binding; TAS:ProtInc
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0042802; F:identical protein binding; IPI:IntAct
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0051287; F:NAD binding; IEA:Ensembl
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IDA:UniProtKB
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0005515; F:protein binding; IPI:UniProtKB
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0008270; F:zinc ion binding; IEA:InterPro
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0006284; P:base-excision repair; IEA:Ensembl
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0032869; P:cellular response to insulin stimulus; IDA:BHF-UCL
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0042769; P:DNA damage response, detection of DNA damage; IEA:Ensembl
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0006281; P:DNA repair; TAS:UniProtKB
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0006302; P:double-strand break repair; IMP:UniProtKB
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0010467; P:gene expression; TAS:Reactome
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0030225; P:macrophage differentiation; TAS:UniProtKB
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:Reactome
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0060391; P:positive regulation of SMAD protein import into nucleus; IEA:Ensembl
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:2000679; P:positive regulation of transcription regulatory region DNA binding; IEA:Ensembl
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0006471; P:protein ADP-ribosylation; IDA:UniProtKB
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0016540; P:protein autoprocessing; IEA:Ensembl
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0070212; P:protein poly-ADP-ribosylation; IDA:UniProtKB
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0040009; P:regulation of growth rate; IEA:Ensembl
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0000723; P:telomere maintenance; IEA:Ensembl
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
P09874	PARP1	Poly [ADP-ribose] polymerase 1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q9UGN5	PARP2	Poly [ADP-ribose] polymerase 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UGN5	PARP2	Poly [ADP-ribose] polymerase 2	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IEA:UniProtKB-EC
Q9UGN5	PARP2	Poly [ADP-ribose] polymerase 2	GO:0005515; F:protein binding; IPI:IntAct
Q9UGN5	PARP2	Poly [ADP-ribose] polymerase 2	GO:0006284; P:base-excision repair; IEA:Ensembl
Q9UGN5	PARP2	Poly [ADP-ribose] polymerase 2	GO:0006281; P:DNA repair; TAS:ProtInc
Q9UGN5	PARP2	Poly [ADP-ribose] polymerase 2	GO:0097191; P:extrinsic apoptotic signaling pathway; IEA:Ensembl
Q9UGN5	PARP2	Poly [ADP-ribose] polymerase 2	GO:0006471; P:protein ADP-ribosylation; TAS:ProtInc
Q9Y6F1	PARP3	Poly [ADP-ribose] polymerase 3	GO:0003824; F:catalytic activity; TAS:ProtInc
Q9Y6F1	PARP3	Poly [ADP-ribose] polymerase 3	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IDA:MGI
Q9Y6F1	PARP3	Poly [ADP-ribose] polymerase 3	GO:0006281; P:DNA repair; TAS:ProtInc
Q9Y6F1	PARP3	Poly [ADP-ribose] polymerase 3	GO:0006302; P:double-strand break repair; IDA:MGI
Q9Y6F1	PARP3	Poly [ADP-ribose] polymerase 3	GO:0051106; P:positive regulation of DNA ligation; IGI:MGI
Q9Y6F1	PARP3	Poly [ADP-ribose] polymerase 3	GO:0006471; P:protein ADP-ribosylation; IDA:MGI
Q9Y6F1	PARP3	Poly [ADP-ribose] polymerase 3	GO:1990166; P:protein localization to site of double-strand break; IMP:MGI
Q9Y6F1	PARP3	Poly [ADP-ribose] polymerase 3	GO:0060236; P:regulation of mitotic spindle organization; IMP:MGI
Q9Y6F1	PARP3	Poly [ADP-ribose] polymerase 3	GO:0000723; P:telomere maintenance; IMP:MGI
Q9UKK3	PARP4	Poly [ADP-ribose] polymerase 4	GO:0003677; F:DNA binding; TAS:ProtInc
Q9UKK3	PARP4	Poly [ADP-ribose] polymerase 4	GO:0019899; F:enzyme binding; IDA:MGI
Q9UKK3	PARP4	Poly [ADP-ribose] polymerase 4	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IDA:UniProtKB
Q9UKK3	PARP4	Poly [ADP-ribose] polymerase 4	GO:0005515; F:protein binding; IPI:IntAct
Q9UKK3	PARP4	Poly [ADP-ribose] polymerase 4	GO:0008219; P:cell death; IMP:UniProtKB
Q9UKK3	PARP4	Poly [ADP-ribose] polymerase 4	GO:0006464; P:cellular protein modification process; IDA:UniProtKB
Q9UKK3	PARP4	Poly [ADP-ribose] polymerase 4	GO:0006974; P:cellular response to DNA damage stimulus; NAS:UniProtKB
Q9UKK3	PARP4	Poly [ADP-ribose] polymerase 4	GO:0006281; P:DNA repair; NAS:UniProtKB
Q9UKK3	PARP4	Poly [ADP-ribose] polymerase 4	GO:0006954; P:inflammatory response; IMP:UniProtKB
Q9UKK3	PARP4	Poly [ADP-ribose] polymerase 4	GO:0006471; P:protein ADP-ribosylation; NAS:UniProtKB
Q9UKK3	PARP4	Poly [ADP-ribose] polymerase 4	GO:0042493; P:response to drug; NAS:UniProtKB
Q9UKK3	PARP4	Poly [ADP-ribose] polymerase 4	GO:0006810; P:transport; NAS:UniProtKB
Q2NL67	PARP6	Poly [ADP-ribose] polymerase 6	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IEA:UniProtKB-EC
Q8N3A8	PARP8	Poly [ADP-ribose] polymerase 8	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IEA:UniProtKB-EC
Q8IXQ6	PARP9	Poly [ADP-ribose] polymerase 9	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IDA:UniProtKB
Q8IXQ6	PARP9	Poly [ADP-ribose] polymerase 9	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IXQ6	PARP9	Poly [ADP-ribose] polymerase 9	GO:0016477; P:cell migration; TAS:UniProtKB
Q8IXQ6	PARP9	Poly [ADP-ribose] polymerase 9	GO:0006302; P:double-strand break repair; IMP:UniProtKB
Q8IXQ6	PARP9	Poly [ADP-ribose] polymerase 9	GO:0060330; P:regulation of response to interferon-gamma; IDA:UniProtKB
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0035326; F:enhancer binding; IDA:MGI
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IDA:MGI
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0008209; P:androgen metabolic process; IEA:Ensembl
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0071407; P:cellular response to organic cyclic compound; IDA:MGI
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0008210; P:estrogen metabolic process; IEA:Ensembl
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0060325; P:face morphogenesis; IEA:Ensembl
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0008585; P:female gonad development; IEA:Ensembl
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0030097; P:hemopoiesis; IEA:Ensembl
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0001822; P:kidney development; IEA:Ensembl
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0044236; P:multicellular organismal metabolic process; IEA:Ensembl
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0010629; P:negative regulation of gene expression; IMP:MGI
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0006807; P:nitrogen compound metabolic process; IEA:Ensembl
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0060021; P:palate development; IEA:Ensembl
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IEA:Ensembl
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0045732; P:positive regulation of protein catabolic process; IMP:MGI
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0006471; P:protein ADP-ribosylation; IEA:Ensembl
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0048745; P:smooth muscle tissue development; IEA:Ensembl
Q7Z3E1	TIPARP	TCDD-inducible poly [ADP-ribose] polymerase	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q9NVD7	PARVA	Alpha-parvin	GO:0005515; F:protein binding; IPI:IntAct
Q9NVD7	PARVA	Alpha-parvin	GO:0031532; P:actin cytoskeleton reorganization; IEA:InterPro
Q9NVD7	PARVA	Alpha-parvin	GO:0070252; P:actin-mediated cell contraction; ISS:UniProtKB
Q9NVD7	PARVA	Alpha-parvin	GO:0034329; P:cell junction assembly; TAS:Reactome
Q9NVD7	PARVA	Alpha-parvin	GO:0060271; P:cilium morphogenesis; IMP:UniProtKB
Q9NVD7	PARVA	Alpha-parvin	GO:0007163; P:establishment or maintenance of cell polarity; ISS:UniProtKB
Q9NVD7	PARVA	Alpha-parvin	GO:0034113; P:heterotypic cell-cell adhesion; ISS:UniProtKB
Q9NVD7	PARVA	Alpha-parvin	GO:0003148; P:outflow tract septum morphogenesis; ISS:UniProtKB
Q9NVD7	PARVA	Alpha-parvin	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
Q9NVD7	PARVA	Alpha-parvin	GO:0071670; P:smooth muscle cell chemotaxis; ISS:UniProtKB
Q9NVD7	PARVA	Alpha-parvin	GO:0002040; P:sprouting angiogenesis; ISS:UniProtKB
Q9NVD7	PARVA	Alpha-parvin	GO:0034446; P:substrate adhesion-dependent cell spreading; IMP:UniProtKB
Q9HBI1	PARVB	Beta-parvin	GO:0005515; F:protein binding; IPI:IntAct
Q9HBI1	PARVB	Beta-parvin	GO:0031532; P:actin cytoskeleton reorganization; IMP:UniProtKB
Q9HBI1	PARVB	Beta-parvin	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9HBI1	PARVB	Beta-parvin	GO:0034329; P:cell junction assembly; TAS:Reactome
Q9HBI1	PARVB	Beta-parvin	GO:0030031; P:cell projection assembly; IMP:UniProtKB
Q9HBI1	PARVB	Beta-parvin	GO:0071963; P:establishment or maintenance of cell polarity regulating cell shape; IMP:UniProtKB
Q9HBI1	PARVB	Beta-parvin	GO:0030032; P:lamellipodium assembly; IMP:UniProtKB
Q9HBI0	PARVG	Gamma-parvin	GO:0003779; F:actin binding; TAS:UniProtKB
Q9HBI0	PARVG	Gamma-parvin	GO:0031532; P:actin cytoskeleton reorganization; IEA:InterPro
Q9HBI0	PARVG	Gamma-parvin	GO:0007160; P:cell-matrix adhesion; TAS:UniProtKB
Q96RG2	PASK	PAS domain-containing serine/threonine-protein kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96RG2	PASK	PAS domain-containing serine/threonine-protein kinase	GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB
Q96RG2	PASK	PAS domain-containing serine/threonine-protein kinase	GO:0005515; F:protein binding; IPI:UniProtKB
Q96RG2	PASK	PAS domain-containing serine/threonine-protein kinase	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q96RG2	PASK	PAS domain-containing serine/threonine-protein kinase	GO:0004871; F:signal transducer activity; IEA:InterPro
Q96RG2	PASK	PAS domain-containing serine/threonine-protein kinase	GO:0045719; P:negative regulation of glycogen biosynthetic process; IDA:UniProtKB
Q96RG2	PASK	PAS domain-containing serine/threonine-protein kinase	GO:0045727; P:positive regulation of translation; TAS:UniProtKB
Q96RG2	PASK	PAS domain-containing serine/threonine-protein kinase	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q96RG2	PASK	PAS domain-containing serine/threonine-protein kinase	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q96RG2	PASK	PAS domain-containing serine/threonine-protein kinase	GO:2000505; P:regulation of energy homeostasis; ISS:UniProtKB
Q96RG2	PASK	PAS domain-containing serine/threonine-protein kinase	GO:0070092; P:regulation of glucagon secretion; ISS:UniProtKB
Q96RG2	PASK	PAS domain-containing serine/threonine-protein kinase	GO:0043576; P:regulation of respiratory gaseous exchange; ISS:UniProtKB
Q8IV76	PASD1	PAS domain-containing protein 1	GO:0004871; F:signal transducer activity; IEA:InterPro
P0C8F1	PATE4	Prostate and testis expressed protein 4	GO:0050804; P:regulation of synaptic transmission; IEA:Ensembl
P0C8F1	PATE4	Prostate and testis expressed protein 4	GO:0009611; P:response to wounding; IEA:Ensembl
Q86TB9	PATL1	Protein PAT1 homolog 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q86TB9	PATL1	Protein PAT1 homolog 1	GO:0034046; F:poly(G) binding; IDA:MGI
Q86TB9	PATL1	Protein PAT1 homolog 1	GO:0008266; F:poly(U) RNA binding; IDA:MGI
Q86TB9	PATL1	Protein PAT1 homolog 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q86TB9	PATL1	Protein PAT1 homolog 1	GO:0003723; F:RNA binding; IDA:UniProtKB
Q86TB9	PATL1	Protein PAT1 homolog 1	GO:0033962; P:cytoplasmic mRNA processing body assembly; IDA:UniProtKB
Q86TB9	PATL1	Protein PAT1 homolog 1	GO:0000290; P:deadenylation-dependent decapping of nuclear-transcribed mRNA; IDA:UniProtKB
Q86TB9	PATL1	Protein PAT1 homolog 1	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
Q86TB9	PATL1	Protein PAT1 homolog 1	GO:0010467; P:gene expression; TAS:Reactome
Q86TB9	PATL1	Protein PAT1 homolog 1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q86TB9	PATL1	Protein PAT1 homolog 1	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q86TB9	PATL1	Protein PAT1 homolog 1	GO:0016070; P:RNA metabolic process; TAS:Reactome
C9JE40	PATL2	Protein PAT1 homolog 2	GO:0005515; F:protein binding; IPI:UniProtKB
C9JE40	PATL2	Protein PAT1 homolog 2	GO:0003723; F:RNA binding; ISS:UniProtKB
C9JE40	PATL2	Protein PAT1 homolog 2	GO:0010607; P:negative regulation of cytoplasmic mRNA processing body assembly; IEA:Ensembl
C9JE40	PATL2	Protein PAT1 homolog 2	GO:0017148; P:negative regulation of translation; ISS:UniProtKB
Q9HBE1	PATZ1	POZ-, AT hook-, and zinc finger-containing protein 1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9HBE1	PATZ1	POZ-, AT hook-, and zinc finger-containing protein 1	GO:0003677; F:DNA binding; NAS:UniProtKB
Q9HBE1	PATZ1	POZ-, AT hook-, and zinc finger-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HBE1	PATZ1	POZ-, AT hook-, and zinc finger-containing protein 1	GO:0008584; P:male gonad development; IEA:Ensembl
Q9HBE1	PATZ1	POZ-, AT hook-, and zinc finger-containing protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; TAS:UniProtKB
Q9HBE1	PATZ1	POZ-, AT hook-, and zinc finger-containing protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q9HBE1	PATZ1	POZ-, AT hook-, and zinc finger-containing protein 1	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q9HBE1	PATZ1	POZ-, AT hook-, and zinc finger-containing protein 1	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q9HBE1	PATZ1	POZ-, AT hook-, and zinc finger-containing protein 1	GO:0030217; P:T cell differentiation; IEA:Ensembl
Q9HBE1	PATZ1	POZ-, AT hook-, and zinc finger-containing protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96IZ0	PAWR	PRKC apoptosis WT1 regulator protein	GO:0003779; F:actin binding; ISS:UniProtKB
Q96IZ0	PAWR	PRKC apoptosis WT1 regulator protein	GO:0019899; F:enzyme binding; IDA:UniProtKB
Q96IZ0	PAWR	PRKC apoptosis WT1 regulator protein	GO:0043522; F:leucine zipper domain binding; IPI:UniProtKB
Q96IZ0	PAWR	PRKC apoptosis WT1 regulator protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q96IZ0	PAWR	PRKC apoptosis WT1 regulator protein	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q96IZ0	PAWR	PRKC apoptosis WT1 regulator protein	GO:0051017; P:actin filament bundle assembly; ISS:UniProtKB
Q96IZ0	PAWR	PRKC apoptosis WT1 regulator protein	GO:0006915; P:apoptotic process; ISS:UniProtKB
Q96IZ0	PAWR	PRKC apoptosis WT1 regulator protein	GO:0097190; P:apoptotic signaling pathway; IEA:Ensembl
Q96IZ0	PAWR	PRKC apoptosis WT1 regulator protein	GO:0042094; P:interleukin-2 biosynthetic process; IEA:Ensembl
Q96IZ0	PAWR	PRKC apoptosis WT1 regulator protein	GO:0030889; P:negative regulation of B cell proliferation; IEA:Ensembl
Q96IZ0	PAWR	PRKC apoptosis WT1 regulator protein	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q96IZ0	PAWR	PRKC apoptosis WT1 regulator protein	GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl
Q96IZ0	PAWR	PRKC apoptosis WT1 regulator protein	GO:0050860; P:negative regulation of T cell receptor signaling pathway; IEA:Ensembl
Q96IZ0	PAWR	PRKC apoptosis WT1 regulator protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q96IZ0	PAWR	PRKC apoptosis WT1 regulator protein	GO:0042986; P:positive regulation of amyloid precursor protein biosynthetic process; IEA:Ensembl
Q96IZ0	PAWR	PRKC apoptosis WT1 regulator protein	GO:0043065; P:positive regulation of apoptotic process; NAS:UniProtKB
Q96IZ0	PAWR	PRKC apoptosis WT1 regulator protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P15863	PAX1	Paired box protein Pax-1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P15863	PAX1	Paired box protein Pax-1	GO:0060349; P:bone morphogenesis; IEA:Ensembl
P15863	PAX1	Paired box protein Pax-1	GO:0043367; P:CD4-positive, alpha-beta T cell differentiation; IEA:Ensembl
P15863	PAX1	Paired box protein Pax-1	GO:0043374; P:CD8-positive, alpha-beta T cell differentiation; IEA:Ensembl
P15863	PAX1	Paired box protein Pax-1	GO:0008283; P:cell proliferation; IEA:Ensembl
P15863	PAX1	Paired box protein Pax-1	GO:0060017; P:parathyroid gland development; IEA:Ensembl
P15863	PAX1	Paired box protein Pax-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P15863	PAX1	Paired box protein Pax-1	GO:0061056; P:sclerotome development; IEA:Ensembl
P15863	PAX1	Paired box protein Pax-1	GO:0001501; P:skeletal system development; TAS:ProtInc
P15863	PAX1	Paired box protein Pax-1	GO:0001756; P:somitogenesis; IEA:Ensembl
P15863	PAX1	Paired box protein Pax-1	GO:0048538; P:thymus development; IEA:Ensembl
P15863	PAX1	Paired box protein Pax-1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P23760	PAX3	Paired box protein Pax-3	GO:0003682; F:chromatin binding; IEA:Ensembl
P23760	PAX3	Paired box protein Pax-3	GO:0005515; F:protein binding; IPI:IntAct
P23760	PAX3	Paired box protein Pax-3	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P23760	PAX3	Paired box protein Pax-3	GO:0043565; F:sequence-specific DNA binding; IDA:MGI
P23760	PAX3	Paired box protein Pax-3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P23760	PAX3	Paired box protein Pax-3	GO:0006915; P:apoptotic process; TAS:ProtInc
P23760	PAX3	Paired box protein Pax-3	GO:0008283; P:cell proliferation; IEA:Ensembl
P23760	PAX3	Paired box protein Pax-3	GO:0048066; P:developmental pigmentation; IEA:Ensembl
P23760	PAX3	Paired box protein Pax-3	GO:0007507; P:heart development; IEA:Ensembl
P23760	PAX3	Paired box protein Pax-3	GO:0060594; P:mammary gland specification; IEA:Ensembl
P23760	PAX3	Paired box protein Pax-3	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
P23760	PAX3	Paired box protein Pax-3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P23760	PAX3	Paired box protein Pax-3	GO:0001755; P:neural crest cell migration; IEA:Ensembl
P23760	PAX3	Paired box protein Pax-3	GO:0001843; P:neural tube closure; IEA:Ensembl
P23760	PAX3	Paired box protein Pax-3	GO:0048663; P:neuron fate commitment; IEA:Ensembl
P23760	PAX3	Paired box protein Pax-3	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P23760	PAX3	Paired box protein Pax-3	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P23760	PAX3	Paired box protein Pax-3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
P23760	PAX3	Paired box protein Pax-3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:MGI
P23760	PAX3	Paired box protein Pax-3	GO:0014807; P:regulation of somitogenesis; IEA:Ensembl
P23760	PAX3	Paired box protein Pax-3	GO:0007605; P:sensory perception of sound; TAS:ProtInc
P23760	PAX3	Paired box protein Pax-3	GO:0021527; P:spinal cord association neuron differentiation; IEA:Ensembl
P23760	PAX3	Paired box protein Pax-3	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q02962	PAX2	Paired box protein Pax-2	GO:0000987; F:core promoter proximal region sequence-specific DNA binding; IDA:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0003677; F:DNA binding; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0016175; F:superoxide-generating NADPH oxidase activity; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0007568; P:aging; IEA:Ensembl
Q02962	PAX2	Paired box protein Pax-2	GO:0007409; P:axonogenesis; TAS:ProtInc
Q02962	PAX2	Paired box protein Pax-2	GO:0048854; P:brain morphogenesis; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEP:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0043010; P:camera-type eye development; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0001709; P:cell fate determination; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0071364; P:cellular response to epidermal growth factor stimulus; IEA:Ensembl
Q02962	PAX2	Paired box protein Pax-2	GO:0071333; P:cellular response to glucose stimulus; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0070301; P:cellular response to hydrogen peroxide; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
Q02962	PAX2	Paired box protein Pax-2	GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0090102; P:cochlea development; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0090103; P:cochlea morphogenesis; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0010001; P:glial cell differentiation; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0042472; P:inner ear morphogenesis; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0060231; P:mesenchymal to epithelial transition; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0003337; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0007501; P:mesodermal cell fate specification; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0072177; P:mesonephric duct development; IEA:Ensembl
Q02962	PAX2	Paired box protein Pax-2	GO:0072172; P:mesonephric tubule formation; IEA:Ensembl
Q02962	PAX2	Paired box protein Pax-2	GO:0001823; P:mesonephros development; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0072205; P:metanephric collecting duct development; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0072221; P:metanephric distal convoluted tubule development; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0072207; P:metanephric epithelium development; IEP:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0072162; P:metanephric mesenchymal cell differentiation; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0072075; P:metanephric mesenchyme development; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0072289; P:metanephric nephron tubule formation; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:1900215; P:negative regulation of apoptotic process involved in metanephric collecting duct development; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:1900218; P:negative regulation of apoptotic process involved in metanephric nephron tubule development; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0045918; P:negative regulation of cytolysis; IMP:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0072305; P:negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:1900212; P:negative regulation of mesenchymal cell apoptotic process involved in metanephros development; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0043069; P:negative regulation of programmed cell death; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:2000378; P:negative regulation of reactive oxygen species metabolic process; IDA:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q02962	PAX2	Paired box protein Pax-2	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0072179; P:nephric duct formation; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0001843; P:neural tube closure; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0061360; P:optic chiasma development; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0002072; P:optic cup morphogenesis involved in camera-type eye development; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0021554; P:optic nerve development; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0021631; P:optic nerve morphogenesis; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0021633; P:optic nerve structural organization; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0055114; P:oxidation-reduction process; ISS:GOC
Q02962	PAX2	Paired box protein Pax-2	GO:0031016; P:pancreas development; IEA:Ensembl
Q02962	PAX2	Paired box protein Pax-2	GO:0061205; P:paramesonephric duct development; IEA:Ensembl
Q02962	PAX2	Paired box protein Pax-2	GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0072108; P:positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:2000594; P:positive regulation of metanephric DCT cell differentiation; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0072300; P:positive regulation of metanephric glomerulus development; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:2000597; P:positive regulation of optic nerve formation; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0039003; P:pronephric field specification; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0048793; P:pronephros development; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0043491; P:protein kinase B signaling; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0072593; P:reactive oxygen species metabolic process; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0072307; P:regulation of metanephric nephron tubule epithelial cell differentiation; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0035566; P:regulation of metanephros size; IMP:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0031667; P:response to nutrient levels; IEA:Ensembl
Q02962	PAX2	Paired box protein Pax-2	GO:0003406; P:retinal pigment epithelium development; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0048863; P:stem cell differentiation; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q02962	PAX2	Paired box protein Pax-2	GO:0006351; P:transcription, DNA-templated; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0072189; P:ureter development; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0035799; P:ureter maturation; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0072197; P:ureter morphogenesis; IEA:Ensembl
Q02962	PAX2	Paired box protein Pax-2	GO:0001655; P:urogenital system development; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0021650; P:vestibulocochlear nerve formation; ISS:UniProtKB
Q02962	PAX2	Paired box protein Pax-2	GO:0007601; P:visual perception; TAS:ProtInc
Q02548	PAX5	Paired box protein Pax-5	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q02548	PAX5	Paired box protein Pax-5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q02548	PAX5	Paired box protein Pax-5	GO:0006959; P:humoral immune response; TAS:ProtInc
Q02548	PAX5	Paired box protein Pax-5	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q02548	PAX5	Paired box protein Pax-5	GO:0051573; P:negative regulation of histone H3-K9 methylation; IEA:Ensembl
Q02548	PAX5	Paired box protein Pax-5	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q02548	PAX5	Paired box protein Pax-5	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q02548	PAX5	Paired box protein Pax-5	GO:0009887; P:organ morphogenesis; TAS:ProtInc
Q02548	PAX5	Paired box protein Pax-5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q02548	PAX5	Paired box protein Pax-5	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q02548	PAX5	Paired box protein Pax-5	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q02548	PAX5	Paired box protein Pax-5	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
O43316	PAX4	Paired box protein Pax-4	GO:0003677; F:DNA binding; TAS:ProtInc
O43316	PAX4	Paired box protein Pax-4	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
O43316	PAX4	Paired box protein Pax-4	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O43316	PAX4	Paired box protein Pax-4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O43316	PAX4	Paired box protein Pax-4	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O43316	PAX4	Paired box protein Pax-4	GO:0007623; P:circadian rhythm; IEA:Ensembl
O43316	PAX4	Paired box protein Pax-4	GO:0031018; P:endocrine pancreas development; TAS:Reactome
O43316	PAX4	Paired box protein Pax-4	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
O43316	PAX4	Paired box protein Pax-4	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O43316	PAX4	Paired box protein Pax-4	GO:0009887; P:organ morphogenesis; TAS:ProtInc
O43316	PAX4	Paired box protein Pax-4	GO:0045597; P:positive regulation of cell differentiation; IEA:Ensembl
O43316	PAX4	Paired box protein Pax-4	GO:0051591; P:response to cAMP; IEA:Ensembl
O43316	PAX4	Paired box protein Pax-4	GO:0042493; P:response to drug; IEA:Ensembl
O43316	PAX4	Paired box protein Pax-4	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
O43316	PAX4	Paired box protein Pax-4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P26367	PAX6	Paired box protein Pax-6	GO:0003680; F:AT DNA binding; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0003677; F:DNA binding; TAS:ProtInc
P26367	PAX6	Paired box protein Pax-6	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0035035; F:histone acetyltransferase binding; ISS:BHF-UCL
P26367	PAX6	Paired box protein Pax-6	GO:0005515; F:protein binding; IPI:IntAct
P26367	PAX6	Paired box protein Pax-6	GO:0019901; F:protein kinase binding; ISS:BHF-UCL
P26367	PAX6	Paired box protein Pax-6	GO:0070412; F:R-SMAD binding; IPI:BHF-UCL
P26367	PAX6	Paired box protein Pax-6	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IDA:BHF-UCL
P26367	PAX6	Paired box protein Pax-6	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:BHF-UCL
P26367	PAX6	Paired box protein Pax-6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P26367	PAX6	Paired box protein Pax-6	GO:0008134; F:transcription factor binding; ISS:BHF-UCL
P26367	PAX6	Paired box protein Pax-6	GO:0004842; F:ubiquitin-protein ligase activity; ISS:UniProtKB
P26367	PAX6	Paired box protein Pax-6	GO:0048708; P:astrocyte differentiation; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0007411; P:axon guidance; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0001568; P:blood vessel development; IMP:DFLAT
P26367	PAX6	Paired box protein Pax-6	GO:0001709; P:cell fate determination; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0007417; P:central nervous system development; TAS:ProtInc
P26367	PAX6	Paired box protein Pax-6	GO:0021796; P:cerebral cortex regionalization; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0021902; P:commitment of neuronal cell to specific neuron type in forebrain; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0061303; P:cornea development in camera-type eye; IMP:DFLAT
P26367	PAX6	Paired box protein Pax-6	GO:0009950; P:dorsal/ventral axis specification; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0048596; P:embryonic camera-type eye morphogenesis; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0001654; P:eye development; TAS:ProtInc
P26367	PAX6	Paired box protein Pax-6	GO:0042462; P:eye photoreceptor cell development; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0021797; P:forebrain anterior/posterior pattern specification; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0021798; P:forebrain dorsal/ventral pattern formation; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0021905; P:forebrain-midbrain boundary formation; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0042593; P:glucose homeostasis; IMP:DFLAT
P26367	PAX6	Paired box protein Pax-6	GO:0030902; P:hindbrain development; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0061072; P:iris morphogenesis; IMP:DFLAT
P26367	PAX6	Paired box protein Pax-6	GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0032808; P:lacrimal gland development; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0002088; P:lens development in camera-type eye; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0050768; P:negative regulation of neurogenesis; ISS:UniProtKB
P26367	PAX6	Paired box protein Pax-6	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0048663; P:neuron fate commitment; NAS:UniProtKB
P26367	PAX6	Paired box protein Pax-6	GO:0001764; P:neuron migration; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0021778; P:oligodendrocyte cell fate specification; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P26367	PAX6	Paired box protein Pax-6	GO:0003322; P:pancreatic A cell development; IMP:BHF-UCL
P26367	PAX6	Paired box protein Pax-6	GO:0021983; P:pituitary gland development; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0042660; P:positive regulation of cell fate specification; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0030858; P:positive regulation of epithelial cell differentiation; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL
P26367	PAX6	Paired box protein Pax-6	GO:0002052; P:positive regulation of neuroblast proliferation; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P26367	PAX6	Paired box protein Pax-6	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:BHF-UCL
P26367	PAX6	Paired box protein Pax-6	GO:0033365; P:protein localization to organelle; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0016567; P:protein ubiquitination; ISS:GOC
P26367	PAX6	Paired box protein Pax-6	GO:0030334; P:regulation of cell migration; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0048505; P:regulation of timing of cell differentiation; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0021918; P:regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0021912; P:regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0021913; P:regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0009611; P:response to wounding; IEP:UniProtKB
P26367	PAX6	Paired box protein Pax-6	GO:0007435; P:salivary gland morphogenesis; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0006366; P:transcription from RNA polymerase II promoter; IMP:BHF-UCL
P26367	PAX6	Paired box protein Pax-6	GO:0003309; P:type B pancreatic cell differentiation; IEA:Ensembl
P26367	PAX6	Paired box protein Pax-6	GO:0007601; P:visual perception; TAS:ProtInc
P23759	PAX7	Paired box protein Pax-7	GO:0000983; F:RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P23759	PAX7	Paired box protein Pax-7	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P23759	PAX7	Paired box protein Pax-7	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P23759	PAX7	Paired box protein Pax-7	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P23759	PAX7	Paired box protein Pax-7	GO:0051216; P:cartilage development; IEA:Ensembl
P23759	PAX7	Paired box protein Pax-7	GO:0006338; P:chromatin remodeling; IEA:Ensembl
P23759	PAX7	Paired box protein Pax-7	GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl
P23759	PAX7	Paired box protein Pax-7	GO:0048706; P:embryonic skeletal system development; IEA:Ensembl
P23759	PAX7	Paired box protein Pax-7	GO:0060415; P:muscle tissue morphogenesis; IEA:Ensembl
P23759	PAX7	Paired box protein Pax-7	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
P23759	PAX7	Paired box protein Pax-7	GO:0048663; P:neuron fate commitment; IEA:Ensembl
P23759	PAX7	Paired box protein Pax-7	GO:0031062; P:positive regulation of histone methylation; IEA:Ensembl
P23759	PAX7	Paired box protein Pax-7	GO:2000288; P:positive regulation of myoblast proliferation; IEA:Ensembl
P23759	PAX7	Paired box protein Pax-7	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P23759	PAX7	Paired box protein Pax-7	GO:0010453; P:regulation of cell fate commitment; IEA:Ensembl
P23759	PAX7	Paired box protein Pax-7	GO:0043393; P:regulation of protein binding; IEA:Ensembl
P23759	PAX7	Paired box protein Pax-7	GO:0014813; P:satellite cell commitment; IEA:Ensembl
P23759	PAX7	Paired box protein Pax-7	GO:0043403; P:skeletal muscle tissue regeneration; IEA:Ensembl
P23759	PAX7	Paired box protein Pax-7	GO:0021527; P:spinal cord association neuron differentiation; IEA:Ensembl
P55771	PAX9	Paired box protein Pax-9	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P55771	PAX9	Paired box protein Pax-9	GO:0005515; F:protein binding; IPI:UniProtKB
P55771	PAX9	Paired box protein Pax-9	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P55771	PAX9	Paired box protein Pax-9	GO:0007492; P:endoderm development; IEA:Ensembl
P55771	PAX9	Paired box protein Pax-9	GO:0060325; P:face morphogenesis; IEA:Ensembl
P55771	PAX9	Paired box protein Pax-9	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P55771	PAX9	Paired box protein Pax-9	GO:0042476; P:odontogenesis; IEA:Ensembl
P55771	PAX9	Paired box protein Pax-9	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P55771	PAX9	Paired box protein Pax-9	GO:0042481; P:regulation of odontogenesis; IEA:Ensembl
P55771	PAX9	Paired box protein Pax-9	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q06710	PAX8	Paired box protein Pax-8	GO:0003677; F:DNA binding; IDA:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0005515; F:protein binding; IPI:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IDA:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0004996; F:thyroid-stimulating hormone receptor activity; TAS:ProtInc
Q06710	PAX8	Paired box protein Pax-8	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q06710	PAX8	Paired box protein Pax-8	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEP:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0071371; P:cellular response to gonadotropin stimulus; IDA:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0007417; P:central nervous system development; IEP:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0042472; P:inner ear morphogenesis; ISS:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0001822; P:kidney development; IEP:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0003337; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; IEP:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0072164; P:mesonephric tubule development; IEA:Ensembl
Q06710	PAX8	Paired box protein Pax-8	GO:0001823; P:mesonephros development; ISS:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0072278; P:metanephric comma-shaped body morphogenesis; IEP:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0072221; P:metanephric distal convoluted tubule development; ISS:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0072207; P:metanephric epithelium development; IEP:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0072289; P:metanephric nephron tubule formation; ISS:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0072284; P:metanephric S-shaped body morphogenesis; IEP:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:1900215; P:negative regulation of apoptotic process involved in metanephric collecting duct development; ISS:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:1900218; P:negative regulation of apoptotic process involved in metanephric nephron tubule development; ISS:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0072305; P:negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis; ISS:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:1900212; P:negative regulation of mesenchymal cell apoptotic process involved in metanephros development; ISS:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0071599; P:otic vesicle development; IEP:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; ISS:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0072108; P:positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; ISS:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:2000594; P:positive regulation of metanephric DCT cell differentiation; ISS:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:2000611; P:positive regulation of thyroid hormone generation; IMP:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0039003; P:pronephric field specification; ISS:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0048793; P:pronephros development; ISS:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0042981; P:regulation of apoptotic process; ISS:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0072307; P:regulation of metanephric nephron tubule epithelial cell differentiation; ISS:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:2000612; P:regulation of thyroid-stimulating hormone secretion; IMP:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0030878; P:thyroid gland development; IMP:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0038194; P:thyroid-stimulating hormone signaling pathway; TAS:GOC
Q06710	PAX8	Paired box protein Pax-8	GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB
Q06710	PAX8	Paired box protein Pax-8	GO:0001655; P:urogenital system development; ISS:UniProtKB
Q9Y5B6	PAXBP1	PAX3- and PAX7-binding protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y5B6	PAXBP1	PAX3- and PAX7-binding protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9Y5B6	PAXBP1	PAX3- and PAX7-binding protein 1	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
Q9Y5B6	PAXBP1	PAX3- and PAX7-binding protein 1	GO:0031062; P:positive regulation of histone methylation; IEA:Ensembl
Q9Y5B6	PAXBP1	PAX3- and PAX7-binding protein 1	GO:2000288; P:positive regulation of myoblast proliferation; IEA:Ensembl
Q9Y5B6	PAXBP1	PAX3- and PAX7-binding protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9Y5B6	PAXBP1	PAX3- and PAX7-binding protein 1	GO:0014842; P:regulation of satellite cell proliferation; IEA:Ensembl
Q9Y5B6	PAXBP1	PAX3- and PAX7-binding protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZW49	PAXIP1	PAX-interacting protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q6ZW49	PAXIP1	PAX-interacting protein 1	GO:0060612; P:adipose tissue development; IEA:Ensembl
Q6ZW49	PAXIP1	PAX-interacting protein 1	GO:0060717; P:chorion development; IEA:Ensembl
Q6ZW49	PAXIP1	PAX-interacting protein 1	GO:0030330; P:DNA damage response, signal transduction by p53 class mediator; IMP:UniProtKB
Q6ZW49	PAXIP1	PAX-interacting protein 1	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q6ZW49	PAXIP1	PAX-interacting protein 1	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q6ZW49	PAXIP1	PAX-interacting protein 1	GO:0043542; P:endothelial cell migration; IEA:Ensembl
Q6ZW49	PAXIP1	PAX-interacting protein 1	GO:0051568; P:histone H3-K4 methylation; IDA:UniProtKB
Q6ZW49	PAXIP1	PAX-interacting protein 1	GO:0035066; P:positive regulation of histone acetylation; ISS:UniProtKB
Q6ZW49	PAXIP1	PAX-interacting protein 1	GO:0000416; P:positive regulation of histone H3-K36 methylation; ISS:UniProtKB
Q6ZW49	PAXIP1	PAX-interacting protein 1	GO:0051571; P:positive regulation of histone H3-K4 methylation; ISS:UniProtKB
Q6ZW49	PAXIP1	PAX-interacting protein 1	GO:0045830; P:positive regulation of isotype switching; ISS:UniProtKB
Q6ZW49	PAXIP1	PAX-interacting protein 1	GO:0031398; P:positive regulation of protein ubiquitination; ISS:UniProtKB
Q6ZW49	PAXIP1	PAX-interacting protein 1	GO:0060261; P:positive regulation of transcription initiation from RNA polymerase II promoter; IMP:UniProtKB
Q6ZW49	PAXIP1	PAX-interacting protein 1	GO:0010212; P:response to ionizing radiation; IDA:UniProtKB
Q6ZW49	PAXIP1	PAX-interacting protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZW49	PAXIP1	PAX-interacting protein 1	GO:0001570; P:vasculogenesis; IEA:Ensembl
P49023	PXN	Paxillin	GO:0008013; F:beta-catenin binding; IPI:UniProtKB
P49023	PXN	Paxillin	GO:0005515; F:protein binding; IPI:UniProtKB
P49023	PXN	Paxillin	GO:0017166; F:vinculin binding; IPI:UniProtKB
P49023	PXN	Paxillin	GO:0008270; F:zinc ion binding; IEA:InterPro
P49023	PXN	Paxillin	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
P49023	PXN	Paxillin	GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl
P49023	PXN	Paxillin	GO:0007155; P:cell adhesion; NAS:ProtInc
P49023	PXN	Paxillin	GO:0034329; P:cell junction assembly; TAS:Reactome
P49023	PXN	Paxillin	GO:0006928; P:cellular component movement; IEA:Ensembl
P49023	PXN	Paxillin	GO:0034614; P:cellular response to reactive oxygen species; IEP:BHF-UCL
P49023	PXN	Paxillin	GO:0007010; P:cytoskeleton organization; IEA:Ensembl
P49023	PXN	Paxillin	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P49023	PXN	Paxillin	GO:0048041; P:focal adhesion assembly; IEA:Ensembl
P49023	PXN	Paxillin	GO:0060396; P:growth hormone receptor signaling pathway; IDA:BHF-UCL
P49023	PXN	Paxillin	GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl
P49023	PXN	Paxillin	GO:0030032; P:lamellipodium assembly; IEA:Ensembl
P49023	PXN	Paxillin	GO:0006936; P:muscle contraction; TAS:Reactome
P49023	PXN	Paxillin	GO:0018108; P:peptidyl-tyrosine phosphorylation; IEA:Ensembl
P49023	PXN	Paxillin	GO:0007172; P:signal complex assembly; TAS:ProtInc
P49023	PXN	Paxillin	GO:0007165; P:signal transduction; TAS:ProtInc
Q86U86	PBRM1	Protein polybromo-1	GO:0003682; F:chromatin binding; NAS:UniProtKB
Q86U86	PBRM1	Protein polybromo-1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86U86	PBRM1	Protein polybromo-1	GO:0005515; F:protein binding; IPI:IntAct
Q86U86	PBRM1	Protein polybromo-1	GO:0006338; P:chromatin remodeling; TAS:UniProtKB
Q86U86	PBRM1	Protein polybromo-1	GO:0007507; P:heart development; IEA:Ensembl
Q86U86	PBRM1	Protein polybromo-1	GO:0007067; P:mitosis; TAS:UniProtKB
Q86U86	PBRM1	Protein polybromo-1	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q86U86	PBRM1	Protein polybromo-1	GO:0001890; P:placenta development; IEA:Ensembl
Q86U86	PBRM1	Protein polybromo-1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q86U86	PBRM1	Protein polybromo-1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96AQ6	PBXIP1	Pre-B-cell leukemia transcription factor-interacting protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q96AQ6	PBXIP1	Pre-B-cell leukemia transcription factor-interacting protein 1	GO:0003714; F:transcription corepressor activity; NAS:UniProtKB
Q96AQ6	PBXIP1	Pre-B-cell leukemia transcription factor-interacting protein 1	GO:0030154; P:cell differentiation; NAS:UniProtKB
Q96AQ6	PBXIP1	Pre-B-cell leukemia transcription factor-interacting protein 1	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
Q96AQ6	PBXIP1	Pre-B-cell leukemia transcription factor-interacting protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB
P30039	PBLD	Phenazine biosynthesis-like domain-containing protein	GO:0016853; F:isomerase activity; IEA:UniProtKB-KW
P30039	PBLD	Phenazine biosynthesis-like domain-containing protein	GO:0005515; F:protein binding; IPI:UniProt
P30039	PBLD	Phenazine biosynthesis-like domain-containing protein	GO:0009058; P:biosynthetic process; IEA:InterPro
P30039	PBLD	Phenazine biosynthesis-like domain-containing protein	GO:0030277; P:maintenance of gastrointestinal epithelium; IMP:UniProt
P30039	PBLD	Phenazine biosynthesis-like domain-containing protein	GO:0010633; P:negative regulation of epithelial cell migration; IMP:UniProt
P30039	PBLD	Phenazine biosynthesis-like domain-containing protein	GO:0050680; P:negative regulation of epithelial cell proliferation; IMP:UniProt
P30039	PBLD	Phenazine biosynthesis-like domain-containing protein	GO:0010719; P:negative regulation of epithelial to mesenchymal transition; IMP:UniProt
P30039	PBLD	Phenazine biosynthesis-like domain-containing protein	GO:0060394; P:negative regulation of pathway-restricted SMAD protein phosphorylation; IMP:UniProt
P30039	PBLD	Phenazine biosynthesis-like domain-containing protein	GO:0060392; P:negative regulation of SMAD protein import into nucleus; IGI:UniProt
P30039	PBLD	Phenazine biosynthesis-like domain-containing protein	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IMP:UniProt
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0003677; F:DNA binding; IDA:UniProtKB
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0005515; F:protein binding; IPI:IntAct
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0030325; P:adrenal gland development; IEA:Ensembl
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0035162; P:embryonic hemopoiesis; IEA:Ensembl
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0048706; P:embryonic skeletal system development; IEA:Ensembl
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0009887; P:organ morphogenesis; IEA:Ensembl
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IEA:Ensembl
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0030278; P:regulation of ossification; IEA:Ensembl
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0007548; P:sex differentiation; IEA:UniProtKB-KW
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0048536; P:spleen development; IEA:Ensembl
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0006694; P:steroid biosynthetic process; IEA:UniProtKB-KW
P40424	PBX1	Pre-B-cell leukemia transcription factor 1	GO:0048538; P:thymus development; IEA:Ensembl
P40425	PBX2	Pre-B-cell leukemia transcription factor 2	GO:0003682; F:chromatin binding; IEA:Ensembl
P40425	PBX2	Pre-B-cell leukemia transcription factor 2	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P40425	PBX2	Pre-B-cell leukemia transcription factor 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P40425	PBX2	Pre-B-cell leukemia transcription factor 2	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P40425	PBX2	Pre-B-cell leukemia transcription factor 2	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
P40425	PBX2	Pre-B-cell leukemia transcription factor 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P40425	PBX2	Pre-B-cell leukemia transcription factor 2	GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl
P40425	PBX2	Pre-B-cell leukemia transcription factor 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P40426	PBX3	Pre-B-cell leukemia transcription factor 3	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P40426	PBX3	Pre-B-cell leukemia transcription factor 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P40426	PBX3	Pre-B-cell leukemia transcription factor 3	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P40426	PBX3	Pre-B-cell leukemia transcription factor 3	GO:0007387; P:anterior compartment pattern formation; TAS:ProtInc
P40426	PBX3	Pre-B-cell leukemia transcription factor 3	GO:0021516; P:dorsal spinal cord development; IEA:Ensembl
P40426	PBX3	Pre-B-cell leukemia transcription factor 3	GO:0048666; P:neuron development; IEA:Ensembl
P40426	PBX3	Pre-B-cell leukemia transcription factor 3	GO:0007388; P:posterior compartment specification; TAS:ProtInc
P40426	PBX3	Pre-B-cell leukemia transcription factor 3	GO:0002087; P:regulation of respiratory gaseous exchange by neurological system process; IEA:Ensembl
P40426	PBX3	Pre-B-cell leukemia transcription factor 3	GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl
P40426	PBX3	Pre-B-cell leukemia transcription factor 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BYU1	PBX4	Pre-B-cell leukemia transcription factor 4	GO:0043565; F:sequence-specific DNA binding; ISS:BHF-UCL
Q9BYU1	PBX4	Pre-B-cell leukemia transcription factor 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9BYU1	PBX4	Pre-B-cell leukemia transcription factor 4	GO:0045893; P:positive regulation of transcription, DNA-templated; IC:BHF-UCL
Q9BYU1	PBX4	Pre-B-cell leukemia transcription factor 4	GO:0006366; P:transcription from RNA polymerase II promoter; IC:BHF-UCL
Q9BZA7	PCDH11X	Protocadherin-11 X-linked	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9BZA7	PCDH11X	Protocadherin-11 X-linked	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9BZA7	PCDH11X	Protocadherin-11 X-linked	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q9BZA8	PCDH11Y	Protocadherin-11 Y-linked	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9BZA8	PCDH11Y	Protocadherin-11 Y-linked	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q8NF37	LPCAT1	Lysophosphatidylcholine acyltransferase 1	GO:0047184; F:1-acylglycerophosphocholine O-acyltransferase activity; IDA:UniProtKB
Q8NF37	LPCAT1	Lysophosphatidylcholine acyltransferase 1	GO:0047159; F:1-alkenylglycerophosphocholine O-acyltransferase activity; IEA:Ensembl
Q8NF37	LPCAT1	Lysophosphatidylcholine acyltransferase 1	GO:0047192; F:1-alkylglycerophosphocholine O-acetyltransferase activity; IEA:UniProtKB-EC
Q8NF37	LPCAT1	Lysophosphatidylcholine acyltransferase 1	GO:0047191; F:1-alkylglycerophosphocholine O-acyltransferase activity; IEA:Ensembl
Q8NF37	LPCAT1	Lysophosphatidylcholine acyltransferase 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8NF37	LPCAT1	Lysophosphatidylcholine acyltransferase 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q8NF37	LPCAT1	Lysophosphatidylcholine acyltransferase 1	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q8NF37	LPCAT1	Lysophosphatidylcholine acyltransferase 1	GO:2001246; P:negative regulation of phosphatidylcholine biosynthetic process; IEA:Ensembl
Q8NF37	LPCAT1	Lysophosphatidylcholine acyltransferase 1	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
Q8NF37	LPCAT1	Lysophosphatidylcholine acyltransferase 1	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; IDA:UniProtKB
Q8NF37	LPCAT1	Lysophosphatidylcholine acyltransferase 1	GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome
Q8NF37	LPCAT1	Lysophosphatidylcholine acyltransferase 1	GO:0008654; P:phospholipid biosynthetic process; ISS:UniProtKB
Q8NF37	LPCAT1	Lysophosphatidylcholine acyltransferase 1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q8NF37	LPCAT1	Lysophosphatidylcholine acyltransferase 1	GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl
Q8NF37	LPCAT1	Lysophosphatidylcholine acyltransferase 1	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
Q8NF37	LPCAT1	Lysophosphatidylcholine acyltransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8NF37	LPCAT1	Lysophosphatidylcholine acyltransferase 1	GO:0043129; P:surfactant homeostasis; IEA:Ensembl
Q8NF37	LPCAT1	Lysophosphatidylcholine acyltransferase 1	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
Q7L5N7	LPCAT2	Lysophosphatidylcholine acyltransferase 2	GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; IEA:UniProtKB-EC
Q7L5N7	LPCAT2	Lysophosphatidylcholine acyltransferase 2	GO:0047184; F:1-acylglycerophosphocholine O-acyltransferase activity; IDA:UniProtKB
Q7L5N7	LPCAT2	Lysophosphatidylcholine acyltransferase 2	GO:0047192; F:1-alkylglycerophosphocholine O-acetyltransferase activity; ISS:UniProtKB
Q7L5N7	LPCAT2	Lysophosphatidylcholine acyltransferase 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q7L5N7	LPCAT2	Lysophosphatidylcholine acyltransferase 2	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q7L5N7	LPCAT2	Lysophosphatidylcholine acyltransferase 2	GO:0061024; P:membrane organization; ISS:UniProtKB
Q7L5N7	LPCAT2	Lysophosphatidylcholine acyltransferase 2	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; IDA:UniProtKB
Q7L5N7	LPCAT2	Lysophosphatidylcholine acyltransferase 2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q7L5N7	LPCAT2	Lysophosphatidylcholine acyltransferase 2	GO:0006663; P:platelet activating factor biosynthetic process; ISS:UniProtKB
Q7L5N7	LPCAT2	Lysophosphatidylcholine acyltransferase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15365	PCBP1	Poly(rC)-binding protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15365	PCBP1	Poly(rC)-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q15365	PCBP1	Poly(rC)-binding protein 1	GO:0003723; F:RNA binding; IDA:UniProtKB
Q15365	PCBP1	Poly(rC)-binding protein 1	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
Q15365	PCBP1	Poly(rC)-binding protein 1	GO:0010467; P:gene expression; TAS:Reactome
Q15365	PCBP1	Poly(rC)-binding protein 1	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q15365	PCBP1	Poly(rC)-binding protein 1	GO:0008380; P:RNA splicing; TAS:Reactome
Q15366	PCBP2	Poly(rC)-binding protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q15366	PCBP2	Poly(rC)-binding protein 2	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q15366	PCBP2	Poly(rC)-binding protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15366	PCBP2	Poly(rC)-binding protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q15366	PCBP2	Poly(rC)-binding protein 2	GO:0003723; F:RNA binding; IDA:UniProtKB
Q15366	PCBP2	Poly(rC)-binding protein 2	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q15366	PCBP2	Poly(rC)-binding protein 2	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q15366	PCBP2	Poly(rC)-binding protein 2	GO:0010467; P:gene expression; TAS:Reactome
Q15366	PCBP2	Poly(rC)-binding protein 2	GO:0045087; P:innate immune response; TAS:Reactome
Q15366	PCBP2	Poly(rC)-binding protein 2	GO:0016071; P:mRNA metabolic process; NAS:UniProtKB
Q15366	PCBP2	Poly(rC)-binding protein 2	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q15366	PCBP2	Poly(rC)-binding protein 2	GO:0050687; P:negative regulation of defense response to virus; IMP:UniProtKB
Q15366	PCBP2	Poly(rC)-binding protein 2	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
Q15366	PCBP2	Poly(rC)-binding protein 2	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q15366	PCBP2	Poly(rC)-binding protein 2	GO:0008380; P:RNA splicing; TAS:Reactome
P57721	PCBP3	Poly(rC)-binding protein 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P57721	PCBP3	Poly(rC)-binding protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P57721	PCBP3	Poly(rC)-binding protein 3	GO:0003723; F:RNA binding; NAS:UniProtKB
P57721	PCBP3	Poly(rC)-binding protein 3	GO:0016071; P:mRNA metabolic process; NAS:UniProtKB
P57723	PCBP4	Poly(rC)-binding protein 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P57723	PCBP4	Poly(rC)-binding protein 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P57723	PCBP4	Poly(rC)-binding protein 4	GO:0003723; F:RNA binding; NAS:UniProtKB
P05165	PCCA	Propionyl-CoA carboxylase alpha chain, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P05165	PCCA	Propionyl-CoA carboxylase alpha chain, mitochondrial	GO:0009374; F:biotin binding; TAS:ProtInc
P05165	PCCA	Propionyl-CoA carboxylase alpha chain, mitochondrial	GO:0004075; F:biotin carboxylase activity; IEA:InterPro
P05165	PCCA	Propionyl-CoA carboxylase alpha chain, mitochondrial	GO:0019899; F:enzyme binding; IPI:UniProtKB
P05165	PCCA	Propionyl-CoA carboxylase alpha chain, mitochondrial	GO:0046872; F:metal ion binding; IEA:InterPro
P05165	PCCA	Propionyl-CoA carboxylase alpha chain, mitochondrial	GO:0004658; F:propionyl-CoA carboxylase activity; TAS:ProtInc
P05165	PCCA	Propionyl-CoA carboxylase alpha chain, mitochondrial	GO:0006768; P:biotin metabolic process; TAS:Reactome
P05165	PCCA	Propionyl-CoA carboxylase alpha chain, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P05165	PCCA	Propionyl-CoA carboxylase alpha chain, mitochondrial	GO:0006635; P:fatty acid beta-oxidation; TAS:Reactome
P05165	PCCA	Propionyl-CoA carboxylase alpha chain, mitochondrial	GO:0019626; P:short-chain fatty acid catabolic process; TAS:Reactome
P05165	PCCA	Propionyl-CoA carboxylase alpha chain, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P05165	PCCA	Propionyl-CoA carboxylase alpha chain, mitochondrial	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P05165	PCCA	Propionyl-CoA carboxylase alpha chain, mitochondrial	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
P05166	PCCB	Propionyl-CoA carboxylase beta chain, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P05166	PCCB	Propionyl-CoA carboxylase beta chain, mitochondrial	GO:0004658; F:propionyl-CoA carboxylase activity; TAS:ProtInc
P05166	PCCB	Propionyl-CoA carboxylase beta chain, mitochondrial	GO:0006768; P:biotin metabolic process; TAS:Reactome
P05166	PCCB	Propionyl-CoA carboxylase beta chain, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P05166	PCCB	Propionyl-CoA carboxylase beta chain, mitochondrial	GO:0006635; P:fatty acid beta-oxidation; TAS:Reactome
P05166	PCCB	Propionyl-CoA carboxylase beta chain, mitochondrial	GO:0019626; P:short-chain fatty acid catabolic process; TAS:Reactome
P05166	PCCB	Propionyl-CoA carboxylase beta chain, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P05166	PCCB	Propionyl-CoA carboxylase beta chain, mitochondrial	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P05166	PCCB	Propionyl-CoA carboxylase beta chain, mitochondrial	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9P2E7	PCDH10	Protocadherin-10	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9P2E7	PCDH10	Protocadherin-10	GO:0007156; P:homophilic cell adhesion; IEA:Ensembl
Q9NPG4	PCDH12	Protocadherin-12	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NPG4	PCDH12	Protocadherin-12	GO:0016339; P:calcium-dependent cell-cell adhesion; IEA:Ensembl
Q9NPG4	PCDH12	Protocadherin-12	GO:0005977; P:glycogen metabolic process; IEA:Ensembl
Q9NPG4	PCDH12	Protocadherin-12	GO:0007156; P:homophilic cell adhesion; IEA:Ensembl
Q9NPG4	PCDH12	Protocadherin-12	GO:0060711; P:labyrinthine layer development; IEA:Ensembl
Q9NPG4	PCDH12	Protocadherin-12	GO:0008038; P:neuron recognition; TAS:ProtInc
Q96QU1	PCDH15	Protocadherin-15	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96QU1	PCDH15	Protocadherin-15	GO:0050957; P:equilibrioception; IMP:HGNC
Q96QU1	PCDH15	Protocadherin-15	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q96QU1	PCDH15	Protocadherin-15	GO:0045494; P:photoreceptor cell maintenance; IMP:HGNC
Q96QU1	PCDH15	Protocadherin-15	GO:0050953; P:sensory perception of light stimulus; IMP:HGNC
Q96QU1	PCDH15	Protocadherin-15	GO:0007605; P:sensory perception of sound; IMP:HGNC
Q96JQ0	DCHS1	Protocadherin-16	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96JQ0	DCHS1	Protocadherin-16	GO:0016339; P:calcium-dependent cell-cell adhesion; NAS:UniProtKB
Q96JQ0	DCHS1	Protocadherin-16	GO:0007157; P:heterophilic cell-cell adhesion; ISS:UniProtKB
Q96JQ0	DCHS1	Protocadherin-16	GO:0035329; P:hippo signaling; ISS:UniProtKB
Q96JQ0	DCHS1	Protocadherin-16	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q96JQ0	DCHS1	Protocadherin-16	GO:0022008; P:neurogenesis; ISS:UniProtKB
O14917	PCDH17	Protocadherin-17	GO:0005509; F:calcium ion binding; IEA:InterPro
O14917	PCDH17	Protocadherin-17	GO:0005515; F:protein binding; IPI:UniProtKB
O14917	PCDH17	Protocadherin-17	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9HCL0	PCDH18	Protocadherin-18	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9HCL0	PCDH18	Protocadherin-18	GO:0007420; P:brain development; ISS:UniProtKB
Q9HCL0	PCDH18	Protocadherin-18	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q8TAB3	PCDH19	Protocadherin-19	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8TAB3	PCDH19	Protocadherin-19	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q8N6Y1	PCDH20	Protocadherin-20	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8N6Y1	PCDH20	Protocadherin-20	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8N6Y1	PCDH20	Protocadherin-20	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q6V1P9	DCHS2	Protocadherin-23	GO:0005509; F:calcium ion binding; IEA:InterPro
Q6V1P9	DCHS2	Protocadherin-23	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5I3	PCDHA1	Protocadherin alpha-1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5I3	PCDHA1	Protocadherin alpha-1	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9Y5I3	PCDHA1	Protocadherin alpha-1	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5I3	PCDHA1	Protocadherin alpha-1	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y5H9	PCDHA2	Protocadherin alpha-2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5H9	PCDHA2	Protocadherin alpha-2	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9Y5H9	PCDHA2	Protocadherin alpha-2	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5H9	PCDHA2	Protocadherin alpha-2	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y5H8	PCDHA3	Protocadherin alpha-3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5H8	PCDHA3	Protocadherin alpha-3	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9Y5H8	PCDHA3	Protocadherin alpha-3	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5H8	PCDHA3	Protocadherin alpha-3	GO:0007399; P:nervous system development; TAS:ProtInc
Q9UN74	PCDHA4	Protocadherin alpha-4	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UN74	PCDHA4	Protocadherin alpha-4	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9UN74	PCDHA4	Protocadherin alpha-4	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9UN74	PCDHA4	Protocadherin alpha-4	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y5H7	PCDHA5	Protocadherin alpha-5	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5H7	PCDHA5	Protocadherin alpha-5	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9Y5H7	PCDHA5	Protocadherin alpha-5	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5H7	PCDHA5	Protocadherin alpha-5	GO:0007399; P:nervous system development; TAS:ProtInc
Q9UN73	PCDHA6	Protocadherin alpha-6	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UN73	PCDHA6	Protocadherin alpha-6	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9UN73	PCDHA6	Protocadherin alpha-6	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9UN73	PCDHA6	Protocadherin alpha-6	GO:0007399; P:nervous system development; TAS:ProtInc
Q9UN72	PCDHA7	Protocadherin alpha-7	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UN72	PCDHA7	Protocadherin alpha-7	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9UN72	PCDHA7	Protocadherin alpha-7	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9UN72	PCDHA7	Protocadherin alpha-7	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y5H6	PCDHA8	Protocadherin alpha-8	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5H6	PCDHA8	Protocadherin alpha-8	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9Y5H6	PCDHA8	Protocadherin alpha-8	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5H6	PCDHA8	Protocadherin alpha-8	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y5H5	PCDHA9	Protocadherin alpha-9	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5H5	PCDHA9	Protocadherin alpha-9	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5I2	PCDHA10	Protocadherin alpha-10	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5I2	PCDHA10	Protocadherin alpha-10	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9Y5I2	PCDHA10	Protocadherin alpha-10	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5I2	PCDHA10	Protocadherin alpha-10	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y5I1	PCDHA11	Protocadherin alpha-11	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5I1	PCDHA11	Protocadherin alpha-11	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9Y5I1	PCDHA11	Protocadherin alpha-11	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5I1	PCDHA11	Protocadherin alpha-11	GO:0007399; P:nervous system development; TAS:ProtInc
Q9UN75	PCDHA12	Protocadherin alpha-12	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UN75	PCDHA12	Protocadherin alpha-12	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5I0	PCDHA13	Protocadherin alpha-13	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5I0	PCDHA13	Protocadherin alpha-13	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5F3	PCDHB1	Protocadherin beta-1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5F3	PCDHB1	Protocadherin beta-1	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5E7	PCDHB2	Protocadherin beta-2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5E7	PCDHB2	Protocadherin beta-2	GO:0016339; P:calcium-dependent cell-cell adhesion; NAS:UniProtKB
Q9Y5E7	PCDHB2	Protocadherin beta-2	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9Y5E7	PCDHB2	Protocadherin beta-2	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5E7	PCDHB2	Protocadherin beta-2	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y5E7	PCDHB2	Protocadherin beta-2	GO:0007416; P:synapse assembly; TAS:UniProtKB
Q9Y5E7	PCDHB2	Protocadherin beta-2	GO:0007268; P:synaptic transmission; TAS:UniProtKB
Q9Y5E6	PCDHB3	Protocadherin beta-3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5E6	PCDHB3	Protocadherin beta-3	GO:0016339; P:calcium-dependent cell-cell adhesion; NAS:UniProtKB
Q9Y5E6	PCDHB3	Protocadherin beta-3	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9Y5E6	PCDHB3	Protocadherin beta-3	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5E6	PCDHB3	Protocadherin beta-3	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y5E6	PCDHB3	Protocadherin beta-3	GO:0007416; P:synapse assembly; TAS:UniProtKB
Q9Y5E6	PCDHB3	Protocadherin beta-3	GO:0007268; P:synaptic transmission; TAS:UniProtKB
Q9Y5E5	PCDHB4	Protocadherin beta-4	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5E5	PCDHB4	Protocadherin beta-4	GO:0016339; P:calcium-dependent cell-cell adhesion; NAS:UniProtKB
Q9Y5E5	PCDHB4	Protocadherin beta-4	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9Y5E5	PCDHB4	Protocadherin beta-4	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5E5	PCDHB4	Protocadherin beta-4	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y5E5	PCDHB4	Protocadherin beta-4	GO:0007416; P:synapse assembly; TAS:UniProtKB
Q9Y5E5	PCDHB4	Protocadherin beta-4	GO:0007268; P:synaptic transmission; TAS:UniProtKB
Q9Y5E3	PCDHB6	Protocadherin beta-6	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5E3	PCDHB6	Protocadherin beta-6	GO:0016339; P:calcium-dependent cell-cell adhesion; NAS:UniProtKB
Q9Y5E3	PCDHB6	Protocadherin beta-6	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9Y5E3	PCDHB6	Protocadherin beta-6	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5E3	PCDHB6	Protocadherin beta-6	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y5E3	PCDHB6	Protocadherin beta-6	GO:0007416; P:synapse assembly; TAS:UniProtKB
Q9Y5E3	PCDHB6	Protocadherin beta-6	GO:0007268; P:synaptic transmission; TAS:UniProtKB
Q9Y5E4	PCDHB5	Protocadherin beta-5	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5E4	PCDHB5	Protocadherin beta-5	GO:0016339; P:calcium-dependent cell-cell adhesion; NAS:UniProtKB
Q9Y5E4	PCDHB5	Protocadherin beta-5	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5E4	PCDHB5	Protocadherin beta-5	GO:0007416; P:synapse assembly; TAS:UniProtKB
Q9Y5E4	PCDHB5	Protocadherin beta-5	GO:0007268; P:synaptic transmission; TAS:UniProtKB
Q9Y5E2	PCDHB7	Protocadherin beta-7	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5E2	PCDHB7	Protocadherin beta-7	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5E1	PCDHB9	Protocadherin beta-9	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5E1	PCDHB9	Protocadherin beta-9	GO:0016339; P:calcium-dependent cell-cell adhesion; NAS:UniProtKB
Q9Y5E1	PCDHB9	Protocadherin beta-9	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5E1	PCDHB9	Protocadherin beta-9	GO:0007416; P:synapse assembly; TAS:UniProtKB
Q9Y5E1	PCDHB9	Protocadherin beta-9	GO:0007268; P:synaptic transmission; TAS:UniProtKB
Q9UN67	PCDHB10	Protocadherin beta-10	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UN67	PCDHB10	Protocadherin beta-10	GO:0016339; P:calcium-dependent cell-cell adhesion; NAS:UniProtKB
Q9UN67	PCDHB10	Protocadherin beta-10	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9UN67	PCDHB10	Protocadherin beta-10	GO:0007416; P:synapse assembly; TAS:UniProtKB
Q9UN67	PCDHB10	Protocadherin beta-10	GO:0007268; P:synaptic transmission; TAS:UniProtKB
Q9UN66	PCDHB8	Protocadherin beta-8	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UN66	PCDHB8	Protocadherin beta-8	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5F2	PCDHB11	Protocadherin beta-11	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5F2	PCDHB11	Protocadherin beta-11	GO:0016339; P:calcium-dependent cell-cell adhesion; NAS:UniProtKB
Q9Y5F2	PCDHB11	Protocadherin beta-11	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9Y5F2	PCDHB11	Protocadherin beta-11	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5F2	PCDHB11	Protocadherin beta-11	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y5F2	PCDHB11	Protocadherin beta-11	GO:0007416; P:synapse assembly; TAS:UniProtKB
Q9Y5F2	PCDHB11	Protocadherin beta-11	GO:0007268; P:synaptic transmission; TAS:UniProtKB
Q9Y5F1	PCDHB12	Protocadherin beta-12	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5F1	PCDHB12	Protocadherin beta-12	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9Y5F1	PCDHB12	Protocadherin beta-12	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5F1	PCDHB12	Protocadherin beta-12	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y5F0	PCDHB13	Protocadherin beta-13	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5F0	PCDHB13	Protocadherin beta-13	GO:0016339; P:calcium-dependent cell-cell adhesion; NAS:UniProtKB
Q9Y5F0	PCDHB13	Protocadherin beta-13	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5F0	PCDHB13	Protocadherin beta-13	GO:0007416; P:synapse assembly; TAS:UniProtKB
Q9Y5F0	PCDHB13	Protocadherin beta-13	GO:0007268; P:synaptic transmission; TAS:UniProtKB
Q9Y5E8	PCDHB15	Protocadherin beta-15	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5E8	PCDHB15	Protocadherin beta-15	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9Y5E8	PCDHB15	Protocadherin beta-15	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5E8	PCDHB15	Protocadherin beta-15	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y5E9	PCDHB14	Protocadherin beta-14	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5E9	PCDHB14	Protocadherin beta-14	GO:0016339; P:calcium-dependent cell-cell adhesion; NAS:UniProtKB
Q9Y5E9	PCDHB14	Protocadherin beta-14	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5E9	PCDHB14	Protocadherin beta-14	GO:0007416; P:synapse assembly; TAS:UniProtKB
Q9Y5E9	PCDHB14	Protocadherin beta-14	GO:0007268; P:synaptic transmission; TAS:UniProtKB
Q9NRJ7	PCDHB16	Protocadherin beta-16	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NRJ7	PCDHB16	Protocadherin beta-16	GO:0016339; P:calcium-dependent cell-cell adhesion; NAS:UniProtKB
Q9NRJ7	PCDHB16	Protocadherin beta-16	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9NRJ7	PCDHB16	Protocadherin beta-16	GO:0007416; P:synapse assembly; TAS:UniProtKB
Q9NRJ7	PCDHB16	Protocadherin beta-16	GO:0007268; P:synaptic transmission; TAS:UniProtKB
Q96TA0	PCDHB18	Putative protocadherin beta-18	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96TA0	PCDHB18	Putative protocadherin beta-18	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9H158	PCDHAC1	Protocadherin alpha-C1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9H158	PCDHAC1	Protocadherin alpha-C1	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9H158	PCDHAC1	Protocadherin alpha-C1	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9H158	PCDHAC1	Protocadherin alpha-C1	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y5I4	PCDHAC2	Protocadherin alpha-C2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5I4	PCDHAC2	Protocadherin alpha-C2	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9Y5I4	PCDHAC2	Protocadherin alpha-C2	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5I4	PCDHAC2	Protocadherin alpha-C2	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y5H4	PCDHGA1	Protocadherin gamma-A1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5H4	PCDHGA1	Protocadherin gamma-A1	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5H1	PCDHGA2	Protocadherin gamma-A2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5H1	PCDHGA2	Protocadherin gamma-A2	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5H0	PCDHGA3	Protocadherin gamma-A3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5H0	PCDHGA3	Protocadherin gamma-A3	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5G9	PCDHGA4	Protocadherin gamma-A4	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5G9	PCDHGA4	Protocadherin gamma-A4	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5G9	PCDHGA4	Protocadherin gamma-A4	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q9Y5G8	PCDHGA5	Protocadherin gamma-A5	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5G8	PCDHGA5	Protocadherin gamma-A5	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5G7	PCDHGA6	Protocadherin gamma-A6	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5G7	PCDHGA6	Protocadherin gamma-A6	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5G6	PCDHGA7	Protocadherin gamma-A7	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5G6	PCDHGA7	Protocadherin gamma-A7	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5G5	PCDHGA8	Protocadherin gamma-A8	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5G5	PCDHGA8	Protocadherin gamma-A8	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5G4	PCDHGA9	Protocadherin gamma-A9	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5G4	PCDHGA9	Protocadherin gamma-A9	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y5G4	PCDHGA9	Protocadherin gamma-A9	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5H3	PCDHGA10	Protocadherin gamma-A10	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5H3	PCDHGA10	Protocadherin gamma-A10	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
O60330	PCDHGA12	Protocadherin gamma-A12	GO:0005509; F:calcium ion binding; IEA:InterPro
O60330	PCDHGA12	Protocadherin gamma-A12	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5H2	PCDHGA11	Protocadherin gamma-A11	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5H2	PCDHGA11	Protocadherin gamma-A11	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5G3	PCDHGB1	Protocadherin gamma-B1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5G3	PCDHGB1	Protocadherin gamma-B1	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5G2	PCDHGB2	Protocadherin gamma-B2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5G2	PCDHGB2	Protocadherin gamma-B2	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5G1	PCDHGB3	Protocadherin gamma-B3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5G1	PCDHGB3	Protocadherin gamma-B3	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9UN71	PCDHGB4	Protocadherin gamma-B4	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UN71	PCDHGB4	Protocadherin gamma-B4	GO:0016339; P:calcium-dependent cell-cell adhesion; NAS:UniProtKB
Q9UN71	PCDHGB4	Protocadherin gamma-B4	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9UN71	PCDHGB4	Protocadherin gamma-B4	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5G0	PCDHGB5	Protocadherin gamma-B5	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5G0	PCDHGB5	Protocadherin gamma-B5	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5F9	PCDHGB6	Protocadherin gamma-B6	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5F9	PCDHGB6	Protocadherin gamma-B6	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5F8	PCDHGB7	Protocadherin gamma-B7	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5F8	PCDHGB7	Protocadherin gamma-B7	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5F7	PCDHGC4	Protocadherin gamma-C4	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5F7	PCDHGC4	Protocadherin gamma-C4	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q9Y5F6	PCDHGC5	Protocadherin gamma-C5	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y5F6	PCDHGC5	Protocadherin gamma-C5	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q08174	PCDH1	Protocadherin-1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q08174	PCDH1	Protocadherin-1	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q08174	PCDH1	Protocadherin-1	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q08174	PCDH1	Protocadherin-1	GO:0007399; P:nervous system development; TAS:ProtInc
Q9UN70	PCDHGC3	Protocadherin gamma-C3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UN70	PCDHGC3	Protocadherin gamma-C3	GO:0016339; P:calcium-dependent cell-cell adhesion; NAS:UniProtKB
Q9UN70	PCDHGC3	Protocadherin gamma-C3	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
O60245	PCDH7	Protocadherin-7	GO:0005509; F:calcium ion binding; IEA:InterPro
O60245	PCDH7	Protocadherin-7	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
O95206	PCDH8	Protocadherin-8	GO:0005509; F:calcium ion binding; IEA:InterPro
O95206	PCDH8	Protocadherin-8	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O95206	PCDH8	Protocadherin-8	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
O95206	PCDH8	Protocadherin-8	GO:0016331; P:morphogenesis of embryonic epithelium; IEA:Ensembl
O95206	PCDH8	Protocadherin-8	GO:0001756; P:somitogenesis; IEA:Ensembl
O95206	PCDH8	Protocadherin-8	GO:0007268; P:synaptic transmission; IEA:Ensembl
Q9HC56	PCDH9	Protocadherin-9	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9HC56	PCDH9	Protocadherin-9	GO:0030900; P:forebrain development; IEA:Ensembl
Q9HC56	PCDH9	Protocadherin-9	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
Q4G0U5	PCDP1	Primary ciliary dyskinesia protein 1	GO:0060271; P:cilium morphogenesis; IEA:Ensembl
Q4G0U5	PCDP1	Primary ciliary dyskinesia protein 1	GO:0003341; P:cilium movement; IEA:Ensembl
O94913	PCF11	Pre-mRNA cleavage complex 2 protein Pcf11	GO:0010467; P:gene expression; TAS:Reactome
O94913	PCF11	Pre-mRNA cleavage complex 2 protein Pcf11	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
O94913	PCF11	Pre-mRNA cleavage complex 2 protein Pcf11	GO:0006379; P:mRNA cleavage; NAS:UniProtKB
O94913	PCF11	Pre-mRNA cleavage complex 2 protein Pcf11	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
O94913	PCF11	Pre-mRNA cleavage complex 2 protein Pcf11	GO:0008380; P:RNA splicing; TAS:Reactome
O94913	PCF11	Pre-mRNA cleavage complex 2 protein Pcf11	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
O94913	PCF11	Pre-mRNA cleavage complex 2 protein Pcf11	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q96NT5	SLC46A1	Proton-coupled folate transporter	GO:0005542; F:folic acid binding; IEA:UniProtKB-KW
Q96NT5	SLC46A1	Proton-coupled folate transporter	GO:0008517; F:folic acid transporter activity; IDA:UniProtKB
Q96NT5	SLC46A1	Proton-coupled folate transporter	GO:0015232; F:heme transporter activity; IEA:Ensembl
Q96NT5	SLC46A1	Proton-coupled folate transporter	GO:0015350; F:methotrexate transporter activity; IEA:Ensembl
Q96NT5	SLC46A1	Proton-coupled folate transporter	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
Q96NT5	SLC46A1	Proton-coupled folate transporter	GO:0046655; P:folic acid metabolic process; TAS:Reactome
Q96NT5	SLC46A1	Proton-coupled folate transporter	GO:0015884; P:folic acid transport; IDA:UniProtKB
Q96NT5	SLC46A1	Proton-coupled folate transporter	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96NT5	SLC46A1	Proton-coupled folate transporter	GO:0055085; P:transmembrane transport; TAS:Reactome
Q96NT5	SLC46A1	Proton-coupled folate transporter	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q96NT5	SLC46A1	Proton-coupled folate transporter	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9BSM1	PCGF1	Polycomb group RING finger protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9BSM1	PCGF1	Polycomb group RING finger protein 1	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q9BSM1	PCGF1	Polycomb group RING finger protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BSM1	PCGF1	Polycomb group RING finger protein 1	GO:0035518; P:histone H2A monoubiquitination; IDA:UniProtKB
Q9BSM1	PCGF1	Polycomb group RING finger protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9BSM1	PCGF1	Polycomb group RING finger protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q3KNV8	PCGF3	Polycomb group RING finger protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q3KNV8	PCGF3	Polycomb group RING finger protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q3KNV8	PCGF3	Polycomb group RING finger protein 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q3KNV8	PCGF3	Polycomb group RING finger protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86SE9	PCGF5	Polycomb group RING finger protein 5	GO:0005515; F:protein binding; IPI:IntAct
Q86SE9	PCGF5	Polycomb group RING finger protein 5	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86SE9	PCGF5	Polycomb group RING finger protein 5	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q86SE9	PCGF5	Polycomb group RING finger protein 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P35227	PCGF2	Polycomb group RING finger protein 2	GO:0003682; F:chromatin binding; IEA:Ensembl
P35227	PCGF2	Polycomb group RING finger protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P35227	PCGF2	Polycomb group RING finger protein 2	GO:0005515; F:protein binding; IPI:IntAct
P35227	PCGF2	Polycomb group RING finger protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P35227	PCGF2	Polycomb group RING finger protein 2	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
P35227	PCGF2	Polycomb group RING finger protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
P35227	PCGF2	Polycomb group RING finger protein 2	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P35227	PCGF2	Polycomb group RING finger protein 2	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P35227	PCGF2	Polycomb group RING finger protein 2	GO:0016573; P:histone acetylation; IEA:Ensembl
P35227	PCGF2	Polycomb group RING finger protein 2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P35227	PCGF2	Polycomb group RING finger protein 2	GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl
P35227	PCGF2	Polycomb group RING finger protein 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
P35227	PCGF2	Polycomb group RING finger protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BYE7	PCGF6	Polycomb group RING finger protein 6	GO:0003677; F:DNA binding; IDA:UniProtKB
Q9BYE7	PCGF6	Polycomb group RING finger protein 6	GO:0005515; F:protein binding; IPI:IntAct
Q9BYE7	PCGF6	Polycomb group RING finger protein 6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9BYE7	PCGF6	Polycomb group RING finger protein 6	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BYE7	PCGF6	Polycomb group RING finger protein 6	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9BYE7	PCGF6	Polycomb group RING finger protein 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15645	TRIP13	Pachytene checkpoint protein 2 homolog	GO:0005524; F:ATP binding; NAS:UniProtKB
Q15645	TRIP13	Pachytene checkpoint protein 2 homolog	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q15645	TRIP13	Pachytene checkpoint protein 2 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q15645	TRIP13	Pachytene checkpoint protein 2 homolog	GO:0003712; F:transcription cofactor activity; TAS:ProtInc
Q15645	TRIP13	Pachytene checkpoint protein 2 homolog	GO:0006302; P:double-strand break repair; ISS:UniProtKB
Q15645	TRIP13	Pachytene checkpoint protein 2 homolog	GO:0007144; P:female meiosis I; IEA:Ensembl
Q15645	TRIP13	Pachytene checkpoint protein 2 homolog	GO:0007141; P:male meiosis I; IEA:Ensembl
Q15645	TRIP13	Pachytene checkpoint protein 2 homolog	GO:0001556; P:oocyte maturation; IEA:Ensembl
Q15645	TRIP13	Pachytene checkpoint protein 2 homolog	GO:0048477; P:oogenesis; ISS:UniProtKB
Q15645	TRIP13	Pachytene checkpoint protein 2 homolog	GO:0007131; P:reciprocal meiotic recombination; ISS:UniProtKB
Q15645	TRIP13	Pachytene checkpoint protein 2 homolog	GO:2001141; P:regulation of RNA biosynthetic process; TAS:GOC
Q15645	TRIP13	Pachytene checkpoint protein 2 homolog	GO:0007286; P:spermatid development; IEA:Ensembl
Q15645	TRIP13	Pachytene checkpoint protein 2 homolog	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q15645	TRIP13	Pachytene checkpoint protein 2 homolog	GO:0007130; P:synaptonemal complex assembly; ISS:UniProtKB
Q15645	TRIP13	Pachytene checkpoint protein 2 homolog	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q5JVF3	PCID2	PCI domain-containing protein 2	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q5JVF3	PCID2	PCI domain-containing protein 2	GO:2000117; P:negative regulation of cysteine-type endopeptidase activity; IMP:UniProtKB
Q5JVF3	PCID2	PCI domain-containing protein 2	GO:0045579; P:positive regulation of B cell differentiation; IEA:Ensembl
Q5JVF3	PCID2	PCI domain-containing protein 2	GO:0090267; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; IMP:UniProtKB
Q5JVF3	PCID2	PCI domain-containing protein 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q5JVF3	PCID2	PCI domain-containing protein 2	GO:0043488; P:regulation of mRNA stability; IMP:UniProtKB
Q5JVF3	PCID2	PCI domain-containing protein 2	GO:0048536; P:spleen development; ISS:UniProtKB
Q9H4Z3	PCIF1	Phosphorylated CTD-interacting factor 1	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
P35558	PCK1	Phosphoenolpyruvate carboxykinase, cytosolic [GTP]	GO:0031406; F:carboxylic acid binding; IDA:BHF-UCL
P35558	PCK1	Phosphoenolpyruvate carboxykinase, cytosolic [GTP]	GO:0019003; F:GDP binding; IEA:Ensembl
P35558	PCK1	Phosphoenolpyruvate carboxykinase, cytosolic [GTP]	GO:0005525; F:GTP binding; IDA:BHF-UCL
P35558	PCK1	Phosphoenolpyruvate carboxykinase, cytosolic [GTP]	GO:0000287; F:magnesium ion binding; IDA:BHF-UCL
P35558	PCK1	Phosphoenolpyruvate carboxykinase, cytosolic [GTP]	GO:0030145; F:manganese ion binding; IDA:BHF-UCL
P35558	PCK1	Phosphoenolpyruvate carboxykinase, cytosolic [GTP]	GO:0004613; F:phosphoenolpyruvate carboxykinase (GTP) activity; ISS:BHF-UCL
P35558	PCK1	Phosphoenolpyruvate carboxykinase, cytosolic [GTP]	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P35558	PCK1	Phosphoenolpyruvate carboxykinase, cytosolic [GTP]	GO:0017144; P:drug metabolic process; TAS:Reactome
P35558	PCK1	Phosphoenolpyruvate carboxykinase, cytosolic [GTP]	GO:0006094; P:gluconeogenesis; ISS:BHF-UCL
P35558	PCK1	Phosphoenolpyruvate carboxykinase, cytosolic [GTP]	GO:0042593; P:glucose homeostasis; ISS:BHF-UCL
P35558	PCK1	Phosphoenolpyruvate carboxykinase, cytosolic [GTP]	GO:0006006; P:glucose metabolic process; IMP:BHF-UCL
P35558	PCK1	Phosphoenolpyruvate carboxykinase, cytosolic [GTP]	GO:0046327; P:glycerol biosynthetic process from pyruvate; ISS:BHF-UCL
P35558	PCK1	Phosphoenolpyruvate carboxykinase, cytosolic [GTP]	GO:0006475; P:internal protein amino acid acetylation; IDA:UniProtKB
P35558	PCK1	Phosphoenolpyruvate carboxykinase, cytosolic [GTP]	GO:0006107; P:oxaloacetate metabolic process; IEA:Ensembl
P35558	PCK1	Phosphoenolpyruvate carboxykinase, cytosolic [GTP]	GO:0014823; P:response to activity; IEA:Ensembl
P35558	PCK1	Phosphoenolpyruvate carboxykinase, cytosolic [GTP]	GO:0032868; P:response to insulin; IDA:BHF-UCL
P35558	PCK1	Phosphoenolpyruvate carboxykinase, cytosolic [GTP]	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16822	PCK2	Phosphoenolpyruvate carboxykinase [GTP], mitochondrial	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q16822	PCK2	Phosphoenolpyruvate carboxykinase [GTP], mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q16822	PCK2	Phosphoenolpyruvate carboxykinase [GTP], mitochondrial	GO:0004613; F:phosphoenolpyruvate carboxykinase (GTP) activity; IEA:UniProtKB-EC
Q16822	PCK2	Phosphoenolpyruvate carboxykinase [GTP], mitochondrial	GO:0004611; F:phosphoenolpyruvate carboxykinase activity; TAS:ProtInc
Q16822	PCK2	Phosphoenolpyruvate carboxykinase [GTP], mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q16822	PCK2	Phosphoenolpyruvate carboxykinase [GTP], mitochondrial	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q16822	PCK2	Phosphoenolpyruvate carboxykinase [GTP], mitochondrial	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
Q16822	PCK2	Phosphoenolpyruvate carboxykinase [GTP], mitochondrial	GO:0006094; P:gluconeogenesis; TAS:Reactome
Q16822	PCK2	Phosphoenolpyruvate carboxykinase [GTP], mitochondrial	GO:0006006; P:glucose metabolic process; TAS:Reactome
Q16822	PCK2	Phosphoenolpyruvate carboxykinase [GTP], mitochondrial	GO:0006116; P:NADH oxidation; IEA:Ensembl
Q16822	PCK2	Phosphoenolpyruvate carboxykinase [GTP], mitochondrial	GO:0006107; P:oxaloacetate metabolic process; IEA:Ensembl
Q16822	PCK2	Phosphoenolpyruvate carboxykinase [GTP], mitochondrial	GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl
Q16822	PCK2	Phosphoenolpyruvate carboxykinase [GTP], mitochondrial	GO:0006090; P:pyruvate metabolic process; IEA:Ensembl
Q16822	PCK2	Phosphoenolpyruvate carboxykinase [GTP], mitochondrial	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
Q16822	PCK2	Phosphoenolpyruvate carboxykinase [GTP], mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:0071345; P:cellular response to cytokine stimulus; ISS:BHF-UCL
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:0071398; P:cellular response to fatty acid; ISS:BHF-UCL
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:0071354; P:cellular response to interleukin-6; ISS:BHF-UCL
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:0044320; P:cellular response to leptin stimulus; IEA:Ensembl
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:0071356; P:cellular response to tumor necrosis factor; ISS:BHF-UCL
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:0006112; P:energy reserve metabolic process; IC:BHF-UCL
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:0070584; P:mitochondrion morphogenesis; IMP:BHF-UCL
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:2001170; P:negative regulation of ATP biosynthetic process; IMP:BHF-UCL
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:0090005; P:negative regulation of establishment of protein localization to plasma membrane; IDA:BHF-UCL
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:2001274; P:negative regulation of glucose import in response to insulin stimulus; IDA:BHF-UCL
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:0046627; P:negative regulation of insulin receptor signaling pathway; IDA:BHF-UCL
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:0090298; P:negative regulation of mitochondrial DNA replication; IMP:BHF-UCL
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:0001933; P:negative regulation of protein phosphorylation; IDA:BHF-UCL
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:2001171; P:positive regulation of ATP biosynthetic process; ISS:BHF-UCL
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:0070346; P:positive regulation of fat cell proliferation; IDA:BHF-UCL
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IMP:BHF-UCL
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; IDA:BHF-UCL
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:0010635; P:regulation of mitochondrial fusion; IC:BHF-UCL
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:0051881; P:regulation of mitochondrial membrane potential; ISS:BHF-UCL
Q7Z2X4	PID1	PTB-containing, cubilin and LRP1-interacting protein	GO:2000377; P:regulation of reactive oxygen species metabolic process; ISS:BHF-UCL
Q9Y6V0	PCLO	Protein piccolo	GO:0005509; F:calcium ion binding; ISS:UniProtKB
Q9Y6V0	PCLO	Protein piccolo	GO:0005544; F:calcium-dependent phospholipid binding; ISS:UniProtKB
Q9Y6V0	PCLO	Protein piccolo	GO:0005522; F:profilin binding; ISS:UniProtKB
Q9Y6V0	PCLO	Protein piccolo	GO:0005215; F:transporter activity; IEA:InterPro
Q9Y6V0	PCLO	Protein piccolo	GO:0019933; P:cAMP-mediated signaling; IEA:Ensembl
Q9Y6V0	PCLO	Protein piccolo	GO:0007010; P:cytoskeleton organization; ISS:UniProtKB
Q9Y6V0	PCLO	Protein piccolo	GO:0030073; P:insulin secretion; IEA:Ensembl
Q9Y6V0	PCLO	Protein piccolo	GO:0017157; P:regulation of exocytosis; IEA:Ensembl
Q9Y6V0	PCLO	Protein piccolo	GO:0016079; P:synaptic vesicle exocytosis; NAS:UniProtKB
Q15154	PCM1	Pericentriolar material 1 protein	GO:0042802; F:identical protein binding; ISS:BHF-UCL
Q15154	PCM1	Pericentriolar material 1 protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q15154	PCM1	Pericentriolar material 1 protein	GO:0051297; P:centrosome organization; IMP:BHF-UCL
Q15154	PCM1	Pericentriolar material 1 protein	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q15154	PCM1	Pericentriolar material 1 protein	GO:0031122; P:cytoplasmic microtubule organization; IMP:UniProtKB
Q15154	PCM1	Pericentriolar material 1 protein	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q15154	PCM1	Pericentriolar material 1 protein	GO:0022027; P:interkinetic nuclear migration; ISS:BHF-UCL
Q15154	PCM1	Pericentriolar material 1 protein	GO:0035735; P:intraciliary transport involved in cilium morphogenesis; IMP:UniProtKB
Q15154	PCM1	Pericentriolar material 1 protein	GO:0034453; P:microtubule anchoring; ISS:BHF-UCL
Q15154	PCM1	Pericentriolar material 1 protein	GO:0034454; P:microtubule anchoring at centrosome; IEA:Ensembl
Q15154	PCM1	Pericentriolar material 1 protein	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q15154	PCM1	Pericentriolar material 1 protein	GO:0050768; P:negative regulation of neurogenesis; ISS:BHF-UCL
Q15154	PCM1	Pericentriolar material 1 protein	GO:0097150; P:neuronal stem cell maintenance; IEA:Ensembl
Q15154	PCM1	Pericentriolar material 1 protein	GO:0090316; P:positive regulation of intracellular protein transport; IMP:UniProtKB
Q15154	PCM1	Pericentriolar material 1 protein	GO:0071539; P:protein localization to centrosome; ISS:BHF-UCL
Q96MG8	PCMTD1	Protein-L-isoaspartate O-methyltransferase domain-containing protein 1	GO:0004719; F:protein-L-isoaspartate (D-aspartate) O-methyltransferase activity; IEA:InterPro
Q9NV79	PCMTD2	Protein-L-isoaspartate O-methyltransferase domain-containing protein 2	GO:0004719; F:protein-L-isoaspartate (D-aspartate) O-methyltransferase activity; IEA:InterPro
P12004	PCNA	Proliferating cell nuclear antigen	GO:0032139; F:dinucleotide insertion or deletion binding; IDA:BHF-UCL
P12004	PCNA	Proliferating cell nuclear antigen	GO:0070182; F:DNA polymerase binding; IPI:UniProt
P12004	PCNA	Proliferating cell nuclear antigen	GO:0030337; F:DNA polymerase processivity factor activity; IEA:InterPro
P12004	PCNA	Proliferating cell nuclear antigen	GO:0042802; F:identical protein binding; IPI:IntAct
P12004	PCNA	Proliferating cell nuclear antigen	GO:0032405; F:MutLalpha complex binding; IDA:HGNC
P12004	PCNA	Proliferating cell nuclear antigen	GO:0005515; F:protein binding; IPI:UniProtKB
P12004	PCNA	Proliferating cell nuclear antigen	GO:0000701; F:purine-specific mismatch base pair DNA N-glycosylase activity; IDA:BHF-UCL
P12004	PCNA	Proliferating cell nuclear antigen	GO:0030971; F:receptor tyrosine kinase binding; IPI:UniProtKB
P12004	PCNA	Proliferating cell nuclear antigen	GO:0006284; P:base-excision repair; TAS:Reactome
P12004	PCNA	Proliferating cell nuclear antigen	GO:0008283; P:cell proliferation; TAS:ProtInc
P12004	PCNA	Proliferating cell nuclear antigen	GO:0006281; P:DNA repair; NAS:UniProtKB
P12004	PCNA	Proliferating cell nuclear antigen	GO:0006260; P:DNA replication; NAS:UniProtKB
P12004	PCNA	Proliferating cell nuclear antigen	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P12004	PCNA	Proliferating cell nuclear antigen	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
P12004	PCNA	Proliferating cell nuclear antigen	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P12004	PCNA	Proliferating cell nuclear antigen	GO:0007507; P:heart development; IEA:Ensembl
P12004	PCNA	Proliferating cell nuclear antigen	GO:0006298; P:mismatch repair; IDA:BHF-UCL
P12004	PCNA	Proliferating cell nuclear antigen	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P12004	PCNA	Proliferating cell nuclear antigen	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P12004	PCNA	Proliferating cell nuclear antigen	GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome
P12004	PCNA	Proliferating cell nuclear antigen	GO:0048015; P:phosphatidylinositol-mediated signaling; NAS:UniProtKB
P12004	PCNA	Proliferating cell nuclear antigen	GO:0032077; P:positive regulation of deoxyribonuclease activity; IDA:UniProtKB
P12004	PCNA	Proliferating cell nuclear antigen	GO:0006275; P:regulation of DNA replication; IEA:InterPro
P12004	PCNA	Proliferating cell nuclear antigen	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; TAS:Reactome
P12004	PCNA	Proliferating cell nuclear antigen	GO:0046686; P:response to cadmium ion; IEA:Ensembl
P12004	PCNA	Proliferating cell nuclear antigen	GO:0033993; P:response to lipid; IEA:Ensembl
P12004	PCNA	Proliferating cell nuclear antigen	GO:0000723; P:telomere maintenance; TAS:Reactome
P12004	PCNA	Proliferating cell nuclear antigen	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
P12004	PCNA	Proliferating cell nuclear antigen	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
P12004	PCNA	Proliferating cell nuclear antigen	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P12004	PCNA	Proliferating cell nuclear antigen	GO:0019985; P:translesion synthesis; IDA:UniProtKB
Q8WW12	PCNP	PEST proteolytic signal-containing nuclear protein	GO:0005515; F:protein binding; IPI:HGNC
Q8WW12	PCNP	PEST proteolytic signal-containing nuclear protein	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8WW12	PCNP	PEST proteolytic signal-containing nuclear protein	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:HGNC
Q8WW12	PCNP	PEST proteolytic signal-containing nuclear protein	GO:0016567; P:protein ubiquitination; IDA:HGNC
O95613	PCNT	Pericentrin	GO:0005515; F:protein binding; IPI:UniProtKB
O95613	PCNT	Pericentrin	GO:0048854; P:brain morphogenesis; IEA:Ensembl
O95613	PCNT	Pericentrin	GO:0021696; P:cerebellar cortex morphogenesis; IEA:Ensembl
O95613	PCNT	Pericentrin	GO:0042384; P:cilium assembly; IDA:MGI
O95613	PCNT	Pericentrin	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
O95613	PCNT	Pericentrin	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O95613	PCNT	Pericentrin	GO:0035108; P:limb morphogenesis; IEA:Ensembl
O95613	PCNT	Pericentrin	GO:0000226; P:microtubule cytoskeleton organization; IMP:UniProtKB
O95613	PCNT	Pericentrin	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O95613	PCNT	Pericentrin	GO:0035264; P:multicellular organism growth; IEA:Ensembl
O95613	PCNT	Pericentrin	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
O95613	PCNT	Pericentrin	GO:0061351; P:neural precursor cell proliferation; IEA:Ensembl
O95613	PCNT	Pericentrin	GO:0001764; P:neuron migration; IEA:Ensembl
O95613	PCNT	Pericentrin	GO:0021772; P:olfactory bulb development; IEA:Ensembl
O95613	PCNT	Pericentrin	GO:0090316; P:positive regulation of intracellular protein transport; IMP:UniProtKB
O95613	PCNT	Pericentrin	GO:0007051; P:spindle organization; IEA:Ensembl
Q15113	PCOLCE	Procollagen C-endopeptidase enhancer 1	GO:0005518; F:collagen binding; IDA:MGI
Q15113	PCOLCE	Procollagen C-endopeptidase enhancer 1	GO:0008201; F:heparin binding; IDA:MGI
Q15113	PCOLCE	Procollagen C-endopeptidase enhancer 1	GO:0016504; F:peptidase activator activity; IDA:MGI
Q15113	PCOLCE	Procollagen C-endopeptidase enhancer 1	GO:0005515; F:protein binding; IPI:IntAct
Q15113	PCOLCE	Procollagen C-endopeptidase enhancer 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q15113	PCOLCE	Procollagen C-endopeptidase enhancer 1	GO:0010952; P:positive regulation of peptidase activity; IDA:GOC
Q15113	PCOLCE	Procollagen C-endopeptidase enhancer 1	GO:0006508; P:proteolysis; IEA:Ensembl
Q9UKZ9	PCOLCE2	Procollagen C-endopeptidase enhancer 2	GO:0005518; F:collagen binding; IDA:MGI
Q9UKZ9	PCOLCE2	Procollagen C-endopeptidase enhancer 2	GO:0008201; F:heparin binding; IDA:MGI
Q9UKZ9	PCOLCE2	Procollagen C-endopeptidase enhancer 2	GO:0016504; F:peptidase activator activity; IDA:MGI
Q9UKZ9	PCOLCE2	Procollagen C-endopeptidase enhancer 2	GO:0004872; F:receptor activity; IEA:InterPro
Q9UKZ9	PCOLCE2	Procollagen C-endopeptidase enhancer 2	GO:0010952; P:positive regulation of peptidase activity; IDA:GOC
Q9UKZ9	PCOLCE2	Procollagen C-endopeptidase enhancer 2	GO:0006898; P:receptor-mediated endocytosis; IEA:InterPro
P48539	PCP4	Purkinje cell protein 4	GO:0007417; P:central nervous system development; TAS:ProtInc
Q8IVA1	PCP2	Purkinje cell protein 2 homolog	GO:0030695; F:GTPase regulator activity; IEA:InterPro
Q8IVA1	PCP2	Purkinje cell protein 2 homolog	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:Ensembl
Q8IVA1	PCP2	Purkinje cell protein 2 homolog	GO:0016056; P:rhodopsin mediated signaling pathway; IEA:Ensembl
P42785	PRCP	Lysosomal Pro-X carboxypeptidase	GO:0005515; F:protein binding; IPI:IntAct
P42785	PRCP	Lysosomal Pro-X carboxypeptidase	GO:0004185; F:serine-type carboxypeptidase activity; TAS:Reactome
P42785	PRCP	Lysosomal Pro-X carboxypeptidase	GO:0007596; P:blood coagulation; TAS:Reactome
P42785	PRCP	Lysosomal Pro-X carboxypeptidase	GO:0007597; P:blood coagulation, intrinsic pathway; TAS:Reactome
Q9UHG2	PCSK1N	ProSAAS	GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc
Q9UHG2	PCSK1N	ProSAAS	GO:0005102; F:receptor binding; TAS:ProtInc
Q9UHG2	PCSK1N	ProSAAS	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:Ensembl
Q9UHG2	PCSK1N	ProSAAS	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
Q9UHG2	PCSK1N	ProSAAS	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
Q9UHG2	PCSK1N	ProSAAS	GO:0016486; P:peptide hormone processing; IEA:Ensembl
Q9UHG2	PCSK1N	ProSAAS	GO:0009409; P:response to cold; IEA:Ensembl
Q9UHG2	PCSK1N	ProSAAS	GO:0002021; P:response to dietary excess; IEA:Ensembl
Q6UW60	PCSK4	Proprotein convertase subtilisin/kexin type 4	GO:0004252; F:serine-type endopeptidase activity; IBA:RefGenome
Q6UW60	PCSK4	Proprotein convertase subtilisin/kexin type 4	GO:0007340; P:acrosome reaction; IEA:Ensembl
Q6UW60	PCSK4	Proprotein convertase subtilisin/kexin type 4	GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl
Q6UW60	PCSK4	Proprotein convertase subtilisin/kexin type 4	GO:0006508; P:proteolysis; IBA:RefGenome
Q6UW60	PCSK4	Proprotein convertase subtilisin/kexin type 4	GO:0048240; P:sperm capacitation; IEA:Ensembl
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0008233; F:peptidase activity; IDA:MGI
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0042277; F:peptide binding; ISS:BHF-UCL
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0004252; F:serine-type endopeptidase activity; IDA:BHF-UCL
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0009952; P:anterior/posterior pattern specification; IMP:BHF-UCL
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0042089; P:cytokine biosynthetic process; ISS:BHF-UCL
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0007566; P:embryo implantation; ISS:BHF-UCL
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0048566; P:embryonic digestive tract development; IMP:BHF-UCL
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0048706; P:embryonic skeletal system development; IMP:BHF-UCL
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0007507; P:heart development; ISS:BHF-UCL
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0001822; P:kidney development; IMP:BHF-UCL
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0035108; P:limb morphogenesis; ISS:BHF-UCL
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0032455; P:nerve growth factor processing; TAS:Reactome
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0043043; P:peptide biosynthetic process; IDA:BHF-UCL
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0016486; P:peptide hormone processing; IDA:BHF-UCL
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0016485; P:protein processing; IDA:BHF-UCL
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0002001; P:renin secretion into blood stream; IEP:BHF-UCL
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0030323; P:respiratory tube development; ISS:BHF-UCL
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0006465; P:signal peptide processing; IDA:HGNC
Q92824	PCSK5	Proprotein convertase subtilisin/kexin type 5	GO:0019058; P:viral life cycle; IEP:BHF-UCL
P29122	PCSK6	Proprotein convertase subtilisin/kexin type 6	GO:0004175; F:endopeptidase activity; IDA:BHF-UCL
P29122	PCSK6	Proprotein convertase subtilisin/kexin type 6	GO:0008201; F:heparin binding; IDA:BHF-UCL
P29122	PCSK6	Proprotein convertase subtilisin/kexin type 6	GO:0048406; F:nerve growth factor binding; IDA:BHF-UCL
P29122	PCSK6	Proprotein convertase subtilisin/kexin type 6	GO:0004252; F:serine-type endopeptidase activity; IDA:BHF-UCL
P29122	PCSK6	Proprotein convertase subtilisin/kexin type 6	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
P29122	PCSK6	Proprotein convertase subtilisin/kexin type 6	GO:0009100; P:glycoprotein metabolic process; IDA:BHF-UCL
P29122	PCSK6	Proprotein convertase subtilisin/kexin type 6	GO:0032455; P:nerve growth factor processing; TAS:Reactome
P29122	PCSK6	Proprotein convertase subtilisin/kexin type 6	GO:0032902; P:nerve growth factor production; IDA:BHF-UCL
P29122	PCSK6	Proprotein convertase subtilisin/kexin type 6	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P29122	PCSK6	Proprotein convertase subtilisin/kexin type 6	GO:0016486; P:peptide hormone processing; IDA:BHF-UCL
P29122	PCSK6	Proprotein convertase subtilisin/kexin type 6	GO:0016485; P:protein processing; IDA:BHF-UCL
P29122	PCSK6	Proprotein convertase subtilisin/kexin type 6	GO:0030510; P:regulation of BMP signaling pathway; TAS:BHF-UCL
P29122	PCSK6	Proprotein convertase subtilisin/kexin type 6	GO:0032940; P:secretion by cell; IDA:BHF-UCL
P29122	PCSK6	Proprotein convertase subtilisin/kexin type 6	GO:0007354; P:zygotic determination of anterior/posterior axis, embryo; IEA:Ensembl
Q16549	PCSK7	Proprotein convertase subtilisin/kexin type 7	GO:0008233; F:peptidase activity; IDA:MGI
Q16549	PCSK7	Proprotein convertase subtilisin/kexin type 7	GO:0004252; F:serine-type endopeptidase activity; IBA:RefGenome
Q16549	PCSK7	Proprotein convertase subtilisin/kexin type 7	GO:0016486; P:peptide hormone processing; NAS:UniProtKB
Q16549	PCSK7	Proprotein convertase subtilisin/kexin type 7	GO:0016485; P:protein processing; IDA:MGI
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0034185; F:apolipoprotein binding; ISS:UniProtKB
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0034190; F:apolipoprotein receptor binding; IDA:BHF-UCL
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0030169; F:low-density lipoprotein particle binding; ISS:UniProtKB
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0050750; F:low-density lipoprotein particle receptor binding; IDA:HGNC
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0043621; F:protein self-association; IDA:UniProtKB
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0004252; F:serine-type endopeptidase activity; IDA:HGNC
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0019871; F:sodium channel inhibitor activity; IDA:UniProtKB
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0034189; F:very-low-density lipoprotein particle binding; ISS:UniProtKB
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0070326; F:very-low-density lipoprotein particle receptor binding; IDA:BHF-UCL
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0032869; P:cellular response to insulin stimulus; ISS:HGNC
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0009267; P:cellular response to starvation; ISS:HGNC
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0042632; P:cholesterol homeostasis; IMP:HGNC
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0001822; P:kidney development; ISS:HGNC
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0042157; P:lipoprotein metabolic process; IEA:Ensembl
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0001889; P:liver development; ISS:HGNC
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0032802; P:low-density lipoprotein particle receptor catabolic process; IDA:UniProtKB
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0007041; P:lysosomal transport; IDA:BHF-UCL
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0043086; P:negative regulation of catalytic activity; IEA:InterPro
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0010989; P:negative regulation of low-density lipoprotein particle clearance; IDA:BHF-UCL
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0001920; P:negative regulation of receptor recycling; IDA:BHF-UCL
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0022008; P:neurogenesis; ISS:HGNC
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0030182; P:neuron differentiation; ISS:HGNC
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0006644; P:phospholipid metabolic process; IEA:Ensembl
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0043525; P:positive regulation of neuron apoptotic process; IMP:HGNC
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0002092; P:positive regulation of receptor internalization; IDA:BHF-UCL
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0016540; P:protein autoprocessing; IDA:HGNC
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0006508; P:proteolysis; IBA:RefGenome
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0032803; P:regulation of low-density lipoprotein particle receptor catabolic process; IEA:Ensembl
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0043523; P:regulation of neuron apoptotic process; ISS:UniProtKB
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0010469; P:regulation of receptor activity; IDA:BHF-UCL
Q8NBP7	PCSK9	Proprotein convertase subtilisin/kexin type 9	GO:0006641; P:triglyceride metabolic process; IEA:Ensembl
Q9Y365	STARD10	PCTP-like protein	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q9Y365	STARD10	PCTP-like protein	GO:0005515; F:protein binding; IPI:IntAct
Q9Y365	STARD10	PCTP-like protein	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
P49585	PCYT1A	Choline-phosphate cytidylyltransferase A	GO:0004105; F:choline-phosphate cytidylyltransferase activity; ISS:UniProtKB
P49585	PCYT1A	Choline-phosphate cytidylyltransferase A	GO:0008289; F:lipid binding; IEA:Ensembl
P49585	PCYT1A	Choline-phosphate cytidylyltransferase A	GO:0006657; P:CDP-choline pathway; ISS:UniProtKB
P49585	PCYT1A	Choline-phosphate cytidylyltransferase A	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
P49585	PCYT1A	Choline-phosphate cytidylyltransferase A	GO:0006656; P:phosphatidylcholine biosynthetic process; ISS:UniProtKB
P49585	PCYT1A	Choline-phosphate cytidylyltransferase A	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P49585	PCYT1A	Choline-phosphate cytidylyltransferase A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y5K3	PCYT1B	Choline-phosphate cytidylyltransferase B	GO:0004105; F:choline-phosphate cytidylyltransferase activity; TAS:ProtInc
Q9Y5K3	PCYT1B	Choline-phosphate cytidylyltransferase B	GO:0006657; P:CDP-choline pathway; TAS:GOC
Q9Y5K3	PCYT1B	Choline-phosphate cytidylyltransferase B	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9Y5K3	PCYT1B	Choline-phosphate cytidylyltransferase B	GO:0001541; P:ovarian follicle development; IEA:Ensembl
Q9Y5K3	PCYT1B	Choline-phosphate cytidylyltransferase B	GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome
Q9Y5K3	PCYT1B	Choline-phosphate cytidylyltransferase B	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9Y5K3	PCYT1B	Choline-phosphate cytidylyltransferase B	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y5K3	PCYT1B	Choline-phosphate cytidylyltransferase B	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q99447	PCYT2	Ethanolamine-phosphate cytidylyltransferase	GO:0004306; F:ethanolamine-phosphate cytidylyltransferase activity; TAS:UniProtKB
Q99447	PCYT2	Ethanolamine-phosphate cytidylyltransferase	GO:0016779; F:nucleotidyltransferase activity; IEA:UniProtKB-KW
Q99447	PCYT2	Ethanolamine-phosphate cytidylyltransferase	GO:0009058; P:biosynthetic process; IEA:InterPro
Q99447	PCYT2	Ethanolamine-phosphate cytidylyltransferase	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q99447	PCYT2	Ethanolamine-phosphate cytidylyltransferase	GO:0006646; P:phosphatidylethanolamine biosynthetic process; TAS:Reactome
Q99447	PCYT2	Ethanolamine-phosphate cytidylyltransferase	GO:0008654; P:phospholipid biosynthetic process; TAS:UniProtKB
Q99447	PCYT2	Ethanolamine-phosphate cytidylyltransferase	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q99447	PCYT2	Ethanolamine-phosphate cytidylyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UHG3	PCYOX1	Prenylcysteine oxidase 1	GO:0008555; F:chloride-transporting ATPase activity; IEA:Ensembl
Q9UHG3	PCYOX1	Prenylcysteine oxidase 1	GO:0001735; F:prenylcysteine oxidase activity; IDA:BHF-UCL
Q9UHG3	PCYOX1	Prenylcysteine oxidase 1	GO:0030327; P:prenylated protein catabolic process; NAS:UniProtKB
Q9UHG3	PCYOX1	Prenylcysteine oxidase 1	GO:0030328; P:prenylcysteine catabolic process; IEA:Ensembl
Q9UHG3	PCYOX1	Prenylcysteine oxidase 1	GO:0030329; P:prenylcysteine metabolic process; NAS:UniProtKB
Q8NBM8	PCYOX1L	Prenylcysteine oxidase-like	GO:0001735; F:prenylcysteine oxidase activity; IEA:InterPro
Q8NBM8	PCYOX1L	Prenylcysteine oxidase-like	GO:0030328; P:prenylcysteine catabolic process; IEA:InterPro
Q9NZQ7	CD274	Programmed cell death 1 ligand 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NZQ7	CD274	Programmed cell death 1 ligand 1	GO:0007166; P:cell surface receptor signaling pathway; IDA:UniProtKB
Q9NZQ7	CD274	Programmed cell death 1 ligand 1	GO:0006955; P:immune response; IDA:UniProtKB
Q9NZQ7	CD274	Programmed cell death 1 ligand 1	GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl
Q9NZQ7	CD274	Programmed cell death 1 ligand 1	GO:2001181; P:positive regulation of interleukin-10 secretion; IDA:UniProtKB
Q9NZQ7	CD274	Programmed cell death 1 ligand 1	GO:0042102; P:positive regulation of T cell proliferation; TAS:UniProtKB
Q9NZQ7	CD274	Programmed cell death 1 ligand 1	GO:0007165; P:signal transduction; IDA:UniProtKB
Q9NZQ7	CD274	Programmed cell death 1 ligand 1	GO:0031295; P:T cell costimulation; IDA:UniProtKB
Q9BQ51	PDCD1LG2	Programmed cell death 1 ligand 2	GO:0006955; P:immune response; NAS:UniProtKB
Q9BQ51	PDCD1LG2	Programmed cell death 1 ligand 2	GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl
Q9BQ51	PDCD1LG2	Programmed cell death 1 ligand 2	GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl
Q9BQ51	PDCD1LG2	Programmed cell death 1 ligand 2	GO:0031295; P:T cell costimulation; TAS:Reactome
Q9Y5Y4	PTGDR2	Prostaglandin D2 receptor 2	GO:0004930; F:G-protein coupled receptor activity; IDA:UniProtKB
Q9Y5Y4	PTGDR2	Prostaglandin D2 receptor 2	GO:0004982; F:N-formyl peptide receptor activity; IEA:InterPro
Q9Y5Y4	PTGDR2	Prostaglandin D2 receptor 2	GO:0004956; F:prostaglandin D receptor activity; IDA:UniProtKB
Q9Y5Y4	PTGDR2	Prostaglandin D2 receptor 2	GO:0004958; F:prostaglandin F receptor activity; IEA:Ensembl
Q9Y5Y4	PTGDR2	Prostaglandin D2 receptor 2	GO:0001785; F:prostaglandin J receptor activity; IEA:Ensembl
Q9Y5Y4	PTGDR2	Prostaglandin D2 receptor 2	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IEA:Ensembl
Q9Y5Y4	PTGDR2	Prostaglandin D2 receptor 2	GO:0019722; P:calcium-mediated signaling; IDA:UniProtKB
Q9Y5Y4	PTGDR2	Prostaglandin D2 receptor 2	GO:0006935; P:chemotaxis; IDA:UniProtKB
Q9Y5Y4	PTGDR2	Prostaglandin D2 receptor 2	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:UniProtKB
Q9Y5Y4	PTGDR2	Prostaglandin D2 receptor 2	GO:0006955; P:immune response; TAS:ProtInc
Q9Y5Y4	PTGDR2	Prostaglandin D2 receptor 2	GO:0045745; P:positive regulation of G-protein coupled receptor protein signaling pathway; IEA:Ensembl
Q13258	PTGDR	Prostaglandin D2 receptor	GO:0004956; F:prostaglandin D receptor activity; NAS:UniProtKB
Q13258	PTGDR	Prostaglandin D2 receptor	GO:0001785; F:prostaglandin J receptor activity; IEA:Ensembl
Q13258	PTGDR	Prostaglandin D2 receptor	GO:0005515; F:protein binding; IPI:BHF-UCL
Q13258	PTGDR	Prostaglandin D2 receptor	GO:0046085; P:adenosine metabolic process; IEA:Ensembl
Q13258	PTGDR	Prostaglandin D2 receptor	GO:0071799; P:cellular response to prostaglandin D stimulus; IEA:Ensembl
Q13258	PTGDR	Prostaglandin D2 receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
Q13258	PTGDR	Prostaglandin D2 receptor	GO:0006954; P:inflammatory response; IEA:Ensembl
Q13258	PTGDR	Prostaglandin D2 receptor	GO:0030238; P:male sex determination; IEA:Ensembl
Q13258	PTGDR	Prostaglandin D2 receptor	GO:0030431; P:sleep; IEA:Ensembl
Q9BUL8	PDCD10	Programmed cell death protein 10	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BUL8	PDCD10	Programmed cell death protein 10	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q9BUL8	PDCD10	Programmed cell death protein 10	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q9BUL8	PDCD10	Programmed cell death protein 10	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q9BUL8	PDCD10	Programmed cell death protein 10	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9BUL8	PDCD10	Programmed cell death protein 10	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q9BUL8	PDCD10	Programmed cell death protein 10	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q9BUL8	PDCD10	Programmed cell death protein 10	GO:0043406; P:positive regulation of MAP kinase activity; IDA:UniProtKB
Q8WUM4	PDCD6IP	Programmed cell death 6-interacting protein	GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB
Q8WUM4	PDCD6IP	Programmed cell death 6-interacting protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WUM4	PDCD6IP	Programmed cell death 6-interacting protein	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8WUM4	PDCD6IP	Programmed cell death 6-interacting protein	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8WUM4	PDCD6IP	Programmed cell death 6-interacting protein	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q8WUM4	PDCD6IP	Programmed cell death 6-interacting protein	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8WUM4	PDCD6IP	Programmed cell death 6-interacting protein	GO:0019058; P:viral life cycle; TAS:Reactome
Q8WUM4	PDCD6IP	Programmed cell death 6-interacting protein	GO:0016032; P:viral process; TAS:Reactome
Q15116	PDCD1	Programmed cell death protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q15116	PDCD1	Programmed cell death protein 1	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q15116	PDCD1	Programmed cell death protein 1	GO:0006915; P:apoptotic process; TAS:ProtInc
Q15116	PDCD1	Programmed cell death protein 1	GO:0006959; P:humoral immune response; TAS:ProtInc
Q15116	PDCD1	Programmed cell death protein 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q15116	PDCD1	Programmed cell death protein 1	GO:0007165; P:signal transduction; TAS:GOC
Q15116	PDCD1	Programmed cell death protein 1	GO:0031295; P:T cell costimulation; TAS:Reactome
Q16342	PDCD2	Programmed cell death protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q16342	PDCD2	Programmed cell death protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q16342	PDCD2	Programmed cell death protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q16342	PDCD2	Programmed cell death protein 2	GO:0006915; P:apoptotic process; TAS:ProtInc
Q53EL6	PDCD4	Programmed cell death protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q53EL6	PDCD4	Programmed cell death protein 4	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q53EL6	PDCD4	Programmed cell death protein 4	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q53EL6	PDCD4	Programmed cell death protein 4	GO:0007569; P:cell aging; IDA:UniProtKB
Q53EL6	PDCD4	Programmed cell death protein 4	GO:0045786; P:negative regulation of cell cycle; NAS:UniProtKB
Q53EL6	PDCD4	Programmed cell death protein 4	GO:0043508; P:negative regulation of JUN kinase activity; ISS:UniProtKB
Q53EL6	PDCD4	Programmed cell death protein 4	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
O14737	PDCD5	Programmed cell death protein 5	GO:0003677; F:DNA binding; IEA:InterPro
O14737	PDCD5	Programmed cell death protein 5	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O14737	PDCD5	Programmed cell death protein 5	GO:0043065; P:positive regulation of apoptotic process; IMP:FlyBase
O75340	PDCD6	Programmed cell death protein 6	GO:0060090; F:binding, bridging; IMP:UniProtKB
O75340	PDCD6	Programmed cell death protein 6	GO:0005509; F:calcium ion binding; ISS:UniProtKB
O75340	PDCD6	Programmed cell death protein 6	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; IBA:RefGenome
O75340	PDCD6	Programmed cell death protein 6	GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB
O75340	PDCD6	Programmed cell death protein 6	GO:0005515; F:protein binding; IPI:UniProtKB
O75340	PDCD6	Programmed cell death protein 6	GO:0046983; F:protein dimerization activity; IPI:UniProtKB
O75340	PDCD6	Programmed cell death protein 6	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
O75340	PDCD6	Programmed cell death protein 6	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
O75340	PDCD6	Programmed cell death protein 6	GO:0097190; P:apoptotic signaling pathway; TAS:ProtInc
O75340	PDCD6	Programmed cell death protein 6	GO:0034605; P:cellular response to heat; IDA:UniProtKB
O75340	PDCD6	Programmed cell death protein 6	GO:0006886; P:intracellular protein transport; IDA:UniProtKB
O75340	PDCD6	Programmed cell death protein 6	GO:0051898; P:negative regulation of protein kinase B signaling; IDA:UniProtKB
O75340	PDCD6	Programmed cell death protein 6	GO:0032007; P:negative regulation of TOR signaling; IDA:UniProtKB
O75340	PDCD6	Programmed cell death protein 6	GO:0030948; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; IDA:UniProtKB
O75340	PDCD6	Programmed cell death protein 6	GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB
O75340	PDCD6	Programmed cell death protein 6	GO:0010595; P:positive regulation of endothelial cell migration; IDA:UniProtKB
O75340	PDCD6	Programmed cell death protein 6	GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:UniProtKB
O75340	PDCD6	Programmed cell death protein 6	GO:0006508; P:proteolysis; IBA:RefGenome
O75340	PDCD6	Programmed cell death protein 6	GO:0051592; P:response to calcium ion; ISS:UniProtKB
O75340	PDCD6	Programmed cell death protein 6	GO:0036324; P:vascular endothelial growth factor receptor-2 signaling pathway; IDA:UniProtKB
Q8N8D1	PDCD7	Programmed cell death protein 7	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8N8D1	PDCD7	Programmed cell death protein 7	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
Q8N8D1	PDCD7	Programmed cell death protein 7	GO:0070234; P:positive regulation of T cell apoptotic process; IEA:Ensembl
Q8N8D1	PDCD7	Programmed cell death protein 7	GO:0051384; P:response to glucocorticoid; ISS:HGNC
Q8N8D1	PDCD7	Programmed cell death protein 7	GO:0008380; P:RNA splicing; IC:HGNC
Q9H2J4	PDCL3	Phosducin-like protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H2J4	PDCL3	Phosducin-like protein 3	GO:0044183; F:protein binding involved in protein folding; IPI:MGI
Q9H2J4	PDCL3	Phosducin-like protein 3	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q9H2J4	PDCL3	Phosducin-like protein 3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9H2J4	PDCL3	Phosducin-like protein 3	GO:2000059; P:negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IMP:MGI
Q9H2J4	PDCL3	Phosducin-like protein 3	GO:0045766; P:positive regulation of angiogenesis; IMP:MGI
Q9H2J4	PDCL3	Phosducin-like protein 3	GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:MGI
Q9H2J4	PDCL3	Phosducin-like protein 3	GO:0006457; P:protein folding; IPI:GOC
Q9H2J4	PDCL3	Phosducin-like protein 3	GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; IMP:MGI
Q9H2J4	PDCL3	Phosducin-like protein 3	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9BRP1	PDCD2L	Programmed cell death protein 2-like	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9Y233	PDE10A	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; IEA:UniProtKB-EC
Q9Y233	PDE10A	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	GO:0004114; F:3',5'-cyclic-nucleotide phosphodiesterase activity; TAS:ProtInc
Q9Y233	PDE10A	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	GO:0030552; F:cAMP binding; IDA:UniProtKB
Q9Y233	PDE10A	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	GO:0030553; F:cGMP binding; NAS:UniProtKB
Q9Y233	PDE10A	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	GO:0004118; F:cGMP-stimulated cyclic-nucleotide phosphodiesterase activity; IDA:UniProtKB
Q9Y233	PDE10A	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y233	PDE10A	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	GO:0007596; P:blood coagulation; TAS:Reactome
Q9Y233	PDE10A	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	GO:0006198; P:cAMP catabolic process; IEA:UniProtKB-UniPathway
Q9Y233	PDE10A	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	GO:0046069; P:cGMP catabolic process; IEA:UniProtKB-UniPathway
Q9Y233	PDE10A	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	GO:0043949; P:regulation of cAMP-mediated signaling; IEA:Ensembl
Q9Y233	PDE10A	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	GO:0010738; P:regulation of protein kinase A signaling; IEA:Ensembl
Q9Y233	PDE10A	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	GO:0007165; P:signal transduction; IEA:InterPro
Q6L8Q7	PDE12	2',5'-phosphodiesterase 12	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6L8Q7	PDE12	2',5'-phosphodiesterase 12	GO:0004535; F:poly(A)-specific ribonuclease activity; IEA:UniProtKB-EC
Q6L8Q7	PDE12	2',5'-phosphodiesterase 12	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9HCR9	PDE11A	Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; IEA:UniProtKB-EC
Q9HCR9	PDE11A	Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	GO:0004114; F:3',5'-cyclic-nucleotide phosphodiesterase activity; TAS:ProtInc
Q9HCR9	PDE11A	Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	GO:0030552; F:cAMP binding; IEA:Ensembl
Q9HCR9	PDE11A	Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	GO:0030553; F:cGMP binding; IDA:UniProtKB
Q9HCR9	PDE11A	Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	GO:0004118; F:cGMP-stimulated cyclic-nucleotide phosphodiesterase activity; IDA:UniProtKB
Q9HCR9	PDE11A	Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	GO:0004112; F:cyclic-nucleotide phosphodiesterase activity; NAS:UniProtKB
Q9HCR9	PDE11A	Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HCR9	PDE11A	Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	GO:0007596; P:blood coagulation; TAS:Reactome
Q9HCR9	PDE11A	Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	GO:0006198; P:cAMP catabolic process; IEA:Ensembl
Q9HCR9	PDE11A	Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	GO:0046069; P:cGMP catabolic process; IEA:Ensembl
Q9HCR9	PDE11A	Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	GO:0007165; P:signal transduction; TAS:ProtInc
P54750	PDE1A	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; IEA:Ensembl
P54750	PDE1A	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	GO:0048101; F:calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity; IEA:Ensembl
P54750	PDE1A	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	GO:0004117; F:calmodulin-dependent cyclic-nucleotide phosphodiesterase activity; TAS:ProtInc
P54750	PDE1A	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	GO:0030553; F:cGMP binding; IEA:Ensembl
P54750	PDE1A	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P54750	PDE1A	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
P54750	PDE1A	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	GO:0007596; P:blood coagulation; TAS:Reactome
P54750	PDE1A	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	GO:0006198; P:cAMP catabolic process; IEA:Ensembl
P54750	PDE1A	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	GO:0046069; P:cGMP catabolic process; IEA:Ensembl
P54750	PDE1A	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P54750	PDE1A	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P54750	PDE1A	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	GO:0045087; P:innate immune response; TAS:Reactome
P54750	PDE1A	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P54750	PDE1A	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	GO:0034391; P:regulation of smooth muscle cell apoptotic process; IEA:Ensembl
P54750	PDE1A	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	GO:0048660; P:regulation of smooth muscle cell proliferation; IEA:Ensembl
P54750	PDE1A	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	GO:0007165; P:signal transduction; TAS:Reactome
Q14123	PDE1C	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	GO:0004117; F:calmodulin-dependent cyclic-nucleotide phosphodiesterase activity; TAS:ProtInc
Q14123	PDE1C	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14123	PDE1C	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
Q14123	PDE1C	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q14123	PDE1C	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q14123	PDE1C	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	GO:0045087; P:innate immune response; TAS:Reactome
Q14123	PDE1C	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	GO:0008152; P:metabolic process; TAS:GOC
Q14123	PDE1C	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q14123	PDE1C	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	GO:0007165; P:signal transduction; TAS:Reactome
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; IEA:Ensembl
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0048101; F:calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity; IEA:Ensembl
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0004117; F:calmodulin-dependent cyclic-nucleotide phosphodiesterase activity; TAS:ProtInc
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0006915; P:apoptotic process; TAS:ProtInc
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0007596; P:blood coagulation; TAS:Reactome
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0006198; P:cAMP catabolic process; IDA:UniProtKB
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0097011; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; IDA:UniProtKB
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0036006; P:cellular response to macrophage colony-stimulating factor stimulus; IDA:UniProtKB
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0046069; P:cGMP catabolic process; IDA:UniProtKB
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0045087; P:innate immune response; TAS:Reactome
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0030224; P:monocyte differentiation; IEP:UniProtKB
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0042053; P:regulation of dopamine metabolic process; IEA:Ensembl
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0001505; P:regulation of neurotransmitter levels; IEA:Ensembl
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0001975; P:response to amphetamine; IEA:Ensembl
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0042428; P:serotonin metabolic process; IEA:Ensembl
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0007165; P:signal transduction; TAS:Reactome
Q01064	PDE1B	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	GO:0008542; P:visual learning; IEA:Ensembl
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0005262; F:calcium channel activity; TAS:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0030552; F:cAMP binding; IMP:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0030553; F:cGMP binding; IDA:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0004118; F:cGMP-stimulated cyclic-nucleotide phosphodiesterase activity; IDA:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0004112; F:cyclic-nucleotide phosphodiesterase activity; IDA:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0008144; F:drug binding; IDA:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0005515; F:protein binding; IPI:IntAct
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0030911; F:TPR domain binding; IPI:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0007596; P:blood coagulation; TAS:Reactome
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0070588; P:calcium ion transmembrane transport; TAS:GOC
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0006198; P:cAMP catabolic process; IDA:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0019933; P:cAMP-mediated signaling; IMP:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0071321; P:cellular response to cGMP; IDA:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0035690; P:cellular response to drug; IEP:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0097011; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; IDA:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0036006; P:cellular response to macrophage colony-stimulating factor stimulus; IDA:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0071260; P:cellular response to mechanical stimulus; ISS:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0046069; P:cGMP catabolic process; IDA:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0019934; P:cGMP-mediated signaling; IMP:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0061028; P:establishment of endothelial barrier; ISS:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0008152; P:metabolic process; IDA:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0030224; P:monocyte differentiation; IEP:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0030818; P:negative regulation of cAMP biosynthetic process; ISS:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0033159; P:negative regulation of protein import into nucleus, translocation; IDA:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0043116; P:negative regulation of vascular permeability; IMP:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0050729; P:positive regulation of inflammatory response; ISS:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0043117; P:positive regulation of vascular permeability; IMP:UniProtKB
O00408	PDE2A	cGMP-dependent 3',5'-cyclic phosphodiesterase	GO:0006626; P:protein targeting to mitochondrion; ISS:UniProtKB
Q14432	PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; IEA:Ensembl
Q14432	PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	GO:0030552; F:cAMP binding; IEA:Ensembl
Q14432	PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	GO:0004119; F:cGMP-inhibited cyclic-nucleotide phosphodiesterase activity; TAS:ProtInc
Q14432	PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14432	PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	GO:0007596; P:blood coagulation; TAS:Reactome
Q14432	PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	GO:0006198; P:cAMP catabolic process; IDA:UniProtKB
Q14432	PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	GO:0019933; P:cAMP-mediated signaling; IMP:UniProtKB
Q14432	PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	GO:0071321; P:cellular response to cGMP; IDA:UniProtKB
Q14432	PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:UniProtKB
Q14432	PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	GO:0019934; P:cGMP-mediated signaling; IMP:UniProtKB
Q14432	PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	GO:0016101; P:diterpenoid metabolic process; IEA:Ensembl
Q14432	PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q14432	PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q14432	PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	GO:0043116; P:negative regulation of vascular permeability; IMP:UniProtKB
Q14432	PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	GO:0001556; P:oocyte maturation; IEA:Ensembl
Q14432	PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	GO:0060282; P:positive regulation of oocyte development; IEA:Ensembl
Q14432	PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	GO:0043117; P:positive regulation of vascular permeability; IMP:UniProtKB
Q14432	PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	GO:0040020; P:regulation of meiosis; IEA:Ensembl
Q14432	PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	GO:0051591; P:response to cAMP; IEA:Ensembl
Q14432	PDE3A	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	GO:0042493; P:response to drug; IEA:Ensembl
Q13370	PDE3B	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	GO:0004114; F:3',5'-cyclic-nucleotide phosphodiesterase activity; TAS:BHF-UCL
Q13370	PDE3B	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	GO:0004119; F:cGMP-inhibited cyclic-nucleotide phosphodiesterase activity; TAS:ProtInc
Q13370	PDE3B	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13370	PDE3B	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	GO:0005515; F:protein binding; IPI:IntAct
Q13370	PDE3B	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	GO:0043422; F:protein kinase B binding; ISS:BHF-UCL
Q13370	PDE3B	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q13370	PDE3B	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	GO:0007596; P:blood coagulation; TAS:Reactome
Q13370	PDE3B	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	GO:0006198; P:cAMP catabolic process; IEP:BHF-UCL
Q13370	PDE3B	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	GO:0032869; P:cellular response to insulin stimulus; ISS:BHF-UCL
Q13370	PDE3B	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	GO:0031018; P:endocrine pancreas development; IEA:Ensembl
Q13370	PDE3B	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	GO:0042593; P:glucose homeostasis; IEA:Ensembl
Q13370	PDE3B	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q13370	PDE3B	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	GO:0016525; P:negative regulation of angiogenesis; IMP:UniProtKB
Q13370	PDE3B	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	GO:0043951; P:negative regulation of cAMP-mediated signaling; IC:BHF-UCL
Q13370	PDE3B	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	GO:0007162; P:negative regulation of cell adhesion; IMP:BHF-UCL
Q13370	PDE3B	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	GO:0033629; P:negative regulation of cell adhesion mediated by integrin; IC:BHF-UCL
Q13370	PDE3B	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	GO:0050995; P:negative regulation of lipid catabolic process; IMP:BHF-UCL
Q13370	PDE3B	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	GO:0050796; P:regulation of insulin secretion; IEA:Ensembl
P27815	PDE4A	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; IDA:BHF-UCL
P27815	PDE4A	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	GO:0030552; F:cAMP binding; IGI:BHF-UCL
P27815	PDE4A	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P27815	PDE4A	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	GO:0005515; F:protein binding; IPI:UniProtKB
P27815	PDE4A	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	GO:0006198; P:cAMP catabolic process; IMP:UniProtKB
P27815	PDE4A	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	GO:0035690; P:cellular response to drug; IEA:Ensembl
P27815	PDE4A	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	GO:0043949; P:regulation of cAMP-mediated signaling; IEA:Ensembl
P27815	PDE4A	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	GO:0010738; P:regulation of protein kinase A signaling; IEA:Ensembl
P27815	PDE4A	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	GO:0007608; P:sensory perception of smell; IEA:Ensembl
P27815	PDE4A	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	GO:0007165; P:signal transduction; TAS:ProtInc
Q07343	PDE4B	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; IDA:BHF-UCL
Q07343	PDE4B	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	GO:0004114; F:3',5'-cyclic-nucleotide phosphodiesterase activity; ISS:BHF-UCL
Q07343	PDE4B	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	GO:0030552; F:cAMP binding; IGI:BHF-UCL
Q07343	PDE4B	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	GO:0044325; F:ion channel binding; ISS:BHF-UCL
Q07343	PDE4B	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q07343	PDE4B	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	GO:0006198; P:cAMP catabolic process; IDA:BHF-UCL
Q07343	PDE4B	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	GO:0035690; P:cellular response to drug; ISS:BHF-UCL
Q07343	PDE4B	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	GO:0071872; P:cellular response to epinephrine stimulus; ISS:BHF-UCL
Q07343	PDE4B	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	GO:0071222; P:cellular response to lipopolysaccharide; ISS:BHF-UCL
Q07343	PDE4B	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	GO:0050900; P:leukocyte migration; ISS:BHF-UCL
Q07343	PDE4B	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	GO:1901898; P:negative regulation of relaxation of cardiac muscle; ISS:BHF-UCL
Q07343	PDE4B	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	GO:0030593; P:neutrophil chemotaxis; ISS:BHF-UCL
Q07343	PDE4B	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	GO:0001780; P:neutrophil homeostasis; ISS:BHF-UCL
Q07343	PDE4B	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	GO:0032729; P:positive regulation of interferon-gamma production; IMP:BHF-UCL
Q07343	PDE4B	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	GO:0032743; P:positive regulation of interleukin-2 production; IMP:BHF-UCL
Q07343	PDE4B	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	GO:0086004; P:regulation of cardiac muscle cell contraction; ISS:BHF-UCL
Q07343	PDE4B	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	GO:1901841; P:regulation of high voltage-gated calcium channel activity; ISS:BHF-UCL
Q07343	PDE4B	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	GO:0050852; P:T cell receptor signaling pathway; IMP:BHF-UCL
Q08493	PDE4C	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; TAS:ProtInc
Q08493	PDE4C	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q08493	PDE4C	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	GO:0006198; P:cAMP catabolic process; IEA:UniProtKB-UniPathway
Q08493	PDE4C	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	GO:0007165; P:signal transduction; IEA:InterPro
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; IDA:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0004114; F:3',5'-cyclic-nucleotide phosphodiesterase activity; NAS:UniProtKB
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0051117; F:ATPase binding; IPI:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0031698; F:beta-2 adrenergic receptor binding; ISS:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0030552; F:cAMP binding; IDA:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0008144; F:drug binding; IPI:UniProtKB
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0019899; F:enzyme binding; ISS:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0005515; F:protein binding; IPI:IntAct
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0097110; F:scaffold protein binding; IPI:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0031625; F:ubiquitin protein ligase binding; IPI:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0071875; P:adrenergic receptor signaling pathway; ISS:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0086024; P:adrenergic receptor signaling pathway involved in positive regulation of heart rate; IC:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0007568; P:aging; IEA:Ensembl
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0006198; P:cAMP catabolic process; IDA:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0019933; P:cAMP-mediated signaling; NAS:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0071320; P:cellular response to cAMP; IDA:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0071872; P:cellular response to epinephrine stimulus; IDA:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0061028; P:establishment of endothelial barrier; ISS:UniProtKB
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0045822; P:negative regulation of heart contraction; ISS:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; ISS:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:1901898; P:negative regulation of relaxation of cardiac muscle; ISS:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0030593; P:neutrophil chemotaxis; IEA:Ensembl
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0032729; P:positive regulation of interferon-gamma production; IMP:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0032743; P:positive regulation of interleukin-2 production; IMP:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0032754; P:positive regulation of interleukin-5 production; IMP:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0086004; P:regulation of cardiac muscle cell contraction; ISS:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:1901844; P:regulation of cell communication by electrical coupling involved in cardiac conduction; IC:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0002027; P:regulation of heart rate; ISS:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0010469; P:regulation of receptor activity; ISS:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; ISS:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0060314; P:regulation of ryanodine-sensitive calcium-release channel activity; ISS:BHF-UCL
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0006939; P:smooth muscle contraction; IEA:Ensembl
Q08499	PDE4D	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	GO:0050852; P:T cell receptor signaling pathway; IMP:BHF-UCL
O76074	PDE5A	cGMP-specific 3',5'-cyclic phosphodiesterase	GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; IEA:UniProtKB-EC
O76074	PDE5A	cGMP-specific 3',5'-cyclic phosphodiesterase	GO:0004114; F:3',5'-cyclic-nucleotide phosphodiesterase activity; NAS:UniProtKB
O76074	PDE5A	cGMP-specific 3',5'-cyclic phosphodiesterase	GO:0030553; F:cGMP binding; TAS:UniProtKB
O76074	PDE5A	cGMP-specific 3',5'-cyclic phosphodiesterase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O76074	PDE5A	cGMP-specific 3',5'-cyclic phosphodiesterase	GO:0007596; P:blood coagulation; TAS:Reactome
O76074	PDE5A	cGMP-specific 3',5'-cyclic phosphodiesterase	GO:0046069; P:cGMP catabolic process; IDA:UniProtKB
O76074	PDE5A	cGMP-specific 3',5'-cyclic phosphodiesterase	GO:0055118; P:negative regulation of cardiac muscle contraction; IEA:Ensembl
O76074	PDE5A	cGMP-specific 3',5'-cyclic phosphodiesterase	GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl
O76074	PDE5A	cGMP-specific 3',5'-cyclic phosphodiesterase	GO:0010613; P:positive regulation of cardiac muscle hypertrophy; IEA:Ensembl
O76074	PDE5A	cGMP-specific 3',5'-cyclic phosphodiesterase	GO:0043406; P:positive regulation of MAP kinase activity; IEA:Ensembl
O76074	PDE5A	cGMP-specific 3',5'-cyclic phosphodiesterase	GO:0060282; P:positive regulation of oocyte development; IEA:Ensembl
O76074	PDE5A	cGMP-specific 3',5'-cyclic phosphodiesterase	GO:0055119; P:relaxation of cardiac muscle; IEA:Ensembl
O76074	PDE5A	cGMP-specific 3',5'-cyclic phosphodiesterase	GO:0007165; P:signal transduction; IEA:InterPro
P16499	PDE6A	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha	GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; IMP:BHF-UCL
P16499	PDE6A	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P16499	PDE6A	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha	GO:0051480; P:cytosolic calcium ion homeostasis; IMP:BHF-UCL
P16499	PDE6A	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha	GO:0046037; P:GMP metabolic process; IMP:BHF-UCL
P16499	PDE6A	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P16499	PDE6A	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
P16499	PDE6A	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
P16499	PDE6A	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
P16499	PDE6A	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha	GO:0007601; P:visual perception; TAS:ProtInc
P35913	PDE6B	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta	GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; IMP:BHF-UCL
P35913	PDE6B	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P35913	PDE6B	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta	GO:0051480; P:cytosolic calcium ion homeostasis; IMP:BHF-UCL
P35913	PDE6B	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta	GO:0046037; P:GMP metabolic process; IMP:BHF-UCL
P35913	PDE6B	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P35913	PDE6B	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
P35913	PDE6B	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
P35913	PDE6B	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
P35913	PDE6B	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta	GO:0007601; P:visual perception; TAS:ProtInc
P51160	PDE6C	Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'	GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; IEA:UniProtKB-EC
P51160	PDE6C	Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'	GO:0030553; F:cGMP binding; IEA:UniProtKB-KW
P51160	PDE6C	Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P51160	PDE6C	Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'	GO:0007603; P:phototransduction, visible light; IEA:Ensembl
P51160	PDE6C	Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'	GO:0046549; P:retinal cone cell development; IEA:Ensembl
P51160	PDE6C	Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'	GO:0007601; P:visual perception; TAS:ProtInc
O43924	PDE6D	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	GO:0004114; F:3',5'-cyclic-nucleotide phosphodiesterase activity; IEA:InterPro
O43924	PDE6D	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	GO:0005095; F:GTPase inhibitor activity; ISS:UniProtKB
O43924	PDE6D	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	GO:0005515; F:protein binding; IPI:UniProtKB
O43924	PDE6D	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	GO:0017137; F:Rab GTPase binding; IPI:UniProtKB
O43924	PDE6D	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	GO:0043086; P:negative regulation of catalytic activity; ISS:GOC
O43924	PDE6D	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	GO:0033124; P:regulation of GTP catabolic process; ISS:UniProtKB
O43924	PDE6D	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
O43924	PDE6D	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	GO:0007601; P:visual perception; TAS:ProtInc
Q13946	PDE7A	High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; TAS:UniProtKB
Q13946	PDE7A	High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13946	PDE7A	High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	GO:0006198; P:cAMP catabolic process; IEA:UniProtKB-UniPathway
Q13946	PDE7A	High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	GO:0007165; P:signal transduction; IEA:InterPro
Q9NP56	PDE7B	cAMP-specific 3',5'-cyclic phosphodiesterase 7B	GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; TAS:ProtInc
Q9NP56	PDE7B	cAMP-specific 3',5'-cyclic phosphodiesterase 7B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NP56	PDE7B	cAMP-specific 3',5'-cyclic phosphodiesterase 7B	GO:0006198; P:cAMP catabolic process; IEA:UniProtKB-UniPathway
Q9NP56	PDE7B	cAMP-specific 3',5'-cyclic phosphodiesterase 7B	GO:0007165; P:signal transduction; TAS:ProtInc
Q9NP56	PDE7B	cAMP-specific 3',5'-cyclic phosphodiesterase 7B	GO:0007268; P:synaptic transmission; TAS:ProtInc
O60658	PDE8A	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; IEA:Ensembl
O60658	PDE8A	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	GO:0004114; F:3',5'-cyclic-nucleotide phosphodiesterase activity; NAS:UniProtKB
O60658	PDE8A	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60658	PDE8A	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	GO:0000156; F:phosphorelay response regulator activity; IEA:InterPro
O60658	PDE8A	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	GO:0006198; P:cAMP catabolic process; IEA:UniProtKB-UniPathway
O60658	PDE8A	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	GO:0009187; P:cyclic nucleotide metabolic process; NAS:UniProtKB
O60658	PDE8A	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
O95263	PDE8B	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B	GO:0004114; F:3',5'-cyclic-nucleotide phosphodiesterase activity; NAS:UniProtKB
O95263	PDE8B	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95263	PDE8B	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B	GO:0000156; F:phosphorelay response regulator activity; IEA:InterPro
O95263	PDE8B	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B	GO:0006198; P:cAMP catabolic process; IEA:UniProtKB-UniPathway
O95263	PDE8B	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B	GO:0009187; P:cyclic nucleotide metabolic process; NAS:UniProtKB
O95263	PDE8B	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B	GO:0046676; P:negative regulation of insulin secretion; IEA:Ensembl
O76083	PDE9A	High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; IEA:UniProtKB-EC
O76083	PDE9A	High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	GO:0004114; F:3',5'-cyclic-nucleotide phosphodiesterase activity; TAS:ProtInc
O76083	PDE9A	High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O76083	PDE9A	High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	GO:0005515; F:protein binding; IPI:IntAct
O76083	PDE9A	High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	GO:0007596; P:blood coagulation; TAS:Reactome
O76083	PDE9A	High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	GO:0019934; P:cGMP-mediated signaling; IEA:Ensembl
O76083	PDE9A	High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	GO:0008152; P:metabolic process; TAS:GOC
O76083	PDE9A	High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	GO:0007165; P:signal transduction; TAS:ProtInc
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0005518; F:collagen binding; IDA:MGI
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0008083; F:growth factor activity; IDA:UniProtKB
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0048407; F:platelet-derived growth factor binding; IPI:BHF-UCL
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0005161; F:platelet-derived growth factor receptor binding; IDA:BHF-UCL
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0005515; F:protein binding; IPI:IntAct
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0030036; P:actin cytoskeleton organization; ISS:UniProtKB
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0001525; P:angiogenesis; ISS:UniProtKB
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0007596; P:blood coagulation; TAS:Reactome
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0001775; P:cell activation; TAS:BHF-UCL
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0030031; P:cell projection assembly; ISS:UniProtKB
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0009790; P:embryo development; TAS:BHF-UCL
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0001942; P:hair follicle development; ISS:UniProtKB
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0045087; P:innate immune response; TAS:Reactome
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0048839; P:inner ear development; IEA:Ensembl
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0048286; P:lung alveolus development; ISS:UniProtKB
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0050919; P:negative chemotaxis; IDA:BHF-UCL
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0010512; P:negative regulation of phosphatidylinositol biosynthetic process; IDA:BHF-UCL
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0010544; P:negative regulation of platelet activation; IDA:BHF-UCL
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0009887; P:organ morphogenesis; ISS:UniProtKB
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0030168; P:platelet activation; TAS:Reactome
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0002576; P:platelet degranulation; TAS:Reactome
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IDA:BHF-UCL
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0045740; P:positive regulation of DNA replication; IDA:BHF-UCL
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0048146; P:positive regulation of fibroblast proliferation; IDA:BHF-UCL
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0043406; P:positive regulation of MAP kinase activity; IDA:UniProtKB
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0043410; P:positive regulation of MAPK cascade; IMP:UniProtKB
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0002053; P:positive regulation of mesenchymal cell proliferation; ISS:UniProtKB
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0035793; P:positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway; IDA:UniProtKB
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IDA:UniProtKB
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0031954; P:positive regulation of protein autophosphorylation; IDA:UniProtKB
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:UniProtKB
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0032956; P:regulation of actin cytoskeleton organization; TAS:BHF-UCL
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0060683; P:regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling; ISS:UniProtKB
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; ISS:UniProtKB
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0014910; P:regulation of smooth muscle cell migration; IDA:BHF-UCL
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0042493; P:response to drug; IEA:Ensembl
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0032355; P:response to estradiol; IEA:Ensembl
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0001666; P:response to hypoxia; IEA:Ensembl
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0010035; P:response to inorganic substance; IEA:Ensembl
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0032526; P:response to retinoic acid; IEA:Ensembl
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0009611; P:response to wounding; IDA:BHF-UCL
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0043588; P:skin development; ISS:UniProtKB
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl
P04085	PDGFA	Platelet-derived growth factor subunit A	GO:0042060; P:wound healing; TAS:BHF-UCL
Q9NRA1	PDGFC	Platelet-derived growth factor C	GO:0005161; F:platelet-derived growth factor receptor binding; IPI:BHF-UCL
Q9NRA1	PDGFC	Platelet-derived growth factor C	GO:0005515; F:protein binding; IPI:IntAct
Q9NRA1	PDGFC	Platelet-derived growth factor C	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q9NRA1	PDGFC	Platelet-derived growth factor C	GO:0007171; P:activation of transmembrane receptor protein tyrosine kinase activity; IEA:Ensembl
Q9NRA1	PDGFC	Platelet-derived growth factor C	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
Q9NRA1	PDGFC	Platelet-derived growth factor C	GO:0007417; P:central nervous system development; TAS:UniProtKB
Q9NRA1	PDGFC	Platelet-derived growth factor C	GO:0009887; P:organ morphogenesis; IEA:Ensembl
Q9NRA1	PDGFC	Platelet-derived growth factor C	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IDA:BHF-UCL
Q9NRA1	PDGFC	Platelet-derived growth factor C	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
Q9NRA1	PDGFC	Platelet-derived growth factor C	GO:0045740; P:positive regulation of DNA replication; IDA:BHF-UCL
Q9NRA1	PDGFC	Platelet-derived growth factor C	GO:0048146; P:positive regulation of fibroblast proliferation; IDA:BHF-UCL
Q9NRA1	PDGFC	Platelet-derived growth factor C	GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
Q9GZP0	PDGFD	Platelet-derived growth factor D	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
Q9GZP0	PDGFD	Platelet-derived growth factor D	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9GZP0	PDGFD	Platelet-derived growth factor D	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IEA:InterPro
Q9GZP0	PDGFD	Platelet-derived growth factor D	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
Q9GZP0	PDGFD	Platelet-derived growth factor D	GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0042056; F:chemoattractant activity; IDA:BHF-UCL
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0005518; F:collagen binding; IDA:MGI
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0008083; F:growth factor activity; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0042802; F:identical protein binding; IPI:IntAct
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0048407; F:platelet-derived growth factor binding; IPI:BHF-UCL
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0005161; F:platelet-derived growth factor receptor binding; NAS:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0005515; F:protein binding; IPI:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0016176; F:superoxide-generating NADPH oxidase activator activity; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0032147; P:activation of protein kinase activity; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0032148; P:activation of protein kinase B activity; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0007596; P:blood coagulation; TAS:Reactome
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0048514; P:blood vessel morphogenesis; IEA:Ensembl
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0060445; P:branching involved in salivary gland morphogenesis; IEA:Ensembl
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0060326; P:cell chemotaxis; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0016049; P:cell growth; IEA:Ensembl
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0030031; P:cell projection assembly; IEA:Ensembl
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0071363; P:cellular response to growth factor stimulus; IDA:BHF-UCL
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0071506; P:cellular response to mycophenolic acid; ISS:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0006260; P:DNA replication; IEA:Ensembl
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0001892; P:embryonic placenta development; ISS:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0060664; P:epithelial cell proliferation involved in salivary gland morphogenesis; IEA:Ensembl
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0007507; P:heart development; ISS:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0045087; P:innate immune response; TAS:Reactome
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0072264; P:metanephric glomerular endothelium development; IEA:Ensembl
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0072255; P:metanephric glomerular mesangial cell development; ISS:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0072262; P:metanephric glomerular mesangial cell proliferation involved in metanephros development; IEA:Ensembl
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0002548; P:monocyte chemotaxis; IDA:BHF-UCL
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0010512; P:negative regulation of phosphatidylinositol biosynthetic process; IDA:BHF-UCL
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0010544; P:negative regulation of platelet activation; IDA:BHF-UCL
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0038001; P:paracrine signaling; ISS:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0030168; P:platelet activation; TAS:Reactome
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0002576; P:platelet degranulation; TAS:Reactome
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IDA:BHF-UCL
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0050918; P:positive chemotaxis; IDA:GOC
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IDA:BHF-UCL
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0090280; P:positive regulation of calcium ion import; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0050921; P:positive regulation of chemotaxis; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0045737; P:positive regulation of cyclin-dependent protein kinase activity; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:2000573; P:positive regulation of DNA biosynthetic process; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0045740; P:positive regulation of DNA replication; IDA:BHF-UCL
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:BHF-UCL
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0045743; P:positive regulation of fibroblast growth factor receptor signaling pathway; IEA:Ensembl
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0048146; P:positive regulation of fibroblast proliferation; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0003104; P:positive regulation of glomerular filtration; ISS:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0072126; P:positive regulation of glomerular mesangial cell proliferation; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:1900127; P:positive regulation of hyaluronan biosynthetic process; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0043406; P:positive regulation of MAP kinase activity; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0043410; P:positive regulation of MAPK cascade; IMP:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:2000591; P:positive regulation of metanephric mesenchymal cell migration; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0035793; P:positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0045840; P:positive regulation of mitosis; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0031954; P:positive regulation of protein autophosphorylation; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0061098; P:positive regulation of protein tyrosine kinase activity; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0014911; P:positive regulation of smooth muscle cell migration; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0072593; P:reactive oxygen species metabolic process; IMP:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0042493; P:response to drug; IEA:Ensembl
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0032355; P:response to estradiol; IEA:Ensembl
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0001666; P:response to hypoxia; IEA:Ensembl
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0032868; P:response to insulin; IEA:Ensembl
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0009611; P:response to wounding; NAS:UniProtKB
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0006929; P:substrate-dependent cell migration; IEA:Ensembl
P01127	PDGFB	Platelet-derived growth factor subunit B	GO:0007179; P:transforming growth factor beta receptor signaling pathway; ISS:UniProtKB
P07237	P4HB	Protein disulfide-isomerase	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P07237	P4HB	Protein disulfide-isomerase	GO:0004656; F:procollagen-proline 4-dioxygenase activity; TAS:ProtInc
P07237	P4HB	Protein disulfide-isomerase	GO:0005515; F:protein binding; IPI:IntAct
P07237	P4HB	Protein disulfide-isomerase	GO:0003756; F:protein disulfide isomerase activity; IBA:RefGenome
P07237	P4HB	Protein disulfide-isomerase	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
P07237	P4HB	Protein disulfide-isomerase	GO:0045454; P:cell redox homeostasis; IEA:InterPro
P07237	P4HB	Protein disulfide-isomerase	GO:0071456; P:cellular response to hypoxia; IMP:BHF-UCL
P07237	P4HB	Protein disulfide-isomerase	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P07237	P4HB	Protein disulfide-isomerase	GO:0006662; P:glycerol ether metabolic process; IEA:InterPro
P07237	P4HB	Protein disulfide-isomerase	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
P07237	P4HB	Protein disulfide-isomerase	GO:0018401; P:peptidyl-proline hydroxylation to 4-hydroxy-L-proline; IDA:MGI
P07237	P4HB	Protein disulfide-isomerase	GO:0006457; P:protein folding; IBA:RefGenome
P07237	P4HB	Protein disulfide-isomerase	GO:1902175; P:regulation of intrinsic apoptotic signaling pathway in response to oxidative stress; IMP:BHF-UCL
P07237	P4HB	Protein disulfide-isomerase	GO:0034976; P:response to endoplasmic reticulum stress; IMP:BHF-UCL
P07237	P4HB	Protein disulfide-isomerase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q13087	PDIA2	Protein disulfide-isomerase A2	GO:0005515; F:protein binding; IPI:IntAct
Q13087	PDIA2	Protein disulfide-isomerase A2	GO:0003756; F:protein disulfide isomerase activity; IBA:RefGenome
Q13087	PDIA2	Protein disulfide-isomerase A2	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
Q13087	PDIA2	Protein disulfide-isomerase A2	GO:0005496; F:steroid binding; IEA:UniProtKB-KW
Q13087	PDIA2	Protein disulfide-isomerase A2	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q13087	PDIA2	Protein disulfide-isomerase A2	GO:0006662; P:glycerol ether metabolic process; IEA:InterPro
Q13087	PDIA2	Protein disulfide-isomerase A2	GO:0019511; P:peptidyl-proline hydroxylation; IBA:GOC
Q13087	PDIA2	Protein disulfide-isomerase A2	GO:0006457; P:protein folding; IBA:RefGenome
Q13087	PDIA2	Protein disulfide-isomerase A2	GO:0006621; P:protein retention in ER lumen; TAS:ProtInc
Q13087	PDIA2	Protein disulfide-isomerase A2	GO:1902175; P:regulation of intrinsic apoptotic signaling pathway in response to oxidative stress; IBA:RefGenome
Q13087	PDIA2	Protein disulfide-isomerase A2	GO:0034976; P:response to endoplasmic reticulum stress; IBA:RefGenome
P30101	PDIA3	Protein disulfide-isomerase A3	GO:0004197; F:cysteine-type endopeptidase activity; TAS:ProtInc
P30101	PDIA3	Protein disulfide-isomerase A3	GO:0004629; F:phospholipase C activity; TAS:ProtInc
P30101	PDIA3	Protein disulfide-isomerase A3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P30101	PDIA3	Protein disulfide-isomerase A3	GO:0005515; F:protein binding; IPI:UniProtKB
P30101	PDIA3	Protein disulfide-isomerase A3	GO:0003756; F:protein disulfide isomerase activity; IBA:RefGenome
P30101	PDIA3	Protein disulfide-isomerase A3	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
P30101	PDIA3	Protein disulfide-isomerase A3	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P30101	PDIA3	Protein disulfide-isomerase A3	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P30101	PDIA3	Protein disulfide-isomerase A3	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P30101	PDIA3	Protein disulfide-isomerase A3	GO:0045454; P:cell redox homeostasis; IEA:InterPro
P30101	PDIA3	Protein disulfide-isomerase A3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P30101	PDIA3	Protein disulfide-isomerase A3	GO:0006662; P:glycerol ether metabolic process; IEA:InterPro
P30101	PDIA3	Protein disulfide-isomerase A3	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl
P30101	PDIA3	Protein disulfide-isomerase A3	GO:0043687; P:post-translational protein modification; TAS:Reactome
P30101	PDIA3	Protein disulfide-isomerase A3	GO:0006457; P:protein folding; IBA:RefGenome
P30101	PDIA3	Protein disulfide-isomerase A3	GO:0006606; P:protein import into nucleus; TAS:ProtInc
P30101	PDIA3	Protein disulfide-isomerase A3	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
P30101	PDIA3	Protein disulfide-isomerase A3	GO:0006621; P:protein retention in ER lumen; TAS:ProtInc
P30101	PDIA3	Protein disulfide-isomerase A3	GO:0006508; P:proteolysis; TAS:GOC
P30101	PDIA3	Protein disulfide-isomerase A3	GO:0034976; P:response to endoplasmic reticulum stress; IBA:RefGenome
P30101	PDIA3	Protein disulfide-isomerase A3	GO:0007165; P:signal transduction; TAS:ProtInc
P13667	PDIA4	Protein disulfide-isomerase A4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P13667	PDIA4	Protein disulfide-isomerase A4	GO:0005515; F:protein binding; IPI:IntAct
P13667	PDIA4	Protein disulfide-isomerase A4	GO:0003756; F:protein disulfide isomerase activity; ISS:UniProt
P13667	PDIA4	Protein disulfide-isomerase A4	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
P13667	PDIA4	Protein disulfide-isomerase A4	GO:0045454; P:cell redox homeostasis; IEA:InterPro
P13667	PDIA4	Protein disulfide-isomerase A4	GO:0061077; P:chaperone-mediated protein folding; ISS:UniProt
P13667	PDIA4	Protein disulfide-isomerase A4	GO:0006662; P:glycerol ether metabolic process; IEA:InterPro
P13667	PDIA4	Protein disulfide-isomerase A4	GO:0006457; P:protein folding; IBA:RefGenome
P13667	PDIA4	Protein disulfide-isomerase A4	GO:0009306; P:protein secretion; TAS:ProtInc
P13667	PDIA4	Protein disulfide-isomerase A4	GO:0034976; P:response to endoplasmic reticulum stress; IBA:RefGenome
Q14554	PDIA5	Protein disulfide-isomerase A5	GO:0016491; F:oxidoreductase activity; TAS:UniProtKB
Q14554	PDIA5	Protein disulfide-isomerase A5	GO:0003756; F:protein disulfide isomerase activity; TAS:UniProtKB
Q14554	PDIA5	Protein disulfide-isomerase A5	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
Q14554	PDIA5	Protein disulfide-isomerase A5	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q14554	PDIA5	Protein disulfide-isomerase A5	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q14554	PDIA5	Protein disulfide-isomerase A5	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q14554	PDIA5	Protein disulfide-isomerase A5	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q14554	PDIA5	Protein disulfide-isomerase A5	GO:0006662; P:glycerol ether metabolic process; IEA:InterPro
Q14554	PDIA5	Protein disulfide-isomerase A5	GO:0055114; P:oxidation-reduction process; TAS:UniProtKB
Q14554	PDIA5	Protein disulfide-isomerase A5	GO:0006457; P:protein folding; TAS:UniProtKB
Q14554	PDIA5	Protein disulfide-isomerase A5	GO:0034976; P:response to endoplasmic reticulum stress; IBA:RefGenome
Q15084	PDIA6	Protein disulfide-isomerase A6	GO:0016853; F:isomerase activity; IEA:UniProtKB-KW
Q15084	PDIA6	Protein disulfide-isomerase A6	GO:0005515; F:protein binding; IPI:UniProtKB
Q15084	PDIA6	Protein disulfide-isomerase A6	GO:0003756; F:protein disulfide isomerase activity; IBA:RefGenome
Q15084	PDIA6	Protein disulfide-isomerase A6	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
Q15084	PDIA6	Protein disulfide-isomerase A6	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q15084	PDIA6	Protein disulfide-isomerase A6	GO:0043277; P:apoptotic cell clearance; IBA:RefGenome
Q15084	PDIA6	Protein disulfide-isomerase A6	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q15084	PDIA6	Protein disulfide-isomerase A6	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q15084	PDIA6	Protein disulfide-isomerase A6	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q15084	PDIA6	Protein disulfide-isomerase A6	GO:0006662; P:glycerol ether metabolic process; IEA:InterPro
Q15084	PDIA6	Protein disulfide-isomerase A6	GO:0006457; P:protein folding; IBA:RefGenome
Q15084	PDIA6	Protein disulfide-isomerase A6	GO:0034976; P:response to endoplasmic reticulum stress; IBA:RefGenome
Q8N807	PDILT	Protein disulfide-isomerase-like protein of the testis	GO:0003756; F:protein disulfide isomerase activity; IBA:RefGenome
Q8N807	PDILT	Protein disulfide-isomerase-like protein of the testis	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8N807	PDILT	Protein disulfide-isomerase-like protein of the testis	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q8N807	PDILT	Protein disulfide-isomerase-like protein of the testis	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8N807	PDILT	Protein disulfide-isomerase-like protein of the testis	GO:0006457; P:protein folding; IBA:RefGenome
Q8N807	PDILT	Protein disulfide-isomerase-like protein of the testis	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q9Y2S7	POLDIP2	Polymerase delta-interacting protein 2	GO:0003677; F:DNA binding; IEA:InterPro
Q9BY77	POLDIP3	Polymerase delta-interacting protein 3	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9BY77	POLDIP3	Polymerase delta-interacting protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BY77	POLDIP3	Polymerase delta-interacting protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BY77	POLDIP3	Polymerase delta-interacting protein 3	GO:0016973; P:poly(A)+ mRNA export from nucleus; IDA:UniProtKB
Q9BY77	POLDIP3	Polymerase delta-interacting protein 3	GO:0045727; P:positive regulation of translation; IMP:UniProtKB
Q8N165	PDIK1L	Serine/threonine-protein kinase PDIK1L	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8N165	PDIK1L	Serine/threonine-protein kinase PDIK1L	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q15118	PDK1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q15118	PDK1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q15118	PDK1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q15118	PDK1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q15118	PDK1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	GO:0004740; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity; IDA:UniProtKB
Q15118	PDK1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	GO:0008283; P:cell proliferation; IMP:UniProtKB
Q15118	PDK1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q15118	PDK1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	GO:0006006; P:glucose metabolic process; TAS:ProtInc
Q15118	PDK1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	GO:0097411; P:hypoxia-inducible factor-1alpha signaling pathway; IMP:UniProtKB
Q15118	PDK1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IMP:UniProtKB
Q15118	PDK1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	GO:0006468; P:protein phosphorylation; IDA:GOC
Q15118	PDK1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	GO:0006090; P:pyruvate metabolic process; TAS:Reactome
Q15118	PDK1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	GO:0010510; P:regulation of acetyl-CoA biosynthetic process from pyruvate; TAS:Reactome
Q15118	PDK1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	GO:0010906; P:regulation of glucose metabolic process; IMP:UniProtKB
Q15118	PDK1	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15119	PDK2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	GO:0005524; F:ATP binding; IDA:UniProtKB
Q15119	PDK2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q15119	PDK2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q15119	PDK2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q15119	PDK2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	GO:0004740; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity; IDA:UniProtKB
Q15119	PDK2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q15119	PDK2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	GO:0031670; P:cellular response to nutrient; ISS:UniProtKB
Q15119	PDK2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	GO:0034614; P:cellular response to reactive oxygen species; IMP:UniProtKB
Q15119	PDK2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	GO:0042593; P:glucose homeostasis; ISS:UniProtKB
Q15119	PDK2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	GO:0006006; P:glucose metabolic process; TAS:ProtInc
Q15119	PDK2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	GO:0008286; P:insulin receptor signaling pathway; ISS:UniProtKB
Q15119	PDK2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IMP:UniProtKB
Q15119	PDK2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	GO:0006468; P:protein phosphorylation; IDA:GOC
Q15119	PDK2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	GO:0006090; P:pyruvate metabolic process; TAS:Reactome
Q15119	PDK2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	GO:0010510; P:regulation of acetyl-CoA biosynthetic process from pyruvate; ISS:UniProtKB
Q15119	PDK2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	GO:0010565; P:regulation of cellular ketone metabolic process; ISS:UniProtKB
Q15119	PDK2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	GO:0006111; P:regulation of gluconeogenesis; ISS:UniProtKB
Q15119	PDK2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	GO:0010906; P:regulation of glucose metabolic process; ISS:UniProtKB
Q15119	PDK2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	GO:0006885; P:regulation of pH; ISS:UniProtKB
Q15119	PDK2	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15120	PDK3	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	GO:0005524; F:ATP binding; IDA:UniProtKB
Q15120	PDK3	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q15120	PDK3	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q15120	PDK3	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q15120	PDK3	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	GO:0004740; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity; IDA:UniProtKB
Q15120	PDK3	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q15120	PDK3	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q15120	PDK3	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	GO:0071398; P:cellular response to fatty acid; IMP:UniProtKB
Q15120	PDK3	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	GO:0071333; P:cellular response to glucose stimulus; ISS:UniProtKB
Q15120	PDK3	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW
Q15120	PDK3	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	GO:0097411; P:hypoxia-inducible factor-1alpha signaling pathway; IMP:UniProtKB
Q15120	PDK3	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB
Q15120	PDK3	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	GO:0035357; P:peroxisome proliferator activated receptor signaling pathway; IMP:UniProtKB
Q15120	PDK3	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	GO:0006090; P:pyruvate metabolic process; TAS:Reactome
Q15120	PDK3	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	GO:0010510; P:regulation of acetyl-CoA biosynthetic process from pyruvate; IMP:UniProtKB
Q15120	PDK3	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	GO:0010906; P:regulation of glucose metabolic process; IMP:UniProtKB
Q15120	PDK3	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	GO:2000377; P:regulation of reactive oxygen species metabolic process; IMP:UniProtKB
Q15120	PDK3	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0005524; F:ATP binding; IDA:UniProtKB
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0004740; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity; ISS:UniProtKB
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0071398; P:cellular response to fatty acid; IMP:UniProtKB
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0009267; P:cellular response to starvation; IDA:UniProtKB
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0042593; P:glucose homeostasis; ISS:UniProtKB
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0008286; P:insulin receptor signaling pathway; IMP:UniProtKB
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:2000811; P:negative regulation of anoikis; IMP:UniProtKB
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0006468; P:protein phosphorylation; IDA:GOC
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0006090; P:pyruvate metabolic process; TAS:Reactome
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0072593; P:reactive oxygen species metabolic process; IMP:UniProtKB
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0010510; P:regulation of acetyl-CoA biosynthetic process from pyruvate; IMP:UniProtKB
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0045124; P:regulation of bone resorption; IEA:Ensembl
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0010565; P:regulation of cellular ketone metabolic process; ISS:UniProtKB
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0042304; P:regulation of fatty acid biosynthetic process; IMP:UniProtKB
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0046320; P:regulation of fatty acid oxidation; ISS:UniProtKB
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0010906; P:regulation of glucose metabolic process; IMP:UniProtKB
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0006885; P:regulation of pH; ISS:UniProtKB
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0042594; P:response to starvation; ISS:UniProtKB
Q16654	PDK4	[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00151	PDLIM1	PDZ and LIM domain protein 1	GO:0003713; F:transcription coactivator activity; IEA:Ensembl
O00151	PDLIM1	PDZ and LIM domain protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
O00151	PDLIM1	PDZ and LIM domain protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:Ensembl
O00151	PDLIM1	PDZ and LIM domain protein 1	GO:0001666; P:response to hypoxia; IEA:Ensembl
O00151	PDLIM1	PDZ and LIM domain protein 1	GO:0006979; P:response to oxidative stress; TAS:ProtInc
Q96JY6	PDLIM2	PDZ and LIM domain protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q53GG5	PDLIM3	PDZ and LIM domain protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q53GG5	PDLIM3	PDZ and LIM domain protein 3	GO:0008307; F:structural constituent of muscle; IEA:Ensembl
Q53GG5	PDLIM3	PDZ and LIM domain protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q53GG5	PDLIM3	PDZ and LIM domain protein 3	GO:0007015; P:actin filament organization; IEA:Ensembl
Q53GG5	PDLIM3	PDZ and LIM domain protein 3	GO:0007507; P:heart development; IEA:Ensembl
P50479	PDLIM4	PDZ and LIM domain protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
P50479	PDLIM4	PDZ and LIM domain protein 4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96HC4	PDLIM5	PDZ and LIM domain protein 5	GO:0003779; F:actin binding; ISS:UniProtKB
Q96HC4	PDLIM5	PDZ and LIM domain protein 5	GO:0042805; F:actinin binding; ISS:UniProtKB
Q96HC4	PDLIM5	PDZ and LIM domain protein 5	GO:0005080; F:protein kinase C binding; ISS:UniProtKB
Q96HC4	PDLIM5	PDZ and LIM domain protein 5	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96HC4	PDLIM5	PDZ and LIM domain protein 5	GO:0061001; P:regulation of dendritic spine morphogenesis; ISS:UniProtKB
Q96HC4	PDLIM5	PDZ and LIM domain protein 5	GO:0051963; P:regulation of synapse assembly; ISS:UniProtKB
Q9NR12	PDLIM7	PDZ and LIM domain protein 7	GO:0005515; F:protein binding; IPI:IntAct
Q9NR12	PDLIM7	PDZ and LIM domain protein 7	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NR12	PDLIM7	PDZ and LIM domain protein 7	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
Q9NR12	PDLIM7	PDZ and LIM domain protein 7	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9NR12	PDLIM7	PDZ and LIM domain protein 7	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9NR12	PDLIM7	PDZ and LIM domain protein 7	GO:0001503; P:ossification; IEA:UniProtKB-KW
Q9NR12	PDLIM7	PDZ and LIM domain protein 7	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
Q9NR12	PDLIM7	PDZ and LIM domain protein 7	GO:0006898; P:receptor-mediated endocytosis; TAS:ProtInc
Q9P0J1	PDP1	[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial	GO:0004741; F:[pyruvate dehydrogenase (lipoamide)] phosphatase activity; IEA:UniProtKB-EC
Q9P0J1	PDP1	[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9P0J1	PDP1	[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial	GO:0004722; F:protein serine/threonine phosphatase activity; IDA:UniProtKB
Q9P0J1	PDP1	[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q9P0J1	PDP1	[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial	GO:0035970; P:peptidyl-threonine dephosphorylation; IDA:UniProtKB
Q9P0J1	PDP1	[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial	GO:0006090; P:pyruvate metabolic process; TAS:Reactome
Q9P0J1	PDP1	[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial	GO:0010510; P:regulation of acetyl-CoA biosynthetic process from pyruvate; TAS:Reactome
Q9P0J1	PDP1	[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9P2J9	PDP2	[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 2, mitochondrial	GO:0004741; F:[pyruvate dehydrogenase (lipoamide)] phosphatase activity; IEA:UniProtKB-EC
Q9P2J9	PDP2	[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 2, mitochondrial	GO:0004724; F:magnesium-dependent protein serine/threonine phosphatase activity; IEA:Ensembl
Q9P2J9	PDP2	[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 2, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9P2J9	PDP2	[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 2, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q9P2J9	PDP2	[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 2, mitochondrial	GO:0035970; P:peptidyl-threonine dephosphorylation; IEA:Ensembl
Q9P2J9	PDP2	[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 2, mitochondrial	GO:0006090; P:pyruvate metabolic process; TAS:Reactome
Q9P2J9	PDP2	[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 2, mitochondrial	GO:0010510; P:regulation of acetyl-CoA biosynthetic process from pyruvate; TAS:Reactome
Q9P2J9	PDP2	[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 2, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0004676; F:3-phosphoinositide-dependent protein kinase activity; IDA:BHF-UCL
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0016301; F:kinase activity; EXP:Reactome
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0005515; F:protein binding; IPI:UniProtKB
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0004674; F:protein serine/threonine kinase activity; IDA:BHF-UCL
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0032148; P:activation of protein kinase B activity; IDA:BHF-UCL
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0007596; P:blood coagulation; TAS:Reactome
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0032869; P:cellular response to insulin stimulus; IMP:BHF-UCL
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0097191; P:extrinsic apoptotic signaling pathway; IMP:UniProtKB
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0048041; P:focal adhesion assembly; IEA:Ensembl
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0006972; P:hyperosmotic response; IEA:Ensembl
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0045087; P:innate immune response; TAS:Reactome
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0035556; P:intracellular signal transduction; IDA:MGI
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IEA:Ensembl
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0006469; P:negative regulation of protein kinase activity; IDA:BHF-UCL
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0034122; P:negative regulation of toll-like receptor signaling pathway; IEA:Ensembl
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0018107; P:peptidyl-threonine phosphorylation; IDA:BHF-UCL
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0030168; P:platelet activation; TAS:Reactome
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; IMP:BHF-UCL
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0046777; P:protein autophosphorylation; TAS:UniProtKB
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0010594; P:regulation of endothelial cell migration; IEA:Ensembl
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0043122; P:regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0043304; P:regulation of mast cell degranulation; IEA:Ensembl
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0007268; P:synaptic transmission; TAS:Reactome
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0031295; P:T cell costimulation; TAS:Reactome
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15530	PDPK1	3-phosphoinositide-dependent protein kinase 1	GO:0003323; P:type B pancreatic cell development; IEA:Ensembl
Q6A1A2	PDPK2	Putative 3-phosphoinositide-dependent protein kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6A1A2	PDPK2	Putative 3-phosphoinositide-dependent protein kinase 2	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q86YL7	PDPN	Podoplanin	GO:0000902; P:cell morphogenesis; ISS:UniProtKB
Q86YL7	PDPN	Podoplanin	GO:0008283; P:cell proliferation; IEA:Ensembl
Q86YL7	PDPN	Podoplanin	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
Q86YL7	PDPN	Podoplanin	GO:0006928; P:cellular component movement; IEA:Ensembl
Q86YL7	PDPN	Podoplanin	GO:0009790; P:embryo development; IEA:Ensembl
Q86YL7	PDPN	Podoplanin	GO:0006954; P:inflammatory response; IEA:Ensembl
Q86YL7	PDPN	Podoplanin	GO:0048286; P:lung alveolus development; IEA:Ensembl
Q86YL7	PDPN	Podoplanin	GO:0030324; P:lung development; ISS:UniProtKB
Q86YL7	PDPN	Podoplanin	GO:0001946; P:lymphangiogenesis; ISS:UniProtKB
Q86YL7	PDPN	Podoplanin	GO:0007399; P:nervous system development; IEA:Ensembl
Q86YL7	PDPN	Podoplanin	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
Q86YL7	PDPN	Podoplanin	GO:0051272; P:positive regulation of cellular component movement; ISS:UniProtKB
Q86YL7	PDPN	Podoplanin	GO:0010572; P:positive regulation of platelet activation; IEA:Ensembl
Q86YL7	PDPN	Podoplanin	GO:0006693; P:prostaglandin metabolic process; IEA:Ensembl
Q86YL7	PDPN	Podoplanin	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
Q86YL7	PDPN	Podoplanin	GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl
Q86YL7	PDPN	Podoplanin	GO:0055093; P:response to hyperoxia; IEA:Ensembl
Q86YL7	PDPN	Podoplanin	GO:0007165; P:signal transduction; IEA:Ensembl
Q86YL7	PDPN	Podoplanin	GO:0035239; P:tube morphogenesis; IEA:Ensembl
Q8NCN5	PDPR	Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial	GO:0004047; F:aminomethyltransferase activity; IEA:InterPro
Q8NCN5	PDPR	Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial	GO:0016491; F:oxidoreductase activity; IEA:InterPro
Q8NCN5	PDPR	Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q8NCN5	PDPR	Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial	GO:0006546; P:glycine catabolic process; IEA:InterPro
Q8NCN5	PDPR	Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial	GO:0006090; P:pyruvate metabolic process; TAS:Reactome
Q8NCN5	PDPR	Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial	GO:0010510; P:regulation of acetyl-CoA biosynthetic process from pyruvate; TAS:Reactome
Q8NCN5	PDPR	Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NUG6	PDRG1	p53 and DNA damage-regulated protein 1	GO:0006457; P:protein folding; IEA:InterPro
Q29RF7	PDS5A	Sister chromatid cohesion protein PDS5 homolog A	GO:0005515; F:protein binding; IPI:UniProtKB
Q29RF7	PDS5A	Sister chromatid cohesion protein PDS5 homolog A	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q29RF7	PDS5A	Sister chromatid cohesion protein PDS5 homolog A	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q29RF7	PDS5A	Sister chromatid cohesion protein PDS5 homolog A	GO:0008156; P:negative regulation of DNA replication; IMP:UniProtKB
Q9NTI5	PDS5B	Sister chromatid cohesion protein PDS5 homolog B	GO:0005524; F:ATP binding; TAS:ProtInc
Q9NTI5	PDS5B	Sister chromatid cohesion protein PDS5 homolog B	GO:0003677; F:DNA binding; TAS:ProtInc
Q9NTI5	PDS5B	Sister chromatid cohesion protein PDS5 homolog B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NTI5	PDS5B	Sister chromatid cohesion protein PDS5 homolog B	GO:0008283; P:cell proliferation; TAS:ProtInc
Q9NTI5	PDS5B	Sister chromatid cohesion protein PDS5 homolog B	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9NTI5	PDS5B	Sister chromatid cohesion protein PDS5 homolog B	GO:0007064; P:mitotic sister chromatid cohesion; IMP:UniProtKB
Q9NTI5	PDS5B	Sister chromatid cohesion protein PDS5 homolog B	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q9NTI5	PDS5B	Sister chromatid cohesion protein PDS5 homolog B	GO:0042127; P:regulation of cell proliferation; IDA:MGI
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0003682; F:chromatin binding; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0001046; F:core promoter sequence-specific DNA binding; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:BHF-UCL
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0007417; P:central nervous system development; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0051594; P:detection of glucose; ISS:BHF-UCL
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0048565; P:digestive tract development; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0031018; P:endocrine pancreas development; TAS:Reactome
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0031017; P:exocrine pancreas development; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0042593; P:glucose homeostasis; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0006006; P:glucose metabolic process; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0030073; P:insulin secretion; IDA:BHF-UCL
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0001889; P:liver development; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0016331; P:morphogenesis of embryonic epithelium; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0007263; P:nitric oxide mediated signal transduction; IDA:BHF-UCL
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0031100; P:organ regeneration; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0010260; P:organ senescence; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0010942; P:positive regulation of cell death; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0043388; P:positive regulation of DNA binding; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0010157; P:response to chlorate; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0034097; P:response to cytokine; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0042493; P:response to drug; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0070542; P:response to fatty acid; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0010040; P:response to iron(II) ion; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0043201; P:response to leucine; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0035094; P:response to nicotine; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0033273; P:response to vitamin; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0009611; P:response to wounding; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0048863; P:stem cell differentiation; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0060290; P:transdifferentiation; IEA:Ensembl
P52945	PDX1	Pancreas/duodenum homeobox protein 1	GO:0003309; P:type B pancreatic cell differentiation; IDA:BHF-UCL
Q6P996	PDXDC1	Pyridoxal-dependent decarboxylase domain-containing protein 1	GO:0016831; F:carboxy-lyase activity; IEA:UniProtKB-KW
Q6P996	PDXDC1	Pyridoxal-dependent decarboxylase domain-containing protein 1	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q6P996	PDXDC1	Pyridoxal-dependent decarboxylase domain-containing protein 1	GO:0019752; P:carboxylic acid metabolic process; IEA:InterPro
Q6P474	PDXDC2P	Putative pyridoxal-dependent decarboxylase domain-containing protein 2	GO:0016831; F:carboxy-lyase activity; IEA:UniProtKB-KW
Q6P474	PDXDC2P	Putative pyridoxal-dependent decarboxylase domain-containing protein 2	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q6P474	PDXDC2P	Putative pyridoxal-dependent decarboxylase domain-containing protein 2	GO:0019752; P:carboxylic acid metabolic process; IEA:InterPro
O00764	PDXK	Pyridoxal kinase	GO:0005524; F:ATP binding; IDA:UniProtKB
O00764	PDXK	Pyridoxal kinase	GO:0031403; F:lithium ion binding; IDA:UniProtKB
O00764	PDXK	Pyridoxal kinase	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
O00764	PDXK	Pyridoxal kinase	GO:0030955; F:potassium ion binding; IDA:UniProtKB
O00764	PDXK	Pyridoxal kinase	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O00764	PDXK	Pyridoxal kinase	GO:0008478; F:pyridoxal kinase activity; IDA:UniProtKB
O00764	PDXK	Pyridoxal kinase	GO:0030170; F:pyridoxal phosphate binding; IDA:UniProtKB
O00764	PDXK	Pyridoxal kinase	GO:0031402; F:sodium ion binding; IDA:UniProtKB
O00764	PDXK	Pyridoxal kinase	GO:0008270; F:zinc ion binding; IDA:UniProtKB
O00764	PDXK	Pyridoxal kinase	GO:0008283; P:cell proliferation; IDA:UniProtKB
O00764	PDXK	Pyridoxal kinase	GO:0009443; P:pyridoxal 5'-phosphate salvage; IEA:InterPro
O00764	PDXK	Pyridoxal kinase	GO:0042823; P:pyridoxal phosphate biosynthetic process; IDA:UniProtKB
O00764	PDXK	Pyridoxal kinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00764	PDXK	Pyridoxal kinase	GO:0042816; P:vitamin B6 metabolic process; IC:UniProtKB
O00764	PDXK	Pyridoxal kinase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
O00764	PDXK	Pyridoxal kinase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9NZ53	PODXL2	Podocalyxin-like protein 2	GO:0005539; F:glycosaminoglycan binding; TAS:ProtInc
Q9NZ53	PODXL2	Podocalyxin-like protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NZ53	PODXL2	Podocalyxin-like protein 2	GO:0050901; P:leukocyte tethering or rolling; IDA:UniProtKB
P01213	PDYN	Proenkephalin-B	GO:0008219; P:cell death; IEA:UniProtKB-KW
P01213	PDYN	Proenkephalin-B	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
P01213	PDYN	Proenkephalin-B	GO:0007268; P:synaptic transmission; IEA:UniProtKB-KW
Q5EBL8	PDZD11	PDZ domain-containing protein 11	GO:0005515; F:protein binding; IPI:IntAct
Q5EBL8	PDZD11	PDZ domain-containing protein 11	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
O15018	PDZD2	PDZ domain-containing protein 2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9H5P4	PDZD7	PDZ domain-containing protein 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NEN9	PDZD8	PDZ domain-containing protein 8	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NEN9	PDZD8	PDZ domain-containing protein 8	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q8NEN9	PDZD8	PDZ domain-containing protein 8	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8NEN9	PDZD8	PDZ domain-containing protein 8	GO:0022604; P:regulation of cell morphogenesis; IMP:UniProtKB
Q8NEN9	PDZD8	PDZ domain-containing protein 8	GO:0016032; P:viral process; IEA:UniProtKB-KW
P34995	PTGER1	Prostaglandin E2 receptor EP1 subtype	GO:0004957; F:prostaglandin E receptor activity; TAS:ProtInc
P34995	PTGER1	Prostaglandin E2 receptor EP1 subtype	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P34995	PTGER1	Prostaglandin E2 receptor EP1 subtype	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P43116	PTGER2	Prostaglandin E2 receptor EP2 subtype	GO:0004957; F:prostaglandin E receptor activity; TAS:ProtInc
P43116	PTGER2	Prostaglandin E2 receptor EP2 subtype	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; ISS:BHF-UCL
P43116	PTGER2	Prostaglandin E2 receptor EP2 subtype	GO:0071380; P:cellular response to prostaglandin E stimulus; ISS:BHF-UCL
P43116	PTGER2	Prostaglandin E2 receptor EP2 subtype	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P43116	PTGER2	Prostaglandin E2 receptor EP2 subtype	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P43116	PTGER2	Prostaglandin E2 receptor EP2 subtype	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P43115	PTGER3	Prostaglandin E2 receptor EP3 subtype	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; TAS:ProtInc
P43115	PTGER3	Prostaglandin E2 receptor EP3 subtype	GO:0004957; F:prostaglandin E receptor activity; NAS:UniProtKB
P43115	PTGER3	Prostaglandin E2 receptor EP3 subtype	GO:0008219; P:cell death; TAS:ProtInc
P43115	PTGER3	Prostaglandin E2 receptor EP3 subtype	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P43115	PTGER3	Prostaglandin E2 receptor EP3 subtype	GO:0030522; P:intracellular receptor signaling pathway; TAS:GOC
P43115	PTGER3	Prostaglandin E2 receptor EP3 subtype	GO:0031622; P:positive regulation of fever generation; ISS:BHF-UCL
P43115	PTGER3	Prostaglandin E2 receptor EP3 subtype	GO:0006351; P:transcription, DNA-templated; TAS:ProtInc
P35408	PTGER4	Prostaglandin E2 receptor EP4 subtype	GO:0004957; F:prostaglandin E receptor activity; IDA:UniProtKB
P35408	PTGER4	Prostaglandin E2 receptor EP4 subtype	GO:0005515; F:protein binding; IPI:UniProtKB
P35408	PTGER4	Prostaglandin E2 receptor EP4 subtype	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IDA:UniProtKB
P35408	PTGER4	Prostaglandin E2 receptor EP4 subtype	GO:0060348; P:bone development; ISS:UniProtKB
P35408	PTGER4	Prostaglandin E2 receptor EP4 subtype	GO:0071260; P:cellular response to mechanical stimulus; ISS:UniProtKB
P35408	PTGER4	Prostaglandin E2 receptor EP4 subtype	GO:0070371; P:ERK1 and ERK2 cascade; ISS:UniProtKB
P35408	PTGER4	Prostaglandin E2 receptor EP4 subtype	GO:0006955; P:immune response; IEP:UniProtKB
P35408	PTGER4	Prostaglandin E2 receptor EP4 subtype	GO:0007254; P:JNK cascade; ISS:UniProtKB
P35408	PTGER4	Prostaglandin E2 receptor EP4 subtype	GO:0050710; P:negative regulation of cytokine secretion; ISS:UniProtKB
P35408	PTGER4	Prostaglandin E2 receptor EP4 subtype	GO:2000420; P:negative regulation of eosinophil extravasation; IDA:UniProtKB
P35408	PTGER4	Prostaglandin E2 receptor EP4 subtype	GO:0050728; P:negative regulation of inflammatory response; IDA:UniProtKB
P35408	PTGER4	Prostaglandin E2 receptor EP4 subtype	GO:0033624; P:negative regulation of integrin activation; IDA:UniProtKB
P35408	PTGER4	Prostaglandin E2 receptor EP4 subtype	GO:0050715; P:positive regulation of cytokine secretion; ISS:UniProtKB
P35408	PTGER4	Prostaglandin E2 receptor EP4 subtype	GO:0050729; P:positive regulation of inflammatory response; ISS:UniProtKB
P35408	PTGER4	Prostaglandin E2 receptor EP4 subtype	GO:0030278; P:regulation of ossification; IEA:Ensembl
P35408	PTGER4	Prostaglandin E2 receptor EP4 subtype	GO:0051492; P:regulation of stress fiber assembly; ISS:UniProtKB
P35408	PTGER4	Prostaglandin E2 receptor EP4 subtype	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P35408	PTGER4	Prostaglandin E2 receptor EP4 subtype	GO:0009612; P:response to mechanical stimulus; IEP:UniProtKB
P35408	PTGER4	Prostaglandin E2 receptor EP4 subtype	GO:0042093; P:T-helper cell differentiation; ISS:UniProtKB
Q15121	PEA15	Astrocytic phosphoprotein PEA-15	GO:0005515; F:protein binding; IPI:UniProtKB
Q15121	PEA15	Astrocytic phosphoprotein PEA-15	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q15121	PEA15	Astrocytic phosphoprotein PEA-15	GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW
Q15121	PEA15	Astrocytic phosphoprotein PEA-15	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IDA:UniProtKB
Q15121	PEA15	Astrocytic phosphoprotein PEA-15	GO:0046325; P:negative regulation of glucose import; IDA:UniProtKB
Q15121	PEA15	Astrocytic phosphoprotein PEA-15	GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
Q15121	PEA15	Astrocytic phosphoprotein PEA-15	GO:0043278; P:response to morphine; IEA:Ensembl
Q15121	PEA15	Astrocytic phosphoprotein PEA-15	GO:0006810; P:transport; TAS:ProtInc
Q9H792	PEAK1	Pseudopodium-enriched atypical kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H792	PEAK1	Pseudopodium-enriched atypical kinase 1	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB
Q9H792	PEAK1	Pseudopodium-enriched atypical kinase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H792	PEAK1	Pseudopodium-enriched atypical kinase 1	GO:0016477; P:cell migration; IDA:UniProtKB
Q9H792	PEAK1	Pseudopodium-enriched atypical kinase 1	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:GOC
Q9H792	PEAK1	Pseudopodium-enriched atypical kinase 1	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q9H792	PEAK1	Pseudopodium-enriched atypical kinase 1	GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:UniProtKB
Q5VY43	PEAR1	Platelet endothelial aggregation receptor 1	GO:0043654; P:recognition of apoptotic cell; IEA:Ensembl
Q13951	CBFB	Core-binding factor subunit beta	GO:0003677; F:DNA binding; IEA:Ensembl
Q13951	CBFB	Core-binding factor subunit beta	GO:0005515; F:protein binding; IPI:UniProtKB
Q13951	CBFB	Core-binding factor subunit beta	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q13951	CBFB	Core-binding factor subunit beta	GO:0003713; F:transcription coactivator activity; IEA:InterPro
Q13951	CBFB	Core-binding factor subunit beta	GO:0048469; P:cell maturation; IEA:Ensembl
Q13951	CBFB	Core-binding factor subunit beta	GO:0060216; P:definitive hemopoiesis; IEA:Ensembl
Q13951	CBFB	Core-binding factor subunit beta	GO:0030098; P:lymphocyte differentiation; IEA:Ensembl
Q13951	CBFB	Core-binding factor subunit beta	GO:0030099; P:myeloid cell differentiation; IEA:Ensembl
Q13951	CBFB	Core-binding factor subunit beta	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
Q13951	CBFB	Core-binding factor subunit beta	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q13951	CBFB	Core-binding factor subunit beta	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P30086	PEBP1	Phosphatidylethanolamine-binding protein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P30086	PEBP1	Phosphatidylethanolamine-binding protein 1	GO:0019899; F:enzyme binding; IPI:UniProtKB
P30086	PEBP1	Phosphatidylethanolamine-binding protein 1	GO:0008429; F:phosphatidylethanolamine binding; TAS:ProtInc
P30086	PEBP1	Phosphatidylethanolamine-binding protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P30086	PEBP1	Phosphatidylethanolamine-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
P30086	PEBP1	Phosphatidylethanolamine-binding protein 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P30086	PEBP1	Phosphatidylethanolamine-binding protein 1	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q96S96	PEBP4	Phosphatidylethanolamine-binding protein 4	GO:0005515; F:protein binding; IPI:IntAct
P16284	PECAM1	Platelet endothelial cell adhesion molecule	GO:0005515; F:protein binding; IPI:UniProtKB
P16284	PECAM1	Platelet endothelial cell adhesion molecule	GO:0007596; P:blood coagulation; TAS:Reactome
P16284	PECAM1	Platelet endothelial cell adhesion molecule	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P16284	PECAM1	Platelet endothelial cell adhesion molecule	GO:0008037; P:cell recognition; TAS:ProtInc
P16284	PECAM1	Platelet endothelial cell adhesion molecule	GO:0050904; P:diapedesis; IDA:UniProtKB
P16284	PECAM1	Platelet endothelial cell adhesion molecule	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P16284	PECAM1	Platelet endothelial cell adhesion molecule	GO:0072011; P:glomerular endothelium development; IEP:UniProtKB
P16284	PECAM1	Platelet endothelial cell adhesion molecule	GO:0050900; P:leukocyte migration; TAS:Reactome
P16284	PECAM1	Platelet endothelial cell adhesion molecule	GO:0006909; P:phagocytosis; IDA:UniProtKB
P16284	PECAM1	Platelet endothelial cell adhesion molecule	GO:0030168; P:platelet activation; TAS:Reactome
P16284	PECAM1	Platelet endothelial cell adhesion molecule	GO:0002576; P:platelet degranulation; TAS:Reactome
P16284	PECAM1	Platelet endothelial cell adhesion molecule	GO:0007165; P:signal transduction; TAS:ProtInc
Q9BY49	PECR	Peroxisomal trans-2-enoyl-CoA reductase	GO:0005102; F:receptor binding; IPI:UniProtKB
Q9BY49	PECR	Peroxisomal trans-2-enoyl-CoA reductase	GO:0019166; F:trans-2-enoyl-CoA reductase (NADPH) activity; IDA:UniProtKB
Q9BY49	PECR	Peroxisomal trans-2-enoyl-CoA reductase	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-UniPathway
Q9BY49	PECR	Peroxisomal trans-2-enoyl-CoA reductase	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q9BY49	PECR	Peroxisomal trans-2-enoyl-CoA reductase	GO:0033306; P:phytol metabolic process; IDA:UniProtKB
Q96HM7	PCED1B	PC-esterase domain-containing protein 1B	GO:0016787; F:hydrolase activity; IEA:InterPro
P36955	SERPINF1	Pigment epithelium-derived factor	GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome
P36955	SERPINF1	Pigment epithelium-derived factor	GO:0007568; P:aging; IEA:Ensembl
P36955	SERPINF1	Pigment epithelium-derived factor	GO:0008283; P:cell proliferation; TAS:ProtInc
P36955	SERPINF1	Pigment epithelium-derived factor	GO:0001822; P:kidney development; IEA:Ensembl
P36955	SERPINF1	Pigment epithelium-derived factor	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P36955	SERPINF1	Pigment epithelium-derived factor	GO:0016525; P:negative regulation of angiogenesis; IDA:UniProtKB
P36955	SERPINF1	Pigment epithelium-derived factor	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P36955	SERPINF1	Pigment epithelium-derived factor	GO:0060770; P:negative regulation of epithelial cell proliferation involved in prostate gland development; IEA:Ensembl
P36955	SERPINF1	Pigment epithelium-derived factor	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
P36955	SERPINF1	Pigment epithelium-derived factor	GO:0050769; P:positive regulation of neurogenesis; IDA:UniProtKB
P36955	SERPINF1	Pigment epithelium-derived factor	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
P36955	SERPINF1	Pigment epithelium-derived factor	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P36955	SERPINF1	Pigment epithelium-derived factor	GO:0032526; P:response to retinoic acid; IEA:Ensembl
P36955	SERPINF1	Pigment epithelium-derived factor	GO:0007614; P:short-term memory; IEA:Ensembl
Q9UBV8	PEF1	Peflin	GO:0005509; F:calcium ion binding; TAS:ProtInc
Q9UBV8	PEF1	Peflin	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; IBA:RefGenome
Q9UBV8	PEF1	Peflin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UBV8	PEF1	Peflin	GO:0005515; F:protein binding; IPI:IntAct
Q9UBV8	PEF1	Peflin	GO:0046983; F:protein dimerization activity; IPI:UniProtKB
Q9UBV8	PEF1	Peflin	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q9UBV8	PEF1	Peflin	GO:0006508; P:proteolysis; IBA:RefGenome
Q9UBV8	PEF1	Peflin	GO:0051592; P:response to calcium ion; IPI:UniProtKB
Q86TG7	PEG10	Retrotransposon-derived protein PEG10	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86TG7	PEG10	Retrotransposon-derived protein PEG10	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q86TG7	PEG10	Retrotransposon-derived protein PEG10	GO:0005515; F:protein binding; IPI:IntAct
Q86TG7	PEG10	Retrotransposon-derived protein PEG10	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86TG7	PEG10	Retrotransposon-derived protein PEG10	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q86TG7	PEG10	Retrotransposon-derived protein PEG10	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q86TG7	PEG10	Retrotransposon-derived protein PEG10	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:HGNC
Q86TG7	PEG10	Retrotransposon-derived protein PEG10	GO:0001890; P:placenta development; IEA:Ensembl
Q9GZU2	PEG3	Paternally-expressed gene 3 protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9GZU2	PEG3	Paternally-expressed gene 3 protein	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9GZU2	PEG3	Paternally-expressed gene 3 protein	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q9GZU2	PEG3	Paternally-expressed gene 3 protein	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9GZU2	PEG3	Paternally-expressed gene 3 protein	GO:0071514; P:genetic imprinting; IEA:Ensembl
Q9GZU2	PEG3	Paternally-expressed gene 3 protein	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9GZU2	PEG3	Paternally-expressed gene 3 protein	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q9GZU2	PEG3	Paternally-expressed gene 3 protein	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
Q9GZU2	PEG3	Paternally-expressed gene 3 protein	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q9HAT8	PELI2	E3 ubiquitin-protein ligase pellino homolog 2	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9HAT8	PELI2	E3 ubiquitin-protein ligase pellino homolog 2	GO:0005515; F:protein binding; IPI:IntAct
Q9HAT8	PELI2	E3 ubiquitin-protein ligase pellino homolog 2	GO:0045087; P:innate immune response; TAS:Reactome
Q9HAT8	PELI2	E3 ubiquitin-protein ligase pellino homolog 2	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q9HAT8	PELI2	E3 ubiquitin-protein ligase pellino homolog 2	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
Q9HAT8	PELI2	E3 ubiquitin-protein ligase pellino homolog 2	GO:0043410; P:positive regulation of MAPK cascade; IDA:MGI
Q9HAT8	PELI2	E3 ubiquitin-protein ligase pellino homolog 2	GO:0001934; P:positive regulation of protein phosphorylation; IDA:MGI
Q9HAT8	PELI2	E3 ubiquitin-protein ligase pellino homolog 2	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9HAT8	PELI2	E3 ubiquitin-protein ligase pellino homolog 2	GO:0008063; P:Toll signaling pathway; IEA:InterPro
Q9HAT8	PELI2	E3 ubiquitin-protein ligase pellino homolog 2	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q9HAT8	PELI2	E3 ubiquitin-protein ligase pellino homolog 2	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q9HAT8	PELI2	E3 ubiquitin-protein ligase pellino homolog 2	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q9HAT8	PELI2	E3 ubiquitin-protein ligase pellino homolog 2	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q9HAT8	PELI2	E3 ubiquitin-protein ligase pellino homolog 2	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q9HAT8	PELI2	E3 ubiquitin-protein ligase pellino homolog 2	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q9HAT8	PELI2	E3 ubiquitin-protein ligase pellino homolog 2	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q9HAT8	PELI2	E3 ubiquitin-protein ligase pellino homolog 2	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0005515; F:protein binding; IPI:IntAct
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0045087; P:innate immune response; TAS:Reactome
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IEA:Ensembl
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0030890; P:positive regulation of B cell proliferation; IEA:Ensembl
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0001819; P:positive regulation of cytokine production; IEA:Ensembl
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0031398; P:positive regulation of protein ubiquitination; IEA:Ensembl
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0034141; P:positive regulation of toll-like receptor 3 signaling pathway; IEA:Ensembl
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0034145; P:positive regulation of toll-like receptor 4 signaling pathway; IEA:Ensembl
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0070936; P:protein K48-linked ubiquitination; IEA:Ensembl
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0043331; P:response to dsRNA; IEA:Ensembl
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0008063; P:Toll signaling pathway; IEA:InterPro
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q96FA3	PELI1	E3 ubiquitin-protein ligase pellino homolog 1	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q8N2H9	PELI3	E3 ubiquitin-protein ligase pellino homolog 3	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q8N2H9	PELI3	E3 ubiquitin-protein ligase pellino homolog 3	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:MGI
Q8N2H9	PELI3	E3 ubiquitin-protein ligase pellino homolog 3	GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; IMP:MGI
Q8N2H9	PELI3	E3 ubiquitin-protein ligase pellino homolog 3	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8N2H9	PELI3	E3 ubiquitin-protein ligase pellino homolog 3	GO:0008063; P:Toll signaling pathway; IEA:InterPro
Q9BRX2	PELO	Protein pelota homolog	GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW
Q9BRX2	PELO	Protein pelota homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BRX2	PELO	Protein pelota homolog	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9BRX2	PELO	Protein pelota homolog	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q9BRX2	PELO	Protein pelota homolog	GO:0008283; P:cell proliferation; IEA:Ensembl
Q9BRX2	PELO	Protein pelota homolog	GO:0051276; P:chromosome organization; IEA:Ensembl
Q8IZL8	PELP1	Proline-, glutamic acid- and leucine-rich protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IZL8	PELP1	Proline-, glutamic acid- and leucine-rich protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q8IZL8	PELP1	Proline-, glutamic acid- and leucine-rich protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UBM1	PEMT	Phosphatidylethanolamine N-methyltransferase	GO:0080101; F:phosphatidyl-N-dimethylethanolamine N-methyltransferase activity; IEA:UniProtKB-EC
Q9UBM1	PEMT	Phosphatidylethanolamine N-methyltransferase	GO:0000773; F:phosphatidyl-N-methylethanolamine N-methyltransferase activity; IEA:UniProtKB-EC
Q9UBM1	PEMT	Phosphatidylethanolamine N-methyltransferase	GO:0004608; F:phosphatidylethanolamine N-methyltransferase activity; TAS:ProtInc
Q9UBM1	PEMT	Phosphatidylethanolamine N-methyltransferase	GO:0008283; P:cell proliferation; TAS:ProtInc
Q9UBM1	PEMT	Phosphatidylethanolamine N-methyltransferase	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9UBM1	PEMT	Phosphatidylethanolamine N-methyltransferase	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q9UBM1	PEMT	Phosphatidylethanolamine N-methyltransferase	GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome
Q9UBM1	PEMT	Phosphatidylethanolamine N-methyltransferase	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9UBM1	PEMT	Phosphatidylethanolamine N-methyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NZ42	PSENEN	Gamma-secretase subunit PEN-2	GO:0005515; F:protein binding; IPI:IntAct
Q9NZ42	PSENEN	Gamma-secretase subunit PEN-2	GO:0042987; P:amyloid precursor protein catabolic process; TAS:HGNC
Q9NZ42	PSENEN	Gamma-secretase subunit PEN-2	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q9NZ42	PSENEN	Gamma-secretase subunit PEN-2	GO:0006509; P:membrane protein ectodomain proteolysis; IDA:HGNC
Q9NZ42	PSENEN	Gamma-secretase subunit PEN-2	GO:0031293; P:membrane protein intracellular domain proteolysis; TAS:Reactome
Q9NZ42	PSENEN	Gamma-secretase subunit PEN-2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9NZ42	PSENEN	Gamma-secretase subunit PEN-2	GO:0007220; P:Notch receptor processing; TAS:HGNC
Q9NZ42	PSENEN	Gamma-secretase subunit PEN-2	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q9NZ42	PSENEN	Gamma-secretase subunit PEN-2	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q9NZ42	PSENEN	Gamma-secretase subunit PEN-2	GO:0043085; P:positive regulation of catalytic activity; IDA:HGNC
Q9NZ42	PSENEN	Gamma-secretase subunit PEN-2	GO:0016485; P:protein processing; IDA:HGNC
P01210	PENK	Proenkephalin-A	GO:0005184; F:neuropeptide hormone activity; TAS:ProtInc
P01210	PENK	Proenkephalin-A	GO:0005515; F:protein binding; IPI:IntAct
P01210	PENK	Proenkephalin-A	GO:0002118; P:aggressive behavior; IEA:Ensembl
P01210	PENK	Proenkephalin-A	GO:0001662; P:behavioral fear response; IEA:Ensembl
P01210	PENK	Proenkephalin-A	GO:0007626; P:locomotory behavior; IEA:Ensembl
P01210	PENK	Proenkephalin-A	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
P01210	PENK	Proenkephalin-A	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P01210	PENK	Proenkephalin-A	GO:0007165; P:signal transduction; TAS:ProtInc
P01210	PENK	Proenkephalin-A	GO:0001964; P:startle response; IEA:Ensembl
Q96RR1	PEO1	Twinkle protein, mitochondrial	GO:0043139; F:5'-3' DNA helicase activity; IDA:UniProtKB
Q96RR1	PEO1	Twinkle protein, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96RR1	PEO1	Twinkle protein, mitochondrial	GO:0002020; F:protease binding; IPI:UniProtKB
Q96RR1	PEO1	Twinkle protein, mitochondrial	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
Q96RR1	PEO1	Twinkle protein, mitochondrial	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q96RR1	PEO1	Twinkle protein, mitochondrial	GO:0006268; P:DNA unwinding involved in DNA replication; IEA:Ensembl
Q96RR1	PEO1	Twinkle protein, mitochondrial	GO:0006264; P:mitochondrial DNA replication; IMP:UniProtKB
Q96RR1	PEO1	Twinkle protein, mitochondrial	GO:0034214; P:protein hexamerization; IDA:UniProtKB
Q96RR1	PEO1	Twinkle protein, mitochondrial	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
Q96RR1	PEO1	Twinkle protein, mitochondrial	GO:0006390; P:transcription from mitochondrial promoter; IMP:UniProtKB
P0DJD8	PGA3	Pepsin A-3	GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW
P0DJD8	PGA3	Pepsin A-3	GO:0007586; P:digestion; IEA:UniProtKB-KW
P0DJD7	PGA4	Pepsin A-4	GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW
P0DJD7	PGA4	Pepsin A-4	GO:0007586; P:digestion; IEA:UniProtKB-KW
P0DJD9	PGA5	Pepsin A-5	GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW
P0DJD9	PGA5	Pepsin A-5	GO:0007586; P:digestion; IEA:UniProtKB-KW
P20142	PGC	Gastricsin	GO:0004190; F:aspartic-type endopeptidase activity; TAS:ProtInc
P20142	PGC	Gastricsin	GO:0007586; P:digestion; TAS:ProtInc
P20142	PGC	Gastricsin	GO:0006508; P:proteolysis; TAS:ProtInc
P12955	PEPD	Xaa-Pro dipeptidase	GO:0004177; F:aminopeptidase activity; IEA:InterPro
P12955	PEPD	Xaa-Pro dipeptidase	GO:0016805; F:dipeptidase activity; IEA:UniProtKB-KW
P12955	PEPD	Xaa-Pro dipeptidase	GO:0030145; F:manganese ion binding; IEA:InterPro
P12955	PEPD	Xaa-Pro dipeptidase	GO:0004181; F:metallocarboxypeptidase activity; TAS:ProtInc
P12955	PEPD	Xaa-Pro dipeptidase	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
P12955	PEPD	Xaa-Pro dipeptidase	GO:0030574; P:collagen catabolic process; IEA:UniProtKB-KW
P12955	PEPD	Xaa-Pro dipeptidase	GO:0006508; P:proteolysis; TAS:ProtInc
Q8NDH3	NPEPL1	Probable aminopeptidase NPEPL1	GO:0004177; F:aminopeptidase activity; IEA:UniProtKB-KW
Q8NDH3	NPEPL1	Probable aminopeptidase NPEPL1	GO:0030145; F:manganese ion binding; IEA:InterPro
Q8NDH3	NPEPL1	Probable aminopeptidase NPEPL1	GO:0008235; F:metalloexopeptidase activity; IEA:InterPro
O60437	PPL	Periplakin	GO:0005515; F:protein binding; IPI:IntAct
O60437	PPL	Periplakin	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
O60437	PPL	Periplakin	GO:0031424; P:keratinization; IEA:UniProtKB-KW
O15534	PER1	Period circadian protein homolog 1	GO:0070888; F:E-box binding; IDA:BHF-UCL
O15534	PER1	Period circadian protein homolog 1	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:BHF-UCL
O15534	PER1	Period circadian protein homolog 1	GO:0004871; F:signal transducer activity; IEA:InterPro
O15534	PER1	Period circadian protein homolog 1	GO:0000989; F:transcription factor binding transcription factor activity; ISS:BHF-UCL
O15534	PER1	Period circadian protein homolog 1	GO:0032922; P:circadian regulation of gene expression; IDA:UniProtKB
O15534	PER1	Period circadian protein homolog 1	GO:0007623; P:circadian rhythm; TAS:ProtInc
O15534	PER1	Period circadian protein homolog 1	GO:0009649; P:entrainment of circadian clock; TAS:ProtInc
O15534	PER1	Period circadian protein homolog 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
O15534	PER1	Period circadian protein homolog 1	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
O15534	PER1	Period circadian protein homolog 1	GO:0042634; P:regulation of hair cycle; IMP:UniProtKB
O15534	PER1	Period circadian protein homolog 1	GO:0009416; P:response to light stimulus; IEA:Ensembl
O15534	PER1	Period circadian protein homolog 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15055	PER2	Period circadian protein homolog 2	GO:0004871; F:signal transducer activity; IEA:InterPro
O15055	PER2	Period circadian protein homolog 2	GO:0000989; F:transcription factor binding transcription factor activity; ISS:BHF-UCL
O15055	PER2	Period circadian protein homolog 2	GO:0007623; P:circadian rhythm; TAS:ProtInc
O15055	PER2	Period circadian protein homolog 2	GO:0042754; P:negative regulation of circadian rhythm; ISS:UniProtKB
O15055	PER2	Period circadian protein homolog 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
O15055	PER2	Period circadian protein homolog 2	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
O15055	PER2	Period circadian protein homolog 2	GO:0051726; P:regulation of cell cycle; ISS:UniProtKB
O15055	PER2	Period circadian protein homolog 2	GO:0050767; P:regulation of neurogenesis; ISS:UniProtKB
O15055	PER2	Period circadian protein homolog 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P56645	PER3	Period circadian protein homolog 3	GO:0005515; F:protein binding; IPI:IntAct
P56645	PER3	Period circadian protein homolog 3	GO:0004871; F:signal transducer activity; IEA:InterPro
P56645	PER3	Period circadian protein homolog 3	GO:0032922; P:circadian regulation of gene expression; IEA:InterPro
P56645	PER3	Period circadian protein homolog 3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P56645	PER3	Period circadian protein homolog 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P14222	PRF1	Perforin-1	GO:0005509; F:calcium ion binding; ISS:UniProtKB
P14222	PRF1	Perforin-1	GO:0005515; F:protein binding; IPI:IntAct
P14222	PRF1	Perforin-1	GO:0022829; F:wide pore channel activity; IDA:UniProtKB
P14222	PRF1	Perforin-1	GO:0006915; P:apoptotic process; TAS:ProtInc
P14222	PRF1	Perforin-1	GO:0006968; P:cellular defense response; TAS:ProtInc
P14222	PRF1	Perforin-1	GO:0019835; P:cytolysis; ISS:UniProtKB
P14222	PRF1	Perforin-1	GO:0002357; P:defense response to tumor cell; ISS:UniProtKB
P14222	PRF1	Perforin-1	GO:0051607; P:defense response to virus; ISS:UniProtKB
P14222	PRF1	Perforin-1	GO:0002418; P:immune response to tumor cell; ISS:UniProtKB
P14222	PRF1	Perforin-1	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
P14222	PRF1	Perforin-1	GO:0055085; P:transmembrane transport; IDA:GOC
P11678	EPX	Eosinophil peroxidase	GO:0020037; F:heme binding; IEA:InterPro
P11678	EPX	Eosinophil peroxidase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P11678	EPX	Eosinophil peroxidase	GO:0004601; F:peroxidase activity; TAS:ProtInc
P11678	EPX	Eosinophil peroxidase	GO:0002215; P:defense response to nematode; IEA:Ensembl
P11678	EPX	Eosinophil peroxidase	GO:0072677; P:eosinophil migration; IEA:Ensembl
P11678	EPX	Eosinophil peroxidase	GO:0042744; P:hydrogen peroxide catabolic process; IEA:UniProtKB-KW
P11678	EPX	Eosinophil peroxidase	GO:0032693; P:negative regulation of interleukin-10 production; IEA:Ensembl
P11678	EPX	Eosinophil peroxidase	GO:0032714; P:negative regulation of interleukin-5 production; IEA:Ensembl
P11678	EPX	Eosinophil peroxidase	GO:0032753; P:positive regulation of interleukin-4 production; IEA:Ensembl
P41219	PRPH	Peripherin	GO:0005198; F:structural molecule activity; NAS:ProtInc
P41219	PRPH	Peripherin	GO:0045104; P:intermediate filament cytoskeleton organization; IEA:Ensembl
Q5SV97	PERM1	PGC-1 and ERR-induced regulator in muscle protein 1	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
Q5SV97	PERM1	PGC-1 and ERR-induced regulator in muscle protein 1	GO:0014850; P:response to muscle activity; IDA:UniProtKB
Q5SV97	PERM1	PGC-1 and ERR-induced regulator in muscle protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P22079	LPO	Lactoperoxidase	GO:0020037; F:heme binding; IEA:InterPro
P22079	LPO	Lactoperoxidase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P22079	LPO	Lactoperoxidase	GO:0036393; F:thiocyanate peroxidase activity; IDA:UniProt
P22079	LPO	Lactoperoxidase	GO:0042742; P:defense response to bacterium; IDA:UniProt
P22079	LPO	Lactoperoxidase	GO:0001580; P:detection of chemical stimulus involved in sensory perception of bitter taste; IDA:UniProt
P22079	LPO	Lactoperoxidase	GO:0042744; P:hydrogen peroxide catabolic process; IEA:UniProtKB-KW
P22079	LPO	Lactoperoxidase	GO:0006979; P:response to oxidative stress; NAS:UniProtKB
P22079	LPO	Lactoperoxidase	GO:0018969; P:thiocyanate metabolic process; IDA:GOC
P05164	MPO	Myeloperoxidase	GO:0003682; F:chromatin binding; TAS:ProtInc
P05164	MPO	Myeloperoxidase	GO:0020037; F:heme binding; IEA:InterPro
P05164	MPO	Myeloperoxidase	GO:0008201; F:heparin binding; IDA:MGI
P05164	MPO	Myeloperoxidase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P05164	MPO	Myeloperoxidase	GO:0004601; F:peroxidase activity; IDA:BHF-UCL
P05164	MPO	Myeloperoxidase	GO:0007568; P:aging; IEA:Ensembl
P05164	MPO	Myeloperoxidase	GO:0006952; P:defense response; TAS:ProtInc
P05164	MPO	Myeloperoxidase	GO:0050832; P:defense response to fungus; IEA:Ensembl
P05164	MPO	Myeloperoxidase	GO:0042744; P:hydrogen peroxide catabolic process; IDA:BHF-UCL
P05164	MPO	Myeloperoxidase	GO:0002149; P:hypochlorous acid biosynthetic process; IEA:Ensembl
P05164	MPO	Myeloperoxidase	GO:0034374; P:low-density lipoprotein particle remodeling; IDA:BHF-UCL
P05164	MPO	Myeloperoxidase	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
P05164	MPO	Myeloperoxidase	GO:0044130; P:negative regulation of growth of symbiont in host; IEA:Ensembl
P05164	MPO	Myeloperoxidase	GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL
P05164	MPO	Myeloperoxidase	GO:0019430; P:removal of superoxide radicals; IEA:Ensembl
P05164	MPO	Myeloperoxidase	GO:0002679; P:respiratory burst involved in defense response; IEA:Ensembl
P05164	MPO	Myeloperoxidase	GO:0032094; P:response to food; IEA:Ensembl
P05164	MPO	Myeloperoxidase	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P05164	MPO	Myeloperoxidase	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P05164	MPO	Myeloperoxidase	GO:0006979; P:response to oxidative stress; TAS:UniProtKB
P05164	MPO	Myeloperoxidase	GO:0001878; P:response to yeast; IEA:Ensembl
Q96FX8	PERP	p53 apoptosis effector related to PMP-22	GO:0097202; P:activation of cysteine-type endopeptidase activity; IDA:BHF-UCL
Q96FX8	PERP	p53 apoptosis effector related to PMP-22	GO:0097186; P:amelogenesis; IEA:Ensembl
Q96FX8	PERP	p53 apoptosis effector related to PMP-22	GO:0002934; P:desmosome organization; IEA:Ensembl
Q96FX8	PERP	p53 apoptosis effector related to PMP-22	GO:0034113; P:heterotypic cell-cell adhesion; IEA:Ensembl
Q96FX8	PERP	p53 apoptosis effector related to PMP-22	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IEA:Ensembl
Q96FX8	PERP	p53 apoptosis effector related to PMP-22	GO:0045862; P:positive regulation of proteolysis; IDA:BHF-UCL
O75420	GIGYF1	PERQ amino acid-rich with GYF domain-containing protein 1	GO:0048009; P:insulin-like growth factor receptor signaling pathway; IEA:Ensembl
Q6Y7W6	GIGYF2	PERQ amino acid-rich with GYF domain-containing protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6Y7W6	GIGYF2	PERQ amino acid-rich with GYF domain-containing protein 2	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
Q6Y7W6	GIGYF2	PERQ amino acid-rich with GYF domain-containing protein 2	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q6Y7W6	GIGYF2	PERQ amino acid-rich with GYF domain-containing protein 2	GO:0044267; P:cellular protein metabolic process; IEA:Ensembl
Q6Y7W6	GIGYF2	PERQ amino acid-rich with GYF domain-containing protein 2	GO:0007631; P:feeding behavior; IEA:Ensembl
Q6Y7W6	GIGYF2	PERQ amino acid-rich with GYF domain-containing protein 2	GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl
Q6Y7W6	GIGYF2	PERQ amino acid-rich with GYF domain-containing protein 2	GO:0048009; P:insulin-like growth factor receptor signaling pathway; IEA:Ensembl
Q6Y7W6	GIGYF2	PERQ amino acid-rich with GYF domain-containing protein 2	GO:0031571; P:mitotic G1 DNA damage checkpoint; IEA:Ensembl
Q6Y7W6	GIGYF2	PERQ amino acid-rich with GYF domain-containing protein 2	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q6Y7W6	GIGYF2	PERQ amino acid-rich with GYF domain-containing protein 2	GO:0050881; P:musculoskeletal movement; IEA:Ensembl
Q6Y7W6	GIGYF2	PERQ amino acid-rich with GYF domain-containing protein 2	GO:0017148; P:negative regulation of translation; IMP:MGI
Q6Y7W6	GIGYF2	PERQ amino acid-rich with GYF domain-containing protein 2	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q6Y7W6	GIGYF2	PERQ amino acid-rich with GYF domain-containing protein 2	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q6Y7W6	GIGYF2	PERQ amino acid-rich with GYF domain-containing protein 2	GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl
P07202	TPO	Thyroid peroxidase	GO:0005509; F:calcium ion binding; IEA:InterPro
P07202	TPO	Thyroid peroxidase	GO:0020037; F:heme binding; IEA:InterPro
P07202	TPO	Thyroid peroxidase	GO:0004447; F:iodide peroxidase activity; IEA:UniProtKB-EC
P07202	TPO	Thyroid peroxidase	GO:0004601; F:peroxidase activity; TAS:ProtInc
P07202	TPO	Thyroid peroxidase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P07202	TPO	Thyroid peroxidase	GO:0035162; P:embryonic hemopoiesis; IDA:DFLAT
P07202	TPO	Thyroid peroxidase	GO:0042446; P:hormone biosynthetic process; IEA:UniProtKB-KW
P07202	TPO	Thyroid peroxidase	GO:0042744; P:hydrogen peroxide catabolic process; IEA:UniProtKB-KW
P07202	TPO	Thyroid peroxidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P07202	TPO	Thyroid peroxidase	GO:0006590; P:thyroid hormone generation; TAS:Reactome
O00541	PES1	Pescadillo homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O00541	PES1	Pescadillo homolog	GO:0005515; F:protein binding; IPI:UniProtKB
O00541	PES1	Pescadillo homolog	GO:0043021; F:ribonucleoprotein complex binding; IEA:UniProtKB-HAMAP
O00541	PES1	Pescadillo homolog	GO:0008283; P:cell proliferation; IMP:UniProtKB
O00541	PES1	Pescadillo homolog	GO:0000466; P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IMP:UniProtKB
O00541	PES1	Pescadillo homolog	GO:0000463; P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IMP:UniProtKB
O00541	PES1	Pescadillo homolog	GO:0007000; P:nucleolus organization; IEA:Ensembl
O00541	PES1	Pescadillo homolog	GO:0033365; P:protein localization to organelle; IEA:Ensembl
O00541	PES1	Pescadillo homolog	GO:0051726; P:regulation of cell cycle; IMP:UniProtKB
O00541	PES1	Pescadillo homolog	GO:0042273; P:ribosomal large subunit biogenesis; IC:UniProtKB
O00541	PES1	Pescadillo homolog	GO:0006364; P:rRNA processing; IMP:MGI
O60683	PEX10	Peroxisome biogenesis factor 10	GO:0005515; F:protein binding; IPI:UniProtKB
O60683	PEX10	Peroxisome biogenesis factor 10	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
O60683	PEX10	Peroxisome biogenesis factor 10	GO:0008270; F:zinc ion binding; IEA:InterPro
O60683	PEX10	Peroxisome biogenesis factor 10	GO:0007031; P:peroxisome organization; IDA:UniProtKB
O60683	PEX10	Peroxisome biogenesis factor 10	GO:0016558; P:protein import into peroxisome matrix; IDA:UniProtKB
O00623	PEX12	Peroxisome assembly protein 12	GO:0005515; F:protein binding; IPI:UniProtKB
O00623	PEX12	Peroxisome assembly protein 12	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
O00623	PEX12	Peroxisome assembly protein 12	GO:0008270; F:zinc ion binding; IMP:UniProtKB
O00623	PEX12	Peroxisome assembly protein 12	GO:0007031; P:peroxisome organization; IMP:UniProtKB
O00623	PEX12	Peroxisome assembly protein 12	GO:0016558; P:protein import into peroxisome matrix; IMP:UniProtKB
O00623	PEX12	Peroxisome assembly protein 12	GO:0006625; P:protein targeting to peroxisome; NAS:UniProtKB
Q92968	PEX13	Peroxisomal membrane protein PEX13	GO:0005515; F:protein binding; IPI:UniProtKB
Q92968	PEX13	Peroxisomal membrane protein PEX13	GO:0021795; P:cerebral cortex cell migration; ISS:UniProtKB
Q92968	PEX13	Peroxisomal membrane protein PEX13	GO:0001561; P:fatty acid alpha-oxidation; ISS:UniProtKB
Q92968	PEX13	Peroxisomal membrane protein PEX13	GO:0007626; P:locomotory behavior; ISS:UniProtKB
Q92968	PEX13	Peroxisomal membrane protein PEX13	GO:0060152; P:microtubule-based peroxisome localization; ISS:UniProtKB
Q92968	PEX13	Peroxisomal membrane protein PEX13	GO:0001764; P:neuron migration; ISS:UniProtKB
Q92968	PEX13	Peroxisomal membrane protein PEX13	GO:0016560; P:protein import into peroxisome matrix, docking; IMP:UniProtKB
Q92968	PEX13	Peroxisomal membrane protein PEX13	GO:0001967; P:suckling behavior; ISS:UniProtKB
O75381	PEX14	Peroxisomal membrane protein PEX14	GO:0048487; F:beta-tubulin binding; IPI:UniProtKB
O75381	PEX14	Peroxisomal membrane protein PEX14	GO:0008017; F:microtubule binding; IDA:UniProtKB
O75381	PEX14	Peroxisomal membrane protein PEX14	GO:0005515; F:protein binding; IPI:UniProtKB
O75381	PEX14	Peroxisomal membrane protein PEX14	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
O75381	PEX14	Peroxisomal membrane protein PEX14	GO:0005102; F:receptor binding; IPI:UniProtKB
O75381	PEX14	Peroxisomal membrane protein PEX14	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
O75381	PEX14	Peroxisomal membrane protein PEX14	GO:0034453; P:microtubule anchoring; IDA:UniProtKB
O75381	PEX14	Peroxisomal membrane protein PEX14	GO:0032091; P:negative regulation of protein binding; IDA:UniProtKB
O75381	PEX14	Peroxisomal membrane protein PEX14	GO:1901094; P:negative regulation of protein homotetramerization; IDA:UniProtKB
O75381	PEX14	Peroxisomal membrane protein PEX14	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
O75381	PEX14	Peroxisomal membrane protein PEX14	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
O75381	PEX14	Peroxisomal membrane protein PEX14	GO:0007031; P:peroxisome organization; ISS:UniProtKB
O75381	PEX14	Peroxisomal membrane protein PEX14	GO:0036250; P:peroxisome transport along microtubule; IDA:UniProtKB
O75381	PEX14	Peroxisomal membrane protein PEX14	GO:0006461; P:protein complex assembly; IDA:UniProtKB
O75381	PEX14	Peroxisomal membrane protein PEX14	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
O75381	PEX14	Peroxisomal membrane protein PEX14	GO:0016558; P:protein import into peroxisome matrix; IMP:UniProtKB
O75381	PEX14	Peroxisomal membrane protein PEX14	GO:0044721; P:protein import into peroxisome matrix, substrate release; IDA:UniProtKB
O75381	PEX14	Peroxisomal membrane protein PEX14	GO:0016561; P:protein import into peroxisome matrix, translocation; IDA:UniProtKB
Q9Y5Y5	PEX16	Peroxisomal membrane protein PEX16	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y5Y5	PEX16	Peroxisomal membrane protein PEX16	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q9Y5Y5	PEX16	Peroxisomal membrane protein PEX16	GO:0032581; P:ER-dependent peroxisome organization; IDA:UniProtKB
Q9Y5Y5	PEX16	Peroxisomal membrane protein PEX16	GO:0016557; P:peroxisome membrane biogenesis; IMP:UniProtKB
Q9Y5Y5	PEX16	Peroxisomal membrane protein PEX16	GO:0007031; P:peroxisome organization; IMP:UniProtKB
Q9Y5Y5	PEX16	Peroxisomal membrane protein PEX16	GO:0016558; P:protein import into peroxisome matrix; IMP:MGI
Q9Y5Y5	PEX16	Peroxisomal membrane protein PEX16	GO:0045046; P:protein import into peroxisome membrane; IMP:UniProtKB
Q9Y5Y5	PEX16	Peroxisomal membrane protein PEX16	GO:0070972; P:protein localization to endoplasmic reticulum; IDA:UniProtKB
Q9Y5Y5	PEX16	Peroxisomal membrane protein PEX16	GO:0006625; P:protein targeting to peroxisome; IMP:UniProtKB
Q9Y5Y5	PEX16	Peroxisomal membrane protein PEX16	GO:0022615; P:protein to membrane docking; IDA:UniProtKB
P40855	PEX19	Peroxisomal biogenesis factor 19	GO:0051117; F:ATPase binding; IPI:UniProtKB
P40855	PEX19	Peroxisomal biogenesis factor 19	GO:0036105; F:peroxisome membrane class-1 targeting sequence binding; IDA:UniProtKB
P40855	PEX19	Peroxisomal biogenesis factor 19	GO:0005515; F:protein binding; IPI:UniProtKB
P40855	PEX19	Peroxisomal biogenesis factor 19	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
P40855	PEX19	Peroxisomal biogenesis factor 19	GO:0061077; P:chaperone-mediated protein folding; IDA:UniProtKB
P40855	PEX19	Peroxisomal biogenesis factor 19	GO:0072321; P:chaperone-mediated protein transport; IDA:UniProtKB
P40855	PEX19	Peroxisomal biogenesis factor 19	GO:0072663; P:establishment of protein localization to peroxisome; IMP:UniProtKB
P40855	PEX19	Peroxisomal biogenesis factor 19	GO:1900131; P:negative regulation of lipid binding; IDA:UniProtKB
P40855	PEX19	Peroxisomal biogenesis factor 19	GO:0016559; P:peroxisome fission; IMP:UniProtKB
P40855	PEX19	Peroxisomal biogenesis factor 19	GO:0016557; P:peroxisome membrane biogenesis; IDA:UniProtKB
P40855	PEX19	Peroxisomal biogenesis factor 19	GO:0007031; P:peroxisome organization; IMP:UniProtKB
P40855	PEX19	Peroxisomal biogenesis factor 19	GO:0045046; P:protein import into peroxisome membrane; IDA:UniProtKB
P40855	PEX19	Peroxisomal biogenesis factor 19	GO:0050821; P:protein stabilization; IDA:UniProtKB
P40855	PEX19	Peroxisomal biogenesis factor 19	GO:0006625; P:protein targeting to peroxisome; IDA:UniProtKB
P40855	PEX19	Peroxisomal biogenesis factor 19	GO:0055085; P:transmembrane transport; TAS:Reactome
O43933	PEX1	Peroxisome biogenesis factor 1	GO:0005524; F:ATP binding; IMP:UniProtKB
O43933	PEX1	Peroxisome biogenesis factor 1	GO:0042623; F:ATPase activity, coupled; IMP:UniProtKB
O43933	PEX1	Peroxisome biogenesis factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
O43933	PEX1	Peroxisome biogenesis factor 1	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
O43933	PEX1	Peroxisome biogenesis factor 1	GO:0032403; F:protein complex binding; IDA:UniProtKB
O43933	PEX1	Peroxisome biogenesis factor 1	GO:0006200; P:ATP catabolic process; IMP:GOC
O43933	PEX1	Peroxisome biogenesis factor 1	GO:0060152; P:microtubule-based peroxisome localization; IMP:UniProtKB
O43933	PEX1	Peroxisome biogenesis factor 1	GO:0007031; P:peroxisome organization; IMP:UniProtKB
O43933	PEX1	Peroxisome biogenesis factor 1	GO:0016558; P:protein import into peroxisome matrix; IMP:UniProtKB
O43933	PEX1	Peroxisome biogenesis factor 1	GO:0006625; P:protein targeting to peroxisome; IMP:UniProtKB
Q7Z412	PEX26	Peroxisome assembly protein 26	GO:0051117; F:ATPase binding; IPI:UniProtKB
Q7Z412	PEX26	Peroxisome assembly protein 26	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z412	PEX26	Peroxisome assembly protein 26	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q7Z412	PEX26	Peroxisome assembly protein 26	GO:0032403; F:protein complex binding; IDA:UniProtKB
Q7Z412	PEX26	Peroxisome assembly protein 26	GO:0016558; P:protein import into peroxisome matrix; IDA:UniProtKB
Q7Z412	PEX26	Peroxisome assembly protein 26	GO:0045046; P:protein import into peroxisome membrane; IEA:InterPro
P28328	PEX2	Peroxisome biogenesis factor 2	GO:0005515; F:protein binding; IPI:UniProtKB
P28328	PEX2	Peroxisome biogenesis factor 2	GO:0008270; F:zinc ion binding; IEA:InterPro
P28328	PEX2	Peroxisome biogenesis factor 2	GO:0006699; P:bile acid biosynthetic process; IEA:Ensembl
P28328	PEX2	Peroxisome biogenesis factor 2	GO:0042632; P:cholesterol homeostasis; IEA:Ensembl
P28328	PEX2	Peroxisome biogenesis factor 2	GO:0006635; P:fatty acid beta-oxidation; IMP:UniProtKB
P28328	PEX2	Peroxisome biogenesis factor 2	GO:0050680; P:negative regulation of epithelial cell proliferation; IMP:UniProtKB
P28328	PEX2	Peroxisome biogenesis factor 2	GO:0048147; P:negative regulation of fibroblast proliferation; IMP:UniProtKB
P28328	PEX2	Peroxisome biogenesis factor 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
P28328	PEX2	Peroxisome biogenesis factor 2	GO:0001764; P:neuron migration; IEA:Ensembl
P28328	PEX2	Peroxisome biogenesis factor 2	GO:0007031; P:peroxisome organization; IMP:UniProtKB
P28328	PEX2	Peroxisome biogenesis factor 2	GO:0031648; P:protein destabilization; IMP:UniProtKB
P28328	PEX2	Peroxisome biogenesis factor 2	GO:0016558; P:protein import into peroxisome matrix; IMP:UniProtKB
P28328	PEX2	Peroxisome biogenesis factor 2	GO:0045540; P:regulation of cholesterol biosynthetic process; IEA:Ensembl
P28328	PEX2	Peroxisome biogenesis factor 2	GO:0000038; P:very long-chain fatty acid metabolic process; IMP:UniProtKB
P56589	PEX3	Peroxisomal biogenesis factor 3	GO:0008289; F:lipid binding; IDA:UniProtKB
P56589	PEX3	Peroxisomal biogenesis factor 3	GO:0005515; F:protein binding; IPI:UniProtKB
P56589	PEX3	Peroxisomal biogenesis factor 3	GO:0046983; F:protein dimerization activity; IDA:UniProtKB
P56589	PEX3	Peroxisomal biogenesis factor 3	GO:0016557; P:peroxisome membrane biogenesis; IEA:Ensembl
P56589	PEX3	Peroxisomal biogenesis factor 3	GO:0007031; P:peroxisome organization; IMP:UniProtKB
P56589	PEX3	Peroxisomal biogenesis factor 3	GO:0045046; P:protein import into peroxisome membrane; IMP:UniProtKB
P56589	PEX3	Peroxisomal biogenesis factor 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8IYB4	PEX5L	PEX5-related protein	GO:0005052; F:peroxisome matrix targeting signal-1 binding; IBA:RefGenome
Q8IYB4	PEX5L	PEX5-related protein	GO:0000268; F:peroxisome targeting sequence binding; IDA:UniProtKB
Q8IYB4	PEX5L	PEX5-related protein	GO:0031267; F:small GTPase binding; IPI:UniProtKB
Q8IYB4	PEX5L	PEX5-related protein	GO:0045185; P:maintenance of protein location; IEA:Ensembl
Q8IYB4	PEX5L	PEX5-related protein	GO:0016558; P:protein import into peroxisome matrix; IBA:RefGenome
Q8IYB4	PEX5L	PEX5-related protein	GO:0016560; P:protein import into peroxisome matrix, docking; IBA:RefGenome
Q8IYB4	PEX5L	PEX5-related protein	GO:0043949; P:regulation of cAMP-mediated signaling; ISS:UniProtKB
Q8IYB4	PEX5L	PEX5-related protein	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0019899; F:enzyme binding; IPI:UniProtKB
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0005052; F:peroxisome matrix targeting signal-1 binding; IDA:UniProtKB
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0000268; F:peroxisome targeting sequence binding; IDA:UniProtKB
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0031267; F:small GTPase binding; IPI:UniProtKB
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0048468; P:cell development; IEA:Ensembl
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0021795; P:cerebral cortex cell migration; IEA:Ensembl
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0021895; P:cerebral cortex neuron differentiation; IEA:Ensembl
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0007029; P:endoplasmic reticulum organization; IEA:Ensembl
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0006635; P:fatty acid beta-oxidation; IEA:Ensembl
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0007006; P:mitochondrial membrane organization; IEA:Ensembl
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:1901094; P:negative regulation of protein homotetramerization; IDA:UniProtKB
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0050905; P:neuromuscular process; IEA:Ensembl
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0001764; P:neuron migration; IEA:Ensembl
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0016558; P:protein import into peroxisome matrix; IGI:UniProtKB
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0016560; P:protein import into peroxisome matrix, docking; IDA:UniProtKB
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0016561; P:protein import into peroxisome matrix, translocation; IDA:UniProtKB
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0045046; P:protein import into peroxisome membrane; IMP:UniProtKB
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0006625; P:protein targeting to peroxisome; IDA:UniProtKB
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0051262; P:protein tetramerization; IDA:UniProtKB
P50542	PEX5	Peroxisomal targeting signal 1 receptor	GO:0000038; P:very long-chain fatty acid metabolic process; IEA:Ensembl
Q13608	PEX6	Peroxisome assembly factor 2	GO:0005524; F:ATP binding; IMP:UniProtKB
Q13608	PEX6	Peroxisome assembly factor 2	GO:0016887; F:ATPase activity; IMP:UniProtKB
Q13608	PEX6	Peroxisome assembly factor 2	GO:0042623; F:ATPase activity, coupled; IMP:UniProtKB
Q13608	PEX6	Peroxisome assembly factor 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q13608	PEX6	Peroxisome assembly factor 2	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q13608	PEX6	Peroxisome assembly factor 2	GO:0032403; F:protein complex binding; IDA:UniProtKB
Q13608	PEX6	Peroxisome assembly factor 2	GO:0006200; P:ATP catabolic process; IMP:GOC
Q13608	PEX6	Peroxisome assembly factor 2	GO:0007031; P:peroxisome organization; IMP:UniProtKB
Q13608	PEX6	Peroxisome assembly factor 2	GO:0016561; P:protein import into peroxisome matrix, translocation; IMP:UniProtKB
Q13608	PEX6	Peroxisome assembly factor 2	GO:0050821; P:protein stabilization; IMP:UniProtKB
Q13608	PEX6	Peroxisome assembly factor 2	GO:0006625; P:protein targeting to peroxisome; IMP:UniProtKB
O00628	PEX7	Peroxisomal targeting signal 2 receptor	GO:0019899; F:enzyme binding; IPI:UniProtKB
O00628	PEX7	Peroxisomal targeting signal 2 receptor	GO:0005053; F:peroxisome matrix targeting signal-2 binding; IDA:UniProtKB
O00628	PEX7	Peroxisomal targeting signal 2 receptor	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O00628	PEX7	Peroxisomal targeting signal 2 receptor	GO:0001958; P:endochondral ossification; IEA:Ensembl
O00628	PEX7	Peroxisomal targeting signal 2 receptor	GO:0008611; P:ether lipid biosynthetic process; IMP:UniProtKB
O00628	PEX7	Peroxisomal targeting signal 2 receptor	GO:0006635; P:fatty acid beta-oxidation; IEA:Ensembl
O00628	PEX7	Peroxisomal targeting signal 2 receptor	GO:0001764; P:neuron migration; IEA:Ensembl
O00628	PEX7	Peroxisomal targeting signal 2 receptor	GO:0007031; P:peroxisome organization; IMP:UniProtKB
O00628	PEX7	Peroxisomal targeting signal 2 receptor	GO:0016558; P:protein import into peroxisome matrix; IMP:UniProtKB
Q96BD5	PHF21A	PHD finger protein 21A	GO:0003682; F:chromatin binding; IEA:Ensembl
Q96BD5	PHF21A	PHD finger protein 21A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96BD5	PHF21A	PHD finger protein 21A	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96BD5	PHF21A	PHD finger protein 21A	GO:0007596; P:blood coagulation; TAS:Reactome
Q96BD5	PHF21A	PHD finger protein 21A	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q96BD5	PHF21A	PHD finger protein 21A	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q96BD5	PHF21A	PHD finger protein 21A	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96BD5	PHF21A	PHD finger protein 21A	GO:0001967; P:suckling behavior; IEA:Ensembl
Q96BD5	PHF21A	PHD finger protein 21A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P43088	PTGFR	Prostaglandin F2-alpha receptor	GO:0004958; F:prostaglandin F receptor activity; IDA:UniProtKB
P43088	PTGFR	Prostaglandin F2-alpha receptor	GO:0035584; P:calcium-mediated signaling using intracellular calcium source; IDA:UniProtKB
P43088	PTGFR	Prostaglandin F2-alpha receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P43088	PTGFR	Prostaglandin F2-alpha receptor	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P43088	PTGFR	Prostaglandin F2-alpha receptor	GO:0007567; P:parturition; TAS:ProtInc
P43088	PTGFR	Prostaglandin F2-alpha receptor	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
Q96EK2	PHF21B	PHD finger protein 21B	GO:0008270; F:zinc ion binding; IEA:InterPro
P10720	PF4V1	Platelet factor 4 variant	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P10720	PF4V1	Platelet factor 4 variant	GO:0060326; P:cell chemotaxis; IEA:GOC
P10720	PF4V1	Platelet factor 4 variant	GO:0006955; P:immune response; IEA:InterPro
O60925	PFDN1	Prefoldin subunit 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O60925	PFDN1	Prefoldin subunit 1	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
O60925	PFDN1	Prefoldin subunit 1	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
O60925	PFDN1	Prefoldin subunit 1	GO:0042113; P:B cell activation; IEA:Ensembl
O60925	PFDN1	Prefoldin subunit 1	GO:0007049; P:cell cycle; TAS:ProtInc
O60925	PFDN1	Prefoldin subunit 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O60925	PFDN1	Prefoldin subunit 1	GO:0021549; P:cerebellum development; IEA:Ensembl
O60925	PFDN1	Prefoldin subunit 1	GO:0006457; P:protein folding; TAS:Reactome
O60925	PFDN1	Prefoldin subunit 1	GO:0006355; P:regulation of transcription, DNA-templated; TAS:GOC
O60925	PFDN1	Prefoldin subunit 1	GO:0021537; P:telencephalon development; IEA:Ensembl
Q9UHV9	PFDN2	Prefoldin subunit 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UHV9	PFDN2	Prefoldin subunit 2	GO:0051082; F:unfolded protein binding; NAS:UniProtKB
Q9UHV9	PFDN2	Prefoldin subunit 2	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
Q9UHV9	PFDN2	Prefoldin subunit 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UHV9	PFDN2	Prefoldin subunit 2	GO:0006457; P:protein folding; NAS:UniProtKB
P61758	VBP1	Prefoldin subunit 3	GO:0005515; F:protein binding; IPI:IntAct
P61758	VBP1	Prefoldin subunit 3	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
P61758	VBP1	Prefoldin subunit 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P61758	VBP1	Prefoldin subunit 3	GO:0006457; P:protein folding; TAS:Reactome
Q9NQP4	PFDN4	Prefoldin subunit 4	GO:0051087; F:chaperone binding; TAS:UniProtKB
Q9NQP4	PFDN4	Prefoldin subunit 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NQP4	PFDN4	Prefoldin subunit 4	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
Q9NQP4	PFDN4	Prefoldin subunit 4	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9NQP4	PFDN4	Prefoldin subunit 4	GO:0006457; P:protein folding; TAS:UniProtKB
Q99471	PFDN5	Prefoldin subunit 5	GO:0005515; F:protein binding; IPI:IntAct
Q99471	PFDN5	Prefoldin subunit 5	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q99471	PFDN5	Prefoldin subunit 5	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
Q99471	PFDN5	Prefoldin subunit 5	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q99471	PFDN5	Prefoldin subunit 5	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
Q99471	PFDN5	Prefoldin subunit 5	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:BHF-UCL
Q99471	PFDN5	Prefoldin subunit 5	GO:0006457; P:protein folding; TAS:Reactome
Q99471	PFDN5	Prefoldin subunit 5	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
Q99471	PFDN5	Prefoldin subunit 5	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
O15212	PFDN6	Prefoldin subunit 6	GO:0051087; F:chaperone binding; IDA:UniProtKB
O15212	PFDN6	Prefoldin subunit 6	GO:0051082; F:unfolded protein binding; NAS:UniProtKB
O15212	PFDN6	Prefoldin subunit 6	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
O15212	PFDN6	Prefoldin subunit 6	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O15212	PFDN6	Prefoldin subunit 6	GO:0051131; P:chaperone-mediated protein complex assembly; IDA:UniProtKB
O15212	PFDN6	Prefoldin subunit 6	GO:0006457; P:protein folding; NAS:UniProtKB
Q9BZM1	PLA2G12A	Group XIIA secretory phospholipase A2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9BZM1	PLA2G12A	Group XIIA secretory phospholipase A2	GO:0047498; F:calcium-dependent phospholipase A2 activity; NAS:UniProtKB
Q9BZM1	PLA2G12A	Group XIIA secretory phospholipase A2	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9BZM1	PLA2G12A	Group XIIA secretory phospholipase A2	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q9BZM1	PLA2G12A	Group XIIA secretory phospholipase A2	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
Q9BZM1	PLA2G12A	Group XIIA secretory phospholipase A2	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
Q9BZM1	PLA2G12A	Group XIIA secretory phospholipase A2	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
Q9BZM1	PLA2G12A	Group XIIA secretory phospholipase A2	GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome
Q9BZM1	PLA2G12A	Group XIIA secretory phospholipase A2	GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome
Q9BZM1	PLA2G12A	Group XIIA secretory phospholipase A2	GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome
Q9BZM1	PLA2G12A	Group XIIA secretory phospholipase A2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9BZM1	PLA2G12A	Group XIIA secretory phospholipase A2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BX93	PLA2G12B	Group XIIB secretory phospholipase A2-like protein	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9BX93	PLA2G12B	Group XIIB secretory phospholipase A2-like protein	GO:0004623; F:phospholipase A2 activity; IEA:InterPro
Q9BX93	PLA2G12B	Group XIIB secretory phospholipase A2-like protein	GO:0016042; P:lipid catabolic process; IEA:InterPro
Q9H720	CWH43	PGAP2-interacting protein	GO:0006506; P:GPI anchor biosynthetic process; IEA:UniProtKB-KW
P18669	PGAM1	Phosphoglycerate mutase 1	GO:0004083; F:bisphosphoglycerate 2-phosphatase activity; IEA:UniProtKB-EC
P18669	PGAM1	Phosphoglycerate mutase 1	GO:0004082; F:bisphosphoglycerate mutase activity; IEA:UniProtKB-EC
P18669	PGAM1	Phosphoglycerate mutase 1	GO:0004619; F:phosphoglycerate mutase activity; IMP:UniProtKB
P18669	PGAM1	Phosphoglycerate mutase 1	GO:0005515; F:protein binding; IPI:IntAct
P18669	PGAM1	Phosphoglycerate mutase 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P18669	PGAM1	Phosphoglycerate mutase 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P18669	PGAM1	Phosphoglycerate mutase 1	GO:0006094; P:gluconeogenesis; TAS:Reactome
P18669	PGAM1	Phosphoglycerate mutase 1	GO:0006006; P:glucose metabolic process; TAS:Reactome
P18669	PGAM1	Phosphoglycerate mutase 1	GO:0006096; P:glycolytic process; IDA:UniProt
P18669	PGAM1	Phosphoglycerate mutase 1	GO:0006110; P:regulation of glycolytic process; IDA:UniProtKB
P18669	PGAM1	Phosphoglycerate mutase 1	GO:0043456; P:regulation of pentose-phosphate shunt; IDA:UniProtKB
P18669	PGAM1	Phosphoglycerate mutase 1	GO:0045730; P:respiratory burst; IDA:UniProtKB
P18669	PGAM1	Phosphoglycerate mutase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P15259	PGAM2	Phosphoglycerate mutase 2	GO:0046538; F:2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity; IEA:Ensembl
P15259	PGAM2	Phosphoglycerate mutase 2	GO:0004083; F:bisphosphoglycerate 2-phosphatase activity; IEA:UniProtKB-EC
P15259	PGAM2	Phosphoglycerate mutase 2	GO:0004082; F:bisphosphoglycerate mutase activity; IEA:UniProtKB-EC
P15259	PGAM2	Phosphoglycerate mutase 2	GO:0048037; F:cofactor binding; IEA:Ensembl
P15259	PGAM2	Phosphoglycerate mutase 2	GO:0004619; F:phosphoglycerate mutase activity; IMP:UniProtKB
P15259	PGAM2	Phosphoglycerate mutase 2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P15259	PGAM2	Phosphoglycerate mutase 2	GO:0006094; P:gluconeogenesis; TAS:Reactome
P15259	PGAM2	Phosphoglycerate mutase 2	GO:0006006; P:glucose metabolic process; TAS:Reactome
P15259	PGAM2	Phosphoglycerate mutase 2	GO:0006096; P:glycolytic process; IMP:UniProtKB
P15259	PGAM2	Phosphoglycerate mutase 2	GO:0046689; P:response to mercury ion; IEA:Ensembl
P15259	PGAM2	Phosphoglycerate mutase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P15259	PGAM2	Phosphoglycerate mutase 2	GO:0007283; P:spermatogenesis; IEA:Ensembl
P15259	PGAM2	Phosphoglycerate mutase 2	GO:0006941; P:striated muscle contraction; IMP:UniProtKB
Q8N0Y7	PGAM4	Probable phosphoglycerate mutase 4	GO:0004083; F:bisphosphoglycerate 2-phosphatase activity; IEA:UniProtKB-EC
Q8N0Y7	PGAM4	Probable phosphoglycerate mutase 4	GO:0004082; F:bisphosphoglycerate mutase activity; IEA:UniProtKB-EC
Q8N0Y7	PGAM4	Probable phosphoglycerate mutase 4	GO:0004619; F:phosphoglycerate mutase activity; NAS:UniProtKB
Q8N0Y7	PGAM4	Probable phosphoglycerate mutase 4	GO:0006096; P:glycolytic process; NAS:UniProtKB
Q8N0Y7	PGAM4	Probable phosphoglycerate mutase 4	GO:1902093; P:positive regulation of sperm motility; NAS:UniProt
Q96HS1	PGAM5	Serine/threonine-protein phosphatase PGAM5, mitochondrial	GO:0005096; F:GTPase activator activity; IMP:UniProtKB
Q96HS1	PGAM5	Serine/threonine-protein phosphatase PGAM5, mitochondrial	GO:0016791; F:phosphatase activity; IMP:UniProtKB
Q96HS1	PGAM5	Serine/threonine-protein phosphatase PGAM5, mitochondrial	GO:0004721; F:phosphoprotein phosphatase activity; IEA:UniProtKB-EC
Q96HS1	PGAM5	Serine/threonine-protein phosphatase PGAM5, mitochondrial	GO:0032403; F:protein complex binding; IDA:UniProtKB
Q96HS1	PGAM5	Serine/threonine-protein phosphatase PGAM5, mitochondrial	GO:0016311; P:dephosphorylation; IMP:GOC
Q96HS1	PGAM5	Serine/threonine-protein phosphatase PGAM5, mitochondrial	GO:0070266; P:necroptotic process; IMP:UniProtKB
Q96HS1	PGAM5	Serine/threonine-protein phosphatase PGAM5, mitochondrial	GO:0043547; P:positive regulation of GTPase activity; IMP:GOC
Q75T13	PGAP1	GPI inositol-deacylase	GO:0004518; F:nuclease activity; ISS:UniProtKB
Q75T13	PGAP1	GPI inositol-deacylase	GO:0042578; F:phosphoric ester hydrolase activity; ISS:UniProtKB
Q75T13	PGAP1	GPI inositol-deacylase	GO:0009948; P:anterior/posterior axis specification; IEA:Ensembl
Q75T13	PGAP1	GPI inositol-deacylase	GO:0016255; P:attachment of GPI anchor to protein; TAS:Reactome
Q75T13	PGAP1	GPI inositol-deacylase	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
Q75T13	PGAP1	GPI inositol-deacylase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q75T13	PGAP1	GPI inositol-deacylase	GO:0009880; P:embryonic pattern specification; IEA:Ensembl
Q75T13	PGAP1	GPI inositol-deacylase	GO:0021871; P:forebrain regionalization; IEA:Ensembl
Q75T13	PGAP1	GPI inositol-deacylase	GO:0060322; P:head development; IEA:Ensembl
Q75T13	PGAP1	GPI inositol-deacylase	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q75T13	PGAP1	GPI inositol-deacylase	GO:0015798; P:myo-inositol transport; ISS:UniProtKB
Q75T13	PGAP1	GPI inositol-deacylase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q75T13	PGAP1	GPI inositol-deacylase	GO:0007605; P:sensory perception of sound; IEA:Ensembl
Q9UHJ9	PGAP2	Post-GPI attachment to proteins factor 2	GO:0008565; F:protein transporter activity; ISS:UniProtKB
Q9UHJ9	PGAP2	Post-GPI attachment to proteins factor 2	GO:0006506; P:GPI anchor biosynthetic process; ISS:UniProtKB
Q9UHJ9	PGAP2	Post-GPI attachment to proteins factor 2	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IEA:Ensembl
Q9UHJ9	PGAP2	Post-GPI attachment to proteins factor 2	GO:1902230; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
Q9UHJ9	PGAP2	Post-GPI attachment to proteins factor 2	GO:0042770; P:signal transduction in response to DNA damage; IEA:Ensembl
Q96FM1	PGAP3	Post-GPI attachment to proteins factor 3	GO:0016788; F:hydrolase activity, acting on ester bonds; IMP:UniProtKB
Q96FM1	PGAP3	Post-GPI attachment to proteins factor 3	GO:0006506; P:GPI anchor biosynthetic process; IEA:UniProtKB-KW
Q96FM1	PGAP3	Post-GPI attachment to proteins factor 3	GO:0006505; P:GPI anchor metabolic process; IMP:UniProtKB
Q96JS3	PGBD1	PiggyBac transposable element-derived protein 1	GO:0005044; F:scavenger receptor activity; IEA:InterPro
Q96JS3	PGBD1	PiggyBac transposable element-derived protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0005515; F:protein binding; IPI:UniProtKB
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0007420; P:brain development; IEA:Ensembl
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0048738; P:cardiac muscle tissue development; IEA:Ensembl
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; IEA:Ensembl
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0002062; P:chondrocyte differentiation; IEA:Ensembl
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0001958; P:endochondral ossification; IEA:Ensembl
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0008104; P:protein localization; IEA:Ensembl
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P98160	HSPG2	Basement membrane-specific heparan sulfate proteoglycan core protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P16112	ACAN	Aggrecan core protein	GO:0030246; F:carbohydrate binding; IEA:InterPro
P16112	ACAN	Aggrecan core protein	GO:0005201; F:extracellular matrix structural constituent; TAS:UniProtKB
P16112	ACAN	Aggrecan core protein	GO:0005540; F:hyaluronic acid binding; IEA:InterPro
P16112	ACAN	Aggrecan core protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P16112	ACAN	Aggrecan core protein	GO:0005515; F:protein binding; IPI:UniProtKB
P16112	ACAN	Aggrecan core protein	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P16112	ACAN	Aggrecan core protein	GO:0007155; P:cell adhesion; IEA:InterPro
P16112	ACAN	Aggrecan core protein	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P16112	ACAN	Aggrecan core protein	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P16112	ACAN	Aggrecan core protein	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P16112	ACAN	Aggrecan core protein	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
P16112	ACAN	Aggrecan core protein	GO:0042340; P:keratan sulfate catabolic process; TAS:Reactome
P16112	ACAN	Aggrecan core protein	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
P16112	ACAN	Aggrecan core protein	GO:0006508; P:proteolysis; NAS:UniProtKB
P16112	ACAN	Aggrecan core protein	GO:0001501; P:skeletal system development; NAS:UniProtKB
P16112	ACAN	Aggrecan core protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96GW7	BCAN	Brevican core protein	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q96GW7	BCAN	Brevican core protein	GO:0005540; F:hyaluronic acid binding; IEA:UniProtKB-KW
Q96GW7	BCAN	Brevican core protein	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q96GW7	BCAN	Brevican core protein	GO:0007155; P:cell adhesion; IEA:InterPro
Q96GW7	BCAN	Brevican core protein	GO:0030206; P:chondroitin sulfate biosynthetic process; TAS:Reactome
Q96GW7	BCAN	Brevican core protein	GO:0030207; P:chondroitin sulfate catabolic process; TAS:Reactome
Q96GW7	BCAN	Brevican core protein	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q96GW7	BCAN	Brevican core protein	GO:0030208; P:dermatan sulfate biosynthetic process; TAS:Reactome
Q96GW7	BCAN	Brevican core protein	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q96GW7	BCAN	Brevican core protein	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q96GW7	BCAN	Brevican core protein	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q96GW7	BCAN	Brevican core protein	GO:0021766; P:hippocampus development; IEA:Ensembl
Q96GW7	BCAN	Brevican core protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P15428	HPGD	15-hydroxyprostaglandin dehydrogenase [NAD(+)]	GO:0016404; F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; IDA:UniProtKB
P15428	HPGD	15-hydroxyprostaglandin dehydrogenase [NAD(+)]	GO:0003824; F:catalytic activity; IDA:UniProtKB
P15428	HPGD	15-hydroxyprostaglandin dehydrogenase [NAD(+)]	GO:0051287; F:NAD binding; IDA:UniProtKB
P15428	HPGD	15-hydroxyprostaglandin dehydrogenase [NAD(+)]	GO:0070403; F:NAD+ binding; IDA:UniProtKB
P15428	HPGD	15-hydroxyprostaglandin dehydrogenase [NAD(+)]	GO:0004957; F:prostaglandin E receptor activity; IDA:UniProtKB
P15428	HPGD	15-hydroxyprostaglandin dehydrogenase [NAD(+)]	GO:0042803; F:protein homodimerization activity; TAS:UniProtKB
P15428	HPGD	15-hydroxyprostaglandin dehydrogenase [NAD(+)]	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P15428	HPGD	15-hydroxyprostaglandin dehydrogenase [NAD(+)]	GO:0019371; P:cyclooxygenase pathway; TAS:Reactome
P15428	HPGD	15-hydroxyprostaglandin dehydrogenase [NAD(+)]	GO:0097070; P:ductus arteriosus closure; ISS:UniProtKB
P15428	HPGD	15-hydroxyprostaglandin dehydrogenase [NAD(+)]	GO:0007565; P:female pregnancy; IDA:UniProtKB
P15428	HPGD	15-hydroxyprostaglandin dehydrogenase [NAD(+)]	GO:2001300; P:lipoxin metabolic process; TAS:Reactome
P15428	HPGD	15-hydroxyprostaglandin dehydrogenase [NAD(+)]	GO:0019372; P:lipoxygenase pathway; TAS:UniProtKB
P15428	HPGD	15-hydroxyprostaglandin dehydrogenase [NAD(+)]	GO:0045786; P:negative regulation of cell cycle; IDA:UniProtKB
P15428	HPGD	15-hydroxyprostaglandin dehydrogenase [NAD(+)]	GO:0030728; P:ovulation; ISS:UniProtKB
P15428	HPGD	15-hydroxyprostaglandin dehydrogenase [NAD(+)]	GO:0007567; P:parturition; IDA:UniProtKB
P15428	HPGD	15-hydroxyprostaglandin dehydrogenase [NAD(+)]	GO:0006693; P:prostaglandin metabolic process; IDA:UniProtKB
P15428	HPGD	15-hydroxyprostaglandin dehydrogenase [NAD(+)]	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P15428	HPGD	15-hydroxyprostaglandin dehydrogenase [NAD(+)]	GO:0070493; P:thrombin receptor signaling pathway; ISS:UniProtKB
P15428	HPGD	15-hydroxyprostaglandin dehydrogenase [NAD(+)]	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
Q9H7Z7	PTGES2	Prostaglandin E synthase 2	GO:0003677; F:DNA binding; IEA:Ensembl
Q9H7Z7	PTGES2	Prostaglandin E synthase 2	GO:0009055; F:electron carrier activity; IEA:InterPro
Q9H7Z7	PTGES2	Prostaglandin E synthase 2	GO:0043295; F:glutathione binding; ISS:UniProtKB
Q9H7Z7	PTGES2	Prostaglandin E synthase 2	GO:0020037; F:heme binding; ISS:UniProtKB
Q9H7Z7	PTGES2	Prostaglandin E synthase 2	GO:0016829; F:lyase activity; ISS:UniProtKB
Q9H7Z7	PTGES2	Prostaglandin E synthase 2	GO:0050220; F:prostaglandin-E synthase activity; IEA:UniProtKB-EC
Q9H7Z7	PTGES2	Prostaglandin E synthase 2	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
Q9H7Z7	PTGES2	Prostaglandin E synthase 2	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q9H7Z7	PTGES2	Prostaglandin E synthase 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q9H7Z7	PTGES2	Prostaglandin E synthase 2	GO:0001516; P:prostaglandin biosynthetic process; IEA:UniProtKB-UniPathway
Q9H7Z7	PTGES2	Prostaglandin E synthase 2	GO:0046903; P:secretion; IEA:Ensembl
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0005018; F:platelet-derived growth factor alpha-receptor activity; IDA:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0048407; F:platelet-derived growth factor binding; IDA:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0005161; F:platelet-derived growth factor receptor binding; IPI:BHF-UCL
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IDA:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0038085; F:vascular endothelial growth factor binding; IPI:BHF-UCL
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0005021; F:vascular endothelial growth factor-activated receptor activity; IDA:BHF-UCL
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0030325; P:adrenal gland development; IEA:Ensembl
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0055003; P:cardiac myofibril assembly; ISS:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0001775; P:cell activation; TAS:BHF-UCL
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0060326; P:cell chemotaxis; IMP:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0048701; P:embryonic cranial skeleton morphogenesis; ISS:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0048557; P:embryonic digestive tract morphogenesis; ISS:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0048704; P:embryonic skeletal system morphogenesis; ISS:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0008210; P:estrogen metabolic process; IEA:Ensembl
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0060325; P:face morphogenesis; IEA:Ensembl
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0045087; P:innate immune response; TAS:Reactome
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0033327; P:Leydig cell differentiation; IEA:Ensembl
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0030324; P:lung development; IEA:Ensembl
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0001553; P:luteinization; ISS:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0030539; P:male genitalia development; IEA:Ensembl
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0072277; P:metanephric glomerular capillary formation; ISS:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0010544; P:negative regulation of platelet activation; IDA:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0060021; P:palate development; IEA:Ensembl
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0048015; P:phosphatidylinositol-mediated signaling; IMP:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0070527; P:platelet aggregation; IMP:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IDA:BHF-UCL
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0035790; P:platelet-derived growth factor receptor-alpha signaling pathway; IMP:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0038091; P:positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway; IDA:BHF-UCL
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IMP:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0045740; P:positive regulation of DNA replication; IDA:BHF-UCL
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0048146; P:positive regulation of fibroblast proliferation; IDA:BHF-UCL
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IMP:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; TAS:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0010863; P:positive regulation of phospholipase C activity; IMP:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:2000249; P:regulation of actin cytoskeleton reorganization; TAS:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0050920; P:regulation of chemotaxis; IMP:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:2000739; P:regulation of mesenchymal stem cell differentiation; IMP:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0061298; P:retina vasculature development in camera-type eye; ISS:UniProtKB
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0016032; P:viral process; IEA:UniProtKB-KW
P16234	PDGFRA	Platelet-derived growth factor receptor alpha	GO:0042060; P:wound healing; ISS:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0004992; F:platelet activating factor receptor activity; TAS:ProtInc
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0005019; F:platelet-derived growth factor beta-receptor activity; IDA:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0048407; F:platelet-derived growth factor binding; IDA:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0005161; F:platelet-derived growth factor receptor binding; IPI:BHF-UCL
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0005017; F:platelet-derived growth factor-activated receptor activity; TAS:ProtInc
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0005515; F:protein binding; IPI:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0005102; F:receptor binding; IPI:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0038085; F:vascular endothelial growth factor binding; IPI:BHF-UCL
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0030325; P:adrenal gland development; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0035909; P:aorta morphogenesis; ISS:BHF-UCL
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0055003; P:cardiac myofibril assembly; ISS:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0060326; P:cell chemotaxis; IDA:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0016477; P:cell migration; IMP:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0060981; P:cell migration involved in coronary angiogenesis; ISS:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0035441; P:cell migration involved in vasculogenesis; ISS:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0036120; P:cellular response to platelet-derived growth factor stimulus; TAS:GOC
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GOC
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0006024; P:glycosaminoglycan biosynthetic process; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0045087; P:innate immune response; TAS:Reactome
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0048839; P:inner ear development; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0072278; P:metanephric comma-shaped body morphogenesis; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0072277; P:metanephric glomerular capillary formation; ISS:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0072262; P:metanephric glomerular mesangial cell proliferation involved in metanephros development; ISS:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0035789; P:metanephric mesenchymal cell migration; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0072075; P:metanephric mesenchyme development; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0072284; P:metanephric S-shaped body morphogenesis; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0046488; P:phosphatidylinositol metabolic process; IMP:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0048015; P:phosphatidylinositol-mediated signaling; IMP:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IDA:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0035791; P:platelet-derived growth factor receptor-beta signaling pathway; IMP:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0090280; P:positive regulation of calcium ion import; ISS:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0030335; P:positive regulation of cell migration; IDA:BHF-UCL
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0038091; P:positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway; IDA:BHF-UCL
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0050921; P:positive regulation of chemotaxis; ISS:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0032967; P:positive regulation of collagen biosynthetic process; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:2000573; P:positive regulation of DNA biosynthetic process; ISS:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0043406; P:positive regulation of MAP kinase activity; ISS:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0035793; P:positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway; ISS:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0045840; P:positive regulation of mitosis; ISS:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IDA:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; ISS:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0010863; P:positive regulation of phospholipase C activity; IDA:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0032516; P:positive regulation of phosphoprotein phosphatase activity; IDA:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; ISS:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0014911; P:positive regulation of smooth muscle cell migration; IMP:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IMP:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0032956; P:regulation of actin cytoskeleton organization; ISS:BHF-UCL
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0032355; P:response to estradiol; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0034405; P:response to fluid shear stress; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0055093; P:response to hyperoxia; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0032526; P:response to retinoic acid; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0009636; P:response to toxic substance; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0061298; P:retina vasculature development in camera-type eye; ISS:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0007165; P:signal transduction; IDA:UniProtKB
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0071670; P:smooth muscle cell chemotaxis; ISS:BHF-UCL
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0048745; P:smooth muscle tissue development; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0001894; P:tissue homeostasis; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl
P09619	PDGFRB	Platelet-derived growth factor receptor beta	GO:0042060; P:wound healing; IEA:Ensembl
Q8TBF2	FAM213B	Prostamide/prostaglandin F synthase	GO:0016616; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; ISS:UniProtKB
Q8TBF2	FAM213B	Prostamide/prostaglandin F synthase	GO:0047017; F:prostaglandin-F synthase activity; ISS:UniProt
Q8TBF2	FAM213B	Prostamide/prostaglandin F synthase	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
Q8TBF2	FAM213B	Prostamide/prostaglandin F synthase	GO:0019371; P:cyclooxygenase pathway; TAS:Reactome
Q8TBF2	FAM213B	Prostamide/prostaglandin F synthase	GO:0001516; P:prostaglandin biosynthetic process; ISS:UniProtKB
Q8TBF2	FAM213B	Prostamide/prostaglandin F synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15198	PDGFRL	Platelet-derived growth factor receptor-like protein	GO:0004992; F:platelet activating factor receptor activity; TAS:ProtInc
Q15198	PDGFRL	Platelet-derived growth factor receptor-like protein	GO:0005019; F:platelet-derived growth factor beta-receptor activity; TAS:ProtInc
Q15198	PDGFRL	Platelet-derived growth factor receptor-like protein	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GOC
Q15198	PDGFRL	Platelet-derived growth factor receptor-like protein	GO:0035791; P:platelet-derived growth factor receptor-beta signaling pathway; TAS:GOC
P23219	PTGS1	Prostaglandin G/H synthase 1	GO:0051213; F:dioxygenase activity; IEA:UniProtKB-KW
P23219	PTGS1	Prostaglandin G/H synthase 1	GO:0020037; F:heme binding; IEA:InterPro
P23219	PTGS1	Prostaglandin G/H synthase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P23219	PTGS1	Prostaglandin G/H synthase 1	GO:0004601; F:peroxidase activity; IEA:InterPro
P23219	PTGS1	Prostaglandin G/H synthase 1	GO:0004666; F:prostaglandin-endoperoxide synthase activity; IDA:BHF-UCL
P23219	PTGS1	Prostaglandin G/H synthase 1	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P23219	PTGS1	Prostaglandin G/H synthase 1	GO:0019371; P:cyclooxygenase pathway; IDA:BHF-UCL
P23219	PTGS1	Prostaglandin G/H synthase 1	GO:0006629; P:lipid metabolic process; NAS:ProtInc
P23219	PTGS1	Prostaglandin G/H synthase 1	GO:0001516; P:prostaglandin biosynthetic process; ISS:UniProtKB
P23219	PTGS1	Prostaglandin G/H synthase 1	GO:0008217; P:regulation of blood pressure; ISS:UniProtKB
P23219	PTGS1	Prostaglandin G/H synthase 1	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P23219	PTGS1	Prostaglandin G/H synthase 1	GO:0006979; P:response to oxidative stress; IEA:InterPro
P23219	PTGS1	Prostaglandin G/H synthase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P23219	PTGS1	Prostaglandin G/H synthase 1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0050473; F:arachidonate 15-lipoxygenase activity; TAS:Reactome
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0019899; F:enzyme binding; IPI:UniProtKB
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0020037; F:heme binding; ISS:UniProtKB
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0008289; F:lipid binding; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0004601; F:peroxidase activity; NAS:UniProtKB
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0004666; F:prostaglandin-endoperoxide synthase activity; IDA:UniProtKB
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0042640; P:anagen; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0001525; P:angiogenesis; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0030282; P:bone mineralization; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0006928; P:cellular component movement; TAS:ProtInc
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0071318; P:cellular response to ATP; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0071456; P:cellular response to hypoxia; IEP:UniProtKB
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0034644; P:cellular response to UV; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0019371; P:cyclooxygenase pathway; IDA:BHF-UCL
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0046697; P:decidualization; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0007566; P:embryo implantation; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0006954; P:inflammatory response; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0007612; P:learning; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0019372; P:lipoxygenase pathway; TAS:Reactome
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0035633; P:maintenance of blood-brain barrier; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0007613; P:memory; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0051926; P:negative regulation of calcium ion transport; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0045786; P:negative regulation of cell cycle; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0045986; P:negative regulation of smooth muscle contraction; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0032227; P:negative regulation of synaptic transmission, dopaminergic; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0030728; P:ovulation; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0090336; P:positive regulation of brown fat cell differentiation; ISS:BHF-UCL
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; ISS:BHF-UCL
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0031622; P:positive regulation of fever generation; ISS:BHF-UCL
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0090271; P:positive regulation of fibroblast growth factor production; ISS:BHF-UCL
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0042346; P:positive regulation of NF-kappaB import into nucleus; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; ISS:BHF-UCL
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0090362; P:positive regulation of platelet-derived growth factor production; ISS:BHF-UCL
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0031394; P:positive regulation of prostaglandin biosynthetic process; NAS:BHF-UCL
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0045987; P:positive regulation of smooth muscle contraction; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0031915; P:positive regulation of synaptic plasticity; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0071636; P:positive regulation of transforming growth factor beta production; ISS:BHF-UCL
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0010575; P:positive regulation vascular endothelial growth factor production; ISS:BHF-UCL
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0001516; P:prostaglandin biosynthetic process; ISS:UniProtKB
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0006693; P:prostaglandin metabolic process; TAS:ProtInc
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0008217; P:regulation of blood pressure; ISS:UniProtKB
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0050727; P:regulation of inflammatory response; NAS:UniProtKB
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0042493; P:response to drug; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0032355; P:response to estradiol; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0070542; P:response to fatty acid; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0009750; P:response to fructose; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0010226; P:response to lithium ion; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0010042; P:response to manganese ion; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0006979; P:response to oxidative stress; IEA:InterPro
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0034612; P:response to tumor necrosis factor; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0033280; P:response to vitamin D; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P35354	PTGS2	Prostaglandin G/H synthase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P00558	PGK1	Phosphoglycerate kinase 1	GO:0005524; F:ATP binding; ISS:UniProtKB
P00558	PGK1	Phosphoglycerate kinase 1	GO:0004618; F:phosphoglycerate kinase activity; ISS:UniProtKB
P00558	PGK1	Phosphoglycerate kinase 1	GO:0005515; F:protein binding; IPI:IntAct
P00558	PGK1	Phosphoglycerate kinase 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P00558	PGK1	Phosphoglycerate kinase 1	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
P00558	PGK1	Phosphoglycerate kinase 1	GO:0006094; P:gluconeogenesis; TAS:Reactome
P00558	PGK1	Phosphoglycerate kinase 1	GO:0006006; P:glucose metabolic process; TAS:Reactome
P00558	PGK1	Phosphoglycerate kinase 1	GO:0006096; P:glycolytic process; TAS:Reactome
P00558	PGK1	Phosphoglycerate kinase 1	GO:0016310; P:phosphorylation; ISS:UniProtKB
P00558	PGK1	Phosphoglycerate kinase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P07205	PGK2	Phosphoglycerate kinase 2	GO:0005524; F:ATP binding; ISS:UniProtKB
P07205	PGK2	Phosphoglycerate kinase 2	GO:0004618; F:phosphoglycerate kinase activity; ISS:UniProtKB
P07205	PGK2	Phosphoglycerate kinase 2	GO:0006096; P:glycolytic process; NAS:UniProtKB
P07205	PGK2	Phosphoglycerate kinase 2	GO:0016310; P:phosphorylation; ISS:UniProtKB
Q8NBL1	POGLUT1	Protein O-glucosyltransferase 1	GO:0046527; F:glucosyltransferase activity; IDA:MGI
Q8NBL1	POGLUT1	Protein O-glucosyltransferase 1	GO:0035251; F:UDP-glucosyltransferase activity; IDA:UniProtKB
Q8NBL1	POGLUT1	Protein O-glucosyltransferase 1	GO:0035252; F:UDP-xylosyltransferase activity; IEA:Ensembl
Q8NBL1	POGLUT1	Protein O-glucosyltransferase 1	GO:0072358; P:cardiovascular system development; IEA:Ensembl
Q8NBL1	POGLUT1	Protein O-glucosyltransferase 1	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q8NBL1	POGLUT1	Protein O-glucosyltransferase 1	GO:0006493; P:protein O-linked glycosylation; IDA:MGI
Q8NBL1	POGLUT1	Protein O-glucosyltransferase 1	GO:0008593; P:regulation of Notch signaling pathway; IEA:Ensembl
P36871	PGM1	Phosphoglucomutase-1	GO:0000287; F:magnesium ion binding; IEA:InterPro
P36871	PGM1	Phosphoglucomutase-1	GO:0004614; F:phosphoglucomutase activity; IDA:UniProtKB
P36871	PGM1	Phosphoglucomutase-1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P36871	PGM1	Phosphoglucomutase-1	GO:0019388; P:galactose catabolic process; IBA:RefGenome
P36871	PGM1	Phosphoglucomutase-1	GO:0006094; P:gluconeogenesis; TAS:UniProtKB
P36871	PGM1	Phosphoglucomutase-1	GO:0006006; P:glucose metabolic process; NAS:UniProtKB
P36871	PGM1	Phosphoglucomutase-1	GO:0005978; P:glycogen biosynthetic process; IBA:RefGenome
P36871	PGM1	Phosphoglucomutase-1	GO:0005980; P:glycogen catabolic process; TAS:Reactome
P36871	PGM1	Phosphoglucomutase-1	GO:0006096; P:glycolytic process; TAS:UniProtKB
P36871	PGM1	Phosphoglucomutase-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6PCE3	PGM2L1	Glucose 1,6-bisphosphate synthase	GO:0047933; F:glucose-1,6-bisphosphate synthase activity; IDA:UniProtKB
Q6PCE3	PGM2L1	Glucose 1,6-bisphosphate synthase	GO:0004614; F:phosphoglucomutase activity; IBA:RefGenome
Q6PCE3	PGM2L1	Glucose 1,6-bisphosphate synthase	GO:0016052; P:carbohydrate catabolic process; IBA:RefGenome
Q6PCE3	PGM2L1	Glucose 1,6-bisphosphate synthase	GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW
Q6PCE3	PGM2L1	Glucose 1,6-bisphosphate synthase	GO:0016310; P:phosphorylation; IDA:GOC
Q96G03	PGM2	Phosphoglucomutase-2	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q96G03	PGM2	Phosphoglucomutase-2	GO:0004614; F:phosphoglucomutase activity; IBA:RefGenome
Q96G03	PGM2	Phosphoglucomutase-2	GO:0008973; F:phosphopentomutase activity; IDA:UniProtKB
Q96G03	PGM2	Phosphoglucomutase-2	GO:0016052; P:carbohydrate catabolic process; IBA:RefGenome
Q96G03	PGM2	Phosphoglucomutase-2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q96G03	PGM2	Phosphoglucomutase-2	GO:0046386; P:deoxyribose phosphate catabolic process; IEA:UniProtKB-UniPathway
Q96G03	PGM2	Phosphoglucomutase-2	GO:0019388; P:galactose catabolic process; TAS:Reactome
Q96G03	PGM2	Phosphoglucomutase-2	GO:0006006; P:glucose metabolic process; TAS:Reactome
Q96G03	PGM2	Phosphoglucomutase-2	GO:0005978; P:glycogen biosynthetic process; TAS:Reactome
Q96G03	PGM2	Phosphoglucomutase-2	GO:0005980; P:glycogen catabolic process; TAS:Reactome
Q96G03	PGM2	Phosphoglucomutase-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15124	PGM5	Phosphoglucomutase-like protein 5	GO:0016868; F:intramolecular transferase activity, phosphotransferases; IEA:InterPro
Q15124	PGM5	Phosphoglucomutase-like protein 5	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q15124	PGM5	Phosphoglucomutase-like protein 5	GO:0005198; F:structural molecule activity; NAS:UniProtKB
Q15124	PGM5	Phosphoglucomutase-like protein 5	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q15124	PGM5	Phosphoglucomutase-like protein 5	GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW
Q9NXJ5	PGPEP1	Pyroglutamyl-peptidase 1	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
A6NFU8	PGPEP1L	Pyroglutamyl-peptidase 1-like protein	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
Q32NB8	PGS1	CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q32NB8	PGS1	CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial	GO:0005509; F:calcium ion binding; ISS:BHF-UCL
Q32NB8	PGS1	CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial	GO:0008444; F:CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity; ISS:BHF-UCL
Q32NB8	PGS1	CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial	GO:0032049; P:cardiolipin biosynthetic process; ISS:BHF-UCL
Q32NB8	PGS1	CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial	GO:0046339; P:diacylglycerol metabolic process; ISS:BHF-UCL
Q32NB8	PGS1	CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q32NB8	PGS1	CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial	GO:0006655; P:phosphatidylglycerol biosynthetic process; ISS:BHF-UCL
Q32NB8	PGS1	CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q32NB8	PGS1	CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
A6NDG6	PGP	Phosphoglycolate phosphatase	GO:0000287; F:magnesium ion binding; ISS:UniProtKB
A6NDG6	PGP	Phosphoglycolate phosphatase	GO:0098519; F:nucleotide phosphatase activity, acting on free nucleotides; ISS:UniProtKB
A6NDG6	PGP	Phosphoglycolate phosphatase	GO:0008967; F:phosphoglycolate phosphatase activity; IEA:UniProtKB-EC
A6NDG6	PGP	Phosphoglycolate phosphatase	GO:0004725; F:protein tyrosine phosphatase activity; ISS:UniProtKB
A6NDG6	PGP	Phosphoglycolate phosphatase	GO:0005975; P:carbohydrate metabolic process; IEA:UniProtKB-KW
A6NDG6	PGP	Phosphoglycolate phosphatase	GO:0016311; P:dephosphorylation; ISS:UniProtKB
A6NDG6	PGP	Phosphoglycolate phosphatase	GO:0035335; P:peptidyl-tyrosine dephosphorylation; ISS:UniProtKB
O00264	PGRMC1	Membrane-associated progesterone receptor component 1	GO:0020037; F:heme binding; IEA:InterPro
O00264	PGRMC1	Membrane-associated progesterone receptor component 1	GO:0005515; F:protein binding; IPI:IntAct
O00264	PGRMC1	Membrane-associated progesterone receptor component 1	GO:0005496; F:steroid binding; TAS:ProtInc
O00264	PGRMC1	Membrane-associated progesterone receptor component 1	GO:0007411; P:axon guidance; IEA:Ensembl
O15173	PGRMC2	Membrane-associated progesterone receptor component 2	GO:0020037; F:heme binding; IEA:InterPro
O15173	PGRMC2	Membrane-associated progesterone receptor component 2	GO:0005496; F:steroid binding; TAS:ProtInc
O15173	PGRMC2	Membrane-associated progesterone receptor component 2	GO:0003707; F:steroid hormone receptor activity; TAS:ProtInc
O15173	PGRMC2	Membrane-associated progesterone receptor component 2	GO:0043401; P:steroid hormone mediated signaling pathway; TAS:GOC
O75594	PGLYRP1	Peptidoglycan recognition protein 1	GO:0008745; F:N-acetylmuramoyl-L-alanine amidase activity; IEA:InterPro
O75594	PGLYRP1	Peptidoglycan recognition protein 1	GO:0042834; F:peptidoglycan binding; IDA:UniProtKB
O75594	PGLYRP1	Peptidoglycan recognition protein 1	GO:0016019; F:peptidoglycan receptor activity; IDA:UniProtKB
O75594	PGLYRP1	Peptidoglycan recognition protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
O75594	PGLYRP1	Peptidoglycan recognition protein 1	GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProtKB
O75594	PGLYRP1	Peptidoglycan recognition protein 1	GO:0016045; P:detection of bacterium; IDA:UniProtKB
O75594	PGLYRP1	Peptidoglycan recognition protein 1	GO:0044117; P:growth of symbiont in host; IEA:Ensembl
O75594	PGLYRP1	Peptidoglycan recognition protein 1	GO:0006955; P:immune response; TAS:ProtInc
O75594	PGLYRP1	Peptidoglycan recognition protein 1	GO:0045087; P:innate immune response; NAS:UniProtKB
O75594	PGLYRP1	Peptidoglycan recognition protein 1	GO:0032689; P:negative regulation of interferon-gamma production; IEA:Ensembl
O75594	PGLYRP1	Peptidoglycan recognition protein 1	GO:0032827; P:negative regulation of natural killer cell differentiation involved in immune response; IEA:Ensembl
O75594	PGLYRP1	Peptidoglycan recognition protein 1	GO:0002221; P:pattern recognition receptor signaling pathway; IDA:GOC
O75594	PGLYRP1	Peptidoglycan recognition protein 1	GO:0009253; P:peptidoglycan catabolic process; IEA:InterPro
Q96PD5	PGLYRP2	N-acetylmuramoyl-L-alanine amidase	GO:0008745; F:N-acetylmuramoyl-L-alanine amidase activity; TAS:UniProtKB
Q96PD5	PGLYRP2	N-acetylmuramoyl-L-alanine amidase	GO:0042834; F:peptidoglycan binding; IDA:UniProtKB
Q96PD5	PGLYRP2	N-acetylmuramoyl-L-alanine amidase	GO:0016019; F:peptidoglycan receptor activity; IDA:UniProtKB
Q96PD5	PGLYRP2	N-acetylmuramoyl-L-alanine amidase	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96PD5	PGLYRP2	N-acetylmuramoyl-L-alanine amidase	GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProtKB
Q96PD5	PGLYRP2	N-acetylmuramoyl-L-alanine amidase	GO:0016045; P:detection of bacterium; IDA:UniProtKB
Q96PD5	PGLYRP2	N-acetylmuramoyl-L-alanine amidase	GO:0044117; P:growth of symbiont in host; IEA:Ensembl
Q96PD5	PGLYRP2	N-acetylmuramoyl-L-alanine amidase	GO:0045087; P:innate immune response; NAS:UniProtKB
Q96PD5	PGLYRP2	N-acetylmuramoyl-L-alanine amidase	GO:0032689; P:negative regulation of interferon-gamma production; IEA:Ensembl
Q96PD5	PGLYRP2	N-acetylmuramoyl-L-alanine amidase	GO:0032827; P:negative regulation of natural killer cell differentiation involved in immune response; IEA:Ensembl
Q96PD5	PGLYRP2	N-acetylmuramoyl-L-alanine amidase	GO:0002221; P:pattern recognition receptor signaling pathway; IDA:GOC
Q96PD5	PGLYRP2	N-acetylmuramoyl-L-alanine amidase	GO:0001519; P:peptide amidation; NAS:UniProtKB
Q96PD5	PGLYRP2	N-acetylmuramoyl-L-alanine amidase	GO:0009253; P:peptidoglycan catabolic process; IEA:InterPro
Q96LB9	PGLYRP3	Peptidoglycan recognition protein 3	GO:0008745; F:N-acetylmuramoyl-L-alanine amidase activity; IEA:InterPro
Q96LB9	PGLYRP3	Peptidoglycan recognition protein 3	GO:0042834; F:peptidoglycan binding; IDA:UniProtKB
Q96LB9	PGLYRP3	Peptidoglycan recognition protein 3	GO:0016019; F:peptidoglycan receptor activity; IDA:UniProtKB
Q96LB9	PGLYRP3	Peptidoglycan recognition protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96LB9	PGLYRP3	Peptidoglycan recognition protein 3	GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProtKB
Q96LB9	PGLYRP3	Peptidoglycan recognition protein 3	GO:0016045; P:detection of bacterium; IDA:UniProtKB
Q96LB9	PGLYRP3	Peptidoglycan recognition protein 3	GO:0044117; P:growth of symbiont in host; IEA:Ensembl
Q96LB9	PGLYRP3	Peptidoglycan recognition protein 3	GO:0045087; P:innate immune response; NAS:UniProtKB
Q96LB9	PGLYRP3	Peptidoglycan recognition protein 3	GO:0032689; P:negative regulation of interferon-gamma production; IEA:Ensembl
Q96LB9	PGLYRP3	Peptidoglycan recognition protein 3	GO:0032827; P:negative regulation of natural killer cell differentiation involved in immune response; IEA:Ensembl
Q96LB9	PGLYRP3	Peptidoglycan recognition protein 3	GO:0002221; P:pattern recognition receptor signaling pathway; IDA:GOC
Q96LB9	PGLYRP3	Peptidoglycan recognition protein 3	GO:0009253; P:peptidoglycan catabolic process; IEA:InterPro
Q96LB8	PGLYRP4	Peptidoglycan recognition protein 4	GO:0008745; F:N-acetylmuramoyl-L-alanine amidase activity; IEA:InterPro
Q96LB8	PGLYRP4	Peptidoglycan recognition protein 4	GO:0042834; F:peptidoglycan binding; IDA:UniProtKB
Q96LB8	PGLYRP4	Peptidoglycan recognition protein 4	GO:0016019; F:peptidoglycan receptor activity; IDA:UniProtKB
Q96LB8	PGLYRP4	Peptidoglycan recognition protein 4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96LB8	PGLYRP4	Peptidoglycan recognition protein 4	GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProtKB
Q96LB8	PGLYRP4	Peptidoglycan recognition protein 4	GO:0016045; P:detection of bacterium; IDA:UniProtKB
Q96LB8	PGLYRP4	Peptidoglycan recognition protein 4	GO:0044117; P:growth of symbiont in host; IEA:Ensembl
Q96LB8	PGLYRP4	Peptidoglycan recognition protein 4	GO:0045087; P:innate immune response; NAS:UniProtKB
Q96LB8	PGLYRP4	Peptidoglycan recognition protein 4	GO:0032689; P:negative regulation of interferon-gamma production; IEA:Ensembl
Q96LB8	PGLYRP4	Peptidoglycan recognition protein 4	GO:0032827; P:negative regulation of natural killer cell differentiation involved in immune response; IEA:Ensembl
Q96LB8	PGLYRP4	Peptidoglycan recognition protein 4	GO:0002221; P:pattern recognition receptor signaling pathway; IDA:GOC
Q96LB8	PGLYRP4	Peptidoglycan recognition protein 4	GO:0009253; P:peptidoglycan catabolic process; IEA:InterPro
P21810	BGN	Biglycan	GO:0050840; F:extracellular matrix binding; IEA:Ensembl
P21810	BGN	Biglycan	GO:0005201; F:extracellular matrix structural constituent; NAS:UniProtKB
P21810	BGN	Biglycan	GO:0005539; F:glycosaminoglycan binding; IEA:Ensembl
P21810	BGN	Biglycan	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
P21810	BGN	Biglycan	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P21810	BGN	Biglycan	GO:0030206; P:chondroitin sulfate biosynthetic process; TAS:Reactome
P21810	BGN	Biglycan	GO:0030207; P:chondroitin sulfate catabolic process; TAS:Reactome
P21810	BGN	Biglycan	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
P21810	BGN	Biglycan	GO:0030208; P:dermatan sulfate biosynthetic process; TAS:Reactome
P21810	BGN	Biglycan	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P21810	BGN	Biglycan	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P21810	BGN	Biglycan	GO:0019800; P:peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan; IEA:Ensembl
P21810	BGN	Biglycan	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P07585	DCN	Decorin	GO:0050840; F:extracellular matrix binding; IEA:Ensembl
P07585	DCN	Decorin	GO:0005539; F:glycosaminoglycan binding; IEA:Ensembl
P07585	DCN	Decorin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P07585	DCN	Decorin	GO:0007568; P:aging; IEA:Ensembl
P07585	DCN	Decorin	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P07585	DCN	Decorin	GO:0030206; P:chondroitin sulfate biosynthetic process; TAS:Reactome
P07585	DCN	Decorin	GO:0030207; P:chondroitin sulfate catabolic process; TAS:Reactome
P07585	DCN	Decorin	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
P07585	DCN	Decorin	GO:0030208; P:dermatan sulfate biosynthetic process; TAS:Reactome
P07585	DCN	Decorin	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P07585	DCN	Decorin	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P07585	DCN	Decorin	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P07585	DCN	Decorin	GO:0001822; P:kidney development; IEA:Ensembl
P07585	DCN	Decorin	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P07585	DCN	Decorin	GO:0019800; P:peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan; IEA:Ensembl
P07585	DCN	Decorin	GO:0001890; P:placenta development; IEA:Ensembl
P07585	DCN	Decorin	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P07585	DCN	Decorin	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P07585	DCN	Decorin	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
P07585	DCN	Decorin	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P07585	DCN	Decorin	GO:0042060; P:wound healing; IEA:Ensembl
Q92696	RABGGTA	Geranylgeranyl transferase type-2 subunit alpha	GO:0004663; F:Rab geranylgeranyltransferase activity; ISS:UniProtKB
Q92696	RABGGTA	Geranylgeranyl transferase type-2 subunit alpha	GO:0017137; F:Rab GTPase binding; ISS:UniProtKB
Q92696	RABGGTA	Geranylgeranyl transferase type-2 subunit alpha	GO:0008270; F:zinc ion binding; IEA:InterPro
Q92696	RABGGTA	Geranylgeranyl transferase type-2 subunit alpha	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q92696	RABGGTA	Geranylgeranyl transferase type-2 subunit alpha	GO:0018344; P:protein geranylgeranylation; ISS:UniProtKB
Q92696	RABGGTA	Geranylgeranyl transferase type-2 subunit alpha	GO:0007601; P:visual perception; TAS:ProtInc
P53609	PGGT1B	Geranylgeranyl transferase type-1 subunit beta	GO:0004662; F:CAAX-protein geranylgeranyltransferase activity; ISS:UniProtKB
P53609	PGGT1B	Geranylgeranyl transferase type-1 subunit beta	GO:0004661; F:protein geranylgeranyltransferase activity; IDA:UniProtKB
P53609	PGGT1B	Geranylgeranyl transferase type-1 subunit beta	GO:0008270; F:zinc ion binding; ISS:UniProtKB
P53609	PGGT1B	Geranylgeranyl transferase type-1 subunit beta	GO:0051771; P:negative regulation of nitric-oxide synthase biosynthetic process; IEA:Ensembl
P53609	PGGT1B	Geranylgeranyl transferase type-1 subunit beta	GO:0045787; P:positive regulation of cell cycle; IEA:Ensembl
P53609	PGGT1B	Geranylgeranyl transferase type-1 subunit beta	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P53609	PGGT1B	Geranylgeranyl transferase type-1 subunit beta	GO:0018344; P:protein geranylgeranylation; IDA:UniProtKB
P53609	PGGT1B	Geranylgeranyl transferase type-1 subunit beta	GO:0034097; P:response to cytokine; IEA:Ensembl
P53611	RABGGTB	Geranylgeranyl transferase type-2 subunit beta	GO:0005515; F:protein binding; IPI:IntAct
P53611	RABGGTB	Geranylgeranyl transferase type-2 subunit beta	GO:0004663; F:Rab geranylgeranyltransferase activity; ISS:UniProtKB
P53611	RABGGTB	Geranylgeranyl transferase type-2 subunit beta	GO:0017137; F:Rab GTPase binding; ISS:UniProtKB
P53611	RABGGTB	Geranylgeranyl transferase type-2 subunit beta	GO:0008270; F:zinc ion binding; ISS:UniProtKB
P53611	RABGGTB	Geranylgeranyl transferase type-2 subunit beta	GO:0006464; P:cellular protein modification process; NAS:UniProtKB
P53611	RABGGTB	Geranylgeranyl transferase type-2 subunit beta	GO:0018344; P:protein geranylgeranylation; ISS:UniProtKB
P53611	RABGGTB	Geranylgeranyl transferase type-2 subunit beta	GO:0007601; P:visual perception; TAS:ProtInc
P00439	PAH	Phenylalanine-4-hydroxylase	GO:0016597; F:amino acid binding; IEA:InterPro
P00439	PAH	Phenylalanine-4-hydroxylase	GO:0005506; F:iron ion binding; IEA:InterPro
P00439	PAH	Phenylalanine-4-hydroxylase	GO:0004505; F:phenylalanine 4-monooxygenase activity; EXP:Reactome
P00439	PAH	Phenylalanine-4-hydroxylase	GO:0042423; P:catecholamine biosynthetic process; NAS:BHF-UCL
P00439	PAH	Phenylalanine-4-hydroxylase	GO:0008652; P:cellular amino acid biosynthetic process; TAS:ProtInc
P00439	PAH	Phenylalanine-4-hydroxylase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P00439	PAH	Phenylalanine-4-hydroxylase	GO:0006559; P:L-phenylalanine catabolic process; TAS:Reactome
P00439	PAH	Phenylalanine-4-hydroxylase	GO:0042136; P:neurotransmitter biosynthetic process; NAS:BHF-UCL
P00439	PAH	Phenylalanine-4-hydroxylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NWQ8	PAG1	Phosphoprotein associated with glycosphingolipid-enriched microdomains 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NWQ8	PAG1	Phosphoprotein associated with glycosphingolipid-enriched microdomains 1	GO:0042169; F:SH2 domain binding; IDA:HGNC
Q9NWQ8	PAG1	Phosphoprotein associated with glycosphingolipid-enriched microdomains 1	GO:0005070; F:SH3/SH2 adaptor activity; NAS:HGNC
Q9NWQ8	PAG1	Phosphoprotein associated with glycosphingolipid-enriched microdomains 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q9NWQ8	PAG1	Phosphoprotein associated with glycosphingolipid-enriched microdomains 1	GO:0035556; P:intracellular signal transduction; IDA:HGNC
Q9NWQ8	PAG1	Phosphoprotein associated with glycosphingolipid-enriched microdomains 1	GO:0050868; P:negative regulation of T cell activation; IEA:Ensembl
Q9NWQ8	PAG1	Phosphoprotein associated with glycosphingolipid-enriched microdomains 1	GO:0009967; P:positive regulation of signal transduction; NAS:GOC
Q9NWQ8	PAG1	Phosphoprotein associated with glycosphingolipid-enriched microdomains 1	GO:0050863; P:regulation of T cell activation; IDA:ProtInc
Q9NWQ8	PAG1	Phosphoprotein associated with glycosphingolipid-enriched microdomains 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q9NWQ8	PAG1	Phosphoprotein associated with glycosphingolipid-enriched microdomains 1	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q9C0D0	PHACTR1	Phosphatase and actin regulator 1	GO:0003779; F:actin binding; ISS:UniProtKB
Q9C0D0	PHACTR1	Phosphatase and actin regulator 1	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
Q9C0D0	PHACTR1	Phosphatase and actin regulator 1	GO:0031532; P:actin cytoskeleton reorganization; ISS:UniProtKB
Q9C0D0	PHACTR1	Phosphatase and actin regulator 1	GO:0031032; P:actomyosin structure organization; IMP:UniProtKB
Q9C0D0	PHACTR1	Phosphatase and actin regulator 1	GO:0048870; P:cell motility; IMP:UniProtKB
Q9C0D0	PHACTR1	Phosphatase and actin regulator 1	GO:0043149; P:stress fiber assembly; IMP:UniProtKB
O75167	PHACTR2	Phosphatase and actin regulator 2	GO:0005515; F:protein binding; IPI:IntAct
O75167	PHACTR2	Phosphatase and actin regulator 2	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
Q96KR7	PHACTR3	Phosphatase and actin regulator 3	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
Q8IZ21	PHACTR4	Phosphatase and actin regulator 4	GO:0003779; F:actin binding; ISS:UniProtKB
Q8IZ21	PHACTR4	Phosphatase and actin regulator 4	GO:0008157; F:protein phosphatase 1 binding; ISS:UniProtKB
Q8IZ21	PHACTR4	Phosphatase and actin regulator 4	GO:0071862; F:protein phosphatase type 1 activator activity; ISS:UniProtKB
Q8IZ21	PHACTR4	Phosphatase and actin regulator 4	GO:0030036; P:actin cytoskeleton organization; ISS:UniProtKB
Q8IZ21	PHACTR4	Phosphatase and actin regulator 4	GO:0061386; P:closure of optic fissure; ISS:UniProtKB
Q8IZ21	PHACTR4	Phosphatase and actin regulator 4	GO:0048484; P:enteric nervous system development; ISS:UniProtKB
Q8IZ21	PHACTR4	Phosphatase and actin regulator 4	GO:2001045; P:negative regulation of integrin-mediated signaling pathway; ISS:UniProtKB
Q8IZ21	PHACTR4	Phosphatase and actin regulator 4	GO:0001755; P:neural crest cell migration; ISS:UniProtKB
Q8IZ21	PHACTR4	Phosphatase and actin regulator 4	GO:0001843; P:neural tube closure; ISS:UniProtKB
Q8IZ21	PHACTR4	Phosphatase and actin regulator 4	GO:0043085; P:positive regulation of catalytic activity; ISS:UniProtKB
Q8IZ21	PHACTR4	Phosphatase and actin regulator 4	GO:0051726; P:regulation of cell cycle; ISS:UniProtKB
Q8IZ21	PHACTR4	Phosphatase and actin regulator 4	GO:0007266; P:Rho protein signal transduction; ISS:UniProtKB
Q9H814	PHAX	Phosphorylated adapter RNA export protein	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9H814	PHAX	Phosphorylated adapter RNA export protein	GO:0015643; F:toxic substance binding; IEA:Ensembl
Q9H814	PHAX	Phosphorylated adapter RNA export protein	GO:0010467; P:gene expression; TAS:Reactome
Q9H814	PHAX	Phosphorylated adapter RNA export protein	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
Q9H814	PHAX	Phosphorylated adapter RNA export protein	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9H814	PHAX	Phosphorylated adapter RNA export protein	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9H814	PHAX	Phosphorylated adapter RNA export protein	GO:0006408; P:snRNA export from nucleus; TAS:BHF-UCL
Q9H814	PHAX	Phosphorylated adapter RNA export protein	GO:0000387; P:spliceosomal snRNP assembly; TAS:Reactome
Q99623	PHB2	Prohibitin-2	GO:0030331; F:estrogen receptor binding; NAS:UniProtKB
Q99623	PHB2	Prohibitin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q99623	PHB2	Prohibitin-2	GO:0060749; P:mammary gland alveolus development; IEA:Ensembl
Q99623	PHB2	Prohibitin-2	GO:0060744; P:mammary gland branching involved in thelarche; IEA:Ensembl
Q99623	PHB2	Prohibitin-2	GO:0033147; P:negative regulation of intracellular estrogen receptor signaling pathway; IEA:Ensembl
Q99623	PHB2	Prohibitin-2	GO:0033600; P:negative regulation of mammary gland epithelial cell proliferation; IEA:Ensembl
Q99623	PHB2	Prohibitin-2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q99623	PHB2	Prohibitin-2	GO:0060762; P:regulation of branching involved in mammary gland duct morphogenesis; IEA:Ensembl
Q99623	PHB2	Prohibitin-2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P35232	PHB	Prohibitin	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P35232	PHB	Prohibitin	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
P35232	PHB	Prohibitin	GO:0005515; F:protein binding; IPI:UniProtKB
P35232	PHB	Prohibitin	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IEA:Ensembl
P35232	PHB	Prohibitin	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
P35232	PHB	Prohibitin	GO:0071354; P:cellular response to interleukin-6; IDA:BHF-UCL
P35232	PHB	Prohibitin	GO:0071897; P:DNA biosynthetic process; IEA:Ensembl
P35232	PHB	Prohibitin	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
P35232	PHB	Prohibitin	GO:0016575; P:histone deacetylation; IDA:UniProtKB
P35232	PHB	Prohibitin	GO:0060766; P:negative regulation of androgen receptor signaling pathway; IDA:BHF-UCL
P35232	PHB	Prohibitin	GO:0030308; P:negative regulation of cell growth; IMP:BHF-UCL
P35232	PHB	Prohibitin	GO:0008285; P:negative regulation of cell proliferation; IMP:BHF-UCL
P35232	PHB	Prohibitin	GO:2000323; P:negative regulation of glucocorticoid receptor signaling pathway; IDA:BHF-UCL
P35232	PHB	Prohibitin	GO:0010944; P:negative regulation of transcription by competitive promoter binding; IDA:BHF-UCL
P35232	PHB	Prohibitin	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P35232	PHB	Prohibitin	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P35232	PHB	Prohibitin	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P35232	PHB	Prohibitin	GO:0050847; P:progesterone receptor signaling pathway; IDA:BHF-UCL
P35232	PHB	Prohibitin	GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB
P35232	PHB	Prohibitin	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
P35232	PHB	Prohibitin	GO:0007165; P:signal transduction; TAS:UniProtKB
P78364	PHC1	Polyhomeotic-like protein 1	GO:0003682; F:chromatin binding; IEA:Ensembl
P78364	PHC1	Polyhomeotic-like protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P78364	PHC1	Polyhomeotic-like protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
P78364	PHC1	Polyhomeotic-like protein 1	GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl
P78364	PHC1	Polyhomeotic-like protein 1	GO:0016574; P:histone ubiquitination; IDA:UniProtKB
P78364	PHC1	Polyhomeotic-like protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8IXK0	PHC2	Polyhomeotic-like protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IXK0	PHC2	Polyhomeotic-like protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q8IXK0	PHC2	Polyhomeotic-like protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IXK0	PHC2	Polyhomeotic-like protein 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8IXK0	PHC2	Polyhomeotic-like protein 2	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q8NDX5	PHC3	Polyhomeotic-like protein 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NDX5	PHC3	Polyhomeotic-like protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8NDX5	PHC3	Polyhomeotic-like protein 3	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P78562	PHEX	Phosphate-regulating neutral endopeptidase	GO:0004177; F:aminopeptidase activity; IEA:UniProtKB-KW
P78562	PHEX	Phosphate-regulating neutral endopeptidase	GO:0004222; F:metalloendopeptidase activity; TAS:ProtInc
P78562	PHEX	Phosphate-regulating neutral endopeptidase	GO:0008270; F:zinc ion binding; TAS:ProtInc
P78562	PHEX	Phosphate-regulating neutral endopeptidase	GO:0030282; P:bone mineralization; IEA:Ensembl
P78562	PHEX	Phosphate-regulating neutral endopeptidase	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P78562	PHEX	Phosphate-regulating neutral endopeptidase	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P78562	PHEX	Phosphate-regulating neutral endopeptidase	GO:0019637; P:organophosphate metabolic process; IEA:Ensembl
P78562	PHEX	Phosphate-regulating neutral endopeptidase	GO:0006508; P:proteolysis; IDA:UniProtKB
P78562	PHEX	Phosphate-regulating neutral endopeptidase	GO:0001501; P:skeletal system development; TAS:ProtInc
Q8WUB8	PHF10	PHD finger protein 10	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WUB8	PHF10	PHD finger protein 10	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q8WUB8	PHF10	PHD finger protein 10	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8WUB8	PHF10	PHD finger protein 10	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UIL8	PHF11	PHD finger protein 11	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UIL8	PHF11	PHD finger protein 11	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UIL8	PHF11	PHD finger protein 11	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96QT6	PHF12	PHD finger protein 12	GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB
Q96QT6	PHF12	PHD finger protein 12	GO:0005515; F:protein binding; IPI:UniProtKB
Q96QT6	PHF12	PHD finger protein 12	GO:0001106; F:RNA polymerase II transcription corepressor activity; IDA:MGI
Q96QT6	PHF12	PHD finger protein 12	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96QT6	PHF12	PHD finger protein 12	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q96QT6	PHF12	PHD finger protein 12	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q86YI8	PHF13	PHD finger protein 13	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q86YI8	PHF13	PHD finger protein 13	GO:0035064; F:methylated histone binding; NAS:UniProtKB
Q86YI8	PHF13	PHD finger protein 13	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86YI8	PHF13	PHD finger protein 13	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q86YI8	PHF13	PHD finger protein 13	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q86YI8	PHF13	PHD finger protein 13	GO:0000278; P:mitotic cell cycle; IMP:UniProtKB
Q86YI8	PHF13	PHD finger protein 13	GO:0007076; P:mitotic chromosome condensation; IMP:UniProtKB
O94880	PHF14	PHD finger protein 14	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5T6S3	PHF19	PHD finger protein 19	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q5T6S3	PHF19	PHD finger protein 19	GO:0005515; F:protein binding; IPI:UniProtKB
Q5T6S3	PHF19	PHD finger protein 19	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5T6S3	PHF19	PHD finger protein 19	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q5T6S3	PHF19	PHD finger protein 19	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q5T6S3	PHF19	PHD finger protein 19	GO:0061087; P:positive regulation of histone H3-K27 methylation; IMP:UniProtKB
Q5T6S3	PHF19	PHD finger protein 19	GO:0019827; P:stem cell maintenance; IEA:Ensembl
Q5T6S3	PHF19	PHD finger protein 19	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43189	PHF1	PHD finger protein 1	GO:0035064; F:methylated histone binding; IDA:UniProtKB
O43189	PHF1	PHD finger protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O43189	PHF1	PHD finger protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
O43189	PHF1	PHD finger protein 1	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
O43189	PHF1	PHD finger protein 1	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
O43189	PHF1	PHD finger protein 1	GO:0061086; P:negative regulation of histone H3-K27 methylation; IMP:UniProtKB
O43189	PHF1	PHD finger protein 1	GO:0061087; P:positive regulation of histone H3-K27 methylation; IMP:UniProtKB
O43189	PHF1	PHD finger protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BVI0	PHF20	PHD finger protein 20	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BVI0	PHF20	PHD finger protein 20	GO:0005515; F:protein binding; IPI:IntAct
Q9BVI0	PHF20	PHD finger protein 20	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BVI0	PHF20	PHD finger protein 20	GO:0006325; P:chromatin organization; TAS:Reactome
Q9BVI0	PHF20	PHD finger protein 20	GO:0043984; P:histone H4-K16 acetylation; IDA:UniProtKB
Q9BVI0	PHF20	PHD finger protein 20	GO:0043981; P:histone H4-K5 acetylation; IDA:UniProtKB
Q9BVI0	PHF20	PHD finger protein 20	GO:0043982; P:histone H4-K8 acetylation; IDA:UniProtKB
Q9BVI0	PHF20	PHD finger protein 20	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9BVI0	PHF20	PHD finger protein 20	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BUL5	PHF23	PHD finger protein 23	GO:0008270; F:zinc ion binding; IEA:InterPro
O75151	PHF2	Lysine-specific demethylase PHF2	GO:0051213; F:dioxygenase activity; IEA:UniProtKB-KW
O75151	PHF2	Lysine-specific demethylase PHF2	GO:0032454; F:histone demethylase activity (H3-K9 specific); IDA:UniProtKB
O75151	PHF2	Lysine-specific demethylase PHF2	GO:0005506; F:iron ion binding; IDA:UniProtKB
O75151	PHF2	Lysine-specific demethylase PHF2	GO:0035064; F:methylated histone binding; IDA:UniProtKB
O75151	PHF2	Lysine-specific demethylase PHF2	GO:0005515; F:protein binding; IPI:UniProtKB
O75151	PHF2	Lysine-specific demethylase PHF2	GO:0008270; F:zinc ion binding; IDA:UniProtKB
O75151	PHF2	Lysine-specific demethylase PHF2	GO:0001889; P:liver development; TAS:UniProtKB
O75151	PHF2	Lysine-specific demethylase PHF2	GO:0061188; P:negative regulation of chromatin silencing at rDNA; IMP:UniProtKB
O75151	PHF2	Lysine-specific demethylase PHF2	GO:0006482; P:protein demethylation; IDA:UniProtKB
O75151	PHF2	Lysine-specific demethylase PHF2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q92576	PHF3	PHD finger protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q92576	PHF3	PHD finger protein 3	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
Q92576	PHF3	PHD finger protein 3	GO:0006351; P:transcription, DNA-templated; IEA:InterPro
Q7RTV0	PHF5A	PHD finger-like domain-containing protein 5A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7RTV0	PHF5A	PHD finger-like domain-containing protein 5A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7RTV0	PHF5A	PHD finger-like domain-containing protein 5A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q7RTV0	PHF5A	PHD finger-like domain-containing protein 5A	GO:0010467; P:gene expression; TAS:Reactome
Q7RTV0	PHF5A	PHD finger-like domain-containing protein 5A	GO:0000398; P:mRNA splicing, via spliceosome; IDA:UniProtKB
Q7RTV0	PHF5A	PHD finger-like domain-containing protein 5A	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q7RTV0	PHF5A	PHD finger-like domain-containing protein 5A	GO:0008380; P:RNA splicing; TAS:Reactome
Q7RTV0	PHF5A	PHD finger-like domain-containing protein 5A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IWS0	PHF6	PHD finger protein 6	GO:0019899; F:enzyme binding; IPI:UniProt
Q8IWS0	PHF6	PHD finger protein 6	GO:0042393; F:histone binding; IPI:UniProt
Q8IWS0	PHF6	PHD finger protein 6	GO:0042826; F:histone deacetylase binding; IPI:UniProt
Q8IWS0	PHF6	PHD finger protein 6	GO:0051219; F:phosphoprotein binding; IPI:UniProt
Q8IWS0	PHF6	PHD finger protein 6	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IWS0	PHF6	PHD finger protein 6	GO:0005515; F:protein binding; IPI:UniProt
Q8IWS0	PHF6	PHD finger protein 6	GO:0043021; F:ribonucleoprotein complex binding; IPI:UniProt
Q8IWS0	PHF6	PHD finger protein 6	GO:0097110; F:scaffold protein binding; IPI:UniProt
Q8IWS0	PHF6	PHD finger protein 6	GO:0015631; F:tubulin binding; IPI:UniProt
Q8IWS0	PHF6	PHD finger protein 6	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IWS0	PHF6	PHD finger protein 6	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8IWS0	PHF6	PHD finger protein 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BWX1	PHF7	PHD finger protein 7	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0032452; F:histone demethylase activity; IDA:UniProtKB
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0071558; F:histone demethylase activity (H3-K27 specific); IDA:UniProtKB
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0051864; F:histone demethylase activity (H3-K36 specific); IDA:UniProtKB
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0032454; F:histone demethylase activity (H3-K9 specific); IDA:UniProtKB
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0035575; F:histone demethylase activity (H4-K20 specific); IDA:UniProtKB
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0005506; F:iron ion binding; IDA:UniProtKB
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0016706; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; IDA:UniProtKB
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0005515; F:protein binding; IPI:IntAct
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0007420; P:brain development; ISS:UniProtKB
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:UniProtKB
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0071557; P:histone H3-K27 demethylation; IDA:UniProtKB
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0070544; P:histone H3-K36 demethylation; IDA:UniProtKB
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0033169; P:histone H3-K9 demethylation; IDA:UniProtKB
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0035574; P:histone H4-K20 demethylation; IDA:UniProtKB
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0061188; P:negative regulation of chromatin silencing at rDNA; IDA:UniProtKB
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0045943; P:positive regulation of transcription from RNA polymerase I promoter; IDA:UniProtKB
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UPP1	PHF8	Histone lysine demethylase PHF8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WWQ0	PHIP	PH-interacting protein	GO:0070577; F:lysine-acetylated histone binding; IDA:UniProtKB
Q8WWQ0	PHIP	PH-interacting protein	GO:0005158; F:insulin receptor binding; NAS:UniProtKB
Q8WWQ0	PHIP	PH-interacting protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WWQ0	PHIP	PH-interacting protein	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q8WWQ0	PHIP	PH-interacting protein	GO:0008286; P:insulin receptor signaling pathway; NAS:UniProtKB
Q8WWQ0	PHIP	PH-interacting protein	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB
Q8WWQ0	PHIP	PH-interacting protein	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IDA:MGI
Q8WWQ0	PHIP	PH-interacting protein	GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB
Q8WWQ0	PHIP	PH-interacting protein	GO:0043568; P:positive regulation of insulin-like growth factor receptor signaling pathway; ISS:UniProtKB
Q8WWQ0	PHIP	PH-interacting protein	GO:0045840; P:positive regulation of mitosis; ISS:UniProtKB
Q8WWQ0	PHIP	PH-interacting protein	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IEA:Ensembl
Q8WWQ0	PHIP	PH-interacting protein	GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IEA:Ensembl
Q8WWQ0	PHIP	PH-interacting protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q8WWQ0	PHIP	PH-interacting protein	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q8WWQ0	PHIP	PH-interacting protein	GO:0006606; P:protein import into nucleus; IEA:Ensembl
Q8WWQ0	PHIP	PH-interacting protein	GO:0022604; P:regulation of cell morphogenesis; IMP:UniProtKB
Q8WWQ0	PHIP	PH-interacting protein	GO:0040008; P:regulation of growth; IEA:Ensembl
Q8WWQ0	PHIP	PH-interacting protein	GO:0001932; P:regulation of protein phosphorylation; ISS:UniProtKB
Q16816	PHKG1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q16816	PHKG1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	GO:0004689; F:phosphorylase kinase activity; IEA:UniProtKB-EC
Q16816	PHKG1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	GO:0050321; F:tau-protein kinase activity; IEA:UniProtKB-EC
Q16816	PHKG1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q16816	PHKG1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	GO:0006006; P:glucose metabolic process; TAS:Reactome
Q16816	PHKG1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	GO:0005978; P:glycogen biosynthetic process; IEA:InterPro
Q16816	PHKG1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	GO:0005980; P:glycogen catabolic process; TAS:Reactome
Q16816	PHKG1	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P15735	PHKG2	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P15735	PHKG2	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	GO:0004689; F:phosphorylase kinase activity; TAS:UniProtKB
P15735	PHKG2	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	GO:0004674; F:protein serine/threonine kinase activity; TAS:UniProtKB
P15735	PHKG2	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	GO:0050321; F:tau-protein kinase activity; TAS:UniProtKB
P15735	PHKG2	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P15735	PHKG2	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P15735	PHKG2	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	GO:0006006; P:glucose metabolic process; TAS:Reactome
P15735	PHKG2	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	GO:0005978; P:glycogen biosynthetic process; IEA:InterPro
P15735	PHKG2	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	GO:0005980; P:glycogen catabolic process; TAS:Reactome
P15735	PHKG2	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	GO:0005977; P:glycogen metabolic process; TAS:ProtInc
P15735	PHKG2	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	GO:0045819; P:positive regulation of glycogen catabolic process; TAS:UniProtKB
P15735	PHKG2	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P15735	PHKG2	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8WV24	PHLDA1	Pleckstrin homology-like domain family A member 1	GO:0005515; F:protein binding; IPI:IntAct
Q8WV24	PHLDA1	Pleckstrin homology-like domain family A member 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8WV24	PHLDA1	Pleckstrin homology-like domain family A member 1	GO:0045210; P:FasL biosynthetic process; IEA:Ensembl
Q8WV24	PHLDA1	Pleckstrin homology-like domain family A member 1	GO:0021879; P:forebrain neuron differentiation; IEA:Ensembl
Q8WV24	PHLDA1	Pleckstrin homology-like domain family A member 1	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q53GA4	PHLDA2	Pleckstrin homology-like domain family A member 2	GO:0006915; P:apoptotic process; TAS:ProtInc
Q53GA4	PHLDA2	Pleckstrin homology-like domain family A member 2	GO:0009887; P:organ morphogenesis; IEA:Ensembl
Q53GA4	PHLDA2	Pleckstrin homology-like domain family A member 2	GO:0001890; P:placenta development; IEA:Ensembl
Q53GA4	PHLDA2	Pleckstrin homology-like domain family A member 2	GO:0030334; P:regulation of cell migration; IEA:Ensembl
Q53GA4	PHLDA2	Pleckstrin homology-like domain family A member 2	GO:0045995; P:regulation of embryonic development; IEA:Ensembl
Q53GA4	PHLDA2	Pleckstrin homology-like domain family A member 2	GO:0010468; P:regulation of gene expression; IEA:Ensembl
Q53GA4	PHLDA2	Pleckstrin homology-like domain family A member 2	GO:0070873; P:regulation of glycogen metabolic process; IEA:Ensembl
Q9Y5J5	PHLDA3	Pleckstrin homology-like domain family A member 3	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB
Q9Y5J5	PHLDA3	Pleckstrin homology-like domain family A member 3	GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; IDA:UniProtKB
Q9Y5J5	PHLDA3	Pleckstrin homology-like domain family A member 3	GO:0080025; F:phosphatidylinositol-3,5-bisphosphate binding; IDA:UniProtKB
Q9Y5J5	PHLDA3	Pleckstrin homology-like domain family A member 3	GO:0032266; F:phosphatidylinositol-3-phosphate binding; IDA:UniProtKB
Q9Y5J5	PHLDA3	Pleckstrin homology-like domain family A member 3	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProtKB
Q9Y5J5	PHLDA3	Pleckstrin homology-like domain family A member 3	GO:0010314; F:phosphatidylinositol-5-phosphate binding; IDA:UniProtKB
Q9Y5J5	PHLDA3	Pleckstrin homology-like domain family A member 3	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q9Y5J5	PHLDA3	Pleckstrin homology-like domain family A member 3	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IDA:UniProtKB
Q9Y5J5	PHLDA3	Pleckstrin homology-like domain family A member 3	GO:0051898; P:negative regulation of protein kinase B signaling; IDA:UniProtKB
Q9Y5J5	PHLDA3	Pleckstrin homology-like domain family A member 3	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q86SQ0	PHLDB2	Pleckstrin homology-like domain family B member 2	GO:0005515; F:protein binding; IPI:IntAct
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0004621; F:glycosylphosphatidylinositol phospholipase D activity; IDA:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0004630; F:phospholipase D activity; IDA:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0017080; F:sodium channel regulator activity; ISS:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0002042; P:cell migration involved in sprouting angiogenesis; IMP:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0071277; P:cellular response to calcium ion; IDA:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0071397; P:cellular response to cholesterol; IMP:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0035690; P:cellular response to drug; IDA:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0032869; P:cellular response to insulin stimulus; IDA:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0071467; P:cellular response to pH; IDA:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0071401; P:cellular response to triglyceride; IMP:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0002062; P:chondrocyte differentiation; ISS:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0002430; P:complement receptor mediated signaling pathway; IDA:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0006507; P:GPI anchor release; IDA:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0035701; P:hematopoietic stem cell migration; TAS:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0097241; P:hematopoietic stem cell migration to bone marrow; TAS:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0008286; P:insulin receptor signaling pathway; IDA:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0010897; P:negative regulation of triglyceride catabolic process; ISS:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0001503; P:ossification; ISS:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0046470; P:phosphatidylcholine metabolic process; ISS:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0010694; P:positive regulation of alkaline phosphatase activity; ISS:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0045919; P:positive regulation of cytolysis; IDA:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0010595; P:positive regulation of endothelial cell migration; IMP:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0010907; P:positive regulation of glucose metabolic process; ISS:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0010983; P:positive regulation of high-density lipoprotein particle clearance; ISS:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0051044; P:positive regulation of membrane protein ectodomain proteolysis; IDA:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0051047; P:positive regulation of secretion; ISS:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0010867; P:positive regulation of triglyceride biosynthetic process; ISS:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:1900076; P:regulation of cellular response to insulin stimulus; IDA:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0009749; P:response to glucose; IDA:UniProtKB
P80108	GPLD1	Phosphatidylinositol-glycan-specific phospholipase D	GO:0070633; P:transepithelial transport; ISS:UniProtKB
O60346	PHLPP1	PH domain leucine-rich repeat-containing protein phosphatase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60346	PHLPP1	PH domain leucine-rich repeat-containing protein phosphatase 1	GO:0004721; F:phosphoprotein phosphatase activity; IEA:UniProtKB-KW
O60346	PHLPP1	PH domain leucine-rich repeat-containing protein phosphatase 1	GO:0005515; F:protein binding; IPI:IntAct
O60346	PHLPP1	PH domain leucine-rich repeat-containing protein phosphatase 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O60346	PHLPP1	PH domain leucine-rich repeat-containing protein phosphatase 1	GO:0009649; P:entrainment of circadian clock; IEA:Ensembl
O60346	PHLPP1	PH domain leucine-rich repeat-containing protein phosphatase 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O60346	PHLPP1	PH domain leucine-rich repeat-containing protein phosphatase 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O60346	PHLPP1	PH domain leucine-rich repeat-containing protein phosphatase 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
O60346	PHLPP1	PH domain leucine-rich repeat-containing protein phosphatase 1	GO:0045087; P:innate immune response; TAS:Reactome
O60346	PHLPP1	PH domain leucine-rich repeat-containing protein phosphatase 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O60346	PHLPP1	PH domain leucine-rich repeat-containing protein phosphatase 1	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q6ZVD8	PHLPP2	PH domain leucine-rich repeat-containing protein phosphatase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZVD8	PHLPP2	PH domain leucine-rich repeat-containing protein phosphatase 2	GO:0004722; F:protein serine/threonine phosphatase activity; IEA:Ensembl
Q6ZVD8	PHLPP2	PH domain leucine-rich repeat-containing protein phosphatase 2	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q6ZVD8	PHLPP2	PH domain leucine-rich repeat-containing protein phosphatase 2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q6ZVD8	PHLPP2	PH domain leucine-rich repeat-containing protein phosphatase 2	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q6ZVD8	PHLPP2	PH domain leucine-rich repeat-containing protein phosphatase 2	GO:0045087; P:innate immune response; TAS:Reactome
Q6ZVD8	PHLPP2	PH domain leucine-rich repeat-containing protein phosphatase 2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q6ZVD8	PHLPP2	PH domain leucine-rich repeat-containing protein phosphatase 2	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q6ZVD8	PHLPP2	PH domain leucine-rich repeat-containing protein phosphatase 2	GO:0006470; P:protein dephosphorylation; IEA:Ensembl
Q13371	PDCL	Phosducin-like protein	GO:0005057; F:receptor signaling protein activity; TAS:ProtInc
Q13371	PDCL	Phosducin-like protein	GO:0035556; P:intracellular signal transduction; TAS:GOC
Q13371	PDCL	Phosducin-like protein	GO:0061084; P:negative regulation of protein refolding; IEA:Ensembl
Q13371	PDCL	Phosducin-like protein	GO:0006457; P:protein folding; IEA:Ensembl
Q13371	PDCL	Phosducin-like protein	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; TAS:ProtInc
Q13371	PDCL	Phosducin-like protein	GO:0007165; P:signal transduction; NAS:UniProtKB
Q13371	PDCL	Phosducin-like protein	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q9Y3A3	MOB4	MOB-like protein phocein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y3A3	MOB4	MOB-like protein phocein	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3A3	MOB4	MOB-like protein phocein	GO:0006810; P:transport; IEA:UniProtKB-KW
Q8TCT1	PHOSPHO1	Phosphoethanolamine/phosphocholine phosphatase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TCT1	PHOSPHO1	Phosphoethanolamine/phosphocholine phosphatase	GO:0052731; F:phosphocholine phosphatase activity; EXP:Reactome
Q8TCT1	PHOSPHO1	Phosphoethanolamine/phosphocholine phosphatase	GO:0052732; F:phosphoethanolamine phosphatase activity; EXP:Reactome
Q8TCT1	PHOSPHO1	Phosphoethanolamine/phosphocholine phosphatase	GO:0016462; F:pyrophosphatase activity; IDA:MGI
Q8TCT1	PHOSPHO1	Phosphoethanolamine/phosphocholine phosphatase	GO:0035630; P:bone mineralization involved in bone maturation; IEA:Ensembl
Q8TCT1	PHOSPHO1	Phosphoethanolamine/phosphocholine phosphatase	GO:0016311; P:dephosphorylation; EXP:GOC
Q8TCT1	PHOSPHO1	Phosphoethanolamine/phosphocholine phosphatase	GO:0001958; P:endochondral ossification; IEA:Ensembl
Q8TCT1	PHOSPHO1	Phosphoethanolamine/phosphocholine phosphatase	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q8TCT1	PHOSPHO1	Phosphoethanolamine/phosphocholine phosphatase	GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome
Q8TCT1	PHOSPHO1	Phosphoethanolamine/phosphocholine phosphatase	GO:0006646; P:phosphatidylethanolamine biosynthetic process; TAS:Reactome
Q8TCT1	PHOSPHO1	Phosphoethanolamine/phosphocholine phosphatase	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q8TCT1	PHOSPHO1	Phosphoethanolamine/phosphocholine phosphatase	GO:0030500; P:regulation of bone mineralization; IEA:UniProtKB-KW
Q8TCT1	PHOSPHO1	Phosphoethanolamine/phosphocholine phosphatase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8TCD6	PHOSPHO2	Pyridoxal phosphate phosphatase PHOSPHO2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TCD6	PHOSPHO2	Pyridoxal phosphate phosphatase PHOSPHO2	GO:0033883; F:pyridoxal phosphatase activity; IEA:UniProtKB-EC
P20941	PDC	Phosducin	GO:0004859; F:phospholipase inhibitor activity; TAS:ProtInc
P20941	PDC	Phosducin	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P20941	PDC	Phosducin	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
P20941	PDC	Phosducin	GO:0007602; P:phototransduction; TAS:ProtInc
P20941	PDC	Phosducin	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q9NRX4	PHPT1	14 kDa phosphohistidine phosphatase	GO:0019855; F:calcium channel inhibitor activity; IDA:BHF-UCL
Q9NRX4	PHPT1	14 kDa phosphohistidine phosphatase	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q9NRX4	PHPT1	14 kDa phosphohistidine phosphatase	GO:0008969; F:phosphohistidine phosphatase activity; IDA:BHF-UCL
Q9NRX4	PHPT1	14 kDa phosphohistidine phosphatase	GO:0004721; F:phosphoprotein phosphatase activity; IEA:UniProtKB-KW
Q9NRX4	PHPT1	14 kDa phosphohistidine phosphatase	GO:2000984; P:negative regulation of ATP citrate synthase activity; IDA:BHF-UCL
Q9NRX4	PHPT1	14 kDa phosphohistidine phosphatase	GO:0051350; P:negative regulation of lyase activity; IDA:BHF-UCL
Q9NRX4	PHPT1	14 kDa phosphohistidine phosphatase	GO:0050860; P:negative regulation of T cell receptor signaling pathway; IMP:BHF-UCL
Q9NRX4	PHPT1	14 kDa phosphohistidine phosphatase	GO:0035971; P:peptidyl-histidine dephosphorylation; IDA:BHF-UCL
Q9NRX4	PHPT1	14 kDa phosphohistidine phosphatase	GO:2000147; P:positive regulation of cell motility; IMP:BHF-UCL
Q9NRX4	PHPT1	14 kDa phosphohistidine phosphatase	GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl
Q9NRX4	PHPT1	14 kDa phosphohistidine phosphatase	GO:0006470; P:protein dephosphorylation; IDA:BHF-UCL
Q9NRX4	PHPT1	14 kDa phosphohistidine phosphatase	GO:2000249; P:regulation of actin cytoskeleton reorganization; IMP:BHF-UCL
Q9P1Y6	PHRF1	PHD and RING finger domain-containing protein 1	GO:0070063; F:RNA polymerase binding; ISS:UniProtKB
Q9P1Y6	PHRF1	PHD and RING finger domain-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9P1Y6	PHRF1	PHD and RING finger domain-containing protein 1	GO:0006397; P:mRNA processing; IEA:Ensembl
Q9P1Y6	PHRF1	PHD and RING finger domain-containing protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; IEA:Ensembl
Q9H0N5	PCBD2	Pterin-4-alpha-carbinolamine dehydratase 2	GO:0008124; F:4-alpha-hydroxytetrahydrobiopterin dehydratase activity; IEA:UniProtKB-EC
Q9H0N5	PCBD2	Pterin-4-alpha-carbinolamine dehydratase 2	GO:0004505; F:phenylalanine 4-monooxygenase activity; IEA:Ensembl
Q9H0N5	PCBD2	Pterin-4-alpha-carbinolamine dehydratase 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H0N5	PCBD2	Pterin-4-alpha-carbinolamine dehydratase 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9H0N5	PCBD2	Pterin-4-alpha-carbinolamine dehydratase 2	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q9H0N5	PCBD2	Pterin-4-alpha-carbinolamine dehydratase 2	GO:0051289; P:protein homotetramerization; IEA:Ensembl
Q9H0N5	PCBD2	Pterin-4-alpha-carbinolamine dehydratase 2	GO:0006729; P:tetrahydrobiopterin biosynthetic process; IEA:UniProtKB-KW
P61457	PCBD1	Pterin-4-alpha-carbinolamine dehydratase	GO:0008124; F:4-alpha-hydroxytetrahydrobiopterin dehydratase activity; EXP:Reactome
P61457	PCBD1	Pterin-4-alpha-carbinolamine dehydratase	GO:0042802; F:identical protein binding; IPI:IntAct
P61457	PCBD1	Pterin-4-alpha-carbinolamine dehydratase	GO:0004505; F:phenylalanine 4-monooxygenase activity; IEA:Ensembl
P61457	PCBD1	Pterin-4-alpha-carbinolamine dehydratase	GO:0005515; F:protein binding; IPI:IntAct
P61457	PCBD1	Pterin-4-alpha-carbinolamine dehydratase	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P61457	PCBD1	Pterin-4-alpha-carbinolamine dehydratase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P61457	PCBD1	Pterin-4-alpha-carbinolamine dehydratase	GO:0006559; P:L-phenylalanine catabolic process; TAS:Reactome
P61457	PCBD1	Pterin-4-alpha-carbinolamine dehydratase	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P61457	PCBD1	Pterin-4-alpha-carbinolamine dehydratase	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P61457	PCBD1	Pterin-4-alpha-carbinolamine dehydratase	GO:0051289; P:protein homotetramerization; IEA:Ensembl
P61457	PCBD1	Pterin-4-alpha-carbinolamine dehydratase	GO:0043496; P:regulation of protein homodimerization activity; IEA:Ensembl
P61457	PCBD1	Pterin-4-alpha-carbinolamine dehydratase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P61457	PCBD1	Pterin-4-alpha-carbinolamine dehydratase	GO:0006729; P:tetrahydrobiopterin biosynthetic process; IEA:UniProtKB-KW
P61457	PCBD1	Pterin-4-alpha-carbinolamine dehydratase	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UMS5	PHTF1	Putative homeodomain transcription factor 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UMS5	PHTF1	Putative homeodomain transcription factor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9UMS5	PHTF1	Putative homeodomain transcription factor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N3S3	PHTF2	Putative homeodomain transcription factor 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N3S3	PHTF2	Putative homeodomain transcription factor 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N3S3	PHTF2	Putative homeodomain transcription factor 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O14813	PHOX2A	Paired mesoderm homeobox protein 2A	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:BHF-UCL
O14813	PHOX2A	Paired mesoderm homeobox protein 2A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
O14813	PHOX2A	Paired mesoderm homeobox protein 2A	GO:0071542; P:dopaminergic neuron differentiation; IC:BHF-UCL
O14813	PHOX2A	Paired mesoderm homeobox protein 2A	GO:0021703; P:locus ceruleus development; IEA:Ensembl
O14813	PHOX2A	Paired mesoderm homeobox protein 2A	GO:0030901; P:midbrain development; IEA:Ensembl
O14813	PHOX2A	Paired mesoderm homeobox protein 2A	GO:0003357; P:noradrenergic neuron differentiation; NAS:BHF-UCL
O14813	PHOX2A	Paired mesoderm homeobox protein 2A	GO:0021623; P:oculomotor nerve formation; IEA:Ensembl
O14813	PHOX2A	Paired mesoderm homeobox protein 2A	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
O14813	PHOX2A	Paired mesoderm homeobox protein 2A	GO:0043576; P:regulation of respiratory gaseous exchange; IEA:Ensembl
O14813	PHOX2A	Paired mesoderm homeobox protein 2A	GO:0021523; P:somatic motor neuron differentiation; IEA:Ensembl
O14813	PHOX2A	Paired mesoderm homeobox protein 2A	GO:0048485; P:sympathetic nervous system development; IEA:Ensembl
O14813	PHOX2A	Paired mesoderm homeobox protein 2A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O14813	PHOX2A	Paired mesoderm homeobox protein 2A	GO:0021642; P:trochlear nerve formation; IEA:Ensembl
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0048483; P:autonomic nervous system development; IMP:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0003360; P:brainstem development; IEP:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0021533; P:cell differentiation in hindbrain; ISS:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0071773; P:cellular response to BMP stimulus; ISS:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0071542; P:dopaminergic neuron differentiation; ISS:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0048894; P:efferent axon development in a lateral line nerve; ISS:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0048484; P:enteric nervous system development; IEP:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0010001; P:glial cell differentiation; ISS:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0021934; P:hindbrain tangential cell migration; ISS:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0048839; P:inner ear development; ISS:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0021723; P:medullary reticular formation development; ISS:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0071157; P:negative regulation of cell cycle arrest; ISS:UniProtKB
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:1901166; P:neural crest cell migration involved in autonomic nervous system development; ISS:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0001764; P:neuron migration; ISS:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0003358; P:noradrenergic neuron development; ISS:UniProtKB
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0003357; P:noradrenergic neuron differentiation; ISS:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0048486; P:parasympathetic nervous system development; ISS:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; ISS:UniProtKB
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0010468; P:regulation of gene expression; ISS:UniProtKB
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0002087; P:regulation of respiratory gaseous exchange by neurological system process; ISS:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0060541; P:respiratory system development; ISS:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0061452; P:retrotrapezoid nucleus neuron differentiation; ISS:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0061549; P:sympathetic ganglion development; ISS:UniProtKB
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0048485; P:sympathetic nervous system development; ISS:BHF-UCL
Q99453	PHOX2B	Paired mesoderm homeobox protein 2B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5SRE7	PHYHD1	Phytanoyl-CoA dioxygenase domain-containing protein 1	GO:0051213; F:dioxygenase activity; IEA:UniProtKB-KW
Q5SRE7	PHYHD1	Phytanoyl-CoA dioxygenase domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43692	PI15	Peptidase inhibitor 15	GO:0030414; F:peptidase inhibitor activity; IEA:UniProtKB-KW
Q6UXB8	PI16	Peptidase inhibitor 16	GO:0030414; F:peptidase inhibitor activity; IEA:UniProtKB-KW
P43119	PTGIR	Prostacyclin receptor	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P43119	PTGIR	Prostacyclin receptor	GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:Reactome
P43119	PTGIR	Prostacyclin receptor	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IMP:BHF-UCL
P43119	PTGIR	Prostacyclin receptor	GO:0007596; P:blood coagulation; TAS:Reactome
P43119	PTGIR	Prostacyclin receptor	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P43119	PTGIR	Prostacyclin receptor	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P43119	PTGIR	Prostacyclin receptor	GO:0010642; P:negative regulation of platelet-derived growth factor receptor signaling pathway; ISS:BHF-UCL
P43119	PTGIR	Prostacyclin receptor	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IDA:BHF-UCL
P43119	PTGIR	Prostacyclin receptor	GO:0030819; P:positive regulation of cAMP biosynthetic process; IMP:BHF-UCL
P43119	PTGIR	Prostacyclin receptor	GO:0043950; P:positive regulation of cAMP-mediated signaling; IMP:BHF-UCL
P43119	PTGIR	Prostacyclin receptor	GO:0043087; P:regulation of GTPase activity; TAS:GOC
P43119	PTGIR	Prostacyclin receptor	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
Q99570	PIK3R4	Phosphoinositide 3-kinase regulatory subunit 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q99570	PIK3R4	Phosphoinositide 3-kinase regulatory subunit 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q99570	PIK3R4	Phosphoinositide 3-kinase regulatory subunit 4	GO:0004672; F:protein kinase activity; NAS:UniProtKB
Q99570	PIK3R4	Phosphoinositide 3-kinase regulatory subunit 4	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q99570	PIK3R4	Phosphoinositide 3-kinase regulatory subunit 4	GO:0045087; P:innate immune response; TAS:Reactome
Q99570	PIK3R4	Phosphoinositide 3-kinase regulatory subunit 4	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q99570	PIK3R4	Phosphoinositide 3-kinase regulatory subunit 4	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q99570	PIK3R4	Phosphoinositide 3-kinase regulatory subunit 4	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q99570	PIK3R4	Phosphoinositide 3-kinase regulatory subunit 4	GO:0006468; P:protein phosphorylation; NAS:UniProtKB
Q99570	PIK3R4	Phosphoinositide 3-kinase regulatory subunit 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99570	PIK3R4	Phosphoinositide 3-kinase regulatory subunit 4	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q99570	PIK3R4	Phosphoinositide 3-kinase regulatory subunit 4	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q8WYR1	PIK3R5	Phosphoinositide 3-kinase regulatory subunit 5	GO:0046935; F:1-phosphatidylinositol-3-kinase regulator activity; IEA:Ensembl
Q8WYR1	PIK3R5	Phosphoinositide 3-kinase regulatory subunit 5	GO:0031683; F:G-protein beta/gamma-subunit complex binding; ISS:UniProtKB
Q8WYR1	PIK3R5	Phosphoinositide 3-kinase regulatory subunit 5	GO:0007596; P:blood coagulation; TAS:Reactome
Q8WYR1	PIK3R5	Phosphoinositide 3-kinase regulatory subunit 5	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q8WYR1	PIK3R5	Phosphoinositide 3-kinase regulatory subunit 5	GO:0007186; P:G-protein coupled receptor signaling pathway; ISS:UniProtKB
Q8WYR1	PIK3R5	Phosphoinositide 3-kinase regulatory subunit 5	GO:0014065; P:phosphatidylinositol 3-kinase signaling; ISS:UniProtKB
Q8WYR1	PIK3R5	Phosphoinositide 3-kinase regulatory subunit 5	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q8WYR1	PIK3R5	Phosphoinositide 3-kinase regulatory subunit 5	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q8WYR1	PIK3R5	Phosphoinositide 3-kinase regulatory subunit 5	GO:0030168; P:platelet activation; TAS:Reactome
Q8WYR1	PIK3R5	Phosphoinositide 3-kinase regulatory subunit 5	GO:0043406; P:positive regulation of MAP kinase activity; ISS:UniProtKB
Q8WYR1	PIK3R5	Phosphoinositide 3-kinase regulatory subunit 5	GO:0051897; P:positive regulation of protein kinase B signaling; ISS:UniProtKB
Q8WYR1	PIK3R5	Phosphoinositide 3-kinase regulatory subunit 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P48426	PIP4K2A	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	GO:0016308; F:1-phosphatidylinositol-4-phosphate 5-kinase activity; NAS:UniProtKB
P48426	PIP4K2A	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	GO:0016309; F:1-phosphatidylinositol-5-phosphate 4-kinase activity; IEA:UniProtKB-EC
P48426	PIP4K2A	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P48426	PIP4K2A	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	GO:0035855; P:megakaryocyte development; IEA:Ensembl
P48426	PIP4K2A	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
P48426	PIP4K2A	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	GO:0046854; P:phosphatidylinositol phosphorylation; NAS:GOC
P48426	PIP4K2A	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P48426	PIP4K2A	Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P78356	PIP4K2B	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	GO:0016308; F:1-phosphatidylinositol-4-phosphate 5-kinase activity; IDA:MGI
P78356	PIP4K2B	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	GO:0016309; F:1-phosphatidylinositol-5-phosphate 4-kinase activity; IEA:UniProtKB-EC
P78356	PIP4K2B	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P78356	PIP4K2B	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	GO:0005057; F:receptor signaling protein activity; TAS:ProtInc
P78356	PIP4K2B	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P78356	PIP4K2B	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	GO:0035556; P:intracellular signal transduction; TAS:GOC
P78356	PIP4K2B	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
P78356	PIP4K2B	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	GO:0046854; P:phosphatidylinositol phosphorylation; IDA:GOC
P78356	PIP4K2B	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P78356	PIP4K2B	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5UE93	PIK3R6	Phosphoinositide 3-kinase regulatory subunit 6	GO:0046935; F:1-phosphatidylinositol-3-kinase regulator activity; ISS:UniProtKB
Q5UE93	PIK3R6	Phosphoinositide 3-kinase regulatory subunit 6	GO:0046934; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; IEA:Ensembl
Q5UE93	PIK3R6	Phosphoinositide 3-kinase regulatory subunit 6	GO:0005515; F:protein binding; IPI:IntAct
Q5UE93	PIK3R6	Phosphoinositide 3-kinase regulatory subunit 6	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q5UE93	PIK3R6	Phosphoinositide 3-kinase regulatory subunit 6	GO:0007596; P:blood coagulation; TAS:Reactome
Q5UE93	PIK3R6	Phosphoinositide 3-kinase regulatory subunit 6	GO:0007186; P:G-protein coupled receptor signaling pathway; ISS:UniProtKB
Q5UE93	PIK3R6	Phosphoinositide 3-kinase regulatory subunit 6	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q5UE93	PIK3R6	Phosphoinositide 3-kinase regulatory subunit 6	GO:0046854; P:phosphatidylinositol phosphorylation; ISS:GOC
Q5UE93	PIK3R6	Phosphoinositide 3-kinase regulatory subunit 6	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q5UE93	PIK3R6	Phosphoinositide 3-kinase regulatory subunit 6	GO:0030168; P:platelet activation; TAS:Reactome
Q5UE93	PIK3R6	Phosphoinositide 3-kinase regulatory subunit 6	GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB
Q5UE93	PIK3R6	Phosphoinositide 3-kinase regulatory subunit 6	GO:0043406; P:positive regulation of MAP kinase activity; ISS:UniProtKB
Q5UE93	PIK3R6	Phosphoinositide 3-kinase regulatory subunit 6	GO:0043551; P:regulation of phosphatidylinositol 3-kinase activity; ISS:GOC
Q5UE93	PIK3R6	Phosphoinositide 3-kinase regulatory subunit 6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8TBX8	PIP4K2C	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	GO:0016309; F:1-phosphatidylinositol-5-phosphate 4-kinase activity; IEA:UniProtKB-EC
Q8TBX8	PIP4K2C	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8TBX8	PIP4K2C	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	GO:0042802; F:identical protein binding; IPI:IntAct
P42356	PI4KA	Phosphatidylinositol 4-kinase alpha	GO:0004430; F:1-phosphatidylinositol 4-kinase activity; IBA:RefGenome
P42356	PI4KA	Phosphatidylinositol 4-kinase alpha	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P42356	PI4KA	Phosphatidylinositol 4-kinase alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P42356	PI4KA	Phosphatidylinositol 4-kinase alpha	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
P42356	PI4KA	Phosphatidylinositol 4-kinase alpha	GO:0048015; P:phosphatidylinositol-mediated signaling; IEA:InterPro
P42356	PI4KA	Phosphatidylinositol 4-kinase alpha	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P42356	PI4KA	Phosphatidylinositol 4-kinase alpha	GO:0007165; P:signal transduction; NAS:ProtInc
P42356	PI4KA	Phosphatidylinositol 4-kinase alpha	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UBF8	PI4KB	Phosphatidylinositol 4-kinase beta	GO:0004430; F:1-phosphatidylinositol 4-kinase activity; TAS:Reactome
Q9UBF8	PI4KB	Phosphatidylinositol 4-kinase beta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UBF8	PI4KB	Phosphatidylinositol 4-kinase beta	GO:0005515; F:protein binding; IPI:IntAct
Q9UBF8	PI4KB	Phosphatidylinositol 4-kinase beta	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q9UBF8	PI4KB	Phosphatidylinositol 4-kinase beta	GO:0048015; P:phosphatidylinositol-mediated signaling; IEA:InterPro
Q9UBF8	PI4KB	Phosphatidylinositol 4-kinase beta	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9UBF8	PI4KB	Phosphatidylinositol 4-kinase beta	GO:0006898; P:receptor-mediated endocytosis; TAS:ProtInc
Q9UBF8	PI4KB	Phosphatidylinositol 4-kinase beta	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UBF8	PI4KB	Phosphatidylinositol 4-kinase beta	GO:0044281; P:small molecule metabolic process; TAS:Reactome
A4QPH2	PI4KAP2	Putative phosphatidylinositol 4-kinase alpha-like protein P2	GO:0016301; F:kinase activity; IEA:UniProtKB-KW
A4QPH2	PI4KAP2	Putative phosphatidylinositol 4-kinase alpha-like protein P2	GO:0016773; F:phosphotransferase activity, alcohol group as acceptor; IEA:InterPro
A4QPH2	PI4KAP2	Putative phosphatidylinositol 4-kinase alpha-like protein P2	GO:0046854; P:phosphatidylinositol phosphorylation; IEA:InterPro
A4QPH2	PI4KAP2	Putative phosphatidylinositol 4-kinase alpha-like protein P2	GO:0048015; P:phosphatidylinositol-mediated signaling; IEA:InterPro
Q8N8J0	PI4KAP1	Putative inactive phosphatidylinositol 4-kinase alpha-like protein P1	GO:0046854; P:phosphatidylinositol phosphorylation; IEA:InterPro
Q8N8J0	PI4KAP1	Putative inactive phosphatidylinositol 4-kinase alpha-like protein P1	GO:0048015; P:phosphatidylinositol-mediated signaling; IEA:InterPro
O14986	PIP5K1B	Phosphatidylinositol 4-phosphate 5-kinase type-1 beta	GO:0016308; F:1-phosphatidylinositol-4-phosphate 5-kinase activity; IEA:Ensembl
O14986	PIP5K1B	Phosphatidylinositol 4-phosphate 5-kinase type-1 beta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O14986	PIP5K1B	Phosphatidylinositol 4-phosphate 5-kinase type-1 beta	GO:0005515; F:protein binding; IPI:UniProtKB
O14986	PIP5K1B	Phosphatidylinositol 4-phosphate 5-kinase type-1 beta	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
O14986	PIP5K1B	Phosphatidylinositol 4-phosphate 5-kinase type-1 beta	GO:0046854; P:phosphatidylinositol phosphorylation; NAS:GOC
O14986	PIP5K1B	Phosphatidylinositol 4-phosphate 5-kinase type-1 beta	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
O14986	PIP5K1B	Phosphatidylinositol 4-phosphate 5-kinase type-1 beta	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0016308; F:1-phosphatidylinositol-4-phosphate 5-kinase activity; IDA:UniProtKB
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0019900; F:kinase binding; IDA:UniProtKB
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0005515; F:protein binding; IPI:UniProtKB
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0031532; P:actin cytoskeleton reorganization; IMP:UniProtKB
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0032863; P:activation of Rac GTPase activity; IMP:UniProtKB
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0060326; P:cell chemotaxis; IMP:UniProtKB
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0016477; P:cell migration; NAS:UniProtKB
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0010761; P:fibroblast migration; IEA:Ensembl
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0048041; P:focal adhesion assembly; IMP:UniProtKB
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0006650; P:glycerophospholipid metabolic process; TAS:ProtInc
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0030216; P:keratinocyte differentiation; TAS:UniProtKB
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0006909; P:phagocytosis; TAS:UniProtKB
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0046854; P:phosphatidylinositol phosphorylation; IDA:GOC
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0008654; P:phospholipid biosynthetic process; IDA:UniProtKB
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0072661; P:protein targeting to plasma membrane; IMP:UniProtKB
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0097178; P:ruffle assembly; IMP:UniProtKB
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0007165; P:signal transduction; TAS:ProtInc
Q99755	PIP5K1A	Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60331	PIP5K1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	GO:0016308; F:1-phosphatidylinositol-4-phosphate 5-kinase activity; IEA:UniProtKB-EC
O60331	PIP5K1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O60331	PIP5K1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	GO:0005515; F:protein binding; IPI:IntAct
O60331	PIP5K1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	GO:0030036; P:actin cytoskeleton organization; TAS:UniProtKB
O60331	PIP5K1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	GO:0034333; P:adherens junction assembly; TAS:UniProtKB
O60331	PIP5K1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	GO:0007411; P:axon guidance; TAS:Reactome
O60331	PIP5K1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	GO:0016337; P:single organismal cell-cell adhesion; TAS:UniProtKB
O60331	PIP5K1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	GO:0072583; P:clathrin-mediated endocytosis; TAS:UniProtKB
O60331	PIP5K1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	GO:0007016; P:cytoskeletal anchoring at plasma membrane; IEA:Ensembl
O60331	PIP5K1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	GO:0030593; P:neutrophil chemotaxis; TAS:UniProtKB
O60331	PIP5K1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	GO:0006909; P:phagocytosis; TAS:UniProtKB
O60331	PIP5K1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
O60331	PIP5K1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
O60331	PIP5K1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	GO:0070527; P:platelet aggregation; IEA:Ensembl
O60331	PIP5K1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60331	PIP5K1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	GO:0048488; P:synaptic vesicle endocytosis; TAS:UniProtKB
O60331	PIP5K1C	Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma	GO:0016079; P:synaptic vesicle exocytosis; TAS:UniProtKB
Q5T9C9	PIP5KL1	Phosphatidylinositol 4-phosphate 5-kinase-like protein 1	GO:0016308; F:1-phosphatidylinositol-4-phosphate 5-kinase activity; IEA:UniProtKB-EC
Q5T9C9	PIP5KL1	Phosphatidylinositol 4-phosphate 5-kinase-like protein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q15735	INPP5J	Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A	GO:0052659; F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity; IEA:UniProtKB-EC
Q15735	INPP5J	Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A	GO:0052658; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; IEA:UniProtKB-EC
Q15735	INPP5J	Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A	GO:0004445; F:inositol-polyphosphate 5-phosphatase activity; IEA:UniProtKB-EC
Q15735	INPP5J	Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A	GO:0034485; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; IEA:Ensembl
Q15735	INPP5J	Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q15735	INPP5J	Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A	GO:0031115; P:negative regulation of microtubule polymerization; IEA:Ensembl
Q15735	INPP5J	Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A	GO:0010977; P:negative regulation of neuron projection development; IEA:Ensembl
Q15735	INPP5J	Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A	GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; IEA:Ensembl
Q15735	INPP5J	Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q15735	INPP5J	Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A	GO:0046856; P:phosphatidylinositol dephosphorylation; IEA:InterPro
Q15735	INPP5J	Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q15735	INPP5J	Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0050681; F:androgen receptor binding; NAS:UniProtKB
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0019899; F:enzyme binding; IPI:UniProtKB
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0005515; F:protein binding; IPI:UniProtKB
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0019789; F:SUMO ligase activity; IDA:BHF-UCL
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0003713; F:transcription coactivator activity; NAS:UniProtKB
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0008270; F:zinc ion binding; IEA:InterPro
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0007259; P:JAK-STAT cascade; TAS:ProtInc
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; ISS:UniProtKB
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0033235; P:positive regulation of protein sumoylation; IDA:UniProtKB
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0051152; P:positive regulation of smooth muscle cell differentiation; IEA:Ensembl
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0016925; P:protein sumoylation; ISS:UniProtKB
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0065004; P:protein-DNA complex assembly; IEA:Ensembl
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0042127; P:regulation of cell proliferation; ISS:UniProtKB
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; TAS:Reactome
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0007283; P:spermatogenesis; IEA:Ensembl
O75925	PIAS1	E3 SUMO-protein ligase PIAS1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75928	PIAS2	E3 SUMO-protein ligase PIAS2	GO:0050681; F:androgen receptor binding; NAS:UniProtKB
O75928	PIAS2	E3 SUMO-protein ligase PIAS2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O75928	PIAS2	E3 SUMO-protein ligase PIAS2	GO:0005515; F:protein binding; IPI:UniProtKB
O75928	PIAS2	E3 SUMO-protein ligase PIAS2	GO:0019789; F:SUMO ligase activity; IDA:BHF-UCL
O75928	PIAS2	E3 SUMO-protein ligase PIAS2	GO:0003713; F:transcription coactivator activity; NAS:UniProtKB
O75928	PIAS2	E3 SUMO-protein ligase PIAS2	GO:0008270; F:zinc ion binding; TAS:ProtInc
O75928	PIAS2	E3 SUMO-protein ligase PIAS2	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
O75928	PIAS2	E3 SUMO-protein ligase PIAS2	GO:0060766; P:negative regulation of androgen receptor signaling pathway; IDA:UniProtKB
O75928	PIAS2	E3 SUMO-protein ligase PIAS2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O75928	PIAS2	E3 SUMO-protein ligase PIAS2	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
O75928	PIAS2	E3 SUMO-protein ligase PIAS2	GO:0016925; P:protein sumoylation; IDA:UniProtKB
O75928	PIAS2	E3 SUMO-protein ligase PIAS2	GO:0045667; P:regulation of osteoblast differentiation; IEA:Ensembl
O75928	PIAS2	E3 SUMO-protein ligase PIAS2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NRD5	PICK1	PRKCA-binding protein	GO:0051015; F:actin filament binding; ISS:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0071933; F:Arp2/3 complex binding; ISS:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0016887; F:ATPase activity; ISS:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NRD5	PICK1	PRKCA-binding protein	GO:0005515; F:protein binding; IPI:IntAct
Q9NRD5	PICK1	PRKCA-binding protein	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0005080; F:protein kinase C binding; ISS:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0005102; F:receptor binding; ISS:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0006200; P:ATP catabolic process; ISS:GOC
Q9NRD5	PICK1	PRKCA-binding protein	GO:0036294; P:cellular response to decreased oxygen levels; ISS:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0042149; P:cellular response to glucose starvation; ISS:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0097062; P:dendritic spine maintenance; ISS:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0097061; P:dendritic spine organization; ISS:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0043045; P:DNA methylation involved in embryo development; NAS:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0043046; P:DNA methylation involved in gamete generation; TAS:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0021782; P:glial cell development; ISS:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0060292; P:long term synaptic depression; ISS:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0015844; P:monoamine transport; IDA:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0034316; P:negative regulation of Arp2/3 complex-mediated actin nucleation; ISS:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0045161; P:neuronal ion channel clustering; TAS:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0002092; P:positive regulation of receptor internalization; ISS:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IDA:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0006605; P:protein targeting; IEA:Ensembl
Q9NRD5	PICK1	PRKCA-binding protein	GO:0043113; P:receptor clustering; ISS:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; NAS:UniProtKB
Q9NRD5	PICK1	PRKCA-binding protein	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9Y6X2	PIAS3	E3 SUMO-protein ligase PIAS3	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9Y6X2	PIAS3	E3 SUMO-protein ligase PIAS3	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9Y6X2	PIAS3	E3 SUMO-protein ligase PIAS3	GO:0015459; F:potassium channel regulator activity; IEA:Ensembl
Q9Y6X2	PIAS3	E3 SUMO-protein ligase PIAS3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6X2	PIAS3	E3 SUMO-protein ligase PIAS3	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q9Y6X2	PIAS3	E3 SUMO-protein ligase PIAS3	GO:0019789; F:SUMO ligase activity; IEA:Ensembl
Q9Y6X2	PIAS3	E3 SUMO-protein ligase PIAS3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y6X2	PIAS3	E3 SUMO-protein ligase PIAS3	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
Q9Y6X2	PIAS3	E3 SUMO-protein ligase PIAS3	GO:0045838; P:positive regulation of membrane potential; IEA:Ensembl
Q9Y6X2	PIAS3	E3 SUMO-protein ligase PIAS3	GO:0033235; P:positive regulation of protein sumoylation; IDA:UniProtKB
Q9Y6X2	PIAS3	E3 SUMO-protein ligase PIAS3	GO:0016925; P:protein sumoylation; ISS:UniProtKB
Q9Y6X2	PIAS3	E3 SUMO-protein ligase PIAS3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y6X2	PIAS3	E3 SUMO-protein ligase PIAS3	GO:0009725; P:response to hormone; IEA:Ensembl
Q9Y6X2	PIAS3	E3 SUMO-protein ligase PIAS3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WXW3	PIBF1	Progesterone-induced-blocking factor 1	GO:0005515; F:protein binding; IPI:IntAct
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0005545; F:1-phosphatidylinositol binding; ISS:UniProtKB
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0035615; F:clathrin adaptor activity; IMP:Alzheimers_University_of_Toronto
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0030276; F:clathrin binding; IDA:UniProtKB
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0032050; F:clathrin heavy chain binding; IDA:BHF-UCL
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0005515; F:protein binding; IPI:BHF-UCL
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0042987; P:amyloid precursor protein catabolic process; IMP:Alzheimers_University_of_Toronto
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0007409; P:axonogenesis; IEA:Ensembl
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0034205; P:beta-amyloid formation; IMP:Alzheimers_University_of_Toronto
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0035459; P:cargo loading into vesicle; IMP:Alzheimers_University_of_Toronto
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0008283; P:cell proliferation; IMP:Alzheimers_University_of_Toronto
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0048268; P:clathrin coat assembly; IMP:BHF-UCL
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0072583; P:clathrin-mediated endocytosis; IMP:Alzheimers_University_of_Toronto
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0048813; P:dendrite morphogenesis; IEA:Ensembl
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0016197; P:endosomal transport; IMP:BHF-UCL
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0030097; P:hemopoiesis; IEA:Ensembl
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0055072; P:iron ion homeostasis; IMP:Alzheimers_University_of_Toronto
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0097459; P:iron ion import into cell; IMP:Alzheimers_University_of_Toronto
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0010629; P:negative regulation of gene expression; IMP:Alzheimers_University_of_Toronto
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0048261; P:negative regulation of receptor-mediated endocytosis; IDA:BHF-UCL
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0031623; P:receptor internalization; IMP:BHF-UCL
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0006898; P:receptor-mediated endocytosis; IDA:UniProtKB
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0030100; P:regulation of endocytosis; IMP:BHF-UCL
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:1901214; P:regulation of neuron death; IMP:Alzheimers_University_of_Toronto
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0032880; P:regulation of protein localization; IDA:BHF-UCL
Q13492	PICALM	Phosphatidylinositol-binding clathrin assembly protein	GO:0016192; P:vesicle-mediated transport; TAS:ProtInc
Q8N2W9	PIAS4	E3 SUMO-protein ligase PIAS4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N2W9	PIAS4	E3 SUMO-protein ligase PIAS4	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N2W9	PIAS4	E3 SUMO-protein ligase PIAS4	GO:0019789; F:SUMO ligase activity; IMP:UniProtKB
Q8N2W9	PIAS4	E3 SUMO-protein ligase PIAS4	GO:0031625; F:ubiquitin protein ligase binding; IPI:BHF-UCL
Q8N2W9	PIAS4	E3 SUMO-protein ligase PIAS4	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q8N2W9	PIAS4	E3 SUMO-protein ligase PIAS4	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IEA:Ensembl
Q8N2W9	PIAS4	E3 SUMO-protein ligase PIAS4	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8N2W9	PIAS4	E3 SUMO-protein ligase PIAS4	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q8N2W9	PIAS4	E3 SUMO-protein ligase PIAS4	GO:1902231; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
Q8N2W9	PIAS4	E3 SUMO-protein ligase PIAS4	GO:1902174; P:positive regulation of keratinocyte apoptotic process; ISS:BHF-UCL
Q8N2W9	PIAS4	E3 SUMO-protein ligase PIAS4	GO:0033235; P:positive regulation of protein sumoylation; IDA:UniProtKB
Q8N2W9	PIAS4	E3 SUMO-protein ligase PIAS4	GO:0016925; P:protein sumoylation; IMP:UniProtKB
Q8N2W9	PIAS4	E3 SUMO-protein ligase PIAS4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N2W9	PIAS4	E3 SUMO-protein ligase PIAS4	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9HB75	PIDD	p53-induced protein with a death domain	GO:0005123; F:death receptor binding; TAS:ProtInc
Q9HB75	PIDD	p53-induced protein with a death domain	GO:0005515; F:protein binding; IPI:IntAct
Q9HB75	PIDD	p53-induced protein with a death domain	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
Q9HB75	PIDD	p53-induced protein with a death domain	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q9HB75	PIDD	p53-induced protein with a death domain	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; IMP:UniProtKB
Q9HB75	PIDD	p53-induced protein with a death domain	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q9HB75	PIDD	p53-induced protein with a death domain	GO:0043065; P:positive regulation of apoptotic process; TAS:UniProtKB
Q9HB75	PIDD	p53-induced protein with a death domain	GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
Q9HB75	PIDD	p53-induced protein with a death domain	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:UniProtKB
Q9HB75	PIDD	p53-induced protein with a death domain	GO:0007165; P:signal transduction; TAS:ProtInc
Q92508	PIEZO1	Piezo-type mechanosensitive ion channel component 1	GO:0005261; F:cation channel activity; ISS:UniProtKB
Q92508	PIEZO1	Piezo-type mechanosensitive ion channel component 1	GO:0008381; F:mechanically-gated ion channel activity; IEA:Ensembl
Q92508	PIEZO1	Piezo-type mechanosensitive ion channel component 1	GO:0006812; P:cation transport; ISS:UniProtKB
Q92508	PIEZO1	Piezo-type mechanosensitive ion channel component 1	GO:0050982; P:detection of mechanical stimulus; IEA:Ensembl
Q92508	PIEZO1	Piezo-type mechanosensitive ion channel component 1	GO:0033634; P:positive regulation of cell-cell adhesion mediated by integrin; IMP:UniProtKB
Q92508	PIEZO1	Piezo-type mechanosensitive ion channel component 1	GO:0033625; P:positive regulation of integrin activation; IMP:UniProtKB
Q92508	PIEZO1	Piezo-type mechanosensitive ion channel component 1	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
Q9H5I5	PIEZO2	Piezo-type mechanosensitive ion channel component 2	GO:0005261; F:cation channel activity; IEA:Ensembl
Q9H5I5	PIEZO2	Piezo-type mechanosensitive ion channel component 2	GO:0008381; F:mechanically-gated ion channel activity; IEA:Ensembl
Q9H5I5	PIEZO2	Piezo-type mechanosensitive ion channel component 2	GO:0006812; P:cation transport; ISS:UniProtKB
Q9H5I5	PIEZO2	Piezo-type mechanosensitive ion channel component 2	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
Q8TCI5	PIFO	Protein pitchfork	GO:0048487; F:beta-tubulin binding; IDA:UniProtKB
Q8TCI5	PIFO	Protein pitchfork	GO:0043015; F:gamma-tubulin binding; IDA:UniProtKB
Q8TCI5	PIFO	Protein pitchfork	GO:0019894; F:kinesin binding; IPI:UniProtKB
Q8TCI5	PIFO	Protein pitchfork	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TCI5	PIFO	Protein pitchfork	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q8TCI5	PIFO	Protein pitchfork	GO:0017137; F:Rab GTPase binding; IPI:UniProtKB
Q8TCI5	PIFO	Protein pitchfork	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
Q8TCI5	PIFO	Protein pitchfork	GO:0033674; P:positive regulation of kinase activity; IMP:UniProtKB
Q8TCI5	PIFO	Protein pitchfork	GO:0031344; P:regulation of cell projection organization; ISS:UniProtKB
P37287	PIGA	Phosphatidylinositol N-acetylglucosaminyltransferase subunit A	GO:0017176; F:phosphatidylinositol N-acetylglucosaminyltransferase activity; TAS:HGNC
P37287	PIGA	Phosphatidylinositol N-acetylglucosaminyltransferase subunit A	GO:0005515; F:protein binding; IPI:HGNC
P37287	PIGA	Phosphatidylinositol N-acetylglucosaminyltransferase subunit A	GO:0008194; F:UDP-glycosyltransferase activity; TAS:Reactome
P37287	PIGA	Phosphatidylinositol N-acetylglucosaminyltransferase subunit A	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
P37287	PIGA	Phosphatidylinositol N-acetylglucosaminyltransferase subunit A	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P37287	PIGA	Phosphatidylinositol N-acetylglucosaminyltransferase subunit A	GO:0006506; P:GPI anchor biosynthetic process; TAS:HGNC
P37287	PIGA	Phosphatidylinositol N-acetylglucosaminyltransferase subunit A	GO:0009893; P:positive regulation of metabolic process; TAS:HGNC
P37287	PIGA	Phosphatidylinositol N-acetylglucosaminyltransferase subunit A	GO:0043687; P:post-translational protein modification; TAS:Reactome
P37287	PIGA	Phosphatidylinositol N-acetylglucosaminyltransferase subunit A	GO:0016254; P:preassembly of GPI anchor in ER membrane; TAS:Reactome
Q9H611	PIF1	ATP-dependent DNA helicase PIF1	GO:0005524; F:ATP binding; IDA:HGNC
Q9H611	PIF1	ATP-dependent DNA helicase PIF1	GO:0043141; F:ATP-dependent 5'-3' DNA helicase activity; IDA:HGNC
Q9H611	PIF1	ATP-dependent DNA helicase PIF1	GO:0033682; F:ATP-dependent 5'-3' DNA/RNA helicase activity; IDA:BHF-UCL
Q9H611	PIF1	ATP-dependent DNA helicase PIF1	GO:0051880; F:G-quadruplex DNA binding; IEA:UniProtKB-HAMAP
Q9H611	PIF1	ATP-dependent DNA helicase PIF1	GO:0000287; F:magnesium ion binding; IDA:HGNC
Q9H611	PIF1	ATP-dependent DNA helicase PIF1	GO:0017116; F:single-stranded DNA-dependent ATP-dependent DNA helicase activity; IDA:HGNC
Q9H611	PIF1	ATP-dependent DNA helicase PIF1	GO:0010521; F:telomerase inhibitor activity; IEA:UniProtKB-HAMAP
Q9H611	PIF1	ATP-dependent DNA helicase PIF1	GO:0042162; F:telomeric DNA binding; IDA:HGNC
Q9H611	PIF1	ATP-dependent DNA helicase PIF1	GO:0006200; P:ATP catabolic process; IDA:GOC
Q9H611	PIF1	ATP-dependent DNA helicase PIF1	GO:0032508; P:DNA duplex unwinding; IDA:GOC
Q9H611	PIF1	ATP-dependent DNA helicase PIF1	GO:0006310; P:DNA recombination; IEA:UniProtKB-HAMAP
Q9H611	PIF1	ATP-dependent DNA helicase PIF1	GO:0006281; P:DNA repair; IEA:UniProtKB-HAMAP
Q9H611	PIF1	ATP-dependent DNA helicase PIF1	GO:0000002; P:mitochondrial genome maintenance; IEA:UniProtKB-HAMAP
Q9H611	PIF1	ATP-dependent DNA helicase PIF1	GO:0051974; P:negative regulation of telomerase activity; IDA:HGNC
Q9H611	PIF1	ATP-dependent DNA helicase PIF1	GO:0032211; P:negative regulation of telomere maintenance via telomerase; IEA:UniProtKB-HAMAP
Q9H611	PIF1	ATP-dependent DNA helicase PIF1	GO:0032204; P:regulation of telomere maintenance; IDA:HGNC
Q9H611	PIF1	ATP-dependent DNA helicase PIF1	GO:0000723; P:telomere maintenance; IEA:InterPro
Q92521	PIGB	GPI mannosyltransferase 3	GO:0000030; F:mannosyltransferase activity; IDA:UniProtKB
Q92521	PIGB	GPI mannosyltransferase 3	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
Q92521	PIGB	GPI mannosyltransferase 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q92521	PIGB	GPI mannosyltransferase 3	GO:0006506; P:GPI anchor biosynthetic process; IDA:UniProtKB
Q92521	PIGB	GPI mannosyltransferase 3	GO:0097502; P:mannosylation; IDA:GOC
Q92521	PIGB	GPI mannosyltransferase 3	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q92521	PIGB	GPI mannosyltransferase 3	GO:0016254; P:preassembly of GPI anchor in ER membrane; TAS:Reactome
Q92535	PIGC	Phosphatidylinositol N-acetylglucosaminyltransferase subunit C	GO:0003824; F:catalytic activity; TAS:ProtInc
Q92535	PIGC	Phosphatidylinositol N-acetylglucosaminyltransferase subunit C	GO:0017176; F:phosphatidylinositol N-acetylglucosaminyltransferase activity; IEA:UniProtKB-EC
Q92535	PIGC	Phosphatidylinositol N-acetylglucosaminyltransferase subunit C	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
Q92535	PIGC	Phosphatidylinositol N-acetylglucosaminyltransferase subunit C	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q92535	PIGC	Phosphatidylinositol N-acetylglucosaminyltransferase subunit C	GO:0006506; P:GPI anchor biosynthetic process; TAS:ProtInc
Q92535	PIGC	Phosphatidylinositol N-acetylglucosaminyltransferase subunit C	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q92535	PIGC	Phosphatidylinositol N-acetylglucosaminyltransferase subunit C	GO:0016254; P:preassembly of GPI anchor in ER membrane; TAS:Reactome
Q07326	PIGF	Phosphatidylinositol-glycan biosynthesis class F protein	GO:0004307; F:ethanolaminephosphotransferase activity; TAS:ProtInc
Q07326	PIGF	Phosphatidylinositol-glycan biosynthesis class F protein	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
Q07326	PIGF	Phosphatidylinositol-glycan biosynthesis class F protein	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q07326	PIGF	Phosphatidylinositol-glycan biosynthesis class F protein	GO:0006506; P:GPI anchor biosynthetic process; ISS:UniProtKB
Q07326	PIGF	Phosphatidylinositol-glycan biosynthesis class F protein	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q07326	PIGF	Phosphatidylinositol-glycan biosynthesis class F protein	GO:0016254; P:preassembly of GPI anchor in ER membrane; TAS:Reactome
Q14442	PIGH	Phosphatidylinositol N-acetylglucosaminyltransferase subunit H	GO:0003824; F:catalytic activity; TAS:ProtInc
Q14442	PIGH	Phosphatidylinositol N-acetylglucosaminyltransferase subunit H	GO:0017176; F:phosphatidylinositol N-acetylglucosaminyltransferase activity; IEA:UniProtKB-EC
Q14442	PIGH	Phosphatidylinositol N-acetylglucosaminyltransferase subunit H	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
Q14442	PIGH	Phosphatidylinositol N-acetylglucosaminyltransferase subunit H	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q14442	PIGH	Phosphatidylinositol N-acetylglucosaminyltransferase subunit H	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q14442	PIGH	Phosphatidylinositol N-acetylglucosaminyltransferase subunit H	GO:0006506; P:GPI anchor biosynthetic process; TAS:ProtInc
Q14442	PIGH	Phosphatidylinositol N-acetylglucosaminyltransferase subunit H	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q14442	PIGH	Phosphatidylinositol N-acetylglucosaminyltransferase subunit H	GO:0016254; P:preassembly of GPI anchor in ER membrane; TAS:Reactome
Q9Y2B2	PIGL	N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase	GO:0000225; F:N-acetylglucosaminylphosphatidylinositol deacetylase activity; NAS:UniProtKB
Q9Y2B2	PIGL	N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
Q9Y2B2	PIGL	N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9Y2B2	PIGL	N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase	GO:0006506; P:GPI anchor biosynthetic process; NAS:UniProtKB
Q9Y2B2	PIGL	N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9Y2B2	PIGL	N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase	GO:0016254; P:preassembly of GPI anchor in ER membrane; TAS:Reactome
Q5H8A4	PIGG	GPI ethanolamine phosphate transferase 2	GO:0051267; F:CP2 mannose-ethanolamine phosphotransferase activity; IDA:MGI
Q5H8A4	PIGG	GPI ethanolamine phosphate transferase 2	GO:0016780; F:phosphotransferase activity, for other substituted phosphate groups; TAS:Reactome
Q5H8A4	PIGG	GPI ethanolamine phosphate transferase 2	GO:0016740; F:transferase activity; IEA:UniProtKB-KW
Q5H8A4	PIGG	GPI ethanolamine phosphate transferase 2	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
Q5H8A4	PIGG	GPI ethanolamine phosphate transferase 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q5H8A4	PIGG	GPI ethanolamine phosphate transferase 2	GO:0006506; P:GPI anchor biosynthetic process; IDA:MGI
Q5H8A4	PIGG	GPI ethanolamine phosphate transferase 2	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q5H8A4	PIGG	GPI ethanolamine phosphate transferase 2	GO:0016254; P:preassembly of GPI anchor in ER membrane; TAS:Reactome
Q9H3S5	PIGM	GPI mannosyltransferase 1	GO:0000030; F:mannosyltransferase activity; IEA:Ensembl
Q9H3S5	PIGM	GPI mannosyltransferase 1	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
Q9H3S5	PIGM	GPI mannosyltransferase 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9H3S5	PIGM	GPI mannosyltransferase 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9H3S5	PIGM	GPI mannosyltransferase 1	GO:0016254; P:preassembly of GPI anchor in ER membrane; TAS:Reactome
O95427	PIGN	GPI ethanolamine phosphate transferase 1	GO:0016740; F:transferase activity; IEA:UniProtKB-KW
O95427	PIGN	GPI ethanolamine phosphate transferase 1	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
O95427	PIGN	GPI ethanolamine phosphate transferase 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O95427	PIGN	GPI ethanolamine phosphate transferase 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
O95427	PIGN	GPI ethanolamine phosphate transferase 1	GO:0016254; P:preassembly of GPI anchor in ER membrane; TAS:Reactome
Q8TEQ8	PIGO	GPI ethanolamine phosphate transferase 3	GO:0016740; F:transferase activity; IEA:UniProtKB-KW
Q8TEQ8	PIGO	GPI ethanolamine phosphate transferase 3	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
Q8TEQ8	PIGO	GPI ethanolamine phosphate transferase 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8TEQ8	PIGO	GPI ethanolamine phosphate transferase 3	GO:0006506; P:GPI anchor biosynthetic process; ISS:UniProtKB
Q8TEQ8	PIGO	GPI ethanolamine phosphate transferase 3	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q8TEQ8	PIGO	GPI ethanolamine phosphate transferase 3	GO:0016254; P:preassembly of GPI anchor in ER membrane; TAS:Reactome
Q9BRB3	PIGQ	Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q	GO:0017176; F:phosphatidylinositol N-acetylglucosaminyltransferase activity; IEA:UniProtKB-EC
Q9BRB3	PIGQ	Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
Q9BRB3	PIGQ	Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
Q9BRB3	PIGQ	Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9BRB3	PIGQ	Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9BRB3	PIGQ	Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q	GO:0016254; P:preassembly of GPI anchor in ER membrane; TAS:Reactome
P57054	PIGP	Phosphatidylinositol N-acetylglucosaminyltransferase subunit P	GO:0017176; F:phosphatidylinositol N-acetylglucosaminyltransferase activity; IEA:UniProtKB-EC
P57054	PIGP	Phosphatidylinositol N-acetylglucosaminyltransferase subunit P	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
P57054	PIGP	Phosphatidylinositol N-acetylglucosaminyltransferase subunit P	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P57054	PIGP	Phosphatidylinositol N-acetylglucosaminyltransferase subunit P	GO:0043687; P:post-translational protein modification; TAS:Reactome
P57054	PIGP	Phosphatidylinositol N-acetylglucosaminyltransferase subunit P	GO:0016254; P:preassembly of GPI anchor in ER membrane; TAS:Reactome
P01833	PIGR	Polymeric immunoglobulin receptor	GO:0001792; F:polymeric immunoglobulin receptor activity; IDA:UniProt
P01833	PIGR	Polymeric immunoglobulin receptor	GO:0001580; P:detection of chemical stimulus involved in sensory perception of bitter taste; IDA:UniProt
P01833	PIGR	Polymeric immunoglobulin receptor	GO:0007173; P:epidermal growth factor receptor signaling pathway; IDA:UniProt
P01833	PIGR	Polymeric immunoglobulin receptor	GO:0038093; P:Fc receptor signaling pathway; IDA:UniProt
P01833	PIGR	Polymeric immunoglobulin receptor	GO:0002415; P:immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor; IDA:UniProt
P01833	PIGR	Polymeric immunoglobulin receptor	GO:0043113; P:receptor clustering; IDA:UniProt
P01833	PIGR	Polymeric immunoglobulin receptor	GO:0001895; P:retina homeostasis; IEP:UniProt
Q96S52	PIGS	GPI transamidase component PIG-S	GO:0003923; F:GPI-anchor transamidase activity; IEA:Ensembl
Q96S52	PIGS	GPI transamidase component PIG-S	GO:0005515; F:protein binding; IPI:UniProtKB
Q96S52	PIGS	GPI transamidase component PIG-S	GO:0016255; P:attachment of GPI anchor to protein; TAS:UniProtKB
Q96S52	PIGS	GPI transamidase component PIG-S	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
Q96S52	PIGS	GPI transamidase component PIG-S	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q96S52	PIGS	GPI transamidase component PIG-S	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q969N2	PIGT	GPI transamidase component PIG-T	GO:0003923; F:GPI-anchor transamidase activity; IEA:Ensembl
Q969N2	PIGT	GPI transamidase component PIG-T	GO:0005515; F:protein binding; IPI:UniProtKB
Q969N2	PIGT	GPI transamidase component PIG-T	GO:0016255; P:attachment of GPI anchor to protein; TAS:UniProtKB
Q969N2	PIGT	GPI transamidase component PIG-T	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
Q969N2	PIGT	GPI transamidase component PIG-T	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q969N2	PIGT	GPI transamidase component PIG-T	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
Q969N2	PIGT	GPI transamidase component PIG-T	GO:0030182; P:neuron differentiation; IEA:Ensembl
Q969N2	PIGT	GPI transamidase component PIG-T	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9NUD9	PIGV	GPI mannosyltransferase 2	GO:0000030; F:mannosyltransferase activity; IMP:UniProtKB
Q9NUD9	PIGV	GPI mannosyltransferase 2	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
Q9NUD9	PIGV	GPI mannosyltransferase 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9NUD9	PIGV	GPI mannosyltransferase 2	GO:0006506; P:GPI anchor biosynthetic process; IMP:UniProtKB
Q9NUD9	PIGV	GPI mannosyltransferase 2	GO:0097502; P:mannosylation; IMP:GOC
Q9NUD9	PIGV	GPI mannosyltransferase 2	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9NUD9	PIGV	GPI mannosyltransferase 2	GO:0016254; P:preassembly of GPI anchor in ER membrane; TAS:Reactome
Q9H490	PIGU	Phosphatidylinositol glycan anchor biosynthesis class U protein	GO:0016255; P:attachment of GPI anchor to protein; IMP:UniProtKB
Q9H490	PIGU	Phosphatidylinositol glycan anchor biosynthesis class U protein	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
Q9H490	PIGU	Phosphatidylinositol glycan anchor biosynthesis class U protein	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9H490	PIGU	Phosphatidylinositol glycan anchor biosynthesis class U protein	GO:0006506; P:GPI anchor biosynthetic process; IDA:HGNC
Q9H490	PIGU	Phosphatidylinositol glycan anchor biosynthesis class U protein	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9H490	PIGU	Phosphatidylinositol glycan anchor biosynthesis class U protein	GO:0046425; P:regulation of JAK-STAT cascade; IDA:HGNC
Q7Z7B1	PIGW	Phosphatidylinositol-glycan biosynthesis class W protein	GO:0016746; F:transferase activity, transferring acyl groups; IEA:UniProtKB-KW
Q7Z7B1	PIGW	Phosphatidylinositol-glycan biosynthesis class W protein	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
Q7Z7B1	PIGW	Phosphatidylinositol-glycan biosynthesis class W protein	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q7Z7B1	PIGW	Phosphatidylinositol-glycan biosynthesis class W protein	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q7Z7B1	PIGW	Phosphatidylinositol-glycan biosynthesis class W protein	GO:0016254; P:preassembly of GPI anchor in ER membrane; TAS:Reactome
Q8TBF5	PIGX	Phosphatidylinositol-glycan biosynthesis class X protein	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
Q8TBF5	PIGX	Phosphatidylinositol-glycan biosynthesis class X protein	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8TBF5	PIGX	Phosphatidylinositol-glycan biosynthesis class X protein	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q8TBF5	PIGX	Phosphatidylinositol-glycan biosynthesis class X protein	GO:0016254; P:preassembly of GPI anchor in ER membrane; TAS:Reactome
Q3MUY2	PIGY	Phosphatidylinositol N-acetylglucosaminyltransferase subunit Y	GO:0006506; P:GPI anchor biosynthetic process; IDA:MGI
Q9NWS0	PIH1D1	PIH1 domain-containing protein 1	GO:0000492; P:box C/D snoRNP assembly; IMP:BHF-UCL
Q9NWS0	PIH1D1	PIH1 domain-containing protein 1	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
Q86VD9	PIGZ	GPI mannosyltransferase 4	GO:0000026; F:alpha-1,2-mannosyltransferase activity; IMP:UniProtKB
Q86VD9	PIGZ	GPI mannosyltransferase 4	GO:0000030; F:mannosyltransferase activity; IGI:UniProtKB
Q86VD9	PIGZ	GPI mannosyltransferase 4	GO:0006506; P:GPI anchor biosynthetic process; IMP:UniProtKB
Q86VD9	PIGZ	GPI mannosyltransferase 4	GO:0097502; P:mannosylation; IMP:GOC
Q9UKJ1	PILRA	Paired immunoglobulin-like type 2 receptor alpha	GO:0005515; F:protein binding; IPI:IntAct
Q9UKJ1	PILRA	Paired immunoglobulin-like type 2 receptor alpha	GO:0007165; P:signal transduction; IDA:MGI
Q9UKJ1	PILRA	Paired immunoglobulin-like type 2 receptor alpha	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9UKJ0	PILRB	Paired immunoglobulin-like type 2 receptor beta	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKJ0	PILRB	Paired immunoglobulin-like type 2 receptor beta	GO:0007171; P:activation of transmembrane receptor protein tyrosine kinase activity; NAS:UniProtKB
Q9UKJ0	PILRB	Paired immunoglobulin-like type 2 receptor beta	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:UniProtKB
P11309	PIM1	Serine/threonine-protein kinase pim-1	GO:0005524; F:ATP binding; IDA:UniProtKB
P11309	PIM1	Serine/threonine-protein kinase pim-1	GO:0030145; F:manganese ion binding; IDA:UniProtKB
P11309	PIM1	Serine/threonine-protein kinase pim-1	GO:0005515; F:protein binding; IPI:IntAct
P11309	PIM1	Serine/threonine-protein kinase pim-1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P11309	PIM1	Serine/threonine-protein kinase pim-1	GO:0043024; F:ribosomal small subunit binding; IPI:UniProtKB
P11309	PIM1	Serine/threonine-protein kinase pim-1	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P11309	PIM1	Serine/threonine-protein kinase pim-1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P11309	PIM1	Serine/threonine-protein kinase pim-1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P11309	PIM1	Serine/threonine-protein kinase pim-1	GO:0008283; P:cell proliferation; IDA:UniProtKB
P11309	PIM1	Serine/threonine-protein kinase pim-1	GO:0030212; P:hyaluronan metabolic process; IEA:Ensembl
P11309	PIM1	Serine/threonine-protein kinase pim-1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P11309	PIM1	Serine/threonine-protein kinase pim-1	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P11309	PIM1	Serine/threonine-protein kinase pim-1	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P11309	PIM1	Serine/threonine-protein kinase pim-1	GO:0031659; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle; IDA:UniProtKB
P11309	PIM1	Serine/threonine-protein kinase pim-1	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P11309	PIM1	Serine/threonine-protein kinase pim-1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9P1W9	PIM2	Serine/threonine-protein kinase pim-2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9P1W9	PIM2	Serine/threonine-protein kinase pim-2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9P1W9	PIM2	Serine/threonine-protein kinase pim-2	GO:0008637; P:apoptotic mitochondrial changes; IEA:Ensembl
Q9P1W9	PIM2	Serine/threonine-protein kinase pim-2	GO:0008283; P:cell proliferation; TAS:ProtInc
Q9P1W9	PIM2	Serine/threonine-protein kinase pim-2	GO:0000082; P:G1/S transition of mitotic cell cycle; IDA:UniProtKB
Q9P1W9	PIM2	Serine/threonine-protein kinase pim-2	GO:0007140; P:male meiosis; TAS:ProtInc
Q9P1W9	PIM2	Serine/threonine-protein kinase pim-2	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q9P1W9	PIM2	Serine/threonine-protein kinase pim-2	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q9P1W9	PIM2	Serine/threonine-protein kinase pim-2	GO:0010508; P:positive regulation of autophagy; ISS:UniProtKB
Q9P1W9	PIM2	Serine/threonine-protein kinase pim-2	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; ISS:UniProtKB
Q9P1W9	PIM2	Serine/threonine-protein kinase pim-2	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q9P1W9	PIM2	Serine/threonine-protein kinase pim-2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9P1W9	PIM2	Serine/threonine-protein kinase pim-2	GO:0050821; P:protein stabilization; IMP:UniProtKB
Q9P1W9	PIM2	Serine/threonine-protein kinase pim-2	GO:0009615; P:response to virus; IEP:UniProtKB
Q86V86	PIM3	Serine/threonine-protein kinase pim-3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86V86	PIM3	Serine/threonine-protein kinase pim-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q86V86	PIM3	Serine/threonine-protein kinase pim-3	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q86V86	PIM3	Serine/threonine-protein kinase pim-3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q86V86	PIM3	Serine/threonine-protein kinase pim-3	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q86V86	PIM3	Serine/threonine-protein kinase pim-3	GO:0016572; P:histone phosphorylation; IEA:Ensembl
Q86V86	PIM3	Serine/threonine-protein kinase pim-3	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q86V86	PIM3	Serine/threonine-protein kinase pim-3	GO:0061179; P:negative regulation of insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB
Q86V86	PIM3	Serine/threonine-protein kinase pim-3	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
Q86V86	PIM3	Serine/threonine-protein kinase pim-3	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q86V86	PIM3	Serine/threonine-protein kinase pim-3	GO:0007346; P:regulation of mitotic cell cycle; IMP:UniProtKB
P22061	PCMT1	Protein-L-isoaspartate(D-aspartate) O-methyltransferase	GO:0004719; F:protein-L-isoaspartate (D-aspartate) O-methyltransferase activity; TAS:UniProtKB
P22061	PCMT1	Protein-L-isoaspartate(D-aspartate) O-methyltransferase	GO:0006479; P:protein methylation; TAS:ProtInc
P22061	PCMT1	Protein-L-isoaspartate(D-aspartate) O-methyltransferase	GO:0030091; P:protein repair; TAS:UniProtKB
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:0032794; F:GTPase activating protein binding; IPI:BHF-UCL
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:0031434; F:mitogen-activated protein kinase kinase binding; IPI:BHF-UCL
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IDA:BHF-UCL
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:0050815; F:phosphoserine binding; IDA:BHF-UCL
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:0050816; F:phosphothreonine binding; IDA:BHF-UCL
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:0045087; P:innate immune response; TAS:Reactome
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:2000146; P:negative regulation of cell motility; IDA:BHF-UCL
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:0001934; P:positive regulation of protein phosphorylation; IGI:MGI
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:0032321; P:positive regulation of Rho GTPase activity; IMP:BHF-UCL
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:0051443; P:positive regulation of ubiquitin-protein ligase activity; IDA:BHF-UCL
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:0006457; P:protein folding; IEA:UniProtKB-KW
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:0000413; P:protein peptidyl-prolyl isomerization; IDA:GOC
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:0032465; P:regulation of cytokinesis; IMP:MGI
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:0007088; P:regulation of mitosis; TAS:ProtInc
Q13526	PIN1	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	GO:0060393; P:regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
Q9Y237	PIN4	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4	GO:0003681; F:bent DNA binding; IDA:UniProtKB
Q9Y237	PIN4	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y237	PIN4	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4	GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB
Q9Y237	PIN4	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW
Q9Y237	PIN4	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y237	PIN4	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4	GO:0006457; P:protein folding; IEA:UniProtKB-KW
Q9Y237	PIN4	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4	GO:0006364; P:rRNA processing; IMP:UniProtKB
Q9H307	PNN	Pinin	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H307	PNN	Pinin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H307	PNN	Pinin	GO:0005198; F:structural molecule activity; NAS:ProtInc
Q9H307	PNN	Pinin	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9H307	PNN	Pinin	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q9H307	PNN	Pinin	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H307	PNN	Pinin	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0055131; F:C3HC4-type RING finger domain binding; IPI:BHF-UCL
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0010857; F:calcium-dependent protein kinase activity; IDA:BHF-UCL
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0016301; F:kinase activity; IDA:MGI
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0097237; P:cellular response to toxic substance; IEA:Ensembl
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0000422; P:mitochondrion degradation; IMP:UniProtKB
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0033603; P:positive regulation of dopamine secretion; IEA:Ensembl
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:BHF-UCL
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IMP:BHF-UCL
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0032226; P:positive regulation of synaptic transmission, dopaminergic; IEA:Ensembl
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0016567; P:protein ubiquitination; IMP:UniProtKB
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0043254; P:regulation of protein complex assembly; IDA:BHF-UCL
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0031396; P:regulation of protein ubiquitination; IDA:BHF-UCL
Q9BXM7	PINK1	Serine/threonine-protein kinase PINK1, mitochondrial	GO:0006950; P:response to stress; IDA:UniProtKB
Q96BK5	PINX1	PIN2/TERF1-interacting telomerase inhibitor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96BK5	PINX1	PIN2/TERF1-interacting telomerase inhibitor 1	GO:0010521; F:telomerase inhibitor activity; TAS:UniProtKB
Q96BK5	PINX1	PIN2/TERF1-interacting telomerase inhibitor 1	GO:0070034; F:telomeric RNA binding; IDA:UniProtKB
Q96BK5	PINX1	PIN2/TERF1-interacting telomerase inhibitor 1	GO:0007080; P:mitotic metaphase plate congression; IMP:UniProtKB
Q96BK5	PINX1	PIN2/TERF1-interacting telomerase inhibitor 1	GO:0008285; P:negative regulation of cell proliferation; NAS:UniProtKB
Q96BK5	PINX1	PIN2/TERF1-interacting telomerase inhibitor 1	GO:0051974; P:negative regulation of telomerase activity; TAS:GOC
Q96BK5	PINX1	PIN2/TERF1-interacting telomerase inhibitor 1	GO:0051972; P:regulation of telomerase activity; TAS:UniProtKB
Q96BK5	PINX1	PIN2/TERF1-interacting telomerase inhibitor 1	GO:0007004; P:telomere maintenance via telomerase; IEA:Ensembl
A6NC86	PINLYP	phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein	GO:0004859; F:phospholipase inhibitor activity; IEA:InterPro
Q00169	PITPNA	Phosphatidylinositol transfer protein alpha isoform	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q00169	PITPNA	Phosphatidylinositol transfer protein alpha isoform	GO:0008525; F:phosphatidylcholine transporter activity; TAS:ProtInc
Q00169	PITPNA	Phosphatidylinositol transfer protein alpha isoform	GO:0008526; F:phosphatidylinositol transporter activity; TAS:ProtInc
Q00169	PITPNA	Phosphatidylinositol transfer protein alpha isoform	GO:0007411; P:axon guidance; TAS:Reactome
Q00169	PITPNA	Phosphatidylinositol transfer protein alpha isoform	GO:0006629; P:lipid metabolic process; NAS:ProtInc
Q00169	PITPNA	Phosphatidylinositol transfer protein alpha isoform	GO:0015914; P:phospholipid transport; TAS:GOC
Q00169	PITPNA	Phosphatidylinositol transfer protein alpha isoform	GO:0007601; P:visual perception; TAS:ProtInc
P48739	PITPNB	Phosphatidylinositol transfer protein beta isoform	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
P48739	PITPNB	Phosphatidylinositol transfer protein beta isoform	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
P48739	PITPNB	Phosphatidylinositol transfer protein beta isoform	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P48739	PITPNB	Phosphatidylinositol transfer protein beta isoform	GO:0006629; P:lipid metabolic process; NAS:ProtInc
P48739	PITPNB	Phosphatidylinositol transfer protein beta isoform	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P48739	PITPNB	Phosphatidylinositol transfer protein beta isoform	GO:0015914; P:phospholipid transport; TAS:Reactome
P48739	PITPNB	Phosphatidylinositol transfer protein beta isoform	GO:0044281; P:small molecule metabolic process; TAS:Reactome
A2A3N6	PIPSL	Putative PIP5K1A and PSMD4-like protein	GO:0016307; F:phosphatidylinositol phosphate kinase activity; IEA:InterPro
P12273	PIP	Prolactin-inducible protein	GO:0003779; F:actin binding; NAS:UniProtKB
P12273	PIP	Prolactin-inducible protein	GO:0004190; F:aspartic-type endopeptidase activity; IMP:UniProt
P12273	PIP	Prolactin-inducible protein	GO:0001948; F:glycoprotein binding; IPI:UniProt
P12273	PIP	Prolactin-inducible protein	GO:0019864; F:IgG binding; IDA:UniProt
P12273	PIP	Prolactin-inducible protein	GO:0005515; F:protein binding; IPI:UniProt
P12273	PIP	Prolactin-inducible protein	GO:0046983; F:protein dimerization activity; IDA:UniProt
P12273	PIP	Prolactin-inducible protein	GO:0001580; P:detection of chemical stimulus involved in sensory perception of bitter taste; IDA:UniProt
P12273	PIP	Prolactin-inducible protein	GO:0070233; P:negative regulation of T cell apoptotic process; IMP:UniProt
P12273	PIP	Prolactin-inducible protein	GO:0010628; P:positive regulation of gene expression; IDA:UniProt
P12273	PIP	Prolactin-inducible protein	GO:0006508; P:proteolysis; IMP:UniProt
P12273	PIP	Prolactin-inducible protein	GO:0001895; P:retina homeostasis; IEP:UniProt
O00625	PIR	Pirin	GO:0046872; F:metal ion binding; IDA:UniProtKB
O00625	PIR	Pirin	GO:0005515; F:protein binding; IPI:UniProtKB
O00625	PIR	Pirin	GO:0008127; F:quercetin 2,3-dioxygenase activity; IDA:UniProtKB
O00625	PIR	Pirin	GO:0003712; F:transcription cofactor activity; IMP:UniProtKB
O00625	PIR	Pirin	GO:0030224; P:monocyte differentiation; IMP:MGI
O00625	PIR	Pirin	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O00625	PIR	Pirin	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9UG56	PISD	Phosphatidylserine decarboxylase proenzyme	GO:0004609; F:phosphatidylserine decarboxylase activity; IEA:UniProtKB-EC
Q9UG56	PISD	Phosphatidylserine decarboxylase proenzyme	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9UG56	PISD	Phosphatidylserine decarboxylase proenzyme	GO:0006646; P:phosphatidylethanolamine biosynthetic process; TAS:Reactome
Q9UG56	PISD	Phosphatidylserine decarboxylase proenzyme	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9UG56	PISD	Phosphatidylserine decarboxylase proenzyme	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0003682; F:chromatin binding; IEA:Ensembl
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0001105; F:RNA polymerase II transcription coactivator activity; IDA:BHF-UCL
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0030183; P:B cell differentiation; IEA:Ensembl
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0001708; P:cell fate specification; IEA:Ensembl
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0008340; P:determination of adult lifespan; IEA:Ensembl
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0051169; P:nuclear transport; IEA:Ensembl
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0032962; P:positive regulation of inositol trisphosphate biosynthetic process; IEA:Ensembl
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0043567; P:regulation of insulin-like growth factor receptor signaling pathway; IEA:Ensembl
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0060133; P:somatotropin secreting cell development; IEA:Ensembl
P28069	POU1F1	Pituitary-specific positive transcription factor 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9UKF7	PITPNC1	Cytoplasmic phosphatidylinositol transfer protein 1	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q9UKF7	PITPNC1	Cytoplasmic phosphatidylinositol transfer protein 1	GO:0008526; F:phosphatidylinositol transporter activity; IMP:UniProtKB
Q9UKF7	PITPNC1	Cytoplasmic phosphatidylinositol transfer protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9UKF7	PITPNC1	Cytoplasmic phosphatidylinositol transfer protein 1	GO:0015914; P:phospholipid transport; IMP:GOC
Q9UKF7	PITPNC1	Cytoplasmic phosphatidylinositol transfer protein 1	GO:0007165; P:signal transduction; IMP:UniProtKB
Q9BZ72	PITPNM2	Membrane-associated phosphatidylinositol transfer protein 2	GO:0005509; F:calcium ion binding; NAS:UniProtKB
Q9BZ72	PITPNM2	Membrane-associated phosphatidylinositol transfer protein 2	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q9BZ72	PITPNM2	Membrane-associated phosphatidylinositol transfer protein 2	GO:0008152; P:metabolic process; NAS:UniProtKB
Q9BZ72	PITPNM2	Membrane-associated phosphatidylinositol transfer protein 2	GO:0006810; P:transport; IEA:InterPro
Q9BZ71	PITPNM3	Membrane-associated phosphatidylinositol transfer protein 3	GO:0005509; F:calcium ion binding; TAS:UniProtKB
Q9BZ71	PITPNM3	Membrane-associated phosphatidylinositol transfer protein 3	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q9BZ71	PITPNM3	Membrane-associated phosphatidylinositol transfer protein 3	GO:0008526; F:phosphatidylinositol transporter activity; TAS:UniProtKB
Q9BZ71	PITPNM3	Membrane-associated phosphatidylinositol transfer protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q9BZ71	PITPNM3	Membrane-associated phosphatidylinositol transfer protein 3	GO:0030971; F:receptor tyrosine kinase binding; TAS:UniProtKB
Q9BZ71	PITPNM3	Membrane-associated phosphatidylinositol transfer protein 3	GO:0046488; P:phosphatidylinositol metabolic process; TAS:UniProtKB
Q9BZ71	PITPNM3	Membrane-associated phosphatidylinositol transfer protein 3	GO:0015914; P:phospholipid transport; TAS:GOC
O00562	PITPNM1	Membrane-associated phosphatidylinositol transfer protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O00562	PITPNM1	Membrane-associated phosphatidylinositol transfer protein 1	GO:0008526; F:phosphatidylinositol transporter activity; TAS:ProtInc
O00562	PITPNM1	Membrane-associated phosphatidylinositol transfer protein 1	GO:0007420; P:brain development; TAS:ProtInc
O00562	PITPNM1	Membrane-associated phosphatidylinositol transfer protein 1	GO:0006629; P:lipid metabolic process; NAS:ProtInc
O00562	PITPNM1	Membrane-associated phosphatidylinositol transfer protein 1	GO:0015914; P:phospholipid transport; TAS:GOC
O00562	PITPNM1	Membrane-associated phosphatidylinositol transfer protein 1	GO:0007602; P:phototransduction; TAS:ProtInc
O00562	PITPNM1	Membrane-associated phosphatidylinositol transfer protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P78337	PITX1	Pituitary homeobox 1	GO:0001190; F:RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P78337	PITX1	Pituitary homeobox 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P78337	PITX1	Pituitary homeobox 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P78337	PITX1	Pituitary homeobox 1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P78337	PITX1	Pituitary homeobox 1	GO:0014707; P:branchiomeric skeletal muscle development; IEA:Ensembl
P78337	PITX1	Pituitary homeobox 1	GO:0051216; P:cartilage development; IEA:Ensembl
P78337	PITX1	Pituitary homeobox 1	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
P78337	PITX1	Pituitary homeobox 1	GO:0048625; P:myoblast fate commitment; IEA:Ensembl
P78337	PITX1	Pituitary homeobox 1	GO:0021983; P:pituitary gland development; IEA:Ensembl
P78337	PITX1	Pituitary homeobox 1	GO:0001501; P:skeletal system development; TAS:ProtInc
O75364	PITX3	Pituitary homeobox 3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O75364	PITX3	Pituitary homeobox 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O75364	PITX3	Pituitary homeobox 3	GO:0071542; P:dopaminergic neuron differentiation; ISS:UniProtKB
O75364	PITX3	Pituitary homeobox 3	GO:0002088; P:lens development in camera-type eye; ISS:UniProtKB
O75364	PITX3	Pituitary homeobox 3	GO:0070306; P:lens fiber cell differentiation; IEA:Ensembl
O75364	PITX3	Pituitary homeobox 3	GO:0002089; P:lens morphogenesis in camera-type eye; ISS:UniProtKB
O75364	PITX3	Pituitary homeobox 3	GO:0007626; P:locomotory behavior; IEA:Ensembl
O75364	PITX3	Pituitary homeobox 3	GO:0030901; P:midbrain development; ISS:UniProtKB
O75364	PITX3	Pituitary homeobox 3	GO:0048666; P:neuron development; IEA:Ensembl
O75364	PITX3	Pituitary homeobox 3	GO:0009887; P:organ morphogenesis; TAS:ProtInc
O75364	PITX3	Pituitary homeobox 3	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
O75364	PITX3	Pituitary homeobox 3	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
O75364	PITX3	Pituitary homeobox 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q99697	PITX2	Pituitary homeobox 2	GO:0031490; F:chromatin DNA binding; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0051219; F:phosphoprotein binding; IPI:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0005515; F:protein binding; IPI:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0043021; F:ribonucleoprotein complex binding; IC:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IDA:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0001105; F:RNA polymerase II transcription coactivator activity; IDA:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0001085; F:RNA polymerase II transcription factor binding; IPI:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0001191; F:RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription; IDA:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:MGI
Q99697	PITX2	Pituitary homeobox 2	GO:0008134; F:transcription factor binding; IPI:MGI
Q99697	PITX2	Pituitary homeobox 2	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IDA:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0055009; P:atrial cardiac muscle tissue morphogenesis; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0003171; P:atrioventricular valve development; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0043010; P:camera-type eye development; IMP:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0003253; P:cardiac neural crest cell migration involved in outflow tract morphogenesis; ISS:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0061325; P:cell proliferation involved in outflow tract morphogenesis; ISS:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0035993; P:deltoid tuberosity development; IMP:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0007368; P:determination of left/right symmetry; ISS:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0031076; P:embryonic camera-type eye development; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0048557; P:embryonic digestive tract morphogenesis; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0061031; P:endodermal digestive tract morphogenesis; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0002074; P:extraocular skeletal muscle development; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0008585; P:female gonad development; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0035315; P:hair cell differentiation; IC:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0021855; P:hypothalamus cell migration; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0061072; P:iris morphogenesis; IMP:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0060460; P:left lung morphogenesis; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0070986; P:left/right axis specification; ISS:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0008584; P:male gonad development; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0007520; P:myoblast fusion; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0001764; P:neuron migration; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0042476; P:odontogenesis; IMP:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0001569; P:patterning of blood vessels; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0043388; P:positive regulation of DNA binding; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:2000288; P:positive regulation of myoblast proliferation; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0060127; P:prolactin secreting cell differentiation; TAS:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0003350; P:pulmonary myocardium development; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0060577; P:pulmonary vein morphogenesis; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0030334; P:regulation of cell migration; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q99697	PITX2	Pituitary homeobox 2	GO:0006355; P:regulation of transcription, DNA-templated; IDA:MGI
Q99697	PITX2	Pituitary homeobox 2	GO:0009725; P:response to hormone; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0033189; P:response to vitamin A; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0060126; P:somatotropin secreting cell differentiation; TAS:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0048536; P:spleen development; ISS:BHF-UCL
Q99697	PITX2	Pituitary homeobox 2	GO:0021763; P:subthalamic nucleus development; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0060578; P:superior vena cava morphogenesis; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0035886; P:vascular smooth muscle cell differentiation; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0055015; P:ventricular cardiac muscle cell development; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0060412; P:ventricular septum morphogenesis; IEA:Ensembl
Q99697	PITX2	Pituitary homeobox 2	GO:0016055; P:Wnt signaling pathway; IEA:Ensembl
Q96J94	PIWIL1	Piwi-like protein 1	GO:0003729; F:mRNA binding; ISS:UniProtKB
Q96J94	PIWIL1	Piwi-like protein 1	GO:0034584; F:piRNA binding; ISS:UniProtKB
Q96J94	PIWIL1	Piwi-like protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q96J94	PIWIL1	Piwi-like protein 1	GO:0003727; F:single-stranded RNA binding; IEA:Ensembl
Q96J94	PIWIL1	Piwi-like protein 1	GO:0031047; P:gene silencing by RNA; ISS:UniProtKB
Q96J94	PIWIL1	Piwi-like protein 1	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q96J94	PIWIL1	Piwi-like protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q96J94	PIWIL1	Piwi-like protein 1	GO:0034587; P:piRNA metabolic process; IEA:Ensembl
Q96J94	PIWIL1	Piwi-like protein 1	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q96J94	PIWIL1	Piwi-like protein 1	GO:0007286; P:spermatid development; ISS:UniProtKB
Q8TC59	PIWIL2	Piwi-like protein 2	GO:0003729; F:mRNA binding; IEA:Ensembl
Q8TC59	PIWIL2	Piwi-like protein 2	GO:0034584; F:piRNA binding; IDA:UniProtKB
Q8TC59	PIWIL2	Piwi-like protein 2	GO:0043046; P:DNA methylation involved in gamete generation; ISS:UniProtKB
Q8TC59	PIWIL2	Piwi-like protein 2	GO:0031047; P:gene silencing by RNA; ISS:UniProtKB
Q8TC59	PIWIL2	Piwi-like protein 2	GO:0030718; P:germ-line stem cell maintenance; ISS:UniProtKB
Q8TC59	PIWIL2	Piwi-like protein 2	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q8TC59	PIWIL2	Piwi-like protein 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8TC59	PIWIL2	Piwi-like protein 2	GO:0048477; P:oogenesis; ISS:UniProtKB
Q8TC59	PIWIL2	Piwi-like protein 2	GO:0034587; P:piRNA metabolic process; ISS:UniProtKB
Q8TC59	PIWIL2	Piwi-like protein 2	GO:0060903; P:positive regulation of meiosis I; IEA:Ensembl
Q8TC59	PIWIL2	Piwi-like protein 2	GO:0045727; P:positive regulation of translation; ISS:UniProtKB
Q8TC59	PIWIL2	Piwi-like protein 2	GO:0000966; P:RNA 5'-end processing; ISS:UniProtKB
Q8TC59	PIWIL2	Piwi-like protein 2	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q7Z3Z4	PIWIL4	Piwi-like protein 4	GO:0034584; F:piRNA binding; ISS:UniProtKB
Q7Z3Z4	PIWIL4	Piwi-like protein 4	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q7Z3Z4	PIWIL4	Piwi-like protein 4	GO:0043046; P:DNA methylation involved in gamete generation; ISS:UniProtKB
Q7Z3Z4	PIWIL4	Piwi-like protein 4	GO:0031047; P:gene silencing by RNA; ISS:UniProtKB
Q7Z3Z4	PIWIL4	Piwi-like protein 4	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q7Z3Z4	PIWIL4	Piwi-like protein 4	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q7Z3Z4	PIWIL4	Piwi-like protein 4	GO:0034587; P:piRNA metabolic process; ISS:UniProtKB
Q7Z3Z4	PIWIL4	Piwi-like protein 4	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q7Z3Z4	PIWIL4	Piwi-like protein 4	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q7Z3Z3	PIWIL3	Piwi-like protein 3	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q7Z3Z3	PIWIL3	Piwi-like protein 3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q7Z3Z3	PIWIL3	Piwi-like protein 3	GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW
Q7Z3Z3	PIWIL3	Piwi-like protein 3	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q7Z3Z3	PIWIL3	Piwi-like protein 3	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q7Z3Z3	PIWIL3	Piwi-like protein 3	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q7Z3Z3	PIWIL3	Piwi-like protein 3	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q8NG27	PJA1	E3 ubiquitin-protein ligase Praja-1	GO:0005515; F:protein binding; IPI:IntAct
Q8NG27	PJA1	E3 ubiquitin-protein ligase Praja-1	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q8NG27	PJA1	E3 ubiquitin-protein ligase Praja-1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8NG27	PJA1	E3 ubiquitin-protein ligase Praja-1	GO:0030163; P:protein catabolic process; IEA:Ensembl
O43164	PJA2	E3 ubiquitin-protein ligase Praja-2	GO:0034236; F:protein kinase A catalytic subunit binding; IMP:UniProtKB
O43164	PJA2	E3 ubiquitin-protein ligase Praja-2	GO:0034237; F:protein kinase A regulatory subunit binding; IMP:UniProtKB
O43164	PJA2	E3 ubiquitin-protein ligase Praja-2	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
O43164	PJA2	E3 ubiquitin-protein ligase Praja-2	GO:0008270; F:zinc ion binding; IEA:InterPro
O43164	PJA2	E3 ubiquitin-protein ligase Praja-2	GO:0007616; P:long-term memory; ISS:UniProtKB
O43164	PJA2	E3 ubiquitin-protein ligase Praja-2	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
O43164	PJA2	E3 ubiquitin-protein ligase Praja-2	GO:0010738; P:regulation of protein kinase A signaling; IMP:UniProtKB
Q0ZLH3	DFNB59	Pejvakin	GO:0007605; P:sensory perception of sound; IEA:UniProtKB-KW
Q9NWT1	PAK1IP1	p21-activated protein kinase-interacting protein 1	GO:0009968; P:negative regulation of signal transduction; IEA:UniProtKB-KW
Q8TDX9	PKD1L1	Polycystic kidney disease protein 1-like 1	GO:0005262; F:calcium channel activity; IDA:UniProtKB
Q8TDX9	PKD1L1	Polycystic kidney disease protein 1-like 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TDX9	PKD1L1	Polycystic kidney disease protein 1-like 1	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
Q8TDX9	PKD1L1	Polycystic kidney disease protein 1-like 1	GO:0050982; P:detection of mechanical stimulus; IBA:RefGenome
Q8TDX9	PKD1L1	Polycystic kidney disease protein 1-like 1	GO:0003127; P:detection of nodal flow; ISS:BHF-UCL
Q8TDX9	PKD1L1	Polycystic kidney disease protein 1-like 1	GO:0070986; P:left/right axis specification; ISS:BHF-UCL
Q7Z442	PKD1L2	Polycystic kidney disease protein 1-like 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q7Z442	PKD1L2	Polycystic kidney disease protein 1-like 2	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q7Z442	PKD1L2	Polycystic kidney disease protein 1-like 2	GO:0005261; F:cation channel activity; IEA:Ensembl
Q7Z442	PKD1L2	Polycystic kidney disease protein 1-like 2	GO:0033040; F:sour taste receptor activity; IEA:Ensembl
Q7Z442	PKD1L2	Polycystic kidney disease protein 1-like 2	GO:0071468; P:cellular response to acidity; IEA:Ensembl
Q7Z442	PKD1L2	Polycystic kidney disease protein 1-like 2	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q7Z443	PKD1L3	Polycystic kidney disease protein 1-like 3	GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW
Q7Z443	PKD1L3	Polycystic kidney disease protein 1-like 3	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q7Z443	PKD1L3	Polycystic kidney disease protein 1-like 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z443	PKD1L3	Polycystic kidney disease protein 1-like 3	GO:0006812; P:cation transport; ISS:BHF-UCL
Q7Z443	PKD1L3	Polycystic kidney disease protein 1-like 3	GO:0071468; P:cellular response to acidity; ISS:BHF-UCL
Q7Z443	PKD1L3	Polycystic kidney disease protein 1-like 3	GO:0001581; P:detection of chemical stimulus involved in sensory perception of sour taste; ISS:BHF-UCL
Q7Z443	PKD1L3	Polycystic kidney disease protein 1-like 3	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q7Z443	PKD1L3	Polycystic kidney disease protein 1-like 3	GO:0050915; P:sensory perception of sour taste; IMP:UniProt
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0051393; F:alpha-actinin binding; IPI:BHF-UCL
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0005227; F:calcium activated cation channel activity; IDA:BHF-UCL
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0005262; F:calcium channel activity; IDA:UniProtKB
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0015269; F:calcium-activated potassium channel activity; IDA:BHF-UCL
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0005261; F:cation channel activity; IDA:BHF-UCL
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0008092; F:cytoskeletal protein binding; IPI:UniProtKB
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0042802; F:identical protein binding; ISS:BHF-UCL
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0051371; F:muscle alpha-actinin binding; IPI:BHF-UCL
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0005272; F:sodium channel activity; IDA:BHF-UCL
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0033040; F:sour taste receptor activity; IEA:Ensembl
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0006812; P:cation transport; ISS:BHF-UCL
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0071468; P:cellular response to acidity; ISS:BHF-UCL
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0001581; P:detection of chemical stimulus involved in sensory perception of sour taste; ISS:BHF-UCL
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0050982; P:detection of mechanical stimulus; IBA:RefGenome
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0071805; P:potassium ion transmembrane transport; IDA:BHF-UCL
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0070207; P:protein homotrimerization; IDA:UniProtKB
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0050915; P:sensory perception of sour taste; IMP:UniProt
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0007224; P:smoothened signaling pathway; ISS:UniProtKB
Q9P0L9	PKD2L1	Polycystic kidney disease 2-like 1 protein	GO:0035725; P:sodium ion transmembrane transport; IDA:BHF-UCL
Q9NZM6	PKD2L2	Polycystic kidney disease 2-like 2 protein	GO:0005262; F:calcium channel activity; IBA:RefGenome
Q9NZM6	PKD2L2	Polycystic kidney disease 2-like 2 protein	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NZM6	PKD2L2	Polycystic kidney disease 2-like 2 protein	GO:0070588; P:calcium ion transmembrane transport; IBA:GOC
Q9NZM6	PKD2L2	Polycystic kidney disease 2-like 2 protein	GO:0050982; P:detection of mechanical stimulus; IBA:RefGenome
Q8NEB9	PIK3C3	Phosphatidylinositol 3-kinase catalytic subunit type 3	GO:0016303; F:1-phosphatidylinositol-3-kinase activity; IMP:UniProtKB
Q8NEB9	PIK3C3	Phosphatidylinositol 3-kinase catalytic subunit type 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NEB9	PIK3C3	Phosphatidylinositol 3-kinase catalytic subunit type 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NEB9	PIK3C3	Phosphatidylinositol 3-kinase catalytic subunit type 3	GO:0004672; F:protein kinase activity; IEA:Ensembl
Q8NEB9	PIK3C3	Phosphatidylinositol 3-kinase catalytic subunit type 3	GO:0000045; P:autophagic vacuole assembly; IEA:Ensembl
Q8NEB9	PIK3C3	Phosphatidylinositol 3-kinase catalytic subunit type 3	GO:0000910; P:cytokinesis; IMP:UniProtKB
Q8NEB9	PIK3C3	Phosphatidylinositol 3-kinase catalytic subunit type 3	GO:0045022; P:early endosome to late endosome transport; IMP:UniProtKB
Q8NEB9	PIK3C3	Phosphatidylinositol 3-kinase catalytic subunit type 3	GO:0007032; P:endosome organization; IEA:Ensembl
Q8NEB9	PIK3C3	Phosphatidylinositol 3-kinase catalytic subunit type 3	GO:0045087; P:innate immune response; TAS:Reactome
Q8NEB9	PIK3C3	Phosphatidylinositol 3-kinase catalytic subunit type 3	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q8NEB9	PIK3C3	Phosphatidylinositol 3-kinase catalytic subunit type 3	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q8NEB9	PIK3C3	Phosphatidylinositol 3-kinase catalytic subunit type 3	GO:0036092; P:phosphatidylinositol-3-phosphate biosynthetic process; IMP:GOC
Q8NEB9	PIK3C3	Phosphatidylinositol 3-kinase catalytic subunit type 3	GO:0048015; P:phosphatidylinositol-mediated signaling; IEA:Ensembl
Q8NEB9	PIK3C3	Phosphatidylinositol 3-kinase catalytic subunit type 3	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q8NEB9	PIK3C3	Phosphatidylinositol 3-kinase catalytic subunit type 3	GO:0016485; P:protein processing; IEA:Ensembl
Q8NEB9	PIK3C3	Phosphatidylinositol 3-kinase catalytic subunit type 3	GO:0050708; P:regulation of protein secretion; IEA:Ensembl
Q8NEB9	PIK3C3	Phosphatidylinositol 3-kinase catalytic subunit type 3	GO:0043201; P:response to leucine; IEA:Ensembl
Q8NEB9	PIK3C3	Phosphatidylinositol 3-kinase catalytic subunit type 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8NEB9	PIK3C3	Phosphatidylinositol 3-kinase catalytic subunit type 3	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q8NEB9	PIK3C3	Phosphatidylinositol 3-kinase catalytic subunit type 3	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0016303; F:1-phosphatidylinositol-3-kinase activity; IDA:UniProtKB
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0035005; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; IBA:RefGenome
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0016301; F:kinase activity; TAS:Reactome
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0035004; F:phosphatidylinositol 3-kinase activity; TAS:UniProtKB
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0046934; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; TAS:Reactome
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0005515; F:protein binding; IPI:UniProtKB
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0030295; F:protein kinase activator activity; IEA:Ensembl
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0007596; P:blood coagulation; TAS:Reactome
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0060048; P:cardiac muscle contraction; TAS:UniProtKB
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0043542; P:endothelial cell migration; TAS:UniProtKB
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0006006; P:glucose metabolic process; IEA:Ensembl
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0044029; P:hypomethylation of CpG island; IEA:Ensembl
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0045087; P:innate immune response; TAS:Reactome
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0038028; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase; TAS:UniProtKB
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0050900; P:leukocyte migration; TAS:Reactome
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:2000811; P:negative regulation of anoikis; IMP:UniProtKB
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:2000270; P:negative regulation of fibroblast apoptotic process; IEA:Ensembl
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0046854; P:phosphatidylinositol phosphorylation; ISS:BHF-UCL
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0036092; P:phosphatidylinositol-3-phosphate biosynthetic process; IDA:GOC
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0030168; P:platelet activation; TAS:UniProtKB
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IEA:Ensembl
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0043491; P:protein kinase B signaling; IEA:Ensembl
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:2000653; P:regulation of genetic imprinting; IEA:Ensembl
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0031295; P:T cell costimulation; TAS:Reactome
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P42336	PIK3CA	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	GO:0001944; P:vasculature development; TAS:UniProtKB
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0016303; F:1-phosphatidylinositol-3-kinase activity; IBA:RefGenome
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0035005; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; IBA:RefGenome
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0035004; F:phosphatidylinositol 3-kinase activity; TAS:UniProtKB
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0046934; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; IBA:RefGenome
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0005515; F:protein binding; IPI:IntAct
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0000187; P:activation of MAPK activity; TAS:ProtInc
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0006914; P:autophagy; IEA:UniProtKB-KW
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0007596; P:blood coagulation; TAS:Reactome
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0016477; P:cell migration; TAS:UniProtKB
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0006935; P:chemotaxis; TAS:ProtInc
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0040016; P:embryonic cleavage; IEA:Ensembl
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:UniProtKB
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0007156; P:homophilic cell adhesion; IEA:Ensembl
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0045087; P:innate immune response; TAS:Reactome
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0050900; P:leukocyte migration; TAS:Reactome
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0014065; P:phosphatidylinositol 3-kinase signaling; TAS:UniProtKB
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0030168; P:platelet activation; TAS:UniProtKB
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0070527; P:platelet aggregation; TAS:UniProtKB
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0010508; P:positive regulation of autophagy; TAS:UniProtKB
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0001952; P:regulation of cell-matrix adhesion; IEA:Ensembl
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:2000369; P:regulation of clathrin-mediated endocytosis; TAS:UniProtKB
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0007165; P:signal transduction; NAS:ProtInc
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P42338	PIK3CB	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0016303; F:1-phosphatidylinositol-3-kinase activity; NAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0035005; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; IBA:RefGenome
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0035004; F:phosphatidylinositol 3-kinase activity; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0046934; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; IBA:RefGenome
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0005515; F:protein binding; IPI:IntAct
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0002250; P:adaptive immune response; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0042113; P:B cell activation; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0035754; P:B cell chemotaxis; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0001782; P:B cell homeostasis; IEA:Ensembl
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0050853; P:B cell receptor signaling pathway; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0001816; P:cytokine production; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0006954; P:inflammatory response; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0045087; P:innate immune response; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0002551; P:mast cell chemotaxis; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0043303; P:mast cell degranulation; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0060374; P:mast cell differentiation; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0030101; P:natural killer cell activation; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0035747; P:natural killer cell chemotaxis; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0001779; P:natural killer cell differentiation; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0030593; P:neutrophil chemotaxis; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0072672; P:neutrophil extravasation; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0014065; P:phosphatidylinositol 3-kinase signaling; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0036092; P:phosphatidylinositol-3-phosphate biosynthetic process; NAS:GOC
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0006468; P:protein phosphorylation; NAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0002679; P:respiratory burst involved in defense response; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0007165; P:signal transduction; NAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0042110; P:T cell activation; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0010818; P:T cell chemotaxis; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0030217; P:T cell differentiation; TAS:UniProtKB
O00329	PIK3CD	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	GO:0050852; P:T cell receptor signaling pathway; TAS:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0016303; F:1-phosphatidylinositol-3-kinase activity; IBA:RefGenome
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0035005; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; IBA:RefGenome
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0046875; F:ephrin receptor binding; IPI:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0035004; F:phosphatidylinositol 3-kinase activity; TAS:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0046934; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; IBA:RefGenome
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0005515; F:protein binding; IPI:IntAct
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0004672; F:protein kinase activity; TAS:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0002250; P:adaptive immune response; TAS:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0007596; P:blood coagulation; TAS:Reactome
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0001816; P:cytokine production; TAS:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0002407; P:dendritic cell chemotaxis; TAS:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0097284; P:hepatocyte apoptotic process; IEA:Ensembl
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0006954; P:inflammatory response; TAS:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0045087; P:innate immune response; TAS:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0043303; P:mast cell degranulation; TAS:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0035747; P:natural killer cell chemotaxis; TAS:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0055118; P:negative regulation of cardiac muscle contraction; TAS:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:2000270; P:negative regulation of fibroblast apoptotic process; IEA:Ensembl
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0010897; P:negative regulation of triglyceride catabolic process; IEA:Ensembl
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0030593; P:neutrophil chemotaxis; TAS:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0072672; P:neutrophil extravasation; TAS:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0014065; P:phosphatidylinositol 3-kinase signaling; IDA:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0030168; P:platelet activation; TAS:Reactome
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0070527; P:platelet aggregation; TAS:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0002675; P:positive regulation of acute inflammatory response; IEA:Ensembl
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0043406; P:positive regulation of MAP kinase activity; IDA:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0033628; P:regulation of cell adhesion mediated by integrin; TAS:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0002679; P:respiratory burst involved in defense response; TAS:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0032252; P:secretory granule localization; IEA:Ensembl
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0042110; P:T cell activation; TAS:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0010818; P:T cell chemotaxis; TAS:UniProtKB
P48736	PIK3CG	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	GO:0042098; P:T cell proliferation; TAS:UniProtKB
Q9ULU4	ZMYND8	Protein kinase C-binding protein 1	GO:0016301; F:kinase activity; IEA:UniProtKB-KW
Q9ULU4	ZMYND8	Protein kinase C-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9ULU4	ZMYND8	Protein kinase C-binding protein 1	GO:0070491; F:repressing transcription factor binding; ISS:BHF-UCL
Q9ULU4	ZMYND8	Protein kinase C-binding protein 1	GO:0001106; F:RNA polymerase II transcription corepressor activity; ISS:BHF-UCL
Q9ULU4	ZMYND8	Protein kinase C-binding protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9ULU4	ZMYND8	Protein kinase C-binding protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:GOC
P98161	PKD1	Polycystin-1	GO:0005262; F:calcium channel activity; IBA:RefGenome
P98161	PKD1	Polycystin-1	GO:0030246; F:carbohydrate binding; IEA:InterPro
P98161	PKD1	Polycystin-1	GO:0005261; F:cation channel activity; ISS:BHF-UCL
P98161	PKD1	Polycystin-1	GO:0044325; F:ion channel binding; IPI:BHF-UCL
P98161	PKD1	Polycystin-1	GO:0005515; F:protein binding; IPI:UniProtKB
P98161	PKD1	Polycystin-1	GO:0019904; F:protein domain specific binding; IPI:BHF-UCL
P98161	PKD1	Polycystin-1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P98161	PKD1	Polycystin-1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P98161	PKD1	Polycystin-1	GO:0048754; P:branching morphogenesis of an epithelial tube; IDA:UniProtKB
P98161	PKD1	Polycystin-1	GO:0070588; P:calcium ion transmembrane transport; IBA:GOC
P98161	PKD1	Polycystin-1	GO:0007161; P:calcium-independent cell-matrix adhesion; TAS:ProtInc
P98161	PKD1	Polycystin-1	GO:0001502; P:cartilage condensation; IEA:Ensembl
P98161	PKD1	Polycystin-1	GO:0051216; P:cartilage development; IEP:UniProtKB
P98161	PKD1	Polycystin-1	GO:0007050; P:cell cycle arrest; ISS:BHF-UCL
P98161	PKD1	Polycystin-1	GO:0007160; P:cell-matrix adhesion; TAS:ProtInc
P98161	PKD1	Polycystin-1	GO:0042994; P:cytoplasmic sequestering of transcription factor; ISS:BHF-UCL
P98161	PKD1	Polycystin-1	GO:0050982; P:detection of mechanical stimulus; ISS:BHF-UCL
P98161	PKD1	Polycystin-1	GO:0048565; P:digestive tract development; IEP:UniProtKB
P98161	PKD1	Polycystin-1	GO:0001892; P:embryonic placenta development; ISS:BHF-UCL
P98161	PKD1	Polycystin-1	GO:0048806; P:genitalia development; IEP:UniProtKB
P98161	PKD1	Polycystin-1	GO:0007507; P:heart development; IEP:UniProtKB
P98161	PKD1	Polycystin-1	GO:0007156; P:homophilic cell adhesion; TAS:ProtInc
P98161	PKD1	Polycystin-1	GO:0001701; P:in utero embryonic development; ISS:BHF-UCL
P98161	PKD1	Polycystin-1	GO:0007259; P:JAK-STAT cascade; ISS:BHF-UCL
P98161	PKD1	Polycystin-1	GO:0001822; P:kidney development; ISS:BHF-UCL
P98161	PKD1	Polycystin-1	GO:0001889; P:liver development; IEA:Ensembl
P98161	PKD1	Polycystin-1	GO:0060428; P:lung epithelium development; IEP:UniProtKB
P98161	PKD1	Polycystin-1	GO:0072177; P:mesonephric duct development; IEP:UniProtKB
P98161	PKD1	Polycystin-1	GO:0072164; P:mesonephric tubule development; IEP:UniProtKB
P98161	PKD1	Polycystin-1	GO:0072218; P:metanephric ascending thin limb development; IEP:UniProtKB
P98161	PKD1	Polycystin-1	GO:0072205; P:metanephric collecting duct development; IEP:UniProtKB
P98161	PKD1	Polycystin-1	GO:0072287; P:metanephric distal tubule morphogenesis; IEP:UniProtKB
P98161	PKD1	Polycystin-1	GO:0072237; P:metanephric proximal tubule development; IEP:UniProtKB
P98161	PKD1	Polycystin-1	GO:0021915; P:neural tube development; IEP:UniProtKB
P98161	PKD1	Polycystin-1	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
P98161	PKD1	Polycystin-1	GO:0006807; P:nitrogen compound metabolic process; IEA:Ensembl
P98161	PKD1	Polycystin-1	GO:0018105; P:peptidyl-serine phosphorylation; ISS:BHF-UCL
P98161	PKD1	Polycystin-1	GO:0060674; P:placenta blood vessel development; ISS:BHF-UCL
P98161	PKD1	Polycystin-1	GO:0031659; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle; IDA:BHF-UCL
P98161	PKD1	Polycystin-1	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P98161	PKD1	Polycystin-1	GO:0032092; P:positive regulation of protein binding; ISS:BHF-UCL
P98161	PKD1	Polycystin-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P98161	PKD1	Polycystin-1	GO:0006611; P:protein export from nucleus; ISS:BHF-UCL
P98161	PKD1	Polycystin-1	GO:0060236; P:regulation of mitotic spindle organization; IEA:Ensembl
P98161	PKD1	Polycystin-1	GO:0061136; P:regulation of proteasomal protein catabolic process; IDA:MGI
P98161	PKD1	Polycystin-1	GO:0043588; P:skin development; IEP:UniProtKB
P98161	PKD1	Polycystin-1	GO:0021510; P:spinal cord development; IEP:UniProtKB
Q504Y2	PKDCC	Protein kinase domain-containing protein, cytoplasmic	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q504Y2	PKDCC	Protein kinase domain-containing protein, cytoplasmic	GO:0004672; F:protein kinase activity; ISS:UniProtKB
Q504Y2	PKDCC	Protein kinase domain-containing protein, cytoplasmic	GO:0030282; P:bone mineralization; IEA:Ensembl
Q504Y2	PKDCC	Protein kinase domain-containing protein, cytoplasmic	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q504Y2	PKDCC	Protein kinase domain-containing protein, cytoplasmic	GO:0048566; P:embryonic digestive tract development; ISS:UniProtKB
Q504Y2	PKDCC	Protein kinase domain-containing protein, cytoplasmic	GO:0048286; P:lung alveolus development; ISS:UniProtKB
Q504Y2	PKDCC	Protein kinase domain-containing protein, cytoplasmic	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q504Y2	PKDCC	Protein kinase domain-containing protein, cytoplasmic	GO:0042997; P:negative regulation of Golgi to plasma membrane protein transport; ISS:UniProtKB
Q504Y2	PKDCC	Protein kinase domain-containing protein, cytoplasmic	GO:0060021; P:palate development; ISS:UniProtKB
Q504Y2	PKDCC	Protein kinase domain-containing protein, cytoplasmic	GO:0030501; P:positive regulation of bone mineralization; ISS:UniProtKB
Q504Y2	PKDCC	Protein kinase domain-containing protein, cytoplasmic	GO:0032332; P:positive regulation of chondrocyte differentiation; ISS:UniProtKB
Q504Y2	PKDCC	Protein kinase domain-containing protein, cytoplasmic	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q504Y2	PKDCC	Protein kinase domain-containing protein, cytoplasmic	GO:0001501; P:skeletal system development; IEA:Ensembl
Q9NTG1	PKDREJ	Polycystic kidney disease and receptor for egg jelly-related protein	GO:0005262; F:calcium channel activity; IBA:RefGenome
Q9NTG1	PKDREJ	Polycystic kidney disease and receptor for egg jelly-related protein	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NTG1	PKDREJ	Polycystic kidney disease and receptor for egg jelly-related protein	GO:0007340; P:acrosome reaction; TAS:ProtInc
Q9NTG1	PKDREJ	Polycystic kidney disease and receptor for egg jelly-related protein	GO:0070588; P:calcium ion transmembrane transport; IBA:GOC
Q9NTG1	PKDREJ	Polycystic kidney disease and receptor for egg jelly-related protein	GO:0050982; P:detection of mechanical stimulus; IBA:RefGenome
Q9NTG1	PKDREJ	Polycystic kidney disease and receptor for egg jelly-related protein	GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
Q9NTG1	PKDREJ	Polycystic kidney disease and receptor for egg jelly-related protein	GO:0060046; P:regulation of acrosome reaction; IEA:Ensembl
Q13563	PKD2	Polycystin-2	GO:0042805; F:actinin binding; IDA:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0051117; F:ATPase binding; ISS:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0005509; F:calcium ion binding; ISS:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0048763; F:calcium-induced calcium release activity; IDA:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0008092; F:cytoskeletal protein binding; IDA:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0043398; F:HLH domain binding; IPI:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0042802; F:identical protein binding; IPI:IntAct
Q13563	PKD2	Polycystin-2	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0051219; F:phosphoprotein binding; IPI:UniProt
Q13563	PKD2	Polycystin-2	GO:0005267; F:potassium channel activity; ISS:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q13563	PKD2	Polycystin-2	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0005102; F:receptor binding; IPI:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0005245; F:voltage-gated calcium channel activity; IDA:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0022843; F:voltage-gated cation channel activity; IDA:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0005244; F:voltage-gated ion channel activity; IDA:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0005248; F:voltage-gated sodium channel activity; IDA:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0035904; P:aorta development; IEP:UniProtKB
Q13563	PKD2	Polycystin-2	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEP:UniProtKB
Q13563	PKD2	Polycystin-2	GO:0070588; P:calcium ion transmembrane transport; IDA:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0006816; P:calcium ion transport; IDA:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0007050; P:cell cycle arrest; ISS:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0071498; P:cellular response to fluid shear stress; IMP:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0071464; P:cellular response to hydrostatic pressure; IDA:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0071470; P:cellular response to osmotic stress; IDA:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0034614; P:cellular response to reactive oxygen species; NAS:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0051298; P:centrosome duplication; NAS:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0042994; P:cytoplasmic sequestering of transcription factor; IMP:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0050982; P:detection of mechanical stimulus; ISS:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0003127; P:detection of nodal flow; ISS:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0007368; P:determination of left/right symmetry; ISS:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0071910; P:determination of liver left/right asymmetry; IMP:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0001892; P:embryonic placenta development; ISS:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0007507; P:heart development; IEP:UniProtKB
Q13563	PKD2	Polycystin-2	GO:0001947; P:heart looping; IMP:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0007259; P:JAK-STAT cascade; ISS:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0001889; P:liver development; IEP:UniProtKB
Q13563	PKD2	Polycystin-2	GO:0072177; P:mesonephric duct development; IEP:UniProtKB
Q13563	PKD2	Polycystin-2	GO:0072164; P:mesonephric tubule development; IEP:UniProtKB
Q13563	PKD2	Polycystin-2	GO:0072218; P:metanephric ascending thin limb development; IEP:UniProtKB
Q13563	PKD2	Polycystin-2	GO:0072214; P:metanephric cortex development; IEP:UniProtKB
Q13563	PKD2	Polycystin-2	GO:0072219; P:metanephric cortical collecting duct development; IEP:UniProtKB
Q13563	PKD2	Polycystin-2	GO:0072235; P:metanephric distal tubule development; IEP:UniProtKB
Q13563	PKD2	Polycystin-2	GO:0072075; P:metanephric mesenchyme development; IEP:UniProtKB
Q13563	PKD2	Polycystin-2	GO:0035502; P:metanephric part of ureteric bud development; IEP:UniProtKB
Q13563	PKD2	Polycystin-2	GO:0072284; P:metanephric S-shaped body morphogenesis; IEP:UniProtKB
Q13563	PKD2	Polycystin-2	GO:0072208; P:metanephric smooth muscle tissue development; IEP:UniProtKB
Q13563	PKD2	Polycystin-2	GO:0008285; P:negative regulation of cell proliferation; NAS:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IMP:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0060315; P:negative regulation of ryanodine-sensitive calcium-release channel activity; ISS:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0021915; P:neural tube development; IEP:UniProtKB
Q13563	PKD2	Polycystin-2	GO:0060674; P:placenta blood vessel development; ISS:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0071158; P:positive regulation of cell cycle arrest; IMP:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0031659; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle; IDA:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0031587; P:positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; IMP:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IMP:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0090279; P:regulation of calcium ion import; IDA:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0030814; P:regulation of cAMP metabolic process; ISS:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0042127; P:regulation of cell proliferation; IMP:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0051209; P:release of sequestered calcium ion into cytosol; IDA:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0061441; P:renal artery morphogenesis; IEP:UniProtKB
Q13563	PKD2	Polycystin-2	GO:0061333; P:renal tubule morphogenesis; ISS:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0035725; P:sodium ion transmembrane transport; IDA:BHF-UCL
Q13563	PKD2	Polycystin-2	GO:0021510; P:spinal cord development; IEP:UniProtKB
Q96PX9	PLEKHG4B	Pleckstrin homology domain-containing family G member 4B	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q9HB21	PLEKHA1	Pleckstrin homology domain-containing family A member 1	GO:0030165; F:PDZ domain binding; IPI:UniProtKB
Q9HB21	PLEKHA1	Pleckstrin homology domain-containing family A member 1	GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; IDA:UniProtKB
Q9HB21	PLEKHA1	Pleckstrin homology domain-containing family A member 1	GO:0005515; F:protein binding; IPI:IntAct
Q9HB21	PLEKHA1	Pleckstrin homology domain-containing family A member 1	GO:0008209; P:androgen metabolic process; IEA:Ensembl
Q9HB21	PLEKHA1	Pleckstrin homology domain-containing family A member 1	GO:0050853; P:B cell receptor signaling pathway; IDA:UniProtKB
Q9HB21	PLEKHA1	Pleckstrin homology domain-containing family A member 1	GO:0070301; P:cellular response to hydrogen peroxide; IDA:UniProtKB
Q9HB21	PLEKHA1	Pleckstrin homology domain-containing family A member 1	GO:0045184; P:establishment of protein localization; IDA:UniProtKB
Q9HB21	PLEKHA1	Pleckstrin homology domain-containing family A member 1	GO:0008210; P:estrogen metabolic process; IEA:Ensembl
Q9HB21	PLEKHA1	Pleckstrin homology domain-containing family A member 1	GO:0060325; P:face morphogenesis; IEA:Ensembl
Q9HB21	PLEKHA1	Pleckstrin homology domain-containing family A member 1	GO:0033327; P:Leydig cell differentiation; IEA:Ensembl
Q9HB21	PLEKHA1	Pleckstrin homology domain-containing family A member 1	GO:0001553; P:luteinization; IEA:Ensembl
Q9HB21	PLEKHA1	Pleckstrin homology domain-containing family A member 1	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q9HB21	PLEKHA1	Pleckstrin homology domain-containing family A member 1	GO:0051898; P:negative regulation of protein kinase B signaling; IMP:UniProtKB
Q9HB21	PLEKHA1	Pleckstrin homology domain-containing family A member 1	GO:0060021; P:palate development; IEA:Ensembl
Q9HB21	PLEKHA1	Pleckstrin homology domain-containing family A member 1	GO:0014065; P:phosphatidylinositol 3-kinase signaling; IDA:UniProtKB
Q9HB21	PLEKHA1	Pleckstrin homology domain-containing family A member 1	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IEA:Ensembl
Q9HB21	PLEKHA1	Pleckstrin homology domain-containing family A member 1	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q9HB21	PLEKHA1	Pleckstrin homology domain-containing family A member 1	GO:0031529; P:ruffle organization; IDA:UniProtKB
Q9HB21	PLEKHA1	Pleckstrin homology domain-containing family A member 1	GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl
Q9HB21	PLEKHA1	Pleckstrin homology domain-containing family A member 1	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q9HB19	PLEKHA2	Pleckstrin homology domain-containing family A member 2	GO:0005545; F:1-phosphatidylinositol binding; IEA:Ensembl
Q9HB19	PLEKHA2	Pleckstrin homology domain-containing family A member 2	GO:0001968; F:fibronectin binding; IMP:UniProtKB
Q9HB19	PLEKHA2	Pleckstrin homology domain-containing family A member 2	GO:0043236; F:laminin binding; IMP:UniProtKB
Q9HB19	PLEKHA2	Pleckstrin homology domain-containing family A member 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HB19	PLEKHA2	Pleckstrin homology domain-containing family A member 2	GO:0001954; P:positive regulation of cell-matrix adhesion; IMP:UniProtKB
Q9HB20	PLEKHA3	Pleckstrin homology domain-containing family A member 3	GO:0005545; F:1-phosphatidylinositol binding; IEA:Ensembl
Q9HB20	PLEKHA3	Pleckstrin homology domain-containing family A member 3	GO:0005543; F:phospholipid binding; IDA:UniProtKB
Q9H4M7	PLEKHA4	Pleckstrin homology domain-containing family A member 4	GO:0005545; F:1-phosphatidylinositol binding; NAS:UniProtKB
Q9HAU0	PLEKHA5	Pleckstrin homology domain-containing family A member 5	GO:0005545; F:1-phosphatidylinositol binding; NAS:UniProtKB
Q9HAU0	PLEKHA5	Pleckstrin homology domain-containing family A member 5	GO:0005515; F:protein binding; IPI:IntAct
Q96JA3	PLEKHA8	Pleckstrin homology domain-containing family A member 8	GO:0097001; F:ceramide binding; IDA:UniProtKB
Q96JA3	PLEKHA8	Pleckstrin homology domain-containing family A member 8	GO:0051861; F:glycolipid binding; IDA:UniProtKB
Q96JA3	PLEKHA8	Pleckstrin homology domain-containing family A member 8	GO:0017089; F:glycolipid transporter activity; IDA:UniProtKB
Q96JA3	PLEKHA8	Pleckstrin homology domain-containing family A member 8	GO:0070273; F:phosphatidylinositol-4-phosphate binding; IDA:UniProtKB
Q96JA3	PLEKHA8	Pleckstrin homology domain-containing family A member 8	GO:0035621; P:ER to Golgi ceramide transport; IDA:UniProtKB
Q96JA3	PLEKHA8	Pleckstrin homology domain-containing family A member 8	GO:0006869; P:lipid transport; IDA:UniProtKB
Q96JA3	PLEKHA8	Pleckstrin homology domain-containing family A member 8	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O95397	PLEKHA8P1	Putative protein PLEKHA9	GO:0051861; F:glycolipid binding; IEA:InterPro
O95397	PLEKHA8P1	Putative protein PLEKHA9	GO:0017089; F:glycolipid transporter activity; IEA:InterPro
Q6IQ23	PLEKHA7	Pleckstrin homology domain-containing family A member 7	GO:0070097; F:delta-catenin binding; IDA:UniProtKB
Q6IQ23	PLEKHA7	Pleckstrin homology domain-containing family A member 7	GO:0090136; P:epithelial cell-cell adhesion; IMP:UniProtKB
Q6IQ23	PLEKHA7	Pleckstrin homology domain-containing family A member 7	GO:0045218; P:zonula adherens maintenance; IMP:UniProtKB
Q9UF11	PLEKHB1	Pleckstrin homology domain-containing family B member 1	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q9UF11	PLEKHB1	Pleckstrin homology domain-containing family B member 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9UF11	PLEKHB1	Pleckstrin homology domain-containing family B member 1	GO:0007602; P:phototransduction; NAS:UniProtKB
Q9UF11	PLEKHB1	Pleckstrin homology domain-containing family B member 1	GO:0045595; P:regulation of cell differentiation; IEA:Ensembl
P08F94	PKHD1	Fibrocystin	GO:0005515; F:protein binding; IPI:UniProtKB
P08F94	PKHD1	Fibrocystin	GO:0004872; F:receptor activity; NAS:UniProtKB
P08F94	PKHD1	Fibrocystin	GO:0016337; P:single organismal cell-cell adhesion; ISS:UniProtKB
P08F94	PKHD1	Fibrocystin	GO:0006874; P:cellular calcium ion homeostasis; IMP:UniProt
P08F94	PKHD1	Fibrocystin	GO:0042384; P:cilium assembly; ISS:UniProtKB
P08F94	PKHD1	Fibrocystin	GO:0042592; P:homeostatic process; NAS:UniProtKB
P08F94	PKHD1	Fibrocystin	GO:0001822; P:kidney development; ISS:UniProtKB
P08F94	PKHD1	Fibrocystin	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProt
P08F94	PKHD1	Fibrocystin	GO:0051271; P:negative regulation of cellular component movement; ISS:UniProtKB
P08F94	PKHD1	Fibrocystin	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IMP:UniProt
P08F94	PKHD1	Fibrocystin	GO:0051898; P:negative regulation of protein kinase B signaling; IMP:UniProt
P08F94	PKHD1	Fibrocystin	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProt
P08F94	PKHD1	Fibrocystin	GO:0010824; P:regulation of centrosome duplication; IMP:UniProtKB
P08F94	PKHD1	Fibrocystin	GO:0070372; P:regulation of ERK1 and ERK2 cascade; IMP:UniProt
P08F94	PKHD1	Fibrocystin	GO:0032006; P:regulation of TOR signaling; IMP:UniProt
Q96S99	PLEKHF1	Pleckstrin homology domain-containing family F member 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96S99	PLEKHF1	Pleckstrin homology domain-containing family F member 1	GO:0032266; F:phosphatidylinositol-3-phosphate binding; IDA:BHF-UCL
Q96S99	PLEKHF1	Pleckstrin homology domain-containing family F member 1	GO:0070273; F:phosphatidylinositol-4-phosphate binding; IDA:BHF-UCL
Q96S99	PLEKHF1	Pleckstrin homology domain-containing family F member 1	GO:0010314; F:phosphatidylinositol-5-phosphate binding; IDA:BHF-UCL
Q96S99	PLEKHF1	Pleckstrin homology domain-containing family F member 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q96S99	PLEKHF1	Pleckstrin homology domain-containing family F member 1	GO:0007032; P:endosome organization; IMP:BHF-UCL
Q96S99	PLEKHF1	Pleckstrin homology domain-containing family F member 1	GO:0010508; P:positive regulation of autophagy; IDA:BHF-UCL
Q96S99	PLEKHF1	Pleckstrin homology domain-containing family F member 1	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl
Q96S99	PLEKHF1	Pleckstrin homology domain-containing family F member 1	GO:0072659; P:protein localization to plasma membrane; IMP:BHF-UCL
Q96S99	PLEKHF1	Pleckstrin homology domain-containing family F member 1	GO:0016050; P:vesicle organization; IMP:BHF-UCL
Q9H8W4	PLEKHF2	Pleckstrin homology domain-containing family F member 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H8W4	PLEKHF2	Pleckstrin homology domain-containing family F member 2	GO:0005515; F:protein binding; IPI:IntAct
Q9H8W4	PLEKHF2	Pleckstrin homology domain-containing family F member 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9ULL1	PLEKHG1	Pleckstrin homology domain-containing family G member 1	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
A1L390	PLEKHG3	Pleckstrin homology domain-containing family G member 3	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q9H7P9	PLEKHG2	Pleckstrin homology domain-containing family G member 2	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q9H7P9	PLEKHG2	Pleckstrin homology domain-containing family G member 2	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q9H7P9	PLEKHG2	Pleckstrin homology domain-containing family G member 2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9H7P9	PLEKHG2	Pleckstrin homology domain-containing family G member 2	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q9H7P9	PLEKHG2	Pleckstrin homology domain-containing family G member 2	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q9H7P9	PLEKHG2	Pleckstrin homology domain-containing family G member 2	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q58EX7	PLEKHG4	Puratrophin-1	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
O94827	PLEKHG5	Pleckstrin homology domain-containing family G member 5	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:Ensembl
O94827	PLEKHG5	Pleckstrin homology domain-containing family G member 5	GO:0004871; F:signal transducer activity; IMP:UniProtKB
O94827	PLEKHG5	Pleckstrin homology domain-containing family G member 5	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
O94827	PLEKHG5	Pleckstrin homology domain-containing family G member 5	GO:0035767; P:endothelial cell chemotaxis; ISS:UniProtKB
O94827	PLEKHG5	Pleckstrin homology domain-containing family G member 5	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O94827	PLEKHG5	Pleckstrin homology domain-containing family G member 5	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
O94827	PLEKHG5	Pleckstrin homology domain-containing family G member 5	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
O94827	PLEKHG5	Pleckstrin homology domain-containing family G member 5	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
O94827	PLEKHG5	Pleckstrin homology domain-containing family G member 5	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q3KR16	PLEKHG6	Pleckstrin homology domain-containing family G member 6	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q3KR16	PLEKHG6	Pleckstrin homology domain-containing family G member 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q3KR16	PLEKHG6	Pleckstrin homology domain-containing family G member 6	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q6ZR37	PLEKHG7	Pleckstrin homology domain-containing family G member 7	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q8IVE3	PLEKHH2	Pleckstrin homology domain-containing family H member 2	GO:0003779; F:actin binding; ISS:UniProtKB
Q8IVE3	PLEKHH2	Pleckstrin homology domain-containing family H member 2	GO:0030835; P:negative regulation of actin filament depolymerization; ISS:UniProtKB
Q7Z736	PLEKHH3	Pleckstrin homology domain-containing family H member 3	GO:0007165; P:signal transduction; IEA:InterPro
Q86WI1	PKHD1L1	Fibrocystin-L	GO:0004872; F:receptor activity; NAS:UniProtKB
Q86WI1	PKHD1L1	Fibrocystin-L	GO:0006955; P:immune response; NAS:UniProtKB
Q9Y4G2	PLEKHM1	Pleckstrin homology domain-containing family M member 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y4G2	PLEKHM1	Pleckstrin homology domain-containing family M member 1	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8IWE5	PLEKHM2	Pleckstrin homology domain-containing family M member 2	GO:0019894; F:kinesin binding; IDA:UniProtKB
Q8IWE5	PLEKHM2	Pleckstrin homology domain-containing family M member 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IWE5	PLEKHM2	Pleckstrin homology domain-containing family M member 2	GO:0007030; P:Golgi organization; IMP:UniProtKB
Q6ZWE6	PLEKHM3	Pleckstrin homology domain-containing family M member 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZWE6	PLEKHM3	Pleckstrin homology domain-containing family M member 3	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q69YJ1	PLEKHM1P	Putative pleckstrin homology domain-containing family M member 1P	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q69YJ1	PLEKHM1P	Putative pleckstrin homology domain-containing family M member 1P	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q53GL0	PLEKHO1	Pleckstrin homology domain-containing family O member 1	GO:0005515; F:protein binding; IPI:IntAct
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0050681; F:androgen receptor binding; IDA:UniProtKB
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0017049; F:GTP-Rho binding; IDA:UniProtKB
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0042393; F:histone binding; IDA:UniProtKB
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0042826; F:histone deacetylase binding; IDA:UniProtKB
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0035402; F:histone kinase activity (H3-T11 specific); IDA:UniProtKB
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IDA:UniProtKB
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0005515; F:protein binding; IPI:UniProtKB
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0004697; F:protein kinase C activity; IEA:UniProtKB-EC
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0005080; F:protein kinase C binding; IPI:UniProtKB
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0048365; F:Rac GTPase binding; IDA:UniProtKB
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0007257; P:activation of JUN kinase activity; TAS:ProtInc
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0010631; P:epithelial cell migration; IMP:UniProtKB
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0035407; P:histone H3-T11 phosphorylation; IDA:UniProtKB
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0006972; P:hyperosmotic response; IEA:Ensembl
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:2000145; P:regulation of cell motility; IMP:UniProtKB
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0007165; P:signal transduction; TAS:ProtInc
Q16512	PKN1	Serine/threonine-protein kinase N1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q16513	PKN2	Serine/threonine-protein kinase N2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q16513	PKN2	Serine/threonine-protein kinase N2	GO:0042826; F:histone deacetylase binding; IDA:UniProtKB
Q16513	PKN2	Serine/threonine-protein kinase N2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q16513	PKN2	Serine/threonine-protein kinase N2	GO:0005515; F:protein binding; IPI:UniProtKB
Q16513	PKN2	Serine/threonine-protein kinase N2	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q16513	PKN2	Serine/threonine-protein kinase N2	GO:0004697; F:protein kinase C activity; IEA:UniProtKB-EC
Q16513	PKN2	Serine/threonine-protein kinase N2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q16513	PKN2	Serine/threonine-protein kinase N2	GO:0043297; P:apical junction assembly; IMP:UniProtKB
Q16513	PKN2	Serine/threonine-protein kinase N2	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q16513	PKN2	Serine/threonine-protein kinase N2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q16513	PKN2	Serine/threonine-protein kinase N2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q16513	PKN2	Serine/threonine-protein kinase N2	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q16513	PKN2	Serine/threonine-protein kinase N2	GO:0010631; P:epithelial cell migration; IDA:UniProtKB
Q16513	PKN2	Serine/threonine-protein kinase N2	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB
Q16513	PKN2	Serine/threonine-protein kinase N2	GO:0045931; P:positive regulation of mitotic cell cycle; IMP:UniProtKB
Q16513	PKN2	Serine/threonine-protein kinase N2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q16513	PKN2	Serine/threonine-protein kinase N2	GO:2000145; P:regulation of cell motility; IMP:UniProtKB
Q16513	PKN2	Serine/threonine-protein kinase N2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q16513	PKN2	Serine/threonine-protein kinase N2	GO:0007165; P:signal transduction; TAS:ProtInc
Q16513	PKN2	Serine/threonine-protein kinase N2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6P5Z2	PKN3	Serine/threonine-protein kinase N3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6P5Z2	PKN3	Serine/threonine-protein kinase N3	GO:0005515; F:protein binding; IPI:IntAct
Q6P5Z2	PKN3	Serine/threonine-protein kinase N3	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q6P5Z2	PKN3	Serine/threonine-protein kinase N3	GO:0004697; F:protein kinase C activity; IEA:UniProtKB-EC
Q6P5Z2	PKN3	Serine/threonine-protein kinase N3	GO:0010631; P:epithelial cell migration; IDA:UniProtKB
Q6P5Z2	PKN3	Serine/threonine-protein kinase N3	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q6P5Z2	PKN3	Serine/threonine-protein kinase N3	GO:0007165; P:signal transduction; TAS:ProtInc
Q96KN3	PKNOX2	Homeobox protein PKNOX2	GO:0003677; F:DNA binding; IDA:MGI
Q96KN3	PKNOX2	Homeobox protein PKNOX2	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q96KN3	PKNOX2	Homeobox protein PKNOX2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q96KN3	PKNOX2	Homeobox protein PKNOX2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P55347	PKNOX1	Homeobox protein PKNOX1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P55347	PKNOX1	Homeobox protein PKNOX1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P55347	PKNOX1	Homeobox protein PKNOX1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P55347	PKNOX1	Homeobox protein PKNOX1	GO:0001525; P:angiogenesis; IEA:Ensembl
P55347	PKNOX1	Homeobox protein PKNOX1	GO:0043010; P:camera-type eye development; IEA:Ensembl
P55347	PKNOX1	Homeobox protein PKNOX1	GO:0030218; P:erythrocyte differentiation; IEA:Ensembl
P55347	PKNOX1	Homeobox protein PKNOX1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P55347	PKNOX1	Homeobox protein PKNOX1	GO:0030217; P:T cell differentiation; IEA:Ensembl
P55347	PKNOX1	Homeobox protein PKNOX1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q13835	PKP1	Plakophilin-1	GO:0019215; F:intermediate filament binding; NAS:UniProtKB
Q13835	PKP1	Plakophilin-1	GO:0005521; F:lamin binding; IDA:BHF-UCL
Q13835	PKP1	Plakophilin-1	GO:0005515; F:protein binding; IPI:BHF-UCL
Q13835	PKP1	Plakophilin-1	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q13835	PKP1	Plakophilin-1	GO:0030280; F:structural constituent of epidermis; NAS:UniProtKB
Q13835	PKP1	Plakophilin-1	GO:0006915; P:apoptotic process; TAS:Reactome
Q13835	PKP1	Plakophilin-1	GO:0007155; P:cell adhesion; NAS:UniProtKB
Q13835	PKP1	Plakophilin-1	GO:0016337; P:single organismal cell-cell adhesion; IEA:InterPro
Q13835	PKP1	Plakophilin-1	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q13835	PKP1	Plakophilin-1	GO:0045110; P:intermediate filament bundle assembly; IDA:BHF-UCL
Q13835	PKP1	Plakophilin-1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q13835	PKP1	Plakophilin-1	GO:0007165; P:signal transduction; NAS:UniProtKB
Q99959	PKP2	Plakophilin-2	GO:0019215; F:intermediate filament binding; IDA:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0044325; F:ion channel binding; ISS:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0005515; F:protein binding; IPI:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0032947; F:protein complex scaffold; IMP:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0005080; F:protein kinase C binding; IPI:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0017080; F:sodium channel regulator activity; ISS:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0034334; P:adherens junction maintenance; ISS:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0086069; P:bundle of His cell to Purkinje myocyte communication; IMP:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0086001; P:cardiac muscle cell action potential; ISS:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0086002; P:cardiac muscle cell action potential involved in contraction; IMP:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0086064; P:cell communication by electrical coupling involved in cardiac conduction; ISS:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
Q99959	PKP2	Plakophilin-2	GO:0086019; P:cell-cell signaling involved in cardiac conduction; IMP:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0002159; P:desmosome assembly; IMP:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0016264; P:gap junction assembly; ISS:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0007507; P:heart development; ISS:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0045110; P:intermediate filament bundle assembly; IMP:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0055088; P:lipid homeostasis; ISS:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0048496; P:maintenance of organ identity; IMP:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0030336; P:negative regulation of cell migration; ISS:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0008285; P:negative regulation of cell proliferation; ISS:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0010765; P:positive regulation of sodium ion transport; ISS:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:2000810; P:regulation of tight junction assembly; ISS:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL
Q99959	PKP2	Plakophilin-2	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IMP:BHF-UCL
Q99569	PKP4	Plakophilin-4	GO:0005515; F:protein binding; IPI:UniProtKB
Q99569	PKP4	Plakophilin-4	GO:0016337; P:single organismal cell-cell adhesion; IEA:InterPro
Q99569	PKP4	Plakophilin-4	GO:0007043; P:cell-cell junction assembly; ISS:UniProtKB
Q99569	PKP4	Plakophilin-4	GO:0007267; P:cell-cell signaling; NAS:UniProtKB
Q99569	PKP4	Plakophilin-4	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB
Q99569	PKP4	Plakophilin-4	GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB
Q99569	PKP4	Plakophilin-4	GO:0032321; P:positive regulation of Rho GTPase activity; IDA:UniProtKB
Q99569	PKP4	Plakophilin-4	GO:0030155; P:regulation of cell adhesion; NAS:UniProtKB
Q9Y446	PKP3	Plakophilin-3	GO:0050839; F:cell adhesion molecule binding; IPI:UniProt
Q9Y446	PKP3	Plakophilin-3	GO:0016337; P:single organismal cell-cell adhesion; IEA:InterPro
Q9Y446	PKP3	Plakophilin-3	GO:0002159; P:desmosome assembly; IMP:UniProt
Q9Y446	PKP3	Plakophilin-3	GO:0090002; P:establishment of protein localization to plasma membrane; IMP:UniProt
Q8TCW9	PROKR1	Prokineticin receptor 1	GO:0004983; F:neuropeptide Y receptor activity; IEA:InterPro
Q8TCW9	PROKR1	Prokineticin receptor 1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q8NFJ6	PROKR2	Prokineticin receptor 2	GO:0004983; F:neuropeptide Y receptor activity; IEA:InterPro
Q8NFJ6	PROKR2	Prokineticin receptor 2	GO:0007623; P:circadian rhythm; IEA:Ensembl
Q9H875	PRKRIP1	PRKR-interacting protein 1	GO:0003725; F:double-stranded RNA binding; ISS:UniProt
Q9H875	PRKRIP1	PRKR-interacting protein 1	GO:0019901; F:protein kinase binding; ISS:UniProt
Q9H875	PRKRIP1	PRKR-interacting protein 1	GO:0004860; F:protein kinase inhibitor activity; ISS:UniProt
Q9H875	PRKRIP1	PRKR-interacting protein 1	GO:0042326; P:negative regulation of phosphorylation; ISS:UniProt
Q9H875	PRKRIP1	PRKR-interacting protein 1	GO:0006469; P:negative regulation of protein kinase activity; ISS:UniProt
Q9H875	PRKRIP1	PRKR-interacting protein 1	GO:0003014; P:renal system process; IDA:UniProt
Q53H76	PLA1A	Phospholipase A1 member A	GO:0008970; F:phosphatidylcholine 1-acylhydrolase activity; TAS:ProtInc
Q53H76	PLA1A	Phospholipase A1 member A	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q53H76	PLA1A	Phospholipase A1 member A	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q53H76	PLA1A	Phospholipase A1 member A	GO:0006658; P:phosphatidylserine metabolic process; TAS:ProtInc
Q13018	PLA2R1	Secretory phospholipase A2 receptor	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q13018	PLA2R1	Secretory phospholipase A2 receptor	GO:0043274; F:phospholipase binding; IPI:UniProtKB
Q13018	PLA2R1	Secretory phospholipase A2 receptor	GO:0004872; F:receptor activity; IDA:UniProtKB
Q13018	PLA2R1	Secretory phospholipase A2 receptor	GO:0001816; P:cytokine production; IMP:UniProtKB
Q13018	PLA2R1	Secretory phospholipase A2 receptor	GO:1900139; P:negative regulation of arachidonic acid secretion; ISS:UniProtKB
Q13018	PLA2R1	Secretory phospholipase A2 receptor	GO:1900138; P:negative regulation of phospholipase A2 activity; ISS:UniProtKB
Q13018	PLA2R1	Secretory phospholipase A2 receptor	GO:0090403; P:oxidative stress-induced premature senescence; IMP:UniProtKB
Q13018	PLA2R1	Secretory phospholipase A2 receptor	GO:0090238; P:positive regulation of arachidonic acid secretion; ISS:UniProtKB
Q13018	PLA2R1	Secretory phospholipase A2 receptor	GO:0043517; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; IMP:UniProtKB
Q13018	PLA2R1	Secretory phospholipase A2 receptor	GO:0072593; P:reactive oxygen species metabolic process; IDA:UniProtKB
Q13018	PLA2R1	Secretory phospholipase A2 receptor	GO:0006898; P:receptor-mediated endocytosis; IDA:UniProtKB
Q13018	PLA2R1	Secretory phospholipase A2 receptor	GO:0090399; P:replicative senescence; IMP:UniProtKB
Q9HBJ0	PLAC1	Placenta-specific protein 1	GO:0001890; P:placenta development; IEP:UniProtKB
Q9HBJ0	PLAC1	Placenta-specific protein 1	GO:0090214; P:spongiotrophoblast layer developmental growth; IEA:Ensembl
Q9NZF1	PLAC8	Placenta-specific gene 8 protein	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9NZF1	PLAC8	Placenta-specific gene 8 protein	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
Q9NZF1	PLAC8	Placenta-specific gene 8 protein	GO:0042742; P:defense response to bacterium; IEA:Ensembl
Q9NZF1	PLAC8	Placenta-specific gene 8 protein	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q9NZF1	PLAC8	Placenta-specific gene 8 protein	GO:0040015; P:negative regulation of multicellular organism growth; IEA:Ensembl
Q9NZF1	PLAC8	Placenta-specific gene 8 protein	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q9NZF1	PLAC8	Placenta-specific gene 8 protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9NZF1	PLAC8	Placenta-specific gene 8 protein	GO:0009409; P:response to cold; IEA:Ensembl
Q6DJT9	PLAG1	Zinc finger protein PLAG1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6DJT9	PLAG1	Zinc finger protein PLAG1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6DJT9	PLAG1	Zinc finger protein PLAG1	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q6DJT9	PLAG1	Zinc finger protein PLAG1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q6DJT9	PLAG1	Zinc finger protein PLAG1	GO:0022612; P:gland morphogenesis; IEA:Ensembl
Q6DJT9	PLAG1	Zinc finger protein PLAG1	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q6DJT9	PLAG1	Zinc finger protein PLAG1	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
Q6DJT9	PLAG1	Zinc finger protein PLAG1	GO:0035265; P:organ growth; IEA:Ensembl
Q6DJT9	PLAG1	Zinc finger protein PLAG1	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
Q6DJT9	PLAG1	Zinc finger protein PLAG1	GO:0060252; P:positive regulation of glial cell proliferation; IEA:Ensembl
Q6DJT9	PLAG1	Zinc finger protein PLAG1	GO:0060736; P:prostate gland growth; IEA:Ensembl
Q6DJT9	PLAG1	Zinc finger protein PLAG1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
Q6DJT9	PLAG1	Zinc finger protein PLAG1	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
P14923	JUP	Junction plakoglobin	GO:0045294; F:alpha-catenin binding; IPI:BHF-UCL
P14923	JUP	Junction plakoglobin	GO:0045296; F:cadherin binding; IPI:BHF-UCL
P14923	JUP	Junction plakoglobin	GO:0005515; F:protein binding; IPI:UniProtKB
P14923	JUP	Junction plakoglobin	GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
P14923	JUP	Junction plakoglobin	GO:0019901; F:protein kinase binding; IBA:RefGenome
P14923	JUP	Junction plakoglobin	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
P14923	JUP	Junction plakoglobin	GO:0005199; F:structural constituent of cell wall; IC:BHF-UCL
P14923	JUP	Junction plakoglobin	GO:0005198; F:structural molecule activity; NAS:BHF-UCL
P14923	JUP	Junction plakoglobin	GO:0003713; F:transcription coactivator activity; IDA:BHF-UCL
P14923	JUP	Junction plakoglobin	GO:0034332; P:adherens junction organization; TAS:Reactome
P14923	JUP	Junction plakoglobin	GO:0003181; P:atrioventricular valve morphogenesis; IBA:RefGenome
P14923	JUP	Junction plakoglobin	GO:0086069; P:bundle of His cell to Purkinje myocyte communication; IMP:BHF-UCL
P14923	JUP	Junction plakoglobin	GO:0034329; P:cell junction assembly; TAS:Reactome
P14923	JUP	Junction plakoglobin	GO:0016477; P:cell migration; IMP:BHF-UCL
P14923	JUP	Junction plakoglobin	GO:0000902; P:cell morphogenesis; IBA:RefGenome
P14923	JUP	Junction plakoglobin	GO:0016337; P:single organismal cell-cell adhesion; IDA:BHF-UCL
P14923	JUP	Junction plakoglobin	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P14923	JUP	Junction plakoglobin	GO:0071681; P:cellular response to indole-3-methanol; IDA:UniProtKB
P14923	JUP	Junction plakoglobin	GO:0007016; P:cytoskeletal anchoring at plasma membrane; NAS:BHF-UCL
P14923	JUP	Junction plakoglobin	GO:0002159; P:desmosome assembly; IDA:BHF-UCL
P14923	JUP	Junction plakoglobin	GO:0050982; P:detection of mechanical stimulus; IDA:BHF-UCL
P14923	JUP	Junction plakoglobin	GO:0007398; P:ectoderm development; IBA:RefGenome
P14923	JUP	Junction plakoglobin	GO:0071603; P:endothelial cell-cell adhesion; ISS:BHF-UCL
P14923	JUP	Junction plakoglobin	GO:0090002; P:establishment of protein localization to plasma membrane; IMP:UniProt
P14923	JUP	Junction plakoglobin	GO:0007369; P:gastrulation; IBA:RefGenome
P14923	JUP	Junction plakoglobin	GO:0016331; P:morphogenesis of embryonic epithelium; IBA:RefGenome
P14923	JUP	Junction plakoglobin	GO:0003136; P:negative regulation of heart induction by canonical Wnt signaling pathway; IBA:RefGenome
P14923	JUP	Junction plakoglobin	GO:0003308; P:negative regulation of Wnt signaling pathway involved in heart development; IBA:RefGenome
P14923	JUP	Junction plakoglobin	GO:0007399; P:nervous system development; IBA:RefGenome
P14923	JUP	Junction plakoglobin	GO:0048599; P:oocyte development; IBA:RefGenome
P14923	JUP	Junction plakoglobin	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IC:BHF-UCL
P14923	JUP	Junction plakoglobin	GO:0042307; P:positive regulation of protein import into nucleus; IDA:BHF-UCL
P14923	JUP	Junction plakoglobin	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P14923	JUP	Junction plakoglobin	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P14923	JUP	Junction plakoglobin	GO:0042127; P:regulation of cell proliferation; IDA:BHF-UCL
P14923	JUP	Junction plakoglobin	GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL
P14923	JUP	Junction plakoglobin	GO:0043588; P:skin development; IBA:RefGenome
P14923	JUP	Junction plakoglobin	GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL
Q9UM63	PLAGL1	Zinc finger protein PLAGL1	GO:0003677; F:DNA binding; IDA:MGI
Q9UM63	PLAGL1	Zinc finger protein PLAGL1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UM63	PLAGL1	Zinc finger protein PLAGL1	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q9UM63	PLAGL1	Zinc finger protein PLAGL1	GO:0006915; P:apoptotic process; TAS:ProtInc
Q9UM63	PLAGL1	Zinc finger protein PLAGL1	GO:0007050; P:cell cycle arrest; TAS:ProtInc
Q9UM63	PLAGL1	Zinc finger protein PLAGL1	GO:0030154; P:cell differentiation; IBA:RefGenome
Q9UM63	PLAGL1	Zinc finger protein PLAGL1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q9UM63	PLAGL1	Zinc finger protein PLAGL1	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q9UM63	PLAGL1	Zinc finger protein PLAGL1	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q9UPG8	PLAGL2	Zinc finger protein PLAGL2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UPG8	PLAGL2	Zinc finger protein PLAGL2	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:MGI
Q9UPG8	PLAGL2	Zinc finger protein PLAGL2	GO:0043565; F:sequence-specific DNA binding; IDA:MGI
Q9UPG8	PLAGL2	Zinc finger protein PLAGL2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9UPG8	PLAGL2	Zinc finger protein PLAGL2	GO:0034378; P:chylomicron assembly; IBA:RefGenome
Q9UPG8	PLAGL2	Zinc finger protein PLAGL2	GO:0006629; P:lipid metabolic process; IEA:Ensembl
Q9UPG8	PLAGL2	Zinc finger protein PLAGL2	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl
Q9UPG8	PLAGL2	Zinc finger protein PLAGL2	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q9Y263	PLAA	Phospholipase A-2-activating protein	GO:0016005; F:phospholipase A2 activator activity; TAS:ProtInc
Q9Y263	PLAA	Phospholipase A-2-activating protein	GO:0005515; F:protein binding; IPI:IntAct
Q9Y263	PLAA	Phospholipase A-2-activating protein	GO:0006954; P:inflammatory response; IEA:Ensembl
Q9Y263	PLAA	Phospholipase A-2-activating protein	GO:0006644; P:phospholipid metabolic process; TAS:ProtInc
Q9Y263	PLAA	Phospholipase A-2-activating protein	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
Q9Y263	PLAA	Phospholipase A-2-activating protein	GO:0007165; P:signal transduction; TAS:ProtInc
Q6P1J6	PLB1	Phospholipase B1, membrane-associated	GO:0004622; F:lysophospholipase activity; IEA:UniProtKB-EC
Q6P1J6	PLB1	Phospholipase B1, membrane-associated	GO:0004623; F:phospholipase A2 activity; IEA:UniProtKB-EC
Q6P1J6	PLB1	Phospholipase B1, membrane-associated	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q6P1J6	PLB1	Phospholipase B1, membrane-associated	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q6P1J6	PLB1	Phospholipase B1, membrane-associated	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
Q6P1J6	PLB1	Phospholipase B1, membrane-associated	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q6P1J6	PLB1	Phospholipase B1, membrane-associated	GO:0007603; P:phototransduction, visible light; TAS:Reactome
Q6P1J6	PLB1	Phospholipase B1, membrane-associated	GO:0001523; P:retinoid metabolic process; TAS:Reactome
Q6P1J6	PLB1	Phospholipase B1, membrane-associated	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6P4A8	PLBD1	Phospholipase B-like 1	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q6P4A8	PLBD1	Phospholipase B-like 1	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q6P4A8	PLBD1	Phospholipase B-like 1	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q6P4A8	PLBD1	Phospholipase B-like 1	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
Q6P4A8	PLBD1	Phospholipase B-like 1	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
Q6P4A8	PLBD1	Phospholipase B-like 1	GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome
Q6P4A8	PLBD1	Phospholipase B-like 1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q6P4A8	PLBD1	Phospholipase B-like 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8NHP8	PLBD2	Putative phospholipase B-like 2	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q8NHP8	PLBD2	Putative phospholipase B-like 2	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q99943	AGPAT1	1-acyl-sn-glycerol-3-phosphate acyltransferase alpha	GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; IGI:BHF-UCL
Q99943	AGPAT1	1-acyl-sn-glycerol-3-phosphate acyltransferase alpha	GO:0016024; P:CDP-diacylglycerol biosynthetic process; IEA:UniProtKB-UniPathway
Q99943	AGPAT1	1-acyl-sn-glycerol-3-phosphate acyltransferase alpha	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q99943	AGPAT1	1-acyl-sn-glycerol-3-phosphate acyltransferase alpha	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q99943	AGPAT1	1-acyl-sn-glycerol-3-phosphate acyltransferase alpha	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q99943	AGPAT1	1-acyl-sn-glycerol-3-phosphate acyltransferase alpha	GO:0006654; P:phosphatidic acid biosynthetic process; IGI:BHF-UCL
Q99943	AGPAT1	1-acyl-sn-glycerol-3-phosphate acyltransferase alpha	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q99943	AGPAT1	1-acyl-sn-glycerol-3-phosphate acyltransferase alpha	GO:0031325; P:positive regulation of cellular metabolic process; TAS:Reactome
Q99943	AGPAT1	1-acyl-sn-glycerol-3-phosphate acyltransferase alpha	GO:0001819; P:positive regulation of cytokine production; IMP:BHF-UCL
Q99943	AGPAT1	1-acyl-sn-glycerol-3-phosphate acyltransferase alpha	GO:0001961; P:positive regulation of cytokine-mediated signaling pathway; IC:BHF-UCL
Q99943	AGPAT1	1-acyl-sn-glycerol-3-phosphate acyltransferase alpha	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99943	AGPAT1	1-acyl-sn-glycerol-3-phosphate acyltransferase alpha	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
Q00722	PLCB2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q00722	PLCB2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2	GO:0004435; F:phosphatidylinositol phospholipase C activity; IEA:InterPro
Q00722	PLCB2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2	GO:0004629; F:phospholipase C activity; TAS:ProtInc
Q00722	PLCB2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
Q00722	PLCB2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2	GO:0007202; P:activation of phospholipase C activity; TAS:ProtInc
Q00722	PLCB2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q00722	PLCB2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q00722	PLCB2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2	GO:0016042; P:lipid catabolic process; IEA:InterPro
Q00722	PLCB2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2	GO:0006644; P:phospholipid metabolic process; TAS:ProtInc
Q00722	PLCB2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2	GO:0050913; P:sensory perception of bitter taste; IEA:Ensembl
Q00722	PLCB2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q00722	PLCB2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0005516; F:calmodulin binding; IPI:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0005096; F:GTPase activator activity; IDA:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0004435; F:phosphatidylinositol phospholipase C activity; NAS:UniProtKB
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0060466; P:activation of meiosis involved in egg activation; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0021987; P:cerebral cortex development; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0045444; P:fat cell differentiation; IEA:Ensembl
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0007213; P:G-protein coupled acetylcholine receptor signaling pathway; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0000086; P:G2/M transition of mitotic cell cycle; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0007215; P:glutamate receptor signaling pathway; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0048009; P:insulin-like growth factor receptor signaling pathway; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0070498; P:interleukin-1-mediated signaling pathway; IDA:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0035722; P:interleukin-12-mediated signaling pathway; IDA:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0035723; P:interleukin-15-mediated signaling pathway; IDA:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0007613; P:memory; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:2000438; P:negative regulation of monocyte extravasation; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0046488; P:phosphatidylinositol metabolic process; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:2000344; P:positive regulation of acrosome reaction; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:2000560; P:positive regulation of CD24 biosynthetic process; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0048639; P:positive regulation of developmental growth; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0040019; P:positive regulation of embryonic development; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0043547; P:positive regulation of GTPase activity; IDA:GOC
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0032735; P:positive regulation of interleukin-12 production; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0046330; P:positive regulation of JNK cascade; IDA:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0045663; P:positive regulation of myoblast differentiation; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0080154; P:regulation of fertilization; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; ISS:BHF-UCL
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0007165; P:signal transduction; NAS:UniProtKB
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NQ66	PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q01970	PLCB3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q01970	PLCB3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3	GO:0005516; F:calmodulin binding; IPI:BHF-UCL
Q01970	PLCB3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3	GO:0004435; F:phosphatidylinositol phospholipase C activity; IEA:UniProtKB-EC
Q01970	PLCB3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3	GO:0004629; F:phospholipase C activity; TAS:ProtInc
Q01970	PLCB3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
Q01970	PLCB3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q01970	PLCB3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q01970	PLCB3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q01970	PLCB3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3	GO:0003073; P:regulation of systemic arterial blood pressure; IDA:MGI
Q01970	PLCB3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q01970	PLCB3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3	GO:0007268; P:synaptic transmission; TAS:Reactome
Q15147	PLCB4	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4	GO:0005509; F:calcium ion binding; IEA:InterPro
Q15147	PLCB4	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4	GO:0004435; F:phosphatidylinositol phospholipase C activity; IEA:UniProtKB-EC
Q15147	PLCB4	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4	GO:0004629; F:phospholipase C activity; TAS:ProtInc
Q15147	PLCB4	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
Q15147	PLCB4	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q15147	PLCB4	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q15147	PLCB4	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q15147	PLCB4	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15120	AGPAT2	1-acyl-sn-glycerol-3-phosphate acyltransferase beta	GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; NAS:UniProtKB
O15120	AGPAT2	1-acyl-sn-glycerol-3-phosphate acyltransferase beta	GO:0016024; P:CDP-diacylglycerol biosynthetic process; IEA:UniProtKB-UniPathway
O15120	AGPAT2	1-acyl-sn-glycerol-3-phosphate acyltransferase beta	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O15120	AGPAT2	1-acyl-sn-glycerol-3-phosphate acyltransferase beta	GO:0008544; P:epidermis development; IEA:Ensembl
O15120	AGPAT2	1-acyl-sn-glycerol-3-phosphate acyltransferase beta	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
O15120	AGPAT2	1-acyl-sn-glycerol-3-phosphate acyltransferase beta	GO:0006654; P:phosphatidic acid biosynthetic process; IGI:BHF-UCL
O15120	AGPAT2	1-acyl-sn-glycerol-3-phosphate acyltransferase beta	GO:0006644; P:phospholipid metabolic process; NAS:UniProtKB
O15120	AGPAT2	1-acyl-sn-glycerol-3-phosphate acyltransferase beta	GO:0001819; P:positive regulation of cytokine production; IMP:BHF-UCL
O15120	AGPAT2	1-acyl-sn-glycerol-3-phosphate acyltransferase beta	GO:0001961; P:positive regulation of cytokine-mediated signaling pathway; IC:BHF-UCL
O15120	AGPAT2	1-acyl-sn-glycerol-3-phosphate acyltransferase beta	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15120	AGPAT2	1-acyl-sn-glycerol-3-phosphate acyltransferase beta	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
Q9NRZ7	AGPAT3	1-acyl-sn-glycerol-3-phosphate acyltransferase gamma	GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; NAS:UniProtKB
Q9NRZ7	AGPAT3	1-acyl-sn-glycerol-3-phosphate acyltransferase gamma	GO:0016024; P:CDP-diacylglycerol biosynthetic process; IEA:UniProtKB-UniPathway
Q9NRZ7	AGPAT3	1-acyl-sn-glycerol-3-phosphate acyltransferase gamma	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9NRZ7	AGPAT3	1-acyl-sn-glycerol-3-phosphate acyltransferase gamma	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9NRZ7	AGPAT3	1-acyl-sn-glycerol-3-phosphate acyltransferase gamma	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
Q9NRZ7	AGPAT3	1-acyl-sn-glycerol-3-phosphate acyltransferase gamma	GO:0008654; P:phospholipid biosynthetic process; NAS:UniProtKB
Q9NRZ7	AGPAT3	1-acyl-sn-glycerol-3-phosphate acyltransferase gamma	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9NRZ7	AGPAT3	1-acyl-sn-glycerol-3-phosphate acyltransferase gamma	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NRZ7	AGPAT3	1-acyl-sn-glycerol-3-phosphate acyltransferase gamma	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
P51178	PLCD1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1	GO:0005509; F:calcium ion binding; IEA:InterPro
P51178	PLCD1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1	GO:0032794; F:GTPase activating protein binding; IPI:BHF-UCL
P51178	PLCD1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1	GO:0004435; F:phosphatidylinositol phospholipase C activity; TAS:ProtInc
P51178	PLCD1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
P51178	PLCD1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1	GO:0001525; P:angiogenesis; IEA:Ensembl
P51178	PLCD1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
P51178	PLCD1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P51178	PLCD1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1	GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl
P51178	PLCD1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
P51178	PLCD1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1	GO:0006644; P:phospholipid metabolic process; TAS:ProtInc
P51178	PLCD1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P51178	PLCD1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8N3E9	PLCD3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8N3E9	PLCD3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3	GO:0004435; F:phosphatidylinositol phospholipase C activity; IEA:UniProtKB-EC
Q8N3E9	PLCD3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
Q8N3E9	PLCD3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3	GO:0001525; P:angiogenesis; IEA:Ensembl
Q8N3E9	PLCD3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q8N3E9	PLCD3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8N3E9	PLCD3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3	GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl
Q8N3E9	PLCD3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q8N3E9	PLCD3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q8N3E9	PLCD3	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BRC7	PLCD4	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9BRC7	PLCD4	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4	GO:0004435; F:phosphatidylinositol phospholipase C activity; IEA:UniProtKB-EC
Q9BRC7	PLCD4	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
Q9BRC7	PLCD4	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4	GO:0007340; P:acrosome reaction; IEA:Ensembl
Q9BRC7	PLCD4	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9BRC7	PLCD4	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q9BRC7	PLCD4	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4	GO:0046488; P:phosphatidylinositol metabolic process; IEA:InterPro
Q9NRZ5	AGPAT4	1-acyl-sn-glycerol-3-phosphate acyltransferase delta	GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; NAS:UniProtKB
Q9NRZ5	AGPAT4	1-acyl-sn-glycerol-3-phosphate acyltransferase delta	GO:0016024; P:CDP-diacylglycerol biosynthetic process; IEA:UniProtKB-UniPathway
Q9NRZ5	AGPAT4	1-acyl-sn-glycerol-3-phosphate acyltransferase delta	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9NRZ5	AGPAT4	1-acyl-sn-glycerol-3-phosphate acyltransferase delta	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9NRZ5	AGPAT4	1-acyl-sn-glycerol-3-phosphate acyltransferase delta	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
Q9NRZ5	AGPAT4	1-acyl-sn-glycerol-3-phosphate acyltransferase delta	GO:0008654; P:phospholipid biosynthetic process; NAS:UniProtKB
Q9NRZ5	AGPAT4	1-acyl-sn-glycerol-3-phosphate acyltransferase delta	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9NRZ5	AGPAT4	1-acyl-sn-glycerol-3-phosphate acyltransferase delta	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NRZ5	AGPAT4	1-acyl-sn-glycerol-3-phosphate acyltransferase delta	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0004435; F:phosphatidylinositol phospholipase C activity; IDA:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0004629; F:phospholipase C activity; IDA:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0017016; F:Ras GTPase binding; TAS:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0005057; F:receptor signaling protein activity; TAS:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0000187; P:activation of MAPK activity; IDA:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0019722; P:calcium-mediated signaling; NAS:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0008283; P:cell proliferation; NAS:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0007010; P:cytoskeleton organization; NAS:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0006651; P:diacylglycerol biosynthetic process; TAS:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0007173; P:epidermal growth factor receptor signaling pathway; NAS:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0032835; P:glomerulus development; IMP:HGNC
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0007507; P:heart development; TAS:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0048016; P:inositol phosphate-mediated signaling; TAS:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; IDA:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0006644; P:phospholipid metabolic process; IC:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; NAS:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0007265; P:Ras protein signal transduction; TAS:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0001558; P:regulation of cell growth; TAS:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; IDA:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0043087; P:regulation of GTPase activity; TAS:GOC
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0045859; P:regulation of protein kinase activity; IDA:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0046578; P:regulation of Ras protein signal transduction; IDA:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0006940; P:regulation of smooth muscle contraction; TAS:UniProtKB
Q9P212	PLCE1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NUQ2	AGPAT5	1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon	GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; NAS:UniProtKB
Q9NUQ2	AGPAT5	1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon	GO:0016024; P:CDP-diacylglycerol biosynthetic process; IEA:UniProtKB-UniPathway
Q9NUQ2	AGPAT5	1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9NUQ2	AGPAT5	1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9NUQ2	AGPAT5	1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
Q9NUQ2	AGPAT5	1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon	GO:0008654; P:phospholipid biosynthetic process; NAS:UniProtKB
Q9NUQ2	AGPAT5	1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9NUQ2	AGPAT5	1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NUQ2	AGPAT5	1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0005509; F:calcium ion binding; IEA:InterPro
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0005168; F:neurotrophin TRKA receptor binding; IPI:UniProtKB
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0004435; F:phosphatidylinositol phospholipase C activity; IDA:UniProtKB
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0004629; F:phospholipase C activity; TAS:Reactome
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0005515; F:protein binding; IPI:UniProtKB
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0005057; F:receptor signaling protein activity; NAS:UniProtKB
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0000186; P:activation of MAPKK activity; TAS:Reactome
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0007202; P:activation of phospholipase C activity; TAS:Reactome
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0007411; P:axon guidance; TAS:Reactome
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0007596; P:blood coagulation; TAS:Reactome
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0071364; P:cellular response to epidermal growth factor stimulus; IDA:UniProtKB
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0045087; P:innate immune response; TAS:Reactome
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0050900; P:leukocyte migration; TAS:Reactome
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0009395; P:phospholipid catabolic process; IEA:InterPro
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0045766; P:positive regulation of angiogenesis; IDA:DFLAT
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IDA:DFLAT
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0010634; P:positive regulation of epithelial cell migration; IMP:UniProtKB
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0007165; P:signal transduction; NAS:UniProtKB
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P19174	PLCG1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	GO:0016032; P:viral process; IEA:UniProtKB-KW
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0004435; F:phosphatidylinositol phospholipase C activity; IDA:UniProtKB
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0004629; F:phospholipase C activity; TAS:Reactome
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0005515; F:protein binding; IPI:IntAct
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0032237; P:activation of store-operated calcium channel activity; IEA:Ensembl
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0030183; P:B cell differentiation; ISS:UniProtKB
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0050853; P:B cell receptor signaling pathway; ISS:UniProtKB
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0007596; P:blood coagulation; TAS:Reactome
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0019722; P:calcium-mediated signaling; NAS:UniProtKB
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0002316; P:follicular B cell differentiation; IEA:Ensembl
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0045087; P:innate immune response; TAS:Reactome
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0032959; P:inositol trisphosphate biosynthetic process; IEA:Ensembl
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0043069; P:negative regulation of programmed cell death; IEA:Ensembl
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0006661; P:phosphatidylinositol biosynthetic process; IDA:UniProtKB
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0009395; P:phospholipid catabolic process; IEA:InterPro
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0030168; P:platelet activation; TAS:Reactome
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0010468; P:regulation of gene expression; IEA:Ensembl
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0051209; P:release of sequestered calcium ion into cytosol; IDA:UniProtKB
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0050852; P:T cell receptor signaling pathway; ISS:UniProtKB
P16885	PLCG2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2	GO:0016055; P:Wnt signaling pathway; TAS:UniProtKB
Q4KWH8	PLCH1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q4KWH8	PLCH1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1	GO:0050429; F:calcium-dependent phospholipase C activity; IDA:MGI
Q4KWH8	PLCH1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1	GO:0004435; F:phosphatidylinositol phospholipase C activity; IEA:UniProtKB-EC
Q4KWH8	PLCH1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
Q4KWH8	PLCH1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q4KWH8	PLCH1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q4KWH8	PLCH1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1	GO:0048015; P:phosphatidylinositol-mediated signaling; IDA:MGI
Q4KWH8	PLCH1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75038	PLCH2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2	GO:0005509; F:calcium ion binding; IEA:InterPro
O75038	PLCH2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2	GO:0004435; F:phosphatidylinositol phospholipase C activity; IEA:UniProtKB-EC
O75038	PLCH2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
O75038	PLCH2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
O75038	PLCH2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
O75038	PLCH2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
O75038	PLCH2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2	GO:0046488; P:phosphatidylinositol metabolic process; IEA:Ensembl
O75038	PLCH2	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UPR0	PLCL2	Inactive phospholipase C-like protein 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UPR0	PLCL2	Inactive phospholipase C-like protein 2	GO:0050811; F:GABA receptor binding; IDA:MGI
Q9UPR0	PLCL2	Inactive phospholipase C-like protein 2	GO:0004435; F:phosphatidylinositol phospholipase C activity; IEA:InterPro
Q9UPR0	PLCL2	Inactive phospholipase C-like protein 2	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
Q9UPR0	PLCL2	Inactive phospholipase C-like protein 2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9UPR0	PLCL2	Inactive phospholipase C-like protein 2	GO:0006629; P:lipid metabolic process; IEA:InterPro
Q15111	PLCL1	Inactive phospholipase C-like protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q15111	PLCL1	Inactive phospholipase C-like protein 1	GO:0004435; F:phosphatidylinositol phospholipase C activity; IEA:InterPro
Q15111	PLCL1	Inactive phospholipase C-like protein 1	GO:0004629; F:phospholipase C activity; TAS:ProtInc
Q15111	PLCL1	Inactive phospholipase C-like protein 1	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
Q15111	PLCL1	Inactive phospholipase C-like protein 1	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
Q15111	PLCL1	Inactive phospholipase C-like protein 1	GO:0006629; P:lipid metabolic process; IEA:InterPro
Q15111	PLCL1	Inactive phospholipase C-like protein 1	GO:0032228; P:regulation of synaptic transmission, GABAergic; IEA:Ensembl
Q9NUJ7	PLCXD1	PI-PLC X domain-containing protein 1	GO:0008081; F:phosphoric diester hydrolase activity; IEA:InterPro
Q9NUJ7	PLCXD1	PI-PLC X domain-containing protein 1	GO:0006629; P:lipid metabolic process; IEA:InterPro
Q0VAA5	PLCXD2	PI-PLC X domain-containing protein 2	GO:0008081; F:phosphoric diester hydrolase activity; IEA:InterPro
Q0VAA5	PLCXD2	PI-PLC X domain-containing protein 2	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
Q0VAA5	PLCXD2	PI-PLC X domain-containing protein 2	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q63HM9	PLCXD3	PI-PLC X domain-containing protein 3	GO:0008081; F:phosphoric diester hydrolase activity; IEA:InterPro
Q63HM9	PLCXD3	PI-PLC X domain-containing protein 3	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
Q63HM9	PLCXD3	PI-PLC X domain-containing protein 3	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q86YW0	PLCZ1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase zeta-1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q86YW0	PLCZ1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase zeta-1	GO:0004435; F:phosphatidylinositol phospholipase C activity; IEA:UniProtKB-EC
Q86YW0	PLCZ1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase zeta-1	GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW
Q86YW0	PLCZ1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase zeta-1	GO:0006816; P:calcium ion transport; IEA:Ensembl
Q86YW0	PLCZ1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase zeta-1	GO:0007343; P:egg activation; IEA:Ensembl
Q86YW0	PLCZ1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase zeta-1	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q86YW0	PLCZ1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase zeta-1	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q86YW0	PLCZ1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase zeta-1	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q86YW0	PLCZ1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase zeta-1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q86YW0	PLCZ1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase zeta-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q13393	PLD1	Phospholipase D1	GO:0070290; F:NAPE-specific phospholipase D activity; IEA:UniProtKB-EC
Q13393	PLD1	Phospholipase D1	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
Q13393	PLD1	Phospholipase D1	GO:0004630; F:phospholipase D activity; TAS:ProtInc
Q13393	PLD1	Phospholipase D1	GO:0005515; F:protein binding; IPI:IntAct
Q13393	PLD1	Phospholipase D1	GO:0006935; P:chemotaxis; TAS:ProtInc
Q13393	PLD1	Phospholipase D1	GO:0050830; P:defense response to Gram-positive bacterium; IEA:Ensembl
Q13393	PLD1	Phospholipase D1	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q13393	PLD1	Phospholipase D1	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q13393	PLD1	Phospholipase D1	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
Q13393	PLD1	Phospholipase D1	GO:0006655; P:phosphatidylglycerol biosynthetic process; TAS:Reactome
Q13393	PLD1	Phospholipase D1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q13393	PLD1	Phospholipase D1	GO:0007265; P:Ras protein signal transduction; TAS:ProtInc
Q13393	PLD1	Phospholipase D1	GO:0007264; P:small GTPase mediated signal transduction; TAS:ProtInc
Q13393	PLD1	Phospholipase D1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O14939	PLD2	Phospholipase D2	GO:0003824; F:catalytic activity; IEA:InterPro
O14939	PLD2	Phospholipase D2	GO:0070290; F:NAPE-specific phospholipase D activity; IEA:UniProtKB-EC
O14939	PLD2	Phospholipase D2	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
O14939	PLD2	Phospholipase D2	GO:0004630; F:phospholipase D activity; TAS:ProtInc
O14939	PLD2	Phospholipase D2	GO:0005515; F:protein binding; IPI:IntAct
O14939	PLD2	Phospholipase D2	GO:0007010; P:cytoskeleton organization; TAS:ProtInc
O14939	PLD2	Phospholipase D2	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
O14939	PLD2	Phospholipase D2	GO:0002031; P:G-protein coupled receptor internalization; IEA:Ensembl
O14939	PLD2	Phospholipase D2	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
O14939	PLD2	Phospholipase D2	GO:0045087; P:innate immune response; TAS:Reactome
O14939	PLD2	Phospholipase D2	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
O14939	PLD2	Phospholipase D2	GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome
O14939	PLD2	Phospholipase D2	GO:0006655; P:phosphatidylglycerol biosynthetic process; TAS:Reactome
O14939	PLD2	Phospholipase D2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
O14939	PLD2	Phospholipase D2	GO:0007264; P:small GTPase mediated signal transduction; TAS:ProtInc
O14939	PLD2	Phospholipase D2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8IV08	PLD3	Phospholipase D3	GO:0070290; F:NAPE-specific phospholipase D activity; IEA:UniProtKB-EC
Q8IV08	PLD3	Phospholipase D3	GO:0004630; F:phospholipase D activity; TAS:ProtInc
Q8IV08	PLD3	Phospholipase D3	GO:0005515; F:protein binding; IPI:IntAct
Q8IV08	PLD3	Phospholipase D3	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q8IV08	PLD3	Phospholipase D3	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q8IV08	PLD3	Phospholipase D3	GO:0006655; P:phosphatidylglycerol biosynthetic process; TAS:Reactome
Q8IV08	PLD3	Phospholipase D3	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q8IV08	PLD3	Phospholipase D3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96BZ4	PLD4	Phospholipase D4	GO:0070290; F:NAPE-specific phospholipase D activity; IEA:UniProtKB-EC
Q96BZ4	PLD4	Phospholipase D4	GO:0004435; F:phosphatidylinositol phospholipase C activity; TAS:Reactome
Q96BZ4	PLD4	Phospholipase D4	GO:0004630; F:phospholipase D activity; IEA:UniProtKB-EC
Q96BZ4	PLD4	Phospholipase D4	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q96BZ4	PLD4	Phospholipase D4	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q96BZ4	PLD4	Phospholipase D4	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q96BZ4	PLD4	Phospholipase D4	GO:0006655; P:phosphatidylglycerol biosynthetic process; TAS:Reactome
Q96BZ4	PLD4	Phospholipase D4	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q96BZ4	PLD4	Phospholipase D4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8N7P1	PLD5	Inactive phospholipase D5	GO:0003824; F:catalytic activity; IEA:InterPro
Q8N2A8	PLD6	Mitochondrial cardiolipin hydrolase	GO:0035755; F:cardiolipin hydrolase activity; IDA:UniProtKB
Q8N2A8	PLD6	Mitochondrial cardiolipin hydrolase	GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW
Q8N2A8	PLD6	Mitochondrial cardiolipin hydrolase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N2A8	PLD6	Mitochondrial cardiolipin hydrolase	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q8N2A8	PLD6	Mitochondrial cardiolipin hydrolase	GO:0043046; P:DNA methylation involved in gamete generation; ISS:UniProtKB
Q8N2A8	PLD6	Mitochondrial cardiolipin hydrolase	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q8N2A8	PLD6	Mitochondrial cardiolipin hydrolase	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q8N2A8	PLD6	Mitochondrial cardiolipin hydrolase	GO:0007126; P:meiotic nuclear division; ISS:UniProtKB
Q8N2A8	PLD6	Mitochondrial cardiolipin hydrolase	GO:0008053; P:mitochondrial fusion; IMP:UniProtKB
Q8N2A8	PLD6	Mitochondrial cardiolipin hydrolase	GO:0030719; P:P granule organization; ISS:UniProtKB
Q8N2A8	PLD6	Mitochondrial cardiolipin hydrolase	GO:0006655; P:phosphatidylglycerol biosynthetic process; TAS:Reactome
Q8N2A8	PLD6	Mitochondrial cardiolipin hydrolase	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q8N2A8	PLD6	Mitochondrial cardiolipin hydrolase	GO:0034587; P:piRNA metabolic process; ISS:UniProtKB
Q8N2A8	PLD6	Mitochondrial cardiolipin hydrolase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8N2A8	PLD6	Mitochondrial cardiolipin hydrolase	GO:0007286; P:spermatid development; ISS:UniProtKB
Q8IUK5	PLXDC1	Plexin domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IUK5	PLXDC1	Plexin domain-containing protein 1	GO:0004872; F:receptor activity; IEA:InterPro
Q8IUK5	PLXDC1	Plexin domain-containing protein 1	GO:0001525; P:angiogenesis; NAS:UniProtKB
Q8IUK5	PLXDC1	Plexin domain-containing protein 1	GO:0021510; P:spinal cord development; IEA:Ensembl
Q15149	PLEC	Plectin	GO:0030506; F:ankyrin binding; IPI:BHF-UCL
Q15149	PLEC	Plectin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15149	PLEC	Plectin	GO:0005515; F:protein binding; IPI:UniProtKB
Q15149	PLEC	Plectin	GO:0008307; F:structural constituent of muscle; IMP:UniProtKB
Q15149	PLEC	Plectin	GO:0006915; P:apoptotic process; TAS:Reactome
Q15149	PLEC	Plectin	GO:0034329; P:cell junction assembly; TAS:Reactome
Q15149	PLEC	Plectin	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q15149	PLEC	Plectin	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q15149	PLEC	Plectin	GO:0031581; P:hemidesmosome assembly; IDA:UniProtKB
Q9NYT0	PLEK2	Pleckstrin-2	GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc
Q9NYT0	PLEK2	Pleckstrin-2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P08567	PLEK	Pleckstrin	GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; IDA:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0005515; F:protein binding; IPI:IntAct
P08567	PLEK	Pleckstrin	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0005080; F:protein kinase C binding; IDA:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0031532; P:actin cytoskeleton reorganization; IDA:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0007596; P:blood coagulation; TAS:Reactome
P08567	PLEK	Pleckstrin	GO:0030030; P:cell projection organization; IDA:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0030866; P:cortical actin cytoskeleton organization; IDA:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0002244; P:hematopoietic progenitor cell differentiation; IEP:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0007229; P:integrin-mediated signaling pathway; IDA:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0050849; P:negative regulation of calcium-mediated signaling; NAS:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0045744; P:negative regulation of G-protein coupled receptor protein signaling pathway; IDA:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0010920; P:negative regulation of inositol phosphate biosynthetic process; IDA:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0046488; P:phosphatidylinositol metabolic process; IDA:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0030845; P:phospholipase C-inhibiting G-protein coupled receptor signaling pathway; IDA:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0030168; P:platelet activation; TAS:Reactome
P08567	PLEK	Pleckstrin	GO:0070527; P:platelet aggregation; ISS:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0002576; P:platelet degranulation; IEP:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0032233; P:positive regulation of actin filament bundle assembly; IDA:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0030836; P:positive regulation of actin filament depolymerization; IDA:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0010925; P:positive regulation of inositol-polyphosphate 5-phosphatase activity; IDA:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0033625; P:positive regulation of integrin activation; ISS:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0010572; P:positive regulation of platelet activation; ISS:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0070528; P:protein kinase C signaling; ISS:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0070560; P:protein secretion by platelet; ISS:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0060305; P:regulation of cell diameter; IDA:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0031529; P:ruffle organization; IDA:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0070493; P:thrombin receptor signaling pathway; IDA:BHF-UCL
P08567	PLEK	Pleckstrin	GO:0006904; P:vesicle docking involved in exocytosis; ISS:BHF-UCL
Q6UQ28	PLET1	Placenta-expressed transcript 1 protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q6UQ28	PLET1	Placenta-expressed transcript 1 protein	GO:0001953; P:negative regulation of cell-matrix adhesion; ISS:UniProtKB
Q6UQ28	PLET1	Placenta-expressed transcript 1 protein	GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB
Q6UQ28	PLET1	Placenta-expressed transcript 1 protein	GO:0035313; P:wound healing, spreading of epidermal cells; ISS:UniProtKB
P02776	PF4	Platelet factor 4	GO:0008009; F:chemokine activity; TAS:UniProtKB
P02776	PF4	Platelet factor 4	GO:0048248; F:CXCR3 chemokine receptor binding; IDA:UniProtKB
P02776	PF4	Platelet factor 4	GO:0008201; F:heparin binding; IDA:UniProtKB
P02776	PF4	Platelet factor 4	GO:0007596; P:blood coagulation; TAS:Reactome
P02776	PF4	Platelet factor 4	GO:0019221; P:cytokine-mediated signaling pathway; IDA:UniProtKB
P02776	PF4	Platelet factor 4	GO:0006955; P:immune response; IEA:InterPro
P02776	PF4	Platelet factor 4	GO:0030595; P:leukocyte chemotaxis; IDA:UniProtKB
P02776	PF4	Platelet factor 4	GO:0016525; P:negative regulation of angiogenesis; IDA:UniProtKB
P02776	PF4	Platelet factor 4	GO:0045918; P:negative regulation of cytolysis; IDA:BHF-UCL
P02776	PF4	Platelet factor 4	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IDA:BHF-UCL
P02776	PF4	Platelet factor 4	GO:0045653; P:negative regulation of megakaryocyte differentiation; IDA:UniProtKB
P02776	PF4	Platelet factor 4	GO:0045347; P:negative regulation of MHC class II biosynthetic process; IDA:BHF-UCL
P02776	PF4	Platelet factor 4	GO:0030168; P:platelet activation; IDA:UniProtKB
P02776	PF4	Platelet factor 4	GO:0002576; P:platelet degranulation; TAS:Reactome
P02776	PF4	Platelet factor 4	GO:0030816; P:positive regulation of cAMP metabolic process; IDA:UniProtKB
P02776	PF4	Platelet factor 4	GO:0043950; P:positive regulation of cAMP-mediated signaling; IDA:UniProtKB
P02776	PF4	Platelet factor 4	GO:0010628; P:positive regulation of gene expression; IDA:BHF-UCL
P02776	PF4	Platelet factor 4	GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; IDA:BHF-UCL
P02776	PF4	Platelet factor 4	GO:0045651; P:positive regulation of macrophage differentiation; IDA:BHF-UCL
P02776	PF4	Platelet factor 4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P02776	PF4	Platelet factor 4	GO:0032760; P:positive regulation of tumor necrosis factor production; IDA:BHF-UCL
P02776	PF4	Platelet factor 4	GO:0042127; P:regulation of cell proliferation; IDA:UniProtKB
P49763	PGF	Placenta growth factor	GO:0008083; F:growth factor activity; IMP:UniProtKB
P49763	PGF	Placenta growth factor	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P49763	PGF	Placenta growth factor	GO:0005515; F:protein binding; IPI:IntAct
P49763	PGF	Placenta growth factor	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
P49763	PGF	Placenta growth factor	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P49763	PGF	Placenta growth factor	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P49763	PGF	Placenta growth factor	GO:0032870; P:cellular response to hormone stimulus; IEA:Ensembl
P49763	PGF	Placenta growth factor	GO:0007565; P:female pregnancy; IEA:Ensembl
P49763	PGF	Placenta growth factor	GO:0031100; P:organ regeneration; IEA:Ensembl
P49763	PGF	Placenta growth factor	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
P49763	PGF	Placenta growth factor	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P49763	PGF	Placenta growth factor	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
P49763	PGF	Placenta growth factor	GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl
P49763	PGF	Placenta growth factor	GO:0060688; P:regulation of morphogenesis of a branching structure; IEA:Ensembl
P49763	PGF	Placenta growth factor	GO:0042493; P:response to drug; IEA:Ensembl
P49763	PGF	Placenta growth factor	GO:0001666; P:response to hypoxia; IEA:Ensembl
P49763	PGF	Placenta growth factor	GO:0007165; P:signal transduction; TAS:ProtInc
P49763	PGF	Placenta growth factor	GO:0002040; P:sprouting angiogenesis; IEA:Ensembl
P49763	PGF	Placenta growth factor	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; TAS:Reactome
O60240	PLIN1	Perilipin-1	GO:0008289; F:lipid binding; NAS:UniProtKB
O60240	PLIN1	Perilipin-1	GO:0006629; P:lipid metabolic process; NAS:UniProtKB
O60240	PLIN1	Perilipin-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60240	PLIN1	Perilipin-1	GO:0019433; P:triglyceride catabolic process; TAS:Reactome
Q99541	PLIN2	Perilipin-2	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q99541	PLIN2	Perilipin-2	GO:0019915; P:lipid storage; IEA:Ensembl
Q99541	PLIN2	Perilipin-2	GO:0015909; P:long-chain fatty acid transport; IEA:Ensembl
Q99541	PLIN2	Perilipin-2	GO:0042493; P:response to drug; IEA:Ensembl
Q99541	PLIN2	Perilipin-2	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
Q99541	PLIN2	Perilipin-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60664	PLIN3	Perilipin-3	GO:0005515; F:protein binding; IPI:UniProtKB
O60664	PLIN3	Perilipin-3	GO:0016192; P:vesicle-mediated transport; TAS:ProtInc
Q00G26	PLIN5	Perilipin-5	GO:0034389; P:lipid particle organization; ISS:UniProtKB
Q00G26	PLIN5	Perilipin-5	GO:0031999; P:negative regulation of fatty acid beta-oxidation; ISS:UniProtKB
Q00G26	PLIN5	Perilipin-5	GO:0060192; P:negative regulation of lipase activity; ISS:UniProtKB
Q00G26	PLIN5	Perilipin-5	GO:0035359; P:negative regulation of peroxisome proliferator activated receptor signaling pathway; ISS:UniProtKB
Q00G26	PLIN5	Perilipin-5	GO:2000378; P:negative regulation of reactive oxygen species metabolic process; ISS:UniProtKB
Q00G26	PLIN5	Perilipin-5	GO:0010897; P:negative regulation of triglyceride catabolic process; ISS:UniProtKB
Q00G26	PLIN5	Perilipin-5	GO:0032000; P:positive regulation of fatty acid beta-oxidation; ISS:UniProtKB
Q00G26	PLIN5	Perilipin-5	GO:0060193; P:positive regulation of lipase activity; ISS:UniProtKB
Q00G26	PLIN5	Perilipin-5	GO:0010884; P:positive regulation of lipid storage; ISS:UniProtKB
Q00G26	PLIN5	Perilipin-5	GO:0010890; P:positive regulation of sequestering of triglyceride; ISS:UniProtKB
Q00G26	PLIN5	Perilipin-5	GO:0010867; P:positive regulation of triglyceride biosynthetic process; ISS:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0010997; F:anaphase-promoting complex binding; IPI:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0016301; F:kinase activity; TAS:Reactome
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0008017; F:microtubule binding; IDA:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0005515; F:protein binding; IPI:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0004672; F:protein kinase activity; IDA:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0007092; P:activation of mitotic anaphase-promoting complex activity; IDA:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0008283; P:cell proliferation; TAS:ProtInc
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0051297; P:centrosome organization; IMP:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0000910; P:cytokinesis; IDA:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0045184; P:establishment of protein localization; IMP:MGI
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0031572; P:G2 DNA damage checkpoint; IDA:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0000086; P:G2/M transition of mitotic cell cycle; IDA:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0007091; P:metaphase/anaphase transition of mitotic cell cycle; TAS:Reactome
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0001578; P:microtubule bundle formation; IDA:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0007067; P:mitosis; IDA:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0000281; P:mitotic cytokinesis; IDA:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0000070; P:mitotic sister chromatid segregation; IMP:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0007094; P:mitotic spindle assembly checkpoint; IMP:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IMP:BHF-UCL
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0040038; P:polar body extrusion after meiotic divisions; IEA:Ensembl
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IMP:BHF-UCL
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0045862; P:positive regulation of proteolysis; IDA:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0051443; P:positive regulation of ubiquitin-protein ligase activity; IMP:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0031648; P:protein destabilization; IDA:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0071168; P:protein localization to chromatin; IDA:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0051726; P:regulation of cell cycle; TAS:Reactome
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0007346; P:regulation of mitotic cell cycle; IMP:UniProtKB
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0030071; P:regulation of mitotic metaphase/anaphase transition; IMP:BHF-UCL
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0043393; P:regulation of protein binding; IMP:BHF-UCL
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P53350	PLK1	Serine/threonine-protein kinase PLK1	GO:0046677; P:response to antibiotic; IEA:Ensembl
Q9NYY3	PLK2	Serine/threonine-protein kinase PLK2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NYY3	PLK2	Serine/threonine-protein kinase PLK2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NYY3	PLK2	Serine/threonine-protein kinase PLK2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9NYY3	PLK2	Serine/threonine-protein kinase PLK2	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q9NYY3	PLK2	Serine/threonine-protein kinase PLK2	GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:UniProtKB
Q9NYY3	PLK2	Serine/threonine-protein kinase PLK2	GO:0060292; P:long term synaptic depression; ISS:UniProtKB
Q9NYY3	PLK2	Serine/threonine-protein kinase PLK2	GO:0060291; P:long-term synaptic potentiation; ISS:UniProtKB
Q9NYY3	PLK2	Serine/threonine-protein kinase PLK2	GO:0007613; P:memory; ISS:UniProtKB
Q9NYY3	PLK2	Serine/threonine-protein kinase PLK2	GO:0007093; P:mitotic cell cycle checkpoint; ISS:UniProtKB
Q9NYY3	PLK2	Serine/threonine-protein kinase PLK2	GO:0007052; P:mitotic spindle organization; IDA:UniProtKB
Q9NYY3	PLK2	Serine/threonine-protein kinase PLK2	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB
Q9NYY3	PLK2	Serine/threonine-protein kinase PLK2	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q9NYY3	PLK2	Serine/threonine-protein kinase PLK2	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q9NYY3	PLK2	Serine/threonine-protein kinase PLK2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9NYY3	PLK2	Serine/threonine-protein kinase PLK2	GO:0032486; P:Rap protein signal transduction; ISS:UniProtKB
Q9NYY3	PLK2	Serine/threonine-protein kinase PLK2	GO:0007265; P:Ras protein signal transduction; ISS:UniProtKB
Q9NYY3	PLK2	Serine/threonine-protein kinase PLK2	GO:0046599; P:regulation of centriole replication; IDA:UniProtKB
Q9NYY3	PLK2	Serine/threonine-protein kinase PLK2	GO:0048167; P:regulation of synaptic plasticity; ISS:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0002039; F:p53 binding; IDA:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0006915; P:apoptotic process; TAS:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0000075; P:cell cycle checkpoint; ISS:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0000910; P:cytokinesis; TAS:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0031122; P:cytoplasmic microtubule organization; IMP:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0007113; P:endomitotic cell cycle; TAS:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0090166; P:Golgi disassembly; IDA:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0007093; P:mitotic cell cycle checkpoint; TAS:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0000084; P:mitotic S phase; IMP:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0090316; P:positive regulation of intracellular protein transport; IMP:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:2000777; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia; IDA:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0043491; P:protein kinase B signaling; ISS:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0051302; P:regulation of cell division; IDA:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0006970; P:response to osmotic stress; IDA:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0009314; P:response to radiation; IDA:UniProtKB
Q9H4B4	PLK3	Serine/threonine-protein kinase PLK3	GO:0000302; P:response to reactive oxygen species; IDA:UniProtKB
O00444	PLK4	Serine/threonine-protein kinase PLK4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O00444	PLK4	Serine/threonine-protein kinase PLK4	GO:0005515; F:protein binding; IPI:UniProtKB
O00444	PLK4	Serine/threonine-protein kinase PLK4	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
O00444	PLK4	Serine/threonine-protein kinase PLK4	GO:0004713; F:protein tyrosine kinase activity; IEA:InterPro
O00444	PLK4	Serine/threonine-protein kinase PLK4	GO:0007099; P:centriole replication; IMP:UniProtKB
O00444	PLK4	Serine/threonine-protein kinase PLK4	GO:0098535; P:de novo centriole assembly; ISS:UniProtKB
O00444	PLK4	Serine/threonine-protein kinase PLK4	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
O00444	PLK4	Serine/threonine-protein kinase PLK4	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O00444	PLK4	Serine/threonine-protein kinase PLK4	GO:0046601; P:positive regulation of centriole replication; IMP:UniProtKB
O00444	PLK4	Serine/threonine-protein kinase PLK4	GO:0006468; P:protein phosphorylation; TAS:ProtInc
O00444	PLK4	Serine/threonine-protein kinase PLK4	GO:0060707; P:trophoblast giant cell differentiation; ISS:UniProtKB
Q9Y342	PLLP	Plasmolipin	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q9Y342	PLLP	Plasmolipin	GO:0042552; P:myelination; IEA:Ensembl
Q9Y342	PLLP	Plasmolipin	GO:0009611; P:response to wounding; IEA:Ensembl
Q496M5	PLK5	Inactive serine/threonine-protein kinase PLK5	GO:0005524; F:ATP binding; IEA:InterPro
Q496M5	PLK5	Inactive serine/threonine-protein kinase PLK5	GO:0004672; F:protein kinase activity; IEA:InterPro
Q496M5	PLK5	Inactive serine/threonine-protein kinase PLK5	GO:0071363; P:cellular response to growth factor stimulus; IDA:UniProtKB
Q496M5	PLK5	Inactive serine/threonine-protein kinase PLK5	GO:0002357; P:defense response to tumor cell; IDA:UniProtKB
Q496M5	PLK5	Inactive serine/threonine-protein kinase PLK5	GO:0031572; P:G2 DNA damage checkpoint; IMP:UniProtKB
Q496M5	PLK5	Inactive serine/threonine-protein kinase PLK5	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q496M5	PLK5	Inactive serine/threonine-protein kinase PLK5	GO:0010976; P:positive regulation of neuron projection development; IDA:UniProtKB
Q496M5	PLK5	Inactive serine/threonine-protein kinase PLK5	GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; IMP:UniProtKB
Q496M5	PLK5	Inactive serine/threonine-protein kinase PLK5	GO:0006927; P:transformed cell apoptotic process; IMP:UniProtKB
P00747	PLG	Plasminogen	GO:0034185; F:apolipoprotein binding; IPI:BHF-UCL
P00747	PLG	Plasminogen	GO:0005515; F:protein binding; IPI:UniProtKB
P00747	PLG	Plasminogen	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P00747	PLG	Plasminogen	GO:0004252; F:serine-type endopeptidase activity; IDA:BHF-UCL
P00747	PLG	Plasminogen	GO:0007596; P:blood coagulation; IMP:HGNC
P00747	PLG	Plasminogen	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P00747	PLG	Plasminogen	GO:0022617; P:extracellular matrix disassembly; IDA:BHF-UCL
P00747	PLG	Plasminogen	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P00747	PLG	Plasminogen	GO:0042730; P:fibrinolysis; TAS:Reactome
P00747	PLG	Plasminogen	GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl
P00747	PLG	Plasminogen	GO:0071674; P:mononuclear cell migration; IEA:Ensembl
P00747	PLG	Plasminogen	GO:0046716; P:muscle cell cellular homeostasis; IEA:Ensembl
P00747	PLG	Plasminogen	GO:0045445; P:myoblast differentiation; IEA:Ensembl
P00747	PLG	Plasminogen	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P00747	PLG	Plasminogen	GO:2000048; P:negative regulation of cell-cell adhesion mediated by cadherin; TAS:BHF-UCL
P00747	PLG	Plasminogen	GO:0010812; P:negative regulation of cell-substrate adhesion; IDA:BHF-UCL
P00747	PLG	Plasminogen	GO:0051918; P:negative regulation of fibrinolysis; IDA:BHF-UCL
P00747	PLG	Plasminogen	GO:0030168; P:platelet activation; TAS:Reactome
P00747	PLG	Plasminogen	GO:0002576; P:platelet degranulation; TAS:Reactome
P00747	PLG	Plasminogen	GO:0051919; P:positive regulation of fibrinolysis; IDA:BHF-UCL
P00747	PLG	Plasminogen	GO:0051603; P:proteolysis involved in cellular protein catabolic process; IEA:Ensembl
P00747	PLG	Plasminogen	GO:0042246; P:tissue regeneration; IEA:Ensembl
P00747	PLG	Plasminogen	GO:0048771; P:tissue remodeling; IEA:UniProtKB-KW
P00747	PLG	Plasminogen	GO:0060707; P:trophoblast giant cell differentiation; IEA:Ensembl
O00168	FXYD1	Phospholemman	GO:0005254; F:chloride channel activity; TAS:ProtInc
O00168	FXYD1	Phospholemman	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
O00168	FXYD1	Phospholemman	GO:1902476; P:chloride transmembrane transport; TAS:GOC
O00168	FXYD1	Phospholemman	GO:0006821; P:chloride transport; TAS:ProtInc
O00168	FXYD1	Phospholemman	GO:0034220; P:ion transmembrane transport; TAS:Reactome
O00168	FXYD1	Phospholemman	GO:0006936; P:muscle contraction; TAS:ProtInc
O00168	FXYD1	Phospholemman	GO:0055085; P:transmembrane transport; TAS:Reactome
Q02809	PLOD1	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1	GO:0005506; F:iron ion binding; IEA:InterPro
Q02809	PLOD1	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1	GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW
Q02809	PLOD1	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1	GO:0008475; F:procollagen-lysine 5-dioxygenase activity; IEA:UniProtKB-EC
Q02809	PLOD1	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1	GO:0042803; F:protein homodimerization activity; TAS:UniProtKB
Q02809	PLOD1	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1	GO:0006464; P:cellular protein modification process; NAS:UniProtKB
Q02809	PLOD1	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1	GO:0008544; P:epidermis development; IMP:UniProtKB
Q02809	PLOD1	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q02809	PLOD1	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1	GO:0046947; P:hydroxylysine biosynthetic process; TAS:UniProtKB
Q02809	PLOD1	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1	GO:0055114; P:oxidation-reduction process; TAS:UniProtKB
Q02809	PLOD1	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1	GO:0001666; P:response to hypoxia; IEP:UniProtKB
O60568	PLOD3	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	GO:0005506; F:iron ion binding; IEA:InterPro
O60568	PLOD3	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW
O60568	PLOD3	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	GO:0050211; F:procollagen galactosyltransferase activity; TAS:Reactome
O60568	PLOD3	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	GO:0033823; F:procollagen glucosyltransferase activity; TAS:Reactome
O60568	PLOD3	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	GO:0008475; F:procollagen-lysine 5-dioxygenase activity; TAS:ProtInc
O60568	PLOD3	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	GO:0005515; F:protein binding; IPI:IntAct
O60568	PLOD3	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	GO:0070831; P:basement membrane assembly; IEA:Ensembl
O60568	PLOD3	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	GO:0006464; P:cellular protein modification process; TAS:ProtInc
O60568	PLOD3	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	GO:0032870; P:cellular response to hormone stimulus; IEA:Ensembl
O60568	PLOD3	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	GO:0030199; P:collagen fibril organization; IEA:Ensembl
O60568	PLOD3	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	GO:0001886; P:endothelial cell morphogenesis; IEA:Ensembl
O60568	PLOD3	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	GO:0048730; P:epidermis morphogenesis; IEA:Ensembl
O60568	PLOD3	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O60568	PLOD3	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O60568	PLOD3	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	GO:0060425; P:lung morphogenesis; IEA:Ensembl
O60568	PLOD3	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	GO:0021915; P:neural tube development; IEA:Ensembl
O60568	PLOD3	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	GO:0008104; P:protein localization; IEA:Ensembl
O60568	PLOD3	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	GO:0042311; P:vasodilation; IEA:Ensembl
O00469	PLOD2	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2	GO:0005506; F:iron ion binding; IEA:InterPro
O00469	PLOD2	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2	GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW
O00469	PLOD2	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2	GO:0008475; F:procollagen-lysine 5-dioxygenase activity; TAS:ProtInc
O00469	PLOD2	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2	GO:0006464; P:cellular protein modification process; TAS:ProtInc
O00469	PLOD2	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O00469	PLOD2	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2	GO:0001666; P:response to hypoxia; IEP:UniProtKB
Q04941	PLP2	Proteolipid protein 2	GO:0019956; F:chemokine binding; IPI:UniProtKB
Q04941	PLP2	Proteolipid protein 2	GO:0015075; F:ion transmembrane transporter activity; TAS:ProtInc
Q04941	PLP2	Proteolipid protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q04941	PLP2	Proteolipid protein 2	GO:0006935; P:chemotaxis; NAS:UniProtKB
Q04941	PLP2	Proteolipid protein 2	GO:0019221; P:cytokine-mediated signaling pathway; NAS:UniProtKB
Q04941	PLP2	Proteolipid protein 2	GO:0034220; P:ion transmembrane transport; TAS:GOC
Q04941	PLP2	Proteolipid protein 2	GO:0006811; P:ion transport; TAS:ProtInc
Q8N8W4	PNPLA1	Patatin-like phospholipase domain-containing protein 1	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q8N8W4	PNPLA1	Patatin-like phospholipase domain-containing protein 1	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q96AD5	PNPLA2	Patatin-like phospholipase domain-containing protein 2	GO:0004806; F:triglyceride lipase activity; ISS:UniProtKB
Q96AD5	PNPLA2	Patatin-like phospholipase domain-containing protein 2	GO:0036155; P:acylglycerol acyl-chain remodeling; TAS:Reactome
Q96AD5	PNPLA2	Patatin-like phospholipase domain-containing protein 2	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q96AD5	PNPLA2	Patatin-like phospholipase domain-containing protein 2	GO:0010891; P:negative regulation of sequestering of triglyceride; IDA:UniProtKB
Q96AD5	PNPLA2	Patatin-like phospholipase domain-containing protein 2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q96AD5	PNPLA2	Patatin-like phospholipase domain-containing protein 2	GO:0010898; P:positive regulation of triglyceride catabolic process; IDA:UniProtKB
Q96AD5	PNPLA2	Patatin-like phospholipase domain-containing protein 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96AD5	PNPLA2	Patatin-like phospholipase domain-containing protein 2	GO:0019433; P:triglyceride catabolic process; IEA:UniProtKB-UniPathway
Q9NST1	PNPLA3	Patatin-like phospholipase domain-containing protein 3	GO:0051265; F:diolein transacylation activity; IDA:UniProtKB
Q9NST1	PNPLA3	Patatin-like phospholipase domain-containing protein 3	GO:0051264; F:mono-olein transacylation activity; IDA:UniProtKB
Q9NST1	PNPLA3	Patatin-like phospholipase domain-containing protein 3	GO:0004623; F:phospholipase A2 activity; IDA:UniProtKB
Q9NST1	PNPLA3	Patatin-like phospholipase domain-containing protein 3	GO:0004806; F:triglyceride lipase activity; IDA:UniProtKB
Q9NST1	PNPLA3	Patatin-like phospholipase domain-containing protein 3	GO:0036155; P:acylglycerol acyl-chain remodeling; TAS:Reactome
Q9NST1	PNPLA3	Patatin-like phospholipase domain-containing protein 3	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9NST1	PNPLA3	Patatin-like phospholipase domain-containing protein 3	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9NST1	PNPLA3	Patatin-like phospholipase domain-containing protein 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NST1	PNPLA3	Patatin-like phospholipase domain-containing protein 3	GO:0019432; P:triglyceride biosynthetic process; IDA:UniProtKB
Q9NST1	PNPLA3	Patatin-like phospholipase domain-containing protein 3	GO:0019433; P:triglyceride catabolic process; IDA:UniProtKB
Q7Z6Z6	PNPLA5	Patatin-like phospholipase domain-containing protein 5	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q7Z6Z6	PNPLA5	Patatin-like phospholipase domain-containing protein 5	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q6ZV29	PNPLA7	Patatin-like phospholipase domain-containing protein 7	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q6ZV29	PNPLA7	Patatin-like phospholipase domain-containing protein 7	GO:0006629; P:lipid metabolic process; IEA:InterPro
P41247	PNPLA4	Patatin-like phospholipase domain-containing protein 4	GO:0004806; F:triglyceride lipase activity; IEA:UniProtKB-EC
P41247	PNPLA4	Patatin-like phospholipase domain-containing protein 4	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q8IY17	PNPLA6	Neuropathy target esterase	GO:0004622; F:lysophospholipase activity; IEA:UniProtKB-EC
Q8IY17	PNPLA6	Neuropathy target esterase	GO:0001525; P:angiogenesis; IEA:Ensembl
Q8IY17	PNPLA6	Neuropathy target esterase	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q8IY17	PNPLA6	Neuropathy target esterase	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
Q8IY17	PNPLA6	Neuropathy target esterase	GO:0009887; P:organ morphogenesis; IEA:Ensembl
Q8IY17	PNPLA6	Neuropathy target esterase	GO:0046470; P:phosphatidylcholine metabolic process; IEA:InterPro
Q9NP80	PNPLA8	Calcium-independent phospholipase A2-gamma	GO:0005524; F:ATP binding; NAS:UniProtKB
Q9NP80	PNPLA8	Calcium-independent phospholipase A2-gamma	GO:0047499; F:calcium-independent phospholipase A2 activity; IDA:UniProtKB
Q9NP80	PNPLA8	Calcium-independent phospholipase A2-gamma	GO:0004622; F:lysophospholipase activity; IEA:UniProtKB-EC
Q9NP80	PNPLA8	Calcium-independent phospholipase A2-gamma	GO:0019369; P:arachidonic acid metabolic process; IDA:UniProtKB
Q9NP80	PNPLA8	Calcium-independent phospholipase A2-gamma	GO:0050482; P:arachidonic acid secretion; IDA:UniProtKB
Q9NP80	PNPLA8	Calcium-independent phospholipase A2-gamma	GO:0008219; P:cell death; IDA:UniProtKB
Q9NP80	PNPLA8	Calcium-independent phospholipase A2-gamma	GO:0006631; P:fatty acid metabolic process; IDA:UniProtKB
Q9NP80	PNPLA8	Calcium-independent phospholipase A2-gamma	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9NP80	PNPLA8	Calcium-independent phospholipase A2-gamma	GO:0043651; P:linoleic acid metabolic process; IDA:UniProtKB
Q9NP80	PNPLA8	Calcium-independent phospholipase A2-gamma	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
Q9NP80	PNPLA8	Calcium-independent phospholipase A2-gamma	GO:0034638; P:phosphatidylcholine catabolic process; IDA:UniProtKB
Q9NP80	PNPLA8	Calcium-independent phospholipase A2-gamma	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
Q9NP80	PNPLA8	Calcium-independent phospholipase A2-gamma	GO:0046338; P:phosphatidylethanolamine catabolic process; IDA:UniProtKB
Q9NP80	PNPLA8	Calcium-independent phospholipase A2-gamma	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9NP80	PNPLA8	Calcium-independent phospholipase A2-gamma	GO:0001516; P:prostaglandin biosynthetic process; IDA:UniProtKB
Q9NP80	PNPLA8	Calcium-independent phospholipase A2-gamma	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0047499; F:calcium-independent phospholipase A2 activity; IEA:Ensembl
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0004623; F:phospholipase A2 activity; TAS:ProtInc
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0035965; P:cardiolipin acyl-chain remodeling; TAS:Reactome
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0032049; P:cardiolipin biosynthetic process; IMP:UniProtKB
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0008219; P:cell death; IEA:UniProtKB-KW
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0045087; P:innate immune response; TAS:Reactome
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0007613; P:memory; IEA:Ensembl
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0051967; P:negative regulation of synaptic transmission, glutamatergic; IEA:Ensembl
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0090238; P:positive regulation of arachidonic acid secretion; IEA:Ensembl
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:2000304; P:positive regulation of ceramide biosynthetic process; IEA:Ensembl
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0045921; P:positive regulation of exocytosis; IEA:Ensembl
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0090037; P:positive regulation of protein kinase C signaling; IEA:Ensembl
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IEA:Ensembl
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0045909; P:positive regulation of vasodilation; IEA:Ensembl
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:1901339; P:regulation of store-operated calcium channel activity; IEA:Ensembl
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0034976; P:response to endoplasmic reticulum stress; IEA:Ensembl
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60733	PLA2G6	85/88 kDa calcium-independent phospholipase A2	GO:0014832; P:urinary bladder smooth muscle contraction; IEA:Ensembl
Q96GD0	PDXP	Pyridoxal phosphate phosphatase	GO:0031072; F:heat shock protein binding; IDA:MGI
Q96GD0	PDXP	Pyridoxal phosphate phosphatase	GO:0000287; F:magnesium ion binding; ISS:UniProtKB
Q96GD0	PDXP	Pyridoxal phosphate phosphatase	GO:0004721; F:phosphoprotein phosphatase activity; IDA:UniProtKB
Q96GD0	PDXP	Pyridoxal phosphate phosphatase	GO:0004647; F:phosphoserine phosphatase activity; IEA:UniProtKB-EC
Q96GD0	PDXP	Pyridoxal phosphate phosphatase	GO:0005515; F:protein binding; IPI:IntAct
Q96GD0	PDXP	Pyridoxal phosphate phosphatase	GO:0033883; F:pyridoxal phosphatase activity; ISS:UniProtKB
Q96GD0	PDXP	Pyridoxal phosphate phosphatase	GO:0031247; P:actin rod assembly; IDA:MGI
Q96GD0	PDXP	Pyridoxal phosphate phosphatase	GO:0071318; P:cellular response to ATP; IDA:MGI
Q96GD0	PDXP	Pyridoxal phosphate phosphatase	GO:0030836; P:positive regulation of actin filament depolymerization; IMP:UniProtKB
Q96GD0	PDXP	Pyridoxal phosphate phosphatase	GO:0006470; P:protein dephosphorylation; IDA:UniProtKB
Q96GD0	PDXP	Pyridoxal phosphate phosphatase	GO:0032361; P:pyridoxal phosphate catabolic process; ISS:UniProtKB
Q96GD0	PDXP	Pyridoxal phosphate phosphatase	GO:0032465; P:regulation of cytokinesis; IMP:UniProtKB
Q96GD0	PDXP	Pyridoxal phosphate phosphatase	GO:0007088; P:regulation of mitosis; IMP:UniProtKB
O43660	PLRG1	Pleiotropic regulator 1	GO:0005515; F:protein binding; IPI:UniProtKB
O43660	PLRG1	Pleiotropic regulator 1	GO:0004871; F:signal transducer activity; TAS:ProtInc
O43660	PLRG1	Pleiotropic regulator 1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
O43660	PLRG1	Pleiotropic regulator 1	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
O43660	PLRG1	Pleiotropic regulator 1	GO:2001141; P:regulation of RNA biosynthetic process; TAS:GOC
O43660	PLRG1	Pleiotropic regulator 1	GO:0007165; P:signal transduction; TAS:GOC
Q9HBL7	PLGRKT	Plasminogen receptor (KT)	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
Q9HBL7	PLGRKT	Plasminogen receptor (KT)	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q9HBL7	PLGRKT	Plasminogen receptor (KT)	GO:0010756; P:positive regulation of plasminogen activation; IEA:Ensembl
O15162	PLSCR1	Phospholipid scramblase 1	GO:0005509; F:calcium ion binding; IDA:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:0042609; F:CD4 receptor binding; IPI:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O15162	PLSCR1	Phospholipid scramblase 1	GO:0019899; F:enzyme binding; IPI:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:0005154; F:epidermal growth factor receptor binding; IPI:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:0017128; F:phospholipid scramblase activity; IDA:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:0005515; F:protein binding; IPI:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:0017124; F:SH3 domain binding; IDA:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:0006953; P:acute-phase response; ISS:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:0006915; P:apoptotic process; IDA:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:0051607; P:defense response to virus; IMP:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:0045071; P:negative regulation of viral genome replication; IMP:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:0006659; P:phosphatidylserine biosynthetic process; ISS:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:0017121; P:phospholipid scrambling; IDA:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:0030168; P:platelet activation; NAS:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:2000373; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; IDA:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:0045089; P:positive regulation of innate immune response; IMP:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:0060368; P:regulation of Fc receptor mediated stimulatory signaling pathway; ISS:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:0033003; P:regulation of mast cell activation; ISS:UniProtKB
O15162	PLSCR1	Phospholipid scramblase 1	GO:0035456; P:response to interferon-beta; IMP:UniProtKB
Q9NRY7	PLSCR2	Phospholipid scramblase 2	GO:0005509; F:calcium ion binding; NAS:UniProtKB
Q9NRY7	PLSCR2	Phospholipid scramblase 2	GO:0017128; F:phospholipid scramblase activity; NAS:UniProtKB
Q9NRY7	PLSCR2	Phospholipid scramblase 2	GO:0017121; P:phospholipid scrambling; NAS:UniProtKB
Q9NRY6	PLSCR3	Phospholipid scramblase 3	GO:0005509; F:calcium ion binding; NAS:UniProtKB
Q9NRY6	PLSCR3	Phospholipid scramblase 3	GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB
Q9NRY6	PLSCR3	Phospholipid scramblase 3	GO:0017128; F:phospholipid scramblase activity; NAS:UniProtKB
Q9NRY6	PLSCR3	Phospholipid scramblase 3	GO:0005515; F:protein binding; IPI:IntAct
Q9NRY6	PLSCR3	Phospholipid scramblase 3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9NRY6	PLSCR3	Phospholipid scramblase 3	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
Q9NRY6	PLSCR3	Phospholipid scramblase 3	GO:0042632; P:cholesterol homeostasis; IEA:Ensembl
Q9NRY6	PLSCR3	Phospholipid scramblase 3	GO:0042593; P:glucose homeostasis; IEA:Ensembl
Q9NRY6	PLSCR3	Phospholipid scramblase 3	GO:0017121; P:phospholipid scrambling; NAS:UniProtKB
Q9NRQ2	PLSCR4	Phospholipid scramblase 4	GO:0005509; F:calcium ion binding; NAS:UniProtKB
Q9NRQ2	PLSCR4	Phospholipid scramblase 4	GO:0042609; F:CD4 receptor binding; IPI:UniProtKB
Q9NRQ2	PLSCR4	Phospholipid scramblase 4	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9NRQ2	PLSCR4	Phospholipid scramblase 4	GO:0017128; F:phospholipid scramblase activity; NAS:UniProtKB
Q9NRQ2	PLSCR4	Phospholipid scramblase 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NRQ2	PLSCR4	Phospholipid scramblase 4	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
Q9NRQ2	PLSCR4	Phospholipid scramblase 4	GO:0017121; P:phospholipid scrambling; NAS:UniProtKB
Q14651	PLS1	Plastin-1	GO:0051015; F:actin filament binding; TAS:ProtInc
Q14651	PLS1	Plastin-1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q14651	PLS1	Plastin-1	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P13796	LCP1	Plastin-2	GO:0003779; F:actin binding; NAS:UniProtKB
P13796	LCP1	Plastin-2	GO:0051015; F:actin filament binding; IMP:UniProt
P13796	LCP1	Plastin-2	GO:0005509; F:calcium ion binding; NAS:UniProtKB
P13796	LCP1	Plastin-2	GO:0051017; P:actin filament bundle assembly; IMP:UniProt
P13796	LCP1	Plastin-2	GO:0016477; P:cell migration; IMP:UniProt
P13796	LCP1	Plastin-2	GO:0031100; P:organ regeneration; IEA:Ensembl
P13796	LCP1	Plastin-2	GO:0010737; P:protein kinase A signaling; IMP:UniProt
P13796	LCP1	Plastin-2	GO:0033157; P:regulation of intracellular protein transport; IDA:UniProtKB
P13796	LCP1	Plastin-2	GO:0002286; P:T cell activation involved in immune response; IDA:UniProtKB
P13797	PLS3	Plastin-3	GO:0005509; F:calcium ion binding; IEA:InterPro
P13797	PLS3	Plastin-3	GO:0060348; P:bone development; IMP:UniProtKB
P55058	PLTP	Phospholipid transfer protein	GO:0008289; F:lipid binding; IEA:InterPro
P55058	PLTP	Phospholipid transfer protein	GO:0006629; P:lipid metabolic process; TAS:ProtInc
P55058	PLTP	Phospholipid transfer protein	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
P55058	PLTP	Phospholipid transfer protein	GO:0030317; P:sperm motility; IEA:Ensembl
P55058	PLTP	Phospholipid transfer protein	GO:0010189; P:vitamin E biosynthetic process; IEA:Ensembl
Q9BX97	PLVAP	Plasmalemma vesicle-associated protein	GO:0005515; F:protein binding; IPI:UniProt
Q9BX97	PLVAP	Plasmalemma vesicle-associated protein	GO:0000165; P:MAPK cascade; IDA:UniProt
Q9BX97	PLVAP	Plasmalemma vesicle-associated protein	GO:0002693; P:positive regulation of cellular extravasation; IMP:UniProt
Q9BX97	PLVAP	Plasmalemma vesicle-associated protein	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IDA:UniProt
Q9UIW2	PLXNA1	Plexin-A1	GO:0004872; F:receptor activity; TAS:UniProtKB
Q9UIW2	PLXNA1	Plexin-A1	GO:0017154; F:semaphorin receptor activity; TAS:UniProtKB
Q9UIW2	PLXNA1	Plexin-A1	GO:0007411; P:axon guidance; TAS:Reactome
Q9UIW2	PLXNA1	Plexin-A1	GO:0060666; P:dichotomous subdivision of terminal units involved in salivary gland branching; IEA:Ensembl
Q9UIW2	PLXNA1	Plexin-A1	GO:0007275; P:multicellular organismal development; TAS:UniProtKB
Q9UIW2	PLXNA1	Plexin-A1	GO:0014910; P:regulation of smooth muscle cell migration; IEA:Ensembl
O75051	PLXNA2	Plexin-A2	GO:0005515; F:protein binding; IPI:IntAct
O75051	PLXNA2	Plexin-A2	GO:0017154; F:semaphorin receptor activity; ISS:UniProtKB
O75051	PLXNA2	Plexin-A2	GO:0007411; P:axon guidance; TAS:Reactome
O75051	PLXNA2	Plexin-A2	GO:0051642; P:centrosome localization; IEA:Ensembl
O75051	PLXNA2	Plexin-A2	GO:0021935; P:cerebellar granule cell precursor tangential migration; IEA:Ensembl
O75051	PLXNA2	Plexin-A2	GO:0060174; P:limb bud formation; IEA:Ensembl
O75051	PLXNA2	Plexin-A2	GO:0021915; P:neural tube development; IEA:Ensembl
O75051	PLXNA2	Plexin-A2	GO:0060037; P:pharyngeal system development; IEA:Ensembl
O75051	PLXNA2	Plexin-A2	GO:0030334; P:regulation of cell migration; ISS:UniProtKB
O75051	PLXNA2	Plexin-A2	GO:0071526; P:semaphorin-plexin signaling pathway; ISS:UniProtKB
O75051	PLXNA2	Plexin-A2	GO:0001756; P:somitogenesis; IEA:Ensembl
P51805	PLXNA3	Plexin-A3	GO:0005515; F:protein binding; IPI:IntAct
P51805	PLXNA3	Plexin-A3	GO:0017154; F:semaphorin receptor activity; IEA:Ensembl
P51805	PLXNA3	Plexin-A3	GO:0004888; F:transmembrane signaling receptor activity; NAS:UniProtKB
P51805	PLXNA3	Plexin-A3	GO:0007411; P:axon guidance; TAS:Reactome
P51805	PLXNA3	Plexin-A3	GO:0021766; P:hippocampus development; IEA:Ensembl
P51805	PLXNA3	Plexin-A3	GO:0007275; P:multicellular organismal development; TAS:UniProtKB
P51805	PLXNA3	Plexin-A3	GO:0050919; P:negative chemotaxis; IEA:Ensembl
P51805	PLXNA3	Plexin-A3	GO:0048843; P:negative regulation of axon extension involved in axon guidance; IEA:Ensembl
P51805	PLXNA3	Plexin-A3	GO:0051495; P:positive regulation of cytoskeleton organization; IEA:Ensembl
P51805	PLXNA3	Plexin-A3	GO:0021860; P:pyramidal neuron development; IEA:Ensembl
P51805	PLXNA3	Plexin-A3	GO:0071526; P:semaphorin-plexin signaling pathway; NAS:BHF-UCL
Q9HCM2	PLXNA4	Plexin-A4	GO:0017154; F:semaphorin receptor activity; IEA:Ensembl
Q9HCM2	PLXNA4	Plexin-A4	GO:0021960; P:anterior commissure morphogenesis; IEA:Ensembl
Q9HCM2	PLXNA4	Plexin-A4	GO:0007411; P:axon guidance; TAS:Reactome
Q9HCM2	PLXNA4	Plexin-A4	GO:0021793; P:chemorepulsion of branchiomotor axon; IEA:Ensembl
Q9HCM2	PLXNA4	Plexin-A4	GO:0021610; P:facial nerve morphogenesis; IEA:Ensembl
Q9HCM2	PLXNA4	Plexin-A4	GO:0021615; P:glossopharyngeal nerve morphogenesis; IEA:Ensembl
Q9HCM2	PLXNA4	Plexin-A4	GO:0021784; P:postganglionic parasympathetic nervous system development; IEA:Ensembl
Q9HCM2	PLXNA4	Plexin-A4	GO:0048841; P:regulation of axon extension involved in axon guidance; IEA:Ensembl
Q9HCM2	PLXNA4	Plexin-A4	GO:0050923; P:regulation of negative chemotaxis; IEA:Ensembl
Q9HCM2	PLXNA4	Plexin-A4	GO:0071526; P:semaphorin-plexin signaling pathway; NAS:BHF-UCL
Q9HCM2	PLXNA4	Plexin-A4	GO:0048485; P:sympathetic nervous system development; IEA:Ensembl
Q9HCM2	PLXNA4	Plexin-A4	GO:0021636; P:trigeminal nerve morphogenesis; IEA:Ensembl
Q9HCM2	PLXNA4	Plexin-A4	GO:0021644; P:vagus nerve morphogenesis; IEA:Ensembl
O43157	PLXNB1	Plexin-B1	GO:0032794; F:GTPase activating protein binding; ISS:BHF-UCL
O43157	PLXNB1	Plexin-B1	GO:0005515; F:protein binding; IPI:UniProtKB
O43157	PLXNB1	Plexin-B1	GO:0004872; F:receptor activity; TAS:ProtInc
O43157	PLXNB1	Plexin-B1	GO:0017154; F:semaphorin receptor activity; IDA:UniProtKB
O43157	PLXNB1	Plexin-B1	GO:0030215; F:semaphorin receptor binding; TAS:UniProtKB
O43157	PLXNB1	Plexin-B1	GO:0004888; F:transmembrane signaling receptor activity; NAS:UniProtKB
O43157	PLXNB1	Plexin-B1	GO:0007411; P:axon guidance; TAS:Reactome
O43157	PLXNB1	Plexin-B1	GO:0016477; P:cell migration; NAS:UniProtKB
O43157	PLXNB1	Plexin-B1	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
O43157	PLXNB1	Plexin-B1	GO:0007162; P:negative regulation of cell adhesion; IDA:UniProtKB
O43157	PLXNB1	Plexin-B1	GO:0033689; P:negative regulation of osteoblast proliferation; ISS:BHF-UCL
O43157	PLXNB1	Plexin-B1	GO:0048812; P:neuron projection morphogenesis; ISS:UniProtKB
O43157	PLXNB1	Plexin-B1	GO:0043931; P:ossification involved in bone maturation; ISS:BHF-UCL
O43157	PLXNB1	Plexin-B1	GO:0050772; P:positive regulation of axonogenesis; IEA:Ensembl
O43157	PLXNB1	Plexin-B1	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; ISS:UniProtKB
O43157	PLXNB1	Plexin-B1	GO:0032321; P:positive regulation of Rho GTPase activity; ISS:UniProtKB
O43157	PLXNB1	Plexin-B1	GO:0008360; P:regulation of cell shape; IDA:UniProtKB
O43157	PLXNB1	Plexin-B1	GO:0051493; P:regulation of cytoskeleton organization; IDA:UniProtKB
O43157	PLXNB1	Plexin-B1	GO:0071526; P:semaphorin-plexin signaling pathway; IDA:UniProtKB
O43157	PLXNB1	Plexin-B1	GO:1900220; P:semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis; ISS:BHF-UCL
O43157	PLXNB1	Plexin-B1	GO:0007165; P:signal transduction; TAS:ProtInc
O15031	PLXNB2	Plexin-B2	GO:0005096; F:GTPase activator activity; IEA:InterPro
O15031	PLXNB2	Plexin-B2	GO:0005515; F:protein binding; IPI:IntAct
O15031	PLXNB2	Plexin-B2	GO:0017154; F:semaphorin receptor activity; ISS:UniProtKB
O15031	PLXNB2	Plexin-B2	GO:0007420; P:brain development; ISS:UniProtKB
O15031	PLXNB2	Plexin-B2	GO:0001843; P:neural tube closure; ISS:UniProtKB
O15031	PLXNB2	Plexin-B2	GO:0007405; P:neuroblast proliferation; ISS:UniProtKB
O15031	PLXNB2	Plexin-B2	GO:0050772; P:positive regulation of axonogenesis; IEA:Ensembl
O15031	PLXNB2	Plexin-B2	GO:0008360; P:regulation of cell shape; ISS:UniProtKB
O15031	PLXNB2	Plexin-B2	GO:2001222; P:regulation of neuron migration; ISS:UniProtKB
O15031	PLXNB2	Plexin-B2	GO:0001932; P:regulation of protein phosphorylation; ISS:UniProtKB
O15031	PLXNB2	Plexin-B2	GO:0032319; P:regulation of Rho GTPase activity; ISS:UniProtKB
O15031	PLXNB2	Plexin-B2	GO:0071526; P:semaphorin-plexin signaling pathway; ISS:UniProtKB
Q9ULL4	PLXNB3	Plexin-B3	GO:0005515; F:protein binding; IPI:IntAct
Q9ULL4	PLXNB3	Plexin-B3	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q9ULL4	PLXNB3	Plexin-B3	GO:0004872; F:receptor activity; IEA:InterPro
Q9ULL4	PLXNB3	Plexin-B3	GO:0007411; P:axon guidance; TAS:Reactome
Q9ULL4	PLXNB3	Plexin-B3	GO:0007162; P:negative regulation of cell adhesion; IDA:UniProtKB
Q9ULL4	PLXNB3	Plexin-B3	GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB
Q9ULL4	PLXNB3	Plexin-B3	GO:0034260; P:negative regulation of GTPase activity; IMP:UniProtKB
Q9ULL4	PLXNB3	Plexin-B3	GO:0010593; P:negative regulation of lamellipodium assembly; ISS:UniProtKB
Q9ULL4	PLXNB3	Plexin-B3	GO:0050918; P:positive chemotaxis; IDA:UniProtKB
Q9ULL4	PLXNB3	Plexin-B3	GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:UniProtKB
Q9ULL4	PLXNB3	Plexin-B3	GO:0007165; P:signal transduction; IEA:InterPro
O60486	PLXNC1	Plexin-C1	GO:0005515; F:protein binding; IPI:IntAct
O60486	PLXNC1	Plexin-C1	GO:0004872; F:receptor activity; IEA:InterPro
O60486	PLXNC1	Plexin-C1	GO:0005102; F:receptor binding; TAS:ProtInc
O60486	PLXNC1	Plexin-C1	GO:0007411; P:axon guidance; TAS:Reactome
O60486	PLXNC1	Plexin-C1	GO:0007155; P:cell adhesion; TAS:ProtInc
O60486	PLXNC1	Plexin-C1	GO:0007165; P:signal transduction; IEA:InterPro
Q9Y4D7	PLXND1	Plexin-D1	GO:0005515; F:protein binding; IPI:IntAct
Q9Y4D7	PLXND1	Plexin-D1	GO:0017154; F:semaphorin receptor activity; ISS:UniProtKB
Q9Y4D7	PLXND1	Plexin-D1	GO:0001525; P:angiogenesis; ISS:UniProtKB
Q9Y4D7	PLXND1	Plexin-D1	GO:0007411; P:axon guidance; TAS:Reactome
Q9Y4D7	PLXND1	Plexin-D1	GO:0060666; P:dichotomous subdivision of terminal units involved in salivary gland branching; IEA:Ensembl
Q9Y4D7	PLXND1	Plexin-D1	GO:0043542; P:endothelial cell migration; ISS:UniProtKB
Q9Y4D7	PLXND1	Plexin-D1	GO:0001569; P:patterning of blood vessels; IEA:Ensembl
Q9Y4D7	PLXND1	Plexin-D1	GO:0032092; P:positive regulation of protein binding; IEA:Ensembl
Q9Y4D7	PLXND1	Plexin-D1	GO:0045765; P:regulation of angiogenesis; ISS:UniProtKB
Q9Y4D7	PLXND1	Plexin-D1	GO:0030334; P:regulation of cell migration; ISS:UniProtKB
Q9Y4D7	PLXND1	Plexin-D1	GO:0071526; P:semaphorin-plexin signaling pathway; ISS:UniProtKB
Q9Y4D7	PLXND1	Plexin-D1	GO:0007416; P:synapse assembly; ISS:UniProtKB
Q13401	PMS2P3	Putative postmeiotic segregation increased 2-like protein 3	GO:0005524; F:ATP binding; IEA:InterPro
Q13401	PMS2P3	Putative postmeiotic segregation increased 2-like protein 3	GO:0030983; F:mismatched DNA binding; IEA:InterPro
Q13401	PMS2P3	Putative postmeiotic segregation increased 2-like protein 3	GO:0006298; P:mismatch repair; IEA:InterPro
Q13401	PMS2P3	Putative postmeiotic segregation increased 2-like protein 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
O95744	PMS2P2	Putative postmeiotic segregation increased 2-like protein 2	GO:0005524; F:ATP binding; IEA:InterPro
O95744	PMS2P2	Putative postmeiotic segregation increased 2-like protein 2	GO:0016887; F:ATPase activity; IBA:RefGenome
O95744	PMS2P2	Putative postmeiotic segregation increased 2-like protein 2	GO:0030983; F:mismatched DNA binding; IEA:InterPro
O95744	PMS2P2	Putative postmeiotic segregation increased 2-like protein 2	GO:0032407; F:MutSalpha complex binding; IBA:RefGenome
O95744	PMS2P2	Putative postmeiotic segregation increased 2-like protein 2	GO:0003697; F:single-stranded DNA binding; IBA:RefGenome
O95744	PMS2P2	Putative postmeiotic segregation increased 2-like protein 2	GO:0006200; P:ATP catabolic process; IBA:GOC
O95744	PMS2P2	Putative postmeiotic segregation increased 2-like protein 2	GO:0006298; P:mismatch repair; IBA:RefGenome
O95744	PMS2P2	Putative postmeiotic segregation increased 2-like protein 2	GO:0007131; P:reciprocal meiotic recombination; IBA:RefGenome
O95744	PMS2P2	Putative postmeiotic segregation increased 2-like protein 2	GO:0016446; P:somatic hypermutation of immunoglobulin genes; IBA:RefGenome
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:0015217; F:ADP transmembrane transporter activity; IDA:UniProtKB
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:0080122; F:AMP transmembrane transporter activity; IDA:UniProtKB
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:0005347; F:ATP transmembrane transporter activity; IGI:BHF-UCL
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:0051087; F:chaperone binding; IPI:BHF-UCL
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:0015228; F:coenzyme A transmembrane transporter activity; IDA:UniProtKB
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:0015230; F:FAD transmembrane transporter activity; IDA:UniProtKB
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:0044610; F:FMN transmembrane transporter activity; IDA:UniProtKB
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:0051724; F:NAD transporter activity; IDA:UniProtKB
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:0005515; F:protein binding; IPI:UniProtKB
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:0015866; P:ADP transport; IDA:GOC
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:0080121; P:AMP transport; IDA:GOC
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:0015867; P:ATP transport; IGI:BHF-UCL
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:0035349; P:coenzyme A transmembrane transport; IDA:GOC
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:0035350; P:FAD transmembrane transport; IDA:GOC
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:0001561; P:fatty acid alpha-oxidation; TAS:Reactome
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:0006635; P:fatty acid beta-oxidation; IGI:BHF-UCL
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:0015908; P:fatty acid transport; IGI:BHF-UCL
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:0043132; P:NAD transport; IDA:GOC
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:1901679; P:nucleotide transmembrane transport; IDA:GOC
O43808	SLC25A17	Peroxisomal membrane protein PMP34	GO:0044281; P:small molecule metabolic process; TAS:Reactome
A4D2B8	PMS2P1	Putative postmeiotic segregation increased 2-like protein 1	GO:0005524; F:ATP binding; IEA:InterPro
A4D2B8	PMS2P1	Putative postmeiotic segregation increased 2-like protein 1	GO:0016887; F:ATPase activity; IBA:RefGenome
A4D2B8	PMS2P1	Putative postmeiotic segregation increased 2-like protein 1	GO:0016301; F:kinase activity; IEA:UniProtKB-KW
A4D2B8	PMS2P1	Putative postmeiotic segregation increased 2-like protein 1	GO:0030983; F:mismatched DNA binding; IEA:InterPro
A4D2B8	PMS2P1	Putative postmeiotic segregation increased 2-like protein 1	GO:0032407; F:MutSalpha complex binding; IBA:RefGenome
A4D2B8	PMS2P1	Putative postmeiotic segregation increased 2-like protein 1	GO:0003697; F:single-stranded DNA binding; IBA:RefGenome
A4D2B8	PMS2P1	Putative postmeiotic segregation increased 2-like protein 1	GO:0006200; P:ATP catabolic process; IBA:GOC
A4D2B8	PMS2P1	Putative postmeiotic segregation increased 2-like protein 1	GO:0006298; P:mismatch repair; IBA:RefGenome
A4D2B8	PMS2P1	Putative postmeiotic segregation increased 2-like protein 1	GO:0007131; P:reciprocal meiotic recombination; IBA:RefGenome
A4D2B8	PMS2P1	Putative postmeiotic segregation increased 2-like protein 1	GO:0016446; P:somatic hypermutation of immunoglobulin genes; IBA:RefGenome
A8MQ11	PMS2P5	Postmeiotic segregation increased 2-like protein 5	GO:0005524; F:ATP binding; IEA:InterPro
A8MQ11	PMS2P5	Postmeiotic segregation increased 2-like protein 5	GO:0016887; F:ATPase activity; IBA:RefGenome
A8MQ11	PMS2P5	Postmeiotic segregation increased 2-like protein 5	GO:0030983; F:mismatched DNA binding; IEA:InterPro
A8MQ11	PMS2P5	Postmeiotic segregation increased 2-like protein 5	GO:0032407; F:MutSalpha complex binding; IBA:RefGenome
A8MQ11	PMS2P5	Postmeiotic segregation increased 2-like protein 5	GO:0003697; F:single-stranded DNA binding; IBA:RefGenome
A8MQ11	PMS2P5	Postmeiotic segregation increased 2-like protein 5	GO:0006200; P:ATP catabolic process; IBA:GOC
A8MQ11	PMS2P5	Postmeiotic segregation increased 2-like protein 5	GO:0006298; P:mismatch repair; IBA:RefGenome
A8MQ11	PMS2P5	Postmeiotic segregation increased 2-like protein 5	GO:0007131; P:reciprocal meiotic recombination; IBA:RefGenome
A8MQ11	PMS2P5	Postmeiotic segregation increased 2-like protein 5	GO:0016446; P:somatic hypermutation of immunoglobulin genes; IBA:RefGenome
Q13670	PMS2P11	Putative postmeiotic segregation increased 2-like protein 11	GO:0005524; F:ATP binding; IEA:InterPro
Q13670	PMS2P11	Putative postmeiotic segregation increased 2-like protein 11	GO:0016887; F:ATPase activity; IBA:RefGenome
Q13670	PMS2P11	Putative postmeiotic segregation increased 2-like protein 11	GO:0016301; F:kinase activity; IEA:UniProtKB-KW
Q13670	PMS2P11	Putative postmeiotic segregation increased 2-like protein 11	GO:0030983; F:mismatched DNA binding; IEA:InterPro
Q13670	PMS2P11	Putative postmeiotic segregation increased 2-like protein 11	GO:0032407; F:MutSalpha complex binding; IBA:RefGenome
Q13670	PMS2P11	Putative postmeiotic segregation increased 2-like protein 11	GO:0003697; F:single-stranded DNA binding; IBA:RefGenome
Q13670	PMS2P11	Putative postmeiotic segregation increased 2-like protein 11	GO:0006200; P:ATP catabolic process; IBA:GOC
Q13670	PMS2P11	Putative postmeiotic segregation increased 2-like protein 11	GO:0006298; P:mismatch repair; IBA:RefGenome
Q13670	PMS2P11	Putative postmeiotic segregation increased 2-like protein 11	GO:0007131; P:reciprocal meiotic recombination; IBA:RefGenome
Q13670	PMS2P11	Putative postmeiotic segregation increased 2-like protein 11	GO:0016446; P:somatic hypermutation of immunoglobulin genes; IBA:RefGenome
P40967	PMEL	Melanocyte protein PMEL	GO:0005515; F:protein binding; IPI:UniProtKB
P40967	PMEL	Melanocyte protein PMEL	GO:0042438; P:melanin biosynthetic process; IEA:UniProtKB-KW
P40967	PMEL	Melanocyte protein PMEL	GO:0032438; P:melanosome organization; IDA:UniProtKB
Q969W9	PMEPA1	Transmembrane prostate androgen-induced protein	GO:0050699; F:WW domain binding; IPI:UniProtKB
Q969W9	PMEPA1	Transmembrane prostate androgen-induced protein	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
Q969W9	PMEPA1	Transmembrane prostate androgen-induced protein	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q969W9	PMEPA1	Transmembrane prostate androgen-induced protein	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q6P1K2	PMF1	Polyamine-modulated factor 1	GO:0043522; F:leucine zipper domain binding; IPI:UniProtKB
Q6P1K2	PMF1	Polyamine-modulated factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q6P1K2	PMF1	Polyamine-modulated factor 1	GO:0003713; F:transcription coactivator activity; IMP:UniProtKB
Q6P1K2	PMF1	Polyamine-modulated factor 1	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q6P1K2	PMF1	Polyamine-modulated factor 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q6P1K2	PMF1	Polyamine-modulated factor 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q6P1K2	PMF1	Polyamine-modulated factor 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6P1K2	PMF1	Polyamine-modulated factor 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P07738	BPGM	Bisphosphoglycerate mutase	GO:0004083; F:bisphosphoglycerate 2-phosphatase activity; IEA:UniProtKB-EC
P07738	BPGM	Bisphosphoglycerate mutase	GO:0004082; F:bisphosphoglycerate mutase activity; TAS:ProtInc
P07738	BPGM	Bisphosphoglycerate mutase	GO:0004619; F:phosphoglycerate mutase activity; IEA:InterPro
P07738	BPGM	Bisphosphoglycerate mutase	GO:0005975; P:carbohydrate metabolic process; NAS:ProtInc
P07738	BPGM	Bisphosphoglycerate mutase	GO:0048821; P:erythrocyte development; IEA:Ensembl
P07738	BPGM	Bisphosphoglycerate mutase	GO:0006096; P:glycolytic process; IEA:UniProtKB-KW
P07738	BPGM	Bisphosphoglycerate mutase	GO:0007585; P:respiratory gaseous exchange; TAS:ProtInc
Q8WZA1	POMGNT1	Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1	GO:0047223; F:beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity; IDA:MGI
Q8WZA1	POMGNT1	Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1	GO:0006493; P:protein O-linked glycosylation; IDA:MGI
Q8NAT1	POMGNT2	Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2	GO:0008375; F:acetylglucosaminyltransferase activity; IDA:UniProtKB
Q8NAT1	POMGNT2	Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2	GO:0097363; F:protein O-GlcNAc transferase activity; IDA:MGI
Q8NAT1	POMGNT2	Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2	GO:0006493; P:protein O-linked glycosylation; IDA:UniProtKB
P29590	PML	Protein PML	GO:0050897; F:cobalt ion binding; IDA:UniProtKB
P29590	PML	Protein PML	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P29590	PML	Protein PML	GO:0005515; F:protein binding; IPI:UniProtKB
P29590	PML	Protein PML	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
P29590	PML	Protein PML	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P29590	PML	Protein PML	GO:0032183; F:SUMO binding; IPI:UniProtKB
P29590	PML	Protein PML	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
P29590	PML	Protein PML	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P29590	PML	Protein PML	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P29590	PML	Protein PML	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
P29590	PML	Protein PML	GO:0006915; P:apoptotic process; IDA:UniProtKB
P29590	PML	Protein PML	GO:0060444; P:branching involved in mammary gland duct morphogenesis; IEA:Ensembl
P29590	PML	Protein PML	GO:0007050; P:cell cycle arrest; IDA:UniProtKB
P29590	PML	Protein PML	GO:0045165; P:cell fate commitment; IEA:Ensembl
P29590	PML	Protein PML	GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl
P29590	PML	Protein PML	GO:0090398; P:cellular senescence; IDA:UniProtKB
P29590	PML	Protein PML	GO:0007182; P:common-partner SMAD protein phosphorylation; IEA:Ensembl
P29590	PML	Protein PML	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P29590	PML	Protein PML	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P29590	PML	Protein PML	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; ISS:UniProtKB
P29590	PML	Protein PML	GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; ISS:UniProtKB
P29590	PML	Protein PML	GO:0097191; P:extrinsic apoptotic signaling pathway; IEA:Ensembl
P29590	PML	Protein PML	GO:0045087; P:innate immune response; IDA:UniProt
P29590	PML	Protein PML	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P29590	PML	Protein PML	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IDA:UniProtKB
P29590	PML	Protein PML	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; ISS:UniProtKB
P29590	PML	Protein PML	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IEA:Ensembl
P29590	PML	Protein PML	GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IEA:Ensembl
P29590	PML	Protein PML	GO:0051457; P:maintenance of protein location in nucleus; IDA:MGI
P29590	PML	Protein PML	GO:0030099; P:myeloid cell differentiation; IEA:Ensembl
P29590	PML	Protein PML	GO:0016525; P:negative regulation of angiogenesis; IMP:UniProtKB
P29590	PML	Protein PML	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
P29590	PML	Protein PML	GO:0008285; P:negative regulation of cell proliferation; IMP:BHF-UCL
P29590	PML	Protein PML	GO:0045930; P:negative regulation of mitotic cell cycle; IDA:UniProtKB
P29590	PML	Protein PML	GO:2000059; P:negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IMP:UniProtKB
P29590	PML	Protein PML	GO:0051974; P:negative regulation of telomerase activity; IMP:UniProtKB
P29590	PML	Protein PML	GO:0032211; P:negative regulation of telomere maintenance via telomerase; IMP:UniProtKB
P29590	PML	Protein PML	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P29590	PML	Protein PML	GO:0032938; P:negative regulation of translation in response to oxidative stress; IDA:UniProtKB
P29590	PML	Protein PML	GO:1902187; P:negative regulation of viral release from host cell; IDA:UniProt
P29590	PML	Protein PML	GO:0030578; P:PML body organization; IDA:UniProtKB
P29590	PML	Protein PML	GO:0060058; P:positive regulation of apoptotic process involved in mammary gland involution; IDA:UniProtKB
P29590	PML	Protein PML	GO:0002230; P:positive regulation of defense response to virus by host; IMP:UniProtKB
P29590	PML	Protein PML	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB
P29590	PML	Protein PML	GO:0031065; P:positive regulation of histone deacetylation; IDA:UniProtKB
P29590	PML	Protein PML	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
P29590	PML	Protein PML	GO:0006461; P:protein complex assembly; IDA:UniProtKB
P29590	PML	Protein PML	GO:0050821; P:protein stabilization; IDA:UniProtKB
P29590	PML	Protein PML	GO:0006605; P:protein targeting; IDA:UniProtKB
P29590	PML	Protein PML	GO:0010522; P:regulation of calcium ion transport into cytosol; ISS:UniProtKB
P29590	PML	Protein PML	GO:2000779; P:regulation of double-strand break repair; IMP:UniProtKB
P29590	PML	Protein PML	GO:0045343; P:regulation of MHC class I biosynthetic process; IEA:Ensembl
P29590	PML	Protein PML	GO:0001932; P:regulation of protein phosphorylation; ISS:UniProtKB
P29590	PML	Protein PML	GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB
P29590	PML	Protein PML	GO:0034097; P:response to cytokine; IDA:BHF-UCL
P29590	PML	Protein PML	GO:0010332; P:response to gamma radiation; IEA:Ensembl
P29590	PML	Protein PML	GO:0001666; P:response to hypoxia; IDA:UniProtKB
P29590	PML	Protein PML	GO:0009411; P:response to UV; IEA:Ensembl
P29590	PML	Protein PML	GO:0048384; P:retinoic acid receptor signaling pathway; IEA:Ensembl
P29590	PML	Protein PML	GO:0007184; P:SMAD protein import into nucleus; IEA:Ensembl
P29590	PML	Protein PML	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P29590	PML	Protein PML	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl
P29590	PML	Protein PML	GO:0016032; P:viral process; IEA:UniProtKB-KW
O15305	PMM2	Phosphomannomutase 2	GO:0004615; F:phosphomannomutase activity; TAS:ProtInc
O15305	PMM2	Phosphomannomutase 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O15305	PMM2	Phosphomannomutase 2	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
O15305	PMM2	Phosphomannomutase 2	GO:0009298; P:GDP-mannose biosynthetic process; TAS:Reactome
O15305	PMM2	Phosphomannomutase 2	GO:0019307; P:mannose biosynthetic process; IEA:InterPro
O15305	PMM2	Phosphomannomutase 2	GO:0043687; P:post-translational protein modification; TAS:Reactome
O15305	PMM2	Phosphomannomutase 2	GO:0006486; P:protein glycosylation; TAS:ProtInc
O15305	PMM2	Phosphomannomutase 2	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q92871	PMM1	Phosphomannomutase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q92871	PMM1	Phosphomannomutase 1	GO:0004615; F:phosphomannomutase activity; IDA:UniProtKB
Q92871	PMM1	Phosphomannomutase 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q92871	PMM1	Phosphomannomutase 1	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q92871	PMM1	Phosphomannomutase 1	GO:0009298; P:GDP-mannose biosynthetic process; TAS:Reactome
Q92871	PMM1	Phosphomannomutase 1	GO:0019307; P:mannose biosynthetic process; IEA:InterPro
Q92871	PMM1	Phosphomannomutase 1	GO:0006013; P:mannose metabolic process; IDA:UniProtKB
Q92871	PMM1	Phosphomannomutase 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q92871	PMM1	Phosphomannomutase 1	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q01453	PMP22	Peripheral myelin protein 22	GO:0005515; F:protein binding; IPI:UniProtKB
Q01453	PMP22	Peripheral myelin protein 22	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q01453	PMP22	Peripheral myelin protein 22	GO:0032288; P:myelin assembly; IEA:Ensembl
Q01453	PMP22	Peripheral myelin protein 22	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q01453	PMP22	Peripheral myelin protein 22	GO:0010977; P:negative regulation of neuron projection development; IEA:Ensembl
Q01453	PMP22	Peripheral myelin protein 22	GO:0007422; P:peripheral nervous system development; TAS:ProtInc
Q01453	PMP22	Peripheral myelin protein 22	GO:0007268; P:synaptic transmission; TAS:ProtInc
P54277	PMS1	PMS1 protein homolog 1	GO:0005524; F:ATP binding; IEA:InterPro
P54277	PMS1	PMS1 protein homolog 1	GO:0016887; F:ATPase activity; IBA:RefGenome
P54277	PMS1	PMS1 protein homolog 1	GO:0003677; F:DNA binding; TAS:ProtInc
P54277	PMS1	PMS1 protein homolog 1	GO:0030983; F:mismatched DNA binding; IEA:InterPro
P54277	PMS1	PMS1 protein homolog 1	GO:0032407; F:MutSalpha complex binding; IBA:RefGenome
P54277	PMS1	PMS1 protein homolog 1	GO:0003697; F:single-stranded DNA binding; IBA:RefGenome
P54277	PMS1	PMS1 protein homolog 1	GO:0006200; P:ATP catabolic process; IBA:GOC
P54277	PMS1	PMS1 protein homolog 1	GO:0006298; P:mismatch repair; IBA:RefGenome
P54277	PMS1	PMS1 protein homolog 1	GO:0007131; P:reciprocal meiotic recombination; IBA:RefGenome
P54277	PMS1	PMS1 protein homolog 1	GO:0042493; P:response to drug; IEA:Ensembl
P54278	PMS2	Mismatch repair endonuclease PMS2	GO:0005524; F:ATP binding; IEA:InterPro
P54278	PMS2	Mismatch repair endonuclease PMS2	GO:0016887; F:ATPase activity; IBA:RefGenome
P54278	PMS2	Mismatch repair endonuclease PMS2	GO:0003677; F:DNA binding; IDA:HGNC
P54278	PMS2	Mismatch repair endonuclease PMS2	GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW
P54278	PMS2	Mismatch repair endonuclease PMS2	GO:0005515; F:protein binding; IPI:UniProtKB
P54278	PMS2	Mismatch repair endonuclease PMS2	GO:0032138; F:single base insertion or deletion binding; IDA:HGNC
P54278	PMS2	Mismatch repair endonuclease PMS2	GO:0006200; P:ATP catabolic process; IBA:GOC
P54278	PMS2	Mismatch repair endonuclease PMS2	GO:0006298; P:mismatch repair; IDA:HGNC
P54278	PMS2	Mismatch repair endonuclease PMS2	GO:0007131; P:reciprocal meiotic recombination; IBA:RefGenome
P54278	PMS2	Mismatch repair endonuclease PMS2	GO:0042493; P:response to drug; IEA:Ensembl
P54278	PMS2	Mismatch repair endonuclease PMS2	GO:0016446; P:somatic hypermutation of immunoglobulin genes; IBA:RefGenome
P54278	PMS2	Mismatch repair endonuclease PMS2	GO:0016447; P:somatic recombination of immunoglobulin gene segments; IEA:Ensembl
Q15126	PMVK	Phosphomevalonate kinase	GO:0005524; F:ATP binding; IDA:UniProtKB
Q15126	PMVK	Phosphomevalonate kinase	GO:0004631; F:phosphomevalonate kinase activity; IDA:UniProtKB
Q15126	PMVK	Phosphomevalonate kinase	GO:0006695; P:cholesterol biosynthetic process; IDA:UniProtKB
Q15126	PMVK	Phosphomevalonate kinase	GO:0019287; P:isopentenyl diphosphate biosynthetic process, mevalonate pathway; IEA:UniProtKB-UniPathway
Q15126	PMVK	Phosphomevalonate kinase	GO:0070723; P:response to cholesterol; IEP:UniProtKB
Q15126	PMVK	Phosphomevalonate kinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15126	PMVK	Phosphomevalonate kinase	GO:0016126; P:sterol biosynthetic process; IDA:UniProtKB
Q99640	PKMYT1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q99640	PKMYT1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	GO:0016301; F:kinase activity; IDA:HGNC
Q99640	PKMYT1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q99640	PKMYT1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	GO:0005515; F:protein binding; IPI:IntAct
Q99640	PKMYT1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q99640	PKMYT1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q99640	PKMYT1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q99640	PKMYT1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q99640	PKMYT1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	GO:0007067; P:mitosis; TAS:ProtInc
Q99640	PKMYT1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q99640	PKMYT1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q99640	PKMYT1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	GO:0051726; P:regulation of cell cycle; TAS:Reactome
Q99640	PKMYT1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
Q99640	PKMYT1	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	GO:0007088; P:regulation of mitosis; TAS:ProtInc
Q6XQN6	NAPRT1	Nicotinate phosphoribosyltransferase	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q6XQN6	NAPRT1	Nicotinate phosphoribosyltransferase	GO:0004516; F:nicotinate phosphoribosyltransferase activity; IDA:UniProtKB
Q6XQN6	NAPRT1	Nicotinate phosphoribosyltransferase	GO:0004514; F:nicotinate-nucleotide diphosphorylase (carboxylating) activity; IEA:InterPro
Q6XQN6	NAPRT1	Nicotinate phosphoribosyltransferase	GO:0009435; P:NAD biosynthetic process; IEA:UniProtKB-UniPathway
Q6XQN6	NAPRT1	Nicotinate phosphoribosyltransferase	GO:0019674; P:NAD metabolic process; TAS:Reactome
Q6XQN6	NAPRT1	Nicotinate phosphoribosyltransferase	GO:0006769; P:nicotinamide metabolic process; TAS:Reactome
Q6XQN6	NAPRT1	Nicotinate phosphoribosyltransferase	GO:0019358; P:nicotinate nucleotide salvage; IEA:InterPro
Q6XQN6	NAPRT1	Nicotinate phosphoribosyltransferase	GO:0006979; P:response to oxidative stress; IMP:UniProtKB
Q6XQN6	NAPRT1	Nicotinate phosphoribosyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6XQN6	NAPRT1	Nicotinate phosphoribosyltransferase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q6XQN6	NAPRT1	Nicotinate phosphoribosyltransferase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q8NA58	PNLDC1	Poly(A)-specific ribonuclease PARN-like domain-containing protein 1	GO:0003676; F:nucleic acid binding; IEA:InterPro
DR   GO:0030103; P:vasopressin secretion; NAS:UniProtKB
Q8N490	PNKD	Probable hydrolase PNKD	GO:0004416; F:hydroxyacylglutathione hydrolase activity; IEA:InterPro
Q8N490	PNKD	Probable hydrolase PNKD	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N490	PNKD	Probable hydrolase PNKD	GO:0006750; P:glutathione biosynthetic process; IEA:InterPro
Q96T60	PNKP	Bifunctional polynucleotide phosphatase/kinase	GO:0005524; F:ATP binding; NAS:UniProtKB
Q96T60	PNKP	Bifunctional polynucleotide phosphatase/kinase	GO:0046404; F:ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity; IDA:UniProtKB
Q96T60	PNKP	Bifunctional polynucleotide phosphatase/kinase	GO:0003684; F:damaged DNA binding; NAS:UniProtKB
Q96T60	PNKP	Bifunctional polynucleotide phosphatase/kinase	GO:0003690; F:double-stranded DNA binding; TAS:UniProtKB
Q96T60	PNKP	Bifunctional polynucleotide phosphatase/kinase	GO:0004519; F:endonuclease activity; NAS:UniProtKB
Q96T60	PNKP	Bifunctional polynucleotide phosphatase/kinase	GO:0019201; F:nucleotide kinase activity; IDA:UniProtKB
Q96T60	PNKP	Bifunctional polynucleotide phosphatase/kinase	GO:0046403; F:polynucleotide 3'-phosphatase activity; IDA:UniProtKB
Q96T60	PNKP	Bifunctional polynucleotide phosphatase/kinase	GO:0005515; F:protein binding; IPI:IntAct
Q96T60	PNKP	Bifunctional polynucleotide phosphatase/kinase	GO:0017076; F:purine nucleotide binding; NAS:UniProtKB
Q96T60	PNKP	Bifunctional polynucleotide phosphatase/kinase	GO:0016311; P:dephosphorylation; IDA:UniProtKB
Q96T60	PNKP	Bifunctional polynucleotide phosphatase/kinase	GO:0042769; P:DNA damage response, detection of DNA damage; IDA:UniProtKB
Q96T60	PNKP	Bifunctional polynucleotide phosphatase/kinase	GO:0006281; P:DNA repair; IGI:UniProtKB
Q96T60	PNKP	Bifunctional polynucleotide phosphatase/kinase	GO:0006261; P:DNA-dependent DNA replication; NAS:UniProtKB
Q96T60	PNKP	Bifunctional polynucleotide phosphatase/kinase	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; NAS:GOC
Q96T60	PNKP	Bifunctional polynucleotide phosphatase/kinase	GO:0046939; P:nucleotide phosphorylation; IDA:UniProtKB
Q96T60	PNKP	Bifunctional polynucleotide phosphatase/kinase	GO:0000718; P:nucleotide-excision repair, DNA damage removal; NAS:UniProtKB
Q96T60	PNKP	Bifunctional polynucleotide phosphatase/kinase	GO:0098506; P:polynucleotide 3' dephosphorylation; IDA:GOC
Q96T60	PNKP	Bifunctional polynucleotide phosphatase/kinase	GO:0006979; P:response to oxidative stress; IDA:UniProtKB
Q96T60	PNKP	Bifunctional polynucleotide phosphatase/kinase	GO:0009314; P:response to radiation; NAS:UniProtKB
Q8TF01	PNISR	Arginine/serine-rich protein PNISR	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UL42	PNMA2	Paraneoplastic antigen Ma2	GO:0005515; F:protein binding; IPI:IntAct
Q9UL42	PNMA2	Paraneoplastic antigen Ma2	GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB
Q9UL41	PNMA3	Paraneoplastic antigen Ma3	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9UL41	PNMA3	Paraneoplastic antigen Ma3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UL41	PNMA3	Paraneoplastic antigen Ma3	GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB
Q8ND90	PNMA1	Paraneoplastic antigen Ma1	GO:0005515; F:protein binding; IPI:IntAct
Q8ND90	PNMA1	Paraneoplastic antigen Ma1	GO:0002437; P:inflammatory response to antigenic stimulus; ISS:UniProtKB
Q8ND90	PNMA1	Paraneoplastic antigen Ma1	GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB
Q96PV4	PNMA5	Paraneoplastic antigen-like protein 5	GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB
P11086	PNMT	Phenylethanolamine N-methyltransferase	GO:0004603; F:phenylethanolamine N-methyltransferase activity; TAS:ProtInc
P11086	PNMT	Phenylethanolamine N-methyltransferase	GO:0042423; P:catecholamine biosynthetic process; TAS:Reactome
P11086	PNMT	Phenylethanolamine N-methyltransferase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P11086	PNMT	Phenylethanolamine N-methyltransferase	GO:0042418; P:epinephrine biosynthetic process; IEA:UniProtKB-UniPathway
P11086	PNMT	Phenylethanolamine N-methyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NRX1	PNO1	RNA-binding protein PNO1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13519	PNOC	Prepronociceptin	GO:0005184; F:neuropeptide hormone activity; TAS:ProtInc
Q13519	PNOC	Prepronociceptin	GO:0005515; F:protein binding; IPI:IntAct
Q13519	PNOC	Prepronociceptin	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
Q13519	PNOC	Prepronociceptin	GO:0007600; P:sensory perception; TAS:ProtInc
Q13519	PNOC	Prepronociceptin	GO:0007165; P:signal transduction; TAS:ProtInc
Q13519	PNOC	Prepronociceptin	GO:0007268; P:synaptic transmission; IEA:UniProtKB-KW
P00491	PNP	Purine nucleoside phosphorylase	GO:0008144; F:drug binding; IDA:UniProtKB
P00491	PNP	Purine nucleoside phosphorylase	GO:0001882; F:nucleoside binding; IDA:UniProtKB
P00491	PNP	Purine nucleoside phosphorylase	GO:0042301; F:phosphate ion binding; IDA:UniProtKB
P00491	PNP	Purine nucleoside phosphorylase	GO:0002060; F:purine nucleobase binding; IDA:UniProtKB
P00491	PNP	Purine nucleoside phosphorylase	GO:0004731; F:purine-nucleoside phosphorylase activity; IDA:UniProtKB
P00491	PNP	Purine nucleoside phosphorylase	GO:0006955; P:immune response; IMP:UniProtKB
P00491	PNP	Purine nucleoside phosphorylase	GO:0006148; P:inosine catabolic process; IDA:MGI
P00491	PNP	Purine nucleoside phosphorylase	GO:0070970; P:interleukin-2 secretion; IMP:UniProtKB
P00491	PNP	Purine nucleoside phosphorylase	GO:0034356; P:NAD biosynthesis via nicotinamide riboside salvage pathway; IGI:UniProtKB
P00491	PNP	Purine nucleoside phosphorylase	GO:0006738; P:nicotinamide riboside catabolic process; IDA:UniProtKB
P00491	PNP	Purine nucleoside phosphorylase	GO:0006139; P:nucleobase-containing compound metabolic process; IDA:UniProtKB
P00491	PNP	Purine nucleoside phosphorylase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P00491	PNP	Purine nucleoside phosphorylase	GO:0046638; P:positive regulation of alpha-beta T cell differentiation; IDA:MGI
P00491	PNP	Purine nucleoside phosphorylase	GO:0042102; P:positive regulation of T cell proliferation; IDA:MGI
P00491	PNP	Purine nucleoside phosphorylase	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P00491	PNP	Purine nucleoside phosphorylase	GO:0006195; P:purine nucleotide catabolic process; TAS:Reactome
P00491	PNP	Purine nucleoside phosphorylase	GO:0043101; P:purine-containing compound salvage; TAS:Reactome
P00491	PNP	Purine nucleoside phosphorylase	GO:0042493; P:response to drug; IDA:UniProtKB
P00491	PNP	Purine nucleoside phosphorylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P00491	PNP	Purine nucleoside phosphorylase	GO:0034418; P:urate biosynthetic process; IDA:MGI
Q9NVS9	PNPO	Pyridoxine-5'-phosphate oxidase	GO:0010181; F:FMN binding; IEA:InterPro
Q9NVS9	PNPO	Pyridoxine-5'-phosphate oxidase	GO:0004733; F:pyridoxamine-phosphate oxidase activity; TAS:Reactome
Q9NVS9	PNPO	Pyridoxine-5'-phosphate oxidase	GO:0008615; P:pyridoxine biosynthetic process; IEA:UniProtKB-KW
Q9NVS9	PNPO	Pyridoxine-5'-phosphate oxidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NVS9	PNPO	Pyridoxine-5'-phosphate oxidase	GO:0042816; P:vitamin B6 metabolic process; TAS:Reactome
Q9NVS9	PNPO	Pyridoxine-5'-phosphate oxidase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9NVS9	PNPO	Pyridoxine-5'-phosphate oxidase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0000175; F:3'-5'-exoribonuclease activity; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0035198; F:miRNA binding; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0034046; F:poly(G) binding; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0008266; F:poly(U) RNA binding; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0004654; F:polyribonucleotide nucleotidyltransferase activity; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0035458; P:cellular response to interferon-beta; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0034599; P:cellular response to oxidative stress; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0000958; P:mitochondrial mRNA catabolic process; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0097222; P:mitochondrial mRNA polyadenylation; IMP:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0000965; P:mitochondrial RNA 3'-end processing; IMP:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0000964; P:mitochondrial RNA 5'-end processing; IMP:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0000957; P:mitochondrial RNA catabolic process; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0070584; P:mitochondrion morphogenesis; ISS:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0071850; P:mitotic cell cycle arrest; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0006402; P:mRNA catabolic process; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0045926; P:negative regulation of growth; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0071042; P:nuclear polyadenylation-dependent mRNA catabolic process; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:2000627; P:positive regulation of miRNA catabolic process; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0000962; P:positive regulation of mitochondrial RNA catabolic process; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0061014; P:positive regulation of mRNA catabolic process; IMP:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0070207; P:protein homotrimerization; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0043457; P:regulation of cellular respiration; ISS:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:2000772; P:regulation of cellular senescence; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0006401; P:RNA catabolic process; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0035927; P:RNA import into mitochondrion; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; IDA:GOC
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0043631; P:RNA polyadenylation; IDA:UniProtKB
Q8TCS8	PNPT1	Polyribonucleotide nucleotidyltransferase 1, mitochondrial	GO:0035928; P:rRNA import into mitochondrion; IDA:UniProtKB
Q12796	PNRC1	Proline-rich nuclear receptor coactivator 1	GO:0005515; F:protein binding; IPI:IntAct
Q12796	PNRC1	Proline-rich nuclear receptor coactivator 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q12796	PNRC1	Proline-rich nuclear receptor coactivator 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NPJ4	PNRC2	Proline-rich nuclear receptor coactivator 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NPJ4	PNRC2	Proline-rich nuclear receptor coactivator 2	GO:0031087; P:deadenylation-independent decapping of nuclear-transcribed mRNA; TAS:UniProtKB
Q9NPJ4	PNRC2	Proline-rich nuclear receptor coactivator 2	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IDA:UniProtKB
Q9NPJ4	PNRC2	Proline-rich nuclear receptor coactivator 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NPJ4	PNRC2	Proline-rich nuclear receptor coactivator 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TEM1	NUP210	Nuclear pore membrane glycoprotein 210	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q8TEM1	NUP210	Nuclear pore membrane glycoprotein 210	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q8TEM1	NUP210	Nuclear pore membrane glycoprotein 210	GO:0015758; P:glucose transport; TAS:Reactome
Q8TEM1	NUP210	Nuclear pore membrane glycoprotein 210	GO:0008645; P:hexose transport; TAS:Reactome
Q8TEM1	NUP210	Nuclear pore membrane glycoprotein 210	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8TEM1	NUP210	Nuclear pore membrane glycoprotein 210	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
Q8TEM1	NUP210	Nuclear pore membrane glycoprotein 210	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q8TEM1	NUP210	Nuclear pore membrane glycoprotein 210	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8TEM1	NUP210	Nuclear pore membrane glycoprotein 210	GO:0010827; P:regulation of glucose transport; TAS:Reactome
Q8TEM1	NUP210	Nuclear pore membrane glycoprotein 210	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8TEM1	NUP210	Nuclear pore membrane glycoprotein 210	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8TEM1	NUP210	Nuclear pore membrane glycoprotein 210	GO:0016032; P:viral process; TAS:Reactome
P14859	POU2F1	POU domain, class 2, transcription factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
P14859	POU2F1	POU domain, class 2, transcription factor 1	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P14859	POU2F1	POU domain, class 2, transcription factor 1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P14859	POU2F1	POU domain, class 2, transcription factor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P14859	POU2F1	POU domain, class 2, transcription factor 1	GO:0010467; P:gene expression; TAS:Reactome
P14859	POU2F1	POU domain, class 2, transcription factor 1	GO:0060235; P:lens induction in camera-type eye; IEA:Ensembl
P14859	POU2F1	POU domain, class 2, transcription factor 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P14859	POU2F1	POU domain, class 2, transcription factor 1	GO:0030910; P:olfactory placode formation; IEA:Ensembl
P14859	POU2F1	POU domain, class 2, transcription factor 1	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
P09086	POU2F2	POU domain, class 2, transcription factor 2	GO:0043565; F:sequence-specific DNA binding; IDA:MGI
P09086	POU2F2	POU domain, class 2, transcription factor 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P09086	POU2F2	POU domain, class 2, transcription factor 2	GO:0048469; P:cell maturation; IEA:Ensembl
P09086	POU2F2	POU domain, class 2, transcription factor 2	GO:0006959; P:humoral immune response; TAS:ProtInc
P09086	POU2F2	POU domain, class 2, transcription factor 2	GO:0002380; P:immunoglobulin secretion involved in immune response; IEA:Ensembl
P09086	POU2F2	POU domain, class 2, transcription factor 2	GO:0002335; P:mature B cell differentiation; IEA:Ensembl
P09086	POU2F2	POU domain, class 2, transcription factor 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P09086	POU2F2	POU domain, class 2, transcription factor 2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9UKI9	POU2F3	POU domain, class 2, transcription factor 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKI9	POU2F3	POU domain, class 2, transcription factor 3	GO:0043565; F:sequence-specific DNA binding; IDA:MGI
Q9UKI9	POU2F3	POU domain, class 2, transcription factor 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9UKI9	POU2F3	POU domain, class 2, transcription factor 3	GO:0008544; P:epidermis development; TAS:ProtInc
Q9UKI9	POU2F3	POU domain, class 2, transcription factor 3	GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
Q9UKI9	POU2F3	POU domain, class 2, transcription factor 3	GO:0043922; P:negative regulation by host of viral transcription; IDA:UniProtKB
Q9UKI9	POU2F3	POU domain, class 2, transcription factor 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UKI9	POU2F3	POU domain, class 2, transcription factor 3	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9UKI9	POU2F3	POU domain, class 2, transcription factor 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UKI9	POU2F3	POU domain, class 2, transcription factor 3	GO:0042060; P:wound healing; IEA:Ensembl
Q03052	POU3F1	POU domain, class 3, transcription factor 1	GO:0001105; F:RNA polymerase II transcription coactivator activity; IEA:Ensembl
Q03052	POU3F1	POU domain, class 3, transcription factor 1	GO:0043565; F:sequence-specific DNA binding; IDA:MGI
Q03052	POU3F1	POU domain, class 3, transcription factor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q03052	POU3F1	POU domain, class 3, transcription factor 1	GO:0008366; P:axon ensheathment; TAS:ProtInc
Q03052	POU3F1	POU domain, class 3, transcription factor 1	GO:0030900; P:forebrain development; IEA:Ensembl
Q03052	POU3F1	POU domain, class 3, transcription factor 1	GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
Q03052	POU3F1	POU domain, class 3, transcription factor 1	GO:0022011; P:myelination in peripheral nervous system; IEA:Ensembl
Q03052	POU3F1	POU domain, class 3, transcription factor 1	GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB
Q03052	POU3F1	POU domain, class 3, transcription factor 1	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
P20265	POU3F2	POU domain, class 3, transcription factor 2	GO:0042802; F:identical protein binding; IPI:IntAct
P20265	POU3F2	POU domain, class 3, transcription factor 2	GO:0005515; F:protein binding; IPI:IntAct
P20265	POU3F2	POU domain, class 3, transcription factor 2	GO:0001105; F:RNA polymerase II transcription coactivator activity; IEA:Ensembl
P20265	POU3F2	POU domain, class 3, transcription factor 2	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P20265	POU3F2	POU domain, class 3, transcription factor 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P20265	POU3F2	POU domain, class 3, transcription factor 2	GO:0014002; P:astrocyte development; IEA:Ensembl
P20265	POU3F2	POU domain, class 3, transcription factor 2	GO:0071310; P:cellular response to organic substance; IEA:Ensembl
P20265	POU3F2	POU domain, class 3, transcription factor 2	GO:0021799; P:cerebral cortex radially oriented cell migration; IEA:Ensembl
P20265	POU3F2	POU domain, class 3, transcription factor 2	GO:0008544; P:epidermis development; IEA:Ensembl
P20265	POU3F2	POU domain, class 3, transcription factor 2	GO:0021869; P:forebrain ventricular zone progenitor cell division; IEA:Ensembl
P20265	POU3F2	POU domain, class 3, transcription factor 2	GO:0021979; P:hypothalamus cell differentiation; IEA:Ensembl
P20265	POU3F2	POU domain, class 3, transcription factor 2	GO:0022011; P:myelination in peripheral nervous system; IEA:Ensembl
P20265	POU3F2	POU domain, class 3, transcription factor 2	GO:0021985; P:neurohypophysis development; IEA:Ensembl
P20265	POU3F2	POU domain, class 3, transcription factor 2	GO:0030182; P:neuron differentiation; IEA:Ensembl
P20265	POU3F2	POU domain, class 3, transcription factor 2	GO:0008284; P:positive regulation of cell proliferation; IDA:MGI
P20265	POU3F2	POU domain, class 3, transcription factor 2	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
P20265	POU3F2	POU domain, class 3, transcription factor 2	GO:0050770; P:regulation of axonogenesis; IEA:Ensembl
P20264	POU3F3	POU domain, class 3, transcription factor 3	GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB
P20264	POU3F3	POU domain, class 3, transcription factor 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P20264	POU3F3	POU domain, class 3, transcription factor 3	GO:0007417; P:central nervous system development; TAS:ProtInc
P20264	POU3F3	POU domain, class 3, transcription factor 3	GO:0021799; P:cerebral cortex radially oriented cell migration; IEA:Ensembl
P20264	POU3F3	POU domain, class 3, transcription factor 3	GO:0021869; P:forebrain ventricular zone progenitor cell division; IEA:Ensembl
P20264	POU3F3	POU domain, class 3, transcription factor 3	GO:0072218; P:metanephric ascending thin limb development; ISS:UniProtKB
P20264	POU3F3	POU domain, class 3, transcription factor 3	GO:0072240; P:metanephric DCT cell differentiation; ISS:UniProtKB
P20264	POU3F3	POU domain, class 3, transcription factor 3	GO:0072236; P:metanephric loop of Henle development; ISS:UniProtKB
P20264	POU3F3	POU domain, class 3, transcription factor 3	GO:0072227; P:metanephric macula densa development; ISS:UniProtKB
P20264	POU3F3	POU domain, class 3, transcription factor 3	GO:0072233; P:metanephric thick ascending limb development; ISS:UniProtKB
P20264	POU3F3	POU domain, class 3, transcription factor 3	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB
P20264	POU3F3	POU domain, class 3, transcription factor 3	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
P20264	POU3F3	POU domain, class 3, transcription factor 3	GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB
P20264	POU3F3	POU domain, class 3, transcription factor 3	GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB
P20264	POU3F3	POU domain, class 3, transcription factor 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P20264	POU3F3	POU domain, class 3, transcription factor 3	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
P20264	POU3F3	POU domain, class 3, transcription factor 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P49335	POU3F4	POU domain, class 3, transcription factor 4	GO:0003680; F:AT DNA binding; IEA:Ensembl
P49335	POU3F4	POU domain, class 3, transcription factor 4	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
P49335	POU3F4	POU domain, class 3, transcription factor 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P49335	POU3F4	POU domain, class 3, transcription factor 4	GO:0090103; P:cochlea morphogenesis; ISS:UniProtKB
P49335	POU3F4	POU domain, class 3, transcription factor 4	GO:0021879; P:forebrain neuron differentiation; IEA:Ensembl
P49335	POU3F4	POU domain, class 3, transcription factor 4	GO:2001054; P:negative regulation of mesenchymal cell apoptotic process; ISS:UniProtKB
P49335	POU3F4	POU domain, class 3, transcription factor 4	GO:0007605; P:sensory perception of sound; TAS:ProtInc
P49335	POU3F4	POU domain, class 3, transcription factor 4	GO:0006366; P:transcription from RNA polymerase II promoter; IEA:Ensembl
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; ISS:BHF-UCL
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0007409; P:axonogenesis; TAS:BHF-UCL
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0021535; P:cell migration in hindbrain; IEA:Ensembl
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0021953; P:central nervous system neuron differentiation; IEA:Ensembl
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0021986; P:habenula development; IEA:Ensembl
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0060384; P:innervation; TAS:BHF-UCL
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0007498; P:mesoderm development; IEA:Ensembl
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0043524; P:negative regulation of neuron apoptotic process; TAS:BHF-UCL
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0048665; P:neuron fate specification; ISS:BHF-UCL
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0048935; P:peripheral nervous system neuron development; ISS:BHF-UCL
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0051355; P:proprioception involved in equilibrioception; IEA:Ensembl
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0050767; P:regulation of neurogenesis; IEA:Ensembl
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0048880; P:sensory system development; ISS:BHF-UCL
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0001967; P:suckling behavior; IEA:Ensembl
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0007416; P:synapse assembly; TAS:ProtInc
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0006366; P:transcription from RNA polymerase II promoter; ISS:GOC
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0021559; P:trigeminal nerve development; ISS:BHF-UCL
Q01851	POU4F1	POU domain, class 4, transcription factor 1	GO:0003223; P:ventricular compact myocardium morphogenesis; IEA:Ensembl
Q12837	POU4F2	POU domain, class 4, transcription factor 2	GO:0003682; F:chromatin binding; IEA:Ensembl
Q12837	POU4F2	POU domain, class 4, transcription factor 2	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:UniProtKB
Q12837	POU4F2	POU domain, class 4, transcription factor 2	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; ISS:UniProtKB
Q12837	POU4F2	POU domain, class 4, transcription factor 2	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:UniProtKB
Q12837	POU4F2	POU domain, class 4, transcription factor 2	GO:0048675; P:axon extension; IEA:Ensembl
Q12837	POU4F2	POU domain, class 4, transcription factor 2	GO:0007411; P:axon guidance; ISS:UniProtKB
Q12837	POU4F2	POU domain, class 4, transcription factor 2	GO:0030520; P:intracellular estrogen receptor signaling pathway; IDA:UniProtKB
Q12837	POU4F2	POU domain, class 4, transcription factor 2	GO:0000165; P:MAPK cascade; IDA:UniProtKB
Q12837	POU4F2	POU domain, class 4, transcription factor 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q12837	POU4F2	POU domain, class 4, transcription factor 2	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q12837	POU4F2	POU domain, class 4, transcription factor 2	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q12837	POU4F2	POU domain, class 4, transcription factor 2	GO:0045597; P:positive regulation of cell differentiation; ISS:UniProtKB
Q12837	POU4F2	POU domain, class 4, transcription factor 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q12837	POU4F2	POU domain, class 4, transcription factor 2	GO:0060041; P:retina development in camera-type eye; ISS:UniProtKB
Q12837	POU4F2	POU domain, class 4, transcription factor 2	GO:0031290; P:retinal ganglion cell axon guidance; IEA:Ensembl
Q12837	POU4F2	POU domain, class 4, transcription factor 2	GO:0007605; P:sensory perception of sound; IEA:Ensembl
Q15319	POU4F3	POU domain, class 4, transcription factor 3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q15319	POU4F3	POU domain, class 4, transcription factor 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q15319	POU4F3	POU domain, class 4, transcription factor 3	GO:0042491; P:auditory receptor cell differentiation; IEA:Ensembl
Q15319	POU4F3	POU domain, class 4, transcription factor 3	GO:0048675; P:axon extension; IEA:Ensembl
Q15319	POU4F3	POU domain, class 4, transcription factor 3	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q15319	POU4F3	POU domain, class 4, transcription factor 3	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q15319	POU4F3	POU domain, class 4, transcription factor 3	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
Q15319	POU4F3	POU domain, class 4, transcription factor 3	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q15319	POU4F3	POU domain, class 4, transcription factor 3	GO:0031290; P:retinal ganglion cell axon guidance; IEA:Ensembl
Q15319	POU4F3	POU domain, class 4, transcription factor 3	GO:0007605; P:sensory perception of sound; TAS:ProtInc
Q15319	POU4F3	POU domain, class 4, transcription factor 3	GO:0021562; P:vestibulocochlear nerve development; IEA:Ensembl
Q15319	POU4F3	POU domain, class 4, transcription factor 3	GO:0007601; P:visual perception; TAS:ProtInc
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0003677; F:DNA binding; IDA:HGNC
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0035198; F:miRNA binding; IDA:UniProtKB
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0043565; F:sequence-specific DNA binding; IDA:MGI
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; ISS:BHF-UCL
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:HGNC
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0031625; F:ubiquitin protein ligase binding; IPI:BHF-UCL
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0001824; P:blastocyst development; ISS:BHF-UCL
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0003130; P:BMP signaling pathway involved in heart induction; IMP:BHF-UCL
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0060913; P:cardiac cell fate determination; IDA:BHF-UCL
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0060795; P:cell fate commitment involved in formation of primary germ layer; IMP:BHF-UCL
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0001714; P:endodermal cell fate specification; IDA:MGI
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0042789; P:mRNA transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0060965; P:negative regulation of gene silencing by miRNA; IMP:UniProtKB
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0035413; P:positive regulation of catenin import into nucleus; IDA:BHF-UCL
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0060391; P:positive regulation of SMAD protein import into nucleus; IDA:BHF-UCL
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0009786; P:regulation of asymmetric cell division; ISS:BHF-UCL
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0010468; P:regulation of gene expression; IMP:UniProtKB
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0090081; P:regulation of heart induction by regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0090308; P:regulation of methylation-dependent chromatin silencing; IDA:BHF-UCL
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0006355; P:regulation of transcription, DNA-templated; IDA:HGNC
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0009611; P:response to wounding; IEP:UniProtKB
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0035019; P:somatic stem cell maintenance; IDA:UniProtKB
Q01860	POU5F1	POU domain, class 5, transcription factor 1	GO:0006366; P:transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q8N7G0	POU5F2	POU domain, class 5, transcription factor 2	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q8N7G0	POU5F2	POU domain, class 5, transcription factor 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8N7G0	POU5F2	POU domain, class 5, transcription factor 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P78424	POU6F2	POU domain, class 6, transcription factor 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P78424	POU6F2	POU domain, class 6, transcription factor 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:UniProtKB
P78424	POU6F2	POU domain, class 6, transcription factor 2	GO:0007417; P:central nervous system development; TAS:ProtInc
P78424	POU6F2	POU domain, class 6, transcription factor 2	GO:0007402; P:ganglion mother cell fate determination; TAS:ProtInc
P78424	POU6F2	POU domain, class 6, transcription factor 2	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
P78424	POU6F2	POU domain, class 6, transcription factor 2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P78424	POU6F2	POU domain, class 6, transcription factor 2	GO:0007601; P:visual perception; TAS:ProtInc
Q14863	POU6F1	POU domain, class 6, transcription factor 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q14863	POU6F1	POU domain, class 6, transcription factor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q14863	POU6F1	POU domain, class 6, transcription factor 1	GO:0007420; P:brain development; TAS:ProtInc
Q14863	POU6F1	POU domain, class 6, transcription factor 1	GO:0007507; P:heart development; TAS:ProtInc
Q14863	POU6F1	POU domain, class 6, transcription factor 1	GO:0007517; P:muscle organ development; TAS:ProtInc
Q14863	POU6F1	POU domain, class 6, transcription factor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NBT0	POC1A	POC1 centriolar protein homolog A	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NBT0	POC1A	POC1 centriolar protein homolog A	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
Q8TC44	POC1B	POC1 centriolar protein homolog B	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TC44	POC1B	POC1 centriolar protein homolog B	GO:0008283; P:cell proliferation; IMP:UniProtKB
Q8TC44	POC1B	POC1 centriolar protein homolog B	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q8NA72	POC5	Centrosomal protein POC5	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q7Z5L7	PODN	Podocan	GO:0005518; F:collagen binding; IDA:UniProtKB
Q7Z5L7	PODN	Podocan	GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB
Q7Z5L7	PODN	Podocan	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q9NP85	NPHS2	Podocin	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NP85	NPHS2	Podocin	GO:0031532; P:actin cytoskeleton reorganization; IDA:UniProtKB
Q9NP85	NPHS2	Podocin	GO:0007588; P:excretion; TAS:ProtInc
Q9NP85	NPHS2	Podocin	GO:0072249; P:metanephric glomerular visceral epithelial cell development; IEP:UniProtKB
O00592	PODXL	Podocalyxin	GO:0005515; F:protein binding; IPI:IntAct
O00592	PODXL	Podocalyxin	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
O00592	PODXL	Podocalyxin	GO:0016477; P:cell migration; ISS:UniProtKB
O00592	PODXL	Podocalyxin	GO:0072175; P:epithelial tube formation; ISS:UniProtKB
O00592	PODXL	Podocalyxin	GO:0072015; P:glomerular visceral epithelial cell development; ISS:UniProtKB
O00592	PODXL	Podocalyxin	GO:0050900; P:leukocyte migration; IEA:Ensembl
O00592	PODXL	Podocalyxin	GO:0007162; P:negative regulation of cell adhesion; ISS:UniProtKB
O00592	PODXL	Podocalyxin	GO:0022408; P:negative regulation of cell-cell adhesion; ISS:UniProtKB
O00592	PODXL	Podocalyxin	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
O00592	PODXL	Podocalyxin	GO:0033634; P:positive regulation of cell-cell adhesion mediated by integrin; IDA:UniProtKB
O00592	PODXL	Podocalyxin	GO:0032534; P:regulation of microvillus assembly; ISS:UniProtKB
Q9P215	POGK	Pogo transposable element with KRAB domain	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9P215	POGK	Pogo transposable element with KRAB domain	GO:0005515; F:protein binding; IPI:IntAct
Q9P215	POGK	Pogo transposable element with KRAB domain	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9P215	POGK	Pogo transposable element with KRAB domain	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q7Z3K3	POGZ	Pogo transposable element with ZNF domain	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7Z3K3	POGZ	Pogo transposable element with ZNF domain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z3K3	POGZ	Pogo transposable element with ZNF domain	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z3K3	POGZ	Pogo transposable element with ZNF domain	GO:0051382; P:kinetochore assembly; IMP:UniProtKB
Q7Z3K3	POGZ	Pogo transposable element with ZNF domain	GO:0007064; P:mitotic sister chromatid cohesion; IMP:UniProtKB
DR   GO:0003677; F:DNA binding; IEA:UniProtKB-KW
DR   GO:0003723; F:RNA binding; IEA:InterPro
DR   GO:0003964; F:RNA-directed DNA polymerase activity; IEA:UniProtKB-KW
DR   GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IEA:UniProtKB-EC
DR   GO:0008270; F:zinc ion binding; IEA:InterPro
DR   GO:0015074; P:DNA integration; IEA:UniProtKB-KW
DR   GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
DR   GO:0003677; F:DNA binding; IEA:UniProtKB-KW
DR   GO:0003723; F:RNA binding; IEA:InterPro
DR   GO:0003964; F:RNA-directed DNA polymerase activity; IEA:UniProtKB-KW
DR   GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IEA:UniProtKB-EC
DR   GO:0008270; F:zinc ion binding; IEA:InterPro
DR   GO:0015074; P:DNA integration; IEA:UniProtKB-KW
DR   GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
DR   GO:0003677; F:DNA binding; IEA:UniProtKB-KW
DR   GO:0003723; F:RNA binding; IEA:InterPro
DR   GO:0003964; F:RNA-directed DNA polymerase activity; IEA:UniProtKB-KW
DR   GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IEA:UniProtKB-EC
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0008270; F:zinc ion binding; IEA:InterPro
DR   GO:0015074; P:DNA integration; IEA:UniProtKB-KW
DR   GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
DR   GO:0003677; F:DNA binding; IEA:UniProtKB-KW
DR   GO:0003723; F:RNA binding; IEA:InterPro
DR   GO:0003964; F:RNA-directed DNA polymerase activity; IEA:UniProtKB-KW
DR   GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IEA:UniProtKB-EC
DR   GO:0008270; F:zinc ion binding; IEA:InterPro
DR   GO:0015074; P:DNA integration; IEA:UniProtKB-KW
DR   GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q9BXR3	ERVK6	HERV-K_7p22.1 provirus ancestral Pol protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BXR3	ERVK6	HERV-K_7p22.1 provirus ancestral Pol protein	GO:0003723; F:RNA binding; IEA:InterPro
Q9BXR3	ERVK6	HERV-K_7p22.1 provirus ancestral Pol protein	GO:0003964; F:RNA-directed DNA polymerase activity; IEA:UniProtKB-KW
Q9BXR3	ERVK6	HERV-K_7p22.1 provirus ancestral Pol protein	GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IEA:UniProtKB-EC
Q9BXR3	ERVK6	HERV-K_7p22.1 provirus ancestral Pol protein	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BXR3	ERVK6	HERV-K_7p22.1 provirus ancestral Pol protein	GO:0015074; P:DNA integration; IEA:UniProtKB-KW
Q9BXR3	ERVK6	HERV-K_7p22.1 provirus ancestral Pol protein	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q9WJR5	ERVK6	HERV-K_19q12 provirus ancestral Pol protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9WJR5	ERVK6	HERV-K_19q12 provirus ancestral Pol protein	GO:0003723; F:RNA binding; IEA:InterPro
Q9WJR5	ERVK6	HERV-K_19q12 provirus ancestral Pol protein	GO:0003964; F:RNA-directed DNA polymerase activity; IEA:UniProtKB-KW
Q9WJR5	ERVK6	HERV-K_19q12 provirus ancestral Pol protein	GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IEA:UniProtKB-EC
Q9WJR5	ERVK6	HERV-K_19q12 provirus ancestral Pol protein	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9WJR5	ERVK6	HERV-K_19q12 provirus ancestral Pol protein	GO:0015074; P:DNA integration; IEA:UniProtKB-KW
Q9WJR5	ERVK6	HERV-K_19q12 provirus ancestral Pol protein	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
DR   GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro
DR   GO:0003887; F:DNA-directed DNA polymerase activity; IEA:UniProtKB-EC
DR   GO:0003723; F:RNA binding; IEA:UniProtKB-KW
DR   GO:0003964; F:RNA-directed DNA polymerase activity; IEA:UniProtKB-KW
DR   GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IEA:UniProtKB-EC
DR   GO:0005198; F:structural molecule activity; IEA:InterPro
DR   GO:0008270; F:zinc ion binding; IEA:InterPro
DR   GO:0046080; P:dUTP metabolic process; IEA:InterPro
DR   GO:0016032; P:viral process; IEA:InterPro
DR   GO:0003677; F:DNA binding; IEA:UniProtKB-KW
DR   GO:0003723; F:RNA binding; IEA:InterPro
DR   GO:0003964; F:RNA-directed DNA polymerase activity; IEA:UniProtKB-KW
DR   GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IEA:UniProtKB-EC
DR   GO:0008270; F:zinc ion binding; IEA:InterPro
DR   GO:0015074; P:DNA integration; IEA:UniProtKB-KW
DR   GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
DR   GO:0003677; F:DNA binding; IEA:UniProtKB-KW
DR   GO:0003723; F:RNA binding; IEA:InterPro
DR   GO:0003964; F:RNA-directed DNA polymerase activity; IEA:UniProtKB-KW
DR   GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IEA:UniProtKB-EC
DR   GO:0008270; F:zinc ion binding; IEA:InterPro
DR   GO:0015074; P:DNA integration; IEA:InterPro
DR   GO:0003677; F:DNA binding; IEA:UniProtKB-KW
DR   GO:0003723; F:RNA binding; IEA:InterPro
DR   GO:0003964; F:RNA-directed DNA polymerase activity; IEA:UniProtKB-KW
DR   GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IEA:UniProtKB-EC
DR   GO:0008270; F:zinc ion binding; IEA:InterPro
DR   GO:0015074; P:DNA integration; IEA:UniProtKB-KW
DR   GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q9Y253	POLH	DNA polymerase eta	GO:0003684; F:damaged DNA binding; TAS:ProtInc
Q9Y253	POLH	DNA polymerase eta	GO:0003887; F:DNA-directed DNA polymerase activity; TAS:Reactome
Q9Y253	POLH	DNA polymerase eta	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y253	POLH	DNA polymerase eta	GO:0005515; F:protein binding; IPI:IntAct
Q9Y253	POLH	DNA polymerase eta	GO:0006281; P:DNA repair; TAS:Reactome
Q9Y253	POLH	DNA polymerase eta	GO:0000731; P:DNA synthesis involved in DNA repair; IDA:UniProtKB
Q9Y253	POLH	DNA polymerase eta	GO:0006261; P:DNA-dependent DNA replication; TAS:GOC
Q9Y253	POLH	DNA polymerase eta	GO:0006301; P:postreplication repair; IEA:Ensembl
Q9Y253	POLH	DNA polymerase eta	GO:0006290; P:pyrimidine dimer repair; IEA:Ensembl
Q9Y253	POLH	DNA polymerase eta	GO:0006282; P:regulation of DNA repair; TAS:ProtInc
Q9Y253	POLH	DNA polymerase eta	GO:0010225; P:response to UV-C; IDA:UniProtKB
Q9UNA4	POLI	DNA polymerase iota	GO:0003684; F:damaged DNA binding; IEA:InterPro
Q9UNA4	POLI	DNA polymerase iota	GO:0003887; F:DNA-directed DNA polymerase activity; TAS:ProtInc
Q9UNA4	POLI	DNA polymerase iota	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UNA4	POLI	DNA polymerase iota	GO:0005515; F:protein binding; IPI:IntAct
Q9UNA4	POLI	DNA polymerase iota	GO:0006281; P:DNA repair; TAS:ProtInc
Q9UNA4	POLI	DNA polymerase iota	GO:0006261; P:DNA-dependent DNA replication; TAS:GOC
Q9UBT6	POLK	DNA polymerase kappa	GO:0003684; F:damaged DNA binding; IEA:InterPro
Q9UBT6	POLK	DNA polymerase kappa	GO:0003887; F:DNA-directed DNA polymerase activity; IEA:UniProtKB-KW
Q9UBT6	POLK	DNA polymerase kappa	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UBT6	POLK	DNA polymerase kappa	GO:0006281; P:DNA repair; TAS:UniProtKB
Q9UBT6	POLK	DNA polymerase kappa	GO:0006297; P:nucleotide-excision repair, DNA gap filling; IMP:UniProtKB
Q5K4E3	PRSS36	Polyserase-2	GO:0004252; F:serine-type endopeptidase activity; IDA:MGI
Q9Y244	POMP	Proteasome maturation protein	GO:0005515; F:protein binding; IPI:IntAct
Q9Y244	POMP	Proteasome maturation protein	GO:0043248; P:proteasome assembly; IMP:UniProtKB
Q9Y6A1	POMT1	Protein O-mannosyl-transferase 1	GO:0004169; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; IEA:UniProtKB-EC
Q9Y6A1	POMT1	Protein O-mannosyl-transferase 1	GO:0000030; F:mannosyltransferase activity; TAS:ProtInc
Q9Y6A1	POMT1	Protein O-mannosyl-transferase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y6A1	POMT1	Protein O-mannosyl-transferase 1	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
Q9Y6A1	POMT1	Protein O-mannosyl-transferase 1	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q9Y6A1	POMT1	Protein O-mannosyl-transferase 1	GO:0097502; P:mannosylation; TAS:GOC
Q9Y6A1	POMT1	Protein O-mannosyl-transferase 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q9Y6A1	POMT1	Protein O-mannosyl-transferase 1	GO:0006493; P:protein O-linked glycosylation; TAS:ProtInc
Q9UKY4	POMT2	Protein O-mannosyl-transferase 2	GO:0004169; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; IEA:UniProtKB-EC
Q9UKY4	POMT2	Protein O-mannosyl-transferase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P27169	PON1	Serum paraoxonase/arylesterase 1	GO:0004063; F:aryldialkylphosphatase activity; IDA:UniProtKB
P27169	PON1	Serum paraoxonase/arylesterase 1	GO:0004064; F:arylesterase activity; IDA:UniProtKB
P27169	PON1	Serum paraoxonase/arylesterase 1	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P27169	PON1	Serum paraoxonase/arylesterase 1	GO:0005543; F:phospholipid binding; IDA:BHF-UCL
P27169	PON1	Serum paraoxonase/arylesterase 1	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
P27169	PON1	Serum paraoxonase/arylesterase 1	GO:0019439; P:aromatic compound catabolic process; IDA:BHF-UCL
P27169	PON1	Serum paraoxonase/arylesterase 1	GO:0046395; P:carboxylic acid catabolic process; IDA:BHF-UCL
P27169	PON1	Serum paraoxonase/arylesterase 1	GO:0016311; P:dephosphorylation; IDA:GOC
P27169	PON1	Serum paraoxonase/arylesterase 1	GO:0046434; P:organophosphate catabolic process; IDA:BHF-UCL
P27169	PON1	Serum paraoxonase/arylesterase 1	GO:0046470; P:phosphatidylcholine metabolic process; IDA:BHF-UCL
P27169	PON1	Serum paraoxonase/arylesterase 1	GO:0051099; P:positive regulation of binding; IDA:BHF-UCL
P27169	PON1	Serum paraoxonase/arylesterase 1	GO:0010875; P:positive regulation of cholesterol efflux; IDA:BHF-UCL
P27169	PON1	Serum paraoxonase/arylesterase 1	GO:0032411; P:positive regulation of transporter activity; IDA:BHF-UCL
P27169	PON1	Serum paraoxonase/arylesterase 1	GO:0009605; P:response to external stimulus; NAS:UniProtKB
P27169	PON1	Serum paraoxonase/arylesterase 1	GO:0009636; P:response to toxic substance; IEA:Ensembl
Q15165	PON2	Serum paraoxonase/arylesterase 2	GO:0004064; F:arylesterase activity; TAS:ProtInc
Q15165	PON2	Serum paraoxonase/arylesterase 2	GO:0042802; F:identical protein binding; IDA:BHF-UCL
Q15165	PON2	Serum paraoxonase/arylesterase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15165	PON2	Serum paraoxonase/arylesterase 2	GO:0019439; P:aromatic compound catabolic process; IDA:BHF-UCL
Q15165	PON2	Serum paraoxonase/arylesterase 2	GO:0006979; P:response to oxidative stress; IEA:Ensembl
Q15166	PON3	Serum paraoxonase/lactonase 3	GO:0018733; F:3,4-dihydrocoumarin hydrolase activity; IEA:Ensembl
Q15166	PON3	Serum paraoxonase/lactonase 3	GO:0004063; F:aryldialkylphosphatase activity; IEA:UniProtKB-EC
Q15166	PON3	Serum paraoxonase/lactonase 3	GO:0004064; F:arylesterase activity; NAS:UniProtKB
Q15166	PON3	Serum paraoxonase/lactonase 3	GO:0047856; F:dihydrocoumarin hydrolase activity; IEA:Ensembl
Q15166	PON3	Serum paraoxonase/lactonase 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15166	PON3	Serum paraoxonase/lactonase 3	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
Q15166	PON3	Serum paraoxonase/lactonase 3	GO:0019439; P:aromatic compound catabolic process; IDA:BHF-UCL
Q15166	PON3	Serum paraoxonase/lactonase 3	GO:0046395; P:carboxylic acid catabolic process; IDA:BHF-UCL
Q15166	PON3	Serum paraoxonase/lactonase 3	GO:0046226; P:coumarin catabolic process; IEA:Ensembl
Q15166	PON3	Serum paraoxonase/lactonase 3	GO:0010124; P:phenylacetate catabolic process; IEA:Ensembl
Q15166	PON3	Serum paraoxonase/lactonase 3	GO:0009605; P:response to external stimulus; NAS:UniProtKB
Q99575	POP1	Ribonucleases P/MRP protein subunit POP1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q99575	POP1	Ribonucleases P/MRP protein subunit POP1	GO:0005515; F:protein binding; IPI:IntAct
Q99575	POP1	Ribonucleases P/MRP protein subunit POP1	GO:0000171; F:ribonuclease MRP activity; IDA:UniProtKB
Q99575	POP1	Ribonucleases P/MRP protein subunit POP1	GO:0004526; F:ribonuclease P activity; IDA:UniProtKB
Q99575	POP1	Ribonucleases P/MRP protein subunit POP1	GO:0090501; P:RNA phosphodiester bond hydrolysis; IDA:GOC
Q99575	POP1	Ribonucleases P/MRP protein subunit POP1	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; IDA:GOC
Q99575	POP1	Ribonucleases P/MRP protein subunit POP1	GO:0001682; P:tRNA 5'-leader removal; IEA:InterPro
Q99575	POP1	Ribonucleases P/MRP protein subunit POP1	GO:0016078; P:tRNA catabolic process; IDA:UniProtKB
Q969H6	POP5	Ribonuclease P/MRP protein subunit POP5	GO:0005515; F:protein binding; IPI:IntAct
Q969H6	POP5	Ribonuclease P/MRP protein subunit POP5	GO:0004526; F:ribonuclease P activity; IEA:UniProtKB-EC
Q969H6	POP5	Ribonuclease P/MRP protein subunit POP5	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
O75817	POP7	Ribonuclease P protein subunit p20	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75817	POP7	Ribonuclease P protein subunit p20	GO:0005515; F:protein binding; IPI:IntAct
O75817	POP7	Ribonuclease P protein subunit p20	GO:0004526; F:ribonuclease P activity; TAS:ProtInc
O75817	POP7	Ribonuclease P protein subunit p20	GO:0090501; P:RNA phosphodiester bond hydrolysis; TAS:GOC
O75817	POP7	Ribonuclease P protein subunit p20	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; TAS:GOC
O75817	POP7	Ribonuclease P protein subunit p20	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q8NE79	BVES	Blood vessel epicardial substance	GO:0005198; F:structural molecule activity; IDA:UniProtKB
Q8NE79	BVES	Blood vessel epicardial substance	GO:0090136; P:epithelial cell-cell adhesion; IDA:UniProtKB
Q8NE79	BVES	Blood vessel epicardial substance	GO:0007517; P:muscle organ development; NAS:UniProtKB
Q8NE79	BVES	Blood vessel epicardial substance	GO:0040017; P:positive regulation of locomotion; ISS:UniProtKB
Q8NE79	BVES	Blood vessel epicardial substance	GO:0001921; P:positive regulation of receptor recycling; ISS:UniProtKB
Q8NE79	BVES	Blood vessel epicardial substance	GO:0043088; P:regulation of Cdc42 GTPase activity; ISS:UniProtKB
Q8NE79	BVES	Blood vessel epicardial substance	GO:0008360; P:regulation of cell shape; ISS:UniProtKB
Q8NE79	BVES	Blood vessel epicardial substance	GO:0032314; P:regulation of Rac GTPase activity; ISS:UniProtKB
Q8NE79	BVES	Blood vessel epicardial substance	GO:0034446; P:substrate adhesion-dependent cell spreading; ISS:UniProtKB
Q8NE79	BVES	Blood vessel epicardial substance	GO:0016192; P:vesicle-mediated transport; ISS:UniProtKB
Q9H237	PORCN	Protein-cysteine N-palmitoyltransferase porcupine	GO:0016746; F:transferase activity, transferring acyl groups; IEA:UniProtKB-KW
Q9H237	PORCN	Protein-cysteine N-palmitoyltransferase porcupine	GO:0009100; P:glycoprotein metabolic process; IEA:Ensembl
Q9H237	PORCN	Protein-cysteine N-palmitoyltransferase porcupine	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9H8P0	SRD5A3	Polyprenol reductase	GO:0003865; F:3-oxo-5-alpha-steroid 4-dehydrogenase activity; IDA:UniProtKB
Q9H8P0	SRD5A3	Polyprenol reductase	GO:0047751; F:cholestenone 5-alpha-reductase activity; IEA:UniProtKB-EC
Q9H8P0	SRD5A3	Polyprenol reductase	GO:0016628; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; IDA:UniProtKB
Q9H8P0	SRD5A3	Polyprenol reductase	GO:0006702; P:androgen biosynthetic process; TAS:Reactome
Q9H8P0	SRD5A3	Polyprenol reductase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9H8P0	SRD5A3	Polyprenol reductase	GO:0019348; P:dolichol metabolic process; IDA:UniProtKB
Q9H8P0	SRD5A3	Polyprenol reductase	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; IMP:UniProtKB
Q9H8P0	SRD5A3	Polyprenol reductase	GO:0006489; P:dolichyl diphosphate biosynthetic process; TAS:Reactome
Q9H8P0	SRD5A3	Polyprenol reductase	GO:0016095; P:polyprenol catabolic process; IDA:UniProtKB
Q9H8P0	SRD5A3	Polyprenol reductase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9H8P0	SRD5A3	Polyprenol reductase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9H8P0	SRD5A3	Polyprenol reductase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H8P0	SRD5A3	Polyprenol reductase	GO:0008202; P:steroid metabolic process; TAS:Reactome
Q8N131	TMEM123	Porimin	GO:0004872; F:receptor activity; NAS:UniProtKB
Q8N131	TMEM123	Porimin	GO:0070267; P:oncosis; IDA:UniProtKB
Q15063	POSTN	Periostin	GO:0008201; F:heparin binding; ISS:UniProtKB
Q15063	POSTN	Periostin	GO:0007155; P:cell adhesion; IDA:UniProtKB
Q15063	POSTN	Periostin	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q15063	POSTN	Periostin	GO:0008593; P:regulation of Notch signaling pathway; IEA:Ensembl
Q15063	POSTN	Periostin	GO:0001501; P:skeletal system development; TAS:ProtInc
Q15063	POSTN	Periostin	GO:0009888; P:tissue development; IEA:Ensembl
Q9NUX5	POT1	Protection of telomeres protein 1	GO:0017151; F:DEAD/H-box RNA helicase binding; IPI:BHF-UCL
Q9NUX5	POT1	Protection of telomeres protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NUX5	POT1	Protection of telomeres protein 1	GO:0043047; F:single-stranded telomeric DNA binding; IMP:UniProtKB
Q9NUX5	POT1	Protection of telomeres protein 1	GO:0010521; F:telomerase inhibitor activity; IDA:BHF-UCL
Q9NUX5	POT1	Protection of telomeres protein 1	GO:0032508; P:DNA duplex unwinding; IDA:BHF-UCL
Q9NUX5	POT1	Protection of telomeres protein 1	GO:0051974; P:negative regulation of telomerase activity; IDA:BHF-UCL
Q9NUX5	POT1	Protection of telomeres protein 1	GO:0032211; P:negative regulation of telomere maintenance via telomerase; IMP:BHF-UCL
Q9NUX5	POT1	Protection of telomeres protein 1	GO:0060383; P:positive regulation of DNA strand elongation; IDA:BHF-UCL
Q9NUX5	POT1	Protection of telomeres protein 1	GO:0051096; P:positive regulation of helicase activity; IDA:BHF-UCL
Q9NUX5	POT1	Protection of telomeres protein 1	GO:0051973; P:positive regulation of telomerase activity; IDA:BHF-UCL
Q9NUX5	POT1	Protection of telomeres protein 1	GO:0032212; P:positive regulation of telomere maintenance via telomerase; IMP:BHF-UCL
Q9NUX5	POT1	Protection of telomeres protein 1	GO:0016233; P:telomere capping; IMP:BHF-UCL
Q9NUX5	POT1	Protection of telomeres protein 1	GO:0032203; P:telomere formation via telomerase; IDA:BHF-UCL
Q9NUX5	POT1	Protection of telomeres protein 1	GO:0000723; P:telomere maintenance; TAS:Reactome
Q9NUX5	POT1	Protection of telomeres protein 1	GO:0007004; P:telomere maintenance via telomerase; IDA:UniProtKB
A5A3E0	POTEF	POTE ankyrin domain family member F	GO:0001895; P:retina homeostasis; IEP:UniProt
Q6S8J3	POTEE	POTE ankyrin domain family member E	GO:0001895; P:retina homeostasis; IEP:UniProt
Q6S8J3	POTEE	POTE ankyrin domain family member E	GO:0021762; P:substantia nigra development; IEP:UniProt
P0CG39	POTEJ	POTE ankyrin domain family member J	GO:0001895; P:retina homeostasis; IEP:UniProt
P0CG38	POTEI	POTE ankyrin domain family member I	GO:0001895; P:retina homeostasis; IEP:UniProt
Q9BZL4	PPP1R12C	Protein phosphatase 1 regulatory subunit 12C	GO:0005515; F:protein binding; IPI:IntAct
B7ZBB8	PPP1R3G	Protein phosphatase 1 regulatory subunit 3G	GO:2001069; F:glycogen binding; IEA:Ensembl
B7ZBB8	PPP1R3G	Protein phosphatase 1 regulatory subunit 3G	GO:0042593; P:glucose homeostasis; IEA:Ensembl
B7ZBB8	PPP1R3G	Protein phosphatase 1 regulatory subunit 3G	GO:2000467; P:positive regulation of glycogen (starch) synthase activity; IEA:Ensembl
B7ZBB8	PPP1R3G	Protein phosphatase 1 regulatory subunit 3G	GO:0045725; P:positive regulation of glycogen biosynthetic process; IEA:Ensembl
Q9UHV8	LGALS13	Galactoside-binding soluble lectin 13	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q9UHV8	LGALS13	Galactoside-binding soluble lectin 13	GO:0004622; F:lysophospholipase activity; TAS:ProtInc
Q9UHV8	LGALS13	Galactoside-binding soluble lectin 13	GO:0005515; F:protein binding; IPI:IntAct
Q9UHV8	LGALS13	Galactoside-binding soluble lectin 13	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9UHV8	LGALS13	Galactoside-binding soluble lectin 13	GO:0006644; P:phospholipid metabolic process; TAS:ProtInc
Q96A00	PPP1R14A	Protein phosphatase 1 regulatory subunit 14A	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
Q96A00	PPP1R14A	Protein phosphatase 1 regulatory subunit 14A	GO:0042325; P:regulation of phosphorylation; IEA:InterPro
Q96C90	PPP1R14B	Protein phosphatase 1 regulatory subunit 14B	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
Q96C90	PPP1R14B	Protein phosphatase 1 regulatory subunit 14B	GO:0042325; P:regulation of phosphorylation; IEA:InterPro
Q8TAE6	PPP1R14C	Protein phosphatase 1 regulatory subunit 14C	GO:0004865; F:protein serine/threonine phosphatase inhibitor activity; IEA:Ensembl
Q8TAE6	PPP1R14C	Protein phosphatase 1 regulatory subunit 14C	GO:0042325; P:regulation of phosphorylation; IEA:InterPro
Q9NXH3	PPP1R14D	Protein phosphatase 1 regulatory subunit 14D	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
Q9NXH3	PPP1R14D	Protein phosphatase 1 regulatory subunit 14D	GO:0042325; P:regulation of phosphorylation; IEA:InterPro
Q96I34	PPP1R16A	Protein phosphatase 1 regulatory subunit 16A	GO:0005515; F:protein binding; IPI:IntAct
Q96T49	PPP1R16B	Protein phosphatase 1 regulatory inhibitor subunit 16B	GO:0005515; F:protein binding; IPI:UniProtKB
Q96T49	PPP1R16B	Protein phosphatase 1 regulatory inhibitor subunit 16B	GO:0019903; F:protein phosphatase binding; NAS:UniProtKB
Q96T49	PPP1R16B	Protein phosphatase 1 regulatory inhibitor subunit 16B	GO:0051489; P:regulation of filopodium assembly; ISS:UniProtKB
Q96T49	PPP1R16B	Protein phosphatase 1 regulatory inhibitor subunit 16B	GO:0007165; P:signal transduction; NAS:UniProtKB
P62136	PPP1CA	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P62136	PPP1CA	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit	GO:0005515; F:protein binding; IPI:UniProtKB
P62136	PPP1CA	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit	GO:0004722; F:protein serine/threonine phosphatase activity; TAS:ProtInc
P62136	PPP1CA	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit	GO:0043021; F:ribonucleoprotein complex binding; IEA:Ensembl
P62136	PPP1CA	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit	GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl
P62136	PPP1CA	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P62136	PPP1CA	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit	GO:0051301; P:cell division; IEA:UniProtKB-KW
P62136	PPP1CA	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit	GO:0005977; P:glycogen metabolic process; IEA:UniProtKB-KW
P62136	PPP1CA	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit	GO:0030324; P:lung development; IEA:Ensembl
P62136	PPP1CA	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
P62136	PPP1CA	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit	GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P62136	PPP1CA	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
P62136	PPP1CA	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit	GO:0005979; P:regulation of glycogen biosynthetic process; IEA:Ensembl
P62136	PPP1CA	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit	GO:0005981; P:regulation of glycogen catabolic process; IEA:Ensembl
P62136	PPP1CA	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P62136	PPP1CA	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P62136	PPP1CA	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit	GO:0019433; P:triglyceride catabolic process; TAS:Reactome
P62140	PPP1CB	Serine/threonine-protein phosphatase PP1-beta catalytic subunit	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P62140	PPP1CB	Serine/threonine-protein phosphatase PP1-beta catalytic subunit	GO:0017018; F:myosin phosphatase activity; ISS:UniProtKB
P62140	PPP1CB	Serine/threonine-protein phosphatase PP1-beta catalytic subunit	GO:0050115; F:myosin-light-chain-phosphatase activity; IDA:UniProtKB
P62140	PPP1CB	Serine/threonine-protein phosphatase PP1-beta catalytic subunit	GO:0005515; F:protein binding; IPI:UniProtKB
P62140	PPP1CB	Serine/threonine-protein phosphatase PP1-beta catalytic subunit	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P62140	PPP1CB	Serine/threonine-protein phosphatase PP1-beta catalytic subunit	GO:0051301; P:cell division; IEA:UniProtKB-KW
P62140	PPP1CB	Serine/threonine-protein phosphatase PP1-beta catalytic subunit	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P62140	PPP1CB	Serine/threonine-protein phosphatase PP1-beta catalytic subunit	GO:0005977; P:glycogen metabolic process; IEA:UniProtKB-KW
P62140	PPP1CB	Serine/threonine-protein phosphatase PP1-beta catalytic subunit	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P62140	PPP1CB	Serine/threonine-protein phosphatase PP1-beta catalytic subunit	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
P62140	PPP1CB	Serine/threonine-protein phosphatase PP1-beta catalytic subunit	GO:0006470; P:protein dephosphorylation; IEA:Ensembl
P62140	PPP1CB	Serine/threonine-protein phosphatase PP1-beta catalytic subunit	GO:0030155; P:regulation of cell adhesion; IDA:UniProtKB
P62140	PPP1CB	Serine/threonine-protein phosphatase PP1-beta catalytic subunit	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P62140	PPP1CB	Serine/threonine-protein phosphatase PP1-beta catalytic subunit	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P62140	PPP1CB	Serine/threonine-protein phosphatase PP1-beta catalytic subunit	GO:0019433; P:triglyceride catabolic process; TAS:Reactome
P36873	PPP1CC	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P36873	PPP1CC	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit	GO:0004721; F:phosphoprotein phosphatase activity; TAS:Reactome
P36873	PPP1CC	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P36873	PPP1CC	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit	GO:0005515; F:protein binding; IPI:IntAct
P36873	PPP1CC	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P36873	PPP1CC	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit	GO:0004722; F:protein serine/threonine phosphatase activity; IMP:UniProtKB
P36873	PPP1CC	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit	GO:0051301; P:cell division; IEA:UniProtKB-KW
P36873	PPP1CC	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit	GO:0005977; P:glycogen metabolic process; IEA:UniProtKB-KW
P36873	PPP1CC	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P36873	PPP1CC	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
P36873	PPP1CC	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit	GO:0006470; P:protein dephosphorylation; IEA:Ensembl
P36873	PPP1CC	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit	GO:0046822; P:regulation of nucleocytoplasmic transport; IEA:Ensembl
P36873	PPP1CC	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P36873	PPP1CC	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P36873	PPP1CC	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit	GO:0019433; P:triglyceride catabolic process; TAS:Reactome
Q15435	PPP1R7	Protein phosphatase 1 regulatory subunit 7	GO:0030234; F:enzyme regulator activity; NAS:UniProtKB
Q15435	PPP1R7	Protein phosphatase 1 regulatory subunit 7	GO:0008599; F:protein phosphatase type 1 regulator activity; TAS:ProtInc
Q15435	PPP1R7	Protein phosphatase 1 regulatory subunit 7	GO:0050790; P:regulation of catalytic activity; NAS:GOC
Q12972	PPP1R8	Nuclear inhibitor of protein phosphatase 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q12972	PPP1R8	Nuclear inhibitor of protein phosphatase 1	GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW
Q12972	PPP1R8	Nuclear inhibitor of protein phosphatase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q12972	PPP1R8	Nuclear inhibitor of protein phosphatase 1	GO:0008599; F:protein phosphatase type 1 regulator activity; IEA:Ensembl
Q12972	PPP1R8	Nuclear inhibitor of protein phosphatase 1	GO:0004865; F:protein serine/threonine phosphatase inhibitor activity; TAS:ProtInc
Q12972	PPP1R8	Nuclear inhibitor of protein phosphatase 1	GO:0008995; F:ribonuclease E activity; TAS:ProtInc
Q12972	PPP1R8	Nuclear inhibitor of protein phosphatase 1	GO:0003723; F:RNA binding; TAS:ProtInc
Q12972	PPP1R8	Nuclear inhibitor of protein phosphatase 1	GO:0008283; P:cell proliferation; IEA:Ensembl
Q12972	PPP1R8	Nuclear inhibitor of protein phosphatase 1	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q12972	PPP1R8	Nuclear inhibitor of protein phosphatase 1	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
Q12972	PPP1R8	Nuclear inhibitor of protein phosphatase 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q12972	PPP1R8	Nuclear inhibitor of protein phosphatase 1	GO:0006401; P:RNA catabolic process; TAS:ProtInc
Q12972	PPP1R8	Nuclear inhibitor of protein phosphatase 1	GO:0090501; P:RNA phosphodiester bond hydrolysis; TAS:GOC
Q12972	PPP1R8	Nuclear inhibitor of protein phosphatase 1	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q12972	PPP1R8	Nuclear inhibitor of protein phosphatase 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96QC0	PPP1R10	Serine/threonine-protein phosphatase 1 regulatory subunit 10	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96QC0	PPP1R10	Serine/threonine-protein phosphatase 1 regulatory subunit 10	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96QC0	PPP1R10	Serine/threonine-protein phosphatase 1 regulatory subunit 10	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96QC0	PPP1R10	Serine/threonine-protein phosphatase 1 regulatory subunit 10	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
Q96QC0	PPP1R10	Serine/threonine-protein phosphatase 1 regulatory subunit 10	GO:0006606; P:protein import into nucleus; TAS:ProtInc
Q96QC0	PPP1R10	Serine/threonine-protein phosphatase 1 regulatory subunit 10	GO:0006351; P:transcription, DNA-templated; IEA:InterPro
O60927	PPP1R11	Protein phosphatase 1 regulatory subunit 11	GO:0005515; F:protein binding; IPI:IntAct
O60927	PPP1R11	Protein phosphatase 1 regulatory subunit 11	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0005515; F:protein binding; IPI:UniProtKB
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0004722; F:protein serine/threonine phosphatase activity; IEA:Ensembl
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0006915; P:apoptotic process; TAS:UniProtKB
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0006672; P:ceramide metabolic process; NAS:UniProtKB
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0010467; P:gene expression; TAS:Reactome
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0000188; P:inactivation of MAPK activity; NAS:UniProtKB
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0007498; P:mesoderm development; IEA:Ensembl
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0007084; P:mitotic nuclear envelope reassembly; TAS:Reactome
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0010719; P:negative regulation of epithelial to mesenchymal transition; IMP:BHF-UCL
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0042518; P:negative regulation of tyrosine phosphorylation of Stat3 protein; NAS:UniProtKB
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IMP:BHF-UCL
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0006470; P:protein dephosphorylation; TAS:UniProtKB
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0070208; P:protein heterotrimerization; IEA:Ensembl
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0030155; P:regulation of cell adhesion; NAS:UniProtKB
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0045595; P:regulation of cell differentiation; NAS:UniProtKB
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0006275; P:regulation of DNA replication; NAS:UniProtKB
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0040008; P:regulation of growth; NAS:UniProtKB
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0031952; P:regulation of protein autophosphorylation; IEA:Ensembl
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0042176; P:regulation of protein catabolic process; IEA:Ensembl
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0010469; P:regulation of receptor activity; IEA:Ensembl
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0030111; P:regulation of Wnt signaling pathway; NAS:UniProtKB
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0010033; P:response to organic substance; NAS:UniProtKB
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0016070; P:RNA metabolic process; TAS:Reactome
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0008380; P:RNA splicing; NAS:UniProtKB
P67775	PPP2CA	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	GO:0019932; P:second-messenger-mediated signaling; NAS:UniProtKB
P62714	PPP2CB	Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P62714	PPP2CB	Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform	GO:0005515; F:protein binding; IPI:UniProtKB
P62714	PPP2CB	Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform	GO:0004722; F:protein serine/threonine phosphatase activity; IEA:Ensembl
P62714	PPP2CB	Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform	GO:0008637; P:apoptotic mitochondrial changes; IEA:Ensembl
P62714	PPP2CB	Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P62714	PPP2CB	Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform	GO:0046580; P:negative regulation of Ras protein signal transduction; IEA:Ensembl
P62714	PPP2CB	Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:Ensembl
P62714	PPP2CB	Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform	GO:0006470; P:protein dephosphorylation; TAS:UniProtKB
P62714	PPP2CB	Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform	GO:0010468; P:regulation of gene expression; IEA:Ensembl
P62714	PPP2CB	Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform	GO:0046677; P:response to antibiotic; IEA:Ensembl
P62714	PPP2CB	Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform	GO:0034976; P:response to endoplasmic reticulum stress; IEA:Ensembl
P62714	PPP2CB	Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0005509; F:calcium ion binding; NAS:UniProtKB
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0005516; F:calmodulin binding; IDA:UniProtKB
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0033192; F:calmodulin-dependent protein phosphatase activity; IDA:UniProtKB
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0008144; F:drug binding; IDA:UniProtKB
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0019899; F:enzyme binding; IDA:UniProtKB
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0004721; F:phosphoprotein phosphatase activity; IEA:UniProtKB-EC
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0005515; F:protein binding; IPI:UniProtKB
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0046983; F:protein dimerization activity; IPI:UniProtKB
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0004722; F:protein serine/threonine phosphatase activity; NAS:UniProtKB
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0033173; P:calcineurin-NFAT signaling cascade; IEA:Ensembl
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0006816; P:calcium ion transport; IEA:Ensembl
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0035690; P:cellular response to drug; IDA:UniProtKB
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0016311; P:dephosphorylation; TAS:UniProtKB
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0000082; P:G1/S transition of mitotic cell cycle; IEA:Ensembl
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0045087; P:innate immune response; TAS:Reactome
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0033555; P:multicellular organismal response to stress; IEA:Ensembl
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0046676; P:negative regulation of insulin secretion; IEA:Ensembl
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0006470; P:protein dephosphorylation; IDA:UniProtKB
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0006606; P:protein import into nucleus; IEA:Ensembl
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0050804; P:regulation of synaptic transmission; IEA:Ensembl
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0001975; P:response to amphetamine; IEA:Ensembl
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0051592; P:response to calcium ion; IDA:UniProtKB
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0048741; P:skeletal muscle fiber development; IEA:Ensembl
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0042110; P:T cell activation; TAS:UniProtKB
Q08209	PPP3CA	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	GO:0014883; P:transition between fast and slow fiber; IEA:Ensembl
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0005516; F:calmodulin binding; IDA:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0033192; F:calmodulin-dependent protein phosphatase activity; ISS:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0008144; F:drug binding; IDA:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0019899; F:enzyme binding; IDA:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0005515; F:protein binding; IPI:IntAct
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0046983; F:protein dimerization activity; IPI:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0030346; F:protein phosphatase 2B binding; IDA:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0004722; F:protein serine/threonine phosphatase activity; NAS:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0048675; P:axon extension; TAS:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0017156; P:calcium ion-dependent exocytosis; ISS:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0035690; P:cellular response to drug; IDA:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0016311; P:dephosphorylation; TAS:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0007507; P:heart development; IEA:Ensembl
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0045087; P:innate immune response; TAS:Reactome
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0007612; P:learning; TAS:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0007613; P:memory; TAS:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0001915; P:negative regulation of T cell mediated cytotoxicity; IEA:Ensembl
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0006470; P:protein dephosphorylation; ISS:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0050796; P:regulation of insulin secretion; ISS:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0048167; P:regulation of synaptic plasticity; TAS:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0034097; P:response to cytokine; IEA:Ensembl
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0007165; P:signal transduction; NAS:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0035176; P:social behavior; IEP:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0042110; P:T cell activation; TAS:UniProtKB
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0030217; P:T cell differentiation; IEA:Ensembl
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0043029; P:T cell homeostasis; IEA:Ensembl
P16298	PPP3CB	Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform	GO:0042098; P:T cell proliferation; NAS:UniProtKB
P48454	PPP3CC	Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P48454	PPP3CC	Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform	GO:0004721; F:phosphoprotein phosphatase activity; IEA:UniProtKB-KW
P48454	PPP3CC	Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform	GO:0006915; P:apoptotic process; TAS:Reactome
P48454	PPP3CC	Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
P48454	PPP3CC	Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
A8MPX8	PP2D1	Protein phosphatase 2C-like domain-containing protein 1	GO:0003824; F:catalytic activity; IEA:InterPro
P60510	PPP4C	Serine/threonine-protein phosphatase 4 catalytic subunit	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P60510	PPP4C	Serine/threonine-protein phosphatase 4 catalytic subunit	GO:0004704; F:NF-kappaB-inducing kinase activity; NAS:UniProtKB
P60510	PPP4C	Serine/threonine-protein phosphatase 4 catalytic subunit	GO:0005515; F:protein binding; IPI:UniProtKB
P60510	PPP4C	Serine/threonine-protein phosphatase 4 catalytic subunit	GO:0004722; F:protein serine/threonine phosphatase activity; IDA:UniProtKB
P60510	PPP4C	Serine/threonine-protein phosphatase 4 catalytic subunit	GO:0016311; P:dephosphorylation; IDA:GOC
P60510	PPP4C	Serine/threonine-protein phosphatase 4 catalytic subunit	GO:0038061; P:NIK/NF-kappaB signaling; NAS:GOC
P60510	PPP4C	Serine/threonine-protein phosphatase 4 catalytic subunit	GO:0010569; P:regulation of double-strand break repair via homologous recombination; IMP:UniProtKB
Q8TF05	PPP4R1	Serine/threonine-protein phosphatase 4 regulatory subunit 1	GO:0005515; F:protein binding; IPI:IntAct
Q8TF05	PPP4R1	Serine/threonine-protein phosphatase 4 regulatory subunit 1	GO:0030362; F:protein phosphatase type 4 regulator activity; NAS:UniProtKB
Q8TF05	PPP4R1	Serine/threonine-protein phosphatase 4 regulatory subunit 1	GO:0016311; P:dephosphorylation; ISS:GOC
Q8TF05	PPP4R1	Serine/threonine-protein phosphatase 4 regulatory subunit 1	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
Q8TF05	PPP4R1	Serine/threonine-protein phosphatase 4 regulatory subunit 1	GO:0050790; P:regulation of catalytic activity; NAS:GOC
Q8TF05	PPP4R1	Serine/threonine-protein phosphatase 4 regulatory subunit 1	GO:0007165; P:signal transduction; NAS:UniProtKB
Q9NY27	PPP4R2	Serine/threonine-protein phosphatase 4 regulatory subunit 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NY27	PPP4R2	Serine/threonine-protein phosphatase 4 regulatory subunit 2	GO:0030674; F:protein binding, bridging; IMP:UniProtKB
Q9NY27	PPP4R2	Serine/threonine-protein phosphatase 4 regulatory subunit 2	GO:0030362; F:protein phosphatase type 4 regulator activity; IMP:UniProtKB
Q9NY27	PPP4R2	Serine/threonine-protein phosphatase 4 regulatory subunit 2	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q9NY27	PPP4R2	Serine/threonine-protein phosphatase 4 regulatory subunit 2	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9NY27	PPP4R2	Serine/threonine-protein phosphatase 4 regulatory subunit 2	GO:0050790; P:regulation of catalytic activity; IMP:GOC
Q9NY27	PPP4R2	Serine/threonine-protein phosphatase 4 regulatory subunit 2	GO:0010569; P:regulation of double-strand break repair via homologous recombination; IMP:UniProtKB
Q9NY27	PPP4R2	Serine/threonine-protein phosphatase 4 regulatory subunit 2	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q6NUP7	PPP4R4	Serine/threonine-protein phosphatase 4 regulatory subunit 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q6NUP7	PPP4R4	Serine/threonine-protein phosphatase 4 regulatory subunit 4	GO:0019888; F:protein phosphatase regulator activity; IDA:MGI
Q6NUP7	PPP4R4	Serine/threonine-protein phosphatase 4 regulatory subunit 4	GO:0032515; P:negative regulation of phosphoprotein phosphatase activity; IDA:MGI
Q6NUP7	PPP4R4	Serine/threonine-protein phosphatase 4 regulatory subunit 4	GO:0080163; P:regulation of protein serine/threonine phosphatase activity; IDA:MGI
Q9UPN7	PPP6R1	Serine/threonine-protein phosphatase 6 regulatory subunit 1	GO:0005515; F:protein binding; IPI:IntAct
Q9UPN7	PPP6R1	Serine/threonine-protein phosphatase 6 regulatory subunit 1	GO:0019903; F:protein phosphatase binding; IPI:MGI
Q9UPN7	PPP6R1	Serine/threonine-protein phosphatase 6 regulatory subunit 1	GO:0043666; P:regulation of phosphoprotein phosphatase activity; IDA:MGI
O75170	PPP6R2	Serine/threonine-protein phosphatase 6 regulatory subunit 2	GO:0005515; F:protein binding; IPI:IntAct
Q5H9R7	PPP6R3	Serine/threonine-protein phosphatase 6 regulatory subunit 3	GO:0005515; F:protein binding; IPI:IntAct
Q5H9R7	PPP6R3	Serine/threonine-protein phosphatase 6 regulatory subunit 3	GO:0019903; F:protein phosphatase binding; IPI:MGI
Q5H9R7	PPP6R3	Serine/threonine-protein phosphatase 6 regulatory subunit 3	GO:0043666; P:regulation of phosphoprotein phosphatase activity; IDA:MGI
P13686	ACP5	Tartrate-resistant acid phosphatase type 5	GO:0003993; F:acid phosphatase activity; TAS:Reactome
P13686	ACP5	Tartrate-resistant acid phosphatase type 5	GO:0008199; F:ferric iron binding; IDA:UniProtKB
P13686	ACP5	Tartrate-resistant acid phosphatase type 5	GO:0008198; F:ferrous iron binding; IDA:UniProtKB
P13686	ACP5	Tartrate-resistant acid phosphatase type 5	GO:0060349; P:bone morphogenesis; IEA:Ensembl
P13686	ACP5	Tartrate-resistant acid phosphatase type 5	GO:0045453; P:bone resorption; IEA:Ensembl
P13686	ACP5	Tartrate-resistant acid phosphatase type 5	GO:0050830; P:defense response to Gram-positive bacterium; IEA:Ensembl
P13686	ACP5	Tartrate-resistant acid phosphatase type 5	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
P13686	ACP5	Tartrate-resistant acid phosphatase type 5	GO:0032691; P:negative regulation of interleukin-1 beta production; IEA:Ensembl
P13686	ACP5	Tartrate-resistant acid phosphatase type 5	GO:0032695; P:negative regulation of interleukin-12 production; IEA:Ensembl
P13686	ACP5	Tartrate-resistant acid phosphatase type 5	GO:0045019; P:negative regulation of nitric oxide biosynthetic process; IEA:Ensembl
P13686	ACP5	Tartrate-resistant acid phosphatase type 5	GO:0032929; P:negative regulation of superoxide anion generation; IEA:Ensembl
P13686	ACP5	Tartrate-resistant acid phosphatase type 5	GO:0032720; P:negative regulation of tumor necrosis factor production; IEA:Ensembl
P13686	ACP5	Tartrate-resistant acid phosphatase type 5	GO:0034097; P:response to cytokine; IEA:Ensembl
P13686	ACP5	Tartrate-resistant acid phosphatase type 5	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P13686	ACP5	Tartrate-resistant acid phosphatase type 5	GO:0006771; P:riboflavin metabolic process; TAS:Reactome
P13686	ACP5	Tartrate-resistant acid phosphatase type 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P13686	ACP5	Tartrate-resistant acid phosphatase type 5	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P13686	ACP5	Tartrate-resistant acid phosphatase type 5	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9NPH0	ACP6	Lysophosphatidic acid phosphatase type 6	GO:0003993; F:acid phosphatase activity; IEA:UniProtKB-EC
Q9NPH0	ACP6	Lysophosphatidic acid phosphatase type 6	GO:0052642; F:lysophosphatidic acid phosphatase activity; IDA:UniProtKB
Q9NPH0	ACP6	Lysophosphatidic acid phosphatase type 6	GO:0016311; P:dephosphorylation; IDA:GOC
Q9NPH0	ACP6	Lysophosphatidic acid phosphatase type 6	GO:2001311; P:lysobisphosphatidic acid metabolic process; IDA:UniProtKB
Q9NPH0	ACP6	Lysophosphatidic acid phosphatase type 6	GO:0006644; P:phospholipid metabolic process; IMP:UniProtKB
Q8IY26	PPAPDC2	Presqualene diphosphate phosphatase	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q8NBV4	PPAPDC3	Probable lipid phosphate phosphatase PPAPDC3	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q8NBV4	PPAPDC3	Probable lipid phosphate phosphatase PPAPDC3	GO:0010832; P:negative regulation of myotube differentiation; IEA:Ensembl
P24666	ACP1	Low molecular weight phosphotyrosine protein phosphatase	GO:0003993; F:acid phosphatase activity; TAS:ProtInc
P24666	ACP1	Low molecular weight phosphotyrosine protein phosphatase	GO:0004726; F:non-membrane spanning protein tyrosine phosphatase activity; IEA:InterPro
P24666	ACP1	Low molecular weight phosphotyrosine protein phosphatase	GO:0005515; F:protein binding; IPI:UniProtKB
P11117	ACP2	Lysosomal acid phosphatase	GO:0003993; F:acid phosphatase activity; TAS:ProtInc
P11117	ACP2	Lysosomal acid phosphatase	GO:0016311; P:dephosphorylation; TAS:GOC
P11117	ACP2	Lysosomal acid phosphatase	GO:0007040; P:lysosome organization; IEA:Ensembl
P11117	ACP2	Lysosomal acid phosphatase	GO:0001501; P:skeletal system development; IEA:Ensembl
P15309	ACPP	Prostatic acid phosphatase	GO:0008253; F:5'-nucleotidase activity; IDA:UniProt
P15309	ACPP	Prostatic acid phosphatase	GO:0003993; F:acid phosphatase activity; IMP:UniProt
P15309	ACPP	Prostatic acid phosphatase	GO:0033265; F:choline binding; IEA:Ensembl
P15309	ACPP	Prostatic acid phosphatase	GO:0042802; F:identical protein binding; IPI:IntAct
P15309	ACPP	Prostatic acid phosphatase	GO:0052642; F:lysophosphatidic acid phosphatase activity; IDA:UniProt
P15309	ACPP	Prostatic acid phosphatase	GO:0016791; F:phosphatase activity; IMP:UniProt
P15309	ACPP	Prostatic acid phosphatase	GO:0005515; F:protein binding; IPI:IntAct
P15309	ACPP	Prostatic acid phosphatase	GO:0042131; F:thiamine phosphate phosphatase activity; ISS:UniProt
P15309	ACPP	Prostatic acid phosphatase	GO:0046085; P:adenosine metabolic process; IDA:UniProt
P15309	ACPP	Prostatic acid phosphatase	GO:0016311; P:dephosphorylation; IMP:UniProt
P15309	ACPP	Prostatic acid phosphatase	GO:0009117; P:nucleotide metabolic process; IEA:Ensembl
P15309	ACPP	Prostatic acid phosphatase	GO:0060168; P:positive regulation of adenosine receptor signaling pathway; IMP:UniProt
P15309	ACPP	Prostatic acid phosphatase	GO:0006144; P:purine nucleobase metabolic process; IEA:Ensembl
P15309	ACPP	Prostatic acid phosphatase	GO:0051930; P:regulation of sensory perception of pain; IMP:UniProt
P15309	ACPP	Prostatic acid phosphatase	GO:0006772; P:thiamine metabolic process; ISS:UniProt
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0003677; F:DNA binding; TAS:ProtInc
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0008144; F:drug binding; IDA:UniProtKB
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:UniProtKB
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0008289; F:lipid binding; IDA:UniProtKB
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0005515; F:protein binding; IPI:UniProtKB
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:BHF-UCL
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0043565; F:sequence-specific DNA binding; ISS:BHF-UCL
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0003707; F:steroid hormone receptor activity; IDA:BHF-UCL
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0031624; F:ubiquitin conjugating enzyme binding; IPI:BHF-UCL
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0008270; F:zinc ion binding; IEA:InterPro
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0035095; P:behavioral response to nicotine; IEA:Ensembl
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0070166; P:enamel mineralization; IEA:Ensembl
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0008544; P:epidermis development; IEA:Ensembl
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0006631; P:fatty acid metabolic process; TAS:ProtInc
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0015908; P:fatty acid transport; TAS:UniProtKB
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0010467; P:gene expression; TAS:Reactome
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0007507; P:heart development; IEA:Ensembl
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0030522; P:intracellular receptor signaling pathway; IDA:GOC
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0042157; P:lipoprotein metabolic process; IEA:Ensembl
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0032099; P:negative regulation of appetite; ISS:UniProtKB
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0010887; P:negative regulation of cholesterol storage; IDA:BHF-UCL
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0045820; P:negative regulation of glycolytic process; IC:BHF-UCL
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; IDA:BHF-UCL
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:1901215; P:negative regulation of neuron death; IEA:Ensembl
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0032091; P:negative regulation of protein binding; IEA:Ensembl
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0010871; P:negative regulation of receptor biosynthetic process; IDA:BHF-UCL
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0010891; P:negative regulation of sequestering of triglyceride; IDA:BHF-UCL
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:2000678; P:negative regulation of transcription regulatory region DNA binding; IEA:Ensembl
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0032000; P:positive regulation of fatty acid beta-oxidation; TAS:UniProtKB
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0046321; P:positive regulation of fatty acid oxidation; ISS:BHF-UCL
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0072366; P:regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0072363; P:regulation of glycolytic by positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0072369; P:regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0032868; P:response to insulin; IEA:Ensembl
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q07869	PPARA	Peroxisome proliferator-activated receptor alpha	GO:0042060; P:wound healing; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0003677; F:DNA binding; ISS:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0008144; F:drug binding; IDA:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0070539; F:linoleic acid binding; IDA:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0008289; F:lipid binding; IDA:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0005515; F:protein binding; IPI:IntAct
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0003707; F:steroid hormone receptor activity; TAS:ProtInc
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0003713; F:transcription coactivator activity; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0008270; F:zinc ion binding; IEA:InterPro
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0060612; P:adipose tissue development; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0042640; P:anagen; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0097190; P:apoptotic signaling pathway; IMP:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0008366; P:axon ensheathment; ISS:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0030154; P:cell differentiation; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0008283; P:cell proliferation; ISS:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0031589; P:cell-substrate adhesion; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0008203; P:cholesterol metabolic process; TAS:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0046697; P:decidualization; TAS:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0007566; P:embryo implantation; TAS:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0006635; P:fatty acid beta-oxidation; ISS:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0009062; P:fatty acid catabolic process; TAS:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0015908; P:fatty acid transport; ISS:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0010467; P:gene expression; TAS:Reactome
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0006006; P:glucose metabolic process; NAS:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0015758; P:glucose transport; NAS:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0007507; P:heart development; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0030522; P:intracellular receptor signaling pathway; IDA:GOC
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0051546; P:keratinocyte migration; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0043616; P:keratinocyte proliferation; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0006629; P:lipid metabolic process; ISS:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0009299; P:mRNA transcription; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0032966; P:negative regulation of collagen biosynthetic process; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0014912; P:negative regulation of smooth muscle cell migration; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0008654; P:phospholipid biosynthetic process; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0045684; P:positive regulation of epidermis development; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0045600; P:positive regulation of fat cell differentiation; NAS:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0045909; P:positive regulation of vasodilation; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0006029; P:proteoglycan metabolic process; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0014823; P:response to activity; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0009749; P:response to glucose; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0033189; P:response to vitamin A; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0006776; P:vitamin A metabolic process; IEA:Ensembl
Q03181	PPARD	Peroxisome proliferator-activated receptor delta	GO:0042060; P:wound healing; IEA:Ensembl
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0033613; F:activating transcription factor binding; IDA:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0050544; F:arachidonic acid binding; ISS:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0003682; F:chromatin binding; IEA:Ensembl
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0003677; F:DNA binding; IDA:UniProtKB
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0008144; F:drug binding; IDA:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0019899; F:enzyme binding; IPI:UniProtKB
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IDA:UniProtKB
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0004955; F:prostaglandin receptor activity; TAS:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0005515; F:protein binding; IPI:IntAct
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0046965; F:retinoid X receptor binding; IDA:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0001012; F:RNA polymerase II regulatory region DNA binding; IEA:Ensembl
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0008270; F:zinc ion binding; IEA:InterPro
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0045165; P:cell fate commitment; ISS:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0048469; P:cell maturation; IDA:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0032869; P:cellular response to insulin stimulus; IMP:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0071285; P:cellular response to lithium ion; IEA:Ensembl
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0030855; P:epithelial cell differentiation; ISS:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0019395; P:fatty acid oxidation; IEA:Ensembl
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GOC
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0010467; P:gene expression; TAS:Reactome
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0042593; P:glucose homeostasis; IMP:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0007507; P:heart development; IEA:Ensembl
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0045087; P:innate immune response; TAS:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0055088; P:lipid homeostasis; TAS:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0006629; P:lipid metabolic process; TAS:ProtInc
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0042953; P:lipoprotein transport; IDA:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0015909; P:long-chain fatty acid transport; ISS:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0045713; P:low-density lipoprotein particle receptor biosynthetic process; IDA:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0030224; P:monocyte differentiation; IDA:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0002674; P:negative regulation of acute inflammatory response; IEA:Ensembl
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0010887; P:negative regulation of cholesterol storage; IDA:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0060336; P:negative regulation of interferon-gamma-mediated signaling pathway; IMP:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; IDA:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0010871; P:negative regulation of receptor biosynthetic process; IDA:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0010891; P:negative regulation of sequestering of triglyceride; IDA:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IDA:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0051974; P:negative regulation of telomerase activity; IEA:Ensembl
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0031100; P:organ regeneration; IEA:Ensembl
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0035357; P:peroxisome proliferator activated receptor signaling pathway; IMP:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0001890; P:placenta development; ISS:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0045600; P:positive regulation of fat cell differentiation; ISS:HGNC
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0046321; P:positive regulation of fatty acid oxidation; IEA:Ensembl
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0048714; P:positive regulation of oligodendrocyte differentiation; IEA:Ensembl
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0008217; P:regulation of blood pressure; IMP:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0060694; P:regulation of cholesterol transporter activity; IC:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0060850; P:regulation of transcription involved in cell fate commitment; ISS:UniProtKB
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0031000; P:response to caffeine; IEA:Ensembl
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0009409; P:response to cold; IEA:Ensembl
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0042493; P:response to drug; IEA:Ensembl
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0043627; P:response to estrogen; IEA:Ensembl
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0033993; P:response to lipid; ISS:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0055098; P:response to low-density lipoprotein particle; IDA:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0007584; P:response to nutrient; TAS:ProtInc
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0032526; P:response to retinoic acid; IDA:UniProtKB
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0033189; P:response to vitamin A; IEA:Ensembl
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0007165; P:signal transduction; IDA:BHF-UCL
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P37231	PPARG	Peroxisome proliferator-activated receptor gamma	GO:0050872; P:white fat cell differentiation; TAS:UniProtKB
Q9BZG2	ACPT	Testicular acid phosphatase	GO:0003993; F:acid phosphatase activity; IEA:UniProtKB-EC
P05187	ALPP	Alkaline phosphatase, placental type	GO:0004035; F:alkaline phosphatase activity; IDA:UniProtKB
P05187	ALPP	Alkaline phosphatase, placental type	GO:0000287; F:magnesium ion binding; ISS:UniProtKB
P05187	ALPP	Alkaline phosphatase, placental type	GO:0008270; F:zinc ion binding; ISS:UniProtKB
P05187	ALPP	Alkaline phosphatase, placental type	GO:0016311; P:dephosphorylation; IDA:GOC
P09923	ALPI	Intestinal-type alkaline phosphatase	GO:0004035; F:alkaline phosphatase activity; ISS:UniProtKB
P09923	ALPI	Intestinal-type alkaline phosphatase	GO:0000287; F:magnesium ion binding; ISS:UniProtKB
P09923	ALPI	Intestinal-type alkaline phosphatase	GO:0008270; F:zinc ion binding; ISS:UniProtKB
P09923	ALPI	Intestinal-type alkaline phosphatase	GO:0016311; P:dephosphorylation; ISS:UniProtKB
P10696	ALPPL2	Alkaline phosphatase, placental-like	GO:0004035; F:alkaline phosphatase activity; NAS:UniProtKB
P10696	ALPPL2	Alkaline phosphatase, placental-like	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P10696	ALPPL2	Alkaline phosphatase, placental-like	GO:0016311; P:dephosphorylation; NAS:GOC
P05186	ALPL	Alkaline phosphatase, tissue-nonspecific isozyme	GO:0004035; F:alkaline phosphatase activity; IEA:UniProtKB-EC
P05186	ALPL	Alkaline phosphatase, tissue-nonspecific isozyme	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P05186	ALPL	Alkaline phosphatase, tissue-nonspecific isozyme	GO:0005515; F:protein binding; IPI:IntAct
P05186	ALPL	Alkaline phosphatase, tissue-nonspecific isozyme	GO:0016462; F:pyrophosphatase activity; IDA:MGI
P05186	ALPL	Alkaline phosphatase, tissue-nonspecific isozyme	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
P05186	ALPL	Alkaline phosphatase, tissue-nonspecific isozyme	GO:0071529; P:cementum mineralization; IEA:Ensembl
P05186	ALPL	Alkaline phosphatase, tissue-nonspecific isozyme	GO:0003006; P:developmental process involved in reproduction; IEA:Ensembl
P05186	ALPL	Alkaline phosphatase, tissue-nonspecific isozyme	GO:0001958; P:endochondral ossification; IEA:Ensembl
P05186	ALPL	Alkaline phosphatase, tissue-nonspecific isozyme	GO:0046677; P:response to antibiotic; IEA:Ensembl
P05186	ALPL	Alkaline phosphatase, tissue-nonspecific isozyme	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P05186	ALPL	Alkaline phosphatase, tissue-nonspecific isozyme	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P05186	ALPL	Alkaline phosphatase, tissue-nonspecific isozyme	GO:0033280; P:response to vitamin D; IEP:BHF-UCL
P05186	ALPL	Alkaline phosphatase, tissue-nonspecific isozyme	GO:0001501; P:skeletal system development; TAS:ProtInc
Q5VZY2	PPAPDC1A	Phosphatidate phosphatase PPAPDC1A	GO:0008195; F:phosphatidate phosphatase activity; IDA:UniProtKB
Q5VZY2	PPAPDC1A	Phosphatidate phosphatase PPAPDC1A	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q5VZY2	PPAPDC1A	Phosphatidate phosphatase PPAPDC1A	GO:0045087; P:innate immune response; TAS:Reactome
Q5VZY2	PPAPDC1A	Phosphatidate phosphatase PPAPDC1A	GO:0046839; P:phospholipid dephosphorylation; IDA:UniProtKB
Q8NEB5	PPAPDC1B	Phosphatidate phosphatase PPAPDC1B	GO:0008195; F:phosphatidate phosphatase activity; IDA:UniProtKB
Q8NEB5	PPAPDC1B	Phosphatidate phosphatase PPAPDC1B	GO:0046839; P:phospholipid dephosphorylation; IDA:UniProtKB
Q4J6C6	PREPL	Prolyl endopeptidase-like	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q4J6C6	PREPL	Prolyl endopeptidase-like	GO:0070008; F:serine-type exopeptidase activity; IEA:InterPro
P48147	PREP	Prolyl endopeptidase	GO:0004252; F:serine-type endopeptidase activity; TAS:ProtInc
P48147	PREP	Prolyl endopeptidase	GO:0070008; F:serine-type exopeptidase activity; IEA:InterPro
P48147	PREP	Prolyl endopeptidase	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
P48147	PREP	Prolyl endopeptidase	GO:0006508; P:proteolysis; TAS:ProtInc
Q9HAB8	PPCS	Phosphopantothenate--cysteine ligase	GO:0004632; F:phosphopantothenate--cysteine ligase activity; IDA:UniProtKB
Q9HAB8	PPCS	Phosphopantothenate--cysteine ligase	GO:0015937; P:coenzyme A biosynthetic process; IDA:UniProtKB
Q9HAB8	PPCS	Phosphopantothenate--cysteine ligase	GO:0009108; P:coenzyme biosynthetic process; TAS:Reactome
Q9HAB8	PPCS	Phosphopantothenate--cysteine ligase	GO:0015939; P:pantothenate metabolic process; TAS:Reactome
Q9HAB8	PPCS	Phosphopantothenate--cysteine ligase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9HAB8	PPCS	Phosphopantothenate--cysteine ligase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9HAB8	PPCS	Phosphopantothenate--cysteine ligase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9UKL6	PCTP	Phosphatidylcholine transfer protein	GO:0031210; F:phosphatidylcholine binding; IDA:UniProtKB
Q9UKL6	PCTP	Phosphatidylcholine transfer protein	GO:0008525; F:phosphatidylcholine transporter activity; IDA:UniProtKB
Q9UKL6	PCTP	Phosphatidylcholine transfer protein	GO:0008203; P:cholesterol metabolic process; IEA:Ensembl
Q9UKL6	PCTP	Phosphatidylcholine transfer protein	GO:0006869; P:lipid transport; NAS:UniProtKB
Q9UKL6	PCTP	Phosphatidylcholine transfer protein	GO:0015914; P:phospholipid transport; IDA:UniProtKB
Q9H3Y8	PPDPF	Pancreatic progenitor cell differentiation and proliferation factor	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9H3Y8	PPDPF	Pancreatic progenitor cell differentiation and proliferation factor	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
O14829	PPEF1	Serine/threonine-protein phosphatase with EF-hands 1	GO:0005509; F:calcium ion binding; IEA:InterPro
O14829	PPEF1	Serine/threonine-protein phosphatase with EF-hands 1	GO:0005506; F:iron ion binding; IEA:InterPro
O14829	PPEF1	Serine/threonine-protein phosphatase with EF-hands 1	GO:0030145; F:manganese ion binding; IEA:InterPro
O14829	PPEF1	Serine/threonine-protein phosphatase with EF-hands 1	GO:0005515; F:protein binding; IPI:IntAct
O14829	PPEF1	Serine/threonine-protein phosphatase with EF-hands 1	GO:0004722; F:protein serine/threonine phosphatase activity; TAS:Reactome
O14829	PPEF1	Serine/threonine-protein phosphatase with EF-hands 1	GO:0050906; P:detection of stimulus involved in sensory perception; IEA:InterPro
O14829	PPEF1	Serine/threonine-protein phosphatase with EF-hands 1	GO:0007603; P:phototransduction, visible light; TAS:Reactome
O14829	PPEF1	Serine/threonine-protein phosphatase with EF-hands 1	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
O14829	PPEF1	Serine/threonine-protein phosphatase with EF-hands 1	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
O14829	PPEF1	Serine/threonine-protein phosphatase with EF-hands 1	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
O14830	PPEF2	Serine/threonine-protein phosphatase with EF-hands 2	GO:0005509; F:calcium ion binding; IEA:InterPro
O14830	PPEF2	Serine/threonine-protein phosphatase with EF-hands 2	GO:0030544; F:Hsp70 protein binding; IDA:BHF-UCL
O14830	PPEF2	Serine/threonine-protein phosphatase with EF-hands 2	GO:0051879; F:Hsp90 protein binding; IDA:BHF-UCL
O14830	PPEF2	Serine/threonine-protein phosphatase with EF-hands 2	GO:0005506; F:iron ion binding; IEA:InterPro
O14830	PPEF2	Serine/threonine-protein phosphatase with EF-hands 2	GO:0030145; F:manganese ion binding; IEA:InterPro
O14830	PPEF2	Serine/threonine-protein phosphatase with EF-hands 2	GO:0031435; F:mitogen-activated protein kinase kinase kinase binding; IPI:BHF-UCL
O14830	PPEF2	Serine/threonine-protein phosphatase with EF-hands 2	GO:0005515; F:protein binding; IPI:IntAct
O14830	PPEF2	Serine/threonine-protein phosphatase with EF-hands 2	GO:0004722; F:protein serine/threonine phosphatase activity; TAS:ProtInc
O14830	PPEF2	Serine/threonine-protein phosphatase with EF-hands 2	GO:0050906; P:detection of stimulus involved in sensory perception; IEA:InterPro
O14830	PPEF2	Serine/threonine-protein phosphatase with EF-hands 2	GO:0043409; P:negative regulation of MAPK cascade; IDA:BHF-UCL
O14830	PPEF2	Serine/threonine-protein phosphatase with EF-hands 2	GO:0010801; P:negative regulation of peptidyl-threonine phosphorylation; IDA:BHF-UCL
O14830	PPEF2	Serine/threonine-protein phosphatase with EF-hands 2	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
O14830	PPEF2	Serine/threonine-protein phosphatase with EF-hands 2	GO:0043506; P:regulation of JUN kinase activity; IC:BHF-UCL
O14830	PPEF2	Serine/threonine-protein phosphatase with EF-hands 2	GO:0043405; P:regulation of MAP kinase activity; IC:BHF-UCL
O14830	PPEF2	Serine/threonine-protein phosphatase with EF-hands 2	GO:0007601; P:visual perception; IEA:UniProtKB-KW
P10619	CTSA	Lysosomal protective protein	GO:0004180; F:carboxypeptidase activity; TAS:ProtInc
P10619	CTSA	Lysosomal protective protein	GO:0008047; F:enzyme activator activity; TAS:ProtInc
P10619	CTSA	Lysosomal protective protein	GO:0004185; F:serine-type carboxypeptidase activity; IEA:InterPro
P10619	CTSA	Lysosomal protective protein	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
P10619	CTSA	Lysosomal protective protein	GO:0006886; P:intracellular protein transport; TAS:ProtInc
P10619	CTSA	Lysosomal protective protein	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
P10619	CTSA	Lysosomal protective protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P10619	CTSA	Lysosomal protective protein	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q8NEY8	PPHLN1	Periphilin-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8NEY8	PPHLN1	Periphilin-1	GO:0031424; P:keratinization; IEA:UniProtKB-KW
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0042277; F:peptide binding; IEA:UniProtKB-KW
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IDA:UniProtKB
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0005515; F:protein binding; IPI:IntAct
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0051082; F:unfolded protein binding; TAS:UniProtKB
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0046790; F:virion binding; NAS:UniProtKB
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0007596; P:blood coagulation; TAS:Reactome
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0030260; P:entry into host cell; TAS:Reactome
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0075713; P:establishment of integrated proviral latency; TAS:Reactome
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0050900; P:leukocyte migration; TAS:Reactome
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0034389; P:lipid particle organization; IMP:UniProtKB
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0030168; P:platelet activation; TAS:Reactome
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0002576; P:platelet degranulation; TAS:Reactome
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0050714; P:positive regulation of protein secretion; IMP:UniProtKB
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0045070; P:positive regulation of viral genome replication; IMP:UniProtKB
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0006457; P:protein folding; TAS:UniProtKB
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0000413; P:protein peptidyl-prolyl isomerization; IDA:UniProtKB
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0045069; P:regulation of viral genome replication; IMP:UniProtKB
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0006278; P:RNA-dependent DNA replication; TAS:Reactome
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0019061; P:uncoating of virus; TAS:Reactome
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0019058; P:viral life cycle; TAS:Reactome
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0016032; P:viral process; TAS:Reactome
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0019076; P:viral release from host cell; TAS:UniProtKB
P62937	PPIA	Peptidyl-prolyl cis-trans isomerase A	GO:0019068; P:virion assembly; TAS:Reactome
P23284	PPIB	Peptidyl-prolyl cis-trans isomerase B	GO:0042277; F:peptide binding; IEA:UniProtKB-KW
P23284	PPIB	Peptidyl-prolyl cis-trans isomerase B	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; NAS:UniProtKB
P23284	PPIB	Peptidyl-prolyl cis-trans isomerase B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P23284	PPIB	Peptidyl-prolyl cis-trans isomerase B	GO:0005515; F:protein binding; IPI:IntAct
P23284	PPIB	Peptidyl-prolyl cis-trans isomerase B	GO:0032403; F:protein complex binding; ISS:UniProt
P23284	PPIB	Peptidyl-prolyl cis-trans isomerase B	GO:0051082; F:unfolded protein binding; TAS:ProtInc
P23284	PPIB	Peptidyl-prolyl cis-trans isomerase B	GO:0060348; P:bone development; IMP:UniProt
P23284	PPIB	Peptidyl-prolyl cis-trans isomerase B	GO:0061077; P:chaperone-mediated protein folding; IDA:UniProt
P23284	PPIB	Peptidyl-prolyl cis-trans isomerase B	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P23284	PPIB	Peptidyl-prolyl cis-trans isomerase B	GO:0040018; P:positive regulation of multicellular organism growth; IMP:UniProt
P23284	PPIB	Peptidyl-prolyl cis-trans isomerase B	GO:0000413; P:protein peptidyl-prolyl isomerization; ISS:UniProt
P23284	PPIB	Peptidyl-prolyl cis-trans isomerase B	GO:0050821; P:protein stabilization; IMP:UniProt
P45877	PPIC	Peptidyl-prolyl cis-trans isomerase C	GO:0016018; F:cyclosporin A binding; TAS:ProtInc
P45877	PPIC	Peptidyl-prolyl cis-trans isomerase C	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW
P45877	PPIC	Peptidyl-prolyl cis-trans isomerase C	GO:0051082; F:unfolded protein binding; TAS:ProtInc
P45877	PPIC	Peptidyl-prolyl cis-trans isomerase C	GO:0006457; P:protein folding; IEA:UniProtKB-KW
P45877	PPIC	Peptidyl-prolyl cis-trans isomerase C	GO:0007165; P:signal transduction; TAS:ProtInc
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0016018; F:cyclosporin A binding; TAS:UniProtKB
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0030331; F:estrogen receptor binding; ISS:UniProtKB
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0031072; F:heat shock protein binding; IPI:UniProtKB
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0030544; F:Hsp70 protein binding; ISS:UniProtKB
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0051879; F:Hsp90 protein binding; IDA:UniProtKB
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IDA:UniProtKB
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0005515; F:protein binding; IPI:IntAct
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0008134; F:transcription factor binding; IDA:UniProtKB
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0071492; P:cellular response to UV-A; IMP:UniProtKB
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0061077; P:chaperone-mediated protein folding; IDA:UniProtKB
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0034389; P:lipid particle organization; IMP:UniProtKB
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0050714; P:positive regulation of protein secretion; IMP:UniProtKB
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0045070; P:positive regulation of viral genome replication; IMP:UniProtKB
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0006461; P:protein complex assembly; IDA:UniProtKB
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0006457; P:protein folding; ISS:UniProtKB
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0000413; P:protein peptidyl-prolyl isomerization; IDA:GOC
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q08752	PPID	Peptidyl-prolyl cis-trans isomerase D	GO:0019076; P:viral release from host cell; TAS:UniProtKB
Q9UNP9	PPIE	Peptidyl-prolyl cis-trans isomerase E	GO:0016018; F:cyclosporin A binding; TAS:ProtInc
Q9UNP9	PPIE	Peptidyl-prolyl cis-trans isomerase E	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9UNP9	PPIE	Peptidyl-prolyl cis-trans isomerase E	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; TAS:UniProtKB
Q9UNP9	PPIE	Peptidyl-prolyl cis-trans isomerase E	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UNP9	PPIE	Peptidyl-prolyl cis-trans isomerase E	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UNP9	PPIE	Peptidyl-prolyl cis-trans isomerase E	GO:0003723; F:RNA binding; TAS:UniProtKB
Q9UNP9	PPIE	Peptidyl-prolyl cis-trans isomerase E	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q9UNP9	PPIE	Peptidyl-prolyl cis-trans isomerase E	GO:0045070; P:positive regulation of viral genome replication; IMP:UniProtKB
Q9UNP9	PPIE	Peptidyl-prolyl cis-trans isomerase E	GO:0006457; P:protein folding; IEA:UniProtKB-KW
Q9UNP9	PPIE	Peptidyl-prolyl cis-trans isomerase E	GO:0000413; P:protein peptidyl-prolyl isomerization; TAS:GOC
Q9UNP9	PPIE	Peptidyl-prolyl cis-trans isomerase E	GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB
P30405	PPIF	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	GO:0016018; F:cyclosporin A binding; IEA:Ensembl
P30405	PPIF	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW
P30405	PPIF	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
P30405	PPIF	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	GO:0008637; P:apoptotic mitochondrial changes; IEA:Ensembl
P30405	PPIF	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	GO:0071243; P:cellular response to arsenic-containing substance; ISS:UniProtKB
P30405	PPIF	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB
P30405	PPIF	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	GO:0070301; P:cellular response to hydrogen peroxide; IMP:UniProtKB
P30405	PPIF	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P30405	PPIF	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	GO:0032780; P:negative regulation of ATPase activity; ISS:UniProtKB
P30405	PPIF	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
P30405	PPIF	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	GO:0090324; P:negative regulation of oxidative phosphorylation; ISS:UniProtKB
P30405	PPIF	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	GO:2000276; P:negative regulation of oxidative phosphorylation uncoupler activity; ISS:UniProtKB
P30405	PPIF	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; IDA:UniProtKB
P30405	PPIF	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	GO:0010940; P:positive regulation of necrotic cell death; IEA:Ensembl
P30405	PPIF	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; ISS:UniProtKB
P30405	PPIF	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	GO:0006457; P:protein folding; IEA:UniProtKB-KW
P30405	PPIF	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	GO:0046902; P:regulation of mitochondrial membrane permeability; ISS:UniProtKB
P30405	PPIF	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	GO:1902445; P:regulation of mitochondrial membrane permeability involved in programmed necrotic cell death; IMP:UniProtKB
P30405	PPIF	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	GO:0010849; P:regulation of proton-transporting ATPase activity, rotational mechanism; ISS:UniProtKB
P30405	PPIF	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	GO:0002931; P:response to ischemia; ISS:UniProtKB
Q13427	PPIG	Peptidyl-prolyl cis-trans isomerase G	GO:0016018; F:cyclosporin A binding; TAS:ProtInc
Q13427	PPIG	Peptidyl-prolyl cis-trans isomerase G	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW
Q13427	PPIG	Peptidyl-prolyl cis-trans isomerase G	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13427	PPIG	Peptidyl-prolyl cis-trans isomerase G	GO:0005515; F:protein binding; IPI:IntAct
Q13427	PPIG	Peptidyl-prolyl cis-trans isomerase G	GO:0006457; P:protein folding; IEA:UniProtKB-KW
Q13427	PPIG	Peptidyl-prolyl cis-trans isomerase G	GO:0008380; P:RNA splicing; TAS:ProtInc
O43447	PPIH	Peptidyl-prolyl cis-trans isomerase H	GO:0016018; F:cyclosporin A binding; TAS:ProtInc
O43447	PPIH	Peptidyl-prolyl cis-trans isomerase H	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IDA:BHF-UCL
O43447	PPIH	Peptidyl-prolyl cis-trans isomerase H	GO:0005515; F:protein binding; IPI:IntAct
O43447	PPIH	Peptidyl-prolyl cis-trans isomerase H	GO:0043021; F:ribonucleoprotein complex binding; IDA:BHF-UCL
O43447	PPIH	Peptidyl-prolyl cis-trans isomerase H	GO:0000398; P:mRNA splicing, via spliceosome; IC:BHF-UCL
O43447	PPIH	Peptidyl-prolyl cis-trans isomerase H	GO:0045070; P:positive regulation of viral genome replication; IMP:UniProtKB
O43447	PPIH	Peptidyl-prolyl cis-trans isomerase H	GO:0006461; P:protein complex assembly; TAS:ProtInc
O43447	PPIH	Peptidyl-prolyl cis-trans isomerase H	GO:0006457; P:protein folding; TAS:ProtInc
O43447	PPIH	Peptidyl-prolyl cis-trans isomerase H	GO:0000413; P:protein peptidyl-prolyl isomerization; IDA:GOC
Q9Y3C6	PPIL1	Peptidyl-prolyl cis-trans isomerase-like 1	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW
Q9Y3C6	PPIL1	Peptidyl-prolyl cis-trans isomerase-like 1	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3C6	PPIL1	Peptidyl-prolyl cis-trans isomerase-like 1	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q9Y3C6	PPIL1	Peptidyl-prolyl cis-trans isomerase-like 1	GO:0006457; P:protein folding; IEA:UniProtKB-KW
Q13356	PPIL2	Peptidyl-prolyl cis-trans isomerase-like 2	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW
Q13356	PPIL2	Peptidyl-prolyl cis-trans isomerase-like 2	GO:0005515; F:protein binding; IPI:IntAct
Q13356	PPIL2	Peptidyl-prolyl cis-trans isomerase-like 2	GO:0004842; F:ubiquitin-protein ligase activity; IDA:MGI
Q13356	PPIL2	Peptidyl-prolyl cis-trans isomerase-like 2	GO:0034450; F:ubiquitin-ubiquitin ligase activity; IDA:MGI
Q13356	PPIL2	Peptidyl-prolyl cis-trans isomerase-like 2	GO:0007596; P:blood coagulation; TAS:Reactome
Q13356	PPIL2	Peptidyl-prolyl cis-trans isomerase-like 2	GO:0050900; P:leukocyte migration; TAS:Reactome
Q13356	PPIL2	Peptidyl-prolyl cis-trans isomerase-like 2	GO:0006457; P:protein folding; IEA:UniProtKB-KW
Q13356	PPIL2	Peptidyl-prolyl cis-trans isomerase-like 2	GO:0000209; P:protein polyubiquitination; IDA:MGI
Q9H2H8	PPIL3	Peptidyl-prolyl cis-trans isomerase-like 3	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW
Q9H2H8	PPIL3	Peptidyl-prolyl cis-trans isomerase-like 3	GO:0005515; F:protein binding; IPI:IntAct
Q9H2H8	PPIL3	Peptidyl-prolyl cis-trans isomerase-like 3	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q9H2H8	PPIL3	Peptidyl-prolyl cis-trans isomerase-like 3	GO:0006457; P:protein folding; IEA:UniProtKB-KW
Q8WUA2	PPIL4	Peptidyl-prolyl cis-trans isomerase-like 4	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8WUA2	PPIL4	Peptidyl-prolyl cis-trans isomerase-like 4	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW
Q8WUA2	PPIL4	Peptidyl-prolyl cis-trans isomerase-like 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8WUA2	PPIL4	Peptidyl-prolyl cis-trans isomerase-like 4	GO:0006457; P:protein folding; IEA:UniProtKB-KW
Q8IXY8	PPIL6	Peptidyl-prolyl cis-trans isomerase-like 6	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW
Q8IXY8	PPIL6	Peptidyl-prolyl cis-trans isomerase-like 6	GO:0006457; P:protein folding; IEA:UniProtKB-KW
O43586	PSTPIP1	Proline-serine-threonine phosphatase-interacting protein 1	GO:0005515; F:protein binding; IPI:IntAct
O43586	PSTPIP1	Proline-serine-threonine phosphatase-interacting protein 1	GO:0007155; P:cell adhesion; TAS:ProtInc
O43586	PSTPIP1	Proline-serine-threonine phosphatase-interacting protein 1	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
O43586	PSTPIP1	Proline-serine-threonine phosphatase-interacting protein 1	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
O43586	PSTPIP1	Proline-serine-threonine phosphatase-interacting protein 1	GO:0045087; P:innate immune response; TAS:Reactome
O43586	PSTPIP1	Proline-serine-threonine phosphatase-interacting protein 1	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
O43586	PSTPIP1	Proline-serine-threonine phosphatase-interacting protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q8TCE9	LGALS14	Placental protein 13-like	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q8TCE9	LGALS14	Placental protein 13-like	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P26678	PLN	Cardiac phospholamban	GO:0051117; F:ATPase binding; ISS:BHF-UCL
P26678	PLN	Cardiac phospholamban	GO:0042030; F:ATPase inhibitor activity; IDA:BHF-UCL
P26678	PLN	Cardiac phospholamban	GO:0005246; F:calcium channel regulator activity; IEA:InterPro
P26678	PLN	Cardiac phospholamban	GO:0004857; F:enzyme inhibitor activity; ISS:BHF-UCL
P26678	PLN	Cardiac phospholamban	GO:0042802; F:identical protein binding; ISS:BHF-UCL
P26678	PLN	Cardiac phospholamban	GO:0005515; F:protein binding; IPI:IntAct
P26678	PLN	Cardiac phospholamban	GO:0086023; P:adrenergic receptor signaling pathway involved in heart process; IEA:Ensembl
P26678	PLN	Cardiac phospholamban	GO:0008015; P:blood circulation; NAS:ProtInc
P26678	PLN	Cardiac phospholamban	GO:0006816; P:calcium ion transport; IEA:Ensembl
P26678	PLN	Cardiac phospholamban	GO:0048738; P:cardiac muscle tissue development; IEA:Ensembl
P26678	PLN	Cardiac phospholamban	GO:0051480; P:cytosolic calcium ion homeostasis; IC:BHF-UCL
P26678	PLN	Cardiac phospholamban	GO:0032780; P:negative regulation of ATPase activity; IDA:BHF-UCL
P26678	PLN	Cardiac phospholamban	GO:1901877; P:negative regulation of calcium ion binding; IDA:BHF-UCL
P26678	PLN	Cardiac phospholamban	GO:0090281; P:negative regulation of calcium ion import; ISS:BHF-UCL
P26678	PLN	Cardiac phospholamban	GO:1902081; P:negative regulation of calcium ion import into sarcoplasmic reticulum; ISS:BHF-UCL
P26678	PLN	Cardiac phospholamban	GO:1901020; P:negative regulation of calcium ion transmembrane transporter activity; IDA:BHF-UCL
P26678	PLN	Cardiac phospholamban	GO:0051926; P:negative regulation of calcium ion transport; IDA:BHF-UCL
P26678	PLN	Cardiac phospholamban	GO:1901895; P:negative regulation of calcium-transporting ATPase activity; IDA:BHF-UCL
P26678	PLN	Cardiac phospholamban	GO:0043086; P:negative regulation of catalytic activity; ISS:BHF-UCL
P26678	PLN	Cardiac phospholamban	GO:0010459; P:negative regulation of heart rate; IMP:BHF-UCL
P26678	PLN	Cardiac phospholamban	GO:0051260; P:protein homooligomerization; IEA:Ensembl
P26678	PLN	Cardiac phospholamban	GO:0051924; P:regulation of calcium ion transport; IDA:UniProtKB
P26678	PLN	Cardiac phospholamban	GO:1901894; P:regulation of calcium-transporting ATPase activity; IDA:UniProtKB
P26678	PLN	Cardiac phospholamban	GO:0086004; P:regulation of cardiac muscle cell contraction; IC:BHF-UCL
P26678	PLN	Cardiac phospholamban	GO:0086036; P:regulation of cardiac muscle cell membrane potential; IC:BHF-UCL
P26678	PLN	Cardiac phospholamban	GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; IEA:Ensembl
P26678	PLN	Cardiac phospholamban	GO:0008016; P:regulation of heart contraction; IMP:BHF-UCL
P26678	PLN	Cardiac phospholamban	GO:1901897; P:regulation of relaxation of cardiac muscle; IC:BHF-UCL
P26678	PLN	Cardiac phospholamban	GO:0060314; P:regulation of ryanodine-sensitive calcium-release channel activity; IEA:Ensembl
P26678	PLN	Cardiac phospholamban	GO:0002026; P:regulation of the force of heart contraction; IC:BHF-UCL
P26678	PLN	Cardiac phospholamban	GO:0086092; P:regulation of the force of heart contraction by cardiac conduction; IEA:Ensembl
P26678	PLN	Cardiac phospholamban	GO:0055119; P:relaxation of cardiac muscle; TAS:BHF-UCL
P26678	PLN	Cardiac phospholamban	GO:0033574; P:response to testosterone; IEA:Ensembl
P26678	PLN	Cardiac phospholamban	GO:0010043; P:response to zinc ion; IEA:Ensembl
P35813	PPM1A	Protein phosphatase 1A	GO:0033192; F:calmodulin-dependent protein phosphatase activity; IDA:UniProtKB
P35813	PPM1A	Protein phosphatase 1A	GO:0000287; F:magnesium ion binding; IEA:InterPro
P35813	PPM1A	Protein phosphatase 1A	GO:0030145; F:manganese ion binding; IEA:InterPro
P35813	PPM1A	Protein phosphatase 1A	GO:0005515; F:protein binding; IPI:UniProtKB
P35813	PPM1A	Protein phosphatase 1A	GO:0004722; F:protein serine/threonine phosphatase activity; IDA:UniProtKB
P35813	PPM1A	Protein phosphatase 1A	GO:0070412; F:R-SMAD binding; IPI:UniProtKB
P35813	PPM1A	Protein phosphatase 1A	GO:0004871; F:signal transducer activity; IMP:UniProtKB
P35813	PPM1A	Protein phosphatase 1A	GO:0007050; P:cell cycle arrest; TAS:Reactome
P35813	PPM1A	Protein phosphatase 1A	GO:0016311; P:dephosphorylation; IDA:BHF-UCL
P35813	PPM1A	Protein phosphatase 1A	GO:0010467; P:gene expression; TAS:Reactome
P35813	PPM1A	Protein phosphatase 1A	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P35813	PPM1A	Protein phosphatase 1A	GO:0006499; P:N-terminal protein myristoylation; ISS:UniProtKB
P35813	PPM1A	Protein phosphatase 1A	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
P35813	PPM1A	Protein phosphatase 1A	GO:0042347; P:negative regulation of NF-kappaB import into nucleus; IMP:UniProtKB
P35813	PPM1A	Protein phosphatase 1A	GO:0010991; P:negative regulation of SMAD protein complex assembly; IDA:UniProtKB
P35813	PPM1A	Protein phosphatase 1A	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:Reactome
P35813	PPM1A	Protein phosphatase 1A	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
P35813	PPM1A	Protein phosphatase 1A	GO:0035970; P:peptidyl-threonine dephosphorylation; IDA:UniProtKB
P35813	PPM1A	Protein phosphatase 1A	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
P35813	PPM1A	Protein phosphatase 1A	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
P35813	PPM1A	Protein phosphatase 1A	GO:0030177; P:positive regulation of Wnt signaling pathway; IDA:BHF-UCL
P35813	PPM1A	Protein phosphatase 1A	GO:0006470; P:protein dephosphorylation; IMP:UniProtKB
P35813	PPM1A	Protein phosphatase 1A	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P35813	PPM1A	Protein phosphatase 1A	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
P35813	PPM1A	Protein phosphatase 1A	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P35813	PPM1A	Protein phosphatase 1A	GO:0016055; P:Wnt signaling pathway; IDA:BHF-UCL
O75688	PPM1B	Protein phosphatase 1B	GO:0000287; F:magnesium ion binding; IEA:InterPro
O75688	PPM1B	Protein phosphatase 1B	GO:0030145; F:manganese ion binding; IEA:InterPro
O75688	PPM1B	Protein phosphatase 1B	GO:0005515; F:protein binding; IPI:UniProtKB
O75688	PPM1B	Protein phosphatase 1B	GO:0004722; F:protein serine/threonine phosphatase activity; IDA:UniProtKB
O75688	PPM1B	Protein phosphatase 1B	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
O75688	PPM1B	Protein phosphatase 1B	GO:0006499; P:N-terminal protein myristoylation; ISS:UniProtKB
O75688	PPM1B	Protein phosphatase 1B	GO:0050687; P:negative regulation of defense response to virus; IMP:UniProtKB
O75688	PPM1B	Protein phosphatase 1B	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
O75688	PPM1B	Protein phosphatase 1B	GO:0032688; P:negative regulation of interferon-beta production; IMP:UniProtKB
O75688	PPM1B	Protein phosphatase 1B	GO:0042347; P:negative regulation of NF-kappaB import into nucleus; IMP:UniProtKB
O75688	PPM1B	Protein phosphatase 1B	GO:0035970; P:peptidyl-threonine dephosphorylation; IDA:UniProtKB
O75688	PPM1B	Protein phosphatase 1B	GO:0006470; P:protein dephosphorylation; IMP:UniProtKB
O15297	PPM1D	Protein phosphatase 1D	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15297	PPM1D	Protein phosphatase 1D	GO:0005515; F:protein binding; IPI:IntAct
O15297	PPM1D	Protein phosphatase 1D	GO:0004722; F:protein serine/threonine phosphatase activity; IDA:UniProtKB
O15297	PPM1D	Protein phosphatase 1D	GO:0000086; P:G2/M transition of mitotic cell cycle; IEA:Ensembl
O15297	PPM1D	Protein phosphatase 1D	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
O15297	PPM1D	Protein phosphatase 1D	GO:0035970; P:peptidyl-threonine dephosphorylation; IDA:UniProtKB
O15297	PPM1D	Protein phosphatase 1D	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
O15297	PPM1D	Protein phosphatase 1D	GO:0009617; P:response to bacterium; IEA:Ensembl
O15297	PPM1D	Protein phosphatase 1D	GO:0009314; P:response to radiation; TAS:ProtInc
Q8WY54	PPM1E	Protein phosphatase 1E	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8WY54	PPM1E	Protein phosphatase 1E	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WY54	PPM1E	Protein phosphatase 1E	GO:0004722; F:protein serine/threonine phosphatase activity; IDA:UniProtKB
Q8WY54	PPM1E	Protein phosphatase 1E	GO:0035690; P:cellular response to drug; IDA:UniProtKB
Q8WY54	PPM1E	Protein phosphatase 1E	GO:0006469; P:negative regulation of protein kinase activity; IDA:UniProtKB
Q8WY54	PPM1E	Protein phosphatase 1E	GO:0035970; P:peptidyl-threonine dephosphorylation; IDA:UniProtKB
Q8WY54	PPM1E	Protein phosphatase 1E	GO:0051496; P:positive regulation of stress fiber assembly; IDA:UniProtKB
P49593	PPM1F	Protein phosphatase 1F	GO:0033192; F:calmodulin-dependent protein phosphatase activity; IDA:UniProtKB
P49593	PPM1F	Protein phosphatase 1F	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P49593	PPM1F	Protein phosphatase 1F	GO:0016791; F:phosphatase activity; IDA:UniProtKB
P49593	PPM1F	Protein phosphatase 1F	GO:0005515; F:protein binding; IPI:UniProtKB
P49593	PPM1F	Protein phosphatase 1F	GO:0004722; F:protein serine/threonine phosphatase activity; IDA:UniProtKB
P49593	PPM1F	Protein phosphatase 1F	GO:0035690; P:cellular response to drug; IDA:UniProtKB
P49593	PPM1F	Protein phosphatase 1F	GO:0016576; P:histone dephosphorylation; IEA:Ensembl
P49593	PPM1F	Protein phosphatase 1F	GO:0097193; P:intrinsic apoptotic signaling pathway; IDA:UniProtKB
P49593	PPM1F	Protein phosphatase 1F	GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; IDA:UniProtKB
P49593	PPM1F	Protein phosphatase 1F	GO:0006469; P:negative regulation of protein kinase activity; IDA:UniProtKB
P49593	PPM1F	Protein phosphatase 1F	GO:0044387; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; IDA:UniProtKB
P49593	PPM1F	Protein phosphatase 1F	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
P49593	PPM1F	Protein phosphatase 1F	GO:0035970; P:peptidyl-threonine dephosphorylation; IDA:UniProtKB
P49593	PPM1F	Protein phosphatase 1F	GO:0010811; P:positive regulation of cell-substrate adhesion; IMP:UniProtKB
P49593	PPM1F	Protein phosphatase 1F	GO:0050921; P:positive regulation of chemotaxis; IMP:UniProtKB
P49593	PPM1F	Protein phosphatase 1F	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P49593	PPM1F	Protein phosphatase 1F	GO:0010634; P:positive regulation of epithelial cell migration; IMP:UniProtKB
P49593	PPM1F	Protein phosphatase 1F	GO:0051894; P:positive regulation of focal adhesion assembly; IMP:UniProtKB
P49593	PPM1F	Protein phosphatase 1F	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
P49593	PPM1F	Protein phosphatase 1F	GO:0045927; P:positive regulation of growth; IMP:UniProtKB
P49593	PPM1F	Protein phosphatase 1F	GO:0051496; P:positive regulation of stress fiber assembly; IDA:UniProtKB
O15355	PPM1G	Protein phosphatase 1G	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15355	PPM1G	Protein phosphatase 1G	GO:0005515; F:protein binding; IPI:IntAct
O15355	PPM1G	Protein phosphatase 1G	GO:0004722; F:protein serine/threonine phosphatase activity; IDA:UniProtKB
O15355	PPM1G	Protein phosphatase 1G	GO:0007050; P:cell cycle arrest; TAS:ProtInc
O15355	PPM1G	Protein phosphatase 1G	GO:0035970; P:peptidyl-threonine dephosphorylation; IDA:UniProtKB
O15355	PPM1G	Protein phosphatase 1G	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
Q9ULR3	PPM1H	Protein phosphatase 1H	GO:0004721; F:phosphoprotein phosphatase activity; IEA:UniProtKB-KW
Q5JR12	PPM1J	Protein phosphatase 1J	GO:0004722; F:protein serine/threonine phosphatase activity; IEA:Ensembl
Q5JR12	PPM1J	Protein phosphatase 1J	GO:0006470; P:protein dephosphorylation; IEA:Ensembl
Q8N3J5	PPM1K	Protein phosphatase 1K, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N3J5	PPM1K	Protein phosphatase 1K, mitochondrial	GO:0004722; F:protein serine/threonine phosphatase activity; IEA:InterPro
Q8N3J5	PPM1K	Protein phosphatase 1K, mitochondrial	GO:0006470; P:protein dephosphorylation; IEA:InterPro
Q5SGD2	PPM1L	Protein phosphatase 1L	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5SGD2	PPM1L	Protein phosphatase 1L	GO:0004722; F:protein serine/threonine phosphatase activity; TAS:Reactome
Q5SGD2	PPM1L	Protein phosphatase 1L	GO:0000165; P:MAPK cascade; IEA:Ensembl
Q5SGD2	PPM1L	Protein phosphatase 1L	GO:0006470; P:protein dephosphorylation; IEA:InterPro
Q5SGD2	PPM1L	Protein phosphatase 1L	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5SGD2	PPM1L	Protein phosphatase 1L	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
Q5SGD2	PPM1L	Protein phosphatase 1L	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q5SGD2	PPM1L	Protein phosphatase 1L	GO:0007178; P:transmembrane receptor protein serine/threonine kinase signaling pathway; IEA:Ensembl
Q96MI6	PPM1M	Protein phosphatase 1M	GO:0008420; F:CTD phosphatase activity; ISS:UniProtKB
Q96MI6	PPM1M	Protein phosphatase 1M	GO:0030145; F:manganese ion binding; ISS:UniProtKB
Q96MI6	PPM1M	Protein phosphatase 1M	GO:0006470; P:protein dephosphorylation; ISS:UniProtKB
Q8N819	PPM1N	Probable protein phosphatase 1N	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q8N819	PPM1N	Probable protein phosphatase 1N	GO:0030145; F:manganese ion binding; IEA:InterPro
Q8N819	PPM1N	Probable protein phosphatase 1N	GO:0004721; F:phosphoprotein phosphatase activity; IEA:UniProtKB-KW
Q9Y570	PPME1	Protein phosphatase methylesterase 1	GO:0052689; F:carboxylic ester hydrolase activity; IEA:InterPro
Q9Y570	PPME1	Protein phosphatase methylesterase 1	GO:0051722; F:protein C-terminal methylesterase activity; IDA:HGNC
Q9Y570	PPME1	Protein phosphatase methylesterase 1	GO:0051721; F:protein phosphatase 2A binding; IDA:HGNC
Q9Y570	PPME1	Protein phosphatase methylesterase 1	GO:0019903; F:protein phosphatase binding; IDA:HGNC
Q9Y570	PPME1	Protein phosphatase methylesterase 1	GO:0004864; F:protein phosphatase inhibitor activity; TAS:ProtInc
Q9Y570	PPME1	Protein phosphatase methylesterase 1	GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:HGNC
Q9Y570	PPME1	Protein phosphatase methylesterase 1	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
Q9Y570	PPME1	Protein phosphatase methylesterase 1	GO:0006482; P:protein demethylation; IEA:InterPro
Q9Y570	PPME1	Protein phosphatase methylesterase 1	GO:0050790; P:regulation of catalytic activity; TAS:GOC
O95428	PAPLN	Papilin	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
O95428	PAPLN	Papilin	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
O95428	PAPLN	Papilin	GO:0008270; F:zinc ion binding; IEA:InterPro
P50336	PPOX	Protoporphyrinogen oxidase	GO:0050660; F:flavin adenine dinucleotide binding; TAS:UniProtKB
P50336	PPOX	Protoporphyrinogen oxidase	GO:0004729; F:oxygen-dependent protoporphyrinogen oxidase activity; IDA:UniProtKB
P50336	PPOX	Protoporphyrinogen oxidase	GO:0006783; P:heme biosynthetic process; IDA:UniProtKB
P50336	PPOX	Protoporphyrinogen oxidase	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
P50336	PPOX	Protoporphyrinogen oxidase	GO:0006779; P:porphyrin-containing compound biosynthetic process; IDA:UniProtKB
P50336	PPOX	Protoporphyrinogen oxidase	GO:0006778; P:porphyrin-containing compound metabolic process; TAS:Reactome
P50336	PPOX	Protoporphyrinogen oxidase	GO:0006782; P:protoporphyrinogen IX biosynthetic process; IEA:UniProtKB-UniPathway
P50336	PPOX	Protoporphyrinogen oxidase	GO:0042493; P:response to drug; IEA:Ensembl
P50336	PPOX	Protoporphyrinogen oxidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P53041	PPP5C	Serine/threonine-protein phosphatase 5	GO:0042802; F:identical protein binding; IPI:IntAct
P53041	PPP5C	Serine/threonine-protein phosphatase 5	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
P53041	PPP5C	Serine/threonine-protein phosphatase 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P53041	PPP5C	Serine/threonine-protein phosphatase 5	GO:0004721; F:phosphoprotein phosphatase activity; ISS:UniProtKB
P53041	PPP5C	Serine/threonine-protein phosphatase 5	GO:0005515; F:protein binding; IPI:UniProtKB
P53041	PPP5C	Serine/threonine-protein phosphatase 5	GO:0004722; F:protein serine/threonine phosphatase activity; TAS:ProtInc
P53041	PPP5C	Serine/threonine-protein phosphatase 5	GO:0003723; F:RNA binding; IEA:Ensembl
P53041	PPP5C	Serine/threonine-protein phosphatase 5	GO:0004871; F:signal transducer activity; IMP:UniProtKB
P53041	PPP5C	Serine/threonine-protein phosphatase 5	GO:0008219; P:cell death; IEA:UniProtKB-KW
P53041	PPP5C	Serine/threonine-protein phosphatase 5	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
P53041	PPP5C	Serine/threonine-protein phosphatase 5	GO:0007067; P:mitosis; TAS:ProtInc
P53041	PPP5C	Serine/threonine-protein phosphatase 5	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
P53041	PPP5C	Serine/threonine-protein phosphatase 5	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
P53041	PPP5C	Serine/threonine-protein phosphatase 5	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P53041	PPP5C	Serine/threonine-protein phosphatase 5	GO:0043278; P:response to morphine; IEA:Ensembl
P53041	PPP5C	Serine/threonine-protein phosphatase 5	GO:0007165; P:signal transduction; IMP:GOC
P53041	PPP5C	Serine/threonine-protein phosphatase 5	GO:0006351; P:transcription, DNA-templated; TAS:ProtInc
O00743	PPP6C	Serine/threonine-protein phosphatase 6 catalytic subunit	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O00743	PPP6C	Serine/threonine-protein phosphatase 6 catalytic subunit	GO:0005515; F:protein binding; IPI:UniProtKB
O00743	PPP6C	Serine/threonine-protein phosphatase 6 catalytic subunit	GO:0004722; F:protein serine/threonine phosphatase activity; IDA:MGI
O00743	PPP6C	Serine/threonine-protein phosphatase 6 catalytic subunit	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:ProtInc
O00743	PPP6C	Serine/threonine-protein phosphatase 6 catalytic subunit	GO:0006470; P:protein dephosphorylation; IDA:MGI
O96001	PPP1R17	Protein phosphatase 1 regulatory subunit 17	GO:0004865; F:protein serine/threonine phosphatase inhibitor activity; IEA:Ensembl
O96001	PPP1R17	Protein phosphatase 1 regulatory subunit 17	GO:0007417; P:central nervous system development; NAS:UniProtKB
O96001	PPP1R17	Protein phosphatase 1 regulatory subunit 17	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
O96001	PPP1R17	Protein phosphatase 1 regulatory subunit 17	GO:0010921; P:regulation of phosphatase activity; ISS:UniProtKB
Q13522	PPP1R1A	Protein phosphatase 1 regulatory subunit 1A	GO:0005515; F:protein binding; IPI:IntAct
Q13522	PPP1R1A	Protein phosphatase 1 regulatory subunit 1A	GO:0004865; F:protein serine/threonine phosphatase inhibitor activity; TAS:ProtInc
Q13522	PPP1R1A	Protein phosphatase 1 regulatory subunit 1A	GO:0005977; P:glycogen metabolic process; IEA:UniProtKB-KW
Q13522	PPP1R1A	Protein phosphatase 1 regulatory subunit 1A	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
Q13522	PPP1R1A	Protein phosphatase 1 regulatory subunit 1A	GO:0007165; P:signal transduction; IEA:InterPro
Q9UD71	PPP1R1B	Protein phosphatase 1 regulatory subunit 1B	GO:0004860; F:protein kinase inhibitor activity; TAS:UniProtKB
Q9UD71	PPP1R1B	Protein phosphatase 1 regulatory subunit 1B	GO:0004864; F:protein phosphatase inhibitor activity; TAS:UniProtKB
Q9UD71	PPP1R1B	Protein phosphatase 1 regulatory subunit 1B	GO:0008599; F:protein phosphatase type 1 regulator activity; TAS:Reactome
Q9UD71	PPP1R1B	Protein phosphatase 1 regulatory subunit 1B	GO:0035556; P:intracellular signal transduction; IEA:Ensembl
Q9UD71	PPP1R1B	Protein phosphatase 1 regulatory subunit 1B	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
Q9UD71	PPP1R1B	Protein phosphatase 1 regulatory subunit 1B	GO:0007621; P:negative regulation of female receptivity; IEA:Ensembl
Q9UD71	PPP1R1B	Protein phosphatase 1 regulatory subunit 1B	GO:0006469; P:negative regulation of protein kinase activity; TAS:GOC
Q9UD71	PPP1R1B	Protein phosphatase 1 regulatory subunit 1B	GO:0050790; P:regulation of catalytic activity; TAS:GOC
Q9UD71	PPP1R1B	Protein phosphatase 1 regulatory subunit 1B	GO:0001975; P:response to amphetamine; IEA:Ensembl
Q9UD71	PPP1R1B	Protein phosphatase 1 regulatory subunit 1B	GO:0007165; P:signal transduction; TAS:UniProtKB
Q9UD71	PPP1R1B	Protein phosphatase 1 regulatory subunit 1B	GO:0006351; P:transcription, DNA-templated; IEA:Ensembl
Q9UD71	PPP1R1B	Protein phosphatase 1 regulatory subunit 1B	GO:0008542; P:visual learning; IEA:Ensembl
Q8WVI7	PPP1R1C	Protein phosphatase 1 regulatory subunit 1C	GO:0004864; F:protein phosphatase inhibitor activity; IDA:UniProtKB
Q8WVI7	PPP1R1C	Protein phosphatase 1 regulatory subunit 1C	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8WVI7	PPP1R1C	Protein phosphatase 1 regulatory subunit 1C	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q8WVI7	PPP1R1C	Protein phosphatase 1 regulatory subunit 1C	GO:0043086; P:negative regulation of catalytic activity; IDA:GOC
Q8WVI7	PPP1R1C	Protein phosphatase 1 regulatory subunit 1C	GO:0030307; P:positive regulation of cell growth; IDA:UniProtKB
Q8WVI7	PPP1R1C	Protein phosphatase 1 regulatory subunit 1C	GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IDA:UniProtKB
Q8WVI7	PPP1R1C	Protein phosphatase 1 regulatory subunit 1C	GO:0007165; P:signal transduction; IEA:InterPro
Q6ZMI0	PPP1R21	Protein phosphatase 1 regulatory subunit 21	GO:0019902; F:phosphatase binding; IDA:UniProtKB
Q5T8A7	PPP1R26	Protein phosphatase 1 regulatory subunit 26	GO:0019902; F:phosphatase binding; IDA:UniProtKB
Q5T8A7	PPP1R26	Protein phosphatase 1 regulatory subunit 26	GO:0005515; F:protein binding; IPI:IntAct
Q5T8A7	PPP1R26	Protein phosphatase 1 regulatory subunit 26	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
Q5T8A7	PPP1R26	Protein phosphatase 1 regulatory subunit 26	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q86WC6	PPP1R27	Protein phosphatase 1 regulatory subunit 27	GO:0019902; F:phosphatase binding; IDA:UniProtKB
Q86WC6	PPP1R27	Protein phosphatase 1 regulatory subunit 27	GO:0005515; F:protein binding; IPI:IntAct
Q86WC6	PPP1R27	Protein phosphatase 1 regulatory subunit 27	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
Q86WC6	PPP1R27	Protein phosphatase 1 regulatory subunit 27	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q5R3F8	ELFN2	Protein phosphatase 1 regulatory subunit 29	GO:0019902; F:phosphatase binding; IDA:UniProtKB
Q5R3F8	ELFN2	Protein phosphatase 1 regulatory subunit 29	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
Q5R3F8	ELFN2	Protein phosphatase 1 regulatory subunit 29	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q7Z5V6	PPP1R32	Protein phosphatase 1 regulatory subunit 32	GO:0019902; F:phosphatase binding; IDA:UniProtKB
Q7Z5V6	PPP1R32	Protein phosphatase 1 regulatory subunit 32	GO:0005515; F:protein binding; IPI:IntAct
Q96LQ0	PPP1R36	Protein phosphatase 1 regulatory subunit 36	GO:0019902; F:phosphatase binding; IDA:UniProtKB
Q96LQ0	PPP1R36	Protein phosphatase 1 regulatory subunit 36	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
Q96LQ0	PPP1R36	Protein phosphatase 1 regulatory subunit 36	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q8TAP8	PPP1R35	Protein phosphatase 1 regulatory subunit 35	GO:0019902; F:phosphatase binding; IDA:UniProtKB
Q8TAP8	PPP1R35	Protein phosphatase 1 regulatory subunit 35	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
Q8TAP8	PPP1R35	Protein phosphatase 1 regulatory subunit 35	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
O75864	PPP1R37	Protein phosphatase 1 regulatory subunit 37	GO:0019902; F:phosphatase binding; IDA:UniProtKB
O75864	PPP1R37	Protein phosphatase 1 regulatory subunit 37	GO:0005515; F:protein binding; IPI:IntAct
O75864	PPP1R37	Protein phosphatase 1 regulatory subunit 37	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
O75864	PPP1R37	Protein phosphatase 1 regulatory subunit 37	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q16821	PPP1R3A	Protein phosphatase 1 regulatory subunit 3A	GO:0005977; P:glycogen metabolic process; IEA:UniProtKB-KW
Q86XI6	PPP1R3B	Protein phosphatase 1 regulatory subunit 3B	GO:0019888; F:protein phosphatase regulator activity; IEA:Ensembl
Q86XI6	PPP1R3B	Protein phosphatase 1 regulatory subunit 3B	GO:0005977; P:glycogen metabolic process; IEA:UniProtKB-KW
Q86XI6	PPP1R3B	Protein phosphatase 1 regulatory subunit 3B	GO:0005979; P:regulation of glycogen biosynthetic process; IEA:Ensembl
Q86XI6	PPP1R3B	Protein phosphatase 1 regulatory subunit 3B	GO:0005981; P:regulation of glycogen catabolic process; IDA:MGI
Q9UQK1	PPP1R3C	Protein phosphatase 1 regulatory subunit 3C	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UQK1	PPP1R3C	Protein phosphatase 1 regulatory subunit 3C	GO:0004722; F:protein serine/threonine phosphatase activity; TAS:ProtInc
Q9UQK1	PPP1R3C	Protein phosphatase 1 regulatory subunit 3C	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9UQK1	PPP1R3C	Protein phosphatase 1 regulatory subunit 3C	GO:0016311; P:dephosphorylation; TAS:GOC
Q9UQK1	PPP1R3C	Protein phosphatase 1 regulatory subunit 3C	GO:0006006; P:glucose metabolic process; TAS:Reactome
Q9UQK1	PPP1R3C	Protein phosphatase 1 regulatory subunit 3C	GO:0005978; P:glycogen biosynthetic process; TAS:Reactome
Q9UQK1	PPP1R3C	Protein phosphatase 1 regulatory subunit 3C	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95685	PPP1R3D	Protein phosphatase 1 regulatory subunit 3D	GO:0004722; F:protein serine/threonine phosphatase activity; TAS:ProtInc
O95685	PPP1R3D	Protein phosphatase 1 regulatory subunit 3D	GO:0016311; P:dephosphorylation; TAS:GOC
O95685	PPP1R3D	Protein phosphatase 1 regulatory subunit 3D	GO:0005977; P:glycogen metabolic process; IEA:UniProtKB-KW
O95685	PPP1R3D	Protein phosphatase 1 regulatory subunit 3D	GO:0005979; P:regulation of glycogen biosynthetic process; IEA:Ensembl
O95685	PPP1R3D	Protein phosphatase 1 regulatory subunit 3D	GO:0005981; P:regulation of glycogen catabolic process; IEA:Ensembl
Q9H7J1	PPP1R3E	Protein phosphatase 1 regulatory subunit 3E	GO:0005977; P:glycogen metabolic process; IEA:UniProtKB-KW
Q6ZSY5	PPP1R3F	Protein phosphatase 1 regulatory subunit 3F	GO:2001069; F:glycogen binding; IDA:MGI
Q6ZSY5	PPP1R3F	Protein phosphatase 1 regulatory subunit 3F	GO:0019903; F:protein phosphatase binding; IPI:MGI
Q6ZSY5	PPP1R3F	Protein phosphatase 1 regulatory subunit 3F	GO:2000465; P:regulation of glycogen (starch) synthase activity; IDA:MGI
Q6ZSY5	PPP1R3F	Protein phosphatase 1 regulatory subunit 3F	GO:0005979; P:regulation of glycogen biosynthetic process; IDA:MGI
Q7Z4L9	PPP1R42	Protein phosphatase 1 regulatory subunit 42	GO:0003779; F:actin binding; ISS:UniProtKB
Q7Z4L9	PPP1R42	Protein phosphatase 1 regulatory subunit 42	GO:0045502; F:dynein binding; ISS:UniProtKB
Q7Z4L9	PPP1R42	Protein phosphatase 1 regulatory subunit 42	GO:0015631; F:tubulin binding; ISS:UniProtKB
Q7Z4L9	PPP1R42	Protein phosphatase 1 regulatory subunit 42	GO:0010921; P:regulation of phosphatase activity; IEA:Ensembl
Q5VV67	PPRC1	Peroxisome proliferator-activated receptor gamma coactivator-related protein 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q5VV67	PPRC1	Peroxisome proliferator-activated receptor gamma coactivator-related protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q5VV67	PPRC1	Peroxisome proliferator-activated receptor gamma coactivator-related protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5VV67	PPRC1	Peroxisome proliferator-activated receptor gamma coactivator-related protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0008474; F:palmitoyl-(protein) hydrolase activity; IDA:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0016290; F:palmitoyl-CoA hydrolase activity; IDA:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0006309; P:apoptotic DNA fragmentation; IDA:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0008306; P:associative learning; IEA:Ensembl
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0007420; P:brain development; IMP:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0044257; P:cellular protein catabolic process; IEA:Ensembl
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0051186; P:cofactor metabolic process; IMP:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0051181; P:cofactor transport; IMP:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0007625; P:grooming behavior; IEA:Ensembl
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0016042; P:lipid catabolic process; IDA:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0007042; P:lysosomal lumen acidification; IMP:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0031579; P:membrane raft organization; IMP:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0030308; P:negative regulation of cell growth; IMP:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0043524; P:negative regulation of neuron apoptotic process; IMP:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0007399; P:nervous system development; IMP:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0048666; P:neuron development; TAS:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0007269; P:neurotransmitter secretion; IEA:Ensembl
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0006907; P:pinocytosis; IMP:MGI
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0048549; P:positive regulation of pinocytosis; IMP:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0048260; P:positive regulation of receptor-mediated endocytosis; IMP:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0030163; P:protein catabolic process; NAS:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0002084; P:protein depalmitoylation; IDA:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0015031; P:protein transport; IMP:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0006898; P:receptor-mediated endocytosis; IMP:MGI
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0032429; P:regulation of phospholipase A2 activity; IEA:Ensembl
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0050803; P:regulation of synapse structure and activity; NAS:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0030149; P:sphingolipid catabolic process; TAS:UniProtKB
P50897	PPT1	Palmitoyl-protein thioesterase 1	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q9UMR5	PPT2	Lysosomal thioesterase PPT2	GO:0008474; F:palmitoyl-(protein) hydrolase activity; NAS:UniProtKB
Q9UMR5	PPT2	Lysosomal thioesterase PPT2	GO:0016790; F:thiolester hydrolase activity; NAS:UniProtKB
Q9UMR5	PPT2	Lysosomal thioesterase PPT2	GO:0006464; P:cellular protein modification process; NAS:UniProtKB
Q8NI37	PPTC7	Protein phosphatase PTC7 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NI37	PPTC7	Protein phosphatase PTC7 homolog	GO:0004721; F:phosphoprotein phosphatase activity; IEA:UniProtKB-KW
Q96BP3	PPWD1	Peptidylprolyl isomerase domain and WD repeat-containing protein 1	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW
Q96BP3	PPWD1	Peptidylprolyl isomerase domain and WD repeat-containing protein 1	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q96BP3	PPWD1	Peptidylprolyl isomerase domain and WD repeat-containing protein 1	GO:0006457; P:protein folding; IEA:UniProtKB-KW
O60828	PQBP1	Polyglutamine-binding protein 1	GO:0003677; F:DNA binding; TAS:ProtInc
O60828	PQBP1	Polyglutamine-binding protein 1	GO:0043021; F:ribonucleoprotein complex binding; IDA:MGI
O60828	PQBP1	Polyglutamine-binding protein 1	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
O60828	PQBP1	Polyglutamine-binding protein 1	GO:0043484; P:regulation of RNA splicing; IMP:MGI
O60828	PQBP1	Polyglutamine-binding protein 1	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
O60828	PQBP1	Polyglutamine-binding protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75807	PPP1R15A	Protein phosphatase 1 regulatory subunit 15A	GO:0005515; F:protein binding; IPI:IntAct
O75807	PPP1R15A	Protein phosphatase 1 regulatory subunit 15A	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O75807	PPP1R15A	Protein phosphatase 1 regulatory subunit 15A	GO:0006915; P:apoptotic process; TAS:ProtInc
O75807	PPP1R15A	Protein phosphatase 1 regulatory subunit 15A	GO:0007050; P:cell cycle arrest; TAS:ProtInc
O75807	PPP1R15A	Protein phosphatase 1 regulatory subunit 15A	GO:0006974; P:cellular response to DNA damage stimulus; TAS:ProtInc
O75807	PPP1R15A	Protein phosphatase 1 regulatory subunit 15A	GO:0030968; P:endoplasmic reticulum unfolded protein response; IEA:Ensembl
O75807	PPP1R15A	Protein phosphatase 1 regulatory subunit 15A	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
O75807	PPP1R15A	Protein phosphatase 1 regulatory subunit 15A	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
O75807	PPP1R15A	Protein phosphatase 1 regulatory subunit 15A	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q5SWA1	PPP1R15B	Protein phosphatase 1 regulatory subunit 15B	GO:0005515; F:protein binding; IPI:IntAct
Q5SWA1	PPP1R15B	Protein phosphatase 1 regulatory subunit 15B	GO:0004722; F:protein serine/threonine phosphatase activity; IEA:Ensembl
Q5SWA1	PPP1R15B	Protein phosphatase 1 regulatory subunit 15B	GO:0006983; P:ER overload response; IEA:Ensembl
Q5SWA1	PPP1R15B	Protein phosphatase 1 regulatory subunit 15B	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q5SWA1	PPP1R15B	Protein phosphatase 1 regulatory subunit 15B	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
Q8NAV1	PRPF38A	Pre-mRNA-splicing factor 38A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8NAV1	PRPF38A	Pre-mRNA-splicing factor 38A	GO:0005515; F:protein binding; IPI:IntAct
Q8NAV1	PRPF38A	Pre-mRNA-splicing factor 38A	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q8NAV1	PRPF38A	Pre-mRNA-splicing factor 38A	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q5VTL8	PRPF38B	Pre-mRNA-splicing factor 38B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q5VTL8	PRPF38B	Pre-mRNA-splicing factor 38B	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q5VTL8	PRPF38B	Pre-mRNA-splicing factor 38B	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
O75400	PRPF40A	Pre-mRNA-processing factor 40 homolog A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75400	PRPF40A	Pre-mRNA-processing factor 40 homolog A	GO:0005515; F:protein binding; IPI:IntAct
O75400	PRPF40A	Pre-mRNA-processing factor 40 homolog A	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
O75400	PRPF40A	Pre-mRNA-processing factor 40 homolog A	GO:0051301; P:cell division; IEA:UniProtKB-KW
O75400	PRPF40A	Pre-mRNA-processing factor 40 homolog A	GO:0016477; P:cell migration; IMP:UniProtKB
O75400	PRPF40A	Pre-mRNA-processing factor 40 homolog A	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
O75400	PRPF40A	Pre-mRNA-processing factor 40 homolog A	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
O75400	PRPF40A	Pre-mRNA-processing factor 40 homolog A	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
O75400	PRPF40A	Pre-mRNA-processing factor 40 homolog A	GO:0032465; P:regulation of cytokinesis; IMP:UniProtKB
O75400	PRPF40A	Pre-mRNA-processing factor 40 homolog A	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q6NWY9	PRPF40B	Pre-mRNA-processing factor 40 homolog B	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q6NWY9	PRPF40B	Pre-mRNA-processing factor 40 homolog B	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q5VWM6	PRAMEF13	PRAME family member 13	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
Q5VWM6	PRAMEF13	PRAME family member 13	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
Q5VWM6	PRAMEF13	PRAME family member 13	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
Q5VWM6	PRAMEF13	PRAME family member 13	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
Q5VWM6	PRAMEF13	PRAME family member 13	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
O60809	PRAMEF10	PRAME family member 10	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
O60809	PRAMEF10	PRAME family member 10	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
O60809	PRAMEF10	PRAME family member 10	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
O60809	PRAMEF10	PRAME family member 10	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
O60809	PRAMEF10	PRAME family member 10	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
Q5VWM1	PRAMEF16	PRAME family member 16	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
Q5VWM1	PRAMEF16	PRAME family member 16	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
Q5VWM1	PRAMEF16	PRAME family member 16	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
Q5VWM1	PRAMEF16	PRAME family member 16	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
Q5VWM1	PRAMEF16	PRAME family member 16	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
Q5VTA0	PRAMEF17	PRAME family member 17	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
Q5VTA0	PRAMEF17	PRAME family member 17	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
Q5VTA0	PRAMEF17	PRAME family member 17	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
Q5VTA0	PRAMEF17	PRAME family member 17	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
Q5VTA0	PRAMEF17	PRAME family member 17	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
O60813	PRAMEF11	PRAME family member 11	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
O60813	PRAMEF11	PRAME family member 11	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
O60813	PRAMEF11	PRAME family member 11	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
O60813	PRAMEF11	PRAME family member 11	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
O60813	PRAMEF11	PRAME family member 11	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
O95522	PRAMEF12	PRAME family member 12	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
O95522	PRAMEF12	PRAME family member 12	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
O95522	PRAMEF12	PRAME family member 12	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
O95522	PRAMEF12	PRAME family member 12	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
O95522	PRAMEF12	PRAME family member 12	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
Q5SWL8	PRAMEF19	PRAME family member 19	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
Q5SWL8	PRAMEF19	PRAME family member 19	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
Q5SWL8	PRAMEF19	PRAME family member 19	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
Q5SWL8	PRAMEF19	PRAME family member 19	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
Q5SWL8	PRAMEF19	PRAME family member 19	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
Q5SWL7	PRAMEF14	PRAME family member 14	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
Q5SWL7	PRAMEF14	PRAME family member 14	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
Q5SWL7	PRAMEF14	PRAME family member 14	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
Q5SWL7	PRAMEF14	PRAME family member 14	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
Q5SWL7	PRAMEF14	PRAME family member 14	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
Q5VWM3	PRAMEF18	PRAME family member 18	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
Q5VWM3	PRAMEF18	PRAME family member 18	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
Q5VWM3	PRAMEF18	PRAME family member 18	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
Q5VWM3	PRAMEF18	PRAME family member 18	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
Q5VWM3	PRAMEF18	PRAME family member 18	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
Q5VT98	PRAMEF20	PRAME family member 20/21	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
Q5VT98	PRAMEF20	PRAME family member 20/21	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
Q5VT98	PRAMEF20	PRAME family member 20/21	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
Q5VT98	PRAMEF20	PRAME family member 20/21	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
Q5VT98	PRAMEF20	PRAME family member 20/21	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
A3QJZ6	PRAMEF22	PRAME family member 22	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
A3QJZ6	PRAMEF22	PRAME family member 22	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
A3QJZ6	PRAMEF22	PRAME family member 22	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
A3QJZ6	PRAMEF22	PRAME family member 22	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
A3QJZ6	PRAMEF22	PRAME family member 22	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
A6NMV5	PRAMEF23	PRAME family member 23	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
A6NMV5	PRAMEF23	PRAME family member 23	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
A6NMV5	PRAMEF23	PRAME family member 23	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
A6NMV5	PRAMEF23	PRAME family member 23	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
A6NMV5	PRAMEF23	PRAME family member 23	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
A6NMC2	PRAMEF24	Putative PRAME family member 24	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
A6NMC2	PRAMEF24	Putative PRAME family member 24	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
A6NMC2	PRAMEF24	Putative PRAME family member 24	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
A6NMC2	PRAMEF24	Putative PRAME family member 24	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
A6NMC2	PRAMEF24	Putative PRAME family member 24	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
A6NGN4	PRAMEF25	Putative PRAME family member 25	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
A6NGN4	PRAMEF25	Putative PRAME family member 25	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
A6NGN4	PRAMEF25	Putative PRAME family member 25	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
A6NGN4	PRAMEF25	Putative PRAME family member 25	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
A6NGN4	PRAMEF25	Putative PRAME family member 25	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
Q9UI14	RABAC1	Prenylated Rab acceptor protein 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q9UI14	RABAC1	Prenylated Rab acceptor protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
O60831	PRAF2	PRA1 family protein 2	GO:0015813; P:L-glutamate transport; ISS:UniProtKB
O60831	PRAF2	PRA1 family protein 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O75915	ARL6IP5	PRA1 family protein 3	GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IDA:UniProt
O75915	ARL6IP5	PRA1 family protein 3	GO:0015813; P:L-glutamate transport; ISS:UniProtKB
O75915	ARL6IP5	PRA1 family protein 3	GO:0010917; P:negative regulation of mitochondrial membrane potential; IMP:UniProt
O75915	ARL6IP5	PRA1 family protein 3	GO:0051051; P:negative regulation of transport; IEA:Ensembl
O75915	ARL6IP5	PRA1 family protein 3	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProt
O75915	ARL6IP5	PRA1 family protein 3	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProt
O75915	ARL6IP5	PRA1 family protein 3	GO:0032874; P:positive regulation of stress-activated MAPK cascade; IMP:UniProt
O95521	PRAMEF1	PRAME family member 1	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
O95521	PRAMEF1	PRAME family member 1	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
O95521	PRAMEF1	PRAME family member 1	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
O95521	PRAMEF1	PRAME family member 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
O95521	PRAMEF1	PRAME family member 1	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
O60811	PRAMEF2	PRAME family member 2	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
O60811	PRAMEF2	PRAME family member 2	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
O60811	PRAMEF2	PRAME family member 2	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
O60811	PRAMEF2	PRAME family member 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
O60811	PRAMEF2	PRAME family member 2	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
Q5TYW8	PRAMEF3	PRAME family member 3	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
Q5TYW8	PRAMEF3	PRAME family member 3	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
Q5TYW8	PRAMEF3	PRAME family member 3	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
Q5TYW8	PRAMEF3	PRAME family member 3	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
Q5TYW8	PRAMEF3	PRAME family member 3	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
O60810	PRAMEF4	PRAME family member 4	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
O60810	PRAMEF4	PRAME family member 4	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
O60810	PRAMEF4	PRAME family member 4	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
O60810	PRAMEF4	PRAME family member 4	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
O60810	PRAMEF4	PRAME family member 4	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
Q5VXH4	PRAMEF6	PRAME family member 6	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
Q5VXH4	PRAMEF6	PRAME family member 6	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
Q5VXH4	PRAMEF6	PRAME family member 6	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
Q5VXH4	PRAMEF6	PRAME family member 6	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
Q5VXH4	PRAMEF6	PRAME family member 6	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
Q5TYX0	PRAMEF5	PRAME family member 5	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
Q5TYX0	PRAMEF5	PRAME family member 5	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
Q5TYX0	PRAMEF5	PRAME family member 5	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
Q5TYX0	PRAMEF5	PRAME family member 5	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
Q5TYX0	PRAMEF5	PRAME family member 5	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
Q5VXH5	PRAMEF7	PRAME family member 7	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
Q5VXH5	PRAMEF7	PRAME family member 7	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
Q5VXH5	PRAMEF7	PRAME family member 7	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
Q5VXH5	PRAMEF7	PRAME family member 7	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
Q5VXH5	PRAMEF7	PRAME family member 7	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
Q5VWM4	PRAMEF8	PRAME family member 8	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
Q5VWM4	PRAMEF8	PRAME family member 8	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
Q5VWM4	PRAMEF8	PRAME family member 8	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
Q5VWM4	PRAMEF8	PRAME family member 8	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
Q5VWM4	PRAMEF8	PRAME family member 8	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
Q5VWM5	PRAMEF9	PRAME family member 9/15	GO:0043066; P:negative regulation of apoptotic process; IEA:InterPro
Q5VWM5	PRAMEF9	PRAME family member 9/15	GO:0045596; P:negative regulation of cell differentiation; IEA:InterPro
Q5VWM5	PRAMEF9	PRAME family member 9/15	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:InterPro
Q5VWM5	PRAMEF9	PRAME family member 9/15	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro
Q5VWM5	PRAMEF9	PRAME family member 9/15	GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro
P78395	PRAME	Melanoma antigen preferentially expressed in tumors	GO:0005515; F:protein binding; IPI:UniProtKB
P78395	PRAME	Melanoma antigen preferentially expressed in tumors	GO:0042974; F:retinoic acid receptor binding; IDA:UniProtKB
P78395	PRAME	Melanoma antigen preferentially expressed in tumors	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P78395	PRAME	Melanoma antigen preferentially expressed in tumors	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P78395	PRAME	Melanoma antigen preferentially expressed in tumors	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P78395	PRAME	Melanoma antigen preferentially expressed in tumors	GO:0045596; P:negative regulation of cell differentiation; IDA:UniProtKB
P78395	PRAME	Melanoma antigen preferentially expressed in tumors	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IDA:UniProtKB
P78395	PRAME	Melanoma antigen preferentially expressed in tumors	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P78395	PRAME	Melanoma antigen preferentially expressed in tumors	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P78395	PRAME	Melanoma antigen preferentially expressed in tumors	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
P78395	PRAME	Melanoma antigen preferentially expressed in tumors	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96QH2	PRAM1	PML-RARA-regulated adapter molecule 1	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q96QH2	PRAM1	PML-RARA-regulated adapter molecule 1	GO:0005515; F:protein binding; IPI:IntAct
Q96QH2	PRAM1	PML-RARA-regulated adapter molecule 1	GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl
Q96QH2	PRAM1	PML-RARA-regulated adapter molecule 1	GO:0043313; P:regulation of neutrophil degranulation; IEA:Ensembl
Q9BXM0	PRX	Periaxin	GO:0005515; F:protein binding; IPI:IntAct
Q9BXM0	PRX	Periaxin	GO:0008366; P:axon ensheathment; NAS:UniProtKB
Q9BXM0	PRX	Periaxin	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q04118	PRB3	Basic salivary proline-rich protein 3	GO:0050829; P:defense response to Gram-negative bacterium; NAS:UniProtKB
O43663	PRC1	Protein regulator of cytokinesis 1	GO:0042802; F:identical protein binding; IPI:IntAct
O43663	PRC1	Protein regulator of cytokinesis 1	GO:0005515; F:protein binding; IPI:UniProtKB
O43663	PRC1	Protein regulator of cytokinesis 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O43663	PRC1	Protein regulator of cytokinesis 1	GO:0000910; P:cytokinesis; IDA:UniProtKB
O43663	PRC1	Protein regulator of cytokinesis 1	GO:0000022; P:mitotic spindle elongation; TAS:ProtInc
P48634	PRRC2A	Protein PRRC2A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P48634	PRRC2A	Protein PRRC2A	GO:0005515; F:protein binding; IPI:IntAct
Q5JSZ5	PRRC2B	Protein PRRC2B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q5JSZ5	PRRC2B	Protein PRRC2B	GO:0005515; F:protein binding; IPI:IntAct
Q9Y520	PRRC2C	Protein PRRC2C	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y520	PRRC2C	Protein PRRC2C	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q8NCQ7	PROCA1	Protein PROCA1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8NCQ7	PROCA1	Protein PROCA1	GO:0004623; F:phospholipase A2 activity; IEA:InterPro
Q8NCQ7	PROCA1	Protein PROCA1	GO:0016042; P:lipid catabolic process; IEA:InterPro
Q92733	PRCC	Proline-rich protein PRCC	GO:0005515; F:protein binding; IPI:UniProtKB
Q92733	PRCC	Proline-rich protein PRCC	GO:0007093; P:mitotic cell cycle checkpoint; IDA:UniProtKB
Q00LT1	PRCD	Progressive rod-cone degeneration protein	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q00LT1	PRCD	Progressive rod-cone degeneration protein	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q9NQV6	PRDM10	PR domain zinc finger protein 10	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NQV6	PRDM10	PR domain zinc finger protein 10	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NQV6	PRDM10	PR domain zinc finger protein 10	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q9NQV6	PRDM10	PR domain zinc finger protein 10	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NQV6	PRDM10	PR domain zinc finger protein 10	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NQV5	PRDM11	PR domain-containing protein 11	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q9H4Q4	PRDM12	PR domain zinc finger protein 12	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H4Q4	PRDM12	PR domain zinc finger protein 12	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H4Q4	PRDM12	PR domain zinc finger protein 12	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q9H4Q4	PRDM12	PR domain zinc finger protein 12	GO:0022008; P:neurogenesis; IEA:Ensembl
Q9H4Q4	PRDM12	PR domain zinc finger protein 12	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H4Q4	PRDM12	PR domain zinc finger protein 12	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H4Q3	PRDM13	PR domain zinc finger protein 13	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H4Q3	PRDM13	PR domain zinc finger protein 13	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H4Q3	PRDM13	PR domain zinc finger protein 13	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q9H4Q3	PRDM13	PR domain zinc finger protein 13	GO:0022008; P:neurogenesis; IEA:Ensembl
Q9H4Q3	PRDM13	PR domain zinc finger protein 13	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H4Q3	PRDM13	PR domain zinc finger protein 13	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9GZV8	PRDM14	PR domain zinc finger protein 14	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9GZV8	PRDM14	PR domain zinc finger protein 14	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9GZV8	PRDM14	PR domain zinc finger protein 14	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q9GZV8	PRDM14	PR domain zinc finger protein 14	GO:0005515; F:protein binding; IPI:IntAct
Q9GZV8	PRDM14	PR domain zinc finger protein 14	GO:0001708; P:cell fate specification; IEA:Ensembl
Q9GZV8	PRDM14	PR domain zinc finger protein 14	GO:0000902; P:cell morphogenesis; IEA:Ensembl
Q9GZV8	PRDM14	PR domain zinc finger protein 14	GO:0009566; P:fertilization; IEA:Ensembl
Q9GZV8	PRDM14	PR domain zinc finger protein 14	GO:0007281; P:germ cell development; IEA:Ensembl
Q9GZV8	PRDM14	PR domain zinc finger protein 14	GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl
Q9GZV8	PRDM14	PR domain zinc finger protein 14	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9GZV8	PRDM14	PR domain zinc finger protein 14	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P57071	PRDM15	PR domain zinc finger protein 15	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P57071	PRDM15	PR domain zinc finger protein 15	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P57071	PRDM15	PR domain zinc finger protein 15	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
P57071	PRDM15	PR domain zinc finger protein 15	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P57071	PRDM15	PR domain zinc finger protein 15	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HAZ2	PRDM16	PR domain zinc finger protein 16	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HAZ2	PRDM16	PR domain zinc finger protein 16	GO:0005515; F:protein binding; IPI:IntAct
Q9HAZ2	PRDM16	PR domain zinc finger protein 16	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q9HAZ2	PRDM16	PR domain zinc finger protein 16	GO:0003713; F:transcription coactivator activity; ISS:UniProtKB
Q9HAZ2	PRDM16	PR domain zinc finger protein 16	GO:0050873; P:brown fat cell differentiation; ISS:UniProtKB
Q9HAZ2	PRDM16	PR domain zinc finger protein 16	GO:0030853; P:negative regulation of granulocyte differentiation; IDA:UniProtKB
Q9HAZ2	PRDM16	PR domain zinc finger protein 16	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9HAZ2	PRDM16	PR domain zinc finger protein 16	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9HAZ2	PRDM16	PR domain zinc finger protein 16	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
Q9HAZ2	PRDM16	PR domain zinc finger protein 16	GO:0022008; P:neurogenesis; IEA:Ensembl
Q9HAZ2	PRDM16	PR domain zinc finger protein 16	GO:0060021; P:palate development; IEA:Ensembl
Q9HAZ2	PRDM16	PR domain zinc finger protein 16	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9HAZ2	PRDM16	PR domain zinc finger protein 16	GO:0043457; P:regulation of cellular respiration; ISS:UniProtKB
Q9HAZ2	PRDM16	PR domain zinc finger protein 16	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
Q9HAZ2	PRDM16	PR domain zinc finger protein 16	GO:0043586; P:tongue development; IEA:Ensembl
Q9HAZ2	PRDM16	PR domain zinc finger protein 16	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HAZ2	PRDM16	PR domain zinc finger protein 16	GO:0050872; P:white fat cell differentiation; IEA:Ensembl
Q969G5	PRKCDBP	Protein kinase C delta-binding protein	GO:0005515; F:protein binding; IPI:IntAct
Q9NRG1	PRTFDC1	Phosphoribosyltransferase domain-containing protein 1	GO:0000287; F:magnesium ion binding; TAS:UniProtKB
Q9NRG1	PRTFDC1	Phosphoribosyltransferase domain-containing protein 1	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
Q9NRG1	PRTFDC1	Phosphoribosyltransferase domain-containing protein 1	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q9NRG1	PRTFDC1	Phosphoribosyltransferase domain-containing protein 1	GO:0009116; P:nucleoside metabolic process; IEA:InterPro
Q13029	PRDM2	PR domain zinc finger protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q13029	PRDM2	PR domain zinc finger protein 2	GO:0018024; F:histone-lysine N-methyltransferase activity; IEA:UniProtKB-EC
Q13029	PRDM2	PR domain zinc finger protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q13029	PRDM2	PR domain zinc finger protein 2	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q13029	PRDM2	PR domain zinc finger protein 2	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q13029	PRDM2	PR domain zinc finger protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75626	PRDM1	PR domain zinc finger protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75626	PRDM1	PR domain zinc finger protein 1	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
O75626	PRDM1	PR domain zinc finger protein 1	GO:0005515; F:protein binding; IPI:IntAct
O75626	PRDM1	PR domain zinc finger protein 1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
O75626	PRDM1	PR domain zinc finger protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O75626	PRDM1	PR domain zinc finger protein 1	GO:0045165; P:cell fate commitment; IEA:Ensembl
O75626	PRDM1	PR domain zinc finger protein 1	GO:0042462; P:eye photoreceptor cell development; IEA:Ensembl
O75626	PRDM1	PR domain zinc finger protein 1	GO:0007281; P:germ cell development; IEA:Ensembl
O75626	PRDM1	PR domain zinc finger protein 1	GO:0001893; P:maternal placenta development; IEA:Ensembl
O75626	PRDM1	PR domain zinc finger protein 1	GO:0030889; P:negative regulation of B cell proliferation; IEA:Ensembl
O75626	PRDM1	PR domain zinc finger protein 1	GO:0031665; P:negative regulation of lipopolysaccharide-mediated signaling pathway; IEA:Ensembl
O75626	PRDM1	PR domain zinc finger protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O75626	PRDM1	PR domain zinc finger protein 1	GO:0045579; P:positive regulation of B cell differentiation; IEA:Ensembl
O75626	PRDM1	PR domain zinc finger protein 1	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
O75626	PRDM1	PR domain zinc finger protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75626	PRDM1	PR domain zinc finger protein 1	GO:0060707; P:trophoblast giant cell differentiation; IEA:Ensembl
Q9UKN5	PRDM4	PR domain zinc finger protein 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UKN5	PRDM4	PR domain zinc finger protein 4	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q9UKN5	PRDM4	PR domain zinc finger protein 4	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q9UKN5	PRDM4	PR domain zinc finger protein 4	GO:0008283; P:cell proliferation; TAS:ProtInc
Q9UKN5	PRDM4	PR domain zinc finger protein 4	GO:0045786; P:negative regulation of cell cycle; TAS:Reactome
Q9UKN5	PRDM4	PR domain zinc finger protein 4	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9UKN5	PRDM4	PR domain zinc finger protein 4	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UKN5	PRDM4	PR domain zinc finger protein 4	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UKN5	PRDM4	PR domain zinc finger protein 4	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9NQX1	PRDM5	PR domain zinc finger protein 5	GO:0046872; F:metal ion binding; IEA:InterPro
Q9NQX1	PRDM5	PR domain zinc finger protein 5	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q9NQX1	PRDM5	PR domain zinc finger protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NQX1	PRDM5	PR domain zinc finger protein 5	GO:0070491; F:repressing transcription factor binding; IDA:UniProtKB
Q9NQX1	PRDM5	PR domain zinc finger protein 5	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q9NQX1	PRDM5	PR domain zinc finger protein 5	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q9NQX1	PRDM5	PR domain zinc finger protein 5	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
Q9NQX1	PRDM5	PR domain zinc finger protein 5	GO:0016575; P:histone deacetylation; IMP:UniProtKB
Q9NQX1	PRDM5	PR domain zinc finger protein 5	GO:0051567; P:histone H3-K9 methylation; IDA:UniProtKB
Q9NQX1	PRDM5	PR domain zinc finger protein 5	GO:0000278; P:mitotic cell cycle; IMP:UniProtKB
Q9NQX1	PRDM5	PR domain zinc finger protein 5	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9NQX1	PRDM5	PR domain zinc finger protein 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NQX0	PRDM6	Putative histone-lysine N-methyltransferase PRDM6	GO:0018024; F:histone-lysine N-methyltransferase activity; IEA:UniProtKB-EC
Q9NQX0	PRDM6	Putative histone-lysine N-methyltransferase PRDM6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NQX0	PRDM6	Putative histone-lysine N-methyltransferase PRDM6	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9NQX0	PRDM6	Putative histone-lysine N-methyltransferase PRDM6	GO:0051151; P:negative regulation of smooth muscle cell differentiation; IEA:Ensembl
Q9NQX0	PRDM6	Putative histone-lysine N-methyltransferase PRDM6	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q9NQX0	PRDM6	Putative histone-lysine N-methyltransferase PRDM6	GO:0022008; P:neurogenesis; IEA:Ensembl
Q9NQX0	PRDM6	Putative histone-lysine N-methyltransferase PRDM6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NQW5	PRDM7	Probable histone-lysine N-methyltransferase PRDM7	GO:0018024; F:histone-lysine N-methyltransferase activity; IEA:UniProtKB-EC
Q9NQW5	PRDM7	Probable histone-lysine N-methyltransferase PRDM7	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9NQW5	PRDM7	Probable histone-lysine N-methyltransferase PRDM7	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q9NQV8	PRDM8	PR domain zinc finger protein 8	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9NQV8	PRDM8	PR domain zinc finger protein 8	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NQV8	PRDM8	PR domain zinc finger protein 8	GO:0046974; F:histone methyltransferase activity (H3-K9 specific); IEA:Ensembl
Q9NQV8	PRDM8	PR domain zinc finger protein 8	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NQV8	PRDM8	PR domain zinc finger protein 8	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
Q9NQV8	PRDM8	PR domain zinc finger protein 8	GO:0021540; P:corpus callosum morphogenesis; IEA:Ensembl
Q9NQV8	PRDM8	PR domain zinc finger protein 8	GO:0021957; P:corticospinal tract morphogenesis; IEA:Ensembl
Q9NQV8	PRDM8	PR domain zinc finger protein 8	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q9NQV8	PRDM8	PR domain zinc finger protein 8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NQV7	PRDM9	Histone-lysine N-methyltransferase PRDM9	GO:0042800; F:histone methyltransferase activity (H3-K4 specific); IEA:Ensembl
Q9NQV7	PRDM9	Histone-lysine N-methyltransferase PRDM9	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NQV7	PRDM9	Histone-lysine N-methyltransferase PRDM9	GO:0010844; F:recombination hotspot binding; IEA:Ensembl
Q9NQV7	PRDM9	Histone-lysine N-methyltransferase PRDM9	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q9NQV7	PRDM9	Histone-lysine N-methyltransferase PRDM9	GO:0006311; P:meiotic gene conversion; IDA:MGI
Q9NQV7	PRDM9	Histone-lysine N-methyltransferase PRDM9	GO:0060903; P:positive regulation of meiosis I; IEA:Ensembl
Q9NQV7	PRDM9	Histone-lysine N-methyltransferase PRDM9	GO:0010845; P:positive regulation of reciprocal meiotic recombination; IMP:MGI
Q9NQV7	PRDM9	Histone-lysine N-methyltransferase PRDM9	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9NQV7	PRDM9	Histone-lysine N-methyltransferase PRDM9	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q9NQV7	PRDM9	Histone-lysine N-methyltransferase PRDM9	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q06830	PRDX1	Peroxiredoxin-1	GO:0020037; F:heme binding; IEA:Ensembl
Q06830	PRDX1	Peroxiredoxin-1	GO:0004601; F:peroxidase activity; IDA:MGI
Q06830	PRDX1	Peroxiredoxin-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q06830	PRDX1	Peroxiredoxin-1	GO:0005515; F:protein binding; IPI:IntAct
Q06830	PRDX1	Peroxiredoxin-1	GO:0008379; F:thioredoxin peroxidase activity; IDA:BHF-UCL
Q06830	PRDX1	Peroxiredoxin-1	GO:0008283; P:cell proliferation; TAS:ProtInc
Q06830	PRDX1	Peroxiredoxin-1	GO:0034101; P:erythrocyte homeostasis; IEA:Ensembl
Q06830	PRDX1	Peroxiredoxin-1	GO:0042744; P:hydrogen peroxide catabolic process; IDA:BHF-UCL
Q06830	PRDX1	Peroxiredoxin-1	GO:0042267; P:natural killer cell mediated cytotoxicity; IEA:Ensembl
Q06830	PRDX1	Peroxiredoxin-1	GO:0042345; P:regulation of NF-kappaB import into nucleus; IEA:Ensembl
Q06830	PRDX1	Peroxiredoxin-1	GO:0032872; P:regulation of stress-activated MAPK cascade; IEA:Ensembl
Q06830	PRDX1	Peroxiredoxin-1	GO:0019430; P:removal of superoxide radicals; IEA:Ensembl
Q06830	PRDX1	Peroxiredoxin-1	GO:0001895; P:retina homeostasis; IEP:UniProt
Q06830	PRDX1	Peroxiredoxin-1	GO:0001501; P:skeletal system development; TAS:ProtInc
P32119	PRDX2	Peroxiredoxin-2	GO:0016209; F:antioxidant activity; IDA:UniProtKB
P32119	PRDX2	Peroxiredoxin-2	GO:0008379; F:thioredoxin peroxidase activity; IDA:UniProtKB
P32119	PRDX2	Peroxiredoxin-2	GO:0034599; P:cellular response to oxidative stress; IDA:BHF-UCL
P32119	PRDX2	Peroxiredoxin-2	GO:0042744; P:hydrogen peroxide catabolic process; TAS:BHF-UCL
P32119	PRDX2	Peroxiredoxin-2	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
P32119	PRDX2	Peroxiredoxin-2	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P32119	PRDX2	Peroxiredoxin-2	GO:0042981; P:regulation of apoptotic process; IMP:UniProtKB
P32119	PRDX2	Peroxiredoxin-2	GO:0019430; P:removal of superoxide radicals; IDA:BHF-UCL
P32119	PRDX2	Peroxiredoxin-2	GO:0006979; P:response to oxidative stress; IMP:UniProtKB
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0008785; F:alkyl hydroperoxide reductase activity; NAS:UniProtKB
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IMP:UniProtKB
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0019900; F:kinase binding; IPI:UniProtKB
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0004601; F:peroxidase activity; IEA:UniProtKB-KW
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0051920; F:peroxiredoxin activity; IEA:UniProtKB-EC
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0034614; P:cellular response to reactive oxygen species; IMP:UniProtKB
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0042744; P:hydrogen peroxide catabolic process; IMP:UniProtKB
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0001893; P:maternal placenta development; IEA:Ensembl
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0007005; P:mitochondrion organization; IMP:UniProtKB
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0030099; P:myeloid cell differentiation; ISS:UniProtKB
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:GOC
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0033673; P:negative regulation of kinase activity; IDA:UniProtKB
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0051881; P:regulation of mitochondrial membrane potential; IMP:UniProtKB
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0042542; P:response to hydrogen peroxide; IDA:UniProtKB
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0032496; P:response to lipopolysaccharide; ISS:UniProtKB
P30048	PRDX3	Thioredoxin-dependent peroxide reductase, mitochondrial	GO:0006979; P:response to oxidative stress; IMP:UniProtKB
Q13162	PRDX4	Peroxiredoxin-4	GO:0005515; F:protein binding; IPI:IntAct
Q13162	PRDX4	Peroxiredoxin-4	GO:0008379; F:thioredoxin peroxidase activity; TAS:ProtInc
Q13162	PRDX4	Peroxiredoxin-4	GO:0007252; P:I-kappaB phosphorylation; TAS:ProtInc
Q13162	PRDX4	Peroxiredoxin-4	GO:0008584; P:male gonad development; IEA:Ensembl
Q13162	PRDX4	Peroxiredoxin-4	GO:2000255; P:negative regulation of male germ cell proliferation; IEA:Ensembl
Q13162	PRDX4	Peroxiredoxin-4	GO:0072593; P:reactive oxygen species metabolic process; IEA:Ensembl
Q13162	PRDX4	Peroxiredoxin-4	GO:0007283; P:spermatogenesis; IEA:Ensembl
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:0016209; F:antioxidant activity; IDA:UniProtKB
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IMP:UniProtKB
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:0004601; F:peroxidase activity; IDA:UniProtKB
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:0051920; F:peroxiredoxin activity; IDA:UniProtKB
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:0072541; F:peroxynitrite reductase activity; IDA:UniProtKB
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:0046983; F:protein dimerization activity; IDA:UniProtKB
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:0005102; F:receptor binding; IPI:UniProtKB
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:0001016; F:RNA polymerase III regulatory region DNA binding; IDA:UniProtKB
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:0034614; P:cellular response to reactive oxygen species; IMP:UniProtKB
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:0042744; P:hydrogen peroxide catabolic process; IDA:UniProtKB
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:0006954; P:inflammatory response; TAS:UniProtKB
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:0070995; P:NADPH oxidation; IDA:UniProtKB
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:GOC
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:0051354; P:negative regulation of oxidoreductase activity; IDA:UniProtKB
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:0016480; P:negative regulation of transcription from RNA polymerase III promoter; IDA:UniProtKB
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:0032967; P:positive regulation of collagen biosynthetic process; IDA:UniProtKB
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:2001057; P:reactive nitrogen species metabolic process; IDA:UniProtKB
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:0060785; P:regulation of apoptosis involved in tissue homeostasis; IDA:UniProtKB
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:2001141; P:regulation of RNA biosynthetic process; IDA:UniProtKB
P30044	PRDX5	Peroxiredoxin-5, mitochondrial	GO:0006979; P:response to oxidative stress; IDA:UniProtKB
P30041	PRDX6	Peroxiredoxin-6	GO:0016209; F:antioxidant activity; NAS:UniProtKB
P30041	PRDX6	Peroxiredoxin-6	GO:0004602; F:glutathione peroxidase activity; IEA:UniProtKB-EC
P30041	PRDX6	Peroxiredoxin-6	GO:0051920; F:peroxiredoxin activity; IEA:UniProtKB-EC
P30041	PRDX6	Peroxiredoxin-6	GO:0004623; F:phospholipase A2 activity; IDA:UniProtKB
P30041	PRDX6	Peroxiredoxin-6	GO:0005515; F:protein binding; IPI:UniProtKB
P30041	PRDX6	Peroxiredoxin-6	GO:0042744; P:hydrogen peroxide catabolic process; IEA:Ensembl
P30041	PRDX6	Peroxiredoxin-6	GO:0009395; P:phospholipid catabolic process; IDA:UniProtKB
P30041	PRDX6	Peroxiredoxin-6	GO:0006979; P:response to oxidative stress; IDA:UniProtKB
Q9HCU5	PREB	Prolactin regulatory element-binding protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9HCU5	PREB	Prolactin regulatory element-binding protein	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q9HCU5	PREB	Prolactin regulatory element-binding protein	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9HCU5	PREB	Prolactin regulatory element-binding protein	GO:0048208; P:COPII vesicle coating; TAS:Reactome
Q9HCU5	PREB	Prolactin regulatory element-binding protein	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q9HCU5	PREB	Prolactin regulatory element-binding protein	GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:Reactome
Q9HCU5	PREB	Prolactin regulatory element-binding protein	GO:0061024; P:membrane organization; TAS:Reactome
Q9HCU5	PREB	Prolactin regulatory element-binding protein	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9HCU5	PREB	Prolactin regulatory element-binding protein	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9HCU5	PREB	Prolactin regulatory element-binding protein	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9HCU5	PREB	Prolactin regulatory element-binding protein	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
Q9HCU5	PREB	Prolactin regulatory element-binding protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P51888	PRELP	Prolargin	GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc
P51888	PRELP	Prolargin	GO:0008201; F:heparin binding; IEA:Ensembl
P51888	PRELP	Prolargin	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P51888	PRELP	Prolargin	GO:0007569; P:cell aging; IEA:Ensembl
P51888	PRELP	Prolargin	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P51888	PRELP	Prolargin	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
P51888	PRELP	Prolargin	GO:0042340; P:keratan sulfate catabolic process; TAS:Reactome
P51888	PRELP	Prolargin	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
P51888	PRELP	Prolargin	GO:0001501; P:skeletal system development; TAS:ProtInc
P51888	PRELP	Prolargin	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q5JRX3	PITRM1	Presequence protease, mitochondrial	GO:0008047; F:enzyme activator activity; TAS:ProtInc
Q5JRX3	PITRM1	Presequence protease, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5JRX3	PITRM1	Presequence protease, mitochondrial	GO:0004222; F:metalloendopeptidase activity; IMP:UniProtKB
Q5JRX3	PITRM1	Presequence protease, mitochondrial	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
Q5JRX3	PITRM1	Presequence protease, mitochondrial	GO:0006508; P:proteolysis; IMP:UniProtKB
Q8TCU6	PREX1	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein	GO:0019899; F:enzyme binding; TAS:UniProtKB
Q8TCU6	PREX1	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein	GO:0005543; F:phospholipid binding; IDA:UniProtKB
Q8TCU6	PREX1	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein	GO:0005515; F:protein binding; IPI:IntAct
Q8TCU6	PREX1	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein	GO:0005100; F:Rho GTPase activator activity; TAS:UniProtKB
Q8TCU6	PREX1	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; TAS:UniProtKB
Q8TCU6	PREX1	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein	GO:0030041; P:actin filament polymerization; TAS:UniProtKB
Q8TCU6	PREX1	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8TCU6	PREX1	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein	GO:0042119; P:neutrophil activation; TAS:UniProtKB
Q8TCU6	PREX1	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein	GO:0032321; P:positive regulation of Rho GTPase activity; TAS:GOC
Q8TCU6	PREX1	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein	GO:0030833; P:regulation of actin filament polymerization; IEA:Ensembl
Q8TCU6	PREX1	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein	GO:0050773; P:regulation of dendrite development; IEA:Ensembl
Q8TCU6	PREX1	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein	GO:0032319; P:regulation of Rho GTPase activity; TAS:GOC
Q8TCU6	PREX1	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein	GO:0006801; P:superoxide metabolic process; TAS:UniProtKB
Q70Z35	PREX2	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein	GO:0030675; F:Rac GTPase activator activity; IDA:MGI
Q70Z35	PREX2	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein	GO:0030676; F:Rac guanyl-nucleotide exchange factor activity; IDA:MGI
Q70Z35	PREX2	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:MGI
Q70Z35	PREX2	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q70Z35	PREX2	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein	GO:0032855; P:positive regulation of Rac GTPase activity; IDA:GOC
Q70Z35	PREX2	Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein	GO:0032314; P:regulation of Rac GTPase activity; IDA:GOC
Q96I23	PYURF	Protein preY, mitochondrial	GO:0005515; F:protein binding; IPI:HGNC
Q96I23	PYURF	Protein preY, mitochondrial	GO:0006506; P:GPI anchor biosynthetic process; IMP:HGNC
Q96I23	PYURF	Protein preY, mitochondrial	GO:0009893; P:positive regulation of metabolic process; IMP:HGNC
P13727	PRG2	Bone marrow proteoglycan	GO:0030246; F:carbohydrate binding; TAS:ProtInc
P13727	PRG2	Bone marrow proteoglycan	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P13727	PRG2	Bone marrow proteoglycan	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
P13727	PRG2	Bone marrow proteoglycan	GO:0006955; P:immune response; IEA:InterPro
Q9Y2Y8	PRG3	Proteoglycan 3	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q9Y2Y8	PRG3	Proteoglycan 3	GO:0045575; P:basophil activation; IDA:UniProtKB
Q9Y2Y8	PRG3	Proteoglycan 3	GO:0001694; P:histamine biosynthetic process; IDA:UniProtKB
Q9Y2Y8	PRG3	Proteoglycan 3	GO:0006955; P:immune response; IEA:InterPro
Q9Y2Y8	PRG3	Proteoglycan 3	GO:0019370; P:leukotriene biosynthetic process; IDA:UniProtKB
Q9Y2Y8	PRG3	Proteoglycan 3	GO:0017148; P:negative regulation of translation; IDA:UniProtKB
Q9Y2Y8	PRG3	Proteoglycan 3	GO:0042119; P:neutrophil activation; IDA:UniProtKB
Q9Y2Y8	PRG3	Proteoglycan 3	GO:0045416; P:positive regulation of interleukin-8 biosynthetic process; IDA:UniProtKB
Q9Y2Y8	PRG3	Proteoglycan 3	GO:0042554; P:superoxide anion generation; IDA:UniProtKB
Q92954	PRG4	Proteoglycan 4	GO:0030247; F:polysaccharide binding; IEA:InterPro
Q92954	PRG4	Proteoglycan 4	GO:0005044; F:scavenger receptor activity; IEA:InterPro
Q92954	PRG4	Proteoglycan 4	GO:0008283; P:cell proliferation; TAS:ProtInc
Q92954	PRG4	Proteoglycan 4	GO:0071425; P:hematopoietic stem cell proliferation; IEA:Ensembl
Q92954	PRG4	Proteoglycan 4	GO:0006955; P:immune response; IEA:InterPro
Q92954	PRG4	Proteoglycan 4	GO:0045409; P:negative regulation of interleukin-6 biosynthetic process; IEA:Ensembl
Q92954	PRG4	Proteoglycan 4	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0050681; F:androgen receptor binding; NAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0031490; F:chromatin DNA binding; ISS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0003677; F:DNA binding; ISS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0016922; F:ligand-dependent nuclear receptor binding; IPI:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IDA:BHF-UCL
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0005515; F:protein binding; IPI:IntAct
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0003723; F:RNA binding; TAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0001104; F:RNA polymerase II transcription cofactor activity; TAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0008134; F:transcription factor binding; TAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0008209; P:androgen metabolic process; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0050873; P:brown fat cell differentiation; TAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0001678; P:cellular glucose homeostasis; NAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0045333; P:cellular respiration; TAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0071398; P:cellular response to fatty acid; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0071250; P:cellular response to nitrite; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0034599; P:cellular response to oxidative stress; ISS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0097067; P:cellular response to thyroid hormone stimulus; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0007586; P:digestion; TAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0019395; P:fatty acid oxidation; NAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0051552; P:flavone metabolic process; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0006012; P:galactose metabolic process; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0006094; P:gluconeogenesis; NAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0007005; P:mitochondrion organization; NAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0006397; P:mRNA processing; TAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0045820; P:negative regulation of glycolytic process; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:2000272; P:negative regulation of receptor activity; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0070997; P:neuron death; IDA:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:2001171; P:positive regulation of ATP biosynthetic process; ISS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:1901857; P:positive regulation of cellular respiration; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:2000507; P:positive regulation of energy homeostasis; ISS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0046321; P:positive regulation of fatty acid oxidation; TAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0045722; P:positive regulation of gluconeogenesis; TAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0035066; P:positive regulation of histone acetylation; TAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:1901860; P:positive regulation of mitochondrial DNA metabolic process; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0010822; P:positive regulation of mitochondrion organization; ISS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:1901863; P:positive regulation of muscle tissue development; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0006461; P:protein complex assembly; TAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0050821; P:protein stabilization; TAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0010941; P:regulation of cell death; IDA:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:2000310; P:regulation of N-methyl-D-aspartate selective glutamate receptor activity; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0022904; P:respiratory electron transport chain; ISS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0009409; P:response to cold; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0071871; P:response to epinephrine; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0043201; P:response to leucine; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0014850; P:response to muscle activity; ISS:BHF-UCL
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0071873; P:response to norepinephrine; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0042594; P:response to starvation; NAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0036273; P:response to statin; IEA:Ensembl
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0008380; P:RNA splicing; TAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0001659; P:temperature homeostasis; TAS:UniProtKB
Q9UBK2	PPARGC1A	Peroxisome proliferator-activated receptor gamma coactivator 1-alpha	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:UniProtKB
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0050682; F:AF-2 domain binding; IPI:UniProtKB
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0030331; F:estrogen receptor binding; IDA:UniProtKB
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IDA:UniProtKB
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0000166; F:nucleotide binding; IEA:InterPro
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0030546; F:receptor activator activity; IDA:UniProtKB
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0003723; F:RNA binding; NAS:UniProtKB
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0001104; F:RNA polymerase II transcription cofactor activity; IDA:UniProtKB
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0007015; P:actin filament organization; IEA:Ensembl
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0060346; P:bone trabecula formation; IEA:Ensembl
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0034614; P:cellular response to reactive oxygen species; IEA:Ensembl
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0030520; P:intracellular estrogen receptor signaling pathway; IDA:UniProtKB
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0001503; P:ossification; IEA:Ensembl
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0010694; P:positive regulation of alkaline phosphatase activity; IEA:Ensembl
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0045780; P:positive regulation of bone resorption; IEA:Ensembl
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0045672; P:positive regulation of osteoclast differentiation; IEA:Ensembl
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0042327; P:positive regulation of phosphorylation; IEA:Ensembl
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:2000273; P:positive regulation of receptor activity; IDA:GOC
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0051591; P:response to cAMP; IEA:Ensembl
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0006390; P:transcription from mitochondrial promoter; IEA:Ensembl
Q86YN6	PPARGC1B	Peroxisome proliferator-activated receptor gamma coactivator 1-beta	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:GOC
P06401	PGR	Progesterone receptor	GO:0003677; F:DNA binding; TAS:ProtInc
P06401	PGR	Progesterone receptor	GO:0019899; F:enzyme binding; IPI:UniProtKB
P06401	PGR	Progesterone receptor	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; IEA:Ensembl
P06401	PGR	Progesterone receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P06401	PGR	Progesterone receptor	GO:0005102; F:receptor binding; IPI:UniProtKB
P06401	PGR	Progesterone receptor	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P06401	PGR	Progesterone receptor	GO:0005496; F:steroid binding; IEA:UniProtKB-KW
P06401	PGR	Progesterone receptor	GO:0003707; F:steroid hormone receptor activity; TAS:ProtInc
P06401	PGR	Progesterone receptor	GO:0008270; F:zinc ion binding; IEA:InterPro
P06401	PGR	Progesterone receptor	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P06401	PGR	Progesterone receptor	GO:0002070; P:epithelial cell maturation; IEA:Ensembl
P06401	PGR	Progesterone receptor	GO:0010467; P:gene expression; TAS:Reactome
P06401	PGR	Progesterone receptor	GO:0010629; P:negative regulation of gene expression; IEP:UniProtKB
P06401	PGR	Progesterone receptor	GO:0001542; P:ovulation from ovarian follicle; IEA:Ensembl
P06401	PGR	Progesterone receptor	GO:0050847; P:progesterone receptor signaling pathway; IEA:Ensembl
P06401	PGR	Progesterone receptor	GO:0050678; P:regulation of epithelial cell proliferation; IEA:Ensembl
P06401	PGR	Progesterone receptor	GO:0007165; P:signal transduction; TAS:ProtInc
P06401	PGR	Progesterone receptor	GO:0060748; P:tertiary branching involved in mammary gland duct morphogenesis; IEA:Ensembl
P06401	PGR	Progesterone receptor	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P49642	PRIM1	DNA primase small subunit	GO:0003896; F:DNA primase activity; TAS:ProtInc
P49642	PRIM1	DNA primase small subunit	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P49642	PRIM1	DNA primase small subunit	GO:0006270; P:DNA replication initiation; TAS:Reactome
P49642	PRIM1	DNA primase small subunit	GO:0006269; P:DNA replication, synthesis of RNA primer; TAS:ProtInc
P49642	PRIM1	DNA primase small subunit	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P49642	PRIM1	DNA primase small subunit	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P49642	PRIM1	DNA primase small subunit	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P49642	PRIM1	DNA primase small subunit	GO:0000723; P:telomere maintenance; TAS:Reactome
P49642	PRIM1	DNA primase small subunit	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
P49642	PRIM1	DNA primase small subunit	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
P49643	PRIM2	DNA primase large subunit	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
P49643	PRIM2	DNA primase large subunit	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P49643	PRIM2	DNA primase large subunit	GO:0003896; F:DNA primase activity; TAS:ProtInc
P49643	PRIM2	DNA primase large subunit	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P49643	PRIM2	DNA primase large subunit	GO:0006270; P:DNA replication initiation; TAS:Reactome
P49643	PRIM2	DNA primase large subunit	GO:0006269; P:DNA replication, synthesis of RNA primer; TAS:ProtInc
P49643	PRIM2	DNA primase large subunit	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P49643	PRIM2	DNA primase large subunit	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P49643	PRIM2	DNA primase large subunit	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P49643	PRIM2	DNA primase large subunit	GO:0000723; P:telomere maintenance; TAS:Reactome
P49643	PRIM2	DNA primase large subunit	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
P49643	PRIM2	DNA primase large subunit	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
Q96MT3	PRICKLE1	Prickle-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96MT3	PRICKLE1	Prickle-like protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96MT3	PRICKLE1	Prickle-like protein 1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:BHF-UCL
Q96MT3	PRICKLE1	Prickle-like protein 1	GO:2000691; P:negative regulation of cardiac muscle cell myoblast differentiation; IDA:UniProtKB
Q96MT3	PRICKLE1	Prickle-like protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
Q96MT3	PRICKLE1	Prickle-like protein 1	GO:0001843; P:neural tube closure; IMP:UniProtKB
Q96MT3	PRICKLE1	Prickle-like protein 1	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:BHF-UCL
Q96MT3	PRICKLE1	Prickle-like protein 1	GO:0031398; P:positive regulation of protein ubiquitination; IDA:BHF-UCL
Q96MT3	PRICKLE1	Prickle-like protein 1	GO:0006606; P:protein import into nucleus; IDA:UniProtKB
Q7Z3G6	PRICKLE2	Prickle-like protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q7Z3G6	PRICKLE2	Prickle-like protein 2	GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; IEA:Ensembl
Q7Z3G6	PRICKLE2	Prickle-like protein 2	GO:0031175; P:neuron projection development; IEA:Ensembl
O43900	PRICKLE3	Prickle-like protein 3	GO:0005515; F:protein binding; IPI:IntAct
O43900	PRICKLE3	Prickle-like protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q2TBC4	PRICKLE4	Prickle-like protein 4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86XR5	PRIMA1	Proline-rich membrane anchor 1	GO:0051649; P:establishment of localization in cell; IEA:Ensembl
Q86XR5	PRIMA1	Proline-rich membrane anchor 1	GO:0042135; P:neurotransmitter catabolic process; IEA:UniProtKB-KW
P04156	PRNP	Major prion protein	GO:0005507; F:copper ion binding; IDA:UniProtKB
P04156	PRNP	Major prion protein	GO:0042802; F:identical protein binding; IPI:IntAct
P04156	PRNP	Major prion protein	GO:0008017; F:microtubule binding; IDA:UniProtKB
P04156	PRNP	Major prion protein	GO:0005515; F:protein binding; IPI:IntAct
P04156	PRNP	Major prion protein	GO:0015631; F:tubulin binding; IDA:UniProtKB
P04156	PRNP	Major prion protein	GO:0007411; P:axon guidance; TAS:Reactome
P04156	PRNP	Major prion protein	GO:0007050; P:cell cycle arrest; IEA:UniProtKB-KW
P04156	PRNP	Major prion protein	GO:0006878; P:cellular copper ion homeostasis; NAS:UniProtKB
P04156	PRNP	Major prion protein	GO:0007611; P:learning or memory; IEA:Ensembl
P04156	PRNP	Major prion protein	GO:0008152; P:metabolic process; TAS:ProtInc
P04156	PRNP	Major prion protein	GO:0046007; P:negative regulation of activated T cell proliferation; ISS:BHF-UCL
P04156	PRNP	Major prion protein	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P04156	PRNP	Major prion protein	GO:0070885; P:negative regulation of calcineurin-NFAT signaling cascade; ISS:BHF-UCL
P04156	PRNP	Major prion protein	GO:0032689; P:negative regulation of interferon-gamma production; ISS:BHF-UCL
P04156	PRNP	Major prion protein	GO:0032700; P:negative regulation of interleukin-17 production; ISS:BHF-UCL
P04156	PRNP	Major prion protein	GO:0032703; P:negative regulation of interleukin-2 production; ISS:BHF-UCL
P04156	PRNP	Major prion protein	GO:0001933; P:negative regulation of protein phosphorylation; ISS:BHF-UCL
P04156	PRNP	Major prion protein	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
P04156	PRNP	Major prion protein	GO:0050860; P:negative regulation of T cell receptor signaling pathway; ISS:BHF-UCL
P04156	PRNP	Major prion protein	GO:0051260; P:protein homooligomerization; IEA:InterPro
P04156	PRNP	Major prion protein	GO:0046686; P:response to cadmium ion; IEA:Ensembl
P04156	PRNP	Major prion protein	GO:0046688; P:response to copper ion; IEA:Ensembl
P04156	PRNP	Major prion protein	GO:0006979; P:response to oxidative stress; ISS:UniProtKB
Q96LW4	PRIMPOL	DNA-directed primase/polymerase protein	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q96LW4	PRIMPOL	DNA-directed primase/polymerase protein	GO:0003896; F:DNA primase activity; IDA:UniProtKB
Q96LW4	PRIMPOL	DNA-directed primase/polymerase protein	GO:0003887; F:DNA-directed DNA polymerase activity; IDA:UniProtKB
Q96LW4	PRIMPOL	DNA-directed primase/polymerase protein	GO:0030145; F:manganese ion binding; TAS:UniProtKB
Q96LW4	PRIMPOL	DNA-directed primase/polymerase protein	GO:0006264; P:mitochondrial DNA replication; IMP:UniProtKB
Q96LW4	PRIMPOL	DNA-directed primase/polymerase protein	GO:0031297; P:replication fork processing; IMP:UniProtKB
Q96LW4	PRIMPOL	DNA-directed primase/polymerase protein	GO:0009411; P:response to UV; IDA:UniProtKB
Q96LW4	PRIMPOL	DNA-directed primase/polymerase protein	GO:0019985; P:translesion synthesis; IMP:UniProtKB
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0004677; F:DNA-dependent protein kinase activity; IDA:MGI
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0005515; F:protein binding; IPI:UniProtKB
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0004672; F:protein kinase activity; TAS:ProtInc
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0004674; F:protein serine/threonine kinase activity; IDA:BHF-UCL
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0002326; P:B cell lineage commitment; IEA:Ensembl
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0007420; P:brain development; IEA:Ensembl
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0032869; P:cellular response to insulin stimulus; IMP:BHF-UCL
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0006281; P:DNA repair; TAS:Reactome
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0006302; P:double-strand break repair; TAS:Reactome
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0006303; P:double-strand break repair via nonhomologous end joining; TAS:Reactome
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0035234; P:ectopic germ cell programmed cell death; IEA:Ensembl
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0007507; P:heart development; IEA:Ensembl
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0033152; P:immunoglobulin V(D)J recombination; IEA:Ensembl
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0045087; P:innate immune response; TAS:Reactome
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0002328; P:pro-B cell differentiation; IEA:Ensembl
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0031648; P:protein destabilization; IEA:Ensembl
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0010332; P:response to gamma radiation; IEA:Ensembl
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0001756; P:somitogenesis; IEA:Ensembl
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0002360; P:T cell lineage commitment; IEA:Ensembl
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0033153; P:T cell receptor V(D)J recombination; IEA:Ensembl
P78527	PRKDC	DNA-dependent protein kinase catalytic subunit	GO:0000723; P:telomere maintenance; IEA:Ensembl
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0051087; F:chaperone binding; IPI:BHF-UCL
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0042802; F:identical protein binding; IPI:IntAct
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0019900; F:kinase binding; IPI:BHF-UCL
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0030165; F:PDZ domain binding; IPI:BHF-UCL
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0005515; F:protein binding; IPI:UniProtKB
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0008270; F:zinc ion binding; IEA:InterPro
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0070842; P:aggresome assembly; IMP:BHF-UCL
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0008219; P:cell death; IDA:UniProtKB
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0007417; P:central nervous system development; TAS:ProtInc
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0000422; P:mitochondrion degradation; IMP:UniProtKB
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0032232; P:negative regulation of actin filament bundle assembly; IDA:BHF-UCL
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0060548; P:negative regulation of cell death; IDA:BHF-UCL
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0033132; P:negative regulation of glucokinase activity; IDA:MGI
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0046676; P:negative regulation of insulin secretion; IDA:MGI
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0043524; P:negative regulation of neuron apoptotic process; IDA:BHF-UCL
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0001933; P:negative regulation of protein phosphorylation; IDA:BHF-UCL
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; IDA:BHF-UCL
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0070997; P:neuron death; IDA:UniProtKB
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:BHF-UCL
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0006513; P:protein monoubiquitination; IDA:UniProtKB
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0016567; P:protein ubiquitination; IMP:UniProtKB
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0010506; P:regulation of autophagy; IDA:UniProtKB
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:2000377; P:regulation of reactive oxygen species metabolic process; IMP:UniProtKB
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60260	PARK2	E3 ubiquitin-protein ligase parkin	GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB
O75569	PRKRA	Interferon-inducible double-stranded RNA-dependent protein kinase activator A	GO:0008047; F:enzyme activator activity; TAS:ProtInc
O75569	PRKRA	Interferon-inducible double-stranded RNA-dependent protein kinase activator A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75569	PRKRA	Interferon-inducible double-stranded RNA-dependent protein kinase activator A	GO:0005515; F:protein binding; IPI:UniProtKB
O75569	PRKRA	Interferon-inducible double-stranded RNA-dependent protein kinase activator A	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
O75569	PRKRA	Interferon-inducible double-stranded RNA-dependent protein kinase activator A	GO:0034599; P:cellular response to oxidative stress; IEA:Ensembl
O75569	PRKRA	Interferon-inducible double-stranded RNA-dependent protein kinase activator A	GO:0010467; P:gene expression; TAS:Reactome
O75569	PRKRA	Interferon-inducible double-stranded RNA-dependent protein kinase activator A	GO:0006955; P:immune response; TAS:ProtInc
O75569	PRKRA	Interferon-inducible double-stranded RNA-dependent protein kinase activator A	GO:0042474; P:middle ear morphogenesis; IEA:Ensembl
O75569	PRKRA	Interferon-inducible double-stranded RNA-dependent protein kinase activator A	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
O75569	PRKRA	Interferon-inducible double-stranded RNA-dependent protein kinase activator A	GO:0042473; P:outer ear morphogenesis; IEA:Ensembl
O75569	PRKRA	Interferon-inducible double-stranded RNA-dependent protein kinase activator A	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
O75569	PRKRA	Interferon-inducible double-stranded RNA-dependent protein kinase activator A	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl
O75569	PRKRA	Interferon-inducible double-stranded RNA-dependent protein kinase activator A	GO:0030422; P:production of siRNA involved in RNA interference; IDA:UniProtKB
O75569	PRKRA	Interferon-inducible double-stranded RNA-dependent protein kinase activator A	GO:0006468; P:protein phosphorylation; IEA:Ensembl
O75569	PRKRA	Interferon-inducible double-stranded RNA-dependent protein kinase activator A	GO:0009615; P:response to virus; TAS:ProtInc
O75569	PRKRA	Interferon-inducible double-stranded RNA-dependent protein kinase activator A	GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl
P51817	PRKX	cAMP-dependent protein kinase catalytic subunit PRKX	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P51817	PRKX	cAMP-dependent protein kinase catalytic subunit PRKX	GO:0004691; F:cAMP-dependent protein kinase activity; IDA:UniProtKB
P51817	PRKX	cAMP-dependent protein kinase catalytic subunit PRKX	GO:0005515; F:protein binding; IPI:UniProtKB
P51817	PRKX	cAMP-dependent protein kinase catalytic subunit PRKX	GO:0001525; P:angiogenesis; IMP:UniProtKB
P51817	PRKX	cAMP-dependent protein kinase catalytic subunit PRKX	GO:0007155; P:cell adhesion; IMP:UniProtKB
P51817	PRKX	cAMP-dependent protein kinase catalytic subunit PRKX	GO:0031589; P:cell-substrate adhesion; IMP:UniProtKB
P51817	PRKX	cAMP-dependent protein kinase catalytic subunit PRKX	GO:0043542; P:endothelial cell migration; IMP:UniProtKB
P51817	PRKX	cAMP-dependent protein kinase catalytic subunit PRKX	GO:0001935; P:endothelial cell proliferation; IMP:UniProtKB
P51817	PRKX	cAMP-dependent protein kinase catalytic subunit PRKX	GO:0060562; P:epithelial tube morphogenesis; IDA:UniProtKB
P51817	PRKX	cAMP-dependent protein kinase catalytic subunit PRKX	GO:0060993; P:kidney morphogenesis; IDA:UniProtKB
P51817	PRKX	cAMP-dependent protein kinase catalytic subunit PRKX	GO:0030099; P:myeloid cell differentiation; IDA:UniProtKB
P51817	PRKX	cAMP-dependent protein kinase catalytic subunit PRKX	GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB
P51817	PRKX	cAMP-dependent protein kinase catalytic subunit PRKX	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P51817	PRKX	cAMP-dependent protein kinase catalytic subunit PRKX	GO:0030155; P:regulation of cell adhesion; IDA:UniProtKB
P51817	PRKX	cAMP-dependent protein kinase catalytic subunit PRKX	GO:0030334; P:regulation of cell migration; IDA:UniProtKB
P51817	PRKX	cAMP-dependent protein kinase catalytic subunit PRKX	GO:2000696; P:regulation of epithelial cell differentiation involved in kidney development; IDA:UniProtKB
O43930	PRKY	Putative serine/threonine-protein kinase PRKY	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43930	PRKY	Putative serine/threonine-protein kinase PRKY	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
O43930	PRKY	Putative serine/threonine-protein kinase PRKY	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q8N945	PRELID2	PRELI domain-containing protein 2	GO:1990050; F:phosphatidic acid transporter activity; IBA:RefGenome
Q8N945	PRELID2	PRELI domain-containing protein 2	GO:0015914; P:phospholipid transport; IBA:RefGenome
Q9Y255	PRELID1	PRELI domain-containing protein 1, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y255	PRELID1	PRELI domain-containing protein 1, mitochondrial	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
Q9Y255	PRELID1	PRELI domain-containing protein 1, mitochondrial	GO:0006955; P:immune response; TAS:ProtInc
Q9Y255	PRELID1	PRELI domain-containing protein 1, mitochondrial	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q9Y255	PRELID1	PRELI domain-containing protein 1, mitochondrial	GO:1902511; P:negative regulation of apoptotic DNA fragmentation; IDA:UniProtKB
Q9Y255	PRELID1	PRELI domain-containing protein 1, mitochondrial	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q9Y255	PRELID1	PRELI domain-containing protein 1, mitochondrial	GO:0010917; P:negative regulation of mitochondrial membrane potential; IDA:UniProtKB
Q9Y255	PRELID1	PRELI domain-containing protein 1, mitochondrial	GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; IDA:UniProtKB
Q9Y255	PRELID1	PRELI domain-containing protein 1, mitochondrial	GO:0015914; P:phospholipid transport; IMP:GOC
Q9Y255	PRELID1	PRELI domain-containing protein 1, mitochondrial	GO:1901857; P:positive regulation of cellular respiration; IDA:UniProtKB
Q9Y255	PRELID1	PRELI domain-containing protein 1, mitochondrial	GO:0010950; P:positive regulation of endopeptidase activity; IDA:UniProtKB
Q9Y255	PRELID1	PRELI domain-containing protein 1, mitochondrial	GO:2001140; P:positive regulation of phospholipid transport; IDA:UniProtKB
Q9Y255	PRELID1	PRELI domain-containing protein 1, mitochondrial	GO:0070234; P:positive regulation of T cell apoptotic process; IDA:UniProtKB
Q9Y255	PRELID1	PRELI domain-containing protein 1, mitochondrial	GO:0097035; P:regulation of membrane lipid distribution; IDA:UniProtKB
Q9Y255	PRELID1	PRELI domain-containing protein 1, mitochondrial	GO:0051881; P:regulation of mitochondrial membrane potential; IDA:UniProtKB
Q9Y255	PRELID1	PRELI domain-containing protein 1, mitochondrial	GO:0045580; P:regulation of T cell differentiation; IDA:UniProtKB
P49683	PRLHR	Prolactin-releasing peptide receptor	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P49683	PRLHR	Prolactin-releasing peptide receptor	GO:0008188; F:neuropeptide receptor activity; TAS:ProtInc
P49683	PRLHR	Prolactin-releasing peptide receptor	GO:0004983; F:neuropeptide Y receptor activity; IEA:InterPro
P49683	PRLHR	Prolactin-releasing peptide receptor	GO:0005515; F:protein binding; IPI:IntAct
P49683	PRLHR	Prolactin-releasing peptide receptor	GO:0007631; P:feeding behavior; IEA:Ensembl
P49683	PRLHR	Prolactin-releasing peptide receptor	GO:0007565; P:female pregnancy; TAS:ProtInc
P49683	PRLHR	Prolactin-releasing peptide receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P49683	PRLHR	Prolactin-releasing peptide receptor	GO:0042445; P:hormone metabolic process; IEA:Ensembl
P49683	PRLHR	Prolactin-releasing peptide receptor	GO:0007218; P:neuropeptide signaling pathway; TAS:GOC
P16471	PRLR	Prolactin receptor	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P16471	PRLR	Prolactin receptor	GO:0042978; F:ornithine decarboxylase activator activity; NAS:UniProtKB
P16471	PRLR	Prolactin receptor	GO:0017046; F:peptide hormone binding; IPI:BHF-UCL
P16471	PRLR	Prolactin receptor	GO:0004925; F:prolactin receptor activity; NAS:UniProtKB
P16471	PRLR	Prolactin receptor	GO:0005515; F:protein binding; IPI:IntAct
P16471	PRLR	Prolactin receptor	GO:0042803; F:protein homodimerization activity; NAS:UniProtKB
P16471	PRLR	Prolactin receptor	GO:0042977; P:activation of JAK2 kinase activity; NAS:UniProtKB
P16471	PRLR	Prolactin receptor	GO:0007171; P:activation of transmembrane receptor protein tyrosine kinase activity; IDA:UniProtKB
P16471	PRLR	Prolactin receptor	GO:0007166; P:cell surface receptor signaling pathway; NAS:UniProtKB
P16471	PRLR	Prolactin receptor	GO:0007566; P:embryo implantation; TAS:ProtInc
P16471	PRLR	Prolactin receptor	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome
P16471	PRLR	Prolactin receptor	GO:0007595; P:lactation; NAS:UniProtKB
P16471	PRLR	Prolactin receptor	GO:0043066; P:negative regulation of apoptotic process; NAS:UniProtKB
P16471	PRLR	Prolactin receptor	GO:0038161; P:prolactin signaling pathway; NAS:GOC
P16471	PRLR	Prolactin receptor	GO:0006694; P:steroid biosynthetic process; NAS:UniProtKB
P16471	PRLR	Prolactin receptor	GO:0042110; P:T cell activation; NAS:UniProtKB
P01236	PRL	Prolactin	GO:0005148; F:prolactin receptor binding; TAS:ProtInc
P01236	PRL	Prolactin	GO:0005515; F:protein binding; IPI:IntAct
P01236	PRL	Prolactin	GO:0008283; P:cell proliferation; TAS:ProtInc
P01236	PRL	Prolactin	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P01236	PRL	Prolactin	GO:0007565; P:female pregnancy; NAS:ProtInc
P01236	PRL	Prolactin	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome
P01236	PRL	Prolactin	GO:0007595; P:lactation; IEA:UniProtKB-KW
P01236	PRL	Prolactin	GO:0046427; P:positive regulation of JAK-STAT cascade; IDA:BHF-UCL
P01236	PRL	Prolactin	GO:0040014; P:regulation of multicellular organism growth; IEP:BHF-UCL
P04554	PRM2	Protamine-2	GO:0003677; F:DNA binding; IEA:InterPro
P04554	PRM2	Protamine-2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P04554	PRM2	Protamine-2	GO:0030261; P:chromosome condensation; IEA:UniProtKB-KW
P04554	PRM2	Protamine-2	GO:0006323; P:DNA packaging; TAS:ProtInc
P04554	PRM2	Protamine-2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P04554	PRM2	Protamine-2	GO:0007283; P:spermatogenesis; IEA:InterPro
Q9NNZ6	PRM3	Protamine-3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NNZ6	PRM3	Protamine-3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9NNZ6	PRM3	Protamine-3	GO:0030261; P:chromosome condensation; IEA:UniProtKB-KW
Q9NNZ6	PRM3	Protamine-3	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9NNZ6	PRM3	Protamine-3	GO:0030317; P:sperm motility; IEA:Ensembl
Q9NNZ6	PRM3	Protamine-3	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q9UKY0	PRND	Prion-like protein doppel	GO:0051260; P:protein homooligomerization; IEA:InterPro
P04070	PROC	Vitamin K-dependent protein C	GO:0005509; F:calcium ion binding; IEA:InterPro
P04070	PROC	Vitamin K-dependent protein C	GO:0005515; F:protein binding; IPI:IntAct
P04070	PROC	Vitamin K-dependent protein C	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
P04070	PROC	Vitamin K-dependent protein C	GO:0007596; P:blood coagulation; IEA:InterPro
P04070	PROC	Vitamin K-dependent protein C	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P04070	PROC	Vitamin K-dependent protein C	GO:0050900; P:leukocyte migration; TAS:Reactome
P04070	PROC	Vitamin K-dependent protein C	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P04070	PROC	Vitamin K-dependent protein C	GO:0030195; P:negative regulation of blood coagulation; TAS:UniProtKB
P04070	PROC	Vitamin K-dependent protein C	GO:0017187; P:peptidyl-glutamic acid carboxylation; TAS:Reactome
P04070	PROC	Vitamin K-dependent protein C	GO:0043687; P:post-translational protein modification; TAS:Reactome
P04070	PROC	Vitamin K-dependent protein C	GO:0006508; P:proteolysis; NAS:UniProtKB
Q9UF12	PRODH2	Probable proline dehydrogenase 2	GO:0004657; F:proline dehydrogenase activity; IEA:InterPro
Q9UF12	PRODH2	Probable proline dehydrogenase 2	GO:0006537; P:glutamate biosynthetic process; IEA:InterPro
Q9UF12	PRODH2	Probable proline dehydrogenase 2	GO:0010133; P:proline catabolic process to glutamate; IEA:UniProtKB-UniPathway
O43272	PRODH	Proline dehydrogenase 1, mitochondrial	GO:0016597; F:amino acid binding; IEA:Ensembl
O43272	PRODH	Proline dehydrogenase 1, mitochondrial	GO:0071949; F:FAD binding; IDA:UniProtKB
O43272	PRODH	Proline dehydrogenase 1, mitochondrial	GO:0004657; F:proline dehydrogenase activity; IDA:UniProtKB
O43272	PRODH	Proline dehydrogenase 1, mitochondrial	GO:0019470; P:4-hydroxyproline catabolic process; TAS:BHF-UCL
O43272	PRODH	Proline dehydrogenase 1, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
O43272	PRODH	Proline dehydrogenase 1, mitochondrial	GO:0006537; P:glutamate biosynthetic process; IEA:InterPro
O43272	PRODH	Proline dehydrogenase 1, mitochondrial	GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; NAS:UniProtKB
O43272	PRODH	Proline dehydrogenase 1, mitochondrial	GO:0006562; P:proline catabolic process; TAS:Reactome
O43272	PRODH	Proline dehydrogenase 1, mitochondrial	GO:0010133; P:proline catabolic process to glutamate; IEA:UniProtKB-UniPathway
O43272	PRODH	Proline dehydrogenase 1, mitochondrial	GO:0006560; P:proline metabolic process; TAS:ProtInc
O43272	PRODH	Proline dehydrogenase 1, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P07737	PFN1	Profilin-1	GO:0003779; F:actin binding; IPI:UniProtKB
P07737	PFN1	Profilin-1	GO:0000774; F:adenyl-nucleotide exchange factor activity; IDA:UniProt
P07737	PFN1	Profilin-1	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProt
P07737	PFN1	Profilin-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P07737	PFN1	Profilin-1	GO:0070064; F:proline-rich region binding; IPI:UniProtKB
P07737	PFN1	Profilin-1	GO:0005515; F:protein binding; IPI:IntAct
P07737	PFN1	Profilin-1	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
P07737	PFN1	Profilin-1	GO:0007596; P:blood coagulation; TAS:Reactome
P07737	PFN1	Profilin-1	GO:0008219; P:cell death; IEA:UniProtKB-KW
P07737	PFN1	Profilin-1	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P07737	PFN1	Profilin-1	GO:0032232; P:negative regulation of actin filament bundle assembly; IMP:UniProt
P07737	PFN1	Profilin-1	GO:0030837; P:negative regulation of actin filament polymerization; IDA:UniProt
P07737	PFN1	Profilin-1	GO:0051497; P:negative regulation of stress fiber assembly; IMP:UniProt
P07737	PFN1	Profilin-1	GO:0001843; P:neural tube closure; IEA:Ensembl
P07737	PFN1	Profilin-1	GO:0030168; P:platelet activation; TAS:Reactome
P07737	PFN1	Profilin-1	GO:0002576; P:platelet degranulation; TAS:Reactome
P07737	PFN1	Profilin-1	GO:0030838; P:positive regulation of actin filament polymerization; IGI:UniProt
P07737	PFN1	Profilin-1	GO:0032781; P:positive regulation of ATPase activity; IDA:UniProt
P07737	PFN1	Profilin-1	GO:0051054; P:positive regulation of DNA metabolic process; IEA:Ensembl
P07737	PFN1	Profilin-1	GO:0010634; P:positive regulation of epithelial cell migration; IMP:UniProt
P07737	PFN1	Profilin-1	GO:1900029; P:positive regulation of ruffle assembly; IMP:UniProt
P07737	PFN1	Profilin-1	GO:0051496; P:positive regulation of stress fiber assembly; IEA:Ensembl
P07737	PFN1	Profilin-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P07737	PFN1	Profilin-1	GO:0050434; P:positive regulation of viral transcription; IEA:Ensembl
P35080	PFN2	Profilin-2	GO:0003785; F:actin monomer binding; IPI:UniProt
P35080	PFN2	Profilin-2	GO:0000774; F:adenyl-nucleotide exchange factor activity; IDA:UniProt
P35080	PFN2	Profilin-2	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProt
P35080	PFN2	Profilin-2	GO:0005515; F:protein binding; IPI:IntAct
P35080	PFN2	Profilin-2	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
P35080	PFN2	Profilin-2	GO:0030837; P:negative regulation of actin filament polymerization; IDA:UniProt
P35080	PFN2	Profilin-2	GO:0010633; P:negative regulation of epithelial cell migration; IMP:UniProt
P35080	PFN2	Profilin-2	GO:1900028; P:negative regulation of ruffle assembly; IMP:UniProt
P35080	PFN2	Profilin-2	GO:0032233; P:positive regulation of actin filament bundle assembly; IMP:UniProt
P35080	PFN2	Profilin-2	GO:0030838; P:positive regulation of actin filament polymerization; IGI:UniProt
P35080	PFN2	Profilin-2	GO:0032781; P:positive regulation of ATPase activity; IDA:UniProt
P35080	PFN2	Profilin-2	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IMP:UniProt
P35080	PFN2	Profilin-2	GO:0051496; P:positive regulation of stress fiber assembly; IMP:UniProt
P35080	PFN2	Profilin-2	GO:2000300; P:regulation of synaptic vesicle exocytosis; IEA:Ensembl
P60673	PFN3	Profilin-3	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
P60673	PFN3	Profilin-3	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
Q8NHR9	PFN4	Profilin-4	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q8NHR9	PFN4	Profilin-4	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
P58294	PROK1	Prokineticin-1	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
P58294	PROK1	Prokineticin-1	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P58294	PROK1	Prokineticin-1	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P58294	PROK1	Prokineticin-1	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P58294	PROK1	Prokineticin-1	GO:0045765; P:regulation of angiogenesis; IEA:Ensembl
Q9HC23	PROK2	Prokineticin-2	GO:0001664; F:G-protein coupled receptor binding; TAS:UniProtKB
Q9HC23	PROK2	Prokineticin-2	GO:0000187; P:activation of MAPK activity; TAS:UniProtKB
Q9HC23	PROK2	Prokineticin-2	GO:0001525; P:angiogenesis; IDA:UniProtKB
Q9HC23	PROK2	Prokineticin-2	GO:0008283; P:cell proliferation; IDA:UniProtKB
Q9HC23	PROK2	Prokineticin-2	GO:0006935; P:chemotaxis; IDA:UniProtKB
Q9HC23	PROK2	Prokineticin-2	GO:0007623; P:circadian rhythm; IEA:Ensembl
Q9HC23	PROK2	Prokineticin-2	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
Q9HC23	PROK2	Prokineticin-2	GO:0006954; P:inflammatory response; NAS:UniProtKB
Q9HC23	PROK2	Prokineticin-2	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q9HC23	PROK2	Prokineticin-2	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
Q9HC23	PROK2	Prokineticin-2	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:UniProtKB
Q9HC23	PROK2	Prokineticin-2	GO:0045987; P:positive regulation of smooth muscle contraction; IDA:UniProtKB
Q9HC23	PROK2	Prokineticin-2	GO:0019233; P:sensory perception of pain; TAS:UniProtKB
Q9HC23	PROK2	Prokineticin-2	GO:0007283; P:spermatogenesis; IMP:UniProtKB
Q16378	PRR4	Proline-rich protein 4	GO:0001895; P:retina homeostasis; IEP:UniProt
Q16378	PRR4	Proline-rich protein 4	GO:0007601; P:visual perception; TAS:ProtInc
Q99935	PROL1	Proline-rich protein 1	GO:0004866; F:endopeptidase inhibitor activity; IDA:UniProtKB
Q99935	PROL1	Proline-rich protein 1	GO:0030414; F:peptidase inhibitor activity; IDA:UniProtKB
Q99935	PROL1	Proline-rich protein 1	GO:0010951; P:negative regulation of endopeptidase activity; IDA:GOC
Q99935	PROL1	Proline-rich protein 1	GO:0051930; P:regulation of sensory perception of pain; IDA:UniProtKB
Q99935	PROL1	Proline-rich protein 1	GO:0001895; P:retina homeostasis; IEP:UniProt
O43490	PROM1	Prominin-1	GO:0042805; F:actinin binding; IDA:BHF-UCL
O43490	PROM1	Prominin-1	GO:0045296; F:cadherin binding; IPI:BHF-UCL
O43490	PROM1	Prominin-1	GO:0005515; F:protein binding; IPI:IntAct
O43490	PROM1	Prominin-1	GO:0060219; P:camera-type eye photoreceptor cell differentiation; ISS:UniProtKB
O43490	PROM1	Prominin-1	GO:0072139; P:glomerular parietal epithelial cell differentiation; IMP:UniProtKB
O43490	PROM1	Prominin-1	GO:0072112; P:glomerular visceral epithelial cell differentiation; IMP:UniProtKB
O43490	PROM1	Prominin-1	GO:0045494; P:photoreceptor cell maintenance; IMP:BHF-UCL
O43490	PROM1	Prominin-1	GO:2000768; P:positive regulation of nephron tubule epithelial cell differentiation; IMP:UniProtKB
O43490	PROM1	Prominin-1	GO:0010842; P:retina layer formation; ISS:UniProtKB
O43490	PROM1	Prominin-1	GO:0060042; P:retina morphogenesis in camera-type eye; IMP:BHF-UCL
Q8N271	PROM2	Prominin-2	GO:0015485; F:cholesterol binding; ISS:UniProt
Q8N271	PROM2	Prominin-2	GO:2001287; P:negative regulation of caveolin-mediated endocytosis; IDA:UniProt
Q8N271	PROM2	Prominin-2	GO:0048550; P:negative regulation of pinocytosis; IDA:UniProt
Q8N271	PROM2	Prominin-2	GO:0031346; P:positive regulation of cell projection organization; IDA:UniProt
Q8N271	PROM2	Prominin-2	GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProt
Q8N271	PROM2	Prominin-2	GO:0043088; P:regulation of Cdc42 GTPase activity; IDA:UniProt
O75360	PROP1	Homeobox protein prophet of Pit-1	GO:0003682; F:chromatin binding; IEA:Ensembl
O75360	PROP1	Homeobox protein prophet of Pit-1	GO:0005515; F:protein binding; IPI:IntAct
O75360	PROP1	Homeobox protein prophet of Pit-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O75360	PROP1	Homeobox protein prophet of Pit-1	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
O75360	PROP1	Homeobox protein prophet of Pit-1	GO:0001568; P:blood vessel development; IEA:Ensembl
O75360	PROP1	Homeobox protein prophet of Pit-1	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
O75360	PROP1	Homeobox protein prophet of Pit-1	GO:0016477; P:cell migration; IEA:Ensembl
O75360	PROP1	Homeobox protein prophet of Pit-1	GO:0007417; P:central nervous system development; TAS:ProtInc
O75360	PROP1	Homeobox protein prophet of Pit-1	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
O75360	PROP1	Homeobox protein prophet of Pit-1	GO:0048850; P:hypophysis morphogenesis; IEA:Ensembl
O75360	PROP1	Homeobox protein prophet of Pit-1	GO:0021979; P:hypothalamus cell differentiation; IEA:Ensembl
O75360	PROP1	Homeobox protein prophet of Pit-1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
O75360	PROP1	Homeobox protein prophet of Pit-1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O75360	PROP1	Homeobox protein prophet of Pit-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O75360	PROP1	Homeobox protein prophet of Pit-1	GO:0060126; P:somatotropin secreting cell differentiation; IEA:Ensembl
P27918	CFP	Properdin	GO:0006956; P:complement activation; TAS:Reactome
P27918	CFP	Properdin	GO:0006957; P:complement activation, alternative pathway; TAS:Reactome
P27918	CFP	Properdin	GO:0042742; P:defense response to bacterium; TAS:ProtInc
P27918	CFP	Properdin	GO:0006955; P:immune response; TAS:ProtInc
P27918	CFP	Properdin	GO:0045087; P:innate immune response; TAS:Reactome
P27918	CFP	Properdin	GO:0030449; P:regulation of complement activation; TAS:Reactome
O94903	PROSC	Proline synthase co-transcribed bacterial homolog protein	GO:0030170; F:pyridoxal phosphate binding; IBA:RefGenome
P07225	PROS1	Vitamin K-dependent protein S	GO:0005509; F:calcium ion binding; IEA:InterPro
P07225	PROS1	Vitamin K-dependent protein S	GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc
P07225	PROS1	Vitamin K-dependent protein S	GO:0007596; P:blood coagulation; TAS:Reactome
P07225	PROS1	Vitamin K-dependent protein S	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P07225	PROS1	Vitamin K-dependent protein S	GO:0042730; P:fibrinolysis; IEA:UniProtKB-KW
P07225	PROS1	Vitamin K-dependent protein S	GO:0045087; P:innate immune response; TAS:Reactome
P07225	PROS1	Vitamin K-dependent protein S	GO:0050900; P:leukocyte migration; TAS:Reactome
P07225	PROS1	Vitamin K-dependent protein S	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
P07225	PROS1	Vitamin K-dependent protein S	GO:0017187; P:peptidyl-glutamic acid carboxylation; TAS:Reactome
P07225	PROS1	Vitamin K-dependent protein S	GO:0030168; P:platelet activation; TAS:Reactome
P07225	PROS1	Vitamin K-dependent protein S	GO:0002576; P:platelet degranulation; TAS:Reactome
P07225	PROS1	Vitamin K-dependent protein S	GO:0043687; P:post-translational protein modification; TAS:Reactome
P07225	PROS1	Vitamin K-dependent protein S	GO:0006508; P:proteolysis; TAS:Reactome
P07225	PROS1	Vitamin K-dependent protein S	GO:0030449; P:regulation of complement activation; TAS:Reactome
Q3B8N5	PROX2	Prospero homeobox protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q3B8N5	PROX2	Prospero homeobox protein 2	GO:0007275; P:multicellular organismal development; IEA:InterPro
Q3B8N5	PROX2	Prospero homeobox protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q3B8N5	PROX2	Prospero homeobox protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q92786	PROX1	Prospero homeobox protein 1	GO:0050692; F:DBD domain binding; IPI:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0003677; F:DNA binding; IMP:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0050693; F:LBD domain binding; IPI:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0016922; F:ligand-dependent nuclear receptor binding; IPI:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q92786	PROX1	Prospero homeobox protein 1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q92786	PROX1	Prospero homeobox protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IC:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0003714; F:transcription corepressor activity; IDA:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0060414; P:aorta smooth muscle tissue morphogenesis; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0055009; P:atrial cardiac muscle tissue morphogenesis; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0007420; P:brain development; IEP:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0001709; P:cell fate determination; IEA:Ensembl
Q92786	PROX1	Prospero homeobox protein 1	GO:0021707; P:cerebellar granule cell differentiation; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0021542; P:dentate gyrus development; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0021516; P:dorsal spinal cord development; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0060059; P:embryonic retina morphogenesis in camera-type eye; IEP:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0060214; P:endocardium formation; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0002194; P:hepatocyte cell migration; IEA:Ensembl
Q92786	PROX1	Prospero homeobox protein 1	GO:0070365; P:hepatocyte differentiation; IEP:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0072574; P:hepatocyte proliferation; IEA:Ensembl
Q92786	PROX1	Prospero homeobox protein 1	GO:0001822; P:kidney development; IEP:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0002088; P:lens development in camera-type eye; IEP:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0070309; P:lens fiber cell morphogenesis; IEP:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0001889; P:liver development; IEP:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0030324; P:lung development; IEP:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0001946; P:lymphangiogenesis; IDA:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0060836; P:lymphatic endothelial cell differentiation; IDA:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0070858; P:negative regulation of bile acid biosynthetic process; IMP:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0008285; P:negative regulation of cell proliferation; IMP:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0045071; P:negative regulation of viral genome replication; IDA:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0021915; P:neural tube development; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0097150; P:neuronal stem cell maintenance; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0030910; P:olfactory placode formation; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0046619; P:optic placode formation involved in camera-type eye formation; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0043049; P:otic placode formation; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0031016; P:pancreas development; IEP:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0045787; P:positive regulation of cell cycle; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:1901978; P:positive regulation of cell cycle checkpoint; IEA:Ensembl
Q92786	PROX1	Prospero homeobox protein 1	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0045737; P:positive regulation of cyclin-dependent protein kinase activity; IDA:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0010595; P:positive regulation of endothelial cell migration; IDA:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:2000979; P:positive regulation of forebrain neuron differentiation; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0060421; P:positive regulation of heart growth; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:2000179; P:positive regulation of neural precursor cell proliferation; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0060298; P:positive regulation of sarcomere organization; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q92786	PROX1	Prospero homeobox protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0010468; P:regulation of gene expression; IDA:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0060849; P:regulation of transcription involved in lymphatic endothelial cell fate commitment; IMP:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0031667; P:response to nutrient levels; IEA:Ensembl
Q92786	PROX1	Prospero homeobox protein 1	GO:0060042; P:retina morphogenesis in camera-type eye; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0030240; P:skeletal muscle thin filament assembly; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0048845; P:venous blood vessel morphogenesis; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0055005; P:ventricular cardiac myofibril assembly; ISS:BHF-UCL
Q92786	PROX1	Prospero homeobox protein 1	GO:0060412; P:ventricular septum morphogenesis; ISS:BHF-UCL
P22891	PROZ	Vitamin K-dependent protein Z	GO:0005509; F:calcium ion binding; IEA:InterPro
P22891	PROZ	Vitamin K-dependent protein Z	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
P22891	PROZ	Vitamin K-dependent protein Z	GO:0007596; P:blood coagulation; IEA:UniProtKB-KW
P22891	PROZ	Vitamin K-dependent protein Z	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P22891	PROZ	Vitamin K-dependent protein Z	GO:0017187; P:peptidyl-glutamic acid carboxylation; TAS:Reactome
P22891	PROZ	Vitamin K-dependent protein Z	GO:0043687; P:post-translational protein modification; TAS:Reactome
P22891	PROZ	Vitamin K-dependent protein Z	GO:0006508; P:proteolysis; TAS:Reactome
Q92620	DHX38	Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q92620	DHX38	Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q92620	DHX38	Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q92620	DHX38	Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16	GO:0005515; F:protein binding; IPI:IntAct
Q92620	DHX38	Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16	GO:0010467; P:gene expression; TAS:Reactome
Q92620	DHX38	Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q92620	DHX38	Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
Q92620	DHX38	Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16	GO:0000398; P:mRNA splicing, via spliceosome; IDA:UniProtKB
Q92620	DHX38	Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16	GO:0008380; P:RNA splicing; TAS:Reactome
Q92620	DHX38	Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q92620	DHX38	Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
O60508	CDC40	Pre-mRNA-processing factor 17	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O60508	CDC40	Pre-mRNA-processing factor 17	GO:0005515; F:protein binding; IPI:IntAct
O60508	CDC40	Pre-mRNA-processing factor 17	GO:0010467; P:gene expression; TAS:Reactome
O60508	CDC40	Pre-mRNA-processing factor 17	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
O60508	CDC40	Pre-mRNA-processing factor 17	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
O60508	CDC40	Pre-mRNA-processing factor 17	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
O60508	CDC40	Pre-mRNA-processing factor 17	GO:0008380; P:RNA splicing; TAS:Reactome
O60508	CDC40	Pre-mRNA-processing factor 17	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
O60508	CDC40	Pre-mRNA-processing factor 17	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q99633	PRPF18	Pre-mRNA-splicing factor 18	GO:0019870; F:potassium channel inhibitor activity; IEA:Ensembl
Q99633	PRPF18	Pre-mRNA-splicing factor 18	GO:0006397; P:mRNA processing; TAS:ProtInc
Q99633	PRPF18	Pre-mRNA-splicing factor 18	GO:0008380; P:RNA splicing; TAS:ProtInc
Q9UMS4	PRPF19	Pre-mRNA-processing factor 19	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UMS4	PRPF19	Pre-mRNA-processing factor 19	GO:0042802; F:identical protein binding; IPI:BHF-UCL
Q9UMS4	PRPF19	Pre-mRNA-processing factor 19	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UMS4	PRPF19	Pre-mRNA-processing factor 19	GO:0004842; F:ubiquitin-protein ligase activity; IDA:MGI
Q9UMS4	PRPF19	Pre-mRNA-processing factor 19	GO:0034450; F:ubiquitin-ubiquitin ligase activity; IDA:MGI
Q9UMS4	PRPF19	Pre-mRNA-processing factor 19	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q9UMS4	PRPF19	Pre-mRNA-processing factor 19	GO:0001833; P:inner cell mass cell proliferation; IEA:Ensembl
Q9UMS4	PRPF19	Pre-mRNA-processing factor 19	GO:0008610; P:lipid biosynthetic process; IEA:Ensembl
Q9UMS4	PRPF19	Pre-mRNA-processing factor 19	GO:0000398; P:mRNA splicing, via spliceosome; IDA:UniProtKB
Q9UMS4	PRPF19	Pre-mRNA-processing factor 19	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
Q9UMS4	PRPF19	Pre-mRNA-processing factor 19	GO:0048711; P:positive regulation of astrocyte differentiation; IEA:Ensembl
Q9UMS4	PRPF19	Pre-mRNA-processing factor 19	GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; IEA:Ensembl
Q9UMS4	PRPF19	Pre-mRNA-processing factor 19	GO:0000209; P:protein polyubiquitination; IDA:MGI
Q9UMS4	PRPF19	Pre-mRNA-processing factor 19	GO:0000245; P:spliceosomal complex assembly; IMP:BHF-UCL
Q8WWY3	PRPF31	U4/U6 small nuclear ribonucleoprotein Prp31	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8WWY3	PRPF31	U4/U6 small nuclear ribonucleoprotein Prp31	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WWY3	PRPF31	U4/U6 small nuclear ribonucleoprotein Prp31	GO:0043021; F:ribonucleoprotein complex binding; IDA:MGI
Q8WWY3	PRPF31	U4/U6 small nuclear ribonucleoprotein Prp31	GO:0070990; F:snRNP binding; IPI:BHF-UCL
Q8WWY3	PRPF31	U4/U6 small nuclear ribonucleoprotein Prp31	GO:0000398; P:mRNA splicing, via spliceosome; IC:BHF-UCL
Q8WWY3	PRPF31	U4/U6 small nuclear ribonucleoprotein Prp31	GO:0000244; P:spliceosomal tri-snRNP complex assembly; IMP:BHF-UCL
Q86UA1	PRPF39	Pre-mRNA-processing factor 39	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q86UA1	PRPF39	Pre-mRNA-processing factor 39	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q13523	PRPF4B	Serine/threonine-protein kinase PRP4 homolog	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13523	PRPF4B	Serine/threonine-protein kinase PRP4 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13523	PRPF4B	Serine/threonine-protein kinase PRP4 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q13523	PRPF4B	Serine/threonine-protein kinase PRP4 homolog	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q13523	PRPF4B	Serine/threonine-protein kinase PRP4 homolog	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q13523	PRPF4B	Serine/threonine-protein kinase PRP4 homolog	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q13523	PRPF4B	Serine/threonine-protein kinase PRP4 homolog	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q13523	PRPF4B	Serine/threonine-protein kinase PRP4 homolog	GO:0008380; P:RNA splicing; TAS:ProtInc
O43172	PRPF4	U4/U6 small nuclear ribonucleoprotein Prp4	GO:0005515; F:protein binding; IPI:IntAct
O43172	PRPF4	U4/U6 small nuclear ribonucleoprotein Prp4	GO:0010467; P:gene expression; TAS:Reactome
O43172	PRPF4	U4/U6 small nuclear ribonucleoprotein Prp4	GO:0000398; P:mRNA splicing, via spliceosome; IC:BHF-UCL
O43172	PRPF4	U4/U6 small nuclear ribonucleoprotein Prp4	GO:0006396; P:RNA processing; TAS:ProtInc
O43172	PRPF4	U4/U6 small nuclear ribonucleoprotein Prp4	GO:0008380; P:RNA splicing; TAS:Reactome
O43172	PRPF4	U4/U6 small nuclear ribonucleoprotein Prp4	GO:0000375; P:RNA splicing, via transesterification reactions; NAS:UniProtKB
O94906	PRPF6	Pre-mRNA-processing factor 6	GO:0050681; F:androgen receptor binding; IPI:MGI
O94906	PRPF6	Pre-mRNA-processing factor 6	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O94906	PRPF6	Pre-mRNA-processing factor 6	GO:0005515; F:protein binding; IPI:IntAct
O94906	PRPF6	Pre-mRNA-processing factor 6	GO:0043021; F:ribonucleoprotein complex binding; IDA:BHF-UCL
O94906	PRPF6	Pre-mRNA-processing factor 6	GO:0003723; F:RNA binding; IDA:MGI
O94906	PRPF6	Pre-mRNA-processing factor 6	GO:0003713; F:transcription coactivator activity; IGI:MGI
O94906	PRPF6	Pre-mRNA-processing factor 6	GO:0010467; P:gene expression; TAS:Reactome
O94906	PRPF6	Pre-mRNA-processing factor 6	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
O94906	PRPF6	Pre-mRNA-processing factor 6	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
O94906	PRPF6	Pre-mRNA-processing factor 6	GO:0006403; P:RNA localization; IMP:MGI
O94906	PRPF6	Pre-mRNA-processing factor 6	GO:0008380; P:RNA splicing; NAS:UniProtKB
O94906	PRPF6	Pre-mRNA-processing factor 6	GO:0000375; P:RNA splicing, via transesterification reactions; NAS:UniProtKB
O94906	PRPF6	Pre-mRNA-processing factor 6	GO:0000245; P:spliceosomal complex assembly; NAS:UniProtKB
O94906	PRPF6	Pre-mRNA-processing factor 6	GO:0000244; P:spliceosomal tri-snRNP complex assembly; IMP:BHF-UCL
Q6P2Q9	PRPF8	Pre-mRNA-processing-splicing factor 8	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6P2Q9	PRPF8	Pre-mRNA-processing-splicing factor 8	GO:0005515; F:protein binding; IPI:UniProtKB
Q6P2Q9	PRPF8	Pre-mRNA-processing-splicing factor 8	GO:0030623; F:U5 snRNA binding; IEA:InterPro
Q6P2Q9	PRPF8	Pre-mRNA-processing-splicing factor 8	GO:0017070; F:U6 snRNA binding; IEA:InterPro
Q6P2Q9	PRPF8	Pre-mRNA-processing-splicing factor 8	GO:0010467; P:gene expression; TAS:Reactome
Q6P2Q9	PRPF8	Pre-mRNA-processing-splicing factor 8	GO:0006397; P:mRNA processing; TAS:ProtInc
Q6P2Q9	PRPF8	Pre-mRNA-processing-splicing factor 8	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q6P2Q9	PRPF8	Pre-mRNA-processing-splicing factor 8	GO:0008380; P:RNA splicing; TAS:UniProtKB
Q6P2Q9	PRPF8	Pre-mRNA-processing-splicing factor 8	GO:0000375; P:RNA splicing, via transesterification reactions; TAS:UniProtKB
P02810	PRH1	Salivary acidic proline-rich phosphoprotein 1/2	GO:0005515; F:protein binding; IPI:IntAct
O43395	PRPF3	U4/U6 small nuclear ribonucleoprotein Prp3	GO:0042802; F:identical protein binding; IPI:IntAct
O43395	PRPF3	U4/U6 small nuclear ribonucleoprotein Prp3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O43395	PRPF3	U4/U6 small nuclear ribonucleoprotein Prp3	GO:0005515; F:protein binding; IPI:IntAct
O43395	PRPF3	U4/U6 small nuclear ribonucleoprotein Prp3	GO:0006397; P:mRNA processing; TAS:ProtInc
O43395	PRPF3	U4/U6 small nuclear ribonucleoprotein Prp3	GO:0000398; P:mRNA splicing, via spliceosome; NAS:UniProtKB
O43395	PRPF3	U4/U6 small nuclear ribonucleoprotein Prp3	GO:0008380; P:RNA splicing; TAS:ProtInc
O43395	PRPF3	U4/U6 small nuclear ribonucleoprotein Prp3	GO:0000375; P:RNA splicing, via transesterification reactions; TAS:UniProtKB
P23942	PRPH2	Peripherin-2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P23942	PRPH2	Peripherin-2	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
P23942	PRPH2	Peripherin-2	GO:0007601; P:visual perception; TAS:ProtInc
Q96S44	TP53RK	TP53-regulating kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96S44	TP53RK	TP53-regulating kinase	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q96S44	TP53RK	TP53-regulating kinase	GO:0002039; F:p53 binding; IDA:HGNC
Q96S44	TP53RK	TP53-regulating kinase	GO:0005515; F:protein binding; IPI:UniProtKB
Q96S44	TP53RK	TP53-regulating kinase	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q96S44	TP53RK	TP53-regulating kinase	GO:0004713; F:protein tyrosine kinase activity; IEA:InterPro
Q96S44	TP53RK	TP53-regulating kinase	GO:0009103; P:lipopolysaccharide biosynthetic process; IEA:InterPro
Q96S44	TP53RK	TP53-regulating kinase	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q96S44	TP53RK	TP53-regulating kinase	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0043531; F:ADP binding; IEA:Ensembl
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0016208; F:AMP binding; IEA:Ensembl
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0005524; F:ATP binding; IDA:UniProtKB
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0030246; F:carbohydrate binding; IEA:Ensembl
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0019003; F:GDP binding; IEA:Ensembl
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0016301; F:kinase activity; IEA:UniProtKB-KW
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0000287; F:magnesium ion binding; IEA:Ensembl
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0004749; F:ribose phosphate diphosphokinase activity; IDA:UniProtKB
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0006015; P:5-phosphoribose 1-diphosphate biosynthetic process; TAS:Reactome
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0006167; P:AMP biosynthetic process; IEA:Ensembl
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0008219; P:cell death; IEA:UniProtKB-KW
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0046101; P:hypoxanthine biosynthetic process; IMP:UniProtKB
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0007399; P:nervous system development; IMP:UniProtKB
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0031100; P:organ regeneration; IEA:Ensembl
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0006144; P:purine nucleobase metabolic process; IMP:UniProtKB
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0006164; P:purine nucleotide biosynthetic process; IMP:UniProtKB
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0006221; P:pyrimidine nucleotide biosynthetic process; NAS:UniProtKB
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P60891	PRPS1	Ribose-phosphate pyrophosphokinase 1	GO:0034418; P:urate biosynthetic process; IMP:UniProtKB
P11908	PRPS2	Ribose-phosphate pyrophosphokinase 2	GO:0043531; F:ADP binding; IEA:Ensembl
P11908	PRPS2	Ribose-phosphate pyrophosphokinase 2	GO:0016208; F:AMP binding; IEA:Ensembl
P11908	PRPS2	Ribose-phosphate pyrophosphokinase 2	GO:0005524; F:ATP binding; ISS:UniProtKB
P11908	PRPS2	Ribose-phosphate pyrophosphokinase 2	GO:0030246; F:carbohydrate binding; IEA:Ensembl
P11908	PRPS2	Ribose-phosphate pyrophosphokinase 2	GO:0019003; F:GDP binding; IEA:Ensembl
P11908	PRPS2	Ribose-phosphate pyrophosphokinase 2	GO:0016301; F:kinase activity; IEA:UniProtKB-KW
P11908	PRPS2	Ribose-phosphate pyrophosphokinase 2	GO:0000287; F:magnesium ion binding; IEA:Ensembl
P11908	PRPS2	Ribose-phosphate pyrophosphokinase 2	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
P11908	PRPS2	Ribose-phosphate pyrophosphokinase 2	GO:0004749; F:ribose phosphate diphosphokinase activity; ISS:UniProtKB
P11908	PRPS2	Ribose-phosphate pyrophosphokinase 2	GO:0006015; P:5-phosphoribose 1-diphosphate biosynthetic process; IEA:UniProtKB-UniPathway
P11908	PRPS2	Ribose-phosphate pyrophosphokinase 2	GO:0006167; P:AMP biosynthetic process; IEA:Ensembl
P11908	PRPS2	Ribose-phosphate pyrophosphokinase 2	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
P11908	PRPS2	Ribose-phosphate pyrophosphokinase 2	GO:0031100; P:organ regeneration; IEA:Ensembl
P21108	PRPS1L1	Ribose-phosphate pyrophosphokinase 3	GO:0005524; F:ATP binding; ISS:UniProtKB
P21108	PRPS1L1	Ribose-phosphate pyrophosphokinase 3	GO:0016301; F:kinase activity; IEA:UniProtKB-KW
P21108	PRPS1L1	Ribose-phosphate pyrophosphokinase 3	GO:0000287; F:magnesium ion binding; IEA:InterPro
P21108	PRPS1L1	Ribose-phosphate pyrophosphokinase 3	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
P21108	PRPS1L1	Ribose-phosphate pyrophosphokinase 3	GO:0004749; F:ribose phosphate diphosphokinase activity; ISS:UniProtKB
P21108	PRPS1L1	Ribose-phosphate pyrophosphokinase 3	GO:0006015; P:5-phosphoribose 1-diphosphate biosynthetic process; IEA:UniProtKB-UniPathway
P21108	PRPS1L1	Ribose-phosphate pyrophosphokinase 3	GO:0009165; P:nucleotide biosynthetic process; IEA:UniProtKB-KW
P21108	PRPS1L1	Ribose-phosphate pyrophosphokinase 3	GO:0009156; P:ribonucleoside monophosphate biosynthetic process; IEA:InterPro
Q9ULL5	PRR12	Proline-rich protein 12	GO:0003677; F:DNA binding; IEA:InterPro
Q9NZ81	PRR13	Proline-rich protein 13	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NZ81	PRR13	Proline-rich protein 13	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IV56	PRR15	Proline-rich protein 15	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P79522	PRR3	Proline-rich protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P79522	PRR3	Proline-rich protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P85299	PRR5	Proline-rich protein 5	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P85299	PRR5	Proline-rich protein 5	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl
P85299	PRR5	Proline-rich protein 5	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
Q6MZQ0	PRR5L	Proline-rich protein 5-like	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q6MZQ0	PRR5L	Proline-rich protein 5-like	GO:0001933; P:negative regulation of protein phosphorylation; IMP:UniProtKB
Q6MZQ0	PRR5L	Proline-rich protein 5-like	GO:0009968; P:negative regulation of signal transduction; IEA:UniProtKB-KW
Q6MZQ0	PRR5L	Proline-rich protein 5-like	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl
Q6MZQ0	PRR5L	Proline-rich protein 5-like	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
Q6MZQ0	PRR5L	Proline-rich protein 5-like	GO:0010762; P:regulation of fibroblast migration; IMP:UniProtKB
Q6MZQ0	PRR5L	Proline-rich protein 5-like	GO:0038203; P:TORC2 signaling; IDA:UniProtKB
P81277	PRLH	Prolactin-releasing peptide	GO:0005179; F:hormone activity; TAS:ProtInc
P81277	PRLH	Prolactin-releasing peptide	GO:0048483; P:autonomic nervous system development; IEA:Ensembl
P81277	PRLH	Prolactin-releasing peptide	GO:0006112; P:energy reserve metabolic process; IEA:Ensembl
P81277	PRLH	Prolactin-releasing peptide	GO:0045444; P:fat cell differentiation; IEA:Ensembl
P81277	PRLH	Prolactin-releasing peptide	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:Ensembl
P81277	PRLH	Prolactin-releasing peptide	GO:0006629; P:lipid metabolic process; IEA:Ensembl
P81277	PRLH	Prolactin-releasing peptide	GO:0002023; P:reduction of food intake in response to dietary excess; IEA:Ensembl
P81277	PRLH	Prolactin-releasing peptide	GO:0009749; P:response to glucose; IEA:Ensembl
P81277	PRLH	Prolactin-releasing peptide	GO:0032868; P:response to insulin; IEA:Ensembl
P81277	PRLH	Prolactin-releasing peptide	GO:0001894; P:tissue homeostasis; IEA:Ensembl
Q99946	PRRT1	Proline-rich transmembrane protein 1	GO:0009607; P:response to biotic stimulus; IEA:InterPro
Q7Z6L0	PRRT2	Proline-rich transmembrane protein 2	GO:0050884; P:neuromuscular process controlling posture; IMP:MGI
Q7Z6L0	PRRT2	Proline-rich transmembrane protein 2	GO:0009607; P:response to biotic stimulus; IEA:InterPro
P54821	PRRX1	Paired mesoderm homeobox protein 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P54821	PRRX1	Paired mesoderm homeobox protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P54821	PRRX1	Paired mesoderm homeobox protein 1	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P54821	PRRX1	Paired mesoderm homeobox protein 1	GO:0048844; P:artery morphogenesis; IEA:Ensembl
P54821	PRRX1	Paired mesoderm homeobox protein 1	GO:0051216; P:cartilage development; IEA:Ensembl
P54821	PRRX1	Paired mesoderm homeobox protein 1	GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl
P54821	PRRX1	Paired mesoderm homeobox protein 1	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
P54821	PRRX1	Paired mesoderm homeobox protein 1	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
P54821	PRRX1	Paired mesoderm homeobox protein 1	GO:0042474; P:middle ear morphogenesis; IEA:Ensembl
P54821	PRRX1	Paired mesoderm homeobox protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P54821	PRRX1	Paired mesoderm homeobox protein 1	GO:0060021; P:palate development; IEA:Ensembl
P54821	PRRX1	Paired mesoderm homeobox protein 1	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl
P54821	PRRX1	Paired mesoderm homeobox protein 1	GO:0045880; P:positive regulation of smoothened signaling pathway; IEA:Ensembl
Q99811	PRRX2	Paired mesoderm homeobox protein 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q99811	PRRX2	Paired mesoderm homeobox protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q99811	PRRX2	Paired mesoderm homeobox protein 2	GO:0048844; P:artery morphogenesis; IEA:Ensembl
Q99811	PRRX2	Paired mesoderm homeobox protein 2	GO:0051216; P:cartilage development; IEA:Ensembl
Q99811	PRRX2	Paired mesoderm homeobox protein 2	GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl
Q99811	PRRX2	Paired mesoderm homeobox protein 2	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
Q99811	PRRX2	Paired mesoderm homeobox protein 2	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q99811	PRRX2	Paired mesoderm homeobox protein 2	GO:0042474; P:middle ear morphogenesis; IEA:Ensembl
Q99811	PRRX2	Paired mesoderm homeobox protein 2	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl
Q99811	PRRX2	Paired mesoderm homeobox protein 2	GO:0045880; P:positive regulation of smoothened signaling pathway; IEA:Ensembl
Q99811	PRRX2	Paired mesoderm homeobox protein 2	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
O95084	PRSS23	Serine protease 23	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q9BQR3	PRSS27	Serine protease 27	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0016887; F:ATPase activity; TAS:UniProtKB
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0005515; F:protein binding; IPI:IntAct
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0030674; F:protein binding, bridging; NAS:UniProtKB
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0006915; P:apoptotic process; TAS:Reactome
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0006200; P:ATP catabolic process; TAS:GOC
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0010467; P:gene expression; TAS:Reactome
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0006511; P:ubiquitin-dependent protein catabolic process; IC:UniProtKB
P62333	PSMC6	26S protease regulatory subunit 10B	GO:0016032; P:viral process; TAS:Reactome
A6NIE9	PRSS29P	Putative serine protease 29	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q8NF86	PRSS33	Serine protease 33	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q8N3Z0	PRSS35	Inactive serine protease 35	GO:0003824; F:catalytic activity; IEA:InterPro
A4D1T9	PRSS37	Probable inactive serine protease 37	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
A1L453	PRSS38	Serine protease 38	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q7RTY9	PRSS41	Putative serine protease 41	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q7Z5A4	PRSS42	Serine protease 42	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
E7EML9	PRSS44	Serine protease 44	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q7RTY3	PRSS45	Serine protease 45	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
E5RG02	PRSS46	Putative serine protease 46	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
A8MTI9	PRSS47	Putative serine protease 47	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
A8MTI9	PRSS47	Putative serine protease 47	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q7RTY5	PRSS48	Serine protease 48	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q2L4Q9	PRSS53	Serine protease 53	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q6PEW0	PRSS54	Inactive serine protease 54	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q6UWB4	PRSS55	Serine protease 55	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
P62191	PSMC1	26S protease regulatory subunit 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P62191	PSMC1	26S protease regulatory subunit 4	GO:0016887; F:ATPase activity; ISS:UniProtKB
P62191	PSMC1	26S protease regulatory subunit 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62191	PSMC1	26S protease regulatory subunit 4	GO:0005515; F:protein binding; IPI:IntAct
P62191	PSMC1	26S protease regulatory subunit 4	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P62191	PSMC1	26S protease regulatory subunit 4	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P62191	PSMC1	26S protease regulatory subunit 4	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P62191	PSMC1	26S protease regulatory subunit 4	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P62191	PSMC1	26S protease regulatory subunit 4	GO:0006915; P:apoptotic process; TAS:Reactome
P62191	PSMC1	26S protease regulatory subunit 4	GO:0006200; P:ATP catabolic process; ISS:GOC
P62191	PSMC1	26S protease regulatory subunit 4	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P62191	PSMC1	26S protease regulatory subunit 4	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P62191	PSMC1	26S protease regulatory subunit 4	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P62191	PSMC1	26S protease regulatory subunit 4	GO:0010467; P:gene expression; TAS:Reactome
P62191	PSMC1	26S protease regulatory subunit 4	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P62191	PSMC1	26S protease regulatory subunit 4	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62191	PSMC1	26S protease regulatory subunit 4	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P62191	PSMC1	26S protease regulatory subunit 4	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P62191	PSMC1	26S protease regulatory subunit 4	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P62191	PSMC1	26S protease regulatory subunit 4	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P62191	PSMC1	26S protease regulatory subunit 4	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P62191	PSMC1	26S protease regulatory subunit 4	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P62191	PSMC1	26S protease regulatory subunit 4	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P62191	PSMC1	26S protease regulatory subunit 4	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62191	PSMC1	26S protease regulatory subunit 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P62191	PSMC1	26S protease regulatory subunit 4	GO:0016032; P:viral process; TAS:Reactome
P0CW18	PRSS56	Serine protease 56	GO:0004252; F:serine-type endopeptidase activity; ISS:UniProtKB
P0CW18	PRSS56	Serine protease 56	GO:0043010; P:camera-type eye development; IMP:UniProtKB
P0CW18	PRSS56	Serine protease 56	GO:0006508; P:proteolysis; ISS:UniProtKB
Q6UWY2	PRSS57	Serine protease 57	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q8IYP2	PRSS58	Serine protease 58	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0016887; F:ATPase activity; ISS:UniProtKB
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0005515; F:protein binding; IPI:IntAct
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0006915; P:apoptotic process; TAS:Reactome
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0006200; P:ATP catabolic process; ISS:GOC
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0001824; P:blastocyst development; IEA:Ensembl
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0010467; P:gene expression; TAS:Reactome
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P17980	PSMC3	26S protease regulatory subunit 6A	GO:2001141; P:regulation of RNA biosynthetic process; TAS:GOC
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0016070; P:RNA metabolic process; TAS:Reactome
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P17980	PSMC3	26S protease regulatory subunit 6A	GO:0016032; P:viral process; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0016887; F:ATPase activity; TAS:ProtInc
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0005515; F:protein binding; IPI:UniProtKB
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0006915; P:apoptotic process; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0006200; P:ATP catabolic process; TAS:GOC
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0001824; P:blastocyst development; IEA:Ensembl
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0010467; P:gene expression; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0006508; P:proteolysis; TAS:ProtInc
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0016070; P:RNA metabolic process; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P43686	PSMC4	26S protease regulatory subunit 6B	GO:0016032; P:viral process; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P35998	PSMC2	26S protease regulatory subunit 7	GO:0016887; F:ATPase activity; IDA:UniProtKB
P35998	PSMC2	26S protease regulatory subunit 7	GO:0005515; F:protein binding; IPI:UniProtKB
P35998	PSMC2	26S protease regulatory subunit 7	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0006915; P:apoptotic process; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0006200; P:ATP catabolic process; IDA:GOC
P35998	PSMC2	26S protease regulatory subunit 7	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0010467; P:gene expression; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0016070; P:RNA metabolic process; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P35998	PSMC2	26S protease regulatory subunit 7	GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB
P35998	PSMC2	26S protease regulatory subunit 7	GO:0016032; P:viral process; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P62195	PSMC5	26S protease regulatory subunit 8	GO:0016887; F:ATPase activity; ISS:UniProtKB
P62195	PSMC5	26S protease regulatory subunit 8	GO:0005515; F:protein binding; IPI:UniProtKB
P62195	PSMC5	26S protease regulatory subunit 8	GO:0031531; F:thyrotropin-releasing hormone receptor binding; IPI:UniProtKB
P62195	PSMC5	26S protease regulatory subunit 8	GO:0003712; F:transcription cofactor activity; TAS:ProtInc
P62195	PSMC5	26S protease regulatory subunit 8	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P62195	PSMC5	26S protease regulatory subunit 8	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0006915; P:apoptotic process; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0010467; P:gene expression; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0043069; P:negative regulation of programmed cell death; NAS:UniProtKB
P62195	PSMC5	26S protease regulatory subunit 8	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
P62195	PSMC5	26S protease regulatory subunit 8	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0090261; P:positive regulation of inclusion body assembly; IEA:Ensembl
P62195	PSMC5	26S protease regulatory subunit 8	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
P62195	PSMC5	26S protease regulatory subunit 8	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
P62195	PSMC5	26S protease regulatory subunit 8	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P62195	PSMC5	26S protease regulatory subunit 8	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P62195	PSMC5	26S protease regulatory subunit 8	GO:0016032; P:viral process; TAS:Reactome
Q16651	PRSS8	Prostasin	GO:0005515; F:protein binding; IPI:UniProtKB
Q16651	PRSS8	Prostasin	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q16651	PRSS8	Prostasin	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
Q16651	PRSS8	Prostasin	GO:0010765; P:positive regulation of sodium ion transport; IEA:Ensembl
Q2VWP7	PRTG	Protogenin	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P24158	PRTN3	Myeloblastin	GO:0019899; F:enzyme binding; IPI:UniProtKB
P24158	PRTN3	Myeloblastin	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
P24158	PRTN3	Myeloblastin	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
P24158	PRTN3	Myeloblastin	GO:0030574; P:collagen catabolic process; IEA:UniProtKB-KW
P24158	PRTN3	Myeloblastin	GO:0097029; P:mature dendritic cell differentiation; IDA:UniProtKB
P24158	PRTN3	Myeloblastin	GO:0050765; P:negative regulation of phagocytosis; IDA:UniProtKB
P24158	PRTN3	Myeloblastin	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q8WUY3	PRUNE2	Protein prune homolog 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8WUY3	PRUNE2	Protein prune homolog 2	GO:0016462; F:pyrophosphatase activity; IEA:InterPro
Q8WUY3	PRUNE2	Protein prune homolog 2	GO:0006915; P:apoptotic process; IBA:RefGenome
Q86TP1	PRUNE	Protein prune homolog	GO:0004427; F:inorganic diphosphatase activity; IEA:UniProtKB-EC
Q86TP1	PRUNE	Protein prune homolog	GO:0030145; F:manganese ion binding; IEA:InterPro
Q86TP1	PRUNE	Protein prune homolog	GO:0005515; F:protein binding; IPI:IntAct
P20472	PVALB	Parvalbumin alpha	GO:0005509; F:calcium ion binding; IEA:Ensembl
P20472	PVALB	Parvalbumin alpha	GO:0051480; P:cytosolic calcium ion homeostasis; IEA:Ensembl
A6NEY8	PRORSD1P	Putative prolyl-tRNA synthetase associated domain-containing protein 1	GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0005515; F:protein binding; IPI:UniProtKB
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0003723; F:RNA binding; TAS:ProtInc
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0006915; P:apoptotic process; TAS:Reactome
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0010467; P:gene expression; TAS:Reactome
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0016070; P:RNA metabolic process; TAS:Reactome
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P25786	PSMA1	Proteasome subunit alpha type-1	GO:0016032; P:viral process; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0005515; F:protein binding; IPI:IntAct
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0006915; P:apoptotic process; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0010467; P:gene expression; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0009615; P:response to virus; IEP:UniProtKB
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0016070; P:RNA metabolic process; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P25787	PSMA2	Proteasome subunit alpha type-2	GO:0016032; P:viral process; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0005515; F:protein binding; IPI:IntAct
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0006915; P:apoptotic process; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0010467; P:gene expression; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0016070; P:RNA metabolic process; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P25788	PSMA3	Proteasome subunit alpha type-3	GO:0016032; P:viral process; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0005515; F:protein binding; IPI:IntAct
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0006915; P:apoptotic process; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0010467; P:gene expression; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0016070; P:RNA metabolic process; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P25789	PSMA4	Proteasome subunit alpha type-4	GO:0016032; P:viral process; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0005515; F:protein binding; IPI:UniProtKB
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0006915; P:apoptotic process; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0010467; P:gene expression; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0016070; P:RNA metabolic process; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P28066	PSMA5	Proteasome subunit alpha type-5	GO:0016032; P:viral process; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0004175; F:endopeptidase activity; NAS:UniProtKB
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0051059; F:NF-kappaB binding; IPI:BHF-UCL
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0005515; F:protein binding; IPI:IntAct
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0035639; F:purine ribonucleoside triphosphate binding; NAS:BHF-UCL
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0003723; F:RNA binding; IEA:Ensembl
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0004298; F:threonine-type endopeptidase activity; IEA:InterPro
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0006915; P:apoptotic process; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0010467; P:gene expression; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:BHF-UCL
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0051603; P:proteolysis involved in cellular protein catabolic process; IEA:InterPro
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0050727; P:regulation of inflammatory response; IC:BHF-UCL
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0016070; P:RNA metabolic process; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P60900	PSMA6	Proteasome subunit alpha type-6	GO:0016032; P:viral process; TAS:Reactome
Q8TAA3	PSMA8	Proteasome subunit alpha type-7-like	GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW
Q8TAA3	PSMA8	Proteasome subunit alpha type-7-like	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q8TAA3	PSMA8	Proteasome subunit alpha type-7-like	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q8TAA3	PSMA8	Proteasome subunit alpha type-7-like	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q8TAA3	PSMA8	Proteasome subunit alpha type-7-like	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q8TAA3	PSMA8	Proteasome subunit alpha type-7-like	GO:0006915; P:apoptotic process; TAS:Reactome
Q8TAA3	PSMA8	Proteasome subunit alpha type-7-like	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q8TAA3	PSMA8	Proteasome subunit alpha type-7-like	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
Q8TAA3	PSMA8	Proteasome subunit alpha type-7-like	GO:0010467; P:gene expression; TAS:Reactome
Q8TAA3	PSMA8	Proteasome subunit alpha type-7-like	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8TAA3	PSMA8	Proteasome subunit alpha type-7-like	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q8TAA3	PSMA8	Proteasome subunit alpha type-7-like	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
Q8TAA3	PSMA8	Proteasome subunit alpha type-7-like	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q8TAA3	PSMA8	Proteasome subunit alpha type-7-like	GO:0000209; P:protein polyubiquitination; TAS:Reactome
Q8TAA3	PSMA8	Proteasome subunit alpha type-7-like	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
Q8TAA3	PSMA8	Proteasome subunit alpha type-7-like	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
Q8TAA3	PSMA8	Proteasome subunit alpha type-7-like	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q8TAA3	PSMA8	Proteasome subunit alpha type-7-like	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q8TAA3	PSMA8	Proteasome subunit alpha type-7-like	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8TAA3	PSMA8	Proteasome subunit alpha type-7-like	GO:0016032; P:viral process; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0042802; F:identical protein binding; IPI:IntAct
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0005515; F:protein binding; IPI:UniProtKB
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0006915; P:apoptotic process; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0010467; P:gene expression; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0016071; P:mRNA metabolic process; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0000209; P:protein polyubiquitination; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0016070; P:RNA metabolic process; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O14818	PSMA7	Proteasome subunit alpha type-7	GO:0016032; P:viral process; TAS:Reactome
A6NEC2	NPEPPSL1	Puromycin-sensitive aminopeptidase-like protein	GO:0004177; F:aminopeptidase activity; IEA:UniProtKB-KW
A6NEC2	NPEPPSL1	Puromycin-sensitive aminopeptidase-like protein	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
A6NEC2	NPEPPSL1	Puromycin-sensitive aminopeptidase-like protein	GO:0008270; F:zinc ion binding; IEA:InterPro
P55786	NPEPPS	Puromycin-sensitive aminopeptidase	GO:0004177; F:aminopeptidase activity; TAS:ProtInc
P55786	NPEPPS	Puromycin-sensitive aminopeptidase	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
P55786	NPEPPS	Puromycin-sensitive aminopeptidase	GO:0008270; F:zinc ion binding; IEA:InterPro
P55786	NPEPPS	Puromycin-sensitive aminopeptidase	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P55786	NPEPPS	Puromycin-sensitive aminopeptidase	GO:0071456; P:cellular response to hypoxia; IDA:UniProtKB
P55786	NPEPPS	Puromycin-sensitive aminopeptidase	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW
P40306	PSMB10	Proteasome subunit beta type-10	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0006915; P:apoptotic process; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0000902; P:cell morphogenesis; IEA:Ensembl
P40306	PSMB10	Proteasome subunit beta type-10	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0010467; P:gene expression; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0006959; P:humoral immune response; TAS:ProtInc
P40306	PSMB10	Proteasome subunit beta type-10	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0016070; P:RNA metabolic process; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P40306	PSMB10	Proteasome subunit beta type-10	GO:0042098; P:T cell proliferation; IEA:Ensembl
P40306	PSMB10	Proteasome subunit beta type-10	GO:0016032; P:viral process; TAS:Reactome
A5LHX3	PSMB11	Proteasome subunit beta type-11	GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW
A5LHX3	PSMB11	Proteasome subunit beta type-11	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
A5LHX3	PSMB11	Proteasome subunit beta type-11	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
A5LHX3	PSMB11	Proteasome subunit beta type-11	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
A5LHX3	PSMB11	Proteasome subunit beta type-11	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
A5LHX3	PSMB11	Proteasome subunit beta type-11	GO:0006915; P:apoptotic process; TAS:Reactome
A5LHX3	PSMB11	Proteasome subunit beta type-11	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
A5LHX3	PSMB11	Proteasome subunit beta type-11	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
A5LHX3	PSMB11	Proteasome subunit beta type-11	GO:0010467; P:gene expression; TAS:Reactome
A5LHX3	PSMB11	Proteasome subunit beta type-11	GO:0000278; P:mitotic cell cycle; TAS:Reactome
A5LHX3	PSMB11	Proteasome subunit beta type-11	GO:0016071; P:mRNA metabolic process; TAS:Reactome
A5LHX3	PSMB11	Proteasome subunit beta type-11	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
A5LHX3	PSMB11	Proteasome subunit beta type-11	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
A5LHX3	PSMB11	Proteasome subunit beta type-11	GO:0000209; P:protein polyubiquitination; TAS:Reactome
A5LHX3	PSMB11	Proteasome subunit beta type-11	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
A5LHX3	PSMB11	Proteasome subunit beta type-11	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
A5LHX3	PSMB11	Proteasome subunit beta type-11	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
A5LHX3	PSMB11	Proteasome subunit beta type-11	GO:0016070; P:RNA metabolic process; TAS:Reactome
A5LHX3	PSMB11	Proteasome subunit beta type-11	GO:0044281; P:small molecule metabolic process; TAS:Reactome
A5LHX3	PSMB11	Proteasome subunit beta type-11	GO:0016032; P:viral process; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0005515; F:protein binding; IPI:IntAct
P20618	PSMB1	Proteasome subunit beta type-1	GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW
P20618	PSMB1	Proteasome subunit beta type-1	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0006915; P:apoptotic process; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0010467; P:gene expression; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0016070; P:RNA metabolic process; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P20618	PSMB1	Proteasome subunit beta type-1	GO:0016032; P:viral process; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0005515; F:protein binding; IPI:IntAct
P49721	PSMB2	Proteasome subunit beta type-2	GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW
P49721	PSMB2	Proteasome subunit beta type-2	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0006915; P:apoptotic process; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0010467; P:gene expression; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P49721	PSMB2	Proteasome subunit beta type-2	GO:0010243; P:response to organonitrogen compound; IEA:Ensembl
P49721	PSMB2	Proteasome subunit beta type-2	GO:0016070; P:RNA metabolic process; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P49721	PSMB2	Proteasome subunit beta type-2	GO:0016032; P:viral process; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0005515; F:protein binding; IPI:IntAct
P49720	PSMB3	Proteasome subunit beta type-3	GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW
P49720	PSMB3	Proteasome subunit beta type-3	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0006915; P:apoptotic process; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0010467; P:gene expression; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0016070; P:RNA metabolic process; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P49720	PSMB3	Proteasome subunit beta type-3	GO:0016032; P:viral process; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0001530; F:lipopolysaccharide binding; IEA:Ensembl
P28070	PSMB4	Proteasome subunit beta type-4	GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW
P28070	PSMB4	Proteasome subunit beta type-4	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0006915; P:apoptotic process; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0010467; P:gene expression; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0002862; P:negative regulation of inflammatory response to antigenic stimulus; IEA:Ensembl
P28070	PSMB4	Proteasome subunit beta type-4	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0016070; P:RNA metabolic process; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P28070	PSMB4	Proteasome subunit beta type-4	GO:0016032; P:viral process; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0005515; F:protein binding; IPI:IntAct
P28074	PSMB5	Proteasome subunit beta type-5	GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW
P28074	PSMB5	Proteasome subunit beta type-5	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0006915; P:apoptotic process; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0010467; P:gene expression; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0006979; P:response to oxidative stress; IEA:Ensembl
P28074	PSMB5	Proteasome subunit beta type-5	GO:0016070; P:RNA metabolic process; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P28074	PSMB5	Proteasome subunit beta type-5	GO:0016032; P:viral process; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0004175; F:endopeptidase activity; NAS:UniProtKB
P28072	PSMB6	Proteasome subunit beta type-6	GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW
P28072	PSMB6	Proteasome subunit beta type-6	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0006915; P:apoptotic process; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0010467; P:gene expression; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0016070; P:RNA metabolic process; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P28072	PSMB6	Proteasome subunit beta type-6	GO:0016032; P:viral process; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0005515; F:protein binding; IPI:IntAct
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0006915; P:apoptotic process; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0010467; P:gene expression; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0000209; P:protein polyubiquitination; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99436	PSMB7	Proteasome subunit beta type-7	GO:0016032; P:viral process; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0005515; F:protein binding; IPI:IntAct
P28062	PSMB8	Proteasome subunit beta type-8	GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW
P28062	PSMB8	Proteasome subunit beta type-8	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0006915; P:apoptotic process; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0045444; P:fat cell differentiation; IMP:UniProtKB
P28062	PSMB8	Proteasome subunit beta type-8	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0010467; P:gene expression; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0016070; P:RNA metabolic process; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P28062	PSMB8	Proteasome subunit beta type-8	GO:0016032; P:viral process; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0005515; F:protein binding; IPI:IntAct
P28065	PSMB9	Proteasome subunit beta type-9	GO:0004298; F:threonine-type endopeptidase activity; IEA:UniProtKB-KW
P28065	PSMB9	Proteasome subunit beta type-9	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0006915; P:apoptotic process; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0010467; P:gene expression; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0016070; P:RNA metabolic process; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P28065	PSMB9	Proteasome subunit beta type-9	GO:0016032; P:viral process; TAS:Reactome
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0005515; F:protein binding; IPI:UniProtKB
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0008134; F:transcription factor binding; IPI:UniProtKB
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0006915; P:apoptotic process; TAS:Reactome
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0007253; P:cytoplasmic sequestering of NF-kappaB; IDA:UniProtKB
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0010467; P:gene expression; TAS:Reactome
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0016071; P:mRNA metabolic process; TAS:Reactome
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0043518; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; IDA:UniProtKB
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0043409; P:negative regulation of MAPK cascade; IMP:UniProtKB
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; IMP:UniProtKB
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0030307; P:positive regulation of cell growth; IDA:UniProtKB
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0045737; P:positive regulation of cyclin-dependent protein kinase activity; IDA:UniProtKB
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0031398; P:positive regulation of protein ubiquitination; IMP:UniProtKB
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0070682; P:proteasome regulatory particle assembly; IMP:UniProtKB
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0000209; P:protein polyubiquitination; TAS:Reactome
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0016070; P:RNA metabolic process; TAS:Reactome
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75832	PSMD10	26S proteasome non-ATPase regulatory subunit 10	GO:0016032; P:viral process; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0005515; F:protein binding; IPI:IntAct
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0006915; P:apoptotic process; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0010467; P:gene expression; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0016071; P:mRNA metabolic process; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0043248; P:proteasome assembly; IMP:UniProtKB
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0000209; P:protein polyubiquitination; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0016070; P:RNA metabolic process; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0048863; P:stem cell differentiation; IMP:UniProtKB
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	GO:0016032; P:viral process; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0006915; P:apoptotic process; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0010467; P:gene expression; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0016071; P:mRNA metabolic process; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0000209; P:protein polyubiquitination; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0016070; P:RNA metabolic process; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00232	PSMD12	26S proteasome non-ATPase regulatory subunit 12	GO:0016032; P:viral process; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0006915; P:apoptotic process; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0010467; P:gene expression; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0007127; P:meiosis I; IEA:Ensembl
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0000209; P:protein polyubiquitination; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UNM6	PSMD13	26S proteasome non-ATPase regulatory subunit 13	GO:0016032; P:viral process; TAS:Reactome
A5PKW4	PSD	PH and SEC7 domain-containing protein 1	GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; IBA:RefGenome
A5PKW4	PSD	PH and SEC7 domain-containing protein 1	GO:0005543; F:phospholipid binding; IEA:InterPro
A5PKW4	PSD	PH and SEC7 domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
A5PKW4	PSD	PH and SEC7 domain-containing protein 1	GO:0004871; F:signal transducer activity; NAS:UniProtKB
A5PKW4	PSD	PH and SEC7 domain-containing protein 1	GO:0030182; P:neuron differentiation; IBA:RefGenome
A5PKW4	PSD	PH and SEC7 domain-containing protein 1	GO:0032012; P:regulation of ARF protein signal transduction; IEA:InterPro
A5PKW4	PSD	PH and SEC7 domain-containing protein 1	GO:0043087; P:regulation of GTPase activity; IBA:GOC
A5PKW4	PSD	PH and SEC7 domain-containing protein 1	GO:0007165; P:signal transduction; NAS:UniProtKB
Q9BQI7	PSD2	PH and SEC7 domain-containing protein 2	GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; IBA:RefGenome
Q9BQI7	PSD2	PH and SEC7 domain-containing protein 2	GO:0005543; F:phospholipid binding; IEA:InterPro
Q9BQI7	PSD2	PH and SEC7 domain-containing protein 2	GO:0030182; P:neuron differentiation; IBA:RefGenome
Q9BQI7	PSD2	PH and SEC7 domain-containing protein 2	GO:0032012; P:regulation of ARF protein signal transduction; IEA:InterPro
Q9BQI7	PSD2	PH and SEC7 domain-containing protein 2	GO:0043087; P:regulation of GTPase activity; IBA:GOC
Q9NYI0	PSD3	PH and SEC7 domain-containing protein 3	GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; IBA:RefGenome
Q9NYI0	PSD3	PH and SEC7 domain-containing protein 3	GO:0030182; P:neuron differentiation; IBA:RefGenome
Q9NYI0	PSD3	PH and SEC7 domain-containing protein 3	GO:0032012; P:regulation of ARF protein signal transduction; IEA:InterPro
Q9NYI0	PSD3	PH and SEC7 domain-containing protein 3	GO:0043087; P:regulation of GTPase activity; IBA:GOC
Q8NDX1	PSD4	PH and SEC7 domain-containing protein 4	GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; IBA:RefGenome
Q8NDX1	PSD4	PH and SEC7 domain-containing protein 4	GO:0005543; F:phospholipid binding; IEA:InterPro
Q8NDX1	PSD4	PH and SEC7 domain-containing protein 4	GO:0030182; P:neuron differentiation; IBA:RefGenome
Q8NDX1	PSD4	PH and SEC7 domain-containing protein 4	GO:0032012; P:regulation of ARF protein signal transduction; IEA:InterPro
Q8NDX1	PSD4	PH and SEC7 domain-containing protein 4	GO:0043087; P:regulation of GTPase activity; IBA:GOC
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0061133; F:endopeptidase activator activity; IMP:UniProtKB
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0008237; F:metallopeptidase activity; TAS:UniProtKB
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0070628; F:proteasome binding; IDA:UniProtKB
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0004221; F:ubiquitin thiolesterase activity; IMP:UniProtKB
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0006915; P:apoptotic process; TAS:Reactome
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0006303; P:double-strand break repair via nonhomologous end joining; IMP:UniProtKB
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0010467; P:gene expression; TAS:Reactome
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0016071; P:mRNA metabolic process; TAS:Reactome
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0010950; P:positive regulation of endopeptidase activity; IMP:GOC
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0070536; P:protein K63-linked deubiquitination; IMP:UniProtKB
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0000209; P:protein polyubiquitination; TAS:Reactome
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0061136; P:regulation of proteasomal protein catabolic process; IMP:UniProtKB
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0016070; P:RNA metabolic process; TAS:Reactome
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:UniProtKB
O00487	PSMD14	26S proteasome non-ATPase regulatory subunit 14	GO:0016032; P:viral process; TAS:Reactome
Q14691	GINS1	DNA replication complex GINS protein PSF1	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
Q14691	GINS1	DNA replication complex GINS protein PSF1	GO:0001833; P:inner cell mass cell proliferation; IEA:Ensembl
Q14691	GINS1	DNA replication complex GINS protein PSF1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9Y248	GINS2	DNA replication complex GINS protein PSF2	GO:0005515; F:protein binding; IPI:IntAct
Q9Y248	GINS2	DNA replication complex GINS protein PSF2	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
Q9Y248	GINS2	DNA replication complex GINS protein PSF2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9BRX5	GINS3	DNA replication complex GINS protein PSF3	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q9UQ72	PSG11	Pregnancy-specific beta-1-glycoprotein 11	GO:0007565; P:female pregnancy; TAS:ProtInc
P11464	PSG1	Pregnancy-specific beta-1-glycoprotein 1	GO:0007565; P:female pregnancy; TAS:ProtInc
P11465	PSG2	Pregnancy-specific beta-1-glycoprotein 2	GO:0016477; P:cell migration; NAS:UniProtKB
P11465	PSG2	Pregnancy-specific beta-1-glycoprotein 2	GO:0007565; P:female pregnancy; NAS:UniProtKB
Q00888	PSG4	Pregnancy-specific beta-1-glycoprotein 4	GO:0007565; P:female pregnancy; TAS:UniProtKB
Q16557	PSG3	Pregnancy-specific beta-1-glycoprotein 3	GO:0006952; P:defense response; TAS:UniProtKB
Q16557	PSG3	Pregnancy-specific beta-1-glycoprotein 3	GO:0007565; P:female pregnancy; TAS:UniProtKB
Q15238	PSG5	Pregnancy-specific beta-1-glycoprotein 5	GO:0005515; F:protein binding; IPI:IntAct
Q15238	PSG5	Pregnancy-specific beta-1-glycoprotein 5	GO:0007565; P:female pregnancy; TAS:ProtInc
Q00889	PSG6	Pregnancy-specific beta-1-glycoprotein 6	GO:0007565; P:female pregnancy; NAS:UniProtKB
Q00887	PSG9	Pregnancy-specific beta-1-glycoprotein 9	GO:0007565; P:female pregnancy; TAS:ProtInc
Q13046	PSG7	Putative pregnancy-specific beta-1-glycoprotein 7	GO:0007565; P:female pregnancy; TAS:ProtInc
O75475	PSIP1	PC4 and SFRS1-interacting protein	GO:0033613; F:activating transcription factor binding; IDA:UniProtKB
O75475	PSIP1	PC4 and SFRS1-interacting protein	GO:0003682; F:chromatin binding; IDA:UniProtKB
O75475	PSIP1	PC4 and SFRS1-interacting protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75475	PSIP1	PC4 and SFRS1-interacting protein	GO:0005515; F:protein binding; IPI:IntAct
O75475	PSIP1	PC4 and SFRS1-interacting protein	GO:0001105; F:RNA polymerase II transcription coactivator activity; IDA:UniProtKB
O75475	PSIP1	PC4 and SFRS1-interacting protein	GO:0097100; F:supercoiled DNA binding; ISS:UniProtKB
O75475	PSIP1	PC4 and SFRS1-interacting protein	GO:0075713; P:establishment of integrated proviral latency; TAS:Reactome
O75475	PSIP1	PC4 and SFRS1-interacting protein	GO:0000395; P:mRNA 5'-splice site recognition; IDA:UniProtKB
O75475	PSIP1	PC4 and SFRS1-interacting protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O75475	PSIP1	PC4 and SFRS1-interacting protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O75475	PSIP1	PC4 and SFRS1-interacting protein	GO:0009408; P:response to heat; ISS:UniProtKB
O75475	PSIP1	PC4 and SFRS1-interacting protein	GO:0006979; P:response to oxidative stress; ISS:UniProtKB
O75475	PSIP1	PC4 and SFRS1-interacting protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75475	PSIP1	PC4 and SFRS1-interacting protein	GO:0016032; P:viral process; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0030234; F:enzyme regulator activity; IEA:InterPro
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0006915; P:apoptotic process; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0010467; P:gene expression; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0000209; P:protein polyubiquitination; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0042176; P:regulation of protein catabolic process; IEA:InterPro
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99460	PSMD1	26S proteasome non-ATPase regulatory subunit 1	GO:0016032; P:viral process; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0030234; F:enzyme regulator activity; IEA:InterPro
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0006915; P:apoptotic process; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0010467; P:gene expression; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0000209; P:protein polyubiquitination; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0042176; P:regulation of protein catabolic process; IEA:InterPro
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q13200	PSMD2	26S proteasome non-ATPase regulatory subunit 2	GO:0016032; P:viral process; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0030234; F:enzyme regulator activity; IEA:InterPro
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0006915; P:apoptotic process; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0010467; P:gene expression; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0016071; P:mRNA metabolic process; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0000209; P:protein polyubiquitination; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0042176; P:regulation of protein catabolic process; IEA:InterPro
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0016070; P:RNA metabolic process; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43242	PSMD3	26S proteasome non-ATPase regulatory subunit 3	GO:0016032; P:viral process; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0042802; F:identical protein binding; IPI:IntAct
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0005515; F:protein binding; IPI:IntAct
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0006915; P:apoptotic process; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0010467; P:gene expression; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0016070; P:RNA metabolic process; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P55036	PSMD4	26S proteasome non-ATPase regulatory subunit 4	GO:0016032; P:viral process; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0005515; F:protein binding; IPI:IntAct
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0006915; P:apoptotic process; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0010467; P:gene expression; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0070682; P:proteasome regulatory particle assembly; TAS:UniProtKB
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0006457; P:protein folding; IEA:GOC
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0000209; P:protein polyubiquitination; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16401	PSMD5	26S proteasome non-ATPase regulatory subunit 5	GO:0016032; P:viral process; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0016887; F:ATPase activity; NAS:UniProtKB
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0006915; P:apoptotic process; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0006200; P:ATP catabolic process; NAS:GOC
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0010467; P:gene expression; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0000209; P:protein polyubiquitination; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0006508; P:proteolysis; NAS:UniProtKB
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15008	PSMD6	26S proteasome non-ATPase regulatory subunit 6	GO:0016032; P:viral process; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0005515; F:protein binding; IPI:UniProtKB
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0006915; P:apoptotic process; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0010467; P:gene expression; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0016070; P:RNA metabolic process; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P51665	PSMD7	26S proteasome non-ATPase regulatory subunit 7	GO:0016032; P:viral process; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0006915; P:apoptotic process; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0010467; P:gene expression; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0016070; P:RNA metabolic process; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P48556	PSMD8	26S proteasome non-ATPase regulatory subunit 8	GO:0016032; P:viral process; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0043425; F:bHLH transcription factor binding; ISS:BHF-UCL
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0005515; F:protein binding; IPI:IntAct
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0003713; F:transcription coactivator activity; ISS:BHF-UCL
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0006915; P:apoptotic process; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0010467; P:gene expression; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0016071; P:mRNA metabolic process; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0046676; P:negative regulation of insulin secretion; ISS:BHF-UCL
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0032024; P:positive regulation of insulin secretion; ISS:BHF-UCL
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:BHF-UCL
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0070682; P:proteasome regulatory particle assembly; IMP:UniProtKB
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0000209; P:protein polyubiquitination; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0016070; P:RNA metabolic process; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0006511; P:ubiquitin-dependent protein catabolic process; NAS:UniProtKB
O00233	PSMD9	26S proteasome non-ATPase regulatory subunit 9	GO:0016032; P:viral process; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0061133; F:endopeptidase activator activity; IEA:Ensembl
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0006915; P:apoptotic process; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0010467; P:gene expression; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0000209; P:protein polyubiquitination; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q06323	PSME1	Proteasome activator complex subunit 1	GO:0016032; P:viral process; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0006915; P:apoptotic process; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0010467; P:gene expression; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0000209; P:protein polyubiquitination; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UL46	PSME2	Proteasome activator complex subunit 2	GO:0016032; P:viral process; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:0061133; F:endopeptidase activator activity; IDA:UniProtKB
P61289	PSME3	Proteasome activator complex subunit 3	GO:0097371; F:MDM2/MDM4 family protein binding; IDA:UniProtKB
P61289	PSME3	Proteasome activator complex subunit 3	GO:0002039; F:p53 binding; IDA:UniProtKB
P61289	PSME3	Proteasome activator complex subunit 3	GO:0005515; F:protein binding; IPI:IntAct
P61289	PSME3	Proteasome activator complex subunit 3	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:0006915; P:apoptotic process; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:0010467; P:gene expression; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IDA:UniProtKB
P61289	PSME3	Proteasome activator complex subunit 3	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:0010950; P:positive regulation of endopeptidase activity; IDA:GOC
P61289	PSME3	Proteasome activator complex subunit 3	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:0061136; P:regulation of proteasomal protein catabolic process; IDA:UniProtKB
P61289	PSME3	Proteasome activator complex subunit 3	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:0016070; P:RNA metabolic process; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P61289	PSME3	Proteasome activator complex subunit 3	GO:0016032; P:viral process; TAS:Reactome
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0070577; F:lysine-acetylated histone binding; ISS:UniProtKB
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0016504; F:peptidase activator activity; ISS:UniProtKB
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0006915; P:apoptotic process; TAS:Reactome
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0006974; P:cellular response to DNA damage stimulus; ISS:UniProtKB
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0006281; P:DNA repair; ISS:UniProtKB
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0010467; P:gene expression; TAS:Reactome
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0010499; P:proteasomal ubiquitin-independent protein catabolic process; ISS:UniProtKB
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0000209; P:protein polyubiquitination; TAS:Reactome
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0035093; P:spermatogenesis, exchange of chromosomal proteins; ISS:UniProtKB
Q14997	PSME4	Proteasome activator complex subunit 4	GO:0016032; P:viral process; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0004866; F:endopeptidase inhibitor activity; NAS:UniProtKB
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0070628; F:proteasome binding; IDA:UniProtKB
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0005515; F:protein binding; IPI:IntAct
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0006915; P:apoptotic process; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0010467; P:gene expression; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0010951; P:negative regulation of endopeptidase activity; NAS:GOC
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:1901799; P:negative regulation of proteasomal protein catabolic process; IDA:UniProtKB
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0000209; P:protein polyubiquitination; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0006521; P:regulation of cellular amino acid metabolic process; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q92530	PSMF1	Proteasome inhibitor PI31 subunit	GO:0016032; P:viral process; TAS:Reactome
O95456	PSMG1	Proteasome assembly chaperone 1	GO:0005515; F:protein binding; IPI:UniProtKB
O95456	PSMG1	Proteasome assembly chaperone 1	GO:0043248; P:proteasome assembly; IDA:UniProtKB
Q969U7	PSMG2	Proteasome assembly chaperone 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q969U7	PSMG2	Proteasome assembly chaperone 2	GO:0007094; P:mitotic spindle assembly checkpoint; IEA:Ensembl
Q969U7	PSMG2	Proteasome assembly chaperone 2	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q969U7	PSMG2	Proteasome assembly chaperone 2	GO:0043248; P:proteasome assembly; IDA:UniProtKB
P49768	PSEN1	Presenilin-1	GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro
P49768	PSEN1	Presenilin-1	GO:0008013; F:beta-catenin binding; IPI:UniProtKB
P49768	PSEN1	Presenilin-1	GO:0045296; F:cadherin binding; IBA:RefGenome
P49768	PSEN1	Presenilin-1	GO:0005262; F:calcium channel activity; IMP:UniProtKB
P49768	PSEN1	Presenilin-1	GO:0004175; F:endopeptidase activity; IDA:MGI
P49768	PSEN1	Presenilin-1	GO:0030165; F:PDZ domain binding; IPI:UniProtKB
P49768	PSEN1	Presenilin-1	GO:0005515; F:protein binding; IPI:IntAct
P49768	PSEN1	Presenilin-1	GO:0000186; P:activation of MAPKK activity; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0042987; P:amyloid precursor protein catabolic process; TAS:HGNC
P49768	PSEN1	Presenilin-1	GO:0042640; P:anagen; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0000045; P:autophagic vacuole assembly; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0034205; P:beta-amyloid formation; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0050435; P:beta-amyloid metabolic process; IBA:RefGenome
P49768	PSEN1	Presenilin-1	GO:0001568; P:blood vessel development; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0048854; P:brain morphogenesis; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0021870; P:Cajal-Retzius cell differentiation; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0070588; P:calcium ion transmembrane transport; IMP:GOC
P49768	PSEN1	Presenilin-1	GO:0006816; P:calcium ion transport; IBA:RefGenome
P49768	PSEN1	Presenilin-1	GO:0001708; P:cell fate specification; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0016337; P:single organismal cell-cell adhesion; IMP:MGI
P49768	PSEN1	Presenilin-1	GO:0006974; P:cellular response to DNA damage stimulus; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0021795; P:cerebral cortex cell migration; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0015871; P:choline transport; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; IGI:UniProtKB
P49768	PSEN1	Presenilin-1	GO:0050673; P:epithelial cell proliferation; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P49768	PSEN1	Presenilin-1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P49768	PSEN1	Presenilin-1	GO:0001947; P:heart looping; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0002244; P:hematopoietic progenitor cell differentiation; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P49768	PSEN1	Presenilin-1	GO:0015813; P:L-glutamate transport; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0006509; P:membrane protein ectodomain proteolysis; IDA:HGNC
P49768	PSEN1	Presenilin-1	GO:0007613; P:memory; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0006839; P:mitochondrial transport; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0002573; P:myeloid leukocyte differentiation; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P49768	PSEN1	Presenilin-1	GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0050771; P:negative regulation of axonogenesis; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0007175; P:negative regulation of epidermal growth factor-activated receptor activity; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:2000059; P:negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0051444; P:negative regulation of ubiquitin-protein ligase activity; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0048666; P:neuron development; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0001764; P:neuron migration; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0007220; P:Notch receptor processing; TAS:HGNC
P49768	PSEN1	Presenilin-1	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
P49768	PSEN1	Presenilin-1	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0043085; P:positive regulation of catalytic activity; IDA:HGNC
P49768	PSEN1	Presenilin-1	GO:0050820; P:positive regulation of coagulation; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0043406; P:positive regulation of MAP kinase activity; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0001921; P:positive regulation of receptor recycling; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0009791; P:post-embryonic development; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0006486; P:protein glycosylation; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0016485; P:protein processing; IDA:HGNC
P49768	PSEN1	Presenilin-1	GO:0015031; P:protein transport; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0042325; P:regulation of phosphorylation; IDA:UniProtKB
P49768	PSEN1	Presenilin-1	GO:0043393; P:regulation of protein binding; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0060075; P:regulation of resting membrane potential; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0051966; P:regulation of synaptic transmission, glutamatergic; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0006979; P:response to oxidative stress; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0043589; P:skin morphogenesis; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0051563; P:smooth endoplasmic reticulum calcium ion homeostasis; IBA:RefGenome
P49768	PSEN1	Presenilin-1	GO:0001756; P:somitogenesis; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0016080; P:synaptic vesicle targeting; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0002286; P:T cell activation involved in immune response; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0050852; P:T cell receptor signaling pathway; IEA:Ensembl
P49768	PSEN1	Presenilin-1	GO:0048538; P:thymus development; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro
P49810	PSEN2	Presenilin-2	GO:0004175; F:endopeptidase activity; IBA:RefGenome
P49810	PSEN2	Presenilin-2	GO:0005515; F:protein binding; IPI:UniProtKB
P49810	PSEN2	Presenilin-2	GO:0042987; P:amyloid precursor protein catabolic process; TAS:HGNC
P49810	PSEN2	Presenilin-2	GO:0042640; P:anagen; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
P49810	PSEN2	Presenilin-2	GO:0050435; P:beta-amyloid metabolic process; IBA:RefGenome
P49810	PSEN2	Presenilin-2	GO:0048854; P:brain morphogenesis; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0006816; P:calcium ion transport; IBA:RefGenome
P49810	PSEN2	Presenilin-2	GO:0060048; P:cardiac muscle contraction; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0001708; P:cell fate specification; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0030900; P:forebrain development; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0002244; P:hematopoietic progenitor cell differentiation; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P49810	PSEN2	Presenilin-2	GO:0040011; P:locomotion; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0048286; P:lung alveolus development; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0006509; P:membrane protein ectodomain proteolysis; IDA:HGNC
P49810	PSEN2	Presenilin-2	GO:0031293; P:membrane protein intracellular domain proteolysis; TAS:Reactome
P49810	PSEN2	Presenilin-2	GO:0007613; P:memory; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0002573; P:myeloid leukocyte differentiation; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0032091; P:negative regulation of protein binding; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0031333; P:negative regulation of protein complex assembly; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P49810	PSEN2	Presenilin-2	GO:0007220; P:Notch receptor processing; TAS:HGNC
P49810	PSEN2	Presenilin-2	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P49810	PSEN2	Presenilin-2	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
P49810	PSEN2	Presenilin-2	GO:0043085; P:positive regulation of catalytic activity; IDA:HGNC
P49810	PSEN2	Presenilin-2	GO:0050820; P:positive regulation of coagulation; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0016485; P:protein processing; IDA:HGNC
P49810	PSEN2	Presenilin-2	GO:0015031; P:protein transport; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0007176; P:regulation of epidermal growth factor-activated receptor activity; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0001666; P:response to hypoxia; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0001756; P:somitogenesis; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0002286; P:T cell activation involved in immune response; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0050852; P:T cell receptor signaling pathway; IEA:Ensembl
P49810	PSEN2	Presenilin-2	GO:0048538; P:thymus development; IEA:Ensembl
P07988	SFTPB	Pulmonary surfactant-associated protein B	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P07988	SFTPB	Pulmonary surfactant-associated protein B	GO:0007585; P:respiratory gaseous exchange; TAS:ProtInc
P07988	SFTPB	Pulmonary surfactant-associated protein B	GO:0006665; P:sphingolipid metabolic process; IEA:InterPro
Q8WXF1	PSPC1	Paraspeckle component 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8WXF1	PSPC1	Paraspeckle component 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8WXF1	PSPC1	Paraspeckle component 1	GO:0005515; F:protein binding; IPI:IntAct
Q8WXF1	PSPC1	Paraspeckle component 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8WXF1	PSPC1	Paraspeckle component 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P11686	SFTPC	Pulmonary surfactant-associated protein C	GO:0005515; F:protein binding; IPI:UniProtKB
P11686	SFTPC	Pulmonary surfactant-associated protein C	GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl
P11686	SFTPC	Pulmonary surfactant-associated protein C	GO:0071732; P:cellular response to nitric oxide; IEA:Ensembl
P11686	SFTPC	Pulmonary surfactant-associated protein C	GO:0007623; P:circadian rhythm; IEA:Ensembl
P11686	SFTPC	Pulmonary surfactant-associated protein C	GO:0051260; P:protein homooligomerization; IEA:Ensembl
P11686	SFTPC	Pulmonary surfactant-associated protein C	GO:0007585; P:respiratory gaseous exchange; IEA:UniProtKB-KW
P11686	SFTPC	Pulmonary surfactant-associated protein C	GO:0051591; P:response to cAMP; IEA:Ensembl
P11686	SFTPC	Pulmonary surfactant-associated protein C	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P11686	SFTPC	Pulmonary surfactant-associated protein C	GO:0009749; P:response to glucose; IEA:Ensembl
P11686	SFTPC	Pulmonary surfactant-associated protein C	GO:0070848; P:response to growth factor; IEA:Ensembl
P11686	SFTPC	Pulmonary surfactant-associated protein C	GO:0055093; P:response to hyperoxia; IEA:Ensembl
P11686	SFTPC	Pulmonary surfactant-associated protein C	GO:0070741; P:response to interleukin-6; IEA:Ensembl
P11686	SFTPC	Pulmonary surfactant-associated protein C	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P11686	SFTPC	Pulmonary surfactant-associated protein C	GO:0032526; P:response to retinoic acid; IEA:Ensembl
P11686	SFTPC	Pulmonary surfactant-associated protein C	GO:0033189; P:response to vitamin A; IEA:Ensembl
O15172	PSPHP1	Putative phosphoserine phosphatase-like protein	GO:0004647; F:phosphoserine phosphatase activity; TAS:ProtInc
O15172	PSPHP1	Putative phosphoserine phosphatase-like protein	GO:0008283; P:cell proliferation; TAS:ProtInc
O15172	PSPHP1	Putative phosphoserine phosphatase-like protein	GO:0016311; P:dephosphorylation; TAS:GOC
O60542	PSPN	Persephin	GO:0005102; F:receptor binding; TAS:ProtInc
O60542	PSPN	Persephin	GO:0007411; P:axon guidance; TAS:Reactome
O60542	PSPN	Persephin	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
O60542	PSPN	Persephin	GO:0007417; P:central nervous system development; TAS:ProtInc
O60542	PSPN	Persephin	GO:0007399; P:nervous system development; TAS:ProtInc
Q6PGN9	PSRC1	Proline/serine-rich coiled-coil protein 1	GO:0008017; F:microtubule binding; ISS:BHF-UCL
Q6PGN9	PSRC1	Proline/serine-rich coiled-coil protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q6PGN9	PSRC1	Proline/serine-rich coiled-coil protein 1	GO:0001578; P:microtubule bundle formation; ISS:BHF-UCL
Q6PGN9	PSRC1	Proline/serine-rich coiled-coil protein 1	GO:0007080; P:mitotic metaphase plate congression; IDA:UniProtKB
Q6PGN9	PSRC1	Proline/serine-rich coiled-coil protein 1	GO:0030308; P:negative regulation of cell growth; ISS:BHF-UCL
Q6PGN9	PSRC1	Proline/serine-rich coiled-coil protein 1	GO:0045737; P:positive regulation of cyclin-dependent protein kinase activity; ISS:BHF-UCL
Q6PGN9	PSRC1	Proline/serine-rich coiled-coil protein 1	GO:0031116; P:positive regulation of microtubule polymerization; ISS:BHF-UCL
Q6PGN9	PSRC1	Proline/serine-rich coiled-coil protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:BHF-UCL
Q6PGN9	PSRC1	Proline/serine-rich coiled-coil protein 1	GO:0060236; P:regulation of mitotic spindle organization; IDA:UniProtKB
Q8IV42	PSTK	L-seryl-tRNA(Sec) kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IV42	PSTK	L-seryl-tRNA(Sec) kinase	GO:0016301; F:kinase activity; IEA:UniProtKB-KW
Q8IV42	PSTK	L-seryl-tRNA(Sec) kinase	GO:0000049; F:tRNA binding; IEA:Ensembl
Q8IV42	PSTK	L-seryl-tRNA(Sec) kinase	GO:0001514; P:selenocysteine incorporation; IEA:Ensembl
Q8IV42	PSTK	L-seryl-tRNA(Sec) kinase	GO:0097056; P:selenocysteinyl-tRNA(Sec) biosynthetic process; IEA:UniProtKB-UniPathway
Q8IYL9	GPR65	Psychosine receptor	GO:0004930; F:G-protein coupled receptor activity; IDA:BHF-UCL
Q8IYL9	GPR65	Psychosine receptor	GO:0031532; P:actin cytoskeleton reorganization; IDA:BHF-UCL
Q8IYL9	GPR65	Psychosine receptor	GO:0032862; P:activation of Rho GTPase activity; IDA:BHF-UCL
Q8IYL9	GPR65	Psychosine receptor	GO:0006915; P:apoptotic process; TAS:ProtInc
Q8IYL9	GPR65	Psychosine receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:BHF-UCL
Q8IYL9	GPR65	Psychosine receptor	GO:0006955; P:immune response; TAS:ProtInc
Q8IYL9	GPR65	Psychosine receptor	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q8IYL9	GPR65	Psychosine receptor	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:BHF-UCL
Q8IYL9	GPR65	Psychosine receptor	GO:0051496; P:positive regulation of stress fiber assembly; IDA:BHF-UCL
Q8IYL9	GPR65	Psychosine receptor	GO:0010447; P:response to acidity; IDA:BHF-UCL
P25105	PTAFR	Platelet-activating factor receptor	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P25105	PTAFR	Platelet-activating factor receptor	GO:0001530; F:lipopolysaccharide binding; IEA:Ensembl
P25105	PTAFR	Platelet-activating factor receptor	GO:0001875; F:lipopolysaccharide receptor activity; IEA:Ensembl
P25105	PTAFR	Platelet-activating factor receptor	GO:0005543; F:phospholipid binding; IDA:UniProtKB
P25105	PTAFR	Platelet-activating factor receptor	GO:0004992; F:platelet activating factor receptor activity; IDA:UniProtKB
P25105	PTAFR	Platelet-activating factor receptor	GO:0006935; P:chemotaxis; TAS:ProtInc
P25105	PTAFR	Platelet-activating factor receptor	GO:0001816; P:cytokine production; IEA:Ensembl
P25105	PTAFR	Platelet-activating factor receptor	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P25105	PTAFR	Platelet-activating factor receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; IMP:UniProtKB
P25105	PTAFR	Platelet-activating factor receptor	GO:0006955; P:immune response; TAS:ProtInc
P25105	PTAFR	Platelet-activating factor receptor	GO:0006954; P:inflammatory response; TAS:ProtInc
P25105	PTAFR	Platelet-activating factor receptor	GO:0032959; P:inositol trisphosphate biosynthetic process; IEA:Ensembl
P25105	PTAFR	Platelet-activating factor receptor	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P25105	PTAFR	Platelet-activating factor receptor	GO:0048015; P:phosphatidylinositol-mediated signaling; IDA:UniProtKB
Q7Z6K3	PTAR1	Protein prenyltransferase alpha subunit repeat-containing protein 1	GO:0008318; F:protein prenyltransferase activity; IEA:InterPro
Q7Z6K3	PTAR1	Protein prenyltransferase alpha subunit repeat-containing protein 1	GO:0018342; P:protein prenylation; IEA:InterPro
P26599	PTBP1	Polypyrimidine tract-binding protein 1	GO:0000166; F:nucleotide binding; IEA:InterPro
P26599	PTBP1	Polypyrimidine tract-binding protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P26599	PTBP1	Polypyrimidine tract-binding protein 1	GO:0008187; F:poly-pyrimidine tract binding; TAS:ProtInc
P26599	PTBP1	Polypyrimidine tract-binding protein 1	GO:0036002; F:pre-mRNA binding; IDA:UniProtKB
P26599	PTBP1	Polypyrimidine tract-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
P26599	PTBP1	Polypyrimidine tract-binding protein 1	GO:0003723; F:RNA binding; TAS:ProtInc
P26599	PTBP1	Polypyrimidine tract-binding protein 1	GO:0000380; P:alternative mRNA splicing, via spliceosome; IEA:Ensembl
P26599	PTBP1	Polypyrimidine tract-binding protein 1	GO:0010467; P:gene expression; TAS:Reactome
P26599	PTBP1	Polypyrimidine tract-binding protein 1	GO:0006397; P:mRNA processing; TAS:ProtInc
P26599	PTBP1	Polypyrimidine tract-binding protein 1	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P26599	PTBP1	Polypyrimidine tract-binding protein 1	GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; IDA:UniProtKB
P26599	PTBP1	Polypyrimidine tract-binding protein 1	GO:0051148; P:negative regulation of muscle cell differentiation; IDA:UniProtKB
P26599	PTBP1	Polypyrimidine tract-binding protein 1	GO:0033119; P:negative regulation of RNA splicing; IDA:UniProtKB
P26599	PTBP1	Polypyrimidine tract-binding protein 1	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB
P26599	PTBP1	Polypyrimidine tract-binding protein 1	GO:0008380; P:RNA splicing; TAS:Reactome
Q9UKA9	PTBP2	Polypyrimidine tract-binding protein 2	GO:0003729; F:mRNA binding; IEA:Ensembl
Q9UKA9	PTBP2	Polypyrimidine tract-binding protein 2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9UKA9	PTBP2	Polypyrimidine tract-binding protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UKA9	PTBP2	Polypyrimidine tract-binding protein 2	GO:0006376; P:mRNA splice site selection; IEA:Ensembl
Q9UKA9	PTBP2	Polypyrimidine tract-binding protein 2	GO:0033119; P:negative regulation of RNA splicing; IDA:UniProtKB
Q9UKA9	PTBP2	Polypyrimidine tract-binding protein 2	GO:2000177; P:regulation of neural precursor cell proliferation; IEA:Ensembl
O95758	PTBP3	Polypyrimidine tract-binding protein 3	GO:0000166; F:nucleotide binding; IEA:InterPro
O95758	PTBP3	Polypyrimidine tract-binding protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O95758	PTBP3	Polypyrimidine tract-binding protein 3	GO:0003723; F:RNA binding; TAS:ProtInc
O95758	PTBP3	Polypyrimidine tract-binding protein 3	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
O95758	PTBP3	Polypyrimidine tract-binding protein 3	GO:0043249; P:erythrocyte maturation; IEA:UniProtKB-KW
O95758	PTBP3	Polypyrimidine tract-binding protein 3	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
O95758	PTBP3	Polypyrimidine tract-binding protein 3	GO:0033119; P:negative regulation of RNA splicing; IDA:UniProtKB
O95758	PTBP3	Polypyrimidine tract-binding protein 3	GO:0045595; P:regulation of cell differentiation; IEA:Ensembl
O95758	PTBP3	Polypyrimidine tract-binding protein 3	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q9Y6C5	PTCH2	Protein patched homolog 2	GO:0097108; F:hedgehog family protein binding; IPI:BHF-UCL
Q9Y6C5	PTCH2	Protein patched homolog 2	GO:0008158; F:hedgehog receptor activity; TAS:BHF-UCL
Q9Y6C5	PTCH2	Protein patched homolog 2	GO:0005119; F:smoothened binding; IPI:BHF-UCL
Q9Y6C5	PTCH2	Protein patched homolog 2	GO:0008544; P:epidermis development; IEA:Ensembl
Q9Y6C5	PTCH2	Protein patched homolog 2	GO:0042633; P:hair cycle; IEA:Ensembl
Q9Y6C5	PTCH2	Protein patched homolog 2	GO:0045879; P:negative regulation of smoothened signaling pathway; TAS:BHF-UCL
Q9Y6C5	PTCH2	Protein patched homolog 2	GO:0007165; P:signal transduction; TAS:GOC
Q13635	PTCH1	Protein patched homolog 1	GO:0015485; F:cholesterol binding; IDA:BHF-UCL
Q13635	PTCH1	Protein patched homolog 1	GO:0030332; F:cyclin binding; IPI:BHF-UCL
Q13635	PTCH1	Protein patched homolog 1	GO:0097108; F:hedgehog family protein binding; IPI:BHF-UCL
Q13635	PTCH1	Protein patched homolog 1	GO:0008158; F:hedgehog receptor activity; IEA:InterPro
Q13635	PTCH1	Protein patched homolog 1	GO:0008201; F:heparin binding; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13635	PTCH1	Protein patched homolog 1	GO:0005119; F:smoothened binding; IPI:BHF-UCL
Q13635	PTCH1	Protein patched homolog 1	GO:0007420; P:brain development; ISS:BHF-UCL
Q13635	PTCH1	Protein patched homolog 1	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0061005; P:cell differentiation involved in kidney development; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0072203; P:cell proliferation involved in metanephros development; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0071397; P:cellular response to cholesterol; IMP:BHF-UCL
Q13635	PTCH1	Protein patched homolog 1	GO:0009953; P:dorsal/ventral pattern formation; ISS:UniProtKB
Q13635	PTCH1	Protein patched homolog 1	GO:0030326; P:embryonic limb morphogenesis; ISS:UniProtKB
Q13635	PTCH1	Protein patched homolog 1	GO:0008544; P:epidermis development; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0042593; P:glucose homeostasis; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0003007; P:heart morphogenesis; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0035137; P:hindlimb morphogenesis; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0043616; P:keratinocyte proliferation; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0035108; P:limb morphogenesis; IMP:BHF-UCL
Q13635	PTCH1	Protein patched homolog 1	GO:0060603; P:mammary gland duct morphogenesis; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0060644; P:mammary gland epithelial cell differentiation; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0051782; P:negative regulation of cell division; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0040015; P:negative regulation of multicellular organism growth; ISS:UniProtKB
Q13635	PTCH1	Protein patched homolog 1	GO:0045668; P:negative regulation of osteoblast differentiation; IMP:BHF-UCL
Q13635	PTCH1	Protein patched homolog 1	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL
Q13635	PTCH1	Protein patched homolog 1	GO:0045879; P:negative regulation of smoothened signaling pathway; ISS:BHF-UCL
Q13635	PTCH1	Protein patched homolog 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q13635	PTCH1	Protein patched homolog 1	GO:0021997; P:neural plate axis specification; ISS:BHF-UCL
Q13635	PTCH1	Protein patched homolog 1	GO:0001843; P:neural tube closure; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0021532; P:neural tube patterning; IMP:BHF-UCL
Q13635	PTCH1	Protein patched homolog 1	GO:0009887; P:organ morphogenesis; ISS:UniProtKB
Q13635	PTCH1	Protein patched homolog 1	GO:0060037; P:pharyngeal system development; IMP:BHF-UCL
Q13635	PTCH1	Protein patched homolog 1	GO:0010875; P:positive regulation of cholesterol efflux; IDA:BHF-UCL
Q13635	PTCH1	Protein patched homolog 1	GO:0016485; P:protein processing; ISS:UniProtKB
Q13635	PTCH1	Protein patched homolog 1	GO:0072661; P:protein targeting to plasma membrane; IDA:BHF-UCL
Q13635	PTCH1	Protein patched homolog 1	GO:0007346; P:regulation of mitotic cell cycle; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0032880; P:regulation of protein localization; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0008589; P:regulation of smoothened signaling pathway; ISS:UniProtKB
Q13635	PTCH1	Protein patched homolog 1	GO:0072001; P:renal system development; IEP:UniProtKB
Q13635	PTCH1	Protein patched homolog 1	GO:0010157; P:response to chlorate; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0042493; P:response to drug; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0032355; P:response to estradiol; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0032526; P:response to retinoic acid; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0007224; P:smoothened signaling pathway; IEP:UniProtKB
Q13635	PTCH1	Protein patched homolog 1	GO:0060831; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; IEA:Ensembl
Q13635	PTCH1	Protein patched homolog 1	GO:0061053; P:somite development; IMP:BHF-UCL
Q13635	PTCH1	Protein patched homolog 1	GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl
Q14761	PTPRCAP	Protein tyrosine phosphatase receptor type C-associated protein	GO:0006952; P:defense response; TAS:ProtInc
O75127	PTCD1	Pentatricopeptide repeat-containing protein 1, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75127	PTCD1	Pentatricopeptide repeat-containing protein 1, mitochondrial	GO:0000049; F:tRNA binding; IDA:UniProtKB
O75127	PTCD1	Pentatricopeptide repeat-containing protein 1, mitochondrial	GO:0042780; P:tRNA 3'-end processing; IDA:UniProtKB
Q8WV60	PTCD2	Pentatricopeptide repeat-containing protein 2, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8WV60	PTCD2	Pentatricopeptide repeat-containing protein 2, mitochondrial	GO:0001822; P:kidney development; IEA:Ensembl
Q8WV60	PTCD2	Pentatricopeptide repeat-containing protein 2, mitochondrial	GO:0001889; P:liver development; IEA:Ensembl
Q8WV60	PTCD2	Pentatricopeptide repeat-containing protein 2, mitochondrial	GO:0007005; P:mitochondrion organization; IEA:Ensembl
Q8WV60	PTCD2	Pentatricopeptide repeat-containing protein 2, mitochondrial	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q8WV60	PTCD2	Pentatricopeptide repeat-containing protein 2, mitochondrial	GO:0048747; P:muscle fiber development; IEA:Ensembl
Q8WV60	PTCD2	Pentatricopeptide repeat-containing protein 2, mitochondrial	GO:0050684; P:regulation of mRNA processing; ISS:UniProtKB
Q8WV60	PTCD2	Pentatricopeptide repeat-containing protein 2, mitochondrial	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IEA:Ensembl
Q96EY7	PTCD3	Pentatricopeptide repeat domain-containing protein 3, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96EY7	PTCD3	Pentatricopeptide repeat domain-containing protein 3, mitochondrial	GO:0043024; F:ribosomal small subunit binding; IDA:UniProtKB
Q96EY7	PTCD3	Pentatricopeptide repeat domain-containing protein 3, mitochondrial	GO:0019843; F:rRNA binding; IDA:UniProtKB
Q96EY7	PTCD3	Pentatricopeptide repeat domain-containing protein 3, mitochondrial	GO:0032543; P:mitochondrial translation; IMP:UniProtKB
Q96EY7	PTCD3	Pentatricopeptide repeat domain-containing protein 3, mitochondrial	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q6ISU1	PTCRA	Pre T-cell antigen receptor alpha	GO:0005515; F:protein binding; IPI:UniProtKB
Q6ISU1	PTCRA	Pre T-cell antigen receptor alpha	GO:0070244; P:negative regulation of thymocyte apoptotic process; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0010997; F:anaphase-promoting complex binding; IPI:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0019899; F:enzyme binding; IPI:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0051717; F:inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity; IDA:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0000287; F:magnesium ion binding; IEA:InterPro
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0030165; F:PDZ domain binding; IPI:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0016314; F:phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; IDA:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0051800; F:phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity; IDA:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0004438; F:phosphatidylinositol-3-phosphatase activity; IDA:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0004721; F:phosphoprotein phosphatase activity; IDA:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0005515; F:protein binding; IPI:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0004722; F:protein serine/threonine phosphatase activity; IDA:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0007092; P:activation of mitotic anaphase-promoting complex activity; IDA:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0007568; P:aging; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0001525; P:angiogenesis; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0006915; P:apoptotic process; ISS:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0048854; P:brain morphogenesis; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0060070; P:canonical Wnt signaling pathway; IDA:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0048738; P:cardiac muscle tissue development; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0016477; P:cell migration; ISS:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0008283; P:cell proliferation; TAS:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0007417; P:central nervous system development; ISS:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0032286; P:central nervous system myelin maintenance; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0021955; P:central nervous system neuron axonogenesis; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0060997; P:dendritic spine morphogenesis; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0021542; P:dentate gyrus development; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0043542; P:endothelial cell migration; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0048853; P:forebrain morphogenesis; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0007507; P:heart development; ISS:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0045087; P:innate immune response; TAS:Reactome
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0046855; P:inositol phosphate dephosphorylation; IDA:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0007611; P:learning or memory; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0045475; P:locomotor rhythm; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0007626; P:locomotory behavior; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0060292; P:long term synaptic depression; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0060179; P:male mating behavior; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0042711; P:maternal behavior; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0007613; P:memory; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0033555; P:multicellular organismal response to stress; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0050771; P:negative regulation of axonogenesis; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0090344; P:negative regulation of cell aging; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0045792; P:negative regulation of cell size; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0031658; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle; IDA:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0061002; P:negative regulation of dendritic spine morphogenesis; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0090394; P:negative regulation of excitatory postsynaptic membrane potential; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0051895; P:negative regulation of focal adhesion assembly; IMP:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IDA:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0031642; P:negative regulation of myelination; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0046621; P:negative regulation of organ growth; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0050765; P:negative regulation of phagocytosis; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0014067; P:negative regulation of phosphatidylinositol 3-kinase signaling; TAS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0051898; P:negative regulation of protein kinase B signaling; IMP:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0001933; P:negative regulation of protein phosphorylation; IDA:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0090071; P:negative regulation of ribosome biogenesis; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:2000808; P:negative regulation of synaptic vesicle clustering; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0007270; P:neuron-neuron synaptic transmission; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:GOC
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0046856; P:phosphatidylinositol dephosphorylation; IDA:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0008284; P:positive regulation of cell proliferation; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:2000463; P:positive regulation of excitatory postsynaptic membrane potential; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:2000060; P:positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0097107; P:postsynaptic density assembly; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0060134; P:prepulse inhibition; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0097105; P:presynaptic membrane assembly; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0060736; P:prostate gland growth; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0006470; P:protein dephosphorylation; IDA:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0043491; P:protein kinase B signaling; ISS:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0050821; P:protein stabilization; IDA:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0002902; P:regulation of B cell apoptotic process; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0032535; P:regulation of cellular component size; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0033032; P:regulation of myeloid cell apoptotic process; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0010975; P:regulation of neuron projection development; ISS:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0031647; P:regulation of protein stability; IMP:UniProtKB
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0046685; P:response to arsenic-containing substance; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0033198; P:response to ATP; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0042493; P:response to drug; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0032355; P:response to estradiol; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0045471; P:response to ethanol; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0009749; P:response to glucose; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0007584; P:response to nutrient; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0010043; P:response to zinc ion; IEA:Ensembl
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0060024; P:rhythmic synaptic transmission; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0035176; P:social behavior; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0007416; P:synapse assembly; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0060074; P:synapse maturation; ISS:BHF-UCL
P60484	PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q96BW5	PTER	Phosphotriesterase-related protein	GO:0016788; F:hydrolase activity, acting on ester bonds; IEA:InterPro
Q96BW5	PTER	Phosphotriesterase-related protein	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96BW5	PTER	Phosphotriesterase-related protein	GO:0009056; P:catabolic process; IEA:InterPro
Q96BW5	PTER	Phosphotriesterase-related protein	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
Q7RTS3	PTF1A	Pancreas transcription factor 1 subunit alpha	GO:0003677; F:DNA binding; ISS:UniProtKB
Q7RTS3	PTF1A	Pancreas transcription factor 1 subunit alpha	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q7RTS3	PTF1A	Pancreas transcription factor 1 subunit alpha	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q7RTS3	PTF1A	Pancreas transcription factor 1 subunit alpha	GO:0035881; P:amacrine cell differentiation; ISS:UniProtKB
Q7RTS3	PTF1A	Pancreas transcription factor 1 subunit alpha	GO:0021549; P:cerebellum development; IMP:UniProtKB
Q7RTS3	PTF1A	Pancreas transcription factor 1 subunit alpha	GO:0009790; P:embryo development; IEA:Ensembl
Q7RTS3	PTF1A	Pancreas transcription factor 1 subunit alpha	GO:0031018; P:endocrine pancreas development; TAS:Reactome
Q7RTS3	PTF1A	Pancreas transcription factor 1 subunit alpha	GO:0031017; P:exocrine pancreas development; ISS:UniProtKB
Q7RTS3	PTF1A	Pancreas transcription factor 1 subunit alpha	GO:0048663; P:neuron fate commitment; IEA:Ensembl
Q7RTS3	PTF1A	Pancreas transcription factor 1 subunit alpha	GO:0031016; P:pancreas development; IMP:UniProtKB
Q7RTS3	PTF1A	Pancreas transcription factor 1 subunit alpha	GO:0061074; P:regulation of neural retina development; ISS:UniProtKB
Q7RTS3	PTF1A	Pancreas transcription factor 1 subunit alpha	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
Q7RTS3	PTF1A	Pancreas transcription factor 1 subunit alpha	GO:0010842; P:retina layer formation; ISS:UniProtKB
Q7RTS3	PTF1A	Pancreas transcription factor 1 subunit alpha	GO:0048384; P:retinoic acid receptor signaling pathway; IEA:Ensembl
Q7RTS3	PTF1A	Pancreas transcription factor 1 subunit alpha	GO:0009888; P:tissue development; IDA:UniProtKB
P41222	PTGDS	Prostaglandin-H2 D-isomerase	GO:0005504; F:fatty acid binding; IDA:UniProtKB
P41222	PTGDS	Prostaglandin-H2 D-isomerase	GO:0004667; F:prostaglandin-D synthase activity; IDA:UniProtKB
P41222	PTGDS	Prostaglandin-H2 D-isomerase	GO:0005501; F:retinoid binding; ISS:UniProtKB
P41222	PTGDS	Prostaglandin-H2 D-isomerase	GO:0005215; F:transporter activity; ISS:UniProtKB
P41222	PTGDS	Prostaglandin-H2 D-isomerase	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P41222	PTGDS	Prostaglandin-H2 D-isomerase	GO:0019371; P:cyclooxygenase pathway; TAS:Reactome
P41222	PTGDS	Prostaglandin-H2 D-isomerase	GO:0001516; P:prostaglandin biosynthetic process; IDA:UniProtKB
P41222	PTGDS	Prostaglandin-H2 D-isomerase	GO:0045187; P:regulation of circadian sleep/wake cycle, sleep; ISS:UniProtKB
P41222	PTGDS	Prostaglandin-H2 D-isomerase	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P41222	PTGDS	Prostaglandin-H2 D-isomerase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P41222	PTGDS	Prostaglandin-H2 D-isomerase	GO:0006810; P:transport; ISS:UniProtKB
O14684	PTGES	Prostaglandin E synthase	GO:0043295; F:glutathione binding; IDA:UniProtKB
O14684	PTGES	Prostaglandin E synthase	GO:0050220; F:prostaglandin-E synthase activity; IDA:UniProtKB
O14684	PTGES	Prostaglandin E synthase	GO:0002526; P:acute inflammatory response; IEA:Ensembl
O14684	PTGES	Prostaglandin E synthase	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
O14684	PTGES	Prostaglandin E synthase	GO:0002544; P:chronic inflammatory response; IEA:Ensembl
O14684	PTGES	Prostaglandin E synthase	GO:0019371; P:cyclooxygenase pathway; TAS:Reactome
O14684	PTGES	Prostaglandin E synthase	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
O14684	PTGES	Prostaglandin E synthase	GO:0001516; P:prostaglandin biosynthetic process; IDA:UniProtKB
O14684	PTGES	Prostaglandin E synthase	GO:0006693; P:prostaglandin metabolic process; TAS:ProtInc
O14684	PTGES	Prostaglandin E synthase	GO:0051592; P:response to calcium ion; IEA:Ensembl
O14684	PTGES	Prostaglandin E synthase	GO:0034097; P:response to cytokine; IEA:Ensembl
O14684	PTGES	Prostaglandin E synthase	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
O14684	PTGES	Prostaglandin E synthase	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
O14684	PTGES	Prostaglandin E synthase	GO:0032526; P:response to retinoic acid; IEA:Ensembl
O14684	PTGES	Prostaglandin E synthase	GO:0007165; P:signal transduction; NAS:ProtInc
O14684	PTGES	Prostaglandin E synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16647	PTGIS	Prostacyclin synthase	GO:0020037; F:heme binding; IDA:UniProtKB
Q16647	PTGIS	Prostacyclin synthase	GO:0005506; F:iron ion binding; IEA:InterPro
Q16647	PTGIS	Prostacyclin synthase	GO:0004497; F:monooxygenase activity; IEA:InterPro
Q16647	PTGIS	Prostacyclin synthase	GO:0016705; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; IEA:InterPro
Q16647	PTGIS	Prostacyclin synthase	GO:0008116; F:prostaglandin-I synthase activity; IDA:UniProtKB
Q16647	PTGIS	Prostacyclin synthase	GO:0005515; F:protein binding; IPI:UniProtKB
Q16647	PTGIS	Prostacyclin synthase	GO:0097190; P:apoptotic signaling pathway; IDA:UniProtKB
Q16647	PTGIS	Prostacyclin synthase	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
Q16647	PTGIS	Prostacyclin synthase	GO:0071456; P:cellular response to hypoxia; IDA:UniProtKB
Q16647	PTGIS	Prostacyclin synthase	GO:0071347; P:cellular response to interleukin-1; IEP:UniProtKB
Q16647	PTGIS	Prostacyclin synthase	GO:0071354; P:cellular response to interleukin-6; IEP:UniProtKB
Q16647	PTGIS	Prostacyclin synthase	GO:0019371; P:cyclooxygenase pathway; TAS:Reactome
Q16647	PTGIS	Prostacyclin synthase	GO:0006690; P:icosanoid metabolic process; TAS:Reactome
Q16647	PTGIS	Prostacyclin synthase	GO:0050728; P:negative regulation of inflammatory response; IDA:UniProtKB
Q16647	PTGIS	Prostacyclin synthase	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q16647	PTGIS	Prostacyclin synthase	GO:0045019; P:negative regulation of nitric oxide biosynthetic process; IDA:UniProtKB
Q16647	PTGIS	Prostacyclin synthase	GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB
Q16647	PTGIS	Prostacyclin synthase	GO:1900119; P:positive regulation of execution phase of apoptosis; IDA:UniProtKB
Q16647	PTGIS	Prostacyclin synthase	GO:0035360; P:positive regulation of peroxisome proliferator activated receptor signaling pathway; IDA:UniProtKB
Q16647	PTGIS	Prostacyclin synthase	GO:0001516; P:prostaglandin biosynthetic process; IDA:UniProtKB
Q16647	PTGIS	Prostacyclin synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16647	PTGIS	Prostacyclin synthase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P49190	PTH2R	Parathyroid hormone 2 receptor	GO:0004991; F:parathyroid hormone receptor activity; TAS:ProtInc
P49190	PTH2R	Parathyroid hormone 2 receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q03431	PTH1R	Parathyroid hormone/parathyroid hormone-related peptide receptor	GO:0004991; F:parathyroid hormone receptor activity; IDA:UniProtKB
Q03431	PTH1R	Parathyroid hormone/parathyroid hormone-related peptide receptor	GO:0017046; F:peptide hormone binding; IDA:UniProtKB
Q03431	PTH1R	Parathyroid hormone/parathyroid hormone-related peptide receptor	GO:0005515; F:protein binding; IPI:IntAct
Q03431	PTH1R	Parathyroid hormone/parathyroid hormone-related peptide receptor	GO:0043621; F:protein self-association; IDA:UniProtKB
Q03431	PTH1R	Parathyroid hormone/parathyroid hormone-related peptide receptor	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; ISS:BHF-UCL
Q03431	PTH1R	Parathyroid hormone/parathyroid hormone-related peptide receptor	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IDA:UniProtKB
Q03431	PTH1R	Parathyroid hormone/parathyroid hormone-related peptide receptor	GO:0007568; P:aging; IEA:Ensembl
Q03431	PTH1R	Parathyroid hormone/parathyroid hormone-related peptide receptor	GO:0030282; P:bone mineralization; IEA:Ensembl
Q03431	PTH1R	Parathyroid hormone/parathyroid hormone-related peptide receptor	GO:0045453; P:bone resorption; IEA:Ensembl
Q03431	PTH1R	Parathyroid hormone/parathyroid hormone-related peptide receptor	GO:0048469; P:cell maturation; IEA:Ensembl
Q03431	PTH1R	Parathyroid hormone/parathyroid hormone-related peptide receptor	GO:0002062; P:chondrocyte differentiation; IEA:Ensembl
Q03431	PTH1R	Parathyroid hormone/parathyroid hormone-related peptide receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q03431	PTH1R	Parathyroid hormone/parathyroid hormone-related peptide receptor	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
Q03431	PTH1R	Parathyroid hormone/parathyroid hormone-related peptide receptor	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q03431	PTH1R	Parathyroid hormone/parathyroid hormone-related peptide receptor	GO:0002076; P:osteoblast development; IEA:Ensembl
Q03431	PTH1R	Parathyroid hormone/parathyroid hormone-related peptide receptor	GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; IC:BHF-UCL
Q03431	PTH1R	Parathyroid hormone/parathyroid hormone-related peptide receptor	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q03431	PTH1R	Parathyroid hormone/parathyroid hormone-related peptide receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
Q03431	PTH1R	Parathyroid hormone/parathyroid hormone-related peptide receptor	GO:0060732; P:positive regulation of inositol phosphate biosynthetic process; ISS:BHF-UCL
Q03431	PTH1R	Parathyroid hormone/parathyroid hormone-related peptide receptor	GO:0001501; P:skeletal system development; TAS:ProtInc
Q8N8N7	PTGR2	Prostaglandin reductase 2	GO:0036132; F:13-prostaglandin reductase activity; IEA:UniProtKB-EC
Q8N8N7	PTGR2	Prostaglandin reductase 2	GO:0047522; F:15-oxoprostaglandin 13-oxidase activity; IDA:UniProtKB
Q8N8N7	PTGR2	Prostaglandin reductase 2	GO:0006693; P:prostaglandin metabolic process; IDA:UniProtKB
Q14914	PTGR1	Prostaglandin reductase 1	GO:0036132; F:13-prostaglandin reductase activity; IEA:UniProtKB-EC
Q14914	PTGR1	Prostaglandin reductase 1	GO:0047522; F:15-oxoprostaglandin 13-oxidase activity; IEA:UniProtKB-EC
Q14914	PTGR1	Prostaglandin reductase 1	GO:0032440; F:2-alkenal reductase [NAD(P)] activity; IEA:UniProtKB-EC
Q14914	PTGR1	Prostaglandin reductase 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q14914	PTGR1	Prostaglandin reductase 1	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
Q14914	PTGR1	Prostaglandin reductase 1	GO:0019371; P:cyclooxygenase pathway; TAS:Reactome
Q14914	PTGR1	Prostaglandin reductase 1	GO:0006691; P:leukotriene metabolic process; NAS:UniProtKB
Q14914	PTGR1	Prostaglandin reductase 1	GO:2001300; P:lipoxin metabolic process; TAS:Reactome
Q14914	PTGR1	Prostaglandin reductase 1	GO:0009636; P:response to toxic substance; IEA:Ensembl
Q14914	PTGR1	Prostaglandin reductase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y3E5	PTRH2	Peptidyl-tRNA hydrolase 2, mitochondrial	GO:0004045; F:aminoacyl-tRNA hydrolase activity; IEA:UniProtKB-EC
Q9Y3E5	PTRH2	Peptidyl-tRNA hydrolase 2, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3E5	PTRH2	Peptidyl-tRNA hydrolase 2, mitochondrial	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9Y3E5	PTRH2	Peptidyl-tRNA hydrolase 2, mitochondrial	GO:2000811; P:negative regulation of anoikis; IMP:UniProtKB
Q9Y3E5	PTRH2	Peptidyl-tRNA hydrolase 2, mitochondrial	GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB
Q9Y3E5	PTRH2	Peptidyl-tRNA hydrolase 2, mitochondrial	GO:2000210; P:positive regulation of anoikis; IMP:UniProtKB
Q3SYG4	BBS9	Protein PTHB1	GO:0005515; F:protein binding; IPI:UniProtKB
Q3SYG4	BBS9	Protein PTHB1	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
Q3SYG4	BBS9	Protein PTHB1	GO:0045444; P:fat cell differentiation; ISS:BHF-UCL
Q3SYG4	BBS9	Protein PTHB1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q3SYG4	BBS9	Protein PTHB1	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q3SYG4	BBS9	Protein PTHB1	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q96NR3	PTCHD1	Patched domain-containing protein 1	GO:0008158; F:hedgehog receptor activity; IEA:InterPro
Q96NR3	PTCHD1	Patched domain-containing protein 1	GO:0050890; P:cognition; IMP:UniProtKB
Q96NR3	PTCHD1	Patched domain-containing protein 1	GO:0007224; P:smoothened signaling pathway; IDA:UniProtKB
Q9P2K9	PTCHD2	Patched domain-containing protein 2	GO:0008158; F:hedgehog receptor activity; IEA:InterPro
Q9P2K9	PTCHD2	Patched domain-containing protein 2	GO:0042632; P:cholesterol homeostasis; ISS:UniProtKB
Q9P2K9	PTCHD2	Patched domain-containing protein 2	GO:0032368; P:regulation of lipid transport; NAS:UniProtKB
Q9P2K9	PTCHD2	Patched domain-containing protein 2	GO:0007224; P:smoothened signaling pathway; NAS:UniProtKB
Q3KNS1	PTCHD3	Patched domain-containing protein 3	GO:0008158; F:hedgehog receptor activity; IEA:InterPro
Q3KNS1	PTCHD3	Patched domain-containing protein 3	GO:0007286; P:spermatid development; NAS:UniProtKB
Q6ZW05	PTCHD4	Patched domain-containing protein 4	GO:0008158; F:hedgehog receptor activity; IEA:InterPro
P12272	PTHLH	Parathyroid hormone-related protein	GO:0005179; F:hormone activity; TAS:ProtInc
P12272	PTHLH	Parathyroid hormone-related protein	GO:0051428; F:peptide hormone receptor binding; IDA:UniProtKB
P12272	PTHLH	Parathyroid hormone-related protein	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IDA:MGI
P12272	PTHLH	Parathyroid hormone-related protein	GO:0046058; P:cAMP metabolic process; TAS:ProtInc
P12272	PTHLH	Parathyroid hormone-related protein	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P12272	PTHLH	Parathyroid hormone-related protein	GO:0001958; P:endochondral ossification; IEA:Ensembl
P12272	PTHLH	Parathyroid hormone-related protein	GO:0007492; P:endoderm development; IEA:Ensembl
P12272	PTHLH	Parathyroid hormone-related protein	GO:0008544; P:epidermis development; TAS:ProtInc
P12272	PTHLH	Parathyroid hormone-related protein	GO:0030855; P:epithelial cell differentiation; IEA:Ensembl
P12272	PTHLH	Parathyroid hormone-related protein	GO:0007565; P:female pregnancy; TAS:ProtInc
P12272	PTHLH	Parathyroid hormone-related protein	GO:0048286; P:lung alveolus development; IEA:Ensembl
P12272	PTHLH	Parathyroid hormone-related protein	GO:0060649; P:mammary gland bud elongation; IEA:Ensembl
P12272	PTHLH	Parathyroid hormone-related protein	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P12272	PTHLH	Parathyroid hormone-related protein	GO:0032331; P:negative regulation of chondrocyte differentiation; IDA:MGI
P12272	PTHLH	Parathyroid hormone-related protein	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P12272	PTHLH	Parathyroid hormone-related protein	GO:0060659; P:nipple sheath formation; IEA:Ensembl
P12272	PTHLH	Parathyroid hormone-related protein	GO:0002076; P:osteoblast development; IEA:Ensembl
P12272	PTHLH	Parathyroid hormone-related protein	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:MGI
P12272	PTHLH	Parathyroid hormone-related protein	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P12272	PTHLH	Parathyroid hormone-related protein	GO:0016485; P:protein processing; IEA:Ensembl
P12272	PTHLH	Parathyroid hormone-related protein	GO:0010468; P:regulation of gene expression; IDA:MGI
P12272	PTHLH	Parathyroid hormone-related protein	GO:0001501; P:skeletal system development; IDA:MGI
P12272	PTHLH	Parathyroid hormone-related protein	GO:0043129; P:surfactant homeostasis; IEA:Ensembl
P01270	PTH	Parathyroid hormone	GO:0005179; F:hormone activity; TAS:ProtInc
P01270	PTH	Parathyroid hormone	GO:0051428; F:peptide hormone receptor binding; IDA:UniProtKB
P01270	PTH	Parathyroid hormone	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IMP:UniProtKB
P01270	PTH	Parathyroid hormone	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P01270	PTH	Parathyroid hormone	GO:0045453; P:bone resorption; NAS:UniProtKB
P01270	PTH	Parathyroid hormone	GO:0046058; P:cAMP metabolic process; TAS:ProtInc
P01270	PTH	Parathyroid hormone	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P01270	PTH	Parathyroid hormone	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
P01270	PTH	Parathyroid hormone	GO:0034645; P:cellular macromolecule biosynthetic process; IDA:MGI
P01270	PTH	Parathyroid hormone	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P01270	PTH	Parathyroid hormone	GO:0008628; P:hormone-mediated apoptotic signaling pathway; TAS:ProtInc
P01270	PTH	Parathyroid hormone	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P01270	PTH	Parathyroid hormone	GO:0030501; P:positive regulation of bone mineralization; IDA:UniProtKB
P01270	PTH	Parathyroid hormone	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:MGI
P01270	PTH	Parathyroid hormone	GO:0046326; P:positive regulation of glucose import; IDA:UniProtKB
P01270	PTH	Parathyroid hormone	GO:0045725; P:positive regulation of glycogen biosynthetic process; IDA:UniProtKB
P01270	PTH	Parathyroid hormone	GO:0009967; P:positive regulation of signal transduction; IEA:Ensembl
P01270	PTH	Parathyroid hormone	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
P01270	PTH	Parathyroid hormone	GO:0010468; P:regulation of gene expression; IDA:MGI
P01270	PTH	Parathyroid hormone	GO:0046686; P:response to cadmium ion; IEA:Ensembl
P01270	PTH	Parathyroid hormone	GO:0042493; P:response to drug; IEA:Ensembl
P01270	PTH	Parathyroid hormone	GO:0045471; P:response to ethanol; IEA:Ensembl
P01270	PTH	Parathyroid hormone	GO:0071774; P:response to fibroblast growth factor; IEA:Ensembl
P01270	PTH	Parathyroid hormone	GO:0010288; P:response to lead ion; IEA:Ensembl
P01270	PTH	Parathyroid hormone	GO:0071107; P:response to parathyroid hormone; IEA:Ensembl
P01270	PTH	Parathyroid hormone	GO:0033280; P:response to vitamin D; IEA:Ensembl
P01270	PTH	Parathyroid hormone	GO:0007266; P:Rho protein signal transduction; IEA:Ensembl
P01270	PTH	Parathyroid hormone	GO:0001501; P:skeletal system development; TAS:ProtInc
P01270	PTH	Parathyroid hormone	GO:0006366; P:transcription from RNA polymerase II promoter; IMP:GOC
Q86Y79	PTRH1	Probable peptidyl-tRNA hydrolase	GO:0004045; F:aminoacyl-tRNA hydrolase activity; IEA:UniProtKB-EC
Q86Y79	PTRH1	Probable peptidyl-tRNA hydrolase	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13882	PTK6	Protein-tyrosine kinase 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13882	PTK6	Protein-tyrosine kinase 6	GO:0042802; F:identical protein binding; IPI:IntAct
Q13882	PTK6	Protein-tyrosine kinase 6	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB
Q13882	PTK6	Protein-tyrosine kinase 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q13882	PTK6	Protein-tyrosine kinase 6	GO:0004674; F:protein serine/threonine kinase activity; IEA:Ensembl
Q13882	PTK6	Protein-tyrosine kinase 6	GO:0016477; P:cell migration; IDA:UniProtKB
Q13882	PTK6	Protein-tyrosine kinase 6	GO:0071300; P:cellular response to retinoic acid; IMP:BHF-UCL
Q13882	PTK6	Protein-tyrosine kinase 6	GO:0060575; P:intestinal epithelial cell differentiation; IEA:Ensembl
Q13882	PTK6	Protein-tyrosine kinase 6	GO:0045926; P:negative regulation of growth; IEA:Ensembl
Q13882	PTK6	Protein-tyrosine kinase 6	GO:0061099; P:negative regulation of protein tyrosine kinase activity; IDA:UniProtKB
Q13882	PTK6	Protein-tyrosine kinase 6	GO:0010976; P:positive regulation of neuron projection development; IMP:BHF-UCL
Q13882	PTK6	Protein-tyrosine kinase 6	GO:0046777; P:protein autophosphorylation; IMP:UniProtKB
Q13882	PTK6	Protein-tyrosine kinase 6	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q13882	PTK6	Protein-tyrosine kinase 6	GO:0042503; P:tyrosine phosphorylation of Stat3 protein; IDA:UniProtKB
Q13882	PTK6	Protein-tyrosine kinase 6	GO:0042506; P:tyrosine phosphorylation of Stat5 protein; IDA:UniProtKB
Q13308	PTK7	Inactive tyrosine-protein kinase 7	GO:0005524; F:ATP binding; IEA:InterPro
Q13308	PTK7	Inactive tyrosine-protein kinase 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q13308	PTK7	Inactive tyrosine-protein kinase 7	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; TAS:ProtInc
Q13308	PTK7	Inactive tyrosine-protein kinase 7	GO:0031532; P:actin cytoskeleton reorganization; IMP:UniProtKB
Q13308	PTK7	Inactive tyrosine-protein kinase 7	GO:0003401; P:axis elongation; IEA:Ensembl
Q13308	PTK7	Inactive tyrosine-protein kinase 7	GO:0060070; P:canonical Wnt signaling pathway; IMP:UniProtKB
Q13308	PTK7	Inactive tyrosine-protein kinase 7	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q13308	PTK7	Inactive tyrosine-protein kinase 7	GO:0016477; P:cell migration; IMP:UniProtKB
Q13308	PTK7	Inactive tyrosine-protein kinase 7	GO:0071300; P:cellular response to retinoic acid; IMP:BHF-UCL
Q13308	PTK7	Inactive tyrosine-protein kinase 7	GO:0090103; P:cochlea morphogenesis; IEA:Ensembl
Q13308	PTK7	Inactive tyrosine-protein kinase 7	GO:0060026; P:convergent extension; IEA:Ensembl
Q13308	PTK7	Inactive tyrosine-protein kinase 7	GO:0045198; P:establishment of epithelial cell apical/basal polarity; IEA:Ensembl
Q13308	PTK7	Inactive tyrosine-protein kinase 7	GO:0001736; P:establishment of planar polarity; IEA:Ensembl
Q13308	PTK7	Inactive tyrosine-protein kinase 7	GO:0060484; P:lung-associated mesenchyme development; IEA:Ensembl
Q13308	PTK7	Inactive tyrosine-protein kinase 7	GO:0001843; P:neural tube closure; IEA:Ensembl
Q13308	PTK7	Inactive tyrosine-protein kinase 7	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:GOC
Q13308	PTK7	Inactive tyrosine-protein kinase 7	GO:0090179; P:planar cell polarity pathway involved in neural tube closure; IEA:Ensembl
Q13308	PTK7	Inactive tyrosine-protein kinase 7	GO:0010976; P:positive regulation of neuron projection development; IMP:BHF-UCL
Q13308	PTK7	Inactive tyrosine-protein kinase 7	GO:0007165; P:signal transduction; TAS:ProtInc
Q13308	PTK7	Inactive tyrosine-protein kinase 7	GO:0042060; P:wound healing; IEA:Ensembl
P06454	PTMA	Prothymosin alpha	GO:0006351; P:transcription, DNA-templated; TAS:ProtInc
P20962	PTMS	Parathymosin	GO:0006260; P:DNA replication; TAS:ProtInc
P20962	PTMS	Parathymosin	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0005158; F:insulin receptor binding; IPI:BHF-UCL
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0004726; F:non-membrane spanning protein tyrosine phosphatase activity; IMP:UniProtKB
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0004721; F:phosphoprotein phosphatase activity; IDA:UniProtKB
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0005515; F:protein binding; IPI:UniProtKB
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0005070; F:SH3/SH2 adaptor activity; IDA:BHF-UCL
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0036302; P:atrioventricular canal development; IMP:BHF-UCL
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0007411; P:axon guidance; TAS:Reactome
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0007596; P:blood coagulation; TAS:Reactome
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0007420; P:brain development; IMP:BHF-UCL
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0000077; P:DNA damage checkpoint; IEA:Ensembl
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0048013; P:ephrin receptor signaling pathway; IDA:UniProtKB
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0038127; P:ERBB signaling pathway; IDA:UniProtKB
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0060325; P:face morphogenesis; IMP:BHF-UCL
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0048806; P:genitalia development; IMP:BHF-UCL
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0042593; P:glucose homeostasis; IEA:Ensembl
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0007507; P:heart development; IMP:BHF-UCL
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0042445; P:hormone metabolic process; IEA:Ensembl
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0009755; P:hormone-mediated signaling pathway; IEA:Ensembl
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0045087; P:innate immune response; TAS:Reactome
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0048839; P:inner ear development; IMP:BHF-UCL
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0050900; P:leukocyte migration; TAS:Reactome
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0048609; P:multicellular organismal reproductive process; IEA:Ensembl
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0051463; P:negative regulation of cortisol secretion; IEA:Ensembl
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0060125; P:negative regulation of growth hormone secretion; IEA:Ensembl
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0046676; P:negative regulation of insulin secretion; IEA:Ensembl
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0035265; P:organ growth; IEA:Ensembl
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:UniProtKB
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:2001275; P:positive regulation of glucose import in response to insulin stimulus; IDA:BHF-UCL
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0046887; P:positive regulation of hormone secretion; IEA:Ensembl
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0033628; P:regulation of cell adhesion mediated by integrin; IMP:UniProtKB
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; TAS:Reactome
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0046825; P:regulation of protein export from nucleus; IEA:Ensembl
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0031295; P:T cell costimulation; TAS:Reactome
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0006641; P:triglyceride metabolic process; IEA:Ensembl
Q06124	PTPN11	Tyrosine-protein phosphatase non-receptor type 11	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q05209	PTPN12	Tyrosine-protein phosphatase non-receptor type 12	GO:0004726; F:non-membrane spanning protein tyrosine phosphatase activity; TAS:ProtInc
Q05209	PTPN12	Tyrosine-protein phosphatase non-receptor type 12	GO:0005515; F:protein binding; IPI:UniProtKB
Q05209	PTPN12	Tyrosine-protein phosphatase non-receptor type 12	GO:0017124; F:SH3 domain binding; IPI:UniProtKB
Q05209	PTPN12	Tyrosine-protein phosphatase non-receptor type 12	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
Q05209	PTPN12	Tyrosine-protein phosphatase non-receptor type 12	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
Q12923	PTPN13	Tyrosine-protein phosphatase non-receptor type 13	GO:0005515; F:protein binding; IPI:UniProtKB
Q12923	PTPN13	Tyrosine-protein phosphatase non-receptor type 13	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
Q12923	PTPN13	Tyrosine-protein phosphatase non-receptor type 13	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:GOC
Q12923	PTPN13	Tyrosine-protein phosphatase non-receptor type 13	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
Q15678	PTPN14	Tyrosine-protein phosphatase non-receptor type 14	GO:0005515; F:protein binding; IPI:UniProtKB
Q15678	PTPN14	Tyrosine-protein phosphatase non-receptor type 14	GO:0004725; F:protein tyrosine phosphatase activity; IMP:UniProtKB
Q15678	PTPN14	Tyrosine-protein phosphatase non-receptor type 14	GO:0030971; F:receptor tyrosine kinase binding; IPI:UniProtKB
Q15678	PTPN14	Tyrosine-protein phosphatase non-receptor type 14	GO:0003712; F:transcription cofactor activity; IMP:UniProtKB
Q15678	PTPN14	Tyrosine-protein phosphatase non-receptor type 14	GO:0001946; P:lymphangiogenesis; IMP:UniProtKB
Q15678	PTPN14	Tyrosine-protein phosphatase non-receptor type 14	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q15678	PTPN14	Tyrosine-protein phosphatase non-receptor type 14	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IMP:GOC
Q15678	PTPN14	Tyrosine-protein phosphatase non-receptor type 14	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
Q15678	PTPN14	Tyrosine-protein phosphatase non-receptor type 14	GO:0046825; P:regulation of protein export from nucleus; IDA:UniProtKB
Q15678	PTPN14	Tyrosine-protein phosphatase non-receptor type 14	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q15678	PTPN14	Tyrosine-protein phosphatase non-receptor type 14	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q99952	PTPN18	Tyrosine-protein phosphatase non-receptor type 18	GO:0004726; F:non-membrane spanning protein tyrosine phosphatase activity; TAS:ProtInc
Q99952	PTPN18	Tyrosine-protein phosphatase non-receptor type 18	GO:0005515; F:protein binding; IPI:IntAct
Q99952	PTPN18	Tyrosine-protein phosphatase non-receptor type 18	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
Q99952	PTPN18	Tyrosine-protein phosphatase non-receptor type 18	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0019899; F:enzyme binding; IPI:UniProtKB
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0046875; F:ephrin receptor binding; IPI:UniProtKB
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0005515; F:protein binding; IPI:IntAct
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0030971; F:receptor tyrosine kinase binding; IPI:UniProtKB
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0031532; P:actin cytoskeleton reorganization; IMP:UniProtKB
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0007596; P:blood coagulation; TAS:Reactome
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0030968; P:endoplasmic reticulum unfolded protein response; IDA:UniProtKB
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0008286; P:insulin receptor signaling pathway; IEA:Ensembl
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0046627; P:negative regulation of insulin receptor signaling pathway; NAS:BHF-UCL
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:UniProtKB
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0030168; P:platelet activation; TAS:Reactome
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0035791; P:platelet-derived growth factor receptor-beta signaling pathway; IMP:UniProtKB
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0030100; P:regulation of endocytosis; IDA:UniProtKB
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:1902202; P:regulation of hepatocyte growth factor receptor signaling pathway; IMP:UniProtKB
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; TAS:Reactome
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0009966; P:regulation of signal transduction; IMP:UniProtKB
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P18031	PTPN1	Tyrosine-protein phosphatase non-receptor type 1	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q4JDL3	PTPN20A	Tyrosine-protein phosphatase non-receptor type 20	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q16825	PTPN21	Tyrosine-protein phosphatase non-receptor type 21	GO:0005515; F:protein binding; IPI:IntAct
Q16825	PTPN21	Tyrosine-protein phosphatase non-receptor type 21	GO:0004725; F:protein tyrosine phosphatase activity; TAS:ProtInc
Q16825	PTPN21	Tyrosine-protein phosphatase non-receptor type 21	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
Q16825	PTPN21	Tyrosine-protein phosphatase non-receptor type 21	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
Q9Y2R2	PTPN22	Tyrosine-protein phosphatase non-receptor type 22	GO:0019900; F:kinase binding; ISS:BHF-UCL
Q9Y2R2	PTPN22	Tyrosine-protein phosphatase non-receptor type 22	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2R2	PTPN22	Tyrosine-protein phosphatase non-receptor type 22	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
Q9Y2R2	PTPN22	Tyrosine-protein phosphatase non-receptor type 22	GO:0017124; F:SH3 domain binding; ISS:BHF-UCL
Q9Y2R2	PTPN22	Tyrosine-protein phosphatase non-receptor type 22	GO:0050868; P:negative regulation of T cell activation; IMP:BHF-UCL
Q9Y2R2	PTPN22	Tyrosine-protein phosphatase non-receptor type 22	GO:0050860; P:negative regulation of T cell receptor signaling pathway; IDA:UniProtKB
Q9Y2R2	PTPN22	Tyrosine-protein phosphatase non-receptor type 22	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:GOC
Q9Y2R2	PTPN22	Tyrosine-protein phosphatase non-receptor type 22	GO:0035644; P:phosphoanandamide dephosphorylation; ISS:BHF-UCL
Q9Y2R2	PTPN22	Tyrosine-protein phosphatase non-receptor type 22	GO:0006470; P:protein dephosphorylation; IDA:BHF-UCL
Q9Y2R2	PTPN22	Tyrosine-protein phosphatase non-receptor type 22	GO:0050855; P:regulation of B cell receptor signaling pathway; NAS:BHF-UCL
Q9Y2R2	PTPN22	Tyrosine-protein phosphatase non-receptor type 22	GO:0045088; P:regulation of innate immune response; IC:BHF-UCL
Q9Y2R2	PTPN22	Tyrosine-protein phosphatase non-receptor type 22	GO:0032817; P:regulation of natural killer cell proliferation; IDA:BHF-UCL
Q9Y2R2	PTPN22	Tyrosine-protein phosphatase non-receptor type 22	GO:0030217; P:T cell differentiation; ISS:BHF-UCL
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0005178; F:integrin binding; IPI:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0005515; F:protein binding; IPI:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0030971; F:receptor tyrosine kinase binding; IPI:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0019905; F:syntaxin binding; IPI:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0030183; P:B cell differentiation; ISS:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0030218; P:erythrocyte differentiation; ISS:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0042593; P:glucose homeostasis; ISS:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0008286; P:insulin receptor signaling pathway; ISS:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0050922; P:negative regulation of chemotaxis; ISS:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; IMP:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0050728; P:negative regulation of inflammatory response; ISS:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0046627; P:negative regulation of insulin receptor signaling pathway; ISS:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0060336; P:negative regulation of interferon-gamma-mediated signaling pathway; ISS:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:1902206; P:negative regulation of interleukin-2-mediated signaling pathway; IMP:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:1902215; P:negative regulation of interleukin-4-mediated signaling pathway; IEA:Ensembl
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0070104; P:negative regulation of interleukin-6-mediated signaling pathway; IEA:Ensembl
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0010888; P:negative regulation of lipid storage; ISS:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:1902227; P:negative regulation of macrophage colony-stimulating factor signaling pathway; ISS:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0045650; P:negative regulation of macrophage differentiation; ISS:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:2000587; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; ISS:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:1902233; P:negative regulation of positive thymic T cell selection; ISS:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:1902212; P:negative regulation of prolactin signaling pathway; ISS:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0050860; P:negative regulation of T cell receptor signaling pathway; ISS:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; ISS:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0060339; P:negative regulation of type I interferon-mediated signaling pathway; IMP:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0042512; P:negative regulation of tyrosine phosphorylation of Stat1 protein; IMP:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0042518; P:negative regulation of tyrosine phosphorylation of Stat3 protein; IDA:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0042524; P:negative regulation of tyrosine phosphorylation of Stat5 protein; ISS:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0042527; P:negative regulation of tyrosine phosphorylation of Stat6 protein; IEA:Ensembl
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:GOC
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0045722; P:positive regulation of gluconeogenesis; ISS:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:1902202; P:regulation of hepatocyte growth factor receptor signaling pathway; IMP:UniProtKB
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; TAS:Reactome
P17706	PTPN2	Tyrosine-protein phosphatase non-receptor type 2	GO:0030217; P:T cell differentiation; ISS:UniProtKB
Q9H3S7	PTPN23	Tyrosine-protein phosphatase non-receptor type 23	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H3S7	PTPN23	Tyrosine-protein phosphatase non-receptor type 23	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q9H3S7	PTPN23	Tyrosine-protein phosphatase non-receptor type 23	GO:0060271; P:cilium morphogenesis; IMP:UniProtKB
Q9H3S7	PTPN23	Tyrosine-protein phosphatase non-receptor type 23	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9H3S7	PTPN23	Tyrosine-protein phosphatase non-receptor type 23	GO:0030334; P:regulation of cell migration; IEA:InterPro
Q9H3S7	PTPN23	Tyrosine-protein phosphatase non-receptor type 23	GO:0043162; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; IMP:UniProtKB
P26045	PTPN3	Tyrosine-protein phosphatase non-receptor type 3	GO:0051117; F:ATPase binding; IPI:BHF-UCL
P26045	PTPN3	Tyrosine-protein phosphatase non-receptor type 3	GO:0001784; F:phosphotyrosine binding; IPI:BHF-UCL
P26045	PTPN3	Tyrosine-protein phosphatase non-receptor type 3	GO:0005515; F:protein binding; IPI:IntAct
P26045	PTPN3	Tyrosine-protein phosphatase non-receptor type 3	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
P26045	PTPN3	Tyrosine-protein phosphatase non-receptor type 3	GO:0051045; P:negative regulation of membrane protein ectodomain proteolysis; IMP:BHF-UCL
P26045	PTPN3	Tyrosine-protein phosphatase non-receptor type 3	GO:0045930; P:negative regulation of mitotic cell cycle; IDA:BHF-UCL
P26045	PTPN3	Tyrosine-protein phosphatase non-receptor type 3	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:GOC
P26045	PTPN3	Tyrosine-protein phosphatase non-receptor type 3	GO:0006470; P:protein dephosphorylation; IDA:BHF-UCL
P29074	PTPN4	Tyrosine-protein phosphatase non-receptor type 4	GO:0004726; F:non-membrane spanning protein tyrosine phosphatase activity; TAS:ProtInc
P29074	PTPN4	Tyrosine-protein phosphatase non-receptor type 4	GO:0005515; F:protein binding; IPI:IntAct
P29074	PTPN4	Tyrosine-protein phosphatase non-receptor type 4	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
P29074	PTPN4	Tyrosine-protein phosphatase non-receptor type 4	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
P54829	PTPN5	Tyrosine-protein phosphatase non-receptor type 5	GO:0001784; F:phosphotyrosine binding; IDA:UniProtKB
P54829	PTPN5	Tyrosine-protein phosphatase non-receptor type 5	GO:0004725; F:protein tyrosine phosphatase activity; IEA:Ensembl
P54829	PTPN5	Tyrosine-protein phosphatase non-receptor type 5	GO:0006470; P:protein dephosphorylation; TAS:UniProtKB
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0005515; F:protein binding; IPI:UniProtKB
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0004725; F:protein tyrosine phosphatase activity; TAS:Reactome
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; IDA:UniProtKB
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0006915; P:apoptotic process; TAS:ProtInc
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0050853; P:B cell receptor signaling pathway; IEA:Ensembl
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0007596; P:blood coagulation; TAS:Reactome
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0030154; P:cell differentiation; IDA:UniProtKB
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0008283; P:cell proliferation; IDA:UniProtKB
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0050900; P:leukocyte migration; TAS:Reactome
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0042267; P:natural killer cell mediated cytotoxicity; IEA:Ensembl
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0008285; P:negative regulation of cell proliferation; NAS:UniProtKB
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0002924; P:negative regulation of humoral immune response mediated by circulating immunoglobulin; IEA:Ensembl
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0043407; P:negative regulation of MAP kinase activity; IEA:Ensembl
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0050732; P:negative regulation of peptidyl-tyrosine phosphorylation; IMP:BHF-UCL
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0050860; P:negative regulation of T cell receptor signaling pathway; IEA:Ensembl
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0008284; P:positive regulation of cell proliferation; IMP:BHF-UCL
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IMP:BHF-UCL
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0006470; P:protein dephosphorylation; IDA:UniProtKB
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0045577; P:regulation of B cell differentiation; IEA:Ensembl
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0070372; P:regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; IMP:BHF-UCL
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; TAS:Reactome
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0031295; P:T cell costimulation; TAS:Reactome
P29350	PTPN6	Tyrosine-protein phosphatase non-receptor type 6	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P35236	PTPN7	Tyrosine-protein phosphatase non-receptor type 7	GO:0005515; F:protein binding; IPI:IntAct
P35236	PTPN7	Tyrosine-protein phosphatase non-receptor type 7	GO:0004725; F:protein tyrosine phosphatase activity; TAS:ProtInc
P35236	PTPN7	Tyrosine-protein phosphatase non-receptor type 7	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
P35236	PTPN7	Tyrosine-protein phosphatase non-receptor type 7	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
P43378	PTPN9	Tyrosine-protein phosphatase non-receptor type 9	GO:0004726; F:non-membrane spanning protein tyrosine phosphatase activity; TAS:ProtInc
P43378	PTPN9	Tyrosine-protein phosphatase non-receptor type 9	GO:0005515; F:protein binding; IPI:IntAct
P43378	PTPN9	Tyrosine-protein phosphatase non-receptor type 9	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
P43378	PTPN9	Tyrosine-protein phosphatase non-receptor type 9	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:GOC
P43378	PTPN9	Tyrosine-protein phosphatase non-receptor type 9	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
P21246	PTN	Pleiotrophin	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P21246	PTN	Pleiotrophin	GO:0004864; F:protein phosphatase inhibitor activity; TAS:ProtInc
P21246	PTN	Pleiotrophin	GO:0030282; P:bone mineralization; IEA:Ensembl
P21246	PTN	Pleiotrophin	GO:0007612; P:learning; IEA:Ensembl
P21246	PTN	Pleiotrophin	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
P21246	PTN	Pleiotrophin	GO:0007399; P:nervous system development; TAS:ProtInc
P21246	PTN	Pleiotrophin	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P21246	PTN	Pleiotrophin	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P21246	PTN	Pleiotrophin	GO:0007185; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; TAS:ProtInc
Q86YD1	PTOV1	Prostate tumor-overexpressed gene 1 protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q86YD1	PTOV1	Prostate tumor-overexpressed gene 1 protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15257	PPP2R4	Serine/threonine-protein phosphatase 2A activator	GO:0005524; F:ATP binding; IDA:HGNC
Q15257	PPP2R4	Serine/threonine-protein phosphatase 2A activator	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IBA:RefGenome
Q15257	PPP2R4	Serine/threonine-protein phosphatase 2A activator	GO:0046982; F:protein heterodimerization activity; TAS:HGNC
Q15257	PPP2R4	Serine/threonine-protein phosphatase 2A activator	GO:0042803; F:protein homodimerization activity; IDA:HGNC
Q15257	PPP2R4	Serine/threonine-protein phosphatase 2A activator	GO:0051721; F:protein phosphatase 2A binding; IDA:HGNC
Q15257	PPP2R4	Serine/threonine-protein phosphatase 2A activator	GO:0008601; F:protein phosphatase type 2A regulator activity; IDA:HGNC
Q15257	PPP2R4	Serine/threonine-protein phosphatase 2A activator	GO:0008160; F:protein tyrosine phosphatase activator activity; IDA:HGNC
Q15257	PPP2R4	Serine/threonine-protein phosphatase 2A activator	GO:0005102; F:receptor binding; IPI:BHF-UCL
Q15257	PPP2R4	Serine/threonine-protein phosphatase 2A activator	GO:0006200; P:ATP catabolic process; IDA:GOC
Q15257	PPP2R4	Serine/threonine-protein phosphatase 2A activator	GO:0030472; P:mitotic spindle organization in nucleus; IBA:RefGenome
Q15257	PPP2R4	Serine/threonine-protein phosphatase 2A activator	GO:0032515; P:negative regulation of phosphoprotein phosphatase activity; IDA:HGNC
Q15257	PPP2R4	Serine/threonine-protein phosphatase 2A activator	GO:0035308; P:negative regulation of protein dephosphorylation; IDA:HGNC
Q15257	PPP2R4	Serine/threonine-protein phosphatase 2A activator	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q15257	PPP2R4	Serine/threonine-protein phosphatase 2A activator	GO:0032516; P:positive regulation of phosphoprotein phosphatase activity; IDA:HGNC
Q15257	PPP2R4	Serine/threonine-protein phosphatase 2A activator	GO:0035307; P:positive regulation of protein dephosphorylation; IDA:HGNC
Q15257	PPP2R4	Serine/threonine-protein phosphatase 2A activator	GO:0006457; P:protein folding; IEA:UniProtKB-KW
Q15257	PPP2R4	Serine/threonine-protein phosphatase 2A activator	GO:0000413; P:protein peptidyl-prolyl isomerization; IBA:GOC
Q15257	PPP2R4	Serine/threonine-protein phosphatase 2A activator	GO:0043666; P:regulation of phosphoprotein phosphatase activity; IDA:HGNC
A2A3K4	PTPDC1	Protein tyrosine phosphatase domain-containing protein 1	GO:0004725; F:protein tyrosine phosphatase activity; IEA:InterPro
A2A3K4	PTPDC1	Protein tyrosine phosphatase domain-containing protein 1	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro
A2A3K4	PTPDC1	Protein tyrosine phosphatase domain-containing protein 1	GO:0060271; P:cilium morphogenesis; IEA:Ensembl
Q8WUK0	PTPMT1	Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1	GO:0008962; F:phosphatidylglycerophosphatase activity; ISS:UniProtKB
Q8WUK0	PTPMT1	Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1	GO:0004439; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; IBA:RefGenome
Q8WUK0	PTPMT1	Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q8WUK0	PTPMT1	Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q8WUK0	PTPMT1	Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1	GO:0032049; P:cardiolipin biosynthetic process; ISS:UniProtKB
Q8WUK0	PTPMT1	Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q8WUK0	PTPMT1	Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1	GO:0046855; P:inositol phosphate dephosphorylation; IBA:RefGenome
Q8WUK0	PTPMT1	Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1	GO:0006655; P:phosphatidylglycerol biosynthetic process; TAS:Reactome
Q8WUK0	PTPMT1	Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q8WUK0	PTPMT1	Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1	GO:0006470; P:protein dephosphorylation; IBA:RefGenome
Q8WUK0	PTPMT1	Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q92932	PTPRN2	Receptor-type tyrosine-protein phosphatase N2	GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; TAS:ProtInc
Q92932	PTPRN2	Receptor-type tyrosine-protein phosphatase N2	GO:0034260; P:negative regulation of GTPase activity; IEA:Ensembl
Q92932	PTPRN2	Receptor-type tyrosine-protein phosphatase N2	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
Q92932	PTPRN2	Receptor-type tyrosine-protein phosphatase N2	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
P18433	PTPRA	Receptor-type tyrosine-protein phosphatase alpha	GO:0005515; F:protein binding; IPI:IntAct
P18433	PTPRA	Receptor-type tyrosine-protein phosphatase alpha	GO:0004725; F:protein tyrosine phosphatase activity; TAS:ProtInc
P18433	PTPRA	Receptor-type tyrosine-protein phosphatase alpha	GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; TAS:ProtInc
P18433	PTPRA	Receptor-type tyrosine-protein phosphatase alpha	GO:0007411; P:axon guidance; TAS:Reactome
P18433	PTPRA	Receptor-type tyrosine-protein phosphatase alpha	GO:0008286; P:insulin receptor signaling pathway; IEA:Ensembl
P18433	PTPRA	Receptor-type tyrosine-protein phosphatase alpha	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
P18433	PTPRA	Receptor-type tyrosine-protein phosphatase alpha	GO:0006468; P:protein phosphorylation; IEA:Ensembl
P23467	PTPRB	Receptor-type tyrosine-protein phosphatase beta	GO:0005515; F:protein binding; IPI:UniProtKB
P23467	PTPRB	Receptor-type tyrosine-protein phosphatase beta	GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; TAS:ProtInc
P23467	PTPRB	Receptor-type tyrosine-protein phosphatase beta	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P23467	PTPRB	Receptor-type tyrosine-protein phosphatase beta	GO:0016311; P:dephosphorylation; IDA:UniProtKB
P23467	PTPRB	Receptor-type tyrosine-protein phosphatase beta	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
P23467	PTPRB	Receptor-type tyrosine-protein phosphatase beta	GO:0006796; P:phosphate-containing compound metabolic process; TAS:ProtInc
P23467	PTPRB	Receptor-type tyrosine-protein phosphatase beta	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0005515; F:protein binding; IPI:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; TAS:ProtInc
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0007411; P:axon guidance; TAS:Reactome
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0042100; P:B cell proliferation; ISS:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0050853; P:B cell receptor signaling pathway; ISS:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0048539; P:bone marrow development; IMP:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0044770; P:cell cycle phase transition; IMP:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0051607; P:defense response to virus; ISS:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0016311; P:dephosphorylation; ISS:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0002244; P:hematopoietic progenitor cell differentiation; IMP:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0002378; P:immunoglobulin biosynthetic process; IMP:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0006933; P:negative regulation of cell adhesion involved in substrate-bound cell migration; IMP:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0001960; P:negative regulation of cytokine-mediated signaling pathway; ISS:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0006469; P:negative regulation of protein kinase activity; IDA:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0001915; P:negative regulation of T cell mediated cytotoxicity; ISS:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:GOC
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0050857; P:positive regulation of antigen receptor-mediated signaling pathway; ISS:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0030890; P:positive regulation of B cell proliferation; IMP:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:2000473; P:positive regulation of hematopoietic stem cell migration; IMP:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0045860; P:positive regulation of protein kinase activity; NAS:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:2000648; P:positive regulation of stem cell proliferation; IMP:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0042102; P:positive regulation of T cell proliferation; ISS:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0006470; P:protein dephosphorylation; ISS:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0051726; P:regulation of cell cycle; ISS:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0051209; P:release of sequestered calcium ion into cytosol; ISS:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0048864; P:stem cell development; IMP:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0030217; P:T cell differentiation; ISS:UniProtKB
P08575	PTPRC	Receptor-type tyrosine-protein phosphatase C	GO:0050852; P:T cell receptor signaling pathway; IDA:UniProtKB
P23468	PTPRD	Receptor-type tyrosine-protein phosphatase delta	GO:0050839; F:cell adhesion molecule binding; ISS:BHF-UCL
P23468	PTPRD	Receptor-type tyrosine-protein phosphatase delta	GO:0005515; F:protein binding; IPI:UniProtKB
P23468	PTPRD	Receptor-type tyrosine-protein phosphatase delta	GO:0005102; F:receptor binding; ISS:BHF-UCL
P23468	PTPRD	Receptor-type tyrosine-protein phosphatase delta	GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; TAS:ProtInc
P23468	PTPRD	Receptor-type tyrosine-protein phosphatase delta	GO:0007157; P:heterophilic cell-cell adhesion; ISS:BHF-UCL
P23468	PTPRD	Receptor-type tyrosine-protein phosphatase delta	GO:0030182; P:neuron differentiation; ISS:BHF-UCL
P23468	PTPRD	Receptor-type tyrosine-protein phosphatase delta	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
P23468	PTPRD	Receptor-type tyrosine-protein phosphatase delta	GO:0006796; P:phosphate-containing compound metabolic process; NAS:ProtInc
P23468	PTPRD	Receptor-type tyrosine-protein phosphatase delta	GO:0050775; P:positive regulation of dendrite morphogenesis; ISS:BHF-UCL
P23468	PTPRD	Receptor-type tyrosine-protein phosphatase delta	GO:0097105; P:presynaptic membrane assembly; ISS:BHF-UCL
P23468	PTPRD	Receptor-type tyrosine-protein phosphatase delta	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
P23468	PTPRD	Receptor-type tyrosine-protein phosphatase delta	GO:0007185; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; TAS:ProtInc
P23469	PTPRE	Receptor-type tyrosine-protein phosphatase epsilon	GO:0005515; F:protein binding; IPI:UniProtKB
P23469	PTPRE	Receptor-type tyrosine-protein phosphatase epsilon	GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; TAS:ProtInc
P23469	PTPRE	Receptor-type tyrosine-protein phosphatase epsilon	GO:0046627; P:negative regulation of insulin receptor signaling pathway; ISS:UniProtKB
P23469	PTPRE	Receptor-type tyrosine-protein phosphatase epsilon	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
P23469	PTPRE	Receptor-type tyrosine-protein phosphatase epsilon	GO:0033003; P:regulation of mast cell activation; IEA:Ensembl
P23469	PTPRE	Receptor-type tyrosine-protein phosphatase epsilon	GO:0007185; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; IEA:Ensembl
P10586	PTPRF	Receptor-type tyrosine-protein phosphatase F	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P10586	PTPRF	Receptor-type tyrosine-protein phosphatase F	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
P10586	PTPRF	Receptor-type tyrosine-protein phosphatase F	GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; TAS:ProtInc
P10586	PTPRF	Receptor-type tyrosine-protein phosphatase F	GO:0007155; P:cell adhesion; TAS:ProtInc
P10586	PTPRF	Receptor-type tyrosine-protein phosphatase F	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:GOC
P10586	PTPRF	Receptor-type tyrosine-protein phosphatase F	GO:0007185; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; TAS:ProtInc
P23470	PTPRG	Receptor-type tyrosine-protein phosphatase gamma	GO:0042802; F:identical protein binding; IPI:UniProtKB
P23470	PTPRG	Receptor-type tyrosine-protein phosphatase gamma	GO:0005515; F:protein binding; IPI:IntAct
P23470	PTPRG	Receptor-type tyrosine-protein phosphatase gamma	GO:0004725; F:protein tyrosine phosphatase activity; IEA:InterPro
P23470	PTPRG	Receptor-type tyrosine-protein phosphatase gamma	GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; TAS:ProtInc
P23470	PTPRG	Receptor-type tyrosine-protein phosphatase gamma	GO:0007420; P:brain development; IEA:Ensembl
P23470	PTPRG	Receptor-type tyrosine-protein phosphatase gamma	GO:0010977; P:negative regulation of neuron projection development; IEA:Ensembl
P23470	PTPRG	Receptor-type tyrosine-protein phosphatase gamma	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:GOC
P23470	PTPRG	Receptor-type tyrosine-protein phosphatase gamma	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc
Q9HD43	PTPRH	Receptor-type tyrosine-protein phosphatase H	GO:0005515; F:protein binding; IPI:IntAct
Q9HD43	PTPRH	Receptor-type tyrosine-protein phosphatase H	GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; TAS:ProtInc
Q9HD43	PTPRH	Receptor-type tyrosine-protein phosphatase H	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9HD43	PTPRH	Receptor-type tyrosine-protein phosphatase H	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
Q9HD43	PTPRH	Receptor-type tyrosine-protein phosphatase H	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0008013; F:beta-catenin binding; IPI:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0070097; F:delta-catenin binding; IPI:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0045295; F:gamma-catenin binding; IPI:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0051019; F:mitogen-activated protein kinase binding; IPI:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0016791; F:phosphatase activity; IDA:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0005161; F:platelet-derived growth factor receptor binding; IPI:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0005515; F:protein binding; IPI:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0007596; P:blood coagulation; IEA:Ensembl
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0060242; P:contact inhibition; NAS:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0007507; P:heart development; IEA:Ensembl
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; IMP:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0043407; P:negative regulation of MAP kinase activity; IDA:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0010642; P:negative regulation of platelet-derived growth factor receptor signaling pathway; IDA:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0051898; P:negative regulation of protein kinase B signaling; IMP:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:2000272; P:negative regulation of receptor activity; IEA:Ensembl
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0050860; P:negative regulation of T cell receptor signaling pathway; IDA:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0043116; P:negative regulation of vascular permeability; IDA:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IMP:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0050918; P:positive chemotaxis; IDA:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0045785; P:positive regulation of cell adhesion; IMP:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0051894; P:positive regulation of focal adhesion assembly; IMP:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0010759; P:positive regulation of macrophage chemotaxis; IEA:Ensembl
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0010572; P:positive regulation of platelet activation; IEA:Ensembl
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0051897; P:positive regulation of protein kinase B signaling; IMP:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0030155; P:regulation of cell adhesion; IMP:UniProtKB
Q12913	PTPRJ	Receptor-type tyrosine-protein phosphatase eta	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0008013; F:beta-catenin binding; IPI:UniProtKB
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0045295; F:gamma-catenin binding; IPI:UniProtKB
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0005515; F:protein binding; IPI:UniProtKB
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; NAS:UniProtKB
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0007155; P:cell adhesion; IMP:UniProtKB
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0016477; P:cell migration; IMP:UniProtKB
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0034614; P:cellular response to reactive oxygen species; IDA:UniProtKB
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0034644; P:cellular response to UV; IDA:UniProtKB
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0048041; P:focal adhesion assembly; IMP:UniProtKB
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0045786; P:negative regulation of cell cycle; IDA:UniProtKB
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0010839; P:negative regulation of keratinocyte proliferation; IDA:UniProtKB
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0031175; P:neuron projection development; IEA:Ensembl
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0006470; P:protein dephosphorylation; IDA:UniProtKB
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0034394; P:protein localization to cell surface; IDA:UniProtKB
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0007165; P:signal transduction; IDA:UniProtKB
Q15262	PTPRK	Receptor-type tyrosine-protein phosphatase kappa	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
Q16849	PTPRN	Receptor-type tyrosine-protein phosphatase-like N	GO:0005515; F:protein binding; IPI:IntAct
Q16849	PTPRN	Receptor-type tyrosine-protein phosphatase-like N	GO:0030507; F:spectrin binding; IPI:BHF-UCL
Q16849	PTPRN	Receptor-type tyrosine-protein phosphatase-like N	GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; TAS:ProtInc
Q16849	PTPRN	Receptor-type tyrosine-protein phosphatase-like N	GO:0019221; P:cytokine-mediated signaling pathway; IEA:Ensembl
Q16849	PTPRN	Receptor-type tyrosine-protein phosphatase-like N	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
Q16849	PTPRN	Receptor-type tyrosine-protein phosphatase-like N	GO:0051591; P:response to cAMP; IEA:Ensembl
Q16849	PTPRN	Receptor-type tyrosine-protein phosphatase-like N	GO:0043627; P:response to estrogen; IEA:Ensembl
Q16849	PTPRN	Receptor-type tyrosine-protein phosphatase-like N	GO:0009749; P:response to glucose; IEA:Ensembl
Q16849	PTPRN	Receptor-type tyrosine-protein phosphatase-like N	GO:0032868; P:response to insulin; IEA:Ensembl
Q16849	PTPRN	Receptor-type tyrosine-protein phosphatase-like N	GO:0000302; P:response to reactive oxygen species; IDA:UniProtKB
P28827	PTPRM	Receptor-type tyrosine-protein phosphatase mu	GO:0045296; F:cadherin binding; IDA:UniProtKB
P28827	PTPRM	Receptor-type tyrosine-protein phosphatase mu	GO:0042802; F:identical protein binding; IPI:IntAct
P28827	PTPRM	Receptor-type tyrosine-protein phosphatase mu	GO:0005515; F:protein binding; IPI:UniProtKB
P28827	PTPRM	Receptor-type tyrosine-protein phosphatase mu	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
P28827	PTPRM	Receptor-type tyrosine-protein phosphatase mu	GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; IDA:UniProtKB
P28827	PTPRM	Receptor-type tyrosine-protein phosphatase mu	GO:0007156; P:homophilic cell adhesion; IDA:UniProtKB
P28827	PTPRM	Receptor-type tyrosine-protein phosphatase mu	GO:0016525; P:negative regulation of angiogenesis; IMP:UniProtKB
P28827	PTPRM	Receptor-type tyrosine-protein phosphatase mu	GO:0010596; P:negative regulation of endothelial cell migration; IMP:UniProtKB
P28827	PTPRM	Receptor-type tyrosine-protein phosphatase mu	GO:0001937; P:negative regulation of endothelial cell proliferation; IMP:UniProtKB
P28827	PTPRM	Receptor-type tyrosine-protein phosphatase mu	GO:0031175; P:neuron projection development; IDA:UniProtKB
P28827	PTPRM	Receptor-type tyrosine-protein phosphatase mu	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:GOC
P28827	PTPRM	Receptor-type tyrosine-protein phosphatase mu	GO:0045909; P:positive regulation of vasodilation; IEA:Ensembl
P28827	PTPRM	Receptor-type tyrosine-protein phosphatase mu	GO:0006470; P:protein dephosphorylation; IDA:UniProtKB
P28827	PTPRM	Receptor-type tyrosine-protein phosphatase mu	GO:0042493; P:response to drug; IDA:UniProtKB
P28827	PTPRM	Receptor-type tyrosine-protein phosphatase mu	GO:0010842; P:retina layer formation; IMP:UniProtKB
P28827	PTPRM	Receptor-type tyrosine-protein phosphatase mu	GO:0031290; P:retinal ganglion cell axon guidance; IDA:UniProtKB
P28827	PTPRM	Receptor-type tyrosine-protein phosphatase mu	GO:0007165; P:signal transduction; IDA:UniProtKB
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0016791; F:phosphatase activity; ISS:UniProtKB
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0005515; F:protein binding; IPI:IntAct
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; NAS:UniProtKB
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0017147; F:Wnt-protein binding; ISS:UniProtKB
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0007411; P:axon guidance; ISS:UniProtKB
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0000902; P:cell morphogenesis; ISS:UniProtKB
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0072112; P:glomerular visceral epithelial cell differentiation; ISS:UniProtKB
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0032835; P:glomerulus development; IMP:UniProtKB
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0030032; P:lamellipodium assembly; ISS:UniProtKB
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0002548; P:monocyte chemotaxis; IMP:UniProtKB
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISS:UniProtKB
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0010812; P:negative regulation of cell-substrate adhesion; ISS:UniProtKB
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0003105; P:negative regulation of glomerular filtration; ISS:UniProtKB
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0010977; P:negative regulation of neuron projection development; ISS:UniProtKB
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0090260; P:negative regulation of retinal ganglion cell axon guidance; ISS:UniProtKB
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IMP:UniProtKB
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0006470; P:protein dephosphorylation; ISS:UniProtKB
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0003093; P:regulation of glomerular filtration; ISS:UniProtKB
Q16827	PTPRO	Receptor-type tyrosine-protein phosphatase O	GO:0036060; P:slit diaphragm assembly; ISS:UniProtKB
Q9UMZ3	PTPRQ	Phosphatidylinositol phosphatase PTPRQ	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q9UMZ3	PTPRQ	Phosphatidylinositol phosphatase PTPRQ	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q9UMZ3	PTPRQ	Phosphatidylinositol phosphatase PTPRQ	GO:0045598; P:regulation of fat cell differentiation; IDA:UniProtKB
Q15256	PTPRR	Receptor-type tyrosine-protein phosphatase R	GO:0005515; F:protein binding; IPI:IntAct
Q15256	PTPRR	Receptor-type tyrosine-protein phosphatase R	GO:0019901; F:protein kinase binding; ISS:UniProtKB
Q15256	PTPRR	Receptor-type tyrosine-protein phosphatase R	GO:0004725; F:protein tyrosine phosphatase activity; TAS:ProtInc
Q15256	PTPRR	Receptor-type tyrosine-protein phosphatase R	GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; TAS:ProtInc
Q15256	PTPRR	Receptor-type tyrosine-protein phosphatase R	GO:0001701; P:in utero embryonic development; IEP:UniProtKB
Q15256	PTPRR	Receptor-type tyrosine-protein phosphatase R	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
Q13332	PTPRS	Receptor-type tyrosine-protein phosphatase S	GO:0005515; F:protein binding; IPI:IntAct
Q13332	PTPRS	Receptor-type tyrosine-protein phosphatase S	GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; TAS:ProtInc
Q13332	PTPRS	Receptor-type tyrosine-protein phosphatase S	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q13332	PTPRS	Receptor-type tyrosine-protein phosphatase S	GO:0021549; P:cerebellum development; IEA:Ensembl
Q13332	PTPRS	Receptor-type tyrosine-protein phosphatase S	GO:0021987; P:cerebral cortex development; IEA:Ensembl
Q13332	PTPRS	Receptor-type tyrosine-protein phosphatase S	GO:0022038; P:corpus callosum development; IEA:Ensembl
Q13332	PTPRS	Receptor-type tyrosine-protein phosphatase S	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q13332	PTPRS	Receptor-type tyrosine-protein phosphatase S	GO:0021766; P:hippocampus development; IEA:Ensembl
Q13332	PTPRS	Receptor-type tyrosine-protein phosphatase S	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
Q13332	PTPRS	Receptor-type tyrosine-protein phosphatase S	GO:0021510; P:spinal cord development; IEA:Ensembl
O14522	PTPRT	Receptor-type tyrosine-protein phosphatase T	GO:0045294; F:alpha-catenin binding; IDA:UniProtKB
O14522	PTPRT	Receptor-type tyrosine-protein phosphatase T	GO:0008013; F:beta-catenin binding; IPI:UniProtKB
O14522	PTPRT	Receptor-type tyrosine-protein phosphatase T	GO:0045296; F:cadherin binding; IPI:UniProtKB
O14522	PTPRT	Receptor-type tyrosine-protein phosphatase T	GO:0070097; F:delta-catenin binding; IPI:UniProtKB
O14522	PTPRT	Receptor-type tyrosine-protein phosphatase T	GO:0045295; F:gamma-catenin binding; IDA:UniProtKB
O14522	PTPRT	Receptor-type tyrosine-protein phosphatase T	GO:0005515; F:protein binding; IPI:IntAct
O14522	PTPRT	Receptor-type tyrosine-protein phosphatase T	GO:0004725; F:protein tyrosine phosphatase activity; IMP:UniProtKB
O14522	PTPRT	Receptor-type tyrosine-protein phosphatase T	GO:0016790; F:thiolester hydrolase activity; IEA:Ensembl
O14522	PTPRT	Receptor-type tyrosine-protein phosphatase T	GO:0007155; P:cell adhesion; NAS:UniProtKB
O14522	PTPRT	Receptor-type tyrosine-protein phosphatase T	GO:0007156; P:homophilic cell adhesion; IDA:UniProtKB
O14522	PTPRT	Receptor-type tyrosine-protein phosphatase T	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IMP:GOC
O14522	PTPRT	Receptor-type tyrosine-protein phosphatase T	GO:0006470; P:protein dephosphorylation; IDA:UniProtKB
O14522	PTPRT	Receptor-type tyrosine-protein phosphatase T	GO:0007165; P:signal transduction; NAS:UniProtKB
O14522	PTPRT	Receptor-type tyrosine-protein phosphatase T	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IMP:UniProtKB
Q92729	PTPRU	Receptor-type tyrosine-protein phosphatase U	GO:0008013; F:beta-catenin binding; IPI:UniProtKB
Q92729	PTPRU	Receptor-type tyrosine-protein phosphatase U	GO:0005515; F:protein binding; IPI:UniProtKB
Q92729	PTPRU	Receptor-type tyrosine-protein phosphatase U	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
Q92729	PTPRU	Receptor-type tyrosine-protein phosphatase U	GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; NAS:UniProtKB
Q92729	PTPRU	Receptor-type tyrosine-protein phosphatase U	GO:0060070; P:canonical Wnt signaling pathway; IDA:UniProtKB
Q92729	PTPRU	Receptor-type tyrosine-protein phosphatase U	GO:0007155; P:cell adhesion; NAS:UniProtKB
Q92729	PTPRU	Receptor-type tyrosine-protein phosphatase U	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q92729	PTPRU	Receptor-type tyrosine-protein phosphatase U	GO:0016337; P:single organismal cell-cell adhesion; IDA:UniProtKB
Q92729	PTPRU	Receptor-type tyrosine-protein phosphatase U	GO:0034109; P:homotypic cell-cell adhesion; IEA:Ensembl
Q92729	PTPRU	Receptor-type tyrosine-protein phosphatase U	GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB
Q92729	PTPRU	Receptor-type tyrosine-protein phosphatase U	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q92729	PTPRU	Receptor-type tyrosine-protein phosphatase U	GO:0031100; P:organ regeneration; IEA:Ensembl
Q92729	PTPRU	Receptor-type tyrosine-protein phosphatase U	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:GOC
Q92729	PTPRU	Receptor-type tyrosine-protein phosphatase U	GO:0006470; P:protein dephosphorylation; IDA:UniProtKB
Q92729	PTPRU	Receptor-type tyrosine-protein phosphatase U	GO:0034394; P:protein localization to cell surface; IDA:UniProtKB
Q92729	PTPRU	Receptor-type tyrosine-protein phosphatase U	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
Q92729	PTPRU	Receptor-type tyrosine-protein phosphatase U	GO:0007185; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; NAS:UniProtKB
P23471	PTPRZ1	Receptor-type tyrosine-protein phosphatase zeta	GO:0005515; F:protein binding; IPI:IntAct
P23471	PTPRZ1	Receptor-type tyrosine-protein phosphatase zeta	GO:0004725; F:protein tyrosine phosphatase activity; ISS:UniProtKB
P23471	PTPRZ1	Receptor-type tyrosine-protein phosphatase zeta	GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; TAS:ProtInc
P23471	PTPRZ1	Receptor-type tyrosine-protein phosphatase zeta	GO:0007409; P:axonogenesis; IEA:Ensembl
P23471	PTPRZ1	Receptor-type tyrosine-protein phosphatase zeta	GO:0007417; P:central nervous system development; TAS:ProtInc
P23471	PTPRZ1	Receptor-type tyrosine-protein phosphatase zeta	GO:0007611; P:learning or memory; ISS:UniProtKB
P23471	PTPRZ1	Receptor-type tyrosine-protein phosphatase zeta	GO:0048709; P:oligodendrocyte differentiation; ISS:UniProtKB
P23471	PTPRZ1	Receptor-type tyrosine-protein phosphatase zeta	GO:0035335; P:peptidyl-tyrosine dephosphorylation; ISS:UniProtKB
P23471	PTPRZ1	Receptor-type tyrosine-protein phosphatase zeta	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
P23471	PTPRZ1	Receptor-type tyrosine-protein phosphatase zeta	GO:0070445; P:regulation of oligodendrocyte progenitor proliferation; ISS:UniProtKB
Q03393	PTS	6-pyruvoyl tetrahydrobiopterin synthase	GO:0003874; F:6-pyruvoyltetrahydropterin synthase activity; TAS:Reactome
Q03393	PTS	6-pyruvoyl tetrahydrobiopterin synthase	GO:0042802; F:identical protein binding; IPI:IntAct
Q03393	PTS	6-pyruvoyl tetrahydrobiopterin synthase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q03393	PTS	6-pyruvoyl tetrahydrobiopterin synthase	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
Q03393	PTS	6-pyruvoyl tetrahydrobiopterin synthase	GO:0007417; P:central nervous system development; TAS:ProtInc
Q03393	PTS	6-pyruvoyl tetrahydrobiopterin synthase	GO:0046209; P:nitric oxide metabolic process; TAS:Reactome
Q03393	PTS	6-pyruvoyl tetrahydrobiopterin synthase	GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome
Q03393	PTS	6-pyruvoyl tetrahydrobiopterin synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q03393	PTS	6-pyruvoyl tetrahydrobiopterin synthase	GO:0006729; P:tetrahydrobiopterin biosynthetic process; TAS:ProtInc
Q6GMV3	PTRHD1	Putative peptidyl-tRNA hydrolase PTRHD1	GO:0004045; F:aminoacyl-tRNA hydrolase activity; IEA:UniProtKB-EC
Q6GMV3	PTRHD1	Putative peptidyl-tRNA hydrolase PTRHD1	GO:0004725; F:protein tyrosine phosphatase activity; IEA:InterPro
Q6NZI2	PTRF	Polymerase I and transcript release factor	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6NZI2	PTRF	Polymerase I and transcript release factor	GO:0005515; F:protein binding; IPI:UniProtKB
Q6NZI2	PTRF	Polymerase I and transcript release factor	GO:0042134; F:rRNA primary transcript binding; IDA:UniProtKB
Q6NZI2	PTRF	Polymerase I and transcript release factor	GO:0010467; P:gene expression; TAS:Reactome
Q6NZI2	PTRF	Polymerase I and transcript release factor	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6NZI2	PTRF	Polymerase I and transcript release factor	GO:0006363; P:termination of RNA polymerase I transcription; IDA:UniProtKB
Q6NZI2	PTRF	Polymerase I and transcript release factor	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
Q6NZI2	PTRF	Polymerase I and transcript release factor	GO:0006361; P:transcription initiation from RNA polymerase I promoter; IDA:UniProtKB
P48651	PTDSS1	Phosphatidylserine synthase 1	GO:0016740; F:transferase activity; IEA:UniProtKB-KW
P48651	PTDSS1	Phosphatidylserine synthase 1	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
P48651	PTDSS1	Phosphatidylserine synthase 1	GO:0006659; P:phosphatidylserine biosynthetic process; TAS:Reactome
P48651	PTDSS1	Phosphatidylserine synthase 1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
P48651	PTDSS1	Phosphatidylserine synthase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BVG9	PTDSS2	Phosphatidylserine synthase 2	GO:0003882; F:CDP-diacylglycerol-serine O-phosphatidyltransferase activity; IEA:Ensembl
Q9BVG9	PTDSS2	Phosphatidylserine synthase 2	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q9BVG9	PTDSS2	Phosphatidylserine synthase 2	GO:0006659; P:phosphatidylserine biosynthetic process; TAS:Reactome
Q9BVG9	PTDSS2	Phosphatidylserine synthase 2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9BVG9	PTDSS2	Phosphatidylserine synthase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95997	PTTG1	Securin	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; NAS:UniProtKB
O95997	PTTG1	Securin	GO:0005515; F:protein binding; IPI:UniProtKB
O95997	PTTG1	Securin	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O95997	PTTG1	Securin	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
O95997	PTTG1	Securin	GO:0051276; P:chromosome organization; IEA:InterPro
O95997	PTTG1	Securin	GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW
O95997	PTTG1	Securin	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
O95997	PTTG1	Securin	GO:0007067; P:mitosis; IEA:UniProtKB-KW
O95997	PTTG1	Securin	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O95997	PTTG1	Securin	GO:0010951; P:negative regulation of endopeptidase activity; NAS:GOC
O95997	PTTG1	Securin	GO:0006355; P:regulation of transcription, DNA-templated; TAS:GOC
O95997	PTTG1	Securin	GO:0007283; P:spermatogenesis; TAS:ProtInc
O95997	PTTG1	Securin	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9NZH4	PTTG3P	Putative pituitary tumor-transforming gene 3 protein	GO:0051276; P:chromosome organization; IEA:InterPro
Q9NZH4	PTTG3P	Putative pituitary tumor-transforming gene 3 protein	GO:0006259; P:DNA metabolic process; IEA:InterPro
Q9NZH5	PTTG2	Securin-2	GO:0051276; P:chromosome organization; IEA:InterPro
Q9NZH5	PTTG2	Securin-2	GO:0006259; P:DNA metabolic process; IEA:InterPro
P53801	PTTG1IP	Pituitary tumor-transforming gene 1 protein-interacting protein	GO:0004872; F:receptor activity; IEA:InterPro
P53801	PTTG1IP	Pituitary tumor-transforming gene 1 protein-interacting protein	GO:0007275; P:multicellular organismal development; IEA:InterPro
P53801	PTTG1IP	Pituitary tumor-transforming gene 1 protein-interacting protein	GO:0006606; P:protein import into nucleus; IDA:UniProtKB
P26022	PTX3	Pentraxin-related protein PTX3	GO:0001872; F:(1->3)-beta-D-glucan binding; IEA:Ensembl
P26022	PTX3	Pentraxin-related protein PTX3	GO:0006954; P:inflammatory response; TAS:ProtInc
P26022	PTX3	Pentraxin-related protein PTX3	GO:0008228; P:opsonization; IEA:Ensembl
P26022	PTX3	Pentraxin-related protein PTX3	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IEA:Ensembl
P26022	PTX3	Pentraxin-related protein PTX3	GO:0050766; P:positive regulation of phagocytosis; IEA:Ensembl
P26022	PTX3	Pentraxin-related protein PTX3	GO:0001878; P:response to yeast; IEA:Ensembl
Q96A99	PTX4	Pentraxin-4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UHX1	PUF60	Poly(U)-binding-splicing factor PUF60	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UHX1	PUF60	Poly(U)-binding-splicing factor PUF60	GO:0042802; F:identical protein binding; IPI:IntAct
Q9UHX1	PUF60	Poly(U)-binding-splicing factor PUF60	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9UHX1	PUF60	Poly(U)-binding-splicing factor PUF60	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UHX1	PUF60	Poly(U)-binding-splicing factor PUF60	GO:0005515; F:protein binding; IPI:IntAct
Q9UHX1	PUF60	Poly(U)-binding-splicing factor PUF60	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9UHX1	PUF60	Poly(U)-binding-splicing factor PUF60	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9UHX1	PUF60	Poly(U)-binding-splicing factor PUF60	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UHX1	PUF60	Poly(U)-binding-splicing factor PUF60	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q9UHX1	PUF60	Poly(U)-binding-splicing factor PUF60	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14671	PUM1	Pumilio homolog 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14671	PUM1	Pumilio homolog 1	GO:0061024; P:membrane organization; TAS:Reactome
Q14671	PUM1	Pumilio homolog 1	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
Q14671	PUM1	Pumilio homolog 1	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q8TB72	PUM2	Pumilio homolog 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8TB72	PUM2	Pumilio homolog 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TB72	PUM2	Pumilio homolog 2	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q8TB72	PUM2	Pumilio homolog 2	GO:0034063; P:stress granule assembly; IEA:Ensembl
Q06203	PPAT	Amidophosphoribosyltransferase	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
Q06203	PPAT	Amidophosphoribosyltransferase	GO:0004044; F:amidophosphoribosyltransferase activity; TAS:ProtInc
Q06203	PPAT	Amidophosphoribosyltransferase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q06203	PPAT	Amidophosphoribosyltransferase	GO:0006189; P:'de novo' IMP biosynthetic process; IEA:UniProtKB-UniPathway
Q06203	PPAT	Amidophosphoribosyltransferase	GO:0035690; P:cellular response to drug; IEA:Ensembl
Q06203	PPAT	Amidophosphoribosyltransferase	GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl
Q06203	PPAT	Amidophosphoribosyltransferase	GO:0000082; P:G1/S transition of mitotic cell cycle; IEA:Ensembl
Q06203	PPAT	Amidophosphoribosyltransferase	GO:0006543; P:glutamine catabolic process; IEA:Ensembl
Q06203	PPAT	Amidophosphoribosyltransferase	GO:0001822; P:kidney development; IEA:Ensembl
Q06203	PPAT	Amidophosphoribosyltransferase	GO:0007595; P:lactation; IEA:Ensembl
Q06203	PPAT	Amidophosphoribosyltransferase	GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
Q06203	PPAT	Amidophosphoribosyltransferase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q06203	PPAT	Amidophosphoribosyltransferase	GO:0009116; P:nucleoside metabolic process; IEA:InterPro
Q06203	PPAT	Amidophosphoribosyltransferase	GO:0031100; P:organ regeneration; IEA:Ensembl
Q06203	PPAT	Amidophosphoribosyltransferase	GO:0051289; P:protein homotetramerization; IEA:Ensembl
Q06203	PPAT	Amidophosphoribosyltransferase	GO:0009113; P:purine nucleobase biosynthetic process; IEA:InterPro
Q06203	PPAT	Amidophosphoribosyltransferase	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
Q06203	PPAT	Amidophosphoribosyltransferase	GO:0006164; P:purine nucleotide biosynthetic process; TAS:ProtInc
Q06203	PPAT	Amidophosphoribosyltransferase	GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome
Q06203	PPAT	Amidophosphoribosyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P22102	GART	Trifunctional purine biosynthetic protein adenosine-3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P22102	GART	Trifunctional purine biosynthetic protein adenosine-3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P22102	GART	Trifunctional purine biosynthetic protein adenosine-3	GO:0008168; F:methyltransferase activity; IEA:InterPro
P22102	GART	Trifunctional purine biosynthetic protein adenosine-3	GO:0004637; F:phosphoribosylamine-glycine ligase activity; IEA:UniProtKB-EC
P22102	GART	Trifunctional purine biosynthetic protein adenosine-3	GO:0004641; F:phosphoribosylformylglycinamidine cyclo-ligase activity; IEA:UniProtKB-EC
P22102	GART	Trifunctional purine biosynthetic protein adenosine-3	GO:0004644; F:phosphoribosylglycinamide formyltransferase activity; TAS:ProtInc
P22102	GART	Trifunctional purine biosynthetic protein adenosine-3	GO:0006189; P:'de novo' IMP biosynthetic process; IEA:UniProtKB-UniPathway
P22102	GART	Trifunctional purine biosynthetic protein adenosine-3	GO:0003360; P:brainstem development; IEA:Ensembl
P22102	GART	Trifunctional purine biosynthetic protein adenosine-3	GO:0021549; P:cerebellum development; IEA:Ensembl
P22102	GART	Trifunctional purine biosynthetic protein adenosine-3	GO:0021987; P:cerebral cortex development; IEA:Ensembl
P22102	GART	Trifunctional purine biosynthetic protein adenosine-3	GO:0006544; P:glycine metabolic process; IEA:Ensembl
P22102	GART	Trifunctional purine biosynthetic protein adenosine-3	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P22102	GART	Trifunctional purine biosynthetic protein adenosine-3	GO:0009113; P:purine nucleobase biosynthetic process; IEA:InterPro
P22102	GART	Trifunctional purine biosynthetic protein adenosine-3	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P22102	GART	Trifunctional purine biosynthetic protein adenosine-3	GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome
P22102	GART	Trifunctional purine biosynthetic protein adenosine-3	GO:0010035; P:response to inorganic substance; IEA:Ensembl
P22102	GART	Trifunctional purine biosynthetic protein adenosine-3	GO:0010033; P:response to organic substance; IEA:Ensembl
P22102	GART	Trifunctional purine biosynthetic protein adenosine-3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P22102	GART	Trifunctional purine biosynthetic protein adenosine-3	GO:0046654; P:tetrahydrofolate biosynthetic process; IEA:Ensembl
O15067	PFAS	Phosphoribosylformylglycinamidine synthase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O15067	PFAS	Phosphoribosylformylglycinamidine synthase	GO:0004642; F:phosphoribosylformylglycinamidine synthase activity; IDA:UniProtKB
O15067	PFAS	Phosphoribosylformylglycinamidine synthase	GO:0006189; P:'de novo' IMP biosynthetic process; NAS:UniProtKB
O15067	PFAS	Phosphoribosylformylglycinamidine synthase	GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW
O15067	PFAS	Phosphoribosylformylglycinamidine synthase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
O15067	PFAS	Phosphoribosylformylglycinamidine synthase	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
O15067	PFAS	Phosphoribosylformylglycinamidine synthase	GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome
O15067	PFAS	Phosphoribosylformylglycinamidine synthase	GO:0042493; P:response to drug; IEA:Ensembl
O15067	PFAS	Phosphoribosylformylglycinamidine synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P22234	PAICS	Multifunctional protein ADE2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P22234	PAICS	Multifunctional protein ADE2	GO:0042802; F:identical protein binding; IPI:IntAct
P22234	PAICS	Multifunctional protein ADE2	GO:0004638; F:phosphoribosylaminoimidazole carboxylase activity; TAS:Reactome
P22234	PAICS	Multifunctional protein ADE2	GO:0004639; F:phosphoribosylaminoimidazolesuccinocarboxamide synthase activity; TAS:Reactome
P22234	PAICS	Multifunctional protein ADE2	GO:0005515; F:protein binding; IPI:IntAct
P22234	PAICS	Multifunctional protein ADE2	GO:0006189; P:'de novo' IMP biosynthetic process; IEA:UniProtKB-UniPathway
P22234	PAICS	Multifunctional protein ADE2	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P22234	PAICS	Multifunctional protein ADE2	GO:0009113; P:purine nucleobase biosynthetic process; TAS:ProtInc
P22234	PAICS	Multifunctional protein ADE2	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P22234	PAICS	Multifunctional protein ADE2	GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome
P22234	PAICS	Multifunctional protein ADE2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P30566	ADSL	Adenylosuccinate lyase	GO:0070626; F:(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity; IEA:UniProtKB-EC
P30566	ADSL	Adenylosuccinate lyase	GO:0004018; F:N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity; IDA:UniProtKB
P30566	ADSL	Adenylosuccinate lyase	GO:0044208; P:'de novo' AMP biosynthetic process; IEA:UniProtKB-UniPathway
P30566	ADSL	Adenylosuccinate lyase	GO:0006189; P:'de novo' IMP biosynthetic process; IEA:UniProtKB-UniPathway
P30566	ADSL	Adenylosuccinate lyase	GO:0009060; P:aerobic respiration; IEA:Ensembl
P30566	ADSL	Adenylosuccinate lyase	GO:0006167; P:AMP biosynthetic process; IDA:UniProtKB
P30566	ADSL	Adenylosuccinate lyase	GO:0008152; P:metabolic process; IDA:GOC
P30566	ADSL	Adenylosuccinate lyase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P30566	ADSL	Adenylosuccinate lyase	GO:0051262; P:protein tetramerization; IDA:UniProtKB
P30566	ADSL	Adenylosuccinate lyase	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P30566	ADSL	Adenylosuccinate lyase	GO:0006164; P:purine nucleotide biosynthetic process; IC:UniProtKB
P30566	ADSL	Adenylosuccinate lyase	GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome
P30566	ADSL	Adenylosuccinate lyase	GO:0001666; P:response to hypoxia; IEA:Ensembl
P30566	ADSL	Adenylosuccinate lyase	GO:0014850; P:response to muscle activity; IEA:Ensembl
P30566	ADSL	Adenylosuccinate lyase	GO:0007584; P:response to nutrient; IEA:Ensembl
P30566	ADSL	Adenylosuccinate lyase	GO:0042594; P:response to starvation; IEA:Ensembl
P30566	ADSL	Adenylosuccinate lyase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P31939	ATIC	Bifunctional purine biosynthesis protein PURH	GO:0003937; F:IMP cyclohydrolase activity; TAS:Reactome
P31939	ATIC	Bifunctional purine biosynthesis protein PURH	GO:0004643; F:phosphoribosylaminoimidazolecarboxamide formyltransferase activity; TAS:Reactome
P31939	ATIC	Bifunctional purine biosynthesis protein PURH	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P31939	ATIC	Bifunctional purine biosynthesis protein PURH	GO:0006189; P:'de novo' IMP biosynthetic process; IEA:UniProtKB-UniPathway
P31939	ATIC	Bifunctional purine biosynthesis protein PURH	GO:0003360; P:brainstem development; IEA:Ensembl
P31939	ATIC	Bifunctional purine biosynthesis protein PURH	GO:0021549; P:cerebellum development; IEA:Ensembl
P31939	ATIC	Bifunctional purine biosynthesis protein PURH	GO:0021987; P:cerebral cortex development; IEA:Ensembl
P31939	ATIC	Bifunctional purine biosynthesis protein PURH	GO:0046452; P:dihydrofolate metabolic process; IEA:Ensembl
P31939	ATIC	Bifunctional purine biosynthesis protein PURH	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
P31939	ATIC	Bifunctional purine biosynthesis protein PURH	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P31939	ATIC	Bifunctional purine biosynthesis protein PURH	GO:0009116; P:nucleoside metabolic process; IEA:Ensembl
P31939	ATIC	Bifunctional purine biosynthesis protein PURH	GO:0031100; P:organ regeneration; IEA:Ensembl
P31939	ATIC	Bifunctional purine biosynthesis protein PURH	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P31939	ATIC	Bifunctional purine biosynthesis protein PURH	GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome
P31939	ATIC	Bifunctional purine biosynthesis protein PURH	GO:0010035; P:response to inorganic substance; IEA:Ensembl
P31939	ATIC	Bifunctional purine biosynthesis protein PURH	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P31939	ATIC	Bifunctional purine biosynthesis protein PURH	GO:0046654; P:tetrahydrofolate biosynthetic process; IEA:Ensembl
Q8N142	ADSSL1	Adenylosuccinate synthetase isozyme 1	GO:0004019; F:adenylosuccinate synthase activity; IDA:UniProtKB
Q8N142	ADSSL1	Adenylosuccinate synthetase isozyme 1	GO:0005525; F:GTP binding; NAS:UniProtKB
Q8N142	ADSSL1	Adenylosuccinate synthetase isozyme 1	GO:0003924; F:GTPase activity; IEA:Ensembl
Q8N142	ADSSL1	Adenylosuccinate synthetase isozyme 1	GO:0000287; F:magnesium ion binding; IEA:UniProtKB-HAMAP
Q8N142	ADSSL1	Adenylosuccinate synthetase isozyme 1	GO:0042301; F:phosphate ion binding; NAS:UniProtKB
Q8N142	ADSSL1	Adenylosuccinate synthetase isozyme 1	GO:0044208; P:'de novo' AMP biosynthetic process; IEA:UniProtKB-UniPathway
Q8N142	ADSSL1	Adenylosuccinate synthetase isozyme 1	GO:0006167; P:AMP biosynthetic process; IDA:UniProtKB
Q8N142	ADSSL1	Adenylosuccinate synthetase isozyme 1	GO:0006531; P:aspartate metabolic process; IEA:Ensembl
Q8N142	ADSSL1	Adenylosuccinate synthetase isozyme 1	GO:0035690; P:cellular response to drug; IEA:Ensembl
Q8N142	ADSSL1	Adenylosuccinate synthetase isozyme 1	GO:0071257; P:cellular response to electrical stimulus; IEA:Ensembl
Q8N142	ADSSL1	Adenylosuccinate synthetase isozyme 1	GO:0006541; P:glutamine metabolic process; IEA:Ensembl
Q8N142	ADSSL1	Adenylosuccinate synthetase isozyme 1	GO:0002376; P:immune system process; NAS:UniProtKB
Q8N142	ADSSL1	Adenylosuccinate synthetase isozyme 1	GO:0046040; P:IMP metabolic process; IEA:Ensembl
Q8N142	ADSSL1	Adenylosuccinate synthetase isozyme 1	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q8N142	ADSSL1	Adenylosuccinate synthetase isozyme 1	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
Q8N142	ADSSL1	Adenylosuccinate synthetase isozyme 1	GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome
Q8N142	ADSSL1	Adenylosuccinate synthetase isozyme 1	GO:0014850; P:response to muscle activity; IEA:Ensembl
Q8N142	ADSSL1	Adenylosuccinate synthetase isozyme 1	GO:0042594; P:response to starvation; IEA:Ensembl
Q8N142	ADSSL1	Adenylosuccinate synthetase isozyme 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P30520	ADSS	Adenylosuccinate synthetase isozyme 2	GO:0004019; F:adenylosuccinate synthase activity; IDA:UniProtKB
P30520	ADSS	Adenylosuccinate synthetase isozyme 2	GO:0005525; F:GTP binding; NAS:UniProtKB
P30520	ADSS	Adenylosuccinate synthetase isozyme 2	GO:0000287; F:magnesium ion binding; IEA:UniProtKB-HAMAP
P30520	ADSS	Adenylosuccinate synthetase isozyme 2	GO:0042301; F:phosphate ion binding; NAS:UniProtKB
P30520	ADSS	Adenylosuccinate synthetase isozyme 2	GO:0005515; F:protein binding; IPI:IntAct
P30520	ADSS	Adenylosuccinate synthetase isozyme 2	GO:0044208; P:'de novo' AMP biosynthetic process; IEA:UniProtKB-UniPathway
P30520	ADSS	Adenylosuccinate synthetase isozyme 2	GO:0006167; P:AMP biosynthetic process; IDA:UniProtKB
P30520	ADSS	Adenylosuccinate synthetase isozyme 2	GO:0006531; P:aspartate metabolic process; IEA:Ensembl
P30520	ADSS	Adenylosuccinate synthetase isozyme 2	GO:0071257; P:cellular response to electrical stimulus; IEA:Ensembl
P30520	ADSS	Adenylosuccinate synthetase isozyme 2	GO:0006184; P:GTP catabolic process; IEA:Ensembl
P30520	ADSS	Adenylosuccinate synthetase isozyme 2	GO:0002376; P:immune system process; NAS:UniProtKB
P30520	ADSS	Adenylosuccinate synthetase isozyme 2	GO:0046040; P:IMP metabolic process; IEA:Ensembl
P30520	ADSS	Adenylosuccinate synthetase isozyme 2	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P30520	ADSS	Adenylosuccinate synthetase isozyme 2	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P30520	ADSS	Adenylosuccinate synthetase isozyme 2	GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome
P30520	ADSS	Adenylosuccinate synthetase isozyme 2	GO:0060359; P:response to ammonium ion; IEA:Ensembl
P30520	ADSS	Adenylosuccinate synthetase isozyme 2	GO:0014074; P:response to purine-containing compound; IEA:Ensembl
P30520	ADSS	Adenylosuccinate synthetase isozyme 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q00577	PURA	Transcriptional activator protein Pur-alpha	GO:0003691; F:double-stranded telomeric DNA binding; IDA:UniProtKB
Q00577	PURA	Transcriptional activator protein Pur-alpha	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q00577	PURA	Transcriptional activator protein Pur-alpha	GO:0005515; F:protein binding; IPI:IntAct
Q00577	PURA	Transcriptional activator protein Pur-alpha	GO:0032422; F:purine-rich negative regulatory element binding; IEA:Ensembl
Q00577	PURA	Transcriptional activator protein Pur-alpha	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q00577	PURA	Transcriptional activator protein Pur-alpha	GO:0003697; F:single-stranded DNA binding; ISS:UniProtKB
Q00577	PURA	Transcriptional activator protein Pur-alpha	GO:0008134; F:transcription factor binding; ISS:UniProtKB
Q00577	PURA	Transcriptional activator protein Pur-alpha	GO:0000900; F:translation repressor activity, nucleic acid binding; IEA:Ensembl
Q00577	PURA	Transcriptional activator protein Pur-alpha	GO:0006270; P:DNA replication initiation; TAS:ProtInc
Q00577	PURA	Transcriptional activator protein Pur-alpha	GO:0006268; P:DNA unwinding involved in DNA replication; IDA:UniProtKB
Q00577	PURA	Transcriptional activator protein Pur-alpha	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q00577	PURA	Transcriptional activator protein Pur-alpha	GO:0007399; P:nervous system development; IEA:Ensembl
Q00577	PURA	Transcriptional activator protein Pur-alpha	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q00577	PURA	Transcriptional activator protein Pur-alpha	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:GOC
Q00577	PURA	Transcriptional activator protein Pur-alpha	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:GOC
Q96QR8	PURB	Transcriptional activator protein Pur-beta	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
Q96QR8	PURB	Transcriptional activator protein Pur-beta	GO:0003729; F:mRNA binding; ISS:UniProtKB
Q96QR8	PURB	Transcriptional activator protein Pur-beta	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96QR8	PURB	Transcriptional activator protein Pur-beta	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q96QR8	PURB	Transcriptional activator protein Pur-beta	GO:0003697; F:single-stranded DNA binding; ISS:UniProtKB
Q96QR8	PURB	Transcriptional activator protein Pur-beta	GO:0008134; F:transcription factor binding; ISS:UniProtKB
Q96QR8	PURB	Transcriptional activator protein Pur-beta	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q96QR8	PURB	Transcriptional activator protein Pur-beta	GO:0045637; P:regulation of myeloid cell differentiation; NAS:UniProtKB
Q96QR8	PURB	Transcriptional activator protein Pur-beta	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UJV8	PURG	Purine-rich element-binding protein gamma	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UJV8	PURG	Purine-rich element-binding protein gamma	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q3MIT2	PUS10	Putative tRNA pseudouridine synthase Pus10	GO:0009982; F:pseudouridine synthase activity; IEA:InterPro
Q3MIT2	PUS10	Putative tRNA pseudouridine synthase Pus10	GO:0003723; F:RNA binding; IEA:InterPro
Q3MIT2	PUS10	Putative tRNA pseudouridine synthase Pus10	GO:0001522; P:pseudouridine synthesis; IEA:InterPro
Q3MIT2	PUS10	Putative tRNA pseudouridine synthase Pus10	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q9BZE2	PUS3	tRNA pseudouridine(38/39) synthase	GO:0009982; F:pseudouridine synthase activity; IEA:Ensembl
Q9BZE2	PUS3	tRNA pseudouridine(38/39) synthase	GO:0003723; F:RNA binding; IEA:InterPro
Q9BZE2	PUS3	tRNA pseudouridine(38/39) synthase	GO:0031119; P:tRNA pseudouridine synthesis; IEA:Ensembl
Q9H0K6	PUS7L	Pseudouridylate synthase 7 homolog-like protein	GO:0009982; F:pseudouridine synthase activity; IEA:InterPro
Q9H0K6	PUS7L	Pseudouridylate synthase 7 homolog-like protein	GO:0003723; F:RNA binding; IEA:InterPro
Q9H0K6	PUS7L	Pseudouridylate synthase 7 homolog-like protein	GO:0001522; P:pseudouridine synthesis; IEA:InterPro
Q9H0K6	PUS7L	Pseudouridylate synthase 7 homolog-like protein	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q96PZ0	PUS7	Pseudouridylate synthase 7 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96PZ0	PUS7	Pseudouridylate synthase 7 homolog	GO:0009982; F:pseudouridine synthase activity; IEA:InterPro
Q96PZ0	PUS7	Pseudouridylate synthase 7 homolog	GO:0001522; P:pseudouridine synthesis; IEA:InterPro
Q96PZ0	PUS7	Pseudouridylate synthase 7 homolog	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q8N0Z8	PUSL1	tRNA pseudouridine synthase-like 1	GO:0009982; F:pseudouridine synthase activity; IEA:InterPro
Q8N0Z8	PUSL1	tRNA pseudouridine synthase-like 1	GO:0003723; F:RNA binding; IEA:InterPro
Q8N0Z8	PUSL1	tRNA pseudouridine synthase-like 1	GO:0001522; P:pseudouridine synthesis; IEA:InterPro
Q8N0Z8	PUSL1	tRNA pseudouridine synthase-like 1	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q15223	PVRL1	Nectin-1	GO:0030246; F:carbohydrate binding; IEA:Ensembl
Q15223	PVRL1	Nectin-1	GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL
Q15223	PVRL1	Nectin-1	GO:0015026; F:coreceptor activity; TAS:ProtInc
Q15223	PVRL1	Nectin-1	GO:0005515; F:protein binding; IPI:IntAct
Q15223	PVRL1	Nectin-1	GO:0042803; F:protein homodimerization activity; ISS:HGNC
Q15223	PVRL1	Nectin-1	GO:0046790; F:virion binding; IEA:Ensembl
Q15223	PVRL1	Nectin-1	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
Q15223	PVRL1	Nectin-1	GO:0034332; P:adherens junction organization; TAS:Reactome
Q15223	PVRL1	Nectin-1	GO:0007411; P:axon guidance; IEA:Ensembl
Q15223	PVRL1	Nectin-1	GO:0007155; P:cell adhesion; NAS:UniProtKB
Q15223	PVRL1	Nectin-1	GO:0034329; P:cell junction assembly; TAS:Reactome
Q15223	PVRL1	Nectin-1	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
Q15223	PVRL1	Nectin-1	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q15223	PVRL1	Nectin-1	GO:0002934; P:desmosome organization; IEA:Ensembl
Q15223	PVRL1	Nectin-1	GO:0070166; P:enamel mineralization; IEA:Ensembl
Q15223	PVRL1	Nectin-1	GO:0007157; P:heterophilic cell-cell adhesion; ISS:HGNC
Q15223	PVRL1	Nectin-1	GO:0007156; P:homophilic cell adhesion; ISS:HGNC
Q15223	PVRL1	Nectin-1	GO:0006955; P:immune response; NAS:UniProtKB
Q15223	PVRL1	Nectin-1	GO:0006826; P:iron ion transport; IEA:Ensembl
Q15223	PVRL1	Nectin-1	GO:0002089; P:lens morphogenesis in camera-type eye; IEA:Ensembl
Q15223	PVRL1	Nectin-1	GO:0051963; P:regulation of synapse assembly; IEA:Ensembl
Q15223	PVRL1	Nectin-1	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
Q15223	PVRL1	Nectin-1	GO:0007165; P:signal transduction; TAS:GOC
Q15223	PVRL1	Nectin-1	GO:0046718; P:viral entry into host cell; NAS:UniProtKB
Q92692	PVRL2	Nectin-2	GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL
Q92692	PVRL2	Nectin-2	GO:0015026; F:coreceptor activity; TAS:ProtInc
Q92692	PVRL2	Nectin-2	GO:0042802; F:identical protein binding; IPI:IntAct
Q92692	PVRL2	Nectin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q92692	PVRL2	Nectin-2	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q92692	PVRL2	Nectin-2	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
Q92692	PVRL2	Nectin-2	GO:0001675; P:acrosome assembly; IEA:Ensembl
Q92692	PVRL2	Nectin-2	GO:0034332; P:adherens junction organization; TAS:Reactome
Q92692	PVRL2	Nectin-2	GO:0051856; ?:?; IDA:BHF-UCL
Q92692	PVRL2	Nectin-2	GO:0034329; P:cell junction assembly; TAS:Reactome
Q92692	PVRL2	Nectin-2	GO:0032990; P:cell part morphogenesis; IEA:Ensembl
Q92692	PVRL2	Nectin-2	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q92692	PVRL2	Nectin-2	GO:0044782; P:cilium organization; IEA:Ensembl
Q92692	PVRL2	Nectin-2	GO:0046814; P:coreceptor-mediated virion attachment to host cell; IDA:BHF-UCL
Q92692	PVRL2	Nectin-2	GO:0007010; P:cytoskeleton organization; IEA:Ensembl
Q92692	PVRL2	Nectin-2	GO:0051654; P:establishment of mitochondrion localization; IEA:Ensembl
Q92692	PVRL2	Nectin-2	GO:0009566; P:fertilization; IEA:Ensembl
Q92692	PVRL2	Nectin-2	GO:0019064; P:fusion of virus membrane with host plasma membrane; IDA:BHF-UCL
Q92692	PVRL2	Nectin-2	GO:0007156; P:homophilic cell adhesion; IDA:BHF-UCL
Q92692	PVRL2	Nectin-2	GO:0002891; P:positive regulation of immunoglobulin mediated immune response; IMP:BHF-UCL
Q92692	PVRL2	Nectin-2	GO:0033005; P:positive regulation of mast cell activation; IMP:BHF-UCL
Q92692	PVRL2	Nectin-2	GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; IMP:BHF-UCL
Q92692	PVRL2	Nectin-2	GO:0002860; P:positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; IMP:BHF-UCL
Q92692	PVRL2	Nectin-2	GO:0050776; P:regulation of immune response; TAS:Reactome
Q92692	PVRL2	Nectin-2	GO:0007165; P:signal transduction; TAS:GOC
Q92692	PVRL2	Nectin-2	GO:0030382; P:sperm mitochondrion organization; IEA:Ensembl
Q92692	PVRL2	Nectin-2	GO:0007286; P:spermatid development; ISS:BHF-UCL
Q92692	PVRL2	Nectin-2	GO:0007289; P:spermatid nucleus differentiation; IEA:Ensembl
Q92692	PVRL2	Nectin-2	GO:0042271; P:susceptibility to natural killer cell mediated cytotoxicity; IMP:BHF-UCL
Q92692	PVRL2	Nectin-2	GO:0060370; P:susceptibility to T cell mediated cytotoxicity; IDA:BHF-UCL
Q9NQS3	PVRL3	Nectin-3	GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL
Q9NQS3	PVRL3	Nectin-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NQS3	PVRL3	Nectin-3	GO:0042803; F:protein homodimerization activity; ISS:HGNC
Q9NQS3	PVRL3	Nectin-3	GO:0034332; P:adherens junction organization; TAS:Reactome
Q9NQS3	PVRL3	Nectin-3	GO:0034329; P:cell junction assembly; TAS:Reactome
Q9NQS3	PVRL3	Nectin-3	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q9NQS3	PVRL3	Nectin-3	GO:0009566; P:fertilization; IEA:Ensembl
Q9NQS3	PVRL3	Nectin-3	GO:0007156; P:homophilic cell adhesion; ISS:HGNC
Q9NQS3	PVRL3	Nectin-3	GO:0002089; P:lens morphogenesis in camera-type eye; IEA:Ensembl
Q9NQS3	PVRL3	Nectin-3	GO:0060042; P:retina morphogenesis in camera-type eye; IEA:Ensembl
P15151	PVR	Poliovirus receptor	GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL
P15151	PVR	Poliovirus receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P15151	PVR	Poliovirus receptor	GO:0004872; F:receptor activity; TAS:ProtInc
P15151	PVR	Poliovirus receptor	GO:0001618; F:virus receptor activity; IEA:Ensembl
P15151	PVR	Poliovirus receptor	GO:0034332; P:adherens junction organization; TAS:Reactome
P15151	PVR	Poliovirus receptor	GO:0034329; P:cell junction assembly; TAS:Reactome
P15151	PVR	Poliovirus receptor	GO:0016477; P:cell migration; IEA:Ensembl
P15151	PVR	Poliovirus receptor	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
P15151	PVR	Poliovirus receptor	GO:0045216; P:cell-cell junction organization; TAS:Reactome
P15151	PVR	Poliovirus receptor	GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; IMP:BHF-UCL
P15151	PVR	Poliovirus receptor	GO:0002860; P:positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target; IMP:BHF-UCL
P15151	PVR	Poliovirus receptor	GO:0050776; P:regulation of immune response; TAS:Reactome
P15151	PVR	Poliovirus receptor	GO:0042271; P:susceptibility to natural killer cell mediated cytotoxicity; IMP:BHF-UCL
P15151	PVR	Poliovirus receptor	GO:0060370; P:susceptibility to T cell mediated cytotoxicity; IDA:BHF-UCL
P15151	PVR	Poliovirus receptor	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q13610	PWP1	Periodic tryptophan protein 1 homolog	GO:0006351; P:transcription, DNA-templated; TAS:ProtInc
Q96N64	PWWP2A	PWWP domain-containing protein 2A	GO:0005515; F:protein binding; IPI:IntAct
Q15269	PWP2	Periodic tryptophan protein 2 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15269	PWP2	Periodic tryptophan protein 2 homolog	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q15269	PWP2	Periodic tryptophan protein 2 homolog	GO:0007165; P:signal transduction; TAS:ProtInc
Q96NY8	PVRL4	Nectin-4	GO:0005515; F:protein binding; IPI:IntAct
Q96NY8	PVRL4	Nectin-4	GO:0034332; P:adherens junction organization; TAS:Reactome
Q96NY8	PVRL4	Nectin-4	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q96NY8	PVRL4	Nectin-4	GO:0034329; P:cell junction assembly; TAS:Reactome
Q96NY8	PVRL4	Nectin-4	GO:0045216; P:cell-cell junction organization; TAS:Reactome
Q96NY8	PVRL4	Nectin-4	GO:0016032; P:viral process; IEA:UniProtKB-KW
O75192	PEX11A	Peroxisomal membrane protein 11A	GO:0005515; F:protein binding; IPI:UniProtKB
O75192	PEX11A	Peroxisomal membrane protein 11A	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O75192	PEX11A	Peroxisomal membrane protein 11A	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
O75192	PEX11A	Peroxisomal membrane protein 11A	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O75192	PEX11A	Peroxisomal membrane protein 11A	GO:0016559; P:peroxisome fission; IEA:InterPro
O75192	PEX11A	Peroxisomal membrane protein 11A	GO:0016557; P:peroxisome membrane biogenesis; IEA:Ensembl
O75192	PEX11A	Peroxisomal membrane protein 11A	GO:0007031; P:peroxisome organization; IMP:UniProtKB
O75192	PEX11A	Peroxisomal membrane protein 11A	GO:0044375; P:regulation of peroxisome size; IDA:UniProtKB
O75192	PEX11A	Peroxisomal membrane protein 11A	GO:0007165; P:signal transduction; IMP:UniProtKB
O75192	PEX11A	Peroxisomal membrane protein 11A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O96011	PEX11B	Peroxisomal membrane protein 11B	GO:0005515; F:protein binding; IPI:UniProtKB
O96011	PEX11B	Peroxisomal membrane protein 11B	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O96011	PEX11B	Peroxisomal membrane protein 11B	GO:0016559; P:peroxisome fission; IDA:UniProtKB
O96011	PEX11B	Peroxisomal membrane protein 11B	GO:0007031; P:peroxisome organization; IDA:UniProtKB
O96011	PEX11B	Peroxisomal membrane protein 11B	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
O96011	PEX11B	Peroxisomal membrane protein 11B	GO:0044375; P:regulation of peroxisome size; IDA:UniProtKB
O96011	PEX11B	Peroxisomal membrane protein 11B	GO:0007165; P:signal transduction; ISS:UniProtKB
Q96HA9	PEX11G	Peroxisomal membrane protein 11C	GO:0005515; F:protein binding; IPI:UniProtKB
Q96HA9	PEX11G	Peroxisomal membrane protein 11C	GO:0016559; P:peroxisome fission; IDA:UniProtKB
Q96HA9	PEX11G	Peroxisomal membrane protein 11C	GO:0044375; P:regulation of peroxisome size; IDA:UniProtKB
Q6UX71	PLXDC2	Plexin domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q6UX71	PLXDC2	Plexin domain-containing protein 2	GO:0004872; F:receptor activity; IEA:InterPro
Q6UX71	PLXDC2	Plexin domain-containing protein 2	GO:0007275; P:multicellular organismal development; IEA:InterPro
Q5TGL8	PXDC1	PX domain-containing protein 1	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
A1KZ92	PXDNL	Peroxidasin-like protein	GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW
A1KZ92	PXDNL	Peroxidasin-like protein	GO:0020037; F:heme binding; ISS:UniProtKB
A1KZ92	PXDNL	Peroxidasin-like protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A1KZ92	PXDNL	Peroxidasin-like protein	GO:0004601; F:peroxidase activity; ISS:UniProtKB
A1KZ92	PXDNL	Peroxidasin-like protein	GO:0042744; P:hydrogen peroxide catabolic process; ISS:UniProtKB
A1KZ92	PXDNL	Peroxidasin-like protein	GO:0055114; P:oxidation-reduction process; ISS:UniProtKB
Q92626	PXDN	Peroxidasin homolog	GO:0005201; F:extracellular matrix structural constituent; IDA:UniProtKB
Q92626	PXDN	Peroxidasin homolog	GO:0020037; F:heme binding; IDA:UniProtKB
Q92626	PXDN	Peroxidasin homolog	GO:0005152; F:interleukin-1 receptor antagonist activity; NAS:UniProtKB
Q92626	PXDN	Peroxidasin homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q92626	PXDN	Peroxidasin homolog	GO:0004601; F:peroxidase activity; IDA:UniProtKB
Q92626	PXDN	Peroxidasin homolog	GO:0030198; P:extracellular matrix organization; IDA:UniProtKB
Q92626	PXDN	Peroxidasin homolog	GO:0042744; P:hydrogen peroxide catabolic process; IDA:UniProtKB
Q92626	PXDN	Peroxidasin homolog	GO:0006955; P:immune response; NAS:UniProtKB
Q92626	PXDN	Peroxidasin homolog	GO:0001960; P:negative regulation of cytokine-mediated signaling pathway; NAS:GOC
Q92626	PXDN	Peroxidasin homolog	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q7Z7A4	PXK	PX domain-containing protein kinase-like protein	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
Q7Z7A4	PXK	PX domain-containing protein kinase-like protein	GO:0008022; F:protein C-terminus binding; ISS:UniProtKB
Q7Z7A4	PXK	PX domain-containing protein kinase-like protein	GO:0016772; F:transferase activity, transferring phosphorus-containing groups; IEA:InterPro
Q7Z7A4	PXK	PX domain-containing protein kinase-like protein	GO:0006954; P:inflammatory response; IMP:UniProtKB
Q7Z7A4	PXK	PX domain-containing protein kinase-like protein	GO:0032780; P:negative regulation of ATPase activity; IEA:Ensembl
Q7Z7A4	PXK	PX domain-containing protein kinase-like protein	GO:0043271; P:negative regulation of ion transport; IEA:Ensembl
Q7Z7A4	PXK	PX domain-containing protein kinase-like protein	GO:0050804; P:regulation of synaptic transmission; ISS:UniProtKB
Q9NR77	PXMP2	Peroxisomal membrane protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6I8	PXMP4	Peroxisomal membrane protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NFP0	PXT1	Peroxisomal testis-specific protein 1	GO:0007283; P:spermatogenesis; IEA:Ensembl
P11498	PC	Pyruvate carboxylase, mitochondrial	GO:0005524; F:ATP binding; TAS:ProtInc
P11498	PC	Pyruvate carboxylase, mitochondrial	GO:0009374; F:biotin binding; TAS:ProtInc
P11498	PC	Pyruvate carboxylase, mitochondrial	GO:0004075; F:biotin carboxylase activity; IEA:InterPro
P11498	PC	Pyruvate carboxylase, mitochondrial	GO:0003677; F:DNA binding; IEA:InterPro
P11498	PC	Pyruvate carboxylase, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P11498	PC	Pyruvate carboxylase, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
P11498	PC	Pyruvate carboxylase, mitochondrial	GO:0004736; F:pyruvate carboxylase activity; TAS:Reactome
P11498	PC	Pyruvate carboxylase, mitochondrial	GO:0006768; P:biotin metabolic process; TAS:Reactome
P11498	PC	Pyruvate carboxylase, mitochondrial	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P11498	PC	Pyruvate carboxylase, mitochondrial	GO:0006094; P:gluconeogenesis; TAS:Reactome
P11498	PC	Pyruvate carboxylase, mitochondrial	GO:0006006; P:glucose metabolic process; TAS:Reactome
P11498	PC	Pyruvate carboxylase, mitochondrial	GO:0006629; P:lipid metabolic process; IEA:UniProtKB-KW
P11498	PC	Pyruvate carboxylase, mitochondrial	GO:0006107; P:oxaloacetate metabolic process; IEA:Ensembl
P11498	PC	Pyruvate carboxylase, mitochondrial	GO:0006090; P:pyruvate metabolic process; IEA:Ensembl
P11498	PC	Pyruvate carboxylase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P11498	PC	Pyruvate carboxylase, mitochondrial	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P11498	PC	Pyruvate carboxylase, mitochondrial	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q8WXC3	PYDC1	Pyrin domain-containing protein 1	GO:0005515; F:protein binding; IPI:HGNC
Q8WXC3	PYDC1	Pyrin domain-containing protein 1	GO:0045087; P:innate immune response; IDA:HGNC
Q8WXC3	PYDC1	Pyrin domain-containing protein 1	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:HGNC
Q8WXC3	PYDC1	Pyrin domain-containing protein 1	GO:0006469; P:negative regulation of protein kinase activity; IDA:HGNC
Q8WXC3	PYDC1	Pyrin domain-containing protein 1	GO:0050718; P:positive regulation of interleukin-1 beta secretion; IDA:HGNC
Q8WXC3	PYDC1	Pyrin domain-containing protein 1	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IDA:HGNC
Q56P42	PYDC2	Pyrin domain-containing protein 2	GO:0005515; F:protein binding; IPI:IntAct
P11216	PYGB	Glycogen phosphorylase, brain form	GO:0008184; F:glycogen phosphorylase activity; NAS:UniProtKB
P11216	PYGB	Glycogen phosphorylase, brain form	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
P11216	PYGB	Glycogen phosphorylase, brain form	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P11216	PYGB	Glycogen phosphorylase, brain form	GO:0006006; P:glucose metabolic process; TAS:Reactome
P11216	PYGB	Glycogen phosphorylase, brain form	GO:0005980; P:glycogen catabolic process; NAS:UniProtKB
P11216	PYGB	Glycogen phosphorylase, brain form	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P06737	PYGL	Glycogen phosphorylase, liver form	GO:0016208; F:AMP binding; IDA:UniProtKB
P06737	PYGL	Glycogen phosphorylase, liver form	GO:0005524; F:ATP binding; IDA:UniProtKB
P06737	PYGL	Glycogen phosphorylase, liver form	GO:0032052; F:bile acid binding; IDA:UniProtKB
P06737	PYGL	Glycogen phosphorylase, liver form	GO:0008144; F:drug binding; IDA:UniProtKB
P06737	PYGL	Glycogen phosphorylase, liver form	GO:0005536; F:glucose binding; NAS:UniProtKB
P06737	PYGL	Glycogen phosphorylase, liver form	GO:0008184; F:glycogen phosphorylase activity; IMP:UniProtKB
P06737	PYGL	Glycogen phosphorylase, liver form	GO:0042803; F:protein homodimerization activity; NAS:UniProtKB
P06737	PYGL	Glycogen phosphorylase, liver form	GO:0002060; F:purine nucleobase binding; IDA:UniProtKB
P06737	PYGL	Glycogen phosphorylase, liver form	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
P06737	PYGL	Glycogen phosphorylase, liver form	GO:0019842; F:vitamin binding; IDA:UniProtKB
P06737	PYGL	Glycogen phosphorylase, liver form	GO:0006015; P:5-phosphoribose 1-diphosphate biosynthetic process; IEA:Ensembl
P06737	PYGL	Glycogen phosphorylase, liver form	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P06737	PYGL	Glycogen phosphorylase, liver form	GO:0042593; P:glucose homeostasis; IMP:UniProtKB
P06737	PYGL	Glycogen phosphorylase, liver form	GO:0006006; P:glucose metabolic process; TAS:Reactome
P06737	PYGL	Glycogen phosphorylase, liver form	GO:0005980; P:glycogen catabolic process; TAS:Reactome
P06737	PYGL	Glycogen phosphorylase, liver form	GO:0005977; P:glycogen metabolic process; IMP:UniProtKB
P06737	PYGL	Glycogen phosphorylase, liver form	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P11217	PYGM	Glycogen phosphorylase, muscle form	GO:0008184; F:glycogen phosphorylase activity; TAS:ProtInc
P11217	PYGM	Glycogen phosphorylase, muscle form	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
P11217	PYGM	Glycogen phosphorylase, muscle form	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
P11217	PYGM	Glycogen phosphorylase, muscle form	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P11217	PYGM	Glycogen phosphorylase, muscle form	GO:0006006; P:glucose metabolic process; TAS:Reactome
P11217	PYGM	Glycogen phosphorylase, muscle form	GO:0005980; P:glycogen catabolic process; TAS:Reactome
P11217	PYGM	Glycogen phosphorylase, muscle form	GO:0005977; P:glycogen metabolic process; TAS:ProtInc
P11217	PYGM	Glycogen phosphorylase, muscle form	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y3Y4	PYGO1	Pygopus homolog 1	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3Y4	PYGO1	Pygopus homolog 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y3Y4	PYGO1	Pygopus homolog 1	GO:0001822; P:kidney development; IEA:Ensembl
Q9Y3Y4	PYGO1	Pygopus homolog 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9Y3Y4	PYGO1	Pygopus homolog 1	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q9Y3Y4	PYGO1	Pygopus homolog 1	GO:0034504; P:protein localization to nucleus; IEA:Ensembl
Q9Y3Y4	PYGO1	Pygopus homolog 1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9BRQ0	PYGO2	Pygopus homolog 2	GO:0005515; F:protein binding; IPI:IntAct
Q9BRQ0	PYGO2	Pygopus homolog 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BRQ0	PYGO2	Pygopus homolog 2	GO:0007420; P:brain development; IEA:Ensembl
Q9BRQ0	PYGO2	Pygopus homolog 2	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
Q9BRQ0	PYGO2	Pygopus homolog 2	GO:0048589; P:developmental growth; IEA:Ensembl
Q9BRQ0	PYGO2	Pygopus homolog 2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9BRQ0	PYGO2	Pygopus homolog 2	GO:0001822; P:kidney development; IEA:Ensembl
Q9BRQ0	PYGO2	Pygopus homolog 2	GO:0002088; P:lens development in camera-type eye; IEA:Ensembl
Q9BRQ0	PYGO2	Pygopus homolog 2	GO:0030879; P:mammary gland development; IEA:Ensembl
Q9BRQ0	PYGO2	Pygopus homolog 2	GO:0060021; P:palate development; IEA:Ensembl
Q9BRQ0	PYGO2	Pygopus homolog 2	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q9BRQ0	PYGO2	Pygopus homolog 2	GO:0051569; P:regulation of histone H3-K4 methylation; IEA:Ensembl
Q9BRQ0	PYGO2	Pygopus homolog 2	GO:0033599; P:regulation of mammary gland epithelial cell proliferation; IEA:Ensembl
P27708	CAD	CAD protein	GO:0070335; F:aspartate binding; ISS:BHF-UCL
P27708	CAD	CAD protein	GO:0004070; F:aspartate carbamoyltransferase activity; ISS:BHF-UCL
P27708	CAD	CAD protein	GO:0005524; F:ATP binding; ISS:BHF-UCL
P27708	CAD	CAD protein	GO:0004088; F:carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; ISS:BHF-UCL
P27708	CAD	CAD protein	GO:0004151; F:dihydroorotase activity; IDA:UniProtKB
P27708	CAD	CAD protein	GO:0019899; F:enzyme binding; IPI:UniProtKB
P27708	CAD	CAD protein	GO:0042802; F:identical protein binding; ISS:BHF-UCL
P27708	CAD	CAD protein	GO:0004672; F:protein kinase activity; ISS:BHF-UCL
P27708	CAD	CAD protein	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P27708	CAD	CAD protein	GO:0006207; P:'de novo' pyrimidine nucleobase biosynthetic process; IDA:UniProtKB
P27708	CAD	CAD protein	GO:0044205; P:'de novo' UMP biosynthetic process; IEA:UniProtKB-UniPathway
P27708	CAD	CAD protein	GO:0070409; P:carbamoyl phosphate biosynthetic process; IEA:InterPro
P27708	CAD	CAD protein	GO:0035690; P:cellular response to drug; IEA:Ensembl
P27708	CAD	CAD protein	GO:0071364; P:cellular response to epidermal growth factor stimulus; IEA:Ensembl
P27708	CAD	CAD protein	GO:0017144; P:drug metabolic process; ISS:BHF-UCL
P27708	CAD	CAD protein	GO:0009790; P:embryo development; IEA:Ensembl
P27708	CAD	CAD protein	GO:0007565; P:female pregnancy; IEA:Ensembl
P27708	CAD	CAD protein	GO:0006543; P:glutamine catabolic process; IEA:InterPro
P27708	CAD	CAD protein	GO:0006541; P:glutamine metabolic process; ISS:BHF-UCL
P27708	CAD	CAD protein	GO:0007595; P:lactation; IEA:Ensembl
P27708	CAD	CAD protein	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P27708	CAD	CAD protein	GO:0031100; P:organ regeneration; IEA:Ensembl
P27708	CAD	CAD protein	GO:0018107; P:peptidyl-threonine phosphorylation; ISS:BHF-UCL
P27708	CAD	CAD protein	GO:0046777; P:protein autophosphorylation; ISS:BHF-UCL
P27708	CAD	CAD protein	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
P27708	CAD	CAD protein	GO:0046134; P:pyrimidine nucleoside biosynthetic process; TAS:Reactome
P27708	CAD	CAD protein	GO:0014075; P:response to amine; IEA:Ensembl
P27708	CAD	CAD protein	GO:0031000; P:response to caffeine; IEA:Ensembl
P27708	CAD	CAD protein	GO:0051414; P:response to cortisol; IEA:Ensembl
P27708	CAD	CAD protein	GO:0033574; P:response to testosterone; IEA:Ensembl
P27708	CAD	CAD protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P27708	CAD	CAD protein	GO:0006228; P:UTP biosynthetic process; IEA:Ensembl
Q8WU10	PYROXD1	Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q8N2H3	PYROXD2	Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q02127	DHODH	Dihydroorotate dehydrogenase (quinone), mitochondrial	GO:0004152; F:dihydroorotate dehydrogenase activity; TAS:Reactome
Q02127	DHODH	Dihydroorotate dehydrogenase (quinone), mitochondrial	GO:0004158; F:dihydroorotate oxidase activity; IEA:Ensembl
Q02127	DHODH	Dihydroorotate dehydrogenase (quinone), mitochondrial	GO:0008144; F:drug binding; IEA:Ensembl
Q02127	DHODH	Dihydroorotate dehydrogenase (quinone), mitochondrial	GO:0010181; F:FMN binding; IEA:Ensembl
Q02127	DHODH	Dihydroorotate dehydrogenase (quinone), mitochondrial	GO:0048039; F:ubiquinone binding; IEA:Ensembl
Q02127	DHODH	Dihydroorotate dehydrogenase (quinone), mitochondrial	GO:0006207; P:'de novo' pyrimidine nucleobase biosynthetic process; IEA:Ensembl
Q02127	DHODH	Dihydroorotate dehydrogenase (quinone), mitochondrial	GO:0044205; P:'de novo' UMP biosynthetic process; IEA:UniProtKB-UniPathway
Q02127	DHODH	Dihydroorotate dehydrogenase (quinone), mitochondrial	GO:0007565; P:female pregnancy; IEA:Ensembl
Q02127	DHODH	Dihydroorotate dehydrogenase (quinone), mitochondrial	GO:0007595; P:lactation; IEA:Ensembl
Q02127	DHODH	Dihydroorotate dehydrogenase (quinone), mitochondrial	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q02127	DHODH	Dihydroorotate dehydrogenase (quinone), mitochondrial	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q02127	DHODH	Dihydroorotate dehydrogenase (quinone), mitochondrial	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
Q02127	DHODH	Dihydroorotate dehydrogenase (quinone), mitochondrial	GO:0046134; P:pyrimidine nucleoside biosynthetic process; TAS:Reactome
Q02127	DHODH	Dihydroorotate dehydrogenase (quinone), mitochondrial	GO:0090140; P:regulation of mitochondrial fission; IEA:Ensembl
Q02127	DHODH	Dihydroorotate dehydrogenase (quinone), mitochondrial	GO:0031000; P:response to caffeine; IEA:Ensembl
Q02127	DHODH	Dihydroorotate dehydrogenase (quinone), mitochondrial	GO:0042493; P:response to drug; IEA:Ensembl
Q02127	DHODH	Dihydroorotate dehydrogenase (quinone), mitochondrial	GO:0042594; P:response to starvation; IEA:Ensembl
Q02127	DHODH	Dihydroorotate dehydrogenase (quinone), mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P17812	CTPS1	CTP synthase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P17812	CTPS1	CTP synthase 1	GO:0003883; F:CTP synthase activity; IDA:UniProtKB
P17812	CTPS1	CTP synthase 1	GO:0044210; P:'de novo' CTP biosynthetic process; IEA:UniProtKB-UniPathway
P17812	CTPS1	CTP synthase 1	GO:0006241; P:CTP biosynthetic process; IDA:UniProtKB
P17812	CTPS1	CTP synthase 1	GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW
P17812	CTPS1	CTP synthase 1	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
P17812	CTPS1	CTP synthase 1	GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome
P17812	CTPS1	CTP synthase 1	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P17812	CTPS1	CTP synthase 1	GO:0042493; P:response to drug; TAS:ProtInc
P17812	CTPS1	CTP synthase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NRF8	CTPS2	CTP synthase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NRF8	CTPS2	CTP synthase 2	GO:0003883; F:CTP synthase activity; EXP:Reactome
Q9NRF8	CTPS2	CTP synthase 2	GO:0044210; P:'de novo' CTP biosynthetic process; IEA:UniProtKB-UniPathway
Q9NRF8	CTPS2	CTP synthase 2	GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW
Q9NRF8	CTPS2	CTP synthase 2	GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome
Q9NRF8	CTPS2	CTP synthase 2	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q9NRF8	CTPS2	CTP synthase 2	GO:0006220; P:pyrimidine nucleotide metabolic process; TAS:ProtInc
Q9NRF8	CTPS2	CTP synthase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P10082	PYY	Peptide YY	GO:0005179; F:hormone activity; TAS:ProtInc
P10082	PYY	Peptide YY	GO:0005515; F:protein binding; IPI:IntAct
P10082	PYY	Peptide YY	GO:0008283; P:cell proliferation; TAS:ProtInc
P10082	PYY	Peptide YY	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P10082	PYY	Peptide YY	GO:0006928; P:cellular component movement; TAS:ProtInc
P10082	PYY	Peptide YY	GO:0007010; P:cytoskeleton organization; TAS:ProtInc
P10082	PYY	Peptide YY	GO:0007586; P:digestion; TAS:ProtInc
P10082	PYY	Peptide YY	GO:0042755; P:eating behavior; IEA:Ensembl
P10082	PYY	Peptide YY	GO:0007631; P:feeding behavior; TAS:ProtInc
P10082	PYY	Peptide YY	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P20742	PZP	Pregnancy zone protein	GO:0004866; F:endopeptidase inhibitor activity; TAS:UniProtKB
P20742	PZP	Pregnancy zone protein	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
P20742	PZP	Pregnancy zone protein	GO:0007565; P:female pregnancy; TAS:UniProtKB
P20742	PZP	Pregnancy zone protein	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
Q9UPQ7	PDZRN3	E3 ubiquitin-protein ligase PDZRN3	GO:0004842; F:ubiquitin-protein ligase activity; ISS:UniProtKB
Q9UPQ7	PDZRN3	E3 ubiquitin-protein ligase PDZRN3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UPQ7	PDZRN3	E3 ubiquitin-protein ligase PDZRN3	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
Q9UPQ7	PDZRN3	E3 ubiquitin-protein ligase PDZRN3	GO:0016567; P:protein ubiquitination; ISS:UniProtKB
Q6ZMN7	PDZRN4	PDZ domain-containing RING finger protein 4	GO:0004842; F:ubiquitin-protein ligase activity; IEA:InterPro
Q6ZMN7	PDZRN4	PDZ domain-containing RING finger protein 4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q04671	OCA2	P protein	GO:0005302; F:L-tyrosine transmembrane transporter activity; TAS:ProtInc
Q04671	OCA2	P protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q04671	OCA2	P protein	GO:0005215; F:transporter activity; TAS:ProtInc
Q04671	OCA2	P protein	GO:0008283; P:cell proliferation; IEA:Ensembl
Q04671	OCA2	P protein	GO:0006726; P:eye pigment biosynthetic process; TAS:ProtInc
Q04671	OCA2	P protein	GO:0042438; P:melanin biosynthetic process; IEA:Ensembl
Q04671	OCA2	P protein	GO:0030318; P:melanocyte differentiation; IEA:Ensembl
Q04671	OCA2	P protein	GO:0007286; P:spermatid development; IEA:Ensembl
Q04671	OCA2	P protein	GO:0015828; P:tyrosine transport; TAS:GOC
O14957	UQCR11	Cytochrome b-c1 complex subunit 10	GO:0009055; F:electron carrier activity; TAS:UniProtKB
O14957	UQCR11	Cytochrome b-c1 complex subunit 10	GO:0008121; F:ubiquinol-cytochrome-c reductase activity; IEA:InterPro
O14957	UQCR11	Cytochrome b-c1 complex subunit 10	GO:0044237; P:cellular metabolic process; TAS:Reactome
O14957	UQCR11	Cytochrome b-c1 complex subunit 10	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
O14957	UQCR11	Cytochrome b-c1 complex subunit 10	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O14957	UQCR11	Cytochrome b-c1 complex subunit 10	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P31930	UQCRC1	Cytochrome b-c1 complex subunit 1, mitochondrial	GO:0046872; F:metal ion binding; IEA:InterPro
P31930	UQCRC1	Cytochrome b-c1 complex subunit 1, mitochondrial	GO:0008121; F:ubiquinol-cytochrome-c reductase activity; TAS:ProtInc
P31930	UQCRC1	Cytochrome b-c1 complex subunit 1, mitochondrial	GO:0009060; P:aerobic respiration; TAS:ProtInc
P31930	UQCRC1	Cytochrome b-c1 complex subunit 1, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P31930	UQCRC1	Cytochrome b-c1 complex subunit 1, mitochondrial	GO:1902600; P:hydrogen ion transmembrane transport; TAS:GOC
P31930	UQCRC1	Cytochrome b-c1 complex subunit 1, mitochondrial	GO:0006122; P:mitochondrial electron transport, ubiquinol to cytochrome c; IEA:Ensembl
P31930	UQCRC1	Cytochrome b-c1 complex subunit 1, mitochondrial	GO:0055114; P:oxidation-reduction process; TAS:ProtInc
P31930	UQCRC1	Cytochrome b-c1 complex subunit 1, mitochondrial	GO:0006119; P:oxidative phosphorylation; TAS:ProtInc
P31930	UQCRC1	Cytochrome b-c1 complex subunit 1, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P31930	UQCRC1	Cytochrome b-c1 complex subunit 1, mitochondrial	GO:0014823; P:response to activity; IEA:Ensembl
P31930	UQCRC1	Cytochrome b-c1 complex subunit 1, mitochondrial	GO:0043279; P:response to alkaloid; IEA:Ensembl
P31930	UQCRC1	Cytochrome b-c1 complex subunit 1, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P22695	UQCRC2	Cytochrome b-c1 complex subunit 2, mitochondrial	GO:0046872; F:metal ion binding; IEA:InterPro
P22695	UQCRC2	Cytochrome b-c1 complex subunit 2, mitochondrial	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
P22695	UQCRC2	Cytochrome b-c1 complex subunit 2, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
P22695	UQCRC2	Cytochrome b-c1 complex subunit 2, mitochondrial	GO:0009060; P:aerobic respiration; TAS:ProtInc
P22695	UQCRC2	Cytochrome b-c1 complex subunit 2, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P22695	UQCRC2	Cytochrome b-c1 complex subunit 2, mitochondrial	GO:0006119; P:oxidative phosphorylation; TAS:ProtInc
P22695	UQCRC2	Cytochrome b-c1 complex subunit 2, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P22695	UQCRC2	Cytochrome b-c1 complex subunit 2, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P07919	UQCRH	Cytochrome b-c1 complex subunit 6, mitochondrial	GO:0008121; F:ubiquinol-cytochrome-c reductase activity; TAS:ProtInc
P07919	UQCRH	Cytochrome b-c1 complex subunit 6, mitochondrial	GO:0009060; P:aerobic respiration; TAS:ProtInc
P07919	UQCRH	Cytochrome b-c1 complex subunit 6, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P07919	UQCRH	Cytochrome b-c1 complex subunit 6, mitochondrial	GO:1902600; P:hydrogen ion transmembrane transport; TAS:GOC
P07919	UQCRH	Cytochrome b-c1 complex subunit 6, mitochondrial	GO:0006122; P:mitochondrial electron transport, ubiquinol to cytochrome c; IEA:InterPro
P07919	UQCRH	Cytochrome b-c1 complex subunit 6, mitochondrial	GO:0055114; P:oxidation-reduction process; TAS:ProtInc
P07919	UQCRH	Cytochrome b-c1 complex subunit 6, mitochondrial	GO:0006119; P:oxidative phosphorylation; TAS:ProtInc
P07919	UQCRH	Cytochrome b-c1 complex subunit 6, mitochondrial	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P07919	UQCRH	Cytochrome b-c1 complex subunit 6, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P07919	UQCRH	Cytochrome b-c1 complex subunit 6, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P14927	UQCRB	Cytochrome b-c1 complex subunit 7	GO:0009060; P:aerobic respiration; TAS:ProtInc
P14927	UQCRB	Cytochrome b-c1 complex subunit 7	GO:0044237; P:cellular metabolic process; TAS:Reactome
P14927	UQCRB	Cytochrome b-c1 complex subunit 7	GO:0006122; P:mitochondrial electron transport, ubiquinol to cytochrome c; IEA:InterPro
P14927	UQCRB	Cytochrome b-c1 complex subunit 7	GO:0055114; P:oxidation-reduction process; TAS:ProtInc
P14927	UQCRB	Cytochrome b-c1 complex subunit 7	GO:0006119; P:oxidative phosphorylation; TAS:ProtInc
P14927	UQCRB	Cytochrome b-c1 complex subunit 7	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P14927	UQCRB	Cytochrome b-c1 complex subunit 7	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UDW1	UQCR10	Cytochrome b-c1 complex subunit 9	GO:0008121; F:ubiquinol-cytochrome-c reductase activity; NAS:UniProtKB
Q9UDW1	UQCR10	Cytochrome b-c1 complex subunit 9	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q9UDW1	UQCR10	Cytochrome b-c1 complex subunit 9	GO:1902600; P:hydrogen ion transmembrane transport; NAS:GOC
Q9UDW1	UQCR10	Cytochrome b-c1 complex subunit 9	GO:0006122; P:mitochondrial electron transport, ubiquinol to cytochrome c; NAS:UniProtKB
Q9UDW1	UQCR10	Cytochrome b-c1 complex subunit 9	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
Q9UDW1	UQCR10	Cytochrome b-c1 complex subunit 9	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O14949	UQCRQ	Cytochrome b-c1 complex subunit 8	GO:0008121; F:ubiquinol-cytochrome-c reductase activity; IEA:InterPro
O14949	UQCRQ	Cytochrome b-c1 complex subunit 8	GO:0044237; P:cellular metabolic process; TAS:Reactome
O14949	UQCRQ	Cytochrome b-c1 complex subunit 8	GO:0021680; P:cerebellar Purkinje cell layer development; IEA:Ensembl
O14949	UQCRQ	Cytochrome b-c1 complex subunit 8	GO:0021766; P:hippocampus development; IEA:Ensembl
O14949	UQCRQ	Cytochrome b-c1 complex subunit 8	GO:0021854; P:hypothalamus development; IEA:Ensembl
O14949	UQCRQ	Cytochrome b-c1 complex subunit 8	GO:0030901; P:midbrain development; IEA:Ensembl
O14949	UQCRQ	Cytochrome b-c1 complex subunit 8	GO:0021548; P:pons development; IEA:Ensembl
O14949	UQCRQ	Cytochrome b-c1 complex subunit 8	GO:0021860; P:pyramidal neuron development; IEA:Ensembl
O14949	UQCRQ	Cytochrome b-c1 complex subunit 8	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
O14949	UQCRQ	Cytochrome b-c1 complex subunit 8	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O14949	UQCRQ	Cytochrome b-c1 complex subunit 8	GO:0021539; P:subthalamus development; IEA:Ensembl
O14949	UQCRQ	Cytochrome b-c1 complex subunit 8	GO:0021794; P:thalamus development; IEA:Ensembl
Q96PU8	QKI	Protein quaking	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96PU8	QKI	Protein quaking	GO:0005515; F:protein binding; IPI:IntAct
Q96PU8	QKI	Protein quaking	GO:0042759; P:long-chain fatty acid biosynthetic process; IEA:Ensembl
Q96PU8	QKI	Protein quaking	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q96PU8	QKI	Protein quaking	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q96PU8	QKI	Protein quaking	GO:0042692; P:muscle cell differentiation; IEA:Ensembl
Q96PU8	QKI	Protein quaking	GO:0042552; P:myelination; IEA:Ensembl
Q96PU8	QKI	Protein quaking	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
Q96PU8	QKI	Protein quaking	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q96PU8	QKI	Protein quaking	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q96PU8	QKI	Protein quaking	GO:0007286; P:spermatid development; IEA:Ensembl
Q96PU8	QKI	Protein quaking	GO:0001570; P:vasculogenesis; IEA:Ensembl
O95825	CRYZL1	Quinone oxidoreductase-like protein 1	GO:0050661; F:NADP binding; NAS:UniProtKB
O95825	CRYZL1	Quinone oxidoreductase-like protein 1	GO:0003960; F:NADPH:quinone reductase activity; NAS:UniProtKB
O95825	CRYZL1	Quinone oxidoreductase-like protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
O95825	CRYZL1	Quinone oxidoreductase-like protein 1	GO:1901661; P:quinone metabolic process; NAS:UniProtKB
Q53FA7	TP53I3	Quinone oxidoreductase PIG3	GO:0070402; F:NADPH binding; IDA:UniProtKB
Q53FA7	TP53I3	Quinone oxidoreductase PIG3	GO:0003960; F:NADPH:quinone reductase activity; IDA:UniProtKB
Q53FA7	TP53I3	Quinone oxidoreductase PIG3	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q53FA7	TP53I3	Quinone oxidoreductase PIG3	GO:0048038; F:quinone binding; IDA:UniProtKB
Q53FA7	TP53I3	Quinone oxidoreductase PIG3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q53FA7	TP53I3	Quinone oxidoreductase PIG3	GO:0006739; P:NADP metabolic process; IDA:UniProtKB
Q08257	CRYZ	Quinone oxidoreductase	GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB
Q08257	CRYZ	Quinone oxidoreductase	GO:0070402; F:NADPH binding; IDA:UniProtKB
Q08257	CRYZ	Quinone oxidoreductase	GO:0003960; F:NADPH:quinone reductase activity; IDA:UniProtKB
Q08257	CRYZ	Quinone oxidoreductase	GO:0008270; F:zinc ion binding; IEA:InterPro
Q08257	CRYZ	Quinone oxidoreductase	GO:0051289; P:protein homotetramerization; IPI:UniProtKB
Q08257	CRYZ	Quinone oxidoreductase	GO:0007601; P:visual perception; TAS:ProtInc
Q08257	CRYZ	Quinone oxidoreductase	GO:0042178; P:xenobiotic catabolic process; IDA:UniProtKB
Q9NXS2	QPCTL	Glutaminyl-peptide cyclotransferase-like protein	GO:0016603; F:glutaminyl-peptide cyclotransferase activity; IDA:UniProtKB
Q9NXS2	QPCTL	Glutaminyl-peptide cyclotransferase-like protein	GO:0008233; F:peptidase activity; IEA:InterPro
Q9NXS2	QPCTL	Glutaminyl-peptide cyclotransferase-like protein	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q9NXS2	QPCTL	Glutaminyl-peptide cyclotransferase-like protein	GO:0017186; P:peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase; IDA:UniProtKB
Q16769	QPCT	Glutaminyl-peptide cyclotransferase	GO:0016603; F:glutaminyl-peptide cyclotransferase activity; IDA:UniProtKB
Q16769	QPCT	Glutaminyl-peptide cyclotransferase	GO:0008233; F:peptidase activity; IEA:InterPro
Q16769	QPCT	Glutaminyl-peptide cyclotransferase	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q16769	QPCT	Glutaminyl-peptide cyclotransferase	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q16769	QPCT	Glutaminyl-peptide cyclotransferase	GO:0017186; P:peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase; IDA:UniProtKB
Q96P65	QRFPR	Pyroglutamylated RFamide peptide receptor	GO:0004930; F:G-protein coupled receptor activity; IDA:UniProtKB
Q96P65	QRFPR	Pyroglutamylated RFamide peptide receptor	GO:0004983; F:neuropeptide Y receptor activity; IEA:InterPro
Q96P65	QRFPR	Pyroglutamylated RFamide peptide receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:UniProtKB
O00391	QSOX1	Sulfhydryl oxidase 1	GO:0016971; F:flavin-linked sulfhydryl oxidase activity; IDA:UniProtKB
O00391	QSOX1	Sulfhydryl oxidase 1	GO:0003756; F:protein disulfide isomerase activity; IDA:UniProtKB
O00391	QSOX1	Sulfhydryl oxidase 1	GO:0045454; P:cell redox homeostasis; IEA:InterPro
O00391	QSOX1	Sulfhydryl oxidase 1	GO:0006457; P:protein folding; IDA:GOC
Q6ZRP7	QSOX2	Sulfhydryl oxidase 2	GO:0016972; F:thiol oxidase activity; IEA:UniProtKB-EC
Q6ZRP7	QSOX2	Sulfhydryl oxidase 2	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q9H974	QTRTD1	Queuine tRNA-ribosyltransferase subunit QTRTD1	GO:0008479; F:queuine tRNA-ribosyltransferase activity; IEA:UniProtKB-HAMAP
Q9H974	QTRTD1	Queuine tRNA-ribosyltransferase subunit QTRTD1	GO:0008270; F:zinc ion binding; IEA:UniProtKB-HAMAP
Q9H974	QTRTD1	Queuine tRNA-ribosyltransferase subunit QTRTD1	GO:0008616; P:queuosine biosynthetic process; ISS:UniProtKB
O15541	RNF113A	RING finger protein 113A	GO:0005515; F:protein binding; IPI:IntAct
O15541	RNF113A	RING finger protein 113A	GO:0008270; F:zinc ion binding; IEA:InterPro
Q7Z4M0	C15orf60	Meiotic recombination protein REC114-like	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q7Z4M0	C15orf60	Meiotic recombination protein REC114-like	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q8IZP6	RNF113B	RING finger protein 113B	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6NVV1	RPL13AP3	Putative 60S ribosomal protein L13a protein RPL13AP3	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q6NVV1	RPL13AP3	Putative 60S ribosomal protein L13a protein RPL13AP3	GO:0006412; P:translation; IEA:InterPro
P50876	RNF144A	Probable E3 ubiquitin-protein ligase RNF144A	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
P50876	RNF144A	Probable E3 ubiquitin-protein ligase RNF144A	GO:0008270; F:zinc ion binding; IEA:InterPro
P50876	RNF144A	Probable E3 ubiquitin-protein ligase RNF144A	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q7Z419	RNF144B	E3 ubiquitin-protein ligase RNF144B	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z419	RNF144B	E3 ubiquitin-protein ligase RNF144B	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q7Z419	RNF144B	E3 ubiquitin-protein ligase RNF144B	GO:0008270; F:zinc ion binding; IEA:InterPro
Q7Z419	RNF144B	E3 ubiquitin-protein ligase RNF144B	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q7Z419	RNF144B	E3 ubiquitin-protein ligase RNF144B	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q59GN2	RPL39P5	Putative 60S ribosomal protein L39-like 5	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q59GN2	RPL39P5	Putative 60S ribosomal protein L39-like 5	GO:0006412; P:translation; IEA:InterPro
Q9Y3T6	R3HCC1	R3H and coiled-coil domain-containing protein 1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9Y3T6	R3HCC1	R3H and coiled-coil domain-containing protein 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q7Z5L2	R3HCC1L	Coiled-coil domain-containing protein R3HCC1L	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8TBN0	RAB3IL1	Guanine nucleotide exchange factor for Rab-3A	GO:0005515; F:protein binding; IPI:IntAct
Q8TBN0	RAB3IL1	Guanine nucleotide exchange factor for Rab-3A	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q8TBN0	RAB3IL1	Guanine nucleotide exchange factor for Rab-3A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8TBN0	RAB3IL1	Guanine nucleotide exchange factor for Rab-3A	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
Q15032	R3HDM1	R3H domain-containing protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y2K5	R3HDM2	R3H domain-containing protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96D70	R3HDM4	R3H domain-containing protein 4	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q86UN2	RTN4RL1	Reticulon-4 receptor-like 1	GO:0004872; F:receptor activity; IDA:UniProtKB
Q86UN2	RTN4RL1	Reticulon-4 receptor-like 1	GO:0031103; P:axon regeneration; TAS:UniProtKB
Q96B01	RAD51AP1	RAD51-associated protein 1	GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB
Q96B01	RAD51AP1	RAD51-associated protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q96B01	RAD51AP1	RAD51-associated protein 1	GO:0003723; F:RNA binding; IDA:UniProtKB
Q96B01	RAD51AP1	RAD51-associated protein 1	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
Q96B01	RAD51AP1	RAD51-associated protein 1	GO:0071479; P:cellular response to ionizing radiation; IDA:UniProtKB
Q96B01	RAD51AP1	RAD51-associated protein 1	GO:0006281; P:DNA repair; NAS:UniProtKB
Q96B01	RAD51AP1	RAD51-associated protein 1	GO:0000724; P:double-strand break repair via homologous recombination; NAS:UniProtKB
Q96B01	RAD51AP1	RAD51-associated protein 1	GO:0010569; P:regulation of double-strand break repair via homologous recombination; IDA:UniProtKB
Q86UN3	RTN4RL2	Reticulon-4 receptor-like 2	GO:0004872; F:receptor activity; IDA:UniProtKB
Q86UN3	RTN4RL2	Reticulon-4 receptor-like 2	GO:0031103; P:axon regeneration; TAS:UniProtKB
Q6MZT1	RGS7BP	Regulator of G-protein signaling 7-binding protein	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:Ensembl
Q6MZT1	RGS7BP	Regulator of G-protein signaling 7-binding protein	GO:0009968; P:negative regulation of signal transduction; IEA:UniProtKB-KW
Q6ZS82	RGS9BP	Regulator of G-protein signaling 9-binding protein	GO:0050908; P:detection of light stimulus involved in visual perception; IEA:Ensembl
Q6ZS82	RGS9BP	Regulator of G-protein signaling 9-binding protein	GO:0009968; P:negative regulation of signal transduction; IEA:UniProtKB-KW
Q6ZS82	RGS9BP	Regulator of G-protein signaling 9-binding protein	GO:0007603; P:phototransduction, visible light; TAS:Reactome
Q6ZS82	RGS9BP	Regulator of G-protein signaling 9-binding protein	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
Q6ZS82	RGS9BP	Regulator of G-protein signaling 9-binding protein	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
Q32P51	HNRNPA1L2	Heterogeneous nuclear ribonucleoprotein A1-like 2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q32P51	HNRNPA1L2	Heterogeneous nuclear ribonucleoprotein A1-like 2	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q32P51	HNRNPA1L2	Heterogeneous nuclear ribonucleoprotein A1-like 2	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q32P51	HNRNPA1L2	Heterogeneous nuclear ribonucleoprotein A1-like 2	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q32P51	HNRNPA1L2	Heterogeneous nuclear ribonucleoprotein A1-like 2	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
O15315	RAD51B	DNA repair protein RAD51 homolog 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O15315	RAD51B	DNA repair protein RAD51 homolog 2	GO:0003677; F:DNA binding; TAS:ProtInc
O15315	RAD51B	DNA repair protein RAD51 homolog 2	GO:0008094; F:DNA-dependent ATPase activity; IDA:UniProtKB
O15315	RAD51B	DNA repair protein RAD51 homolog 2	GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB
O15315	RAD51B	DNA repair protein RAD51 homolog 2	GO:0005515; F:protein binding; IPI:IntAct
O15315	RAD51B	DNA repair protein RAD51 homolog 2	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
O15315	RAD51B	DNA repair protein RAD51 homolog 2	GO:0006200; P:ATP catabolic process; IDA:GOC
O15315	RAD51B	DNA repair protein RAD51 homolog 2	GO:0007596; P:blood coagulation; TAS:Reactome
O15315	RAD51B	DNA repair protein RAD51 homolog 2	GO:0006310; P:DNA recombination; TAS:ProtInc
O15315	RAD51B	DNA repair protein RAD51 homolog 2	GO:0006281; P:DNA repair; TAS:ProtInc
O15315	RAD51B	DNA repair protein RAD51 homolog 2	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
O15315	RAD51B	DNA repair protein RAD51 homolog 2	GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IMP:UniProtKB
O15315	RAD51B	DNA repair protein RAD51 homolog 2	GO:0007131; P:reciprocal meiotic recombination; TAS:ProtInc
O43502	RAD51C	DNA repair protein RAD51 homolog 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43502	RAD51C	DNA repair protein RAD51 homolog 3	GO:0008821; F:crossover junction endodeoxyribonuclease activity; IEA:Ensembl
O43502	RAD51C	DNA repair protein RAD51 homolog 3	GO:0003677; F:DNA binding; TAS:ProtInc
O43502	RAD51C	DNA repair protein RAD51 homolog 3	GO:0008094; F:DNA-dependent ATPase activity; IEA:InterPro
O43502	RAD51C	DNA repair protein RAD51 homolog 3	GO:0005515; F:protein binding; IPI:IntAct
O43502	RAD51C	DNA repair protein RAD51 homolog 3	GO:0007596; P:blood coagulation; TAS:Reactome
O43502	RAD51C	DNA repair protein RAD51 homolog 3	GO:0000737; P:DNA catabolic process, endonucleolytic; IMP:GOC
O43502	RAD51C	DNA repair protein RAD51 homolog 3	GO:0006310; P:DNA recombination; IDA:UniProtKB
O43502	RAD51C	DNA repair protein RAD51 homolog 3	GO:0006281; P:DNA repair; IDA:UniProtKB
O43502	RAD51C	DNA repair protein RAD51 homolog 3	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
O43502	RAD51C	DNA repair protein RAD51 homolog 3	GO:0007066; P:female meiosis sister chromatid cohesion; IEA:Ensembl
O43502	RAD51C	DNA repair protein RAD51 homolog 3	GO:0007141; P:male meiosis I; IEA:Ensembl
O43502	RAD51C	DNA repair protein RAD51 homolog 3	GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IMP:UniProtKB
O43502	RAD51C	DNA repair protein RAD51 homolog 3	GO:0007131; P:reciprocal meiotic recombination; IEA:Ensembl
O43502	RAD51C	DNA repair protein RAD51 homolog 3	GO:0007062; P:sister chromatid cohesion; ISS:UniProtKB
O43502	RAD51C	DNA repair protein RAD51 homolog 3	GO:0007283; P:spermatogenesis; IEA:Ensembl
O75771	RAD51D	DNA repair protein RAD51 homolog 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75771	RAD51D	DNA repair protein RAD51 homolog 4	GO:0003677; F:DNA binding; TAS:ProtInc
O75771	RAD51D	DNA repair protein RAD51 homolog 4	GO:0008094; F:DNA-dependent ATPase activity; IDA:UniProtKB
O75771	RAD51D	DNA repair protein RAD51 homolog 4	GO:0043015; F:gamma-tubulin binding; IDA:UniProtKB
O75771	RAD51D	DNA repair protein RAD51 homolog 4	GO:0005515; F:protein binding; IPI:IntAct
O75771	RAD51D	DNA repair protein RAD51 homolog 4	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
O75771	RAD51D	DNA repair protein RAD51 homolog 4	GO:0006200; P:ATP catabolic process; IDA:GOC
O75771	RAD51D	DNA repair protein RAD51 homolog 4	GO:0006281; P:DNA repair; TAS:ProtInc
O75771	RAD51D	DNA repair protein RAD51 homolog 4	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
O75771	RAD51D	DNA repair protein RAD51 homolog 4	GO:0007131; P:reciprocal meiotic recombination; TAS:ProtInc
O75771	RAD51D	DNA repair protein RAD51 homolog 4	GO:0042148; P:strand invasion; IDA:UniProtKB
O75771	RAD51D	DNA repair protein RAD51 homolog 4	GO:0000723; P:telomere maintenance; IMP:UniProtKB
Q9Y620	RAD54B	DNA repair and recombination protein RAD54B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y620	RAD54B	DNA repair and recombination protein RAD54B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y620	RAD54B	DNA repair and recombination protein RAD54B	GO:0003678; F:DNA helicase activity; TAS:ProtInc
Q9Y620	RAD54B	DNA repair and recombination protein RAD54B	GO:0015616; F:DNA translocase activity; IDA:MGI
Q9Y620	RAD54B	DNA repair and recombination protein RAD54B	GO:0003724; F:RNA helicase activity; TAS:ProtInc
Q9Y620	RAD54B	DNA repair and recombination protein RAD54B	GO:0006200; P:ATP catabolic process; IDA:GOC
Q9Y620	RAD54B	DNA repair and recombination protein RAD54B	GO:0032508; P:DNA duplex unwinding; TAS:GOC
Q9Y620	RAD54B	DNA repair and recombination protein RAD54B	GO:0000724; P:double-strand break repair via homologous recombination; IDA:MGI
Q9Y620	RAD54B	DNA repair and recombination protein RAD54B	GO:0006312; P:mitotic recombination; TAS:ProtInc
Q9Y620	RAD54B	DNA repair and recombination protein RAD54B	GO:0007131; P:reciprocal meiotic recombination; TAS:ProtInc
P61026	RAB10	Ras-related protein Rab-10	GO:0019003; F:GDP binding; IDA:UniProtKB
P61026	RAB10	Ras-related protein Rab-10	GO:0005525; F:GTP binding; IDA:UniProtKB
P61026	RAB10	Ras-related protein Rab-10	GO:0003924; F:GTPase activity; EXP:Reactome
P61026	RAB10	Ras-related protein Rab-10	GO:0031489; F:myosin V binding; IPI:UniProtKB
P61026	RAB10	Ras-related protein Rab-10	GO:0019882; P:antigen processing and presentation; IMP:UniProt
P61026	RAB10	Ras-related protein Rab-10	GO:0007409; P:axonogenesis; ISS:UniProtKB
P61026	RAB10	Ras-related protein Rab-10	GO:0061467; P:basolateral protein localization; ISS:UniProtKB
P61026	RAB10	Ras-related protein Rab-10	GO:0032869; P:cellular response to insulin stimulus; ISS:UniProtKB
P61026	RAB10	Ras-related protein Rab-10	GO:0071786; P:endoplasmic reticulum tubular network organization; IMP:UniProtKB
P61026	RAB10	Ras-related protein Rab-10	GO:0016197; P:endosomal transport; IMP:UniProtKB
P61026	RAB10	Ras-related protein Rab-10	GO:0045200; P:establishment of neuroblast polarity; ISS:UniProtKB
P61026	RAB10	Ras-related protein Rab-10	GO:0097051; P:establishment of protein localization to endoplasmic reticulum membrane; IMP:UniProtKB
P61026	RAB10	Ras-related protein Rab-10	GO:0043001; P:Golgi to plasma membrane protein transport; ISS:UniProtKB
P61026	RAB10	Ras-related protein Rab-10	GO:0006893; P:Golgi to plasma membrane transport; ISS:UniProtKB
P61026	RAB10	Ras-related protein Rab-10	GO:0006184; P:GTP catabolic process; EXP:GOC
P61026	RAB10	Ras-related protein Rab-10	GO:0061024; P:membrane organization; TAS:Reactome
P61026	RAB10	Ras-related protein Rab-10	GO:0030859; P:polarized epithelial cell differentiation; ISS:UniProtKB
P61026	RAB10	Ras-related protein Rab-10	GO:0072659; P:protein localization to plasma membrane; ISS:UniProtKB
P61026	RAB10	Ras-related protein Rab-10	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P61026	RAB10	Ras-related protein Rab-10	GO:0016192; P:vesicle-mediated transport; ISS:UniProtKB
Q6IQ22	RAB12	Ras-related protein Rab-12	GO:0019003; F:GDP binding; IDA:UniProtKB
Q6IQ22	RAB12	Ras-related protein Rab-12	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q6IQ22	RAB12	Ras-related protein Rab-12	GO:0044257; P:cellular protein catabolic process; ISS:UniProtKB
Q6IQ22	RAB12	Ras-related protein Rab-12	GO:0008333; P:endosome to lysosome transport; ISS:UniProtKB
Q6IQ22	RAB12	Ras-related protein Rab-12	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q6IQ22	RAB12	Ras-related protein Rab-12	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P59190	RAB15	Ras-related protein Rab-15	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P59190	RAB15	Ras-related protein Rab-15	GO:0005515; F:protein binding; IPI:UniProt
P59190	RAB15	Ras-related protein Rab-15	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P59190	RAB15	Ras-related protein Rab-15	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9NP72	RAB18	Ras-related protein Rab-18	GO:0019003; F:GDP binding; IDA:UniProtKB
Q9NP72	RAB18	Ras-related protein Rab-18	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9NP72	RAB18	Ras-related protein Rab-18	GO:0003924; F:GTPase activity; NAS:UniProtKB
Q9NP72	RAB18	Ras-related protein Rab-18	GO:0005515; F:protein binding; IPI:IntAct
Q9NP72	RAB18	Ras-related protein Rab-18	GO:0007420; P:brain development; ISS:UniProtKB
Q9NP72	RAB18	Ras-related protein Rab-18	GO:0001654; P:eye development; ISS:UniProtKB
Q9NP72	RAB18	Ras-related protein Rab-18	GO:0006184; P:GTP catabolic process; NAS:GOC
Q9NP72	RAB18	Ras-related protein Rab-18	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9NP72	RAB18	Ras-related protein Rab-18	GO:0007264; P:small GTPase mediated signal transduction; NAS:UniProtKB
A4D1S5	RAB19	Ras-related protein Rab-19	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
A4D1S5	RAB19	Ras-related protein Rab-19	GO:0015031; P:protein transport; IEA:InterPro
A4D1S5	RAB19	Ras-related protein Rab-19	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P61106	RAB14	Ras-related protein Rab-14	GO:0019003; F:GDP binding; IDA:UniProtKB
P61106	RAB14	Ras-related protein Rab-14	GO:0005525; F:GTP binding; IDA:UniProtKB
P61106	RAB14	Ras-related protein Rab-14	GO:0003924; F:GTPase activity; IDA:UniProtKB
P61106	RAB14	Ras-related protein Rab-14	GO:0005515; F:protein binding; IPI:UniProtKB
P61106	RAB14	Ras-related protein Rab-14	GO:0009790; P:embryo development; ISS:UniProtKB
P61106	RAB14	Ras-related protein Rab-14	GO:0032456; P:endocytic recycling; IDA:UniProtKB
P61106	RAB14	Ras-related protein Rab-14	GO:0008543; P:fibroblast growth factor receptor signaling pathway; ISS:UniProtKB
P61106	RAB14	Ras-related protein Rab-14	GO:0006895; P:Golgi to endosome transport; ISS:UniProtKB
P61106	RAB14	Ras-related protein Rab-14	GO:0006184; P:GTP catabolic process; IDA:GOC
P61106	RAB14	Ras-related protein Rab-14	GO:0046907; P:intracellular transport; NAS:UniProtKB
P61106	RAB14	Ras-related protein Rab-14	GO:0061024; P:membrane organization; TAS:Reactome
P61106	RAB14	Ras-related protein Rab-14	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P61106	RAB14	Ras-related protein Rab-14	GO:0032880; P:regulation of protein localization; IDA:UniProtKB
P61106	RAB14	Ras-related protein Rab-14	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P61106	RAB14	Ras-related protein Rab-14	GO:0016192; P:vesicle-mediated transport; NAS:UniProtKB
P51153	RAB13	Ras-related protein Rab-13	GO:0005525; F:GTP binding; IDA:UniProtKB
P51153	RAB13	Ras-related protein Rab-13	GO:0003924; F:GTPase activity; EXP:Reactome
P51153	RAB13	Ras-related protein Rab-13	GO:0005515; F:protein binding; IPI:UniProtKB
P51153	RAB13	Ras-related protein Rab-13	GO:0032869; P:cellular response to insulin stimulus; ISS:UniProtKB
P51153	RAB13	Ras-related protein Rab-13	GO:0030866; P:cortical actin cytoskeleton organization; ISS:UniProtKB
P51153	RAB13	Ras-related protein Rab-13	GO:0032456; P:endocytic recycling; IMP:UniProtKB
P51153	RAB13	Ras-related protein Rab-13	GO:0016197; P:endosomal transport; IMP:UniProtKB
P51153	RAB13	Ras-related protein Rab-13	GO:0035767; P:endothelial cell chemotaxis; ISS:UniProtKB
P51153	RAB13	Ras-related protein Rab-13	GO:0090002; P:establishment of protein localization to plasma membrane; IMP:UniProtKB
P51153	RAB13	Ras-related protein Rab-13	GO:0097368; P:establishment of Sertoli cell barrier; ISS:UniProtKB
P51153	RAB13	Ras-related protein Rab-13	GO:0006184; P:GTP catabolic process; EXP:GOC
P51153	RAB13	Ras-related protein Rab-13	GO:0061024; P:membrane organization; TAS:Reactome
P51153	RAB13	Ras-related protein Rab-13	GO:0031175; P:neuron projection development; IMP:UniProtKB
P51153	RAB13	Ras-related protein Rab-13	GO:0010737; P:protein kinase A signaling; IMP:UniProtKB
P51153	RAB13	Ras-related protein Rab-13	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P51153	RAB13	Ras-related protein Rab-13	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P51153	RAB13	Ras-related protein Rab-13	GO:0070830; P:tight junction assembly; IMP:UniProtKB
P51153	RAB13	Ras-related protein Rab-13	GO:0044795; P:trans-Golgi network to recycling endosome transport; ISS:UniProtKB
P62820	RAB1A	Ras-related protein Rab-1A	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P62820	RAB1A	Ras-related protein Rab-1A	GO:0003924; F:GTPase activity; IDA:UniProtKB
P62820	RAB1A	Ras-related protein Rab-1A	GO:0005515; F:protein binding; IPI:UniProtKB
P62820	RAB1A	Ras-related protein Rab-1A	GO:0000045; P:autophagic vacuole assembly; IMP:UniProtKB
P62820	RAB1A	Ras-related protein Rab-1A	GO:0006914; P:autophagy; IMP:UniProtKB
P62820	RAB1A	Ras-related protein Rab-1A	GO:0016477; P:cell migration; IMP:UniProtKB
P62820	RAB1A	Ras-related protein Rab-1A	GO:0042742; P:defense response to bacterium; IMP:UniProtKB
P62820	RAB1A	Ras-related protein Rab-1A	GO:0006897; P:endocytosis; IMP:UniProtKB
P62820	RAB1A	Ras-related protein Rab-1A	GO:0006888; P:ER to Golgi vesicle-mediated transport; IMP:UniProtKB
P62820	RAB1A	Ras-related protein Rab-1A	GO:0030252; P:growth hormone secretion; IMP:UniProtKB
P62820	RAB1A	Ras-related protein Rab-1A	GO:0006184; P:GTP catabolic process; IDA:UniProtKB
P62820	RAB1A	Ras-related protein Rab-1A	GO:0072606; P:interleukin-8 secretion; IMP:UniProtKB
P62820	RAB1A	Ras-related protein Rab-1A	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P62820	RAB1A	Ras-related protein Rab-1A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P62820	RAB1A	Ras-related protein Rab-1A	GO:0047496; P:vesicle transport along microtubule; IMP:UniProtKB
P62820	RAB1A	Ras-related protein Rab-1A	GO:0016192; P:vesicle-mediated transport; TAS:ProtInc
Q9H0U4	RAB1B	Ras-related protein Rab-1B	GO:0005525; F:GTP binding; IDA:UniProtKB
Q9H0U4	RAB1B	Ras-related protein Rab-1B	GO:0005515; F:protein binding; IPI:IntAct
Q9H0U4	RAB1B	Ras-related protein Rab-1B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9H0U4	RAB1B	Ras-related protein Rab-1B	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9H0T7	RAB17	Ras-related protein Rab-17	GO:0019003; F:GDP binding; IDA:UniProtKB
Q9H0T7	RAB17	Ras-related protein Rab-17	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9H0T7	RAB17	Ras-related protein Rab-17	GO:0032456; P:endocytic recycling; ISS:UniProtKB
Q9H0T7	RAB17	Ras-related protein Rab-17	GO:0032401; P:establishment of melanosome localization; ISS:UniProtKB
Q9H0T7	RAB17	Ras-related protein Rab-17	GO:0046847; P:filopodium assembly; ISS:UniProtKB
Q9H0T7	RAB17	Ras-related protein Rab-17	GO:0002415; P:immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor; ISS:UniProtKB
Q9H0T7	RAB17	Ras-related protein Rab-17	GO:0032402; P:melanosome transport; ISS:UniProtKB
Q9H0T7	RAB17	Ras-related protein Rab-17	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9H0T7	RAB17	Ras-related protein Rab-17	GO:0050773; P:regulation of dendrite development; ISS:UniProtKB
Q9H0T7	RAB17	Ras-related protein Rab-17	GO:0051489; P:regulation of filopodium assembly; ISS:UniProtKB
Q9H0T7	RAB17	Ras-related protein Rab-17	GO:0051963; P:regulation of synapse assembly; ISS:UniProtKB
Q9H0T7	RAB17	Ras-related protein Rab-17	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9H0T7	RAB17	Ras-related protein Rab-17	GO:0045056; P:transcytosis; ISS:UniProtKB
Q92928	RAB1C	Putative Ras-related protein Rab-1C	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q92928	RAB1C	Putative Ras-related protein Rab-1C	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q92928	RAB1C	Putative Ras-related protein Rab-1C	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9NX57	RAB20	Ras-related protein Rab-20	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9NX57	RAB20	Ras-related protein Rab-20	GO:0090383; P:phagosome acidification; IMP:UniProtKB
Q9NX57	RAB20	Ras-related protein Rab-20	GO:0090385; P:phagosome-lysosome fusion; IMP:UniProtKB
Q9NX57	RAB20	Ras-related protein Rab-20	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9NX57	RAB20	Ras-related protein Rab-20	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9UL25	RAB21	Ras-related protein Rab-21	GO:0019003; F:GDP binding; IDA:UniProtKB
Q9UL25	RAB21	Ras-related protein Rab-21	GO:0005525; F:GTP binding; IDA:UniProtKB
Q9UL25	RAB21	Ras-related protein Rab-21	GO:0003924; F:GTPase activity; IDA:UniProtKB
Q9UL25	RAB21	Ras-related protein Rab-21	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UL25	RAB21	Ras-related protein Rab-21	GO:0006184; P:GTP catabolic process; IDA:GOC
Q9UL25	RAB21	Ras-related protein Rab-21	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9UL25	RAB21	Ras-related protein Rab-21	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q969Q5	RAB24	Ras-related protein Rab-24	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q969Q5	RAB24	Ras-related protein Rab-24	GO:0005515; F:protein binding; IPI:UniProtKB
Q969Q5	RAB24	Ras-related protein Rab-24	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q969Q5	RAB24	Ras-related protein Rab-24	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q969Q5	RAB24	Ras-related protein Rab-24	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9ULC3	RAB23	Ras-related protein Rab-23	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9ULC3	RAB23	Ras-related protein Rab-23	GO:0003924; F:GTPase activity; IDA:UniProtKB
Q9ULC3	RAB23	Ras-related protein Rab-23	GO:0000045; P:autophagic vacuole assembly; IMP:UniProtKB
Q9ULC3	RAB23	Ras-related protein Rab-23	GO:0006968; P:cellular defense response; IMP:UniProtKB
Q9ULC3	RAB23	Ras-related protein Rab-23	GO:0097094; P:craniofacial suture morphogenesis; IMP:UniProtKB
Q9ULC3	RAB23	Ras-related protein Rab-23	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
Q9ULC3	RAB23	Ras-related protein Rab-23	GO:0006184; P:GTP catabolic process; IDA:UniProtKB
Q9ULC3	RAB23	Ras-related protein Rab-23	GO:0045861; P:negative regulation of proteolysis; IEA:Ensembl
Q9ULC3	RAB23	Ras-related protein Rab-23	GO:0042992; P:negative regulation of transcription factor import into nucleus; IMP:UniProtKB
Q9ULC3	RAB23	Ras-related protein Rab-23	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9ULC3	RAB23	Ras-related protein Rab-23	GO:0008589; P:regulation of smoothened signaling pathway; IEA:Ensembl
Q9ULC3	RAB23	Ras-related protein Rab-23	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9ULC3	RAB23	Ras-related protein Rab-23	GO:0021513; P:spinal cord dorsal/ventral patterning; IEA:Ensembl
P57735	RAB25	Ras-related protein Rab-25	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P57735	RAB25	Ras-related protein Rab-25	GO:0005515; F:protein binding; IPI:UniProtKB
P57735	RAB25	Ras-related protein Rab-25	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P57735	RAB25	Ras-related protein Rab-25	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P57735	RAB25	Ras-related protein Rab-25	GO:0031268; P:pseudopodium organization; IDA:UniProtKB
P57735	RAB25	Ras-related protein Rab-25	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9ULW5	RAB26	Ras-related protein Rab-26	GO:0019002; F:GMP binding; IMP:UniProtKB
Q9ULW5	RAB26	Ras-related protein Rab-26	GO:0005525; F:GTP binding; IMP:UniProtKB
Q9ULW5	RAB26	Ras-related protein Rab-26	GO:0035272; P:exocrine system development; IMP:UniProtKB
Q9ULW5	RAB26	Ras-related protein Rab-26	GO:0043001; P:Golgi to plasma membrane protein transport; IMP:UniProtKB
Q9ULW5	RAB26	Ras-related protein Rab-26	GO:0045055; P:regulated secretory pathway; IMP:UniProtKB
Q9ULW5	RAB26	Ras-related protein Rab-26	GO:0017157; P:regulation of exocytosis; ISS:UniProtKB
Q9ULW5	RAB26	Ras-related protein Rab-26	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P51157	RAB28	Ras-related protein Rab-28	GO:0019003; F:GDP binding; IDA:UniProtKB
P51157	RAB28	Ras-related protein Rab-28	GO:0005525; F:GTP binding; IDA:UniProtKB
P51157	RAB28	Ras-related protein Rab-28	GO:0003924; F:GTPase activity; TAS:ProtInc
P51157	RAB28	Ras-related protein Rab-28	GO:0006184; P:GTP catabolic process; TAS:GOC
P51157	RAB28	Ras-related protein Rab-28	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P61019	RAB2A	Ras-related protein Rab-2A	GO:0019003; F:GDP binding; IDA:UniProtKB
P61019	RAB2A	Ras-related protein Rab-2A	GO:0005525; F:GTP binding; IDA:UniProtKB
P61019	RAB2A	Ras-related protein Rab-2A	GO:0003924; F:GTPase activity; IDA:UniProtKB
P61019	RAB2A	Ras-related protein Rab-2A	GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:ProtInc
P61019	RAB2A	Ras-related protein Rab-2A	GO:0006184; P:GTP catabolic process; IDA:GOC
P61019	RAB2A	Ras-related protein Rab-2A	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P61019	RAB2A	Ras-related protein Rab-2A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P61019	RAB2A	Ras-related protein Rab-2A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q8WUD1	RAB2B	Ras-related protein Rab-2B	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q8WUD1	RAB2B	Ras-related protein Rab-2B	GO:0045921; P:positive regulation of exocytosis; IMP:UniProtKB
Q8WUD1	RAB2B	Ras-related protein Rab-2B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8WUD1	RAB2B	Ras-related protein Rab-2B	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q8WUD1	RAB2B	Ras-related protein Rab-2B	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q15771	RAB30	Ras-related protein Rab-30	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q15771	RAB30	Ras-related protein Rab-30	GO:0003924; F:GTPase activity; TAS:ProtInc
Q15771	RAB30	Ras-related protein Rab-30	GO:0007030; P:Golgi organization; IMP:UniProtKB
Q15771	RAB30	Ras-related protein Rab-30	GO:0006184; P:GTP catabolic process; TAS:GOC
Q15771	RAB30	Ras-related protein Rab-30	GO:0015031; P:protein transport; IEA:InterPro
Q15771	RAB30	Ras-related protein Rab-30	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q13637	RAB32	Ras-related protein Rab-32	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q13637	RAB32	Ras-related protein Rab-32	GO:0019882; P:antigen processing and presentation; IMP:UniProt
Q13637	RAB32	Ras-related protein Rab-32	GO:0090382; P:phagosome maturation; IMP:UniProtKB
Q13637	RAB32	Ras-related protein Rab-32	GO:0015031; P:protein transport; IEA:InterPro
Q13637	RAB32	Ras-related protein Rab-32	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q13636	RAB31	Ras-related protein Rab-31	GO:0019003; F:GDP binding; IDA:UniProtKB
Q13636	RAB31	Ras-related protein Rab-31	GO:0005525; F:GTP binding; IDA:UniProtKB
Q13636	RAB31	Ras-related protein Rab-31	GO:0003924; F:GTPase activity; TAS:ProtInc
Q13636	RAB31	Ras-related protein Rab-31	GO:0032869; P:cellular response to insulin stimulus; IMP:UniProtKB
Q13636	RAB31	Ras-related protein Rab-31	GO:0043001; P:Golgi to plasma membrane protein transport; IMP:UniProtKB
Q13636	RAB31	Ras-related protein Rab-31	GO:0006184; P:GTP catabolic process; TAS:GOC
Q13636	RAB31	Ras-related protein Rab-31	GO:0090382; P:phagosome maturation; IMP:UniProtKB
Q13636	RAB31	Ras-related protein Rab-31	GO:0031623; P:receptor internalization; IMP:UniProtKB
Q13636	RAB31	Ras-related protein Rab-31	GO:0045055; P:regulated secretory pathway; IMP:UniProtKB
Q13636	RAB31	Ras-related protein Rab-31	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9BZG1	RAB34	Ras-related protein Rab-34	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9BZG1	RAB34	Ras-related protein Rab-34	GO:0005515; F:protein binding; IPI:UniProt
Q9BZG1	RAB34	Ras-related protein Rab-34	GO:0019882; P:antigen processing and presentation; IMP:UniProt
Q9BZG1	RAB34	Ras-related protein Rab-34	GO:0043001; P:Golgi to plasma membrane protein transport; IDA:UniProt
Q9BZG1	RAB34	Ras-related protein Rab-34	GO:0032418; P:lysosome localization; IDA:UniProt
Q9BZG1	RAB34	Ras-related protein Rab-34	GO:0090382; P:phagosome maturation; IMP:UniProtKB
Q9BZG1	RAB34	Ras-related protein Rab-34	GO:0090385; P:phagosome-lysosome fusion; IMP:UniProtKB
Q9BZG1	RAB34	Ras-related protein Rab-34	GO:0072659; P:protein localization to plasma membrane; IDA:UniProt
Q9BZG1	RAB34	Ras-related protein Rab-34	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q15286	RAB35	Ras-related protein Rab-35	GO:0019003; F:GDP binding; IDA:UniProtKB
Q15286	RAB35	Ras-related protein Rab-35	GO:0005525; F:GTP binding; IDA:UniProtKB
Q15286	RAB35	Ras-related protein Rab-35	GO:0003924; F:GTPase activity; TAS:ProtInc
Q15286	RAB35	Ras-related protein Rab-35	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProtKB
Q15286	RAB35	Ras-related protein Rab-35	GO:0005515; F:protein binding; IPI:IntAct
Q15286	RAB35	Ras-related protein Rab-35	GO:0019882; P:antigen processing and presentation; IMP:UniProt
Q15286	RAB35	Ras-related protein Rab-35	GO:1990090; P:cellular response to nerve growth factor stimulus; ISS:UniProtKB
Q15286	RAB35	Ras-related protein Rab-35	GO:0000910; P:cytokinesis; IMP:UniProtKB
Q15286	RAB35	Ras-related protein Rab-35	GO:0016197; P:endosomal transport; IMP:UniProtKB
Q15286	RAB35	Ras-related protein Rab-35	GO:0006184; P:GTP catabolic process; TAS:GOC
Q15286	RAB35	Ras-related protein Rab-35	GO:0031175; P:neuron projection development; ISS:UniProtKB
Q15286	RAB35	Ras-related protein Rab-35	GO:0008104; P:protein localization; IMP:UniProtKB
Q15286	RAB35	Ras-related protein Rab-35	GO:0036010; P:protein localization to endosome; IMP:UniProtKB
Q15286	RAB35	Ras-related protein Rab-35	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q15286	RAB35	Ras-related protein Rab-35	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
O95755	RAB36	Ras-related protein Rab-36	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
O95755	RAB36	Ras-related protein Rab-36	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O95755	RAB36	Ras-related protein Rab-36	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q96AX2	RAB37	Ras-related protein Rab-37	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q96AX2	RAB37	Ras-related protein Rab-37	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96AX2	RAB37	Ras-related protein Rab-37	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P57729	RAB38	Ras-related protein Rab-38	GO:0005525; F:GTP binding; NAS:UniProtKB
P57729	RAB38	Ras-related protein Rab-38	GO:0003924; F:GTPase activity; NAS:UniProtKB
P57729	RAB38	Ras-related protein Rab-38	GO:0006184; P:GTP catabolic process; NAS:GOC
P57729	RAB38	Ras-related protein Rab-38	GO:0090383; P:phagosome acidification; IMP:UniProtKB
P57729	RAB38	Ras-related protein Rab-38	GO:0060155; P:platelet dense granule organization; IEA:Ensembl
P57729	RAB38	Ras-related protein Rab-38	GO:0015031; P:protein transport; NAS:UniProtKB
P57729	RAB38	Ras-related protein Rab-38	GO:0007264; P:small GTPase mediated signal transduction; NAS:UniProtKB
P20336	RAB3A	Ras-related protein Rab-3A	GO:0001671; F:ATPase activator activity; IEA:Ensembl
P20336	RAB3A	Ras-related protein Rab-3A	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P20336	RAB3A	Ras-related protein Rab-3A	GO:0003924; F:GTPase activity; IMP:UniProtKB
P20336	RAB3A	Ras-related protein Rab-3A	GO:0005515; F:protein binding; IPI:UniProtKB
P20336	RAB3A	Ras-related protein Rab-3A	GO:0007409; P:axonogenesis; IEA:Ensembl
P20336	RAB3A	Ras-related protein Rab-3A	GO:0014047; P:glutamate secretion; TAS:Reactome
P20336	RAB3A	Ras-related protein Rab-3A	GO:0006184; P:GTP catabolic process; IMP:GOC
P20336	RAB3A	Ras-related protein Rab-3A	GO:0030324; P:lung development; IEA:Ensembl
P20336	RAB3A	Ras-related protein Rab-3A	GO:0048790; P:maintenance of presynaptic active zone structure; IEA:Ensembl
P20336	RAB3A	Ras-related protein Rab-3A	GO:0007005; P:mitochondrion organization; IEA:Ensembl
P20336	RAB3A	Ras-related protein Rab-3A	GO:0007274; P:neuromuscular synaptic transmission; IEA:Ensembl
P20336	RAB3A	Ras-related protein Rab-3A	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
P20336	RAB3A	Ras-related protein Rab-3A	GO:0009791; P:post-embryonic development; IEA:Ensembl
P20336	RAB3A	Ras-related protein Rab-3A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P20336	RAB3A	Ras-related protein Rab-3A	GO:0031630; P:regulation of synaptic vesicle fusion to presynaptic membrane; IEA:Ensembl
P20336	RAB3A	Ras-related protein Rab-3A	GO:0003016; P:respiratory system process; IEA:Ensembl
P20336	RAB3A	Ras-related protein Rab-3A	GO:0051602; P:response to electrical stimulus; IEA:Ensembl
P20336	RAB3A	Ras-related protein Rab-3A	GO:0050975; P:sensory perception of touch; IEA:Ensembl
P20336	RAB3A	Ras-related protein Rab-3A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P20336	RAB3A	Ras-related protein Rab-3A	GO:0007268; P:synaptic transmission; TAS:Reactome
P20336	RAB3A	Ras-related protein Rab-3A	GO:0016079; P:synaptic vesicle exocytosis; IEA:Ensembl
P20336	RAB3A	Ras-related protein Rab-3A	GO:0016188; P:synaptic vesicle maturation; IEA:Ensembl
P20337	RAB3B	Ras-related protein Rab-3B	GO:0019003; F:GDP binding; IDA:UniProt
P20337	RAB3B	Ras-related protein Rab-3B	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P20337	RAB3B	Ras-related protein Rab-3B	GO:0019882; P:antigen processing and presentation; IMP:UniProt
P20337	RAB3B	Ras-related protein Rab-3B	GO:0018125; P:peptidyl-cysteine methylation; IEA:Ensembl
P20337	RAB3B	Ras-related protein Rab-3B	GO:0051586; P:positive regulation of dopamine uptake involved in synaptic transmission; IDA:UniProt
P20337	RAB3B	Ras-related protein Rab-3B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P20337	RAB3B	Ras-related protein Rab-3B	GO:0017157; P:regulation of exocytosis; IEA:Ensembl
P20337	RAB3B	Ras-related protein Rab-3B	GO:0097494; P:regulation of vesicle size; IDA:UniProt
P20337	RAB3B	Ras-related protein Rab-3B	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q96E17	RAB3C	Ras-related protein Rab-3C	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q96E17	RAB3C	Ras-related protein Rab-3C	GO:0019882; P:antigen processing and presentation; IMP:UniProt
Q96E17	RAB3C	Ras-related protein Rab-3C	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96E17	RAB3C	Ras-related protein Rab-3C	GO:0017157; P:regulation of exocytosis; IEA:Ensembl
Q96E17	RAB3C	Ras-related protein Rab-3C	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
O95716	RAB3D	Ras-related protein Rab-3D	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
O95716	RAB3D	Ras-related protein Rab-3D	GO:0003924; F:GTPase activity; TAS:ProtInc
O95716	RAB3D	Ras-related protein Rab-3D	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
O95716	RAB3D	Ras-related protein Rab-3D	GO:0006184; P:GTP catabolic process; TAS:GOC
O95716	RAB3D	Ras-related protein Rab-3D	GO:0018125; P:peptidyl-cysteine methylation; IEA:Ensembl
O95716	RAB3D	Ras-related protein Rab-3D	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O95716	RAB3D	Ras-related protein Rab-3D	GO:0017157; P:regulation of exocytosis; IEA:Ensembl
O95716	RAB3D	Ras-related protein Rab-3D	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q96QF0	RAB3IP	Rab-3A-interacting protein	GO:0005515; F:protein binding; IPI:BHF-UCL
Q96QF0	RAB3IP	Rab-3A-interacting protein	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q96QF0	RAB3IP	Rab-3A-interacting protein	GO:0042384; P:cilium assembly; IMP:BHF-UCL
Q96QF0	RAB3IP	Rab-3A-interacting protein	GO:0006893; P:Golgi to plasma membrane transport; TAS:BHF-UCL
Q96QF0	RAB3IP	Rab-3A-interacting protein	GO:0033365; P:protein localization to organelle; IMP:BHF-UCL
Q96QF0	RAB3IP	Rab-3A-interacting protein	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96QF0	RAB3IP	Rab-3A-interacting protein	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
Q5JT25	RAB41	Ras-related protein Rab-41	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q5JT25	RAB41	Ras-related protein Rab-41	GO:0015031; P:protein transport; IEA:InterPro
Q5JT25	RAB41	Ras-related protein Rab-41	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q7Z6P3	RAB44	Ras-related protein Rab-44	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q7Z6P3	RAB44	Ras-related protein Rab-44	GO:0015031; P:protein transport; IEA:InterPro
Q7Z6P3	RAB44	Ras-related protein Rab-44	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q86YS6	RAB43	Ras-related protein Rab-43	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q86YS6	RAB43	Ras-related protein Rab-43	GO:0003924; F:GTPase activity; IDA:UniProtKB
Q86YS6	RAB43	Ras-related protein Rab-43	GO:0007030; P:Golgi organization; IMP:UniProtKB
Q86YS6	RAB43	Ras-related protein Rab-43	GO:0006184; P:GTP catabolic process; IDA:GOC
Q86YS6	RAB43	Ras-related protein Rab-43	GO:0090382; P:phagosome maturation; IMP:UniProtKB
Q86YS6	RAB43	Ras-related protein Rab-43	GO:0015031; P:protein transport; IEA:InterPro
Q86YS6	RAB43	Ras-related protein Rab-43	GO:0035526; P:retrograde transport, plasma membrane to Golgi; IMP:UniProtKB
Q86YS6	RAB43	Ras-related protein Rab-43	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q8N4Z0	RAB42	Putative Ras-related protein Rab-42	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q8N4Z0	RAB42	Putative Ras-related protein Rab-42	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P20338	RAB4A	Ras-related protein Rab-4A	GO:0019003; F:GDP binding; IDA:UniProtKB
P20338	RAB4A	Ras-related protein Rab-4A	GO:0005525; F:GTP binding; IDA:UniProtKB
P20338	RAB4A	Ras-related protein Rab-4A	GO:0003924; F:GTPase activity; IDA:UniProtKB
P20338	RAB4A	Ras-related protein Rab-4A	GO:0005515; F:protein binding; IPI:UniProtKB
P20338	RAB4A	Ras-related protein Rab-4A	GO:0008565; F:protein transporter activity; IEA:Ensembl
P20338	RAB4A	Ras-related protein Rab-4A	GO:0019882; P:antigen processing and presentation; IMP:UniProtKB
P20338	RAB4A	Ras-related protein Rab-4A	GO:0006184; P:GTP catabolic process; IDA:GOC
P20338	RAB4A	Ras-related protein Rab-4A	GO:0061024; P:membrane organization; TAS:Reactome
P20338	RAB4A	Ras-related protein Rab-4A	GO:0030100; P:regulation of endocytosis; IEA:Ensembl
P20338	RAB4A	Ras-related protein Rab-4A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P61018	RAB4B	Ras-related protein Rab-4B	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P61018	RAB4B	Ras-related protein Rab-4B	GO:0046323; P:glucose import; IMP:UniProt
P61018	RAB4B	Ras-related protein Rab-4B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P61018	RAB4B	Ras-related protein Rab-4B	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P20339	RAB5A	Ras-related protein Rab-5A	GO:0019003; F:GDP binding; IDA:UniProtKB
P20339	RAB5A	Ras-related protein Rab-5A	GO:0005525; F:GTP binding; IDA:UniProtKB
P20339	RAB5A	Ras-related protein Rab-5A	GO:0003924; F:GTPase activity; IDA:UniProtKB
P20339	RAB5A	Ras-related protein Rab-5A	GO:0005515; F:protein binding; IPI:UniProtKB
P20339	RAB5A	Ras-related protein Rab-5A	GO:0007596; P:blood coagulation; TAS:Reactome
P20339	RAB5A	Ras-related protein Rab-5A	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P20339	RAB5A	Ras-related protein Rab-5A	GO:0006897; P:endocytosis; IDA:UniProtKB
P20339	RAB5A	Ras-related protein Rab-5A	GO:0006184; P:GTP catabolic process; IDA:GOC
P20339	RAB5A	Ras-related protein Rab-5A	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
P20339	RAB5A	Ras-related protein Rab-5A	GO:0045921; P:positive regulation of exocytosis; IMP:UniProtKB
P20339	RAB5A	Ras-related protein Rab-5A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P20339	RAB5A	Ras-related protein Rab-5A	GO:2000286; P:receptor internalization involved in canonical Wnt signaling pathway; IMP:BHF-UCL
P20339	RAB5A	Ras-related protein Rab-5A	GO:0051489; P:regulation of filopodium assembly; IDA:UniProtKB
P20339	RAB5A	Ras-related protein Rab-5A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P61020	RAB5B	Ras-related protein Rab-5B	GO:0019003; F:GDP binding; IDA:UniProtKB
P61020	RAB5B	Ras-related protein Rab-5B	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P61020	RAB5B	Ras-related protein Rab-5B	GO:0030742; F:GTP-dependent protein binding; IDA:UniProtKB
P61020	RAB5B	Ras-related protein Rab-5B	GO:0003924; F:GTPase activity; TAS:ProtInc
P61020	RAB5B	Ras-related protein Rab-5B	GO:0005515; F:protein binding; IPI:UniProtKB
P61020	RAB5B	Ras-related protein Rab-5B	GO:0019882; P:antigen processing and presentation; IMP:UniProt
P61020	RAB5B	Ras-related protein Rab-5B	GO:0007032; P:endosome organization; IEA:Ensembl
P61020	RAB5B	Ras-related protein Rab-5B	GO:0006184; P:GTP catabolic process; TAS:GOC
P61020	RAB5B	Ras-related protein Rab-5B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P61020	RAB5B	Ras-related protein Rab-5B	GO:0030100; P:regulation of endocytosis; IEA:Ensembl
P61020	RAB5B	Ras-related protein Rab-5B	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P51148	RAB5C	Ras-related protein Rab-5C	GO:0019003; F:GDP binding; IDA:UniProtKB
P51148	RAB5C	Ras-related protein Rab-5C	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P51148	RAB5C	Ras-related protein Rab-5C	GO:0003924; F:GTPase activity; TAS:ProtInc
P51148	RAB5C	Ras-related protein Rab-5C	GO:0007032; P:endosome organization; IEA:Ensembl
P51148	RAB5C	Ras-related protein Rab-5C	GO:0006184; P:GTP catabolic process; TAS:GOC
P51148	RAB5C	Ras-related protein Rab-5C	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P51148	RAB5C	Ras-related protein Rab-5C	GO:0030100; P:regulation of endocytosis; IEA:Ensembl
P51148	RAB5C	Ras-related protein Rab-5C	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P20340	RAB6A	Ras-related protein Rab-6A	GO:0005525; F:GTP binding; IDA:UniProtKB
P20340	RAB6A	Ras-related protein Rab-6A	GO:0003924; F:GTPase activity; IDA:UniProtKB
P20340	RAB6A	Ras-related protein Rab-6A	GO:0005515; F:protein binding; IPI:IntAct
P20340	RAB6A	Ras-related protein Rab-6A	GO:0019904; F:protein domain specific binding; IPI:BHF-UCL
P20340	RAB6A	Ras-related protein Rab-6A	GO:0019882; P:antigen processing and presentation; IMP:UniProt
P20340	RAB6A	Ras-related protein Rab-6A	GO:0006184; P:GTP catabolic process; IDA:GOC
P20340	RAB6A	Ras-related protein Rab-6A	GO:0072385; P:minus-end-directed organelle transport along microtubule; TAS:BHF-UCL
P20340	RAB6A	Ras-related protein Rab-6A	GO:0018125; P:peptidyl-cysteine methylation; IDA:MGI
P20340	RAB6A	Ras-related protein Rab-6A	GO:0034067; P:protein localization to Golgi apparatus; IDA:BHF-UCL
P20340	RAB6A	Ras-related protein Rab-6A	GO:0000042; P:protein targeting to Golgi; IDA:UniProtKB
P20340	RAB6A	Ras-related protein Rab-6A	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; TAS:BHF-UCL
P20340	RAB6A	Ras-related protein Rab-6A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9NRW1	RAB6B	Ras-related protein Rab-6B	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9NRW1	RAB6B	Ras-related protein Rab-6B	GO:0003924; F:GTPase activity; NAS:UniProtKB
Q9NRW1	RAB6B	Ras-related protein Rab-6B	GO:0005515; F:protein binding; IPI:IntAct
Q9NRW1	RAB6B	Ras-related protein Rab-6B	GO:0006184; P:GTP catabolic process; NAS:GOC
Q9NRW1	RAB6B	Ras-related protein Rab-6B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9NRW1	RAB6B	Ras-related protein Rab-6B	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; NAS:UniProtKB
Q9NRW1	RAB6B	Ras-related protein Rab-6B	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9H0N0	RAB6C	Ras-related protein Rab-6C	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9H0N0	RAB6C	Ras-related protein Rab-6C	GO:0003924; F:GTPase activity; IDA:UniProtKB
Q9H0N0	RAB6C	Ras-related protein Rab-6C	GO:0022402; P:cell cycle process; IMP:UniProtKB
Q9H0N0	RAB6C	Ras-related protein Rab-6C	GO:0006184; P:GTP catabolic process; IDA:GOC
Q9H0N0	RAB6C	Ras-related protein Rab-6C	GO:0015031; P:protein transport; IEA:InterPro
Q9H0N0	RAB6C	Ras-related protein Rab-6C	GO:0010824; P:regulation of centrosome duplication; IMP:UniProtKB
Q9H0N0	RAB6C	Ras-related protein Rab-6C	GO:0042493; P:response to drug; IDA:UniProtKB
Q9H0N0	RAB6C	Ras-related protein Rab-6C	GO:0007264; P:small GTPase mediated signal transduction; TAS:UniProtKB
P51149	RAB7A	Ras-related protein Rab-7a	GO:0019003; F:GDP binding; IDA:BHF-UCL
P51149	RAB7A	Ras-related protein Rab-7a	GO:0005525; F:GTP binding; IDA:BHF-UCL
P51149	RAB7A	Ras-related protein Rab-7a	GO:0003924; F:GTPase activity; IDA:BHF-UCL
P51149	RAB7A	Ras-related protein Rab-7a	GO:0005515; F:protein binding; IPI:UniProtKB
P51149	RAB7A	Ras-related protein Rab-7a	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P51149	RAB7A	Ras-related protein Rab-7a	GO:0045453; P:bone resorption; IEA:Ensembl
P51149	RAB7A	Ras-related protein Rab-7a	GO:0008219; P:cell death; IEA:UniProtKB-KW
P51149	RAB7A	Ras-related protein Rab-7a	GO:0045022; P:early endosome to late endosome transport; IMP:UniProtKB
P51149	RAB7A	Ras-related protein Rab-7a	GO:0006897; P:endocytosis; TAS:ProtInc
P51149	RAB7A	Ras-related protein Rab-7a	GO:0008333; P:endosome to lysosome transport; IMP:BHF-UCL
P51149	RAB7A	Ras-related protein Rab-7a	GO:0007174; P:epidermal growth factor catabolic process; IMP:BHF-UCL
P51149	RAB7A	Ras-related protein Rab-7a	GO:0006184; P:GTP catabolic process; IDA:GOC
P51149	RAB7A	Ras-related protein Rab-7a	GO:0090383; P:phagosome acidification; IMP:UniProtKB
P51149	RAB7A	Ras-related protein Rab-7a	GO:0090382; P:phagosome maturation; TAS:UniProtKB
P51149	RAB7A	Ras-related protein Rab-7a	GO:0090385; P:phagosome-lysosome fusion; IMP:UniProtKB
P51149	RAB7A	Ras-related protein Rab-7a	GO:0006622; P:protein targeting to lysosome; IMP:BHF-UCL
P51149	RAB7A	Ras-related protein Rab-7a	GO:0015031; P:protein transport; TAS:UniProtKB
P51149	RAB7A	Ras-related protein Rab-7a	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q96AH8	RAB7B	Ras-related protein Rab-7b	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q96AH8	RAB7B	Ras-related protein Rab-7b	GO:0034499; P:late endosome to Golgi transport; IMP:UniProtKB
Q96AH8	RAB7B	Ras-related protein Rab-7b	GO:0034144; P:negative regulation of toll-like receptor 4 signaling pathway; ISS:UniProtKB
Q96AH8	RAB7B	Ras-related protein Rab-7b	GO:0034164; P:negative regulation of toll-like receptor 9 signaling pathway; ISS:UniProtKB
Q96AH8	RAB7B	Ras-related protein Rab-7b	GO:0032755; P:positive regulation of interleukin-6 production; IMP:UniProtKB
Q96AH8	RAB7B	Ras-related protein Rab-7b	GO:0045654; P:positive regulation of megakaryocyte differentiation; IMP:UniProtKB
Q96AH8	RAB7B	Ras-related protein Rab-7b	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
Q96AH8	RAB7B	Ras-related protein Rab-7b	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96AH8	RAB7B	Ras-related protein Rab-7b	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
O14966	RAB7L1	Ras-related protein Rab-7L1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
O14966	RAB7L1	Ras-related protein Rab-7L1	GO:0003924; F:GTPase activity; TAS:ProtInc
O14966	RAB7L1	Ras-related protein Rab-7L1	GO:0006184; P:GTP catabolic process; TAS:GOC
O14966	RAB7L1	Ras-related protein Rab-7L1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O14966	RAB7L1	Ras-related protein Rab-7L1	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P61006	RAB8A	Ras-related protein Rab-8A	GO:0019003; F:GDP binding; IDA:UniProtKB
P61006	RAB8A	Ras-related protein Rab-8A	GO:0005525; F:GTP binding; IDA:UniProtKB
P61006	RAB8A	Ras-related protein Rab-8A	GO:0003924; F:GTPase activity; EXP:Reactome
P61006	RAB8A	Ras-related protein Rab-8A	GO:0005515; F:protein binding; IPI:UniProtKB
P61006	RAB8A	Ras-related protein Rab-8A	GO:0017137; F:Rab GTPase binding; ISS:UniProtKB
P61006	RAB8A	Ras-related protein Rab-8A	GO:0007409; P:axonogenesis; ISS:UniProtKB
P61006	RAB8A	Ras-related protein Rab-8A	GO:0032869; P:cellular response to insulin stimulus; ISS:UniProtKB
P61006	RAB8A	Ras-related protein Rab-8A	GO:0042384; P:cilium assembly; IMP:UniProtKB
P61006	RAB8A	Ras-related protein Rab-8A	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P61006	RAB8A	Ras-related protein Rab-8A	GO:0048210; P:Golgi vesicle fusion to target membrane; IDA:BHF-UCL
P61006	RAB8A	Ras-related protein Rab-8A	GO:0006184; P:GTP catabolic process; EXP:GOC
P61006	RAB8A	Ras-related protein Rab-8A	GO:0061024; P:membrane organization; TAS:Reactome
P61006	RAB8A	Ras-related protein Rab-8A	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P61006	RAB8A	Ras-related protein Rab-8A	GO:0072659; P:protein localization to plasma membrane; ISS:UniProtKB
P61006	RAB8A	Ras-related protein Rab-8A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P61006	RAB8A	Ras-related protein Rab-8A	GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IEA:Ensembl
P61006	RAB8A	Ras-related protein Rab-8A	GO:0051223; P:regulation of protein transport; IEA:Ensembl
P61006	RAB8A	Ras-related protein Rab-8A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P61006	RAB8A	Ras-related protein Rab-8A	GO:0006904; P:vesicle docking involved in exocytosis; IDA:BHF-UCL
Q92930	RAB8B	Ras-related protein Rab-8B	GO:0019003; F:GDP binding; IDA:UniProtKB
Q92930	RAB8B	Ras-related protein Rab-8B	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q92930	RAB8B	Ras-related protein Rab-8B	GO:0003924; F:GTPase activity; NAS:UniProtKB
Q92930	RAB8B	Ras-related protein Rab-8B	GO:0005102; F:receptor binding; IPI:UniProtKB
Q92930	RAB8B	Ras-related protein Rab-8B	GO:0034332; P:adherens junction organization; ISS:UniProtKB
Q92930	RAB8B	Ras-related protein Rab-8B	GO:0019882; P:antigen processing and presentation; IMP:UniProt
Q92930	RAB8B	Ras-related protein Rab-8B	GO:0006184; P:GTP catabolic process; NAS:GOC
Q92930	RAB8B	Ras-related protein Rab-8B	GO:0031346; P:positive regulation of cell projection organization; IEA:Ensembl
Q92930	RAB8B	Ras-related protein Rab-8B	GO:0051461; P:positive regulation of corticotropin secretion; IEA:Ensembl
Q92930	RAB8B	Ras-related protein Rab-8B	GO:0045046; P:protein import into peroxisome membrane; IDA:UniProtKB
Q92930	RAB8B	Ras-related protein Rab-8B	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P51151	RAB9A	Ras-related protein Rab-9A	GO:0019003; F:GDP binding; IDA:UniProtKB
P51151	RAB9A	Ras-related protein Rab-9A	GO:0005525; F:GTP binding; IDA:UniProtKB
P51151	RAB9A	Ras-related protein Rab-9A	GO:0003924; F:GTPase activity; IDA:UniProtKB
P51151	RAB9A	Ras-related protein Rab-9A	GO:0005515; F:protein binding; IPI:UniProtKB
P51151	RAB9A	Ras-related protein Rab-9A	GO:0006184; P:GTP catabolic process; IDA:GOC
P51151	RAB9A	Ras-related protein Rab-9A	GO:0045921; P:positive regulation of exocytosis; IMP:UniProtKB
P51151	RAB9A	Ras-related protein Rab-9A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P51151	RAB9A	Ras-related protein Rab-9A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9NP90	RAB9B	Ras-related protein Rab-9B	GO:0019003; F:GDP binding; IDA:UniProtKB
Q9NP90	RAB9B	Ras-related protein Rab-9B	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9NP90	RAB9B	Ras-related protein Rab-9B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NP90	RAB9B	Ras-related protein Rab-9B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9NP90	RAB9B	Ras-related protein Rab-9B	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9H5N1	RABEP2	Rab GTPase-binding effector protein 2	GO:0005096; F:GTPase activator activity; IEA:InterPro
Q9H5N1	RABEP2	Rab GTPase-binding effector protein 2	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q9H5N1	RABEP2	Rab GTPase-binding effector protein 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q15276	RABEP1	Rab GTPase-binding effector protein 1	GO:0005096; F:GTPase activator activity; IEA:InterPro
Q15276	RABEP1	Rab GTPase-binding effector protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15276	RABEP1	Rab GTPase-binding effector protein 1	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q15276	RABEP1	Rab GTPase-binding effector protein 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q15276	RABEP1	Rab GTPase-binding effector protein 1	GO:0006897; P:endocytosis; TAS:ProtInc
Q15276	RABEP1	Rab GTPase-binding effector protein 1	GO:0061025; P:membrane fusion; TAS:ProtInc
Q15276	RABEP1	Rab GTPase-binding effector protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q7Z6M1	RABEPK	Rab9 effector protein with kelch motifs	GO:0006898; P:receptor-mediated endocytosis; TAS:ProtInc
Q7Z6M1	RABEPK	Rab9 effector protein with kelch motifs	GO:0006904; P:vesicle docking involved in exocytosis; TAS:ProtInc
Q5HYI8	RABL3	Rab-like protein 3	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q5HYI8	RABL3	Rab-like protein 3	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q3YEC7	RABL6	Rab-like protein 6	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q3YEC7	RABL6	Rab-like protein 6	GO:0005515; F:protein binding; IPI:IntAct
Q3YEC7	RABL6	Rab-like protein 6	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P29762	CRABP1	Cellular retinoic acid-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
P29762	CRABP1	Cellular retinoic acid-binding protein 1	GO:0016918; F:retinal binding; IEA:UniProtKB-KW
P29762	CRABP1	Cellular retinoic acid-binding protein 1	GO:0001972; F:retinoic acid binding; IEA:Ensembl
P29762	CRABP1	Cellular retinoic acid-binding protein 1	GO:0005501; F:retinoid binding; TAS:ProtInc
P29762	CRABP1	Cellular retinoic acid-binding protein 1	GO:0019841; F:retinol binding; IEA:UniProtKB-KW
P29762	CRABP1	Cellular retinoic acid-binding protein 1	GO:0005215; F:transporter activity; IEA:InterPro
P29762	CRABP1	Cellular retinoic acid-binding protein 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P29762	CRABP1	Cellular retinoic acid-binding protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
P29373	CRABP2	Cellular retinoic acid-binding protein 2	GO:0016918; F:retinal binding; IEA:UniProtKB-KW
P29373	CRABP2	Cellular retinoic acid-binding protein 2	GO:0001972; F:retinoic acid binding; IEA:Ensembl
P29373	CRABP2	Cellular retinoic acid-binding protein 2	GO:0005501; F:retinoid binding; TAS:ProtInc
P29373	CRABP2	Cellular retinoic acid-binding protein 2	GO:0019841; F:retinol binding; IEA:UniProtKB-KW
P29373	CRABP2	Cellular retinoic acid-binding protein 2	GO:0005215; F:transporter activity; IEA:InterPro
P29373	CRABP2	Cellular retinoic acid-binding protein 2	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
P29373	CRABP2	Cellular retinoic acid-binding protein 2	GO:0008544; P:epidermis development; TAS:ProtInc
P29373	CRABP2	Cellular retinoic acid-binding protein 2	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
P29373	CRABP2	Cellular retinoic acid-binding protein 2	GO:0042573; P:retinoic acid metabolic process; IEA:Ensembl
P29373	CRABP2	Cellular retinoic acid-binding protein 2	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UJ41	RABGEF1	Rab5 GDP/GTP exchange factor	GO:0003677; F:DNA binding; IEA:InterPro
Q9UJ41	RABGEF1	Rab5 GDP/GTP exchange factor	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UJ41	RABGEF1	Rab5 GDP/GTP exchange factor	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q9UJ41	RABGEF1	Rab5 GDP/GTP exchange factor	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UJ41	RABGEF1	Rab5 GDP/GTP exchange factor	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q9UJ41	RABGEF1	Rab5 GDP/GTP exchange factor	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9UJ41	RABGEF1	Rab5 GDP/GTP exchange factor	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0005525; F:GTP binding; IDA:UniProtKB
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0003924; F:GTPase activity; TAS:UniProtKB
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0005515; F:protein binding; IPI:UniProtKB
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0051022; F:Rho GDP-dissociation inhibitor binding; ISS:UniProtKB
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0031996; F:thioesterase binding; IPI:UniProtKB
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0030036; P:actin cytoskeleton organization; IGI:MGI
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0030041; P:actin filament polymerization; TAS:UniProtKB
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0048532; P:anatomical structure arrangement; IEA:Ensembl
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0002093; P:auditory receptor cell morphogenesis; IEA:Ensembl
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0007411; P:axon guidance; TAS:Reactome
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0007596; P:blood coagulation; TAS:Reactome
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0045453; P:bone resorption; IEA:Ensembl
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0007155; P:cell adhesion; TAS:ProtInc
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0048870; P:cell motility; IDA:UniProtKB
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0008283; P:cell proliferation; IEA:Ensembl
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0045216; P:cell-cell junction organization; IEA:Ensembl
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0007160; P:cell-matrix adhesion; NAS:BHF-UCL
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0006928; P:cellular component movement; TAS:ProtInc
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0021799; P:cerebral cortex radially oriented cell migration; IEA:Ensembl
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0090103; P:cochlea morphogenesis; IEA:Ensembl
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0048813; P:dendrite morphogenesis; IEA:Ensembl
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0071542; P:dopaminergic neuron differentiation; IEA:Ensembl
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0021831; P:embryonic olfactory bulb interneuron precursor migration; IEA:Ensembl
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0043652; P:engulfment of apoptotic cell; IEA:Ensembl
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0003382; P:epithelial cell morphogenesis; IEA:Ensembl
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0006972; P:hyperosmotic response; IEA:Ensembl
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0006954; P:inflammatory response; TAS:ProtInc
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0045087; P:innate immune response; TAS:Reactome
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0030032; P:lamellipodium assembly; IMP:UniProtKB
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0051668; P:localization within membrane; IMP:BHF-UCL
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0002551; P:mast cell chemotaxis; IEA:Ensembl
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0032707; P:negative regulation of interleukin-23 production; IDA:BHF-UCL
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0048261; P:negative regulation of receptor-mediated endocytosis; TAS:UniProtKB
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0030168; P:platelet activation; TAS:Reactome
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0030838; P:positive regulation of actin filament polymerization; IEA:Ensembl
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0045740; P:positive regulation of DNA replication; IEA:Ensembl
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0010592; P:positive regulation of lamellipodium assembly; IDA:MGI
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IEA:Ensembl
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0001934; P:positive regulation of protein phosphorylation; IMP:UniProtKB
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0035025; P:positive regulation of Rho protein signal transduction; TAS:UniProtKB
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0030334; P:regulation of cell migration; IMP:UniProtKB
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0010310; P:regulation of hydrogen peroxide metabolic process; TAS:BHF-UCL
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0060263; P:regulation of respiratory burst; IDA:BHF-UCL
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0009611; P:response to wounding; TAS:ProtInc
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0097178; P:ruffle assembly; IEA:Ensembl
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0031529; P:ruffle organization; TAS:UniProtKB
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0071526; P:semaphorin-plexin signaling pathway; ISS:UniProtKB
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0007264; P:small GTPase mediated signal transduction; IEA:Ensembl
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0034446; P:substrate adhesion-dependent cell spreading; IEA:Ensembl
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0031295; P:T cell costimulation; TAS:Reactome
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0016032; P:viral process; TAS:Reactome
P63000	RAC1	Ras-related C3 botulinum toxin substrate 1	GO:0060071; P:Wnt signaling pathway, planar cell polarity pathway; IEA:Ensembl
P15153	RAC2	Ras-related C3 botulinum toxin substrate 2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P15153	RAC2	Ras-related C3 botulinum toxin substrate 2	GO:0003924; F:GTPase activity; TAS:ProtInc
P15153	RAC2	Ras-related C3 botulinum toxin substrate 2	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
P15153	RAC2	Ras-related C3 botulinum toxin substrate 2	GO:0007411; P:axon guidance; TAS:Reactome
P15153	RAC2	Ras-related C3 botulinum toxin substrate 2	GO:0007596; P:blood coagulation; TAS:Reactome
P15153	RAC2	Ras-related C3 botulinum toxin substrate 2	GO:0045453; P:bone resorption; IEA:Ensembl
P15153	RAC2	Ras-related C3 botulinum toxin substrate 2	GO:0030031; P:cell projection assembly; IEA:Ensembl
P15153	RAC2	Ras-related C3 botulinum toxin substrate 2	GO:0030168; P:platelet activation; TAS:Reactome
P15153	RAC2	Ras-related C3 botulinum toxin substrate 2	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P15153	RAC2	Ras-related C3 botulinum toxin substrate 2	GO:0010310; P:regulation of hydrogen peroxide metabolic process; TAS:BHF-UCL
P15153	RAC2	Ras-related C3 botulinum toxin substrate 2	GO:0060263; P:regulation of respiratory burst; IDA:BHF-UCL
P15153	RAC2	Ras-related C3 botulinum toxin substrate 2	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P15153	RAC2	Ras-related C3 botulinum toxin substrate 2	GO:0007165; P:signal transduction; TAS:ProtInc
P15153	RAC2	Ras-related C3 botulinum toxin substrate 2	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P60763	RAC3	Ras-related C3 botulinum toxin substrate 3	GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB
P60763	RAC3	Ras-related C3 botulinum toxin substrate 3	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P60763	RAC3	Ras-related C3 botulinum toxin substrate 3	GO:0003924; F:GTPase activity; IDA:UniProtKB
P60763	RAC3	Ras-related C3 botulinum toxin substrate 3	GO:0005515; F:protein binding; IPI:IntAct
P60763	RAC3	Ras-related C3 botulinum toxin substrate 3	GO:0030036; P:actin cytoskeleton organization; IDA:UniProtKB
P60763	RAC3	Ras-related C3 botulinum toxin substrate 3	GO:0030031; P:cell projection assembly; IDA:UniProtKB
P60763	RAC3	Ras-related C3 botulinum toxin substrate 3	GO:0006184; P:GTP catabolic process; IDA:GOC
P60763	RAC3	Ras-related C3 botulinum toxin substrate 3	GO:0035556; P:intracellular signal transduction; TAS:UniProtKB
P60763	RAC3	Ras-related C3 botulinum toxin substrate 3	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
P60763	RAC3	Ras-related C3 botulinum toxin substrate 3	GO:0031175; P:neuron projection development; IEA:Ensembl
P60763	RAC3	Ras-related C3 botulinum toxin substrate 3	GO:0033630; P:positive regulation of cell adhesion mediated by integrin; IDA:UniProtKB
P60763	RAC3	Ras-related C3 botulinum toxin substrate 3	GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IDA:UniProtKB
P60763	RAC3	Ras-related C3 botulinum toxin substrate 3	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P60763	RAC3	Ras-related C3 botulinum toxin substrate 3	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
O75943	RAD17	Cell cycle checkpoint protein RAD17	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75943	RAD17	Cell cycle checkpoint protein RAD17	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
O75943	RAD17	Cell cycle checkpoint protein RAD17	GO:0005515; F:protein binding; IPI:UniProtKB
O75943	RAD17	Cell cycle checkpoint protein RAD17	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
O75943	RAD17	Cell cycle checkpoint protein RAD17	GO:0000077; P:DNA damage checkpoint; IMP:UniProtKB
O75943	RAD17	Cell cycle checkpoint protein RAD17	GO:0006281; P:DNA repair; TAS:ProtInc
O75943	RAD17	Cell cycle checkpoint protein RAD17	GO:0006260; P:DNA replication; TAS:Reactome
O75943	RAD17	Cell cycle checkpoint protein RAD17	GO:0000076; P:DNA replication checkpoint; TAS:ProtInc
O75943	RAD17	Cell cycle checkpoint protein RAD17	GO:0007093; P:mitotic cell cycle checkpoint; IMP:UniProtKB
O75943	RAD17	Cell cycle checkpoint protein RAD17	GO:0008156; P:negative regulation of DNA replication; IMP:UniProtKB
O75943	RAD17	Cell cycle checkpoint protein RAD17	GO:0042325; P:regulation of phosphorylation; IMP:UniProtKB
Q9NS91	RAD18	E3 ubiquitin-protein ligase RAD18	GO:0003684; F:damaged DNA binding; NAS:UniProtKB
Q9NS91	RAD18	E3 ubiquitin-protein ligase RAD18	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9NS91	RAD18	E3 ubiquitin-protein ligase RAD18	GO:0031593; F:polyubiquitin binding; IDA:UniProtKB
Q9NS91	RAD18	E3 ubiquitin-protein ligase RAD18	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NS91	RAD18	E3 ubiquitin-protein ligase RAD18	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q9NS91	RAD18	E3 ubiquitin-protein ligase RAD18	GO:0000403; F:Y-form DNA binding; IDA:UniProtKB
Q9NS91	RAD18	E3 ubiquitin-protein ligase RAD18	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NS91	RAD18	E3 ubiquitin-protein ligase RAD18	GO:0006281; P:DNA repair; NAS:UniProtKB
Q9NS91	RAD18	E3 ubiquitin-protein ligase RAD18	GO:0045910; P:negative regulation of DNA recombination; IEA:Ensembl
Q9NS91	RAD18	E3 ubiquitin-protein ligase RAD18	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9NS91	RAD18	E3 ubiquitin-protein ligase RAD18	GO:0009411; P:response to UV; IEA:Ensembl
Q9NS91	RAD18	E3 ubiquitin-protein ligase RAD18	GO:0007283; P:spermatogenesis; IEA:Ensembl
O60671	RAD1	Cell cycle checkpoint protein RAD1	GO:0008408; F:3'-5' exonuclease activity; IDA:UniProtKB
O60671	RAD1	Cell cycle checkpoint protein RAD1	GO:0003684; F:damaged DNA binding; NAS:UniProtKB
O60671	RAD1	Cell cycle checkpoint protein RAD1	GO:0008853; F:exodeoxyribonuclease III activity; IEA:UniProtKB-EC
O60671	RAD1	Cell cycle checkpoint protein RAD1	GO:0005515; F:protein binding; IPI:UniProtKB
O60671	RAD1	Cell cycle checkpoint protein RAD1	GO:0000075; P:cell cycle checkpoint; NAS:UniProtKB
O60671	RAD1	Cell cycle checkpoint protein RAD1	GO:0006974; P:cellular response to DNA damage stimulus; TAS:ProtInc
O60671	RAD1	Cell cycle checkpoint protein RAD1	GO:0071479; P:cellular response to ionizing radiation; IDA:UniProtKB
O60671	RAD1	Cell cycle checkpoint protein RAD1	GO:0000077; P:DNA damage checkpoint; IMP:UniProtKB
O60671	RAD1	Cell cycle checkpoint protein RAD1	GO:0006281; P:DNA repair; TAS:ProtInc
O60671	RAD1	Cell cycle checkpoint protein RAD1	GO:0006260; P:DNA replication; TAS:Reactome
O60671	RAD1	Cell cycle checkpoint protein RAD1	GO:0007128; P:meiotic prophase I; TAS:ProtInc
O60671	RAD1	Cell cycle checkpoint protein RAD1	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:GOC
O60671	RAD1	Cell cycle checkpoint protein RAD1	GO:0021762; P:substantia nigra development; IEP:UniProt
O60216	RAD21	Double-strand-break repair protein rad21 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
O60216	RAD21	Double-strand-break repair protein rad21 homolog	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O60216	RAD21	Double-strand-break repair protein rad21 homolog	GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW
O60216	RAD21	Double-strand-break repair protein rad21 homolog	GO:0006310; P:DNA recombination; TAS:ProtInc
O60216	RAD21	Double-strand-break repair protein rad21 homolog	GO:0006302; P:double-strand break repair; TAS:ProtInc
O60216	RAD21	Double-strand-break repair protein rad21 homolog	GO:0007067; P:mitosis; IEA:UniProtKB-KW
O60216	RAD21	Double-strand-break repair protein rad21 homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O60216	RAD21	Double-strand-break repair protein rad21 homolog	GO:0071168; P:protein localization to chromatin; IMP:UniProtKB
O60216	RAD21	Double-strand-break repair protein rad21 homolog	GO:0007131; P:reciprocal meiotic recombination; TAS:ProtInc
O60216	RAD21	Double-strand-break repair protein rad21 homolog	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q92878	RAD50	DNA repair protein RAD50	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q92878	RAD50	DNA repair protein RAD50	GO:0003677; F:DNA binding; IDA:BHF-UCL
Q92878	RAD50	DNA repair protein RAD50	GO:0004518; F:nuclease activity; IEA:InterPro
Q92878	RAD50	DNA repair protein RAD50	GO:0005515; F:protein binding; IPI:UniProtKB
Q92878	RAD50	DNA repair protein RAD50	GO:0030674; F:protein binding, bridging; IDA:UniProtKB
Q92878	RAD50	DNA repair protein RAD50	GO:0008270; F:zinc ion binding; IEA:InterPro
Q92878	RAD50	DNA repair protein RAD50	GO:0006974; P:cellular response to DNA damage stimulus; IDA:MGI
Q92878	RAD50	DNA repair protein RAD50	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
Q92878	RAD50	DNA repair protein RAD50	GO:0032508; P:DNA duplex unwinding; IMP:BHF-UCL
Q92878	RAD50	DNA repair protein RAD50	GO:0006310; P:DNA recombination; IDA:UniProtKB
Q92878	RAD50	DNA repair protein RAD50	GO:0006281; P:DNA repair; IDA:UniProtKB
Q92878	RAD50	DNA repair protein RAD50	GO:0006302; P:double-strand break repair; IMP:UniProtKB
Q92878	RAD50	DNA repair protein RAD50	GO:0000724; P:double-strand break repair via homologous recombination; TAS:Reactome
Q92878	RAD50	DNA repair protein RAD50	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:GOC
Q92878	RAD50	DNA repair protein RAD50	GO:0033674; P:positive regulation of kinase activity; IDA:BHF-UCL
Q92878	RAD50	DNA repair protein RAD50	GO:0031954; P:positive regulation of protein autophosphorylation; IDA:BHF-UCL
Q92878	RAD50	DNA repair protein RAD50	GO:0007131; P:reciprocal meiotic recombination; TAS:ProtInc
Q92878	RAD50	DNA repair protein RAD50	GO:0000019; P:regulation of mitotic recombination; IDA:UniProtKB
Q92878	RAD50	DNA repair protein RAD50	GO:0000723; P:telomere maintenance; TAS:BHF-UCL
Q92878	RAD50	DNA repair protein RAD50	GO:0007004; P:telomere maintenance via telomerase; IDA:UniProtKB
P43351	RAD52	DNA repair protein RAD52 homolog	GO:0003677; F:DNA binding; TAS:ProtInc
P43351	RAD52	DNA repair protein RAD52 homolog	GO:0042802; F:identical protein binding; IPI:IntAct
P43351	RAD52	DNA repair protein RAD52 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
P43351	RAD52	DNA repair protein RAD52 homolog	GO:0000730; P:DNA recombinase assembly; TAS:Reactome
P43351	RAD52	DNA repair protein RAD52 homolog	GO:0006281; P:DNA repair; TAS:Reactome
P43351	RAD52	DNA repair protein RAD52 homolog	GO:0006302; P:double-strand break repair; TAS:Reactome
P43351	RAD52	DNA repair protein RAD52 homolog	GO:0000724; P:double-strand break repair via homologous recombination; TAS:Reactome
P43351	RAD52	DNA repair protein RAD52 homolog	GO:0006312; P:mitotic recombination; TAS:ProtInc
P43351	RAD52	DNA repair protein RAD52 homolog	GO:0007131; P:reciprocal meiotic recombination; TAS:ProtInc
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0005524; F:ATP binding; IDA:MGI
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0003684; F:damaged DNA binding; IEA:InterPro
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0070182; F:DNA polymerase binding; IPI:UniProt
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0043142; F:single-stranded DNA-dependent ATPase activity; IDA:UniProtKB
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0006200; P:ATP catabolic process; IDA:GOC
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0072757; P:cellular response to camptothecin; IDA:UniProtKB
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0071479; P:cellular response to ionizing radiation; IDA:UniProtKB
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0000730; P:DNA recombinase assembly; TAS:Reactome
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0006310; P:DNA recombination; TAS:UniProtKB
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0006281; P:DNA repair; TAS:Reactome
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0006268; P:DNA unwinding involved in DNA replication; IDA:UniProtKB
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0006302; P:double-strand break repair; TAS:Reactome
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0007126; P:meiotic nuclear division; ISS:UniProtKB
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0006312; P:mitotic recombination; TAS:ProtInc
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0051106; P:positive regulation of DNA ligation; IDA:UniProtKB
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0051260; P:protein homooligomerization; IPI:UniProtKB
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0007131; P:reciprocal meiotic recombination; TAS:ProtInc
Q06609	RAD51	DNA repair protein RAD51 homolog 1	GO:0010569; P:regulation of double-strand break repair via homologous recombination; IDA:UniProtKB
Q92698	RAD54L	DNA repair and recombination protein RAD54-like	GO:0036310; F:annealing helicase activity; IDA:UniProtKB
Q92698	RAD54L	DNA repair and recombination protein RAD54-like	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q92698	RAD54L	DNA repair and recombination protein RAD54-like	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q92698	RAD54L	DNA repair and recombination protein RAD54-like	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q92698	RAD54L	DNA repair and recombination protein RAD54-like	GO:0005515; F:protein binding; IPI:IntAct
Q92698	RAD54L	DNA repair and recombination protein RAD54-like	GO:0051276; P:chromosome organization; IEA:Ensembl
Q92698	RAD54L	DNA repair and recombination protein RAD54-like	GO:0006310; P:DNA recombination; TAS:ProtInc
Q92698	RAD54L	DNA repair and recombination protein RAD54-like	GO:0006281; P:DNA repair; TAS:ProtInc
Q92698	RAD54L	DNA repair and recombination protein RAD54-like	GO:0000733; P:DNA strand renaturation; IDA:GOC
Q92698	RAD54L	DNA repair and recombination protein RAD54-like	GO:0000724; P:double-strand break repair via homologous recombination; IEA:Ensembl
Q92698	RAD54L	DNA repair and recombination protein RAD54-like	GO:0007126; P:meiotic nuclear division; TAS:ProtInc
Q92698	RAD54L	DNA repair and recombination protein RAD54-like	GO:0042493; P:response to drug; IEA:Ensembl
Q92698	RAD54L	DNA repair and recombination protein RAD54-like	GO:0010212; P:response to ionizing radiation; IEA:Ensembl
Q99638	RAD9A	Cell cycle checkpoint control protein RAD9A	GO:0008408; F:3'-5' exonuclease activity; IDA:UniProtKB
Q99638	RAD9A	Cell cycle checkpoint control protein RAD9A	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q99638	RAD9A	Cell cycle checkpoint control protein RAD9A	GO:0008853; F:exodeoxyribonuclease III activity; IEA:UniProtKB-EC
Q99638	RAD9A	Cell cycle checkpoint control protein RAD9A	GO:0042826; F:histone deacetylase binding; IPI:UniProtKB
Q99638	RAD9A	Cell cycle checkpoint control protein RAD9A	GO:0005515; F:protein binding; IPI:UniProtKB
Q99638	RAD9A	Cell cycle checkpoint control protein RAD9A	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q99638	RAD9A	Cell cycle checkpoint control protein RAD9A	GO:0017124; F:SH3 domain binding; IPI:UniProtKB
Q99638	RAD9A	Cell cycle checkpoint control protein RAD9A	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q99638	RAD9A	Cell cycle checkpoint control protein RAD9A	GO:0071479; P:cellular response to ionizing radiation; IDA:UniProtKB
Q99638	RAD9A	Cell cycle checkpoint control protein RAD9A	GO:0000077; P:DNA damage checkpoint; IMP:UniProtKB
Q99638	RAD9A	Cell cycle checkpoint control protein RAD9A	GO:0006281; P:DNA repair; TAS:ProtInc
Q99638	RAD9A	Cell cycle checkpoint control protein RAD9A	GO:0006260; P:DNA replication; TAS:Reactome
Q99638	RAD9A	Cell cycle checkpoint control protein RAD9A	GO:0000076; P:DNA replication checkpoint; TAS:ProtInc
Q99638	RAD9A	Cell cycle checkpoint control protein RAD9A	GO:0031573; P:intra-S DNA damage checkpoint; IEA:Ensembl
Q99638	RAD9A	Cell cycle checkpoint control protein RAD9A	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:GOC
Q99638	RAD9A	Cell cycle checkpoint control protein RAD9A	GO:1902231; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
Q6WBX8	RAD9B	Cell cycle checkpoint control protein RAD9B	GO:0005515; F:protein binding; IPI:UniProtKB
Q6WBX8	RAD9B	Cell cycle checkpoint control protein RAD9B	GO:0000077; P:DNA damage checkpoint; IEA:InterPro
Q6WBX8	RAD9B	Cell cycle checkpoint control protein RAD9B	GO:0006281; P:DNA repair; IEA:InterPro
Q6WBX8	RAD9B	Cell cycle checkpoint control protein RAD9B	GO:0006260; P:DNA replication; TAS:Reactome
Q96JH8	RADIL	Ras-associating and dilute domain-containing protein	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q96JH8	RADIL	Ras-associating and dilute domain-containing protein	GO:0007165; P:signal transduction; IEA:InterPro
Q96JH8	RADIL	Ras-associating and dilute domain-containing protein	GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:MGI
P35241	RDX	Radixin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P35241	RDX	Radixin	GO:0005515; F:protein binding; IPI:UniProtKB
P35241	RDX	Radixin	GO:0051693; P:actin filament capping; IEA:UniProtKB-KW
P35241	RDX	Radixin	GO:0045176; P:apical protein localization; IEA:Ensembl
P35241	RDX	Radixin	GO:0061028; P:establishment of endothelial barrier; IGI:UniProt
P35241	RDX	Radixin	GO:0030033; P:microvillus assembly; IEA:Ensembl
P35241	RDX	Radixin	GO:0010628; P:positive regulation of gene expression; IGI:UniProt
P55042	RRAD	GTP-binding protein RAD	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P55042	RRAD	GTP-binding protein RAD	GO:0003924; F:GTPase activity; TAS:ProtInc
P55042	RRAD	GTP-binding protein RAD	GO:0005515; F:protein binding; IPI:UniProtKB
P55042	RRAD	GTP-binding protein RAD	GO:0007264; P:small GTPase mediated signal transduction; TAS:ProtInc
P78406	RAE1	mRNA export factor	GO:0008017; F:microtubule binding; ISS:UniProtKB
P78406	RAE1	mRNA export factor	GO:0003723; F:RNA binding; TAS:ProtInc
P78406	RAE1	mRNA export factor	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P78406	RAE1	mRNA export factor	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
P78406	RAE1	mRNA export factor	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P78406	RAE1	mRNA export factor	GO:0015758; P:glucose transport; TAS:Reactome
P78406	RAE1	mRNA export factor	GO:0008645; P:hexose transport; TAS:Reactome
P78406	RAE1	mRNA export factor	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P78406	RAE1	mRNA export factor	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
P78406	RAE1	mRNA export factor	GO:0006406; P:mRNA export from nucleus; TAS:ProtInc
P78406	RAE1	mRNA export factor	GO:0010827; P:regulation of glucose transport; TAS:Reactome
P78406	RAE1	mRNA export factor	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P78406	RAE1	mRNA export factor	GO:0055085; P:transmembrane transport; TAS:Reactome
P78406	RAE1	mRNA export factor	GO:0016032; P:viral process; TAS:Reactome
P24386	CHM	Rab proteins geranylgeranyltransferase component A 1	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
P24386	CHM	Rab proteins geranylgeranyltransferase component A 1	GO:0004663; F:Rab geranylgeranyltransferase activity; TAS:ProtInc
P24386	CHM	Rab proteins geranylgeranyltransferase component A 1	GO:0017137; F:Rab GTPase binding; IDA:UniProtKB
P24386	CHM	Rab proteins geranylgeranyltransferase component A 1	GO:0001568; P:blood vessel development; IEA:Ensembl
P24386	CHM	Rab proteins geranylgeranyltransferase component A 1	GO:0018344; P:protein geranylgeranylation; IDA:UniProtKB
P24386	CHM	Rab proteins geranylgeranyltransferase component A 1	GO:0006612; P:protein targeting to membrane; IMP:UniProtKB
P24386	CHM	Rab proteins geranylgeranyltransferase component A 1	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
P24386	CHM	Rab proteins geranylgeranyltransferase component A 1	GO:0007601; P:visual perception; TAS:ProtInc
P26374	CHML	Rab proteins geranylgeranyltransferase component A 2	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
P26374	CHML	Rab proteins geranylgeranyltransferase component A 2	GO:0004663; F:Rab geranylgeranyltransferase activity; IEA:InterPro
P26374	CHML	Rab proteins geranylgeranyltransferase component A 2	GO:0017137; F:Rab GTPase binding; IDA:UniProtKB
P26374	CHML	Rab proteins geranylgeranyltransferase component A 2	GO:0006886; P:intracellular protein transport; IEA:InterPro
P26374	CHML	Rab proteins geranylgeranyltransferase component A 2	GO:0018344; P:protein geranylgeranylation; IDA:UniProtKB
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0042802; F:identical protein binding; IPI:IntAct
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0004709; F:MAP kinase kinase kinase activity; IEA:Ensembl
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0005515; F:protein binding; IPI:UniProtKB
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0004672; F:protein kinase activity; TAS:ProtInc
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0007190; P:activation of adenylate cyclase activity; NAS:BHF-UCL
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0000186; P:activation of MAPKK activity; TAS:Reactome
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0006915; P:apoptotic process; TAS:ProtInc
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0007411; P:axon guidance; TAS:Reactome
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0007596; P:blood coagulation; TAS:Reactome
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0008283; P:cell proliferation; TAS:ProtInc
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0071550; P:death-inducing signaling complex assembly; IEA:Ensembl
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0007507; P:heart development; IEA:Ensembl
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0045087; P:innate immune response; TAS:Reactome
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0045104; P:intermediate filament cytoskeleton organization; IEA:Ensembl
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0000165; P:MAPK cascade; TAS:Reactome
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:UniProtKB
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0031333; P:negative regulation of protein complex assembly; IDA:UniProtKB
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0030168; P:platelet activation; TAS:Reactome
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:UniProtKB
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0045595; P:regulation of cell differentiation; TAS:UniProtKB
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:2000145; P:regulation of cell motility; TAS:UniProtKB
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0035023; P:regulation of Rho protein signal transduction; TAS:UniProtKB
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0001666; P:response to hypoxia; IEA:Ensembl
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0007165; P:signal transduction; TAS:ProtInc
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0007268; P:synaptic transmission; TAS:Reactome
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0055085; P:transmembrane transport; TAS:Reactome
P04049	RAF1	RAF proto-oncogene serine/threonine-protein kinase	GO:0042060; P:wound healing; TAS:UniProtKB
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0003677; F:DNA binding; TAS:ProtInc
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0004519; F:endonuclease activity; ISS:UniProtKB
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0042393; F:histone binding; ISS:UniProtKB
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0046872; F:metal ion binding; ISS:UniProtKB
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0005515; F:protein binding; IPI:IntAct
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0004842; F:ubiquitin-protein ligase activity; ISS:UniProtKB
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0008270; F:zinc ion binding; ISS:UniProtKB
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0002250; P:adaptive immune response; IEA:Ensembl
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0030183; P:B cell differentiation; ISS:UniProtKB
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0006310; P:DNA recombination; TAS:ProtInc
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0010390; P:histone monoubiquitination; ISS:UniProtKB
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0006955; P:immune response; TAS:ProtInc
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0070244; P:negative regulation of thymocyte apoptotic process; IEA:Ensembl
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; ISS:GOC
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0002331; P:pre-B cell allelic exclusion; ISS:UniProtKB
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0051865; P:protein autoubiquitination; ISS:UniProtKB
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0045580; P:regulation of T cell differentiation; IEA:Ensembl
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0033077; P:T cell differentiation in thymus; ISS:UniProtKB
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0043029; P:T cell homeostasis; IEA:Ensembl
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0048538; P:thymus development; IEA:Ensembl
P15918	RAG1	V(D)J recombination-activating protein 1	GO:0033151; P:V(D)J recombination; ISS:UniProtKB
P55895	RAG2	V(D)J recombination-activating protein 2	GO:0003682; F:chromatin binding; ISS:UniProtKB
P55895	RAG2	V(D)J recombination-activating protein 2	GO:0003677; F:DNA binding; IEA:InterPro
P55895	RAG2	V(D)J recombination-activating protein 2	GO:0035064; F:methylated histone binding; ISS:UniProtKB
P55895	RAG2	V(D)J recombination-activating protein 2	GO:0035091; F:phosphatidylinositol binding; ISS:UniProtKB
P55895	RAG2	V(D)J recombination-activating protein 2	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; ISS:UniProtKB
P55895	RAG2	V(D)J recombination-activating protein 2	GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; ISS:UniProtKB
P55895	RAG2	V(D)J recombination-activating protein 2	GO:0080025; F:phosphatidylinositol-3,5-bisphosphate binding; ISS:UniProtKB
P55895	RAG2	V(D)J recombination-activating protein 2	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISS:UniProtKB
P55895	RAG2	V(D)J recombination-activating protein 2	GO:0008270; F:zinc ion binding; ISS:UniProtKB
P55895	RAG2	V(D)J recombination-activating protein 2	GO:0030183; P:B cell differentiation; ISS:UniProtKB
P55895	RAG2	V(D)J recombination-activating protein 2	GO:0002358; P:B cell homeostatic proliferation; IEA:Ensembl
P55895	RAG2	V(D)J recombination-activating protein 2	GO:0002326; P:B cell lineage commitment; IEA:Ensembl
P55895	RAG2	V(D)J recombination-activating protein 2	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
P55895	RAG2	V(D)J recombination-activating protein 2	GO:0046622; P:positive regulation of organ growth; IEA:Ensembl
P55895	RAG2	V(D)J recombination-activating protein 2	GO:0002331; P:pre-B cell allelic exclusion; ISS:UniProtKB
P55895	RAG2	V(D)J recombination-activating protein 2	GO:0033077; P:T cell differentiation in thymus; ISS:UniProtKB
P55895	RAG2	V(D)J recombination-activating protein 2	GO:0002360; P:T cell lineage commitment; IEA:Ensembl
P55895	RAG2	V(D)J recombination-activating protein 2	GO:0033151; P:V(D)J recombination; ISS:UniProtKB
Q15109	AGER	Advanced glycosylation end product-specific receptor	GO:0042802; F:identical protein binding; IPI:IntAct
Q15109	AGER	Advanced glycosylation end product-specific receptor	GO:0005515; F:protein binding; IPI:UniProtKB
Q15109	AGER	Advanced glycosylation end product-specific receptor	GO:0004872; F:receptor activity; TAS:ProtInc
Q15109	AGER	Advanced glycosylation end product-specific receptor	GO:0044548; F:S100 protein binding; IPI:UniProtKB
Q15109	AGER	Advanced glycosylation end product-specific receptor	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q15109	AGER	Advanced glycosylation end product-specific receptor	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q15109	AGER	Advanced glycosylation end product-specific receptor	GO:0050930; P:induction of positive chemotaxis; IEA:Ensembl
Q15109	AGER	Advanced glycosylation end product-specific receptor	GO:0006954; P:inflammatory response; TAS:ProtInc
Q15109	AGER	Advanced glycosylation end product-specific receptor	GO:0045087; P:innate immune response; TAS:Reactome
Q15109	AGER	Advanced glycosylation end product-specific receptor	GO:0031175; P:neuron projection development; IGI:UniProtKB
Q15109	AGER	Advanced glycosylation end product-specific receptor	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q15109	AGER	Advanced glycosylation end product-specific receptor	GO:0009611; P:response to wounding; TAS:ProtInc
P46060	RANGAP1	Ran GTPase-activating protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P46060	RANGAP1	Ran GTPase-activating protein 1	GO:0005098; F:Ran GTPase activator activity; TAS:ProtInc
P46060	RANGAP1	Ran GTPase-activating protein 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P46060	RANGAP1	Ran GTPase-activating protein 1	GO:0046826; P:negative regulation of protein export from nucleus; IDA:BHF-UCL
P46060	RANGAP1	Ran GTPase-activating protein 1	GO:0032853; P:positive regulation of Ran GTPase activity; TAS:GOC
P46060	RANGAP1	Ran GTPase-activating protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q7Z5J4	RAI1	Retinoic acid-induced protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q7Z5J4	RAI1	Retinoic acid-induced protein 1	GO:0040015; P:negative regulation of multicellular organism growth; IEA:Ensembl
Q7Z5J4	RAI1	Retinoic acid-induced protein 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q7Z5J4	RAI1	Retinoic acid-induced protein 1	GO:0001501; P:skeletal system development; IEA:Ensembl
Q8NFJ5	GPRC5A	Retinoic acid-induced protein 3	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q8NFJ5	GPRC5A	Retinoic acid-induced protein 3	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y5P3	RAI2	Retinoic acid-induced protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q9Y5P3	RAI2	Retinoic acid-induced protein 2	GO:0009790; P:embryo development; NAS:UniProtKB
P11233	RALA	Ras-related protein Ral-A	GO:0031755; F:Edg-2 lysophosphatidic acid receptor binding; IDA:UniProtKB
P11233	RALA	Ras-related protein Ral-A	GO:0005525; F:GTP binding; TAS:ProtInc
P11233	RALA	Ras-related protein Ral-A	GO:0005515; F:protein binding; IPI:UniProtKB
P11233	RALA	Ras-related protein Ral-A	GO:0031532; P:actin cytoskeleton reorganization; IDA:BHF-UCL
P11233	RALA	Ras-related protein Ral-A	GO:0006935; P:chemotaxis; TAS:ProtInc
P11233	RALA	Ras-related protein Ral-A	GO:0000910; P:cytokinesis; IDA:UniProtKB
P11233	RALA	Ras-related protein Ral-A	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
P11233	RALA	Ras-related protein Ral-A	GO:0006184; P:GTP catabolic process; IEA:InterPro
P11233	RALA	Ras-related protein Ral-A	GO:0061024; P:membrane organization; TAS:Reactome
P11233	RALA	Ras-related protein Ral-A	GO:0051665; P:membrane raft localization; IDA:UniProtKB
P11233	RALA	Ras-related protein Ral-A	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P11233	RALA	Ras-related protein Ral-A	GO:0051491; P:positive regulation of filopodium assembly; IDA:BHF-UCL
P11233	RALA	Ras-related protein Ral-A	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
P11233	RALA	Ras-related protein Ral-A	GO:0017157; P:regulation of exocytosis; IDA:UniProtKB
P11233	RALA	Ras-related protein Ral-A	GO:0007165; P:signal transduction; TAS:ProtInc
P11233	RALA	Ras-related protein Ral-A	GO:0016032; P:viral process; IEA:UniProtKB-KW
P11234	RALB	Ras-related protein Ral-B	GO:0005525; F:GTP binding; IDA:UniProtKB
P11234	RALB	Ras-related protein Ral-B	GO:0003924; F:GTPase activity; IDA:UniProtKB
P11234	RALB	Ras-related protein Ral-B	GO:0005515; F:protein binding; IPI:UniProtKB
P11234	RALB	Ras-related protein Ral-B	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P11234	RALB	Ras-related protein Ral-B	GO:0000910; P:cytokinesis; IDA:UniProtKB
P11234	RALB	Ras-related protein Ral-B	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P11234	RALB	Ras-related protein Ral-B	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
P11234	RALB	Ras-related protein Ral-B	GO:0001928; P:regulation of exocyst assembly; ISS:UniProtKB
P11234	RALB	Ras-related protein Ral-B	GO:0060178; P:regulation of exocyst localization; ISS:UniProtKB
P11234	RALB	Ras-related protein Ral-B	GO:0007165; P:signal transduction; TAS:ProtInc
Q5U651	RASIP1	Ras-interacting protein 1	GO:0001525; P:angiogenesis; ISS:UniProtKB
Q5U651	RASIP1	Ras-interacting protein 1	GO:0048754; P:branching morphogenesis of an epithelial tube; ISS:UniProtKB
Q5U651	RASIP1	Ras-interacting protein 1	GO:0010507; P:negative regulation of autophagy; IMP:BHF-UCL
Q5U651	RASIP1	Ras-interacting protein 1	GO:0032319; P:regulation of Rho GTPase activity; ISS:UniProtKB
Q5U651	RASIP1	Ras-interacting protein 1	GO:0007165; P:signal transduction; IEA:InterPro
Q5U651	RASIP1	Ras-interacting protein 1	GO:0001570; P:vasculogenesis; ISS:UniProtKB
Q86SE5	RALYL	RNA-binding Raly-like protein	GO:0000166; F:nucleotide binding; IEA:InterPro
Q86SE5	RALYL	RNA-binding Raly-like protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O60894	RAMP1	Receptor activity-modifying protein 1	GO:0004948; F:calcitonin receptor activity; IDA:UniProtKB
O60894	RAMP1	Receptor activity-modifying protein 1	GO:0031716; F:calcitonin receptor binding; IPI:UniProtKB
O60894	RAMP1	Receptor activity-modifying protein 1	GO:0015026; F:coreceptor activity; IEA:Ensembl
O60894	RAMP1	Receptor activity-modifying protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
O60894	RAMP1	Receptor activity-modifying protein 1	GO:0008565; F:protein transporter activity; IDA:UniProtKB
O60894	RAMP1	Receptor activity-modifying protein 1	GO:0004872; F:receptor activity; IDA:UniProtKB
O60894	RAMP1	Receptor activity-modifying protein 1	GO:0001525; P:angiogenesis; IDA:UniProtKB
O60894	RAMP1	Receptor activity-modifying protein 1	GO:0006816; P:calcium ion transport; IDA:UniProtKB
O60894	RAMP1	Receptor activity-modifying protein 1	GO:0006886; P:intracellular protein transport; IEA:InterPro
O60894	RAMP1	Receptor activity-modifying protein 1	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:UniProtKB
O60894	RAMP1	Receptor activity-modifying protein 1	GO:0060050; P:positive regulation of protein glycosylation; IDA:UniProtKB
O60894	RAMP1	Receptor activity-modifying protein 1	GO:0072659; P:protein localization to plasma membrane; IDA:UniProtKB
O60894	RAMP1	Receptor activity-modifying protein 1	GO:0015031; P:protein transport; IDA:UniProtKB
O60894	RAMP1	Receptor activity-modifying protein 1	GO:0031623; P:receptor internalization; IDA:UniProtKB
O60894	RAMP1	Receptor activity-modifying protein 1	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; IDA:UniProtKB
Q9UKM9	RALY	RNA-binding protein Raly	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9UKM9	RALY	RNA-binding protein Raly	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UKM9	RALY	RNA-binding protein Raly	GO:0005515; F:protein binding; IPI:UniProt
Q9UKM9	RALY	RNA-binding protein Raly	GO:0003723; F:RNA binding; TAS:ProtInc
Q9UKM9	RALY	RNA-binding protein Raly	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q9BTL3	FAM103A1	RNMT-activating mini protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BTL3	FAM103A1	RNMT-activating mini protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BTL3	FAM103A1	RNMT-activating mini protein	GO:0003723; F:RNA binding; IDA:UniProtKB
Q9BTL3	FAM103A1	RNMT-activating mini protein	GO:0006370; P:7-methylguanosine mRNA capping; IDA:UniProtKB
Q9BTL3	FAM103A1	RNMT-activating mini protein	GO:0032259; P:methylation; IMP:UniProtKB
Q9BTL3	FAM103A1	RNMT-activating mini protein	GO:0036031; P:recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex; IDA:UniProtKB
O60896	RAMP3	Receptor activity-modifying protein 3	GO:0015026; F:coreceptor activity; IEA:Ensembl
O60896	RAMP3	Receptor activity-modifying protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
O60896	RAMP3	Receptor activity-modifying protein 3	GO:0008565; F:protein transporter activity; IDA:UniProtKB
O60896	RAMP3	Receptor activity-modifying protein 3	GO:0004872; F:receptor activity; IDA:UniProtKB
O60896	RAMP3	Receptor activity-modifying protein 3	GO:0006816; P:calcium ion transport; IDA:UniProtKB
O60896	RAMP3	Receptor activity-modifying protein 3	GO:0071392; P:cellular response to estradiol stimulus; ISS:UniProtKB
O60896	RAMP3	Receptor activity-modifying protein 3	GO:0086103; P:G-protein coupled receptor signaling pathway involved in heart process; ISS:UniProtKB
O60896	RAMP3	Receptor activity-modifying protein 3	GO:0006886; P:intracellular protein transport; IEA:InterPro
O60896	RAMP3	Receptor activity-modifying protein 3	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
O60896	RAMP3	Receptor activity-modifying protein 3	GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; IDA:UniProtKB
O60896	RAMP3	Receptor activity-modifying protein 3	GO:0001921; P:positive regulation of receptor recycling; IDA:UniProtKB
O60896	RAMP3	Receptor activity-modifying protein 3	GO:0072659; P:protein localization to plasma membrane; IDA:UniProtKB
O60896	RAMP3	Receptor activity-modifying protein 3	GO:0015031; P:protein transport; IDA:UniProtKB
O60896	RAMP3	Receptor activity-modifying protein 3	GO:0031623; P:receptor internalization; IDA:UniProtKB
O60896	RAMP3	Receptor activity-modifying protein 3	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; IEA:InterPro
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0015026; F:coreceptor activity; ISS:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0008565; F:protein transporter activity; IDA:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0034333; P:adherens junction assembly; IDA:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0001525; P:angiogenesis; IDA:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0070831; P:basement membrane assembly; ISS:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0006816; P:calcium ion transport; IDA:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0006171; P:cAMP biosynthetic process; IDA:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0032870; P:cellular response to hormone stimulus; IEA:Ensembl
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; ISS:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0007565; P:female pregnancy; IEA:Ensembl
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:Ensembl
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0007507; P:heart development; ISS:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0006886; P:intracellular protein transport; IEA:InterPro
O60895	RAMP2	Receptor activity-modifying protein 2	GO:2000352; P:negative regulation of endothelial cell apoptotic process; IDA:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0043116; P:negative regulation of vascular permeability; IDA:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0045766; P:positive regulation of angiogenesis; ISS:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:2001214; P:positive regulation of vasculogenesis; IEA:Ensembl
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0072659; P:protein localization to plasma membrane; IDA:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0015031; P:protein transport; IDA:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0031623; P:receptor internalization; IDA:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0008217; P:regulation of blood pressure; ISS:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; IEA:InterPro
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0032355; P:response to estradiol; IEA:Ensembl
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0001666; P:response to hypoxia; IEA:Ensembl
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0032570; P:response to progesterone; IEA:Ensembl
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0002040; P:sprouting angiogenesis; ISS:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0070830; P:tight junction assembly; IDA:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0097084; P:vascular smooth muscle cell development; ISS:UniProtKB
O60895	RAMP2	Receptor activity-modifying protein 2	GO:0001570; P:vasculogenesis; IMP:UniProtKB
Q9H6Z4	RANBP3	Ran-binding protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q9H6Z4	RANBP3	Ran-binding protein 3	GO:0070412; F:R-SMAD binding; IPI:UniProtKB
Q9H6Z4	RANBP3	Ran-binding protein 3	GO:0008536; F:Ran GTPase binding; TAS:ProtInc
Q9H6Z4	RANBP3	Ran-binding protein 3	GO:0046907; P:intracellular transport; IEA:InterPro
Q9H6Z4	RANBP3	Ran-binding protein 3	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96S59	RANBP9	Ran-binding protein 9	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q96S59	RANBP9	Ran-binding protein 9	GO:0005515; F:protein binding; IPI:UniProtKB
Q96S59	RANBP9	Ran-binding protein 9	GO:0008536; F:Ran GTPase binding; TAS:ProtInc
Q96S59	RANBP9	Ran-binding protein 9	GO:0007411; P:axon guidance; TAS:Reactome
Q96S59	RANBP9	Ran-binding protein 9	GO:0007020; P:microtubule nucleation; NAS:UniProtKB
Q96S59	RANBP9	Ran-binding protein 9	GO:0006461; P:protein complex assembly; TAS:ProtInc
P43487	RANBP1	Ran-specific GTPase-activating protein	GO:0005092; F:GDP-dissociation inhibitor activity; TAS:ProtInc
P43487	RANBP1	Ran-specific GTPase-activating protein	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
P43487	RANBP1	Ran-specific GTPase-activating protein	GO:0008536; F:Ran GTPase binding; TAS:ProtInc
P43487	RANBP1	Ran-specific GTPase-activating protein	GO:0046907; P:intracellular transport; IEA:InterPro
P43487	RANBP1	Ran-specific GTPase-activating protein	GO:0046604; P:positive regulation of mitotic centrosome separation; IEA:Ensembl
P43487	RANBP1	Ran-specific GTPase-activating protein	GO:0050790; P:regulation of catalytic activity; TAS:GOC
P43487	RANBP1	Ran-specific GTPase-activating protein	GO:0007165; P:signal transduction; TAS:UniProtKB
P43487	RANBP1	Ran-specific GTPase-activating protein	GO:0007051; P:spindle organization; IEA:Ensembl
P43487	RANBP1	Ran-specific GTPase-activating protein	GO:0016032; P:viral process; TAS:Reactome
P62826	RAN	GTP-binding nuclear protein Ran	GO:0050681; F:androgen receptor binding; NAS:UniProtKB
P62826	RAN	GTP-binding nuclear protein Ran	GO:0003682; F:chromatin binding; TAS:UniProtKB
P62826	RAN	GTP-binding nuclear protein Ran	GO:0005525; F:GTP binding; IDA:UniProtKB
P62826	RAN	GTP-binding nuclear protein Ran	GO:0003924; F:GTPase activity; TAS:UniProtKB
P62826	RAN	GTP-binding nuclear protein Ran	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62826	RAN	GTP-binding nuclear protein Ran	GO:0005515; F:protein binding; IPI:UniProtKB
P62826	RAN	GTP-binding nuclear protein Ran	GO:0003713; F:transcription coactivator activity; NAS:UniProtKB
P62826	RAN	GTP-binding nuclear protein Ran	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
P62826	RAN	GTP-binding nuclear protein Ran	GO:0006259; P:DNA metabolic process; TAS:UniProtKB
P62826	RAN	GTP-binding nuclear protein Ran	GO:0010467; P:gene expression; TAS:Reactome
P62826	RAN	GTP-binding nuclear protein Ran	GO:0075733; P:intracellular transport of virus; TAS:Reactome
P62826	RAN	GTP-binding nuclear protein Ran	GO:0007067; P:mitosis; TAS:UniProtKB
P62826	RAN	GTP-binding nuclear protein Ran	GO:0007052; P:mitotic spindle organization; TAS:UniProtKB
P62826	RAN	GTP-binding nuclear protein Ran	GO:0032092; P:positive regulation of protein binding; IDA:BHF-UCL
P62826	RAN	GTP-binding nuclear protein Ran	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
P62826	RAN	GTP-binding nuclear protein Ran	GO:0006611; P:protein export from nucleus; IDA:BHF-UCL
P62826	RAN	GTP-binding nuclear protein Ran	GO:0007165; P:signal transduction; TAS:UniProtKB
P62826	RAN	GTP-binding nuclear protein Ran	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P62826	RAN	GTP-binding nuclear protein Ran	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P62826	RAN	GTP-binding nuclear protein Ran	GO:0019058; P:viral life cycle; TAS:Reactome
P62826	RAN	GTP-binding nuclear protein Ran	GO:0016032; P:viral process; TAS:Reactome
P62834	RAP1A	Ras-related protein Rap-1A	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P62834	RAP1A	Ras-related protein Rap-1A	GO:0003924; F:GTPase activity; TAS:ProtInc
P62834	RAP1A	Ras-related protein Rap-1A	GO:0005515; F:protein binding; IPI:UniProtKB
P62834	RAP1A	Ras-related protein Rap-1A	GO:0032403; F:protein complex binding; IDA:UniProtKB
P62834	RAP1A	Ras-related protein Rap-1A	GO:0008565; F:protein transporter activity; IDA:UniProtKB
P62834	RAP1A	Ras-related protein Rap-1A	GO:0017034; F:Rap guanyl-nucleotide exchange factor activity; ISS:UniProtKB
P62834	RAP1A	Ras-related protein Rap-1A	GO:0000186; P:activation of MAPKK activity; TAS:Reactome
P62834	RAP1A	Ras-related protein Rap-1A	GO:0007596; P:blood coagulation; TAS:Reactome
P62834	RAP1A	Ras-related protein Rap-1A	GO:0071320; P:cellular response to cAMP; IDA:UniProtKB
P62834	RAP1A	Ras-related protein Rap-1A	GO:1990090; P:cellular response to nerve growth factor stimulus; ISS:UniProtKB
P62834	RAP1A	Ras-related protein Rap-1A	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P62834	RAP1A	Ras-related protein Rap-1A	GO:0061028; P:establishment of endothelial barrier; IMP:UniProtKB
P62834	RAP1A	Ras-related protein Rap-1A	GO:0038180; P:nerve growth factor signaling pathway; ISS:UniProtKB
P62834	RAP1A	Ras-related protein Rap-1A	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P62834	RAP1A	Ras-related protein Rap-1A	GO:0030168; P:platelet activation; TAS:Reactome
P62834	RAP1A	Ras-related protein Rap-1A	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
P62834	RAP1A	Ras-related protein Rap-1A	GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB
P62834	RAP1A	Ras-related protein Rap-1A	GO:0045860; P:positive regulation of protein kinase activity; ISS:UniProtKB
P62834	RAP1A	Ras-related protein Rap-1A	GO:0032854; P:positive regulation of Rap GTPase activity; ISS:UniProtKB
P62834	RAP1A	Ras-related protein Rap-1A	GO:2001214; P:positive regulation of vasculogenesis; ISS:UniProtKB
P62834	RAP1A	Ras-related protein Rap-1A	GO:0015031; P:protein transport; IDA:UniProtKB
P62834	RAP1A	Ras-related protein Rap-1A	GO:0032486; P:Rap protein signal transduction; IMP:UniProtKB
P62834	RAP1A	Ras-related protein Rap-1A	GO:1901888; P:regulation of cell junction assembly; IMP:UniProtKB
P62834	RAP1A	Ras-related protein Rap-1A	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P62834	RAP1A	Ras-related protein Rap-1A	GO:0007165; P:signal transduction; TAS:ProtInc
P62834	RAP1A	Ras-related protein Rap-1A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P61224	RAP1B	Ras-related protein Rap-1b	GO:0019003; F:GDP binding; IDA:UniProtKB
P61224	RAP1B	Ras-related protein Rap-1b	GO:0005525; F:GTP binding; IDA:UniProtKB
P61224	RAP1B	Ras-related protein Rap-1b	GO:0003924; F:GTPase activity; IDA:UniProtKB
P61224	RAP1B	Ras-related protein Rap-1b	GO:0005515; F:protein binding; IPI:UniProtKB
P61224	RAP1B	Ras-related protein Rap-1b	GO:0032403; F:protein complex binding; IDA:MGI
P61224	RAP1B	Ras-related protein Rap-1b	GO:0007596; P:blood coagulation; TAS:Reactome
P61224	RAP1B	Ras-related protein Rap-1b	GO:0008283; P:cell proliferation; IEA:Ensembl
P61224	RAP1B	Ras-related protein Rap-1b	GO:0071320; P:cellular response to cAMP; IDA:UniProtKB
P61224	RAP1B	Ras-related protein Rap-1b	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P61224	RAP1B	Ras-related protein Rap-1b	GO:0061028; P:establishment of endothelial barrier; IMP:UniProtKB
P61224	RAP1B	Ras-related protein Rap-1b	GO:0030168; P:platelet activation; TAS:Reactome
P61224	RAP1B	Ras-related protein Rap-1b	GO:0032486; P:Rap protein signal transduction; IMP:UniProtKB
P61224	RAP1B	Ras-related protein Rap-1b	GO:1901888; P:regulation of cell junction assembly; IMP:UniProtKB
P61224	RAP1B	Ras-related protein Rap-1b	GO:2000114; P:regulation of establishment of cell polarity; IMP:UniProtKB
P61224	RAP1B	Ras-related protein Rap-1b	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P61224	RAP1B	Ras-related protein Rap-1b	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P10114	RAP2A	Ras-related protein Rap-2a	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P10114	RAP2A	Ras-related protein Rap-2a	GO:0003924; F:GTPase activity; IDA:UniProtKB
P10114	RAP2A	Ras-related protein Rap-2a	GO:0005515; F:protein binding; IPI:UniProtKB
P10114	RAP2A	Ras-related protein Rap-2a	GO:0031532; P:actin cytoskeleton reorganization; IDA:UniProtKB
P10114	RAP2A	Ras-related protein Rap-2a	GO:0034613; P:cellular protein localization; IDA:UniProtKB
P10114	RAP2A	Ras-related protein Rap-2a	GO:0045184; P:establishment of protein localization; IDA:MGI
P10114	RAP2A	Ras-related protein Rap-2a	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
P10114	RAP2A	Ras-related protein Rap-2a	GO:0031954; P:positive regulation of protein autophosphorylation; IDA:UniProtKB
P10114	RAP2A	Ras-related protein Rap-2a	GO:0032486; P:Rap protein signal transduction; ISS:UniProtKB
P10114	RAP2A	Ras-related protein Rap-2a	GO:0048814; P:regulation of dendrite morphogenesis; IDA:UniProtKB
P10114	RAP2A	Ras-related protein Rap-2a	GO:0046328; P:regulation of JNK cascade; IDA:UniProtKB
P61225	RAP2B	Ras-related protein Rap-2b	GO:0019003; F:GDP binding; IDA:UniProt
P61225	RAP2B	Ras-related protein Rap-2b	GO:0005525; F:GTP binding; IDA:UniProt
P61225	RAP2B	Ras-related protein Rap-2b	GO:0006184; P:GTP catabolic process; IEA:InterPro
P61225	RAP2B	Ras-related protein Rap-2b	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
P61225	RAP2B	Ras-related protein Rap-2b	GO:0031954; P:positive regulation of protein autophosphorylation; IEA:Ensembl
P61225	RAP2B	Ras-related protein Rap-2b	GO:0032486; P:Rap protein signal transduction; ISS:UniProtKB
P61225	RAP2B	Ras-related protein Rap-2b	GO:0061097; P:regulation of protein tyrosine kinase activity; ISS:UniProtKB
P61225	RAP2B	Ras-related protein Rap-2b	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y3L5	RAP2C	Ras-related protein Rap-2c	GO:0019003; F:GDP binding; IDA:UniProt
Q9Y3L5	RAP2C	Ras-related protein Rap-2c	GO:0005525; F:GTP binding; IDA:UniProt
Q9Y3L5	RAP2C	Ras-related protein Rap-2c	GO:0003713; F:transcription coactivator activity; IDA:UniProt
Q9Y3L5	RAP2C	Ras-related protein Rap-2c	GO:0006184; P:GTP catabolic process; IEA:InterPro
Q9Y3L5	RAP2C	Ras-related protein Rap-2c	GO:0030336; P:negative regulation of cell migration; ISS:UniProtKB
Q9Y3L5	RAP2C	Ras-related protein Rap-2c	GO:0031954; P:positive regulation of protein autophosphorylation; ISS:UniProtKB
Q9Y3L5	RAP2C	Ras-related protein Rap-2c	GO:0032486; P:Rap protein signal transduction; ISS:UniProtKB
Q9Y3L5	RAP2C	Ras-related protein Rap-2c	GO:0061097; P:regulation of protein tyrosine kinase activity; ISS:UniProtKB
Q9Y3L5	RAP2C	Ras-related protein Rap-2c	GO:2001141; P:regulation of RNA biosynthetic process; IDA:GOC
Q70E73	RAPH1	Ras-associated and pleckstrin homology domains-containing protein 1	GO:0048675; P:axon extension; IEA:Ensembl
Q70E73	RAPH1	Ras-associated and pleckstrin homology domains-containing protein 1	GO:0007160; P:cell-matrix adhesion; IEA:InterPro
Q70E73	RAPH1	Ras-associated and pleckstrin homology domains-containing protein 1	GO:0007165; P:signal transduction; IEA:InterPro
Q13702	RAPSN	43 kDa receptor-associated protein of the synapse	GO:0033130; F:acetylcholine receptor binding; IDA:MGI
Q13702	RAPSN	43 kDa receptor-associated protein of the synapse	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13702	RAPSN	43 kDa receptor-associated protein of the synapse	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
Q13702	RAPSN	43 kDa receptor-associated protein of the synapse	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q13702	RAPSN	43 kDa receptor-associated protein of the synapse	GO:0007271; P:synaptic transmission, cholinergic; IGI:MGI
P10276	RARA	Retinoic acid receptor alpha	GO:0031490; F:chromatin DNA binding; IDA:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0008144; F:drug binding; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0019899; F:enzyme binding; IPI:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0048027; F:mRNA 5'-UTR binding; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0035014; F:phosphatidylinositol 3-kinase regulator activity; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0051018; F:protein kinase A binding; IDA:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0043422; F:protein kinase B binding; IPI:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0005102; F:receptor binding; IDA:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0001972; F:retinoic acid binding; IDA:BHF-UCL
P10276	RARA	Retinoic acid receptor alpha	GO:0003708; F:retinoic acid receptor activity; IDA:BHF-UCL
P10276	RARA	Retinoic acid receptor alpha	GO:0044323; F:retinoic acid-responsive element binding; IDA:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P10276	RARA	Retinoic acid receptor alpha	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P10276	RARA	Retinoic acid receptor alpha	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0000900; F:translation repressor activity, nucleic acid binding; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0008270; F:zinc ion binding; IEA:InterPro
P10276	RARA	Retinoic acid receptor alpha	GO:0043277; P:apoptotic cell clearance; IMP:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0071391; P:cellular response to estrogen stimulus; IDA:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0071300; P:cellular response to retinoic acid; IDA:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0060591; P:chondroblast differentiation; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0007565; P:female pregnancy; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0010467; P:gene expression; TAS:Reactome
P10276	RARA	Retinoic acid receptor alpha	GO:0007281; P:germ cell development; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0003417; P:growth plate cartilage development; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0030520; P:intracellular estrogen receptor signaling pathway; IDA:BHF-UCL
P10276	RARA	Retinoic acid receptor alpha	GO:0001889; P:liver development; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0035264; P:multicellular organism growth; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0061037; P:negative regulation of cartilage development; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0030853; P:negative regulation of granulocyte differentiation; IDA:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0032689; P:negative regulation of interferon-gamma production; IDA:BHF-UCL
P10276	RARA	Retinoic acid receptor alpha	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0045947; P:negative regulation of translational initiation; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0032720; P:negative regulation of tumor necrosis factor production; IDA:BHF-UCL
P10276	RARA	Retinoic acid receptor alpha	GO:0051099; P:positive regulation of binding; IMP:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0045787; P:positive regulation of cell cycle; IMP:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0032736; P:positive regulation of interleukin-13 production; IDA:BHF-UCL
P10276	RARA	Retinoic acid receptor alpha	GO:0032753; P:positive regulation of interleukin-4 production; IDA:BHF-UCL
P10276	RARA	Retinoic acid receptor alpha	GO:0032754; P:positive regulation of interleukin-5 production; IDA:BHF-UCL
P10276	RARA	Retinoic acid receptor alpha	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0045630; P:positive regulation of T-helper 2 cell differentiation; IDA:BHF-UCL
P10276	RARA	Retinoic acid receptor alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0030850; P:prostate gland development; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0006468; P:protein phosphorylation; IMP:UniProtKB
P10276	RARA	Retinoic acid receptor alpha	GO:0042981; P:regulation of apoptotic process; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0031641; P:regulation of myelination; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0034097; P:response to cytokine; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0032355; P:response to estradiol; IDA:BHF-UCL
P10276	RARA	Retinoic acid receptor alpha	GO:0045471; P:response to ethanol; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0032526; P:response to retinoic acid; IMP:BHF-UCL
P10276	RARA	Retinoic acid receptor alpha	GO:0033189; P:response to vitamin A; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0048384; P:retinoic acid receptor signaling pathway; IMP:BHF-UCL
P10276	RARA	Retinoic acid receptor alpha	GO:0060010; P:Sertoli cell fate commitment; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0007165; P:signal transduction; IDA:BHF-UCL
P10276	RARA	Retinoic acid receptor alpha	GO:0007283; P:spermatogenesis; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P10276	RARA	Retinoic acid receptor alpha	GO:0001657; P:ureteric bud development; IEA:Ensembl
P10276	RARA	Retinoic acid receptor alpha	GO:0055012; P:ventricular cardiac muscle cell differentiation; IEA:Ensembl
P10826	RARB	Retinoic acid receptor beta	GO:0003677; F:DNA binding; TAS:ProtInc
P10826	RARB	Retinoic acid receptor beta	GO:0008144; F:drug binding; IEA:Ensembl
P10826	RARB	Retinoic acid receptor beta	GO:0005515; F:protein binding; IPI:IntAct
P10826	RARB	Retinoic acid receptor beta	GO:0003708; F:retinoic acid receptor activity; TAS:ProtInc
P10826	RARB	Retinoic acid receptor beta	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P10826	RARB	Retinoic acid receptor beta	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P10826	RARB	Retinoic acid receptor beta	GO:0008270; F:zinc ion binding; IEA:InterPro
P10826	RARB	Retinoic acid receptor beta	GO:0048566; P:embryonic digestive tract development; IMP:DFLAT
P10826	RARB	Retinoic acid receptor beta	GO:0048048; P:embryonic eye morphogenesis; IEA:Ensembl
P10826	RARB	Retinoic acid receptor beta	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
P10826	RARB	Retinoic acid receptor beta	GO:0010467; P:gene expression; TAS:Reactome
P10826	RARB	Retinoic acid receptor beta	GO:0003417; P:growth plate cartilage development; IEA:Ensembl
P10826	RARB	Retinoic acid receptor beta	GO:0035264; P:multicellular organism growth; IEA:Ensembl
P10826	RARB	Retinoic acid receptor beta	GO:0061037; P:negative regulation of cartilage development; IEA:Ensembl
P10826	RARB	Retinoic acid receptor beta	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P10826	RARB	Retinoic acid receptor beta	GO:0032331; P:negative regulation of chondrocyte differentiation; IEA:Ensembl
P10826	RARB	Retinoic acid receptor beta	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P10826	RARB	Retinoic acid receptor beta	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P10826	RARB	Retinoic acid receptor beta	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P10826	RARB	Retinoic acid receptor beta	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P10826	RARB	Retinoic acid receptor beta	GO:0031641; P:regulation of myelination; IEA:Ensembl
P10826	RARB	Retinoic acid receptor beta	GO:0007165; P:signal transduction; TAS:ProtInc
P10826	RARB	Retinoic acid receptor beta	GO:0021756; P:striatum development; IEA:Ensembl
P10826	RARB	Retinoic acid receptor beta	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P10826	RARB	Retinoic acid receptor beta	GO:0001657; P:ureteric bud development; IEA:Ensembl
P10826	RARB	Retinoic acid receptor beta	GO:0055012; P:ventricular cardiac muscle cell differentiation; IEA:Ensembl
P13631	RARG	Retinoic acid receptor gamma	GO:0003677; F:DNA binding; ISS:BHF-UCL
P13631	RARG	Retinoic acid receptor gamma	GO:0005515; F:protein binding; IPI:UniProtKB
P13631	RARG	Retinoic acid receptor gamma	GO:0003708; F:retinoic acid receptor activity; IEA:Ensembl
P13631	RARG	Retinoic acid receptor gamma	GO:0046965; F:retinoid X receptor binding; ISS:BHF-UCL
P13631	RARG	Retinoic acid receptor gamma	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P13631	RARG	Retinoic acid receptor gamma	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
P13631	RARG	Retinoic acid receptor gamma	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P13631	RARG	Retinoic acid receptor gamma	GO:0008270; F:zinc ion binding; IEA:InterPro
P13631	RARG	Retinoic acid receptor gamma	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P13631	RARG	Retinoic acid receptor gamma	GO:0060070; P:canonical Wnt signaling pathway; TAS:BHF-UCL
P13631	RARG	Retinoic acid receptor gamma	GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl
P13631	RARG	Retinoic acid receptor gamma	GO:0048048; P:embryonic eye morphogenesis; ISS:BHF-UCL
P13631	RARG	Retinoic acid receptor gamma	GO:0035116; P:embryonic hindlimb morphogenesis; ISS:BHF-UCL
P13631	RARG	Retinoic acid receptor gamma	GO:0010467; P:gene expression; TAS:Reactome
P13631	RARG	Retinoic acid receptor gamma	GO:0003430; P:growth plate cartilage chondrocyte growth; IEA:Ensembl
P13631	RARG	Retinoic acid receptor gamma	GO:0070384; P:Harderian gland development; IEA:Ensembl
P13631	RARG	Retinoic acid receptor gamma	GO:0035264; P:multicellular organism growth; IEA:Ensembl
P13631	RARG	Retinoic acid receptor gamma	GO:0061037; P:negative regulation of cartilage development; IEA:Ensembl
P13631	RARG	Retinoic acid receptor gamma	GO:0008285; P:negative regulation of cell proliferation; ISS:BHF-UCL
P13631	RARG	Retinoic acid receptor gamma	GO:0032331; P:negative regulation of chondrocyte differentiation; IEA:Ensembl
P13631	RARG	Retinoic acid receptor gamma	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P13631	RARG	Retinoic acid receptor gamma	GO:0043065; P:positive regulation of apoptotic process; ISS:BHF-UCL
P13631	RARG	Retinoic acid receptor gamma	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P13631	RARG	Retinoic acid receptor gamma	GO:0043068; P:positive regulation of programmed cell death; ISS:BHF-UCL
P13631	RARG	Retinoic acid receptor gamma	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P13631	RARG	Retinoic acid receptor gamma	GO:0060740; P:prostate gland epithelium morphogenesis; IEA:Ensembl
P13631	RARG	Retinoic acid receptor gamma	GO:0008361; P:regulation of cell size; TAS:BHF-UCL
P13631	RARG	Retinoic acid receptor gamma	GO:0031641; P:regulation of myelination; IEA:Ensembl
P13631	RARG	Retinoic acid receptor gamma	GO:0032526; P:response to retinoic acid; IDA:BHF-UCL
P13631	RARG	Retinoic acid receptor gamma	GO:0048384; P:retinoic acid receptor signaling pathway; IDA:BHF-UCL
P13631	RARG	Retinoic acid receptor gamma	GO:0060534; P:trachea cartilage development; IEA:Ensembl
P13631	RARG	Retinoic acid receptor gamma	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q99969	RARRES2	Retinoic acid receptor responder protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q99969	RARRES2	Retinoic acid receptor responder protein 2	GO:0005102; F:receptor binding; IPI:UniProtKB
Q99969	RARRES2	Retinoic acid receptor responder protein 2	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
Q99969	RARRES2	Retinoic acid receptor responder protein 2	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
Q99969	RARRES2	Retinoic acid receptor responder protein 2	GO:0048566; P:embryonic digestive tract development; IMP:DFLAT
Q99969	RARRES2	Retinoic acid receptor responder protein 2	GO:0001701; P:in utero embryonic development; IEP:DFLAT
Q99969	RARRES2	Retinoic acid receptor responder protein 2	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q99969	RARRES2	Retinoic acid receptor responder protein 2	GO:0050921; P:positive regulation of chemotaxis; ISS:UniProtKB
Q99969	RARRES2	Retinoic acid receptor responder protein 2	GO:0045600; P:positive regulation of fat cell differentiation; ISS:UniProtKB
Q99969	RARRES2	Retinoic acid receptor responder protein 2	GO:2001275; P:positive regulation of glucose import in response to insulin stimulus; IDA:UniProtKB
Q99969	RARRES2	Retinoic acid receptor responder protein 2	GO:0010759; P:positive regulation of macrophage chemotaxis; IMP:DFLAT
Q99969	RARRES2	Retinoic acid receptor responder protein 2	GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB
Q99969	RARRES2	Retinoic acid receptor responder protein 2	GO:0050994; P:regulation of lipid catabolic process; ISS:UniProtKB
Q99969	RARRES2	Retinoic acid receptor responder protein 2	GO:0001523; P:retinoid metabolic process; IDA:UniProtKB
C9J798	RASA4B	Putative Ras GTPase-activating protein 4B	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
C9J798	RASA4B	Putative Ras GTPase-activating protein 4B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
C9J798	RASA4B	Putative Ras GTPase-activating protein 4B	GO:0035556; P:intracellular signal transduction; IEA:InterPro
C9J798	RASA4B	Putative Ras GTPase-activating protein 4B	GO:0051056; P:regulation of small GTPase mediated signal transduction; IEA:InterPro
P20936	RASA1	Ras GTPase-activating protein 1	GO:0001948; F:glycoprotein binding; IPI:UniProtKB
P20936	RASA1	Ras GTPase-activating protein 1	GO:0051020; F:GTPase binding; IPI:UniProtKB
P20936	RASA1	Ras GTPase-activating protein 1	GO:0019870; F:potassium channel inhibitor activity; NAS:UniProtKB
P20936	RASA1	Ras GTPase-activating protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P20936	RASA1	Ras GTPase-activating protein 1	GO:0005099; F:Ras GTPase activator activity; IBA:RefGenome
P20936	RASA1	Ras GTPase-activating protein 1	GO:0005102; F:receptor binding; IPI:UniProtKB
P20936	RASA1	Ras GTPase-activating protein 1	GO:0009790; P:embryo development; ISS:UniProtKB
P20936	RASA1	Ras GTPase-activating protein 1	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
P20936	RASA1	Ras GTPase-activating protein 1	GO:0000281; P:mitotic cytokinesis; ISS:UniProtKB
P20936	RASA1	Ras GTPase-activating protein 1	GO:0007162; P:negative regulation of cell adhesion; IDA:UniProtKB
P20936	RASA1	Ras GTPase-activating protein 1	GO:0001953; P:negative regulation of cell-matrix adhesion; IDA:UniProtKB
P20936	RASA1	Ras GTPase-activating protein 1	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB
P20936	RASA1	Ras GTPase-activating protein 1	GO:0046580; P:negative regulation of Ras protein signal transduction; IBA:RefGenome
P20936	RASA1	Ras GTPase-activating protein 1	GO:0032320; P:positive regulation of Ras GTPase activity; IBA:RefGenome
P20936	RASA1	Ras GTPase-activating protein 1	GO:0030833; P:regulation of actin filament polymerization; IDA:UniProtKB
P20936	RASA1	Ras GTPase-activating protein 1	GO:0008360; P:regulation of cell shape; NAS:UniProtKB
P20936	RASA1	Ras GTPase-activating protein 1	GO:0051252; P:regulation of RNA metabolic process; NAS:UniProtKB
P20936	RASA1	Ras GTPase-activating protein 1	GO:0007165; P:signal transduction; IDA:UniProtKB
P20936	RASA1	Ras GTPase-activating protein 1	GO:0001570; P:vasculogenesis; ISS:UniProtKB
Q14644	RASA3	Ras GTPase-activating protein 3	GO:0015278; F:calcium-release channel activity; IDA:BHF-UCL
Q14644	RASA3	Ras GTPase-activating protein 3	GO:0005096; F:GTPase activator activity; TAS:ProtInc
Q14644	RASA3	Ras GTPase-activating protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14644	RASA3	Ras GTPase-activating protein 3	GO:0005099; F:Ras GTPase activator activity; IBA:RefGenome
Q14644	RASA3	Ras GTPase-activating protein 3	GO:0070588; P:calcium ion transmembrane transport; IDA:GOC
Q14644	RASA3	Ras GTPase-activating protein 3	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q14644	RASA3	Ras GTPase-activating protein 3	GO:0046580; P:negative regulation of Ras protein signal transduction; IBA:RefGenome
Q14644	RASA3	Ras GTPase-activating protein 3	GO:0032320; P:positive regulation of Ras GTPase activity; IBA:RefGenome
Q14644	RASA3	Ras GTPase-activating protein 3	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y272	RASD1	Dexamethasone-induced Ras-related protein 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9Y272	RASD1	Dexamethasone-induced Ras-related protein 1	GO:0003924; F:GTPase activity; TAS:ProtInc
Q9Y272	RASD1	Dexamethasone-induced Ras-related protein 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q9Y272	RASD1	Dexamethasone-induced Ras-related protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q9Y272	RASD1	Dexamethasone-induced Ras-related protein 1	GO:0007263; P:nitric oxide mediated signal transduction; IEA:Ensembl
Q9Y272	RASD1	Dexamethasone-induced Ras-related protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y272	RASD1	Dexamethasone-induced Ras-related protein 1	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q7Z444	ERAS	GTPase ERas	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q7Z444	ERAS	GTPase ERas	GO:0006184; P:GTP catabolic process; IEA:InterPro
Q7Z444	ERAS	GTPase ERas	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q8IZ41	RASEF	Ras and EF-hand domain-containing protein	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8IZ41	RASEF	Ras and EF-hand domain-containing protein	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q8IZ41	RASEF	Ras and EF-hand domain-containing protein	GO:0015031; P:protein transport; IEA:InterPro
Q8IZ41	RASEF	Ras and EF-hand domain-containing protein	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9NS23	RASSF1	Ras association domain-containing protein 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q9NS23	RASSF1	Ras association domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NS23	RASSF1	Ras association domain-containing protein 1	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q9NS23	RASSF1	Ras association domain-containing protein 1	GO:0008270; F:zinc ion binding; TAS:UniProtKB
Q9NS23	RASSF1	Ras association domain-containing protein 1	GO:0007050; P:cell cycle arrest; IMP:UniProtKB
Q9NS23	RASSF1	Ras association domain-containing protein 1	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
Q9NS23	RASSF1	Ras association domain-containing protein 1	GO:0071157; P:negative regulation of cell cycle arrest; IDA:UniProtKB
Q9NS23	RASSF1	Ras association domain-containing protein 1	GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB
Q9NS23	RASSF1	Ras association domain-containing protein 1	GO:0050821; P:protein stabilization; IDA:UniProtKB
Q9NS23	RASSF1	Ras association domain-containing protein 1	GO:0007265; P:Ras protein signal transduction; IDA:UniProtKB
Q15283	RASA2	Ras GTPase-activating protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15283	RASA2	Ras GTPase-activating protein 2	GO:0005099; F:Ras GTPase activator activity; IBA:RefGenome
Q15283	RASA2	Ras GTPase-activating protein 2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q15283	RASA2	Ras GTPase-activating protein 2	GO:0046580; P:negative regulation of Ras protein signal transduction; IBA:RefGenome
Q15283	RASA2	Ras GTPase-activating protein 2	GO:0032320; P:positive regulation of Ras GTPase activity; IBA:RefGenome
Q15283	RASA2	Ras GTPase-activating protein 2	GO:0007165; P:signal transduction; TAS:ProtInc
P50749	RASSF2	Ras association domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
P50749	RASSF2	Ras association domain-containing protein 2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P50749	RASSF2	Ras association domain-containing protein 2	GO:0007165; P:signal transduction; IEA:InterPro
Q86WH2	RASSF3	Ras association domain-containing protein 3	GO:0042802; F:identical protein binding; IPI:IntAct
Q86WH2	RASSF3	Ras association domain-containing protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q86WH2	RASSF3	Ras association domain-containing protein 3	GO:0007165; P:signal transduction; IEA:InterPro
Q8WWW0	RASSF5	Ras association domain-containing protein 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8WWW0	RASSF5	Ras association domain-containing protein 5	GO:0005515; F:protein binding; IPI:IntAct
Q8WWW0	RASSF5	Ras association domain-containing protein 5	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8WWW0	RASSF5	Ras association domain-containing protein 5	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8WWW0	RASSF5	Ras association domain-containing protein 5	GO:0031398; P:positive regulation of protein ubiquitination; IEA:Ensembl
Q6ZTQ3	RASSF6	Ras association domain-containing protein 6	GO:0005515; F:protein binding; IPI:IntAct
Q6ZTQ3	RASSF6	Ras association domain-containing protein 6	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q6ZTQ3	RASSF6	Ras association domain-containing protein 6	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q6ZTQ3	RASSF6	Ras association domain-containing protein 6	GO:0007165; P:signal transduction; IEA:InterPro
Q9H2L5	RASSF4	Ras association domain-containing protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q9H2L5	RASSF4	Ras association domain-containing protein 4	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9H2L5	RASSF4	Ras association domain-containing protein 4	GO:0007165; P:signal transduction; IEA:InterPro
Q8NHQ8	RASSF8	Ras association domain-containing protein 8	GO:0007165; P:signal transduction; IEA:InterPro
O75901	RASSF9	Ras association domain-containing protein 9	GO:0005515; F:protein binding; IPI:UniProtKB
O75901	RASSF9	Ras association domain-containing protein 9	GO:0005215; F:transporter activity; NAS:UniProtKB
O75901	RASSF9	Ras association domain-containing protein 9	GO:0016197; P:endosomal transport; NAS:UniProtKB
O75901	RASSF9	Ras association domain-containing protein 9	GO:0006605; P:protein targeting; NAS:UniProtKB
O75901	RASSF9	Ras association domain-containing protein 9	GO:0007165; P:signal transduction; IEA:InterPro
A6NK89	RASSF10	Ras association domain-containing protein 10	GO:0007165; P:signal transduction; IEA:InterPro
Q02833	RASSF7	Ras association domain-containing protein 7	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q02833	RASSF7	Ras association domain-containing protein 7	GO:0007165; P:signal transduction; IEA:InterPro
P01112	HRAS	GTPase HRas	GO:0005525; F:GTP binding; IDA:UniProtKB
P01112	HRAS	GTPase HRas	GO:0005515; F:protein binding; IPI:UniProtKB
P01112	HRAS	GTPase HRas	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P01112	HRAS	GTPase HRas	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
P01112	HRAS	GTPase HRas	GO:0000186; P:activation of MAPKK activity; TAS:Reactome
P01112	HRAS	GTPase HRas	GO:0007411; P:axon guidance; TAS:Reactome
P01112	HRAS	GTPase HRas	GO:0007596; P:blood coagulation; TAS:Reactome
P01112	HRAS	GTPase HRas	GO:0007050; P:cell cycle arrest; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0008283; P:cell proliferation; IEA:Ensembl
P01112	HRAS	GTPase HRas	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P01112	HRAS	GTPase HRas	GO:0090398; P:cellular senescence; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0006935; P:chemotaxis; TAS:ProtInc
P01112	HRAS	GTPase HRas	GO:0006897; P:endocytosis; IEA:Ensembl
P01112	HRAS	GTPase HRas	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P01112	HRAS	GTPase HRas	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P01112	HRAS	GTPase HRas	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P01112	HRAS	GTPase HRas	GO:0006184; P:GTP catabolic process; IEA:InterPro
P01112	HRAS	GTPase HRas	GO:0045087; P:innate immune response; TAS:Reactome
P01112	HRAS	GTPase HRas	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P01112	HRAS	GTPase HRas	GO:0097193; P:intrinsic apoptotic signaling pathway; IEA:Ensembl
P01112	HRAS	GTPase HRas	GO:0050900; P:leukocyte migration; TAS:Reactome
P01112	HRAS	GTPase HRas	GO:0000165; P:MAPK cascade; TAS:Reactome
P01112	HRAS	GTPase HRas	GO:0007093; P:mitotic cell cycle checkpoint; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0010629; P:negative regulation of gene expression; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P01112	HRAS	GTPase HRas	GO:0034259; P:negative regulation of Rho GTPase activity; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P01112	HRAS	GTPase HRas	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P01112	HRAS	GTPase HRas	GO:2000251; P:positive regulation of actin cytoskeleton reorganization; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0030335; P:positive regulation of cell migration; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0045740; P:positive regulation of DNA replication; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0050679; P:positive regulation of epithelial cell proliferation; IMP:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0046330; P:positive regulation of JNK cascade; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0043406; P:positive regulation of MAP kinase activity; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0043410; P:positive regulation of MAPK cascade; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:2000630; P:positive regulation of miRNA metabolic process; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0001934; P:positive regulation of protein phosphorylation; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0032855; P:positive regulation of Rac GTPase activity; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0035022; P:positive regulation of Rac protein signal transduction; IEA:Ensembl
P01112	HRAS	GTPase HRas	GO:1900029; P:positive regulation of ruffle assembly; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0090303; P:positive regulation of wound healing; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P01112	HRAS	GTPase HRas	GO:0007265; P:Ras protein signal transduction; IDA:BHF-UCL
P01112	HRAS	GTPase HRas	GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IEA:Ensembl
P01112	HRAS	GTPase HRas	GO:0032228; P:regulation of synaptic transmission, GABAergic; IEA:Ensembl
P01112	HRAS	GTPase HRas	GO:0007165; P:signal transduction; NAS:ProtInc
P01112	HRAS	GTPase HRas	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P01112	HRAS	GTPase HRas	GO:0035176; P:social behavior; IEA:Ensembl
P01112	HRAS	GTPase HRas	GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl
P01112	HRAS	GTPase HRas	GO:0007268; P:synaptic transmission; TAS:Reactome
P01112	HRAS	GTPase HRas	GO:0008542; P:visual learning; IEA:Ensembl
P01116	KRAS	GTPase KRas	GO:0019003; F:GDP binding; IEA:Ensembl
P01116	KRAS	GTPase KRas	GO:0019002; F:GMP binding; IEA:Ensembl
P01116	KRAS	GTPase KRas	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P01116	KRAS	GTPase KRas	GO:0005515; F:protein binding; IPI:IntAct
P01116	KRAS	GTPase KRas	GO:0032403; F:protein complex binding; IDA:MGI
P01116	KRAS	GTPase KRas	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
P01116	KRAS	GTPase KRas	GO:0000186; P:activation of MAPKK activity; TAS:Reactome
P01116	KRAS	GTPase KRas	GO:0007411; P:axon guidance; TAS:Reactome
P01116	KRAS	GTPase KRas	GO:0007596; P:blood coagulation; TAS:Reactome
P01116	KRAS	GTPase KRas	GO:0019221; P:cytokine-mediated signaling pathway; IEA:Ensembl
P01116	KRAS	GTPase KRas	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P01116	KRAS	GTPase KRas	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P01116	KRAS	GTPase KRas	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P01116	KRAS	GTPase KRas	GO:0006184; P:GTP catabolic process; IEA:InterPro
P01116	KRAS	GTPase KRas	GO:0045087; P:innate immune response; TAS:Reactome
P01116	KRAS	GTPase KRas	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P01116	KRAS	GTPase KRas	GO:0050900; P:leukocyte migration; TAS:Reactome
P01116	KRAS	GTPase KRas	GO:0000165; P:MAPK cascade; TAS:Reactome
P01116	KRAS	GTPase KRas	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P01116	KRAS	GTPase KRas	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P01116	KRAS	GTPase KRas	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P01116	KRAS	GTPase KRas	GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL
P01116	KRAS	GTPase KRas	GO:0043406; P:positive regulation of MAP kinase activity; IEA:Ensembl
P01116	KRAS	GTPase KRas	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:Ensembl
P01116	KRAS	GTPase KRas	GO:0051000; P:positive regulation of nitric-oxide synthase activity; IEA:Ensembl
P01116	KRAS	GTPase KRas	GO:0001934; P:positive regulation of protein phosphorylation; IMP:BHF-UCL
P01116	KRAS	GTPase KRas	GO:0035022; P:positive regulation of Rac protein signal transduction; IEA:Ensembl
P01116	KRAS	GTPase KRas	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
P01116	KRAS	GTPase KRas	GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IEA:Ensembl
P01116	KRAS	GTPase KRas	GO:0032228; P:regulation of synaptic transmission, GABAergic; IEA:Ensembl
P01116	KRAS	GTPase KRas	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P01116	KRAS	GTPase KRas	GO:0051385; P:response to mineralocorticoid; IEA:Ensembl
P01116	KRAS	GTPase KRas	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P01116	KRAS	GTPase KRas	GO:0035176; P:social behavior; IEA:Ensembl
P01116	KRAS	GTPase KRas	GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl
P01116	KRAS	GTPase KRas	GO:0008542; P:visual learning; IEA:Ensembl
O43374	RASA4	Ras GTPase-activating protein 4	GO:0005096; F:GTPase activator activity; IDA:UniProtKB
O43374	RASA4	Ras GTPase-activating protein 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43374	RASA4	Ras GTPase-activating protein 4	GO:0005099; F:Ras GTPase activator activity; IBA:RefGenome
O43374	RASA4	Ras GTPase-activating protein 4	GO:0035556; P:intracellular signal transduction; IEA:InterPro
O43374	RASA4	Ras GTPase-activating protein 4	GO:0046580; P:negative regulation of Ras protein signal transduction; IBA:RefGenome
O43374	RASA4	Ras GTPase-activating protein 4	GO:0032320; P:positive regulation of Ras GTPase activity; IBA:RefGenome
O95294	RASAL1	RasGAP-activating-like protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95294	RASAL1	RasGAP-activating-like protein 1	GO:0005543; F:phospholipid binding; TAS:ProtInc
O95294	RASAL1	RasGAP-activating-like protein 1	GO:0005099; F:Ras GTPase activator activity; IBA:RefGenome
O95294	RASAL1	RasGAP-activating-like protein 1	GO:0035556; P:intracellular signal transduction; IEA:InterPro
O95294	RASAL1	RasGAP-activating-like protein 1	GO:0046580; P:negative regulation of Ras protein signal transduction; IBA:RefGenome
O95294	RASAL1	RasGAP-activating-like protein 1	GO:0032320; P:positive regulation of Ras GTPase activity; IBA:RefGenome
O95294	RASAL1	RasGAP-activating-like protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q9NYN1	RASL12	Ras-like protein family member 12	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9NYN1	RASL12	Ras-like protein family member 12	GO:0006184; P:GTP catabolic process; IEA:InterPro
Q9NYN1	RASL12	Ras-like protein family member 12	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q86YV0	RASAL3	RAS protein activator like-3	GO:0005099; F:Ras GTPase activator activity; IBA:RefGenome
Q86YV0	RASAL3	RAS protein activator like-3	GO:0046580; P:negative regulation of Ras protein signal transduction; IBA:RefGenome
Q86YV0	RASAL3	RAS protein activator like-3	GO:0032320; P:positive regulation of Ras GTPase activity; IBA:RefGenome
Q86YV0	RASAL3	RAS protein activator like-3	GO:0007165; P:signal transduction; IEA:InterPro
O14807	MRAS	Ras-related protein M-Ras	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
O14807	MRAS	Ras-related protein M-Ras	GO:0030742; F:GTP-dependent protein binding; IPI:UniProtKB
O14807	MRAS	Ras-related protein M-Ras	GO:0003924; F:GTPase activity; TAS:ProtInc
O14807	MRAS	Ras-related protein M-Ras	GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc
O14807	MRAS	Ras-related protein M-Ras	GO:0007275; P:multicellular organismal development; TAS:ProtInc
O14807	MRAS	Ras-related protein M-Ras	GO:0007517; P:muscle organ development; TAS:ProtInc
O14807	MRAS	Ras-related protein M-Ras	GO:0007265; P:Ras protein signal transduction; TAS:ProtInc
P01111	NRAS	GTPase NRas	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P01111	NRAS	GTPase NRas	GO:0032403; F:protein complex binding; IDA:MGI
P01111	NRAS	GTPase NRas	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
P01111	NRAS	GTPase NRas	GO:0000186; P:activation of MAPKK activity; TAS:Reactome
P01111	NRAS	GTPase NRas	GO:0007411; P:axon guidance; TAS:Reactome
P01111	NRAS	GTPase NRas	GO:0007596; P:blood coagulation; TAS:Reactome
P01111	NRAS	GTPase NRas	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P01111	NRAS	GTPase NRas	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P01111	NRAS	GTPase NRas	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P01111	NRAS	GTPase NRas	GO:0006184; P:GTP catabolic process; IEA:InterPro
P01111	NRAS	GTPase NRas	GO:0045087; P:innate immune response; TAS:Reactome
P01111	NRAS	GTPase NRas	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P01111	NRAS	GTPase NRas	GO:0050900; P:leukocyte migration; TAS:Reactome
P01111	NRAS	GTPase NRas	GO:0000165; P:MAPK cascade; TAS:Reactome
P01111	NRAS	GTPase NRas	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P01111	NRAS	GTPase NRas	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P01111	NRAS	GTPase NRas	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P01111	NRAS	GTPase NRas	GO:0035022; P:positive regulation of Rac protein signal transduction; IEA:Ensembl
P01111	NRAS	GTPase NRas	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
P01111	NRAS	GTPase NRas	GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IEA:Ensembl
P01111	NRAS	GTPase NRas	GO:0032228; P:regulation of synaptic transmission, GABAergic; IEA:Ensembl
P01111	NRAS	GTPase NRas	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P01111	NRAS	GTPase NRas	GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl
P01111	NRAS	GTPase NRas	GO:0008542; P:visual learning; IEA:Ensembl
Q8IY67	RAVER1	Ribonucleoprotein PTB-binding 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8IY67	RAVER1	Ribonucleoprotein PTB-binding 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9HCJ3	RAVER2	Ribonucleoprotein PTB-binding 2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9HCJ3	RAVER2	Ribonucleoprotein PTB-binding 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96IS3	RAX2	Retina and anterior neural fold homeobox protein 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q96IS3	RAX2	Retina and anterior neural fold homeobox protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q96IS3	RAX2	Retina and anterior neural fold homeobox protein 2	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q96IS3	RAX2	Retina and anterior neural fold homeobox protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96IS3	RAX2	Retina and anterior neural fold homeobox protein 2	GO:0007601; P:visual perception; IEA:UniProtKB-KW
P62491	RAB11A	Ras-related protein Rab-11A	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P62491	RAB11A	Ras-related protein Rab-11A	GO:0003924; F:GTPase activity; IDA:UniProtKB
P62491	RAB11A	Ras-related protein Rab-11A	GO:0005515; F:protein binding; IPI:UniProtKB
P62491	RAB11A	Ras-related protein Rab-11A	GO:0019905; F:syntaxin binding; NAS:UniProtKB
P62491	RAB11A	Ras-related protein Rab-11A	GO:0000910; P:cytokinesis; IMP:UniProtKB
P62491	RAB11A	Ras-related protein Rab-11A	GO:0032402; P:melanosome transport; ISS:UniProtKB
P62491	RAB11A	Ras-related protein Rab-11A	GO:0031175; P:neuron projection development; IMP:UniProtKB
P62491	RAB11A	Ras-related protein Rab-11A	GO:0048227; P:plasma membrane to endosome transport; NAS:UniProtKB
P62491	RAB11A	Ras-related protein Rab-11A	GO:0045773; P:positive regulation of axon extension; IEA:Ensembl
P62491	RAB11A	Ras-related protein Rab-11A	GO:0072659; P:protein localization to plasma membrane; IDA:UniProtKB
P62491	RAB11A	Ras-related protein Rab-11A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P62491	RAB11A	Ras-related protein Rab-11A	GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IEA:Ensembl
P62491	RAB11A	Ras-related protein Rab-11A	GO:0051223; P:regulation of protein transport; IEA:Ensembl
P62491	RAB11A	Ras-related protein Rab-11A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P62491	RAB11A	Ras-related protein Rab-11A	GO:0055085; P:transmembrane transport; TAS:Reactome
P62491	RAB11A	Ras-related protein Rab-11A	GO:0016192; P:vesicle-mediated transport; IDA:UniProtKB
P62491	RAB11A	Ras-related protein Rab-11A	GO:0006833; P:water transport; TAS:Reactome
Q8IXT5	RBM12B	RNA-binding protein 12B	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8IXT5	RBM12B	RNA-binding protein 12B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IXT5	RBM12B	RNA-binding protein 12B	GO:0005515; F:protein binding; IPI:IntAct
Q8NDT2	RBM15B	Putative RNA-binding protein 15B	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8NDT2	RBM15B	Putative RNA-binding protein 15B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8NDT2	RBM15B	Putative RNA-binding protein 15B	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NDT2	RBM15B	Putative RNA-binding protein 15B	GO:0003723; F:RNA binding; NAS:UniProtKB
Q8NDT2	RBM15B	Putative RNA-binding protein 15B	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q8NDT2	RBM15B	Putative RNA-binding protein 15B	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB
Q8NDT2	RBM15B	Putative RNA-binding protein 15B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NDT2	RBM15B	Putative RNA-binding protein 15B	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q8NDT2	RBM15B	Putative RNA-binding protein 15B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NDT2	RBM15B	Putative RNA-binding protein 15B	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q15907	RAB11B	Ras-related protein Rab-11B	GO:0019003; F:GDP binding; IDA:UniProtKB
Q15907	RAB11B	Ras-related protein Rab-11B	GO:0005525; F:GTP binding; IDA:UniProtKB
Q15907	RAB11B	Ras-related protein Rab-11B	GO:0003924; F:GTPase activity; IDA:UniProtKB
Q15907	RAB11B	Ras-related protein Rab-11B	GO:0005515; F:protein binding; IPI:UniProtKB
Q15907	RAB11B	Ras-related protein Rab-11B	GO:0071468; P:cellular response to acidity; IDA:UniProtKB
Q15907	RAB11B	Ras-related protein Rab-11B	GO:0045054; P:constitutive secretory pathway; IMP:UniProtKB
Q15907	RAB11B	Ras-related protein Rab-11B	GO:0006184; P:GTP catabolic process; IDA:GOC
Q15907	RAB11B	Ras-related protein Rab-11B	GO:0035773; P:insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB
Q15907	RAB11B	Ras-related protein Rab-11B	GO:0032402; P:melanosome transport; ISS:UniProtKB
Q15907	RAB11B	Ras-related protein Rab-11B	GO:0001881; P:receptor recycling; ISS:UniProtKB
Q15907	RAB11B	Ras-related protein Rab-11B	GO:0045055; P:regulated secretory pathway; ISS:UniProtKB
Q15907	RAB11B	Ras-related protein Rab-11B	GO:0044070; P:regulation of anion transport; IMP:UniProtKB
Q15907	RAB11B	Ras-related protein Rab-11B	GO:2001135; P:regulation of endocytic recycling; ISS:UniProtKB
Q15907	RAB11B	Ras-related protein Rab-11B	GO:2000008; P:regulation of protein localization to cell surface; IMP:UniProtKB
Q15907	RAB11B	Ras-related protein Rab-11B	GO:1990126; P:retrograde transport, endosome to plasma membrane; IMP:UniProtKB
Q15907	RAB11B	Ras-related protein Rab-11B	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q15907	RAB11B	Ras-related protein Rab-11B	GO:0033572; P:transferrin transport; ISS:UniProtKB
Q9UL26	RAB22A	Ras-related protein Rab-22A	GO:0019003; F:GDP binding; IDA:UniProtKB
Q9UL26	RAB22A	Ras-related protein Rab-22A	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9UL26	RAB22A	Ras-related protein Rab-22A	GO:0003924; F:GTPase activity; TAS:UniProtKB
Q9UL26	RAB22A	Ras-related protein Rab-22A	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UL26	RAB22A	Ras-related protein Rab-22A	GO:0006897; P:endocytosis; IDA:UniProtKB
Q9UL26	RAB22A	Ras-related protein Rab-22A	GO:0007032; P:endosome organization; IEP:UniProtKB
Q9UL26	RAB22A	Ras-related protein Rab-22A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9UL26	RAB22A	Ras-related protein Rab-22A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P51159	RAB27A	Ras-related protein Rab-27A	GO:0019003; F:GDP binding; IDA:UniProtKB
P51159	RAB27A	Ras-related protein Rab-27A	GO:0005525; F:GTP binding; ISS:UniProtKB
P51159	RAB27A	Ras-related protein Rab-27A	GO:0003924; F:GTPase activity; ISS:UniProtKB
P51159	RAB27A	Ras-related protein Rab-27A	GO:0005515; F:protein binding; IPI:UniProtKB
P51159	RAB27A	Ras-related protein Rab-27A	GO:0019882; P:antigen processing and presentation; IMP:UniProt
P51159	RAB27A	Ras-related protein Rab-27A	GO:0007596; P:blood coagulation; IEA:Ensembl
P51159	RAB27A	Ras-related protein Rab-27A	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P51159	RAB27A	Ras-related protein Rab-27A	GO:0043316; P:cytotoxic T cell degranulation; IEA:Ensembl
P51159	RAB27A	Ras-related protein Rab-27A	GO:0006887; P:exocytosis; IDA:UniProtKB
P51159	RAB27A	Ras-related protein Rab-27A	GO:0030318; P:melanocyte differentiation; IEA:Ensembl
P51159	RAB27A	Ras-related protein Rab-27A	GO:0032402; P:melanosome transport; IEA:Ensembl
P51159	RAB27A	Ras-related protein Rab-27A	GO:0071985; P:multivesicular body sorting pathway; IMP:UniProtKB
P51159	RAB27A	Ras-related protein Rab-27A	GO:0043320; P:natural killer cell degranulation; IEA:Ensembl
P51159	RAB27A	Ras-related protein Rab-27A	GO:0045921; P:positive regulation of exocytosis; IMP:UniProtKB
P51159	RAB27A	Ras-related protein Rab-27A	GO:0006605; P:protein targeting; IEA:Ensembl
P51159	RAB27A	Ras-related protein Rab-27A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
O00194	RAB27B	Ras-related protein Rab-27B	GO:0019003; F:GDP binding; IDA:UniProtKB
O00194	RAB27B	Ras-related protein Rab-27B	GO:0005525; F:GTP binding; ISS:UniProtKB
O00194	RAB27B	Ras-related protein Rab-27B	GO:0003924; F:GTPase activity; ISS:UniProtKB
O00194	RAB27B	Ras-related protein Rab-27B	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
O00194	RAB27B	Ras-related protein Rab-27B	GO:0071985; P:multivesicular body sorting pathway; IMP:UniProtKB
O00194	RAB27B	Ras-related protein Rab-27B	GO:0045921; P:positive regulation of exocytosis; IMP:UniProtKB
O00194	RAB27B	Ras-related protein Rab-27B	GO:0015031; P:protein transport; IEA:InterPro
O00194	RAB27B	Ras-related protein Rab-27B	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9H082	RAB33B	Ras-related protein Rab-33B	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9H082	RAB33B	Ras-related protein Rab-33B	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q9H082	RAB33B	Ras-related protein Rab-33B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9H082	RAB33B	Ras-related protein Rab-33B	GO:2000785; P:regulation of autophagic vacuole assembly; ISS:UniProtKB
Q9H082	RAB33B	Ras-related protein Rab-33B	GO:2000156; P:regulation of retrograde vesicle-mediated transport, Golgi to ER; IMP:UniProtKB
Q9H082	RAB33B	Ras-related protein Rab-33B	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q14088	RAB33A	Ras-related protein Rab-33A	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q14088	RAB33A	Ras-related protein Rab-33A	GO:0003924; F:GTPase activity; TAS:ProtInc
Q14088	RAB33A	Ras-related protein Rab-33A	GO:0005515; F:protein binding; IPI:IntAct
Q14088	RAB33A	Ras-related protein Rab-33A	GO:0019882; P:antigen processing and presentation; IMP:UniProt
Q14088	RAB33A	Ras-related protein Rab-33A	GO:0006184; P:GTP catabolic process; TAS:GOC
Q14088	RAB33A	Ras-related protein Rab-33A	GO:0015031; P:protein transport; IEA:InterPro
Q14088	RAB33A	Ras-related protein Rab-33A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q8WXH6	RAB40A	Ras-related protein Rab-40A	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q8WXH6	RAB40A	Ras-related protein Rab-40A	GO:0015031; P:protein transport; IEA:InterPro
Q8WXH6	RAB40A	Ras-related protein Rab-40A	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8WXH6	RAB40A	Ras-related protein Rab-40A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q96S21	RAB40C	Ras-related protein Rab-40C	GO:0019003; F:GDP binding; IEA:Ensembl
Q96S21	RAB40C	Ras-related protein Rab-40C	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q96S21	RAB40C	Ras-related protein Rab-40C	GO:0015031; P:protein transport; IEA:InterPro
Q96S21	RAB40C	Ras-related protein Rab-40C	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q96S21	RAB40C	Ras-related protein Rab-40C	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q12829	RAB40B	Ras-related protein Rab-40B	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q12829	RAB40B	Ras-related protein Rab-40B	GO:0015031; P:protein transport; IEA:InterPro
Q12829	RAB40B	Ras-related protein Rab-40B	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q12829	RAB40B	Ras-related protein Rab-40B	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P0C0E4	RAB40AL	Ras-related protein Rab-40A-like	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P0C0E4	RAB40AL	Ras-related protein Rab-40A-like	GO:0015031; P:protein transport; IEA:InterPro
P0C0E4	RAB40AL	Ras-related protein Rab-40A-like	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
P0C0E4	RAB40AL	Ras-related protein Rab-40A-like	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q15042	RAB3GAP1	Rab3 GTPase-activating protein catalytic subunit	GO:0005097; F:Rab GTPase activator activity; IDA:UniProtKB
Q15042	RAB3GAP1	Rab3 GTPase-activating protein catalytic subunit	GO:0017137; F:Rab GTPase binding; IPI:UniProtKB
Q15042	RAB3GAP1	Rab3 GTPase-activating protein catalytic subunit	GO:0007420; P:brain development; IMP:BHF-UCL
Q15042	RAB3GAP1	Rab3 GTPase-activating protein catalytic subunit	GO:0043010; P:camera-type eye development; IMP:BHF-UCL
Q15042	RAB3GAP1	Rab3 GTPase-activating protein catalytic subunit	GO:0060325; P:face morphogenesis; IMP:BHF-UCL
Q15042	RAB3GAP1	Rab3 GTPase-activating protein catalytic subunit	GO:0021854; P:hypothalamus development; IMP:BHF-UCL
Q15042	RAB3GAP1	Rab3 GTPase-activating protein catalytic subunit	GO:0034389; P:lipid particle organization; IMP:MGI
Q15042	RAB3GAP1	Rab3 GTPase-activating protein catalytic subunit	GO:0032851; P:positive regulation of Rab GTPase activity; IDA:GOC
Q15042	RAB3GAP1	Rab3 GTPase-activating protein catalytic subunit	GO:0043087; P:regulation of GTPase activity; IDA:UniProtKB
Q14964	RAB39A	Ras-related protein Rab-39A	GO:0005525; F:GTP binding; NAS:UniProtKB
Q14964	RAB39A	Ras-related protein Rab-39A	GO:0090383; P:phagosome acidification; IMP:UniProtKB
Q14964	RAB39A	Ras-related protein Rab-39A	GO:0090385; P:phagosome-lysosome fusion; IMP:UniProtKB
Q14964	RAB39A	Ras-related protein Rab-39A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q14964	RAB39A	Ras-related protein Rab-39A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q96DA2	RAB39B	Ras-related protein Rab-39B	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q96DA2	RAB39B	Ras-related protein Rab-39B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96DA2	RAB39B	Ras-related protein Rab-39B	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q96DA2	RAB39B	Ras-related protein Rab-39B	GO:0050808; P:synapse organization; ISS:UniProtKB
Q96DA2	RAB39B	Ras-related protein Rab-39B	GO:0016192; P:vesicle-mediated transport; ISS:UniProtKB
Q8IUD2	ERC1	ELKS/Rab6-interacting/CAST family member 1	GO:0043522; F:leucine zipper domain binding; NAS:UniProtKB
Q8IUD2	ERC1	ELKS/Rab6-interacting/CAST family member 1	GO:0005515; F:protein binding; IPI:IntAct
Q8IUD2	ERC1	ELKS/Rab6-interacting/CAST family member 1	GO:0007252; P:I-kappaB phosphorylation; IDA:UniProtKB
Q8IUD2	ERC1	ELKS/Rab6-interacting/CAST family member 1	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
Q8IUD2	ERC1	ELKS/Rab6-interacting/CAST family member 1	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:UniProtKB
Q8IUD2	ERC1	ELKS/Rab6-interacting/CAST family member 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8IUD2	ERC1	ELKS/Rab6-interacting/CAST family member 1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q8IUD2	ERC1	ELKS/Rab6-interacting/CAST family member 1	GO:0042147; P:retrograde transport, endosome to Golgi; IEA:Ensembl
Q9NYW8	RBAK	RB-associated KRAB zinc finger protein	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9NYW8	RBAK	RB-associated KRAB zinc finger protein	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9NYW8	RBAK	RB-associated KRAB zinc finger protein	GO:0045892; P:negative regulation of transcription, DNA-templated; TAS:UniProtKB
Q9NYW8	RBAK	RB-associated KRAB zinc finger protein	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q9NYW8	RBAK	RB-associated KRAB zinc finger protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q09028	RBBP4	Histone-binding protein RBBP4	GO:0042393; F:histone binding; NAS:BHF-UCL
Q09028	RBBP4	Histone-binding protein RBBP4	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
Q09028	RBBP4	Histone-binding protein RBBP4	GO:0005515; F:protein binding; IPI:UniProtKB
Q09028	RBBP4	Histone-binding protein RBBP4	GO:0006200; P:ATP catabolic process; IDA:GOC
Q09028	RBBP4	Histone-binding protein RBBP4	GO:0043044; P:ATP-dependent chromatin remodeling; IDA:UniProt
Q09028	RBBP4	Histone-binding protein RBBP4	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
Q09028	RBBP4	Histone-binding protein RBBP4	GO:0031497; P:chromatin assembly; IDA:UniProtKB
Q09028	RBBP4	Histone-binding protein RBBP4	GO:0006338; P:chromatin remodeling; IDA:HGNC
Q09028	RBBP4	Histone-binding protein RBBP4	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q09028	RBBP4	Histone-binding protein RBBP4	GO:0006335; P:DNA replication-dependent nucleosome assembly; IDA:UniProt
Q09028	RBBP4	Histone-binding protein RBBP4	GO:0006336; P:DNA replication-independent nucleosome assembly; IDA:UniProt
Q09028	RBBP4	Histone-binding protein RBBP4	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q09028	RBBP4	Histone-binding protein RBBP4	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q09028	RBBP4	Histone-binding protein RBBP4	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q09028	RBBP4	Histone-binding protein RBBP4	GO:0006334; P:nucleosome assembly; TAS:Reactome
Q09028	RBBP4	Histone-binding protein RBBP4	GO:0051726; P:regulation of cell cycle; TAS:Reactome
Q09028	RBBP4	Histone-binding protein RBBP4	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q09028	RBBP4	Histone-binding protein RBBP4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z6E9	RBBP6	E3 ubiquitin-protein ligase RBBP6	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7Z6E9	RBBP6	E3 ubiquitin-protein ligase RBBP6	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z6E9	RBBP6	E3 ubiquitin-protein ligase RBBP6	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q7Z6E9	RBBP6	E3 ubiquitin-protein ligase RBBP6	GO:0008270; F:zinc ion binding; IEA:InterPro
Q7Z6E9	RBBP6	E3 ubiquitin-protein ligase RBBP6	GO:0048568; P:embryonic organ development; IEA:Ensembl
Q7Z6E9	RBBP6	E3 ubiquitin-protein ligase RBBP6	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q7Z6E9	RBBP6	E3 ubiquitin-protein ligase RBBP6	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q7Z6E9	RBBP6	E3 ubiquitin-protein ligase RBBP6	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q7Z6E9	RBBP6	E3 ubiquitin-protein ligase RBBP6	GO:0061053; P:somite development; IEA:Ensembl
Q16576	RBBP7	Histone-binding protein RBBP7	GO:0005515; F:protein binding; IPI:UniProtKB
Q16576	RBBP7	Histone-binding protein RBBP7	GO:0008283; P:cell proliferation; TAS:ProtInc
Q16576	RBBP7	Histone-binding protein RBBP7	GO:0070370; P:cellular heat acclimation; IDA:UniProtKB
Q16576	RBBP7	Histone-binding protein RBBP7	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
Q16576	RBBP7	Histone-binding protein RBBP7	GO:0006325; P:chromatin organization; TAS:Reactome
Q16576	RBBP7	Histone-binding protein RBBP7	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q16576	RBBP7	Histone-binding protein RBBP7	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q16576	RBBP7	Histone-binding protein RBBP7	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q16576	RBBP7	Histone-binding protein RBBP7	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q16576	RBBP7	Histone-binding protein RBBP7	GO:0006334; P:nucleosome assembly; TAS:Reactome
Q16576	RBBP7	Histone-binding protein RBBP7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15291	RBBP5	Retinoblastoma-binding protein 5	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q15291	RBBP5	Retinoblastoma-binding protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q15291	RBBP5	Retinoblastoma-binding protein 5	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q15291	RBBP5	Retinoblastoma-binding protein 5	GO:0006974; P:cellular response to DNA damage stimulus; IDA:MGI
Q15291	RBBP5	Retinoblastoma-binding protein 5	GO:0051568; P:histone H3-K4 methylation; IDA:UniProtKB
Q15291	RBBP5	Retinoblastoma-binding protein 5	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q15291	RBBP5	Retinoblastoma-binding protein 5	GO:0043627; P:response to estrogen; IDA:UniProtKB
Q15291	RBBP5	Retinoblastoma-binding protein 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75884	RBBP9	Putative hydrolase RBBP9	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
O75884	RBBP9	Putative hydrolase RBBP9	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q8TDY2	RB1CC1	RB1-inducible coiled-coil protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TDY2	RB1CC1	RB1-inducible coiled-coil protein 1	GO:0000045; P:autophagic vacuole assembly; IEA:Ensembl
Q8TDY2	RB1CC1	RB1-inducible coiled-coil protein 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8TDY2	RB1CC1	RB1-inducible coiled-coil protein 1	GO:0007507; P:heart development; IEA:Ensembl
Q8TDY2	RB1CC1	RB1-inducible coiled-coil protein 1	GO:0007254; P:JNK cascade; IEA:Ensembl
Q8TDY2	RB1CC1	RB1-inducible coiled-coil protein 1	GO:0001889; P:liver development; IEA:Ensembl
Q8TDY2	RB1CC1	RB1-inducible coiled-coil protein 1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q8TDY2	RB1CC1	RB1-inducible coiled-coil protein 1	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl
Q8TDY2	RB1CC1	RB1-inducible coiled-coil protein 1	GO:0045793; P:positive regulation of cell size; IEA:Ensembl
Q8TDY2	RB1CC1	RB1-inducible coiled-coil protein 1	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
Q8TDY2	RB1CC1	RB1-inducible coiled-coil protein 1	GO:0010506; P:regulation of autophagy; ISS:UniProtKB
Q8TDY2	RB1CC1	RB1-inducible coiled-coil protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8TDY2	RB1CC1	RB1-inducible coiled-coil protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N0V3	RBFA	Putative ribosome-binding factor A, mitochondrial	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q5R372	RABGAP1L	Rab GTPase-activating protein 1-like	GO:0005097; F:Rab GTPase activator activity; IDA:MGI
Q5R372	RABGAP1L	Rab GTPase-activating protein 1-like	GO:0017137; F:Rab GTPase binding; IDA:BHF-UCL
Q5R372	RABGAP1L	Rab GTPase-activating protein 1-like	GO:0032851; P:positive regulation of Rab GTPase activity; IDA:GOC
Q5R372	RABGAP1L	Rab GTPase-activating protein 1-like	GO:0032880; P:regulation of protein localization; IDA:MGI
Q9H2M9	RAB3GAP2	Rab3 GTPase-activating protein non-catalytic subunit	GO:0008047; F:enzyme activator activity; TAS:ProtInc
Q9H2M9	RAB3GAP2	Rab3 GTPase-activating protein non-catalytic subunit	GO:0030234; F:enzyme regulator activity; ISS:UniProtKB
Q9H2M9	RAB3GAP2	Rab3 GTPase-activating protein non-catalytic subunit	GO:0005096; F:GTPase activator activity; TAS:ProtInc
Q9H2M9	RAB3GAP2	Rab3 GTPase-activating protein non-catalytic subunit	GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB
Q9H2M9	RAB3GAP2	Rab3 GTPase-activating protein non-catalytic subunit	GO:0006886; P:intracellular protein transport; TAS:ProtInc
Q9H2M9	RAB3GAP2	Rab3 GTPase-activating protein non-catalytic subunit	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
Q9H2M9	RAB3GAP2	Rab3 GTPase-activating protein non-catalytic subunit	GO:0043547; P:positive regulation of GTPase activity; TAS:GOC
Q9H2M9	RAB3GAP2	Rab3 GTPase-activating protein non-catalytic subunit	GO:0043087; P:regulation of GTPase activity; ISS:UniProtKB
Q9Y3P9	RABGAP1	Rab GTPase-activating protein 1	GO:0003677; F:DNA binding; IEA:InterPro
Q9Y3P9	RABGAP1	Rab GTPase-activating protein 1	GO:0005096; F:GTPase activator activity; TAS:ProtInc
Q9Y3P9	RABGAP1	Rab GTPase-activating protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3P9	RABGAP1	Rab GTPase-activating protein 1	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q9Y3P9	RABGAP1	Rab GTPase-activating protein 1	GO:0015631; F:tubulin binding; TAS:ProtInc
Q9Y3P9	RABGAP1	Rab GTPase-activating protein 1	GO:0007049; P:cell cycle; TAS:ProtInc
Q9Y3P9	RABGAP1	Rab GTPase-activating protein 1	GO:0043547; P:positive regulation of GTPase activity; TAS:GOC
P28749	RBL1	Retinoblastoma-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P28749	RBL1	Retinoblastoma-like protein 1	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P28749	RBL1	Retinoblastoma-like protein 1	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
P28749	RBL1	Retinoblastoma-like protein 1	GO:0010467; P:gene expression; TAS:Reactome
P28749	RBL1	Retinoblastoma-like protein 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P28749	RBL1	Retinoblastoma-like protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P28749	RBL1	Retinoblastoma-like protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
P28749	RBL1	Retinoblastoma-like protein 1	GO:0051726; P:regulation of cell cycle; IEA:InterPro
P28749	RBL1	Retinoblastoma-like protein 1	GO:0043550; P:regulation of lipid kinase activity; IDA:UniProtKB
P28749	RBL1	Retinoblastoma-like protein 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P28749	RBL1	Retinoblastoma-like protein 1	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
P28749	RBL1	Retinoblastoma-like protein 1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P28749	RBL1	Retinoblastoma-like protein 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9UBK7	RABL2A	Rab-like protein 2A	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9UBK7	RABL2A	Rab-like protein 2A	GO:0003924; F:GTPase activity; TAS:ProtInc
Q9UBK7	RABL2A	Rab-like protein 2A	GO:0006184; P:GTP catabolic process; TAS:GOC
Q9UBK7	RABL2A	Rab-like protein 2A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9UNT1	RABL2B	Rab-like protein 2B	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9UNT1	RABL2B	Rab-like protein 2B	GO:0003924; F:GTPase activity; TAS:ProtInc
Q9UNT1	RABL2B	Rab-like protein 2B	GO:0006184; P:GTP catabolic process; TAS:GOC
Q9UNT1	RABL2B	Rab-like protein 2B	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q08999	RBL2	Retinoblastoma-like protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q08999	RBL2	Retinoblastoma-like protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q08999	RBL2	Retinoblastoma-like protein 2	GO:0007049; P:cell cycle; IEA:InterPro
Q08999	RBL2	Retinoblastoma-like protein 2	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q08999	RBL2	Retinoblastoma-like protein 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q08999	RBL2	Retinoblastoma-like protein 2	GO:0051726; P:regulation of cell cycle; IEA:InterPro
Q08999	RBL2	Retinoblastoma-like protein 2	GO:0043550; P:regulation of lipid kinase activity; IDA:UniProtKB
Q08999	RBL2	Retinoblastoma-like protein 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:InterPro
Q08999	RBL2	Retinoblastoma-like protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P98175	RBM10	RNA-binding protein 10	GO:0042802; F:identical protein binding; IPI:IntAct
P98175	RBM10	RNA-binding protein 10	GO:0000166; F:nucleotide binding; IEA:InterPro
P98175	RBM10	RNA-binding protein 10	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P98175	RBM10	RNA-binding protein 10	GO:0005515; F:protein binding; IPI:IntAct
P98175	RBM10	RNA-binding protein 10	GO:0032403; F:protein complex binding; IDA:UniProtKB
P98175	RBM10	RNA-binding protein 10	GO:0008270; F:zinc ion binding; IEA:InterPro
P98175	RBM10	RNA-binding protein 10	GO:0070935; P:3'-UTR-mediated mRNA stabilization; IEA:Ensembl
P98175	RBM10	RNA-binding protein 10	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
P98175	RBM10	RNA-binding protein 10	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P98175	RBM10	RNA-binding protein 10	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P98175	RBM10	RNA-binding protein 10	GO:0034393; P:positive regulation of smooth muscle cell apoptotic process; IEA:Ensembl
P98175	RBM10	RNA-binding protein 10	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
P57052	RBM11	Splicing regulator RBM11	GO:0000166; F:nucleotide binding; IEA:InterPro
P57052	RBM11	Splicing regulator RBM11	GO:0008266; F:poly(U) RNA binding; IDA:MGI
P57052	RBM11	Splicing regulator RBM11	GO:0042803; F:protein homodimerization activity; IDA:MGI
P57052	RBM11	Splicing regulator RBM11	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P57052	RBM11	Splicing regulator RBM11	GO:0034599; P:cellular response to oxidative stress; IDA:MGI
P57052	RBM11	Splicing regulator RBM11	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
P57052	RBM11	Splicing regulator RBM11	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P57052	RBM11	Splicing regulator RBM11	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:MGI
P57052	RBM11	Splicing regulator RBM11	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q9NTZ6	RBM12	RNA-binding protein 12	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9NTZ6	RBM12	RNA-binding protein 12	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96PK6	RBM14	RNA-binding protein 14	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IPI:UniProtKB
Q96PK6	RBM14	RNA-binding protein 14	GO:0000166; F:nucleotide binding; IEA:InterPro
Q96PK6	RBM14	RNA-binding protein 14	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96PK6	RBM14	RNA-binding protein 14	GO:0005515; F:protein binding; IPI:UniProtKB
Q96PK6	RBM14	RNA-binding protein 14	GO:0030674; F:protein binding, bridging; NAS:UniProtKB
Q96PK6	RBM14	RNA-binding protein 14	GO:0003723; F:RNA binding; NAS:UniProtKB
Q96PK6	RBM14	RNA-binding protein 14	GO:0001104; F:RNA polymerase II transcription cofactor activity; NAS:UniProtKB
Q96PK6	RBM14	RNA-binding protein 14	GO:0006310; P:DNA recombination; NAS:UniProtKB
Q96PK6	RBM14	RNA-binding protein 14	GO:0006281; P:DNA repair; NAS:UniProtKB
Q96PK6	RBM14	RNA-binding protein 14	GO:0006260; P:DNA replication; NAS:UniProtKB
Q96PK6	RBM14	RNA-binding protein 14	GO:0042921; P:glucocorticoid receptor signaling pathway; NAS:UniProtKB
Q96PK6	RBM14	RNA-binding protein 14	GO:0016575; P:histone deacetylation; IPI:UniProtKB
Q96PK6	RBM14	RNA-binding protein 14	GO:0030520; P:intracellular estrogen receptor signaling pathway; NAS:UniProtKB
Q96PK6	RBM14	RNA-binding protein 14	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q96PK6	RBM14	RNA-binding protein 14	GO:0009725; P:response to hormone; TAS:UniProtKB
Q96PK6	RBM14	RNA-binding protein 14	GO:0006366; P:transcription from RNA polymerase II promoter; NAS:GOC
Q96T37	RBM15	Putative RNA-binding protein 15	GO:0000166; F:nucleotide binding; IEA:InterPro
Q96T37	RBM15	Putative RNA-binding protein 15	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96T37	RBM15	Putative RNA-binding protein 15	GO:0005515; F:protein binding; IPI:UniProtKB
Q96T37	RBM15	Putative RNA-binding protein 15	GO:0045638; P:negative regulation of myeloid cell differentiation; IEA:Ensembl
Q96T37	RBM15	Putative RNA-binding protein 15	GO:0001569; P:patterning of blood vessels; IEA:Ensembl
Q96T37	RBM15	Putative RNA-binding protein 15	GO:0060674; P:placenta blood vessel development; IEA:Ensembl
Q96T37	RBM15	Putative RNA-binding protein 15	GO:0007221; P:positive regulation of transcription of Notch receptor target; IEA:Ensembl
Q96T37	RBM15	Putative RNA-binding protein 15	GO:0048536; P:spleen development; IEA:Ensembl
Q96T37	RBM15	Putative RNA-binding protein 15	GO:0060412; P:ventricular septum morphogenesis; IEA:Ensembl
Q96T37	RBM15	Putative RNA-binding protein 15	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q5T481	RBM20	RNA-binding protein 20	GO:0000166; F:nucleotide binding; IEA:InterPro
Q5T481	RBM20	RNA-binding protein 20	GO:0003723; F:RNA binding; ISS:UniProtKB
Q5T481	RBM20	RNA-binding protein 20	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5T481	RBM20	RNA-binding protein 20	GO:0007507; P:heart development; IMP:UniProtKB
Q5T481	RBM20	RNA-binding protein 20	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q5T481	RBM20	RNA-binding protein 20	GO:0033120; P:positive regulation of RNA splicing; IMP:UniProtKB
Q5T481	RBM20	RNA-binding protein 20	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q9NW64	RBM22	Pre-mRNA-splicing factor RBM22	GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB
Q9NW64	RBM22	Pre-mRNA-splicing factor RBM22	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NW64	RBM22	Pre-mRNA-splicing factor RBM22	GO:0005487; F:nucleocytoplasmic transporter activity; IDA:UniProtKB
Q9NW64	RBM22	Pre-mRNA-splicing factor RBM22	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9NW64	RBM22	Pre-mRNA-splicing factor RBM22	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NW64	RBM22	Pre-mRNA-splicing factor RBM22	GO:0036002; F:pre-mRNA binding; IDA:UniProtKB
Q9NW64	RBM22	Pre-mRNA-splicing factor RBM22	GO:0017069; F:snRNA binding; IDA:UniProtKB
Q9NW64	RBM22	Pre-mRNA-splicing factor RBM22	GO:0035690; P:cellular response to drug; IDA:UniProtKB
Q9NW64	RBM22	Pre-mRNA-splicing factor RBM22	GO:0045292; P:mRNA cis splicing, via spliceosome; IDA:UniProtKB
Q9NW64	RBM22	Pre-mRNA-splicing factor RBM22	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q9NW64	RBM22	Pre-mRNA-splicing factor RBM22	GO:0090316; P:positive regulation of intracellular protein transport; IDA:UniProtKB
Q9NW64	RBM22	Pre-mRNA-splicing factor RBM22	GO:0033120; P:positive regulation of RNA splicing; IDA:UniProtKB
Q9NW64	RBM22	Pre-mRNA-splicing factor RBM22	GO:0000060; P:protein import into nucleus, translocation; IDA:UniProtKB
Q96H35	RBM18	Probable RNA-binding protein 18	GO:0000166; F:nucleotide binding; IEA:InterPro
Q96H35	RBM18	Probable RNA-binding protein 18	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9Y4C8	RBM19	Probable RNA-binding protein 19	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9Y4C8	RBM19	Probable RNA-binding protein 19	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9Y4C8	RBM19	Probable RNA-binding protein 19	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y4C8	RBM19	Probable RNA-binding protein 19	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9Y4C8	RBM19	Probable RNA-binding protein 19	GO:0040019; P:positive regulation of embryonic development; ISS:UniProtKB
Q86U06	RBM23	Probable RNA-binding protein 23	GO:0000166; F:nucleotide binding; IEA:InterPro
Q86U06	RBM23	Probable RNA-binding protein 23	GO:0005515; F:protein binding; IPI:IntAct
Q86U06	RBM23	Probable RNA-binding protein 23	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q86U06	RBM23	Probable RNA-binding protein 23	GO:0006397; P:mRNA processing; IEA:InterPro
Q9BX46	RBM24	RNA-binding protein 24	GO:0003730; F:mRNA 3'-UTR binding; ISS:UniProtKB
Q9BX46	RBM24	RNA-binding protein 24	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9BX46	RBM24	RNA-binding protein 24	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9BX46	RBM24	RNA-binding protein 24	GO:0043488; P:regulation of mRNA stability; ISS:UniProtKB
Q9BX46	RBM24	RNA-binding protein 24	GO:0010830; P:regulation of myotube differentiation; ISS:UniProtKB
P49756	RBM25	RNA-binding protein 25	GO:0003729; F:mRNA binding; IDA:UniProtKB
P49756	RBM25	RNA-binding protein 25	GO:0000166; F:nucleotide binding; IEA:InterPro
P49756	RBM25	RNA-binding protein 25	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P49756	RBM25	RNA-binding protein 25	GO:0005515; F:protein binding; IPI:UniProtKB
P49756	RBM25	RNA-binding protein 25	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
P49756	RBM25	RNA-binding protein 25	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB
P49756	RBM25	RNA-binding protein 25	GO:0042981; P:regulation of apoptotic process; IDA:UniProtKB
P49756	RBM25	RNA-binding protein 25	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q5T8P6	RBM26	RNA-binding protein 26	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5T8P6	RBM26	RNA-binding protein 26	GO:0000166; F:nucleotide binding; IEA:InterPro
Q5T8P6	RBM26	RNA-binding protein 26	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q5T8P6	RBM26	RNA-binding protein 26	GO:0005515; F:protein binding; IPI:UniProtKB
Q5T8P6	RBM26	RNA-binding protein 26	GO:0006397; P:mRNA processing; IEA:InterPro
Q5T8P6	RBM26	RNA-binding protein 26	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q9NW13	RBM28	RNA-binding protein 28	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9NW13	RBM28	RNA-binding protein 28	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NW13	RBM28	RNA-binding protein 28	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9NW13	RBM28	RNA-binding protein 28	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q96EV2	RBM33	RNA-binding protein 33	GO:0000166; F:nucleotide binding; IEA:InterPro
Q96EV2	RBM33	RNA-binding protein 33	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P42696	RBM34	RNA-binding protein 34	GO:0000166; F:nucleotide binding; IEA:InterPro
P42696	RBM34	RNA-binding protein 34	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H0Z9	RBM38	RNA-binding protein 38	GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB
Q9H0Z9	RBM38	RNA-binding protein 38	GO:0003729; F:mRNA binding; IDA:UniProtKB
Q9H0Z9	RBM38	RNA-binding protein 38	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9H0Z9	RBM38	RNA-binding protein 38	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H0Z9	RBM38	RNA-binding protein 38	GO:0070935; P:3'-UTR-mediated mRNA stabilization; IDA:UniProtKB
Q9H0Z9	RBM38	RNA-binding protein 38	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9H0Z9	RBM38	RNA-binding protein 38	GO:0007050; P:cell cycle arrest; IDA:UniProtKB
Q9H0Z9	RBM38	RNA-binding protein 38	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9H0Z9	RBM38	RNA-binding protein 38	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; IDA:UniProtKB
Q9H0Z9	RBM38	RNA-binding protein 38	GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IDA:UniProtKB
Q9H0Z9	RBM38	RNA-binding protein 38	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9H0Z9	RBM38	RNA-binding protein 38	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q9H0Z9	RBM38	RNA-binding protein 38	GO:0010830; P:regulation of myotube differentiation; IEA:Ensembl
Q9H0Z9	RBM38	RNA-binding protein 38	GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB
Q9H0Z9	RBM38	RNA-binding protein 38	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q14498	RBM39	RNA-binding protein 39	GO:0000166; F:nucleotide binding; IEA:InterPro
Q14498	RBM39	RNA-binding protein 39	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14498	RBM39	RNA-binding protein 39	GO:0005515; F:protein binding; IPI:UniProtKB
Q14498	RBM39	RNA-binding protein 39	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q14498	RBM39	RNA-binding protein 39	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q14498	RBM39	RNA-binding protein 39	GO:0006396; P:RNA processing; TAS:ProtInc
Q14498	RBM39	RNA-binding protein 39	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q14498	RBM39	RNA-binding protein 39	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P98179	RBM3	Putative RNA-binding protein 3	GO:0000166; F:nucleotide binding; IEA:InterPro
P98179	RBM3	Putative RNA-binding protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P98179	RBM3	Putative RNA-binding protein 3	GO:0005515; F:protein binding; IPI:IntAct
P98179	RBM3	Putative RNA-binding protein 3	GO:0043023; F:ribosomal large subunit binding; IEA:Ensembl
P98179	RBM3	Putative RNA-binding protein 3	GO:0003723; F:RNA binding; TAS:ProtInc
P98179	RBM3	Putative RNA-binding protein 3	GO:0045727; P:positive regulation of translation; ISS:UniProtKB
P98179	RBM3	Putative RNA-binding protein 3	GO:0035196; P:production of miRNAs involved in gene silencing by miRNA; IEA:Ensembl
P98179	RBM3	Putative RNA-binding protein 3	GO:0006417; P:regulation of translation; ISS:UniProtKB
P98179	RBM3	Putative RNA-binding protein 3	GO:0009409; P:response to cold; IEA:Ensembl
P98179	RBM3	Putative RNA-binding protein 3	GO:0006396; P:RNA processing; TAS:ProtInc
P98179	RBM3	Putative RNA-binding protein 3	GO:0006412; P:translation; IEA:Ensembl
Q9P2N5	RBM27	RNA-binding protein 27	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9P2N5	RBM27	RNA-binding protein 27	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9P2N5	RBM27	RNA-binding protein 27	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9P2N5	RBM27	RNA-binding protein 27	GO:0006397; P:mRNA processing; IEA:InterPro
Q96LT9	RNPC3	RNA-binding protein 40	GO:0000166; F:nucleotide binding; IEA:InterPro
Q96LT9	RNPC3	RNA-binding protein 40	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q96LT9	RNPC3	RNA-binding protein 40	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q96LT9	RNPC3	RNA-binding protein 40	GO:0008380; P:RNA splicing; IC:UniProtKB
Q96IZ5	RBM41	RNA-binding protein 41	GO:0000166; F:nucleotide binding; IEA:InterPro
Q96IZ5	RBM41	RNA-binding protein 41	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9BTD8	RBM42	RNA-binding protein 42	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9BTD8	RBM42	RNA-binding protein 42	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6ZSC3	RBM43	RNA-binding protein 43	GO:0000166; F:nucleotide binding; IEA:InterPro
Q6ZSC3	RBM43	RNA-binding protein 43	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q6ZP01	RBM44	RNA-binding protein 44	GO:0000166; F:nucleotide binding; IEA:InterPro
Q6ZP01	RBM44	RNA-binding protein 44	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q6ZP01	RBM44	RNA-binding protein 44	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q8TBY0	RBM46	Probable RNA-binding protein 46	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8TBY0	RBM46	Probable RNA-binding protein 46	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
A0AV96	RBM47	RNA-binding protein 47	GO:0000166; F:nucleotide binding; IEA:InterPro
A0AV96	RBM47	RNA-binding protein 47	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q5RL73	RBM48	RNA-binding protein 48	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9BQ04	RBM4B	RNA-binding protein 4B	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9BQ04	RBM4B	RNA-binding protein 4B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BQ04	RBM4B	RNA-binding protein 4B	GO:0005515; F:protein binding; IPI:IntAct
Q9BQ04	RBM4B	RNA-binding protein 4B	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BQ04	RBM4B	RNA-binding protein 4B	GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB
Q9BQ04	RBM4B	RNA-binding protein 4B	GO:0007623; P:circadian rhythm; ISS:UniProtKB
Q9BQ04	RBM4B	RNA-binding protein 4B	GO:0043153; P:entrainment of circadian clock by photoperiod; ISS:UniProtKB
Q9BQ04	RBM4B	RNA-binding protein 4B	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9BQ04	RBM4B	RNA-binding protein 4B	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
Q9BQ04	RBM4B	RNA-binding protein 4B	GO:0006417; P:regulation of translation; ISS:UniProtKB
Q9BQ04	RBM4B	RNA-binding protein 4B	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q8IUH3	RBM45	RNA-binding protein 45	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8IUH3	RBM45	RNA-binding protein 45	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IUH3	RBM45	RNA-binding protein 45	GO:0003723; F:RNA binding; IDA:UniProtKB
Q8IUH3	RBM45	RNA-binding protein 45	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8IUH3	RBM45	RNA-binding protein 45	GO:0007399; P:nervous system development; ISS:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0035198; F:miRNA binding; IDA:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0003730; F:mRNA 3'-UTR binding; ISS:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0003729; F:mRNA binding; IDA:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9BWF3	RBM4	RNA-binding protein 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0097157; F:pre-mRNA intronic binding; IDA:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0097158; F:pre-mRNA intronic pyrimidine-rich binding; IDA:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0003723; F:RNA binding; IDA:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BWF3	RBM4	RNA-binding protein 4	GO:0002190; P:cap-independent translational initiation; IDA:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9BWF3	RBM4	RNA-binding protein 4	GO:0097167; P:circadian regulation of translation; ISS:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0043153; P:entrainment of circadian clock by photoperiod; ISS:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0002192; P:IRES-dependent translational initiation; IDA:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9BWF3	RBM4	RNA-binding protein 4	GO:0017148; P:negative regulation of translation; IDA:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0032055; P:negative regulation of translation in response to stress; IDA:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0035278; P:negative regulation of translation involved in gene silencing by miRNA; IDA:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0045947; P:negative regulation of translational initiation; IDA:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0051149; P:positive regulation of muscle cell differentiation; IDA:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0046822; P:regulation of nucleocytoplasmic transport; IDA:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0046685; P:response to arsenic-containing substance; IDA:UniProtKB
Q9BWF3	RBM4	RNA-binding protein 4	GO:0006396; P:RNA processing; TAS:ProtInc
Q9BWF3	RBM4	RNA-binding protein 4	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q9BWF3	RBM4	RNA-binding protein 4	GO:0051403; P:stress-activated MAPK cascade; IDA:UniProtKB
P52756	RBM5	RNA-binding protein 5	GO:0003677; F:DNA binding; TAS:ProtInc
P52756	RBM5	RNA-binding protein 5	GO:0003729; F:mRNA binding; IDA:UniProtKB
P52756	RBM5	RNA-binding protein 5	GO:0000166; F:nucleotide binding; IEA:InterPro
P52756	RBM5	RNA-binding protein 5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P52756	RBM5	RNA-binding protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
P52756	RBM5	RNA-binding protein 5	GO:0003723; F:RNA binding; TAS:ProtInc
P52756	RBM5	RNA-binding protein 5	GO:0008270; F:zinc ion binding; IEA:InterPro
P52756	RBM5	RNA-binding protein 5	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P52756	RBM5	RNA-binding protein 5	GO:0010467; P:gene expression; TAS:Reactome
P52756	RBM5	RNA-binding protein 5	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P52756	RBM5	RNA-binding protein 5	GO:0008285; P:negative regulation of cell proliferation; TAS:UniProtKB
P52756	RBM5	RNA-binding protein 5	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P52756	RBM5	RNA-binding protein 5	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB
P52756	RBM5	RNA-binding protein 5	GO:0006396; P:RNA processing; TAS:ProtInc
P52756	RBM5	RNA-binding protein 5	GO:0008380; P:RNA splicing; TAS:Reactome
P52756	RBM5	RNA-binding protein 5	GO:0000245; P:spliceosomal complex assembly; IDA:UniProtKB
P78332	RBM6	RNA-binding protein 6	GO:0003677; F:DNA binding; TAS:ProtInc
P78332	RBM6	RNA-binding protein 6	GO:0000166; F:nucleotide binding; IEA:InterPro
P78332	RBM6	RNA-binding protein 6	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P78332	RBM6	RNA-binding protein 6	GO:0003723; F:RNA binding; TAS:ProtInc
P78332	RBM6	RNA-binding protein 6	GO:0006396; P:RNA processing; TAS:ProtInc
Q9Y580	RBM7	RNA-binding protein 7	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9Y580	RBM7	RNA-binding protein 7	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y580	RBM7	RNA-binding protein 7	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q9Y5S9	RBM8A	RNA-binding protein 8A	GO:0003729; F:mRNA binding; NAS:UniProtKB
Q9Y5S9	RBM8A	RNA-binding protein 8A	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9Y5S9	RBM8A	RNA-binding protein 8A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y5S9	RBM8A	RNA-binding protein 8A	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y5S9	RBM8A	RNA-binding protein 8A	GO:0003723; F:RNA binding; NAS:UniProtKB
Q9Y5S9	RBM8A	RNA-binding protein 8A	GO:0010467; P:gene expression; TAS:Reactome
Q9Y5S9	RBM8A	RNA-binding protein 8A	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q9Y5S9	RBM8A	RNA-binding protein 8A	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
Q9Y5S9	RBM8A	RNA-binding protein 8A	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9Y5S9	RBM8A	RNA-binding protein 8A	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q9Y5S9	RBM8A	RNA-binding protein 8A	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IMP:UniProtKB
Q9Y5S9	RBM8A	RNA-binding protein 8A	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IMP:UniProtKB
Q9Y5S9	RBM8A	RNA-binding protein 8A	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q9Y5S9	RBM8A	RNA-binding protein 8A	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9Y5S9	RBM8A	RNA-binding protein 8A	GO:0008380; P:RNA splicing; TAS:Reactome
Q9Y5S9	RBM8A	RNA-binding protein 8A	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q9Y5S9	RBM8A	RNA-binding protein 8A	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
P29558	RBMS1	RNA-binding motif, single-stranded-interacting protein 1	GO:0003690; F:double-stranded DNA binding; NAS:UniProtKB
P29558	RBMS1	RNA-binding motif, single-stranded-interacting protein 1	GO:0000166; F:nucleotide binding; IEA:InterPro
P29558	RBMS1	RNA-binding motif, single-stranded-interacting protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P29558	RBMS1	RNA-binding motif, single-stranded-interacting protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P29558	RBMS1	RNA-binding motif, single-stranded-interacting protein 1	GO:0003723; F:RNA binding; NAS:UniProtKB
P29558	RBMS1	RNA-binding motif, single-stranded-interacting protein 1	GO:0003697; F:single-stranded DNA binding; NAS:UniProtKB
P29558	RBMS1	RNA-binding motif, single-stranded-interacting protein 1	GO:0006260; P:DNA replication; NAS:UniProtKB
P29558	RBMS1	RNA-binding motif, single-stranded-interacting protein 1	GO:0006396; P:RNA processing; TAS:ProtInc
Q15434	RBMS2	RNA-binding motif, single-stranded-interacting protein 2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q15434	RBMS2	RNA-binding motif, single-stranded-interacting protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15434	RBMS2	RNA-binding motif, single-stranded-interacting protein 2	GO:0003723; F:RNA binding; TAS:ProtInc
Q15434	RBMS2	RNA-binding motif, single-stranded-interacting protein 2	GO:0006396; P:RNA processing; TAS:ProtInc
Q6XE24	RBMS3	RNA-binding motif, single-stranded-interacting protein 3	GO:0000166; F:nucleotide binding; IEA:InterPro
Q6XE24	RBMS3	RNA-binding motif, single-stranded-interacting protein 3	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9Y388	RBMX2	RNA-binding motif protein, X-linked 2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9Y388	RBMX2	RNA-binding motif protein, X-linked 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y388	RBMX2	RNA-binding motif protein, X-linked 2	GO:0005515; F:protein binding; IPI:IntAct
P38159	RBMX	RNA-binding motif protein, X chromosome	GO:0003682; F:chromatin binding; IDA:UniProtKB
P38159	RBMX	RNA-binding motif protein, X chromosome	GO:0001047; F:core promoter binding; IDA:UniProtKB
P38159	RBMX	RNA-binding motif protein, X chromosome	GO:0003729; F:mRNA binding; IDA:UniProtKB
P38159	RBMX	RNA-binding motif protein, X chromosome	GO:0000166; F:nucleotide binding; IEA:InterPro
P38159	RBMX	RNA-binding motif protein, X chromosome	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P38159	RBMX	RNA-binding motif protein, X chromosome	GO:0005515; F:protein binding; IPI:UniProtKB
P38159	RBMX	RNA-binding motif protein, X chromosome	GO:0003723; F:RNA binding; IDA:UniProtKB
P38159	RBMX	RNA-binding motif protein, X chromosome	GO:0003727; F:single-stranded RNA binding; IEA:Ensembl
P38159	RBMX	RNA-binding motif protein, X chromosome	GO:0071347; P:cellular response to interleukin-1; IDA:UniProtKB
P38159	RBMX	RNA-binding motif protein, X chromosome	GO:0010467; P:gene expression; TAS:Reactome
P38159	RBMX	RNA-binding motif protein, X chromosome	GO:0006509; P:membrane protein ectodomain proteolysis; IDA:UniProtKB
P38159	RBMX	RNA-binding motif protein, X chromosome	GO:0006376; P:mRNA splice site selection; IEA:Ensembl
P38159	RBMX	RNA-binding motif protein, X chromosome	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P38159	RBMX	RNA-binding motif protein, X chromosome	GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; ISS:UniProtKB
P38159	RBMX	RNA-binding motif protein, X chromosome	GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; ISS:UniProtKB
P38159	RBMX	RNA-binding motif protein, X chromosome	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P38159	RBMX	RNA-binding motif protein, X chromosome	GO:0051260; P:protein homooligomerization; ISS:UniProtKB
P38159	RBMX	RNA-binding motif protein, X chromosome	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB
P38159	RBMX	RNA-binding motif protein, X chromosome	GO:0008380; P:RNA splicing; TAS:Reactome
P38159	RBMX	RNA-binding motif protein, X chromosome	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9H1K0	ZFYVE20	Rabenosyn-5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H1K0	ZFYVE20	Rabenosyn-5	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9H1K0	ZFYVE20	Rabenosyn-5	GO:0007596; P:blood coagulation; TAS:Reactome
Q9H1K0	ZFYVE20	Rabenosyn-5	GO:0016197; P:endosomal transport; NAS:UniProtKB
Q9H1K0	ZFYVE20	Rabenosyn-5	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9H2T7	RANBP17	Ran-binding protein 17	GO:0005525; F:GTP binding; NAS:UniProtKB
Q9H2T7	RANBP17	Ran-binding protein 17	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q9H2T7	RANBP17	Ran-binding protein 17	GO:0006606; P:protein import into nucleus; NAS:UniProtKB
Q6VN20	RANBP10	Ran-binding protein 10	GO:0005087; F:Ran guanyl-nucleotide exchange factor activity; IEA:Ensembl
Q6VN20	RANBP10	Ran-binding protein 10	GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl
Q15311	RALBP1	RalA-binding protein 1	GO:0016887; F:ATPase activity; IDA:UniProtKB
Q15311	RALBP1	RalA-binding protein 1	GO:0043492; F:ATPase activity, coupled to movement of substances; IDA:UniProtKB
Q15311	RALBP1	RalA-binding protein 1	GO:0005096; F:GTPase activator activity; IDA:UniProtKB
Q15311	RALBP1	RalA-binding protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15311	RALBP1	RalA-binding protein 1	GO:0030675; F:Rac GTPase activator activity; IDA:UniProtKB
Q15311	RALBP1	RalA-binding protein 1	GO:0048365; F:Rac GTPase binding; IPI:UniProtKB
Q15311	RALBP1	RalA-binding protein 1	GO:0017160; F:Ral GTPase binding; IPI:UniProtKB
Q15311	RALBP1	RalA-binding protein 1	GO:0006200; P:ATP catabolic process; IDA:GOC
Q15311	RALBP1	RalA-binding protein 1	GO:0006935; P:chemotaxis; TAS:ProtInc
Q15311	RALBP1	RalA-binding protein 1	GO:0043089; P:positive regulation of Cdc42 GTPase activity; IDA:UniProtKB
Q15311	RALBP1	RalA-binding protein 1	GO:0032855; P:positive regulation of Rac GTPase activity; IDA:GOC
Q15311	RALBP1	RalA-binding protein 1	GO:0043087; P:regulation of GTPase activity; IDA:UniProtKB
Q15311	RALBP1	RalA-binding protein 1	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q15311	RALBP1	RalA-binding protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q15311	RALBP1	RalA-binding protein 1	GO:0007264; P:small GTPase mediated signal transduction; IPI:UniProtKB
Q15311	RALBP1	RalA-binding protein 1	GO:0006810; P:transport; IDA:UniProtKB
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:InterPro
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0005515; F:protein binding; IPI:UniProtKB
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0008536; F:Ran GTPase binding; TAS:ProtInc
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0008270; F:zinc ion binding; IEA:InterPro
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0015758; P:glucose transport; TAS:Reactome
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0008645; P:hexose transport; TAS:Reactome
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0033132; P:negative regulation of glucokinase activity; IEA:Ensembl
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0006457; P:protein folding; IEA:InterPro
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0006606; P:protein import into nucleus; TAS:ProtInc
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0016925; P:protein sumoylation; IDA:UniProtKB
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0090526; P:regulation of gluconeogenesis involved in cellular glucose homeostasis; IEA:Ensembl
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0010827; P:regulation of glucose transport; TAS:Reactome
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0055085; P:transmembrane transport; TAS:Reactome
P49792	RANBP2	E3 SUMO-protein ligase RanBP2	GO:0016032; P:viral process; TAS:Reactome
Q92804	TAF15	TATA-binding protein-associated factor 2N	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q92804	TAF15	TATA-binding protein-associated factor 2N	GO:0000166; F:nucleotide binding; IEA:InterPro
Q92804	TAF15	TATA-binding protein-associated factor 2N	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q92804	TAF15	TATA-binding protein-associated factor 2N	GO:0005515; F:protein binding; IPI:UniProtKB
Q92804	TAF15	TATA-binding protein-associated factor 2N	GO:0008270; F:zinc ion binding; IEA:InterPro
Q92804	TAF15	TATA-binding protein-associated factor 2N	GO:0045893; P:positive regulation of transcription, DNA-templated; TAS:UniProtKB
Q9UBG7	RBPJL	Recombining binding protein suppressor of hairless-like protein	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:InterPro
Q9UBG7	RBPJL	Recombining binding protein suppressor of hairless-like protein	GO:0000982; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9UBG7	RBPJL	Recombining binding protein suppressor of hairless-like protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9UBG7	RBPJL	Recombining binding protein suppressor of hairless-like protein	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q9UBG7	RBPJL	Recombining binding protein suppressor of hairless-like protein	GO:0007165; P:signal transduction; TAS:ProtInc
Q93062	RBPMS	RNA-binding protein with multiple splicing	GO:0000166; F:nucleotide binding; IEA:InterPro
Q93062	RBPMS	RNA-binding protein with multiple splicing	GO:0008143; F:poly(A) binding; IDA:UniProtKB
Q93062	RBPMS	RNA-binding protein with multiple splicing	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q93062	RBPMS	RNA-binding protein with multiple splicing	GO:0005515; F:protein binding; IPI:UniProtKB
Q93062	RBPMS	RNA-binding protein with multiple splicing	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q93062	RBPMS	RNA-binding protein with multiple splicing	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:UniProtKB
Q93062	RBPMS	RNA-binding protein with multiple splicing	GO:0060391; P:positive regulation of SMAD protein import into nucleus; IDA:UniProtKB
Q93062	RBPMS	RNA-binding protein with multiple splicing	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q93062	RBPMS	RNA-binding protein with multiple splicing	GO:0006396; P:RNA processing; TAS:ProtInc
Q93062	RBPMS	RNA-binding protein with multiple splicing	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZRY4	RBPMS2	RNA-binding protein with multiple splicing 2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q6ZRY4	RBPMS2	RNA-binding protein with multiple splicing 2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9H477	RBKS	Ribokinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H477	RBKS	Ribokinase	GO:0004747; F:ribokinase activity; IEA:InterPro
Q9H477	RBKS	Ribokinase	GO:0019303; P:D-ribose catabolic process; IEA:UniProtKB-UniPathway
Q9H477	RBKS	Ribokinase	GO:0006014; P:D-ribose metabolic process; IEA:InterPro
P25800	LMO1	Rhombotin-1	GO:0008270; F:zinc ion binding; IEA:InterPro
P25800	LMO1	Rhombotin-1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P25800	LMO1	Rhombotin-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P25791	LMO2	Rhombotin-2	GO:0043425; F:bHLH transcription factor binding; IPI:BHF-UCL
P25791	LMO2	Rhombotin-2	GO:0003682; F:chromatin binding; IEA:Ensembl
P25791	LMO2	Rhombotin-2	GO:0048037; F:cofactor binding; IPI:BHF-UCL
P25791	LMO2	Rhombotin-2	GO:0070888; F:E-box binding; IDA:BHF-UCL
P25791	LMO2	Rhombotin-2	GO:0005515; F:protein binding; IPI:IntAct
P25791	LMO2	Rhombotin-2	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
P25791	LMO2	Rhombotin-2	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:BHF-UCL
P25791	LMO2	Rhombotin-2	GO:0001190; F:RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription; IDA:BHF-UCL
P25791	LMO2	Rhombotin-2	GO:0001228; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:BHF-UCL
P25791	LMO2	Rhombotin-2	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:BHF-UCL
P25791	LMO2	Rhombotin-2	GO:0008270; F:zinc ion binding; IEA:InterPro
P25791	LMO2	Rhombotin-2	GO:0097067; P:cellular response to thyroid hormone stimulus; IDA:UniProtKB
P25791	LMO2	Rhombotin-2	GO:0035162; P:embryonic hemopoiesis; IEA:Ensembl
P25791	LMO2	Rhombotin-2	GO:0042789; P:mRNA transcription from RNA polymerase II promoter; IDA:BHF-UCL
P25791	LMO2	Rhombotin-2	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P25791	LMO2	Rhombotin-2	GO:0045647; P:negative regulation of erythrocyte differentiation; IEA:Ensembl
P25791	LMO2	Rhombotin-2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P62877	RBX1	E3 ubiquitin-protein ligase RBX1	GO:0019788; F:NEDD8 ligase activity; IDA:UniProtKB
P62877	RBX1	E3 ubiquitin-protein ligase RBX1	GO:0005515; F:protein binding; IPI:UniProtKB
P62877	RBX1	E3 ubiquitin-protein ligase RBX1	GO:0031625; F:ubiquitin protein ligase binding; IDA:UniProtKB
P62877	RBX1	E3 ubiquitin-protein ligase RBX1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:MGI
P62877	RBX1	E3 ubiquitin-protein ligase RBX1	GO:0008270; F:zinc ion binding; IEA:InterPro
P62877	RBX1	E3 ubiquitin-protein ligase RBX1	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
P62877	RBX1	E3 ubiquitin-protein ligase RBX1	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
P62877	RBX1	E3 ubiquitin-protein ligase RBX1	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P62877	RBX1	E3 ubiquitin-protein ligase RBX1	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
P62877	RBX1	E3 ubiquitin-protein ligase RBX1	GO:0006513; P:protein monoubiquitination; IDA:UniProtKB
P62877	RBX1	E3 ubiquitin-protein ligase RBX1	GO:0045116; P:protein neddylation; IDA:UniProtKB
P62877	RBX1	E3 ubiquitin-protein ligase RBX1	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
P62877	RBX1	E3 ubiquitin-protein ligase RBX1	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
P62877	RBX1	E3 ubiquitin-protein ligase RBX1	GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
P62877	RBX1	E3 ubiquitin-protein ligase RBX1	GO:0016032; P:viral process; TAS:Reactome
Q9UBF6	RNF7	RING-box protein 2	GO:0005507; F:copper ion binding; TAS:ProtInc
Q9UBF6	RNF7	RING-box protein 2	GO:0019788; F:NEDD8 ligase activity; IDA:UniProtKB
Q9UBF6	RNF7	RING-box protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBF6	RNF7	RING-box protein 2	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q9UBF6	RNF7	RING-box protein 2	GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; TAS:ProtInc
Q9UBF6	RNF7	RING-box protein 2	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
Q9UBF6	RNF7	RING-box protein 2	GO:0045116; P:protein neddylation; IDA:UniProtKB
Q9UBF6	RNF7	RING-box protein 2	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9UBF6	RNF7	RING-box protein 2	GO:0051775; P:response to redox state; TAS:ProtInc
P0DJD3	RBMY1A1	RNA-binding motif protein, Y chromosome, family 1 member A1	GO:0003729; F:mRNA binding; IDA:UniProtKB
P0DJD3	RBMY1A1	RNA-binding motif protein, Y chromosome, family 1 member A1	GO:0000166; F:nucleotide binding; IEA:InterPro
P0DJD3	RBMY1A1	RNA-binding motif protein, Y chromosome, family 1 member A1	GO:0005515; F:protein binding; IPI:UniProtKB
P0DJD3	RBMY1A1	RNA-binding motif protein, Y chromosome, family 1 member A1	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
P0DJD3	RBMY1A1	RNA-binding motif protein, Y chromosome, family 1 member A1	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB
P0DJD3	RBMY1A1	RNA-binding motif protein, Y chromosome, family 1 member A1	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
A6NDE4	RBMY1B	RNA-binding motif protein, Y chromosome, family 1 member B	GO:0000166; F:nucleotide binding; IEA:InterPro
A6NDE4	RBMY1B	RNA-binding motif protein, Y chromosome, family 1 member B	GO:0005515; F:protein binding; IPI:UniProtKB
A6NDE4	RBMY1B	RNA-binding motif protein, Y chromosome, family 1 member B	GO:0003723; F:RNA binding; NAS:UniProtKB
A6NDE4	RBMY1B	RNA-binding motif protein, Y chromosome, family 1 member B	GO:0008584; P:male gonad development; IMP:UniProtKB
A6NDE4	RBMY1B	RNA-binding motif protein, Y chromosome, family 1 member B	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
A6NDE4	RBMY1B	RNA-binding motif protein, Y chromosome, family 1 member B	GO:0008380; P:RNA splicing; IDA:UniProtKB
A6NDE4	RBMY1B	RNA-binding motif protein, Y chromosome, family 1 member B	GO:0007283; P:spermatogenesis; TAS:UniProtKB
P0DJD4	RBMY1C	RNA-binding motif protein, Y chromosome, family 1 member C	GO:0000166; F:nucleotide binding; IEA:InterPro
P0DJD4	RBMY1C	RNA-binding motif protein, Y chromosome, family 1 member C	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
P0DJD4	RBMY1C	RNA-binding motif protein, Y chromosome, family 1 member C	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
P0DJD4	RBMY1C	RNA-binding motif protein, Y chromosome, family 1 member C	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
P0C7P1	RBMY1D	RNA-binding motif protein, Y chromosome, family 1 member D	GO:0000166; F:nucleotide binding; IEA:InterPro
P0C7P1	RBMY1D	RNA-binding motif protein, Y chromosome, family 1 member D	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
P0C7P1	RBMY1D	RNA-binding motif protein, Y chromosome, family 1 member D	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
P0C7P1	RBMY1D	RNA-binding motif protein, Y chromosome, family 1 member D	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
A6NEQ0	RBMY1E	RNA-binding motif protein, Y chromosome, family 1 member E	GO:0000166; F:nucleotide binding; IEA:InterPro
A6NEQ0	RBMY1E	RNA-binding motif protein, Y chromosome, family 1 member E	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
A6NEQ0	RBMY1E	RNA-binding motif protein, Y chromosome, family 1 member E	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
A6NEQ0	RBMY1E	RNA-binding motif protein, Y chromosome, family 1 member E	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q15415	RBMY1F	RNA-binding motif protein, Y chromosome, family 1 member F/J	GO:0000166; F:nucleotide binding; IEA:InterPro
Q15415	RBMY1F	RNA-binding motif protein, Y chromosome, family 1 member F/J	GO:0003723; F:RNA binding; NAS:UniProtKB
Q15415	RBMY1F	RNA-binding motif protein, Y chromosome, family 1 member F/J	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q15415	RBMY1F	RNA-binding motif protein, Y chromosome, family 1 member F/J	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q15415	RBMY1F	RNA-binding motif protein, Y chromosome, family 1 member F/J	GO:0007283; P:spermatogenesis; NAS:UniProtKB
P06400	RB1	Retinoblastoma-associated protein	GO:0050681; F:androgen receptor binding; NAS:UniProtKB
P06400	RB1	Retinoblastoma-associated protein	GO:0001047; F:core promoter binding; IDA:UniProtKB
P06400	RB1	Retinoblastoma-associated protein	GO:0003677; F:DNA binding; TAS:ProtInc
P06400	RB1	Retinoblastoma-associated protein	GO:0042802; F:identical protein binding; IPI:IntAct
P06400	RB1	Retinoblastoma-associated protein	GO:0019900; F:kinase binding; IDA:UniProtKB
P06400	RB1	Retinoblastoma-associated protein	GO:0051219; F:phosphoprotein binding; IPI:UniProtKB
P06400	RB1	Retinoblastoma-associated protein	GO:0005515; F:protein binding; IPI:UniProtKB
P06400	RB1	Retinoblastoma-associated protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P06400	RB1	Retinoblastoma-associated protein	GO:0003713; F:transcription coactivator activity; NAS:UniProtKB
P06400	RB1	Retinoblastoma-associated protein	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P06400	RB1	Retinoblastoma-associated protein	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P06400	RB1	Retinoblastoma-associated protein	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
P06400	RB1	Retinoblastoma-associated protein	GO:0007050; P:cell cycle arrest; TAS:BHF-UCL
P06400	RB1	Retinoblastoma-associated protein	GO:0000075; P:cell cycle checkpoint; TAS:ProtInc
P06400	RB1	Retinoblastoma-associated protein	GO:0048667; P:cell morphogenesis involved in neuron differentiation; IEA:Ensembl
P06400	RB1	Retinoblastoma-associated protein	GO:0006338; P:chromatin remodeling; TAS:BHF-UCL
P06400	RB1	Retinoblastoma-associated protein	GO:0048565; P:digestive tract development; IEA:Ensembl
P06400	RB1	Retinoblastoma-associated protein	GO:0043353; P:enucleate erythrocyte differentiation; IEA:Ensembl
P06400	RB1	Retinoblastoma-associated protein	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P06400	RB1	Retinoblastoma-associated protein	GO:0034349; P:glial cell apoptotic process; IEA:Ensembl
P06400	RB1	Retinoblastoma-associated protein	GO:0097284; P:hepatocyte apoptotic process; IEA:Ensembl
P06400	RB1	Retinoblastoma-associated protein	GO:0034088; P:maintenance of mitotic sister chromatid cohesion; IMP:BHF-UCL
P06400	RB1	Retinoblastoma-associated protein	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P06400	RB1	Retinoblastoma-associated protein	GO:0007093; P:mitotic cell cycle checkpoint; TAS:BHF-UCL
P06400	RB1	Retinoblastoma-associated protein	GO:0045445; P:myoblast differentiation; IMP:UniProtKB
P06400	RB1	Retinoblastoma-associated protein	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
P06400	RB1	Retinoblastoma-associated protein	GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; TAS:BHF-UCL
P06400	RB1	Retinoblastoma-associated protein	GO:0006469; P:negative regulation of protein kinase activity; IPI:UniProtKB
P06400	RB1	Retinoblastoma-associated protein	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; TAS:BHF-UCL
P06400	RB1	Retinoblastoma-associated protein	GO:0045879; P:negative regulation of smoothened signaling pathway; IEA:Ensembl
P06400	RB1	Retinoblastoma-associated protein	GO:0007070; P:negative regulation of transcription from RNA polymerase II promoter during mitosis; TAS:BHF-UCL
P06400	RB1	Retinoblastoma-associated protein	GO:0071930; P:negative regulation of transcription involved in G1/S transition of mitotic cell cycle; IEA:Ensembl
P06400	RB1	Retinoblastoma-associated protein	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P06400	RB1	Retinoblastoma-associated protein	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
P06400	RB1	Retinoblastoma-associated protein	GO:0042551; P:neuron maturation; IEA:Ensembl
P06400	RB1	Retinoblastoma-associated protein	GO:0031175; P:neuron projection development; IEA:Ensembl
P06400	RB1	Retinoblastoma-associated protein	GO:0045651; P:positive regulation of macrophage differentiation; IEA:Ensembl
P06400	RB1	Retinoblastoma-associated protein	GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; IMP:BHF-UCL
P06400	RB1	Retinoblastoma-associated protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P06400	RB1	Retinoblastoma-associated protein	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
P06400	RB1	Retinoblastoma-associated protein	GO:0071459; P:protein localization to chromosome, centromeric region; IMP:BHF-UCL
P06400	RB1	Retinoblastoma-associated protein	GO:0007265; P:Ras protein signal transduction; IEP:BHF-UCL
P06400	RB1	Retinoblastoma-associated protein	GO:0090230; P:regulation of centromere complex assembly; TAS:BHF-UCL
P06400	RB1	Retinoblastoma-associated protein	GO:0071922; P:regulation of cohesin localization to chromatin; IMP:BHF-UCL
P06400	RB1	Retinoblastoma-associated protein	GO:0043550; P:regulation of lipid kinase activity; IDA:UniProtKB
P06400	RB1	Retinoblastoma-associated protein	GO:0007346; P:regulation of mitotic cell cycle; IMP:BHF-UCL
P06400	RB1	Retinoblastoma-associated protein	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; TAS:BHF-UCL
P06400	RB1	Retinoblastoma-associated protein	GO:0031134; P:sister chromatid biorientation; IMP:BHF-UCL
P06400	RB1	Retinoblastoma-associated protein	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
P06400	RB1	Retinoblastoma-associated protein	GO:0051146; P:striated muscle cell differentiation; IEA:Ensembl
P06400	RB1	Retinoblastoma-associated protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P06400	RB1	Retinoblastoma-associated protein	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q5TC82	RC3H1	Roquin-1	GO:0003730; F:mRNA 3'-UTR binding; ISS:BHF-UCL
Q5TC82	RC3H1	Roquin-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q5TC82	RC3H1	Roquin-1	GO:0004842; F:ubiquitin-protein ligase activity; TAS:BHF-UCL
Q5TC82	RC3H1	Roquin-1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5TC82	RC3H1	Roquin-1	GO:0033962; P:cytoplasmic mRNA processing body assembly; ISS:BHF-UCL
Q5TC82	RC3H1	Roquin-1	GO:0046007; P:negative regulation of activated T cell proliferation; ISS:BHF-UCL
Q5TC82	RC3H1	Roquin-1	GO:0030889; P:negative regulation of B cell proliferation; ISS:BHF-UCL
Q5TC82	RC3H1	Roquin-1	GO:0002635; P:negative regulation of germinal center formation; ISS:BHF-UCL
Q5TC82	RC3H1	Roquin-1	GO:0045623; P:negative regulation of T-helper cell differentiation; ISS:BHF-UCL
Q5TC82	RC3H1	Roquin-1	GO:0000956; P:nuclear-transcribed mRNA catabolic process; ISS:BHF-UCL
Q5TC82	RC3H1	Roquin-1	GO:0010608; P:posttranscriptional regulation of gene expression; ISS:BHF-UCL
Q5TC82	RC3H1	Roquin-1	GO:0016567; P:protein ubiquitination; TAS:GOC
Q5TC82	RC3H1	Roquin-1	GO:0002634; P:regulation of germinal center formation; ISS:BHF-UCL
Q5TC82	RC3H1	Roquin-1	GO:0043488; P:regulation of mRNA stability; ISS:BHF-UCL
Q5TC82	RC3H1	Roquin-1	GO:0050856; P:regulation of T cell receptor signaling pathway; ISS:BHF-UCL
Q9HBD1	RC3H2	Roquin-2	GO:0003677; F:DNA binding; IDA:UniProtKB
Q9HBD1	RC3H2	Roquin-2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9HBD1	RC3H2	Roquin-2	GO:0004842; F:ubiquitin-protein ligase activity; IDA:FlyBase
Q9HBD1	RC3H2	Roquin-2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9HBD1	RC3H2	Roquin-2	GO:0000209; P:protein polyubiquitination; IMP:FlyBase
P53805	RCAN1	Calcipressin-1	GO:0003677; F:DNA binding; TAS:ProtInc
P53805	RCAN1	Calcipressin-1	GO:0042802; F:identical protein binding; IPI:IntAct
P53805	RCAN1	Calcipressin-1	GO:0005515; F:protein binding; IPI:IntAct
P53805	RCAN1	Calcipressin-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P53805	RCAN1	Calcipressin-1	GO:0008015; P:blood circulation; TAS:ProtInc
P53805	RCAN1	Calcipressin-1	GO:0019722; P:calcium-mediated signaling; IEA:InterPro
P53805	RCAN1	Calcipressin-1	GO:0007417; P:central nervous system development; TAS:ProtInc
P53805	RCAN1	Calcipressin-1	GO:0051151; P:negative regulation of smooth muscle cell differentiation; IEA:Ensembl
P53805	RCAN1	Calcipressin-1	GO:0043666; P:regulation of phosphoprotein phosphatase activity; IEA:Ensembl
P53805	RCAN1	Calcipressin-1	GO:0006355; P:regulation of transcription, DNA-templated; TAS:GOC
P53805	RCAN1	Calcipressin-1	GO:0043627; P:response to estrogen; IEA:Ensembl
P53805	RCAN1	Calcipressin-1	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P53805	RCAN1	Calcipressin-1	GO:0007165; P:signal transduction; TAS:ProtInc
P53805	RCAN1	Calcipressin-1	GO:0048741; P:skeletal muscle fiber development; IEA:Ensembl
Q14206	RCAN2	Calcipressin-2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q14206	RCAN2	Calcipressin-2	GO:0019722; P:calcium-mediated signaling; IEA:InterPro
Q9UKA8	RCAN3	Calcipressin-3	GO:0003723; F:RNA binding; TAS:ProtInc
Q9UKA8	RCAN3	Calcipressin-3	GO:0031013; F:troponin I binding; IPI:UniProtKB
Q9UKA8	RCAN3	Calcipressin-3	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q9UKA8	RCAN3	Calcipressin-3	GO:0019722; P:calcium-mediated signaling; IEA:InterPro
O00559	EBAG9	Receptor-binding cancer antigen expressed on SiSo cells	GO:0016505; F:peptidase activator activity involved in apoptotic process; NAS:UniProtKB
O00559	EBAG9	Receptor-binding cancer antigen expressed on SiSo cells	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
Q8NDN9	RCBTB1	RCC1 and BTB domain-containing protein 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8NDN9	RCBTB1	RCC1 and BTB domain-containing protein 1	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q8NDN9	RCBTB1	RCC1 and BTB domain-containing protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NDN9	RCBTB1	RCC1 and BTB domain-containing protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95199	RCBTB2	RCC1 and BTB domain-containing protein 2	GO:0005087; F:Ran guanyl-nucleotide exchange factor activity; TAS:ProtInc
O95199	RCBTB2	RCC1 and BTB domain-containing protein 2	GO:0032316; P:regulation of Ran GTPase activity; TAS:GOC
P18754	RCC1	Regulator of chromosome condensation	GO:0003682; F:chromatin binding; IDA:UniProtKB
P18754	RCC1	Regulator of chromosome condensation	GO:0042393; F:histone binding; IDA:UniProtKB
P18754	RCC1	Regulator of chromosome condensation	GO:0031492; F:nucleosomal DNA binding; IDA:UniProtKB
P18754	RCC1	Regulator of chromosome condensation	GO:0005515; F:protein binding; IPI:UniProtKB
P18754	RCC1	Regulator of chromosome condensation	GO:0005087; F:Ran guanyl-nucleotide exchange factor activity; IDA:UniProtKB
P18754	RCC1	Regulator of chromosome condensation	GO:0007059; P:chromosome segregation; IMP:UniProtKB
P18754	RCC1	Regulator of chromosome condensation	GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:UniProtKB
P18754	RCC1	Regulator of chromosome condensation	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P18754	RCC1	Regulator of chromosome condensation	GO:0007052; P:mitotic spindle organization; IDA:UniProtKB
P18754	RCC1	Regulator of chromosome condensation	GO:0007088; P:regulation of mitosis; IDA:UniProtKB
P18754	RCC1	Regulator of chromosome condensation	GO:0032316; P:regulation of Ran GTPase activity; IDA:GOC
P18754	RCC1	Regulator of chromosome condensation	GO:0051225; P:spindle assembly; IMP:UniProtKB
P18754	RCC1	Regulator of chromosome condensation	GO:0016032; P:viral process; TAS:Reactome
Q9P258	RCC2	Protein RCC2	GO:0008017; F:microtubule binding; IMP:UniProt
Q9P258	RCC2	Protein RCC2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9P258	RCC2	Protein RCC2	GO:0005515; F:protein binding; IPI:UniProt
Q9P258	RCC2	Protein RCC2	GO:0048041; P:focal adhesion assembly; IDA:UniProt
Q9P258	RCC2	Protein RCC2	GO:0007229; P:integrin-mediated signaling pathway; IDA:UniProt
Q9P258	RCC2	Protein RCC2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9P258	RCC2	Protein RCC2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9P258	RCC2	Protein RCC2	GO:0051895; P:negative regulation of focal adhesion assembly; ISS:UniProt
Q9P258	RCC2	Protein RCC2	GO:0034260; P:negative regulation of GTPase activity; ISS:UniProt
Q9P258	RCC2	Protein RCC2	GO:1900025; P:negative regulation of substrate adhesion-dependent cell spreading; ISS:UniProt
Q9P258	RCC2	Protein RCC2	GO:0051987; P:positive regulation of attachment of spindle microtubules to kinetochore; IMP:UniProt
Q9P258	RCC2	Protein RCC2	GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IMP:UniProt
Q9P258	RCC2	Protein RCC2	GO:0030334; P:regulation of cell migration; ISS:UniProt
Q92600	RQCD1	Cell differentiation protein RCD1 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q92600	RQCD1	Cell differentiation protein RCD1 homolog	GO:0019221; P:cytokine-mediated signaling pathway; IEA:Ensembl
Q92600	RQCD1	Cell differentiation protein RCD1 homolog	GO:0010467; P:gene expression; TAS:Reactome
Q92600	RQCD1	Cell differentiation protein RCD1 homolog	GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW
Q92600	RQCD1	Cell differentiation protein RCD1 homolog	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q92600	RQCD1	Cell differentiation protein RCD1 homolog	GO:0033147; P:negative regulation of intracellular estrogen receptor signaling pathway; IMP:UniProtKB
Q92600	RQCD1	Cell differentiation protein RCD1 homolog	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q92600	RQCD1	Cell differentiation protein RCD1 homolog	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
Q92600	RQCD1	Cell differentiation protein RCD1 homolog	GO:2000327; P:positive regulation of ligand-dependent nuclear receptor transcription coactivator activity; IDA:UniProtKB
Q92600	RQCD1	Cell differentiation protein RCD1 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q92600	RQCD1	Cell differentiation protein RCD1 homolog	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q92600	RQCD1	Cell differentiation protein RCD1 homolog	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q92600	RQCD1	Cell differentiation protein RCD1 homolog	GO:0007548; P:sex differentiation; TAS:ProtInc
Q92600	RQCD1	Cell differentiation protein RCD1 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2P8	RCL1	RNA 3'-terminal phosphate cyclase-like protein	GO:0003963; F:RNA-3'-phosphate cyclase activity; NAS:UniProtKB
Q9Y2P8	RCL1	RNA 3'-terminal phosphate cyclase-like protein	GO:0042254; P:ribosome biogenesis; IEA:UniProtKB-KW
Q9Y2P8	RCL1	RNA 3'-terminal phosphate cyclase-like protein	GO:0006396; P:RNA processing; IEA:InterPro
Q15293	RCN1	Reticulocalbin-1	GO:0005509; F:calcium ion binding; TAS:ProtInc
Q15293	RCN1	Reticulocalbin-1	GO:0005515; F:protein binding; IPI:IntAct
Q15293	RCN1	Reticulocalbin-1	GO:0043010; P:camera-type eye development; IEA:Ensembl
Q15293	RCN1	Reticulocalbin-1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q14257	RCN2	Reticulocalbin-2	GO:0005509; F:calcium ion binding; TAS:ProtInc
Q14257	RCN2	Reticulocalbin-2	GO:0005515; F:protein binding; IPI:IntAct
Q96D15	RCN3	Reticulocalbin-3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96D15	RCN3	Reticulocalbin-3	GO:0005515; F:protein binding; IPI:IntAct
Q9UKL0	RCOR1	REST corepressor 1	GO:0003682; F:chromatin binding; IEA:InterPro
Q9UKL0	RCOR1	REST corepressor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKL0	RCOR1	REST corepressor 1	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IDA:UniProtKB
Q9UKL0	RCOR1	REST corepressor 1	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q9UKL0	RCOR1	REST corepressor 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q9UKL0	RCOR1	REST corepressor 1	GO:0070933; P:histone H4 deacetylation; IDA:UniProtKB
Q9UKL0	RCOR1	REST corepressor 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:GOC
Q9UKL0	RCOR1	REST corepressor 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UKL0	RCOR1	REST corepressor 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q8IZ40	RCOR2	REST corepressor 2	GO:0003682; F:chromatin binding; IEA:InterPro
Q8IZ40	RCOR2	REST corepressor 2	GO:0003677; F:DNA binding; IEA:InterPro
Q8IZ40	RCOR2	REST corepressor 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q8IZ40	RCOR2	REST corepressor 2	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
Q8IZ40	RCOR2	REST corepressor 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q8IZ40	RCOR2	REST corepressor 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9P2K3	RCOR3	REST corepressor 3	GO:0003682; F:chromatin binding; IEA:InterPro
Q9P2K3	RCOR3	REST corepressor 3	GO:0003677; F:DNA binding; IEA:InterPro
Q9P2K3	RCOR3	REST corepressor 3	GO:0005515; F:protein binding; IPI:IntAct
Q9P2K3	RCOR3	REST corepressor 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9P2K3	RCOR3	REST corepressor 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H4I0	RAD21L1	Double-strand-break repair protein rad21-like protein 1	GO:0070197; P:attachment of telomeric heterochromatin to nuclear envelope; IEA:Ensembl
Q9H4I0	RAD21L1	Double-strand-break repair protein rad21-like protein 1	GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW
Q9H4I0	RAD21L1	Double-strand-break repair protein rad21-like protein 1	GO:0000724; P:double-strand break repair via homologous recombination; IEA:Ensembl
Q9H4I0	RAD21L1	Double-strand-break repair protein rad21-like protein 1	GO:0009566; P:fertilization; IEA:Ensembl
Q9H4I0	RAD21L1	Double-strand-break repair protein rad21-like protein 1	GO:0030999; P:linear element assembly; IEA:Ensembl
Q9H4I0	RAD21L1	Double-strand-break repair protein rad21-like protein 1	GO:0007128; P:meiotic prophase I; ISS:UniProtKB
Q9H4I0	RAD21L1	Double-strand-break repair protein rad21-like protein 1	GO:0072520; P:seminiferous tubule development; IEA:Ensembl
Q9H4I0	RAD21L1	Double-strand-break repair protein rad21-like protein 1	GO:0007283; P:spermatogenesis; IEA:Ensembl
P54725	RAD23A	UV excision repair protein RAD23 homolog A	GO:0003684; F:damaged DNA binding; IEA:InterPro
P54725	RAD23A	UV excision repair protein RAD23 homolog A	GO:0031593; F:polyubiquitin binding; IDA:UniProtKB
P54725	RAD23A	UV excision repair protein RAD23 homolog A	GO:0005515; F:protein binding; IPI:IntAct
P54725	RAD23A	UV excision repair protein RAD23 homolog A	GO:0003697; F:single-stranded DNA binding; TAS:ProtInc
P54725	RAD23A	UV excision repair protein RAD23 homolog A	GO:0006289; P:nucleotide-excision repair; IEA:InterPro
P54725	RAD23A	UV excision repair protein RAD23 homolog A	GO:0045070; P:positive regulation of viral genome replication; IMP:UniProtKB
P54725	RAD23A	UV excision repair protein RAD23 homolog A	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:InterPro
P54725	RAD23A	UV excision repair protein RAD23 homolog A	GO:0032434; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
P54725	RAD23A	UV excision repair protein RAD23 homolog A	GO:0016032; P:viral process; IEA:UniProtKB-KW
P54727	RAD23B	UV excision repair protein RAD23 homolog B	GO:0003684; F:damaged DNA binding; IEA:InterPro
P54727	RAD23B	UV excision repair protein RAD23 homolog B	GO:0031593; F:polyubiquitin binding; IDA:UniProtKB
P54727	RAD23B	UV excision repair protein RAD23 homolog B	GO:0005515; F:protein binding; IPI:UniProtKB
P54727	RAD23B	UV excision repair protein RAD23 homolog B	GO:0003697; F:single-stranded DNA binding; TAS:ProtInc
P54727	RAD23B	UV excision repair protein RAD23 homolog B	GO:0006281; P:DNA repair; TAS:Reactome
P54727	RAD23B	UV excision repair protein RAD23 homolog B	GO:0006289; P:nucleotide-excision repair; IDA:UniProtKB
P54727	RAD23B	UV excision repair protein RAD23 homolog B	GO:0000715; P:nucleotide-excision repair, DNA damage recognition; IDA:UniProtKB
P54727	RAD23B	UV excision repair protein RAD23 homolog B	GO:0000718; P:nucleotide-excision repair, DNA damage removal; TAS:Reactome
P54727	RAD23B	UV excision repair protein RAD23 homolog B	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:InterPro
P54727	RAD23B	UV excision repair protein RAD23 homolog B	GO:0032434; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
P54727	RAD23B	UV excision repair protein RAD23 homolog B	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q7Z3Z2	RD3	Protein RD3	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q7Z3Z2	RD3	Protein RD3	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
Q7Z3Z2	RD3	Protein RD3	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q8TC12	RDH11	Retinol dehydrogenase 11	GO:0052650; F:NADP-retinol dehydrogenase activity; IDA:MGI
Q8TC12	RDH11	Retinol dehydrogenase 11	GO:0004745; F:retinol dehydrogenase activity; ISS:UniProtKB
Q8TC12	RDH11	Retinol dehydrogenase 11	GO:0016062; P:adaptation of rhodopsin mediated signaling; IEA:Ensembl
Q8TC12	RDH11	Retinol dehydrogenase 11	GO:0007603; P:phototransduction, visible light; TAS:Reactome
Q8TC12	RDH11	Retinol dehydrogenase 11	GO:0042574; P:retinal metabolic process; IDA:MGI
Q8TC12	RDH11	Retinol dehydrogenase 11	GO:0001523; P:retinoid metabolic process; TAS:Reactome
Q8TC12	RDH11	Retinol dehydrogenase 11	GO:0042572; P:retinol metabolic process; ISS:UniProtKB
Q8IZV5	RDH10	Retinol dehydrogenase 10	GO:0052650; F:NADP-retinol dehydrogenase activity; IEA:UniProtKB-EC
Q8IZV5	RDH10	Retinol dehydrogenase 10	GO:0004745; F:retinol dehydrogenase activity; IDA:UniProtKB
Q8IZV5	RDH10	Retinol dehydrogenase 10	GO:0060449; P:bud elongation involved in lung branching; IEA:Ensembl
Q8IZV5	RDH10	Retinol dehydrogenase 10	GO:0043583; P:ear development; IEA:Ensembl
Q8IZV5	RDH10	Retinol dehydrogenase 10	GO:0031076; P:embryonic camera-type eye development; IEA:Ensembl
Q8IZV5	RDH10	Retinol dehydrogenase 10	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
Q8IZV5	RDH10	Retinol dehydrogenase 10	GO:0048703; P:embryonic viscerocranium morphogenesis; IEA:Ensembl
Q8IZV5	RDH10	Retinol dehydrogenase 10	GO:0008406; P:gonad development; IEA:Ensembl
Q8IZV5	RDH10	Retinol dehydrogenase 10	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q8IZV5	RDH10	Retinol dehydrogenase 10	GO:0001656; P:metanephros development; IEA:Ensembl
Q8IZV5	RDH10	Retinol dehydrogenase 10	GO:0014032; P:neural crest cell development; IEA:Ensembl
Q8IZV5	RDH10	Retinol dehydrogenase 10	GO:0043584; P:nose development; IEA:Ensembl
Q8IZV5	RDH10	Retinol dehydrogenase 10	GO:0007603; P:phototransduction, visible light; TAS:Reactome
Q8IZV5	RDH10	Retinol dehydrogenase 10	GO:0060431; P:primary lung bud formation; IEA:Ensembl
Q8IZV5	RDH10	Retinol dehydrogenase 10	GO:0042574; P:retinal metabolic process; IDA:UniProtKB
Q8IZV5	RDH10	Retinol dehydrogenase 10	GO:0002138; P:retinoic acid biosynthetic process; IEA:Ensembl
Q8IZV5	RDH10	Retinol dehydrogenase 10	GO:0001523; P:retinoid metabolic process; TAS:Reactome
Q8IZV5	RDH10	Retinol dehydrogenase 10	GO:0042572; P:retinol metabolic process; IDA:UniProtKB
Q8IZV5	RDH10	Retinol dehydrogenase 10	GO:0007601; P:visual perception; IDA:MGI
Q8NBN7	RDH13	Retinol dehydrogenase 13	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q96NR8	RDH12	Retinol dehydrogenase 12	GO:0005515; F:protein binding; IPI:IntAct
Q96NR8	RDH12	Retinol dehydrogenase 12	GO:0004745; F:retinol dehydrogenase activity; IDA:UniProtKB
Q96NR8	RDH12	Retinol dehydrogenase 12	GO:0045494; P:photoreceptor cell maintenance; TAS:UniProtKB
Q96NR8	RDH12	Retinol dehydrogenase 12	GO:0007603; P:phototransduction, visible light; TAS:Reactome
Q96NR8	RDH12	Retinol dehydrogenase 12	GO:0001523; P:retinoid metabolic process; TAS:Reactome
Q96NR8	RDH12	Retinol dehydrogenase 12	GO:0042572; P:retinol metabolic process; IDA:UniProtKB
Q96NR8	RDH12	Retinol dehydrogenase 12	GO:0007601; P:visual perception; TAS:UniProtKB
Q9HBH5	RDH14	Retinol dehydrogenase 14	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
O75452	RDH16	Retinol dehydrogenase 16	GO:0009055; F:electron carrier activity; TAS:UniProtKB
O75452	RDH16	Retinol dehydrogenase 16	GO:0004745; F:retinol dehydrogenase activity; TAS:ProtInc
O75452	RDH16	Retinol dehydrogenase 16	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q92781	RDH5	11-cis retinol dehydrogenase	GO:0004745; F:retinol dehydrogenase activity; TAS:ProtInc
Q92781	RDH5	11-cis retinol dehydrogenase	GO:0007603; P:phototransduction, visible light; TAS:Reactome
Q92781	RDH5	11-cis retinol dehydrogenase	GO:0001523; P:retinoid metabolic process; TAS:Reactome
Q92781	RDH5	11-cis retinol dehydrogenase	GO:0042572; P:retinol metabolic process; IEA:UniProtKB-UniPathway
Q92781	RDH5	11-cis retinol dehydrogenase	GO:0007601; P:visual perception; TAS:ProtInc
Q9NYR8	RDH8	Retinol dehydrogenase 8	GO:0004303; F:estradiol 17-beta-dehydrogenase activity; IEA:InterPro
Q9NYR8	RDH8	Retinol dehydrogenase 8	GO:0052650; F:NADP-retinol dehydrogenase activity; IEA:UniProtKB-EC
Q9NYR8	RDH8	Retinol dehydrogenase 8	GO:0004745; F:retinol dehydrogenase activity; TAS:ProtInc
Q9NYR8	RDH8	Retinol dehydrogenase 8	GO:0006703; P:estrogen biosynthetic process; IEA:InterPro
Q9NYR8	RDH8	Retinol dehydrogenase 8	GO:0007603; P:phototransduction, visible light; TAS:Reactome
Q9NYR8	RDH8	Retinol dehydrogenase 8	GO:0001523; P:retinoid metabolic process; TAS:Reactome
Q9NYR8	RDH8	Retinol dehydrogenase 8	GO:0006694; P:steroid biosynthetic process; TAS:ProtInc
Q9NYR8	RDH8	Retinol dehydrogenase 8	GO:0007601; P:visual perception; TAS:ProtInc
Q8N3Y7	SDR16C5	Epidermal retinol dehydrogenase 2	GO:0004745; F:retinol dehydrogenase activity; IDA:UniProtKB
Q8N3Y7	SDR16C5	Epidermal retinol dehydrogenase 2	GO:0050908; P:detection of light stimulus involved in visual perception; NAS:UniProtKB
Q8N3Y7	SDR16C5	Epidermal retinol dehydrogenase 2	GO:0043616; P:keratinocyte proliferation; IMP:UniProtKB
Q8N3Y7	SDR16C5	Epidermal retinol dehydrogenase 2	GO:0042574; P:retinal metabolic process; IDA:UniProtKB
Q8N3Y7	SDR16C5	Epidermal retinol dehydrogenase 2	GO:0042572; P:retinol metabolic process; IDA:UniProtKB
Q8NG50	RDM1	RAD52 motif-containing protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NG50	RDM1	RAD52 motif-containing protein 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8NG50	RDM1	RAD52 motif-containing protein 1	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q8NG50	RDM1	RAD52 motif-containing protein 1	GO:0006310; P:DNA recombination; IEA:InterPro
Q8NG50	RDM1	RAD52 motif-containing protein 1	GO:0006281; P:DNA repair; IEA:InterPro
Q8TAI7	RHEBL1	GTPase RhebL1	GO:0005525; F:GTP binding; IDA:UniProtKB
Q8TAI7	RHEBL1	GTPase RhebL1	GO:0006184; P:GTP catabolic process; IEA:InterPro
Q8TAI7	RHEBL1	GTPase RhebL1	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q8TAI7	RHEBL1	GTPase RhebL1	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q8TAI7	RHEBL1	GTPase RhebL1	GO:0031929; P:TOR signaling; IMP:UniProtKB
DR   GO:0003723; F:RNA binding; IEA:UniProtKB-KW
DR   GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
DR   GO:0003723; F:RNA binding; IEA:UniProtKB-KW
DR   GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
DR   GO:0003723; F:RNA binding; IEA:UniProtKB-KW
DR   GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q69383	ERVK-6	HERV-K_7q22.1 provirus Rec protein	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q69383	ERVK-6	HERV-K_7q22.1 provirus Rec protein	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
DR   GO:0003723; F:RNA binding; IEA:UniProtKB-KW
DR   GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
DR   GO:0003723; F:RNA binding; IEA:UniProtKB-KW
DR   GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
DR   GO:0003723; F:RNA binding; IEA:UniProtKB-KW
DR   GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
O95072	REC8	Meiotic recombination protein REC8 homolog	GO:0000724; P:double-strand break repair via homologous recombination; IEA:Ensembl
O95072	REC8	Meiotic recombination protein REC8 homolog	GO:0009566; P:fertilization; IEA:Ensembl
O95072	REC8	Meiotic recombination protein REC8 homolog	GO:0030999; P:linear element assembly; IEA:Ensembl
O95072	REC8	Meiotic recombination protein REC8 homolog	GO:0007141; P:male meiosis I; IEA:Ensembl
O95072	REC8	Meiotic recombination protein REC8 homolog	GO:0007126; P:meiotic nuclear division; TAS:ProtInc
O95072	REC8	Meiotic recombination protein REC8 homolog	GO:0001556; P:oocyte maturation; IEA:Ensembl
O95072	REC8	Meiotic recombination protein REC8 homolog	GO:0007131; P:reciprocal meiotic recombination; TAS:ProtInc
O95072	REC8	Meiotic recombination protein REC8 homolog	GO:0072520; P:seminiferous tubule development; IEA:Ensembl
O95072	REC8	Meiotic recombination protein REC8 homolog	GO:0007062; P:sister chromatid cohesion; TAS:ProtInc
O95072	REC8	Meiotic recombination protein REC8 homolog	GO:0007286; P:spermatid development; IEA:Ensembl
O95072	REC8	Meiotic recombination protein REC8 homolog	GO:0007283; P:spermatogenesis; TAS:ProtInc
DR   GO:0003723; F:RNA binding; IEA:UniProtKB-KW
DR   GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
DR   GO:0003723; F:RNA binding; IEA:UniProtKB-KW
DR   GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
O95980	RECK	Reversion-inducing cysteine-rich protein with Kazal motifs	GO:0004866; F:endopeptidase inhibitor activity; IDA:MGI
O95980	RECK	Reversion-inducing cysteine-rich protein with Kazal motifs	GO:0008191; F:metalloendopeptidase inhibitor activity; TAS:ProtInc
O95980	RECK	Reversion-inducing cysteine-rich protein with Kazal motifs	GO:0005515; F:protein binding; IPI:IntAct
O95980	RECK	Reversion-inducing cysteine-rich protein with Kazal motifs	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
O95980	RECK	Reversion-inducing cysteine-rich protein with Kazal motifs	GO:0001955; P:blood vessel maturation; IEA:Ensembl
O95980	RECK	Reversion-inducing cysteine-rich protein with Kazal motifs	GO:0007566; P:embryo implantation; IEA:Ensembl
O95980	RECK	Reversion-inducing cysteine-rich protein with Kazal motifs	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
O95980	RECK	Reversion-inducing cysteine-rich protein with Kazal motifs	GO:0010951; P:negative regulation of endopeptidase activity; IDA:GOC
P35243	RCVRN	Recoverin	GO:0005509; F:calcium ion binding; TAS:ProtInc
P35243	RCVRN	Recoverin	GO:0008048; F:calcium sensitive guanylate cyclase activator activity; TAS:ProtInc
P35243	RCVRN	Recoverin	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P35243	RCVRN	Recoverin	GO:0031284; P:positive regulation of guanylate cyclase activity; TAS:GOC
P35243	RCVRN	Recoverin	GO:0051924; P:regulation of calcium ion transport; IEA:Ensembl
P35243	RCVRN	Recoverin	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
P35243	RCVRN	Recoverin	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
P35243	RCVRN	Recoverin	GO:0007165; P:signal transduction; TAS:ProtInc
P35243	RCVRN	Recoverin	GO:0007601; P:visual perception; TAS:ProtInc
P46063	RECQL	ATP-dependent DNA helicase Q1	GO:0036310; F:annealing helicase activity; IDA:UniProtKB
P46063	RECQL	ATP-dependent DNA helicase Q1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P46063	RECQL	ATP-dependent DNA helicase Q1	GO:0043140; F:ATP-dependent 3'-5' DNA helicase activity; IEA:InterPro
P46063	RECQL	ATP-dependent DNA helicase Q1	GO:0004003; F:ATP-dependent DNA helicase activity; TAS:ProtInc
P46063	RECQL	ATP-dependent DNA helicase Q1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P46063	RECQL	ATP-dependent DNA helicase Q1	GO:0003678; F:DNA helicase activity; IDA:UniProtKB
P46063	RECQL	ATP-dependent DNA helicase Q1	GO:0005515; F:protein binding; IPI:UniProtKB
P46063	RECQL	ATP-dependent DNA helicase Q1	GO:0032508; P:DNA duplex unwinding; IDA:GOC
P46063	RECQL	ATP-dependent DNA helicase Q1	GO:0006310; P:DNA recombination; IEA:InterPro
P46063	RECQL	ATP-dependent DNA helicase Q1	GO:0006281; P:DNA repair; TAS:ProtInc
P46063	RECQL	ATP-dependent DNA helicase Q1	GO:0006260; P:DNA replication; IEA:InterPro
P46063	RECQL	ATP-dependent DNA helicase Q1	GO:0000733; P:DNA strand renaturation; IDA:UniProtKB
O94762	RECQL5	ATP-dependent DNA helicase Q5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O94762	RECQL5	ATP-dependent DNA helicase Q5	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
O94762	RECQL5	ATP-dependent DNA helicase Q5	GO:0003678; F:DNA helicase activity; IDA:UniProtKB
O94762	RECQL5	ATP-dependent DNA helicase Q5	GO:0003676; F:nucleic acid binding; IEA:InterPro
O94762	RECQL5	ATP-dependent DNA helicase Q5	GO:0000993; F:RNA polymerase II core binding; IDA:UniProtKB
O94762	RECQL5	ATP-dependent DNA helicase Q5	GO:0051304; P:chromosome separation; IMP:UniProtKB
O94762	RECQL5	ATP-dependent DNA helicase Q5	GO:0032508; P:DNA duplex unwinding; IDA:GOC
O94762	RECQL5	ATP-dependent DNA helicase Q5	GO:0006259; P:DNA metabolic process; NAS:UniProtKB
O94762	RECQL5	ATP-dependent DNA helicase Q5	GO:0006310; P:DNA recombination; IEA:InterPro
O94762	RECQL5	ATP-dependent DNA helicase Q5	GO:0006281; P:DNA repair; IMP:UniProtKB
O94762	RECQL5	ATP-dependent DNA helicase Q5	GO:0006260; P:DNA replication; IMP:UniProtKB
O94762	RECQL5	ATP-dependent DNA helicase Q5	GO:0007067; P:mitosis; IMP:UniProtKB
O94762	RECQL5	ATP-dependent DNA helicase Q5	GO:0034244; P:negative regulation of transcription elongation from RNA polymerase II promoter; IDA:UniProtKB
O94761	RECQL4	ATP-dependent DNA helicase Q4	GO:0036310; F:annealing helicase activity; IDA:UniProtKB
O94761	RECQL4	ATP-dependent DNA helicase Q4	GO:0005524; F:ATP binding; IDA:UniProtKB
O94761	RECQL4	ATP-dependent DNA helicase Q4	GO:0043140; F:ATP-dependent 3'-5' DNA helicase activity; IMP:UniProtKB
O94761	RECQL4	ATP-dependent DNA helicase Q4	GO:0000405; F:bubble DNA binding; IDA:UniProtKB
O94761	RECQL4	ATP-dependent DNA helicase Q4	GO:0008270; F:zinc ion binding; IEA:InterPro
O94761	RECQL4	ATP-dependent DNA helicase Q4	GO:0032508; P:DNA duplex unwinding; IDA:UniProtKB
O94761	RECQL4	ATP-dependent DNA helicase Q4	GO:0006310; P:DNA recombination; IEA:InterPro
O94761	RECQL4	ATP-dependent DNA helicase Q4	GO:0006281; P:DNA repair; TAS:ProtInc
O94761	RECQL4	ATP-dependent DNA helicase Q4	GO:0006260; P:DNA replication; IDA:UniProtKB
O94761	RECQL4	ATP-dependent DNA helicase Q4	GO:0000733; P:DNA strand renaturation; IDA:UniProtKB
O94761	RECQL4	ATP-dependent DNA helicase Q4	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0004000; F:adenosine deaminase activity; IEA:InterPro
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0003726; F:double-stranded RNA adenosine deaminase activity; IDA:HGNC
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0003725; F:double-stranded RNA binding; IDA:HGNC
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0003729; F:mRNA binding; TAS:BHF-UCL
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0005515; F:protein binding; IPI:IntAct
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0003723; F:RNA binding; IEA:InterPro
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0006382; P:adenosine to inosine editing; IEA:Ensembl
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0016553; P:base conversion or substitution editing; IC:HGNC
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0010467; P:gene expression; TAS:Reactome
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0016556; P:mRNA modification; TAS:Reactome
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0044387; P:negative regulation of protein kinase activity by regulation of protein phosphorylation; IDA:UniProtKB
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0045070; P:positive regulation of viral genome replication; IMP:UniProtKB
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0051726; P:regulation of cell cycle; IDA:UniProtKB
P78563	ADARB1	Double-stranded RNA-specific editase 1	GO:0006396; P:RNA processing; IEA:InterPro
Q9NS39	ADARB2	Double-stranded RNA-specific editase B2	GO:0004000; F:adenosine deaminase activity; TAS:ProtInc
Q9NS39	ADARB2	Double-stranded RNA-specific editase B2	GO:0003725; F:double-stranded RNA binding; TAS:ProtInc
Q9NS39	ADARB2	Double-stranded RNA-specific editase B2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NS39	ADARB2	Double-stranded RNA-specific editase B2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NS39	ADARB2	Double-stranded RNA-specific editase B2	GO:0003727; F:single-stranded RNA binding; TAS:ProtInc
Q9NS39	ADARB2	Double-stranded RNA-specific editase B2	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q13123	IK	Protein Red	GO:0042802; F:identical protein binding; IPI:IntAct
Q13123	IK	Protein Red	GO:0005515; F:protein binding; IPI:IntAct
Q13123	IK	Protein Red	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q13123	IK	Protein Red	GO:0006955; P:immune response; TAS:ProtInc
Q9H902	REEP1	Receptor expression-enhancing protein 1	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q9H902	REEP1	Receptor expression-enhancing protein 1	GO:0031849; F:olfactory receptor binding; IMP:HGNC
Q9H902	REEP1	Receptor expression-enhancing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H902	REEP1	Receptor expression-enhancing protein 1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9H902	REEP1	Receptor expression-enhancing protein 1	GO:0071786; P:endoplasmic reticulum tubular network organization; IMP:UniProtKB
Q9H902	REEP1	Receptor expression-enhancing protein 1	GO:0051205; P:protein insertion into membrane; IDA:HGNC
Q9BRK0	REEP2	Receptor expression-enhancing protein 2	GO:0071786; P:endoplasmic reticulum tubular network organization; IMP:UniProtKB
Q9BRK0	REEP2	Receptor expression-enhancing protein 2	GO:0032596; P:protein transport into membrane raft; IEA:Ensembl
Q9BRK0	REEP2	Receptor expression-enhancing protein 2	GO:0050913; P:sensory perception of bitter taste; IEA:Ensembl
Q9BRK0	REEP2	Receptor expression-enhancing protein 2	GO:0050916; P:sensory perception of sweet taste; IEA:Ensembl
Q6NUK4	REEP3	Receptor expression-enhancing protein 3	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q6NUK4	REEP3	Receptor expression-enhancing protein 3	GO:0007084; P:mitotic nuclear envelope reassembly; IMP:UniProtKB
Q6NUK4	REEP3	Receptor expression-enhancing protein 3	GO:0006998; P:nuclear envelope organization; IMP:UniProtKB
Q9H6H4	REEP4	Receptor expression-enhancing protein 4	GO:0008017; F:microtubule binding; ISS:UniProtKB
Q9H6H4	REEP4	Receptor expression-enhancing protein 4	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9H6H4	REEP4	Receptor expression-enhancing protein 4	GO:0007084; P:mitotic nuclear envelope reassembly; IMP:UniProtKB
Q9H6H4	REEP4	Receptor expression-enhancing protein 4	GO:0006998; P:nuclear envelope organization; IMP:UniProtKB
Q00765	REEP5	Receptor expression-enhancing protein 5	GO:0005515; F:protein binding; IPI:IntAct
P48304	REG1B	Lithostathine-1-beta	GO:0030246; F:carbohydrate binding; IEA:InterPro
P48304	REG1B	Lithostathine-1-beta	GO:0008283; P:cell proliferation; TAS:ProtInc
P05451	REG1A	Lithostathine-1-alpha	GO:0030246; F:carbohydrate binding; IEA:InterPro
P05451	REG1A	Lithostathine-1-alpha	GO:0008083; F:growth factor activity; IDA:MGI
P05451	REG1A	Lithostathine-1-alpha	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q06141	REG3A	Regenerating islet-derived protein 3-alpha	GO:0030246; F:carbohydrate binding; TAS:ProtInc
Q06141	REG3A	Regenerating islet-derived protein 3-alpha	GO:0006953; P:acute-phase response; IEA:UniProtKB-KW
Q06141	REG3A	Regenerating islet-derived protein 3-alpha	GO:0008283; P:cell proliferation; TAS:ProtInc
Q06141	REG3A	Regenerating islet-derived protein 3-alpha	GO:0007157; P:heterophilic cell-cell adhesion; TAS:ProtInc
Q06141	REG3A	Regenerating islet-derived protein 3-alpha	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q06141	REG3A	Regenerating islet-derived protein 3-alpha	GO:0045617; P:negative regulation of keratinocyte differentiation; ISS:UniProtKB
Q06141	REG3A	Regenerating islet-derived protein 3-alpha	GO:0010838; P:positive regulation of keratinocyte proliferation; ISS:UniProtKB
Q06141	REG3A	Regenerating islet-derived protein 3-alpha	GO:0090303; P:positive regulation of wound healing; ISS:UniProtKB
Q6UW15	REG3G	Regenerating islet-derived protein 3-gamma	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q6UW15	REG3G	Regenerating islet-derived protein 3-gamma	GO:0006953; P:acute-phase response; IEA:UniProtKB-KW
Q6UW15	REG3G	Regenerating islet-derived protein 3-gamma	GO:0050830; P:defense response to Gram-positive bacterium; ISS:UniProtKB
Q6UW15	REG3G	Regenerating islet-derived protein 3-gamma	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; ISS:UniProtKB
Q6UW15	REG3G	Regenerating islet-derived protein 3-gamma	GO:0045617; P:negative regulation of keratinocyte differentiation; ISS:UniProtKB
Q6UW15	REG3G	Regenerating islet-derived protein 3-gamma	GO:0010838; P:positive regulation of keratinocyte proliferation; ISS:UniProtKB
Q6UW15	REG3G	Regenerating islet-derived protein 3-gamma	GO:0090303; P:positive regulation of wound healing; ISS:UniProtKB
Q9BYZ8	REG4	Regenerating islet-derived protein 4	GO:0008201; F:heparin binding; IDA:UniProt
Q9BYZ8	REG4	Regenerating islet-derived protein 4	GO:2001065; F:mannan binding; IDA:UniProt
P04808	RLN1	Prorelaxin H1	GO:0005179; F:hormone activity; TAS:ProtInc
P04808	RLN1	Prorelaxin H1	GO:0007565; P:female pregnancy; NAS:ProtInc
P04808	RLN1	Prorelaxin H1	GO:0007165; P:signal transduction; NAS:ProtInc
P04090	RLN2	Prorelaxin H2	GO:0007565; P:female pregnancy; TAS:ProtInc
Q01201	RELB	Transcription factor RelB	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q01201	RELB	Transcription factor RelB	GO:0005515; F:protein binding; IPI:IntAct
Q01201	RELB	Transcription factor RelB	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q01201	RELB	Transcription factor RelB	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q01201	RELB	Transcription factor RelB	GO:0019882; P:antigen processing and presentation; IEA:Ensembl
Q01201	RELB	Transcription factor RelB	GO:0043011; P:myeloid dendritic cell differentiation; IEA:Ensembl
Q01201	RELB	Transcription factor RelB	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
Q01201	RELB	Transcription factor RelB	GO:0045063; P:T-helper 1 cell differentiation; IEA:Ensembl
Q01201	RELB	Transcription factor RelB	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NC24	RELL2	RELT-like protein 2	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
P78509	RELN	Reelin	GO:0070325; F:lipoprotein particle receptor binding; ISS:BHF-UCL
P78509	RELN	Reelin	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P78509	RELN	Reelin	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; ISS:UniProtKB
P78509	RELN	Reelin	GO:0008236; F:serine-type peptidase activity; IEA:UniProtKB-KW
P78509	RELN	Reelin	GO:0070326; F:very-low-density lipoprotein particle receptor binding; ISS:BHF-UCL
P78509	RELN	Reelin	GO:0008306; P:associative learning; IEA:Ensembl
P78509	RELN	Reelin	GO:0007411; P:axon guidance; ISS:UniProtKB
P78509	RELN	Reelin	GO:0007420; P:brain development; ISS:UniProtKB
P78509	RELN	Reelin	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P78509	RELN	Reelin	GO:0000904; P:cell morphogenesis involved in differentiation; ISS:UniProtKB
P78509	RELN	Reelin	GO:0007417; P:central nervous system development; ISS:UniProtKB
P78509	RELN	Reelin	GO:0021800; P:cerebral cortex tangential migration; ISS:UniProtKB
P78509	RELN	Reelin	GO:0016358; P:dendrite development; IEA:Ensembl
P78509	RELN	Reelin	GO:0010001; P:glial cell differentiation; ISS:UniProtKB
P78509	RELN	Reelin	GO:0021766; P:hippocampus development; ISS:BHF-UCL
P78509	RELN	Reelin	GO:0097477; P:lateral motor column neuron migration; IEA:Ensembl
P78509	RELN	Reelin	GO:0007616; P:long-term memory; IEA:Ensembl
P78509	RELN	Reelin	GO:0097114; P:N-methyl-D-aspartate receptor clustering; IEA:Ensembl
P78509	RELN	Reelin	GO:0001764; P:neuron migration; ISS:UniProtKB
P78509	RELN	Reelin	GO:0018108; P:peptidyl-tyrosine phosphorylation; ISS:UniProtKB
P78509	RELN	Reelin	GO:2000969; P:positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; ISS:BHF-UCL
P78509	RELN	Reelin	GO:0032793; P:positive regulation of CREB transcription factor activity; ISS:BHF-UCL
P78509	RELN	Reelin	GO:0061003; P:positive regulation of dendritic spine morphogenesis; ISS:BHF-UCL
P78509	RELN	Reelin	GO:2000463; P:positive regulation of excitatory postsynaptic membrane potential; ISS:BHF-UCL
P78509	RELN	Reelin	GO:1902078; P:positive regulation of lateral motor column neuron migration; IEA:Ensembl
P78509	RELN	Reelin	GO:1900273; P:positive regulation of long-term synaptic potentiation; ISS:BHF-UCL
P78509	RELN	Reelin	GO:0010976; P:positive regulation of neuron projection development; ISS:BHF-UCL
P78509	RELN	Reelin	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISS:BHF-UCL
P78509	RELN	Reelin	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl
P78509	RELN	Reelin	GO:0045860; P:positive regulation of protein kinase activity; ISS:UniProtKB
P78509	RELN	Reelin	GO:0061098; P:positive regulation of protein tyrosine kinase activity; ISS:BHF-UCL
P78509	RELN	Reelin	GO:0051057; P:positive regulation of small GTPase mediated signal transduction; ISS:UniProtKB
P78509	RELN	Reelin	GO:0090129; P:positive regulation of synapse maturation; ISS:BHF-UCL
P78509	RELN	Reelin	GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; ISS:BHF-UCL
P78509	RELN	Reelin	GO:0032008; P:positive regulation of TOR signaling; IEA:Ensembl
P78509	RELN	Reelin	GO:0097119; P:postsynaptic density protein 95 clustering; IEA:Ensembl
P78509	RELN	Reelin	GO:0097120; P:receptor localization to synapse; IEA:Ensembl
P78509	RELN	Reelin	GO:0038026; P:reelin-mediated signaling pathway; ISS:BHF-UCL
P78509	RELN	Reelin	GO:0050795; P:regulation of behavior; ISS:BHF-UCL
P78509	RELN	Reelin	GO:2000310; P:regulation of N-methyl-D-aspartate selective glutamate receptor activity; ISS:BHF-UCL
P78509	RELN	Reelin	GO:0050804; P:regulation of synaptic transmission; ISS:BHF-UCL
P78509	RELN	Reelin	GO:0048265; P:response to pain; ISS:UniProtKB
P78509	RELN	Reelin	GO:0021511; P:spinal cord patterning; ISS:UniProtKB
P78509	RELN	Reelin	GO:0021517; P:ventral spinal cord development; IEA:Ensembl
Q04864	REL	Proto-oncogene c-Rel	GO:0005515; F:protein binding; IPI:IntAct
Q04864	REL	Proto-oncogene c-Rel	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q04864	REL	Proto-oncogene c-Rel	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
Q04864	REL	Proto-oncogene c-Rel	GO:0001816; P:cytokine production; IEA:Ensembl
Q04864	REL	Proto-oncogene c-Rel	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
Q04864	REL	Proto-oncogene c-Rel	GO:1901215; P:negative regulation of neuron death; IEA:Ensembl
Q04864	REL	Proto-oncogene c-Rel	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
Q04864	REL	Proto-oncogene c-Rel	GO:0045084; P:positive regulation of interleukin-12 biosynthetic process; IEA:Ensembl
Q04864	REL	Proto-oncogene c-Rel	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q04864	REL	Proto-oncogene c-Rel	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75628	REM1	GTP-binding protein REM 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
O75628	REM1	GTP-binding protein REM 1	GO:0006184; P:GTP catabolic process; IEA:InterPro
O75628	REM1	GTP-binding protein REM 1	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q8IYK8	REM2	GTP-binding protein REM 2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q8IYK8	REM2	GTP-binding protein REM 2	GO:0003924; F:GTPase activity; IEA:Ensembl
Q8IYK8	REM2	GTP-binding protein REM 2	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9H1J1	UPF3A	Regulator of nonsense transcripts 3A	GO:0005487; F:nucleocytoplasmic transporter activity; NAS:UniProtKB
Q9H1J1	UPF3A	Regulator of nonsense transcripts 3A	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9H1J1	UPF3A	Regulator of nonsense transcripts 3A	GO:0005515; F:protein binding; IPI:IntAct
Q9H1J1	UPF3A	Regulator of nonsense transcripts 3A	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9H1J1	UPF3A	Regulator of nonsense transcripts 3A	GO:0010467; P:gene expression; TAS:Reactome
Q9H1J1	UPF3A	Regulator of nonsense transcripts 3A	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9H1J1	UPF3A	Regulator of nonsense transcripts 3A	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q9H1J1	UPF3A	Regulator of nonsense transcripts 3A	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; NAS:UniProtKB
Q9H1J1	UPF3A	Regulator of nonsense transcripts 3A	GO:0006913; P:nucleocytoplasmic transport; NAS:GOC
Q9H1J1	UPF3A	Regulator of nonsense transcripts 3A	GO:0045727; P:positive regulation of translation; IDA:UniProtKB
Q9H1J1	UPF3A	Regulator of nonsense transcripts 3A	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9BZI7	UPF3B	Regulator of nonsense transcripts 3B	GO:0003729; F:mRNA binding; IDA:UniProtKB
Q9BZI7	UPF3B	Regulator of nonsense transcripts 3B	GO:0005487; F:nucleocytoplasmic transporter activity; NAS:UniProtKB
Q9BZI7	UPF3B	Regulator of nonsense transcripts 3B	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9BZI7	UPF3B	Regulator of nonsense transcripts 3B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BZI7	UPF3B	Regulator of nonsense transcripts 3B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BZI7	UPF3B	Regulator of nonsense transcripts 3B	GO:0010467; P:gene expression; TAS:Reactome
Q9BZI7	UPF3B	Regulator of nonsense transcripts 3B	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q9BZI7	UPF3B	Regulator of nonsense transcripts 3B	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
Q9BZI7	UPF3B	Regulator of nonsense transcripts 3B	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9BZI7	UPF3B	Regulator of nonsense transcripts 3B	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q9BZI7	UPF3B	Regulator of nonsense transcripts 3B	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IDA:UniProtKB
Q9BZI7	UPF3B	Regulator of nonsense transcripts 3B	GO:0045727; P:positive regulation of translation; IDA:UniProtKB
Q9BZI7	UPF3B	Regulator of nonsense transcripts 3B	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9BZI7	UPF3B	Regulator of nonsense transcripts 3B	GO:0008380; P:RNA splicing; TAS:Reactome
Q9BZI7	UPF3B	Regulator of nonsense transcripts 3B	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q9BZI7	UPF3B	Regulator of nonsense transcripts 3B	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
P51606	RENBP	N-acylglucosamine 2-epimerase	GO:0005524; F:ATP binding; IEA:Ensembl
P51606	RENBP	N-acylglucosamine 2-epimerase	GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc
P51606	RENBP	N-acylglucosamine 2-epimerase	GO:0050121; F:N-acylglucosamine 2-epimerase activity; ISS:UniProtKB
P51606	RENBP	N-acylglucosamine 2-epimerase	GO:0006044; P:N-acetylglucosamine metabolic process; IEA:Ensembl
P51606	RENBP	N-acylglucosamine 2-epimerase	GO:0006051; P:N-acetylmannosamine metabolic process; IEA:Ensembl
P51606	RENBP	N-acylglucosamine 2-epimerase	GO:0019262; P:N-acetylneuraminate catabolic process; TAS:UniProtKB
P51606	RENBP	N-acylglucosamine 2-epimerase	GO:0008217; P:regulation of blood pressure; TAS:ProtInc
P00797	REN	Renin	GO:0004190; F:aspartic-type endopeptidase activity; IDA:HGNC
P00797	REN	Renin	GO:0008233; F:peptidase activity; IDA:HGNC
P00797	REN	Renin	GO:0005102; F:receptor binding; IPI:HGNC
P00797	REN	Renin	GO:0002003; P:angiotensin maturation; IDA:HGNC
P00797	REN	Renin	GO:0050435; P:beta-amyloid metabolic process; IEA:Ensembl
P00797	REN	Renin	GO:0048469; P:cell maturation; IEA:Ensembl
P00797	REN	Renin	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P00797	REN	Renin	GO:0035690; P:cellular response to drug; IEA:Ensembl
P00797	REN	Renin	GO:0042756; P:drinking behavior; IEA:Ensembl
P00797	REN	Renin	GO:0009755; P:hormone-mediated signaling pathway; IEA:Ensembl
P00797	REN	Renin	GO:0001822; P:kidney development; IMP:BHF-UCL
P00797	REN	Renin	GO:0008584; P:male gonad development; IEA:Ensembl
P00797	REN	Renin	GO:0001823; P:mesonephros development; IEA:Ensembl
P00797	REN	Renin	GO:0006508; P:proteolysis; IDA:HGNC
P00797	REN	Renin	GO:0008217; P:regulation of blood pressure; TAS:ProtInc
P00797	REN	Renin	GO:0043408; P:regulation of MAPK cascade; IDA:HGNC
P00797	REN	Renin	GO:0002018; P:renin-angiotensin regulation of aldosterone production; IEA:Ensembl
P00797	REN	Renin	GO:0051591; P:response to cAMP; IEA:Ensembl
P00797	REN	Renin	GO:0070305; P:response to cGMP; IEA:Ensembl
P00797	REN	Renin	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
O75787	ATP6AP2	Renin receptor	GO:0004190; F:aspartic-type endopeptidase activity; EXP:Reactome
O75787	ATP6AP2	Renin receptor	GO:0005515; F:protein binding; IPI:HGNC
O75787	ATP6AP2	Renin receptor	GO:0004872; F:receptor activity; IEA:InterPro
O75787	ATP6AP2	Renin receptor	GO:0002003; P:angiotensin maturation; IDA:HGNC
O75787	ATP6AP2	Renin receptor	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O75787	ATP6AP2	Renin receptor	GO:0032914; P:positive regulation of transforming growth factor beta1 production; IDA:HGNC
O75787	ATP6AP2	Renin receptor	GO:0006508; P:proteolysis; EXP:GOC
O75787	ATP6AP2	Renin receptor	GO:0043408; P:regulation of MAPK cascade; IDA:HGNC
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0004004; F:ATP-dependent RNA helicase activity; IDA:UniProtKB
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0003682; F:chromatin binding; IDA:HGNC
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0003677; F:DNA binding; IEA:InterPro
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0004386; F:helicase activity; NAS:UniProtKB
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0005515; F:protein binding; IPI:IntAct
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0003723; F:RNA binding; NAS:UniProtKB
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0006200; P:ATP catabolic process; IDA:GOC
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0006281; P:DNA repair; IDA:HGNC
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0006260; P:DNA replication; IMP:HGNC
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0009048; P:dosage compensation by inactivation of X chromosome; IEA:Ensembl
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0010467; P:gene expression; TAS:Reactome
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0071044; P:histone mRNA catabolic process; IMP:UniProtKB
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0006406; P:mRNA export from nucleus; TAS:HGNC
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0000956; P:nuclear-transcribed mRNA catabolic process; IMP:UniProt
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IDA:UniProtKB
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0006449; P:regulation of translational termination; IMP:UniProtKB
Q92900	UPF1	Regulator of nonsense transcripts 1	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9HAU5	UPF2	Regulator of nonsense transcripts 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HAU5	UPF2	Regulator of nonsense transcripts 2	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9HAU5	UPF2	Regulator of nonsense transcripts 2	GO:0010467; P:gene expression; TAS:Reactome
Q9HAU5	UPF2	Regulator of nonsense transcripts 2	GO:0001889; P:liver development; IEA:Ensembl
Q9HAU5	UPF2	Regulator of nonsense transcripts 2	GO:0006406; P:mRNA export from nucleus; TAS:HGNC
Q9HAU5	UPF2	Regulator of nonsense transcripts 2	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9HAU5	UPF2	Regulator of nonsense transcripts 2	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IMP:UniProtKB
Q9HAU5	UPF2	Regulator of nonsense transcripts 2	GO:0031100; P:organ regeneration; IEA:Ensembl
Q9HAU5	UPF2	Regulator of nonsense transcripts 2	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q6BDI9	REP15	Rab15 effector protein	GO:0005515; F:protein binding; IPI:UniProt
Q6BDI9	REP15	Rab15 effector protein	GO:0001881; P:receptor recycling; IMP:UniProt
Q6BDI9	REP15	Rab15 effector protein	GO:0033572; P:transferrin transport; IDA:UniProt
Q9BWE0	REPIN1	Replication initiator 1	GO:0003677; F:DNA binding; TAS:ProtInc
Q9BWE0	REPIN1	Replication initiator 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BWE0	REPIN1	Replication initiator 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BWE0	REPIN1	Replication initiator 1	GO:0006260; P:DNA replication; TAS:ProtInc
Q96D71	REPS1	RalBP1-associated Eps domain-containing protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96D71	REPS1	RalBP1-associated Eps domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96D71	REPS1	RalBP1-associated Eps domain-containing protein 1	GO:0017124; F:SH3 domain binding; IPI:UniProtKB
Q8NFH8	REPS2	RalBP1-associated Eps domain-containing protein 2	GO:0005509; F:calcium ion binding; TAS:ProtInc
Q8NFH8	REPS2	RalBP1-associated Eps domain-containing protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q8NFH8	REPS2	RalBP1-associated Eps domain-containing protein 2	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:ProtInc
Q8NFH8	REPS2	RalBP1-associated Eps domain-containing protein 2	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q92785	DPF2	Zinc finger protein ubi-d4	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:UniProt
Q92785	DPF2	Zinc finger protein ubi-d4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q92785	DPF2	Zinc finger protein ubi-d4	GO:0006915; P:apoptotic process; TAS:ProtInc
Q92785	DPF2	Zinc finger protein ubi-d4	GO:0097190; P:apoptotic signaling pathway; TAS:ProtInc
Q92785	DPF2	Zinc finger protein ubi-d4	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q92785	DPF2	Zinc finger protein ubi-d4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15258	RER1	Protein RER1	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; IDA:UniProtKB
Q9P2R6	RERE	Arginine-glutamic acid dipeptide repeats protein	GO:0003682; F:chromatin binding; IEA:InterPro
Q9P2R6	RERE	Arginine-glutamic acid dipeptide repeats protein	GO:0008267; F:poly-glutamine tract binding; TAS:ProtInc
Q9P2R6	RERE	Arginine-glutamic acid dipeptide repeats protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P2R6	RERE	Arginine-glutamic acid dipeptide repeats protein	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9P2R6	RERE	Arginine-glutamic acid dipeptide repeats protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9P2R6	RERE	Arginine-glutamic acid dipeptide repeats protein	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9P2R6	RERE	Arginine-glutamic acid dipeptide repeats protein	GO:0006338; P:chromatin remodeling; IEA:Ensembl
Q9P2R6	RERE	Arginine-glutamic acid dipeptide repeats protein	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9P2R6	RERE	Arginine-glutamic acid dipeptide repeats protein	GO:0006607; P:NLS-bearing protein import into nucleus; TAS:ProtInc
Q9P2R6	RERE	Arginine-glutamic acid dipeptide repeats protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H628	RERGL	Ras-related and estrogen-regulated growth inhibitor-like protein	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9H628	RERGL	Ras-related and estrogen-regulated growth inhibitor-like protein	GO:0006184; P:GTP catabolic process; IEA:InterPro
Q9H628	RERGL	Ras-related and estrogen-regulated growth inhibitor-like protein	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q96A58	RERG	Ras-related and estrogen-regulated growth inhibitor	GO:0030331; F:estrogen receptor binding; NAS:UniProtKB
Q96A58	RERG	Ras-related and estrogen-regulated growth inhibitor	GO:0019003; F:GDP binding; TAS:UniProtKB
Q96A58	RERG	Ras-related and estrogen-regulated growth inhibitor	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q96A58	RERG	Ras-related and estrogen-regulated growth inhibitor	GO:0003924; F:GTPase activity; IDA:UniProtKB
Q96A58	RERG	Ras-related and estrogen-regulated growth inhibitor	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q96A58	RERG	Ras-related and estrogen-regulated growth inhibitor	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q96A58	RERG	Ras-related and estrogen-regulated growth inhibitor	GO:0009725; P:response to hormone; IDA:UniProtKB
Q96A58	RERG	Ras-related and estrogen-regulated growth inhibitor	GO:0007264; P:small GTPase mediated signal transduction; NAS:UniProtKB
Q5W5W9	RESP18	Regulated endocrine-specific protein 18	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q13127	REST	RE1-silencing transcription factor	GO:0003682; F:chromatin binding; ISS:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0001047; F:core promoter binding; IDA:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0001046; F:core promoter sequence-specific DNA binding; IDA:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13127	REST	RE1-silencing transcription factor	GO:0015271; F:outward rectifier potassium channel activity; IMP:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0005515; F:protein binding; IPI:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IDA:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0060379; P:cardiac muscle cell myoblast differentiation; ISS:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0035690; P:cellular response to drug; IMP:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0071257; P:cellular response to electrical stimulus; IMP:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0071385; P:cellular response to glucocorticoid stimulus; IDA:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0070933; P:histone H4 deacetylation; IDA:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0043922; P:negative regulation by host of viral transcription; IDA:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0032348; P:negative regulation of aldosterone biosynthetic process; IMP:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:2000798; P:negative regulation of amniotic stem cell differentiation; IMP:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0045955; P:negative regulation of calcium ion-dependent exocytosis; ISS:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:2000065; P:negative regulation of cortisol biosynthetic process; IMP:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:2000706; P:negative regulation of dense core granule biogenesis; ISS:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0046676; P:negative regulation of insulin secretion; IMP:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:2000740; P:negative regulation of mesenchymal stem cell differentiation; IMP:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0050768; P:negative regulation of neurogenesis; ISS:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0045665; P:negative regulation of neuron differentiation; IMP:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q13127	REST	RE1-silencing transcription factor	GO:0071805; P:potassium ion transmembrane transport; IMP:GOC
Q13127	REST	RE1-silencing transcription factor	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q6H3X3	RAET1G	Retinoic acid early transcript 1G protein	GO:0003823; F:antigen binding; IBA:RefGenome
Q6H3X3	RAET1G	Retinoic acid early transcript 1G protein	GO:0046703; F:natural killer cell lectin-like receptor binding; IPI:UniProtKB
Q6H3X3	RAET1G	Retinoic acid early transcript 1G protein	GO:0019882; P:antigen processing and presentation; IBA:RefGenome
Q6H3X3	RAET1G	Retinoic acid early transcript 1G protein	GO:0042267; P:natural killer cell mediated cytotoxicity; IDA:UniProtKB
P09455	RBP1	Retinol-binding protein 1	GO:0016918; F:retinal binding; IEA:UniProtKB-KW
P09455	RBP1	Retinol-binding protein 1	GO:0005501; F:retinoid binding; TAS:ProtInc
P09455	RBP1	Retinol-binding protein 1	GO:0019841; F:retinol binding; IEA:UniProtKB-KW
P09455	RBP1	Retinol-binding protein 1	GO:0005215; F:transporter activity; IEA:InterPro
P09455	RBP1	Retinol-binding protein 1	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P09455	RBP1	Retinol-binding protein 1	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P09455	RBP1	Retinol-binding protein 1	GO:0006776; P:vitamin A metabolic process; TAS:ProtInc
Q5VY80	RAET1L	Retinoic acid early transcript 1L protein	GO:0003823; F:antigen binding; IBA:RefGenome
Q5VY80	RAET1L	Retinoic acid early transcript 1L protein	GO:0046703; F:natural killer cell lectin-like receptor binding; IBA:RefGenome
Q5VY80	RAET1L	Retinoic acid early transcript 1L protein	GO:0019882; P:antigen processing and presentation; IBA:RefGenome
Q5VY80	RAET1L	Retinoic acid early transcript 1L protein	GO:0042267; P:natural killer cell mediated cytotoxicity; IBA:RefGenome
P50120	RBP2	Retinol-binding protein 2	GO:0016918; F:retinal binding; IEA:UniProtKB-KW
P50120	RBP2	Retinol-binding protein 2	GO:0005501; F:retinoid binding; TAS:ProtInc
P50120	RBP2	Retinol-binding protein 2	GO:0019841; F:retinol binding; IEA:UniProtKB-KW
P50120	RBP2	Retinol-binding protein 2	GO:0005215; F:transporter activity; IEA:InterPro
P50120	RBP2	Retinol-binding protein 2	GO:0008544; P:epidermis development; TAS:ProtInc
P50120	RBP2	Retinol-binding protein 2	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P50120	RBP2	Retinol-binding protein 2	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P50120	RBP2	Retinol-binding protein 2	GO:0006776; P:vitamin A metabolic process; TAS:ProtInc
P10745	RBP3	Retinol-binding protein 3	GO:0016918; F:retinal binding; IEA:UniProtKB-KW
P10745	RBP3	Retinol-binding protein 3	GO:0005501; F:retinoid binding; TAS:ProtInc
P10745	RBP3	Retinol-binding protein 3	GO:0019841; F:retinol binding; IEA:Ensembl
P10745	RBP3	Retinol-binding protein 3	GO:0008236; F:serine-type peptidase activity; IEA:InterPro
P10745	RBP3	Retinol-binding protein 3	GO:0006629; P:lipid metabolic process; TAS:ProtInc
P10745	RBP3	Retinol-binding protein 3	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P10745	RBP3	Retinol-binding protein 3	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P10745	RBP3	Retinol-binding protein 3	GO:0006810; P:transport; IEA:UniProtKB-KW
P10745	RBP3	Retinol-binding protein 3	GO:0007601; P:visual perception; TAS:ProtInc
P02753	RBP4	Retinol-binding protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
P02753	RBP4	Retinol-binding protein 4	GO:0016918; F:retinal binding; IEA:UniProtKB-KW
P02753	RBP4	Retinol-binding protein 4	GO:0019841; F:retinol binding; IDA:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0034632; F:retinol transporter activity; IC:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0048738; P:cardiac muscle tissue development; ISS:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0050908; P:detection of light stimulus involved in visual perception; IEA:Ensembl
P02753	RBP4	Retinol-binding protein 4	GO:0048562; P:embryonic organ morphogenesis; ISS:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0060059; P:embryonic retina morphogenesis in camera-type eye; ISS:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0048706; P:embryonic skeletal system development; ISS:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0001654; P:eye development; IMP:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0048807; P:female genitalia morphogenesis; ISS:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0006094; P:gluconeogenesis; IMP:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0042593; P:glucose homeostasis; IDA:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0007507; P:heart development; ISS:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0060347; P:heart trabecula formation; ISS:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0030324; P:lung development; ISS:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0030277; P:maintenance of gastrointestinal epithelium; IDA:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0008584; P:male gonad development; IEA:Ensembl
P02753	RBP4	Retinol-binding protein 4	GO:0060044; P:negative regulation of cardiac muscle cell proliferation; ISS:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P02753	RBP4	Retinol-binding protein 4	GO:0051024; P:positive regulation of immunoglobulin secretion; ISS:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0032024; P:positive regulation of insulin secretion; IMP:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0045471; P:response to ethanol; IEA:Ensembl
P02753	RBP4	Retinol-binding protein 4	GO:0032868; P:response to insulin; IEA:Ensembl
P02753	RBP4	Retinol-binding protein 4	GO:0032526; P:response to retinoic acid; IDA:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0042574; P:retinal metabolic process; IEA:Ensembl
P02753	RBP4	Retinol-binding protein 4	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P02753	RBP4	Retinol-binding protein 4	GO:0042572; P:retinol metabolic process; IMP:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0034633; P:retinol transport; IC:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0007283; P:spermatogenesis; IEA:Ensembl
P02753	RBP4	Retinol-binding protein 4	GO:0060157; P:urinary bladder development; ISS:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0060065; P:uterus development; ISS:BHF-UCL
P02753	RBP4	Retinol-binding protein 4	GO:0060068; P:vagina development; ISS:BHF-UCL
P82980	RBP5	Retinol-binding protein 5	GO:0016918; F:retinal binding; IEA:UniProtKB-KW
P82980	RBP5	Retinol-binding protein 5	GO:0005501; F:retinoid binding; TAS:UniProtKB
P82980	RBP5	Retinol-binding protein 5	GO:0019841; F:retinol binding; IEA:UniProtKB-KW
P82980	RBP5	Retinol-binding protein 5	GO:0005215; F:transporter activity; IEA:InterPro
Q9BQ08	RETNLB	Resistin-like beta	GO:0008283; P:cell proliferation; NAS:UniProtKB
Q9HD89	RETN	Resistin	GO:0007568; P:aging; IEA:Ensembl
Q9HD89	RETN	Resistin	GO:0045444; P:fat cell differentiation; IEA:Ensembl
Q9HD89	RETN	Resistin	GO:2000252; P:negative regulation of feeding behavior; IEA:Ensembl
Q9HD89	RETN	Resistin	GO:0010714; P:positive regulation of collagen metabolic process; IEA:Ensembl
Q9HD89	RETN	Resistin	GO:2000872; P:positive regulation of progesterone secretion; IEA:Ensembl
Q9HD89	RETN	Resistin	GO:0014911; P:positive regulation of smooth muscle cell migration; IEA:Ensembl
Q9HD89	RETN	Resistin	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
Q9HD89	RETN	Resistin	GO:0050806; P:positive regulation of synaptic transmission; IEA:Ensembl
Q9HD89	RETN	Resistin	GO:0032868; P:response to insulin; IEA:Ensembl
Q9HD89	RETN	Resistin	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
Q96R05	RBP7	Retinoid-binding protein 7	GO:0016918; F:retinal binding; IEA:UniProtKB-KW
Q96R05	RBP7	Retinoid-binding protein 7	GO:0019841; F:retinol binding; IEA:UniProtKB-KW
Q96R05	RBP7	Retinoid-binding protein 7	GO:0005215; F:transporter activity; IEA:InterPro
Q6NUM9	RETSAT	All-trans-retinol 13,14-reductase	GO:0051786; F:all-trans-retinol 13,14-reductase activity; ISS:HGNC
Q6NUM9	RETSAT	All-trans-retinol 13,14-reductase	GO:0016491; F:oxidoreductase activity; ISS:HGNC
Q6NUM9	RETSAT	All-trans-retinol 13,14-reductase	GO:0055114; P:oxidation-reduction process; ISS:HGNC
Q6NUM9	RETSAT	All-trans-retinol 13,14-reductase	GO:0042572; P:retinol metabolic process; ISS:HGNC
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0005509; F:calcium ion binding; IDA:FlyBase
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0005515; F:protein binding; IPI:UniProtKB
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0004713; F:protein tyrosine kinase activity; TAS:ProtInc
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0004872; F:receptor activity; TAS:ProtInc
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IEA:UniProtKB-EC
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0071300; P:cellular response to retinoic acid; IMP:BHF-UCL
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0001838; P:embryonic epithelial tube formation; IEA:Ensembl
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0048484; P:enteric nervous system development; IEA:Ensembl
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0007156; P:homophilic cell adhesion; IEA:InterPro
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0060384; P:innervation; IEA:Ensembl
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0097021; P:lymphocyte migration into lymphoid organs; ISS:UniProtKB
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0000165; P:MAPK cascade; IEA:Ensembl
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0033619; P:membrane protein proteolysis; IDA:UniProtKB
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0001755; P:neural crest cell migration; IEA:Ensembl
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0007158; P:neuron cell-cell adhesion; IMP:UniProtKB
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0042551; P:neuron maturation; IEA:Ensembl
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:GOC
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0061146; P:Peyer's patch morphogenesis; ISS:UniProtKB
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0033630; P:positive regulation of cell adhesion mediated by integrin; IDA:UniProtKB
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0045793; P:positive regulation of cell size; IEA:Ensembl
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IMP:UniProtKB
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0072300; P:positive regulation of metanephric glomerulus development; ISS:UniProtKB
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0014042; P:positive regulation of neuron maturation; IEA:Ensembl
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0010976; P:positive regulation of neuron projection development; IMP:BHF-UCL
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0007497; P:posterior midgut development; TAS:ProtInc
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0050770; P:regulation of axonogenesis; IEA:Ensembl
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0030155; P:regulation of cell adhesion; IDA:UniProtKB
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0042493; P:response to drug; IEA:Ensembl
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0048265; P:response to pain; ISS:UniProtKB
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0007165; P:signal transduction; TAS:ProtInc
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:Ensembl
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0035799; P:ureter maturation; IEA:Ensembl
P07949	RET	Proto-oncogene tyrosine-protein kinase receptor Ret	GO:0001657; P:ureteric bud development; IEA:Ensembl
Q9UBZ9	REV1	DNA repair protein REV1	GO:0003684; F:damaged DNA binding; TAS:ProtInc
Q9UBZ9	REV1	DNA repair protein REV1	GO:0017125; F:deoxycytidyl transferase activity; IEA:Ensembl
Q9UBZ9	REV1	DNA repair protein REV1	GO:0003887; F:DNA-directed DNA polymerase activity; TAS:Reactome
Q9UBZ9	REV1	DNA repair protein REV1	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q9UBZ9	REV1	DNA repair protein REV1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBZ9	REV1	DNA repair protein REV1	GO:0006281; P:DNA repair; TAS:Reactome
Q9UBZ9	REV1	DNA repair protein REV1	GO:0006260; P:DNA replication; TAS:ProtInc
Q9UBZ9	REV1	DNA repair protein REV1	GO:0006261; P:DNA-dependent DNA replication; TAS:GOC
Q9UBZ9	REV1	DNA repair protein REV1	GO:0042276; P:error-prone translesion synthesis; TAS:UniProtKB
Q9UBZ9	REV1	DNA repair protein REV1	GO:0009411; P:response to UV; IDA:UniProtKB
Q8N1G1	REXO1	RNA exonuclease 1 homolog	GO:0004527; F:exonuclease activity; IEA:UniProtKB-KW
Q8N1G1	REXO1	RNA exonuclease 1 homolog	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9GZR2	REXO4	RNA exonuclease 4	GO:0004527; F:exonuclease activity; IEA:UniProtKB-KW
Q9GZR2	REXO4	RNA exonuclease 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9GZR2	REXO4	RNA exonuclease 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9GZR2	REXO4	RNA exonuclease 4	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q96IC2	ORFNames=44M2.3	Putative RNA exonuclease NEF-sp	GO:0004527; F:exonuclease activity; IEA:UniProtKB-KW
Q96IC2	ORFNames=44M2.3	Putative RNA exonuclease NEF-sp	GO:0000166; F:nucleotide binding; IEA:InterPro
Q96IC2	ORFNames=44M2.3	Putative RNA exonuclease NEF-sp	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9UGC7	MTRF1L	Peptide chain release factor 1-like, mitochondrial	GO:0016149; F:translation release factor activity, codon specific; IEA:InterPro
O75570	MTRF1	Peptide chain release factor 1, mitochondrial	GO:0003747; F:translation release factor activity; TAS:ProtInc
O75570	MTRF1	Peptide chain release factor 1, mitochondrial	GO:0016149; F:translation release factor activity, codon specific; IEA:InterPro
O75570	MTRF1	Peptide chain release factor 1, mitochondrial	GO:0006449; P:regulation of translational termination; TAS:ProtInc
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0003682; F:chromatin binding; IEA:Ensembl
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0005515; F:protein binding; IPI:UniProtKB
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0003697; F:single-stranded DNA binding; TAS:ProtInc
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0000730; P:DNA recombinase assembly; TAS:Reactome
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0006310; P:DNA recombination; TAS:ProtInc
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0006281; P:DNA repair; TAS:Reactome
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0006260; P:DNA replication; TAS:Reactome
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0006261; P:DNA-dependent DNA replication; TAS:ProtInc
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0006302; P:double-strand break repair; TAS:Reactome
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0000724; P:double-strand break repair via homologous recombination; TAS:Reactome
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0030097; P:hemopoiesis; IEA:Ensembl
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0007126; P:meiotic nuclear division; IEA:Ensembl
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0000718; P:nucleotide-excision repair, DNA damage removal; TAS:Reactome
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0000723; P:telomere maintenance; TAS:Reactome
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
P27694	RPA1	Replication protein A 70 kDa DNA-binding subunit	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P15927	RPA2	Replication protein A 32 kDa subunit	GO:0005515; F:protein binding; IPI:UniProtKB
P15927	RPA2	Replication protein A 32 kDa subunit	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
P15927	RPA2	Replication protein A 32 kDa subunit	GO:0003697; F:single-stranded DNA binding; IEA:Ensembl
P15927	RPA2	Replication protein A 32 kDa subunit	GO:0000730; P:DNA recombinase assembly; TAS:Reactome
P15927	RPA2	Replication protein A 32 kDa subunit	GO:0006281; P:DNA repair; TAS:Reactome
P15927	RPA2	Replication protein A 32 kDa subunit	GO:0006260; P:DNA replication; IDA:UniProtKB
P15927	RPA2	Replication protein A 32 kDa subunit	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P15927	RPA2	Replication protein A 32 kDa subunit	GO:0006302; P:double-strand break repair; TAS:Reactome
P15927	RPA2	Replication protein A 32 kDa subunit	GO:0000724; P:double-strand break repair via homologous recombination; TAS:Reactome
P15927	RPA2	Replication protein A 32 kDa subunit	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P15927	RPA2	Replication protein A 32 kDa subunit	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P15927	RPA2	Replication protein A 32 kDa subunit	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P15927	RPA2	Replication protein A 32 kDa subunit	GO:0000718; P:nucleotide-excision repair, DNA damage removal; TAS:Reactome
P15927	RPA2	Replication protein A 32 kDa subunit	GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome
P15927	RPA2	Replication protein A 32 kDa subunit	GO:0010569; P:regulation of double-strand break repair via homologous recombination; IMP:UniProtKB
P15927	RPA2	Replication protein A 32 kDa subunit	GO:0000723; P:telomere maintenance; TAS:Reactome
P15927	RPA2	Replication protein A 32 kDa subunit	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
P15927	RPA2	Replication protein A 32 kDa subunit	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
P15927	RPA2	Replication protein A 32 kDa subunit	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
Q13156	RPA4	Replication protein A 30 kDa subunit	GO:0003697; F:single-stranded DNA binding; TAS:ProtInc
Q13156	RPA4	Replication protein A 30 kDa subunit	GO:0000077; P:DNA damage checkpoint; IDA:UniProtKB
Q13156	RPA4	Replication protein A 30 kDa subunit	GO:0006270; P:DNA replication initiation; TAS:ProtInc
Q13156	RPA4	Replication protein A 30 kDa subunit	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q13156	RPA4	Replication protein A 30 kDa subunit	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q13156	RPA4	Replication protein A 30 kDa subunit	GO:0006289; P:nucleotide-excision repair; IDA:UniProtKB
P35244	RPA3	Replication protein A 14 kDa subunit	GO:0005515; F:protein binding; IPI:IntAct
P35244	RPA3	Replication protein A 14 kDa subunit	GO:0003697; F:single-stranded DNA binding; TAS:ProtInc
P35244	RPA3	Replication protein A 14 kDa subunit	GO:0000730; P:DNA recombinase assembly; TAS:Reactome
P35244	RPA3	Replication protein A 14 kDa subunit	GO:0006281; P:DNA repair; TAS:Reactome
P35244	RPA3	Replication protein A 14 kDa subunit	GO:0006260; P:DNA replication; TAS:Reactome
P35244	RPA3	Replication protein A 14 kDa subunit	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P35244	RPA3	Replication protein A 14 kDa subunit	GO:0006302; P:double-strand break repair; TAS:Reactome
P35244	RPA3	Replication protein A 14 kDa subunit	GO:0000724; P:double-strand break repair via homologous recombination; TAS:Reactome
P35244	RPA3	Replication protein A 14 kDa subunit	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P35244	RPA3	Replication protein A 14 kDa subunit	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P35244	RPA3	Replication protein A 14 kDa subunit	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P35244	RPA3	Replication protein A 14 kDa subunit	GO:0000718; P:nucleotide-excision repair, DNA damage removal; TAS:Reactome
P35244	RPA3	Replication protein A 14 kDa subunit	GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome
P35244	RPA3	Replication protein A 14 kDa subunit	GO:0000723; P:telomere maintenance; TAS:Reactome
P35244	RPA3	Replication protein A 14 kDa subunit	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
P35244	RPA3	Replication protein A 14 kDa subunit	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
P35244	RPA3	Replication protein A 14 kDa subunit	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
F8VTS6	RFPL4AL1	Ret finger protein-like 4A-like protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
P35251	RFC1	Replication factor C subunit 1	GO:0005524; F:ATP binding; TAS:ProtInc
P35251	RFC1	Replication factor C subunit 1	GO:0003689; F:DNA clamp loader activity; IEA:InterPro
P35251	RFC1	Replication factor C subunit 1	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
P35251	RFC1	Replication factor C subunit 1	GO:0008047; F:enzyme activator activity; TAS:ProtInc
P35251	RFC1	Replication factor C subunit 1	GO:0005515; F:protein binding; IPI:UniProtKB
P35251	RFC1	Replication factor C subunit 1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P35251	RFC1	Replication factor C subunit 1	GO:0006281; P:DNA repair; TAS:Reactome
P35251	RFC1	Replication factor C subunit 1	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P35251	RFC1	Replication factor C subunit 1	GO:0006261; P:DNA-dependent DNA replication; TAS:ProtInc
P35251	RFC1	Replication factor C subunit 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P35251	RFC1	Replication factor C subunit 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P35251	RFC1	Replication factor C subunit 1	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P35251	RFC1	Replication factor C subunit 1	GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome
P35251	RFC1	Replication factor C subunit 1	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
P35251	RFC1	Replication factor C subunit 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P35251	RFC1	Replication factor C subunit 1	GO:0000723; P:telomere maintenance; TAS:Reactome
P35251	RFC1	Replication factor C subunit 1	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
P35251	RFC1	Replication factor C subunit 1	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
P35251	RFC1	Replication factor C subunit 1	GO:0007004; P:telomere maintenance via telomerase; TAS:ProtInc
P35251	RFC1	Replication factor C subunit 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P35251	RFC1	Replication factor C subunit 1	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P35250	RFC2	Replication factor C subunit 2	GO:0005524; F:ATP binding; TAS:ProtInc
P35250	RFC2	Replication factor C subunit 2	GO:0003677; F:DNA binding; IEA:InterPro
P35250	RFC2	Replication factor C subunit 2	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
P35250	RFC2	Replication factor C subunit 2	GO:0005515; F:protein binding; IPI:IntAct
P35250	RFC2	Replication factor C subunit 2	GO:0006281; P:DNA repair; TAS:Reactome
P35250	RFC2	Replication factor C subunit 2	GO:0006260; P:DNA replication; TAS:Reactome
P35250	RFC2	Replication factor C subunit 2	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P35250	RFC2	Replication factor C subunit 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P35250	RFC2	Replication factor C subunit 2	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P35250	RFC2	Replication factor C subunit 2	GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome
P35250	RFC2	Replication factor C subunit 2	GO:0000723; P:telomere maintenance; TAS:Reactome
P35250	RFC2	Replication factor C subunit 2	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
P35250	RFC2	Replication factor C subunit 2	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
P35250	RFC2	Replication factor C subunit 2	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P40938	RFC3	Replication factor C subunit 3	GO:0003689; F:DNA clamp loader activity; TAS:UniProtKB
P40938	RFC3	Replication factor C subunit 3	GO:0000166; F:nucleotide binding; IEA:InterPro
P40938	RFC3	Replication factor C subunit 3	GO:0005515; F:protein binding; IPI:UniProtKB
P40938	RFC3	Replication factor C subunit 3	GO:0006200; P:ATP catabolic process; IDA:GOC
P40938	RFC3	Replication factor C subunit 3	GO:0006281; P:DNA repair; TAS:Reactome
P40938	RFC3	Replication factor C subunit 3	GO:0006260; P:DNA replication; IDA:UniProtKB
P40938	RFC3	Replication factor C subunit 3	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P40938	RFC3	Replication factor C subunit 3	GO:0000731; P:DNA synthesis involved in DNA repair; TAS:UniProtKB
P40938	RFC3	Replication factor C subunit 3	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P40938	RFC3	Replication factor C subunit 3	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P40938	RFC3	Replication factor C subunit 3	GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome
P40938	RFC3	Replication factor C subunit 3	GO:0046683; P:response to organophosphorus; IEP:UniProtKB
P40938	RFC3	Replication factor C subunit 3	GO:0000723; P:telomere maintenance; TAS:Reactome
P40938	RFC3	Replication factor C subunit 3	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
P40938	RFC3	Replication factor C subunit 3	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
P40938	RFC3	Replication factor C subunit 3	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P35249	RFC4	Replication factor C subunit 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P35249	RFC4	Replication factor C subunit 4	GO:0003677; F:DNA binding; IEA:InterPro
P35249	RFC4	Replication factor C subunit 4	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
P35249	RFC4	Replication factor C subunit 4	GO:0005515; F:protein binding; IPI:UniProtKB
P35249	RFC4	Replication factor C subunit 4	GO:0006281; P:DNA repair; NAS:UniProtKB
P35249	RFC4	Replication factor C subunit 4	GO:0006260; P:DNA replication; NAS:UniProtKB
P35249	RFC4	Replication factor C subunit 4	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P35249	RFC4	Replication factor C subunit 4	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P35249	RFC4	Replication factor C subunit 4	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P35249	RFC4	Replication factor C subunit 4	GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome
P35249	RFC4	Replication factor C subunit 4	GO:0048015; P:phosphatidylinositol-mediated signaling; NAS:UniProtKB
P35249	RFC4	Replication factor C subunit 4	GO:0000723; P:telomere maintenance; TAS:Reactome
P35249	RFC4	Replication factor C subunit 4	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
P35249	RFC4	Replication factor C subunit 4	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
P35249	RFC4	Replication factor C subunit 4	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P40937	RFC5	Replication factor C subunit 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P40937	RFC5	Replication factor C subunit 5	GO:0003677; F:DNA binding; IEA:InterPro
P40937	RFC5	Replication factor C subunit 5	GO:0019899; F:enzyme binding; NAS:UniProtKB
P40937	RFC5	Replication factor C subunit 5	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
P40937	RFC5	Replication factor C subunit 5	GO:0005515; F:protein binding; IPI:UniProtKB
P40937	RFC5	Replication factor C subunit 5	GO:0006281; P:DNA repair; NAS:UniProtKB
P40937	RFC5	Replication factor C subunit 5	GO:0006260; P:DNA replication; NAS:UniProtKB
P40937	RFC5	Replication factor C subunit 5	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
P40937	RFC5	Replication factor C subunit 5	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P40937	RFC5	Replication factor C subunit 5	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P40937	RFC5	Replication factor C subunit 5	GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome
P40937	RFC5	Replication factor C subunit 5	GO:0000723; P:telomere maintenance; TAS:Reactome
P40937	RFC5	Replication factor C subunit 5	GO:0000722; P:telomere maintenance via recombination; TAS:Reactome
P40937	RFC5	Replication factor C subunit 5	GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome
P40937	RFC5	Replication factor C subunit 5	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
Q8TAC1	RFESD	Rieske domain-containing protein	GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:UniProtKB-KW
Q8TAC1	RFESD	Rieske domain-containing protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TAC1	RFESD	Rieske domain-containing protein	GO:0016491; F:oxidoreductase activity; IEA:InterPro
Q8WZ73	RFFL	E3 ubiquitin-protein ligase rififylin	GO:0002039; F:p53 binding; IPI:UniProtKB
Q8WZ73	RFFL	E3 ubiquitin-protein ligase rififylin	GO:0002020; F:protease binding; IPI:UniProtKB
Q8WZ73	RFFL	E3 ubiquitin-protein ligase rififylin	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WZ73	RFFL	E3 ubiquitin-protein ligase rififylin	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q8WZ73	RFFL	E3 ubiquitin-protein ligase rififylin	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q8WZ73	RFFL	E3 ubiquitin-protein ligase rififylin	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q8WZ73	RFFL	E3 ubiquitin-protein ligase rififylin	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WZ73	RFFL	E3 ubiquitin-protein ligase rififylin	GO:0006886; P:intracellular protein transport; IEA:Ensembl
Q8WZ73	RFFL	E3 ubiquitin-protein ligase rififylin	GO:2001271; P:negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis; IMP:UniProtKB
Q8WZ73	RFFL	E3 ubiquitin-protein ligase rififylin	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IMP:UniProtKB
Q8WZ73	RFFL	E3 ubiquitin-protein ligase rififylin	GO:1901797; P:negative regulation of signal transduction by p53 class mediator; IMP:UniProtKB
Q8WZ73	RFFL	E3 ubiquitin-protein ligase rififylin	GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; IMP:UniProtKB
Q8WZ73	RFFL	E3 ubiquitin-protein ligase rififylin	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q8WZ73	RFFL	E3 ubiquitin-protein ligase rififylin	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
Q8WZ73	RFFL	E3 ubiquitin-protein ligase rififylin	GO:0010762; P:regulation of fibroblast migration; ISS:UniProtKB
Q8WZ73	RFFL	E3 ubiquitin-protein ligase rififylin	GO:0032006; P:regulation of TOR signaling; IC:UniProtKB
Q8WZ73	RFFL	E3 ubiquitin-protein ligase rififylin	GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q6WKZ4	RAB11FIP1	Rab11 family-interacting protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q7L804	RAB11FIP2	Rab11 family-interacting protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q7L804	RAB11FIP2	Rab11 family-interacting protein 2	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q7L804	RAB11FIP2	Rab11 family-interacting protein 2	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q7L804	RAB11FIP2	Rab11 family-interacting protein 2	GO:0030010; P:establishment of cell polarity; IMP:UniProtKB
Q7L804	RAB11FIP2	Rab11 family-interacting protein 2	GO:0035773; P:insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB
Q7L804	RAB11FIP2	Rab11 family-interacting protein 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q7L804	RAB11FIP2	Rab11 family-interacting protein 2	GO:0045055; P:regulated secretory pathway; ISS:UniProtKB
Q7L804	RAB11FIP2	Rab11 family-interacting protein 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q7L804	RAB11FIP2	Rab11 family-interacting protein 2	GO:0006833; P:water transport; TAS:Reactome
O75154	RAB11FIP3	Rab11 family-interacting protein 3	GO:0030306; F:ADP-ribosylation factor binding; IPI:UniProtKB
O75154	RAB11FIP3	Rab11 family-interacting protein 3	GO:0005509; F:calcium ion binding; IEA:InterPro
O75154	RAB11FIP3	Rab11 family-interacting protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
O75154	RAB11FIP3	Rab11 family-interacting protein 3	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O75154	RAB11FIP3	Rab11 family-interacting protein 3	GO:0017137; F:Rab GTPase binding; IPI:UniProtKB
O75154	RAB11FIP3	Rab11 family-interacting protein 3	GO:0000910; P:cytokinesis; IMP:UniProtKB
O75154	RAB11FIP3	Rab11 family-interacting protein 3	GO:0032456; P:endocytic recycling; IDA:UniProtKB
O75154	RAB11FIP3	Rab11 family-interacting protein 3	GO:0016192; P:vesicle-mediated transport; TAS:UniProtKB
Q86YS3	RAB11FIP4	Rab11 family-interacting protein 4	GO:0030306; F:ADP-ribosylation factor binding; IPI:UniProtKB
Q86YS3	RAB11FIP4	Rab11 family-interacting protein 4	GO:0005509; F:calcium ion binding; IEA:InterPro
Q86YS3	RAB11FIP4	Rab11 family-interacting protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q86YS3	RAB11FIP4	Rab11 family-interacting protein 4	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q86YS3	RAB11FIP4	Rab11 family-interacting protein 4	GO:0017137; F:Rab GTPase binding; IPI:UniProtKB
Q86YS3	RAB11FIP4	Rab11 family-interacting protein 4	GO:0000910; P:cytokinesis; IMP:UniProtKB
Q86YS3	RAB11FIP4	Rab11 family-interacting protein 4	GO:0006810; P:transport; IEA:UniProtKB-KW
Q86YS3	RAB11FIP4	Rab11 family-interacting protein 4	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9BXF6	RAB11FIP5	Rab11 family-interacting protein 5	GO:0043015; F:gamma-tubulin binding; IDA:UniProtKB
Q9BXF6	RAB11FIP5	Rab11 family-interacting protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BXF6	RAB11FIP5	Rab11 family-interacting protein 5	GO:0071468; P:cellular response to acidity; IDA:UniProtKB
Q9BXF6	RAB11FIP5	Rab11 family-interacting protein 5	GO:0035773; P:insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB
Q9BXF6	RAB11FIP5	Rab11 family-interacting protein 5	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9BXF6	RAB11FIP5	Rab11 family-interacting protein 5	GO:0045055; P:regulated secretory pathway; ISS:UniProtKB
Q9BXF6	RAB11FIP5	Rab11 family-interacting protein 5	GO:2000008; P:regulation of protein localization to cell surface; IMP:UniProtKB
Q9Y644	RFNG	Beta-1,3-N-acetylglucosaminyltransferase radical fringe	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y644	RFNG	Beta-1,3-N-acetylglucosaminyltransferase radical fringe	GO:0033829; F:O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity; IEA:UniProtKB-EC
Q9Y644	RFNG	Beta-1,3-N-acetylglucosaminyltransferase radical fringe	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9Y644	RFNG	Beta-1,3-N-acetylglucosaminyltransferase radical fringe	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q9Y644	RFNG	Beta-1,3-N-acetylglucosaminyltransferase radical fringe	GO:0009887; P:organ morphogenesis; NAS:UniProtKB
Q9Y644	RFNG	Beta-1,3-N-acetylglucosaminyltransferase radical fringe	GO:0007389; P:pattern specification process; IEA:InterPro
Q9Y644	RFNG	Beta-1,3-N-acetylglucosaminyltransferase radical fringe	GO:0045747; P:positive regulation of Notch signaling pathway; IEA:Ensembl
Q9Y644	RFNG	Beta-1,3-N-acetylglucosaminyltransferase radical fringe	GO:0032092; P:positive regulation of protein binding; IEA:Ensembl
Q9NWB1	RBFOX1	RNA binding protein fox-1 homolog 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9NWB1	RBFOX1	RNA binding protein fox-1 homolog 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NWB1	RBFOX1	RNA binding protein fox-1 homolog 1	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q9NWB1	RBFOX1	RNA binding protein fox-1 homolog 1	GO:0003723; F:RNA binding; NAS:UniProtKB
Q9NWB1	RBFOX1	RNA binding protein fox-1 homolog 1	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9NWB1	RBFOX1	RNA binding protein fox-1 homolog 1	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q9NWB1	RBFOX1	RNA binding protein fox-1 homolog 1	GO:0043484; P:regulation of RNA splicing; IEA:InterPro
Q9NWB1	RBFOX1	RNA binding protein fox-1 homolog 1	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q9NWB1	RBFOX1	RNA binding protein fox-1 homolog 1	GO:0050658; P:RNA transport; NAS:UniProtKB
O43251	RBFOX2	RNA binding protein fox-1 homolog 2	GO:0003729; F:mRNA binding; IEA:Ensembl
O43251	RBFOX2	RNA binding protein fox-1 homolog 2	GO:0000166; F:nucleotide binding; IEA:InterPro
O43251	RBFOX2	RNA binding protein fox-1 homolog 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O43251	RBFOX2	RNA binding protein fox-1 homolog 2	GO:0005515; F:protein binding; IPI:IntAct
O43251	RBFOX2	RNA binding protein fox-1 homolog 2	GO:0003723; F:RNA binding; IDA:UniProtKB
O43251	RBFOX2	RNA binding protein fox-1 homolog 2	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
O43251	RBFOX2	RNA binding protein fox-1 homolog 2	GO:0008134; F:transcription factor binding; IDA:UniProtKB
O43251	RBFOX2	RNA binding protein fox-1 homolog 2	GO:0048813; P:dendrite morphogenesis; IEA:Ensembl
O43251	RBFOX2	RNA binding protein fox-1 homolog 2	GO:0030520; P:intracellular estrogen receptor signaling pathway; IDA:UniProtKB
O43251	RBFOX2	RNA binding protein fox-1 homolog 2	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
O43251	RBFOX2	RNA binding protein fox-1 homolog 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
O43251	RBFOX2	RNA binding protein fox-1 homolog 2	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
O43251	RBFOX2	RNA binding protein fox-1 homolog 2	GO:0021942; P:radial glia guided migration of Purkinje cell; IEA:Ensembl
O43251	RBFOX2	RNA binding protein fox-1 homolog 2	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; ISS:BHF-UCL
O43251	RBFOX2	RNA binding protein fox-1 homolog 2	GO:0042127; P:regulation of cell proliferation; TAS:UniProtKB
O43251	RBFOX2	RNA binding protein fox-1 homolog 2	GO:0010724; P:regulation of definitive erythrocyte differentiation; IEA:Ensembl
O43251	RBFOX2	RNA binding protein fox-1 homolog 2	GO:0016070; P:RNA metabolic process; TAS:UniProtKB
O43251	RBFOX2	RNA binding protein fox-1 homolog 2	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
A6NFN3	RBFOX3	RNA binding protein fox-1 homolog 3	GO:0003677; F:DNA binding; IEA:Ensembl
A6NFN3	RBFOX3	RNA binding protein fox-1 homolog 3	GO:0000166; F:nucleotide binding; IEA:InterPro
A6NFN3	RBFOX3	RNA binding protein fox-1 homolog 3	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
A6NFN3	RBFOX3	RNA binding protein fox-1 homolog 3	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
A6NFN3	RBFOX3	RNA binding protein fox-1 homolog 3	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IEA:Ensembl
A6NFN3	RBFOX3	RNA binding protein fox-1 homolog 3	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
O75678	RFPL2	Ret finger protein-like 2	GO:0008270; F:zinc ion binding; IEA:InterPro
O75677	RFPL1	Ret finger protein-like 1	GO:0008270; F:zinc ion binding; IEA:InterPro
O75679	RFPL3	Ret finger protein-like 3	GO:0008270; F:zinc ion binding; IEA:InterPro
A6NLU0	RFPL4A	Ret finger protein-like 4A	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6ZWI9	RFPL4B	Ret finger protein-like 4B	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96AA3	RFT1	Protein RFT1 homolog	GO:0005319; F:lipid transporter activity; IEA:InterPro
Q96AA3	RFT1	Protein RFT1 homolog	GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW
Q96AA3	RFT1	Protein RFT1 homolog	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q96AA3	RFT1	Protein RFT1 homolog	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q96AA3	RFT1	Protein RFT1 homolog	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q96AA3	RFT1	Protein RFT1 homolog	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q14699	RFTN1	Raftlin	GO:0003725; F:double-stranded RNA binding; IDA:MGI
Q14699	RFTN1	Raftlin	GO:0033227; P:dsRNA transport; IMP:MGI
Q14699	RFTN1	Raftlin	GO:0043330; P:response to exogenous dsRNA; IMP:MGI
Q14699	RFTN1	Raftlin	GO:0034138; P:toll-like receptor 3 signaling pathway; IMP:MGI
Q6PCD5	RFWD3	E3 ubiquitin-protein ligase RFWD3	GO:0097371; F:MDM2/MDM4 family protein binding; IPI:UniProtKB
Q6PCD5	RFWD3	E3 ubiquitin-protein ligase RFWD3	GO:0002039; F:p53 binding; IPI:UniProtKB
Q6PCD5	RFWD3	E3 ubiquitin-protein ligase RFWD3	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q6PCD5	RFWD3	E3 ubiquitin-protein ligase RFWD3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6PCD5	RFWD3	E3 ubiquitin-protein ligase RFWD3	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q6PCD5	RFWD3	E3 ubiquitin-protein ligase RFWD3	GO:0031571; P:mitotic G1 DNA damage checkpoint; IMP:UniProtKB
Q6PCD5	RFWD3	E3 ubiquitin-protein ligase RFWD3	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q6PCD5	RFWD3	E3 ubiquitin-protein ligase RFWD3	GO:0010212; P:response to ionizing radiation; IDA:UniProtKB
P22670	RFX1	MHC class II regulatory factor RFX1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P22670	RFX1	MHC class II regulatory factor RFX1	GO:0005515; F:protein binding; IPI:BHF-UCL
P22670	RFX1	MHC class II regulatory factor RFX1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P22670	RFX1	MHC class II regulatory factor RFX1	GO:0006955; P:immune response; TAS:ProtInc
P22670	RFX1	MHC class II regulatory factor RFX1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:GOC
P22670	RFX1	MHC class II regulatory factor RFX1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:GOC
Q8NHY2	RFWD2	E3 ubiquitin-protein ligase RFWD2	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q8NHY2	RFWD2	E3 ubiquitin-protein ligase RFWD2	GO:0005515; F:protein binding; IPI:IntAct
Q8NHY2	RFWD2	E3 ubiquitin-protein ligase RFWD2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8NHY2	RFWD2	E3 ubiquitin-protein ligase RFWD2	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
Q8NHY2	RFWD2	E3 ubiquitin-protein ligase RFWD2	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
P48378	RFX2	DNA-binding protein RFX2	GO:0003677; F:DNA binding; TAS:ProtInc
P48378	RFX2	DNA-binding protein RFX2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P48378	RFX2	DNA-binding protein RFX2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P48380	RFX3	Transcription factor RFX3	GO:0003677; F:DNA binding; TAS:ProtInc
P48380	RFX3	Transcription factor RFX3	GO:0005515; F:protein binding; IPI:UniProtKB
P48380	RFX3	Transcription factor RFX3	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P48380	RFX3	Transcription factor RFX3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
P48380	RFX3	Transcription factor RFX3	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P48380	RFX3	Transcription factor RFX3	GO:0048469; P:cell maturation; ISS:BHF-UCL
P48380	RFX3	Transcription factor RFX3	GO:0042384; P:cilium assembly; ISS:BHF-UCL
P48380	RFX3	Transcription factor RFX3	GO:0060285; P:cilium-dependent cell motility; ISS:UniProtKB
P48380	RFX3	Transcription factor RFX3	GO:0031018; P:endocrine pancreas development; ISS:UniProtKB
P48380	RFX3	Transcription factor RFX3	GO:0060287; P:epithelial cilium movement involved in determination of left/right asymmetry; ISS:UniProtKB
P48380	RFX3	Transcription factor RFX3	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P48380	RFX3	Transcription factor RFX3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P48380	RFX3	Transcription factor RFX3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P48380	RFX3	Transcription factor RFX3	GO:2000078; P:positive regulation of type B pancreatic cell development; ISS:BHF-UCL
P48380	RFX3	Transcription factor RFX3	GO:0050796; P:regulation of insulin secretion; ISS:UniProtKB
P48380	RFX3	Transcription factor RFX3	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
P48380	RFX3	Transcription factor RFX3	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:GOC
P48380	RFX3	Transcription factor RFX3	GO:0072560; P:type B pancreatic cell maturation; IEA:Ensembl
Q33E94	RFX4	Transcription factor RFX4	GO:0003682; F:chromatin binding; IEA:Ensembl
Q33E94	RFX4	Transcription factor RFX4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q33E94	RFX4	Transcription factor RFX4	GO:0021696; P:cerebellar cortex morphogenesis; IEA:Ensembl
Q33E94	RFX4	Transcription factor RFX4	GO:0021516; P:dorsal spinal cord development; IEA:Ensembl
Q33E94	RFX4	Transcription factor RFX4	GO:0030900; P:forebrain development; IEA:Ensembl
Q33E94	RFX4	Transcription factor RFX4	GO:0030901; P:midbrain development; IEA:Ensembl
Q33E94	RFX4	Transcription factor RFX4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q33E94	RFX4	Transcription factor RFX4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P48382	RFX5	DNA-binding protein RFX5	GO:0003677; F:DNA binding; TAS:ProtInc
P48382	RFX5	DNA-binding protein RFX5	GO:0005515; F:protein binding; IPI:IntAct
P48382	RFX5	DNA-binding protein RFX5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
P48382	RFX5	DNA-binding protein RFX5	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P48382	RFX5	DNA-binding protein RFX5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8HWS3	RFX6	DNA-binding protein RFX6	GO:0005515; F:protein binding; IPI:UniProtKB
Q8HWS3	RFX6	DNA-binding protein RFX6	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q8HWS3	RFX6	DNA-binding protein RFX6	GO:0031018; P:endocrine pancreas development; IMP:UniProtKB
Q8HWS3	RFX6	DNA-binding protein RFX6	GO:0042593; P:glucose homeostasis; IMP:UniProtKB
Q8HWS3	RFX6	DNA-binding protein RFX6	GO:0003310; P:pancreatic A cell differentiation; ISS:UniProtKB
Q8HWS3	RFX6	DNA-binding protein RFX6	GO:0003311; P:pancreatic D cell differentiation; ISS:UniProtKB
Q8HWS3	RFX6	DNA-binding protein RFX6	GO:0090104; P:pancreatic epsilon cell differentiation; ISS:UniProtKB
Q8HWS3	RFX6	DNA-binding protein RFX6	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q8HWS3	RFX6	DNA-binding protein RFX6	GO:0050796; P:regulation of insulin secretion; IMP:UniProtKB
Q8HWS3	RFX6	DNA-binding protein RFX6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8HWS3	RFX6	DNA-binding protein RFX6	GO:0003309; P:type B pancreatic cell differentiation; ISS:UniProtKB
Q2KHR2	RFX7	DNA-binding protein RFX7	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q2KHR2	RFX7	DNA-binding protein RFX7	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q6ZV50	RFX8	DNA-binding protein RFX8	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZV50	RFX8	DNA-binding protein RFX8	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZV50	RFX8	DNA-binding protein RFX8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O00287	RFXAP	Regulatory factor X-associated protein	GO:0003677; F:DNA binding; TAS:ProtInc
O00287	RFXAP	Regulatory factor X-associated protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
O00287	RFXAP	Regulatory factor X-associated protein	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
O00287	RFXAP	Regulatory factor X-associated protein	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
O14593	RFXANK	DNA-binding protein RFXANK	GO:0003677; F:DNA binding; TAS:ProtInc
O14593	RFXANK	DNA-binding protein RFXANK	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
O14593	RFXANK	DNA-binding protein RFXANK	GO:0003712; F:transcription cofactor activity; TAS:ProtInc
O14593	RFXANK	DNA-binding protein RFXANK	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O14593	RFXANK	DNA-binding protein RFXANK	GO:0007265; P:Ras protein signal transduction; IEA:Ensembl
O14593	RFXANK	DNA-binding protein RFXANK	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0043014; F:alpha-tubulin binding; IDA:UniProtKB
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0048487; F:beta-tubulin binding; IDA:UniProtKB
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0043015; F:gamma-tubulin binding; IDA:UniProtKB
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0005096; F:GTPase activator activity; IDA:UniProtKB
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0000915; P:actomyosin contractile ring assembly; IMP:UniProtKB
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0007108; P:cytokinesis, initiation of separation; IMP:UniProtKB
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0009790; P:embryo development; ISS:UniProtKB
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0007018; P:microtubule-based movement; TAS:Reactome
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0000281; P:mitotic cytokinesis; IDA:UniProtKB
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0007405; P:neuroblast proliferation; ISS:UniProtKB
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0032467; P:positive regulation of cytokinesis; IDA:UniProtKB
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0043547; P:positive regulation of GTPase activity; IDA:GOC
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0051988; P:regulation of attachment of spindle microtubules to kinetochore; IMP:UniProtKB
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0007283; P:spermatogenesis; IEP:UniProtKB
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0051256; P:spindle midzone assembly involved in mitosis; IDA:UniProtKB
Q9H0H5	RACGAP1	Rac GTPase-activating protein 1	GO:0008272; P:sulfate transport; IDA:UniProtKB
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0005515; F:protein binding; IPI:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0030295; F:protein kinase activator activity; IDA:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0070412; F:R-SMAD binding; IPI:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0071456; P:cellular response to hypoxia; IMP:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0006956; P:complement activation; IMP:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0072537; P:fibroblast activation; ISS:UniProtKB
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0071850; P:mitotic cell cycle arrest; IDA:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0016525; P:negative regulation of angiogenesis; IDA:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0043537; P:negative regulation of blood vessel endothelial cell migration; IDA:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0008285; P:negative regulation of cell proliferation; IMP:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:2000048; P:negative regulation of cell-cell adhesion mediated by cadherin; IDA:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0050710; P:negative regulation of cytokine secretion; IMP:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0001937; P:negative regulation of endothelial cell proliferation; IDA:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0001100; P:negative regulation of exit from mitosis; IDA:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0090272; P:negative regulation of fibroblast growth factor production; IDA:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:1901991; P:negative regulation of mitotic cell cycle phase transition; IDA:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0071158; P:positive regulation of cell cycle arrest; IDA:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0032967; P:positive regulation of collagen biosynthetic process; IDA:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0031659; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle; IDA:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0050715; P:positive regulation of cytokine secretion; IMP:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:2000573; P:positive regulation of DNA biosynthetic process; ISS:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:2000353; P:positive regulation of endothelial cell apoptotic process; IDA:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IDA:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0003331; P:positive regulation of extracellular matrix constituent secretion; IDA:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:1901313; P:positive regulation of gene expression involved in extracellular matrix organization; IDA:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0045840; P:positive regulation of mitosis; IMP:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL
Q9H4X1	RGCC	Regulator of cell cycle RGCC	GO:0051496; P:positive regulation of stress fiber assembly; IDA:BHF-UCL
Q8N9B8	RASGEF1A	Ras-GEF domain-containing family member 1A	GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q8N9B8	RASGEF1A	Ras-GEF domain-containing family member 1A	GO:0016477; P:cell migration; IDA:UniProtKB
Q8N9B8	RASGEF1A	Ras-GEF domain-containing family member 1A	GO:0046579; P:positive regulation of Ras protein signal transduction; IDA:FlyBase
Q8N9B8	RASGEF1A	Ras-GEF domain-containing family member 1A	GO:0032318; P:regulation of Ras GTPase activity; IDA:GOC
Q8N9B8	RASGEF1A	Ras-GEF domain-containing family member 1A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q0VAM2	RASGEF1B	Ras-GEF domain-containing family member 1B	GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q0VAM2	RASGEF1B	Ras-GEF domain-containing family member 1B	GO:0032318; P:regulation of Ras GTPase activity; IDA:GOC
Q0VAM2	RASGEF1B	Ras-GEF domain-containing family member 1B	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q8N431	RASGEF1C	Ras-GEF domain-containing family member 1C	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW
Q8N431	RASGEF1C	Ras-GEF domain-containing family member 1C	GO:0051056; P:regulation of small GTPase mediated signal transduction; IEA:InterPro
Q8N431	RASGEF1C	Ras-GEF domain-containing family member 1C	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q8IZJ4	RGL4	Ral-GDS-related protein	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW
Q8IZJ4	RGL4	Ral-GDS-related protein	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9NZL6	RGL1	Ral guanine nucleotide dissociation stimulator-like 1	GO:0008321; F:Ral guanyl-nucleotide exchange factor activity; NAS:UniProtKB
Q9NZL6	RGL1	Ral guanine nucleotide dissociation stimulator-like 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9NZL6	RGL1	Ral guanine nucleotide dissociation stimulator-like 1	GO:0032315; P:regulation of Ral GTPase activity; NAS:GOC
Q9NZL6	RGL1	Ral guanine nucleotide dissociation stimulator-like 1	GO:0007264; P:small GTPase mediated signal transduction; NAS:UniProtKB
Q9NZL6	RGL1	Ral guanine nucleotide dissociation stimulator-like 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15211	RGL2	Ral guanine nucleotide dissociation stimulator-like 2	GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; NAS:UniProtKB
O15211	RGL2	Ral guanine nucleotide dissociation stimulator-like 2	GO:0007265; P:Ras protein signal transduction; NAS:UniProtKB
O15211	RGL2	Ral guanine nucleotide dissociation stimulator-like 2	GO:0032318; P:regulation of Ras GTPase activity; NAS:GOC
Q3MIN7	RGL3	Ral guanine nucleotide dissociation stimulator-like 3	GO:0008321; F:Ral guanyl-nucleotide exchange factor activity; IEA:Ensembl
Q3MIN7	RGL3	Ral guanine nucleotide dissociation stimulator-like 3	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q96B86	RGMA	Repulsive guidance molecule A	GO:0007411; P:axon guidance; TAS:Reactome
Q6ZVN8	HFE2	Hemojuvelin	GO:0015026; F:coreceptor activity; IEA:Ensembl
Q6ZVN8	HFE2	Hemojuvelin	GO:0005515; F:protein binding; IPI:UniProtKB
Q6ZVN8	HFE2	Hemojuvelin	GO:0007411; P:axon guidance; TAS:Reactome
Q6ZVN8	HFE2	Hemojuvelin	GO:0030509; P:BMP signaling pathway; IEA:Ensembl
Q6ZVN8	HFE2	Hemojuvelin	GO:0055072; P:iron ion homeostasis; IDA:MGI
Q6ZVN8	HFE2	Hemojuvelin	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q6NW40	RGMB	RGM domain family member B	GO:0042802; F:identical protein binding; ISS:HGNC
Q6NW40	RGMB	RGM domain family member B	GO:0007411; P:axon guidance; TAS:Reactome
Q6NW40	RGMB	RGM domain family member B	GO:0030509; P:BMP signaling pathway; ISS:HGNC
Q6NW40	RGMB	RGM domain family member B	GO:0007155; P:cell adhesion; ISS:HGNC
Q6NW40	RGMB	RGM domain family member B	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:HGNC
Q6NW40	RGMB	RGM domain family member B	GO:0007165; P:signal transduction; ISS:HGNC
Q15493	RGN	Regucalcin	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q15493	RGN	Regucalcin	GO:0030234; F:enzyme regulator activity; IEA:InterPro
Q15493	RGN	Regucalcin	GO:0004341; F:gluconolactonase activity; IDA:UniProtKB
Q15493	RGN	Regucalcin	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q15493	RGN	Regucalcin	GO:0006874; P:cellular calcium ion homeostasis; ISS:UniProtKB
Q15493	RGN	Regucalcin	GO:0019853; P:L-ascorbic acid biosynthetic process; IEA:Ensembl
Q15493	RGN	Regucalcin	GO:0032781; P:positive regulation of ATPase activity; ISS:UniProtKB
Q15493	RGN	Regucalcin	GO:0050848; P:regulation of calcium-mediated signaling; ISS:UniProtKB
Q6GYQ0	RALGAPA1	Ral GTPase-activating protein subunit alpha-1	GO:0005096; F:GTPase activator activity; IEA:InterPro
Q6GYQ0	RALGAPA1	Ral GTPase-activating protein subunit alpha-1	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q6GYQ0	RALGAPA1	Ral GTPase-activating protein subunit alpha-1	GO:0017123; F:Ral GTPase activator activity; ISS:UniProtKB
Q6GYQ0	RALGAPA1	Ral GTPase-activating protein subunit alpha-1	GO:0032859; P:activation of Ral GTPase activity; ISS:UniProtKB
Q6GYQ0	RALGAPA1	Ral GTPase-activating protein subunit alpha-1	GO:0043547; P:positive regulation of GTPase activity; IBA:RefGenome
Q6GYQ0	RALGAPA1	Ral GTPase-activating protein subunit alpha-1	GO:0051056; P:regulation of small GTPase mediated signal transduction; IEA:InterPro
Q6GYQ0	RALGAPA1	Ral GTPase-activating protein subunit alpha-1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:Ensembl
Q2PPJ7	RALGAPA2	Ral GTPase-activating protein subunit alpha-2	GO:0005096; F:GTPase activator activity; IBA:RefGenome
Q2PPJ7	RALGAPA2	Ral GTPase-activating protein subunit alpha-2	GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB
Q2PPJ7	RALGAPA2	Ral GTPase-activating protein subunit alpha-2	GO:0017123; F:Ral GTPase activator activity; ISS:UniProtKB
Q2PPJ7	RALGAPA2	Ral GTPase-activating protein subunit alpha-2	GO:0032859; P:activation of Ral GTPase activity; ISS:UniProtKB
Q2PPJ7	RALGAPA2	Ral GTPase-activating protein subunit alpha-2	GO:0061024; P:membrane organization; TAS:Reactome
P0DJD0	RGPD1	RANBP2-like and GRIP domain-containing protein 1	GO:0000042; P:protein targeting to Golgi; IEA:InterPro
Q99666	RGPD5	RANBP2-like and GRIP domain-containing protein 5/6	GO:0000042; P:protein targeting to Golgi; IEA:InterPro
P0DJD1	RGPD2	RANBP2-like and GRIP domain-containing protein 2	GO:0000042; P:protein targeting to Golgi; IEA:InterPro
Q7Z3J3	RGPD4	RanBP2-like and GRIP domain-containing protein 4	GO:0000042; P:protein targeting to Golgi; IEA:InterPro
O14715	RGPD8	RANBP2-like and GRIP domain-containing protein 8	GO:0008536; F:Ran GTPase binding; NAS:UniProtKB
O14715	RGPD8	RANBP2-like and GRIP domain-containing protein 8	GO:0000042; P:protein targeting to Golgi; IEA:InterPro
Q5JS13	RALGPS1	Ras-specific guanine nucleotide-releasing factor RalGPS1	GO:0005085; F:guanyl-nucleotide exchange factor activity; NAS:UniProtKB
Q5JS13	RALGPS1	Ras-specific guanine nucleotide-releasing factor RalGPS1	GO:0008321; F:Ral guanyl-nucleotide exchange factor activity; IDA:FlyBase
Q5JS13	RALGPS1	Ras-specific guanine nucleotide-releasing factor RalGPS1	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
Q5JS13	RALGPS1	Ras-specific guanine nucleotide-releasing factor RalGPS1	GO:0043087; P:regulation of GTPase activity; NAS:GOC
Q5JS13	RALGPS1	Ras-specific guanine nucleotide-releasing factor RalGPS1	GO:0032315; P:regulation of Ral GTPase activity; IDA:GOC
Q5JS13	RALGPS1	Ras-specific guanine nucleotide-releasing factor RalGPS1	GO:0032485; P:regulation of Ral protein signal transduction; IDA:FlyBase
Q5JS13	RALGPS1	Ras-specific guanine nucleotide-releasing factor RalGPS1	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
A6NKT7	RGPD3	RanBP2-like and GRIP domain-containing protein 3	GO:0000042; P:protein targeting to Golgi; IEA:InterPro
Q86X27	RALGPS2	Ras-specific guanine nucleotide-releasing factor RalGPS2	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW
Q86X27	RALGPS2	Ras-specific guanine nucleotide-releasing factor RalGPS2	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q13972	RASGRF1	Ras-specific guanine nucleotide-releasing factor 1	GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:ProtInc
Q13972	RASGRF1	Ras-specific guanine nucleotide-releasing factor 1	GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; TAS:ProtInc
Q13972	RASGRF1	Ras-specific guanine nucleotide-releasing factor 1	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q13972	RASGRF1	Ras-specific guanine nucleotide-releasing factor 1	GO:0032863; P:activation of Rac GTPase activity; ISS:HGNC
Q13972	RASGRF1	Ras-specific guanine nucleotide-releasing factor 1	GO:0007616; P:long-term memory; NAS:UniProtKB
Q13972	RASGRF1	Ras-specific guanine nucleotide-releasing factor 1	GO:0031175; P:neuron projection development; ISS:HGNC
Q13972	RASGRF1	Ras-specific guanine nucleotide-releasing factor 1	GO:0032320; P:positive regulation of Ras GTPase activity; ISS:HGNC
Q13972	RASGRF1	Ras-specific guanine nucleotide-releasing factor 1	GO:0046579; P:positive regulation of Ras protein signal transduction; ISS:UniProtKB
Q13972	RASGRF1	Ras-specific guanine nucleotide-releasing factor 1	GO:0035020; P:regulation of Rac protein signal transduction; ISS:HGNC
Q13972	RASGRF1	Ras-specific guanine nucleotide-releasing factor 1	GO:0046578; P:regulation of Ras protein signal transduction; ISS:HGNC
Q13972	RASGRF1	Ras-specific guanine nucleotide-releasing factor 1	GO:0048167; P:regulation of synaptic plasticity; ISS:UniProtKB
Q13972	RASGRF1	Ras-specific guanine nucleotide-releasing factor 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q13972	RASGRF1	Ras-specific guanine nucleotide-releasing factor 1	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q13972	RASGRF1	Ras-specific guanine nucleotide-releasing factor 1	GO:0007268; P:synaptic transmission; TAS:Reactome
O14827	RASGRF2	Ras-specific guanine nucleotide-releasing factor 2	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
O14827	RASGRF2	Ras-specific guanine nucleotide-releasing factor 2	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
O14827	RASGRF2	Ras-specific guanine nucleotide-releasing factor 2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O14827	RASGRF2	Ras-specific guanine nucleotide-releasing factor 2	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
O14827	RASGRF2	Ras-specific guanine nucleotide-releasing factor 2	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
O14827	RASGRF2	Ras-specific guanine nucleotide-releasing factor 2	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
O14827	RASGRF2	Ras-specific guanine nucleotide-releasing factor 2	GO:0007268; P:synaptic transmission; TAS:Reactome
P47804	RGR	RPE-retinal G protein-coupled receptor	GO:0004950; F:chemokine receptor activity; IEA:InterPro
P47804	RGR	RPE-retinal G protein-coupled receptor	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P47804	RGR	RPE-retinal G protein-coupled receptor	GO:0009881; F:photoreceptor activity; IEA:UniProtKB-KW
P47804	RGR	RPE-retinal G protein-coupled receptor	GO:0005515; F:protein binding; IPI:IntAct
P47804	RGR	RPE-retinal G protein-coupled receptor	GO:0006935; P:chemotaxis; IEA:InterPro
P47804	RGR	RPE-retinal G protein-coupled receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P47804	RGR	RPE-retinal G protein-coupled receptor	GO:0007602; P:phototransduction; IEA:UniProtKB-KW
P47804	RGR	RPE-retinal G protein-coupled receptor	GO:0018298; P:protein-chromophore linkage; IEA:UniProtKB-KW
P47804	RGR	RPE-retinal G protein-coupled receptor	GO:0007601; P:visual perception; TAS:ProtInc
O43665	RGS10	Regulator of G-protein signaling 10	GO:0005096; F:GTPase activator activity; IBA:RefGenome
O43665	RGS10	Regulator of G-protein signaling 10	GO:0043547; P:positive regulation of GTPase activity; IBA:GOC
O43665	RGS10	Regulator of G-protein signaling 10	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
O14924	RGS12	Regulator of G-protein signaling 12	GO:0005096; F:GTPase activator activity; IBA:RefGenome
O14924	RGS12	Regulator of G-protein signaling 12	GO:0030695; F:GTPase regulator activity; IDA:UniProtKB
O14924	RGS12	Regulator of G-protein signaling 12	GO:0005057; F:receptor signaling protein activity; IEA:InterPro
O14924	RGS12	Regulator of G-protein signaling 12	GO:0043547; P:positive regulation of GTPase activity; IBA:GOC
O14924	RGS12	Regulator of G-protein signaling 12	GO:0050790; P:regulation of catalytic activity; IDA:GOC
O14924	RGS12	Regulator of G-protein signaling 12	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; TAS:ProtInc
O14924	RGS12	Regulator of G-protein signaling 12	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
O14924	RGS12	Regulator of G-protein signaling 12	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O94810	RGS11	Regulator of G-protein signaling 11	GO:0031681; F:G-protein beta-subunit binding; IPI:UniProt
O94810	RGS11	Regulator of G-protein signaling 11	GO:0005096; F:GTPase activator activity; IBA:RefGenome
O94810	RGS11	Regulator of G-protein signaling 11	GO:0004871; F:signal transducer activity; IEA:InterPro
O94810	RGS11	Regulator of G-protein signaling 11	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:InterPro
O94810	RGS11	Regulator of G-protein signaling 11	GO:0035556; P:intracellular signal transduction; IEA:InterPro
O94810	RGS11	Regulator of G-protein signaling 11	GO:0043547; P:positive regulation of GTPase activity; IBA:GOC
O94810	RGS11	Regulator of G-protein signaling 11	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; TAS:ProtInc
O94810	RGS11	Regulator of G-protein signaling 11	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
O14921	RGS13	Regulator of G-protein signaling 13	GO:0005096; F:GTPase activator activity; IBA:RefGenome
O14921	RGS13	Regulator of G-protein signaling 13	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:Ensembl
O14921	RGS13	Regulator of G-protein signaling 13	GO:0043547; P:positive regulation of GTPase activity; IBA:GOC
O14921	RGS13	Regulator of G-protein signaling 13	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
O43566	RGS14	Regulator of G-protein signaling 14	GO:0005092; F:GDP-dissociation inhibitor activity; IDA:UniProtKB
O43566	RGS14	Regulator of G-protein signaling 14	GO:0005096; F:GTPase activator activity; IDA:UniProtKB
O43566	RGS14	Regulator of G-protein signaling 14	GO:0008017; F:microtubule binding; IDA:UniProtKB
O43566	RGS14	Regulator of G-protein signaling 14	GO:0030159; F:receptor signaling complex scaffold activity; ISS:UniProtKB
O43566	RGS14	Regulator of G-protein signaling 14	GO:0005057; F:receptor signaling protein activity; ISS:UniProtKB
O43566	RGS14	Regulator of G-protein signaling 14	GO:0051301; P:cell division; IMP:UniProtKB
O43566	RGS14	Regulator of G-protein signaling 14	GO:0007059; P:chromosome segregation; ISS:UniProtKB
O43566	RGS14	Regulator of G-protein signaling 14	GO:0035556; P:intracellular signal transduction; ISS:GOC
O43566	RGS14	Regulator of G-protein signaling 14	GO:0007612; P:learning; ISS:UniProtKB
O43566	RGS14	Regulator of G-protein signaling 14	GO:0007616; P:long-term memory; ISS:UniProtKB
O43566	RGS14	Regulator of G-protein signaling 14	GO:0060291; P:long-term synaptic potentiation; ISS:UniProtKB
O43566	RGS14	Regulator of G-protein signaling 14	GO:0007067; P:mitosis; IEA:Ensembl
O43566	RGS14	Regulator of G-protein signaling 14	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
O43566	RGS14	Regulator of G-protein signaling 14	GO:0043407; P:negative regulation of MAP kinase activity; ISS:UniProtKB
O43566	RGS14	Regulator of G-protein signaling 14	GO:0031914; P:negative regulation of synaptic plasticity; ISS:UniProtKB
O43566	RGS14	Regulator of G-protein signaling 14	GO:0006913; P:nucleocytoplasmic transport; ISS:UniProtKB
O43566	RGS14	Regulator of G-protein signaling 14	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; ISS:UniProtKB
O43566	RGS14	Regulator of G-protein signaling 14	GO:0043547; P:positive regulation of GTPase activity; IDA:GOC
O43566	RGS14	Regulator of G-protein signaling 14	GO:0050769; P:positive regulation of neurogenesis; ISS:UniProtKB
O43566	RGS14	Regulator of G-protein signaling 14	GO:0043620; P:regulation of DNA-templated transcription in response to stress; ISS:UniProtKB
O43566	RGS14	Regulator of G-protein signaling 14	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; TAS:ProtInc
O43566	RGS14	Regulator of G-protein signaling 14	GO:0006979; P:response to oxidative stress; ISS:UniProtKB
O43566	RGS14	Regulator of G-protein signaling 14	GO:0007051; P:spindle organization; IMP:UniProtKB
O43566	RGS14	Regulator of G-protein signaling 14	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
O43566	RGS14	Regulator of G-protein signaling 14	GO:0008542; P:visual learning; ISS:UniProtKB
O43566	RGS14	Regulator of G-protein signaling 14	GO:0010070; P:zygote asymmetric cell division; ISS:UniProtKB
O15492	RGS16	Regulator of G-protein signaling 16	GO:0005516; F:calmodulin binding; TAS:ProtInc
O15492	RGS16	Regulator of G-protein signaling 16	GO:0005096; F:GTPase activator activity; IBA:RefGenome
O15492	RGS16	Regulator of G-protein signaling 16	GO:0005515; F:protein binding; IPI:UniProtKB
O15492	RGS16	Regulator of G-protein signaling 16	GO:0043547; P:positive regulation of GTPase activity; IBA:GOC
O15492	RGS16	Regulator of G-protein signaling 16	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; TAS:ProtInc
O15492	RGS16	Regulator of G-protein signaling 16	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
O15492	RGS16	Regulator of G-protein signaling 16	GO:0007601; P:visual perception; TAS:ProtInc
Q9NS28	RGS18	Regulator of G-protein signaling 18	GO:0005096; F:GTPase activator activity; IBA:RefGenome
Q9NS28	RGS18	Regulator of G-protein signaling 18	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:Ensembl
Q9NS28	RGS18	Regulator of G-protein signaling 18	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
P49795	RGS19	Regulator of G-protein signaling 19	GO:0005096; F:GTPase activator activity; IBA:RefGenome
P49795	RGS19	Regulator of G-protein signaling 19	GO:0005515; F:protein binding; IPI:UniProtKB
P49795	RGS19	Regulator of G-protein signaling 19	GO:0006914; P:autophagy; IEA:UniProtKB-KW
P49795	RGS19	Regulator of G-protein signaling 19	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P49795	RGS19	Regulator of G-protein signaling 19	GO:0043547; P:positive regulation of GTPase activity; IBA:GOC
P49795	RGS19	Regulator of G-protein signaling 19	GO:0007264; P:small GTPase mediated signal transduction; TAS:ProtInc
P49795	RGS19	Regulator of G-protein signaling 19	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
Q9UGC6	RGS17	Regulator of G-protein signaling 17	GO:0005096; F:GTPase activator activity; IBA:RefGenome
Q9UGC6	RGS17	Regulator of G-protein signaling 17	GO:0043547; P:positive regulation of GTPase activity; IBA:GOC
Q9UGC6	RGS17	Regulator of G-protein signaling 17	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
Q08116	RGS1	Regulator of G-protein signaling 1	GO:0005516; F:calmodulin binding; TAS:ProtInc
Q08116	RGS1	Regulator of G-protein signaling 1	GO:0005096; F:GTPase activator activity; IBA:RefGenome
Q08116	RGS1	Regulator of G-protein signaling 1	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:ProtInc
Q08116	RGS1	Regulator of G-protein signaling 1	GO:0006955; P:immune response; TAS:ProtInc
Q08116	RGS1	Regulator of G-protein signaling 1	GO:0043547; P:positive regulation of GTPase activity; IBA:GOC
Q08116	RGS1	Regulator of G-protein signaling 1	GO:0007165; P:signal transduction; NAS:ProtInc
Q08116	RGS1	Regulator of G-protein signaling 1	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
O76081	RGS20	Regulator of G-protein signaling 20	GO:0005096; F:GTPase activator activity; IBA:RefGenome
O76081	RGS20	Regulator of G-protein signaling 20	GO:0005515; F:protein binding; IPI:IntAct
O76081	RGS20	Regulator of G-protein signaling 20	GO:0043547; P:positive regulation of GTPase activity; IBA:GOC
O76081	RGS20	Regulator of G-protein signaling 20	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; TAS:ProtInc
O76081	RGS20	Regulator of G-protein signaling 20	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
Q2M5E4	RGS21	Regulator of G-protein signaling 21	GO:0005096; F:GTPase activator activity; IBA:RefGenome
Q2M5E4	RGS21	Regulator of G-protein signaling 21	GO:0043547; P:positive regulation of GTPase activity; IBA:GOC
Q2M5E4	RGS21	Regulator of G-protein signaling 21	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
Q8NE09	RGS22	Regulator of G-protein signaling 22	GO:0005096; F:GTPase activator activity; IBA:RefGenome
Q8NE09	RGS22	Regulator of G-protein signaling 22	GO:0043547; P:positive regulation of GTPase activity; IBA:GOC
Q8NE09	RGS22	Regulator of G-protein signaling 22	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
P41220	RGS2	Regulator of G-protein signaling 2	GO:0005516; F:calmodulin binding; TAS:ProtInc
P41220	RGS2	Regulator of G-protein signaling 2	GO:0005096; F:GTPase activator activity; IBA:RefGenome
P41220	RGS2	Regulator of G-protein signaling 2	GO:0005515; F:protein binding; IPI:UniProtKB
P41220	RGS2	Regulator of G-protein signaling 2	GO:0050873; P:brown fat cell differentiation; IEA:Ensembl
P41220	RGS2	Regulator of G-protein signaling 2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P41220	RGS2	Regulator of G-protein signaling 2	GO:0010614; P:negative regulation of cardiac muscle hypertrophy; ISS:BHF-UCL
P41220	RGS2	Regulator of G-protein signaling 2	GO:0045744; P:negative regulation of G-protein coupled receptor protein signaling pathway; ISS:BHF-UCL
P41220	RGS2	Regulator of G-protein signaling 2	GO:0043407; P:negative regulation of MAP kinase activity; ISS:BHF-UCL
P41220	RGS2	Regulator of G-protein signaling 2	GO:0010519; P:negative regulation of phospholipase activity; ISS:BHF-UCL
P41220	RGS2	Regulator of G-protein signaling 2	GO:0060452; P:positive regulation of cardiac muscle contraction; ISS:BHF-UCL
P41220	RGS2	Regulator of G-protein signaling 2	GO:0031116; P:positive regulation of microtubule polymerization; IEA:Ensembl
P41220	RGS2	Regulator of G-protein signaling 2	GO:0071877; P:regulation of adrenergic receptor signaling pathway; ISS:BHF-UCL
P41220	RGS2	Regulator of G-protein signaling 2	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; TAS:ProtInc
P41220	RGS2	Regulator of G-protein signaling 2	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
P41220	RGS2	Regulator of G-protein signaling 2	GO:0055119; P:relaxation of cardiac muscle; ISS:BHF-UCL
P41220	RGS2	Regulator of G-protein signaling 2	GO:0060087; P:relaxation of vascular smooth muscle; IEA:Ensembl
P41220	RGS2	Regulator of G-protein signaling 2	GO:0007283; P:spermatogenesis; IEA:Ensembl
P41220	RGS2	Regulator of G-protein signaling 2	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
P49796	RGS3	Regulator of G-protein signaling 3	GO:0005096; F:GTPase activator activity; IBA:RefGenome
P49796	RGS3	Regulator of G-protein signaling 3	GO:0000188; P:inactivation of MAPK activity; TAS:ProtInc
P49796	RGS3	Regulator of G-protein signaling 3	GO:0043547; P:positive regulation of GTPase activity; IBA:GOC
P49796	RGS3	Regulator of G-protein signaling 3	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; TAS:ProtInc
P49796	RGS3	Regulator of G-protein signaling 3	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
P49798	RGS4	Regulator of G-protein signaling 4	GO:0005516; F:calmodulin binding; TAS:ProtInc
P49798	RGS4	Regulator of G-protein signaling 4	GO:0005096; F:GTPase activator activity; IBA:RefGenome
P49798	RGS4	Regulator of G-protein signaling 4	GO:0000188; P:inactivation of MAPK activity; TAS:ProtInc
P49798	RGS4	Regulator of G-protein signaling 4	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; TAS:ProtInc
P49798	RGS4	Regulator of G-protein signaling 4	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
O15539	RGS5	Regulator of G-protein signaling 5	GO:0005096; F:GTPase activator activity; IBA:RefGenome
O15539	RGS5	Regulator of G-protein signaling 5	GO:0043547; P:positive regulation of GTPase activity; IBA:GOC
O15539	RGS5	Regulator of G-protein signaling 5	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; TAS:ProtInc
O15539	RGS5	Regulator of G-protein signaling 5	GO:0007165; P:signal transduction; IEA:Ensembl
O15539	RGS5	Regulator of G-protein signaling 5	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
P49758	RGS6	Regulator of G-protein signaling 6	GO:0005096; F:GTPase activator activity; IBA:RefGenome
P49758	RGS6	Regulator of G-protein signaling 6	GO:0005515; F:protein binding; IPI:IntAct
P49758	RGS6	Regulator of G-protein signaling 6	GO:0004871; F:signal transducer activity; IEA:InterPro
P49758	RGS6	Regulator of G-protein signaling 6	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:InterPro
P49758	RGS6	Regulator of G-protein signaling 6	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P49758	RGS6	Regulator of G-protein signaling 6	GO:0043547; P:positive regulation of GTPase activity; IBA:GOC
P49758	RGS6	Regulator of G-protein signaling 6	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P49758	RGS6	Regulator of G-protein signaling 6	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; TAS:ProtInc
P49758	RGS6	Regulator of G-protein signaling 6	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
P49802	RGS7	Regulator of G-protein signaling 7	GO:0031681; F:G-protein beta-subunit binding; IPI:UniProt
P49802	RGS7	Regulator of G-protein signaling 7	GO:0005096; F:GTPase activator activity; IBA:RefGenome
P49802	RGS7	Regulator of G-protein signaling 7	GO:0004871; F:signal transducer activity; IEA:InterPro
P49802	RGS7	Regulator of G-protein signaling 7	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:InterPro
P49802	RGS7	Regulator of G-protein signaling 7	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P49802	RGS7	Regulator of G-protein signaling 7	GO:0043547; P:positive regulation of GTPase activity; IBA:GOC
P49802	RGS7	Regulator of G-protein signaling 7	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
P57771	RGS8	Regulator of G-protein signaling 8	GO:0005096; F:GTPase activator activity; IBA:RefGenome
P57771	RGS8	Regulator of G-protein signaling 8	GO:0043547; P:positive regulation of GTPase activity; IBA:GOC
P57771	RGS8	Regulator of G-protein signaling 8	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
O75916	RGS9	Regulator of G-protein signaling 9	GO:0005096; F:GTPase activator activity; IBA:RefGenome
O75916	RGS9	Regulator of G-protein signaling 9	GO:0004871; F:signal transducer activity; IEA:InterPro
O75916	RGS9	Regulator of G-protein signaling 9	GO:0007212; P:dopamine receptor signaling pathway; IEA:Ensembl
O75916	RGS9	Regulator of G-protein signaling 9	GO:0035556; P:intracellular signal transduction; IEA:InterPro
O75916	RGS9	Regulator of G-protein signaling 9	GO:0007399; P:nervous system development; IEA:Ensembl
O75916	RGS9	Regulator of G-protein signaling 9	GO:0007603; P:phototransduction, visible light; TAS:Reactome
O75916	RGS9	Regulator of G-protein signaling 9	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; TAS:ProtInc
O75916	RGS9	Regulator of G-protein signaling 9	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome
O75916	RGS9	Regulator of G-protein signaling 9	GO:0043627; P:response to estrogen; IEA:Ensembl
O75916	RGS9	Regulator of G-protein signaling 9	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
O75916	RGS9	Regulator of G-protein signaling 9	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
O75916	RGS9	Regulator of G-protein signaling 9	GO:0007601; P:visual perception; IEA:UniProtKB-KW
A5PLK6	RGSL1	Regulator of G-protein signaling protein-like	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
Q02094	RHAG	Ammonium transporter Rh type A	GO:0008519; F:ammonium transmembrane transporter activity; IDA:UniProtKB
Q02094	RHAG	Ammonium transporter Rh type A	GO:0030506; F:ankyrin binding; IPI:UniProtKB
Q02094	RHAG	Ammonium transporter Rh type A	GO:0072488; P:ammonium transmembrane transport; IDA:GOC
Q02094	RHAG	Ammonium transporter Rh type A	GO:0015696; P:ammonium transport; IDA:UniProtKB
Q02094	RHAG	Ammonium transporter Rh type A	GO:0015701; P:bicarbonate transport; TAS:Reactome
Q02094	RHAG	Ammonium transporter Rh type A	GO:0015670; P:carbon dioxide transport; IDA:UniProtKB
Q02094	RHAG	Ammonium transporter Rh type A	GO:0006873; P:cellular ion homeostasis; IDA:UniProtKB
Q02094	RHAG	Ammonium transporter Rh type A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q02094	RHAG	Ammonium transporter Rh type A	GO:0055085; P:transmembrane transport; TAS:Reactome
Q6NTF9	RHBDD2	Rhomboid domain-containing protein 2	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q9Y3P4	RHBDD3	Rhomboid domain-containing protein 3	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q9H310	RHBG	Ammonium transporter Rh type B	GO:0008519; F:ammonium transmembrane transporter activity; IDA:UniProtKB
Q9H310	RHBG	Ammonium transporter Rh type B	GO:0030506; F:ankyrin binding; IPI:UniProtKB
Q9H310	RHBG	Ammonium transporter Rh type B	GO:0072488; P:ammonium transmembrane transport; IDA:GOC
Q9H310	RHBG	Ammonium transporter Rh type B	GO:0015696; P:ammonium transport; IDA:UniProtKB
Q9H310	RHBG	Ammonium transporter Rh type B	GO:0070634; P:transepithelial ammonium transport; IDA:UniProtKB
Q9H310	RHBG	Ammonium transporter Rh type B	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9NX52	RHBDL2	Rhomboid-related protein 2	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
O75783	RHBDL1	Rhomboid-related protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
O75783	RHBDL1	Rhomboid-related protein 1	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
O75783	RHBDL1	Rhomboid-related protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
P58872	RHBDL3	Rhomboid-related protein 3	GO:0005509; F:calcium ion binding; IEA:InterPro
P58872	RHBDL3	Rhomboid-related protein 3	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q8TEB9	RHBDD1	Rhomboid-related protein 4	GO:0004175; F:endopeptidase activity; IDA:UniProtKB
Q8TEB9	RHBDD1	Rhomboid-related protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TEB9	RHBDD1	Rhomboid-related protein 4	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
Q8TEB9	RHBDD1	Rhomboid-related protein 4	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8TEB9	RHBDD1	Rhomboid-related protein 4	GO:0034620; P:cellular response to unfolded protein; ISS:UniProtKB
Q8TEB9	RHBDD1	Rhomboid-related protein 4	GO:0034644; P:cellular response to UV; ISS:UniProtKB
Q8TEB9	RHBDD1	Rhomboid-related protein 4	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; ISS:UniProtKB
Q8TEB9	RHBDD1	Rhomboid-related protein 4	GO:0031293; P:membrane protein intracellular domain proteolysis; ISS:UniProtKB
Q8TEB9	RHBDD1	Rhomboid-related protein 4	GO:0033619; P:membrane protein proteolysis; IDA:UniProtKB
Q8TEB9	RHBDD1	Rhomboid-related protein 4	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q8TEB9	RHBDD1	Rhomboid-related protein 4	GO:0045732; P:positive regulation of protein catabolic process; IDA:UniProtKB
Q8TEB9	RHBDD1	Rhomboid-related protein 4	GO:0010954; P:positive regulation of protein processing; ISS:UniProtKB
Q8TEB9	RHBDD1	Rhomboid-related protein 4	GO:0051047; P:positive regulation of secretion; IMP:UniProtKB
Q8TEB9	RHBDD1	Rhomboid-related protein 4	GO:0043687; P:post-translational protein modification; ISS:UniProtKB
Q8TEB9	RHBDD1	Rhomboid-related protein 4	GO:0048515; P:spermatid differentiation; ISS:UniProtKB
Q9BYZ6	RHOBTB2	Rho-related BTB domain-containing protein 2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9BYZ6	RHOBTB2	Rho-related BTB domain-containing protein 2	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q9BYZ6	RHOBTB2	Rho-related BTB domain-containing protein 2	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
O94844	RHOBTB1	Rho-related BTB domain-containing protein 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
O94844	RHOBTB1	Rho-related BTB domain-containing protein 1	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
O94844	RHOBTB1	Rho-related BTB domain-containing protein 1	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P18577	RHCE	Blood group Rh(CE) polypeptide	GO:0008519; F:ammonium transmembrane transporter activity; IEA:InterPro
O94955	RHOBTB3	Rho-related BTB domain-containing protein 3	GO:0005524; F:ATP binding; IDA:UniProtKB
O94955	RHOBTB3	Rho-related BTB domain-containing protein 3	GO:0016887; F:ATPase activity; IDA:UniProtKB
O94955	RHOBTB3	Rho-related BTB domain-containing protein 3	GO:0005525; F:GTP binding; IEA:InterPro
O94955	RHOBTB3	Rho-related BTB domain-containing protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
O94955	RHOBTB3	Rho-related BTB domain-containing protein 3	GO:0017137; F:Rab GTPase binding; IPI:UniProtKB
O94955	RHOBTB3	Rho-related BTB domain-containing protein 3	GO:0006200; P:ATP catabolic process; IDA:GOC
O94955	RHOBTB3	Rho-related BTB domain-containing protein 3	GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB
O94955	RHOBTB3	Rho-related BTB domain-containing protein 3	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9UBD6	RHCG	Ammonium transporter Rh type C	GO:0008519; F:ammonium transmembrane transporter activity; IDA:UniProtKB
Q9UBD6	RHCG	Ammonium transporter Rh type C	GO:0030506; F:ankyrin binding; IDA:UniProtKB
Q9UBD6	RHCG	Ammonium transporter Rh type C	GO:0015837; P:amine transport; NAS:UniProtKB
Q9UBD6	RHCG	Ammonium transporter Rh type C	GO:0072488; P:ammonium transmembrane transport; IDA:GOC
Q9UBD6	RHCG	Ammonium transporter Rh type C	GO:0015696; P:ammonium transport; IDA:UniProtKB
Q9UBD6	RHCG	Ammonium transporter Rh type C	GO:0006873; P:cellular ion homeostasis; IDA:UniProtKB
Q9UBD6	RHCG	Ammonium transporter Rh type C	GO:0030855; P:epithelial cell differentiation; NAS:UniProtKB
Q9UBD6	RHCG	Ammonium transporter Rh type C	GO:0042592; P:homeostatic process; NAS:UniProtKB
Q9UBD6	RHCG	Ammonium transporter Rh type C	GO:0006885; P:regulation of pH; IEA:Ensembl
Q9UBD6	RHCG	Ammonium transporter Rh type C	GO:0070634; P:transepithelial ammonium transport; IDA:UniProtKB
Q9UBD6	RHCG	Ammonium transporter Rh type C	GO:0055085; P:transmembrane transport; TAS:Reactome
Q96CC6	RHBDF1	Inactive rhomboid protein 1	GO:0016477; P:cell migration; IMP:UniProtKB
Q96CC6	RHBDF1	Inactive rhomboid protein 1	GO:0008283; P:cell proliferation; IMP:UniProtKB
Q96CC6	RHBDF1	Inactive rhomboid protein 1	GO:0050709; P:negative regulation of protein secretion; IDA:UniProtKB
Q96CC6	RHBDF1	Inactive rhomboid protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96CC6	RHBDF1	Inactive rhomboid protein 1	GO:0006508; P:proteolysis; IEA:InterPro
Q96CC6	RHBDF1	Inactive rhomboid protein 1	GO:0042058; P:regulation of epidermal growth factor receptor signaling pathway; IMP:UniProtKB
Q96CC6	RHBDF1	Inactive rhomboid protein 1	GO:0061136; P:regulation of proteasomal protein catabolic process; IDA:UniProtKB
Q96CC6	RHBDF1	Inactive rhomboid protein 1	GO:0050708; P:regulation of protein secretion; IMP:UniProtKB
Q6PJF5	RHBDF2	Inactive rhomboid protein 2	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q6PJF5	RHBDF2	Inactive rhomboid protein 2	GO:0050709; P:negative regulation of protein secretion; ISS:UniProtKB
Q6PJF5	RHBDF2	Inactive rhomboid protein 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q02161	RHD	Blood group Rh(D) polypeptide	GO:0008519; F:ammonium transmembrane transporter activity; IEA:InterPro
Q15382	RHEB	GTP-binding protein Rheb	GO:0019003; F:GDP binding; IEA:Ensembl
Q15382	RHEB	GTP-binding protein Rheb	GO:0005525; F:GTP binding; ISS:UniProtKB
Q15382	RHEB	GTP-binding protein Rheb	GO:0003924; F:GTPase activity; TAS:ProtInc
Q15382	RHEB	GTP-binding protein Rheb	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15382	RHEB	GTP-binding protein Rheb	GO:0005515; F:protein binding; IPI:IntAct
Q15382	RHEB	GTP-binding protein Rheb	GO:0007050; P:cell cycle arrest; TAS:Reactome
Q15382	RHEB	GTP-binding protein Rheb	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q15382	RHEB	GTP-binding protein Rheb	GO:0032008; P:positive regulation of TOR signaling; IMP:UniProtKB
Q15382	RHEB	GTP-binding protein Rheb	GO:0007165; P:signal transduction; TAS:ProtInc
Q15382	RHEB	GTP-binding protein Rheb	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q96D21	RASD2	GTP-binding protein Rhes	GO:0031681; F:G-protein beta-subunit binding; IPI:UniProtKB
Q96D21	RASD2	GTP-binding protein Rhes	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q96D21	RASD2	GTP-binding protein Rhes	GO:0003924; F:GTPase activity; NAS:UniProtKB
Q96D21	RASD2	GTP-binding protein Rhes	GO:0007626; P:locomotory behavior; ISS:UniProtKB
Q96D21	RASD2	GTP-binding protein Rhes	GO:0031397; P:negative regulation of protein ubiquitination; IEA:Ensembl
Q96D21	RASD2	GTP-binding protein Rhes	GO:0051897; P:positive regulation of protein kinase B signaling; ISS:UniProtKB
Q96D21	RASD2	GTP-binding protein Rhes	GO:0033235; P:positive regulation of protein sumoylation; ISS:UniProtKB
Q96D21	RASD2	GTP-binding protein Rhes	GO:0043949; P:regulation of cAMP-mediated signaling; ISS:UniProtKB
Q96D21	RASD2	GTP-binding protein Rhes	GO:0007264; P:small GTPase mediated signal transduction; IC:UniProtKB
Q96D21	RASD2	GTP-binding protein Rhes	GO:0001963; P:synaptic transmission, dopaminergic; IEA:Ensembl
Q07960	ARHGAP1	Rho GTPase-activating protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q07960	ARHGAP1	Rho GTPase-activating protein 1	GO:0030675; F:Rac GTPase activator activity; IEA:Ensembl
Q07960	ARHGAP1	Rho GTPase-activating protein 1	GO:0005100; F:Rho GTPase activator activity; IDA:MGI
Q07960	ARHGAP1	Rho GTPase-activating protein 1	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
Q07960	ARHGAP1	Rho GTPase-activating protein 1	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
Q07960	ARHGAP1	Rho GTPase-activating protein 1	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q07960	ARHGAP1	Rho GTPase-activating protein 1	GO:0007266; P:Rho protein signal transduction; TAS:ProtInc
Q07960	ARHGAP1	Rho GTPase-activating protein 1	GO:0007264; P:small GTPase mediated signal transduction; IDA:MGI
P0C7M4	RHOXF2B	Rhox homeobox family member 2B	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P0C7M4	RHOXF2B	Rhox homeobox family member 2B	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P98171	ARHGAP4	Rho GTPase-activating protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
P98171	ARHGAP4	Rho GTPase-activating protein 4	GO:0005100; F:Rho GTPase activator activity; TAS:ProtInc
P98171	ARHGAP4	Rho GTPase-activating protein 4	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
P98171	ARHGAP4	Rho GTPase-activating protein 4	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
P98171	ARHGAP4	Rho GTPase-activating protein 4	GO:0007010; P:cytoskeleton organization; TAS:ProtInc
P98171	ARHGAP4	Rho GTPase-activating protein 4	GO:0030517; P:negative regulation of axon extension; IEA:Ensembl
P98171	ARHGAP4	Rho GTPase-activating protein 4	GO:0010764; P:negative regulation of fibroblast migration; IEA:Ensembl
P98171	ARHGAP4	Rho GTPase-activating protein 4	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P98171	ARHGAP4	Rho GTPase-activating protein 4	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
P98171	ARHGAP4	Rho GTPase-activating protein 4	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
P98171	ARHGAP4	Rho GTPase-activating protein 4	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P98171	ARHGAP4	Rho GTPase-activating protein 4	GO:0007266; P:Rho protein signal transduction; TAS:ProtInc
P98171	ARHGAP4	Rho GTPase-activating protein 4	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q13017	ARHGAP5	Rho GTPase-activating protein 5	GO:0005525; F:GTP binding; IEA:InterPro
Q13017	ARHGAP5	Rho GTPase-activating protein 5	GO:0003924; F:GTPase activity; TAS:ProtInc
Q13017	ARHGAP5	Rho GTPase-activating protein 5	GO:0005515; F:protein binding; IPI:IntAct
Q13017	ARHGAP5	Rho GTPase-activating protein 5	GO:0005100; F:Rho GTPase activator activity; TAS:ProtInc
Q13017	ARHGAP5	Rho GTPase-activating protein 5	GO:0042169; F:SH2 domain binding; IPI:UniProtKB
Q13017	ARHGAP5	Rho GTPase-activating protein 5	GO:0007155; P:cell adhesion; TAS:ProtInc
Q13017	ARHGAP5	Rho GTPase-activating protein 5	GO:0006184; P:GTP catabolic process; TAS:GOC
Q13017	ARHGAP5	Rho GTPase-activating protein 5	GO:0030879; P:mammary gland development; IEA:Ensembl
Q13017	ARHGAP5	Rho GTPase-activating protein 5	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
Q13017	ARHGAP5	Rho GTPase-activating protein 5	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl
Q13017	ARHGAP5	Rho GTPase-activating protein 5	GO:0032321; P:positive regulation of Rho GTPase activity; TAS:GOC
Q13017	ARHGAP5	Rho GTPase-activating protein 5	GO:0008361; P:regulation of cell size; IEA:Ensembl
Q13017	ARHGAP5	Rho GTPase-activating protein 5	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q13017	ARHGAP5	Rho GTPase-activating protein 5	GO:0007266; P:Rho protein signal transduction; TAS:ProtInc
Q13017	ARHGAP5	Rho GTPase-activating protein 5	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
O43182	ARHGAP6	Rho GTPase-activating protein 6	GO:0016004; F:phospholipase activator activity; IDA:BHF-UCL
O43182	ARHGAP6	Rho GTPase-activating protein 6	GO:0043274; F:phospholipase binding; IPI:BHF-UCL
O43182	ARHGAP6	Rho GTPase-activating protein 6	GO:0005100; F:Rho GTPase activator activity; ISS:BHF-UCL
O43182	ARHGAP6	Rho GTPase-activating protein 6	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
O43182	ARHGAP6	Rho GTPase-activating protein 6	GO:0030041; P:actin filament polymerization; NAS:UniProtKB
O43182	ARHGAP6	Rho GTPase-activating protein 6	GO:0007202; P:activation of phospholipase C activity; IDA:BHF-UCL
O43182	ARHGAP6	Rho GTPase-activating protein 6	GO:0048041; P:focal adhesion assembly; IEA:Ensembl
O43182	ARHGAP6	Rho GTPase-activating protein 6	GO:0051895; P:negative regulation of focal adhesion assembly; IMP:BHF-UCL
O43182	ARHGAP6	Rho GTPase-activating protein 6	GO:0051497; P:negative regulation of stress fiber assembly; IMP:BHF-UCL
O43182	ARHGAP6	Rho GTPase-activating protein 6	GO:0010518; P:positive regulation of phospholipase activity; IDA:BHF-UCL
O43182	ARHGAP6	Rho GTPase-activating protein 6	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
O43182	ARHGAP6	Rho GTPase-activating protein 6	GO:0043087; P:regulation of GTPase activity; ISS:BHF-UCL
O43182	ARHGAP6	Rho GTPase-activating protein 6	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
O43182	ARHGAP6	Rho GTPase-activating protein 6	GO:0007266; P:Rho protein signal transduction; NAS:UniProtKB
O43182	ARHGAP6	Rho GTPase-activating protein 6	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0008289; F:lipid binding; IEA:InterPro
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0005100; F:Rho GTPase activator activity; IDA:UniProtKB
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0042169; F:SH2 domain binding; IPI:UniProtKB
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0030036; P:actin cytoskeleton organization; ISS:UniProtKB
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0006915; P:apoptotic process; IDA:UniProtKB
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0048041; P:focal adhesion assembly; ISS:UniProtKB
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0030900; P:forebrain development; ISS:UniProtKB
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0003007; P:heart morphogenesis; ISS:UniProtKB
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0021575; P:hindbrain morphogenesis; ISS:UniProtKB
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0035024; P:negative regulation of Rho protein signal transduction; IMP:UniProtKB
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0051497; P:negative regulation of stress fiber assembly; IDA:UniProtKB
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0001843; P:neural tube closure; ISS:UniProtKB
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:1900119; P:positive regulation of execution phase of apoptosis; IDA:UniProtKB
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0035307; P:positive regulation of protein dephosphorylation; IDA:UniProtKB
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0032321; P:positive regulation of Rho GTPase activity; IDA:GOC
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0032956; P:regulation of actin cytoskeleton organization; IMP:UniProtKB
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q96QB1	DLC1	Rho GTPase-activating protein 7	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9BRR9	ARHGAP9	Rho GTPase-activating protein 9	GO:0005096; F:GTPase activator activity; IDA:MGI
Q9BRR9	ARHGAP9	Rho GTPase-activating protein 9	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB
Q9BRR9	ARHGAP9	Rho GTPase-activating protein 9	GO:0043547; P:positive regulation of GTPase activity; IDA:GOC
Q9BRR9	ARHGAP9	Rho GTPase-activating protein 9	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q9BRR9	ARHGAP9	Rho GTPase-activating protein 9	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
A1A4S6	ARHGAP10	Rho GTPase-activating protein 10	GO:0005515; F:protein binding; IPI:IntAct
A1A4S6	ARHGAP10	Rho GTPase-activating protein 10	GO:0005100; F:Rho GTPase activator activity; IEA:Ensembl
A1A4S6	ARHGAP10	Rho GTPase-activating protein 10	GO:0006915; P:apoptotic process; TAS:Reactome
A1A4S6	ARHGAP10	Rho GTPase-activating protein 10	GO:0007010; P:cytoskeleton organization; IEA:Ensembl
A1A4S6	ARHGAP10	Rho GTPase-activating protein 10	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
A1A4S6	ARHGAP10	Rho GTPase-activating protein 10	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
A1A4S6	ARHGAP10	Rho GTPase-activating protein 10	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
A1A4S6	ARHGAP10	Rho GTPase-activating protein 10	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P85298	ARHGAP8	Rho GTPase-activating protein 8	GO:0005515; F:protein binding; IPI:BHF-UCL
P85298	ARHGAP8	Rho GTPase-activating protein 8	GO:0005100; F:Rho GTPase activator activity; IDA:BHF-UCL
P85298	ARHGAP8	Rho GTPase-activating protein 8	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL
P85298	ARHGAP8	Rho GTPase-activating protein 8	GO:0032321; P:positive regulation of Rho GTPase activity; IDA:GOC
P85298	ARHGAP8	Rho GTPase-activating protein 8	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P85298	ARHGAP8	Rho GTPase-activating protein 8	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q8IWW6	ARHGAP12	Rho GTPase-activating protein 12	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q8IWW6	ARHGAP12	Rho GTPase-activating protein 12	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q8IWW6	ARHGAP12	Rho GTPase-activating protein 12	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q53QZ3	ARHGAP15	Rho GTPase-activating protein 15	GO:0030675; F:Rac GTPase activator activity; IDA:MGI
Q53QZ3	ARHGAP15	Rho GTPase-activating protein 15	GO:0032855; P:positive regulation of Rac GTPase activity; IDA:GOC
Q53QZ3	ARHGAP15	Rho GTPase-activating protein 15	GO:0008360; P:regulation of cell shape; IDA:MGI
Q53QZ3	ARHGAP15	Rho GTPase-activating protein 15	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q53QZ3	ARHGAP15	Rho GTPase-activating protein 15	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q68EM7	ARHGAP17	Rho GTPase-activating protein 17	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q68EM7	ARHGAP17	Rho GTPase-activating protein 17	GO:0005515; F:protein binding; IPI:IntAct
Q68EM7	ARHGAP17	Rho GTPase-activating protein 17	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q68EM7	ARHGAP17	Rho GTPase-activating protein 17	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q8N392	ARHGAP18	Rho GTPase-activating protein 18	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q8N392	ARHGAP18	Rho GTPase-activating protein 18	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q8N392	ARHGAP18	Rho GTPase-activating protein 18	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q14CB8	ARHGAP19	Rho GTPase-activating protein 19	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q14CB8	ARHGAP19	Rho GTPase-activating protein 19	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q14CB8	ARHGAP19	Rho GTPase-activating protein 19	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9P2F6	ARHGAP20	Rho GTPase-activating protein 20	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q9P2F6	ARHGAP20	Rho GTPase-activating protein 20	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q9P2F6	ARHGAP20	Rho GTPase-activating protein 20	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q5T5U3	ARHGAP21	Rho GTPase-activating protein 21	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q5T5U3	ARHGAP21	Rho GTPase-activating protein 21	GO:0005515; F:protein binding; IPI:IntAct
Q5T5U3	ARHGAP21	Rho GTPase-activating protein 21	GO:0051683; P:establishment of Golgi localization; IDA:BHF-UCL
Q5T5U3	ARHGAP21	Rho GTPase-activating protein 21	GO:0007030; P:Golgi organization; IMP:BHF-UCL
Q5T5U3	ARHGAP21	Rho GTPase-activating protein 21	GO:0051684; P:maintenance of Golgi location; IMP:BHF-UCL
Q5T5U3	ARHGAP21	Rho GTPase-activating protein 21	GO:0072384; P:organelle transport along microtubule; IMP:BHF-UCL
Q5T5U3	ARHGAP21	Rho GTPase-activating protein 21	GO:0007165; P:signal transduction; IEA:InterPro
Q7Z5H3	ARHGAP22	Rho GTPase-activating protein 22	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q7Z5H3	ARHGAP22	Rho GTPase-activating protein 22	GO:0005515; F:protein binding; IPI:IntAct
Q7Z5H3	ARHGAP22	Rho GTPase-activating protein 22	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q7Z5H3	ARHGAP22	Rho GTPase-activating protein 22	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q7Z5H3	ARHGAP22	Rho GTPase-activating protein 22	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q7Z5H3	ARHGAP22	Rho GTPase-activating protein 22	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z5H3	ARHGAP22	Rho GTPase-activating protein 22	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q7Z5H3	ARHGAP22	Rho GTPase-activating protein 22	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9P227	ARHGAP23	Rho GTPase-activating protein 23	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q9P227	ARHGAP23	Rho GTPase-activating protein 23	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q9P227	ARHGAP23	Rho GTPase-activating protein 23	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q8N264	ARHGAP24	Rho GTPase-activating protein 24	GO:0005515; F:protein binding; IPI:IntAct
Q8N264	ARHGAP24	Rho GTPase-activating protein 24	GO:0030675; F:Rac GTPase activator activity; IEA:Ensembl
Q8N264	ARHGAP24	Rho GTPase-activating protein 24	GO:0032863; P:activation of Rac GTPase activity; IEA:Ensembl
Q8N264	ARHGAP24	Rho GTPase-activating protein 24	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q8N264	ARHGAP24	Rho GTPase-activating protein 24	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8N264	ARHGAP24	Rho GTPase-activating protein 24	GO:0035021; P:negative regulation of Rac protein signal transduction; IEA:Ensembl
Q8N264	ARHGAP24	Rho GTPase-activating protein 24	GO:1900028; P:negative regulation of ruffle assembly; IEA:Ensembl
Q8N264	ARHGAP24	Rho GTPase-activating protein 24	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q8N264	ARHGAP24	Rho GTPase-activating protein 24	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q8N264	ARHGAP24	Rho GTPase-activating protein 24	GO:0035313; P:wound healing, spreading of epidermal cells; IEA:Ensembl
P42331	ARHGAP25	Rho GTPase-activating protein 25	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
P42331	ARHGAP25	Rho GTPase-activating protein 25	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P42331	ARHGAP25	Rho GTPase-activating protein 25	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9UNA1	ARHGAP26	Rho GTPase-activating protein 26	GO:0005543; F:phospholipid binding; IDA:FlyBase
Q9UNA1	ARHGAP26	Rho GTPase-activating protein 26	GO:0005515; F:protein binding; IPI:IntAct
Q9UNA1	ARHGAP26	Rho GTPase-activating protein 26	GO:0005100; F:Rho GTPase activator activity; NAS:UniProtKB
Q9UNA1	ARHGAP26	Rho GTPase-activating protein 26	GO:0030036; P:actin cytoskeleton organization; NAS:UniProtKB
Q9UNA1	ARHGAP26	Rho GTPase-activating protein 26	GO:0046847; P:filopodium assembly; IEA:InterPro
Q9UNA1	ARHGAP26	Rho GTPase-activating protein 26	GO:0007399; P:nervous system development; NAS:UniProtKB
Q9UNA1	ARHGAP26	Rho GTPase-activating protein 26	GO:0032321; P:positive regulation of Rho GTPase activity; NAS:GOC
Q9UNA1	ARHGAP26	Rho GTPase-activating protein 26	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q9UNA1	ARHGAP26	Rho GTPase-activating protein 26	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q6ZUM4	ARHGAP27	Rho GTPase-activating protein 27	GO:0030675; F:Rac GTPase activator activity; ISS:HGNC
Q6ZUM4	ARHGAP27	Rho GTPase-activating protein 27	GO:0017124; F:SH3 domain binding; ISS:HGNC
Q6ZUM4	ARHGAP27	Rho GTPase-activating protein 27	GO:0043089; P:positive regulation of Cdc42 GTPase activity; ISS:HGNC
Q6ZUM4	ARHGAP27	Rho GTPase-activating protein 27	GO:0032855; P:positive regulation of Rac GTPase activity; ISS:GOC
Q6ZUM4	ARHGAP27	Rho GTPase-activating protein 27	GO:0006898; P:receptor-mediated endocytosis; ISS:HGNC
Q6ZUM4	ARHGAP27	Rho GTPase-activating protein 27	GO:0007165; P:signal transduction; IEA:InterPro
Q9P2N2	ARHGAP28	Rho GTPase-activating protein 28	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q9P2N2	ARHGAP28	Rho GTPase-activating protein 28	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q9P2N2	ARHGAP28	Rho GTPase-activating protein 28	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q52LW3	ARHGAP29	Rho GTPase-activating protein 29	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q52LW3	ARHGAP29	Rho GTPase-activating protein 29	GO:0030165; F:PDZ domain binding; IDA:MGI
Q52LW3	ARHGAP29	Rho GTPase-activating protein 29	GO:0005100; F:Rho GTPase activator activity; TAS:ProtInc
Q52LW3	ARHGAP29	Rho GTPase-activating protein 29	GO:0032321; P:positive regulation of Rho GTPase activity; TAS:GOC
Q52LW3	ARHGAP29	Rho GTPase-activating protein 29	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q52LW3	ARHGAP29	Rho GTPase-activating protein 29	GO:0007266; P:Rho protein signal transduction; TAS:ProtInc
Q52LW3	ARHGAP29	Rho GTPase-activating protein 29	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q7Z6I6	ARHGAP30	Rho GTPase-activating protein 30	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q7Z6I6	ARHGAP30	Rho GTPase-activating protein 30	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q7Z6I6	ARHGAP30	Rho GTPase-activating protein 30	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
A7KAX9	ARHGAP32	Rho GTPase-activating protein 32	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
A7KAX9	ARHGAP32	Rho GTPase-activating protein 32	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
A7KAX9	ARHGAP32	Rho GTPase-activating protein 32	GO:0005515; F:protein binding; IPI:IntAct
A7KAX9	ARHGAP32	Rho GTPase-activating protein 32	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
A7KAX9	ARHGAP32	Rho GTPase-activating protein 32	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
O14559	ARHGAP33	Rho GTPase-activating protein 33	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
O14559	ARHGAP33	Rho GTPase-activating protein 33	GO:0005515; F:protein binding; IPI:IntAct
O14559	ARHGAP33	Rho GTPase-activating protein 33	GO:0030675; F:Rac GTPase activator activity; IEA:Ensembl
O14559	ARHGAP33	Rho GTPase-activating protein 33	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O14559	ARHGAP33	Rho GTPase-activating protein 33	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
O14559	ARHGAP33	Rho GTPase-activating protein 33	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q2M1Z3	ARHGAP31	Rho GTPase-activating protein 31	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q2M1Z3	ARHGAP31	Rho GTPase-activating protein 31	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q2M1Z3	ARHGAP31	Rho GTPase-activating protein 31	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9NRY4	ARHGAP35	Rho GTPase-activating protein 35	GO:0003677; F:DNA binding; TAS:ProtInc
Q9NRY4	ARHGAP35	Rho GTPase-activating protein 35	GO:0005525; F:GTP binding; IEA:InterPro
Q9NRY4	ARHGAP35	Rho GTPase-activating protein 35	GO:0005100; F:Rho GTPase activator activity; TAS:Reactome
Q9NRY4	ARHGAP35	Rho GTPase-activating protein 35	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q9NRY4	ARHGAP35	Rho GTPase-activating protein 35	GO:0007411; P:axon guidance; TAS:Reactome
Q9NRY4	ARHGAP35	Rho GTPase-activating protein 35	GO:0043010; P:camera-type eye development; IEA:Ensembl
Q9NRY4	ARHGAP35	Rho GTPase-activating protein 35	GO:0030900; P:forebrain development; IEA:Ensembl
Q9NRY4	ARHGAP35	Rho GTPase-activating protein 35	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9NRY4	ARHGAP35	Rho GTPase-activating protein 35	GO:0043116; P:negative regulation of vascular permeability; IEA:Ensembl
Q9NRY4	ARHGAP35	Rho GTPase-activating protein 35	GO:0001843; P:neural tube closure; IEA:Ensembl
Q9NRY4	ARHGAP35	Rho GTPase-activating protein 35	GO:0032321; P:positive regulation of Rho GTPase activity; TAS:GOC
Q9NRY4	ARHGAP35	Rho GTPase-activating protein 35	GO:0008360; P:regulation of cell shape; IEA:Ensembl
Q9NRY4	ARHGAP35	Rho GTPase-activating protein 35	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q9NRY4	ARHGAP35	Rho GTPase-activating protein 35	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9NRY4	ARHGAP35	Rho GTPase-activating protein 35	GO:0006351; P:transcription, DNA-templated; TAS:ProtInc
Q6ZRI8	ARHGAP36	Rho GTPase-activating protein 36	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q6ZRI8	ARHGAP36	Rho GTPase-activating protein 36	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q6ZRI8	ARHGAP36	Rho GTPase-activating protein 36	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q5TG30	ARHGAP40	Rho GTPase-activating protein 40	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q5TG30	ARHGAP40	Rho GTPase-activating protein 40	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q5TG30	ARHGAP40	Rho GTPase-activating protein 40	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9C0H5	ARHGAP39	Rho GTPase-activating protein 39	GO:0007411; P:axon guidance; TAS:Reactome
Q9C0H5	ARHGAP39	Rho GTPase-activating protein 39	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q9C0H5	ARHGAP39	Rho GTPase-activating protein 39	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
A6NI28	ARHGAP42	Rho GTPase-activating protein 42	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
A6NI28	ARHGAP42	Rho GTPase-activating protein 42	GO:0007165; P:signal transduction; IEA:InterPro
Q17R89	ARHGAP44	Rho GTPase-activating protein 44	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q17R89	ARHGAP44	Rho GTPase-activating protein 44	GO:0005543; F:phospholipid binding; IDA:FlyBase
Q17R89	ARHGAP44	Rho GTPase-activating protein 44	GO:0005515; F:protein binding; IPI:UniProtKB
Q17R89	ARHGAP44	Rho GTPase-activating protein 44	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q17R89	ARHGAP44	Rho GTPase-activating protein 44	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q17R89	ARHGAP44	Rho GTPase-activating protein 44	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q6P4F7	ARHGAP11A	Rho GTPase-activating protein 11A	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q6P4F7	ARHGAP11A	Rho GTPase-activating protein 11A	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q6P4F7	ARHGAP11A	Rho GTPase-activating protein 11A	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q3KRB8	ARHGAP11B	Rho GTPase-activating protein 11B	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q3KRB8	ARHGAP11B	Rho GTPase-activating protein 11B	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q3KRB8	ARHGAP11B	Rho GTPase-activating protein 11B	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9BSD3	RHNO1	RAD9, HUS1, RAD1-interacting nuclear orphan protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BSD3	RHNO1	RAD9, HUS1, RAD1-interacting nuclear orphan protein 1	GO:0071479; P:cellular response to ionizing radiation; IDA:UniProtKB
Q9BSD3	RHNO1	RAD9, HUS1, RAD1-interacting nuclear orphan protein 1	GO:0034644; P:cellular response to UV; IDA:UniProtKB
Q9BSD3	RHNO1	RAD9, HUS1, RAD1-interacting nuclear orphan protein 1	GO:0000077; P:DNA damage checkpoint; IMP:UniProtKB
Q9BSD3	RHNO1	RAD9, HUS1, RAD1-interacting nuclear orphan protein 1	GO:0070318; P:positive regulation of G0 to G1 transition; IMP:UniProtKB
Q9BSD3	RHNO1	RAD9, HUS1, RAD1-interacting nuclear orphan protein 1	GO:0000725; P:recombinational repair; IMP:UniProtKB
P08134	RHOC	Rho-related GTP-binding protein RhoC	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P08134	RHOC	Rho-related GTP-binding protein RhoC	GO:0005515; F:protein binding; IPI:UniProtKB
P08134	RHOC	Rho-related GTP-binding protein RhoC	GO:0004871; F:signal transducer activity; IMP:UniProtKB
P08134	RHOC	Rho-related GTP-binding protein RhoC	GO:0043297; P:apical junction assembly; IDA:UniProtKB
P08134	RHOC	Rho-related GTP-binding protein RhoC	GO:0007411; P:axon guidance; TAS:Reactome
P08134	RHOC	Rho-related GTP-binding protein RhoC	GO:0000910; P:cytokinesis; IDA:UniProtKB
P08134	RHOC	Rho-related GTP-binding protein RhoC	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
P08134	RHOC	Rho-related GTP-binding protein RhoC	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P08134	RHOC	Rho-related GTP-binding protein RhoC	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0019003; F:GDP binding; IEA:Ensembl
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0005525; F:GTP binding; TAS:UniProtKB
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0003924; F:GTPase activity; TAS:UniProtKB
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0005515; F:protein binding; IPI:IntAct
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0006915; P:apoptotic process; TAS:UniProtKB
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0007411; P:axon guidance; TAS:Reactome
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0007596; P:blood coagulation; TAS:Reactome
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0007155; P:cell adhesion; ISS:UniProtKB
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0070301; P:cellular response to hydrogen peroxide; IDA:UniProtKB
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0071479; P:cellular response to ionizing radiation; IDA:UniProtKB
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0000910; P:cytokinesis; IMP:UniProtKB
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0008333; P:endosome to lysosome transport; IDA:UniProtKB
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0006184; P:GTP catabolic process; TAS:GOC
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0045786; P:negative regulation of cell cycle; ISS:UniProtKB
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0030168; P:platelet activation; TAS:Reactome
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0045766; P:positive regulation of angiogenesis; ISS:UniProtKB
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0007266; P:Rho protein signal transduction; TAS:UniProtKB
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P62745	RHOB	Rho-related GTP-binding protein RhoB	GO:0006927; P:transformed cell apoptotic process; ISS:UniProtKB
P61586	RHOA	Transforming protein RhoA	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P61586	RHOA	Transforming protein RhoA	GO:0003924; F:GTPase activity; TAS:UniProtKB
P61586	RHOA	Transforming protein RhoA	GO:0017022; F:myosin binding; IPI:UniProtKB
P61586	RHOA	Transforming protein RhoA	GO:0005515; F:protein binding; IPI:UniProtKB
P61586	RHOA	Transforming protein RhoA	GO:0030036; P:actin cytoskeleton organization; TAS:UniProtKB
P61586	RHOA	Transforming protein RhoA	GO:0043297; P:apical junction assembly; IMP:UniProtKB
P61586	RHOA	Transforming protein RhoA	GO:0007411; P:axon guidance; TAS:Reactome
P61586	RHOA	Transforming protein RhoA	GO:0007596; P:blood coagulation; TAS:Reactome
P61586	RHOA	Transforming protein RhoA	GO:0036089; P:cleavage furrow formation; IDA:UniProtKB
P61586	RHOA	Transforming protein RhoA	GO:0006184; P:GTP catabolic process; TAS:GOC
P61586	RHOA	Transforming protein RhoA	GO:0050771; P:negative regulation of axonogenesis; TAS:Reactome
P61586	RHOA	Transforming protein RhoA	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P61586	RHOA	Transforming protein RhoA	GO:0043931; P:ossification involved in bone maturation; ISS:BHF-UCL
P61586	RHOA	Transforming protein RhoA	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P61586	RHOA	Transforming protein RhoA	GO:0030168; P:platelet activation; TAS:Reactome
P61586	RHOA	Transforming protein RhoA	GO:0050772; P:positive regulation of axonogenesis; TAS:Reactome
P61586	RHOA	Transforming protein RhoA	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB
P61586	RHOA	Transforming protein RhoA	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
P61586	RHOA	Transforming protein RhoA	GO:0045666; P:positive regulation of neuron differentiation; IMP:MGI
P61586	RHOA	Transforming protein RhoA	GO:0042346; P:positive regulation of NF-kappaB import into nucleus; NAS:UniProtKB
P61586	RHOA	Transforming protein RhoA	GO:0051496; P:positive regulation of stress fiber assembly; IDA:MGI
P61586	RHOA	Transforming protein RhoA	GO:0050770; P:regulation of axonogenesis; TAS:Reactome
P61586	RHOA	Transforming protein RhoA	GO:0030334; P:regulation of cell migration; IMP:UniProtKB
P61586	RHOA	Transforming protein RhoA	GO:0033688; P:regulation of osteoblast proliferation; ISS:BHF-UCL
P61586	RHOA	Transforming protein RhoA	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P61586	RHOA	Transforming protein RhoA	GO:0007266; P:Rho protein signal transduction; TAS:UniProtKB
P61586	RHOA	Transforming protein RhoA	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P61586	RHOA	Transforming protein RhoA	GO:0090307; P:spindle assembly involved in mitosis; IMP:BHF-UCL
P61586	RHOA	Transforming protein RhoA	GO:0021762; P:substantia nigra development; IEP:UniProt
P61586	RHOA	Transforming protein RhoA	GO:0061383; P:trabecula morphogenesis; ISS:BHF-UCL
P61586	RHOA	Transforming protein RhoA	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P61586	RHOA	Transforming protein RhoA	GO:0016032; P:viral process; IEA:UniProtKB-KW
O00212	RHOD	Rho-related GTP-binding protein RhoD	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
O00212	RHOD	Rho-related GTP-binding protein RhoD	GO:0003924; F:GTPase activity; TAS:ProtInc
O00212	RHOD	Rho-related GTP-binding protein RhoD	GO:0006184; P:GTP catabolic process; TAS:GOC
O00212	RHOD	Rho-related GTP-binding protein RhoD	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
O00212	RHOD	Rho-related GTP-binding protein RhoD	GO:0007266; P:Rho protein signal transduction; TAS:ProtInc
O00212	RHOD	Rho-related GTP-binding protein RhoD	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q15669	RHOH	Rho-related GTP-binding protein RhoH	GO:0005525; F:GTP binding; IDA:UniProtKB
Q15669	RHOH	Rho-related GTP-binding protein RhoH	GO:0005095; F:GTPase inhibitor activity; NAS:UniProtKB
Q15669	RHOH	Rho-related GTP-binding protein RhoH	GO:0019210; F:kinase inhibitor activity; IDA:UniProtKB
Q15669	RHOH	Rho-related GTP-binding protein RhoH	GO:0005515; F:protein binding; IPI:UniProtKB
Q15669	RHOH	Rho-related GTP-binding protein RhoH	GO:0017048; F:Rho GTPase binding; NAS:UniProtKB
Q15669	RHOH	Rho-related GTP-binding protein RhoH	GO:0045576; P:mast cell activation; IEA:Ensembl
Q15669	RHOH	Rho-related GTP-binding protein RhoH	GO:0043086; P:negative regulation of catalytic activity; NAS:GOC
Q15669	RHOH	Rho-related GTP-binding protein RhoH	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q15669	RHOH	Rho-related GTP-binding protein RhoH	GO:0042326; P:negative regulation of phosphorylation; IDA:GOC
Q15669	RHOH	Rho-related GTP-binding protein RhoH	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q15669	RHOH	Rho-related GTP-binding protein RhoH	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q15669	RHOH	Rho-related GTP-binding protein RhoH	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q15669	RHOH	Rho-related GTP-binding protein RhoH	GO:0030217; P:T cell differentiation; NAS:UniProtKB
P84095	RHOG	Rho-related GTP-binding protein RhoG	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P84095	RHOG	Rho-related GTP-binding protein RhoG	GO:0003924; F:GTPase activity; IDA:MGI
P84095	RHOG	Rho-related GTP-binding protein RhoG	GO:0005515; F:protein binding; IPI:UniProtKB
P84095	RHOG	Rho-related GTP-binding protein RhoG	GO:0030036; P:actin cytoskeleton organization; IDA:MGI
P84095	RHOG	Rho-related GTP-binding protein RhoG	GO:0032863; P:activation of Rac GTPase activity; IMP:UniProtKB
P84095	RHOG	Rho-related GTP-binding protein RhoG	GO:0007411; P:axon guidance; TAS:Reactome
P84095	RHOG	Rho-related GTP-binding protein RhoG	GO:0007596; P:blood coagulation; TAS:Reactome
P84095	RHOG	Rho-related GTP-binding protein RhoG	GO:0060326; P:cell chemotaxis; IMP:UniProtKB
P84095	RHOG	Rho-related GTP-binding protein RhoG	GO:0006184; P:GTP catabolic process; IDA:GOC
P84095	RHOG	Rho-related GTP-binding protein RhoG	GO:0030168; P:platelet activation; TAS:Reactome
P84095	RHOG	Rho-related GTP-binding protein RhoG	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P84095	RHOG	Rho-related GTP-binding protein RhoG	GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; IMP:UniProtKB
P84095	RHOG	Rho-related GTP-binding protein RhoG	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:MGI
P84095	RHOG	Rho-related GTP-binding protein RhoG	GO:0016601; P:Rac protein signal transduction; IDA:MGI
P84095	RHOG	Rho-related GTP-binding protein RhoG	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P84095	RHOG	Rho-related GTP-binding protein RhoG	GO:0007266; P:Rho protein signal transduction; IDA:MGI
P84095	RHOG	Rho-related GTP-binding protein RhoG	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q96L33	RHOV	Rho-related GTP-binding protein RhoV	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q96L33	RHOV	Rho-related GTP-binding protein RhoV	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96L33	RHOV	Rho-related GTP-binding protein RhoV	GO:0005515; F:protein binding; IPI:IntAct
Q96L33	RHOV	Rho-related GTP-binding protein RhoV	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q96L33	RHOV	Rho-related GTP-binding protein RhoV	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q7L0Q8	RHOU	Rho-related GTP-binding protein RhoU	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q7L0Q8	RHOU	Rho-related GTP-binding protein RhoU	GO:0003924; F:GTPase activity; IEA:Ensembl
Q7L0Q8	RHOU	Rho-related GTP-binding protein RhoU	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7L0Q8	RHOU	Rho-related GTP-binding protein RhoU	GO:0005515; F:protein binding; IPI:IntAct
Q7L0Q8	RHOU	Rho-related GTP-binding protein RhoU	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
Q7L0Q8	RHOU	Rho-related GTP-binding protein RhoU	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q7L0Q8	RHOU	Rho-related GTP-binding protein RhoU	GO:0000082; P:G1/S transition of mitotic cell cycle; IEA:Ensembl
Q7L0Q8	RHOU	Rho-related GTP-binding protein RhoU	GO:0016601; P:Rac protein signal transduction; IEA:Ensembl
Q7L0Q8	RHOU	Rho-related GTP-binding protein RhoU	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
Q7L0Q8	RHOU	Rho-related GTP-binding protein RhoU	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q7L0Q8	RHOU	Rho-related GTP-binding protein RhoU	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9HBH0	RHOF	Rho-related GTP-binding protein RhoF	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9HBH0	RHOF	Rho-related GTP-binding protein RhoF	GO:0003924; F:GTPase activity; NAS:UniProtKB
Q9HBH0	RHOF	Rho-related GTP-binding protein RhoF	GO:0007015; P:actin filament organization; IDA:UniProtKB
Q9HBH0	RHOF	Rho-related GTP-binding protein RhoF	GO:0006184; P:GTP catabolic process; NAS:GOC
Q9HBH0	RHOF	Rho-related GTP-binding protein RhoF	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q9HBH0	RHOF	Rho-related GTP-binding protein RhoF	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P17081	RHOQ	Rho-related GTP-binding protein RhoQ	GO:0032427; F:GBD domain binding; IPI:BHF-UCL
P17081	RHOQ	Rho-related GTP-binding protein RhoQ	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P17081	RHOQ	Rho-related GTP-binding protein RhoQ	GO:0003924; F:GTPase activity; IDA:BHF-UCL
P17081	RHOQ	Rho-related GTP-binding protein RhoQ	GO:0005522; F:profilin binding; IPI:BHF-UCL
P17081	RHOQ	Rho-related GTP-binding protein RhoQ	GO:0032869; P:cellular response to insulin stimulus; IMP:BHF-UCL
P17081	RHOQ	Rho-related GTP-binding protein RhoQ	GO:0030866; P:cortical actin cytoskeleton organization; IMP:BHF-UCL
P17081	RHOQ	Rho-related GTP-binding protein RhoQ	GO:0006184; P:GTP catabolic process; IDA:BHF-UCL
P17081	RHOQ	Rho-related GTP-binding protein RhoQ	GO:0008286; P:insulin receptor signaling pathway; IMP:BHF-UCL
P17081	RHOQ	Rho-related GTP-binding protein RhoQ	GO:0090005; P:negative regulation of establishment of protein localization to plasma membrane; IMP:BHF-UCL
P17081	RHOQ	Rho-related GTP-binding protein RhoQ	GO:0051491; P:positive regulation of filopodium assembly; IDA:BHF-UCL
P17081	RHOQ	Rho-related GTP-binding protein RhoQ	GO:0046326; P:positive regulation of glucose import; IMP:BHF-UCL
P17081	RHOQ	Rho-related GTP-binding protein RhoQ	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P17081	RHOQ	Rho-related GTP-binding protein RhoQ	GO:0032956; P:regulation of actin cytoskeleton organization; IC:BHF-UCL
P17081	RHOQ	Rho-related GTP-binding protein RhoQ	GO:0008360; P:regulation of cell shape; IEA:Ensembl
P17081	RHOQ	Rho-related GTP-binding protein RhoQ	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P17081	RHOQ	Rho-related GTP-binding protein RhoQ	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9H4E5	RHOJ	Rho-related GTP-binding protein RhoJ	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9H4E5	RHOJ	Rho-related GTP-binding protein RhoJ	GO:0003924; F:GTPase activity; NAS:UniProtKB
Q9H4E5	RHOJ	Rho-related GTP-binding protein RhoJ	GO:0030036; P:actin cytoskeleton organization; IMP:UniProtKB
Q9H4E5	RHOJ	Rho-related GTP-binding protein RhoJ	GO:0006184; P:GTP catabolic process; NAS:GOC
Q9H4E5	RHOJ	Rho-related GTP-binding protein RhoJ	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
Q9H4E5	RHOJ	Rho-related GTP-binding protein RhoJ	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q9H4E5	RHOJ	Rho-related GTP-binding protein RhoJ	GO:0061299; P:retina vasculature morphogenesis in camera-type eye; IEA:Ensembl
Q9H4E5	RHOJ	Rho-related GTP-binding protein RhoJ	GO:0007266; P:Rho protein signal transduction; IEA:Ensembl
Q9H4E5	RHOJ	Rho-related GTP-binding protein RhoJ	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q8TCX5	RHPN1	Rhophilin-1	GO:0005083; F:small GTPase regulator activity; IEA:Ensembl
Q8TCX5	RHPN1	Rhophilin-1	GO:0007165; P:signal transduction; IEA:InterPro
Q8IUC4	RHPN2	Rhophilin-2	GO:0007165; P:signal transduction; IEA:InterPro
Q8NHV9	RHOXF1	Rhox homeobox family member 1	GO:0003677; F:DNA binding; NAS:UniProtKB
Q8NHV9	RHOXF1	Rhox homeobox family member 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q8NHV9	RHOXF1	Rhox homeobox family member 1	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
Q8NHV9	RHOXF1	Rhox homeobox family member 1	GO:0007276; P:gamete generation; NAS:UniProtKB
Q8NHV9	RHOXF1	Rhox homeobox family member 1	GO:0030518; P:intracellular steroid hormone receptor signaling pathway; NAS:UniProtKB
Q8NHV9	RHOXF1	Rhox homeobox family member 1	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
Q8NHV9	RHOXF1	Rhox homeobox family member 1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q8NHV9	RHOXF1	Rhox homeobox family member 1	GO:0019953; P:sexual reproduction; IEP:UniProtKB
Q8NHV9	RHOXF1	Rhox homeobox family member 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BQY4	RHOXF2	Rhox homeobox family member 2	GO:0005515; F:protein binding; IPI:IntAct
Q9BQY4	RHOXF2	Rhox homeobox family member 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9BQY4	RHOXF2	Rhox homeobox family member 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q7Z5B4	RIC3	Protein RIC-3	GO:0043623; P:cellular protein complex assembly; IEA:Ensembl
Q7Z5B4	RIC3	Protein RIC-3	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
Q7Z5B4	RIC3	Protein RIC-3	GO:0006457; P:protein folding; IEA:Ensembl
Q7Z5B4	RIC3	Protein RIC-3	GO:0007271; P:synaptic transmission, cholinergic; IEA:Ensembl
Q9NPQ8	RIC8A	Synembryn-A	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW
Q9NPQ8	RIC8A	Synembryn-A	GO:0005515; F:protein binding; IPI:IntAct
Q9NPQ8	RIC8A	Synembryn-A	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IEA:Ensembl
Q9NPQ8	RIC8A	Synembryn-A	GO:0071711; P:basement membrane organization; IEA:Ensembl
Q9NPQ8	RIC8A	Synembryn-A	GO:0042074; P:cell migration involved in gastrulation; IEA:Ensembl
Q9NPQ8	RIC8A	Synembryn-A	GO:0070586; P:cell-cell adhesion involved in gastrulation; IEA:Ensembl
Q9NPQ8	RIC8A	Synembryn-A	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9NPQ8	RIC8A	Synembryn-A	GO:0001944; P:vasculature development; IEA:Ensembl
Q9NPQ8	RIC8A	Synembryn-A	GO:0008542; P:visual learning; IEA:Ensembl
Q9NVN3	RIC8B	Synembryn-B	GO:0001965; F:G-protein alpha-subunit binding; IDA:MGI
Q9NVN3	RIC8B	Synembryn-B	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW
Q9NVN3	RIC8B	Synembryn-B	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; IDA:MGI
Q6R327	RICTOR	Rapamycin-insensitive companion of mTOR	GO:0005515; F:protein binding; IPI:UniProtKB
Q6R327	RICTOR	Rapamycin-insensitive companion of mTOR	GO:0043022; F:ribosome binding; IEA:Ensembl
Q6R327	RICTOR	Rapamycin-insensitive companion of mTOR	GO:0031532; P:actin cytoskeleton reorganization; IMP:UniProtKB
Q6R327	RICTOR	Rapamycin-insensitive companion of mTOR	GO:0009790; P:embryo development; ISS:UniProtKB
Q6R327	RICTOR	Rapamycin-insensitive companion of mTOR	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q6R327	RICTOR	Rapamycin-insensitive companion of mTOR	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q6R327	RICTOR	Rapamycin-insensitive companion of mTOR	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q6R327	RICTOR	Rapamycin-insensitive companion of mTOR	GO:0045087; P:innate immune response; TAS:Reactome
Q6R327	RICTOR	Rapamycin-insensitive companion of mTOR	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q6R327	RICTOR	Rapamycin-insensitive companion of mTOR	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q6R327	RICTOR	Rapamycin-insensitive companion of mTOR	GO:0030838; P:positive regulation of actin filament polymerization; IEA:Ensembl
Q6R327	RICTOR	Rapamycin-insensitive companion of mTOR	GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl
Q6R327	RICTOR	Rapamycin-insensitive companion of mTOR	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
Q6R327	RICTOR	Rapamycin-insensitive companion of mTOR	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
Q6R327	RICTOR	Rapamycin-insensitive companion of mTOR	GO:0032008; P:positive regulation of TOR signaling; IMP:UniProtKB
Q6R327	RICTOR	Rapamycin-insensitive companion of mTOR	GO:0032956; P:regulation of actin cytoskeleton organization; IMP:UniProtKB
Q6R327	RICTOR	Rapamycin-insensitive companion of mTOR	GO:0051896; P:regulation of protein kinase B signaling; IDA:UniProtKB
Q6R327	RICTOR	Rapamycin-insensitive companion of mTOR	GO:0032314; P:regulation of Rac GTPase activity; IEA:Ensembl
Q6R327	RICTOR	Rapamycin-insensitive companion of mTOR	GO:0031295; P:T cell costimulation; TAS:Reactome
Q6R327	RICTOR	Rapamycin-insensitive companion of mTOR	GO:0031929; P:TOR signaling; IEA:InterPro
Q5UIP0	RIF1	Telomere-associated protein RIF1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q5UIP0	RIF1	Telomere-associated protein RIF1	GO:0006974; P:cellular response to DNA damage stimulus; IEA:UniProtKB-KW
Q5UIP0	RIF1	Telomere-associated protein RIF1	GO:0019827; P:stem cell maintenance; IEA:Ensembl
Q969G6	RFK	Riboflavin kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q969G6	RFK	Riboflavin kinase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q969G6	RFK	Riboflavin kinase	GO:0008531; F:riboflavin kinase activity; NAS:UniProtKB
Q969G6	RFK	Riboflavin kinase	GO:0006915; P:apoptotic process; IMP:MGI
Q969G6	RFK	Riboflavin kinase	GO:0009398; P:FMN biosynthetic process; IEA:UniProtKB-UniPathway
Q969G6	RFK	Riboflavin kinase	GO:0033864; P:positive regulation of NAD(P)H oxidase activity; IMP:MGI
Q969G6	RFK	Riboflavin kinase	GO:0009231; P:riboflavin biosynthetic process; NAS:UniProtKB
Q969G6	RFK	Riboflavin kinase	GO:0006771; P:riboflavin metabolic process; TAS:Reactome
Q969G6	RFK	Riboflavin kinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q969G6	RFK	Riboflavin kinase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q969G6	RFK	Riboflavin kinase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q96NA2	RILP	Rab-interacting lysosomal protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q96NA2	RILP	Rab-interacting lysosomal protein	GO:0017137; F:Rab GTPase binding; TAS:UniProtKB
Q96NA2	RILP	Rab-interacting lysosomal protein	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q96NA2	RILP	Rab-interacting lysosomal protein	GO:0008333; P:endosome to lysosome transport; IMP:BHF-UCL
Q96NA2	RILP	Rab-interacting lysosomal protein	GO:0015031; P:protein transport; NAS:UniProtKB
O95153	BZRAP1	Peripheral-type benzodiazepine receptor-associated protein 1	GO:0030156; F:benzodiazepine receptor binding; IPI:UniProtKB
O95153	BZRAP1	Peripheral-type benzodiazepine receptor-associated protein 1	GO:0005515; F:protein binding; IPI:IntAct
O15034	RIMBP2	RIMS-binding protein 2	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q8IXN7	RIMKLA	N-acetylaspartylglutamate synthase A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IXN7	RIMKLA	N-acetylaspartylglutamate synthase A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IXN7	RIMKLA	N-acetylaspartylglutamate synthase A	GO:0072590; F:N-acetyl-L-aspartate-L-glutamate ligase activity; ISS:UniProtKB
Q8IXN7	RIMKLA	N-acetylaspartylglutamate synthase A	GO:0006464; P:cellular protein modification process; IEA:InterPro
Q9ULI2	RIMKLB	Beta-citrylglutamate synthase B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9ULI2	RIMKLB	Beta-citrylglutamate synthase B	GO:0072591; F:citrate-L-glutamate ligase activity; ISS:UniProtKB
Q9ULI2	RIMKLB	Beta-citrylglutamate synthase B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9ULI2	RIMKLB	Beta-citrylglutamate synthase B	GO:0072590; F:N-acetyl-L-aspartate-L-glutamate ligase activity; ISS:UniProtKB
Q9ULI2	RIMKLB	Beta-citrylglutamate synthase B	GO:0006464; P:cellular protein modification process; IEA:InterPro
Q86UR5	RIMS1	Regulating synaptic membrane exocytosis protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86UR5	RIMS1	Regulating synaptic membrane exocytosis protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q86UR5	RIMS1	Regulating synaptic membrane exocytosis protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q86UR5	RIMS1	Regulating synaptic membrane exocytosis protein 1	GO:0005083; F:small GTPase regulator activity; TAS:UniProtKB
Q86UR5	RIMS1	Regulating synaptic membrane exocytosis protein 1	GO:0017156; P:calcium ion-dependent exocytosis; TAS:UniProtKB
Q86UR5	RIMS1	Regulating synaptic membrane exocytosis protein 1	GO:0048791; P:calcium ion-dependent exocytosis of neurotransmitter; IEA:Ensembl
Q86UR5	RIMS1	Regulating synaptic membrane exocytosis protein 1	GO:0014047; P:glutamate secretion; TAS:Reactome
Q86UR5	RIMS1	Regulating synaptic membrane exocytosis protein 1	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q86UR5	RIMS1	Regulating synaptic membrane exocytosis protein 1	GO:0061025; P:membrane fusion; NAS:UniProtKB
Q86UR5	RIMS1	Regulating synaptic membrane exocytosis protein 1	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
Q86UR5	RIMS1	Regulating synaptic membrane exocytosis protein 1	GO:0006461; P:protein complex assembly; IDA:UniProtKB
Q86UR5	RIMS1	Regulating synaptic membrane exocytosis protein 1	GO:0045055; P:regulated secretory pathway; NAS:UniProtKB
Q86UR5	RIMS1	Regulating synaptic membrane exocytosis protein 1	GO:0050790; P:regulation of catalytic activity; TAS:GOC
Q86UR5	RIMS1	Regulating synaptic membrane exocytosis protein 1	GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IEA:Ensembl
Q86UR5	RIMS1	Regulating synaptic membrane exocytosis protein 1	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
Q86UR5	RIMS1	Regulating synaptic membrane exocytosis protein 1	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q86UR5	RIMS1	Regulating synaptic membrane exocytosis protein 1	GO:0046903; P:secretion; NAS:UniProtKB
Q86UR5	RIMS1	Regulating synaptic membrane exocytosis protein 1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q86UR5	RIMS1	Regulating synaptic membrane exocytosis protein 1	GO:0016079; P:synaptic vesicle exocytosis; TAS:UniProtKB
Q86UR5	RIMS1	Regulating synaptic membrane exocytosis protein 1	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q9UQ26	RIMS2	Regulating synaptic membrane exocytosis protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UQ26	RIMS2	Regulating synaptic membrane exocytosis protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q9UQ26	RIMS2	Regulating synaptic membrane exocytosis protein 2	GO:0017156; P:calcium ion-dependent exocytosis; IEA:Ensembl
Q9UQ26	RIMS2	Regulating synaptic membrane exocytosis protein 2	GO:0048791; P:calcium ion-dependent exocytosis of neurotransmitter; IEA:Ensembl
Q9UQ26	RIMS2	Regulating synaptic membrane exocytosis protein 2	GO:0019933; P:cAMP-mediated signaling; IEA:Ensembl
Q9UQ26	RIMS2	Regulating synaptic membrane exocytosis protein 2	GO:0030073; P:insulin secretion; IEA:Ensembl
Q9UQ26	RIMS2	Regulating synaptic membrane exocytosis protein 2	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9UQ26	RIMS2	Regulating synaptic membrane exocytosis protein 2	GO:0017157; P:regulation of exocytosis; IEA:Ensembl
Q9UQ26	RIMS2	Regulating synaptic membrane exocytosis protein 2	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
Q9UJD0	RIMS3	Regulating synaptic membrane exocytosis protein 3	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q9UJD0	RIMS3	Regulating synaptic membrane exocytosis protein 3	GO:0006836; P:neurotransmitter transport; IEA:UniProtKB-KW
Q9UJD0	RIMS3	Regulating synaptic membrane exocytosis protein 3	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
Q9H426	RIMS4	Regulating synaptic membrane exocytosis protein 4	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q9H426	RIMS4	Regulating synaptic membrane exocytosis protein 4	GO:0006836; P:neurotransmitter transport; IEA:UniProtKB-KW
Q9H426	RIMS4	Regulating synaptic membrane exocytosis protein 4	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
Q13671	RIN1	Ras and Rab interactor 1	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q13671	RIN1	Ras and Rab interactor 1	GO:0005515; F:protein binding; IPI:IntAct
Q13671	RIN1	Ras and Rab interactor 1	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q13671	RIN1	Ras and Rab interactor 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q8WYP3	RIN2	Ras and Rab interactor 2	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q8WYP3	RIN2	Ras and Rab interactor 2	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; NAS:UniProtKB
Q8WYP3	RIN2	Ras and Rab interactor 2	GO:0005083; F:small GTPase regulator activity; NAS:UniProtKB
Q8WYP3	RIN2	Ras and Rab interactor 2	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q8WYP3	RIN2	Ras and Rab interactor 2	GO:0050790; P:regulation of catalytic activity; NAS:GOC
Q8WYP3	RIN2	Ras and Rab interactor 2	GO:0032313; P:regulation of Rab GTPase activity; NAS:GOC
Q8WYP3	RIN2	Ras and Rab interactor 2	GO:0007264; P:small GTPase mediated signal transduction; NAS:UniProtKB
Q8TB24	RIN3	Ras and Rab interactor 3	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q8TB24	RIN3	Ras and Rab interactor 3	GO:0005515; F:protein binding; IPI:IntAct
Q8TB24	RIN3	Ras and Rab interactor 3	GO:0017137; F:Rab GTPase binding; IDA:UniProtKB
Q8TB24	RIN3	Ras and Rab interactor 3	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IMP:UniProtKB
Q8TB24	RIN3	Ras and Rab interactor 3	GO:0006897; P:endocytosis; NAS:UniProtKB
Q8TB24	RIN3	Ras and Rab interactor 3	GO:0032313; P:regulation of Rab GTPase activity; IMP:GOC
Q8TB24	RIN3	Ras and Rab interactor 3	GO:0007165; P:signal transduction; IEA:InterPro
Q06587	RING1	E3 ubiquitin-protein ligase RING1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q06587	RING1	E3 ubiquitin-protein ligase RING1	GO:0005515; F:protein binding; IPI:UniProtKB
Q06587	RING1	E3 ubiquitin-protein ligase RING1	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q06587	RING1	E3 ubiquitin-protein ligase RING1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q06587	RING1	E3 ubiquitin-protein ligase RING1	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q06587	RING1	E3 ubiquitin-protein ligase RING1	GO:0048593; P:camera-type eye morphogenesis; IEA:Ensembl
Q06587	RING1	E3 ubiquitin-protein ligase RING1	GO:0035518; P:histone H2A monoubiquitination; IDA:UniProtKB
Q06587	RING1	E3 ubiquitin-protein ligase RING1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q06587	RING1	E3 ubiquitin-protein ligase RING1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q99496	RNF2	E3 ubiquitin-protein ligase RING2	GO:0003682; F:chromatin binding; IEA:Ensembl
Q99496	RNF2	E3 ubiquitin-protein ligase RING2	GO:0005515; F:protein binding; IPI:UniProtKB
Q99496	RNF2	E3 ubiquitin-protein ligase RING2	GO:0071535; F:RING-like zinc finger domain binding; IPI:UniProtKB
Q99496	RNF2	E3 ubiquitin-protein ligase RING2	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q99496	RNF2	E3 ubiquitin-protein ligase RING2	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q99496	RNF2	E3 ubiquitin-protein ligase RING2	GO:0009948; P:anterior/posterior axis specification; IEA:Ensembl
Q99496	RNF2	E3 ubiquitin-protein ligase RING2	GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl
Q99496	RNF2	E3 ubiquitin-protein ligase RING2	GO:0035518; P:histone H2A monoubiquitination; IDA:UniProtKB
Q99496	RNF2	E3 ubiquitin-protein ligase RING2	GO:0036353; P:histone H2A-K119 monoubiquitination; ISS:UniProtKB
Q99496	RNF2	E3 ubiquitin-protein ligase RING2	GO:0000278; P:mitotic cell cycle; IEA:Ensembl
Q99496	RNF2	E3 ubiquitin-protein ligase RING2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q99496	RNF2	E3 ubiquitin-protein ligase RING2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P13489	RNH1	Ribonuclease inhibitor	GO:0005515; F:protein binding; IPI:UniProtKB
P13489	RNH1	Ribonuclease inhibitor	GO:0008428; F:ribonuclease inhibitor activity; IDA:UniProtKB
P13489	RNH1	Ribonuclease inhibitor	GO:0006402; P:mRNA catabolic process; NAS:UniProtKB
P13489	RNH1	Ribonuclease inhibitor	GO:0043086; P:negative regulation of catalytic activity; IDA:GOC
P13489	RNH1	Ribonuclease inhibitor	GO:0045765; P:regulation of angiogenesis; IDA:UniProtKB
Q6ZS11	RINL	Ras and Rab interactor-like protein	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q6ZS11	RINL	Ras and Rab interactor-like protein	GO:0005085; F:guanyl-nucleotide exchange factor activity; ISS:UniProtKB
Q6ZS11	RINL	Ras and Rab interactor-like protein	GO:0006897; P:endocytosis; ISS:UniProtKB
Q6ZS11	RINL	Ras and Rab interactor-like protein	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q6ZS11	RINL	Ras and Rab interactor-like protein	GO:0043087; P:regulation of GTPase activity; ISS:GOC
Q6NUQ1	RINT1	RAD50-interacting protein 1	GO:0005515; F:protein binding; IPI:HGNC
Q6NUQ1	RINT1	RAD50-interacting protein 1	GO:0031572; P:G2 DNA damage checkpoint; IMP:HGNC
Q6NUQ1	RINT1	RAD50-interacting protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q6NUQ1	RINT1	RAD50-interacting protein 1	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q9BRS2	RIOK1	Serine/threonine-protein kinase RIO1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BRS2	RIOK1	Serine/threonine-protein kinase RIO1	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q9BVS4	RIOK2	Serine/threonine-protein kinase RIO2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BVS4	RIOK2	Serine/threonine-protein kinase RIO2	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
O14730	RIOK3	Serine/threonine-protein kinase RIO3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O14730	RIOK3	Serine/threonine-protein kinase RIO3	GO:0005515; F:protein binding; IPI:IntAct
O14730	RIOK3	Serine/threonine-protein kinase RIO3	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
O14730	RIOK3	Serine/threonine-protein kinase RIO3	GO:0007059; P:chromosome segregation; TAS:ProtInc
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0070513; F:death domain binding; IPI:BHF-UCL
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0005123; F:death receptor binding; IPI:BHF-UCL
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0032403; F:protein complex binding; IDA:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:Reactome
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0007257; P:activation of JUN kinase activity; TAS:BHF-UCL
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:1990000; P:amyloid fibril formation; IMP:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0006915; P:apoptotic process; IMP:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0044257; P:cellular protein catabolic process; IDA:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0071356; P:cellular response to tumor necrosis factor; IDA:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:BHF-UCL
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0045087; P:innate immune response; TAS:Reactome
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0070266; P:necroptotic process; IMP:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0097527; P:necroptotic signaling pathway; IMP:BHF-UCL
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0036289; P:peptidyl-serine autophosphorylation; IDA:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0032757; P:positive regulation of interleukin-8 production; IDA:BHF-UCL
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0045651; P:positive regulation of macrophage differentiation; IMP:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0060545; P:positive regulation of necroptotic process; IMP:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0043068; P:positive regulation of programmed cell death; IMP:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0001934; P:positive regulation of protein phosphorylation; IMP:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; TAS:BHF-UCL
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0032760; P:positive regulation of tumor necrosis factor production; IDA:BHF-UCL
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0046777; P:protein autophosphorylation; IDA:BHF-UCL
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0051291; P:protein heterooligomerization; IMP:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0070926; P:regulation of ATP:ADP antiporter activity; IMP:BHF-UCL
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:2001239; P:regulation of extrinsic apoptotic signaling pathway in absence of ligand; TAS:Reactome
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0034612; P:response to tumor necrosis factor; IMP:BHF-UCL
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0097343; P:ripoptosome assembly; IMP:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0070231; P:T cell apoptotic process; ISS:UniProtKB
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q13546	RIPK1	Receptor-interacting serine/threonine-protein kinase 1	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IC:BHF-UCL
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0042802; F:identical protein binding; IPI:IntAct
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0004704; F:NF-kappaB-inducing kinase activity; IEA:Ensembl
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0032403; F:protein complex binding; IMP:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0032147; P:activation of protein kinase activity; IMP:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:1990000; P:amyloid fibril formation; IMP:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0097190; P:apoptotic signaling pathway; TAS:ProtInc
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0045087; P:innate immune response; TAS:Reactome
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0048535; P:lymph node development; ISS:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0070266; P:necroptotic process; IMP:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0060545; P:positive regulation of necroptotic process; IDA:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0010922; P:positive regulation of phosphatase activity; IMP:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0051291; P:protein heterooligomerization; IMP:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0046006; P:regulation of activated T cell proliferation; ISS:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0070235; P:regulation of activation-induced cell death of T cells; ISS:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0002819; P:regulation of adaptive immune response; ISS:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:2000452; P:regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation; ISS:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0032649; P:regulation of interferon-gamma production; ISS:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0001914; P:regulation of T cell mediated cytotoxicity; ISS:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0048536; P:spleen development; ISS:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0033077; P:T cell differentiation in thymus; ISS:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0043029; P:T cell homeostasis; ISS:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0048538; P:thymus development; ISS:UniProtKB
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q9Y572	RIPK3	Receptor-interacting serine/threonine-protein kinase 3	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0050700; F:CARD domain binding; IPI:UniProtKB
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0030274; F:LIM domain binding; IPI:UniProtKB
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0005515; F:protein binding; IPI:UniProtKB
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0004871; F:signal transducer activity; TAS:ProtInc
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0000187; P:activation of MAPK activity; TAS:Reactome
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0002250; P:adaptive immune response; ISS:UniProtKB
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0006915; P:apoptotic process; TAS:ProtInc
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0071223; P:cellular response to lipoteichoic acid; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0071225; P:cellular response to muramyl dipeptide; IDA:UniProtKB
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0071224; P:cellular response to peptidoglycan; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0050830; P:defense response to Gram-positive bacterium; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; ISS:UniProtKB
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0006954; P:inflammatory response; TAS:ProtInc
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0045087; P:innate immune response; IDA:UniProtKB
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0007254; P:JNK cascade; TAS:Reactome
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0070427; P:nucleotide-binding oligomerization domain containing 1 signaling pathway; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0070431; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; IDA:UniProtKB
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0046641; P:positive regulation of alpha-beta T cell proliferation; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0032722; P:positive regulation of chemokine production; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0001961; P:positive regulation of cytokine-mediated signaling pathway; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:MGI
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0033091; P:positive regulation of immature T cell proliferation; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0032727; P:positive regulation of interferon-alpha production; NAS:BHF-UCL
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0032728; P:positive regulation of interferon-beta production; NAS:BHF-UCL
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0032729; P:positive regulation of interferon-gamma production; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0032735; P:positive regulation of interleukin-12 production; NAS:BHF-UCL
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0032743; P:positive regulation of interleukin-2 production; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0046330; P:positive regulation of JNK cascade; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:UniProtKB
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IDA:UniProtKB
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0031398; P:positive regulation of protein ubiquitination; IMP:UniProtKB
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0045627; P:positive regulation of T-helper 1 cell differentiation; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0002827; P:positive regulation of T-helper 1 type immune response; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; NAS:BHF-UCL
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0032760; P:positive regulation of tumor necrosis factor production; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0043330; P:response to exogenous dsRNA; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0070555; P:response to interleukin-1; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0070671; P:response to interleukin-12; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0070673; P:response to interleukin-18; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0007165; P:signal transduction; TAS:ProtInc
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0042098; P:T cell proliferation; IEA:Ensembl
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0050852; P:T cell receptor signaling pathway; ISS:UniProtKB
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0034134; P:toll-like receptor 2 signaling pathway; IDA:MGI
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
O43353	RIPK2	Receptor-interacting serine/threonine-protein kinase 2	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P57078	RIPK4	Receptor-interacting serine/threonine-protein kinase 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P57078	RIPK4	Receptor-interacting serine/threonine-protein kinase 4	GO:0005515; F:protein binding; IPI:IntAct
P57078	RIPK4	Receptor-interacting serine/threonine-protein kinase 4	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
P57078	RIPK4	Receptor-interacting serine/threonine-protein kinase 4	GO:0002009; P:morphogenesis of an epithelium; IMP:UniProtKB
P57078	RIPK4	Receptor-interacting serine/threonine-protein kinase 4	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
Q5EBL4	RILPL1	RILP-like protein 1	GO:0003382; P:epithelial cell morphogenesis; ISS:UniProtKB
Q5EBL4	RILPL1	RILP-like protein 1	GO:0006886; P:intracellular protein transport; ISS:UniProtKB
Q5EBL4	RILPL1	RILP-like protein 1	GO:1901214; P:regulation of neuron death; ISS:UniProtKB
Q969X0	RILPL2	RILP-like protein 2	GO:0042802; F:identical protein binding; IPI:IntAct
Q969X0	RILPL2	RILP-like protein 2	GO:0003382; P:epithelial cell morphogenesis; ISS:UniProtKB
Q969X0	RILPL2	RILP-like protein 2	GO:0006886; P:intracellular protein transport; ISS:UniProtKB
Q0D2K3	RIPPLY1	Protein ripply1	GO:0009880; P:embryonic pattern specification; ISS:UniProtKB
Q0D2K3	RIPPLY1	Protein ripply1	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q0D2K3	RIPPLY1	Protein ripply1	GO:0032525; P:somite rostral/caudal axis specification; ISS:UniProtKB
Q0D2K3	RIPPLY1	Protein ripply1	GO:0001757; P:somite specification; ISS:UniProtKB
Q0D2K3	RIPPLY1	Protein ripply1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5TAB7	RIPPLY2	Protein ripply2	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
Q5TAB7	RIPPLY2	Protein ripply2	GO:0001503; P:ossification; IEA:Ensembl
Q5TAB7	RIPPLY2	Protein ripply2	GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl
Q5TAB7	RIPPLY2	Protein ripply2	GO:0032525; P:somite rostral/caudal axis specification; ISS:UniProtKB
Q5TAB7	RIPPLY2	Protein ripply2	GO:0001756; P:somitogenesis; ISS:UniProtKB
Q86UA6	RPAIN	RPA-interacting protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86UA6	RPAIN	RPA-interacting protein	GO:0032403; F:protein complex binding; IPI:MGI
Q86UA6	RPAIN	RPA-interacting protein	GO:0006310; P:DNA recombination; IPI:MGI
Q86UA6	RPAIN	RPA-interacting protein	GO:0006281; P:DNA repair; IPI:MGI
Q86UA6	RPAIN	RPA-interacting protein	GO:0006261; P:DNA-dependent DNA replication; IPI:MGI
Q86UA6	RPAIN	RPA-interacting protein	GO:0006606; P:protein import into nucleus; IDA:MGI
Q86UA6	RPAIN	RPA-interacting protein	GO:0009411; P:response to UV; IDA:MGI
P23921	RRM1	Ribonucleoside-diphosphate reductase large subunit	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P23921	RRM1	Ribonucleoside-diphosphate reductase large subunit	GO:0005515; F:protein binding; IPI:IntAct
P23921	RRM1	Ribonucleoside-diphosphate reductase large subunit	GO:0004748; F:ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ISS:UniProtKB
P23921	RRM1	Ribonucleoside-diphosphate reductase large subunit	GO:0021846; P:cell proliferation in forebrain; IEA:Ensembl
P23921	RRM1	Ribonucleoside-diphosphate reductase large subunit	GO:0009263; P:deoxyribonucleotide biosynthetic process; ISS:UniProtKB
P23921	RRM1	Ribonucleoside-diphosphate reductase large subunit	GO:0006260; P:DNA replication; IEA:UniProtKB-UniPathway
P23921	RRM1	Ribonucleoside-diphosphate reductase large subunit	GO:0008584; P:male gonad development; IEA:Ensembl
P23921	RRM1	Ribonucleoside-diphosphate reductase large subunit	GO:0000278; P:mitotic cell cycle; IEA:Ensembl
P23921	RRM1	Ribonucleoside-diphosphate reductase large subunit	GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome
P23921	RRM1	Ribonucleoside-diphosphate reductase large subunit	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P23921	RRM1	Ribonucleoside-diphosphate reductase large subunit	GO:0051290; P:protein heterotetramerization; IEA:Ensembl
P23921	RRM1	Ribonucleoside-diphosphate reductase large subunit	GO:0006206; P:pyrimidine nucleobase metabolic process; IEA:Ensembl
P23921	RRM1	Ribonucleoside-diphosphate reductase large subunit	GO:0010212; P:response to ionizing radiation; IEA:Ensembl
P23921	RRM1	Ribonucleoside-diphosphate reductase large subunit	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
P23921	RRM1	Ribonucleoside-diphosphate reductase large subunit	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q7LG56	RRM2B	Ribonucleoside-diphosphate reductase subunit M2 B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7LG56	RRM2B	Ribonucleoside-diphosphate reductase subunit M2 B	GO:0004748; F:ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; IEA:UniProtKB-EC
Q7LG56	RRM2B	Ribonucleoside-diphosphate reductase subunit M2 B	GO:0009186; P:deoxyribonucleoside diphosphate metabolic process; IEA:InterPro
Q7LG56	RRM2B	Ribonucleoside-diphosphate reductase subunit M2 B	GO:0009200; P:deoxyribonucleoside triphosphate metabolic process; IEA:Ensembl
Q7LG56	RRM2B	Ribonucleoside-diphosphate reductase subunit M2 B	GO:0009263; P:deoxyribonucleotide biosynthetic process; IEA:Ensembl
Q7LG56	RRM2B	Ribonucleoside-diphosphate reductase subunit M2 B	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q7LG56	RRM2B	Ribonucleoside-diphosphate reductase subunit M2 B	GO:0001822; P:kidney development; IEA:Ensembl
Q7LG56	RRM2B	Ribonucleoside-diphosphate reductase subunit M2 B	GO:0006264; P:mitochondrial DNA replication; IEA:Ensembl
Q7LG56	RRM2B	Ribonucleoside-diphosphate reductase subunit M2 B	GO:1902254; P:negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator; IEA:Ensembl
Q7LG56	RRM2B	Ribonucleoside-diphosphate reductase subunit M2 B	GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome
Q7LG56	RRM2B	Ribonucleoside-diphosphate reductase subunit M2 B	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q7LG56	RRM2B	Ribonucleoside-diphosphate reductase subunit M2 B	GO:0003014; P:renal system process; IEA:Ensembl
Q7LG56	RRM2B	Ribonucleoside-diphosphate reductase subunit M2 B	GO:0006979; P:response to oxidative stress; IEA:Ensembl
Q7LG56	RRM2B	Ribonucleoside-diphosphate reductase subunit M2 B	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P31350	RRM2	Ribonucleoside-diphosphate reductase subunit M2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P31350	RRM2	Ribonucleoside-diphosphate reductase subunit M2	GO:0005515; F:protein binding; IPI:IntAct
P31350	RRM2	Ribonucleoside-diphosphate reductase subunit M2	GO:0004748; F:ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ISS:UniProtKB
P31350	RRM2	Ribonucleoside-diphosphate reductase subunit M2	GO:0009186; P:deoxyribonucleoside diphosphate metabolic process; IEA:InterPro
P31350	RRM2	Ribonucleoside-diphosphate reductase subunit M2	GO:0009263; P:deoxyribonucleotide biosynthetic process; ISS:UniProtKB
P31350	RRM2	Ribonucleoside-diphosphate reductase subunit M2	GO:0006260; P:DNA replication; IEA:UniProtKB-UniPathway
P31350	RRM2	Ribonucleoside-diphosphate reductase subunit M2	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P31350	RRM2	Ribonucleoside-diphosphate reductase subunit M2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P31350	RRM2	Ribonucleoside-diphosphate reductase subunit M2	GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome
P31350	RRM2	Ribonucleoside-diphosphate reductase subunit M2	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P31350	RRM2	Ribonucleoside-diphosphate reductase subunit M2	GO:0051290; P:protein heterotetramerization; IEA:Ensembl
P31350	RRM2	Ribonucleoside-diphosphate reductase subunit M2	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; TAS:Reactome
P31350	RRM2	Ribonucleoside-diphosphate reductase subunit M2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9HB40	SCPEP1	Retinoid-inducible serine carboxypeptidase	GO:0004185; F:serine-type carboxypeptidase activity; IEA:InterPro
Q9HB40	SCPEP1	Retinoid-inducible serine carboxypeptidase	GO:0042573; P:retinoic acid metabolic process; IEA:Ensembl
Q92963	RIT1	GTP-binding protein Rit1	GO:0005516; F:calmodulin binding; TAS:ProtInc
Q92963	RIT1	GTP-binding protein Rit1	GO:0005525; F:GTP binding; TAS:ProtInc
Q92963	RIT1	GTP-binding protein Rit1	GO:0005515; F:protein binding; IPI:IntAct
Q92963	RIT1	GTP-binding protein Rit1	GO:0006184; P:GTP catabolic process; IEA:InterPro
Q92963	RIT1	GTP-binding protein Rit1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q92963	RIT1	GTP-binding protein Rit1	GO:0007265; P:Ras protein signal transduction; IDA:UniProtKB
Q92963	RIT1	GTP-binding protein Rit1	GO:0007165; P:signal transduction; TAS:ProtInc
Q92963	RIT1	GTP-binding protein Rit1	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q96K30	RITA1	RBPJ-interacting and tubulin-associated protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96K30	RITA1	RBPJ-interacting and tubulin-associated protein 1	GO:0015631; F:tubulin binding; IDA:UniProtKB
Q96K30	RITA1	RBPJ-interacting and tubulin-associated protein 1	GO:0045746; P:negative regulation of Notch signaling pathway; IDA:UniProtKB
Q96K30	RITA1	RBPJ-interacting and tubulin-associated protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:UniProtKB
Q96K30	RITA1	RBPJ-interacting and tubulin-associated protein 1	GO:0022008; P:neurogenesis; ISS:UniProtKB
Q96K30	RITA1	RBPJ-interacting and tubulin-associated protein 1	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
Q96K30	RITA1	RBPJ-interacting and tubulin-associated protein 1	GO:0051168; P:nuclear export; IDA:UniProtKB
Q99578	RIT2	GTP-binding protein Rit2	GO:0005516; F:calmodulin binding; TAS:ProtInc
Q99578	RIT2	GTP-binding protein Rit2	GO:0005525; F:GTP binding; TAS:ProtInc
Q99578	RIT2	GTP-binding protein Rit2	GO:0003924; F:GTPase activity; NAS:UniProtKB
Q99578	RIT2	GTP-binding protein Rit2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q99578	RIT2	GTP-binding protein Rit2	GO:0007165; P:signal transduction; TAS:ProtInc
Q99578	RIT2	GTP-binding protein Rit2	GO:0007264; P:small GTPase mediated signal transduction; NAS:UniProtKB
Q99578	RIT2	GTP-binding protein Rit2	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q15835	GRK1	Rhodopsin kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q15835	GRK1	Rhodopsin kinase	GO:0004703; F:G-protein coupled receptor kinase activity; IEA:InterPro
Q15835	GRK1	Rhodopsin kinase	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q15835	GRK1	Rhodopsin kinase	GO:0050254; F:rhodopsin kinase activity; IDA:UniProtKB
Q15835	GRK1	Rhodopsin kinase	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q15835	GRK1	Rhodopsin kinase	GO:0008594; P:photoreceptor cell morphogenesis; IEA:Ensembl
Q15835	GRK1	Rhodopsin kinase	GO:0007603; P:phototransduction, visible light; TAS:Reactome
Q15835	GRK1	Rhodopsin kinase	GO:0042327; P:positive regulation of phosphorylation; IEA:Ensembl
Q15835	GRK1	Rhodopsin kinase	GO:0060060; P:post-embryonic retina morphogenesis in camera-type eye; IEA:Ensembl
Q15835	GRK1	Rhodopsin kinase	GO:0046777; P:protein autophosphorylation; IMP:UniProtKB
Q15835	GRK1	Rhodopsin kinase	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; TAS:ProtInc
Q15835	GRK1	Rhodopsin kinase	GO:0022400; P:regulation of rhodopsin mediated signaling pathway; IDA:UniProtKB
Q15835	GRK1	Rhodopsin kinase	GO:0016056; P:rhodopsin mediated signaling pathway; TAS:Reactome
Q15835	GRK1	Rhodopsin kinase	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
Q15835	GRK1	Rhodopsin kinase	GO:0007601; P:visual perception; TAS:ProtInc
P62906	RPL10A	60S ribosomal protein L10a	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62906	RPL10A	60S ribosomal protein L10a	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P62906	RPL10A	60S ribosomal protein L10a	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P62906	RPL10A	60S ribosomal protein L10a	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62906	RPL10A	60S ribosomal protein L10a	GO:0010467; P:gene expression; TAS:Reactome
P62906	RPL10A	60S ribosomal protein L10a	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62906	RPL10A	60S ribosomal protein L10a	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62906	RPL10A	60S ribosomal protein L10a	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62906	RPL10A	60S ribosomal protein L10a	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62906	RPL10A	60S ribosomal protein L10a	GO:0006412; P:translation; NAS:UniProtKB
P62906	RPL10A	60S ribosomal protein L10a	GO:0006414; P:translational elongation; TAS:Reactome
P62906	RPL10A	60S ribosomal protein L10a	GO:0006413; P:translational initiation; TAS:Reactome
P62906	RPL10A	60S ribosomal protein L10a	GO:0006415; P:translational termination; TAS:Reactome
P62906	RPL10A	60S ribosomal protein L10a	GO:0019058; P:viral life cycle; TAS:Reactome
P62906	RPL10A	60S ribosomal protein L10a	GO:0016032; P:viral process; TAS:Reactome
P62906	RPL10A	60S ribosomal protein L10a	GO:0019083; P:viral transcription; TAS:Reactome
Q96L21	RPL10L	60S ribosomal protein L10-like	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q96L21	RPL10L	60S ribosomal protein L10-like	GO:0007283; P:spermatogenesis; IEP:UniProtKB
Q96L21	RPL10L	60S ribosomal protein L10-like	GO:0006412; P:translation; IEA:InterPro
P27635	RPL10	60S ribosomal protein L10	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P27635	RPL10	60S ribosomal protein L10	GO:0005515; F:protein binding; IPI:IntAct
P27635	RPL10	60S ribosomal protein L10	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P27635	RPL10	60S ribosomal protein L10	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P27635	RPL10	60S ribosomal protein L10	GO:0010467; P:gene expression; TAS:Reactome
P27635	RPL10	60S ribosomal protein L10	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P27635	RPL10	60S ribosomal protein L10	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P27635	RPL10	60S ribosomal protein L10	GO:0016070; P:RNA metabolic process; TAS:Reactome
P27635	RPL10	60S ribosomal protein L10	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P27635	RPL10	60S ribosomal protein L10	GO:0006412; P:translation; NAS:UniProtKB
P27635	RPL10	60S ribosomal protein L10	GO:0006414; P:translational elongation; TAS:Reactome
P27635	RPL10	60S ribosomal protein L10	GO:0006413; P:translational initiation; TAS:Reactome
P27635	RPL10	60S ribosomal protein L10	GO:0006415; P:translational termination; TAS:Reactome
P27635	RPL10	60S ribosomal protein L10	GO:0019058; P:viral life cycle; TAS:Reactome
P27635	RPL10	60S ribosomal protein L10	GO:0016032; P:viral process; TAS:Reactome
P27635	RPL10	60S ribosomal protein L10	GO:0019083; P:viral transcription; TAS:Reactome
P62913	RPL11	60S ribosomal protein L11	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62913	RPL11	60S ribosomal protein L11	GO:0005515; F:protein binding; IPI:UniProtKB
P62913	RPL11	60S ribosomal protein L11	GO:0003723; F:RNA binding; TAS:ProtInc
P62913	RPL11	60S ribosomal protein L11	GO:0019843; F:rRNA binding; IEA:UniProtKB-KW
P62913	RPL11	60S ribosomal protein L11	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P62913	RPL11	60S ribosomal protein L11	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62913	RPL11	60S ribosomal protein L11	GO:0010467; P:gene expression; TAS:Reactome
P62913	RPL11	60S ribosomal protein L11	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62913	RPL11	60S ribosomal protein L11	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62913	RPL11	60S ribosomal protein L11	GO:0034504; P:protein localization to nucleus; ISS:UniProtKB
P62913	RPL11	60S ribosomal protein L11	GO:0006605; P:protein targeting; IMP:UniProtKB
P62913	RPL11	60S ribosomal protein L11	GO:0042273; P:ribosomal large subunit biogenesis; IMP:UniProtKB
P62913	RPL11	60S ribosomal protein L11	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62913	RPL11	60S ribosomal protein L11	GO:0006364; P:rRNA processing; IMP:UniProtKB
P62913	RPL11	60S ribosomal protein L11	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62913	RPL11	60S ribosomal protein L11	GO:0006412; P:translation; NAS:UniProtKB
P62913	RPL11	60S ribosomal protein L11	GO:0006414; P:translational elongation; TAS:Reactome
P62913	RPL11	60S ribosomal protein L11	GO:0006413; P:translational initiation; TAS:Reactome
P62913	RPL11	60S ribosomal protein L11	GO:0006415; P:translational termination; TAS:Reactome
P62913	RPL11	60S ribosomal protein L11	GO:0019058; P:viral life cycle; TAS:Reactome
P62913	RPL11	60S ribosomal protein L11	GO:0016032; P:viral process; TAS:Reactome
P62913	RPL11	60S ribosomal protein L11	GO:0019083; P:viral transcription; TAS:Reactome
P30050	RPL12	60S ribosomal protein L12	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P30050	RPL12	60S ribosomal protein L12	GO:0005515; F:protein binding; IPI:IntAct
P30050	RPL12	60S ribosomal protein L12	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P30050	RPL12	60S ribosomal protein L12	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P30050	RPL12	60S ribosomal protein L12	GO:0010467; P:gene expression; TAS:Reactome
P30050	RPL12	60S ribosomal protein L12	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P30050	RPL12	60S ribosomal protein L12	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P30050	RPL12	60S ribosomal protein L12	GO:0016070; P:RNA metabolic process; TAS:Reactome
P30050	RPL12	60S ribosomal protein L12	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P30050	RPL12	60S ribosomal protein L12	GO:0006412; P:translation; NAS:UniProtKB
P30050	RPL12	60S ribosomal protein L12	GO:0006414; P:translational elongation; TAS:Reactome
P30050	RPL12	60S ribosomal protein L12	GO:0006413; P:translational initiation; TAS:Reactome
P30050	RPL12	60S ribosomal protein L12	GO:0006415; P:translational termination; TAS:Reactome
P30050	RPL12	60S ribosomal protein L12	GO:0019058; P:viral life cycle; TAS:Reactome
P30050	RPL12	60S ribosomal protein L12	GO:0016032; P:viral process; TAS:Reactome
P30050	RPL12	60S ribosomal protein L12	GO:0019083; P:viral transcription; TAS:Reactome
P40429	RPL13A	60S ribosomal protein L13a	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P40429	RPL13A	60S ribosomal protein L13a	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P40429	RPL13A	60S ribosomal protein L13a	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P40429	RPL13A	60S ribosomal protein L13a	GO:0071346; P:cellular response to interferon-gamma; IDA:UniProtKB
P40429	RPL13A	60S ribosomal protein L13a	GO:0010467; P:gene expression; TAS:Reactome
P40429	RPL13A	60S ribosomal protein L13a	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P40429	RPL13A	60S ribosomal protein L13a	GO:1901194; P:negative regulation of formation of translation preinitiation complex; IDA:UniProtKB
P40429	RPL13A	60S ribosomal protein L13a	GO:0017148; P:negative regulation of translation; IDA:UniProtKB
P40429	RPL13A	60S ribosomal protein L13a	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P40429	RPL13A	60S ribosomal protein L13a	GO:0016070; P:RNA metabolic process; TAS:Reactome
P40429	RPL13A	60S ribosomal protein L13a	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P40429	RPL13A	60S ribosomal protein L13a	GO:0006412; P:translation; NAS:UniProtKB
P40429	RPL13A	60S ribosomal protein L13a	GO:0006414; P:translational elongation; TAS:Reactome
P40429	RPL13A	60S ribosomal protein L13a	GO:0006413; P:translational initiation; TAS:Reactome
P40429	RPL13A	60S ribosomal protein L13a	GO:0006415; P:translational termination; TAS:Reactome
P40429	RPL13A	60S ribosomal protein L13a	GO:0019058; P:viral life cycle; TAS:Reactome
P40429	RPL13A	60S ribosomal protein L13a	GO:0016032; P:viral process; TAS:Reactome
P40429	RPL13A	60S ribosomal protein L13a	GO:0019083; P:viral transcription; TAS:Reactome
P26373	RPL13	60S ribosomal protein L13	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P26373	RPL13	60S ribosomal protein L13	GO:0005515; F:protein binding; IPI:IntAct
P26373	RPL13	60S ribosomal protein L13	GO:0003723; F:RNA binding; TAS:ProtInc
P26373	RPL13	60S ribosomal protein L13	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P26373	RPL13	60S ribosomal protein L13	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P26373	RPL13	60S ribosomal protein L13	GO:0010467; P:gene expression; TAS:Reactome
P26373	RPL13	60S ribosomal protein L13	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P26373	RPL13	60S ribosomal protein L13	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P26373	RPL13	60S ribosomal protein L13	GO:0016070; P:RNA metabolic process; TAS:Reactome
P26373	RPL13	60S ribosomal protein L13	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P26373	RPL13	60S ribosomal protein L13	GO:0006412; P:translation; NAS:UniProtKB
P26373	RPL13	60S ribosomal protein L13	GO:0006414; P:translational elongation; TAS:Reactome
P26373	RPL13	60S ribosomal protein L13	GO:0006413; P:translational initiation; TAS:Reactome
P26373	RPL13	60S ribosomal protein L13	GO:0006415; P:translational termination; TAS:Reactome
P26373	RPL13	60S ribosomal protein L13	GO:0019058; P:viral life cycle; TAS:Reactome
P26373	RPL13	60S ribosomal protein L13	GO:0016032; P:viral process; TAS:Reactome
P26373	RPL13	60S ribosomal protein L13	GO:0019083; P:viral transcription; TAS:Reactome
P50914	RPL14	60S ribosomal protein L14	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P50914	RPL14	60S ribosomal protein L14	GO:0005515; F:protein binding; IPI:IntAct
P50914	RPL14	60S ribosomal protein L14	GO:0003723; F:RNA binding; TAS:ProtInc
P50914	RPL14	60S ribosomal protein L14	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P50914	RPL14	60S ribosomal protein L14	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P50914	RPL14	60S ribosomal protein L14	GO:0010467; P:gene expression; TAS:Reactome
P50914	RPL14	60S ribosomal protein L14	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P50914	RPL14	60S ribosomal protein L14	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P50914	RPL14	60S ribosomal protein L14	GO:0042273; P:ribosomal large subunit biogenesis; IMP:UniProtKB
P50914	RPL14	60S ribosomal protein L14	GO:0016070; P:RNA metabolic process; TAS:Reactome
P50914	RPL14	60S ribosomal protein L14	GO:0006364; P:rRNA processing; IMP:UniProtKB
P50914	RPL14	60S ribosomal protein L14	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P50914	RPL14	60S ribosomal protein L14	GO:0006412; P:translation; NAS:UniProtKB
P50914	RPL14	60S ribosomal protein L14	GO:0006414; P:translational elongation; TAS:Reactome
P50914	RPL14	60S ribosomal protein L14	GO:0006413; P:translational initiation; TAS:Reactome
P50914	RPL14	60S ribosomal protein L14	GO:0006415; P:translational termination; TAS:Reactome
P50914	RPL14	60S ribosomal protein L14	GO:0019058; P:viral life cycle; TAS:Reactome
P50914	RPL14	60S ribosomal protein L14	GO:0016032; P:viral process; TAS:Reactome
P50914	RPL14	60S ribosomal protein L14	GO:0019083; P:viral transcription; TAS:Reactome
P61313	RPL15	60S ribosomal protein L15	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P61313	RPL15	60S ribosomal protein L15	GO:0005515; F:protein binding; IPI:UniProtKB
P61313	RPL15	60S ribosomal protein L15	GO:0003723; F:RNA binding; TAS:ProtInc
P61313	RPL15	60S ribosomal protein L15	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P61313	RPL15	60S ribosomal protein L15	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P61313	RPL15	60S ribosomal protein L15	GO:0010467; P:gene expression; TAS:Reactome
P61313	RPL15	60S ribosomal protein L15	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P61313	RPL15	60S ribosomal protein L15	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P61313	RPL15	60S ribosomal protein L15	GO:0016070; P:RNA metabolic process; TAS:Reactome
P61313	RPL15	60S ribosomal protein L15	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P61313	RPL15	60S ribosomal protein L15	GO:0006412; P:translation; NAS:UniProtKB
P61313	RPL15	60S ribosomal protein L15	GO:0006414; P:translational elongation; TAS:Reactome
P61313	RPL15	60S ribosomal protein L15	GO:0006413; P:translational initiation; TAS:Reactome
P61313	RPL15	60S ribosomal protein L15	GO:0006415; P:translational termination; TAS:Reactome
P61313	RPL15	60S ribosomal protein L15	GO:0019058; P:viral life cycle; TAS:Reactome
P61313	RPL15	60S ribosomal protein L15	GO:0016032; P:viral process; TAS:Reactome
P61313	RPL15	60S ribosomal protein L15	GO:0019083; P:viral transcription; TAS:Reactome
P18621	RPL17	60S ribosomal protein L17	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P18621	RPL17	60S ribosomal protein L17	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P18621	RPL17	60S ribosomal protein L17	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P18621	RPL17	60S ribosomal protein L17	GO:0010467; P:gene expression; TAS:Reactome
P18621	RPL17	60S ribosomal protein L17	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P18621	RPL17	60S ribosomal protein L17	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P18621	RPL17	60S ribosomal protein L17	GO:0016070; P:RNA metabolic process; TAS:Reactome
P18621	RPL17	60S ribosomal protein L17	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P18621	RPL17	60S ribosomal protein L17	GO:0006412; P:translation; NAS:UniProtKB
P18621	RPL17	60S ribosomal protein L17	GO:0006414; P:translational elongation; TAS:Reactome
P18621	RPL17	60S ribosomal protein L17	GO:0006413; P:translational initiation; TAS:Reactome
P18621	RPL17	60S ribosomal protein L17	GO:0006415; P:translational termination; TAS:Reactome
P18621	RPL17	60S ribosomal protein L17	GO:0019058; P:viral life cycle; TAS:Reactome
P18621	RPL17	60S ribosomal protein L17	GO:0016032; P:viral process; TAS:Reactome
P18621	RPL17	60S ribosomal protein L17	GO:0019083; P:viral transcription; TAS:Reactome
Q02543	RPL18A	60S ribosomal protein L18a	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q02543	RPL18A	60S ribosomal protein L18a	GO:0003723; F:RNA binding; TAS:ProtInc
Q02543	RPL18A	60S ribosomal protein L18a	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q02543	RPL18A	60S ribosomal protein L18a	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q02543	RPL18A	60S ribosomal protein L18a	GO:0010467; P:gene expression; TAS:Reactome
Q02543	RPL18A	60S ribosomal protein L18a	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q02543	RPL18A	60S ribosomal protein L18a	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
Q02543	RPL18A	60S ribosomal protein L18a	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q02543	RPL18A	60S ribosomal protein L18a	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
Q02543	RPL18A	60S ribosomal protein L18a	GO:0006412; P:translation; NAS:UniProtKB
Q02543	RPL18A	60S ribosomal protein L18a	GO:0006414; P:translational elongation; TAS:Reactome
Q02543	RPL18A	60S ribosomal protein L18a	GO:0006413; P:translational initiation; TAS:Reactome
Q02543	RPL18A	60S ribosomal protein L18a	GO:0006415; P:translational termination; TAS:Reactome
Q02543	RPL18A	60S ribosomal protein L18a	GO:0019058; P:viral life cycle; TAS:Reactome
Q02543	RPL18A	60S ribosomal protein L18a	GO:0016032; P:viral process; TAS:Reactome
Q02543	RPL18A	60S ribosomal protein L18a	GO:0019083; P:viral transcription; TAS:Reactome
Q07020	RPL18	60S ribosomal protein L18	GO:0003723; F:RNA binding; TAS:ProtInc
Q07020	RPL18	60S ribosomal protein L18	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q07020	RPL18	60S ribosomal protein L18	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q07020	RPL18	60S ribosomal protein L18	GO:0010467; P:gene expression; TAS:Reactome
Q07020	RPL18	60S ribosomal protein L18	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q07020	RPL18	60S ribosomal protein L18	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
Q07020	RPL18	60S ribosomal protein L18	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q07020	RPL18	60S ribosomal protein L18	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
Q07020	RPL18	60S ribosomal protein L18	GO:0006412; P:translation; NAS:UniProtKB
Q07020	RPL18	60S ribosomal protein L18	GO:0006414; P:translational elongation; TAS:Reactome
Q07020	RPL18	60S ribosomal protein L18	GO:0006413; P:translational initiation; TAS:Reactome
Q07020	RPL18	60S ribosomal protein L18	GO:0006415; P:translational termination; TAS:Reactome
Q07020	RPL18	60S ribosomal protein L18	GO:0019058; P:viral life cycle; TAS:Reactome
Q07020	RPL18	60S ribosomal protein L18	GO:0016032; P:viral process; TAS:Reactome
Q07020	RPL18	60S ribosomal protein L18	GO:0019083; P:viral transcription; TAS:Reactome
P84098	RPL19	60S ribosomal protein L19	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P84098	RPL19	60S ribosomal protein L19	GO:0003723; F:RNA binding; TAS:UniProtKB
P84098	RPL19	60S ribosomal protein L19	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P84098	RPL19	60S ribosomal protein L19	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P84098	RPL19	60S ribosomal protein L19	GO:0010467; P:gene expression; TAS:Reactome
P84098	RPL19	60S ribosomal protein L19	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P84098	RPL19	60S ribosomal protein L19	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P84098	RPL19	60S ribosomal protein L19	GO:0016070; P:RNA metabolic process; TAS:Reactome
P84098	RPL19	60S ribosomal protein L19	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P84098	RPL19	60S ribosomal protein L19	GO:0006412; P:translation; NAS:UniProtKB
P84098	RPL19	60S ribosomal protein L19	GO:0006414; P:translational elongation; TAS:Reactome
P84098	RPL19	60S ribosomal protein L19	GO:0006413; P:translational initiation; TAS:Reactome
P84098	RPL19	60S ribosomal protein L19	GO:0006415; P:translational termination; TAS:Reactome
P84098	RPL19	60S ribosomal protein L19	GO:0019058; P:viral life cycle; TAS:Reactome
P84098	RPL19	60S ribosomal protein L19	GO:0016032; P:viral process; TAS:Reactome
P84098	RPL19	60S ribosomal protein L19	GO:0019083; P:viral transcription; TAS:Reactome
O76021	RSL1D1	Ribosomal L1 domain-containing protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O76021	RSL1D1	Ribosomal L1 domain-containing protein 1	GO:0032880; P:regulation of protein localization; IMP:MGI
P46778	RPL21	60S ribosomal protein L21	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P46778	RPL21	60S ribosomal protein L21	GO:0003723; F:RNA binding; TAS:ProtInc
P46778	RPL21	60S ribosomal protein L21	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P46778	RPL21	60S ribosomal protein L21	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P46778	RPL21	60S ribosomal protein L21	GO:0010467; P:gene expression; TAS:Reactome
P46778	RPL21	60S ribosomal protein L21	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P46778	RPL21	60S ribosomal protein L21	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P46778	RPL21	60S ribosomal protein L21	GO:0016070; P:RNA metabolic process; TAS:Reactome
P46778	RPL21	60S ribosomal protein L21	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P46778	RPL21	60S ribosomal protein L21	GO:0006412; P:translation; NAS:UniProtKB
P46778	RPL21	60S ribosomal protein L21	GO:0006414; P:translational elongation; TAS:Reactome
P46778	RPL21	60S ribosomal protein L21	GO:0006413; P:translational initiation; TAS:Reactome
P46778	RPL21	60S ribosomal protein L21	GO:0006415; P:translational termination; TAS:Reactome
P46778	RPL21	60S ribosomal protein L21	GO:0019058; P:viral life cycle; TAS:Reactome
P46778	RPL21	60S ribosomal protein L21	GO:0016032; P:viral process; TAS:Reactome
P46778	RPL21	60S ribosomal protein L21	GO:0019083; P:viral transcription; TAS:Reactome
Q6P5R6	RPL22L1	60S ribosomal protein L22-like 1	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q6P5R6	RPL22L1	60S ribosomal protein L22-like 1	GO:0006412; P:translation; IEA:InterPro
P35268	RPL22	60S ribosomal protein L22	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P35268	RPL22	60S ribosomal protein L22	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P35268	RPL22	60S ribosomal protein L22	GO:0005515; F:protein binding; IPI:UniProt
P35268	RPL22	60S ribosomal protein L22	GO:0003723; F:RNA binding; TAS:ProtInc
P35268	RPL22	60S ribosomal protein L22	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P35268	RPL22	60S ribosomal protein L22	GO:0046632; P:alpha-beta T cell differentiation; IEA:Ensembl
P35268	RPL22	60S ribosomal protein L22	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P35268	RPL22	60S ribosomal protein L22	GO:0010467; P:gene expression; TAS:Reactome
P35268	RPL22	60S ribosomal protein L22	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P35268	RPL22	60S ribosomal protein L22	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P35268	RPL22	60S ribosomal protein L22	GO:0016070; P:RNA metabolic process; TAS:Reactome
P35268	RPL22	60S ribosomal protein L22	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P35268	RPL22	60S ribosomal protein L22	GO:0006412; P:translation; NAS:UniProtKB
P35268	RPL22	60S ribosomal protein L22	GO:0006414; P:translational elongation; TAS:Reactome
P35268	RPL22	60S ribosomal protein L22	GO:0006413; P:translational initiation; TAS:Reactome
P35268	RPL22	60S ribosomal protein L22	GO:0006415; P:translational termination; TAS:Reactome
P35268	RPL22	60S ribosomal protein L22	GO:0019058; P:viral life cycle; TAS:Reactome
P35268	RPL22	60S ribosomal protein L22	GO:0016032; P:viral process; TAS:Reactome
P35268	RPL22	60S ribosomal protein L22	GO:0019083; P:viral transcription; TAS:Reactome
P62750	RPL23A	60S ribosomal protein L23a	GO:0000166; F:nucleotide binding; IEA:InterPro
P62750	RPL23A	60S ribosomal protein L23a	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62750	RPL23A	60S ribosomal protein L23a	GO:0005515; F:protein binding; IPI:UniProtKB
P62750	RPL23A	60S ribosomal protein L23a	GO:0019843; F:rRNA binding; IEA:UniProtKB-KW
P62750	RPL23A	60S ribosomal protein L23a	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P62750	RPL23A	60S ribosomal protein L23a	GO:0008283; P:cell proliferation; IMP:UniProtKB
P62750	RPL23A	60S ribosomal protein L23a	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62750	RPL23A	60S ribosomal protein L23a	GO:0010467; P:gene expression; TAS:Reactome
P62750	RPL23A	60S ribosomal protein L23a	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62750	RPL23A	60S ribosomal protein L23a	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62750	RPL23A	60S ribosomal protein L23a	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62750	RPL23A	60S ribosomal protein L23a	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62750	RPL23A	60S ribosomal protein L23a	GO:0006412; P:translation; NAS:UniProtKB
P62750	RPL23A	60S ribosomal protein L23a	GO:0006414; P:translational elongation; TAS:Reactome
P62750	RPL23A	60S ribosomal protein L23a	GO:0006413; P:translational initiation; TAS:Reactome
P62750	RPL23A	60S ribosomal protein L23a	GO:0006415; P:translational termination; TAS:Reactome
P62750	RPL23A	60S ribosomal protein L23a	GO:0019058; P:viral life cycle; TAS:Reactome
P62750	RPL23A	60S ribosomal protein L23a	GO:0016032; P:viral process; TAS:Reactome
P62750	RPL23A	60S ribosomal protein L23a	GO:0019083; P:viral transcription; TAS:Reactome
P62829	RPL23	60S ribosomal protein L23	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62829	RPL23	60S ribosomal protein L23	GO:0005515; F:protein binding; IPI:IntAct
P62829	RPL23	60S ribosomal protein L23	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P62829	RPL23	60S ribosomal protein L23	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62829	RPL23	60S ribosomal protein L23	GO:0010467; P:gene expression; TAS:Reactome
P62829	RPL23	60S ribosomal protein L23	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62829	RPL23	60S ribosomal protein L23	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62829	RPL23	60S ribosomal protein L23	GO:0006610; P:ribosomal protein import into nucleus; NAS:UniProtKB
P62829	RPL23	60S ribosomal protein L23	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62829	RPL23	60S ribosomal protein L23	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62829	RPL23	60S ribosomal protein L23	GO:0006412; P:translation; NAS:UniProtKB
P62829	RPL23	60S ribosomal protein L23	GO:0006414; P:translational elongation; TAS:Reactome
P62829	RPL23	60S ribosomal protein L23	GO:0006413; P:translational initiation; TAS:Reactome
P62829	RPL23	60S ribosomal protein L23	GO:0006415; P:translational termination; TAS:Reactome
P62829	RPL23	60S ribosomal protein L23	GO:0019058; P:viral life cycle; TAS:Reactome
P62829	RPL23	60S ribosomal protein L23	GO:0016032; P:viral process; TAS:Reactome
P62829	RPL23	60S ribosomal protein L23	GO:0019083; P:viral transcription; TAS:Reactome
P83731	RPL24	60S ribosomal protein L24	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P83731	RPL24	60S ribosomal protein L24	GO:0003723; F:RNA binding; TAS:ProtInc
P83731	RPL24	60S ribosomal protein L24	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P83731	RPL24	60S ribosomal protein L24	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P83731	RPL24	60S ribosomal protein L24	GO:0010467; P:gene expression; TAS:Reactome
P83731	RPL24	60S ribosomal protein L24	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P83731	RPL24	60S ribosomal protein L24	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P83731	RPL24	60S ribosomal protein L24	GO:0016070; P:RNA metabolic process; TAS:Reactome
P83731	RPL24	60S ribosomal protein L24	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P83731	RPL24	60S ribosomal protein L24	GO:0006412; P:translation; NAS:UniProtKB
P83731	RPL24	60S ribosomal protein L24	GO:0006414; P:translational elongation; TAS:Reactome
P83731	RPL24	60S ribosomal protein L24	GO:0006413; P:translational initiation; TAS:Reactome
P83731	RPL24	60S ribosomal protein L24	GO:0006415; P:translational termination; TAS:Reactome
P83731	RPL24	60S ribosomal protein L24	GO:0019058; P:viral life cycle; TAS:Reactome
P83731	RPL24	60S ribosomal protein L24	GO:0016032; P:viral process; TAS:Reactome
P83731	RPL24	60S ribosomal protein L24	GO:0019083; P:viral transcription; TAS:Reactome
Q9UNX3	RPL26L1	60S ribosomal protein L26-like 1	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q9UNX3	RPL26L1	60S ribosomal protein L26-like 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UNX3	RPL26L1	60S ribosomal protein L26-like 1	GO:0010467; P:gene expression; TAS:Reactome
Q9UNX3	RPL26L1	60S ribosomal protein L26-like 1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9UNX3	RPL26L1	60S ribosomal protein L26-like 1	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
Q9UNX3	RPL26L1	60S ribosomal protein L26-like 1	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9UNX3	RPL26L1	60S ribosomal protein L26-like 1	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
Q9UNX3	RPL26L1	60S ribosomal protein L26-like 1	GO:0006412; P:translation; TAS:Reactome
Q9UNX3	RPL26L1	60S ribosomal protein L26-like 1	GO:0006414; P:translational elongation; TAS:Reactome
Q9UNX3	RPL26L1	60S ribosomal protein L26-like 1	GO:0006413; P:translational initiation; TAS:Reactome
Q9UNX3	RPL26L1	60S ribosomal protein L26-like 1	GO:0006415; P:translational termination; TAS:Reactome
Q9UNX3	RPL26L1	60S ribosomal protein L26-like 1	GO:0019058; P:viral life cycle; TAS:Reactome
Q9UNX3	RPL26L1	60S ribosomal protein L26-like 1	GO:0016032; P:viral process; TAS:Reactome
Q9UNX3	RPL26L1	60S ribosomal protein L26-like 1	GO:0019083; P:viral transcription; TAS:Reactome
P61254	RPL26	60S ribosomal protein L26	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P61254	RPL26	60S ribosomal protein L26	GO:0003723; F:RNA binding; TAS:ProtInc
P61254	RPL26	60S ribosomal protein L26	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P61254	RPL26	60S ribosomal protein L26	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P61254	RPL26	60S ribosomal protein L26	GO:0010467; P:gene expression; TAS:Reactome
P61254	RPL26	60S ribosomal protein L26	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P61254	RPL26	60S ribosomal protein L26	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P61254	RPL26	60S ribosomal protein L26	GO:0042273; P:ribosomal large subunit biogenesis; IMP:UniProtKB
P61254	RPL26	60S ribosomal protein L26	GO:0016070; P:RNA metabolic process; TAS:Reactome
P61254	RPL26	60S ribosomal protein L26	GO:0006364; P:rRNA processing; IMP:UniProtKB
P61254	RPL26	60S ribosomal protein L26	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P61254	RPL26	60S ribosomal protein L26	GO:0006412; P:translation; NAS:UniProtKB
P61254	RPL26	60S ribosomal protein L26	GO:0006414; P:translational elongation; TAS:Reactome
P61254	RPL26	60S ribosomal protein L26	GO:0006413; P:translational initiation; TAS:Reactome
P61254	RPL26	60S ribosomal protein L26	GO:0006415; P:translational termination; TAS:Reactome
P61254	RPL26	60S ribosomal protein L26	GO:0019058; P:viral life cycle; TAS:Reactome
P61254	RPL26	60S ribosomal protein L26	GO:0016032; P:viral process; TAS:Reactome
P61254	RPL26	60S ribosomal protein L26	GO:0019083; P:viral transcription; TAS:Reactome
P46776	RPL27A	60S ribosomal protein L27a	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P46776	RPL27A	60S ribosomal protein L27a	GO:0005515; F:protein binding; IPI:IntAct
P46776	RPL27A	60S ribosomal protein L27a	GO:0003723; F:RNA binding; TAS:ProtInc
P46776	RPL27A	60S ribosomal protein L27a	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P46776	RPL27A	60S ribosomal protein L27a	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P46776	RPL27A	60S ribosomal protein L27a	GO:0010467; P:gene expression; TAS:Reactome
P46776	RPL27A	60S ribosomal protein L27a	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P46776	RPL27A	60S ribosomal protein L27a	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P46776	RPL27A	60S ribosomal protein L27a	GO:0016070; P:RNA metabolic process; TAS:Reactome
P46776	RPL27A	60S ribosomal protein L27a	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P46776	RPL27A	60S ribosomal protein L27a	GO:0006412; P:translation; NAS:UniProtKB
P46776	RPL27A	60S ribosomal protein L27a	GO:0006414; P:translational elongation; TAS:Reactome
P46776	RPL27A	60S ribosomal protein L27a	GO:0006413; P:translational initiation; TAS:Reactome
P46776	RPL27A	60S ribosomal protein L27a	GO:0006415; P:translational termination; TAS:Reactome
P46776	RPL27A	60S ribosomal protein L27a	GO:0019058; P:viral life cycle; TAS:Reactome
P46776	RPL27A	60S ribosomal protein L27a	GO:0016032; P:viral process; TAS:Reactome
P46776	RPL27A	60S ribosomal protein L27a	GO:0019083; P:viral transcription; TAS:Reactome
P61353	RPL27	60S ribosomal protein L27	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P61353	RPL27	60S ribosomal protein L27	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P61353	RPL27	60S ribosomal protein L27	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P61353	RPL27	60S ribosomal protein L27	GO:0010467; P:gene expression; TAS:Reactome
P61353	RPL27	60S ribosomal protein L27	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P61353	RPL27	60S ribosomal protein L27	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P61353	RPL27	60S ribosomal protein L27	GO:0016070; P:RNA metabolic process; TAS:Reactome
P61353	RPL27	60S ribosomal protein L27	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P61353	RPL27	60S ribosomal protein L27	GO:0006412; P:translation; NAS:UniProtKB
P61353	RPL27	60S ribosomal protein L27	GO:0006414; P:translational elongation; TAS:Reactome
P61353	RPL27	60S ribosomal protein L27	GO:0006413; P:translational initiation; TAS:Reactome
P61353	RPL27	60S ribosomal protein L27	GO:0006415; P:translational termination; TAS:Reactome
P61353	RPL27	60S ribosomal protein L27	GO:0019058; P:viral life cycle; TAS:Reactome
P61353	RPL27	60S ribosomal protein L27	GO:0016032; P:viral process; TAS:Reactome
P61353	RPL27	60S ribosomal protein L27	GO:0019083; P:viral transcription; TAS:Reactome
P46779	RPL28	60S ribosomal protein L28	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P46779	RPL28	60S ribosomal protein L28	GO:0005515; F:protein binding; IPI:IntAct
P46779	RPL28	60S ribosomal protein L28	GO:0003723; F:RNA binding; TAS:ProtInc
P46779	RPL28	60S ribosomal protein L28	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P46779	RPL28	60S ribosomal protein L28	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P46779	RPL28	60S ribosomal protein L28	GO:0010467; P:gene expression; TAS:Reactome
P46779	RPL28	60S ribosomal protein L28	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P46779	RPL28	60S ribosomal protein L28	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P46779	RPL28	60S ribosomal protein L28	GO:0016070; P:RNA metabolic process; TAS:Reactome
P46779	RPL28	60S ribosomal protein L28	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P46779	RPL28	60S ribosomal protein L28	GO:0006412; P:translation; NAS:UniProtKB
P46779	RPL28	60S ribosomal protein L28	GO:0006414; P:translational elongation; TAS:Reactome
P46779	RPL28	60S ribosomal protein L28	GO:0006413; P:translational initiation; TAS:Reactome
P46779	RPL28	60S ribosomal protein L28	GO:0006415; P:translational termination; TAS:Reactome
P46779	RPL28	60S ribosomal protein L28	GO:0019058; P:viral life cycle; TAS:Reactome
P46779	RPL28	60S ribosomal protein L28	GO:0016032; P:viral process; TAS:Reactome
P46779	RPL28	60S ribosomal protein L28	GO:0019083; P:viral transcription; TAS:Reactome
P47914	RPL29	60S ribosomal protein L29	GO:0008201; F:heparin binding; TAS:ProtInc
P47914	RPL29	60S ribosomal protein L29	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P47914	RPL29	60S ribosomal protein L29	GO:0003723; F:RNA binding; TAS:ProtInc
P47914	RPL29	60S ribosomal protein L29	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P47914	RPL29	60S ribosomal protein L29	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P47914	RPL29	60S ribosomal protein L29	GO:0007566; P:embryo implantation; TAS:ProtInc
P47914	RPL29	60S ribosomal protein L29	GO:0010467; P:gene expression; TAS:Reactome
P47914	RPL29	60S ribosomal protein L29	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P47914	RPL29	60S ribosomal protein L29	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P47914	RPL29	60S ribosomal protein L29	GO:0016070; P:RNA metabolic process; TAS:Reactome
P47914	RPL29	60S ribosomal protein L29	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P47914	RPL29	60S ribosomal protein L29	GO:0006412; P:translation; NAS:UniProtKB
P47914	RPL29	60S ribosomal protein L29	GO:0006414; P:translational elongation; TAS:Reactome
P47914	RPL29	60S ribosomal protein L29	GO:0006413; P:translational initiation; TAS:Reactome
P47914	RPL29	60S ribosomal protein L29	GO:0006415; P:translational termination; TAS:Reactome
P47914	RPL29	60S ribosomal protein L29	GO:0019058; P:viral life cycle; TAS:Reactome
P47914	RPL29	60S ribosomal protein L29	GO:0016032; P:viral process; TAS:Reactome
P47914	RPL29	60S ribosomal protein L29	GO:0019083; P:viral transcription; TAS:Reactome
P62888	RPL30	60S ribosomal protein L30	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62888	RPL30	60S ribosomal protein L30	GO:0005515; F:protein binding; IPI:UniProt
P62888	RPL30	60S ribosomal protein L30	GO:0003723; F:RNA binding; TAS:UniProtKB
P62888	RPL30	60S ribosomal protein L30	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P62888	RPL30	60S ribosomal protein L30	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62888	RPL30	60S ribosomal protein L30	GO:0010467; P:gene expression; TAS:Reactome
P62888	RPL30	60S ribosomal protein L30	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62888	RPL30	60S ribosomal protein L30	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62888	RPL30	60S ribosomal protein L30	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62888	RPL30	60S ribosomal protein L30	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62888	RPL30	60S ribosomal protein L30	GO:0006412; P:translation; NAS:UniProtKB
P62888	RPL30	60S ribosomal protein L30	GO:0006414; P:translational elongation; TAS:Reactome
P62888	RPL30	60S ribosomal protein L30	GO:0006413; P:translational initiation; TAS:Reactome
P62888	RPL30	60S ribosomal protein L30	GO:0006415; P:translational termination; TAS:Reactome
P62888	RPL30	60S ribosomal protein L30	GO:0019058; P:viral life cycle; TAS:Reactome
P62888	RPL30	60S ribosomal protein L30	GO:0016032; P:viral process; TAS:Reactome
P62888	RPL30	60S ribosomal protein L30	GO:0019083; P:viral transcription; TAS:Reactome
P62899	RPL31	60S ribosomal protein L31	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62899	RPL31	60S ribosomal protein L31	GO:0003723; F:RNA binding; TAS:ProtInc
P62899	RPL31	60S ribosomal protein L31	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P62899	RPL31	60S ribosomal protein L31	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62899	RPL31	60S ribosomal protein L31	GO:0010467; P:gene expression; TAS:Reactome
P62899	RPL31	60S ribosomal protein L31	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62899	RPL31	60S ribosomal protein L31	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62899	RPL31	60S ribosomal protein L31	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62899	RPL31	60S ribosomal protein L31	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62899	RPL31	60S ribosomal protein L31	GO:0006412; P:translation; NAS:UniProtKB
P62899	RPL31	60S ribosomal protein L31	GO:0006414; P:translational elongation; TAS:Reactome
P62899	RPL31	60S ribosomal protein L31	GO:0006413; P:translational initiation; TAS:Reactome
P62899	RPL31	60S ribosomal protein L31	GO:0006415; P:translational termination; TAS:Reactome
P62899	RPL31	60S ribosomal protein L31	GO:0019058; P:viral life cycle; TAS:Reactome
P62899	RPL31	60S ribosomal protein L31	GO:0016032; P:viral process; TAS:Reactome
P62899	RPL31	60S ribosomal protein L31	GO:0019083; P:viral transcription; TAS:Reactome
P62910	RPL32	60S ribosomal protein L32	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62910	RPL32	60S ribosomal protein L32	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P62910	RPL32	60S ribosomal protein L32	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62910	RPL32	60S ribosomal protein L32	GO:0010467; P:gene expression; TAS:Reactome
P62910	RPL32	60S ribosomal protein L32	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62910	RPL32	60S ribosomal protein L32	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62910	RPL32	60S ribosomal protein L32	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62910	RPL32	60S ribosomal protein L32	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62910	RPL32	60S ribosomal protein L32	GO:0006412; P:translation; NAS:UniProtKB
P62910	RPL32	60S ribosomal protein L32	GO:0006414; P:translational elongation; TAS:Reactome
P62910	RPL32	60S ribosomal protein L32	GO:0006413; P:translational initiation; TAS:Reactome
P62910	RPL32	60S ribosomal protein L32	GO:0006415; P:translational termination; TAS:Reactome
P62910	RPL32	60S ribosomal protein L32	GO:0019058; P:viral life cycle; TAS:Reactome
P62910	RPL32	60S ribosomal protein L32	GO:0016032; P:viral process; TAS:Reactome
P62910	RPL32	60S ribosomal protein L32	GO:0019083; P:viral transcription; TAS:Reactome
P49207	RPL34	60S ribosomal protein L34	GO:0003723; F:RNA binding; TAS:ProtInc
P49207	RPL34	60S ribosomal protein L34	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P49207	RPL34	60S ribosomal protein L34	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P49207	RPL34	60S ribosomal protein L34	GO:0010467; P:gene expression; TAS:Reactome
P49207	RPL34	60S ribosomal protein L34	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P49207	RPL34	60S ribosomal protein L34	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P49207	RPL34	60S ribosomal protein L34	GO:0016070; P:RNA metabolic process; TAS:Reactome
P49207	RPL34	60S ribosomal protein L34	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P49207	RPL34	60S ribosomal protein L34	GO:0006412; P:translation; NAS:UniProtKB
P49207	RPL34	60S ribosomal protein L34	GO:0006414; P:translational elongation; TAS:Reactome
P49207	RPL34	60S ribosomal protein L34	GO:0006413; P:translational initiation; TAS:Reactome
P49207	RPL34	60S ribosomal protein L34	GO:0006415; P:translational termination; TAS:Reactome
P49207	RPL34	60S ribosomal protein L34	GO:0019058; P:viral life cycle; TAS:Reactome
P49207	RPL34	60S ribosomal protein L34	GO:0016032; P:viral process; TAS:Reactome
P49207	RPL34	60S ribosomal protein L34	GO:0019083; P:viral transcription; TAS:Reactome
P18077	RPL35A	60S ribosomal protein L35a	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P18077	RPL35A	60S ribosomal protein L35a	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P18077	RPL35A	60S ribosomal protein L35a	GO:0000049; F:tRNA binding; IEA:UniProtKB-KW
P18077	RPL35A	60S ribosomal protein L35a	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P18077	RPL35A	60S ribosomal protein L35a	GO:0010467; P:gene expression; TAS:Reactome
P18077	RPL35A	60S ribosomal protein L35a	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P18077	RPL35A	60S ribosomal protein L35a	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P18077	RPL35A	60S ribosomal protein L35a	GO:0042273; P:ribosomal large subunit biogenesis; IMP:UniProtKB
P18077	RPL35A	60S ribosomal protein L35a	GO:0016070; P:RNA metabolic process; TAS:Reactome
P18077	RPL35A	60S ribosomal protein L35a	GO:0006364; P:rRNA processing; IMP:UniProtKB
P18077	RPL35A	60S ribosomal protein L35a	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P18077	RPL35A	60S ribosomal protein L35a	GO:0006412; P:translation; NAS:UniProtKB
P18077	RPL35A	60S ribosomal protein L35a	GO:0006414; P:translational elongation; TAS:Reactome
P18077	RPL35A	60S ribosomal protein L35a	GO:0006413; P:translational initiation; TAS:Reactome
P18077	RPL35A	60S ribosomal protein L35a	GO:0006415; P:translational termination; TAS:Reactome
P18077	RPL35A	60S ribosomal protein L35a	GO:0019058; P:viral life cycle; TAS:Reactome
P18077	RPL35A	60S ribosomal protein L35a	GO:0016032; P:viral process; TAS:Reactome
P18077	RPL35A	60S ribosomal protein L35a	GO:0019083; P:viral transcription; TAS:Reactome
P42766	RPL35	60S ribosomal protein L35	GO:0003729; F:mRNA binding; TAS:ProtInc
P42766	RPL35	60S ribosomal protein L35	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P42766	RPL35	60S ribosomal protein L35	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P42766	RPL35	60S ribosomal protein L35	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P42766	RPL35	60S ribosomal protein L35	GO:0010467; P:gene expression; TAS:Reactome
P42766	RPL35	60S ribosomal protein L35	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P42766	RPL35	60S ribosomal protein L35	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P42766	RPL35	60S ribosomal protein L35	GO:0016070; P:RNA metabolic process; TAS:Reactome
P42766	RPL35	60S ribosomal protein L35	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P42766	RPL35	60S ribosomal protein L35	GO:0006412; P:translation; NAS:UniProtKB
P42766	RPL35	60S ribosomal protein L35	GO:0006414; P:translational elongation; TAS:Reactome
P42766	RPL35	60S ribosomal protein L35	GO:0006413; P:translational initiation; TAS:Reactome
P42766	RPL35	60S ribosomal protein L35	GO:0006415; P:translational termination; TAS:Reactome
P42766	RPL35	60S ribosomal protein L35	GO:0019058; P:viral life cycle; TAS:Reactome
P42766	RPL35	60S ribosomal protein L35	GO:0016032; P:viral process; TAS:Reactome
P42766	RPL35	60S ribosomal protein L35	GO:0019083; P:viral transcription; TAS:Reactome
P83881	RPL36A	60S ribosomal protein L36a	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P83881	RPL36A	60S ribosomal protein L36a	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P83881	RPL36A	60S ribosomal protein L36a	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P83881	RPL36A	60S ribosomal protein L36a	GO:0010467; P:gene expression; TAS:Reactome
P83881	RPL36A	60S ribosomal protein L36a	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P83881	RPL36A	60S ribosomal protein L36a	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P83881	RPL36A	60S ribosomal protein L36a	GO:0016070; P:RNA metabolic process; TAS:Reactome
P83881	RPL36A	60S ribosomal protein L36a	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P83881	RPL36A	60S ribosomal protein L36a	GO:0006412; P:translation; NAS:UniProtKB
P83881	RPL36A	60S ribosomal protein L36a	GO:0006414; P:translational elongation; TAS:Reactome
P83881	RPL36A	60S ribosomal protein L36a	GO:0006413; P:translational initiation; TAS:Reactome
P83881	RPL36A	60S ribosomal protein L36a	GO:0006415; P:translational termination; TAS:Reactome
P83881	RPL36A	60S ribosomal protein L36a	GO:0019058; P:viral life cycle; TAS:Reactome
P83881	RPL36A	60S ribosomal protein L36a	GO:0016032; P:viral process; TAS:Reactome
P83881	RPL36A	60S ribosomal protein L36a	GO:0019083; P:viral transcription; TAS:Reactome
Q969Q0	RPL36AL	60S ribosomal protein L36a-like	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q969Q0	RPL36AL	60S ribosomal protein L36a-like	GO:0006412; P:translation; IEA:InterPro
Q9Y3U8	RPL36	60S ribosomal protein L36	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y3U8	RPL36	60S ribosomal protein L36	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q9Y3U8	RPL36	60S ribosomal protein L36	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9Y3U8	RPL36	60S ribosomal protein L36	GO:0010467; P:gene expression; TAS:Reactome
Q9Y3U8	RPL36	60S ribosomal protein L36	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9Y3U8	RPL36	60S ribosomal protein L36	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
Q9Y3U8	RPL36	60S ribosomal protein L36	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9Y3U8	RPL36	60S ribosomal protein L36	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
Q9Y3U8	RPL36	60S ribosomal protein L36	GO:0006412; P:translation; NAS:UniProtKB
Q9Y3U8	RPL36	60S ribosomal protein L36	GO:0006414; P:translational elongation; TAS:Reactome
Q9Y3U8	RPL36	60S ribosomal protein L36	GO:0006413; P:translational initiation; TAS:Reactome
Q9Y3U8	RPL36	60S ribosomal protein L36	GO:0006415; P:translational termination; TAS:Reactome
Q9Y3U8	RPL36	60S ribosomal protein L36	GO:0019058; P:viral life cycle; TAS:Reactome
Q9Y3U8	RPL36	60S ribosomal protein L36	GO:0016032; P:viral process; TAS:Reactome
Q9Y3U8	RPL36	60S ribosomal protein L36	GO:0019083; P:viral transcription; TAS:Reactome
P61513	RPL37A	60S ribosomal protein L37a	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P61513	RPL37A	60S ribosomal protein L37a	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P61513	RPL37A	60S ribosomal protein L37a	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P61513	RPL37A	60S ribosomal protein L37a	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P61513	RPL37A	60S ribosomal protein L37a	GO:0010467; P:gene expression; TAS:Reactome
P61513	RPL37A	60S ribosomal protein L37a	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P61513	RPL37A	60S ribosomal protein L37a	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P61513	RPL37A	60S ribosomal protein L37a	GO:0016070; P:RNA metabolic process; TAS:Reactome
P61513	RPL37A	60S ribosomal protein L37a	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P61513	RPL37A	60S ribosomal protein L37a	GO:0006412; P:translation; NAS:UniProtKB
P61513	RPL37A	60S ribosomal protein L37a	GO:0006414; P:translational elongation; TAS:Reactome
P61513	RPL37A	60S ribosomal protein L37a	GO:0006413; P:translational initiation; TAS:Reactome
P61513	RPL37A	60S ribosomal protein L37a	GO:0006415; P:translational termination; TAS:Reactome
P61513	RPL37A	60S ribosomal protein L37a	GO:0019058; P:viral life cycle; TAS:Reactome
P61513	RPL37A	60S ribosomal protein L37a	GO:0016032; P:viral process; TAS:Reactome
P61513	RPL37A	60S ribosomal protein L37a	GO:0019083; P:viral transcription; TAS:Reactome
A6NKH3	RPL37L	Putative 60S ribosomal protein L37a-like	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A6NKH3	RPL37L	Putative 60S ribosomal protein L37a-like	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
A6NKH3	RPL37L	Putative 60S ribosomal protein L37a-like	GO:0006412; P:translation; IEA:InterPro
P61927	RPL37	60S ribosomal protein L37	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P61927	RPL37	60S ribosomal protein L37	GO:0003723; F:RNA binding; TAS:UniProtKB
P61927	RPL37	60S ribosomal protein L37	GO:0019843; F:rRNA binding; IEA:UniProtKB-KW
P61927	RPL37	60S ribosomal protein L37	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P61927	RPL37	60S ribosomal protein L37	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P61927	RPL37	60S ribosomal protein L37	GO:0010467; P:gene expression; TAS:Reactome
P61927	RPL37	60S ribosomal protein L37	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P61927	RPL37	60S ribosomal protein L37	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P61927	RPL37	60S ribosomal protein L37	GO:0016070; P:RNA metabolic process; TAS:Reactome
P61927	RPL37	60S ribosomal protein L37	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P61927	RPL37	60S ribosomal protein L37	GO:0006412; P:translation; NAS:UniProtKB
P61927	RPL37	60S ribosomal protein L37	GO:0006414; P:translational elongation; TAS:Reactome
P61927	RPL37	60S ribosomal protein L37	GO:0006413; P:translational initiation; TAS:Reactome
P61927	RPL37	60S ribosomal protein L37	GO:0006415; P:translational termination; TAS:Reactome
P61927	RPL37	60S ribosomal protein L37	GO:0019058; P:viral life cycle; TAS:Reactome
P61927	RPL37	60S ribosomal protein L37	GO:0016032; P:viral process; TAS:Reactome
P61927	RPL37	60S ribosomal protein L37	GO:0019083; P:viral transcription; TAS:Reactome
P63173	RPL38	60S ribosomal protein L38	GO:0003723; F:RNA binding; TAS:ProtInc
P63173	RPL38	60S ribosomal protein L38	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P63173	RPL38	60S ribosomal protein L38	GO:0034463; P:90S preribosome assembly; IEA:Ensembl
P63173	RPL38	60S ribosomal protein L38	GO:0048318; P:axial mesoderm development; IEA:Ensembl
P63173	RPL38	60S ribosomal protein L38	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P63173	RPL38	60S ribosomal protein L38	GO:0010467; P:gene expression; TAS:Reactome
P63173	RPL38	60S ribosomal protein L38	GO:0042474; P:middle ear morphogenesis; IEA:Ensembl
P63173	RPL38	60S ribosomal protein L38	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P63173	RPL38	60S ribosomal protein L38	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P63173	RPL38	60S ribosomal protein L38	GO:0001503; P:ossification; IEA:Ensembl
P63173	RPL38	60S ribosomal protein L38	GO:0006417; P:regulation of translation; IEA:Ensembl
P63173	RPL38	60S ribosomal protein L38	GO:0016070; P:RNA metabolic process; TAS:Reactome
P63173	RPL38	60S ribosomal protein L38	GO:0007605; P:sensory perception of sound; IEA:Ensembl
P63173	RPL38	60S ribosomal protein L38	GO:0001501; P:skeletal system development; IEA:Ensembl
P63173	RPL38	60S ribosomal protein L38	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P63173	RPL38	60S ribosomal protein L38	GO:0006412; P:translation; NAS:UniProtKB
P63173	RPL38	60S ribosomal protein L38	GO:0006414; P:translational elongation; TAS:Reactome
P63173	RPL38	60S ribosomal protein L38	GO:0006413; P:translational initiation; TAS:Reactome
P63173	RPL38	60S ribosomal protein L38	GO:0006415; P:translational termination; TAS:Reactome
P63173	RPL38	60S ribosomal protein L38	GO:0019058; P:viral life cycle; TAS:Reactome
P63173	RPL38	60S ribosomal protein L38	GO:0016032; P:viral process; TAS:Reactome
P63173	RPL38	60S ribosomal protein L38	GO:0019083; P:viral transcription; TAS:Reactome
Q96EH5	RPL39L	60S ribosomal protein L39-like	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q96EH5	RPL39L	60S ribosomal protein L39-like	GO:0007283; P:spermatogenesis; IEP:UniProtKB
Q96EH5	RPL39L	60S ribosomal protein L39-like	GO:0006412; P:translation; IEA:InterPro
P62891	RPL39	60S ribosomal protein L39	GO:0003723; F:RNA binding; TAS:UniProtKB
P62891	RPL39	60S ribosomal protein L39	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P62891	RPL39	60S ribosomal protein L39	GO:0019731; P:antibacterial humoral response; IDA:UniProt
P62891	RPL39	60S ribosomal protein L39	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62891	RPL39	60S ribosomal protein L39	GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProt
P62891	RPL39	60S ribosomal protein L39	GO:0010467; P:gene expression; TAS:Reactome
P62891	RPL39	60S ribosomal protein L39	GO:0002227; P:innate immune response in mucosa; IDA:UniProt
P62891	RPL39	60S ribosomal protein L39	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62891	RPL39	60S ribosomal protein L39	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62891	RPL39	60S ribosomal protein L39	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62891	RPL39	60S ribosomal protein L39	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62891	RPL39	60S ribosomal protein L39	GO:0006412; P:translation; NAS:UniProtKB
P62891	RPL39	60S ribosomal protein L39	GO:0006414; P:translational elongation; TAS:Reactome
P62891	RPL39	60S ribosomal protein L39	GO:0006413; P:translational initiation; TAS:Reactome
P62891	RPL39	60S ribosomal protein L39	GO:0006415; P:translational termination; TAS:Reactome
P62891	RPL39	60S ribosomal protein L39	GO:0019058; P:viral life cycle; TAS:Reactome
P62891	RPL39	60S ribosomal protein L39	GO:0016032; P:viral process; TAS:Reactome
P62891	RPL39	60S ribosomal protein L39	GO:0019083; P:viral transcription; TAS:Reactome
Q92901	RPL3L	60S ribosomal protein L3-like	GO:0003723; F:RNA binding; TAS:ProtInc
Q92901	RPL3L	60S ribosomal protein L3-like	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q92901	RPL3L	60S ribosomal protein L3-like	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q92901	RPL3L	60S ribosomal protein L3-like	GO:0010467; P:gene expression; TAS:Reactome
Q92901	RPL3L	60S ribosomal protein L3-like	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q92901	RPL3L	60S ribosomal protein L3-like	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
Q92901	RPL3L	60S ribosomal protein L3-like	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q92901	RPL3L	60S ribosomal protein L3-like	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
Q92901	RPL3L	60S ribosomal protein L3-like	GO:0006412; P:translation; NAS:UniProtKB
Q92901	RPL3L	60S ribosomal protein L3-like	GO:0006414; P:translational elongation; TAS:Reactome
Q92901	RPL3L	60S ribosomal protein L3-like	GO:0006413; P:translational initiation; TAS:Reactome
Q92901	RPL3L	60S ribosomal protein L3-like	GO:0006415; P:translational termination; TAS:Reactome
Q92901	RPL3L	60S ribosomal protein L3-like	GO:0019058; P:viral life cycle; TAS:Reactome
Q92901	RPL3L	60S ribosomal protein L3-like	GO:0016032; P:viral process; TAS:Reactome
Q92901	RPL3L	60S ribosomal protein L3-like	GO:0019083; P:viral transcription; TAS:Reactome
Q9NSD7	RXFP3	Relaxin-3 receptor 1	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q9NSD7	RXFP3	Relaxin-3 receptor 1	GO:0004982; F:N-formyl peptide receptor activity; IEA:InterPro
Q9NSD7	RXFP3	Relaxin-3 receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q9NSD7	RXFP3	Relaxin-3 receptor 1	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProt
Q9NSD7	RXFP3	Relaxin-3 receptor 1	GO:0051482; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway; IEA:Ensembl
Q8TDU9	RXFP4	Relaxin-3 receptor 2	GO:0004945; F:angiotensin type II receptor activity; IEA:InterPro
P39023	RPL3	60S ribosomal protein L3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P39023	RPL3	60S ribosomal protein L3	GO:0003723; F:RNA binding; TAS:ProtInc
P39023	RPL3	60S ribosomal protein L3	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P39023	RPL3	60S ribosomal protein L3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P39023	RPL3	60S ribosomal protein L3	GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl
P39023	RPL3	60S ribosomal protein L3	GO:0010467; P:gene expression; TAS:Reactome
P39023	RPL3	60S ribosomal protein L3	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P39023	RPL3	60S ribosomal protein L3	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P39023	RPL3	60S ribosomal protein L3	GO:0016070; P:RNA metabolic process; TAS:Reactome
P39023	RPL3	60S ribosomal protein L3	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P39023	RPL3	60S ribosomal protein L3	GO:0006412; P:translation; NAS:UniProtKB
P39023	RPL3	60S ribosomal protein L3	GO:0006414; P:translational elongation; TAS:Reactome
P39023	RPL3	60S ribosomal protein L3	GO:0006413; P:translational initiation; TAS:Reactome
P39023	RPL3	60S ribosomal protein L3	GO:0006415; P:translational termination; TAS:Reactome
P39023	RPL3	60S ribosomal protein L3	GO:0019058; P:viral life cycle; TAS:Reactome
P39023	RPL3	60S ribosomal protein L3	GO:0016032; P:viral process; TAS:Reactome
P39023	RPL3	60S ribosomal protein L3	GO:0019083; P:viral transcription; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0005515; F:protein binding; IPI:BHF-UCL
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0000187; P:activation of MAPK activity; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0006915; P:apoptotic process; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0006281; P:DNA repair; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0016197; P:endosomal transport; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0010467; P:gene expression; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0006006; P:glucose metabolic process; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0005978; P:glycogen biosynthetic process; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0045087; P:innate immune response; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0075733; P:intracellular transport of virus; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0007254; P:JNK cascade; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0061024; P:membrane organization; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0007220; P:Notch receptor processing; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0032479; P:regulation of type I interferon production; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0006412; P:translation; NAS:UniProtKB
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0006414; P:translational elongation; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0006413; P:translational initiation; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0006415; P:translational termination; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0055085; P:transmembrane transport; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0019058; P:viral life cycle; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0016032; P:viral process; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0019082; P:viral protein processing; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0019083; P:viral transcription; TAS:Reactome
P62987	UBA52	Ubiquitin-60S ribosomal protein L40	GO:0019068; P:virion assembly; TAS:Reactome
P62945	RPL41	60S ribosomal protein L41	GO:0003723; F:RNA binding; TAS:ProtInc
P62945	RPL41	60S ribosomal protein L41	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P62945	RPL41	60S ribosomal protein L41	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62945	RPL41	60S ribosomal protein L41	GO:0010467; P:gene expression; TAS:Reactome
P62945	RPL41	60S ribosomal protein L41	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62945	RPL41	60S ribosomal protein L41	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62945	RPL41	60S ribosomal protein L41	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62945	RPL41	60S ribosomal protein L41	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62945	RPL41	60S ribosomal protein L41	GO:0006412; P:translation; NAS:UniProtKB
P62945	RPL41	60S ribosomal protein L41	GO:0006414; P:translational elongation; TAS:Reactome
P62945	RPL41	60S ribosomal protein L41	GO:0006413; P:translational initiation; TAS:Reactome
P62945	RPL41	60S ribosomal protein L41	GO:0006415; P:translational termination; TAS:Reactome
P62945	RPL41	60S ribosomal protein L41	GO:0019058; P:viral life cycle; TAS:Reactome
P62945	RPL41	60S ribosomal protein L41	GO:0016032; P:viral process; TAS:Reactome
P62945	RPL41	60S ribosomal protein L41	GO:0019083; P:viral transcription; TAS:Reactome
P36578	RPL4	60S ribosomal protein L4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P36578	RPL4	60S ribosomal protein L4	GO:0005515; F:protein binding; IPI:IntAct
P36578	RPL4	60S ribosomal protein L4	GO:0003723; F:RNA binding; TAS:ProtInc
P36578	RPL4	60S ribosomal protein L4	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P36578	RPL4	60S ribosomal protein L4	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P36578	RPL4	60S ribosomal protein L4	GO:0010467; P:gene expression; TAS:Reactome
P36578	RPL4	60S ribosomal protein L4	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P36578	RPL4	60S ribosomal protein L4	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P36578	RPL4	60S ribosomal protein L4	GO:0016070; P:RNA metabolic process; TAS:Reactome
P36578	RPL4	60S ribosomal protein L4	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P36578	RPL4	60S ribosomal protein L4	GO:0006412; P:translation; NAS:UniProtKB
P36578	RPL4	60S ribosomal protein L4	GO:0006414; P:translational elongation; TAS:Reactome
P36578	RPL4	60S ribosomal protein L4	GO:0006413; P:translational initiation; TAS:Reactome
P36578	RPL4	60S ribosomal protein L4	GO:0006415; P:translational termination; TAS:Reactome
P36578	RPL4	60S ribosomal protein L4	GO:0019058; P:viral life cycle; TAS:Reactome
P36578	RPL4	60S ribosomal protein L4	GO:0016032; P:viral process; TAS:Reactome
P36578	RPL4	60S ribosomal protein L4	GO:0019083; P:viral transcription; TAS:Reactome
P46777	RPL5	60S ribosomal protein L5	GO:0008097; F:5S rRNA binding; IEA:InterPro
P46777	RPL5	60S ribosomal protein L5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P46777	RPL5	60S ribosomal protein L5	GO:0005515; F:protein binding; IPI:UniProtKB
P46777	RPL5	60S ribosomal protein L5	GO:0003723; F:RNA binding; TAS:ProtInc
P46777	RPL5	60S ribosomal protein L5	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P46777	RPL5	60S ribosomal protein L5	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P46777	RPL5	60S ribosomal protein L5	GO:0010467; P:gene expression; TAS:Reactome
P46777	RPL5	60S ribosomal protein L5	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P46777	RPL5	60S ribosomal protein L5	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P46777	RPL5	60S ribosomal protein L5	GO:0042273; P:ribosomal large subunit biogenesis; IMP:UniProtKB
P46777	RPL5	60S ribosomal protein L5	GO:0016070; P:RNA metabolic process; TAS:Reactome
P46777	RPL5	60S ribosomal protein L5	GO:0006364; P:rRNA processing; IMP:UniProtKB
P46777	RPL5	60S ribosomal protein L5	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P46777	RPL5	60S ribosomal protein L5	GO:0006412; P:translation; NAS:UniProtKB
P46777	RPL5	60S ribosomal protein L5	GO:0006414; P:translational elongation; TAS:Reactome
P46777	RPL5	60S ribosomal protein L5	GO:0006413; P:translational initiation; TAS:Reactome
P46777	RPL5	60S ribosomal protein L5	GO:0006415; P:translational termination; TAS:Reactome
P46777	RPL5	60S ribosomal protein L5	GO:0019058; P:viral life cycle; TAS:Reactome
P46777	RPL5	60S ribosomal protein L5	GO:0016032; P:viral process; TAS:Reactome
P46777	RPL5	60S ribosomal protein L5	GO:0019083; P:viral transcription; TAS:Reactome
Q02878	RPL6	60S ribosomal protein L6	GO:0003677; F:DNA binding; TAS:ProtInc
Q02878	RPL6	60S ribosomal protein L6	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q02878	RPL6	60S ribosomal protein L6	GO:0003723; F:RNA binding; TAS:ProtInc
Q02878	RPL6	60S ribosomal protein L6	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q02878	RPL6	60S ribosomal protein L6	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q02878	RPL6	60S ribosomal protein L6	GO:0010467; P:gene expression; TAS:Reactome
Q02878	RPL6	60S ribosomal protein L6	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q02878	RPL6	60S ribosomal protein L6	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
Q02878	RPL6	60S ribosomal protein L6	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
Q02878	RPL6	60S ribosomal protein L6	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q02878	RPL6	60S ribosomal protein L6	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
Q02878	RPL6	60S ribosomal protein L6	GO:0006412; P:translation; NAS:UniProtKB
Q02878	RPL6	60S ribosomal protein L6	GO:0006414; P:translational elongation; TAS:Reactome
Q02878	RPL6	60S ribosomal protein L6	GO:0006413; P:translational initiation; TAS:Reactome
Q02878	RPL6	60S ribosomal protein L6	GO:0006415; P:translational termination; TAS:Reactome
Q02878	RPL6	60S ribosomal protein L6	GO:0019058; P:viral life cycle; TAS:Reactome
Q02878	RPL6	60S ribosomal protein L6	GO:0016032; P:viral process; TAS:Reactome
Q02878	RPL6	60S ribosomal protein L6	GO:0019083; P:viral transcription; TAS:Reactome
P62424	RPL7A	60S ribosomal protein L7a	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62424	RPL7A	60S ribosomal protein L7a	GO:0005515; F:protein binding; IPI:IntAct
P62424	RPL7A	60S ribosomal protein L7a	GO:0003723; F:RNA binding; TAS:ProtInc
P62424	RPL7A	60S ribosomal protein L7a	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P62424	RPL7A	60S ribosomal protein L7a	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62424	RPL7A	60S ribosomal protein L7a	GO:0010467; P:gene expression; TAS:Reactome
P62424	RPL7A	60S ribosomal protein L7a	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62424	RPL7A	60S ribosomal protein L7a	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62424	RPL7A	60S ribosomal protein L7a	GO:0042254; P:ribosome biogenesis; IEA:InterPro
P62424	RPL7A	60S ribosomal protein L7a	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62424	RPL7A	60S ribosomal protein L7a	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62424	RPL7A	60S ribosomal protein L7a	GO:0006412; P:translation; NAS:UniProtKB
P62424	RPL7A	60S ribosomal protein L7a	GO:0006414; P:translational elongation; TAS:Reactome
P62424	RPL7A	60S ribosomal protein L7a	GO:0006413; P:translational initiation; TAS:Reactome
P62424	RPL7A	60S ribosomal protein L7a	GO:0006415; P:translational termination; TAS:Reactome
P62424	RPL7A	60S ribosomal protein L7a	GO:0019058; P:viral life cycle; TAS:Reactome
P62424	RPL7A	60S ribosomal protein L7a	GO:0016032; P:viral process; TAS:Reactome
P62424	RPL7A	60S ribosomal protein L7a	GO:0019083; P:viral transcription; TAS:Reactome
Q6DKI1	RPL7L1	60S ribosomal protein L7-like 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P18124	RPL7	60S ribosomal protein L7	GO:0003677; F:DNA binding; IDA:MGI
P18124	RPL7	60S ribosomal protein L7	GO:0003729; F:mRNA binding; IDA:MGI
P18124	RPL7	60S ribosomal protein L7	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P18124	RPL7	60S ribosomal protein L7	GO:0005515; F:protein binding; IPI:IntAct
P18124	RPL7	60S ribosomal protein L7	GO:0042803; F:protein homodimerization activity; IPI:MGI
P18124	RPL7	60S ribosomal protein L7	GO:0003723; F:RNA binding; TAS:ProtInc
P18124	RPL7	60S ribosomal protein L7	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P18124	RPL7	60S ribosomal protein L7	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P18124	RPL7	60S ribosomal protein L7	GO:0010467; P:gene expression; TAS:Reactome
P18124	RPL7	60S ribosomal protein L7	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P18124	RPL7	60S ribosomal protein L7	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P18124	RPL7	60S ribosomal protein L7	GO:0042273; P:ribosomal large subunit biogenesis; IMP:UniProtKB
P18124	RPL7	60S ribosomal protein L7	GO:0016070; P:RNA metabolic process; TAS:Reactome
P18124	RPL7	60S ribosomal protein L7	GO:0006364; P:rRNA processing; IMP:UniProtKB
P18124	RPL7	60S ribosomal protein L7	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P18124	RPL7	60S ribosomal protein L7	GO:0006412; P:translation; NAS:UniProtKB
P18124	RPL7	60S ribosomal protein L7	GO:0006414; P:translational elongation; TAS:Reactome
P18124	RPL7	60S ribosomal protein L7	GO:0006413; P:translational initiation; TAS:Reactome
P18124	RPL7	60S ribosomal protein L7	GO:0006415; P:translational termination; TAS:Reactome
P18124	RPL7	60S ribosomal protein L7	GO:0019058; P:viral life cycle; TAS:Reactome
P18124	RPL7	60S ribosomal protein L7	GO:0016032; P:viral process; TAS:Reactome
P18124	RPL7	60S ribosomal protein L7	GO:0019083; P:viral transcription; TAS:Reactome
P62917	RPL8	60S ribosomal protein L8	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62917	RPL8	60S ribosomal protein L8	GO:0003723; F:RNA binding; TAS:ProtInc
P62917	RPL8	60S ribosomal protein L8	GO:0019843; F:rRNA binding; IEA:UniProtKB-KW
P62917	RPL8	60S ribosomal protein L8	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P62917	RPL8	60S ribosomal protein L8	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62917	RPL8	60S ribosomal protein L8	GO:0010467; P:gene expression; TAS:Reactome
P62917	RPL8	60S ribosomal protein L8	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62917	RPL8	60S ribosomal protein L8	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62917	RPL8	60S ribosomal protein L8	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62917	RPL8	60S ribosomal protein L8	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62917	RPL8	60S ribosomal protein L8	GO:0006412; P:translation; NAS:UniProtKB
P62917	RPL8	60S ribosomal protein L8	GO:0006414; P:translational elongation; TAS:Reactome
P62917	RPL8	60S ribosomal protein L8	GO:0006413; P:translational initiation; TAS:Reactome
P62917	RPL8	60S ribosomal protein L8	GO:0006415; P:translational termination; TAS:Reactome
P62917	RPL8	60S ribosomal protein L8	GO:0019058; P:viral life cycle; TAS:Reactome
P62917	RPL8	60S ribosomal protein L8	GO:0016032; P:viral process; TAS:Reactome
P62917	RPL8	60S ribosomal protein L8	GO:0019083; P:viral transcription; TAS:Reactome
P32969	RPL9	60S ribosomal protein L9	GO:0003723; F:RNA binding; TAS:ProtInc
P32969	RPL9	60S ribosomal protein L9	GO:0019843; F:rRNA binding; IEA:InterPro
P32969	RPL9	60S ribosomal protein L9	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P32969	RPL9	60S ribosomal protein L9	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P32969	RPL9	60S ribosomal protein L9	GO:0010467; P:gene expression; TAS:Reactome
P32969	RPL9	60S ribosomal protein L9	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P32969	RPL9	60S ribosomal protein L9	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P32969	RPL9	60S ribosomal protein L9	GO:0016070; P:RNA metabolic process; TAS:Reactome
P32969	RPL9	60S ribosomal protein L9	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P32969	RPL9	60S ribosomal protein L9	GO:0006412; P:translation; NAS:UniProtKB
P32969	RPL9	60S ribosomal protein L9	GO:0006414; P:translational elongation; TAS:Reactome
P32969	RPL9	60S ribosomal protein L9	GO:0006413; P:translational initiation; TAS:Reactome
P32969	RPL9	60S ribosomal protein L9	GO:0006415; P:translational termination; TAS:Reactome
P32969	RPL9	60S ribosomal protein L9	GO:0019058; P:viral life cycle; TAS:Reactome
P32969	RPL9	60S ribosomal protein L9	GO:0016032; P:viral process; TAS:Reactome
P32969	RPL9	60S ribosomal protein L9	GO:0019083; P:viral transcription; TAS:Reactome
Q8NHW5	RPLP0P6	60S acidic ribosomal protein P0-like	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q8NHW5	RPLP0P6	60S acidic ribosomal protein P0-like	GO:0042254; P:ribosome biogenesis; IEA:InterPro
Q8NHW5	RPLP0P6	60S acidic ribosomal protein P0-like	GO:0006414; P:translational elongation; IEA:InterPro
P05388	RPLP0	60S acidic ribosomal protein P0	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P05388	RPLP0	60S acidic ribosomal protein P0	GO:0005515; F:protein binding; IPI:UniProtKB
P05388	RPLP0	60S acidic ribosomal protein P0	GO:0003723; F:RNA binding; TAS:ProtInc
P05388	RPLP0	60S acidic ribosomal protein P0	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P05388	RPLP0	60S acidic ribosomal protein P0	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P05388	RPLP0	60S acidic ribosomal protein P0	GO:0010467; P:gene expression; TAS:Reactome
P05388	RPLP0	60S acidic ribosomal protein P0	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P05388	RPLP0	60S acidic ribosomal protein P0	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P05388	RPLP0	60S acidic ribosomal protein P0	GO:0042254; P:ribosome biogenesis; IEA:InterPro
P05388	RPLP0	60S acidic ribosomal protein P0	GO:0016070; P:RNA metabolic process; TAS:Reactome
P05388	RPLP0	60S acidic ribosomal protein P0	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P05388	RPLP0	60S acidic ribosomal protein P0	GO:0006412; P:translation; NAS:UniProtKB
P05388	RPLP0	60S acidic ribosomal protein P0	GO:0006414; P:translational elongation; TAS:Reactome
P05388	RPLP0	60S acidic ribosomal protein P0	GO:0006413; P:translational initiation; TAS:Reactome
P05388	RPLP0	60S acidic ribosomal protein P0	GO:0006415; P:translational termination; TAS:Reactome
P05388	RPLP0	60S acidic ribosomal protein P0	GO:0019058; P:viral life cycle; TAS:Reactome
P05388	RPLP0	60S acidic ribosomal protein P0	GO:0016032; P:viral process; TAS:Reactome
P05388	RPLP0	60S acidic ribosomal protein P0	GO:0019083; P:viral transcription; TAS:Reactome
P05386	RPLP1	60S acidic ribosomal protein P1	GO:0005515; F:protein binding; IPI:UniProtKB
P05386	RPLP1	60S acidic ribosomal protein P1	GO:0003723; F:RNA binding; TAS:ProtInc
P05386	RPLP1	60S acidic ribosomal protein P1	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P05386	RPLP1	60S acidic ribosomal protein P1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P05386	RPLP1	60S acidic ribosomal protein P1	GO:0010467; P:gene expression; TAS:Reactome
P05386	RPLP1	60S acidic ribosomal protein P1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P05386	RPLP1	60S acidic ribosomal protein P1	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P05386	RPLP1	60S acidic ribosomal protein P1	GO:0016070; P:RNA metabolic process; TAS:Reactome
P05386	RPLP1	60S acidic ribosomal protein P1	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P05386	RPLP1	60S acidic ribosomal protein P1	GO:0006412; P:translation; NAS:UniProtKB
P05386	RPLP1	60S acidic ribosomal protein P1	GO:0006414; P:translational elongation; TAS:Reactome
P05386	RPLP1	60S acidic ribosomal protein P1	GO:0006413; P:translational initiation; TAS:Reactome
P05386	RPLP1	60S acidic ribosomal protein P1	GO:0006415; P:translational termination; TAS:Reactome
P05386	RPLP1	60S acidic ribosomal protein P1	GO:0019058; P:viral life cycle; TAS:Reactome
P05386	RPLP1	60S acidic ribosomal protein P1	GO:0016032; P:viral process; TAS:Reactome
P05386	RPLP1	60S acidic ribosomal protein P1	GO:0019083; P:viral transcription; TAS:Reactome
P05387	RPLP2	60S acidic ribosomal protein P2	GO:0003723; F:RNA binding; TAS:ProtInc
P05387	RPLP2	60S acidic ribosomal protein P2	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P05387	RPLP2	60S acidic ribosomal protein P2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P05387	RPLP2	60S acidic ribosomal protein P2	GO:0010467; P:gene expression; TAS:Reactome
P05387	RPLP2	60S acidic ribosomal protein P2	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P05387	RPLP2	60S acidic ribosomal protein P2	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P05387	RPLP2	60S acidic ribosomal protein P2	GO:0016070; P:RNA metabolic process; TAS:Reactome
P05387	RPLP2	60S acidic ribosomal protein P2	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P05387	RPLP2	60S acidic ribosomal protein P2	GO:0006412; P:translation; NAS:UniProtKB
P05387	RPLP2	60S acidic ribosomal protein P2	GO:0006414; P:translational elongation; TAS:Reactome
P05387	RPLP2	60S acidic ribosomal protein P2	GO:0006413; P:translational initiation; TAS:Reactome
P05387	RPLP2	60S acidic ribosomal protein P2	GO:0006415; P:translational termination; TAS:Reactome
P05387	RPLP2	60S acidic ribosomal protein P2	GO:0019058; P:viral life cycle; TAS:Reactome
P05387	RPLP2	60S acidic ribosomal protein P2	GO:0016032; P:viral process; TAS:Reactome
P05387	RPLP2	60S acidic ribosomal protein P2	GO:0019083; P:viral transcription; TAS:Reactome
P12271	RLBP1	Retinaldehyde-binding protein 1	GO:0005502; F:11-cis retinal binding; IEA:Ensembl
P12271	RLBP1	Retinaldehyde-binding protein 1	GO:0019841; F:retinol binding; IEA:UniProtKB-KW
P12271	RLBP1	Retinaldehyde-binding protein 1	GO:0005215; F:transporter activity; IEA:InterPro
P12271	RLBP1	Retinaldehyde-binding protein 1	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P12271	RLBP1	Retinaldehyde-binding protein 1	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P12271	RLBP1	Retinaldehyde-binding protein 1	GO:0007601; P:visual perception; TAS:ProtInc
P12271	RLBP1	Retinaldehyde-binding protein 1	GO:0006776; P:vitamin A metabolic process; TAS:ProtInc
Q13129	RLF	Zinc finger protein Rlf	GO:0003677; F:DNA binding; NAS:UniProtKB
Q13129	RLF	Zinc finger protein Rlf	GO:0005515; F:protein binding; IPI:IntAct
Q13129	RLF	Zinc finger protein Rlf	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q13129	RLF	Zinc finger protein Rlf	GO:0051276; P:chromosome organization; IDA:UniProtKB
Q13129	RLF	Zinc finger protein Rlf	GO:0015074; P:DNA integration; IDA:UniProtKB
Q13129	RLF	Zinc finger protein Rlf	GO:0009294; P:DNA mediated transformation; NAS:UniProtKB
Q13129	RLF	Zinc finger protein Rlf	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q13129	RLF	Zinc finger protein Rlf	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q13129	RLF	Zinc finger protein Rlf	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q13129	RLF	Zinc finger protein Rlf	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86X10	RALGAPB	Ral GTPase-activating protein subunit beta	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q86X10	RALGAPB	Ral GTPase-activating protein subunit beta	GO:0017123; F:Ral GTPase activator activity; ISS:UniProtKB
Q86X10	RALGAPB	Ral GTPase-activating protein subunit beta	GO:0032859; P:activation of Ral GTPase activity; ISS:UniProtKB
Q86X10	RALGAPB	Ral GTPase-activating protein subunit beta	GO:0061024; P:membrane organization; TAS:Reactome
Q86X10	RALGAPB	Ral GTPase-activating protein subunit beta	GO:0032484; P:Ral protein signal transduction; IEA:Ensembl
Q86X10	RALGAPB	Ral GTPase-activating protein subunit beta	GO:0060178; P:regulation of exocyst localization; IEA:Ensembl
Q9UHA3	RSL24D1	Probable ribosome biogenesis protein RLP24	GO:0042254; P:ribosome biogenesis; IEA:UniProtKB-KW
Q9BYD6	MRPL1	39S ribosomal protein L1, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BYD6	MRPL1	39S ribosomal protein L1, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q9BYD6	MRPL1	39S ribosomal protein L1, mitochondrial	GO:0006412; P:translation; IEA:InterPro
Q5T653	MRPL2	39S ribosomal protein L2, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q5T653	MRPL2	39S ribosomal protein L2, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q5T653	MRPL2	39S ribosomal protein L2, mitochondrial	GO:0006412; P:translation; IEA:InterPro
P09001	MRPL3	39S ribosomal protein L3, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P09001	MRPL3	39S ribosomal protein L3, mitochondrial	GO:0003723; F:RNA binding; TAS:ProtInc
P09001	MRPL3	39S ribosomal protein L3, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P09001	MRPL3	39S ribosomal protein L3, mitochondrial	GO:0006412; P:translation; TAS:ProtInc
Q9BYD3	MRPL4	39S ribosomal protein L4, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BYD3	MRPL4	39S ribosomal protein L4, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q9BYD3	MRPL4	39S ribosomal protein L4, mitochondrial	GO:0006412; P:translation; IEA:InterPro
Q9BYD2	MRPL9	39S ribosomal protein L9, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BYD2	MRPL9	39S ribosomal protein L9, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q9BYD2	MRPL9	39S ribosomal protein L9, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
Q7Z7H8	MRPL10	39S ribosomal protein L10, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7Z7H8	MRPL10	39S ribosomal protein L10, mitochondrial	GO:0003735; F:structural constituent of ribosome; ISS:UniProtKB
Q7Z7H8	MRPL10	39S ribosomal protein L10, mitochondrial	GO:0042254; P:ribosome biogenesis; IEA:InterPro
Q7Z7H8	MRPL10	39S ribosomal protein L10, mitochondrial	GO:0006412; P:translation; ISS:UniProtKB
P52815	MRPL12	39S ribosomal protein L12, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
P52815	MRPL12	39S ribosomal protein L12, mitochondrial	GO:0003723; F:RNA binding; TAS:ProtInc
P52815	MRPL12	39S ribosomal protein L12, mitochondrial	GO:0003735; F:structural constituent of ribosome; TAS:ProtInc
P52815	MRPL12	39S ribosomal protein L12, mitochondrial	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:HGNC
P52815	MRPL12	39S ribosomal protein L12, mitochondrial	GO:0006390; P:transcription from mitochondrial promoter; IDA:HGNC
P52815	MRPL12	39S ribosomal protein L12, mitochondrial	GO:0006412; P:translation; IEA:InterPro
Q9Y3B7	MRPL11	39S ribosomal protein L11, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y3B7	MRPL11	39S ribosomal protein L11, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3B7	MRPL11	39S ribosomal protein L11, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q9Y3B7	MRPL11	39S ribosomal protein L11, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
Q9BYD1	MRPL13	39S ribosomal protein L13, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BYD1	MRPL13	39S ribosomal protein L13, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BYD1	MRPL13	39S ribosomal protein L13, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q9BYD1	MRPL13	39S ribosomal protein L13, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
Q6P1L8	MRPL14	39S ribosomal protein L14, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6P1L8	MRPL14	39S ribosomal protein L14, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q6P1L8	MRPL14	39S ribosomal protein L14, mitochondrial	GO:0006412; P:translation; IEA:InterPro
Q9P015	MRPL15	39S ribosomal protein L15, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9P015	MRPL15	39S ribosomal protein L15, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q9P015	MRPL15	39S ribosomal protein L15, mitochondrial	GO:0006412; P:translation; IEA:InterPro
Q9NX20	MRPL16	39S ribosomal protein L16, mitochondrial	GO:0019843; F:rRNA binding; IEA:InterPro
Q9NX20	MRPL16	39S ribosomal protein L16, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q9NX20	MRPL16	39S ribosomal protein L16, mitochondrial	GO:0006412; P:translation; IEA:InterPro
Q9NRX2	MRPL17	39S ribosomal protein L17, mitochondrial	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q9NRX2	MRPL17	39S ribosomal protein L17, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q9NRX2	MRPL17	39S ribosomal protein L17, mitochondrial	GO:0006412; P:translation; IEA:InterPro
Q9H0U6	MRPL18	39S ribosomal protein L18, mitochondrial	GO:0008097; F:5S rRNA binding; IDA:UniProtKB
Q9H0U6	MRPL18	39S ribosomal protein L18, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q9H0U6	MRPL18	39S ribosomal protein L18, mitochondrial	GO:0035928; P:rRNA import into mitochondrion; IDA:UniProtKB
Q9H0U6	MRPL18	39S ribosomal protein L18, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
P49406	MRPL19	39S ribosomal protein L19, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P49406	MRPL19	39S ribosomal protein L19, mitochondrial	GO:0006412; P:translation; IEA:InterPro
Q9BYC9	MRPL20	39S ribosomal protein L20, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BYC9	MRPL20	39S ribosomal protein L20, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BYC9	MRPL20	39S ribosomal protein L20, mitochondrial	GO:0019843; F:rRNA binding; IEA:InterPro
Q9BYC9	MRPL20	39S ribosomal protein L20, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q9BYC9	MRPL20	39S ribosomal protein L20, mitochondrial	GO:0006412; P:translation; IEA:InterPro
Q7Z2W9	MRPL21	39S ribosomal protein L21, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7Z2W9	MRPL21	39S ribosomal protein L21, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q7Z2W9	MRPL21	39S ribosomal protein L21, mitochondrial	GO:0006412; P:translation; IEA:InterPro
Q9NWU5	MRPL22	39S ribosomal protein L22, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NWU5	MRPL22	39S ribosomal protein L22, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q9NWU5	MRPL22	39S ribosomal protein L22, mitochondrial	GO:0006412; P:translation; IEA:InterPro
Q16540	MRPL23	39S ribosomal protein L23, mitochondrial	GO:0000166; F:nucleotide binding; IEA:InterPro
Q16540	MRPL23	39S ribosomal protein L23, mitochondrial	GO:0003723; F:RNA binding; TAS:ProtInc
Q16540	MRPL23	39S ribosomal protein L23, mitochondrial	GO:0003735; F:structural constituent of ribosome; TAS:ProtInc
Q16540	MRPL23	39S ribosomal protein L23, mitochondrial	GO:0006412; P:translation; TAS:ProtInc
Q96A35	MRPL24	39S ribosomal protein L24, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q96A35	MRPL24	39S ribosomal protein L24, mitochondrial	GO:0006412; P:translation; IEA:InterPro
Q9P0M9	MRPL27	39S ribosomal protein L27, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9P0M9	MRPL27	39S ribosomal protein L27, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q9P0M9	MRPL27	39S ribosomal protein L27, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
Q13084	MRPL28	39S ribosomal protein L28, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13084	MRPL28	39S ribosomal protein L28, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q13084	MRPL28	39S ribosomal protein L28, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q13084	MRPL28	39S ribosomal protein L28, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
Q9BYC8	MRPL32	39S ribosomal protein L32, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BYC8	MRPL32	39S ribosomal protein L32, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q9BYC8	MRPL32	39S ribosomal protein L32, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
O75394	MRPL33	39S ribosomal protein L33, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
O75394	MRPL33	39S ribosomal protein L33, mitochondrial	GO:0006412; P:translation; IEA:InterPro
Q9BQ48	MRPL34	39S ribosomal protein L34, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q9BQ48	MRPL34	39S ribosomal protein L34, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
Q9NZE8	MRPL35	39S ribosomal protein L35, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q9NZE8	MRPL35	39S ribosomal protein L35, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
Q9P0J6	MRPL36	39S ribosomal protein L36, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q9P0J6	MRPL36	39S ribosomal protein L36, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
Q9BZE1	MRPL37	39S ribosomal protein L37, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BZE1	MRPL37	39S ribosomal protein L37, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q9BZE1	MRPL37	39S ribosomal protein L37, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
Q9NYK5	MRPL39	39S ribosomal protein L39, mitochondrial	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9NYK5	MRPL39	39S ribosomal protein L39, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NQ50	MRPL40	39S ribosomal protein L40, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NQ50	MRPL40	39S ribosomal protein L40, mitochondrial	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q8IXM3	MRPL41	39S ribosomal protein L41, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IXM3	MRPL41	39S ribosomal protein L41, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q8IXM3	MRPL41	39S ribosomal protein L41, mitochondrial	GO:0003735; F:structural constituent of ribosome; IDA:UniProtKB
Q8IXM3	MRPL41	39S ribosomal protein L41, mitochondrial	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8IXM3	MRPL41	39S ribosomal protein L41, mitochondrial	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8IXM3	MRPL41	39S ribosomal protein L41, mitochondrial	GO:0006412; P:translation; IDA:UniProtKB
Q9Y6G3	MRPL42	39S ribosomal protein L42, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y6G3	MRPL42	39S ribosomal protein L42, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q9Y6G3	MRPL42	39S ribosomal protein L42, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
Q8N983	MRPL43	39S ribosomal protein L43, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8N983	MRPL43	39S ribosomal protein L43, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q8N983	MRPL43	39S ribosomal protein L43, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
Q9H9J2	MRPL44	39S ribosomal protein L44, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H9J2	MRPL44	39S ribosomal protein L44, mitochondrial	GO:0004525; F:ribonuclease III activity; IEA:InterPro
Q9H9J2	MRPL44	39S ribosomal protein L44, mitochondrial	GO:0070125; P:mitochondrial translational elongation; IMP:UniProtKB
Q9H9J2	MRPL44	39S ribosomal protein L44, mitochondrial	GO:0006396; P:RNA processing; IEA:InterPro
Q9BRJ2	MRPL45	39S ribosomal protein L45, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H2W6	MRPL46	39S ribosomal protein L46, mitochondrial	GO:0016787; F:hydrolase activity; IEA:InterPro
Q9HD33	MRPL47	39S ribosomal protein L47, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q9HD33	MRPL47	39S ribosomal protein L47, mitochondrial	GO:0006412; P:translation; IEA:InterPro
Q96GC5	MRPL48	39S ribosomal protein L48, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q13405	MRPL49	39S ribosomal protein L49, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q13405	MRPL49	39S ribosomal protein L49, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q13405	MRPL49	39S ribosomal protein L49, mitochondrial	GO:0006412; P:translation; IEA:InterPro
Q4U2R6	MRPL51	39S ribosomal protein L51, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q4U2R6	MRPL51	39S ribosomal protein L51, mitochondrial	GO:0003735; F:structural constituent of ribosome; ISS:UniProtKB
Q4U2R6	MRPL51	39S ribosomal protein L51, mitochondrial	GO:0006412; P:translation; ISS:UniProtKB
Q86TS9	MRPL52	39S ribosomal protein L52, mitochondrial	GO:0003735; F:structural constituent of ribosome; ISS:UniProtKB
Q86TS9	MRPL52	39S ribosomal protein L52, mitochondrial	GO:0006412; P:translation; ISS:UniProtKB
Q6P161	MRPL54	39S ribosomal protein L54, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7Z7F7	MRPL55	39S ribosomal protein L55, mitochondrial	GO:0003735; F:structural constituent of ribosome; ISS:UniProtKB
Q7Z7F7	MRPL55	39S ribosomal protein L55, mitochondrial	GO:0006412; P:translation; ISS:UniProtKB
Q96TC7	RMDN3	Regulator of microtubule dynamics protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q96TC7	RMDN3	Regulator of microtubule dynamics protein 3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q96TC7	RMDN3	Regulator of microtubule dynamics protein 3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96TC7	RMDN3	Regulator of microtubule dynamics protein 3	GO:0006874; P:cellular calcium ion homeostasis; IMP:UniProtKB
Q9H9A7	RMI1	RecQ-mediated genome instability protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H9A7	RMI1	RecQ-mediated genome instability protein 1	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q96E14	RMI2	RecQ-mediated genome instability protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96E14	RMI2	RecQ-mediated genome instability protein 2	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q9NWS8	RMND1	Required for meiotic nuclear division protein 1 homolog	GO:0006412; P:translation; IEA:UniProtKB-KW
O94763	URI1	Unconventional prefoldin RPB5 interactor 1	GO:0003682; F:chromatin binding; IDA:UniProtKB
O94763	URI1	Unconventional prefoldin RPB5 interactor 1	GO:0005515; F:protein binding; IPI:UniProtKB
O94763	URI1	Unconventional prefoldin RPB5 interactor 1	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
O94763	URI1	Unconventional prefoldin RPB5 interactor 1	GO:0001106; F:RNA polymerase II transcription corepressor activity; IDA:UniProtKB
O94763	URI1	Unconventional prefoldin RPB5 interactor 1	GO:0071363; P:cellular response to growth factor stimulus; IDA:UniProtKB
O94763	URI1	Unconventional prefoldin RPB5 interactor 1	GO:0071383; P:cellular response to steroid hormone stimulus; IDA:UniProtKB
O94763	URI1	Unconventional prefoldin RPB5 interactor 1	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
O94763	URI1	Unconventional prefoldin RPB5 interactor 1	GO:0010923; P:negative regulation of phosphatase activity; IMP:UniProtKB
O94763	URI1	Unconventional prefoldin RPB5 interactor 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O94763	URI1	Unconventional prefoldin RPB5 interactor 1	GO:0006457; P:protein folding; IEA:InterPro
O94763	URI1	Unconventional prefoldin RPB5 interactor 1	GO:0001558; P:regulation of cell growth; IDA:UniProtKB
O94763	URI1	Unconventional prefoldin RPB5 interactor 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
O94763	URI1	Unconventional prefoldin RPB5 interactor 1	GO:0009615; P:response to virus; IMP:UniProtKB
Q9HC36	RNMTL1	RNA methyltransferase-like protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9HC36	RNMTL1	RNA methyltransferase-like protein 1	GO:0008173; F:RNA methyltransferase activity; IEA:InterPro
Q9HC36	RNMTL1	RNA methyltransferase-like protein 1	GO:0006396; P:RNA processing; IEA:InterPro
Q96E39	RBMXL1	RNA binding motif protein, X-linked-like-1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q96E39	RBMXL1	RNA binding motif protein, X-linked-like-1	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q96E39	RBMXL1	RNA binding motif protein, X-linked-like-1	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q96E39	RBMXL1	RNA binding motif protein, X-linked-like-1	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
O75526	RBMXL2	RNA-binding motif protein, X-linked-like-2	GO:0000166; F:nucleotide binding; IEA:InterPro
O75526	RBMXL2	RNA-binding motif protein, X-linked-like-2	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q8N7X1	RBMXL3	RNA-binding motif protein, X-linked-like-3	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8N7X1	RBMXL3	RNA-binding motif protein, X-linked-like-3	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
O00237	RNF103	E3 ubiquitin-protein ligase RNF103	GO:0005515; F:protein binding; IPI:UniProtKB
O00237	RNF103	E3 ubiquitin-protein ligase RNF103	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
O00237	RNF103	E3 ubiquitin-protein ligase RNF103	GO:0008270; F:zinc ion binding; IEA:InterPro
O00237	RNF103	E3 ubiquitin-protein ligase RNF103	GO:0007417; P:central nervous system development; TAS:ProtInc
O00237	RNF103	E3 ubiquitin-protein ligase RNF103	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
O00237	RNF103	E3 ubiquitin-protein ligase RNF103	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q6ZNA4	RNF111	E3 ubiquitin-protein ligase Arkadia	GO:0005515; F:protein binding; IPI:IntAct
Q6ZNA4	RNF111	E3 ubiquitin-protein ligase Arkadia	GO:0032184; F:SUMO polymer binding; IDA:UniProtKB
Q6ZNA4	RNF111	E3 ubiquitin-protein ligase Arkadia	GO:0004842; F:ubiquitin-protein ligase activity; IMP:BHF-UCL
Q6ZNA4	RNF111	E3 ubiquitin-protein ligase Arkadia	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6ZNA4	RNF111	E3 ubiquitin-protein ligase Arkadia	GO:0010467; P:gene expression; TAS:Reactome
Q6ZNA4	RNF111	E3 ubiquitin-protein ligase Arkadia	GO:0007389; P:pattern specification process; IEA:Ensembl
Q6ZNA4	RNF111	E3 ubiquitin-protein ligase Arkadia	GO:0031398; P:positive regulation of protein ubiquitination; IEA:Ensembl
Q6ZNA4	RNF111	E3 ubiquitin-protein ligase Arkadia	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
Q6ZNA4	RNF111	E3 ubiquitin-protein ligase Arkadia	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:BHF-UCL
Q6ZNA4	RNF111	E3 ubiquitin-protein ligase Arkadia	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl
Q6ZNA4	RNF111	E3 ubiquitin-protein ligase Arkadia	GO:0000209; P:protein polyubiquitination; IEA:Ensembl
Q6ZNA4	RNF111	E3 ubiquitin-protein ligase Arkadia	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q6ZNA4	RNF111	E3 ubiquitin-protein ligase Arkadia	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
Q6ZNA4	RNF111	E3 ubiquitin-protein ligase Arkadia	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q6ZNA4	RNF111	E3 ubiquitin-protein ligase Arkadia	GO:0030579; P:ubiquitin-dependent SMAD protein catabolic process; IEA:Ensembl
Q9ULX5	RNF112	RING finger protein 112	GO:0005525; F:GTP binding; IEA:InterPro
Q9ULX5	RNF112	RING finger protein 112	GO:0003924; F:GTPase activity; IEA:InterPro
Q9ULX5	RNF112	RING finger protein 112	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9H920	RNF121	RING finger protein 121	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y4L5	RNF115	E3 ubiquitin-protein ligase RNF115	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y4L5	RNF115	E3 ubiquitin-protein ligase RNF115	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9Y4L5	RNF115	E3 ubiquitin-protein ligase RNF115	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y4L5	RNF115	E3 ubiquitin-protein ligase RNF115	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
Q9Y508	RNF114	E3 ubiquitin-protein ligase RNF114	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9Y508	RNF114	E3 ubiquitin-protein ligase RNF114	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y508	RNF114	E3 ubiquitin-protein ligase RNF114	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9Y508	RNF114	E3 ubiquitin-protein ligase RNF114	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9Y508	RNF114	E3 ubiquitin-protein ligase RNF114	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9Y508	RNF114	E3 ubiquitin-protein ligase RNF114	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q9H9V4	RNF122	RING finger protein 122	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96EQ8	RNF125	E3 ubiquitin-protein ligase RNF125	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q96EQ8	RNF125	E3 ubiquitin-protein ligase RNF125	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96EQ8	RNF125	E3 ubiquitin-protein ligase RNF125	GO:0045087; P:innate immune response; TAS:Reactome
Q96EQ8	RNF125	E3 ubiquitin-protein ligase RNF125	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
Q9BV68	RNF126	E3 ubiquitin-protein ligase RNF126	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9BV68	RNF126	E3 ubiquitin-protein ligase RNF126	GO:0005515; F:protein binding; IPI:IntAct
Q9BV68	RNF126	E3 ubiquitin-protein ligase RNF126	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5XPI4	RNF123	E3 ubiquitin-protein ligase RNF123	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q5XPI4	RNF123	E3 ubiquitin-protein ligase RNF123	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5XPI4	RNF123	E3 ubiquitin-protein ligase RNF123	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8WVZ7	RNF133	E3 ubiquitin-protein ligase RNF133	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q8WVZ7	RNF133	E3 ubiquitin-protein ligase RNF133	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WVZ7	RNF133	E3 ubiquitin-protein ligase RNF133	GO:0051865; P:protein autoubiquitination; IEA:Ensembl
Q8TEB7	RNF128	E3 ubiquitin-protein ligase RNF128	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q8TEB7	RNF128	E3 ubiquitin-protein ligase RNF128	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TEB7	RNF128	E3 ubiquitin-protein ligase RNF128	GO:0042036; P:negative regulation of cytokine biosynthetic process; IEA:Ensembl
Q8IUD6	RNF135	E3 ubiquitin-protein ligase RNF135	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IUD6	RNF135	E3 ubiquitin-protein ligase RNF135	GO:0043021; F:ribonucleoprotein complex binding; IPI:UniProtKB
Q8IUD6	RNF135	E3 ubiquitin-protein ligase RNF135	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q8IUD6	RNF135	E3 ubiquitin-protein ligase RNF135	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IUD6	RNF135	E3 ubiquitin-protein ligase RNF135	GO:0045087; P:innate immune response; TAS:Reactome
Q8IUD6	RNF135	E3 ubiquitin-protein ligase RNF135	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
Q8IUD6	RNF135	E3 ubiquitin-protein ligase RNF135	GO:0032728; P:positive regulation of interferon-beta production; IMP:UniProtKB
Q8IUD6	RNF135	E3 ubiquitin-protein ligase RNF135	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q8IUD6	RNF135	E3 ubiquitin-protein ligase RNF135	GO:0045088; P:regulation of innate immune response; IMP:UniProtKB
Q8WVD3	RNF138	E3 ubiquitin-protein ligase RNF138	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q8WVD3	RNF138	E3 ubiquitin-protein ligase RNF138	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q8WVD3	RNF138	E3 ubiquitin-protein ligase RNF138	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WVD3	RNF138	E3 ubiquitin-protein ligase RNF138	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8WVD3	RNF138	E3 ubiquitin-protein ligase RNF138	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q8WU17	RNF139	E3 ubiquitin-protein ligase RNF139	GO:0016874; F:ligase activity; TAS:UniProtKB
Q8WU17	RNF139	E3 ubiquitin-protein ligase RNF139	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WU17	RNF139	E3 ubiquitin-protein ligase RNF139	GO:0004872; F:receptor activity; TAS:UniProtKB
Q8WU17	RNF139	E3 ubiquitin-protein ligase RNF139	GO:0019787; F:small conjugating protein ligase activity; IDA:UniProtKB
Q8WU17	RNF139	E3 ubiquitin-protein ligase RNF139	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q8WU17	RNF139	E3 ubiquitin-protein ligase RNF139	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WU17	RNF139	E3 ubiquitin-protein ligase RNF139	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q8WU17	RNF139	E3 ubiquitin-protein ligase RNF139	GO:0017148; P:negative regulation of translation; IDA:UniProtKB
Q8WU17	RNF139	E3 ubiquitin-protein ligase RNF139	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q8WU17	RNF139	E3 ubiquitin-protein ligase RNF139	GO:0060628; P:regulation of ER to Golgi vesicle-mediated transport; IDA:UniProtKB
Q8WU17	RNF139	E3 ubiquitin-protein ligase RNF139	GO:0070613; P:regulation of protein processing; IDA:UniProtKB
Q8WU17	RNF139	E3 ubiquitin-protein ligase RNF139	GO:0031396; P:regulation of protein ubiquitination; IDA:UniProtKB
Q96MT1	RNF145	RING finger protein 145	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WVD5	RNF141	RING finger protein 141	GO:0003677; F:DNA binding; IEA:Ensembl
Q8WVD5	RNF141	RING finger protein 141	GO:0004842; F:ubiquitin-protein ligase activity; IDA:FlyBase
Q8WVD5	RNF141	RING finger protein 141	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WVD5	RNF141	RING finger protein 141	GO:0051865; P:protein autoubiquitination; IDA:FlyBase
Q8WVD5	RNF141	RING finger protein 141	GO:0006355; P:regulation of transcription, DNA-templated; IEA:Ensembl
Q9NTX7	RNF146	E3 ubiquitin-protein ligase RNF146	GO:0072572; F:poly-ADP-D-ribose binding; IDA:UniProtKB
Q9NTX7	RNF146	E3 ubiquitin-protein ligase RNF146	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NTX7	RNF146	E3 ubiquitin-protein ligase RNF146	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9NTX7	RNF146	E3 ubiquitin-protein ligase RNF146	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NTX7	RNF146	E3 ubiquitin-protein ligase RNF146	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:UniProtKB
Q9NTX7	RNF146	E3 ubiquitin-protein ligase RNF146	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
Q9NTX7	RNF146	E3 ubiquitin-protein ligase RNF146	GO:0070936; P:protein K48-linked ubiquitination; IMP:UniProtKB
Q9NTX7	RNF146	E3 ubiquitin-protein ligase RNF146	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q9NTX7	RNF146	E3 ubiquitin-protein ligase RNF146	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q8NC42	RNF149	E3 ubiquitin-protein ligase RNF149	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q8NC42	RNF149	E3 ubiquitin-protein ligase RNF149	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8NC42	RNF149	E3 ubiquitin-protein ligase RNF149	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9ULK6	RNF150	RING finger protein 150	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N7C7	RNF148	RING finger protein 148	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N8N0	RNF152	E3 ubiquitin-protein ligase RNF152	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q8N8N0	RNF152	E3 ubiquitin-protein ligase RNF152	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N8N0	RNF152	E3 ubiquitin-protein ligase RNF152	GO:0006915; P:apoptotic process; TAS:UniProtKB
Q8N8N0	RNF152	E3 ubiquitin-protein ligase RNF152	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
Q2KHN1	RNF151	RING finger protein 151	GO:0004842; F:ubiquitin-protein ligase activity; IEA:InterPro
Q2KHN1	RNF151	RING finger protein 151	GO:0008270; F:zinc ion binding; IEA:InterPro
Q2KHN1	RNF151	RING finger protein 151	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q2KHN1	RNF151	RING finger protein 151	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q96A37	RNF166	RING finger protein 166	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6ZSG1	RNF165	RING finger protein 165	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H6Y7	RNF167	E3 ubiquitin-protein ligase RNF167	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H6Y7	RNF167	E3 ubiquitin-protein ligase RNF167	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9H6Y7	RNF167	E3 ubiquitin-protein ligase RNF167	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H6Y7	RNF167	E3 ubiquitin-protein ligase RNF167	GO:0045786; P:negative regulation of cell cycle; IMP:UniProtKB
Q9H6Y7	RNF167	E3 ubiquitin-protein ligase RNF167	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q96PX1	RNF157	RING finger protein 157	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0042393; F:histone binding; IDA:UniProtKB
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0070530; F:K63-linked polyubiquitin binding; IDA:UniProtKB
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0031491; F:nucleosome binding; IDA:UniProtKB
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0006302; P:double-strand break repair; IDA:UniProtKB
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0070535; P:histone H2A K63-linked ubiquitination; IDA:UniProtKB
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0035518; P:histone H2A monoubiquitination; IDA:UniProtKB
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0036351; P:histone H2A-K13 ubiquitination; IDA:UniProtKB
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0036352; P:histone H2A-K15 ubiquitination; IDA:UniProtKB
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0036297; P:interstrand cross-link repair; TAS:UniProtKB
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0045190; P:isotype switching; ISS:UniProtKB
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0045900; P:negative regulation of translational elongation; IMP:UniProtKB
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0045739; P:positive regulation of DNA repair; IDA:UniProtKB
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0010212; P:response to ionizing radiation; IDA:UniProtKB
Q8IYW5	RNF168	E3 ubiquitin-protein ligase RNF168	GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q8NCN4	RNF169	E3 ubiquitin-protein ligase RNF169	GO:0070530; F:K63-linked polyubiquitin binding; IDA:UniProtKB
Q8NCN4	RNF169	E3 ubiquitin-protein ligase RNF169	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q8NCN4	RNF169	E3 ubiquitin-protein ligase RNF169	GO:0031491; F:nucleosome binding; IDA:UniProtKB
Q8NCN4	RNF169	E3 ubiquitin-protein ligase RNF169	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8NCN4	RNF169	E3 ubiquitin-protein ligase RNF169	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q8NCN4	RNF169	E3 ubiquitin-protein ligase RNF169	GO:2000780; P:negative regulation of double-strand break repair; IDA:UniProtKB
Q8NCN4	RNF169	E3 ubiquitin-protein ligase RNF169	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q96K19	RNF170	E3 ubiquitin-protein ligase RNF170	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q96K19	RNF170	E3 ubiquitin-protein ligase RNF170	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96K19	RNF170	E3 ubiquitin-protein ligase RNF170	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8N4F7	RNF175	RING finger protein 175	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86T96	RNF180	E3 ubiquitin-protein ligase RNF180	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q86T96	RNF180	E3 ubiquitin-protein ligase RNF180	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86T96	RNF180	E3 ubiquitin-protein ligase RNF180	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q9P0P0	RNF181	E3 ubiquitin-protein ligase RNF181	GO:0004842; F:ubiquitin-protein ligase activity; IDA:FlyBase
Q9P0P0	RNF181	E3 ubiquitin-protein ligase RNF181	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9P0P0	RNF181	E3 ubiquitin-protein ligase RNF181	GO:0051865; P:protein autoubiquitination; IDA:FlyBase
Q8N6D2	RNF182	E3 ubiquitin-protein ligase RNF182	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N6D2	RNF182	E3 ubiquitin-protein ligase RNF182	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q8N6D2	RNF182	E3 ubiquitin-protein ligase RNF182	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N6D2	RNF182	E3 ubiquitin-protein ligase RNF182	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q96D59	RNF183	RING finger protein 183	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96GF1	RNF185	E3 ubiquitin-protein ligase RNF185	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q96GF1	RNF185	E3 ubiquitin-protein ligase RNF185	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96GF1	RNF185	E3 ubiquitin-protein ligase RNF185	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q96GF1	RNF185	E3 ubiquitin-protein ligase RNF185	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9NXI6	RNF186	RING finger protein 186	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5TA31	RNF187	E3 ubiquitin-protein ligase RNF187	GO:0005515; F:protein binding; IPI:UniProtKB
Q5TA31	RNF187	E3 ubiquitin-protein ligase RNF187	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q5TA31	RNF187	E3 ubiquitin-protein ligase RNF187	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5TA31	RNF187	E3 ubiquitin-protein ligase RNF187	GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB
Q5TA31	RNF187	E3 ubiquitin-protein ligase RNF187	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q5TA31	RNF187	E3 ubiquitin-protein ligase RNF187	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q5TA31	RNF187	E3 ubiquitin-protein ligase RNF187	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
Q5TA31	RNF187	E3 ubiquitin-protein ligase RNF187	GO:0070936; P:protein K48-linked ubiquitination; IMP:UniProtKB
Q9NV58	RNF19A	E3 ubiquitin-protein ligase RNF19A	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9NV58	RNF19A	E3 ubiquitin-protein ligase RNF19A	GO:0008134; F:transcription factor binding; TAS:UniProtKB
Q9NV58	RNF19A	E3 ubiquitin-protein ligase RNF19A	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NV58	RNF19A	E3 ubiquitin-protein ligase RNF19A	GO:0000226; P:microtubule cytoskeleton organization; TAS:UniProtKB
Q9NV58	RNF19A	E3 ubiquitin-protein ligase RNF19A	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q6ZRF8	RNF207	RING finger protein 207	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H0X6	RNF208	RING finger protein 208	GO:0004842; F:ubiquitin-protein ligase activity; IDA:FlyBase
Q9H0X6	RNF208	RING finger protein 208	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H0X6	RNF208	RING finger protein 208	GO:0051865; P:protein autoubiquitination; IDA:FlyBase
Q63HN8	RNF213	E3 ubiquitin-protein ligase RNF213	GO:0016887; F:ATPase activity; IDA:UniProtKB
Q63HN8	RNF213	E3 ubiquitin-protein ligase RNF213	GO:0000166; F:nucleotide binding; IEA:InterPro
Q63HN8	RNF213	E3 ubiquitin-protein ligase RNF213	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q63HN8	RNF213	E3 ubiquitin-protein ligase RNF213	GO:0008270; F:zinc ion binding; IEA:InterPro
Q63HN8	RNF213	E3 ubiquitin-protein ligase RNF213	GO:0006200; P:ATP catabolic process; IDA:UniProtKB
Q63HN8	RNF213	E3 ubiquitin-protein ligase RNF213	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
Q63HN8	RNF213	E3 ubiquitin-protein ligase RNF213	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q6ZMZ0	RNF19B	E3 ubiquitin-protein ligase RNF19B	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q6ZMZ0	RNF19B	E3 ubiquitin-protein ligase RNF19B	GO:0005515; F:protein binding; IPI:IntAct
Q6ZMZ0	RNF19B	E3 ubiquitin-protein ligase RNF19B	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6ZMZ0	RNF19B	E3 ubiquitin-protein ligase RNF19B	GO:0072643; P:interferon-gamma secretion; IEA:Ensembl
Q6ZMZ0	RNF19B	E3 ubiquitin-protein ligase RNF19B	GO:0042267; P:natural killer cell mediated cytotoxicity; IEA:Ensembl
Q6ZMZ0	RNF19B	E3 ubiquitin-protein ligase RNF19B	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q495C1	RNF212	Probable E3 SUMO-protein ligase RNF212	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q495C1	RNF212	Probable E3 SUMO-protein ligase RNF212	GO:0008270; F:zinc ion binding; IEA:InterPro
Q495C1	RNF212	Probable E3 SUMO-protein ligase RNF212	GO:0051026; P:chiasma assembly; ISS:UniProtKB
Q495C1	RNF212	Probable E3 SUMO-protein ligase RNF212	GO:0006311; P:meiotic gene conversion; ISS:UniProtKB
Q495C1	RNF212	Probable E3 SUMO-protein ligase RNF212	GO:0016925; P:protein sumoylation; IEA:UniProtKB-UniPathway
Q495C1	RNF212	Probable E3 SUMO-protein ligase RNF212	GO:0007131; P:reciprocal meiotic recombination; ISS:UniProtKB
Q9Y6U7	RNF215	RING finger protein 215	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8ND24	RNF214	RING finger protein 214	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5W0B1	RNF219	RING finger protein 219	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NWF9	RNF216	E3 ubiquitin-protein ligase RNF216	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9NWF9	RNF216	E3 ubiquitin-protein ligase RNF216	GO:0005515; F:protein binding; IPI:IntAct
Q9NWF9	RNF216	E3 ubiquitin-protein ligase RNF216	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NWF9	RNF216	E3 ubiquitin-protein ligase RNF216	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9NWF9	RNF216	E3 ubiquitin-protein ligase RNF216	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9NWF9	RNF216	E3 ubiquitin-protein ligase RNF216	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
Q9NWF9	RNF216	E3 ubiquitin-protein ligase RNF216	GO:0050691; P:regulation of defense response to virus by host; IDA:UniProtKB
Q9NWF9	RNF216	E3 ubiquitin-protein ligase RNF216	GO:0032648; P:regulation of interferon-beta production; IDA:UniProtKB
Q9NWF9	RNF216	E3 ubiquitin-protein ligase RNF216	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q5VTB9	RNF220	E3 ubiquitin-protein ligase RNF220	GO:0004842; F:ubiquitin-protein ligase activity; ISS:UniProtKB
Q5VTB9	RNF220	E3 ubiquitin-protein ligase RNF220	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5VTB9	RNF220	E3 ubiquitin-protein ligase RNF220	GO:0051865; P:protein autoubiquitination; ISS:UniProtKB
Q5VTB9	RNF220	E3 ubiquitin-protein ligase RNF220	GO:0016567; P:protein ubiquitination; ISS:UniProtKB
P0DH78	RNF224	RING finger protein 224	GO:0008270; F:zinc ion binding; IEA:InterPro
A6NCQ9	RNF222	RING finger protein 222	GO:0008270; F:zinc ion binding; IEA:InterPro
E7ERA6	RNF223	RING finger protein 223	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TC41	RNF217	Probable E3 ubiquitin-protein ligase RNF217	GO:0004842; F:ubiquitin-protein ligase activity; ISS:UniProtKB
Q8TC41	RNF217	Probable E3 ubiquitin-protein ligase RNF217	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TC41	RNF217	Probable E3 ubiquitin-protein ligase RNF217	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ISS:UniProtKB
Q05823	RNASEL	2-5A-dependent ribonuclease	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q05823	RNASEL	2-5A-dependent ribonuclease	GO:0004521; F:endoribonuclease activity; NAS:UniProtKB
Q05823	RNASEL	2-5A-dependent ribonuclease	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q05823	RNASEL	2-5A-dependent ribonuclease	GO:0005515; F:protein binding; IPI:IntAct
Q05823	RNASEL	2-5A-dependent ribonuclease	GO:0004672; F:protein kinase activity; IEA:InterPro
Q05823	RNASEL	2-5A-dependent ribonuclease	GO:0003723; F:RNA binding; IDA:UniProtKB
Q05823	RNASEL	2-5A-dependent ribonuclease	GO:0019843; F:rRNA binding; IEA:Ensembl
Q05823	RNASEL	2-5A-dependent ribonuclease	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q05823	RNASEL	2-5A-dependent ribonuclease	GO:0051607; P:defense response to virus; IDA:UniProtKB
Q05823	RNASEL	2-5A-dependent ribonuclease	GO:0006397; P:mRNA processing; IEA:InterPro
Q05823	RNASEL	2-5A-dependent ribonuclease	GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB
Q05823	RNASEL	2-5A-dependent ribonuclease	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q05823	RNASEL	2-5A-dependent ribonuclease	GO:0006468; P:protein phosphorylation; NAS:UniProtKB
Q05823	RNASEL	2-5A-dependent ribonuclease	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; NAS:GOC
Q05823	RNASEL	2-5A-dependent ribonuclease	GO:0006364; P:rRNA processing; IEA:Ensembl
Q05823	RNASEL	2-5A-dependent ribonuclease	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P07998	RNASE1	Ribonuclease pancreatic	GO:0003676; F:nucleic acid binding; IEA:InterPro
P07998	RNASE1	Ribonuclease pancreatic	GO:0004522; F:pancreatic ribonuclease activity; TAS:ProtInc
P07998	RNASE1	Ribonuclease pancreatic	GO:0005515; F:protein binding; IPI:IntAct
P07998	RNASE1	Ribonuclease pancreatic	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; TAS:GOC
P10153	RNASE2	Non-secretory ribonuclease	GO:0003676; F:nucleic acid binding; IEA:InterPro
P10153	RNASE2	Non-secretory ribonuclease	GO:0004522; F:pancreatic ribonuclease activity; IEA:UniProtKB-EC
P10153	RNASE2	Non-secretory ribonuclease	GO:0004540; F:ribonuclease activity; TAS:ProtInc
P10153	RNASE2	Non-secretory ribonuclease	GO:0006935; P:chemotaxis; IDA:UniProtKB
P10153	RNASE2	Non-secretory ribonuclease	GO:0006401; P:RNA catabolic process; TAS:ProtInc
P10153	RNASE2	Non-secretory ribonuclease	GO:0090501; P:RNA phosphodiester bond hydrolysis; TAS:GOC
P34096	RNASE4	Ribonuclease 4	GO:0003676; F:nucleic acid binding; IEA:InterPro
P34096	RNASE4	Ribonuclease 4	GO:0004522; F:pancreatic ribonuclease activity; NAS:UniProtKB
P34096	RNASE4	Ribonuclease 4	GO:0006379; P:mRNA cleavage; NAS:UniProtKB
P34096	RNASE4	Ribonuclease 4	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; NAS:GOC
Q93091	RNASE6	Ribonuclease K6	GO:0016892; F:endoribonuclease activity, producing 3'-phosphomonoesters; IEA:InterPro
Q93091	RNASE6	Ribonuclease K6	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q93091	RNASE6	Ribonuclease K6	GO:0004540; F:ribonuclease activity; TAS:ProtInc
Q93091	RNASE6	Ribonuclease K6	GO:0006952; P:defense response; TAS:ProtInc
Q93091	RNASE6	Ribonuclease K6	GO:0006401; P:RNA catabolic process; TAS:ProtInc
Q93091	RNASE6	Ribonuclease K6	GO:0090501; P:RNA phosphodiester bond hydrolysis; TAS:GOC
Q9H1E1	RNASE7	Ribonuclease 7	GO:0016892; F:endoribonuclease activity, producing 3'-phosphomonoesters; IEA:InterPro
Q9H1E1	RNASE7	Ribonuclease 7	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9H1E1	RNASE7	Ribonuclease 7	GO:0004540; F:ribonuclease activity; IDA:UniProtKB
Q9H1E1	RNASE7	Ribonuclease 7	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
Q9H1E1	RNASE7	Ribonuclease 7	GO:0045087; P:innate immune response; NAS:UniProtKB
Q9H1E1	RNASE7	Ribonuclease 7	GO:0009617; P:response to bacterium; NAS:UniProtKB
Q9H1E1	RNASE7	Ribonuclease 7	GO:0090501; P:RNA phosphodiester bond hydrolysis; IDA:GOC
Q8TDE3	RNASE8	Ribonuclease 8	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8TDE3	RNASE8	Ribonuclease 8	GO:0004522; F:pancreatic ribonuclease activity; IDA:UniProtKB
Q8TDE3	RNASE8	Ribonuclease 8	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; IDA:GOC
P60153	RNASE9	Inactive ribonuclease-like protein 9	GO:0016892; F:endoribonuclease activity, producing 3'-phosphomonoesters; IEA:InterPro
P60153	RNASE9	Inactive ribonuclease-like protein 9	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q86VV4	RANBP3L	Ran-binding protein 3-like	GO:0046907; P:intracellular transport; IEA:InterPro
O60518	RANBP6	Ran-binding protein 6	GO:0005515; F:protein binding; IPI:IntAct
O60518	RANBP6	Ran-binding protein 6	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9NRR4	DROSHA	Ribonuclease 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NRR4	DROSHA	Ribonuclease 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NRR4	DROSHA	Ribonuclease 3	GO:0005515; F:protein binding; IPI:IntAct
Q9NRR4	DROSHA	Ribonuclease 3	GO:0004525; F:ribonuclease III activity; IDA:WormBase
Q9NRR4	DROSHA	Ribonuclease 3	GO:0010467; P:gene expression; TAS:Reactome
Q9NRR4	DROSHA	Ribonuclease 3	GO:0010586; P:miRNA metabolic process; IEA:Ensembl
Q9NRR4	DROSHA	Ribonuclease 3	GO:0031054; P:pre-miRNA processing; IEA:Ensembl
Q9NRR4	DROSHA	Ribonuclease 3	GO:0031053; P:primary miRNA processing; IDA:WormBase
Q9NRR4	DROSHA	Ribonuclease 3	GO:0042254; P:ribosome biogenesis; IEA:UniProtKB-KW
Q9NRR4	DROSHA	Ribonuclease 3	GO:0090501; P:RNA phosphodiester bond hydrolysis; IDA:GOC
Q9NRR4	DROSHA	Ribonuclease 3	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; IDA:GOC
Q9NRR4	DROSHA	Ribonuclease 3	GO:0016075; P:rRNA catabolic process; IEA:InterPro
Q92730	RND1	Rho-related GTP-binding protein Rho6	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q92730	RND1	Rho-related GTP-binding protein Rho6	GO:0003924; F:GTPase activity; NAS:UniProtKB
Q92730	RND1	Rho-related GTP-binding protein Rho6	GO:0005515; F:protein binding; IPI:IntAct
Q92730	RND1	Rho-related GTP-binding protein Rho6	GO:0005102; F:receptor binding; IPI:UniProtKB
Q92730	RND1	Rho-related GTP-binding protein Rho6	GO:0007015; P:actin filament organization; IDA:UniProtKB
Q92730	RND1	Rho-related GTP-binding protein Rho6	GO:0007411; P:axon guidance; TAS:Reactome
Q92730	RND1	Rho-related GTP-binding protein Rho6	GO:0006184; P:GTP catabolic process; NAS:GOC
Q92730	RND1	Rho-related GTP-binding protein Rho6	GO:0007162; P:negative regulation of cell adhesion; IDA:UniProtKB
Q92730	RND1	Rho-related GTP-binding protein Rho6	GO:0016322; P:neuron remodeling; IDA:UniProtKB
Q92730	RND1	Rho-related GTP-binding protein Rho6	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P52198	RND2	Rho-related GTP-binding protein RhoN	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P52198	RND2	Rho-related GTP-binding protein RhoN	GO:0003924; F:GTPase activity; TAS:ProtInc
P52198	RND2	Rho-related GTP-binding protein RhoN	GO:0005515; F:protein binding; IPI:UniProtKB
P52198	RND2	Rho-related GTP-binding protein RhoN	GO:0006184; P:GTP catabolic process; TAS:GOC
P52198	RND2	Rho-related GTP-binding protein RhoN	GO:0048672; P:positive regulation of collateral sprouting; IEA:Ensembl
P52198	RND2	Rho-related GTP-binding protein RhoN	GO:0007165; P:signal transduction; TAS:ProtInc
P52198	RND2	Rho-related GTP-binding protein RhoN	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P61587	RND3	Rho-related GTP-binding protein RhoE	GO:0005525; F:GTP binding; TAS:ProtInc
P61587	RND3	Rho-related GTP-binding protein RhoE	GO:0003924; F:GTPase activity; TAS:ProtInc
P61587	RND3	Rho-related GTP-binding protein RhoE	GO:0005515; F:protein binding; IPI:IntAct
P61587	RND3	Rho-related GTP-binding protein RhoE	GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc
P61587	RND3	Rho-related GTP-binding protein RhoE	GO:0007155; P:cell adhesion; TAS:ProtInc
P61587	RND3	Rho-related GTP-binding protein RhoE	GO:0006184; P:GTP catabolic process; TAS:GOC
P61587	RND3	Rho-related GTP-binding protein RhoE	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q8N5U6	RNF10	RING finger protein 10	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N5U6	RNF10	RING finger protein 10	GO:0044212; F:transcription regulatory region DNA binding; ISS:UniProtKB
Q8N5U6	RNF10	RING finger protein 10	GO:0004842; F:ubiquitin-protein ligase activity; IDA:FlyBase
Q8N5U6	RNF10	RING finger protein 10	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N5U6	RNF10	RING finger protein 10	GO:0010626; P:negative regulation of Schwann cell proliferation; ISS:UniProtKB
Q8N5U6	RNF10	RING finger protein 10	GO:0031643; P:positive regulation of myelination; ISS:UniProtKB
Q8N5U6	RNF10	RING finger protein 10	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q8N5U6	RNF10	RING finger protein 10	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q8N5U6	RNF10	RING finger protein 10	GO:0051865; P:protein autoubiquitination; IDA:FlyBase
Q8N5U6	RNF10	RING finger protein 10	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y3C5	RNF11	RING finger protein 11	GO:0003677; F:DNA binding; TAS:ProtInc
Q9Y3C5	RNF11	RING finger protein 11	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3C5	RNF11	RING finger protein 11	GO:0004842; F:ubiquitin-protein ligase activity; IDA:FlyBase
Q9Y3C5	RNF11	RING finger protein 11	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q9Y3C5	RNF11	RING finger protein 11	GO:0051865; P:protein autoubiquitination; IDA:FlyBase
Q9Y3C5	RNF11	RING finger protein 11	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9NVW2	RLIM	E3 ubiquitin-protein ligase RLIM	GO:0003714; F:transcription corepressor activity; NAS:UniProtKB
Q9NVW2	RLIM	E3 ubiquitin-protein ligase RLIM	GO:0004842; F:ubiquitin-protein ligase activity; ISS:UniProtKB
Q9NVW2	RLIM	E3 ubiquitin-protein ligase RLIM	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NVW2	RLIM	E3 ubiquitin-protein ligase RLIM	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q9NVW2	RLIM	E3 ubiquitin-protein ligase RLIM	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9NVW2	RLIM	E3 ubiquitin-protein ligase RLIM	GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB
Q9NVW2	RLIM	E3 ubiquitin-protein ligase RLIM	GO:0016567; P:protein ubiquitination; ISS:UniProtKB
Q9NVW2	RLIM	E3 ubiquitin-protein ligase RLIM	GO:0060816; P:random inactivation of X chromosome; IDA:UniProtKB
Q9NVW2	RLIM	E3 ubiquitin-protein ligase RLIM	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NVW2	RLIM	E3 ubiquitin-protein ligase RLIM	GO:0006511; P:ubiquitin-dependent protein catabolic process; ISS:UniProtKB
O43567	RNF13	E3 ubiquitin-protein ligase RNF13	GO:0004842; F:ubiquitin-protein ligase activity; ISS:UniProtKB
O43567	RNF13	E3 ubiquitin-protein ligase RNF13	GO:0008270; F:zinc ion binding; IEA:InterPro
O43567	RNF13	E3 ubiquitin-protein ligase RNF13	GO:0051865; P:protein autoubiquitination; ISS:UniProtKB
Q9UBS8	RNF14	E3 ubiquitin-protein ligase RNF14	GO:0050681; F:androgen receptor binding; IPI:UniProtKB
Q9UBS8	RNF14	E3 ubiquitin-protein ligase RNF14	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBS8	RNF14	E3 ubiquitin-protein ligase RNF14	GO:0019787; F:small conjugating protein ligase activity; IDA:UniProtKB
Q9UBS8	RNF14	E3 ubiquitin-protein ligase RNF14	GO:0003713; F:transcription coactivator activity; NAS:UniProtKB
Q9UBS8	RNF14	E3 ubiquitin-protein ligase RNF14	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UBS8	RNF14	E3 ubiquitin-protein ligase RNF14	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
Q9UBS8	RNF14	E3 ubiquitin-protein ligase RNF14	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UBS8	RNF14	E3 ubiquitin-protein ligase RNF14	GO:0016567; P:protein ubiquitination; IEP:UniProtKB
Q9UBS8	RNF14	E3 ubiquitin-protein ligase RNF14	GO:0060765; P:regulation of androgen receptor signaling pathway; IDA:UniProtKB
Q9UBS8	RNF14	E3 ubiquitin-protein ligase RNF14	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:UniProtKB
Q9UBS8	RNF14	E3 ubiquitin-protein ligase RNF14	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UBS8	RNF14	E3 ubiquitin-protein ligase RNF14	GO:0032355; P:response to estradiol; IDA:BHF-UCL
Q9UBS8	RNF14	E3 ubiquitin-protein ligase RNF14	GO:0007165; P:signal transduction; TAS:UniProtKB
Q9UBS8	RNF14	E3 ubiquitin-protein ligase RNF14	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BXT8	RNF17	RING finger protein 17	GO:0016788; F:hydrolase activity, acting on ester bonds; IEA:InterPro
Q9BXT8	RNF17	RING finger protein 17	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9BXT8	RNF17	RING finger protein 17	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BXT8	RNF17	RING finger protein 17	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9BXT8	RNF17	RING finger protein 17	GO:0007286; P:spermatid development; IEA:Ensembl
Q9Y225	RNF24	RING finger protein 24	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BY78	RNF26	RING finger protein 26	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q96BH1	RNF25	E3 ubiquitin-protein ligase RNF25	GO:0051059; F:NF-kappaB binding; IPI:UniProtKB
Q96BH1	RNF25	E3 ubiquitin-protein ligase RNF25	GO:0004842; F:ubiquitin-protein ligase activity; ISS:UniProtKB
Q96BH1	RNF25	E3 ubiquitin-protein ligase RNF25	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96BH1	RNF25	E3 ubiquitin-protein ligase RNF25	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q96BH1	RNF25	E3 ubiquitin-protein ligase RNF25	GO:0016567; P:protein ubiquitination; ISS:UniProtKB
Q96EP0	RNF31	E3 ubiquitin-protein ligase RNF31	GO:0005515; F:protein binding; IPI:UniProtKB
Q96EP0	RNF31	E3 ubiquitin-protein ligase RNF31	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
Q96EP0	RNF31	E3 ubiquitin-protein ligase RNF31	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q96EP0	RNF31	E3 ubiquitin-protein ligase RNF31	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96EP0	RNF31	E3 ubiquitin-protein ligase RNF31	GO:0023035; P:CD40 signaling pathway; ISS:BHF-UCL
Q96EP0	RNF31	E3 ubiquitin-protein ligase RNF31	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q96EP0	RNF31	E3 ubiquitin-protein ligase RNF31	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q96EP0	RNF31	E3 ubiquitin-protein ligase RNF31	GO:0097039; P:protein linear polyubiquitination; IDA:UniProtKB
Q96EP0	RNF31	E3 ubiquitin-protein ligase RNF31	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q96EP0	RNF31	E3 ubiquitin-protein ligase RNF31	GO:0050852; P:T cell receptor signaling pathway; IDA:UniProtKB
Q9H0A6	RNF32	RING finger protein 32	GO:0005515; F:protein binding; IPI:IntAct
Q9H0A6	RNF32	RING finger protein 32	GO:0008270; F:zinc ion binding; IEA:InterPro
Q969K3	RNF34	E3 ubiquitin-protein ligase RNF34	GO:1901981; F:phosphatidylinositol phosphate binding; IDA:UniProtKB
Q969K3	RNF34	E3 ubiquitin-protein ligase RNF34	GO:0005515; F:protein binding; IPI:IntAct
Q969K3	RNF34	E3 ubiquitin-protein ligase RNF34	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q969K3	RNF34	E3 ubiquitin-protein ligase RNF34	GO:0008270; F:zinc ion binding; IEA:InterPro
Q969K3	RNF34	E3 ubiquitin-protein ligase RNF34	GO:2001271; P:negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis; IMP:UniProtKB
Q969K3	RNF34	E3 ubiquitin-protein ligase RNF34	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IMP:UniProtKB
Q969K3	RNF34	E3 ubiquitin-protein ligase RNF34	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q969K3	RNF34	E3 ubiquitin-protein ligase RNF34	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
O94941	UBOX5	RING finger protein 37	GO:0034450; F:ubiquitin-ubiquitin ligase activity; IEA:Ensembl
O94941	UBOX5	RING finger protein 37	GO:0008270; F:zinc ion binding; IEA:InterPro
O94941	UBOX5	RING finger protein 37	GO:0000209; P:protein polyubiquitination; IEA:Ensembl
Q9H0F5	RNF38	E3 ubiquitin-protein ligase RNF38	GO:0004842; F:ubiquitin-protein ligase activity; IDA:FlyBase
Q9H0F5	RNF38	E3 ubiquitin-protein ligase RNF38	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H0F5	RNF38	E3 ubiquitin-protein ligase RNF38	GO:0008584; P:male gonad development; IEA:Ensembl
Q9H0F5	RNF38	E3 ubiquitin-protein ligase RNF38	GO:0016567; P:protein ubiquitination; IDA:FlyBase
Q9H2S5	RNF39	RING finger protein 39	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H4P4	RNF41	E3 ubiquitin-protein ligase NRDP1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H4P4	RNF41	E3 ubiquitin-protein ligase NRDP1	GO:0031386; F:protein tag; IEA:InterPro
Q9H4P4	RNF41	E3 ubiquitin-protein ligase NRDP1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9H4P4	RNF41	E3 ubiquitin-protein ligase NRDP1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H4P4	RNF41	E3 ubiquitin-protein ligase NRDP1	GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:UniProtKB
Q9H4P4	RNF41	E3 ubiquitin-protein ligase NRDP1	GO:0030336; P:negative regulation of cell migration; IMP:MGI
Q9H4P4	RNF41	E3 ubiquitin-protein ligase NRDP1	GO:0008285; P:negative regulation of cell proliferation; IDA:MGI
Q9H4P4	RNF41	E3 ubiquitin-protein ligase NRDP1	GO:0051865; P:protein autoubiquitination; IDA:FlyBase
Q9H4P4	RNF41	E3 ubiquitin-protein ligase NRDP1	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q9H4P4	RNF41	E3 ubiquitin-protein ligase NRDP1	GO:0045619; P:regulation of lymphocyte differentiation; IEA:Ensembl
Q9H4P4	RNF41	E3 ubiquitin-protein ligase NRDP1	GO:0043408; P:regulation of MAPK cascade; IDA:MGI
Q9H4P4	RNF41	E3 ubiquitin-protein ligase NRDP1	GO:0045637; P:regulation of myeloid cell differentiation; IEA:Ensembl
Q9H4P4	RNF41	E3 ubiquitin-protein ligase NRDP1	GO:0051896; P:regulation of protein kinase B signaling; IDA:MGI
Q9H4P4	RNF41	E3 ubiquitin-protein ligase NRDP1	GO:2000377; P:regulation of reactive oxygen species metabolic process; IMP:UniProtKB
Q68DV7	RNF43	E3 ubiquitin-protein ligase RNF43	GO:0005109; F:frizzled binding; IPI:UniProtKB
Q68DV7	RNF43	E3 ubiquitin-protein ligase RNF43	GO:0005515; F:protein binding; IPI:IntAct
Q68DV7	RNF43	E3 ubiquitin-protein ligase RNF43	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q68DV7	RNF43	E3 ubiquitin-protein ligase RNF43	GO:0008270; F:zinc ion binding; IEA:InterPro
Q68DV7	RNF43	E3 ubiquitin-protein ligase RNF43	GO:0030178; P:negative regulation of Wnt signaling pathway; IMP:UniProtKB
Q68DV7	RNF43	E3 ubiquitin-protein ligase RNF43	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q68DV7	RNF43	E3 ubiquitin-protein ligase RNF43	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q68DV7	RNF43	E3 ubiquitin-protein ligase RNF43	GO:0072089; P:stem cell proliferation; ISS:UniProtKB
Q68DV7	RNF43	E3 ubiquitin-protein ligase RNF43	GO:0038018; P:Wnt receptor catabolic process; IDA:UniProtKB
Q68DV7	RNF43	E3 ubiquitin-protein ligase RNF43	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q7L0R7	RNF44	RING finger protein 44	GO:0008270; F:zinc ion binding; IEA:InterPro
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0050681; F:androgen receptor binding; NAS:UniProtKB
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0003677; F:DNA binding; ISS:UniProtKB
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0031491; F:nucleosome binding; ISS:UniProtKB
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0005515; F:protein binding; IPI:UniProtKB
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0032184; F:SUMO polymer binding; ISS:UniProtKB
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0003713; F:transcription coactivator activity; NAS:UniProtKB
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0004842; F:ubiquitin-protein ligase activity; ISS:UniProtKB
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0008270; F:zinc ion binding; TAS:ProtInc
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0051865; P:protein autoubiquitination; ISS:UniProtKB
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0070979; P:protein K11-linked ubiquitination; ISS:UniProtKB
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0070936; P:protein K48-linked ubiquitination; ISS:UniProtKB
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0085020; P:protein K6-linked ubiquitination; ISS:UniProtKB
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0070534; P:protein K63-linked ubiquitination; ISS:UniProtKB
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0090234; P:regulation of kinetochore assembly; IMP:UniProtKB
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0090169; P:regulation of spindle assembly; IMP:UniProtKB
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0046685; P:response to arsenic-containing substance; IDA:UniProtKB
P78317	RNF4	E3 ubiquitin-protein ligase RNF4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q99942	RNF5	E3 ubiquitin-protein ligase RNF5	GO:0005515; F:protein binding; IPI:UniProtKB
Q99942	RNF5	E3 ubiquitin-protein ligase RNF5	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q99942	RNF5	E3 ubiquitin-protein ligase RNF5	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q99942	RNF5	E3 ubiquitin-protein ligase RNF5	GO:0044257; P:cellular protein catabolic process; IMP:UniProtKB
Q99942	RNF5	E3 ubiquitin-protein ligase RNF5	GO:0071712; P:ER-associated misfolded protein catabolic process; IMP:UniProtKB
Q99942	RNF5	E3 ubiquitin-protein ligase RNF5	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
Q99942	RNF5	E3 ubiquitin-protein ligase RNF5	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
Q9Y252	RNF6	E3 ubiquitin-protein ligase RNF6	GO:0050681; F:androgen receptor binding; IPI:UniProtKB
Q9Y252	RNF6	E3 ubiquitin-protein ligase RNF6	GO:0003677; F:DNA binding; IEA:Ensembl
Q9Y252	RNF6	E3 ubiquitin-protein ligase RNF6	GO:0005515; F:protein binding; IPI:IntAct
Q9Y252	RNF6	E3 ubiquitin-protein ligase RNF6	GO:0004842; F:ubiquitin-protein ligase activity; IMP:UniProtKB
Q9Y252	RNF6	E3 ubiquitin-protein ligase RNF6	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y252	RNF6	E3 ubiquitin-protein ligase RNF6	GO:0030517; P:negative regulation of axon extension; ISS:UniProtKB
Q9Y252	RNF6	E3 ubiquitin-protein ligase RNF6	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q9Y252	RNF6	E3 ubiquitin-protein ligase RNF6	GO:0044314; P:protein K27-linked ubiquitination; IDA:UniProtKB
Q9Y252	RNF6	E3 ubiquitin-protein ligase RNF6	GO:0070936; P:protein K48-linked ubiquitination; ISS:UniProtKB
Q9Y252	RNF6	E3 ubiquitin-protein ligase RNF6	GO:0085020; P:protein K6-linked ubiquitination; IDA:UniProtKB
Q9Y252	RNF6	E3 ubiquitin-protein ligase RNF6	GO:0060765; P:regulation of androgen receptor signaling pathway; IMP:UniProtKB
Q9Y252	RNF6	E3 ubiquitin-protein ligase RNF6	GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB
Q9Y252	RNF6	E3 ubiquitin-protein ligase RNF6	GO:0006511; P:ubiquitin-dependent protein catabolic process; ISS:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0003682; F:chromatin binding; IDA:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0042393; F:histone binding; IDA:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0005515; F:protein binding; IPI:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0008270; F:zinc ion binding; IDA:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0006302; P:double-strand break repair; IDA:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0006303; P:double-strand break repair via nonhomologous end joining; ISS:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0043486; P:histone exchange; ISS:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0070535; P:histone H2A K63-linked ubiquitination; IDA:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0033522; P:histone H2A ubiquitination; IDA:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0033523; P:histone H2B ubiquitination; ISS:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0036297; P:interstrand cross-link repair; TAS:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0045190; P:isotype switching; ISS:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0007067; P:mitosis; IEA:UniProtKB-KW
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0045900; P:negative regulation of translational elongation; IMP:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0045739; P:positive regulation of DNA repair; IDA:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0010212; P:response to ionizing radiation; IDA:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0007286; P:spermatid development; ISS:UniProtKB
O76064	RNF8	E3 ubiquitin-protein ligase RNF8	GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q5M7Z0	RNFT1	RING finger and transmembrane domain-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96EX2	RNFT2	RING finger and transmembrane domain-containing protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
O60930	RNASEH1	Ribonuclease H1	GO:0000287; F:magnesium ion binding; IEA:InterPro
O60930	RNASEH1	Ribonuclease H1	GO:0003676; F:nucleic acid binding; TAS:ProtInc
O60930	RNASEH1	Ribonuclease H1	GO:0004540; F:ribonuclease activity; TAS:ProtInc
O60930	RNASEH1	Ribonuclease H1	GO:0003723; F:RNA binding; TAS:ProtInc
O60930	RNASEH1	Ribonuclease H1	GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IEA:UniProtKB-EC
O60930	RNASEH1	Ribonuclease H1	GO:0006264; P:mitochondrial DNA replication; IEA:Ensembl
O60930	RNASEH1	Ribonuclease H1	GO:0006401; P:RNA catabolic process; TAS:ProtInc
O60930	RNASEH1	Ribonuclease H1	GO:0090501; P:RNA phosphodiester bond hydrolysis; TAS:GOC
O75792	RNASEH2A	Ribonuclease H2 subunit A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75792	RNASEH2A	Ribonuclease H2 subunit A	GO:0004540; F:ribonuclease activity; TAS:ProtInc
O75792	RNASEH2A	Ribonuclease H2 subunit A	GO:0003723; F:RNA binding; IEA:InterPro
O75792	RNASEH2A	Ribonuclease H2 subunit A	GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IDA:UniProtKB
O75792	RNASEH2A	Ribonuclease H2 subunit A	GO:0006260; P:DNA replication; TAS:UniProtKB
O75792	RNASEH2A	Ribonuclease H2 subunit A	GO:0006298; P:mismatch repair; IDA:MGI
O75792	RNASEH2A	Ribonuclease H2 subunit A	GO:0006401; P:RNA catabolic process; IDA:UniProtKB
O75792	RNASEH2A	Ribonuclease H2 subunit A	GO:0090501; P:RNA phosphodiester bond hydrolysis; TAS:GOC
O75792	RNASEH2A	Ribonuclease H2 subunit A	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; IDA:GOC
Q5TBB1	RNASEH2B	Ribonuclease H2 subunit B	GO:0004523; F:RNA-DNA hybrid ribonuclease activity; IEA:Ensembl
Q5TBB1	RNASEH2B	Ribonuclease H2 subunit B	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q5TBB1	RNASEH2B	Ribonuclease H2 subunit B	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
Q5TBB1	RNASEH2B	Ribonuclease H2 subunit B	GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl
Q5TBB1	RNASEH2B	Ribonuclease H2 subunit B	GO:2000001; P:regulation of DNA damage checkpoint; IEA:Ensembl
Q5TBB1	RNASEH2B	Ribonuclease H2 subunit B	GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; IEA:Ensembl
Q5TBB1	RNASEH2B	Ribonuclease H2 subunit B	GO:0009259; P:ribonucleotide metabolic process; IEA:Ensembl
Q5TBB1	RNASEH2B	Ribonuclease H2 subunit B	GO:0006401; P:RNA catabolic process; IDA:UniProtKB
Q8TDP1	RNASEH2C	Ribonuclease H2 subunit C	GO:0006401; P:RNA catabolic process; IDA:UniProtKB
Q6P5S7	RNASEK	Ribonuclease kappa	GO:0004521; F:endoribonuclease activity; IDA:UniProtKB
Q6P5S7	RNASEK	Ribonuclease kappa	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; IDA:GOC
Q6P5S7	RNASEK	Ribonuclease kappa	GO:0009303; P:rRNA transcription; IDA:UniProtKB
Q5VYX0	RNLS	Renalase	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q5VYX0	RNLS	Renalase	GO:0071871; P:response to epinephrine; IEA:Ensembl
Q5VYX0	RNLS	Renalase	GO:0002931; P:response to ischemia; IEA:Ensembl
Q5VYX0	RNLS	Renalase	GO:1902074; P:response to salt; IEA:Ensembl
Q9HAU8	RNPEPL1	Arginyl aminopeptidase-like 1	GO:0004177; F:aminopeptidase activity; IEA:UniProtKB-KW
Q9HAU8	RNPEPL1	Arginyl aminopeptidase-like 1	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
Q9HAU8	RNPEPL1	Arginyl aminopeptidase-like 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9HAU8	RNPEPL1	Arginyl aminopeptidase-like 1	GO:0019370; P:leukotriene biosynthetic process; IEA:InterPro
Q15287	RNPS1	RNA-binding protein with serine-rich domain 1	GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB
Q15287	RNPS1	RNA-binding protein with serine-rich domain 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q15287	RNPS1	RNA-binding protein with serine-rich domain 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15287	RNPS1	RNA-binding protein with serine-rich domain 1	GO:0005515; F:protein binding; IPI:IntAct
Q15287	RNPS1	RNA-binding protein with serine-rich domain 1	GO:0003723; F:RNA binding; TAS:ProtInc
Q15287	RNPS1	RNA-binding protein with serine-rich domain 1	GO:0010467; P:gene expression; TAS:Reactome
Q15287	RNPS1	RNA-binding protein with serine-rich domain 1	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q15287	RNPS1	RNA-binding protein with serine-rich domain 1	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
Q15287	RNPS1	RNA-binding protein with serine-rich domain 1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q15287	RNPS1	RNA-binding protein with serine-rich domain 1	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q15287	RNPS1	RNA-binding protein with serine-rich domain 1	GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; IDA:UniProtKB
Q15287	RNPS1	RNA-binding protein with serine-rich domain 1	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IDA:UniProtKB
Q15287	RNPS1	RNA-binding protein with serine-rich domain 1	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q15287	RNPS1	RNA-binding protein with serine-rich domain 1	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IMP:UniProtKB
Q15287	RNPS1	RNA-binding protein with serine-rich domain 1	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q15287	RNPS1	RNA-binding protein with serine-rich domain 1	GO:0008380; P:RNA splicing; TAS:Reactome
Q15287	RNPS1	RNA-binding protein with serine-rich domain 1	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q15287	RNPS1	RNA-binding protein with serine-rich domain 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q15287	RNPS1	RNA-binding protein with serine-rich domain 1	GO:0006351; P:transcription, DNA-templated; TAS:ProtInc
Q5GAN6	RNASE10	Inactive ribonuclease-like protein 10	GO:0016892; F:endoribonuclease activity, producing 3'-phosphomonoesters; IEA:InterPro
Q5GAN6	RNASE10	Inactive ribonuclease-like protein 10	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q5GAN6	RNASE10	Inactive ribonuclease-like protein 10	GO:0034113; P:heterotypic cell-cell adhesion; ISS:UniProtKB
Q5GAN6	RNASE10	Inactive ribonuclease-like protein 10	GO:0022409; P:positive regulation of cell-cell adhesion; ISS:UniProtKB
Q5GAN6	RNASE10	Inactive ribonuclease-like protein 10	GO:1902093; P:positive regulation of sperm motility; ISS:UniProtKB
Q5GAN6	RNASE10	Inactive ribonuclease-like protein 10	GO:0080154; P:regulation of fertilization; ISS:UniProtKB
Q5GAN6	RNASE10	Inactive ribonuclease-like protein 10	GO:0007338; P:single fertilization; IEA:UniProtKB-KW
Q8TAA1	RNASE11	Probable ribonuclease 11	GO:0016892; F:endoribonuclease activity, producing 3'-phosphomonoesters; IEA:InterPro
Q8TAA1	RNASE11	Probable ribonuclease 11	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q5GAN4	RNASE12	Probable inactive ribonuclease-like protein 12	GO:0016892; F:endoribonuclease activity, producing 3'-phosphomonoesters; IEA:InterPro
Q5GAN4	RNASE12	Probable inactive ribonuclease-like protein 12	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q5GAN3	RNASE13	Probable inactive ribonuclease-like protein 13	GO:0016892; F:endoribonuclease activity, producing 3'-phosphomonoesters; IEA:InterPro
Q5GAN3	RNASE13	Probable inactive ribonuclease-like protein 13	GO:0003676; F:nucleic acid binding; IEA:InterPro
O00584	RNASET2	Ribonuclease T2	GO:0004540; F:ribonuclease activity; IDA:UniProtKB
O00584	RNASET2	Ribonuclease T2	GO:0033897; F:ribonuclease T2 activity; IEA:InterPro
O00584	RNASET2	Ribonuclease T2	GO:0003723; F:RNA binding; IEA:InterPro
O00584	RNASET2	Ribonuclease T2	GO:0006401; P:RNA catabolic process; IDA:UniProtKB
O00584	RNASET2	Ribonuclease T2	GO:0090501; P:RNA phosphodiester bond hydrolysis; IDA:GOC
Q9H777	ELAC1	Zinc phosphodiesterase ELAC protein 1	GO:0016891; F:endoribonuclease activity, producing 5'-phosphomonoesters; IEA:InterPro
Q9H777	ELAC1	Zinc phosphodiesterase ELAC protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H777	ELAC1	Zinc phosphodiesterase ELAC protein 1	GO:0042779; P:tRNA 3'-trailer cleavage; IEA:InterPro
Q9BQ52	ELAC2	Zinc phosphodiesterase ELAC protein 2	GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW
Q9BQ52	ELAC2	Zinc phosphodiesterase ELAC protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BQ52	ELAC2	Zinc phosphodiesterase ELAC protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BQ52	ELAC2	Zinc phosphodiesterase ELAC protein 2	GO:0072684; P:mitochondrial tRNA 3'-trailer cleavage, endonucleolytic; IMP:UniProtKB
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:0005515; F:protein binding; IPI:UniProtKB
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:0008270; F:zinc ion binding; IEA:InterPro
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:0045087; P:innate immune response; IDA:UniProt
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:0090086; P:negative regulation of protein deubiquitination; IMP:UniProtKB
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:1902187; P:negative regulation of viral release from host cell; IDA:UniProt
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:0032897; P:negative regulation of viral transcription; IDA:UniProt
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:0045787; P:positive regulation of cell cycle; IMP:UniProtKB
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProt
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:0031648; P:protein destabilization; IMP:UniProtKB
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:0006513; P:protein monoubiquitination; IDA:UniProtKB
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:0070206; P:protein trimerization; IDA:UniProtKB
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
P19474	TRIM21	E3 ubiquitin-protein ligase TRIM21	GO:0032479; P:regulation of type I interferon production; TAS:Reactome
P10155	TROVE2	60 kDa SS-A/Ro ribonucleoprotein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P10155	TROVE2	60 kDa SS-A/Ro ribonucleoprotein	GO:0003723; F:RNA binding; TAS:ProtInc
P10155	TROVE2	60 kDa SS-A/Ro ribonucleoprotein	GO:0060271; P:cilium morphogenesis; IEA:Ensembl
P10155	TROVE2	60 kDa SS-A/Ro ribonucleoprotein	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:ProtInc
Q13151	HNRNPA0	Heterogeneous nuclear ribonucleoprotein A0	GO:0017091; F:AU-rich element binding; IDA:UniProtKB
Q13151	HNRNPA0	Heterogeneous nuclear ribonucleoprotein A0	GO:0000166; F:nucleotide binding; IEA:InterPro
Q13151	HNRNPA0	Heterogeneous nuclear ribonucleoprotein A0	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13151	HNRNPA0	Heterogeneous nuclear ribonucleoprotein A0	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q13151	HNRNPA0	Heterogeneous nuclear ribonucleoprotein A0	GO:0003723; F:RNA binding; TAS:ProtInc
Q13151	HNRNPA0	Heterogeneous nuclear ribonucleoprotein A0	GO:0070935; P:3'-UTR-mediated mRNA stabilization; ISS:UniProtKB
Q13151	HNRNPA0	Heterogeneous nuclear ribonucleoprotein A0	GO:0010467; P:gene expression; TAS:Reactome
Q13151	HNRNPA0	Heterogeneous nuclear ribonucleoprotein A0	GO:0006954; P:inflammatory response; ISS:UniProtKB
Q13151	HNRNPA0	Heterogeneous nuclear ribonucleoprotein A0	GO:0006397; P:mRNA processing; TAS:ProtInc
Q13151	HNRNPA0	Heterogeneous nuclear ribonucleoprotein A0	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q13151	HNRNPA0	Heterogeneous nuclear ribonucleoprotein A0	GO:0032496; P:response to lipopolysaccharide; ISS:UniProtKB
Q13151	HNRNPA0	Heterogeneous nuclear ribonucleoprotein A0	GO:0008380; P:RNA splicing; TAS:Reactome
P09651	HNRNPA1	Heterogeneous nuclear ribonucleoprotein A1	GO:0000166; F:nucleotide binding; IEA:InterPro
P09651	HNRNPA1	Heterogeneous nuclear ribonucleoprotein A1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P09651	HNRNPA1	Heterogeneous nuclear ribonucleoprotein A1	GO:0005515; F:protein binding; IPI:UniProtKB
P09651	HNRNPA1	Heterogeneous nuclear ribonucleoprotein A1	GO:0003723; F:RNA binding; TAS:ProtInc
P09651	HNRNPA1	Heterogeneous nuclear ribonucleoprotein A1	GO:0003697; F:single-stranded DNA binding; IDA:HGNC
P09651	HNRNPA1	Heterogeneous nuclear ribonucleoprotein A1	GO:0003727; F:single-stranded RNA binding; IC:HGNC
P09651	HNRNPA1	Heterogeneous nuclear ribonucleoprotein A1	GO:0000380; P:alternative mRNA splicing, via spliceosome; IEA:Ensembl
P09651	HNRNPA1	Heterogeneous nuclear ribonucleoprotein A1	GO:0008219; P:cell death; IEA:UniProtKB-KW
P09651	HNRNPA1	Heterogeneous nuclear ribonucleoprotein A1	GO:0010467; P:gene expression; TAS:Reactome
P09651	HNRNPA1	Heterogeneous nuclear ribonucleoprotein A1	GO:0006397; P:mRNA processing; TAS:ProtInc
P09651	HNRNPA1	Heterogeneous nuclear ribonucleoprotein A1	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P09651	HNRNPA1	Heterogeneous nuclear ribonucleoprotein A1	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
P09651	HNRNPA1	Heterogeneous nuclear ribonucleoprotein A1	GO:0051168; P:nuclear export; IDA:HGNC
P09651	HNRNPA1	Heterogeneous nuclear ribonucleoprotein A1	GO:0051170; P:nuclear import; IDA:HGNC
P09651	HNRNPA1	Heterogeneous nuclear ribonucleoprotein A1	GO:0006405; P:RNA export from nucleus; IC:HGNC
P09651	HNRNPA1	Heterogeneous nuclear ribonucleoprotein A1	GO:0008380; P:RNA splicing; TAS:Reactome
P09651	HNRNPA1	Heterogeneous nuclear ribonucleoprotein A1	GO:0016032; P:viral process; IEA:UniProtKB-KW
P22626	HNRNPA2B1	Heterogeneous nuclear ribonucleoproteins A2/B1	GO:0000166; F:nucleotide binding; IEA:InterPro
P22626	HNRNPA2B1	Heterogeneous nuclear ribonucleoproteins A2/B1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P22626	HNRNPA2B1	Heterogeneous nuclear ribonucleoproteins A2/B1	GO:0097157; F:pre-mRNA intronic binding; IEA:Ensembl
P22626	HNRNPA2B1	Heterogeneous nuclear ribonucleoproteins A2/B1	GO:0005515; F:protein binding; IPI:HGNC
P22626	HNRNPA2B1	Heterogeneous nuclear ribonucleoproteins A2/B1	GO:0003723; F:RNA binding; IDA:HGNC
P22626	HNRNPA2B1	Heterogeneous nuclear ribonucleoproteins A2/B1	GO:0043047; F:single-stranded telomeric DNA binding; IDA:HGNC
P22626	HNRNPA2B1	Heterogeneous nuclear ribonucleoproteins A2/B1	GO:0010467; P:gene expression; TAS:Reactome
P22626	HNRNPA2B1	Heterogeneous nuclear ribonucleoproteins A2/B1	GO:0006397; P:mRNA processing; IDA:HGNC
P22626	HNRNPA2B1	Heterogeneous nuclear ribonucleoproteins A2/B1	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P22626	HNRNPA2B1	Heterogeneous nuclear ribonucleoproteins A2/B1	GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; IEA:Ensembl
P22626	HNRNPA2B1	Heterogeneous nuclear ribonucleoproteins A2/B1	GO:0008380; P:RNA splicing; TAS:Reactome
P22626	HNRNPA2B1	Heterogeneous nuclear ribonucleoproteins A2/B1	GO:0050658; P:RNA transport; IDA:HGNC
P51991	HNRNPA3	Heterogeneous nuclear ribonucleoprotein A3	GO:0000166; F:nucleotide binding; IEA:InterPro
P51991	HNRNPA3	Heterogeneous nuclear ribonucleoprotein A3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P51991	HNRNPA3	Heterogeneous nuclear ribonucleoprotein A3	GO:0005515; F:protein binding; IPI:UniProt
P51991	HNRNPA3	Heterogeneous nuclear ribonucleoprotein A3	GO:0003723; F:RNA binding; TAS:ProtInc
P51991	HNRNPA3	Heterogeneous nuclear ribonucleoprotein A3	GO:0010467; P:gene expression; TAS:Reactome
P51991	HNRNPA3	Heterogeneous nuclear ribonucleoprotein A3	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P51991	HNRNPA3	Heterogeneous nuclear ribonucleoprotein A3	GO:0008380; P:RNA splicing; TAS:Reactome
Q99729	HNRNPAB	Heterogeneous nuclear ribonucleoprotein A/B	GO:0003729; F:mRNA binding; TAS:ProtInc
Q99729	HNRNPAB	Heterogeneous nuclear ribonucleoprotein A/B	GO:0000166; F:nucleotide binding; IEA:InterPro
Q99729	HNRNPAB	Heterogeneous nuclear ribonucleoprotein A/B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q99729	HNRNPAB	Heterogeneous nuclear ribonucleoprotein A/B	GO:0003723; F:RNA binding; TAS:ProtInc
Q99729	HNRNPAB	Heterogeneous nuclear ribonucleoprotein A/B	GO:0001837; P:epithelial to mesenchymal transition; ISS:HGNC
Q99729	HNRNPAB	Heterogeneous nuclear ribonucleoprotein A/B	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:HGNC
Q9Y6N7	ROBO1	Roundabout homolog 1	GO:0008046; F:axon guidance receptor activity; TAS:ProtInc
Q9Y6N7	ROBO1	Roundabout homolog 1	GO:0042802; F:identical protein binding; IDA:UniProtKB
Q9Y6N7	ROBO1	Roundabout homolog 1	GO:0030275; F:LRR domain binding; IPI:UniProtKB
Q9Y6N7	ROBO1	Roundabout homolog 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6N7	ROBO1	Roundabout homolog 1	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
Q9Y6N7	ROBO1	Roundabout homolog 1	GO:0007411; P:axon guidance; TAS:Reactome
Q9Y6N7	ROBO1	Roundabout homolog 1	GO:0016199; P:axon midline choice point recognition; ISS:UniProtKB
Q9Y6N7	ROBO1	Roundabout homolog 1	GO:0007155; P:cell adhesion; TAS:ProtInc
Q9Y6N7	ROBO1	Roundabout homolog 1	GO:0002042; P:cell migration involved in sprouting angiogenesis; IMP:BHF-UCL
Q9Y6N7	ROBO1	Roundabout homolog 1	GO:0021836; P:chemorepulsion involved in postnatal olfactory bulb interneuron migration; IDA:UniProtKB
Q9Y6N7	ROBO1	Roundabout homolog 1	GO:0007156; P:homophilic cell adhesion; IDA:UniProtKB
Q9Y6N7	ROBO1	Roundabout homolog 1	GO:0060763; P:mammary duct terminal end bud growth; IEA:Ensembl
Q9Y6N7	ROBO1	Roundabout homolog 1	GO:0070100; P:negative regulation of chemokine-mediated signaling pathway; IMP:BHF-UCL
Q9Y6N7	ROBO1	Roundabout homolog 1	GO:0033600; P:negative regulation of mammary gland epithelial cell proliferation; IMP:BHF-UCL
Q9Y6N7	ROBO1	Roundabout homolog 1	GO:0050925; P:negative regulation of negative chemotaxis; IDA:UniProtKB
Q9Y6N7	ROBO1	Roundabout homolog 1	GO:0007399; P:nervous system development; TAS:ProtInc
Q9Y6N7	ROBO1	Roundabout homolog 1	GO:0050772; P:positive regulation of axonogenesis; IDA:UniProtKB
Q9Y6N7	ROBO1	Roundabout homolog 1	GO:0035385; P:Roundabout signaling pathway; IMP:BHF-UCL
Q9HCK4	ROBO2	Roundabout homolog 2	GO:0008046; F:axon guidance receptor activity; ISS:UniProtKB
Q9HCK4	ROBO2	Roundabout homolog 2	GO:0042802; F:identical protein binding; IDA:UniProtKB
Q9HCK4	ROBO2	Roundabout homolog 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HCK4	ROBO2	Roundabout homolog 2	GO:0061364; P:apoptotic process involved in luteolysis; IEP:UniProtKB
Q9HCK4	ROBO2	Roundabout homolog 2	GO:0007411; P:axon guidance; ISS:UniProtKB
Q9HCK4	ROBO2	Roundabout homolog 2	GO:0016199; P:axon midline choice point recognition; ISS:UniProtKB
Q9HCK4	ROBO2	Roundabout homolog 2	GO:0007420; P:brain development; IEP:UniProtKB
Q9HCK4	ROBO2	Roundabout homolog 2	GO:0032870; P:cellular response to hormone stimulus; IEP:UniProtKB
Q9HCK4	ROBO2	Roundabout homolog 2	GO:0007417; P:central nervous system development; NAS:UniProtKB
Q9HCK4	ROBO2	Roundabout homolog 2	GO:0007156; P:homophilic cell adhesion; IDA:UniProtKB
Q9HCK4	ROBO2	Roundabout homolog 2	GO:0001656; P:metanephros development; ISS:UniProtKB
Q9HCK4	ROBO2	Roundabout homolog 2	GO:0050925; P:negative regulation of negative chemotaxis; IDA:UniProtKB
Q9HCK4	ROBO2	Roundabout homolog 2	GO:0051964; P:negative regulation of synapse assembly; ISS:UniProtKB
Q9HCK4	ROBO2	Roundabout homolog 2	GO:0021891; P:olfactory bulb interneuron development; ISS:UniProtKB
Q9HCK4	ROBO2	Roundabout homolog 2	GO:0050772; P:positive regulation of axonogenesis; IDA:UniProtKB
Q9HCK4	ROBO2	Roundabout homolog 2	GO:0031290; P:retinal ganglion cell axon guidance; ISS:UniProtKB
Q9HCK4	ROBO2	Roundabout homolog 2	GO:0001657; P:ureteric bud development; IMP:UniProtKB
Q96MS0	ROBO3	Roundabout homolog 3	GO:0007411; P:axon guidance; NAS:UniProtKB
Q96MS0	ROBO3	Roundabout homolog 3	GO:0016199; P:axon midline choice point recognition; ISS:UniProtKB
Q96MS0	ROBO3	Roundabout homolog 3	GO:0001764; P:neuron migration; IEA:Ensembl
Q8WZ75	ROBO4	Roundabout homolog 4	GO:0004872; F:receptor activity; TAS:UniProtKB
Q8WZ75	ROBO4	Roundabout homolog 4	GO:0001525; P:angiogenesis; IGI:UniProtKB
Q8WZ75	ROBO4	Roundabout homolog 4	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8WZ75	ROBO4	Roundabout homolog 4	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
Q8WZ75	ROBO4	Roundabout homolog 4	GO:0030334; P:regulation of cell migration; NAS:UniProtKB
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0003383; P:apical constriction; IEA:Ensembl
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0006915; P:apoptotic process; TAS:Reactome
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0007411; P:axon guidance; TAS:Reactome
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0032060; P:bleb assembly; IEA:Ensembl
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0007159; P:leukocyte cell-cell adhesion; IDA:BHF-UCL
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0050900; P:leukocyte migration; IDA:BHF-UCL
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0050901; P:leukocyte tethering or rolling; IDA:BHF-UCL
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0022614; P:membrane to membrane docking; IDA:BHF-UCL
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0051451; P:myoblast migration; ISS:UniProtKB
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0016525; P:negative regulation of angiogenesis; IMP:UniProtKB
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0051894; P:positive regulation of focal adhesion assembly; ISS:UniProtKB
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0032956; P:regulation of actin cytoskeleton organization; TAS:UniProtKB
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0030155; P:regulation of cell adhesion; TAS:UniProtKB
Q13464	ROCK1	Rho-associated protein kinase 1	GO:2000145; P:regulation of cell motility; TAS:UniProtKB
Q13464	ROCK1	Rho-associated protein kinase 1	GO:2000114; P:regulation of establishment of cell polarity; TAS:UniProtKB
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0051893; P:regulation of focal adhesion assembly; TAS:UniProtKB
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0045616; P:regulation of keratinocyte differentiation; IMP:UniProtKB
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0051492; P:regulation of stress fiber assembly; TAS:UniProtKB
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0007266; P:Rho protein signal transduction; TAS:ProtInc
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q13464	ROCK1	Rho-associated protein kinase 1	GO:0006939; P:smooth muscle contraction; TAS:UniProtKB
O75116	ROCK2	Rho-associated protein kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75116	ROCK2	Rho-associated protein kinase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75116	ROCK2	Rho-associated protein kinase 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75116	ROCK2	Rho-associated protein kinase 2	GO:0005515; F:protein binding; IPI:UniProtKB
O75116	ROCK2	Rho-associated protein kinase 2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
O75116	ROCK2	Rho-associated protein kinase 2	GO:0005198; F:structural molecule activity; NAS:ProtInc
O75116	ROCK2	Rho-associated protein kinase 2	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
O75116	ROCK2	Rho-associated protein kinase 2	GO:0007411; P:axon guidance; TAS:Reactome
O75116	ROCK2	Rho-associated protein kinase 2	GO:0051298; P:centrosome duplication; IMP:UniProtKB
O75116	ROCK2	Rho-associated protein kinase 2	GO:0000910; P:cytokinesis; NAS:ProtInc
O75116	ROCK2	Rho-associated protein kinase 2	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
O75116	ROCK2	Rho-associated protein kinase 2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
O75116	ROCK2	Rho-associated protein kinase 2	GO:0016525; P:negative regulation of angiogenesis; IMP:UniProtKB
O75116	ROCK2	Rho-associated protein kinase 2	GO:0001843; P:neural tube closure; IEA:Ensembl
O75116	ROCK2	Rho-associated protein kinase 2	GO:0010825; P:positive regulation of centrosome duplication; IEA:Ensembl
O75116	ROCK2	Rho-associated protein kinase 2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
O75116	ROCK2	Rho-associated protein kinase 2	GO:0032956; P:regulation of actin cytoskeleton organization; TAS:UniProtKB
O75116	ROCK2	Rho-associated protein kinase 2	GO:0030155; P:regulation of cell adhesion; TAS:UniProtKB
O75116	ROCK2	Rho-associated protein kinase 2	GO:2000145; P:regulation of cell motility; TAS:UniProtKB
O75116	ROCK2	Rho-associated protein kinase 2	GO:2000114; P:regulation of establishment of cell polarity; TAS:UniProtKB
O75116	ROCK2	Rho-associated protein kinase 2	GO:0051893; P:regulation of focal adhesion assembly; TAS:UniProtKB
O75116	ROCK2	Rho-associated protein kinase 2	GO:0045616; P:regulation of keratinocyte differentiation; IMP:UniProtKB
O75116	ROCK2	Rho-associated protein kinase 2	GO:0051492; P:regulation of stress fiber assembly; TAS:UniProtKB
O75116	ROCK2	Rho-associated protein kinase 2	GO:0006939; P:smooth muscle contraction; TAS:UniProtKB
Q9GZN7	ROGDI	Protein rogdi homolog	GO:0030097; P:hemopoiesis; IEA:Ensembl
Q9GZN7	ROGDI	Protein rogdi homolog	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q03395	ROM1	Rod outer segment membrane protein 1	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q03395	ROM1	Rod outer segment membrane protein 1	GO:0007601; P:visual perception; TAS:ProtInc
P60602	ROMO1	Reactive oxygen species modulator 1	GO:0034614; P:cellular response to reactive oxygen species; IMP:UniProtKB
P60602	ROMO1	Reactive oxygen species modulator 1	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
P60602	ROMO1	Reactive oxygen species modulator 1	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P60602	ROMO1	Reactive oxygen species modulator 1	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IDA:UniProtKB
P60602	ROMO1	Reactive oxygen species modulator 1	GO:0001302; P:replicative cell aging; IMP:UniProtKB
Q04912	MST1R	Macrophage-stimulating protein receptor	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q04912	MST1R	Macrophage-stimulating protein receptor	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q04912	MST1R	Macrophage-stimulating protein receptor	GO:0005011; F:macrophage colony-stimulating factor receptor activity; TAS:ProtInc
Q04912	MST1R	Macrophage-stimulating protein receptor	GO:0005515; F:protein binding; IPI:IntAct
Q04912	MST1R	Macrophage-stimulating protein receptor	GO:0006928; P:cellular component movement; TAS:ProtInc
Q04912	MST1R	Macrophage-stimulating protein receptor	GO:0006952; P:defense response; TAS:ProtInc
Q04912	MST1R	Macrophage-stimulating protein receptor	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q04912	MST1R	Macrophage-stimulating protein receptor	GO:0038145; P:macrophage colony-stimulating factor signaling pathway; TAS:GOC
Q04912	MST1R	Macrophage-stimulating protein receptor	GO:0007275; P:multicellular organismal development; IEA:InterPro
Q04912	MST1R	Macrophage-stimulating protein receptor	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q04912	MST1R	Macrophage-stimulating protein receptor	GO:0043406; P:positive regulation of MAP kinase activity; IDA:UniProtKB
Q04912	MST1R	Macrophage-stimulating protein receptor	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:UniProtKB
Q04912	MST1R	Macrophage-stimulating protein receptor	GO:0009615; P:response to virus; IDA:UniProtKB
Q04912	MST1R	Macrophage-stimulating protein receptor	GO:0007165; P:signal transduction; TAS:ProtInc
Q04912	MST1R	Macrophage-stimulating protein receptor	GO:0007338; P:single fertilization; TAS:ProtInc
Q04912	MST1R	Macrophage-stimulating protein receptor	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:InterPro
Q9BZX4	ROPN1B	Ropporin-1B	GO:0005515; F:protein binding; IPI:IntAct
Q9BZX4	ROPN1B	Ropporin-1B	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q9BZX4	ROPN1B	Ropporin-1B	GO:0042803; F:protein homodimerization activity; NAS:UniProtKB
Q9BZX4	ROPN1B	Ropporin-1B	GO:0030159; F:receptor signaling complex scaffold activity; NAS:UniProtKB
Q9BZX4	ROPN1B	Ropporin-1B	GO:0007340; P:acrosome reaction; NAS:UniProtKB
Q9BZX4	ROPN1B	Ropporin-1B	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
Q9BZX4	ROPN1B	Ropporin-1B	GO:0000910; P:cytokinesis; NAS:UniProtKB
Q9BZX4	ROPN1B	Ropporin-1B	GO:0007342; P:fusion of sperm to egg plasma membrane; NAS:UniProtKB
Q9BZX4	ROPN1B	Ropporin-1B	GO:0007266; P:Rho protein signal transduction; TAS:UniProtKB
Q9BZX4	ROPN1B	Ropporin-1B	GO:0030317; P:sperm motility; TAS:UniProtKB
Q9BZX4	ROPN1B	Ropporin-1B	GO:0007283; P:spermatogenesis; NAS:UniProtKB
Q96C74	ROPN1L	Ropporin-1-like protein	GO:0005515; F:protein binding; IPI:BHF-UCL
Q96C74	ROPN1L	Ropporin-1-like protein	GO:0003351; P:epithelial cilium movement; IC:BHF-UCL
Q01973	ROR1	Tyrosine-protein kinase transmembrane receptor ROR1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q01973	ROR1	Tyrosine-protein kinase transmembrane receptor ROR1	GO:0005515; F:protein binding; IPI:IntAct
Q01973	ROR1	Tyrosine-protein kinase transmembrane receptor ROR1	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; TAS:ProtInc
Q01973	ROR1	Tyrosine-protein kinase transmembrane receptor ROR1	GO:0017147; F:Wnt-protein binding; IPI:UniProtKB
Q01973	ROR1	Tyrosine-protein kinase transmembrane receptor ROR1	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:GOC
Q01973	ROR1	Tyrosine-protein kinase transmembrane receptor ROR1	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0005515; F:protein binding; IPI:IntAct
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; TAS:ProtInc
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0017147; F:Wnt-protein binding; IPI:UniProtKB
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0001502; P:cartilage condensation; IEA:Ensembl
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0030154; P:cell differentiation; IEA:Ensembl
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0030538; P:embryonic genitalia morphogenesis; IEA:Ensembl
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0007254; P:JNK cascade; IEA:Ensembl
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEA:Ensembl
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:GOC
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0007165; P:signal transduction; TAS:ProtInc
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0001756; P:somitogenesis; IEA:Ensembl
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:InterPro
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0007223; P:Wnt signaling pathway, calcium modulating pathway; IEA:Ensembl
Q01974	ROR2	Tyrosine-protein kinase transmembrane receptor ROR2	GO:0060071; P:Wnt signaling pathway, planar cell polarity pathway; IEA:Ensembl
P35398	RORA	Nuclear receptor ROR-alpha	GO:0098531; F:direct ligand regulated sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0003677; F:DNA binding; IDA:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; IEA:InterPro
P35398	RORA	Nuclear receptor ROR-alpha	GO:0008142; F:oxysterol binding; IDA:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P35398	RORA	Nuclear receptor ROR-alpha	GO:0001223; F:transcription coactivator binding; IPI:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0001222; F:transcription corepressor binding; IPI:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0008270; F:zinc ion binding; IEA:InterPro
P35398	RORA	Nuclear receptor ROR-alpha	GO:0001525; P:angiogenesis; IMP:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0071456; P:cellular response to hypoxia; IMP:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0036315; P:cellular response to sterol; IDA:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0021930; P:cerebellar granule cell precursor proliferation; ISS:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0021702; P:cerebellar Purkinje cell differentiation; IEA:Ensembl
P35398	RORA	Nuclear receptor ROR-alpha	GO:0046068; P:cGMP metabolic process; IEA:Ensembl
P35398	RORA	Nuclear receptor ROR-alpha	GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0010467; P:gene expression; TAS:Reactome
P35398	RORA	Nuclear receptor ROR-alpha	GO:0030522; P:intracellular receptor signaling pathway; IDA:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0042692; P:muscle cell differentiation; IMP:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0045599; P:negative regulation of fat cell differentiation; ISS:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0050728; P:negative regulation of inflammatory response; IMP:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0006809; P:nitric oxide biosynthetic process; IEA:Ensembl
P35398	RORA	Nuclear receptor ROR-alpha	GO:0042753; P:positive regulation of circadian rhythm; ISS:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
P35398	RORA	Nuclear receptor ROR-alpha	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0010575; P:positive regulation vascular endothelial growth factor production; IMP:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:2000188; P:regulation of cholesterol homeostasis; ISS:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0010906; P:regulation of glucose metabolic process; ISS:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0043030; P:regulation of macrophage activation; IEA:Ensembl
P35398	RORA	Nuclear receptor ROR-alpha	GO:0008589; P:regulation of smoothened signaling pathway; ISS:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0019218; P:regulation of steroid metabolic process; ISS:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0060850; P:regulation of transcription involved in cell fate commitment; ISS:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0072539; P:T-helper 17 cell differentiation; ISS:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P35398	RORA	Nuclear receptor ROR-alpha	GO:0070328; P:triglyceride homeostasis; IMP:UniProtKB
P35398	RORA	Nuclear receptor ROR-alpha	GO:0006805; P:xenobiotic metabolic process; ISS:UniProtKB
Q92753	RORB	Nuclear receptor ROR-beta	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; TAS:ProtInc
Q92753	RORB	Nuclear receptor ROR-beta	GO:0005515; F:protein binding; IPI:IntAct
Q92753	RORB	Nuclear receptor ROR-beta	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q92753	RORB	Nuclear receptor ROR-beta	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q92753	RORB	Nuclear receptor ROR-beta	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
Q92753	RORB	Nuclear receptor ROR-beta	GO:0008270; F:zinc ion binding; IEA:InterPro
Q92753	RORB	Nuclear receptor ROR-beta	GO:0035881; P:amacrine cell differentiation; ISS:UniProtKB
Q92753	RORB	Nuclear receptor ROR-beta	GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB
Q92753	RORB	Nuclear receptor ROR-beta	GO:0042462; P:eye photoreceptor cell development; ISS:UniProtKB
Q92753	RORB	Nuclear receptor ROR-beta	GO:0010467; P:gene expression; TAS:Reactome
Q92753	RORB	Nuclear receptor ROR-beta	GO:0030522; P:intracellular receptor signaling pathway; TAS:GOC
Q92753	RORB	Nuclear receptor ROR-beta	GO:0045668; P:negative regulation of osteoblast differentiation; ISS:UniProtKB
Q92753	RORB	Nuclear receptor ROR-beta	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q92753	RORB	Nuclear receptor ROR-beta	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q92753	RORB	Nuclear receptor ROR-beta	GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB
Q92753	RORB	Nuclear receptor ROR-beta	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
Q92753	RORB	Nuclear receptor ROR-beta	GO:0060041; P:retina development in camera-type eye; ISS:UniProtKB
Q92753	RORB	Nuclear receptor ROR-beta	GO:0046549; P:retinal cone cell development; ISS:UniProtKB
Q92753	RORB	Nuclear receptor ROR-beta	GO:0046548; P:retinal rod cell development; ISS:UniProtKB
Q92753	RORB	Nuclear receptor ROR-beta	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q92753	RORB	Nuclear receptor ROR-beta	GO:0007601; P:visual perception; IEA:UniProtKB-KW
P51449	RORC	Nuclear receptor ROR-gamma	GO:0098531; F:direct ligand regulated sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P51449	RORC	Nuclear receptor ROR-gamma	GO:0003677; F:DNA binding; ISS:UniProtKB
P51449	RORC	Nuclear receptor ROR-gamma	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; TAS:ProtInc
P51449	RORC	Nuclear receptor ROR-gamma	GO:0008142; F:oxysterol binding; IDA:UniProtKB
P51449	RORC	Nuclear receptor ROR-gamma	GO:0005515; F:protein binding; IPI:IntAct
P51449	RORC	Nuclear receptor ROR-gamma	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P51449	RORC	Nuclear receptor ROR-gamma	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
P51449	RORC	Nuclear receptor ROR-gamma	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P51449	RORC	Nuclear receptor ROR-gamma	GO:0008270; F:zinc ion binding; IEA:InterPro
P51449	RORC	Nuclear receptor ROR-gamma	GO:0060612; P:adipose tissue development; ISS:UniProtKB
P51449	RORC	Nuclear receptor ROR-gamma	GO:0036315; P:cellular response to sterol; IDA:UniProtKB
P51449	RORC	Nuclear receptor ROR-gamma	GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB
P51449	RORC	Nuclear receptor ROR-gamma	GO:0010467; P:gene expression; TAS:Reactome
P51449	RORC	Nuclear receptor ROR-gamma	GO:0030522; P:intracellular receptor signaling pathway; TAS:GOC
P51449	RORC	Nuclear receptor ROR-gamma	GO:0048535; P:lymph node development; IEA:Ensembl
P51449	RORC	Nuclear receptor ROR-gamma	GO:0048537; P:mucosal-associated lymphoid tissue development; IEA:Ensembl
P51449	RORC	Nuclear receptor ROR-gamma	GO:0070244; P:negative regulation of thymocyte apoptotic process; ISS:UniProtKB
P51449	RORC	Nuclear receptor ROR-gamma	GO:0048541; P:Peyer's patch development; ISS:UniProtKB
P51449	RORC	Nuclear receptor ROR-gamma	GO:0042753; P:positive regulation of circadian rhythm; ISS:UniProtKB
P51449	RORC	Nuclear receptor ROR-gamma	GO:0006468; P:protein phosphorylation; IEA:Ensembl
P51449	RORC	Nuclear receptor ROR-gamma	GO:0045598; P:regulation of fat cell differentiation; ISS:UniProtKB
P51449	RORC	Nuclear receptor ROR-gamma	GO:0010906; P:regulation of glucose metabolic process; ISS:UniProtKB
P51449	RORC	Nuclear receptor ROR-gamma	GO:0019218; P:regulation of steroid metabolic process; ISS:UniProtKB
P51449	RORC	Nuclear receptor ROR-gamma	GO:0060850; P:regulation of transcription involved in cell fate commitment; ISS:UniProtKB
P51449	RORC	Nuclear receptor ROR-gamma	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
P51449	RORC	Nuclear receptor ROR-gamma	GO:0072539; P:T-helper 17 cell differentiation; ISS:UniProtKB
P51449	RORC	Nuclear receptor ROR-gamma	GO:0042093; P:T-helper cell differentiation; ISS:UniProtKB
P51449	RORC	Nuclear receptor ROR-gamma	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P51449	RORC	Nuclear receptor ROR-gamma	GO:0006805; P:xenobiotic metabolic process; ISS:UniProtKB
P08922	ROS1	Proto-oncogene tyrosine-protein kinase ROS	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P08922	ROS1	Proto-oncogene tyrosine-protein kinase ROS	GO:0005515; F:protein binding; IPI:IntAct
P08922	ROS1	Proto-oncogene tyrosine-protein kinase ROS	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
P08922	ROS1	Proto-oncogene tyrosine-protein kinase ROS	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
P08922	ROS1	Proto-oncogene tyrosine-protein kinase ROS	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IEA:UniProtKB-EC
P08922	ROS1	Proto-oncogene tyrosine-protein kinase ROS	GO:0030154; P:cell differentiation; ISS:UniProtKB
P08922	ROS1	Proto-oncogene tyrosine-protein kinase ROS	GO:0016049; P:cell growth; IDA:UniProtKB
P08922	ROS1	Proto-oncogene tyrosine-protein kinase ROS	GO:0008283; P:cell proliferation; ISS:UniProtKB
P08922	ROS1	Proto-oncogene tyrosine-protein kinase ROS	GO:0002066; P:columnar/cuboidal epithelial cell development; ISS:UniProtKB
P08922	ROS1	Proto-oncogene tyrosine-protein kinase ROS	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
P08922	ROS1	Proto-oncogene tyrosine-protein kinase ROS	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:GOC
P08922	ROS1	Proto-oncogene tyrosine-protein kinase ROS	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P08922	ROS1	Proto-oncogene tyrosine-protein kinase ROS	GO:0070372; P:regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
P08922	ROS1	Proto-oncogene tyrosine-protein kinase ROS	GO:0010966; P:regulation of phosphate transport; IEA:Ensembl
P08922	ROS1	Proto-oncogene tyrosine-protein kinase ROS	GO:0032006; P:regulation of TOR signaling; IDA:UniProtKB
P08922	ROS1	Proto-oncogene tyrosine-protein kinase ROS	GO:0007283; P:spermatogenesis; ISS:UniProtKB
P08922	ROS1	Proto-oncogene tyrosine-protein kinase ROS	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:InterPro
DR   GO:0005525; F:GTP binding; IEA:UniProtKB-KW
DR   GO:0006184; P:GTP catabolic process; IEA:InterPro
DR   GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q8IWN7	RP1L1	Retinitis pigmentosa 1-like 1 protein	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
Q8IWN7	RP1L1	Retinitis pigmentosa 1-like 1 protein	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8IWN7	RP1L1	Retinitis pigmentosa 1-like 1 protein	GO:0042461; P:photoreceptor cell development; ISS:UniProtKB
Q8IWN7	RP1L1	Retinitis pigmentosa 1-like 1 protein	GO:0045494; P:photoreceptor cell maintenance; ISS:UniProtKB
Q8IWN7	RP1L1	Retinitis pigmentosa 1-like 1 protein	GO:0007601; P:visual perception; IEA:UniProtKB-KW
P56715	RP1	Oxygen-regulated protein 1	GO:0008017; F:microtubule binding; ISS:UniProtKB
P56715	RP1	Oxygen-regulated protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P56715	RP1	Oxygen-regulated protein 1	GO:0035082; P:axoneme assembly; ISS:UniProtKB
P56715	RP1	Oxygen-regulated protein 1	GO:0071482; P:cellular response to light stimulus; IEA:Ensembl
P56715	RP1	Oxygen-regulated protein 1	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P56715	RP1	Oxygen-regulated protein 1	GO:0042461; P:photoreceptor cell development; ISS:UniProtKB
P56715	RP1	Oxygen-regulated protein 1	GO:0045494; P:photoreceptor cell maintenance; ISS:UniProtKB
P56715	RP1	Oxygen-regulated protein 1	GO:0035845; P:photoreceptor cell outer segment organization; ISS:UniProtKB
P56715	RP1	Oxygen-regulated protein 1	GO:0007603; P:phototransduction, visible light; TAS:ProtInc
P56715	RP1	Oxygen-regulated protein 1	GO:0046549; P:retinal cone cell development; ISS:UniProtKB
P56715	RP1	Oxygen-regulated protein 1	GO:0046548; P:retinal rod cell development; ISS:UniProtKB
P56715	RP1	Oxygen-regulated protein 1	GO:0007601; P:visual perception; TAS:ProtInc
Q8N5L8	RPP25L	Ribonuclease P protein subunit p25-like protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y2J0	RPH3A	Rabphilin-3A	GO:0005509; F:calcium ion binding; ISS:UniProtKB
Q9Y2J0	RPH3A	Rabphilin-3A	GO:0005544; F:calcium-dependent phospholipid binding; ISS:UniProtKB
Q9Y2J0	RPH3A	Rabphilin-3A	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2J0	RPH3A	Rabphilin-3A	GO:0005215; F:transporter activity; IEA:InterPro
Q9Y2J0	RPH3A	Rabphilin-3A	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q8TA86	RP9	Retinitis pigmentosa 9 protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8TA86	RP9	Retinitis pigmentosa 9 protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TA86	RP9	Retinitis pigmentosa 9 protein	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TA86	RP9	Retinitis pigmentosa 9 protein	GO:0008380; P:RNA splicing; TAS:UniProtKB
Q9P1U0	ZNRD1	DNA-directed RNA polymerase I subunit RPA12	GO:0003899; F:DNA-directed RNA polymerase activity; IEA:UniProtKB-KW
Q9P1U0	ZNRD1	DNA-directed RNA polymerase I subunit RPA12	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9P1U0	ZNRD1	DNA-directed RNA polymerase I subunit RPA12	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9P1U0	ZNRD1	DNA-directed RNA polymerase I subunit RPA12	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
Q9P1U0	ZNRD1	DNA-directed RNA polymerase I subunit RPA12	GO:0006363; P:termination of RNA polymerase I transcription; IBA:RefGenome
O95602	POLR1A	DNA-directed RNA polymerase I subunit RPA1	GO:0003677; F:DNA binding; IEA:InterPro
O95602	POLR1A	DNA-directed RNA polymerase I subunit RPA1	GO:0003899; F:DNA-directed RNA polymerase activity; IEA:UniProtKB-KW
O95602	POLR1A	DNA-directed RNA polymerase I subunit RPA1	GO:0005515; F:protein binding; IPI:IntAct
O95602	POLR1A	DNA-directed RNA polymerase I subunit RPA1	GO:0008270; F:zinc ion binding; IEA:InterPro
O95602	POLR1A	DNA-directed RNA polymerase I subunit RPA1	GO:0010467; P:gene expression; TAS:Reactome
O95602	POLR1A	DNA-directed RNA polymerase I subunit RPA1	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
O95602	POLR1A	DNA-directed RNA polymerase I subunit RPA1	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
O95602	POLR1A	DNA-directed RNA polymerase I subunit RPA1	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
O95602	POLR1A	DNA-directed RNA polymerase I subunit RPA1	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
Q9H9Y6	POLR1B	DNA-directed RNA polymerase I subunit RPA2	GO:0003677; F:DNA binding; IEA:InterPro
Q9H9Y6	POLR1B	DNA-directed RNA polymerase I subunit RPA2	GO:0003899; F:DNA-directed RNA polymerase activity; IEA:UniProtKB-KW
Q9H9Y6	POLR1B	DNA-directed RNA polymerase I subunit RPA2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H9Y6	POLR1B	DNA-directed RNA polymerase I subunit RPA2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H9Y6	POLR1B	DNA-directed RNA polymerase I subunit RPA2	GO:0032549; F:ribonucleoside binding; IEA:InterPro
Q9H9Y6	POLR1B	DNA-directed RNA polymerase I subunit RPA2	GO:0009790; P:embryo development; IEA:Ensembl
Q9H9Y6	POLR1B	DNA-directed RNA polymerase I subunit RPA2	GO:0007566; P:embryo implantation; IEA:Ensembl
Q9H9Y6	POLR1B	DNA-directed RNA polymerase I subunit RPA2	GO:0010467; P:gene expression; TAS:Reactome
Q9H9Y6	POLR1B	DNA-directed RNA polymerase I subunit RPA2	GO:0017126; P:nucleologenesis; IEA:Ensembl
Q9H9Y6	POLR1B	DNA-directed RNA polymerase I subunit RPA2	GO:0009303; P:rRNA transcription; IEA:Ensembl
Q9H9Y6	POLR1B	DNA-directed RNA polymerase I subunit RPA2	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
Q9H9Y6	POLR1B	DNA-directed RNA polymerase I subunit RPA2	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
Q9H9Y6	POLR1B	DNA-directed RNA polymerase I subunit RPA2	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
Q9H9Y6	POLR1B	DNA-directed RNA polymerase I subunit RPA2	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
O15446	CD3EAP	DNA-directed RNA polymerase I subunit RPA34	GO:0003899; F:DNA-directed RNA polymerase activity; IEA:UniProtKB-KW
O15446	CD3EAP	DNA-directed RNA polymerase I subunit RPA34	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O15446	CD3EAP	DNA-directed RNA polymerase I subunit RPA34	GO:0009303; P:rRNA transcription; TAS:ProtInc
O15446	CD3EAP	DNA-directed RNA polymerase I subunit RPA34	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc
Q3B726	TWISTNB	DNA-directed RNA polymerase I subunit RPA43	GO:0003899; F:DNA-directed RNA polymerase activity; IEA:UniProtKB-KW
Q3B726	TWISTNB	DNA-directed RNA polymerase I subunit RPA43	GO:0006360; P:transcription from RNA polymerase I promoter; IBA:GOC
Q9GZS1	POLR1E	DNA-directed RNA polymerase I subunit RPA49	GO:0003677; F:DNA binding; IEA:InterPro
Q9GZS1	POLR1E	DNA-directed RNA polymerase I subunit RPA49	GO:0003899; F:DNA-directed RNA polymerase activity; IEA:UniProtKB-KW
Q9GZS1	POLR1E	DNA-directed RNA polymerase I subunit RPA49	GO:0009303; P:rRNA transcription; ISS:HGNC
Q9GZS1	POLR1E	DNA-directed RNA polymerase I subunit RPA49	GO:0006360; P:transcription from RNA polymerase I promoter; IBA:GOC
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0003677; F:DNA binding; IEA:InterPro
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0003899; F:DNA-directed RNA polymerase activity; TAS:ProtInc
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0005515; F:protein binding; IPI:UniProtKB
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0006281; P:DNA repair; TAS:Reactome
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0010467; P:gene expression; TAS:Reactome
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0045087; P:innate immune response; TAS:Reactome
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0008380; P:RNA splicing; TAS:Reactome
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0006386; P:termination of RNA polymerase III transcription; TAS:Reactome
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0006385; P:transcription elongation from RNA polymerase III promoter; TAS:Reactome
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0006360; P:transcription from RNA polymerase I promoter; IBA:GOC
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P19388	POLR2E	DNA-directed RNA polymerases I, II, and III subunit RPABC1	GO:0016032; P:viral process; TAS:Reactome
P61218	POLR2F	DNA-directed RNA polymerases I, II, and III subunit RPABC2	GO:0003677; F:DNA binding; IEA:InterPro
P61218	POLR2F	DNA-directed RNA polymerases I, II, and III subunit RPABC2	GO:0003899; F:DNA-directed RNA polymerase activity; IEA:UniProtKB-KW
P61218	POLR2F	DNA-directed RNA polymerases I, II, and III subunit RPABC2	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
P61218	POLR2F	DNA-directed RNA polymerases I, II, and III subunit RPABC2	GO:0006281; P:DNA repair; TAS:Reactome
P61218	POLR2F	DNA-directed RNA polymerases I, II, and III subunit RPABC2	GO:0010467; P:gene expression; TAS:Reactome
P61218	POLR2F	DNA-directed RNA polymerases I, II, and III subunit RPABC2	GO:0045087; P:innate immune response; TAS:Reactome
P61218	POLR2F	DNA-directed RNA polymerases I, II, and III subunit RPABC2	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P61218	POLR2F	DNA-directed RNA polymerases I, II, and III subunit RPABC2	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P61218	POLR2F	DNA-directed RNA polymerases I, II, and III subunit RPABC2	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
P61218	POLR2F	DNA-directed RNA polymerases I, II, and III subunit RPABC2	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P61218	POLR2F	DNA-directed RNA polymerases I, II, and III subunit RPABC2	GO:0008380; P:RNA splicing; TAS:Reactome
P61218	POLR2F	DNA-directed RNA polymerases I, II, and III subunit RPABC2	GO:0006386; P:termination of RNA polymerase III transcription; TAS:Reactome
P61218	POLR2F	DNA-directed RNA polymerases I, II, and III subunit RPABC2	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P61218	POLR2F	DNA-directed RNA polymerases I, II, and III subunit RPABC2	GO:0006385; P:transcription elongation from RNA polymerase III promoter; TAS:Reactome
P61218	POLR2F	DNA-directed RNA polymerases I, II, and III subunit RPABC2	GO:0006360; P:transcription from RNA polymerase I promoter; IBA:GOC
P61218	POLR2F	DNA-directed RNA polymerases I, II, and III subunit RPABC2	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
P61218	POLR2F	DNA-directed RNA polymerases I, II, and III subunit RPABC2	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
P61218	POLR2F	DNA-directed RNA polymerases I, II, and III subunit RPABC2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P61218	POLR2F	DNA-directed RNA polymerases I, II, and III subunit RPABC2	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P61218	POLR2F	DNA-directed RNA polymerases I, II, and III subunit RPABC2	GO:0016032; P:viral process; TAS:Reactome
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0003899; F:DNA-directed RNA polymerase activity; IEA:UniProtKB-KW
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0006281; P:DNA repair; TAS:Reactome
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0010467; P:gene expression; TAS:Reactome
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0045087; P:innate immune response; TAS:Reactome
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0008380; P:RNA splicing; TAS:Reactome
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0006386; P:termination of RNA polymerase III transcription; TAS:Reactome
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0006385; P:transcription elongation from RNA polymerase III promoter; TAS:Reactome
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P52434	POLR2H	DNA-directed RNA polymerases I, II, and III subunit RPABC3	GO:0016032; P:viral process; TAS:Reactome
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0003677; F:DNA binding; IEA:InterPro
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0003899; F:DNA-directed RNA polymerase activity; TAS:ProtInc
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0008270; F:zinc ion binding; IBA:RefGenome
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0006281; P:DNA repair; TAS:Reactome
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0010467; P:gene expression; TAS:Reactome
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0045087; P:innate immune response; TAS:Reactome
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0006356; P:regulation of transcription from RNA polymerase I promoter; TAS:ProtInc
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0008380; P:RNA splicing; TAS:Reactome
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0006386; P:termination of RNA polymerase III transcription; TAS:Reactome
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0006385; P:transcription elongation from RNA polymerase III promoter; TAS:Reactome
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0006360; P:transcription from RNA polymerase I promoter; IBA:GOC
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P62875	POLR2L	DNA-directed RNA polymerases I, II, and III subunit RPABC5	GO:0016032; P:viral process; TAS:Reactome
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0003677; F:DNA binding; IEA:InterPro
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0003899; F:DNA-directed RNA polymerase activity; IEA:UniProtKB-KW
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0008270; F:zinc ion binding; TAS:ProtInc
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0006281; P:DNA repair; TAS:Reactome
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0010467; P:gene expression; TAS:Reactome
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0045087; P:innate immune response; TAS:Reactome
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0006356; P:regulation of transcription from RNA polymerase I promoter; TAS:ProtInc
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0008380; P:RNA splicing; TAS:Reactome
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0006386; P:termination of RNA polymerase III transcription; TAS:Reactome
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0006385; P:transcription elongation from RNA polymerase III promoter; TAS:Reactome
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P53803	POLR2K	DNA-directed RNA polymerases I, II, and III subunit RPABC4	GO:0016032; P:viral process; TAS:Reactome
O15160	POLR1C	DNA-directed RNA polymerases I and III subunit RPAC1	GO:0003677; F:DNA binding; IEA:InterPro
O15160	POLR1C	DNA-directed RNA polymerases I and III subunit RPAC1	GO:0003899; F:DNA-directed RNA polymerase activity; TAS:ProtInc
O15160	POLR1C	DNA-directed RNA polymerases I and III subunit RPAC1	GO:0010467; P:gene expression; TAS:Reactome
O15160	POLR1C	DNA-directed RNA polymerases I and III subunit RPAC1	GO:0045087; P:innate immune response; TAS:Reactome
O15160	POLR1C	DNA-directed RNA polymerases I and III subunit RPAC1	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
O15160	POLR1C	DNA-directed RNA polymerases I and III subunit RPAC1	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
O15160	POLR1C	DNA-directed RNA polymerases I and III subunit RPAC1	GO:0006386; P:termination of RNA polymerase III transcription; TAS:Reactome
O15160	POLR1C	DNA-directed RNA polymerases I and III subunit RPAC1	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
O15160	POLR1C	DNA-directed RNA polymerases I and III subunit RPAC1	GO:0006385; P:transcription elongation from RNA polymerase III promoter; TAS:Reactome
O15160	POLR1C	DNA-directed RNA polymerases I and III subunit RPAC1	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
O15160	POLR1C	DNA-directed RNA polymerases I and III subunit RPAC1	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
O15160	POLR1C	DNA-directed RNA polymerases I and III subunit RPAC1	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
Q9Y2S0	POLR1D	DNA-directed RNA polymerases I and III subunit RPAC2	GO:0003677; F:DNA binding; IEA:InterPro
Q9Y2S0	POLR1D	DNA-directed RNA polymerases I and III subunit RPAC2	GO:0003899; F:DNA-directed RNA polymerase activity; IEA:UniProtKB-KW
Q9Y2S0	POLR1D	DNA-directed RNA polymerases I and III subunit RPAC2	GO:0010467; P:gene expression; TAS:Reactome
Q9Y2S0	POLR1D	DNA-directed RNA polymerases I and III subunit RPAC2	GO:0045087; P:innate immune response; TAS:Reactome
Q9Y2S0	POLR1D	DNA-directed RNA polymerases I and III subunit RPAC2	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q9Y2S0	POLR1D	DNA-directed RNA polymerases I and III subunit RPAC2	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
Q9Y2S0	POLR1D	DNA-directed RNA polymerases I and III subunit RPAC2	GO:0006386; P:termination of RNA polymerase III transcription; TAS:Reactome
Q9Y2S0	POLR1D	DNA-directed RNA polymerases I and III subunit RPAC2	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
Q9Y2S0	POLR1D	DNA-directed RNA polymerases I and III subunit RPAC2	GO:0006385; P:transcription elongation from RNA polymerase III promoter; TAS:Reactome
Q9Y2S0	POLR1D	DNA-directed RNA polymerases I and III subunit RPAC2	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
Q9Y2S0	POLR1D	DNA-directed RNA polymerases I and III subunit RPAC2	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
Q9Y2S0	POLR1D	DNA-directed RNA polymerases I and III subunit RPAC2	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
Q9BWH6	RPAP1	RNA polymerase II-associated protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BWH6	RPAP1	RNA polymerase II-associated protein 1	GO:0003899; F:DNA-directed RNA polymerase activity; IEA:UniProtKB-KW
Q8IXW5	RPAP2	Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2	GO:0008420; F:CTD phosphatase activity; IMP:UniProtKB
Q8IXW5	RPAP2	Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IXW5	RPAP2	Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2	GO:0070940; P:dephosphorylation of RNA polymerase II C-terminal domain; IMP:UniProtKB
Q8IXW5	RPAP2	Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2	GO:0009301; P:snRNA transcription; IMP:UniProtKB
Q9H6T3	RPAP3	RNA polymerase II-associated protein 3	GO:0005515; F:protein binding; IPI:IntAct
P52435	POLR2J	DNA-directed RNA polymerase II subunit RPB11-a	GO:0003677; F:DNA binding; IEA:InterPro
P52435	POLR2J	DNA-directed RNA polymerase II subunit RPB11-a	GO:0003899; F:DNA-directed RNA polymerase activity; TAS:ProtInc
P52435	POLR2J	DNA-directed RNA polymerase II subunit RPB11-a	GO:0030275; F:LRR domain binding; IPI:UniProtKB
P52435	POLR2J	DNA-directed RNA polymerase II subunit RPB11-a	GO:0005515; F:protein binding; IPI:UniProtKB
P52435	POLR2J	DNA-directed RNA polymerase II subunit RPB11-a	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
P52435	POLR2J	DNA-directed RNA polymerase II subunit RPB11-a	GO:0006281; P:DNA repair; TAS:Reactome
P52435	POLR2J	DNA-directed RNA polymerase II subunit RPB11-a	GO:0010467; P:gene expression; TAS:Reactome
P52435	POLR2J	DNA-directed RNA polymerase II subunit RPB11-a	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P52435	POLR2J	DNA-directed RNA polymerase II subunit RPB11-a	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P52435	POLR2J	DNA-directed RNA polymerase II subunit RPB11-a	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P52435	POLR2J	DNA-directed RNA polymerase II subunit RPB11-a	GO:0008380; P:RNA splicing; TAS:Reactome
P52435	POLR2J	DNA-directed RNA polymerase II subunit RPB11-a	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P52435	POLR2J	DNA-directed RNA polymerase II subunit RPB11-a	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
P52435	POLR2J	DNA-directed RNA polymerase II subunit RPB11-a	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P52435	POLR2J	DNA-directed RNA polymerase II subunit RPB11-a	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P52435	POLR2J	DNA-directed RNA polymerase II subunit RPB11-a	GO:0016032; P:viral process; TAS:Reactome
Q9GZM3	POLR2J2	DNA-directed RNA polymerase II subunit RPB11-b1	GO:0003677; F:DNA binding; IEA:InterPro
Q9GZM3	POLR2J2	DNA-directed RNA polymerase II subunit RPB11-b1	GO:0003899; F:DNA-directed RNA polymerase activity; IEA:UniProtKB-KW
Q9GZM3	POLR2J2	DNA-directed RNA polymerase II subunit RPB11-b1	GO:0006351; P:transcription, DNA-templated; IEA:InterPro
Q9H1A7	POLR2J3	DNA-directed RNA polymerase II subunit RPB11-b2	GO:0003677; F:DNA binding; IEA:InterPro
Q9H1A7	POLR2J3	DNA-directed RNA polymerase II subunit RPB11-b2	GO:0003899; F:DNA-directed RNA polymerase activity; IEA:UniProtKB-KW
Q9H1A7	POLR2J3	DNA-directed RNA polymerase II subunit RPB11-b2	GO:0006351; P:transcription, DNA-templated; IEA:InterPro
P24928	POLR2A	DNA-directed RNA polymerase II subunit RPB1	GO:0003677; F:DNA binding; NAS:UniProtKB
P24928	POLR2A	DNA-directed RNA polymerase II subunit RPB1	GO:0003899; F:DNA-directed RNA polymerase activity; NAS:UniProtKB
P24928	POLR2A	DNA-directed RNA polymerase II subunit RPB1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P24928	POLR2A	DNA-directed RNA polymerase II subunit RPB1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P24928	POLR2A	DNA-directed RNA polymerase II subunit RPB1	GO:0005515; F:protein binding; IPI:UniProtKB
P24928	POLR2A	DNA-directed RNA polymerase II subunit RPB1	GO:0003968; F:RNA-directed RNA polymerase activity; IEA:UniProtKB-KW
P24928	POLR2A	DNA-directed RNA polymerase II subunit RPB1	GO:0031625; F:ubiquitin protein ligase binding; IPI:BHF-UCL
P24928	POLR2A	DNA-directed RNA polymerase II subunit RPB1	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
P24928	POLR2A	DNA-directed RNA polymerase II subunit RPB1	GO:0006281; P:DNA repair; TAS:Reactome
P24928	POLR2A	DNA-directed RNA polymerase II subunit RPB1	GO:0010467; P:gene expression; TAS:Reactome
P24928	POLR2A	DNA-directed RNA polymerase II subunit RPB1	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P24928	POLR2A	DNA-directed RNA polymerase II subunit RPB1	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P24928	POLR2A	DNA-directed RNA polymerase II subunit RPB1	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P24928	POLR2A	DNA-directed RNA polymerase II subunit RPB1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P24928	POLR2A	DNA-directed RNA polymerase II subunit RPB1	GO:0008380; P:RNA splicing; TAS:Reactome
P24928	POLR2A	DNA-directed RNA polymerase II subunit RPB1	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P24928	POLR2A	DNA-directed RNA polymerase II subunit RPB1	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
P24928	POLR2A	DNA-directed RNA polymerase II subunit RPB1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P24928	POLR2A	DNA-directed RNA polymerase II subunit RPB1	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P24928	POLR2A	DNA-directed RNA polymerase II subunit RPB1	GO:0016032; P:viral process; TAS:Reactome
P30876	POLR2B	DNA-directed RNA polymerase II subunit RPB2	GO:0003682; F:chromatin binding; IEA:Ensembl
P30876	POLR2B	DNA-directed RNA polymerase II subunit RPB2	GO:0003677; F:DNA binding; TAS:ProtInc
P30876	POLR2B	DNA-directed RNA polymerase II subunit RPB2	GO:0003899; F:DNA-directed RNA polymerase activity; IEA:UniProtKB-KW
P30876	POLR2B	DNA-directed RNA polymerase II subunit RPB2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P30876	POLR2B	DNA-directed RNA polymerase II subunit RPB2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P30876	POLR2B	DNA-directed RNA polymerase II subunit RPB2	GO:0005515; F:protein binding; IPI:UniProtKB
P30876	POLR2B	DNA-directed RNA polymerase II subunit RPB2	GO:0032549; F:ribonucleoside binding; IEA:InterPro
P30876	POLR2B	DNA-directed RNA polymerase II subunit RPB2	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
P30876	POLR2B	DNA-directed RNA polymerase II subunit RPB2	GO:0006281; P:DNA repair; TAS:Reactome
P30876	POLR2B	DNA-directed RNA polymerase II subunit RPB2	GO:0010467; P:gene expression; TAS:Reactome
P30876	POLR2B	DNA-directed RNA polymerase II subunit RPB2	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P30876	POLR2B	DNA-directed RNA polymerase II subunit RPB2	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P30876	POLR2B	DNA-directed RNA polymerase II subunit RPB2	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P30876	POLR2B	DNA-directed RNA polymerase II subunit RPB2	GO:0008380; P:RNA splicing; TAS:Reactome
P30876	POLR2B	DNA-directed RNA polymerase II subunit RPB2	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P30876	POLR2B	DNA-directed RNA polymerase II subunit RPB2	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
P30876	POLR2B	DNA-directed RNA polymerase II subunit RPB2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P30876	POLR2B	DNA-directed RNA polymerase II subunit RPB2	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P30876	POLR2B	DNA-directed RNA polymerase II subunit RPB2	GO:0016032; P:viral process; TAS:Reactome
P19387	POLR2C	DNA-directed RNA polymerase II subunit RPB3	GO:0003677; F:DNA binding; IEA:InterPro
P19387	POLR2C	DNA-directed RNA polymerase II subunit RPB3	GO:0003899; F:DNA-directed RNA polymerase activity; IEA:UniProtKB-KW
P19387	POLR2C	DNA-directed RNA polymerase II subunit RPB3	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
P19387	POLR2C	DNA-directed RNA polymerase II subunit RPB3	GO:0006281; P:DNA repair; TAS:Reactome
P19387	POLR2C	DNA-directed RNA polymerase II subunit RPB3	GO:0010467; P:gene expression; TAS:Reactome
P19387	POLR2C	DNA-directed RNA polymerase II subunit RPB3	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P19387	POLR2C	DNA-directed RNA polymerase II subunit RPB3	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P19387	POLR2C	DNA-directed RNA polymerase II subunit RPB3	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P19387	POLR2C	DNA-directed RNA polymerase II subunit RPB3	GO:0008380; P:RNA splicing; TAS:Reactome
P19387	POLR2C	DNA-directed RNA polymerase II subunit RPB3	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P19387	POLR2C	DNA-directed RNA polymerase II subunit RPB3	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
P19387	POLR2C	DNA-directed RNA polymerase II subunit RPB3	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P19387	POLR2C	DNA-directed RNA polymerase II subunit RPB3	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P19387	POLR2C	DNA-directed RNA polymerase II subunit RPB3	GO:0016032; P:viral process; TAS:Reactome
O15514	POLR2D	DNA-directed RNA polymerase II subunit RPB4	GO:0003899; F:DNA-directed RNA polymerase activity; IMP:UniProtKB
O15514	POLR2D	DNA-directed RNA polymerase II subunit RPB4	GO:0000166; F:nucleotide binding; IEA:InterPro
O15514	POLR2D	DNA-directed RNA polymerase II subunit RPB4	GO:0031369; F:translation initiation factor binding; IBA:RefGenome
O15514	POLR2D	DNA-directed RNA polymerase II subunit RPB4	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
O15514	POLR2D	DNA-directed RNA polymerase II subunit RPB4	GO:0006281; P:DNA repair; TAS:Reactome
O15514	POLR2D	DNA-directed RNA polymerase II subunit RPB4	GO:0010467; P:gene expression; TAS:Reactome
O15514	POLR2D	DNA-directed RNA polymerase II subunit RPB4	GO:0031990; P:mRNA export from nucleus in response to heat stress; IBA:RefGenome
O15514	POLR2D	DNA-directed RNA polymerase II subunit RPB4	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
O15514	POLR2D	DNA-directed RNA polymerase II subunit RPB4	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; IBA:RefGenome
O15514	POLR2D	DNA-directed RNA polymerase II subunit RPB4	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
O15514	POLR2D	DNA-directed RNA polymerase II subunit RPB4	GO:0045948; P:positive regulation of translational initiation; IBA:RefGenome
O15514	POLR2D	DNA-directed RNA polymerase II subunit RPB4	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
O15514	POLR2D	DNA-directed RNA polymerase II subunit RPB4	GO:0034402; P:recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex; IBA:RefGenome
O15514	POLR2D	DNA-directed RNA polymerase II subunit RPB4	GO:0008380; P:RNA splicing; TAS:Reactome
O15514	POLR2D	DNA-directed RNA polymerase II subunit RPB4	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
O15514	POLR2D	DNA-directed RNA polymerase II subunit RPB4	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
O15514	POLR2D	DNA-directed RNA polymerase II subunit RPB4	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IBA:RefGenome
O15514	POLR2D	DNA-directed RNA polymerase II subunit RPB4	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
O15514	POLR2D	DNA-directed RNA polymerase II subunit RPB4	GO:0016032; P:viral process; TAS:Reactome
P62487	POLR2G	DNA-directed RNA polymerase II subunit RPB7	GO:0003899; F:DNA-directed RNA polymerase activity; IEA:UniProtKB-KW
P62487	POLR2G	DNA-directed RNA polymerase II subunit RPB7	GO:0003697; F:single-stranded DNA binding; IBA:RefGenome
P62487	POLR2G	DNA-directed RNA polymerase II subunit RPB7	GO:0003727; F:single-stranded RNA binding; IBA:RefGenome
P62487	POLR2G	DNA-directed RNA polymerase II subunit RPB7	GO:0031369; F:translation initiation factor binding; IBA:RefGenome
P62487	POLR2G	DNA-directed RNA polymerase II subunit RPB7	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
P62487	POLR2G	DNA-directed RNA polymerase II subunit RPB7	GO:0006915; P:apoptotic process; IEA:Ensembl
P62487	POLR2G	DNA-directed RNA polymerase II subunit RPB7	GO:0006281; P:DNA repair; TAS:Reactome
P62487	POLR2G	DNA-directed RNA polymerase II subunit RPB7	GO:0010467; P:gene expression; TAS:Reactome
P62487	POLR2G	DNA-directed RNA polymerase II subunit RPB7	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P62487	POLR2G	DNA-directed RNA polymerase II subunit RPB7	GO:0000291; P:nuclear-transcribed mRNA catabolic process, exonucleolytic; IBA:RefGenome
P62487	POLR2G	DNA-directed RNA polymerase II subunit RPB7	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P62487	POLR2G	DNA-directed RNA polymerase II subunit RPB7	GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; IBA:RefGenome
P62487	POLR2G	DNA-directed RNA polymerase II subunit RPB7	GO:0045948; P:positive regulation of translational initiation; IBA:RefGenome
P62487	POLR2G	DNA-directed RNA polymerase II subunit RPB7	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P62487	POLR2G	DNA-directed RNA polymerase II subunit RPB7	GO:0008380; P:RNA splicing; TAS:Reactome
P62487	POLR2G	DNA-directed RNA polymerase II subunit RPB7	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P62487	POLR2G	DNA-directed RNA polymerase II subunit RPB7	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
P62487	POLR2G	DNA-directed RNA polymerase II subunit RPB7	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IBA:RefGenome
P62487	POLR2G	DNA-directed RNA polymerase II subunit RPB7	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P62487	POLR2G	DNA-directed RNA polymerase II subunit RPB7	GO:0016032; P:viral process; TAS:Reactome
P36954	POLR2I	DNA-directed RNA polymerase II subunit RPB9	GO:0003677; F:DNA binding; IEA:InterPro
P36954	POLR2I	DNA-directed RNA polymerase II subunit RPB9	GO:0003899; F:DNA-directed RNA polymerase activity; TAS:ProtInc
P36954	POLR2I	DNA-directed RNA polymerase II subunit RPB9	GO:0008270; F:zinc ion binding; TAS:ProtInc
P36954	POLR2I	DNA-directed RNA polymerase II subunit RPB9	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
P36954	POLR2I	DNA-directed RNA polymerase II subunit RPB9	GO:0006281; P:DNA repair; TAS:Reactome
P36954	POLR2I	DNA-directed RNA polymerase II subunit RPB9	GO:0010467; P:gene expression; TAS:Reactome
P36954	POLR2I	DNA-directed RNA polymerase II subunit RPB9	GO:0001193; P:maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter; IBA:RefGenome
P36954	POLR2I	DNA-directed RNA polymerase II subunit RPB9	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P36954	POLR2I	DNA-directed RNA polymerase II subunit RPB9	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P36954	POLR2I	DNA-directed RNA polymerase II subunit RPB9	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P36954	POLR2I	DNA-directed RNA polymerase II subunit RPB9	GO:0008380; P:RNA splicing; TAS:Reactome
P36954	POLR2I	DNA-directed RNA polymerase II subunit RPB9	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P36954	POLR2I	DNA-directed RNA polymerase II subunit RPB9	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
P36954	POLR2I	DNA-directed RNA polymerase II subunit RPB9	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IBA:RefGenome
P36954	POLR2I	DNA-directed RNA polymerase II subunit RPB9	GO:0006283; P:transcription-coupled nucleotide-excision repair; IBA:RefGenome
P36954	POLR2I	DNA-directed RNA polymerase II subunit RPB9	GO:0016032; P:viral process; TAS:Reactome
Q9Y2Y1	POLR3K	DNA-directed RNA polymerase III subunit RPC10	GO:0003677; F:DNA binding; IEA:InterPro
Q9Y2Y1	POLR3K	DNA-directed RNA polymerase III subunit RPC10	GO:0003899; F:DNA-directed RNA polymerase activity; TAS:ProtInc
Q9Y2Y1	POLR3K	DNA-directed RNA polymerase III subunit RPC10	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y2Y1	POLR3K	DNA-directed RNA polymerase III subunit RPC10	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q9Y2Y1	POLR3K	DNA-directed RNA polymerase III subunit RPC10	GO:0010467; P:gene expression; TAS:Reactome
Q9Y2Y1	POLR3K	DNA-directed RNA polymerase III subunit RPC10	GO:0045087; P:innate immune response; TAS:Reactome
Q9Y2Y1	POLR3K	DNA-directed RNA polymerase III subunit RPC10	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q9Y2Y1	POLR3K	DNA-directed RNA polymerase III subunit RPC10	GO:0006386; P:termination of RNA polymerase III transcription; IBA:RefGenome
Q9Y2Y1	POLR3K	DNA-directed RNA polymerase III subunit RPC10	GO:0006385; P:transcription elongation from RNA polymerase III promoter; TAS:Reactome
Q9Y2Y1	POLR3K	DNA-directed RNA polymerase III subunit RPC10	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
O14802	POLR3A	DNA-directed RNA polymerase III subunit RPC1	GO:0003682; F:chromatin binding; IEA:Ensembl
O14802	POLR3A	DNA-directed RNA polymerase III subunit RPC1	GO:0003677; F:DNA binding; IEA:InterPro
O14802	POLR3A	DNA-directed RNA polymerase III subunit RPC1	GO:0003899; F:DNA-directed RNA polymerase activity; NAS:UniProtKB
O14802	POLR3A	DNA-directed RNA polymerase III subunit RPC1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14802	POLR3A	DNA-directed RNA polymerase III subunit RPC1	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
O14802	POLR3A	DNA-directed RNA polymerase III subunit RPC1	GO:0010467; P:gene expression; TAS:Reactome
O14802	POLR3A	DNA-directed RNA polymerase III subunit RPC1	GO:0045087; P:innate immune response; IMP:UniProtKB
O14802	POLR3A	DNA-directed RNA polymerase III subunit RPC1	GO:0032728; P:positive regulation of interferon-beta production; IMP:UniProtKB
O14802	POLR3A	DNA-directed RNA polymerase III subunit RPC1	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
O14802	POLR3A	DNA-directed RNA polymerase III subunit RPC1	GO:0006386; P:termination of RNA polymerase III transcription; TAS:Reactome
O14802	POLR3A	DNA-directed RNA polymerase III subunit RPC1	GO:0006385; P:transcription elongation from RNA polymerase III promoter; TAS:Reactome
O14802	POLR3A	DNA-directed RNA polymerase III subunit RPC1	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
O14802	POLR3A	DNA-directed RNA polymerase III subunit RPC1	GO:0006351; P:transcription, DNA-templated; NAS:UniProtKB
Q9NW08	POLR3B	DNA-directed RNA polymerase III subunit RPC2	GO:0003677; F:DNA binding; IEA:InterPro
Q9NW08	POLR3B	DNA-directed RNA polymerase III subunit RPC2	GO:0003899; F:DNA-directed RNA polymerase activity; IEA:UniProtKB-KW
Q9NW08	POLR3B	DNA-directed RNA polymerase III subunit RPC2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NW08	POLR3B	DNA-directed RNA polymerase III subunit RPC2	GO:0032549; F:ribonucleoside binding; IEA:InterPro
Q9NW08	POLR3B	DNA-directed RNA polymerase III subunit RPC2	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q9NW08	POLR3B	DNA-directed RNA polymerase III subunit RPC2	GO:0010467; P:gene expression; TAS:Reactome
Q9NW08	POLR3B	DNA-directed RNA polymerase III subunit RPC2	GO:0045087; P:innate immune response; TAS:Reactome
Q9NW08	POLR3B	DNA-directed RNA polymerase III subunit RPC2	GO:0045089; P:positive regulation of innate immune response; IMP:UniProtKB
Q9NW08	POLR3B	DNA-directed RNA polymerase III subunit RPC2	GO:0032728; P:positive regulation of interferon-beta production; IMP:UniProtKB
Q9NW08	POLR3B	DNA-directed RNA polymerase III subunit RPC2	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q9NW08	POLR3B	DNA-directed RNA polymerase III subunit RPC2	GO:0006386; P:termination of RNA polymerase III transcription; TAS:Reactome
Q9NW08	POLR3B	DNA-directed RNA polymerase III subunit RPC2	GO:0006385; P:transcription elongation from RNA polymerase III promoter; TAS:Reactome
Q9NW08	POLR3B	DNA-directed RNA polymerase III subunit RPC2	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
Q9BUI4	POLR3C	DNA-directed RNA polymerase III subunit RPC3	GO:0003677; F:DNA binding; IEA:InterPro
Q9BUI4	POLR3C	DNA-directed RNA polymerase III subunit RPC3	GO:0003899; F:DNA-directed RNA polymerase activity; TAS:ProtInc
Q9BUI4	POLR3C	DNA-directed RNA polymerase III subunit RPC3	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q9BUI4	POLR3C	DNA-directed RNA polymerase III subunit RPC3	GO:0010467; P:gene expression; TAS:Reactome
Q9BUI4	POLR3C	DNA-directed RNA polymerase III subunit RPC3	GO:0045087; P:innate immune response; TAS:Reactome
Q9BUI4	POLR3C	DNA-directed RNA polymerase III subunit RPC3	GO:0045089; P:positive regulation of innate immune response; IMP:UniProtKB
Q9BUI4	POLR3C	DNA-directed RNA polymerase III subunit RPC3	GO:0032728; P:positive regulation of interferon-beta production; IMP:UniProtKB
Q9BUI4	POLR3C	DNA-directed RNA polymerase III subunit RPC3	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q9BUI4	POLR3C	DNA-directed RNA polymerase III subunit RPC3	GO:0006359; P:regulation of transcription from RNA polymerase III promoter; TAS:ProtInc
Q9BUI4	POLR3C	DNA-directed RNA polymerase III subunit RPC3	GO:0006386; P:termination of RNA polymerase III transcription; TAS:Reactome
Q9BUI4	POLR3C	DNA-directed RNA polymerase III subunit RPC3	GO:0006385; P:transcription elongation from RNA polymerase III promoter; TAS:Reactome
Q9BUI4	POLR3C	DNA-directed RNA polymerase III subunit RPC3	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
P05423	POLR3D	DNA-directed RNA polymerase III subunit RPC4	GO:0003682; F:chromatin binding; IEA:Ensembl
P05423	POLR3D	DNA-directed RNA polymerase III subunit RPC4	GO:0003677; F:DNA binding; IEA:InterPro
P05423	POLR3D	DNA-directed RNA polymerase III subunit RPC4	GO:0003899; F:DNA-directed RNA polymerase activity; IEA:UniProtKB-KW
P05423	POLR3D	DNA-directed RNA polymerase III subunit RPC4	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P05423	POLR3D	DNA-directed RNA polymerase III subunit RPC4	GO:0010467; P:gene expression; TAS:Reactome
P05423	POLR3D	DNA-directed RNA polymerase III subunit RPC4	GO:0045087; P:innate immune response; TAS:Reactome
P05423	POLR3D	DNA-directed RNA polymerase III subunit RPC4	GO:0045089; P:positive regulation of innate immune response; IDA:UniProtKB
P05423	POLR3D	DNA-directed RNA polymerase III subunit RPC4	GO:0032728; P:positive regulation of interferon-beta production; IDA:UniProtKB
P05423	POLR3D	DNA-directed RNA polymerase III subunit RPC4	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
P05423	POLR3D	DNA-directed RNA polymerase III subunit RPC4	GO:0006386; P:termination of RNA polymerase III transcription; TAS:Reactome
P05423	POLR3D	DNA-directed RNA polymerase III subunit RPC4	GO:0006385; P:transcription elongation from RNA polymerase III promoter; TAS:Reactome
P05423	POLR3D	DNA-directed RNA polymerase III subunit RPC4	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
Q9NVU0	POLR3E	DNA-directed RNA polymerase III subunit RPC5	GO:0003899; F:DNA-directed RNA polymerase activity; IEA:UniProtKB-KW
Q9NVU0	POLR3E	DNA-directed RNA polymerase III subunit RPC5	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q9NVU0	POLR3E	DNA-directed RNA polymerase III subunit RPC5	GO:0010467; P:gene expression; TAS:Reactome
Q9NVU0	POLR3E	DNA-directed RNA polymerase III subunit RPC5	GO:0045087; P:innate immune response; TAS:Reactome
Q9NVU0	POLR3E	DNA-directed RNA polymerase III subunit RPC5	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q9NVU0	POLR3E	DNA-directed RNA polymerase III subunit RPC5	GO:0006386; P:termination of RNA polymerase III transcription; TAS:Reactome
Q9NVU0	POLR3E	DNA-directed RNA polymerase III subunit RPC5	GO:0006385; P:transcription elongation from RNA polymerase III promoter; TAS:Reactome
Q9NVU0	POLR3E	DNA-directed RNA polymerase III subunit RPC5	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
Q9H1D9	POLR3F	DNA-directed RNA polymerase III subunit RPC6	GO:0003677; F:DNA binding; IEA:InterPro
Q9H1D9	POLR3F	DNA-directed RNA polymerase III subunit RPC6	GO:0003899; F:DNA-directed RNA polymerase activity; NAS:UniProtKB
Q9H1D9	POLR3F	DNA-directed RNA polymerase III subunit RPC6	GO:0005515; F:protein binding; IPI:IntAct
Q9H1D9	POLR3F	DNA-directed RNA polymerase III subunit RPC6	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q9H1D9	POLR3F	DNA-directed RNA polymerase III subunit RPC6	GO:0010467; P:gene expression; TAS:Reactome
Q9H1D9	POLR3F	DNA-directed RNA polymerase III subunit RPC6	GO:0045087; P:innate immune response; TAS:Reactome
Q9H1D9	POLR3F	DNA-directed RNA polymerase III subunit RPC6	GO:0045089; P:positive regulation of innate immune response; IMP:UniProtKB
Q9H1D9	POLR3F	DNA-directed RNA polymerase III subunit RPC6	GO:0032728; P:positive regulation of interferon-beta production; IMP:UniProtKB
Q9H1D9	POLR3F	DNA-directed RNA polymerase III subunit RPC6	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q9H1D9	POLR3F	DNA-directed RNA polymerase III subunit RPC6	GO:0006359; P:regulation of transcription from RNA polymerase III promoter; NAS:UniProtKB
Q9H1D9	POLR3F	DNA-directed RNA polymerase III subunit RPC6	GO:0006386; P:termination of RNA polymerase III transcription; TAS:Reactome
Q9H1D9	POLR3F	DNA-directed RNA polymerase III subunit RPC6	GO:0006385; P:transcription elongation from RNA polymerase III promoter; TAS:Reactome
Q9H1D9	POLR3F	DNA-directed RNA polymerase III subunit RPC6	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
O15318	POLR3G	DNA-directed RNA polymerase III subunit RPC7	GO:0003899; F:DNA-directed RNA polymerase activity; TAS:ProtInc
O15318	POLR3G	DNA-directed RNA polymerase III subunit RPC7	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
O15318	POLR3G	DNA-directed RNA polymerase III subunit RPC7	GO:0010467; P:gene expression; TAS:Reactome
O15318	POLR3G	DNA-directed RNA polymerase III subunit RPC7	GO:0045087; P:innate immune response; TAS:Reactome
O15318	POLR3G	DNA-directed RNA polymerase III subunit RPC7	GO:0045089; P:positive regulation of innate immune response; IMP:UniProtKB
O15318	POLR3G	DNA-directed RNA polymerase III subunit RPC7	GO:0032728; P:positive regulation of interferon-beta production; IMP:UniProtKB
O15318	POLR3G	DNA-directed RNA polymerase III subunit RPC7	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
O15318	POLR3G	DNA-directed RNA polymerase III subunit RPC7	GO:0006359; P:regulation of transcription from RNA polymerase III promoter; TAS:ProtInc
O15318	POLR3G	DNA-directed RNA polymerase III subunit RPC7	GO:0006386; P:termination of RNA polymerase III transcription; TAS:Reactome
O15318	POLR3G	DNA-directed RNA polymerase III subunit RPC7	GO:0006385; P:transcription elongation from RNA polymerase III promoter; TAS:Reactome
O15318	POLR3G	DNA-directed RNA polymerase III subunit RPC7	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
Q9Y535	POLR3H	DNA-directed RNA polymerase III subunit RPC8	GO:0003677; F:DNA binding; IEA:InterPro
Q9Y535	POLR3H	DNA-directed RNA polymerase III subunit RPC8	GO:0003899; F:DNA-directed RNA polymerase activity; IDA:UniProtKB
Q9Y535	POLR3H	DNA-directed RNA polymerase III subunit RPC8	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q9Y535	POLR3H	DNA-directed RNA polymerase III subunit RPC8	GO:0010467; P:gene expression; TAS:Reactome
Q9Y535	POLR3H	DNA-directed RNA polymerase III subunit RPC8	GO:0045087; P:innate immune response; TAS:Reactome
Q9Y535	POLR3H	DNA-directed RNA polymerase III subunit RPC8	GO:0006139; P:nucleobase-containing compound metabolic process; IDA:UniProtKB
Q9Y535	POLR3H	DNA-directed RNA polymerase III subunit RPC8	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q9Y535	POLR3H	DNA-directed RNA polymerase III subunit RPC8	GO:0006386; P:termination of RNA polymerase III transcription; TAS:Reactome
Q9Y535	POLR3H	DNA-directed RNA polymerase III subunit RPC8	GO:0006385; P:transcription elongation from RNA polymerase III promoter; TAS:Reactome
Q9Y535	POLR3H	DNA-directed RNA polymerase III subunit RPC8	GO:0006383; P:transcription from RNA polymerase III promoter; IDA:UniProtKB
Q9Y535	POLR3H	DNA-directed RNA polymerase III subunit RPC8	GO:0006384; P:transcription initiation from RNA polymerase III promoter; IBA:RefGenome
Q9BT43	POLR3GL	DNA-directed RNA polymerase III subunit RPC7-like	GO:0010467; P:gene expression; TAS:Reactome
Q9BT43	POLR3GL	DNA-directed RNA polymerase III subunit RPC7-like	GO:0045087; P:innate immune response; TAS:Reactome
Q9BT43	POLR3GL	DNA-directed RNA polymerase III subunit RPC7-like	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q9BT43	POLR3GL	DNA-directed RNA polymerase III subunit RPC7-like	GO:0006386; P:termination of RNA polymerase III transcription; TAS:Reactome
Q9BT43	POLR3GL	DNA-directed RNA polymerase III subunit RPC7-like	GO:0006385; P:transcription elongation from RNA polymerase III promoter; TAS:Reactome
Q9BT43	POLR3GL	DNA-directed RNA polymerase III subunit RPC7-like	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
O75575	CRCP	DNA-directed RNA polymerase III subunit RPC9	GO:0001635; F:calcitonin gene-related polypeptide receptor activity; IEA:Ensembl
O75575	CRCP	DNA-directed RNA polymerase III subunit RPC9	GO:0003899; F:DNA-directed RNA polymerase activity; IDA:UniProtKB
O75575	CRCP	DNA-directed RNA polymerase III subunit RPC9	GO:0000166; F:nucleotide binding; IEA:InterPro
O75575	CRCP	DNA-directed RNA polymerase III subunit RPC9	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
O75575	CRCP	DNA-directed RNA polymerase III subunit RPC9	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
O75575	CRCP	DNA-directed RNA polymerase III subunit RPC9	GO:0007218; P:neuropeptide signaling pathway; IEA:Ensembl
O75575	CRCP	DNA-directed RNA polymerase III subunit RPC9	GO:0006383; P:transcription from RNA polymerase III promoter; IDA:UniProtKB
Q16518	RPE65	Retinoid isomerohydrolase	GO:0052885; F:all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity; IEA:UniProtKB-EC
Q16518	RPE65	Retinoid isomerohydrolase	GO:0052884; F:all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity; IEA:UniProtKB-EC
Q16518	RPE65	Retinoid isomerohydrolase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q16518	RPE65	Retinoid isomerohydrolase	GO:0004744; F:retinal isomerase activity; IEA:Ensembl
Q16518	RPE65	Retinoid isomerohydrolase	GO:0071257; P:cellular response to electrical stimulus; IEA:Ensembl
Q16518	RPE65	Retinoid isomerohydrolase	GO:0050908; P:detection of light stimulus involved in visual perception; IMP:UniProt
Q16518	RPE65	Retinoid isomerohydrolase	GO:0008286; P:insulin receptor signaling pathway; IEA:Ensembl
Q16518	RPE65	Retinoid isomerohydrolase	GO:0007603; P:phototransduction, visible light; TAS:Reactome
Q16518	RPE65	Retinoid isomerohydrolase	GO:0007468; P:regulation of rhodopsin gene expression; IEA:Ensembl
Q16518	RPE65	Retinoid isomerohydrolase	GO:0001895; P:retina homeostasis; IMP:UniProt
Q16518	RPE65	Retinoid isomerohydrolase	GO:0060042; P:retina morphogenesis in camera-type eye; IEA:Ensembl
Q16518	RPE65	Retinoid isomerohydrolase	GO:0042574; P:retinal metabolic process; IEA:Ensembl
Q16518	RPE65	Retinoid isomerohydrolase	GO:0001523; P:retinoid metabolic process; TAS:Reactome
Q16518	RPE65	Retinoid isomerohydrolase	GO:0007601; P:visual perception; TAS:ProtInc
Q16518	RPE65	Retinoid isomerohydrolase	GO:0006776; P:vitamin A metabolic process; TAS:ProtInc
Q2QD12	RPEL1	Ribulose-phosphate 3-epimerase-like protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q2QD12	RPEL1	Ribulose-phosphate 3-epimerase-like protein 1	GO:0004750; F:ribulose-phosphate 3-epimerase activity; IEA:UniProtKB-EC
Q2QD12	RPEL1	Ribulose-phosphate 3-epimerase-like protein 1	GO:0006098; P:pentose-phosphate shunt; IEA:InterPro
Q96AT9	RPE	Ribulose-phosphate 3-epimerase	GO:0042802; F:identical protein binding; IPI:IntAct
Q96AT9	RPE	Ribulose-phosphate 3-epimerase	GO:0046872; F:metal ion binding; IDA:UniProtKB
Q96AT9	RPE	Ribulose-phosphate 3-epimerase	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q96AT9	RPE	Ribulose-phosphate 3-epimerase	GO:0004750; F:ribulose-phosphate 3-epimerase activity; IDA:UniProtKB
Q96AT9	RPE	Ribulose-phosphate 3-epimerase	GO:0005975; P:carbohydrate metabolic process; IDA:UniProtKB
Q96AT9	RPE	Ribulose-phosphate 3-epimerase	GO:0006098; P:pentose-phosphate shunt; IDA:UniProtKB
Q96AT9	RPE	Ribulose-phosphate 3-epimerase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H9Y2	RPF1	Ribosome production factor 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H9Y2	RPF1	Ribosome production factor 1	GO:0003723; F:RNA binding; IDA:UniProtKB
Q9H9Y2	RPF1	Ribosome production factor 1	GO:0019843; F:rRNA binding; IEA:UniProtKB-KW
Q9H9Y2	RPF1	Ribosome production factor 1	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q9H7B2	RPF2	Ribosome production factor 2 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13905	RAPGEF1	Rap guanine nucleotide exchange factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13905	RAPGEF1	Rap guanine nucleotide exchange factor 1	GO:0017034; F:Rap guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q13905	RAPGEF1	Rap guanine nucleotide exchange factor 1	GO:0000186; P:activation of MAPKK activity; TAS:Reactome
Q13905	RAPGEF1	Rap guanine nucleotide exchange factor 1	GO:0001568; P:blood vessel development; IEA:Ensembl
Q13905	RAPGEF1	Rap guanine nucleotide exchange factor 1	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
Q13905	RAPGEF1	Rap guanine nucleotide exchange factor 1	GO:0071320; P:cellular response to cAMP; IDA:UniProtKB
Q13905	RAPGEF1	Rap guanine nucleotide exchange factor 1	GO:1990090; P:cellular response to nerve growth factor stimulus; IDA:UniProtKB
Q13905	RAPGEF1	Rap guanine nucleotide exchange factor 1	GO:0061028; P:establishment of endothelial barrier; IMP:UniProtKB
Q13905	RAPGEF1	Rap guanine nucleotide exchange factor 1	GO:0038180; P:nerve growth factor signaling pathway; IDA:UniProtKB
Q13905	RAPGEF1	Rap guanine nucleotide exchange factor 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q13905	RAPGEF1	Rap guanine nucleotide exchange factor 1	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IEA:Ensembl
Q13905	RAPGEF1	Rap guanine nucleotide exchange factor 1	GO:0010976; P:positive regulation of neuron projection development; IMP:UniProtKB
Q13905	RAPGEF1	Rap guanine nucleotide exchange factor 1	GO:0032854; P:positive regulation of Rap GTPase activity; IDA:UniProtKB
Q13905	RAPGEF1	Rap guanine nucleotide exchange factor 1	GO:0032486; P:Rap protein signal transduction; IMP:UniProtKB
Q13905	RAPGEF1	Rap guanine nucleotide exchange factor 1	GO:1901888; P:regulation of cell junction assembly; IMP:UniProtKB
Q13905	RAPGEF1	Rap guanine nucleotide exchange factor 1	GO:0007165; P:signal transduction; NAS:ProtInc
Q13905	RAPGEF1	Rap guanine nucleotide exchange factor 1	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0031697; F:beta-1 adrenergic receptor binding; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0005509; F:calcium ion binding; NAS:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0030552; F:cAMP binding; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0019992; F:diacylglycerol binding; NAS:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0030165; F:PDZ domain binding; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0046582; F:Rap GTPase activator activity; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0017034; F:Rap guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0004871; F:signal transducer activity; TAS:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0050699; F:WW domain binding; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0071880; P:adenylate cyclase-activating adrenergic receptor signaling pathway; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0001568; P:blood vessel development; ISS:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0031547; P:brain-derived neurotrophic factor receptor signaling pathway; ISS:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0019933; P:cAMP-mediated signaling; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0071320; P:cellular response to cAMP; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0071321; P:cellular response to cGMP; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:1990090; P:cellular response to nerve growth factor stimulus; ISS:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0061028; P:establishment of endothelial barrier; IMP:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0021884; P:forebrain neuron development; ISS:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0035556; P:intracellular signal transduction; TAS:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0000165; P:MAPK cascade; NAS:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0050774; P:negative regulation of dendrite morphogenesis; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0048022; P:negative regulation of melanin biosynthetic process; ISS:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0038180; P:nerve growth factor signaling pathway; ISS:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0001764; P:neuron migration; ISS:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0031175; P:neuron projection development; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0007218; P:neuropeptide signaling pathway; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:2000481; P:positive regulation of cAMP-dependent protein kinase activity; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0043950; P:positive regulation of cAMP-mediated signaling; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:2000670; P:positive regulation of dendritic cell apoptotic process; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:2001224; P:positive regulation of neuron migration; ISS:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0032092; P:positive regulation of protein binding; ISS:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0045860; P:positive regulation of protein kinase activity; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0032854; P:positive regulation of Rap GTPase activity; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0032320; P:positive regulation of Ras GTPase activity; IDA:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:2001214; P:positive regulation of vasculogenesis; ISS:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0032486; P:Rap protein signal transduction; IMP:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:1901888; P:regulation of cell junction assembly; IMP:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0048167; P:regulation of synaptic plasticity; ISS:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0007264; P:small GTPase mediated signal transduction; TAS:UniProtKB
Q9Y4G8	RAPGEF2	Rap guanine nucleotide exchange factor 2	GO:0021591; P:ventricular system development; ISS:UniProtKB
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0030552; F:cAMP binding; IEA:UniProtKB-KW
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0008603; F:cAMP-dependent protein kinase regulator activity; IEA:InterPro
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:ProtInc
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0005515; F:protein binding; IPI:IntAct
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0017034; F:Rap guanyl-nucleotide exchange factor activity; IMP:UniProtKB
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0007596; P:blood coagulation; TAS:Reactome
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0019933; P:cAMP-mediated signaling; NAS:BHF-UCL
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0008283; P:cell proliferation; TAS:ProtInc
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0071320; P:cellular response to cAMP; IDA:UniProtKB
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0061028; P:establishment of endothelial barrier; IMP:UniProtKB
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0030168; P:platelet activation; TAS:Reactome
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0030822; P:positive regulation of cAMP catabolic process; NAS:BHF-UCL
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0032854; P:positive regulation of Rap GTPase activity; IMP:UniProtKB
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0051496; P:positive regulation of stress fiber assembly; IMP:UniProtKB
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0032486; P:Rap protein signal transduction; IMP:UniProtKB
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:2000249; P:regulation of actin cytoskeleton reorganization; IMP:UniProtKB
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0007165; P:signal transduction; TAS:ProtInc
O95398	RAPGEF3	Rap guanine nucleotide exchange factor 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8WZA2	RAPGEF4	Rap guanine nucleotide exchange factor 4	GO:0030552; F:cAMP binding; IEA:Ensembl
Q8WZA2	RAPGEF4	Rap guanine nucleotide exchange factor 4	GO:0008603; F:cAMP-dependent protein kinase regulator activity; IEA:InterPro
Q8WZA2	RAPGEF4	Rap guanine nucleotide exchange factor 4	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW
Q8WZA2	RAPGEF4	Rap guanine nucleotide exchange factor 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WZA2	RAPGEF4	Rap guanine nucleotide exchange factor 4	GO:0017016; F:Ras GTPase binding; ISS:UniProtKB
Q8WZA2	RAPGEF4	Rap guanine nucleotide exchange factor 4	GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; IEA:Ensembl
Q8WZA2	RAPGEF4	Rap guanine nucleotide exchange factor 4	GO:0007596; P:blood coagulation; TAS:Reactome
Q8WZA2	RAPGEF4	Rap guanine nucleotide exchange factor 4	GO:0017156; P:calcium ion-dependent exocytosis; IEA:Ensembl
Q8WZA2	RAPGEF4	Rap guanine nucleotide exchange factor 4	GO:0019933; P:cAMP-mediated signaling; IEA:Ensembl
Q8WZA2	RAPGEF4	Rap guanine nucleotide exchange factor 4	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q8WZA2	RAPGEF4	Rap guanine nucleotide exchange factor 4	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q8WZA2	RAPGEF4	Rap guanine nucleotide exchange factor 4	GO:0030073; P:insulin secretion; IEA:Ensembl
Q8WZA2	RAPGEF4	Rap guanine nucleotide exchange factor 4	GO:0030168; P:platelet activation; TAS:Reactome
Q8WZA2	RAPGEF4	Rap guanine nucleotide exchange factor 4	GO:0017157; P:regulation of exocytosis; IEA:Ensembl
Q8WZA2	RAPGEF4	Rap guanine nucleotide exchange factor 4	GO:0043087; P:regulation of GTPase activity; TAS:GOC
Q8WZA2	RAPGEF4	Rap guanine nucleotide exchange factor 4	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
Q8WZA2	RAPGEF4	Rap guanine nucleotide exchange factor 4	GO:0032318; P:regulation of Ras GTPase activity; ISS:GOC
Q8WZA2	RAPGEF4	Rap guanine nucleotide exchange factor 4	GO:0051056; P:regulation of small GTPase mediated signal transduction; IEA:InterPro
Q8WZA2	RAPGEF4	Rap guanine nucleotide exchange factor 4	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q8WZA2	RAPGEF4	Rap guanine nucleotide exchange factor 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q92565	RAPGEF5	Rap guanine nucleotide exchange factor 5	GO:0030742; F:GTP-dependent protein binding; IPI:UniProtKB
Q92565	RAPGEF5	Rap guanine nucleotide exchange factor 5	GO:0017034; F:Rap guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q92565	RAPGEF5	Rap guanine nucleotide exchange factor 5	GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; TAS:UniProtKB
Q92565	RAPGEF5	Rap guanine nucleotide exchange factor 5	GO:0007399; P:nervous system development; NAS:UniProtKB
Q92565	RAPGEF5	Rap guanine nucleotide exchange factor 5	GO:0032317; P:regulation of Rap GTPase activity; IDA:GOC
Q92565	RAPGEF5	Rap guanine nucleotide exchange factor 5	GO:0032318; P:regulation of Ras GTPase activity; TAS:GOC
Q92565	RAPGEF5	Rap guanine nucleotide exchange factor 5	GO:0007264; P:small GTPase mediated signal transduction; NAS:UniProtKB
Q8TEU7	RAPGEF6	Rap guanine nucleotide exchange factor 6	GO:0030742; F:GTP-dependent protein binding; IDA:UniProtKB
Q8TEU7	RAPGEF6	Rap guanine nucleotide exchange factor 6	GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q8TEU7	RAPGEF6	Rap guanine nucleotide exchange factor 6	GO:0005515; F:protein binding; IPI:IntAct
Q8TEU7	RAPGEF6	Rap guanine nucleotide exchange factor 6	GO:0017016; F:Ras GTPase binding; IDA:UniProtKB
Q8TEU7	RAPGEF6	Rap guanine nucleotide exchange factor 6	GO:0007265; P:Ras protein signal transduction; NAS:UniProtKB
Q8TEU7	RAPGEF6	Rap guanine nucleotide exchange factor 6	GO:0043087; P:regulation of GTPase activity; NAS:UniProtKB
Q8TEU7	RAPGEF6	Rap guanine nucleotide exchange factor 6	GO:0051056; P:regulation of small GTPase mediated signal transduction; IEA:InterPro
Q9UHV5	RAPGEFL1	Rap guanine nucleotide exchange factor-like 1	GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:ProtInc
Q9UHV5	RAPGEFL1	Rap guanine nucleotide exchange factor-like 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q9UHV5	RAPGEFL1	Rap guanine nucleotide exchange factor-like 1	GO:0007399; P:nervous system development; TAS:ProtInc
Q9UHV5	RAPGEFL1	Rap guanine nucleotide exchange factor-like 1	GO:0043087; P:regulation of GTPase activity; TAS:GOC
Q9UHV5	RAPGEFL1	Rap guanine nucleotide exchange factor-like 1	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P47736	RAP1GAP	Rap1 GTPase-activating protein 1	GO:0005096; F:GTPase activator activity; TAS:ProtInc
P47736	RAP1GAP	Rap1 GTPase-activating protein 1	GO:0003924; F:GTPase activity; NAS:UniProtKB
P47736	RAP1GAP	Rap1 GTPase-activating protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P47736	RAP1GAP	Rap1 GTPase-activating protein 1	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P47736	RAP1GAP	Rap1 GTPase-activating protein 1	GO:0046582; F:Rap GTPase activator activity; IDA:UniProtKB
P47736	RAP1GAP	Rap1 GTPase-activating protein 1	GO:0017016; F:Ras GTPase binding; IPI:UniProtKB
P47736	RAP1GAP	Rap1 GTPase-activating protein 1	GO:0006184; P:GTP catabolic process; NAS:GOC
P47736	RAP1GAP	Rap1 GTPase-activating protein 1	GO:0032854; P:positive regulation of Rap GTPase activity; IDA:UniProtKB
P47736	RAP1GAP	Rap1 GTPase-activating protein 1	GO:0032318; P:regulation of Ras GTPase activity; IDA:UniProtKB
P47736	RAP1GAP	Rap1 GTPase-activating protein 1	GO:0007165; P:signal transduction; NAS:UniProtKB
Q684P5	RAP1GAP2	Rap1 GTPase-activating protein 2	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q684P5	RAP1GAP2	Rap1 GTPase-activating protein 2	GO:0051056; P:regulation of small GTPase mediated signal transduction; IEA:InterPro
Q96KN7	RPGRIP1	X-linked retinitis pigmentosa GTPase regulator-interacting protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96KN7	RPGRIP1	X-linked retinitis pigmentosa GTPase regulator-interacting protein 1	GO:0042462; P:eye photoreceptor cell development; IEA:Ensembl
Q96KN7	RPGRIP1	X-linked retinitis pigmentosa GTPase regulator-interacting protein 1	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q96KN7	RPGRIP1	X-linked retinitis pigmentosa GTPase regulator-interacting protein 1	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
Q96KN7	RPGRIP1	X-linked retinitis pigmentosa GTPase regulator-interacting protein 1	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q92834	RPGR	X-linked retinitis pigmentosa GTPase regulator	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW
Q92834	RPGR	X-linked retinitis pigmentosa GTPase regulator	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q92834	RPGR	X-linked retinitis pigmentosa GTPase regulator	GO:0005515; F:protein binding; IPI:IntAct
Q92834	RPGR	X-linked retinitis pigmentosa GTPase regulator	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q92834	RPGR	X-linked retinitis pigmentosa GTPase regulator	GO:0042462; P:eye photoreceptor cell development; IEA:Ensembl
Q92834	RPGR	X-linked retinitis pigmentosa GTPase regulator	GO:0006886; P:intracellular protein transport; TAS:ProtInc
Q92834	RPGR	X-linked retinitis pigmentosa GTPase regulator	GO:0042073; P:intraciliary transport; ISS:UniProtKB
Q92834	RPGR	X-linked retinitis pigmentosa GTPase regulator	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q92834	RPGR	X-linked retinitis pigmentosa GTPase regulator	GO:0007601; P:visual perception; IMP:UniProtKB
Q9UNE2	RPH3AL	Rab effector Noc2	GO:0008092; F:cytoskeletal protein binding; TAS:ProtInc
Q9UNE2	RPH3AL	Rab effector Noc2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UNE2	RPH3AL	Rab effector Noc2	GO:0006887; P:exocytosis; TAS:ProtInc
Q9UNE2	RPH3AL	Rab effector Noc2	GO:0042593; P:glucose homeostasis; IEA:Ensembl
Q9UNE2	RPH3AL	Rab effector Noc2	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9UNE2	RPH3AL	Rab effector Noc2	GO:0045744; P:negative regulation of G-protein coupled receptor protein signaling pathway; IEA:Ensembl
Q9UNE2	RPH3AL	Rab effector Noc2	GO:0050714; P:positive regulation of protein secretion; IEA:Ensembl
Q9UNE2	RPH3AL	Rab effector Noc2	GO:0017158; P:regulation of calcium ion-dependent exocytosis; IEA:Ensembl
Q9UNE2	RPH3AL	Rab effector Noc2	GO:0042493; P:response to drug; IEA:Ensembl
P49247	RPIA	Ribose-5-phosphate isomerase	GO:0048029; F:monosaccharide binding; IEA:Ensembl
P49247	RPIA	Ribose-5-phosphate isomerase	GO:0004751; F:ribose-5-phosphate isomerase activity; NAS:UniProtKB
P49247	RPIA	Ribose-5-phosphate isomerase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P49247	RPIA	Ribose-5-phosphate isomerase	GO:0006098; P:pentose-phosphate shunt; TAS:Reactome
P49247	RPIA	Ribose-5-phosphate isomerase	GO:0009052; P:pentose-phosphate shunt, non-oxidative branch; IEA:Ensembl
P49247	RPIA	Ribose-5-phosphate isomerase	GO:0019693; P:ribose phosphate metabolic process; IEA:Ensembl
P49247	RPIA	Ribose-5-phosphate isomerase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y6S9	RPS6KL1	Ribosomal protein S6 kinase-like 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y6S9	RPS6KL1	Ribosomal protein S6 kinase-like 1	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
P04843	RPN1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1	GO:0004579; F:dolichyl-diphosphooligosaccharide-protein glycotransferase activity; IEA:InterPro
P04843	RPN1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P04843	RPN1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1	GO:0005515; F:protein binding; IPI:UniProt
P04843	RPN1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P04843	RPN1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P04843	RPN1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1	GO:0010467; P:gene expression; TAS:Reactome
P04843	RPN1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
P04843	RPN1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1	GO:0018279; P:protein N-linked glycosylation via asparagine; IMP:UniProt
P04843	RPN1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P04843	RPN1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1	GO:0006412; P:translation; TAS:Reactome
P04844	RPN2	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2	GO:0043022; F:ribosome binding; IEA:Ensembl
P04844	RPN2	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2	GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW
P04844	RPN2	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2	GO:0007568; P:aging; IEA:Ensembl
P04844	RPN2	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P04844	RPN2	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P04844	RPN2	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2	GO:0010467; P:gene expression; TAS:Reactome
P04844	RPN2	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2	GO:0043687; P:post-translational protein modification; TAS:Reactome
P04844	RPN2	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2	GO:0018279; P:protein N-linked glycosylation via asparagine; NAS:HGNC
P04844	RPN2	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2	GO:0042493; P:response to drug; IEA:Ensembl
P04844	RPN2	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P04844	RPN2	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2	GO:0006412; P:translation; TAS:Reactome
O00411	POLRMT	DNA-directed RNA polymerase, mitochondrial	GO:0003677; F:DNA binding; IEA:InterPro
O00411	POLRMT	DNA-directed RNA polymerase, mitochondrial	GO:0003899; F:DNA-directed RNA polymerase activity; IDA:UniProtKB
O00411	POLRMT	DNA-directed RNA polymerase, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O00411	POLRMT	DNA-directed RNA polymerase, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
O00411	POLRMT	DNA-directed RNA polymerase, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
O00411	POLRMT	DNA-directed RNA polymerase, mitochondrial	GO:0006390; P:transcription from mitochondrial promoter; IDA:UniProtKB
O00411	POLRMT	DNA-directed RNA polymerase, mitochondrial	GO:0006391; P:transcription initiation from mitochondrial promoter; TAS:Reactome
O95059	RPP14	Ribonuclease P protein subunit p14	GO:0004526; F:ribonuclease P activity; IEA:UniProtKB-EC
O95059	RPP14	Ribonuclease P protein subunit p14	GO:0003723; F:RNA binding; TAS:ProtInc
O95059	RPP14	Ribonuclease P protein subunit p14	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q9H633	RPP21	Ribonuclease P protein subunit p21	GO:0004526; F:ribonuclease P activity; IEA:UniProtKB-EC
Q9H633	RPP21	Ribonuclease P protein subunit p21	GO:0042493; P:response to drug; IEP:UniProtKB
Q9H633	RPP21	Ribonuclease P protein subunit p21	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q9BUL9	RPP25	Ribonuclease P protein subunit p25	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BUL9	RPP25	Ribonuclease P protein subunit p25	GO:0005515; F:protein binding; IPI:IntAct
Q9BUL9	RPP25	Ribonuclease P protein subunit p25	GO:0004526; F:ribonuclease P activity; IEA:UniProtKB-EC
Q9BUL9	RPP25	Ribonuclease P protein subunit p25	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
O95707	POP4	Ribonuclease P protein subunit p29	GO:0005515; F:protein binding; IPI:IntAct
O95707	POP4	Ribonuclease P protein subunit p29	GO:0004526; F:ribonuclease P activity; TAS:ProtInc
O95707	POP4	Ribonuclease P protein subunit p29	GO:0003723; F:RNA binding; TAS:ProtInc
O95707	POP4	Ribonuclease P protein subunit p29	GO:0006379; P:mRNA cleavage; IEA:InterPro
O95707	POP4	Ribonuclease P protein subunit p29	GO:0090501; P:RNA phosphodiester bond hydrolysis; TAS:GOC
O95707	POP4	Ribonuclease P protein subunit p29	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; TAS:GOC
O95707	POP4	Ribonuclease P protein subunit p29	GO:0006364; P:rRNA processing; TAS:ProtInc
O95707	POP4	Ribonuclease P protein subunit p29	GO:0008033; P:tRNA processing; TAS:ProtInc
P78346	RPP30	Ribonuclease P protein subunit p30	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P78346	RPP30	Ribonuclease P protein subunit p30	GO:0004526; F:ribonuclease P activity; TAS:ProtInc
P78346	RPP30	Ribonuclease P protein subunit p30	GO:0090501; P:RNA phosphodiester bond hydrolysis; TAS:GOC
P78346	RPP30	Ribonuclease P protein subunit p30	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; TAS:GOC
P78346	RPP30	Ribonuclease P protein subunit p30	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
P78345	RPP38	Ribonuclease P protein subunit p38	GO:0005515; F:protein binding; IPI:IntAct
P78345	RPP38	Ribonuclease P protein subunit p38	GO:0004526; F:ribonuclease P activity; TAS:ProtInc
P78345	RPP38	Ribonuclease P protein subunit p38	GO:0090501; P:RNA phosphodiester bond hydrolysis; TAS:GOC
P78345	RPP38	Ribonuclease P protein subunit p38	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; TAS:GOC
P78345	RPP38	Ribonuclease P protein subunit p38	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
O75818	RPP40	Ribonuclease P protein subunit p40	GO:0004526; F:ribonuclease P activity; TAS:ProtInc
O75818	RPP40	Ribonuclease P protein subunit p40	GO:0090501; P:RNA phosphodiester bond hydrolysis; TAS:GOC
O75818	RPP40	Ribonuclease P protein subunit p40	GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; TAS:GOC
O75818	RPP40	Ribonuclease P protein subunit p40	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q96P16	RPRD1A	Regulation of nuclear pre-mRNA domain-containing protein 1A	GO:0070940; P:dephosphorylation of RNA polymerase II C-terminal domain; IMP:UniProtKB
Q9NQG5	RPRD1B	Regulation of nuclear pre-mRNA domain-containing protein 1B	GO:0005515; F:protein binding; IPI:IntAct
Q9NQG5	RPRD1B	Regulation of nuclear pre-mRNA domain-containing protein 1B	GO:0000993; F:RNA polymerase II core binding; IDA:UniProtKB
Q9NQG5	RPRD1B	Regulation of nuclear pre-mRNA domain-containing protein 1B	GO:0070940; P:dephosphorylation of RNA polymerase II C-terminal domain; IMP:UniProtKB
Q9NQG5	RPRD1B	Regulation of nuclear pre-mRNA domain-containing protein 1B	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q9NQG5	RPRD1B	Regulation of nuclear pre-mRNA domain-containing protein 1B	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9NQG5	RPRD1B	Regulation of nuclear pre-mRNA domain-containing protein 1B	GO:0010564; P:regulation of cell cycle process; IDA:UniProtKB
Q9NQG5	RPRD1B	Regulation of nuclear pre-mRNA domain-containing protein 1B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NS64	RPRM	Protein reprimo	GO:0007050; P:cell cycle arrest; TAS:ProtInc
Q9NS64	RPRM	Protein reprimo	GO:0007346; P:regulation of mitotic cell cycle; IEA:Ensembl
Q6XPR3	RPTN	Repetin	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8N122	RPTOR	Regulatory-associated protein of mTOR	GO:0071889; F:14-3-3 protein binding; IDA:UniProtKB
Q8N122	RPTOR	Regulatory-associated protein of mTOR	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N122	RPTOR	Regulatory-associated protein of mTOR	GO:0032403; F:protein complex binding; IPI:UniProtKB
Q8N122	RPTOR	Regulatory-associated protein of mTOR	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q8N122	RPTOR	Regulatory-associated protein of mTOR	GO:0001030; F:RNA polymerase III type 1 promoter DNA binding; IDA:UniProtKB
Q8N122	RPTOR	Regulatory-associated protein of mTOR	GO:0001031; F:RNA polymerase III type 2 promoter DNA binding; IDA:UniProtKB
Q8N122	RPTOR	Regulatory-associated protein of mTOR	GO:0001032; F:RNA polymerase III type 3 promoter DNA binding; IDA:UniProtKB
Q8N122	RPTOR	Regulatory-associated protein of mTOR	GO:0001156; F:TFIIIC-class transcription factor binding; IDA:UniProtKB
Q8N122	RPTOR	Regulatory-associated protein of mTOR	GO:0007050; P:cell cycle arrest; TAS:Reactome
Q8N122	RPTOR	Regulatory-associated protein of mTOR	GO:0016049; P:cell growth; IMP:UniProtKB
Q8N122	RPTOR	Regulatory-associated protein of mTOR	GO:0071230; P:cellular response to amino acid stimulus; IMP:UniProtKB
Q8N122	RPTOR	Regulatory-associated protein of mTOR	GO:0031669; P:cellular response to nutrient levels; IMP:UniProtKB
Q8N122	RPTOR	Regulatory-associated protein of mTOR	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q8N122	RPTOR	Regulatory-associated protein of mTOR	GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl
Q8N122	RPTOR	Regulatory-associated protein of mTOR	GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IDA:UniProtKB
Q8N122	RPTOR	Regulatory-associated protein of mTOR	GO:0032008; P:positive regulation of TOR signaling; IDA:UniProtKB
Q8N122	RPTOR	Regulatory-associated protein of mTOR	GO:0045945; P:positive regulation of transcription from RNA polymerase III promoter; IMP:UniProtKB
Q8N122	RPTOR	Regulatory-associated protein of mTOR	GO:0008361; P:regulation of cell size; IMP:UniProtKB
Q8N122	RPTOR	Regulatory-associated protein of mTOR	GO:0031929; P:TOR signaling; IDA:UniProtKB
Q5VZM2	RRAGB	Ras-related GTP-binding protein B	GO:0005525; F:GTP binding; IDA:HGNC
Q5VZM2	RRAGB	Ras-related GTP-binding protein B	GO:0032561; F:guanyl ribonucleotide binding; IDA:UniProtKB
Q5VZM2	RRAGB	Ras-related GTP-binding protein B	GO:0005515; F:protein binding; IPI:UniProtKB
Q5VZM2	RRAGB	Ras-related GTP-binding protein B	GO:0034613; P:cellular protein localization; IMP:UniProtKB
Q5VZM2	RRAGB	Ras-related GTP-binding protein B	GO:0071230; P:cellular response to amino acid stimulus; IMP:UniProtKB
Q5VZM2	RRAGB	Ras-related GTP-binding protein B	GO:0032008; P:positive regulation of TOR signaling; IMP:UniProtKB
Q7L523	RRAGA	Ras-related GTP-binding protein A	GO:0005525; F:GTP binding; IDA:UniProtKB
Q7L523	RRAGA	Ras-related GTP-binding protein A	GO:0051219; F:phosphoprotein binding; IDA:UniProtKB
Q7L523	RRAGA	Ras-related GTP-binding protein A	GO:0005515; F:protein binding; IPI:UniProtKB
Q7L523	RRAGA	Ras-related GTP-binding protein A	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q7L523	RRAGA	Ras-related GTP-binding protein A	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q7L523	RRAGA	Ras-related GTP-binding protein A	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q7L523	RRAGA	Ras-related GTP-binding protein A	GO:0008219; P:cell death; IDA:UniProtKB
Q7L523	RRAGA	Ras-related GTP-binding protein A	GO:0034613; P:cellular protein localization; IMP:UniProtKB
Q7L523	RRAGA	Ras-related GTP-binding protein A	GO:0071230; P:cellular response to amino acid stimulus; IMP:UniProtKB
Q7L523	RRAGA	Ras-related GTP-binding protein A	GO:0019048; P:modulation by virus of host morphology or physiology; IDA:UniProtKB
Q7L523	RRAGA	Ras-related GTP-binding protein A	GO:0045919; P:positive regulation of cytolysis; IDA:UniProtKB
Q7L523	RRAGA	Ras-related GTP-binding protein A	GO:0032008; P:positive regulation of TOR signaling; NAS:UniProtKB
Q9HB90	RRAGC	Ras-related GTP-binding protein C	GO:0019003; F:GDP binding; IDA:UniProtKB
Q9HB90	RRAGC	Ras-related GTP-binding protein C	GO:0005525; F:GTP binding; IDA:HGNC
Q9HB90	RRAGC	Ras-related GTP-binding protein C	GO:0003924; F:GTPase activity; IDA:UniProtKB
Q9HB90	RRAGC	Ras-related GTP-binding protein C	GO:0000287; F:magnesium ion binding; NAS:UniProtKB
Q9HB90	RRAGC	Ras-related GTP-binding protein C	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HB90	RRAGC	Ras-related GTP-binding protein C	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q9HB90	RRAGC	Ras-related GTP-binding protein C	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q9HB90	RRAGC	Ras-related GTP-binding protein C	GO:0016049; P:cell growth; NAS:UniProtKB
Q9HB90	RRAGC	Ras-related GTP-binding protein C	GO:0034613; P:cellular protein localization; ISS:UniProtKB
Q9HB90	RRAGC	Ras-related GTP-binding protein C	GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB
Q9HB90	RRAGC	Ras-related GTP-binding protein C	GO:0006184; P:GTP catabolic process; IDA:GOC
Q9HB90	RRAGC	Ras-related GTP-binding protein C	GO:0008380; P:RNA splicing; NAS:UniProtKB
Q9HB90	RRAGC	Ras-related GTP-binding protein C	GO:0007264; P:small GTPase mediated signal transduction; TAS:UniProtKB
Q9HB90	RRAGC	Ras-related GTP-binding protein C	GO:0006351; P:transcription, DNA-templated; NAS:UniProtKB
Q9NQL2	RRAGD	Ras-related GTP-binding protein D	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9NQL2	RRAGD	Ras-related GTP-binding protein D	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NQL2	RRAGD	Ras-related GTP-binding protein D	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q9NQL2	RRAGD	Ras-related GTP-binding protein D	GO:0034613; P:cellular protein localization; ISS:UniProtKB
Q9NQL2	RRAGD	Ras-related GTP-binding protein D	GO:0071230; P:cellular response to amino acid stimulus; ISS:UniProtKB
Q9NQL2	RRAGD	Ras-related GTP-binding protein D	GO:0032008; P:positive regulation of TOR signaling; NAS:UniProtKB
P62070	RRAS2	Ras-related protein R-Ras2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P62070	RRAS2	Ras-related protein R-Ras2	GO:0003924; F:GTPase activity; TAS:ProtInc
P62070	RRAS2	Ras-related protein R-Ras2	GO:0005515; F:protein binding; IPI:IntAct
P62070	RRAS2	Ras-related protein R-Ras2	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
P62070	RRAS2	Ras-related protein R-Ras2	GO:0007265; P:Ras protein signal transduction; IEA:Ensembl
P10301	RRAS	Ras-related protein R-Ras	GO:0019003; F:GDP binding; IDA:UniProtKB
P10301	RRAS	Ras-related protein R-Ras	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P10301	RRAS	Ras-related protein R-Ras	GO:0003924; F:GTPase activity; IDA:UniProtKB
P10301	RRAS	Ras-related protein R-Ras	GO:0005515; F:protein binding; IPI:UniProtKB
P10301	RRAS	Ras-related protein R-Ras	GO:0032403; F:protein complex binding; IDA:MGI
P10301	RRAS	Ras-related protein R-Ras	GO:0007411; P:axon guidance; TAS:Reactome
P10301	RRAS	Ras-related protein R-Ras	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
P10301	RRAS	Ras-related protein R-Ras	GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB
P10301	RRAS	Ras-related protein R-Ras	GO:0007265; P:Ras protein signal transduction; TAS:ProtInc
P10301	RRAS	Ras-related protein R-Ras	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9P2E9	RRBP1	Ribosome-binding protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9P2E9	RRBP1	Ribosome-binding protein 1	GO:0004872; F:receptor activity; TAS:ProtInc
Q9P2E9	RRBP1	Ribosome-binding protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9P2E9	RRBP1	Ribosome-binding protein 1	GO:0006412; P:translation; TAS:ProtInc
Q92766	RREB1	Ras-responsive element-binding protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q92766	RREB1	Ras-responsive element-binding protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q92766	RREB1	Ras-responsive element-binding protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q92766	RREB1	Ras-responsive element-binding protein 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q92766	RREB1	Ras-responsive element-binding protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q92766	RREB1	Ras-responsive element-binding protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; TAS:UniProtKB
Q92766	RREB1	Ras-responsive element-binding protein 1	GO:0007265; P:Ras protein signal transduction; TAS:ProtInc
Q92766	RREB1	Ras-responsive element-binding protein 1	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q92766	RREB1	Ras-responsive element-binding protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q96E11	MRRF	Ribosome-recycling factor, mitochondrial	GO:0032790; P:ribosome disassembly; IDA:UniProtKB
Q96E11	MRRF	Ribosome-recycling factor, mitochondrial	GO:0006412; P:translation; IEA:UniProtKB-KW
Q969S9	GFM2	Ribosome-releasing factor 2, mitochondrial	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q969S9	GFM2	Ribosome-releasing factor 2, mitochondrial	GO:0003924; F:GTPase activity; IDA:UniProtKB
Q969S9	GFM2	Ribosome-releasing factor 2, mitochondrial	GO:0006184; P:GTP catabolic process; IDA:GOC
Q969S9	GFM2	Ribosome-releasing factor 2, mitochondrial	GO:0032543; P:mitochondrial translation; IDA:UniProtKB
Q969S9	GFM2	Ribosome-releasing factor 2, mitochondrial	GO:0032790; P:ribosome disassembly; IDA:UniProtKB
Q9UI43	FTSJ2	Putative ribosomal RNA methyltransferase 2	GO:0008650; F:rRNA (uridine-2'-O-)-methyltransferase activity; NAS:BHF-UCL
Q9UI43	FTSJ2	Putative ribosomal RNA methyltransferase 2	GO:0008283; P:cell proliferation; NAS:BHF-UCL
Q9UI43	FTSJ2	Putative ribosomal RNA methyltransferase 2	GO:0031167; P:rRNA methylation; NAS:BHF-UCL
Q9UI43	FTSJ2	Putative ribosomal RNA methyltransferase 2	GO:0006364; P:rRNA processing; NAS:BHF-UCL
Q9NYV6	RRN3	RNA polymerase I-specific transcription initiation factor RRN3	GO:0008283; P:cell proliferation; IEA:Ensembl
Q9NYV6	RRN3	RNA polymerase I-specific transcription initiation factor RRN3	GO:0007028; P:cytoplasm organization; IEA:Ensembl
Q9NYV6	RRN3	RNA polymerase I-specific transcription initiation factor RRN3	GO:0010467; P:gene expression; TAS:Reactome
Q9NYV6	RRN3	RNA polymerase I-specific transcription initiation factor RRN3	GO:0048872; P:homeostasis of number of cells; IEA:Ensembl
Q9NYV6	RRN3	RNA polymerase I-specific transcription initiation factor RRN3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9NYV6	RRN3	RNA polymerase I-specific transcription initiation factor RRN3	GO:1902254; P:negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator; IEA:Ensembl
Q9NYV6	RRN3	RNA polymerase I-specific transcription initiation factor RRN3	GO:0007000; P:nucleolus organization; IEA:Ensembl
Q9NYV6	RRN3	RNA polymerase I-specific transcription initiation factor RRN3	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q9NYV6	RRN3	RNA polymerase I-specific transcription initiation factor RRN3	GO:2000142; P:regulation of DNA-templated transcription, initiation; IEA:Ensembl
Q9NYV6	RRN3	RNA polymerase I-specific transcription initiation factor RRN3	GO:0042254; P:ribosome biogenesis; IEA:Ensembl
Q9NYV6	RRN3	RNA polymerase I-specific transcription initiation factor RRN3	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
Q9NYV6	RRN3	RNA polymerase I-specific transcription initiation factor RRN3	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
Q96FB5	RRNAD1	Protein RRNAD1	GO:0000179; F:rRNA (adenine-N6,N6-)-dimethyltransferase activity; IEA:InterPro
Q5JTH9	RRP12	RRP12-like protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14684	RRP1B	Ribosomal RNA processing protein 1 homolog B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14684	RRP1B	Ribosomal RNA processing protein 1 homolog B	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q14684	RRP1B	Ribosomal RNA processing protein 1 homolog B	GO:0006364; P:rRNA processing; IEA:InterPro
P56182	RRP1	Ribosomal RNA processing protein 1 homolog A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P56182	RRP1	Ribosomal RNA processing protein 1 homolog A	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q96EU6	RRP36	Ribosomal RNA processing protein 36 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96EU6	RRP36	Ribosomal RNA processing protein 36 homolog	GO:0042274; P:ribosomal small subunit biogenesis; IDA:UniProtKB
Q96EU6	RRP36	Ribosomal RNA processing protein 36 homolog	GO:0006364; P:rRNA processing; IDA:UniProtKB
Q9Y2L1	DIS3	Exosome complex exonuclease RRP44	GO:0000175; F:3'-5'-exoribonuclease activity; IMP:UniProtKB
Q9Y2L1	DIS3	Exosome complex exonuclease RRP44	GO:0004519; F:endonuclease activity; IMP:UniProtKB
Q9Y2L1	DIS3	Exosome complex exonuclease RRP44	GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q9Y2L1	DIS3	Exosome complex exonuclease RRP44	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2L1	DIS3	Exosome complex exonuclease RRP44	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9Y2L1	DIS3	Exosome complex exonuclease RRP44	GO:0071034; P:CUT catabolic process; IMP:UniProtKB
Q9Y2L1	DIS3	Exosome complex exonuclease RRP44	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
Q9Y2L1	DIS3	Exosome complex exonuclease RRP44	GO:0010467; P:gene expression; TAS:Reactome
Q9Y2L1	DIS3	Exosome complex exonuclease RRP44	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9Y2L1	DIS3	Exosome complex exonuclease RRP44	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q9Y2L1	DIS3	Exosome complex exonuclease RRP44	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IMP:GOC
Q9Y2L1	DIS3	Exosome complex exonuclease RRP44	GO:0043087; P:regulation of GTPase activity; IDA:GOC
Q9Y2L1	DIS3	Exosome complex exonuclease RRP44	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9Y2L1	DIS3	Exosome complex exonuclease RRP44	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; IMP:GOC
Q9Y2L1	DIS3	Exosome complex exonuclease RRP44	GO:0016075; P:rRNA catabolic process; IMP:UniProtKB
Q9Y2L1	DIS3	Exosome complex exonuclease RRP44	GO:0006364; P:rRNA processing; TAS:UniProtKB
Q14690	PDCD11	Protein RRP5 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14690	PDCD11	Protein RRP5 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q14690	PDCD11	Protein RRP5 homolog	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q14690	PDCD11	Protein RRP5 homolog	GO:0006397; P:mRNA processing; IEA:InterPro
Q14690	PDCD11	Protein RRP5 homolog	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q9Y3A4	RRP7A	Ribosomal RNA-processing protein 7 homolog A	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9Y3A4	RRP7A	Ribosomal RNA-processing protein 7 homolog A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O43159	RRP8	Ribosomal RNA-processing protein 8	GO:0035064; F:methylated histone binding; IDA:UniProtKB
O43159	RRP8	Ribosomal RNA-processing protein 8	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O43159	RRP8	Ribosomal RNA-processing protein 8	GO:0005515; F:protein binding; IPI:IntAct
O43159	RRP8	Ribosomal RNA-processing protein 8	GO:0008757; F:S-adenosylmethionine-dependent methyltransferase activity; TAS:UniProtKB
O43159	RRP8	Ribosomal RNA-processing protein 8	GO:0042149; P:cellular response to glucose starvation; IMP:UniProtKB
O43159	RRP8	Ribosomal RNA-processing protein 8	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
O43159	RRP8	Ribosomal RNA-processing protein 8	GO:0000183; P:chromatin silencing at rDNA; IDA:UniProtKB
O43159	RRP8	Ribosomal RNA-processing protein 8	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IMP:UniProtKB
O43159	RRP8	Ribosomal RNA-processing protein 8	GO:0071158; P:positive regulation of cell cycle arrest; IMP:UniProtKB
O43159	RRP8	Ribosomal RNA-processing protein 8	GO:0046015; P:regulation of transcription by glucose; IMP:UniProtKB
O43159	RRP8	Ribosomal RNA-processing protein 8	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
O43159	RRP8	Ribosomal RNA-processing protein 8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15050	RRS1	Ribosome biogenesis regulatory protein homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15050	RRS1	Ribosome biogenesis regulatory protein homolog	GO:0007080; P:mitotic metaphase plate congression; IMP:UniProtKB
Q15050	RRS1	Ribosome biogenesis regulatory protein homolog	GO:0042254; P:ribosome biogenesis; IEA:UniProtKB-KW
P46783	RPS10	40S ribosomal protein S10	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P46783	RPS10	40S ribosomal protein S10	GO:0005515; F:protein binding; IPI:UniProtKB
P46783	RPS10	40S ribosomal protein S10	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P46783	RPS10	40S ribosomal protein S10	GO:0010467; P:gene expression; TAS:Reactome
P46783	RPS10	40S ribosomal protein S10	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P46783	RPS10	40S ribosomal protein S10	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P46783	RPS10	40S ribosomal protein S10	GO:0016070; P:RNA metabolic process; TAS:Reactome
P46783	RPS10	40S ribosomal protein S10	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P46783	RPS10	40S ribosomal protein S10	GO:0006412; P:translation; IC:UniProtKB
P46783	RPS10	40S ribosomal protein S10	GO:0006414; P:translational elongation; TAS:Reactome
P46783	RPS10	40S ribosomal protein S10	GO:0006413; P:translational initiation; TAS:Reactome
P46783	RPS10	40S ribosomal protein S10	GO:0006415; P:translational termination; TAS:Reactome
P46783	RPS10	40S ribosomal protein S10	GO:0019058; P:viral life cycle; TAS:Reactome
P46783	RPS10	40S ribosomal protein S10	GO:0016032; P:viral process; TAS:Reactome
P46783	RPS10	40S ribosomal protein S10	GO:0019083; P:viral transcription; TAS:Reactome
P62280	RPS11	40S ribosomal protein S11	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62280	RPS11	40S ribosomal protein S11	GO:0019843; F:rRNA binding; IEA:UniProtKB-KW
P62280	RPS11	40S ribosomal protein S11	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P62280	RPS11	40S ribosomal protein S11	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62280	RPS11	40S ribosomal protein S11	GO:0010467; P:gene expression; TAS:Reactome
P62280	RPS11	40S ribosomal protein S11	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62280	RPS11	40S ribosomal protein S11	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62280	RPS11	40S ribosomal protein S11	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62280	RPS11	40S ribosomal protein S11	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62280	RPS11	40S ribosomal protein S11	GO:0006412; P:translation; NAS:UniProtKB
P62280	RPS11	40S ribosomal protein S11	GO:0006414; P:translational elongation; TAS:Reactome
P62280	RPS11	40S ribosomal protein S11	GO:0006413; P:translational initiation; TAS:Reactome
P62280	RPS11	40S ribosomal protein S11	GO:0006415; P:translational termination; TAS:Reactome
P62280	RPS11	40S ribosomal protein S11	GO:0019058; P:viral life cycle; TAS:Reactome
P62280	RPS11	40S ribosomal protein S11	GO:0016032; P:viral process; TAS:Reactome
P62280	RPS11	40S ribosomal protein S11	GO:0019083; P:viral transcription; TAS:Reactome
P25398	RPS12	40S ribosomal protein S12	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P25398	RPS12	40S ribosomal protein S12	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P25398	RPS12	40S ribosomal protein S12	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P25398	RPS12	40S ribosomal protein S12	GO:0010467; P:gene expression; TAS:Reactome
P25398	RPS12	40S ribosomal protein S12	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P25398	RPS12	40S ribosomal protein S12	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P25398	RPS12	40S ribosomal protein S12	GO:0016070; P:RNA metabolic process; TAS:Reactome
P25398	RPS12	40S ribosomal protein S12	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P25398	RPS12	40S ribosomal protein S12	GO:0006412; P:translation; NAS:UniProtKB
P25398	RPS12	40S ribosomal protein S12	GO:0006414; P:translational elongation; TAS:Reactome
P25398	RPS12	40S ribosomal protein S12	GO:0006413; P:translational initiation; TAS:Reactome
P25398	RPS12	40S ribosomal protein S12	GO:0006415; P:translational termination; TAS:Reactome
P25398	RPS12	40S ribosomal protein S12	GO:0019058; P:viral life cycle; TAS:Reactome
P25398	RPS12	40S ribosomal protein S12	GO:0016032; P:viral process; TAS:Reactome
P25398	RPS12	40S ribosomal protein S12	GO:0019083; P:viral transcription; TAS:Reactome
P62277	RPS13	40S ribosomal protein S13	GO:0003729; F:mRNA binding; IDA:UniProtKB
P62277	RPS13	40S ribosomal protein S13	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62277	RPS13	40S ribosomal protein S13	GO:0005515; F:protein binding; IPI:UniProtKB
P62277	RPS13	40S ribosomal protein S13	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P62277	RPS13	40S ribosomal protein S13	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62277	RPS13	40S ribosomal protein S13	GO:0010467; P:gene expression; TAS:Reactome
P62277	RPS13	40S ribosomal protein S13	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62277	RPS13	40S ribosomal protein S13	GO:0033119; P:negative regulation of RNA splicing; IDA:UniProtKB
P62277	RPS13	40S ribosomal protein S13	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62277	RPS13	40S ribosomal protein S13	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62277	RPS13	40S ribosomal protein S13	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62277	RPS13	40S ribosomal protein S13	GO:0006412; P:translation; IC:UniProtKB
P62277	RPS13	40S ribosomal protein S13	GO:0006414; P:translational elongation; TAS:Reactome
P62277	RPS13	40S ribosomal protein S13	GO:0006413; P:translational initiation; TAS:Reactome
P62277	RPS13	40S ribosomal protein S13	GO:0006415; P:translational termination; TAS:Reactome
P62277	RPS13	40S ribosomal protein S13	GO:0019058; P:viral life cycle; TAS:Reactome
P62277	RPS13	40S ribosomal protein S13	GO:0016032; P:viral process; TAS:Reactome
P62277	RPS13	40S ribosomal protein S13	GO:0019083; P:viral transcription; TAS:Reactome
P62263	RPS14	40S ribosomal protein S14	GO:0048027; F:mRNA 5'-UTR binding; IDA:UniProtKB
P62263	RPS14	40S ribosomal protein S14	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62263	RPS14	40S ribosomal protein S14	GO:0003723; F:RNA binding; ISS:UniProtKB
P62263	RPS14	40S ribosomal protein S14	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P62263	RPS14	40S ribosomal protein S14	GO:0045182; F:translation regulator activity; IMP:UniProtKB
P62263	RPS14	40S ribosomal protein S14	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62263	RPS14	40S ribosomal protein S14	GO:0030218; P:erythrocyte differentiation; IMP:UniProtKB
P62263	RPS14	40S ribosomal protein S14	GO:0010467; P:gene expression; TAS:Reactome
P62263	RPS14	40S ribosomal protein S14	GO:0030490; P:maturation of SSU-rRNA; ISS:UniProtKB
P62263	RPS14	40S ribosomal protein S14	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62263	RPS14	40S ribosomal protein S14	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P62263	RPS14	40S ribosomal protein S14	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62263	RPS14	40S ribosomal protein S14	GO:0006417; P:regulation of translation; IMP:GOC
P62263	RPS14	40S ribosomal protein S14	GO:0000028; P:ribosomal small subunit assembly; IMP:UniProtKB
P62263	RPS14	40S ribosomal protein S14	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62263	RPS14	40S ribosomal protein S14	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62263	RPS14	40S ribosomal protein S14	GO:0006412; P:translation; IMP:UniProtKB
P62263	RPS14	40S ribosomal protein S14	GO:0006414; P:translational elongation; TAS:Reactome
P62263	RPS14	40S ribosomal protein S14	GO:0006413; P:translational initiation; TAS:Reactome
P62263	RPS14	40S ribosomal protein S14	GO:0006415; P:translational termination; TAS:Reactome
P62263	RPS14	40S ribosomal protein S14	GO:0019058; P:viral life cycle; TAS:Reactome
P62263	RPS14	40S ribosomal protein S14	GO:0016032; P:viral process; TAS:Reactome
P62263	RPS14	40S ribosomal protein S14	GO:0019083; P:viral transcription; TAS:Reactome
P62244	RPS15A	40S ribosomal protein S15a	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62244	RPS15A	40S ribosomal protein S15a	GO:0003723; F:RNA binding; NAS:UniProtKB
P62244	RPS15A	40S ribosomal protein S15a	GO:0003735; F:structural constituent of ribosome; IDA:UniProtKB
P62244	RPS15A	40S ribosomal protein S15a	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62244	RPS15A	40S ribosomal protein S15a	GO:0010467; P:gene expression; TAS:Reactome
P62244	RPS15A	40S ribosomal protein S15a	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62244	RPS15A	40S ribosomal protein S15a	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62244	RPS15A	40S ribosomal protein S15a	GO:0045787; P:positive regulation of cell cycle; IDA:UniProtKB
P62244	RPS15A	40S ribosomal protein S15a	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P62244	RPS15A	40S ribosomal protein S15a	GO:0009615; P:response to virus; IDA:UniProtKB
P62244	RPS15A	40S ribosomal protein S15a	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62244	RPS15A	40S ribosomal protein S15a	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62244	RPS15A	40S ribosomal protein S15a	GO:0006412; P:translation; NAS:UniProtKB
P62244	RPS15A	40S ribosomal protein S15a	GO:0006414; P:translational elongation; TAS:Reactome
P62244	RPS15A	40S ribosomal protein S15a	GO:0006413; P:translational initiation; TAS:Reactome
P62244	RPS15A	40S ribosomal protein S15a	GO:0006415; P:translational termination; TAS:Reactome
P62244	RPS15A	40S ribosomal protein S15a	GO:0019058; P:viral life cycle; TAS:Reactome
P62244	RPS15A	40S ribosomal protein S15a	GO:0016032; P:viral process; TAS:Reactome
P62244	RPS15A	40S ribosomal protein S15a	GO:0019083; P:viral transcription; TAS:Reactome
P62841	RPS15	40S ribosomal protein S15	GO:0003677; F:DNA binding; NAS:UniProtKB
P62841	RPS15	40S ribosomal protein S15	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62841	RPS15	40S ribosomal protein S15	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P62841	RPS15	40S ribosomal protein S15	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62841	RPS15	40S ribosomal protein S15	GO:0010467; P:gene expression; TAS:Reactome
P62841	RPS15	40S ribosomal protein S15	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62841	RPS15	40S ribosomal protein S15	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62841	RPS15	40S ribosomal protein S15	GO:0042274; P:ribosomal small subunit biogenesis; IMP:UniProtKB
P62841	RPS15	40S ribosomal protein S15	GO:0000056; P:ribosomal small subunit export from nucleus; IMP:UniProtKB
P62841	RPS15	40S ribosomal protein S15	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62841	RPS15	40S ribosomal protein S15	GO:0006364; P:rRNA processing; IMP:UniProtKB
P62841	RPS15	40S ribosomal protein S15	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62841	RPS15	40S ribosomal protein S15	GO:0006412; P:translation; IC:UniProtKB
P62841	RPS15	40S ribosomal protein S15	GO:0006414; P:translational elongation; TAS:Reactome
P62841	RPS15	40S ribosomal protein S15	GO:0006413; P:translational initiation; TAS:Reactome
P62841	RPS15	40S ribosomal protein S15	GO:0006415; P:translational termination; TAS:Reactome
P62841	RPS15	40S ribosomal protein S15	GO:0019058; P:viral life cycle; TAS:Reactome
P62841	RPS15	40S ribosomal protein S15	GO:0016032; P:viral process; TAS:Reactome
P62841	RPS15	40S ribosomal protein S15	GO:0019083; P:viral transcription; TAS:Reactome
P62249	RPS16	40S ribosomal protein S16	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62249	RPS16	40S ribosomal protein S16	GO:0003723; F:RNA binding; IDA:UniProtKB
P62249	RPS16	40S ribosomal protein S16	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P62249	RPS16	40S ribosomal protein S16	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62249	RPS16	40S ribosomal protein S16	GO:0010467; P:gene expression; TAS:Reactome
P62249	RPS16	40S ribosomal protein S16	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62249	RPS16	40S ribosomal protein S16	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62249	RPS16	40S ribosomal protein S16	GO:0042274; P:ribosomal small subunit biogenesis; IMP:UniProtKB
P62249	RPS16	40S ribosomal protein S16	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62249	RPS16	40S ribosomal protein S16	GO:0006364; P:rRNA processing; IMP:UniProtKB
P62249	RPS16	40S ribosomal protein S16	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62249	RPS16	40S ribosomal protein S16	GO:0006412; P:translation; NAS:UniProtKB
P62249	RPS16	40S ribosomal protein S16	GO:0006414; P:translational elongation; TAS:Reactome
P62249	RPS16	40S ribosomal protein S16	GO:0006413; P:translational initiation; TAS:Reactome
P62249	RPS16	40S ribosomal protein S16	GO:0006415; P:translational termination; TAS:Reactome
P62249	RPS16	40S ribosomal protein S16	GO:0019058; P:viral life cycle; TAS:Reactome
P62249	RPS16	40S ribosomal protein S16	GO:0016032; P:viral process; TAS:Reactome
P62249	RPS16	40S ribosomal protein S16	GO:0019083; P:viral transcription; TAS:Reactome
P0CW22	RPS17L	40S ribosomal protein S17-like	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P0CW22	RPS17L	40S ribosomal protein S17-like	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P0CW22	RPS17L	40S ribosomal protein S17-like	GO:0006412; P:translation; IEA:InterPro
P08708	RPS17	40S ribosomal protein S17	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P08708	RPS17	40S ribosomal protein S17	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P08708	RPS17	40S ribosomal protein S17	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P08708	RPS17	40S ribosomal protein S17	GO:0034101; P:erythrocyte homeostasis; IMP:UniProtKB
P08708	RPS17	40S ribosomal protein S17	GO:0010467; P:gene expression; TAS:Reactome
P08708	RPS17	40S ribosomal protein S17	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P08708	RPS17	40S ribosomal protein S17	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P08708	RPS17	40S ribosomal protein S17	GO:0000028; P:ribosomal small subunit assembly; IBA:RefGenome
P08708	RPS17	40S ribosomal protein S17	GO:0042274; P:ribosomal small subunit biogenesis; IMP:UniProtKB
P08708	RPS17	40S ribosomal protein S17	GO:0016070; P:RNA metabolic process; TAS:Reactome
P08708	RPS17	40S ribosomal protein S17	GO:0006364; P:rRNA processing; IMP:UniProtKB
P08708	RPS17	40S ribosomal protein S17	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P08708	RPS17	40S ribosomal protein S17	GO:0006412; P:translation; IC:UniProtKB
P08708	RPS17	40S ribosomal protein S17	GO:0006414; P:translational elongation; IBA:RefGenome
P08708	RPS17	40S ribosomal protein S17	GO:0006413; P:translational initiation; NAS:UniProtKB
P08708	RPS17	40S ribosomal protein S17	GO:0006415; P:translational termination; TAS:Reactome
P08708	RPS17	40S ribosomal protein S17	GO:0019058; P:viral life cycle; TAS:Reactome
P08708	RPS17	40S ribosomal protein S17	GO:0016032; P:viral process; TAS:Reactome
P08708	RPS17	40S ribosomal protein S17	GO:0019083; P:viral transcription; TAS:Reactome
P62269	RPS18	40S ribosomal protein S18	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62269	RPS18	40S ribosomal protein S18	GO:0005515; F:protein binding; IPI:UniProt
P62269	RPS18	40S ribosomal protein S18	GO:0019843; F:rRNA binding; IEA:UniProtKB-KW
P62269	RPS18	40S ribosomal protein S18	GO:0003735; F:structural constituent of ribosome; IBA:RefGenome
P62269	RPS18	40S ribosomal protein S18	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62269	RPS18	40S ribosomal protein S18	GO:0010467; P:gene expression; TAS:Reactome
P62269	RPS18	40S ribosomal protein S18	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62269	RPS18	40S ribosomal protein S18	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62269	RPS18	40S ribosomal protein S18	GO:0042254; P:ribosome biogenesis; IBA:RefGenome
P62269	RPS18	40S ribosomal protein S18	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62269	RPS18	40S ribosomal protein S18	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62269	RPS18	40S ribosomal protein S18	GO:0006412; P:translation; IC:UniProtKB
P62269	RPS18	40S ribosomal protein S18	GO:0006414; P:translational elongation; TAS:Reactome
P62269	RPS18	40S ribosomal protein S18	GO:0006413; P:translational initiation; TAS:Reactome
P62269	RPS18	40S ribosomal protein S18	GO:0006415; P:translational termination; TAS:Reactome
P62269	RPS18	40S ribosomal protein S18	GO:0019058; P:viral life cycle; TAS:Reactome
P62269	RPS18	40S ribosomal protein S18	GO:0016032; P:viral process; TAS:Reactome
P62269	RPS18	40S ribosomal protein S18	GO:0019083; P:viral transcription; TAS:Reactome
P39019	RPS19	40S ribosomal protein S19	GO:0017134; F:fibroblast growth factor binding; IPI:BHF-UCL
P39019	RPS19	40S ribosomal protein S19	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P39019	RPS19	40S ribosomal protein S19	GO:0005515; F:protein binding; IPI:IntAct
P39019	RPS19	40S ribosomal protein S19	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P39019	RPS19	40S ribosomal protein S19	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P39019	RPS19	40S ribosomal protein S19	GO:0003735; F:structural constituent of ribosome; IDA:UniProtKB
P39019	RPS19	40S ribosomal protein S19	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P39019	RPS19	40S ribosomal protein S19	GO:0030218; P:erythrocyte differentiation; IMP:HGNC
P39019	RPS19	40S ribosomal protein S19	GO:0010467; P:gene expression; TAS:Reactome
P39019	RPS19	40S ribosomal protein S19	GO:0030490; P:maturation of SSU-rRNA; IMP:UniProtKB
P39019	RPS19	40S ribosomal protein S19	GO:0000462; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IMP:UniProtKB
P39019	RPS19	40S ribosomal protein S19	GO:0002548; P:monocyte chemotaxis; IDA:UniProtKB
P39019	RPS19	40S ribosomal protein S19	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P39019	RPS19	40S ribosomal protein S19	GO:0060266; P:negative regulation of respiratory burst involved in inflammatory response; IDA:UniProtKB
P39019	RPS19	40S ribosomal protein S19	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P39019	RPS19	40S ribosomal protein S19	GO:0007000; P:nucleolus organization; IMP:UniProtKB
P39019	RPS19	40S ribosomal protein S19	GO:0051272; P:positive regulation of cellular component movement; TAS:HGNC
P39019	RPS19	40S ribosomal protein S19	GO:0060265; P:positive regulation of respiratory burst involved in inflammatory response; IDA:UniProtKB
P39019	RPS19	40S ribosomal protein S19	GO:0051262; P:protein tetramerization; IDA:UniProtKB
P39019	RPS19	40S ribosomal protein S19	GO:0009991; P:response to extracellular stimulus; TAS:HGNC
P39019	RPS19	40S ribosomal protein S19	GO:0000028; P:ribosomal small subunit assembly; IMP:UniProtKB
P39019	RPS19	40S ribosomal protein S19	GO:0042274; P:ribosomal small subunit biogenesis; IMP:UniProtKB
P39019	RPS19	40S ribosomal protein S19	GO:0016070; P:RNA metabolic process; TAS:Reactome
P39019	RPS19	40S ribosomal protein S19	GO:0006364; P:rRNA processing; IMP:UniProtKB
P39019	RPS19	40S ribosomal protein S19	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P39019	RPS19	40S ribosomal protein S19	GO:0006412; P:translation; IC:UniProtKB
P39019	RPS19	40S ribosomal protein S19	GO:0006414; P:translational elongation; TAS:Reactome
P39019	RPS19	40S ribosomal protein S19	GO:0006413; P:translational initiation; TAS:Reactome
P39019	RPS19	40S ribosomal protein S19	GO:0006415; P:translational termination; TAS:Reactome
P39019	RPS19	40S ribosomal protein S19	GO:0019058; P:viral life cycle; TAS:Reactome
P39019	RPS19	40S ribosomal protein S19	GO:0016032; P:viral process; TAS:Reactome
P39019	RPS19	40S ribosomal protein S19	GO:0019083; P:viral transcription; TAS:Reactome
P60866	RPS20	40S ribosomal protein S20	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P60866	RPS20	40S ribosomal protein S20	GO:0005515; F:protein binding; IPI:IntAct
P60866	RPS20	40S ribosomal protein S20	GO:0003723; F:RNA binding; NAS:UniProtKB
P60866	RPS20	40S ribosomal protein S20	GO:0003735; F:structural constituent of ribosome; IDA:UniProtKB
P60866	RPS20	40S ribosomal protein S20	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P60866	RPS20	40S ribosomal protein S20	GO:0010467; P:gene expression; TAS:Reactome
P60866	RPS20	40S ribosomal protein S20	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P60866	RPS20	40S ribosomal protein S20	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P60866	RPS20	40S ribosomal protein S20	GO:0016070; P:RNA metabolic process; TAS:Reactome
P60866	RPS20	40S ribosomal protein S20	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P60866	RPS20	40S ribosomal protein S20	GO:0006412; P:translation; NAS:UniProtKB
P60866	RPS20	40S ribosomal protein S20	GO:0006414; P:translational elongation; TAS:Reactome
P60866	RPS20	40S ribosomal protein S20	GO:0006413; P:translational initiation; TAS:Reactome
P60866	RPS20	40S ribosomal protein S20	GO:0006415; P:translational termination; TAS:Reactome
P60866	RPS20	40S ribosomal protein S20	GO:0019058; P:viral life cycle; TAS:Reactome
P60866	RPS20	40S ribosomal protein S20	GO:0016032; P:viral process; TAS:Reactome
P60866	RPS20	40S ribosomal protein S20	GO:0019083; P:viral transcription; TAS:Reactome
P63220	RPS21	40S ribosomal protein S21	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P63220	RPS21	40S ribosomal protein S21	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
P63220	RPS21	40S ribosomal protein S21	GO:0003735; F:structural constituent of ribosome; IBA:RefGenome
P63220	RPS21	40S ribosomal protein S21	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P63220	RPS21	40S ribosomal protein S21	GO:0000447; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IBA:RefGenome
P63220	RPS21	40S ribosomal protein S21	GO:0000461; P:endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IBA:RefGenome
P63220	RPS21	40S ribosomal protein S21	GO:0010467; P:gene expression; TAS:Reactome
P63220	RPS21	40S ribosomal protein S21	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P63220	RPS21	40S ribosomal protein S21	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P63220	RPS21	40S ribosomal protein S21	GO:0042274; P:ribosomal small subunit biogenesis; IBA:RefGenome
P63220	RPS21	40S ribosomal protein S21	GO:0016070; P:RNA metabolic process; TAS:Reactome
P63220	RPS21	40S ribosomal protein S21	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P63220	RPS21	40S ribosomal protein S21	GO:0006412; P:translation; NAS:UniProtKB
P63220	RPS21	40S ribosomal protein S21	GO:0006414; P:translational elongation; TAS:Reactome
P63220	RPS21	40S ribosomal protein S21	GO:0006413; P:translational initiation; TAS:Reactome
P63220	RPS21	40S ribosomal protein S21	GO:0006415; P:translational termination; TAS:Reactome
P63220	RPS21	40S ribosomal protein S21	GO:0019058; P:viral life cycle; TAS:Reactome
P63220	RPS21	40S ribosomal protein S21	GO:0016032; P:viral process; TAS:Reactome
P63220	RPS21	40S ribosomal protein S21	GO:0019083; P:viral transcription; TAS:Reactome
P62266	RPS23	40S ribosomal protein S23	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62266	RPS23	40S ribosomal protein S23	GO:0005515; F:protein binding; IPI:IntAct
P62266	RPS23	40S ribosomal protein S23	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P62266	RPS23	40S ribosomal protein S23	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62266	RPS23	40S ribosomal protein S23	GO:0010467; P:gene expression; TAS:Reactome
P62266	RPS23	40S ribosomal protein S23	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62266	RPS23	40S ribosomal protein S23	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62266	RPS23	40S ribosomal protein S23	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62266	RPS23	40S ribosomal protein S23	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62266	RPS23	40S ribosomal protein S23	GO:0006412; P:translation; IC:UniProtKB
P62266	RPS23	40S ribosomal protein S23	GO:0006414; P:translational elongation; TAS:Reactome
P62266	RPS23	40S ribosomal protein S23	GO:0006413; P:translational initiation; TAS:Reactome
P62266	RPS23	40S ribosomal protein S23	GO:0006415; P:translational termination; TAS:Reactome
P62266	RPS23	40S ribosomal protein S23	GO:0019058; P:viral life cycle; TAS:Reactome
P62266	RPS23	40S ribosomal protein S23	GO:0016032; P:viral process; TAS:Reactome
P62266	RPS23	40S ribosomal protein S23	GO:0019083; P:viral transcription; TAS:Reactome
P62847	RPS24	40S ribosomal protein S24	GO:0000166; F:nucleotide binding; IEA:InterPro
P62847	RPS24	40S ribosomal protein S24	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62847	RPS24	40S ribosomal protein S24	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P62847	RPS24	40S ribosomal protein S24	GO:0031369; F:translation initiation factor binding; ISS:UniProtKB
P62847	RPS24	40S ribosomal protein S24	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62847	RPS24	40S ribosomal protein S24	GO:0034101; P:erythrocyte homeostasis; IMP:UniProtKB
P62847	RPS24	40S ribosomal protein S24	GO:0010467; P:gene expression; TAS:Reactome
P62847	RPS24	40S ribosomal protein S24	GO:0000462; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IBA:RefGenome
P62847	RPS24	40S ribosomal protein S24	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62847	RPS24	40S ribosomal protein S24	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62847	RPS24	40S ribosomal protein S24	GO:0042274; P:ribosomal small subunit biogenesis; IMP:UniProtKB
P62847	RPS24	40S ribosomal protein S24	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62847	RPS24	40S ribosomal protein S24	GO:0006364; P:rRNA processing; IMP:UniProtKB
P62847	RPS24	40S ribosomal protein S24	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62847	RPS24	40S ribosomal protein S24	GO:0006412; P:translation; IC:UniProtKB
P62847	RPS24	40S ribosomal protein S24	GO:0006414; P:translational elongation; TAS:Reactome
P62847	RPS24	40S ribosomal protein S24	GO:0006413; P:translational initiation; TAS:Reactome
P62847	RPS24	40S ribosomal protein S24	GO:0006415; P:translational termination; TAS:Reactome
P62847	RPS24	40S ribosomal protein S24	GO:0019058; P:viral life cycle; TAS:Reactome
P62847	RPS24	40S ribosomal protein S24	GO:0016032; P:viral process; TAS:Reactome
P62847	RPS24	40S ribosomal protein S24	GO:0019083; P:viral transcription; TAS:Reactome
P62851	RPS25	40S ribosomal protein S25	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62851	RPS25	40S ribosomal protein S25	GO:0005515; F:protein binding; IPI:UniProt
P62851	RPS25	40S ribosomal protein S25	GO:0003723; F:RNA binding; NAS:UniProtKB
P62851	RPS25	40S ribosomal protein S25	GO:0003735; F:structural constituent of ribosome; IEA:Ensembl
P62851	RPS25	40S ribosomal protein S25	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62851	RPS25	40S ribosomal protein S25	GO:0010467; P:gene expression; TAS:Reactome
P62851	RPS25	40S ribosomal protein S25	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62851	RPS25	40S ribosomal protein S25	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62851	RPS25	40S ribosomal protein S25	GO:0000028; P:ribosomal small subunit assembly; IEA:Ensembl
P62851	RPS25	40S ribosomal protein S25	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62851	RPS25	40S ribosomal protein S25	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62851	RPS25	40S ribosomal protein S25	GO:0006412; P:translation; NAS:UniProtKB
P62851	RPS25	40S ribosomal protein S25	GO:0006414; P:translational elongation; TAS:Reactome
P62851	RPS25	40S ribosomal protein S25	GO:0006413; P:translational initiation; TAS:Reactome
P62851	RPS25	40S ribosomal protein S25	GO:0006415; P:translational termination; TAS:Reactome
P62851	RPS25	40S ribosomal protein S25	GO:0019058; P:viral life cycle; TAS:Reactome
P62851	RPS25	40S ribosomal protein S25	GO:0016032; P:viral process; TAS:Reactome
P62851	RPS25	40S ribosomal protein S25	GO:0019083; P:viral transcription; TAS:Reactome
Q5JNZ5	RPS26P11	Putative 40S ribosomal protein S26-like 1	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q5JNZ5	RPS26P11	Putative 40S ribosomal protein S26-like 1	GO:0006412; P:translation; IEA:InterPro
P62854	RPS26	40S ribosomal protein S26	GO:0003729; F:mRNA binding; IDA:UniProtKB
P62854	RPS26	40S ribosomal protein S26	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62854	RPS26	40S ribosomal protein S26	GO:0005515; F:protein binding; IPI:IntAct
P62854	RPS26	40S ribosomal protein S26	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P62854	RPS26	40S ribosomal protein S26	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62854	RPS26	40S ribosomal protein S26	GO:0010467; P:gene expression; TAS:Reactome
P62854	RPS26	40S ribosomal protein S26	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62854	RPS26	40S ribosomal protein S26	GO:0033119; P:negative regulation of RNA splicing; IDA:UniProtKB
P62854	RPS26	40S ribosomal protein S26	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62854	RPS26	40S ribosomal protein S26	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62854	RPS26	40S ribosomal protein S26	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62854	RPS26	40S ribosomal protein S26	GO:0006412; P:translation; IC:UniProtKB
P62854	RPS26	40S ribosomal protein S26	GO:0006414; P:translational elongation; TAS:Reactome
P62854	RPS26	40S ribosomal protein S26	GO:0006413; P:translational initiation; TAS:Reactome
P62854	RPS26	40S ribosomal protein S26	GO:0006415; P:translational termination; TAS:Reactome
P62854	RPS26	40S ribosomal protein S26	GO:0019058; P:viral life cycle; TAS:Reactome
P62854	RPS26	40S ribosomal protein S26	GO:0016032; P:viral process; TAS:Reactome
P62854	RPS26	40S ribosomal protein S26	GO:0019083; P:viral transcription; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0003735; F:structural constituent of ribosome; IDA:UniProtKB
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0000187; P:activation of MAPK activity; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0006915; P:apoptotic process; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0006281; P:DNA repair; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0016197; P:endosomal transport; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0010467; P:gene expression; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0006006; P:glucose metabolic process; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0005978; P:glycogen biosynthetic process; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0045087; P:innate immune response; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0075733; P:intracellular transport of virus; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0007254; P:JNK cascade; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0061024; P:membrane organization; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0007220; P:Notch receptor processing; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0032479; P:regulation of type I interferon production; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0006412; P:translation; IC:UniProtKB
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0006414; P:translational elongation; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0006413; P:translational initiation; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0006415; P:translational termination; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0055085; P:transmembrane transport; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0019058; P:viral life cycle; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0016032; P:viral process; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0019082; P:viral protein processing; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0019083; P:viral transcription; TAS:Reactome
P62979	RPS27A	Ubiquitin-40S ribosomal protein S27a	GO:0019068; P:virion assembly; TAS:Reactome
Q71UM5	RPS27L	40S ribosomal protein S27-like	GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; IDA:UniProtKB
Q71UM5	RPS27L	40S ribosomal protein S27-like	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q71UM5	RPS27L	40S ribosomal protein S27-like	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q71UM5	RPS27L	40S ribosomal protein S27-like	GO:0005515; F:protein binding; IPI:IntAct
Q71UM5	RPS27L	40S ribosomal protein S27-like	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q71UM5	RPS27L	40S ribosomal protein S27-like	GO:0008494; F:translation activator activity; IDA:UniProtKB
Q71UM5	RPS27L	40S ribosomal protein S27-like	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:GOC
Q71UM5	RPS27L	40S ribosomal protein S27-like	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q71UM5	RPS27L	40S ribosomal protein S27-like	GO:0006281; P:DNA repair; IMP:UniProtKB
Q71UM5	RPS27L	40S ribosomal protein S27-like	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IDA:UniProtKB
Q71UM5	RPS27L	40S ribosomal protein S27-like	GO:0031571; P:mitotic G1 DNA damage checkpoint; IMP:UniProtKB
Q71UM5	RPS27L	40S ribosomal protein S27-like	GO:0045727; P:positive regulation of translation; IDA:GOC
Q71UM5	RPS27L	40S ribosomal protein S27-like	GO:0006412; P:translation; IDA:UniProtKB
P42677	RPS27	40S ribosomal protein S27	GO:0003677; F:DNA binding; NAS:UniProtKB
P42677	RPS27	40S ribosomal protein S27	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P42677	RPS27	40S ribosomal protein S27	GO:0005515; F:protein binding; IPI:IntAct
P42677	RPS27	40S ribosomal protein S27	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P42677	RPS27	40S ribosomal protein S27	GO:0008270; F:zinc ion binding; NAS:UniProtKB
P42677	RPS27	40S ribosomal protein S27	GO:0008283; P:cell proliferation; NAS:UniProtKB
P42677	RPS27	40S ribosomal protein S27	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P42677	RPS27	40S ribosomal protein S27	GO:0010467; P:gene expression; TAS:Reactome
P42677	RPS27	40S ribosomal protein S27	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P42677	RPS27	40S ribosomal protein S27	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P42677	RPS27	40S ribosomal protein S27	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P42677	RPS27	40S ribosomal protein S27	GO:0016070; P:RNA metabolic process; TAS:Reactome
P42677	RPS27	40S ribosomal protein S27	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P42677	RPS27	40S ribosomal protein S27	GO:0006412; P:translation; NAS:UniProtKB
P42677	RPS27	40S ribosomal protein S27	GO:0006414; P:translational elongation; TAS:Reactome
P42677	RPS27	40S ribosomal protein S27	GO:0006413; P:translational initiation; TAS:Reactome
P42677	RPS27	40S ribosomal protein S27	GO:0006415; P:translational termination; TAS:Reactome
P42677	RPS27	40S ribosomal protein S27	GO:0019058; P:viral life cycle; TAS:Reactome
P42677	RPS27	40S ribosomal protein S27	GO:0016032; P:viral process; TAS:Reactome
P42677	RPS27	40S ribosomal protein S27	GO:0019083; P:viral transcription; TAS:Reactome
P62857	RPS28	40S ribosomal protein S28	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62857	RPS28	40S ribosomal protein S28	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P62857	RPS28	40S ribosomal protein S28	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62857	RPS28	40S ribosomal protein S28	GO:0010467; P:gene expression; TAS:Reactome
P62857	RPS28	40S ribosomal protein S28	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62857	RPS28	40S ribosomal protein S28	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62857	RPS28	40S ribosomal protein S28	GO:0042274; P:ribosomal small subunit biogenesis; IMP:UniProtKB
P62857	RPS28	40S ribosomal protein S28	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62857	RPS28	40S ribosomal protein S28	GO:0006364; P:rRNA processing; IMP:UniProtKB
P62857	RPS28	40S ribosomal protein S28	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62857	RPS28	40S ribosomal protein S28	GO:0006412; P:translation; IC:UniProtKB
P62857	RPS28	40S ribosomal protein S28	GO:0006414; P:translational elongation; TAS:Reactome
P62857	RPS28	40S ribosomal protein S28	GO:0006413; P:translational initiation; TAS:Reactome
P62857	RPS28	40S ribosomal protein S28	GO:0006415; P:translational termination; TAS:Reactome
P62857	RPS28	40S ribosomal protein S28	GO:0019058; P:viral life cycle; TAS:Reactome
P62857	RPS28	40S ribosomal protein S28	GO:0016032; P:viral process; TAS:Reactome
P62857	RPS28	40S ribosomal protein S28	GO:0019083; P:viral transcription; TAS:Reactome
P62273	RPS29	40S ribosomal protein S29	GO:0003735; F:structural constituent of ribosome; IDA:UniProtKB
P62273	RPS29	40S ribosomal protein S29	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P62273	RPS29	40S ribosomal protein S29	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62273	RPS29	40S ribosomal protein S29	GO:0010467; P:gene expression; TAS:Reactome
P62273	RPS29	40S ribosomal protein S29	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62273	RPS29	40S ribosomal protein S29	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62273	RPS29	40S ribosomal protein S29	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62273	RPS29	40S ribosomal protein S29	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62273	RPS29	40S ribosomal protein S29	GO:0006412; P:translation; IC:UniProtKB
P62273	RPS29	40S ribosomal protein S29	GO:0006414; P:translational elongation; TAS:Reactome
P62273	RPS29	40S ribosomal protein S29	GO:0006413; P:translational initiation; TAS:Reactome
P62273	RPS29	40S ribosomal protein S29	GO:0006415; P:translational termination; TAS:Reactome
P62273	RPS29	40S ribosomal protein S29	GO:0019058; P:viral life cycle; TAS:Reactome
P62273	RPS29	40S ribosomal protein S29	GO:0016032; P:viral process; TAS:Reactome
P62273	RPS29	40S ribosomal protein S29	GO:0019083; P:viral transcription; TAS:Reactome
P15880	RPS2	40S ribosomal protein S2	GO:0019899; F:enzyme binding; IPI:UniProtKB
P15880	RPS2	40S ribosomal protein S2	GO:0017134; F:fibroblast growth factor binding; IPI:UniProtKB
P15880	RPS2	40S ribosomal protein S2	GO:0003729; F:mRNA binding; IDA:UniProtKB
P15880	RPS2	40S ribosomal protein S2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P15880	RPS2	40S ribosomal protein S2	GO:0005515; F:protein binding; IPI:UniProtKB
P15880	RPS2	40S ribosomal protein S2	GO:0003735; F:structural constituent of ribosome; IDA:UniProtKB
P15880	RPS2	40S ribosomal protein S2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P15880	RPS2	40S ribosomal protein S2	GO:0010467; P:gene expression; TAS:Reactome
P15880	RPS2	40S ribosomal protein S2	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P15880	RPS2	40S ribosomal protein S2	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P15880	RPS2	40S ribosomal protein S2	GO:0051347; P:positive regulation of transferase activity; IDA:UniProtKB
P15880	RPS2	40S ribosomal protein S2	GO:0016070; P:RNA metabolic process; TAS:Reactome
P15880	RPS2	40S ribosomal protein S2	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P15880	RPS2	40S ribosomal protein S2	GO:0006412; P:translation; IC:UniProtKB
P15880	RPS2	40S ribosomal protein S2	GO:0006414; P:translational elongation; TAS:Reactome
P15880	RPS2	40S ribosomal protein S2	GO:0006413; P:translational initiation; TAS:Reactome
P15880	RPS2	40S ribosomal protein S2	GO:0006415; P:translational termination; TAS:Reactome
P15880	RPS2	40S ribosomal protein S2	GO:0019058; P:viral life cycle; TAS:Reactome
P15880	RPS2	40S ribosomal protein S2	GO:0016032; P:viral process; TAS:Reactome
P15880	RPS2	40S ribosomal protein S2	GO:0019083; P:viral transcription; TAS:Reactome
P62861	FAU	40S ribosomal protein S30	GO:0003723; F:RNA binding; TAS:ProtInc
P62861	FAU	40S ribosomal protein S30	GO:0003735; F:structural constituent of ribosome; IDA:UniProtKB
P62861	FAU	40S ribosomal protein S30	GO:0019731; P:antibacterial humoral response; IDA:UniProt
P62861	FAU	40S ribosomal protein S30	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62861	FAU	40S ribosomal protein S30	GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProt
P62861	FAU	40S ribosomal protein S30	GO:0010467; P:gene expression; TAS:Reactome
P62861	FAU	40S ribosomal protein S30	GO:0002227; P:innate immune response in mucosa; IDA:UniProt
P62861	FAU	40S ribosomal protein S30	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62861	FAU	40S ribosomal protein S30	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62861	FAU	40S ribosomal protein S30	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62861	FAU	40S ribosomal protein S30	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62861	FAU	40S ribosomal protein S30	GO:0006412; P:translation; IC:UniProtKB
P62861	FAU	40S ribosomal protein S30	GO:0006414; P:translational elongation; TAS:Reactome
P62861	FAU	40S ribosomal protein S30	GO:0006413; P:translational initiation; TAS:Reactome
P62861	FAU	40S ribosomal protein S30	GO:0006415; P:translational termination; TAS:Reactome
P62861	FAU	40S ribosomal protein S30	GO:0019058; P:viral life cycle; TAS:Reactome
P62861	FAU	40S ribosomal protein S30	GO:0016032; P:viral process; TAS:Reactome
P62861	FAU	40S ribosomal protein S30	GO:0019083; P:viral transcription; TAS:Reactome
P61247	RPS3A	40S ribosomal protein S3a	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P61247	RPS3A	40S ribosomal protein S3a	GO:0005515; F:protein binding; IPI:UniProtKB
P61247	RPS3A	40S ribosomal protein S3a	GO:0003723; F:RNA binding; NAS:UniProtKB
P61247	RPS3A	40S ribosomal protein S3a	GO:0003735; F:structural constituent of ribosome; IBA:RefGenome
P61247	RPS3A	40S ribosomal protein S3a	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P61247	RPS3A	40S ribosomal protein S3a	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P61247	RPS3A	40S ribosomal protein S3a	GO:0002181; P:cytoplasmic translation; IBA:RefGenome
P61247	RPS3A	40S ribosomal protein S3a	GO:0010467; P:gene expression; TAS:Reactome
P61247	RPS3A	40S ribosomal protein S3a	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P61247	RPS3A	40S ribosomal protein S3a	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P61247	RPS3A	40S ribosomal protein S3a	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P61247	RPS3A	40S ribosomal protein S3a	GO:0016070; P:RNA metabolic process; TAS:Reactome
P61247	RPS3A	40S ribosomal protein S3a	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P61247	RPS3A	40S ribosomal protein S3a	GO:0006412; P:translation; IMP:UniProtKB
P61247	RPS3A	40S ribosomal protein S3a	GO:0006414; P:translational elongation; TAS:Reactome
P61247	RPS3A	40S ribosomal protein S3a	GO:0006413; P:translational initiation; TAS:UniProtKB
P61247	RPS3A	40S ribosomal protein S3a	GO:0006415; P:translational termination; TAS:Reactome
P61247	RPS3A	40S ribosomal protein S3a	GO:0019058; P:viral life cycle; TAS:Reactome
P61247	RPS3A	40S ribosomal protein S3a	GO:0016032; P:viral process; TAS:Reactome
P61247	RPS3A	40S ribosomal protein S3a	GO:0019083; P:viral transcription; TAS:Reactome
P23396	RPS3	40S ribosomal protein S3	GO:0003684; F:damaged DNA binding; IDA:UniProtKB
P23396	RPS3	40S ribosomal protein S3	GO:0003906; F:DNA-(apurinic or apyrimidinic site) lyase activity; IDA:UniProtKB
P23396	RPS3	40S ribosomal protein S3	GO:0004519; F:endonuclease activity; IMP:UniProtKB
P23396	RPS3	40S ribosomal protein S3	GO:0019899; F:enzyme binding; IPI:UniProtKB
P23396	RPS3	40S ribosomal protein S3	GO:0051536; F:iron-sulfur cluster binding; NAS:UniProtKB
P23396	RPS3	40S ribosomal protein S3	GO:0003729; F:mRNA binding; IDA:UniProtKB
P23396	RPS3	40S ribosomal protein S3	GO:0051059; F:NF-kappaB binding; IPI:UniProtKB
P23396	RPS3	40S ribosomal protein S3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P23396	RPS3	40S ribosomal protein S3	GO:0005515; F:protein binding; IPI:UniProtKB
P23396	RPS3	40S ribosomal protein S3	GO:0051018; F:protein kinase A binding; IPI:UniProtKB
P23396	RPS3	40S ribosomal protein S3	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P23396	RPS3	40S ribosomal protein S3	GO:0003735; F:structural constituent of ribosome; IDA:UniProtKB
P23396	RPS3	40S ribosomal protein S3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P23396	RPS3	40S ribosomal protein S3	GO:0006974; P:cellular response to DNA damage stimulus; IEP:UniProtKB
P23396	RPS3	40S ribosomal protein S3	GO:0002181; P:cytoplasmic translation; IBA:RefGenome
P23396	RPS3	40S ribosomal protein S3	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
P23396	RPS3	40S ribosomal protein S3	GO:0010467; P:gene expression; TAS:Reactome
P23396	RPS3	40S ribosomal protein S3	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P23396	RPS3	40S ribosomal protein S3	GO:0045738; P:negative regulation of DNA repair; IMP:UniProtKB
P23396	RPS3	40S ribosomal protein S3	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P23396	RPS3	40S ribosomal protein S3	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IMP:GOC
P23396	RPS3	40S ribosomal protein S3	GO:2001235; P:positive regulation of apoptotic signaling pathway; IDA:UniProtKB
P23396	RPS3	40S ribosomal protein S3	GO:1902546; P:positive regulation of DNA N-glycosylase activity; IDA:UniProtKB
P23396	RPS3	40S ribosomal protein S3	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
P23396	RPS3	40S ribosomal protein S3	GO:0016070; P:RNA metabolic process; TAS:Reactome
P23396	RPS3	40S ribosomal protein S3	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P23396	RPS3	40S ribosomal protein S3	GO:0006412; P:translation; NAS:UniProtKB
P23396	RPS3	40S ribosomal protein S3	GO:0006414; P:translational elongation; TAS:Reactome
P23396	RPS3	40S ribosomal protein S3	GO:0006413; P:translational initiation; NAS:UniProtKB
P23396	RPS3	40S ribosomal protein S3	GO:0006415; P:translational termination; TAS:Reactome
P23396	RPS3	40S ribosomal protein S3	GO:0019058; P:viral life cycle; TAS:Reactome
P23396	RPS3	40S ribosomal protein S3	GO:0016032; P:viral process; TAS:Reactome
P23396	RPS3	40S ribosomal protein S3	GO:0019083; P:viral transcription; TAS:Reactome
P62701	RPS4X	40S ribosomal protein S4, X isoform	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62701	RPS4X	40S ribosomal protein S4, X isoform	GO:0019843; F:rRNA binding; IEA:UniProtKB-KW
P62701	RPS4X	40S ribosomal protein S4, X isoform	GO:0003735; F:structural constituent of ribosome; IMP:UniProtKB
P62701	RPS4X	40S ribosomal protein S4, X isoform	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62701	RPS4X	40S ribosomal protein S4, X isoform	GO:0010467; P:gene expression; TAS:Reactome
P62701	RPS4X	40S ribosomal protein S4, X isoform	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62701	RPS4X	40S ribosomal protein S4, X isoform	GO:0007275; P:multicellular organismal development; IMP:UniProtKB
P62701	RPS4X	40S ribosomal protein S4, X isoform	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62701	RPS4X	40S ribosomal protein S4, X isoform	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
P62701	RPS4X	40S ribosomal protein S4, X isoform	GO:0045727; P:positive regulation of translation; IMP:UniProtKB
P62701	RPS4X	40S ribosomal protein S4, X isoform	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62701	RPS4X	40S ribosomal protein S4, X isoform	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62701	RPS4X	40S ribosomal protein S4, X isoform	GO:0006412; P:translation; IMP:UniProtKB
P62701	RPS4X	40S ribosomal protein S4, X isoform	GO:0006414; P:translational elongation; TAS:Reactome
P62701	RPS4X	40S ribosomal protein S4, X isoform	GO:0006413; P:translational initiation; TAS:Reactome
P62701	RPS4X	40S ribosomal protein S4, X isoform	GO:0006415; P:translational termination; TAS:Reactome
P62701	RPS4X	40S ribosomal protein S4, X isoform	GO:0019058; P:viral life cycle; TAS:Reactome
P62701	RPS4X	40S ribosomal protein S4, X isoform	GO:0016032; P:viral process; TAS:Reactome
P62701	RPS4X	40S ribosomal protein S4, X isoform	GO:0019083; P:viral transcription; TAS:Reactome
P22090	RPS4Y1	40S ribosomal protein S4, Y isoform 1	GO:0003723; F:RNA binding; TAS:ProtInc
P22090	RPS4Y1	40S ribosomal protein S4, Y isoform 1	GO:0019843; F:rRNA binding; IEA:UniProtKB-KW
P22090	RPS4Y1	40S ribosomal protein S4, Y isoform 1	GO:0003735; F:structural constituent of ribosome; IMP:UniProtKB
P22090	RPS4Y1	40S ribosomal protein S4, Y isoform 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P22090	RPS4Y1	40S ribosomal protein S4, Y isoform 1	GO:0010467; P:gene expression; TAS:Reactome
P22090	RPS4Y1	40S ribosomal protein S4, Y isoform 1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P22090	RPS4Y1	40S ribosomal protein S4, Y isoform 1	GO:0007275; P:multicellular organismal development; IMP:UniProtKB
P22090	RPS4Y1	40S ribosomal protein S4, Y isoform 1	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P22090	RPS4Y1	40S ribosomal protein S4, Y isoform 1	GO:0016070; P:RNA metabolic process; TAS:Reactome
P22090	RPS4Y1	40S ribosomal protein S4, Y isoform 1	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P22090	RPS4Y1	40S ribosomal protein S4, Y isoform 1	GO:0006412; P:translation; IMP:UniProtKB
P22090	RPS4Y1	40S ribosomal protein S4, Y isoform 1	GO:0006414; P:translational elongation; TAS:Reactome
P22090	RPS4Y1	40S ribosomal protein S4, Y isoform 1	GO:0006413; P:translational initiation; TAS:Reactome
P22090	RPS4Y1	40S ribosomal protein S4, Y isoform 1	GO:0006415; P:translational termination; TAS:Reactome
P22090	RPS4Y1	40S ribosomal protein S4, Y isoform 1	GO:0019058; P:viral life cycle; TAS:Reactome
P22090	RPS4Y1	40S ribosomal protein S4, Y isoform 1	GO:0016032; P:viral process; TAS:Reactome
P22090	RPS4Y1	40S ribosomal protein S4, Y isoform 1	GO:0019083; P:viral transcription; TAS:Reactome
Q8TD47	RPS4Y2	40S ribosomal protein S4, Y isoform 2	GO:0019843; F:rRNA binding; IEA:UniProtKB-KW
Q8TD47	RPS4Y2	40S ribosomal protein S4, Y isoform 2	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q8TD47	RPS4Y2	40S ribosomal protein S4, Y isoform 2	GO:0006412; P:translation; IEA:InterPro
P46782	RPS5	40S ribosomal protein S5	GO:0003729; F:mRNA binding; IDA:UniProtKB
P46782	RPS5	40S ribosomal protein S5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P46782	RPS5	40S ribosomal protein S5	GO:0003723; F:RNA binding; NAS:UniProtKB
P46782	RPS5	40S ribosomal protein S5	GO:0003735; F:structural constituent of ribosome; IDA:UniProtKB
P46782	RPS5	40S ribosomal protein S5	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P46782	RPS5	40S ribosomal protein S5	GO:0010467; P:gene expression; TAS:Reactome
P46782	RPS5	40S ribosomal protein S5	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P46782	RPS5	40S ribosomal protein S5	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P46782	RPS5	40S ribosomal protein S5	GO:0006450; P:regulation of translational fidelity; IGI:UniProtKB
P46782	RPS5	40S ribosomal protein S5	GO:0016070; P:RNA metabolic process; TAS:Reactome
P46782	RPS5	40S ribosomal protein S5	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P46782	RPS5	40S ribosomal protein S5	GO:0006412; P:translation; IGI:UniProtKB
P46782	RPS5	40S ribosomal protein S5	GO:0006414; P:translational elongation; TAS:Reactome
P46782	RPS5	40S ribosomal protein S5	GO:0006413; P:translational initiation; IC:UniProtKB
P46782	RPS5	40S ribosomal protein S5	GO:0006415; P:translational termination; TAS:Reactome
P46782	RPS5	40S ribosomal protein S5	GO:0019058; P:viral life cycle; TAS:Reactome
P46782	RPS5	40S ribosomal protein S5	GO:0016032; P:viral process; TAS:Reactome
P46782	RPS5	40S ribosomal protein S5	GO:0019083; P:viral transcription; TAS:Reactome
P62753	RPS6	40S ribosomal protein S6	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62753	RPS6	40S ribosomal protein S6	GO:0005515; F:protein binding; IPI:UniProtKB
P62753	RPS6	40S ribosomal protein S6	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P62753	RPS6	40S ribosomal protein S6	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P62753	RPS6	40S ribosomal protein S6	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62753	RPS6	40S ribosomal protein S6	GO:0010467; P:gene expression; TAS:Reactome
P62753	RPS6	40S ribosomal protein S6	GO:0042593; P:glucose homeostasis; ISS:UniProtKB
P62753	RPS6	40S ribosomal protein S6	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P62753	RPS6	40S ribosomal protein S6	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62753	RPS6	40S ribosomal protein S6	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62753	RPS6	40S ribosomal protein S6	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P62753	RPS6	40S ribosomal protein S6	GO:0042274; P:ribosomal small subunit biogenesis; IMP:UniProtKB
P62753	RPS6	40S ribosomal protein S6	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62753	RPS6	40S ribosomal protein S6	GO:0006364; P:rRNA processing; IMP:UniProtKB
P62753	RPS6	40S ribosomal protein S6	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62753	RPS6	40S ribosomal protein S6	GO:0031929; P:TOR signaling; IDA:UniProtKB
P62753	RPS6	40S ribosomal protein S6	GO:0006412; P:translation; IC:UniProtKB
P62753	RPS6	40S ribosomal protein S6	GO:0006414; P:translational elongation; TAS:Reactome
P62753	RPS6	40S ribosomal protein S6	GO:0006413; P:translational initiation; TAS:Reactome
P62753	RPS6	40S ribosomal protein S6	GO:0006415; P:translational termination; TAS:Reactome
P62753	RPS6	40S ribosomal protein S6	GO:0019058; P:viral life cycle; TAS:Reactome
P62753	RPS6	40S ribosomal protein S6	GO:0016032; P:viral process; TAS:Reactome
P62753	RPS6	40S ribosomal protein S6	GO:0019083; P:viral transcription; TAS:Reactome
P62081	RPS7	40S ribosomal protein S7	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62081	RPS7	40S ribosomal protein S7	GO:0005515; F:protein binding; IPI:UniProtKB
P62081	RPS7	40S ribosomal protein S7	GO:0003723; F:RNA binding; NAS:UniProtKB
P62081	RPS7	40S ribosomal protein S7	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P62081	RPS7	40S ribosomal protein S7	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62081	RPS7	40S ribosomal protein S7	GO:0010467; P:gene expression; TAS:Reactome
P62081	RPS7	40S ribosomal protein S7	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62081	RPS7	40S ribosomal protein S7	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62081	RPS7	40S ribosomal protein S7	GO:0042274; P:ribosomal small subunit biogenesis; IMP:UniProtKB
P62081	RPS7	40S ribosomal protein S7	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62081	RPS7	40S ribosomal protein S7	GO:0006364; P:rRNA processing; IMP:UniProtKB
P62081	RPS7	40S ribosomal protein S7	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62081	RPS7	40S ribosomal protein S7	GO:0006412; P:translation; NAS:UniProtKB
P62081	RPS7	40S ribosomal protein S7	GO:0006414; P:translational elongation; TAS:Reactome
P62081	RPS7	40S ribosomal protein S7	GO:0006413; P:translational initiation; TAS:Reactome
P62081	RPS7	40S ribosomal protein S7	GO:0006415; P:translational termination; TAS:Reactome
P62081	RPS7	40S ribosomal protein S7	GO:0019058; P:viral life cycle; TAS:Reactome
P62081	RPS7	40S ribosomal protein S7	GO:0016032; P:viral process; TAS:Reactome
P62081	RPS7	40S ribosomal protein S7	GO:0019083; P:viral transcription; TAS:Reactome
P62241	RPS8	40S ribosomal protein S8	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62241	RPS8	40S ribosomal protein S8	GO:0003735; F:structural constituent of ribosome; IBA:RefGenome
P62241	RPS8	40S ribosomal protein S8	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62241	RPS8	40S ribosomal protein S8	GO:0010467; P:gene expression; TAS:Reactome
P62241	RPS8	40S ribosomal protein S8	GO:0000462; P:maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IBA:RefGenome
P62241	RPS8	40S ribosomal protein S8	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P62241	RPS8	40S ribosomal protein S8	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P62241	RPS8	40S ribosomal protein S8	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62241	RPS8	40S ribosomal protein S8	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P62241	RPS8	40S ribosomal protein S8	GO:0006412; P:translation; NAS:UniProtKB
P62241	RPS8	40S ribosomal protein S8	GO:0006414; P:translational elongation; TAS:Reactome
P62241	RPS8	40S ribosomal protein S8	GO:0006413; P:translational initiation; TAS:Reactome
P62241	RPS8	40S ribosomal protein S8	GO:0006415; P:translational termination; TAS:Reactome
P62241	RPS8	40S ribosomal protein S8	GO:0019058; P:viral life cycle; TAS:Reactome
P62241	RPS8	40S ribosomal protein S8	GO:0016032; P:viral process; TAS:Reactome
P62241	RPS8	40S ribosomal protein S8	GO:0019083; P:viral transcription; TAS:Reactome
P46781	RPS9	40S ribosomal protein S9	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P46781	RPS9	40S ribosomal protein S9	GO:0005515; F:protein binding; IPI:UniProtKB
P46781	RPS9	40S ribosomal protein S9	GO:0019843; F:rRNA binding; IEA:UniProtKB-KW
P46781	RPS9	40S ribosomal protein S9	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P46781	RPS9	40S ribosomal protein S9	GO:0045182; F:translation regulator activity; IMP:UniProtKB
P46781	RPS9	40S ribosomal protein S9	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P46781	RPS9	40S ribosomal protein S9	GO:0010467; P:gene expression; TAS:Reactome
P46781	RPS9	40S ribosomal protein S9	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P46781	RPS9	40S ribosomal protein S9	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P46781	RPS9	40S ribosomal protein S9	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
P46781	RPS9	40S ribosomal protein S9	GO:0006417; P:regulation of translation; IMP:GOC
P46781	RPS9	40S ribosomal protein S9	GO:0016070; P:RNA metabolic process; TAS:Reactome
P46781	RPS9	40S ribosomal protein S9	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P46781	RPS9	40S ribosomal protein S9	GO:0006412; P:translation; IMP:UniProtKB
P46781	RPS9	40S ribosomal protein S9	GO:0006414; P:translational elongation; TAS:Reactome
P46781	RPS9	40S ribosomal protein S9	GO:0006413; P:translational initiation; TAS:Reactome
P46781	RPS9	40S ribosomal protein S9	GO:0006415; P:translational termination; TAS:Reactome
P46781	RPS9	40S ribosomal protein S9	GO:0019058; P:viral life cycle; TAS:Reactome
P46781	RPS9	40S ribosomal protein S9	GO:0016032; P:viral process; TAS:Reactome
P46781	RPS9	40S ribosomal protein S9	GO:0019083; P:viral transcription; TAS:Reactome
Q9HA92	RSAD1	Radical S-adenosyl methionine domain-containing protein 1, mitochondrial	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
Q9HA92	RSAD1	Radical S-adenosyl methionine domain-containing protein 1, mitochondrial	GO:0004109; F:coproporphyrinogen oxidase activity; IEA:InterPro
Q9HA92	RSAD1	Radical S-adenosyl methionine domain-containing protein 1, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HA92	RSAD1	Radical S-adenosyl methionine domain-containing protein 1, mitochondrial	GO:0006779; P:porphyrin-containing compound biosynthetic process; IEA:UniProtKB-KW
Q8WXG1	RSAD2	Radical S-adenosyl methionine domain-containing protein 2	GO:0051539; F:4 iron, 4 sulfur cluster binding; IDA:UniProtKB
Q8WXG1	RSAD2	Radical S-adenosyl methionine domain-containing protein 2	GO:0003824; F:catalytic activity; IEA:InterPro
Q8WXG1	RSAD2	Radical S-adenosyl methionine domain-containing protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8WXG1	RSAD2	Radical S-adenosyl methionine domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WXG1	RSAD2	Radical S-adenosyl methionine domain-containing protein 2	GO:0043621; F:protein self-association; IDA:UniProtKB
Q8WXG1	RSAD2	Radical S-adenosyl methionine domain-containing protein 2	GO:0035710; P:CD4-positive, alpha-beta T cell activation; ISS:UniProtKB
Q8WXG1	RSAD2	Radical S-adenosyl methionine domain-containing protein 2	GO:0043367; P:CD4-positive, alpha-beta T cell differentiation; ISS:UniProtKB
Q8WXG1	RSAD2	Radical S-adenosyl methionine domain-containing protein 2	GO:0051607; P:defense response to virus; IDA:UniProtKB
Q8WXG1	RSAD2	Radical S-adenosyl methionine domain-containing protein 2	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q8WXG1	RSAD2	Radical S-adenosyl methionine domain-containing protein 2	GO:0050709; P:negative regulation of protein secretion; IDA:UniProtKB
Q8WXG1	RSAD2	Radical S-adenosyl methionine domain-containing protein 2	GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB
Q8WXG1	RSAD2	Radical S-adenosyl methionine domain-containing protein 2	GO:0001503; P:ossification; IEA:Ensembl
Q8WXG1	RSAD2	Radical S-adenosyl methionine domain-containing protein 2	GO:2000553; P:positive regulation of T-helper 2 cell cytokine production; ISS:UniProtKB
Q8WXG1	RSAD2	Radical S-adenosyl methionine domain-containing protein 2	GO:0034157; P:positive regulation of toll-like receptor 7 signaling pathway; ISS:UniProtKB
Q8WXG1	RSAD2	Radical S-adenosyl methionine domain-containing protein 2	GO:0034165; P:positive regulation of toll-like receptor 9 signaling pathway; ISS:UniProtKB
Q8WXG1	RSAD2	Radical S-adenosyl methionine domain-containing protein 2	GO:0030278; P:regulation of ossification; IEA:Ensembl
Q8WXG1	RSAD2	Radical S-adenosyl methionine domain-containing protein 2	GO:0009615; P:response to virus; IDA:UniProtKB
Q8WXG1	RSAD2	Radical S-adenosyl methionine domain-containing protein 2	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q92681	RSC1A1	Regulatory solute carrier protein family 1 member 1	GO:0008200; F:ion channel inhibitor activity; TAS:ProtInc
Q92681	RSC1A1	Regulatory solute carrier protein family 1 member 1	GO:0050892; P:intestinal absorption; IEA:Ensembl
Q92681	RSC1A1	Regulatory solute carrier protein family 1 member 1	GO:0051051; P:negative regulation of transport; IDA:MGI
Q92681	RSC1A1	Regulatory solute carrier protein family 1 member 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q92681	RSC1A1	Regulatory solute carrier protein family 1 member 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q92681	RSC1A1	Regulatory solute carrier protein family 1 member 1	GO:0006810; P:transport; TAS:ProtInc
Q96T23	RSF1	Remodeling and spacing factor 1	GO:0042393; F:histone binding; IDA:UniProtKB
Q96T23	RSF1	Remodeling and spacing factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96T23	RSF1	Remodeling and spacing factor 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96T23	RSF1	Remodeling and spacing factor 1	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
Q96T23	RSF1	Remodeling and spacing factor 1	GO:0006338; P:chromatin remodeling; IDA:UniProtKB
Q96T23	RSF1	Remodeling and spacing factor 1	GO:0006352; P:DNA-templated transcription, initiation; IDA:UniProtKB
Q96T23	RSF1	Remodeling and spacing factor 1	GO:0043392; P:negative regulation of DNA binding; IDA:UniProtKB
Q96T23	RSF1	Remodeling and spacing factor 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q96T23	RSF1	Remodeling and spacing factor 1	GO:0006334; P:nucleosome assembly; IDA:UniProtKB
Q96T23	RSF1	Remodeling and spacing factor 1	GO:0016584; P:nucleosome positioning; IDA:UniProtKB
Q96T23	RSF1	Remodeling and spacing factor 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q96T23	RSF1	Remodeling and spacing factor 1	GO:0050434; P:positive regulation of viral transcription; IDA:UniProtKB
Q9BU20	RSG1	REM2- and Rab-like small GTPase 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9BU20	RSG1	REM2- and Rab-like small GTPase 1	GO:0034613; P:cellular protein localization; ISS:UniProtKB
Q9BU20	RSG1	REM2- and Rab-like small GTPase 1	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q9BU20	RSG1	REM2- and Rab-like small GTPase 1	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q9BU20	RSG1	REM2- and Rab-like small GTPase 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9BU20	RSG1	REM2- and Rab-like small GTPase 1	GO:0017157; P:regulation of exocytosis; ISS:UniProtKB
Q9BU20	RSG1	REM2- and Rab-like small GTPase 1	GO:0031338; P:regulation of vesicle fusion; ISS:UniProtKB
Q9BU20	RSG1	REM2- and Rab-like small GTPase 1	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q5TD94	RSPH4A	Radial spoke head protein 4 homolog A	GO:0035082; P:axoneme assembly; IMP:BHF-UCL
Q5TD94	RSPH4A	Radial spoke head protein 4 homolog A	GO:0003341; P:cilium movement; IMP:BHF-UCL
Q96S79	RASL10B	Ras-like protein family member 10B	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q96S79	RASL10B	Ras-like protein family member 10B	GO:0006184; P:GTP catabolic process; IEA:InterPro
Q96S79	RASL10B	Ras-like protein family member 10B	GO:0090277; P:positive regulation of peptide hormone secretion; ISS:UniProtKB
Q96S79	RASL10B	Ras-like protein family member 10B	GO:0003050; P:regulation of systemic arterial blood pressure by atrial natriuretic peptide; ISS:UniProtKB
Q96S79	RASL10B	Ras-like protein family member 10B	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q92737	RASL10A	Ras-like protein family member 10A	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q92737	RASL10A	Ras-like protein family member 10A	GO:0003924; F:GTPase activity; TAS:ProtInc
Q92737	RASL10A	Ras-like protein family member 10A	GO:0007264; P:small GTPase mediated signal transduction; TAS:ProtInc
Q6T310	RASL11A	Ras-like protein family member 11A	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q6T310	RASL11A	Ras-like protein family member 11A	GO:0006184; P:GTP catabolic process; IEA:InterPro
Q6T310	RASL11A	Ras-like protein family member 11A	GO:0045943; P:positive regulation of transcription from RNA polymerase I promoter; ISS:UniProtKB
Q6T310	RASL11A	Ras-like protein family member 11A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q6T310	RASL11A	Ras-like protein family member 11A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BPW5	RASL11B	Ras-like protein family member 11B	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9BPW5	RASL11B	Ras-like protein family member 11B	GO:0006184; P:GTP catabolic process; IEA:InterPro
Q9BPW5	RASL11B	Ras-like protein family member 11B	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P14678	SNRPB	Small nuclear ribonucleoprotein-associated proteins B and B'	GO:0071208; F:histone pre-mRNA DCP binding; IEA:Ensembl
P14678	SNRPB	Small nuclear ribonucleoprotein-associated proteins B and B'	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P14678	SNRPB	Small nuclear ribonucleoprotein-associated proteins B and B'	GO:0005515; F:protein binding; IPI:IntAct
P14678	SNRPB	Small nuclear ribonucleoprotein-associated proteins B and B'	GO:0010467; P:gene expression; TAS:Reactome
P14678	SNRPB	Small nuclear ribonucleoprotein-associated proteins B and B'	GO:0008334; P:histone mRNA metabolic process; TAS:Reactome
P14678	SNRPB	Small nuclear ribonucleoprotein-associated proteins B and B'	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
P14678	SNRPB	Small nuclear ribonucleoprotein-associated proteins B and B'	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P14678	SNRPB	Small nuclear ribonucleoprotein-associated proteins B and B'	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
P14678	SNRPB	Small nuclear ribonucleoprotein-associated proteins B and B'	GO:0016070; P:RNA metabolic process; TAS:Reactome
P14678	SNRPB	Small nuclear ribonucleoprotein-associated proteins B and B'	GO:0008380; P:RNA splicing; TAS:Reactome
P14678	SNRPB	Small nuclear ribonucleoprotein-associated proteins B and B'	GO:0000387; P:spliceosomal snRNP assembly; IDA:UniProtKB
P14678	SNRPB	Small nuclear ribonucleoprotein-associated proteins B and B'	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
P14678	SNRPB	Small nuclear ribonucleoprotein-associated proteins B and B'	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
P63162	SNRPN	Small nuclear ribonucleoprotein-associated protein N	GO:0005515; F:protein binding; IPI:UniProtKB
P63162	SNRPN	Small nuclear ribonucleoprotein-associated protein N	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
P63162	SNRPN	Small nuclear ribonucleoprotein-associated protein N	GO:0009725; P:response to hormone; IEA:Ensembl
P63162	SNRPN	Small nuclear ribonucleoprotein-associated protein N	GO:0008380; P:RNA splicing; TAS:UniProtKB
Q8WYR4	RSPH1	Radial spoke head 1 homolog	GO:0035082; P:axoneme assembly; IMP:UniProtKB
Q8WYR4	RSPH1	Radial spoke head 1 homolog	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q9H1X1	RSPH9	Radial spoke head protein 9 homolog	GO:0035082; P:axoneme assembly; IMP:BHF-UCL
Q9H1X1	RSPH9	Radial spoke head protein 9 homolog	GO:0003341; P:cilium movement; IMP:BHF-UCL
Q6UXX9	RSPO2	R-spondin-2	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
Q6UXX9	RSPO2	R-spondin-2	GO:0005102; F:receptor binding; IPI:UniProtKB
Q6UXX9	RSPO2	R-spondin-2	GO:0030282; P:bone mineralization; IEA:Ensembl
Q6UXX9	RSPO2	R-spondin-2	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
Q6UXX9	RSPO2	R-spondin-2	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
Q6UXX9	RSPO2	R-spondin-2	GO:0060441; P:epithelial tube branching involved in lung morphogenesis; IEA:Ensembl
Q6UXX9	RSPO2	R-spondin-2	GO:0060437; P:lung growth; IEA:Ensembl
Q6UXX9	RSPO2	R-spondin-2	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
Q6UXX9	RSPO2	R-spondin-2	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl
Q6UXX9	RSPO2	R-spondin-2	GO:0060535; P:trachea cartilage morphogenesis; IEA:Ensembl
Q6UXX9	RSPO2	R-spondin-2	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q2MKA7	RSPO1	R-spondin-1	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
Q2MKA7	RSPO1	R-spondin-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q2MKA7	RSPO1	R-spondin-1	GO:0005102; F:receptor binding; IPI:UniProtKB
Q2MKA7	RSPO1	R-spondin-1	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
Q2MKA7	RSPO1	R-spondin-1	GO:0007140; P:male meiosis; IEA:Ensembl
Q2MKA7	RSPO1	R-spondin-1	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:UniProtKB
Q2MKA7	RSPO1	R-spondin-1	GO:2000052; P:positive regulation of non-canonical Wnt signaling pathway; IEA:Ensembl
Q2MKA7	RSPO1	R-spondin-1	GO:0030177; P:positive regulation of Wnt signaling pathway; IDA:UniProtKB
Q2MKA7	RSPO1	R-spondin-1	GO:0010468; P:regulation of gene expression; IEA:Ensembl
Q2MKA7	RSPO1	R-spondin-1	GO:2000254; P:regulation of male germ cell proliferation; IEA:Ensembl
Q2MKA7	RSPO1	R-spondin-1	GO:0002090; P:regulation of receptor internalization; IDA:BHF-UCL
Q2I0M5	RSPO4	R-spondin-4	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
Q2I0M5	RSPO4	R-spondin-4	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q96DX4	RSPRY1	RING finger and SPRY domain-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BXY4	RSPO3	R-spondin-3	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
Q9BXY4	RSPO3	R-spondin-3	GO:0005102; F:receptor binding; IPI:UniProtKB
Q9BXY4	RSPO3	R-spondin-3	GO:0060670; P:branching involved in labyrinthine layer morphogenesis; IEA:Ensembl
Q9BXY4	RSPO3	R-spondin-3	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
Q96IZ7	RSRC1	Serine/Arginine-related protein 53	GO:0005515; F:protein binding; IPI:UniProtKB
Q96IZ7	RSRC1	Serine/Arginine-related protein 53	GO:0000380; P:alternative mRNA splicing, via spliceosome; IEA:Ensembl
Q96IZ7	RSRC1	Serine/Arginine-related protein 53	GO:0000398; P:mRNA splicing, via spliceosome; IDA:UniProtKB
Q96IZ7	RSRC1	Serine/Arginine-related protein 53	GO:0006913; P:nucleocytoplasmic transport; ISS:UniProtKB
Q96IZ7	RSRC1	Serine/Arginine-related protein 53	GO:0006468; P:protein phosphorylation; IEA:Ensembl
Q96IZ7	RSRC1	Serine/Arginine-related protein 53	GO:0046677; P:response to antibiotic; IEA:Ensembl
Q96IZ7	RSRC1	Serine/Arginine-related protein 53	GO:0008380; P:RNA splicing; IDA:MGI
Q7L4I2	RSRC2	Arginine/serine-rich coiled-coil protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P08865	RPSA	40S ribosomal protein SA	GO:0005055; F:laminin receptor activity; IEA:UniProtKB-HAMAP
P08865	RPSA	40S ribosomal protein SA	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P08865	RPSA	40S ribosomal protein SA	GO:0005515; F:protein binding; IPI:UniProtKB
P08865	RPSA	40S ribosomal protein SA	GO:0043022; F:ribosome binding; IPI:UniProtKB
P08865	RPSA	40S ribosomal protein SA	GO:0003735; F:structural constituent of ribosome; IBA:RefGenome
P08865	RPSA	40S ribosomal protein SA	GO:0007155; P:cell adhesion; NAS:ProtInc
P08865	RPSA	40S ribosomal protein SA	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P08865	RPSA	40S ribosomal protein SA	GO:0000447; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IBA:RefGenome
P08865	RPSA	40S ribosomal protein SA	GO:0000461; P:endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IBA:RefGenome
P08865	RPSA	40S ribosomal protein SA	GO:0010467; P:gene expression; TAS:Reactome
P08865	RPSA	40S ribosomal protein SA	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P08865	RPSA	40S ribosomal protein SA	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome
P08865	RPSA	40S ribosomal protein SA	GO:0000028; P:ribosomal small subunit assembly; IBA:RefGenome
P08865	RPSA	40S ribosomal protein SA	GO:0016070; P:RNA metabolic process; TAS:Reactome
P08865	RPSA	40S ribosomal protein SA	GO:0006407; P:rRNA export from nucleus; IBA:RefGenome
P08865	RPSA	40S ribosomal protein SA	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P08865	RPSA	40S ribosomal protein SA	GO:0006412; P:translation; IC:UniProtKB
P08865	RPSA	40S ribosomal protein SA	GO:0006414; P:translational elongation; TAS:Reactome
P08865	RPSA	40S ribosomal protein SA	GO:0006413; P:translational initiation; TAS:Reactome
P08865	RPSA	40S ribosomal protein SA	GO:0006415; P:translational termination; TAS:Reactome
P08865	RPSA	40S ribosomal protein SA	GO:0019058; P:viral life cycle; TAS:Reactome
P08865	RPSA	40S ribosomal protein SA	GO:0016032; P:viral process; TAS:Reactome
P08865	RPSA	40S ribosomal protein SA	GO:0019083; P:viral transcription; TAS:Reactome
Q15404	RSU1	Ras suppressor protein 1	GO:0034329; P:cell junction assembly; TAS:Reactome
Q15404	RSU1	Ras suppressor protein 1	GO:0007265; P:Ras protein signal transduction; IEA:Ensembl
Q15404	RSU1	Ras suppressor protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y399	MRPS2	28S ribosomal protein S2, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q9Y399	MRPS2	28S ribosomal protein S2, mitochondrial	GO:0006412; P:translation; IEA:InterPro
P82675	MRPS5	28S ribosomal protein S5, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P82675	MRPS5	28S ribosomal protein S5, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P82675	MRPS5	28S ribosomal protein S5, mitochondrial	GO:0006412; P:translation; IEA:InterPro
P82932	MRPS6	28S ribosomal protein S6, mitochondrial	GO:0019843; F:rRNA binding; IEA:InterPro
P82932	MRPS6	28S ribosomal protein S6, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P82932	MRPS6	28S ribosomal protein S6, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
Q9Y2R9	MRPS7	28S ribosomal protein S7, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y2R9	MRPS7	28S ribosomal protein S7, mitochondrial	GO:0003723; F:RNA binding; ISS:UniProtKB
Q9Y2R9	MRPS7	28S ribosomal protein S7, mitochondrial	GO:0003735; F:structural constituent of ribosome; ISS:UniProtKB
Q9Y2R9	MRPS7	28S ribosomal protein S7, mitochondrial	GO:0006412; P:translation; ISS:UniProtKB
P82933	MRPS9	28S ribosomal protein S9, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P82933	MRPS9	28S ribosomal protein S9, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
P82933	MRPS9	28S ribosomal protein S9, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P82933	MRPS9	28S ribosomal protein S9, mitochondrial	GO:0042769; P:DNA damage response, detection of DNA damage; NAS:UniProtKB
P82933	MRPS9	28S ribosomal protein S9, mitochondrial	GO:0043043; P:peptide biosynthetic process; IC:UniProtKB
P82933	MRPS9	28S ribosomal protein S9, mitochondrial	GO:0006412; P:translation; IEA:InterPro
P82912	MRPS11	28S ribosomal protein S11, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P82912	MRPS11	28S ribosomal protein S11, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P82912	MRPS11	28S ribosomal protein S11, mitochondrial	GO:0042769; P:DNA damage response, detection of DNA damage; NAS:UniProtKB
P82912	MRPS11	28S ribosomal protein S11, mitochondrial	GO:0006412; P:translation; IEA:InterPro
O15235	MRPS12	28S ribosomal protein S12, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O15235	MRPS12	28S ribosomal protein S12, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
O15235	MRPS12	28S ribosomal protein S12, mitochondrial	GO:0003735; F:structural constituent of ribosome; TAS:ProtInc
O15235	MRPS12	28S ribosomal protein S12, mitochondrial	GO:0006412; P:translation; IEA:InterPro
O60783	MRPS14	28S ribosomal protein S14, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O60783	MRPS14	28S ribosomal protein S14, mitochondrial	GO:0003735; F:structural constituent of ribosome; TAS:UniProtKB
O60783	MRPS14	28S ribosomal protein S14, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
P82914	MRPS15	28S ribosomal protein S15, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P82914	MRPS15	28S ribosomal protein S15, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P82914	MRPS15	28S ribosomal protein S15, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
Q9Y3D3	MRPS16	28S ribosomal protein S16, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y3D3	MRPS16	28S ribosomal protein S16, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q9Y3D3	MRPS16	28S ribosomal protein S16, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
Q9Y2R5	MRPS17	28S ribosomal protein S17, mitochondrial	GO:0019843; F:rRNA binding; IEA:UniProtKB-KW
Q9Y2R5	MRPS17	28S ribosomal protein S17, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q9Y2R5	MRPS17	28S ribosomal protein S17, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
Q9NVS2	MRPS18A	28S ribosomal protein S18a, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q9NVS2	MRPS18A	28S ribosomal protein S18a, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
Q9Y676	MRPS18B	28S ribosomal protein S18b, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q9Y676	MRPS18B	28S ribosomal protein S18b, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
Q9Y3D5	MRPS18C	28S ribosomal protein S18c, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q9Y3D5	MRPS18C	28S ribosomal protein S18c, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
P82921	MRPS21	28S ribosomal protein S21, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P82921	MRPS21	28S ribosomal protein S21, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P82921	MRPS21	28S ribosomal protein S21, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
P82650	MRPS22	28S ribosomal protein S22, mitochondrial	GO:0003735; F:structural constituent of ribosome; IDA:MGI
Q9Y3D9	MRPS23	28S ribosomal protein S23, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y3D9	MRPS23	28S ribosomal protein S23, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q9Y3D9	MRPS23	28S ribosomal protein S23, mitochondrial	GO:0006412; P:translation; IEA:InterPro
Q96EL2	MRPS24	28S ribosomal protein S24, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96EL2	MRPS24	28S ribosomal protein S24, mitochondrial	GO:0003735; F:structural constituent of ribosome; ISS:UniProtKB
Q96EL2	MRPS24	28S ribosomal protein S24, mitochondrial	GO:0006412; P:translation; ISS:UniProtKB
Q9BYN8	MRPS26	28S ribosomal protein S26, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BYN8	MRPS26	28S ribosomal protein S26, mitochondrial	GO:0042769; P:DNA damage response, detection of DNA damage; NAS:UniProtKB
Q9BYN8	MRPS26	28S ribosomal protein S26, mitochondrial	GO:0043043; P:peptide biosynthetic process; IC:UniProtKB
Q92552	MRPS27	28S ribosomal protein S27, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y2Q9	MRPS28	28S ribosomal protein S28, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P51398	DAP3	28S ribosomal protein S29, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P51398	DAP3	28S ribosomal protein S29, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
P51398	DAP3	28S ribosomal protein S29, mitochondrial	GO:0008637; P:apoptotic mitochondrial changes; IEA:Ensembl
P51398	DAP3	28S ribosomal protein S29, mitochondrial	GO:0097190; P:apoptotic signaling pathway; TAS:ProtInc
Q9NP92	MRPS30	28S ribosomal protein S30, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NP92	MRPS30	28S ribosomal protein S30, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
Q9NP92	MRPS30	28S ribosomal protein S30, mitochondrial	GO:0006915; P:apoptotic process; TAS:ProtInc
Q9NP92	MRPS30	28S ribosomal protein S30, mitochondrial	GO:0006412; P:translation; IEA:InterPro
Q92665	MRPS31	28S ribosomal protein S31, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q92665	MRPS31	28S ribosomal protein S31, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q92665	MRPS31	28S ribosomal protein S31, mitochondrial	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q92665	MRPS31	28S ribosomal protein S31, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:InterPro
P82673	MRPS35	28S ribosomal protein S35, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P82673	MRPS35	28S ribosomal protein S35, mitochondrial	GO:0042769; P:DNA damage response, detection of DNA damage; NAS:UniProtKB
P82673	MRPS35	28S ribosomal protein S35, mitochondrial	GO:0043043; P:peptide biosynthetic process; IC:UniProtKB
P82909	MRPS36	28S ribosomal protein S36, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
P82909	MRPS36	28S ribosomal protein S36, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
Q9Y291	MRPS33	28S ribosomal protein S33, mitochondrial	GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB
Q9Y291	MRPS33	28S ribosomal protein S33, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
Q8WWV3	RTN4IP1	Reticulon-4-interacting protein 1, mitochondrial	GO:0016491; F:oxidoreductase activity; IEA:InterPro
Q8WWV3	RTN4IP1	Reticulon-4-interacting protein 1, mitochondrial	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BQC6	MRPL57	Ribosomal protein 63, mitochondrial	GO:0003735; F:structural constituent of ribosome; IEA:Ensembl
Q9BQC6	MRPL57	Ribosomal protein 63, mitochondrial	GO:0006412; P:translation; IEA:Ensembl
O00442	RTCA	RNA 3'-terminal phosphate cyclase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O00442	RTCA	RNA 3'-terminal phosphate cyclase	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O00442	RTCA	RNA 3'-terminal phosphate cyclase	GO:0003723; F:RNA binding; TAS:ProtInc
O00442	RTCA	RNA 3'-terminal phosphate cyclase	GO:0003963; F:RNA-3'-phosphate cyclase activity; TAS:ProtInc
O00442	RTCA	RNA 3'-terminal phosphate cyclase	GO:0006396; P:RNA processing; IEA:InterPro
Q9Y3I0	RTCB	tRNA-splicing ligase RtcB homolog	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y3I0	RTCB	tRNA-splicing ligase RtcB homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y3I0	RTCB	tRNA-splicing ligase RtcB homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y3I0	RTCB	tRNA-splicing ligase RtcB homolog	GO:0003972; F:RNA ligase (ATP) activity; IDA:UniProtKB
Q9Y3I0	RTCB	tRNA-splicing ligase RtcB homolog	GO:0017166; F:vinculin binding; IPI:UniProtKB
Q9Y3I0	RTCB	tRNA-splicing ligase RtcB homolog	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9Y3I0	RTCB	tRNA-splicing ligase RtcB homolog	GO:0001890; P:placenta development; IEA:Ensembl
Q9Y3I0	RTCB	tRNA-splicing ligase RtcB homolog	GO:0006388; P:tRNA splicing, via endonucleolytic cleavage and ligation; IDA:UniProtKB
Q9NZ71	RTEL1	Regulator of telomere elongation helicase 1	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
Q9NZ71	RTEL1	Regulator of telomere elongation helicase 1	GO:0005524; F:ATP binding; IMP:UniProtKB
Q9NZ71	RTEL1	Regulator of telomere elongation helicase 1	GO:0004003; F:ATP-dependent DNA helicase activity; IMP:UniProtKB
Q9NZ71	RTEL1	Regulator of telomere elongation helicase 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NZ71	RTEL1	Regulator of telomere elongation helicase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NZ71	RTEL1	Regulator of telomere elongation helicase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NZ71	RTEL1	Regulator of telomere elongation helicase 1	GO:0032508; P:DNA duplex unwinding; IMP:GOC
Q9NZ71	RTEL1	Regulator of telomere elongation helicase 1	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q9NZ71	RTEL1	Regulator of telomere elongation helicase 1	GO:0010569; P:regulation of double-strand break repair via homologous recombination; IMP:UniProtKB
Q9NZ71	RTEL1	Regulator of telomere elongation helicase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NZ71	RTEL1	Regulator of telomere elongation helicase 1	GO:0000723; P:telomere maintenance; IMP:UniProtKB
Q92541	RTF1	RNA polymerase-associated protein RTF1 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q92541	RTF1	RNA polymerase-associated protein RTF1 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q92541	RTF1	RNA polymerase-associated protein RTF1 homolog	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
Q92541	RTF1	RNA polymerase-associated protein RTF1 homolog	GO:0006352; P:DNA-templated transcription, initiation; IEA:InterPro
Q92541	RTF1	RNA polymerase-associated protein RTF1 homolog	GO:0001711; P:endodermal cell fate commitment; ISS:UniProtKB
Q92541	RTF1	RNA polymerase-associated protein RTF1 homolog	GO:0080182; P:histone H3-K4 trimethylation; IEA:Ensembl
Q92541	RTF1	RNA polymerase-associated protein RTF1 homolog	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q92541	RTF1	RNA polymerase-associated protein RTF1 homolog	GO:0051571; P:positive regulation of histone H3-K4 methylation; IEA:Ensembl
Q92541	RTF1	RNA polymerase-associated protein RTF1 homolog	GO:0032968; P:positive regulation of transcription elongation from RNA polymerase II promoter; IDA:UniProtKB
Q92541	RTF1	RNA polymerase-associated protein RTF1 homolog	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q92541	RTF1	RNA polymerase-associated protein RTF1 homolog	GO:0019827; P:stem cell maintenance; IDA:UniProtKB
Q92541	RTF1	RNA polymerase-associated protein RTF1 homolog	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9BST9	RTKN	Rhotekin	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9BST9	RTKN	Rhotekin	GO:0017049; F:GTP-Rho binding; IDA:UniProtKB
Q9BST9	RTKN	Rhotekin	GO:0005095; F:GTPase inhibitor activity; IDA:UniProtKB
Q9BST9	RTKN	Rhotekin	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BST9	RTKN	Rhotekin	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9BST9	RTKN	Rhotekin	GO:0043086; P:negative regulation of catalytic activity; IDA:GOC
Q9BST9	RTKN	Rhotekin	GO:0007266; P:Rho protein signal transduction; IDA:UniProtKB
Q9BST9	RTKN	Rhotekin	GO:0007165; P:signal transduction; IDA:UniProtKB
Q8IZC4	RTKN2	Rhotekin-2	GO:0030097; P:hemopoiesis; IEA:Ensembl
Q8IZC4	RTKN2	Rhotekin-2	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q8IZC4	RTKN2	Rhotekin-2	GO:0007165; P:signal transduction; IEA:InterPro
A6NKG5	RTL1	Retrotransposon-like protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q16799	RTN1	Reticulon-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q16799	RTN1	Reticulon-1	GO:0030182; P:neuron differentiation; IEP:UniProtKB
O75298	RTN2	Reticulon-2	GO:0005515; F:protein binding; IPI:UniProtKB
O75298	RTN2	Reticulon-2	GO:0008219; P:cell death; IEA:UniProtKB-KW
O75298	RTN2	Reticulon-2	GO:0065002; P:intracellular protein transmembrane transport; IEA:Ensembl
O75298	RTN2	Reticulon-2	GO:0046324; P:regulation of glucose import; IEA:Ensembl
O95197	RTN3	Reticulon-3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O95197	RTN3	Reticulon-3	GO:0071786; P:endoplasmic reticulum tubular network organization; IMP:UniProtKB
O95197	RTN3	Reticulon-3	GO:0006950; P:response to stress; IEA:UniProtKB-KW
O95197	RTN3	Reticulon-3	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
O95197	RTN3	Reticulon-3	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9BZR6	RTN4R	Reticulon-4 receptor	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BZR6	RTN4R	Reticulon-4 receptor	GO:0004872; F:receptor activity; NAS:UniProtKB
Q9BZR6	RTN4R	Reticulon-4 receptor	GO:0007409; P:axonogenesis; NAS:UniProtKB
Q9BZR6	RTN4R	Reticulon-4 receptor	GO:0050771; P:negative regulation of axonogenesis; TAS:Reactome
Q9BZR6	RTN4R	Reticulon-4 receptor	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9BZR6	RTN4R	Reticulon-4 receptor	GO:0050770; P:regulation of axonogenesis; TAS:Reactome
Q9NQC3	RTN4	Reticulon-4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NQC3	RTN4	Reticulon-4	GO:0005515; F:protein binding; IPI:IntAct
Q9NQC3	RTN4	Reticulon-4	GO:0001525; P:angiogenesis; IEA:Ensembl
Q9NQC3	RTN4	Reticulon-4	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q9NQC3	RTN4	Reticulon-4	GO:0007413; P:axonal fasciculation; ISS:UniProtKB
Q9NQC3	RTN4	Reticulon-4	GO:0060317; P:cardiac epithelial to mesenchymal transition; IEA:Ensembl
Q9NQC3	RTN4	Reticulon-4	GO:0021801; P:cerebral cortex radial glia guided migration; ISS:UniProtKB
Q9NQC3	RTN4	Reticulon-4	GO:0071786; P:endoplasmic reticulum tubular network organization; IMP:UniProtKB
Q9NQC3	RTN4	Reticulon-4	GO:0030517; P:negative regulation of axon extension; IDA:UniProtKB
Q9NQC3	RTN4	Reticulon-4	GO:0050771; P:negative regulation of axonogenesis; TAS:Reactome
Q9NQC3	RTN4	Reticulon-4	GO:0030308; P:negative regulation of cell growth; IMP:DFLAT
Q9NQC3	RTN4	Reticulon-4	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9NQC3	RTN4	Reticulon-4	GO:0042981; P:regulation of apoptotic process; NAS:UniProtKB
Q9NQC3	RTN4	Reticulon-4	GO:0050770; P:regulation of axonogenesis; TAS:Reactome
Q9NQC3	RTN4	Reticulon-4	GO:2000172; P:regulation of branching morphogenesis of a nerve; ISS:UniProtKB
Q9NQC3	RTN4	Reticulon-4	GO:0030334; P:regulation of cell migration; IDA:MGI
P59025	RTP1	Receptor-transporting protein 1	GO:0031849; F:olfactory receptor binding; IMP:HGNC
P59025	RTP1	Receptor-transporting protein 1	GO:0051205; P:protein insertion into membrane; IDA:HGNC
Q9BQQ7	RTP3	Receptor-transporting protein 3	GO:0005515; F:protein binding; IPI:HGNC
Q9BQQ7	RTP3	Receptor-transporting protein 3	GO:0001580; P:detection of chemical stimulus involved in sensory perception of bitter taste; IDA:HGNC
Q9BQQ7	RTP3	Receptor-transporting protein 3	GO:0006612; P:protein targeting to membrane; IDA:HGNC
Q96DX8	RTP4	Receptor-transporting protein 4	GO:0005515; F:protein binding; IPI:HGNC
Q96DX8	RTP4	Receptor-transporting protein 4	GO:0001580; P:detection of chemical stimulus involved in sensory perception of bitter taste; IDA:HGNC
Q96DX8	RTP4	Receptor-transporting protein 4	GO:0006612; P:protein targeting to membrane; IDA:HGNC
Q5QGT7	RTP2	Receptor-transporting protein 2	GO:0031849; F:olfactory receptor binding; IMP:HGNC
Q5QGT7	RTP2	Receptor-transporting protein 2	GO:0051205; P:protein insertion into membrane; IDA:HGNC
Q86VV8	RTTN	Rotatin	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
P08621	SNRNP70	U1 small nuclear ribonucleoprotein 70 kDa	GO:0000166; F:nucleotide binding; IEA:InterPro
P08621	SNRNP70	U1 small nuclear ribonucleoprotein 70 kDa	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P08621	SNRNP70	U1 small nuclear ribonucleoprotein 70 kDa	GO:0005515; F:protein binding; IPI:UniProtKB
P08621	SNRNP70	U1 small nuclear ribonucleoprotein 70 kDa	GO:0003723; F:RNA binding; IMP:UniProtKB
P08621	SNRNP70	U1 small nuclear ribonucleoprotein 70 kDa	GO:0010467; P:gene expression; TAS:Reactome
P08621	SNRNP70	U1 small nuclear ribonucleoprotein 70 kDa	GO:0006397; P:mRNA processing; TAS:ProtInc
P08621	SNRNP70	U1 small nuclear ribonucleoprotein 70 kDa	GO:0000398; P:mRNA splicing, via spliceosome; IDA:UniProtKB
P08621	SNRNP70	U1 small nuclear ribonucleoprotein 70 kDa	GO:0043484; P:regulation of RNA splicing; IMP:UniProtKB
P08621	SNRNP70	U1 small nuclear ribonucleoprotein 70 kDa	GO:0008380; P:RNA splicing; TAS:Reactome
P09234	SNRPC	U1 small nuclear ribonucleoprotein C	GO:0003729; F:mRNA binding; IEA:UniProtKB-HAMAP
P09234	SNRPC	U1 small nuclear ribonucleoprotein C	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P09234	SNRPC	U1 small nuclear ribonucleoprotein C	GO:0005515; F:protein binding; IPI:UniProtKB
P09234	SNRPC	U1 small nuclear ribonucleoprotein C	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P09234	SNRPC	U1 small nuclear ribonucleoprotein C	GO:0003727; F:single-stranded RNA binding; IDA:UniProtKB
P09234	SNRPC	U1 small nuclear ribonucleoprotein C	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P09234	SNRPC	U1 small nuclear ribonucleoprotein C	GO:0000395; P:mRNA 5'-splice site recognition; IEA:UniProtKB-HAMAP
P09234	SNRPC	U1 small nuclear ribonucleoprotein C	GO:0000398; P:mRNA splicing, via spliceosome; IDA:UniProtKB
P09234	SNRPC	U1 small nuclear ribonucleoprotein C	GO:0000387; P:spliceosomal snRNP assembly; IDA:UniProtKB
P09661	SNRPA1	U2 small nuclear ribonucleoprotein A'	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P09661	SNRPA1	U2 small nuclear ribonucleoprotein A'	GO:0005515; F:protein binding; IPI:IntAct
P09661	SNRPA1	U2 small nuclear ribonucleoprotein A'	GO:0010467; P:gene expression; TAS:Reactome
P09661	SNRPA1	U2 small nuclear ribonucleoprotein A'	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P09661	SNRPA1	U2 small nuclear ribonucleoprotein A'	GO:0008380; P:RNA splicing; TAS:Reactome
P08579	SNRPB2	U2 small nuclear ribonucleoprotein B''	GO:0000166; F:nucleotide binding; IEA:InterPro
P08579	SNRPB2	U2 small nuclear ribonucleoprotein B''	GO:0005515; F:protein binding; IPI:IntAct
P08579	SNRPB2	U2 small nuclear ribonucleoprotein B''	GO:0017069; F:snRNA binding; IEA:InterPro
P08579	SNRPB2	U2 small nuclear ribonucleoprotein B''	GO:0010467; P:gene expression; TAS:Reactome
P08579	SNRPB2	U2 small nuclear ribonucleoprotein B''	GO:0006397; P:mRNA processing; TAS:ProtInc
P08579	SNRPB2	U2 small nuclear ribonucleoprotein B''	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P08579	SNRPB2	U2 small nuclear ribonucleoprotein B''	GO:0008380; P:RNA splicing; TAS:Reactome
Q92622	KIAA0226	Run domain Beclin-1 interacting and cysteine-rich containing protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q92622	KIAA0226	Run domain Beclin-1 interacting and cysteine-rich containing protein	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q92622	KIAA0226	Run domain Beclin-1 interacting and cysteine-rich containing protein	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q92622	KIAA0226	Run domain Beclin-1 interacting and cysteine-rich containing protein	GO:0010507; P:negative regulation of autophagy; IMP:UniProtKB
Q92622	KIAA0226	Run domain Beclin-1 interacting and cysteine-rich containing protein	GO:0045806; P:negative regulation of endocytosis; IMP:UniProtKB
Q96T51	RUFY1	RUN and FYVE domain-containing protein 1	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q96T51	RUFY1	RUN and FYVE domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q96T51	RUFY1	RUN and FYVE domain-containing protein 1	GO:0008565; F:protein transporter activity; IEA:Ensembl
Q96T51	RUFY1	RUN and FYVE domain-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96T51	RUFY1	RUN and FYVE domain-containing protein 1	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q96T51	RUFY1	RUN and FYVE domain-containing protein 1	GO:0030100; P:regulation of endocytosis; IEA:Ensembl
Q8WXA3	RUFY2	RUN and FYVE domain-containing protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7L099	RUFY3	Protein RUFY3	GO:0050771; P:negative regulation of axonogenesis; ISS:HGNC
Q6ZNE9	RUFY4	RUN and FYVE domain-containing protein 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q59EK9	RUNDC3A	RUN domain-containing protein 3A	GO:0030250; F:guanylate cyclase activator activity; IEA:Ensembl
Q59EK9	RUNDC3A	RUN domain-containing protein 3A	GO:0005083; F:small GTPase regulator activity; TAS:ProtInc
Q59EK9	RUNDC3A	RUN domain-containing protein 3A	GO:0030828; P:positive regulation of cGMP biosynthetic process; IEA:Ensembl
Q59EK9	RUNDC3A	RUN domain-containing protein 3A	GO:0007264; P:small GTPase mediated signal transduction; TAS:ProtInc
Q01196	RUNX1	Runt-related transcription factor 1	GO:0005524; F:ATP binding; IEA:InterPro
Q01196	RUNX1	Runt-related transcription factor 1	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q01196	RUNX1	Runt-related transcription factor 1	GO:0003677; F:DNA binding; IDA:UniProtKB
Q01196	RUNX1	Runt-related transcription factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q01196	RUNX1	Runt-related transcription factor 1	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
Q01196	RUNX1	Runt-related transcription factor 1	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q01196	RUNX1	Runt-related transcription factor 1	GO:0000975; F:regulatory region DNA binding; IDA:UniProtKB
Q01196	RUNX1	Runt-related transcription factor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q01196	RUNX1	Runt-related transcription factor 1	GO:0008134; F:transcription factor binding; IDA:UniProtKB
Q01196	RUNX1	Runt-related transcription factor 1	GO:0048266; P:behavioral response to pain; IEA:Ensembl
Q01196	RUNX1	Runt-related transcription factor 1	GO:0007417; P:central nervous system development; IEA:Ensembl
Q01196	RUNX1	Runt-related transcription factor 1	GO:0060216; P:definitive hemopoiesis; IEA:Ensembl
Q01196	RUNX1	Runt-related transcription factor 1	GO:0035162; P:embryonic hemopoiesis; IEA:Ensembl
Q01196	RUNX1	Runt-related transcription factor 1	GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl
Q01196	RUNX1	Runt-related transcription factor 1	GO:0071425; P:hematopoietic stem cell proliferation; TAS:UniProtKB
Q01196	RUNX1	Runt-related transcription factor 1	GO:0030097; P:hemopoiesis; IDA:UniProtKB
Q01196	RUNX1	Runt-related transcription factor 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q01196	RUNX1	Runt-related transcription factor 1	GO:0001889; P:liver development; IEA:Ensembl
Q01196	RUNX1	Runt-related transcription factor 1	GO:0030099; P:myeloid cell differentiation; IDA:UniProtKB
Q01196	RUNX1	Runt-related transcription factor 1	GO:0002318; P:myeloid progenitor cell differentiation; IEA:Ensembl
Q01196	RUNX1	Runt-related transcription factor 1	GO:0030853; P:negative regulation of granulocyte differentiation; IMP:UniProtKB
Q01196	RUNX1	Runt-related transcription factor 1	GO:0048935; P:peripheral nervous system neuron development; TAS:BHF-UCL
Q01196	RUNX1	Runt-related transcription factor 1	GO:0045766; P:positive regulation of angiogenesis; ISS:UniProtKB
Q01196	RUNX1	Runt-related transcription factor 1	GO:0030854; P:positive regulation of granulocyte differentiation; IMP:UniProtKB
Q01196	RUNX1	Runt-related transcription factor 1	GO:2000872; P:positive regulation of progesterone secretion; IEA:Ensembl
Q01196	RUNX1	Runt-related transcription factor 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q01196	RUNX1	Runt-related transcription factor 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q01196	RUNX1	Runt-related transcription factor 1	GO:0071336; P:regulation of hair follicle cell proliferation; IEA:Ensembl
Q01196	RUNX1	Runt-related transcription factor 1	GO:0009966; P:regulation of signal transduction; IEA:Ensembl
Q01196	RUNX1	Runt-related transcription factor 1	GO:0001501; P:skeletal system development; IEA:Ensembl
Q01196	RUNX1	Runt-related transcription factor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13950	RUNX2	Runt-related transcription factor 2	GO:0005524; F:ATP binding; IEA:InterPro
Q13950	RUNX2	Runt-related transcription factor 2	GO:0003682; F:chromatin binding; IEA:Ensembl
Q13950	RUNX2	Runt-related transcription factor 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q13950	RUNX2	Runt-related transcription factor 2	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl
Q13950	RUNX2	Runt-related transcription factor 2	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q13950	RUNX2	Runt-related transcription factor 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
Q13950	RUNX2	Runt-related transcription factor 2	GO:0030509; P:BMP signaling pathway; ISS:BHF-UCL
Q13950	RUNX2	Runt-related transcription factor 2	GO:0048469; P:cell maturation; IEA:Ensembl
Q13950	RUNX2	Runt-related transcription factor 2	GO:0071773; P:cellular response to BMP stimulus; ISS:BHF-UCL
Q13950	RUNX2	Runt-related transcription factor 2	GO:0002063; P:chondrocyte development; IEA:Ensembl
Q13950	RUNX2	Runt-related transcription factor 2	GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl
Q13950	RUNX2	Runt-related transcription factor 2	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
Q13950	RUNX2	Runt-related transcription factor 2	GO:0001958; P:endochondral ossification; IEA:Ensembl
Q13950	RUNX2	Runt-related transcription factor 2	GO:0010467; P:gene expression; TAS:Reactome
Q13950	RUNX2	Runt-related transcription factor 2	GO:0045879; P:negative regulation of smoothened signaling pathway; IEA:Ensembl
Q13950	RUNX2	Runt-related transcription factor 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q13950	RUNX2	Runt-related transcription factor 2	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
Q13950	RUNX2	Runt-related transcription factor 2	GO:0001503; P:ossification; TAS:UniProtKB
Q13950	RUNX2	Runt-related transcription factor 2	GO:0002076; P:osteoblast development; IEA:Ensembl
Q13950	RUNX2	Runt-related transcription factor 2	GO:0001649; P:osteoblast differentiation; IEP:UniProtKB
Q13950	RUNX2	Runt-related transcription factor 2	GO:0002051; P:osteoblast fate commitment; IEA:Ensembl
Q13950	RUNX2	Runt-related transcription factor 2	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q13950	RUNX2	Runt-related transcription factor 2	GO:0032332; P:positive regulation of chondrocyte differentiation; IEA:Ensembl
Q13950	RUNX2	Runt-related transcription factor 2	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
Q13950	RUNX2	Runt-related transcription factor 2	GO:1901522; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; ISS:BHF-UCL
Q13950	RUNX2	Runt-related transcription factor 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q13950	RUNX2	Runt-related transcription factor 2	GO:0040036; P:regulation of fibroblast growth factor receptor signaling pathway; IEA:Ensembl
Q13950	RUNX2	Runt-related transcription factor 2	GO:0042487; P:regulation of odontogenesis of dentin-containing tooth; IEA:Ensembl
Q13950	RUNX2	Runt-related transcription factor 2	GO:0048863; P:stem cell differentiation; IEA:Ensembl
Q13950	RUNX2	Runt-related transcription factor 2	GO:0030217; P:T cell differentiation; IEA:Ensembl
Q13950	RUNX2	Runt-related transcription factor 2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q13761	RUNX3	Runt-related transcription factor 3	GO:0005524; F:ATP binding; NAS:UniProtKB
Q13761	RUNX3	Runt-related transcription factor 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q13761	RUNX3	Runt-related transcription factor 3	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; ISS:BHF-UCL
Q13761	RUNX3	Runt-related transcription factor 3	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; ISS:BHF-UCL
Q13761	RUNX3	Runt-related transcription factor 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q13761	RUNX3	Runt-related transcription factor 3	GO:0007411; P:axon guidance; IEA:Ensembl
Q13761	RUNX3	Runt-related transcription factor 3	GO:0048469; P:cell maturation; IEA:Ensembl
Q13761	RUNX3	Runt-related transcription factor 3	GO:0002062; P:chondrocyte differentiation; IEA:Ensembl
Q13761	RUNX3	Runt-related transcription factor 3	GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl
Q13761	RUNX3	Runt-related transcription factor 3	GO:0032609; P:interferon-gamma production; IEA:Ensembl
Q13761	RUNX3	Runt-related transcription factor 3	GO:0045786; P:negative regulation of cell cycle; ISS:UniProtKB
Q13761	RUNX3	Runt-related transcription factor 3	GO:0050680; P:negative regulation of epithelial cell proliferation; ISS:UniProtKB
Q13761	RUNX3	Runt-related transcription factor 3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q13761	RUNX3	Runt-related transcription factor 3	GO:0048935; P:peripheral nervous system neuron development; TAS:BHF-UCL
Q13761	RUNX3	Runt-related transcription factor 3	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl
Q13761	RUNX3	Runt-related transcription factor 3	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q13761	RUNX3	Runt-related transcription factor 3	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q13761	RUNX3	Runt-related transcription factor 3	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9BVN2	RUSC1	RUN and SH3 domain-containing protein 1	GO:0003779; F:actin binding; ISS:UniProtKB
Q9BVN2	RUSC1	RUN and SH3 domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9BVN2	RUSC1	RUN and SH3 domain-containing protein 1	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
Q9BVN2	RUSC1	RUN and SH3 domain-containing protein 1	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
Q9BVN2	RUSC1	RUN and SH3 domain-containing protein 1	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q9UJJ7	RPUSD1	RNA pseudouridylate synthase domain-containing protein 1	GO:0009982; F:pseudouridine synthase activity; IEA:InterPro
Q9UJJ7	RPUSD1	RNA pseudouridylate synthase domain-containing protein 1	GO:0003723; F:RNA binding; IEA:InterPro
Q9UJJ7	RPUSD1	RNA pseudouridylate synthase domain-containing protein 1	GO:0001522; P:pseudouridine synthesis; IEA:InterPro
Q8IZ73	RPUSD2	RNA pseudouridylate synthase domain-containing protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IZ73	RPUSD2	RNA pseudouridylate synthase domain-containing protein 2	GO:0009982; F:pseudouridine synthase activity; IEA:InterPro
Q8IZ73	RPUSD2	RNA pseudouridylate synthase domain-containing protein 2	GO:0001522; P:pseudouridine synthesis; IEA:InterPro
Q6P087	RPUSD3	RNA pseudouridylate synthase domain-containing protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6P087	RPUSD3	RNA pseudouridylate synthase domain-containing protein 3	GO:0009982; F:pseudouridine synthase activity; IEA:InterPro
Q6P087	RPUSD3	RNA pseudouridylate synthase domain-containing protein 3	GO:0001522; P:pseudouridine synthesis; IEA:InterPro
Q96CM3	RPUSD4	RNA pseudouridylate synthase domain-containing protein 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96CM3	RPUSD4	RNA pseudouridylate synthase domain-containing protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q96CM3	RPUSD4	RNA pseudouridylate synthase domain-containing protein 4	GO:0009982; F:pseudouridine synthase activity; IEA:InterPro
Q96CM3	RPUSD4	RNA pseudouridylate synthase domain-containing protein 4	GO:0001522; P:pseudouridine synthesis; IEA:InterPro
Q9Y265	RUVBL1	RuvB-like 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y265	RUVBL1	RuvB-like 1	GO:0003678; F:DNA helicase activity; IDA:UniProtKB
Q9Y265	RUVBL1	RuvB-like 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y265	RUVBL1	RuvB-like 1	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
Q9Y265	RUVBL1	RuvB-like 1	GO:0006325; P:chromatin organization; TAS:Reactome
Q9Y265	RUVBL1	RuvB-like 1	GO:0032508; P:DNA duplex unwinding; IDA:GOC
Q9Y265	RUVBL1	RuvB-like 1	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q9Y265	RUVBL1	RuvB-like 1	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q9Y265	RUVBL1	RuvB-like 1	GO:0043968; P:histone H2A acetylation; IDA:UniProtKB
Q9Y265	RUVBL1	RuvB-like 1	GO:0043967; P:histone H4 acetylation; IDA:UniProtKB
Q9Y265	RUVBL1	RuvB-like 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9Y265	RUVBL1	RuvB-like 1	GO:0006334; P:nucleosome assembly; TAS:Reactome
Q9Y265	RUVBL1	RuvB-like 1	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q9Y265	RUVBL1	RuvB-like 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9Y265	RUVBL1	RuvB-like 1	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q9Y265	RUVBL1	RuvB-like 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y230	RUVBL2	RuvB-like 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y230	RUVBL2	RuvB-like 2	GO:0043141; F:ATP-dependent 5'-3' DNA helicase activity; IEA:InterPro
Q9Y230	RUVBL2	RuvB-like 2	GO:0004003; F:ATP-dependent DNA helicase activity; TAS:ProtInc
Q9Y230	RUVBL2	RuvB-like 2	GO:0031490; F:chromatin DNA binding; IDA:UniProt
Q9Y230	RUVBL2	RuvB-like 2	GO:0003684; F:damaged DNA binding; IEA:InterPro
Q9Y230	RUVBL2	RuvB-like 2	GO:0003678; F:DNA helicase activity; IDA:UniProtKB
Q9Y230	RUVBL2	RuvB-like 2	GO:0042802; F:identical protein binding; IDA:UniProtKB
Q9Y230	RUVBL2	RuvB-like 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y230	RUVBL2	RuvB-like 2	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IDA:UniProt
Q9Y230	RUVBL2	RuvB-like 2	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IDA:UniProt
Q9Y230	RUVBL2	RuvB-like 2	GO:0051082; F:unfolded protein binding; TAS:ProtInc
Q9Y230	RUVBL2	RuvB-like 2	GO:0006200; P:ATP catabolic process; IDA:GOC
Q9Y230	RUVBL2	RuvB-like 2	GO:0071392; P:cellular response to estradiol stimulus; IMP:UniProt
Q9Y230	RUVBL2	RuvB-like 2	GO:0034644; P:cellular response to UV; IMP:UniProtKB
Q9Y230	RUVBL2	RuvB-like 2	GO:0006325; P:chromatin organization; TAS:Reactome
Q9Y230	RUVBL2	RuvB-like 2	GO:0006338; P:chromatin remodeling; IMP:UniProt
Q9Y230	RUVBL2	RuvB-like 2	GO:0032508; P:DNA duplex unwinding; IDA:GOC
Q9Y230	RUVBL2	RuvB-like 2	GO:0006310; P:DNA recombination; TAS:ProtInc
Q9Y230	RUVBL2	RuvB-like 2	GO:0006281; P:DNA repair; TAS:ProtInc
Q9Y230	RUVBL2	RuvB-like 2	GO:0071169; P:establishment of protein localization to chromatin; IMP:UniProt
Q9Y230	RUVBL2	RuvB-like 2	GO:0043968; P:histone H2A acetylation; IDA:UniProtKB
Q9Y230	RUVBL2	RuvB-like 2	GO:0043967; P:histone H4 acetylation; IDA:UniProtKB
Q9Y230	RUVBL2	RuvB-like 2	GO:0071899; P:negative regulation of estrogen receptor binding; IMP:UniProt
Q9Y230	RUVBL2	RuvB-like 2	GO:0035066; P:positive regulation of histone acetylation; IMP:UniProt
Q9Y230	RUVBL2	RuvB-like 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProt
Q9Y230	RUVBL2	RuvB-like 2	GO:0006457; P:protein folding; TAS:ProtInc
Q9Y230	RUVBL2	RuvB-like 2	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q9Y230	RUVBL2	RuvB-like 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y230	RUVBL2	RuvB-like 2	GO:0071733; P:transcriptional activation by promoter-enhancer looping; IMP:UniProt
P62304	SNRPE	Small nuclear ribonucleoprotein E	GO:0005515; F:protein binding; IPI:UniProtKB
P62304	SNRPE	Small nuclear ribonucleoprotein E	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
P62304	SNRPE	Small nuclear ribonucleoprotein E	GO:0010467; P:gene expression; TAS:Reactome
P62304	SNRPE	Small nuclear ribonucleoprotein E	GO:0042633; P:hair cycle; IMP:UniProtKB
P62304	SNRPE	Small nuclear ribonucleoprotein E	GO:0008334; P:histone mRNA metabolic process; TAS:Reactome
P62304	SNRPE	Small nuclear ribonucleoprotein E	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
P62304	SNRPE	Small nuclear ribonucleoprotein E	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P62304	SNRPE	Small nuclear ribonucleoprotein E	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
P62304	SNRPE	Small nuclear ribonucleoprotein E	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62304	SNRPE	Small nuclear ribonucleoprotein E	GO:0008380; P:RNA splicing; TAS:Reactome
P62304	SNRPE	Small nuclear ribonucleoprotein E	GO:0000245; P:spliceosomal complex assembly; NAS:UniProtKB
P62304	SNRPE	Small nuclear ribonucleoprotein E	GO:0000387; P:spliceosomal snRNP assembly; IDA:UniProtKB
P62304	SNRPE	Small nuclear ribonucleoprotein E	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
P62304	SNRPE	Small nuclear ribonucleoprotein E	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
DR   GO:0003723; F:RNA binding; IEA:UniProtKB-KW
DR   GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
DR   GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
P62306	SNRPF	Small nuclear ribonucleoprotein F	GO:0005515; F:protein binding; IPI:IntAct
P62306	SNRPF	Small nuclear ribonucleoprotein F	GO:0003723; F:RNA binding; IMP:UniProtKB
P62306	SNRPF	Small nuclear ribonucleoprotein F	GO:0010467; P:gene expression; TAS:Reactome
P62306	SNRPF	Small nuclear ribonucleoprotein F	GO:0008334; P:histone mRNA metabolic process; TAS:Reactome
P62306	SNRPF	Small nuclear ribonucleoprotein F	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
P62306	SNRPF	Small nuclear ribonucleoprotein F	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P62306	SNRPF	Small nuclear ribonucleoprotein F	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
P62306	SNRPF	Small nuclear ribonucleoprotein F	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62306	SNRPF	Small nuclear ribonucleoprotein F	GO:0008380; P:RNA splicing; IMP:UniProtKB
P62306	SNRPF	Small nuclear ribonucleoprotein F	GO:0000387; P:spliceosomal snRNP assembly; IDA:UniProtKB
P62306	SNRPF	Small nuclear ribonucleoprotein F	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
P62306	SNRPF	Small nuclear ribonucleoprotein F	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
P62308	SNRPG	Small nuclear ribonucleoprotein G	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62308	SNRPG	Small nuclear ribonucleoprotein G	GO:0005515; F:protein binding; IPI:IntAct
P62308	SNRPG	Small nuclear ribonucleoprotein G	GO:0010467; P:gene expression; TAS:Reactome
P62308	SNRPG	Small nuclear ribonucleoprotein G	GO:0008334; P:histone mRNA metabolic process; TAS:Reactome
P62308	SNRPG	Small nuclear ribonucleoprotein G	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
P62308	SNRPG	Small nuclear ribonucleoprotein G	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P62308	SNRPG	Small nuclear ribonucleoprotein G	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
P62308	SNRPG	Small nuclear ribonucleoprotein G	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62308	SNRPG	Small nuclear ribonucleoprotein G	GO:0008380; P:RNA splicing; TAS:UniProtKB
P62308	SNRPG	Small nuclear ribonucleoprotein G	GO:0000245; P:spliceosomal complex assembly; NAS:UniProtKB
P62308	SNRPG	Small nuclear ribonucleoprotein G	GO:0000387; P:spliceosomal snRNP assembly; IDA:UniProtKB
P62308	SNRPG	Small nuclear ribonucleoprotein G	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
P62308	SNRPG	Small nuclear ribonucleoprotein G	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q9H446	RWDD1	RWD domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3V2	RWDD3	RWD domain-containing protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q9HBX9	RXFP1	Relaxin receptor 1	GO:0004930; F:G-protein coupled receptor activity; IEA:InterPro
Q9HBX9	RXFP1	Relaxin receptor 1	GO:0042562; F:hormone binding; IEA:Ensembl
Q9HBX9	RXFP1	Relaxin receptor 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HBX9	RXFP1	Relaxin receptor 1	GO:0005515; F:protein binding; IPI:IntAct
Q9HBX9	RXFP1	Relaxin receptor 1	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IEA:Ensembl
Q9HBX9	RXFP1	Relaxin receptor 1	GO:0030154; P:cell differentiation; IEA:Ensembl
Q9HBX9	RXFP1	Relaxin receptor 1	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q9HBX9	RXFP1	Relaxin receptor 1	GO:0060427; P:lung connective tissue development; IEA:Ensembl
Q9HBX9	RXFP1	Relaxin receptor 1	GO:0060658; P:nipple morphogenesis; IEA:Ensembl
Q9HBX9	RXFP1	Relaxin receptor 1	GO:0007567; P:parturition; IEA:Ensembl
Q8WXD0	RXFP2	Relaxin receptor 2	GO:0017046; F:peptide hormone binding; IEA:Ensembl
Q8WXD0	RXFP2	Relaxin receptor 2	GO:0016500; F:protein-hormone receptor activity; IEA:Ensembl
Q8WXD0	RXFP2	Relaxin receptor 2	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
Q8WXD0	RXFP2	Relaxin receptor 2	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IEA:Ensembl
Q8WXD0	RXFP2	Relaxin receptor 2	GO:0008584; P:male gonad development; IEA:Ensembl
Q8WXD0	RXFP2	Relaxin receptor 2	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q8WXD0	RXFP2	Relaxin receptor 2	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q8WXD0	RXFP2	Relaxin receptor 2	GO:0001556; P:oocyte maturation; IEA:Ensembl
Q8WXD0	RXFP2	Relaxin receptor 2	GO:0030819; P:positive regulation of cAMP biosynthetic process; IEA:Ensembl
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0004886; F:9-cis retinoic acid receptor activity; TAS:ProtInc
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0031490; F:chromatin DNA binding; IEA:Ensembl
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0003677; F:DNA binding; IDA:MGI
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0019899; F:enzyme binding; IPI:UniProtKB
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:BHF-UCL
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0003708; F:retinoic acid receptor activity; TAS:BHF-UCL
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0044323; F:retinoic acid-responsive element binding; IDA:UniProtKB
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0042809; F:vitamin D receptor binding; IPI:BHF-UCL
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0008270; F:zinc ion binding; IEA:InterPro
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0060038; P:cardiac muscle cell proliferation; IEA:Ensembl
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0008203; P:cholesterol metabolic process; TAS:BHF-UCL
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0007566; P:embryo implantation; IEA:Ensembl
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0010467; P:gene expression; TAS:Reactome
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0001893; P:maternal placenta development; IEA:Ensembl
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0019048; P:modulation by virus of host morphology or physiology; IDA:UniProtKB
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0035357; P:peroxisome proliferator activated receptor signaling pathway; IDA:UniProtKB
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0060687; P:regulation of branching involved in prostate gland morphogenesis; IEA:Ensembl
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0032526; P:response to retinoic acid; IMP:BHF-UCL
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0048384; P:retinoic acid receptor signaling pathway; IMP:BHF-UCL
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0060528; P:secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development; IEA:Ensembl
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0055012; P:ventricular cardiac muscle cell differentiation; IEA:Ensembl
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IEA:Ensembl
P19793	RXRA	Retinoic acid receptor RXR-alpha	GO:0006766; P:vitamin metabolic process; TAS:ProtInc
P28702	RXRB	Retinoic acid receptor RXR-beta	GO:0004886; F:9-cis retinoic acid receptor activity; TAS:ProtInc
P28702	RXRB	Retinoic acid receptor RXR-beta	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:BHF-UCL
P28702	RXRB	Retinoic acid receptor RXR-beta	GO:0005515; F:protein binding; IPI:IntAct
P28702	RXRB	Retinoic acid receptor RXR-beta	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P28702	RXRB	Retinoic acid receptor RXR-beta	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
P28702	RXRB	Retinoic acid receptor RXR-beta	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P28702	RXRB	Retinoic acid receptor RXR-beta	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P28702	RXRB	Retinoic acid receptor RXR-beta	GO:0044212; F:transcription regulatory region DNA binding; IEA:Ensembl
P28702	RXRB	Retinoic acid receptor RXR-beta	GO:0008270; F:zinc ion binding; IEA:InterPro
P28702	RXRB	Retinoic acid receptor RXR-beta	GO:0060038; P:cardiac muscle cell proliferation; IEA:Ensembl
P28702	RXRB	Retinoic acid receptor RXR-beta	GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl
P28702	RXRB	Retinoic acid receptor RXR-beta	GO:0010467; P:gene expression; TAS:Reactome
P28702	RXRB	Retinoic acid receptor RXR-beta	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P28702	RXRB	Retinoic acid receptor RXR-beta	GO:0001893; P:maternal placenta development; IEA:Ensembl
P28702	RXRB	Retinoic acid receptor RXR-beta	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P28702	RXRB	Retinoic acid receptor RXR-beta	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P28702	RXRB	Retinoic acid receptor RXR-beta	GO:0055012; P:ventricular cardiac muscle cell differentiation; IEA:Ensembl
P48443	RXRG	Retinoic acid receptor RXR-gamma	GO:0004886; F:9-cis retinoic acid receptor activity; TAS:ProtInc
P48443	RXRG	Retinoic acid receptor RXR-gamma	GO:0005515; F:protein binding; IPI:IntAct
P48443	RXRG	Retinoic acid receptor RXR-gamma	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P48443	RXRG	Retinoic acid receptor RXR-gamma	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P48443	RXRG	Retinoic acid receptor RXR-gamma	GO:0008270; F:zinc ion binding; IEA:InterPro
P48443	RXRG	Retinoic acid receptor RXR-gamma	GO:0010467; P:gene expression; TAS:Reactome
P48443	RXRG	Retinoic acid receptor RXR-gamma	GO:0007507; P:heart development; IEA:Ensembl
P48443	RXRG	Retinoic acid receptor RXR-gamma	GO:0030182; P:neuron differentiation; IEA:Ensembl
P48443	RXRG	Retinoic acid receptor RXR-gamma	GO:0007422; P:peripheral nervous system development; IEA:Ensembl
P48443	RXRG	Retinoic acid receptor RXR-gamma	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P48443	RXRG	Retinoic acid receptor RXR-gamma	GO:0031641; P:regulation of myelination; IEA:Ensembl
P48443	RXRG	Retinoic acid receptor RXR-gamma	GO:0032526; P:response to retinoic acid; IEA:Ensembl
P48443	RXRG	Retinoic acid receptor RXR-gamma	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
P48443	RXRG	Retinoic acid receptor RXR-gamma	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q9Y2V3	RAX	Retinal homeobox protein Rx	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9Y2V3	RAX	Retinal homeobox protein Rx	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9Y2V3	RAX	Retinal homeobox protein Rx	GO:0043010; P:camera-type eye development; IEA:Ensembl
Q9Y2V3	RAX	Retinal homeobox protein Rx	GO:0021854; P:hypothalamus development; IEA:Ensembl
Q9Y2V3	RAX	Retinal homeobox protein Rx	GO:0060173; P:limb development; IEA:Ensembl
Q9Y2V3	RAX	Retinal homeobox protein Rx	GO:0007389; P:pattern specification process; IEA:Ensembl
Q9Y2V3	RAX	Retinal homeobox protein Rx	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2V3	RAX	Retinal homeobox protein Rx	GO:0007601; P:visual perception; TAS:ProtInc
Q8N488	RYBP	RING1 and YY1-binding protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N488	RYBP	RING1 and YY1-binding protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N488	RYBP	RING1 and YY1-binding protein	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q8N488	RYBP	RING1 and YY1-binding protein	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N488	RYBP	RING1 and YY1-binding protein	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8N488	RYBP	RING1 and YY1-binding protein	GO:0035518; P:histone H2A monoubiquitination; IDA:UniProtKB
Q8N488	RYBP	RING1 and YY1-binding protein	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q8N488	RYBP	RING1 and YY1-binding protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q8N488	RYBP	RING1 and YY1-binding protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P34925	RYK	Tyrosine-protein kinase RYK	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P34925	RYK	Tyrosine-protein kinase RYK	GO:0005515; F:protein binding; IPI:UniProtKB
P34925	RYK	Tyrosine-protein kinase RYK	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; TAS:ProtInc
P34925	RYK	Tyrosine-protein kinase RYK	GO:0004888; F:transmembrane signaling receptor activity; IDA:UniProtKB
P34925	RYK	Tyrosine-protein kinase RYK	GO:0042813; F:Wnt-activated receptor activity; IEA:Ensembl
P34925	RYK	Tyrosine-protein kinase RYK	GO:0007411; P:axon guidance; ISS:UniProtKB
P34925	RYK	Tyrosine-protein kinase RYK	GO:0071679; P:commissural neuron axon guidance; IEA:Ensembl
P34925	RYK	Tyrosine-protein kinase RYK	GO:0022038; P:corpus callosum development; ISS:UniProtKB
P34925	RYK	Tyrosine-protein kinase RYK	GO:0050919; P:negative chemotaxis; IEA:Ensembl
P34925	RYK	Tyrosine-protein kinase RYK	GO:0048843; P:negative regulation of axon extension involved in axon guidance; IEA:Ensembl
P34925	RYK	Tyrosine-protein kinase RYK	GO:0030182; P:neuron differentiation; ISS:UniProtKB
P34925	RYK	Tyrosine-protein kinase RYK	GO:0031175; P:neuron projection development; ISS:UniProtKB
P34925	RYK	Tyrosine-protein kinase RYK	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:GOC
P34925	RYK	Tyrosine-protein kinase RYK	GO:0043410; P:positive regulation of MAPK cascade; IDA:UniProtKB
P34925	RYK	Tyrosine-protein kinase RYK	GO:0007165; P:signal transduction; TAS:ProtInc
P34925	RYK	Tyrosine-protein kinase RYK	GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl
P34925	RYK	Tyrosine-protein kinase RYK	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P21817	RYR1	Ryanodine receptor 1	GO:0005262; F:calcium channel activity; ISS:UniProtKB
P21817	RYR1	Ryanodine receptor 1	GO:0005509; F:calcium ion binding; IEA:InterPro
P21817	RYR1	Ryanodine receptor 1	GO:0015278; F:calcium-release channel activity; TAS:ProtInc
P21817	RYR1	Ryanodine receptor 1	GO:0005516; F:calmodulin binding; ISS:BHF-UCL
P21817	RYR1	Ryanodine receptor 1	GO:0005515; F:protein binding; IPI:IntAct
P21817	RYR1	Ryanodine receptor 1	GO:0005219; F:ryanodine-sensitive calcium-release channel activity; ISS:UniProtKB
P21817	RYR1	Ryanodine receptor 1	GO:0005245; F:voltage-gated calcium channel activity; ISS:UniProtKB
P21817	RYR1	Ryanodine receptor 1	GO:0006816; P:calcium ion transport; ISS:BHF-UCL
P21817	RYR1	Ryanodine receptor 1	GO:0071313; P:cellular response to caffeine; ISS:UniProtKB
P21817	RYR1	Ryanodine receptor 1	GO:0051480; P:cytosolic calcium ion homeostasis; ISS:BHF-UCL
P21817	RYR1	Ryanodine receptor 1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P21817	RYR1	Ryanodine receptor 1	GO:0006936; P:muscle contraction; ISS:UniProtKB
P21817	RYR1	Ryanodine receptor 1	GO:0043931; P:ossification involved in bone maturation; ISS:UniProtKB
P21817	RYR1	Ryanodine receptor 1	GO:0003151; P:outflow tract morphogenesis; ISS:UniProtKB
P21817	RYR1	Ryanodine receptor 1	GO:0051209; P:release of sequestered calcium ion into cytosol; ISS:BHF-UCL
P21817	RYR1	Ryanodine receptor 1	GO:0014808; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; ISS:UniProtKB
P21817	RYR1	Ryanodine receptor 1	GO:0031000; P:response to caffeine; ISS:BHF-UCL
P21817	RYR1	Ryanodine receptor 1	GO:0001666; P:response to hypoxia; IDA:BHF-UCL
P21817	RYR1	Ryanodine receptor 1	GO:0048741; P:skeletal muscle fiber development; ISS:UniProtKB
P21817	RYR1	Ryanodine receptor 1	GO:0043588; P:skin development; ISS:UniProtKB
P21817	RYR1	Ryanodine receptor 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q92736	RYR2	Ryanodine receptor 2	GO:0005262; F:calcium channel activity; ISS:UniProtKB
Q92736	RYR2	Ryanodine receptor 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q92736	RYR2	Ryanodine receptor 2	GO:0048763; F:calcium-induced calcium release activity; IDA:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0015278; F:calcium-release channel activity; IDA:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0005516; F:calmodulin binding; IMP:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0019899; F:enzyme binding; IPI:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0042802; F:identical protein binding; IPI:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0005218; F:intracellular ligand-gated calcium channel activity; ISS:UniProtKB
Q92736	RYR2	Ryanodine receptor 2	GO:0044325; F:ion channel binding; ISS:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q92736	RYR2	Ryanodine receptor 2	GO:0034236; F:protein kinase A catalytic subunit binding; IDA:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0034237; F:protein kinase A regulatory subunit binding; IDA:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0005219; F:ryanodine-sensitive calcium-release channel activity; IDA:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0043924; F:suramin binding; IMP:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0030509; P:BMP signaling pathway; IEA:Ensembl
Q92736	RYR2	Ryanodine receptor 2	GO:0006816; P:calcium ion transport; IDA:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0060402; P:calcium ion transport into cytosol; IDA:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0019722; P:calcium-mediated signaling; ISS:UniProtKB
Q92736	RYR2	Ryanodine receptor 2	GO:0035584; P:calcium-mediated signaling using intracellular calcium source; IDA:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
Q92736	RYR2	Ryanodine receptor 2	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0003300; P:cardiac muscle hypertrophy; ISS:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0086064; P:cell communication by electrical coupling involved in cardiac conduction; IC:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0006874; P:cellular calcium ion homeostasis; ISS:UniProtKB
Q92736	RYR2	Ryanodine receptor 2	GO:0071313; P:cellular response to caffeine; ISS:UniProtKB
Q92736	RYR2	Ryanodine receptor 2	GO:0071872; P:cellular response to epinephrine stimulus; TAS:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0051480; P:cytosolic calcium ion homeostasis; ISS:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0005513; P:detection of calcium ion; IDA:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0003143; P:embryonic heart tube morphogenesis; ISS:UniProtKB
Q92736	RYR2	Ryanodine receptor 2	GO:0072599; P:establishment of protein localization to endoplasmic reticulum; IDA:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q92736	RYR2	Ryanodine receptor 2	GO:0003220; P:left ventricular cardiac muscle tissue morphogenesis; ISS:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:1901896; P:positive regulation of calcium-transporting ATPase activity; IDA:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0010460; P:positive regulation of heart rate; ISS:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0086094; P:positive regulation of ryanodine-sensitive calcium-release channel activity by adrenergic receptor signaling pathway involved in positive regulation of cardiac muscle contraction; ISS:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0051284; P:positive regulation of sequestering of calcium ion; IDA:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0086029; P:Purkinje myocyte to ventricular cardiac muscle cell signaling; ISS:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0055117; P:regulation of cardiac muscle contraction; IMP:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; ISS:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0002027; P:regulation of heart rate; IMP:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0051209; P:release of sequestered calcium ion into cytosol; IDA:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0014808; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; IMP:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0031000; P:response to caffeine; IDA:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0001666; P:response to hypoxia; ISS:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0051775; P:response to redox state; IDA:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0070296; P:sarcoplasmic reticulum calcium ion transport; TAS:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q92736	RYR2	Ryanodine receptor 2	GO:0097050; P:type B pancreatic cell apoptotic process; IMP:BHF-UCL
Q92736	RYR2	Ryanodine receptor 2	GO:0086005; P:ventricular cardiac muscle cell action potential; ISS:BHF-UCL
Q15413	RYR3	Ryanodine receptor 3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q15413	RYR3	Ryanodine receptor 3	GO:0048763; F:calcium-induced calcium release activity; IEA:Ensembl
Q15413	RYR3	Ryanodine receptor 3	GO:0015278; F:calcium-release channel activity; IMP:UniProtKB
Q15413	RYR3	Ryanodine receptor 3	GO:0005219; F:ryanodine-sensitive calcium-release channel activity; ISS:UniProtKB
Q15413	RYR3	Ryanodine receptor 3	GO:0070588; P:calcium ion transmembrane transport; ISS:UniProtKB
Q15413	RYR3	Ryanodine receptor 3	GO:0006816; P:calcium ion transport; IMP:UniProtKB
Q15413	RYR3	Ryanodine receptor 3	GO:0071318; P:cellular response to ATP; ISS:UniProtKB
Q15413	RYR3	Ryanodine receptor 3	GO:0071313; P:cellular response to caffeine; ISS:UniProtKB
Q15413	RYR3	Ryanodine receptor 3	GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB
Q15413	RYR3	Ryanodine receptor 3	GO:0071286; P:cellular response to magnesium ion; ISS:UniProtKB
Q15413	RYR3	Ryanodine receptor 3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q15413	RYR3	Ryanodine receptor 3	GO:0051481; P:negative regulation of cytosolic calcium ion concentration; IEA:Ensembl
Q15413	RYR3	Ryanodine receptor 3	GO:0051289; P:protein homotetramerization; ISS:UniProtKB
Q15413	RYR3	Ryanodine receptor 3	GO:0006941; P:striated muscle contraction; IEA:Ensembl
Q15413	RYR3	Ryanodine receptor 3	GO:0055085; P:transmembrane transport; TAS:Reactome
P04271	S100B	Protein S100-B	GO:0005509; F:calcium ion binding; NAS:UniProtKB
P04271	S100B	Protein S100-B	GO:0048306; F:calcium-dependent protein binding; IDA:UniProtKB
P04271	S100B	Protein S100-B	GO:0042802; F:identical protein binding; IPI:IntAct
P04271	S100B	Protein S100-B	GO:0005515; F:protein binding; IPI:UniProtKB
P04271	S100B	Protein S100-B	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P04271	S100B	Protein S100-B	GO:0050786; F:RAGE receptor binding; IPI:UniProtKB
P04271	S100B	Protein S100-B	GO:0044548; F:S100 protein binding; IPI:UniProtKB
P04271	S100B	Protein S100-B	GO:0048156; F:tau protein binding; ISS:UniProtKB
P04271	S100B	Protein S100-B	GO:0008270; F:zinc ion binding; ISS:UniProtKB
P04271	S100B	Protein S100-B	GO:0048708; P:astrocyte differentiation; IEA:Ensembl
P04271	S100B	Protein S100-B	GO:0007409; P:axonogenesis; TAS:ProtInc
P04271	S100B	Protein S100-B	GO:0008283; P:cell proliferation; TAS:ProtInc
P04271	S100B	Protein S100-B	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
P04271	S100B	Protein S100-B	GO:0007417; P:central nervous system development; TAS:ProtInc
P04271	S100B	Protein S100-B	GO:0045087; P:innate immune response; TAS:Reactome
P04271	S100B	Protein S100-B	GO:0007611; P:learning or memory; ISS:UniProtKB
P04271	S100B	Protein S100-B	GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl
P04271	S100B	Protein S100-B	GO:0007613; P:memory; IEA:Ensembl
P04271	S100B	Protein S100-B	GO:2001015; P:negative regulation of skeletal muscle cell differentiation; IEA:Ensembl
P04271	S100B	Protein S100-B	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P04271	S100B	Protein S100-B	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P04271	S100B	Protein S100-B	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
P04271	S100B	Protein S100-B	GO:0008360; P:regulation of cell shape; IEA:Ensembl
P04271	S100B	Protein S100-B	GO:0048168; P:regulation of neuronal synaptic plasticity; IEA:Ensembl
P04271	S100B	Protein S100-B	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P04271	S100B	Protein S100-B	GO:0051597; P:response to methylmercury; IEA:Ensembl
P29377	S100G	Protein S100-G	GO:0005509; F:calcium ion binding; TAS:ProtInc
P29377	S100G	Protein S100-G	GO:0005499; F:vitamin D binding; IEA:UniProtKB-KW
P25815	S100P	Protein S100-P	GO:0005509; F:calcium ion binding; TAS:ProtInc
P25815	S100P	Protein S100-P	GO:0048306; F:calcium-dependent protein binding; IPI:HGNC
P25815	S100P	Protein S100-P	GO:0000287; F:magnesium ion binding; TAS:HGNC
P25815	S100P	Protein S100-P	GO:0005515; F:protein binding; IPI:IntAct
P25815	S100P	Protein S100-P	GO:0043542; P:endothelial cell migration; IMP:UniProtKB
P25815	S100P	Protein S100-P	GO:0010033; P:response to organic substance; IEP:UniProtKB
Q8WXG8	S100Z	Protein S100-Z	GO:0005509; F:calcium ion binding; IEA:InterPro
P23297	S100A1	Protein S100-A1	GO:0051117; F:ATPase binding; IPI:UniProtKB
P23297	S100A1	Protein S100-A1	GO:0005509; F:calcium ion binding; TAS:ProtInc
P23297	S100A1	Protein S100-A1	GO:0042802; F:identical protein binding; IPI:IntAct
P23297	S100A1	Protein S100-A1	GO:0005515; F:protein binding; IPI:UniProtKB
P23297	S100A1	Protein S100-A1	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P23297	S100A1	Protein S100-A1	GO:0044548; F:S100 protein binding; IPI:UniProtKB
P23297	S100A1	Protein S100-A1	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
P23297	S100A1	Protein S100-A1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P23297	S100A1	Protein S100-A1	GO:1901387; P:positive regulation of voltage-gated calcium channel activity; IEA:Ensembl
P23297	S100A1	Protein S100-A1	GO:0008016; P:regulation of heart contraction; NAS:UniProtKB
P23297	S100A1	Protein S100-A1	GO:0021762; P:substantia nigra development; IEP:UniProt
P29034	S100A2	Protein S100-A2	GO:0005509; F:calcium ion binding; NAS:UniProtKB
P29034	S100A2	Protein S100-A2	GO:0042802; F:identical protein binding; IPI:IntAct
P29034	S100A2	Protein S100-A2	GO:0005515; F:protein binding; IPI:IntAct
P29034	S100A2	Protein S100-A2	GO:0043542; P:endothelial cell migration; IMP:UniProtKB
P33764	S100A3	Protein S100-A3	GO:0005509; F:calcium ion binding; IEA:InterPro
P33764	S100A3	Protein S100-A3	GO:0008270; F:zinc ion binding; IEA:InterPro
P26447	S100A4	Protein S100-A4	GO:0005509; F:calcium ion binding; TAS:ProtInc
P26447	S100A4	Protein S100-A4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P26447	S100A4	Protein S100-A4	GO:0005515; F:protein binding; IPI:UniProtKB
P26447	S100A4	Protein S100-A4	GO:0050786; F:RAGE receptor binding; IPI:UniProtKB
P26447	S100A4	Protein S100-A4	GO:0001837; P:epithelial to mesenchymal transition; TAS:HGNC
P26447	S100A4	Protein S100-A4	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
P33763	S100A5	Protein S100-A5	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P33763	S100A5	Protein S100-A5	GO:0005507; F:copper ion binding; IDA:UniProtKB
P33763	S100A5	Protein S100-A5	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P33763	S100A5	Protein S100-A5	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P06703	S100A6	Protein S100-A6	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P06703	S100A6	Protein S100-A6	GO:0048306; F:calcium-dependent protein binding; IDA:UniProtKB
P06703	S100A6	Protein S100-A6	GO:0015075; F:ion transmembrane transporter activity; IEA:Ensembl
P06703	S100A6	Protein S100-A6	GO:0005515; F:protein binding; IPI:UniProtKB
P06703	S100A6	Protein S100-A6	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P06703	S100A6	Protein S100-A6	GO:0044548; F:S100 protein binding; IPI:UniProtKB
P06703	S100A6	Protein S100-A6	GO:0005523; F:tropomyosin binding; IDA:UniProtKB
P06703	S100A6	Protein S100-A6	GO:0008270; F:zinc ion binding; IEA:Ensembl
P06703	S100A6	Protein S100-A6	GO:0007409; P:axonogenesis; NAS:UniProtKB
P06703	S100A6	Protein S100-A6	GO:0048146; P:positive regulation of fibroblast proliferation; NAS:UniProtKB
P06703	S100A6	Protein S100-A6	GO:0007165; P:signal transduction; TAS:UniProtKB
P31151	S100A7	Protein S100-A7	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P31151	S100A7	Protein S100-A7	GO:0005515; F:protein binding; IPI:UniProtKB
P31151	S100A7	Protein S100-A7	GO:0050786; F:RAGE receptor binding; IPI:UniProtKB
P31151	S100A7	Protein S100-A7	GO:0008270; F:zinc ion binding; NAS:UniProtKB
P31151	S100A7	Protein S100-A7	GO:0001525; P:angiogenesis; NAS:UniProtKB
P31151	S100A7	Protein S100-A7	GO:0050829; P:defense response to Gram-negative bacterium; IMP:UniProtKB
P31151	S100A7	Protein S100-A7	GO:0008544; P:epidermis development; TAS:ProtInc
P31151	S100A7	Protein S100-A7	GO:0045087; P:innate immune response; NAS:UniProtKB
P31151	S100A7	Protein S100-A7	GO:0030216; P:keratinocyte differentiation; NAS:UniProtKB
P31151	S100A7	Protein S100-A7	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P31151	S100A7	Protein S100-A7	GO:0071624; P:positive regulation of granulocyte chemotaxis; IDA:UniProtKB
P31151	S100A7	Protein S100-A7	GO:0090026; P:positive regulation of monocyte chemotaxis; IDA:UniProtKB
P31151	S100A7	Protein S100-A7	GO:0010820; P:positive regulation of T cell chemotaxis; IDA:UniProtKB
P31151	S100A7	Protein S100-A7	GO:0032496; P:response to lipopolysaccharide; IEP:UniProtKB
P31151	S100A7	Protein S100-A7	GO:0000302; P:response to reactive oxygen species; IDA:UniProtKB
P31151	S100A7	Protein S100-A7	GO:0051238; P:sequestering of metal ion; IDA:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0050544; F:arachidonic acid binding; TAS:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0005509; F:calcium ion binding; TAS:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0008017; F:microtubule binding; TAS:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0005515; F:protein binding; IPI:IntAct
P05109	S100A8	Protein S100-A8	GO:0050786; F:RAGE receptor binding; TAS:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0035662; F:Toll-like receptor 4 binding; TAS:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0008270; F:zinc ion binding; TAS:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0002526; P:acute inflammatory response; IEA:Ensembl
P05109	S100A8	Protein S100-A8	GO:0006914; P:autophagy; IDA:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0032602; P:chemokine production; TAS:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0002544; P:chronic inflammatory response; IEA:Ensembl
P05109	S100A8	Protein S100-A8	GO:0001816; P:cytokine production; TAS:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0042742; P:defense response to bacterium; TAS:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0050832; P:defense response to fungus; TAS:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0006954; P:inflammatory response; TAS:ProtInc
P05109	S100A8	Protein S100-A8	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
P05109	S100A8	Protein S100-A8	GO:0002523; P:leukocyte migration involved in inflammatory response; IDA:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0070488; P:neutrophil aggregation; IDA:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0030593; P:neutrophil chemotaxis; IDA:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0030307; P:positive regulation of cell growth; TAS:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0050729; P:positive regulation of inflammatory response; IDA:UniProtKB
P05109	S100A8	Protein S100-A8	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IDA:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0051493; P:regulation of cytoskeleton organization; TAS:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0045471; P:response to ethanol; IEA:Ensembl
P05109	S100A8	Protein S100-A8	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P05109	S100A8	Protein S100-A8	GO:0010043; P:response to zinc ion; IEA:Ensembl
P05109	S100A8	Protein S100-A8	GO:0032119; P:sequestering of zinc ion; TAS:UniProtKB
P05109	S100A8	Protein S100-A8	GO:0042060; P:wound healing; IEA:Ensembl
P06702	S100A9	Protein S100-A9	GO:0016209; F:antioxidant activity; IEA:UniProtKB-KW
P06702	S100A9	Protein S100-A9	GO:0050544; F:arachidonic acid binding; TAS:UniProtKB
P06702	S100A9	Protein S100-A9	GO:0005509; F:calcium ion binding; TAS:UniProtKB
P06702	S100A9	Protein S100-A9	GO:0008017; F:microtubule binding; TAS:UniProtKB
P06702	S100A9	Protein S100-A9	GO:0005515; F:protein binding; IPI:IntAct
P06702	S100A9	Protein S100-A9	GO:0050786; F:RAGE receptor binding; TAS:UniProtKB
P06702	S100A9	Protein S100-A9	GO:0004871; F:signal transducer activity; TAS:ProtInc
P06702	S100A9	Protein S100-A9	GO:0035662; F:Toll-like receptor 4 binding; TAS:UniProtKB
P06702	S100A9	Protein S100-A9	GO:0008270; F:zinc ion binding; TAS:UniProtKB
P06702	S100A9	Protein S100-A9	GO:0031532; P:actin cytoskeleton reorganization; IEA:Ensembl
P06702	S100A9	Protein S100-A9	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P06702	S100A9	Protein S100-A9	GO:0006914; P:autophagy; IDA:UniProtKB
P06702	S100A9	Protein S100-A9	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P06702	S100A9	Protein S100-A9	GO:0032602; P:chemokine production; TAS:UniProtKB
P06702	S100A9	Protein S100-A9	GO:0002544; P:chronic inflammatory response; IEA:Ensembl
P06702	S100A9	Protein S100-A9	GO:0001816; P:cytokine production; TAS:UniProtKB
P06702	S100A9	Protein S100-A9	GO:0042742; P:defense response to bacterium; TAS:UniProtKB
P06702	S100A9	Protein S100-A9	GO:0050832; P:defense response to fungus; TAS:UniProtKB
P06702	S100A9	Protein S100-A9	GO:0006954; P:inflammatory response; TAS:ProtInc
P06702	S100A9	Protein S100-A9	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
P06702	S100A9	Protein S100-A9	GO:0002523; P:leukocyte migration involved in inflammatory response; IDA:UniProtKB
P06702	S100A9	Protein S100-A9	GO:0070488; P:neutrophil aggregation; IDA:UniProtKB
P06702	S100A9	Protein S100-A9	GO:0030593; P:neutrophil chemotaxis; IDA:UniProtKB
P06702	S100A9	Protein S100-A9	GO:0030307; P:positive regulation of cell growth; TAS:UniProtKB
P06702	S100A9	Protein S100-A9	GO:0050729; P:positive regulation of inflammatory response; IDA:UniProtKB
P06702	S100A9	Protein S100-A9	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IDA:UniProtKB
P06702	S100A9	Protein S100-A9	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:UniProtKB
P06702	S100A9	Protein S100-A9	GO:0051493; P:regulation of cytoskeleton organization; TAS:UniProtKB
P06702	S100A9	Protein S100-A9	GO:0045113; P:regulation of integrin biosynthetic process; IEA:Ensembl
P06702	S100A9	Protein S100-A9	GO:0045471; P:response to ethanol; IEA:Ensembl
P06702	S100A9	Protein S100-A9	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P06702	S100A9	Protein S100-A9	GO:0010043; P:response to zinc ion; IEA:Ensembl
P06702	S100A9	Protein S100-A9	GO:0032119; P:sequestering of zinc ion; TAS:UniProtKB
P06702	S100A9	Protein S100-A9	GO:0007165; P:signal transduction; TAS:GOC
P60903	S100A10	Protein S100-A10	GO:0005509; F:calcium ion binding; IEA:InterPro
P60903	S100A10	Protein S100-A10	GO:0044325; F:ion channel binding; IPI:UniProt
P60903	S100A10	Protein S100-A10	GO:0005515; F:protein binding; IPI:IntAct
P60903	S100A10	Protein S100-A10	GO:0042803; F:protein homodimerization activity; IDA:UniProt
P60903	S100A10	Protein S100-A10	GO:0071229; P:cellular response to acid; IEA:Ensembl
P60903	S100A10	Protein S100-A10	GO:0090002; P:establishment of protein localization to plasma membrane; IDA:UniProt
P60903	S100A10	Protein S100-A10	GO:0006900; P:membrane budding; IDA:UniProt
P60903	S100A10	Protein S100-A10	GO:0001765; P:membrane raft assembly; IDA:UniProt
P60903	S100A10	Protein S100-A10	GO:0051099; P:positive regulation of binding; IEA:Ensembl
P60903	S100A10	Protein S100-A10	GO:0051894; P:positive regulation of focal adhesion assembly; IMP:UniProt
P60903	S100A10	Protein S100-A10	GO:0032855; P:positive regulation of Rac GTPase activity; IMP:UniProt
P60903	S100A10	Protein S100-A10	GO:0051496; P:positive regulation of stress fiber assembly; IMP:UniProt
P60903	S100A10	Protein S100-A10	GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IMP:UniProt
P60903	S100A10	Protein S100-A10	GO:0051290; P:protein heterotetramerization; IDA:UniProt
P31949	S100A11	Protein S100-A11	GO:0005509; F:calcium ion binding; IEA:InterPro
P31949	S100A11	Protein S100-A11	GO:0048306; F:calcium-dependent protein binding; IDA:UniProtKB
P31949	S100A11	Protein S100-A11	GO:0005515; F:protein binding; IPI:IntAct
P31949	S100A11	Protein S100-A11	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P31949	S100A11	Protein S100-A11	GO:0044548; F:S100 protein binding; IPI:UniProtKB
P31949	S100A11	Protein S100-A11	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P31949	S100A11	Protein S100-A11	GO:0008156; P:negative regulation of DNA replication; TAS:ProtInc
P31949	S100A11	Protein S100-A11	GO:0007165; P:signal transduction; TAS:UniProtKB
P80511	S100A12	Protein S100-A12	GO:0005509; F:calcium ion binding; TAS:UniProtKB
P80511	S100A12	Protein S100-A12	GO:0005507; F:copper ion binding; TAS:UniProtKB
P80511	S100A12	Protein S100-A12	GO:0005515; F:protein binding; IPI:UniProtKB
P80511	S100A12	Protein S100-A12	GO:0050786; F:RAGE receptor binding; IDA:UniProtKB
P80511	S100A12	Protein S100-A12	GO:0008270; F:zinc ion binding; TAS:UniProtKB
P80511	S100A12	Protein S100-A12	GO:0050663; P:cytokine secretion; TAS:UniProtKB
P80511	S100A12	Protein S100-A12	GO:0042742; P:defense response to bacterium; TAS:UniProtKB
P80511	S100A12	Protein S100-A12	GO:0050832; P:defense response to fungus; IDA:UniProtKB
P80511	S100A12	Protein S100-A12	GO:0006954; P:inflammatory response; TAS:ProtInc
P80511	S100A12	Protein S100-A12	GO:0045087; P:innate immune response; TAS:UniProtKB
P80511	S100A12	Protein S100-A12	GO:0031640; P:killing of cells of other organism; IEA:UniProtKB-KW
P80511	S100A12	Protein S100-A12	GO:0045576; P:mast cell activation; TAS:UniProtKB
P80511	S100A12	Protein S100-A12	GO:0002548; P:monocyte chemotaxis; TAS:UniProtKB
P80511	S100A12	Protein S100-A12	GO:0030593; P:neutrophil chemotaxis; TAS:UniProtKB
P80511	S100A12	Protein S100-A12	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
P80511	S100A12	Protein S100-A12	GO:0050729; P:positive regulation of inflammatory response; TAS:UniProtKB
P80511	S100A12	Protein S100-A12	GO:0043406; P:positive regulation of MAP kinase activity; TAS:UniProtKB
P80511	S100A12	Protein S100-A12	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:UniProtKB
P80511	S100A12	Protein S100-A12	GO:0006805; P:xenobiotic metabolic process; IDA:UniProtKB
Q99584	S100A13	Protein S100-A13	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q99584	S100A13	Protein S100-A13	GO:0005507; F:copper ion binding; IDA:UniProtKB
Q99584	S100A13	Protein S100-A13	GO:0017134; F:fibroblast growth factor binding; IPI:UniProtKB
Q99584	S100A13	Protein S100-A13	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q99584	S100A13	Protein S100-A13	GO:0005515; F:protein binding; IPI:UniProtKB
Q99584	S100A13	Protein S100-A13	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q99584	S100A13	Protein S100-A13	GO:0050786; F:RAGE receptor binding; IPI:UniProtKB
Q99584	S100A13	Protein S100-A13	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q99584	S100A13	Protein S100-A13	GO:0050663; P:cytokine secretion; IMP:UniProtKB
Q99584	S100A13	Protein S100-A13	GO:0050703; P:interleukin-1 alpha secretion; IDA:UniProtKB
Q99584	S100A13	Protein S100-A13	GO:0043303; P:mast cell degranulation; NAS:UniProtKB
Q99584	S100A13	Protein S100-A13	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q99584	S100A13	Protein S100-A13	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q99584	S100A13	Protein S100-A13	GO:0008360; P:regulation of cell shape; IEA:Ensembl
Q99584	S100A13	Protein S100-A13	GO:0046688; P:response to copper ion; IEA:Ensembl
Q99584	S100A13	Protein S100-A13	GO:0051602; P:response to electrical stimulus; IEA:Ensembl
Q9HCY8	S100A14	Protein S100-A14	GO:0005509; F:calcium ion binding; NAS:UniProtKB
Q9HCY8	S100A14	Protein S100-A14	GO:0042379; F:chemokine receptor binding; IMP:UniProtKB
Q9HCY8	S100A14	Protein S100-A14	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9HCY8	S100A14	Protein S100-A14	GO:0055074; P:calcium ion homeostasis; NAS:UniProtKB
Q9HCY8	S100A14	Protein S100-A14	GO:0042742; P:defense response to bacterium; IEP:UniProtKB
Q9HCY8	S100A14	Protein S100-A14	GO:0071624; P:positive regulation of granulocyte chemotaxis; IDA:UniProtKB
Q9HCY8	S100A14	Protein S100-A14	GO:0090026; P:positive regulation of monocyte chemotaxis; IDA:UniProtKB
Q9HCY8	S100A14	Protein S100-A14	GO:0032496; P:response to lipopolysaccharide; IEP:UniProtKB
Q9HCY8	S100A14	Protein S100-A14	GO:0034142; P:toll-like receptor 4 signaling pathway; IDA:UniProtKB
Q96FQ6	S100A16	Protein S100-A16	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q96FQ6	S100A16	Protein S100-A16	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96FQ6	S100A16	Protein S100-A16	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q96FQ6	S100A16	Protein S100-A16	GO:0051592; P:response to calcium ion; IEA:Ensembl
Q8N1F8	STK11IP	Serine/threonine-protein kinase 11-interacting protein	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q8N1F8	STK11IP	Serine/threonine-protein kinase 11-interacting protein	GO:0008104; P:protein localization; IDA:UniProtKB
Q13621	SLC12A1	Solute carrier family 12 member 1	GO:0008511; F:sodium:potassium:chloride symporter activity; TAS:ProtInc
Q13621	SLC12A1	Solute carrier family 12 member 1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q13621	SLC12A1	Solute carrier family 12 member 1	GO:1902476; P:chloride transmembrane transport; TAS:GOC
Q13621	SLC12A1	Solute carrier family 12 member 1	GO:0006821; P:chloride transport; TAS:GOC
Q13621	SLC12A1	Solute carrier family 12 member 1	GO:0034220; P:ion transmembrane transport; ISS:BHF-UCL
Q13621	SLC12A1	Solute carrier family 12 member 1	GO:0006811; P:ion transport; TAS:Reactome
Q13621	SLC12A1	Solute carrier family 12 member 1	GO:0006813; P:potassium ion transport; IEA:UniProtKB-KW
Q13621	SLC12A1	Solute carrier family 12 member 1	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q13621	SLC12A1	Solute carrier family 12 member 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q13621	SLC12A1	Solute carrier family 12 member 1	GO:0006810; P:transport; TAS:ProtInc
P55011	SLC12A2	Solute carrier family 12 member 2	GO:0008519; F:ammonium transmembrane transporter activity; IDA:UniProtKB
P55011	SLC12A2	Solute carrier family 12 member 2	GO:0005515; F:protein binding; IPI:IntAct
P55011	SLC12A2	Solute carrier family 12 member 2	GO:0008511; F:sodium:potassium:chloride symporter activity; TAS:ProtInc
P55011	SLC12A2	Solute carrier family 12 member 2	GO:0072488; P:ammonium transmembrane transport; IDA:GOC
P55011	SLC12A2	Solute carrier family 12 member 2	GO:0015696; P:ammonium transport; IDA:UniProtKB
P55011	SLC12A2	Solute carrier family 12 member 2	GO:0060444; P:branching involved in mammary gland duct morphogenesis; IEA:Ensembl
P55011	SLC12A2	Solute carrier family 12 member 2	GO:1902476; P:chloride transmembrane transport; TAS:GOC
P55011	SLC12A2	Solute carrier family 12 member 2	GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; IEA:Ensembl
P55011	SLC12A2	Solute carrier family 12 member 2	GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:Ensembl
P55011	SLC12A2	Solute carrier family 12 member 2	GO:0006972; P:hyperosmotic response; IEA:Ensembl
P55011	SLC12A2	Solute carrier family 12 member 2	GO:0006811; P:ion transport; TAS:Reactome
P55011	SLC12A2	Solute carrier family 12 member 2	GO:0060763; P:mammary duct terminal end bud growth; IEA:Ensembl
P55011	SLC12A2	Solute carrier family 12 member 2	GO:0035264; P:multicellular organism growth; IEA:Ensembl
P55011	SLC12A2	Solute carrier family 12 member 2	GO:0045795; P:positive regulation of cell volume; IEA:Ensembl
P55011	SLC12A2	Solute carrier family 12 member 2	GO:0006813; P:potassium ion transport; IEA:UniProtKB-KW
P55011	SLC12A2	Solute carrier family 12 member 2	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
P55011	SLC12A2	Solute carrier family 12 member 2	GO:0070634; P:transepithelial ammonium transport; IDA:UniProtKB
P55011	SLC12A2	Solute carrier family 12 member 2	GO:0030321; P:transepithelial chloride transport; IDA:UniProtKB
P55011	SLC12A2	Solute carrier family 12 member 2	GO:0055085; P:transmembrane transport; TAS:Reactome
P55011	SLC12A2	Solute carrier family 12 member 2	GO:0006810; P:transport; TAS:ProtInc
P55017	SLC12A3	Solute carrier family 12 member 3	GO:0005515; F:protein binding; IPI:UniProtKB
P55017	SLC12A3	Solute carrier family 12 member 3	GO:0015378; F:sodium:chloride symporter activity; TAS:ProtInc
P55017	SLC12A3	Solute carrier family 12 member 3	GO:0005215; F:transporter activity; ISS:UniProtKB
P55017	SLC12A3	Solute carrier family 12 member 3	GO:1902476; P:chloride transmembrane transport; TAS:GOC
P55017	SLC12A3	Solute carrier family 12 member 3	GO:0006821; P:chloride transport; TAS:GOC
P55017	SLC12A3	Solute carrier family 12 member 3	GO:0006811; P:ion transport; TAS:Reactome
P55017	SLC12A3	Solute carrier family 12 member 3	GO:0035725; P:sodium ion transmembrane transport; ISS:BHF-UCL
P55017	SLC12A3	Solute carrier family 12 member 3	GO:0006814; P:sodium ion transport; ISS:UniProtKB
P55017	SLC12A3	Solute carrier family 12 member 3	GO:0055085; P:transmembrane transport; TAS:Reactome
P55017	SLC12A3	Solute carrier family 12 member 3	GO:0006810; P:transport; TAS:ProtInc
Q9UP95	SLC12A4	Solute carrier family 12 member 4	GO:0015379; F:potassium:chloride symporter activity; TAS:ProtInc
Q9UP95	SLC12A4	Solute carrier family 12 member 4	GO:0006884; P:cell volume homeostasis; TAS:ProtInc
Q9UP95	SLC12A4	Solute carrier family 12 member 4	GO:1902476; P:chloride transmembrane transport; TAS:GOC
Q9UP95	SLC12A4	Solute carrier family 12 member 4	GO:0006821; P:chloride transport; TAS:GOC
Q9UP95	SLC12A4	Solute carrier family 12 member 4	GO:0006811; P:ion transport; TAS:Reactome
Q9UP95	SLC12A4	Solute carrier family 12 member 4	GO:0006813; P:potassium ion transport; IEA:UniProtKB-KW
Q9UP95	SLC12A4	Solute carrier family 12 member 4	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UP95	SLC12A4	Solute carrier family 12 member 4	GO:0006810; P:transport; TAS:ProtInc
Q9H2X9	SLC12A5	Solute carrier family 12 member 5	GO:0015379; F:potassium:chloride symporter activity; NAS:UniProtKB
Q9H2X9	SLC12A5	Solute carrier family 12 member 5	GO:0006873; P:cellular ion homeostasis; NAS:UniProtKB
Q9H2X9	SLC12A5	Solute carrier family 12 member 5	GO:1902476; P:chloride transmembrane transport; NAS:GOC
Q9H2X9	SLC12A5	Solute carrier family 12 member 5	GO:0006811; P:ion transport; TAS:Reactome
Q9H2X9	SLC12A5	Solute carrier family 12 member 5	GO:0007612; P:learning; IEA:Ensembl
Q9H2X9	SLC12A5	Solute carrier family 12 member 5	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q9H2X9	SLC12A5	Solute carrier family 12 member 5	GO:0006813; P:potassium ion transport; IEA:UniProtKB-KW
Q9H2X9	SLC12A5	Solute carrier family 12 member 5	GO:0042493; P:response to drug; IEA:Ensembl
Q9H2X9	SLC12A5	Solute carrier family 12 member 5	GO:0007268; P:synaptic transmission; IEA:Ensembl
Q9H2X9	SLC12A5	Solute carrier family 12 member 5	GO:0040040; P:thermosensory behavior; IEA:Ensembl
Q9H2X9	SLC12A5	Solute carrier family 12 member 5	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9H2X9	SLC12A5	Solute carrier family 12 member 5	GO:0006810; P:transport; NAS:UniProtKB
Q9UHW9	SLC12A6	Solute carrier family 12 member 6	GO:0015379; F:potassium:chloride symporter activity; IDA:UniProtKB
Q9UHW9	SLC12A6	Solute carrier family 12 member 6	GO:0001525; P:angiogenesis; NAS:UniProtKB
Q9UHW9	SLC12A6	Solute carrier family 12 member 6	GO:0071477; P:cellular hypotonic salinity response; IDA:UniProtKB
Q9UHW9	SLC12A6	Solute carrier family 12 member 6	GO:1902476; P:chloride transmembrane transport; IDA:GOC
Q9UHW9	SLC12A6	Solute carrier family 12 member 6	GO:0006821; P:chloride transport; IDA:GOC
Q9UHW9	SLC12A6	Solute carrier family 12 member 6	GO:0006811; P:ion transport; IDA:UniProtKB
Q9UHW9	SLC12A6	Solute carrier family 12 member 6	GO:0006813; P:potassium ion transport; IEA:UniProtKB-KW
Q9UHW9	SLC12A6	Solute carrier family 12 member 6	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9Y666	SLC12A7	Solute carrier family 12 member 7	GO:0015379; F:potassium:chloride symporter activity; TAS:ProtInc
Q9Y666	SLC12A7	Solute carrier family 12 member 7	GO:0006884; P:cell volume homeostasis; IEA:Ensembl
Q9Y666	SLC12A7	Solute carrier family 12 member 7	GO:1902476; P:chloride transmembrane transport; TAS:GOC
Q9Y666	SLC12A7	Solute carrier family 12 member 7	GO:0006821; P:chloride transport; TAS:GOC
Q9Y666	SLC12A7	Solute carrier family 12 member 7	GO:0006811; P:ion transport; TAS:Reactome
Q9Y666	SLC12A7	Solute carrier family 12 member 7	GO:0006813; P:potassium ion transport; IEA:UniProtKB-KW
Q9Y666	SLC12A7	Solute carrier family 12 member 7	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9Y666	SLC12A7	Solute carrier family 12 member 7	GO:0006810; P:transport; TAS:ProtInc
A0AV02	SLC12A8	Solute carrier family 12 member 8	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
A0AV02	SLC12A8	Solute carrier family 12 member 8	GO:0006813; P:potassium ion transport; IEA:UniProtKB-KW
Q9BXP2	SLC12A9	Solute carrier family 12 member 9	GO:0015377; F:cation:chloride symporter activity; TAS:ProtInc
Q9BXP2	SLC12A9	Solute carrier family 12 member 9	GO:1902476; P:chloride transmembrane transport; TAS:GOC
Q9BXP2	SLC12A9	Solute carrier family 12 member 9	GO:0006821; P:chloride transport; TAS:GOC
Q9BZW2	SLC13A1	Solute carrier family 13 member 1	GO:0015382; F:sodium:sulfate symporter activity; IEA:Ensembl
Q9BZW2	SLC13A1	Solute carrier family 13 member 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q13183	SLC13A2	Solute carrier family 13 member 2	GO:0015361; F:low affinity sodium:dicarboxylate symporter activity; TAS:ProtInc
Q13183	SLC13A2	Solute carrier family 13 member 2	GO:0006835; P:dicarboxylic acid transport; TAS:GOC
Q13183	SLC13A2	Solute carrier family 13 member 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q13183	SLC13A2	Solute carrier family 13 member 2	GO:0006810; P:transport; TAS:ProtInc
Q8WWT9	SLC13A3	Solute carrier family 13 member 3	GO:0015362; F:high affinity sodium:dicarboxylate symporter activity; IEA:Ensembl
Q8WWT9	SLC13A3	Solute carrier family 13 member 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UKG4	SLC13A4	Solute carrier family 13 member 4	GO:0015382; F:sodium:sulfate symporter activity; TAS:ProtInc
Q9UKG4	SLC13A4	Solute carrier family 13 member 4	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
Q9UKG4	SLC13A4	Solute carrier family 13 member 4	GO:0008272; P:sulfate transport; TAS:ProtInc
Q9UKG4	SLC13A4	Solute carrier family 13 member 4	GO:0055085; P:transmembrane transport; TAS:Reactome
Q86YT5	SLC13A5	Solute carrier family 13 member 5	GO:0015137; F:citrate transmembrane transporter activity; IEA:Ensembl
Q86YT5	SLC13A5	Solute carrier family 13 member 5	GO:0017153; F:sodium:dicarboxylate symporter activity; IEA:Ensembl
Q86YT5	SLC13A5	Solute carrier family 13 member 5	GO:0015141; F:succinate transmembrane transporter activity; IEA:Ensembl
Q86YT5	SLC13A5	Solute carrier family 13 member 5	GO:0055085; P:transmembrane transport; TAS:Reactome
Q92503	SEC14L1	SEC14-like protein 1	GO:0006810; P:transport; IEA:InterPro
O76054	SEC14L2	SEC14-like protein 2	GO:0005543; F:phospholipid binding; NAS:UniProtKB
O76054	SEC14L2	SEC14-like protein 2	GO:0005215; F:transporter activity; IEA:InterPro
O76054	SEC14L2	SEC14-like protein 2	GO:0008431; F:vitamin E binding; NAS:UniProtKB
O76054	SEC14L2	SEC14-like protein 2	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
O76054	SEC14L2	SEC14-like protein 2	GO:0045540; P:regulation of cholesterol biosynthetic process; NAS:UniProtKB
O76054	SEC14L2	SEC14-like protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UDX4	SEC14L3	SEC14-like protein 3	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q9UDX4	SEC14L3	SEC14-like protein 3	GO:0005215; F:transporter activity; IEA:InterPro
O43304	SEC14L5	SEC14-like protein 5	GO:0005215; F:transporter activity; IEA:InterPro
Q9UDX3	SEC14L4	SEC14-like protein 4	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q9UDX3	SEC14L4	SEC14-like protein 4	GO:0005215; F:transporter activity; IEA:InterPro
B5MCN3	SEC14L6	Putative SEC14-like protein 6	GO:0005215; F:transporter activity; IEA:InterPro
P46059	SLC15A1	Solute carrier family 15 member 1	GO:0015333; F:peptide:proton symporter activity; TAS:ProtInc
P46059	SLC15A1	Solute carrier family 15 member 1	GO:0005427; F:proton-dependent oligopeptide secondary active transmembrane transporter activity; IEA:Ensembl
P46059	SLC15A1	Solute carrier family 15 member 1	GO:0007586; P:digestion; TAS:ProtInc
P46059	SLC15A1	Solute carrier family 15 member 1	GO:0006811; P:ion transport; TAS:Reactome
P46059	SLC15A1	Solute carrier family 15 member 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P46059	SLC15A1	Solute carrier family 15 member 1	GO:0015992; P:proton transport; TAS:GOC
P46059	SLC15A1	Solute carrier family 15 member 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P46059	SLC15A1	Solute carrier family 15 member 1	GO:0006810; P:transport; TAS:ProtInc
Q16348	SLC15A2	Solute carrier family 15 member 2	GO:0042895; F:antibiotic transporter activity; IEA:Ensembl
Q16348	SLC15A2	Solute carrier family 15 member 2	GO:0042936; F:dipeptide transporter activity; IEA:Ensembl
Q16348	SLC15A2	Solute carrier family 15 member 2	GO:0015334; F:high affinity oligopeptide transporter activity; IEA:Ensembl
Q16348	SLC15A2	Solute carrier family 15 member 2	GO:0015333; F:peptide:proton symporter activity; TAS:ProtInc
Q16348	SLC15A2	Solute carrier family 15 member 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q16348	SLC15A2	Solute carrier family 15 member 2	GO:0015893; P:drug transport; NAS:UniProtKB
Q16348	SLC15A2	Solute carrier family 15 member 2	GO:0006811; P:ion transport; TAS:Reactome
Q16348	SLC15A2	Solute carrier family 15 member 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q16348	SLC15A2	Solute carrier family 15 member 2	GO:0015992; P:proton transport; TAS:GOC
Q16348	SLC15A2	Solute carrier family 15 member 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q16348	SLC15A2	Solute carrier family 15 member 2	GO:0006810; P:transport; TAS:ProtInc
Q8IY34	SLC15A3	Solute carrier family 15 member 3	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q8IY34	SLC15A3	Solute carrier family 15 member 3	GO:0006811; P:ion transport; TAS:Reactome
Q8IY34	SLC15A3	Solute carrier family 15 member 3	GO:0015833; P:peptide transport; IEA:UniProtKB-KW
Q8IY34	SLC15A3	Solute carrier family 15 member 3	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8IY34	SLC15A3	Solute carrier family 15 member 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8N697	SLC15A4	Solute carrier family 15 member 4	GO:0005290; F:L-histidine transmembrane transporter activity; IEA:Ensembl
Q8N697	SLC15A4	Solute carrier family 15 member 4	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q8N697	SLC15A4	Solute carrier family 15 member 4	GO:0006811; P:ion transport; TAS:Reactome
Q8N697	SLC15A4	Solute carrier family 15 member 4	GO:0006857; P:oligopeptide transport; IEA:InterPro
Q8N697	SLC15A4	Solute carrier family 15 member 4	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8N697	SLC15A4	Solute carrier family 15 member 4	GO:0055085; P:transmembrane transport; TAS:Reactome
A6NIM6	SLC15A5	Solute carrier family 15 member 5	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
A6NIM6	SLC15A5	Solute carrier family 15 member 5	GO:0015833; P:peptide transport; IEA:UniProtKB-KW
A6NIM6	SLC15A5	Solute carrier family 15 member 5	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9Y2C5	SLC17A4	Probable small intestine urate exporter	GO:0005436; F:sodium:phosphate symporter activity; TAS:ProtInc
Q9Y2C5	SLC17A4	Probable small intestine urate exporter	GO:0035435; P:phosphate ion transmembrane transport; TAS:GOC
Q9Y2C5	SLC17A4	Probable small intestine urate exporter	GO:0006796; P:phosphate-containing compound metabolic process; TAS:ProtInc
Q9Y2C5	SLC17A4	Probable small intestine urate exporter	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
Q9Y2C5	SLC17A4	Probable small intestine urate exporter	GO:0006814; P:sodium ion transport; TAS:ProtInc
Q9NRA2	SLC17A5	Sialin	GO:0015136; F:sialic acid transmembrane transporter activity; IDA:MGI
Q9NRA2	SLC17A5	Sialin	GO:0005351; F:sugar:proton symporter activity; TAS:ProtInc
Q9NRA2	SLC17A5	Sialin	GO:0006865; P:amino acid transport; IEA:UniProtKB-KW
Q9NRA2	SLC17A5	Sialin	GO:0006820; P:anion transport; TAS:ProtInc
Q9NRA2	SLC17A5	Sialin	GO:0006811; P:ion transport; TAS:Reactome
Q9NRA2	SLC17A5	Sialin	GO:0015992; P:proton transport; TAS:GOC
Q9NRA2	SLC17A5	Sialin	GO:0015739; P:sialic acid transport; IDA:MGI
Q9NRA2	SLC17A5	Sialin	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9BYT1	SLC17A9	Solute carrier family 17 member 9	GO:0005215; F:transporter activity; IEA:InterPro
Q9BYT1	SLC17A9	Solute carrier family 17 member 9	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q9BYT1	SLC17A9	Solute carrier family 17 member 9	GO:0055085; P:transmembrane transport; IEA:InterPro
Q6NT16	SLC18B1	MFS-type transporter SLC18B1	GO:0055085; P:transmembrane transport; IEA:InterPro
P41440	SLC19A1	Folate transporter 1	GO:0005542; F:folic acid binding; IEA:UniProtKB-KW
P41440	SLC19A1	Folate transporter 1	GO:0008517; F:folic acid transporter activity; TAS:ProtInc
P41440	SLC19A1	Folate transporter 1	GO:0015350; F:methotrexate transporter activity; TAS:ProtInc
P41440	SLC19A1	Folate transporter 1	GO:0046655; P:folic acid metabolic process; TAS:Reactome
P41440	SLC19A1	Folate transporter 1	GO:0015884; P:folic acid transport; TAS:ProtInc
P41440	SLC19A1	Folate transporter 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P41440	SLC19A1	Folate transporter 1	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P41440	SLC19A1	Folate transporter 1	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
O60779	SLC19A2	Thiamine transporter 1	GO:0008517; F:folic acid transporter activity; NAS:UniProtKB
O60779	SLC19A2	Thiamine transporter 1	GO:0015234; F:thiamine transmembrane transporter activity; TAS:UniProtKB
O60779	SLC19A2	Thiamine transporter 1	GO:0015403; F:thiamine uptake transmembrane transporter activity; ISS:BHF-UCL
O60779	SLC19A2	Thiamine transporter 1	GO:0015884; P:folic acid transport; NAS:GOC
O60779	SLC19A2	Thiamine transporter 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60779	SLC19A2	Thiamine transporter 1	GO:0071934; P:thiamine transmembrane transport; ISS:GOC
O60779	SLC19A2	Thiamine transporter 1	GO:0015888; P:thiamine transport; NAS:UniProtKB
O60779	SLC19A2	Thiamine transporter 1	GO:0042723; P:thiamine-containing compound metabolic process; TAS:Reactome
O60779	SLC19A2	Thiamine transporter 1	GO:0006766; P:vitamin metabolic process; TAS:Reactome
O60779	SLC19A2	Thiamine transporter 1	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9BZV2	SLC19A3	Thiamine transporter 2	GO:0015403; F:thiamine uptake transmembrane transporter activity; ISS:BHF-UCL
Q9BZV2	SLC19A3	Thiamine transporter 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BZV2	SLC19A3	Thiamine transporter 2	GO:0071934; P:thiamine transmembrane transport; ISS:GOC
Q9BZV2	SLC19A3	Thiamine transporter 2	GO:0042723; P:thiamine-containing compound metabolic process; TAS:Reactome
Q9BZV2	SLC19A3	Thiamine transporter 2	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9BZV2	SLC19A3	Thiamine transporter 2	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q86SG5	S100A7A	Protein S100-A7A	GO:0005509; F:calcium ion binding; IEA:InterPro
Q86SG5	S100A7A	Protein S100-A7A	GO:0043621; F:protein self-association; IPI:MGI
Q5SY68	S100A7L2	Protein S100-A7-like 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q96BU1	S100PBP	S100P-binding protein	GO:0048306; F:calcium-dependent protein binding; IPI:HGNC
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0046625; F:sphingolipid binding; IEA:Ensembl
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0038036; F:sphingosine-1-phosphate receptor activity; IDA:UniProtKB
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0031532; P:actin cytoskeleton reorganization; ISS:UniProtKB
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IEA:Ensembl
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0001955; P:blood vessel maturation; ISS:UniProtKB
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0007420; P:brain development; IEA:Ensembl
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0003245; P:cardiac muscle tissue growth involved in heart morphogenesis; ISS:UniProtKB
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0007155; P:cell adhesion; TAS:ProtInc
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0016477; P:cell migration; ISS:UniProtKB
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0006935; P:chemotaxis; ISS:UniProtKB
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0045446; P:endothelial cell differentiation; IEA:Ensembl
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0061384; P:heart trabecula morphogenesis; ISS:UniProtKB
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0030032; P:lamellipodium assembly; ISS:UniProtKB
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0051497; P:negative regulation of stress fiber assembly; IEA:Ensembl
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0030182; P:neuron differentiation; IEA:Ensembl
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0051482; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway; IEA:Ensembl
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0050927; P:positive regulation of positive chemotaxis; IEA:Ensembl
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0032320; P:positive regulation of Ras GTPase activity; IEA:Ensembl
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0030500; P:regulation of bone mineralization; ISS:UniProtKB
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0045124; P:regulation of bone resorption; ISS:UniProtKB
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0030155; P:regulation of cell adhesion; IEA:Ensembl
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0003376; P:sphingosine-1-phosphate signaling pathway; IDA:UniProtKB
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0072678; P:T cell migration; ISS:UniProtKB
P21453	S1PR1	Sphingosine 1-phosphate receptor 1	GO:0019226; P:transmission of nerve impulse; IEA:Ensembl
O95136	S1PR2	Sphingosine 1-phosphate receptor 2	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O95136	S1PR2	Sphingosine 1-phosphate receptor 2	GO:0008289; F:lipid binding; TAS:ProtInc
O95136	S1PR2	Sphingosine 1-phosphate receptor 2	GO:0038036; F:sphingosine-1-phosphate receptor activity; IEA:InterPro
O95136	S1PR2	Sphingosine 1-phosphate receptor 2	GO:0000187; P:activation of MAPK activity; TAS:ProtInc
O95136	S1PR2	Sphingosine 1-phosphate receptor 2	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
O95136	S1PR2	Sphingosine 1-phosphate receptor 2	GO:0090394; P:negative regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
O95136	S1PR2	Sphingosine 1-phosphate receptor 2	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q99500	S1PR3	Sphingosine 1-phosphate receptor 3	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q99500	S1PR3	Sphingosine 1-phosphate receptor 3	GO:0008289; F:lipid binding; TAS:ProtInc
Q99500	S1PR3	Sphingosine 1-phosphate receptor 3	GO:0038036; F:sphingosine-1-phosphate receptor activity; IEA:InterPro
Q99500	S1PR3	Sphingosine 1-phosphate receptor 3	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IEA:Ensembl
Q99500	S1PR3	Sphingosine 1-phosphate receptor 3	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q99500	S1PR3	Sphingosine 1-phosphate receptor 3	GO:0001816; P:cytokine production; IEA:Ensembl
Q99500	S1PR3	Sphingosine 1-phosphate receptor 3	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q99500	S1PR3	Sphingosine 1-phosphate receptor 3	GO:0006954; P:inflammatory response; TAS:ProtInc
Q99500	S1PR3	Sphingosine 1-phosphate receptor 3	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q99500	S1PR3	Sphingosine 1-phosphate receptor 3	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
Q99500	S1PR3	Sphingosine 1-phosphate receptor 3	GO:0032651; P:regulation of interleukin-1 beta production; IEA:Ensembl
O95977	S1PR4	Sphingosine 1-phosphate receptor 4	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
O95977	S1PR4	Sphingosine 1-phosphate receptor 4	GO:0008289; F:lipid binding; TAS:ProtInc
O95977	S1PR4	Sphingosine 1-phosphate receptor 4	GO:0038036; F:sphingosine-1-phosphate receptor activity; IEA:InterPro
O95977	S1PR4	Sphingosine 1-phosphate receptor 4	GO:0007202; P:activation of phospholipase C activity; TAS:ProtInc
O95977	S1PR4	Sphingosine 1-phosphate receptor 4	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
O95977	S1PR4	Sphingosine 1-phosphate receptor 4	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
O95977	S1PR4	Sphingosine 1-phosphate receptor 4	GO:0006955; P:immune response; TAS:ProtInc
O95977	S1PR4	Sphingosine 1-phosphate receptor 4	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
Q9H228	S1PR5	Sphingosine 1-phosphate receptor 5	GO:0038036; F:sphingosine-1-phosphate receptor activity; IEA:InterPro
Q9H228	S1PR5	Sphingosine 1-phosphate receptor 5	GO:0045664; P:regulation of neuron differentiation; IEA:Ensembl
Q8WUM9	SLC20A1	Sodium-dependent phosphate transporter 1	GO:0005316; F:high affinity inorganic phosphate:sodium symporter activity; IEA:Ensembl
Q8WUM9	SLC20A1	Sodium-dependent phosphate transporter 1	GO:0005315; F:inorganic phosphate transmembrane transporter activity; IEA:InterPro
Q8WUM9	SLC20A1	Sodium-dependent phosphate transporter 1	GO:0004872; F:receptor activity; TAS:ProtInc
Q8WUM9	SLC20A1	Sodium-dependent phosphate transporter 1	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q8WUM9	SLC20A1	Sodium-dependent phosphate transporter 1	GO:0005436; F:sodium:phosphate symporter activity; TAS:ProtInc
Q8WUM9	SLC20A1	Sodium-dependent phosphate transporter 1	GO:0006811; P:ion transport; TAS:Reactome
Q8WUM9	SLC20A1	Sodium-dependent phosphate transporter 1	GO:0035435; P:phosphate ion transmembrane transport; TAS:GOC
Q8WUM9	SLC20A1	Sodium-dependent phosphate transporter 1	GO:0006796; P:phosphate-containing compound metabolic process; TAS:ProtInc
Q8WUM9	SLC20A1	Sodium-dependent phosphate transporter 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q8WUM9	SLC20A1	Sodium-dependent phosphate transporter 1	GO:0007165; P:signal transduction; IMP:GOC
Q8WUM9	SLC20A1	Sodium-dependent phosphate transporter 1	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
Q8WUM9	SLC20A1	Sodium-dependent phosphate transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8WUM9	SLC20A1	Sodium-dependent phosphate transporter 1	GO:0006810; P:transport; TAS:ProtInc
Q08357	SLC20A2	Sodium-dependent phosphate transporter 2	GO:0005315; F:inorganic phosphate transmembrane transporter activity; IEA:InterPro
Q08357	SLC20A2	Sodium-dependent phosphate transporter 2	GO:0004872; F:receptor activity; TAS:ProtInc
Q08357	SLC20A2	Sodium-dependent phosphate transporter 2	GO:0005436; F:sodium:phosphate symporter activity; TAS:ProtInc
Q08357	SLC20A2	Sodium-dependent phosphate transporter 2	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
Q08357	SLC20A2	Sodium-dependent phosphate transporter 2	GO:0006811; P:ion transport; TAS:Reactome
Q08357	SLC20A2	Sodium-dependent phosphate transporter 2	GO:0035435; P:phosphate ion transmembrane transport; TAS:GOC
Q08357	SLC20A2	Sodium-dependent phosphate transporter 2	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
Q08357	SLC20A2	Sodium-dependent phosphate transporter 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q08357	SLC20A2	Sodium-dependent phosphate transporter 2	GO:0006810; P:transport; TAS:ProtInc
Q08357	SLC20A2	Sodium-dependent phosphate transporter 2	GO:0016032; P:viral process; IEA:UniProtKB-KW
O15245	SLC22A1	Solute carrier family 22 member 1	GO:0005277; F:acetylcholine transmembrane transporter activity; IEA:Ensembl
O15245	SLC22A1	Solute carrier family 22 member 1	GO:0005329; F:dopamine transmembrane transporter activity; IEA:Ensembl
O15245	SLC22A1	Solute carrier family 22 member 1	GO:0005333; F:norepinephrine transmembrane transporter activity; IEA:Ensembl
O15245	SLC22A1	Solute carrier family 22 member 1	GO:0015101; F:organic cation transmembrane transporter activity; TAS:UniProtKB
O15245	SLC22A1	Solute carrier family 22 member 1	GO:0005515; F:protein binding; IPI:IntAct
O15245	SLC22A1	Solute carrier family 22 member 1	GO:0015651; F:quaternary ammonium group transmembrane transporter activity; IEA:Ensembl
O15245	SLC22A1	Solute carrier family 22 member 1	GO:0008513; F:secondary active organic cation transmembrane transporter activity; IEA:Ensembl
O15245	SLC22A1	Solute carrier family 22 member 1	GO:0015872; P:dopamine transport; IEA:Ensembl
O15245	SLC22A1	Solute carrier family 22 member 1	GO:0006855; P:drug transmembrane transport; TAS:Reactome
O15245	SLC22A1	Solute carrier family 22 member 1	GO:0048241; P:epinephrine transport; IEA:Ensembl
O15245	SLC22A1	Solute carrier family 22 member 1	GO:0010248; P:establishment or maintenance of transmembrane electrochemical gradient; IEA:Ensembl
O15245	SLC22A1	Solute carrier family 22 member 1	GO:0015874; P:norepinephrine transport; IEA:Ensembl
O15245	SLC22A1	Solute carrier family 22 member 1	GO:0015695; P:organic cation transport; TAS:UniProtKB
O15245	SLC22A1	Solute carrier family 22 member 1	GO:0051260; P:protein homooligomerization; IEA:Ensembl
O15245	SLC22A1	Solute carrier family 22 member 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15245	SLC22A1	Solute carrier family 22 member 1	GO:0055085; P:transmembrane transport; TAS:Reactome
O15244	SLC22A2	Solute carrier family 22 member 2	GO:0015220; F:choline transmembrane transporter activity; IEA:Ensembl
O15244	SLC22A2	Solute carrier family 22 member 2	GO:0015101; F:organic cation transmembrane transporter activity; IDA:MGI
O15244	SLC22A2	Solute carrier family 22 member 2	GO:0015651; F:quaternary ammonium group transmembrane transporter activity; IEA:Ensembl
O15244	SLC22A2	Solute carrier family 22 member 2	GO:0005496; F:steroid binding; IEA:Ensembl
O15244	SLC22A2	Solute carrier family 22 member 2	GO:0007589; P:body fluid secretion; TAS:ProtInc
O15244	SLC22A2	Solute carrier family 22 member 2	GO:0006855; P:drug transmembrane transport; TAS:Reactome
O15244	SLC22A2	Solute carrier family 22 member 2	GO:0051608; P:histamine transport; IEA:Ensembl
O15244	SLC22A2	Solute carrier family 22 member 2	GO:0042136; P:neurotransmitter biosynthetic process; TAS:Reactome
O15244	SLC22A2	Solute carrier family 22 member 2	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
O15244	SLC22A2	Solute carrier family 22 member 2	GO:0015695; P:organic cation transport; IDA:MGI
O15244	SLC22A2	Solute carrier family 22 member 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15244	SLC22A2	Solute carrier family 22 member 2	GO:0007268; P:synaptic transmission; TAS:Reactome
O15244	SLC22A2	Solute carrier family 22 member 2	GO:0055085; P:transmembrane transport; TAS:Reactome
O75751	SLC22A3	Solute carrier family 22 member 3	GO:0005329; F:dopamine transmembrane transporter activity; IEA:Ensembl
O75751	SLC22A3	Solute carrier family 22 member 3	GO:0015101; F:organic cation transmembrane transporter activity; IDA:MGI
O75751	SLC22A3	Solute carrier family 22 member 3	GO:0005515; F:protein binding; IPI:IntAct
O75751	SLC22A3	Solute carrier family 22 member 3	GO:0015651; F:quaternary ammonium group transmembrane transporter activity; IDA:MGI
O75751	SLC22A3	Solute carrier family 22 member 3	GO:0019534; F:toxin transporter activity; IEA:Ensembl
O75751	SLC22A3	Solute carrier family 22 member 3	GO:0015872; P:dopamine transport; IEA:Ensembl
O75751	SLC22A3	Solute carrier family 22 member 3	GO:0006855; P:drug transmembrane transport; TAS:Reactome
O75751	SLC22A3	Solute carrier family 22 member 3	GO:0051615; P:histamine uptake; IEA:Ensembl
O75751	SLC22A3	Solute carrier family 22 member 3	GO:0015695; P:organic cation transport; IDA:MGI
O75751	SLC22A3	Solute carrier family 22 member 3	GO:0015697; P:quaternary ammonium group transport; IDA:MGI
O75751	SLC22A3	Solute carrier family 22 member 3	GO:0032098; P:regulation of appetite; IEA:Ensembl
O75751	SLC22A3	Solute carrier family 22 member 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75751	SLC22A3	Solute carrier family 22 member 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9H015	SLC22A4	Solute carrier family 22 member 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H015	SLC22A4	Solute carrier family 22 member 4	GO:0015226; F:carnitine transmembrane transporter activity; IDA:MGI
Q9H015	SLC22A4	Solute carrier family 22 member 4	GO:0015491; F:cation:cation antiporter activity; IDA:BHF-UCL
Q9H015	SLC22A4	Solute carrier family 22 member 4	GO:0000166; F:nucleotide binding; TAS:ProtInc
Q9H015	SLC22A4	Solute carrier family 22 member 4	GO:0030165; F:PDZ domain binding; IPI:BHF-UCL
Q9H015	SLC22A4	Solute carrier family 22 member 4	GO:0005515; F:protein binding; IPI:BHF-UCL
Q9H015	SLC22A4	Solute carrier family 22 member 4	GO:0015651; F:quaternary ammonium group transmembrane transporter activity; IDA:BHF-UCL
Q9H015	SLC22A4	Solute carrier family 22 member 4	GO:0008513; F:secondary active organic cation transmembrane transporter activity; TAS:ProtInc
Q9H015	SLC22A4	Solute carrier family 22 member 4	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q9H015	SLC22A4	Solute carrier family 22 member 4	GO:0007589; P:body fluid secretion; TAS:ProtInc
Q9H015	SLC22A4	Solute carrier family 22 member 4	GO:0009437; P:carnitine metabolic process; IEA:Ensembl
Q9H015	SLC22A4	Solute carrier family 22 member 4	GO:1902603; P:carnitine transmembrane transport; IDA:GOC
Q9H015	SLC22A4	Solute carrier family 22 member 4	GO:0015879; P:carnitine transport; IDA:MGI
Q9H015	SLC22A4	Solute carrier family 22 member 4	GO:0015695; P:organic cation transport; TAS:ProtInc
Q9H015	SLC22A4	Solute carrier family 22 member 4	GO:0015697; P:quaternary ammonium group transport; IDA:BHF-UCL
Q9H015	SLC22A4	Solute carrier family 22 member 4	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q9H015	SLC22A4	Solute carrier family 22 member 4	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9H015	SLC22A4	Solute carrier family 22 member 4	GO:0006641; P:triglyceride metabolic process; IEA:Ensembl
O76082	SLC22A5	Solute carrier family 22 member 5	GO:0042895; F:antibiotic transporter activity; IEA:Ensembl
O76082	SLC22A5	Solute carrier family 22 member 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O76082	SLC22A5	Solute carrier family 22 member 5	GO:0015226; F:carnitine transmembrane transporter activity; IDA:BHF-UCL
O76082	SLC22A5	Solute carrier family 22 member 5	GO:0015238; F:drug transmembrane transporter activity; IC:BHF-UCL
O76082	SLC22A5	Solute carrier family 22 member 5	GO:0030165; F:PDZ domain binding; IPI:BHF-UCL
O76082	SLC22A5	Solute carrier family 22 member 5	GO:0005515; F:protein binding; IPI:BHF-UCL
O76082	SLC22A5	Solute carrier family 22 member 5	GO:0015651; F:quaternary ammonium group transmembrane transporter activity; IDA:BHF-UCL
O76082	SLC22A5	Solute carrier family 22 member 5	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
O76082	SLC22A5	Solute carrier family 22 member 5	GO:1902603; P:carnitine transmembrane transport; IDA:GOC
O76082	SLC22A5	Solute carrier family 22 member 5	GO:0015879; P:carnitine transport; IDA:BHF-UCL
O76082	SLC22A5	Solute carrier family 22 member 5	GO:0006855; P:drug transmembrane transport; IC:GOC
O76082	SLC22A5	Solute carrier family 22 member 5	GO:0015893; P:drug transport; IC:BHF-UCL
O76082	SLC22A5	Solute carrier family 22 member 5	GO:0060731; P:positive regulation of intestinal epithelial structure maintenance; IMP:BHF-UCL
O76082	SLC22A5	Solute carrier family 22 member 5	GO:0015697; P:quaternary ammonium group transport; IDA:BHF-UCL
O76082	SLC22A5	Solute carrier family 22 member 5	GO:0052106; P:quorum sensing involved in interaction with host; IMP:BHF-UCL
O76082	SLC22A5	Solute carrier family 22 member 5	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
O76082	SLC22A5	Solute carrier family 22 member 5	GO:0070715; P:sodium-dependent organic cation transport; IDA:BHF-UCL
O76082	SLC22A5	Solute carrier family 22 member 5	GO:0055085; P:transmembrane transport; TAS:Reactome
Q4U2R8	SLC22A6	Solute carrier family 22 member 6	GO:0031404; F:chloride ion binding; IEA:Ensembl
Q4U2R8	SLC22A6	Solute carrier family 22 member 6	GO:0005452; F:inorganic anion exchanger activity; IDA:UniProtKB
Q4U2R8	SLC22A6	Solute carrier family 22 member 6	GO:0008514; F:organic anion transmembrane transporter activity; IDA:UniProtKB
Q4U2R8	SLC22A6	Solute carrier family 22 member 6	GO:0005515; F:protein binding; IPI:IntAct
Q4U2R8	SLC22A6	Solute carrier family 22 member 6	GO:0015347; F:sodium-independent organic anion transmembrane transporter activity; IDA:UniProtKB
Q4U2R8	SLC22A6	Solute carrier family 22 member 6	GO:0015742; P:alpha-ketoglutarate transport; IDA:UniProtKB
Q4U2R8	SLC22A6	Solute carrier family 22 member 6	GO:0015711; P:organic anion transport; IDA:UniProtKB
Q4U2R8	SLC22A6	Solute carrier family 22 member 6	GO:0051260; P:protein homooligomerization; IEA:Ensembl
Q4U2R8	SLC22A6	Solute carrier family 22 member 6	GO:0097254; P:renal tubular secretion; IMP:UniProtKB
Q4U2R8	SLC22A6	Solute carrier family 22 member 6	GO:0031427; P:response to methotrexate; IEA:Ensembl
Q4U2R8	SLC22A6	Solute carrier family 22 member 6	GO:0043252; P:sodium-independent organic anion transport; IDA:UniProtKB
Q4U2R8	SLC22A6	Solute carrier family 22 member 6	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9Y694	SLC22A7	Solute carrier family 22 member 7	GO:0015347; F:sodium-independent organic anion transmembrane transporter activity; TAS:ProtInc
Q9Y694	SLC22A7	Solute carrier family 22 member 7	GO:0015711; P:organic anion transport; TAS:ProtInc
Q9Y694	SLC22A7	Solute carrier family 22 member 7	GO:0035634; P:response to stilbenoid; IEA:Ensembl
Q9Y694	SLC22A7	Solute carrier family 22 member 7	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8TCC7	SLC22A8	Solute carrier family 22 member 8	GO:0005452; F:inorganic anion exchanger activity; IDA:UniProtKB
Q8TCC7	SLC22A8	Solute carrier family 22 member 8	GO:0008514; F:organic anion transmembrane transporter activity; IEA:Ensembl
Q8TCC7	SLC22A8	Solute carrier family 22 member 8	GO:0015651; F:quaternary ammonium group transmembrane transporter activity; IEA:Ensembl
Q8TCC7	SLC22A8	Solute carrier family 22 member 8	GO:0034635; P:glutathione transport; IEA:Ensembl
Q8TCC7	SLC22A8	Solute carrier family 22 member 8	GO:0031427; P:response to methotrexate; IEA:Ensembl
Q8TCC7	SLC22A8	Solute carrier family 22 member 8	GO:0009636; P:response to toxic substance; IEA:UniProtKB-KW
Q8TCC7	SLC22A8	Solute carrier family 22 member 8	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8IVM8	SLC22A9	Solute carrier family 22 member 9	GO:0055085; P:transmembrane transport; IEA:InterPro
Q63ZE4	SLC22A10	Solute carrier family 22 member 10	GO:0022857; F:transmembrane transporter activity; IEA:InterPro
Q9NSA0	SLC22A11	Solute carrier family 22 member 11	GO:0005452; F:inorganic anion exchanger activity; IDA:UniProtKB
Q9NSA0	SLC22A11	Solute carrier family 22 member 11	GO:0008514; F:organic anion transmembrane transporter activity; IDA:UniProtKB
Q9NSA0	SLC22A11	Solute carrier family 22 member 11	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NSA0	SLC22A11	Solute carrier family 22 member 11	GO:0015347; F:sodium-independent organic anion transmembrane transporter activity; IDA:UniProtKB
Q9NSA0	SLC22A11	Solute carrier family 22 member 11	GO:0015711; P:organic anion transport; IDA:UniProtKB
Q9NSA0	SLC22A11	Solute carrier family 22 member 11	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9NSA0	SLC22A11	Solute carrier family 22 member 11	GO:0046415; P:urate metabolic process; IMP:BHF-UCL
Q96S37	SLC22A12	Solute carrier family 22 member 12	GO:0030165; F:PDZ domain binding; IPI:UniProtKB
Q96S37	SLC22A12	Solute carrier family 22 member 12	GO:0015143; F:urate transmembrane transporter activity; IDA:UniProtKB
Q96S37	SLC22A12	Solute carrier family 22 member 12	GO:0019725; P:cellular homeostasis; NAS:UniProtKB
Q96S37	SLC22A12	Solute carrier family 22 member 12	GO:0015849; P:organic acid transport; IDA:GOC
Q96S37	SLC22A12	Solute carrier family 22 member 12	GO:0042493; P:response to drug; IDA:UniProtKB
Q96S37	SLC22A12	Solute carrier family 22 member 12	GO:0055085; P:transmembrane transport; TAS:Reactome
Q96S37	SLC22A12	Solute carrier family 22 member 12	GO:0046415; P:urate metabolic process; IMP:BHF-UCL
Q96S37	SLC22A12	Solute carrier family 22 member 12	GO:0015747; P:urate transport; IDA:UniProtKB
Q9Y226	SLC22A13	Solute carrier family 22 member 13	GO:0090416; F:nicotinate transporter activity; IDA:UniProt
Q9Y226	SLC22A13	Solute carrier family 22 member 13	GO:0015101; F:organic cation transmembrane transporter activity; NAS:UniProtKB
Q9Y226	SLC22A13	Solute carrier family 22 member 13	GO:2001142; P:nicotinate transport; IDA:UniProt
Q9Y226	SLC22A13	Solute carrier family 22 member 13	GO:0015695; P:organic cation transport; NAS:UniProtKB
Q9Y226	SLC22A13	Solute carrier family 22 member 13	GO:0015747; P:urate transport; IDA:UniProt
Q9Y267	SLC22A14	Solute carrier family 22 member 14	GO:0015101; F:organic cation transmembrane transporter activity; NAS:UniProtKB
Q9Y267	SLC22A14	Solute carrier family 22 member 14	GO:0015695; P:organic cation transport; NAS:UniProtKB
Q8IZD6	SLC22A15	Solute carrier family 22 member 15	GO:0022857; F:transmembrane transporter activity; IEA:InterPro
Q8IZD6	SLC22A15	Solute carrier family 22 member 15	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q86VW1	SLC22A16	Solute carrier family 22 member 16	GO:0005275; F:amine transmembrane transporter activity; IDA:MGI
Q86VW1	SLC22A16	Solute carrier family 22 member 16	GO:0015226; F:carnitine transmembrane transporter activity; IDA:UniProtKB
Q86VW1	SLC22A16	Solute carrier family 22 member 16	GO:0015101; F:organic cation transmembrane transporter activity; IDA:MGI
Q86VW1	SLC22A16	Solute carrier family 22 member 16	GO:0046717; P:acid secretion; IDA:UniProtKB
Q86VW1	SLC22A16	Solute carrier family 22 member 16	GO:0015837; P:amine transport; IDA:GOC
Q86VW1	SLC22A16	Solute carrier family 22 member 16	GO:1902603; P:carnitine transmembrane transport; IDA:GOC
Q86VW1	SLC22A16	Solute carrier family 22 member 16	GO:0015879; P:carnitine transport; IDA:UniProtKB
Q86VW1	SLC22A16	Solute carrier family 22 member 16	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q86VW1	SLC22A16	Solute carrier family 22 member 16	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q86VW1	SLC22A16	Solute carrier family 22 member 16	GO:0015695; P:organic cation transport; IDA:UniProtKB
Q86VW1	SLC22A16	Solute carrier family 22 member 16	GO:0007338; P:single fertilization; IMP:UniProtKB
Q86VW1	SLC22A16	Solute carrier family 22 member 16	GO:0030317; P:sperm motility; IMP:UniProtKB
Q86VW1	SLC22A16	Solute carrier family 22 member 16	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q86VW1	SLC22A16	Solute carrier family 22 member 16	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8WUG5	SLC22A17	Solute carrier family 22 member 17	GO:0004888; F:transmembrane signaling receptor activity; ISS:UniProtKB
Q8WUG5	SLC22A17	Solute carrier family 22 member 17	GO:0022857; F:transmembrane transporter activity; IEA:InterPro
Q8WUG5	SLC22A17	Solute carrier family 22 member 17	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q8WUG5	SLC22A17	Solute carrier family 22 member 17	GO:0015891; P:siderophore transport; ISS:UniProtKB
Q8WUG5	SLC22A17	Solute carrier family 22 member 17	GO:0007165; P:signal transduction; ISS:GOC
Q96BI1	SLC22A18	Solute carrier family 22 member 18	GO:0015238; F:drug transmembrane transporter activity; IDA:UniProtKB
Q96BI1	SLC22A18	Solute carrier family 22 member 18	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q96BI1	SLC22A18	Solute carrier family 22 member 18	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q96BI1	SLC22A18	Solute carrier family 22 member 18	GO:0006855; P:drug transmembrane transport; IDA:GOC
Q96BI1	SLC22A18	Solute carrier family 22 member 18	GO:0015893; P:drug transport; IDA:UniProtKB
Q96BI1	SLC22A18	Solute carrier family 22 member 18	GO:0007588; P:excretion; NAS:UniProtKB
Q96BI1	SLC22A18	Solute carrier family 22 member 18	GO:0015695; P:organic cation transport; NAS:UniProtKB
Q96BI1	SLC22A18	Solute carrier family 22 member 18	GO:0055085; P:transmembrane transport; TAS:Reactome
A6NK97	SLC22A20	Solute carrier family 22 member 20	GO:0022857; F:transmembrane transporter activity; IEA:InterPro
A6NK97	SLC22A20	Solute carrier family 22 member 20	GO:0006811; P:ion transport; IEA:UniProtKB-KW
A1A5C7	SLC22A23	Solute carrier family 22 member 23	GO:0022857; F:transmembrane transporter activity; IEA:InterPro
A1A5C7	SLC22A23	Solute carrier family 22 member 23	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q6T423	SLC22A25	Solute carrier family 22 member 25	GO:0055085; P:transmembrane transport; IEA:InterPro
Q8N4F4	SLC22A24	Solute carrier family 22 member 24	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q8N4F4	SLC22A24	Solute carrier family 22 member 24	GO:0055085; P:transmembrane transport; IEA:InterPro
A6NKX4	SLC22A31	Putative solute carrier family 22 member 31	GO:0022857; F:transmembrane transporter activity; IEA:InterPro
A6NKX4	SLC22A31	Putative solute carrier family 22 member 31	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0033300; F:dehydroascorbic acid transporter activity; IMP:UniProtKB
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0008520; F:L-ascorbate:sodium symporter activity; IDA:UniProtKB
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0015229; F:L-ascorbic acid transporter activity; IDA:UniProtKB
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0015205; F:nucleobase transmembrane transporter activity; TAS:ProtInc
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0005515; F:protein binding; IPI:IntAct
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0015081; F:sodium ion transmembrane transporter activity; IDA:UniProtKB
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0070890; F:sodium-dependent L-ascorbate transmembrane transporter activity; IDA:UniProtKB
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0007420; P:brain development; ISS:UniProtKB
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0070837; P:dehydroascorbic acid transport; IMP:UniProtKB
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0019852; P:L-ascorbic acid metabolic process; TAS:Reactome
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0015882; P:L-ascorbic acid transport; IDA:UniProtKB
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0030324; P:lung development; IEA:Ensembl
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0015851; P:nucleobase transport; TAS:ProtInc
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0009636; P:response to toxic substance; IDA:UniProtKB
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0035725; P:sodium ion transmembrane transport; IDA:GOC
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0006814; P:sodium ion transport; IDA:UniProtKB
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0070904; P:transepithelial L-ascorbic acid transport; IDA:UniProtKB
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0035461; P:vitamin transmembrane transport; IDA:GOC
Q9UHI7	SLC23A1	Solute carrier family 23 member 1	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9UGH3	SLC23A2	Solute carrier family 23 member 2	GO:0008520; F:L-ascorbate:sodium symporter activity; IEA:Ensembl
Q9UGH3	SLC23A2	Solute carrier family 23 member 2	GO:0015229; F:L-ascorbic acid transporter activity; IDA:UniProtKB
Q9UGH3	SLC23A2	Solute carrier family 23 member 2	GO:0015205; F:nucleobase transmembrane transporter activity; TAS:ProtInc
Q9UGH3	SLC23A2	Solute carrier family 23 member 2	GO:0070890; F:sodium-dependent L-ascorbate transmembrane transporter activity; IDA:UniProtKB
Q9UGH3	SLC23A2	Solute carrier family 23 member 2	GO:0008523; F:sodium-dependent multivitamin transmembrane transporter activity; NAS:UniProtKB
Q9UGH3	SLC23A2	Solute carrier family 23 member 2	GO:0019852; P:L-ascorbic acid metabolic process; NAS:UniProtKB
Q9UGH3	SLC23A2	Solute carrier family 23 member 2	GO:0015882; P:L-ascorbic acid transport; IDA:UniProtKB
Q9UGH3	SLC23A2	Solute carrier family 23 member 2	GO:0015993; P:molecular hydrogen transport; NAS:UniProtKB
Q9UGH3	SLC23A2	Solute carrier family 23 member 2	GO:0015851; P:nucleobase transport; TAS:ProtInc
Q9UGH3	SLC23A2	Solute carrier family 23 member 2	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
Q9UGH3	SLC23A2	Solute carrier family 23 member 2	GO:0006979; P:response to oxidative stress; IEA:Ensembl
Q9UGH3	SLC23A2	Solute carrier family 23 member 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UGH3	SLC23A2	Solute carrier family 23 member 2	GO:0070904; P:transepithelial L-ascorbic acid transport; IDA:UniProtKB
Q9UGH3	SLC23A2	Solute carrier family 23 member 2	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9UGH3	SLC23A2	Solute carrier family 23 member 2	GO:0035461; P:vitamin transmembrane transport; IDA:GOC
Q9UGH3	SLC23A2	Solute carrier family 23 member 2	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q6PIS1	SLC23A3	Solute carrier family 23 member 3	GO:0005215; F:transporter activity; IEA:InterPro
Q6PIS1	SLC23A3	Solute carrier family 23 member 3	GO:0055085; P:transmembrane transport; IEA:InterPro
Q9Y6Y8	SEC23IP	SEC23-interacting protein	GO:0046872; F:metal ion binding; IEA:InterPro
Q9Y6Y8	SEC23IP	SEC23-interacting protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y6Y8	SEC23IP	SEC23-interacting protein	GO:0007030; P:Golgi organization; TAS:ProtInc
Q9Y6Y8	SEC23IP	SEC23-interacting protein	GO:0006886; P:intracellular protein transport; TAS:ProtInc
Q9BSK2	SLC25A33	Solute carrier family 25 member 33	GO:0006810; P:transport; IEA:UniProtKB-KW
Q6PIV7	SLC25A34	Solute carrier family 25 member 34	GO:0006810; P:transport; IEA:UniProtKB-KW
Q3KQZ1	SLC25A35	Solute carrier family 25 member 35	GO:0006810; P:transport; IEA:UniProtKB-KW
Q96CQ1	SLC25A36	Solute carrier family 25 member 36	GO:0032355; P:response to estradiol; IDA:BHF-UCL
Q96CQ1	SLC25A36	Solute carrier family 25 member 36	GO:0055085; P:transmembrane transport; IEA:InterPro
Q96DW6	SLC25A38	Solute carrier family 25 member 38	GO:0030218; P:erythrocyte differentiation; IMP:UniProtKB
Q96DW6	SLC25A38	Solute carrier family 25 member 38	GO:0006783; P:heme biosynthetic process; TAS:UniProtKB
Q96DW6	SLC25A38	Solute carrier family 25 member 38	GO:0006810; P:transport; IEA:UniProtKB-KW
Q9BZJ4	SLC25A39	Solute carrier family 25 member 39	GO:0006783; P:heme biosynthetic process; IEA:UniProtKB-KW
Q9BZJ4	SLC25A39	Solute carrier family 25 member 39	GO:0006810; P:transport; IEA:UniProtKB-KW
Q8TBP6	SLC25A40	Solute carrier family 25 member 40	GO:0055085; P:transmembrane transport; IEA:InterPro
Q8N5S1	SLC25A41	Solute carrier family 25 member 41	GO:0055085; P:transmembrane transport; IEA:InterPro
Q86VD7	SLC25A42	Mitochondrial coenzyme A transporter SLC25A42	GO:0043262; F:adenosine-diphosphatase activity; IDA:UniProtKB
Q86VD7	SLC25A42	Mitochondrial coenzyme A transporter SLC25A42	GO:0015217; F:ADP transmembrane transporter activity; IDA:UniProtKB
Q86VD7	SLC25A42	Mitochondrial coenzyme A transporter SLC25A42	GO:0080122; F:AMP transmembrane transporter activity; IDA:UniProtKB
Q86VD7	SLC25A42	Mitochondrial coenzyme A transporter SLC25A42	GO:0005347; F:ATP transmembrane transporter activity; IDA:UniProtKB
Q86VD7	SLC25A42	Mitochondrial coenzyme A transporter SLC25A42	GO:0015228; F:coenzyme A transmembrane transporter activity; IDA:UniProtKB
Q86VD7	SLC25A42	Mitochondrial coenzyme A transporter SLC25A42	GO:0015866; P:ADP transport; IDA:UniProtKB
Q86VD7	SLC25A42	Mitochondrial coenzyme A transporter SLC25A42	GO:0080121; P:AMP transport; IDA:UniProtKB
Q86VD7	SLC25A42	Mitochondrial coenzyme A transporter SLC25A42	GO:0015867; P:ATP transport; IDA:UniProtKB
Q86VD7	SLC25A42	Mitochondrial coenzyme A transporter SLC25A42	GO:0035349; P:coenzyme A transmembrane transport; IDA:UniProtKB
Q86VD7	SLC25A42	Mitochondrial coenzyme A transporter SLC25A42	GO:0008152; P:metabolic process; IDA:GOC
Q8WUT9	SLC25A43	Solute carrier family 25 member 43	GO:0055085; P:transmembrane transport; IEA:InterPro
Q96H78	SLC25A44	Solute carrier family 25 member 44	GO:0055085; P:transmembrane transport; IEA:InterPro
Q8N413	SLC25A45	Solute carrier family 25 member 45	GO:0055085; P:transmembrane transport; IEA:InterPro
Q6Q0C1	SLC25A47	Solute carrier family 25 member 47	GO:0055085; P:transmembrane transport; IEA:InterPro
Q96AG3	SLC25A46	Solute carrier family 25 member 46	GO:0006810; P:transport; IEA:UniProtKB-KW
Q6ZT89	SLC25A48	Solute carrier family 25 member 48	GO:0055085; P:transmembrane transport; IEA:InterPro
Q9H1U9	SLC25A51	Solute carrier family 25 member 51	GO:0006810; P:transport; IEA:UniProtKB-KW
Q5H9E4	SLC25A53	Solute carrier family 25 member 53	GO:0006810; P:transport; IEA:UniProtKB-KW
Q3SY17	SLC25A52	Solute carrier family 25 member 52	GO:0006810; P:transport; IEA:UniProtKB-KW
Q8NG04	SLC26A10	Solute carrier family 26 member 10	GO:0015297; F:antiporter activity; IEA:UniProtKB-KW
Q8NG04	SLC26A10	Solute carrier family 26 member 10	GO:0015116; F:sulfate transmembrane transporter activity; IEA:InterPro
Q86WA9	SLC26A11	Sodium-independent sulfate anion transporter	GO:0008509; F:anion transmembrane transporter activity; IDA:UniProtKB
Q86WA9	SLC26A11	Sodium-independent sulfate anion transporter	GO:0015301; F:anion:anion antiporter activity; IEA:UniProtKB-KW
Q86WA9	SLC26A11	Sodium-independent sulfate anion transporter	GO:0008271; F:secondary active sulfate transmembrane transporter activity; IEA:InterPro
Q86WA9	SLC26A11	Sodium-independent sulfate anion transporter	GO:0008272; P:sulfate transport; IDA:UniProtKB
Q9H2B4	SLC26A1	Sulfate anion transporter 1	GO:0015301; F:anion:anion antiporter activity; ISS:UniProtKB
Q9H2B4	SLC26A1	Sulfate anion transporter 1	GO:0015108; F:chloride transmembrane transporter activity; ISS:UniProtKB
Q9H2B4	SLC26A1	Sulfate anion transporter 1	GO:0019531; F:oxalate transmembrane transporter activity; ISS:UniProtKB
Q9H2B4	SLC26A1	Sulfate anion transporter 1	GO:0008271; F:secondary active sulfate transmembrane transporter activity; IEA:InterPro
Q9H2B4	SLC26A1	Sulfate anion transporter 1	GO:0015116; F:sulfate transmembrane transporter activity; ISS:UniProtKB
Q9H2B4	SLC26A1	Sulfate anion transporter 1	GO:0050428; P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process; TAS:Reactome
Q9H2B4	SLC26A1	Sulfate anion transporter 1	GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; TAS:Reactome
Q9H2B4	SLC26A1	Sulfate anion transporter 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9H2B4	SLC26A1	Sulfate anion transporter 1	GO:1902476; P:chloride transmembrane transport; ISS:GOC
Q9H2B4	SLC26A1	Sulfate anion transporter 1	GO:0006821; P:chloride transport; ISS:UniProtKB
Q9H2B4	SLC26A1	Sulfate anion transporter 1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9H2B4	SLC26A1	Sulfate anion transporter 1	GO:0006811; P:ion transport; TAS:Reactome
Q9H2B4	SLC26A1	Sulfate anion transporter 1	GO:0019532; P:oxalate transport; ISS:UniProtKB
Q9H2B4	SLC26A1	Sulfate anion transporter 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H2B4	SLC26A1	Sulfate anion transporter 1	GO:1902358; P:sulfate transmembrane transport; ISS:GOC
Q9H2B4	SLC26A1	Sulfate anion transporter 1	GO:0008272; P:sulfate transport; ISS:UniProtKB
Q9H2B4	SLC26A1	Sulfate anion transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9H2B4	SLC26A1	Sulfate anion transporter 1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P50443	SLC26A2	Sulfate transporter	GO:0008271; F:secondary active sulfate transmembrane transporter activity; IEA:InterPro
P50443	SLC26A2	Sulfate transporter	GO:0015116; F:sulfate transmembrane transporter activity; TAS:ProtInc
P50443	SLC26A2	Sulfate transporter	GO:0050428; P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process; TAS:Reactome
P50443	SLC26A2	Sulfate transporter	GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; TAS:Reactome
P50443	SLC26A2	Sulfate transporter	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P50443	SLC26A2	Sulfate transporter	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P50443	SLC26A2	Sulfate transporter	GO:0006811; P:ion transport; TAS:Reactome
P50443	SLC26A2	Sulfate transporter	GO:0001503; P:ossification; IEA:Ensembl
P50443	SLC26A2	Sulfate transporter	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P50443	SLC26A2	Sulfate transporter	GO:1902358; P:sulfate transmembrane transport; TAS:GOC
P50443	SLC26A2	Sulfate transporter	GO:0008272; P:sulfate transport; TAS:ProtInc
P50443	SLC26A2	Sulfate transporter	GO:0055085; P:transmembrane transport; TAS:Reactome
P50443	SLC26A2	Sulfate transporter	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P40879	SLC26A3	Chloride anion exchanger	GO:0015301; F:anion:anion antiporter activity; IEA:Ensembl
P40879	SLC26A3	Chloride anion exchanger	GO:0015106; F:bicarbonate transmembrane transporter activity; ISS:UniProtKB
P40879	SLC26A3	Chloride anion exchanger	GO:0015108; F:chloride transmembrane transporter activity; ISS:UniProtKB
P40879	SLC26A3	Chloride anion exchanger	GO:0005515; F:protein binding; IPI:IntAct
P40879	SLC26A3	Chloride anion exchanger	GO:0008271; F:secondary active sulfate transmembrane transporter activity; IEA:InterPro
P40879	SLC26A3	Chloride anion exchanger	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P40879	SLC26A3	Chloride anion exchanger	GO:0003712; F:transcription cofactor activity; TAS:ProtInc
P40879	SLC26A3	Chloride anion exchanger	GO:0005215; F:transporter activity; TAS:ProtInc
P40879	SLC26A3	Chloride anion exchanger	GO:0006820; P:anion transport; TAS:ProtInc
P40879	SLC26A3	Chloride anion exchanger	GO:0071320; P:cellular response to cAMP; ISS:UniProtKB
P40879	SLC26A3	Chloride anion exchanger	GO:1902476; P:chloride transmembrane transport; ISS:GOC
P40879	SLC26A3	Chloride anion exchanger	GO:0007588; P:excretion; TAS:ProtInc
P40879	SLC26A3	Chloride anion exchanger	GO:0051454; P:intracellular pH elevation; ISS:UniProtKB
P40879	SLC26A3	Chloride anion exchanger	GO:0006811; P:ion transport; TAS:Reactome
P40879	SLC26A3	Chloride anion exchanger	GO:0060081; P:membrane hyperpolarization; ISS:UniProtKB
P40879	SLC26A3	Chloride anion exchanger	GO:2001141; P:regulation of RNA biosynthetic process; TAS:GOC
P40879	SLC26A3	Chloride anion exchanger	GO:0006355; P:regulation of transcription, DNA-templated; TAS:GOC
P40879	SLC26A3	Chloride anion exchanger	GO:0048240; P:sperm capacitation; ISS:UniProtKB
P40879	SLC26A3	Chloride anion exchanger	GO:0055085; P:transmembrane transport; TAS:Reactome
O43511	SLC26A4	Pendrin	GO:0015108; F:chloride transmembrane transporter activity; TAS:ProtInc
O43511	SLC26A4	Pendrin	GO:0015111; F:iodide transmembrane transporter activity; TAS:ProtInc
O43511	SLC26A4	Pendrin	GO:0008271; F:secondary active sulfate transmembrane transporter activity; IEA:InterPro
O43511	SLC26A4	Pendrin	GO:0015116; F:sulfate transmembrane transporter activity; TAS:ProtInc
O43511	SLC26A4	Pendrin	GO:1902476; P:chloride transmembrane transport; TAS:GOC
O43511	SLC26A4	Pendrin	GO:0015698; P:inorganic anion transport; TAS:ProtInc
O43511	SLC26A4	Pendrin	GO:0006811; P:ion transport; TAS:Reactome
O43511	SLC26A4	Pendrin	GO:0006885; P:regulation of pH; ISS:UniProtKB
O43511	SLC26A4	Pendrin	GO:0032880; P:regulation of protein localization; ISS:UniProtKB
O43511	SLC26A4	Pendrin	GO:0007605; P:sensory perception of sound; TAS:ProtInc
O43511	SLC26A4	Pendrin	GO:1902358; P:sulfate transmembrane transport; TAS:GOC
O43511	SLC26A4	Pendrin	GO:0008272; P:sulfate transport; TAS:ProtInc
O43511	SLC26A4	Pendrin	GO:0055085; P:transmembrane transport; TAS:Reactome
P58743	SLC26A5	Prestin	GO:0008271; F:secondary active sulfate transmembrane transporter activity; IEA:InterPro
P58743	SLC26A5	Prestin	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
P58743	SLC26A5	Prestin	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
P58743	SLC26A5	Prestin	GO:0007605; P:sensory perception of sound; IMP:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0015301; F:anion:anion antiporter activity; IDA:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0015106; F:bicarbonate transmembrane transporter activity; IDA:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0015108; F:chloride transmembrane transporter activity; IDA:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0015562; F:efflux transmembrane transporter activity; ISS:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0015660; F:formate efflux transmembrane transporter activity; ISS:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0015499; F:formate transmembrane transporter activity; ISS:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0015659; F:formate uptake transmembrane transporter activity; ISS:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0019531; F:oxalate transmembrane transporter activity; IMP:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0030165; F:PDZ domain binding; ISS:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0008271; F:secondary active sulfate transmembrane transporter activity; IEA:InterPro
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0015116; F:sulfate transmembrane transporter activity; IDA:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0038166; P:angiotensin-activated signaling pathway; IDA:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0006820; P:anion transport; IDA:GOC
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0015701; P:bicarbonate transport; IDA:GOC
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0071320; P:cellular response to cAMP; ISS:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0071332; P:cellular response to fructose stimulus; ISS:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0071346; P:cellular response to interferon-gamma; IDA:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:1902476; P:chloride transmembrane transport; IDA:GOC
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0006821; P:chloride transport; IDA:GOC
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0042045; P:epithelial fluid transport; ISS:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0015724; P:formate transport; ISS:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0050892; P:intestinal absorption; ISS:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0051454; P:intracellular pH elevation; ISS:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0006811; P:ion transport; TAS:Reactome
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0015797; P:mannitol transport; ISS:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0019532; P:oxalate transport; IMP:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0046724; P:oxalic acid secretion; ISS:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:2001150; P:positive regulation of dipeptide transmembrane transport; ISS:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0070528; P:protein kinase C signaling; IDA:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0051453; P:regulation of intracellular pH; IDA:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0048240; P:sperm capacitation; ISS:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:1902358; P:sulfate transmembrane transport; IDA:GOC
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0008272; P:sulfate transport; IMP:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0030321; P:transepithelial chloride transport; IMP:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0070633; P:transepithelial transport; ISS:UniProtKB
Q9BXS9	SLC26A6	Solute carrier family 26 member 6	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8TE54	SLC26A7	Anion exchange transporter	GO:0015301; F:anion:anion antiporter activity; IEA:UniProtKB-KW
Q8TE54	SLC26A7	Anion exchange transporter	GO:0015106; F:bicarbonate transmembrane transporter activity; ISS:UniProtKB
Q8TE54	SLC26A7	Anion exchange transporter	GO:0005254; F:chloride channel activity; IDA:UniProtKB
Q8TE54	SLC26A7	Anion exchange transporter	GO:0019531; F:oxalate transmembrane transporter activity; IDA:UniProtKB
Q8TE54	SLC26A7	Anion exchange transporter	GO:0015116; F:sulfate transmembrane transporter activity; IDA:UniProtKB
Q8TE54	SLC26A7	Anion exchange transporter	GO:0006820; P:anion transport; IDA:UniProtKB
Q8TE54	SLC26A7	Anion exchange transporter	GO:0015701; P:bicarbonate transport; ISS:UniProtKB
Q8TE54	SLC26A7	Anion exchange transporter	GO:1902476; P:chloride transmembrane transport; IDA:GOC
Q8TE54	SLC26A7	Anion exchange transporter	GO:0006821; P:chloride transport; IDA:UniProtKB
Q8TE54	SLC26A7	Anion exchange transporter	GO:0001696; P:gastric acid secretion; IEA:Ensembl
Q8TE54	SLC26A7	Anion exchange transporter	GO:0006811; P:ion transport; TAS:Reactome
Q8TE54	SLC26A7	Anion exchange transporter	GO:0019532; P:oxalate transport; IDA:UniProtKB
Q8TE54	SLC26A7	Anion exchange transporter	GO:1902358; P:sulfate transmembrane transport; IDA:GOC
Q8TE54	SLC26A7	Anion exchange transporter	GO:0008272; P:sulfate transport; IDA:UniProtKB
Q8TE54	SLC26A7	Anion exchange transporter	GO:0055085; P:transmembrane transport; TAS:Reactome
Q96RN1	SLC26A8	Testis anion transporter 1	GO:0015301; F:anion:anion antiporter activity; IEA:UniProtKB-KW
Q96RN1	SLC26A8	Testis anion transporter 1	GO:0005254; F:chloride channel activity; IDA:UniProtKB
Q96RN1	SLC26A8	Testis anion transporter 1	GO:0019531; F:oxalate transmembrane transporter activity; IDA:UniProtKB
Q96RN1	SLC26A8	Testis anion transporter 1	GO:0005515; F:protein binding; IPI:IntAct
Q96RN1	SLC26A8	Testis anion transporter 1	GO:0015116; F:sulfate transmembrane transporter activity; IDA:UniProtKB
Q96RN1	SLC26A8	Testis anion transporter 1	GO:0006820; P:anion transport; IDA:UniProtKB
Q96RN1	SLC26A8	Testis anion transporter 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96RN1	SLC26A8	Testis anion transporter 1	GO:1902476; P:chloride transmembrane transport; IDA:GOC
Q96RN1	SLC26A8	Testis anion transporter 1	GO:0006821; P:chloride transport; IDA:UniProtKB
Q96RN1	SLC26A8	Testis anion transporter 1	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q96RN1	SLC26A8	Testis anion transporter 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q96RN1	SLC26A8	Testis anion transporter 1	GO:0019532; P:oxalate transport; IDA:UniProtKB
Q96RN1	SLC26A8	Testis anion transporter 1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q96RN1	SLC26A8	Testis anion transporter 1	GO:1902358; P:sulfate transmembrane transport; IDA:GOC
Q96RN1	SLC26A8	Testis anion transporter 1	GO:0008272; P:sulfate transport; IDA:UniProtKB
Q7LBE3	SLC26A9	Solute carrier family 26 member 9	GO:0015301; F:anion:anion antiporter activity; IDA:UniProt
Q7LBE3	SLC26A9	Solute carrier family 26 member 9	GO:0051117; F:ATPase binding; IPI:UniProt
Q7LBE3	SLC26A9	Solute carrier family 26 member 9	GO:0005254; F:chloride channel activity; IDA:UniProt
Q7LBE3	SLC26A9	Solute carrier family 26 member 9	GO:0008271; F:secondary active sulfate transmembrane transporter activity; IEA:InterPro
Q7LBE3	SLC26A9	Solute carrier family 26 member 9	GO:0006820; P:anion transport; IDA:UniProt
Q7LBE3	SLC26A9	Solute carrier family 26 member 9	GO:0015701; P:bicarbonate transport; IDA:UniProt
Q7LBE3	SLC26A9	Solute carrier family 26 member 9	GO:1902476; P:chloride transmembrane transport; IDA:GOC
Q7LBE3	SLC26A9	Solute carrier family 26 member 9	GO:0006821; P:chloride transport; IDA:UniProt
Q7LBE3	SLC26A9	Solute carrier family 26 member 9	GO:0006811; P:ion transport; TAS:Reactome
Q7LBE3	SLC26A9	Solute carrier family 26 member 9	GO:0010628; P:positive regulation of gene expression; IDA:UniProt
Q7LBE3	SLC26A9	Solute carrier family 26 member 9	GO:0055085; P:transmembrane transport; TAS:Reactome
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0015245; F:fatty acid transporter activity; IEA:Ensembl
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0031957; F:very long-chain fatty acid-CoA ligase activity; IEA:Ensembl
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0033211; P:adiponectin-activated signaling pathway; IEA:Ensembl
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0032049; P:cardiolipin biosynthetic process; IMP:UniProtKB
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0015909; P:long-chain fatty acid transport; TAS:Reactome
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0001579; P:medium-chain fatty acid transport; IEA:Ensembl
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0071072; P:negative regulation of phospholipid biosynthetic process; IMP:UniProtKB
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0006654; P:phosphatidic acid biosynthetic process; IMP:UniProtKB
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0006656; P:phosphatidylcholine biosynthetic process; IMP:UniProtKB
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0006646; P:phosphatidylethanolamine biosynthetic process; IMP:UniProtKB
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0006655; P:phosphatidylglycerol biosynthetic process; IMP:UniProtKB
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0006661; P:phosphatidylinositol biosynthetic process; IMP:UniProtKB
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0006659; P:phosphatidylserine biosynthetic process; IMP:UniProtKB
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0031652; P:positive regulation of heat generation; IEA:Ensembl
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IEA:Ensembl
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0009409; P:response to cold; IEA:Ensembl
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0032868; P:response to insulin; IEA:Ensembl
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6PCB7	SLC27A1	Long-chain fatty acid transport protein 1	GO:0055085; P:transmembrane transport; TAS:Reactome
O14975	SLC27A2	Very long-chain acyl-CoA synthetase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O14975	SLC27A2	Very long-chain acyl-CoA synthetase	GO:0019899; F:enzyme binding; IPI:UniProtKB
O14975	SLC27A2	Very long-chain acyl-CoA synthetase	GO:0015245; F:fatty acid transporter activity; IEA:Ensembl
O14975	SLC27A2	Very long-chain acyl-CoA synthetase	GO:0004467; F:long-chain fatty acid-CoA ligase activity; IDA:UniProtKB
O14975	SLC27A2	Very long-chain acyl-CoA synthetase	GO:0050197; F:phytanate-CoA ligase activity; IDA:UniProtKB
O14975	SLC27A2	Very long-chain acyl-CoA synthetase	GO:0070251; F:pristanate-CoA ligase activity; IDA:UniProtKB
O14975	SLC27A2	Very long-chain acyl-CoA synthetase	GO:0005102; F:receptor binding; IPI:UniProtKB
O14975	SLC27A2	Very long-chain acyl-CoA synthetase	GO:0031957; F:very long-chain fatty acid-CoA ligase activity; IDA:UniProtKB
O14975	SLC27A2	Very long-chain acyl-CoA synthetase	GO:0006699; P:bile acid biosynthetic process; IDA:UniProtKB
O14975	SLC27A2	Very long-chain acyl-CoA synthetase	GO:0008206; P:bile acid metabolic process; TAS:Reactome
O14975	SLC27A2	Very long-chain acyl-CoA synthetase	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O14975	SLC27A2	Very long-chain acyl-CoA synthetase	GO:0001561; P:fatty acid alpha-oxidation; IDA:UniProtKB
O14975	SLC27A2	Very long-chain acyl-CoA synthetase	GO:0006635; P:fatty acid beta-oxidation; IDA:UniProtKB
O14975	SLC27A2	Very long-chain acyl-CoA synthetase	GO:0044539; P:long-chain fatty acid import; IDA:UniProtKB
O14975	SLC27A2	Very long-chain acyl-CoA synthetase	GO:0001676; P:long-chain fatty acid metabolic process; IDA:UniProtKB
O14975	SLC27A2	Very long-chain acyl-CoA synthetase	GO:0097089; P:methyl-branched fatty acid metabolic process; IDA:UniProtKB
O14975	SLC27A2	Very long-chain acyl-CoA synthetase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O14975	SLC27A2	Very long-chain acyl-CoA synthetase	GO:0042760; P:very long-chain fatty acid catabolic process; IEA:Ensembl
Q6P1M0	SLC27A4	Long-chain fatty acid transport protein 4	GO:0015245; F:fatty acid transporter activity; TAS:ProtInc
Q6P1M0	SLC27A4	Long-chain fatty acid transport protein 4	GO:0004467; F:long-chain fatty acid-CoA ligase activity; IDA:UniProtKB
Q6P1M0	SLC27A4	Long-chain fatty acid transport protein 4	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
Q6P1M0	SLC27A4	Long-chain fatty acid transport protein 4	GO:0031957; F:very long-chain fatty acid-CoA ligase activity; IEA:Ensembl
Q6P1M0	SLC27A4	Long-chain fatty acid transport protein 4	GO:0015908; P:fatty acid transport; TAS:ProtInc
Q6P1M0	SLC27A4	Long-chain fatty acid transport protein 4	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q6P1M0	SLC27A4	Long-chain fatty acid transport protein 4	GO:0044539; P:long-chain fatty acid import; IDA:UniProtKB
Q6P1M0	SLC27A4	Long-chain fatty acid transport protein 4	GO:0001676; P:long-chain fatty acid metabolic process; IDA:UniProtKB
Q6P1M0	SLC27A4	Long-chain fatty acid transport protein 4	GO:0015909; P:long-chain fatty acid transport; TAS:Reactome
Q6P1M0	SLC27A4	Long-chain fatty acid transport protein 4	GO:0001579; P:medium-chain fatty acid transport; IEA:Ensembl
Q6P1M0	SLC27A4	Long-chain fatty acid transport protein 4	GO:0007584; P:response to nutrient; IEA:Ensembl
Q6P1M0	SLC27A4	Long-chain fatty acid transport protein 4	GO:0043588; P:skin development; IEA:Ensembl
Q6P1M0	SLC27A4	Long-chain fatty acid transport protein 4	GO:0055085; P:transmembrane transport; TAS:Reactome
Q6P1M0	SLC27A4	Long-chain fatty acid transport protein 4	GO:0006810; P:transport; TAS:ProtInc
Q6P1M0	SLC27A4	Long-chain fatty acid transport protein 4	GO:0042760; P:very long-chain fatty acid catabolic process; IEA:Ensembl
Q5K4L6	SLC27A3	Long-chain fatty acid transport protein 3	GO:0004321; F:fatty-acyl-CoA synthase activity; IEA:Ensembl
Q5K4L6	SLC27A3	Long-chain fatty acid transport protein 3	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q5K4L6	SLC27A3	Long-chain fatty acid transport protein 3	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
Q5K4L6	SLC27A3	Long-chain fatty acid transport protein 3	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW
Q9Y2P5	SLC27A5	Bile acyl-CoA synthetase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y2P5	SLC27A5	Bile acyl-CoA synthetase	GO:0047747; F:cholate-CoA ligase activity; IEA:UniProtKB-EC
Q9Y2P5	SLC27A5	Bile acyl-CoA synthetase	GO:0015245; F:fatty acid transporter activity; IEA:Ensembl
Q9Y2P5	SLC27A5	Bile acyl-CoA synthetase	GO:0031957; F:very long-chain fatty acid-CoA ligase activity; IDA:UniProtKB
Q9Y2P5	SLC27A5	Bile acyl-CoA synthetase	GO:0015721; P:bile acid and bile salt transport; TAS:Reactome
Q9Y2P5	SLC27A5	Bile acyl-CoA synthetase	GO:0006699; P:bile acid biosynthetic process; IDA:UniProtKB
Q9Y2P5	SLC27A5	Bile acyl-CoA synthetase	GO:0008206; P:bile acid metabolic process; TAS:Reactome
Q9Y2P5	SLC27A5	Bile acyl-CoA synthetase	GO:0046951; P:ketone body biosynthetic process; IEA:Ensembl
Q9Y2P5	SLC27A5	Bile acyl-CoA synthetase	GO:0015911; P:plasma membrane long-chain fatty acid transport; IEA:Ensembl
Q9Y2P5	SLC27A5	Bile acyl-CoA synthetase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y2P5	SLC27A5	Bile acyl-CoA synthetase	GO:0006642; P:triglyceride mobilization; IEA:Ensembl
Q9Y2P5	SLC27A5	Bile acyl-CoA synthetase	GO:0000038; P:very long-chain fatty acid metabolic process; IDA:UniProtKB
Q9Y2P4	SLC27A6	Long-chain fatty acid transport protein 6	GO:0004467; F:long-chain fatty acid-CoA ligase activity; TAS:ProtInc
Q9Y2P4	SLC27A6	Long-chain fatty acid transport protein 6	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
Q9Y2P4	SLC27A6	Long-chain fatty acid transport protein 6	GO:0031957; F:very long-chain fatty acid-CoA ligase activity; IEA:Ensembl
Q9Y2P4	SLC27A6	Long-chain fatty acid transport protein 6	GO:0001676; P:long-chain fatty acid metabolic process; TAS:GOC
Q9Y2P4	SLC27A6	Long-chain fatty acid transport protein 6	GO:0015909; P:long-chain fatty acid transport; TAS:Reactome
Q9Y2P4	SLC27A6	Long-chain fatty acid transport protein 6	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9Y2P4	SLC27A6	Long-chain fatty acid transport protein 6	GO:0000038; P:very long-chain fatty acid metabolic process; TAS:ProtInc
O00337	SLC28A1	Sodium/nucleoside cotransporter 1	GO:0001882; F:nucleoside binding; IEA:InterPro
O00337	SLC28A1	Sodium/nucleoside cotransporter 1	GO:0005337; F:nucleoside transmembrane transporter activity; TAS:ProtInc
O00337	SLC28A1	Sodium/nucleoside cotransporter 1	GO:0005415; F:nucleoside:sodium symporter activity; IEA:InterPro
O00337	SLC28A1	Sodium/nucleoside cotransporter 1	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
O00337	SLC28A1	Sodium/nucleoside cotransporter 1	GO:1901642; P:nucleoside transmembrane transport; TAS:GOC
O00337	SLC28A1	Sodium/nucleoside cotransporter 1	GO:0015858; P:nucleoside transport; TAS:ProtInc
O00337	SLC28A1	Sodium/nucleoside cotransporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
O43868	SLC28A2	Sodium/nucleoside cotransporter 2	GO:0001882; F:nucleoside binding; IEA:InterPro
O43868	SLC28A2	Sodium/nucleoside cotransporter 2	GO:0005415; F:nucleoside:sodium symporter activity; IEA:InterPro
O43868	SLC28A2	Sodium/nucleoside cotransporter 2	GO:0015211; F:purine nucleoside transmembrane transporter activity; TAS:ProtInc
O43868	SLC28A2	Sodium/nucleoside cotransporter 2	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
O43868	SLC28A2	Sodium/nucleoside cotransporter 2	GO:0015860; P:purine nucleoside transmembrane transport; TAS:ProtInc
O43868	SLC28A2	Sodium/nucleoside cotransporter 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9HAS3	SLC28A3	Solute carrier family 28 member 3	GO:0001882; F:nucleoside binding; IEA:InterPro
Q9HAS3	SLC28A3	Solute carrier family 28 member 3	GO:0015390; F:purine-specific nucleoside:sodium symporter activity; IEA:Ensembl
Q9HAS3	SLC28A3	Solute carrier family 28 member 3	GO:0015389; F:pyrimidine- and adenine-specific:sodium symporter activity; IEA:Ensembl
Q9HAS3	SLC28A3	Solute carrier family 28 member 3	GO:0015864; P:pyrimidine nucleoside transport; IEA:Ensembl
Q9HAS3	SLC28A3	Solute carrier family 28 member 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q14542	SLC29A2	Equilibrative nucleoside transporter 2	GO:0005337; F:nucleoside transmembrane transporter activity; TAS:ProtInc
Q14542	SLC29A2	Equilibrative nucleoside transporter 2	GO:0008283; P:cell proliferation; TAS:ProtInc
Q14542	SLC29A2	Equilibrative nucleoside transporter 2	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
Q14542	SLC29A2	Equilibrative nucleoside transporter 2	GO:1901642; P:nucleoside transmembrane transport; TAS:GOC
Q14542	SLC29A2	Equilibrative nucleoside transporter 2	GO:0015858; P:nucleoside transport; IDA:UniProtKB
Q14542	SLC29A2	Equilibrative nucleoside transporter 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q99808	SLC29A1	Equilibrative nucleoside transporter 1	GO:0005337; F:nucleoside transmembrane transporter activity; TAS:ProtInc
Q99808	SLC29A1	Equilibrative nucleoside transporter 1	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
Q99808	SLC29A1	Equilibrative nucleoside transporter 1	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
Q99808	SLC29A1	Equilibrative nucleoside transporter 1	GO:0007595; P:lactation; IEA:Ensembl
Q99808	SLC29A1	Equilibrative nucleoside transporter 1	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
Q99808	SLC29A1	Equilibrative nucleoside transporter 1	GO:1901642; P:nucleoside transmembrane transport; TAS:GOC
Q99808	SLC29A1	Equilibrative nucleoside transporter 1	GO:0015858; P:nucleoside transport; IDA:UniProtKB
Q99808	SLC29A1	Equilibrative nucleoside transporter 1	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
Q99808	SLC29A1	Equilibrative nucleoside transporter 1	GO:0030431; P:sleep; IEA:Ensembl
Q99808	SLC29A1	Equilibrative nucleoside transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q99808	SLC29A1	Equilibrative nucleoside transporter 1	GO:0015862; P:uridine transport; IEA:Ensembl
Q9BZD2	SLC29A3	Equilibrative nucleoside transporter 3	GO:0005337; F:nucleoside transmembrane transporter activity; IEA:InterPro
Q9BZD2	SLC29A3	Equilibrative nucleoside transporter 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q7RTT9	SLC29A4	Equilibrative nucleoside transporter 4	GO:0005337; F:nucleoside transmembrane transporter activity; IEA:InterPro
Q7RTT9	SLC29A4	Equilibrative nucleoside transporter 4	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9NR83	SLC2A4RG	SLC2A4 regulator	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NR83	SLC2A4RG	SLC2A4 regulator	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NR83	SLC2A4RG	SLC2A4 regulator	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:UniProtKB
Q9NR83	SLC2A4RG	SLC2A4 regulator	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q9NR83	SLC2A4RG	SLC2A4 regulator	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UHR5	SAP30BP	SAP30-binding protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UHR5	SAP30BP	SAP30-binding protein	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9UHR5	SAP30BP	SAP30-binding protein	GO:0010942; P:positive regulation of cell death; IDA:UniProtKB
Q9UHR5	SAP30BP	SAP30-binding protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UHR5	SAP30BP	SAP30-binding protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5RGS2	SPATA31A2	Spermatogenesis-associated protein 31A2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q5RGS2	SPATA31A2	Spermatogenesis-associated protein 31A2	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q5VVP1	SPATA31A6	Spermatogenesis-associated protein 31A6	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q5VVP1	SPATA31A6	Spermatogenesis-associated protein 31A6	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q4VX67	SPATA31A4	Spermatogenesis-associated protein 31A4	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q4VX67	SPATA31A4	Spermatogenesis-associated protein 31A4	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q5VU36	SPATA31A5	Spermatogenesis-associated protein 31A5	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q5VU36	SPATA31A5	Spermatogenesis-associated protein 31A5	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q5TZJ5	SPATA31A1	Spermatogenesis-associated protein 31A1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q5TZJ5	SPATA31A1	Spermatogenesis-associated protein 31A1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q8IWB4	SPATA31A7	Spermatogenesis-associated protein 31A7	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8IWB4	SPATA31A7	Spermatogenesis-associated protein 31A7	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q5VZV4	SPATA31B1	Putative spermatogenesis-associated protein 31B1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q5VZV4	SPATA31B1	Putative spermatogenesis-associated protein 31B1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
P0DKV0	SPATA31C1	Spermatogenesis-associated protein 31C1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P0DKV0	SPATA31C1	Spermatogenesis-associated protein 31C1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
B4DYI2	SPATA31C2	Spermatogenesis-associated protein 31C2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
B4DYI2	SPATA31C2	Spermatogenesis-associated protein 31C2	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q5VYP0	SPATA31A3	Spermatogenesis-associated protein 31A3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q5VYP0	SPATA31A3	Spermatogenesis-associated protein 31A3	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q6ZQQ2	SPATA31D1	Spermatogenesis-associated protein 31D1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q6ZQQ2	SPATA31D1	Spermatogenesis-associated protein 31D1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q6ZUB0	SPATA31D4	Putative spermatogenesis-associated protein 31D4	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q6ZUB0	SPATA31D4	Putative spermatogenesis-associated protein 31D4	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q6ZUB1	SPATA31E1	Spermatogenesis-associated protein 31E1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q6ZUB1	SPATA31E1	Spermatogenesis-associated protein 31E1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
P0C874	SPATA31D3	Putative spermatogenesis-associated protein 31D3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P0C874	SPATA31D3	Putative spermatogenesis-associated protein 31D3	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
P78382	SLC35A1	CMP-sialic acid transporter	GO:0005456; F:CMP-N-acetylneuraminate transmembrane transporter activity; TAS:ProtInc
P78382	SLC35A1	CMP-sialic acid transporter	GO:0005351; F:sugar:proton symporter activity; IEA:InterPro
P78382	SLC35A1	CMP-sialic acid transporter	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
P78382	SLC35A1	CMP-sialic acid transporter	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P78382	SLC35A1	CMP-sialic acid transporter	GO:0015782; P:CMP-N-acetylneuraminate transport; TAS:ProtInc
P78382	SLC35A1	CMP-sialic acid transporter	GO:0055085; P:transmembrane transport; TAS:Reactome
P78381	SLC35A2	UDP-galactose translocator	GO:0005338; F:nucleotide-sugar transmembrane transporter activity; IEA:InterPro
P78381	SLC35A2	UDP-galactose translocator	GO:0005515; F:protein binding; IPI:IntAct
P78381	SLC35A2	UDP-galactose translocator	GO:0005351; F:sugar:proton symporter activity; IEA:InterPro
P78381	SLC35A2	UDP-galactose translocator	GO:0005459; F:UDP-galactose transmembrane transporter activity; TAS:ProtInc
P78381	SLC35A2	UDP-galactose translocator	GO:0006012; P:galactose metabolic process; TAS:ProtInc
P78381	SLC35A2	UDP-galactose translocator	GO:0015780; P:nucleotide-sugar transport; IEA:InterPro
P78381	SLC35A2	UDP-galactose translocator	GO:0055085; P:transmembrane transport; TAS:Reactome
P78381	SLC35A2	UDP-galactose translocator	GO:0015785; P:UDP-galactose transport; TAS:ProtInc
Q9Y2D2	SLC35A3	UDP-N-acetylglucosamine transporter	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2D2	SLC35A3	UDP-N-acetylglucosamine transporter	GO:0005351; F:sugar:proton symporter activity; IEA:InterPro
Q9Y2D2	SLC35A3	UDP-N-acetylglucosamine transporter	GO:0005462; F:UDP-N-acetylglucosamine transmembrane transporter activity; TAS:ProtInc
Q9Y2D2	SLC35A3	UDP-N-acetylglucosamine transporter	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9Y2D2	SLC35A3	UDP-N-acetylglucosamine transporter	GO:0006047; P:UDP-N-acetylglucosamine metabolic process; TAS:ProtInc
Q9Y2D2	SLC35A3	UDP-N-acetylglucosamine transporter	GO:0015788; P:UDP-N-acetylglucosamine transport; IMP:UniProtKB
Q96G79	SLC35A4	Probable UDP-sugar transporter protein SLC35A4	GO:0005351; F:sugar:proton symporter activity; IEA:InterPro
Q9BS91	SLC35A5	Probable UDP-sugar transporter protein SLC35A5	GO:0005338; F:nucleotide-sugar transmembrane transporter activity; IEA:InterPro
Q9BS91	SLC35A5	Probable UDP-sugar transporter protein SLC35A5	GO:0005351; F:sugar:proton symporter activity; IEA:InterPro
Q9BS91	SLC35A5	Probable UDP-sugar transporter protein SLC35A5	GO:0015780; P:nucleotide-sugar transport; IEA:InterPro
P78383	SLC35B1	Solute carrier family 35 member B1	GO:0005459; F:UDP-galactose transmembrane transporter activity; TAS:ProtInc
P78383	SLC35B1	Solute carrier family 35 member B1	GO:0006810; P:transport; TAS:ProtInc
P78383	SLC35B1	Solute carrier family 35 member B1	GO:0072334; P:UDP-galactose transmembrane transport; TAS:GOC
Q8TB61	SLC35B2	Adenosine 3'-phospho 5'-phosphosulfate transporter 1	GO:0046964; F:3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity; IDA:UniProtKB
Q8TB61	SLC35B2	Adenosine 3'-phospho 5'-phosphosulfate transporter 1	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q8TB61	SLC35B2	Adenosine 3'-phospho 5'-phosphosulfate transporter 1	GO:1902559; P:3'-phospho-5'-adenylyl sulfate transmembrane transport; IDA:GOC
Q8TB61	SLC35B2	Adenosine 3'-phospho 5'-phosphosulfate transporter 1	GO:0050428; P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process; TAS:Reactome
Q8TB61	SLC35B2	Adenosine 3'-phospho 5'-phosphosulfate transporter 1	GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; TAS:Reactome
Q8TB61	SLC35B2	Adenosine 3'-phospho 5'-phosphosulfate transporter 1	GO:0046963; P:3'-phosphoadenosine 5'-phosphosulfate transport; IDA:UniProtKB
Q8TB61	SLC35B2	Adenosine 3'-phospho 5'-phosphosulfate transporter 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q8TB61	SLC35B2	Adenosine 3'-phospho 5'-phosphosulfate transporter 1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q8TB61	SLC35B2	Adenosine 3'-phospho 5'-phosphosulfate transporter 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q8TB61	SLC35B2	Adenosine 3'-phospho 5'-phosphosulfate transporter 1	GO:0007165; P:signal transduction; IMP:GOC
Q8TB61	SLC35B2	Adenosine 3'-phospho 5'-phosphosulfate transporter 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8TB61	SLC35B2	Adenosine 3'-phospho 5'-phosphosulfate transporter 1	GO:0055085; P:transmembrane transport; IEA:InterPro
Q8TB61	SLC35B2	Adenosine 3'-phospho 5'-phosphosulfate transporter 1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9H1N7	SLC35B3	Adenosine 3'-phospho 5'-phosphosulfate transporter 2	GO:0050428; P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process; TAS:Reactome
Q9H1N7	SLC35B3	Adenosine 3'-phospho 5'-phosphosulfate transporter 2	GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; TAS:Reactome
Q9H1N7	SLC35B3	Adenosine 3'-phospho 5'-phosphosulfate transporter 2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9H1N7	SLC35B3	Adenosine 3'-phospho 5'-phosphosulfate transporter 2	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9H1N7	SLC35B3	Adenosine 3'-phospho 5'-phosphosulfate transporter 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H1N7	SLC35B3	Adenosine 3'-phospho 5'-phosphosulfate transporter 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9H1N7	SLC35B3	Adenosine 3'-phospho 5'-phosphosulfate transporter 2	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q969S0	SLC35B4	UDP-xylose and UDP-N-acetylglucosamine transporter	GO:0005462; F:UDP-N-acetylglucosamine transmembrane transporter activity; IDA:UniProtKB
Q969S0	SLC35B4	UDP-xylose and UDP-N-acetylglucosamine transporter	GO:0005464; F:UDP-xylose transmembrane transporter activity; IDA:UniProtKB
Q969S0	SLC35B4	UDP-xylose and UDP-N-acetylglucosamine transporter	GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW
Q969S0	SLC35B4	UDP-xylose and UDP-N-acetylglucosamine transporter	GO:0006111; P:regulation of gluconeogenesis; IEA:Ensembl
Q969S0	SLC35B4	UDP-xylose and UDP-N-acetylglucosamine transporter	GO:0055085; P:transmembrane transport; TAS:Reactome
Q969S0	SLC35B4	UDP-xylose and UDP-N-acetylglucosamine transporter	GO:0015788; P:UDP-N-acetylglucosamine transport; IDA:UniProtKB
Q969S0	SLC35B4	UDP-xylose and UDP-N-acetylglucosamine transporter	GO:0015790; P:UDP-xylose transport; IDA:UniProtKB
Q9NQQ7	SLC35C2	Solute carrier family 35 member C2	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
Q9NQQ7	SLC35C2	Solute carrier family 35 member C2	GO:0045747; P:positive regulation of Notch signaling pathway; IEA:Ensembl
Q9NQQ7	SLC35C2	Solute carrier family 35 member C2	GO:0036066; P:protein O-linked fucosylation; IEA:Ensembl
Q9NQQ7	SLC35C2	Solute carrier family 35 member C2	GO:0006810; P:transport; IEA:UniProtKB-KW
Q9NTN3	SLC35D1	UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter	GO:0005461; F:UDP-glucuronic acid transmembrane transporter activity; TAS:Reactome
Q9NTN3	SLC35D1	UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter	GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW
Q9NTN3	SLC35D1	UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter	GO:0052695; P:cellular glucuronidation; TAS:Reactome
Q9NTN3	SLC35D1	UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter	GO:0030206; P:chondroitin sulfate biosynthetic process; IEA:Ensembl
Q9NTN3	SLC35D1	UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter	GO:0048706; P:embryonic skeletal system development; IEA:Ensembl
Q9NTN3	SLC35D1	UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NTN3	SLC35D1	UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9NTN3	SLC35D1	UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter	GO:0006065; P:UDP-glucuronate biosynthetic process; TAS:Reactome
Q9NTN3	SLC35D1	UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter	GO:0015787; P:UDP-glucuronic acid transport; TAS:GOC
Q9NTN3	SLC35D1	UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q76EJ3	SLC35D2	UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter	GO:0005338; F:nucleotide-sugar transmembrane transporter activity; NAS:UniProtKB
Q76EJ3	SLC35D2	UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter	GO:1901264; P:carbohydrate derivative transport; NAS:GOC
Q76EJ3	SLC35D2	UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q76EJ3	SLC35D2	UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter	GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW
Q76EJ3	SLC35D2	UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
Q76EJ3	SLC35D2	UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q76EJ3	SLC35D2	UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
Q76EJ3	SLC35D2	UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
Q76EJ3	SLC35D2	UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter	GO:1901679; P:nucleotide transmembrane transport; NAS:GOC
Q76EJ3	SLC35D2	UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q76EJ3	SLC35D2	UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter	GO:0055085; P:transmembrane transport; TAS:Reactome
Q5M8T2	SLC35D3	Solute carrier family 35 member D3	GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW
Q96K37	SLC35E1	Solute carrier family 35 member E1	GO:0006810; P:transport; IEA:UniProtKB-KW
Q5T1Q4	SLC35F1	Solute carrier family 35 member F1	GO:0006810; P:transport; IEA:UniProtKB-KW
Q8IXU6	SLC35F2	Solute carrier family 35 member F2	GO:0006810; P:transport; IEA:UniProtKB-KW
Q8IY50	SLC35F3	Solute carrier family 35 member F3	GO:0006810; P:transport; IEA:UniProtKB-KW
A4IF30	SLC35F4	Solute carrier family 35 member F4	GO:0006810; P:transport; IEA:UniProtKB-KW
Q8WV83	SLC35F5	Solute carrier family 35 member F5	GO:0006810; P:transport; IEA:UniProtKB-KW
Q8N357	SLC35F6	Solute carrier family 35 member F6	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N357	SLC35F6	Solute carrier family 35 member F6	GO:1901029; P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; IMP:UniProtKB
Q8N357	SLC35F6	Solute carrier family 35 member F6	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
Q8N357	SLC35F6	Solute carrier family 35 member F6	GO:0006810; P:transport; IEA:UniProtKB-KW
Q7Z2H8	SLC36A1	Proton-coupled amino acid transporter 1	GO:0015187; F:glycine transmembrane transporter activity; IEA:Ensembl
Q7Z2H8	SLC36A1	Proton-coupled amino acid transporter 1	GO:0015078; F:hydrogen ion transmembrane transporter activity; IEA:Ensembl
Q7Z2H8	SLC36A1	Proton-coupled amino acid transporter 1	GO:0015180; F:L-alanine transmembrane transporter activity; IEA:Ensembl
Q7Z2H8	SLC36A1	Proton-coupled amino acid transporter 1	GO:0015193; F:L-proline transmembrane transporter activity; IEA:Ensembl
Q7Z2H8	SLC36A1	Proton-coupled amino acid transporter 1	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q7Z2H8	SLC36A1	Proton-coupled amino acid transporter 1	GO:0006865; P:amino acid transport; TAS:Reactome
Q7Z2H8	SLC36A1	Proton-coupled amino acid transporter 1	GO:0006811; P:ion transport; TAS:Reactome
Q7Z2H8	SLC36A1	Proton-coupled amino acid transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q495M3	SLC36A2	Proton-coupled amino acid transporter 2	GO:0015187; F:glycine transmembrane transporter activity; IMP:UniProtKB
Q495M3	SLC36A2	Proton-coupled amino acid transporter 2	GO:0005280; F:hydrogen:amino acid symporter activity; IEA:Ensembl
Q495M3	SLC36A2	Proton-coupled amino acid transporter 2	GO:0015180; F:L-alanine transmembrane transporter activity; IEA:Ensembl
Q495M3	SLC36A2	Proton-coupled amino acid transporter 2	GO:0015193; F:L-proline transmembrane transporter activity; IEA:Ensembl
Q495M3	SLC36A2	Proton-coupled amino acid transporter 2	GO:0006865; P:amino acid transport; TAS:Reactome
Q495M3	SLC36A2	Proton-coupled amino acid transporter 2	GO:0006811; P:ion transport; TAS:Reactome
Q495M3	SLC36A2	Proton-coupled amino acid transporter 2	GO:0035524; P:proline transmembrane transport; IMP:UniProtKB
Q495M3	SLC36A2	Proton-coupled amino acid transporter 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q6YBV0	SLC36A4	Proton-coupled amino acid transporter 4	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q6YBV0	SLC36A4	Proton-coupled amino acid transporter 4	GO:0015808; P:L-alanine transport; IDA:UniProtKB
Q6YBV0	SLC36A4	Proton-coupled amino acid transporter 4	GO:0015824; P:proline transport; IDA:UniProtKB
Q6YBV0	SLC36A4	Proton-coupled amino acid transporter 4	GO:0015827; P:tryptophan transport; IDA:UniProtKB
Q9H2H9	SLC38A1	Sodium-coupled neutral amino acid transporter 1	GO:0015186; F:L-glutamine transmembrane transporter activity; IEA:Ensembl
Q9H2H9	SLC38A1	Sodium-coupled neutral amino acid transporter 1	GO:0015175; F:neutral amino acid transmembrane transporter activity; NAS:UniProtKB
Q9H2H9	SLC38A1	Sodium-coupled neutral amino acid transporter 1	GO:0005283; F:sodium:amino acid symporter activity; NAS:UniProtKB
Q9H2H9	SLC38A1	Sodium-coupled neutral amino acid transporter 1	GO:0003333; P:amino acid transmembrane transport; NAS:GOC
Q9H2H9	SLC38A1	Sodium-coupled neutral amino acid transporter 1	GO:0006865; P:amino acid transport; TAS:Reactome
Q9H2H9	SLC38A1	Sodium-coupled neutral amino acid transporter 1	GO:0006811; P:ion transport; TAS:Reactome
Q9H2H9	SLC38A1	Sodium-coupled neutral amino acid transporter 1	GO:0001504; P:neurotransmitter uptake; TAS:Reactome
Q9H2H9	SLC38A1	Sodium-coupled neutral amino acid transporter 1	GO:0015804; P:neutral amino acid transport; NAS:UniProtKB
Q9H2H9	SLC38A1	Sodium-coupled neutral amino acid transporter 1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9H2H9	SLC38A1	Sodium-coupled neutral amino acid transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q96QD8	SLC38A2	Sodium-coupled neutral amino acid transporter 2	GO:0015171; F:amino acid transmembrane transporter activity; IEA:Ensembl
Q96QD8	SLC38A2	Sodium-coupled neutral amino acid transporter 2	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q96QD8	SLC38A2	Sodium-coupled neutral amino acid transporter 2	GO:0006865; P:amino acid transport; TAS:Reactome
Q96QD8	SLC38A2	Sodium-coupled neutral amino acid transporter 2	GO:0014047; P:glutamate secretion; TAS:Reactome
Q96QD8	SLC38A2	Sodium-coupled neutral amino acid transporter 2	GO:0006811; P:ion transport; TAS:Reactome
Q96QD8	SLC38A2	Sodium-coupled neutral amino acid transporter 2	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
Q96QD8	SLC38A2	Sodium-coupled neutral amino acid transporter 2	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q96QD8	SLC38A2	Sodium-coupled neutral amino acid transporter 2	GO:0007268; P:synaptic transmission; TAS:Reactome
Q96QD8	SLC38A2	Sodium-coupled neutral amino acid transporter 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q969I6	SLC38A4	Sodium-coupled neutral amino acid transporter 4	GO:0015171; F:amino acid transmembrane transporter activity; IEA:Ensembl
Q969I6	SLC38A4	Sodium-coupled neutral amino acid transporter 4	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q969I6	SLC38A4	Sodium-coupled neutral amino acid transporter 4	GO:0006865; P:amino acid transport; TAS:Reactome
Q969I6	SLC38A4	Sodium-coupled neutral amino acid transporter 4	GO:0006811; P:ion transport; TAS:Reactome
Q969I6	SLC38A4	Sodium-coupled neutral amino acid transporter 4	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q969I6	SLC38A4	Sodium-coupled neutral amino acid transporter 4	GO:0055085; P:transmembrane transport; TAS:Reactome
Q99624	SLC38A3	Sodium-coupled neutral amino acid transporter 3	GO:0015297; F:antiporter activity; IEA:UniProtKB-KW
Q99624	SLC38A3	Sodium-coupled neutral amino acid transporter 3	GO:0015180; F:L-alanine transmembrane transporter activity; IDA:UniProtKB
Q99624	SLC38A3	Sodium-coupled neutral amino acid transporter 3	GO:0015182; F:L-asparagine transmembrane transporter activity; IDA:UniProtKB
Q99624	SLC38A3	Sodium-coupled neutral amino acid transporter 3	GO:0015186; F:L-glutamine transmembrane transporter activity; IDA:UniProtKB
Q99624	SLC38A3	Sodium-coupled neutral amino acid transporter 3	GO:0005290; F:L-histidine transmembrane transporter activity; IDA:UniProtKB
Q99624	SLC38A3	Sodium-coupled neutral amino acid transporter 3	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q99624	SLC38A3	Sodium-coupled neutral amino acid transporter 3	GO:0006865; P:amino acid transport; TAS:Reactome
Q99624	SLC38A3	Sodium-coupled neutral amino acid transporter 3	GO:0006867; P:asparagine transport; IDA:UniProtKB
Q99624	SLC38A3	Sodium-coupled neutral amino acid transporter 3	GO:0006868; P:glutamine transport; IDA:UniProtKB
Q99624	SLC38A3	Sodium-coupled neutral amino acid transporter 3	GO:0015817; P:histidine transport; IDA:UniProtKB
Q99624	SLC38A3	Sodium-coupled neutral amino acid transporter 3	GO:0006811; P:ion transport; TAS:Reactome
Q99624	SLC38A3	Sodium-coupled neutral amino acid transporter 3	GO:0015808; P:L-alanine transport; IDA:UniProtKB
Q99624	SLC38A3	Sodium-coupled neutral amino acid transporter 3	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q99624	SLC38A3	Sodium-coupled neutral amino acid transporter 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8WUX1	SLC38A5	Sodium-coupled neutral amino acid transporter 5	GO:0015187; F:glycine transmembrane transporter activity; IEA:Ensembl
Q8WUX1	SLC38A5	Sodium-coupled neutral amino acid transporter 5	GO:0006865; P:amino acid transport; TAS:Reactome
Q8WUX1	SLC38A5	Sodium-coupled neutral amino acid transporter 5	GO:0006811; P:ion transport; TAS:Reactome
Q8WUX1	SLC38A5	Sodium-coupled neutral amino acid transporter 5	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8IZM9	SLC38A6	Probable sodium-coupled neutral amino acid transporter 6	GO:0006865; P:amino acid transport; IEA:UniProtKB-KW
Q8IZM9	SLC38A6	Probable sodium-coupled neutral amino acid transporter 6	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q9NVC3	SLC38A7	Putative sodium-coupled neutral amino acid transporter 7	GO:0015180; F:L-alanine transmembrane transporter activity; IEA:Ensembl
Q9NVC3	SLC38A7	Putative sodium-coupled neutral amino acid transporter 7	GO:0015179; F:L-amino acid transmembrane transporter activity; ISS:UniProtKB
Q9NVC3	SLC38A7	Putative sodium-coupled neutral amino acid transporter 7	GO:0015182; F:L-asparagine transmembrane transporter activity; IEA:Ensembl
Q9NVC3	SLC38A7	Putative sodium-coupled neutral amino acid transporter 7	GO:0015183; F:L-aspartate transmembrane transporter activity; IEA:Ensembl
Q9NVC3	SLC38A7	Putative sodium-coupled neutral amino acid transporter 7	GO:0005313; F:L-glutamate transmembrane transporter activity; IEA:Ensembl
Q9NVC3	SLC38A7	Putative sodium-coupled neutral amino acid transporter 7	GO:0015186; F:L-glutamine transmembrane transporter activity; ISS:UniProtKB
Q9NVC3	SLC38A7	Putative sodium-coupled neutral amino acid transporter 7	GO:0005290; F:L-histidine transmembrane transporter activity; IEA:Ensembl
Q9NVC3	SLC38A7	Putative sodium-coupled neutral amino acid transporter 7	GO:0015190; F:L-leucine transmembrane transporter activity; IEA:Ensembl
Q9NVC3	SLC38A7	Putative sodium-coupled neutral amino acid transporter 7	GO:0015191; F:L-methionine transmembrane transporter activity; IEA:Ensembl
Q9NVC3	SLC38A7	Putative sodium-coupled neutral amino acid transporter 7	GO:0015194; F:L-serine transmembrane transporter activity; IEA:Ensembl
Q9NVC3	SLC38A7	Putative sodium-coupled neutral amino acid transporter 7	GO:1902475; P:L-alpha-amino acid transmembrane transport; ISS:GOC
Q9NVC3	SLC38A7	Putative sodium-coupled neutral amino acid transporter 7	GO:0006814; P:sodium ion transport; ISS:UniProtKB
A6NNN8	SLC38A8	Putative sodium-coupled neutral amino acid transporter 8	GO:0006865; P:amino acid transport; IEA:UniProtKB-KW
A6NNN8	SLC38A8	Putative sodium-coupled neutral amino acid transporter 8	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q8NBW4	SLC38A9	Putative sodium-coupled neutral amino acid transporter 9	GO:0006865; P:amino acid transport; IEA:UniProtKB-KW
Q8NBW4	SLC38A9	Putative sodium-coupled neutral amino acid transporter 9	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q9HBR0	SLC38A10	Putative sodium-coupled neutral amino acid transporter 10	GO:0006865; P:amino acid transport; IEA:UniProtKB-KW
Q9HBR0	SLC38A10	Putative sodium-coupled neutral amino acid transporter 10	GO:0060348; P:bone development; IEA:Ensembl
Q9HBR0	SLC38A10	Putative sodium-coupled neutral amino acid transporter 10	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q08AI6	SLC38A11	Putative sodium-coupled neutral amino acid transporter 11	GO:0006865; P:amino acid transport; IEA:UniProtKB-KW
Q08AI6	SLC38A11	Putative sodium-coupled neutral amino acid transporter 11	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q9NY26	SLC39A1	Zinc transporter ZIP1	GO:0022890; F:inorganic cation transmembrane transporter activity; TAS:ProtInc
Q9NY26	SLC39A1	Zinc transporter ZIP1	GO:0005385; F:zinc ion transmembrane transporter activity; IEA:Ensembl
Q9NY26	SLC39A1	Zinc transporter ZIP1	GO:0006812; P:cation transport; TAS:ProtInc
Q9NY26	SLC39A1	Zinc transporter ZIP1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9NY26	SLC39A1	Zinc transporter ZIP1	GO:0071577; P:zinc ion transmembrane transport; IMP:UniProtKB
Q9NP94	SLC39A2	Zinc transporter ZIP2	GO:0005385; F:zinc ion transmembrane transporter activity; IMP:UniProtKB
Q9NP94	SLC39A2	Zinc transporter ZIP2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9NP94	SLC39A2	Zinc transporter ZIP2	GO:0006829; P:zinc ion transport; TAS:ProtInc
Q9BRY0	SLC39A3	Zinc transporter ZIP3	GO:0005385; F:zinc ion transmembrane transporter activity; IEA:Ensembl
Q9BRY0	SLC39A3	Zinc transporter ZIP3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q6P5W5	SLC39A4	Zinc transporter ZIP4	GO:0005385; F:zinc ion transmembrane transporter activity; IEA:Ensembl
Q6P5W5	SLC39A4	Zinc transporter ZIP4	GO:0034224; P:cellular response to zinc ion starvation; IEA:Ensembl
Q6P5W5	SLC39A4	Zinc transporter ZIP4	GO:0006882; P:cellular zinc ion homeostasis; IEA:Ensembl
Q6P5W5	SLC39A4	Zinc transporter ZIP4	GO:0055085; P:transmembrane transport; TAS:Reactome
Q6ZMH5	SLC39A5	Zinc transporter ZIP5	GO:0046873; F:metal ion transmembrane transporter activity; IEA:InterPro
Q6ZMH5	SLC39A5	Zinc transporter ZIP5	GO:0034224; P:cellular response to zinc ion starvation; IEA:Ensembl
Q6ZMH5	SLC39A5	Zinc transporter ZIP5	GO:0070315; P:G1 to G0 transition involved in cell differentiation; ISS:UniProtKB
Q6ZMH5	SLC39A5	Zinc transporter ZIP5	GO:0061351; P:neural precursor cell proliferation; ISS:UniProt
Q6ZMH5	SLC39A5	Zinc transporter ZIP5	GO:0055085; P:transmembrane transport; TAS:Reactome
Q6ZMH5	SLC39A5	Zinc transporter ZIP5	GO:0006829; P:zinc ion transport; IEA:UniProtKB-KW
Q13433	SLC39A6	Zinc transporter ZIP6	GO:0005385; F:zinc ion transmembrane transporter activity; IDA:BHF-UCL
Q13433	SLC39A6	Zinc transporter ZIP6	GO:0006882; P:cellular zinc ion homeostasis; IDA:BHF-UCL
Q13433	SLC39A6	Zinc transporter ZIP6	GO:0055085; P:transmembrane transport; TAS:Reactome
Q13433	SLC39A6	Zinc transporter ZIP6	GO:0071578; P:zinc ion transmembrane import; IDA:BHF-UCL
Q13433	SLC39A6	Zinc transporter ZIP6	GO:0071577; P:zinc ion transmembrane transport; IMP:UniProtKB
Q8N1S5	SLC39A11	Zinc transporter ZIP11	GO:0046873; F:metal ion transmembrane transporter activity; IEA:InterPro
Q8N1S5	SLC39A11	Zinc transporter ZIP11	GO:0006829; P:zinc ion transport; IEA:UniProtKB-KW
Q9ULF5	SLC39A10	Zinc transporter ZIP10	GO:0046873; F:metal ion transmembrane transporter activity; IEA:InterPro
Q9ULF5	SLC39A10	Zinc transporter ZIP10	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9ULF5	SLC39A10	Zinc transporter ZIP10	GO:0006829; P:zinc ion transport; IEA:UniProtKB-KW
Q9NUM3	SLC39A9	Zinc transporter ZIP9	GO:0046873; F:metal ion transmembrane transporter activity; IEA:InterPro
Q9NUM3	SLC39A9	Zinc transporter ZIP9	GO:0006829; P:zinc ion transport; IEA:UniProtKB-KW
Q9C0K1	SLC39A8	Zinc transporter ZIP8	GO:0046873; F:metal ion transmembrane transporter activity; IEA:InterPro
Q9C0K1	SLC39A8	Zinc transporter ZIP8	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9C0K1	SLC39A8	Zinc transporter ZIP8	GO:0006829; P:zinc ion transport; IMP:UniProtKB
Q92504	SLC39A7	Zinc transporter SLC39A7	GO:0046873; F:metal ion transmembrane transporter activity; IEA:InterPro
Q92504	SLC39A7	Zinc transporter SLC39A7	GO:0005515; F:protein binding; IPI:IntAct
Q92504	SLC39A7	Zinc transporter SLC39A7	GO:0055085; P:transmembrane transport; TAS:Reactome
Q92504	SLC39A7	Zinc transporter SLC39A7	GO:0006829; P:zinc ion transport; IEA:UniProtKB-KW
Q504Y0	SLC39A12	Zinc transporter ZIP12	GO:0046873; F:metal ion transmembrane transporter activity; IEA:InterPro
Q504Y0	SLC39A12	Zinc transporter ZIP12	GO:0006829; P:zinc ion transport; IEA:UniProtKB-KW
Q96H72	SLC39A13	Zinc transporter ZIP13	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q96H72	SLC39A13	Zinc transporter ZIP13	GO:0005385; F:zinc ion transmembrane transporter activity; IDA:BHF-UCL
Q96H72	SLC39A13	Zinc transporter ZIP13	GO:0006882; P:cellular zinc ion homeostasis; IDA:BHF-UCL
Q96H72	SLC39A13	Zinc transporter ZIP13	GO:0061448; P:connective tissue development; IMP:BHF-UCL
Q96H72	SLC39A13	Zinc transporter ZIP13	GO:0071577; P:zinc ion transmembrane transport; IDA:BHF-UCL
Q15043	SLC39A14	Zinc transporter ZIP14	GO:0015093; F:ferrous iron transmembrane transporter activity; IEA:Ensembl
Q15043	SLC39A14	Zinc transporter ZIP14	GO:0005385; F:zinc ion transmembrane transporter activity; IDA:BHF-UCL
Q15043	SLC39A14	Zinc transporter ZIP14	GO:0006882; P:cellular zinc ion homeostasis; IDA:BHF-UCL
Q15043	SLC39A14	Zinc transporter ZIP14	GO:0055085; P:transmembrane transport; TAS:Reactome
Q15043	SLC39A14	Zinc transporter ZIP14	GO:0071578; P:zinc ion transmembrane import; IDA:BHF-UCL
Q15043	SLC39A14	Zinc transporter ZIP14	GO:0071577; P:zinc ion transmembrane transport; IMP:UniProtKB
Q8TF17	SH3TC2	SH3 domain and tetratricopeptide repeat-containing protein 2	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q8TF17	SH3TC2	SH3 domain and tetratricopeptide repeat-containing protein 2	GO:0032287; P:peripheral nervous system myelin maintenance; IEA:Ensembl
Q8TF17	SH3TC2	SH3 domain and tetratricopeptide repeat-containing protein 2	GO:1901184; P:regulation of ERBB signaling pathway; IEA:Ensembl
Q8TF17	SH3TC2	SH3 domain and tetratricopeptide repeat-containing protein 2	GO:0033157; P:regulation of intracellular protein transport; IEA:Ensembl
Q9NP59	SLC40A1	Solute carrier family 40 member 1	GO:0005381; F:iron ion transmembrane transporter activity; IMP:BHF-UCL
Q9NP59	SLC40A1	Solute carrier family 40 member 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NP59	SLC40A1	Solute carrier family 40 member 1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q9NP59	SLC40A1	Solute carrier family 40 member 1	GO:0006879; P:cellular iron ion homeostasis; IMP:BHF-UCL
Q9NP59	SLC40A1	Solute carrier family 40 member 1	GO:0003158; P:endothelium development; IEA:Ensembl
Q9NP59	SLC40A1	Solute carrier family 40 member 1	GO:0034755; P:iron ion transmembrane transport; IMP:BHF-UCL
Q9NP59	SLC40A1	Solute carrier family 40 member 1	GO:0002260; P:lymphocyte homeostasis; IEA:Ensembl
Q9NP59	SLC40A1	Solute carrier family 40 member 1	GO:0060586; P:multicellular organismal iron ion homeostasis; IEA:Ensembl
Q9NP59	SLC40A1	Solute carrier family 40 member 1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q9NP59	SLC40A1	Solute carrier family 40 member 1	GO:0060345; P:spleen trabecula formation; IEA:Ensembl
Q9NP59	SLC40A1	Solute carrier family 40 member 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8IVJ1	SLC41A1	Solute carrier family 41 member 1	GO:0008324; F:cation transmembrane transporter activity; IEA:InterPro
Q8IVJ1	SLC41A1	Solute carrier family 41 member 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q96JW4	SLC41A2	Solute carrier family 41 member 2	GO:0008324; F:cation transmembrane transporter activity; IEA:InterPro
Q96JW4	SLC41A2	Solute carrier family 41 member 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q96GZ6	SLC41A3	Solute carrier family 41 member 3	GO:0008324; F:cation transmembrane transporter activity; IEA:InterPro
Q8NBI5	SLC43A3	Solute carrier family 43 member 3	GO:0055085; P:transmembrane transport; IEA:InterPro
Q9Y2W3	SLC45A1	Proton-associated sugar transporter A	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q9Y2W3	SLC45A1	Proton-associated sugar transporter A	GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW
Q9UMX9	SLC45A2	Membrane-associated transporter protein	GO:0048066; P:developmental pigmentation; IEA:Ensembl
Q9UMX9	SLC45A2	Membrane-associated transporter protein	GO:0042438; P:melanin biosynthetic process; IEA:UniProtKB-KW
Q9UMX9	SLC45A2	Membrane-associated transporter protein	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q9UMX9	SLC45A2	Membrane-associated transporter protein	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q96JT2	SLC45A3	Solute carrier family 45 member 3	GO:0055085; P:transmembrane transport; IEA:InterPro
Q5BKX6	SLC45A4	Solute carrier family 45 member 4	GO:0006810; P:transport; IEA:UniProtKB-KW
Q7Z3Q1	SLC46A3	Solute carrier family 46 member 3	GO:0055085; P:transmembrane transport; IEA:InterPro
Q96FL8	SLC47A1	Multidrug and toxin extrusion protein 1	GO:0015238; F:drug transmembrane transporter activity; IEA:Ensembl
Q96FL8	SLC47A1	Multidrug and toxin extrusion protein 1	GO:0005451; F:monovalent cation:proton antiporter activity; IEA:Ensembl
Q96FL8	SLC47A1	Multidrug and toxin extrusion protein 1	GO:0015695; P:organic cation transport; IEA:Ensembl
Q96FL8	SLC47A1	Multidrug and toxin extrusion protein 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q86VL8	SLC47A2	Multidrug and toxin extrusion protein 2	GO:0015297; F:antiporter activity; IEA:InterPro
Q86VL8	SLC47A2	Multidrug and toxin extrusion protein 2	GO:0015238; F:drug transmembrane transporter activity; IEA:InterPro
Q86VL8	SLC47A2	Multidrug and toxin extrusion protein 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q6U841	SLC4A10	Sodium-driven chloride bicarbonate exchanger	GO:0005452; F:inorganic anion exchanger activity; IEA:InterPro
Q6U841	SLC4A10	Sodium-driven chloride bicarbonate exchanger	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q6U841	SLC4A10	Sodium-driven chloride bicarbonate exchanger	GO:0015701; P:bicarbonate transport; NAS:UniProtKB
Q6U841	SLC4A10	Sodium-driven chloride bicarbonate exchanger	GO:0006821; P:chloride transport; NAS:UniProtKB
Q6U841	SLC4A10	Sodium-driven chloride bicarbonate exchanger	GO:0006811; P:ion transport; TAS:Reactome
Q6U841	SLC4A10	Sodium-driven chloride bicarbonate exchanger	GO:0006885; P:regulation of pH; IEA:Ensembl
Q6U841	SLC4A10	Sodium-driven chloride bicarbonate exchanger	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q6U841	SLC4A10	Sodium-driven chloride bicarbonate exchanger	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8NBS3	SLC4A11	Sodium bicarbonate transporter-like protein 11	GO:0015106; F:bicarbonate transmembrane transporter activity; IDA:HGNC
Q8NBS3	SLC4A11	Sodium bicarbonate transporter-like protein 11	GO:0046715; F:borate transmembrane transporter activity; IDA:HGNC
Q8NBS3	SLC4A11	Sodium bicarbonate transporter-like protein 11	GO:0015252; F:hydrogen ion channel activity; IDA:HGNC
Q8NBS3	SLC4A11	Sodium bicarbonate transporter-like protein 11	GO:0005452; F:inorganic anion exchanger activity; IEA:InterPro
Q8NBS3	SLC4A11	Sodium bicarbonate transporter-like protein 11	GO:0046983; F:protein dimerization activity; IDA:UniProtKB
Q8NBS3	SLC4A11	Sodium bicarbonate transporter-like protein 11	GO:0005272; F:sodium channel activity; IDA:HGNC
Q8NBS3	SLC4A11	Sodium bicarbonate transporter-like protein 11	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q8NBS3	SLC4A11	Sodium bicarbonate transporter-like protein 11	GO:0015701; P:bicarbonate transport; IDA:HGNC
Q8NBS3	SLC4A11	Sodium bicarbonate transporter-like protein 11	GO:0035445; P:borate transmembrane transport; IDA:GOC
Q8NBS3	SLC4A11	Sodium bicarbonate transporter-like protein 11	GO:0046713; P:borate transport; IDA:HGNC
Q8NBS3	SLC4A11	Sodium bicarbonate transporter-like protein 11	GO:0030003; P:cellular cation homeostasis; IDA:HGNC
Q8NBS3	SLC4A11	Sodium bicarbonate transporter-like protein 11	GO:0042044; P:fluid transport; ISS:UniProtKB
Q8NBS3	SLC4A11	Sodium bicarbonate transporter-like protein 11	GO:0015992; P:proton transport; IDA:HGNC
Q8NBS3	SLC4A11	Sodium bicarbonate transporter-like protein 11	GO:0035725; P:sodium ion transmembrane transport; IDA:GOC
Q8NBS3	SLC4A11	Sodium bicarbonate transporter-like protein 11	GO:0006814; P:sodium ion transport; IDA:HGNC
Q9Y6R1	SLC4A4	Electrogenic sodium bicarbonate cotransporter 1	GO:0005452; F:inorganic anion exchanger activity; IEA:InterPro
Q9Y6R1	SLC4A4	Electrogenic sodium bicarbonate cotransporter 1	GO:0005515; F:protein binding; IPI:DFLAT
Q9Y6R1	SLC4A4	Electrogenic sodium bicarbonate cotransporter 1	GO:0008510; F:sodium:bicarbonate symporter activity; TAS:ProtInc
Q9Y6R1	SLC4A4	Electrogenic sodium bicarbonate cotransporter 1	GO:0015701; P:bicarbonate transport; TAS:Reactome
Q9Y6R1	SLC4A4	Electrogenic sodium bicarbonate cotransporter 1	GO:0006811; P:ion transport; TAS:Reactome
Q9Y6R1	SLC4A4	Electrogenic sodium bicarbonate cotransporter 1	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
Q9Y6R1	SLC4A4	Electrogenic sodium bicarbonate cotransporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9Y6R1	SLC4A4	Electrogenic sodium bicarbonate cotransporter 1	GO:0006810; P:transport; TAS:ProtInc
Q9BY07	SLC4A5	Electrogenic sodium bicarbonate cotransporter 4	GO:0005452; F:inorganic anion exchanger activity; IEA:InterPro
Q9BY07	SLC4A5	Electrogenic sodium bicarbonate cotransporter 4	GO:0008510; F:sodium:bicarbonate symporter activity; NAS:UniProtKB
Q9BY07	SLC4A5	Electrogenic sodium bicarbonate cotransporter 4	GO:0015701; P:bicarbonate transport; NAS:UniProtKB
Q9BY07	SLC4A5	Electrogenic sodium bicarbonate cotransporter 4	GO:0006811; P:ion transport; TAS:Reactome
Q9BY07	SLC4A5	Electrogenic sodium bicarbonate cotransporter 4	GO:0035725; P:sodium ion transmembrane transport; NAS:GOC
Q9BY07	SLC4A5	Electrogenic sodium bicarbonate cotransporter 4	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9Y6M7	SLC4A7	Sodium bicarbonate cotransporter 3	GO:0005452; F:inorganic anion exchanger activity; IEA:InterPro
Q9Y6M7	SLC4A7	Sodium bicarbonate cotransporter 3	GO:0008510; F:sodium:bicarbonate symporter activity; NAS:UniProtKB
Q9Y6M7	SLC4A7	Sodium bicarbonate cotransporter 3	GO:0060117; P:auditory receptor cell development; IEA:Ensembl
Q9Y6M7	SLC4A7	Sodium bicarbonate cotransporter 3	GO:0015701; P:bicarbonate transport; NAS:UniProtKB
Q9Y6M7	SLC4A7	Sodium bicarbonate cotransporter 3	GO:0021747; P:cochlear nucleus development; IEA:Ensembl
Q9Y6M7	SLC4A7	Sodium bicarbonate cotransporter 3	GO:0006811; P:ion transport; TAS:Reactome
Q9Y6M7	SLC4A7	Sodium bicarbonate cotransporter 3	GO:0061299; P:retina vasculature morphogenesis in camera-type eye; IEA:Ensembl
Q9Y6M7	SLC4A7	Sodium bicarbonate cotransporter 3	GO:0046666; P:retinal cell programmed cell death; IEA:Ensembl
Q9Y6M7	SLC4A7	Sodium bicarbonate cotransporter 3	GO:0035725; P:sodium ion transmembrane transport; NAS:GOC
Q9Y6M7	SLC4A7	Sodium bicarbonate cotransporter 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q2Y0W8	SLC4A8	Electroneutral sodium bicarbonate exchanger 1	GO:0005452; F:inorganic anion exchanger activity; IEA:InterPro
Q2Y0W8	SLC4A8	Electroneutral sodium bicarbonate exchanger 1	GO:0015701; P:bicarbonate transport; TAS:Reactome
Q2Y0W8	SLC4A8	Electroneutral sodium bicarbonate exchanger 1	GO:0006811; P:ion transport; TAS:Reactome
Q2Y0W8	SLC4A8	Electroneutral sodium bicarbonate exchanger 1	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q2Y0W8	SLC4A8	Electroneutral sodium bicarbonate exchanger 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9NWF4	SLC52A1	Solute carrier family 52, riboflavin transporter, member 1	GO:0032217; F:riboflavin transporter activity; IDA:UniProtKB
Q9NWF4	SLC52A1	Solute carrier family 52, riboflavin transporter, member 1	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
Q9NWF4	SLC52A1	Solute carrier family 52, riboflavin transporter, member 1	GO:0032218; P:riboflavin transport; IDA:UniProtKB
Q9HAB3	SLC52A2	Solute carrier family 52, riboflavin transporter, member 2	GO:0032217; F:riboflavin transporter activity; IDA:UniProtKB
Q9HAB3	SLC52A2	Solute carrier family 52, riboflavin transporter, member 2	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
Q9HAB3	SLC52A2	Solute carrier family 52, riboflavin transporter, member 2	GO:0032218; P:riboflavin transport; IDA:UniProtKB
Q9NQ40	SLC52A3	Solute carrier family 52, riboflavin transporter, member 3	GO:0032217; F:riboflavin transporter activity; IDA:UniProtKB
Q9NQ40	SLC52A3	Solute carrier family 52, riboflavin transporter, member 3	GO:0034605; P:cellular response to heat; IEA:Ensembl
Q9NQ40	SLC52A3	Solute carrier family 52, riboflavin transporter, member 3	GO:0006771; P:riboflavin metabolic process; TAS:Reactome
Q9NQ40	SLC52A3	Solute carrier family 52, riboflavin transporter, member 3	GO:0032218; P:riboflavin transport; IDA:UniProtKB
Q9NQ40	SLC52A3	Solute carrier family 52, riboflavin transporter, member 3	GO:0007605; P:sensory perception of sound; IMP:UniProtKB
Q9NQ40	SLC52A3	Solute carrier family 52, riboflavin transporter, member 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NQ40	SLC52A3	Solute carrier family 52, riboflavin transporter, member 3	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9NQ40	SLC52A3	Solute carrier family 52, riboflavin transporter, member 3	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
P18405	SRD5A1	3-oxo-5-alpha-steroid 4-dehydrogenase 1	GO:0003865; F:3-oxo-5-alpha-steroid 4-dehydrogenase activity; IDA:UniProtKB
P18405	SRD5A1	3-oxo-5-alpha-steroid 4-dehydrogenase 1	GO:0047751; F:cholestenone 5-alpha-reductase activity; IEA:UniProtKB-EC
P18405	SRD5A1	3-oxo-5-alpha-steroid 4-dehydrogenase 1	GO:0009055; F:electron carrier activity; TAS:UniProtKB
P18405	SRD5A1	3-oxo-5-alpha-steroid 4-dehydrogenase 1	GO:0006702; P:androgen biosynthetic process; TAS:Reactome
P18405	SRD5A1	3-oxo-5-alpha-steroid 4-dehydrogenase 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P18405	SRD5A1	3-oxo-5-alpha-steroid 4-dehydrogenase 1	GO:0007530; P:sex determination; NAS:ProtInc
P18405	SRD5A1	3-oxo-5-alpha-steroid 4-dehydrogenase 1	GO:0007548; P:sex differentiation; IEA:UniProtKB-KW
P18405	SRD5A1	3-oxo-5-alpha-steroid 4-dehydrogenase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P18405	SRD5A1	3-oxo-5-alpha-steroid 4-dehydrogenase 1	GO:0008202; P:steroid metabolic process; TAS:Reactome
P31213	SRD5A2	3-oxo-5-alpha-steroid 4-dehydrogenase 2	GO:0003865; F:3-oxo-5-alpha-steroid 4-dehydrogenase activity; IEA:InterPro
P31213	SRD5A2	3-oxo-5-alpha-steroid 4-dehydrogenase 2	GO:0047751; F:cholestenone 5-alpha-reductase activity; IEA:UniProtKB-EC
P31213	SRD5A2	3-oxo-5-alpha-steroid 4-dehydrogenase 2	GO:0009917; F:sterol 5-alpha reductase activity; IDA:UniProtKB
P31213	SRD5A2	3-oxo-5-alpha-steroid 4-dehydrogenase 2	GO:0006702; P:androgen biosynthetic process; TAS:Reactome
P31213	SRD5A2	3-oxo-5-alpha-steroid 4-dehydrogenase 2	GO:0008209; P:androgen metabolic process; IDA:UniProtKB
P31213	SRD5A2	3-oxo-5-alpha-steroid 4-dehydrogenase 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P31213	SRD5A2	3-oxo-5-alpha-steroid 4-dehydrogenase 2	GO:0007267; P:cell-cell signaling; TAS:UniProtKB
P31213	SRD5A2	3-oxo-5-alpha-steroid 4-dehydrogenase 2	GO:0008584; P:male gonad development; IMP:UniProtKB
P31213	SRD5A2	3-oxo-5-alpha-steroid 4-dehydrogenase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P31213	SRD5A2	3-oxo-5-alpha-steroid 4-dehydrogenase 2	GO:0008202; P:steroid metabolic process; TAS:Reactome
P61619	SEC61A1	Protein transport protein Sec61 subunit alpha isoform 1	GO:0005515; F:protein binding; IPI:IntAct
P61619	SEC61A1	Protein transport protein Sec61 subunit alpha isoform 1	GO:0043022; F:ribosome binding; ISS:UniProtKB
P61619	SEC61A1	Protein transport protein Sec61 subunit alpha isoform 1	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P61619	SEC61A1	Protein transport protein Sec61 subunit alpha isoform 1	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P61619	SEC61A1	Protein transport protein Sec61 subunit alpha isoform 1	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P61619	SEC61A1	Protein transport protein Sec61 subunit alpha isoform 1	GO:0016049; P:cell growth; IMP:MGI
P61619	SEC61A1	Protein transport protein Sec61 subunit alpha isoform 1	GO:0007029; P:endoplasmic reticulum organization; IMP:MGI
P61619	SEC61A1	Protein transport protein Sec61 subunit alpha isoform 1	GO:0006620; P:posttranslational protein targeting to membrane; IMP:MGI
P61619	SEC61A1	Protein transport protein Sec61 subunit alpha isoform 1	GO:0045047; P:protein targeting to ER; ISS:UniProtKB
P61619	SEC61A1	Protein transport protein Sec61 subunit alpha isoform 1	GO:0034341; P:response to interferon-gamma; IEA:Ensembl
P61619	SEC61A1	Protein transport protein Sec61 subunit alpha isoform 1	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; IMP:MGI
Q9H9S3	SEC61A2	Protein transport protein Sec61 subunit alpha isoform 2	GO:0043022; F:ribosome binding; IEA:Ensembl
Q9H9S3	SEC61A2	Protein transport protein Sec61 subunit alpha isoform 2	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q9H9S3	SEC61A2	Protein transport protein Sec61 subunit alpha isoform 2	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q9H9S3	SEC61A2	Protein transport protein Sec61 subunit alpha isoform 2	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q9H9S3	SEC61A2	Protein transport protein Sec61 subunit alpha isoform 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P48066	SLC6A11	Sodium- and chloride-dependent GABA transporter 3	GO:0005332; F:gamma-aminobutyric acid:sodium symporter activity; IEA:Ensembl
P48066	SLC6A11	Sodium- and chloride-dependent GABA transporter 3	GO:0042165; F:neurotransmitter binding; IEA:Ensembl
P48066	SLC6A11	Sodium- and chloride-dependent GABA transporter 3	GO:0005328; F:neurotransmitter:sodium symporter activity; IEA:InterPro
P48066	SLC6A11	Sodium- and chloride-dependent GABA transporter 3	GO:0007420; P:brain development; IEA:Ensembl
P48066	SLC6A11	Sodium- and chloride-dependent GABA transporter 3	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
P48066	SLC6A11	Sodium- and chloride-dependent GABA transporter 3	GO:0042493; P:response to drug; IEA:Ensembl
P48066	SLC6A11	Sodium- and chloride-dependent GABA transporter 3	GO:0007268; P:synaptic transmission; TAS:Reactome
P48066	SLC6A11	Sodium- and chloride-dependent GABA transporter 3	GO:0055085; P:transmembrane transport; TAS:Reactome
P48065	SLC6A12	Sodium- and chloride-dependent betaine transporter	GO:0005332; F:gamma-aminobutyric acid:sodium symporter activity; IEA:InterPro
P48065	SLC6A12	Sodium- and chloride-dependent betaine transporter	GO:0005328; F:neurotransmitter:sodium symporter activity; IEA:InterPro
P48065	SLC6A12	Sodium- and chloride-dependent betaine transporter	GO:0006865; P:amino acid transport; TAS:Reactome
P48065	SLC6A12	Sodium- and chloride-dependent betaine transporter	GO:0071474; P:cellular hyperosmotic response; IEA:Ensembl
P48065	SLC6A12	Sodium- and chloride-dependent betaine transporter	GO:0009992; P:cellular water homeostasis; IEA:Ensembl
P48065	SLC6A12	Sodium- and chloride-dependent betaine transporter	GO:0006811; P:ion transport; TAS:Reactome
P48065	SLC6A12	Sodium- and chloride-dependent betaine transporter	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
P48065	SLC6A12	Sodium- and chloride-dependent betaine transporter	GO:0010033; P:response to organic substance; IEA:Ensembl
P48065	SLC6A12	Sodium- and chloride-dependent betaine transporter	GO:0007268; P:synaptic transmission; TAS:Reactome
P48065	SLC6A12	Sodium- and chloride-dependent betaine transporter	GO:0055085; P:transmembrane transport; TAS:Reactome
P48065	SLC6A12	Sodium- and chloride-dependent betaine transporter	GO:0006810; P:transport; TAS:ProtInc
Q9NSD5	SLC6A13	Sodium- and chloride-dependent GABA transporter 2	GO:0005332; F:gamma-aminobutyric acid:sodium symporter activity; IEA:InterPro
Q9NSD5	SLC6A13	Sodium- and chloride-dependent GABA transporter 2	GO:0005328; F:neurotransmitter:sodium symporter activity; IEA:InterPro
Q9NSD5	SLC6A13	Sodium- and chloride-dependent GABA transporter 2	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
Q9NSD5	SLC6A13	Sodium- and chloride-dependent GABA transporter 2	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9NSD5	SLC6A13	Sodium- and chloride-dependent GABA transporter 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UN76	SLC6A14	Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)	GO:0015171; F:amino acid transmembrane transporter activity; TAS:ProtInc
Q9UN76	SLC6A14	Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)	GO:0005328; F:neurotransmitter:sodium symporter activity; IEA:InterPro
Q9UN76	SLC6A14	Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)	GO:0003333; P:amino acid transmembrane transport; TAS:GOC
Q9UN76	SLC6A14	Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)	GO:0006865; P:amino acid transport; TAS:Reactome
Q9UN76	SLC6A14	Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
Q9UN76	SLC6A14	Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)	GO:0006811; P:ion transport; TAS:Reactome
Q9UN76	SLC6A14	Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)	GO:0009636; P:response to toxic substance; IDA:UniProtKB
Q9UN76	SLC6A14	Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UN76	SLC6A14	Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)	GO:0006810; P:transport; TAS:ProtInc
Q9H2J7	SLC6A15	Sodium-dependent neutral amino acid transporter B(0)AT2	GO:0005326; F:neurotransmitter transporter activity; NAS:UniProtKB
Q9H2J7	SLC6A15	Sodium-dependent neutral amino acid transporter B(0)AT2	GO:0005328; F:neurotransmitter:sodium symporter activity; IEA:InterPro
Q9H2J7	SLC6A15	Sodium-dependent neutral amino acid transporter B(0)AT2	GO:0005298; F:proline:sodium symporter activity; IEA:Ensembl
Q9H2J7	SLC6A15	Sodium-dependent neutral amino acid transporter B(0)AT2	GO:0006865; P:amino acid transport; TAS:Reactome
Q9H2J7	SLC6A15	Sodium-dependent neutral amino acid transporter B(0)AT2	GO:0006811; P:ion transport; TAS:Reactome
Q9H2J7	SLC6A15	Sodium-dependent neutral amino acid transporter B(0)AT2	GO:0015820; P:leucine transport; ISS:UniProtKB
Q9H2J7	SLC6A15	Sodium-dependent neutral amino acid transporter B(0)AT2	GO:0006836; P:neurotransmitter transport; NAS:UniProtKB
Q9H2J7	SLC6A15	Sodium-dependent neutral amino acid transporter B(0)AT2	GO:0015804; P:neutral amino acid transport; IDA:UniProtKB
Q9H2J7	SLC6A15	Sodium-dependent neutral amino acid transporter B(0)AT2	GO:0015824; P:proline transport; ISS:UniProtKB
Q9H2J7	SLC6A15	Sodium-dependent neutral amino acid transporter B(0)AT2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9GZN6	SLC6A16	Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5	GO:0005326; F:neurotransmitter transporter activity; NAS:UniProtKB
Q9GZN6	SLC6A16	Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5	GO:0005328; F:neurotransmitter:sodium symporter activity; IEA:InterPro
Q9GZN6	SLC6A16	Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5	GO:0006836; P:neurotransmitter transport; NAS:UniProtKB
Q9H1V8	SLC6A17	Sodium-dependent neutral amino acid transporter SLC6A17	GO:0005328; F:neurotransmitter:sodium symporter activity; IEA:InterPro
Q9H1V8	SLC6A17	Sodium-dependent neutral amino acid transporter SLC6A17	GO:0032328; P:alanine transport; ISS:UniProtKB
Q9H1V8	SLC6A17	Sodium-dependent neutral amino acid transporter SLC6A17	GO:0015816; P:glycine transport; ISS:UniProtKB
Q9H1V8	SLC6A17	Sodium-dependent neutral amino acid transporter SLC6A17	GO:0015820; P:leucine transport; ISS:UniProtKB
Q9H1V8	SLC6A17	Sodium-dependent neutral amino acid transporter SLC6A17	GO:0015804; P:neutral amino acid transport; ISS:UniProtKB
Q9H1V8	SLC6A17	Sodium-dependent neutral amino acid transporter SLC6A17	GO:0015824; P:proline transport; ISS:UniProtKB
Q96N87	SLC6A18	Sodium-dependent neutral amino acid transporter B(0)AT3	GO:0005328; F:neurotransmitter:sodium symporter activity; IEA:InterPro
Q96N87	SLC6A18	Sodium-dependent neutral amino acid transporter B(0)AT3	GO:0006865; P:amino acid transport; TAS:Reactome
Q96N87	SLC6A18	Sodium-dependent neutral amino acid transporter B(0)AT3	GO:0006811; P:ion transport; TAS:Reactome
Q96N87	SLC6A18	Sodium-dependent neutral amino acid transporter B(0)AT3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q695T7	SLC6A19	Sodium-dependent neutral amino acid transporter B(0)AT1	GO:0005328; F:neurotransmitter:sodium symporter activity; IEA:InterPro
Q695T7	SLC6A19	Sodium-dependent neutral amino acid transporter B(0)AT1	GO:0015175; F:neutral amino acid transmembrane transporter activity; IEA:Ensembl
Q695T7	SLC6A19	Sodium-dependent neutral amino acid transporter B(0)AT1	GO:0006865; P:amino acid transport; TAS:Reactome
Q695T7	SLC6A19	Sodium-dependent neutral amino acid transporter B(0)AT1	GO:0006811; P:ion transport; TAS:Reactome
Q695T7	SLC6A19	Sodium-dependent neutral amino acid transporter B(0)AT1	GO:0007584; P:response to nutrient; IEA:Ensembl
Q695T7	SLC6A19	Sodium-dependent neutral amino acid transporter B(0)AT1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9NP91	SLC6A20	Sodium- and chloride-dependent transporter XTRP3	GO:0015171; F:amino acid transmembrane transporter activity; IDA:UniProtKB
Q9NP91	SLC6A20	Sodium- and chloride-dependent transporter XTRP3	GO:0005328; F:neurotransmitter:sodium symporter activity; IEA:InterPro
Q9NP91	SLC6A20	Sodium- and chloride-dependent transporter XTRP3	GO:0006865; P:amino acid transport; IDA:UniProtKB
Q9NP91	SLC6A20	Sodium- and chloride-dependent transporter XTRP3	GO:0015816; P:glycine transport; IMP:UniProtKB
Q9NP91	SLC6A20	Sodium- and chloride-dependent transporter XTRP3	GO:0006811; P:ion transport; TAS:Reactome
Q9NP91	SLC6A20	Sodium- and chloride-dependent transporter XTRP3	GO:0015824; P:proline transport; IMP:UniProtKB
Q9NP91	SLC6A20	Sodium- and chloride-dependent transporter XTRP3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8N1H7	SIX6OS1	Protein SIX6OS1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8N1H7	SIX6OS1	Protein SIX6OS1	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q8TCU3	SLC7A13	Solute carrier family 7 member 13	GO:0015171; F:amino acid transmembrane transporter activity; IEA:InterPro
Q8TBB6	SLC7A14	Probable cationic amino acid transporter	GO:0015171; F:amino acid transmembrane transporter activity; IEA:InterPro
Q8TBB6	SLC7A14	Probable cationic amino acid transporter	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q96CW6	SLC7A6OS	Probable RNA polymerase II nuclear localization protein SLC7A6OS	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P0DJI8	SAA1	Serum amyloid A-1 protein	GO:0001664; F:G-protein coupled receptor binding; IDA:UniProtKB
P0DJI8	SAA1	Serum amyloid A-1 protein	GO:0006953; P:acute-phase response; NAS:UniProtKB
P0DJI8	SAA1	Serum amyloid A-1 protein	GO:0045087; P:innate immune response; TAS:Reactome
P0DJI8	SAA1	Serum amyloid A-1 protein	GO:0048247; P:lymphocyte chemotaxis; IDA:UniProtKB
P0DJI8	SAA1	Serum amyloid A-1 protein	GO:0048246; P:macrophage chemotaxis; IDA:UniProtKB
P0DJI8	SAA1	Serum amyloid A-1 protein	GO:0050728; P:negative regulation of inflammatory response; NAS:UniProtKB
P0DJI8	SAA1	Serum amyloid A-1 protein	GO:0030593; P:neutrophil chemotaxis; NAS:UniProtKB
P0DJI8	SAA1	Serum amyloid A-1 protein	GO:0030168; P:platelet activation; NAS:UniProtKB
P0DJI8	SAA1	Serum amyloid A-1 protein	GO:0045785; P:positive regulation of cell adhesion; IDA:UniProtKB
P0DJI8	SAA1	Serum amyloid A-1 protein	GO:0050715; P:positive regulation of cytokine secretion; IDA:UniProtKB
P0DJI8	SAA1	Serum amyloid A-1 protein	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB
P0DJI8	SAA1	Serum amyloid A-1 protein	GO:0050716; P:positive regulation of interleukin-1 secretion; NAS:UniProtKB
P0DJI8	SAA1	Serum amyloid A-1 protein	GO:0050708; P:regulation of protein secretion; NAS:UniProtKB
P0DJI9	SAA2	Serum amyloid A-2 protein	GO:0006953; P:acute-phase response; IEA:UniProtKB-KW
P35542	SAA4	Serum amyloid A-4 protein	GO:0006953; P:acute-phase response; IEA:UniProtKB-KW
Q96ER3	SAAL1	Protein SAAL1	GO:0006953; P:acute-phase response; IEA:InterPro
Q9NTJ5	SACM1L	Phosphatidylinositide phosphatase SAC1	GO:0016791; F:phosphatase activity; ISS:UniProtKB
Q9NTJ5	SACM1L	Phosphatidylinositide phosphatase SAC1	GO:0034593; F:phosphatidylinositol bisphosphate phosphatase activity; IEA:Ensembl
Q9NTJ5	SACM1L	Phosphatidylinositide phosphatase SAC1	GO:0004438; F:phosphatidylinositol-3-phosphatase activity; IEA:Ensembl
Q9NTJ5	SACM1L	Phosphatidylinositide phosphatase SAC1	GO:0043812; F:phosphatidylinositol-4-phosphate phosphatase activity; IEA:Ensembl
Q9NTJ5	SACM1L	Phosphatidylinositide phosphatase SAC1	GO:0005515; F:protein binding; IPI:IntAct
Q9NTJ5	SACM1L	Phosphatidylinositide phosphatase SAC1	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q9NTJ5	SACM1L	Phosphatidylinositide phosphatase SAC1	GO:0046856; P:phosphatidylinositol dephosphorylation; IEA:Ensembl
Q9NTJ5	SACM1L	Phosphatidylinositide phosphatase SAC1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q9NTJ5	SACM1L	Phosphatidylinositide phosphatase SAC1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y2H2	INPP5F	Phosphatidylinositide phosphatase SAC2	GO:0042578; F:phosphoric ester hydrolase activity; IEA:InterPro
Q9Y2H2	INPP5F	Phosphatidylinositide phosphatase SAC2	GO:0014898; P:cardiac muscle hypertrophy in response to stress; IEA:Ensembl
Q9Y2H2	INPP5F	Phosphatidylinositide phosphatase SAC2	GO:0031161; P:phosphatidylinositol catabolic process; IEA:Ensembl
Q9Y2H2	INPP5F	Phosphatidylinositide phosphatase SAC2	GO:0048015; P:phosphatidylinositol-mediated signaling; IEA:Ensembl
Q9Y2H2	INPP5F	Phosphatidylinositide phosphatase SAC2	GO:0051896; P:regulation of protein kinase B signaling; IEA:Ensembl
A6NKF1	SAC3D1	SAC3 domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
A6NKF1	SAC3D1	SAC3 domain-containing protein 1	GO:0051298; P:centrosome duplication; IEA:Ensembl
A6NKF1	SAC3D1	SAC3 domain-containing protein 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
A6NKF1	SAC3D1	SAC3 domain-containing protein 1	GO:0046426; P:negative regulation of JAK-STAT cascade; IEA:Ensembl
A6NKF1	SAC3D1	SAC3 domain-containing protein 1	GO:0050776; P:regulation of immune response; IEA:Ensembl
A6NKF1	SAC3D1	SAC3 domain-containing protein 1	GO:0051225; P:spindle assembly; IEA:Ensembl
Q9HBV2	SPACA1	Sperm acrosome membrane-associated protein 1	GO:0001675; P:acrosome assembly; IEA:Ensembl
Q8IXA5	SPACA3	Sperm acrosome membrane-associated protein 3	GO:0003796; F:lysozyme activity; IDA:UniProtKB
Q8IXA5	SPACA3	Sperm acrosome membrane-associated protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IXA5	SPACA3	Sperm acrosome membrane-associated protein 3	GO:0016998; P:cell wall macromolecule catabolic process; TAS:UniProtKB
Q8IXA5	SPACA3	Sperm acrosome membrane-associated protein 3	GO:0050830; P:defense response to Gram-positive bacterium; TAS:UniProtKB
Q8IXA5	SPACA3	Sperm acrosome membrane-associated protein 3	GO:0042117; P:monocyte activation; TAS:UniProtKB
Q8IXA5	SPACA3	Sperm acrosome membrane-associated protein 3	GO:0009253; P:peptidoglycan catabolic process; TAS:UniProtKB
Q8IXA5	SPACA3	Sperm acrosome membrane-associated protein 3	GO:0043032; P:positive regulation of macrophage activation; TAS:UniProtKB
Q8IXA5	SPACA3	Sperm acrosome membrane-associated protein 3	GO:0050766; P:positive regulation of phagocytosis; TAS:UniProtKB
Q8IXA5	SPACA3	Sperm acrosome membrane-associated protein 3	GO:0009615; P:response to virus; TAS:UniProtKB
Q8IXA5	SPACA3	Sperm acrosome membrane-associated protein 3	GO:0035036; P:sperm-egg recognition; IEA:Ensembl
Q8TDM5	SPACA4	Sperm acrosome membrane-associated protein 4	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9NZJ4	SACS	Sacsin	GO:0005524; F:ATP binding; IEA:InterPro
Q9NZJ4	SACS	Sacsin	GO:0051087; F:chaperone binding; IDA:UniProtKB
Q9NZJ4	SACS	Sacsin	GO:0030544; F:Hsp70 protein binding; IPI:BHF-UCL
Q9NZJ4	SACS	Sacsin	GO:0070628; F:proteasome binding; IPI:BHF-UCL
Q9NZJ4	SACS	Sacsin	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9NZJ4	SACS	Sacsin	GO:0090084; P:negative regulation of inclusion body assembly; IMP:BHF-UCL
Q9NZJ4	SACS	Sacsin	GO:0006457; P:protein folding; NAS:UniProtKB
Q9UBE0	SAE1	SUMO-activating enzyme subunit 1	GO:0043008; F:ATP-dependent protein binding; IDA:UniProtKB
Q9UBE0	SAE1	SUMO-activating enzyme subunit 1	GO:0008047; F:enzyme activator activity; TAS:ProtInc
Q9UBE0	SAE1	SUMO-activating enzyme subunit 1	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9UBE0	SAE1	SUMO-activating enzyme subunit 1	GO:0005515; F:protein binding; IPI:IntAct
Q9UBE0	SAE1	SUMO-activating enzyme subunit 1	GO:0008022; F:protein C-terminus binding; IDA:UniProtKB
Q9UBE0	SAE1	SUMO-activating enzyme subunit 1	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q9UBE0	SAE1	SUMO-activating enzyme subunit 1	GO:0004839; F:ubiquitin activating enzyme activity; TAS:UniProtKB
Q9UBE0	SAE1	SUMO-activating enzyme subunit 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UBE0	SAE1	SUMO-activating enzyme subunit 1	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
Q9UBE0	SAE1	SUMO-activating enzyme subunit 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9UBE0	SAE1	SUMO-activating enzyme subunit 1	GO:0016925; P:protein sumoylation; IDA:UniProtKB
Q9UBE0	SAE1	SUMO-activating enzyme subunit 1	GO:0016567; P:protein ubiquitination; TAS:UniProtKB
Q9UBT2	UBA2	SUMO-activating enzyme subunit 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UBT2	UBA2	SUMO-activating enzyme subunit 2	GO:0008047; F:enzyme activator activity; TAS:ProtInc
Q9UBT2	UBA2	SUMO-activating enzyme subunit 2	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9UBT2	UBA2	SUMO-activating enzyme subunit 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UBT2	UBA2	SUMO-activating enzyme subunit 2	GO:0005515; F:protein binding; IPI:IntAct
Q9UBT2	UBA2	SUMO-activating enzyme subunit 2	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q9UBT2	UBA2	SUMO-activating enzyme subunit 2	GO:0019948; F:SUMO activating enzyme activity; IDA:UniProtKB
Q9UBT2	UBA2	SUMO-activating enzyme subunit 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UBT2	UBA2	SUMO-activating enzyme subunit 2	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
Q9UBT2	UBA2	SUMO-activating enzyme subunit 2	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9UBT2	UBA2	SUMO-activating enzyme subunit 2	GO:0016925; P:protein sumoylation; IDA:UniProtKB
Q15424	SAFB	Scaffold attachment factor B1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q15424	SAFB	Scaffold attachment factor B1	GO:0001047; F:core promoter binding; IEA:Ensembl
Q15424	SAFB	Scaffold attachment factor B1	GO:0003690; F:double-stranded DNA binding; TAS:ProtInc
Q15424	SAFB	Scaffold attachment factor B1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q15424	SAFB	Scaffold attachment factor B1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15424	SAFB	Scaffold attachment factor B1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15424	SAFB	Scaffold attachment factor B1	GO:0006325; P:chromatin organization; TAS:ProtInc
Q15424	SAFB	Scaffold attachment factor B1	GO:0040007; P:growth; IEA:Ensembl
Q15424	SAFB	Scaffold attachment factor B1	GO:0042445; P:hormone metabolic process; IEA:Ensembl
Q15424	SAFB	Scaffold attachment factor B1	GO:0030520; P:intracellular estrogen receptor signaling pathway; IEA:Ensembl
Q15424	SAFB	Scaffold attachment factor B1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q15424	SAFB	Scaffold attachment factor B1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14151	SAFB2	Scaffold attachment factor B2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q14151	SAFB2	Scaffold attachment factor B2	GO:0042802; F:identical protein binding; IPI:IntAct
Q14151	SAFB2	Scaffold attachment factor B2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q14151	SAFB2	Scaffold attachment factor B2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14151	SAFB2	Scaffold attachment factor B2	GO:0005515; F:protein binding; IPI:IntAct
Q14151	SAFB2	Scaffold attachment factor B2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q14151	SAFB2	Scaffold attachment factor B2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43865	AHCYL1	Putative adenosylhomocysteinase 2	GO:0004013; F:adenosylhomocysteinase activity; IEA:UniProtKB-EC
O43865	AHCYL1	Putative adenosylhomocysteinase 2	GO:0005515; F:protein binding; IPI:IntAct
O43865	AHCYL1	Putative adenosylhomocysteinase 2	GO:0006378; P:mRNA polyadenylation; IEA:Ensembl
O43865	AHCYL1	Putative adenosylhomocysteinase 2	GO:0006730; P:one-carbon metabolic process; IEA:UniProtKB-KW
O43865	AHCYL1	Putative adenosylhomocysteinase 2	GO:0010765; P:positive regulation of sodium ion transport; IEA:Ensembl
O43865	AHCYL1	Putative adenosylhomocysteinase 2	GO:0006611; P:protein export from nucleus; IEA:Ensembl
O43865	AHCYL1	Putative adenosylhomocysteinase 2	GO:0044070; P:regulation of anion transport; IEA:Ensembl
O43865	AHCYL1	Putative adenosylhomocysteinase 2	GO:0032412; P:regulation of ion transmembrane transporter activity; IEA:Ensembl
O43865	AHCYL1	Putative adenosylhomocysteinase 2	GO:0031440; P:regulation of mRNA 3'-end processing; IEA:Ensembl
Q96HN2	AHCYL2	Putative adenosylhomocysteinase 3	GO:0004013; F:adenosylhomocysteinase activity; IEA:UniProtKB-EC
Q96HN2	AHCYL2	Putative adenosylhomocysteinase 3	GO:0006730; P:one-carbon metabolic process; IEA:UniProtKB-KW
P23526	AHCY	Adenosylhomocysteinase	GO:0004013; F:adenosylhomocysteinase activity; TAS:UniProtKB
P23526	AHCY	Adenosylhomocysteinase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P23526	AHCY	Adenosylhomocysteinase	GO:0032259; P:methylation; TAS:Reactome
P23526	AHCY	Adenosylhomocysteinase	GO:0006730; P:one-carbon metabolic process; IEA:UniProtKB-KW
P23526	AHCY	Adenosylhomocysteinase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P23526	AHCY	Adenosylhomocysteinase	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
P23526	AHCY	Adenosylhomocysteinase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9NSC2	SALL1	Sal-like protein 1	GO:0008013; F:beta-catenin binding; IDA:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9NSC2	SALL1	Sal-like protein 1	GO:0003677; F:DNA binding; NAS:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NSC2	SALL1	Sal-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0030325; P:adrenal gland development; IEP:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0001658; P:branching involved in ureteric bud morphogenesis; ISS:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0048566; P:embryonic digestive tract development; IMP:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0042733; P:embryonic digit morphogenesis; IMP:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0035136; P:forelimb morphogenesis; IEA:Ensembl
Q9NSC2	SALL1	Sal-like protein 1	GO:0008406; P:gonad development; IEP:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0007507; P:heart development; IMP:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0035137; P:hindlimb morphogenesis; IEA:Ensembl
Q9NSC2	SALL1	Sal-like protein 1	GO:0016575; P:histone deacetylation; ISS:GOC
Q9NSC2	SALL1	Sal-like protein 1	GO:0031129; P:inductive cell-cell signaling; ISS:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0001822; P:kidney development; IMP:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0072073; P:kidney epithelium development; ISS:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0060173; P:limb development; IMP:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0003337; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; IEP:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0045879; P:negative regulation of smoothened signaling pathway; IEA:Ensembl
Q9NSC2	SALL1	Sal-like protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0001843; P:neural tube closure; IEA:Ensembl
Q9NSC2	SALL1	Sal-like protein 1	GO:0021889; P:olfactory bulb interneuron differentiation; ISS:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0061034; P:olfactory bulb mitral cell layer development; IMP:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0021553; P:olfactory nerve development; ISS:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0042473; P:outer ear morphogenesis; IMP:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0021983; P:pituitary gland development; IEP:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
Q9NSC2	SALL1	Sal-like protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0030177; P:positive regulation of Wnt signaling pathway; IDA:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:2000177; P:regulation of neural precursor cell proliferation; IEA:Ensembl
Q9NSC2	SALL1	Sal-like protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NSC2	SALL1	Sal-like protein 1	GO:0001657; P:ureteric bud development; ISS:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0072092; P:ureteric bud invasion; ISS:UniProtKB
Q9NSC2	SALL1	Sal-like protein 1	GO:0003281; P:ventricular septum development; ISS:UniProtKB
Q9Y467	SALL2	Sal-like protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y467	SALL2	Sal-like protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y467	SALL2	Sal-like protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q9Y467	SALL2	Sal-like protein 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9Y467	SALL2	Sal-like protein 2	GO:0021915; P:neural tube development; IEA:Ensembl
Q9Y467	SALL2	Sal-like protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BXA9	SALL3	Sal-like protein 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BXA9	SALL3	Sal-like protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BXA9	SALL3	Sal-like protein 3	GO:0035136; P:forelimb morphogenesis; IEA:Ensembl
Q9BXA9	SALL3	Sal-like protein 3	GO:0035137; P:hindlimb morphogenesis; IEA:Ensembl
Q9BXA9	SALL3	Sal-like protein 3	GO:0045879; P:negative regulation of smoothened signaling pathway; IEA:Ensembl
Q9BXA9	SALL3	Sal-like protein 3	GO:0021891; P:olfactory bulb interneuron development; IEA:Ensembl
Q9BXA9	SALL3	Sal-like protein 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9BXA9	SALL3	Sal-like protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UJQ4	SALL4	Sal-like protein 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UJQ4	SALL4	Sal-like protein 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UJQ4	SALL4	Sal-like protein 4	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
Q9UJQ4	SALL4	Sal-like protein 4	GO:0001833; P:inner cell mass cell proliferation; IEA:Ensembl
Q9UJQ4	SALL4	Sal-like protein 4	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UJQ4	SALL4	Sal-like protein 4	GO:0001843; P:neural tube closure; IEA:Ensembl
Q9UJQ4	SALL4	Sal-like protein 4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UJQ4	SALL4	Sal-like protein 4	GO:0019827; P:stem cell maintenance; IEA:Ensembl
Q9UJQ4	SALL4	Sal-like protein 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UJQ4	SALL4	Sal-like protein 4	GO:0003281; P:ventricular septum development; IEA:Ensembl
Q96NU1	SAMD11	Sterile alpha motif domain-containing protein 11	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9Y512	SAMM50	Sorting and assembly machinery component 50 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y512	SAMM50	Sorting and assembly machinery component 50 homolog	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9Y512	SAMM50	Sorting and assembly machinery component 50 homolog	GO:0045040; P:protein import into mitochondrial outer membrane; IDA:BHF-UCL
Q9Y512	SAMM50	Sorting and assembly machinery component 50 homolog	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
Q70HW3	SLC25A26	S-adenosylmethionine mitochondrial carrier protein	GO:0000095; F:S-adenosyl-L-methionine transmembrane transporter activity; IMP:UniProtKB
Q70HW3	SLC25A26	S-adenosylmethionine mitochondrial carrier protein	GO:1901962; P:S-adenosyl-L-methionine transmembrane transport; IMP:GOC
Q70HW3	SLC25A26	S-adenosylmethionine mitochondrial carrier protein	GO:0015805; P:S-adenosyl-L-methionine transport; IMP:UniProtKB
Q8N6K7	SAMD3	Sterile alpha motif domain-containing protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q96LT4	SAMD8	Sphingomyelin synthase-related protein 1	GO:0016740; F:transferase activity; IEA:UniProtKB-KW
Q96LT4	SAMD8	Sphingomyelin synthase-related protein 1	GO:0046513; P:ceramide biosynthetic process; IDA:UniProtKB
Q96LT4	SAMD8	Sphingomyelin synthase-related protein 1	GO:2000303; P:regulation of ceramide biosynthetic process; IDA:UniProtKB
Q96LT4	SAMD8	Sphingomyelin synthase-related protein 1	GO:0006686; P:sphingomyelin biosynthetic process; NAS:UniProtKB
Q5K651	SAMD9	Sterile alpha motif domain-containing protein 9	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3Z3	SAMHD1	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1	GO:0032567; F:dGTP binding; IDA:UniProtKB
Q9Y3Z3	SAMHD1	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1	GO:0008832; F:dGTPase activity; IDA:UniProtKB
Q9Y3Z3	SAMHD1	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1	GO:0003676; F:nucleic acid binding; IDA:UniProtKB
Q9Y3Z3	SAMHD1	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1	GO:0008081; F:phosphoric diester hydrolase activity; IEA:InterPro
Q9Y3Z3	SAMHD1	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3Z3	SAMHD1	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1	GO:0003723; F:RNA binding; IDA:UniProtKB
Q9Y3Z3	SAMHD1	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q9Y3Z3	SAMHD1	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1	GO:0046061; P:dATP catabolic process; IDA:UniProtKB
Q9Y3Z3	SAMHD1	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1	GO:0051607; P:defense response to virus; IMP:UniProtKB
Q9Y3Z3	SAMHD1	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1	GO:0006203; P:dGTP catabolic process; IDA:UniProtKB
Q9Y3Z3	SAMHD1	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1	GO:0006955; P:immune response; NAS:UniProtKB
Q9Y3Z3	SAMHD1	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q9Y3Z3	SAMHD1	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1	GO:0051289; P:protein homotetramerization; IDA:UniProtKB
Q9Y3Z3	SAMHD1	Deoxynucleoside triphosphate triphosphohydrolase SAMHD1	GO:0045088; P:regulation of innate immune response; IMP:UniProtKB
Q9NSI8	SAMSN1	SAM domain-containing protein SAMSN-1	GO:0001784; F:phosphotyrosine binding; IDA:MGI
Q9NSI8	SAMSN1	SAM domain-containing protein SAMSN-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NSI8	SAMSN1	SAM domain-containing protein SAMSN-1	GO:0002820; P:negative regulation of adaptive immune response; ISS:UniProtKB
Q9NSI8	SAMSN1	SAM domain-containing protein SAMSN-1	GO:0050869; P:negative regulation of B cell activation; ISS:UniProtKB
Q9NSI8	SAMSN1	SAM domain-containing protein SAMSN-1	GO:0050732; P:negative regulation of peptidyl-tyrosine phosphorylation; ISS:UniProtKB
P02743	APCS	Serum amyloid P-component	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P02743	APCS	Serum amyloid P-component	GO:0051082; F:unfolded protein binding; TAS:ProtInc
P02743	APCS	Serum amyloid P-component	GO:0006953; P:acute-phase response; TAS:ProtInc
P02743	APCS	Serum amyloid P-component	GO:0051131; P:chaperone-mediated protein complex assembly; TAS:ProtInc
P02743	APCS	Serum amyloid P-component	GO:0006457; P:protein folding; TAS:ProtInc
O00422	SAP18	Histone deacetylase complex subunit SAP18	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O00422	SAP18	Histone deacetylase complex subunit SAP18	GO:0005515; F:protein binding; IPI:IntAct
O00422	SAP18	Histone deacetylase complex subunit SAP18	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
O00422	SAP18	Histone deacetylase complex subunit SAP18	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
O00422	SAP18	Histone deacetylase complex subunit SAP18	GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; IDA:UniProtKB
O00422	SAP18	Histone deacetylase complex subunit SAP18	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
O00422	SAP18	Histone deacetylase complex subunit SAP18	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB
O00422	SAP18	Histone deacetylase complex subunit SAP18	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O00422	SAP18	Histone deacetylase complex subunit SAP18	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
O00422	SAP18	Histone deacetylase complex subunit SAP18	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TEE9	SAP25	Histone deacetylase complex subunit SAP25	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8TEE9	SAP25	Histone deacetylase complex subunit SAP25	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75446	SAP30	Histone deacetylase complex subunit SAP30	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O75446	SAP30	Histone deacetylase complex subunit SAP30	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75446	SAP30	Histone deacetylase complex subunit SAP30	GO:0005515; F:protein binding; IPI:UniProtKB
O75446	SAP30	Histone deacetylase complex subunit SAP30	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
O75446	SAP30	Histone deacetylase complex subunit SAP30	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O75446	SAP30	Histone deacetylase complex subunit SAP30	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
O75446	SAP30	Histone deacetylase complex subunit SAP30	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
O75446	SAP30	Histone deacetylase complex subunit SAP30	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17900	GM2A	Ganglioside GM2 activator	GO:0004563; F:beta-N-acetylhexosaminidase activity; IEA:Ensembl
P17900	GM2A	Ganglioside GM2 activator	GO:0005319; F:lipid transporter activity; IEA:Ensembl
P17900	GM2A	Ganglioside GM2 activator	GO:0016004; F:phospholipase activator activity; IEA:Ensembl
P17900	GM2A	Ganglioside GM2 activator	GO:0006689; P:ganglioside catabolic process; IEA:Ensembl
P17900	GM2A	Ganglioside GM2 activator	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
P17900	GM2A	Ganglioside GM2 activator	GO:0007611; P:learning or memory; IEA:Ensembl
P17900	GM2A	Ganglioside GM2 activator	GO:0019915; P:lipid storage; IEA:Ensembl
P17900	GM2A	Ganglioside GM2 activator	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
P17900	GM2A	Ganglioside GM2 activator	GO:0009313; P:oligosaccharide catabolic process; IEA:Ensembl
P17900	GM2A	Ganglioside GM2 activator	GO:0051345; P:positive regulation of hydrolase activity; IEA:Ensembl
P17900	GM2A	Ganglioside GM2 activator	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P17900	GM2A	Ganglioside GM2 activator	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q6NUJ1	PSAPL1	Proactivator polypeptide-like 1	GO:0006665; P:sphingolipid metabolic process; IEA:UniProtKB-KW
P07602	PSAP	Prosaposin	GO:0008047; F:enzyme activator activity; TAS:ProtInc
P07602	PSAP	Prosaposin	GO:0008289; F:lipid binding; TAS:ProtInc
P07602	PSAP	Prosaposin	GO:0005515; F:protein binding; IPI:UniProt
P07602	PSAP	Prosaposin	GO:0007596; P:blood coagulation; TAS:Reactome
P07602	PSAP	Prosaposin	GO:0071310; P:cellular response to organic substance; IEA:Ensembl
P07602	PSAP	Prosaposin	GO:0060742; P:epithelial cell differentiation involved in prostate gland development; IEA:Ensembl
P07602	PSAP	Prosaposin	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
P07602	PSAP	Prosaposin	GO:0006869; P:lipid transport; TAS:ProtInc
P07602	PSAP	Prosaposin	GO:0030168; P:platelet activation; TAS:Reactome
P07602	PSAP	Prosaposin	GO:0002576; P:platelet degranulation; TAS:Reactome
P07602	PSAP	Prosaposin	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
P07602	PSAP	Prosaposin	GO:0060736; P:prostate gland growth; IEA:Ensembl
P07602	PSAP	Prosaposin	GO:0019216; P:regulation of lipid metabolic process; IEA:Ensembl
P07602	PSAP	Prosaposin	GO:0043408; P:regulation of MAPK cascade; IEA:Ensembl
P07602	PSAP	Prosaposin	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P07602	PSAP	Prosaposin	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q9NR31	SAR1A	GTP-binding protein SAR1a	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9NR31	SAR1A	GTP-binding protein SAR1a	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9NR31	SAR1A	GTP-binding protein SAR1a	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q9Y6B6	SAR1B	GTP-binding protein SAR1b	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9Y6B6	SAR1B	GTP-binding protein SAR1b	GO:0003924; F:GTPase activity; TAS:Reactome
Q9Y6B6	SAR1B	GTP-binding protein SAR1b	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y6B6	SAR1B	GTP-binding protein SAR1b	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q9Y6B6	SAR1B	GTP-binding protein SAR1b	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q9Y6B6	SAR1B	GTP-binding protein SAR1b	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9Y6B6	SAR1B	GTP-binding protein SAR1b	GO:0048208; P:COPII vesicle coating; TAS:Reactome
Q9Y6B6	SAR1B	GTP-binding protein SAR1b	GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:Reactome
Q9Y6B6	SAR1B	GTP-binding protein SAR1b	GO:0006184; P:GTP catabolic process; TAS:GOC
Q9Y6B6	SAR1B	GTP-binding protein SAR1b	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9Y6B6	SAR1B	GTP-binding protein SAR1b	GO:0061024; P:membrane organization; TAS:Reactome
Q9Y6B6	SAR1B	GTP-binding protein SAR1b	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9Y6B6	SAR1B	GTP-binding protein SAR1b	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9Y6B6	SAR1B	GTP-binding protein SAR1b	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96BY9	TMEM66	Store-operated calcium entry-associated regulatory factor	GO:0005515; F:protein binding; IPI:UniProtKB
Q96BY9	TMEM66	Store-operated calcium entry-associated regulatory factor	GO:0015279; F:store-operated calcium channel activity; IDA:UniProtKB
Q96BY9	TMEM66	Store-operated calcium entry-associated regulatory factor	GO:0070588; P:calcium ion transmembrane transport; IDA:GOC
Q96BY9	TMEM66	Store-operated calcium entry-associated regulatory factor	GO:2001256; P:regulation of store-operated calcium entry; IDA:UniProtKB
O00631	SLN	Sarcolipin	GO:0051117; F:ATPase binding; ISS:BHF-UCL
O00631	SLN	Sarcolipin	GO:0004857; F:enzyme inhibitor activity; ISS:BHF-UCL
O00631	SLN	Sarcolipin	GO:0006816; P:calcium ion transport; NAS:UniProtKB
O00631	SLN	Sarcolipin	GO:1901877; P:negative regulation of calcium ion binding; ISS:BHF-UCL
O00631	SLN	Sarcolipin	GO:0090281; P:negative regulation of calcium ion import; ISS:BHF-UCL
O00631	SLN	Sarcolipin	GO:1901020; P:negative regulation of calcium ion transmembrane transporter activity; ISS:BHF-UCL
O00631	SLN	Sarcolipin	GO:0043086; P:negative regulation of catalytic activity; ISS:BHF-UCL
O00631	SLN	Sarcolipin	GO:0043242; P:negative regulation of protein complex disassembly; ISS:BHF-UCL
O00631	SLN	Sarcolipin	GO:1901881; P:positive regulation of protein depolymerization; ISS:BHF-UCL
O00631	SLN	Sarcolipin	GO:0051924; P:regulation of calcium ion transport; ISS:UniProtKB
O00631	SLN	Sarcolipin	GO:1901894; P:regulation of calcium-transporting ATPase activity; IDA:UniProtKB
O00631	SLN	Sarcolipin	GO:1901077; P:regulation of relaxation of muscle; ISS:UniProtKB
O00631	SLN	Sarcolipin	GO:0070296; P:sarcoplasmic reticulum calcium ion transport; ISS:UniProtKB
Q9UL12	SARDH	Sarcosine dehydrogenase, mitochondrial	GO:0004047; F:aminomethyltransferase activity; IEA:InterPro
Q9UL12	SARDH	Sarcosine dehydrogenase, mitochondrial	GO:0008480; F:sarcosine dehydrogenase activity; IEA:UniProtKB-EC
Q9UL12	SARDH	Sarcosine dehydrogenase, mitochondrial	GO:0006546; P:glycine catabolic process; IEA:InterPro
Q6SZW1	SARM1	Sterile alpha and TIR motif-containing protein 1	GO:0045087; P:innate immune response; TAS:Reactome
Q6SZW1	SARM1	Sterile alpha and TIR motif-containing protein 1	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q6SZW1	SARM1	Sterile alpha and TIR motif-containing protein 1	GO:0048814; P:regulation of dendrite morphogenesis; ISS:UniProtKB
Q6SZW1	SARM1	Sterile alpha and TIR motif-containing protein 1	GO:1901214; P:regulation of neuron death; ISS:UniProtKB
Q6SZW1	SARM1	Sterile alpha and TIR motif-containing protein 1	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q6SZW1	SARM1	Sterile alpha and TIR motif-containing protein 1	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q6SZW1	SARM1	Sterile alpha and TIR motif-containing protein 1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P82979	SARNP	SAP domain-containing ribonucleoprotein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P82979	SARNP	SAP domain-containing ribonucleoprotein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P82979	SARNP	SAP domain-containing ribonucleoprotein	GO:0006406; P:mRNA export from nucleus; IDA:UniProtKB
P82979	SARNP	SAP domain-containing ribonucleoprotein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P82979	SARNP	SAP domain-containing ribonucleoprotein	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
P82979	SARNP	SAP domain-containing ribonucleoprotein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15020	SART3	Squamous cell carcinoma antigen recognized by T-cells 3	GO:0000166; F:nucleotide binding; IEA:InterPro
Q15020	SART3	Squamous cell carcinoma antigen recognized by T-cells 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15020	SART3	Squamous cell carcinoma antigen recognized by T-cells 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q15020	SART3	Squamous cell carcinoma antigen recognized by T-cells 3	GO:0010468; P:regulation of gene expression; IDA:MGI
Q15020	SART3	Squamous cell carcinoma antigen recognized by T-cells 3	GO:0006396; P:RNA processing; IEA:InterPro
Q9NQZ2	UTP3	Something about silencing protein 10	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NQZ2	UTP3	Something about silencing protein 10	GO:0007420; P:brain development; ISS:UniProtKB
Q9NQZ2	UTP3	Something about silencing protein 10	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q6UVJ0	SASS6	Spindle assembly abnormal protein 6 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q6UVJ0	SASS6	Spindle assembly abnormal protein 6 homolog	GO:0007099; P:centriole replication; IMP:UniProtKB
Q6UVJ0	SASS6	Spindle assembly abnormal protein 6 homolog	GO:0051298; P:centrosome duplication; IMP:UniProtKB
O94885	SASH1	SAM and SH3 domain-containing protein 1	GO:0031435; F:mitogen-activated protein kinase kinase kinase binding; IDA:MGI
O94885	SASH1	SAM and SH3 domain-containing protein 1	GO:0008022; F:protein C-terminus binding; IDA:MGI
O94885	SASH1	SAM and SH3 domain-containing protein 1	GO:0032947; F:protein complex scaffold; IDA:MGI
O94885	SASH1	SAM and SH3 domain-containing protein 1	GO:0019901; F:protein kinase binding; IDA:MGI
O94885	SASH1	SAM and SH3 domain-containing protein 1	GO:0045766; P:positive regulation of angiogenesis; IMP:MGI
O94885	SASH1	SAM and SH3 domain-containing protein 1	GO:0010595; P:positive regulation of endothelial cell migration; IDA:MGI
O94885	SASH1	SAM and SH3 domain-containing protein 1	GO:0043507; P:positive regulation of JUN kinase activity; IMP:MGI
O94885	SASH1	SAM and SH3 domain-containing protein 1	GO:0031666; P:positive regulation of lipopolysaccharide-mediated signaling pathway; IMP:MGI
O94885	SASH1	SAM and SH3 domain-containing protein 1	GO:1901224; P:positive regulation of NIK/NF-kappaB signaling; IMP:MGI
O94885	SASH1	SAM and SH3 domain-containing protein 1	GO:1900745; P:positive regulation of p38MAPK cascade; IMP:MGI
O94885	SASH1	SAM and SH3 domain-containing protein 1	GO:0000209; P:protein polyubiquitination; IDA:MGI
O94885	SASH1	SAM and SH3 domain-containing protein 1	GO:1902498; P:regulation of protein autoubiquitination; IDA:MGI
O94885	SASH1	SAM and SH3 domain-containing protein 1	GO:1900044; P:regulation of protein K63-linked ubiquitination; IDA:MGI
Q9NV23	OLAH	S-acyl fatty acid synthase thioesterase, medium chain	GO:0016295; F:myristoyl-[acyl-carrier-protein] hydrolase activity; IEA:UniProtKB-EC
Q9NV23	OLAH	S-acyl fatty acid synthase thioesterase, medium chain	GO:0004320; F:oleoyl-[acyl-carrier-protein] hydrolase activity; IEA:UniProtKB-EC
Q9NV23	OLAH	S-acyl fatty acid synthase thioesterase, medium chain	GO:0016296; F:palmitoyl-[acyl-carrier-protein] hydrolase activity; IEA:UniProtKB-EC
Q9NV23	OLAH	S-acyl fatty acid synthase thioesterase, medium chain	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
O75995	SASH3	SAM and SH3 domain-containing protein 3	GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl
O75995	SASH3	SAM and SH3 domain-containing protein 3	GO:0030890; P:positive regulation of B cell proliferation; IEA:Ensembl
O75995	SASH3	SAM and SH3 domain-containing protein 3	GO:0043372; P:positive regulation of CD4-positive, alpha-beta T cell differentiation; IEA:Ensembl
O75995	SASH3	SAM and SH3 domain-containing protein 3	GO:0002639; P:positive regulation of immunoglobulin production; IEA:Ensembl
O75995	SASH3	SAM and SH3 domain-containing protein 3	GO:0032729; P:positive regulation of interferon-gamma production; IEA:Ensembl
O75995	SASH3	SAM and SH3 domain-containing protein 3	GO:0032733; P:positive regulation of interleukin-10 production; IEA:Ensembl
O75995	SASH3	SAM and SH3 domain-containing protein 3	GO:0032743; P:positive regulation of interleukin-2 production; IEA:Ensembl
O75995	SASH3	SAM and SH3 domain-containing protein 3	GO:0032753; P:positive regulation of interleukin-4 production; IEA:Ensembl
O75995	SASH3	SAM and SH3 domain-containing protein 3	GO:0046622; P:positive regulation of organ growth; IEA:Ensembl
O75995	SASH3	SAM and SH3 domain-containing protein 3	GO:0002726; P:positive regulation of T cell cytokine production; IEA:Ensembl
O75995	SASH3	SAM and SH3 domain-containing protein 3	GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl
O75995	SASH3	SAM and SH3 domain-containing protein 3	GO:0032760; P:positive regulation of tumor necrosis factor production; IEA:Ensembl
P21673	SAT1	Diamine acetyltransferase 1	GO:0004145; F:diamine N-acetyltransferase activity; TAS:ProtInc
P21673	SAT1	Diamine acetyltransferase 1	GO:0005515; F:protein binding; IPI:IntAct
P21673	SAT1	Diamine acetyltransferase 1	GO:0019809; F:spermidine binding; IEA:Ensembl
P21673	SAT1	Diamine acetyltransferase 1	GO:0001525; P:angiogenesis; IEP:UniProtKB
P21673	SAT1	Diamine acetyltransferase 1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P21673	SAT1	Diamine acetyltransferase 1	GO:0006596; P:polyamine biosynthetic process; TAS:Reactome
P21673	SAT1	Diamine acetyltransferase 1	GO:0006595; P:polyamine metabolic process; TAS:Reactome
P21673	SAT1	Diamine acetyltransferase 1	GO:0009447; P:putrescine catabolic process; IEA:UniProtKB-UniPathway
P21673	SAT1	Diamine acetyltransferase 1	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P21673	SAT1	Diamine acetyltransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P21673	SAT1	Diamine acetyltransferase 1	GO:0032918; P:spermidine acetylation; IEA:Ensembl
Q96F10	SAT2	Diamine acetyltransferase 2	GO:0004145; F:diamine N-acetyltransferase activity; IDA:UniProt
Q96F10	SAT2	Diamine acetyltransferase 2	GO:0046204; P:nor-spermidine metabolic process; IDA:UniProt
Q96F10	SAT2	Diamine acetyltransferase 2	GO:0032920; P:putrescine acetylation; IDA:UniProt
Q96F10	SAT2	Diamine acetyltransferase 2	GO:0009447; P:putrescine catabolic process; IEA:UniProtKB-UniPathway
Q96F10	SAT2	Diamine acetyltransferase 2	GO:0032918; P:spermidine acetylation; IDA:UniProt
Q96F10	SAT2	Diamine acetyltransferase 2	GO:0032919; P:spermine acetylation; IDA:UniProt
Q01826	SATB1	DNA-binding protein SATB1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q01826	SATB1	DNA-binding protein SATB1	GO:0003690; F:double-stranded DNA binding; TAS:ProtInc
Q01826	SATB1	DNA-binding protein SATB1	GO:0005515; F:protein binding; IPI:IntAct
Q01826	SATB1	DNA-binding protein SATB1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q01826	SATB1	DNA-binding protein SATB1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q01826	SATB1	DNA-binding protein SATB1	GO:0050798; P:activated T cell proliferation; IEA:Ensembl
Q01826	SATB1	DNA-binding protein SATB1	GO:0006915; P:apoptotic process; TAS:Reactome
Q01826	SATB1	DNA-binding protein SATB1	GO:0043367; P:CD4-positive, alpha-beta T cell differentiation; IEA:Ensembl
Q01826	SATB1	DNA-binding protein SATB1	GO:0043374; P:CD8-positive, alpha-beta T cell differentiation; IEA:Ensembl
Q01826	SATB1	DNA-binding protein SATB1	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q01826	SATB1	DNA-binding protein SATB1	GO:0006325; P:chromatin organization; TAS:ProtInc
Q01826	SATB1	DNA-binding protein SATB1	GO:0006338; P:chromatin remodeling; IEA:Ensembl
Q01826	SATB1	DNA-binding protein SATB1	GO:0008544; P:epidermis development; IEA:Ensembl
Q01826	SATB1	DNA-binding protein SATB1	GO:0016571; P:histone methylation; IEA:Ensembl
Q01826	SATB1	DNA-binding protein SATB1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:MGI
Q01826	SATB1	DNA-binding protein SATB1	GO:0060004; P:reflex; IEA:Ensembl
Q01826	SATB1	DNA-binding protein SATB1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q01826	SATB1	DNA-binding protein SATB1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9UPW6	SATB2	DNA-binding protein SATB2	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9UPW6	SATB2	DNA-binding protein SATB2	GO:0005515; F:protein binding; IPI:IntAct
Q9UPW6	SATB2	DNA-binding protein SATB2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9UPW6	SATB2	DNA-binding protein SATB2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9UPW6	SATB2	DNA-binding protein SATB2	GO:0051216; P:cartilage development; IEA:Ensembl
Q9UPW6	SATB2	DNA-binding protein SATB2	GO:0071310; P:cellular response to organic substance; IEA:Ensembl
Q9UPW6	SATB2	DNA-binding protein SATB2	GO:0006338; P:chromatin remodeling; IEA:Ensembl
Q9UPW6	SATB2	DNA-binding protein SATB2	GO:0009880; P:embryonic pattern specification; IEA:Ensembl
Q9UPW6	SATB2	DNA-binding protein SATB2	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
Q9UPW6	SATB2	DNA-binding protein SATB2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UPW6	SATB2	DNA-binding protein SATB2	GO:0001764; P:neuron migration; IEA:Ensembl
Q9UPW6	SATB2	DNA-binding protein SATB2	GO:0002076; P:osteoblast development; IEA:Ensembl
Q9UPW6	SATB2	DNA-binding protein SATB2	GO:0060021; P:palate development; IEA:Ensembl
Q9UPW6	SATB2	DNA-binding protein SATB2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UPW6	SATB2	DNA-binding protein SATB2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86VE3	SATL1	Spermidine/spermine N(1)-acetyltransferase-like protein 1	GO:0008080; F:N-acetyltransferase activity; IEA:InterPro
P43007	SLC1A4	Neutral amino acid transporter A	GO:0005254; F:chloride channel activity; IDA:UniProtKB
P43007	SLC1A4	Neutral amino acid transporter A	GO:0015180; F:L-alanine transmembrane transporter activity; IDA:UniProtKB
P43007	SLC1A4	Neutral amino acid transporter A	GO:0015184; F:L-cystine transmembrane transporter activity; IDA:UniProtKB
P43007	SLC1A4	Neutral amino acid transporter A	GO:0015186; F:L-glutamine transmembrane transporter activity; TAS:BHF-UCL
P43007	SLC1A4	Neutral amino acid transporter A	GO:0034590; F:L-hydroxyproline transmembrane transporter activity; IDA:UniProtKB
P43007	SLC1A4	Neutral amino acid transporter A	GO:0015193; F:L-proline transmembrane transporter activity; IDA:UniProtKB
P43007	SLC1A4	Neutral amino acid transporter A	GO:0015194; F:L-serine transmembrane transporter activity; IDA:UniProtKB
P43007	SLC1A4	Neutral amino acid transporter A	GO:0015195; F:L-threonine transmembrane transporter activity; IDA:UniProtKB
P43007	SLC1A4	Neutral amino acid transporter A	GO:0017153; F:sodium:dicarboxylate symporter activity; IEA:InterPro
P43007	SLC1A4	Neutral amino acid transporter A	GO:0006865; P:amino acid transport; TAS:Reactome
P43007	SLC1A4	Neutral amino acid transporter A	GO:1902476; P:chloride transmembrane transport; IDA:GOC
P43007	SLC1A4	Neutral amino acid transporter A	GO:0006821; P:chloride transport; IDA:GOC
P43007	SLC1A4	Neutral amino acid transporter A	GO:0050890; P:cognition; IMP:UniProtKB
P43007	SLC1A4	Neutral amino acid transporter A	GO:0006868; P:glutamine transport; TAS:BHF-UCL
P43007	SLC1A4	Neutral amino acid transporter A	GO:0034589; P:hydroxyproline transport; IDA:UniProtKB
P43007	SLC1A4	Neutral amino acid transporter A	GO:0006811; P:ion transport; TAS:Reactome
P43007	SLC1A4	Neutral amino acid transporter A	GO:0015808; P:L-alanine transport; IDA:UniProtKB
P43007	SLC1A4	Neutral amino acid transporter A	GO:0015811; P:L-cystine transport; IDA:UniProtKB
P43007	SLC1A4	Neutral amino acid transporter A	GO:0015825; P:L-serine transport; IDA:UniProtKB
P43007	SLC1A4	Neutral amino acid transporter A	GO:0035524; P:proline transmembrane transport; IDA:GOC
P43007	SLC1A4	Neutral amino acid transporter A	GO:0015824; P:proline transport; IDA:UniProtKB
P43007	SLC1A4	Neutral amino acid transporter A	GO:0035249; P:synaptic transmission, glutamatergic; NAS:UniProtKB
P43007	SLC1A4	Neutral amino acid transporter A	GO:0015826; P:threonine transport; IDA:UniProtKB
P43007	SLC1A4	Neutral amino acid transporter A	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9H4B6	SAV1	Protein salvador homolog 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H4B6	SAV1	Protein salvador homolog 1	GO:0001942; P:hair follicle development; IEA:Ensembl
Q9H4B6	SAV1	Protein salvador homolog 1	GO:0035329; P:hippo signaling; ISS:UniProtKB
Q9H4B6	SAV1	Protein salvador homolog 1	GO:0060575; P:intestinal epithelial cell differentiation; IEA:Ensembl
Q9H4B6	SAV1	Protein salvador homolog 1	GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
Q9H4B6	SAV1	Protein salvador homolog 1	GO:0060487; P:lung epithelial cell differentiation; IEA:Ensembl
Q9H4B6	SAV1	Protein salvador homolog 1	GO:0060044; P:negative regulation of cardiac muscle cell proliferation; IEA:Ensembl
Q9H4B6	SAV1	Protein salvador homolog 1	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
Q9H4B6	SAV1	Protein salvador homolog 1	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q9H4B6	SAV1	Protein salvador homolog 1	GO:2000036; P:regulation of stem cell maintenance; IEA:Ensembl
Q9H4B6	SAV1	Protein salvador homolog 1	GO:0060412; P:ventricular septum morphogenesis; IEA:Ensembl
Q9Y3A5	SBDS	Ribosome maturation protein SBDS	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q9Y3A5	SBDS	Ribosome maturation protein SBDS	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y3A5	SBDS	Ribosome maturation protein SBDS	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y3A5	SBDS	Ribosome maturation protein SBDS	GO:0043022; F:ribosome binding; IDA:UniProtKB
Q9Y3A5	SBDS	Ribosome maturation protein SBDS	GO:0019843; F:rRNA binding; IDA:UniProtKB
Q9Y3A5	SBDS	Ribosome maturation protein SBDS	GO:0048539; P:bone marrow development; IMP:UniProtKB
Q9Y3A5	SBDS	Ribosome maturation protein SBDS	GO:0030282; P:bone mineralization; IMP:UniProtKB
Q9Y3A5	SBDS	Ribosome maturation protein SBDS	GO:0008283; P:cell proliferation; IMP:UniProtKB
Q9Y3A5	SBDS	Ribosome maturation protein SBDS	GO:0001833; P:inner cell mass cell proliferation; IEA:Ensembl
Q9Y3A5	SBDS	Ribosome maturation protein SBDS	GO:0030595; P:leukocyte chemotaxis; IDA:UniProtKB
Q9Y3A5	SBDS	Ribosome maturation protein SBDS	GO:0042256; P:mature ribosome assembly; IDA:UniProtKB
Q9Y3A5	SBDS	Ribosome maturation protein SBDS	GO:0043148; P:mitotic spindle stabilization; IDA:UniProtKB
Q9Y3A5	SBDS	Ribosome maturation protein SBDS	GO:0042273; P:ribosomal large subunit biogenesis; IBA:RefGenome
Q9Y3A5	SBDS	Ribosome maturation protein SBDS	GO:0006364; P:rRNA processing; IMP:UniProtKB
Q52WX2	SBK1	Serine/threonine-protein kinase SBK1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q52WX2	SBK1	Serine/threonine-protein kinase SBK1	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
P0C263	SBK2	Serine/threonine-protein kinase SBK2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P0C263	SBK2	Serine/threonine-protein kinase SBK2	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
P0C263	SBK2	Serine/threonine-protein kinase SBK2	GO:0023014; P:signal transduction by phosphorylation; IBA:GOC
P0C264	SBK3	Uncharacterized serine/threonine-protein kinase SBK3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P0C264	SBK3	Uncharacterized serine/threonine-protein kinase SBK3	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
A3KN83	SBNO1	Protein strawberry notch homolog 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q9Y2G9	SBNO2	Protein strawberry notch homolog 2	GO:0002281; P:macrophage activation involved in immune response; IMP:UniProtKB
Q9Y2G9	SBNO2	Protein strawberry notch homolog 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q9Y2G9	SBNO2	Protein strawberry notch homolog 2	GO:0050727; P:regulation of inflammatory response; IMP:UniProtKB
Q9Y2G9	SBNO2	Protein strawberry notch homolog 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13228	SELENBP1	Selenium-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q13228	SELENBP1	Selenium-binding protein 1	GO:0008430; F:selenium binding; TAS:ProtInc
Q13228	SELENBP1	Selenium-binding protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q93073	SECISBP2L	Selenocysteine insertion sequence-binding protein 2-like	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IVN8	SBSPON	Somatomedin-B and thrombospondin type-1 domain-containing protein	GO:0030247; F:polysaccharide binding; IEA:InterPro
Q8IVN8	SBSPON	Somatomedin-B and thrombospondin type-1 domain-containing protein	GO:0005044; F:scavenger receptor activity; IEA:InterPro
Q8IVN8	SBSPON	Somatomedin-B and thrombospondin type-1 domain-containing protein	GO:0006955; P:immune response; IEA:InterPro
P67812	SEC11A	Signal peptidase complex catalytic subunit SEC11A	GO:0008236; F:serine-type peptidase activity; IEA:InterPro
P67812	SEC11A	Signal peptidase complex catalytic subunit SEC11A	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P67812	SEC11A	Signal peptidase complex catalytic subunit SEC11A	GO:0010467; P:gene expression; TAS:Reactome
P67812	SEC11A	Signal peptidase complex catalytic subunit SEC11A	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P67812	SEC11A	Signal peptidase complex catalytic subunit SEC11A	GO:0006465; P:signal peptide processing; IEA:InterPro
P67812	SEC11A	Signal peptidase complex catalytic subunit SEC11A	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P67812	SEC11A	Signal peptidase complex catalytic subunit SEC11A	GO:0006412; P:translation; TAS:Reactome
Q9BY50	SEC11C	Signal peptidase complex catalytic subunit SEC11C	GO:0008236; F:serine-type peptidase activity; IEA:InterPro
Q9BY50	SEC11C	Signal peptidase complex catalytic subunit SEC11C	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9BY50	SEC11C	Signal peptidase complex catalytic subunit SEC11C	GO:0010467; P:gene expression; TAS:Reactome
Q9BY50	SEC11C	Signal peptidase complex catalytic subunit SEC11C	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
Q9BY50	SEC11C	Signal peptidase complex catalytic subunit SEC11C	GO:0006465; P:signal peptide processing; IEA:InterPro
Q9BY50	SEC11C	Signal peptidase complex catalytic subunit SEC11C	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
Q9BY50	SEC11C	Signal peptidase complex catalytic subunit SEC11C	GO:0006412; P:translation; TAS:Reactome
P0C7V7	SEC11B	Putative signal peptidase complex catalytic subunit SEC11B	GO:0008236; F:serine-type peptidase activity; IEA:InterPro
P0C7V7	SEC11B	Putative signal peptidase complex catalytic subunit SEC11B	GO:0006465; P:signal peptide processing; IEA:InterPro
O15027	SEC16A	Protein transport protein Sec16A	GO:0048208; P:COPII vesicle coating; IEA:InterPro
O15027	SEC16A	Protein transport protein Sec16A	GO:0007029; P:endoplasmic reticulum organization; IDA:UniProtKB
O15027	SEC16A	Protein transport protein Sec16A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O15027	SEC16A	Protein transport protein Sec16A	GO:0021762; P:substantia nigra development; IEP:UniProt
Q96JE7	SEC16B	Protein transport protein Sec16B	GO:0048208; P:COPII vesicle coating; IEA:InterPro
Q96JE7	SEC16B	Protein transport protein Sec16B	GO:0007029; P:endoplasmic reticulum organization; IDA:UniProtKB
Q96JE7	SEC16B	Protein transport protein Sec16B	GO:0016559; P:peroxisome fission; IMP:UniProtKB
Q96JE7	SEC16B	Protein transport protein Sec16B	GO:0007031; P:peroxisome organization; IDA:UniProtKB
Q96JE7	SEC16B	Protein transport protein Sec16B	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
Q96JE7	SEC16B	Protein transport protein Sec16B	GO:0070863; P:positive regulation of protein exit from endoplasmic reticulum; IMP:UniProtKB
Q96JE7	SEC16B	Protein transport protein Sec16B	GO:0070972; P:protein localization to endoplasmic reticulum; IDA:UniProtKB
Q96JE7	SEC16B	Protein transport protein Sec16B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96IW7	SEC22A	Vesicle-trafficking protein SEC22a	GO:0005484; F:SNAP receptor activity; IBA:RefGenome
Q96IW7	SEC22A	Vesicle-trafficking protein SEC22a	GO:0000149; F:SNARE binding; IBA:RefGenome
Q96IW7	SEC22A	Vesicle-trafficking protein SEC22a	GO:0005215; F:transporter activity; TAS:ProtInc
Q96IW7	SEC22A	Vesicle-trafficking protein SEC22a	GO:0006888; P:ER to Golgi vesicle-mediated transport; IBA:RefGenome
Q96IW7	SEC22A	Vesicle-trafficking protein SEC22a	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96IW7	SEC22A	Vesicle-trafficking protein SEC22a	GO:0048280; P:vesicle fusion with Golgi apparatus; IBA:RefGenome
O75396	SEC22B	Vesicle-trafficking protein SEC22b	GO:0005515; F:protein binding; IPI:UniProtKB
O75396	SEC22B	Vesicle-trafficking protein SEC22b	GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:ProtInc
O75396	SEC22B	Vesicle-trafficking protein SEC22b	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9BRL7	SEC22C	Vesicle-trafficking protein SEC22c	GO:0005484; F:SNAP receptor activity; IBA:RefGenome
Q9BRL7	SEC22C	Vesicle-trafficking protein SEC22c	GO:0000149; F:SNARE binding; IBA:RefGenome
Q9BRL7	SEC22C	Vesicle-trafficking protein SEC22c	GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:ProtInc
Q9BRL7	SEC22C	Vesicle-trafficking protein SEC22c	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9BRL7	SEC22C	Vesicle-trafficking protein SEC22c	GO:0048280; P:vesicle fusion with Golgi apparatus; IBA:RefGenome
Q15436	SEC23A	Protein transport protein Sec23A	GO:0005515; F:protein binding; IPI:IntAct
Q15436	SEC23A	Protein transport protein Sec23A	GO:0008270; F:zinc ion binding; IEA:InterPro
Q15436	SEC23A	Protein transport protein Sec23A	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q15436	SEC23A	Protein transport protein Sec23A	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q15436	SEC23A	Protein transport protein Sec23A	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q15436	SEC23A	Protein transport protein Sec23A	GO:0048208; P:COPII vesicle coating; TAS:Reactome
Q15436	SEC23A	Protein transport protein Sec23A	GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:Reactome
Q15436	SEC23A	Protein transport protein Sec23A	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q15436	SEC23A	Protein transport protein Sec23A	GO:0061024; P:membrane organization; TAS:Reactome
Q15436	SEC23A	Protein transport protein Sec23A	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q15436	SEC23A	Protein transport protein Sec23A	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q15436	SEC23A	Protein transport protein Sec23A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15436	SEC23A	Protein transport protein Sec23A	GO:0016192; P:vesicle-mediated transport; TAS:ProtInc
Q15437	SEC23B	Protein transport protein Sec23B	GO:0008270; F:zinc ion binding; IEA:InterPro
Q15437	SEC23B	Protein transport protein Sec23B	GO:0006888; P:ER to Golgi vesicle-mediated transport; IEA:InterPro
Q15437	SEC23B	Protein transport protein Sec23B	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q15437	SEC23B	Protein transport protein Sec23B	GO:0016192; P:vesicle-mediated transport; TAS:ProtInc
O95486	SEC24A	Protein transport protein Sec24A	GO:0008270; F:zinc ion binding; IEA:InterPro
O95486	SEC24A	Protein transport protein Sec24A	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
O95486	SEC24A	Protein transport protein Sec24A	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
O95486	SEC24A	Protein transport protein Sec24A	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O95486	SEC24A	Protein transport protein Sec24A	GO:0048208; P:COPII vesicle coating; TAS:Reactome
O95486	SEC24A	Protein transport protein Sec24A	GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:Reactome
O95486	SEC24A	Protein transport protein Sec24A	GO:0006886; P:intracellular protein transport; IEA:InterPro
O95486	SEC24A	Protein transport protein Sec24A	GO:0061024; P:membrane organization; TAS:Reactome
O95486	SEC24A	Protein transport protein Sec24A	GO:0043687; P:post-translational protein modification; TAS:Reactome
O95486	SEC24A	Protein transport protein Sec24A	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
O95486	SEC24A	Protein transport protein Sec24A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95487	SEC24B	Protein transport protein Sec24B	GO:0005515; F:protein binding; IPI:UniProtKB
O95487	SEC24B	Protein transport protein Sec24B	GO:0005215; F:transporter activity; TAS:ProtInc
O95487	SEC24B	Protein transport protein Sec24B	GO:0008270; F:zinc ion binding; IEA:InterPro
O95487	SEC24B	Protein transport protein Sec24B	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
O95487	SEC24B	Protein transport protein Sec24B	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
O95487	SEC24B	Protein transport protein Sec24B	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O95487	SEC24B	Protein transport protein Sec24B	GO:0048208; P:COPII vesicle coating; TAS:Reactome
O95487	SEC24B	Protein transport protein Sec24B	GO:0006888; P:ER to Golgi vesicle-mediated transport; IEA:InterPro
O95487	SEC24B	Protein transport protein Sec24B	GO:0006886; P:intracellular protein transport; IEA:InterPro
O95487	SEC24B	Protein transport protein Sec24B	GO:0061024; P:membrane organization; TAS:Reactome
O95487	SEC24B	Protein transport protein Sec24B	GO:0043687; P:post-translational protein modification; TAS:Reactome
O95487	SEC24B	Protein transport protein Sec24B	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
O95487	SEC24B	Protein transport protein Sec24B	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95487	SEC24B	Protein transport protein Sec24B	GO:0016192; P:vesicle-mediated transport; TAS:ProtInc
P53992	SEC24C	Protein transport protein Sec24C	GO:0005515; F:protein binding; IPI:UniProtKB
P53992	SEC24C	Protein transport protein Sec24C	GO:0008270; F:zinc ion binding; IEA:InterPro
P53992	SEC24C	Protein transport protein Sec24C	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P53992	SEC24C	Protein transport protein Sec24C	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P53992	SEC24C	Protein transport protein Sec24C	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P53992	SEC24C	Protein transport protein Sec24C	GO:0048208; P:COPII vesicle coating; TAS:Reactome
P53992	SEC24C	Protein transport protein Sec24C	GO:0006888; P:ER to Golgi vesicle-mediated transport; NAS:UniProtKB
P53992	SEC24C	Protein transport protein Sec24C	GO:0006886; P:intracellular protein transport; IEA:InterPro
P53992	SEC24C	Protein transport protein Sec24C	GO:0061024; P:membrane organization; TAS:Reactome
P53992	SEC24C	Protein transport protein Sec24C	GO:0043687; P:post-translational protein modification; TAS:Reactome
P53992	SEC24C	Protein transport protein Sec24C	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
P53992	SEC24C	Protein transport protein Sec24C	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O94855	SEC24D	Protein transport protein Sec24D	GO:0008270; F:zinc ion binding; IEA:InterPro
O94855	SEC24D	Protein transport protein Sec24D	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
O94855	SEC24D	Protein transport protein Sec24D	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
O94855	SEC24D	Protein transport protein Sec24D	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O94855	SEC24D	Protein transport protein Sec24D	GO:0048208; P:COPII vesicle coating; TAS:Reactome
O94855	SEC24D	Protein transport protein Sec24D	GO:0006888; P:ER to Golgi vesicle-mediated transport; NAS:UniProtKB
O94855	SEC24D	Protein transport protein Sec24D	GO:0006886; P:intracellular protein transport; IEA:InterPro
O94855	SEC24D	Protein transport protein Sec24D	GO:0061024; P:membrane organization; TAS:Reactome
O94855	SEC24D	Protein transport protein Sec24D	GO:0043687; P:post-translational protein modification; TAS:Reactome
O94855	SEC24D	Protein transport protein Sec24D	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
O94855	SEC24D	Protein transport protein Sec24D	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O94979	SEC31A	Protein transport protein Sec31A	GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB
O94979	SEC31A	Protein transport protein Sec31A	GO:0005515; F:protein binding; IPI:UniProtKB
O94979	SEC31A	Protein transport protein Sec31A	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
O94979	SEC31A	Protein transport protein Sec31A	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
O94979	SEC31A	Protein transport protein Sec31A	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
O94979	SEC31A	Protein transport protein Sec31A	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O94979	SEC31A	Protein transport protein Sec31A	GO:0048208; P:COPII vesicle coating; TAS:Reactome
O94979	SEC31A	Protein transport protein Sec31A	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
O94979	SEC31A	Protein transport protein Sec31A	GO:0006888; P:ER to Golgi vesicle-mediated transport; NAS:UniProtKB
O94979	SEC31A	Protein transport protein Sec31A	GO:0061024; P:membrane organization; TAS:Reactome
O94979	SEC31A	Protein transport protein Sec31A	GO:0043687; P:post-translational protein modification; TAS:Reactome
O94979	SEC31A	Protein transport protein Sec31A	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
O94979	SEC31A	Protein transport protein Sec31A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O94979	SEC31A	Protein transport protein Sec31A	GO:0051592; P:response to calcium ion; IDA:UniProtKB
Q9NQW1	SEC31B	Protein transport protein Sec31B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9NQW1	SEC31B	Protein transport protein Sec31B	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
P13866	SLC5A1	Sodium/glucose cotransporter 1	GO:0005412; F:glucose:sodium symporter activity; IDA:MGI
P13866	SLC5A1	Sodium/glucose cotransporter 1	GO:0005515; F:protein binding; IPI:IntAct
P13866	SLC5A1	Sodium/glucose cotransporter 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P13866	SLC5A1	Sodium/glucose cotransporter 1	GO:0015758; P:glucose transport; IMP:MGI
P13866	SLC5A1	Sodium/glucose cotransporter 1	GO:0008645; P:hexose transport; TAS:Reactome
P13866	SLC5A1	Sodium/glucose cotransporter 1	GO:0050892; P:intestinal absorption; IEA:Ensembl
P13866	SLC5A1	Sodium/glucose cotransporter 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P13866	SLC5A1	Sodium/glucose cotransporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P31639	SLC5A2	Sodium/glucose cotransporter 2	GO:0005362; F:low-affinity glucose:sodium symporter activity; TAS:ProtInc
P31639	SLC5A2	Sodium/glucose cotransporter 2	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
P31639	SLC5A2	Sodium/glucose cotransporter 2	GO:0015758; P:glucose transport; TAS:GOC
P31639	SLC5A2	Sodium/glucose cotransporter 2	GO:0055085; P:transmembrane transport; TAS:Reactome
P31639	SLC5A2	Sodium/glucose cotransporter 2	GO:0006810; P:transport; TAS:ProtInc
P53794	SLC5A3	Sodium/myo-inositol cotransporter	GO:0005367; F:myo-inositol:sodium symporter activity; TAS:ProtInc
P53794	SLC5A3	Sodium/myo-inositol cotransporter	GO:0015798; P:myo-inositol transport; TAS:GOC
P53794	SLC5A3	Sodium/myo-inositol cotransporter	GO:0055085; P:transmembrane transport; TAS:Reactome
P53794	SLC5A3	Sodium/myo-inositol cotransporter	GO:0006810; P:transport; TAS:ProtInc
Q9NY91	SLC5A4	Low affinity sodium-glucose cotransporter	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q9NY91	SLC5A4	Low affinity sodium-glucose cotransporter	GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW
Q9NY91	SLC5A4	Low affinity sodium-glucose cotransporter	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q92911	SLC5A5	Sodium/iodide cotransporter	GO:0015111; F:iodide transmembrane transporter activity; IMP:UniProtKB
Q92911	SLC5A5	Sodium/iodide cotransporter	GO:0008507; F:sodium:iodide symporter activity; IEA:Ensembl
Q92911	SLC5A5	Sodium/iodide cotransporter	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q92911	SLC5A5	Sodium/iodide cotransporter	GO:0071320; P:cellular response to cAMP; IEP:UniProtKB
Q92911	SLC5A5	Sodium/iodide cotransporter	GO:0071371; P:cellular response to gonadotropin stimulus; IEP:UniProtKB
Q92911	SLC5A5	Sodium/iodide cotransporter	GO:0015705; P:iodide transport; IMP:UniProtKB
Q92911	SLC5A5	Sodium/iodide cotransporter	GO:0006811; P:ion transport; TAS:Reactome
Q92911	SLC5A5	Sodium/iodide cotransporter	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q92911	SLC5A5	Sodium/iodide cotransporter	GO:0006590; P:thyroid hormone generation; TAS:Reactome
Q92911	SLC5A5	Sodium/iodide cotransporter	GO:0055085; P:transmembrane transport; TAS:Reactome
Q92911	SLC5A5	Sodium/iodide cotransporter	GO:0006810; P:transport; TAS:ProtInc
Q9Y289	SLC5A6	Sodium-dependent multivitamin transporter	GO:0008523; F:sodium-dependent multivitamin transmembrane transporter activity; TAS:ProtInc
Q9Y289	SLC5A6	Sodium-dependent multivitamin transporter	GO:0006768; P:biotin metabolic process; TAS:Reactome
Q9Y289	SLC5A6	Sodium-dependent multivitamin transporter	GO:0015878; P:biotin transport; IEA:Ensembl
Q9Y289	SLC5A6	Sodium-dependent multivitamin transporter	GO:0015939; P:pantothenate metabolic process; TAS:Reactome
Q9Y289	SLC5A6	Sodium-dependent multivitamin transporter	GO:0015887; P:pantothenate transmembrane transport; IEA:Ensembl
Q9Y289	SLC5A6	Sodium-dependent multivitamin transporter	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y289	SLC5A6	Sodium-dependent multivitamin transporter	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9Y289	SLC5A6	Sodium-dependent multivitamin transporter	GO:0006810; P:transport; TAS:ProtInc
Q9Y289	SLC5A6	Sodium-dependent multivitamin transporter	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9Y289	SLC5A6	Sodium-dependent multivitamin transporter	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q9GZV3	SLC5A7	High affinity choline transporter 1	GO:0033265; F:choline binding; IEA:Ensembl
Q9GZV3	SLC5A7	High affinity choline transporter 1	GO:0015220; F:choline transmembrane transporter activity; IMP:UniProtKB
Q9GZV3	SLC5A7	High affinity choline transporter 1	GO:0005307; F:choline:sodium symporter activity; IMP:MGI
Q9GZV3	SLC5A7	High affinity choline transporter 1	GO:0008292; P:acetylcholine biosynthetic process; IMP:UniProtKB
Q9GZV3	SLC5A7	High affinity choline transporter 1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9GZV3	SLC5A7	High affinity choline transporter 1	GO:0007274; P:neuromuscular synaptic transmission; IEA:Ensembl
Q9GZV3	SLC5A7	High affinity choline transporter 1	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
Q9GZV3	SLC5A7	High affinity choline transporter 1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9GZV3	SLC5A7	High affinity choline transporter 1	GO:0007271; P:synaptic transmission, cholinergic; IEA:Ensembl
Q9GZV3	SLC5A7	High affinity choline transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8N695	SLC5A8	Sodium-coupled monocarboxylate transporter 1	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q8N695	SLC5A8	Sodium-coupled monocarboxylate transporter 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8N695	SLC5A8	Sodium-coupled monocarboxylate transporter 1	GO:0006811; P:ion transport; TAS:Reactome
Q8N695	SLC5A8	Sodium-coupled monocarboxylate transporter 1	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q8N695	SLC5A8	Sodium-coupled monocarboxylate transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q2M3M2	SLC5A9	Sodium/glucose cotransporter 4	GO:0005215; F:transporter activity; IEA:InterPro
Q2M3M2	SLC5A9	Sodium/glucose cotransporter 4	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q2M3M2	SLC5A9	Sodium/glucose cotransporter 4	GO:0055085; P:transmembrane transport; TAS:Reactome
A0PJK1	SLC5A10	Sodium/glucose cotransporter 5	GO:0005215; F:transporter activity; IEA:InterPro
A0PJK1	SLC5A10	Sodium/glucose cotransporter 5	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
A0PJK1	SLC5A10	Sodium/glucose cotransporter 5	GO:0055085; P:transmembrane transport; IEA:InterPro
Q8WWX8	SLC5A11	Sodium/myo-inositol cotransporter 2	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q8WWX8	SLC5A11	Sodium/myo-inositol cotransporter 2	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8WWX8	SLC5A11	Sodium/myo-inositol cotransporter 2	GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW
Q8WWX8	SLC5A11	Sodium/myo-inositol cotransporter 2	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q8WWX8	SLC5A11	Sodium/myo-inositol cotransporter 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q1EHB4	SLC5A12	Sodium-coupled monocarboxylate transporter 2	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q1EHB4	SLC5A12	Sodium-coupled monocarboxylate transporter 2	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
O75845	SC5D	Lathosterol oxidase	GO:0000248; F:C-5 sterol desaturase activity; TAS:ProtInc
O75845	SC5D	Lathosterol oxidase	GO:0005506; F:iron ion binding; IEA:InterPro
O75845	SC5D	Lathosterol oxidase	GO:0050046; F:lathosterol oxidase activity; IEA:UniProtKB-EC
O75845	SC5D	Lathosterol oxidase	GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome
O75845	SC5D	Lathosterol oxidase	GO:0033490; P:cholesterol biosynthetic process via lathosterol; IEA:Ensembl
O75845	SC5D	Lathosterol oxidase	GO:0006633; P:fatty acid biosynthetic process; IEA:InterPro
O75845	SC5D	Lathosterol oxidase	GO:0006629; P:lipid metabolic process; TAS:ProtInc
O75845	SC5D	Lathosterol oxidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P60468	SEC61B	Protein transport protein Sec61 subunit beta	GO:0048408; F:epidermal growth factor binding; IPI:UniProtKB
P60468	SEC61B	Protein transport protein Sec61 subunit beta	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P60468	SEC61B	Protein transport protein Sec61 subunit beta	GO:0005515; F:protein binding; IPI:UniProtKB
P60468	SEC61B	Protein transport protein Sec61 subunit beta	GO:0043022; F:ribosome binding; IEA:Ensembl
P60468	SEC61B	Protein transport protein Sec61 subunit beta	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P60468	SEC61B	Protein transport protein Sec61 subunit beta	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P60468	SEC61B	Protein transport protein Sec61 subunit beta	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P60468	SEC61B	Protein transport protein Sec61 subunit beta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P60468	SEC61B	Protein transport protein Sec61 subunit beta	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
P60468	SEC61B	Protein transport protein Sec61 subunit beta	GO:0010467; P:gene expression; TAS:Reactome
P60468	SEC61B	Protein transport protein Sec61 subunit beta	GO:0000060; P:protein import into nucleus, translocation; IMP:UniProtKB
P60468	SEC61B	Protein transport protein Sec61 subunit beta	GO:0030970; P:retrograde protein transport, ER to cytosol; IMP:UniProtKB
P60468	SEC61B	Protein transport protein Sec61 subunit beta	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P60468	SEC61B	Protein transport protein Sec61 subunit beta	GO:0006412; P:translation; TAS:Reactome
P60059	SEC61G	Protein transport protein Sec61 subunit gamma	GO:0015450; F:P-P-bond-hydrolysis-driven protein transmembrane transporter activity; IEA:InterPro
P60059	SEC61G	Protein transport protein Sec61 subunit gamma	GO:0008565; F:protein transporter activity; ISS:UniProtKB
P60059	SEC61G	Protein transport protein Sec61 subunit gamma	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P60059	SEC61G	Protein transport protein Sec61 subunit gamma	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P60059	SEC61G	Protein transport protein Sec61 subunit gamma	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P60059	SEC61G	Protein transport protein Sec61 subunit gamma	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P60059	SEC61G	Protein transport protein Sec61 subunit gamma	GO:0010467; P:gene expression; TAS:Reactome
P60059	SEC61G	Protein transport protein Sec61 subunit gamma	GO:0045047; P:protein targeting to ER; ISS:UniProtKB
P60059	SEC61G	Protein transport protein Sec61 subunit gamma	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P60059	SEC61G	Protein transport protein Sec61 subunit gamma	GO:0006412; P:translation; TAS:Reactome
P30531	SLC6A1	Sodium- and chloride-dependent GABA transporter 1	GO:0005332; F:gamma-aminobutyric acid:sodium symporter activity; IEA:Ensembl
P30531	SLC6A1	Sodium- and chloride-dependent GABA transporter 1	GO:0005328; F:neurotransmitter:sodium symporter activity; IEA:InterPro
P30531	SLC6A1	Sodium- and chloride-dependent GABA transporter 1	GO:0051939; P:gamma-aminobutyric acid import; IEA:Ensembl
P30531	SLC6A1	Sodium- and chloride-dependent GABA transporter 1	GO:0007612; P:learning; IEA:Ensembl
P30531	SLC6A1	Sodium- and chloride-dependent GABA transporter 1	GO:0032229; P:negative regulation of synaptic transmission, GABAergic; IEA:Ensembl
P30531	SLC6A1	Sodium- and chloride-dependent GABA transporter 1	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
P30531	SLC6A1	Sodium- and chloride-dependent GABA transporter 1	GO:0014054; P:positive regulation of gamma-aminobutyric acid secretion; IEA:Ensembl
P30531	SLC6A1	Sodium- and chloride-dependent GABA transporter 1	GO:0051260; P:protein homooligomerization; IEA:Ensembl
P30531	SLC6A1	Sodium- and chloride-dependent GABA transporter 1	GO:0051592; P:response to calcium ion; IEA:Ensembl
P30531	SLC6A1	Sodium- and chloride-dependent GABA transporter 1	GO:0042220; P:response to cocaine; IEA:Ensembl
P30531	SLC6A1	Sodium- and chloride-dependent GABA transporter 1	GO:0032355; P:response to estradiol; IEA:Ensembl
P30531	SLC6A1	Sodium- and chloride-dependent GABA transporter 1	GO:0010288; P:response to lead ion; IEA:Ensembl
P30531	SLC6A1	Sodium- and chloride-dependent GABA transporter 1	GO:0014074; P:response to purine-containing compound; IEA:Ensembl
P30531	SLC6A1	Sodium- and chloride-dependent GABA transporter 1	GO:0009744; P:response to sucrose; IEA:Ensembl
P30531	SLC6A1	Sodium- and chloride-dependent GABA transporter 1	GO:0009636; P:response to toxic substance; IEA:Ensembl
P30531	SLC6A1	Sodium- and chloride-dependent GABA transporter 1	GO:0007268; P:synaptic transmission; TAS:Reactome
P30531	SLC6A1	Sodium- and chloride-dependent GABA transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P30531	SLC6A1	Sodium- and chloride-dependent GABA transporter 1	GO:0006810; P:transport; NAS:ProtInc
Q92791	LEPREL4	Synaptonemal complex protein SC65	GO:0007130; P:synaptonemal complex assembly; TAS:ProtInc
P23975	SLC6A2	Sodium-dependent noradrenaline transporter	GO:0008504; F:monoamine transmembrane transporter activity; IDA:MGI
P23975	SLC6A2	Sodium-dependent noradrenaline transporter	GO:0005334; F:norepinephrine:sodium symporter activity; TAS:ProtInc
P23975	SLC6A2	Sodium-dependent noradrenaline transporter	GO:0005515; F:protein binding; IPI:UniProtKB
P23975	SLC6A2	Sodium-dependent noradrenaline transporter	GO:0015844; P:monoamine transport; IDA:MGI
P23975	SLC6A2	Sodium-dependent noradrenaline transporter	GO:0015874; P:norepinephrine transport; IEA:Ensembl
P23975	SLC6A2	Sodium-dependent noradrenaline transporter	GO:0042493; P:response to drug; IEA:Ensembl
P23975	SLC6A2	Sodium-dependent noradrenaline transporter	GO:0048265; P:response to pain; IEA:Ensembl
P23975	SLC6A2	Sodium-dependent noradrenaline transporter	GO:0007268; P:synaptic transmission; TAS:ProtInc
P23975	SLC6A2	Sodium-dependent noradrenaline transporter	GO:0055085; P:transmembrane transport; TAS:Reactome
P23975	SLC6A2	Sodium-dependent noradrenaline transporter	GO:0006810; P:transport; TAS:ProtInc
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0035240; F:dopamine binding; IEA:Ensembl
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0005329; F:dopamine transmembrane transporter activity; IDA:UniProtKB
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0005330; F:dopamine:sodium symporter activity; IEA:Ensembl
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0008144; F:drug binding; IEA:Ensembl
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0008504; F:monoamine transmembrane transporter activity; IDA:MGI
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0005515; F:protein binding; IPI:UniProtKB
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0021984; P:adenohypophysis development; IEA:Ensembl
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0007568; P:aging; IEA:Ensembl
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0042416; P:dopamine biosynthetic process; IEA:Ensembl
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0042420; P:dopamine catabolic process; IEA:Ensembl
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0015872; P:dopamine transport; IDA:UniProtKB
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0007595; P:lactation; IEA:Ensembl
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0015844; P:monoamine transport; IDA:MGI
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0042136; P:neurotransmitter biosynthetic process; TAS:Reactome
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0060134; P:prepulse inhibition; IEA:Ensembl
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0042053; P:regulation of dopamine metabolic process; IEA:Ensembl
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0051591; P:response to cAMP; IEA:Ensembl
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0042220; P:response to cocaine; IEA:Ensembl
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0042493; P:response to drug; IEA:Ensembl
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0045471; P:response to ethanol; IEA:Ensembl
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0010039; P:response to iron ion; IEA:Ensembl
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0035094; P:response to nicotine; IEA:Ensembl
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0007608; P:sensory perception of smell; IEA:Ensembl
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0007268; P:synaptic transmission; TAS:Reactome
Q01959	SLC6A3	Sodium-dependent dopamine transporter	GO:0055085; P:transmembrane transport; TAS:Reactome
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0051015; F:actin filament binding; ISS:UniProtKB
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0019811; F:cocaine binding; IEA:Ensembl
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0008504; F:monoamine transmembrane transporter activity; IDA:MGI
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0005515; F:protein binding; IPI:UniProtKB
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0017137; F:Rab GTPase binding; IPI:UniProtKB
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0015222; F:serotonin transmembrane transporter activity; IDA:UniProtKB
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0005335; F:serotonin:sodium symporter activity; IDA:UniProtKB
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0048854; P:brain morphogenesis; ISS:BHF-UCL
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0071321; P:cellular response to cGMP; IEA:Ensembl
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0007623; P:circadian rhythm; IEA:Ensembl
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0007613; P:memory; IEA:Ensembl
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0015844; P:monoamine transport; IDA:MGI
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0021941; P:negative regulation of cerebellar granule cell precursor proliferation; IEA:Ensembl
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0046621; P:negative regulation of organ growth; ISS:BHF-UCL
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0032227; P:negative regulation of synaptic transmission, dopaminergic; IEA:Ensembl
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0045787; P:positive regulation of cell cycle; IEA:Ensembl
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0051260; P:protein homooligomerization; IEA:Ensembl
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0051259; P:protein oligomerization; ISS:UniProtKB
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0042493; P:response to drug; IEA:Ensembl
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0032355; P:response to estradiol; IEA:Ensembl
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0001666; P:response to hypoxia; IEA:Ensembl
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0007584; P:response to nutrient; IEA:Ensembl
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0009636; P:response to toxic substance; IDA:UniProtKB
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0006837; P:serotonin transport; IDA:UniProtKB
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0051610; P:serotonin uptake; IDA:UniProtKB
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0035176; P:social behavior; ISS:BHF-UCL
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0042713; P:sperm ejaculation; IEA:Ensembl
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0021794; P:thalamus development; IMP:UniProtKB
P31645	SLC6A4	Sodium-dependent serotonin transporter	GO:0042310; P:vasoconstriction; IEA:Ensembl
Q9Y345	SLC6A5	Sodium- and chloride-dependent glycine transporter 2	GO:0015375; F:glycine:sodium symporter activity; TAS:ProtInc
Q9Y345	SLC6A5	Sodium- and chloride-dependent glycine transporter 2	GO:0005328; F:neurotransmitter:sodium symporter activity; IEA:InterPro
Q9Y345	SLC6A5	Sodium- and chloride-dependent glycine transporter 2	GO:0015816; P:glycine transport; TAS:GOC
Q9Y345	SLC6A5	Sodium- and chloride-dependent glycine transporter 2	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q9Y345	SLC6A5	Sodium- and chloride-dependent glycine transporter 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9Y345	SLC6A5	Sodium- and chloride-dependent glycine transporter 2	GO:0006810; P:transport; TAS:ProtInc
P31641	SLC6A6	Sodium- and chloride-dependent taurine transporter	GO:0005328; F:neurotransmitter:sodium symporter activity; IEA:InterPro
P31641	SLC6A6	Sodium- and chloride-dependent taurine transporter	GO:0030977; F:taurine binding; IEA:Ensembl
P31641	SLC6A6	Sodium- and chloride-dependent taurine transporter	GO:0005369; F:taurine:sodium symporter activity; TAS:ProtInc
P31641	SLC6A6	Sodium- and chloride-dependent taurine transporter	GO:0006865; P:amino acid transport; TAS:Reactome
P31641	SLC6A6	Sodium- and chloride-dependent taurine transporter	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
P31641	SLC6A6	Sodium- and chloride-dependent taurine transporter	GO:0006811; P:ion transport; TAS:Reactome
P31641	SLC6A6	Sodium- and chloride-dependent taurine transporter	GO:0015734; P:taurine transport; IEA:Ensembl
P31641	SLC6A6	Sodium- and chloride-dependent taurine transporter	GO:0055085; P:transmembrane transport; TAS:Reactome
P31641	SLC6A6	Sodium- and chloride-dependent taurine transporter	GO:0006810; P:transport; TAS:ProtInc
Q99884	SLC6A7	Sodium-dependent proline transporter	GO:0005328; F:neurotransmitter:sodium symporter activity; IEA:InterPro
Q99884	SLC6A7	Sodium-dependent proline transporter	GO:0015824; P:proline transport; TAS:ProtInc
Q99884	SLC6A7	Sodium-dependent proline transporter	GO:0055085; P:transmembrane transport; TAS:Reactome
Q99884	SLC6A7	Sodium-dependent proline transporter	GO:0006810; P:transport; TAS:ProtInc
P48029	SLC6A8	Sodium- and chloride-dependent creatine transporter 1	GO:0015220; F:choline transmembrane transporter activity; IEA:Ensembl
P48029	SLC6A8	Sodium- and chloride-dependent creatine transporter 1	GO:0005308; F:creatine transmembrane transporter activity; NAS:UniProtKB
P48029	SLC6A8	Sodium- and chloride-dependent creatine transporter 1	GO:0005309; F:creatine:sodium symporter activity; TAS:ProtInc
P48029	SLC6A8	Sodium- and chloride-dependent creatine transporter 1	GO:0005328; F:neurotransmitter:sodium symporter activity; IEA:InterPro
P48029	SLC6A8	Sodium- and chloride-dependent creatine transporter 1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P48029	SLC6A8	Sodium- and chloride-dependent creatine transporter 1	GO:0006600; P:creatine metabolic process; TAS:Reactome
P48029	SLC6A8	Sodium- and chloride-dependent creatine transporter 1	GO:1902598; P:creatine transmembrane transport; NAS:GOC
P48029	SLC6A8	Sodium- and chloride-dependent creatine transporter 1	GO:0015881; P:creatine transport; NAS:UniProtKB
P48029	SLC6A8	Sodium- and chloride-dependent creatine transporter 1	GO:0006936; P:muscle contraction; TAS:ProtInc
P48029	SLC6A8	Sodium- and chloride-dependent creatine transporter 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P48029	SLC6A8	Sodium- and chloride-dependent creatine transporter 1	GO:0006810; P:transport; TAS:ProtInc
P48067	SLC6A9	Sodium- and chloride-dependent glycine transporter 1	GO:0015375; F:glycine:sodium symporter activity; TAS:ProtInc
P48067	SLC6A9	Sodium- and chloride-dependent glycine transporter 1	GO:0005328; F:neurotransmitter:sodium symporter activity; IEA:InterPro
P48067	SLC6A9	Sodium- and chloride-dependent glycine transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P48067	SLC6A9	Sodium- and chloride-dependent glycine transporter 1	GO:0006810; P:transport; TAS:ProtInc
Q9UPN6	SCAF8	Protein SCAF8	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9UPN6	SCAF8	Protein SCAF8	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9UPN6	SCAF8	Protein SCAF8	GO:0043175; F:RNA polymerase core enzyme binding; IPI:UniProtKB
Q9UPN6	SCAF8	Protein SCAF8	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9UPN6	SCAF8	Protein SCAF8	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q99590	SCAF11	Protein SCAF11	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q99590	SCAF11	Protein SCAF11	GO:0005515; F:protein binding; IPI:UniProtKB
Q99590	SCAF11	Protein SCAF11	GO:0008270; F:zinc ion binding; IEA:InterPro
Q99590	SCAF11	Protein SCAF11	GO:0006397; P:mRNA processing; TAS:ProtInc
Q99590	SCAF11	Protein SCAF11	GO:0008380; P:RNA splicing; IDA:UniProtKB
Q99590	SCAF11	Protein SCAF11	GO:0000375; P:RNA splicing, via transesterification reactions; IDA:UniProtKB
Q99590	SCAF11	Protein SCAF11	GO:0000245; P:spliceosomal complex assembly; IDA:UniProtKB
Q8N9R8	SCAI	Protein SCAI	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N9R8	SCAI	Protein SCAI	GO:0003714; F:transcription corepressor activity; IMP:UniProtKB
Q8N9R8	SCAI	Protein SCAI	GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB
Q8N9R8	SCAI	Protein SCAI	GO:0035024; P:negative regulation of Rho protein signal transduction; ISS:UniProtKB
Q8N9R8	SCAI	Protein SCAI	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N9R8	SCAI	Protein SCAI	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15127	SCAMP2	Secretory carrier-associated membrane protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
O15127	SCAMP2	Secretory carrier-associated membrane protein 2	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:ProtInc
O15127	SCAMP2	Secretory carrier-associated membrane protein 2	GO:0015031; P:protein transport; IDA:UniProtKB
O15126	SCAMP1	Secretory carrier-associated membrane protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
O15126	SCAMP1	Secretory carrier-associated membrane protein 1	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:ProtInc
O15126	SCAMP1	Secretory carrier-associated membrane protein 1	GO:0015031; P:protein transport; IDA:UniProtKB
O14828	SCAMP3	Secretory carrier-associated membrane protein 3	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:ProtInc
O14828	SCAMP3	Secretory carrier-associated membrane protein 3	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O14828	SCAMP3	Secretory carrier-associated membrane protein 3	GO:0032526; P:response to retinoic acid; IEA:Ensembl
Q969E2	SCAMP4	Secretory carrier-associated membrane protein 4	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8TAC9	SCAMP5	Secretory carrier-associated membrane protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TAC9	SCAMP5	Secretory carrier-associated membrane protein 5	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q8TAC9	SCAMP5	Secretory carrier-associated membrane protein 5	GO:0045806; P:negative regulation of endocytosis; IDA:UniProtKB
Q8TAC9	SCAMP5	Secretory carrier-associated membrane protein 5	GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; IDA:UniProtKB
Q8TAC9	SCAMP5	Secretory carrier-associated membrane protein 5	GO:0050715; P:positive regulation of cytokine secretion; IDA:UniProtKB
Q8TAC9	SCAMP5	Secretory carrier-associated membrane protein 5	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8TAC9	SCAMP5	Secretory carrier-associated membrane protein 5	GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB
Q9BY12	SCAPER	S phase cyclin A-associated protein in the endoplasmic reticulum	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q12770	SCAP	Sterol regulatory element-binding protein cleavage-activating protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q12770	SCAP	Sterol regulatory element-binding protein cleavage-activating protein	GO:0051082; F:unfolded protein binding; NAS:UniProtKB
Q12770	SCAP	Sterol regulatory element-binding protein cleavage-activating protein	GO:0007568; P:aging; IEA:Ensembl
Q12770	SCAP	Sterol regulatory element-binding protein cleavage-activating protein	GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW
Q12770	SCAP	Sterol regulatory element-binding protein cleavage-activating protein	GO:0045541; P:negative regulation of cholesterol biosynthetic process; NAS:UniProtKB
Q12770	SCAP	Sterol regulatory element-binding protein cleavage-activating protein	GO:0045716; P:positive regulation of low-density lipoprotein particle receptor biosynthetic process; NAS:UniProtKB
Q12770	SCAP	Sterol regulatory element-binding protein cleavage-activating protein	GO:0042304; P:regulation of fatty acid biosynthetic process; IEA:Ensembl
Q12770	SCAP	Sterol regulatory element-binding protein cleavage-activating protein	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q12770	SCAP	Sterol regulatory element-binding protein cleavage-activating protein	GO:0032868; P:response to insulin; IEA:Ensembl
Q12770	SCAP	Sterol regulatory element-binding protein cleavage-activating protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q12770	SCAP	Sterol regulatory element-binding protein cleavage-activating protein	GO:0032933; P:SREBP signaling pathway; IMP:UniProtKB
Q6AZY7	SCARA3	Scavenger receptor class A member 3	GO:0005044; F:scavenger receptor activity; TAS:ProtInc
Q6AZY7	SCARA3	Scavenger receptor class A member 3	GO:0006898; P:receptor-mediated endocytosis; TAS:GOC
Q6AZY7	SCARA3	Scavenger receptor class A member 3	GO:0006979; P:response to oxidative stress; TAS:ProtInc
Q6AZY7	SCARA3	Scavenger receptor class A member 3	GO:0009650; P:UV protection; TAS:ProtInc
Q6ZMJ2	SCARA5	Scavenger receptor class A member 5	GO:0070287; F:ferritin receptor activity; ISS:UniProtKB
Q6ZMJ2	SCARA5	Scavenger receptor class A member 5	GO:0005044; F:scavenger receptor activity; IEA:InterPro
Q6ZMJ2	SCARA5	Scavenger receptor class A member 5	GO:0006879; P:cellular iron ion homeostasis; ISS:UniProtKB
Q6ZMJ2	SCARA5	Scavenger receptor class A member 5	GO:0034605; P:cellular response to heat; IEA:Ensembl
Q6ZMJ2	SCARA5	Scavenger receptor class A member 5	GO:0006897; P:endocytosis; ISS:UniProtKB
Q6ZMJ2	SCARA5	Scavenger receptor class A member 5	GO:0034755; P:iron ion transmembrane transport; ISS:UniProtKB
Q6ZMJ2	SCARA5	Scavenger receptor class A member 5	GO:0070207; P:protein homotrimerization; ISS:UniProtKB
Q6ZMJ2	SCARA5	Scavenger receptor class A member 5	GO:0006898; P:receptor-mediated endocytosis; ISS:GOC
Q9Y6X3	MAU2	MAU2 chromatid cohesion factor homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6X3	MAU2	MAU2 chromatid cohesion factor homolog	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q9Y6X3	MAU2	MAU2 chromatid cohesion factor homolog	GO:0034088; P:maintenance of mitotic sister chromatid cohesion; IMP:UniProtKB
Q9Y6X3	MAU2	MAU2 chromatid cohesion factor homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q86SK9	SCD5	Stearoyl-CoA desaturase 5	GO:0005506; F:iron ion binding; IEA:InterPro
Q86SK9	SCD5	Stearoyl-CoA desaturase 5	GO:0004768; F:stearoyl-CoA 9-desaturase activity; IEA:UniProtKB-EC
Q86SK9	SCD5	Stearoyl-CoA desaturase 5	GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW
O95171	SCEL	Sciellin	GO:0005515; F:protein binding; IPI:UniProtKB
O95171	SCEL	Sciellin	GO:0008270; F:zinc ion binding; IEA:InterPro
O95171	SCEL	Sciellin	GO:0009790; P:embryo development; ISS:UniProtKB
O95171	SCEL	Sciellin	GO:0008544; P:epidermis development; ISS:UniProtKB
O95171	SCEL	Sciellin	GO:0030216; P:keratinocyte differentiation; IDA:UniProtKB
Q8WVM8	SCFD1	Sec1 family domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q8WVM8	SCFD1	Sec1 family domain-containing protein 1	GO:0019905; F:syntaxin binding; ISS:UniProtKB
Q8WVM8	SCFD1	Sec1 family domain-containing protein 1	GO:0006892; P:post-Golgi vesicle-mediated transport; ISS:UniProtKB
Q8WVM8	SCFD1	Sec1 family domain-containing protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8WVM8	SCFD1	Sec1 family domain-containing protein 1	GO:0060628; P:regulation of ER to Golgi vesicle-mediated transport; ISS:UniProtKB
Q8WVM8	SCFD1	Sec1 family domain-containing protein 1	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q8WVM8	SCFD1	Sec1 family domain-containing protein 1	GO:0009636; P:response to toxic substance; IEP:UniProtKB
Q8WVM8	SCFD1	Sec1 family domain-containing protein 1	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; ISS:UniProtKB
Q8WVM8	SCFD1	Sec1 family domain-containing protein 1	GO:0006904; P:vesicle docking involved in exocytosis; IEA:InterPro
Q8WU76	SCFD2	Sec1 family domain-containing protein 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8WU76	SCFD2	Sec1 family domain-containing protein 2	GO:0006904; P:vesicle docking involved in exocytosis; IEA:InterPro
P21583	KITLG	Kit ligand	GO:0005515; F:protein binding; IPI:IntAct
P21583	KITLG	Kit ligand	GO:0005173; F:stem cell factor receptor binding; TAS:ProtInc
P21583	KITLG	Kit ligand	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P21583	KITLG	Kit ligand	GO:0008283; P:cell proliferation; TAS:ProtInc
P21583	KITLG	Kit ligand	GO:0035234; P:ectopic germ cell programmed cell death; IEA:Ensembl
P21583	KITLG	Kit ligand	GO:0035162; P:embryonic hemopoiesis; IDA:DFLAT
P21583	KITLG	Kit ligand	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P21583	KITLG	Kit ligand	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P21583	KITLG	Kit ligand	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P21583	KITLG	Kit ligand	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P21583	KITLG	Kit ligand	GO:0045087; P:innate immune response; TAS:Reactome
P21583	KITLG	Kit ligand	GO:0008584; P:male gonad development; IEP:UniProtKB
P21583	KITLG	Kit ligand	GO:0033026; P:negative regulation of mast cell apoptotic process; IEA:Ensembl
P21583	KITLG	Kit ligand	GO:0001755; P:neural crest cell migration; IEA:Ensembl
P21583	KITLG	Kit ligand	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P21583	KITLG	Kit ligand	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P21583	KITLG	Kit ligand	GO:0045740; P:positive regulation of DNA replication; IDA:BHF-UCL
P21583	KITLG	Kit ligand	GO:0043406; P:positive regulation of MAP kinase activity; IEA:Ensembl
P21583	KITLG	Kit ligand	GO:0070668; P:positive regulation of mast cell proliferation; IEA:Ensembl
P21583	KITLG	Kit ligand	GO:0045636; P:positive regulation of melanocyte differentiation; IEA:Ensembl
P21583	KITLG	Kit ligand	GO:0002763; P:positive regulation of myeloid leukocyte differentiation; IEA:Ensembl
P21583	KITLG	Kit ligand	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
P21583	KITLG	Kit ligand	GO:0046579; P:positive regulation of Ras protein signal transduction; IEA:Ensembl
P21583	KITLG	Kit ligand	GO:0007165; P:signal transduction; TAS:ProtInc
P05060	CHGB	Secretogranin-1	GO:0005179; F:hormone activity; TAS:ProtInc
P05060	CHGB	Secretogranin-1	GO:0005515; F:protein binding; IPI:IntAct
P13521	SCG2	Secretogranin-2	GO:0042056; F:chemoattractant activity; IDA:HGNC
P13521	SCG2	Secretogranin-2	GO:0005125; F:cytokine activity; IDA:HGNC
P13521	SCG2	Secretogranin-2	GO:0001525; P:angiogenesis; IDA:HGNC
P13521	SCG2	Secretogranin-2	GO:0006928; P:cellular component movement; IDA:HGNC
P13521	SCG2	Secretogranin-2	GO:0043542; P:endothelial cell migration; TAS:HGNC
P13521	SCG2	Secretogranin-2	GO:0048245; P:eosinophil chemotaxis; IDA:HGNC
P13521	SCG2	Secretogranin-2	GO:0050930; P:induction of positive chemotaxis; IDA:HGNC
P13521	SCG2	Secretogranin-2	GO:0006954; P:inflammatory response; TAS:HGNC
P13521	SCG2	Secretogranin-2	GO:0035556; P:intracellular signal transduction; IDA:HGNC
P13521	SCG2	Secretogranin-2	GO:0000165; P:MAPK cascade; IDA:HGNC
P13521	SCG2	Secretogranin-2	GO:2000352; P:negative regulation of endothelial cell apoptotic process; IDA:BHF-UCL
P13521	SCG2	Secretogranin-2	GO:0001937; P:negative regulation of endothelial cell proliferation; TAS:HGNC
P13521	SCG2	Secretogranin-2	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IDA:BHF-UCL
P13521	SCG2	Secretogranin-2	GO:0050918; P:positive chemotaxis; IDA:GOC
P13521	SCG2	Secretogranin-2	GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:HGNC
P13521	SCG2	Secretogranin-2	GO:0009306; P:protein secretion; TAS:ProtInc
Q8WXD2	SCG3	Secretogranin-3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8WXD2	SCG3	Secretogranin-3	GO:0007596; P:blood coagulation; TAS:Reactome
Q8WXD2	SCG3	Secretogranin-3	GO:0030168; P:platelet activation; TAS:Reactome
Q8WXD2	SCG3	Secretogranin-3	GO:0002576; P:platelet degranulation; TAS:Reactome
Q9P0W5	SCHIP1	Schwannomin-interacting protein 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q9P0W5	SCHIP1	Schwannomin-interacting protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q6UWF3	SCIMP	SLP adapter and CSK-interacting membrane protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q6UWF3	SCIMP	SLP adapter and CSK-interacting membrane protein	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
Q96NL6	SCLT1	Sodium channel and clathrin linker 1	GO:0017080; F:sodium channel regulator activity; IEA:Ensembl
Q96NL6	SCLT1	Sodium channel and clathrin linker 1	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q96NL6	SCLT1	Sodium channel and clathrin linker 1	GO:0045162; P:clustering of voltage-gated sodium channels; IEA:Ensembl
Q96I15	SCLY	Selenocysteine lyase	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q96I15	SCLY	Selenocysteine lyase	GO:0009000; F:selenocysteine lyase activity; TAS:ProtInc
Q96I15	SCLY	Selenocysteine lyase	GO:0016740; F:transferase activity; IEA:UniProtKB-KW
Q96I15	SCLY	Selenocysteine lyase	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
Q6NUK1	SLC25A24	Calcium-binding mitochondrial carrier protein SCaMC-1	GO:0005347; F:ATP transmembrane transporter activity; IMP:UniProtKB
Q6NUK1	SLC25A24	Calcium-binding mitochondrial carrier protein SCaMC-1	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q6NUK1	SLC25A24	Calcium-binding mitochondrial carrier protein SCaMC-1	GO:0015867; P:ATP transport; IMP:UniProtKB
Q6NUK1	SLC25A24	Calcium-binding mitochondrial carrier protein SCaMC-1	GO:0071277; P:cellular response to calcium ion; IMP:UniProtKB
Q6NUK1	SLC25A24	Calcium-binding mitochondrial carrier protein SCaMC-1	GO:0034599; P:cellular response to oxidative stress; IMP:UniProtKB
Q6NUK1	SLC25A24	Calcium-binding mitochondrial carrier protein SCaMC-1	GO:0006839; P:mitochondrial transport; IMP:UniProtKB
Q6NUK1	SLC25A24	Calcium-binding mitochondrial carrier protein SCaMC-1	GO:0010941; P:regulation of cell death; IMP:UniProtKB
Q6KCM7	SLC25A25	Calcium-binding mitochondrial carrier protein SCaMC-2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q6KCM7	SLC25A25	Calcium-binding mitochondrial carrier protein SCaMC-2	GO:0060612; P:adipose tissue development; IEA:Ensembl
Q6KCM7	SLC25A25	Calcium-binding mitochondrial carrier protein SCaMC-2	GO:0046034; P:ATP metabolic process; IEA:Ensembl
Q6KCM7	SLC25A25	Calcium-binding mitochondrial carrier protein SCaMC-2	GO:0070588; P:calcium ion transmembrane transport; IEA:Ensembl
Q6KCM7	SLC25A25	Calcium-binding mitochondrial carrier protein SCaMC-2	GO:0043010; P:camera-type eye development; IEA:Ensembl
Q6KCM7	SLC25A25	Calcium-binding mitochondrial carrier protein SCaMC-2	GO:0045333; P:cellular respiration; IEA:Ensembl
Q6KCM7	SLC25A25	Calcium-binding mitochondrial carrier protein SCaMC-2	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q6KCM7	SLC25A25	Calcium-binding mitochondrial carrier protein SCaMC-2	GO:0014823; P:response to activity; IEA:Ensembl
Q6KCM7	SLC25A25	Calcium-binding mitochondrial carrier protein SCaMC-2	GO:0002021; P:response to dietary excess; IEA:Ensembl
Q6KCM7	SLC25A25	Calcium-binding mitochondrial carrier protein SCaMC-2	GO:0032094; P:response to food; IEA:Ensembl
Q9BV35	SLC25A23	Calcium-binding mitochondrial carrier protein SCaMC-3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9BV35	SLC25A23	Calcium-binding mitochondrial carrier protein SCaMC-3	GO:0055085; P:transmembrane transport; IEA:InterPro
Q96GD3	SCMH1	Polycomb protein SCMH1	GO:0003677; F:DNA binding; TAS:ProtInc
Q96GD3	SCMH1	Polycomb protein SCMH1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q96GD3	SCMH1	Polycomb protein SCMH1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q96GD3	SCMH1	Polycomb protein SCMH1	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q96GD3	SCMH1	Polycomb protein SCMH1	GO:0006338; P:chromatin remodeling; IEA:Ensembl
Q96GD3	SCMH1	Polycomb protein SCMH1	GO:0016458; P:gene silencing; ISS:UniProtKB
Q96GD3	SCMH1	Polycomb protein SCMH1	GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB
Q96GD3	SCMH1	Polycomb protein SCMH1	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q96GD3	SCMH1	Polycomb protein SCMH1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UN30	SCML1	Sex comb on midleg-like protein 1	GO:0003677; F:DNA binding; TAS:ProtInc
Q9UN30	SCML1	Sex comb on midleg-like protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9UN30	SCML1	Sex comb on midleg-like protein 1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q9UN30	SCML1	Sex comb on midleg-like protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UQR0	SCML2	Sex comb on midleg-like protein 2	GO:0003677; F:DNA binding; TAS:ProtInc
Q9UQR0	SCML2	Sex comb on midleg-like protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9UQR0	SCML2	Sex comb on midleg-like protein 2	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q9UQR0	SCML2	Sex comb on midleg-like protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N228	SCML4	Sex comb on midleg-like protein 4	GO:0003677; F:DNA binding; IEA:InterPro
Q8N228	SCML4	Sex comb on midleg-like protein 4	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N228	SCML4	Sex comb on midleg-like protein 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P35498	SCN1A	Sodium channel protein type 1 subunit alpha	GO:0005248; F:voltage-gated sodium channel activity; NAS:UniProtKB
P35498	SCN1A	Sodium channel protein type 1 subunit alpha	GO:0007628; P:adult walking behavior; IEA:Ensembl
P35498	SCN1A	Sodium channel protein type 1 subunit alpha	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
P35498	SCN1A	Sodium channel protein type 1 subunit alpha	GO:0050884; P:neuromuscular process controlling posture; IEA:Ensembl
P35498	SCN1A	Sodium channel protein type 1 subunit alpha	GO:0019228; P:neuronal action potential; IBA:RefGenome
P35498	SCN1A	Sodium channel protein type 1 subunit alpha	GO:0019227; P:neuronal action potential propagation; IEA:Ensembl
P35498	SCN1A	Sodium channel protein type 1 subunit alpha	GO:0035725; P:sodium ion transmembrane transport; NAS:GOC
P35498	SCN1A	Sodium channel protein type 1 subunit alpha	GO:0006814; P:sodium ion transport; NAS:UniProtKB
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0019871; F:sodium channel inhibitor activity; ISS:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0017080; F:sodium channel regulator activity; IDA:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0005248; F:voltage-gated sodium channel activity; IDA:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0086006; F:voltage-gated sodium channel activity involved in cardiac muscle cell action potential; IMP:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0086062; F:voltage-gated sodium channel activity involved in Purkinje myocyte action potential; IMP:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0007411; P:axon guidance; ISS:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0061337; P:cardiac conduction; ISS:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0086002; P:cardiac muscle cell action potential involved in contraction; IMP:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0021966; P:corticospinal neuron axon guidance; ISS:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0040011; P:locomotion; ISS:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0051899; P:membrane depolarization; IDA:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0086012; P:membrane depolarization during cardiac muscle cell action potential; ISS:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0086047; P:membrane depolarization during Purkinje myocyte cell action potential; IMP:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0019227; P:neuronal action potential propagation; ISS:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0010976; P:positive regulation of neuron projection development; ISS:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0010765; P:positive regulation of sodium ion transport; IDA:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0060371; P:regulation of atrial cardiac muscle cell membrane depolarization; IMP:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:2000649; P:regulation of sodium ion transmembrane transporter activity; IDA:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; ISS:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0046684; P:response to pyrethroid; IEA:Ensembl
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0035725; P:sodium ion transmembrane transport; IDA:BHF-UCL
Q07699	SCN1B	Sodium channel subunit beta-1	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q99250	SCN2A	Sodium channel protein type 2 subunit alpha	GO:0005248; F:voltage-gated sodium channel activity; ISS:UniProtKB
Q99250	SCN2A	Sodium channel protein type 2 subunit alpha	GO:0008627; P:intrinsic apoptotic signaling pathway in response to osmotic stress; IEA:Ensembl
Q99250	SCN2A	Sodium channel protein type 2 subunit alpha	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q99250	SCN2A	Sodium channel protein type 2 subunit alpha	GO:0042552; P:myelination; ISS:BHF-UCL
Q99250	SCN2A	Sodium channel protein type 2 subunit alpha	GO:0051402; P:neuron apoptotic process; IEA:Ensembl
Q99250	SCN2A	Sodium channel protein type 2 subunit alpha	GO:0019228; P:neuronal action potential; IBA:RefGenome
Q99250	SCN2A	Sodium channel protein type 2 subunit alpha	GO:0035725; P:sodium ion transmembrane transport; ISS:UniProtKB
Q99250	SCN2A	Sodium channel protein type 2 subunit alpha	GO:0006814; P:sodium ion transport; TAS:ProtInc
O60939	SCN2B	Sodium channel subunit beta-2	GO:0017080; F:sodium channel regulator activity; IDA:BHF-UCL
O60939	SCN2B	Sodium channel subunit beta-2	GO:0086006; F:voltage-gated sodium channel activity involved in cardiac muscle cell action potential; IMP:BHF-UCL
O60939	SCN2B	Sodium channel subunit beta-2	GO:0086002; P:cardiac muscle cell action potential involved in contraction; IMP:BHF-UCL
O60939	SCN2B	Sodium channel subunit beta-2	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
O60939	SCN2B	Sodium channel subunit beta-2	GO:0086012; P:membrane depolarization during cardiac muscle cell action potential; IMP:GOC
O60939	SCN2B	Sodium channel subunit beta-2	GO:0007399; P:nervous system development; IEA:Ensembl
O60939	SCN2B	Sodium channel subunit beta-2	GO:0060371; P:regulation of atrial cardiac muscle cell membrane depolarization; IMP:BHF-UCL
O60939	SCN2B	Sodium channel subunit beta-2	GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL
O60939	SCN2B	Sodium channel subunit beta-2	GO:2000649; P:regulation of sodium ion transmembrane transporter activity; IDA:BHF-UCL
O60939	SCN2B	Sodium channel subunit beta-2	GO:0046684; P:response to pyrethroid; IEA:Ensembl
O60939	SCN2B	Sodium channel subunit beta-2	GO:0035725; P:sodium ion transmembrane transport; IDA:BHF-UCL
O60939	SCN2B	Sodium channel subunit beta-2	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q9NY46	SCN3A	Sodium channel protein type 3 subunit alpha	GO:0005248; F:voltage-gated sodium channel activity; NAS:UniProtKB
Q9NY46	SCN3A	Sodium channel protein type 3 subunit alpha	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q9NY46	SCN3A	Sodium channel protein type 3 subunit alpha	GO:0019228; P:neuronal action potential; IBA:RefGenome
Q9NY46	SCN3A	Sodium channel protein type 3 subunit alpha	GO:0035725; P:sodium ion transmembrane transport; NAS:GOC
Q9NY46	SCN3A	Sodium channel protein type 3 subunit alpha	GO:0006814; P:sodium ion transport; NAS:UniProtKB
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0017080; F:sodium channel regulator activity; IDA:BHF-UCL
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0005248; F:voltage-gated sodium channel activity; NAS:UniProtKB
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0086006; F:voltage-gated sodium channel activity involved in cardiac muscle cell action potential; IDA:BHF-UCL
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0086014; P:atrial cardiac muscle cell action potential; IMP:BHF-UCL
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0007411; P:axon guidance; TAS:Reactome
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0086002; P:cardiac muscle cell action potential involved in contraction; IMP:BHF-UCL
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0051899; P:membrane depolarization; IDA:BHF-UCL
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0086010; P:membrane depolarization during action potential; IDA:BHF-UCL
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0086012; P:membrane depolarization during cardiac muscle cell action potential; IMP:BHF-UCL
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0010460; P:positive regulation of heart rate; ISS:BHF-UCL
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0010765; P:positive regulation of sodium ion transport; IDA:BHF-UCL
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0072659; P:protein localization to plasma membrane; IMP:BHF-UCL
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0060371; P:regulation of atrial cardiac muscle cell membrane depolarization; IMP:BHF-UCL
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:2000649; P:regulation of sodium ion transmembrane transporter activity; IMP:BHF-UCL
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0060373; P:regulation of ventricular cardiac muscle cell membrane depolarization; IMP:BHF-UCL
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0086070; P:SA node cell to atrial cardiac muscle cell communication; ISS:BHF-UCL
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0019233; P:sensory perception of pain; IEA:Ensembl
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0035725; P:sodium ion transmembrane transport; IDA:BHF-UCL
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0006814; P:sodium ion transport; NAS:UniProtKB
Q9NY72	SCN3B	Sodium channel subunit beta-3	GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL
P35499	SCN4A	Sodium channel protein type 4 subunit alpha	GO:0005248; F:voltage-gated sodium channel activity; IBA:RefGenome
P35499	SCN4A	Sodium channel protein type 4 subunit alpha	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
P35499	SCN4A	Sodium channel protein type 4 subunit alpha	GO:0006936; P:muscle contraction; TAS:ProtInc
P35499	SCN4A	Sodium channel protein type 4 subunit alpha	GO:0019228; P:neuronal action potential; IBA:RefGenome
P35499	SCN4A	Sodium channel protein type 4 subunit alpha	GO:0035725; P:sodium ion transmembrane transport; IBA:RefGenome
P35499	SCN4A	Sodium channel protein type 4 subunit alpha	GO:0006814; P:sodium ion transport; TAS:ProtInc
Q8IWT1	SCN4B	Sodium channel subunit beta-4	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q8IWT1	SCN4B	Sodium channel subunit beta-4	GO:0017080; F:sodium channel regulator activity; IDA:UniProtKB
Q8IWT1	SCN4B	Sodium channel subunit beta-4	GO:0005248; F:voltage-gated sodium channel activity; IDA:UniProtKB
Q8IWT1	SCN4B	Sodium channel subunit beta-4	GO:0086006; F:voltage-gated sodium channel activity involved in cardiac muscle cell action potential; IMP:BHF-UCL
Q8IWT1	SCN4B	Sodium channel subunit beta-4	GO:0086067; P:AV node cell to bundle of His cell communication; IMP:BHF-UCL
Q8IWT1	SCN4B	Sodium channel subunit beta-4	GO:0086002; P:cardiac muscle cell action potential involved in contraction; IMP:BHF-UCL
Q8IWT1	SCN4B	Sodium channel subunit beta-4	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
Q8IWT1	SCN4B	Sodium channel subunit beta-4	GO:0086012; P:membrane depolarization during cardiac muscle cell action potential; IMP:BHF-UCL
Q8IWT1	SCN4B	Sodium channel subunit beta-4	GO:0010765; P:positive regulation of sodium ion transport; IDA:BHF-UCL
Q8IWT1	SCN4B	Sodium channel subunit beta-4	GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL
Q8IWT1	SCN4B	Sodium channel subunit beta-4	GO:2000649; P:regulation of sodium ion transmembrane transporter activity; IDA:UniProtKB
Q8IWT1	SCN4B	Sodium channel subunit beta-4	GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL
Q8IWT1	SCN4B	Sodium channel subunit beta-4	GO:0035725; P:sodium ion transmembrane transport; IDA:BHF-UCL
Q8IWT1	SCN4B	Sodium channel subunit beta-4	GO:0006814; P:sodium ion transport; IDA:UniProtKB
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0030506; F:ankyrin binding; IDA:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0005516; F:calmodulin binding; IPI:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0019899; F:enzyme binding; IPI:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0017134; F:fibroblast growth factor binding; IPI:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0050998; F:nitric-oxide synthase binding; IPI:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0005515; F:protein binding; IPI:IntAct
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0097110; F:scaffold protein binding; IPI:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0031625; F:ubiquitin protein ligase binding; IPI:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0005248; F:voltage-gated sodium channel activity; IDA:UniProtKB
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0086006; F:voltage-gated sodium channel activity involved in cardiac muscle cell action potential; IDA:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0086067; P:AV node cell to bundle of His cell communication; IMP:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0003360; P:brainstem development; ISS:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0086069; P:bundle of His cell to Purkinje myocyte communication; IMP:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0086002; P:cardiac muscle cell action potential involved in contraction; IMP:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0003231; P:cardiac ventricle development; ISS:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0071277; P:cellular response to calcium ion; IDA:UniProtKB
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0021549; P:cerebellum development; ISS:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0051899; P:membrane depolarization; IDA:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0086010; P:membrane depolarization during action potential; IDA:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0086012; P:membrane depolarization during cardiac muscle cell action potential; IMP:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0086046; P:membrane depolarization during SA node cell action potential; ISS:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0019228; P:neuronal action potential; IBA:RefGenome
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0042475; P:odontogenesis of dentin-containing tooth; ISS:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0045760; P:positive regulation of action potential; ISS:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0050679; P:positive regulation of epithelial cell proliferation; ISS:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0010765; P:positive regulation of sodium ion transport; IDA:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0060371; P:regulation of atrial cardiac muscle cell membrane depolarization; IMP:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0060372; P:regulation of atrial cardiac muscle cell membrane repolarization; IMP:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0086004; P:regulation of cardiac muscle cell contraction; IMP:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0002027; P:regulation of heart rate; IMP:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:1902305; P:regulation of sodium ion transmembrane transport; IDA:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0060373; P:regulation of ventricular cardiac muscle cell membrane depolarization; IMP:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0014894; P:response to denervation involved in regulation of muscle adaptation; ISS:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0086070; P:SA node cell to atrial cardiac muscle cell communication; IMP:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0035725; P:sodium ion transmembrane transport; IDA:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0006814; P:sodium ion transport; IDA:UniProtKB
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0021537; P:telencephalon development; ISS:BHF-UCL
Q14524	SCN5A	Sodium channel protein type 5 subunit alpha	GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL
Q01118	SCN7A	Sodium channel protein type 7 subunit alpha	GO:0005248; F:voltage-gated sodium channel activity; IBA:RefGenome
Q01118	SCN7A	Sodium channel protein type 7 subunit alpha	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q01118	SCN7A	Sodium channel protein type 7 subunit alpha	GO:0006936; P:muscle contraction; TAS:ProtInc
Q01118	SCN7A	Sodium channel protein type 7 subunit alpha	GO:0019228; P:neuronal action potential; IBA:RefGenome
Q01118	SCN7A	Sodium channel protein type 7 subunit alpha	GO:0055078; P:sodium ion homeostasis; IEA:Ensembl
Q01118	SCN7A	Sodium channel protein type 7 subunit alpha	GO:0035725; P:sodium ion transmembrane transport; IBA:RefGenome
Q01118	SCN7A	Sodium channel protein type 7 subunit alpha	GO:0006814; P:sodium ion transport; TAS:ProtInc
Q9UQD0	SCN8A	Sodium channel protein type 8 subunit alpha	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UQD0	SCN8A	Sodium channel protein type 8 subunit alpha	GO:0005248; F:voltage-gated sodium channel activity; IDA:UniProtKB
Q9UQD0	SCN8A	Sodium channel protein type 8 subunit alpha	GO:0007628; P:adult walking behavior; IEA:Ensembl
Q9UQD0	SCN8A	Sodium channel protein type 8 subunit alpha	GO:0007411; P:axon guidance; TAS:Reactome
Q9UQD0	SCN8A	Sodium channel protein type 8 subunit alpha	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q9UQD0	SCN8A	Sodium channel protein type 8 subunit alpha	GO:0007517; P:muscle organ development; IEA:Ensembl
Q9UQD0	SCN8A	Sodium channel protein type 8 subunit alpha	GO:0042552; P:myelination; ISS:BHF-UCL
Q9UQD0	SCN8A	Sodium channel protein type 8 subunit alpha	GO:0007399; P:nervous system development; TAS:ProtInc
Q9UQD0	SCN8A	Sodium channel protein type 8 subunit alpha	GO:0050905; P:neuromuscular process; IEA:Ensembl
Q9UQD0	SCN8A	Sodium channel protein type 8 subunit alpha	GO:0019228; P:neuronal action potential; IBA:RefGenome
Q9UQD0	SCN8A	Sodium channel protein type 8 subunit alpha	GO:0007422; P:peripheral nervous system development; ISS:BHF-UCL
Q9UQD0	SCN8A	Sodium channel protein type 8 subunit alpha	GO:0009636; P:response to toxic substance; IEA:Ensembl
Q9UQD0	SCN8A	Sodium channel protein type 8 subunit alpha	GO:0007605; P:sensory perception of sound; IEA:Ensembl
Q9UQD0	SCN8A	Sodium channel protein type 8 subunit alpha	GO:0035725; P:sodium ion transmembrane transport; IDA:GOC
Q9UQD0	SCN8A	Sodium channel protein type 8 subunit alpha	GO:0006814; P:sodium ion transport; NAS:UniProtKB
Q15858	SCN9A	Sodium channel protein type 9 subunit alpha	GO:0031402; F:sodium ion binding; IEA:Ensembl
Q15858	SCN9A	Sodium channel protein type 9 subunit alpha	GO:0005248; F:voltage-gated sodium channel activity; IBA:RefGenome
Q15858	SCN9A	Sodium channel protein type 9 subunit alpha	GO:0048266; P:behavioral response to pain; IEA:Ensembl
Q15858	SCN9A	Sodium channel protein type 9 subunit alpha	GO:0006954; P:inflammatory response; IEA:Ensembl
Q15858	SCN9A	Sodium channel protein type 9 subunit alpha	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q15858	SCN9A	Sodium channel protein type 9 subunit alpha	GO:0019228; P:neuronal action potential; IBA:RefGenome
Q15858	SCN9A	Sodium channel protein type 9 subunit alpha	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q15858	SCN9A	Sodium channel protein type 9 subunit alpha	GO:0009636; P:response to toxic substance; IEA:Ensembl
Q15858	SCN9A	Sodium channel protein type 9 subunit alpha	GO:0035725; P:sodium ion transmembrane transport; IBA:RefGenome
Q15858	SCN9A	Sodium channel protein type 9 subunit alpha	GO:0006814; P:sodium ion transport; TAS:ProtInc
Q9Y5Y9	SCN10A	Sodium channel protein type 10 subunit alpha	GO:0005248; F:voltage-gated sodium channel activity; IDA:BHF-UCL
Q9Y5Y9	SCN10A	Sodium channel protein type 10 subunit alpha	GO:0086067; P:AV node cell to bundle of His cell communication; IMP:BHF-UCL
Q9Y5Y9	SCN10A	Sodium channel protein type 10 subunit alpha	GO:0086069; P:bundle of His cell to Purkinje myocyte communication; IMP:BHF-UCL
Q9Y5Y9	SCN10A	Sodium channel protein type 10 subunit alpha	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q9Y5Y9	SCN10A	Sodium channel protein type 10 subunit alpha	GO:0019228; P:neuronal action potential; IBA:RefGenome
Q9Y5Y9	SCN10A	Sodium channel protein type 10 subunit alpha	GO:0060371; P:regulation of atrial cardiac muscle cell membrane depolarization; IMP:BHF-UCL
Q9Y5Y9	SCN10A	Sodium channel protein type 10 subunit alpha	GO:0055117; P:regulation of cardiac muscle contraction; IMP:BHF-UCL
Q9Y5Y9	SCN10A	Sodium channel protein type 10 subunit alpha	GO:0002027; P:regulation of heart rate; IMP:BHF-UCL
Q9Y5Y9	SCN10A	Sodium channel protein type 10 subunit alpha	GO:0034765; P:regulation of ion transmembrane transport; IDA:BHF-UCL
Q9Y5Y9	SCN10A	Sodium channel protein type 10 subunit alpha	GO:0007600; P:sensory perception; TAS:ProtInc
Q9Y5Y9	SCN10A	Sodium channel protein type 10 subunit alpha	GO:0035725; P:sodium ion transmembrane transport; IDA:BHF-UCL
Q9Y5Y9	SCN10A	Sodium channel protein type 10 subunit alpha	GO:0006814; P:sodium ion transport; TAS:ProtInc
Q9UI33	SCN11A	Sodium channel protein type 11 subunit alpha	GO:0005248; F:voltage-gated sodium channel activity; IBA:RefGenome
Q9UI33	SCN11A	Sodium channel protein type 11 subunit alpha	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q9UI33	SCN11A	Sodium channel protein type 11 subunit alpha	GO:0019228; P:neuronal action potential; IBA:RefGenome
Q9UI33	SCN11A	Sodium channel protein type 11 subunit alpha	GO:0051930; P:regulation of sensory perception of pain; ISS:UniProtKB
Q9UI33	SCN11A	Sodium channel protein type 11 subunit alpha	GO:0042493; P:response to drug; TAS:ProtInc
Q9UI33	SCN11A	Sodium channel protein type 11 subunit alpha	GO:0035725; P:sodium ion transmembrane transport; IBA:RefGenome
Q9UI33	SCN11A	Sodium channel protein type 11 subunit alpha	GO:0006814; P:sodium ion transport; TAS:ProtInc
P57086	SCAND1	SCAN domain-containing protein 1	GO:0042802; F:identical protein binding; ISS:UniProtKB
P57086	SCAND1	SCAN domain-containing protein 1	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
P57086	SCAND1	SCAN domain-containing protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
P57086	SCAND1	SCAN domain-containing protein 1	GO:0003713; F:transcription coactivator activity; IBA:RefGenome
P57086	SCAND1	SCAN domain-containing protein 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
P57086	SCAND1	SCAN domain-containing protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q9GZW5	SCAND2P	Putative SCAN domain-containing protein SCAND2P	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q6R2W3	SCAND3	SCAN domain-containing protein 3	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q6R2W3	SCAND3	SCAN domain-containing protein 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q6R2W3	SCAND3	SCAN domain-containing protein 3	GO:0015074; P:DNA integration; IEA:InterPro
Q9BWG6	SCNM1	Sodium channel modifier 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BWG6	SCNM1	Sodium channel modifier 1	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9BWG6	SCNM1	Sodium channel modifier 1	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
P37088	SCNN1A	Amiloride-sensitive sodium channel subunit alpha	GO:0015280; F:ligand-gated sodium channel activity; IEA:Ensembl
P37088	SCNN1A	Amiloride-sensitive sodium channel subunit alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P37088	SCNN1A	Amiloride-sensitive sodium channel subunit alpha	GO:0050699; F:WW domain binding; IPI:BHF-UCL
P37088	SCNN1A	Amiloride-sensitive sodium channel subunit alpha	GO:0007588; P:excretion; TAS:ProtInc
P37088	SCNN1A	Amiloride-sensitive sodium channel subunit alpha	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P37088	SCNN1A	Amiloride-sensitive sodium channel subunit alpha	GO:0050891; P:multicellular organismal water homeostasis; IDA:UniProtKB
P37088	SCNN1A	Amiloride-sensitive sodium channel subunit alpha	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
P37088	SCNN1A	Amiloride-sensitive sodium channel subunit alpha	GO:0050909; P:sensory perception of taste; IEA:UniProtKB-KW
P37088	SCNN1A	Amiloride-sensitive sodium channel subunit alpha	GO:0055078; P:sodium ion homeostasis; IDA:UniProtKB
P37088	SCNN1A	Amiloride-sensitive sodium channel subunit alpha	GO:0035725; P:sodium ion transmembrane transport; IDA:UniProtKB
P37088	SCNN1A	Amiloride-sensitive sodium channel subunit alpha	GO:0006814; P:sodium ion transport; TAS:ProtInc
P37088	SCNN1A	Amiloride-sensitive sodium channel subunit alpha	GO:0055085; P:transmembrane transport; TAS:Reactome
P51168	SCNN1B	Amiloride-sensitive sodium channel subunit beta	GO:0015280; F:ligand-gated sodium channel activity; TAS:ProtInc
P51168	SCNN1B	Amiloride-sensitive sodium channel subunit beta	GO:0005515; F:protein binding; IPI:UniProtKB
P51168	SCNN1B	Amiloride-sensitive sodium channel subunit beta	GO:0050699; F:WW domain binding; IPI:BHF-UCL
P51168	SCNN1B	Amiloride-sensitive sodium channel subunit beta	GO:0007588; P:excretion; TAS:ProtInc
P51168	SCNN1B	Amiloride-sensitive sodium channel subunit beta	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P51168	SCNN1B	Amiloride-sensitive sodium channel subunit beta	GO:0050891; P:multicellular organismal water homeostasis; IDA:UniProtKB
P51168	SCNN1B	Amiloride-sensitive sodium channel subunit beta	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
P51168	SCNN1B	Amiloride-sensitive sodium channel subunit beta	GO:0050909; P:sensory perception of taste; IEA:UniProtKB-KW
P51168	SCNN1B	Amiloride-sensitive sodium channel subunit beta	GO:0055078; P:sodium ion homeostasis; IDA:UniProtKB
P51168	SCNN1B	Amiloride-sensitive sodium channel subunit beta	GO:0035725; P:sodium ion transmembrane transport; IDA:UniProtKB
P51168	SCNN1B	Amiloride-sensitive sodium channel subunit beta	GO:0006814; P:sodium ion transport; TAS:ProtInc
P51168	SCNN1B	Amiloride-sensitive sodium channel subunit beta	GO:0055085; P:transmembrane transport; TAS:Reactome
P51172	SCNN1D	Amiloride-sensitive sodium channel subunit delta	GO:0015280; F:ligand-gated sodium channel activity; TAS:ProtInc
P51172	SCNN1D	Amiloride-sensitive sodium channel subunit delta	GO:0005515; F:protein binding; IPI:IntAct
P51172	SCNN1D	Amiloride-sensitive sodium channel subunit delta	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P51172	SCNN1D	Amiloride-sensitive sodium channel subunit delta	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
P51172	SCNN1D	Amiloride-sensitive sodium channel subunit delta	GO:0050909; P:sensory perception of taste; IEA:UniProtKB-KW
P51172	SCNN1D	Amiloride-sensitive sodium channel subunit delta	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
P51172	SCNN1D	Amiloride-sensitive sodium channel subunit delta	GO:0006814; P:sodium ion transport; TAS:ProtInc
P51172	SCNN1D	Amiloride-sensitive sodium channel subunit delta	GO:0055085; P:transmembrane transport; TAS:Reactome
P51170	SCNN1G	Amiloride-sensitive sodium channel subunit gamma	GO:0015280; F:ligand-gated sodium channel activity; TAS:ProtInc
P51170	SCNN1G	Amiloride-sensitive sodium channel subunit gamma	GO:0005515; F:protein binding; IPI:UniProtKB
P51170	SCNN1G	Amiloride-sensitive sodium channel subunit gamma	GO:0005272; F:sodium channel activity; TAS:ProtInc
P51170	SCNN1G	Amiloride-sensitive sodium channel subunit gamma	GO:0050699; F:WW domain binding; IPI:BHF-UCL
P51170	SCNN1G	Amiloride-sensitive sodium channel subunit gamma	GO:0007588; P:excretion; TAS:ProtInc
P51170	SCNN1G	Amiloride-sensitive sodium channel subunit gamma	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P51170	SCNN1G	Amiloride-sensitive sodium channel subunit gamma	GO:0050891; P:multicellular organismal water homeostasis; IDA:UniProtKB
P51170	SCNN1G	Amiloride-sensitive sodium channel subunit gamma	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
P51170	SCNN1G	Amiloride-sensitive sodium channel subunit gamma	GO:0050909; P:sensory perception of taste; IEA:UniProtKB-KW
P51170	SCNN1G	Amiloride-sensitive sodium channel subunit gamma	GO:0055078; P:sodium ion homeostasis; IDA:UniProtKB
P51170	SCNN1G	Amiloride-sensitive sodium channel subunit gamma	GO:0035725; P:sodium ion transmembrane transport; IDA:UniProtKB
P51170	SCNN1G	Amiloride-sensitive sodium channel subunit gamma	GO:0006814; P:sodium ion transport; TAS:ProtInc
P51170	SCNN1G	Amiloride-sensitive sodium channel subunit gamma	GO:0055085; P:transmembrane transport; TAS:Reactome
O75880	SCO1	Protein SCO1 homolog, mitochondrial	GO:0005507; F:copper ion binding; IEA:InterPro
O75880	SCO1	Protein SCO1 homolog, mitochondrial	GO:0006878; P:cellular copper ion homeostasis; IEA:InterPro
O75880	SCO1	Protein SCO1 homolog, mitochondrial	GO:0006825; P:copper ion transport; IEA:InterPro
O75880	SCO1	Protein SCO1 homolog, mitochondrial	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
O75880	SCO1	Protein SCO1 homolog, mitochondrial	GO:0008535; P:respiratory chain complex IV assembly; TAS:ProtInc
O43819	SCO2	Protein SCO2 homolog, mitochondrial	GO:0005507; F:copper ion binding; NAS:UniProtKB
O43819	SCO2	Protein SCO2 homolog, mitochondrial	GO:0006878; P:cellular copper ion homeostasis; IEA:InterPro
O43819	SCO2	Protein SCO2 homolog, mitochondrial	GO:0006825; P:copper ion transport; IEA:InterPro
O43819	SCO2	Protein SCO2 homolog, mitochondrial	GO:0001654; P:eye development; IMP:UniProtKB
O43819	SCO2	Protein SCO2 homolog, mitochondrial	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O43819	SCO2	Protein SCO2 homolog, mitochondrial	GO:0003012; P:muscle system process; IEA:Ensembl
O43819	SCO2	Protein SCO2 homolog, mitochondrial	GO:0055114; P:oxidation-reduction process; TAS:UniProtKB
O43819	SCO2	Protein SCO2 homolog, mitochondrial	GO:0008535; P:respiratory chain complex IV assembly; IEA:Ensembl
O43819	SCO2	Protein SCO2 homolog, mitochondrial	GO:0022904; P:respiratory electron transport chain; IEA:Ensembl
O43819	SCO2	Protein SCO2 homolog, mitochondrial	GO:0014823; P:response to activity; IEA:Ensembl
Q9UIL1	SCOC	Short coiled-coil protein	GO:0005515; F:protein binding; IPI:IntAct
Q9UIL1	SCOC	Short coiled-coil protein	GO:0016239; P:positive regulation of macroautophagy; IDA:BHF-UCL
P55809	OXCT1	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial	GO:0008260; F:3-oxoacid CoA-transferase activity; IMP:UniProtKB
P55809	OXCT1	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial	GO:0042803; F:protein homodimerization activity; NAS:UniProtKB
P55809	OXCT1	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial	GO:0060612; P:adipose tissue development; IEA:Ensembl
P55809	OXCT1	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial	GO:0007420; P:brain development; IEA:Ensembl
P55809	OXCT1	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial	GO:0046950; P:cellular ketone body metabolic process; IMP:UniProtKB
P55809	OXCT1	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P55809	OXCT1	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial	GO:0071229; P:cellular response to acid; IEA:Ensembl
P55809	OXCT1	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
P55809	OXCT1	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial	GO:0007507; P:heart development; IEA:Ensembl
P55809	OXCT1	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial	GO:0046952; P:ketone body catabolic process; TAS:Reactome
P55809	OXCT1	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial	GO:0042182; P:ketone catabolic process; IEA:Ensembl
P55809	OXCT1	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial	GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl
P55809	OXCT1	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial	GO:0014823; P:response to activity; IEA:Ensembl
P55809	OXCT1	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial	GO:0042493; P:response to drug; IEA:Ensembl
P55809	OXCT1	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial	GO:0045471; P:response to ethanol; IEA:Ensembl
P55809	OXCT1	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial	GO:0009725; P:response to hormone; IEA:Ensembl
P55809	OXCT1	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial	GO:0007584; P:response to nutrient; IEA:Ensembl
P55809	OXCT1	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial	GO:0042594; P:response to starvation; IEA:Ensembl
P55809	OXCT1	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BYC2	OXCT2	Succinyl-CoA:3-ketoacid coenzyme A transferase 2, mitochondrial	GO:0008260; F:3-oxoacid CoA-transferase activity; IEA:UniProtKB-EC
Q9BYC2	OXCT2	Succinyl-CoA:3-ketoacid coenzyme A transferase 2, mitochondrial	GO:0046952; P:ketone body catabolic process; IEA:InterPro
Q9UJQ7	SCP2D1	SCP2 sterol-binding domain-containing protein 1	GO:0032934; F:sterol binding; IEA:InterPro
Q8NBX0	SCCPDH	Saccharopine dehydrogenase-like oxidoreductase	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0005545; F:1-phosphatidylinositol binding; TAS:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0034186; F:apolipoprotein A-I binding; IPI:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0034185; F:apolipoprotein binding; IPI:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0008035; F:high-density lipoprotein particle binding; IEA:Ensembl
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0070506; F:high-density lipoprotein particle receptor activity; IDA:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0001530; F:lipopolysaccharide binding; IDA:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0001875; F:lipopolysaccharide receptor activity; IDA:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0030169; F:low-density lipoprotein particle binding; IDA:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0001786; F:phosphatidylserine binding; ISS:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0005515; F:protein binding; IPI:IntAct
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0005215; F:transporter activity; TAS:ProtInc
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0051856; ?:?; IMP:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0006702; P:androgen biosynthetic process; IEA:Ensembl
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0043534; P:blood vessel endothelial cell migration; IEA:Ensembl
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0007155; P:cell adhesion; IEA:InterPro
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0006707; P:cholesterol catabolic process; IEA:Ensembl
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0033344; P:cholesterol efflux; ISS:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0042632; P:cholesterol homeostasis; ISS:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0070508; P:cholesterol import; ISS:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0032497; P:detection of lipopolysaccharide; IDA:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0001935; P:endothelial cell proliferation; IEA:Ensembl
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0034384; P:high-density lipoprotein particle clearance; IDA:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0034375; P:high-density lipoprotein particle remodeling; ISS:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0015920; P:lipopolysaccharide transport; IDA:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IDA:GOC
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0034383; P:low-density lipoprotein particle clearance; ISS:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0015914; P:phospholipid transport; ISS:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0010886; P:positive regulation of cholesterol storage; IDA:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0010595; P:positive regulation of endothelial cell migration; TAS:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0051000; P:positive regulation of nitric-oxide synthase activity; IDA:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0010867; P:positive regulation of triglyceride biosynthetic process; ISS:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0006898; P:receptor-mediated endocytosis; IDA:GOC
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0043654; P:recognition of apoptotic cell; IDA:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0050764; P:regulation of phagocytosis; IC:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0010899; P:regulation of phosphatidylcholine catabolic process; ISS:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0043691; P:reverse cholesterol transport; IEP:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0070328; P:triglyceride homeostasis; ISS:BHF-UCL
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q8WTV0	SCARB1	Scavenger receptor class B member 1	GO:0042060; P:wound healing; TAS:BHF-UCL
Q14108	SCARB2	Lysosome membrane protein 2	GO:0019899; F:enzyme binding; IPI:BHF-UCL
Q14108	SCARB2	Lysosome membrane protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q14108	SCARB2	Lysosome membrane protein 2	GO:0004872; F:receptor activity; IEA:InterPro
Q14108	SCARB2	Lysosome membrane protein 2	GO:0007155; P:cell adhesion; IEA:InterPro
Q14108	SCARB2	Lysosome membrane protein 2	GO:0006622; P:protein targeting to lysosome; IMP:BHF-UCL
O75711	SCRG1	Scrapie-responsive protein 1	GO:0007399; P:nervous system development; TAS:ProtInc
Q14160	SCRIB	Protein scribble homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q14160	SCRIB	Protein scribble homolog	GO:0032863; P:activation of Rac GTPase activity; IMP:UniProtKB
Q14160	SCRIB	Protein scribble homolog	GO:0060561; P:apoptotic process involved in morphogenesis; IMP:UniProtKB
Q14160	SCRIB	Protein scribble homolog	GO:0043615; P:astrocyte cell migration; IEA:Ensembl
Q14160	SCRIB	Protein scribble homolog	GO:0008105; P:asymmetric protein localization; IEA:Ensembl
Q14160	SCRIB	Protein scribble homolog	GO:0016477; P:cell migration; IMP:UniProtKB
Q14160	SCRIB	Protein scribble homolog	GO:0008283; P:cell proliferation; IDA:UniProtKB
Q14160	SCRIB	Protein scribble homolog	GO:0016337; P:single organismal cell-cell adhesion; IGI:UniProtKB
Q14160	SCRIB	Protein scribble homolog	GO:0035089; P:establishment of apical/basal cell polarity; IMP:UniProtKB
Q14160	SCRIB	Protein scribble homolog	GO:0060603; P:mammary gland duct morphogenesis; ISS:UniProtKB
Q14160	SCRIB	Protein scribble homolog	GO:0045930; P:negative regulation of mitotic cell cycle; IDA:UniProtKB
Q14160	SCRIB	Protein scribble homolog	GO:0001843; P:neural tube closure; IMP:UniProtKB
Q14160	SCRIB	Protein scribble homolog	GO:0050918; P:positive chemotaxis; IMP:UniProtKB
Q14160	SCRIB	Protein scribble homolog	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q14160	SCRIB	Protein scribble homolog	GO:0001921; P:positive regulation of receptor recycling; IMP:UniProtKB
Q14160	SCRIB	Protein scribble homolog	GO:0071896; P:protein localization to adherens junction; IMP:BHF-UCL
Q14160	SCRIB	Protein scribble homolog	GO:0048488; P:synaptic vesicle endocytosis; IEA:Ensembl
Q14160	SCRIB	Protein scribble homolog	GO:0016080; P:synaptic vesicle targeting; IEA:Ensembl
Q14160	SCRIB	Protein scribble homolog	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q14160	SCRIB	Protein scribble homolog	GO:0042060; P:wound healing; IEA:Ensembl
Q12765	SCRN1	Secernin-1	GO:0016805; F:dipeptidase activity; IEA:InterPro
Q12765	SCRN1	Secernin-1	GO:0006887; P:exocytosis; ISS:UniProtKB
Q96FV2	SCRN2	Secernin-2	GO:0016805; F:dipeptidase activity; IEA:InterPro
Q0VDG4	SCRN3	Secernin-3	GO:0016805; F:dipeptidase activity; IEA:InterPro
Q9BWW7	SCRT1	Transcriptional repressor scratch 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BWW7	SCRT1	Transcriptional repressor scratch 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BWW7	SCRT1	Transcriptional repressor scratch 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9BWW7	SCRT1	Transcriptional repressor scratch 1	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q9BWW7	SCRT1	Transcriptional repressor scratch 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NQ03	SCRT2	Transcriptional repressor scratch 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NQ03	SCRT2	Transcriptional repressor scratch 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NQ03	SCRT2	Transcriptional repressor scratch 2	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IC:BHF-UCL
Q9NQ03	SCRT2	Transcriptional repressor scratch 2	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; ISS:BHF-UCL
Q9NQ03	SCRT2	Transcriptional repressor scratch 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q8WVN6	SECTM1	Secreted and transmembrane protein 1	GO:0005125; F:cytokine activity; TAS:ProtInc
Q8WVN6	SECTM1	Secreted and transmembrane protein 1	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q8WVN6	SECTM1	Secreted and transmembrane protein 1	GO:0006955; P:immune response; TAS:ProtInc
Q8WVN6	SECTM1	Secreted and transmembrane protein 1	GO:0007498; P:mesoderm development; TAS:ProtInc
Q8WVN6	SECTM1	Secreted and transmembrane protein 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q8WVN6	SECTM1	Secreted and transmembrane protein 1	GO:0007165; P:signal transduction; IMP:GOC
P47872	SCTR	Secretin receptor	GO:0015055; F:secretin receptor activity; TAS:ProtInc
P47872	SCTR	Secretin receptor	GO:0007586; P:digestion; TAS:ProtInc
P47872	SCTR	Secretin receptor	GO:0007588; P:excretion; TAS:ProtInc
P47872	SCTR	Secretin receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q8IWY4	SCUBE1	Signal peptide, CUB and EGF-like domain-containing protein 1	GO:0005509; F:calcium ion binding; TAS:UniProtKB
Q8IWY4	SCUBE1	Signal peptide, CUB and EGF-like domain-containing protein 1	GO:0042802; F:identical protein binding; IDA:MGI
Q8IWY4	SCUBE1	Signal peptide, CUB and EGF-like domain-containing protein 1	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
Q8IWY4	SCUBE1	Signal peptide, CUB and EGF-like domain-containing protein 1	GO:0007512; P:adult heart development; NAS:UniProtKB
Q8IWY4	SCUBE1	Signal peptide, CUB and EGF-like domain-containing protein 1	GO:0007596; P:blood coagulation; NAS:UniProtKB
Q8IWY4	SCUBE1	Signal peptide, CUB and EGF-like domain-containing protein 1	GO:0045446; P:endothelial cell differentiation; NAS:UniProtKB
Q8IWY4	SCUBE1	Signal peptide, CUB and EGF-like domain-containing protein 1	GO:0006954; P:inflammatory response; NAS:UniProtKB
Q8IWY4	SCUBE1	Signal peptide, CUB and EGF-like domain-containing protein 1	GO:0009791; P:post-embryonic development; NAS:UniProtKB
Q8IWY4	SCUBE1	Signal peptide, CUB and EGF-like domain-containing protein 1	GO:0051260; P:protein homooligomerization; IPI:UniProtKB
Q9NQ36	SCUBE2	Signal peptide, CUB and EGF-like domain-containing protein 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8IX30	SCUBE3	Signal peptide, CUB and EGF-like domain-containing protein 3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8IX30	SCUBE3	Signal peptide, CUB and EGF-like domain-containing protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IX30	SCUBE3	Signal peptide, CUB and EGF-like domain-containing protein 3	GO:0051291; P:protein heterooligomerization; IPI:UniProtKB
Q8IX30	SCUBE3	Signal peptide, CUB and EGF-like domain-containing protein 3	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0043425; F:bHLH transcription factor binding; IPI:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0003677; F:DNA binding; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0030509; P:BMP signaling pathway; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0030154; P:cell differentiation; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0002062; P:chondrocyte differentiation; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0030199; P:collagen fibril organization; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0035993; P:deltoid tuberosity development; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0001958; P:endochondral ossification; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0003188; P:heart valve formation; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0003179; P:heart valve morphogenesis; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0001707; P:mesoderm formation; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0061036; P:positive regulation of cartilage development; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0032967; P:positive regulation of collagen biosynthetic process; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:2000543; P:positive regulation of gastrulation; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0061035; P:regulation of cartilage development; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0060008; P:Sertoli cell differentiation; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0035990; P:tendon cell differentiation; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0035989; P:tendon development; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0035992; P:tendon formation; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0001894; P:tissue homeostasis; ISS:UniProtKB
Q7RTU7	SCXA	Basic helix-loop-helix transcription factor scleraxis	GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB
Q6P3W7	SCYL2	SCY1-like protein 2	GO:0005524; F:ATP binding; IEA:InterPro
Q6P3W7	SCYL2	SCY1-like protein 2	GO:0005515; F:protein binding; IPI:BHF-UCL
Q6P3W7	SCYL2	SCY1-like protein 2	GO:0004672; F:protein kinase activity; IEA:InterPro
Q6P3W7	SCYL2	SCY1-like protein 2	GO:0005102; F:receptor binding; IPI:BHF-UCL
Q6P3W7	SCYL2	SCY1-like protein 2	GO:0008333; P:endosome to lysosome transport; IDA:BHF-UCL
Q6P3W7	SCYL2	SCY1-like protein 2	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:BHF-UCL
Q6P3W7	SCYL2	SCY1-like protein 2	GO:2000370; P:positive regulation of clathrin-mediated endocytosis; IDA:BHF-UCL
Q6P3W7	SCYL2	SCY1-like protein 2	GO:0002092; P:positive regulation of receptor internalization; IDA:BHF-UCL
Q6P3W7	SCYL2	SCY1-like protein 2	GO:2000286; P:receptor internalization involved in canonical Wnt signaling pathway; IDA:BHF-UCL
Q9NVU7	SDAD1	Protein SDA1 homolog	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
Q9NVU7	SDAD1	Protein SDA1 homolog	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9NVU7	SDAD1	Protein SDA1 homolog	GO:0042273; P:ribosomal large subunit biogenesis; ISS:UniProtKB
Q9NVU7	SDAD1	Protein SDA1 homolog	GO:0000055; P:ribosomal large subunit export from nucleus; IEA:InterPro
P18827	SDC1	Syndecan-1	GO:0005515; F:protein binding; IPI:UniProtKB
P18827	SDC1	Syndecan-1	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P18827	SDC1	Syndecan-1	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
P18827	SDC1	Syndecan-1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P18827	SDC1	Syndecan-1	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
P18827	SDC1	Syndecan-1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P18827	SDC1	Syndecan-1	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
P18827	SDC1	Syndecan-1	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
P18827	SDC1	Syndecan-1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P18827	SDC1	Syndecan-1	GO:0006954; P:inflammatory response; IEA:Ensembl
P18827	SDC1	Syndecan-1	GO:0042157; P:lipoprotein metabolic process; TAS:Reactome
P18827	SDC1	Syndecan-1	GO:0048627; P:myoblast development; ISS:UniProtKB
P18827	SDC1	Syndecan-1	GO:0042476; P:odontogenesis; IEA:Ensembl
P18827	SDC1	Syndecan-1	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P18827	SDC1	Syndecan-1	GO:0051592; P:response to calcium ion; IEA:Ensembl
P18827	SDC1	Syndecan-1	GO:0051591; P:response to cAMP; IEA:Ensembl
P18827	SDC1	Syndecan-1	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P18827	SDC1	Syndecan-1	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
P18827	SDC1	Syndecan-1	GO:0009636; P:response to toxic substance; IEA:Ensembl
P18827	SDC1	Syndecan-1	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P18827	SDC1	Syndecan-1	GO:0060009; P:Sertoli cell development; IEA:Ensembl
P18827	SDC1	Syndecan-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P18827	SDC1	Syndecan-1	GO:0055002; P:striated muscle cell development; IEP:UniProtKB
P18827	SDC1	Syndecan-1	GO:0001657; P:ureteric bud development; IEA:Ensembl
P18827	SDC1	Syndecan-1	GO:0042060; P:wound healing; IEA:Ensembl
P34741	SDC2	Syndecan-2	GO:0030165; F:PDZ domain binding; IPI:BHF-UCL
P34741	SDC2	Syndecan-2	GO:0005515; F:protein binding; IPI:IntAct
P34741	SDC2	Syndecan-2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P34741	SDC2	Syndecan-2	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
P34741	SDC2	Syndecan-2	GO:0048813; P:dendrite morphogenesis; IEA:Ensembl
P34741	SDC2	Syndecan-2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P34741	SDC2	Syndecan-2	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
P34741	SDC2	Syndecan-2	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
P34741	SDC2	Syndecan-2	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P34741	SDC2	Syndecan-2	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P34741	SDC2	Syndecan-2	GO:0048814; P:regulation of dendrite morphogenesis; ISS:UniProtKB
P34741	SDC2	Syndecan-2	GO:0031000; P:response to caffeine; IEA:Ensembl
P34741	SDC2	Syndecan-2	GO:0001666; P:response to hypoxia; IEA:Ensembl
P34741	SDC2	Syndecan-2	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P34741	SDC2	Syndecan-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P34741	SDC2	Syndecan-2	GO:0042060; P:wound healing; IEA:Ensembl
O75056	SDC3	Syndecan-3	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O75056	SDC3	Syndecan-3	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
O75056	SDC3	Syndecan-3	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O75056	SDC3	Syndecan-3	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
O75056	SDC3	Syndecan-3	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
O75056	SDC3	Syndecan-3	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
O75056	SDC3	Syndecan-3	GO:0007603; P:phototransduction, visible light; TAS:Reactome
O75056	SDC3	Syndecan-3	GO:0001523; P:retinoid metabolic process; TAS:Reactome
O75056	SDC3	Syndecan-3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P31431	SDC4	Syndecan-4	GO:0005515; F:protein binding; IPI:IntAct
P31431	SDC4	Syndecan-4	GO:0070053; F:thrombospondin receptor activity; IMP:BHF-UCL
P31431	SDC4	Syndecan-4	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P31431	SDC4	Syndecan-4	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
P31431	SDC4	Syndecan-4	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P31431	SDC4	Syndecan-4	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome
P31431	SDC4	Syndecan-4	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
P31431	SDC4	Syndecan-4	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P31431	SDC4	Syndecan-4	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P31431	SDC4	Syndecan-4	GO:0051894; P:positive regulation of focal adhesion assembly; IEA:Ensembl
P31431	SDC4	Syndecan-4	GO:0045860; P:positive regulation of protein kinase activity; IEA:Ensembl
P31431	SDC4	Syndecan-4	GO:0051496; P:positive regulation of stress fiber assembly; IEA:Ensembl
P31431	SDC4	Syndecan-4	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P31431	SDC4	Syndecan-4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P31431	SDC4	Syndecan-4	GO:0001657; P:ureteric bud development; IEA:Ensembl
O00560	SDCBP	Syntenin-1	GO:0008093; F:cytoskeletal adaptor activity; NAS:UniProtKB
O00560	SDCBP	Syntenin-1	GO:0005109; F:frizzled binding; IPI:BHF-UCL
O00560	SDCBP	Syntenin-1	GO:0042802; F:identical protein binding; IPI:IntAct
O00560	SDCBP	Syntenin-1	GO:0005137; F:interleukin-5 receptor binding; ISS:UniProtKB
O00560	SDCBP	Syntenin-1	GO:0005515; F:protein binding; IPI:IntAct
O00560	SDCBP	Syntenin-1	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
O00560	SDCBP	Syntenin-1	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
O00560	SDCBP	Syntenin-1	GO:0045545; F:syndecan binding; NAS:UniProtKB
O00560	SDCBP	Syntenin-1	GO:0030036; P:actin cytoskeleton organization; NAS:UniProtKB
O00560	SDCBP	Syntenin-1	GO:0007411; P:axon guidance; TAS:Reactome
O00560	SDCBP	Syntenin-1	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
O00560	SDCBP	Syntenin-1	GO:0046330; P:positive regulation of JNK cascade; IC:BHF-UCL
O00560	SDCBP	Syntenin-1	GO:0042327; P:positive regulation of phosphorylation; IDA:BHF-UCL
O00560	SDCBP	Syntenin-1	GO:0006612; P:protein targeting to membrane; NAS:UniProtKB
O00560	SDCBP	Syntenin-1	GO:0007265; P:Ras protein signal transduction; IEA:Ensembl
O00560	SDCBP	Syntenin-1	GO:0006930; P:substrate-dependent cell migration, cell extension; NAS:UniProtKB
O00560	SDCBP	Syntenin-1	GO:0007268; P:synaptic transmission; NAS:UniProtKB
Q9H190	SDCBP2	Syntenin-2	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q9H190	SDCBP2	Syntenin-2	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q9H190	SDCBP2	Syntenin-2	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q9H190	SDCBP2	Syntenin-2	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
Q9H190	SDCBP2	Syntenin-2	GO:0046907; P:intracellular transport; NAS:UniProtKB
Q9H190	SDCBP2	Syntenin-2	GO:0007399; P:nervous system development; NAS:UniProtKB
Q86SQ7	SDCCAG8	Serologically defined colon cancer antigen 8	GO:0005515; F:protein binding; IPI:UniProtKB
Q86SQ7	SDCCAG8	Serologically defined colon cancer antigen 8	GO:0030010; P:establishment of cell polarity; ISS:UniProtKB
Q86SQ7	SDCCAG8	Serologically defined colon cancer antigen 8	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q86SQ7	SDCCAG8	Serologically defined colon cancer antigen 8	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q86SQ7	SDCCAG8	Serologically defined colon cancer antigen 8	GO:0035148; P:tube formation; ISS:UniProtKB
P48061	CXCL12	Stromal cell-derived factor 1	GO:0008009; F:chemokine activity; TAS:UniProtKB
P48061	CXCL12	Stromal cell-derived factor 1	GO:0042379; F:chemokine receptor binding; IMP:UniProtKB
P48061	CXCL12	Stromal cell-derived factor 1	GO:0045236; F:CXCR chemokine receptor binding; IDA:BHF-UCL
P48061	CXCL12	Stromal cell-derived factor 1	GO:0005102; F:receptor binding; TAS:ProtInc
P48061	CXCL12	Stromal cell-derived factor 1	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P48061	CXCL12	Stromal cell-derived factor 1	GO:0001667; P:ameboidal cell migration; IEA:Ensembl
P48061	CXCL12	Stromal cell-derived factor 1	GO:0008015; P:blood circulation; TAS:ProtInc
P48061	CXCL12	Stromal cell-derived factor 1	GO:0007155; P:cell adhesion; TAS:ProtInc
P48061	CXCL12	Stromal cell-derived factor 1	GO:0060326; P:cell chemotaxis; TAS:GOC
P48061	CXCL12	Stromal cell-derived factor 1	GO:0006874; P:cellular calcium ion homeostasis; TAS:ProtInc
P48061	CXCL12	Stromal cell-derived factor 1	GO:0070098; P:chemokine-mediated signaling pathway; IDA:BHF-UCL
P48061	CXCL12	Stromal cell-derived factor 1	GO:0006935; P:chemotaxis; TAS:UniProtKB
P48061	CXCL12	Stromal cell-derived factor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P48061	CXCL12	Stromal cell-derived factor 1	GO:0007281; P:germ cell development; IEA:Ensembl
P48061	CXCL12	Stromal cell-derived factor 1	GO:0008354; P:germ cell migration; IEA:Ensembl
P48061	CXCL12	Stromal cell-derived factor 1	GO:0006955; P:immune response; TAS:ProtInc
P48061	CXCL12	Stromal cell-derived factor 1	GO:0050930; P:induction of positive chemotaxis; IEA:Ensembl
P48061	CXCL12	Stromal cell-derived factor 1	GO:0008045; P:motor neuron axon guidance; IEA:Ensembl
P48061	CXCL12	Stromal cell-derived factor 1	GO:1902230; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; IDA:BHF-UCL
P48061	CXCL12	Stromal cell-derived factor 1	GO:2000107; P:negative regulation of leukocyte apoptotic process; IDA:BHF-UCL
P48061	CXCL12	Stromal cell-derived factor 1	GO:0001764; P:neuron migration; IEA:Ensembl
P48061	CXCL12	Stromal cell-derived factor 1	GO:0031100; P:organ regeneration; IEA:Ensembl
P48061	CXCL12	Stromal cell-derived factor 1	GO:0001569; P:patterning of blood vessels; IEA:Ensembl
P48061	CXCL12	Stromal cell-derived factor 1	GO:0048842; P:positive regulation of axon extension involved in axon guidance; IEA:Ensembl
P48061	CXCL12	Stromal cell-derived factor 1	GO:0090280; P:positive regulation of calcium ion import; TAS:BHF-UCL
P48061	CXCL12	Stromal cell-derived factor 1	GO:0033603; P:positive regulation of dopamine secretion; IEA:Ensembl
P48061	CXCL12	Stromal cell-derived factor 1	GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl
P48061	CXCL12	Stromal cell-derived factor 1	GO:0090026; P:positive regulation of monocyte chemotaxis; IDA:UniProtKB
P48061	CXCL12	Stromal cell-derived factor 1	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P48061	CXCL12	Stromal cell-derived factor 1	GO:0008064; P:regulation of actin polymerization or depolymerization; TAS:ProtInc
P48061	CXCL12	Stromal cell-derived factor 1	GO:0009408; P:response to heat; IEA:Ensembl
P48061	CXCL12	Stromal cell-derived factor 1	GO:0001666; P:response to hypoxia; IEA:Ensembl
P48061	CXCL12	Stromal cell-derived factor 1	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P48061	CXCL12	Stromal cell-derived factor 1	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P48061	CXCL12	Stromal cell-derived factor 1	GO:0009314; P:response to radiation; IEA:Ensembl
P48061	CXCL12	Stromal cell-derived factor 1	GO:0009615; P:response to virus; TAS:ProtInc
P48061	CXCL12	Stromal cell-derived factor 1	GO:0007165; P:signal transduction; TAS:ProtInc
P48061	CXCL12	Stromal cell-derived factor 1	GO:0042098; P:T cell proliferation; IEA:Ensembl
P48061	CXCL12	Stromal cell-derived factor 1	GO:0022029; P:telencephalon cell migration; IEA:Ensembl
Q99470	SDF2	Stromal cell-derived factor 2	GO:0004169; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; TAS:ProtInc
Q99470	SDF2	Stromal cell-derived factor 2	GO:0006486; P:protein glycosylation; TAS:ProtInc
Q99470	SDF2	Stromal cell-derived factor 2	GO:0035269; P:protein O-linked mannosylation; TAS:GOC
P31040	SDHA	Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
P31040	SDHA	Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
P31040	SDHA	Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial	GO:0008177; F:succinate dehydrogenase (ubiquinone) activity; IEA:UniProtKB-EC
P31040	SDHA	Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P31040	SDHA	Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial	GO:0007399; P:nervous system development; IMP:UniProtKB
P31040	SDHA	Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
P31040	SDHA	Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial	GO:0022904; P:respiratory electron transport chain; IDA:UniProtKB
P31040	SDHA	Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P31040	SDHA	Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial	GO:0006105; P:succinate metabolic process; IDA:UniProtKB
P31040	SDHA	Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; TAS:UniProtKB
P21912	SDHB	Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial	GO:0051537; F:2 iron, 2 sulfur cluster binding; ISS:UniProtKB
P21912	SDHB	Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial	GO:0051538; F:3 iron, 4 sulfur cluster binding; ISS:UniProtKB
P21912	SDHB	Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial	GO:0051539; F:4 iron, 4 sulfur cluster binding; ISS:UniProtKB
P21912	SDHB	Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial	GO:0009055; F:electron carrier activity; IEA:InterPro
P21912	SDHB	Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P21912	SDHB	Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
P21912	SDHB	Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial	GO:0008177; F:succinate dehydrogenase (ubiquinone) activity; IEA:UniProtKB-EC
P21912	SDHB	Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial	GO:0048039; F:ubiquinone binding; ISS:UniProtKB
P21912	SDHB	Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial	GO:0009060; P:aerobic respiration; TAS:ProtInc
P21912	SDHB	Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P21912	SDHB	Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P21912	SDHB	Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P21912	SDHB	Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial	GO:0006105; P:succinate metabolic process; IEA:Ensembl
P21912	SDHB	Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; TAS:Reactome
A6NFY7	SDHAF1	Succinate dehydrogenase assembly factor 1, mitochondrial	GO:0016226; P:iron-sulfur cluster assembly; NAS:UniProtKB
A6NFY7	SDHAF1	Succinate dehydrogenase assembly factor 1, mitochondrial	GO:0034553; P:mitochondrial respiratory chain complex II assembly; IMP:UniProtKB
Q9NX18	SDHAF2	Succinate dehydrogenase assembly factor 2, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NX18	SDHAF2	Succinate dehydrogenase assembly factor 2, mitochondrial	GO:0006121; P:mitochondrial electron transport, succinate to ubiquinone; IMP:UniProtKB
Q9NX18	SDHAF2	Succinate dehydrogenase assembly factor 2, mitochondrial	GO:0018293; P:protein-FAD linkage; IMP:UniProtKB
P20132	SDS	L-serine dehydratase/L-threonine deaminase	GO:0003941; F:L-serine ammonia-lyase activity; IDA:UniProtKB
P20132	SDS	L-serine dehydratase/L-threonine deaminase	GO:0004794; F:L-threonine ammonia-lyase activity; IEA:UniProtKB-EC
P20132	SDS	L-serine dehydratase/L-threonine deaminase	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P20132	SDS	L-serine dehydratase/L-threonine deaminase	GO:0030170; F:pyridoxal phosphate binding; IDA:UniProtKB
P20132	SDS	L-serine dehydratase/L-threonine deaminase	GO:0006094; P:gluconeogenesis; IEA:UniProtKB-UniPathway
P20132	SDS	L-serine dehydratase/L-threonine deaminase	GO:0006565; P:L-serine catabolic process; IDA:UniProtKB
P20132	SDS	L-serine dehydratase/L-threonine deaminase	GO:0042866; P:pyruvate biosynthetic process; IDA:UniProtKB
P20132	SDS	L-serine dehydratase/L-threonine deaminase	GO:0043200; P:response to amino acid; IEA:Ensembl
P20132	SDS	L-serine dehydratase/L-threonine deaminase	GO:0033590; P:response to cobalamin; IEA:Ensembl
Q6ZPB5	SDIM1	Stress-responsive DNAJB4-interacting membrane protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q6ZPB5	SDIM1	Stress-responsive DNAJB4-interacting membrane protein 1	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q6ZPB5	SDIM1	Stress-responsive DNAJB4-interacting membrane protein 1	GO:0033554; P:cellular response to stress; IEP:UniProtKB
Q6ZPB5	SDIM1	Stress-responsive DNAJB4-interacting membrane protein 1	GO:0060548; P:negative regulation of cell death; IDA:UniProtKB
Q6ZPB5	SDIM1	Stress-responsive DNAJB4-interacting membrane protein 1	GO:0051402; P:neuron apoptotic process; IDA:UniProtKB
Q7Z5N4	SDK1	Protein sidekick-1	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q58EX2	SDK2	Protein sidekick-2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9BRJ7	NUDT16L1	Protein syndesmos	GO:0016787; F:hydrolase activity; IEA:InterPro
Q9BRJ7	NUDT16L1	Protein syndesmos	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BRJ7	NUDT16L1	Protein syndesmos	GO:0030515; F:snoRNA binding; IDA:UniProtKB
O95810	SDPR	Serum deprivation-response protein	GO:0001786; F:phosphatidylserine binding; IDA:UniProtKB
O95810	SDPR	Serum deprivation-response protein	GO:0005543; F:phospholipid binding; TAS:ProtInc
O95810	SDPR	Serum deprivation-response protein	GO:0005515; F:protein binding; IPI:IntAct
Q9H7L9	SUDS3	Sin3 histone deacetylase corepressor complex component SDS3	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9H7L9	SUDS3	Sin3 histone deacetylase corepressor complex component SDS3	GO:0042826; F:histone deacetylase binding; ISS:UniProtKB
Q9H7L9	SUDS3	Sin3 histone deacetylase corepressor complex component SDS3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H7L9	SUDS3	Sin3 histone deacetylase corepressor complex component SDS3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9H7L9	SUDS3	Sin3 histone deacetylase corepressor complex component SDS3	GO:0016575; P:histone deacetylation; IDA:UniProtKB
Q9H7L9	SUDS3	Sin3 histone deacetylase corepressor complex component SDS3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q9H7L9	SUDS3	Sin3 histone deacetylase corepressor complex component SDS3	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q9H7L9	SUDS3	Sin3 histone deacetylase corepressor complex component SDS3	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q9H7L9	SUDS3	Sin3 histone deacetylase corepressor complex component SDS3	GO:0021762; P:substantia nigra development; IEP:UniProt
Q9H7L9	SUDS3	Sin3 histone deacetylase corepressor complex component SDS3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96GA7	SDSL	Serine dehydratase-like	GO:0003941; F:L-serine ammonia-lyase activity; IEA:UniProtKB-EC
Q96GA7	SDSL	Serine dehydratase-like	GO:0004794; F:L-threonine ammonia-lyase activity; IEA:UniProtKB-EC
Q96GA7	SDSL	Serine dehydratase-like	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q96GA7	SDSL	Serine dehydratase-like	GO:0006520; P:cellular amino acid metabolic process; IEA:InterPro
Q9UBV2	SEL1L	Protein sel-1 homolog 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBV2	SEL1L	Protein sel-1 homolog 1	GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW
Q9UBV2	SEL1L	Protein sel-1 homolog 1	GO:0034976; P:response to endoplasmic reticulum stress; IEA:Ensembl
Q9BYH1	SEZ6L	Seizure 6-like protein	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
Q9BYH1	SEZ6L	Seizure 6-like protein	GO:0021680; P:cerebellar Purkinje cell layer development; IEA:Ensembl
Q9BYH1	SEZ6L	Seizure 6-like protein	GO:0090036; P:regulation of protein kinase C signaling; IEA:Ensembl
Q9BYH1	SEZ6L	Seizure 6-like protein	GO:0060074; P:synapse maturation; IEA:Ensembl
Q6UXD5	SEZ6L2	Seizure 6-like protein 2	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
Q6UXD5	SEZ6L2	Seizure 6-like protein 2	GO:0021680; P:cerebellar Purkinje cell layer development; IEA:Ensembl
Q6UXD5	SEZ6L2	Seizure 6-like protein 2	GO:0090036; P:regulation of protein kinase C signaling; IEA:Ensembl
Q6UXD5	SEZ6L2	Seizure 6-like protein 2	GO:0060074; P:synapse maturation; IEA:Ensembl
Q9HB31	SEBOX	Homeobox protein SEBOX	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9HB31	SEBOX	Homeobox protein SEBOX	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9HB31	SEBOX	Homeobox protein SEBOX	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9HB31	SEBOX	Homeobox protein SEBOX	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9HB31	SEBOX	Homeobox protein SEBOX	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96T21	SECISBP2	Selenocysteine insertion sequence-binding protein 2	GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB
Q96T21	SECISBP2	Selenocysteine insertion sequence-binding protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96T21	SECISBP2	Selenocysteine insertion sequence-binding protein 2	GO:0043021; F:ribonucleoprotein complex binding; IEA:Ensembl
Q96T21	SECISBP2	Selenocysteine insertion sequence-binding protein 2	GO:0035368; F:selenocysteine insertion sequence binding; IEA:Ensembl
Q96T21	SECISBP2	Selenocysteine insertion sequence-binding protein 2	GO:0006412; P:translation; IEA:UniProtKB-KW
P55735	SEC13	Protein SEC13 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
P55735	SEC13	Protein SEC13 homolog	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
P55735	SEC13	Protein SEC13 homolog	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P55735	SEC13	Protein SEC13 homolog	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P55735	SEC13	Protein SEC13 homolog	GO:0048208; P:COPII vesicle coating; TAS:Reactome
P55735	SEC13	Protein SEC13 homolog	GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:Reactome
P55735	SEC13	Protein SEC13 homolog	GO:0006886; P:intracellular protein transport; NAS:UniProtKB
P55735	SEC13	Protein SEC13 homolog	GO:0061024; P:membrane organization; TAS:Reactome
P55735	SEC13	Protein SEC13 homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P55735	SEC13	Protein SEC13 homolog	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
P55735	SEC13	Protein SEC13 homolog	GO:0043687; P:post-translational protein modification; TAS:Reactome
P55735	SEC13	Protein SEC13 homolog	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q12981	BNIP1	Vesicle transport protein SEC20	GO:0005515; F:protein binding; IPI:UniProtKB
Q12981	BNIP1	Vesicle transport protein SEC20	GO:0005484; F:SNAP receptor activity; IDA:FlyBase
Q12981	BNIP1	Vesicle transport protein SEC20	GO:0006915; P:apoptotic process; IPI:MGI
Q12981	BNIP1	Vesicle transport protein SEC20	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q12981	BNIP1	Vesicle transport protein SEC20	GO:0016320; P:endoplasmic reticulum membrane fusion; IMP:HGNC
Q12981	BNIP1	Vesicle transport protein SEC20	GO:0007029; P:endoplasmic reticulum organization; IMP:HGNC
Q12981	BNIP1	Vesicle transport protein SEC20	GO:0097194; P:execution phase of apoptosis; IC:BHF-UCL
Q12981	BNIP1	Vesicle transport protein SEC20	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
Q12981	BNIP1	Vesicle transport protein SEC20	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q99442	SEC62	Translocation protein SEC62	GO:0008565; F:protein transporter activity; IEA:InterPro
Q99442	SEC62	Translocation protein SEC62	GO:0004872; F:receptor activity; TAS:ProtInc
Q99442	SEC62	Translocation protein SEC62	GO:0006613; P:cotranslational protein targeting to membrane; TAS:ProtInc
Q99442	SEC62	Translocation protein SEC62	GO:0006620; P:posttranslational protein targeting to membrane; IMP:MGI
Q9UGP8	SEC63	Translocation protein SEC63 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UGP8	SEC63	Translocation protein SEC63 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q9UGP8	SEC63	Translocation protein SEC63 homolog	GO:0008565; F:protein transporter activity; IEA:InterPro
Q9UGP8	SEC63	Translocation protein SEC63 homolog	GO:0004872; F:receptor activity; TAS:ProtInc
Q9UGP8	SEC63	Translocation protein SEC63 homolog	GO:0001889; P:liver development; IEA:Ensembl
Q9UGP8	SEC63	Translocation protein SEC63 homolog	GO:0010259; P:multicellular organismal aging; IEA:Ensembl
Q9UGP8	SEC63	Translocation protein SEC63 homolog	GO:0006807; P:nitrogen compound metabolic process; IEA:Ensembl
Q9UGP8	SEC63	Translocation protein SEC63 homolog	GO:0006620; P:posttranslational protein targeting to membrane; IMP:MGI
Q9UGP8	SEC63	Translocation protein SEC63 homolog	GO:0031204; P:posttranslational protein targeting to membrane, translocation; IEA:InterPro
Q9UGP8	SEC63	Translocation protein SEC63 homolog	GO:0006612; P:protein targeting to membrane; TAS:ProtInc
Q9UGP8	SEC63	Translocation protein SEC63 homolog	GO:0072001; P:renal system development; IEA:Ensembl
Q9UGP8	SEC63	Translocation protein SEC63 homolog	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; IMP:MGI
P09683	SCT	Secretin	GO:0005179; F:hormone activity; NAS:UniProtKB
P09683	SCT	Secretin	GO:0021542; P:dentate gyrus development; IEA:Ensembl
P09683	SCT	Secretin	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P09683	SCT	Secretin	GO:0097150; P:neuronal stem cell maintenance; IEA:Ensembl
P09683	SCT	Secretin	GO:0030157; P:pancreatic juice secretion; NAS:UniProtKB
P09683	SCT	Secretin	GO:0008542; P:visual learning; IEA:Ensembl
O76038	SCGN	Secretagogin	GO:0005509; F:calcium ion binding; NAS:UniProtKB
Q96EE3	SEH1L	Nucleoporin SEH1	GO:0051315; P:attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; IMP:UniProtKB
Q96EE3	SEH1L	Nucleoporin SEH1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q96EE3	SEH1L	Nucleoporin SEH1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q96EE3	SEH1L	Nucleoporin SEH1	GO:0015758; P:glucose transport; TAS:Reactome
Q96EE3	SEH1L	Nucleoporin SEH1	GO:0008645; P:hexose transport; TAS:Reactome
Q96EE3	SEH1L	Nucleoporin SEH1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q96EE3	SEH1L	Nucleoporin SEH1	GO:0007080; P:mitotic metaphase plate congression; IMP:UniProtKB
Q96EE3	SEH1L	Nucleoporin SEH1	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
Q96EE3	SEH1L	Nucleoporin SEH1	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q96EE3	SEH1L	Nucleoporin SEH1	GO:0006999; P:nuclear pore organization; IMP:UniProtKB
Q96EE3	SEH1L	Nucleoporin SEH1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96EE3	SEH1L	Nucleoporin SEH1	GO:0010827; P:regulation of glucose transport; TAS:Reactome
Q96EE3	SEH1L	Nucleoporin SEH1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96EE3	SEH1L	Nucleoporin SEH1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q96EE3	SEH1L	Nucleoporin SEH1	GO:0016032; P:viral process; TAS:Reactome
Q9H4I8	SERHL2	Serine hydrolase-like protein 2	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
P57772	EEFSEC	Selenocysteine-specific elongation factor	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P57772	EEFSEC	Selenocysteine-specific elongation factor	GO:0003924; F:GTPase activity; IEA:Ensembl
P57772	EEFSEC	Selenocysteine-specific elongation factor	GO:0043021; F:ribonucleoprotein complex binding; IEA:Ensembl
P57772	EEFSEC	Selenocysteine-specific elongation factor	GO:0035368; F:selenocysteine insertion sequence binding; IEA:Ensembl
P57772	EEFSEC	Selenocysteine-specific elongation factor	GO:0003746; F:translation elongation factor activity; IEA:Ensembl
P57772	EEFSEC	Selenocysteine-specific elongation factor	GO:0000049; F:tRNA binding; IEA:Ensembl
P57772	EEFSEC	Selenocysteine-specific elongation factor	GO:0001514; P:selenocysteine incorporation; IEA:Ensembl
Q8IZQ5	SELH	Selenoprotein H	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IZQ5	SELH	Selenoprotein H	GO:0008430; F:selenium binding; IEA:InterPro
Q8IZQ5	SELH	Selenoprotein H	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q9Y6D0	SELK	Selenoprotein K	GO:0006816; P:calcium ion transport; IEA:UniProtKB-KW
Q9Y6D0	SELK	Selenoprotein K	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IMP:UniProtKB
Q9Y6D0	SELK	Selenoprotein K	GO:2000406; P:positive regulation of T cell migration; IEA:Ensembl
Q9Y6D0	SELK	Selenoprotein K	GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl
Q9Y6D0	SELK	Selenoprotein K	GO:0045728; P:respiratory burst after phagocytosis; IEA:Ensembl
Q9Y6D0	SELK	Selenoprotein K	GO:0006979; P:response to oxidative stress; IMP:UniProtKB
Q9NZV5	SEPN1	Selenoprotein N	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NZV5	SEPN1	Selenoprotein N	GO:0005515; F:protein binding; IPI:IntAct
Q14242	SELPLG	P-selectin glycoprotein ligand 1	GO:0005515; F:protein binding; IPI:IntAct
Q14242	SELPLG	P-selectin glycoprotein ligand 1	GO:0005102; F:receptor binding; NAS:ProtInc
Q14242	SELPLG	P-selectin glycoprotein ligand 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q14242	SELPLG	P-selectin glycoprotein ligand 1	GO:0007155; P:cell adhesion; TAS:ProtInc
Q14242	SELPLG	P-selectin glycoprotein ligand 1	GO:0071354; P:cellular response to interleukin-6; IDA:MGI
Q14242	SELPLG	P-selectin glycoprotein ligand 1	GO:0050902; P:leukocyte adhesive activation; ISS:UniProtKB
Q14242	SELPLG	P-selectin glycoprotein ligand 1	GO:0050900; P:leukocyte migration; TAS:Reactome
Q14242	SELPLG	P-selectin glycoprotein ligand 1	GO:0050901; P:leukocyte tethering or rolling; IEA:Ensembl
Q9BQE4	VIMP	Selenoprotein S	GO:0016209; F:antioxidant activity; IDA:UniProtKB
Q9BQE4	VIMP	Selenoprotein S	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9BQE4	VIMP	Selenoprotein S	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BQE4	VIMP	Selenoprotein S	GO:0004872; F:receptor activity; NAS:UniProtKB
Q9BQE4	VIMP	Selenoprotein S	GO:0008430; F:selenium binding; IEA:InterPro
Q9BQE4	VIMP	Selenoprotein S	GO:0045454; P:cell redox homeostasis; IDA:UniProtKB
Q9BQE4	VIMP	Selenoprotein S	GO:0032869; P:cellular response to insulin stimulus; TAS:BHF-UCL
Q9BQE4	VIMP	Selenoprotein S	GO:0071222; P:cellular response to lipopolysaccharide; IMP:BHF-UCL
Q9BQE4	VIMP	Selenoprotein S	GO:0034599; P:cellular response to oxidative stress; IMP:BHF-UCL
Q9BQE4	VIMP	Selenoprotein S	GO:0030968; P:endoplasmic reticulum unfolded protein response; IDA:UniProtKB
Q9BQE4	VIMP	Selenoprotein S	GO:0006983; P:ER overload response; IDA:BHF-UCL
Q9BQE4	VIMP	Selenoprotein S	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9BQE4	VIMP	Selenoprotein S	GO:0045184; P:establishment of protein localization; TAS:UniProtKB
Q9BQE4	VIMP	Selenoprotein S	GO:0002865; P:negative regulation of acute inflammatory response to antigenic stimulus; IMP:BHF-UCL
Q9BQE4	VIMP	Selenoprotein S	GO:0046325; P:negative regulation of glucose import; TAS:BHF-UCL
Q9BQE4	VIMP	Selenoprotein S	GO:0045719; P:negative regulation of glycogen biosynthetic process; TAS:BHF-UCL
Q9BQE4	VIMP	Selenoprotein S	GO:0050728; P:negative regulation of inflammatory response; IC:BHF-UCL
Q9BQE4	VIMP	Selenoprotein S	GO:0032715; P:negative regulation of interleukin-6 production; ISS:BHF-UCL
Q9BQE4	VIMP	Selenoprotein S	GO:1902236; P:negative regulation of intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IMP:BHF-UCL
Q9BQE4	VIMP	Selenoprotein S	GO:2000110; P:negative regulation of macrophage apoptotic process; IMP:BHF-UCL
Q9BQE4	VIMP	Selenoprotein S	GO:0051771; P:negative regulation of nitric-oxide synthase biosynthetic process; IMP:BHF-UCL
Q9BQE4	VIMP	Selenoprotein S	GO:0032720; P:negative regulation of tumor necrosis factor production; ISS:BHF-UCL
Q9BQE4	VIMP	Selenoprotein S	GO:0006111; P:regulation of gluconeogenesis; TAS:BHF-UCL
Q9BQE4	VIMP	Selenoprotein S	GO:0080164; P:regulation of nitric oxide metabolic process; IMP:BHF-UCL
Q9BQE4	VIMP	Selenoprotein S	GO:0009749; P:response to glucose; IEP:UniProtKB
Q9BQE4	VIMP	Selenoprotein S	GO:0051775; P:response to redox state; IDA:UniProtKB
Q9BQE4	VIMP	Selenoprotein S	GO:0030970; P:retrograde protein transport, ER to cytosol; IDA:UniProtKB
P62341	SELT	Selenoprotein T	GO:0008430; F:selenium binding; NAS:UniProtKB
P62341	SELT	Selenoprotein T	GO:0045454; P:cell redox homeostasis; IEA:InterPro
P62341	SELT	Selenoprotein T	GO:0001514; P:selenocysteine incorporation; NAS:UniProtKB
P59797	SELV	Selenoprotein V	GO:0008430; F:selenium binding; IEA:InterPro
P59797	SELV	Selenoprotein V	GO:0045454; P:cell redox homeostasis; IEA:InterPro
P63302	SEPW1	Selenoprotein W	GO:0016209; F:antioxidant activity; IEA:UniProtKB-KW
P63302	SEPW1	Selenoprotein W	GO:0008430; F:selenium binding; IEA:InterPro
P63302	SEPW1	Selenoprotein W	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q14563	SEMA3A	Semaphorin-3A	GO:0045499; F:chemorepellent activity; TAS:BHF-UCL
Q14563	SEMA3A	Semaphorin-3A	GO:0004872; F:receptor activity; IEA:InterPro
Q14563	SEMA3A	Semaphorin-3A	GO:0006915; P:apoptotic process; IEA:Ensembl
Q14563	SEMA3A	Semaphorin-3A	GO:0048846; P:axon extension involved in axon guidance; ISS:BHF-UCL
Q14563	SEMA3A	Semaphorin-3A	GO:0007411; P:axon guidance; TAS:BHF-UCL
Q14563	SEMA3A	Semaphorin-3A	GO:0007413; P:axonal fasciculation; IEA:Ensembl
Q14563	SEMA3A	Semaphorin-3A	GO:0060385; P:axonogenesis involved in innervation; ISS:BHF-UCL
Q14563	SEMA3A	Semaphorin-3A	GO:0048813; P:dendrite morphogenesis; IEA:Ensembl
Q14563	SEMA3A	Semaphorin-3A	GO:0060666; P:dichotomous subdivision of terminal units involved in salivary gland branching; IEA:Ensembl
Q14563	SEMA3A	Semaphorin-3A	GO:0048843; P:negative regulation of axon extension involved in axon guidance; IEA:Ensembl
Q14563	SEMA3A	Semaphorin-3A	GO:0010633; P:negative regulation of epithelial cell migration; IEA:Ensembl
Q14563	SEMA3A	Semaphorin-3A	GO:0021675; P:nerve development; ISS:BHF-UCL
Q14563	SEMA3A	Semaphorin-3A	GO:0001764; P:neuron migration; ISS:BHF-UCL
Q14563	SEMA3A	Semaphorin-3A	GO:0021772; P:olfactory bulb development; IMP:UniProtKB
Q14563	SEMA3A	Semaphorin-3A	GO:2001224; P:positive regulation of neuron migration; IEA:Ensembl
Q14563	SEMA3A	Semaphorin-3A	GO:0048841; P:regulation of axon extension involved in axon guidance; IDA:UniProtKB
Q14563	SEMA3A	Semaphorin-3A	GO:0002027; P:regulation of heart rate; IEA:Ensembl
Q14563	SEMA3A	Semaphorin-3A	GO:0071526; P:semaphorin-plexin signaling pathway; TAS:BHF-UCL
Q14563	SEMA3A	Semaphorin-3A	GO:1902285; P:semaphorin-plexin signaling pathway involved in neuron projection guidance; ISS:BHF-UCL
Q14563	SEMA3A	Semaphorin-3A	GO:0048880; P:sensory system development; TAS:BHF-UCL
Q14563	SEMA3A	Semaphorin-3A	GO:0061549; P:sympathetic ganglion development; ISS:BHF-UCL
Q14563	SEMA3A	Semaphorin-3A	GO:0048485; P:sympathetic nervous system development; TAS:BHF-UCL
Q14563	SEMA3A	Semaphorin-3A	GO:0097490; P:sympathetic neuron projection extension; ISS:BHF-UCL
Q14563	SEMA3A	Semaphorin-3A	GO:0097491; P:sympathetic neuron projection guidance; ISS:BHF-UCL
Q13214	SEMA3B	Semaphorin-3B	GO:0004872; F:receptor activity; IEA:InterPro
Q13214	SEMA3B	Semaphorin-3B	GO:0007411; P:axon guidance; TAS:ProtInc
Q13214	SEMA3B	Semaphorin-3B	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q99985	SEMA3C	Semaphorin-3C	GO:0004872; F:receptor activity; IEA:InterPro
Q99985	SEMA3C	Semaphorin-3C	GO:0007411; P:axon guidance; ISS:UniProtKB
Q99985	SEMA3C	Semaphorin-3C	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
Q99985	SEMA3C	Semaphorin-3C	GO:0003215; P:cardiac right ventricle morphogenesis; IEA:Ensembl
Q99985	SEMA3C	Semaphorin-3C	GO:0060666; P:dichotomous subdivision of terminal units involved in salivary gland branching; IEA:Ensembl
Q99985	SEMA3C	Semaphorin-3C	GO:0006955; P:immune response; TAS:ProtInc
Q99985	SEMA3C	Semaphorin-3C	GO:0060174; P:limb bud formation; IEA:Ensembl
Q99985	SEMA3C	Semaphorin-3C	GO:0001755; P:neural crest cell migration; IEA:Ensembl
Q99985	SEMA3C	Semaphorin-3C	GO:0021915; P:neural tube development; IEA:Ensembl
Q99985	SEMA3C	Semaphorin-3C	GO:0003151; P:outflow tract morphogenesis; IEA:Ensembl
Q99985	SEMA3C	Semaphorin-3C	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q99985	SEMA3C	Semaphorin-3C	GO:0003350; P:pulmonary myocardium development; IEA:Ensembl
Q99985	SEMA3C	Semaphorin-3C	GO:0042493; P:response to drug; TAS:ProtInc
Q99985	SEMA3C	Semaphorin-3C	GO:0001756; P:somitogenesis; IEA:Ensembl
O95025	SEMA3D	Semaphorin-3D	GO:0004872; F:receptor activity; IEA:InterPro
O95025	SEMA3D	Semaphorin-3D	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O95025	SEMA3D	Semaphorin-3D	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
O15041	SEMA3E	Semaphorin-3E	GO:0005515; F:protein binding; IPI:IntAct
O15041	SEMA3E	Semaphorin-3E	GO:0004872; F:receptor activity; IEA:InterPro
O15041	SEMA3E	Semaphorin-3E	GO:0007411; P:axon guidance; TAS:Reactome
O15041	SEMA3E	Semaphorin-3E	GO:0016525; P:negative regulation of angiogenesis; ISS:UniProtKB
O15041	SEMA3E	Semaphorin-3E	GO:0001953; P:negative regulation of cell-matrix adhesion; ISS:UniProtKB
O15041	SEMA3E	Semaphorin-3E	GO:0001569; P:patterning of blood vessels; ISS:UniProtKB
O15041	SEMA3E	Semaphorin-3E	GO:2000249; P:regulation of actin cytoskeleton reorganization; ISS:UniProtKB
O15041	SEMA3E	Semaphorin-3E	GO:0008360; P:regulation of cell shape; ISS:UniProtKB
O15041	SEMA3E	Semaphorin-3E	GO:0071526; P:semaphorin-plexin signaling pathway; ISS:UniProtKB
O15041	SEMA3E	Semaphorin-3E	GO:0002040; P:sprouting angiogenesis; ISS:UniProtKB
O15041	SEMA3E	Semaphorin-3E	GO:0050808; P:synapse organization; ISS:UniProtKB
Q13275	SEMA3F	Semaphorin-3F	GO:0045499; F:chemorepellent activity; IDA:MGI
Q13275	SEMA3F	Semaphorin-3F	GO:0004872; F:receptor activity; IEA:InterPro
Q13275	SEMA3F	Semaphorin-3F	GO:0048846; P:axon extension involved in axon guidance; ISS:BHF-UCL
Q13275	SEMA3F	Semaphorin-3F	GO:0007411; P:axon guidance; IDA:MGI
Q13275	SEMA3F	Semaphorin-3F	GO:0048843; P:negative regulation of axon extension involved in axon guidance; IEA:Ensembl
Q13275	SEMA3F	Semaphorin-3F	GO:0021675; P:nerve development; ISS:BHF-UCL
Q13275	SEMA3F	Semaphorin-3F	GO:0001755; P:neural crest cell migration; IEA:Ensembl
Q13275	SEMA3F	Semaphorin-3F	GO:1902285; P:semaphorin-plexin signaling pathway involved in neuron projection guidance; ISS:BHF-UCL
Q13275	SEMA3F	Semaphorin-3F	GO:0061549; P:sympathetic ganglion development; ISS:BHF-UCL
Q13275	SEMA3F	Semaphorin-3F	GO:0097490; P:sympathetic neuron projection extension; ISS:BHF-UCL
Q13275	SEMA3F	Semaphorin-3F	GO:0097491; P:sympathetic neuron projection guidance; ISS:BHF-UCL
Q9NS98	SEMA3G	Semaphorin-3G	GO:0004872; F:receptor activity; IEA:InterPro
Q9NS98	SEMA3G	Semaphorin-3G	GO:0007275; P:multicellular organismal development; IEA:InterPro
Q9H3S1	SEMA4A	Semaphorin-4A	GO:0005515; F:protein binding; IPI:IntAct
Q9H3S1	SEMA4A	Semaphorin-4A	GO:0004872; F:receptor activity; IEA:InterPro
Q9H3S1	SEMA4A	Semaphorin-4A	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q9H3S1	SEMA4A	Semaphorin-4A	GO:0007411; P:axon guidance; TAS:Reactome
Q9H3S1	SEMA4A	Semaphorin-4A	GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl
Q9H3S1	SEMA4A	Semaphorin-4A	GO:0008360; P:regulation of cell shape; IEA:Ensembl
Q9H3S1	SEMA4A	Semaphorin-4A	GO:0010594; P:regulation of endothelial cell migration; IEA:Ensembl
Q9H3S1	SEMA4A	Semaphorin-4A	GO:0071526; P:semaphorin-plexin signaling pathway; IEA:Ensembl
Q9H3S1	SEMA4A	Semaphorin-4A	GO:0045063; P:T-helper 1 cell differentiation; IEA:Ensembl
Q9NPR2	SEMA4B	Semaphorin-4B	GO:0004872; F:receptor activity; IEA:InterPro
Q9NPR2	SEMA4B	Semaphorin-4B	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9NPR2	SEMA4B	Semaphorin-4B	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q9C0C4	SEMA4C	Semaphorin-4C	GO:0004872; F:receptor activity; IEA:InterPro
Q9C0C4	SEMA4C	Semaphorin-4C	GO:0021535; P:cell migration in hindbrain; ISS:UniProtKB
Q9C0C4	SEMA4C	Semaphorin-4C	GO:0021549; P:cerebellum development; IEA:Ensembl
Q9C0C4	SEMA4C	Semaphorin-4C	GO:0042692; P:muscle cell differentiation; IDA:UniProtKB
Q9C0C4	SEMA4C	Semaphorin-4C	GO:0001843; P:neural tube closure; ISS:UniProtKB
Q9C0C4	SEMA4C	Semaphorin-4C	GO:0032874; P:positive regulation of stress-activated MAPK cascade; IDA:UniProtKB
Q9C0C4	SEMA4C	Semaphorin-4C	GO:0071526; P:semaphorin-plexin signaling pathway; ISS:UniProtKB
Q92854	SEMA4D	Semaphorin-4D	GO:0005515; F:protein binding; IPI:UniProtKB
Q92854	SEMA4D	Semaphorin-4D	GO:0004872; F:receptor activity; IDA:HGNC
Q92854	SEMA4D	Semaphorin-4D	GO:0005102; F:receptor binding; IDA:UniProtKB
Q92854	SEMA4D	Semaphorin-4D	GO:0030215; F:semaphorin receptor binding; IPI:UniProtKB
Q92854	SEMA4D	Semaphorin-4D	GO:0004888; F:transmembrane signaling receptor activity; IMP:UniProtKB
Q92854	SEMA4D	Semaphorin-4D	GO:0007411; P:axon guidance; TAS:Reactome
Q92854	SEMA4D	Semaphorin-4D	GO:0007155; P:cell adhesion; TAS:ProtInc
Q92854	SEMA4D	Semaphorin-4D	GO:0006955; P:immune response; TAS:ProtInc
Q92854	SEMA4D	Semaphorin-4D	GO:0070486; P:leukocyte aggregation; IMP:UniProtKB
Q92854	SEMA4D	Semaphorin-4D	GO:0010693; P:negative regulation of alkaline phosphatase activity; IMP:BHF-UCL
Q92854	SEMA4D	Semaphorin-4D	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
Q92854	SEMA4D	Semaphorin-4D	GO:0007162; P:negative regulation of cell adhesion; IDA:UniProtKB
Q92854	SEMA4D	Semaphorin-4D	GO:0045668; P:negative regulation of osteoblast differentiation; ISS:BHF-UCL
Q92854	SEMA4D	Semaphorin-4D	GO:0050732; P:negative regulation of peptidyl-tyrosine phosphorylation; ISS:BHF-UCL
Q92854	SEMA4D	Semaphorin-4D	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q92854	SEMA4D	Semaphorin-4D	GO:0043931; P:ossification involved in bone maturation; IMP:BHF-UCL
Q92854	SEMA4D	Semaphorin-4D	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
Q92854	SEMA4D	Semaphorin-4D	GO:0048672; P:positive regulation of collateral sprouting; IMP:UniProtKB
Q92854	SEMA4D	Semaphorin-4D	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISS:BHF-UCL
Q92854	SEMA4D	Semaphorin-4D	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IMP:UniProtKB
Q92854	SEMA4D	Semaphorin-4D	GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB
Q92854	SEMA4D	Semaphorin-4D	GO:0032321; P:positive regulation of Rho GTPase activity; IMP:UniProtKB
Q92854	SEMA4D	Semaphorin-4D	GO:0031344; P:regulation of cell projection organization; IMP:UniProtKB
Q92854	SEMA4D	Semaphorin-4D	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
Q92854	SEMA4D	Semaphorin-4D	GO:0048814; P:regulation of dendrite morphogenesis; IMP:UniProtKB
Q92854	SEMA4D	Semaphorin-4D	GO:0071526; P:semaphorin-plexin signaling pathway; IDA:UniProtKB
Q92854	SEMA4D	Semaphorin-4D	GO:1900220; P:semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis; ISS:BHF-UCL
O95754	SEMA4F	Semaphorin-4F	GO:0004872; F:receptor activity; IEA:InterPro
O95754	SEMA4F	Semaphorin-4F	GO:0007411; P:axon guidance; TAS:ProtInc
O95754	SEMA4F	Semaphorin-4F	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O95754	SEMA4F	Semaphorin-4F	GO:0030517; P:negative regulation of axon extension; IEA:Ensembl
O95754	SEMA4F	Semaphorin-4F	GO:0007399; P:nervous system development; TAS:ProtInc
O95754	SEMA4F	Semaphorin-4F	GO:0031290; P:retinal ganglion cell axon guidance; IEA:Ensembl
Q9NTN9	SEMA4G	Semaphorin-4G	GO:0004872; F:receptor activity; IEA:InterPro
Q9NTN9	SEMA4G	Semaphorin-4G	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9NTN9	SEMA4G	Semaphorin-4G	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q13591	SEMA5A	Semaphorin-5A	GO:0008046; F:axon guidance receptor activity; IEA:Ensembl
Q13591	SEMA5A	Semaphorin-5A	GO:0035373; F:chondroitin sulfate proteoglycan binding; ISS:UniProtKB
Q13591	SEMA5A	Semaphorin-5A	GO:0043395; F:heparan sulfate proteoglycan binding; ISS:UniProtKB
Q13591	SEMA5A	Semaphorin-5A	GO:0030215; F:semaphorin receptor binding; ISS:UniProtKB
Q13591	SEMA5A	Semaphorin-5A	GO:0045545; F:syndecan binding; ISS:UniProtKB
Q13591	SEMA5A	Semaphorin-5A	GO:0007411; P:axon guidance; TAS:Reactome
Q13591	SEMA5A	Semaphorin-5A	GO:0007413; P:axonal fasciculation; ISS:UniProtKB
Q13591	SEMA5A	Semaphorin-5A	GO:0002043; P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis; ISS:UniProtKB
Q13591	SEMA5A	Semaphorin-5A	GO:0007155; P:cell adhesion; TAS:ProtInc
Q13591	SEMA5A	Semaphorin-5A	GO:0060326; P:cell chemotaxis; ISS:UniProtKB
Q13591	SEMA5A	Semaphorin-5A	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q13591	SEMA5A	Semaphorin-5A	GO:0021536; P:diencephalon development; ISS:UniProtKB
Q13591	SEMA5A	Semaphorin-5A	GO:0048843; P:negative regulation of axon extension involved in axon guidance; ISS:UniProtKB
Q13591	SEMA5A	Semaphorin-5A	GO:0007162; P:negative regulation of cell adhesion; ISS:UniProtKB
Q13591	SEMA5A	Semaphorin-5A	GO:2000352; P:negative regulation of endothelial cell apoptotic process; ISS:UniProtKB
Q13591	SEMA5A	Semaphorin-5A	GO:0007399; P:nervous system development; TAS:ProtInc
Q13591	SEMA5A	Semaphorin-5A	GO:0001569; P:patterning of blood vessels; IEA:Ensembl
Q13591	SEMA5A	Semaphorin-5A	GO:0050918; P:positive chemotaxis; ISS:UniProtKB
Q13591	SEMA5A	Semaphorin-5A	GO:0030836; P:positive regulation of actin filament depolymerization; ISS:UniProtKB
Q13591	SEMA5A	Semaphorin-5A	GO:0045766; P:positive regulation of angiogenesis; ISS:UniProtKB
Q13591	SEMA5A	Semaphorin-5A	GO:0048842; P:positive regulation of axon extension involved in axon guidance; ISS:UniProtKB
Q13591	SEMA5A	Semaphorin-5A	GO:0035413; P:positive regulation of catenin import into nucleus; ISS:UniProtKB
Q13591	SEMA5A	Semaphorin-5A	GO:2001028; P:positive regulation of endothelial cell chemotaxis; ISS:UniProtKB
Q13591	SEMA5A	Semaphorin-5A	GO:0001938; P:positive regulation of endothelial cell proliferation; ISS:UniProtKB
Q13591	SEMA5A	Semaphorin-5A	GO:0051897; P:positive regulation of protein kinase B signaling; ISS:UniProtKB
Q13591	SEMA5A	Semaphorin-5A	GO:1990256; P:signal clustering; ISS:UniProtKB
Q9P283	SEMA5B	Semaphorin-5B	GO:0004872; F:receptor activity; IEA:InterPro
Q9P283	SEMA5B	Semaphorin-5B	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9P283	SEMA5B	Semaphorin-5B	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q9H2E6	SEMA6A	Semaphorin-6A	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H2E6	SEMA6A	Semaphorin-6A	GO:0004888; F:transmembrane signaling receptor activity; IEA:Ensembl
Q9H2E6	SEMA6A	Semaphorin-6A	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q9H2E6	SEMA6A	Semaphorin-6A	GO:0007411; P:axon guidance; NAS:UniProtKB
Q9H2E6	SEMA6A	Semaphorin-6A	GO:0007166; P:cell surface receptor signaling pathway; NAS:UniProtKB
Q9H2E6	SEMA6A	Semaphorin-6A	GO:0051642; P:centrosome localization; IEA:Ensembl
Q9H2E6	SEMA6A	Semaphorin-6A	GO:0007010; P:cytoskeleton organization; NAS:UniProtKB
Q9H2E6	SEMA6A	Semaphorin-6A	GO:0007399; P:nervous system development; NAS:UniProtKB
Q9H2E6	SEMA6A	Semaphorin-6A	GO:0001764; P:neuron migration; IEA:Ensembl
Q9H2E6	SEMA6A	Semaphorin-6A	GO:0009887; P:organ morphogenesis; NAS:UniProtKB
Q9H2E6	SEMA6A	Semaphorin-6A	GO:2001224; P:positive regulation of neuron migration; IEA:Ensembl
Q9H2E6	SEMA6A	Semaphorin-6A	GO:0071526; P:semaphorin-plexin signaling pathway; IEA:Ensembl
Q9H3T3	SEMA6B	Semaphorin-6B	GO:0004872; F:receptor activity; IEA:InterPro
Q9H3T3	SEMA6B	Semaphorin-6B	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9H3T3	SEMA6B	Semaphorin-6B	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q9H3T2	SEMA6C	Semaphorin-6C	GO:0004872; F:receptor activity; IEA:InterPro
Q9H3T2	SEMA6C	Semaphorin-6C	GO:0007411; P:axon guidance; IEA:Ensembl
Q8NFY4	SEMA6D	Semaphorin-6D	GO:0004872; F:receptor activity; IEA:InterPro
Q8NFY4	SEMA6D	Semaphorin-6D	GO:0007411; P:axon guidance; TAS:Reactome
Q8NFY4	SEMA6D	Semaphorin-6D	GO:0014912; P:negative regulation of smooth muscle cell migration; IEA:Ensembl
Q8NFY4	SEMA6D	Semaphorin-6D	GO:0014911; P:positive regulation of smooth muscle cell migration; IEA:Ensembl
Q8NFY4	SEMA6D	Semaphorin-6D	GO:0021591; P:ventricular system development; IEA:Ensembl
O75326	SEMA7A	Semaphorin-7A	GO:0005515; F:protein binding; IPI:IntAct
O75326	SEMA7A	Semaphorin-7A	GO:0004872; F:receptor activity; IEA:InterPro
O75326	SEMA7A	Semaphorin-7A	GO:0007411; P:axon guidance; TAS:Reactome
O75326	SEMA7A	Semaphorin-7A	GO:0006955; P:immune response; TAS:ProtInc
O75326	SEMA7A	Semaphorin-7A	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
O75326	SEMA7A	Semaphorin-7A	GO:0007229; P:integrin-mediated signaling pathway; IDA:UniProtKB
O75326	SEMA7A	Semaphorin-7A	GO:0045773; P:positive regulation of axon extension; IDA:UniProtKB
O75326	SEMA7A	Semaphorin-7A	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
O75326	SEMA7A	Semaphorin-7A	GO:0060907; P:positive regulation of macrophage cytokine production; ISS:UniProtKB
O75326	SEMA7A	Semaphorin-7A	GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB
P04279	SEMG1	Semenogelin-1	GO:0005515; F:protein binding; IPI:UniProtKB
P04279	SEMG1	Semenogelin-1	GO:0005198; F:structural molecule activity; IEA:InterPro
P04279	SEMG1	Semenogelin-1	GO:0007320; P:insemination; TAS:ProtInc
Q02383	SEMG2	Semenogelin-2	GO:0005198; F:structural molecule activity; IEA:InterPro
Q02383	SEMG2	Semenogelin-2	GO:0019953; P:sexual reproduction; IEA:InterPro
Q8WW01	TSEN15	tRNA-splicing endonuclease subunit Sen15	GO:0000213; F:tRNA-intron endonuclease activity; IEA:InterPro
Q8WW01	TSEN15	tRNA-splicing endonuclease subunit Sen15	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q8WW01	TSEN15	tRNA-splicing endonuclease subunit Sen15	GO:0006388; P:tRNA splicing, via endonucleolytic cleavage and ligation; IEA:InterPro
Q8NCE0	TSEN2	tRNA-splicing endonuclease subunit Sen2	GO:0016829; F:lyase activity; IEA:UniProtKB-KW
Q8NCE0	TSEN2	tRNA-splicing endonuclease subunit Sen2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8NCE0	TSEN2	tRNA-splicing endonuclease subunit Sen2	GO:0000213; F:tRNA-intron endonuclease activity; IEA:InterPro
Q8NCE0	TSEN2	tRNA-splicing endonuclease subunit Sen2	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q8NCE0	TSEN2	tRNA-splicing endonuclease subunit Sen2	GO:0006388; P:tRNA splicing, via endonucleolytic cleavage and ligation; IDA:UniProtKB
Q9BSV6	TSEN34	tRNA-splicing endonuclease subunit Sen34	GO:0016829; F:lyase activity; IEA:UniProtKB-KW
Q9BSV6	TSEN34	tRNA-splicing endonuclease subunit Sen34	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9BSV6	TSEN34	tRNA-splicing endonuclease subunit Sen34	GO:0000213; F:tRNA-intron endonuclease activity; IEA:InterPro
Q9BSV6	TSEN34	tRNA-splicing endonuclease subunit Sen34	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9BSV6	TSEN34	tRNA-splicing endonuclease subunit Sen34	GO:0000379; P:tRNA-type intron splice site recognition and cleavage; IEA:InterPro
Q7Z6J9	TSEN54	tRNA-splicing endonuclease subunit Sen54	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q7Z6J9	TSEN54	tRNA-splicing endonuclease subunit Sen54	GO:0006388; P:tRNA splicing, via endonucleolytic cleavage and ligation; IDA:UniProtKB
Q9HC62	SENP2	Sentrin-specific protease 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HC62	SENP2	Sentrin-specific protease 2	GO:0016929; F:SUMO-specific protease activity; IDA:UniProtKB
Q9HC62	SENP2	Sentrin-specific protease 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9HC62	SENP2	Sentrin-specific protease 2	GO:0009950; P:dorsal/ventral axis specification; IEA:Ensembl
Q9HC62	SENP2	Sentrin-specific protease 2	GO:0007507; P:heart development; IEA:Ensembl
Q9HC62	SENP2	Sentrin-specific protease 2	GO:0060711; P:labyrinthine layer development; IEA:Ensembl
Q9HC62	SENP2	Sentrin-specific protease 2	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q9HC62	SENP2	Sentrin-specific protease 2	GO:0035562; P:negative regulation of chromatin binding; IEA:Ensembl
Q9HC62	SENP2	Sentrin-specific protease 2	GO:0032091; P:negative regulation of protein binding; IEA:Ensembl
Q9HC62	SENP2	Sentrin-specific protease 2	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
Q9HC62	SENP2	Sentrin-specific protease 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9HC62	SENP2	Sentrin-specific protease 2	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9HC62	SENP2	Sentrin-specific protease 2	GO:0016926; P:protein desumoylation; ISS:UniProtKB
Q9HC62	SENP2	Sentrin-specific protease 2	GO:0016925; P:protein sumoylation; TAS:Reactome
Q9HC62	SENP2	Sentrin-specific protease 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9HC62	SENP2	Sentrin-specific protease 2	GO:0032875; P:regulation of DNA endoreduplication; IEA:Ensembl
Q9HC62	SENP2	Sentrin-specific protease 2	GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl
Q9HC62	SENP2	Sentrin-specific protease 2	GO:0030111; P:regulation of Wnt signaling pathway; NAS:UniProtKB
Q9HC62	SENP2	Sentrin-specific protease 2	GO:0060712; P:spongiotrophoblast layer development; IEA:Ensembl
Q9HC62	SENP2	Sentrin-specific protease 2	GO:0060707; P:trophoblast giant cell differentiation; IEA:Ensembl
Q9HC62	SENP2	Sentrin-specific protease 2	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9P0U3	SENP1	Sentrin-specific protease 1	GO:0004175; F:endopeptidase activity; TAS:ProtInc
Q9P0U3	SENP1	Sentrin-specific protease 1	GO:0005515; F:protein binding; IPI:IntAct
Q9P0U3	SENP1	Sentrin-specific protease 1	GO:0016929; F:SUMO-specific protease activity; ISS:UniProtKB
Q9P0U3	SENP1	Sentrin-specific protease 1	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
Q9P0U3	SENP1	Sentrin-specific protease 1	GO:0097190; P:apoptotic signaling pathway; IMP:UniProtKB
Q9P0U3	SENP1	Sentrin-specific protease 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9P0U3	SENP1	Sentrin-specific protease 1	GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q9P0U3	SENP1	Sentrin-specific protease 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IGI:MGI
Q9P0U3	SENP1	Sentrin-specific protease 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9P0U3	SENP1	Sentrin-specific protease 1	GO:0016926; P:protein desumoylation; ISS:UniProtKB
Q9P0U3	SENP1	Sentrin-specific protease 1	GO:0016925; P:protein sumoylation; TAS:Reactome
Q9P0U3	SENP1	Sentrin-specific protease 1	GO:0006508; P:proteolysis; TAS:ProtInc
Q9P0U3	SENP1	Sentrin-specific protease 1	GO:0010724; P:regulation of definitive erythrocyte differentiation; IEA:Ensembl
Q9H4L4	SENP3	Sentrin-specific protease 3	GO:0005515; F:protein binding; IPI:IntAct
Q9H4L4	SENP3	Sentrin-specific protease 3	GO:0004843; F:ubiquitin-specific protease activity; IEA:Ensembl
Q96HI0	SENP5	Sentrin-specific protease 5	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
Q96HI0	SENP5	Sentrin-specific protease 5	GO:0005515; F:protein binding; IPI:IntAct
Q96HI0	SENP5	Sentrin-specific protease 5	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q96HI0	SENP5	Sentrin-specific protease 5	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q96HI0	SENP5	Sentrin-specific protease 5	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q96HI0	SENP5	Sentrin-specific protease 5	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q96HI0	SENP5	Sentrin-specific protease 5	GO:0016925; P:protein sumoylation; TAS:Reactome
Q9GZR1	SENP6	Sentrin-specific protease 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q9GZR1	SENP6	Sentrin-specific protease 6	GO:0016929; F:SUMO-specific protease activity; IMP:UniProtKB
Q9GZR1	SENP6	Sentrin-specific protease 6	GO:0016926; P:protein desumoylation; IMP:UniProtKB
Q9GZR1	SENP6	Sentrin-specific protease 6	GO:0070646; P:protein modification by small protein removal; IDA:UniProtKB
Q9GZR1	SENP6	Sentrin-specific protease 6	GO:0016925; P:protein sumoylation; IEA:UniProtKB-UniPathway
Q9GZR1	SENP6	Sentrin-specific protease 6	GO:0090234; P:regulation of kinetochore assembly; IMP:UniProtKB
Q9GZR1	SENP6	Sentrin-specific protease 6	GO:0090169; P:regulation of spindle assembly; IMP:UniProtKB
Q96LD8	SENP8	Sentrin-specific protease 8	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
Q9BQF6	SENP7	Sentrin-specific protease 7	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
Q9BQF6	SENP7	Sentrin-specific protease 7	GO:0005515; F:protein binding; IPI:IntAct
Q9P0V9	SEPT10	Septin-10	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9P0V9	SEPT10	Septin-10	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9P0V9	SEPT10	Septin-10	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q9NVA2	SEPT11	Septin-11	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9NVA2	SEPT11	Septin-11	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NVA2	SEPT11	Septin-11	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9NVA2	SEPT11	Septin-11	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q9NVA2	SEPT11	Septin-11	GO:0051291; P:protein heterooligomerization; IDA:UniProtKB
Q8IYM1	SEPT12	Septin-12	GO:0019003; F:GDP binding; ISS:UniProtKB
Q8IYM1	SEPT12	Septin-12	GO:0005525; F:GTP binding; IDA:UniProtKB
Q8IYM1	SEPT12	Septin-12	GO:0035091; F:phosphatidylinositol binding; ISS:UniProtKB
Q8IYM1	SEPT12	Septin-12	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IYM1	SEPT12	Septin-12	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q8IYM1	SEPT12	Septin-12	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8IYM1	SEPT12	Septin-12	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q6ZU15	SEPT14	Septin-14	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q6ZU15	SEPT14	Septin-14	GO:0005515; F:protein binding; IPI:IntAct
Q6ZU15	SEPT14	Septin-14	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q6ZU15	SEPT14	Septin-14	GO:0051301; P:cell division; IEA:UniProtKB-KW
O60613	SEP15	15 kDa selenoprotein	GO:0008430; F:selenium binding; IDA:UniProtKB
O60613	SEP15	15 kDa selenoprotein	GO:0051084; P:'de novo' posttranslational protein folding; TAS:UniProtKB
P49908	SEPP1	Selenoprotein P	GO:0008430; F:selenium binding; TAS:ProtInc
P49908	SEPP1	Selenoprotein P	GO:0007420; P:brain development; IEA:Ensembl
P49908	SEPP1	Selenoprotein P	GO:0040007; P:growth; IEA:Ensembl
P49908	SEPP1	Selenoprotein P	GO:0007626; P:locomotory behavior; IEA:Ensembl
P49908	SEPP1	Selenoprotein P	GO:0009791; P:post-embryonic development; IEA:Ensembl
P49908	SEPP1	Selenoprotein P	GO:0006979; P:response to oxidative stress; TAS:ProtInc
P49908	SEPP1	Selenoprotein P	GO:0001887; P:selenium compound metabolic process; IEA:Ensembl
P49908	SEPP1	Selenoprotein P	GO:0019953; P:sexual reproduction; IEA:Ensembl
Q12884	FAP	Seprase	GO:0008239; F:dipeptidyl-peptidase activity; NAS:UniProtKB
Q12884	FAP	Seprase	GO:0004175; F:endopeptidase activity; IDA:BHF-UCL
Q12884	FAP	Seprase	GO:0004222; F:metalloendopeptidase activity; TAS:UniProtKB
Q12884	FAP	Seprase	GO:0008233; F:peptidase activity; IDA:MGI
Q12884	FAP	Seprase	GO:0002020; F:protease binding; IPI:BHF-UCL
Q12884	FAP	Seprase	GO:0005515; F:protein binding; IPI:UniProtKB
Q12884	FAP	Seprase	GO:0046983; F:protein dimerization activity; NAS:UniProtKB
Q12884	FAP	Seprase	GO:0042803; F:protein homodimerization activity; NAS:UniProtKB
Q12884	FAP	Seprase	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q12884	FAP	Seprase	GO:0008236; F:serine-type peptidase activity; IDA:UniProtKB
Q12884	FAP	Seprase	GO:0043542; P:endothelial cell migration; IDA:UniProtKB
Q12884	FAP	Seprase	GO:0010716; P:negative regulation of extracellular matrix disassembly; IDA:UniProtKB
Q12884	FAP	Seprase	GO:0051917; P:regulation of fibrinolysis; IC:BHF-UCL
Q8WYJ6	SEPT1	Septin-1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q8WYJ6	SEPT1	Septin-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WYJ6	SEPT1	Septin-1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8WYJ6	SEPT1	Septin-1	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q15019	SEPT2	Septin-2	GO:0030234; F:enzyme regulator activity; IEA:Ensembl
Q15019	SEPT2	Septin-2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q15019	SEPT2	Septin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q15019	SEPT2	Septin-2	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q15019	SEPT2	Septin-2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q15019	SEPT2	Septin-2	GO:0031175; P:neuron projection development; IEA:Ensembl
Q15019	SEPT2	Septin-2	GO:0002036; P:regulation of L-glutamate transport; IEA:Ensembl
Q15019	SEPT2	Septin-2	GO:0032880; P:regulation of protein localization; IEA:Ensembl
Q15019	SEPT2	Septin-2	GO:0007224; P:smoothened signaling pathway; ISS:UniProtKB
Q9UH03	SEPT3	Neuronal-specific septin-3	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9UH03	SEPT3	Neuronal-specific septin-3	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9UH03	SEPT3	Neuronal-specific septin-3	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q99719	SEPT5	Septin-5	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q99719	SEPT5	Septin-5	GO:0003924; F:GTPase activity; TAS:ProtInc
Q99719	SEPT5	Septin-5	GO:0005515; F:protein binding; IPI:UniProtKB
Q99719	SEPT5	Septin-5	GO:0005198; F:structural molecule activity; TAS:ProtInc
Q99719	SEPT5	Septin-5	GO:0000910; P:cytokinesis; TAS:ProtInc
Q99719	SEPT5	Septin-5	GO:0006184; P:GTP catabolic process; TAS:GOC
Q99719	SEPT5	Septin-5	GO:0017157; P:regulation of exocytosis; IMP:UniProtKB
Q99719	SEPT5	Septin-5	GO:0016080; P:synaptic vesicle targeting; TAS:UniProtKB
Q14141	SEPT6	Septin-6	GO:0005525; F:GTP binding; TAS:UniProtKB
Q14141	SEPT6	Septin-6	GO:0005515; F:protein binding; IPI:UniProtKB
Q14141	SEPT6	Septin-6	GO:0000910; P:cytokinesis; TAS:UniProtKB
Q14141	SEPT6	Septin-6	GO:0016032; P:viral process; IEA:UniProtKB-KW
O43236	SEPT4	Septin-4	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
O43236	SEPT4	Septin-4	GO:0003924; F:GTPase activity; TAS:ProtInc
O43236	SEPT4	Septin-4	GO:0005515; F:protein binding; IPI:IntAct
O43236	SEPT4	Septin-4	GO:0005198; F:structural molecule activity; TAS:ProtInc
O43236	SEPT4	Septin-4	GO:0006915; P:apoptotic process; NAS:UniProtKB
O43236	SEPT4	Septin-4	GO:0007420; P:brain development; IEA:Ensembl
O43236	SEPT4	Septin-4	GO:0000910; P:cytokinesis; TAS:ProtInc
O43236	SEPT4	Septin-4	GO:0006184; P:GTP catabolic process; TAS:GOC
O43236	SEPT4	Septin-4	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
O43236	SEPT4	Septin-4	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
O43236	SEPT4	Septin-4	GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB
O43236	SEPT4	Septin-4	GO:0042981; P:regulation of apoptotic process; NAS:UniProtKB
O43236	SEPT4	Septin-4	GO:0048240; P:sperm capacitation; IEA:Ensembl
O43236	SEPT4	Septin-4	GO:0030382; P:sperm mitochondrion organization; IEA:Ensembl
Q16181	SEPT7	Septin-7	GO:0005525; F:GTP binding; TAS:ProtInc
Q16181	SEPT7	Septin-7	GO:0042802; F:identical protein binding; IPI:IntAct
Q16181	SEPT7	Septin-7	GO:0005515; F:protein binding; IPI:UniProtKB
Q16181	SEPT7	Septin-7	GO:0005198; F:structural molecule activity; TAS:ProtInc
Q16181	SEPT7	Septin-7	GO:0060271; P:cilium morphogenesis; ISS:UniProtKB
Q16181	SEPT7	Septin-7	GO:0000910; P:cytokinesis; TAS:ProtInc
Q16181	SEPT7	Septin-7	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q16181	SEPT7	Septin-7	GO:0051291; P:protein heterooligomerization; IDA:UniProtKB
Q16181	SEPT7	Septin-7	GO:0016476; P:regulation of embryonic cell shape; ISS:UniProtKB
Q92599	SEPT8	Septin-8	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q92599	SEPT8	Septin-8	GO:0005515; F:protein binding; IPI:UniProtKB
Q92599	SEPT8	Septin-8	GO:0007049; P:cell cycle; IEA:InterPro
Q9UHD8	SEPT9	Septin-9	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9UHD8	SEPT9	Septin-9	GO:0003924; F:GTPase activity; TAS:ProtInc
Q9UHD8	SEPT9	Septin-9	GO:0005515; F:protein binding; IPI:IntAct
Q9UHD8	SEPT9	Septin-9	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9UHD8	SEPT9	Septin-9	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q9UHD8	SEPT9	Septin-9	GO:0006184; P:GTP catabolic process; TAS:GOC
Q9UHD8	SEPT9	Septin-9	GO:0051291; P:protein heterooligomerization; IDA:UniProtKB
O43175	PHGDH	D-3-phosphoglycerate dehydrogenase	GO:0009055; F:electron carrier activity; TAS:UniProtKB
O43175	PHGDH	D-3-phosphoglycerate dehydrogenase	GO:0051287; F:NAD binding; IEA:InterPro
O43175	PHGDH	D-3-phosphoglycerate dehydrogenase	GO:0004617; F:phosphoglycerate dehydrogenase activity; TAS:Reactome
O43175	PHGDH	D-3-phosphoglycerate dehydrogenase	GO:0007420; P:brain development; TAS:ProtInc
O43175	PHGDH	D-3-phosphoglycerate dehydrogenase	GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome
O43175	PHGDH	D-3-phosphoglycerate dehydrogenase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
O43175	PHGDH	D-3-phosphoglycerate dehydrogenase	GO:0070314; P:G1 to G0 transition; IEA:Ensembl
O43175	PHGDH	D-3-phosphoglycerate dehydrogenase	GO:0009448; P:gamma-aminobutyric acid metabolic process; IEA:Ensembl
O43175	PHGDH	D-3-phosphoglycerate dehydrogenase	GO:0021782; P:glial cell development; IEA:Ensembl
O43175	PHGDH	D-3-phosphoglycerate dehydrogenase	GO:0006541; P:glutamine metabolic process; IEA:Ensembl
O43175	PHGDH	D-3-phosphoglycerate dehydrogenase	GO:0006544; P:glycine metabolic process; IEA:Ensembl
O43175	PHGDH	D-3-phosphoglycerate dehydrogenase	GO:0006564; P:L-serine biosynthetic process; TAS:Reactome
O43175	PHGDH	D-3-phosphoglycerate dehydrogenase	GO:0021915; P:neural tube development; IEA:Ensembl
O43175	PHGDH	D-3-phosphoglycerate dehydrogenase	GO:0031175; P:neuron projection development; IEA:Ensembl
O43175	PHGDH	D-3-phosphoglycerate dehydrogenase	GO:0010468; P:regulation of gene expression; IEA:Ensembl
O43175	PHGDH	D-3-phosphoglycerate dehydrogenase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43175	PHGDH	D-3-phosphoglycerate dehydrogenase	GO:0021510; P:spinal cord development; IEA:Ensembl
O43175	PHGDH	D-3-phosphoglycerate dehydrogenase	GO:0019530; P:taurine metabolic process; IEA:Ensembl
O43175	PHGDH	D-3-phosphoglycerate dehydrogenase	GO:0006566; P:threonine metabolic process; IEA:Ensembl
P78330	PSPH	Phosphoserine phosphatase	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P78330	PSPH	Phosphoserine phosphatase	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
P78330	PSPH	Phosphoserine phosphatase	GO:0004647; F:phosphoserine phosphatase activity; IDA:UniProtKB
P78330	PSPH	Phosphoserine phosphatase	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P78330	PSPH	Phosphoserine phosphatase	GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome
P78330	PSPH	Phosphoserine phosphatase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P78330	PSPH	Phosphoserine phosphatase	GO:0016311; P:dephosphorylation; IDA:GOC
P78330	PSPH	Phosphoserine phosphatase	GO:0006564; P:L-serine biosynthetic process; IBA:RefGenome
P78330	PSPH	Phosphoserine phosphatase	GO:0006563; P:L-serine metabolic process; IDA:UniProtKB
P78330	PSPH	Phosphoserine phosphatase	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P78330	PSPH	Phosphoserine phosphatase	GO:0031667; P:response to nutrient levels; IEA:Ensembl
P78330	PSPH	Phosphoserine phosphatase	GO:0033574; P:response to testosterone; IEA:Ensembl
P78330	PSPH	Phosphoserine phosphatase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NRX5	SERINC1	Serine incorporator 1	GO:0015194; F:L-serine transmembrane transporter activity; ISS:HGNC
Q9NRX5	SERINC1	Serine incorporator 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NRX5	SERINC1	Serine incorporator 1	GO:0015825; P:L-serine transport; ISS:HGNC
Q9NRX5	SERINC1	Serine incorporator 1	GO:0006658; P:phosphatidylserine metabolic process; ISS:HGNC
Q9NRX5	SERINC1	Serine incorporator 1	GO:0008654; P:phospholipid biosynthetic process; IEA:UniProtKB-KW
Q9NRX5	SERINC1	Serine incorporator 1	GO:0051347; P:positive regulation of transferase activity; ISS:HGNC
Q9NRX5	SERINC1	Serine incorporator 1	GO:0006665; P:sphingolipid metabolic process; ISS:HGNC
Q96SA4	SERINC2	Serine incorporator 2	GO:0006658; P:phosphatidylserine metabolic process; IEA:Ensembl
Q96SA4	SERINC2	Serine incorporator 2	GO:0051347; P:positive regulation of transferase activity; IEA:Ensembl
Q13530	SERINC3	Serine incorporator 3	GO:1902237; P:positive regulation of intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IEA:Ensembl
A6NH21	SERINC4	Serine incorporator 4	GO:0008654; P:phospholipid biosynthetic process; IEA:UniProtKB-KW
Q86VE9	SERINC5	Serine incorporator 5	GO:0042552; P:myelination; IEA:Ensembl
Q86VE9	SERINC5	Serine incorporator 5	GO:0006658; P:phosphatidylserine metabolic process; ISS:HGNC
Q86VE9	SERINC5	Serine incorporator 5	GO:0008654; P:phospholipid biosynthetic process; IEA:UniProtKB-KW
Q86VE9	SERINC5	Serine incorporator 5	GO:0051347; P:positive regulation of transferase activity; ISS:HGNC
Q9Y617	PSAT1	Phosphoserine aminotransferase	GO:0004648; F:O-phospho-L-serine:2-oxoglutarate aminotransferase activity; NAS:UniProtKB
Q9Y617	PSAT1	Phosphoserine aminotransferase	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q9Y617	PSAT1	Phosphoserine aminotransferase	GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome
Q9Y617	PSAT1	Phosphoserine aminotransferase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9Y617	PSAT1	Phosphoserine aminotransferase	GO:0006564; P:L-serine biosynthetic process; NAS:UniProtKB
Q9Y617	PSAT1	Phosphoserine aminotransferase	GO:0008615; P:pyridoxine biosynthetic process; NAS:UniProtKB
Q9Y617	PSAT1	Phosphoserine aminotransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75920	SERF1A	Small EDRK-rich factor 1	GO:0007399; P:nervous system development; TAS:ProtInc
Q9NQF3	SERHL	Serine hydrolase-like protein	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q9Y6X1	SERP1	Stress-associated endoplasmic reticulum protein 1	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q9Y6X1	SERP1	Stress-associated endoplasmic reticulum protein 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9Y6X1	SERP1	Stress-associated endoplasmic reticulum protein 1	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q9Y6X1	SERP1	Stress-associated endoplasmic reticulum protein 1	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q9Y6X1	SERP1	Stress-associated endoplasmic reticulum protein 1	GO:0006006; P:glucose metabolic process; IEA:Ensembl
Q9Y6X1	SERP1	Stress-associated endoplasmic reticulum protein 1	GO:0010259; P:multicellular organismal aging; IEA:Ensembl
Q9Y6X1	SERP1	Stress-associated endoplasmic reticulum protein 1	GO:0048644; P:muscle organ morphogenesis; IEA:Ensembl
Q9Y6X1	SERP1	Stress-associated endoplasmic reticulum protein 1	GO:0007009; P:plasma membrane organization; TAS:ProtInc
Q9Y6X1	SERP1	Stress-associated endoplasmic reticulum protein 1	GO:0060124; P:positive regulation of growth hormone secretion; IEA:Ensembl
Q9Y6X1	SERP1	Stress-associated endoplasmic reticulum protein 1	GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl
Q9Y6X1	SERP1	Stress-associated endoplasmic reticulum protein 1	GO:0046622; P:positive regulation of organ growth; IEA:Ensembl
Q9Y6X1	SERP1	Stress-associated endoplasmic reticulum protein 1	GO:0045727; P:positive regulation of translation; IEA:Ensembl
Q9Y6X1	SERP1	Stress-associated endoplasmic reticulum protein 1	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q9Y6X1	SERP1	Stress-associated endoplasmic reticulum protein 1	GO:0006486; P:protein glycosylation; TAS:ProtInc
Q9Y6X1	SERP1	Stress-associated endoplasmic reticulum protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9Y6X1	SERP1	Stress-associated endoplasmic reticulum protein 1	GO:0006950; P:response to stress; TAS:ProtInc
Q9Y6X1	SERP1	Stress-associated endoplasmic reticulum protein 1	GO:0001501; P:skeletal system development; IEA:Ensembl
Q8N6R1	SERP2	Stress-associated endoplasmic reticulum protein 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
A8MV23	SERPINE3	Serpin E3	GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome
A8MV23	SERPINE3	Serpin E3	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
A8MV23	SERPINE3	Serpin E3	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
P50454	SERPINH1	Serpin H1	GO:0005518; F:collagen binding; NAS:UniProtKB
P50454	SERPINH1	Serpin H1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P50454	SERPINH1	Serpin H1	GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome
P50454	SERPINH1	Serpin H1	GO:0032964; P:collagen biosynthetic process; IEA:Ensembl
P50454	SERPINH1	Serpin H1	GO:0030199; P:collagen fibril organization; IEA:Ensembl
P50454	SERPINH1	Serpin H1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P50454	SERPINH1	Serpin H1	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P50454	SERPINH1	Serpin H1	GO:0051604; P:protein maturation; IEA:Ensembl
P50454	SERPINH1	Serpin H1	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
P50454	SERPINH1	Serpin H1	GO:0006986; P:response to unfolded protein; TAS:ProtInc
Q86VW0	SESTD1	SEC14 domain and spectrin repeat-containing protein 1	GO:0070300; F:phosphatidic acid binding; IDA:UniProtKB
Q86VW0	SESTD1	SEC14 domain and spectrin repeat-containing protein 1	GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; IDA:UniProtKB
Q86VW0	SESTD1	SEC14 domain and spectrin repeat-containing protein 1	GO:0080025; F:phosphatidylinositol-3,5-bisphosphate binding; IDA:UniProtKB
Q86VW0	SESTD1	SEC14 domain and spectrin repeat-containing protein 1	GO:0032266; F:phosphatidylinositol-3-phosphate binding; IDA:UniProtKB
Q86VW0	SESTD1	SEC14 domain and spectrin repeat-containing protein 1	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProtKB
Q86VW0	SESTD1	SEC14 domain and spectrin repeat-containing protein 1	GO:0070273; F:phosphatidylinositol-4-phosphate binding; IDA:UniProtKB
Q86VW0	SESTD1	SEC14 domain and spectrin repeat-containing protein 1	GO:0010314; F:phosphatidylinositol-5-phosphate binding; IDA:UniProtKB
Q86VW0	SESTD1	SEC14 domain and spectrin repeat-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6P5	SESN1	Sestrin-1	GO:0007050; P:cell cycle arrest; TAS:ProtInc
Q9Y6P5	SESN1	Sestrin-1	GO:0006974; P:cellular response to DNA damage stimulus; TAS:ProtInc
Q9Y6P5	SESN1	Sestrin-1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P58004	SESN2	Sestrin-2	GO:0007050; P:cell cycle arrest; IEA:InterPro
P58005	SESN3	Sestrin-3	GO:0007050; P:cell cycle arrest; IEA:InterPro
Q8N4B1	FAM109A	Sesquipedalian-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N4B1	FAM109A	Sesquipedalian-1	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q8N4B1	FAM109A	Sesquipedalian-1	GO:0007032; P:endosome organization; IMP:UniProtKB
Q8N4B1	FAM109A	Sesquipedalian-1	GO:0001881; P:receptor recycling; IMP:UniProtKB
Q8N4B1	FAM109A	Sesquipedalian-1	GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB
Q6ICB4	FAM109B	Sesquipedalian-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q6ICB4	FAM109B	Sesquipedalian-2	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q6ICB4	FAM109B	Sesquipedalian-2	GO:0007032; P:endosome organization; IMP:UniProtKB
Q6ICB4	FAM109B	Sesquipedalian-2	GO:0001881; P:receptor recycling; IMP:UniProtKB
Q6ICB4	FAM109B	Sesquipedalian-2	GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB
O15047	SETD1A	Histone-lysine N-methyltransferase SETD1A	GO:0042800; F:histone methyltransferase activity (H3-K4 specific); IDA:UniProtKB
O15047	SETD1A	Histone-lysine N-methyltransferase SETD1A	GO:0000166; F:nucleotide binding; IEA:InterPro
O15047	SETD1A	Histone-lysine N-methyltransferase SETD1A	GO:0005515; F:protein binding; IPI:UniProtKB
O15047	SETD1A	Histone-lysine N-methyltransferase SETD1A	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
O15047	SETD1A	Histone-lysine N-methyltransferase SETD1A	GO:0051568; P:histone H3-K4 methylation; IDA:GOC
O15047	SETD1A	Histone-lysine N-methyltransferase SETD1A	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O15047	SETD1A	Histone-lysine N-methyltransferase SETD1A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UPS6	SETD1B	Histone-lysine N-methyltransferase SETD1B	GO:0018024; F:histone-lysine N-methyltransferase activity; IEA:UniProtKB-EC
Q9UPS6	SETD1B	Histone-lysine N-methyltransferase SETD1B	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9UPS6	SETD1B	Histone-lysine N-methyltransferase SETD1B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UPS6	SETD1B	Histone-lysine N-methyltransferase SETD1B	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9UPS6	SETD1B	Histone-lysine N-methyltransferase SETD1B	GO:0051568; P:histone H3-K4 methylation; IDA:UniProtKB
Q9UPS6	SETD1B	Histone-lysine N-methyltransferase SETD1B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UPS6	SETD1B	Histone-lysine N-methyltransferase SETD1B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15047	SETDB1	Histone-lysine N-methyltransferase SETDB1	GO:0003677; F:DNA binding; IEA:InterPro
Q15047	SETDB1	Histone-lysine N-methyltransferase SETDB1	GO:0018024; F:histone-lysine N-methyltransferase activity; IEA:UniProtKB-EC
Q15047	SETDB1	Histone-lysine N-methyltransferase SETDB1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15047	SETDB1	Histone-lysine N-methyltransferase SETDB1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q15047	SETDB1	Histone-lysine N-methyltransferase SETDB1	GO:0060348; P:bone development; IEA:Ensembl
Q15047	SETDB1	Histone-lysine N-methyltransferase SETDB1	GO:0001833; P:inner cell mass cell proliferation; IEA:Ensembl
Q15047	SETDB1	Histone-lysine N-methyltransferase SETDB1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q15047	SETDB1	Histone-lysine N-methyltransferase SETDB1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96T68	SETDB2	Histone-lysine N-methyltransferase SETDB2	GO:0003677; F:DNA binding; IEA:InterPro
Q96T68	SETDB2	Histone-lysine N-methyltransferase SETDB2	GO:0046974; F:histone methyltransferase activity (H3-K9 specific); IDA:UniProtKB
Q96T68	SETDB2	Histone-lysine N-methyltransferase SETDB2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96T68	SETDB2	Histone-lysine N-methyltransferase SETDB2	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q96T68	SETDB2	Histone-lysine N-methyltransferase SETDB2	GO:0001947; P:heart looping; ISS:UniProtKB
Q96T68	SETDB2	Histone-lysine N-methyltransferase SETDB2	GO:0051567; P:histone H3-K9 methylation; IDA:UniProtKB
Q96T68	SETDB2	Histone-lysine N-methyltransferase SETDB2	GO:0070986; P:left/right axis specification; ISS:UniProtKB
Q96T68	SETDB2	Histone-lysine N-methyltransferase SETDB2	GO:0007067; P:mitosis; IMP:UniProtKB
Q96T68	SETDB2	Histone-lysine N-methyltransferase SETDB2	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q9Y6X0	SETBP1	SET-binding protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BYW2	SETD2	Histone-lysine N-methyltransferase SETD2	GO:0018024; F:histone-lysine N-methyltransferase activity; IDA:UniProtKB
Q9BYW2	SETD2	Histone-lysine N-methyltransferase SETD2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BYW2	SETD2	Histone-lysine N-methyltransferase SETD2	GO:0001525; P:angiogenesis; IEA:Ensembl
Q9BYW2	SETD2	Histone-lysine N-methyltransferase SETD2	GO:0035441; P:cell migration involved in vasculogenesis; IEA:Ensembl
Q9BYW2	SETD2	Histone-lysine N-methyltransferase SETD2	GO:0060977; P:coronary vasculature morphogenesis; IEA:Ensembl
Q9BYW2	SETD2	Histone-lysine N-methyltransferase SETD2	GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl
Q9BYW2	SETD2	Histone-lysine N-methyltransferase SETD2	GO:0060669; P:embryonic placenta morphogenesis; IEA:Ensembl
Q9BYW2	SETD2	Histone-lysine N-methyltransferase SETD2	GO:0030900; P:forebrain development; IEA:Ensembl
Q9BYW2	SETD2	Histone-lysine N-methyltransferase SETD2	GO:0097198; P:histone H3-K36 trimethylation; IDA:UniProtKB
Q9BYW2	SETD2	Histone-lysine N-methyltransferase SETD2	GO:0048332; P:mesoderm morphogenesis; IEA:Ensembl
Q9BYW2	SETD2	Histone-lysine N-methyltransferase SETD2	GO:0006298; P:mismatch repair; IMP:UniProtKB
Q9BYW2	SETD2	Histone-lysine N-methyltransferase SETD2	GO:0001763; P:morphogenesis of a branching structure; IEA:Ensembl
Q9BYW2	SETD2	Histone-lysine N-methyltransferase SETD2	GO:0001843; P:neural tube closure; IEA:Ensembl
Q9BYW2	SETD2	Histone-lysine N-methyltransferase SETD2	GO:0034728; P:nucleosome organization; IMP:UniProtKB
Q9BYW2	SETD2	Histone-lysine N-methyltransferase SETD2	GO:0060039; P:pericardium development; IEA:Ensembl
Q9BYW2	SETD2	Histone-lysine N-methyltransferase SETD2	GO:0010793; P:regulation of mRNA export from nucleus; IMP:UniProtKB
Q9BYW2	SETD2	Histone-lysine N-methyltransferase SETD2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9BYW2	SETD2	Histone-lysine N-methyltransferase SETD2	GO:0048864; P:stem cell development; IEA:Ensembl
Q9BYW2	SETD2	Histone-lysine N-methyltransferase SETD2	GO:0006368; P:transcription elongation from RNA polymerase II promoter; IMP:UniProtKB
Q86TU7	SETD3	Histone-lysine N-methyltransferase setd3	GO:0046975; F:histone methyltransferase activity (H3-K36 specific); ISS:UniProtKB
Q86TU7	SETD3	Histone-lysine N-methyltransferase setd3	GO:0042800; F:histone methyltransferase activity (H3-K4 specific); IEA:Ensembl
Q86TU7	SETD3	Histone-lysine N-methyltransferase setd3	GO:0003713; F:transcription coactivator activity; ISS:UniProtKB
Q86TU7	SETD3	Histone-lysine N-methyltransferase setd3	GO:0010452; P:histone H3-K36 methylation; ISS:UniProtKB
Q86TU7	SETD3	Histone-lysine N-methyltransferase setd3	GO:0018027; P:peptidyl-lysine dimethylation; ISS:UniProtKB
Q86TU7	SETD3	Histone-lysine N-methyltransferase setd3	GO:0018026; P:peptidyl-lysine monomethylation; ISS:UniProtKB
Q86TU7	SETD3	Histone-lysine N-methyltransferase setd3	GO:0018023; P:peptidyl-lysine trimethylation; ISS:UniProtKB
Q86TU7	SETD3	Histone-lysine N-methyltransferase setd3	GO:0051149; P:positive regulation of muscle cell differentiation; IEA:Ensembl
Q86TU7	SETD3	Histone-lysine N-methyltransferase setd3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q86TU7	SETD3	Histone-lysine N-methyltransferase setd3	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q86TU7	SETD3	Histone-lysine N-methyltransferase setd3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NVD3	SETD4	SET domain-containing protein 4	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q8TBK2	SETD6	N-lysine methyltransferase SETD6	GO:0051059; F:NF-kappaB binding; IPI:UniProtKB
Q8TBK2	SETD6	N-lysine methyltransferase SETD6	GO:0005515; F:protein binding; IPI:IntAct
Q8TBK2	SETD6	N-lysine methyltransferase SETD6	GO:0016279; F:protein-lysine N-methyltransferase activity; IDA:UniProtKB
Q8TBK2	SETD6	N-lysine methyltransferase SETD6	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
Q8TBK2	SETD6	N-lysine methyltransferase SETD6	GO:0018026; P:peptidyl-lysine monomethylation; IDA:UniProtKB
Q8TBK2	SETD6	N-lysine methyltransferase SETD6	GO:0050727; P:regulation of inflammatory response; IMP:UniProtKB
Q8WTS6	SETD7	Histone-lysine N-methyltransferase SETD7	GO:0018024; F:histone-lysine N-methyltransferase activity; IDA:UniProtKB
Q8WTS6	SETD7	Histone-lysine N-methyltransferase SETD7	GO:0002039; F:p53 binding; IPI:UniProtKB
Q8WTS6	SETD7	Histone-lysine N-methyltransferase SETD7	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WTS6	SETD7	Histone-lysine N-methyltransferase SETD7	GO:0016279; F:protein-lysine N-methyltransferase activity; IDA:UniProtKB
Q8WTS6	SETD7	Histone-lysine N-methyltransferase SETD7	GO:0016568; P:chromatin modification; NAS:UniProtKB
Q8WTS6	SETD7	Histone-lysine N-methyltransferase SETD7	GO:0018027; P:peptidyl-lysine dimethylation; IDA:UniProtKB
Q8WTS6	SETD7	Histone-lysine N-methyltransferase SETD7	GO:0018026; P:peptidyl-lysine monomethylation; IDA:UniProtKB
Q8WTS6	SETD7	Histone-lysine N-methyltransferase SETD7	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8WTS6	SETD7	Histone-lysine N-methyltransferase SETD7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NQR1	SETD8	N-lysine methyltransferase SETD8	GO:0018024; F:histone-lysine N-methyltransferase activity; IDA:UniProtKB
Q9NQR1	SETD8	N-lysine methyltransferase SETD8	GO:0002039; F:p53 binding; IPI:UniProtKB
Q9NQR1	SETD8	N-lysine methyltransferase SETD8	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NQR1	SETD8	N-lysine methyltransferase SETD8	GO:0016279; F:protein-lysine N-methyltransferase activity; IDA:UniProtKB
Q9NQR1	SETD8	N-lysine methyltransferase SETD8	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q9NQR1	SETD8	N-lysine methyltransferase SETD8	GO:0034968; P:histone lysine methylation; IDA:GOC
Q9NQR1	SETD8	N-lysine methyltransferase SETD8	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9NQR1	SETD8	N-lysine methyltransferase SETD8	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9NQR1	SETD8	N-lysine methyltransferase SETD8	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q9NQR1	SETD8	N-lysine methyltransferase SETD8	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9NQR1	SETD8	N-lysine methyltransferase SETD8	GO:0018026; P:peptidyl-lysine monomethylation; IDA:UniProtKB
Q9NQR1	SETD8	N-lysine methyltransferase SETD8	GO:0043516; P:regulation of DNA damage response, signal transduction by p53 class mediator; IMP:UniProtKB
Q9NQR1	SETD8	N-lysine methyltransferase SETD8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NE22	SETD9	SET domain-containing protein 9	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
P0DME0	SETSIP	Protein SETSIP	GO:0003682; F:chromatin binding; IDA:UniProtKB
P0DME0	SETSIP	Protein SETSIP	GO:0045446; P:endothelial cell differentiation; IDA:UniProtKB
P0DME0	SETSIP	Protein SETSIP	GO:0006334; P:nucleosome assembly; IEA:InterPro
P0DME0	SETSIP	Protein SETSIP	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P0DME0	SETSIP	Protein SETSIP	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q53H47	SETMAR	Histone-lysine N-methyltransferase SETMAR	GO:0004519; F:endonuclease activity; IDA:UniProtKB
Q53H47	SETMAR	Histone-lysine N-methyltransferase SETMAR	GO:0018024; F:histone-lysine N-methyltransferase activity; IEA:UniProtKB-EC
Q53H47	SETMAR	Histone-lysine N-methyltransferase SETMAR	GO:0005515; F:protein binding; IPI:UniProtKB
Q53H47	SETMAR	Histone-lysine N-methyltransferase SETMAR	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q53H47	SETMAR	Histone-lysine N-methyltransferase SETMAR	GO:0043566; F:structure-specific DNA binding; IDA:UniProtKB
Q53H47	SETMAR	Histone-lysine N-methyltransferase SETMAR	GO:0004803; F:transposase activity; TAS:UniProtKB
Q53H47	SETMAR	Histone-lysine N-methyltransferase SETMAR	GO:0008270; F:zinc ion binding; IEA:InterPro
Q53H47	SETMAR	Histone-lysine N-methyltransferase SETMAR	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:UniProtKB
Q53H47	SETMAR	Histone-lysine N-methyltransferase SETMAR	GO:0000729; P:DNA double-strand break processing; IDA:UniProtKB
Q53H47	SETMAR	Histone-lysine N-methyltransferase SETMAR	GO:0015074; P:DNA integration; IEA:InterPro
Q53H47	SETMAR	Histone-lysine N-methyltransferase SETMAR	GO:0071157; P:negative regulation of cell cycle arrest; IMP:UniProtKB
Q53H47	SETMAR	Histone-lysine N-methyltransferase SETMAR	GO:2001251; P:negative regulation of chromosome organization; IDA:UniProtKB
Q53H47	SETMAR	Histone-lysine N-methyltransferase SETMAR	GO:2001034; P:positive regulation of double-strand break repair via nonhomologous end joining; IDA:UniProtKB
Q53H47	SETMAR	Histone-lysine N-methyltransferase SETMAR	GO:0006313; P:transposition, DNA-mediated; TAS:UniProtKB
Q7Z333	SETX	Probable helicase senataxin	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q7Z333	SETX	Probable helicase senataxin	GO:0003677; F:DNA binding; IC:UniProtKB
Q7Z333	SETX	Probable helicase senataxin	GO:0003678; F:DNA helicase activity; TAS:UniProtKB
Q7Z333	SETX	Probable helicase senataxin	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q7Z333	SETX	Probable helicase senataxin	GO:0007623; P:circadian rhythm; IEA:Ensembl
Q7Z333	SETX	Probable helicase senataxin	GO:0032508; P:DNA duplex unwinding; TAS:GOC
Q7Z333	SETX	Probable helicase senataxin	GO:0006302; P:double-strand break repair; IDA:UniProtKB
Q7Z333	SETX	Probable helicase senataxin	GO:0006396; P:RNA processing; TAS:UniProtKB
Q7Z333	SETX	Probable helicase senataxin	GO:0006369; P:termination of RNA polymerase II transcription; IEA:Ensembl
Q01105	SET	Protein SET	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q01105	SET	Protein SET	GO:0042393; F:histone binding; TAS:UniProtKB
Q01105	SET	Protein SET	GO:0005515; F:protein binding; IPI:UniProtKB
Q01105	SET	Protein SET	GO:0004864; F:protein phosphatase inhibitor activity; TAS:ProtInc
Q01105	SET	Protein SET	GO:0008601; F:protein phosphatase type 2A regulator activity; TAS:UniProtKB
Q01105	SET	Protein SET	GO:0006260; P:DNA replication; TAS:ProtInc
Q01105	SET	Protein SET	GO:0010467; P:gene expression; TAS:Reactome
Q01105	SET	Protein SET	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q01105	SET	Protein SET	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q01105	SET	Protein SET	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
Q01105	SET	Protein SET	GO:0035067; P:negative regulation of histone acetylation; TAS:UniProtKB
Q01105	SET	Protein SET	GO:0043524; P:negative regulation of neuron apoptotic process; IGI:MGI
Q01105	SET	Protein SET	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q01105	SET	Protein SET	GO:0006913; P:nucleocytoplasmic transport; NAS:UniProtKB
Q01105	SET	Protein SET	GO:0006334; P:nucleosome assembly; TAS:ProtInc
Q01105	SET	Protein SET	GO:0006337; P:nucleosome disassembly; TAS:UniProtKB
Q01105	SET	Protein SET	GO:0050790; P:regulation of catalytic activity; TAS:GOC
Q01105	SET	Protein SET	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q53EL9	SEZ6	Seizure protein 6 homolog	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
Q53EL9	SEZ6	Seizure protein 6 homolog	GO:0021680; P:cerebellar Purkinje cell layer development; IEA:Ensembl
Q53EL9	SEZ6	Seizure protein 6 homolog	GO:2000171; P:negative regulation of dendrite development; IEA:Ensembl
Q53EL9	SEZ6	Seizure protein 6 homolog	GO:1900006; P:positive regulation of dendrite development; IEA:Ensembl
Q53EL9	SEZ6	Seizure protein 6 homolog	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
Q53EL9	SEZ6	Seizure protein 6 homolog	GO:0090036; P:regulation of protein kinase C signaling; IEA:Ensembl
Q53EL9	SEZ6	Seizure protein 6 homolog	GO:0060074; P:synapse maturation; IEA:Ensembl
Q15637	SF1	Splicing factor 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15637	SF1	Splicing factor 1	GO:0003723; F:RNA binding; TAS:UniProtKB
Q15637	SF1	Splicing factor 1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q15637	SF1	Splicing factor 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q15637	SF1	Splicing factor 1	GO:0033327; P:Leydig cell differentiation; IEA:Ensembl
Q15637	SF1	Splicing factor 1	GO:0030238; P:male sex determination; IEA:Ensembl
Q15637	SF1	Splicing factor 1	GO:0000389; P:mRNA 3'-splice site recognition; TAS:HGNC
Q15637	SF1	Splicing factor 1	GO:0000398; P:mRNA splicing, via spliceosome; IC:HGNC
Q15637	SF1	Splicing factor 1	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IEA:Ensembl
Q15637	SF1	Splicing factor 1	GO:0050810; P:regulation of steroid biosynthetic process; IEA:Ensembl
Q15637	SF1	Splicing factor 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q15637	SF1	Splicing factor 1	GO:0000245; P:spliceosomal complex assembly; NAS:UniProtKB
Q15637	SF1	Splicing factor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15459	SF3A1	Splicing factor 3A subunit 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15459	SF3A1	Splicing factor 3A subunit 1	GO:0005515; F:protein binding; IPI:IntAct
Q15459	SF3A1	Splicing factor 3A subunit 1	GO:0003723; F:RNA binding; IDA:UniProtKB
Q15459	SF3A1	Splicing factor 3A subunit 1	GO:0010467; P:gene expression; TAS:Reactome
Q15459	SF3A1	Splicing factor 3A subunit 1	GO:0000389; P:mRNA 3'-splice site recognition; TAS:HGNC
Q15459	SF3A1	Splicing factor 3A subunit 1	GO:0006397; P:mRNA processing; IMP:HGNC
Q15459	SF3A1	Splicing factor 3A subunit 1	GO:0000398; P:mRNA splicing, via spliceosome; IDA:UniProtKB
Q15459	SF3A1	Splicing factor 3A subunit 1	GO:0008380; P:RNA splicing; TAS:Reactome
Q15428	SF3A2	Splicing factor 3A subunit 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15428	SF3A2	Splicing factor 3A subunit 2	GO:0005515; F:protein binding; IPI:IntAct
Q15428	SF3A2	Splicing factor 3A subunit 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q15428	SF3A2	Splicing factor 3A subunit 2	GO:0010467; P:gene expression; TAS:Reactome
Q15428	SF3A2	Splicing factor 3A subunit 2	GO:0000389; P:mRNA 3'-splice site recognition; TAS:HGNC
Q15428	SF3A2	Splicing factor 3A subunit 2	GO:0006397; P:mRNA processing; IMP:HGNC
Q15428	SF3A2	Splicing factor 3A subunit 2	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q15428	SF3A2	Splicing factor 3A subunit 2	GO:0008380; P:RNA splicing; TAS:Reactome
Q12874	SF3A3	Splicing factor 3A subunit 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q12874	SF3A3	Splicing factor 3A subunit 3	GO:0005515; F:protein binding; IPI:IntAct
Q12874	SF3A3	Splicing factor 3A subunit 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q12874	SF3A3	Splicing factor 3A subunit 3	GO:0010467; P:gene expression; TAS:Reactome
Q12874	SF3A3	Splicing factor 3A subunit 3	GO:0000389; P:mRNA 3'-splice site recognition; TAS:HGNC
Q12874	SF3A3	Splicing factor 3A subunit 3	GO:0006397; P:mRNA processing; IMP:HGNC
Q12874	SF3A3	Splicing factor 3A subunit 3	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q12874	SF3A3	Splicing factor 3A subunit 3	GO:0008380; P:RNA splicing; TAS:Reactome
Q12874	SF3A3	Splicing factor 3A subunit 3	GO:0000375; P:RNA splicing, via transesterification reactions; TAS:UniProtKB
O75533	SF3B1	Splicing factor 3B subunit 1	GO:0003682; F:chromatin binding; IEA:Ensembl
O75533	SF3B1	Splicing factor 3B subunit 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75533	SF3B1	Splicing factor 3B subunit 1	GO:0005515; F:protein binding; IPI:IntAct
O75533	SF3B1	Splicing factor 3B subunit 1	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
O75533	SF3B1	Splicing factor 3B subunit 1	GO:0010467; P:gene expression; TAS:Reactome
O75533	SF3B1	Splicing factor 3B subunit 1	GO:0000398; P:mRNA splicing, via spliceosome; NAS:UniProtKB
O75533	SF3B1	Splicing factor 3B subunit 1	GO:0008380; P:RNA splicing; TAS:Reactome
O75533	SF3B1	Splicing factor 3B subunit 1	GO:0000375; P:RNA splicing, via transesterification reactions; NAS:UniProtKB
Q13435	SF3B2	Splicing factor 3B subunit 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13435	SF3B2	Splicing factor 3B subunit 2	GO:0005515; F:protein binding; IPI:IntAct
Q13435	SF3B2	Splicing factor 3B subunit 2	GO:0010467; P:gene expression; TAS:Reactome
Q13435	SF3B2	Splicing factor 3B subunit 2	GO:0006397; P:mRNA processing; TAS:ProtInc
Q13435	SF3B2	Splicing factor 3B subunit 2	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q13435	SF3B2	Splicing factor 3B subunit 2	GO:0008380; P:RNA splicing; TAS:Reactome
Q13435	SF3B2	Splicing factor 3B subunit 2	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q15393	SF3B3	Splicing factor 3B subunit 3	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q15393	SF3B3	Splicing factor 3B subunit 3	GO:0010467; P:gene expression; TAS:Reactome
Q15393	SF3B3	Splicing factor 3B subunit 3	GO:0006397; P:mRNA processing; TAS:ProtInc
Q15393	SF3B3	Splicing factor 3B subunit 3	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q15393	SF3B3	Splicing factor 3B subunit 3	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q15393	SF3B3	Splicing factor 3B subunit 3	GO:0008380; P:RNA splicing; TAS:Reactome
Q15393	SF3B3	Splicing factor 3B subunit 3	GO:0000375; P:RNA splicing, via transesterification reactions; TAS:UniProtKB
Q15427	SF3B4	Splicing factor 3B subunit 4	GO:0000166; F:nucleotide binding; IEA:InterPro
Q15427	SF3B4	Splicing factor 3B subunit 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15427	SF3B4	Splicing factor 3B subunit 4	GO:0005515; F:protein binding; IPI:IntAct
Q15427	SF3B4	Splicing factor 3B subunit 4	GO:0010467; P:gene expression; TAS:Reactome
Q15427	SF3B4	Splicing factor 3B subunit 4	GO:0006397; P:mRNA processing; TAS:ProtInc
Q15427	SF3B4	Splicing factor 3B subunit 4	GO:0000398; P:mRNA splicing, via spliceosome; IC:HGNC
Q15427	SF3B4	Splicing factor 3B subunit 4	GO:0008380; P:RNA splicing; TAS:Reactome
Q15427	SF3B4	Splicing factor 3B subunit 4	GO:0000375; P:RNA splicing, via transesterification reactions; TAS:ProtInc
Q9BWJ5	SF3B5	Splicing factor 3B subunit 5	GO:0010467; P:gene expression; TAS:Reactome
Q9BWJ5	SF3B5	Splicing factor 3B subunit 5	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q9BWJ5	SF3B5	Splicing factor 3B subunit 5	GO:0008380; P:RNA splicing; TAS:Reactome
Q9Y3B4	SF3B6	Splicing factor 3B subunit 6	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9Y3B4	SF3B6	Splicing factor 3B subunit 6	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9Y3B4	SF3B6	Splicing factor 3B subunit 6	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y3B4	SF3B6	Splicing factor 3B subunit 6	GO:0010467; P:gene expression; TAS:Reactome
Q9Y3B4	SF3B6	Splicing factor 3B subunit 6	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q9Y3B4	SF3B6	Splicing factor 3B subunit 6	GO:0008380; P:RNA splicing; TAS:Reactome
A8K8P3	SFI1	Protein SFI1 homolog	GO:0019902; F:phosphatase binding; IDA:UniProtKB
A8K8P3	SFI1	Protein SFI1 homolog	GO:0005515; F:protein binding; IPI:IntAct
A8K8P3	SFI1	Protein SFI1 homolog	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
A8K8P3	SFI1	Protein SFI1 homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
A8K8P3	SFI1	Protein SFI1 homolog	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q8IWL1	SFTPA2	Pulmonary surfactant-associated protein A2	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q8IWL1	SFTPA2	Pulmonary surfactant-associated protein A2	GO:0007585; P:respiratory gaseous exchange; IEA:UniProtKB-KW
P23246	SFPQ	Splicing factor, proline- and glutamine-rich	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P23246	SFPQ	Splicing factor, proline- and glutamine-rich	GO:0000166; F:nucleotide binding; IEA:InterPro
P23246	SFPQ	Splicing factor, proline- and glutamine-rich	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P23246	SFPQ	Splicing factor, proline- and glutamine-rich	GO:0005515; F:protein binding; IPI:IntAct
P23246	SFPQ	Splicing factor, proline- and glutamine-rich	GO:0000380; P:alternative mRNA splicing, via spliceosome; IMP:BHF-UCL
P23246	SFPQ	Splicing factor, proline- and glutamine-rich	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
P23246	SFPQ	Splicing factor, proline- and glutamine-rich	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
P23246	SFPQ	Splicing factor, proline- and glutamine-rich	GO:0006397; P:mRNA processing; TAS:ProtInc
P23246	SFPQ	Splicing factor, proline- and glutamine-rich	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P23246	SFPQ	Splicing factor, proline- and glutamine-rich	GO:0008380; P:RNA splicing; TAS:ProtInc
P23246	SFPQ	Splicing factor, proline- and glutamine-rich	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95104	SCAF4	Splicing factor, arginine/serine-rich 15	GO:0000166; F:nucleotide binding; IEA:InterPro
O95104	SCAF4	Splicing factor, arginine/serine-rich 15	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H7N4	SCAF1	Splicing factor, arginine/serine-rich 19	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9H7N4	SCAF1	Splicing factor, arginine/serine-rich 19	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9H7N4	SCAF1	Splicing factor, arginine/serine-rich 19	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q9H7N4	SCAF1	Splicing factor, arginine/serine-rich 19	GO:0006366; P:transcription from RNA polymerase II promoter; IEA:Ensembl
Q86XK3	SFR1	Swi5-dependent recombination DNA repair protein 1 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q86XK3	SFR1	Swi5-dependent recombination DNA repair protein 1 homolog	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0004197; F:cysteine-type endopeptidase activity; IMP:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0008144; F:drug binding; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0005109; F:frizzled binding; IPI:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0008201; F:heparin binding; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0042802; F:identical protein binding; IPI:BHF-UCL
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0030165; F:PDZ domain binding; IBA:RefGenome
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0042813; F:Wnt-activated receptor activity; IBA:RefGenome
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0017147; F:Wnt-protein binding; IPI:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0060346; P:bone trabecula formation; IEA:Ensembl
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0007420; P:brain development; IBA:RefGenome
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0060070; P:canonical Wnt signaling pathway; IDA:BHF-UCL
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0071773; P:cellular response to BMP stimulus; IEP:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0071392; P:cellular response to estradiol stimulus; IEP:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0071391; P:cellular response to estrogen stimulus; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0044344; P:cellular response to fibroblast growth factor stimulus; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0071363; P:cellular response to growth factor stimulus; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0071504; P:cellular response to heparin; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0071456; P:cellular response to hypoxia; IEP:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0071347; P:cellular response to interleukin-1; IEP:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0071380; P:cellular response to prostaglandin E stimulus; IEP:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0009267; P:cellular response to starvation; IEP:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0071356; P:cellular response to tumor necrosis factor; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0071305; P:cellular response to vitamin D; IEP:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0071481; P:cellular response to X-ray; IEA:Ensembl
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0090246; P:convergent extension involved in somitogenesis; IEA:Ensembl
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0048546; P:digestive tract morphogenesis; IEA:Ensembl
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0009950; P:dorsal/ventral axis specification; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0009790; P:embryo development; IBA:RefGenome
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0008585; P:female gonad development; IEA:Ensembl
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0008406; P:gonad development; IBA:RefGenome
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0002244; P:hematopoietic progenitor cell differentiation; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0060218; P:hematopoietic stem cell differentiation; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0008584; P:male gonad development; IEA:Ensembl
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0022601; P:menstrual cycle phase; IEP:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0060766; P:negative regulation of androgen receptor signaling pathway; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0045578; P:negative regulation of B cell differentiation; IMP:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0030514; P:negative regulation of BMP signaling pathway; IEA:Ensembl
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0046851; P:negative regulation of bone remodeling; IMP:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:2000080; P:negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0050680; P:negative regulation of epithelial cell proliferation; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0010719; P:negative regulation of epithelial to mesenchymal transition; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:2000270; P:negative regulation of fibroblast apoptotic process; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0048147; P:negative regulation of fibroblast proliferation; IDA:BHF-UCL
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0046676; P:negative regulation of insulin secretion; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0043508; P:negative regulation of JUN kinase activity; IEA:Ensembl
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0030279; P:negative regulation of ossification; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0033689; P:negative regulation of osteoblast proliferation; IMP:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0045671; P:negative regulation of osteoclast differentiation; IEA:Ensembl
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0050732; P:negative regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:2000041; P:negative regulation of planar cell polarity pathway involved in axis elongation; IEA:Ensembl
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0030178; P:negative regulation of Wnt signaling pathway; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:2000054; P:negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0014034; P:neural crest cell fate commitment; IEA:Ensembl
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0001843; P:neural tube closure; IEA:Ensembl
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0001649; P:osteoblast differentiation; IEP:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0090179; P:planar cell polarity pathway involved in neural tube closure; IEA:Ensembl
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0030307; P:positive regulation of cell growth; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0001954; P:positive regulation of cell-matrix adhesion; ISS:BHF-UCL
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0050679; P:positive regulation of epithelial cell proliferation; IMP:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; IDA:BHF-UCL
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0045600; P:positive regulation of fat cell differentiation; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:2000271; P:positive regulation of fibroblast apoptotic process; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0051894; P:positive regulation of focal adhesion assembly; ISS:BHF-UCL
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:2000052; P:positive regulation of non-canonical Wnt signaling pathway; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0032855; P:positive regulation of Rac GTPase activity; ISS:BHF-UCL
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0045880; P:positive regulation of smoothened signaling pathway; IMP:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0051496; P:positive regulation of stress fiber assembly; ISS:BHF-UCL
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0030177; P:positive regulation of Wnt signaling pathway; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0060527; P:prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis; IEA:Ensembl
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0006508; P:proteolysis; IMP:GOC
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0045765; P:regulation of angiogenesis; ISS:BHF-UCL
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0060687; P:regulation of branching involved in prostate gland morphogenesis; IEA:Ensembl
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0010564; P:regulation of cell cycle process; IMP:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0042493; P:response to drug; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0014070; P:response to organic cyclic compound; IDA:UniProtKB
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0044345; P:stromal-epithelial cell signaling involved in prostate gland development; IEA:Ensembl
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0001657; P:ureteric bud development; IEA:Ensembl
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0001944; P:vasculature development; IBA:RefGenome
Q8N474	SFRP1	Secreted frizzled-related protein 1	GO:0090244; P:Wnt signaling pathway involved in somitogenesis; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0061133; F:endopeptidase activator activity; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0001968; F:fibronectin binding; ISS:BHF-UCL
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0005178; F:integrin binding; ISS:BHF-UCL
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0010577; F:metalloenzyme activator activity; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0030165; F:PDZ domain binding; IBA:RefGenome
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0048018; F:receptor agonist activity; ISS:BHF-UCL
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0042813; F:Wnt-activated receptor activity; IBA:RefGenome
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0017147; F:Wnt-protein binding; IBA:RefGenome
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0060349; P:bone morphogenesis; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0007420; P:brain development; IBA:RefGenome
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0003214; P:cardiac left ventricle morphogenesis; IMP:BHF-UCL
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0007267; P:cell-cell signaling; ISS:BHF-UCL
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0031668; P:cellular response to extracellular stimulus; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0071481; P:cellular response to X-ray; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0002063; P:chondrocyte development; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0030199; P:collagen fibril organization; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0060028; P:convergent extension involved in axis elongation; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0048546; P:digestive tract morphogenesis; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0009790; P:embryo development; IBA:RefGenome
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0008406; P:gonad development; IBA:RefGenome
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0071425; P:hematopoietic stem cell proliferation; ISS:UniProtKB
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0008584; P:male gonad development; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0030514; P:negative regulation of BMP signaling pathway; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:UniProtKB
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0030336; P:negative regulation of cell migration; ISS:UniProtKB
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0061185; P:negative regulation of dermatome development; ISS:BHF-UCL
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0050680; P:negative regulation of epithelial cell proliferation; IDA:UniProtKB
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0010719; P:negative regulation of epithelial to mesenchymal transition; IDA:UniProtKB
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0010629; P:negative regulation of gene expression; ISS:UniProtKB
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:1902230; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; ISS:BHF-UCL
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0043508; P:negative regulation of JUN kinase activity; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0042662; P:negative regulation of mesodermal cell fate specification; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0050732; P:negative regulation of peptidyl-tyrosine phosphorylation; ISS:UniProtKB
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:2000041; P:negative regulation of planar cell polarity pathway involved in axis elongation; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0030178; P:negative regulation of Wnt signaling pathway; IDA:UniProtKB
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0001843; P:neural tube closure; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0003151; P:outflow tract morphogenesis; IMP:BHF-UCL
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0001569; P:patterning of blood vessels; ISS:BHF-UCL
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0090179; P:planar cell polarity pathway involved in neural tube closure; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0045766; P:positive regulation of angiogenesis; ISS:BHF-UCL
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0043065; P:positive regulation of apoptotic process; IMP:BHF-UCL
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; ISS:BHF-UCL
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0035413; P:positive regulation of catenin import into nucleus; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0033630; P:positive regulation of cell adhesion mediated by integrin; ISS:BHF-UCL
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0030307; P:positive regulation of cell growth; ISS:UniProtKB
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0045600; P:positive regulation of fat cell differentiation; IDA:MGI
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISS:BHF-UCL
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:2000035; P:regulation of stem cell division; ISS:UniProtKB
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0042493; P:response to drug; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0007584; P:response to nutrient; IEA:Ensembl
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0061056; P:sclerotome development; ISS:BHF-UCL
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0001944; P:vasculature development; IBA:RefGenome
Q96HF1	SFRP2	Secreted frizzled-related protein 2	GO:0090244; P:Wnt signaling pathway involved in somitogenesis; IEA:Ensembl
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0030165; F:PDZ domain binding; IBA:RefGenome
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0042813; F:Wnt-activated receptor activity; IBA:RefGenome
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0017147; F:Wnt-protein binding; ISS:UniProtKB
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0007420; P:brain development; IBA:RefGenome
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0090103; P:cochlea morphogenesis; IBA:RefGenome
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0060029; P:convergent extension involved in organogenesis; IEA:Ensembl
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0060429; P:epithelium development; IBA:RefGenome
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0008406; P:gonad development; IBA:RefGenome
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0060056; P:mammary gland involution; IBA:RefGenome
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:UniProtKB
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0061037; P:negative regulation of cartilage development; IBA:RefGenome
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0010721; P:negative regulation of cell development; IEA:Ensembl
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0070367; P:negative regulation of hepatocyte differentiation; IBA:RefGenome
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0030178; P:negative regulation of Wnt signaling pathway; IDA:UniProtKB
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0014033; P:neural crest cell differentiation; IEA:Ensembl
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0043065; P:positive regulation of apoptotic process; IGI:MGI
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0045600; P:positive regulation of fat cell differentiation; IDA:MGI
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0001501; P:skeletal system development; TAS:ProtInc
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0061053; P:somite development; IEA:Ensembl
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0001944; P:vasculature development; IBA:RefGenome
Q92765	FRZB	Secreted frizzled-related protein 3	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0030165; F:PDZ domain binding; IBA:RefGenome
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0042813; F:Wnt-activated receptor activity; IBA:RefGenome
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0017147; F:Wnt-protein binding; IBA:RefGenome
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0007420; P:brain development; IBA:RefGenome
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0046697; P:decidualization; IBA:RefGenome
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0009790; P:embryo development; IBA:RefGenome
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0060429; P:epithelium development; IBA:RefGenome
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0008406; P:gonad development; IBA:RefGenome
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0060056; P:mammary gland involution; IBA:RefGenome
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0022601; P:menstrual cycle phase; NAS:BHF-UCL
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:BHF-UCL
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0008285; P:negative regulation of cell proliferation; IMP:BHF-UCL
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0046329; P:negative regulation of JNK cascade; IBA:RefGenome
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:2000119; P:negative regulation of sodium-dependent phosphate transport; IDA:BHF-UCL
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0055062; P:phosphate ion homeostasis; IDA:BHF-UCL
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0043065; P:positive regulation of apoptotic process; IMP:BHF-UCL
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IGI:MGI
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0045606; P:positive regulation of epidermal cell differentiation; IDA:BHF-UCL
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0010628; P:positive regulation of gene expression; IDA:BHF-UCL
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:1902174; P:positive regulation of keratinocyte apoptotic process; IDA:BHF-UCL
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0002092; P:positive regulation of receptor internalization; IDA:BHF-UCL
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0009725; P:response to hormone; NAS:BHF-UCL
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0001944; P:vasculature development; IBA:RefGenome
Q6FHJ7	SFRP4	Secreted frizzled-related protein 4	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0030165; F:PDZ domain binding; IBA:RefGenome
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0042813; F:Wnt-activated receptor activity; IBA:RefGenome
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0017147; F:Wnt-protein binding; IBA:RefGenome
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0006915; P:apoptotic process; TAS:ProtInc
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0007420; P:brain development; IBA:RefGenome
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0060028; P:convergent extension involved in axis elongation; IEA:Ensembl
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0048546; P:digestive tract morphogenesis; IEA:Ensembl
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0009790; P:embryo development; IBA:RefGenome
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0007163; P:establishment or maintenance of cell polarity; TAS:ProtInc
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0008406; P:gonad development; IBA:RefGenome
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0035414; P:negative regulation of catenin import into nucleus; IMP:BHF-UCL
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0008285; P:negative regulation of cell proliferation; IMP:BHF-UCL
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0043508; P:negative regulation of JUN kinase activity; IEA:Ensembl
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:2000041; P:negative regulation of planar cell polarity pathway involved in axis elongation; IEA:Ensembl
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0051898; P:negative regulation of protein kinase B signaling; IMP:BHF-UCL
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:2000057; P:negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis; IMP:BHF-UCL
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0090179; P:planar cell polarity pathway involved in neural tube closure; IEA:Ensembl
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0007165; P:signal transduction; TAS:ProtInc
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0001944; P:vasculature development; IBA:RefGenome
Q5T4F7	SFRP5	Secreted frizzled-related protein 5	GO:0007601; P:visual perception; TAS:ProtInc
Q12872	SFSWAP	Splicing factor, suppressor of white-apricot homolog	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q12872	SFSWAP	Splicing factor, suppressor of white-apricot homolog	GO:0006397; P:mRNA processing; TAS:ProtInc
Q12872	SFSWAP	Splicing factor, suppressor of white-apricot homolog	GO:0006376; P:mRNA splice site selection; TAS:ProtInc
Q12872	SFSWAP	Splicing factor, suppressor of white-apricot homolog	GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; ISS:UniProtKB
Q12872	SFSWAP	Splicing factor, suppressor of white-apricot homolog	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q12872	SFSWAP	Splicing factor, suppressor of white-apricot homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WV19	SFT2D1	Vesicle transport protein SFT2A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8WV19	SFT2D1	Vesicle transport protein SFT2A	GO:0016192; P:vesicle-mediated transport; IEA:InterPro
O95562	SFT2D2	Vesicle transport protein SFT2B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O95562	SFT2D2	Vesicle transport protein SFT2B	GO:0016192; P:vesicle-mediated transport; IEA:InterPro
Q587I9	SFT2D3	Vesicle transport protein SFT2C	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q587I9	SFT2D3	Vesicle transport protein SFT2C	GO:0016192; P:vesicle-mediated transport; IEA:InterPro
Q8IWL2	SFTPA1	Pulmonary surfactant-associated protein A1	GO:0030246; F:carbohydrate binding; IEA:InterPro
Q8IWL2	SFTPA1	Pulmonary surfactant-associated protein A1	GO:0005319; F:lipid transporter activity; TAS:ProtInc
Q8IWL2	SFTPA1	Pulmonary surfactant-associated protein A1	GO:0006869; P:lipid transport; TAS:GOC
Q8IWL2	SFTPA1	Pulmonary surfactant-associated protein A1	GO:0007585; P:respiratory gaseous exchange; IEA:UniProtKB-KW
P35247	SFTPD	Pulmonary surfactant-associated protein D	GO:0030246; F:carbohydrate binding; TAS:UniProtKB
P35247	SFTPD	Pulmonary surfactant-associated protein D	GO:0005515; F:protein binding; IPI:UniProtKB
P35247	SFTPD	Pulmonary surfactant-associated protein D	GO:0042742; P:defense response to bacterium; TAS:UniProtKB
P35247	SFTPD	Pulmonary surfactant-associated protein D	GO:0045087; P:innate immune response; TAS:UniProtKB
P35247	SFTPD	Pulmonary surfactant-associated protein D	GO:0048286; P:lung alveolus development; IMP:UniProtKB
P35247	SFTPD	Pulmonary surfactant-associated protein D	GO:0048246; P:macrophage chemotaxis; TAS:UniProtKB
P35247	SFTPD	Pulmonary surfactant-associated protein D	GO:0045085; P:negative regulation of interleukin-2 biosynthetic process; TAS:UniProtKB
P35247	SFTPD	Pulmonary surfactant-associated protein D	GO:0042130; P:negative regulation of T cell proliferation; TAS:UniProtKB
P35247	SFTPD	Pulmonary surfactant-associated protein D	GO:0050766; P:positive regulation of phagocytosis; TAS:UniProtKB
P35247	SFTPD	Pulmonary surfactant-associated protein D	GO:0072593; P:reactive oxygen species metabolic process; TAS:UniProtKB
P35247	SFTPD	Pulmonary surfactant-associated protein D	GO:0006898; P:receptor-mediated endocytosis; TAS:UniProtKB
P35247	SFTPD	Pulmonary surfactant-associated protein D	GO:0001817; P:regulation of cytokine production; NAS:UniProtKB
P35247	SFTPD	Pulmonary surfactant-associated protein D	GO:0007585; P:respiratory gaseous exchange; IEA:UniProtKB-KW
P35247	SFTPD	Pulmonary surfactant-associated protein D	GO:0043129; P:surfactant homeostasis; IMP:UniProtKB
Q9H9B4	SFXN1	Sideroflexin-1	GO:0008324; F:cation transmembrane transporter activity; IEA:InterPro
Q9H9B4	SFXN1	Sideroflexin-1	GO:0030218; P:erythrocyte differentiation; IEA:Ensembl
Q9H9B4	SFXN1	Sideroflexin-1	GO:0055072; P:iron ion homeostasis; IEA:UniProtKB-KW
Q9H9B4	SFXN1	Sideroflexin-1	GO:0006826; P:iron ion transport; IEA:Ensembl
Q96NB2	SFXN2	Sideroflexin-2	GO:0008324; F:cation transmembrane transporter activity; IEA:InterPro
Q96NB2	SFXN2	Sideroflexin-2	GO:0055072; P:iron ion homeostasis; IEA:UniProtKB-KW
Q9BWM7	SFXN3	Sideroflexin-3	GO:0008324; F:cation transmembrane transporter activity; IEA:InterPro
Q9BWM7	SFXN3	Sideroflexin-3	GO:0055072; P:iron ion homeostasis; IEA:UniProtKB-KW
Q6P4A7	SFXN4	Sideroflexin-4	GO:0008324; F:cation transmembrane transporter activity; IEA:InterPro
Q6P4A7	SFXN4	Sideroflexin-4	GO:0055072; P:iron ion homeostasis; IEA:UniProtKB-KW
Q8TD22	SFXN5	Sideroflexin-5	GO:0008324; F:cation transmembrane transporter activity; IEA:InterPro
Q8TD22	SFXN5	Sideroflexin-5	GO:0015137; F:citrate transmembrane transporter activity; IEA:Ensembl
Q8TD22	SFXN5	Sideroflexin-5	GO:0055072; P:iron ion homeostasis; IEA:UniProtKB-KW
Q08648	SPAG11B	Sperm-associated antigen 11B	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q9H5K3	POMK	Protein O-mannose kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H5K3	POMK	Protein O-mannose kinase	GO:0016773; F:phosphotransferase activity, alcohol group as acceptor; IDA:UniProtKB
Q9H5K3	POMK	Protein O-mannose kinase	GO:0004672; F:protein kinase activity; IEA:InterPro
Q9H5K3	POMK	Protein O-mannose kinase	GO:0007420; P:brain development; TAS:UniProtKB
Q9H5K3	POMK	Protein O-mannose kinase	GO:0046835; P:carbohydrate phosphorylation; IDA:UniProtKB
Q9H5K3	POMK	Protein O-mannose kinase	GO:0007611; P:learning or memory; IEA:Ensembl
Q9H5K3	POMK	Protein O-mannose kinase	GO:0050905; P:neuromuscular process; IEA:Ensembl
Q9H5K3	POMK	Protein O-mannose kinase	GO:0001764; P:neuron migration; IEA:Ensembl
Q9H5K3	POMK	Protein O-mannose kinase	GO:0006493; P:protein O-linked glycosylation; IDA:UniProtKB
Q9H5K3	POMK	Protein O-mannose kinase	GO:0019233; P:sensory perception of pain; IEA:Ensembl
O95968	SCGB1D1	Secretoglobin family 1D member 1	GO:0046982; F:protein heterodimerization activity; IDA:UniProt
Q86YV5	SGK223	Tyrosine-protein kinase SgK223	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86YV5	SGK223	Tyrosine-protein kinase SgK223	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC
O75556	SCGB2A1	Mammaglobin-B	GO:0046982; F:protein heterodimerization activity; IDA:UniProt
O75556	SCGB2A1	Mammaglobin-B	GO:0005496; F:steroid binding; IEA:InterPro
O75556	SCGB2A1	Mammaglobin-B	GO:0030521; P:androgen receptor signaling pathway; IDA:UniProt
Q96QR1	SCGB3A1	Secretoglobin family 3A member 1	GO:0005125; F:cytokine activity; NAS:UniProtKB
Q96QR1	SCGB3A1	Secretoglobin family 3A member 1	GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB
Q96QR1	SCGB3A1	Secretoglobin family 3A member 1	GO:0042127; P:regulation of cell proliferation; NAS:UniProtKB
Q96LW2	SGK494	Uncharacterized serine/threonine-protein kinase SgK494	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96LW2	SGK494	Uncharacterized serine/threonine-protein kinase SgK494	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q16586	SGCA	Alpha-sarcoglycan	GO:0005509; F:calcium ion binding; IEA:InterPro
Q16586	SGCA	Alpha-sarcoglycan	GO:0006936; P:muscle contraction; TAS:ProtInc
Q16586	SGCA	Alpha-sarcoglycan	GO:0007517; P:muscle organ development; TAS:ProtInc
Q92629	SGCD	Delta-sarcoglycan	GO:0007517; P:muscle organ development; TAS:ProtInc
Q16585	SGCB	Beta-sarcoglycan	GO:0035051; P:cardiocyte differentiation; IEA:Ensembl
Q16585	SGCB	Beta-sarcoglycan	GO:0007517; P:muscle organ development; TAS:ProtInc
O43556	SGCE	Epsilon-sarcoglycan	GO:0005509; F:calcium ion binding; IEA:InterPro
O43556	SGCE	Epsilon-sarcoglycan	GO:0007160; P:cell-matrix adhesion; TAS:ProtInc
O43556	SGCE	Epsilon-sarcoglycan	GO:0007517; P:muscle organ development; TAS:ProtInc
Q13326	SGCG	Gamma-sarcoglycan	GO:0005515; F:protein binding; IPI:IntAct
Q13326	SGCG	Gamma-sarcoglycan	GO:0007517; P:muscle organ development; TAS:ProtInc
Q96LD1	SGCZ	Zeta-sarcoglycan	GO:0061024; P:membrane organization; TAS:BHF-UCL
Q96LD1	SGCZ	Zeta-sarcoglycan	GO:0046716; P:muscle cell cellular homeostasis; TAS:BHF-UCL
Q96LD1	SGCZ	Zeta-sarcoglycan	GO:0055001; P:muscle cell development; TAS:BHF-UCL
Q96ES7	CCDC101	SAGA-associated factor 29 homolog	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q96ES7	CCDC101	SAGA-associated factor 29 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q96ES7	CCDC101	SAGA-associated factor 29 homolog	GO:0006325; P:chromatin organization; TAS:Reactome
Q96ES7	CCDC101	SAGA-associated factor 29 homolog	GO:0071169; P:establishment of protein localization to chromatin; TAS:UniProtKB
Q96ES7	CCDC101	SAGA-associated factor 29 homolog	GO:0043966; P:histone H3 acetylation; IDA:BHF-UCL
Q96ES7	CCDC101	SAGA-associated factor 29 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96ES7	CCDC101	SAGA-associated factor 29 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BQI5	SGIP1	SH3-containing GRB2-like protein 3-interacting protein 1	GO:0008017; F:microtubule binding; ISS:UniProtKB
Q9BQI5	SGIP1	SH3-containing GRB2-like protein 3-interacting protein 1	GO:0005543; F:phospholipid binding; ISS:UniProtKB
Q9BQI5	SGIP1	SH3-containing GRB2-like protein 3-interacting protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BQI5	SGIP1	SH3-containing GRB2-like protein 3-interacting protein 1	GO:0017124; F:SH3 domain binding; IPI:UniProtKB
Q9BQI5	SGIP1	SH3-containing GRB2-like protein 3-interacting protein 1	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q9BQI5	SGIP1	SH3-containing GRB2-like protein 3-interacting protein 1	GO:2000507; P:positive regulation of energy homeostasis; ISS:UniProtKB
Q9BQI5	SGIP1	SH3-containing GRB2-like protein 3-interacting protein 1	GO:2000253; P:positive regulation of feeding behavior; ISS:UniProtKB
Q9BQI5	SGIP1	SH3-containing GRB2-like protein 3-interacting protein 1	GO:0048260; P:positive regulation of receptor-mediated endocytosis; ISS:UniProtKB
Q9BQI5	SGIP1	SH3-containing GRB2-like protein 3-interacting protein 1	GO:0002021; P:response to dietary excess; ISS:UniProtKB
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0005246; F:calcium channel regulator activity; TAS:UniProtKB
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0017081; F:chloride channel regulator activity; TAS:UniProtKB
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0015459; F:potassium channel regulator activity; TAS:UniProtKB
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0017080; F:sodium channel regulator activity; TAS:UniProtKB
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0006974; P:cellular response to DNA damage stimulus; IEA:Ensembl
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0007616; P:long-term memory; TAS:UniProtKB
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0032411; P:positive regulation of transporter activity; TAS:UniProtKB
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0006468; P:protein phosphorylation; TAS:ProtInc
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0008217; P:regulation of blood pressure; TAS:UniProtKB
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0050790; P:regulation of catalytic activity; TAS:UniProtKB
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0001558; P:regulation of cell growth; TAS:UniProtKB
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0030334; P:regulation of cell migration; TAS:UniProtKB
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0042127; P:regulation of cell proliferation; TAS:UniProtKB
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0060453; P:regulation of gastric acid secretion; TAS:UniProtKB
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; TAS:UniProtKB
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0070294; P:renal sodium ion absorption; TAS:UniProtKB
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0006950; P:response to stress; TAS:ProtInc
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0006814; P:sodium ion transport; TAS:ProtInc
O00141	SGK1	Serine/threonine-protein kinase Sgk1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9HBY8	SGK2	Serine/threonine-protein kinase Sgk2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9HBY8	SGK2	Serine/threonine-protein kinase Sgk2	GO:0015459; F:potassium channel regulator activity; IDA:UniProtKB
Q9HBY8	SGK2	Serine/threonine-protein kinase Sgk2	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
Q9HBY8	SGK2	Serine/threonine-protein kinase Sgk2	GO:0017080; F:sodium channel regulator activity; NAS:UniProtKB
Q9HBY8	SGK2	Serine/threonine-protein kinase Sgk2	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
Q9HBY8	SGK2	Serine/threonine-protein kinase Sgk2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9HBY8	SGK2	Serine/threonine-protein kinase Sgk2	GO:0032411; P:positive regulation of transporter activity; TAS:UniProtKB
Q9HBY8	SGK2	Serine/threonine-protein kinase Sgk2	GO:0006468; P:protein phosphorylation; NAS:UniProtKB
Q9HBY8	SGK2	Serine/threonine-protein kinase Sgk2	GO:0001558; P:regulation of cell growth; TAS:UniProtKB
Q9HBY8	SGK2	Serine/threonine-protein kinase Sgk2	GO:0042127; P:regulation of cell proliferation; TAS:UniProtKB
Q9HBY8	SGK2	Serine/threonine-protein kinase Sgk2	GO:0006979; P:response to oxidative stress; TAS:ProtInc
Q9HBY8	SGK2	Serine/threonine-protein kinase Sgk2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q96BR1	SGK3	Serine/threonine-protein kinase Sgk3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96BR1	SGK3	Serine/threonine-protein kinase Sgk3	GO:0005246; F:calcium channel regulator activity; TAS:UniProtKB
Q96BR1	SGK3	Serine/threonine-protein kinase Sgk3	GO:0017081; F:chloride channel regulator activity; TAS:UniProtKB
Q96BR1	SGK3	Serine/threonine-protein kinase Sgk3	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
Q96BR1	SGK3	Serine/threonine-protein kinase Sgk3	GO:0015459; F:potassium channel regulator activity; TAS:UniProtKB
Q96BR1	SGK3	Serine/threonine-protein kinase Sgk3	GO:0005515; F:protein binding; IPI:IntAct
Q96BR1	SGK3	Serine/threonine-protein kinase Sgk3	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q96BR1	SGK3	Serine/threonine-protein kinase Sgk3	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
Q96BR1	SGK3	Serine/threonine-protein kinase Sgk3	GO:0017080; F:sodium channel regulator activity; TAS:UniProtKB
Q96BR1	SGK3	Serine/threonine-protein kinase Sgk3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q96BR1	SGK3	Serine/threonine-protein kinase Sgk3	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q96BR1	SGK3	Serine/threonine-protein kinase Sgk3	GO:0001558; P:regulation of cell growth; TAS:UniProtKB
Q96BR1	SGK3	Serine/threonine-protein kinase Sgk3	GO:0030334; P:regulation of cell migration; TAS:UniProtKB
Q96BR1	SGK3	Serine/threonine-protein kinase Sgk3	GO:0042127; P:regulation of cell proliferation; TAS:UniProtKB
Q96BR1	SGK3	Serine/threonine-protein kinase Sgk3	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; TAS:UniProtKB
Q96BR1	SGK3	Serine/threonine-protein kinase Sgk3	GO:0006950; P:response to stress; TAS:ProtInc
Q96BR1	SGK3	Serine/threonine-protein kinase Sgk3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8NE28	SGK071	Probable inactive protein kinase-like protein SgK071	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NE28	SGK071	Probable inactive protein kinase-like protein SgK071	GO:0004672; F:protein kinase activity; IEA:InterPro
Q99720	SIGMAR1	Sigma non-opioid intracellular receptor 1	GO:0008144; F:drug binding; TAS:ProtInc
Q99720	SIGMAR1	Sigma non-opioid intracellular receptor 1	GO:0004985; F:opioid receptor activity; IEA:Ensembl
Q99720	SIGMAR1	Sigma non-opioid intracellular receptor 1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q99720	SIGMAR1	Sigma non-opioid intracellular receptor 1	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q99720	SIGMAR1	Sigma non-opioid intracellular receptor 1	GO:0007399; P:nervous system development; IEA:Ensembl
Q99720	SIGMAR1	Sigma non-opioid intracellular receptor 1	GO:0043523; P:regulation of neuron apoptotic process; IMP:UniProtKB
Q5FBB7	SGOL1	Shugoshin-like 1	GO:0019900; F:kinase binding; IDA:MGI
Q5FBB7	SGOL1	Shugoshin-like 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q5FBB7	SGOL1	Shugoshin-like 1	GO:0008608; P:attachment of spindle microtubules to kinetochore; IDA:UniProtKB
Q5FBB7	SGOL1	Shugoshin-like 1	GO:0010457; P:centriole-centriole cohesion; IDA:UniProtKB
Q5FBB7	SGOL1	Shugoshin-like 1	GO:0007059; P:chromosome segregation; IDA:UniProtKB
Q5FBB7	SGOL1	Shugoshin-like 1	GO:0045132; P:meiotic chromosome segregation; IMP:MGI
Q5FBB7	SGOL1	Shugoshin-like 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q5FBB7	SGOL1	Shugoshin-like 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q562F6	SGOL2	Shugoshin-like 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q562F6	SGOL2	Shugoshin-like 2	GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW
Q562F6	SGOL2	Shugoshin-like 2	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q562F6	SGOL2	Shugoshin-like 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0016831; F:carboxy-lyase activity; IEA:InterPro
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0005515; F:protein binding; IPI:IntAct
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0008117; F:sphinganine-1-phosphate aldolase activity; IDA:UniProtKB
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0008209; P:androgen metabolic process; IEA:Ensembl
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0019752; P:carboxylic acid metabolic process; IEA:InterPro
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0006672; P:ceramide metabolic process; IDA:UniProtKB
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0008210; P:estrogen metabolic process; IEA:Ensembl
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0097194; P:execution phase of apoptosis; IDA:UniProtKB
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0060325; P:face morphogenesis; IEA:Ensembl
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0010761; P:fibroblast migration; IEA:Ensembl
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0030097; P:hemopoiesis; IEA:Ensembl
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0001822; P:kidney development; IEA:Ensembl
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0033327; P:Leydig cell differentiation; IEA:Ensembl
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0001553; P:luteinization; IEA:Ensembl
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0060021; P:palate development; IEA:Ensembl
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IEA:Ensembl
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0009791; P:post-embryonic development; IEA:Ensembl
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0007283; P:spermatogenesis; IEA:Ensembl
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0030149; P:sphingolipid catabolic process; NAS:UniProtKB
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
O95470	SGPL1	Sphingosine-1-phosphate lyase 1	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q9BX95	SGPP1	Sphingosine-1-phosphate phosphatase 1	GO:0042392; F:sphingosine-1-phosphate phosphatase activity; IEA:Ensembl
Q9BX95	SGPP1	Sphingosine-1-phosphate phosphatase 1	GO:0097191; P:extrinsic apoptotic signaling pathway; IEA:Ensembl
Q9BX95	SGPP1	Sphingosine-1-phosphate phosphatase 1	GO:0097193; P:intrinsic apoptotic signaling pathway; IEA:Ensembl
Q9BX95	SGPP1	Sphingosine-1-phosphate phosphatase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BX95	SGPP1	Sphingosine-1-phosphate phosphatase 1	GO:0006668; P:sphinganine-1-phosphate metabolic process; IEA:Ensembl
Q9BX95	SGPP1	Sphingosine-1-phosphate phosphatase 1	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
Q9BX95	SGPP1	Sphingosine-1-phosphate phosphatase 1	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q9BX95	SGPP1	Sphingosine-1-phosphate phosphatase 1	GO:0006670; P:sphingosine metabolic process; IEA:Ensembl
Q8IWX5	SGPP2	Sphingosine-1-phosphate phosphatase 2	GO:0042392; F:sphingosine-1-phosphate phosphatase activity; IDA:UniProtKB
Q8IWX5	SGPP2	Sphingosine-1-phosphate phosphatase 2	GO:0016311; P:dephosphorylation; IDA:GOC
Q8IWX5	SGPP2	Sphingosine-1-phosphate phosphatase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8IWX5	SGPP2	Sphingosine-1-phosphate phosphatase 2	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
Q8IWX5	SGPP2	Sphingosine-1-phosphate phosphatase 2	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q8IWX5	SGPP2	Sphingosine-1-phosphate phosphatase 2	GO:0006670; P:sphingosine metabolic process; IDA:UniProtKB
O43147	SGSM2	Small G protein signaling modulator 2	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q96HU1	SGSM3	Small G protein signaling modulator 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q96HU1	SGSM3	Small G protein signaling modulator 3	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q96HU1	SGSM3	Small G protein signaling modulator 3	GO:0017137; F:Rab GTPase binding; IDA:UniProtKB
Q96HU1	SGSM3	Small G protein signaling modulator 3	GO:0007050; P:cell cycle arrest; IEA:UniProtKB-KW
Q96HU1	SGSM3	Small G protein signaling modulator 3	GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl
Q96HU1	SGSM3	Small G protein signaling modulator 3	GO:0032486; P:Rap protein signal transduction; IEP:UniProtKB
Q96HU1	SGSM3	Small G protein signaling modulator 3	GO:0032483; P:regulation of Rab protein signal transduction; IEP:UniProtKB
O95905	ECD	Protein SGT1	GO:0005515; F:protein binding; IPI:IntAct
O95905	ECD	Protein SGT1	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
O95905	ECD	Protein SGT1	GO:0008283; P:cell proliferation; IEA:Ensembl
O95905	ECD	Protein SGT1	GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl
O95905	ECD	Protein SGT1	GO:0006110; P:regulation of glycolytic process; TAS:ProtInc
O95905	ECD	Protein SGT1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O95905	ECD	Protein SGT1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q2NKQ1	SGSM1	Small G protein signaling modulator 1	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
O43765	SGTA	Small glutamine-rich tetratricopeptide repeat-containing protein alpha	GO:0005515; F:protein binding; IPI:IntAct
O43765	SGTA	Small glutamine-rich tetratricopeptide repeat-containing protein alpha	GO:0016032; P:viral process; IEA:UniProtKB-KW
O60880	SH2D1A	SH2 domain-containing protein 1A	GO:0005515; F:protein binding; IPI:IntAct
O60880	SH2D1A	SH2 domain-containing protein 1A	GO:0005070; F:SH3/SH2 adaptor activity; NAS:UniProtKB
O60880	SH2D1A	SH2 domain-containing protein 1A	GO:0007267; P:cell-cell signaling; IDA:UniProtKB
O60880	SH2D1A	SH2 domain-containing protein 1A	GO:0006968; P:cellular defense response; NAS:UniProtKB
O60880	SH2D1A	SH2 domain-containing protein 1A	GO:0006959; P:humoral immune response; IEA:Ensembl
O60880	SH2D1A	SH2 domain-containing protein 1A	GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; IEA:Ensembl
O60880	SH2D1A	SH2 domain-containing protein 1A	GO:0009967; P:positive regulation of signal transduction; NAS:GOC
O14796	SH2D1B	SH2 domain-containing protein 1B	GO:0005515; F:protein binding; IPI:IntAct
O14796	SH2D1B	SH2 domain-containing protein 1B	GO:0030674; F:protein binding, bridging; TAS:UniProtKB
O14796	SH2D1B	SH2 domain-containing protein 1B	GO:0002366; P:leukocyte activation involved in immune response; ISS:UniProtKB
O14796	SH2D1B	SH2 domain-containing protein 1B	GO:0045089; P:positive regulation of innate immune response; ISS:UniProtKB
O14796	SH2D1B	SH2 domain-containing protein 1B	GO:0002717; P:positive regulation of natural killer cell mediated immunity; ISS:UniProtKB
Q9NP31	SH2D2A	SH2 domain-containing protein 2A	GO:0005515; F:protein binding; IPI:IntAct
Q9NP31	SH2D2A	SH2 domain-containing protein 2A	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
Q9NP31	SH2D2A	SH2 domain-containing protein 2A	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q9NP31	SH2D2A	SH2 domain-containing protein 2A	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9NP31	SH2D2A	SH2 domain-containing protein 2A	GO:0008283; P:cell proliferation; IEA:Ensembl
Q9NP31	SH2D2A	SH2 domain-containing protein 2A	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
Q9NP31	SH2D2A	SH2 domain-containing protein 2A	GO:0007165; P:signal transduction; TAS:ProtInc
Q9BRG2	SH2D3A	SH2 domain-containing protein 3A	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:InterPro
Q9BRG2	SH2D3A	SH2 domain-containing protein 3A	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
Q9BRG2	SH2D3A	SH2 domain-containing protein 3A	GO:0007254; P:JNK cascade; TAS:ProtInc
Q9BRG2	SH2D3A	SH2 domain-containing protein 3A	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
Q9BRG2	SH2D3A	SH2 domain-containing protein 3A	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9H788	SH2D4A	SH2 domain-containing protein 4A	GO:0019902; F:phosphatase binding; IDA:UniProtKB
Q9H788	SH2D4A	SH2 domain-containing protein 4A	GO:0005515; F:protein binding; IPI:IntAct
Q9H788	SH2D4A	SH2 domain-containing protein 4A	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q9NRF2	SH2B1	SH2B adapter protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NRF2	SH2B1	SH2B adapter protein 1	GO:0004871; F:signal transducer activity; IEA:InterPro
Q9NRF2	SH2B1	SH2B adapter protein 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q9NRF2	SH2B1	SH2B adapter protein 1	GO:0006928; P:cellular component movement; IEA:Ensembl
Q9NRF2	SH2B1	SH2B adapter protein 1	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9NRF2	SH2B1	SH2B adapter protein 1	GO:0030032; P:lamellipodium assembly; IEA:Ensembl
Q9NRF2	SH2B1	SH2B adapter protein 1	GO:0045840; P:positive regulation of mitosis; IEA:Ensembl
Q9NRF2	SH2B1	SH2B adapter protein 1	GO:2000278; P:regulation of DNA biosynthetic process; IEA:Ensembl
O14492	SH2B2	SH2B adapter protein 2	GO:0008269; F:JAK pathway signal transduction adaptor activity; IDA:UniProtKB
O14492	SH2B2	SH2B adapter protein 2	GO:0005515; F:protein binding; IPI:IntAct
O14492	SH2B2	SH2B adapter protein 2	GO:0005070; F:SH3/SH2 adaptor activity; IDA:UniProtKB
O14492	SH2B2	SH2B adapter protein 2	GO:0004871; F:signal transducer activity; IEA:InterPro
O14492	SH2B2	SH2B adapter protein 2	GO:0007596; P:blood coagulation; TAS:Reactome
O14492	SH2B2	SH2B adapter protein 2	GO:0008286; P:insulin receptor signaling pathway; ISS:BHF-UCL
O14492	SH2B2	SH2B adapter protein 2	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
O14492	SH2B2	SH2B adapter protein 2	GO:0009967; P:positive regulation of signal transduction; IDA:GOC
O14492	SH2B2	SH2B adapter protein 2	GO:0046425; P:regulation of JAK-STAT cascade; IDA:GOC
O14492	SH2B2	SH2B adapter protein 2	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UQQ2	SH2B3	SH2B adapter protein 3	GO:0042301; F:phosphate ion binding; IEA:Ensembl
Q9UQQ2	SH2B3	SH2B adapter protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q9UQQ2	SH2B3	SH2B adapter protein 3	GO:0004871; F:signal transducer activity; IEA:InterPro
Q9UQQ2	SH2B3	SH2B adapter protein 3	GO:0007596; P:blood coagulation; TAS:Reactome
Q9UQQ2	SH2B3	SH2B adapter protein 3	GO:0030154; P:cell differentiation; IEA:Ensembl
Q9UQQ2	SH2B3	SH2B adapter protein 3	GO:0035162; P:embryonic hemopoiesis; IEA:Ensembl
Q9UQQ2	SH2B3	SH2B adapter protein 3	GO:0035556; P:intracellular signal transduction; IEA:Ensembl
Q8N5H7	SH2D3C	SH2 domain-containing protein 3C	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:InterPro
Q8N5H7	SH2D3C	SH2 domain-containing protein 3C	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
Q8N5H7	SH2D3C	SH2 domain-containing protein 3C	GO:0007254; P:JNK cascade; TAS:ProtInc
Q8N5H7	SH2D3C	SH2 domain-containing protein 3C	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
Q8N5H7	SH2D3C	SH2 domain-containing protein 3C	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q5HYK7	SH3D19	SH3 domain-containing protein 19	GO:0070064; F:proline-rich region binding; IPI:BHF-UCL
Q5HYK7	SH3D19	SH3 domain-containing protein 19	GO:0005515; F:protein binding; IPI:UniProtKB
Q5HYK7	SH3D19	SH3 domain-containing protein 19	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q5HYK7	SH3D19	SH3 domain-containing protein 19	GO:0061024; P:membrane organization; TAS:Reactome
Q5HYK7	SH3D19	SH3 domain-containing protein 19	GO:0051044; P:positive regulation of membrane protein ectodomain proteolysis; IMP:BHF-UCL
Q5HYK7	SH3D19	SH3 domain-containing protein 19	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
Q5HYK7	SH3D19	SH3 domain-containing protein 19	GO:0022604; P:regulation of cell morphogenesis; IMP:UniProtKB
Q9P0V3	SH3BP4	SH3 domain-binding protein 4	GO:0005092; F:GDP-dissociation inhibitor activity; IMP:UniProtKB
Q9P0V3	SH3BP4	SH3 domain-binding protein 4	GO:0042802; F:identical protein binding; IPI:IntAct
Q9P0V3	SH3BP4	SH3 domain-binding protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q9P0V3	SH3BP4	SH3 domain-binding protein 4	GO:0017016; F:Ras GTPase binding; IPI:UniProtKB
Q9P0V3	SH3BP4	SH3 domain-binding protein 4	GO:0071230; P:cellular response to amino acid stimulus; IMP:UniProtKB
Q9P0V3	SH3BP4	SH3 domain-binding protein 4	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q9P0V3	SH3BP4	SH3 domain-binding protein 4	GO:0030308; P:negative regulation of cell growth; IMP:UniProtKB
Q9P0V3	SH3BP4	SH3 domain-binding protein 4	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q9P0V3	SH3BP4	SH3 domain-binding protein 4	GO:0034260; P:negative regulation of GTPase activity; IDA:UniProtKB
Q9P0V3	SH3BP4	SH3 domain-binding protein 4	GO:0032007; P:negative regulation of TOR signaling; IMP:UniProtKB
Q9P0V3	SH3BP4	SH3 domain-binding protein 4	GO:0010508; P:positive regulation of autophagy; IMP:UniProtKB
Q9P0V3	SH3BP4	SH3 domain-binding protein 4	GO:0061462; P:protein localization to lysosome; IMP:UniProtKB
Q9P0V3	SH3BP4	SH3 domain-binding protein 4	GO:0050790; P:regulation of catalytic activity; IMP:UniProtKB
P55822	SH3BGR	SH3 domain-binding glutamic acid-rich protein	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
P55822	SH3BGR	SH3 domain-binding glutamic acid-rich protein	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
P55822	SH3BGR	SH3 domain-binding glutamic acid-rich protein	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q99961	SH3GL1	Endophilin-A2	GO:0042802; F:identical protein binding; IPI:IntAct
Q99961	SH3GL1	Endophilin-A2	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q99961	SH3GL1	Endophilin-A2	GO:0005515; F:protein binding; IPI:IntAct
Q99961	SH3GL1	Endophilin-A2	GO:0007417; P:central nervous system development; TAS:ProtInc
Q99961	SH3GL1	Endophilin-A2	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q99961	SH3GL1	Endophilin-A2	GO:0007165; P:signal transduction; TAS:ProtInc
Q99962	SH3GL2	Endophilin-A1	GO:0042802; F:identical protein binding; IPI:IntAct
Q99962	SH3GL2	Endophilin-A1	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q99962	SH3GL2	Endophilin-A1	GO:0005515; F:protein binding; IPI:UniProtKB
Q99962	SH3GL2	Endophilin-A1	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
Q99962	SH3GL2	Endophilin-A1	GO:0007411; P:axon guidance; TAS:Reactome
Q99962	SH3GL2	Endophilin-A1	GO:0007417; P:central nervous system development; TAS:ProtInc
Q99962	SH3GL2	Endophilin-A1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q99962	SH3GL2	Endophilin-A1	GO:0061024; P:membrane organization; TAS:Reactome
Q99962	SH3GL2	Endophilin-A1	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
Q99962	SH3GL2	Endophilin-A1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q99962	SH3GL2	Endophilin-A1	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
Q99962	SH3GL2	Endophilin-A1	GO:0002090; P:regulation of receptor internalization; IEA:Ensembl
Q99962	SH3GL2	Endophilin-A1	GO:0007165; P:signal transduction; TAS:ProtInc
Q99962	SH3GL2	Endophilin-A1	GO:0048488; P:synaptic vesicle endocytosis; IEA:Ensembl
Q99963	SH3GL3	Endophilin-A3	GO:0042802; F:identical protein binding; IPI:IntAct
Q99963	SH3GL3	Endophilin-A3	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q99963	SH3GL3	Endophilin-A3	GO:0005515; F:protein binding; IPI:UniProtKB
Q99963	SH3GL3	Endophilin-A3	GO:0007417; P:central nervous system development; TAS:ProtInc
Q99963	SH3GL3	Endophilin-A3	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q99963	SH3GL3	Endophilin-A3	GO:0007165; P:signal transduction; TAS:ProtInc
Q96B97	SH3KBP1	SH3 domain-containing kinase-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q96B97	SH3KBP1	SH3 domain-containing kinase-binding protein 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q96B97	SH3KBP1	SH3 domain-containing kinase-binding protein 1	GO:0016477; P:cell migration; IMP:UniProtKB
Q96B97	SH3KBP1	SH3 domain-containing kinase-binding protein 1	GO:0007267; P:cell-cell signaling; NAS:UniProtKB
Q96B97	SH3KBP1	SH3 domain-containing kinase-binding protein 1	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q96B97	SH3KBP1	SH3 domain-containing kinase-binding protein 1	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q96B97	SH3KBP1	SH3 domain-containing kinase-binding protein 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q96B97	SH3KBP1	SH3 domain-containing kinase-binding protein 1	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
Q96B97	SH3KBP1	SH3 domain-containing kinase-binding protein 1	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
O75368	SH3BGRL	SH3 domain-binding glutamic acid-rich-like protein	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
O75368	SH3BGRL	SH3 domain-binding glutamic acid-rich-like protein	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
Q9H299	SH3BGRL3	SH3 domain-binding glutamic acid-rich-like protein 3	GO:0009055; F:electron carrier activity; IEA:InterPro
Q9H299	SH3BGRL3	SH3 domain-binding glutamic acid-rich-like protein 3	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
Q9H299	SH3BGRL3	SH3 domain-binding glutamic acid-rich-like protein 3	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q7Z6J0	SH3RF1	E3 ubiquitin-protein ligase SH3RF1	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q7Z6J0	SH3RF1	E3 ubiquitin-protein ligase SH3RF1	GO:0005515; F:protein binding; IPI:IntAct
Q7Z6J0	SH3RF1	E3 ubiquitin-protein ligase SH3RF1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q7Z6J0	SH3RF1	E3 ubiquitin-protein ligase SH3RF1	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q7Z6J0	SH3RF1	E3 ubiquitin-protein ligase SH3RF1	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
Q7Z6J0	SH3RF1	E3 ubiquitin-protein ligase SH3RF1	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB
Q7Z6J0	SH3RF1	E3 ubiquitin-protein ligase SH3RF1	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q7Z6J0	SH3RF1	E3 ubiquitin-protein ligase SH3RF1	GO:0046328; P:regulation of JNK cascade; IEA:InterPro
Q8TEC5	SH3RF2	Putative E3 ubiquitin-protein ligase SH3RF2	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q8TEC5	SH3RF2	Putative E3 ubiquitin-protein ligase SH3RF2	GO:0019902; F:phosphatase binding; IDA:UniProtKB
Q8TEC5	SH3RF2	Putative E3 ubiquitin-protein ligase SH3RF2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TEC5	SH3RF2	Putative E3 ubiquitin-protein ligase SH3RF2	GO:0008157; F:protein phosphatase 1 binding; IDA:UniProtKB
Q8TEC5	SH3RF2	Putative E3 ubiquitin-protein ligase SH3RF2	GO:0004864; F:protein phosphatase inhibitor activity; IEA:UniProtKB-KW
Q8TEC5	SH3RF2	Putative E3 ubiquitin-protein ligase SH3RF2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TEC5	SH3RF2	Putative E3 ubiquitin-protein ligase SH3RF2	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q8TEC5	SH3RF2	Putative E3 ubiquitin-protein ligase SH3RF2	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8TEJ3	SH3RF3	SH3 domain-containing RING finger protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q8TEJ3	SH3RF3	SH3 domain-containing RING finger protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96HL8	SH3YL1	SH3 domain-containing YSC84-like protein 1	GO:0019902; F:phosphatase binding; IDA:MGI
Q96HL8	SH3YL1	SH3 domain-containing YSC84-like protein 1	GO:0035091; F:phosphatidylinositol binding; IDA:MGI
Q96HL8	SH3YL1	SH3 domain-containing YSC84-like protein 1	GO:0006661; P:phosphatidylinositol biosynthetic process; IEA:Ensembl
Q96HL8	SH3YL1	SH3 domain-containing YSC84-like protein 1	GO:1900027; P:regulation of ruffle assembly; IEA:Ensembl
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0071532; F:ankyrin repeat binding; ISS:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0030160; F:GKAP/Homer scaffold activity; ISS:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0042802; F:identical protein binding; ISS:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0035255; F:ionotropic glutamate receptor binding; ISS:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0008022; F:protein C-terminus binding; ISS:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0032403; F:protein complex binding; ISS:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0097110; F:scaffold protein binding; ISS:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0017124; F:SH3 domain binding; ISS:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0031877; F:somatostatin receptor binding; ISS:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0030534; P:adult behavior; IMP:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0008306; P:associative learning; ISS:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0007016; P:cytoskeletal anchoring at plasma membrane; NAS:UniProtKB
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0060997; P:dendritic spine morphogenesis; ISS:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0050894; P:determination of affect; IMP:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0046959; P:habituation; IEA:Ensembl
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0007616; P:long-term memory; ISS:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0032232; P:negative regulation of actin filament bundle assembly; ISS:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0050885; P:neuromuscular process controlling balance; ISS:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0042048; P:olfactory behavior; IEA:Ensembl
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0060999; P:positive regulation of dendritic spine development; ISS:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:2000463; P:positive regulation of excitatory postsynaptic membrane potential; ISS:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0006461; P:protein complex assembly; ISS:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0035418; P:protein localization to synapse; ISS:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:2000311; P:regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; ISS:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0060013; P:righting reflex; IEA:Ensembl
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0035176; P:social behavior; IMP:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0060074; P:synapse maturation; ISS:BHF-UCL
Q9Y566	SHANK1	SH3 and multiple ankyrin repeat domains protein 1	GO:0071625; P:vocalization behavior; IMP:BHF-UCL
Q9UPX8	SHANK2	SH3 and multiple ankyrin repeat domains protein 2	GO:0030160; F:GKAP/Homer scaffold activity; NAS:UniProtKB
Q9UPX8	SHANK2	SH3 and multiple ankyrin repeat domains protein 2	GO:0035255; F:ionotropic glutamate receptor binding; ISS:BHF-UCL
Q9UPX8	SHANK2	SH3 and multiple ankyrin repeat domains protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UPX8	SHANK2	SH3 and multiple ankyrin repeat domains protein 2	GO:0030534; P:adult behavior; IMP:BHF-UCL
Q9UPX8	SHANK2	SH3 and multiple ankyrin repeat domains protein 2	GO:0007612; P:learning; IMP:BHF-UCL
Q9UPX8	SHANK2	SH3 and multiple ankyrin repeat domains protein 2	GO:0060292; P:long term synaptic depression; ISS:BHF-UCL
Q9UPX8	SHANK2	SH3 and multiple ankyrin repeat domains protein 2	GO:0060291; P:long-term synaptic potentiation; ISS:BHF-UCL
Q9UPX8	SHANK2	SH3 and multiple ankyrin repeat domains protein 2	GO:0035176; P:social behavior; IMP:BHF-UCL
Q9UPX8	SHANK2	SH3 and multiple ankyrin repeat domains protein 2	GO:0007416; P:synapse assembly; ISS:BHF-UCL
Q9UPX8	SHANK2	SH3 and multiple ankyrin repeat domains protein 2	GO:0071625; P:vocalization behavior; IMP:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0030160; F:GKAP/Homer scaffold activity; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0042802; F:identical protein binding; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0035255; F:ionotropic glutamate receptor binding; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0008022; F:protein C-terminus binding; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0097110; F:scaffold protein binding; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0017124; F:SH3 domain binding; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0008270; F:zinc ion binding; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0030534; P:adult behavior; IMP:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0097113; P:alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0048854; P:brain morphogenesis; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0060997; P:dendritic spine morphogenesis; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0097117; P:guanylate kinase-associated protein clustering; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0007612; P:learning; IMP:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0000165; P:MAPK cascade; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0007613; P:memory; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0097114; P:N-methyl-D-aspartate receptor clustering; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0032232; P:negative regulation of actin filament bundle assembly; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0045794; P:negative regulation of cell volume; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:2000969; P:positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0060999; P:positive regulation of dendritic spine development; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:2000463; P:positive regulation of excitatory postsynaptic membrane potential; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:1900451; P:positive regulation of glutamate receptor signaling pathway; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0048170; P:positive regulation of long-term neuronal synaptic plasticity; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0051835; P:positive regulation of synapse structural plasticity; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0097107; P:postsynaptic density assembly; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0061001; P:regulation of dendritic spine morphogenesis; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:1900452; P:regulation of long term synaptic depression; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:1900271; P:regulation of long-term synaptic potentiation; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0035176; P:social behavior; IMP:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0021773; P:striatal medium spiny neuron differentiation; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0007416; P:synapse assembly; ISS:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0042297; P:vocal learning; IMP:BHF-UCL
Q9BYB0	SHANK3	SH3 and multiple ankyrin repeat domains protein 3	GO:0071625; P:vocalization behavior; IMP:BHF-UCL
P04278	SHBG	Sex hormone-binding globulin	GO:0005497; F:androgen binding; TAS:ProtInc
P04278	SHBG	Sex hormone-binding globulin	GO:0007285; P:primary spermatocyte growth; IEA:Ensembl
Q15464	SHB	SH2 domain-containing adapter protein B	GO:0005515; F:protein binding; IPI:IntAct
Q15464	SHB	SH2 domain-containing adapter protein B	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
Q15464	SHB	SH2 domain-containing adapter protein B	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q15464	SHB	SH2 domain-containing adapter protein B	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q15464	SHB	SH2 domain-containing adapter protein B	GO:0042100; P:B cell proliferation; IEA:Ensembl
Q15464	SHB	SH2 domain-containing adapter protein B	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q15464	SHB	SH2 domain-containing adapter protein B	GO:0030097; P:hemopoiesis; IEA:Ensembl
Q15464	SHB	SH2 domain-containing adapter protein B	GO:1900194; P:negative regulation of oocyte maturation; IEA:Ensembl
Q15464	SHB	SH2 domain-containing adapter protein B	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
Q15464	SHB	SH2 domain-containing adapter protein B	GO:0007165; P:signal transduction; TAS:ProtInc
P29353	SHC1	SHC-transforming protein 1	GO:0046875; F:ephrin receptor binding; IPI:UniProtKB
P29353	SHC1	SHC-transforming protein 1	GO:0005154; F:epidermal growth factor receptor binding; ISS:BHF-UCL
P29353	SHC1	SHC-transforming protein 1	GO:0005158; F:insulin receptor binding; IPI:UniProtKB
P29353	SHC1	SHC-transforming protein 1	GO:0005159; F:insulin-like growth factor receptor binding; IPI:UniProtKB
P29353	SHC1	SHC-transforming protein 1	GO:0005168; F:neurotrophin TRKA receptor binding; IPI:UniProtKB
P29353	SHC1	SHC-transforming protein 1	GO:0005543; F:phospholipid binding; TAS:UniProtKB
P29353	SHC1	SHC-transforming protein 1	GO:0005515; F:protein binding; IPI:IntAct
P29353	SHC1	SHC-transforming protein 1	GO:0004713; F:protein tyrosine kinase activity; TAS:Reactome
P29353	SHC1	SHC-transforming protein 1	GO:0005068; F:transmembrane receptor protein tyrosine kinase adaptor activity; TAS:UniProtKB
P29353	SHC1	SHC-transforming protein 1	GO:0031532; P:actin cytoskeleton reorganization; IEA:Ensembl
P29353	SHC1	SHC-transforming protein 1	GO:0000187; P:activation of MAPK activity; IDA:UniProtKB
P29353	SHC1	SHC-transforming protein 1	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P29353	SHC1	SHC-transforming protein 1	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P29353	SHC1	SHC-transforming protein 1	GO:0007596; P:blood coagulation; TAS:Reactome
P29353	SHC1	SHC-transforming protein 1	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
P29353	SHC1	SHC-transforming protein 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P29353	SHC1	SHC-transforming protein 1	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P29353	SHC1	SHC-transforming protein 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P29353	SHC1	SHC-transforming protein 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P29353	SHC1	SHC-transforming protein 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P29353	SHC1	SHC-transforming protein 1	GO:0007507; P:heart development; IEA:Ensembl
P29353	SHC1	SHC-transforming protein 1	GO:0045087; P:innate immune response; TAS:Reactome
P29353	SHC1	SHC-transforming protein 1	GO:0008286; P:insulin receptor signaling pathway; ISS:BHF-UCL
P29353	SHC1	SHC-transforming protein 1	GO:0050900; P:leukocyte migration; TAS:Reactome
P29353	SHC1	SHC-transforming protein 1	GO:0000165; P:MAPK cascade; IDA:UniProtKB
P29353	SHC1	SHC-transforming protein 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P29353	SHC1	SHC-transforming protein 1	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:GOC
P29353	SHC1	SHC-transforming protein 1	GO:0030168; P:platelet activation; TAS:Reactome
P29353	SHC1	SHC-transforming protein 1	GO:0008284; P:positive regulation of cell proliferation; NAS:UniProtKB
P29353	SHC1	SHC-transforming protein 1	GO:0045740; P:positive regulation of DNA replication; ISS:BHF-UCL
P29353	SHC1	SHC-transforming protein 1	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
P29353	SHC1	SHC-transforming protein 1	GO:0007176; P:regulation of epidermal growth factor-activated receptor activity; TAS:ProtInc
P29353	SHC1	SHC-transforming protein 1	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
P98077	SHC2	SHC-transforming protein 2	GO:0005515; F:protein binding; IPI:IntAct
P98077	SHC2	SHC-transforming protein 2	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P98077	SHC2	SHC-transforming protein 2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P98077	SHC2	SHC-transforming protein 2	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
Q92529	SHC3	SHC-transforming protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q92529	SHC3	SHC-transforming protein 3	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q92529	SHC3	SHC-transforming protein 3	GO:0007417; P:central nervous system development; TAS:ProtInc
Q92529	SHC3	SHC-transforming protein 3	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:ProtInc
Q92529	SHC3	SHC-transforming protein 3	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q92529	SHC3	SHC-transforming protein 3	GO:0007611; P:learning or memory; IEA:Ensembl
Q92529	SHC3	SHC-transforming protein 3	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q92529	SHC3	SHC-transforming protein 3	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
Q92529	SHC3	SHC-transforming protein 3	GO:0035249; P:synaptic transmission, glutamatergic; IEA:Ensembl
Q92529	SHC3	SHC-transforming protein 3	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc
Q6S5L8	SHC4	SHC-transforming protein 4	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8NEM2	SHCBP1	SHC SH2 domain-binding protein 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; ISS:UniProtKB
Q8NEM2	SHCBP1	SHC SH2 domain-binding protein 1	GO:2000177; P:regulation of neural precursor cell proliferation; ISS:UniProtKB
Q7M4L6	SHF	SH2 domain-containing adapter protein F	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0004445; F:inositol-polyphosphate 5-phosphatase activity; TAS:ProtInc
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0034594; F:phosphatidylinositol trisphosphate phosphatase activity; IEA:Ensembl
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0008340; P:determination of adult lifespan; IEA:Ensembl
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0016064; P:immunoglobulin mediated immune response; IEA:Ensembl
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0035556; P:intracellular signal transduction; IEA:Ensembl
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0050900; P:leukocyte migration; TAS:Reactome
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0030889; P:negative regulation of B cell proliferation; IEA:Ensembl
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0045779; P:negative regulation of bone resorption; IEA:Ensembl
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0050777; P:negative regulation of immune response; IEA:Ensembl
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0045409; P:negative regulation of interleukin-6 biosynthetic process; IEA:Ensembl
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0045656; P:negative regulation of monocyte differentiation; IEA:Ensembl
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0045659; P:negative regulation of neutrophil differentiation; IEA:Ensembl
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0045671; P:negative regulation of osteoclast differentiation; IEA:Ensembl
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0009968; P:negative regulation of signal transduction; IEA:Ensembl
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0006796; P:phosphate-containing compound metabolic process; TAS:ProtInc
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0046856; P:phosphatidylinositol dephosphorylation; IEA:InterPro
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0045579; P:positive regulation of B cell differentiation; IEA:Ensembl
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0045648; P:positive regulation of erythrocyte differentiation; IEA:Ensembl
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q92835	INPP5D	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q8TBC3	SHKBP1	SH3KBP1-binding protein 1	GO:0051260; P:protein homooligomerization; IEA:InterPro
Q15465	SHH	Sonic hedgehog protein	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0005539; F:glycosaminoglycan binding; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0043237; F:laminin-1 binding; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0016015; F:morphogen activity; NAS:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:0005113; F:patched binding; IDA:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:0008233; F:peptidase activity; IEA:UniProtKB-KW
Q15465	SHH	Sonic hedgehog protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0004871; F:signal transducer activity; IDA:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0008209; P:androgen metabolic process; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0097190; P:apoptotic signaling pathway; ISS:UniProt
Q15465	SHH	Sonic hedgehog protein	GO:0060840; P:artery development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0007411; P:axon guidance; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0060020; P:Bergmann glial cell differentiation; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0007596; P:blood coagulation; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0060445; P:branching involved in salivary gland morphogenesis; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0001658; P:branching involved in ureteric bud morphogenesis; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0048754; P:branching morphogenesis of an epithelial tube; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0060447; P:bud outgrowth involved in lung branching; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0043010; P:camera-type eye development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0043369; P:CD4-positive or CD8-positive, alpha-beta T cell lineage commitment; IDA:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:0048468; P:cell development; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0001708; P:cell fate specification; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0007267; P:cell-cell signaling; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0071285; P:cellular response to lithium ion; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0007417; P:central nervous system development; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0021930; P:cerebellar granule cell precursor proliferation; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0003140; P:determination of left/right asymmetry in lateral mesoderm; ISS:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0009953; P:dorsal/ventral pattern formation; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0007398; P:ectoderm development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0009790; P:embryo development; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0048557; P:embryonic digestive tract morphogenesis; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0042733; P:embryonic digit morphogenesis; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0048617; P:embryonic foregut morphogenesis; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0030326; P:embryonic limb morphogenesis; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0009880; P:embryonic pattern specification; TAS:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:0048706; P:embryonic skeletal system development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0006897; P:endocytosis; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0060664; P:epithelial cell proliferation involved in salivary gland morphogenesis; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0060738; P:epithelial-mesenchymal signaling involved in prostate gland development; IDA:MGI
Q15465	SHH	Sonic hedgehog protein	GO:0030010; P:establishment of cell polarity; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0030900; P:forebrain development; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0048859; P:formation of anatomical boundary; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0007507; P:heart development; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0001947; P:heart looping; ISS:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:0030902; P:hindbrain development; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0007442; P:hindgut morphogenesis; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0048839; P:inner ear development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0016539; P:intein-mediated protein splicing; IEA:InterPro
Q15465	SHH	Sonic hedgehog protein	GO:0045109; P:intermediate filament organization; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0060459; P:left lung development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0060174; P:limb bud formation; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0030324; P:lung development; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0060428; P:lung epithelium development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0060463; P:lung lobe morphogenesis; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0060484; P:lung-associated mesenchyme development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0002320; P:lymphoid progenitor cell differentiation; IMP:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:0030539; P:male genitalia development; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0060916; P:mesenchymal cell proliferation involved in lung development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0060783; P:mesenchymal smoothened signaling pathway involved in prostate gland development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0072136; P:metanephric mesenchymal cell proliferation involved in metanephros development; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0001656; P:metanephros development; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0030901; P:midbrain development; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0080125; P:multicellular structure septum development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0045445; P:myoblast differentiation; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0014902; P:myotube differentiation; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0046639; P:negative regulation of alpha-beta T cell differentiation; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProt
Q15465	SHH	Sonic hedgehog protein	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0045596; P:negative regulation of cell differentiation; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0030336; P:negative regulation of cell migration; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0090370; P:negative regulation of cholesterol efflux; ISS:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:2000357; P:negative regulation of kidney smooth muscle cell differentiation; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:2001054; P:negative regulation of mesenchymal cell apoptotic process; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0034244; P:negative regulation of transcription elongation from RNA polymerase II promoter; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:2000062; P:negative regulation of ureter smooth muscle cell differentiation; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0045060; P:negative thymic T cell selection; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0001755; P:neural crest cell migration; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0007405; P:neuroblast proliferation; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0048663; P:neuron fate commitment; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0014003; P:oligodendrocyte development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0048645; P:organ formation; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0002076; P:osteoblast development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0060021; P:palate development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0031016; P:pancreas development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0007389; P:pattern specification process; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0001569; P:patterning of blood vessels; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0009949; P:polarity specification of anterior/posterior axis; ISS:UniProt
Q15465	SHH	Sonic hedgehog protein	GO:0046638; P:positive regulation of alpha-beta T cell differentiation; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0051781; P:positive regulation of cell division; IDA:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0060769; P:positive regulation of epithelial cell proliferation involved in prostate gland development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0007228; P:positive regulation of hh target transcription factor activity; ISS:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:0033092; P:positive regulation of immature T cell proliferation in thymus; ISS:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:2000358; P:positive regulation of kidney smooth muscle cell differentiation; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:2000729; P:positive regulation of mesenchymal cell proliferation involved in ureter development; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0002052; P:positive regulation of neuroblast proliferation; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0048714; P:positive regulation of oligodendrocyte differentiation; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0042307; P:positive regulation of protein import into nucleus; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0061189; P:positive regulation of sclerotome development; IDA:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:0014858; P:positive regulation of skeletal muscle cell proliferation; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0048643; P:positive regulation of skeletal muscle tissue development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0045880; P:positive regulation of smoothened signaling pathway; ISS:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:0051155; P:positive regulation of striated muscle cell differentiation; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0033089; P:positive regulation of T cell differentiation in thymus; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:2000063; P:positive regulation of ureter smooth muscle cell differentiation; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0030177; P:positive regulation of Wnt signaling pathway; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0045059; P:positive thymic T cell selection; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0060516; P:primary prostatic bud elongation; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0060523; P:prostate epithelial cord elongation; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0030850; P:prostate gland development; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0034504; P:protein localization to nucleus; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0042127; P:regulation of cell proliferation; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0060782; P:regulation of mesenchymal cell proliferation involved in prostate gland development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:1900175; P:regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry; NAS:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:0042481; P:regulation of odontogenesis; ISS:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:0060685; P:regulation of prostatic bud formation; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:1900180; P:regulation of protein localization to nucleus; IDA:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:0030162; P:regulation of proteolysis; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0072001; P:renal system development; IEP:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0060458; P:right lung development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0060662; P:salivary gland cavitation; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0007224; P:smoothened signaling pathway; IEP:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0021938; P:smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0061053; P:somite development; ISS:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:0021513; P:spinal cord dorsal/ventral patterning; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0021522; P:spinal cord motor neuron differentiation; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0048864; P:stem cell development; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0014706; P:striated muscle tissue development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0033077; P:T cell differentiation in thymus; ISS:BHF-UCL
Q15465	SHH	Sonic hedgehog protein	GO:0021978; P:telencephalon regionalization; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0021794; P:thalamus development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0048538; P:thymus development; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0030878; P:thyroid gland development; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0060439; P:trachea morphogenesis; IEA:Ensembl
Q15465	SHH	Sonic hedgehog protein	GO:0001570; P:vasculogenesis; ISS:UniProtKB
Q15465	SHH	Sonic hedgehog protein	GO:0007418; P:ventral midline development; TAS:BHF-UCL
O15357	INPPL1	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
O15357	INPPL1	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	GO:0005515; F:protein binding; IPI:UniProtKB
O15357	INPPL1	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	GO:0042169; F:SH2 domain binding; IPI:UniProtKB
O15357	INPPL1	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	GO:0007015; P:actin filament organization; IMP:UniProtKB
O15357	INPPL1	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	GO:0007155; P:cell adhesion; TAS:UniProtKB
O15357	INPPL1	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	GO:0001958; P:endochondral ossification; IMP:UniProtKB
O15357	INPPL1	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	GO:0006897; P:endocytosis; IMP:UniProtKB
O15357	INPPL1	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	GO:0006006; P:glucose metabolic process; IEA:Ensembl
O15357	INPPL1	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	GO:0002376; P:immune system process; IEA:UniProtKB-KW
O15357	INPPL1	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
O15357	INPPL1	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
O15357	INPPL1	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
O15357	INPPL1	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
O15357	INPPL1	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	GO:0046856; P:phosphatidylinositol dephosphorylation; IEA:InterPro
O15357	INPPL1	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
O15357	INPPL1	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	GO:0009791; P:post-embryonic development; IEA:Ensembl
O15357	INPPL1	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	GO:0032868; P:response to insulin; IEA:Ensembl
O15357	INPPL1	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	GO:0097178; P:ruffle assembly; IEA:Ensembl
O15357	INPPL1	Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y371	SH3GLB1	Endophilin-B1	GO:0005504; F:fatty acid binding; IEA:Ensembl
Q9Y371	SH3GLB1	Endophilin-B1	GO:0042802; F:identical protein binding; IPI:IntAct
Q9Y371	SH3GLB1	Endophilin-B1	GO:0042171; F:lysophosphatidic acid acyltransferase activity; IEA:Ensembl
Q9Y371	SH3GLB1	Endophilin-B1	GO:0005515; F:protein binding; IPI:IntAct
Q9Y371	SH3GLB1	Endophilin-B1	GO:0042803; F:protein homodimerization activity; IPI:HGNC
Q9Y371	SH3GLB1	Endophilin-B1	GO:0051084; P:'de novo' posttranslational protein folding; IEA:Ensembl
Q9Y371	SH3GLB1	Endophilin-B1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9Y371	SH3GLB1	Endophilin-B1	GO:0006654; P:phosphatidic acid biosynthetic process; IEA:Ensembl
Q9Y371	SH3GLB1	Endophilin-B1	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; IEA:Ensembl
Q9Y371	SH3GLB1	Endophilin-B1	GO:0032461; P:positive regulation of protein oligomerization; IDA:UniProtKB
Q9Y371	SH3GLB1	Endophilin-B1	GO:0051259; P:protein oligomerization; IDA:UniProtKB
Q9NR46	SH3GLB2	Endophilin-B2	GO:0005515; F:protein binding; IPI:IntAct
Q9UQ13	SHOC2	Leucine-rich repeat protein SHOC-2	GO:0019903; F:protein phosphatase binding; IDA:UniProtKB
Q9UQ13	SHOC2	Leucine-rich repeat protein SHOC-2	GO:0019888; F:protein phosphatase regulator activity; TAS:UniProtKB
Q9UQ13	SHOC2	Leucine-rich repeat protein SHOC-2	GO:0008543; P:fibroblast growth factor receptor signaling pathway; NAS:UniProtKB
Q9UQ13	SHOC2	Leucine-rich repeat protein SHOC-2	GO:0046579; P:positive regulation of Ras protein signal transduction; IMP:UniProtKB
Q9UQ13	SHOC2	Leucine-rich repeat protein SHOC-2	GO:0007265; P:Ras protein signal transduction; NAS:UniProtKB
Q9UQ13	SHOC2	Leucine-rich repeat protein SHOC-2	GO:0050790; P:regulation of catalytic activity; TAS:GOC
A0MZ66	KIAA1598	Shootin-1	GO:0007411; P:axon guidance; TAS:Reactome
O60902	SHOX2	Short stature homeobox protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O60902	SHOX2	Short stature homeobox protein 2	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
O60902	SHOX2	Short stature homeobox protein 2	GO:0003209; P:cardiac atrium morphogenesis; IEA:Ensembl
O60902	SHOX2	Short stature homeobox protein 2	GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; IEA:Ensembl
O60902	SHOX2	Short stature homeobox protein 2	GO:0002063; P:chondrocyte development; IEA:Ensembl
O60902	SHOX2	Short stature homeobox protein 2	GO:0048557; P:embryonic digestive tract morphogenesis; IEA:Ensembl
O60902	SHOX2	Short stature homeobox protein 2	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
O60902	SHOX2	Short stature homeobox protein 2	GO:0060272; P:embryonic skeletal joint morphogenesis; IEA:Ensembl
O60902	SHOX2	Short stature homeobox protein 2	GO:0007507; P:heart development; TAS:ProtInc
O60902	SHOX2	Short stature homeobox protein 2	GO:0003170; P:heart valve development; IEA:Ensembl
O60902	SHOX2	Short stature homeobox protein 2	GO:0060415; P:muscle tissue morphogenesis; IEA:Ensembl
O60902	SHOX2	Short stature homeobox protein 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O60902	SHOX2	Short stature homeobox protein 2	GO:0007399; P:nervous system development; TAS:ProtInc
O60902	SHOX2	Short stature homeobox protein 2	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
O60902	SHOX2	Short stature homeobox protein 2	GO:0050772; P:positive regulation of axonogenesis; IEA:Ensembl
O60902	SHOX2	Short stature homeobox protein 2	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl
O60902	SHOX2	Short stature homeobox protein 2	GO:0048743; P:positive regulation of skeletal muscle fiber development; IEA:Ensembl
O60902	SHOX2	Short stature homeobox protein 2	GO:0045880; P:positive regulation of smoothened signaling pathway; IEA:Ensembl
O60902	SHOX2	Short stature homeobox protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O60902	SHOX2	Short stature homeobox protein 2	GO:2000172; P:regulation of branching morphogenesis of a nerve; IEA:Ensembl
O60902	SHOX2	Short stature homeobox protein 2	GO:0032330; P:regulation of chondrocyte differentiation; IEA:Ensembl
O60902	SHOX2	Short stature homeobox protein 2	GO:0001501; P:skeletal system development; TAS:ProtInc
O15266	SHOX	Short stature homeobox protein	GO:0005515; F:protein binding; IPI:IntAct
O15266	SHOX	Short stature homeobox protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O15266	SHOX	Short stature homeobox protein	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
O15266	SHOX	Short stature homeobox protein	GO:0001501; P:skeletal system development; TAS:ProtInc
O15266	SHOX	Short stature homeobox protein	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9UHJ6	SHPK	Sedoheptulokinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UHJ6	SHPK	Sedoheptulokinase	GO:0050277; F:sedoheptulokinase activity; IDA:UniProtKB
Q9UHJ6	SHPK	Sedoheptulokinase	GO:0005975; P:carbohydrate metabolic process; IDA:UniProtKB
Q9UHJ6	SHPK	Sedoheptulokinase	GO:0035963; P:cellular response to interleukin-13; ISS:UniProtKB
Q9UHJ6	SHPK	Sedoheptulokinase	GO:0071353; P:cellular response to interleukin-4; ISS:UniProtKB
Q9UHJ6	SHPK	Sedoheptulokinase	GO:0071222; P:cellular response to lipopolysaccharide; IDA:UniProtKB
Q9UHJ6	SHPK	Sedoheptulokinase	GO:0009052; P:pentose-phosphate shunt, non-oxidative branch; ISS:UniProtKB
Q9UHJ6	SHPK	Sedoheptulokinase	GO:0016310; P:phosphorylation; IDA:UniProtKB
Q9UHJ6	SHPK	Sedoheptulokinase	GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB
Q9UHJ6	SHPK	Sedoheptulokinase	GO:0043030; P:regulation of macrophage activation; ISS:UniProtKB
Q149N8	SHPRH	E3 ubiquitin-protein ligase SHPRH	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q149N8	SHPRH	E3 ubiquitin-protein ligase SHPRH	GO:0003677; F:DNA binding; IEA:InterPro
Q149N8	SHPRH	E3 ubiquitin-protein ligase SHPRH	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q149N8	SHPRH	E3 ubiquitin-protein ligase SHPRH	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q149N8	SHPRH	E3 ubiquitin-protein ligase SHPRH	GO:0008270; F:zinc ion binding; IEA:InterPro
Q149N8	SHPRH	E3 ubiquitin-protein ligase SHPRH	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q149N8	SHPRH	E3 ubiquitin-protein ligase SHPRH	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q149N8	SHPRH	E3 ubiquitin-protein ligase SHPRH	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
P78324	SIRPA	Tyrosine-protein phosphatase non-receptor type substrate 1	GO:0007596; P:blood coagulation; TAS:Reactome
P78324	SIRPA	Tyrosine-protein phosphatase non-receptor type substrate 1	GO:0007155; P:cell adhesion; TAS:ProtInc
P78324	SIRPA	Tyrosine-protein phosphatase non-receptor type substrate 1	GO:0050900; P:leukocyte migration; TAS:Reactome
Q6PI26	SHQ1	Protein SHQ1 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q6PI26	SHQ1	Protein SHQ1 homolog	GO:2000233; P:negative regulation of rRNA processing; IDA:MGI
Q6PI26	SHQ1	Protein SHQ1 homolog	GO:0043065; P:positive regulation of apoptotic process; IDA:MGI
Q6PI26	SHQ1	Protein SHQ1 homolog	GO:0022618; P:ribonucleoprotein complex assembly; IDA:UniProtKB
Q2M3G4	SHROOM1	Protein Shroom1	GO:0051015; F:actin filament binding; ISS:UniProtKB
Q2M3G4	SHROOM1	Protein Shroom1	GO:0051017; P:actin filament bundle assembly; ISS:UniProtKB
Q2M3G4	SHROOM1	Protein Shroom1	GO:0000902; P:cell morphogenesis; ISS:UniProtKB
Q13796	SHROOM2	Protein Shroom2	GO:0003779; F:actin binding; ISS:UniProtKB
Q13796	SHROOM2	Protein Shroom2	GO:0051015; F:actin filament binding; ISS:UniProtKB
Q13796	SHROOM2	Protein Shroom2	GO:0008013; F:beta-catenin binding; ISS:UniProtKB
Q13796	SHROOM2	Protein Shroom2	GO:0015280; F:ligand-gated sodium channel activity; TAS:ProtInc
Q13796	SHROOM2	Protein Shroom2	GO:0005515; F:protein binding; IPI:IntAct
Q13796	SHROOM2	Protein Shroom2	GO:0045176; P:apical protein localization; ISS:HGNC
Q13796	SHROOM2	Protein Shroom2	GO:0007420; P:brain development; ISS:HGNC
Q13796	SHROOM2	Protein Shroom2	GO:0043010; P:camera-type eye development; ISS:HGNC
Q13796	SHROOM2	Protein Shroom2	GO:0048593; P:camera-type eye morphogenesis; ISS:HGNC
Q13796	SHROOM2	Protein Shroom2	GO:0016477; P:cell migration; ISS:UniProtKB
Q13796	SHROOM2	Protein Shroom2	GO:0045217; P:cell-cell junction maintenance; IEA:Ensembl
Q13796	SHROOM2	Protein Shroom2	GO:0043482; P:cellular pigment accumulation; ISS:HGNC
Q13796	SHROOM2	Protein Shroom2	GO:0043583; P:ear development; ISS:HGNC
Q13796	SHROOM2	Protein Shroom2	GO:0032401; P:establishment of melanosome localization; ISS:HGNC
Q13796	SHROOM2	Protein Shroom2	GO:0008057; P:eye pigment granule organization; ISS:HGNC
Q13796	SHROOM2	Protein Shroom2	GO:0002089; P:lens morphogenesis in camera-type eye; ISS:HGNC
Q13796	SHROOM2	Protein Shroom2	GO:0032438; P:melanosome organization; ISS:HGNC
Q13796	SHROOM2	Protein Shroom2	GO:0030835; P:negative regulation of actin filament depolymerization; IEA:Ensembl
Q13796	SHROOM2	Protein Shroom2	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
Q8TF72	SHROOM3	Protein Shroom3	GO:0030036; P:actin cytoskeleton organization; IEA:Ensembl
Q8TF72	SHROOM3	Protein Shroom3	GO:0045176; P:apical protein localization; ISS:HGNC
Q8TF72	SHROOM3	Protein Shroom3	GO:0000902; P:cell morphogenesis; ISS:HGNC
Q8TF72	SHROOM3	Protein Shroom3	GO:0043482; P:cellular pigment accumulation; ISS:HGNC
Q8TF72	SHROOM3	Protein Shroom3	GO:0002066; P:columnar/cuboidal epithelial cell development; IEA:Ensembl
Q8TF72	SHROOM3	Protein Shroom3	GO:0001843; P:neural tube closure; IEA:Ensembl
Q8TF72	SHROOM3	Protein Shroom3	GO:0007389; P:pattern specification process; ISS:HGNC
Q8TF72	SHROOM3	Protein Shroom3	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
Q9ULL8	SHROOM4	Protein Shroom4	GO:0051015; F:actin filament binding; ISS:UniProtKB
Q9ULL8	SHROOM4	Protein Shroom4	GO:0030036; P:actin cytoskeleton organization; NAS:UniProtKB
Q9ULL8	SHROOM4	Protein Shroom4	GO:0007015; P:actin filament organization; ISS:UniProtKB
Q9ULL8	SHROOM4	Protein Shroom4	GO:0007420; P:brain development; IDA:UniProtKB
Q9ULL8	SHROOM4	Protein Shroom4	GO:0050890; P:cognition; IDA:UniProtKB
Q9H0F6	SHARPIN	Sharpin	GO:0031593; F:polyubiquitin binding; IDA:UniProtKB
Q9H0F6	SHARPIN	Sharpin	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H0F6	SHARPIN	Sharpin	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H0F6	SHARPIN	Sharpin	GO:0030262; P:apoptotic nuclear changes; IEA:Ensembl
Q9H0F6	SHARPIN	Sharpin	GO:0007420; P:brain development; IEA:Ensembl
Q9H0F6	SHARPIN	Sharpin	GO:0031424; P:keratinization; IEA:Ensembl
Q9H0F6	SHARPIN	Sharpin	GO:0007005; P:mitochondrion organization; IEA:Ensembl
Q9H0F6	SHARPIN	Sharpin	GO:0050728; P:negative regulation of inflammatory response; ISS:UniProtKB
Q9H0F6	SHARPIN	Sharpin	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q9H0F6	SHARPIN	Sharpin	GO:0051260; P:protein homooligomerization; IEA:Ensembl
Q9H0F6	SHARPIN	Sharpin	GO:0097039; P:protein linear polyubiquitination; IDA:UniProtKB
Q9H0F6	SHARPIN	Sharpin	GO:2000348; P:regulation of CD40 signaling pathway; IDA:UniProtKB
Q9H0F6	SHARPIN	Sharpin	GO:0010803; P:regulation of tumor necrosis factor-mediated signaling pathway; IDA:UniProtKB
Q6UWI4	SHISA2	Protein shisa-2 homolog	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
A0PJX4	SHISA3	Protein shisa-3 homolog	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8N114	SHISA5	Protein shisa-5	GO:0005515; F:protein binding; IPI:IntAct
Q8N114	SHISA5	Protein shisa-5	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q8N114	SHISA5	Protein shisa-5	GO:0050699; F:WW domain binding; IPI:UniProtKB
Q8N114	SHISA5	Protein shisa-5	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IEA:Ensembl
Q8N114	SHISA5	Protein shisa-5	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
B4DS77	SHISA9	Protein shisa-9	GO:0048172; P:regulation of short-term neuronal synaptic plasticity; ISS:UniProtKB
O43166	SIPA1L1	Signal-induced proliferation-associated 1-like protein 1	GO:0005096; F:GTPase activator activity; IEA:InterPro
O43166	SIPA1L1	Signal-induced proliferation-associated 1-like protein 1	GO:0031532; P:actin cytoskeleton reorganization; ISS:UniProtKB
O43166	SIPA1L1	Signal-induced proliferation-associated 1-like protein 1	GO:0032861; P:activation of Rap GTPase activity; ISS:UniProtKB
O43166	SIPA1L1	Signal-induced proliferation-associated 1-like protein 1	GO:0048013; P:ephrin receptor signaling pathway; ISS:UniProtKB
O43166	SIPA1L1	Signal-induced proliferation-associated 1-like protein 1	GO:0050770; P:regulation of axonogenesis; ISS:UniProtKB
O43166	SIPA1L1	Signal-induced proliferation-associated 1-like protein 1	GO:0061001; P:regulation of dendritic spine morphogenesis; ISS:UniProtKB
O43166	SIPA1L1	Signal-induced proliferation-associated 1-like protein 1	GO:0032317; P:regulation of Rap GTPase activity; ISS:UniProtKB
O43166	SIPA1L1	Signal-induced proliferation-associated 1-like protein 1	GO:0051056; P:regulation of small GTPase mediated signal transduction; IEA:InterPro
O43166	SIPA1L1	Signal-induced proliferation-associated 1-like protein 1	GO:0048167; P:regulation of synaptic plasticity; ISS:UniProtKB
Q9P2F8	SIPA1L2	Signal-induced proliferation-associated 1-like protein 2	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q9P2F8	SIPA1L2	Signal-induced proliferation-associated 1-like protein 2	GO:0051056; P:regulation of small GTPase mediated signal transduction; IEA:InterPro
O60292	SIPA1L3	Signal-induced proliferation-associated 1-like protein 3	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
O60292	SIPA1L3	Signal-induced proliferation-associated 1-like protein 3	GO:0051056; P:regulation of small GTPase mediated signal transduction; IEA:InterPro
Q9Y274	ST3GAL6	Type 2 lactosamine alpha-2,3-sialyltransferase	GO:0052798; F:beta-galactoside alpha-2,3-sialyltransferase activity; IDA:UniProtKB
Q9Y274	ST3GAL6	Type 2 lactosamine alpha-2,3-sialyltransferase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9Y274	ST3GAL6	Type 2 lactosamine alpha-2,3-sialyltransferase	GO:0006464; P:cellular protein modification process; IDA:UniProtKB
Q9Y274	ST3GAL6	Type 2 lactosamine alpha-2,3-sialyltransferase	GO:0071354; P:cellular response to interleukin-6; IEP:UniProtKB
Q9Y274	ST3GAL6	Type 2 lactosamine alpha-2,3-sialyltransferase	GO:0006664; P:glycolipid metabolic process; IDA:UniProtKB
Q9Y274	ST3GAL6	Type 2 lactosamine alpha-2,3-sialyltransferase	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9Y274	ST3GAL6	Type 2 lactosamine alpha-2,3-sialyltransferase	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
Q9Y274	ST3GAL6	Type 2 lactosamine alpha-2,3-sialyltransferase	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
Q9Y274	ST3GAL6	Type 2 lactosamine alpha-2,3-sialyltransferase	GO:0009311; P:oligosaccharide metabolic process; IDA:UniProtKB
Q9Y274	ST3GAL6	Type 2 lactosamine alpha-2,3-sialyltransferase	GO:0006486; P:protein glycosylation; IEA:InterPro
Q9Y274	ST3GAL6	Type 2 lactosamine alpha-2,3-sialyltransferase	GO:0097503; P:sialylation; IDA:GOC
Q9Y274	ST3GAL6	Type 2 lactosamine alpha-2,3-sialyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q11201	ST3GAL1	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1	GO:0003836; F:beta-galactoside (CMP) alpha-2,3-sialyltransferase activity; ISS:UniProtKB
Q11201	ST3GAL1	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q11201	ST3GAL1	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q11201	ST3GAL1	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q11201	ST3GAL1	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q11201	ST3GAL1	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
Q11201	ST3GAL1	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
Q11201	ST3GAL1	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1	GO:0006054; P:N-acetylneuraminate metabolic process; ISS:UniProtKB
Q11201	ST3GAL1	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1	GO:0016266; P:O-glycan processing; TAS:Reactome
Q11201	ST3GAL1	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q11201	ST3GAL1	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1	GO:0006487; P:protein N-linked glycosylation; ISS:UniProtKB
Q11201	ST3GAL1	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1	GO:0006468; P:protein phosphorylation; IEA:Ensembl
Q11201	ST3GAL1	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1	GO:0097503; P:sialylation; ISS:UniProtKB
Q11201	ST3GAL1	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16842	ST3GAL2	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2	GO:0003836; F:beta-galactoside (CMP) alpha-2,3-sialyltransferase activity; TAS:ProtInc
Q16842	ST3GAL2	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2	GO:0006040; P:amino sugar metabolic process; TAS:ProtInc
Q16842	ST3GAL2	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q16842	ST3GAL2	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q16842	ST3GAL2	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q16842	ST3GAL2	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q16842	ST3GAL2	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
Q16842	ST3GAL2	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
Q16842	ST3GAL2	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2	GO:0016266; P:O-glycan processing; TAS:Reactome
Q16842	ST3GAL2	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q16842	ST3GAL2	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2	GO:0097503; P:sialylation; TAS:GOC
Q16842	ST3GAL2	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q11206	ST3GAL4	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4	GO:0003836; F:beta-galactoside (CMP) alpha-2,3-sialyltransferase activity; TAS:ProtInc
Q11206	ST3GAL4	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4	GO:0047288; F:monosialoganglioside sialyltransferase activity; IEA:Ensembl
Q11206	ST3GAL4	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q11206	ST3GAL4	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q11206	ST3GAL4	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q11206	ST3GAL4	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
Q11206	ST3GAL4	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
Q11206	ST3GAL4	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4	GO:0016266; P:O-glycan processing; TAS:Reactome
Q11206	ST3GAL4	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q11206	ST3GAL4	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q11206	ST3GAL4	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4	GO:0097503; P:sialylation; TAS:GOC
Q11206	ST3GAL4	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NSC7	ST6GALNAC1	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1	GO:0001665; F:alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity; IEA:UniProtKB-EC
Q9NSC7	ST6GALNAC1	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1	GO:0008373; F:sialyltransferase activity; NAS:UniProtKB
Q9NSC7	ST6GALNAC1	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1	GO:0009312; P:oligosaccharide biosynthetic process; IEA:Ensembl
Q9NSC7	ST6GALNAC1	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1	GO:0006486; P:protein glycosylation; NAS:UniProtKB
Q9NSC7	ST6GALNAC1	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1	GO:0097503; P:sialylation; NAS:GOC
Q9UJ37	ST6GALNAC2	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2	GO:0008373; F:sialyltransferase activity; IEA:InterPro
Q9UJ37	ST6GALNAC2	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UJ37	ST6GALNAC2	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2	GO:0016266; P:O-glycan processing; TAS:Reactome
Q9UJ37	ST6GALNAC2	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q8NDV1	ST6GALNAC3	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3	GO:0008373; F:sialyltransferase activity; IDA:BHF-UCL
Q8NDV1	ST6GALNAC3	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3	GO:0009100; P:glycoprotein metabolic process; IDA:BHF-UCL
Q8NDV1	ST6GALNAC3	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3	GO:0006687; P:glycosphingolipid metabolic process; IDA:BHF-UCL
Q8NDV1	ST6GALNAC3	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3	GO:0006677; P:glycosylceramide metabolic process; IDA:BHF-UCL
Q8NDV1	ST6GALNAC3	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q8NDV1	ST6GALNAC3	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3	GO:0097503; P:sialylation; IDA:GOC
Q9H4F1	ST6GALNAC4	Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase	GO:0047290; F:(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity; IEA:UniProtKB-EC
Q9H4F1	ST6GALNAC4	Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase	GO:0008373; F:sialyltransferase activity; TAS:ProtInc
Q9H4F1	ST6GALNAC4	Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9H4F1	ST6GALNAC4	Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase	GO:0006664; P:glycolipid metabolic process; TAS:ProtInc
Q9H4F1	ST6GALNAC4	Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase	GO:0016266; P:O-glycan processing; TAS:Reactome
Q9H4F1	ST6GALNAC4	Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9H4F1	ST6GALNAC4	Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase	GO:0097503; P:sialylation; TAS:GOC
Q9BVH7	ST6GALNAC5	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5	GO:0001665; F:alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity; ISS:BHF-UCL
Q9BVH7	ST6GALNAC5	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5	GO:0008373; F:sialyltransferase activity; ISS:BHF-UCL
Q9BVH7	ST6GALNAC5	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5	GO:0006688; P:glycosphingolipid biosynthetic process; ISS:BHF-UCL
Q9BVH7	ST6GALNAC5	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5	GO:0009312; P:oligosaccharide biosynthetic process; ISS:BHF-UCL
Q9BVH7	ST6GALNAC5	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q9BVH7	ST6GALNAC5	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5	GO:0097503; P:sialylation; ISS:GOC
Q969X2	ST6GALNAC6	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	GO:0001665; F:alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity; ISS:BHF-UCL
Q969X2	ST6GALNAC6	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	GO:0008373; F:sialyltransferase activity; IDA:BHF-UCL
Q969X2	ST6GALNAC6	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	GO:0009988; P:cell-cell recognition; IC:BHF-UCL
Q969X2	ST6GALNAC6	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	GO:0001574; P:ganglioside biosynthetic process; ISS:BHF-UCL
Q969X2	ST6GALNAC6	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	GO:0009100; P:glycoprotein metabolic process; IDA:BHF-UCL
Q969X2	ST6GALNAC6	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	GO:0006687; P:glycosphingolipid metabolic process; IDA:BHF-UCL
Q969X2	ST6GALNAC6	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	GO:0006677; P:glycosylceramide metabolic process; IDA:BHF-UCL
Q969X2	ST6GALNAC6	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	GO:0009312; P:oligosaccharide biosynthetic process; ISS:BHF-UCL
Q969X2	ST6GALNAC6	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	GO:0006486; P:protein glycosylation; IEA:InterPro
Q969X2	ST6GALNAC6	Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	GO:0097503; P:sialylation; IDA:GOC
Q92185	ST8SIA1	Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase	GO:0003828; F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; IEA:UniProtKB-EC
Q92185	ST8SIA1	Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase	GO:0008373; F:sialyltransferase activity; TAS:ProtInc
Q92185	ST8SIA1	Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
Q92185	ST8SIA1	Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase	GO:0034605; P:cellular response to heat; IEA:Ensembl
Q92185	ST8SIA1	Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase	GO:0006688; P:glycosphingolipid biosynthetic process; TAS:ProtInc
Q92185	ST8SIA1	Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q92185	ST8SIA1	Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
Q92185	ST8SIA1	Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase	GO:0097503; P:sialylation; TAS:GOC
Q92186	ST8SIA2	Alpha-2,8-sialyltransferase 8B	GO:0003828; F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; IDA:BHF-UCL
Q92186	ST8SIA2	Alpha-2,8-sialyltransferase 8B	GO:0033691; F:sialic acid binding; IC:BHF-UCL
Q92186	ST8SIA2	Alpha-2,8-sialyltransferase 8B	GO:0007411; P:axon guidance; TAS:Reactome
Q92186	ST8SIA2	Alpha-2,8-sialyltransferase 8B	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
Q92186	ST8SIA2	Alpha-2,8-sialyltransferase 8B	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q92186	ST8SIA2	Alpha-2,8-sialyltransferase 8B	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q92186	ST8SIA2	Alpha-2,8-sialyltransferase 8B	GO:0001574; P:ganglioside biosynthetic process; IDA:BHF-UCL
Q92186	ST8SIA2	Alpha-2,8-sialyltransferase 8B	GO:0006491; P:N-glycan processing; IDA:BHF-UCL
Q92186	ST8SIA2	Alpha-2,8-sialyltransferase 8B	GO:0007399; P:nervous system development; TAS:ProtInc
Q92186	ST8SIA2	Alpha-2,8-sialyltransferase 8B	GO:0009311; P:oligosaccharide metabolic process; IDA:BHF-UCL
Q92186	ST8SIA2	Alpha-2,8-sialyltransferase 8B	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q92186	ST8SIA2	Alpha-2,8-sialyltransferase 8B	GO:0006486; P:protein glycosylation; IDA:BHF-UCL
Q92186	ST8SIA2	Alpha-2,8-sialyltransferase 8B	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q92186	ST8SIA2	Alpha-2,8-sialyltransferase 8B	GO:0097503; P:sialylation; IDA:GOC
O43173	ST8SIA3	Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase	GO:0003828; F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; IDA:BHF-UCL
O43173	ST8SIA3	Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase	GO:0033691; F:sialic acid binding; IC:BHF-UCL
O43173	ST8SIA3	Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O43173	ST8SIA3	Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase	GO:0001574; P:ganglioside biosynthetic process; IDA:BHF-UCL
O43173	ST8SIA3	Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase	GO:0009100; P:glycoprotein metabolic process; IDA:BHF-UCL
O43173	ST8SIA3	Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase	GO:0006688; P:glycosphingolipid biosynthetic process; TAS:ProtInc
O43173	ST8SIA3	Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase	GO:0006491; P:N-glycan processing; IDA:BHF-UCL
O43173	ST8SIA3	Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase	GO:0009311; P:oligosaccharide metabolic process; IDA:BHF-UCL
O43173	ST8SIA3	Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase	GO:0043687; P:post-translational protein modification; TAS:Reactome
O43173	ST8SIA3	Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase	GO:0006486; P:protein glycosylation; IDA:BHF-UCL
O43173	ST8SIA3	Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
O43173	ST8SIA3	Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase	GO:0097503; P:sialylation; IDA:GOC
Q92187	ST8SIA4	CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase	GO:0003828; F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; IDA:BHF-UCL
Q92187	ST8SIA4	CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase	GO:0033691; F:sialic acid binding; IC:BHF-UCL
Q92187	ST8SIA4	CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase	GO:0007411; P:axon guidance; TAS:Reactome
Q92187	ST8SIA4	CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q92187	ST8SIA4	CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase	GO:0001574; P:ganglioside biosynthetic process; IDA:BHF-UCL
Q92187	ST8SIA4	CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase	GO:0006491; P:N-glycan processing; IDA:BHF-UCL
Q92187	ST8SIA4	CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase	GO:0007399; P:nervous system development; TAS:ProtInc
Q92187	ST8SIA4	CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase	GO:0009311; P:oligosaccharide metabolic process; IDA:BHF-UCL
Q92187	ST8SIA4	CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase	GO:0006486; P:protein glycosylation; IDA:BHF-UCL
Q92187	ST8SIA4	CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase	GO:0097503; P:sialylation; IDA:GOC
O15466	ST8SIA5	Alpha-2,8-sialyltransferase 8E	GO:0003828; F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; IEA:Ensembl
O15466	ST8SIA5	Alpha-2,8-sialyltransferase 8E	GO:0008373; F:sialyltransferase activity; TAS:ProtInc
O15466	ST8SIA5	Alpha-2,8-sialyltransferase 8E	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
O15466	ST8SIA5	Alpha-2,8-sialyltransferase 8E	GO:0006688; P:glycosphingolipid biosynthetic process; TAS:ProtInc
O15466	ST8SIA5	Alpha-2,8-sialyltransferase 8E	GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway
O15466	ST8SIA5	Alpha-2,8-sialyltransferase 8E	GO:0097503; P:sialylation; TAS:GOC
P61647	ST8SIA6	Alpha-2,8-sialyltransferase 8F	GO:0008373; F:sialyltransferase activity; ISS:BHF-UCL
P61647	ST8SIA6	Alpha-2,8-sialyltransferase 8F	GO:0016051; P:carbohydrate biosynthetic process; ISS:BHF-UCL
P61647	ST8SIA6	Alpha-2,8-sialyltransferase 8F	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P61647	ST8SIA6	Alpha-2,8-sialyltransferase 8F	GO:0001574; P:ganglioside biosynthetic process; ISS:BHF-UCL
P61647	ST8SIA6	Alpha-2,8-sialyltransferase 8F	GO:0009247; P:glycolipid biosynthetic process; ISS:BHF-UCL
P61647	ST8SIA6	Alpha-2,8-sialyltransferase 8F	GO:0009100; P:glycoprotein metabolic process; ISS:BHF-UCL
P61647	ST8SIA6	Alpha-2,8-sialyltransferase 8F	GO:0009311; P:oligosaccharide metabolic process; ISS:BHF-UCL
P61647	ST8SIA6	Alpha-2,8-sialyltransferase 8F	GO:0043687; P:post-translational protein modification; TAS:Reactome
P61647	ST8SIA6	Alpha-2,8-sialyltransferase 8F	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
P61647	ST8SIA6	Alpha-2,8-sialyltransferase 8F	GO:0006493; P:protein O-linked glycosylation; ISS:BHF-UCL
P61647	ST8SIA6	Alpha-2,8-sialyltransferase 8F	GO:0097503; P:sialylation; ISS:GOC
Q9HAT2	SIAE	Sialate O-acetylesterase	GO:0001681; F:sialate O-acetylesterase activity; IDA:UniProt
Q9HAT2	SIAE	Sialate O-acetylesterase	GO:0005975; P:carbohydrate metabolic process; IDA:UniProt
Q9HAT2	SIAE	Sialate O-acetylesterase	GO:0002682; P:regulation of immune system process; IMP:UniProt
Q8IUQ4	SIAH1	E3 ubiquitin-protein ligase SIAH1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IUQ4	SIAH1	E3 ubiquitin-protein ligase SIAH1	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q8IUQ4	SIAH1	E3 ubiquitin-protein ligase SIAH1	GO:0004842; F:ubiquitin-protein ligase activity; IMP:UniProtKB
Q8IUQ4	SIAH1	E3 ubiquitin-protein ligase SIAH1	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q8IUQ4	SIAH1	E3 ubiquitin-protein ligase SIAH1	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q8IUQ4	SIAH1	E3 ubiquitin-protein ligase SIAH1	GO:0006915; P:apoptotic process; TAS:ProtInc
Q8IUQ4	SIAH1	E3 ubiquitin-protein ligase SIAH1	GO:0007411; P:axon guidance; TAS:Reactome
Q8IUQ4	SIAH1	E3 ubiquitin-protein ligase SIAH1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q8IUQ4	SIAH1	E3 ubiquitin-protein ligase SIAH1	GO:0007399; P:nervous system development; TAS:ProtInc
Q8IUQ4	SIAH1	E3 ubiquitin-protein ligase SIAH1	GO:0051402; P:neuron apoptotic process; ISS:UniProtKB
Q8IUQ4	SIAH1	E3 ubiquitin-protein ligase SIAH1	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q8IUQ4	SIAH1	E3 ubiquitin-protein ligase SIAH1	GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
Q8IUQ4	SIAH1	E3 ubiquitin-protein ligase SIAH1	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB
Q8IUQ4	SIAH1	E3 ubiquitin-protein ligase SIAH1	GO:0030163; P:protein catabolic process; IDA:UniProtKB
Q8IUQ4	SIAH1	E3 ubiquitin-protein ligase SIAH1	GO:0031648; P:protein destabilization; IEA:Ensembl
Q8IUQ4	SIAH1	E3 ubiquitin-protein ligase SIAH1	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ISS:UniProtKB
Q8IUQ4	SIAH1	E3 ubiquitin-protein ligase SIAH1	GO:0006508; P:proteolysis; TAS:ProtInc
Q8IUQ4	SIAH1	E3 ubiquitin-protein ligase SIAH1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q8IUQ4	SIAH1	E3 ubiquitin-protein ligase SIAH1	GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:MGI
O43255	SIAH2	E3 ubiquitin-protein ligase SIAH2	GO:0005515; F:protein binding; IPI:UniProtKB
O43255	SIAH2	E3 ubiquitin-protein ligase SIAH2	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
O43255	SIAH2	E3 ubiquitin-protein ligase SIAH2	GO:0004842; F:ubiquitin-protein ligase activity; IEA:InterPro
O43255	SIAH2	E3 ubiquitin-protein ligase SIAH2	GO:0008270; F:zinc ion binding; IEA:InterPro
O43255	SIAH2	E3 ubiquitin-protein ligase SIAH2	GO:0007411; P:axon guidance; TAS:Reactome
O43255	SIAH2	E3 ubiquitin-protein ligase SIAH2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
O43255	SIAH2	E3 ubiquitin-protein ligase SIAH2	GO:0044257; P:cellular protein catabolic process; IGI:MGI
O43255	SIAH2	E3 ubiquitin-protein ligase SIAH2	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
O43255	SIAH2	E3 ubiquitin-protein ligase SIAH2	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IGI:MGI
O43255	SIAH2	E3 ubiquitin-protein ligase SIAH2	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
O43255	SIAH2	E3 ubiquitin-protein ligase SIAH2	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB
O43255	SIAH2	E3 ubiquitin-protein ligase SIAH2	GO:0031396; P:regulation of protein ubiquitination; IEA:Ensembl
O43255	SIAH2	E3 ubiquitin-protein ligase SIAH2	GO:2001141; P:regulation of RNA biosynthetic process; TAS:GOC
O43255	SIAH2	E3 ubiquitin-protein ligase SIAH2	GO:0007264; P:small GTPase mediated signal transduction; TAS:ProtInc
O43255	SIAH2	E3 ubiquitin-protein ligase SIAH2	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
Q8IW03	SIAH3	Seven in absentia homolog 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IW03	SIAH3	Seven in absentia homolog 3	GO:0007275; P:multicellular organismal development; IEA:InterPro
Q8IW03	SIAH3	Seven in absentia homolog 3	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
P21815	IBSP	Bone sialoprotein 2	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
P21815	IBSP	Bone sialoprotein 2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P21815	IBSP	Bone sialoprotein 2	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P21815	IBSP	Bone sialoprotein 2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P21815	IBSP	Bone sialoprotein 2	GO:0001503; P:ossification; IEA:InterPro
Q9NR45	NANS	Sialic acid synthase	GO:0050462; F:N-acetylneuraminate synthase activity; IEA:UniProtKB-EC
Q9NR45	NANS	Sialic acid synthase	GO:0008781; F:N-acylneuraminate cytidylyltransferase activity; NAS:UniProtKB
Q9NR45	NANS	Sialic acid synthase	GO:0047444; F:N-acylneuraminate-9-phosphate synthase activity; IEA:UniProtKB-EC
Q9NR45	NANS	Sialic acid synthase	GO:0009103; P:lipopolysaccharide biosynthetic process; NAS:UniProtKB
P15907	ST6GAL1	Beta-galactoside alpha-2,6-sialyltransferase 1	GO:0003835; F:beta-galactoside alpha-2,6-sialyltransferase activity; IDA:UniProtKB
P15907	ST6GAL1	Beta-galactoside alpha-2,6-sialyltransferase 1	GO:0008373; F:sialyltransferase activity; IDA:UniProtKB
P15907	ST6GAL1	Beta-galactoside alpha-2,6-sialyltransferase 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P15907	ST6GAL1	Beta-galactoside alpha-2,6-sialyltransferase 1	GO:0006959; P:humoral immune response; TAS:ProtInc
P15907	ST6GAL1	Beta-galactoside alpha-2,6-sialyltransferase 1	GO:0006054; P:N-acetylneuraminate metabolic process; IDA:UniProtKB
P15907	ST6GAL1	Beta-galactoside alpha-2,6-sialyltransferase 1	GO:0016266; P:O-glycan processing; TAS:Reactome
P15907	ST6GAL1	Beta-galactoside alpha-2,6-sialyltransferase 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
P15907	ST6GAL1	Beta-galactoside alpha-2,6-sialyltransferase 1	GO:0018279; P:protein N-linked glycosylation via asparagine; IDA:UniProtKB
P15907	ST6GAL1	Beta-galactoside alpha-2,6-sialyltransferase 1	GO:0097503; P:sialylation; IDA:UniProtKB
Q96JF0	ST6GAL2	Beta-galactoside alpha-2,6-sialyltransferase 2	GO:0003835; F:beta-galactoside alpha-2,6-sialyltransferase activity; IDA:UniProtKB
Q96JF0	ST6GAL2	Beta-galactoside alpha-2,6-sialyltransferase 2	GO:0040007; P:growth; NAS:UniProtKB
Q96JF0	ST6GAL2	Beta-galactoside alpha-2,6-sialyltransferase 2	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
Q96JF0	ST6GAL2	Beta-galactoside alpha-2,6-sialyltransferase 2	GO:0009311; P:oligosaccharide metabolic process; IDA:UniProtKB
Q96JF0	ST6GAL2	Beta-galactoside alpha-2,6-sialyltransferase 2	GO:0006486; P:protein glycosylation; IEA:InterPro
Q96JF0	ST6GAL2	Beta-galactoside alpha-2,6-sialyltransferase 2	GO:0097503; P:sialylation; IDA:GOC
Q11203	ST3GAL3	CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase	GO:0003836; F:beta-galactoside (CMP) alpha-2,3-sialyltransferase activity; IEA:Ensembl
Q11203	ST3GAL3	CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase	GO:0008118; F:N-acetyllactosaminide alpha-2,3-sialyltransferase activity; TAS:ProtInc
Q11203	ST3GAL3	CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q11203	ST3GAL3	CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q11203	ST3GAL3	CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q11203	ST3GAL3	CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase	GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome
Q11203	ST3GAL3	CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase	GO:0042339; P:keratan sulfate metabolic process; TAS:Reactome
Q11203	ST3GAL3	CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase	GO:0016266; P:O-glycan processing; TAS:Reactome
Q11203	ST3GAL3	CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q11203	ST3GAL3	CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase	GO:0097503; P:sialylation; TAS:GOC
Q11203	ST3GAL3	CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9UNP4	ST3GAL5	Lactosylceramide alpha-2,3-sialyltransferase	GO:0047291; F:lactosylceramide alpha-2,3-sialyltransferase activity; IDA:UniProtKB
Q9UNP4	ST3GAL5	Lactosylceramide alpha-2,3-sialyltransferase	GO:0004513; F:neolactotetraosylceramide alpha-2,3-sialyltransferase activity; TAS:ProtInc
Q9UNP4	ST3GAL5	Lactosylceramide alpha-2,3-sialyltransferase	GO:0008373; F:sialyltransferase activity; TAS:ProtInc
Q9UNP4	ST3GAL5	Lactosylceramide alpha-2,3-sialyltransferase	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
Q9UNP4	ST3GAL5	Lactosylceramide alpha-2,3-sialyltransferase	GO:0001574; P:ganglioside biosynthetic process; NAS:UniProtKB
Q9UNP4	ST3GAL5	Lactosylceramide alpha-2,3-sialyltransferase	GO:0006688; P:glycosphingolipid biosynthetic process; TAS:ProtInc
Q9UNP4	ST3GAL5	Lactosylceramide alpha-2,3-sialyltransferase	GO:0006486; P:protein glycosylation; IEA:InterPro
Q9UNP4	ST3GAL5	Lactosylceramide alpha-2,3-sialyltransferase	GO:0097503; P:sialylation; IDA:GOC
Q9NXL6	SIDT1	SID1 transmembrane family member 1	GO:0051033; F:RNA transmembrane transporter activity; IEA:InterPro
Q9NXL6	SIDT1	SID1 transmembrane family member 1	GO:0033227; P:dsRNA transport; IEA:InterPro
Q8NBJ9	SIDT2	SID1 transmembrane family member 2	GO:0051033; F:RNA transmembrane transporter activity; IEA:InterPro
Q8NBJ9	SIDT2	SID1 transmembrane family member 2	GO:0033227; P:dsRNA transport; IEA:InterPro
Q96LC7	SIGLEC10	Sialic acid-binding Ig-like lectin 10	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q96RL6	SIGLEC11	Sialic acid-binding Ig-like lectin 11	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q96PQ1	SIGLEC12	Sialic acid-binding Ig-like lectin 12	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q08ET2	SIGLEC14	Sialic acid-binding Ig-like lectin 14	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q08ET2	SIGLEC14	Sialic acid-binding Ig-like lectin 14	GO:0045087; P:innate immune response; TAS:Reactome
Q6ZMC9	SIGLEC15	Sialic acid-binding Ig-like lectin 15	GO:0071402; P:cellular response to lipoprotein particle stimulus; IEA:Ensembl
Q6ZMC9	SIGLEC15	Sialic acid-binding Ig-like lectin 15	GO:0045087; P:innate immune response; TAS:Reactome
Q6ZMC9	SIGLEC15	Sialic acid-binding Ig-like lectin 15	GO:0032956; P:regulation of actin cytoskeleton organization; IEA:Ensembl
Q6ZMC9	SIGLEC15	Sialic acid-binding Ig-like lectin 15	GO:0045124; P:regulation of bone resorption; IEA:Ensembl
Q6ZMC9	SIGLEC15	Sialic acid-binding Ig-like lectin 15	GO:2001204; P:regulation of osteoclast development; IEA:Ensembl
A6NMB1	SIGLEC16	Sialic acid-binding Ig-like lectin 16	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
A6NMB1	SIGLEC16	Sialic acid-binding Ig-like lectin 16	GO:0045087; P:innate immune response; TAS:Reactome
Q6IA17	SIGIRR	Single Ig IL-1-related receptor	GO:0005515; F:protein binding; IPI:UniProtKB
Q6IA17	SIGIRR	Single Ig IL-1-related receptor	GO:0006953; P:acute-phase response; ISS:HGNC
Q6IA17	SIGIRR	Single Ig IL-1-related receptor	GO:0045079; P:negative regulation of chemokine biosynthetic process; ISS:HGNC
Q6IA17	SIGIRR	Single Ig IL-1-related receptor	GO:0001960; P:negative regulation of cytokine-mediated signaling pathway; ISS:HGNC
Q6IA17	SIGIRR	Single Ig IL-1-related receptor	GO:0031665; P:negative regulation of lipopolysaccharide-mediated signaling pathway; TAS:HGNC
Q6IA17	SIGIRR	Single Ig IL-1-related receptor	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IMP:HGNC
Q6IA17	SIGIRR	Single Ig IL-1-related receptor	GO:0007165; P:signal transduction; IEA:InterPro
O15389	SIGLEC5	Sialic acid-binding Ig-like lectin 5	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
O43699	SIGLEC6	Sialic acid-binding Ig-like lectin 6	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
O43699	SIGLEC6	Sialic acid-binding Ig-like lectin 6	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9Y286	SIGLEC7	Sialic acid-binding Ig-like lectin 7	GO:0030246; F:carbohydrate binding; TAS:ProtInc
Q9Y286	SIGLEC7	Sialic acid-binding Ig-like lectin 7	GO:0004872; F:receptor activity; TAS:ProtInc
Q9Y286	SIGLEC7	Sialic acid-binding Ig-like lectin 7	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9NYZ4	SIGLEC8	Sialic acid-binding Ig-like lectin 8	GO:0030246; F:carbohydrate binding; TAS:ProtInc
Q9NYZ4	SIGLEC8	Sialic acid-binding Ig-like lectin 8	GO:0005515; F:protein binding; IPI:IntAct
Q9NYZ4	SIGLEC8	Sialic acid-binding Ig-like lectin 8	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q9NYZ4	SIGLEC8	Sialic acid-binding Ig-like lectin 8	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9NYZ4	SIGLEC8	Sialic acid-binding Ig-like lectin 8	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y336	SIGLEC9	Sialic acid-binding Ig-like lectin 9	GO:0030246; F:carbohydrate binding; NAS:UniProtKB
Q9Y336	SIGLEC9	Sialic acid-binding Ig-like lectin 9	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9Y336	SIGLEC9	Sialic acid-binding Ig-like lectin 9	GO:0007166; P:cell surface receptor signaling pathway; NAS:UniProtKB
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0071889; F:14-3-3 protein binding; IDA:UniProtKB
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0005524; F:ATP binding; IDA:UniProtKB
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0008140; F:cAMP response element binding protein binding; ISS:UniProtKB
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0005515; F:protein binding; IPI:IntAct
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0043276; P:anoikis; IEA:Ensembl
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0055007; P:cardiac muscle cell differentiation; ISS:UniProtKB
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0032792; P:negative regulation of CREB transcription factor activity; ISS:UniProtKB
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0045721; P:negative regulation of gluconeogenesis; ISS:UniProtKB
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0010868; P:negative regulation of triglyceride biosynthetic process; ISS:UniProtKB
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:2000210; P:positive regulation of anoikis; IMP:BHF-UCL
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0045595; P:regulation of cell differentiation; ISS:UniProtKB
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0007346; P:regulation of mitotic cell cycle; ISS:UniProtKB
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0010830; P:regulation of myotube differentiation; ISS:UniProtKB
P57059	SIK1	Serine/threonine-protein kinase SIK1	GO:0002028; P:regulation of sodium ion transport; ISS:UniProtKB
Q9Y2K2	SIK3	Serine/threonine-protein kinase SIK3	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9Y2K2	SIK3	Serine/threonine-protein kinase SIK3	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q9Y2K2	SIK3	Serine/threonine-protein kinase SIK3	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2K2	SIK3	Serine/threonine-protein kinase SIK3	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9Y2K2	SIK3	Serine/threonine-protein kinase SIK3	GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; IEA:Ensembl
Q9Y2K2	SIK3	Serine/threonine-protein kinase SIK3	GO:0001958; P:endochondral ossification; IEA:Ensembl
Q9Y2K2	SIK3	Serine/threonine-protein kinase SIK3	GO:0035108; P:limb morphogenesis; IEA:Ensembl
Q9Y2K2	SIK3	Serine/threonine-protein kinase SIK3	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q9Y2K2	SIK3	Serine/threonine-protein kinase SIK3	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9Y2K2	SIK3	Serine/threonine-protein kinase SIK3	GO:0032880; P:regulation of protein localization; IEA:Ensembl
Q9H0K1	SIK2	Serine/threonine-protein kinase SIK2	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9H0K1	SIK2	Serine/threonine-protein kinase SIK2	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q9H0K1	SIK2	Serine/threonine-protein kinase SIK2	GO:0005515; F:protein binding; IPI:IntAct
Q9H0K1	SIK2	Serine/threonine-protein kinase SIK2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9H0K1	SIK2	Serine/threonine-protein kinase SIK2	GO:0008286; P:insulin receptor signaling pathway; IEA:Ensembl
Q9H0K1	SIK2	Serine/threonine-protein kinase SIK2	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q9H0K1	SIK2	Serine/threonine-protein kinase SIK2	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q9H0K1	SIK2	Serine/threonine-protein kinase SIK2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9H0K1	SIK2	Serine/threonine-protein kinase SIK2	GO:0046626; P:regulation of insulin receptor signaling pathway; ISS:UniProtKB
Q9BRV8	SIKE1	Suppressor of IKBKE 1	GO:0005515; F:protein binding; IPI:IntAct
Q9BRV8	SIKE1	Suppressor of IKBKE 1	GO:0045087; P:innate immune response; TAS:Reactome
Q9H173	SIL1	Nucleotide exchange factor SIL1	GO:0051082; F:unfolded protein binding; NAS:UniProtKB
Q9H173	SIL1	Nucleotide exchange factor SIL1	GO:0006886; P:intracellular protein transport; NAS:UniProtKB
Q9H173	SIL1	Nucleotide exchange factor SIL1	GO:0006457; P:protein folding; NAS:UniProtKB
P81133	SIM1	Single-minded homolog 1	GO:0003677; F:DNA binding; TAS:ProtInc
P81133	SIM1	Single-minded homolog 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P81133	SIM1	Single-minded homolog 1	GO:0004871; F:signal transducer activity; IEA:InterPro
P81133	SIM1	Single-minded homolog 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P81133	SIM1	Single-minded homolog 1	GO:0007399; P:nervous system development; TAS:ProtInc
P81133	SIM1	Single-minded homolog 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P81133	SIM1	Single-minded homolog 1	GO:0001657; P:ureteric bud development; IEA:Ensembl
Q14190	SIM2	Single-minded homolog 2	GO:0003677; F:DNA binding; TAS:ProtInc
Q14190	SIM2	Single-minded homolog 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q14190	SIM2	Single-minded homolog 2	GO:0004871; F:signal transducer activity; IEA:InterPro
Q14190	SIM2	Single-minded homolog 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q14190	SIM2	Single-minded homolog 2	GO:0009880; P:embryonic pattern specification; IEA:Ensembl
Q14190	SIM2	Single-minded homolog 2	GO:0030324; P:lung development; IEA:Ensembl
Q14190	SIM2	Single-minded homolog 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q14190	SIM2	Single-minded homolog 2	GO:0007399; P:nervous system development; TAS:ProtInc
Q14190	SIM2	Single-minded homolog 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NDZ2	SIMC1	SUMO-interacting motif-containing protein 1	GO:0032184; F:SUMO polymer binding; IDA:UniProtKB
Q9BPZ7	MAPKAP1	Target of rapamycin complex 2 subunit MAPKAP1	GO:0070300; F:phosphatidic acid binding; IDA:UniProtKB
Q9BPZ7	MAPKAP1	Target of rapamycin complex 2 subunit MAPKAP1	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB
Q9BPZ7	MAPKAP1	Target of rapamycin complex 2 subunit MAPKAP1	GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; IDA:UniProtKB
Q9BPZ7	MAPKAP1	Target of rapamycin complex 2 subunit MAPKAP1	GO:0080025; F:phosphatidylinositol-3,5-bisphosphate binding; IDA:UniProtKB
Q9BPZ7	MAPKAP1	Target of rapamycin complex 2 subunit MAPKAP1	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProtKB
Q9BPZ7	MAPKAP1	Target of rapamycin complex 2 subunit MAPKAP1	GO:0005515; F:protein binding; IPI:IntAct
Q9BPZ7	MAPKAP1	Target of rapamycin complex 2 subunit MAPKAP1	GO:0017016; F:Ras GTPase binding; IDA:UniProtKB
Q9BPZ7	MAPKAP1	Target of rapamycin complex 2 subunit MAPKAP1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q9BPZ7	MAPKAP1	Target of rapamycin complex 2 subunit MAPKAP1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9BPZ7	MAPKAP1	Target of rapamycin complex 2 subunit MAPKAP1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q9BPZ7	MAPKAP1	Target of rapamycin complex 2 subunit MAPKAP1	GO:0045087; P:innate immune response; TAS:Reactome
Q9BPZ7	MAPKAP1	Target of rapamycin complex 2 subunit MAPKAP1	GO:0046580; P:negative regulation of Ras protein signal transduction; IMP:UniProtKB
Q9BPZ7	MAPKAP1	Target of rapamycin complex 2 subunit MAPKAP1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9BPZ7	MAPKAP1	Target of rapamycin complex 2 subunit MAPKAP1	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q9BPZ7	MAPKAP1	Target of rapamycin complex 2 subunit MAPKAP1	GO:0021762; P:substantia nigra development; IEP:UniProt
Q9BPZ7	MAPKAP1	Target of rapamycin complex 2 subunit MAPKAP1	GO:0031295; P:T cell costimulation; TAS:Reactome
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0003682; F:chromatin binding; IEA:Ensembl
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0003677; F:DNA binding; IEA:Ensembl
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0005515; F:protein binding; IPI:UniProtKB
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0033558; F:protein deacetylase activity; IMP:BHF-UCL
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0001106; F:RNA polymerase II transcription corepressor activity; IEA:Ensembl
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0002218; P:activation of innate immune response; IMP:BHF-UCL
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0007568; P:aging; IEA:Ensembl
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0007596; P:blood coagulation; TAS:Reactome
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0034613; P:cellular protein localization; IEA:Ensembl
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0006260; P:DNA replication; IEA:Ensembl
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:1901675; P:negative regulation of histone H3-K27 acetylation; IMP:BHF-UCL
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:1900181; P:negative regulation of protein localization to nucleus; IMP:BHF-UCL
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:2000678; P:negative regulation of transcription regulatory region DNA binding; IMP:BHF-UCL
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0031937; P:positive regulation of chromatin silencing; IMP:BHF-UCL
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0002230; P:positive regulation of defense response to virus by host; IMP:BHF-UCL
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IEA:Ensembl
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0006476; P:protein deacetylation; IMP:BHF-UCL
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0043619; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; IEA:Ensembl
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0051595; P:response to methylglyoxal; IEA:Ensembl
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0010243; P:response to organonitrogen compound; IEA:Ensembl
Q96ST3	SIN3A	Paired amphipathic helix protein Sin3a	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75182	SIN3B	Paired amphipathic helix protein Sin3b	GO:0003682; F:chromatin binding; IEA:Ensembl
O75182	SIN3B	Paired amphipathic helix protein Sin3b	GO:0005515; F:protein binding; IPI:UniProtKB
O75182	SIN3B	Paired amphipathic helix protein Sin3b	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
O75182	SIN3B	Paired amphipathic helix protein Sin3b	GO:0048738; P:cardiac muscle tissue development; IEA:Ensembl
O75182	SIN3B	Paired amphipathic helix protein Sin3b	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O75182	SIN3B	Paired amphipathic helix protein Sin3b	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
O75182	SIN3B	Paired amphipathic helix protein Sin3b	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
O75182	SIN3B	Paired amphipathic helix protein Sin3b	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75182	SIN3B	Paired amphipathic helix protein Sin3b	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96FS4	SIPA1	Signal-induced proliferation-associated protein 1	GO:0005096; F:GTPase activator activity; TAS:ProtInc
Q96FS4	SIPA1	Signal-induced proliferation-associated protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q96FS4	SIPA1	Signal-induced proliferation-associated protein 1	GO:0046582; F:Rap GTPase activator activity; NAS:UniProtKB
Q96FS4	SIPA1	Signal-induced proliferation-associated protein 1	GO:0008283; P:cell proliferation; TAS:ProtInc
Q96FS4	SIPA1	Signal-induced proliferation-associated protein 1	GO:0042631; P:cellular response to water deprivation; IEA:Ensembl
Q96FS4	SIPA1	Signal-induced proliferation-associated protein 1	GO:0007010; P:cytoskeleton organization; NAS:UniProtKB
Q96FS4	SIPA1	Signal-induced proliferation-associated protein 1	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
Q96FS4	SIPA1	Signal-induced proliferation-associated protein 1	GO:0007162; P:negative regulation of cell adhesion; NAS:UniProtKB
Q96FS4	SIPA1	Signal-induced proliferation-associated protein 1	GO:0045786; P:negative regulation of cell cycle; NAS:UniProtKB
Q96FS4	SIPA1	Signal-induced proliferation-associated protein 1	GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB
Q96FS4	SIPA1	Signal-induced proliferation-associated protein 1	GO:0043547; P:positive regulation of GTPase activity; TAS:GOC
Q96FS4	SIPA1	Signal-induced proliferation-associated protein 1	GO:0032854; P:positive regulation of Rap GTPase activity; NAS:GOC
Q96FS4	SIPA1	Signal-induced proliferation-associated protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0043425; F:bHLH transcription factor binding; IPI:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0019213; F:deacetylase activity; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0042393; F:histone binding; IPI:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0004407; F:histone deacetylase activity; IDA:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0043398; F:HLH domain binding; IPI:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0042802; F:identical protein binding; IPI:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0051019; F:mitogen-activated protein kinase binding; IPI:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0070403; F:NAD+ binding; IEA:InterPro
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0017136; F:NAD-dependent histone deacetylase activity; IDA:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0046969; F:NAD-dependent histone deacetylase activity (H3-K9 specific); ISS:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0034979; F:NAD-dependent protein deacetylase activity; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0002039; F:p53 binding; IPI:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0033558; F:protein deacetylase activity; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0003714; F:transcription corepressor activity; IDA:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0001525; P:angiogenesis; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0007569; P:cell aging; TAS:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0001678; P:cellular glucose homeostasis; ISS:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0070301; P:cellular response to hydrogen peroxide; IDA:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0071456; P:cellular response to hypoxia; IMP:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0071479; P:cellular response to ionizing radiation; ISS:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0009267; P:cellular response to starvation; ISS:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0071356; P:cellular response to tumor necrosis factor; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0035356; P:cellular triglyceride homeostasis; ISS:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0042632; P:cholesterol homeostasis; ISS:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0006325; P:chromatin organization; IMP:UniProt
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0006342; P:chromatin silencing; TAS:ProtInc
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0000183; P:chromatin silencing at rDNA; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0006281; P:DNA repair; TAS:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0006260; P:DNA replication; TAS:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0000731; P:DNA synthesis involved in DNA repair; ISS:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0006343; P:establishment of chromatin silencing; IDA:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0055089; P:fatty acid homeostasis; ISS:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0016575; P:histone deacetylation; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0070932; P:histone H3 deacetylation; IDA:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IMP:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0006344; P:maintenance of chromatin silencing; IMP:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0006346; P:methylation-dependent chromatin silencing; TAS:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0060766; P:negative regulation of androgen receptor signaling pathway; IMP:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:2000480; P:negative regulation of cAMP-dependent protein kinase activity; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0030308; P:negative regulation of cell growth; IMP:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:2000655; P:negative regulation of cellular response to testosterone stimulus; IMP:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:2000773; P:negative regulation of cellular senescence; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0043518; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; IDA:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0045599; P:negative regulation of fat cell differentiation; ISS:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0051097; P:negative regulation of helicase activity; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; ISS:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:1902176; P:negative regulation of intrinsic apoptotic signaling pathway in response to oxidative stress; IMP:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:2000757; P:negative regulation of peptidyl-lysine acetylation; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0042326; P:negative regulation of phosphorylation; IMP:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0031393; P:negative regulation of prostaglandin biosynthetic process; ISS:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0051898; P:negative regulation of protein kinase B signaling; IMP:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0032007; P:negative regulation of TOR signaling; IMP:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; ISS:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0001542; P:ovulation from ovarian follicle; IEA:Ensembl
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0018394; P:peptidyl-lysine acetylation; IMP:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0034983; P:peptidyl-lysine deacetylation; IDA:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0002821; P:positive regulation of adaptive immune response; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:2000481; P:positive regulation of cAMP-dependent protein kinase activity; IMP:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:2000774; P:positive regulation of cellular senescence; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0010875; P:positive regulation of cholesterol efflux; ISS:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0031937; P:positive regulation of chromatin silencing; IMP:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0045739; P:positive regulation of DNA repair; IMP:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0051574; P:positive regulation of histone H3-K9 methylation; IMP:UniProt
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0046628; P:positive regulation of insulin receptor signaling pathway; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0016239; P:positive regulation of macroautophagy; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:2000111; P:positive regulation of macrophage apoptotic process; ISS:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0045348; P:positive regulation of MHC class II biosynthetic process; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0006476; P:protein deacetylation; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0031648; P:protein destabilization; ISS:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0000720; P:pyrimidine dimer repair by nucleotide-excision repair; IMP:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0070857; P:regulation of bile acid biosynthetic process; ISS:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0042127; P:regulation of cell proliferation; IMP:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0032071; P:regulation of endodeoxyribonuclease activity; IMP:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0010906; P:regulation of glucose metabolic process; ISS:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0007346; P:regulation of mitotic cell cycle; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0035358; P:regulation of peroxisome proliferator activated receptor signaling pathway; ISS:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0033158; P:regulation of protein import into nucleus, translocation; IMP:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0034391; P:regulation of smooth muscle cell apoptotic process; ISS:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0042542; P:response to hydrogen peroxide; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0032868; P:response to insulin; ISS:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0006979; P:response to oxidative stress; IDA:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0000012; P:single strand break repair; IMP:UniProtKB
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0006642; P:triglyceride mobilization; ISS:BHF-UCL
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q96EB6	SIRT1	NAD-dependent protein deacetylase sirtuin-1	GO:0050872; P:white fat cell differentiation; ISS:BHF-UCL
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0035035; F:histone acetyltransferase binding; IPI:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0004407; F:histone deacetylase activity; IDA:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0042826; F:histone deacetylase binding; IPI:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0070403; F:NAD+ binding; IDA:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0017136; F:NAD-dependent histone deacetylase activity; IDA:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0046970; F:NAD-dependent histone deacetylase activity (H4-K16 specific); IDA:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0034979; F:NAD-dependent protein deacetylase activity; IDA:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0005515; F:protein binding; IPI:IntAct
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0033558; F:protein deacetylase activity; IDA:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0042903; F:tubulin deacetylase activity; IDA:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0006342; P:chromatin silencing; NAS:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0000183; P:chromatin silencing at rDNA; NAS:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0006348; P:chromatin silencing at telomere; NAS:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0016458; P:gene silencing; NAS:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0016575; P:histone deacetylation; TAS:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0070933; P:histone H4 deacetylation; IDA:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0045599; P:negative regulation of fat cell differentiation; ISS:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0070446; P:negative regulation of oligodendrocyte progenitor proliferation; ISS:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0045843; P:negative regulation of striated muscle tissue development; IDA:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0034983; P:peptidyl-lysine deacetylation; IDA:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0006471; P:protein ADP-ribosylation; NAS:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0006476; P:protein deacetylation; IDA:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0051726; P:regulation of cell cycle; IMP:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0007096; P:regulation of exit from mitosis; NAS:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0042325; P:regulation of phosphorylation; NAS:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0051775; P:response to redox state; NAS:UniProtKB
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0021762; P:substantia nigra development; IEP:UniProt
Q8IXJ6	SIRT2	NAD-dependent protein deacetylase sirtuin-2	GO:0090042; P:tubulin deacetylation; IDA:UniProtKB
Q9NTG7	SIRT3	NAD-dependent protein deacetylase sirtuin-3, mitochondrial	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; TAS:ProtInc
Q9NTG7	SIRT3	NAD-dependent protein deacetylase sirtuin-3, mitochondrial	GO:0070403; F:NAD+ binding; IEA:InterPro
Q9NTG7	SIRT3	NAD-dependent protein deacetylase sirtuin-3, mitochondrial	GO:0032041; F:NAD-dependent histone deacetylase activity (H3-K14 specific); IEA:Ensembl
Q9NTG7	SIRT3	NAD-dependent protein deacetylase sirtuin-3, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NTG7	SIRT3	NAD-dependent protein deacetylase sirtuin-3, mitochondrial	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q9NTG7	SIRT3	NAD-dependent protein deacetylase sirtuin-3, mitochondrial	GO:0009060; P:aerobic respiration; IMP:UniProtKB
Q9NTG7	SIRT3	NAD-dependent protein deacetylase sirtuin-3, mitochondrial	GO:0034983; P:peptidyl-lysine deacetylation; IMP:UniProtKB
Q9NTG7	SIRT3	NAD-dependent protein deacetylase sirtuin-3, mitochondrial	GO:0006471; P:protein ADP-ribosylation; TAS:ProtInc
Q9NTG7	SIRT3	NAD-dependent protein deacetylase sirtuin-3, mitochondrial	GO:0006476; P:protein deacetylation; IDA:UniProtKB
Q9Y6E7	SIRT4	NAD-dependent protein deacetylase sirtuin-4	GO:0016787; F:hydrolase activity; IEA:UniProtKB-HAMAP
Q9Y6E7	SIRT4	NAD-dependent protein deacetylase sirtuin-4	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IDA:UniProtKB
Q9Y6E7	SIRT4	NAD-dependent protein deacetylase sirtuin-4	GO:0070403; F:NAD+ binding; IEA:UniProtKB-HAMAP
Q9Y6E7	SIRT4	NAD-dependent protein deacetylase sirtuin-4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6E7	SIRT4	NAD-dependent protein deacetylase sirtuin-4	GO:0008270; F:zinc ion binding; IEA:UniProtKB-HAMAP
Q9Y6E7	SIRT4	NAD-dependent protein deacetylase sirtuin-4	GO:0006974; P:cellular response to DNA damage stimulus; ISS:UniProtKB
Q9Y6E7	SIRT4	NAD-dependent protein deacetylase sirtuin-4	GO:0006342; P:chromatin silencing; TAS:ProtInc
Q9Y6E7	SIRT4	NAD-dependent protein deacetylase sirtuin-4	GO:0006541; P:glutamine metabolic process; ISS:UniProtKB
Q9Y6E7	SIRT4	NAD-dependent protein deacetylase sirtuin-4	GO:0046322; P:negative regulation of fatty acid oxidation; ISS:UniProtKB
Q9Y6E7	SIRT4	NAD-dependent protein deacetylase sirtuin-4	GO:0046676; P:negative regulation of insulin secretion; IMP:UniProtKB
Q9Y6E7	SIRT4	NAD-dependent protein deacetylase sirtuin-4	GO:0034983; P:peptidyl-lysine deacetylation; ISS:UniProtKB
Q9Y6E7	SIRT4	NAD-dependent protein deacetylase sirtuin-4	GO:0046889; P:positive regulation of lipid biosynthetic process; ISS:UniProtKB
Q9Y6E7	SIRT4	NAD-dependent protein deacetylase sirtuin-4	GO:0006471; P:protein ADP-ribosylation; ISS:UniProtKB
Q9Y6E7	SIRT4	NAD-dependent protein deacetylase sirtuin-4	GO:0072350; P:tricarboxylic acid metabolic process; ISS:UniProtKB
Q9NXA8	SIRT5	NAD-dependent protein deacylase sirtuin-5, mitochondrial	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; TAS:ProtInc
Q9NXA8	SIRT5	NAD-dependent protein deacylase sirtuin-5, mitochondrial	GO:0070403; F:NAD+ binding; IDA:UniProtKB
Q9NXA8	SIRT5	NAD-dependent protein deacylase sirtuin-5, mitochondrial	GO:0036054; F:protein-malonyllysine demalonylase activity; IDA:UniProtKB
Q9NXA8	SIRT5	NAD-dependent protein deacylase sirtuin-5, mitochondrial	GO:0036055; F:protein-succinyllysine desuccinylase activity; IDA:UniProtKB
Q9NXA8	SIRT5	NAD-dependent protein deacylase sirtuin-5, mitochondrial	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q9NXA8	SIRT5	NAD-dependent protein deacylase sirtuin-5, mitochondrial	GO:0006342; P:chromatin silencing; TAS:ProtInc
Q9NXA8	SIRT5	NAD-dependent protein deacylase sirtuin-5, mitochondrial	GO:2000378; P:negative regulation of reactive oxygen species metabolic process; IDA:UniProtKB
Q9NXA8	SIRT5	NAD-dependent protein deacylase sirtuin-5, mitochondrial	GO:0036047; P:peptidyl-lysine demalonylation; IDA:UniProtKB
Q9NXA8	SIRT5	NAD-dependent protein deacylase sirtuin-5, mitochondrial	GO:0036049; P:peptidyl-lysine desuccinylation; IDA:UniProtKB
Q9NXA8	SIRT5	NAD-dependent protein deacylase sirtuin-5, mitochondrial	GO:0006471; P:protein ADP-ribosylation; TAS:ProtInc
Q9NXA8	SIRT5	NAD-dependent protein deacylase sirtuin-5, mitochondrial	GO:0006476; P:protein deacetylation; IDA:UniProtKB
Q9NXA8	SIRT5	NAD-dependent protein deacylase sirtuin-5, mitochondrial	GO:0036048; P:protein desuccinylation; IDA:UniProtKB
Q8N6T7	SIRT6	NAD-dependent protein deacetylase sirtuin-6	GO:0003956; F:NAD(P)+-protein-arginine ADP-ribosyltransferase activity; ISS:UniProtKB
Q8N6T7	SIRT6	NAD-dependent protein deacetylase sirtuin-6	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; TAS:BHF-UCL
Q8N6T7	SIRT6	NAD-dependent protein deacetylase sirtuin-6	GO:0070403; F:NAD+ binding; ISS:UniProtKB
Q8N6T7	SIRT6	NAD-dependent protein deacetylase sirtuin-6	GO:0017136; F:NAD-dependent histone deacetylase activity; ISS:UniProtKB
Q8N6T7	SIRT6	NAD-dependent protein deacetylase sirtuin-6	GO:0046969; F:NAD-dependent histone deacetylase activity (H3-K9 specific); IDA:UniProtKB
Q8N6T7	SIRT6	NAD-dependent protein deacetylase sirtuin-6	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N6T7	SIRT6	NAD-dependent protein deacetylase sirtuin-6	GO:0008270; F:zinc ion binding; ISS:UniProtKB
Q8N6T7	SIRT6	NAD-dependent protein deacetylase sirtuin-6	GO:0016575; P:histone deacetylation; ISS:GOC
Q8N6T7	SIRT6	NAD-dependent protein deacetylase sirtuin-6	GO:0070932; P:histone H3 deacetylation; IDA:GOC
Q8N6T7	SIRT6	NAD-dependent protein deacetylase sirtuin-6	GO:0006471; P:protein ADP-ribosylation; ISS:UniProtKB
Q8N6T7	SIRT6	NAD-dependent protein deacetylase sirtuin-6	GO:0010569; P:regulation of double-strand break repair via homologous recombination; IDA:UniProtKB
Q9NRC8	SIRT7	NAD-dependent protein deacetylase sirtuin-7	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q9NRC8	SIRT7	NAD-dependent protein deacetylase sirtuin-7	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NRC8	SIRT7	NAD-dependent protein deacetylase sirtuin-7	GO:0070403; F:NAD+ binding; IEA:InterPro
Q9NRC8	SIRT7	NAD-dependent protein deacetylase sirtuin-7	GO:0097372; F:NAD-dependent histone deacetylase activity (H3-K18 specific); IDA:UniProtKB
Q9NRC8	SIRT7	NAD-dependent protein deacetylase sirtuin-7	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NRC8	SIRT7	NAD-dependent protein deacetylase sirtuin-7	GO:0070932; P:histone H3 deacetylation; IDA:UniProtKB
Q9NRC8	SIRT7	NAD-dependent protein deacetylase sirtuin-7	GO:0070933; P:histone H4 deacetylation; IDA:GOC
Q9NRC8	SIRT7	NAD-dependent protein deacetylase sirtuin-7	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9NRC8	SIRT7	NAD-dependent protein deacetylase sirtuin-7	GO:0007072; P:positive regulation of transcription on exit from mitosis; IMP:UniProtKB
Q9NRC8	SIRT7	NAD-dependent protein deacetylase sirtuin-7	GO:0009303; P:rRNA transcription; IMP:UniProtKB
O00241	SIRPB1	Signal-regulatory protein beta-1	GO:0005515; F:protein binding; IPI:IntAct
O00241	SIRPB1	Signal-regulatory protein beta-1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
O00241	SIRPB1	Signal-regulatory protein beta-1	GO:0045087; P:innate immune response; TAS:Reactome
O00241	SIRPB1	Signal-regulatory protein beta-1	GO:0007165; P:signal transduction; TAS:ProtInc
Q9P1W8	SIRPG	Signal-regulatory protein gamma	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P1W8	SIRPG	Signal-regulatory protein gamma	GO:0007596; P:blood coagulation; TAS:Reactome
Q9P1W8	SIRPG	Signal-regulatory protein gamma	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9P1W8	SIRPG	Signal-regulatory protein gamma	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9P1W8	SIRPG	Signal-regulatory protein gamma	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
Q9P1W8	SIRPG	Signal-regulatory protein gamma	GO:0050900; P:leukocyte migration; TAS:Reactome
Q9P1W8	SIRPG	Signal-regulatory protein gamma	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q9P1W8	SIRPG	Signal-regulatory protein gamma	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q9P1W8	SIRPG	Signal-regulatory protein gamma	GO:0022409; P:positive regulation of cell-cell adhesion; IDA:UniProtKB
Q9P1W8	SIRPG	Signal-regulatory protein gamma	GO:0050870; P:positive regulation of T cell activation; IDA:UniProtKB
Q9Y3P8	SIT1	Signaling threshold-regulating transmembrane adapter 1	GO:0019900; F:kinase binding; IPI:UniProtKB
Q9Y3P8	SIT1	Signaling threshold-regulating transmembrane adapter 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y3P8	SIT1	Signaling threshold-regulating transmembrane adapter 1	GO:0042169; F:SH2 domain binding; TAS:HGNC
Q9Y3P8	SIT1	Signaling threshold-regulating transmembrane adapter 1	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q9Y3P8	SIT1	Signaling threshold-regulating transmembrane adapter 1	GO:0050863; P:regulation of T cell activation; IDA:UniProtKB
Q9Y3P8	SIT1	Signaling threshold-regulating transmembrane adapter 1	GO:0007165; P:signal transduction; TAS:ProtInc
O15304	SIVA1	Apoptosis regulatory protein Siva	GO:0005175; F:CD27 receptor binding; IPI:HGNC
O15304	SIVA1	Apoptosis regulatory protein Siva	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15304	SIVA1	Apoptosis regulatory protein Siva	GO:0005515; F:protein binding; IPI:HGNC
O15304	SIVA1	Apoptosis regulatory protein Siva	GO:0001618; F:virus receptor activity; ISS:HGNC
O15304	SIVA1	Apoptosis regulatory protein Siva	GO:0008270; F:zinc ion binding; IDA:HGNC
O15304	SIVA1	Apoptosis regulatory protein Siva	GO:0006924; P:activation-induced cell death of T cells; IDA:HGNC
O15304	SIVA1	Apoptosis regulatory protein Siva	GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:BHF-UCL
O15304	SIVA1	Apoptosis regulatory protein Siva	GO:0097193; P:intrinsic apoptotic signaling pathway; IDA:BHF-UCL
O15304	SIVA1	Apoptosis regulatory protein Siva	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:HGNC
O15304	SIVA1	Apoptosis regulatory protein Siva	GO:1901030; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; IDA:BHF-UCL
O15304	SIVA1	Apoptosis regulatory protein Siva	GO:0009615; P:response to virus; ISS:GOC
O15304	SIVA1	Apoptosis regulatory protein Siva	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q15475	SIX1	Homeobox protein SIX1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q15475	SIX1	Homeobox protein SIX1	GO:0003677; F:DNA binding; IDA:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0035909; P:aorta morphogenesis; IEA:Ensembl
Q15475	SIX1	Homeobox protein SIX1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q15475	SIX1	Homeobox protein SIX1	GO:0001658; P:branching involved in ureteric bud morphogenesis; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0090103; P:cochlea morphogenesis; IEA:Ensembl
Q15475	SIX1	Homeobox protein SIX1	GO:0048701; P:embryonic cranial skeleton morphogenesis; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0048704; P:embryonic skeletal system morphogenesis; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0030855; P:epithelial cell differentiation; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0021610; P:facial nerve morphogenesis; IEA:Ensembl
Q15475	SIX1	Homeobox protein SIX1	GO:0048699; P:generation of neurons; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0048839; P:inner ear development; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0042472; P:inner ear morphogenesis; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0001822; P:kidney development; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0072172; P:mesonephric tubule formation; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0072075; P:metanephric mesenchyme development; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0042474; P:middle ear morphogenesis; IEA:Ensembl
Q15475	SIX1	Homeobox protein SIX1	GO:0051451; P:myoblast migration; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0090191; P:negative regulation of branching involved in ureteric bud morphogenesis; IEA:Ensembl
Q15475	SIX1	Homeobox protein SIX1	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q15475	SIX1	Homeobox protein SIX1	GO:0048665; P:neuron fate specification; IEA:Ensembl
Q15475	SIX1	Homeobox protein SIX1	GO:0001759; P:organ induction; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0071599; P:otic vesicle development; IEA:Ensembl
Q15475	SIX1	Homeobox protein SIX1	GO:0003151; P:outflow tract morphogenesis; IEA:Ensembl
Q15475	SIX1	Homeobox protein SIX1	GO:0007389; P:pattern specification process; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0060037; P:pharyngeal system development; IEA:Ensembl
Q15475	SIX1	Homeobox protein SIX1	GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:2000729; P:positive regulation of mesenchymal cell proliferation involved in ureter development; IEA:Ensembl
Q15475	SIX1	Homeobox protein SIX1	GO:0072513; P:positive regulation of secondary heart field cardioblast proliferation; IEA:Ensembl
Q15475	SIX1	Homeobox protein SIX1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0072107; P:positive regulation of ureteric bud formation; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0034504; P:protein localization to nucleus; IDA:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0072095; P:regulation of branch elongation involved in ureteric bud branching; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0045664; P:regulation of neuron differentiation; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0032880; P:regulation of protein localization; IEA:Ensembl
Q15475	SIX1	Homeobox protein SIX1	GO:0008582; P:regulation of synaptic growth at neuromuscular junction; IEA:Ensembl
Q15475	SIX1	Homeobox protein SIX1	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0007605; P:sensory perception of sound; IEA:Ensembl
Q15475	SIX1	Homeobox protein SIX1	GO:0007519; P:skeletal muscle tissue development; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0048538; P:thymus development; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0030878; P:thyroid gland development; ISS:UniProtKB
Q15475	SIX1	Homeobox protein SIX1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15475	SIX1	Homeobox protein SIX1	GO:0072193; P:ureter smooth muscle cell differentiation; IEA:Ensembl
Q15475	SIX1	Homeobox protein SIX1	GO:0001657; P:ureteric bud development; ISS:UniProtKB
Q9NPC8	SIX2	Homeobox protein SIX2	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q9NPC8	SIX2	Homeobox protein SIX2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
Q9NPC8	SIX2	Homeobox protein SIX2	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q9NPC8	SIX2	Homeobox protein SIX2	GO:0008283; P:cell proliferation; IEA:Ensembl
Q9NPC8	SIX2	Homeobox protein SIX2	GO:0002062; P:chondrocyte differentiation; IEA:Ensembl
Q9NPC8	SIX2	Homeobox protein SIX2	GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl
Q9NPC8	SIX2	Homeobox protein SIX2	GO:0001822; P:kidney development; IMP:UniProtKB
Q9NPC8	SIX2	Homeobox protein SIX2	GO:0003337; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; IEA:Ensembl
Q9NPC8	SIX2	Homeobox protein SIX2	GO:0007501; P:mesodermal cell fate specification; IEA:Ensembl
Q9NPC8	SIX2	Homeobox protein SIX2	GO:0042474; P:middle ear morphogenesis; IEA:Ensembl
Q9NPC8	SIX2	Homeobox protein SIX2	GO:0045596; P:negative regulation of cell differentiation; IEA:Ensembl
Q9NPC8	SIX2	Homeobox protein SIX2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9NPC8	SIX2	Homeobox protein SIX2	GO:0006606; P:protein import into nucleus; IEA:Ensembl
O95343	SIX3	Homeobox protein SIX3	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
O95343	SIX3	Homeobox protein SIX3	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
O95343	SIX3	Homeobox protein SIX3	GO:0007420; P:brain development; TAS:ProtInc
O95343	SIX3	Homeobox protein SIX3	GO:0048512; P:circadian behavior; IEA:Ensembl
O95343	SIX3	Homeobox protein SIX3	GO:0021536; P:diencephalon development; IEA:Ensembl
O95343	SIX3	Homeobox protein SIX3	GO:0021797; P:forebrain anterior/posterior pattern specification; IEA:Ensembl
O95343	SIX3	Homeobox protein SIX3	GO:0060235; P:lens induction in camera-type eye; IEA:Ensembl
O95343	SIX3	Homeobox protein SIX3	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
O95343	SIX3	Homeobox protein SIX3	GO:0030178; P:negative regulation of Wnt signaling pathway; IEA:Ensembl
O95343	SIX3	Homeobox protein SIX3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O95343	SIX3	Homeobox protein SIX3	GO:0006606; P:protein import into nucleus; IEA:Ensembl
O95343	SIX3	Homeobox protein SIX3	GO:0021537; P:telencephalon development; IEA:Ensembl
O95343	SIX3	Homeobox protein SIX3	GO:0007601; P:visual perception; TAS:ProtInc
Q9UIU6	SIX4	Homeobox protein SIX4	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q9UIU6	SIX4	Homeobox protein SIX4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q9UIU6	SIX4	Homeobox protein SIX4	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q9UIU6	SIX4	Homeobox protein SIX4	GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl
Q9UIU6	SIX4	Homeobox protein SIX4	GO:0048699; P:generation of neurons; IEA:Ensembl
Q9UIU6	SIX4	Homeobox protein SIX4	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q9UIU6	SIX4	Homeobox protein SIX4	GO:0072075; P:metanephric mesenchyme development; IEA:Ensembl
Q9UIU6	SIX4	Homeobox protein SIX4	GO:0051451; P:myoblast migration; IEA:Ensembl
Q9UIU6	SIX4	Homeobox protein SIX4	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q9UIU6	SIX4	Homeobox protein SIX4	GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; IEA:Ensembl
Q9UIU6	SIX4	Homeobox protein SIX4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UIU6	SIX4	Homeobox protein SIX4	GO:0072107; P:positive regulation of ureteric bud formation; IEA:Ensembl
Q9UIU6	SIX4	Homeobox protein SIX4	GO:0072095; P:regulation of branch elongation involved in ureteric bud branching; IEA:Ensembl
Q9UIU6	SIX4	Homeobox protein SIX4	GO:0032880; P:regulation of protein localization; IEA:Ensembl
Q9UIU6	SIX4	Homeobox protein SIX4	GO:0008582; P:regulation of synaptic growth at neuromuscular junction; IEA:Ensembl
Q9UIU6	SIX4	Homeobox protein SIX4	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
Q9UIU6	SIX4	Homeobox protein SIX4	GO:0048538; P:thymus development; IEA:Ensembl
Q8N196	SIX5	Homeobox protein SIX5	GO:0005515; F:protein binding; IPI:IntAct
Q8N196	SIX5	Homeobox protein SIX5	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q8N196	SIX5	Homeobox protein SIX5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8N196	SIX5	Homeobox protein SIX5	GO:0002088; P:lens development in camera-type eye; IEA:Ensembl
Q8N196	SIX5	Homeobox protein SIX5	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q8N196	SIX5	Homeobox protein SIX5	GO:0007286; P:spermatid development; IEA:Ensembl
Q8N196	SIX5	Homeobox protein SIX5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95475	SIX6	Homeobox protein SIX6	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O95475	SIX6	Homeobox protein SIX6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O95475	SIX6	Homeobox protein SIX6	GO:0009887; P:organ morphogenesis; TAS:ProtInc
O95475	SIX6	Homeobox protein SIX6	GO:0007601; P:visual perception; TAS:ProtInc
P42285	SKIV2L2	Superkiller viralicidic activity 2-like 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P42285	SKIV2L2	Superkiller viralicidic activity 2-like 2	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
P42285	SKIV2L2	Superkiller viralicidic activity 2-like 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P42285	SKIV2L2	Superkiller viralicidic activity 2-like 2	GO:0005515; F:protein binding; IPI:IntAct
P42285	SKIV2L2	Superkiller viralicidic activity 2-like 2	GO:0000460; P:maturation of 5.8S rRNA; IMP:UniProtKB
P42285	SKIV2L2	Superkiller viralicidic activity 2-like 2	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q96BD8	SKA1	Spindle and kinetochore-associated protein 1	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q96BD8	SKA1	Spindle and kinetochore-associated protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96BD8	SKA1	Spindle and kinetochore-associated protein 1	GO:0051301; P:cell division; IMP:UniProtKB
Q96BD8	SKA1	Spindle and kinetochore-associated protein 1	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q96BD8	SKA1	Spindle and kinetochore-associated protein 1	GO:0007067; P:mitosis; IMP:UniProtKB
Q96BD8	SKA1	Spindle and kinetochore-associated protein 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q96BD8	SKA1	Spindle and kinetochore-associated protein 1	GO:0031110; P:regulation of microtubule polymerization or depolymerization; IDA:UniProtKB
Q8WVK7	SKA2	Spindle and kinetochore-associated protein 2	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q8WVK7	SKA2	Spindle and kinetochore-associated protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WVK7	SKA2	Spindle and kinetochore-associated protein 2	GO:0051301; P:cell division; IMP:UniProtKB
Q8WVK7	SKA2	Spindle and kinetochore-associated protein 2	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q8WVK7	SKA2	Spindle and kinetochore-associated protein 2	GO:0007067; P:mitosis; IMP:UniProtKB
Q8WVK7	SKA2	Spindle and kinetochore-associated protein 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8WVK7	SKA2	Spindle and kinetochore-associated protein 2	GO:0031110; P:regulation of microtubule polymerization or depolymerization; IDA:UniProtKB
Q8IX90	SKA3	Spindle and kinetochore-associated protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IX90	SKA3	Spindle and kinetochore-associated protein 3	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q8IX90	SKA3	Spindle and kinetochore-associated protein 3	GO:0007067; P:mitosis; IMP:UniProtKB
Q8IX90	SKA3	Spindle and kinetochore-associated protein 3	GO:0031110; P:regulation of microtubule polymerization or depolymerization; IDA:UniProtKB
Q86WV1	SKAP1	Src kinase-associated phosphoprotein 1	GO:0005515; F:protein binding; IPI:IntAct
Q86WV1	SKAP1	Src kinase-associated phosphoprotein 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q86WV1	SKAP1	Src kinase-associated phosphoprotein 1	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
Q86WV1	SKAP1	Src kinase-associated phosphoprotein 1	GO:0042169; F:SH2 domain binding; IDA:UniProtKB
Q86WV1	SKAP1	Src kinase-associated phosphoprotein 1	GO:0017124; F:SH3 domain binding; TAS:BHF-UCL
Q86WV1	SKAP1	Src kinase-associated phosphoprotein 1	GO:0005070; F:SH3/SH2 adaptor activity; IC:UniProtKB
Q86WV1	SKAP1	Src kinase-associated phosphoprotein 1	GO:0009967; P:positive regulation of signal transduction; IC:GOC
Q86WV1	SKAP1	Src kinase-associated phosphoprotein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q86WV1	SKAP1	Src kinase-associated phosphoprotein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q86WV1	SKAP1	Src kinase-associated phosphoprotein 1	GO:0050852; P:T cell receptor signaling pathway; IMP:UniProtKB
O75563	SKAP2	Src kinase-associated phosphoprotein 2	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
O75563	SKAP2	Src kinase-associated phosphoprotein 2	GO:0042113; P:B cell activation; IEA:UniProtKB-KW
O75563	SKAP2	Src kinase-associated phosphoprotein 2	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
O75563	SKAP2	Src kinase-associated phosphoprotein 2	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
O75563	SKAP2	Src kinase-associated phosphoprotein 2	GO:0006461; P:protein complex assembly; TAS:ProtInc
O75563	SKAP2	Src kinase-associated phosphoprotein 2	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y448	KNSTRN	Small kinetochore-associated protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y448	KNSTRN	Small kinetochore-associated protein	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q9Y448	KNSTRN	Small kinetochore-associated protein	GO:0000070; P:mitotic sister chromatid segregation; IMP:UniProtKB
Q9Y448	KNSTRN	Small kinetochore-associated protein	GO:0051988; P:regulation of attachment of spindle microtubules to kinetochore; IMP:UniProtKB
Q9Y448	KNSTRN	Small kinetochore-associated protein	GO:0007051; P:spindle organization; IMP:UniProtKB
P12757	SKIL	Ski-like protein	GO:0003682; F:chromatin binding; IEA:Ensembl
P12757	SKIL	Ski-like protein	GO:0005515; F:protein binding; IPI:IntAct
P12757	SKIL	Ski-like protein	GO:0032403; F:protein complex binding; IDA:UniProtKB
P12757	SKIL	Ski-like protein	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P12757	SKIL	Ski-like protein	GO:0046332; F:SMAD binding; IPI:UniProtKB
P12757	SKIL	Ski-like protein	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
P12757	SKIL	Ski-like protein	GO:0001825; P:blastocyst formation; IEA:Ensembl
P12757	SKIL	Ski-like protein	GO:0007050; P:cell cycle arrest; IEA:Ensembl
P12757	SKIL	Ski-like protein	GO:0010467; P:gene expression; TAS:Reactome
P12757	SKIL	Ski-like protein	GO:0070306; P:lens fiber cell differentiation; IEA:Ensembl
P12757	SKIL	Ski-like protein	GO:0002260; P:lymphocyte homeostasis; IEA:Ensembl
P12757	SKIL	Ski-like protein	GO:0045596; P:negative regulation of cell differentiation; IEA:Ensembl
P12757	SKIL	Ski-like protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P12757	SKIL	Ski-like protein	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
P12757	SKIL	Ski-like protein	GO:0050772; P:positive regulation of axonogenesis; IEA:Ensembl
P12757	SKIL	Ski-like protein	GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
P12757	SKIL	Ski-like protein	GO:1902231; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
P12757	SKIL	Ski-like protein	GO:0070208; P:protein heterotrimerization; IDA:UniProtKB
P12757	SKIL	Ski-like protein	GO:0070207; P:protein homotrimerization; IDA:UniProtKB
P12757	SKIL	Ski-like protein	GO:0042981; P:regulation of apoptotic process; IBA:RefGenome
P12757	SKIL	Ski-like protein	GO:0046677; P:response to antibiotic; IEP:UniProtKB
P12757	SKIL	Ski-like protein	GO:0034097; P:response to cytokine; IEA:Ensembl
P12757	SKIL	Ski-like protein	GO:0070848; P:response to growth factor; IDA:UniProtKB
P12757	SKIL	Ski-like protein	GO:0007519; P:skeletal muscle tissue development; IDA:UniProtKB
P12757	SKIL	Ski-like protein	GO:0007283; P:spermatogenesis; IEA:Ensembl
P12757	SKIL	Ski-like protein	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P12757	SKIL	Ski-like protein	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
P12757	SKIL	Ski-like protein	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q15477	SKIV2L	Helicase SKI2W	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q15477	SKIV2L	Helicase SKI2W	GO:0004004; F:ATP-dependent RNA helicase activity; TAS:ProtInc
Q15477	SKIV2L	Helicase SKI2W	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q15477	SKIV2L	Helicase SKI2W	GO:0006200; P:ATP catabolic process; TAS:GOC
P12755	SKI	Ski oncogene	GO:0003682; F:chromatin binding; IEA:Ensembl
P12755	SKI	Ski oncogene	GO:0046811; F:histone deacetylase inhibitor activity; ISS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0005515; F:protein binding; IPI:UniProtKB
P12755	SKI	Ski oncogene	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P12755	SKI	Ski oncogene	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P12755	SKI	Ski oncogene	GO:0070491; F:repressing transcription factor binding; IPI:UniProtKB
P12755	SKI	Ski oncogene	GO:0046332; F:SMAD binding; IPI:UniProtKB
P12755	SKI	Ski oncogene	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
P12755	SKI	Ski oncogene	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P12755	SKI	Ski oncogene	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P12755	SKI	Ski oncogene	GO:0009948; P:anterior/posterior axis specification; ISS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0030509; P:BMP signaling pathway; TAS:Reactome
P12755	SKI	Ski oncogene	GO:0060349; P:bone morphogenesis; ISS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0043010; P:camera-type eye development; ISS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0048593; P:camera-type eye morphogenesis; ISS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0048870; P:cell motility; NAS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0008283; P:cell proliferation; NAS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0030326; P:embryonic limb morphogenesis; ISS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0060325; P:face morphogenesis; ISS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0010467; P:gene expression; TAS:Reactome
P12755	SKI	Ski oncogene	GO:0002089; P:lens morphogenesis in camera-type eye; ISS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0022011; P:myelination in peripheral nervous system; ISS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0014902; P:myotube differentiation; IDA:UniProtKB
P12755	SKI	Ski oncogene	GO:0032926; P:negative regulation of activin receptor signaling pathway; IDA:UniProtKB
P12755	SKI	Ski oncogene	GO:0030514; P:negative regulation of BMP signaling pathway; IDA:UniProtKB
P12755	SKI	Ski oncogene	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
P12755	SKI	Ski oncogene	GO:0048147; P:negative regulation of fibroblast proliferation; ISS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0045668; P:negative regulation of osteoblast differentiation; IDA:UniProtKB
P12755	SKI	Ski oncogene	GO:0010626; P:negative regulation of Schwann cell proliferation; IGI:MGI
P12755	SKI	Ski oncogene	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P12755	SKI	Ski oncogene	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
P12755	SKI	Ski oncogene	GO:0001843; P:neural tube closure; ISS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0043585; P:nose morphogenesis; ISS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0021772; P:olfactory bulb development; ISS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0060021; P:palate development; ISS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0043388; P:positive regulation of DNA binding; IDA:UniProtKB
P12755	SKI	Ski oncogene	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0030177; P:positive regulation of Wnt signaling pathway; NAS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0070207; P:protein homotrimerization; IDA:UniProtKB
P12755	SKI	Ski oncogene	GO:0042981; P:regulation of apoptotic process; ISS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0060041; P:retina development in camera-type eye; ISS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0048741; P:skeletal muscle fiber development; ISS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0060395; P:SMAD protein signal transduction; IDA:UniProtKB
P12755	SKI	Ski oncogene	GO:0035019; P:somatic stem cell maintenance; ISS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P12755	SKI	Ski oncogene	GO:0006351; P:transcription, DNA-templated; ISS:BHF-UCL
P12755	SKI	Ski oncogene	GO:0007179; P:transforming growth factor beta receptor signaling pathway; NAS:BHF-UCL
P84550	SKOR1	SKI family transcriptional corepressor 1	GO:0046332; F:SMAD binding; IPI:UniProtKB
P84550	SKOR1	SKI family transcriptional corepressor 1	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
P84550	SKOR1	SKI family transcriptional corepressor 1	GO:0030514; P:negative regulation of BMP signaling pathway; IDA:UniProtKB
P84550	SKOR1	SKI family transcriptional corepressor 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
P84550	SKOR1	SKI family transcriptional corepressor 1	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IBA:RefGenome
P84550	SKOR1	SKI family transcriptional corepressor 1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P84550	SKOR1	SKI family transcriptional corepressor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q2VWA4	SKOR2	SKI family transcriptional corepressor 2	GO:0046332; F:SMAD binding; IPI:UniProtKB
Q2VWA4	SKOR2	SKI family transcriptional corepressor 2	GO:0003714; F:transcription corepressor activity; ISS:UniProtKB
Q2VWA4	SKOR2	SKI family transcriptional corepressor 2	GO:0021702; P:cerebellar Purkinje cell differentiation; IEA:Ensembl
Q2VWA4	SKOR2	SKI family transcriptional corepressor 2	GO:0030514; P:negative regulation of BMP signaling pathway; IEA:Ensembl
Q2VWA4	SKOR2	SKI family transcriptional corepressor 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q2VWA4	SKOR2	SKI family transcriptional corepressor 2	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
Q2VWA4	SKOR2	SKI family transcriptional corepressor 2	GO:0045880; P:positive regulation of smoothened signaling pathway; IEA:Ensembl
Q2VWA4	SKOR2	SKI family transcriptional corepressor 2	GO:0021936; P:regulation of cerebellar granule cell precursor proliferation; IEA:Ensembl
Q2VWA4	SKOR2	SKI family transcriptional corepressor 2	GO:0048814; P:regulation of dendrite morphogenesis; IEA:Ensembl
Q2VWA4	SKOR2	SKI family transcriptional corepressor 2	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q2VWA4	SKOR2	SKI family transcriptional corepressor 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P63208	SKP1	S-phase kinase-associated protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P63208	SKP1	S-phase kinase-associated protein 1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
P63208	SKP1	S-phase kinase-associated protein 1	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P63208	SKP1	S-phase kinase-associated protein 1	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P63208	SKP1	S-phase kinase-associated protein 1	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P63208	SKP1	S-phase kinase-associated protein 1	GO:0035518; P:histone H2A monoubiquitination; IDA:UniProtKB
P63208	SKP1	S-phase kinase-associated protein 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P63208	SKP1	S-phase kinase-associated protein 1	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P63208	SKP1	S-phase kinase-associated protein 1	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P63208	SKP1	S-phase kinase-associated protein 1	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
P63208	SKP1	S-phase kinase-associated protein 1	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P63208	SKP1	S-phase kinase-associated protein 1	GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
P63208	SKP1	S-phase kinase-associated protein 1	GO:0016032; P:viral process; TAS:Reactome
Q13309	SKP2	S-phase kinase-associated protein 2	GO:0042802; F:identical protein binding; IPI:IntAct
Q13309	SKP2	S-phase kinase-associated protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q13309	SKP2	S-phase kinase-associated protein 2	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q13309	SKP2	S-phase kinase-associated protein 2	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
Q13309	SKP2	S-phase kinase-associated protein 2	GO:0008283; P:cell proliferation; TAS:ProtInc
Q13309	SKP2	S-phase kinase-associated protein 2	GO:0071460; P:cellular response to cell-matrix adhesion; IEA:Ensembl
Q13309	SKP2	S-phase kinase-associated protein 2	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q13309	SKP2	S-phase kinase-associated protein 2	GO:0000086; P:G2/M transition of mitotic cell cycle; IEA:Ensembl
Q13309	SKP2	S-phase kinase-associated protein 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q13309	SKP2	S-phase kinase-associated protein 2	GO:0033148; P:positive regulation of intracellular estrogen receptor signaling pathway; IEA:Ensembl
Q13309	SKP2	S-phase kinase-associated protein 2	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
Q13309	SKP2	S-phase kinase-associated protein 2	GO:0000209; P:protein polyubiquitination; IEA:Ensembl
Q13309	SKP2	S-phase kinase-associated protein 2	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
Q5T5P2	KIAA1217	Sickle tail protein homolog	GO:0048706; P:embryonic skeletal system development; ISS:UniProtKB
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0048306; F:calcium-dependent protein binding; IDA:UniProtKB
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0005515; F:protein binding; IPI:UniProtKB
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0015385; F:sodium:proton antiporter activity; IDA:UniProtKB
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0015299; F:solute:proton antiporter activity; TAS:UniProtKB
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0055007; P:cardiac muscle cell differentiation; IEA:Ensembl
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0016049; P:cell growth; IEA:Ensembl
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0071468; P:cellular response to acidity; ISS:UniProtKB
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0030214; P:hyaluronan catabolic process; TAS:Reactome
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0030212; P:hyaluronan metabolic process; TAS:Reactome
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:1902600; P:hydrogen ion transmembrane transport; TAS:GOC
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0006811; P:ion transport; TAS:Reactome
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0070997; P:neuron death; IEA:Ensembl
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0045760; P:positive regulation of action potential; IEA:Ensembl
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0030307; P:positive regulation of cell growth; IEA:Ensembl
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0035794; P:positive regulation of mitochondrial membrane permeability; IEA:Ensembl
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0051259; P:protein oligomerization; ISS:UniProtKB
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0051453; P:regulation of intracellular pH; IDA:UniProtKB
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0006885; P:regulation of pH; IDA:UniProtKB
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0051930; P:regulation of sensory perception of pain; IEA:Ensembl
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0002026; P:regulation of the force of heart contraction; IEA:Ensembl
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0001101; P:response to acid; IDA:UniProtKB
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0010447; P:response to acidity; IDA:UniProtKB
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0042493; P:response to drug; IEA:Ensembl
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0071436; P:sodium ion export; ISS:UniProtKB
P19634	SLC9A1	Sodium/hydrogen exchanger 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UBY0	SLC9A2	Sodium/hydrogen exchanger 2	GO:0015385; F:sodium:proton antiporter activity; TAS:ProtInc
Q9UBY0	SLC9A2	Sodium/hydrogen exchanger 2	GO:0006811; P:ion transport; TAS:Reactome
Q9UBY0	SLC9A2	Sodium/hydrogen exchanger 2	GO:0008104; P:protein localization; IEA:Ensembl
Q9UBY0	SLC9A2	Sodium/hydrogen exchanger 2	GO:0006885; P:regulation of pH; IEA:Ensembl
Q9UBY0	SLC9A2	Sodium/hydrogen exchanger 2	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
Q9UBY0	SLC9A2	Sodium/hydrogen exchanger 2	GO:0055085; P:transmembrane transport; TAS:Reactome
P48764	SLC9A3	Sodium/hydrogen exchanger 3	GO:0030165; F:PDZ domain binding; ISS:UniProtKB
P48764	SLC9A3	Sodium/hydrogen exchanger 3	GO:0005515; F:protein binding; IPI:UniProtKB
P48764	SLC9A3	Sodium/hydrogen exchanger 3	GO:0015385; F:sodium:proton antiporter activity; ISS:UniProtKB
P48764	SLC9A3	Sodium/hydrogen exchanger 3	GO:0006811; P:ion transport; TAS:Reactome
P48764	SLC9A3	Sodium/hydrogen exchanger 3	GO:0006885; P:regulation of pH; IEA:Ensembl
P48764	SLC9A3	Sodium/hydrogen exchanger 3	GO:0035725; P:sodium ion transmembrane transport; ISS:GOC
P48764	SLC9A3	Sodium/hydrogen exchanger 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q6AI14	SLC9A4	Sodium/hydrogen exchanger 4	GO:0015385; F:sodium:proton antiporter activity; IEA:InterPro
Q6AI14	SLC9A4	Sodium/hydrogen exchanger 4	GO:0006811; P:ion transport; TAS:Reactome
Q6AI14	SLC9A4	Sodium/hydrogen exchanger 4	GO:0006885; P:regulation of pH; IEA:InterPro
Q6AI14	SLC9A4	Sodium/hydrogen exchanger 4	GO:0055085; P:transmembrane transport; TAS:Reactome
Q14940	SLC9A5	Sodium/hydrogen exchanger 5	GO:0015385; F:sodium:proton antiporter activity; TAS:ProtInc
Q14940	SLC9A5	Sodium/hydrogen exchanger 5	GO:0006811; P:ion transport; TAS:Reactome
Q14940	SLC9A5	Sodium/hydrogen exchanger 5	GO:0006885; P:regulation of pH; IEA:InterPro
Q14940	SLC9A5	Sodium/hydrogen exchanger 5	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
Q14940	SLC9A5	Sodium/hydrogen exchanger 5	GO:0055085; P:transmembrane transport; TAS:Reactome
Q14940	SLC9A5	Sodium/hydrogen exchanger 5	GO:0006810; P:transport; TAS:ProtInc
Q92581	SLC9A6	Sodium/hydrogen exchanger 6	GO:0015385; F:sodium:proton antiporter activity; TAS:ProtInc
Q92581	SLC9A6	Sodium/hydrogen exchanger 6	GO:0048675; P:axon extension; IDA:MGI
Q92581	SLC9A6	Sodium/hydrogen exchanger 6	GO:0097484; P:dendrite extension; IDA:MGI
Q92581	SLC9A6	Sodium/hydrogen exchanger 6	GO:0006811; P:ion transport; TAS:Reactome
Q92581	SLC9A6	Sodium/hydrogen exchanger 6	GO:0048812; P:neuron projection morphogenesis; IDA:MGI
Q92581	SLC9A6	Sodium/hydrogen exchanger 6	GO:0006885; P:regulation of pH; IEA:InterPro
Q92581	SLC9A6	Sodium/hydrogen exchanger 6	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
Q92581	SLC9A6	Sodium/hydrogen exchanger 6	GO:0055085; P:transmembrane transport; TAS:Reactome
Q92581	SLC9A6	Sodium/hydrogen exchanger 6	GO:0006810; P:transport; TAS:ProtInc
Q96T83	SLC9A7	Sodium/hydrogen exchanger 7	GO:0015386; F:potassium:proton antiporter activity; IDA:UniProtKB
Q96T83	SLC9A7	Sodium/hydrogen exchanger 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q96T83	SLC9A7	Sodium/hydrogen exchanger 7	GO:0042803; F:protein homodimerization activity; TAS:UniProtKB
Q96T83	SLC9A7	Sodium/hydrogen exchanger 7	GO:0015385; F:sodium:proton antiporter activity; IDA:UniProtKB
Q96T83	SLC9A7	Sodium/hydrogen exchanger 7	GO:0006811; P:ion transport; TAS:Reactome
Q96T83	SLC9A7	Sodium/hydrogen exchanger 7	GO:0071805; P:potassium ion transmembrane transport; IDA:GOC
Q96T83	SLC9A7	Sodium/hydrogen exchanger 7	GO:0006885; P:regulation of pH; IDA:UniProtKB
Q96T83	SLC9A7	Sodium/hydrogen exchanger 7	GO:0035725; P:sodium ion transmembrane transport; IDA:GOC
Q96T83	SLC9A7	Sodium/hydrogen exchanger 7	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9Y2E8	SLC9A8	Sodium/hydrogen exchanger 8	GO:0015386; F:potassium:proton antiporter activity; IEA:Ensembl
Q9Y2E8	SLC9A8	Sodium/hydrogen exchanger 8	GO:0015385; F:sodium:proton antiporter activity; IEA:Ensembl
Q9Y2E8	SLC9A8	Sodium/hydrogen exchanger 8	GO:0006811; P:ion transport; TAS:Reactome
Q9Y2E8	SLC9A8	Sodium/hydrogen exchanger 8	GO:0051453; P:regulation of intracellular pH; IEA:Ensembl
Q9Y2E8	SLC9A8	Sodium/hydrogen exchanger 8	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8IVB4	SLC9A9	Sodium/hydrogen exchanger 9	GO:0015385; F:sodium:proton antiporter activity; IEA:InterPro
Q8IVB4	SLC9A9	Sodium/hydrogen exchanger 9	GO:0006811; P:ion transport; TAS:Reactome
Q8IVB4	SLC9A9	Sodium/hydrogen exchanger 9	GO:0006885; P:regulation of pH; IEA:InterPro
Q8IVB4	SLC9A9	Sodium/hydrogen exchanger 9	GO:0055085; P:transmembrane transport; TAS:Reactome
Q4ZJI4	SLC9B1	Sodium/hydrogen exchanger 9B1	GO:0015299; F:solute:proton antiporter activity; IEA:InterPro
Q4ZJI4	SLC9B1	Sodium/hydrogen exchanger 9B1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q4ZJI4	SLC9B1	Sodium/hydrogen exchanger 9B1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q86UD5	SLC9B2	Mitochondrial sodium/hydrogen exchanger 9B2	GO:0015299; F:solute:proton antiporter activity; IEA:InterPro
Q86UD5	SLC9B2	Mitochondrial sodium/hydrogen exchanger 9B2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q86UD5	SLC9B2	Mitochondrial sodium/hydrogen exchanger 9B2	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q86UD5	SLC9B2	Mitochondrial sodium/hydrogen exchanger 9B2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q4G0N8	SLC9C1	Sodium/hydrogen exchanger 10	GO:0015299; F:solute:proton antiporter activity; IEA:InterPro
Q4G0N8	SLC9C1	Sodium/hydrogen exchanger 10	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q4G0N8	SLC9C1	Sodium/hydrogen exchanger 10	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q4G0N8	SLC9C1	Sodium/hydrogen exchanger 10	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q4G0N8	SLC9C1	Sodium/hydrogen exchanger 10	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q4G0N8	SLC9C1	Sodium/hydrogen exchanger 10	GO:0030317; P:sperm motility; IEA:Ensembl
Q4G0N8	SLC9C1	Sodium/hydrogen exchanger 10	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q4G0N8	SLC9C1	Sodium/hydrogen exchanger 10	GO:0055085; P:transmembrane transport; TAS:Reactome
Q5TAH2	SLC9C2	Sodium/hydrogen exchanger 11	GO:0015299; F:solute:proton antiporter activity; IEA:InterPro
Q5TAH2	SLC9C2	Sodium/hydrogen exchanger 11	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
A6NJY1	SLC9B1P1	Putative SLC9B1-like protein SLC9B1P1	GO:0015299; F:solute:proton antiporter activity; IEA:InterPro
Q13291	SLAMF1	Signaling lymphocytic activation molecule	GO:0003823; F:antigen binding; TAS:ProtInc
Q13291	SLAMF1	Signaling lymphocytic activation molecule	GO:0005515; F:protein binding; IPI:IntAct
Q13291	SLAMF1	Signaling lymphocytic activation molecule	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q13291	SLAMF1	Signaling lymphocytic activation molecule	GO:0046649; P:lymphocyte activation; IEA:InterPro
Q13291	SLAMF1	Signaling lymphocytic activation molecule	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q13291	SLAMF1	Signaling lymphocytic activation molecule	GO:0007165; P:signal transduction; TAS:GOC
Q13291	SLAMF1	Signaling lymphocytic activation molecule	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9UIB8	CD84	SLAM family member 5	GO:0005515; F:protein binding; IPI:IntAct
Q9UIB8	CD84	SLAM family member 5	GO:0004872; F:receptor activity; IEA:InterPro
Q9UIB8	CD84	SLAM family member 5	GO:0007596; P:blood coagulation; TAS:Reactome
Q9UIB8	CD84	SLAM family member 5	GO:0006952; P:defense response; TAS:ProtInc
Q9UIB8	CD84	SLAM family member 5	GO:0007156; P:homophilic cell adhesion; TAS:ProtInc
Q9UIB8	CD84	SLAM family member 5	GO:0050900; P:leukocyte migration; TAS:Reactome
Q96DU3	SLAMF6	SLAM family member 6	GO:0004872; F:receptor activity; IEA:InterPro
Q9NQ25	SLAMF7	SLAM family member 7	GO:0004872; F:receptor activity; IEA:InterPro
Q9NQ25	SLAMF7	SLAM family member 7	GO:0007155; P:cell adhesion; NAS:UniProtKB
Q9NQ25	SLAMF7	SLAM family member 7	GO:0030101; P:natural killer cell activation; NAS:UniProtKB
Q9NQ25	SLAMF7	SLAM family member 7	GO:0042267; P:natural killer cell mediated cytotoxicity; NAS:UniProtKB
Q9NQ25	SLAMF7	SLAM family member 7	GO:0032814; P:regulation of natural killer cell activation; IEA:Ensembl
Q9P0V8	SLAMF8	SLAM family member 8	GO:0004872; F:receptor activity; IEA:InterPro
Q9P0V8	SLAMF8	SLAM family member 8	GO:0035690; P:cellular response to drug; IEA:Ensembl
Q9P0V8	SLAMF8	SLAM family member 8	GO:0042742; P:defense response to bacterium; IEA:Ensembl
Q9P0V8	SLAMF8	SLAM family member 8	GO:0090383; P:phagosome acidification; IEA:Ensembl
Q9P0V8	SLAMF8	SLAM family member 8	GO:0043549; P:regulation of kinase activity; IEA:Ensembl
Q9P0V8	SLAMF8	SLAM family member 8	GO:0033860; P:regulation of NAD(P)H oxidase activity; IEA:Ensembl
Q96A28	SLAMF9	SLAM family member 9	GO:0004872; F:receptor activity; IEA:InterPro
Q9P270	SLAIN2	SLAIN motif-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P270	SLAIN2	SLAIN motif-containing protein 2	GO:0031122; P:cytoplasmic microtubule organization; IMP:UniProtKB
Q9P270	SLAIN2	SLAIN motif-containing protein 2	GO:0007020; P:microtubule nucleation; IMP:UniProtKB
Q9P270	SLAIN2	SLAIN motif-containing protein 2	GO:0031116; P:positive regulation of microtubule polymerization; IMP:UniProtKB
Q13239	SLA	Src-like-adapter	GO:0005515; F:protein binding; IPI:IntAct
Q13239	SLA	Src-like-adapter	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
Q13239	SLA	Src-like-adapter	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
Q9H6Q3	SLA2	Src-like-adapter 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H6Q3	SLA2	Src-like-adapter 2	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q9H6Q3	SLA2	Src-like-adapter 2	GO:0005070; F:SH3/SH2 adaptor activity; IDA:UniProtKB
Q9H6Q3	SLA2	Src-like-adapter 2	GO:0050851; P:antigen receptor-mediated signaling pathway; TAS:UniProtKB
Q9H6Q3	SLA2	Src-like-adapter 2	GO:0019724; P:B cell mediated immunity; TAS:UniProtKB
Q9H6Q3	SLA2	Src-like-adapter 2	GO:0030522; P:intracellular receptor signaling pathway; TAS:UniProtKB
Q9H6Q3	SLA2	Src-like-adapter 2	GO:0050869; P:negative regulation of B cell activation; TAS:UniProtKB
Q9H6Q3	SLA2	Src-like-adapter 2	GO:0050849; P:negative regulation of calcium-mediated signaling; IDA:UniProtKB
Q9H6Q3	SLA2	Src-like-adapter 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9H6Q3	SLA2	Src-like-adapter 2	GO:0009967; P:positive regulation of signal transduction; IDA:GOC
Q9H6Q3	SLA2	Src-like-adapter 2	GO:0050776; P:regulation of immune response; NAS:UniProtKB
Q9H6Q3	SLA2	Src-like-adapter 2	GO:0042110; P:T cell activation; TAS:UniProtKB
Q14493	SLBP	Histone RNA hairpin-binding protein	GO:0071208; F:histone pre-mRNA DCP binding; ISS:UniProtKB
Q14493	SLBP	Histone RNA hairpin-binding protein	GO:0071207; F:histone pre-mRNA stem-loop binding; ISS:UniProtKB
Q14493	SLBP	Histone RNA hairpin-binding protein	GO:0003729; F:mRNA binding; IDA:UniProtKB
Q14493	SLBP	Histone RNA hairpin-binding protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14493	SLBP	Histone RNA hairpin-binding protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q14493	SLBP	Histone RNA hairpin-binding protein	GO:0010467; P:gene expression; TAS:Reactome
Q14493	SLBP	Histone RNA hairpin-binding protein	GO:0006398; P:histone mRNA 3'-end processing; ISS:UniProtKB
Q14493	SLBP	Histone RNA hairpin-binding protein	GO:0008334; P:histone mRNA metabolic process; TAS:Reactome
Q14493	SLBP	Histone RNA hairpin-binding protein	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q14493	SLBP	Histone RNA hairpin-binding protein	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
Q14493	SLBP	Histone RNA hairpin-binding protein	GO:0051028; P:mRNA transport; IDA:UniProtKB
Q14493	SLBP	Histone RNA hairpin-binding protein	GO:0033260; P:nuclear cell cycle DNA replication; IMP:UniProtKB
Q14493	SLBP	Histone RNA hairpin-binding protein	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q14493	SLBP	Histone RNA hairpin-binding protein	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q07837	SLC3A1	Neutral and basic amino acid transport protein rBAT	GO:0015171; F:amino acid transmembrane transporter activity; TAS:ProtInc
Q07837	SLC3A1	Neutral and basic amino acid transport protein rBAT	GO:0015174; F:basic amino acid transmembrane transporter activity; TAS:ProtInc
Q07837	SLC3A1	Neutral and basic amino acid transport protein rBAT	GO:0003824; F:catalytic activity; IEA:InterPro
Q07837	SLC3A1	Neutral and basic amino acid transport protein rBAT	GO:0043169; F:cation binding; IEA:InterPro
Q07837	SLC3A1	Neutral and basic amino acid transport protein rBAT	GO:0015184; F:L-cystine transmembrane transporter activity; TAS:ProtInc
Q07837	SLC3A1	Neutral and basic amino acid transport protein rBAT	GO:0005515; F:protein binding; IPI:UniProtKB
Q07837	SLC3A1	Neutral and basic amino acid transport protein rBAT	GO:0003333; P:amino acid transmembrane transport; TAS:GOC
Q07837	SLC3A1	Neutral and basic amino acid transport protein rBAT	GO:0006865; P:amino acid transport; TAS:Reactome
Q07837	SLC3A1	Neutral and basic amino acid transport protein rBAT	GO:0015802; P:basic amino acid transport; TAS:ProtInc
Q07837	SLC3A1	Neutral and basic amino acid transport protein rBAT	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
Q07837	SLC3A1	Neutral and basic amino acid transport protein rBAT	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
Q07837	SLC3A1	Neutral and basic amino acid transport protein rBAT	GO:0006811; P:ion transport; TAS:Reactome
Q07837	SLC3A1	Neutral and basic amino acid transport protein rBAT	GO:0015811; P:L-cystine transport; TAS:ProtInc
Q07837	SLC3A1	Neutral and basic amino acid transport protein rBAT	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9BRT9	GINS4	DNA replication complex GINS protein SLD5	GO:0005515; F:protein binding; IPI:IntAct
Q9BRT9	GINS4	DNA replication complex GINS protein SLD5	GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome
Q9BRT9	GINS4	DNA replication complex GINS protein SLD5	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q08AF3	SLFN5	Schlafen family member 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q08AF3	SLFN5	Schlafen family member 5	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P01286	GHRH	Somatoliberin	GO:0016608; F:growth hormone-releasing hormone activity; IDA:BHF-UCL
P01286	GHRH	Somatoliberin	GO:0031770; F:growth hormone-releasing hormone receptor binding; IPI:BHF-UCL
P01286	GHRH	Somatoliberin	GO:0021984; P:adenohypophysis development; ISS:BHF-UCL
P01286	GHRH	Somatoliberin	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; ISS:BHF-UCL
P01286	GHRH	Somatoliberin	GO:0019933; P:cAMP-mediated signaling; IDA:BHF-UCL
P01286	GHRH	Somatoliberin	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P01286	GHRH	Somatoliberin	GO:0030252; P:growth hormone secretion; IDA:MGI
P01286	GHRH	Somatoliberin	GO:0030819; P:positive regulation of cAMP biosynthetic process; IDA:BHF-UCL
P01286	GHRH	Somatoliberin	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P01286	GHRH	Somatoliberin	GO:0046005; P:positive regulation of circadian sleep/wake cycle, REM sleep; NAS:BHF-UCL
P01286	GHRH	Somatoliberin	GO:0060124; P:positive regulation of growth hormone secretion; IDA:BHF-UCL
P01286	GHRH	Somatoliberin	GO:0043568; P:positive regulation of insulin-like growth factor receptor signaling pathway; NAS:BHF-UCL
P01286	GHRH	Somatoliberin	GO:0040018; P:positive regulation of multicellular organism growth; IMP:BHF-UCL
P01286	GHRH	Somatoliberin	GO:0032094; P:response to food; ISS:BHF-UCL
Q96PX8	SLITRK1	SLIT and NTRK-like protein 1	GO:0030534; P:adult behavior; IEA:Ensembl
Q96PX8	SLITRK1	SLIT and NTRK-like protein 1	GO:0007409; P:axonogenesis; IEA:Ensembl
Q96PX8	SLITRK1	SLIT and NTRK-like protein 1	GO:0042592; P:homeostatic process; IEA:Ensembl
Q96PX8	SLITRK1	SLIT and NTRK-like protein 1	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q9H156	SLITRK2	SLIT and NTRK-like protein 2	GO:0007409; P:axonogenesis; IEA:Ensembl
O94933	SLITRK3	SLIT and NTRK-like protein 3	GO:0007409; P:axonogenesis; IEA:Ensembl
Q8IW52	SLITRK4	SLIT and NTRK-like protein 4	GO:0007409; P:axonogenesis; IEA:Ensembl
O94991	SLITRK5	SLIT and NTRK-like protein 5	GO:0030534; P:adult behavior; IEA:Ensembl
O94991	SLITRK5	SLIT and NTRK-like protein 5	GO:0007409; P:axonogenesis; IEA:Ensembl
O94991	SLITRK5	SLIT and NTRK-like protein 5	GO:0072358; P:cardiovascular system development; IEA:Ensembl
O94991	SLITRK5	SLIT and NTRK-like protein 5	GO:0048813; P:dendrite morphogenesis; IEA:Ensembl
O94991	SLITRK5	SLIT and NTRK-like protein 5	GO:0007625; P:grooming behavior; IEA:Ensembl
O94991	SLITRK5	SLIT and NTRK-like protein 5	GO:0009410; P:response to xenobiotic stimulus; IEA:Ensembl
O94991	SLITRK5	SLIT and NTRK-like protein 5	GO:0043588; P:skin development; IEA:Ensembl
O94991	SLITRK5	SLIT and NTRK-like protein 5	GO:0021756; P:striatum development; IEA:Ensembl
O94991	SLITRK5	SLIT and NTRK-like protein 5	GO:0007268; P:synaptic transmission; IEA:Ensembl
Q9H5Y7	SLITRK6	SLIT and NTRK-like protein 6	GO:0002093; P:auditory receptor cell morphogenesis; IEA:Ensembl
Q9H5Y7	SLITRK6	SLIT and NTRK-like protein 6	GO:0007409; P:axonogenesis; IEA:Ensembl
Q9H5Y7	SLITRK6	SLIT and NTRK-like protein 6	GO:0090102; P:cochlea development; IEA:Ensembl
Q9H5Y7	SLITRK6	SLIT and NTRK-like protein 6	GO:0060384; P:innervation; IEA:Ensembl
Q9H5Y7	SLITRK6	SLIT and NTRK-like protein 6	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q9H5Y7	SLITRK6	SLIT and NTRK-like protein 6	GO:0007605; P:sensory perception of sound; IEA:UniProtKB-KW
Q9H5Y7	SLITRK6	SLIT and NTRK-like protein 6	GO:0001964; P:startle response; IEA:Ensembl
Q9H5Y7	SLITRK6	SLIT and NTRK-like protein 6	GO:0007416; P:synapse assembly; IMP:MGI
Q9H5Y7	SLITRK6	SLIT and NTRK-like protein 6	GO:0060005; P:vestibular reflex; IEA:Ensembl
Q9H5Y7	SLITRK6	SLIT and NTRK-like protein 6	GO:0021562; P:vestibulocochlear nerve development; IEA:Ensembl
Q9H5Y7	SLITRK6	SLIT and NTRK-like protein 6	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q9GZT3	SLIRP	SRA stem-loop-interacting RNA-binding protein, mitochondrial	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9GZT3	SLIRP	SRA stem-loop-interacting RNA-binding protein, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9GZT3	SLIRP	SRA stem-loop-interacting RNA-binding protein, mitochondrial	GO:0000961; P:negative regulation of mitochondrial RNA catabolic process; IEA:Ensembl
Q9GZT3	SLIRP	SRA stem-loop-interacting RNA-binding protein, mitochondrial	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9GZT3	SLIRP	SRA stem-loop-interacting RNA-binding protein, mitochondrial	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q68CJ6	NUGGC	Nuclear GTPase SLIP-GC	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q68CJ6	NUGGC	Nuclear GTPase SLIP-GC	GO:0003924; F:GTPase activity; IEA:InterPro
Q68CJ6	NUGGC	Nuclear GTPase SLIP-GC	GO:0006974; P:cellular response to DNA damage stimulus; IEA:Ensembl
Q68CJ6	NUGGC	Nuclear GTPase SLIP-GC	GO:0016446; P:somatic hypermutation of immunoglobulin genes; IEA:Ensembl
O75093	SLIT1	Slit homolog 1 protein	GO:0005509; F:calcium ion binding; NAS:UniProtKB
O75093	SLIT1	Slit homolog 1 protein	GO:0048495; F:Roundabout binding; IPI:UniProtKB
O75093	SLIT1	Slit homolog 1 protein	GO:0048846; P:axon extension involved in axon guidance; IDA:UniProtKB
O75093	SLIT1	Slit homolog 1 protein	GO:0007411; P:axon guidance; IDA:UniProtKB
O75093	SLIT1	Slit homolog 1 protein	GO:0033563; P:dorsal/ventral axon guidance; IEA:Ensembl
O75093	SLIT1	Slit homolog 1 protein	GO:0040023; P:establishment of nucleus localization; IEA:Ensembl
O75093	SLIT1	Slit homolog 1 protein	GO:0048853; P:forebrain morphogenesis; NAS:UniProtKB
O75093	SLIT1	Slit homolog 1 protein	GO:0008045; P:motor neuron axon guidance; IMP:UniProtKB
O75093	SLIT1	Slit homolog 1 protein	GO:0050919; P:negative chemotaxis; IDA:UniProtKB
O75093	SLIT1	Slit homolog 1 protein	GO:0048843; P:negative regulation of axon extension involved in axon guidance; IEA:Ensembl
O75093	SLIT1	Slit homolog 1 protein	GO:0051964; P:negative regulation of synapse assembly; ISS:UniProtKB
O75093	SLIT1	Slit homolog 1 protein	GO:0031290; P:retinal ganglion cell axon guidance; IEA:Ensembl
O75093	SLIT1	Slit homolog 1 protein	GO:0021510; P:spinal cord development; IEA:Ensembl
O75093	SLIT1	Slit homolog 1 protein	GO:0022028; P:tangential migration from the subventricular zone to the olfactory bulb; IEA:Ensembl
O94813	SLIT2	Slit homolog 2 protein	GO:0005509; F:calcium ion binding; NAS:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0045499; F:chemorepellent activity; IEA:Ensembl
O94813	SLIT2	Slit homolog 2 protein	GO:0005095; F:GTPase inhibitor activity; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0008201; F:heparin binding; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0042802; F:identical protein binding; IPI:IntAct
O94813	SLIT2	Slit homolog 2 protein	GO:0043237; F:laminin-1 binding; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0005515; F:protein binding; IPI:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0043394; F:proteoglycan binding; IPI:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0048495; F:Roundabout binding; IPI:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0061364; P:apoptotic process involved in luteolysis; IEP:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0048846; P:axon extension involved in axon guidance; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0007411; P:axon guidance; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0048754; P:branching morphogenesis of an epithelial tube; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0002042; P:cell migration involved in sprouting angiogenesis; IMP:BHF-UCL
O94813	SLIT2	Slit homolog 2 protein	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
O94813	SLIT2	Slit homolog 2 protein	GO:0071504; P:cellular response to heparin; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0032870; P:cellular response to hormone stimulus; IEP:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0021836; P:chemorepulsion involved in postnatal olfactory bulb interneuron migration; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0021972; P:corticospinal neuron axon guidance through spinal cord; IMP:BHF-UCL
O94813	SLIT2	Slit homolog 2 protein	GO:0033563; P:dorsal/ventral axon guidance; IEA:Ensembl
O94813	SLIT2	Slit homolog 2 protein	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O94813	SLIT2	Slit homolog 2 protein	GO:0050929; P:induction of negative chemotaxis; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0060763; P:mammary duct terminal end bud growth; IEA:Ensembl
O94813	SLIT2	Slit homolog 2 protein	GO:0001656; P:metanephros development; IEA:Ensembl
O94813	SLIT2	Slit homolog 2 protein	GO:0008045; P:motor neuron axon guidance; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0050919; P:negative chemotaxis; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0030837; P:negative regulation of actin filament polymerization; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0043086; P:negative regulation of catalytic activity; IDA:GOC
O94813	SLIT2	Slit homolog 2 protein	GO:0030308; P:negative regulation of cell growth; IMP:BHF-UCL
O94813	SLIT2	Slit homolog 2 protein	GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
O94813	SLIT2	Slit homolog 2 protein	GO:0090288; P:negative regulation of cellular response to growth factor stimulus; IDA:BHF-UCL
O94813	SLIT2	Slit homolog 2 protein	GO:0070100; P:negative regulation of chemokine-mediated signaling pathway; IMP:BHF-UCL
O94813	SLIT2	Slit homolog 2 protein	GO:0010596; P:negative regulation of endothelial cell migration; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
O94813	SLIT2	Slit homolog 2 protein	GO:0010593; P:negative regulation of lamellipodium assembly; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0002689; P:negative regulation of leukocyte chemotaxis; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0090027; P:negative regulation of monocyte chemotaxis; ISS:BHF-UCL
O94813	SLIT2	Slit homolog 2 protein	GO:0071676; P:negative regulation of mononuclear cell migration; IDA:BHF-UCL
O94813	SLIT2	Slit homolog 2 protein	GO:0090024; P:negative regulation of neutrophil chemotaxis; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0001933; P:negative regulation of protein phosphorylation; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0090260; P:negative regulation of retinal ganglion cell axon guidance; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0051058; P:negative regulation of small GTPase mediated signal transduction; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0071672; P:negative regulation of smooth muscle cell chemotaxis; IDA:BHF-UCL
O94813	SLIT2	Slit homolog 2 protein	GO:0014912; P:negative regulation of smooth muscle cell migration; IDA:BHF-UCL
O94813	SLIT2	Slit homolog 2 protein	GO:0043116; P:negative regulation of vascular permeability; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0050772; P:positive regulation of axonogenesis; TAS:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0051414; P:response to cortisol; IEP:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0031290; P:retinal ganglion cell axon guidance; IDA:UniProtKB
O94813	SLIT2	Slit homolog 2 protein	GO:0035385; P:Roundabout signaling pathway; IMP:BHF-UCL
O94813	SLIT2	Slit homolog 2 protein	GO:0001657; P:ureteric bud development; IMP:UniProtKB
O75094	SLIT3	Slit homolog 3 protein	GO:0005509; F:calcium ion binding; IEA:InterPro
O75094	SLIT3	Slit homolog 3 protein	GO:0048495; F:Roundabout binding; IPI:UniProtKB
O75094	SLIT3	Slit homolog 3 protein	GO:0061364; P:apoptotic process involved in luteolysis; IEP:UniProtKB
O75094	SLIT3	Slit homolog 3 protein	GO:0048846; P:axon extension involved in axon guidance; IDA:UniProtKB
O75094	SLIT3	Slit homolog 3 protein	GO:0007411; P:axon guidance; IDA:UniProtKB
O75094	SLIT3	Slit homolog 3 protein	GO:0032870; P:cellular response to hormone stimulus; IEP:UniProtKB
O75094	SLIT3	Slit homolog 3 protein	GO:0050919; P:negative chemotaxis; IDA:UniProtKB
O75094	SLIT3	Slit homolog 3 protein	GO:0030308; P:negative regulation of cell growth; IMP:BHF-UCL
O75094	SLIT3	Slit homolog 3 protein	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
O75094	SLIT3	Slit homolog 3 protein	GO:0070100; P:negative regulation of chemokine-mediated signaling pathway; IMP:BHF-UCL
O75094	SLIT3	Slit homolog 3 protein	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
O75094	SLIT3	Slit homolog 3 protein	GO:0009887; P:organ morphogenesis; IEA:Ensembl
O75094	SLIT3	Slit homolog 3 protein	GO:0051414; P:response to cortisol; IEP:UniProtKB
O75094	SLIT3	Slit homolog 3 protein	GO:0035385; P:Roundabout signaling pathway; IMP:BHF-UCL
Q9H2G2	SLK	STE20-like serine/threonine-protein kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H2G2	SLK	STE20-like serine/threonine-protein kinase	GO:0042802; F:identical protein binding; IPI:IntAct
Q9H2G2	SLK	STE20-like serine/threonine-protein kinase	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q9H2G2	SLK	STE20-like serine/threonine-protein kinase	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9H2G2	SLK	STE20-like serine/threonine-protein kinase	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
Q9H2G2	SLK	STE20-like serine/threonine-protein kinase	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9H2G2	SLK	STE20-like serine/threonine-protein kinase	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q9H2G2	SLK	STE20-like serine/threonine-protein kinase	GO:0023014; P:signal transduction by phosphorylation; IBA:GOC
Q14BN4	SLMAP	Sarcolemmal membrane-associated protein	GO:0005515; F:protein binding; IPI:IntAct
Q14BN4	SLMAP	Sarcolemmal membrane-associated protein	GO:0006936; P:muscle contraction; TAS:ProtInc
Q96N28	SLMO1	Protein slowmo homolog 1	GO:1990050; F:phosphatidic acid transporter activity; IBA:RefGenome
Q96N28	SLMO1	Protein slowmo homolog 1	GO:0015914; P:phospholipid transport; IBA:RefGenome
Q9Y3B1	SLMO2	Protein slowmo homolog 2	GO:1990050; F:phosphatidic acid transporter activity; IBA:RefGenome
Q9Y3B1	SLMO2	Protein slowmo homolog 2	GO:0015914; P:phospholipid transport; IBA:RefGenome
P0C7P3	SLFN14	Schlafen family member 14	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q68D06	SLFN13	Schlafen family member 13	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IYM2	SLFN12	Schlafen family member 12	GO:0005524; F:ATP binding; IEA:InterPro
Q7Z7L1	SLFN11	Schlafen family member 11	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q7Z7L1	SLFN11	Schlafen family member 11	GO:0000049; F:tRNA binding; IDA:UniProtKB
Q7Z7L1	SLFN11	Schlafen family member 11	GO:0051607; P:defense response to virus; IMP:UniProtKB
Q7Z7L1	SLFN11	Schlafen family member 11	GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IMP:UniProtKB
Q499Z3	SLFNL1	Schlafen-like protein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P03973	SLPI	Antileukoproteinase	GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc
P03973	SLPI	Antileukoproteinase	GO:0019899; F:enzyme binding; IPI:UniProtKB
P03973	SLPI	Antileukoproteinase	GO:0005515; F:protein binding; IPI:UniProtKB
P03973	SLPI	Antileukoproteinase	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
P03973	SLPI	Antileukoproteinase	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
P03973	SLPI	Antileukoproteinase	GO:0032091; P:negative regulation of protein binding; IDA:UniProtKB
P03973	SLPI	Antileukoproteinase	GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB
Q9NWH9	SLTM	SAFB-like transcription modulator	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9NWH9	SLTM	SAFB-like transcription modulator	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NWH9	SLTM	SAFB-like transcription modulator	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9NWH9	SLTM	SAFB-like transcription modulator	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NWH9	SLTM	SAFB-like transcription modulator	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95391	SLU7	Pre-mRNA-splicing factor SLU7	GO:0030628; F:pre-mRNA 3'-splice site binding; IDA:HGNC
O95391	SLU7	Pre-mRNA-splicing factor SLU7	GO:0005515; F:protein binding; IPI:IntAct
O95391	SLU7	Pre-mRNA-splicing factor SLU7	GO:0000386; F:second spliceosomal transesterification activity; IDA:HGNC
O95391	SLU7	Pre-mRNA-splicing factor SLU7	GO:0008270; F:zinc ion binding; IDA:HGNC
O95391	SLU7	Pre-mRNA-splicing factor SLU7	GO:0000380; P:alternative mRNA splicing, via spliceosome; IDA:HGNC
O95391	SLU7	Pre-mRNA-splicing factor SLU7	GO:0034605; P:cellular response to heat; IDA:UniProtKB
O95391	SLU7	Pre-mRNA-splicing factor SLU7	GO:0006886; P:intracellular protein transport; IDA:UniProtKB
O95391	SLU7	Pre-mRNA-splicing factor SLU7	GO:0000389; P:mRNA 3'-splice site recognition; IDA:HGNC
O95391	SLU7	Pre-mRNA-splicing factor SLU7	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
O95391	SLU7	Pre-mRNA-splicing factor SLU7	GO:0000375; P:RNA splicing, via transesterification reactions; IDA:HGNC
P55000	SLURP1	Secreted Ly-6/uPAR-related protein 1	GO:0005125; F:cytokine activity; NAS:UniProtKB
P55000	SLURP1	Secreted Ly-6/uPAR-related protein 1	GO:0001775; P:cell activation; NAS:UniProtKB
P55000	SLURP1	Secreted Ly-6/uPAR-related protein 1	GO:0007155; P:cell adhesion; TAS:UniProtKB
Q9BQ83	SLX1A	Structure-specific endonuclease subunit SLX1	GO:0017108; F:5'-flap endonuclease activity; IDA:UniProtKB
Q9BQ83	SLX1A	Structure-specific endonuclease subunit SLX1	GO:0008821; F:crossover junction endodeoxyribonuclease activity; IDA:UniProtKB
Q9BQ83	SLX1A	Structure-specific endonuclease subunit SLX1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BQ83	SLX1A	Structure-specific endonuclease subunit SLX1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BQ83	SLX1A	Structure-specific endonuclease subunit SLX1	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
Q9BQ83	SLX1A	Structure-specific endonuclease subunit SLX1	GO:0010792; P:DNA double-strand break processing involved in repair via single-strand annealing; IMP:UniProtKB
Q9BQ83	SLX1A	Structure-specific endonuclease subunit SLX1	GO:0006281; P:DNA repair; IMP:UniProtKB
Q9BQ83	SLX1A	Structure-specific endonuclease subunit SLX1	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
Q5VYV7	SLX4IP	Protein SLX4IP	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IY92	SLX4	Structure-specific endonuclease subunit SLX4	GO:0017108; F:5'-flap endonuclease activity; IEA:InterPro
Q8IY92	SLX4	Structure-specific endonuclease subunit SLX4	GO:0008047; F:enzyme activator activity; IDA:UniProtKB
Q8IY92	SLX4	Structure-specific endonuclease subunit SLX4	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IY92	SLX4	Structure-specific endonuclease subunit SLX4	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
Q8IY92	SLX4	Structure-specific endonuclease subunit SLX4	GO:0010792; P:DNA double-strand break processing involved in repair via single-strand annealing; IMP:UniProtKB
Q8IY92	SLX4	Structure-specific endonuclease subunit SLX4	GO:0006281; P:DNA repair; IMP:UniProtKB
Q8IY92	SLX4	Structure-specific endonuclease subunit SLX4	GO:0006260; P:DNA replication; IEA:InterPro
Q8IY92	SLX4	Structure-specific endonuclease subunit SLX4	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
Q8IY92	SLX4	Structure-specific endonuclease subunit SLX4	GO:0006289; P:nucleotide-excision repair; IMP:UniProtKB
Q8IY92	SLX4	Structure-specific endonuclease subunit SLX4	GO:0043085; P:positive regulation of catalytic activity; IDA:GOC
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0008013; F:beta-catenin binding; IPI:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0031490; F:chromatin DNA binding; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0070410; F:co-SMAD binding; IPI:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0000987; F:core promoter proximal region sequence-specific DNA binding; IDA:UniProtKB
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0019902; F:phosphatase binding; IPI:UniProtKB
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0005515; F:protein binding; IPI:UniProtKB
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0070412; F:R-SMAD binding; IPI:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0043565; F:sequence-specific DNA binding; IDA:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0005160; F:transforming growth factor beta receptor binding; IPI:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0030618; F:transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity; IDA:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0031625; F:ubiquitin protein ligase binding; IPI:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0097296; P:activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0032924; P:activin receptor signaling pathway; IMP:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0007050; P:cell cycle arrest; IMP:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0045216; P:cell-cell junction organization; IMP:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0048589; P:developmental growth; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0048617; P:embryonic foregut morphogenesis; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0009880; P:embryonic pattern specification; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0007492; P:endoderm development; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0019049; P:evasion or tolerance of host defenses by virus; IDA:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0097191; P:extrinsic apoptotic signaling pathway; IMP:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0010467; P:gene expression; TAS:Reactome
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0001947; P:heart looping; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0006955; P:immune response; IMP:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0002520; P:immune system development; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0035556; P:intracellular signal transduction; IDA:GOC
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0070306; P:lens fiber cell differentiation; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0001889; P:liver development; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0001707; P:mesoderm formation; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0030308; P:negative regulation of cell growth; IDA:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0045930; P:negative regulation of mitotic cell cycle; IMP:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0033689; P:negative regulation of osteoblast proliferation; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0042177; P:negative regulation of protein catabolic process; IMP:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0001933; P:negative regulation of protein phosphorylation; IMP:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0061045; P:negative regulation of wound healing; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0038092; P:nodal signaling pathway; IMP:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0002076; P:osteoblast development; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0048340; P:paraxial mesoderm morphogenesis; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0060039; P:pericardium development; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0010694; P:positive regulation of alkaline phosphatase activity; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0030501; P:positive regulation of bone mineralization; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0035413; P:positive regulation of catenin import into nucleus; IMP:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0032332; P:positive regulation of chondrocyte differentiation; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IDA:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0051894; P:positive regulation of focal adhesion assembly; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:1901313; P:positive regulation of gene expression involved in extracellular matrix organization; IMP:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0032731; P:positive regulation of interleukin-1 beta production; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0050927; P:positive regulation of positive chemotaxis; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0051496; P:positive regulation of stress fiber assembly; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0042993; P:positive regulation of transcription factor import into nucleus; IDA:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0032916; P:positive regulation of transforming growth factor beta3 production; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0031053; P:primary miRNA processing; TAS:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0050821; P:protein stabilization; IMP:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0051098; P:regulation of binding; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0050678; P:regulation of epithelial cell proliferation; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0050776; P:regulation of immune response; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0016202; P:regulation of striated muscle tissue development; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IMP:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0032909; P:regulation of transforming growth factor beta2 production; IMP:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0001666; P:response to hypoxia; IMP:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0007183; P:SMAD protein complex assembly; IDA:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0001756; P:somitogenesis; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0042110; P:T cell activation; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0030878; P:thyroid gland development; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0060290; P:transdifferentiation; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0006810; P:transport; IDA:BHF-UCL
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0001657; P:ureteric bud development; IEA:Ensembl
P84022	SMAD3	Mothers against decapentaplegic homolog 3	GO:0042060; P:wound healing; TAS:BHF-UCL
Q9Y6J3	SMAD5-AS1	SMAD5 antisense gene protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0033613; F:activating transcription factor binding; IPI:UniProtKB
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0003682; F:chromatin binding; IEA:Ensembl
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0070410; F:co-SMAD binding; IPI:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0003690; F:double-stranded DNA binding; ISS:UniProtKB
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0070411; F:I-SMAD binding; IPI:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0019902; F:phosphatase binding; IPI:UniProtKB
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0070412; F:R-SMAD binding; IPI:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0046332; F:SMAD binding; IPI:UniProtKB
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0005160; F:transforming growth factor beta receptor binding; IPI:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0030618; F:transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity; IDA:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0034713; F:type I transforming growth factor beta receptor binding; IPI:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0031625; F:ubiquitin protein ligase binding; IPI:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0032924; P:activin receptor signaling pathway; IMP:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0009952; P:anterior/posterior pattern specification; ISS:UniProtKB
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0045165; P:cell fate commitment; ISS:UniProtKB
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0007182; P:common-partner SMAD protein phosphorylation; IDA:MGI
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0048589; P:developmental growth; IEA:Ensembl
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0048617; P:embryonic foregut morphogenesis; IEA:Ensembl
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0001706; P:endoderm formation; IEA:Ensembl
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0007369; P:gastrulation; TAS:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0010467; P:gene expression; TAS:Reactome
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0030073; P:insulin secretion; IEA:Ensembl
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0035556; P:intracellular signal transduction; ISS:UniProtKB
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0030324; P:lung development; IEA:Ensembl
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0001707; P:mesoderm formation; ISS:UniProtKB
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:Reactome
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0038092; P:nodal signaling pathway; IMP:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0035265; P:organ growth; IEA:Ensembl
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0060021; P:palate development; ISS:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0031016; P:pancreas development; IEA:Ensembl
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0048340; P:paraxial mesoderm morphogenesis; ISS:UniProtKB
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0060039; P:pericardium development; IEA:Ensembl
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0030513; P:positive regulation of BMP signaling pathway; IMP:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; ISS:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:1900224; P:positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry; IMP:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0031053; P:primary miRNA processing; TAS:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0051098; P:regulation of binding; ISS:UniProtKB
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IMP:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0070723; P:response to cholesterol; IDA:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0009749; P:response to glucose; IEA:Ensembl
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0007183; P:SMAD protein complex assembly; IDA:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0001657; P:ureteric bud development; IEA:Ensembl
Q15796	SMAD2	Mothers against decapentaplegic homolog 2	GO:0007352; P:zygotic specification of dorsal/ventral axis; IMP:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0003682; F:chromatin binding; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0000987; F:core promoter proximal region sequence-specific DNA binding; IDA:UniProtKB
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0070411; F:I-SMAD binding; IPI:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0042802; F:identical protein binding; IPI:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0070412; F:R-SMAD binding; IPI:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0001076; F:RNA polymerase II transcription factor binding transcription factor activity; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0030616; F:transforming growth factor beta receptor, common-partner cytoplasmic mediator activity; IDA:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0036302; P:atrioventricular canal development; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0003190; P:atrioventricular valve formation; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0007411; P:axon guidance; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0003360; P:brainstem development; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0003279; P:cardiac septum development; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0008283; P:cell proliferation; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0048589; P:developmental growth; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0060956; P:endocardial cell differentiation; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0007492; P:endoderm development; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0042118; P:endothelial cell activation; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0003198; P:epithelial to mesenchymal transition involved in endocardial cushion formation; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0048859; P:formation of anatomical boundary; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0010467; P:gene expression; TAS:Reactome
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0035556; P:intracellular signal transduction; IDA:GOC
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0007498; P:mesoderm development; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0072133; P:metanephric mesenchyme morphogenesis; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0060548; P:negative regulation of cell death; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0030308; P:negative regulation of cell growth; IDA:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0042177; P:negative regulation of protein catabolic process; IMP:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:Reactome
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0072134; P:nephrogenic mesenchyme morphogenesis; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0014033; P:neural crest cell differentiation; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0048663; P:neuron fate commitment; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0060021; P:palate development; ISS:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0030513; P:positive regulation of BMP signaling pathway; IMP:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0003251; P:positive regulation of cell proliferation involved in heart valve morphogenesis; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; ISS:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; ISS:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0060391; P:positive regulation of SMAD protein import into nucleus; ISS:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0051098; P:regulation of binding; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0051797; P:regulation of hair follicle development; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IMP:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0032909; P:regulation of transforming growth factor beta2 production; IMP:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0001666; P:response to hypoxia; IMP:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0071559; P:response to transforming growth factor beta; IDA:UniProtKB
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0048733; P:sebaceous gland development; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0007183; P:SMAD protein complex assembly; IDA:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0060395; P:SMAD protein signal transduction; IDA:BHF-UCL
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0032525; P:somite rostral/caudal axis specification; IEA:Ensembl
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
Q13485	SMAD4	Mothers against decapentaplegic homolog 4	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0070410; F:co-SMAD binding; IPI:BHF-UCL
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0070411; F:I-SMAD binding; IPI:BHF-UCL
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0042802; F:identical protein binding; IPI:BHF-UCL
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0005057; F:receptor signaling protein activity; NAS:UniProtKB
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0030618; F:transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity; TAS:BHF-UCL
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0030509; P:BMP signaling pathway; ISS:UniProtKB
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0060348; P:bone development; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0060038; P:cardiac muscle cell proliferation; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0051216; P:cartilage development; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0071773; P:cellular response to BMP stimulus; ISS:BHF-UCL
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0009880; P:embryonic pattern specification; ISS:UniProtKB
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0007276; P:gamete generation; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0030902; P:hindbrain development; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0042592; P:homeostatic process; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0006954; P:inflammatory response; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0001822; P:kidney development; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0000165; P:MAPK cascade; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0001710; P:mesodermal cell fate commitment; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0030901; P:midbrain development; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0010656; P:negative regulation of muscle cell apoptotic process; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0002051; P:osteoblast fate commitment; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0061036; P:positive regulation of cartilage development; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0050775; P:positive regulation of dendrite morphogenesis; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0010628; P:positive regulation of gene expression; IDA:BHF-UCL
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IC:BHF-UCL
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:1901522; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; ISS:BHF-UCL
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0031053; P:primary miRNA processing; TAS:BHF-UCL
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0006468; P:protein phosphorylation; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0042493; P:response to drug; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0010243; P:response to organonitrogen compound; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0007165; P:signal transduction; NAS:UniProtKB
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0007183; P:SMAD protein complex assembly; IDA:BHF-UCL
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; NAS:UniProtKB
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0001657; P:ureteric bud development; IEA:Ensembl
Q15797	SMAD1	Mothers against decapentaplegic homolog 1	GO:0042060; P:wound healing; IEA:Ensembl
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0005057; F:receptor signaling protein activity; NAS:UniProtKB
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0030618; F:transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity; TAS:BHF-UCL
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0031625; F:ubiquitin protein ligase binding; IPI:BHF-UCL
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0030509; P:BMP signaling pathway; ISS:UniProtKB
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0060348; P:bone development; IEA:Ensembl
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0060048; P:cardiac muscle contraction; IEA:Ensembl
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0051216; P:cartilage development; IEA:Ensembl
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0071773; P:cellular response to BMP stimulus; ISS:BHF-UCL
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0009880; P:embryonic pattern specification; ISS:UniProtKB
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0030218; P:erythrocyte differentiation; IEA:Ensembl
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0007281; P:germ cell development; IEA:Ensembl
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0035556; P:intracellular signal transduction; NAS:GOC
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0001880; P:Mullerian duct regression; IEA:Ensembl
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0002051; P:osteoblast fate commitment; IEA:Ensembl
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:1901522; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; ISS:BHF-UCL
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0006468; P:protein phosphorylation; IEA:Ensembl
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0007165; P:signal transduction; NAS:UniProtKB
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0007179; P:transforming growth factor beta receptor signaling pathway; NAS:UniProtKB
Q99717	SMAD5	Mothers against decapentaplegic homolog 5	GO:0001657; P:ureteric bud development; IEA:Ensembl
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0003682; F:chromatin binding; IDA:UniProtKB
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0070410; F:co-SMAD binding; IPI:BHF-UCL
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0070411; F:I-SMAD binding; IPI:BHF-UCL
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0005515; F:protein binding; IPI:IntAct
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0070412; F:R-SMAD binding; IPI:BHF-UCL
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0030617; F:transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity; IDA:BHF-UCL
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0070698; F:type I activin receptor binding; IDA:BHF-UCL
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0034713; F:type I transforming growth factor beta receptor binding; IDA:BHF-UCL
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0031625; F:ubiquitin protein ligase binding; IPI:BHF-UCL
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0030509; P:BMP signaling pathway; TAS:Reactome
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0031589; P:cell-substrate adhesion; IMP:UniProtKB
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0006955; P:immune response; IMP:BHF-UCL
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0035556; P:intracellular signal transduction; IDA:GOC
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0043066; P:negative regulation of apoptotic process; IMP:BHF-UCL
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0030514; P:negative regulation of BMP signaling pathway; IDA:BHF-UCL
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0008285; P:negative regulation of cell proliferation; IMP:BHF-UCL
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0060394; P:negative regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0010991; P:negative regulation of SMAD protein complex assembly; IDA:BHF-UCL
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IMP:BHF-UCL
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0043627; P:response to estrogen; IEA:Ensembl
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0034616; P:response to laminar fluid shear stress; IEP:BHF-UCL
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:InterPro
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0001657; P:ureteric bud development; IEA:Ensembl
O43541	SMAD6	Mothers against decapentaplegic homolog 6	GO:0007352; P:zygotic specification of dorsal/ventral axis; IMP:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0048185; F:activin binding; IPI:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0008013; F:beta-catenin binding; IPI:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0070411; F:I-SMAD binding; IPI:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0005515; F:protein binding; IPI:UniProtKB
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0030617; F:transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity; IDA:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0034713; F:type I transforming growth factor beta receptor binding; IPI:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0031625; F:ubiquitin protein ligase binding; IPI:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0034333; P:adherens junction assembly; IMP:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0048844; P:artery morphogenesis; ISS:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0030509; P:BMP signaling pathway; TAS:Reactome
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0034629; P:cellular protein complex localization; IDA:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IMP:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0010467; P:gene expression; TAS:Reactome
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0030514; P:negative regulation of BMP signaling pathway; IDA:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0030336; P:negative regulation of cell migration; TAS:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0010719; P:negative regulation of epithelial to mesenchymal transition; TAS:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0060394; P:negative regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; IDA:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0010801; P:negative regulation of peptidyl-threonine phosphorylation; IDA:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0031397; P:negative regulation of protein ubiquitination; IDA:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0010944; P:negative regulation of transcription by competitive promoter binding; IDA:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0051444; P:negative regulation of ubiquitin-protein ligase activity; IDA:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0060389; P:pathway-restricted SMAD protein phosphorylation; ISS:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0022409; P:positive regulation of cell-cell adhesion; IDA:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0031398; P:positive regulation of protein ubiquitination; IDA:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0050821; P:protein stabilization; IDA:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0032925; P:regulation of activin receptor signaling pathway; IDA:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0055117; P:regulation of cardiac muscle contraction; ISS:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IC:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0060373; P:regulation of ventricular cardiac muscle cell membrane depolarization; IC:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0034616; P:response to laminar fluid shear stress; IEP:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0001657; P:ureteric bud development; IEA:Ensembl
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; ISS:BHF-UCL
O15105	SMAD7	Mothers against decapentaplegic homolog 7	GO:0060412; P:ventricular septum morphogenesis; ISS:BHF-UCL
O15198	SMAD9	Mothers against decapentaplegic homolog 9	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O15198	SMAD9	Mothers against decapentaplegic homolog 9	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15198	SMAD9	Mothers against decapentaplegic homolog 9	GO:0005515; F:protein binding; IPI:IntAct
O15198	SMAD9	Mothers against decapentaplegic homolog 9	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O15198	SMAD9	Mothers against decapentaplegic homolog 9	GO:0030618; F:transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity; TAS:BHF-UCL
O15198	SMAD9	Mothers against decapentaplegic homolog 9	GO:0030509; P:BMP signaling pathway; TAS:BHF-UCL
O15198	SMAD9	Mothers against decapentaplegic homolog 9	GO:0060348; P:bone development; IEA:Ensembl
O15198	SMAD9	Mothers against decapentaplegic homolog 9	GO:0051216; P:cartilage development; IEA:Ensembl
O15198	SMAD9	Mothers against decapentaplegic homolog 9	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
O15198	SMAD9	Mothers against decapentaplegic homolog 9	GO:0030902; P:hindbrain development; IEA:Ensembl
O15198	SMAD9	Mothers against decapentaplegic homolog 9	GO:0035556; P:intracellular signal transduction; TAS:GOC
O15198	SMAD9	Mothers against decapentaplegic homolog 9	GO:0030901; P:midbrain development; IEA:Ensembl
O15198	SMAD9	Mothers against decapentaplegic homolog 9	GO:0001880; P:Mullerian duct regression; IEA:Ensembl
O15198	SMAD9	Mothers against decapentaplegic homolog 9	GO:0045597; P:positive regulation of cell differentiation; IEA:Ensembl
O15198	SMAD9	Mothers against decapentaplegic homolog 9	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
O15198	SMAD9	Mothers against decapentaplegic homolog 9	GO:0006468; P:protein phosphorylation; IEA:Ensembl
O15198	SMAD9	Mothers against decapentaplegic homolog 9	GO:0001666; P:response to hypoxia; IEA:Ensembl
O15198	SMAD9	Mothers against decapentaplegic homolog 9	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15198	SMAD9	Mothers against decapentaplegic homolog 9	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:InterPro
O15198	SMAD9	Mothers against decapentaplegic homolog 9	GO:0001657; P:ureteric bud development; IEA:Ensembl
Q9UPU9	SAMD4A	Protein Smaug homolog 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UPU9	SAMD4A	Protein Smaug homolog 1	GO:0030371; F:translation repressor activity; IDA:MGI
Q9UPU9	SAMD4A	Protein Smaug homolog 1	GO:0017148; P:negative regulation of translation; IDA:GOC
Q9UPU9	SAMD4A	Protein Smaug homolog 1	GO:0045727; P:positive regulation of translation; IDA:MGI
Q5PRF9	SAMD4B	Protein Smaug homolog 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q5PRF9	SAMD4B	Protein Smaug homolog 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5PRF9	SAMD4B	Protein Smaug homolog 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IYB5	SMAP1	Stromal membrane-associated protein 1	GO:0008060; F:ARF GTPase activator activity; IEA:Ensembl
Q8IYB5	SMAP1	Stromal membrane-associated protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IYB5	SMAP1	Stromal membrane-associated protein 1	GO:0045648; P:positive regulation of erythrocyte differentiation; IEA:Ensembl
Q8IYB5	SMAP1	Stromal membrane-associated protein 1	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
Q8IYB5	SMAP1	Stromal membrane-associated protein 1	GO:2000369; P:regulation of clathrin-mediated endocytosis; IEA:Ensembl
Q9NZC9	SMARCAL1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1	GO:0036310; F:annealing helicase activity; IDA:UniProtKB
Q9NZC9	SMARCAL1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NZC9	SMARCAL1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1	GO:0003677; F:DNA binding; IEA:InterPro
Q9NZC9	SMARCAL1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1	GO:0008094; F:DNA-dependent ATPase activity; IMP:UniProtKB
Q9NZC9	SMARCAL1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q9NZC9	SMARCAL1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1	GO:0006200; P:ATP catabolic process; IMP:GOC
Q9NZC9	SMARCAL1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1	GO:0016568; P:chromatin modification; IEA:InterPro
Q9NZC9	SMARCAL1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1	GO:0006259; P:DNA metabolic process; IMP:UniProtKB
Q9NZC9	SMARCAL1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1	GO:0000733; P:DNA strand renaturation; IDA:GOC
Q9NZC9	SMARCAL1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q8WU79	SMAP2	Stromal membrane-associated protein 2	GO:0008060; F:ARF GTPase activator activity; IEA:InterPro
Q8WU79	SMAP2	Stromal membrane-associated protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WU79	SMAP2	Stromal membrane-associated protein 2	GO:0032312; P:regulation of ARF GTPase activity; IEA:InterPro
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0005524; F:ATP binding; IDA:UniProtKB
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0043141; F:ATP-dependent 5'-3' DNA helicase activity; IDA:UniProtKB
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0032575; F:ATP-dependent 5'-3' RNA helicase activity; IDA:UniProtKB
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0003677; F:DNA binding; IDA:UniProtKB
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0003678; F:DNA helicase activity; TAS:ProtInc
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0008094; F:DNA-dependent ATPase activity; IDA:UniProtKB
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0005515; F:protein binding; IPI:UniProtKB
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0043022; F:ribosome binding; IDA:UniProtKB
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0003723; F:RNA binding; IDA:UniProtKB
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0008186; F:RNA-dependent ATPase activity; IDA:UniProtKB
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0003697; F:single-stranded DNA binding; TAS:ProtInc
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0000049; F:tRNA binding; IDA:UniProtKB
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0008270; F:zinc ion binding; IEA:InterPro
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0006200; P:ATP catabolic process; IDA:GOC
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0008219; P:cell death; IEA:UniProtKB-KW
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0032508; P:DNA duplex unwinding; IDA:GOC
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0006310; P:DNA recombination; TAS:ProtInc
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0006281; P:DNA repair; TAS:ProtInc
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0006260; P:DNA replication; TAS:ProtInc
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0051260; P:protein homooligomerization; IPI:MGI
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P38935	IGHMBP2	DNA-binding protein SMUBP-2	GO:0006412; P:translation; NAS:UniProtKB
Q9UHJ3	SFMBT1	Scm-like with four MBT domains protein 1	GO:0042393; F:histone binding; IDA:UniProtKB
Q9UHJ3	SFMBT1	Scm-like with four MBT domains protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UHJ3	SFMBT1	Scm-like with four MBT domains protein 1	GO:0003714; F:transcription corepressor activity; TAS:UniProtKB
Q9UHJ3	SFMBT1	Scm-like with four MBT domains protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9UHJ3	SFMBT1	Scm-like with four MBT domains protein 1	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q9UHJ3	SFMBT1	Scm-like with four MBT domains protein 1	GO:0048635; P:negative regulation of muscle organ development; IMP:UniProtKB
Q9UHJ3	SFMBT1	Scm-like with four MBT domains protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UHJ3	SFMBT1	Scm-like with four MBT domains protein 1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q9UHJ3	SFMBT1	Scm-like with four MBT domains protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5VUG0	SFMBT2	Scm-like with four MBT domains protein 2	GO:0042393; F:histone binding; IDA:UniProtKB
Q5VUG0	SFMBT2	Scm-like with four MBT domains protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q5VUG0	SFMBT2	Scm-like with four MBT domains protein 2	GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB
Q5VUG0	SFMBT2	Scm-like with four MBT domains protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q8NDV3	SMC1B	Structural maintenance of chromosomes protein 1B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NDV3	SMC1B	Structural maintenance of chromosomes protein 1B	GO:0003677; F:DNA binding; IEA:Ensembl
Q8NDV3	SMC1B	Structural maintenance of chromosomes protein 1B	GO:0006310; P:DNA recombination; IEA:InterPro
Q8NDV3	SMC1B	Structural maintenance of chromosomes protein 1B	GO:0006281; P:DNA repair; IEA:InterPro
Q8NDV3	SMC1B	Structural maintenance of chromosomes protein 1B	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q8NDV3	SMC1B	Structural maintenance of chromosomes protein 1B	GO:0007062; P:sister chromatid cohesion; IEA:Ensembl
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0003777; F:microtubule motor activity; NAS:UniProtKB
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0005515; F:protein binding; IPI:UniProtKB
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0006310; P:DNA recombination; IEA:InterPro
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0006281; P:DNA repair; TAS:UniProtKB
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0010467; P:gene expression; TAS:Reactome
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0007126; P:meiotic nuclear division; ISS:UniProtKB
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0007093; P:mitotic cell cycle checkpoint; IDA:UniProtKB
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0007064; P:mitotic sister chromatid cohesion; TAS:UniProtKB
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0000070; P:mitotic sister chromatid segregation; TAS:UniProtKB
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0007052; P:mitotic spindle organization; TAS:UniProtKB
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0032876; P:negative regulation of DNA endoreduplication; IMP:BHF-UCL
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0009314; P:response to radiation; IEP:UniProtKB
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0008380; P:RNA splicing; TAS:Reactome
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0042770; P:signal transduction in response to DNA damage; IDA:UniProtKB
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0007062; P:sister chromatid cohesion; IMP:BHF-UCL
Q14683	SMC1A	Structural maintenance of chromosomes protein 1A	GO:0019827; P:stem cell maintenance; IEA:Ensembl
O95347	SMC2	Structural maintenance of chromosomes protein 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O95347	SMC2	Structural maintenance of chromosomes protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
O95347	SMC2	Structural maintenance of chromosomes protein 2	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
O95347	SMC2	Structural maintenance of chromosomes protein 2	GO:0006310; P:DNA recombination; IEA:InterPro
O95347	SMC2	Structural maintenance of chromosomes protein 2	GO:0006281; P:DNA repair; IEA:InterPro
O95347	SMC2	Structural maintenance of chromosomes protein 2	GO:0051383; P:kinetochore organization; IEA:Ensembl
O95347	SMC2	Structural maintenance of chromosomes protein 2	GO:0010032; P:meiotic chromosome condensation; IEA:Ensembl
O95347	SMC2	Structural maintenance of chromosomes protein 2	GO:0045132; P:meiotic chromosome segregation; IEA:Ensembl
O95347	SMC2	Structural maintenance of chromosomes protein 2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O95347	SMC2	Structural maintenance of chromosomes protein 2	GO:0007076; P:mitotic chromosome condensation; IDA:UniProtKB
Q9UQE7	SMC3	Structural maintenance of chromosomes protein 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UQE7	SMC3	Structural maintenance of chromosomes protein 3	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9UQE7	SMC3	Structural maintenance of chromosomes protein 3	GO:0045502; F:dynein binding; IDA:UniProtKB
Q9UQE7	SMC3	Structural maintenance of chromosomes protein 3	GO:0003777; F:microtubule motor activity; NAS:UniProtKB
Q9UQE7	SMC3	Structural maintenance of chromosomes protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UQE7	SMC3	Structural maintenance of chromosomes protein 3	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q9UQE7	SMC3	Structural maintenance of chromosomes protein 3	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q9UQE7	SMC3	Structural maintenance of chromosomes protein 3	GO:0007126; P:meiotic nuclear division; IDA:UniProtKB
Q9UQE7	SMC3	Structural maintenance of chromosomes protein 3	GO:0007067; P:mitosis; TAS:ProtInc
Q9UQE7	SMC3	Structural maintenance of chromosomes protein 3	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9UQE7	SMC3	Structural maintenance of chromosomes protein 3	GO:0007052; P:mitotic spindle organization; IEP:UniProtKB
Q9UQE7	SMC3	Structural maintenance of chromosomes protein 3	GO:0032876; P:negative regulation of DNA endoreduplication; IMP:BHF-UCL
Q9UQE7	SMC3	Structural maintenance of chromosomes protein 3	GO:0006275; P:regulation of DNA replication; IMP:UniProtKB
Q9UQE7	SMC3	Structural maintenance of chromosomes protein 3	GO:0007165; P:signal transduction; IDA:UniProtKB
Q9UQE7	SMC3	Structural maintenance of chromosomes protein 3	GO:0007062; P:sister chromatid cohesion; NAS:UniProtKB
Q9UQE7	SMC3	Structural maintenance of chromosomes protein 3	GO:0019827; P:stem cell maintenance; IEA:Ensembl
Q9NTJ3	SMC4	Structural maintenance of chromosomes protein 4	GO:0005524; F:ATP binding; TAS:UniProtKB
Q9NTJ3	SMC4	Structural maintenance of chromosomes protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q9NTJ3	SMC4	Structural maintenance of chromosomes protein 4	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q9NTJ3	SMC4	Structural maintenance of chromosomes protein 4	GO:0006310; P:DNA recombination; IEA:InterPro
Q9NTJ3	SMC4	Structural maintenance of chromosomes protein 4	GO:0006281; P:DNA repair; IEA:InterPro
Q9NTJ3	SMC4	Structural maintenance of chromosomes protein 4	GO:0051383; P:kinetochore organization; IEA:Ensembl
Q9NTJ3	SMC4	Structural maintenance of chromosomes protein 4	GO:0010032; P:meiotic chromosome condensation; IEA:Ensembl
Q9NTJ3	SMC4	Structural maintenance of chromosomes protein 4	GO:0045132; P:meiotic chromosome segregation; IEA:Ensembl
Q9NTJ3	SMC4	Structural maintenance of chromosomes protein 4	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9NTJ3	SMC4	Structural maintenance of chromosomes protein 4	GO:0007076; P:mitotic chromosome condensation; IDA:UniProtKB
Q9NTJ3	SMC4	Structural maintenance of chromosomes protein 4	GO:0000070; P:mitotic sister chromatid segregation; TAS:UniProtKB
Q8IY18	SMC5	Structural maintenance of chromosomes protein 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IY18	SMC5	Structural maintenance of chromosomes protein 5	GO:0005515; F:protein binding; IPI:IntAct
Q8IY18	SMC5	Structural maintenance of chromosomes protein 5	GO:0090398; P:cellular senescence; IMP:UniProtKB
Q8IY18	SMC5	Structural maintenance of chromosomes protein 5	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
Q8IY18	SMC5	Structural maintenance of chromosomes protein 5	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q8IY18	SMC5	Structural maintenance of chromosomes protein 5	GO:0034184; P:positive regulation of maintenance of mitotic sister chromatid cohesion; IMP:UniProtKB
Q8IY18	SMC5	Structural maintenance of chromosomes protein 5	GO:0045842; P:positive regulation of mitotic metaphase/anaphase transition; IMP:UniProtKB
Q8IY18	SMC5	Structural maintenance of chromosomes protein 5	GO:0000722; P:telomere maintenance via recombination; IMP:UniProtKB
Q96SB8	SMC6	Structural maintenance of chromosomes protein 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96SB8	SMC6	Structural maintenance of chromosomes protein 6	GO:0005515; F:protein binding; IPI:IntAct
Q96SB8	SMC6	Structural maintenance of chromosomes protein 6	GO:0090398; P:cellular senescence; IMP:UniProtKB
Q96SB8	SMC6	Structural maintenance of chromosomes protein 6	GO:0000724; P:double-strand break repair via homologous recombination; IEA:InterPro
Q96SB8	SMC6	Structural maintenance of chromosomes protein 6	GO:0000722; P:telomere maintenance via recombination; IMP:UniProtKB
P28370	SMARCA1	Probable global transcription activator SNF2L1	GO:0036310; F:annealing helicase activity; IDA:UniProtKB
P28370	SMARCA1	Probable global transcription activator SNF2L1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P28370	SMARCA1	Probable global transcription activator SNF2L1	GO:0003682; F:chromatin binding; IEA:InterPro
P28370	SMARCA1	Probable global transcription activator SNF2L1	GO:0003677; F:DNA binding; IEA:InterPro
P28370	SMARCA1	Probable global transcription activator SNF2L1	GO:0004386; F:helicase activity; TAS:ProtInc
P28370	SMARCA1	Probable global transcription activator SNF2L1	GO:0005515; F:protein binding; IPI:HGNC
P28370	SMARCA1	Probable global transcription activator SNF2L1	GO:0006200; P:ATP catabolic process; IDA:GOC
P28370	SMARCA1	Probable global transcription activator SNF2L1	GO:0043044; P:ATP-dependent chromatin remodeling; IDA:MGI
P28370	SMARCA1	Probable global transcription activator SNF2L1	GO:0007420; P:brain development; IMP:HGNC
P28370	SMARCA1	Probable global transcription activator SNF2L1	GO:0006338; P:chromatin remodeling; IDA:HGNC
P28370	SMARCA1	Probable global transcription activator SNF2L1	GO:0000733; P:DNA strand renaturation; IDA:GOC
P28370	SMARCA1	Probable global transcription activator SNF2L1	GO:0030182; P:neuron differentiation; ISS:HGNC
P28370	SMARCA1	Probable global transcription activator SNF2L1	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:HGNC
P28370	SMARCA1	Probable global transcription activator SNF2L1	GO:2000177; P:regulation of neural precursor cell proliferation; IEA:Ensembl
P28370	SMARCA1	Probable global transcription activator SNF2L1	GO:0006351; P:transcription, DNA-templated; IMP:HGNC
P51531	SMARCA2	Probable global transcription activator SNF2L2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P51531	SMARCA2	Probable global transcription activator SNF2L2	GO:0008094; F:DNA-dependent ATPase activity; TAS:BHF-UCL
P51531	SMARCA2	Probable global transcription activator SNF2L2	GO:0004386; F:helicase activity; TAS:ProtInc
P51531	SMARCA2	Probable global transcription activator SNF2L2	GO:0005515; F:protein binding; IPI:UniProtKB
P51531	SMARCA2	Probable global transcription activator SNF2L2	GO:0001105; F:RNA polymerase II transcription coactivator activity; IDA:UniProtKB
P51531	SMARCA2	Probable global transcription activator SNF2L2	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P51531	SMARCA2	Probable global transcription activator SNF2L2	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P51531	SMARCA2	Probable global transcription activator SNF2L2	GO:0035887; P:aortic smooth muscle cell differentiation; IEA:Ensembl
P51531	SMARCA2	Probable global transcription activator SNF2L2	GO:0006200; P:ATP catabolic process; TAS:GOC
P51531	SMARCA2	Probable global transcription activator SNF2L2	GO:0006338; P:chromatin remodeling; TAS:BHF-UCL
P51531	SMARCA2	Probable global transcription activator SNF2L2	GO:0030308; P:negative regulation of cell growth; IMP:BHF-UCL
P51531	SMARCA2	Probable global transcription activator SNF2L2	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P51531	SMARCA2	Probable global transcription activator SNF2L2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:BHF-UCL
P51531	SMARCA2	Probable global transcription activator SNF2L2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
P51531	SMARCA2	Probable global transcription activator SNF2L2	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
P51531	SMARCA2	Probable global transcription activator SNF2L2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P51531	SMARCA2	Probable global transcription activator SNF2L2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P51531	SMARCA2	Probable global transcription activator SNF2L2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P51531	SMARCA2	Probable global transcription activator SNF2L2	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
O60264	SMARCA5	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5	GO:0005524; F:ATP binding; IDA:UniProtKB
O60264	SMARCA5	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5	GO:0016887; F:ATPase activity; IDA:UniProtKB
O60264	SMARCA5	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5	GO:0003682; F:chromatin binding; IEA:InterPro
O60264	SMARCA5	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5	GO:0003677; F:DNA binding; IDA:UniProtKB
O60264	SMARCA5	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5	GO:0004386; F:helicase activity; TAS:ProtInc
O60264	SMARCA5	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5	GO:0005515; F:protein binding; IPI:UniProtKB
O60264	SMARCA5	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5	GO:0006200; P:ATP catabolic process; IDA:GOC
O60264	SMARCA5	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5	GO:0043044; P:ATP-dependent chromatin remodeling; IMP:BHF-UCL
O60264	SMARCA5	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5	GO:0034080; P:CENP-A containing nucleosome assembly at centromere; TAS:Reactome
O60264	SMARCA5	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5	GO:0006338; P:chromatin remodeling; IDA:UniProtKB
O60264	SMARCA5	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5	GO:0000183; P:chromatin silencing at rDNA; IEA:Ensembl
O60264	SMARCA5	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5	GO:0006352; P:DNA-templated transcription, initiation; IDA:UniProtKB
O60264	SMARCA5	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5	GO:0006302; P:double-strand break repair; IEA:Ensembl
O60264	SMARCA5	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5	GO:0009790; P:embryo development; IEA:Ensembl
O60264	SMARCA5	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5	GO:0006334; P:nucleosome assembly; IDA:UniProtKB
O60264	SMARCA5	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5	GO:0016584; P:nucleosome positioning; IDA:UniProtKB
O60264	SMARCA5	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q969G3	SMARCE1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1	GO:0003682; F:chromatin binding; TAS:ProtInc
Q969G3	SMARCE1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q969G3	SMARCE1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1	GO:0016922; F:ligand-dependent nuclear receptor binding; IPI:BHF-UCL
Q969G3	SMARCE1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1	GO:0008080; F:N-acetyltransferase activity; IDA:UniProtKB
Q969G3	SMARCE1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1	GO:0005515; F:protein binding; IPI:IntAct
Q969G3	SMARCE1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q969G3	SMARCE1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1	GO:0003723; F:RNA binding; IEA:Ensembl
Q969G3	SMARCE1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1	GO:0003713; F:transcription coactivator activity; NAS:BHF-UCL
Q969G3	SMARCE1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1	GO:0043044; P:ATP-dependent chromatin remodeling; IDA:UniProt
Q969G3	SMARCE1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1	GO:0006338; P:chromatin remodeling; IDA:BHF-UCL
Q969G3	SMARCE1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1	GO:0008152; P:metabolic process; IDA:GOC
Q969G3	SMARCE1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q969G3	SMARCE1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q969G3	SMARCE1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1	GO:0006337; P:nucleosome disassembly; IDA:BHF-UCL
Q969G3	SMARCE1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; NAS:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0050681; F:androgen receptor binding; IPI:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P51532	SMARCA4	Transcription activator BRG1	GO:0003682; F:chromatin binding; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0008094; F:DNA-dependent ATPase activity; IGI:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0004386; F:helicase activity; TAS:ProtInc
P51532	SMARCA4	Transcription activator BRG1	GO:0070577; F:lysine-acetylated histone binding; IDA:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0002039; F:p53 binding; IPI:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0005515; F:protein binding; IPI:UniProtKB
P51532	SMARCA4	Transcription activator BRG1	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
P51532	SMARCA4	Transcription activator BRG1	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0001105; F:RNA polymerase II transcription coactivator activity; IDA:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0030957; F:Tat protein binding; IPI:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0003713; F:transcription coactivator activity; IMP:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
P51532	SMARCA4	Transcription activator BRG1	GO:0035887; P:aortic smooth muscle cell differentiation; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0006200; P:ATP catabolic process; IGI:GOC
P51532	SMARCA4	Transcription activator BRG1	GO:0043044; P:ATP-dependent chromatin remodeling; IDA:UniProt
P51532	SMARCA4	Transcription activator BRG1	GO:0001832; P:blastocyst growth; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0001835; P:blastocyst hatching; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0000902; P:cell morphogenesis; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0006338; P:chromatin remodeling; IDA:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0060318; P:definitive erythrocyte differentiation; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0010424; P:DNA methylation on cytosine within a CG sequence; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0048562; P:embryonic organ morphogenesis; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0048730; P:epidermis morphogenesis; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0030900; P:forebrain development; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0007403; P:glial cell fate determination; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0060347; P:heart trabecula formation; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0030902; P:hindbrain development; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0043966; P:histone H3 acetylation; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0001889; P:liver development; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0006346; P:methylation-dependent chromatin silencing; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0060766; P:negative regulation of androgen receptor signaling pathway; IMP:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0030308; P:negative regulation of cell growth; IMP:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; TAS:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0007070; P:negative regulation of transcription from RNA polymerase II promoter during mitosis; TAS:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0003407; P:neural retina development; IEP:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0006337; P:nucleosome disassembly; IDA:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0043923; P:positive regulation by host of viral transcription; IMP:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0043388; P:positive regulation of DNA binding; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; NAS:BHF-UCL
P51532	SMARCA4	Transcription activator BRG1	GO:0019827; P:stem cell maintenance; IEA:Ensembl
P51532	SMARCA4	Transcription activator BRG1	GO:0001570; P:vasculogenesis; IEA:Ensembl
P62314	SNRPD1	Small nuclear ribonucleoprotein Sm D1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62314	SNRPD1	Small nuclear ribonucleoprotein Sm D1	GO:0005515; F:protein binding; IPI:UniProtKB
P62314	SNRPD1	Small nuclear ribonucleoprotein Sm D1	GO:0003723; F:RNA binding; TAS:ProtInc
P62314	SNRPD1	Small nuclear ribonucleoprotein Sm D1	GO:0010467; P:gene expression; TAS:Reactome
P62314	SNRPD1	Small nuclear ribonucleoprotein Sm D1	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P62314	SNRPD1	Small nuclear ribonucleoprotein Sm D1	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
P62314	SNRPD1	Small nuclear ribonucleoprotein Sm D1	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62314	SNRPD1	Small nuclear ribonucleoprotein Sm D1	GO:0008380; P:RNA splicing; TAS:Reactome
P62314	SNRPD1	Small nuclear ribonucleoprotein Sm D1	GO:0000245; P:spliceosomal complex assembly; TAS:ProtInc
P62314	SNRPD1	Small nuclear ribonucleoprotein Sm D1	GO:0000387; P:spliceosomal snRNP assembly; IDA:UniProtKB
P62316	SNRPD2	Small nuclear ribonucleoprotein Sm D2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62316	SNRPD2	Small nuclear ribonucleoprotein Sm D2	GO:0005515; F:protein binding; IPI:UniProtKB
P62316	SNRPD2	Small nuclear ribonucleoprotein Sm D2	GO:0010467; P:gene expression; TAS:Reactome
P62316	SNRPD2	Small nuclear ribonucleoprotein Sm D2	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P62316	SNRPD2	Small nuclear ribonucleoprotein Sm D2	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
P62316	SNRPD2	Small nuclear ribonucleoprotein Sm D2	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62316	SNRPD2	Small nuclear ribonucleoprotein Sm D2	GO:0008380; P:RNA splicing; TAS:Reactome
P62316	SNRPD2	Small nuclear ribonucleoprotein Sm D2	GO:0000245; P:spliceosomal complex assembly; TAS:ProtInc
P62316	SNRPD2	Small nuclear ribonucleoprotein Sm D2	GO:0000387; P:spliceosomal snRNP assembly; IDA:UniProtKB
P62318	SNRPD3	Small nuclear ribonucleoprotein Sm D3	GO:0019899; F:enzyme binding; IPI:UniProtKB
P62318	SNRPD3	Small nuclear ribonucleoprotein Sm D3	GO:0071208; F:histone pre-mRNA DCP binding; ISS:UniProtKB
P62318	SNRPD3	Small nuclear ribonucleoprotein Sm D3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62318	SNRPD3	Small nuclear ribonucleoprotein Sm D3	GO:0005515; F:protein binding; IPI:UniProtKB
P62318	SNRPD3	Small nuclear ribonucleoprotein Sm D3	GO:0010467; P:gene expression; TAS:Reactome
P62318	SNRPD3	Small nuclear ribonucleoprotein Sm D3	GO:0008334; P:histone mRNA metabolic process; TAS:Reactome
P62318	SNRPD3	Small nuclear ribonucleoprotein Sm D3	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
P62318	SNRPD3	Small nuclear ribonucleoprotein Sm D3	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
P62318	SNRPD3	Small nuclear ribonucleoprotein Sm D3	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
P62318	SNRPD3	Small nuclear ribonucleoprotein Sm D3	GO:0016070; P:RNA metabolic process; TAS:Reactome
P62318	SNRPD3	Small nuclear ribonucleoprotein Sm D3	GO:0008380; P:RNA splicing; TAS:Reactome
P62318	SNRPD3	Small nuclear ribonucleoprotein Sm D3	GO:0000387; P:spliceosomal snRNP assembly; IDA:UniProtKB
P62318	SNRPD3	Small nuclear ribonucleoprotein Sm D3	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
P62318	SNRPD3	Small nuclear ribonucleoprotein Sm D3	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q96Q15	SMG1	Serine/threonine-protein kinase SMG1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96Q15	SMG1	Serine/threonine-protein kinase SMG1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96Q15	SMG1	Serine/threonine-protein kinase SMG1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96Q15	SMG1	Serine/threonine-protein kinase SMG1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96Q15	SMG1	Serine/threonine-protein kinase SMG1	GO:0004672; F:protein kinase activity; TAS:UniProtKB
Q96Q15	SMG1	Serine/threonine-protein kinase SMG1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q96Q15	SMG1	Serine/threonine-protein kinase SMG1	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q96Q15	SMG1	Serine/threonine-protein kinase SMG1	GO:0010467; P:gene expression; TAS:Reactome
Q96Q15	SMG1	Serine/threonine-protein kinase SMG1	GO:0006406; P:mRNA export from nucleus; TAS:UniProtKB
Q96Q15	SMG1	Serine/threonine-protein kinase SMG1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q96Q15	SMG1	Serine/threonine-protein kinase SMG1	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IDA:UniProtKB
Q96Q15	SMG1	Serine/threonine-protein kinase SMG1	GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB
Q96Q15	SMG1	Serine/threonine-protein kinase SMG1	GO:0046854; P:phosphatidylinositol phosphorylation; IDA:UniProtKB
Q96Q15	SMG1	Serine/threonine-protein kinase SMG1	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q96Q15	SMG1	Serine/threonine-protein kinase SMG1	GO:0006950; P:response to stress; IDA:UniProtKB
Q96Q15	SMG1	Serine/threonine-protein kinase SMG1	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9UPR3	SMG5	Protein SMG5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UPR3	SMG5	Protein SMG5	GO:0051721; F:protein phosphatase 2A binding; IDA:HGNC
Q9UPR3	SMG5	Protein SMG5	GO:0010467; P:gene expression; TAS:Reactome
Q9UPR3	SMG5	Protein SMG5	GO:0006406; P:mRNA export from nucleus; TAS:HGNC
Q9UPR3	SMG5	Protein SMG5	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9UPR3	SMG5	Protein SMG5	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:HGNC
Q9UPR3	SMG5	Protein SMG5	GO:0035303; P:regulation of dephosphorylation; IMP:HGNC
Q9UPR3	SMG5	Protein SMG5	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q92540	SMG7	Protein SMG7	GO:0005515; F:protein binding; IPI:UniProtKB
Q92540	SMG7	Protein SMG7	GO:0051721; F:protein phosphatase 2A binding; IDA:HGNC
Q92540	SMG7	Protein SMG7	GO:0010467; P:gene expression; TAS:Reactome
Q92540	SMG7	Protein SMG7	GO:0006406; P:mRNA export from nucleus; TAS:HGNC
Q92540	SMG7	Protein SMG7	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q92540	SMG7	Protein SMG7	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:HGNC
Q92540	SMG7	Protein SMG7	GO:0035303; P:regulation of dephosphorylation; TAS:HGNC
Q92540	SMG7	Protein SMG7	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q8ND04	SMG8	Protein SMG8	GO:0005515; F:protein binding; IPI:UniProtKB
Q8ND04	SMG8	Protein SMG8	GO:0010467; P:gene expression; TAS:Reactome
Q8ND04	SMG8	Protein SMG8	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q8ND04	SMG8	Protein SMG8	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IMP:UniProtKB
Q8ND04	SMG8	Protein SMG8	GO:0045859; P:regulation of protein kinase activity; IMP:UniProtKB
Q8ND04	SMG8	Protein SMG8	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9H0W8	SMG9	Protein SMG9	GO:0042802; F:identical protein binding; IPI:IntAct
Q9H0W8	SMG9	Protein SMG9	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H0W8	SMG9	Protein SMG9	GO:0010467; P:gene expression; TAS:Reactome
Q9H0W8	SMG9	Protein SMG9	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9H0W8	SMG9	Protein SMG9	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IMP:UniProtKB
Q9H0W8	SMG9	Protein SMG9	GO:0016070; P:RNA metabolic process; TAS:Reactome
A6NHR9	SMCHD1	Structural maintenance of chromosomes flexible hinge domain-containing protein 1	GO:0005524; F:ATP binding; IEA:InterPro
A6NHR9	SMCHD1	Structural maintenance of chromosomes flexible hinge domain-containing protein 1	GO:0051276; P:chromosome organization; IEA:InterPro
A6NHR9	SMCHD1	Structural maintenance of chromosomes flexible hinge domain-containing protein 1	GO:0060821; P:inactivation of X chromosome by DNA methylation; IEA:Ensembl
Q16637	SMN1	Survival motor neuron protein	GO:0042802; F:identical protein binding; IPI:IntAct
Q16637	SMN1	Survival motor neuron protein	GO:0005515; F:protein binding; IPI:IntAct
Q16637	SMN1	Survival motor neuron protein	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q16637	SMN1	Survival motor neuron protein	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q16637	SMN1	Survival motor neuron protein	GO:0010467; P:gene expression; TAS:Reactome
Q16637	SMN1	Survival motor neuron protein	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
Q16637	SMN1	Survival motor neuron protein	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q16637	SMN1	Survival motor neuron protein	GO:0042307; P:positive regulation of protein import into nucleus; IDA:UniProtKB
Q16637	SMN1	Survival motor neuron protein	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q16637	SMN1	Survival motor neuron protein	GO:0000245; P:spliceosomal complex assembly; IMP:UniProtKB
Q16637	SMN1	Survival motor neuron protein	GO:0000387; P:spliceosomal snRNP assembly; IDA:UniProtKB
Q9H4F8	SMOC1	SPARC-related modular calcium-binding protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9H4F8	SMOC1	SPARC-related modular calcium-binding protein 1	GO:0050840; F:extracellular matrix binding; IEA:Ensembl
Q9H4F8	SMOC1	SPARC-related modular calcium-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9H4F8	SMOC1	SPARC-related modular calcium-binding protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9H4F8	SMOC1	SPARC-related modular calcium-binding protein 1	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q9H4F8	SMOC1	SPARC-related modular calcium-binding protein 1	GO:0001654; P:eye development; IMP:UniProtKB
Q9H4F8	SMOC1	SPARC-related modular calcium-binding protein 1	GO:0060173; P:limb development; IMP:UniProtKB
Q9H4F8	SMOC1	SPARC-related modular calcium-binding protein 1	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
Q9H4F8	SMOC1	SPARC-related modular calcium-binding protein 1	GO:0045667; P:regulation of osteoblast differentiation; IMP:UniProtKB
Q9H4F8	SMOC1	SPARC-related modular calcium-binding protein 1	GO:0007165; P:signal transduction; IEA:InterPro
Q9H3U7	SMOC2	SPARC-related modular calcium-binding protein 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9H3U7	SMOC2	SPARC-related modular calcium-binding protein 2	GO:0008201; F:heparin binding; IEA:Ensembl
Q9H3U7	SMOC2	SPARC-related modular calcium-binding protein 2	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q9H3U7	SMOC2	SPARC-related modular calcium-binding protein 2	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
Q9H3U7	SMOC2	SPARC-related modular calcium-binding protein 2	GO:0007165; P:signal transduction; IEA:InterPro
Q9NWM0	SMOX	Spermine oxidase	GO:0052895; F:N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity; IEA:UniProtKB-EC
Q9NWM0	SMOX	Spermine oxidase	GO:0052894; F:norspermine:oxygen oxidoreductase activity; IEA:UniProtKB-EC
Q9NWM0	SMOX	Spermine oxidase	GO:0046592; F:polyamine oxidase activity; IDA:UniProtKB
Q9NWM0	SMOX	Spermine oxidase	GO:0052901; F:spermine:oxygen oxidoreductase (spermidine-forming) activity; IEA:UniProtKB-EC
Q9NWM0	SMOX	Spermine oxidase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9NWM0	SMOX	Spermine oxidase	GO:0055114; P:oxidation-reduction process; IDA:GOC
Q9NWM0	SMOX	Spermine oxidase	GO:0006596; P:polyamine biosynthetic process; TAS:Reactome
Q9NWM0	SMOX	Spermine oxidase	GO:0006598; P:polyamine catabolic process; IDA:UniProtKB
Q9NWM0	SMOX	Spermine oxidase	GO:0006595; P:polyamine metabolic process; TAS:Reactome
Q9NWM0	SMOX	Spermine oxidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NWM0	SMOX	Spermine oxidase	GO:0046208; P:spermine catabolic process; IDA:UniProtKB
Q9NWM0	SMOX	Spermine oxidase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q99835	SMO	Smoothened homolog	GO:0008144; F:drug binding; IDA:UniProtKB
Q99835	SMO	Smoothened homolog	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q99835	SMO	Smoothened homolog	GO:0005113; F:patched binding; IPI:BHF-UCL
Q99835	SMO	Smoothened homolog	GO:0030165; F:PDZ domain binding; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q99835	SMO	Smoothened homolog	GO:0042813; F:Wnt-activated receptor activity; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0017147; F:Wnt-protein binding; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0021984; P:adenohypophysis development; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0060413; P:atrial septum morphogenesis; IEA:Ensembl
Q99835	SMO	Smoothened homolog	GO:0048846; P:axon extension involved in axon guidance; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0060070; P:canonical Wnt signaling pathway; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0010002; P:cardioblast differentiation; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0001708; P:cell fate specification; IEA:Ensembl
Q99835	SMO	Smoothened homolog	GO:0071397; P:cellular response to cholesterol; ISS:BHF-UCL
Q99835	SMO	Smoothened homolog	GO:0021953; P:central nervous system neuron differentiation; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0021696; P:cerebellar cortex morphogenesis; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0060830; P:ciliary receptor clustering involved in smoothened signaling pathway; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0060248; P:detection of cell density by contact stimulus involved in contact inhibition; IMP:BHF-UCL
Q99835	SMO	Smoothened homolog	GO:0003140; P:determination of left/right asymmetry in lateral mesoderm; ISS:BHF-UCL
Q99835	SMO	Smoothened homolog	GO:0007368; P:determination of left/right symmetry; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0021904; P:dorsal/ventral neural tube patterning; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0031076; P:embryonic camera-type eye development; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0048557; P:embryonic digestive tract morphogenesis; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0048702; P:embryonic neurocranium morphogenesis; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0048703; P:embryonic viscerocranium morphogenesis; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0060684; P:epithelial-mesenchymal cell signaling; IEA:Ensembl
Q99835	SMO	Smoothened homolog	GO:0031017; P:exocrine pancreas development; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0021561; P:facial nerve development; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0021508; P:floor plate formation; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0048853; P:forebrain morphogenesis; ISS:BHF-UCL
Q99835	SMO	Smoothened homolog	GO:0008406; P:gonad development; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl
Q99835	SMO	Smoothened homolog	GO:0001947; P:heart looping; ISS:BHF-UCL
Q99835	SMO	Smoothened homolog	GO:0003007; P:heart morphogenesis; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q99835	SMO	Smoothened homolog	GO:0060644; P:mammary gland epithelial cell differentiation; IEA:Ensembl
Q99835	SMO	Smoothened homolog	GO:0072285; P:mesenchymal to epithelial transition involved in metanephric renal vesicle formation; ISS:UniProtKB
Q99835	SMO	Smoothened homolog	GO:0007494; P:midgut development; ISS:BHF-UCL
Q99835	SMO	Smoothened homolog	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q99835	SMO	Smoothened homolog	GO:0042693; P:muscle cell fate commitment; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0043066; P:negative regulation of apoptotic process; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0043392; P:negative regulation of DNA binding; ISS:UniProtKB
Q99835	SMO	Smoothened homolog	GO:0030857; P:negative regulation of epithelial cell differentiation; IEA:Ensembl
Q99835	SMO	Smoothened homolog	GO:0010629; P:negative regulation of gene expression; ISS:UniProtKB
Q99835	SMO	Smoothened homolog	GO:0051799; P:negative regulation of hair follicle development; IEA:Ensembl
Q99835	SMO	Smoothened homolog	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q99835	SMO	Smoothened homolog	GO:0001755; P:neural crest cell migration; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0048663; P:neuron fate commitment; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0031102; P:neuron projection regeneration; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0042475; P:odontogenesis of dentin-containing tooth; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0001649; P:osteoblast differentiation; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0032474; P:otolith morphogenesis; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0061113; P:pancreas morphogenesis; IEA:Ensembl
Q99835	SMO	Smoothened homolog	GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; ISS:UniProtKB
Q99835	SMO	Smoothened homolog	GO:0050679; P:positive regulation of epithelial cell proliferation; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB
Q99835	SMO	Smoothened homolog	GO:0007228; P:positive regulation of hh target transcription factor activity; ISS:BHF-UCL
Q99835	SMO	Smoothened homolog	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0002052; P:positive regulation of neuroblast proliferation; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0042307; P:positive regulation of protein import into nucleus; IEA:Ensembl
Q99835	SMO	Smoothened homolog	GO:0045880; P:positive regulation of smoothened signaling pathway; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q99835	SMO	Smoothened homolog	GO:0034504; P:protein localization to nucleus; IEA:Ensembl
Q99835	SMO	Smoothened homolog	GO:0050821; P:protein stabilization; IEA:Ensembl
Q99835	SMO	Smoothened homolog	GO:2000826; P:regulation of heart morphogenesis; ISS:BHF-UCL
Q99835	SMO	Smoothened homolog	GO:2000036; P:regulation of stem cell maintenance; IEA:Ensembl
Q99835	SMO	Smoothened homolog	GO:0072001; P:renal system development; IEP:UniProtKB
Q99835	SMO	Smoothened homolog	GO:0048752; P:semicircular canal morphogenesis; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0007224; P:smoothened signaling pathway; IMP:UniProtKB
Q99835	SMO	Smoothened homolog	GO:0021938; P:smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0021910; P:smoothened signaling pathway involved in ventral spinal cord patterning; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0061053; P:somite development; ISS:BHF-UCL
Q99835	SMO	Smoothened homolog	GO:0007283; P:spermatogenesis; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0021794; P:thalamus development; IEA:Ensembl
Q99835	SMO	Smoothened homolog	GO:0003323; P:type B pancreatic cell development; IEA:Ensembl
Q99835	SMO	Smoothened homolog	GO:0001570; P:vasculogenesis; IBA:RefGenome
Q99835	SMO	Smoothened homolog	GO:0007371; P:ventral midline determination; ISS:BHF-UCL
Q9UHP9	SMPX	Small muscular protein	GO:0006941; P:striated muscle contraction; TAS:ProtInc
Q92922	SMARCC1	SWI/SNF complex subunit SMARCC1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q92922	SMARCC1	SWI/SNF complex subunit SMARCC1	GO:0003677; F:DNA binding; IEA:InterPro
Q92922	SMARCC1	SWI/SNF complex subunit SMARCC1	GO:0005515; F:protein binding; IPI:UniProtKB
Q92922	SMARCC1	SWI/SNF complex subunit SMARCC1	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q92922	SMARCC1	SWI/SNF complex subunit SMARCC1	GO:0003713; F:transcription coactivator activity; NAS:BHF-UCL
Q92922	SMARCC1	SWI/SNF complex subunit SMARCC1	GO:0043044; P:ATP-dependent chromatin remodeling; IDA:UniProt
Q92922	SMARCC1	SWI/SNF complex subunit SMARCC1	GO:0006338; P:chromatin remodeling; IDA:UniProtKB
Q92922	SMARCC1	SWI/SNF complex subunit SMARCC1	GO:0008286; P:insulin receptor signaling pathway; IEA:Ensembl
Q92922	SMARCC1	SWI/SNF complex subunit SMARCC1	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q92922	SMARCC1	SWI/SNF complex subunit SMARCC1	GO:0006337; P:nucleosome disassembly; IDA:BHF-UCL
Q92922	SMARCC1	SWI/SNF complex subunit SMARCC1	GO:0009887; P:organ morphogenesis; IEA:Ensembl
Q92922	SMARCC1	SWI/SNF complex subunit SMARCC1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q92922	SMARCC1	SWI/SNF complex subunit SMARCC1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q92922	SMARCC1	SWI/SNF complex subunit SMARCC1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; NAS:BHF-UCL
Q92922	SMARCC1	SWI/SNF complex subunit SMARCC1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TAQ2	SMARCC2	SWI/SNF complex subunit SMARCC2	GO:0003682; F:chromatin binding; IEA:InterPro
Q8TAQ2	SMARCC2	SWI/SNF complex subunit SMARCC2	GO:0003677; F:DNA binding; IEA:InterPro
Q8TAQ2	SMARCC2	SWI/SNF complex subunit SMARCC2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TAQ2	SMARCC2	SWI/SNF complex subunit SMARCC2	GO:0003713; F:transcription coactivator activity; NAS:BHF-UCL
Q8TAQ2	SMARCC2	SWI/SNF complex subunit SMARCC2	GO:0043044; P:ATP-dependent chromatin remodeling; IDA:UniProt
Q8TAQ2	SMARCC2	SWI/SNF complex subunit SMARCC2	GO:0006338; P:chromatin remodeling; IDA:UniProtKB
Q8TAQ2	SMARCC2	SWI/SNF complex subunit SMARCC2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q8TAQ2	SMARCC2	SWI/SNF complex subunit SMARCC2	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q8TAQ2	SMARCC2	SWI/SNF complex subunit SMARCC2	GO:0006337; P:nucleosome disassembly; IDA:BHF-UCL
Q8TAQ2	SMARCC2	SWI/SNF complex subunit SMARCC2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q8TAQ2	SMARCC2	SWI/SNF complex subunit SMARCC2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; NAS:BHF-UCL
Q8TAQ2	SMARCC2	SWI/SNF complex subunit SMARCC2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H4L7	SMARCAD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H4L7	SMARCAD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1	GO:0003677; F:DNA binding; IDA:UniProtKB
Q9H4L7	SMARCAD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q9H4L7	SMARCAD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1	GO:0003676; F:nucleic acid binding; NAS:UniProtKB
Q9H4L7	SMARCAD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H4L7	SMARCAD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1	GO:0043044; P:ATP-dependent chromatin remodeling; IMP:UniProtKB
Q9H4L7	SMARCAD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1	GO:0016568; P:chromatin modification; NAS:UniProtKB
Q9H4L7	SMARCAD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1	GO:0006338; P:chromatin remodeling; NAS:UniProtKB
Q9H4L7	SMARCAD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1	GO:0051304; P:chromosome separation; IMP:UniProtKB
Q9H4L7	SMARCAD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1	GO:0000729; P:DNA double-strand break processing; IMP:UniProtKB
Q9H4L7	SMARCAD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1	GO:0070932; P:histone H3 deacetylation; IMP:UniProtKB
Q9H4L7	SMARCAD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1	GO:0070933; P:histone H4 deacetylation; IMP:UniProtKB
Q9H4L7	SMARCAD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1	GO:0009117; P:nucleotide metabolic process; NAS:UniProtKB
Q9H4L7	SMARCAD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
Q9H4L7	SMARCAD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1	GO:0051260; P:protein homooligomerization; NAS:UniProtKB
Q9H4L7	SMARCAD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1	GO:0000018; P:regulation of DNA recombination; IEP:UniProtKB
Q92925	SMARCD2	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2	GO:0005515; F:protein binding; IPI:IntAct
Q92925	SMARCD2	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2	GO:0003713; F:transcription coactivator activity; NAS:UniProtKB
Q92925	SMARCD2	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2	GO:0043044; P:ATP-dependent chromatin remodeling; IDA:UniProt
Q92925	SMARCD2	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2	GO:0006338; P:chromatin remodeling; IDA:BHF-UCL
Q92925	SMARCD2	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2	GO:0006337; P:nucleosome disassembly; IDA:BHF-UCL
Q92925	SMARCD2	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; NAS:UniProtKB
Q92925	SMARCD2	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NCR6	SMRP1	Spermatid-specific manchette-related protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8NCR6	SMRP1	Spermatid-specific manchette-related protein 1	GO:0043623; P:cellular protein complex assembly; IEA:Ensembl
Q8NCR6	SMRP1	Spermatid-specific manchette-related protein 1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q6STE5	SMARCD3	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3	GO:0016922; F:ligand-dependent nuclear receptor binding; IPI:BHF-UCL
Q6STE5	SMARCD3	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IMP:BHF-UCL
Q6STE5	SMARCD3	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3	GO:0035257; F:nuclear hormone receptor binding; IPI:UniProtKB
Q6STE5	SMARCD3	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3	GO:0005515; F:protein binding; IPI:IntAct
Q6STE5	SMARCD3	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3	GO:0005102; F:receptor binding; IPI:UniProtKB
Q6STE5	SMARCD3	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3	GO:0003713; F:transcription coactivator activity; NAS:BHF-UCL
Q6STE5	SMARCD3	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q6STE5	SMARCD3	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3	GO:0003219; P:cardiac right ventricle formation; IEA:Ensembl
Q6STE5	SMARCD3	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q6STE5	SMARCD3	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3	GO:0006338; P:chromatin remodeling; IDA:BHF-UCL
Q6STE5	SMARCD3	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3	GO:0042692; P:muscle cell differentiation; IEA:Ensembl
Q6STE5	SMARCD3	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3	GO:0003407; P:neural retina development; IEP:BHF-UCL
Q6STE5	SMARCD3	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3	GO:0006337; P:nucleosome disassembly; IDA:BHF-UCL
Q6STE5	SMARCD3	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3	GO:0002052; P:positive regulation of neuroblast proliferation; IDA:BHF-UCL
Q6STE5	SMARCD3	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q6STE5	SMARCD3	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3	GO:0043393; P:regulation of protein binding; IEA:Ensembl
Q6STE5	SMARCD3	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q6STE5	SMARCD3	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3	GO:0003139; P:secondary heart field specification; IEA:Ensembl
Q6STE5	SMARCD3	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q6STE5	SMARCD3	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3	GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB
Q96GM5	SMARCD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96GM5	SMARCD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1	GO:0032947; F:protein complex scaffold; IDA:UniProtKB
Q96GM5	SMARCD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1	GO:0003713; F:transcription coactivator activity; NAS:BHF-UCL
Q96GM5	SMARCD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1	GO:0006338; P:chromatin remodeling; IMP:UniProtKB
Q96GM5	SMARCD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1	GO:0048096; P:chromatin-mediated maintenance of transcription; IMP:UniProtKB
Q96GM5	SMARCD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q96GM5	SMARCD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1	GO:0006337; P:nucleosome disassembly; IDA:BHF-UCL
Q96GM5	SMARCD1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; NAS:BHF-UCL
Q86VZ5	SGMS1	Phosphatidylcholine:ceramide cholinephosphotransferase 1	GO:0047493; F:ceramide cholinephosphotransferase activity; IDA:UniProtKB
Q86VZ5	SGMS1	Phosphatidylcholine:ceramide cholinephosphotransferase 1	GO:0016301; F:kinase activity; IEA:UniProtKB-KW
Q86VZ5	SGMS1	Phosphatidylcholine:ceramide cholinephosphotransferase 1	GO:0033188; F:sphingomyelin synthase activity; IMP:HGNC
Q86VZ5	SGMS1	Phosphatidylcholine:ceramide cholinephosphotransferase 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q86VZ5	SGMS1	Phosphatidylcholine:ceramide cholinephosphotransferase 1	GO:0016049; P:cell growth; IDA:HGNC
Q86VZ5	SGMS1	Phosphatidylcholine:ceramide cholinephosphotransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q86VZ5	SGMS1	Phosphatidylcholine:ceramide cholinephosphotransferase 1	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
Q86VZ5	SGMS1	Phosphatidylcholine:ceramide cholinephosphotransferase 1	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q86VZ5	SGMS1	Phosphatidylcholine:ceramide cholinephosphotransferase 1	GO:0006686; P:sphingomyelin biosynthetic process; IDA:UniProtKB
Q8NHU3	SGMS2	Phosphatidylcholine:ceramide cholinephosphotransferase 2	GO:0047493; F:ceramide cholinephosphotransferase activity; IDA:UniProtKB
Q8NHU3	SGMS2	Phosphatidylcholine:ceramide cholinephosphotransferase 2	GO:0016301; F:kinase activity; IEA:UniProtKB-KW
Q8NHU3	SGMS2	Phosphatidylcholine:ceramide cholinephosphotransferase 2	GO:0033188; F:sphingomyelin synthase activity; IEA:UniProtKB-EC
Q8NHU3	SGMS2	Phosphatidylcholine:ceramide cholinephosphotransferase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8NHU3	SGMS2	Phosphatidylcholine:ceramide cholinephosphotransferase 2	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
Q8NHU3	SGMS2	Phosphatidylcholine:ceramide cholinephosphotransferase 2	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q8NHU3	SGMS2	Phosphatidylcholine:ceramide cholinephosphotransferase 2	GO:0006686; P:sphingomyelin biosynthetic process; IDA:UniProtKB
P61278	SST	Somatostatin	GO:0005179; F:hormone activity; TAS:UniProtKB
P61278	SST	Somatostatin	GO:0007166; P:cell surface receptor signaling pathway; TAS:UniProtKB
P61278	SST	Somatostatin	GO:0007267; P:cell-cell signaling; TAS:UniProtKB
P61278	SST	Somatostatin	GO:0007586; P:digestion; TAS:UniProtKB
P61278	SST	Somatostatin	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:UniProtKB
P61278	SST	Somatostatin	GO:0008628; P:hormone-mediated apoptotic signaling pathway; TAS:UniProtKB
P61278	SST	Somatostatin	GO:0006972; P:hyperosmotic response; IEA:Ensembl
P61278	SST	Somatostatin	GO:0008285; P:negative regulation of cell proliferation; TAS:UniProtKB
P61278	SST	Somatostatin	GO:0030334; P:regulation of cell migration; IEA:Ensembl
P61278	SST	Somatostatin	GO:0043200; P:response to amino acid; IEA:Ensembl
P61278	SST	Somatostatin	GO:0042493; P:response to drug; IEA:Ensembl
P61278	SST	Somatostatin	GO:0009408; P:response to heat; IEA:Ensembl
P61278	SST	Somatostatin	GO:0007584; P:response to nutrient; TAS:UniProtKB
P61278	SST	Somatostatin	GO:0048545; P:response to steroid hormone; IEA:Ensembl
P61278	SST	Somatostatin	GO:0007268; P:synaptic transmission; TAS:UniProtKB
A8MU46	SMTNL1	Smoothelin-like protein 1	GO:0045908; P:negative regulation of vasodilation; ISS:UniProtKB
A8MU46	SMTNL1	Smoothelin-like protein 1	GO:0045907; P:positive regulation of vasoconstriction; ISS:UniProtKB
P53814	SMTN	Smoothelin	GO:0003779; F:actin binding; TAS:ProtInc
P53814	SMTN	Smoothelin	GO:0008307; F:structural constituent of muscle; TAS:ProtInc
P53814	SMTN	Smoothelin	GO:0007517; P:muscle organ development; TAS:ProtInc
P53814	SMTN	Smoothelin	GO:0006939; P:smooth muscle contraction; TAS:ProtInc
Q2TAY7	SMU1	WD40 repeat-containing protein SMU1	GO:0005515; F:protein binding; IPI:IntAct
Q9HCE7	SMURF1	E3 ubiquitin-protein ligase SMURF1	GO:0048185; F:activin binding; NAS:BHF-UCL
Q9HCE7	SMURF1	E3 ubiquitin-protein ligase SMURF1	GO:0070411; F:I-SMAD binding; IPI:BHF-UCL
Q9HCE7	SMURF1	E3 ubiquitin-protein ligase SMURF1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HCE7	SMURF1	E3 ubiquitin-protein ligase SMURF1	GO:0070412; F:R-SMAD binding; IPI:BHF-UCL
Q9HCE7	SMURF1	E3 ubiquitin-protein ligase SMURF1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9HCE7	SMURF1	E3 ubiquitin-protein ligase SMURF1	GO:0030509; P:BMP signaling pathway; IDA:UniProtKB
Q9HCE7	SMURF1	E3 ubiquitin-protein ligase SMURF1	GO:0030154; P:cell differentiation; IDA:UniProtKB
Q9HCE7	SMURF1	E3 ubiquitin-protein ligase SMURF1	GO:0007398; P:ectoderm development; TAS:UniProtKB
Q9HCE7	SMURF1	E3 ubiquitin-protein ligase SMURF1	GO:0030514; P:negative regulation of BMP signaling pathway; TAS:UniProtKB
Q9HCE7	SMURF1	E3 ubiquitin-protein ligase SMURF1	GO:0030279; P:negative regulation of ossification; IEA:Ensembl
Q9HCE7	SMURF1	E3 ubiquitin-protein ligase SMURF1	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
Q9HCE7	SMURF1	E3 ubiquitin-protein ligase SMURF1	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:BHF-UCL
Q9HCE7	SMURF1	E3 ubiquitin-protein ligase SMURF1	GO:0006611; P:protein export from nucleus; IDA:BHF-UCL
Q9HCE7	SMURF1	E3 ubiquitin-protein ligase SMURF1	GO:0034394; P:protein localization to cell surface; IDA:BHF-UCL
Q9HCE7	SMURF1	E3 ubiquitin-protein ligase SMURF1	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q9HCE7	SMURF1	E3 ubiquitin-protein ligase SMURF1	GO:0016567; P:protein ubiquitination; IDA:BHF-UCL
Q9HCE7	SMURF1	E3 ubiquitin-protein ligase SMURF1	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9HCE7	SMURF1	E3 ubiquitin-protein ligase SMURF1	GO:0032801; P:receptor catabolic process; IDA:BHF-UCL
Q9HCE7	SMURF1	E3 ubiquitin-protein ligase SMURF1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q9HCE7	SMURF1	E3 ubiquitin-protein ligase SMURF1	GO:0030579; P:ubiquitin-dependent SMAD protein catabolic process; IDA:BHF-UCL
Q9HAU4	SMURF2	E3 ubiquitin-protein ligase SMURF2	GO:0042802; F:identical protein binding; IPI:IntAct
Q9HAU4	SMURF2	E3 ubiquitin-protein ligase SMURF2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HAU4	SMURF2	E3 ubiquitin-protein ligase SMURF2	GO:0046332; F:SMAD binding; IPI:BHF-UCL
Q9HAU4	SMURF2	E3 ubiquitin-protein ligase SMURF2	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9HAU4	SMURF2	E3 ubiquitin-protein ligase SMURF2	GO:0030509; P:BMP signaling pathway; TAS:Reactome
Q9HAU4	SMURF2	E3 ubiquitin-protein ligase SMURF2	GO:0010467; P:gene expression; TAS:Reactome
Q9HAU4	SMURF2	E3 ubiquitin-protein ligase SMURF2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:Reactome
Q9HAU4	SMURF2	E3 ubiquitin-protein ligase SMURF2	GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB
Q9HAU4	SMURF2	E3 ubiquitin-protein ligase SMURF2	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q9HAU4	SMURF2	E3 ubiquitin-protein ligase SMURF2	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:RefGenome
Q9HAU4	SMURF2	E3 ubiquitin-protein ligase SMURF2	GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; NAS:UniProtKB
Q9HAU4	SMURF2	E3 ubiquitin-protein ligase SMURF2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q9HAU4	SMURF2	E3 ubiquitin-protein ligase SMURF2	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
Q9HAU4	SMURF2	E3 ubiquitin-protein ligase SMURF2	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IBA:RefGenome
Q9HAU4	SMURF2	E3 ubiquitin-protein ligase SMURF2	GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9HAU4	SMURF2	E3 ubiquitin-protein ligase SMURF2	GO:0030579; P:ubiquitin-dependent SMAD protein catabolic process; IDA:BHF-UCL
Q53HV7	SMUG1	Single-strand selective monofunctional uracil DNA glycosylase	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q53HV7	SMUG1	Single-strand selective monofunctional uracil DNA glycosylase	GO:0019104; F:DNA N-glycosylase activity; IDA:HGNC
Q53HV7	SMUG1	Single-strand selective monofunctional uracil DNA glycosylase	GO:0000703; F:oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity; IEA:Ensembl
Q53HV7	SMUG1	Single-strand selective monofunctional uracil DNA glycosylase	GO:0005515; F:protein binding; IPI:IntAct
Q53HV7	SMUG1	Single-strand selective monofunctional uracil DNA glycosylase	GO:0017065; F:single-strand selective uracil DNA N-glycosylase activity; IDA:HGNC
Q53HV7	SMUG1	Single-strand selective monofunctional uracil DNA glycosylase	GO:0004844; F:uracil DNA N-glycosylase activity; IDA:HGNC
Q53HV7	SMUG1	Single-strand selective monofunctional uracil DNA glycosylase	GO:0006284; P:base-excision repair; IDA:HGNC
Q53HV7	SMUG1	Single-strand selective monofunctional uracil DNA glycosylase	GO:0006285; P:base-excision repair, AP site formation; TAS:Reactome
Q53HV7	SMUG1	Single-strand selective monofunctional uracil DNA glycosylase	GO:0045008; P:depyrimidination; TAS:Reactome
Q53HV7	SMUG1	Single-strand selective monofunctional uracil DNA glycosylase	GO:0006281; P:DNA repair; TAS:Reactome
Q8NB12	SMYD1	Histone-lysine N-methyltransferase SMYD1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NB12	SMYD1	Histone-lysine N-methyltransferase SMYD1	GO:0018024; F:histone-lysine N-methyltransferase activity; IEA:UniProtKB-EC
Q8NB12	SMYD1	Histone-lysine N-methyltransferase SMYD1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NB12	SMYD1	Histone-lysine N-methyltransferase SMYD1	GO:0005515; F:protein binding; IPI:IntAct
Q8NB12	SMYD1	Histone-lysine N-methyltransferase SMYD1	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
Q8NB12	SMYD1	Histone-lysine N-methyltransferase SMYD1	GO:0006338; P:chromatin remodeling; IEA:Ensembl
Q8NB12	SMYD1	Histone-lysine N-methyltransferase SMYD1	GO:0007507; P:heart development; IEA:Ensembl
Q8NB12	SMYD1	Histone-lysine N-methyltransferase SMYD1	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q8NB12	SMYD1	Histone-lysine N-methyltransferase SMYD1	GO:0045663; P:positive regulation of myoblast differentiation; IDA:BHF-UCL
Q8NB12	SMYD1	Histone-lysine N-methyltransferase SMYD1	GO:0010831; P:positive regulation of myotube differentiation; IDA:BHF-UCL
Q8NB12	SMYD1	Histone-lysine N-methyltransferase SMYD1	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q8NB12	SMYD1	Histone-lysine N-methyltransferase SMYD1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NRG4	SMYD2	N-lysine methyltransferase SMYD2	GO:0046975; F:histone methyltransferase activity (H3-K36 specific); ISS:UniProtKB
Q9NRG4	SMYD2	N-lysine methyltransferase SMYD2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NRG4	SMYD2	N-lysine methyltransferase SMYD2	GO:0002039; F:p53 binding; IPI:UniProtKB
Q9NRG4	SMYD2	N-lysine methyltransferase SMYD2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NRG4	SMYD2	N-lysine methyltransferase SMYD2	GO:0016279; F:protein-lysine N-methyltransferase activity; IDA:UniProtKB
Q9NRG4	SMYD2	N-lysine methyltransferase SMYD2	GO:0000993; F:RNA polymerase II core binding; ISS:UniProtKB
Q9NRG4	SMYD2	N-lysine methyltransferase SMYD2	GO:0008285; P:negative regulation of cell proliferation; ISS:UniProtKB
Q9NRG4	SMYD2	N-lysine methyltransferase SMYD2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q9NRG4	SMYD2	N-lysine methyltransferase SMYD2	GO:0018027; P:peptidyl-lysine dimethylation; ISS:UniProtKB
Q9NRG4	SMYD2	N-lysine methyltransferase SMYD2	GO:0018026; P:peptidyl-lysine monomethylation; IDA:UniProtKB
Q9NRG4	SMYD2	N-lysine methyltransferase SMYD2	GO:0043516; P:regulation of DNA damage response, signal transduction by p53 class mediator; IMP:UniProtKB
Q9NRG4	SMYD2	N-lysine methyltransferase SMYD2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H7B4	SMYD3	Histone-lysine N-methyltransferase SMYD3	GO:0018024; F:histone-lysine N-methyltransferase activity; ISS:UniProtKB
Q9H7B4	SMYD3	Histone-lysine N-methyltransferase SMYD3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IYR2	SMYD4	SET and MYND domain-containing protein 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IYR2	SMYD4	SET and MYND domain-containing protein 4	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q6GMV2	SMYD5	SET and MYND domain-containing protein 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6GMV2	SMYD5	SET and MYND domain-containing protein 5	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q6IEE8	SLFN12L	Schlafen family member 12-like	GO:0005524; F:ATP binding; IEA:InterPro
P54920	NAPA	Alpha-soluble NSF attachment protein	GO:0005515; F:protein binding; IPI:UniProtKB
P54920	NAPA	Alpha-soluble NSF attachment protein	GO:0045176; P:apical protein localization; IEA:Ensembl
P54920	NAPA	Alpha-soluble NSF attachment protein	GO:0007420; P:brain development; IEA:Ensembl
P54920	NAPA	Alpha-soluble NSF attachment protein	GO:0006891; P:intra-Golgi vesicle-mediated transport; TAS:ProtInc
P54920	NAPA	Alpha-soluble NSF attachment protein	GO:0006886; P:intracellular protein transport; IEA:Ensembl
P54920	NAPA	Alpha-soluble NSF attachment protein	GO:0061025; P:membrane fusion; TAS:ProtInc
P54920	NAPA	Alpha-soluble NSF attachment protein	GO:0061024; P:membrane organization; TAS:Reactome
P54920	NAPA	Alpha-soluble NSF attachment protein	GO:0030182; P:neuron differentiation; IEA:Ensembl
P54920	NAPA	Alpha-soluble NSF attachment protein	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
P54920	NAPA	Alpha-soluble NSF attachment protein	GO:0010807; P:regulation of synaptic vesicle priming; IEA:Ensembl
P54920	NAPA	Alpha-soluble NSF attachment protein	GO:0035494; P:SNARE complex disassembly; IEA:Ensembl
P54920	NAPA	Alpha-soluble NSF attachment protein	GO:0035249; P:synaptic transmission, glutamatergic; IEA:Ensembl
Q9H115	NAPB	Beta-soluble NSF attachment protein	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9H115	NAPB	Beta-soluble NSF attachment protein	GO:0010807; P:regulation of synaptic vesicle priming; IEA:Ensembl
Q9H115	NAPB	Beta-soluble NSF attachment protein	GO:0035494; P:SNARE complex disassembly; IEA:Ensembl
Q9H115	NAPB	Beta-soluble NSF attachment protein	GO:0035249; P:synaptic transmission, glutamatergic; IEA:Ensembl
Q99747	NAPG	Gamma-soluble NSF attachment protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q99747	NAPG	Gamma-soluble NSF attachment protein	GO:0006891; P:intra-Golgi vesicle-mediated transport; TAS:ProtInc
Q99747	NAPG	Gamma-soluble NSF attachment protein	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q99747	NAPG	Gamma-soluble NSF attachment protein	GO:0061025; P:membrane fusion; TAS:ProtInc
Q99747	NAPG	Gamma-soluble NSF attachment protein	GO:0006461; P:protein complex assembly; NAS:UniProtKB
Q99747	NAPG	Gamma-soluble NSF attachment protein	GO:0050821; P:protein stabilization; NAS:UniProtKB
O95863	SNAI1	Zinc finger protein SNAI1	GO:0019900; F:kinase binding; IPI:UniProtKB
O95863	SNAI1	Zinc finger protein SNAI1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95863	SNAI1	Zinc finger protein SNAI1	GO:0005515; F:protein binding; IPI:UniProtKB
O95863	SNAI1	Zinc finger protein SNAI1	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IDA:BHF-UCL
O95863	SNAI1	Zinc finger protein SNAI1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
O95863	SNAI1	Zinc finger protein SNAI1	GO:0060536; P:cartilage morphogenesis; IEA:Ensembl
O95863	SNAI1	Zinc finger protein SNAI1	GO:0016477; P:cell migration; IEA:Ensembl
O95863	SNAI1	Zinc finger protein SNAI1	GO:0001837; P:epithelial to mesenchymal transition; IDA:UniProtKB
O95863	SNAI1	Zinc finger protein SNAI1	GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl
O95863	SNAI1	Zinc finger protein SNAI1	GO:0060972; P:left/right pattern formation; IEA:Ensembl
O95863	SNAI1	Zinc finger protein SNAI1	GO:0001707; P:mesoderm formation; ISS:UniProtKB
O95863	SNAI1	Zinc finger protein SNAI1	GO:0060806; P:negative regulation of cell differentiation involved in embryonic placenta development; IEA:Ensembl
O95863	SNAI1	Zinc finger protein SNAI1	GO:0043518; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; IMP:BHF-UCL
O95863	SNAI1	Zinc finger protein SNAI1	GO:1902230; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; IMP:BHF-UCL
O95863	SNAI1	Zinc finger protein SNAI1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
O95863	SNAI1	Zinc finger protein SNAI1	GO:0010957; P:negative regulation of vitamin D biosynthetic process; IDA:BHF-UCL
O95863	SNAI1	Zinc finger protein SNAI1	GO:0061314; P:Notch signaling involved in heart development; ISS:BHF-UCL
O95863	SNAI1	Zinc finger protein SNAI1	GO:0001649; P:osteoblast differentiation; IEP:UniProtKB
O95863	SNAI1	Zinc finger protein SNAI1	GO:0060021; P:palate development; IEA:Ensembl
O95863	SNAI1	Zinc finger protein SNAI1	GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB
O95863	SNAI1	Zinc finger protein SNAI1	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IMP:UniProtKB
O95863	SNAI1	Zinc finger protein SNAI1	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
O95863	SNAI1	Zinc finger protein SNAI1	GO:2000810; P:regulation of tight junction assembly; IMP:BHF-UCL
O95863	SNAI1	Zinc finger protein SNAI1	GO:0060707; P:trophoblast giant cell differentiation; IEA:Ensembl
O43623	SNAI2	Zinc finger protein SNAI2	GO:0003682; F:chromatin binding; IEA:Ensembl
O43623	SNAI2	Zinc finger protein SNAI2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43623	SNAI2	Zinc finger protein SNAI2	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IDA:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
O43623	SNAI2	Zinc finger protein SNAI2	GO:0043565; F:sequence-specific DNA binding; IDA:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0060070; P:canonical Wnt signaling pathway; IMP:UniProtKB
O43623	SNAI2	Zinc finger protein SNAI2	GO:0060536; P:cartilage morphogenesis; IEA:Ensembl
O43623	SNAI2	Zinc finger protein SNAI2	GO:0003273; P:cell migration involved in endocardial cushion formation; ISS:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0071364; P:cellular response to epidermal growth factor stimulus; IDA:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEA:Ensembl
O43623	SNAI2	Zinc finger protein SNAI2	GO:0071479; P:cellular response to ionizing radiation; IEA:Ensembl
O43623	SNAI2	Zinc finger protein SNAI2	GO:0035921; P:desmosome disassembly; IMP:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0009790; P:embryo development; IEA:Ensembl
O43623	SNAI2	Zinc finger protein SNAI2	GO:0001837; P:epithelial to mesenchymal transition; IMP:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0003198; P:epithelial to mesenchymal transition involved in endocardial cushion formation; ISS:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0060429; P:epithelium development; ISS:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:2000811; P:negative regulation of anoikis; IMP:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0035414; P:negative regulation of catenin import into nucleus; IDA:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0006933; P:negative regulation of cell adhesion involved in substrate-bound cell migration; IEA:Ensembl
O43623	SNAI2	Zinc finger protein SNAI2	GO:0033629; P:negative regulation of cell adhesion mediated by integrin; IC:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:1900387; P:negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0032331; P:negative regulation of chondrocyte differentiation; IMP:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0043518; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; IMP:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; ISS:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:1902230; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; IMP:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0010839; P:negative regulation of keratinocyte proliferation; IDA:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:2000647; P:negative regulation of stem cell proliferation; IEA:Ensembl
O43623	SNAI2	Zinc finger protein SNAI2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0010957; P:negative regulation of vitamin D biosynthetic process; IDA:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0070563; P:negative regulation of vitamin D receptor signaling pathway; IDA:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0014032; P:neural crest cell development; IMP:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0007219; P:Notch signaling pathway; IMP:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0001649; P:osteoblast differentiation; IEP:UniProtKB
O43623	SNAI2	Zinc finger protein SNAI2	GO:0060021; P:palate development; IEA:Ensembl
O43623	SNAI2	Zinc finger protein SNAI2	GO:0043473; P:pigmentation; IMP:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0030335; P:positive regulation of cell migration; IMP:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0045600; P:positive regulation of fat cell differentiation; IEA:Ensembl
O43623	SNAI2	Zinc finger protein SNAI2	GO:0035066; P:positive regulation of histone acetylation; IEA:Ensembl
O43623	SNAI2	Zinc finger protein SNAI2	GO:0060693; P:regulation of branching involved in salivary gland morphogenesis; IEA:Ensembl
O43623	SNAI2	Zinc finger protein SNAI2	GO:0032642; P:regulation of chemokine production; IMP:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0045667; P:regulation of osteoblast differentiation; IMP:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:2000810; P:regulation of tight junction assembly; IMP:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0007605; P:sensory perception of sound; IMP:BHF-UCL
O43623	SNAI2	Zinc finger protein SNAI2	GO:0050872; P:white fat cell differentiation; IEA:Ensembl
Q3KNW1	SNAI3	Zinc finger protein SNAI3	GO:0005507; F:copper ion binding; IEA:InterPro
Q3KNW1	SNAI3	Zinc finger protein SNAI3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q3KNW1	SNAI3	Zinc finger protein SNAI3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q3KNW1	SNAI3	Zinc finger protein SNAI3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95295	SNAPIN	SNARE-associated protein Snapin	GO:0005515; F:protein binding; IPI:UniProtKB
O95295	SNAPIN	SNARE-associated protein Snapin	GO:0000149; F:SNARE binding; IDA:MGI
O95295	SNAPIN	SNARE-associated protein Snapin	GO:0008089; P:anterograde axon cargo transport; ISS:UniProtKB
O95295	SNAPIN	SNARE-associated protein Snapin	GO:0048490; P:anterograde synaptic vesicle transport; ISS:UniProtKB
O95295	SNAPIN	SNARE-associated protein Snapin	GO:0006886; P:intracellular protein transport; TAS:ProtInc
O95295	SNAPIN	SNARE-associated protein Snapin	GO:0032438; P:melanosome organization; NAS:UniProtKB
O95295	SNAPIN	SNARE-associated protein Snapin	GO:0031175; P:neuron projection development; ISS:UniProtKB
O95295	SNAPIN	SNARE-associated protein Snapin	GO:0007269; P:neurotransmitter secretion; TAS:ProtInc
O95295	SNAPIN	SNARE-associated protein Snapin	GO:1902824; P:positive regulation of late endosome to lysosome transport; TAS:ParkinsonsUK-UCL
O95295	SNAPIN	SNARE-associated protein Snapin	GO:0043393; P:regulation of protein binding; IMP:ParkinsonsUK-UCL
O95295	SNAPIN	SNARE-associated protein Snapin	GO:0016079; P:synaptic vesicle exocytosis; IDA:MGI
O95295	SNAPIN	SNARE-associated protein Snapin	GO:0031629; P:synaptic vesicle fusion to presynaptic membrane; IEA:Ensembl
O95295	SNAPIN	SNARE-associated protein Snapin	GO:0016188; P:synaptic vesicle maturation; IEA:Ensembl
O95295	SNAPIN	SNARE-associated protein Snapin	GO:0048489; P:synaptic vesicle transport; IMP:UniProtKB
O95295	SNAPIN	SNARE-associated protein Snapin	GO:0072553; P:terminal button organization; IEA:Ensembl
O95295	SNAPIN	SNARE-associated protein Snapin	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q16613	AANAT	Serotonin N-acetyltransferase	GO:0004059; F:aralkylamine N-acetyltransferase activity; IDA:UniProtKB
Q16613	AANAT	Serotonin N-acetyltransferase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q16613	AANAT	Serotonin N-acetyltransferase	GO:0071320; P:cellular response to cAMP; IDA:UniProtKB
Q16613	AANAT	Serotonin N-acetyltransferase	GO:0007623; P:circadian rhythm; IMP:UniProtKB
Q16613	AANAT	Serotonin N-acetyltransferase	GO:0046219; P:indolalkylamine biosynthetic process; TAS:Reactome
Q16613	AANAT	Serotonin N-acetyltransferase	GO:0030187; P:melatonin biosynthetic process; IDA:UniProtKB
Q16613	AANAT	Serotonin N-acetyltransferase	GO:0006474; P:N-terminal protein amino acid acetylation; IDA:UniProtKB
Q16613	AANAT	Serotonin N-acetyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y6H5	SNCAIP	Synphilin-1	GO:0042802; F:identical protein binding; IPI:IntAct
Q9Y6H5	SNCAIP	Synphilin-1	GO:0005515; F:protein binding; IPI:IntAct
Q9Y6H5	SNCAIP	Synphilin-1	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q9Y6H5	SNCAIP	Synphilin-1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9Y6H5	SNCAIP	Synphilin-1	GO:0042417; P:dopamine metabolic process; IDA:MGI
Q9Y6H5	SNCAIP	Synphilin-1	GO:0090083; P:regulation of inclusion body assembly; IDA:BHF-UCL
Q9Y6H5	SNCAIP	Synphilin-1	GO:0046928; P:regulation of neurotransmitter secretion; IDA:MGI
Q7KZF4	SND1	Staphylococcal nuclease domain-containing protein 1	GO:0004518; F:nuclease activity; IEA:InterPro
Q7KZF4	SND1	Staphylococcal nuclease domain-containing protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7KZF4	SND1	Staphylococcal nuclease domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q7KZF4	SND1	Staphylococcal nuclease domain-containing protein 1	GO:0003712; F:transcription cofactor activity; TAS:ProtInc
Q7KZF4	SND1	Staphylococcal nuclease domain-containing protein 1	GO:0031047; P:gene silencing by RNA; IEA:InterPro
Q7KZF4	SND1	Staphylococcal nuclease domain-containing protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7KZF4	SND1	Staphylococcal nuclease domain-containing protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7KZF4	SND1	Staphylococcal nuclease domain-containing protein 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q8TER0	SNED1	Sushi, nidogen and EGF-like domain-containing protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8TER0	SNED1	Sushi, nidogen and EGF-like domain-containing protein 1	GO:0007160; P:cell-matrix adhesion; IEA:InterPro
Q12824	SMARCB1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0002039; F:p53 binding; IPI:BHF-UCL
Q12824	SMARCB1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0005515; F:protein binding; IPI:IntAct
Q12824	SMARCB1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0030957; F:Tat protein binding; IPI:BHF-UCL
Q12824	SMARCB1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0003713; F:transcription coactivator activity; IMP:BHF-UCL
Q12824	SMARCB1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0043044; P:ATP-dependent chromatin remodeling; IDA:UniProt
Q12824	SMARCB1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0001835; P:blastocyst hatching; IEA:Ensembl
Q12824	SMARCB1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0030154; P:cell differentiation; IBA:RefGenome
Q12824	SMARCB1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0006338; P:chromatin remodeling; IDA:BHF-UCL
Q12824	SMARCB1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0015074; P:DNA integration; TAS:ProtInc
Q12824	SMARCB1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0006281; P:DNA repair; IBA:RefGenome
Q12824	SMARCB1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0044772; P:mitotic cell cycle phase transition; IBA:RefGenome
Q12824	SMARCB1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0008285; P:negative regulation of cell proliferation; IBA:RefGenome
Q12824	SMARCB1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q12824	SMARCB1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0006337; P:nucleosome disassembly; IDA:BHF-UCL
Q12824	SMARCB1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0043923; P:positive regulation by host of viral transcription; IMP:BHF-UCL
Q12824	SMARCB1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q12824	SMARCB1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q12824	SMARCB1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; NAS:BHF-UCL
Q12824	SMARCB1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0039692; P:single stranded viral RNA replication via double stranded DNA intermediate; IDA:MGI
Q12824	SMARCB1	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96H20	SNF8	Vacuolar-sorting protein SNF8	GO:0005515; F:protein binding; IPI:IntAct
Q96H20	SNF8	Vacuolar-sorting protein SNF8	GO:0008134; F:transcription factor binding; IDA:MGI
Q96H20	SNF8	Vacuolar-sorting protein SNF8	GO:0016197; P:endosomal transport; TAS:Reactome
Q96H20	SNF8	Vacuolar-sorting protein SNF8	GO:0061024; P:membrane organization; TAS:Reactome
Q96H20	SNF8	Vacuolar-sorting protein SNF8	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96H20	SNF8	Vacuolar-sorting protein SNF8	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q96H20	SNF8	Vacuolar-sorting protein SNF8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43759	SYNGR1	Synaptogyrin-1	GO:0006605; P:protein targeting; IEA:Ensembl
O43759	SYNGR1	Synaptogyrin-1	GO:0048169; P:regulation of long-term neuronal synaptic plasticity; ISS:UniProtKB
O43759	SYNGR1	Synaptogyrin-1	GO:0048172; P:regulation of short-term neuronal synaptic plasticity; ISS:UniProtKB
O43760	SYNGR2	Synaptogyrin-2	GO:0006605; P:protein targeting; IEA:Ensembl
O43761	SYNGR3	Synaptogyrin-3	GO:0032411; P:positive regulation of transporter activity; ISS:UniProtKB
O43761	SYNGR3	Synaptogyrin-3	GO:0021762; P:substantia nigra development; IEP:UniProt
Q8TAD8	SNIP1	Smad nuclear-interacting protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8TAD8	SNIP1	Smad nuclear-interacting protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q8TAD8	SNIP1	Smad nuclear-interacting protein 1	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
Q8TAD8	SNIP1	Smad nuclear-interacting protein 1	GO:0035196; P:production of miRNAs involved in gene silencing by miRNA; IMP:UniProtKB
Q8TAD8	SNIP1	Smad nuclear-interacting protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:Ensembl
O75324	SNN	Stannin	GO:0009628; P:response to abiotic stimulus; TAS:ProtInc
O75324	SNN	Stannin	GO:0006950; P:response to stress; TAS:ProtInc
O00161	SNAP23	Synaptosomal-associated protein 23	GO:0005515; F:protein binding; IPI:UniProtKB
O00161	SNAP23	Synaptosomal-associated protein 23	GO:0006887; P:exocytosis; IEA:Ensembl
O00161	SNAP23	Synaptosomal-associated protein 23	GO:0061025; P:membrane fusion; TAS:ProtInc
O00161	SNAP23	Synaptosomal-associated protein 23	GO:0061024; P:membrane organization; TAS:Reactome
O00161	SNAP23	Synaptosomal-associated protein 23	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
O00161	SNAP23	Synaptosomal-associated protein 23	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O00161	SNAP23	Synaptosomal-associated protein 23	GO:0006903; P:vesicle targeting; TAS:ProtInc
P60880	SNAP25	Synaptosomal-associated protein 25	GO:0005515; F:protein binding; IPI:UniProtKB
P60880	SNAP25	Synaptosomal-associated protein 25	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P60880	SNAP25	Synaptosomal-associated protein 25	GO:0014047; P:glutamate secretion; TAS:Reactome
P60880	SNAP25	Synaptosomal-associated protein 25	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
P60880	SNAP25	Synaptosomal-associated protein 25	GO:0001504; P:neurotransmitter uptake; NAS:UniProtKB
P60880	SNAP25	Synaptosomal-associated protein 25	GO:0050796; P:regulation of insulin secretion; TAS:UniProtKB
P60880	SNAP25	Synaptosomal-associated protein 25	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P60880	SNAP25	Synaptosomal-associated protein 25	GO:0007268; P:synaptic transmission; NAS:UniProtKB
P60880	SNAP25	Synaptosomal-associated protein 25	GO:0016081; P:synaptic vesicle docking involved in exocytosis; NAS:UniProtKB
O95721	SNAP29	Synaptosomal-associated protein 29	GO:0005484; F:SNAP receptor activity; TAS:ProtInc
O95721	SNAP29	Synaptosomal-associated protein 29	GO:0000046; P:autophagic vacuole fusion; IMP:UniProtKB
O95721	SNAP29	Synaptosomal-associated protein 29	GO:0006887; P:exocytosis; TAS:ProtInc
O95721	SNAP29	Synaptosomal-associated protein 29	GO:0061025; P:membrane fusion; TAS:ProtInc
O95721	SNAP29	Synaptosomal-associated protein 29	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O95721	SNAP29	Synaptosomal-associated protein 29	GO:0006903; P:vesicle targeting; TAS:ProtInc
Q5SQN1	SNAP47	Synaptosomal-associated protein 47	GO:0005515; F:protein binding; IPI:UniProtKB
Q16533	SNAPC1	snRNA-activating protein complex subunit 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q16533	SNAPC1	snRNA-activating protein complex subunit 1	GO:0010467; P:gene expression; TAS:Reactome
Q16533	SNAPC1	snRNA-activating protein complex subunit 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q16533	SNAPC1	snRNA-activating protein complex subunit 1	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
Q13487	SNAPC2	snRNA-activating protein complex subunit 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q13487	SNAPC2	snRNA-activating protein complex subunit 2	GO:0010467; P:gene expression; TAS:Reactome
Q13487	SNAPC2	snRNA-activating protein complex subunit 2	GO:0009301; P:snRNA transcription; TAS:ProtInc
Q13487	SNAPC2	snRNA-activating protein complex subunit 2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q13487	SNAPC2	snRNA-activating protein complex subunit 2	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
Q92966	SNAPC3	snRNA-activating protein complex subunit 3	GO:0003677; F:DNA binding; TAS:ProtInc
Q92966	SNAPC3	snRNA-activating protein complex subunit 3	GO:0010467; P:gene expression; TAS:Reactome
Q92966	SNAPC3	snRNA-activating protein complex subunit 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q92966	SNAPC3	snRNA-activating protein complex subunit 3	GO:0009301; P:snRNA transcription; TAS:ProtInc
Q92966	SNAPC3	snRNA-activating protein complex subunit 3	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q92966	SNAPC3	snRNA-activating protein complex subunit 3	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
Q5SXM2	SNAPC4	snRNA-activating protein complex subunit 4	GO:0003682; F:chromatin binding; IEA:InterPro
Q5SXM2	SNAPC4	snRNA-activating protein complex subunit 4	GO:0003677; F:DNA binding; IDA:UniProtKB
Q5SXM2	SNAPC4	snRNA-activating protein complex subunit 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q5SXM2	SNAPC4	snRNA-activating protein complex subunit 4	GO:0010467; P:gene expression; TAS:Reactome
Q5SXM2	SNAPC4	snRNA-activating protein complex subunit 4	GO:0009301; P:snRNA transcription; TAS:ProtInc
Q5SXM2	SNAPC4	snRNA-activating protein complex subunit 4	GO:0042795; P:snRNA transcription from RNA polymerase II promoter; IDA:UniProtKB
Q5SXM2	SNAPC4	snRNA-activating protein complex subunit 4	GO:0042796; P:snRNA transcription from RNA polymerase III promoter; IDA:UniProtKB
Q5SXM2	SNAPC4	snRNA-activating protein complex subunit 4	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q5SXM2	SNAPC4	snRNA-activating protein complex subunit 4	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
O75971	SNAPC5	snRNA-activating protein complex subunit 5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O75971	SNAPC5	snRNA-activating protein complex subunit 5	GO:0010467; P:gene expression; TAS:Reactome
O75971	SNAPC5	snRNA-activating protein complex subunit 5	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
O75971	SNAPC5	snRNA-activating protein complex subunit 5	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
O75971	SNAPC5	snRNA-activating protein complex subunit 5	GO:0006384; P:transcription initiation from RNA polymerase III promoter; TAS:ProtInc
O15079	SNPH	Syntaphilin	GO:0017075; F:syntaxin-1 binding; NAS:UniProtKB
O15079	SNPH	Syntaphilin	GO:0007420; P:brain development; IEA:Ensembl
O15079	SNPH	Syntaphilin	GO:0030182; P:neuron differentiation; IEA:Ensembl
O15079	SNPH	Syntaphilin	GO:0007269; P:neurotransmitter secretion; NAS:UniProtKB
O15079	SNPH	Syntaphilin	GO:0016081; P:synaptic vesicle docking involved in exocytosis; NAS:UniProtKB
Q9BV90	SNRNP25	U11/U12 small nuclear ribonucleoprotein 25 kDa protein	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9BV90	SNRNP25	U11/U12 small nuclear ribonucleoprotein 25 kDa protein	GO:0008380; P:RNA splicing; IC:HGNC
Q8WVK2	SNRNP27	U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein	GO:0003676; F:nucleic acid binding; NAS:UniProtKB
Q8WVK2	SNRNP27	U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein	GO:0005515; F:protein binding; IPI:IntAct
Q8WVK2	SNRNP27	U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q8WVK2	SNRNP27	U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q96DI7	SNRNP40	U5 small nuclear ribonucleoprotein 40 kDa protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96DI7	SNRNP40	U5 small nuclear ribonucleoprotein 40 kDa protein	GO:0005515; F:protein binding; IPI:IntAct
Q96DI7	SNRNP40	U5 small nuclear ribonucleoprotein 40 kDa protein	GO:0010467; P:gene expression; TAS:Reactome
Q96DI7	SNRNP40	U5 small nuclear ribonucleoprotein 40 kDa protein	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q96DI7	SNRNP40	U5 small nuclear ribonucleoprotein 40 kDa protein	GO:0006396; P:RNA processing; TAS:ProtInc
Q96DI7	SNRNP40	U5 small nuclear ribonucleoprotein 40 kDa protein	GO:0008380; P:RNA splicing; TAS:Reactome
Q96DI7	SNRNP40	U5 small nuclear ribonucleoprotein 40 kDa protein	GO:0000375; P:RNA splicing, via transesterification reactions; TAS:UniProtKB
Q6IEG0	SNRNP48	U11/U12 small nuclear ribonucleoprotein 48 kDa protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6IEG0	SNRNP48	U11/U12 small nuclear ribonucleoprotein 48 kDa protein	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q6IEG0	SNRNP48	U11/U12 small nuclear ribonucleoprotein 48 kDa protein	GO:0008380; P:RNA splicing; IC:HGNC
Q9NRH2	SNRK	SNF-related serine/threonine-protein kinase	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9NRH2	SNRK	SNF-related serine/threonine-protein kinase	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q9NRH2	SNRK	SNF-related serine/threonine-protein kinase	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9NRH2	SNRK	SNF-related serine/threonine-protein kinase	GO:0030099; P:myeloid cell differentiation; TAS:UniProtKB
Q9NRH2	SNRK	SNF-related serine/threonine-protein kinase	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P09012	SNRPA	U1 small nuclear ribonucleoprotein A	GO:0000166; F:nucleotide binding; IEA:InterPro
P09012	SNRPA	U1 small nuclear ribonucleoprotein A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P09012	SNRPA	U1 small nuclear ribonucleoprotein A	GO:0005515; F:protein binding; IPI:IntAct
P09012	SNRPA	U1 small nuclear ribonucleoprotein A	GO:0003723; F:RNA binding; IDA:UniProtKB
P09012	SNRPA	U1 small nuclear ribonucleoprotein A	GO:0017069; F:snRNA binding; IEA:InterPro
P09012	SNRPA	U1 small nuclear ribonucleoprotein A	GO:0010467; P:gene expression; TAS:Reactome
P09012	SNRPA	U1 small nuclear ribonucleoprotein A	GO:0000398; P:mRNA splicing, via spliceosome; IC:HGNC
P09012	SNRPA	U1 small nuclear ribonucleoprotein A	GO:0008380; P:RNA splicing; TAS:Reactome
Q13424	SNTA1	Alpha-1-syntrophin	GO:0051117; F:ATPase binding; IPI:BHF-UCL
Q13424	SNTA1	Alpha-1-syntrophin	GO:0044325; F:ion channel binding; IPI:BHF-UCL
Q13424	SNTA1	Alpha-1-syntrophin	GO:0050998; F:nitric-oxide synthase binding; IPI:BHF-UCL
Q13424	SNTA1	Alpha-1-syntrophin	GO:0005515; F:protein binding; IPI:UniProtKB
Q13424	SNTA1	Alpha-1-syntrophin	GO:0006936; P:muscle contraction; TAS:ProtInc
Q13424	SNTA1	Alpha-1-syntrophin	GO:1902083; P:negative regulation of peptidyl-cysteine S-nitrosylation; IMP:BHF-UCL
Q13424	SNTA1	Alpha-1-syntrophin	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
Q13424	SNTA1	Alpha-1-syntrophin	GO:0002027; P:regulation of heart rate; IMP:BHF-UCL
Q13424	SNTA1	Alpha-1-syntrophin	GO:1902305; P:regulation of sodium ion transmembrane transport; IMP:BHF-UCL
Q13424	SNTA1	Alpha-1-syntrophin	GO:0003117; P:regulation of vasoconstriction by circulating norepinephrine; IEA:Ensembl
Q13424	SNTA1	Alpha-1-syntrophin	GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL
Q13424	SNTA1	Alpha-1-syntrophin	GO:0086005; P:ventricular cardiac muscle cell action potential; IMP:BHF-UCL
A6NMZ2	SNTN	Sentan	GO:0005509; F:calcium ion binding; IEA:InterPro
Q13884	SNTB1	Beta-1-syntrophin	GO:0005515; F:protein binding; IPI:UniProtKB
Q13884	SNTB1	Beta-1-syntrophin	GO:0006936; P:muscle contraction; TAS:ProtInc
Q13425	SNTB2	Beta-2-syntrophin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13425	SNTB2	Beta-2-syntrophin	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NSN8	SNTG1	Gamma-1-syntrophin	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q9NSN8	SNTG1	Gamma-1-syntrophin	GO:0007154; P:cell communication; TAS:ProtInc
Q9NY99	SNTG2	Gamma-2-syntrophin	GO:0030165; F:PDZ domain binding; IPI:UniProtKB
Q9NY99	SNTG2	Gamma-2-syntrophin	GO:0007417; P:central nervous system development; TAS:ProtInc
O43290	SART1	U4/U6.U5 tri-snRNP-associated protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O43290	SART1	U4/U6.U5 tri-snRNP-associated protein 1	GO:0005515; F:protein binding; IPI:IntAct
O43290	SART1	U4/U6.U5 tri-snRNP-associated protein 1	GO:0007050; P:cell cycle arrest; NAS:UniProtKB
O43290	SART1	U4/U6.U5 tri-snRNP-associated protein 1	GO:0097193; P:intrinsic apoptotic signaling pathway; NAS:UniProtKB
O43290	SART1	U4/U6.U5 tri-snRNP-associated protein 1	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
O43290	SART1	U4/U6.U5 tri-snRNP-associated protein 1	GO:0045585; P:positive regulation of cytotoxic T cell differentiation; IDA:UniProtKB
O43290	SART1	U4/U6.U5 tri-snRNP-associated protein 1	GO:0000387; P:spliceosomal snRNP assembly; TAS:BHF-UCL
Q53GS9	USP39	U4/U6.U5 tri-snRNP-associated protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q53GS9	USP39	U4/U6.U5 tri-snRNP-associated protein 2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q53GS9	USP39	U4/U6.U5 tri-snRNP-associated protein 2	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q53GS9	USP39	U4/U6.U5 tri-snRNP-associated protein 2	GO:0006397; P:mRNA processing; TAS:ProtInc
Q53GS9	USP39	U4/U6.U5 tri-snRNP-associated protein 2	GO:0008380; P:RNA splicing; TAS:ProtInc
Q53GS9	USP39	U4/U6.U5 tri-snRNP-associated protein 2	GO:0000245; P:spliceosomal complex assembly; TAS:ProtInc
Q53GS9	USP39	U4/U6.U5 tri-snRNP-associated protein 2	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q13573	SNW1	SNW domain-containing protein 1	GO:0005112; F:Notch binding; IPI:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0035257; F:nuclear hormone receptor binding; IDA:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0042974; F:retinoic acid receptor binding; IDA:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0046332; F:SMAD binding; IDA:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0042809; F:vitamin D receptor binding; IDA:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0071300; P:cellular response to retinoic acid; IDA:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0010467; P:gene expression; TAS:Reactome
Q13573	SNW1	SNW domain-containing protein 1	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IMP:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0000398; P:mRNA splicing, via spliceosome; IDA:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q13573	SNW1	SNW domain-containing protein 1	GO:0043923; P:positive regulation by host of viral transcription; IDA:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0051571; P:positive regulation of histone H3-K4 methylation; IMP:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; IMP:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0050769; P:positive regulation of neurogenesis; ISS:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0070564; P:positive regulation of vitamin D receptor signaling pathway; IDA:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0048385; P:regulation of retinoic acid receptor signaling pathway; IDA:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q13573	SNW1	SNW domain-containing protein 1	GO:0070562; P:regulation of vitamin D receptor signaling pathway; IDA:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0048384; P:retinoic acid receptor signaling pathway; IDA:UniProtKB
Q13573	SNW1	SNW domain-containing protein 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q13573	SNW1	SNW domain-containing protein 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9Y5X0	SNX10	Sorting nexin-10	GO:0005545; F:1-phosphatidylinositol binding; IMP:UniProtKB
Q9Y5X0	SNX10	Sorting nexin-10	GO:0051117; F:ATPase binding; IPI:UniProtKB
Q9Y5X0	SNX10	Sorting nexin-10	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q9Y5X0	SNX10	Sorting nexin-10	GO:0007032; P:endosome organization; IMP:UniProtKB
Q9Y5X0	SNX10	Sorting nexin-10	GO:0006886; P:intracellular protein transport; IBA:RefGenome
Q9Y5X0	SNX10	Sorting nexin-10	GO:0030316; P:osteoclast differentiation; ISS:UniProtKB
Q9Y5X0	SNX10	Sorting nexin-10	GO:0071539; P:protein localization to centrosome; IMP:UniProtKB
Q9Y5X0	SNX10	Sorting nexin-10	GO:0061512; P:protein localization to cilium; IMP:UniProtKB
Q9Y5W9	SNX11	Sorting nexin-11	GO:1901981; F:phosphatidylinositol phosphate binding; IDA:UniProtKB
Q9Y5W9	SNX11	Sorting nexin-11	GO:0006886; P:intracellular protein transport; IBA:RefGenome
Q9Y5W9	SNX11	Sorting nexin-11	GO:0016050; P:vesicle organization; IMP:UniProtKB
Q9UMY4	SNX12	Sorting nexin-12	GO:0035091; F:phosphatidylinositol binding; IBA:RefGenome
Q9UMY4	SNX12	Sorting nexin-12	GO:0005515; F:protein binding; IPI:IntAct
Q9UMY4	SNX12	Sorting nexin-12	GO:0006886; P:intracellular protein transport; IBA:RefGenome
Q9Y5W8	SNX13	Sorting nexin-13	GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB
Q9Y5W8	SNX13	Sorting nexin-13	GO:0006886; P:intracellular protein transport; IMP:UniProtKB
Q9Y5W8	SNX13	Sorting nexin-13	GO:0043547; P:positive regulation of GTPase activity; IDA:UniProtKB
Q9Y5W8	SNX13	Sorting nexin-13	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
Q9Y5W7	SNX14	Sorting nexin-14	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
Q9Y5W7	SNX14	Sorting nexin-14	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9Y5W7	SNX14	Sorting nexin-14	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
Q9NRS6	SNX15	Sorting nexin-15	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
Q9NRS6	SNX15	Sorting nexin-15	GO:0006886; P:intracellular protein transport; NAS:UniProtKB
P57768	SNX16	Sorting nexin-16	GO:0042802; F:identical protein binding; IPI:UniProtKB
P57768	SNX16	Sorting nexin-16	GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB
P57768	SNX16	Sorting nexin-16	GO:0045022; P:early endosome to late endosome transport; IMP:UniProtKB
P57768	SNX16	Sorting nexin-16	GO:0008333; P:endosome to lysosome transport; IMP:UniProtKB
P57768	SNX16	Sorting nexin-16	GO:0006622; P:protein targeting to lysosome; IMP:UniProtKB
Q15036	SNX17	Sorting nexin-17	GO:0050750; F:low-density lipoprotein particle receptor binding; IDA:UniProtKB
Q15036	SNX17	Sorting nexin-17	GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB
Q15036	SNX17	Sorting nexin-17	GO:0005515; F:protein binding; IPI:UniProtKB
Q15036	SNX17	Sorting nexin-17	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q15036	SNX17	Sorting nexin-17	GO:0005102; F:receptor binding; NAS:UniProtKB
Q15036	SNX17	Sorting nexin-17	GO:0006707; P:cholesterol catabolic process; IC:UniProtKB
Q15036	SNX17	Sorting nexin-17	GO:0016197; P:endosomal transport; NAS:UniProtKB
Q15036	SNX17	Sorting nexin-17	GO:0006886; P:intracellular protein transport; NAS:UniProtKB
Q15036	SNX17	Sorting nexin-17	GO:0006898; P:receptor-mediated endocytosis; IEA:Ensembl
Q15036	SNX17	Sorting nexin-17	GO:0030100; P:regulation of endocytosis; NAS:UniProtKB
Q15036	SNX17	Sorting nexin-17	GO:0007165; P:signal transduction; IEA:InterPro
Q96RF0	SNX18	Sorting nexin-18	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:FlyBase
Q96RF0	SNX18	Sorting nexin-18	GO:0005515; F:protein binding; IPI:UniProtKB
Q96RF0	SNX18	Sorting nexin-18	GO:0036089; P:cleavage furrow formation; IMP:UniProtKB
Q96RF0	SNX18	Sorting nexin-18	GO:0006897; P:endocytosis; IDA:UniProtKB
Q96RF0	SNX18	Sorting nexin-18	GO:0016197; P:endosomal transport; IMP:UniProtKB
Q96RF0	SNX18	Sorting nexin-18	GO:0006886; P:intracellular protein transport; IBA:RefGenome
Q96RF0	SNX18	Sorting nexin-18	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q96RF0	SNX18	Sorting nexin-18	GO:0000281; P:mitotic cytokinesis; IMP:UniProtKB
Q96RF0	SNX18	Sorting nexin-18	GO:0043547; P:positive regulation of GTPase activity; IDA:UniProtKB
Q92543	SNX19	Sorting nexin-19	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
Q92543	SNX19	Sorting nexin-19	GO:0005515; F:protein binding; IPI:IntAct
Q92543	SNX19	Sorting nexin-19	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q13596	SNX1	Sorting nexin-1	GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB
Q13596	SNX1	Sorting nexin-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13596	SNX1	Sorting nexin-1	GO:0034498; P:early endosome to Golgi transport; IMP:UniProtKB
Q13596	SNX1	Sorting nexin-1	GO:0006897; P:endocytosis; TAS:ProtInc
Q13596	SNX1	Sorting nexin-1	GO:0006886; P:intracellular protein transport; IMP:UniProtKB
Q13596	SNX1	Sorting nexin-1	GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl
Q7Z614	SNX20	Sorting nexin-20	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
Q7Z614	SNX20	Sorting nexin-20	GO:0005515; F:protein binding; IPI:IntAct
Q7Z614	SNX20	Sorting nexin-20	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q969T3	SNX21	Sorting nexin-21	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
Q969T3	SNX21	Sorting nexin-21	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96L94	SNX22	Sorting nexin-22	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
Q96L94	SNX22	Sorting nexin-22	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9Y343	SNX24	Sorting nexin-24	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
Q9Y343	SNX24	Sorting nexin-24	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9H3E2	SNX25	Sorting nexin-25	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
Q9H3E2	SNX25	Sorting nexin-25	GO:0060394; P:negative regulation of pathway-restricted SMAD protein phosphorylation; IMP:UniProt
Q9H3E2	SNX25	Sorting nexin-25	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IMP:UniProt
Q9H3E2	SNX25	Sorting nexin-25	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9H3E2	SNX25	Sorting nexin-25	GO:0032801; P:receptor catabolic process; IMP:UniProt
Q9H3E2	SNX25	Sorting nexin-25	GO:0038032; P:termination of G-protein coupled receptor signaling pathway; IEA:InterPro
Q96L92	SNX27	Sorting nexin-27	GO:0032266; F:phosphatidylinositol-3-phosphate binding; IDA:UniProtKB
Q96L92	SNX27	Sorting nexin-27	GO:0005515; F:protein binding; IPI:UniProtKB
Q96L92	SNX27	Sorting nexin-27	GO:0016197; P:endosomal transport; IMP:UniProtKB
Q96L92	SNX27	Sorting nexin-27	GO:0008333; P:endosome to lysosome transport; IEA:Ensembl
Q96L92	SNX27	Sorting nexin-27	GO:0001770; P:establishment of natural killer cell polarity; TAS:UniProtKB
Q96L92	SNX27	Sorting nexin-27	GO:0006886; P:intracellular protein transport; IMP:UniProtKB
Q96L92	SNX27	Sorting nexin-27	GO:1990126; P:retrograde transport, endosome to plasma membrane; IMP:UniProtKB
Q96L92	SNX27	Sorting nexin-27	GO:0007165; P:signal transduction; IEA:InterPro
Q8TEQ0	SNX29	Sorting nexin-29	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
O60749	SNX2	Sorting nexin-2	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
O60749	SNX2	Sorting nexin-2	GO:0005515; F:protein binding; IPI:UniProtKB
O60749	SNX2	Sorting nexin-2	GO:0006897; P:endocytosis; IEA:InterPro
O60749	SNX2	Sorting nexin-2	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q5VWJ9	SNX30	Sorting nexin-30	GO:0035091; F:phosphatidylinositol binding; IBA:RefGenome
Q5VWJ9	SNX30	Sorting nexin-30	GO:0005515; F:protein binding; IPI:IntAct
Q5VWJ9	SNX30	Sorting nexin-30	GO:0006915; P:apoptotic process; IBA:RefGenome
Q5VWJ9	SNX30	Sorting nexin-30	GO:0006886; P:intracellular protein transport; IBA:RefGenome
Q8N9S9	SNX31	Sorting nexin-31	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
Q8N9S9	SNX31	Sorting nexin-31	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q86XE0	SNX32	Sorting nexin-32	GO:0035091; F:phosphatidylinositol binding; IBA:RefGenome
Q86XE0	SNX32	Sorting nexin-32	GO:0006886; P:intracellular protein transport; IBA:RefGenome
Q8WV41	SNX33	Sorting nexin-33	GO:0042802; F:identical protein binding; IPI:IntAct
Q8WV41	SNX33	Sorting nexin-33	GO:0035091; F:phosphatidylinositol binding; IBA:RefGenome
Q8WV41	SNX33	Sorting nexin-33	GO:0005515; F:protein binding; IPI:IntAct
Q8WV41	SNX33	Sorting nexin-33	GO:0036089; P:cleavage furrow formation; IMP:UniProtKB
Q8WV41	SNX33	Sorting nexin-33	GO:0006897; P:endocytosis; IMP:UniProtKB
Q8WV41	SNX33	Sorting nexin-33	GO:0016197; P:endosomal transport; IMP:UniProtKB
Q8WV41	SNX33	Sorting nexin-33	GO:0007032; P:endosome organization; IMP:UniProtKB
Q8WV41	SNX33	Sorting nexin-33	GO:0006886; P:intracellular protein transport; IBA:RefGenome
Q8WV41	SNX33	Sorting nexin-33	GO:0044351; P:macropinocytosis; IMP:UniProtKB
Q8WV41	SNX33	Sorting nexin-33	GO:0097320; P:membrane tubulation; IDA:UniProtKB
Q8WV41	SNX33	Sorting nexin-33	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q8WV41	SNX33	Sorting nexin-33	GO:0000281; P:mitotic cytokinesis; IMP:UniProtKB
O60493	SNX3	Sorting nexin-3	GO:0032266; F:phosphatidylinositol-3-phosphate binding; IDA:UniProtKB
O60493	SNX3	Sorting nexin-3	GO:0005515; F:protein binding; IPI:IntAct
O60493	SNX3	Sorting nexin-3	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
O60493	SNX3	Sorting nexin-3	GO:0006897; P:endocytosis; TAS:ProtInc
O60493	SNX3	Sorting nexin-3	GO:0042541; P:hemoglobin biosynthetic process; IBA:RefGenome
O60493	SNX3	Sorting nexin-3	GO:0006886; P:intracellular protein transport; IBA:RefGenome
O95219	SNX4	Sorting nexin-4	GO:0035091; F:phosphatidylinositol binding; IMP:UniProtKB
O95219	SNX4	Sorting nexin-4	GO:0005515; F:protein binding; IPI:UniProtKB
O95219	SNX4	Sorting nexin-4	GO:0032456; P:endocytic recycling; IMP:UniProtKB
O95219	SNX4	Sorting nexin-4	GO:0006897; P:endocytosis; TAS:ProtInc
O95219	SNX4	Sorting nexin-4	GO:0006886; P:intracellular protein transport; IBA:RefGenome
O95219	SNX4	Sorting nexin-4	GO:0015031; P:protein transport; IMP:UniProtKB
Q9Y5X3	SNX5	Sorting nexin-5	GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB
Q9Y5X3	SNX5	Sorting nexin-5	GO:0006886; P:intracellular protein transport; IBA:RefGenome
Q9Y5X3	SNX5	Sorting nexin-5	GO:0006907; P:pinocytosis; IDA:UniProtKB
Q9UNH7	SNX6	Sorting nexin-6	GO:0035091; F:phosphatidylinositol binding; IBA:RefGenome
Q9UNH7	SNX6	Sorting nexin-6	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UNH7	SNX6	Sorting nexin-6	GO:0042803; F:protein homodimerization activity; IPI:HGNC
Q9UNH7	SNX6	Sorting nexin-6	GO:0006886; P:intracellular protein transport; IMP:UniProtKB
Q9UNH7	SNX6	Sorting nexin-6	GO:0007175; P:negative regulation of epidermal growth factor-activated receptor activity; NAS:UniProtKB
Q9UNH7	SNX6	Sorting nexin-6	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UNH7	SNX6	Sorting nexin-6	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:HGNC
Q9UNH7	SNX6	Sorting nexin-6	GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB
Q9UNH6	SNX7	Sorting nexin-7	GO:0035091; F:phosphatidylinositol binding; IBA:RefGenome
Q9UNH6	SNX7	Sorting nexin-7	GO:0005515; F:protein binding; IPI:IntAct
Q9UNH6	SNX7	Sorting nexin-7	GO:0006915; P:apoptotic process; IBA:RefGenome
Q9UNH6	SNX7	Sorting nexin-7	GO:0006886; P:intracellular protein transport; IBA:RefGenome
Q9Y5X2	SNX8	Sorting nexin-8	GO:0042802; F:identical protein binding; IPI:IntAct
Q9Y5X2	SNX8	Sorting nexin-8	GO:0035091; F:phosphatidylinositol binding; IMP:UniProtKB
Q9Y5X2	SNX8	Sorting nexin-8	GO:0005515; F:protein binding; IPI:IntAct
Q9Y5X2	SNX8	Sorting nexin-8	GO:0034498; P:early endosome to Golgi transport; IMP:UniProtKB
Q9Y5X2	SNX8	Sorting nexin-8	GO:0006886; P:intracellular protein transport; IMP:UniProtKB
Q9Y5X1	SNX9	Sorting nexin-9	GO:0005545; F:1-phosphatidylinositol binding; IDA:UniProtKB
Q9Y5X1	SNX9	Sorting nexin-9	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y5X1	SNX9	Sorting nexin-9	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q9Y5X1	SNX9	Sorting nexin-9	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q9Y5X1	SNX9	Sorting nexin-9	GO:0036089; P:cleavage furrow formation; IMP:UniProtKB
Q9Y5X1	SNX9	Sorting nexin-9	GO:0006897; P:endocytosis; IMP:UniProtKB
Q9Y5X1	SNX9	Sorting nexin-9	GO:0016197; P:endosomal transport; IMP:UniProtKB
Q9Y5X1	SNX9	Sorting nexin-9	GO:0006886; P:intracellular protein transport; IMP:UniProtKB
Q9Y5X1	SNX9	Sorting nexin-9	GO:0060988; P:lipid tube assembly; IDA:UniProtKB
Q9Y5X1	SNX9	Sorting nexin-9	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9Y5X1	SNX9	Sorting nexin-9	GO:0000281; P:mitotic cytokinesis; IMP:UniProtKB
Q9Y5X1	SNX9	Sorting nexin-9	GO:0043547; P:positive regulation of GTPase activity; IDA:UniProtKB
Q9Y5X1	SNX9	Sorting nexin-9	GO:0032461; P:positive regulation of protein oligomerization; IDA:UniProtKB
Q9Y5X1	SNX9	Sorting nexin-9	GO:0006898; P:receptor-mediated endocytosis; IMP:UniProtKB
Q9BZZ2	SIGLEC1	Sialoadhesin	GO:0030246; F:carbohydrate binding; NAS:UniProtKB
Q9BZZ2	SIGLEC1	Sialoadhesin	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
Q9BZZ2	SIGLEC1	Sialoadhesin	GO:0007160; P:cell-matrix adhesion; NAS:UniProtKB
Q9BZZ2	SIGLEC1	Sialoadhesin	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q9BZZ2	SIGLEC1	Sialoadhesin	GO:0006954; P:inflammatory response; NAS:UniProtKB
Q9BZZ2	SIGLEC1	Sialoadhesin	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl
Q9BZZ2	SIGLEC1	Sialoadhesin	GO:0070234; P:positive regulation of T cell apoptotic process; IEA:Ensembl
P46721	SLCO1A2	Solute carrier organic anion transporter family member 1A2	GO:0008514; F:organic anion transmembrane transporter activity; TAS:ProtInc
P46721	SLCO1A2	Solute carrier organic anion transporter family member 1A2	GO:0015721; P:bile acid and bile salt transport; TAS:Reactome
P46721	SLCO1A2	Solute carrier organic anion transporter family member 1A2	GO:0008206; P:bile acid metabolic process; TAS:Reactome
P46721	SLCO1A2	Solute carrier organic anion transporter family member 1A2	GO:0015711; P:organic anion transport; TAS:ProtInc
P46721	SLCO1A2	Solute carrier organic anion transporter family member 1A2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P46721	SLCO1A2	Solute carrier organic anion transporter family member 1A2	GO:0043252; P:sodium-independent organic anion transport; TAS:Reactome
P46721	SLCO1A2	Solute carrier organic anion transporter family member 1A2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9Y6L6	SLCO1B1	Solute carrier organic anion transporter family member 1B1	GO:0015347; F:sodium-independent organic anion transmembrane transporter activity; TAS:ProtInc
Q9Y6L6	SLCO1B1	Solute carrier organic anion transporter family member 1B1	GO:0015721; P:bile acid and bile salt transport; TAS:Reactome
Q9Y6L6	SLCO1B1	Solute carrier organic anion transporter family member 1B1	GO:0008206; P:bile acid metabolic process; TAS:Reactome
Q9Y6L6	SLCO1B1	Solute carrier organic anion transporter family member 1B1	GO:0015711; P:organic anion transport; TAS:ProtInc
Q9Y6L6	SLCO1B1	Solute carrier organic anion transporter family member 1B1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y6L6	SLCO1B1	Solute carrier organic anion transporter family member 1B1	GO:0043252; P:sodium-independent organic anion transport; TAS:Reactome
Q9Y6L6	SLCO1B1	Solute carrier organic anion transporter family member 1B1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9NPD5	SLCO1B3	Solute carrier organic anion transporter family member 1B3	GO:0008514; F:organic anion transmembrane transporter activity; TAS:ProtInc
Q9NPD5	SLCO1B3	Solute carrier organic anion transporter family member 1B3	GO:0015721; P:bile acid and bile salt transport; TAS:Reactome
Q9NPD5	SLCO1B3	Solute carrier organic anion transporter family member 1B3	GO:0008206; P:bile acid metabolic process; TAS:Reactome
Q9NPD5	SLCO1B3	Solute carrier organic anion transporter family member 1B3	GO:0015711; P:organic anion transport; TAS:ProtInc
Q9NPD5	SLCO1B3	Solute carrier organic anion transporter family member 1B3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NPD5	SLCO1B3	Solute carrier organic anion transporter family member 1B3	GO:0043252; P:sodium-independent organic anion transport; TAS:Reactome
Q9NPD5	SLCO1B3	Solute carrier organic anion transporter family member 1B3	GO:0055085; P:transmembrane transport; TAS:Reactome
G3V0H7	SLCO1B7	Putative solute carrier organic anion transporter family member 1B7	GO:0005215; F:transporter activity; IEA:InterPro
Q9NYB5	SLCO1C1	Solute carrier organic anion transporter family member 1C1	GO:0005215; F:transporter activity; IEA:InterPro
Q9NYB5	SLCO1C1	Solute carrier organic anion transporter family member 1C1	GO:0043252; P:sodium-independent organic anion transport; TAS:Reactome
Q9NYB5	SLCO1C1	Solute carrier organic anion transporter family member 1C1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q92959	SLCO2A1	Solute carrier organic anion transporter family member 2A1	GO:0005319; F:lipid transporter activity; TAS:ProtInc
Q92959	SLCO2A1	Solute carrier organic anion transporter family member 2A1	GO:0015132; F:prostaglandin transmembrane transporter activity; IEA:Ensembl
Q92959	SLCO2A1	Solute carrier organic anion transporter family member 2A1	GO:0006869; P:lipid transport; TAS:ProtInc
Q92959	SLCO2A1	Solute carrier organic anion transporter family member 2A1	GO:0043252; P:sodium-independent organic anion transport; TAS:Reactome
Q92959	SLCO2A1	Solute carrier organic anion transporter family member 2A1	GO:0055085; P:transmembrane transport; TAS:Reactome
O94956	SLCO2B1	Solute carrier organic anion transporter family member 2B1	GO:0015125; F:bile acid transmembrane transporter activity; IEA:Ensembl
O94956	SLCO2B1	Solute carrier organic anion transporter family member 2B1	GO:0008514; F:organic anion transmembrane transporter activity; IDA:UniProtKB
O94956	SLCO2B1	Solute carrier organic anion transporter family member 2B1	GO:0015347; F:sodium-independent organic anion transmembrane transporter activity; IDA:UniProtKB
O94956	SLCO2B1	Solute carrier organic anion transporter family member 2B1	GO:0001889; P:liver development; IEA:Ensembl
O94956	SLCO2B1	Solute carrier organic anion transporter family member 2B1	GO:0071718; P:sodium-independent icosanoid transport; IEA:Ensembl
O94956	SLCO2B1	Solute carrier organic anion transporter family member 2B1	GO:0043252; P:sodium-independent organic anion transport; TAS:Reactome
O94956	SLCO2B1	Solute carrier organic anion transporter family member 2B1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UIG8	SLCO3A1	Solute carrier organic anion transporter family member 3A1	GO:0005215; F:transporter activity; IEA:InterPro
Q9UIG8	SLCO3A1	Solute carrier organic anion transporter family member 3A1	GO:0043252; P:sodium-independent organic anion transport; TAS:Reactome
Q9UIG8	SLCO3A1	Solute carrier organic anion transporter family member 3A1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q96BD0	SLCO4A1	Solute carrier organic anion transporter family member 4A1	GO:0005215; F:transporter activity; IEA:InterPro
Q96BD0	SLCO4A1	Solute carrier organic anion transporter family member 4A1	GO:0043252; P:sodium-independent organic anion transport; TAS:Reactome
Q96BD0	SLCO4A1	Solute carrier organic anion transporter family member 4A1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q6ZQN7	SLCO4C1	Solute carrier organic anion transporter family member 4C1	GO:0005215; F:transporter activity; IEA:InterPro
Q6ZQN7	SLCO4C1	Solute carrier organic anion transporter family member 4C1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q6ZQN7	SLCO4C1	Solute carrier organic anion transporter family member 4C1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q6ZQN7	SLCO4C1	Solute carrier organic anion transporter family member 4C1	GO:0043252; P:sodium-independent organic anion transport; TAS:Reactome
Q6ZQN7	SLCO4C1	Solute carrier organic anion transporter family member 4C1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q6ZQN7	SLCO4C1	Solute carrier organic anion transporter family member 4C1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9H2Y9	SLCO5A1	Solute carrier organic anion transporter family member 5A1	GO:0005215; F:transporter activity; IEA:InterPro
Q86UG4	SLCO6A1	Solute carrier organic anion transporter family member 6A1	GO:0005215; F:transporter activity; IEA:InterPro
P35610	SOAT1	Sterol O-acyltransferase 1	GO:0015485; F:cholesterol binding; IDA:BHF-UCL
P35610	SOAT1	Sterol O-acyltransferase 1	GO:0034736; F:cholesterol O-acyltransferase activity; IDA:BHF-UCL
P35610	SOAT1	Sterol O-acyltransferase 1	GO:0000062; F:fatty-acyl-CoA binding; IDA:BHF-UCL
P35610	SOAT1	Sterol O-acyltransferase 1	GO:0005515; F:protein binding; IPI:IntAct
P35610	SOAT1	Sterol O-acyltransferase 1	GO:0004772; F:sterol O-acyltransferase activity; IMP:BHF-UCL
P35610	SOAT1	Sterol O-acyltransferase 1	GO:0033344; P:cholesterol efflux; IMP:BHF-UCL
P35610	SOAT1	Sterol O-acyltransferase 1	GO:0034435; P:cholesterol esterification; IDA:BHF-UCL
P35610	SOAT1	Sterol O-acyltransferase 1	GO:0042632; P:cholesterol homeostasis; TAS:BHF-UCL
P35610	SOAT1	Sterol O-acyltransferase 1	GO:0008203; P:cholesterol metabolic process; IDA:BHF-UCL
P35610	SOAT1	Sterol O-acyltransferase 1	GO:0010878; P:cholesterol storage; IMP:BHF-UCL
P35610	SOAT1	Sterol O-acyltransferase 1	GO:0010742; P:macrophage derived foam cell differentiation; IMP:BHF-UCL
P35610	SOAT1	Sterol O-acyltransferase 1	GO:0042986; P:positive regulation of amyloid precursor protein biosynthetic process; IMP:BHF-UCL
P35610	SOAT1	Sterol O-acyltransferase 1	GO:0034379; P:very-low-density lipoprotein particle assembly; IMP:BHF-UCL
O75908	SOAT2	Sterol O-acyltransferase 2	GO:0015485; F:cholesterol binding; IDA:BHF-UCL
O75908	SOAT2	Sterol O-acyltransferase 2	GO:0034736; F:cholesterol O-acyltransferase activity; IDA:BHF-UCL
O75908	SOAT2	Sterol O-acyltransferase 2	GO:0000062; F:fatty-acyl-CoA binding; IDA:BHF-UCL
O75908	SOAT2	Sterol O-acyltransferase 2	GO:0016746; F:transferase activity, transferring acyl groups; TAS:ProtInc
O75908	SOAT2	Sterol O-acyltransferase 2	GO:0033344; P:cholesterol efflux; IMP:BHF-UCL
O75908	SOAT2	Sterol O-acyltransferase 2	GO:0034435; P:cholesterol esterification; IDA:BHF-UCL
O75908	SOAT2	Sterol O-acyltransferase 2	GO:0042632; P:cholesterol homeostasis; TAS:BHF-UCL
O75908	SOAT2	Sterol O-acyltransferase 2	GO:0008203; P:cholesterol metabolic process; IDA:BHF-UCL
O75908	SOAT2	Sterol O-acyltransferase 2	GO:0030299; P:intestinal cholesterol absorption; IC:BHF-UCL
O75908	SOAT2	Sterol O-acyltransferase 2	GO:0010742; P:macrophage derived foam cell differentiation; TAS:BHF-UCL
O75908	SOAT2	Sterol O-acyltransferase 2	GO:0034379; P:very-low-density lipoprotein particle assembly; IMP:BHF-UCL
Q3KNW5	SLC10A6	Solute carrier family 10 member 6	GO:0008508; F:bile acid:sodium symporter activity; IEA:InterPro
Q3KNW5	SLC10A6	Solute carrier family 10 member 6	GO:0043250; F:sodium-dependent organic anion transmembrane transporter activity; IEA:Ensembl
Q3KNW5	SLC10A6	Solute carrier family 10 member 6	GO:0043251; P:sodium-dependent organic anion transport; IEA:Ensembl
Q3KNW5	SLC10A6	Solute carrier family 10 member 6	GO:0055085; P:transmembrane transport; TAS:Reactome
A7XYQ1	SOBP	Sine oculis-binding protein homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A7XYQ1	SOBP	Sine oculis-binding protein homolog	GO:0032184; F:SUMO polymer binding; IDA:UniProtKB
A7XYQ1	SOBP	Sine oculis-binding protein homolog	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
A7XYQ1	SOBP	Sine oculis-binding protein homolog	GO:0007626; P:locomotory behavior; IEA:Ensembl
A7XYQ1	SOBP	Sine oculis-binding protein homolog	GO:0007605; P:sensory perception of sound; IEA:Ensembl
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0005159; F:insulin-like growth factor receptor binding; IPI:UniProtKB
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0019210; F:kinase inhibitor activity; ISS:UniProtKB
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0005515; F:protein binding; IPI:UniProtKB
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0004860; F:protein kinase inhibitor activity; TAS:ProtInc
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0019221; P:cytokine-mediated signaling pathway; ISS:UniProtKB
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0045444; P:fat cell differentiation; IEA:Ensembl
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0007259; P:JAK-STAT cascade; TAS:ProtInc
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0046627; P:negative regulation of insulin receptor signaling pathway; ISS:UniProtKB
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0046426; P:negative regulation of JAK-STAT cascade; ISS:UniProtKB
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0006469; P:negative regulation of protein kinase activity; TAS:GOC
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0042518; P:negative regulation of tyrosine phosphorylation of Stat3 protein; ISS:UniProtKB
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; TAS:Reactome
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0001932; P:regulation of protein phosphorylation; ISS:UniProtKB
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
O15524	SOCS1	Suppressor of cytokine signaling 1	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
O14508	SOCS2	Suppressor of cytokine signaling 2	GO:0005131; F:growth hormone receptor binding; NAS:UniProtKB
O14508	SOCS2	Suppressor of cytokine signaling 2	GO:0005159; F:insulin-like growth factor receptor binding; IPI:UniProtKB
O14508	SOCS2	Suppressor of cytokine signaling 2	GO:0008269; F:JAK pathway signal transduction adaptor activity; TAS:ProtInc
O14508	SOCS2	Suppressor of cytokine signaling 2	GO:0005515; F:protein binding; IPI:IntAct
O14508	SOCS2	Suppressor of cytokine signaling 2	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
O14508	SOCS2	Suppressor of cytokine signaling 2	GO:0007568; P:aging; IEA:Ensembl
O14508	SOCS2	Suppressor of cytokine signaling 2	GO:0032870; P:cellular response to hormone stimulus; IDA:BHF-UCL
O14508	SOCS2	Suppressor of cytokine signaling 2	GO:0060396; P:growth hormone receptor signaling pathway; IDA:BHF-UCL
O14508	SOCS2	Suppressor of cytokine signaling 2	GO:0007259; P:JAK-STAT cascade; TAS:ProtInc
O14508	SOCS2	Suppressor of cytokine signaling 2	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome
O14508	SOCS2	Suppressor of cytokine signaling 2	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
O14508	SOCS2	Suppressor of cytokine signaling 2	GO:0009968; P:negative regulation of signal transduction; IEA:UniProtKB-KW
O14508	SOCS2	Suppressor of cytokine signaling 2	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
O14508	SOCS2	Suppressor of cytokine signaling 2	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
O14508	SOCS2	Suppressor of cytokine signaling 2	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
O14508	SOCS2	Suppressor of cytokine signaling 2	GO:0046425; P:regulation of JAK-STAT cascade; TAS:GOC
O14508	SOCS2	Suppressor of cytokine signaling 2	GO:0009966; P:regulation of signal transduction; NAS:UniProtKB
O14508	SOCS2	Suppressor of cytokine signaling 2	GO:0032355; P:response to estradiol; IDA:BHF-UCL
O14543	SOCS3	Suppressor of cytokine signaling 3	GO:0005515; F:protein binding; IPI:IntAct
O14543	SOCS3	Suppressor of cytokine signaling 3	GO:0004860; F:protein kinase inhibitor activity; TAS:ProtInc
O14543	SOCS3	Suppressor of cytokine signaling 3	GO:0060670; P:branching involved in labyrinthine layer morphogenesis; IEA:Ensembl
O14543	SOCS3	Suppressor of cytokine signaling 3	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
O14543	SOCS3	Suppressor of cytokine signaling 3	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
O14543	SOCS3	Suppressor of cytokine signaling 3	GO:0007259; P:JAK-STAT cascade; TAS:ProtInc
O14543	SOCS3	Suppressor of cytokine signaling 3	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome
O14543	SOCS3	Suppressor of cytokine signaling 3	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
O14543	SOCS3	Suppressor of cytokine signaling 3	GO:0046627; P:negative regulation of insulin receptor signaling pathway; IEA:Ensembl
O14543	SOCS3	Suppressor of cytokine signaling 3	GO:0006469; P:negative regulation of protein kinase activity; TAS:GOC
O14543	SOCS3	Suppressor of cytokine signaling 3	GO:0060674; P:placenta blood vessel development; IEA:Ensembl
O14543	SOCS3	Suppressor of cytokine signaling 3	GO:0045597; P:positive regulation of cell differentiation; IEA:Ensembl
O14543	SOCS3	Suppressor of cytokine signaling 3	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
O14543	SOCS3	Suppressor of cytokine signaling 3	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
O14543	SOCS3	Suppressor of cytokine signaling 3	GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; TAS:Reactome
O14543	SOCS3	Suppressor of cytokine signaling 3	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
O14543	SOCS3	Suppressor of cytokine signaling 3	GO:0060708; P:spongiotrophoblast differentiation; IEA:Ensembl
O14543	SOCS3	Suppressor of cytokine signaling 3	GO:0060707; P:trophoblast giant cell differentiation; IEA:Ensembl
O14543	SOCS3	Suppressor of cytokine signaling 3	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q8WXH5	SOCS4	Suppressor of cytokine signaling 4	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8WXH5	SOCS4	Suppressor of cytokine signaling 4	GO:0007175; P:negative regulation of epidermal growth factor-activated receptor activity; IDA:UniProtKB
Q8WXH5	SOCS4	Suppressor of cytokine signaling 4	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8WXH5	SOCS4	Suppressor of cytokine signaling 4	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
O75159	SOCS5	Suppressor of cytokine signaling 5	GO:0005515; F:protein binding; IPI:UniProtKB
O75159	SOCS5	Suppressor of cytokine signaling 5	GO:0030971; F:receptor tyrosine kinase binding; IPI:UniProtKB
O75159	SOCS5	Suppressor of cytokine signaling 5	GO:0016049; P:cell growth; NAS:UniProtKB
O75159	SOCS5	Suppressor of cytokine signaling 5	GO:0019221; P:cytokine-mediated signaling pathway; ISS:UniProtKB
O75159	SOCS5	Suppressor of cytokine signaling 5	GO:0007173; P:epidermal growth factor receptor signaling pathway; IEA:Ensembl
O75159	SOCS5	Suppressor of cytokine signaling 5	GO:0035556; P:intracellular signal transduction; IEA:InterPro
O75159	SOCS5	Suppressor of cytokine signaling 5	GO:0007175; P:negative regulation of epidermal growth factor-activated receptor activity; IDA:UniProtKB
O75159	SOCS5	Suppressor of cytokine signaling 5	GO:0009968; P:negative regulation of signal transduction; NAS:UniProtKB
O75159	SOCS5	Suppressor of cytokine signaling 5	GO:0045629; P:negative regulation of T-helper 2 cell differentiation; ISS:UniProtKB
O75159	SOCS5	Suppressor of cytokine signaling 5	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB
O75159	SOCS5	Suppressor of cytokine signaling 5	GO:0045627; P:positive regulation of T-helper 1 cell differentiation; ISS:UniProtKB
O75159	SOCS5	Suppressor of cytokine signaling 5	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
O75159	SOCS5	Suppressor of cytokine signaling 5	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
O14512	SOCS7	Suppressor of cytokine signaling 7	GO:0005515; F:protein binding; IPI:IntAct
O14512	SOCS7	Suppressor of cytokine signaling 7	GO:0017124; F:SH3 domain binding; NAS:UniProtKB
O14512	SOCS7	Suppressor of cytokine signaling 7	GO:0045444; P:fat cell differentiation; IEA:Ensembl
O14512	SOCS7	Suppressor of cytokine signaling 7	GO:0008286; P:insulin receptor signaling pathway; IEA:Ensembl
O14512	SOCS7	Suppressor of cytokine signaling 7	GO:0035556; P:intracellular signal transduction; IEA:InterPro
O14512	SOCS7	Suppressor of cytokine signaling 7	GO:0009968; P:negative regulation of signal transduction; IEA:UniProtKB-KW
O14512	SOCS7	Suppressor of cytokine signaling 7	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
O14512	SOCS7	Suppressor of cytokine signaling 7	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
O14544	SOCS6	Suppressor of cytokine signaling 6	GO:0006952; P:defense response; TAS:ProtInc
O14544	SOCS6	Suppressor of cytokine signaling 6	GO:0007259; P:JAK-STAT cascade; TAS:ProtInc
O14544	SOCS6	Suppressor of cytokine signaling 6	GO:0009968; P:negative regulation of signal transduction; IEA:UniProtKB-KW
O14544	SOCS6	Suppressor of cytokine signaling 6	GO:0050868; P:negative regulation of T cell activation; IEA:Ensembl
O14544	SOCS6	Suppressor of cytokine signaling 6	GO:0010498; P:proteasomal protein catabolic process; IMP:MGI
O14544	SOCS6	Suppressor of cytokine signaling 6	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
O14544	SOCS6	Suppressor of cytokine signaling 6	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0051087; F:chaperone binding; IPI:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0005507; F:copper ion binding; IDA:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0042802; F:identical protein binding; IPI:IntAct
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0005515; F:protein binding; IPI:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0042803; F:protein homodimerization activity; NAS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0030346; F:protein phosphatase 2B binding; IDA:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0048365; F:Rac GTPase binding; IDA:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0004784; F:superoxide dismutase activity; IDA:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0000187; P:activation of MAPK activity; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0008089; P:anterograde axon cargo transport; ISS:BHF-UCL
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0006309; P:apoptotic DNA fragmentation; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0060088; P:auditory receptor cell stereocilium organization; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0007596; P:blood coagulation; TAS:Reactome
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0007569; P:cell aging; IMP:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0006879; P:cellular iron ion homeostasis; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0006302; P:double-strand break repair; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0007566; P:embryo implantation; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0006749; P:glutathione metabolic process; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0060047; P:heart contraction; IDA:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0050665; P:hydrogen peroxide biosynthetic process; IDA:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0007626; P:locomotory behavior; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0046716; P:muscle cell cellular homeostasis; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0002262; P:myeloid cell homeostasis; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0045541; P:negative regulation of cholesterol biosynthetic process; IDA:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0060052; P:neurofilament cytoskeleton organization; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0001541; P:ovarian follicle development; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0032287; P:peripheral nervous system myelin maintenance; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0001890; P:placenta development; NAS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0030168; P:platelet activation; TAS:Reactome
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0002576; P:platelet degranulation; TAS:Reactome
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0043065; P:positive regulation of apoptotic process; IC:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0043085; P:positive regulation of catalytic activity; IDA:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0001819; P:positive regulation of cytokine production; IDA:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:1902177; P:positive regulation of intrinsic apoptotic signaling pathway in response to oxidative stress; IMP:BHF-UCL
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0032930; P:positive regulation of superoxide anion generation; IDA:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0072593; P:reactive oxygen species metabolic process; IDA:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0008217; P:regulation of blood pressure; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0051881; P:regulation of mitochondrial membrane potential; IMP:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0040014; P:regulation of multicellular organism growth; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0046620; P:regulation of organ growth; NAS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0045859; P:regulation of protein kinase activity; IDA:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0032314; P:regulation of Rac GTPase activity; IDA:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0033081; P:regulation of T cell differentiation in thymus; NAS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0060087; P:relaxation of vascular smooth muscle; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0019430; P:removal of superoxide radicals; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0001975; P:response to amphetamine; IEA:Ensembl
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0048678; P:response to axon injury; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0046688; P:response to copper ion; IEA:Ensembl
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0042493; P:response to drug; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0045471; P:response to ethanol; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0009408; P:response to heat; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0042542; P:response to hydrogen peroxide; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0031667; P:response to nutrient levels; IEA:Ensembl
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0010033; P:response to organic substance; IDA:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0000303; P:response to superoxide; IDA:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0001895; P:retina homeostasis; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0008090; P:retrograde axon cargo transport; ISS:BHF-UCL
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0007605; P:sensory perception of sound; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0007283; P:spermatogenesis; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0042554; P:superoxide anion generation; IEA:Ensembl
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0006801; P:superoxide metabolic process; ISS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0048538; P:thymus development; NAS:UniProtKB
P00441	SOD1	Superoxide dismutase [Cu-Zn]	GO:0019226; P:transmission of nerve impulse; ISS:UniProtKB
P08294	SOD3	Extracellular superoxide dismutase [Cu-Zn]	GO:0005507; F:copper ion binding; IBA:RefGenome
P08294	SOD3	Extracellular superoxide dismutase [Cu-Zn]	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P08294	SOD3	Extracellular superoxide dismutase [Cu-Zn]	GO:0005515; F:protein binding; IPI:BHF-UCL
P08294	SOD3	Extracellular superoxide dismutase [Cu-Zn]	GO:0004784; F:superoxide dismutase activity; IBA:RefGenome
P08294	SOD3	Extracellular superoxide dismutase [Cu-Zn]	GO:0008270; F:zinc ion binding; IBA:RefGenome
P08294	SOD3	Extracellular superoxide dismutase [Cu-Zn]	GO:0019430; P:removal of superoxide radicals; IBA:RefGenome
P08294	SOD3	Extracellular superoxide dismutase [Cu-Zn]	GO:0046688; P:response to copper ion; IEA:Ensembl
P08294	SOD3	Extracellular superoxide dismutase [Cu-Zn]	GO:0001666; P:response to hypoxia; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0003677; F:DNA binding; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0042802; F:identical protein binding; IPI:IntAct
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0030145; F:manganese ion binding; IDA:UniProtKB
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0019825; F:oxygen binding; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0004784; F:superoxide dismutase activity; IDA:UniProtKB
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0001315; P:age-dependent response to reactive oxygen species; IMP:UniProtKB
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0071361; P:cellular response to ethanol; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0003032; P:detection of oxygen; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0048773; P:erythrophore differentiation; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0006749; P:glutathione metabolic process; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0007507; P:heart development; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0030097; P:hemopoiesis; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0050665; P:hydrogen peroxide biosynthetic process; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0055072; P:iron ion homeostasis; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0001889; P:liver development; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0007626; P:locomotory behavior; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0008285; P:negative regulation of cell proliferation; IMP:BHF-UCL
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0045599; P:negative regulation of fat cell differentiation; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0048147; P:negative regulation of fibroblast proliferation; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:1902176; P:negative regulation of intrinsic apoptotic signaling pathway in response to oxidative stress; IMP:BHF-UCL
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0043524; P:negative regulation of neuron apoptotic process; IGI:BHF-UCL
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0048666; P:neuron development; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0032364; P:oxygen homeostasis; IMP:BHF-UCL
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0009791; P:post-embryonic development; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0051289; P:protein homotetramerization; IPI:UniProtKB
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0008217; P:regulation of blood pressure; ISS:BHF-UCL
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0050790; P:regulation of catalytic activity; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0051881; P:regulation of mitochondrial membrane potential; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0001836; P:release of cytochrome c from mitochondria; ISS:BHF-UCL
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0019430; P:removal of superoxide radicals; IMP:BHF-UCL
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0022904; P:respiratory electron transport chain; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0014823; P:response to activity; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0048678; P:response to axon injury; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0046686; P:response to cadmium ion; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0042493; P:response to drug; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0051602; P:response to electrical stimulus; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0010332; P:response to gamma radiation; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0055093; P:response to hyperoxia; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0001666; P:response to hypoxia; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0033591; P:response to L-ascorbic acid; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0010042; P:response to manganese ion; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0010269; P:response to selenium ion; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0034021; P:response to silicon dioxide; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0000303; P:response to superoxide; IMP:BHF-UCL
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0010043; P:response to zinc ion; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0042554; P:superoxide anion generation; IEA:Ensembl
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0006801; P:superoxide metabolic process; IDA:UniProtKB
P04179	SOD2	Superoxide dismutase [Mn], mitochondrial	GO:0003069; P:vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure; ISS:BHF-UCL
O94964	SOGA1	Protein SOGA1	GO:0008286; P:insulin receptor signaling pathway; ISS:UniProt
O94964	SOGA1	Protein SOGA1	GO:0045721; P:negative regulation of gluconeogenesis; ISS:UniProt
O94964	SOGA1	Protein SOGA1	GO:0010506; P:regulation of autophagy; ISS:UniProtKB
Q5TF21	SOGA3	Protein SOGA3	GO:0010506; P:regulation of autophagy; IEA:InterPro
Q5JUK2	SOHLH1	Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5JUK2	SOHLH1	Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q5JUK2	SOHLH1	Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q5JUK2	SOHLH1	Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 1	GO:0048477; P:oogenesis; IEA:Ensembl
Q5JUK2	SOHLH1	Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 1	GO:0001541; P:ovarian follicle development; IEA:Ensembl
Q5JUK2	SOHLH1	Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q5JUK2	SOHLH1	Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q5JUK2	SOHLH1	Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NX45	SOHLH2	Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NX45	SOHLH2	Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9NX45	SOHLH2	Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9NX45	SOHLH2	Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2	GO:0048477; P:oogenesis; IEA:UniProtKB-KW
Q9NX45	SOHLH2	Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NX45	SOHLH2	Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q9NX45	SOHLH2	Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P01242	GH2	Growth hormone variant	GO:0005179; F:hormone activity; TAS:ProtInc
P01242	GH2	Growth hormone variant	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome
P01241	GH1	Somatotropin	GO:0008083; F:growth factor activity; IPI:BHF-UCL
P01241	GH1	Somatotropin	GO:0005131; F:growth hormone receptor binding; IPI:BHF-UCL
P01241	GH1	Somatotropin	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P01241	GH1	Somatotropin	GO:0005148; F:prolactin receptor binding; IPI:BHF-UCL
P01241	GH1	Somatotropin	GO:0005515; F:protein binding; IPI:IntAct
P01241	GH1	Somatotropin	GO:0070977; P:bone maturation; IDA:BHF-UCL
P01241	GH1	Somatotropin	GO:0015758; P:glucose transport; IDA:MGI
P01241	GH1	Somatotropin	GO:0060396; P:growth hormone receptor signaling pathway; IDA:BHF-UCL
P01241	GH1	Somatotropin	GO:0007259; P:JAK-STAT cascade; IDA:BHF-UCL
P01241	GH1	Somatotropin	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome
P01241	GH1	Somatotropin	GO:0010535; P:positive regulation of activation of JAK2 kinase activity; IDA:BHF-UCL
P01241	GH1	Somatotropin	GO:0043568; P:positive regulation of insulin-like growth factor receptor signaling pathway; IDA:BHF-UCL
P01241	GH1	Somatotropin	GO:0046427; P:positive regulation of JAK-STAT cascade; IDA:BHF-UCL
P01241	GH1	Somatotropin	GO:0043406; P:positive regulation of MAP kinase activity; TAS:BHF-UCL
P01241	GH1	Somatotropin	GO:0040018; P:positive regulation of multicellular organism growth; IDA:BHF-UCL
P01241	GH1	Somatotropin	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL
P01241	GH1	Somatotropin	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IDA:BHF-UCL
P01241	GH1	Somatotropin	GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IDA:BHF-UCL
P01241	GH1	Somatotropin	GO:0042523; P:positive regulation of tyrosine phosphorylation of Stat5 protein; IDA:BHF-UCL
P01241	GH1	Somatotropin	GO:0032355; P:response to estradiol; IDA:BHF-UCL
P18583	SON	Protein SON	GO:0003677; F:DNA binding; TAS:ProtInc
P18583	SON	Protein SON	GO:0003676; F:nucleic acid binding; TAS:UniProtKB
P18583	SON	Protein SON	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P18583	SON	Protein SON	GO:0005515; F:protein binding; IPI:UniProtKB
P18583	SON	Protein SON	GO:0003723; F:RNA binding; IDA:UniProtKB
P18583	SON	Protein SON	GO:0000910; P:cytokinesis; IMP:UniProtKB
P18583	SON	Protein SON	GO:0000226; P:microtubule cytoskeleton organization; IMP:UniProtKB
P18583	SON	Protein SON	GO:0006397; P:mRNA processing; IDA:UniProtKB
P18583	SON	Protein SON	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P18583	SON	Protein SON	GO:0051726; P:regulation of cell cycle; IMP:UniProtKB
P18583	SON	Protein SON	GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB
P18583	SON	Protein SON	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q8WY21	SORCS1	VPS10 domain-containing receptor SorCS1	GO:0008188; F:neuropeptide receptor activity; NAS:UniProtKB
Q8WY21	SORCS1	VPS10 domain-containing receptor SorCS1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WY21	SORCS1	VPS10 domain-containing receptor SorCS1	GO:0007218; P:neuropeptide signaling pathway; NAS:UniProtKB
Q96PQ0	SORCS2	VPS10 domain-containing receptor SorCS2	GO:0008188; F:neuropeptide receptor activity; NAS:UniProtKB
Q96PQ0	SORCS2	VPS10 domain-containing receptor SorCS2	GO:0007218; P:neuropeptide signaling pathway; NAS:UniProtKB
Q9UPU3	SORCS3	VPS10 domain-containing receptor SorCS3	GO:0008188; F:neuropeptide receptor activity; NAS:UniProtKB
Q9UPU3	SORCS3	VPS10 domain-containing receptor SorCS3	GO:0007218; P:neuropeptide signaling pathway; NAS:UniProtKB
P30626	SRI	Sorcin	GO:0005246; F:calcium channel regulator activity; TAS:ProtInc
P30626	SRI	Sorcin	GO:0005509; F:calcium ion binding; IEA:InterPro
P30626	SRI	Sorcin	GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; IBA:RefGenome
P30626	SRI	Sorcin	GO:0044325; F:ion channel binding; TAS:BHF-UCL
P30626	SRI	Sorcin	GO:0002020; F:protease binding; IPI:BHF-UCL
P30626	SRI	Sorcin	GO:0005515; F:protein binding; IPI:IntAct
P30626	SRI	Sorcin	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P30626	SRI	Sorcin	GO:0005102; F:receptor binding; TAS:ProtInc
P30626	SRI	Sorcin	GO:0001508; P:action potential; TAS:ProtInc
P30626	SRI	Sorcin	GO:0006816; P:calcium ion transport; IEA:Ensembl
P30626	SRI	Sorcin	GO:0042994; P:cytoplasmic sequestering of transcription factor; IEA:Ensembl
P30626	SRI	Sorcin	GO:0007507; P:heart development; TAS:ProtInc
P30626	SRI	Sorcin	GO:0006880; P:intracellular sequestering of iron ion; TAS:ProtInc
P30626	SRI	Sorcin	GO:0007517; P:muscle organ development; TAS:ProtInc
P30626	SRI	Sorcin	GO:0010459; P:negative regulation of heart rate; IMP:BHF-UCL
P30626	SRI	Sorcin	GO:0060315; P:negative regulation of ryanodine-sensitive calcium-release channel activity; IDA:BHF-UCL
P30626	SRI	Sorcin	GO:2000678; P:negative regulation of transcription regulatory region DNA binding; IEA:Ensembl
P30626	SRI	Sorcin	GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl
P30626	SRI	Sorcin	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IEA:Ensembl
P30626	SRI	Sorcin	GO:0006508; P:proteolysis; IBA:RefGenome
P30626	SRI	Sorcin	GO:0051924; P:regulation of calcium ion transport; IMP:BHF-UCL
P30626	SRI	Sorcin	GO:0086004; P:regulation of cardiac muscle cell contraction; IMP:BHF-UCL
P30626	SRI	Sorcin	GO:0010649; P:regulation of cell communication by electrical coupling; TAS:BHF-UCL
P30626	SRI	Sorcin	GO:1901844; P:regulation of cell communication by electrical coupling involved in cardiac conduction; IMP:BHF-UCL
P30626	SRI	Sorcin	GO:0008016; P:regulation of heart contraction; TAS:ProtInc
P30626	SRI	Sorcin	GO:1901841; P:regulation of high voltage-gated calcium channel activity; IMP:BHF-UCL
P30626	SRI	Sorcin	GO:1901077; P:regulation of relaxation of muscle; IMP:BHF-UCL
P30626	SRI	Sorcin	GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; TAS:BHF-UCL
P30626	SRI	Sorcin	GO:0006942; P:regulation of striated muscle contraction; TAS:ProtInc
P30626	SRI	Sorcin	GO:0007165; P:signal transduction; TAS:UniProtKB
P30626	SRI	Sorcin	GO:0006810; P:transport; TAS:ProtInc
Q92673	SORL1	Sortilin-related receptor	GO:0030306; F:ADP-ribosylation factor binding; IPI:Alzheimers_University_of_Toronto
Q92673	SORL1	Sortilin-related receptor	GO:0001540; F:beta-amyloid binding; IDA:Alzheimers_University_of_Toronto
Q92673	SORL1	Sortilin-related receptor	GO:0030169; F:low-density lipoprotein particle binding; IPI:BHF-UCL
Q92673	SORL1	Sortilin-related receptor	GO:0005515; F:protein binding; IPI:UniProtKB
Q92673	SORL1	Sortilin-related receptor	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q92673	SORL1	Sortilin-related receptor	GO:0042987; P:amyloid precursor protein catabolic process; IDA:Alzheimers_University_of_Toronto
Q92673	SORL1	Sortilin-related receptor	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q92673	SORL1	Sortilin-related receptor	GO:0016477; P:cell migration; IEA:Ensembl
Q92673	SORL1	Sortilin-related receptor	GO:0008283; P:cell proliferation; IEA:Ensembl
Q92673	SORL1	Sortilin-related receptor	GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW
Q92673	SORL1	Sortilin-related receptor	GO:0061502; P:early endosome to recycling endosome transport; IMP:Alzheimers_University_of_Toronto
Q92673	SORL1	Sortilin-related receptor	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q92673	SORL1	Sortilin-related receptor	GO:1902430; P:negative regulation of beta-amyloid formation; IDA:Alzheimers_University_of_Toronto
Q92673	SORL1	Sortilin-related receptor	GO:0032091; P:negative regulation of protein binding; IDA:Alzheimers_University_of_Toronto
Q92673	SORL1	Sortilin-related receptor	GO:0032460; P:negative regulation of protein oligomerization; IMP:Alzheimers_University_of_Toronto
Q92673	SORL1	Sortilin-related receptor	GO:2001137; P:positive regulation of endocytic recycling; IMP:Alzheimers_University_of_Toronto
Q92673	SORL1	Sortilin-related receptor	GO:0045732; P:positive regulation of protein catabolic process; IDA:Alzheimers_University_of_Toronto
Q92673	SORL1	Sortilin-related receptor	GO:0070863; P:positive regulation of protein exit from endoplasmic reticulum; IDA:Alzheimers_University_of_Toronto
Q92673	SORL1	Sortilin-related receptor	GO:0006892; P:post-Golgi vesicle-mediated transport; IDA:Alzheimers_University_of_Toronto
Q92673	SORL1	Sortilin-related receptor	GO:0036010; P:protein localization to endosome; IMP:Alzheimers_University_of_Toronto
Q92673	SORL1	Sortilin-related receptor	GO:0051604; P:protein maturation; IDA:Alzheimers_University_of_Toronto
Q92673	SORL1	Sortilin-related receptor	GO:0045053; P:protein retention in Golgi apparatus; IDA:Alzheimers_University_of_Toronto
Q92673	SORL1	Sortilin-related receptor	GO:0006605; P:protein targeting; IMP:UniProtKB
Q92673	SORL1	Sortilin-related receptor	GO:0000042; P:protein targeting to Golgi; IDA:Alzheimers_University_of_Toronto
Q92673	SORL1	Sortilin-related receptor	GO:0006622; P:protein targeting to lysosome; IDA:Alzheimers_University_of_Toronto
Q92673	SORL1	Sortilin-related receptor	GO:0006898; P:receptor-mediated endocytosis; TAS:ProtInc
Q92673	SORL1	Sortilin-related receptor	GO:0014910; P:regulation of smooth muscle cell migration; IDA:UniProtKB
Q92673	SORL1	Sortilin-related receptor	GO:0007165; P:signal transduction; TAS:GOC
Q99523	SORT1	Sortilin	GO:0019899; F:enzyme binding; IPI:BHF-UCL
Q99523	SORT1	Sortilin	GO:0048406; F:nerve growth factor binding; IPI:BHF-UCL
Q99523	SORT1	Sortilin	GO:0010465; F:nerve growth factor receptor activity; IDA:BHF-UCL
Q99523	SORT1	Sortilin	GO:0030379; F:neurotensin receptor activity, non-G-protein coupled; IDA:BHF-UCL
Q99523	SORT1	Sortilin	GO:0005515; F:protein binding; IPI:IntAct
Q99523	SORT1	Sortilin	GO:0006897; P:endocytosis; IDA:BHF-UCL
Q99523	SORT1	Sortilin	GO:0008333; P:endosome to lysosome transport; IDA:BHF-UCL
Q99523	SORT1	Sortilin	GO:0032509; P:endosome transport via multivesicular body sorting pathway; IDA:BHF-UCL
Q99523	SORT1	Sortilin	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IDA:BHF-UCL
Q99523	SORT1	Sortilin	GO:0007186; P:G-protein coupled receptor signaling pathway; IMP:BHF-UCL
Q99523	SORT1	Sortilin	GO:0046323; P:glucose import; IMP:BHF-UCL
Q99523	SORT1	Sortilin	GO:0006895; P:Golgi to endosome transport; IDA:BHF-UCL
Q99523	SORT1	Sortilin	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q99523	SORT1	Sortilin	GO:0014902; P:myotube differentiation; IMP:BHF-UCL
Q99523	SORT1	Sortilin	GO:0051005; P:negative regulation of lipoprotein lipase activity; IDA:BHF-UCL
Q99523	SORT1	Sortilin	GO:0038180; P:nerve growth factor signaling pathway; IDA:GOC
Q99523	SORT1	Sortilin	GO:0007218; P:neuropeptide signaling pathway; IDA:BHF-UCL
Q99523	SORT1	Sortilin	GO:0048011; P:neurotrophin TRK receptor signaling pathway; IMP:BHF-UCL
Q99523	SORT1	Sortilin	GO:0001503; P:ossification; IEA:UniProtKB-KW
Q99523	SORT1	Sortilin	GO:0048227; P:plasma membrane to endosome transport; IDA:BHF-UCL
Q99523	SORT1	Sortilin	GO:0010468; P:regulation of gene expression; IMP:BHF-UCL
Q99523	SORT1	Sortilin	GO:0032868; P:response to insulin; IMP:BHF-UCL
Q99523	SORT1	Sortilin	GO:0016050; P:vesicle organization; IDA:BHF-UCL
Q07889	SOS1	Son of sevenless homolog 1	GO:0003677; F:DNA binding; IEA:InterPro
Q07889	SOS1	Son of sevenless homolog 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q07889	SOS1	Son of sevenless homolog 1	GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; EXP:Reactome
Q07889	SOS1	Son of sevenless homolog 1	GO:0005100; F:Rho GTPase activator activity; TAS:ProtInc
Q07889	SOS1	Son of sevenless homolog 1	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; TAS:ProtInc
Q07889	SOS1	Son of sevenless homolog 1	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q07889	SOS1	Son of sevenless homolog 1	GO:0007411; P:axon guidance; TAS:Reactome
Q07889	SOS1	Son of sevenless homolog 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q07889	SOS1	Son of sevenless homolog 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q07889	SOS1	Son of sevenless homolog 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q07889	SOS1	Son of sevenless homolog 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q07889	SOS1	Son of sevenless homolog 1	GO:0045087; P:innate immune response; TAS:Reactome
Q07889	SOS1	Son of sevenless homolog 1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q07889	SOS1	Son of sevenless homolog 1	GO:0050900; P:leukocyte migration; TAS:Reactome
Q07889	SOS1	Son of sevenless homolog 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q07889	SOS1	Son of sevenless homolog 1	GO:0030168; P:platelet activation; TAS:Reactome
Q07889	SOS1	Son of sevenless homolog 1	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q07889	SOS1	Son of sevenless homolog 1	GO:0045742; P:positive regulation of epidermal growth factor receptor signaling pathway; IEA:Ensembl
Q07889	SOS1	Son of sevenless homolog 1	GO:0032321; P:positive regulation of Rho GTPase activity; TAS:GOC
Q07889	SOS1	Son of sevenless homolog 1	GO:0051057; P:positive regulation of small GTPase mediated signal transduction; IEA:Ensembl
Q07889	SOS1	Son of sevenless homolog 1	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
Q07889	SOS1	Son of sevenless homolog 1	GO:0032318; P:regulation of Ras GTPase activity; EXP:GOC
Q07889	SOS1	Son of sevenless homolog 1	GO:0032319; P:regulation of Rho GTPase activity; TAS:GOC
Q07889	SOS1	Son of sevenless homolog 1	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q07889	SOS1	Son of sevenless homolog 1	GO:0007165; P:signal transduction; NAS:ProtInc
Q07889	SOS1	Son of sevenless homolog 1	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q07890	SOS2	Son of sevenless homolog 2	GO:0003677; F:DNA binding; IEA:InterPro
Q07890	SOS2	Son of sevenless homolog 2	GO:0005515; F:protein binding; IPI:IntAct
Q07890	SOS2	Son of sevenless homolog 2	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q07890	SOS2	Son of sevenless homolog 2	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q07890	SOS2	Son of sevenless homolog 2	GO:0007411; P:axon guidance; TAS:Reactome
Q07890	SOS2	Son of sevenless homolog 2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q07890	SOS2	Son of sevenless homolog 2	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q07890	SOS2	Son of sevenless homolog 2	GO:0051057; P:positive regulation of small GTPase mediated signal transduction; IEA:Ensembl
Q07890	SOS2	Son of sevenless homolog 2	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q07890	SOS2	Son of sevenless homolog 2	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9BQ15	NABP2	SOSS complex subunit B1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BQ15	NABP2	SOSS complex subunit B1	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
Q9BQ15	NABP2	SOSS complex subunit B1	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
Q9BQ15	NABP2	SOSS complex subunit B1	GO:0006281; P:DNA repair; IMP:UniProtKB
Q9BQ15	NABP2	SOSS complex subunit B1	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
Q9BQ15	NABP2	SOSS complex subunit B1	GO:0007093; P:mitotic cell cycle checkpoint; IMP:UniProtKB
Q9BQ15	NABP2	SOSS complex subunit B1	GO:0010212; P:response to ionizing radiation; IMP:UniProtKB
Q96AH0	NABP1	SOSS complex subunit B2	GO:0003723; F:RNA binding; IEA:Ensembl
Q96AH0	NABP1	SOSS complex subunit B2	GO:0003697; F:single-stranded DNA binding; ISS:UniProtKB
Q96AH0	NABP1	SOSS complex subunit B2	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
Q96AH0	NABP1	SOSS complex subunit B2	GO:0006281; P:DNA repair; IMP:UniProtKB
Q96AH0	NABP1	SOSS complex subunit B2	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
Q96AH0	NABP1	SOSS complex subunit B2	GO:0007093; P:mitotic cell cycle checkpoint; IMP:UniProtKB
Q96AH0	NABP1	SOSS complex subunit B2	GO:0010212; P:response to ionizing radiation; IMP:UniProtKB
Q6X4U4	SOSTDC1	Sclerostin domain-containing protein 1	GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl
Q6X4U4	SOSTDC1	Sclerostin domain-containing protein 1	GO:0060648; P:mammary gland bud morphogenesis; IEA:Ensembl
Q6X4U4	SOSTDC1	Sclerostin domain-containing protein 1	GO:0030514; P:negative regulation of BMP signaling pathway; IEA:Ensembl
Q6X4U4	SOSTDC1	Sclerostin domain-containing protein 1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEA:Ensembl
Q6X4U4	SOSTDC1	Sclerostin domain-containing protein 1	GO:0010454; P:negative regulation of cell fate commitment; IEA:Ensembl
Q6X4U4	SOSTDC1	Sclerostin domain-containing protein 1	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
Q6X4U4	SOSTDC1	Sclerostin domain-containing protein 1	GO:0007389; P:pattern specification process; IEA:Ensembl
Q6X4U4	SOSTDC1	Sclerostin domain-containing protein 1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9NRY2	INIP	SOSS complex subunit C	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NRY2	INIP	SOSS complex subunit C	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
Q9NRY2	INIP	SOSS complex subunit C	GO:0006281; P:DNA repair; IMP:UniProtKB
Q9NRY2	INIP	SOSS complex subunit C	GO:0010212; P:response to ionizing radiation; IMP:UniProtKB
Q9BQB4	SOST	Sclerostin	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
Q9BQB4	SOST	Sclerostin	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BQB4	SOST	Sclerostin	GO:0008134; F:transcription factor binding; IDA:UniProtKB
Q9BQB4	SOST	Sclerostin	GO:0071374; P:cellular response to parathyroid hormone stimulus; IDA:UniProtKB
Q9BQB4	SOST	Sclerostin	GO:0030514; P:negative regulation of BMP signaling pathway; IDA:MGI
Q9BQB4	SOST	Sclerostin	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:BHF-UCL
Q9BQB4	SOST	Sclerostin	GO:0030279; P:negative regulation of ossification; NAS:UniProtKB
Q9BQB4	SOST	Sclerostin	GO:0031333; P:negative regulation of protein complex assembly; IDA:BHF-UCL
Q9BQB4	SOST	Sclerostin	GO:2000054; P:negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification; IDA:BHF-UCL
Q9BQB4	SOST	Sclerostin	GO:0001503; P:ossification; IEA:Ensembl
Q9BQB4	SOST	Sclerostin	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q9BQB4	SOST	Sclerostin	GO:0009612; P:response to mechanical stimulus; IEP:UniProtKB
Q9BQB4	SOST	Sclerostin	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P56693	SOX10	Transcription factor SOX-10	GO:0003682; F:chromatin binding; IEA:Ensembl
P56693	SOX10	Transcription factor SOX-10	GO:0042802; F:identical protein binding; IPI:IntAct
P56693	SOX10	Transcription factor SOX-10	GO:0005515; F:protein binding; IPI:IntAct
P56693	SOX10	Transcription factor SOX-10	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl
P56693	SOX10	Transcription factor SOX-10	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IEA:Ensembl
P56693	SOX10	Transcription factor SOX-10	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P56693	SOX10	Transcription factor SOX-10	GO:0001190; F:RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P56693	SOX10	Transcription factor SOX-10	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P56693	SOX10	Transcription factor SOX-10	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P56693	SOX10	Transcription factor SOX-10	GO:0048469; P:cell maturation; IEA:Ensembl
P56693	SOX10	Transcription factor SOX-10	GO:0048589; P:developmental growth; IEA:Ensembl
P56693	SOX10	Transcription factor SOX-10	GO:0048546; P:digestive tract morphogenesis; IEA:Ensembl
P56693	SOX10	Transcription factor SOX-10	GO:0048484; P:enteric nervous system development; IEA:Ensembl
P56693	SOX10	Transcription factor SOX-10	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P56693	SOX10	Transcription factor SOX-10	GO:0030318; P:melanocyte differentiation; IEA:Ensembl
P56693	SOX10	Transcription factor SOX-10	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P56693	SOX10	Transcription factor SOX-10	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEA:Ensembl
P56693	SOX10	Transcription factor SOX-10	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
P56693	SOX10	Transcription factor SOX-10	GO:0001755; P:neural crest cell migration; IEA:Ensembl
P56693	SOX10	Transcription factor SOX-10	GO:0048709; P:oligodendrocyte differentiation; IEA:Ensembl
P56693	SOX10	Transcription factor SOX-10	GO:0007422; P:peripheral nervous system development; IEA:Ensembl
P56693	SOX10	Transcription factor SOX-10	GO:0014015; P:positive regulation of gliogenesis; IEA:Ensembl
P56693	SOX10	Transcription factor SOX-10	GO:0002052; P:positive regulation of neuroblast proliferation; IEA:Ensembl
P56693	SOX10	Transcription factor SOX-10	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P35716	SOX11	Transcription factor SOX-11	GO:0001158; F:enhancer sequence-specific DNA binding; IDA:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0001071; F:nucleic acid binding transcription factor activity; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IDA:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0001105; F:RNA polymerase II transcription coactivator activity; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0008135; F:translation factor activity, nucleic acid binding; IDA:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0003211; P:cardiac ventricle formation; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0061386; P:closure of optic fissure; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0061303; P:cornea development in camera-type eye; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0048557; P:embryonic digestive tract morphogenesis; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0048704; P:embryonic skeletal system morphogenesis; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0061029; P:eyelid development in camera-type eye; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0021782; P:glial cell development; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0014009; P:glial cell proliferation; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0060022; P:hard palate development; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0001822; P:kidney development; IEA:Ensembl
P35716	SOX11	Transcription factor SOX-11	GO:0002089; P:lens morphogenesis in camera-type eye; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0060174; P:limb bud formation; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0060425; P:lung morphogenesis; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0060548; P:negative regulation of cell death; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0060253; P:negative regulation of glial cell proliferation; IMP:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0050672; P:negative regulation of lymphocyte proliferation; IMP:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:2000678; P:negative regulation of transcription regulatory region DNA binding; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0014032; P:neural crest cell development; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0001841; P:neural tube formation; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0060563; P:neuroepithelial cell differentiation; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0030182; P:neuron differentiation; IEP:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0003357; P:noradrenergic neuron differentiation; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0014003; P:oligodendrocyte development; IEA:Ensembl
P35716	SOX11	Transcription factor SOX-11	GO:0003151; P:outflow tract morphogenesis; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0030513; P:positive regulation of BMP signaling pathway; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0035332; P:positive regulation of hippo signaling; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0046887; P:positive regulation of hormone secretion; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:2001111; P:positive regulation of lens epithelial cell proliferation; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0050769; P:positive regulation of neurogenesis; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0045666; P:positive regulation of neuron differentiation; IMP:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0045778; P:positive regulation of ossification; IMP:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0045669; P:positive regulation of osteoblast differentiation; IMP:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:2000648; P:positive regulation of stem cell proliferation; IMP:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IEP:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0072395; P:signal transduction involved in cell cycle checkpoint; IEP:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
P35716	SOX11	Transcription factor SOX-11	GO:0001501; P:skeletal system development; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0060023; P:soft palate development; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0061053; P:somite development; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0021510; P:spinal cord development; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0048485; P:sympathetic nervous system development; ISS:UniProtKB
P35716	SOX11	Transcription factor SOX-11	GO:0006412; P:translation; IDA:GOC
P35716	SOX11	Transcription factor SOX-11	GO:0060412; P:ventricular septum morphogenesis; ISS:UniProtKB
Q9UN79	SOX13	Transcription factor SOX-13	GO:0005515; F:protein binding; IPI:IntAct
Q9UN79	SOX13	Transcription factor SOX-13	GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB
Q9UN79	SOX13	Transcription factor SOX-13	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9UN79	SOX13	Transcription factor SOX-13	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q9UN79	SOX13	Transcription factor SOX-13	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95416	SOX14	Transcription factor SOX-14	GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB
O95416	SOX14	Transcription factor SOX-14	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
O95416	SOX14	Transcription factor SOX-14	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
O95416	SOX14	Transcription factor SOX-14	GO:0007399; P:nervous system development; TAS:UniProtKB
O95416	SOX14	Transcription factor SOX-14	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60248	SOX15	Protein SOX-15	GO:0003682; F:chromatin binding; IEA:Ensembl
O60248	SOX15	Protein SOX-15	GO:0003677; F:DNA binding; NAS:UniProtKB
O60248	SOX15	Protein SOX-15	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
O60248	SOX15	Protein SOX-15	GO:0030154; P:cell differentiation; ISS:BHF-UCL
O60248	SOX15	Protein SOX-15	GO:0006325; P:chromatin organization; NAS:UniProtKB
O60248	SOX15	Protein SOX-15	GO:0008584; P:male gonad development; TAS:ProtInc
O60248	SOX15	Protein SOX-15	GO:0048627; P:myoblast development; ISS:BHF-UCL
O60248	SOX15	Protein SOX-15	GO:0045843; P:negative regulation of striated muscle tissue development; ISS:BHF-UCL
O60248	SOX15	Protein SOX-15	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
O60248	SOX15	Protein SOX-15	GO:0070318; P:positive regulation of G0 to G1 transition; ISS:BHF-UCL
O60248	SOX15	Protein SOX-15	GO:2000288; P:positive regulation of myoblast proliferation; ISS:BHF-UCL
O60248	SOX15	Protein SOX-15	GO:0014718; P:positive regulation of satellite cell activation involved in skeletal muscle regeneration; ISS:BHF-UCL
O60248	SOX15	Protein SOX-15	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
O60248	SOX15	Protein SOX-15	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O60248	SOX15	Protein SOX-15	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
O60248	SOX15	Protein SOX-15	GO:0043403; P:skeletal muscle tissue regeneration; IEA:Ensembl
O15370	SOX12	Transcription factor SOX-12	GO:0003677; F:DNA binding; NAS:UniProtKB
O15370	SOX12	Transcription factor SOX-12	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; ISS:UniProtKB
O15370	SOX12	Transcription factor SOX-12	GO:0001105; F:RNA polymerase II transcription coactivator activity; ISS:UniProtKB
O15370	SOX12	Transcription factor SOX-12	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; ISS:UniProtKB
O15370	SOX12	Transcription factor SOX-12	GO:0045165; P:cell fate commitment; IEP:UniProtKB
O15370	SOX12	Transcription factor SOX-12	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
O15370	SOX12	Transcription factor SOX-12	GO:0065004; P:protein-DNA complex assembly; IEA:Ensembl
O15370	SOX12	Transcription factor SOX-12	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; NAS:UniProtKB
O15370	SOX12	Transcription factor SOX-12	GO:0021510; P:spinal cord development; ISS:UniProtKB
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0008013; F:beta-catenin binding; IPI:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0003713; F:transcription coactivator activity; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0044212; F:transcription regulatory region DNA binding; ISS:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0001525; P:angiogenesis; ISS:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0060913; P:cardiac cell fate determination; IMP:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0003142; P:cardiogenic plate morphogenesis; ISS:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0042074; P:cell migration involved in gastrulation; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0061009; P:common bile duct development; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0048617; P:embryonic foregut morphogenesis; ISS:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0035050; P:embryonic heart tube development; ISS:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0003143; P:embryonic heart tube morphogenesis; ISS:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0060956; P:endocardial cell differentiation; ISS:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0060214; P:endocardium formation; ISS:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0001706; P:endoderm formation; IDA:UniProtKB
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0007493; P:endodermal cell fate determination; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0061031; P:endodermal digestive tract morphogenesis; ISS:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0061010; P:gall bladder development; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0060914; P:heart formation; TAS:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0001947; P:heart looping; ISS:UniProtKB
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0001828; P:inner cell mass cellular morphogenesis; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0042789; P:mRNA transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0030308; P:negative regulation of cell growth; IMP:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0042662; P:negative regulation of mesodermal cell fate specification; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0003308; P:negative regulation of Wnt signaling pathway involved in heart development; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0003151; P:outflow tract morphogenesis; ISS:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0045597; P:positive regulation of cell differentiation; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0048643; P:positive regulation of skeletal muscle tissue development; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0031648; P:protein destabilization; IMP:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0050821; P:protein stabilization; IMP:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:2000043; P:regulation of cardiac cell fate specification; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0045995; P:regulation of embryonic development; ISS:UniProtKB
Q9H6I2	SOX17	Transcription factor SOX-17	GO:2000035; P:regulation of stem cell division; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0072091; P:regulation of stem cell proliferation; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0060807; P:regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification; ISS:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0072001; P:renal system development; IMP:BHF-UCL
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0021903; P:rostrocaudal neural tube patterning; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0048866; P:stem cell fate specification; IEA:Ensembl
Q9H6I2	SOX17	Transcription factor SOX-17	GO:0001570; P:vasculogenesis; ISS:BHF-UCL
P35713	SOX18	Transcription factor SOX-18	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:BHF-UCL
P35713	SOX18	Transcription factor SOX-18	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:BHF-UCL
P35713	SOX18	Transcription factor SOX-18	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P35713	SOX18	Transcription factor SOX-18	GO:0001525; P:angiogenesis; IEP:UniProtKB
P35713	SOX18	Transcription factor SOX-18	GO:0043534; P:blood vessel endothelial cell migration; IEP:UniProtKB
P35713	SOX18	Transcription factor SOX-18	GO:0048469; P:cell maturation; IEA:Ensembl
P35713	SOX18	Transcription factor SOX-18	GO:0035050; P:embryonic heart tube development; ISS:BHF-UCL
P35713	SOX18	Transcription factor SOX-18	GO:0060956; P:endocardial cell differentiation; ISS:BHF-UCL
P35713	SOX18	Transcription factor SOX-18	GO:0060214; P:endocardium formation; ISS:BHF-UCL
P35713	SOX18	Transcription factor SOX-18	GO:0061028; P:establishment of endothelial barrier; IMP:UniProtKB
P35713	SOX18	Transcription factor SOX-18	GO:0022405; P:hair cycle process; IMP:UniProtKB
P35713	SOX18	Transcription factor SOX-18	GO:0001942; P:hair follicle development; IEA:Ensembl
P35713	SOX18	Transcription factor SOX-18	GO:0001947; P:heart looping; ISS:BHF-UCL
P35713	SOX18	Transcription factor SOX-18	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P35713	SOX18	Transcription factor SOX-18	GO:0001946; P:lymphangiogenesis; IMP:UniProtKB
P35713	SOX18	Transcription factor SOX-18	GO:0060836; P:lymphatic endothelial cell differentiation; ISS:BHF-UCL
P35713	SOX18	Transcription factor SOX-18	GO:0042789; P:mRNA transcription from RNA polymerase II promoter; IDA:BHF-UCL
P35713	SOX18	Transcription factor SOX-18	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P35713	SOX18	Transcription factor SOX-18	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:BHF-UCL
P35713	SOX18	Transcription factor SOX-18	GO:0003151; P:outflow tract morphogenesis; ISS:BHF-UCL
P35713	SOX18	Transcription factor SOX-18	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P35713	SOX18	Transcription factor SOX-18	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:BHF-UCL
P35713	SOX18	Transcription factor SOX-18	GO:0072091; P:regulation of stem cell proliferation; IEA:Ensembl
P35713	SOX18	Transcription factor SOX-18	GO:0048866; P:stem cell fate specification; IEA:Ensembl
P35713	SOX18	Transcription factor SOX-18	GO:0001944; P:vasculature development; ISS:BHF-UCL
P35713	SOX18	Transcription factor SOX-18	GO:0001570; P:vasculogenesis; ISS:BHF-UCL
O00570	SOX1	Transcription factor SOX-1	GO:0001046; F:core promoter sequence-specific DNA binding; IDA:UniProtKB
O00570	SOX1	Transcription factor SOX-1	GO:0003677; F:DNA binding; NAS:UniProtKB
O00570	SOX1	Transcription factor SOX-1	GO:0005515; F:protein binding; IPI:IntAct
O00570	SOX1	Transcription factor SOX-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
O00570	SOX1	Transcription factor SOX-1	GO:0006325; P:chromatin organization; NAS:UniProtKB
O00570	SOX1	Transcription factor SOX-1	GO:0021884; P:forebrain neuron development; IEA:Ensembl
O00570	SOX1	Transcription factor SOX-1	GO:0002089; P:lens morphogenesis in camera-type eye; IEA:Ensembl
O00570	SOX1	Transcription factor SOX-1	GO:0001764; P:neuron migration; IEA:Ensembl
O00570	SOX1	Transcription factor SOX-1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
O00570	SOX1	Transcription factor SOX-1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O00570	SOX1	Transcription factor SOX-1	GO:0021521; P:ventral spinal cord interneuron specification; IEA:Ensembl
Q9Y651	SOX21	Transcription factor SOX-21	GO:0003677; F:DNA binding; ISS:UniProtKB
Q9Y651	SOX21	Transcription factor SOX-21	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; NAS:UniProtKB
Q9Y651	SOX21	Transcription factor SOX-21	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q9Y651	SOX21	Transcription factor SOX-21	GO:0001942; P:hair follicle development; IEA:Ensembl
Q9Y651	SOX21	Transcription factor SOX-21	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; NAS:UniProtKB
Q9Y651	SOX21	Transcription factor SOX-21	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
Q9Y651	SOX21	Transcription factor SOX-21	GO:0048863; P:stem cell differentiation; IDA:UniProtKB
Q9Y651	SOX21	Transcription factor SOX-21	GO:0006366; P:transcription from RNA polymerase II promoter; NAS:GOC
P48431	SOX2	Transcription factor SOX-2	GO:0003682; F:chromatin binding; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0003677; F:DNA binding; IDA:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0035198; F:miRNA binding; IDA:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0005515; F:protein binding; IPI:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0043565; F:sequence-specific DNA binding; IDA:MGI
P48431	SOX2	Transcription factor SOX-2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0021984; P:adenohypophysis development; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0007050; P:cell cycle arrest; IDA:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0021987; P:cerebral cortex development; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0006325; P:chromatin organization; NAS:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0050973; P:detection of mechanical stimulus involved in equilibrioception; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0048852; P:diencephalon morphogenesis; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0001714; P:endodermal cell fate specification; IDA:MGI
P48431	SOX2	Transcription factor SOX-2	GO:0060441; P:epithelial tube branching involved in lung morphogenesis; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0001654; P:eye development; IEP:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0030900; P:forebrain development; IEP:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0021879; P:forebrain neuron differentiation; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0021781; P:glial cell fate commitment; NAS:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0048839; P:inner ear development; IEP:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0060235; P:lens induction in camera-type eye; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0048286; P:lung alveolus development; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0030539; P:male genitalia development; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0050680; P:negative regulation of epithelial cell proliferation; IDA:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0045665; P:negative regulation of neuron differentiation; ISS:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0048663; P:neuron fate commitment; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0097150; P:neuronal stem cell maintenance; ISS:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0030910; P:olfactory placode formation; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0001649; P:osteoblast differentiation; IDA:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0046148; P:pigment biosynthetic process; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0021983; P:pituitary gland development; IEP:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0030858; P:positive regulation of epithelial cell differentiation; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0043410; P:positive regulation of MAPK cascade; IDA:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0002052; P:positive regulation of neuroblast proliferation; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0045747; P:positive regulation of Notch signaling pathway; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0043281; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0010468; P:regulation of gene expression; IMP:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0070848; P:response to growth factor; IDA:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0032526; P:response to retinoic acid; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0009611; P:response to wounding; IEP:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0060042; P:retina morphogenesis in camera-type eye; IEA:Ensembl
P48431	SOX2	Transcription factor SOX-2	GO:0035019; P:somatic stem cell maintenance; IDA:UniProtKB
P48431	SOX2	Transcription factor SOX-2	GO:0043586; P:tongue development; IEA:Ensembl
O94993	SOX30	Transcription factor SOX-30	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
O94993	SOX30	Transcription factor SOX-30	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:UniProtKB
O94993	SOX30	Transcription factor SOX-30	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O94993	SOX30	Transcription factor SOX-30	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O94993	SOX30	Transcription factor SOX-30	GO:0031960; P:response to corticosteroid; IEP:UniProtKB
O94993	SOX30	Transcription factor SOX-30	GO:0007283; P:spermatogenesis; IEA:Ensembl
O94993	SOX30	Transcription factor SOX-30	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:GOC
O94993	SOX30	Transcription factor SOX-30	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P41225	SOX3	Transcription factor SOX-3	GO:0003677; F:DNA binding; TAS:ProtInc
P41225	SOX3	Transcription factor SOX-3	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; ISS:UniProtKB
P41225	SOX3	Transcription factor SOX-3	GO:0001106; F:RNA polymerase II transcription corepressor activity; ISS:UniProtKB
P41225	SOX3	Transcription factor SOX-3	GO:0007417; P:central nervous system development; TAS:ProtInc
P41225	SOX3	Transcription factor SOX-3	GO:0060324; P:face development; ISS:UniProtKB
P41225	SOX3	Transcription factor SOX-3	GO:0021854; P:hypothalamus development; ISS:UniProtKB
P41225	SOX3	Transcription factor SOX-3	GO:0045665; P:negative regulation of neuron differentiation; ISS:UniProtKB
P41225	SOX3	Transcription factor SOX-3	GO:0009887; P:organ morphogenesis; IEA:Ensembl
P41225	SOX3	Transcription factor SOX-3	GO:0021983; P:pituitary gland development; ISS:UniProtKB
P41225	SOX3	Transcription factor SOX-3	GO:0007423; P:sensory organ development; ISS:UniProtKB
P41225	SOX3	Transcription factor SOX-3	GO:0060009; P:Sertoli cell development; IEA:Ensembl
P41225	SOX3	Transcription factor SOX-3	GO:0007530; P:sex determination; IMP:UniProtKB
P41225	SOX3	Transcription factor SOX-3	GO:0048515; P:spermatid differentiation; IEA:Ensembl
P35711	SOX5	Transcription factor SOX-5	GO:0005515; F:protein binding; IPI:IntAct
P35711	SOX5	Transcription factor SOX-5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P35711	SOX5	Transcription factor SOX-5	GO:0044212; F:transcription regulatory region DNA binding; IEA:Ensembl
P35711	SOX5	Transcription factor SOX-5	GO:0051216; P:cartilage development; IEA:Ensembl
P35711	SOX5	Transcription factor SOX-5	GO:0045165; P:cell fate commitment; IEA:Ensembl
P35711	SOX5	Transcription factor SOX-5	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IDA:UniProtKB
P35711	SOX5	Transcription factor SOX-5	GO:0021953; P:central nervous system neuron differentiation; IEA:Ensembl
P35711	SOX5	Transcription factor SOX-5	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P35711	SOX5	Transcription factor SOX-5	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
P35711	SOX5	Transcription factor SOX-5	GO:0048709; P:oligodendrocyte differentiation; IEA:Ensembl
P35711	SOX5	Transcription factor SOX-5	GO:0061036; P:positive regulation of cartilage development; IDA:UniProtKB
P35711	SOX5	Transcription factor SOX-5	GO:0032332; P:positive regulation of chondrocyte differentiation; IDA:UniProtKB
P35711	SOX5	Transcription factor SOX-5	GO:2000741; P:positive regulation of mesenchymal stem cell differentiation; IDA:UniProtKB
P35711	SOX5	Transcription factor SOX-5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P35711	SOX5	Transcription factor SOX-5	GO:0060164; P:regulation of timing of neuron differentiation; IEA:Ensembl
P35711	SOX5	Transcription factor SOX-5	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P35712	SOX6	Transcription factor SOX-6	GO:0003677; F:DNA binding; NAS:UniProtKB
P35712	SOX6	Transcription factor SOX-6	GO:0005515; F:protein binding; IPI:IntAct
P35712	SOX6	Transcription factor SOX-6	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P35712	SOX6	Transcription factor SOX-6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
P35712	SOX6	Transcription factor SOX-6	GO:0044212; F:transcription regulatory region DNA binding; IEA:Ensembl
P35712	SOX6	Transcription factor SOX-6	GO:0048708; P:astrocyte differentiation; IEA:Ensembl
P35712	SOX6	Transcription factor SOX-6	GO:0035051; P:cardiocyte differentiation; IEA:Ensembl
P35712	SOX6	Transcription factor SOX-6	GO:0051216; P:cartilage development; IEA:Ensembl
P35712	SOX6	Transcription factor SOX-6	GO:0000902; P:cell morphogenesis; IEA:Ensembl
P35712	SOX6	Transcription factor SOX-6	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IDA:UniProtKB
P35712	SOX6	Transcription factor SOX-6	GO:0048821; P:erythrocyte development; IEA:Ensembl
P35712	SOX6	Transcription factor SOX-6	GO:0016458; P:gene silencing; IEA:Ensembl
P35712	SOX6	Transcription factor SOX-6	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P35712	SOX6	Transcription factor SOX-6	GO:0042692; P:muscle cell differentiation; IEA:Ensembl
P35712	SOX6	Transcription factor SOX-6	GO:0007517; P:muscle organ development; NAS:UniProtKB
P35712	SOX6	Transcription factor SOX-6	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P35712	SOX6	Transcription factor SOX-6	GO:0021778; P:oligodendrocyte cell fate specification; IEA:Ensembl
P35712	SOX6	Transcription factor SOX-6	GO:0061036; P:positive regulation of cartilage development; IDA:UniProtKB
P35712	SOX6	Transcription factor SOX-6	GO:0032332; P:positive regulation of chondrocyte differentiation; IDA:UniProtKB
P35712	SOX6	Transcription factor SOX-6	GO:2000741; P:positive regulation of mesenchymal stem cell differentiation; IDA:UniProtKB
P35712	SOX6	Transcription factor SOX-6	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P35712	SOX6	Transcription factor SOX-6	GO:0009791; P:post-embryonic development; IEA:Ensembl
P35712	SOX6	Transcription factor SOX-6	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P35712	SOX6	Transcription factor SOX-6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q06945	SOX4	Transcription factor SOX-4	GO:0001046; F:core promoter sequence-specific DNA binding; IDA:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0001071; F:nucleic acid binding transcription factor activity; IMP:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0005515; F:protein binding; IPI:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0001105; F:RNA polymerase II transcription coactivator activity; ISS:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q06945	SOX4	Transcription factor SOX-4	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; ISS:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0035910; P:ascending aorta morphogenesis; ISS:BHF-UCL
Q06945	SOX4	Transcription factor SOX-4	GO:0003289; P:atrial septum primum morphogenesis; ISS:BHF-UCL
Q06945	SOX4	Transcription factor SOX-4	GO:0060070; P:canonical Wnt signaling pathway; ISS:BHF-UCL
Q06945	SOX4	Transcription factor SOX-4	GO:0003215; P:cardiac right ventricle morphogenesis; ISS:BHF-UCL
Q06945	SOX4	Transcription factor SOX-4	GO:0003211; P:cardiac ventricle formation; ISS:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0071333; P:cellular response to glucose stimulus; ISS:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0042769; P:DNA damage response, detection of DNA damage; IDA:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; IMP:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0031018; P:endocrine pancreas development; IEA:Ensembl
Q06945	SOX4	Transcription factor SOX-4	GO:0021782; P:glial cell development; ISS:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0014009; P:glial cell proliferation; ISS:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0042593; P:glucose homeostasis; ISS:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0007507; P:heart development; ISS:BHF-UCL
Q06945	SOX4	Transcription factor SOX-4	GO:0060993; P:kidney morphogenesis; ISS:BHF-UCL
Q06945	SOX4	Transcription factor SOX-4	GO:0060174; P:limb bud formation; ISS:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0003183; P:mitral valve morphogenesis; ISS:BHF-UCL
Q06945	SOX4	Transcription factor SOX-4	GO:0060548; P:negative regulation of cell death; ISS:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0046826; P:negative regulation of protein export from nucleus; IMP:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0031397; P:negative regulation of protein ubiquitination; IMP:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0001841; P:neural tube formation; ISS:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0060563; P:neuroepithelial cell differentiation; ISS:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0003357; P:noradrenergic neuron differentiation; ISS:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; ISS:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0008284; P:positive regulation of cell proliferation; IMP:BHF-UCL
Q06945	SOX4	Transcription factor SOX-4	GO:0032024; P:positive regulation of insulin secretion; ISS:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:2000761; P:positive regulation of N-terminal peptidyl-lysine acetylation; IDA:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0045727; P:positive regulation of translation; IMP:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0030177; P:positive regulation of Wnt signaling pathway; ISS:BHF-UCL
Q06945	SOX4	Transcription factor SOX-4	GO:0002328; P:pro-B cell differentiation; ISS:BHF-UCL
Q06945	SOX4	Transcription factor SOX-4	GO:0050821; P:protein stabilization; IMP:BHF-UCL
Q06945	SOX4	Transcription factor SOX-4	GO:0031647; P:regulation of protein stability; IMP:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0006355; P:regulation of transcription, DNA-templated; IDA:BHF-UCL
Q06945	SOX4	Transcription factor SOX-4	GO:0001501; P:skeletal system development; ISS:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
Q06945	SOX4	Transcription factor SOX-4	GO:0021510; P:spinal cord development; ISS:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0021522; P:spinal cord motor neuron differentiation; ISS:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0048485; P:sympathetic nervous system development; ISS:UniProtKB
Q06945	SOX4	Transcription factor SOX-4	GO:0030217; P:T cell differentiation; ISS:BHF-UCL
Q06945	SOX4	Transcription factor SOX-4	GO:0060412; P:ventricular septum morphogenesis; ISS:BHF-UCL
Q9BT81	SOX7	Transcription factor SOX-7	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9BT81	SOX7	Transcription factor SOX-7	GO:0044212; F:transcription regulatory region DNA binding; ISS:BHF-UCL
Q9BT81	SOX7	Transcription factor SOX-7	GO:0001706; P:endoderm formation; IDA:UniProtKB
Q9BT81	SOX7	Transcription factor SOX-7	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q9BT81	SOX7	Transcription factor SOX-7	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9BT81	SOX7	Transcription factor SOX-7	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
Q9BT81	SOX7	Transcription factor SOX-7	GO:0060828; P:regulation of canonical Wnt signaling pathway; IDA:UniProtKB
Q9BT81	SOX7	Transcription factor SOX-7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P57073	SOX8	Transcription factor SOX-8	GO:0003677; F:DNA binding; NAS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P57073	SOX8	Transcription factor SOX-8	GO:0060612; P:adipose tissue development; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0060018; P:astrocyte fate commitment; IEA:Ensembl
P57073	SOX8	Transcription factor SOX-8	GO:0045165; P:cell fate commitment; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0048469; P:cell maturation; IEA:Ensembl
P57073	SOX8	Transcription factor SOX-8	GO:0048484; P:enteric nervous system development; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0045444; P:fat cell differentiation; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0001701; P:in utero embryonic development; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0008584; P:male gonad development; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0072289; P:metanephric nephron tubule formation; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0061138; P:morphogenesis of a branching epithelium; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0045662; P:negative regulation of myoblast differentiation; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0046533; P:negative regulation of photoreceptor cell differentiation; IEA:Ensembl
P57073	SOX8	Transcription factor SOX-8	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0001755; P:neural crest cell migration; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0048709; P:oligodendrocyte differentiation; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0001649; P:osteoblast differentiation; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0007422; P:peripheral nervous system development; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0014015; P:positive regulation of gliogenesis; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0090184; P:positive regulation of kidney development; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0033690; P:positive regulation of osteoblast proliferation; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0010817; P:regulation of hormone levels; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0072034; P:renal vesicle induction; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0060041; P:retina development in camera-type eye; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0060221; P:retinal rod cell differentiation; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0060009; P:Sertoli cell development; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0007165; P:signal transduction; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
P57073	SOX8	Transcription factor SOX-8	GO:0007283; P:spermatogenesis; ISS:UniProtKB
P57073	SOX8	Transcription factor SOX-8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P57073	SOX8	Transcription factor SOX-8	GO:0072197; P:ureter morphogenesis; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0003682; F:chromatin binding; IDA:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0001046; F:core promoter sequence-specific DNA binding; IDA:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0035326; F:enhancer binding; IDA:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0001158; F:enhancer sequence-specific DNA binding; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0005515; F:protein binding; IPI:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0034236; F:protein kinase A catalytic subunit binding; IPI:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0004672; F:protein kinase activity; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0060018; P:astrocyte fate commitment; IEA:Ensembl
P48436	SOX9	Transcription factor SOX-9	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
P48436	SOX9	Transcription factor SOX-9	GO:0019933; P:cAMP-mediated signaling; IDA:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0001502; P:cartilage condensation; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0051216; P:cartilage development; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0001708; P:cell fate specification; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0071364; P:cellular response to epidermal growth factor stimulus; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0071504; P:cellular response to heparin; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0071347; P:cellular response to interleukin-1; IEP:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0071260; P:cellular response to mechanical stimulus; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0071300; P:cellular response to retinoic acid; IEP:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IDA:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0003413; P:chondrocyte differentiation involved in endochondral bone morphogenesis; IMP:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0003415; P:chondrocyte hypertrophy; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0006338; P:chromatin remodeling; IDA:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0090103; P:cochlea morphogenesis; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0003203; P:endocardial cushion morphogenesis; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0031018; P:endocrine pancreas development; IEA:Ensembl
P48436	SOX9	Transcription factor SOX-9	GO:0007173; P:epidermal growth factor receptor signaling pathway; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0060517; P:epithelial cell proliferation involved in prostatic bud elongation; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0001837; P:epithelial to mesenchymal transition; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0070371; P:ERK1 and ERK2 cascade; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
P48436	SOX9	Transcription factor SOX-9	GO:0001942; P:hair follicle development; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0003170; P:heart valve development; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0003188; P:heart valve formation; IEA:Ensembl
P48436	SOX9	Transcription factor SOX-9	GO:0003179; P:heart valve morphogenesis; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0060729; P:intestinal epithelial structure maintenance; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0035622; P:intrahepatic bile duct development; IEA:Ensembl
P48436	SOX9	Transcription factor SOX-9	GO:0060174; P:limb bud formation; IEA:Ensembl
P48436	SOX9	Transcription factor SOX-9	GO:0019100; P:male germ-line sex determination; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0008584; P:male gonad development; IMP:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0030879; P:mammary gland development; IEA:Ensembl
P48436	SOX9	Transcription factor SOX-9	GO:0072289; P:metanephric nephron tubule formation; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0061138; P:morphogenesis of a branching epithelium; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0070168; P:negative regulation of biomineral tissue development; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0030502; P:negative regulation of bone mineralization; IEA:Ensembl
P48436	SOX9	Transcription factor SOX-9	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0032331; P:negative regulation of chondrocyte differentiation; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0050680; P:negative regulation of epithelial cell proliferation; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0002683; P:negative regulation of immune system process; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0045662; P:negative regulation of myoblast differentiation; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0030279; P:negative regulation of ossification; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0046533; P:negative regulation of photoreceptor cell differentiation; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0014032; P:neural crest cell development; IEA:Ensembl
P48436	SOX9	Transcription factor SOX-9	GO:0030903; P:notochord development; IEA:Ensembl
P48436	SOX9	Transcription factor SOX-9	GO:0006334; P:nucleosome assembly; IDA:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0048709; P:oligodendrocyte differentiation; IEA:Ensembl
P48436	SOX9	Transcription factor SOX-9	GO:0001503; P:ossification; IEA:Ensembl
P48436	SOX9	Transcription factor SOX-9	GO:0030916; P:otic vesicle formation; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0061036; P:positive regulation of cartilage development; IDA:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:2000138; P:positive regulation of cell proliferation involved in heart morphogenesis; IEA:Ensembl
P48436	SOX9	Transcription factor SOX-9	GO:0032332; P:positive regulation of chondrocyte differentiation; IDA:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0030858; P:positive regulation of epithelial cell differentiation; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0010634; P:positive regulation of epithelial cell migration; IMP:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0050679; P:positive regulation of epithelial cell proliferation; IEP:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0090184; P:positive regulation of kidney development; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:2000020; P:positive regulation of male gonad development; IDA:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0002053; P:positive regulation of mesenchymal cell proliferation; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:2000741; P:positive regulation of mesenchymal stem cell differentiation; IDA:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl
P48436	SOX9	Transcription factor SOX-9	GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0030850; P:prostate gland development; IEP:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0006461; P:protein complex assembly; IDA:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0043491; P:protein kinase B signaling; IEA:Ensembl
P48436	SOX9	Transcription factor SOX-9	GO:0042981; P:regulation of apoptotic process; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0030155; P:regulation of cell adhesion; IEA:Ensembl
P48436	SOX9	Transcription factor SOX-9	GO:0010564; P:regulation of cell cycle process; IMP:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0042127; P:regulation of cell proliferation; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0060784; P:regulation of cell proliferation involved in tissue homeostasis; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0072034; P:renal vesicle induction; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0060041; P:retina development in camera-type eye; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0060221; P:retinal rod cell differentiation; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0060009; P:Sertoli cell development; IEA:Ensembl
P48436	SOX9	Transcription factor SOX-9	GO:0060008; P:Sertoli cell differentiation; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0007165; P:signal transduction; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0001501; P:skeletal system development; IMP:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0035019; P:somatic stem cell maintenance; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0007283; P:spermatogenesis; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0001894; P:tissue homeostasis; ISS:UniProtKB
P48436	SOX9	Transcription factor SOX-9	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:GOC
P48436	SOX9	Transcription factor SOX-9	GO:0072197; P:ureter morphogenesis; IEA:Ensembl
P48436	SOX9	Transcription factor SOX-9	GO:0072190; P:ureter urothelium development; IEA:Ensembl
Q9P0Z9	PIPOX	Peroxisomal sarcosine oxidase	GO:0050031; F:L-pipecolate oxidase activity; IDA:UniProtKB
Q9P0Z9	PIPOX	Peroxisomal sarcosine oxidase	GO:0005102; F:receptor binding; IPI:UniProtKB
Q9P0Z9	PIPOX	Peroxisomal sarcosine oxidase	GO:0008115; F:sarcosine oxidase activity; IDA:UniProtKB
Q9P0Z9	PIPOX	Peroxisomal sarcosine oxidase	GO:0033514; P:L-lysine catabolic process to acetyl-CoA via L-pipecolate; IDA:UniProtKB
Q9P0Z9	PIPOX	Peroxisomal sarcosine oxidase	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
Q9P0Z9	PIPOX	Peroxisomal sarcosine oxidase	GO:0046653; P:tetrahydrofolate metabolic process; IEA:InterPro
P23497	SP100	Nuclear autoantigen Sp-100	GO:0070087; F:chromo shadow domain binding; IPI:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0003677; F:DNA binding; IEA:InterPro
P23497	SP100	Nuclear autoantigen Sp-100	GO:0042802; F:identical protein binding; IPI:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0019900; F:kinase binding; IPI:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0005515; F:protein binding; IPI:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P23497	SP100	Nuclear autoantigen Sp-100	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0003713; F:transcription coactivator activity; IDA:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0003714; F:transcription corepressor activity; IDA:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P23497	SP100	Nuclear autoantigen Sp-100	GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IDA:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0060333; P:interferon-gamma-mediated signaling pathway; IC:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0051271; P:negative regulation of cellular component movement; IMP:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0043392; P:negative regulation of DNA binding; IDA:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0010596; P:negative regulation of endothelial cell migration; IMP:UniProtKB
P23497	SP100	Nuclear autoantigen Sp-100	GO:0046826; P:negative regulation of protein export from nucleus; IMP:UniProtKB
P23497	SP100	Nuclear autoantigen Sp-100	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0032897; P:negative regulation of viral transcription; IDA:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0045765; P:regulation of angiogenesis; IMP:UniProtKB
P23497	SP100	Nuclear autoantigen Sp-100	GO:1902041; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; IMP:UniProtKB
P23497	SP100	Nuclear autoantigen Sp-100	GO:1902044; P:regulation of Fas signaling pathway; IMP:UniProtKB
P23497	SP100	Nuclear autoantigen Sp-100	GO:0034097; P:response to cytokine; IDA:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0034341; P:response to interferon-gamma; IDA:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0032526; P:response to retinoic acid; IDA:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0034340; P:response to type I interferon; IDA:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0048384; P:retinoic acid receptor signaling pathway; IC:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0000723; P:telomere maintenance; IMP:UniProtKB
P23497	SP100	Nuclear autoantigen Sp-100	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P23497	SP100	Nuclear autoantigen Sp-100	GO:0060337; P:type I interferon signaling pathway; IC:BHF-UCL
P23497	SP100	Nuclear autoantigen Sp-100	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9HB58	SP110	Sp110 nuclear body protein	GO:0003677; F:DNA binding; TAS:ProtInc
Q9HB58	SP110	Sp110 nuclear body protein	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q9HB58	SP110	Sp110 nuclear body protein	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9HB58	SP110	Sp110 nuclear body protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9HB58	SP110	Sp110 nuclear body protein	GO:0007165; P:signal transduction; TAS:GOC
Q9HB58	SP110	Sp110 nuclear body protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HB58	SP110	Sp110 nuclear body protein	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9H0E3	SAP130	Histone deacetylase complex subunit SAP130	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q9H0E3	SAP130	Histone deacetylase complex subunit SAP130	GO:0006325; P:chromatin organization; TAS:Reactome
Q9H0E3	SAP130	Histone deacetylase complex subunit SAP130	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
Q9H0E3	SAP130	Histone deacetylase complex subunit SAP130	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q9H0E3	SAP130	Histone deacetylase complex subunit SAP130	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13342	SP140	Nuclear body protein SP140	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q13342	SP140	Nuclear body protein SP140	GO:0005515; F:protein binding; IPI:IntAct
Q13342	SP140	Nuclear body protein SP140	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q13342	SP140	Nuclear body protein SP140	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13342	SP140	Nuclear body protein SP140	GO:0006952; P:defense response; TAS:ProtInc
Q13342	SP140	Nuclear body protein SP140	GO:0006355; P:regulation of transcription, DNA-templated; TAS:GOC
Q9H930	SP140L	Nuclear body protein SP140-like protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H930	SP140L	Nuclear body protein SP140-like protein	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y5B9	SUPT16H	FACT complex subunit SPT16	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y5B9	SUPT16H	FACT complex subunit SPT16	GO:0005515; F:protein binding; IPI:IntAct
Q9Y5B9	SUPT16H	FACT complex subunit SPT16	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q9Y5B9	SUPT16H	FACT complex subunit SPT16	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q9Y5B9	SUPT16H	FACT complex subunit SPT16	GO:0010467; P:gene expression; TAS:Reactome
Q9Y5B9	SUPT16H	FACT complex subunit SPT16	GO:0006337; P:nucleosome disassembly; TAS:ProtInc
Q9Y5B9	SUPT16H	FACT complex subunit SPT16	GO:0032786; P:positive regulation of DNA-templated transcription, elongation; TAS:ProtInc
Q9Y5B9	SUPT16H	FACT complex subunit SPT16	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
Q9Y5B9	SUPT16H	FACT complex subunit SPT16	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q9Y5B9	SUPT16H	FACT complex subunit SPT16	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q9Y5B9	SUPT16H	FACT complex subunit SPT16	GO:0016032; P:viral process; TAS:Reactome
Q15506	SPA17	Sperm surface protein Sp17	GO:0007339; P:binding of sperm to zona pellucida; IEA:InterPro
Q15506	SPA17	Sperm surface protein Sp17	GO:0003351; P:epithelial cilium movement; NAS:BHF-UCL
Q15506	SPA17	Sperm surface protein Sp17	GO:0007338; P:single fertilization; TAS:ProtInc
Q15506	SPA17	Sperm surface protein Sp17	GO:0007283; P:spermatogenesis; TAS:ProtInc
P08047	SP1	Transcription factor Sp1	GO:0043425; F:bHLH transcription factor binding; ISS:BHF-UCL
P08047	SP1	Transcription factor Sp1	GO:0003677; F:DNA binding; IDA:UniProtKB
P08047	SP1	Transcription factor Sp1	GO:0003690; F:double-stranded DNA binding; IDA:BHF-UCL
P08047	SP1	Transcription factor Sp1	GO:0035326; F:enhancer binding; IEA:Ensembl
P08047	SP1	Transcription factor Sp1	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
P08047	SP1	Transcription factor Sp1	GO:0071837; F:HMG box domain binding; IPI:UniProtKB
P08047	SP1	Transcription factor Sp1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P08047	SP1	Transcription factor Sp1	GO:0005515; F:protein binding; IPI:UniProtKB
P08047	SP1	Transcription factor Sp1	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P08047	SP1	Transcription factor Sp1	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P08047	SP1	Transcription factor Sp1	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; ISS:BHF-UCL
P08047	SP1	Transcription factor Sp1	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P08047	SP1	Transcription factor Sp1	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl
P08047	SP1	Transcription factor Sp1	GO:0001103; F:RNA polymerase II repressing transcription factor binding; ISS:BHF-UCL
P08047	SP1	Transcription factor Sp1	GO:0043565; F:sequence-specific DNA binding; IDA:HGNC
P08047	SP1	Transcription factor Sp1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P08047	SP1	Transcription factor Sp1	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P08047	SP1	Transcription factor Sp1	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
P08047	SP1	Transcription factor Sp1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P08047	SP1	Transcription factor Sp1	GO:0060216; P:definitive hemopoiesis; IEA:Ensembl
P08047	SP1	Transcription factor Sp1	GO:0048596; P:embryonic camera-type eye morphogenesis; IEA:Ensembl
P08047	SP1	Transcription factor Sp1	GO:0001892; P:embryonic placenta development; IEA:Ensembl
P08047	SP1	Transcription factor Sp1	GO:0060136; P:embryonic process involved in female pregnancy; IEA:Ensembl
P08047	SP1	Transcription factor Sp1	GO:0048706; P:embryonic skeletal system development; IEA:Ensembl
P08047	SP1	Transcription factor Sp1	GO:0043353; P:enucleate erythrocyte differentiation; IEA:Ensembl
P08047	SP1	Transcription factor Sp1	GO:0010467; P:gene expression; TAS:Reactome
P08047	SP1	Transcription factor Sp1	GO:0001889; P:liver development; IEA:Ensembl
P08047	SP1	Transcription factor Sp1	GO:0030324; P:lung development; IEA:Ensembl
P08047	SP1	Transcription factor Sp1	GO:0030219; P:megakaryocyte differentiation; IEA:Ensembl
P08047	SP1	Transcription factor Sp1	GO:0001503; P:ossification; IEA:Ensembl
P08047	SP1	Transcription factor Sp1	GO:0043923; P:positive regulation by host of viral transcription; IDA:UniProtKB
P08047	SP1	Transcription factor Sp1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P08047	SP1	Transcription factor Sp1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P08047	SP1	Transcription factor Sp1	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
P08047	SP1	Transcription factor Sp1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P08047	SP1	Transcription factor Sp1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P08047	SP1	Transcription factor Sp1	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
P08047	SP1	Transcription factor Sp1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P08047	SP1	Transcription factor Sp1	GO:0001829; P:trophectodermal cell differentiation; IEA:Ensembl
P08047	SP1	Transcription factor Sp1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q8NEM7	SUPT20H	Transcription factor SPT20 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q8NEM7	SUPT20H	Transcription factor SPT20 homolog	GO:0003712; F:transcription cofactor activity; IEA:InterPro
Q8NEM7	SUPT20H	Transcription factor SPT20 homolog	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q8NEM7	SUPT20H	Transcription factor SPT20 homolog	GO:0006325; P:chromatin organization; TAS:Reactome
Q8NEM7	SUPT20H	Transcription factor SPT20 homolog	GO:0007369; P:gastrulation; IEA:UniProtKB-KW
Q3ZLR7	SUPT20HL1	Transcription factor SPT20 homolog-like 1	GO:0003712; F:transcription cofactor activity; IEA:InterPro
P0C7V6	SUPT20HL2	Putative transcription factor SPT20 homolog-like 2	GO:0003712; F:transcription cofactor activity; IEA:InterPro
Q02086	SP2	Transcription factor Sp2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q02086	SP2	Transcription factor Sp2	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
Q02086	SP2	Transcription factor Sp2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q02086	SP2	Transcription factor Sp2	GO:0072358; P:cardiovascular system development; IEA:Ensembl
Q02086	SP2	Transcription factor Sp2	GO:0048568; P:embryonic organ development; IEA:Ensembl
Q02086	SP2	Transcription factor Sp2	GO:0048144; P:fibroblast proliferation; IEA:Ensembl
Q02086	SP2	Transcription factor Sp2	GO:0006955; P:immune response; TAS:ProtInc
Q02086	SP2	Transcription factor Sp2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q02086	SP2	Transcription factor Sp2	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q02086	SP2	Transcription factor Sp2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q02086	SP2	Transcription factor Sp2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HAJ7	SAP30L	Histone deacetylase complex subunit SAP30L	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9HAJ7	SAP30L	Histone deacetylase complex subunit SAP30L	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HAJ7	SAP30L	Histone deacetylase complex subunit SAP30L	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9HAJ7	SAP30L	Histone deacetylase complex subunit SAP30L	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q02447	SP3	Transcription factor Sp3	GO:0003682; F:chromatin binding; IEA:Ensembl
Q02447	SP3	Transcription factor Sp3	GO:0000987; F:core promoter proximal region sequence-specific DNA binding; IEA:Ensembl
Q02447	SP3	Transcription factor Sp3	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
Q02447	SP3	Transcription factor Sp3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q02447	SP3	Transcription factor Sp3	GO:0005515; F:protein binding; IPI:UniProtKB
Q02447	SP3	Transcription factor Sp3	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IEA:Ensembl
Q02447	SP3	Transcription factor Sp3	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl
Q02447	SP3	Transcription factor Sp3	GO:0030183; P:B cell differentiation; IEA:Ensembl
Q02447	SP3	Transcription factor Sp3	GO:0060216; P:definitive hemopoiesis; IEA:Ensembl
Q02447	SP3	Transcription factor Sp3	GO:0048596; P:embryonic camera-type eye morphogenesis; IEA:Ensembl
Q02447	SP3	Transcription factor Sp3	GO:0001892; P:embryonic placenta development; IEA:Ensembl
Q02447	SP3	Transcription factor Sp3	GO:0060136; P:embryonic process involved in female pregnancy; IEA:Ensembl
Q02447	SP3	Transcription factor Sp3	GO:0048706; P:embryonic skeletal system development; IEA:Ensembl
Q02447	SP3	Transcription factor Sp3	GO:0043353; P:enucleate erythrocyte differentiation; IEA:Ensembl
Q02447	SP3	Transcription factor Sp3	GO:0030851; P:granulocyte differentiation; IEA:Ensembl
Q02447	SP3	Transcription factor Sp3	GO:0001889; P:liver development; IEA:Ensembl
Q02447	SP3	Transcription factor Sp3	GO:0030324; P:lung development; IEA:Ensembl
Q02447	SP3	Transcription factor Sp3	GO:0030219; P:megakaryocyte differentiation; IEA:Ensembl
Q02447	SP3	Transcription factor Sp3	GO:0030224; P:monocyte differentiation; IEA:Ensembl
Q02447	SP3	Transcription factor Sp3	GO:0001779; P:natural killer cell differentiation; IEA:Ensembl
Q02447	SP3	Transcription factor Sp3	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q02447	SP3	Transcription factor Sp3	GO:0001503; P:ossification; IEA:Ensembl
Q02447	SP3	Transcription factor Sp3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q02447	SP3	Transcription factor Sp3	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q02447	SP3	Transcription factor Sp3	GO:0030217; P:T cell differentiation; IEA:Ensembl
Q02447	SP3	Transcription factor Sp3	GO:0001829; P:trophectodermal cell differentiation; IEA:Ensembl
Q02446	SP4	Transcription factor Sp4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q02446	SP4	Transcription factor Sp4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q02446	SP4	Transcription factor Sp4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q02446	SP4	Transcription factor Sp4	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q02446	SP4	Transcription factor Sp4	GO:0008016; P:regulation of heart contraction; IEA:Ensembl
Q02446	SP4	Transcription factor Sp4	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q02446	SP4	Transcription factor Sp4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6BEB4	SP5	Transcription factor Sp5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6BEB4	SP5	Transcription factor Sp5	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q6BEB4	SP5	Transcription factor Sp5	GO:0060349; P:bone morphogenesis; IEA:Ensembl
Q6BEB4	SP5	Transcription factor Sp5	GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl
Q6BEB4	SP5	Transcription factor Sp5	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6BEB4	SP5	Transcription factor Sp5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q3SY56	SP6	Transcription factor Sp6	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q3SY56	SP6	Transcription factor Sp6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q3SY56	SP6	Transcription factor Sp6	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q3SY56	SP6	Transcription factor Sp6	GO:0042481; P:regulation of odontogenesis; IEA:Ensembl
Q3SY56	SP6	Transcription factor Sp6	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q3SY56	SP6	Transcription factor Sp6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TDD2	SP7	Transcription factor Sp7	GO:0017151; F:DEAD/H-box RNA helicase binding; ISS:BHF-UCL
Q8TDD2	SP7	Transcription factor Sp7	GO:0003677; F:DNA binding; ISS:BHF-UCL
Q8TDD2	SP7	Transcription factor Sp7	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TDD2	SP7	Transcription factor Sp7	GO:0060218; P:hematopoietic stem cell differentiation; IDA:BHF-UCL
Q8TDD2	SP7	Transcription factor Sp7	GO:0001649; P:osteoblast differentiation; IDA:BHF-UCL
Q8TDD2	SP7	Transcription factor Sp7	GO:2000738; P:positive regulation of stem cell differentiation; IDA:BHF-UCL
Q8TDD2	SP7	Transcription factor Sp7	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q8TDD2	SP7	Transcription factor Sp7	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q8TDD2	SP7	Transcription factor Sp7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IXZ3	SP8	Transcription factor Sp8	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IXZ3	SP8	Transcription factor Sp8	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IXZ3	SP8	Transcription factor Sp8	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
Q8IXZ3	SP8	Transcription factor Sp8	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
Q8IXZ3	SP8	Transcription factor Sp8	GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl
Q8IXZ3	SP8	Transcription factor Sp8	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8IXZ3	SP8	Transcription factor Sp8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P0CG40	SP9	Transcription factor Sp9	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P0CG40	SP9	Transcription factor Sp9	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P0CG40	SP9	Transcription factor Sp9	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
P0CG40	SP9	Transcription factor Sp9	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P0CG40	SP9	Transcription factor Sp9	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86U17	SERPINA11	Serpin A11	GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome
Q86U17	SERPINA11	Serpin A11	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
Q86U17	SERPINA11	Serpin A11	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
Q8IW75	SERPINA12	Serpin A12	GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome
Q8IW75	SERPINA12	Serpin A12	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
Q8IW75	SERPINA12	Serpin A12	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
Q6UXR4	SERPINA13P	Putative serpin A13	GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome
Q6UXR4	SERPINA13P	Putative serpin A13	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
Q6UXR4	SERPINA13P	Putative serpin A13	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
Q86W54	SPATA24	Spermatogenesis-associated protein 24	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86W54	SPATA24	Spermatogenesis-associated protein 24	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q86W54	SPATA24	Spermatogenesis-associated protein 24	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q86W54	SPATA24	Spermatogenesis-associated protein 24	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q86W54	SPATA24	Spermatogenesis-associated protein 24	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q86W54	SPATA24	Spermatogenesis-associated protein 24	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BVQ7	SPATA5L1	Spermatogenesis-associated protein 5-like protein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BVQ7	SPATA5L1	Spermatogenesis-associated protein 5-like protein 1	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q86WD7	SERPINA9	Serpin A9	GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:UniProtKB
Q86WD7	SERPINA9	Serpin A9	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
Q86WD7	SERPINA9	Serpin A9	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
Q07617	SPAG1	Sperm-associated antigen 1	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q07617	SPAG1	Sperm-associated antigen 1	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q07617	SPAG1	Sperm-associated antigen 1	GO:0070286; P:axonemal dynein complex assembly; ISS:UniProtKB
Q07617	SPAG1	Sperm-associated antigen 1	GO:0007338; P:single fertilization; TAS:ProtInc
Q9NPE6	SPAG4	Sperm-associated antigen 4 protein	GO:0005198; F:structural molecule activity; TAS:ProtInc
Q9NPE6	SPAG4	Sperm-associated antigen 4 protein	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q96R06	SPAG5	Sperm-associated antigen 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q96R06	SPAG5	Sperm-associated antigen 5	GO:0007049; P:cell cycle; NAS:UniProtKB
Q96R06	SPAG5	Sperm-associated antigen 5	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q96R06	SPAG5	Sperm-associated antigen 5	GO:0000070; P:mitotic sister chromatid segregation; IMP:UniProtKB
Q96R06	SPAG5	Sperm-associated antigen 5	GO:0048015; P:phosphatidylinositol-mediated signaling; NAS:UniProtKB
Q96R06	SPAG5	Sperm-associated antigen 5	GO:0051988; P:regulation of attachment of spindle microtubules to kinetochore; IMP:UniProtKB
Q96R06	SPAG5	Sperm-associated antigen 5	GO:0007051; P:spindle organization; IMP:UniProtKB
O75602	SPAG6	Sperm-associated antigen 6	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
O75602	SPAG6	Sperm-associated antigen 6	GO:0007286; P:spermatid development; TAS:ProtInc
O75391	SPAG7	Sperm-associated antigen 7	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q99932	SPAG8	Sperm-associated antigen 8	GO:0032092; P:positive regulation of protein binding; IEA:Ensembl
Q99932	SPAG8	Sperm-associated antigen 8	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q86XZ4	SPATS2	Spermatogenesis-associated serine-rich protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UBP0	SPAST	Spastin	GO:0043014; F:alpha-tubulin binding; IPI:UniProtKB
Q9UBP0	SPAST	Spastin	GO:0005524; F:ATP binding; IEA:UniProtKB-HAMAP
Q9UBP0	SPAST	Spastin	GO:0048487; F:beta-tubulin binding; IPI:UniProtKB
Q9UBP0	SPAST	Spastin	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q9UBP0	SPAST	Spastin	GO:0008568; F:microtubule-severing ATPase activity; IDA:UniProtKB
Q9UBP0	SPAST	Spastin	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBP0	SPAST	Spastin	GO:0006200; P:ATP catabolic process; IDA:GOC
Q9UBP0	SPAST	Spastin	GO:0007409; P:axonogenesis; IEA:UniProtKB-HAMAP
Q9UBP0	SPAST	Spastin	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9UBP0	SPAST	Spastin	GO:0007109; P:cytokinesis, completion of separation; IMP:UniProtKB
Q9UBP0	SPAST	Spastin	GO:0006888; P:ER to Golgi vesicle-mediated transport; IMP:UniProtKB
Q9UBP0	SPAST	Spastin	GO:0001578; P:microtubule bundle formation; IDA:UniProtKB
Q9UBP0	SPAST	Spastin	GO:0051013; P:microtubule severing; IDA:UniProtKB
Q9UBP0	SPAST	Spastin	GO:0031117; P:positive regulation of microtubule depolymerization; IEA:UniProtKB-HAMAP
Q9UBP0	SPAST	Spastin	GO:0034214; P:protein hexamerization; IDA:UniProtKB
Q9UBP0	SPAST	Spastin	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
Q8NB90	SPATA5	Spermatogenesis-associated protein 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NB90	SPATA5	Spermatogenesis-associated protein 5	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q8NB90	SPATA5	Spermatogenesis-associated protein 5	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8NB90	SPATA5	Spermatogenesis-associated protein 5	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8NB90	SPATA5	Spermatogenesis-associated protein 5	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q9NWH7	SPATA6	Spermatogenesis-associated protein 6	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9NWH7	SPATA6	Spermatogenesis-associated protein 6	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9NWH7	SPATA6	Spermatogenesis-associated protein 6	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q9P0W8	SPATA7	Spermatogenesis-associated protein 7	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q9P0W8	SPATA7	Spermatogenesis-associated protein 7	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q9UM82	SPATA2	Spermatogenesis-associated protein 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9UM82	SPATA2	Spermatogenesis-associated protein 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9UM82	SPATA2	Spermatogenesis-associated protein 2	GO:0007283; P:spermatogenesis; NAS:UniProtKB
Q9BWV2	SPATA9	Spermatogenesis-associated protein 9	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9BWV2	SPATA9	Spermatogenesis-associated protein 9	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9BWV2	SPATA9	Spermatogenesis-associated protein 9	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
P48595	SERPINB10	Serpin B10	GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome
P48595	SERPINB10	Serpin B10	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P48595	SERPINB10	Serpin B10	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
Q96P63	SERPINB12	Serpin B12	GO:0019899; F:enzyme binding; NAS:UniProtKB
Q96P63	SERPINB12	Serpin B12	GO:0004867; F:serine-type endopeptidase inhibitor activity; IMP:UniProtKB
Q96P63	SERPINB12	Serpin B12	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
Q96P63	SERPINB12	Serpin B12	GO:0042177; P:negative regulation of protein catabolic process; NAS:UniProtKB
Q96P63	SERPINB12	Serpin B12	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
Q96P15	SERPINB11	Serpin B11	GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome
Q96P15	SERPINB11	Serpin B11	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
Q96P15	SERPINB11	Serpin B11	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
Q9UIV8	SERPINB13	Serpin B13	GO:0004867; F:serine-type endopeptidase inhibitor activity; NAS:UniProtKB
Q9UIV8	SERPINB13	Serpin B13	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
Q9UIV8	SERPINB13	Serpin B13	GO:0030162; P:regulation of proteolysis; NAS:UniProtKB
Q9UIV8	SERPINB13	Serpin B13	GO:0009411; P:response to UV; TAS:ProtInc
Q8IY81	FTSJ3	pre-rRNA processing protein FTSJ3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IY81	FTSJ3	pre-rRNA processing protein FTSJ3	GO:0005515; F:protein binding; IPI:IntAct
Q8IY81	FTSJ3	pre-rRNA processing protein FTSJ3	GO:0008649; F:rRNA methyltransferase activity; IEA:InterPro
P29508	SERPINB3	Serpin B3	GO:0004867; F:serine-type endopeptidase inhibitor activity; NAS:UniProtKB
P29508	SERPINB3	Serpin B3	GO:0001618; F:virus receptor activity; IDA:UniProtKB
P29508	SERPINB3	Serpin B3	GO:0043086; P:negative regulation of catalytic activity; IDA:UniProtKB
P29508	SERPINB3	Serpin B3	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P29508	SERPINB3	Serpin B3	GO:0010466; P:negative regulation of peptidase activity; IDA:UniProtKB
P29508	SERPINB3	Serpin B3	GO:0045861; P:negative regulation of proteolysis; IDA:UniProtKB
P29508	SERPINB3	Serpin B3	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
P29508	SERPINB3	Serpin B3	GO:0009615; P:response to virus; IDA:GOC
P48594	SERPINB4	Serpin B4	GO:0004867; F:serine-type endopeptidase inhibitor activity; NAS:UniProtKB
P48594	SERPINB4	Serpin B4	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P48594	SERPINB4	Serpin B4	GO:0010466; P:negative regulation of peptidase activity; IDA:UniProtKB
P48594	SERPINB4	Serpin B4	GO:0030162; P:regulation of proteolysis; NAS:UniProtKB
P36952	SERPINB5	Serpin B5	GO:0005515; F:protein binding; IPI:UniProtKB
P36952	SERPINB5	Serpin B5	GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome
P36952	SERPINB5	Serpin B5	GO:0006928; P:cellular component movement; TAS:ProtInc
P36952	SERPINB5	Serpin B5	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
P36952	SERPINB5	Serpin B5	GO:0002009; P:morphogenesis of an epithelium; IEA:Ensembl
P36952	SERPINB5	Serpin B5	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P36952	SERPINB5	Serpin B5	GO:0060512; P:prostate gland morphogenesis; IEA:Ensembl
P36952	SERPINB5	Serpin B5	GO:0050678; P:regulation of epithelial cell proliferation; IEA:Ensembl
P36952	SERPINB5	Serpin B5	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
P35237	SERPINB6	Serpin B6	GO:0002020; F:protease binding; IPI:BHF-UCL
P35237	SERPINB6	Serpin B6	GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:BHF-UCL
P35237	SERPINB6	Serpin B6	GO:0010951; P:negative regulation of endopeptidase activity; IDA:BHF-UCL
P35237	SERPINB6	Serpin B6	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
O75635	SERPINB7	Serpin B7	GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome
O75635	SERPINB7	Serpin B7	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
O75635	SERPINB7	Serpin B7	GO:0032967; P:positive regulation of collagen biosynthetic process; IEA:Ensembl
O75635	SERPINB7	Serpin B7	GO:0072126; P:positive regulation of glomerular mesangial cell proliferation; IEA:Ensembl
O75635	SERPINB7	Serpin B7	GO:0090362; P:positive regulation of platelet-derived growth factor production; IEA:Ensembl
O75635	SERPINB7	Serpin B7	GO:0032914; P:positive regulation of transforming growth factor beta1 production; IEA:Ensembl
O75635	SERPINB7	Serpin B7	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
P50452	SERPINB8	Serpin B8	GO:0005515; F:protein binding; IPI:UniProtKB
P50452	SERPINB8	Serpin B8	GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:UniProtKB
P50452	SERPINB8	Serpin B8	GO:0010951; P:negative regulation of endopeptidase activity; IDA:UniProtKB
P50452	SERPINB8	Serpin B8	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
P50453	SERPINB9	Serpin B9	GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IDA:UniProtKB
P50453	SERPINB9	Serpin B9	GO:0002020; F:protease binding; IPI:UniProtKB
P50453	SERPINB9	Serpin B9	GO:0005515; F:protein binding; IPI:UniProtKB
P50453	SERPINB9	Serpin B9	GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:UniProtKB
P50453	SERPINB9	Serpin B9	GO:0071391; P:cellular response to estrogen stimulus; IEP:UniProtKB
P50453	SERPINB9	Serpin B9	GO:0006955; P:immune response; IDA:UniProtKB
P50453	SERPINB9	Serpin B9	GO:0002448; P:mast cell mediated immunity; IEP:UniProtKB
P50453	SERPINB9	Serpin B9	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P50453	SERPINB9	Serpin B9	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:GOC
P50453	SERPINB9	Serpin B9	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P50453	SERPINB9	Serpin B9	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
Q8NBT2	SPC24	Kinetochore protein Spc24	GO:0005515; F:protein binding; IPI:IntAct
Q8NBT2	SPC24	Kinetochore protein Spc24	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q8NBT2	SPC24	Kinetochore protein Spc24	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9HBM1	SPC25	Kinetochore protein Spc25	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HBM1	SPC25	Kinetochore protein Spc25	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q9HBM1	SPC25	Kinetochore protein Spc25	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9HBM1	SPC25	Kinetochore protein Spc25	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9HBM1	SPC25	Kinetochore protein Spc25	GO:0007052; P:mitotic spindle organization; IMP:UniProtKB
Q9Y6A9	SPCS1	Signal peptidase complex subunit 1	GO:0008233; F:peptidase activity; IEA:UniProtKB-KW
Q9Y6A9	SPCS1	Signal peptidase complex subunit 1	GO:0005515; F:protein binding; IPI:IntAct
Q9Y6A9	SPCS1	Signal peptidase complex subunit 1	GO:0043022; F:ribosome binding; IEA:Ensembl
Q9Y6A9	SPCS1	Signal peptidase complex subunit 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9Y6A9	SPCS1	Signal peptidase complex subunit 1	GO:0010467; P:gene expression; TAS:Reactome
Q9Y6A9	SPCS1	Signal peptidase complex subunit 1	GO:0006508; P:proteolysis; TAS:UniProtKB
Q9Y6A9	SPCS1	Signal peptidase complex subunit 1	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
Q9Y6A9	SPCS1	Signal peptidase complex subunit 1	GO:0006465; P:signal peptide processing; IEA:InterPro
Q9Y6A9	SPCS1	Signal peptidase complex subunit 1	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
Q9Y6A9	SPCS1	Signal peptidase complex subunit 1	GO:0006412; P:translation; TAS:Reactome
Q15005	SPCS2	Signal peptidase complex subunit 2	GO:0008233; F:peptidase activity; IEA:UniProtKB-KW
Q15005	SPCS2	Signal peptidase complex subunit 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q15005	SPCS2	Signal peptidase complex subunit 2	GO:0010467; P:gene expression; TAS:Reactome
Q15005	SPCS2	Signal peptidase complex subunit 2	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
Q15005	SPCS2	Signal peptidase complex subunit 2	GO:0006465; P:signal peptide processing; IEA:InterPro
Q15005	SPCS2	Signal peptidase complex subunit 2	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
Q15005	SPCS2	Signal peptidase complex subunit 2	GO:0006412; P:translation; TAS:Reactome
P61009	SPCS3	Signal peptidase complex subunit 3	GO:0008233; F:peptidase activity; IEA:UniProtKB-KW
P61009	SPCS3	Signal peptidase complex subunit 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P61009	SPCS3	Signal peptidase complex subunit 3	GO:0010467; P:gene expression; TAS:Reactome
P61009	SPCS3	Signal peptidase complex subunit 3	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P61009	SPCS3	Signal peptidase complex subunit 3	GO:0006465; P:signal peptide processing; IEA:InterPro
P61009	SPCS3	Signal peptidase complex subunit 3	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P61009	SPCS3	Signal peptidase complex subunit 3	GO:0006412; P:translation; TAS:Reactome
Q9HD40	SEPSECS	O-phosphoseryl-tRNA(Sec) selenium transferase	GO:0005515; F:protein binding; IPI:IntAct
Q9HD40	SEPSECS	O-phosphoseryl-tRNA(Sec) selenium transferase	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q9HD40	SEPSECS	O-phosphoseryl-tRNA(Sec) selenium transferase	GO:0016785; F:transferase activity, transferring selenium-containing groups; IEA:InterPro
Q9HD40	SEPSECS	O-phosphoseryl-tRNA(Sec) selenium transferase	GO:0000049; F:tRNA binding; ISS:HGNC
Q9HD40	SEPSECS	O-phosphoseryl-tRNA(Sec) selenium transferase	GO:0001514; P:selenocysteine incorporation; ISS:HGNC
Q9HD40	SEPSECS	O-phosphoseryl-tRNA(Sec) selenium transferase	GO:0097056; P:selenocysteinyl-tRNA(Sec) biosynthetic process; IEA:UniProtKB-UniPathway
Q5TCZ1	SH3PXD2A	SH3 and PX domain-containing protein 2A	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
Q5TCZ1	SH3PXD2A	SH3 and PX domain-containing protein 2A	GO:0005515; F:protein binding; IPI:IntAct
Q5TCZ1	SH3PXD2A	SH3 and PX domain-containing protein 2A	GO:0006801; P:superoxide metabolic process; IDA:UniProtKB
A1X283	SH3PXD2B	SH3 and PX domain-containing protein 2B	GO:0080025; F:phosphatidylinositol-3,5-bisphosphate binding; ISS:UniProtKB
A1X283	SH3PXD2B	SH3 and PX domain-containing protein 2B	GO:0032266; F:phosphatidylinositol-3-phosphate binding; ISS:UniProtKB
A1X283	SH3PXD2B	SH3 and PX domain-containing protein 2B	GO:0070273; F:phosphatidylinositol-4-phosphate binding; IEA:Ensembl
A1X283	SH3PXD2B	SH3 and PX domain-containing protein 2B	GO:0010314; F:phosphatidylinositol-5-phosphate binding; ISS:UniProtKB
A1X283	SH3PXD2B	SH3 and PX domain-containing protein 2B	GO:0005515; F:protein binding; IPI:UniProtKB
A1X283	SH3PXD2B	SH3 and PX domain-containing protein 2B	GO:0042169; F:SH2 domain binding; ISS:UniProtKB
A1X283	SH3PXD2B	SH3 and PX domain-containing protein 2B	GO:0060612; P:adipose tissue development; ISS:UniProtKB
A1X283	SH3PXD2B	SH3 and PX domain-containing protein 2B	GO:0060348; P:bone development; IMP:UniProtKB
A1X283	SH3PXD2B	SH3 and PX domain-containing protein 2B	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
A1X283	SH3PXD2B	SH3 and PX domain-containing protein 2B	GO:0022617; P:extracellular matrix disassembly; IMP:UniProtKB
A1X283	SH3PXD2B	SH3 and PX domain-containing protein 2B	GO:0001654; P:eye development; IMP:UniProtKB
A1X283	SH3PXD2B	SH3 and PX domain-containing protein 2B	GO:0007507; P:heart development; IMP:UniProtKB
A1X283	SH3PXD2B	SH3 and PX domain-containing protein 2B	GO:0071800; P:podosome assembly; ISS:UniProtKB
A1X283	SH3PXD2B	SH3 and PX domain-containing protein 2B	GO:0045600; P:positive regulation of fat cell differentiation; IEA:Ensembl
A1X283	SH3PXD2B	SH3 and PX domain-containing protein 2B	GO:0072657; P:protein localization to membrane; IDA:UniProtKB
A1X283	SH3PXD2B	SH3 and PX domain-containing protein 2B	GO:0001501; P:skeletal system development; IMP:UniProtKB
A1X283	SH3PXD2B	SH3 and PX domain-containing protein 2B	GO:0006801; P:superoxide metabolic process; IDA:UniProtKB
O95238	SPDEF	SAM pointed domain-containing Ets transcription factor	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O95238	SPDEF	SAM pointed domain-containing Ets transcription factor	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
O95238	SPDEF	SAM pointed domain-containing Ets transcription factor	GO:0030154; P:cell differentiation; IBA:RefGenome
O95238	SPDEF	SAM pointed domain-containing Ets transcription factor	GO:0060576; P:intestinal epithelial cell development; IEA:Ensembl
O95238	SPDEF	SAM pointed domain-containing Ets transcription factor	GO:0060480; P:lung goblet cell differentiation; IEA:Ensembl
O95238	SPDEF	SAM pointed domain-containing Ets transcription factor	GO:0007275; P:multicellular organismal development; TAS:ProtInc
O95238	SPDEF	SAM pointed domain-containing Ets transcription factor	GO:0010454; P:negative regulation of cell fate commitment; IEA:Ensembl
O95238	SPDEF	SAM pointed domain-containing Ets transcription factor	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
O95238	SPDEF	SAM pointed domain-containing Ets transcription factor	GO:0043065; P:positive regulation of apoptotic process; IDA:BHF-UCL
O95238	SPDEF	SAM pointed domain-containing Ets transcription factor	GO:0010455; P:positive regulation of cell fate commitment; IEA:Ensembl
O95238	SPDEF	SAM pointed domain-containing Ets transcription factor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O95238	SPDEF	SAM pointed domain-containing Ets transcription factor	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q96EA4	SPDL1	Protein Spindly	GO:0043515; F:kinetochore binding; IDA:UniProtKB
Q96EA4	SPDL1	Protein Spindly	GO:0005515; F:protein binding; IPI:UniProtKB
Q96EA4	SPDL1	Protein Spindly	GO:0000132; P:establishment of mitotic spindle orientation; IMP:UniProtKB
Q96EA4	SPDL1	Protein Spindly	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q96EA4	SPDL1	Protein Spindly	GO:0007080; P:mitotic metaphase plate congression; IMP:UniProtKB
Q96EA4	SPDL1	Protein Spindly	GO:0034501; P:protein localization to kinetochore; IMP:UniProtKB
Q96EA4	SPDL1	Protein Spindly	GO:0031577; P:spindle checkpoint; IEA:InterPro
Q5MJ70	SPDYA	Speedy protein A	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q5MJ70	SPDYA	Speedy protein A	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q5MJ70	SPDYA	Speedy protein A	GO:0000082; P:G1/S transition of mitotic cell cycle; IDA:UniProtKB
Q5MJ70	SPDYA	Speedy protein A	GO:0007140; P:male meiosis; ISS:UniProtKB
Q5MJ70	SPDYA	Speedy protein A	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q5MJ70	SPDYA	Speedy protein A	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q5MJ70	SPDYA	Speedy protein A	GO:0045737; P:positive regulation of cyclin-dependent protein kinase activity; IEA:Ensembl
Q5MJ68	SPDYC	Speedy protein C	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q5MJ68	SPDYC	Speedy protein C	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9H9C1	VIPAS39	Spermatogenesis-defective protein 39 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H9C1	VIPAS39	Spermatogenesis-defective protein 39 homolog	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9H9C1	VIPAS39	Spermatogenesis-defective protein 39 homolog	GO:0008333; P:endosome to lysosome transport; IMP:UniProtKB
Q9H9C1	VIPAS39	Spermatogenesis-defective protein 39 homolog	GO:0006886; P:intracellular protein transport; IMP:UniProtKB
Q9H9C1	VIPAS39	Spermatogenesis-defective protein 39 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H9C1	VIPAS39	Spermatogenesis-defective protein 39 homolog	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q9H9C1	VIPAS39	Spermatogenesis-defective protein 39 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BSE5	AGMAT	Agmatinase, mitochondrial	GO:0008783; F:agmatinase activity; IEA:UniProtKB-EC
Q9BSE5	AGMAT	Agmatinase, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BSE5	AGMAT	Agmatinase, mitochondrial	GO:0097055; P:agmatine biosynthetic process; TAS:Reactome
Q9BSE5	AGMAT	Agmatinase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9BSE5	AGMAT	Agmatinase, mitochondrial	GO:0006595; P:polyamine metabolic process; TAS:Reactome
Q9BSE5	AGMAT	Agmatinase, mitochondrial	GO:0033388; P:putrescine biosynthetic process from arginine; IEA:UniProtKB-UniPathway
Q9BSE5	AGMAT	Agmatinase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BSE5	AGMAT	Agmatinase, mitochondrial	GO:0008295; P:spermidine biosynthetic process; IEA:UniProtKB-KW
P19623	SRM	Spermidine synthase	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P19623	SRM	Spermidine synthase	GO:0004766; F:spermidine synthase activity; IDA:UniProtKB
P19623	SRM	Spermidine synthase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P19623	SRM	Spermidine synthase	GO:0006595; P:polyamine metabolic process; TAS:Reactome
P19623	SRM	Spermidine synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P19623	SRM	Spermidine synthase	GO:0008295; P:spermidine biosynthetic process; IDA:UniProtKB
Q9C093	SPEF2	Sperm flagellar protein 2	GO:0035082; P:axoneme assembly; IEA:Ensembl
Q9C093	SPEF2	Sperm flagellar protein 2	GO:0048854; P:brain morphogenesis; IEA:Ensembl
Q9C093	SPEF2	Sperm flagellar protein 2	GO:0048702; P:embryonic neurocranium morphogenesis; IEA:Ensembl
Q9C093	SPEF2	Sperm flagellar protein 2	GO:0009566; P:fertilization; IEA:Ensembl
Q9C093	SPEF2	Sperm flagellar protein 2	GO:0002520; P:immune system development; IEA:Ensembl
Q9C093	SPEF2	Sperm flagellar protein 2	GO:0010259; P:multicellular organismal aging; IEA:Ensembl
Q9C093	SPEF2	Sperm flagellar protein 2	GO:0060541; P:respiratory system development; IEA:Ensembl
Q9C093	SPEF2	Sperm flagellar protein 2	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q15772	SPEG	Striated muscle preferentially expressed protein kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q15772	SPEG	Striated muscle preferentially expressed protein kinase	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q15772	SPEG	Striated muscle preferentially expressed protein kinase	GO:0055013; P:cardiac muscle cell development; IEA:Ensembl
Q15772	SPEG	Striated muscle preferentially expressed protein kinase	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q15772	SPEG	Striated muscle preferentially expressed protein kinase	GO:0007517; P:muscle organ development; TAS:ProtInc
Q15772	SPEG	Striated muscle preferentially expressed protein kinase	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q15772	SPEG	Striated muscle preferentially expressed protein kinase	GO:0060541; P:respiratory system development; IEA:Ensembl
Q8N4L4	SPEM1	Spermatid maturation protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8N4L4	SPEM1	Spermatid maturation protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8N4L4	SPEM1	Spermatid maturation protein 1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q6UW49	SPESP1	Sperm equatorial segment protein 1	GO:0007340; P:acrosome reaction; IEA:Ensembl
Q6UW49	SPESP1	Sperm equatorial segment protein 1	GO:0007342; P:fusion of sperm to egg plasma membrane; IEA:Ensembl
Q6UW49	SPESP1	Sperm equatorial segment protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
O75934	BCAS2	Pre-mRNA-splicing factor SPF27	GO:0005515; F:protein binding; IPI:UniProtKB
O75934	BCAS2	Pre-mRNA-splicing factor SPF27	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
O75934	BCAS2	Pre-mRNA-splicing factor SPF27	GO:0008380; P:RNA splicing; TAS:UniProtKB
O75934	BCAS2	Pre-mRNA-splicing factor SPF27	GO:0000375; P:RNA splicing, via transesterification reactions; TAS:UniProtKB
O75940	SMNDC1	Survival of motor neuron-related-splicing factor 30	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75940	SMNDC1	Survival of motor neuron-related-splicing factor 30	GO:0005515; F:protein binding; IPI:IntAct
O75940	SMNDC1	Survival of motor neuron-related-splicing factor 30	GO:0006915; P:apoptotic process; TAS:ProtInc
O75940	SMNDC1	Survival of motor neuron-related-splicing factor 30	GO:0006397; P:mRNA processing; TAS:ProtInc
O75940	SMNDC1	Survival of motor neuron-related-splicing factor 30	GO:0008380; P:RNA splicing; TAS:ProtInc
O75940	SMNDC1	Survival of motor neuron-related-splicing factor 30	GO:0000375; P:RNA splicing, via transesterification reactions; TAS:UniProtKB
Q96I25	RBM17	Splicing factor 45	GO:0000166; F:nucleotide binding; IEA:InterPro
Q96I25	RBM17	Splicing factor 45	GO:0005515; F:protein binding; IPI:UniProtKB
Q96I25	RBM17	Splicing factor 45	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q96I25	RBM17	Splicing factor 45	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q96I25	RBM17	Splicing factor 45	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q8N0X2	SPAG16	Sperm-associated antigen 16 protein	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q8N0X2	SPAG16	Sperm-associated antigen 16 protein	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q9NZD8	SPG21	Maspardin	GO:0042609; F:CD4 receptor binding; IPI:UniProtKB
Q9NZD8	SPG21	Maspardin	GO:0050851; P:antigen receptor-mediated signaling pathway; IC:UniProtKB
Q9NZD8	SPG21	Maspardin	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q8N0X7	SPG20	Spartin	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N0X7	SPG20	Spartin	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q8N0X7	SPG20	Spartin	GO:0009838; P:abscission; IMP:UniProtKB
Q8N0X7	SPG20	Spartin	GO:0060612; P:adipose tissue development; IEA:Ensembl
Q8N0X7	SPG20	Spartin	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q8N0X7	SPG20	Spartin	GO:0051301; P:cell division; IMP:UniProtKB
Q8N0X7	SPG20	Spartin	GO:0034389; P:lipid particle organization; IEA:Ensembl
Q8N0X7	SPG20	Spartin	GO:0030514; P:negative regulation of BMP signaling pathway; IEA:Ensembl
Q8N0X7	SPG20	Spartin	GO:0048698; P:negative regulation of collateral sprouting in absence of injury; IEA:Ensembl
Q8N0X7	SPG20	Spartin	GO:0050905; P:neuromuscular process; IEA:Ensembl
Q8N0X7	SPG20	Spartin	GO:0051881; P:regulation of mitochondrial membrane potential; IMP:MGI
Q9UQ90	SPG7	Paraplegin	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UQ90	SPG7	Paraplegin	GO:0004222; F:metalloendopeptidase activity; IDA:MGI
Q9UQ90	SPG7	Paraplegin	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q9UQ90	SPG7	Paraplegin	GO:0008233; F:peptidase activity; TAS:ProtInc
Q9UQ90	SPG7	Paraplegin	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UQ90	SPG7	Paraplegin	GO:0051082; F:unfolded protein binding; TAS:ProtInc
Q9UQ90	SPG7	Paraplegin	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UQ90	SPG7	Paraplegin	GO:0008089; P:anterograde axon cargo transport; IEA:Ensembl
Q9UQ90	SPG7	Paraplegin	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9UQ90	SPG7	Paraplegin	GO:0007005; P:mitochondrion organization; IEA:Ensembl
Q9UQ90	SPG7	Paraplegin	GO:0007399; P:nervous system development; TAS:ProtInc
Q9UQ90	SPG7	Paraplegin	GO:0006508; P:proteolysis; TAS:ProtInc
Q15513	SPHAR	Protein SPHAR	GO:0006260; P:DNA replication; TAS:ProtInc
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0005516; F:calmodulin binding; IDA:UniProtKB
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0017050; F:D-erythro-sphingosine kinase activity; IDA:UniProtKB
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0004143; F:diacylglycerol kinase activity; IEA:InterPro
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0003677; F:DNA binding; IDA:MGI
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0003951; F:NAD+ kinase activity; IEA:InterPro
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0051721; F:protein phosphatase 2A binding; IPI:BHF-UCL
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0008481; F:sphinganine kinase activity; IDA:MGI
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0001568; P:blood vessel development; IEA:Ensembl
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0007420; P:brain development; IEA:Ensembl
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0019722; P:calcium-mediated signaling; IDA:UniProtKB
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0009267; P:cellular response to starvation; IEA:Ensembl
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0019371; P:cyclooxygenase pathway; IEA:Ensembl
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0007565; P:female pregnancy; IEA:Ensembl
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0006954; P:inflammatory response; IEA:Ensembl
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0035556; P:intracellular signal transduction; TAS:UniProtKB
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0046834; P:lipid phosphorylation; IDA:GOC
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0030307; P:positive regulation of cell growth; IDA:UniProtKB
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0048146; P:positive regulation of fibroblast proliferation; IDA:MGI
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0045931; P:positive regulation of mitotic cell cycle; IDA:UniProtKB
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0001956; P:positive regulation of neurotransmitter secretion; IEA:Ensembl
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0042346; P:positive regulation of NF-kappaB import into nucleus; IMP:UniProtKB
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0045987; P:positive regulation of smooth muscle contraction; IDA:UniProtKB
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0006457; P:protein folding; TAS:Reactome
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:InterPro
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0032651; P:regulation of interleukin-1 beta production; IEA:Ensembl
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0010803; P:regulation of tumor necrosis factor-mediated signaling pathway; IDA:UniProtKB
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0014075; P:response to amine; IEA:Ensembl
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0033198; P:response to ATP; IEA:Ensembl
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0070555; P:response to interleukin-1; IEA:Ensembl
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0032026; P:response to magnesium ion; IEA:Ensembl
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0032570; P:response to progesterone; IEA:Ensembl
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0046521; P:sphingoid catabolic process; NAS:UniProtKB
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q9NYA1	SPHK1	Sphingosine kinase 1	GO:0006670; P:sphingosine metabolic process; IDA:UniProtKB
Q9NRA0	SPHK2	Sphingosine kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NRA0	SPHK2	Sphingosine kinase 2	GO:0017050; F:D-erythro-sphingosine kinase activity; IEA:Ensembl
Q9NRA0	SPHK2	Sphingosine kinase 2	GO:0004143; F:diacylglycerol kinase activity; IEA:InterPro
Q9NRA0	SPHK2	Sphingosine kinase 2	GO:0003951; F:NAD+ kinase activity; IEA:InterPro
Q9NRA0	SPHK2	Sphingosine kinase 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NRA0	SPHK2	Sphingosine kinase 2	GO:0017016; F:Ras GTPase binding; NAS:UniProtKB
Q9NRA0	SPHK2	Sphingosine kinase 2	GO:0008481; F:sphinganine kinase activity; NAS:UniProtKB
Q9NRA0	SPHK2	Sphingosine kinase 2	GO:0001568; P:blood vessel development; IEA:Ensembl
Q9NRA0	SPHK2	Sphingosine kinase 2	GO:0007420; P:brain development; IEA:Ensembl
Q9NRA0	SPHK2	Sphingosine kinase 2	GO:0008283; P:cell proliferation; NAS:UniProtKB
Q9NRA0	SPHK2	Sphingosine kinase 2	GO:0046834; P:lipid phosphorylation; NAS:GOC
Q9NRA0	SPHK2	Sphingosine kinase 2	GO:0043066; P:negative regulation of apoptotic process; NAS:UniProtKB
Q9NRA0	SPHK2	Sphingosine kinase 2	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q9NRA0	SPHK2	Sphingosine kinase 2	GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:InterPro
Q9NRA0	SPHK2	Sphingosine kinase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NRA0	SPHK2	Sphingosine kinase 2	GO:0006669; P:sphinganine-1-phosphate biosynthetic process; NAS:UniProtKB
Q9NRA0	SPHK2	Sphingosine kinase 2	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
Q9NRA0	SPHK2	Sphingosine kinase 2	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q9NRA0	SPHK2	Sphingosine kinase 2	GO:0006670; P:sphingosine metabolic process; IEA:Ensembl
P51688	SGSH	N-sulphoglucosamine sulphohydrolase	GO:0003824; F:catalytic activity; TAS:ProtInc
P51688	SGSH	N-sulphoglucosamine sulphohydrolase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P51688	SGSH	N-sulphoglucosamine sulphohydrolase	GO:0016250; F:N-sulfoglucosamine sulfohydrolase activity; IEA:UniProtKB-EC
P51688	SGSH	N-sulphoglucosamine sulphohydrolase	GO:0008484; F:sulfuric ester hydrolase activity; IEA:InterPro
P51688	SGSH	N-sulphoglucosamine sulphohydrolase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P51688	SGSH	N-sulphoglucosamine sulphohydrolase	GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome
P51688	SGSH	N-sulphoglucosamine sulphohydrolase	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
P51688	SGSH	N-sulphoglucosamine sulphohydrolase	GO:0006029; P:proteoglycan metabolic process; TAS:ProtInc
P51688	SGSH	N-sulphoglucosamine sulphohydrolase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q99865	SPIN2A	Spindlin-2A	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q99865	SPIN2A	Spindlin-2A	GO:0007276; P:gamete generation; IEA:InterPro
P17947	SPI1	Transcription factor PU.1	GO:0001047; F:core promoter binding; IDA:UniProtKB
P17947	SPI1	Transcription factor PU.1	GO:0051525; F:NFAT protein binding; ISS:BHF-UCL
P17947	SPI1	Transcription factor PU.1	GO:0005515; F:protein binding; IPI:UniProtKB
P17947	SPI1	Transcription factor PU.1	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
P17947	SPI1	Transcription factor PU.1	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; ISS:BHF-UCL
P17947	SPI1	Transcription factor PU.1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
P17947	SPI1	Transcription factor PU.1	GO:0001205; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
P17947	SPI1	Transcription factor PU.1	GO:0001085; F:RNA polymerase II transcription factor binding; ISS:BHF-UCL
P17947	SPI1	Transcription factor PU.1	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
P17947	SPI1	Transcription factor PU.1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P17947	SPI1	Transcription factor PU.1	GO:0060033; P:anatomical structure regression; IEA:Ensembl
P17947	SPI1	Transcription factor PU.1	GO:1902262; P:apoptotic process involved in patterning of blood vessels; IEA:Ensembl
P17947	SPI1	Transcription factor PU.1	GO:0030218; P:erythrocyte differentiation; IEA:Ensembl
P17947	SPI1	Transcription factor PU.1	GO:0030851; P:granulocyte differentiation; IEA:Ensembl
P17947	SPI1	Transcription factor PU.1	GO:0043966; P:histone H3 acetylation; IMP:UniProtKB
P17947	SPI1	Transcription factor PU.1	GO:0044027; P:hypermethylation of CpG island; IDA:UniProtKB
P17947	SPI1	Transcription factor PU.1	GO:0030098; P:lymphocyte differentiation; IEA:Ensembl
P17947	SPI1	Transcription factor PU.1	GO:0002320; P:lymphoid progenitor cell differentiation; IEA:Ensembl
P17947	SPI1	Transcription factor PU.1	GO:0030225; P:macrophage differentiation; IEA:Ensembl
P17947	SPI1	Transcription factor PU.1	GO:0043011; P:myeloid dendritic cell differentiation; IEA:Ensembl
P17947	SPI1	Transcription factor PU.1	GO:0045814; P:negative regulation of gene expression, epigenetic; IDA:UniProtKB
P17947	SPI1	Transcription factor PU.1	GO:0090241; P:negative regulation of histone H4 acetylation; IMP:UniProtKB
P17947	SPI1	Transcription factor PU.1	GO:0045347; P:negative regulation of MHC class II biosynthetic process; IEA:Ensembl
P17947	SPI1	Transcription factor PU.1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P17947	SPI1	Transcription factor PU.1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P17947	SPI1	Transcription factor PU.1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P17947	SPI1	Transcription factor PU.1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
P17947	SPI1	Transcription factor PU.1	GO:0045646; P:regulation of erythrocyte differentiation; IMP:BHF-UCL
P17947	SPI1	Transcription factor PU.1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
P17947	SPI1	Transcription factor PU.1	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
P17947	SPI1	Transcription factor PU.1	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q9BPZ2	SPIN2B	Spindlin-2B	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9BPZ2	SPIN2B	Spindlin-2B	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9BPZ2	SPIN2B	Spindlin-2B	GO:0007276; P:gamete generation; IEA:InterPro
O75830	SERPINI2	Serpin I2	GO:0005515; F:protein binding; IPI:IntAct
O75830	SERPINI2	Serpin I2	GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome
O75830	SERPINI2	Serpin I2	GO:0006928; P:cellular component movement; TAS:ProtInc
O75830	SERPINI2	Serpin I2	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
O75830	SERPINI2	Serpin I2	GO:0030155; P:regulation of cell adhesion; IEA:Ensembl
O75830	SERPINI2	Serpin I2	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
Q01892	SPIB	Transcription factor Spi-B	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q01892	SPIB	Transcription factor Spi-B	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q01892	SPIB	Transcription factor Spi-B	GO:0030154; P:cell differentiation; IBA:RefGenome
Q01892	SPIB	Transcription factor Spi-B	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q01892	SPIB	Transcription factor Spi-B	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q8N0Z3	SPICE1	Spindle and centriole-associated protein 1	GO:0051310; P:metaphase plate congression; IMP:UniProtKB
Q8N0Z3	SPICE1	Spindle and centriole-associated protein 1	GO:0046599; P:regulation of centriole replication; IMP:UniProtKB
Q8N0Z3	SPICE1	Spindle and centriole-associated protein 1	GO:0090307; P:spindle assembly involved in mitosis; IMP:UniProtKB
Q14159	SPIDR	DNA repair-scaffolding protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q14159	SPIDR	DNA repair-scaffolding protein	GO:0072757; P:cellular response to camptothecin; IDA:UniProtKB
Q14159	SPIDR	DNA repair-scaffolding protein	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q14159	SPIDR	DNA repair-scaffolding protein	GO:0072711; P:cellular response to hydroxyurea; IDA:UniProtKB
Q14159	SPIDR	DNA repair-scaffolding protein	GO:0071479; P:cellular response to ionizing radiation; IDA:UniProtKB
Q14159	SPIDR	DNA repair-scaffolding protein	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
Q14159	SPIDR	DNA repair-scaffolding protein	GO:2000781; P:positive regulation of double-strand break repair; IMP:UniProtKB
Q14159	SPIDR	DNA repair-scaffolding protein	GO:0031334; P:positive regulation of protein complex assembly; IDA:UniProtKB
Q14159	SPIDR	DNA repair-scaffolding protein	GO:0010569; P:regulation of double-strand break repair via homologous recombination; IDA:UniProtKB
Q14159	SPIDR	DNA repair-scaffolding protein	GO:0070202; P:regulation of establishment of protein localization to chromosome; IDA:UniProtKB
Q8N5J4	SPIC	Transcription factor Spi-C	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q8N5J4	SPIC	Transcription factor Spi-C	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q8N5J4	SPIC	Transcription factor Spi-C	GO:0001824; P:blastocyst development; IEA:Ensembl
Q8N5J4	SPIC	Transcription factor Spi-C	GO:0030154; P:cell differentiation; IBA:RefGenome
Q8N5J4	SPIC	Transcription factor Spi-C	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8N5J4	SPIC	Transcription factor Spi-C	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q8N5J4	SPIC	Transcription factor Spi-C	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q9Y657	SPIN1	Spindlin-1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y657	SPIN1	Spindlin-1	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q9Y657	SPIN1	Spindlin-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y657	SPIN1	Spindlin-1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9Y657	SPIN1	Spindlin-1	GO:0007276; P:gamete generation; IEA:InterPro
Q9Y657	SPIN1	Spindlin-1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9Y657	SPIN1	Spindlin-1	GO:0030177; P:positive regulation of Wnt signaling pathway; IDA:UniProtKB
Q9Y657	SPIN1	Spindlin-1	GO:0009303; P:rRNA transcription; IDA:UniProtKB
Q5JUX0	SPIN3	Spindlin-3	GO:0007276; P:gamete generation; IEA:InterPro
Q56A73	SPIN4	Spindlin-4	GO:0007276; P:gamete generation; IEA:InterPro
Q08AE8	SPIRE1	Protein spire homolog 1	GO:0030036; P:actin cytoskeleton organization; IMP:UniProtKB
Q08AE8	SPIRE1	Protein spire homolog 1	GO:0036089; P:cleavage furrow formation; ISS:UniProtKB
Q08AE8	SPIRE1	Protein spire homolog 1	GO:0051295; P:establishment of meiotic spindle localization; IMP:UniProtKB
Q08AE8	SPIRE1	Protein spire homolog 1	GO:0070649; P:formin-nucleated actin cable assembly; ISS:UniProtKB
Q08AE8	SPIRE1	Protein spire homolog 1	GO:0048193; P:Golgi vesicle transport; IEA:Ensembl
Q08AE8	SPIRE1	Protein spire homolog 1	GO:0046907; P:intracellular transport; ISS:UniProtKB
Q08AE8	SPIRE1	Protein spire homolog 1	GO:0040038; P:polar body extrusion after meiotic divisions; ISS:UniProtKB
Q08AE8	SPIRE1	Protein spire homolog 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q08AE8	SPIRE1	Protein spire homolog 1	GO:0016192; P:vesicle-mediated transport; ISS:UniProtKB
Q8WWL2	SPIRE2	Protein spire homolog 2	GO:0030036; P:actin cytoskeleton organization; IMP:UniProtKB
Q8WWL2	SPIRE2	Protein spire homolog 2	GO:0036089; P:cleavage furrow formation; ISS:UniProtKB
Q8WWL2	SPIRE2	Protein spire homolog 2	GO:0051295; P:establishment of meiotic spindle localization; IMP:UniProtKB
Q8WWL2	SPIRE2	Protein spire homolog 2	GO:0070649; P:formin-nucleated actin cable assembly; ISS:UniProtKB
Q8WWL2	SPIRE2	Protein spire homolog 2	GO:0046907; P:intracellular transport; ISS:UniProtKB
Q8WWL2	SPIRE2	Protein spire homolog 2	GO:0040038; P:polar body extrusion after meiotic divisions; ISS:UniProtKB
Q8WWL2	SPIRE2	Protein spire homolog 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8WWL2	SPIRE2	Protein spire homolog 2	GO:0016192; P:vesicle-mediated transport; ISS:UniProtKB
O43278	SPINT1	Kunitz-type protease inhibitor 1	GO:0004867; F:serine-type endopeptidase inhibitor activity; TAS:ProtInc
O43278	SPINT1	Kunitz-type protease inhibitor 1	GO:0060670; P:branching involved in labyrinthine layer morphogenesis; IEA:Ensembl
O43278	SPINT1	Kunitz-type protease inhibitor 1	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
O43278	SPINT1	Kunitz-type protease inhibitor 1	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
O43278	SPINT1	Kunitz-type protease inhibitor 1	GO:0060674; P:placenta blood vessel development; IEA:Ensembl
O43291	SPINT2	Kunitz-type protease inhibitor 2	GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc
O43291	SPINT2	Kunitz-type protease inhibitor 2	GO:0004867; F:serine-type endopeptidase inhibitor activity; TAS:ProtInc
O43291	SPINT2	Kunitz-type protease inhibitor 2	GO:0006928; P:cellular component movement; TAS:ProtInc
O43291	SPINT2	Kunitz-type protease inhibitor 2	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
Q6UDR6	SPINT4	Kunitz-type protease inhibitor 4	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
P49223	SPINT3	Kunitz-type protease inhibitor 3	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q2M3C7	SPHKAP	A-kinase anchor protein SPHKAP	GO:0005515; F:protein binding; IPI:IntAct
Q2M3C7	SPHKAP	A-kinase anchor protein SPHKAP	GO:0051018; F:protein kinase A binding; IDA:UniProtKB
O95149	SNUPN	Snurportin-1	GO:0008565; F:protein transporter activity; IEA:InterPro
O95149	SNUPN	Snurportin-1	GO:0000339; F:RNA cap binding; TAS:ProtInc
O95149	SNUPN	Snurportin-1	GO:0010467; P:gene expression; TAS:Reactome
O95149	SNUPN	Snurportin-1	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
O95149	SNUPN	Snurportin-1	GO:0006606; P:protein import into nucleus; IEA:InterPro
O95149	SNUPN	Snurportin-1	GO:0016070; P:RNA metabolic process; TAS:Reactome
O95149	SNUPN	Snurportin-1	GO:0061015; P:snRNA import into nucleus; IEA:InterPro
O95149	SNUPN	Snurportin-1	GO:0000387; P:spliceosomal snRNP assembly; TAS:Reactome
Q9NZQ3	NCKIPSD	NCK-interacting protein with SH3 domain	GO:0008092; F:cytoskeletal protein binding; NAS:UniProtKB
Q9NZQ3	NCKIPSD	NCK-interacting protein with SH3 domain	GO:0005515; F:protein binding; IPI:IntAct
Q9NZQ3	NCKIPSD	NCK-interacting protein with SH3 domain	GO:0007010; P:cytoskeleton organization; NAS:UniProtKB
Q9NZQ3	NCKIPSD	NCK-interacting protein with SH3 domain	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q9NZQ3	NCKIPSD	NCK-interacting protein with SH3 domain	GO:0045087; P:innate immune response; TAS:Reactome
Q9NZQ3	NCKIPSD	NCK-interacting protein with SH3 domain	GO:0006607; P:NLS-bearing protein import into nucleus; TAS:ProtInc
Q9NZQ3	NCKIPSD	NCK-interacting protein with SH3 domain	GO:0007165; P:signal transduction; TAS:ProtInc
Q9H2V7	SPNS1	Protein spinster homolog 1	GO:0005515; F:protein binding; IPI:IntAct
Q9H2V7	SPNS1	Protein spinster homolog 1	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q9H2V7	SPNS1	Protein spinster homolog 1	GO:0055085; P:transmembrane transport; IEA:InterPro
Q8IVW8	SPNS2	Protein spinster homolog 2	GO:0046624; F:sphingolipid transporter activity; IEA:Ensembl
Q8IVW8	SPNS2	Protein spinster homolog 2	GO:0001782; P:B cell homeostasis; IEA:Ensembl
Q8IVW8	SPNS2	Protein spinster homolog 2	GO:0060348; P:bone development; IEA:Ensembl
Q8IVW8	SPNS2	Protein spinster homolog 2	GO:0048535; P:lymph node development; IEA:Ensembl
Q8IVW8	SPNS2	Protein spinster homolog 2	GO:0072676; P:lymphocyte migration; IEA:Ensembl
Q8IVW8	SPNS2	Protein spinster homolog 2	GO:0048073; P:regulation of eye pigmentation; IEA:Ensembl
Q8IVW8	SPNS2	Protein spinster homolog 2	GO:0002920; P:regulation of humoral immune response; IEA:Ensembl
Q8IVW8	SPNS2	Protein spinster homolog 2	GO:0006665; P:sphingolipid metabolic process; IEA:Ensembl
Q8IVW8	SPNS2	Protein spinster homolog 2	GO:0003376; P:sphingosine-1-phosphate signaling pathway; IEA:Ensembl
Q8IVW8	SPNS2	Protein spinster homolog 2	GO:0043029; P:T cell homeostasis; IEA:Ensembl
Q8IVW8	SPNS2	Protein spinster homolog 2	GO:0055085; P:transmembrane transport; IEA:InterPro
Q6ZMD2	SPNS3	Protein spinster homolog 3	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q6ZMD2	SPNS3	Protein spinster homolog 3	GO:0055085; P:transmembrane transport; IEA:InterPro
Q9NS26	SPANXA1	Sperm protein associated with the nucleus on the X chromosome A	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q9NS25	SPANXB1	Sperm protein associated with the nucleus on the X chromosome B/F	GO:0007286; P:spermatid development; NAS:UniProtKB
Q9Y5K1	SPO11	Meiotic recombination protein SPO11	GO:0005524; F:ATP binding; IEA:InterPro
Q9Y5K1	SPO11	Meiotic recombination protein SPO11	GO:0003677; F:DNA binding; TAS:ProtInc
Q9Y5K1	SPO11	Meiotic recombination protein SPO11	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q9Y5K1	SPO11	Meiotic recombination protein SPO11	GO:0007292; P:female gamete generation; TAS:ProtInc
Q9Y5K1	SPO11	Meiotic recombination protein SPO11	GO:0007141; P:male meiosis I; IEA:Ensembl
Q9Y5K1	SPO11	Meiotic recombination protein SPO11	GO:0001541; P:ovarian follicle development; IEA:Ensembl
Q9Y5K1	SPO11	Meiotic recombination protein SPO11	GO:0034502; P:protein localization to chromosome; IEA:Ensembl
Q9Y5K1	SPO11	Meiotic recombination protein SPO11	GO:0007131; P:reciprocal meiotic recombination; TAS:ProtInc
Q9Y5K1	SPO11	Meiotic recombination protein SPO11	GO:0007286; P:spermatid development; IEA:Ensembl
Q9Y5K1	SPO11	Meiotic recombination protein SPO11	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q9Y5K1	SPO11	Meiotic recombination protein SPO11	GO:0007129; P:synapsis; IEA:Ensembl
Q6ZMY3	SPOCD1	SPOC domain-containing protein 1	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q6ZMY3	SPOCD1	SPOC domain-containing protein 1	GO:0006351; P:transcription, DNA-templated; IEA:InterPro
Q9HCB6	SPON1	Spondin-1	GO:0005515; F:protein binding; IPI:IntAct
Q9HCB6	SPON1	Spondin-1	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9BUD6	SPON2	Spondin-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BUD6	SPON2	Spondin-2	GO:0007411; P:axon guidance; TAS:ProtInc
Q9BUD6	SPON2	Spondin-2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q9BUD6	SPON2	Spondin-2	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q6IQ16	SPOPL	Speckle-type POZ protein-like	GO:0031397; P:negative regulation of protein ubiquitination; IMP:UniProtKB
Q6IQ16	SPOPL	Speckle-type POZ protein-like	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q6IQ16	SPOPL	Speckle-type POZ protein-like	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
O43791	SPOP	Speckle-type POZ protein	GO:0005515; F:protein binding; IPI:IntAct
O43791	SPOP	Speckle-type POZ protein	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
O43791	SPOP	Speckle-type POZ protein	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
O43791	SPOP	Speckle-type POZ protein	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q13103	SPP2	Secreted phosphoprotein 24	GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc
Q13103	SPP2	Secreted phosphoprotein 24	GO:0046849; P:bone remodeling; IEA:InterPro
Q13103	SPP2	Secreted phosphoprotein 24	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
Q13103	SPP2	Secreted phosphoprotein 24	GO:0006461; P:protein complex assembly; IEA:Ensembl
Q13103	SPP2	Secreted phosphoprotein 24	GO:0001501; P:skeletal system development; TAS:ProtInc
Q8TCT8	SPPL2A	Signal peptide peptidase-like 2A	GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro
Q8TCT8	SPPL2A	Signal peptide peptidase-like 2A	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TCT8	SPPL2A	Signal peptide peptidase-like 2A	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q8TCT8	SPPL2A	Signal peptide peptidase-like 2A	GO:0006509; P:membrane protein ectodomain proteolysis; IDA:UniProtKB
Q8TCT8	SPPL2A	Signal peptide peptidase-like 2A	GO:0031293; P:membrane protein intracellular domain proteolysis; IDA:UniProtKB
Q8TCT8	SPPL2A	Signal peptide peptidase-like 2A	GO:0050776; P:regulation of immune response; IMP:UniProtKB
Q8IUH8	SPPL2C	Signal peptide peptidase-like 2C	GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro
Q8IUH8	SPPL2C	Signal peptide peptidase-like 2C	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q8TCT7	SPPL2B	Signal peptide peptidase-like 2B	GO:0042500; F:aspartic endopeptidase activity, intramembrane cleaving; IMP:UniProtKB
Q8TCT7	SPPL2B	Signal peptide peptidase-like 2B	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TCT7	SPPL2B	Signal peptide peptidase-like 2B	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q8TCT7	SPPL2B	Signal peptide peptidase-like 2B	GO:0006509; P:membrane protein ectodomain proteolysis; IDA:UniProtKB
Q8TCT7	SPPL2B	Signal peptide peptidase-like 2B	GO:0031293; P:membrane protein intracellular domain proteolysis; IDA:UniProtKB
Q8TCT7	SPPL2B	Signal peptide peptidase-like 2B	GO:0050776; P:regulation of immune response; IMP:UniProtKB
Q8TCT6	SPPL3	Signal peptide peptidase-like 3	GO:0042500; F:aspartic endopeptidase activity, intramembrane cleaving; IMP:UniProtKB
Q8TCT6	SPPL3	Signal peptide peptidase-like 3	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P35321	SPRR1A	Cornifin-A	GO:0005515; F:protein binding; IPI:UniProtKB
P35321	SPRR1A	Cornifin-A	GO:0030674; F:protein binding, bridging; IDA:UniProtKB
P35321	SPRR1A	Cornifin-A	GO:0005198; F:structural molecule activity; IDA:UniProtKB
P35321	SPRR1A	Cornifin-A	GO:0008544; P:epidermis development; TAS:ProtInc
P35321	SPRR1A	Cornifin-A	GO:0031424; P:keratinization; IEA:UniProtKB-KW
P35321	SPRR1A	Cornifin-A	GO:0030216; P:keratinocyte differentiation; IDA:UniProtKB
P35321	SPRR1A	Cornifin-A	GO:0018149; P:peptide cross-linking; IDA:UniProtKB
P22528	SPRR1B	Cornifin-B	GO:0030674; F:protein binding, bridging; IDA:UniProtKB
P22528	SPRR1B	Cornifin-B	GO:0005198; F:structural molecule activity; IDA:UniProtKB
P22528	SPRR1B	Cornifin-B	GO:0008544; P:epidermis development; TAS:ProtInc
P22528	SPRR1B	Cornifin-B	GO:0031424; P:keratinization; IEA:UniProtKB-KW
P22528	SPRR1B	Cornifin-B	GO:0030216; P:keratinocyte differentiation; IDA:UniProtKB
P22528	SPRR1B	Cornifin-B	GO:0018149; P:peptide cross-linking; IDA:UniProtKB
P35326	SPRR2A	Small proline-rich protein 2A	GO:0005515; F:protein binding; IPI:IntAct
P35326	SPRR2A	Small proline-rich protein 2A	GO:0008544; P:epidermis development; NAS:UniProtKB
P35326	SPRR2A	Small proline-rich protein 2A	GO:0031424; P:keratinization; IEA:UniProtKB-KW
P35326	SPRR2A	Small proline-rich protein 2A	GO:0030216; P:keratinocyte differentiation; NAS:UniProtKB
P35325	SPRR2B	Small proline-rich protein 2B	GO:0008544; P:epidermis development; NAS:UniProtKB
P35325	SPRR2B	Small proline-rich protein 2B	GO:0031424; P:keratinization; IEA:UniProtKB-KW
P35325	SPRR2B	Small proline-rich protein 2B	GO:0030216; P:keratinocyte differentiation; NAS:UniProtKB
P22531	SPRR2E	Small proline-rich protein 2E	GO:0005515; F:protein binding; IPI:UniProtKB
P22531	SPRR2E	Small proline-rich protein 2E	GO:0005198; F:structural molecule activity; TAS:UniProtKB
P22531	SPRR2E	Small proline-rich protein 2E	GO:0008544; P:epidermis development; NAS:UniProtKB
P22531	SPRR2E	Small proline-rich protein 2E	GO:0031424; P:keratinization; IEA:UniProtKB-KW
P22532	SPRR2D	Small proline-rich protein 2D	GO:0008544; P:epidermis development; NAS:UniProtKB
P22532	SPRR2D	Small proline-rich protein 2D	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q9BYE4	SPRR2G	Small proline-rich protein 2G	GO:0008544; P:epidermis development; NAS:UniProtKB
Q9BYE4	SPRR2G	Small proline-rich protein 2G	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q9BYE4	SPRR2G	Small proline-rich protein 2G	GO:0030216; P:keratinocyte differentiation; NAS:UniProtKB
Q96RM1	SPRR2F	Small proline-rich protein 2F	GO:0008544; P:epidermis development; NAS:UniProtKB
Q96RM1	SPRR2F	Small proline-rich protein 2F	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q96RM1	SPRR2F	Small proline-rich protein 2F	GO:0030216; P:keratinocyte differentiation; NAS:UniProtKB
P09486	SPARC	SPARC	GO:0005509; F:calcium ion binding; TAS:ProtInc
P09486	SPARC	SPARC	GO:0005518; F:collagen binding; TAS:ProtInc
P09486	SPARC	SPARC	GO:0050840; F:extracellular matrix binding; IEA:Ensembl
P09486	SPARC	SPARC	GO:0005515; F:protein binding; IPI:IntAct
P09486	SPARC	SPARC	GO:0007596; P:blood coagulation; TAS:Reactome
P09486	SPARC	SPARC	GO:0060348; P:bone development; IEA:Ensembl
P09486	SPARC	SPARC	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P09486	SPARC	SPARC	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P09486	SPARC	SPARC	GO:0007507; P:heart development; IEA:Ensembl
P09486	SPARC	SPARC	GO:0048839; P:inner ear development; IEA:Ensembl
P09486	SPARC	SPARC	GO:0030324; P:lung development; IEA:Ensembl
P09486	SPARC	SPARC	GO:0001503; P:ossification; TAS:ProtInc
P09486	SPARC	SPARC	GO:0030168; P:platelet activation; TAS:Reactome
P09486	SPARC	SPARC	GO:0002576; P:platelet degranulation; TAS:Reactome
P09486	SPARC	SPARC	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P09486	SPARC	SPARC	GO:0046686; P:response to cadmium ion; IEA:Ensembl
P09486	SPARC	SPARC	GO:0051592; P:response to calcium ion; IEA:Ensembl
P09486	SPARC	SPARC	GO:0051591; P:response to cAMP; IEA:Ensembl
P09486	SPARC	SPARC	GO:0034097; P:response to cytokine; IEA:Ensembl
P09486	SPARC	SPARC	GO:0045471; P:response to ethanol; IEA:Ensembl
P09486	SPARC	SPARC	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P09486	SPARC	SPARC	GO:0009629; P:response to gravity; IEA:Ensembl
P09486	SPARC	SPARC	GO:0033591; P:response to L-ascorbic acid; IEA:Ensembl
P09486	SPARC	SPARC	GO:0010288; P:response to lead ion; IEA:Ensembl
P09486	SPARC	SPARC	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P09486	SPARC	SPARC	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P09486	SPARC	SPARC	GO:0007165; P:signal transduction; IEA:InterPro
Q7Z699	SPRED1	Sprouty-related, EVH1 domain-containing protein 1	GO:0019902; F:phosphatase binding; IDA:UniProtKB
Q7Z699	SPRED1	Sprouty-related, EVH1 domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q7Z699	SPRED1	Sprouty-related, EVH1 domain-containing protein 1	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
Q7Z699	SPRED1	Sprouty-related, EVH1 domain-containing protein 1	GO:0030291; F:protein serine/threonine kinase inhibitor activity; ISS:BHF-UCL
Q7Z699	SPRED1	Sprouty-related, EVH1 domain-containing protein 1	GO:0005173; F:stem cell factor receptor binding; ISS:UniProtKB
Q7Z699	SPRED1	Sprouty-related, EVH1 domain-containing protein 1	GO:0000188; P:inactivation of MAPK activity; ISS:UniProtKB
Q7Z699	SPRED1	Sprouty-related, EVH1 domain-containing protein 1	GO:0007275; P:multicellular organismal development; IEA:InterPro
Q7Z699	SPRED1	Sprouty-related, EVH1 domain-containing protein 1	GO:0010801; P:negative regulation of peptidyl-threonine phosphorylation; IMP:BHF-UCL
Q7Z699	SPRED1	Sprouty-related, EVH1 domain-containing protein 1	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q7Z699	SPRED1	Sprouty-related, EVH1 domain-containing protein 1	GO:0043517; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; ISS:BHF-UCL
Q7Z699	SPRED1	Sprouty-related, EVH1 domain-containing protein 1	GO:0090311; P:regulation of protein deacetylation; ISS:BHF-UCL
Q7Z698	SPRED2	Sprouty-related, EVH1 domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z698	SPRED2	Sprouty-related, EVH1 domain-containing protein 2	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
Q7Z698	SPRED2	Sprouty-related, EVH1 domain-containing protein 2	GO:0030291; F:protein serine/threonine kinase inhibitor activity; ISS:BHF-UCL
Q7Z698	SPRED2	Sprouty-related, EVH1 domain-containing protein 2	GO:0005173; F:stem cell factor receptor binding; ISS:UniProtKB
Q7Z698	SPRED2	Sprouty-related, EVH1 domain-containing protein 2	GO:0000188; P:inactivation of MAPK activity; ISS:UniProtKB
Q7Z698	SPRED2	Sprouty-related, EVH1 domain-containing protein 2	GO:0007275; P:multicellular organismal development; IEA:InterPro
Q7Z698	SPRED2	Sprouty-related, EVH1 domain-containing protein 2	GO:0010801; P:negative regulation of peptidyl-threonine phosphorylation; IMP:BHF-UCL
Q7Z698	SPRED2	Sprouty-related, EVH1 domain-containing protein 2	GO:0043517; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; ISS:BHF-UCL
Q7Z698	SPRED2	Sprouty-related, EVH1 domain-containing protein 2	GO:0090311; P:regulation of protein deacetylation; ISS:BHF-UCL
Q2MJR0	SPRED3	Sprouty-related, EVH1 domain-containing protein 3	GO:0000188; P:inactivation of MAPK activity; IEA:Ensembl
Q2MJR0	SPRED3	Sprouty-related, EVH1 domain-containing protein 3	GO:0007275; P:multicellular organismal development; IEA:InterPro
P35270	SPR	Sepiapterin reductase	GO:0004033; F:aldo-keto reductase (NADP) activity; TAS:UniProtKB
P35270	SPR	Sepiapterin reductase	GO:0050661; F:NADP binding; TAS:UniProtKB
P35270	SPR	Sepiapterin reductase	GO:0004757; F:sepiapterin reductase activity; ISS:UniProtKB
P35270	SPR	Sepiapterin reductase	GO:0006809; P:nitric oxide biosynthetic process; IDA:UniProtKB
P35270	SPR	Sepiapterin reductase	GO:0046209; P:nitric oxide metabolic process; TAS:Reactome
P35270	SPR	Sepiapterin reductase	GO:0055114; P:oxidation-reduction process; TAS:UniProtKB
P35270	SPR	Sepiapterin reductase	GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome
P35270	SPR	Sepiapterin reductase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P35270	SPR	Sepiapterin reductase	GO:0006729; P:tetrahydrobiopterin biosynthetic process; TAS:UniProtKB
Q14515	SPARCL1	SPARC-like protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q14515	SPARCL1	SPARC-like protein 1	GO:0007165; P:signal transduction; IEA:InterPro
Q9UBC9	SPRR3	Small proline-rich protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBC9	SPRR3	Small proline-rich protein 3	GO:0005198; F:structural molecule activity; TAS:UniProtKB
Q9UBC9	SPRR3	Small proline-rich protein 3	GO:0008544; P:epidermis development; NAS:UniProtKB
Q9UBC9	SPRR3	Small proline-rich protein 3	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q9UBC9	SPRR3	Small proline-rich protein 3	GO:0030216; P:keratinocyte differentiation; NAS:UniProtKB
Q9UBC9	SPRR3	Small proline-rich protein 3	GO:0018149; P:peptide cross-linking; IEA:InterPro
Q9UBC9	SPRR3	Small proline-rich protein 3	GO:0042060; P:wound healing; TAS:UniProtKB
Q96PI1	SPRR4	Small proline-rich protein 4	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q96PI1	SPRR4	Small proline-rich protein 4	GO:0018149; P:peptide cross-linking; IEA:InterPro
Q9H040	SPRTN	SprT-like domain-containing protein Spartan	GO:0003677; F:DNA binding; IEA:InterPro
Q9H040	SPRTN	SprT-like domain-containing protein Spartan	GO:0070530; F:K63-linked polyubiquitin binding; IDA:UniProtKB
Q9H040	SPRTN	SprT-like domain-containing protein Spartan	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H040	SPRTN	SprT-like domain-containing protein Spartan	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H040	SPRTN	SprT-like domain-containing protein Spartan	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
Q9H040	SPRTN	SprT-like domain-containing protein Spartan	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q9H040	SPRTN	SprT-like domain-containing protein Spartan	GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB
Q9H040	SPRTN	SprT-like domain-containing protein Spartan	GO:0009411; P:response to UV; IDA:UniProtKB
Q9H040	SPRTN	SprT-like domain-containing protein Spartan	GO:0019985; P:translesion synthesis; IDA:UniProtKB
P49903	SEPHS1	Selenide, water dikinase 1	GO:0005524; F:ATP binding; TAS:ProtInc
P49903	SEPHS1	Selenide, water dikinase 1	GO:0005525; F:GTP binding; TAS:ProtInc
P49903	SEPHS1	Selenide, water dikinase 1	GO:0005515; F:protein binding; IPI:UniProtKB
P49903	SEPHS1	Selenide, water dikinase 1	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
P49903	SEPHS1	Selenide, water dikinase 1	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P49903	SEPHS1	Selenide, water dikinase 1	GO:0004756; F:selenide, water dikinase activity; IEA:UniProtKB-EC
P49903	SEPHS1	Selenide, water dikinase 1	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q99611	SEPHS2	Selenide, water dikinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q99611	SEPHS2	Selenide, water dikinase 2	GO:0004756; F:selenide, water dikinase activity; NAS:UniProtKB
Q99611	SEPHS2	Selenide, water dikinase 2	GO:0016260; P:selenocysteine biosynthetic process; NAS:UniProtKB
Q9NUQ6	SPATS2L	SPATS2-like protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96BD6	SPSB1	SPRY domain-containing SOCS box protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q96BD6	SPSB1	SPRY domain-containing SOCS box protein 1	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q96BD6	SPSB1	SPRY domain-containing SOCS box protein 1	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q99619	SPSB2	SPRY domain-containing SOCS box protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q99619	SPSB2	SPRY domain-containing SOCS box protein 2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q99619	SPSB2	SPRY domain-containing SOCS box protein 2	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q6PJ21	SPSB3	SPRY domain-containing SOCS box protein 3	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q6PJ21	SPSB3	SPRY domain-containing SOCS box protein 3	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q96A44	SPSB4	SPRY domain-containing SOCS box protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q96A44	SPSB4	SPRY domain-containing SOCS box protein 4	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q96A44	SPSB4	SPRY domain-containing SOCS box protein 4	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
P52788	SMS	Spermine synthase	GO:0004766; F:spermidine synthase activity; TAS:ProtInc
P52788	SMS	Spermine synthase	GO:0016768; F:spermine synthase activity; IEA:UniProtKB-EC
P52788	SMS	Spermine synthase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P52788	SMS	Spermine synthase	GO:0006555; P:methionine metabolic process; TAS:ProtInc
P52788	SMS	Spermine synthase	GO:0006595; P:polyamine metabolic process; TAS:Reactome
P52788	SMS	Spermine synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P52788	SMS	Spermine synthase	GO:0006597; P:spermine biosynthetic process; IEA:UniProtKB-UniPathway
Q96N96	SPATA13	Spermatogenesis-associated protein 13	GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q96N96	SPATA13	Spermatogenesis-associated protein 13	GO:0005515; F:protein binding; IPI:UniProtKB
Q96N96	SPATA13	Spermatogenesis-associated protein 13	GO:0030676; F:Rac guanyl-nucleotide exchange factor activity; IDA:UniProtKB
Q96N96	SPATA13	Spermatogenesis-associated protein 13	GO:0016477; P:cell migration; IMP:UniProtKB
Q96N96	SPATA13	Spermatogenesis-associated protein 13	GO:0046847; P:filopodium assembly; IMP:UniProtKB
Q96N96	SPATA13	Spermatogenesis-associated protein 13	GO:0030032; P:lamellipodium assembly; IMP:UniProtKB
Q96N96	SPATA13	Spermatogenesis-associated protein 13	GO:0030334; P:regulation of cell migration; IMP:UniProtKB
Q96N96	SPATA13	Spermatogenesis-associated protein 13	GO:0043087; P:regulation of GTPase activity; IDA:GOC
Q96N96	SPATA13	Spermatogenesis-associated protein 13	GO:0032314; P:regulation of Rac GTPase activity; IDA:GOC
Q9BXB7	SPATA16	Spermatogenesis-associated protein 16	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9BXB7	SPATA16	Spermatogenesis-associated protein 16	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9BXB7	SPATA16	Spermatogenesis-associated protein 16	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q7Z5L4	SPATA19	Spermatogenesis-associated protein 19, mitochondrial	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q7Z5L4	SPATA19	Spermatogenesis-associated protein 19, mitochondrial	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q7Z5L4	SPATA19	Spermatogenesis-associated protein 19, mitochondrial	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q7Z572	SPATA21	Spermatogenesis-associated protein 21	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8TB22	SPATA20	Spermatogenesis-associated protein 20	GO:0003824; F:catalytic activity; IEA:InterPro
Q8TB22	SPATA20	Spermatogenesis-associated protein 20	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8TB22	SPATA20	Spermatogenesis-associated protein 20	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8TB22	SPATA20	Spermatogenesis-associated protein 20	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q8NHS9	SPATA22	Spermatogenesis-associated protein 22	GO:0009566; P:fertilization; IEA:Ensembl
Q8NHS9	SPATA22	Spermatogenesis-associated protein 22	GO:0007276; P:gamete generation; IEA:Ensembl
Q8NHS9	SPATA22	Spermatogenesis-associated protein 22	GO:0000711; P:meiotic DNA repair synthesis; IEA:Ensembl
Q8NHS9	SPATA22	Spermatogenesis-associated protein 22	GO:0051445; P:regulation of meiotic cell cycle; IEA:Ensembl
Q8NHS9	SPATA22	Spermatogenesis-associated protein 22	GO:0061458; P:reproductive system development; IEA:Ensembl
Q8NHS9	SPATA22	Spermatogenesis-associated protein 22	GO:0007129; P:synapsis; IEA:Ensembl
Q9BR10	SPATA25	Spermatogenesis-associated protein 25	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9BR10	SPATA25	Spermatogenesis-associated protein 25	GO:0007283; P:spermatogenesis; IEP:UniProtKB
Q96LK8	SPATA32	Spermatogenesis-associated protein 32	GO:0007283; P:spermatogenesis; IEA:Ensembl
P63272	SUPT4H1	Transcription elongation factor SPT4	GO:0005515; F:protein binding; IPI:IntAct
P63272	SUPT4H1	Transcription elongation factor SPT4	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
P63272	SUPT4H1	Transcription elongation factor SPT4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P63272	SUPT4H1	Transcription elongation factor SPT4	GO:0008270; F:zinc ion binding; IEA:InterPro
P63272	SUPT4H1	Transcription elongation factor SPT4	GO:0006338; P:chromatin remodeling; TAS:ProtInc
P63272	SUPT4H1	Transcription elongation factor SPT4	GO:0010467; P:gene expression; TAS:Reactome
P63272	SUPT4H1	Transcription elongation factor SPT4	GO:0032785; P:negative regulation of DNA-templated transcription, elongation; IDA:UniProtKB
P63272	SUPT4H1	Transcription elongation factor SPT4	GO:0034244; P:negative regulation of transcription elongation from RNA polymerase II promoter; IEA:Ensembl
P63272	SUPT4H1	Transcription elongation factor SPT4	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P63272	SUPT4H1	Transcription elongation factor SPT4	GO:0032786; P:positive regulation of DNA-templated transcription, elongation; IDA:UniProtKB
P63272	SUPT4H1	Transcription elongation factor SPT4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P63272	SUPT4H1	Transcription elongation factor SPT4	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P63272	SUPT4H1	Transcription elongation factor SPT4	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P63272	SUPT4H1	Transcription elongation factor SPT4	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
P63272	SUPT4H1	Transcription elongation factor SPT4	GO:0006368; P:transcription elongation from RNA polymerase II promoter; IDA:UniProtKB
P63272	SUPT4H1	Transcription elongation factor SPT4	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
P63272	SUPT4H1	Transcription elongation factor SPT4	GO:0016032; P:viral process; TAS:Reactome
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0003682; F:chromatin binding; IEA:Ensembl
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0019899; F:enzyme binding; IPI:UniProtKB
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0005515; F:protein binding; IPI:IntAct
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0007049; P:cell cycle; NAS:UniProtKB
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0006338; P:chromatin remodeling; NAS:UniProtKB
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0006354; P:DNA-templated transcription, elongation; IDA:UniProtKB
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0010467; P:gene expression; TAS:Reactome
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0032785; P:negative regulation of DNA-templated transcription, elongation; IDA:UniProtKB
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0032786; P:positive regulation of DNA-templated transcription, elongation; IDA:UniProtKB
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0016239; P:positive regulation of macroautophagy; IMP:BHF-UCL
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0010033; P:response to organic substance; TAS:UniProtKB
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0039692; P:single stranded viral RNA replication via double stranded DNA intermediate; NAS:UniProtKB
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0006368; P:transcription elongation from RNA polymerase II promoter; IDA:UniProtKB
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
O00267	SUPT5H	Transcription elongation factor SPT5	GO:0016032; P:viral process; TAS:Reactome
Q7KZ85	SUPT6H	Transcription elongation factor SPT6	GO:0003677; F:DNA binding; IEA:InterPro
Q7KZ85	SUPT6H	Transcription elongation factor SPT6	GO:0042393; F:histone binding; IDA:UniProtKB
Q7KZ85	SUPT6H	Transcription elongation factor SPT6	GO:0016788; F:hydrolase activity, acting on ester bonds; IEA:InterPro
Q7KZ85	SUPT6H	Transcription elongation factor SPT6	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7KZ85	SUPT6H	Transcription elongation factor SPT6	GO:0005515; F:protein binding; IPI:UniProtKB
Q7KZ85	SUPT6H	Transcription elongation factor SPT6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q7KZ85	SUPT6H	Transcription elongation factor SPT6	GO:0006338; P:chromatin remodeling; NAS:UniProtKB
Q7KZ85	SUPT6H	Transcription elongation factor SPT6	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q7KZ85	SUPT6H	Transcription elongation factor SPT6	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q7KZ85	SUPT6H	Transcription elongation factor SPT6	GO:0061086; P:negative regulation of histone H3-K27 methylation; IMP:UniProtKB
Q7KZ85	SUPT6H	Transcription elongation factor SPT6	GO:0032968; P:positive regulation of transcription elongation from RNA polymerase II promoter; IMP:UniProtKB
Q7KZ85	SUPT6H	Transcription elongation factor SPT6	GO:0045191; P:regulation of isotype switching; ISS:UniProtKB
Q7KZ85	SUPT6H	Transcription elongation factor SPT6	GO:0010793; P:regulation of mRNA export from nucleus; ISS:UniProtKB
Q7KZ85	SUPT6H	Transcription elongation factor SPT6	GO:0050684; P:regulation of mRNA processing; ISS:UniProtKB
Q7KZ85	SUPT6H	Transcription elongation factor SPT6	GO:0051147; P:regulation of muscle cell differentiation; ISS:UniProtKB
Q7KZ85	SUPT6H	Transcription elongation factor SPT6	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q7KZ85	SUPT6H	Transcription elongation factor SPT6	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q7KZ85	SUPT6H	Transcription elongation factor SPT6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7KZ85	SUPT6H	Transcription elongation factor SPT6	GO:0016032; P:viral process; IEA:UniProtKB-KW
P02549	SPTA1	Spectrin alpha chain, erythrocytic 1	GO:0051015; F:actin filament binding; TAS:ProtInc
P02549	SPTA1	Spectrin alpha chain, erythrocytic 1	GO:0005509; F:calcium ion binding; IEA:InterPro
P02549	SPTA1	Spectrin alpha chain, erythrocytic 1	GO:0005515; F:protein binding; IPI:IntAct
P02549	SPTA1	Spectrin alpha chain, erythrocytic 1	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P02549	SPTA1	Spectrin alpha chain, erythrocytic 1	GO:0051693; P:actin filament capping; IEA:UniProtKB-KW
P02549	SPTA1	Spectrin alpha chain, erythrocytic 1	GO:0007015; P:actin filament organization; TAS:ProtInc
P02549	SPTA1	Spectrin alpha chain, erythrocytic 1	GO:0007411; P:axon guidance; TAS:Reactome
P02549	SPTA1	Spectrin alpha chain, erythrocytic 1	GO:0030097; P:hemopoiesis; IEA:Ensembl
P02549	SPTA1	Spectrin alpha chain, erythrocytic 1	GO:0002260; P:lymphocyte homeostasis; IEA:Ensembl
P02549	SPTA1	Spectrin alpha chain, erythrocytic 1	GO:0007009; P:plasma membrane organization; IEA:Ensembl
P02549	SPTA1	Spectrin alpha chain, erythrocytic 1	GO:0006779; P:porphyrin-containing compound biosynthetic process; IEA:Ensembl
P02549	SPTA1	Spectrin alpha chain, erythrocytic 1	GO:0032092; P:positive regulation of protein binding; IEA:Ensembl
P02549	SPTA1	Spectrin alpha chain, erythrocytic 1	GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl
P02549	SPTA1	Spectrin alpha chain, erythrocytic 1	GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW
P11277	SPTB	Spectrin beta chain, erythrocytic	GO:0003779; F:actin binding; TAS:ProtInc
P11277	SPTB	Spectrin beta chain, erythrocytic	GO:0051015; F:actin filament binding; IDA:UniProtKB
P11277	SPTB	Spectrin beta chain, erythrocytic	GO:0030506; F:ankyrin binding; IPI:BHF-UCL
P11277	SPTB	Spectrin beta chain, erythrocytic	GO:0005515; F:protein binding; IPI:UniProtKB
P11277	SPTB	Spectrin beta chain, erythrocytic	GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro
P11277	SPTB	Spectrin beta chain, erythrocytic	GO:0051693; P:actin filament capping; IEA:UniProtKB-KW
P11277	SPTB	Spectrin beta chain, erythrocytic	GO:0007411; P:axon guidance; TAS:Reactome
P11277	SPTB	Spectrin beta chain, erythrocytic	GO:0030097; P:hemopoiesis; IEA:Ensembl
P11277	SPTB	Spectrin beta chain, erythrocytic	GO:0007009; P:plasma membrane organization; IEA:Ensembl
P11277	SPTB	Spectrin beta chain, erythrocytic	GO:0006779; P:porphyrin-containing compound biosynthetic process; IEA:Ensembl
Q01082	SPTBN1	Spectrin beta chain, non-erythrocytic 1	GO:0003779; F:actin binding; TAS:ProtInc
Q01082	SPTBN1	Spectrin beta chain, non-erythrocytic 1	GO:0030506; F:ankyrin binding; IPI:BHF-UCL
Q01082	SPTBN1	Spectrin beta chain, non-erythrocytic 1	GO:0005543; F:phospholipid binding; IEA:InterPro
Q01082	SPTBN1	Spectrin beta chain, non-erythrocytic 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q01082	SPTBN1	Spectrin beta chain, non-erythrocytic 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q01082	SPTBN1	Spectrin beta chain, non-erythrocytic 1	GO:0005200; F:structural constituent of cytoskeleton; IMP:BHF-UCL
Q01082	SPTBN1	Spectrin beta chain, non-erythrocytic 1	GO:0051693; P:actin filament capping; IEA:UniProtKB-KW
Q01082	SPTBN1	Spectrin beta chain, non-erythrocytic 1	GO:0007411; P:axon guidance; TAS:Reactome
Q01082	SPTBN1	Spectrin beta chain, non-erythrocytic 1	GO:0007182; P:common-partner SMAD protein phosphorylation; IEA:Ensembl
Q01082	SPTBN1	Spectrin beta chain, non-erythrocytic 1	GO:0043001; P:Golgi to plasma membrane protein transport; IMP:BHF-UCL
Q01082	SPTBN1	Spectrin beta chain, non-erythrocytic 1	GO:0071709; P:membrane assembly; IMP:BHF-UCL
Q01082	SPTBN1	Spectrin beta chain, non-erythrocytic 1	GO:0000281; P:mitotic cytokinesis; IMP:BHF-UCL
Q01082	SPTBN1	Spectrin beta chain, non-erythrocytic 1	GO:0007009; P:plasma membrane organization; IMP:BHF-UCL
Q01082	SPTBN1	Spectrin beta chain, non-erythrocytic 1	GO:0072661; P:protein targeting to plasma membrane; IMP:BHF-UCL
Q01082	SPTBN1	Spectrin beta chain, non-erythrocytic 1	GO:0007184; P:SMAD protein import into nucleus; IEA:Ensembl
O15269	SPTLC1	Serine palmitoyltransferase 1	GO:0005515; F:protein binding; IPI:UniProtKB
O15269	SPTLC1	Serine palmitoyltransferase 1	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
O15269	SPTLC1	Serine palmitoyltransferase 1	GO:0004758; F:serine C-palmitoyltransferase activity; IDA:UniProtKB
O15269	SPTLC1	Serine palmitoyltransferase 1	GO:0046513; P:ceramide biosynthetic process; IEA:Ensembl
O15269	SPTLC1	Serine palmitoyltransferase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15269	SPTLC1	Serine palmitoyltransferase 1	GO:0046511; P:sphinganine biosynthetic process; IEA:Ensembl
O15269	SPTLC1	Serine palmitoyltransferase 1	GO:0030148; P:sphingolipid biosynthetic process; TAS:UniProtKB
O15269	SPTLC1	Serine palmitoyltransferase 1	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
O15269	SPTLC1	Serine palmitoyltransferase 1	GO:0006686; P:sphingomyelin biosynthetic process; IEA:Ensembl
O15269	SPTLC1	Serine palmitoyltransferase 1	GO:0046512; P:sphingosine biosynthetic process; IEA:Ensembl
O15270	SPTLC2	Serine palmitoyltransferase 2	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
O15270	SPTLC2	Serine palmitoyltransferase 2	GO:0004758; F:serine C-palmitoyltransferase activity; IDA:UniProtKB
O15270	SPTLC2	Serine palmitoyltransferase 2	GO:0046513; P:ceramide biosynthetic process; IEA:Ensembl
O15270	SPTLC2	Serine palmitoyltransferase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O15270	SPTLC2	Serine palmitoyltransferase 2	GO:0046511; P:sphinganine biosynthetic process; IEA:Ensembl
O15270	SPTLC2	Serine palmitoyltransferase 2	GO:0030148; P:sphingolipid biosynthetic process; TAS:UniProtKB
O15270	SPTLC2	Serine palmitoyltransferase 2	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
O15270	SPTLC2	Serine palmitoyltransferase 2	GO:0006686; P:sphingomyelin biosynthetic process; IEA:Ensembl
O15270	SPTLC2	Serine palmitoyltransferase 2	GO:0046512; P:sphingosine biosynthetic process; IEA:Ensembl
Q9NUV7	SPTLC3	Serine palmitoyltransferase 3	GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro
Q9NUV7	SPTLC3	Serine palmitoyltransferase 3	GO:0004758; F:serine C-palmitoyltransferase activity; IDA:UniProtKB
Q9NUV7	SPTLC3	Serine palmitoyltransferase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NUV7	SPTLC3	Serine palmitoyltransferase 3	GO:0046520; P:sphingoid biosynthetic process; IDA:MGI
Q9NUV7	SPTLC3	Serine palmitoyltransferase 3	GO:0030148; P:sphingolipid biosynthetic process; TAS:UniProtKB
Q9NUV7	SPTLC3	Serine palmitoyltransferase 3	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q96JI7	SPG11	Spatacsin	GO:0005515; F:protein binding; IPI:UniProtKB
Q96JI7	SPG11	Spatacsin	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q13813	SPTAN1	Spectrin alpha chain, non-erythrocytic 1	GO:0003779; F:actin binding; TAS:ProtInc
Q13813	SPTAN1	Spectrin alpha chain, non-erythrocytic 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q13813	SPTAN1	Spectrin alpha chain, non-erythrocytic 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13813	SPTAN1	Spectrin alpha chain, non-erythrocytic 1	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
Q13813	SPTAN1	Spectrin alpha chain, non-erythrocytic 1	GO:0051693; P:actin filament capping; IEA:UniProtKB-KW
Q13813	SPTAN1	Spectrin alpha chain, non-erythrocytic 1	GO:0006915; P:apoptotic process; TAS:Reactome
Q13813	SPTAN1	Spectrin alpha chain, non-erythrocytic 1	GO:0007411; P:axon guidance; TAS:Reactome
Q13813	SPTAN1	Spectrin alpha chain, non-erythrocytic 1	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
O15020	SPTBN2	Spectrin beta chain, non-erythrocytic 2	GO:0003779; F:actin binding; TAS:ProtInc
O15020	SPTBN2	Spectrin beta chain, non-erythrocytic 2	GO:0005543; F:phospholipid binding; IEA:InterPro
O15020	SPTBN2	Spectrin beta chain, non-erythrocytic 2	GO:0005200; F:structural constituent of cytoskeleton; TAS:UniProtKB
O15020	SPTBN2	Spectrin beta chain, non-erythrocytic 2	GO:0051693; P:actin filament capping; IEA:UniProtKB-KW
O15020	SPTBN2	Spectrin beta chain, non-erythrocytic 2	GO:0030534; P:adult behavior; IEA:Ensembl
O15020	SPTBN2	Spectrin beta chain, non-erythrocytic 2	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome
O15020	SPTBN2	Spectrin beta chain, non-erythrocytic 2	GO:0007411; P:axon guidance; TAS:Reactome
O15020	SPTBN2	Spectrin beta chain, non-erythrocytic 2	GO:0008219; P:cell death; IEA:UniProtKB-KW
O15020	SPTBN2	Spectrin beta chain, non-erythrocytic 2	GO:0021692; P:cerebellar Purkinje cell layer morphogenesis; IEA:Ensembl
O15020	SPTBN2	Spectrin beta chain, non-erythrocytic 2	GO:0035264; P:multicellular organism growth; IEA:Ensembl
O15020	SPTBN2	Spectrin beta chain, non-erythrocytic 2	GO:0007416; P:synapse assembly; IEA:Ensembl
O15020	SPTBN2	Spectrin beta chain, non-erythrocytic 2	GO:0016192; P:vesicle-mediated transport; IDA:UniProtKB
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0003779; F:actin binding; TAS:UniProtKB
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0030506; F:ankyrin binding; IDA:UniProtKB
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0019902; F:phosphatase binding; IPI:BHF-UCL
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0005543; F:phospholipid binding; IEA:InterPro
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0005515; F:protein binding; IPI:IntAct
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0030507; F:spectrin binding; ISS:BHF-UCL
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0005200; F:structural constituent of cytoskeleton; TAS:UniProtKB
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0051693; P:actin filament capping; IEA:UniProtKB-KW
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0007628; P:adult walking behavior; ISS:BHF-UCL
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0007411; P:axon guidance; TAS:Reactome
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0007409; P:axonogenesis; ISS:BHF-UCL
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0061337; P:cardiac conduction; ISS:BHF-UCL
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0021952; P:central nervous system projection neuron axonogenesis; ISS:BHF-UCL
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0045162; P:clustering of voltage-gated sodium channels; ISS:BHF-UCL
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0007016; P:cytoskeletal anchoring at plasma membrane; TAS:UniProtKB
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0090002; P:establishment of protein localization to plasma membrane; ISS:BHF-UCL
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0009566; P:fertilization; IEA:Ensembl
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0010459; P:negative regulation of heart rate; ISS:BHF-UCL
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0033135; P:regulation of peptidyl-serine phosphorylation; ISS:BHF-UCL
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0002028; P:regulation of sodium ion transport; ISS:BHF-UCL
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0007605; P:sensory perception of sound; ISS:BHF-UCL
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0019226; P:transmission of nerve impulse; ISS:BHF-UCL
Q9H254	SPTBN4	Spectrin beta chain, non-erythrocytic 4	GO:0016192; P:vesicle-mediated transport; TAS:UniProtKB
Q9NRC6	SPTBN5	Spectrin beta chain, non-erythrocytic 5	GO:0003779; F:actin binding; NAS:UniProtKB
Q9NRC6	SPTBN5	Spectrin beta chain, non-erythrocytic 5	GO:0034452; F:dynactin binding; IDA:MGI
Q9NRC6	SPTBN5	Spectrin beta chain, non-erythrocytic 5	GO:0045505; F:dynein intermediate chain binding; IDA:MGI
Q9NRC6	SPTBN5	Spectrin beta chain, non-erythrocytic 5	GO:0019894; F:kinesin binding; IDA:MGI
Q9NRC6	SPTBN5	Spectrin beta chain, non-erythrocytic 5	GO:0032029; F:myosin tail binding; IDA:MGI
Q9NRC6	SPTBN5	Spectrin beta chain, non-erythrocytic 5	GO:0043621; F:protein self-association; IDA:MGI
Q9NRC6	SPTBN5	Spectrin beta chain, non-erythrocytic 5	GO:0030507; F:spectrin binding; IDA:MGI
Q9NRC6	SPTBN5	Spectrin beta chain, non-erythrocytic 5	GO:0030036; P:actin cytoskeleton organization; NAS:UniProtKB
Q9NRC6	SPTBN5	Spectrin beta chain, non-erythrocytic 5	GO:0051693; P:actin filament capping; IEA:UniProtKB-KW
Q9NRC6	SPTBN5	Spectrin beta chain, non-erythrocytic 5	GO:0007411; P:axon guidance; TAS:Reactome
Q9NRC6	SPTBN5	Spectrin beta chain, non-erythrocytic 5	GO:0007030; P:Golgi organization; IMP:MGI
Q9NRC6	SPTBN5	Spectrin beta chain, non-erythrocytic 5	GO:0007041; P:lysosomal transport; IMP:MGI
Q9NRC6	SPTBN5	Spectrin beta chain, non-erythrocytic 5	GO:0051260; P:protein homooligomerization; IDA:MGI
Q969W0	SPTSSA	Serine palmitoyltransferase small subunit A	GO:0005515; F:protein binding; IPI:UniProtKB
Q969W0	SPTSSA	Serine palmitoyltransferase small subunit A	GO:0030148; P:sphingolipid biosynthetic process; TAS:UniProtKB
Q8NFR3	SPTSSB	Serine palmitoyltransferase small subunit B	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NFR3	SPTSSB	Serine palmitoyltransferase small subunit B	GO:0030148; P:sphingolipid biosynthetic process; TAS:UniProtKB
Q8TED4	SLC37A2	Sugar phosphate exchanger 2	GO:0005215; F:transporter activity; IEA:InterPro
Q8TED4	SLC37A2	Sugar phosphate exchanger 2	GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW
Q8TED4	SLC37A2	Sugar phosphate exchanger 2	GO:0055085; P:transmembrane transport; IEA:InterPro
Q8NCC5	SLC37A3	Sugar phosphate exchanger 3	GO:0005215; F:transporter activity; IEA:InterPro
Q8NCC5	SLC37A3	Sugar phosphate exchanger 3	GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW
Q8NCC5	SLC37A3	Sugar phosphate exchanger 3	GO:0055085; P:transmembrane transport; IEA:InterPro
O43609	SPRY1	Protein sprouty homolog 1	GO:0005515; F:protein binding; IPI:IntAct
O43609	SPRY1	Protein sprouty homolog 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O43609	SPRY1	Protein sprouty homolog 1	GO:0001656; P:metanephros development; IEA:Ensembl
O43609	SPRY1	Protein sprouty homolog 1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
O43609	SPRY1	Protein sprouty homolog 1	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
O43609	SPRY1	Protein sprouty homolog 1	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IEA:Ensembl
O43609	SPRY1	Protein sprouty homolog 1	GO:0040037; P:negative regulation of fibroblast growth factor receptor signaling pathway; IEA:Ensembl
O43609	SPRY1	Protein sprouty homolog 1	GO:0043407; P:negative regulation of MAP kinase activity; IEA:Ensembl
O43609	SPRY1	Protein sprouty homolog 1	GO:0051387; P:negative regulation of neurotrophin TRK receptor signaling pathway; IEA:Ensembl
O43609	SPRY1	Protein sprouty homolog 1	GO:0034261; P:negative regulation of Ras GTPase activity; IEA:Ensembl
O43609	SPRY1	Protein sprouty homolog 1	GO:0046580; P:negative regulation of Ras protein signal transduction; IEA:Ensembl
O43609	SPRY1	Protein sprouty homolog 1	GO:0001759; P:organ induction; IEA:Ensembl
O43609	SPRY1	Protein sprouty homolog 1	GO:0001657; P:ureteric bud development; IEA:Ensembl
Q9C004	SPRY4	Protein sprouty homolog 4	GO:0005515; F:protein binding; IPI:IntAct
Q9C004	SPRY4	Protein sprouty homolog 4	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9C004	SPRY4	Protein sprouty homolog 4	GO:0043407; P:negative regulation of MAP kinase activity; IEA:Ensembl
O43597	SPRY2	Protein sprouty homolog 2	GO:0005515; F:protein binding; IPI:UniProtKB
O43597	SPRY2	Protein sprouty homolog 2	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
O43597	SPRY2	Protein sprouty homolog 2	GO:0043539; F:protein serine/threonine kinase activator activity; IMP:UniProtKB
O43597	SPRY2	Protein sprouty homolog 2	GO:0030291; F:protein serine/threonine kinase inhibitor activity; IC:BHF-UCL
O43597	SPRY2	Protein sprouty homolog 2	GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl
O43597	SPRY2	Protein sprouty homolog 2	GO:0045165; P:cell fate commitment; IEA:Ensembl
O43597	SPRY2	Protein sprouty homolog 2	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O43597	SPRY2	Protein sprouty homolog 2	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
O43597	SPRY2	Protein sprouty homolog 2	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
O43597	SPRY2	Protein sprouty homolog 2	GO:0060437; P:lung growth; IEA:Ensembl
O43597	SPRY2	Protein sprouty homolog 2	GO:0060425; P:lung morphogenesis; IEA:Ensembl
O43597	SPRY2	Protein sprouty homolog 2	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
O43597	SPRY2	Protein sprouty homolog 2	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
O43597	SPRY2	Protein sprouty homolog 2	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
O43597	SPRY2	Protein sprouty homolog 2	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IEA:Ensembl
O43597	SPRY2	Protein sprouty homolog 2	GO:0040037; P:negative regulation of fibroblast growth factor receptor signaling pathway; IEA:Ensembl
O43597	SPRY2	Protein sprouty homolog 2	GO:0043407; P:negative regulation of MAP kinase activity; IEA:Ensembl
O43597	SPRY2	Protein sprouty homolog 2	GO:0051387; P:negative regulation of neurotrophin TRK receptor signaling pathway; IEA:Ensembl
O43597	SPRY2	Protein sprouty homolog 2	GO:0010801; P:negative regulation of peptidyl-threonine phosphorylation; IDA:BHF-UCL
O43597	SPRY2	Protein sprouty homolog 2	GO:0034261; P:negative regulation of Ras GTPase activity; IEA:Ensembl
O43597	SPRY2	Protein sprouty homolog 2	GO:0046580; P:negative regulation of Ras protein signal transduction; IEA:Ensembl
O43597	SPRY2	Protein sprouty homolog 2	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB
O43597	SPRY2	Protein sprouty homolog 2	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
O43597	SPRY2	Protein sprouty homolog 2	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IMP:UniProtKB
O43597	SPRY2	Protein sprouty homolog 2	GO:0051897; P:positive regulation of protein kinase B signaling; IMP:UniProtKB
O43597	SPRY2	Protein sprouty homolog 2	GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IMP:GOC
O43597	SPRY2	Protein sprouty homolog 2	GO:0007605; P:sensory perception of sound; IEA:Ensembl
O43610	SPRY3	Protein sprouty homolog 3	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
O43610	SPRY3	Protein sprouty homolog 3	GO:0009966; P:regulation of signal transduction; IEA:InterPro
P21549	AGXT	Serine--pyruvate aminotransferase	GO:0008453; F:alanine-glyoxylate transaminase activity; IDA:UniProtKB
P21549	AGXT	Serine--pyruvate aminotransferase	GO:0016597; F:amino acid binding; IDA:UniProtKB
P21549	AGXT	Serine--pyruvate aminotransferase	GO:0005515; F:protein binding; IPI:HGNC
P21549	AGXT	Serine--pyruvate aminotransferase	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P21549	AGXT	Serine--pyruvate aminotransferase	GO:0030170; F:pyridoxal phosphate binding; IDA:UniProtKB
P21549	AGXT	Serine--pyruvate aminotransferase	GO:0005102; F:receptor binding; IPI:UniProtKB
P21549	AGXT	Serine--pyruvate aminotransferase	GO:0004760; F:serine-pyruvate transaminase activity; IEA:UniProtKB-EC
P21549	AGXT	Serine--pyruvate aminotransferase	GO:0008483; F:transaminase activity; IDA:UniProtKB
P21549	AGXT	Serine--pyruvate aminotransferase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P21549	AGXT	Serine--pyruvate aminotransferase	GO:0019265; P:glycine biosynthetic process, by transamination of glyoxylate; IDA:UniProtKB
P21549	AGXT	Serine--pyruvate aminotransferase	GO:0009436; P:glyoxylate catabolic process; IDA:UniProtKB
P21549	AGXT	Serine--pyruvate aminotransferase	GO:0046487; P:glyoxylate metabolic process; IMP:HGNC
P21549	AGXT	Serine--pyruvate aminotransferase	GO:0042853; P:L-alanine catabolic process; IDA:UniProtKB
P21549	AGXT	Serine--pyruvate aminotransferase	GO:0019448; P:L-cysteine catabolic process; IDA:UniProtKB
P21549	AGXT	Serine--pyruvate aminotransferase	GO:0046724; P:oxalic acid secretion; IEA:Ensembl
P21549	AGXT	Serine--pyruvate aminotransferase	GO:0006625; P:protein targeting to peroxisome; IMP:HGNC
P21549	AGXT	Serine--pyruvate aminotransferase	GO:0042866; P:pyruvate biosynthetic process; IEA:Ensembl
P21549	AGXT	Serine--pyruvate aminotransferase	GO:0051591; P:response to cAMP; IEA:Ensembl
P21549	AGXT	Serine--pyruvate aminotransferase	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P21549	AGXT	Serine--pyruvate aminotransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BXG8	SPZ1	Spermatogenic leucine zipper protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BXG8	SPZ1	Spermatogenic leucine zipper protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9BXG8	SPZ1	Spermatogenic leucine zipper protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y6N5	SQRDL	Sulfide:quinone oxidoreductase, mitochondrial	GO:0070224; F:sulfide:quinone oxidoreductase activity; TAS:Reactome
Q9Y6N5	SQRDL	Sulfide:quinone oxidoreductase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9Y6N5	SQRDL	Sulfide:quinone oxidoreductase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9Y6N5	SQRDL	Sulfide:quinone oxidoreductase, mitochondrial	GO:0070221; P:sulfide oxidation, using sulfide:quinone oxidoreductase; TAS:Reactome
Q9Y6N5	SQRDL	Sulfide:quinone oxidoreductase, mitochondrial	GO:0000098; P:sulfur amino acid catabolic process; TAS:Reactome
Q9Y6N5	SQRDL	Sulfide:quinone oxidoreductase, mitochondrial	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
Q13501	SQSTM1	Sequestosome-1	GO:0042802; F:identical protein binding; IPI:IntAct
Q13501	SQSTM1	Sequestosome-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13501	SQSTM1	Sequestosome-1	GO:0019901; F:protein kinase binding; IDA:UniProtKB
Q13501	SQSTM1	Sequestosome-1	GO:0005080; F:protein kinase C binding; IPI:UniProtKB
Q13501	SQSTM1	Sequestosome-1	GO:0004674; F:protein serine/threonine kinase activity; NAS:UniProtKB
Q13501	SQSTM1	Sequestosome-1	GO:0030971; F:receptor tyrosine kinase binding; TAS:ProtInc
Q13501	SQSTM1	Sequestosome-1	GO:0042169; F:SH2 domain binding; IDA:UniProtKB
Q13501	SQSTM1	Sequestosome-1	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
Q13501	SQSTM1	Sequestosome-1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13501	SQSTM1	Sequestosome-1	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q13501	SQSTM1	Sequestosome-1	GO:0006914; P:autophagy; IMP:UniProtKB
Q13501	SQSTM1	Sequestosome-1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q13501	SQSTM1	Sequestosome-1	GO:0016197; P:endosomal transport; TAS:UniProtKB
Q13501	SQSTM1	Sequestosome-1	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q13501	SQSTM1	Sequestosome-1	GO:0035556; P:intracellular signal transduction; TAS:UniProtKB
Q13501	SQSTM1	Sequestosome-1	GO:0016236; P:macroautophagy; ISS:UniProtKB
Q13501	SQSTM1	Sequestosome-1	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
Q13501	SQSTM1	Sequestosome-1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q13501	SQSTM1	Sequestosome-1	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q13501	SQSTM1	Sequestosome-1	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
Q13501	SQSTM1	Sequestosome-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:UniProtKB
Q13501	SQSTM1	Sequestosome-1	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q13501	SQSTM1	Sequestosome-1	GO:0008104; P:protein localization; TAS:UniProtKB
Q13501	SQSTM1	Sequestosome-1	GO:0006468; P:protein phosphorylation; NAS:GOC
Q13501	SQSTM1	Sequestosome-1	GO:0043122; P:regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q13501	SQSTM1	Sequestosome-1	GO:0046578; P:regulation of Ras protein signal transduction; NAS:UniProtKB
Q13501	SQSTM1	Sequestosome-1	GO:0006950; P:response to stress; TAS:UniProtKB
Q13501	SQSTM1	Sequestosome-1	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
O15042	U2SURP	U2 snRNP-associated SURP motif-containing protein	GO:0000166; F:nucleotide binding; IEA:InterPro
O15042	U2SURP	U2 snRNP-associated SURP motif-containing protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O15042	U2SURP	U2 snRNP-associated SURP motif-containing protein	GO:0005515; F:protein binding; IPI:UniProtKB
O15042	U2SURP	U2 snRNP-associated SURP motif-containing protein	GO:0006396; P:RNA processing; IEA:InterPro
Q8N9Q2	SREK1IP1	Protein SREK1IP1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8N9Q2	SREK1IP1	Protein SREK1IP1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N9Q2	SREK1IP1	Protein SREK1IP1	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q8N9Q2	SREK1IP1	Protein SREK1IP1	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q9HD15	SRA1	Steroid receptor RNA activator 1	GO:0003677; F:DNA binding; IEA:Ensembl
Q9HD15	SRA1	Steroid receptor RNA activator 1	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IBA:RefGenome
Q9HD15	SRA1	Steroid receptor RNA activator 1	GO:0005515; F:protein binding; IPI:IntAct
Q9HD15	SRA1	Steroid receptor RNA activator 1	GO:0010861; F:thyroid hormone receptor activator activity; IEA:Ensembl
Q9HD15	SRA1	Steroid receptor RNA activator 1	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q9HD15	SRA1	Steroid receptor RNA activator 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9HD15	SRA1	Steroid receptor RNA activator 1	GO:0030154; P:cell differentiation; IDA:UniProtKB
Q9HD15	SRA1	Steroid receptor RNA activator 1	GO:0008283; P:cell proliferation; IDA:UniProtKB
Q9HD15	SRA1	Steroid receptor RNA activator 1	GO:2000273; P:positive regulation of receptor activity; IBA:RefGenome
Q9HD15	SRA1	Steroid receptor RNA activator 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9HD15	SRA1	Steroid receptor RNA activator 1	GO:0042981; P:regulation of apoptotic process; IDA:UniProtKB
Q9HD15	SRA1	Steroid receptor RNA activator 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96JX3	SERAC1	Protein SERAC1	GO:0016788; F:hydrolase activity, acting on ester bonds; IEA:InterPro
Q96JX3	SERAC1	Protein SERAC1	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q96JX3	SERAC1	Protein SERAC1	GO:0006505; P:GPI anchor metabolic process; IEA:InterPro
Q96JX3	SERAC1	Protein SERAC1	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q96JX3	SERAC1	Protein SERAC1	GO:0008654; P:phospholipid biosynthetic process; IEA:UniProtKB-KW
Q8WTU2	SRCRB4D	Scavenger receptor cysteine-rich domain-containing group B protein	GO:0005044; F:scavenger receptor activity; IEA:InterPro
Q8N5C6	SRBD1	S1 RNA-binding domain-containing protein 1	GO:0016788; F:hydrolase activity, acting on ester bonds; IEA:InterPro
Q8N5C6	SRBD1	S1 RNA-binding domain-containing protein 1	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q8N5C6	SRBD1	S1 RNA-binding domain-containing protein 1	GO:0006139; P:nucleobase-containing compound metabolic process; IEA:InterPro
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0003682; F:chromatin binding; IEA:Ensembl
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0003677; F:DNA binding; ISS:UniProtKB
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:HGNC
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0032810; F:sterol response element binding; IDA:HGNC
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0007568; P:aging; IEA:Ensembl
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0071398; P:cellular response to fatty acid; IEA:Ensembl
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0009267; P:cellular response to starvation; ISS:HGNC
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0008286; P:insulin receptor signaling pathway; IEA:Ensembl
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0008610; P:lipid biosynthetic process; ISS:UniProtKB
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0006629; P:lipid metabolic process; TAS:ProtInc
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0030324; P:lung development; IEA:Ensembl
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0046676; P:negative regulation of insulin secretion; IEA:Ensembl
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0045542; P:positive regulation of cholesterol biosynthetic process; IEA:Ensembl
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0031065; P:positive regulation of histone deacetylation; IEA:Ensembl
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0010867; P:positive regulation of triglyceride biosynthetic process; ISS:UniProtKB
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0019217; P:regulation of fatty acid metabolic process; IEA:Ensembl
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0003062; P:regulation of heart rate by chemical signal; IEA:Ensembl
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0051591; P:response to cAMP; IEA:Ensembl
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0042493; P:response to drug; IEA:Ensembl
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0032094; P:response to food; IEA:Ensembl
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0033762; P:response to glucagon; IEA:Ensembl
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0009749; P:response to glucose; IEA:Ensembl
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0032570; P:response to progesterone; IEA:Ensembl
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0032526; P:response to retinoic acid; IEA:Ensembl
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P36956	SREBF1	Sterol regulatory element-binding protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q12772	SREBF2	Sterol regulatory element-binding protein 2	GO:0070888; F:E-box binding; IDA:BHF-UCL
Q12772	SREBF2	Sterol regulatory element-binding protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q12772	SREBF2	Sterol regulatory element-binding protein 2	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q12772	SREBF2	Sterol regulatory element-binding protein 2	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:BHF-UCL
Q12772	SREBF2	Sterol regulatory element-binding protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q12772	SREBF2	Sterol regulatory element-binding protein 2	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q12772	SREBF2	Sterol regulatory element-binding protein 2	GO:0071499; P:cellular response to laminar fluid shear stress; NAS:BHF-UCL
Q12772	SREBF2	Sterol regulatory element-binding protein 2	GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW
Q12772	SREBF2	Sterol regulatory element-binding protein 2	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q12772	SREBF2	Sterol regulatory element-binding protein 2	GO:0090370; P:negative regulation of cholesterol efflux; IDA:BHF-UCL
Q12772	SREBF2	Sterol regulatory element-binding protein 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q12772	SREBF2	Sterol regulatory element-binding protein 2	GO:0010886; P:positive regulation of cholesterol storage; IDA:BHF-UCL
Q12772	SREBF2	Sterol regulatory element-binding protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q12772	SREBF2	Sterol regulatory element-binding protein 2	GO:2000188; P:regulation of cholesterol homeostasis; IEA:Ensembl
Q12772	SREBF2	Sterol regulatory element-binding protein 2	GO:0072368; P:regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q12772	SREBF2	Sterol regulatory element-binding protein 2	GO:0055098; P:response to low-density lipoprotein particle; IEP:BHF-UCL
Q12772	SREBF2	Sterol regulatory element-binding protein 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q12772	SREBF2	Sterol regulatory element-binding protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BX66	SORBS1	Sorbin and SH3 domain-containing protein 1	GO:0003779; F:actin binding; TAS:ProtInc
Q9BX66	SORBS1	Sorbin and SH3 domain-containing protein 1	GO:0008092; F:cytoskeletal protein binding; TAS:ProtInc
Q9BX66	SORBS1	Sorbin and SH3 domain-containing protein 1	GO:0005158; F:insulin receptor binding; IDA:UniProtKB
Q9BX66	SORBS1	Sorbin and SH3 domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BX66	SORBS1	Sorbin and SH3 domain-containing protein 1	GO:0005070; F:SH3/SH2 adaptor activity; ISS:BHF-UCL
Q9BX66	SORBS1	Sorbin and SH3 domain-containing protein 1	GO:0007160; P:cell-matrix adhesion; TAS:ProtInc
Q9BX66	SORBS1	Sorbin and SH3 domain-containing protein 1	GO:0032869; P:cellular response to insulin stimulus; ISS:BHF-UCL
Q9BX66	SORBS1	Sorbin and SH3 domain-containing protein 1	GO:0048041; P:focal adhesion assembly; ISS:UniProtKB
Q9BX66	SORBS1	Sorbin and SH3 domain-containing protein 1	GO:0015758; P:glucose transport; ISS:UniProtKB
Q9BX66	SORBS1	Sorbin and SH3 domain-containing protein 1	GO:0008286; P:insulin receptor signaling pathway; ISS:UniProtKB
Q9BX66	SORBS1	Sorbin and SH3 domain-containing protein 1	GO:0006936; P:muscle contraction; TAS:Reactome
Q9BX66	SORBS1	Sorbin and SH3 domain-containing protein 1	GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; ISS:BHF-UCL
Q9BX66	SORBS1	Sorbin and SH3 domain-containing protein 1	GO:0046326; P:positive regulation of glucose import; ISS:BHF-UCL
Q9BX66	SORBS1	Sorbin and SH3 domain-containing protein 1	GO:0045725; P:positive regulation of glycogen biosynthetic process; ISS:BHF-UCL
Q9BX66	SORBS1	Sorbin and SH3 domain-containing protein 1	GO:0046889; P:positive regulation of lipid biosynthetic process; ISS:BHF-UCL
Q9BX66	SORBS1	Sorbin and SH3 domain-containing protein 1	GO:0009967; P:positive regulation of signal transduction; ISS:GOC
Q9BX66	SORBS1	Sorbin and SH3 domain-containing protein 1	GO:0043149; P:stress fiber assembly; ISS:UniProtKB
O94875	SORBS2	Sorbin and SH3 domain-containing protein 2	GO:0008093; F:cytoskeletal adaptor activity; TAS:ProtInc
O94875	SORBS2	Sorbin and SH3 domain-containing protein 2	GO:0046872; F:metal ion binding; IEA:InterPro
O94875	SORBS2	Sorbin and SH3 domain-containing protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O94875	SORBS2	Sorbin and SH3 domain-containing protein 2	GO:0005515; F:protein binding; IPI:IntAct
O94875	SORBS2	Sorbin and SH3 domain-containing protein 2	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
O94875	SORBS2	Sorbin and SH3 domain-containing protein 2	GO:0008307; F:structural constituent of muscle; TAS:ProtInc
Q14247	CTTN	Src substrate cortactin	GO:0005515; F:protein binding; IPI:UniProtKB
P23327	HRC	Sarcoplasmic reticulum histidine-rich calcium-binding protein	GO:0051117; F:ATPase binding; IPI:BHF-UCL
P23327	HRC	Sarcoplasmic reticulum histidine-rich calcium-binding protein	GO:0005509; F:calcium ion binding; TAS:ProtInc
P23327	HRC	Sarcoplasmic reticulum histidine-rich calcium-binding protein	GO:0044325; F:ion channel binding; IPI:BHF-UCL
P23327	HRC	Sarcoplasmic reticulum histidine-rich calcium-binding protein	GO:0005515; F:protein binding; IPI:BHF-UCL
P23327	HRC	Sarcoplasmic reticulum histidine-rich calcium-binding protein	GO:0055074; P:calcium ion homeostasis; IEA:Ensembl
P23327	HRC	Sarcoplasmic reticulum histidine-rich calcium-binding protein	GO:0006936; P:muscle contraction; TAS:ProtInc
P23327	HRC	Sarcoplasmic reticulum histidine-rich calcium-binding protein	GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; TAS:BHF-UCL
Q6ZRS2	SRCAP	Helicase SRCAP	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6ZRS2	SRCAP	Helicase SRCAP	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZRS2	SRCAP	Helicase SRCAP	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q6ZRS2	SRCAP	Helicase SRCAP	GO:0004402; F:histone acetyltransferase activity; TAS:ProtInc
Q6ZRS2	SRCAP	Helicase SRCAP	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q6ZRS2	SRCAP	Helicase SRCAP	GO:0016573; P:histone acetylation; TAS:GOC
Q6ZRS2	SRCAP	Helicase SRCAP	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q6ZRS2	SRCAP	Helicase SRCAP	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZRS2	SRCAP	Helicase SRCAP	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q86TD4	SRL	Sarcalumenin	GO:0005525; F:GTP binding; IEA:InterPro
Q86TD4	SRL	Sarcalumenin	GO:0003924; F:GTPase activity; IEA:InterPro
Q9C0H9	SRCIN1	SRC kinase signaling inhibitor 1	GO:0005515; F:protein binding; IPI:IntAct
Q9C0H9	SRCIN1	SRC kinase signaling inhibitor 1	GO:0019901; F:protein kinase binding; IDA:UniProtKB
Q9C0H9	SRCIN1	SRC kinase signaling inhibitor 1	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q9C0H9	SRCIN1	SRC kinase signaling inhibitor 1	GO:0007162; P:negative regulation of cell adhesion; IEA:Ensembl
Q9C0H9	SRCIN1	SRC kinase signaling inhibitor 1	GO:0050709; P:negative regulation of protein secretion; IEA:Ensembl
Q9C0H9	SRCIN1	SRC kinase signaling inhibitor 1	GO:0061099; P:negative regulation of protein tyrosine kinase activity; IDA:UniProtKB
Q9C0H9	SRCIN1	SRC kinase signaling inhibitor 1	GO:0061098; P:positive regulation of protein tyrosine kinase activity; IDA:UniProtKB
Q9C0H9	SRCIN1	SRC kinase signaling inhibitor 1	GO:0030334; P:regulation of cell migration; IMP:UniProtKB
Q9C0H9	SRCIN1	SRC kinase signaling inhibitor 1	GO:0061001; P:regulation of dendritic spine morphogenesis; IMP:UniProtKB
Q9C0H9	SRCIN1	SRC kinase signaling inhibitor 1	GO:0034446; P:substrate adhesion-dependent cell spreading; IMP:UniProtKB
A1L4H1	SSC5D	Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D	GO:0050840; F:extracellular matrix binding; ISS:UniProtKB
A1L4H1	SSC5D	Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D	GO:0001968; F:fibronectin binding; ISS:UniProtKB
A1L4H1	SSC5D	Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D	GO:0043236; F:laminin binding; ISS:UniProtKB
A1L4H1	SSC5D	Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D	GO:0005044; F:scavenger receptor activity; IEA:InterPro
A1L4H1	SSC5D	Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D	GO:0042494; P:detection of bacterial lipoprotein; ISS:UniProtKB
A1L4H1	SSC5D	Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
A1L4H1	SSC5D	Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
A1L4H1	SSC5D	Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D	GO:2000483; P:negative regulation of interleukin-8 secretion; ISS:UniProtKB
A1L4H1	SSC5D	Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D	GO:0006898; P:receptor-mediated endocytosis; ISS:GOC
DR   GO:0005044; F:scavenger receptor activity; IEA:InterPro
DR   GO:0002376; P:immune system process; IEA:UniProtKB-KW
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0046875; F:ephrin receptor binding; IPI:UniProtKB
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0070851; F:growth factor receptor binding; IPI:UniProtKB
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0020037; F:heme binding; IDA:UniProtKB
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0005178; F:integrin binding; TAS:BHF-UCL
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0044325; F:ion channel binding; IPI:BHF-UCL
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0016301; F:kinase activity; TAS:Reactome
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; TAS:BHF-UCL
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0051219; F:phosphoprotein binding; IPI:UniProtKB
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0005515; F:protein binding; IPI:UniProtKB
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0004672; F:protein kinase activity; IDA:UniProtKB
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0005102; F:receptor binding; IPI:UniProtKB
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0042169; F:SH2 domain binding; IPI:UniProtKB
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0007411; P:axon guidance; TAS:Reactome
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0007596; P:blood coagulation; TAS:Reactome
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0045453; P:bone resorption; ISS:UniProtKB
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0060444; P:branching involved in mammary gland duct morphogenesis; IEA:Ensembl
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0071393; P:cellular response to progesterone stimulus; ISS:BHF-UCL
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0030900; P:forebrain development; IEA:Ensembl
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0045087; P:innate immune response; TAS:Reactome
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0035556; P:intracellular signal transduction; IDA:BHF-UCL
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0050900; P:leukocyte migration; TAS:Reactome
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0061024; P:membrane organization; TAS:Reactome
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:2000811; P:negative regulation of anoikis; IMP:UniProtKB
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0051895; P:negative regulation of focal adhesion assembly; ISS:BHF-UCL
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0051902; P:negative regulation of mitochondrial depolarization; IMP:UniProtKB
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0032463; P:negative regulation of protein homooligomerization; IMP:UniProtKB
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0048477; P:oogenesis; IEA:Ensembl
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:MGI
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0030168; P:platelet activation; TAS:Reactome
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0033625; P:positive regulation of integrin activation; TAS:BHF-UCL
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0071803; P:positive regulation of podosome assembly; IEA:Ensembl
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0051897; P:positive regulation of protein kinase B signaling; IMP:UniProtKB
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0050847; P:progesterone receptor signaling pathway; ISS:BHF-UCL
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0007265; P:Ras protein signal transduction; TAS:Reactome
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0045124; P:regulation of bone resorption; TAS:BHF-UCL
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0033146; P:regulation of intracellular estrogen receptor signaling pathway; IEA:Ensembl
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0043393; P:regulation of protein binding; IEA:Ensembl
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0043114; P:regulation of vascular permeability; TAS:BHF-UCL
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0070555; P:response to interleukin-1; IMP:BHF-UCL
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0007172; P:signal complex assembly; TAS:ProtInc
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0007165; P:signal transduction; TAS:ProtInc
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0031295; P:T cell costimulation; TAS:Reactome
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0060065; P:uterus development; IEA:Ensembl
P12931	SRC	Proto-oncogene tyrosine-protein kinase Src	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q96GP6	SCARF2	Scavenger receptor class F member 2	GO:0005515; F:protein binding; IPI:IntAct
Q96GP6	SCARF2	Scavenger receptor class F member 2	GO:0005044; F:scavenger receptor activity; IEA:Ensembl
Q96GP6	SCARF2	Scavenger receptor class F member 2	GO:0007157; P:heterophilic cell-cell adhesion; IEA:Ensembl
Q14162	SCARF1	Scavenger receptor class F member 1	GO:0030169; F:low-density lipoprotein particle binding; IDA:UniProtKB
Q14162	SCARF1	Scavenger receptor class F member 1	GO:0005044; F:scavenger receptor activity; IDA:UniProtKB
Q14162	SCARF1	Scavenger receptor class F member 1	GO:0004888; F:transmembrane signaling receptor activity; TAS:UniProtKB
Q14162	SCARF1	Scavenger receptor class F member 1	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q14162	SCARF1	Scavenger receptor class F member 1	GO:0006707; P:cholesterol catabolic process; IC:UniProtKB
Q14162	SCARF1	Scavenger receptor class F member 1	GO:0016358; P:dendrite development; IEA:Ensembl
Q14162	SCARF1	Scavenger receptor class F member 1	GO:0016322; P:neuron remodeling; ISS:UniProtKB
Q14162	SCARF1	Scavenger receptor class F member 1	GO:0048680; P:positive regulation of axon regeneration; ISS:UniProtKB
Q14162	SCARF1	Scavenger receptor class F member 1	GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB
Q14162	SCARF1	Scavenger receptor class F member 1	GO:0006898; P:receptor-mediated endocytosis; TAS:UniProtKB
Q14162	SCARF1	Scavenger receptor class F member 1	GO:0007165; P:signal transduction; TAS:GOC
Q8WXA9	SREK1	Splicing regulatory glutamine/lysine-rich protein 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8WXA9	SREK1	Splicing regulatory glutamine/lysine-rich protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8WXA9	SREK1	Splicing regulatory glutamine/lysine-rich protein 1	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q8WXA9	SREK1	Splicing regulatory glutamine/lysine-rich protein 1	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q8NEF9	SRFBP1	Serum response factor-binding protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8NEF9	SRFBP1	Serum response factor-binding protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NEF9	SRFBP1	Serum response factor-binding protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P11831	SRF	Serum response factor	GO:0031490; F:chromatin DNA binding; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0005515; F:protein binding; IPI:UniProtKB
P11831	SRF	Serum response factor	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P11831	SRF	Serum response factor	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; ISS:BHF-UCL
P11831	SRF	Serum response factor	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:UniProtKB
P11831	SRF	Serum response factor	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0001076; F:RNA polymerase II transcription factor binding transcription factor activity; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0001228; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; ISS:BHF-UCL
P11831	SRF	Serum response factor	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P11831	SRF	Serum response factor	GO:0010736; F:serum response element binding; IDA:BHF-UCL
P11831	SRF	Serum response factor	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P11831	SRF	Serum response factor	GO:0060055; P:angiogenesis involved in wound healing; TAS:BHF-UCL
P11831	SRF	Serum response factor	GO:0008306; P:associative learning; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0055003; P:cardiac myofibril assembly; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0060947; P:cardiac vascular smooth muscle cell differentiation; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0002042; P:cell migration involved in sprouting angiogenesis; IMP:BHF-UCL
P11831	SRF	Serum response factor	GO:0007160; P:cell-matrix adhesion; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0090398; P:cellular senescence; IMP:BHF-UCL
P11831	SRF	Serum response factor	GO:0030038; P:contractile actin filament bundle assembly; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0048589; P:developmental growth; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0035912; P:dorsal aorta morphogenesis; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0090136; P:epithelial cell-cell adhesion; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0010669; P:epithelial structure maintenance; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0048821; P:erythrocyte development; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0061029; P:eyelid development in camera-type eye; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0007507; P:heart development; ISS:BHF-UCL
P11831	SRF	Serum response factor	GO:0001947; P:heart looping; ISS:BHF-UCL
P11831	SRF	Serum response factor	GO:0060347; P:heart trabecula formation; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0060218; P:hematopoietic stem cell differentiation; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0021766; P:hippocampus development; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0060292; P:long term synaptic depression; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0007616; P:long-term memory; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0035855; P:megakaryocyte development; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0001707; P:mesoderm formation; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0002011; P:morphogenesis of an epithelial sheet; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0042789; P:mRNA transcription from RNA polymerase II promoter; ISS:BHF-UCL
P11831	SRF	Serum response factor	GO:0046716; P:muscle cell cellular homeostasis; ISS:BHF-UCL
P11831	SRF	Serum response factor	GO:1900222; P:negative regulation of beta-amyloid clearance; IMP:BHF-UCL
P11831	SRF	Serum response factor	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0048666; P:neuron development; TAS:BHF-UCL
P11831	SRF	Serum response factor	GO:0001764; P:neuron migration; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0031175; P:neuron projection development; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0001569; P:patterning of blood vessels; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0030168; P:platelet activation; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0030220; P:platelet formation; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0045597; P:positive regulation of cell differentiation; IDA:MGI
P11831	SRF	Serum response factor	GO:0051491; P:positive regulation of filopodium assembly; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P11831	SRF	Serum response factor	GO:0045987; P:positive regulation of smooth muscle contraction; IDA:BHF-UCL
P11831	SRF	Serum response factor	GO:0046016; P:positive regulation of transcription by glucose; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
P11831	SRF	Serum response factor	GO:0003257; P:positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; IGI:BHF-UCL
P11831	SRF	Serum response factor	GO:0060261; P:positive regulation of transcription initiation from RNA polymerase II promoter; IDA:BHF-UCL
P11831	SRF	Serum response factor	GO:0010735; P:positive regulation of transcription via serum response element binding; IDA:BHF-UCL
P11831	SRF	Serum response factor	GO:0045059; P:positive thymic T cell selection; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0090009; P:primitive streak formation; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0030155; P:regulation of cell adhesion; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0051150; P:regulation of smooth muscle cell differentiation; TAS:BHF-UCL
P11831	SRF	Serum response factor	GO:0033561; P:regulation of water loss via skin; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0034097; P:response to cytokine; IMP:BHF-UCL
P11831	SRF	Serum response factor	GO:0009725; P:response to hormone; IDA:BHF-UCL
P11831	SRF	Serum response factor	GO:0001666; P:response to hypoxia; IEP:BHF-UCL
P11831	SRF	Serum response factor	GO:0009636; P:response to toxic substance; TAS:BHF-UCL
P11831	SRF	Serum response factor	GO:0045214; P:sarcomere organization; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0043589; P:skin morphogenesis; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0043149; P:stress fiber assembly; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0022028; P:tangential migration from the subventricular zone to the olfactory bulb; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0070830; P:tight junction assembly; IEA:Ensembl
P11831	SRF	Serum response factor	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:BHF-UCL
P11831	SRF	Serum response factor	GO:0001829; P:trophectodermal cell differentiation; IDA:MGI
P0DJJ0	SRGAP2C	SLIT-ROBO Rho GTPase-activating protein 2C	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
P0DJJ0	SRGAP2C	SLIT-ROBO Rho GTPase-activating protein 2C	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P0DJJ0	SRGAP2C	SLIT-ROBO Rho GTPase-activating protein 2C	GO:0021816; P:extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration; IDA:UniProtKB
P0DJJ0	SRGAP2C	SLIT-ROBO Rho GTPase-activating protein 2C	GO:0061000; P:negative regulation of dendritic spine development; IDA:UniProtKB
P0DJJ0	SRGAP2C	SLIT-ROBO Rho GTPase-activating protein 2C	GO:0051490; P:negative regulation of filopodium assembly; IDA:UniProtKB
P0DJJ0	SRGAP2C	SLIT-ROBO Rho GTPase-activating protein 2C	GO:2001224; P:positive regulation of neuron migration; IDA:UniProtKB
Q9UGK8	SERGEF	Secretion-regulating guanine nucleotide exchange factor	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UGK8	SERGEF	Secretion-regulating guanine nucleotide exchange factor	GO:0005087; F:Ran guanyl-nucleotide exchange factor activity; TAS:UniProtKB
Q9UGK8	SERGEF	Secretion-regulating guanine nucleotide exchange factor	GO:0050709; P:negative regulation of protein secretion; IDA:HGNC
Q9UGK8	SERGEF	Secretion-regulating guanine nucleotide exchange factor	GO:0032316; P:regulation of Ran GTPase activity; TAS:GOC
Q9UGK8	SERGEF	Secretion-regulating guanine nucleotide exchange factor	GO:0007165; P:signal transduction; TAS:UniProtKB
P10124	SRGN	Serglycin	GO:0005515; F:protein binding; IPI:UniProtKB
P10124	SRGN	Serglycin	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
P10124	SRGN	Serglycin	GO:0007596; P:blood coagulation; TAS:Reactome
P10124	SRGN	Serglycin	GO:0008626; P:granzyme-mediated apoptotic signaling pathway; IDA:UniProtKB
P10124	SRGN	Serglycin	GO:0033382; P:maintenance of granzyme B location in T cell secretory granule; ISS:UniProtKB
P10124	SRGN	Serglycin	GO:0033373; P:maintenance of protease location in mast cell secretory granule; ISS:UniProtKB
P10124	SRGN	Serglycin	GO:0033364; P:mast cell secretory granule organization; ISS:UniProtKB
P10124	SRGN	Serglycin	GO:0030502; P:negative regulation of bone mineralization; IDA:UniProtKB
P10124	SRGN	Serglycin	GO:0050710; P:negative regulation of cytokine secretion; ISS:UniProtKB
P10124	SRGN	Serglycin	GO:0030168; P:platelet activation; TAS:Reactome
P10124	SRGN	Serglycin	GO:0002576; P:platelet degranulation; TAS:Reactome
P10124	SRGN	Serglycin	GO:0016485; P:protein processing; ISS:UniProtKB
P10124	SRGN	Serglycin	GO:0033371; P:T cell secretory granule organization; ISS:UniProtKB
Q7Z6B7	SRGAP1	SLIT-ROBO Rho GTPase-activating protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q7Z6B7	SRGAP1	SLIT-ROBO Rho GTPase-activating protein 1	GO:0005100; F:Rho GTPase activator activity; IEA:Ensembl
Q7Z6B7	SRGAP1	SLIT-ROBO Rho GTPase-activating protein 1	GO:0007411; P:axon guidance; TAS:Reactome
Q7Z6B7	SRGAP1	SLIT-ROBO Rho GTPase-activating protein 1	GO:0016477; P:cell migration; IEA:Ensembl
Q7Z6B7	SRGAP1	SLIT-ROBO Rho GTPase-activating protein 1	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q7Z6B7	SRGAP1	SLIT-ROBO Rho GTPase-activating protein 1	GO:0007266; P:Rho protein signal transduction; IEA:Ensembl
Q7Z6B7	SRGAP1	SLIT-ROBO Rho GTPase-activating protein 1	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
O75044	SRGAP2	SLIT-ROBO Rho GTPase-activating protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
O75044	SRGAP2	SLIT-ROBO Rho GTPase-activating protein 2	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O75044	SRGAP2	SLIT-ROBO Rho GTPase-activating protein 2	GO:0030675; F:Rac GTPase activator activity; IDA:UniProtKB
O75044	SRGAP2	SLIT-ROBO Rho GTPase-activating protein 2	GO:0048365; F:Rac GTPase binding; IDA:UniProtKB
O75044	SRGAP2	SLIT-ROBO Rho GTPase-activating protein 2	GO:0051014; P:actin filament severing; IDA:UniProtKB
O75044	SRGAP2	SLIT-ROBO Rho GTPase-activating protein 2	GO:0007411; P:axon guidance; TAS:Reactome
O75044	SRGAP2	SLIT-ROBO Rho GTPase-activating protein 2	GO:0060996; P:dendritic spine development; IDA:UniProtKB
O75044	SRGAP2	SLIT-ROBO Rho GTPase-activating protein 2	GO:0021816; P:extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration; ISS:UniProtKB
O75044	SRGAP2	SLIT-ROBO Rho GTPase-activating protein 2	GO:0046847; P:filopodium assembly; IDA:UniProtKB
O75044	SRGAP2	SLIT-ROBO Rho GTPase-activating protein 2	GO:0003363; P:lamellipodium assembly involved in ameboidal cell migration; IMP:UniProtKB
O75044	SRGAP2	SLIT-ROBO Rho GTPase-activating protein 2	GO:2001223; P:negative regulation of neuron migration; IDA:UniProtKB
O75044	SRGAP2	SLIT-ROBO Rho GTPase-activating protein 2	GO:0048812; P:neuron projection morphogenesis; ISS:UniProtKB
O75044	SRGAP2	SLIT-ROBO Rho GTPase-activating protein 2	GO:0032855; P:positive regulation of Rac GTPase activity; IDA:UniProtKB
O75044	SRGAP2	SLIT-ROBO Rho GTPase-activating protein 2	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
O75044	SRGAP2	SLIT-ROBO Rho GTPase-activating protein 2	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
O75044	SRGAP2	SLIT-ROBO Rho GTPase-activating protein 2	GO:0034446; P:substrate adhesion-dependent cell spreading; IMP:UniProtKB
O43295	SRGAP3	SLIT-ROBO Rho GTPase-activating protein 3	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
O43295	SRGAP3	SLIT-ROBO Rho GTPase-activating protein 3	GO:0005515; F:protein binding; IPI:IntAct
O43295	SRGAP3	SLIT-ROBO Rho GTPase-activating protein 3	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
O43295	SRGAP3	SLIT-ROBO Rho GTPase-activating protein 3	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9H3Y6	SRMS	Tyrosine-protein kinase Srms	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H3Y6	SRMS	Tyrosine-protein kinase Srms	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC
Q9H3Y6	SRMS	Tyrosine-protein kinase Srms	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H3Y6	SRMS	Tyrosine-protein kinase Srms	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
Q9H3Y6	SRMS	Tyrosine-protein kinase Srms	GO:0038083; P:peptidyl-tyrosine autophosphorylation; IDA:UniProtKB
P49458	SRP9	Signal recognition particle 9 kDa protein	GO:0008312; F:7S RNA binding; IEA:InterPro
P49458	SRP9	Signal recognition particle 9 kDa protein	GO:0003723; F:RNA binding; TAS:ProtInc
P49458	SRP9	Signal recognition particle 9 kDa protein	GO:0005047; F:signal recognition particle binding; TAS:ProtInc
P49458	SRP9	Signal recognition particle 9 kDa protein	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P49458	SRP9	Signal recognition particle 9 kDa protein	GO:0010467; P:gene expression; TAS:Reactome
P49458	SRP9	Signal recognition particle 9 kDa protein	GO:0045900; P:negative regulation of translational elongation; IEA:InterPro
P49458	SRP9	Signal recognition particle 9 kDa protein	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P49458	SRP9	Signal recognition particle 9 kDa protein	GO:0006412; P:translation; TAS:Reactome
P37108	SRP14	Signal recognition particle 14 kDa protein	GO:0008312; F:7S RNA binding; TAS:ProtInc
P37108	SRP14	Signal recognition particle 14 kDa protein	GO:0030942; F:endoplasmic reticulum signal peptide binding; IEA:InterPro
P37108	SRP14	Signal recognition particle 14 kDa protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P37108	SRP14	Signal recognition particle 14 kDa protein	GO:0005515; F:protein binding; IPI:UniProt
P37108	SRP14	Signal recognition particle 14 kDa protein	GO:0003723; F:RNA binding; TAS:ProtInc
P37108	SRP14	Signal recognition particle 14 kDa protein	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P37108	SRP14	Signal recognition particle 14 kDa protein	GO:0006613; P:cotranslational protein targeting to membrane; TAS:ProtInc
P37108	SRP14	Signal recognition particle 14 kDa protein	GO:0010467; P:gene expression; TAS:Reactome
P37108	SRP14	Signal recognition particle 14 kDa protein	GO:0045047; P:protein targeting to ER; IMP:UniProtKB
P37108	SRP14	Signal recognition particle 14 kDa protein	GO:0042493; P:response to drug; IDA:UniProtKB
P37108	SRP14	Signal recognition particle 14 kDa protein	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P37108	SRP14	Signal recognition particle 14 kDa protein	GO:0006412; P:translation; TAS:Reactome
P09132	SRP19	Signal recognition particle 19 kDa protein	GO:0008312; F:7S RNA binding; IDA:UniProtKB
P09132	SRP19	Signal recognition particle 19 kDa protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P09132	SRP19	Signal recognition particle 19 kDa protein	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P09132	SRP19	Signal recognition particle 19 kDa protein	GO:0006613; P:cotranslational protein targeting to membrane; TAS:ProtInc
P09132	SRP19	Signal recognition particle 19 kDa protein	GO:0010467; P:gene expression; TAS:Reactome
P09132	SRP19	Signal recognition particle 19 kDa protein	GO:0042493; P:response to drug; IDA:UniProtKB
P09132	SRP19	Signal recognition particle 19 kDa protein	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P09132	SRP19	Signal recognition particle 19 kDa protein	GO:0006412; P:translation; TAS:Reactome
P61011	SRP54	Signal recognition particle 54 kDa protein	GO:0008312; F:7S RNA binding; IDA:UniProtKB
P61011	SRP54	Signal recognition particle 54 kDa protein	GO:0008144; F:drug binding; IDA:UniProtKB
P61011	SRP54	Signal recognition particle 54 kDa protein	GO:0030942; F:endoplasmic reticulum signal peptide binding; IDA:UniProtKB
P61011	SRP54	Signal recognition particle 54 kDa protein	GO:0019003; F:GDP binding; IDA:UniProtKB
P61011	SRP54	Signal recognition particle 54 kDa protein	GO:0005525; F:GTP binding; IDA:UniProtKB
P61011	SRP54	Signal recognition particle 54 kDa protein	GO:0003924; F:GTPase activity; IEA:InterPro
P61011	SRP54	Signal recognition particle 54 kDa protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P61011	SRP54	Signal recognition particle 54 kDa protein	GO:0043021; F:ribonucleoprotein complex binding; IDA:MGI
P61011	SRP54	Signal recognition particle 54 kDa protein	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P61011	SRP54	Signal recognition particle 54 kDa protein	GO:0010467; P:gene expression; TAS:Reactome
P61011	SRP54	Signal recognition particle 54 kDa protein	GO:0006184; P:GTP catabolic process; IDA:GOC
P61011	SRP54	Signal recognition particle 54 kDa protein	GO:0045047; P:protein targeting to ER; IMP:UniProtKB
P61011	SRP54	Signal recognition particle 54 kDa protein	GO:0042493; P:response to drug; IDA:UniProtKB
P61011	SRP54	Signal recognition particle 54 kDa protein	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P61011	SRP54	Signal recognition particle 54 kDa protein	GO:0006617; P:SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition; ISS:UniProtKB
P61011	SRP54	Signal recognition particle 54 kDa protein	GO:0006616; P:SRP-dependent cotranslational protein targeting to membrane, translocation; ISS:UniProtKB
P61011	SRP54	Signal recognition particle 54 kDa protein	GO:0006412; P:translation; TAS:Reactome
Q9UHB9	SRP68	Signal recognition particle subunit SRP68	GO:0008312; F:7S RNA binding; IEA:InterPro
Q9UHB9	SRP68	Signal recognition particle subunit SRP68	GO:0030942; F:endoplasmic reticulum signal peptide binding; IEA:InterPro
Q9UHB9	SRP68	Signal recognition particle subunit SRP68	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UHB9	SRP68	Signal recognition particle subunit SRP68	GO:0005047; F:signal recognition particle binding; IPI:UniProtKB
Q9UHB9	SRP68	Signal recognition particle subunit SRP68	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UHB9	SRP68	Signal recognition particle subunit SRP68	GO:0010467; P:gene expression; TAS:Reactome
Q9UHB9	SRP68	Signal recognition particle subunit SRP68	GO:0042493; P:response to drug; IDA:UniProtKB
Q9UHB9	SRP68	Signal recognition particle subunit SRP68	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
Q9UHB9	SRP68	Signal recognition particle subunit SRP68	GO:0006412; P:translation; TAS:Reactome
O76094	SRP72	Signal recognition particle subunit SRP72	GO:0008312; F:7S RNA binding; IEA:InterPro
O76094	SRP72	Signal recognition particle subunit SRP72	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O76094	SRP72	Signal recognition particle subunit SRP72	GO:0005047; F:signal recognition particle binding; IPI:UniProtKB
O76094	SRP72	Signal recognition particle subunit SRP72	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O76094	SRP72	Signal recognition particle subunit SRP72	GO:0010467; P:gene expression; TAS:Reactome
O76094	SRP72	Signal recognition particle subunit SRP72	GO:0042493; P:response to drug; IDA:UniProtKB
O76094	SRP72	Signal recognition particle subunit SRP72	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
O76094	SRP72	Signal recognition particle subunit SRP72	GO:0006412; P:translation; TAS:Reactome
Q96SB4	SRPK1	SRSF protein kinase 1	GO:0005524; F:ATP binding; IDA:UniProtKB
Q96SB4	SRPK1	SRSF protein kinase 1	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q96SB4	SRPK1	SRSF protein kinase 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96SB4	SRPK1	SRSF protein kinase 1	GO:0005515; F:protein binding; IPI:IntAct
Q96SB4	SRPK1	SRSF protein kinase 1	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q96SB4	SRPK1	SRSF protein kinase 1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q96SB4	SRPK1	SRSF protein kinase 1	GO:0007059; P:chromosome segregation; IDA:UniProtKB
Q96SB4	SRPK1	SRSF protein kinase 1	GO:0045087; P:innate immune response; IC:BHF-UCL
Q96SB4	SRPK1	SRSF protein kinase 1	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q96SB4	SRPK1	SRSF protein kinase 1	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q96SB4	SRPK1	SRSF protein kinase 1	GO:0045071; P:negative regulation of viral genome replication; IDA:BHF-UCL
Q96SB4	SRPK1	SRSF protein kinase 1	GO:0045070; P:positive regulation of viral genome replication; IDA:BHF-UCL
Q96SB4	SRPK1	SRSF protein kinase 1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q96SB4	SRPK1	SRSF protein kinase 1	GO:0050684; P:regulation of mRNA processing; IDA:UniProtKB
Q96SB4	SRPK1	SRSF protein kinase 1	GO:0048024; P:regulation of mRNA splicing, via spliceosome; TAS:UniProtKB
Q96SB4	SRPK1	SRSF protein kinase 1	GO:0008380; P:RNA splicing; TAS:ProtInc
Q96SB4	SRPK1	SRSF protein kinase 1	GO:0035092; P:sperm chromatin condensation; TAS:UniProtKB
Q96SB4	SRPK1	SRSF protein kinase 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
P78362	SRPK2	SRSF protein kinase 2	GO:0071889; F:14-3-3 protein binding; ISS:BHF-UCL
P78362	SRPK2	SRSF protein kinase 2	GO:0005524; F:ATP binding; IDA:UniProtKB
P78362	SRPK2	SRSF protein kinase 2	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
P78362	SRPK2	SRSF protein kinase 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P78362	SRPK2	SRSF protein kinase 2	GO:0005515; F:protein binding; IPI:IntAct
P78362	SRPK2	SRSF protein kinase 2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P78362	SRPK2	SRSF protein kinase 2	GO:0001525; P:angiogenesis; ISS:BHF-UCL
P78362	SRPK2	SRSF protein kinase 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P78362	SRPK2	SRSF protein kinase 2	GO:0045087; P:innate immune response; IC:BHF-UCL
P78362	SRPK2	SRSF protein kinase 2	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
P78362	SRPK2	SRSF protein kinase 2	GO:0045071; P:negative regulation of viral genome replication; IDA:BHF-UCL
P78362	SRPK2	SRSF protein kinase 2	GO:0035063; P:nuclear speck organization; ISS:BHF-UCL
P78362	SRPK2	SRSF protein kinase 2	GO:0045787; P:positive regulation of cell cycle; ISS:BHF-UCL
P78362	SRPK2	SRSF protein kinase 2	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P78362	SRPK2	SRSF protein kinase 2	GO:0010628; P:positive regulation of gene expression; ISS:BHF-UCL
P78362	SRPK2	SRSF protein kinase 2	GO:0043525; P:positive regulation of neuron apoptotic process; ISS:BHF-UCL
P78362	SRPK2	SRSF protein kinase 2	GO:0045070; P:positive regulation of viral genome replication; IDA:BHF-UCL
P78362	SRPK2	SRSF protein kinase 2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P78362	SRPK2	SRSF protein kinase 2	GO:0048024; P:regulation of mRNA splicing, via spliceosome; TAS:UniProtKB
P78362	SRPK2	SRSF protein kinase 2	GO:0008380; P:RNA splicing; IDA:UniProtKB
P78362	SRPK2	SRSF protein kinase 2	GO:0000245; P:spliceosomal complex assembly; IDA:UniProtKB
Q9UPE1	SRPK3	SRSF protein kinase 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UPE1	SRPK3	SRSF protein kinase 3	GO:0005515; F:protein binding; IPI:IntAct
Q9UPE1	SRPK3	SRSF protein kinase 3	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q9UPE1	SRPK3	SRSF protein kinase 3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9UPE1	SRPK3	SRSF protein kinase 3	GO:0060537; P:muscle tissue development; ISS:UniProtKB
Q9UPE1	SRPK3	SRSF protein kinase 3	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
Q9Y5M8	SRPRB	Signal recognition particle receptor subunit beta	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9Y5M8	SRPRB	Signal recognition particle receptor subunit beta	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q9Y5M8	SRPRB	Signal recognition particle receptor subunit beta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9Y5M8	SRPRB	Signal recognition particle receptor subunit beta	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q9Y5M8	SRPRB	Signal recognition particle receptor subunit beta	GO:0010467; P:gene expression; TAS:Reactome
Q9Y5M8	SRPRB	Signal recognition particle receptor subunit beta	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9Y5M8	SRPRB	Signal recognition particle receptor subunit beta	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
Q9Y5M8	SRPRB	Signal recognition particle receptor subunit beta	GO:0006412; P:translation; TAS:Reactome
P08240	SRPR	Signal recognition particle receptor subunit alpha	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P08240	SRPR	Signal recognition particle receptor subunit alpha	GO:0003924; F:GTPase activity; IEA:InterPro
P08240	SRPR	Signal recognition particle receptor subunit alpha	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P08240	SRPR	Signal recognition particle receptor subunit alpha	GO:0005047; F:signal recognition particle binding; TAS:ProtInc
P08240	SRPR	Signal recognition particle receptor subunit alpha	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P08240	SRPR	Signal recognition particle receptor subunit alpha	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P08240	SRPR	Signal recognition particle receptor subunit alpha	GO:0006613; P:cotranslational protein targeting to membrane; TAS:ProtInc
P08240	SRPR	Signal recognition particle receptor subunit alpha	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P08240	SRPR	Signal recognition particle receptor subunit alpha	GO:0010467; P:gene expression; TAS:Reactome
P08240	SRPR	Signal recognition particle receptor subunit alpha	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P08240	SRPR	Signal recognition particle receptor subunit alpha	GO:0006412; P:translation; TAS:Reactome
O60687	SRPX2	Sushi repeat-containing protein SRPX2	GO:0036458; F:hepatocyte growth factor binding; IDA:UniProtKB
O60687	SRPX2	Sushi repeat-containing protein SRPX2	GO:0042802; F:identical protein binding; IDA:UniProtKB
O60687	SRPX2	Sushi repeat-containing protein SRPX2	GO:0005515; F:protein binding; IPI:UniProtKB
O60687	SRPX2	Sushi repeat-containing protein SRPX2	GO:0005102; F:receptor binding; IPI:UniProtKB
O60687	SRPX2	Sushi repeat-containing protein SRPX2	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
O60687	SRPX2	Sushi repeat-containing protein SRPX2	GO:0048870; P:cell motility; IDA:UniProtKB
O60687	SRPX2	Sushi repeat-containing protein SRPX2	GO:0016337; P:single organismal cell-cell adhesion; IDA:UniProtKB
O60687	SRPX2	Sushi repeat-containing protein SRPX2	GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; ISS:UniProtKB
O60687	SRPX2	Sushi repeat-containing protein SRPX2	GO:0051965; P:positive regulation of synapse assembly; IDA:UniProtKB
O60687	SRPX2	Sushi repeat-containing protein SRPX2	GO:0042325; P:regulation of phosphorylation; IDA:UniProtKB
P78539	SRPX	Sushi repeat-containing protein SRPX	GO:0006914; P:autophagy; IEA:Ensembl
P78539	SRPX	Sushi repeat-containing protein SRPX	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P78539	SRPX	Sushi repeat-containing protein SRPX	GO:0060244; P:negative regulation of cell proliferation involved in contact inhibition; IEA:Ensembl
P78539	SRPX	Sushi repeat-containing protein SRPX	GO:0001845; P:phagolysosome assembly; IEA:Ensembl
P78539	SRPX	Sushi repeat-containing protein SRPX	GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P78539	SRPX	Sushi repeat-containing protein SRPX	GO:0034976; P:response to endoplasmic reticulum stress; IEA:Ensembl
Q9UH36	SRRD	SRR1-like protein	GO:0048511; P:rhythmic process; IEA:UniProtKB-KW
Q8IYB3	SRRM1	Serine/arginine repetitive matrix protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IYB3	SRRM1	Serine/arginine repetitive matrix protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IYB3	SRRM1	Serine/arginine repetitive matrix protein 1	GO:0010467; P:gene expression; TAS:Reactome
Q8IYB3	SRRM1	Serine/arginine repetitive matrix protein 1	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q8IYB3	SRRM1	Serine/arginine repetitive matrix protein 1	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
Q8IYB3	SRRM1	Serine/arginine repetitive matrix protein 1	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q8IYB3	SRRM1	Serine/arginine repetitive matrix protein 1	GO:0008380; P:RNA splicing; TAS:Reactome
Q8IYB3	SRRM1	Serine/arginine repetitive matrix protein 1	GO:0000375; P:RNA splicing, via transesterification reactions; TAS:UniProtKB
Q8IYB3	SRRM1	Serine/arginine repetitive matrix protein 1	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q8IYB3	SRRM1	Serine/arginine repetitive matrix protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q9UQ35	SRRM2	Serine/arginine repetitive matrix protein 2	GO:0070742; F:C2H2 zinc finger domain binding; IDA:UniProtKB
Q9UQ35	SRRM2	Serine/arginine repetitive matrix protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UQ35	SRRM2	Serine/arginine repetitive matrix protein 2	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q9UQ35	SRRM2	Serine/arginine repetitive matrix protein 2	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
A7MD48	SRRM4	Serine/arginine repetitive matrix protein 4	GO:0003729; F:mRNA binding; ISS:UniProtKB
A7MD48	SRRM4	Serine/arginine repetitive matrix protein 4	GO:0030154; P:cell differentiation; ISS:UniProtKB
A7MD48	SRRM4	Serine/arginine repetitive matrix protein 4	GO:0006397; P:mRNA processing; ISS:UniProtKB
A7MD48	SRRM4	Serine/arginine repetitive matrix protein 4	GO:0007399; P:nervous system development; ISS:UniProtKB
A7MD48	SRRM4	Serine/arginine repetitive matrix protein 4	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IEA:Ensembl
A7MD48	SRRM4	Serine/arginine repetitive matrix protein 4	GO:0043484; P:regulation of RNA splicing; ISS:UniProtKB
A7MD48	SRRM4	Serine/arginine repetitive matrix protein 4	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
A7MD48	SRRM4	Serine/arginine repetitive matrix protein 4	GO:0007605; P:sensory perception of sound; IEA:Ensembl
Q9BXP5	SRRT	Serrate RNA effector molecule homolog	GO:0003677; F:DNA binding; ISS:UniProtKB
Q9BXP5	SRRT	Serrate RNA effector molecule homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BXP5	SRRT	Serrate RNA effector molecule homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BXP5	SRRT	Serrate RNA effector molecule homolog	GO:0008283; P:cell proliferation; ISS:UniProtKB
Q9BXP5	SRRT	Serrate RNA effector molecule homolog	GO:0097150; P:neuronal stem cell maintenance; ISS:UniProtKB
Q9BXP5	SRRT	Serrate RNA effector molecule homolog	GO:0031053; P:primary miRNA processing; IMP:UniProtKB
Q9BXP5	SRRT	Serrate RNA effector molecule homolog	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
Q9BXP5	SRRT	Serrate RNA effector molecule homolog	GO:0046685; P:response to arsenic-containing substance; NAS:UniProtKB
Q9BXP5	SRRT	Serrate RNA effector molecule homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9GZT4	SRR	Serine racemase	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9GZT4	SRR	Serine racemase	GO:0005509; F:calcium ion binding; ISS:UniProtKB
Q9GZT4	SRR	Serine racemase	GO:0008721; F:D-serine ammonia-lyase activity; IEA:UniProtKB-EC
Q9GZT4	SRR	Serine racemase	GO:0016594; F:glycine binding; ISS:UniProtKB
Q9GZT4	SRR	Serine racemase	GO:0003941; F:L-serine ammonia-lyase activity; IDA:UniProtKB
Q9GZT4	SRR	Serine racemase	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q9GZT4	SRR	Serine racemase	GO:0030165; F:PDZ domain binding; IPI:UniProtKB
Q9GZT4	SRR	Serine racemase	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q9GZT4	SRR	Serine racemase	GO:0030170; F:pyridoxal phosphate binding; IDA:UniProtKB
Q9GZT4	SRR	Serine racemase	GO:0030378; F:serine racemase activity; IDA:UniProtKB
Q9GZT4	SRR	Serine racemase	GO:0018114; F:threonine racemase activity; ISS:UniProtKB
Q9GZT4	SRR	Serine racemase	GO:0007568; P:aging; IEA:Ensembl
Q9GZT4	SRR	Serine racemase	GO:0007420; P:brain development; IEA:Ensembl
Q9GZT4	SRR	Serine racemase	GO:0070179; P:D-serine biosynthetic process; IDA:UniProtKB
Q9GZT4	SRR	Serine racemase	GO:0070178; P:D-serine metabolic process; IDA:UniProtKB
Q9GZT4	SRR	Serine racemase	GO:0006563; P:L-serine metabolic process; IDA:UniProtKB
Q9GZT4	SRR	Serine racemase	GO:0051289; P:protein homotetramerization; ISS:UniProtKB
Q9GZT4	SRR	Serine racemase	GO:0042866; P:pyruvate biosynthetic process; IDA:UniProtKB
Q9GZT4	SRR	Serine racemase	GO:0042493; P:response to drug; IEA:Ensembl
Q9GZT4	SRR	Serine racemase	GO:0032496; P:response to lipopolysaccharide; IEP:UniProtKB
Q9GZT4	SRR	Serine racemase	GO:0043278; P:response to morphine; IEA:Ensembl
Q9GZT4	SRR	Serine racemase	GO:0009069; P:serine family amino acid metabolic process; ISS:UniProtKB
O75494	SRSF10	Serine/arginine-rich splicing factor 10	GO:0000166; F:nucleotide binding; IEA:InterPro
O75494	SRSF10	Serine/arginine-rich splicing factor 10	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75494	SRSF10	Serine/arginine-rich splicing factor 10	GO:0005515; F:protein binding; IPI:UniProtKB
O75494	SRSF10	Serine/arginine-rich splicing factor 10	GO:0003723; F:RNA binding; NAS:UniProtKB
O75494	SRSF10	Serine/arginine-rich splicing factor 10	GO:0050733; F:RS domain binding; NAS:UniProtKB
O75494	SRSF10	Serine/arginine-rich splicing factor 10	GO:0051082; F:unfolded protein binding; NAS:UniProtKB
O75494	SRSF10	Serine/arginine-rich splicing factor 10	GO:0016482; P:cytoplasmic transport; IDA:UniProtKB
O75494	SRSF10	Serine/arginine-rich splicing factor 10	GO:0006406; P:mRNA export from nucleus; NAS:UniProtKB
O75494	SRSF10	Serine/arginine-rich splicing factor 10	GO:0006376; P:mRNA splice site selection; IDA:UniProtKB
O75494	SRSF10	Serine/arginine-rich splicing factor 10	GO:0000398; P:mRNA splicing, via spliceosome; IDA:UniProtKB
O75494	SRSF10	Serine/arginine-rich splicing factor 10	GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; IDA:UniProtKB
O75494	SRSF10	Serine/arginine-rich splicing factor 10	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
O75494	SRSF10	Serine/arginine-rich splicing factor 10	GO:0000375; P:RNA splicing, via transesterification reactions; IDA:UniProtKB
O75494	SRSF10	Serine/arginine-rich splicing factor 10	GO:0000244; P:spliceosomal tri-snRNP complex assembly; NAS:UniProtKB
Q05519	SRSF11	Serine/arginine-rich splicing factor 11	GO:0000166; F:nucleotide binding; IEA:InterPro
Q05519	SRSF11	Serine/arginine-rich splicing factor 11	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q05519	SRSF11	Serine/arginine-rich splicing factor 11	GO:0005515; F:protein binding; IPI:IntAct
Q05519	SRSF11	Serine/arginine-rich splicing factor 11	GO:0010467; P:gene expression; TAS:Reactome
Q05519	SRSF11	Serine/arginine-rich splicing factor 11	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q05519	SRSF11	Serine/arginine-rich splicing factor 11	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
Q05519	SRSF11	Serine/arginine-rich splicing factor 11	GO:0006397; P:mRNA processing; TAS:ProtInc
Q05519	SRSF11	Serine/arginine-rich splicing factor 11	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q05519	SRSF11	Serine/arginine-rich splicing factor 11	GO:0008380; P:RNA splicing; TAS:Reactome
Q05519	SRSF11	Serine/arginine-rich splicing factor 11	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q05519	SRSF11	Serine/arginine-rich splicing factor 11	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q8WXF0	SRSF12	Serine/arginine-rich splicing factor 12	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8WXF0	SRSF12	Serine/arginine-rich splicing factor 12	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8WXF0	SRSF12	Serine/arginine-rich splicing factor 12	GO:0003723; F:RNA binding; NAS:UniProtKB
Q8WXF0	SRSF12	Serine/arginine-rich splicing factor 12	GO:0050733; F:RS domain binding; NAS:UniProtKB
Q8WXF0	SRSF12	Serine/arginine-rich splicing factor 12	GO:0051082; F:unfolded protein binding; NAS:UniProtKB
Q8WXF0	SRSF12	Serine/arginine-rich splicing factor 12	GO:0016482; P:cytoplasmic transport; ISS:UniProtKB
Q8WXF0	SRSF12	Serine/arginine-rich splicing factor 12	GO:0000395; P:mRNA 5'-splice site recognition; IDA:UniProtKB
Q8WXF0	SRSF12	Serine/arginine-rich splicing factor 12	GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; ISS:UniProtKB
Q8WXF0	SRSF12	Serine/arginine-rich splicing factor 12	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB
Q8WXF0	SRSF12	Serine/arginine-rich splicing factor 12	GO:0000244; P:spliceosomal tri-snRNP complex assembly; NAS:UniProtKB
Q07955	SRSF1	Serine/arginine-rich splicing factor 1	GO:0003729; F:mRNA binding; IDA:MGI
Q07955	SRSF1	Serine/arginine-rich splicing factor 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q07955	SRSF1	Serine/arginine-rich splicing factor 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q07955	SRSF1	Serine/arginine-rich splicing factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q07955	SRSF1	Serine/arginine-rich splicing factor 1	GO:0003723; F:RNA binding; IDA:UniProtKB
Q07955	SRSF1	Serine/arginine-rich splicing factor 1	GO:0060048; P:cardiac muscle contraction; IEA:Ensembl
Q07955	SRSF1	Serine/arginine-rich splicing factor 1	GO:0010467; P:gene expression; TAS:Reactome
Q07955	SRSF1	Serine/arginine-rich splicing factor 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q07955	SRSF1	Serine/arginine-rich splicing factor 1	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q07955	SRSF1	Serine/arginine-rich splicing factor 1	GO:0000395; P:mRNA 5'-splice site recognition; IDA:UniProtKB
Q07955	SRSF1	Serine/arginine-rich splicing factor 1	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
Q07955	SRSF1	Serine/arginine-rich splicing factor 1	GO:0006397; P:mRNA processing; TAS:ProtInc
Q07955	SRSF1	Serine/arginine-rich splicing factor 1	GO:0006376; P:mRNA splice site selection; TAS:ProtInc
Q07955	SRSF1	Serine/arginine-rich splicing factor 1	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q07955	SRSF1	Serine/arginine-rich splicing factor 1	GO:0008380; P:RNA splicing; TAS:Reactome
Q07955	SRSF1	Serine/arginine-rich splicing factor 1	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q07955	SRSF1	Serine/arginine-rich splicing factor 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q01130	SRSF2	Serine/arginine-rich splicing factor 2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q01130	SRSF2	Serine/arginine-rich splicing factor 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q01130	SRSF2	Serine/arginine-rich splicing factor 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q01130	SRSF2	Serine/arginine-rich splicing factor 2	GO:0003714; F:transcription corepressor activity; NAS:UniProtKB
Q01130	SRSF2	Serine/arginine-rich splicing factor 2	GO:0010467; P:gene expression; TAS:Reactome
Q01130	SRSF2	Serine/arginine-rich splicing factor 2	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q01130	SRSF2	Serine/arginine-rich splicing factor 2	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
Q01130	SRSF2	Serine/arginine-rich splicing factor 2	GO:0006397; P:mRNA processing; TAS:ProtInc
Q01130	SRSF2	Serine/arginine-rich splicing factor 2	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q01130	SRSF2	Serine/arginine-rich splicing factor 2	GO:2001141; P:regulation of RNA biosynthetic process; NAS:GOC
Q01130	SRSF2	Serine/arginine-rich splicing factor 2	GO:0008380; P:RNA splicing; TAS:Reactome
Q01130	SRSF2	Serine/arginine-rich splicing factor 2	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q01130	SRSF2	Serine/arginine-rich splicing factor 2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
P84103	SRSF3	Serine/arginine-rich splicing factor 3	GO:0000166; F:nucleotide binding; IEA:InterPro
P84103	SRSF3	Serine/arginine-rich splicing factor 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P84103	SRSF3	Serine/arginine-rich splicing factor 3	GO:0005515; F:protein binding; IPI:UniProtKB
P84103	SRSF3	Serine/arginine-rich splicing factor 3	GO:0003723; F:RNA binding; TAS:ProtInc
P84103	SRSF3	Serine/arginine-rich splicing factor 3	GO:0010467; P:gene expression; TAS:Reactome
P84103	SRSF3	Serine/arginine-rich splicing factor 3	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
P84103	SRSF3	Serine/arginine-rich splicing factor 3	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
P84103	SRSF3	Serine/arginine-rich splicing factor 3	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P84103	SRSF3	Serine/arginine-rich splicing factor 3	GO:0008380; P:RNA splicing; TAS:Reactome
P84103	SRSF3	Serine/arginine-rich splicing factor 3	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
P84103	SRSF3	Serine/arginine-rich splicing factor 3	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q08170	SRSF4	Serine/arginine-rich splicing factor 4	GO:0000166; F:nucleotide binding; IEA:InterPro
Q08170	SRSF4	Serine/arginine-rich splicing factor 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q08170	SRSF4	Serine/arginine-rich splicing factor 4	GO:0010467; P:gene expression; TAS:Reactome
Q08170	SRSF4	Serine/arginine-rich splicing factor 4	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q08170	SRSF4	Serine/arginine-rich splicing factor 4	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
Q08170	SRSF4	Serine/arginine-rich splicing factor 4	GO:0006397; P:mRNA processing; TAS:ProtInc
Q08170	SRSF4	Serine/arginine-rich splicing factor 4	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q08170	SRSF4	Serine/arginine-rich splicing factor 4	GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; IDA:UniProtKB
Q08170	SRSF4	Serine/arginine-rich splicing factor 4	GO:0008380; P:RNA splicing; TAS:Reactome
Q08170	SRSF4	Serine/arginine-rich splicing factor 4	GO:0000375; P:RNA splicing, via transesterification reactions; TAS:ProtInc
Q08170	SRSF4	Serine/arginine-rich splicing factor 4	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q08170	SRSF4	Serine/arginine-rich splicing factor 4	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q13247	SRSF6	Serine/arginine-rich splicing factor 6	GO:0000166; F:nucleotide binding; IEA:InterPro
Q13247	SRSF6	Serine/arginine-rich splicing factor 6	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13247	SRSF6	Serine/arginine-rich splicing factor 6	GO:0036002; F:pre-mRNA binding; IDA:UniProtKB
Q13247	SRSF6	Serine/arginine-rich splicing factor 6	GO:0003723; F:RNA binding; IDA:UniProtKB
Q13247	SRSF6	Serine/arginine-rich splicing factor 6	GO:0000380; P:alternative mRNA splicing, via spliceosome; IDA:UniProtKB
Q13247	SRSF6	Serine/arginine-rich splicing factor 6	GO:0010467; P:gene expression; TAS:Reactome
Q13247	SRSF6	Serine/arginine-rich splicing factor 6	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q13247	SRSF6	Serine/arginine-rich splicing factor 6	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
Q13247	SRSF6	Serine/arginine-rich splicing factor 6	GO:0006376; P:mRNA splice site selection; IMP:UniProtKB
Q13247	SRSF6	Serine/arginine-rich splicing factor 6	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q13247	SRSF6	Serine/arginine-rich splicing factor 6	GO:0060548; P:negative regulation of cell death; IDA:MGI
Q13247	SRSF6	Serine/arginine-rich splicing factor 6	GO:0045617; P:negative regulation of keratinocyte differentiation; IMP:UniProtKB
Q13247	SRSF6	Serine/arginine-rich splicing factor 6	GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; IDA:UniProtKB
Q13247	SRSF6	Serine/arginine-rich splicing factor 6	GO:0060501; P:positive regulation of epithelial cell proliferation involved in lung morphogenesis; IDA:MGI
Q13247	SRSF6	Serine/arginine-rich splicing factor 6	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IMP:UniProtKB
Q13247	SRSF6	Serine/arginine-rich splicing factor 6	GO:0010837; P:regulation of keratinocyte proliferation; IMP:UniProtKB
Q13247	SRSF6	Serine/arginine-rich splicing factor 6	GO:0061041; P:regulation of wound healing; IMP:UniProtKB
Q13247	SRSF6	Serine/arginine-rich splicing factor 6	GO:0008380; P:RNA splicing; TAS:Reactome
Q13247	SRSF6	Serine/arginine-rich splicing factor 6	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q13247	SRSF6	Serine/arginine-rich splicing factor 6	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q16629	SRSF7	Serine/arginine-rich splicing factor 7	GO:0000166; F:nucleotide binding; IEA:InterPro
Q16629	SRSF7	Serine/arginine-rich splicing factor 7	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q16629	SRSF7	Serine/arginine-rich splicing factor 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q16629	SRSF7	Serine/arginine-rich splicing factor 7	GO:0008270; F:zinc ion binding; IEA:InterPro
Q16629	SRSF7	Serine/arginine-rich splicing factor 7	GO:0010467; P:gene expression; TAS:Reactome
Q16629	SRSF7	Serine/arginine-rich splicing factor 7	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q16629	SRSF7	Serine/arginine-rich splicing factor 7	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
Q16629	SRSF7	Serine/arginine-rich splicing factor 7	GO:0006397; P:mRNA processing; TAS:ProtInc
Q16629	SRSF7	Serine/arginine-rich splicing factor 7	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q16629	SRSF7	Serine/arginine-rich splicing factor 7	GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; IDA:UniProtKB
Q16629	SRSF7	Serine/arginine-rich splicing factor 7	GO:0008380; P:RNA splicing; TAS:Reactome
Q16629	SRSF7	Serine/arginine-rich splicing factor 7	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q16629	SRSF7	Serine/arginine-rich splicing factor 7	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q13243	SRSF5	Serine/arginine-rich splicing factor 5	GO:0000166; F:nucleotide binding; IEA:InterPro
Q13243	SRSF5	Serine/arginine-rich splicing factor 5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13243	SRSF5	Serine/arginine-rich splicing factor 5	GO:0005515; F:protein binding; IPI:HGNC
Q13243	SRSF5	Serine/arginine-rich splicing factor 5	GO:0010467; P:gene expression; TAS:Reactome
Q13243	SRSF5	Serine/arginine-rich splicing factor 5	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q13243	SRSF5	Serine/arginine-rich splicing factor 5	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
Q13243	SRSF5	Serine/arginine-rich splicing factor 5	GO:0006397; P:mRNA processing; TAS:ProtInc
Q13243	SRSF5	Serine/arginine-rich splicing factor 5	GO:0006376; P:mRNA splice site selection; TAS:ProtInc
Q13243	SRSF5	Serine/arginine-rich splicing factor 5	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q13243	SRSF5	Serine/arginine-rich splicing factor 5	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
Q13243	SRSF5	Serine/arginine-rich splicing factor 5	GO:0009611; P:response to wounding; IEA:Ensembl
Q13243	SRSF5	Serine/arginine-rich splicing factor 5	GO:0008380; P:RNA splicing; TAS:Reactome
Q13243	SRSF5	Serine/arginine-rich splicing factor 5	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q13243	SRSF5	Serine/arginine-rich splicing factor 5	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q9BRL6	SRSF8	Serine/arginine-rich splicing factor 8	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9BRL6	SRSF8	Serine/arginine-rich splicing factor 8	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BRL6	SRSF8	Serine/arginine-rich splicing factor 8	GO:0005515; F:protein binding; IPI:IntAct
Q9BRL6	SRSF8	Serine/arginine-rich splicing factor 8	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9BRL6	SRSF8	Serine/arginine-rich splicing factor 8	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q13242	SRSF9	Serine/arginine-rich splicing factor 9	GO:0000166; F:nucleotide binding; IEA:InterPro
Q13242	SRSF9	Serine/arginine-rich splicing factor 9	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13242	SRSF9	Serine/arginine-rich splicing factor 9	GO:0005515; F:protein binding; IPI:IntAct
Q13242	SRSF9	Serine/arginine-rich splicing factor 9	GO:0010467; P:gene expression; TAS:Reactome
Q13242	SRSF9	Serine/arginine-rich splicing factor 9	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q13242	SRSF9	Serine/arginine-rich splicing factor 9	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
Q13242	SRSF9	Serine/arginine-rich splicing factor 9	GO:0006397; P:mRNA processing; TAS:ProtInc
Q13242	SRSF9	Serine/arginine-rich splicing factor 9	GO:0006376; P:mRNA splice site selection; TAS:ProtInc
Q13242	SRSF9	Serine/arginine-rich splicing factor 9	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q13242	SRSF9	Serine/arginine-rich splicing factor 9	GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; IDA:UniProtKB
Q13242	SRSF9	Serine/arginine-rich splicing factor 9	GO:0008380; P:RNA splicing; TAS:Reactome
Q13242	SRSF9	Serine/arginine-rich splicing factor 9	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q13242	SRSF9	Serine/arginine-rich splicing factor 9	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q14140	SERTAD2	SERTA domain-containing protein 2	GO:0003713; F:transcription coactivator activity; IEA:Ensembl
Q14140	SERTAD2	SERTA domain-containing protein 2	GO:0030308; P:negative regulation of cell growth; IDA:MGI
Q14140	SERTAD2	SERTA domain-containing protein 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q14140	SERTAD2	SERTA domain-containing protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UJW9	SERTAD3	SERTA domain-containing protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q9UJW9	SERTAD3	SERTA domain-containing protein 3	GO:0030308; P:negative regulation of cell growth; IDA:MGI
Q9UJW9	SERTAD3	SERTA domain-containing protein 3	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q9UJW9	SERTAD3	SERTA domain-containing protein 3	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UJW9	SERTAD3	SERTA domain-containing protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UHV2	SERTAD1	SERTA domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9UHV2	SERTAD1	SERTA domain-containing protein 1	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q9UHV2	SERTAD1	SERTA domain-containing protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q9UHV2	SERTAD1	SERTA domain-containing protein 1	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
Q9UHV2	SERTAD1	SERTA domain-containing protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BYN0	SRXN1	Sulfiredoxin-1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BYN0	SRXN1	Sulfiredoxin-1	GO:0016667; F:oxidoreductase activity, acting on a sulfur group of donors; IDA:UniProtKB
Q9BYN0	SRXN1	Sulfiredoxin-1	GO:0032542; F:sulfiredoxin activity; IEA:UniProtKB-EC
Q9BYN0	SRXN1	Sulfiredoxin-1	GO:0006979; P:response to oxidative stress; IDA:UniProtKB
Q05066	SRY	Sex-determining region Y protein	GO:0003677; F:DNA binding; IDA:UniProtKB
Q05066	SRY	Sex-determining region Y protein	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q05066	SRY	Sex-determining region Y protein	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q05066	SRY	Sex-determining region Y protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q05066	SRY	Sex-determining region Y protein	GO:0030238; P:male sex determination; NAS:UniProtKB
Q05066	SRY	Sex-determining region Y protein	GO:2000020; P:positive regulation of male gonad development; IDA:UniProtKB
Q05066	SRY	Sex-determining region Y protein	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q05066	SRY	Sex-determining region Y protein	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:GOC
Q05066	SRY	Sex-determining region Y protein	GO:0007548; P:sex differentiation; IEA:UniProtKB-KW
Q05066	SRY	Sex-determining region Y protein	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:GOC
O60232	SSSCA1	Sjoegren syndrome/scleroderma autoantigen 1	GO:0005515; F:protein binding; IPI:IntAct
O60232	SSSCA1	Sjoegren syndrome/scleroderma autoantigen 1	GO:0007067; P:mitosis; TAS:ProtInc
P81877	SSBP2	Single-stranded DNA-binding protein 2	GO:0003697; F:single-stranded DNA binding; NAS:UniProtKB
P81877	SSBP2	Single-stranded DNA-binding protein 2	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9BWW4	SSBP3	Single-stranded DNA-binding protein 3	GO:0003697; F:single-stranded DNA binding; IEA:InterPro
Q9BWW4	SSBP3	Single-stranded DNA-binding protein 3	GO:0060323; P:head morphogenesis; IEA:Ensembl
Q9BWW4	SSBP3	Single-stranded DNA-binding protein 3	GO:0021547; P:midbrain-hindbrain boundary initiation; IEA:Ensembl
Q9BWW4	SSBP3	Single-stranded DNA-binding protein 3	GO:2000744; P:positive regulation of anterior head development; IEA:Ensembl
Q9BWW4	SSBP3	Single-stranded DNA-binding protein 3	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q9BWW4	SSBP3	Single-stranded DNA-binding protein 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9BWW4	SSBP3	Single-stranded DNA-binding protein 3	GO:0021501; P:prechordal plate formation; IEA:Ensembl
Q9BWW4	SSBP3	Single-stranded DNA-binding protein 3	GO:0006461; P:protein complex assembly; IEA:Ensembl
Q9BWW4	SSBP3	Single-stranded DNA-binding protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BWG4	SSBP4	Single-stranded DNA-binding protein 4	GO:0003697; F:single-stranded DNA binding; IEA:InterPro
Q04837	SSBP1	Single-stranded DNA-binding protein, mitochondrial	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q04837	SSBP1	Single-stranded DNA-binding protein, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q04837	SSBP1	Single-stranded DNA-binding protein, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q04837	SSBP1	Single-stranded DNA-binding protein, mitochondrial	GO:0003697; F:single-stranded DNA binding; IEA:InterPro
Q04837	SSBP1	Single-stranded DNA-binding protein, mitochondrial	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q04837	SSBP1	Single-stranded DNA-binding protein, mitochondrial	GO:0070584; P:mitochondrion morphogenesis; IEA:Ensembl
Q04837	SSBP1	Single-stranded DNA-binding protein, mitochondrial	GO:0051096; P:positive regulation of helicase activity; IDA:UniProtKB
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0042803; F:protein homodimerization activity; IC:UniProtKB
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0004777; F:succinate-semialdehyde dehydrogenase (NAD+) activity; IDA:UniProtKB
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0009013; F:succinate-semialdehyde dehydrogenase [NAD(P)+] activity; IEA:InterPro
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0006083; P:acetate metabolic process; ISS:UniProtKB
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0007417; P:central nervous system development; IMP:UniProtKB
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0006681; P:galactosylceramide metabolic process; ISS:UniProtKB
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0009450; P:gamma-aminobutyric acid catabolic process; IDA:UniProtKB
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0006006; P:glucose metabolic process; ISS:UniProtKB
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0006678; P:glucosylceramide metabolic process; IEA:Ensembl
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0006536; P:glutamate metabolic process; ISS:UniProtKB
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0006541; P:glutamine metabolic process; ISS:UniProtKB
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0006749; P:glutathione metabolic process; ISS:UniProtKB
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0006650; P:glycerophospholipid metabolic process; ISS:UniProtKB
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0042135; P:neurotransmitter catabolic process; ISS:UniProtKB
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0009791; P:post-embryonic development; IEA:Ensembl
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0051289; P:protein homotetramerization; IDA:UniProtKB
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0022904; P:respiratory electron transport chain; ISS:UniProtKB
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0046459; P:short-chain fatty acid metabolic process; ISS:UniProtKB
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0006105; P:succinate metabolic process; ISS:UniProtKB
P51649	ALDH5A1	Succinate-semialdehyde dehydrogenase, mitochondrial	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9NQ55	PPAN	Suppressor of SWI4 1 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NQ55	PPAN	Suppressor of SWI4 1 homolog	GO:0008380; P:RNA splicing; TAS:ProtInc
Q8WYL5	SSH1	Protein phosphatase Slingshot homolog 1	GO:0003779; F:actin binding; IDA:UniProtKB
Q8WYL5	SSH1	Protein phosphatase Slingshot homolog 1	GO:0003677; F:DNA binding; IEA:InterPro
Q8WYL5	SSH1	Protein phosphatase Slingshot homolog 1	GO:0004721; F:phosphoprotein phosphatase activity; IDA:UniProtKB
Q8WYL5	SSH1	Protein phosphatase Slingshot homolog 1	GO:0005515; F:protein binding; IPI:IntAct
Q8WYL5	SSH1	Protein phosphatase Slingshot homolog 1	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q8WYL5	SSH1	Protein phosphatase Slingshot homolog 1	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q8WYL5	SSH1	Protein phosphatase Slingshot homolog 1	GO:0030036; P:actin cytoskeleton organization; IMP:UniProtKB
Q8WYL5	SSH1	Protein phosphatase Slingshot homolog 1	GO:0000902; P:cell morphogenesis; IMP:UniProtKB
Q8WYL5	SSH1	Protein phosphatase Slingshot homolog 1	GO:0071318; P:cellular response to ATP; IDA:MGI
Q8WYL5	SSH1	Protein phosphatase Slingshot homolog 1	GO:0006470; P:protein dephosphorylation; IMP:UniProtKB
Q8WYL5	SSH1	Protein phosphatase Slingshot homolog 1	GO:0008064; P:regulation of actin polymerization or depolymerization; IBA:RefGenome
Q8WYL5	SSH1	Protein phosphatase Slingshot homolog 1	GO:0050770; P:regulation of axonogenesis; IBA:RefGenome
Q8WYL5	SSH1	Protein phosphatase Slingshot homolog 1	GO:0032268; P:regulation of cellular protein metabolic process; IDA:MGI
Q8WYL5	SSH1	Protein phosphatase Slingshot homolog 1	GO:0010591; P:regulation of lamellipodium assembly; IBA:RefGenome
Q76I76	SSH2	Protein phosphatase Slingshot homolog 2	GO:0003779; F:actin binding; IDA:UniProtKB
Q76I76	SSH2	Protein phosphatase Slingshot homolog 2	GO:0003677; F:DNA binding; IEA:InterPro
Q76I76	SSH2	Protein phosphatase Slingshot homolog 2	GO:0004721; F:phosphoprotein phosphatase activity; IDA:UniProtKB
Q76I76	SSH2	Protein phosphatase Slingshot homolog 2	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q76I76	SSH2	Protein phosphatase Slingshot homolog 2	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q76I76	SSH2	Protein phosphatase Slingshot homolog 2	GO:0030036; P:actin cytoskeleton organization; IMP:UniProtKB
Q76I76	SSH2	Protein phosphatase Slingshot homolog 2	GO:0006470; P:protein dephosphorylation; IMP:UniProtKB
Q76I76	SSH2	Protein phosphatase Slingshot homolog 2	GO:0008064; P:regulation of actin polymerization or depolymerization; IBA:RefGenome
Q76I76	SSH2	Protein phosphatase Slingshot homolog 2	GO:0050770; P:regulation of axonogenesis; IBA:RefGenome
Q76I76	SSH2	Protein phosphatase Slingshot homolog 2	GO:0010591; P:regulation of lamellipodium assembly; IBA:RefGenome
Q8TE77	SSH3	Protein phosphatase Slingshot homolog 3	GO:0003779; F:actin binding; IBA:RefGenome
Q8TE77	SSH3	Protein phosphatase Slingshot homolog 3	GO:0003677; F:DNA binding; IEA:InterPro
Q8TE77	SSH3	Protein phosphatase Slingshot homolog 3	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q8TE77	SSH3	Protein phosphatase Slingshot homolog 3	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IBA:RefGenome
Q8TE77	SSH3	Protein phosphatase Slingshot homolog 3	GO:0006470; P:protein dephosphorylation; IBA:RefGenome
Q8TE77	SSH3	Protein phosphatase Slingshot homolog 3	GO:0008064; P:regulation of actin polymerization or depolymerization; IBA:RefGenome
Q8TE77	SSH3	Protein phosphatase Slingshot homolog 3	GO:0050770; P:regulation of axonogenesis; IBA:RefGenome
Q8TE77	SSH3	Protein phosphatase Slingshot homolog 3	GO:0010591; P:regulation of lamellipodium assembly; IBA:RefGenome
O43805	SSNA1	Sjoegren syndrome nuclear autoantigen 1	GO:0060830; P:ciliary receptor clustering involved in smoothened signaling pathway; IEA:Ensembl
O43805	SSNA1	Sjoegren syndrome nuclear autoantigen 1	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
O43805	SSNA1	Sjoegren syndrome nuclear autoantigen 1	GO:0042073; P:intraciliary transport; IEA:Ensembl
O43805	SSNA1	Sjoegren syndrome nuclear autoantigen 1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q14714	SSPN	Sarcospan	GO:0007155; P:cell adhesion; TAS:ProtInc
Q14714	SSPN	Sarcospan	GO:0006936; P:muscle contraction; TAS:ProtInc
A2VEC9	SSPO	SCO-spondin	GO:0030414; F:peptidase inhibitor activity; IEA:InterPro
A2VEC9	SSPO	SCO-spondin	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P30872	SSTR1	Somatostatin receptor type 1	GO:0004994; F:somatostatin receptor activity; IDA:MGI
P30872	SSTR1	Somatostatin receptor type 1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P30872	SSTR1	Somatostatin receptor type 1	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P30872	SSTR1	Somatostatin receptor type 1	GO:0071392; P:cellular response to estradiol stimulus; IEA:Ensembl
P30872	SSTR1	Somatostatin receptor type 1	GO:0021549; P:cerebellum development; IEA:Ensembl
P30872	SSTR1	Somatostatin receptor type 1	GO:0007586; P:digestion; TAS:ProtInc
P30872	SSTR1	Somatostatin receptor type 1	GO:0030900; P:forebrain development; IEA:Ensembl
P30872	SSTR1	Somatostatin receptor type 1	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P30872	SSTR1	Somatostatin receptor type 1	GO:0007215; P:glutamate receptor signaling pathway; IEA:Ensembl
P30872	SSTR1	Somatostatin receptor type 1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P30872	SSTR1	Somatostatin receptor type 1	GO:0007584; P:response to nutrient; TAS:ProtInc
P30872	SSTR1	Somatostatin receptor type 1	GO:0042594; P:response to starvation; IEA:Ensembl
P30872	SSTR1	Somatostatin receptor type 1	GO:0007283; P:spermatogenesis; IEA:Ensembl
P30874	SSTR2	Somatostatin receptor type 2	GO:0030165; F:PDZ domain binding; IPI:UniProtKB
P30874	SSTR2	Somatostatin receptor type 2	GO:0005515; F:protein binding; IPI:UniProtKB
P30874	SSTR2	Somatostatin receptor type 2	GO:0004994; F:somatostatin receptor activity; TAS:ProtInc
P30874	SSTR2	Somatostatin receptor type 2	GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IEA:Ensembl
P30874	SSTR2	Somatostatin receptor type 2	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P30874	SSTR2	Somatostatin receptor type 2	GO:0071392; P:cellular response to estradiol stimulus; IEA:Ensembl
P30874	SSTR2	Somatostatin receptor type 2	GO:0071385; P:cellular response to glucocorticoid stimulus; IEA:Ensembl
P30874	SSTR2	Somatostatin receptor type 2	GO:0021549; P:cerebellum development; IEA:Ensembl
P30874	SSTR2	Somatostatin receptor type 2	GO:0007586; P:digestion; TAS:ProtInc
P30874	SSTR2	Somatostatin receptor type 2	GO:0030900; P:forebrain development; IEA:Ensembl
P30874	SSTR2	Somatostatin receptor type 2	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P30874	SSTR2	Somatostatin receptor type 2	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P30874	SSTR2	Somatostatin receptor type 2	GO:0030432; P:peristalsis; IEA:Ensembl
P30874	SSTR2	Somatostatin receptor type 2	GO:0006937; P:regulation of muscle contraction; IEA:Ensembl
P30874	SSTR2	Somatostatin receptor type 2	GO:0007584; P:response to nutrient; TAS:ProtInc
P30874	SSTR2	Somatostatin receptor type 2	GO:0042594; P:response to starvation; IEA:Ensembl
P30874	SSTR2	Somatostatin receptor type 2	GO:0007283; P:spermatogenesis; IEA:Ensembl
P32745	SSTR3	Somatostatin receptor type 3	GO:0005515; F:protein binding; IPI:IntAct
P32745	SSTR3	Somatostatin receptor type 3	GO:0004994; F:somatostatin receptor activity; TAS:ProtInc
P32745	SSTR3	Somatostatin receptor type 3	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P32745	SSTR3	Somatostatin receptor type 3	GO:0071392; P:cellular response to estradiol stimulus; IEA:Ensembl
P32745	SSTR3	Somatostatin receptor type 3	GO:0071385; P:cellular response to glucocorticoid stimulus; IEA:Ensembl
P32745	SSTR3	Somatostatin receptor type 3	GO:0021549; P:cerebellum development; IEA:Ensembl
P32745	SSTR3	Somatostatin receptor type 3	GO:0030900; P:forebrain development; IEA:Ensembl
P32745	SSTR3	Somatostatin receptor type 3	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P32745	SSTR3	Somatostatin receptor type 3	GO:0008628; P:hormone-mediated apoptotic signaling pathway; TAS:ProtInc
P32745	SSTR3	Somatostatin receptor type 3	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P32745	SSTR3	Somatostatin receptor type 3	GO:0042594; P:response to starvation; IEA:Ensembl
P32745	SSTR3	Somatostatin receptor type 3	GO:0038170; P:somatostatin signaling pathway; TAS:GOC
P32745	SSTR3	Somatostatin receptor type 3	GO:0007283; P:spermatogenesis; IEA:Ensembl
P35346	SSTR5	Somatostatin receptor type 5	GO:0004994; F:somatostatin receptor activity; TAS:ProtInc
P35346	SSTR5	Somatostatin receptor type 5	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P35346	SSTR5	Somatostatin receptor type 5	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P35346	SSTR5	Somatostatin receptor type 5	GO:0042593; P:glucose homeostasis; IEA:Ensembl
P35346	SSTR5	Somatostatin receptor type 5	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P35346	SSTR5	Somatostatin receptor type 5	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProt
P35346	SSTR5	Somatostatin receptor type 5	GO:0050796; P:regulation of insulin secretion; IEA:Ensembl
P35346	SSTR5	Somatostatin receptor type 5	GO:0038170; P:somatostatin signaling pathway; TAS:GOC
P31391	SSTR4	Somatostatin receptor type 4	GO:0004994; F:somatostatin receptor activity; TAS:ProtInc
P31391	SSTR4	Somatostatin receptor type 4	GO:0019369; P:arachidonic acid metabolic process; IEA:Ensembl
P31391	SSTR4	Somatostatin receptor type 4	GO:0016477; P:cell migration; IEA:Ensembl
P31391	SSTR4	Somatostatin receptor type 4	GO:0071385; P:cellular response to glucocorticoid stimulus; IEA:Ensembl
P31391	SSTR4	Somatostatin receptor type 4	GO:0030900; P:forebrain development; IEA:Ensembl
P31391	SSTR4	Somatostatin receptor type 4	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P31391	SSTR4	Somatostatin receptor type 4	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P31391	SSTR4	Somatostatin receptor type 4	GO:0030815; P:negative regulation of cAMP metabolic process; IEA:Ensembl
P31391	SSTR4	Somatostatin receptor type 4	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P31391	SSTR4	Somatostatin receptor type 4	GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl
P43307	SSR1	Translocon-associated protein subunit alpha	GO:0005515; F:protein binding; IPI:IntAct
P43307	SSR1	Translocon-associated protein subunit alpha	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P43307	SSR1	Translocon-associated protein subunit alpha	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P43307	SSR1	Translocon-associated protein subunit alpha	GO:0006613; P:cotranslational protein targeting to membrane; TAS:ProtInc
P43307	SSR1	Translocon-associated protein subunit alpha	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P43307	SSR1	Translocon-associated protein subunit alpha	GO:0010467; P:gene expression; TAS:Reactome
P43307	SSR1	Translocon-associated protein subunit alpha	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P43307	SSR1	Translocon-associated protein subunit alpha	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P43307	SSR1	Translocon-associated protein subunit alpha	GO:0006412; P:translation; TAS:Reactome
P43308	SSR2	Translocon-associated protein subunit beta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P43308	SSR2	Translocon-associated protein subunit beta	GO:0006613; P:cotranslational protein targeting to membrane; TAS:ProtInc
P43308	SSR2	Translocon-associated protein subunit beta	GO:0010467; P:gene expression; TAS:Reactome
P43308	SSR2	Translocon-associated protein subunit beta	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P43308	SSR2	Translocon-associated protein subunit beta	GO:0006412; P:translation; TAS:Reactome
Q9UNL2	SSR3	Translocon-associated protein subunit gamma	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9UNL2	SSR3	Translocon-associated protein subunit gamma	GO:0010467; P:gene expression; TAS:Reactome
Q9UNL2	SSR3	Translocon-associated protein subunit gamma	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
Q9UNL2	SSR3	Translocon-associated protein subunit gamma	GO:0006412; P:translation; TAS:Reactome
P51571	SSR4	Translocon-associated protein subunit delta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P51571	SSR4	Translocon-associated protein subunit delta	GO:0010467; P:gene expression; TAS:Reactome
P51571	SSR4	Translocon-associated protein subunit delta	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
P51571	SSR4	Translocon-associated protein subunit delta	GO:0006412; P:translation; TAS:Reactome
Q08945	SSRP1	FACT complex subunit SSRP1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q08945	SSRP1	FACT complex subunit SSRP1	GO:0003677; F:DNA binding; TAS:ProtInc
Q08945	SSRP1	FACT complex subunit SSRP1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q08945	SSRP1	FACT complex subunit SSRP1	GO:0005515; F:protein binding; IPI:UniProtKB
Q08945	SSRP1	FACT complex subunit SSRP1	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q08945	SSRP1	FACT complex subunit SSRP1	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q08945	SSRP1	FACT complex subunit SSRP1	GO:0010467; P:gene expression; TAS:Reactome
Q08945	SSRP1	FACT complex subunit SSRP1	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
Q08945	SSRP1	FACT complex subunit SSRP1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q08945	SSRP1	FACT complex subunit SSRP1	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q08945	SSRP1	FACT complex subunit SSRP1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q08945	SSRP1	FACT complex subunit SSRP1	GO:0016032; P:viral process; TAS:Reactome
Q9NP77	SSU72	RNA polymerase II subunit A C-terminal domain phosphatase SSU72	GO:0008420; F:CTD phosphatase activity; IDA:UniProtKB
Q9NP77	SSU72	RNA polymerase II subunit A C-terminal domain phosphatase SSU72	GO:0005515; F:protein binding; IPI:IntAct
Q9NP77	SSU72	RNA polymerase II subunit A C-terminal domain phosphatase SSU72	GO:0070940; P:dephosphorylation of RNA polymerase II C-terminal domain; IDA:UniProtKB
Q9NP77	SSU72	RNA polymerase II subunit A C-terminal domain phosphatase SSU72	GO:0006378; P:mRNA polyadenylation; IMP:UniProtKB
Q16384	SSX1	Protein SSX1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q16384	SSX1	Protein SSX1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q16384	SSX1	Protein SSX1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q16384	SSX1	Protein SSX1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A6NEJ1	SSX10	Putative protein SSX10	GO:0003676; F:nucleic acid binding; IEA:InterPro
A6NEJ1	SSX10	Putative protein SSX10	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A6NEJ1	SSX10	Putative protein SSX10	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q16385	SSX2	Protein SSX2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q16385	SSX2	Protein SSX2	GO:0005515; F:protein binding; IPI:UniProtKB
Q16385	SSX2	Protein SSX2	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q16385	SSX2	Protein SSX2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q99909	SSX3	Protein SSX3	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q99909	SSX3	Protein SSX3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q99909	SSX3	Protein SSX3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60224	SSX4	Protein SSX4	GO:0003676; F:nucleic acid binding; IEA:InterPro
O60224	SSX4	Protein SSX4	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O60224	SSX4	Protein SSX4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60225	SSX5	Protein SSX5	GO:0003676; F:nucleic acid binding; IEA:InterPro
O60225	SSX5	Protein SSX5	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O60225	SSX5	Protein SSX5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7RTT6	SSX6	Putative protein SSX6	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q7RTT6	SSX6	Putative protein SSX6	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7RTT6	SSX6	Putative protein SSX6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7RTT5	SSX7	Protein SSX7	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q7RTT5	SSX7	Protein SSX7	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7RTT5	SSX7	Protein SSX7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15532	SS18	Protein SSXT	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IDA:UniProtKB
Q15532	SS18	Protein SSXT	GO:0005515; F:protein binding; IPI:UniProtKB
Q15532	SS18	Protein SSXT	GO:0000902; P:cell morphogenesis; IEA:Ensembl
Q15532	SS18	Protein SSXT	GO:0048013; P:ephrin receptor signaling pathway; IEA:Ensembl
Q15532	SS18	Protein SSXT	GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl
Q15532	SS18	Protein SSXT	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q15532	SS18	Protein SSXT	GO:0042493; P:response to drug; IEA:Ensembl
Q15532	SS18	Protein SSXT	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7RTT3	SSX9	Protein SSX9	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q7RTT3	SSX9	Protein SSX9	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7RTT3	SSX9	Protein SSX9	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7RTT4	SSX8	Protein SSX8	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q7RTT4	SSX8	Protein SSX8	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7RTT4	SSX8	Protein SSX8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y5Y6	ST14	Suppressor of tumorigenicity 14 protein	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q9Y5Y6	ST14	Suppressor of tumorigenicity 14 protein	GO:0008236; F:serine-type peptidase activity; IDA:UniProtKB
Q9Y5Y6	ST14	Suppressor of tumorigenicity 14 protein	GO:0006508; P:proteolysis; IDA:UniProtKB
Q9UEE5	STK17A	Serine/threonine-protein kinase 17A	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9UEE5	STK17A	Serine/threonine-protein kinase 17A	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9UEE5	STK17A	Serine/threonine-protein kinase 17A	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9UEE5	STK17A	Serine/threonine-protein kinase 17A	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q9UEE5	STK17A	Serine/threonine-protein kinase 17A	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q9UEE5	STK17A	Serine/threonine-protein kinase 17A	GO:2000271; P:positive regulation of fibroblast apoptotic process; IMP:UniProtKB
Q9UEE5	STK17A	Serine/threonine-protein kinase 17A	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9UEE5	STK17A	Serine/threonine-protein kinase 17A	GO:2000377; P:regulation of reactive oxygen species metabolic process; IMP:UniProtKB
O94768	STK17B	Serine/threonine-protein kinase 17B	GO:0005524; F:ATP binding; IDA:UniProtKB
O94768	STK17B	Serine/threonine-protein kinase 17B	GO:0004672; F:protein kinase activity; ISS:UniProtKB
O94768	STK17B	Serine/threonine-protein kinase 17B	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
O94768	STK17B	Serine/threonine-protein kinase 17B	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O94768	STK17B	Serine/threonine-protein kinase 17B	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
O94768	STK17B	Serine/threonine-protein kinase 17B	GO:2000271; P:positive regulation of fibroblast apoptotic process; IMP:UniProtKB
O94768	STK17B	Serine/threonine-protein kinase 17B	GO:0046777; P:protein autophosphorylation; ISS:UniProtKB
O94768	STK17B	Serine/threonine-protein kinase 17B	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
O60284	ST18	Suppression of tumorigenicity 18 protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O60284	ST18	Suppression of tumorigenicity 18 protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O60284	ST18	Suppression of tumorigenicity 18 protein	GO:0008270; F:zinc ion binding; IEA:InterPro
O60284	ST18	Suppression of tumorigenicity 18 protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P50225	SULT1A1	Sulfotransferase 1A1	GO:0004062; F:aryl sulfotransferase activity; IDA:UniProtKB
P50225	SULT1A1	Sulfotransferase 1A1	GO:0047894; F:flavonol 3-sulfotransferase activity; IDA:BHF-UCL
P50225	SULT1A1	Sulfotransferase 1A1	GO:0050294; F:steroid sulfotransferase activity; IDA:UniProtKB
P50225	SULT1A1	Sulfotransferase 1A1	GO:0008146; F:sulfotransferase activity; TAS:ProtInc
P50225	SULT1A1	Sulfotransferase 1A1	GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; TAS:Reactome
P50225	SULT1A1	Sulfotransferase 1A1	GO:0009308; P:amine metabolic process; TAS:ProtInc
P50225	SULT1A1	Sulfotransferase 1A1	GO:0006584; P:catecholamine metabolic process; IEA:UniProtKB-KW
P50225	SULT1A1	Sulfotransferase 1A1	GO:0008210; P:estrogen metabolic process; IDA:UniProtKB
P50225	SULT1A1	Sulfotransferase 1A1	GO:0009812; P:flavonoid metabolic process; IDA:BHF-UCL
P50225	SULT1A1	Sulfotransferase 1A1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P50225	SULT1A1	Sulfotransferase 1A1	GO:0051923; P:sulfation; IDA:BHF-UCL
P50225	SULT1A1	Sulfotransferase 1A1	GO:0006805; P:xenobiotic metabolic process; IDA:UniProtKB
P50226	SULT1A2	Sulfotransferase 1A2	GO:0004062; F:aryl sulfotransferase activity; IDA:UniProtKB
P50226	SULT1A2	Sulfotransferase 1A2	GO:0047894; F:flavonol 3-sulfotransferase activity; IDA:BHF-UCL
P50226	SULT1A2	Sulfotransferase 1A2	GO:0008146; F:sulfotransferase activity; TAS:ProtInc
P50226	SULT1A2	Sulfotransferase 1A2	GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; TAS:Reactome
P50226	SULT1A2	Sulfotransferase 1A2	GO:0009309; P:amine biosynthetic process; TAS:ProtInc
P50226	SULT1A2	Sulfotransferase 1A2	GO:0006584; P:catecholamine metabolic process; IEA:UniProtKB-KW
P50226	SULT1A2	Sulfotransferase 1A2	GO:0018958; P:phenol-containing compound metabolic process; IDA:UniProtKB
P50226	SULT1A2	Sulfotransferase 1A2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P50226	SULT1A2	Sulfotransferase 1A2	GO:0008202; P:steroid metabolic process; IEA:UniProtKB-KW
P50226	SULT1A2	Sulfotransferase 1A2	GO:0051923; P:sulfation; IDA:BHF-UCL
P50226	SULT1A2	Sulfotransferase 1A2	GO:0006805; P:xenobiotic metabolic process; IDA:UniProtKB
P50224	SULT1A3	Sulfotransferase 1A3/1A4	GO:0004062; F:aryl sulfotransferase activity; TAS:Reactome
P50224	SULT1A3	Sulfotransferase 1A3/1A4	GO:0008146; F:sulfotransferase activity; IDA:BHF-UCL
P50224	SULT1A3	Sulfotransferase 1A3/1A4	GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; TAS:Reactome
P50224	SULT1A3	Sulfotransferase 1A3/1A4	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P50224	SULT1A3	Sulfotransferase 1A3/1A4	GO:0006584; P:catecholamine metabolic process; IEA:UniProtKB-KW
P50224	SULT1A3	Sulfotransferase 1A3/1A4	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P50224	SULT1A3	Sulfotransferase 1A3/1A4	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P50224	SULT1A3	Sulfotransferase 1A3/1A4	GO:0009812; P:flavonoid metabolic process; IDA:BHF-UCL
P50224	SULT1A3	Sulfotransferase 1A3/1A4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P50224	SULT1A3	Sulfotransferase 1A3/1A4	GO:0008202; P:steroid metabolic process; IEA:UniProtKB-KW
P50224	SULT1A3	Sulfotransferase 1A3/1A4	GO:0051923; P:sulfation; IDA:BHF-UCL
P50224	SULT1A3	Sulfotransferase 1A3/1A4	GO:0006805; P:xenobiotic metabolic process; IDA:BHF-UCL
O43704	SULT1B1	Sulfotransferase family cytosolic 1B member 1	GO:0004062; F:aryl sulfotransferase activity; IEA:Ensembl
O43704	SULT1B1	Sulfotransferase family cytosolic 1B member 1	GO:0008146; F:sulfotransferase activity; IDA:UniProtKB
O43704	SULT1B1	Sulfotransferase family cytosolic 1B member 1	GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; TAS:Reactome
O43704	SULT1B1	Sulfotransferase family cytosolic 1B member 1	GO:0006576; P:cellular biogenic amine metabolic process; TAS:ProtInc
O43704	SULT1B1	Sulfotransferase family cytosolic 1B member 1	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
O43704	SULT1B1	Sulfotransferase family cytosolic 1B member 1	GO:0009812; P:flavonoid metabolic process; IDA:BHF-UCL
O43704	SULT1B1	Sulfotransferase family cytosolic 1B member 1	GO:0018958; P:phenol-containing compound metabolic process; IDA:UniProtKB
O43704	SULT1B1	Sulfotransferase family cytosolic 1B member 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43704	SULT1B1	Sulfotransferase family cytosolic 1B member 1	GO:0008202; P:steroid metabolic process; IEA:UniProtKB-KW
O43704	SULT1B1	Sulfotransferase family cytosolic 1B member 1	GO:0051923; P:sulfation; IDA:BHF-UCL
O43704	SULT1B1	Sulfotransferase family cytosolic 1B member 1	GO:0042403; P:thyroid hormone metabolic process; IDA:UniProtKB
O43704	SULT1B1	Sulfotransferase family cytosolic 1B member 1	GO:0006805; P:xenobiotic metabolic process; IDA:BHF-UCL
O00338	SULT1C2	Sulfotransferase 1C2	GO:0008146; F:sulfotransferase activity; IDA:BHF-UCL
O00338	SULT1C2	Sulfotransferase 1C2	GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; TAS:Reactome
O00338	SULT1C2	Sulfotransferase 1C2	GO:0009308; P:amine metabolic process; TAS:ProtInc
O00338	SULT1C2	Sulfotransferase 1C2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00338	SULT1C2	Sulfotransferase 1C2	GO:0051923; P:sulfation; IDA:BHF-UCL
O00338	SULT1C2	Sulfotransferase 1C2	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q6IMI6	SULT1C3	Sulfotransferase 1C3	GO:0004027; F:alcohol sulfotransferase activity; IDA:UniProtKB
Q6IMI6	SULT1C3	Sulfotransferase 1C3	GO:0004062; F:aryl sulfotransferase activity; IEA:Ensembl
Q6IMI6	SULT1C3	Sulfotransferase 1C3	GO:0006790; P:sulfur compound metabolic process; IEA:Ensembl
O75897	SULT1C4	Sulfotransferase 1C4	GO:0008146; F:sulfotransferase activity; NAS:UniProtKB
O75897	SULT1C4	Sulfotransferase 1C4	GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; TAS:Reactome
O75897	SULT1C4	Sulfotransferase 1C4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75897	SULT1C4	Sulfotransferase 1C4	GO:0051923; P:sulfation; IDA:BHF-UCL
O75897	SULT1C4	Sulfotransferase 1C4	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P49888	SULT1E1	Estrogen sulfotransferase	GO:0004304; F:estrone sulfotransferase activity; TAS:ProtInc
P49888	SULT1E1	Estrogen sulfotransferase	GO:0047894; F:flavonol 3-sulfotransferase activity; IDA:BHF-UCL
P49888	SULT1E1	Estrogen sulfotransferase	GO:0005496; F:steroid binding; IEA:UniProtKB-KW
P49888	SULT1E1	Estrogen sulfotransferase	GO:0050294; F:steroid sulfotransferase activity; IDA:UniProtKB
P49888	SULT1E1	Estrogen sulfotransferase	GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; TAS:Reactome
P49888	SULT1E1	Estrogen sulfotransferase	GO:0008210; P:estrogen metabolic process; IDA:UniProtKB
P49888	SULT1E1	Estrogen sulfotransferase	GO:0007565; P:female pregnancy; IEA:Ensembl
P49888	SULT1E1	Estrogen sulfotransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P49888	SULT1E1	Estrogen sulfotransferase	GO:0008202; P:steroid metabolic process; TAS:ProtInc
P49888	SULT1E1	Estrogen sulfotransferase	GO:0051923; P:sulfation; IDA:BHF-UCL
P49888	SULT1E1	Estrogen sulfotransferase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9HBF5	ST20	Suppressor of tumorigenicity 20 protein	GO:0046982; F:protein heterodimerization activity; IBA:RefGenome
Q9HBF5	ST20	Suppressor of tumorigenicity 20 protein	GO:0042803; F:protein homodimerization activity; IBA:RefGenome
Q9HBF5	ST20	Suppressor of tumorigenicity 20 protein	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IBA:RefGenome
Q9HBF5	ST20	Suppressor of tumorigenicity 20 protein	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IBA:RefGenome
Q9HBF5	ST20	Suppressor of tumorigenicity 20 protein	GO:0043066; P:negative regulation of apoptotic process; IBA:RefGenome
Q9HBF5	ST20	Suppressor of tumorigenicity 20 protein	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IBA:RefGenome
Q06520	SULT2A1	Bile salt sulfotransferase	GO:0047704; F:bile-salt sulfotransferase activity; IEA:UniProtKB-EC
Q06520	SULT2A1	Bile salt sulfotransferase	GO:0005515; F:protein binding; IPI:IntAct
Q06520	SULT2A1	Bile salt sulfotransferase	GO:0008146; F:sulfotransferase activity; IDA:BHF-UCL
Q06520	SULT2A1	Bile salt sulfotransferase	GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; TAS:Reactome
Q06520	SULT2A1	Bile salt sulfotransferase	GO:0030573; P:bile acid catabolic process; IEA:UniProtKB-KW
Q06520	SULT2A1	Bile salt sulfotransferase	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q06520	SULT2A1	Bile salt sulfotransferase	GO:0007586; P:digestion; NAS:ProtInc
Q06520	SULT2A1	Bile salt sulfotransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q06520	SULT2A1	Bile salt sulfotransferase	GO:0008202; P:steroid metabolic process; TAS:ProtInc
Q06520	SULT2A1	Bile salt sulfotransferase	GO:0051923; P:sulfation; IDA:BHF-UCL
Q06520	SULT2A1	Bile salt sulfotransferase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
O00204	SULT2B1	Sulfotransferase family cytosolic 2B member 1	GO:0004027; F:alcohol sulfotransferase activity; TAS:Reactome
O00204	SULT2B1	Sulfotransferase family cytosolic 2B member 1	GO:0005515; F:protein binding; IPI:IntAct
O00204	SULT2B1	Sulfotransferase family cytosolic 2B member 1	GO:0050294; F:steroid sulfotransferase activity; IDA:UniProtKB
O00204	SULT2B1	Sulfotransferase family cytosolic 2B member 1	GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; TAS:Reactome
O00204	SULT2B1	Sulfotransferase family cytosolic 2B member 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00204	SULT2B1	Sulfotransferase family cytosolic 2B member 1	GO:0008202; P:steroid metabolic process; IDA:UniProtKB
O00204	SULT2B1	Sulfotransferase family cytosolic 2B member 1	GO:0000103; P:sulfate assimilation; IEA:Ensembl
O00204	SULT2B1	Sulfotransferase family cytosolic 2B member 1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q8WU08	STK32A	Serine/threonine-protein kinase 32A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8WU08	STK32A	Serine/threonine-protein kinase 32A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8WU08	STK32A	Serine/threonine-protein kinase 32A	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q9NY57	STK32B	Serine/threonine-protein kinase 32B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NY57	STK32B	Serine/threonine-protein kinase 32B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NY57	STK32B	Serine/threonine-protein kinase 32B	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q86UX6	STK32C	Serine/threonine-protein kinase 32C	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86UX6	STK32C	Serine/threonine-protein kinase 32C	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86UX6	STK32C	Serine/threonine-protein kinase 32C	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q9Y2H1	STK38L	Serine/threonine-protein kinase 38-like	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9Y2H1	STK38L	Serine/threonine-protein kinase 38-like	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q9Y2H1	STK38L	Serine/threonine-protein kinase 38-like	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y2H1	STK38L	Serine/threonine-protein kinase 38-like	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9Y2H1	STK38L	Serine/threonine-protein kinase 38-like	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q9Y2H1	STK38L	Serine/threonine-protein kinase 38-like	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9Y2H1	STK38L	Serine/threonine-protein kinase 38-like	GO:0051128; P:regulation of cellular component organization; ISS:UniProtKB
Q9BR01	SULT4A1	Sulfotransferase 4A1	GO:0005515; F:protein binding; IPI:IntAct
Q9BR01	SULT4A1	Sulfotransferase 4A1	GO:0008146; F:sulfotransferase activity; NAS:UniProtKB
Q9BR01	SULT4A1	Sulfotransferase 4A1	GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; TAS:Reactome
Q9BR01	SULT4A1	Sulfotransferase 4A1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BR01	SULT4A1	Sulfotransferase 4A1	GO:0008202; P:steroid metabolic process; IEA:UniProtKB-KW
Q9BR01	SULT4A1	Sulfotransferase 4A1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P78524	ST5	Suppression of tumorigenicity 5 protein	GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; IDA:UniProtKB
P78524	ST5	Suppression of tumorigenicity 5 protein	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:MGI
P78524	ST5	Suppression of tumorigenicity 5 protein	GO:0032313; P:regulation of Rab GTPase activity; IDA:GOC
O94864	SUPT7L	STAGA complex 65 subunit gamma	GO:0005515; F:protein binding; IPI:HGNC
O94864	SUPT7L	STAGA complex 65 subunit gamma	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
O94864	SUPT7L	STAGA complex 65 subunit gamma	GO:0006325; P:chromatin organization; TAS:Reactome
O94864	SUPT7L	STAGA complex 65 subunit gamma	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
O94864	SUPT7L	STAGA complex 65 subunit gamma	GO:0051457; P:maintenance of protein location in nucleus; IDA:HGNC
O94864	SUPT7L	STAGA complex 65 subunit gamma	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O94864	SUPT7L	STAGA complex 65 subunit gamma	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6IMI4	SULT6B1	Sulfotransferase 6B1	GO:0008146; F:sulfotransferase activity; IEA:UniProtKB-EC
Q8TDW4	ST7L	Suppressor of tumorigenicity 7 protein-like	GO:0030308; P:negative regulation of cell growth; ISS:BHF-UCL
Q9Y3M8	STARD13	StAR-related lipid transfer protein 13	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q9Y3M8	STARD13	StAR-related lipid transfer protein 13	GO:0008289; F:lipid binding; IEA:InterPro
Q9Y3M8	STARD13	StAR-related lipid transfer protein 13	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3M8	STARD13	StAR-related lipid transfer protein 13	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q9Y3M8	STARD13	StAR-related lipid transfer protein 13	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0005509; F:calcium ion binding; IEA:InterPro
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0005515; F:protein binding; IPI:UniProtKB
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0004871; F:signal transducer activity; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0006103; P:2-oxoglutarate metabolic process; ISS:BHF-UCL
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0000255; P:allantoin metabolic process; ISS:BHF-UCL
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0006101; P:citrate metabolic process; ISS:BHF-UCL
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0006600; P:creatine metabolic process; ISS:BHF-UCL
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0046449; P:creatinine metabolic process; ISS:BHF-UCL
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0046543; P:development of secondary female sexual characteristics; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0046544; P:development of secondary male sexual characteristics; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0060742; P:epithelial cell differentiation involved in prostate gland development; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0006631; P:fatty acid metabolic process; ISS:BHF-UCL
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0007565; P:female pregnancy; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0006549; P:isoleucine metabolic process; ISS:BHF-UCL
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0007259; P:JAK-STAT cascade; TAS:ProtInc
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0007595; P:lactation; IEA:UniProtKB-KW
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0019915; P:lipid storage; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0001553; P:luteinization; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0061180; P:mammary gland epithelium development; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0001779; P:natural killer cell differentiation; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0045647; P:negative regulation of erythrocyte differentiation; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0033026; P:negative regulation of mast cell apoptotic process; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0006107; P:oxaloacetate metabolic process; ISS:BHF-UCL
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0018108; P:peptidyl-tyrosine phosphorylation; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0048541; P:Peyer's patch development; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0042104; P:positive regulation of activated T cell proliferation; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0045579; P:positive regulation of B cell differentiation; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0045588; P:positive regulation of gamma-delta T cell differentiation; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0050729; P:positive regulation of inflammatory response; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0045086; P:positive regulation of interleukin-2 biosynthetic process; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0060376; P:positive regulation of mast cell differentiation; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0070668; P:positive regulation of mast cell proliferation; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0045931; P:positive regulation of mitotic cell cycle; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0032825; P:positive regulation of natural killer cell differentiation; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0038161; P:prolactin signaling pathway; ISS:UniProtKB
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0060740; P:prostate gland epithelium morphogenesis; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0030155; P:regulation of cell adhesion; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0030856; P:regulation of epithelial cell differentiation; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0040014; P:regulation of multicellular organism growth; ISS:BHF-UCL
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0019218; P:regulation of steroid metabolic process; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0006105; P:succinate metabolic process; ISS:BHF-UCL
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0043029; P:T cell homeostasis; IEA:Ensembl
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0019530; P:taurine metabolic process; ISS:BHF-UCL
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P42229	STAT5A	Signal transducer and activator of transcription 5A	GO:0006573; P:valine metabolic process; ISS:BHF-UCL
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0005509; F:calcium ion binding; IEA:InterPro
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0003682; F:chromatin binding; ISS:UniProtKB
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0035259; F:glucocorticoid receptor binding; IPI:BHF-UCL
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0005515; F:protein binding; IPI:UniProtKB
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0046983; F:protein dimerization activity; ISS:UniProtKB
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0004871; F:signal transducer activity; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0006103; P:2-oxoglutarate metabolic process; ISS:BHF-UCL
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0006953; P:acute-phase response; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0000255; P:allantoin metabolic process; ISS:BHF-UCL
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0071364; P:cellular response to epidermal growth factor stimulus; ISS:UniProtKB
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0071363; P:cellular response to growth factor stimulus; ISS:UniProtKB
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0032870; P:cellular response to hormone stimulus; IDA:BHF-UCL
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0006101; P:citrate metabolic process; ISS:BHF-UCL
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0006600; P:creatine metabolic process; ISS:BHF-UCL
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0046449; P:creatinine metabolic process; ISS:BHF-UCL
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0046543; P:development of secondary female sexual characteristics; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0046544; P:development of secondary male sexual characteristics; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0006631; P:fatty acid metabolic process; ISS:BHF-UCL
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0007565; P:female pregnancy; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0006549; P:isoleucine metabolic process; ISS:BHF-UCL
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0007259; P:JAK-STAT cascade; TAS:ProtInc
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; IDA:BHF-UCL
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0007595; P:lactation; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0019915; P:lipid storage; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0001889; P:liver development; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0001553; P:luteinization; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0001779; P:natural killer cell differentiation; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0045647; P:negative regulation of erythrocyte differentiation; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0006107; P:oxaloacetate metabolic process; ISS:BHF-UCL
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0048541; P:Peyer's patch development; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0042104; P:positive regulation of activated T cell proliferation; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0045579; P:positive regulation of B cell differentiation; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0051272; P:positive regulation of cellular component movement; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0045588; P:positive regulation of gamma-delta T cell differentiation; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0050729; P:positive regulation of inflammatory response; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0045086; P:positive regulation of interleukin-2 biosynthetic process; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0045931; P:positive regulation of mitotic cell cycle; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0032825; P:positive regulation of natural killer cell differentiation; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0032819; P:positive regulation of natural killer cell proliferation; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0042448; P:progesterone metabolic process; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0038161; P:prolactin signaling pathway; ISS:UniProtKB
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0030155; P:regulation of cell adhesion; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0030856; P:regulation of epithelial cell differentiation; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0040014; P:regulation of multicellular organism growth; ISS:BHF-UCL
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0019218; P:regulation of steroid metabolic process; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0032355; P:response to estradiol; IDA:BHF-UCL
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0045471; P:response to ethanol; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0001666; P:response to hypoxia; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0070672; P:response to interleukin-15; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0070669; P:response to interleukin-2; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0070670; P:response to interleukin-4; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0006105; P:succinate metabolic process; ISS:BHF-UCL
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0043029; P:T cell homeostasis; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0019530; P:taurine metabolic process; ISS:BHF-UCL
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0006366; P:transcription from RNA polymerase II promoter; IEA:Ensembl
P51692	STAT5B	Signal transducer and activator of transcription 5B	GO:0006573; P:valine metabolic process; ISS:BHF-UCL
Q9NY15	STAB1	Stabilin-1	GO:0005540; F:hyaluronic acid binding; IEA:InterPro
Q9NY15	STAB1	Stabilin-1	GO:0030169; F:low-density lipoprotein particle binding; IDA:UniProtKB
Q9NY15	STAB1	Stabilin-1	GO:0005041; F:low-density lipoprotein receptor activity; IDA:UniProtKB
Q9NY15	STAB1	Stabilin-1	GO:0005515; F:protein binding; IPI:UniProt
Q9NY15	STAB1	Stabilin-1	GO:0015035; F:protein disulfide oxidoreductase activity; NAS:UniProtKB
Q9NY15	STAB1	Stabilin-1	GO:0005044; F:scavenger receptor activity; IDA:UniProtKB
Q9NY15	STAB1	Stabilin-1	GO:0007155; P:cell adhesion; NAS:UniProtKB
Q9NY15	STAB1	Stabilin-1	GO:0007267; P:cell-cell signaling; IDA:UniProtKB
Q9NY15	STAB1	Stabilin-1	GO:0042742; P:defense response to bacterium; IDA:UniProtKB
Q9NY15	STAB1	Stabilin-1	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q9NY15	STAB1	Stabilin-1	GO:0016525; P:negative regulation of angiogenesis; IMP:UniProtKB
Q9NY15	STAB1	Stabilin-1	GO:0055114; P:oxidation-reduction process; NAS:GOC
Q9NY15	STAB1	Stabilin-1	GO:0006898; P:receptor-mediated endocytosis; TAS:UniProtKB
Q8WWQ8	STAB2	Stabilin-2	GO:0005540; F:hyaluronic acid binding; ISS:UniProtKB
Q8WWQ8	STAB2	Stabilin-2	GO:0030169; F:low-density lipoprotein particle binding; IDA:UniProtKB
Q8WWQ8	STAB2	Stabilin-2	GO:0005041; F:low-density lipoprotein receptor activity; IDA:UniProtKB
Q8WWQ8	STAB2	Stabilin-2	GO:0005515; F:protein binding; IPI:IntAct
Q8WWQ8	STAB2	Stabilin-2	GO:0015035; F:protein disulfide oxidoreductase activity; NAS:UniProtKB
Q8WWQ8	STAB2	Stabilin-2	GO:0005044; F:scavenger receptor activity; IDA:UniProtKB
Q8WWQ8	STAB2	Stabilin-2	GO:0001525; P:angiogenesis; NAS:UniProtKB
Q8WWQ8	STAB2	Stabilin-2	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q8WWQ8	STAB2	Stabilin-2	GO:0007155; P:cell adhesion; NAS:UniProtKB
Q8WWQ8	STAB2	Stabilin-2	GO:0042742; P:defense response to bacterium; IDA:UniProtKB
Q8WWQ8	STAB2	Stabilin-2	GO:0006897; P:endocytosis; ISS:UniProtKB
Q8WWQ8	STAB2	Stabilin-2	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q8WWQ8	STAB2	Stabilin-2	GO:0030214; P:hyaluronan catabolic process; TAS:Reactome
Q8WWQ8	STAB2	Stabilin-2	GO:0030212; P:hyaluronan metabolic process; TAS:Reactome
Q8WWQ8	STAB2	Stabilin-2	GO:0055114; P:oxidation-reduction process; NAS:GOC
Q8WWQ8	STAB2	Stabilin-2	GO:0006898; P:receptor-mediated endocytosis; TAS:UniProtKB
Q8WWQ8	STAB2	Stabilin-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95630	STAMBP	STAM-binding protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95630	STAMBP	STAM-binding protein	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
O95630	STAMBP	STAM-binding protein	GO:0005515; F:protein binding; IPI:IntAct
O95630	STAMBP	STAM-binding protein	GO:0004843; F:ubiquitin-specific protease activity; IDA:MGI
O95630	STAMBP	STAM-binding protein	GO:0007259; P:JAK-STAT cascade; TAS:ProtInc
O95630	STAMBP	STAM-binding protein	GO:0000281; P:mitotic cytokinesis; IMP:MGI
O95630	STAMBP	STAM-binding protein	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
O95630	STAMBP	STAM-binding protein	GO:0014067; P:negative regulation of phosphatidylinositol 3-kinase signaling; IMP:UniProtKB
O95630	STAMBP	STAM-binding protein	GO:0046580; P:negative regulation of Ras protein signal transduction; IMP:UniProtKB
O95630	STAMBP	STAM-binding protein	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
O95630	STAMBP	STAM-binding protein	GO:0016579; P:protein deubiquitination; IMP:MGI
Q6ZMT1	STAC2	SH3 and cysteine-rich domain-containing protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZMT1	STAC2	SH3 and cysteine-rich domain-containing protein 2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q96MF2	STAC3	SH3 and cysteine-rich domain-containing protein 3	GO:0042802; F:identical protein binding; IPI:IntAct
Q96MF2	STAC3	SH3 and cysteine-rich domain-containing protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96MF2	STAC3	SH3 and cysteine-rich domain-containing protein 3	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q99469	STAC	SH3 and cysteine-rich domain-containing protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q99469	STAC	SH3 and cysteine-rich domain-containing protein	GO:0005515; F:protein binding; IPI:IntAct
Q99469	STAC	SH3 and cysteine-rich domain-containing protein	GO:0034605; P:cellular response to heat; IEA:Ensembl
Q99469	STAC	SH3 and cysteine-rich domain-containing protein	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q99469	STAC	SH3 and cysteine-rich domain-containing protein	GO:0007165; P:signal transduction; NAS:UniProtKB
Q8WVM7	STAG1	Cohesin subunit SA-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WVM7	STAG1	Cohesin subunit SA-1	GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW
Q8WVM7	STAG1	Cohesin subunit SA-1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q8WVM7	STAG1	Cohesin subunit SA-1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8N3U4	STAG2	Cohesin subunit SA-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N3U4	STAG2	Cohesin subunit SA-2	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q8N3U4	STAG2	Cohesin subunit SA-2	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q8N3U4	STAG2	Cohesin subunit SA-2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q8N3U4	STAG2	Cohesin subunit SA-2	GO:0032876; P:negative regulation of DNA endoreduplication; IMP:BHF-UCL
Q8N3U4	STAG2	Cohesin subunit SA-2	GO:0007062; P:sister chromatid cohesion; IMP:BHF-UCL
Q8N3U4	STAG2	Cohesin subunit SA-2	GO:0019827; P:stem cell maintenance; IEA:Ensembl
Q9UJ98	STAG3	Cohesin subunit SA-3	GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW
Q9UJ98	STAG3	Cohesin subunit SA-3	GO:0007130; P:synaptonemal complex assembly; TAS:ProtInc
Q96FJ0	STAMBPL1	AMSH-like protease	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96FJ0	STAMBPL1	AMSH-like protease	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
Q96FJ0	STAMBPL1	AMSH-like protease	GO:0005515; F:protein binding; IPI:IntAct
Q92783	STAM	Signal transducing adapter molecule 1	GO:0005515; F:protein binding; IPI:IntAct
Q92783	STAM	Signal transducing adapter molecule 1	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
Q92783	STAM	Signal transducing adapter molecule 1	GO:0016197; P:endosomal transport; TAS:Reactome
Q92783	STAM	Signal transducing adapter molecule 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q92783	STAM	Signal transducing adapter molecule 1	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q92783	STAM	Signal transducing adapter molecule 1	GO:0061024; P:membrane organization; TAS:Reactome
Q92783	STAM	Signal transducing adapter molecule 1	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
Q92783	STAM	Signal transducing adapter molecule 1	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
Q92783	STAM	Signal transducing adapter molecule 1	GO:0007165; P:signal transduction; TAS:ProtInc
O75886	STAM2	Signal transducing adapter molecule 2	GO:0005515; F:protein binding; IPI:IntAct
O75886	STAM2	Signal transducing adapter molecule 2	GO:0016197; P:endosomal transport; TAS:Reactome
O75886	STAM2	Signal transducing adapter molecule 2	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
O75886	STAM2	Signal transducing adapter molecule 2	GO:0006886; P:intracellular protein transport; IEA:InterPro
O75886	STAM2	Signal transducing adapter molecule 2	GO:0061024; P:membrane organization; TAS:Reactome
O75886	STAM2	Signal transducing adapter molecule 2	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
Q9ULZ2	STAP1	Signal-transducing adaptor protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9ULZ2	STAP1	Signal-transducing adaptor protein 1	GO:0006886; P:intracellular protein transport; TAS:ProtInc
Q9ULZ2	STAP1	Signal-transducing adaptor protein 1	GO:0061025; P:membrane fusion; TAS:ProtInc
Q9ULZ2	STAP1	Signal-transducing adaptor protein 1	GO:0009967; P:positive regulation of signal transduction; IEA:GOC
Q9ULZ2	STAP1	Signal-transducing adaptor protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q9ULZ2	STAP1	Signal-transducing adaptor protein 1	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IEA:Ensembl
Q9UGK3	STAP2	Signal-transducing adaptor protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q14849	STARD3	StAR-related lipid transfer protein 3	GO:0015485; F:cholesterol binding; IDA:MGI
Q14849	STARD3	StAR-related lipid transfer protein 3	GO:0017127; F:cholesterol transporter activity; IEA:InterPro
Q14849	STARD3	StAR-related lipid transfer protein 3	GO:0008203; P:cholesterol metabolic process; TAS:ProtInc
Q14849	STARD3	StAR-related lipid transfer protein 3	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q14849	STARD3	StAR-related lipid transfer protein 3	GO:0006839; P:mitochondrial transport; TAS:ProtInc
Q14849	STARD3	StAR-related lipid transfer protein 3	GO:0006701; P:progesterone biosynthetic process; IEA:Ensembl
Q14849	STARD3	StAR-related lipid transfer protein 3	GO:0008202; P:steroid metabolic process; TAS:ProtInc
Q96DR4	STARD4	StAR-related lipid transfer protein 4	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q96DR4	STARD4	StAR-related lipid transfer protein 4	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q9NSY2	STARD5	StAR-related lipid transfer protein 5	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
Q9NSY2	STARD5	StAR-related lipid transfer protein 5	GO:0006700; P:C21-steroid hormone biosynthetic process; TAS:Reactome
Q9NSY2	STARD5	StAR-related lipid transfer protein 5	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q9NSY2	STARD5	StAR-related lipid transfer protein 5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NSY2	STARD5	StAR-related lipid transfer protein 5	GO:0008202; P:steroid metabolic process; TAS:Reactome
P59095	STARD6	StAR-related lipid transfer protein 6	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
P59095	STARD6	StAR-related lipid transfer protein 6	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q9NQZ5	STARD7	StAR-related lipid transfer protein 7, mitochondrial	GO:0008289; F:lipid binding; IEA:InterPro
Q92502	STARD8	StAR-related lipid transfer protein 8	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q92502	STARD8	StAR-related lipid transfer protein 8	GO:0008289; F:lipid binding; IEA:InterPro
Q92502	STARD8	StAR-related lipid transfer protein 8	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q92502	STARD8	StAR-related lipid transfer protein 8	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9P2P6	STARD9	StAR-related lipid transfer protein 9	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9P2P6	STARD9	StAR-related lipid transfer protein 9	GO:0008289; F:lipid binding; IEA:InterPro
Q9P2P6	STARD9	StAR-related lipid transfer protein 9	GO:0008017; F:microtubule binding; IDA:UniProtKB
Q9P2P6	STARD9	StAR-related lipid transfer protein 9	GO:0003777; F:microtubule motor activity; IDA:UniProtKB
Q9P2P6	STARD9	StAR-related lipid transfer protein 9	GO:0008152; P:metabolic process; IDA:UniProtKB
Q9P2P6	STARD9	StAR-related lipid transfer protein 9	GO:0007018; P:microtubule-based movement; IEA:InterPro
Q9P2P6	STARD9	StAR-related lipid transfer protein 9	GO:0051225; P:spindle assembly; IMP:UniProtKB
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0015485; F:cholesterol binding; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0017127; F:cholesterol transporter activity; IEA:InterPro
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0006699; P:bile acid biosynthetic process; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0018879; P:biphenyl metabolic process; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0007420; P:brain development; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0006700; P:C21-steroid hormone biosynthetic process; TAS:Reactome
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0071312; P:cellular response to alkaloid; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0071236; P:cellular response to antibiotic; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0071276; P:cellular response to cadmium ion; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0071320; P:cellular response to cAMP; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0071549; P:cellular response to dexamethasone stimulus; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0071872; P:cellular response to epinephrine stimulus; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0071378; P:cellular response to growth hormone stimulus; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0035457; P:cellular response to interferon-alpha; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0071346; P:cellular response to interferon-gamma; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0071373; P:cellular response to luteinizing hormone stimulus; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-UniPathway
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0042747; P:circadian sleep/wake cycle, REM sleep; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0018894; P:dibenzo-p-dioxin metabolic process; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0016101; P:diterpenoid metabolic process; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0006703; P:estrogen biosynthetic process; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0050756; P:fractalkine metabolic process; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0008211; P:glucocorticoid metabolic process; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0017143; P:insecticide metabolic process; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0032367; P:intracellular cholesterol transport; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0008584; P:male gonad development; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0018958; P:phenol-containing compound metabolic process; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0018963; P:phthalate metabolic process; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0050769; P:positive regulation of neurogenesis; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0006701; P:progesterone biosynthetic process; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0048168; P:regulation of neuronal synaptic plasticity; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0050810; P:regulation of steroid biosynthetic process; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0014823; P:response to activity; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0051412; P:response to corticosterone; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0042493; P:response to drug; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0043627; P:response to estrogen; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0045471; P:response to ethanol; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0060992; P:response to fungicide; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0009635; P:response to herbicide; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0010212; P:response to ionizing radiation; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0010288; P:response to lead ion; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0044321; P:response to leptin; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0035094; P:response to nicotine; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0007584; P:response to nutrient; IEA:Ensembl
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0006694; P:steroid biosynthetic process; TAS:ProtInc
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0008202; P:steroid metabolic process; TAS:Reactome
P49675	STAR	Steroidogenic acute regulatory protein, mitochondrial	GO:0061370; P:testosterone biosynthetic process; IEA:Ensembl
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0005509; F:calcium ion binding; IEA:InterPro
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0019899; F:enzyme binding; IPI:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0042802; F:identical protein binding; IPI:IntAct
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0005515; F:protein binding; IPI:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:BHF-UCL
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IDA:BHF-UCL
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0000983; F:RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0004871; F:signal transducer activity; IEA:InterPro
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0005164; F:tumor necrosis factor receptor binding; IPI:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0006915; P:apoptotic process; ISS:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0008015; P:blood circulation; ISS:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0035458; P:cellular response to interferon-beta; IMP:BHF-UCL
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0060333; P:interferon-gamma-mediated signaling pathway; ISS:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0007259; P:JAK-STAT cascade; IDA:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IEA:Ensembl
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0072162; P:metanephric mesenchymal cell differentiation; ISS:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0072136; P:metanephric mesenchymal cell proliferation involved in metanephros development; ISS:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0016525; P:negative regulation of angiogenesis; IMP:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0001937; P:negative regulation of endothelial cell proliferation; IMP:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0034240; P:negative regulation of macrophage fusion; IEA:Ensembl
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0003340; P:negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; ISS:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0072308; P:negative regulation of metanephric nephron tubule epithelial cell differentiation; ISS:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0002053; P:positive regulation of mesenchymal cell proliferation; ISS:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0048661; P:positive regulation of smooth muscle cell proliferation; ISS:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; TAS:Reactome
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0061326; P:renal tubule development; IMP:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0051591; P:response to cAMP; ISS:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0034097; P:response to cytokine; ISS:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0042493; P:response to drug; IEA:Ensembl
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0043330; P:response to exogenous dsRNA; IEA:Ensembl
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0007584; P:response to nutrient; IEA:Ensembl
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0043434; P:response to peptide hormone; ISS:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:GOC
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IDA:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0060337; P:type I interferon signaling pathway; ISS:UniProtKB
P42224	STAT1	Signal transducer and activator of transcription 1-alpha/beta	GO:0016032; P:viral process; IEA:UniProtKB-KW
P52630	STAT2	Signal transducer and activator of transcription 2	GO:0005509; F:calcium ion binding; IEA:InterPro
P52630	STAT2	Signal transducer and activator of transcription 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P52630	STAT2	Signal transducer and activator of transcription 2	GO:0042802; F:identical protein binding; IPI:IntAct
P52630	STAT2	Signal transducer and activator of transcription 2	GO:0005515; F:protein binding; IPI:IntAct
P52630	STAT2	Signal transducer and activator of transcription 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P52630	STAT2	Signal transducer and activator of transcription 2	GO:0004871; F:signal transducer activity; TAS:ProtInc
P52630	STAT2	Signal transducer and activator of transcription 2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P52630	STAT2	Signal transducer and activator of transcription 2	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
P52630	STAT2	Signal transducer and activator of transcription 2	GO:0007259; P:JAK-STAT cascade; TAS:ProtInc
P52630	STAT2	Signal transducer and activator of transcription 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P52630	STAT2	Signal transducer and activator of transcription 2	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P52630	STAT2	Signal transducer and activator of transcription 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P52630	STAT2	Signal transducer and activator of transcription 2	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
P52630	STAT2	Signal transducer and activator of transcription 2	GO:0016032; P:viral process; IEA:UniProtKB-KW
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0005509; F:calcium ion binding; IEA:InterPro
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0003677; F:DNA binding; ISS:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:BHF-UCL
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0005515; F:protein binding; IPI:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0046983; F:protein dimerization activity; ISS:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0019901; F:protein kinase binding; ISS:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:BHF-UCL
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0004871; F:signal transducer activity; TAS:ProtInc
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0006953; P:acute-phase response; IEA:Ensembl
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0048708; P:astrocyte differentiation; ISS:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0008283; P:cell proliferation; IEA:Ensembl
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0006928; P:cellular component movement; TAS:ProtInc
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0032870; P:cellular response to hormone stimulus; IDA:BHF-UCL
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0019221; P:cytokine-mediated signaling pathway; NAS:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0042755; P:eating behavior; ISS:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0001754; P:eye photoreceptor cell differentiation; ISS:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0042593; P:glucose homeostasis; ISS:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0060396; P:growth hormone receptor signaling pathway; IDA:BHF-UCL
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0070102; P:interleukin-6-mediated signaling pathway; IDA:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0030522; P:intracellular receptor signaling pathway; IDA:BHF-UCL
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0007259; P:JAK-STAT cascade; TAS:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; ISS:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0060548; P:negative regulation of cell death; IEA:Ensembl
P40763	STAT3	Signal transducer and activator of transcription 3	GO:2001223; P:negative regulation of neuron migration; IEA:Ensembl
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0007399; P:nervous system development; TAS:ProtInc
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0016310; P:phosphorylation; ISS:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0045747; P:positive regulation of Notch signaling pathway; ISS:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0006606; P:protein import into nucleus; IDA:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0060019; P:radial glial cell differentiation; ISS:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0042493; P:response to drug; IEA:Ensembl
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0032355; P:response to estradiol; IDA:BHF-UCL
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0045471; P:response to ethanol; IEA:Ensembl
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0019953; P:sexual reproduction; ISS:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0007165; P:signal transduction; TAS:ProtInc
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0019827; P:stem cell maintenance; IEA:Ensembl
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0001659; P:temperature homeostasis; ISS:UniProtKB
P40763	STAT3	Signal transducer and activator of transcription 3	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q14765	STAT4	Signal transducer and activator of transcription 4	GO:0005509; F:calcium ion binding; IEA:InterPro
Q14765	STAT4	Signal transducer and activator of transcription 4	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q14765	STAT4	Signal transducer and activator of transcription 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q14765	STAT4	Signal transducer and activator of transcription 4	GO:0004871; F:signal transducer activity; IEA:InterPro
Q14765	STAT4	Signal transducer and activator of transcription 4	GO:0008283; P:cell proliferation; IEA:Ensembl
Q14765	STAT4	Signal transducer and activator of transcription 4	GO:0019221; P:cytokine-mediated signaling pathway; IEA:Ensembl
Q14765	STAT4	Signal transducer and activator of transcription 4	GO:0007259; P:JAK-STAT cascade; TAS:ProtInc
Q14765	STAT4	Signal transducer and activator of transcription 4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q14765	STAT4	Signal transducer and activator of transcription 4	GO:0006468; P:protein phosphorylation; IEA:Ensembl
Q14765	STAT4	Signal transducer and activator of transcription 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0005509; F:calcium ion binding; IEA:InterPro
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0042802; F:identical protein binding; IPI:IntAct
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0005515; F:protein binding; IPI:IntAct
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0004871; F:signal transducer activity; IEA:InterPro
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl
P42226	STAT6	Signal transducer and activator of transcription 6	GO:1902170; P:cellular response to reactive nitrogen species; IEA:Ensembl
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0045087; P:innate immune response; TAS:Reactome
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0035771; P:interleukin-4-mediated signaling pathway; IMP:UniProtKB
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0033598; P:mammary gland epithelial cell proliferation; IEA:Ensembl
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0060443; P:mammary gland morphogenesis; IEA:Ensembl
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0002829; P:negative regulation of type 2 immune response; IEA:Ensembl
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0048295; P:positive regulation of isotype switching to IgE isotypes; IEA:Ensembl
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0007165; P:signal transduction; TAS:ProtInc
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0002296; P:T-helper 1 cell lineage commitment; IEA:Ensembl
P42226	STAT6	Signal transducer and activator of transcription 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P02808	STATH	Statherin	GO:0030197; F:extracellular matrix constituent, lubricant activity; NAS:UniProtKB
P02808	STATH	Statherin	GO:0046848; F:hydroxyapatite binding; NAS:UniProtKB
P02808	STATH	Statherin	GO:0005515; F:protein binding; IPI:UniProtKB
P02808	STATH	Statherin	GO:0030345; F:structural constituent of tooth enamel; NAS:UniProtKB
P02808	STATH	Statherin	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
P02808	STATH	Statherin	GO:0030502; P:negative regulation of bone mineralization; NAS:UniProtKB
P02808	STATH	Statherin	GO:0001503; P:ossification; TAS:ProtInc
P02808	STATH	Statherin	GO:0046541; P:saliva secretion; NAS:UniProtKB
O95793	STAU1	Double-stranded RNA-binding protein Staufen homolog 1	GO:0003725; F:double-stranded RNA binding; TAS:ProtInc
O95793	STAU1	Double-stranded RNA-binding protein Staufen homolog 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O95793	STAU1	Double-stranded RNA-binding protein Staufen homolog 1	GO:0005515; F:protein binding; IPI:IntAct
O95793	STAU1	Double-stranded RNA-binding protein Staufen homolog 1	GO:0008298; P:intracellular mRNA localization; IEA:Ensembl
Q9NUL3	STAU2	Double-stranded RNA-binding protein Staufen homolog 2	GO:0003725; F:double-stranded RNA binding; IDA:MGI
Q9NUL3	STAU2	Double-stranded RNA-binding protein Staufen homolog 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NUL3	STAU2	Double-stranded RNA-binding protein Staufen homolog 2	GO:0005515; F:protein binding; IPI:IntAct
Q9NUL3	STAU2	Double-stranded RNA-binding protein Staufen homolog 2	GO:0006810; P:transport; IEA:UniProtKB-KW
Q9Y2K9	STXBP5L	Syntaxin-binding protein 5-like	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q9Y2K9	STXBP5L	Syntaxin-binding protein 5-like	GO:0042593; P:glucose homeostasis; IEA:Ensembl
Q9Y2K9	STXBP5L	Syntaxin-binding protein 5-like	GO:0046676; P:negative regulation of insulin secretion; IEA:Ensembl
Q9Y2K9	STXBP5L	Syntaxin-binding protein 5-like	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9Y2K9	STXBP5L	Syntaxin-binding protein 5-like	GO:0017157; P:regulation of exocytosis; IEA:Ensembl
O95210	STBD1	Starch-binding domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
O95210	STBD1	Starch-binding domain-containing protein 1	GO:2001070; F:starch binding; IEA:InterPro
O95210	STBD1	Starch-binding domain-containing protein 1	GO:0006936; P:muscle contraction; TAS:ProtInc
P52823	STC1	Stanniocalcin-1	GO:0005179; F:hormone activity; TAS:ProtInc
P52823	STC1	Stanniocalcin-1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P52823	STC1	Stanniocalcin-1	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P52823	STC1	Stanniocalcin-1	GO:0006874; P:cellular calcium ion homeostasis; TAS:ProtInc
P52823	STC1	Stanniocalcin-1	GO:0071320; P:cellular response to cAMP; IEA:Ensembl
P52823	STC1	Stanniocalcin-1	GO:0071385; P:cellular response to glucocorticoid stimulus; IEA:Ensembl
P52823	STC1	Stanniocalcin-1	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
P52823	STC1	Stanniocalcin-1	GO:0046697; P:decidualization; IEA:Ensembl
P52823	STC1	Stanniocalcin-1	GO:0007566; P:embryo implantation; IEA:Ensembl
P52823	STC1	Stanniocalcin-1	GO:0001503; P:ossification; IEA:Ensembl
P52823	STC1	Stanniocalcin-1	GO:0007584; P:response to nutrient; TAS:ProtInc
P52823	STC1	Stanniocalcin-1	GO:0033280; P:response to vitamin D; IEA:Ensembl
O76061	STC2	Stanniocalcin-2	GO:0005179; F:hormone activity; TAS:ProtInc
O76061	STC2	Stanniocalcin-2	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
O76061	STC2	Stanniocalcin-2	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O76061	STC2	Stanniocalcin-2	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
O76061	STC2	Stanniocalcin-2	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
O76061	STC2	Stanniocalcin-2	GO:0046697; P:decidualization; IEA:Ensembl
O76061	STC2	Stanniocalcin-2	GO:0007566; P:embryo implantation; IEA:Ensembl
O76061	STC2	Stanniocalcin-2	GO:0030968; P:endoplasmic reticulum unfolded protein response; IEA:Ensembl
O76061	STC2	Stanniocalcin-2	GO:0040015; P:negative regulation of multicellular organism growth; IEA:Ensembl
O76061	STC2	Stanniocalcin-2	GO:2001256; P:regulation of store-operated calcium entry; IEA:Ensembl
O76061	STC2	Stanniocalcin-2	GO:0007584; P:response to nutrient; TAS:ProtInc
O76061	STC2	Stanniocalcin-2	GO:0006979; P:response to oxidative stress; IEA:Ensembl
O76061	STC2	Stanniocalcin-2	GO:0043434; P:response to peptide hormone; IEA:Ensembl
O76061	STC2	Stanniocalcin-2	GO:0033280; P:response to vitamin D; IEA:Ensembl
Q9UHE8	STEAP1	Metalloreductase STEAP1	GO:0015267; F:channel activity; TAS:ProtInc
Q9UHE8	STEAP1	Metalloreductase STEAP1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UHE8	STEAP1	Metalloreductase STEAP1	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q9UHE8	STEAP1	Metalloreductase STEAP1	GO:0005215; F:transporter activity; TAS:ProtInc
Q9UHE8	STEAP1	Metalloreductase STEAP1	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q9UHE8	STEAP1	Metalloreductase STEAP1	GO:0055072; P:iron ion homeostasis; IEA:UniProtKB-KW
Q9UHE8	STEAP1	Metalloreductase STEAP1	GO:0055085; P:transmembrane transport; TAS:GOC
Q8NFT2	STEAP2	Metalloreductase STEAP2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NFT2	STEAP2	Metalloreductase STEAP2	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q8NFT2	STEAP2	Metalloreductase STEAP2	GO:0005215; F:transporter activity; IDA:UniProtKB
Q8NFT2	STEAP2	Metalloreductase STEAP2	GO:0006897; P:endocytosis; IDA:UniProtKB
Q8NFT2	STEAP2	Metalloreductase STEAP2	GO:0006893; P:Golgi to plasma membrane transport; IDA:UniProtKB
Q8NFT2	STEAP2	Metalloreductase STEAP2	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q8NFT2	STEAP2	Metalloreductase STEAP2	GO:0055072; P:iron ion homeostasis; IEA:UniProtKB-KW
Q8NFT2	STEAP2	Metalloreductase STEAP2	GO:0045055; P:regulated secretory pathway; IDA:UniProtKB
Q8NFT2	STEAP2	Metalloreductase STEAP2	GO:0009725; P:response to hormone; IDA:UniProtKB
Q658P3	STEAP3	Metalloreductase STEAP3	GO:0000293; F:ferric-chelate reductase activity; IEA:Ensembl
Q658P3	STEAP3	Metalloreductase STEAP3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q658P3	STEAP3	Metalloreductase STEAP3	GO:0005515; F:protein binding; IPI:UniProtKB
Q658P3	STEAP3	Metalloreductase STEAP3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q658P3	STEAP3	Metalloreductase STEAP3	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q658P3	STEAP3	Metalloreductase STEAP3	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
Q658P3	STEAP3	Metalloreductase STEAP3	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q658P3	STEAP3	Metalloreductase STEAP3	GO:0009306; P:protein secretion; IMP:UniProtKB
Q658P3	STEAP3	Metalloreductase STEAP3	GO:0033572; P:transferrin transport; TAS:Reactome
Q658P3	STEAP3	Metalloreductase STEAP3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q687X5	STEAP4	Metalloreductase STEAP4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q687X5	STEAP4	Metalloreductase STEAP4	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q687X5	STEAP4	Metalloreductase STEAP4	GO:0045444; P:fat cell differentiation; ISS:UniProtKB
Q687X5	STEAP4	Metalloreductase STEAP4	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q687X5	STEAP4	Metalloreductase STEAP4	GO:0055072; P:iron ion homeostasis; IEA:UniProtKB-KW
Q13285	NR5A1	Steroidogenic factor 1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q13285	NR5A1	Steroidogenic factor 1	GO:0003677; F:DNA binding; IDA:UniProtKB
Q13285	NR5A1	Steroidogenic factor 1	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
Q13285	NR5A1	Steroidogenic factor 1	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q13285	NR5A1	Steroidogenic factor 1	GO:0004879; F:ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; TAS:ProtInc
Q13285	NR5A1	Steroidogenic factor 1	GO:0005543; F:phospholipid binding; IDA:UniProtKB
Q13285	NR5A1	Steroidogenic factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13285	NR5A1	Steroidogenic factor 1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q13285	NR5A1	Steroidogenic factor 1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q13285	NR5A1	Steroidogenic factor 1	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
Q13285	NR5A1	Steroidogenic factor 1	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q13285	NR5A1	Steroidogenic factor 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13285	NR5A1	Steroidogenic factor 1	GO:0030325; P:adrenal gland development; IEA:Ensembl
Q13285	NR5A1	Steroidogenic factor 1	GO:0030154; P:cell differentiation; IEA:Ensembl
Q13285	NR5A1	Steroidogenic factor 1	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q13285	NR5A1	Steroidogenic factor 1	GO:0010467; P:gene expression; TAS:Reactome
Q13285	NR5A1	Steroidogenic factor 1	GO:0042445; P:hormone metabolic process; IEA:Ensembl
Q13285	NR5A1	Steroidogenic factor 1	GO:0030522; P:intracellular receptor signaling pathway; TAS:GOC
Q13285	NR5A1	Steroidogenic factor 1	GO:0001553; P:luteinization; IEA:Ensembl
Q13285	NR5A1	Steroidogenic factor 1	GO:0051457; P:maintenance of protein location in nucleus; IEA:Ensembl
Q13285	NR5A1	Steroidogenic factor 1	GO:0008584; P:male gonad development; TAS:ProtInc
Q13285	NR5A1	Steroidogenic factor 1	GO:0010259; P:multicellular organismal aging; IEA:Ensembl
Q13285	NR5A1	Steroidogenic factor 1	GO:2000195; P:negative regulation of female gonad development; IEA:Ensembl
Q13285	NR5A1	Steroidogenic factor 1	GO:2000020; P:positive regulation of male gonad development; IDA:UniProtKB
Q13285	NR5A1	Steroidogenic factor 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q13285	NR5A1	Steroidogenic factor 1	GO:0007538; P:primary sex determination; TAS:ProtInc
Q13285	NR5A1	Steroidogenic factor 1	GO:0050810; P:regulation of steroid biosynthetic process; TAS:UniProtKB
Q13285	NR5A1	Steroidogenic factor 1	GO:0009888; P:tissue development; IEA:Ensembl
Q13285	NR5A1	Steroidogenic factor 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q15468	STIL	SCL-interrupting locus protein	GO:0005515; F:protein binding; IPI:IntAct
Q15468	STIL	SCL-interrupting locus protein	GO:0008283; P:cell proliferation; TAS:ProtInc
Q15468	STIL	SCL-interrupting locus protein	GO:0007368; P:determination of left/right symmetry; ISS:BHF-UCL
Q15468	STIL	SCL-interrupting locus protein	GO:0000578; P:embryonic axis specification; ISS:BHF-UCL
Q15468	STIL	SCL-interrupting locus protein	GO:0033504; P:floor plate development; ISS:BHF-UCL
Q15468	STIL	SCL-interrupting locus protein	GO:0030900; P:forebrain development; ISS:BHF-UCL
Q15468	STIL	SCL-interrupting locus protein	GO:0001947; P:heart looping; ISS:BHF-UCL
Q15468	STIL	SCL-interrupting locus protein	GO:0001701; P:in utero embryonic development; ISS:BHF-UCL
Q15468	STIL	SCL-interrupting locus protein	GO:0035264; P:multicellular organism growth; ISS:BHF-UCL
Q15468	STIL	SCL-interrupting locus protein	GO:0043066; P:negative regulation of apoptotic process; ISS:BHF-UCL
Q15468	STIL	SCL-interrupting locus protein	GO:0001843; P:neural tube closure; ISS:BHF-UCL
Q15468	STIL	SCL-interrupting locus protein	GO:0021915; P:neural tube development; ISS:BHF-UCL
Q15468	STIL	SCL-interrupting locus protein	GO:0030903; P:notochord development; ISS:BHF-UCL
Q15468	STIL	SCL-interrupting locus protein	GO:0007224; P:smoothened signaling pathway; ISS:BHF-UCL
Q13586	STIM1	Stromal interaction molecule 1	GO:0005246; F:calcium channel regulator activity; IEA:Ensembl
Q13586	STIM1	Stromal interaction molecule 1	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q13586	STIM1	Stromal interaction molecule 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q13586	STIM1	Stromal interaction molecule 1	GO:0051010; F:microtubule plus-end binding; IDA:UniProtKB
Q13586	STIM1	Stromal interaction molecule 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13586	STIM1	Stromal interaction molecule 1	GO:0015279; F:store-operated calcium channel activity; IEA:Ensembl
Q13586	STIM1	Stromal interaction molecule 1	GO:0032237; P:activation of store-operated calcium channel activity; IDA:UniProtKB
Q13586	STIM1	Stromal interaction molecule 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q13586	STIM1	Stromal interaction molecule 1	GO:0005513; P:detection of calcium ion; IDA:UniProtKB
Q13586	STIM1	Stromal interaction molecule 1	GO:0051924; P:regulation of calcium ion transport; IDA:UniProtKB
Q13586	STIM1	Stromal interaction molecule 1	GO:2001256; P:regulation of store-operated calcium entry; IEA:Ensembl
Q13586	STIM1	Stromal interaction molecule 1	GO:0002115; P:store-operated calcium entry; IEA:Ensembl
Q9P246	STIM2	Stromal interaction molecule 2	GO:0005246; F:calcium channel regulator activity; IMP:UniProtKB
Q9P246	STIM2	Stromal interaction molecule 2	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q9P246	STIM2	Stromal interaction molecule 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P246	STIM2	Stromal interaction molecule 2	GO:0015279; F:store-operated calcium channel activity; IDA:UniProtKB
Q9P246	STIM2	Stromal interaction molecule 2	GO:0032237; P:activation of store-operated calcium channel activity; IDA:UniProtKB
Q9P246	STIM2	Stromal interaction molecule 2	GO:0070588; P:calcium ion transmembrane transport; IDA:GOC
Q9P246	STIM2	Stromal interaction molecule 2	GO:0006874; P:cellular calcium ion homeostasis; IMP:UniProtKB
Q9P246	STIM2	Stromal interaction molecule 2	GO:0051928; P:positive regulation of calcium ion transport; IDA:UniProtKB
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0035438; F:cyclic-di-GMP binding; IDA:UniProtKB
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0061507; F:cyclic-GMP-AMP binding; ISS:UniProtKB
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0042802; F:identical protein binding; IPI:IntAct
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0008134; F:transcription factor binding; IDA:BHF-UCL
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0002218; P:activation of innate immune response; IMP:BHF-UCL
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0071360; P:cellular response to exogenous dsRNA; IMP:BHF-UCL
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0035458; P:cellular response to interferon-beta; IEA:Ensembl
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0051607; P:defense response to virus; IDA:UniProtKB
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0045087; P:innate immune response; IDA:UniProtKB
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0032608; P:interferon-beta production; IDA:UniProtKB
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0002230; P:positive regulation of defense response to virus by host; IMP:BHF-UCL
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0032092; P:positive regulation of protein binding; IDA:BHF-UCL
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0033160; P:positive regulation of protein import into nucleus, translocation; IDA:BHF-UCL
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0042993; P:positive regulation of transcription factor import into nucleus; IDA:BHF-UCL
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q86WV6	TMEM173	Stimulator of interferon genes protein	GO:0032479; P:regulation of type I interferon production; TAS:Reactome
P31948	STIP1	Stress-induced-phosphoprotein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P31948	STIP1	Stress-induced-phosphoprotein 1	GO:0005515; F:protein binding; IPI:IntAct
P31948	STIP1	Stress-induced-phosphoprotein 1	GO:0006950; P:response to stress; TAS:ProtInc
O94804	STK10	Serine/threonine-protein kinase 10	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O94804	STK10	Serine/threonine-protein kinase 10	GO:0042802; F:identical protein binding; IPI:IntAct
O94804	STK10	Serine/threonine-protein kinase 10	GO:0042801; F:polo kinase kinase activity; TAS:UniProtKB
O94804	STK10	Serine/threonine-protein kinase 10	GO:0005515; F:protein binding; IPI:UniProtKB
O94804	STK10	Serine/threonine-protein kinase 10	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O94804	STK10	Serine/threonine-protein kinase 10	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
O94804	STK10	Serine/threonine-protein kinase 10	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
O94804	STK10	Serine/threonine-protein kinase 10	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
O94804	STK10	Serine/threonine-protein kinase 10	GO:0071593; P:lymphocyte aggregation; IEA:Ensembl
O94804	STK10	Serine/threonine-protein kinase 10	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
O94804	STK10	Serine/threonine-protein kinase 10	GO:0006468; P:protein phosphorylation; TAS:ProtInc
O94804	STK10	Serine/threonine-protein kinase 10	GO:2000401; P:regulation of lymphocyte migration; IMP:UniProtKB
O94804	STK10	Serine/threonine-protein kinase 10	GO:0023014; P:signal transduction by phosphorylation; IBA:GOC
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0005524; F:ATP binding; IDA:UniProtKB
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0002039; F:p53 binding; IDA:UniProtKB
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0005515; F:protein binding; IPI:UniProtKB
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0030295; F:protein kinase activator activity; IDA:UniProtKB
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0032147; P:activation of protein kinase activity; IDA:MGI
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0043276; P:anoikis; IMP:BHF-UCL
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0007409; P:axonogenesis; IEA:Ensembl
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0007050; P:cell cycle arrest; IDA:UniProtKB
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0006974; P:cellular response to DNA damage stimulus; IEA:UniProtKB-KW
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0030010; P:establishment of cell polarity; ISS:UniProtKB
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0042593; P:glucose homeostasis; ISS:UniProtKB
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0051645; P:Golgi localization; IEA:Ensembl
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IDA:UniProtKB
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0030308; P:negative regulation of cell growth; ISS:UniProtKB
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0060770; P:negative regulation of epithelial cell proliferation involved in prostate gland development; IEA:Ensembl
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0050772; P:positive regulation of axonogenesis; IEA:Ensembl
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0045722; P:positive regulation of gluconeogenesis; IEA:Ensembl
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IMP:BHF-UCL
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0045059; P:positive thymic T cell selection; IEA:Ensembl
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0001558; P:regulation of cell growth; ISS:UniProtKB
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0042304; P:regulation of fatty acid biosynthetic process; TAS:Reactome
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0051896; P:regulation of protein kinase B signaling; IEA:Ensembl
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0030111; P:regulation of Wnt signaling pathway; IEA:Ensembl
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0033762; P:response to glucagon; IEA:Ensembl
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0010212; P:response to ionizing radiation; ISS:UniProtKB
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0033993; P:response to lipid; IEA:Ensembl
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0007286; P:spermatid development; IEA:Ensembl
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0050852; P:T cell receptor signaling pathway; IEA:Ensembl
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0036399; P:TCR signalosome assembly; IEA:Ensembl
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0001894; P:tissue homeostasis; IEA:Ensembl
Q15831	STK11	Serine/threonine-protein kinase STK11	GO:0001944; P:vasculature development; ISS:UniProtKB
O75716	STK16	Serine/threonine-protein kinase 16	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75716	STK16	Serine/threonine-protein kinase 16	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC
O75716	STK16	Serine/threonine-protein kinase 16	GO:0005515; F:protein binding; IPI:UniProtKB
O75716	STK16	Serine/threonine-protein kinase 16	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
O75716	STK16	Serine/threonine-protein kinase 16	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
O75716	STK16	Serine/threonine-protein kinase 16	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEA:Ensembl
O75716	STK16	Serine/threonine-protein kinase 16	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P49842	STK19	Serine/threonine-protein kinase 19	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49842	STK19	Serine/threonine-protein kinase 19	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
P49842	STK19	Serine/threonine-protein kinase 19	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q9Y6E0	STK24	Serine/threonine-protein kinase 24	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y6E0	STK24	Serine/threonine-protein kinase 24	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y6E0	STK24	Serine/threonine-protein kinase 24	GO:0005515; F:protein binding; IPI:IntAct
Q9Y6E0	STK24	Serine/threonine-protein kinase 24	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q9Y6E0	STK24	Serine/threonine-protein kinase 24	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9Y6E0	STK24	Serine/threonine-protein kinase 24	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
Q9Y6E0	STK24	Serine/threonine-protein kinase 24	GO:0006915; P:apoptotic process; TAS:Reactome
Q9Y6E0	STK24	Serine/threonine-protein kinase 24	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q9Y6E0	STK24	Serine/threonine-protein kinase 24	GO:0097194; P:execution phase of apoptosis; IMP:UniProtKB
Q9Y6E0	STK24	Serine/threonine-protein kinase 24	GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IMP:UniProtKB
Q9Y6E0	STK24	Serine/threonine-protein kinase 24	GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB
Q9Y6E0	STK24	Serine/threonine-protein kinase 24	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q9Y6E0	STK24	Serine/threonine-protein kinase 24	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9Y6E0	STK24	Serine/threonine-protein kinase 24	GO:0048679; P:regulation of axon regeneration; IMP:UniProtKB
Q9Y6E0	STK24	Serine/threonine-protein kinase 24	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y6E0	STK24	Serine/threonine-protein kinase 24	GO:0023014; P:signal transduction by phosphorylation; IBA:GOC
O00506	STK25	Serine/threonine-protein kinase 25	GO:0005524; F:ATP binding; IEA:InterPro
O00506	STK25	Serine/threonine-protein kinase 25	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O00506	STK25	Serine/threonine-protein kinase 25	GO:0005515; F:protein binding; IPI:IntAct
O00506	STK25	Serine/threonine-protein kinase 25	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O00506	STK25	Serine/threonine-protein kinase 25	GO:0004672; F:protein kinase activity; IEA:InterPro
O00506	STK25	Serine/threonine-protein kinase 25	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
O00506	STK25	Serine/threonine-protein kinase 25	GO:0006915; P:apoptotic process; IBA:RefGenome
O00506	STK25	Serine/threonine-protein kinase 25	GO:0007163; P:establishment or maintenance of cell polarity; IEA:Ensembl
O00506	STK25	Serine/threonine-protein kinase 25	GO:0051645; P:Golgi localization; IEA:Ensembl
O00506	STK25	Serine/threonine-protein kinase 25	GO:0050772; P:positive regulation of axonogenesis; IEA:Ensembl
O00506	STK25	Serine/threonine-protein kinase 25	GO:0045595; P:regulation of cell differentiation; IBA:RefGenome
O00506	STK25	Serine/threonine-protein kinase 25	GO:0006979; P:response to oxidative stress; TAS:ProtInc
O00506	STK25	Serine/threonine-protein kinase 25	GO:0007165; P:signal transduction; TAS:ProtInc
O00506	STK25	Serine/threonine-protein kinase 25	GO:0023014; P:signal transduction by phosphorylation; IBA:GOC
Q9BXU1	STK31	Serine/threonine-protein kinase 31	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BXU1	STK31	Serine/threonine-protein kinase 31	GO:0016788; F:hydrolase activity, acting on ester bonds; IEA:InterPro
Q9BXU1	STK31	Serine/threonine-protein kinase 31	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9BXU1	STK31	Serine/threonine-protein kinase 31	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q9BYT3	STK33	Serine/threonine-protein kinase 33	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BYT3	STK33	Serine/threonine-protein kinase 33	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB
Q9BYT3	STK33	Serine/threonine-protein kinase 33	GO:0046777; P:protein autophosphorylation; ISS:UniProtKB
Q8TDR2	STK35	Serine/threonine-protein kinase 35	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8TDR2	STK35	Serine/threonine-protein kinase 35	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q9NRP7	STK36	Serine/threonine-protein kinase 36	GO:0005524; F:ATP binding; TAS:UniProtKB
Q9NRP7	STK36	Serine/threonine-protein kinase 36	GO:0000287; F:magnesium ion binding; IC:UniProtKB
Q9NRP7	STK36	Serine/threonine-protein kinase 36	GO:0005515; F:protein binding; IPI:IntAct
Q9NRP7	STK36	Serine/threonine-protein kinase 36	GO:0004674; F:protein serine/threonine kinase activity; TAS:UniProtKB
Q9NRP7	STK36	Serine/threonine-protein kinase 36	GO:0008134; F:transcription factor binding; IDA:UniProtKB
Q9NRP7	STK36	Serine/threonine-protein kinase 36	GO:0007420; P:brain development; IEA:Ensembl
Q9NRP7	STK36	Serine/threonine-protein kinase 36	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q9NRP7	STK36	Serine/threonine-protein kinase 36	GO:0003351; P:epithelial cilium movement; IEA:Ensembl
Q9NRP7	STK36	Serine/threonine-protein kinase 36	GO:0007228; P:positive regulation of hh target transcription factor activity; ISS:UniProtKB
Q9NRP7	STK36	Serine/threonine-protein kinase 36	GO:0045880; P:positive regulation of smoothened signaling pathway; ISS:UniProtKB
Q9NRP7	STK36	Serine/threonine-protein kinase 36	GO:0009791; P:post-embryonic development; ISS:UniProtKB
Q9NRP7	STK36	Serine/threonine-protein kinase 36	GO:0006468; P:protein phosphorylation; TAS:UniProtKB
Q9NRP7	STK36	Serine/threonine-protein kinase 36	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q15208	STK38	Serine/threonine-protein kinase 38	GO:0005524; F:ATP binding; IDA:UniProtKB
Q15208	STK38	Serine/threonine-protein kinase 38	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q15208	STK38	Serine/threonine-protein kinase 38	GO:0031435; F:mitogen-activated protein kinase kinase kinase binding; IPI:UniProtKB
Q15208	STK38	Serine/threonine-protein kinase 38	GO:0005515; F:protein binding; IPI:UniProtKB
Q15208	STK38	Serine/threonine-protein kinase 38	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q15208	STK38	Serine/threonine-protein kinase 38	GO:0006464; P:cellular protein modification process; IDA:ProtInc
Q15208	STK38	Serine/threonine-protein kinase 38	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q15208	STK38	Serine/threonine-protein kinase 38	GO:0043407; P:negative regulation of MAP kinase activity; IDA:UniProtKB
Q15208	STK38	Serine/threonine-protein kinase 38	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9UEW8	STK39	STE20/SPS1-related proline-alanine-rich protein kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UEW8	STK39	STE20/SPS1-related proline-alanine-rich protein kinase	GO:0005515; F:protein binding; IPI:IntAct
Q9UEW8	STK39	STE20/SPS1-related proline-alanine-rich protein kinase	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; NAS:UniProtKB
Q9UEW8	STK39	STE20/SPS1-related proline-alanine-rich protein kinase	GO:0043268; P:positive regulation of potassium ion transport; IEA:Ensembl
Q9UEW8	STK39	STE20/SPS1-related proline-alanine-rich protein kinase	GO:0006468; P:protein phosphorylation; NAS:UniProtKB
Q9UEW8	STK39	STE20/SPS1-related proline-alanine-rich protein kinase	GO:0050727; P:regulation of inflammatory response; IEA:Ensembl
Q9UEW8	STK39	STE20/SPS1-related proline-alanine-rich protein kinase	GO:0006950; P:response to stress; NAS:UniProtKB
Q9UEW8	STK39	STE20/SPS1-related proline-alanine-rich protein kinase	GO:0023014; P:signal transduction by phosphorylation; NAS:GOC
Q13188	STK3	Serine/threonine-protein kinase 3	GO:0005524; F:ATP binding; IDA:UniProtKB
Q13188	STK3	Serine/threonine-protein kinase 3	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q13188	STK3	Serine/threonine-protein kinase 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q13188	STK3	Serine/threonine-protein kinase 3	GO:0046983; F:protein dimerization activity; ISS:UniProtKB
Q13188	STK3	Serine/threonine-protein kinase 3	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q13188	STK3	Serine/threonine-protein kinase 3	GO:0043539; F:protein serine/threonine kinase activator activity; TAS:BHF-UCL
Q13188	STK3	Serine/threonine-protein kinase 3	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q13188	STK3	Serine/threonine-protein kinase 3	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
Q13188	STK3	Serine/threonine-protein kinase 3	GO:0006915; P:apoptotic process; TAS:UniProtKB
Q13188	STK3	Serine/threonine-protein kinase 3	GO:0035329; P:hippo signaling; TAS:UniProtKB
Q13188	STK3	Serine/threonine-protein kinase 3	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q13188	STK3	Serine/threonine-protein kinase 3	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
Q13188	STK3	Serine/threonine-protein kinase 3	GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB
Q13188	STK3	Serine/threonine-protein kinase 3	GO:0071902; P:positive regulation of protein serine/threonine kinase activity; TAS:GOC
Q13188	STK3	Serine/threonine-protein kinase 3	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q13188	STK3	Serine/threonine-protein kinase 3	GO:0007165; P:signal transduction; TAS:ProtInc
Q13188	STK3	Serine/threonine-protein kinase 3	GO:0023014; P:signal transduction by phosphorylation; IBA:GOC
Q8N2I9	STK40	Serine/threonine-protein kinase 40	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8N2I9	STK40	Serine/threonine-protein kinase 40	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N2I9	STK40	Serine/threonine-protein kinase 40	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0005524; F:ATP binding; IDA:UniProtKB
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0042802; F:identical protein binding; IPI:IntAct
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0046983; F:protein dimerization activity; IDA:UniProtKB
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0042803; F:protein homodimerization activity; IDA:MGI
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0043539; F:protein serine/threonine kinase activator activity; TAS:BHF-UCL
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0006915; P:apoptotic process; IDA:UniProtKB
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0060706; P:cell differentiation involved in embryonic placenta development; IEA:Ensembl
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0000902; P:cell morphogenesis; IDA:MGI
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0007417; P:central nervous system development; IEA:Ensembl
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0003157; P:endocardium development; IEA:Ensembl
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0097284; P:hepatocyte apoptotic process; IEA:Ensembl
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0035329; P:hippo signaling; TAS:UniProtKB
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0046621; P:negative regulation of organ growth; IEA:Ensembl
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0001841; P:neural tube formation; IEA:Ensembl
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0001569; P:patterning of blood vessels; IEA:Ensembl
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q13043	STK4	Serine/threonine-protein kinase 4	GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0071902; P:positive regulation of protein serine/threonine kinase activity; TAS:GOC
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0060215; P:primitive hemopoiesis; IEA:Ensembl
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0046777; P:protein autophosphorylation; IDA:MGI
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0007165; P:signal transduction; TAS:ProtInc
Q13043	STK4	Serine/threonine-protein kinase 4	GO:0023014; P:signal transduction by phosphorylation; IBA:GOC
H3BQB6	STMND1	Stathmin domain-containing protein 1	GO:0031110; P:regulation of microtubule polymerization or depolymerization; IEA:InterPro
Q9UBI4	STOML1	Stomatin-like protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9UBI4	STOML1	Stomatin-like protein 1	GO:0032934; F:sterol binding; IEA:InterPro
Q8TAV4	STOML3	Stomatin-like protein 3	GO:0007165; P:signal transduction; IEA:Ensembl
Q9UJZ1	STOML2	Stomatin-like protein 2, mitochondrial	GO:1901612; F:cardiolipin binding; IDA:UniProtKB
Q9UJZ1	STOML2	Stomatin-like protein 2, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UJZ1	STOML2	Stomatin-like protein 2, mitochondrial	GO:0005102; F:receptor binding; TAS:ProtInc
Q9UJZ1	STOML2	Stomatin-like protein 2, mitochondrial	GO:0035710; P:CD4-positive, alpha-beta T cell activation; ISS:UniProtKB
Q9UJZ1	STOML2	Stomatin-like protein 2, mitochondrial	GO:0006874; P:cellular calcium ion homeostasis; IMP:UniProtKB
Q9UJZ1	STOML2	Stomatin-like protein 2, mitochondrial	GO:0032623; P:interleukin-2 production; ISS:UniProtKB
Q9UJZ1	STOML2	Stomatin-like protein 2, mitochondrial	GO:0010876; P:lipid localization; ISS:UniProtKB
Q9UJZ1	STOML2	Stomatin-like protein 2, mitochondrial	GO:0042776; P:mitochondrial ATP synthesis coupled proton transport; IMP:UniProtKB
Q9UJZ1	STOML2	Stomatin-like protein 2, mitochondrial	GO:0006851; P:mitochondrial calcium ion transport; IMP:UniProtKB
Q9UJZ1	STOML2	Stomatin-like protein 2, mitochondrial	GO:0034982; P:mitochondrial protein processing; ISS:UniProtKB
Q9UJZ1	STOML2	Stomatin-like protein 2, mitochondrial	GO:0007005; P:mitochondrion organization; IMP:UniProtKB
Q9UJZ1	STOML2	Stomatin-like protein 2, mitochondrial	GO:1900210; P:positive regulation of cardiolipin metabolic process; IMP:UniProtKB
Q9UJZ1	STOML2	Stomatin-like protein 2, mitochondrial	GO:0090297; P:positive regulation of mitochondrial DNA replication; IMP:UniProtKB
Q9UJZ1	STOML2	Stomatin-like protein 2, mitochondrial	GO:0010918; P:positive regulation of mitochondrial membrane potential; IMP:UniProtKB
Q9UJZ1	STOML2	Stomatin-like protein 2, mitochondrial	GO:0051259; P:protein oligomerization; IDA:UniProtKB
Q9UJZ1	STOML2	Stomatin-like protein 2, mitochondrial	GO:1990046; P:stress-induced mitochondrial fusion; ISS:UniProtKB
Q9UJZ1	STOML2	Stomatin-like protein 2, mitochondrial	GO:0050852; P:T cell receptor signaling pathway; IMP:UniProtKB
P16949	STMN1	Stathmin	GO:0004871; F:signal transducer activity; TAS:ProtInc
P16949	STMN1	Stathmin	GO:0015631; F:tubulin binding; IDA:MGI
P16949	STMN1	Stathmin	GO:0007409; P:axonogenesis; IEA:Ensembl
P16949	STMN1	Stathmin	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
P16949	STMN1	Stathmin	GO:0007019; P:microtubule depolymerization; IDA:MGI
P16949	STMN1	Stathmin	GO:0007052; P:mitotic spindle organization; IDA:MGI
P16949	STMN1	Stathmin	GO:0031115; P:negative regulation of microtubule polymerization; IEA:Ensembl
P16949	STMN1	Stathmin	GO:0051272; P:positive regulation of cellular component movement; IEA:Ensembl
P16949	STMN1	Stathmin	GO:0009615; P:response to virus; IEP:UniProtKB
P16949	STMN1	Stathmin	GO:0007165; P:signal transduction; NAS:ProtInc
Q93045	STMN2	Stathmin-2	GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB
Q93045	STMN2	Stathmin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q93045	STMN2	Stathmin-2	GO:1990090; P:cellular response to nerve growth factor stimulus; IDA:UniProtKB
Q93045	STMN2	Stathmin-2	GO:0007026; P:negative regulation of microtubule depolymerization; IDA:UniProtKB
Q93045	STMN2	Stathmin-2	GO:0031115; P:negative regulation of microtubule polymerization; IDA:UniProtKB
Q93045	STMN2	Stathmin-2	GO:0010977; P:negative regulation of neuron projection development; IDA:UniProtKB
Q93045	STMN2	Stathmin-2	GO:0031117; P:positive regulation of microtubule depolymerization; IDA:UniProtKB
Q93045	STMN2	Stathmin-2	GO:0010976; P:positive regulation of neuron projection development; IDA:UniProtKB
Q9NZ72	STMN3	Stathmin-3	GO:0019904; F:protein domain specific binding; ISS:HGNC
Q9NZ72	STMN3	Stathmin-3	GO:0031122; P:cytoplasmic microtubule organization; ISS:HGNC
Q9NZ72	STMN3	Stathmin-3	GO:0035021; P:negative regulation of Rac protein signal transduction; ISS:HGNC
Q9NZ72	STMN3	Stathmin-3	GO:0007399; P:nervous system development; TAS:ProtInc
Q9NZ72	STMN3	Stathmin-3	GO:0031175; P:neuron projection development; ISS:HGNC
Q9NZ72	STMN3	Stathmin-3	GO:0051493; P:regulation of cytoskeleton organization; ISS:HGNC
Q9NZ72	STMN3	Stathmin-3	GO:0031110; P:regulation of microtubule polymerization or depolymerization; IEA:InterPro
Q9NZ72	STMN3	Stathmin-3	GO:0032314; P:regulation of Rac GTPase activity; ISS:HGNC
Q9H169	STMN4	Stathmin-4	GO:0031110; P:regulation of microtubule polymerization or depolymerization; IEA:InterPro
Q9H668	OBFC1	CST complex subunit STN1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H668	OBFC1	CST complex subunit STN1	GO:0003697; F:single-stranded DNA binding; ISS:UniProtKB
Q9H668	OBFC1	CST complex subunit STN1	GO:0043047; F:single-stranded telomeric DNA binding; IDA:UniProtKB
Q9H668	OBFC1	CST complex subunit STN1	GO:0045740; P:positive regulation of DNA replication; ISS:UniProtKB
Q9H668	OBFC1	CST complex subunit STN1	GO:0000723; P:telomere maintenance; IMP:UniProtKB
Q9H668	OBFC1	CST complex subunit STN1	GO:0010833; P:telomere maintenance via telomere lengthening; IMP:UniProtKB
P27105	STOM	Erythrocyte band 7 integral membrane protein	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
Q8WXE9	STON2	Stonin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WXE9	STON2	Stonin-2	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q8WXE9	STON2	Stonin-2	GO:0030100; P:regulation of endocytosis; ISS:UniProtKB
Q8WXE9	STON2	Stonin-2	GO:0048488; P:synaptic vesicle endocytosis; IGI:UniProtKB
Q9Y6Q2	STON1	Stonin-1	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q9Y6Q2	STON1	Stonin-1	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9Y6Q2	STON1	Stonin-1	GO:0030100; P:regulation of endocytosis; IDA:UniProtKB
Q6ZVD7	STOX1	Storkhead-box protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9P2F5	STOX2	Storkhead-box protein 2	GO:0009790; P:embryo development; IEP:UniProtKB
Q9P2F5	STOX2	Storkhead-box protein 2	GO:0001893; P:maternal placenta development; IEP:UniProtKB
P09430	TNP1	Spermatid nuclear transition protein 1	GO:0003677; F:DNA binding; IMP:UniProtKB
P09430	TNP1	Spermatid nuclear transition protein 1	GO:0006338; P:chromatin remodeling; IDA:UniProtKB
P09430	TNP1	Spermatid nuclear transition protein 1	GO:0006342; P:chromatin silencing; IEP:UniProtKB
P09430	TNP1	Spermatid nuclear transition protein 1	GO:0035042; P:fertilization, exchange of chromosomal proteins; TAS:UniProtKB
P09430	TNP1	Spermatid nuclear transition protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P09430	TNP1	Spermatid nuclear transition protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P09430	TNP1	Spermatid nuclear transition protein 1	GO:0006337; P:nucleosome disassembly; IMP:UniProtKB
P09430	TNP1	Spermatid nuclear transition protein 1	GO:0019953; P:sexual reproduction; IMP:UniProtKB
P09430	TNP1	Spermatid nuclear transition protein 1	GO:0000012; P:single strand break repair; IDA:UniProtKB
P09430	TNP1	Spermatid nuclear transition protein 1	GO:0030317; P:sperm motility; IMP:UniProtKB
P09430	TNP1	Spermatid nuclear transition protein 1	GO:0007286; P:spermatid development; IDA:UniProtKB
P09430	TNP1	Spermatid nuclear transition protein 1	GO:0007289; P:spermatid nucleus differentiation; TAS:UniProtKB
P09430	TNP1	Spermatid nuclear transition protein 1	GO:0007290; P:spermatid nucleus elongation; IMP:UniProtKB
Q05952	TNP2	Nuclear transition protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q05952	TNP2	Nuclear transition protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q05952	TNP2	Nuclear transition protein 2	GO:0007340; P:acrosome reaction; IEA:Ensembl
Q05952	TNP2	Nuclear transition protein 2	GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl
Q05952	TNP2	Nuclear transition protein 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q05952	TNP2	Nuclear transition protein 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q05952	TNP2	Nuclear transition protein 2	GO:0007341; P:penetration of zona pellucida; IEA:Ensembl
Q05952	TNP2	Nuclear transition protein 2	GO:0030317; P:sperm motility; IEA:Ensembl
Q05952	TNP2	Nuclear transition protein 2	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q9H6E5	TUT1	Speckle targeted PIP5K1A-regulated poly(A) polymerase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H6E5	TUT1	Speckle targeted PIP5K1A-regulated poly(A) polymerase	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9H6E5	TUT1	Speckle targeted PIP5K1A-regulated poly(A) polymerase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H6E5	TUT1	Speckle targeted PIP5K1A-regulated poly(A) polymerase	GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB
Q9H6E5	TUT1	Speckle targeted PIP5K1A-regulated poly(A) polymerase	GO:0004652; F:polynucleotide adenylyltransferase activity; IDA:UniProtKB
Q9H6E5	TUT1	Speckle targeted PIP5K1A-regulated poly(A) polymerase	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H6E5	TUT1	Speckle targeted PIP5K1A-regulated poly(A) polymerase	GO:0003723; F:RNA binding; IDA:UniProtKB
Q9H6E5	TUT1	Speckle targeted PIP5K1A-regulated poly(A) polymerase	GO:0050265; F:RNA uridylyltransferase activity; IDA:UniProtKB
Q9H6E5	TUT1	Speckle targeted PIP5K1A-regulated poly(A) polymerase	GO:0006379; P:mRNA cleavage; IDA:UniProtKB
Q9H6E5	TUT1	Speckle targeted PIP5K1A-regulated poly(A) polymerase	GO:0006378; P:mRNA polyadenylation; IDA:UniProtKB
Q9H6E5	TUT1	Speckle targeted PIP5K1A-regulated poly(A) polymerase	GO:0016180; P:snRNA processing; IMP:UniProtKB
Q5TH74	STPG1	O(6)-methylguanine-induced apoptosis 2	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0004872; F:receptor activity; IEA:InterPro
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0051183; F:vitamin transporter activity; IEA:InterPro
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0030325; P:adrenal gland development; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0061143; P:alveolar primary septum development; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0048844; P:artery morphogenesis; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0001568; P:blood vessel development; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0050890; P:cognition; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0048589; P:developmental growth; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0060539; P:diaphragm development; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0048546; P:digestive tract morphogenesis; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0097070; P:ductus arteriosus closure; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0043583; P:ear development; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0060900; P:embryonic camera-type eye formation; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0048566; P:embryonic digestive tract development; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0061029; P:eyelid development in camera-type eye; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0060325; P:face morphogenesis; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0007631; P:feeding behavior; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0030540; P:female genitalia development; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0060322; P:head development; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0060323; P:head morphogenesis; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0007507; P:heart development; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0001822; P:kidney development; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0007612; P:learning; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0048286; P:lung alveolus development; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0030324; P:lung development; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0060426; P:lung vasculature development; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0050905; P:neuromuscular process; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0043585; P:nose morphogenesis; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0061205; P:paramesonephric duct development; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0007603; P:phototransduction, visible light; TAS:Reactome
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0048520; P:positive regulation of behavior; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0061156; P:pulmonary artery morphogenesis; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0003184; P:pulmonary valve morphogenesis; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0042573; P:retinoic acid metabolic process; IEA:Ensembl
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0001523; P:retinoid metabolic process; TAS:Reactome
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0048745; P:smooth muscle tissue development; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0061038; P:uterus morphogenesis; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0003281; P:ventricular septum development; IMP:DFLAT
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0071939; P:vitamin A import; IEA:Ensembl
Q9BX79	STRA6	Stimulated by retinoic acid gene 6 protein homolog	GO:0042297; P:vocal learning; IMP:DFLAT
Q7Z7C7	STRA8	Stimulated by retinoic acid gene 8 protein homolog	GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl
Q7Z7C7	STRA8	Stimulated by retinoic acid gene 8 protein homolog	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q7Z7C7	STRA8	Stimulated by retinoic acid gene 8 protein homolog	GO:0007066; P:female meiosis sister chromatid cohesion; IEA:Ensembl
Q7Z7C7	STRA8	Stimulated by retinoic acid gene 8 protein homolog	GO:0009566; P:fertilization; IEA:Ensembl
Q7Z7C7	STRA8	Stimulated by retinoic acid gene 8 protein homolog	GO:0010032; P:meiotic chromosome condensation; IEA:Ensembl
Q7Z7C7	STRA8	Stimulated by retinoic acid gene 8 protein homolog	GO:0042138; P:meiotic DNA double-strand break formation; IEA:Ensembl
Q7Z7C7	STRA8	Stimulated by retinoic acid gene 8 protein homolog	GO:0033315; P:meiotic DNA replication checkpoint; IEA:Ensembl
Q7Z7C7	STRA8	Stimulated by retinoic acid gene 8 protein homolog	GO:0048599; P:oocyte development; IEA:Ensembl
Q7Z7C7	STRA8	Stimulated by retinoic acid gene 8 protein homolog	GO:0001541; P:ovarian follicle development; IEA:Ensembl
Q7Z7C7	STRA8	Stimulated by retinoic acid gene 8 protein homolog	GO:0007131; P:reciprocal meiotic recombination; IEA:Ensembl
Q7Z7C7	STRA8	Stimulated by retinoic acid gene 8 protein homolog	GO:0046620; P:regulation of organ growth; IEA:Ensembl
Q7Z7C7	STRA8	Stimulated by retinoic acid gene 8 protein homolog	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q7Z7C7	STRA8	Stimulated by retinoic acid gene 8 protein homolog	GO:0007129; P:synapsis; IEA:Ensembl
Q7RTN6	STRADA	STE20-related kinase adapter protein alpha	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q7RTN6	STRADA	STE20-related kinase adapter protein alpha	GO:0019900; F:kinase binding; IPI:BHF-UCL
Q7RTN6	STRADA	STE20-related kinase adapter protein alpha	GO:0005515; F:protein binding; IPI:UniProtKB
Q7RTN6	STRADA	STE20-related kinase adapter protein alpha	GO:0030295; F:protein kinase activator activity; IDA:UniProtKB
Q7RTN6	STRADA	STE20-related kinase adapter protein alpha	GO:0016772; F:transferase activity, transferring phosphorus-containing groups; IEA:InterPro
Q7RTN6	STRADA	STE20-related kinase adapter protein alpha	GO:0032147; P:activation of protein kinase activity; IDA:UniProtKB
Q7RTN6	STRADA	STE20-related kinase adapter protein alpha	GO:0007050; P:cell cycle arrest; TAS:Reactome
Q7RTN6	STRADA	STE20-related kinase adapter protein alpha	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q7RTN6	STRADA	STE20-related kinase adapter protein alpha	GO:0006611; P:protein export from nucleus; IDA:UniProtKB
Q7RTN6	STRADA	STE20-related kinase adapter protein alpha	GO:0006468; P:protein phosphorylation; IDA:GOC
Q9C0K7	STRADB	STE20-related kinase adapter protein beta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9C0K7	STRADB	STE20-related kinase adapter protein beta	GO:0005515; F:protein binding; IPI:IntAct
Q9C0K7	STRADB	STE20-related kinase adapter protein beta	GO:0016772; F:transferase activity, transferring phosphorus-containing groups; IEA:InterPro
Q9C0K7	STRADB	STE20-related kinase adapter protein beta	GO:0032147; P:activation of protein kinase activity; IDA:UniProtKB
Q9C0K7	STRADB	STE20-related kinase adapter protein beta	GO:0007050; P:cell cycle arrest; TAS:Reactome
Q9C0K7	STRADB	STE20-related kinase adapter protein beta	GO:0000902; P:cell morphogenesis; IEA:Ensembl
Q9C0K7	STRADB	STE20-related kinase adapter protein beta	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q9C0K7	STRADB	STE20-related kinase adapter protein beta	GO:0007254; P:JNK cascade; IEA:Ensembl
Q9C0K7	STRADB	STE20-related kinase adapter protein beta	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
Q9C0K7	STRADB	STE20-related kinase adapter protein beta	GO:0006611; P:protein export from nucleus; IDA:UniProtKB
Q9Y3F4	STRAP	Serine-threonine kinase receptor-associated protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y3F4	STRAP	Serine-threonine kinase receptor-associated protein	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3F4	STRAP	Serine-threonine kinase receptor-associated protein	GO:0030277; P:maintenance of gastrointestinal epithelium; IMP:UniProt
Q9Y3F4	STRAP	Serine-threonine kinase receptor-associated protein	GO:0010633; P:negative regulation of epithelial cell migration; IMP:UniProt
Q9Y3F4	STRAP	Serine-threonine kinase receptor-associated protein	GO:0050680; P:negative regulation of epithelial cell proliferation; IMP:UniProt
Q9Y3F4	STRAP	Serine-threonine kinase receptor-associated protein	GO:0010719; P:negative regulation of epithelial to mesenchymal transition; IMP:UniProt
Q9Y3F4	STRAP	Serine-threonine kinase receptor-associated protein	GO:0060394; P:negative regulation of pathway-restricted SMAD protein phosphorylation; IMP:UniProt
Q9Y3F4	STRAP	Serine-threonine kinase receptor-associated protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9Y3F4	STRAP	Serine-threonine kinase receptor-associated protein	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IMP:UniProt
Q9Y3F4	STRAP	Serine-threonine kinase receptor-associated protein	GO:0000387; P:spliceosomal snRNP assembly; IDA:UniProtKB
Q9Y3F4	STRAP	Serine-threonine kinase receptor-associated protein	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q96SI9	STRBP	Spermatid perinuclear RNA-binding protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96SI9	STRBP	Spermatid perinuclear RNA-binding protein	GO:0003725; F:double-stranded RNA binding; IEA:Ensembl
Q96SI9	STRBP	Spermatid perinuclear RNA-binding protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96SI9	STRBP	Spermatid perinuclear RNA-binding protein	GO:0003727; F:single-stranded RNA binding; IEA:Ensembl
Q96SI9	STRBP	Spermatid perinuclear RNA-binding protein	GO:0006928; P:cellular component movement; IEA:Ensembl
Q96SI9	STRBP	Spermatid perinuclear RNA-binding protein	GO:0007638; P:mechanosensory behavior; IEA:Ensembl
Q96SI9	STRBP	Spermatid perinuclear RNA-binding protein	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q96SI9	STRBP	Spermatid perinuclear RNA-binding protein	GO:0007286; P:spermatid development; IEA:Ensembl
Q7RTU9	STRC	Stereocilin	GO:0060088; P:auditory receptor cell stereocilium organization; ISS:UniProtKB
Q7RTU9	STRC	Stereocilin	GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; IEA:Ensembl
Q13033	STRN3	Striatin-3	GO:0070016; F:armadillo repeat domain binding; IPI:UniProtKB
Q13033	STRN3	Striatin-3	GO:0005516; F:calmodulin binding; NAS:UniProtKB
Q13033	STRN3	Striatin-3	GO:0005515; F:protein binding; IPI:IntAct
Q13033	STRN3	Striatin-3	GO:0032403; F:protein complex binding; IDA:UniProtKB
Q13033	STRN3	Striatin-3	GO:0051721; F:protein phosphatase 2A binding; IDA:UniProtKB
Q13033	STRN3	Striatin-3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q13033	STRN3	Striatin-3	GO:0033147; P:negative regulation of intracellular estrogen receptor signaling pathway; ISS:UniProtKB
Q13033	STRN3	Striatin-3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q13033	STRN3	Striatin-3	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q13033	STRN3	Striatin-3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q13033	STRN3	Striatin-3	GO:0032355; P:response to estradiol; ISS:UniProtKB
Q9NRL3	STRN4	Striatin-4	GO:0070016; F:armadillo repeat domain binding; IPI:UniProtKB
Q9NRL3	STRN4	Striatin-4	GO:0005516; F:calmodulin binding; NAS:UniProtKB
Q9NRL3	STRN4	Striatin-4	GO:0005515; F:protein binding; IPI:IntAct
Q9NRL3	STRN4	Striatin-4	GO:0032403; F:protein complex binding; IDA:UniProtKB
Q9NRL3	STRN4	Striatin-4	GO:0051721; F:protein phosphatase 2A binding; IDA:UniProtKB
O43815	STRN	Striatin	GO:0070016; F:armadillo repeat domain binding; IPI:UniProtKB
O43815	STRN	Striatin	GO:0005516; F:calmodulin binding; ISS:UniProtKB
O43815	STRN	Striatin	GO:0030331; F:estrogen receptor binding; IPI:UniProtKB
O43815	STRN	Striatin	GO:0005515; F:protein binding; IPI:IntAct
O43815	STRN	Striatin	GO:0032403; F:protein complex binding; IDA:UniProtKB
O43815	STRN	Striatin	GO:0051721; F:protein phosphatase 2A binding; IDA:UniProtKB
O43815	STRN	Striatin	GO:0016358; P:dendrite development; ISS:UniProtKB
O43815	STRN	Striatin	GO:0007626; P:locomotory behavior; ISS:UniProtKB
O43815	STRN	Striatin	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
O43815	STRN	Striatin	GO:0070830; P:tight junction assembly; NAS:UniProtKB
O43815	STRN	Striatin	GO:0016055; P:Wnt signaling pathway; IMP:UniProtKB
Q5VSL9	STRIP1	Striatin-interacting protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q5VSL9	STRIP1	Striatin-interacting protein 1	GO:0030866; P:cortical actin cytoskeleton organization; IMP:UniProtKB
Q5VSL9	STRIP1	Striatin-interacting protein 1	GO:0022604; P:regulation of cell morphogenesis; IMP:UniProtKB
Q9ULQ0	STRIP2	Striatin-interacting protein 2	GO:0016477; P:cell migration; IMP:UniProtKB
Q9ULQ0	STRIP2	Striatin-interacting protein 2	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q9ULQ0	STRIP2	Striatin-interacting protein 2	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
Q12768	KIAA0196	WASH complex subunit strumpellin	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q12768	KIAA0196	WASH complex subunit strumpellin	GO:0016197; P:endosomal transport; IEA:Ensembl
P08842	STS	Steryl-sulfatase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P08842	STS	Steryl-sulfatase	GO:0004773; F:steryl-sulfatase activity; TAS:Reactome
P08842	STS	Steryl-sulfatase	GO:0008484; F:sulfuric ester hydrolase activity; IDA:MGI
P08842	STS	Steryl-sulfatase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P08842	STS	Steryl-sulfatase	GO:0008544; P:epidermis development; TAS:ProtInc
P08842	STS	Steryl-sulfatase	GO:0007565; P:female pregnancy; IEA:UniProtKB-KW
P08842	STS	Steryl-sulfatase	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
P08842	STS	Steryl-sulfatase	GO:0043687; P:post-translational protein modification; TAS:Reactome
P08842	STS	Steryl-sulfatase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P08842	STS	Steryl-sulfatase	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
P08842	STS	Steryl-sulfatase	GO:0006706; P:steroid catabolic process; TAS:ProtInc
P46977	STT3A	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A	GO:0004579; F:dolichyl-diphosphooligosaccharide-protein glycotransferase activity; IMP:UniProtKB
P46977	STT3A	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A	GO:0005515; F:protein binding; IPI:IntAct
P46977	STT3A	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P46977	STT3A	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A	GO:0043686; P:co-translational protein modification; IMP:UniProtKB
P46977	STT3A	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A	GO:0043687; P:post-translational protein modification; TAS:Reactome
P46977	STT3A	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A	GO:0018279; P:protein N-linked glycosylation via asparagine; IMP:UniProtKB
Q8TCJ2	STT3B	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B	GO:0004579; F:dolichyl-diphosphooligosaccharide-protein glycotransferase activity; IMP:UniProtKB
Q8TCJ2	STT3B	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B	GO:0043686; P:co-translational protein modification; IMP:UniProtKB
Q8TCJ2	STT3B	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q8TCJ2	STT3B	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B	GO:0006516; P:glycoprotein catabolic process; IMP:UniProtKB
Q8TCJ2	STT3B	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B	GO:0043687; P:post-translational protein modification; IMP:UniProtKB
Q8TCJ2	STT3B	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B	GO:0018279; P:protein N-linked glycosylation via asparagine; IMP:UniProtKB
Q8TCJ2	STT3B	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B	GO:0006986; P:response to unfolded protein; IMP:UniProtKB
O60499	STX10	Syntaxin-10	GO:0005484; F:SNAP receptor activity; IBA:RefGenome
O60499	STX10	Syntaxin-10	GO:0048193; P:Golgi vesicle transport; IEA:InterPro
O60499	STX10	Syntaxin-10	GO:0006886; P:intracellular protein transport; IBA:RefGenome
O60499	STX10	Syntaxin-10	GO:0042147; P:retrograde transport, endosome to Golgi; IDA:UniProtKB
O60499	STX10	Syntaxin-10	GO:0006906; P:vesicle fusion; IBA:RefGenome
Q86Y82	STX12	Syntaxin-12	GO:0005515; F:protein binding; IPI:UniProtKB
Q86Y82	STX12	Syntaxin-12	GO:0005484; F:SNAP receptor activity; IBA:RefGenome
Q86Y82	STX12	Syntaxin-12	GO:0000149; F:SNARE binding; IBA:RefGenome
Q86Y82	STX12	Syntaxin-12	GO:0033344; P:cholesterol efflux; IDA:BHF-UCL
Q86Y82	STX12	Syntaxin-12	GO:0006886; P:intracellular protein transport; IBA:RefGenome
Q86Y82	STX12	Syntaxin-12	GO:0050821; P:protein stabilization; IDA:BHF-UCL
Q86Y82	STX12	Syntaxin-12	GO:0016079; P:synaptic vesicle exocytosis; IBA:RefGenome
O75558	STX11	Syntaxin-11	GO:0005515; F:protein binding; IPI:UniProtKB
O75558	STX11	Syntaxin-11	GO:0005484; F:SNAP receptor activity; TAS:ProtInc
O75558	STX11	Syntaxin-11	GO:0043316; P:cytotoxic T cell degranulation; IEA:Ensembl
O75558	STX11	Syntaxin-11	GO:0006886; P:intracellular protein transport; IEA:InterPro
O75558	STX11	Syntaxin-11	GO:0061025; P:membrane fusion; TAS:ProtInc
O75558	STX11	Syntaxin-11	GO:0043320; P:natural killer cell degranulation; IEA:Ensembl
O75558	STX11	Syntaxin-11	GO:0043312; P:neutrophil degranulation; IEA:Ensembl
O14662	STX16	Syntaxin-16	GO:0005515; F:protein binding; IPI:UniProtKB
O14662	STX16	Syntaxin-16	GO:0005484; F:SNAP receptor activity; IDA:HGNC
O14662	STX16	Syntaxin-16	GO:0006891; P:intra-Golgi vesicle-mediated transport; TAS:ProtInc
O14662	STX16	Syntaxin-16	GO:0006886; P:intracellular protein transport; IEA:InterPro
O14662	STX16	Syntaxin-16	GO:0042147; P:retrograde transport, endosome to Golgi; IDA:UniProtKB
P56962	STX17	Syntaxin-17	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
P56962	STX17	Syntaxin-17	GO:0005484; F:SNAP receptor activity; IMP:UniProtKB
P56962	STX17	Syntaxin-17	GO:0000149; F:SNARE binding; IDA:UniProtKB
P56962	STX17	Syntaxin-17	GO:0000046; P:autophagic vacuole fusion; IMP:UniProtKB
P56962	STX17	Syntaxin-17	GO:0097111; P:endoplasmic reticulum-Golgi intermediate compartment organization; IMP:UniProtKB
P56962	STX17	Syntaxin-17	GO:0006888; P:ER to Golgi vesicle-mediated transport; IMP:UniProtKB
P56962	STX17	Syntaxin-17	GO:0006887; P:exocytosis; IBA:RefGenome
P56962	STX17	Syntaxin-17	GO:0007030; P:Golgi organization; IMP:UniProtKB
P56962	STX17	Syntaxin-17	GO:0006886; P:intracellular protein transport; IBA:RefGenome
Q9P2W9	STX18	Syntaxin-18	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P2W9	STX18	Syntaxin-18	GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:ProtInc
Q9P2W9	STX18	Syntaxin-18	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q8N4C7	STX19	Syntaxin-19	GO:0005515; F:protein binding; IPI:IntAct
Q8N4C7	STX19	Syntaxin-19	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q8N4C7	STX19	Syntaxin-19	GO:0016192; P:vesicle-mediated transport; IEA:InterPro
Q16623	STX1A	Syntaxin-1A	GO:0019855; F:calcium channel inhibitor activity; IEA:Ensembl
Q16623	STX1A	Syntaxin-1A	GO:0005515; F:protein binding; IPI:UniProtKB
Q16623	STX1A	Syntaxin-1A	GO:0017156; P:calcium ion-dependent exocytosis; IEA:Ensembl
Q16623	STX1A	Syntaxin-1A	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q16623	STX1A	Syntaxin-1A	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
Q16623	STX1A	Syntaxin-1A	GO:0014047; P:glutamate secretion; TAS:Reactome
Q16623	STX1A	Syntaxin-1A	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q16623	STX1A	Syntaxin-1A	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
Q16623	STX1A	Syntaxin-1A	GO:0045921; P:positive regulation of exocytosis; IEA:Ensembl
Q16623	STX1A	Syntaxin-1A	GO:0001956; P:positive regulation of neurotransmitter secretion; IEA:Ensembl
Q16623	STX1A	Syntaxin-1A	GO:0050796; P:regulation of insulin secretion; TAS:UniProtKB
Q16623	STX1A	Syntaxin-1A	GO:0009629; P:response to gravity; IEA:Ensembl
Q16623	STX1A	Syntaxin-1A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16623	STX1A	Syntaxin-1A	GO:0007268; P:synaptic transmission; TAS:Reactome
Q16623	STX1A	Syntaxin-1A	GO:0016081; P:synaptic vesicle docking involved in exocytosis; IEA:Ensembl
P61266	STX1B	Syntaxin-1B	GO:0005230; F:extracellular ligand-gated ion channel activity; TAS:ProtInc
P61266	STX1B	Syntaxin-1B	GO:0005234; F:extracellular-glutamate-gated ion channel activity; TAS:ProtInc
P61266	STX1B	Syntaxin-1B	GO:0006886; P:intracellular protein transport; IEA:InterPro
P61266	STX1B	Syntaxin-1B	GO:0034220; P:ion transmembrane transport; TAS:GOC
P61266	STX1B	Syntaxin-1B	GO:0006836; P:neurotransmitter transport; IEA:UniProtKB-KW
P61266	STX1B	Syntaxin-1B	GO:0017157; P:regulation of exocytosis; IEA:Ensembl
P61266	STX1B	Syntaxin-1B	GO:0007268; P:synaptic transmission; TAS:ProtInc
P61266	STX1B	Syntaxin-1B	GO:0006810; P:transport; TAS:ProtInc
P61266	STX1B	Syntaxin-1B	GO:0016192; P:vesicle-mediated transport; IEA:Ensembl
P32856	STX2	Syntaxin-2	GO:0048306; F:calcium-dependent protein binding; ISS:HGNC
P32856	STX2	Syntaxin-2	GO:0005515; F:protein binding; IPI:UniProtKB
P32856	STX2	Syntaxin-2	GO:0007340; P:acrosome reaction; ISS:HGNC
P32856	STX2	Syntaxin-2	GO:0030154; P:cell differentiation; IEA:Ensembl
P32856	STX2	Syntaxin-2	GO:0007398; P:ectoderm development; TAS:ProtInc
P32856	STX2	Syntaxin-2	GO:0006886; P:intracellular protein transport; IEA:InterPro
P32856	STX2	Syntaxin-2	GO:0009887; P:organ morphogenesis; TAS:ProtInc
P32856	STX2	Syntaxin-2	GO:0007165; P:signal transduction; TAS:ProtInc
Q13277	STX3	Syntaxin-3	GO:0050544; F:arachidonic acid binding; ISS:HGNC
Q13277	STX3	Syntaxin-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q13277	STX3	Syntaxin-3	GO:0006887; P:exocytosis; IEA:Ensembl
Q13277	STX3	Syntaxin-3	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q13277	STX3	Syntaxin-3	GO:0061025; P:membrane fusion; IEA:Ensembl
Q13277	STX3	Syntaxin-3	GO:0031175; P:neuron projection development; ISS:HGNC
Q13277	STX3	Syntaxin-3	GO:0006836; P:neurotransmitter transport; IEA:UniProtKB-KW
Q12846	STX4	Syntaxin-4	GO:0005515; F:protein binding; IPI:UniProtKB
Q12846	STX4	Syntaxin-4	GO:0007596; P:blood coagulation; TAS:Reactome
Q12846	STX4	Syntaxin-4	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q12846	STX4	Syntaxin-4	GO:0061024; P:membrane organization; TAS:Reactome
Q12846	STX4	Syntaxin-4	GO:0006836; P:neurotransmitter transport; IEA:UniProtKB-KW
Q12846	STX4	Syntaxin-4	GO:0030168; P:platelet activation; TAS:Reactome
Q12846	STX4	Syntaxin-4	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
Q12846	STX4	Syntaxin-4	GO:0016192; P:vesicle-mediated transport; IEA:InterPro
Q13190	STX5	Syntaxin-5	GO:0005515; F:protein binding; IPI:IntAct
Q13190	STX5	Syntaxin-5	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q13190	STX5	Syntaxin-5	GO:0005484; F:SNAP receptor activity; IDA:HGNC
Q13190	STX5	Syntaxin-5	GO:0006888; P:ER to Golgi vesicle-mediated transport; IEA:Ensembl
Q13190	STX5	Syntaxin-5	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q13190	STX5	Syntaxin-5	GO:0042147; P:retrograde transport, endosome to Golgi; IDA:HGNC
Q13190	STX5	Syntaxin-5	GO:0048280; P:vesicle fusion with Golgi apparatus; IEA:Ensembl
Q13190	STX5	Syntaxin-5	GO:0006903; P:vesicle targeting; TAS:ProtInc
O43752	STX6	Syntaxin-6	GO:0005515; F:protein binding; IPI:UniProtKB
O43752	STX6	Syntaxin-6	GO:0005484; F:SNAP receptor activity; IBA:RefGenome
O43752	STX6	Syntaxin-6	GO:0007032; P:endosome organization; IEA:Ensembl
O43752	STX6	Syntaxin-6	GO:0048193; P:Golgi vesicle transport; IEA:InterPro
O43752	STX6	Syntaxin-6	GO:0006886; P:intracellular protein transport; IEA:InterPro
O43752	STX6	Syntaxin-6	GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB
O43752	STX6	Syntaxin-6	GO:0006906; P:vesicle fusion; IPI:UniProtKB
O43752	STX6	Syntaxin-6	GO:0016192; P:vesicle-mediated transport; IEA:Ensembl
O15400	STX7	Syntaxin-7	GO:0005484; F:SNAP receptor activity; IBA:RefGenome
O15400	STX7	Syntaxin-7	GO:0000149; F:SNARE binding; IBA:RefGenome
O15400	STX7	Syntaxin-7	GO:0006886; P:intracellular protein transport; IBA:RefGenome
O15400	STX7	Syntaxin-7	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:ProtInc
O15400	STX7	Syntaxin-7	GO:0016079; P:synaptic vesicle exocytosis; IBA:RefGenome
Q9UNK0	STX8	Syntaxin-8	GO:0005484; F:SNAP receptor activity; IBA:RefGenome
Q9UNK0	STX8	Syntaxin-8	GO:0008333; P:endosome to lysosome transport; IEA:Ensembl
Q9UNK0	STX8	Syntaxin-8	GO:0006886; P:intracellular protein transport; IBA:RefGenome
Q9UNK0	STX8	Syntaxin-8	GO:0006810; P:transport; TAS:ProtInc
Q9UNK0	STX8	Syntaxin-8	GO:0006906; P:vesicle fusion; IBA:RefGenome
P61764	STXBP1	Syntaxin-binding protein 1	GO:0042802; F:identical protein binding; ISS:UniProtKB
P61764	STXBP1	Syntaxin-binding protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P61764	STXBP1	Syntaxin-binding protein 1	GO:0000149; F:SNARE binding; ISS:UniProtKB
P61764	STXBP1	Syntaxin-binding protein 1	GO:0019905; F:syntaxin binding; IPI:UniProtKB
P61764	STXBP1	Syntaxin-binding protein 1	GO:0017075; F:syntaxin-1 binding; ISS:UniProtKB
P61764	STXBP1	Syntaxin-binding protein 1	GO:0007412; P:axon target recognition; ISS:UniProtKB
P61764	STXBP1	Syntaxin-binding protein 1	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P61764	STXBP1	Syntaxin-binding protein 1	GO:0014047; P:glutamate secretion; TAS:Reactome
P61764	STXBP1	Syntaxin-binding protein 1	GO:0060292; P:long term synaptic depression; IEA:Ensembl
P61764	STXBP1	Syntaxin-binding protein 1	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P61764	STXBP1	Syntaxin-binding protein 1	GO:0032229; P:negative regulation of synaptic transmission, GABAergic; ISS:UniProtKB
P61764	STXBP1	Syntaxin-binding protein 1	GO:0007274; P:neuromuscular synaptic transmission; IEA:Ensembl
P61764	STXBP1	Syntaxin-binding protein 1	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
P61764	STXBP1	Syntaxin-binding protein 1	GO:0070527; P:platelet aggregation; IMP:UniProtKB
P61764	STXBP1	Syntaxin-binding protein 1	GO:0002576; P:platelet degranulation; IMP:UniProtKB
P61764	STXBP1	Syntaxin-binding protein 1	GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; IEA:Ensembl
P61764	STXBP1	Syntaxin-binding protein 1	GO:0050821; P:protein stabilization; IEA:Ensembl
P61764	STXBP1	Syntaxin-binding protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P61764	STXBP1	Syntaxin-binding protein 1	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P61764	STXBP1	Syntaxin-binding protein 1	GO:0010807; P:regulation of synaptic vesicle priming; ISS:UniProtKB
P61764	STXBP1	Syntaxin-binding protein 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P61764	STXBP1	Syntaxin-binding protein 1	GO:0007268; P:synaptic transmission; TAS:Reactome
P61764	STXBP1	Syntaxin-binding protein 1	GO:0016188; P:synaptic vesicle maturation; ISS:UniProtKB
P61764	STXBP1	Syntaxin-binding protein 1	GO:0006904; P:vesicle docking involved in exocytosis; IEA:Ensembl
Q15833	STXBP2	Syntaxin-binding protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q15833	STXBP2	Syntaxin-binding protein 2	GO:0030348; F:syntaxin-3 binding; IPI:UniProtKB
Q15833	STXBP2	Syntaxin-binding protein 2	GO:0001909; P:leukocyte mediated cytotoxicity; IMP:UniProtKB
Q15833	STXBP2	Syntaxin-binding protein 2	GO:0043312; P:neutrophil degranulation; IEP:UniProtKB
Q15833	STXBP2	Syntaxin-binding protein 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q15833	STXBP2	Syntaxin-binding protein 2	GO:0043304; P:regulation of mast cell degranulation; ISS:UniProtKB
Q15833	STXBP2	Syntaxin-binding protein 2	GO:0006904; P:vesicle docking involved in exocytosis; IEA:InterPro
O00186	STXBP3	Syntaxin-binding protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
O00186	STXBP3	Syntaxin-binding protein 3	GO:0019905; F:syntaxin binding; IPI:UniProtKB
O00186	STXBP3	Syntaxin-binding protein 3	GO:0007596; P:blood coagulation; TAS:Reactome
O00186	STXBP3	Syntaxin-binding protein 3	GO:0061024; P:membrane organization; TAS:Reactome
O00186	STXBP3	Syntaxin-binding protein 3	GO:0045955; P:negative regulation of calcium ion-dependent exocytosis; IMP:UniProtKB
O00186	STXBP3	Syntaxin-binding protein 3	GO:0043312; P:neutrophil degranulation; IEP:UniProtKB
O00186	STXBP3	Syntaxin-binding protein 3	GO:0030168; P:platelet activation; TAS:Reactome
O00186	STXBP3	Syntaxin-binding protein 3	GO:0070527; P:platelet aggregation; IMP:UniProtKB
O00186	STXBP3	Syntaxin-binding protein 3	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
O00186	STXBP3	Syntaxin-binding protein 3	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O00186	STXBP3	Syntaxin-binding protein 3	GO:0006904; P:vesicle docking involved in exocytosis; IEA:InterPro
Q6ZWJ1	STXBP4	Syntaxin-binding protein 4	GO:0005509; F:calcium ion binding; IEA:InterPro
Q6ZWJ1	STXBP4	Syntaxin-binding protein 4	GO:0015758; P:glucose transport; IEA:Ensembl
Q6ZWJ1	STXBP4	Syntaxin-binding protein 4	GO:0008286; P:insulin receptor signaling pathway; IEA:Ensembl
Q6ZWJ1	STXBP4	Syntaxin-binding protein 4	GO:0006605; P:protein targeting; IEA:Ensembl
Q5T5C0	STXBP5	Syntaxin-binding protein 5	GO:0017075; F:syntaxin-1 binding; ISS:BHF-UCL
Q5T5C0	STXBP5	Syntaxin-binding protein 5	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q5T5C0	STXBP5	Syntaxin-binding protein 5	GO:0045921; P:positive regulation of exocytosis; ISS:BHF-UCL
Q5T5C0	STXBP5	Syntaxin-binding protein 5	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8NFX7	STXBP6	Syntaxin-binding protein 6	GO:0016192; P:vesicle-mediated transport; IEA:InterPro
Q6J9G0	STYK1	Tyrosine-protein kinase STYK1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6J9G0	STYK1	Tyrosine-protein kinase STYK1	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC
Q6J9G0	STYK1	Tyrosine-protein kinase STYK1	GO:0005515; F:protein binding; IPI:IntAct
Q8WUJ0	STYX	Serine/threonine/tyrosine-interacting protein	GO:0004721; F:phosphoprotein phosphatase activity; IEA:UniProtKB-KW
Q8WUJ0	STYX	Serine/threonine/tyrosine-interacting protein	GO:0007283; P:spermatogenesis; IBA:RefGenome
Q9Y6J8	STYXL1	Serine/threonine/tyrosine-interacting-like protein 1	GO:0004721; F:phosphoprotein phosphatase activity; IEA:UniProtKB-KW
Q9Y6J8	STYXL1	Serine/threonine/tyrosine-interacting-like protein 1	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
P53597	SUCLG1	Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial	GO:0003878; F:ATP citrate synthase activity; IEA:InterPro
P53597	SUCLG1	Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial	GO:0048037; F:cofactor binding; IEA:InterPro
P53597	SUCLG1	Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial	GO:0019003; F:GDP binding; IEA:Ensembl
P53597	SUCLG1	Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P53597	SUCLG1	Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P53597	SUCLG1	Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial	GO:0004775; F:succinate-CoA ligase (ADP-forming) activity; IEA:UniProtKB-EC
P53597	SUCLG1	Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial	GO:0004776; F:succinate-CoA ligase (GDP-forming) activity; IEA:UniProtKB-EC
P53597	SUCLG1	Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P53597	SUCLG1	Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P53597	SUCLG1	Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial	GO:0006105; P:succinate metabolic process; IEA:Ensembl
P53597	SUCLG1	Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial	GO:0006104; P:succinyl-CoA metabolic process; IEA:Ensembl
P53597	SUCLG1	Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; TAS:Reactome
Q9P2R7	SUCLA2	Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9P2R7	SUCLA2	Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial	GO:0046872; F:metal ion binding; IEA:InterPro
Q9P2R7	SUCLA2	Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P2R7	SUCLA2	Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial	GO:0004775; F:succinate-CoA ligase (ADP-forming) activity; TAS:UniProtKB
Q9P2R7	SUCLA2	Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q9P2R7	SUCLA2	Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9P2R7	SUCLA2	Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial	GO:0006105; P:succinate metabolic process; IEA:Ensembl
Q9P2R7	SUCLA2	Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial	GO:0006104; P:succinyl-CoA metabolic process; TAS:ProtInc
Q9P2R7	SUCLA2	Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial	GO:0006781; P:succinyl-CoA pathway; NAS:UniProtKB
Q9P2R7	SUCLA2	Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; TAS:Reactome
Q96I99	SUCLG2	Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial	GO:0005524; F:ATP binding; IEA:InterPro
Q96I99	SUCLG2	Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial	GO:0019003; F:GDP binding; IEA:Ensembl
Q96I99	SUCLG2	Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q96I99	SUCLG2	Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial	GO:0004776; F:succinate-CoA ligase (GDP-forming) activity; NAS:UniProtKB
Q96I99	SUCLG2	Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
Q96I99	SUCLG2	Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96I99	SUCLG2	Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial	GO:0006105; P:succinate metabolic process; IEA:Ensembl
Q96I99	SUCLG2	Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial	GO:0006104; P:succinyl-CoA metabolic process; NAS:UniProtKB
Q96I99	SUCLG2	Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial	GO:0006099; P:tricarboxylic acid cycle; TAS:Reactome
Q9HAC7	SUGCT	Succinate--hydroxymethylglutarate CoA-transferase	GO:0047369; F:succinate-hydroxymethylglutarate CoA-transferase activity; IDA:UniProtKB
Q9UBS9	SUCO	SUN domain-containing ossification factor	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9UBS9	SUCO	SUN domain-containing ossification factor	GO:0001503; P:ossification; IEA:UniProtKB-KW
Q9UBS9	SUCO	SUN domain-containing ossification factor	GO:0032967; P:positive regulation of collagen biosynthetic process; ISS:UniProtKB
Q9UBS9	SUCO	SUN domain-containing ossification factor	GO:0045669; P:positive regulation of osteoblast differentiation; ISS:UniProtKB
Q9UBS9	SUCO	SUN domain-containing ossification factor	GO:0046850; P:regulation of bone remodeling; ISS:UniProtKB
Q9BXA5	SUCNR1	Succinate receptor 1	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0005515; F:protein binding; IPI:IntAct
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0003714; F:transcription corepressor activity; TAS:UniProtKB
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0008134; F:transcription factor binding; IDA:MGI
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0042994; P:cytoplasmic sequestering of transcription factor; IEA:Ensembl
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0001947; P:heart looping; IEA:Ensembl
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0045668; P:negative regulation of osteoblast differentiation; TAS:BHF-UCL
Q9UMX1	SUFU	Suppressor of fused homolog	GO:2000059; P:negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; TAS:BHF-UCL
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0045879; P:negative regulation of smoothened signaling pathway; TAS:BHF-UCL
Q9UMX1	SUFU	Suppressor of fused homolog	GO:1901621; P:negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning; IEA:Ensembl
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0042992; P:negative regulation of transcription factor import into nucleus; TAS:BHF-UCL
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0001843; P:neural tube closure; IEA:Ensembl
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0006508; P:proteolysis; TAS:ProtInc
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0001501; P:skeletal system development; TAS:ProtInc
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0043588; P:skin development; IEA:Ensembl
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0021776; P:smoothened signaling pathway involved in spinal cord motor neuron cell fate specification; IEA:Ensembl
Q9UMX1	SUFU	Suppressor of fused homolog	GO:0021775; P:smoothened signaling pathway involved in ventral spinal cord interneuron specification; IEA:Ensembl
Q8IWZ8	SUGP1	SURP and G-patch domain-containing protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IWZ8	SUGP1	SURP and G-patch domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q8IWZ8	SUGP1	SURP and G-patch domain-containing protein 1	GO:0010467; P:gene expression; TAS:Reactome
Q8IWZ8	SUGP1	SURP and G-patch domain-containing protein 1	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
Q8IWZ8	SUGP1	SURP and G-patch domain-containing protein 1	GO:0008380; P:RNA splicing; TAS:Reactome
Q8IX01	SUGP2	SURP and G-patch domain-containing protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IX01	SUGP2	SURP and G-patch domain-containing protein 2	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q8IX01	SUGP2	SURP and G-patch domain-containing protein 2	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q9Y2Z0	SUGT1	Suppressor of G2 allele of SKP1 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2Z0	SUGT1	Suppressor of G2 allele of SKP1 homolog	GO:0045087; P:innate immune response; TAS:Reactome
Q9Y2Z0	SUGT1	Suppressor of G2 allele of SKP1 homolog	GO:0007067; P:mitosis; TAS:ProtInc
Q9Y2Z0	SUGT1	Suppressor of G2 allele of SKP1 homolog	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0003682; F:chromatin binding; IEA:Ensembl
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0003677; F:DNA binding; TAS:UniProtKB
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0005515; F:protein binding; IPI:UniProtKB
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0000150; F:recombinase activity; NAS:UniProtKB
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:InterPro
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:MGI
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:UniProtKB
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0001525; P:angiogenesis; ISS:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0060844; P:arterial endothelial cell fate commitment; IEA:Ensembl
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0036302; P:atrioventricular canal development; ISS:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0009912; P:auditory receptor cell fate commitment; IEA:Ensembl
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0030183; P:B cell differentiation; IEA:Ensembl
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0097101; P:blood vessel endothelial cell fate specification; ISS:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0072554; P:blood vessel lumenization; ISS:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0003214; P:cardiac left ventricle morphogenesis; ISS:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0060486; P:Clara cell differentiation; IEA:Ensembl
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0042742; P:defense response to bacterium; IEA:Ensembl
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0006310; P:DNA recombination; NAS:UniProtKB
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0035912; P:dorsal aorta morphogenesis; ISS:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0003160; P:endocardium morphogenesis; ISS:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0009957; P:epidermal cell fate specification; IEA:Ensembl
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0001837; P:epithelial to mesenchymal transition; ISS:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0003198; P:epithelial to mesenchymal transition involved in endocardial cushion formation; ISS:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0010467; P:gene expression; TAS:Reactome
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0048820; P:hair follicle maturation; IEA:Ensembl
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0006959; P:humoral immune response; IEA:Ensembl
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0002437; P:inflammatory response to antigenic stimulus; IEA:Ensembl
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0072602; P:interleukin-4 secretion; IEA:Ensembl
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0060716; P:labyrinthine layer blood vessel development; ISS:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0030279; P:negative regulation of ossification; ISS:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0061314; P:Notch signaling involved in heart development; IC:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0007219; P:Notch signaling pathway; IMP:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0003151; P:outflow tract morphogenesis; ISS:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0021983; P:pituitary gland development; IEA:Ensembl
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0030513; P:positive regulation of BMP signaling pathway; ISS:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0060045; P:positive regulation of cardiac muscle cell proliferation; ISS:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:2000138; P:positive regulation of cell proliferation involved in heart morphogenesis; ISS:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:1901189; P:positive regulation of ephrin receptor signaling pathway; ISS:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:1901186; P:positive regulation of ERBB signaling pathway; ISS:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0007221; P:positive regulation of transcription of Notch receptor target; IDA:UniProtKB
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0048505; P:regulation of timing of cell differentiation; IEA:Ensembl
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0003256; P:regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; ISS:BHF-UCL
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0048733; P:sebaceous gland development; IEA:Ensembl
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q06330	RBPJ	Recombining binding protein suppressor of hairless	GO:0003222; P:ventricular trabecula myocardium morphogenesis; ISS:BHF-UCL
P14410	SI	Sucrase-isomaltase, intestinal	GO:0004558; F:alpha-glucosidase activity; TAS:Reactome
P14410	SI	Sucrase-isomaltase, intestinal	GO:0030246; F:carbohydrate binding; IEA:InterPro
P14410	SI	Sucrase-isomaltase, intestinal	GO:0004574; F:oligo-1,6-glucosidase activity; IEA:UniProtKB-EC
P14410	SI	Sucrase-isomaltase, intestinal	GO:0004575; F:sucrose alpha-glucosidase activity; TAS:Reactome
P14410	SI	Sucrase-isomaltase, intestinal	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P14410	SI	Sucrase-isomaltase, intestinal	GO:0044245; P:polysaccharide digestion; TAS:Reactome
P14410	SI	Sucrase-isomaltase, intestinal	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0004065; F:arylsulfatase activity; IDA:UniProtKB
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0008449; F:N-acetylglucosamine-6-sulfatase activity; IDA:UniProtKB
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0060348; P:bone development; ISS:BHF-UCL
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0051216; P:cartilage development; ISS:UniProtKB
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0002063; P:chondrocyte development; ISS:UniProtKB
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0048706; P:embryonic skeletal system development; ISS:UniProtKB
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0014846; P:esophagus smooth muscle contraction; ISS:UniProtKB
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0035860; P:glial cell-derived neurotrophic factor receptor signaling pathway; ISS:UniProtKB
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0032836; P:glomerular basement membrane development; ISS:UniProtKB
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0003094; P:glomerular filtration; ISS:UniProtKB
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0030201; P:heparan sulfate proteoglycan metabolic process; IDA:UniProtKB
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0060384; P:innervation; ISS:UniProtKB
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0001822; P:kidney development; ISS:BHF-UCL
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0016525; P:negative regulation of angiogenesis; IDA:UniProtKB
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0001937; P:negative regulation of endothelial cell proliferation; IDA:UniProtKB
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0040037; P:negative regulation of fibroblast growth factor receptor signaling pathway; IMP:UniProtKB
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0060686; P:negative regulation of prostatic bud formation; ISS:UniProtKB
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0030513; P:positive regulation of BMP signaling pathway; IMP:UniProtKB
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0030177; P:positive regulation of Wnt signaling pathway; IDA:UniProtKB
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0010575; P:positive regulation vascular endothelial growth factor production; ISS:UniProtKB
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0040036; P:regulation of fibroblast growth factor receptor signaling pathway; IMP:UniProtKB
Q8IWU6	SULF1	Extracellular sulfatase Sulf-1	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IDA:UniProtKB
Q8IWU5	SULF2	Extracellular sulfatase Sulf-2	GO:0004065; F:arylsulfatase activity; IDA:UniProtKB
Q8IWU5	SULF2	Extracellular sulfatase Sulf-2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8IWU5	SULF2	Extracellular sulfatase Sulf-2	GO:0008449; F:N-acetylglucosamine-6-sulfatase activity; IDA:UniProtKB
Q8IWU5	SULF2	Extracellular sulfatase Sulf-2	GO:0060348; P:bone development; ISS:BHF-UCL
Q8IWU5	SULF2	Extracellular sulfatase Sulf-2	GO:0051216; P:cartilage development; ISS:UniProtKB
Q8IWU5	SULF2	Extracellular sulfatase Sulf-2	GO:0002063; P:chondrocyte development; ISS:UniProtKB
Q8IWU5	SULF2	Extracellular sulfatase Sulf-2	GO:0048706; P:embryonic skeletal system development; ISS:UniProtKB
Q8IWU5	SULF2	Extracellular sulfatase Sulf-2	GO:0014846; P:esophagus smooth muscle contraction; ISS:UniProtKB
Q8IWU5	SULF2	Extracellular sulfatase Sulf-2	GO:0035860; P:glial cell-derived neurotrophic factor receptor signaling pathway; ISS:UniProtKB
Q8IWU5	SULF2	Extracellular sulfatase Sulf-2	GO:0032836; P:glomerular basement membrane development; ISS:UniProtKB
Q8IWU5	SULF2	Extracellular sulfatase Sulf-2	GO:0003094; P:glomerular filtration; ISS:UniProtKB
Q8IWU5	SULF2	Extracellular sulfatase Sulf-2	GO:0030201; P:heparan sulfate proteoglycan metabolic process; IDA:UniProtKB
Q8IWU5	SULF2	Extracellular sulfatase Sulf-2	GO:0060384; P:innervation; ISS:UniProtKB
Q8IWU5	SULF2	Extracellular sulfatase Sulf-2	GO:0001822; P:kidney development; ISS:BHF-UCL
Q8IWU5	SULF2	Extracellular sulfatase Sulf-2	GO:0040037; P:negative regulation of fibroblast growth factor receptor signaling pathway; ISS:UniProtKB
Q8IWU5	SULF2	Extracellular sulfatase Sulf-2	GO:0030177; P:positive regulation of Wnt signaling pathway; IDA:UniProtKB
Q8IWU5	SULF2	Extracellular sulfatase Sulf-2	GO:0010575; P:positive regulation vascular endothelial growth factor production; ISS:UniProtKB
Q8NBK3	SUMF1	Sulfatase-modifying factor 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NBK3	SUMF1	Sulfatase-modifying factor 1	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q8NBK3	SUMF1	Sulfatase-modifying factor 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8NBK3	SUMF1	Sulfatase-modifying factor 1	GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome
Q8NBK3	SUMF1	Sulfatase-modifying factor 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q8NBK3	SUMF1	Sulfatase-modifying factor 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8NBK3	SUMF1	Sulfatase-modifying factor 1	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q8NBJ7	SUMF2	Sulfatase-modifying factor 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NBJ7	SUMF2	Sulfatase-modifying factor 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8NBJ7	SUMF2	Sulfatase-modifying factor 2	GO:0043687; P:post-translational protein modification; TAS:Reactome
P63165	SUMO1	Small ubiquitin-related modifier 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P63165	SUMO1	Small ubiquitin-related modifier 1	GO:0005515; F:protein binding; IPI:UniProtKB
P63165	SUMO1	Small ubiquitin-related modifier 1	GO:0019789; F:SUMO ligase activity; IEA:Ensembl
P63165	SUMO1	Small ubiquitin-related modifier 1	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P63165	SUMO1	Small ubiquitin-related modifier 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P63165	SUMO1	Small ubiquitin-related modifier 1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P63165	SUMO1	Small ubiquitin-related modifier 1	GO:0006281; P:DNA repair; TAS:ProtInc
P63165	SUMO1	Small ubiquitin-related modifier 1	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P63165	SUMO1	Small ubiquitin-related modifier 1	GO:0043392; P:negative regulation of DNA binding; IMP:UniProtKB
P63165	SUMO1	Small ubiquitin-related modifier 1	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IMP:UniProtKB
P63165	SUMO1	Small ubiquitin-related modifier 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P63165	SUMO1	Small ubiquitin-related modifier 1	GO:0060021; P:palate development; ISS:UniProtKB
P63165	SUMO1	Small ubiquitin-related modifier 1	GO:0030578; P:PML body organization; IEA:Ensembl
P63165	SUMO1	Small ubiquitin-related modifier 1	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
P63165	SUMO1	Small ubiquitin-related modifier 1	GO:0031334; P:positive regulation of protein complex assembly; IDA:BHF-UCL
P63165	SUMO1	Small ubiquitin-related modifier 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
P63165	SUMO1	Small ubiquitin-related modifier 1	GO:0090204; P:protein localization to nuclear pore; IEA:Ensembl
P63165	SUMO1	Small ubiquitin-related modifier 1	GO:0016925; P:protein sumoylation; IDA:UniProtKB
P63165	SUMO1	Small ubiquitin-related modifier 1	GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; TAS:Reactome
P63165	SUMO1	Small ubiquitin-related modifier 1	GO:0032880; P:regulation of protein localization; TAS:UniProtKB
P61956	SUMO2	Small ubiquitin-related modifier 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P61956	SUMO2	Small ubiquitin-related modifier 2	GO:0005515; F:protein binding; IPI:IntAct
P61956	SUMO2	Small ubiquitin-related modifier 2	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P61956	SUMO2	Small ubiquitin-related modifier 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P61956	SUMO2	Small ubiquitin-related modifier 2	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
P61956	SUMO2	Small ubiquitin-related modifier 2	GO:0043687; P:post-translational protein modification; TAS:Reactome
P61956	SUMO2	Small ubiquitin-related modifier 2	GO:0016925; P:protein sumoylation; IDA:UniProtKB
P55854	SUMO3	Small ubiquitin-related modifier 3	GO:0005515; F:protein binding; IPI:UniProtKB
P55854	SUMO3	Small ubiquitin-related modifier 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P55854	SUMO3	Small ubiquitin-related modifier 3	GO:0043687; P:post-translational protein modification; TAS:Reactome
P55854	SUMO3	Small ubiquitin-related modifier 3	GO:0016925; P:protein sumoylation; IEA:InterPro
Q6EEV6	SUMO4	Small ubiquitin-related modifier 4	GO:0016925; P:protein sumoylation; IEA:InterPro
O94901	SUN1	SUN domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
O94901	SUN1	SUN domain-containing protein 1	GO:0090286; P:cytoskeletal anchoring at nuclear membrane; IDA:UniProtKB
O94901	SUN1	SUN domain-containing protein 1	GO:0006998; P:nuclear envelope organization; IGI:MGI
O94901	SUN1	SUN domain-containing protein 1	GO:0090292; P:nuclear matrix anchoring at nuclear membrane; IDA:UniProtKB
Q9UH99	SUN2	SUN domain-containing protein 2	GO:0042802; F:identical protein binding; IPI:IntAct
Q9UH99	SUN2	SUN domain-containing protein 2	GO:0005521; F:lamin binding; IDA:UniProtKB
Q9UH99	SUN2	SUN domain-containing protein 2	GO:0008017; F:microtubule binding; TAS:UniProtKB
Q9UH99	SUN2	SUN domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UH99	SUN2	SUN domain-containing protein 2	GO:0051642; P:centrosome localization; ISS:UniProtKB
Q9UH99	SUN2	SUN domain-containing protein 2	GO:0090286; P:cytoskeletal anchoring at nuclear membrane; IDA:UniProtKB
Q9UH99	SUN2	SUN domain-containing protein 2	GO:0007052; P:mitotic spindle organization; TAS:UniProtKB
Q9UH99	SUN2	SUN domain-containing protein 2	GO:0006998; P:nuclear envelope organization; IGI:MGI
Q9UH99	SUN2	SUN domain-containing protein 2	GO:0090292; P:nuclear matrix anchoring at nuclear membrane; IDA:UniProtKB
Q9UH99	SUN2	SUN domain-containing protein 2	GO:0007097; P:nuclear migration; TAS:UniProtKB
Q9UH99	SUN2	SUN domain-containing protein 2	GO:0031022; P:nuclear migration along microfilament; ISS:UniProtKB
Q9UH99	SUN2	SUN domain-containing protein 2	GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB
Q8TC36	SUN5	SUN domain-containing protein 5	GO:0007283; P:spermatogenesis; IEP:UniProtKB
P51687	SUOX	Sulfite oxidase, mitochondrial	GO:0009055; F:electron carrier activity; IEA:InterPro
P51687	SUOX	Sulfite oxidase, mitochondrial	GO:0020037; F:heme binding; IEA:InterPro
P51687	SUOX	Sulfite oxidase, mitochondrial	GO:0030151; F:molybdenum ion binding; IEA:InterPro
P51687	SUOX	Sulfite oxidase, mitochondrial	GO:0043546; F:molybdopterin cofactor binding; IEA:InterPro
P51687	SUOX	Sulfite oxidase, mitochondrial	GO:0008482; F:sulfite oxidase activity; TAS:Reactome
P51687	SUOX	Sulfite oxidase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P51687	SUOX	Sulfite oxidase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P51687	SUOX	Sulfite oxidase, mitochondrial	GO:0070221; P:sulfide oxidation, using sulfide:quinone oxidoreductase; TAS:Reactome
P51687	SUOX	Sulfite oxidase, mitochondrial	GO:0000098; P:sulfur amino acid catabolic process; TAS:Reactome
P51687	SUOX	Sulfite oxidase, mitochondrial	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
O75486	SUPT3H	Transcription initiation protein SPT3 homolog	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
O75486	SUPT3H	Transcription initiation protein SPT3 homolog	GO:0006325; P:chromatin organization; TAS:Reactome
O75486	SUPT3H	Transcription initiation protein SPT3 homolog	GO:0016578; P:histone deubiquitination; IDA:UniProtKB
O75486	SUPT3H	Transcription initiation protein SPT3 homolog	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
O75486	SUPT3H	Transcription initiation protein SPT3 homolog	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
O75486	SUPT3H	Transcription initiation protein SPT3 homolog	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O75486	SUPT3H	Transcription initiation protein SPT3 homolog	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
O75486	SUPT3H	Transcription initiation protein SPT3 homolog	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q15526	SURF1	Surfeit locus protein 1	GO:0004129; F:cytochrome-c oxidase activity; TAS:ProtInc
Q15526	SURF1	Surfeit locus protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q15526	SURF1	Surfeit locus protein 1	GO:0009060; P:aerobic respiration; TAS:ProtInc
Q15526	SURF1	Surfeit locus protein 1	GO:0006754; P:ATP biosynthetic process; IMP:BHF-UCL
Q15526	SURF1	Surfeit locus protein 1	GO:1902600; P:hydrogen ion transmembrane transport; TAS:GOC
Q15526	SURF1	Surfeit locus protein 1	GO:0055114; P:oxidation-reduction process; TAS:ProtInc
Q15526	SURF1	Surfeit locus protein 1	GO:0006119; P:oxidative phosphorylation; IMP:BHF-UCL
Q15526	SURF1	Surfeit locus protein 1	GO:0008535; P:respiratory chain complex IV assembly; TAS:ProtInc
O15260	SURF4	Surfeit locus protein 4	GO:0005515; F:protein binding; IPI:IntAct
O15260	SURF4	Surfeit locus protein 4	GO:0007030; P:Golgi organization; IMP:UniProtKB
O15260	SURF4	Surfeit locus protein 4	GO:0010638; P:positive regulation of organelle organization; IMP:UniProtKB
O75683	SURF6	Surfeit locus protein 6	GO:0003677; F:DNA binding; ISS:UniProtKB
O75683	SURF6	Surfeit locus protein 6	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75683	SURF6	Surfeit locus protein 6	GO:0003723; F:RNA binding; ISS:UniProtKB
O75683	SURF6	Surfeit locus protein 6	GO:0042254; P:ribosome biogenesis; IEA:Ensembl
Q6UWL2	SUSD1	Sushi domain-containing protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UGT4	SUSD2	Sushi domain-containing protein 2	GO:0030247; F:polysaccharide binding; IEA:InterPro
Q9UGT4	SUSD2	Sushi domain-containing protein 2	GO:0005044; F:scavenger receptor activity; IEA:InterPro
Q9UGT4	SUSD2	Sushi domain-containing protein 2	GO:0006955; P:immune response; IEA:InterPro
O60279	SUSD5	Sushi domain-containing protein 5	GO:0005540; F:hyaluronic acid binding; IEA:InterPro
O60279	SUSD5	Sushi domain-containing protein 5	GO:0007155; P:cell adhesion; IEA:InterPro
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0034458; F:3'-5' RNA helicase activity; IDA:UniProtKB
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0004004; F:ATP-dependent RNA helicase activity; IDA:UniProtKB
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0003677; F:DNA binding; IMP:UniProtKB
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0003678; F:DNA helicase activity; IMP:UniProtKB
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0004386; F:helicase activity; TAS:ProtInc
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0003723; F:RNA binding; TAS:ProtInc
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0006200; P:ATP catabolic process; IDA:GOC
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0070827; P:chromatin maintenance; IMP:UniProtKB
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0032508; P:DNA duplex unwinding; IMP:UniProtKB
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0006310; P:DNA recombination; IMP:UniProtKB
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0000958; P:mitochondrial mRNA catabolic process; IMP:UniProtKB
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0035946; P:mitochondrial mRNA surveillance; IMP:UniProtKB
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0035945; P:mitochondrial ncRNA surveillance; IMP:UniProtKB
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0000965; P:mitochondrial RNA 3'-end processing; IMP:UniProtKB
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:2000827; P:mitochondrial RNA surveillance; IMP:UniProtKB
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0070584; P:mitochondrion morphogenesis; IMP:UniProtKB
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0030307; P:positive regulation of cell growth; IMP:UniProtKB
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0000962; P:positive regulation of mitochondrial RNA catabolic process; IDA:UniProtKB
Q8IYB8	SUPV3L1	ATP-dependent RNA helicase SUPV3L1, mitochondrial	GO:0006401; P:RNA catabolic process; IMP:UniProtKB
O43463	SUV39H1	Histone-lysine N-methyltransferase SUV39H1	GO:0003682; F:chromatin binding; TAS:ProtInc
O43463	SUV39H1	Histone-lysine N-methyltransferase SUV39H1	GO:0042054; F:histone methyltransferase activity; IDA:UniProtKB
O43463	SUV39H1	Histone-lysine N-methyltransferase SUV39H1	GO:0046974; F:histone methyltransferase activity (H3-K9 specific); IDA:UniProtKB
O43463	SUV39H1	Histone-lysine N-methyltransferase SUV39H1	GO:0018024; F:histone-lysine N-methyltransferase activity; IDA:UniProtKB
O43463	SUV39H1	Histone-lysine N-methyltransferase SUV39H1	GO:0005515; F:protein binding; IPI:IntAct
O43463	SUV39H1	Histone-lysine N-methyltransferase SUV39H1	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
O43463	SUV39H1	Histone-lysine N-methyltransferase SUV39H1	GO:0008757; F:S-adenosylmethionine-dependent methyltransferase activity; IDA:UniProtKB
O43463	SUV39H1	Histone-lysine N-methyltransferase SUV39H1	GO:0008270; F:zinc ion binding; IEA:InterPro
O43463	SUV39H1	Histone-lysine N-methyltransferase SUV39H1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
O43463	SUV39H1	Histone-lysine N-methyltransferase SUV39H1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O43463	SUV39H1	Histone-lysine N-methyltransferase SUV39H1	GO:0006325; P:chromatin organization; TAS:ProtInc
O43463	SUV39H1	Histone-lysine N-methyltransferase SUV39H1	GO:0000183; P:chromatin silencing at rDNA; IDA:UniProtKB
O43463	SUV39H1	Histone-lysine N-methyltransferase SUV39H1	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
O43463	SUV39H1	Histone-lysine N-methyltransferase SUV39H1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43463	SUV39H1	Histone-lysine N-methyltransferase SUV39H1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9H5I1	SUV39H2	Histone-lysine N-methyltransferase SUV39H2	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9H5I1	SUV39H2	Histone-lysine N-methyltransferase SUV39H2	GO:0046974; F:histone methyltransferase activity (H3-K9 specific); IDA:UniProtKB
Q9H5I1	SUV39H2	Histone-lysine N-methyltransferase SUV39H2	GO:0005515; F:protein binding; IPI:IntAct
Q9H5I1	SUV39H2	Histone-lysine N-methyltransferase SUV39H2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H5I1	SUV39H2	Histone-lysine N-methyltransferase SUV39H2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9H5I1	SUV39H2	Histone-lysine N-methyltransferase SUV39H2	GO:0006333; P:chromatin assembly or disassembly; IMP:UniProtKB
Q9H5I1	SUV39H2	Histone-lysine N-methyltransferase SUV39H2	GO:0006338; P:chromatin remodeling; IDA:UniProtKB
Q9H5I1	SUV39H2	Histone-lysine N-methyltransferase SUV39H2	GO:0007140; P:male meiosis; IEA:Ensembl
Q9H5I1	SUV39H2	Histone-lysine N-methyltransferase SUV39H2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H5I1	SUV39H2	Histone-lysine N-methyltransferase SUV39H2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15022	SUZ12	Polycomb protein SUZ12	GO:0003682; F:chromatin binding; IEA:Ensembl
Q15022	SUZ12	Polycomb protein SUZ12	GO:0042054; F:histone methyltransferase activity; IMP:MGI
Q15022	SUZ12	Polycomb protein SUZ12	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15022	SUZ12	Polycomb protein SUZ12	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q15022	SUZ12	Polycomb protein SUZ12	GO:0005515; F:protein binding; IPI:UniProtKB
Q15022	SUZ12	Polycomb protein SUZ12	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q15022	SUZ12	Polycomb protein SUZ12	GO:0016574; P:histone ubiquitination; IEA:Ensembl
Q15022	SUZ12	Polycomb protein SUZ12	GO:0045596; P:negative regulation of cell differentiation; IMP:UniProtKB
Q15022	SUZ12	Polycomb protein SUZ12	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q15022	SUZ12	Polycomb protein SUZ12	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q15022	SUZ12	Polycomb protein SUZ12	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7L0J3	SV2A	Synaptic vesicle glycoprotein 2A	GO:0004872; F:receptor activity; IEA:Ensembl
Q7L0J3	SV2A	Synaptic vesicle glycoprotein 2A	GO:0022857; F:transmembrane transporter activity; IEA:InterPro
Q7L0J3	SV2A	Synaptic vesicle glycoprotein 2A	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
Q7L0J3	SV2A	Synaptic vesicle glycoprotein 2A	GO:0006836; P:neurotransmitter transport; IEA:UniProtKB-KW
Q7L1I2	SV2B	Synaptic vesicle glycoprotein 2B	GO:0022857; F:transmembrane transporter activity; IEA:InterPro
Q7L1I2	SV2B	Synaptic vesicle glycoprotein 2B	GO:0006836; P:neurotransmitter transport; IEA:UniProtKB-KW
Q496J9	SV2C	Synaptic vesicle glycoprotein 2C	GO:0022857; F:transmembrane transporter activity; IEA:InterPro
Q496J9	SV2C	Synaptic vesicle glycoprotein 2C	GO:0006836; P:neurotransmitter transport; IEA:UniProtKB-KW
Q4FZB7	SUV420H1	Histone-lysine N-methyltransferase SUV420H1	GO:0042799; F:histone methyltransferase activity (H4-K20 specific); IEA:Ensembl
Q4FZB7	SUV420H1	Histone-lysine N-methyltransferase SUV420H1	GO:0018024; F:histone-lysine N-methyltransferase activity; IDA:UniProtKB
Q4FZB7	SUV420H1	Histone-lysine N-methyltransferase SUV420H1	GO:0034773; P:histone H4-K20 trimethylation; IEA:InterPro
Q4FZB7	SUV420H1	Histone-lysine N-methyltransferase SUV420H1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q4FZB7	SUV420H1	Histone-lysine N-methyltransferase SUV420H1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86Y97	SUV420H2	Histone-lysine N-methyltransferase SUV420H2	GO:0070087; F:chromo shadow domain binding; IPI:BHF-UCL
Q86Y97	SUV420H2	Histone-lysine N-methyltransferase SUV420H2	GO:0042799; F:histone methyltransferase activity (H4-K20 specific); IEA:Ensembl
Q86Y97	SUV420H2	Histone-lysine N-methyltransferase SUV420H2	GO:0005515; F:protein binding; IPI:UniProtKB
Q86Y97	SUV420H2	Histone-lysine N-methyltransferase SUV420H2	GO:0034773; P:histone H4-K20 trimethylation; IEA:InterPro
Q86Y97	SUV420H2	Histone-lysine N-methyltransferase SUV420H2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q86Y97	SUV420H2	Histone-lysine N-methyltransferase SUV420H2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q4LDE5	SVEP1	Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q4LDE5	SVEP1	Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q4LDE5	SVEP1	Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
O95425	SVIL	Supervillin	GO:0051015; F:actin filament binding; IDA:UniProtKB
O95425	SVIL	Supervillin	GO:0005515; F:protein binding; IPI:IntAct
O95425	SVIL	Supervillin	GO:0007010; P:cytoskeleton organization; IEA:InterPro
O95425	SVIL	Supervillin	GO:0007519; P:skeletal muscle tissue development; IMP:UniProtKB
Q8N434	SVOPL	Putative transporter SVOPL	GO:0022857; F:transmembrane transporter activity; IEA:InterPro
Q8N4V2	SVOP	Synaptic vesicle 2-related protein	GO:0015075; F:ion transmembrane transporter activity; IEA:InterPro
Q6NVH7	SWSAP1	ATPase SWSAP1	GO:0016887; F:ATPase activity; IDA:UniProtKB
Q6NVH7	SWSAP1	ATPase SWSAP1	GO:0005515; F:protein binding; IPI:IntAct
Q6NVH7	SWSAP1	ATPase SWSAP1	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
Q6NVH7	SWSAP1	ATPase SWSAP1	GO:0006200; P:ATP catabolic process; IDA:UniProtKB
Q6NVH7	SWSAP1	ATPase SWSAP1	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
Q6NVH7	SWSAP1	ATPase SWSAP1	GO:0050821; P:protein stabilization; IMP:UniProtKB
Q9BRV3	SLC50A1	Sugar transporter SWEET1	GO:0042947; F:glucoside transmembrane transporter activity; IDA:UniProtKB
Q9BRV3	SLC50A1	Sugar transporter SWEET1	GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW
Q9BRV3	SLC50A1	Sugar transporter SWEET1	GO:0042946; P:glucoside transport; IDA:GOC
Q9BRV3	SLC50A1	Sugar transporter SWEET1	GO:0045815; P:positive regulation of gene expression, epigenetic; ISS:HGNC
Q1ZZU3	SWI5	DNA repair protein SWI5 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q1ZZU3	SWI5	DNA repair protein SWI5 homolog	GO:0071479; P:cellular response to ionizing radiation; IDA:UniProtKB
Q1ZZU3	SWI5	DNA repair protein SWI5 homolog	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
Q9UH65	SWAP70	Switch-associated protein 70	GO:0005524; F:ATP binding; IEA:Ensembl
Q9UH65	SWAP70	Switch-associated protein 70	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UH65	SWAP70	Switch-associated protein 70	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UH65	SWAP70	Switch-associated protein 70	GO:0045190; P:isotype switching; IEA:Ensembl
P49588	AARS	Alanine--tRNA ligase, cytoplasmic	GO:0004813; F:alanine-tRNA ligase activity; IEA:UniProtKB-EC
P49588	AARS	Alanine--tRNA ligase, cytoplasmic	GO:0016597; F:amino acid binding; IEA:Ensembl
P49588	AARS	Alanine--tRNA ligase, cytoplasmic	GO:0002161; F:aminoacyl-tRNA editing activity; IEA:Ensembl
P49588	AARS	Alanine--tRNA ligase, cytoplasmic	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49588	AARS	Alanine--tRNA ligase, cytoplasmic	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P49588	AARS	Alanine--tRNA ligase, cytoplasmic	GO:0000049; F:tRNA binding; TAS:ProtInc
P49588	AARS	Alanine--tRNA ligase, cytoplasmic	GO:0006419; P:alanyl-tRNA aminoacylation; TAS:ProtInc
P49588	AARS	Alanine--tRNA ligase, cytoplasmic	GO:0008219; P:cell death; IEA:UniProtKB-KW
P49588	AARS	Alanine--tRNA ligase, cytoplasmic	GO:0021680; P:cerebellar Purkinje cell layer development; IEA:Ensembl
P49588	AARS	Alanine--tRNA ligase, cytoplasmic	GO:0030968; P:endoplasmic reticulum unfolded protein response; IEA:Ensembl
P49588	AARS	Alanine--tRNA ligase, cytoplasmic	GO:0010467; P:gene expression; TAS:Reactome
P49588	AARS	Alanine--tRNA ligase, cytoplasmic	GO:0001942; P:hair follicle development; IEA:Ensembl
P49588	AARS	Alanine--tRNA ligase, cytoplasmic	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P49588	AARS	Alanine--tRNA ligase, cytoplasmic	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
P49588	AARS	Alanine--tRNA ligase, cytoplasmic	GO:0006457; P:protein folding; IEA:Ensembl
P49588	AARS	Alanine--tRNA ligase, cytoplasmic	GO:0043200; P:response to amino acid; IEA:Ensembl
P49588	AARS	Alanine--tRNA ligase, cytoplasmic	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
P49588	AARS	Alanine--tRNA ligase, cytoplasmic	GO:0006400; P:tRNA modification; IEA:Ensembl
P49588	AARS	Alanine--tRNA ligase, cytoplasmic	GO:0008033; P:tRNA processing; TAS:ProtInc
Q5JTZ9	AARS2	Alanine--tRNA ligase, mitochondrial	GO:0004813; F:alanine-tRNA ligase activity; IMP:BHF-UCL
Q5JTZ9	AARS2	Alanine--tRNA ligase, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5JTZ9	AARS2	Alanine--tRNA ligase, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5JTZ9	AARS2	Alanine--tRNA ligase, mitochondrial	GO:0000049; F:tRNA binding; IEA:UniProtKB-KW
Q5JTZ9	AARS2	Alanine--tRNA ligase, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
Q5JTZ9	AARS2	Alanine--tRNA ligase, mitochondrial	GO:0070143; P:mitochondrial alanyl-tRNA aminoacylation; IMP:BHF-UCL
Q5JTZ9	AARS2	Alanine--tRNA ligase, mitochondrial	GO:0033108; P:mitochondrial respiratory chain complex assembly; IMP:BHF-UCL
Q5JTZ9	AARS2	Alanine--tRNA ligase, mitochondrial	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q9NX95	SYBU	Syntabulin	GO:0005515; F:protein binding; IPI:IntAct
Q9NX95	SYBU	Syntabulin	GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl
A8MT33	SYCE1L	Synaptonemal complex central element protein 1-like	GO:0007130; P:synaptonemal complex assembly; IEA:InterPro
P49589	CARS	Cysteine--tRNA ligase, cytoplasmic	GO:0005524; F:ATP binding; IDA:UniProtKB
P49589	CARS	Cysteine--tRNA ligase, cytoplasmic	GO:0004817; F:cysteine-tRNA ligase activity; IDA:UniProtKB
P49589	CARS	Cysteine--tRNA ligase, cytoplasmic	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P49589	CARS	Cysteine--tRNA ligase, cytoplasmic	GO:0005515; F:protein binding; IPI:UniProtKB
P49589	CARS	Cysteine--tRNA ligase, cytoplasmic	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P49589	CARS	Cysteine--tRNA ligase, cytoplasmic	GO:0000049; F:tRNA binding; IDA:UniProtKB
P49589	CARS	Cysteine--tRNA ligase, cytoplasmic	GO:0006423; P:cysteinyl-tRNA aminoacylation; IDA:UniProtKB
P49589	CARS	Cysteine--tRNA ligase, cytoplasmic	GO:0010467; P:gene expression; TAS:Reactome
P49589	CARS	Cysteine--tRNA ligase, cytoplasmic	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q8N0S2	SYCE1	Synaptonemal complex central element protein 1	GO:0007130; P:synaptonemal complex assembly; IC:BHF-UCL
Q6PIF2	SYCE2	Synaptonemal complex central element protein 2	GO:0007130; P:synaptonemal complex assembly; IC:BHF-UCL
A1L190	SYCE3	Synaptonemal complex central element protein 3	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
A1L190	SYCE3	Synaptonemal complex central element protein 3	GO:0007131; P:reciprocal meiotic recombination; ISS:UniProtKB
A1L190	SYCE3	Synaptonemal complex central element protein 3	GO:0007283; P:spermatogenesis; ISS:UniProtKB
A1L190	SYCE3	Synaptonemal complex central element protein 3	GO:0007130; P:synaptonemal complex assembly; ISS:UniProtKB
Q9HA77	CARS2	Probable cysteine--tRNA ligase, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9HA77	CARS2	Probable cysteine--tRNA ligase, mitochondrial	GO:0004817; F:cysteine-tRNA ligase activity; IBA:RefGenome
Q9HA77	CARS2	Probable cysteine--tRNA ligase, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HA77	CARS2	Probable cysteine--tRNA ligase, mitochondrial	GO:0006423; P:cysteinyl-tRNA aminoacylation; IBA:RefGenome
Q9HA77	CARS2	Probable cysteine--tRNA ligase, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
Q9HA77	CARS2	Probable cysteine--tRNA ligase, mitochondrial	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q0VAF6	SYCN	Syncollin	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q15431	SYCP1	Synaptonemal complex protein 1	GO:0003677; F:DNA binding; TAS:ProtInc
Q15431	SYCP1	Synaptonemal complex protein 1	GO:0007131; P:reciprocal meiotic recombination; TAS:ProtInc
Q15431	SYCP1	Synaptonemal complex protein 1	GO:0032880; P:regulation of protein localization; IEA:Ensembl
Q15431	SYCP1	Synaptonemal complex protein 1	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q15431	SYCP1	Synaptonemal complex protein 1	GO:0007130; P:synaptonemal complex assembly; ISS:HGNC
Q9BX26	SYCP2	Synaptonemal complex protein 2	GO:0003677; F:DNA binding; NAS:UniProtKB
Q9BX26	SYCP2	Synaptonemal complex protein 2	GO:0007143; P:female meiotic division; IEA:Ensembl
Q9BX26	SYCP2	Synaptonemal complex protein 2	GO:0009566; P:fertilization; IEA:Ensembl
Q9BX26	SYCP2	Synaptonemal complex protein 2	GO:0048808; P:male genitalia morphogenesis; IEA:Ensembl
Q9BX26	SYCP2	Synaptonemal complex protein 2	GO:0007140; P:male meiosis; IEA:Ensembl
Q9BX26	SYCP2	Synaptonemal complex protein 2	GO:0007128; P:meiotic prophase I; NAS:UniProtKB
Q9BX26	SYCP2	Synaptonemal complex protein 2	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q9BX26	SYCP2	Synaptonemal complex protein 2	GO:0007130; P:synaptonemal complex assembly; NAS:UniProtKB
Q8IZU3	SYCP3	Synaptonemal complex protein 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IZU3	SYCP3	Synaptonemal complex protein 3	GO:0007141; P:male meiosis I; NAS:UniProtKB
Q8IZU3	SYCP3	Synaptonemal complex protein 3	GO:0035093; P:spermatogenesis, exchange of chromosomal proteins; IMP:UniProtKB
P14868	DARS	Aspartate--tRNA ligase, cytoplasmic	GO:0004046; F:aminoacylase activity; TAS:ProtInc
P14868	DARS	Aspartate--tRNA ligase, cytoplasmic	GO:0004815; F:aspartate-tRNA ligase activity; TAS:ProtInc
P14868	DARS	Aspartate--tRNA ligase, cytoplasmic	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P14868	DARS	Aspartate--tRNA ligase, cytoplasmic	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P14868	DARS	Aspartate--tRNA ligase, cytoplasmic	GO:0005515; F:protein binding; IPI:IntAct
P14868	DARS	Aspartate--tRNA ligase, cytoplasmic	GO:0006422; P:aspartyl-tRNA aminoacylation; TAS:ProtInc
P14868	DARS	Aspartate--tRNA ligase, cytoplasmic	GO:0010467; P:gene expression; TAS:Reactome
P14868	DARS	Aspartate--tRNA ligase, cytoplasmic	GO:0006461; P:protein complex assembly; TAS:ProtInc
P14868	DARS	Aspartate--tRNA ligase, cytoplasmic	GO:0006412; P:translation; TAS:ProtInc
P14868	DARS	Aspartate--tRNA ligase, cytoplasmic	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q5VT97	SYDE2	Rho GTPase-activating protein SYDE2	GO:0005100; F:Rho GTPase activator activity; ISS:UniProtKB
Q5VT97	SYDE2	Rho GTPase-activating protein SYDE2	GO:0032862; P:activation of Rho GTPase activity; ISS:UniProtKB
Q5VT97	SYDE2	Rho GTPase-activating protein SYDE2	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q5VT97	SYDE2	Rho GTPase-activating protein SYDE2	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q6ZW31	SYDE1	Rho GTPase-activating protein SYDE1	GO:0005100; F:Rho GTPase activator activity; ISS:UniProtKB
Q6ZW31	SYDE1	Rho GTPase-activating protein SYDE1	GO:0032862; P:activation of Rho GTPase activity; ISS:UniProtKB
Q6ZW31	SYDE1	Rho GTPase-activating protein SYDE1	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q6ZW31	SYDE1	Rho GTPase-activating protein SYDE1	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q6PI48	DARS2	Aspartate--tRNA ligase, mitochondrial	GO:0004815; F:aspartate-tRNA ligase activity; TAS:Reactome
Q6PI48	DARS2	Aspartate--tRNA ligase, mitochondrial	GO:0050560; F:aspartate-tRNA(Asn) ligase activity; IDA:BHF-UCL
Q6PI48	DARS2	Aspartate--tRNA ligase, mitochondrial	GO:0005524; F:ATP binding; TAS:BHF-UCL
Q6PI48	DARS2	Aspartate--tRNA ligase, mitochondrial	GO:0005515; F:protein binding; IPI:BHF-UCL
Q6PI48	DARS2	Aspartate--tRNA ligase, mitochondrial	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q6PI48	DARS2	Aspartate--tRNA ligase, mitochondrial	GO:0000049; F:tRNA binding; TAS:BHF-UCL
Q6PI48	DARS2	Aspartate--tRNA ligase, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
Q6PI48	DARS2	Aspartate--tRNA ligase, mitochondrial	GO:0070145; P:mitochondrial asparaginyl-tRNA aminoacylation; IC:BHF-UCL
Q6PI48	DARS2	Aspartate--tRNA ligase, mitochondrial	GO:0043039; P:tRNA aminoacylation; IDA:BHF-UCL
Q6PI48	DARS2	Aspartate--tRNA ligase, mitochondrial	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q5JPH6	EARS2	Probable glutamate--tRNA ligase, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5JPH6	EARS2	Probable glutamate--tRNA ligase, mitochondrial	GO:0004818; F:glutamate-tRNA ligase activity; IDA:UniProtKB
Q5JPH6	EARS2	Probable glutamate--tRNA ligase, mitochondrial	GO:0050561; F:glutamate-tRNA(Gln) ligase activity; IDA:UniProtKB
Q5JPH6	EARS2	Probable glutamate--tRNA ligase, mitochondrial	GO:0000049; F:tRNA binding; IEA:InterPro
Q5JPH6	EARS2	Probable glutamate--tRNA ligase, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
Q5JPH6	EARS2	Probable glutamate--tRNA ligase, mitochondrial	GO:0006424; P:glutamyl-tRNA aminoacylation; IDA:UniProtKB
Q5JPH6	EARS2	Probable glutamate--tRNA ligase, mitochondrial	GO:0070127; P:tRNA aminoacylation for mitochondrial protein translation; IDA:UniProtKB
Q5JPH6	EARS2	Probable glutamate--tRNA ligase, mitochondrial	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
P07814	EPRS	Bifunctional glutamate/proline--tRNA ligase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P07814	EPRS	Bifunctional glutamate/proline--tRNA ligase	GO:0004818; F:glutamate-tRNA ligase activity; TAS:Reactome
P07814	EPRS	Bifunctional glutamate/proline--tRNA ligase	GO:0004827; F:proline-tRNA ligase activity; TAS:Reactome
P07814	EPRS	Bifunctional glutamate/proline--tRNA ligase	GO:0005515; F:protein binding; IPI:IntAct
P07814	EPRS	Bifunctional glutamate/proline--tRNA ligase	GO:0035613; F:RNA stem-loop binding; IDA:UniProtKB
P07814	EPRS	Bifunctional glutamate/proline--tRNA ligase	GO:0071346; P:cellular response to interferon-gamma; IDA:UniProtKB
P07814	EPRS	Bifunctional glutamate/proline--tRNA ligase	GO:0010467; P:gene expression; TAS:Reactome
P07814	EPRS	Bifunctional glutamate/proline--tRNA ligase	GO:0006424; P:glutamyl-tRNA aminoacylation; IEA:InterPro
P07814	EPRS	Bifunctional glutamate/proline--tRNA ligase	GO:0017148; P:negative regulation of translation; IDA:UniProtKB
P07814	EPRS	Bifunctional glutamate/proline--tRNA ligase	GO:0006433; P:prolyl-tRNA aminoacylation; IEA:InterPro
P07814	EPRS	Bifunctional glutamate/proline--tRNA ligase	GO:0006461; P:protein complex assembly; TAS:ProtInc
P07814	EPRS	Bifunctional glutamate/proline--tRNA ligase	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q9HCS7	XAB2	Pre-mRNA-splicing factor SYF1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HCS7	XAB2	Pre-mRNA-splicing factor SYF1	GO:0001824; P:blastocyst development; IEA:Ensembl
Q9HCS7	XAB2	Pre-mRNA-splicing factor SYF1	GO:0006281; P:DNA repair; TAS:Reactome
Q9HCS7	XAB2	Pre-mRNA-splicing factor SYF1	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q9HCS7	XAB2	Pre-mRNA-splicing factor SYF1	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
Q9HCS7	XAB2	Pre-mRNA-splicing factor SYF1	GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB
Q9HCS7	XAB2	Pre-mRNA-splicing factor SYF1	GO:0006283; P:transcription-coupled nucleotide-excision repair; IDA:UniProtKB
O95926	SYF2	Pre-mRNA-splicing factor SYF2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O95926	SYF2	Pre-mRNA-splicing factor SYF2	GO:0048568; P:embryonic organ development; IEA:Ensembl
O95926	SYF2	Pre-mRNA-splicing factor SYF2	GO:0007369; P:gastrulation; IEA:Ensembl
O95926	SYF2	Pre-mRNA-splicing factor SYF2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O95926	SYF2	Pre-mRNA-splicing factor SYF2	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q9Y285	FARSA	Phenylalanine--tRNA ligase alpha subunit	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y285	FARSA	Phenylalanine--tRNA ligase alpha subunit	GO:0004826; F:phenylalanine-tRNA ligase activity; TAS:ProtInc
Q9Y285	FARSA	Phenylalanine--tRNA ligase alpha subunit	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y285	FARSA	Phenylalanine--tRNA ligase alpha subunit	GO:0005515; F:protein binding; IPI:IntAct
Q9Y285	FARSA	Phenylalanine--tRNA ligase alpha subunit	GO:0000049; F:tRNA binding; IEA:InterPro
Q9Y285	FARSA	Phenylalanine--tRNA ligase alpha subunit	GO:0010467; P:gene expression; TAS:Reactome
Q9Y285	FARSA	Phenylalanine--tRNA ligase alpha subunit	GO:0006432; P:phenylalanyl-tRNA aminoacylation; IEA:InterPro
Q9Y285	FARSA	Phenylalanine--tRNA ligase alpha subunit	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q9NSD9	FARSB	Phenylalanine--tRNA ligase beta subunit	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NSD9	FARSB	Phenylalanine--tRNA ligase beta subunit	GO:0000287; F:magnesium ion binding; IEA:InterPro
Q9NSD9	FARSB	Phenylalanine--tRNA ligase beta subunit	GO:0004826; F:phenylalanine-tRNA ligase activity; TAS:ProtInc
Q9NSD9	FARSB	Phenylalanine--tRNA ligase beta subunit	GO:0003723; F:RNA binding; IEA:InterPro
Q9NSD9	FARSB	Phenylalanine--tRNA ligase beta subunit	GO:0010467; P:gene expression; TAS:Reactome
Q9NSD9	FARSB	Phenylalanine--tRNA ligase beta subunit	GO:0006432; P:phenylalanyl-tRNA aminoacylation; IEA:InterPro
Q9NSD9	FARSB	Phenylalanine--tRNA ligase beta subunit	GO:0006412; P:translation; TAS:ProtInc
Q9NSD9	FARSB	Phenylalanine--tRNA ligase beta subunit	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
O95363	FARS2	Phenylalanine--tRNA ligase, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O95363	FARS2	Phenylalanine--tRNA ligase, mitochondrial	GO:0000287; F:magnesium ion binding; IEA:InterPro
O95363	FARS2	Phenylalanine--tRNA ligase, mitochondrial	GO:0004826; F:phenylalanine-tRNA ligase activity; IDA:UniProtKB
O95363	FARS2	Phenylalanine--tRNA ligase, mitochondrial	GO:0000049; F:tRNA binding; IDA:UniProtKB
O95363	FARS2	Phenylalanine--tRNA ligase, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
O95363	FARS2	Phenylalanine--tRNA ligase, mitochondrial	GO:0006432; P:phenylalanyl-tRNA aminoacylation; IDA:UniProtKB
O95363	FARS2	Phenylalanine--tRNA ligase, mitochondrial	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
O95363	FARS2	Phenylalanine--tRNA ligase, mitochondrial	GO:0008033; P:tRNA processing; IDA:UniProtKB
Q96PV0	SYNGAP1	Ras/Rap GTPase-activating protein SynGAP	GO:0005097; F:Rab GTPase activator activity; IEA:Ensembl
Q96PV0	SYNGAP1	Ras/Rap GTPase-activating protein SynGAP	GO:0005099; F:Ras GTPase activator activity; IBA:RefGenome
Q96PV0	SYNGAP1	Ras/Rap GTPase-activating protein SynGAP	GO:0016358; P:dendrite development; IEA:Ensembl
Q96PV0	SYNGAP1	Ras/Rap GTPase-activating protein SynGAP	GO:0050771; P:negative regulation of axonogenesis; IEA:Ensembl
Q96PV0	SYNGAP1	Ras/Rap GTPase-activating protein SynGAP	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q96PV0	SYNGAP1	Ras/Rap GTPase-activating protein SynGAP	GO:0046580; P:negative regulation of Ras protein signal transduction; ISS:UniProtKB
Q96PV0	SYNGAP1	Ras/Rap GTPase-activating protein SynGAP	GO:0007389; P:pattern specification process; IEA:Ensembl
Q96PV0	SYNGAP1	Ras/Rap GTPase-activating protein SynGAP	GO:0032320; P:positive regulation of Ras GTPase activity; IBA:RefGenome
Q96PV0	SYNGAP1	Ras/Rap GTPase-activating protein SynGAP	GO:0007265; P:Ras protein signal transduction; IEA:Ensembl
Q96PV0	SYNGAP1	Ras/Rap GTPase-activating protein SynGAP	GO:0043113; P:receptor clustering; IEA:Ensembl
Q96PV0	SYNGAP1	Ras/Rap GTPase-activating protein SynGAP	GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IEA:Ensembl
Q96PV0	SYNGAP1	Ras/Rap GTPase-activating protein SynGAP	GO:0043408; P:regulation of MAPK cascade; IEA:Ensembl
Q96PV0	SYNGAP1	Ras/Rap GTPase-activating protein SynGAP	GO:0050803; P:regulation of synapse structure and activity; IEA:Ensembl
Q96PV0	SYNGAP1	Ras/Rap GTPase-activating protein SynGAP	GO:0048167; P:regulation of synaptic plasticity; ISS:UniProtKB
Q96PV0	SYNGAP1	Ras/Rap GTPase-activating protein SynGAP	GO:0008542; P:visual learning; IEA:Ensembl
P41250	GARS	Glycine--tRNA ligase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P41250	GARS	Glycine--tRNA ligase	GO:0004820; F:glycine-tRNA ligase activity; IDA:UniProtKB
P41250	GARS	Glycine--tRNA ligase	GO:0046983; F:protein dimerization activity; IDA:UniProtKB
P41250	GARS	Glycine--tRNA ligase	GO:0008219; P:cell death; IEA:UniProtKB-KW
P41250	GARS	Glycine--tRNA ligase	GO:0015966; P:diadenosine tetraphosphate biosynthetic process; IDA:UniProtKB
P41250	GARS	Glycine--tRNA ligase	GO:0010467; P:gene expression; TAS:Reactome
P41250	GARS	Glycine--tRNA ligase	GO:0006426; P:glycyl-tRNA aminoacylation; IEA:InterPro
P41250	GARS	Glycine--tRNA ligase	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
P12081	HARS	Histidine--tRNA ligase, cytoplasmic	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P12081	HARS	Histidine--tRNA ligase, cytoplasmic	GO:0004821; F:histidine-tRNA ligase activity; NAS:UniProtKB
P12081	HARS	Histidine--tRNA ligase, cytoplasmic	GO:0010467; P:gene expression; TAS:Reactome
P12081	HARS	Histidine--tRNA ligase, cytoplasmic	GO:0006427; P:histidyl-tRNA aminoacylation; IEA:InterPro
P12081	HARS	Histidine--tRNA ligase, cytoplasmic	GO:0006412; P:translation; NAS:UniProtKB
P12081	HARS	Histidine--tRNA ligase, cytoplasmic	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
P49590	HARS2	Probable histidine--tRNA ligase, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49590	HARS2	Probable histidine--tRNA ligase, mitochondrial	GO:0004821; F:histidine-tRNA ligase activity; NAS:UniProtKB
P49590	HARS2	Probable histidine--tRNA ligase, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P49590	HARS2	Probable histidine--tRNA ligase, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
P49590	HARS2	Probable histidine--tRNA ligase, mitochondrial	GO:0006427; P:histidyl-tRNA aminoacylation; IEA:InterPro
P49590	HARS2	Probable histidine--tRNA ligase, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
P49590	HARS2	Probable histidine--tRNA ligase, mitochondrial	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
P41252	IARS	Isoleucine--tRNA ligase, cytoplasmic	GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro
P41252	IARS	Isoleucine--tRNA ligase, cytoplasmic	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P41252	IARS	Isoleucine--tRNA ligase, cytoplasmic	GO:0004822; F:isoleucine-tRNA ligase activity; TAS:Reactome
P41252	IARS	Isoleucine--tRNA ligase, cytoplasmic	GO:0005515; F:protein binding; IPI:IntAct
P41252	IARS	Isoleucine--tRNA ligase, cytoplasmic	GO:0010467; P:gene expression; TAS:Reactome
P41252	IARS	Isoleucine--tRNA ligase, cytoplasmic	GO:0006428; P:isoleucyl-tRNA aminoacylation; IEA:InterPro
P41252	IARS	Isoleucine--tRNA ligase, cytoplasmic	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q9NSE4	IARS2	Isoleucine--tRNA ligase, mitochondrial	GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro
Q9NSE4	IARS2	Isoleucine--tRNA ligase, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NSE4	IARS2	Isoleucine--tRNA ligase, mitochondrial	GO:0004822; F:isoleucine-tRNA ligase activity; IEA:UniProtKB-EC
Q9NSE4	IARS2	Isoleucine--tRNA ligase, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
Q9NSE4	IARS2	Isoleucine--tRNA ligase, mitochondrial	GO:0006428; P:isoleucyl-tRNA aminoacylation; IEA:InterPro
Q9NSE4	IARS2	Isoleucine--tRNA ligase, mitochondrial	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
P57105	SYNJ2BP	Synaptojanin-2-binding protein	GO:0048312; P:intracellular distribution of mitochondria; IEA:Ensembl
P57105	SYNJ2BP	Synaptojanin-2-binding protein	GO:0032926; P:negative regulation of activin receptor signaling pathway; IEA:Ensembl
P57105	SYNJ2BP	Synaptojanin-2-binding protein	GO:0032927; P:positive regulation of activin receptor signaling pathway; IEA:Ensembl
P57105	SYNJ2BP	Synaptojanin-2-binding protein	GO:2000010; P:positive regulation of protein localization to cell surface; IEA:Ensembl
P57105	SYNJ2BP	Synaptojanin-2-binding protein	GO:0002092; P:positive regulation of receptor internalization; IEA:Ensembl
Q15046	KARS	Lysine--tRNA ligase	GO:0016597; F:amino acid binding; IEA:Ensembl
Q15046	KARS	Lysine--tRNA ligase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q15046	KARS	Lysine--tRNA ligase	GO:0004824; F:lysine-tRNA ligase activity; IDA:UniProtKB
Q15046	KARS	Lysine--tRNA ligase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15046	KARS	Lysine--tRNA ligase	GO:0005515; F:protein binding; IPI:IntAct
Q15046	KARS	Lysine--tRNA ligase	GO:0000049; F:tRNA binding; NAS:UniProtKB
Q15046	KARS	Lysine--tRNA ligase	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q15046	KARS	Lysine--tRNA ligase	GO:0015966; P:diadenosine tetraphosphate biosynthetic process; IEA:Ensembl
Q15046	KARS	Lysine--tRNA ligase	GO:0010467; P:gene expression; TAS:Reactome
Q15046	KARS	Lysine--tRNA ligase	GO:0006430; P:lysyl-tRNA aminoacylation; IDA:UniProtKB
Q15046	KARS	Lysine--tRNA ligase	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q15046	KARS	Lysine--tRNA ligase	GO:0008033; P:tRNA processing; NAS:UniProtKB
Q15046	KARS	Lysine--tRNA ligase	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9P2J5	LARS	Leucine--tRNA ligase, cytoplasmic	GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro
Q9P2J5	LARS	Leucine--tRNA ligase, cytoplasmic	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9P2J5	LARS	Leucine--tRNA ligase, cytoplasmic	GO:0004823; F:leucine-tRNA ligase activity; TAS:Reactome
Q9P2J5	LARS	Leucine--tRNA ligase, cytoplasmic	GO:0005515; F:protein binding; IPI:IntAct
Q9P2J5	LARS	Leucine--tRNA ligase, cytoplasmic	GO:0010467; P:gene expression; TAS:Reactome
Q9P2J5	LARS	Leucine--tRNA ligase, cytoplasmic	GO:0006429; P:leucyl-tRNA aminoacylation; IEA:InterPro
Q9P2J5	LARS	Leucine--tRNA ligase, cytoplasmic	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q15031	LARS2	Probable leucine--tRNA ligase, mitochondrial	GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro
Q15031	LARS2	Probable leucine--tRNA ligase, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q15031	LARS2	Probable leucine--tRNA ligase, mitochondrial	GO:0004823; F:leucine-tRNA ligase activity; IEA:UniProtKB-EC
Q15031	LARS2	Probable leucine--tRNA ligase, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
Q15031	LARS2	Probable leucine--tRNA ligase, mitochondrial	GO:0006429; P:leucyl-tRNA aminoacylation; IEA:InterPro
Q15031	LARS2	Probable leucine--tRNA ligase, mitochondrial	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
P56192	MARS	Methionine--tRNA ligase, cytoplasmic	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P56192	MARS	Methionine--tRNA ligase, cytoplasmic	GO:0004825; F:methionine-tRNA ligase activity; TAS:Reactome
P56192	MARS	Methionine--tRNA ligase, cytoplasmic	GO:0000049; F:tRNA binding; IEA:UniProtKB-KW
P56192	MARS	Methionine--tRNA ligase, cytoplasmic	GO:0010467; P:gene expression; TAS:Reactome
P56192	MARS	Methionine--tRNA ligase, cytoplasmic	GO:0006431; P:methionyl-tRNA aminoacylation; IEA:InterPro
P56192	MARS	Methionine--tRNA ligase, cytoplasmic	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q96GW9	MARS2	Methionine--tRNA ligase, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96GW9	MARS2	Methionine--tRNA ligase, mitochondrial	GO:0004825; F:methionine-tRNA ligase activity; IDA:UniProtKB
Q96GW9	MARS2	Methionine--tRNA ligase, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
Q96GW9	MARS2	Methionine--tRNA ligase, mitochondrial	GO:0006431; P:methionyl-tRNA aminoacylation; IDA:UniProtKB
Q96GW9	MARS2	Methionine--tRNA ligase, mitochondrial	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q92797	SYMPK	Symplekin	GO:0005515; F:protein binding; IPI:UniProtKB
Q92797	SYMPK	Symplekin	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
Q92797	SYMPK	Symplekin	GO:0006378; P:mRNA polyadenylation; IMP:UniProtKB
Q92797	SYMPK	Symplekin	GO:0035307; P:positive regulation of protein dephosphorylation; IDA:UniProtKB
A6NDD5	SYNDIG1L	Synapse differentiation-inducing gene protein 1-like	GO:0009607; P:response to biotic stimulus; IEA:InterPro
P17600	SYN1	Synapsin-1	GO:0005524; F:ATP binding; IEA:InterPro
P17600	SYN1	Synapsin-1	GO:0003824; F:catalytic activity; IEA:InterPro
P17600	SYN1	Synapsin-1	GO:0005515; F:protein binding; IPI:IntAct
P17600	SYN1	Synapsin-1	GO:0005215; F:transporter activity; TAS:ProtInc
P17600	SYN1	Synapsin-1	GO:0007269; P:neurotransmitter secretion; IEA:InterPro
P17600	SYN1	Synapsin-1	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q92777	SYN2	Synapsin-2	GO:0005524; F:ATP binding; IEA:InterPro
Q92777	SYN2	Synapsin-2	GO:0003824; F:catalytic activity; IEA:InterPro
Q92777	SYN2	Synapsin-2	GO:0007269; P:neurotransmitter secretion; IEA:InterPro
Q92777	SYN2	Synapsin-2	GO:0007268; P:synaptic transmission; TAS:ProtInc
O14994	SYN3	Synapsin-3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O14994	SYN3	Synapsin-3	GO:0003824; F:catalytic activity; IEA:InterPro
O14994	SYN3	Synapsin-3	GO:0007269; P:neurotransmitter secretion; TAS:ProtInc
Q9H7C4	SYNC	Syncoilin	GO:0005198; F:structural molecule activity; IEA:InterPro
Q9H7C4	SYNC	Syncoilin	GO:0045103; P:intermediate filament-based process; IEA:Ensembl
O43776	NARS	Asparagine--tRNA ligase, cytoplasmic	GO:0004816; F:asparagine-tRNA ligase activity; TAS:ProtInc
O43776	NARS	Asparagine--tRNA ligase, cytoplasmic	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43776	NARS	Asparagine--tRNA ligase, cytoplasmic	GO:0003676; F:nucleic acid binding; IEA:InterPro
O43776	NARS	Asparagine--tRNA ligase, cytoplasmic	GO:0006421; P:asparaginyl-tRNA aminoacylation; IEA:InterPro
O43776	NARS	Asparagine--tRNA ligase, cytoplasmic	GO:0010467; P:gene expression; TAS:Reactome
O43776	NARS	Asparagine--tRNA ligase, cytoplasmic	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q8NF91	SYNE1	Nesprin-1	GO:0003779; F:actin binding; IDA:UniProtKB
Q8NF91	SYNE1	Nesprin-1	GO:0051015; F:actin filament binding; ISS:UniProtKB
Q8NF91	SYNE1	Nesprin-1	GO:0005521; F:lamin binding; IPI:UniProtKB
Q8NF91	SYNE1	Nesprin-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8NF91	SYNE1	Nesprin-1	GO:0005515; F:protein binding; IPI:IntAct
Q8NF91	SYNE1	Nesprin-1	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q8NF91	SYNE1	Nesprin-1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q8NF91	SYNE1	Nesprin-1	GO:0090286; P:cytoskeletal anchoring at nuclear membrane; IDA:UniProtKB
Q8NF91	SYNE1	Nesprin-1	GO:0007030; P:Golgi organization; IDA:UniProtKB
Q8NF91	SYNE1	Nesprin-1	GO:0042692; P:muscle cell differentiation; IDA:UniProtKB
Q8NF91	SYNE1	Nesprin-1	GO:0090292; P:nuclear matrix anchoring at nuclear membrane; IDA:UniProtKB
Q8NF91	SYNE1	Nesprin-1	GO:0006997; P:nucleus organization; NAS:UniProtKB
Q8WXH0	SYNE2	Nesprin-2	GO:0003779; F:actin binding; ISS:UniProtKB
Q8WXH0	SYNE2	Nesprin-2	GO:0005515; F:protein binding; IPI:IntAct
Q8WXH0	SYNE2	Nesprin-2	GO:0051642; P:centrosome localization; IMP:UniProtKB
Q8WXH0	SYNE2	Nesprin-2	GO:0090286; P:cytoskeletal anchoring at nuclear membrane; IDA:UniProtKB
Q8WXH0	SYNE2	Nesprin-2	GO:0007163; P:establishment or maintenance of cell polarity; IEA:Ensembl
Q8WXH0	SYNE2	Nesprin-2	GO:0010761; P:fibroblast migration; IEA:Ensembl
Q8WXH0	SYNE2	Nesprin-2	GO:0006998; P:nuclear envelope organization; IEA:Ensembl
Q8WXH0	SYNE2	Nesprin-2	GO:0007097; P:nuclear migration; IMP:UniProtKB
Q8WXH0	SYNE2	Nesprin-2	GO:0031022; P:nuclear migration along microfilament; ISS:UniProtKB
Q8WXH0	SYNE2	Nesprin-2	GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB
Q8WXH0	SYNE2	Nesprin-2	GO:0034504; P:protein localization to nucleus; IEA:Ensembl
Q6ZMZ3	SYNE3	Nesprin-3	GO:0051015; F:actin filament binding; IMP:UniProtKB
Q6ZMZ3	SYNE3	Nesprin-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q6ZMZ3	SYNE3	Nesprin-3	GO:0090286; P:cytoskeletal anchoring at nuclear membrane; IDA:UniProtKB
Q6ZMZ3	SYNE3	Nesprin-3	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q6ZMZ3	SYNE3	Nesprin-3	GO:0090150; P:establishment of protein localization to membrane; IDA:UniProtKB
Q6ZMZ3	SYNE3	Nesprin-3	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
Q8N205	SYNE4	Nesprin-4	GO:0045198; P:establishment of epithelial cell apical/basal polarity; ISS:UniProtKB
O15061	SYNM	Synemin	GO:0019215; F:intermediate filament binding; ISS:UniProtKB
O15061	SYNM	Synemin	GO:0005515; F:protein binding; IPI:UniProtKB
O15061	SYNM	Synemin	GO:0005200; F:structural constituent of cytoskeleton; IDA:UniProtKB
O15061	SYNM	Synemin	GO:0008307; F:structural constituent of muscle; IDA:UniProtKB
O15061	SYNM	Synemin	GO:0017166; F:vinculin binding; IDA:UniProtKB
O15061	SYNM	Synemin	GO:0045104; P:intermediate filament cytoskeleton organization; TAS:UniProtKB
Q9H7V2	SYNDIG1	Synapse differentiation-inducing gene protein 1	GO:0035254; F:glutamate receptor binding; ISS:UniProtKB
Q9H7V2	SYNDIG1	Synapse differentiation-inducing gene protein 1	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q9H7V2	SYNDIG1	Synapse differentiation-inducing gene protein 1	GO:0006886; P:intracellular protein transport; ISS:UniProtKB
Q9H7V2	SYNDIG1	Synapse differentiation-inducing gene protein 1	GO:0051965; P:positive regulation of synapse assembly; IDA:UniProtKB
Q9H7V2	SYNDIG1	Synapse differentiation-inducing gene protein 1	GO:0009607; P:response to biotic stimulus; IEA:InterPro
Q9H7V2	SYNDIG1	Synapse differentiation-inducing gene protein 1	GO:0097091; P:synaptic vesicle clustering; ISS:UniProtKB
O43426	SYNJ1	Synaptojanin-1	GO:0004445; F:inositol-polyphosphate 5-phosphatase activity; TAS:ProtInc
O43426	SYNJ1	Synaptojanin-1	GO:0000166; F:nucleotide binding; IEA:InterPro
O43426	SYNJ1	Synaptojanin-1	GO:0004439; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; IEA:UniProtKB-EC
O43426	SYNJ1	Synaptojanin-1	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
O43426	SYNJ1	Synaptojanin-1	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
O43426	SYNJ1	Synaptojanin-1	GO:0006796; P:phosphate-containing compound metabolic process; TAS:ProtInc
O43426	SYNJ1	Synaptojanin-1	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
O43426	SYNJ1	Synaptojanin-1	GO:0046856; P:phosphatidylinositol dephosphorylation; IEA:InterPro
O43426	SYNJ1	Synaptojanin-1	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
O43426	SYNJ1	Synaptojanin-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43426	SYNJ1	Synaptojanin-1	GO:0048488; P:synaptic vesicle endocytosis; TAS:ProtInc
O15056	SYNJ2	Synaptojanin-2	GO:0000166; F:nucleotide binding; IEA:InterPro
O15056	SYNJ2	Synaptojanin-2	GO:0004439; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; IEA:UniProtKB-EC
O15056	SYNJ2	Synaptojanin-2	GO:0005515; F:protein binding; IPI:IntAct
O15056	SYNJ2	Synaptojanin-2	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
O15056	SYNJ2	Synaptojanin-2	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
O15056	SYNJ2	Synaptojanin-2	GO:0046856; P:phosphatidylinositol dephosphorylation; IEA:InterPro
O15056	SYNJ2	Synaptojanin-2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
O15056	SYNJ2	Synaptojanin-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96I59	NARS2	Probable asparagine--tRNA ligase, mitochondrial	GO:0004816; F:asparagine-tRNA ligase activity; ISS:UniProtKB
Q96I59	NARS2	Probable asparagine--tRNA ligase, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96I59	NARS2	Probable asparagine--tRNA ligase, mitochondrial	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q96I59	NARS2	Probable asparagine--tRNA ligase, mitochondrial	GO:0006421; P:asparaginyl-tRNA aminoacylation; ISS:UniProtKB
Q96I59	NARS2	Probable asparagine--tRNA ligase, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
Q96I59	NARS2	Probable asparagine--tRNA ligase, mitochondrial	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q9UMS6	SYNPO2	Synaptopodin-2	GO:0071889; F:14-3-3 protein binding; ISS:UniProtKB
Q9UMS6	SYNPO2	Synaptopodin-2	GO:0051371; F:muscle alpha-actinin binding; ISS:UniProtKB
Q9UMS6	SYNPO2	Synaptopodin-2	GO:0005515; F:protein binding; IPI:IntAct
Q8N3V7	SYNPO	Synaptopodin	GO:0003779; F:actin binding; ISS:UniProtKB
Q8N3V7	SYNPO	Synaptopodin	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N3V7	SYNPO	Synaptopodin	GO:0032233; P:positive regulation of actin filament bundle assembly; IEA:Ensembl
Q8N3V7	SYNPO	Synaptopodin	GO:0051492; P:regulation of stress fiber assembly; IEA:Ensembl
Q8TBG9	SYNPR	Synaptoporin	GO:0005215; F:transporter activity; IEA:InterPro
Q9UMZ2	SYNRG	Synergin gamma	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9UMZ2	SYNRG	Synergin gamma	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q9UMZ2	SYNRG	Synergin gamma	GO:0006886; P:intracellular protein transport; TAS:ProtInc
P08247	SYP	Synaptophysin	GO:0015485; F:cholesterol binding; IDA:UniProtKB
P08247	SYP	Synaptophysin	GO:0005215; F:transporter activity; IEA:InterPro
P08247	SYP	Synaptophysin	GO:0071310; P:cellular response to organic substance; IEA:Ensembl
P08247	SYP	Synaptophysin	GO:0006897; P:endocytosis; ISS:UniProtKB
P08247	SYP	Synaptophysin	GO:0048169; P:regulation of long-term neuronal synaptic plasticity; ISS:UniProtKB
P08247	SYP	Synaptophysin	GO:0048168; P:regulation of neuronal synaptic plasticity; IBA:RefGenome
P08247	SYP	Synaptophysin	GO:2000474; P:regulation of opioid receptor signaling pathway; ISS:UniProtKB
P08247	SYP	Synaptophysin	GO:0048172; P:regulation of short-term neuronal synaptic plasticity; ISS:UniProtKB
P08247	SYP	Synaptophysin	GO:0016188; P:synaptic vesicle maturation; NAS:UniProtKB
P08247	SYP	Synaptophysin	GO:0048499; P:synaptic vesicle membrane organization; NAS:UniProtKB
Q16563	SYPL1	Synaptophysin-like protein 1	GO:0005215; F:transporter activity; IEA:InterPro
Q16563	SYPL1	Synaptophysin-like protein 1	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q5VXT5	SYPL2	Synaptophysin-like protein 2	GO:0005215; F:transporter activity; IEA:InterPro
Q5VXT5	SYPL2	Synaptophysin-like protein 2	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
Q5VXT5	SYPL2	Synaptophysin-like protein 2	GO:0021762; P:substantia nigra development; IEP:UniProt
Q7L3T8	PARS2	Probable proline--tRNA ligase, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q7L3T8	PARS2	Probable proline--tRNA ligase, mitochondrial	GO:0004827; F:proline-tRNA ligase activity; IEA:UniProtKB-EC
Q7L3T8	PARS2	Probable proline--tRNA ligase, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
Q7L3T8	PARS2	Probable proline--tRNA ligase, mitochondrial	GO:0006433; P:prolyl-tRNA aminoacylation; IEA:InterPro
Q7L3T8	PARS2	Probable proline--tRNA ligase, mitochondrial	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
P47897	QARS	Glutamine--tRNA ligase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P47897	QARS	Glutamine--tRNA ligase	GO:0004819; F:glutamine-tRNA ligase activity; TAS:Reactome
P47897	QARS	Glutamine--tRNA ligase	GO:0010467; P:gene expression; TAS:Reactome
P47897	QARS	Glutamine--tRNA ligase	GO:0006425; P:glutaminyl-tRNA aminoacylation; IEA:InterPro
P47897	QARS	Glutamine--tRNA ligase	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
P54136	RARS	Arginine--tRNA ligase, cytoplasmic	GO:0034618; F:arginine binding; IEA:Ensembl
P54136	RARS	Arginine--tRNA ligase, cytoplasmic	GO:0004814; F:arginine-tRNA ligase activity; TAS:Reactome
P54136	RARS	Arginine--tRNA ligase, cytoplasmic	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P54136	RARS	Arginine--tRNA ligase, cytoplasmic	GO:0005515; F:protein binding; IPI:IntAct
P54136	RARS	Arginine--tRNA ligase, cytoplasmic	GO:0000049; F:tRNA binding; IEA:Ensembl
P54136	RARS	Arginine--tRNA ligase, cytoplasmic	GO:0006420; P:arginyl-tRNA aminoacylation; TAS:ProtInc
P54136	RARS	Arginine--tRNA ligase, cytoplasmic	GO:0010467; P:gene expression; TAS:Reactome
P54136	RARS	Arginine--tRNA ligase, cytoplasmic	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q5T160	RARS2	Probable arginine--tRNA ligase, mitochondrial	GO:0004814; F:arginine-tRNA ligase activity; IEA:UniProtKB-EC
Q5T160	RARS2	Probable arginine--tRNA ligase, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5T160	RARS2	Probable arginine--tRNA ligase, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q5T160	RARS2	Probable arginine--tRNA ligase, mitochondrial	GO:0006420; P:arginyl-tRNA aminoacylation; IEA:InterPro
Q5T160	RARS2	Probable arginine--tRNA ligase, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
Q5T160	RARS2	Probable arginine--tRNA ligase, mitochondrial	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q8N2H4	SYS1	Protein SYS1 homolog	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P49591	SARS	Serine--tRNA ligase, cytoplasmic	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49591	SARS	Serine--tRNA ligase, cytoplasmic	GO:0003723; F:RNA binding; TAS:ProtInc
P49591	SARS	Serine--tRNA ligase, cytoplasmic	GO:0004828; F:serine-tRNA ligase activity; TAS:Reactome
P49591	SARS	Serine--tRNA ligase, cytoplasmic	GO:0010467; P:gene expression; TAS:Reactome
P49591	SARS	Serine--tRNA ligase, cytoplasmic	GO:0097056; P:selenocysteinyl-tRNA(Sec) biosynthetic process; IEA:UniProtKB-UniPathway
P49591	SARS	Serine--tRNA ligase, cytoplasmic	GO:0006434; P:seryl-tRNA aminoacylation; IEA:InterPro
P49591	SARS	Serine--tRNA ligase, cytoplasmic	GO:0006412; P:translation; TAS:ProtInc
P49591	SARS	Serine--tRNA ligase, cytoplasmic	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
P49591	SARS	Serine--tRNA ligase, cytoplasmic	GO:0008033; P:tRNA processing; TAS:ProtInc
Q9NP81	SARS2	Serine--tRNA ligase, mitochondrial	GO:0005524; F:ATP binding; ISS:UniProtKB
Q9NP81	SARS2	Serine--tRNA ligase, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NP81	SARS2	Serine--tRNA ligase, mitochondrial	GO:0004828; F:serine-tRNA ligase activity; ISS:UniProtKB
Q9NP81	SARS2	Serine--tRNA ligase, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
Q9NP81	SARS2	Serine--tRNA ligase, mitochondrial	GO:0097056; P:selenocysteinyl-tRNA(Sec) biosynthetic process; IEA:UniProtKB-UniPathway
Q9NP81	SARS2	Serine--tRNA ligase, mitochondrial	GO:0006434; P:seryl-tRNA aminoacylation; ISS:UniProtKB
Q9NP81	SARS2	Serine--tRNA ligase, mitochondrial	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q6XYQ8	SYT10	Synaptotagmin-10	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6XYQ8	SYT10	Synaptotagmin-10	GO:0005215; F:transporter activity; IEA:InterPro
Q6XYQ8	SYT10	Synaptotagmin-10	GO:0017158; P:regulation of calcium ion-dependent exocytosis; IEA:InterPro
Q9BT88	SYT11	Synaptotagmin-11	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BT88	SYT11	Synaptotagmin-11	GO:0005515; F:protein binding; IPI:IntAct
Q9BT88	SYT11	Synaptotagmin-11	GO:0005215; F:transporter activity; IEA:InterPro
Q7L8C5	SYT13	Synaptotagmin-13	GO:0016192; P:vesicle-mediated transport; IEA:Ensembl
Q8NB59	SYT14	Synaptotagmin-14	GO:0005543; F:phospholipid binding; IEA:Ensembl
Q8NB59	SYT14	Synaptotagmin-14	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q17RD7	SYT16	Synaptotagmin-16	GO:0005543; F:phospholipid binding; IEA:Ensembl
Q17RD7	SYT16	Synaptotagmin-16	GO:0006887; P:exocytosis; IEA:InterPro
Q9BSW7	SYT17	Synaptotagmin-17	GO:0005215; F:transporter activity; IEA:InterPro
P21579	SYT1	Synaptotagmin-1	GO:0005545; F:1-phosphatidylinositol binding; TAS:UniProtKB
P21579	SYT1	Synaptotagmin-1	GO:0005509; F:calcium ion binding; IEA:Ensembl
P21579	SYT1	Synaptotagmin-1	GO:0005544; F:calcium-dependent phospholipid binding; IEA:Ensembl
P21579	SYT1	Synaptotagmin-1	GO:0050750; F:low-density lipoprotein particle receptor binding; IDA:MGI
P21579	SYT1	Synaptotagmin-1	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IEA:Ensembl
P21579	SYT1	Synaptotagmin-1	GO:0001786; F:phosphatidylserine binding; IEA:Ensembl
P21579	SYT1	Synaptotagmin-1	GO:0005543; F:phospholipid binding; TAS:ProtInc
P21579	SYT1	Synaptotagmin-1	GO:0005515; F:protein binding; IPI:UniProtKB
P21579	SYT1	Synaptotagmin-1	GO:0017075; F:syntaxin-1 binding; TAS:UniProtKB
P21579	SYT1	Synaptotagmin-1	GO:0005215; F:transporter activity; IEA:InterPro
P21579	SYT1	Synaptotagmin-1	GO:0005513; P:detection of calcium ion; TAS:UniProtKB
P21579	SYT1	Synaptotagmin-1	GO:0014047; P:glutamate secretion; TAS:Reactome
P21579	SYT1	Synaptotagmin-1	GO:0007269; P:neurotransmitter secretion; TAS:UniProtKB
P21579	SYT1	Synaptotagmin-1	GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; IEA:Ensembl
P21579	SYT1	Synaptotagmin-1	GO:0031340; P:positive regulation of vesicle fusion; IEA:Ensembl
P21579	SYT1	Synaptotagmin-1	GO:0051260; P:protein homooligomerization; TAS:UniProtKB
P21579	SYT1	Synaptotagmin-1	GO:0017157; P:regulation of exocytosis; TAS:UniProtKB
P21579	SYT1	Synaptotagmin-1	GO:0007268; P:synaptic transmission; TAS:Reactome
P21579	SYT1	Synaptotagmin-1	GO:0016079; P:synaptic vesicle exocytosis; IEA:Ensembl
P21579	SYT1	Synaptotagmin-1	GO:0048278; P:vesicle docking; IEA:Ensembl
Q8N9I0	SYT2	Synaptotagmin-2	GO:0005509; F:calcium ion binding; IEA:Ensembl
Q8N9I0	SYT2	Synaptotagmin-2	GO:0005544; F:calcium-dependent phospholipid binding; IEA:Ensembl
Q8N9I0	SYT2	Synaptotagmin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N9I0	SYT2	Synaptotagmin-2	GO:0005215; F:transporter activity; IEA:InterPro
Q8N9I0	SYT2	Synaptotagmin-2	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
Q8N9I0	SYT2	Synaptotagmin-2	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9BQG1	SYT3	Synaptotagmin-3	GO:0005544; F:calcium-dependent phospholipid binding; IEA:Ensembl
Q9BQG1	SYT3	Synaptotagmin-3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BQG1	SYT3	Synaptotagmin-3	GO:0001786; F:phosphatidylserine binding; IEA:Ensembl
Q9BQG1	SYT3	Synaptotagmin-3	GO:0005215; F:transporter activity; IEA:InterPro
Q9BQG1	SYT3	Synaptotagmin-3	GO:0031340; P:positive regulation of vesicle fusion; IEA:Ensembl
Q9BQG1	SYT3	Synaptotagmin-3	GO:0051592; P:response to calcium ion; IEA:Ensembl
Q9H2B2	SYT4	Synaptotagmin-4	GO:0005509; F:calcium ion binding; IEA:Ensembl
Q9H2B2	SYT4	Synaptotagmin-4	GO:0001786; F:phosphatidylserine binding; IEA:Ensembl
Q9H2B2	SYT4	Synaptotagmin-4	GO:0005215; F:transporter activity; IEA:InterPro
Q9H2B2	SYT4	Synaptotagmin-4	GO:0006887; P:exocytosis; IEA:InterPro
Q9H2B2	SYT4	Synaptotagmin-4	GO:0045955; P:negative regulation of calcium ion-dependent exocytosis; IEA:Ensembl
Q9H2B2	SYT4	Synaptotagmin-4	GO:0031339; P:negative regulation of vesicle fusion; IEA:Ensembl
Q9H2B2	SYT4	Synaptotagmin-4	GO:0007269; P:neurotransmitter secretion; IEA:Ensembl
O00445	SYT5	Synaptotagmin-5	GO:0005544; F:calcium-dependent phospholipid binding; IEA:Ensembl
O00445	SYT5	Synaptotagmin-5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O00445	SYT5	Synaptotagmin-5	GO:0005215; F:transporter activity; IEA:InterPro
O00445	SYT5	Synaptotagmin-5	GO:0017156; P:calcium ion-dependent exocytosis; IEA:InterPro
O00445	SYT5	Synaptotagmin-5	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
O00445	SYT5	Synaptotagmin-5	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
O00445	SYT5	Synaptotagmin-5	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00445	SYT5	Synaptotagmin-5	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q5T7P8	SYT6	Synaptotagmin-6	GO:0030276; F:clathrin binding; IDA:BHF-UCL
Q5T7P8	SYT6	Synaptotagmin-6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5T7P8	SYT6	Synaptotagmin-6	GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
Q5T7P8	SYT6	Synaptotagmin-6	GO:0019905; F:syntaxin binding; IDA:BHF-UCL
Q5T7P8	SYT6	Synaptotagmin-6	GO:0005215; F:transporter activity; IEA:InterPro
Q5T7P8	SYT6	Synaptotagmin-6	GO:0060478; P:acrosomal vesicle exocytosis; IMP:BHF-UCL
O43581	SYT7	Synaptotagmin-7	GO:0005509; F:calcium ion binding; IEA:Ensembl
O43581	SYT7	Synaptotagmin-7	GO:0005215; F:transporter activity; IEA:InterPro
O43581	SYT7	Synaptotagmin-7	GO:0001778; P:plasma membrane repair; IEA:Ensembl
O43581	SYT7	Synaptotagmin-7	GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; IEA:Ensembl
O43581	SYT7	Synaptotagmin-7	GO:0050796; P:regulation of insulin secretion; IEA:Ensembl
Q8NBV8	SYT8	Synaptotagmin-8	GO:0005215; F:transporter activity; IEA:InterPro
Q8NBV8	SYT8	Synaptotagmin-8	GO:0007340; P:acrosome reaction; IEA:Ensembl
Q86SS6	SYT9	Synaptotagmin-9	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86SS6	SYT9	Synaptotagmin-9	GO:0005215; F:transporter activity; IEA:InterPro
Q86SS6	SYT9	Synaptotagmin-9	GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; IEA:Ensembl
Q86SS6	SYT9	Synaptotagmin-9	GO:0050796; P:regulation of insulin secretion; IEA:Ensembl
A2RTX5	TARSL2	Probable threonine--tRNA ligase 2, cytoplasmic	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
A2RTX5	TARSL2	Probable threonine--tRNA ligase 2, cytoplasmic	GO:0004829; F:threonine-tRNA ligase activity; IEA:UniProtKB-EC
A2RTX5	TARSL2	Probable threonine--tRNA ligase 2, cytoplasmic	GO:0006435; P:threonyl-tRNA aminoacylation; IEA:InterPro
P26639	TARS	Threonine--tRNA ligase, cytoplasmic	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P26639	TARS	Threonine--tRNA ligase, cytoplasmic	GO:0042803; F:protein homodimerization activity; NAS:UniProtKB
P26639	TARS	Threonine--tRNA ligase, cytoplasmic	GO:0004829; F:threonine-tRNA ligase activity; NAS:UniProtKB
P26639	TARS	Threonine--tRNA ligase, cytoplasmic	GO:0010467; P:gene expression; TAS:Reactome
P26639	TARS	Threonine--tRNA ligase, cytoplasmic	GO:0006435; P:threonyl-tRNA aminoacylation; NAS:UniProtKB
P26639	TARS	Threonine--tRNA ligase, cytoplasmic	GO:0006412; P:translation; NAS:UniProtKB
P26639	TARS	Threonine--tRNA ligase, cytoplasmic	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q9HCH5	SYTL2	Synaptotagmin-like protein 2	GO:0042043; F:neurexin family protein binding; ISS:UniProtKB
Q9HCH5	SYTL2	Synaptotagmin-like protein 2	GO:0019902; F:phosphatase binding; IDA:UniProtKB
Q9HCH5	SYTL2	Synaptotagmin-like protein 2	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IMP:UniProtKB
Q9HCH5	SYTL2	Synaptotagmin-like protein 2	GO:0001786; F:phosphatidylserine binding; IMP:UniProtKB
Q9HCH5	SYTL2	Synaptotagmin-like protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HCH5	SYTL2	Synaptotagmin-like protein 2	GO:0006887; P:exocytosis; IDA:UniProtKB
Q9HCH5	SYTL2	Synaptotagmin-like protein 2	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9HCH5	SYTL2	Synaptotagmin-like protein 2	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q9HCH5	SYTL2	Synaptotagmin-like protein 2	GO:0006904; P:vesicle docking involved in exocytosis; IDA:UniProtKB
Q9HCH5	SYTL2	Synaptotagmin-like protein 2	GO:0016192; P:vesicle-mediated transport; ISS:UniProtKB
Q8IYJ3	SYTL1	Synaptotagmin-like protein 1	GO:0042043; F:neurexin family protein binding; ISS:UniProtKB
Q8IYJ3	SYTL1	Synaptotagmin-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IYJ3	SYTL1	Synaptotagmin-like protein 1	GO:0006887; P:exocytosis; IDA:UniProtKB
Q8IYJ3	SYTL1	Synaptotagmin-like protein 1	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q4VX76	SYTL3	Synaptotagmin-like protein 3	GO:0005544; F:calcium-dependent phospholipid binding; IEA:Ensembl
Q4VX76	SYTL3	Synaptotagmin-like protein 3	GO:0006887; P:exocytosis; IEA:Ensembl
Q4VX76	SYTL3	Synaptotagmin-like protein 3	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q96C24	SYTL4	Synaptotagmin-like protein 4	GO:0042043; F:neurexin family protein binding; ISS:UniProtKB
Q96C24	SYTL4	Synaptotagmin-like protein 4	GO:0005543; F:phospholipid binding; ISS:UniProtKB
Q96C24	SYTL4	Synaptotagmin-like protein 4	GO:0005215; F:transporter activity; IEA:InterPro
Q96C24	SYTL4	Synaptotagmin-like protein 4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96C24	SYTL4	Synaptotagmin-like protein 4	GO:0006887; P:exocytosis; IEA:Ensembl
Q96C24	SYTL4	Synaptotagmin-like protein 4	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q96C24	SYTL4	Synaptotagmin-like protein 4	GO:0071985; P:multivesicular body sorting pathway; IMP:UniProtKB
Q96C24	SYTL4	Synaptotagmin-like protein 4	GO:0046676; P:negative regulation of insulin secretion; IEA:Ensembl
Q96C24	SYTL4	Synaptotagmin-like protein 4	GO:0045921; P:positive regulation of exocytosis; IMP:UniProtKB
Q96C24	SYTL4	Synaptotagmin-like protein 4	GO:0050714; P:positive regulation of protein secretion; IMP:UniProtKB
Q8TDW5	SYTL5	Synaptotagmin-like protein 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TDW5	SYTL5	Synaptotagmin-like protein 5	GO:0005515; F:protein binding; IPI:IntAct
Q8TDW5	SYTL5	Synaptotagmin-like protein 5	GO:0006887; P:exocytosis; IEA:Ensembl
Q8TDW5	SYTL5	Synaptotagmin-like protein 5	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9BW92	TARS2	Threonine--tRNA ligase, mitochondrial	GO:0005524; F:ATP binding; IEA:InterPro
Q9BW92	TARS2	Threonine--tRNA ligase, mitochondrial	GO:0004829; F:threonine-tRNA ligase activity; IEA:InterPro
Q9BW92	TARS2	Threonine--tRNA ligase, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
Q9BW92	TARS2	Threonine--tRNA ligase, mitochondrial	GO:0070159; P:mitochondrial threonyl-tRNA aminoacylation; TAS:BHF-UCL
Q9BW92	TARS2	Threonine--tRNA ligase, mitochondrial	GO:0006435; P:threonyl-tRNA aminoacylation; IEA:InterPro
Q9BW92	TARS2	Threonine--tRNA ligase, mitochondrial	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
P37840	SNCA	Alpha-synuclein	GO:0043014; F:alpha-tubulin binding; IPI:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0005507; F:copper ion binding; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0045502; F:dynein binding; IPI:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0008198; F:ferrous iron binding; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0042393; F:histone binding; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0030544; F:Hsp70 protein binding; IPI:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0042802; F:identical protein binding; IPI:IntAct
P37840	SNCA	Alpha-synuclein	GO:0019894; F:kinesin binding; IPI:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0016491; F:oxidoreductase activity; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0005543; F:phospholipid binding; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0051219; F:phosphoprotein binding; IDA:BHF-UCL
P37840	SNCA	Alpha-synuclein	GO:0005515; F:protein binding; IPI:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0048156; F:tau protein binding; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:BHF-UCL
P37840	SNCA	Alpha-synuclein	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0007568; P:aging; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0048148; P:behavioral response to cocaine; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0071280; P:cellular response to copper ion; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0071872; P:cellular response to epinephrine stimulus; TAS:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0034599; P:cellular response to oxidative stress; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0042416; P:dopamine biosynthetic process; TAS:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0051583; P:dopamine uptake involved in synaptic transmission; TAS:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0043206; P:extracellular fibril organization; TAS:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0006631; P:fatty acid metabolic process; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0001774; P:microglial cell activation; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0042775; P:mitochondrial ATP synthesis coupled electron transport; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0007006; P:mitochondrial membrane organization; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0045963; P:negative regulation of dopamine metabolic process; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0051585; P:negative regulation of dopamine uptake involved in synaptic transmission; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0045920; P:negative regulation of exocytosis; IMP:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0035067; P:negative regulation of histone acetylation; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0031115; P:negative regulation of microtubule polymerization; IDA:BHF-UCL
P37840	SNCA	Alpha-synuclein	GO:0032769; P:negative regulation of monooxygenase activity; IDA:BHF-UCL
P37840	SNCA	Alpha-synuclein	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0051622; P:negative regulation of norepinephrine uptake; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0010642; P:negative regulation of platelet-derived growth factor receptor signaling pathway; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0051612; P:negative regulation of serotonin uptake; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0070495; P:negative regulation of thrombin receptor signaling pathway; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0032410; P:negative regulation of transporter activity; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0006638; P:neutral lipid metabolic process; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0006644; P:phospholipid metabolic process; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0045807; P:positive regulation of endocytosis; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0060732; P:positive regulation of inositol phosphate biosynthetic process; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0001956; P:positive regulation of neurotransmitter secretion; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISS:BHF-UCL
P37840	SNCA	Alpha-synuclein	GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IDA:BHF-UCL
P37840	SNCA	Alpha-synuclein	GO:0001921; P:positive regulation of receptor recycling; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0031648; P:protein destabilization; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0031623; P:receptor internalization; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0050812; P:regulation of acyl-CoA biosynthetic process; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0014059; P:regulation of dopamine secretion; TAS:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0014048; P:regulation of glutamate secretion; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0040012; P:regulation of locomotion; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0043030; P:regulation of macrophage activation; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0010517; P:regulation of phospholipase activity; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0042493; P:response to drug; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0034341; P:response to interferon-gamma; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0070555; P:response to interleukin-1; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0010040; P:response to iron(II) ion; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0032496; P:response to lipopolysaccharide; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0032026; P:response to magnesium ion; IDA:UniProtKB
P37840	SNCA	Alpha-synuclein	GO:0050808; P:synapse organization; IEA:Ensembl
P37840	SNCA	Alpha-synuclein	GO:0048488; P:synaptic vesicle endocytosis; ISS:UniProtKB
Q16143	SNCB	Beta-synuclein	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q16143	SNCB	Beta-synuclein	GO:0004859; F:phospholipase inhibitor activity; TAS:ProtInc
Q16143	SNCB	Beta-synuclein	GO:0042417; P:dopamine metabolic process; IEA:Ensembl
Q16143	SNCB	Beta-synuclein	GO:0043086; P:negative regulation of catalytic activity; TAS:GOC
Q16143	SNCB	Beta-synuclein	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q16143	SNCB	Beta-synuclein	GO:0050808; P:synapse organization; IEA:Ensembl
Q16143	SNCB	Beta-synuclein	GO:0007268; P:synaptic transmission; IEA:Ensembl
O76070	SNCG	Gamma-synuclein	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
O76070	SNCG	Gamma-synuclein	GO:0002118; P:aggressive behavior; IEA:Ensembl
O76070	SNCG	Gamma-synuclein	GO:0071464; P:cellular response to hydrostatic pressure; IEA:Ensembl
O76070	SNCG	Gamma-synuclein	GO:0014059; P:regulation of dopamine secretion; IEA:Ensembl
O76070	SNCG	Gamma-synuclein	GO:0046928; P:regulation of neurotransmitter secretion; IEA:Ensembl
O76070	SNCG	Gamma-synuclein	GO:0042220; P:response to cocaine; IEA:Ensembl
O76070	SNCG	Gamma-synuclein	GO:0042493; P:response to drug; IEA:Ensembl
O76070	SNCG	Gamma-synuclein	GO:0050808; P:synapse organization; IEA:Ensembl
O76070	SNCG	Gamma-synuclein	GO:0007268; P:synaptic transmission; IEA:Ensembl
P26640	VARS	Valine--tRNA ligase	GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro
P26640	VARS	Valine--tRNA ligase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P26640	VARS	Valine--tRNA ligase	GO:0004832; F:valine-tRNA ligase activity; IDA:UniProtKB
P26640	VARS	Valine--tRNA ligase	GO:0010467; P:gene expression; TAS:Reactome
P26640	VARS	Valine--tRNA ligase	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
P26640	VARS	Valine--tRNA ligase	GO:0006438; P:valyl-tRNA aminoacylation; IEA:InterPro
Q5ST30	VARS2	Valine--tRNA ligase, mitochondrial	GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro
Q5ST30	VARS2	Valine--tRNA ligase, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5ST30	VARS2	Valine--tRNA ligase, mitochondrial	GO:0004832; F:valine-tRNA ligase activity; IEA:UniProtKB-EC
Q5ST30	VARS2	Valine--tRNA ligase, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
Q5ST30	VARS2	Valine--tRNA ligase, mitochondrial	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q5ST30	VARS2	Valine--tRNA ligase, mitochondrial	GO:0006438; P:valyl-tRNA aminoacylation; IEA:InterPro
Q86TM6	SYVN1	E3 ubiquitin-protein ligase synoviolin	GO:0016881; F:acid-amino acid ligase activity; IDA:UniProtKB
Q86TM6	SYVN1	E3 ubiquitin-protein ligase synoviolin	GO:0005515; F:protein binding; IPI:UniProtKB
Q86TM6	SYVN1	E3 ubiquitin-protein ligase synoviolin	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86TM6	SYVN1	E3 ubiquitin-protein ligase synoviolin	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q86TM6	SYVN1	E3 ubiquitin-protein ligase synoviolin	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q86TM6	SYVN1	E3 ubiquitin-protein ligase synoviolin	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q86TM6	SYVN1	E3 ubiquitin-protein ligase synoviolin	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q86TM6	SYVN1	E3 ubiquitin-protein ligase synoviolin	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q86TM6	SYVN1	E3 ubiquitin-protein ligase synoviolin	GO:1902236; P:negative regulation of intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IEA:Ensembl
Q86TM6	SYVN1	E3 ubiquitin-protein ligase synoviolin	GO:0018279; P:protein N-linked glycosylation via asparagine; IMP:UniProtKB
Q86TM6	SYVN1	E3 ubiquitin-protein ligase synoviolin	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
P23381	WARS	Tryptophan--tRNA ligase, cytoplasmic	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P23381	WARS	Tryptophan--tRNA ligase, cytoplasmic	GO:0005515; F:protein binding; IPI:UniProtKB
P23381	WARS	Tryptophan--tRNA ligase, cytoplasmic	GO:0004830; F:tryptophan-tRNA ligase activity; NAS:UniProtKB
P23381	WARS	Tryptophan--tRNA ligase, cytoplasmic	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P23381	WARS	Tryptophan--tRNA ligase, cytoplasmic	GO:0010467; P:gene expression; TAS:Reactome
P23381	WARS	Tryptophan--tRNA ligase, cytoplasmic	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P23381	WARS	Tryptophan--tRNA ligase, cytoplasmic	GO:0045765; P:regulation of angiogenesis; IDA:UniProtKB
P23381	WARS	Tryptophan--tRNA ligase, cytoplasmic	GO:0006412; P:translation; TAS:ProtInc
P23381	WARS	Tryptophan--tRNA ligase, cytoplasmic	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
P23381	WARS	Tryptophan--tRNA ligase, cytoplasmic	GO:0006436; P:tryptophanyl-tRNA aminoacylation; NAS:UniProtKB
Q9UGM6	WARS2	Tryptophan--tRNA ligase, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UGM6	WARS2	Tryptophan--tRNA ligase, mitochondrial	GO:0004830; F:tryptophan-tRNA ligase activity; IEA:UniProtKB-EC
Q9UGM6	WARS2	Tryptophan--tRNA ligase, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
Q9UGM6	WARS2	Tryptophan--tRNA ligase, mitochondrial	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q9UGM6	WARS2	Tryptophan--tRNA ligase, mitochondrial	GO:0006436; P:tryptophanyl-tRNA aminoacylation; IEA:InterPro
Q9UGM6	WARS2	Tryptophan--tRNA ligase, mitochondrial	GO:0001570; P:vasculogenesis; IEA:Ensembl
P54577	YARS	Tyrosine--tRNA ligase, cytoplasmic	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P54577	YARS	Tyrosine--tRNA ligase, cytoplasmic	GO:0005153; F:interleukin-8 receptor binding; TAS:ProtInc
P54577	YARS	Tyrosine--tRNA ligase, cytoplasmic	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P54577	YARS	Tyrosine--tRNA ligase, cytoplasmic	GO:0004871; F:signal transducer activity; NAS:ProtInc
P54577	YARS	Tyrosine--tRNA ligase, cytoplasmic	GO:0000049; F:tRNA binding; IEA:UniProtKB-KW
P54577	YARS	Tyrosine--tRNA ligase, cytoplasmic	GO:0004831; F:tyrosine-tRNA ligase activity; TAS:Reactome
P54577	YARS	Tyrosine--tRNA ligase, cytoplasmic	GO:0006915; P:apoptotic process; TAS:ProtInc
P54577	YARS	Tyrosine--tRNA ligase, cytoplasmic	GO:0010467; P:gene expression; TAS:Reactome
P54577	YARS	Tyrosine--tRNA ligase, cytoplasmic	GO:0007165; P:signal transduction; NAS:GOC
P54577	YARS	Tyrosine--tRNA ligase, cytoplasmic	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
P54577	YARS	Tyrosine--tRNA ligase, cytoplasmic	GO:0006437; P:tyrosyl-tRNA aminoacylation; TAS:ProtInc
Q9Y2Z4	YARS2	Tyrosine--tRNA ligase, mitochondrial	GO:0005524; F:ATP binding; TAS:BHF-UCL
Q9Y2Z4	YARS2	Tyrosine--tRNA ligase, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y2Z4	YARS2	Tyrosine--tRNA ligase, mitochondrial	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q9Y2Z4	YARS2	Tyrosine--tRNA ligase, mitochondrial	GO:0000049; F:tRNA binding; IDA:BHF-UCL
Q9Y2Z4	YARS2	Tyrosine--tRNA ligase, mitochondrial	GO:0072545; F:tyrosine binding; IDA:BHF-UCL
Q9Y2Z4	YARS2	Tyrosine--tRNA ligase, mitochondrial	GO:0004831; F:tyrosine-tRNA ligase activity; NAS:UniProtKB
Q9Y2Z4	YARS2	Tyrosine--tRNA ligase, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
Q9Y2Z4	YARS2	Tyrosine--tRNA ligase, mitochondrial	GO:0070184; P:mitochondrial tyrosyl-tRNA aminoacylation; IMP:BHF-UCL
Q9Y2Z4	YARS2	Tyrosine--tRNA ligase, mitochondrial	GO:0006412; P:translation; NAS:UniProtKB
Q9Y2Z4	YARS2	Tyrosine--tRNA ligase, mitochondrial	GO:0043039; P:tRNA aminoacylation; IDA:BHF-UCL
Q9Y2Z4	YARS2	Tyrosine--tRNA ligase, mitochondrial	GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome
Q5T011	SZT2	Protein SZT2	GO:0007417; P:central nervous system development; ISS:UniProt
Q5T011	SZT2	Protein SZT2	GO:0021540; P:corpus callosum morphogenesis; IMP:UniProt
Q5T011	SZT2	Protein SZT2	GO:0009790; P:embryo development; ISS:UniProt
Q5T011	SZT2	Protein SZT2	GO:0043473; P:pigmentation; IEA:Ensembl
Q5T011	SZT2	Protein SZT2	GO:0009791; P:post-embryonic development; ISS:UniProt
Q5T011	SZT2	Protein SZT2	GO:1901668; P:regulation of superoxide dismutase activity; ISS:UniProt
Q9NUM4	TMEM106B	Transmembrane protein 106B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NUM4	TMEM106B	Transmembrane protein 106B	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9NUM4	TMEM106B	Transmembrane protein 106B	GO:0048813; P:dendrite morphogenesis; IMP:UniProtKB
Q9NUM4	TMEM106B	Transmembrane protein 106B	GO:0032418; P:lysosome localization; IMP:UniProtKB
Q9NUM4	TMEM106B	Transmembrane protein 106B	GO:0006810; P:transport; IEA:UniProtKB-KW
Q9Y5J6	TIMM10B	Mitochondrial import inner membrane translocase subunit Tim10 B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y5J6	TIMM10B	Mitochondrial import inner membrane translocase subunit Tim10 B	GO:0007160; P:cell-matrix adhesion; TAS:ProtInc
Q9Y5J6	TIMM10B	Mitochondrial import inner membrane translocase subunit Tim10 B	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9Y5J6	TIMM10B	Mitochondrial import inner membrane translocase subunit Tim10 B	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
Q9H061	TMEM126A	Transmembrane protein 126A	GO:0021554; P:optic nerve development; IMP:BHF-UCL
Q14C87	TMEM132D	Transmembrane protein 132D	GO:0005515; F:protein binding; IPI:IntAct
Q14C87	TMEM132D	Transmembrane protein 132D	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q86TG1	TMEM150A	Transmembrane protein 150A	GO:0009056; P:catabolic process; IEA:Ensembl
Q9NX61	TMEM161A	Transmembrane protein 161A	GO:0034599; P:cellular response to oxidative stress; IDA:BHF-UCL
Q9NX61	TMEM161A	Transmembrane protein 161A	GO:0034644; P:cellular response to UV; IDA:BHF-UCL
Q9NX61	TMEM161A	Transmembrane protein 161A	GO:1902230; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; IMP:BHF-UCL
Q9NX61	TMEM161A	Transmembrane protein 161A	GO:0045739; P:positive regulation of DNA repair; IMP:BHF-UCL
Q9NX61	TMEM161A	Transmembrane protein 161A	GO:0032526; P:response to retinoic acid; IDA:BHF-UCL
Q3YBM2	TMEM176B	Transmembrane protein 176B	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q3YBM2	TMEM176B	Transmembrane protein 176B	GO:2001199; P:negative regulation of dendritic cell differentiation; IEA:Ensembl
Q3YBM2	TMEM176B	Transmembrane protein 176B	GO:0009887; P:organ morphogenesis; TAS:ProtInc
Q96HP8	TMEM176A	Transmembrane protein 176A	GO:2001199; P:negative regulation of dendritic cell differentiation; IEA:Ensembl
Q6ZMB5	TMEM184A	Transmembrane protein 184A	GO:0018992; P:germ-line sex determination; IEA:Ensembl
Q6ZMB5	TMEM184A	Transmembrane protein 184A	GO:0032880; P:regulation of protein localization; IEA:Ensembl
Q6ZMB5	TMEM184A	Transmembrane protein 184A	GO:0051046; P:regulation of secretion; IEA:Ensembl
Q8NFB2	TMEM185A	Transmembrane protein 185A	GO:0005515; F:protein binding; IPI:UniProtKB
B2RXF0	TMEM229A	Transmembrane protein 229A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q15714	TSC22D1	TSC22 domain family protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q15714	TSC22D1	TSC22 domain family protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q15714	TSC22D1	TSC22 domain family protein 1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q15714	TSC22D1	TSC22 domain family protein 1	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q15714	TSC22D1	TSC22 domain family protein 1	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q15714	TSC22D1	TSC22 domain family protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
O75157	TSC22D2	TSC22 domain family protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O75157	TSC22D2	TSC22 domain family protein 2	GO:0006970; P:response to osmotic stress; IEA:Ensembl
Q9Y3Q8	TSC22D4	TSC22 domain family protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3Q8	TSC22D4	TSC22 domain family protein 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9Y3Q8	TSC22D4	TSC22 domain family protein 4	GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB
Q9Y3Q8	TSC22D4	TSC22 domain family protein 4	GO:0006970; P:response to osmotic stress; IEA:Ensembl
Q9Y3Q8	TSC22D4	TSC22 domain family protein 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q99576	TSC22D3	TSC22 domain family protein 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q99576	TSC22D3	TSC22 domain family protein 3	GO:0007589; P:body fluid secretion; IEA:Ensembl
Q99576	TSC22D3	TSC22 domain family protein 3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q99576	TSC22D3	TSC22 domain family protein 3	GO:0070236; P:negative regulation of activation-induced cell death of T cells; IEA:Ensembl
Q99576	TSC22D3	TSC22 domain family protein 3	GO:0048642; P:negative regulation of skeletal muscle tissue development; IEA:Ensembl
Q99576	TSC22D3	TSC22 domain family protein 3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q99576	TSC22D3	TSC22 domain family protein 3	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
Q99576	TSC22D3	TSC22 domain family protein 3	GO:0006970; P:response to osmotic stress; IEA:Ensembl
Q99576	TSC22D3	TSC22 domain family protein 3	GO:0055085; P:transmembrane transport; TAS:Reactome
P48775	TDO2	Tryptophan 2,3-dioxygenase	GO:0016597; F:amino acid binding; IEA:Ensembl
P48775	TDO2	Tryptophan 2,3-dioxygenase	GO:0020037; F:heme binding; IBA:RefGenome
P48775	TDO2	Tryptophan 2,3-dioxygenase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P48775	TDO2	Tryptophan 2,3-dioxygenase	GO:0019825; F:oxygen binding; IEA:Ensembl
P48775	TDO2	Tryptophan 2,3-dioxygenase	GO:0004833; F:tryptophan 2,3-dioxygenase activity; IBA:RefGenome
P48775	TDO2	Tryptophan 2,3-dioxygenase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P48775	TDO2	Tryptophan 2,3-dioxygenase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P48775	TDO2	Tryptophan 2,3-dioxygenase	GO:0006569; P:tryptophan catabolic process; TAS:Reactome
P48775	TDO2	Tryptophan 2,3-dioxygenase	GO:0019442; P:tryptophan catabolic process to acetyl-CoA; IBA:RefGenome
P48775	TDO2	Tryptophan 2,3-dioxygenase	GO:0019441; P:tryptophan catabolic process to kynurenine; IEA:UniProtKB-UniPathway
P52657	GTF2A2	Transcription initiation factor IIA subunit 2	GO:0005515; F:protein binding; IPI:IntAct
P52657	GTF2A2	Transcription initiation factor IIA subunit 2	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P52657	GTF2A2	Transcription initiation factor IIA subunit 2	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P52657	GTF2A2	Transcription initiation factor IIA subunit 2	GO:0017025; F:TBP-class protein binding; IPI:BHF-UCL
P52657	GTF2A2	Transcription initiation factor IIA subunit 2	GO:0003713; F:transcription coactivator activity; IDA:BHF-UCL
P52657	GTF2A2	Transcription initiation factor IIA subunit 2	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P52657	GTF2A2	Transcription initiation factor IIA subunit 2	GO:0010467; P:gene expression; TAS:Reactome
P52657	GTF2A2	Transcription initiation factor IIA subunit 2	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P52657	GTF2A2	Transcription initiation factor IIA subunit 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P52657	GTF2A2	Transcription initiation factor IIA subunit 2	GO:0051123; P:RNA polymerase II transcriptional preinitiation complex assembly; IDA:BHF-UCL
P52657	GTF2A2	Transcription initiation factor IIA subunit 2	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P52657	GTF2A2	Transcription initiation factor IIA subunit 2	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:BHF-UCL
P52657	GTF2A2	Transcription initiation factor IIA subunit 2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P52657	GTF2A2	Transcription initiation factor IIA subunit 2	GO:0016032; P:viral process; TAS:Reactome
P29083	GTF2E1	General transcription factor IIE subunit 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P29083	GTF2E1	General transcription factor IIE subunit 1	GO:0005515; F:protein binding; IPI:UniProtKB
P29083	GTF2E1	General transcription factor IIE subunit 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P29083	GTF2E1	General transcription factor IIE subunit 1	GO:0010467; P:gene expression; TAS:Reactome
P29083	GTF2E1	General transcription factor IIE subunit 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P29083	GTF2E1	General transcription factor IIE subunit 1	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P29083	GTF2E1	General transcription factor IIE subunit 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
P29083	GTF2E1	General transcription factor IIE subunit 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P29083	GTF2E1	General transcription factor IIE subunit 1	GO:0016032; P:viral process; TAS:Reactome
P29084	GTF2E2	Transcription initiation factor IIE subunit beta	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P29084	GTF2E2	Transcription initiation factor IIE subunit beta	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P29084	GTF2E2	Transcription initiation factor IIE subunit beta	GO:0005515; F:protein binding; IPI:UniProtKB
P29084	GTF2E2	Transcription initiation factor IIE subunit beta	GO:0010467; P:gene expression; TAS:Reactome
P29084	GTF2E2	Transcription initiation factor IIE subunit beta	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P29084	GTF2E2	Transcription initiation factor IIE subunit beta	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P29084	GTF2E2	Transcription initiation factor IIE subunit beta	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
P29084	GTF2E2	Transcription initiation factor IIE subunit beta	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P29084	GTF2E2	Transcription initiation factor IIE subunit beta	GO:0016032; P:viral process; TAS:Reactome
P35269	GTF2F1	General transcription factor IIF subunit 1	GO:0003824; F:catalytic activity; IEA:InterPro
P35269	GTF2F1	General transcription factor IIF subunit 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P35269	GTF2F1	General transcription factor IIF subunit 1	GO:0019211; F:phosphatase activator activity; IDA:UniProtKB
P35269	GTF2F1	General transcription factor IIF subunit 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P35269	GTF2F1	General transcription factor IIF subunit 1	GO:0005515; F:protein binding; IPI:UniProtKB
P35269	GTF2F1	General transcription factor IIF subunit 1	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P35269	GTF2F1	General transcription factor IIF subunit 1	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P35269	GTF2F1	General transcription factor IIF subunit 1	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
P35269	GTF2F1	General transcription factor IIF subunit 1	GO:0010467; P:gene expression; TAS:Reactome
P35269	GTF2F1	General transcription factor IIF subunit 1	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P35269	GTF2F1	General transcription factor IIF subunit 1	GO:0043085; P:positive regulation of catalytic activity; IDA:GOC
P35269	GTF2F1	General transcription factor IIF subunit 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P35269	GTF2F1	General transcription factor IIF subunit 1	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P35269	GTF2F1	General transcription factor IIF subunit 1	GO:0009615; P:response to virus; IEP:UniProtKB
P35269	GTF2F1	General transcription factor IIF subunit 1	GO:0008380; P:RNA splicing; TAS:Reactome
P35269	GTF2F1	General transcription factor IIF subunit 1	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P35269	GTF2F1	General transcription factor IIF subunit 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
P35269	GTF2F1	General transcription factor IIF subunit 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P35269	GTF2F1	General transcription factor IIF subunit 1	GO:0016032; P:viral process; TAS:Reactome
P13984	GTF2F2	General transcription factor IIF subunit 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P13984	GTF2F2	General transcription factor IIF subunit 2	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
P13984	GTF2F2	General transcription factor IIF subunit 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P13984	GTF2F2	General transcription factor IIF subunit 2	GO:0005515; F:protein binding; IPI:UniProtKB
P13984	GTF2F2	General transcription factor IIF subunit 2	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
P13984	GTF2F2	General transcription factor IIF subunit 2	GO:0010467; P:gene expression; TAS:Reactome
P13984	GTF2F2	General transcription factor IIF subunit 2	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P13984	GTF2F2	General transcription factor IIF subunit 2	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P13984	GTF2F2	General transcription factor IIF subunit 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P13984	GTF2F2	General transcription factor IIF subunit 2	GO:0008380; P:RNA splicing; TAS:Reactome
P13984	GTF2F2	General transcription factor IIF subunit 2	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P13984	GTF2F2	General transcription factor IIF subunit 2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
P13984	GTF2F2	General transcription factor IIF subunit 2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P13984	GTF2F2	General transcription factor IIF subunit 2	GO:0016032; P:viral process; TAS:Reactome
Q6P1K8	GTF2H2C	General transcription factor IIH subunit 2-like protein	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6P1K8	GTF2H2C	General transcription factor IIH subunit 2-like protein	GO:0006289; P:nucleotide-excision repair; IEA:InterPro
Q6P1K8	GTF2H2C	General transcription factor IIH subunit 2-like protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6P1K8	GTF2H2C	General transcription factor IIH subunit 2-like protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NYW0	TAS2R10	Taste receptor type 2 member 10	GO:0008527; F:taste receptor activity; TAS:UniProtKB
Q9NYW0	TAS2R10	Taste receptor type 2 member 10	GO:0050912; P:detection of chemical stimulus involved in sensory perception of taste; TAS:GOC
Q9NYV9	TAS2R13	Taste receptor type 2 member 13	GO:0008527; F:taste receptor activity; TAS:UniProtKB
Q9NYV9	TAS2R13	Taste receptor type 2 member 13	GO:0050912; P:detection of chemical stimulus involved in sensory perception of taste; TAS:GOC
Q9NYV9	TAS2R13	Taste receptor type 2 member 13	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProt
Q9NYV8	TAS2R14	Taste receptor type 2 member 14	GO:0033038; F:bitter taste receptor activity; IDA:HGNC
Q9NYV8	TAS2R14	Taste receptor type 2 member 14	GO:0008527; F:taste receptor activity; TAS:UniProtKB
Q9NYV8	TAS2R14	Taste receptor type 2 member 14	GO:0001580; P:detection of chemical stimulus involved in sensory perception of bitter taste; IDA:HGNC
Q9NYV8	TAS2R14	Taste receptor type 2 member 14	GO:0007186; P:G-protein coupled receptor signaling pathway; IC:HGNC
Q9NYV7	TAS2R16	Taste receptor type 2 member 16	GO:0033038; F:bitter taste receptor activity; IDA:HGNC
Q9NYV7	TAS2R16	Taste receptor type 2 member 16	GO:0005515; F:protein binding; IPI:HGNC
Q9NYV7	TAS2R16	Taste receptor type 2 member 16	GO:0001580; P:detection of chemical stimulus involved in sensory perception of bitter taste; IDA:HGNC
Q9NYV7	TAS2R16	Taste receptor type 2 member 16	GO:0007186; P:G-protein coupled receptor signaling pathway; IC:HGNC
P59542	TAS2R19	Taste receptor type 2 member 19	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P59542	TAS2R19	Taste receptor type 2 member 19	GO:0050909; P:sensory perception of taste; IEA:UniProtKB-KW
P59543	TAS2R20	Taste receptor type 2 member 20	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P59543	TAS2R20	Taste receptor type 2 member 20	GO:0050909; P:sensory perception of taste; IEA:UniProtKB-KW
P59541	TAS2R30	Taste receptor type 2 member 30	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P59541	TAS2R30	Taste receptor type 2 member 30	GO:0050909; P:sensory perception of taste; IEA:UniProtKB-KW
P59538	TAS2R31	Taste receptor type 2 member 31	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P59538	TAS2R31	Taste receptor type 2 member 31	GO:0050909; P:sensory perception of taste; IEA:UniProtKB-KW
P59533	TAS2R38	Taste receptor type 2 member 38	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P59533	TAS2R38	Taste receptor type 2 member 38	GO:0050909; P:sensory perception of taste; IEA:UniProtKB-KW
P59534	TAS2R39	Taste receptor type 2 member 39	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P59534	TAS2R39	Taste receptor type 2 member 39	GO:0050909; P:sensory perception of taste; IEA:UniProtKB-KW
P59535	TAS2R40	Taste receptor type 2 member 40	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P59535	TAS2R40	Taste receptor type 2 member 40	GO:0050909; P:sensory perception of taste; IEA:UniProtKB-KW
P59536	TAS2R41	Taste receptor type 2 member 41	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P59536	TAS2R41	Taste receptor type 2 member 41	GO:0050909; P:sensory perception of taste; IEA:UniProtKB-KW
Q7RTR8	TAS2R42	Taste receptor type 2 member 42	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
Q7RTR8	TAS2R42	Taste receptor type 2 member 42	GO:0050909; P:sensory perception of taste; IEA:UniProtKB-KW
P59537	TAS2R43	Taste receptor type 2 member 43	GO:0033038; F:bitter taste receptor activity; IDA:HGNC
P59537	TAS2R43	Taste receptor type 2 member 43	GO:0008527; F:taste receptor activity; IDA:HGNC
P59537	TAS2R43	Taste receptor type 2 member 43	GO:0001580; P:detection of chemical stimulus involved in sensory perception of bitter taste; IDA:HGNC
P59537	TAS2R43	Taste receptor type 2 member 43	GO:0007186; P:G-protein coupled receptor signaling pathway; IC:HGNC
P59539	TAS2R45	Taste receptor type 2 member 45	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P59539	TAS2R45	Taste receptor type 2 member 45	GO:0050909; P:sensory perception of taste; IEA:UniProtKB-KW
P59540	TAS2R46	Taste receptor type 2 member 46	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P59540	TAS2R46	Taste receptor type 2 member 46	GO:0050909; P:sensory perception of taste; IEA:UniProtKB-KW
P59544	TAS2R50	Taste receptor type 2 member 50	GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
P59544	TAS2R50	Taste receptor type 2 member 50	GO:0050909; P:sensory perception of taste; IEA:UniProtKB-KW
P59551	TAS2R60	Taste receptor type 2 member 60	GO:0004930; F:G-protein coupled receptor activity; NAS:UniProtKB
P59551	TAS2R60	Taste receptor type 2 member 60	GO:0050913; P:sensory perception of bitter taste; NAS:UniProtKB
Q96EM0	L3HYPDH	Trans-L-3-hydroxyproline dehydratase	GO:0016836; F:hydro-lyase activity; IDA:UniProtKB
Q96EM0	L3HYPDH	Trans-L-3-hydroxyproline dehydratase	GO:0050346; F:trans-L-3-hydroxyproline dehydratase activity; IEA:UniProtKB-EC
Q96EM0	L3HYPDH	Trans-L-3-hydroxyproline dehydratase	GO:0008152; P:metabolic process; IDA:UniProtKB
Q9Y228	TRAF3IP3	TRAF3-interacting JNK-activating modulator	GO:0005515; F:protein binding; IPI:IntAct
C9J1S8	TRIM49D1	Tripartite motif-containing protein 49D1	GO:0008270; F:zinc ion binding; IEA:InterPro
P48230	TM4SF4	Transmembrane 4 L6 family member 4	GO:0042246; P:tissue regeneration; IEA:Ensembl
Q9Y2A0	TP53TG1	TP53-target gene 1 protein	GO:0006974; P:cellular response to DNA damage stimulus; NAS:UniProtKB
Q9Y2A0	TP53TG1	TP53-target gene 1 protein	GO:0006950; P:response to stress; TAS:ProtInc
Q9Y2B4	TP53TG5	TP53-target gene 5 protein	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
Q9Y2B4	TP53TG5	TP53-target gene 5 protein	GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB
Q96A56	TP53INP1	Tumor protein p53-inducible nuclear protein 1	GO:0016209; F:antioxidant activity; ISS:UniProtKB
Q96A56	TP53INP1	Tumor protein p53-inducible nuclear protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96A56	TP53INP1	Tumor protein p53-inducible nuclear protein 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q96A56	TP53INP1	Tumor protein p53-inducible nuclear protein 1	GO:0048102; P:autophagic cell death; IMP:UniProtKB
Q96A56	TP53INP1	Tumor protein p53-inducible nuclear protein 1	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q96A56	TP53INP1	Tumor protein p53-inducible nuclear protein 1	GO:0007050; P:cell cycle arrest; TAS:UniProtKB
Q96A56	TP53INP1	Tumor protein p53-inducible nuclear protein 1	GO:0071361; P:cellular response to ethanol; IEA:Ensembl
Q96A56	TP53INP1	Tumor protein p53-inducible nuclear protein 1	GO:0071447; P:cellular response to hydroperoxide; IEA:Ensembl
Q96A56	TP53INP1	Tumor protein p53-inducible nuclear protein 1	GO:0072703; P:cellular response to methyl methanesulfonate; IEA:Ensembl
Q96A56	TP53INP1	Tumor protein p53-inducible nuclear protein 1	GO:0034644; P:cellular response to UV; IEA:Ensembl
Q96A56	TP53INP1	Tumor protein p53-inducible nuclear protein 1	GO:0030336; P:negative regulation of cell migration; ISS:UniProtKB
Q96A56	TP53INP1	Tumor protein p53-inducible nuclear protein 1	GO:0008285; P:negative regulation of cell proliferation; ISS:UniProtKB
Q96A56	TP53INP1	Tumor protein p53-inducible nuclear protein 1	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q96A56	TP53INP1	Tumor protein p53-inducible nuclear protein 1	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
Q96A56	TP53INP1	Tumor protein p53-inducible nuclear protein 1	GO:0010508; P:positive regulation of autophagy; IMP:UniProtKB
Q96A56	TP53INP1	Tumor protein p53-inducible nuclear protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q96A56	TP53INP1	Tumor protein p53-inducible nuclear protein 1	GO:0009408; P:response to heat; IEA:Ensembl
Q96A56	TP53INP1	Tumor protein p53-inducible nuclear protein 1	GO:0006950; P:response to stress; TAS:UniProtKB
Q96A56	TP53INP1	Tumor protein p53-inducible nuclear protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IXH6	TP53INP2	Tumor protein p53-inducible nuclear protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IXH6	TP53INP2	Tumor protein p53-inducible nuclear protein 2	GO:0000045; P:autophagic vacuole assembly; IDA:UniProtKB
Q8IXH6	TP53INP2	Tumor protein p53-inducible nuclear protein 2	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
Q8IXH6	TP53INP2	Tumor protein p53-inducible nuclear protein 2	GO:0010508; P:positive regulation of autophagy; IMP:UniProtKB
Q8IXH6	TP53INP2	Tumor protein p53-inducible nuclear protein 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q8IXH6	TP53INP2	Tumor protein p53-inducible nuclear protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NYW7	TAS2R1	Taste receptor type 2 member 1	GO:0008527; F:taste receptor activity; TAS:UniProtKB
Q9NYW7	TAS2R1	Taste receptor type 2 member 1	GO:0007635; P:chemosensory behavior; TAS:ProtInc
Q9NYW7	TAS2R1	Taste receptor type 2 member 1	GO:0050912; P:detection of chemical stimulus involved in sensory perception of taste; TAS:GOC
Q9NYW7	TAS2R1	Taste receptor type 2 member 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
Q9NYW6	TAS2R3	Taste receptor type 2 member 3	GO:0008527; F:taste receptor activity; TAS:UniProtKB
Q9NYW6	TAS2R3	Taste receptor type 2 member 3	GO:0050912; P:detection of chemical stimulus involved in sensory perception of taste; TAS:GOC
Q9NYW6	TAS2R3	Taste receptor type 2 member 3	GO:0050909; P:sensory perception of taste; TAS:ProtInc
Q9NYW6	TAS2R3	Taste receptor type 2 member 3	GO:0007165; P:signal transduction; TAS:ProtInc
Q9NYW5	TAS2R4	Taste receptor type 2 member 4	GO:0008527; F:taste receptor activity; TAS:UniProtKB
Q9NYW5	TAS2R4	Taste receptor type 2 member 4	GO:0050912; P:detection of chemical stimulus involved in sensory perception of taste; TAS:GOC
Q9NYW5	TAS2R4	Taste receptor type 2 member 4	GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl
Q9NYW5	TAS2R4	Taste receptor type 2 member 4	GO:0050909; P:sensory perception of taste; TAS:ProtInc
Q9NYW5	TAS2R4	Taste receptor type 2 member 4	GO:0007165; P:signal transduction; TAS:ProtInc
Q9NYW4	TAS2R5	Taste receptor type 2 member 5	GO:0008527; F:taste receptor activity; TAS:UniProtKB
Q9NYW4	TAS2R5	Taste receptor type 2 member 5	GO:0007635; P:chemosensory behavior; TAS:ProtInc
Q9NYW4	TAS2R5	Taste receptor type 2 member 5	GO:0050912; P:detection of chemical stimulus involved in sensory perception of taste; TAS:GOC
Q9NYW4	TAS2R5	Taste receptor type 2 member 5	GO:0050909; P:sensory perception of taste; TAS:ProtInc
Q9NYW4	TAS2R5	Taste receptor type 2 member 5	GO:0007165; P:signal transduction; TAS:ProtInc
Q9NYW3	TAS2R7	Taste receptor type 2 member 7	GO:0008527; F:taste receptor activity; TAS:UniProtKB
Q9NYW3	TAS2R7	Taste receptor type 2 member 7	GO:0050912; P:detection of chemical stimulus involved in sensory perception of taste; TAS:GOC
Q9NYW2	TAS2R8	Taste receptor type 2 member 8	GO:0008527; F:taste receptor activity; TAS:UniProtKB
Q9NYW2	TAS2R8	Taste receptor type 2 member 8	GO:0050912; P:detection of chemical stimulus involved in sensory perception of taste; TAS:GOC
Q9NYW1	TAS2R9	Taste receptor type 2 member 9	GO:0008527; F:taste receptor activity; TAS:UniProtKB
Q9NYW1	TAS2R9	Taste receptor type 2 member 9	GO:0050912; P:detection of chemical stimulus involved in sensory perception of taste; TAS:GOC
P21731	TBXA2R	Thromboxane A2 receptor	GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:Reactome
P21731	TBXA2R	Thromboxane A2 receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P21731	TBXA2R	Thromboxane A2 receptor	GO:0004961; F:thromboxane A2 receptor activity; TAS:ProtInc
P21731	TBXA2R	Thromboxane A2 receptor	GO:0007596; P:blood coagulation; TAS:Reactome
P21731	TBXA2R	Thromboxane A2 receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P21731	TBXA2R	Thromboxane A2 receptor	GO:0006954; P:inflammatory response; IEA:Ensembl
P21731	TBXA2R	Thromboxane A2 receptor	GO:0030168; P:platelet activation; TAS:Reactome
P21731	TBXA2R	Thromboxane A2 receptor	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
P21731	TBXA2R	Thromboxane A2 receptor	GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl
P21731	TBXA2R	Thromboxane A2 receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
P21731	TBXA2R	Thromboxane A2 receptor	GO:0045987; P:positive regulation of smooth muscle contraction; IEA:Ensembl
P21731	TBXA2R	Thromboxane A2 receptor	GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl
P21731	TBXA2R	Thromboxane A2 receptor	GO:0043087; P:regulation of GTPase activity; TAS:GOC
P21731	TBXA2R	Thromboxane A2 receptor	GO:0042493; P:response to drug; IEA:Ensembl
P21731	TBXA2R	Thromboxane A2 receptor	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P21731	TBXA2R	Thromboxane A2 receptor	GO:0007584; P:response to nutrient; IEA:Ensembl
P21731	TBXA2R	Thromboxane A2 receptor	GO:0019932; P:second-messenger-mediated signaling; IEA:Ensembl
P21731	TBXA2R	Thromboxane A2 receptor	GO:0038193; P:thromboxane A2 signaling pathway; TAS:GOC
Q96RJ0	TAAR1	Trace amine-associated receptor 1	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q96RJ0	TAAR1	Trace amine-associated receptor 1	GO:0001594; F:trace-amine receptor activity; IEA:InterPro
Q96RJ0	TAAR1	Trace amine-associated receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q9P1P5	TAAR2	Trace amine-associated receptor 2	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q9P1P5	TAAR2	Trace amine-associated receptor 2	GO:0001594; F:trace-amine receptor activity; IEA:InterPro
Q9P1P5	TAAR2	Trace amine-associated receptor 2	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q9P1P4	TAAR3	Putative trace amine-associated receptor 3	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q9P1P4	TAAR3	Putative trace amine-associated receptor 3	GO:0001594; F:trace-amine receptor activity; ISS:UniProtKB
Q9P1P4	TAAR3	Putative trace amine-associated receptor 3	GO:0007606; P:sensory perception of chemical stimulus; ISS:UniProtKB
O14804	TAAR5	Trace amine-associated receptor 5	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
O14804	TAAR5	Trace amine-associated receptor 5	GO:1990081; F:trimethylamine receptor activity; IDA:UniProtKB
O14804	TAAR5	Trace amine-associated receptor 5	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
O14804	TAAR5	Trace amine-associated receptor 5	GO:0007606; P:sensory perception of chemical stimulus; IEA:Ensembl
O14804	TAAR5	Trace amine-associated receptor 5	GO:0007165; P:signal transduction; TAS:ProtInc
O14804	TAAR5	Trace amine-associated receptor 5	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q96RI8	TAAR6	Trace amine-associated receptor 6	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q96RI8	TAAR6	Trace amine-associated receptor 6	GO:0001594; F:trace-amine receptor activity; IEA:InterPro
Q96RI8	TAAR6	Trace amine-associated receptor 6	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q969N4	TAAR8	Trace amine-associated receptor 8	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q969N4	TAAR8	Trace amine-associated receptor 8	GO:0001594; F:trace-amine receptor activity; IEA:InterPro
Q969N4	TAAR8	Trace amine-associated receptor 8	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q96RI9	TAAR9	Trace amine-associated receptor 9	GO:0004930; F:G-protein coupled receptor activity; TAS:GDB
Q96RI9	TAAR9	Trace amine-associated receptor 9	GO:0001594; F:trace-amine receptor activity; IEA:InterPro
Q96RI9	TAAR9	Trace amine-associated receptor 9	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GDB
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0003824; F:catalytic activity; IEA:InterPro
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0008047; F:enzyme activator activity; TAS:ProtInc
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0019209; F:kinase activator activity; IEA:Ensembl
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0000187; P:activation of MAPK activity; TAS:Reactome
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0000185; P:activation of MAPKKK activity; TAS:ProtInc
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0003007; P:heart morphogenesis; IEA:Ensembl
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0045087; P:innate immune response; TAS:Reactome
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0007254; P:JNK cascade; TAS:Reactome
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0030324; P:lung development; IEA:Ensembl
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:Reactome
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl
Q15750	TAB1	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0070530; F:K63-linked polyubiquitin binding; IDA:UniProtKB
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0000187; P:activation of MAPK activity; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0007507; P:heart development; IMP:UniProtKB
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0045087; P:innate immune response; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0007254; P:JNK cascade; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0045860; P:positive regulation of protein kinase activity; IDA:UniProtKB
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q9NYJ8	TAB2	TGF-beta-activated kinase 1 and MAP3K7-binding protein 2	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0000187; P:activation of MAPK activity; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0045087; P:innate immune response; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0007254; P:JNK cascade; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q8N5C8	TAB3	TGF-beta-activated kinase 1 and MAP3K7-binding protein 3	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
O75410	TACC1	Transforming acidic coiled-coil-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
O75410	TACC1	Transforming acidic coiled-coil-containing protein 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
O75410	TACC1	Transforming acidic coiled-coil-containing protein 1	GO:0051301; P:cell division; IEA:UniProtKB-KW
O75410	TACC1	Transforming acidic coiled-coil-containing protein 1	GO:0021987; P:cerebral cortex development; IEA:Ensembl
O75410	TACC1	Transforming acidic coiled-coil-containing protein 1	GO:0022027; P:interkinetic nuclear migration; IEA:Ensembl
O75410	TACC1	Transforming acidic coiled-coil-containing protein 1	GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl
O75410	TACC1	Transforming acidic coiled-coil-containing protein 1	GO:0022008; P:neurogenesis; IEA:Ensembl
O75410	TACC1	Transforming acidic coiled-coil-containing protein 1	GO:0032886; P:regulation of microtubule-based process; IEA:Ensembl
O95359	TACC2	Transforming acidic coiled-coil-containing protein 2	GO:0035257; F:nuclear hormone receptor binding; IDA:MGI
O95359	TACC2	Transforming acidic coiled-coil-containing protein 2	GO:0030953; P:astral microtubule organization; IEA:Ensembl
O95359	TACC2	Transforming acidic coiled-coil-containing protein 2	GO:0021987; P:cerebral cortex development; IEA:Ensembl
O95359	TACC2	Transforming acidic coiled-coil-containing protein 2	GO:0022027; P:interkinetic nuclear migration; IEA:Ensembl
O95359	TACC2	Transforming acidic coiled-coil-containing protein 2	GO:0022008; P:neurogenesis; IEA:Ensembl
O95359	TACC2	Transforming acidic coiled-coil-containing protein 2	GO:0032886; P:regulation of microtubule-based process; IEA:Ensembl
Q9Y6A5	TACC3	Transforming acidic coiled-coil-containing protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q9Y6A5	TACC3	Transforming acidic coiled-coil-containing protein 3	GO:0030953; P:astral microtubule organization; IEA:Ensembl
Q9Y6A5	TACC3	Transforming acidic coiled-coil-containing protein 3	GO:0021987; P:cerebral cortex development; IEA:Ensembl
Q9Y6A5	TACC3	Transforming acidic coiled-coil-containing protein 3	GO:0042994; P:cytoplasmic sequestering of transcription factor; IEA:Ensembl
Q9Y6A5	TACC3	Transforming acidic coiled-coil-containing protein 3	GO:0030097; P:hemopoiesis; IEA:Ensembl
Q9Y6A5	TACC3	Transforming acidic coiled-coil-containing protein 3	GO:0022027; P:interkinetic nuclear migration; IEA:Ensembl
Q9Y6A5	TACC3	Transforming acidic coiled-coil-containing protein 3	GO:0022008; P:neurogenesis; IEA:Ensembl
Q9Y6A5	TACC3	Transforming acidic coiled-coil-containing protein 3	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
Q9Y6A5	TACC3	Transforming acidic coiled-coil-containing protein 3	GO:0032886; P:regulation of microtubule-based process; IEA:Ensembl
Q9Y6A5	TACC3	Transforming acidic coiled-coil-containing protein 3	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q9BSH4	TACO1	Translational activator of cytochrome c oxidase 1	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
P09758	TACSTD2	Tumor-associated calcium signal transducer 2	GO:0004872; F:receptor activity; TAS:ProtInc
P09758	TACSTD2	Tumor-associated calcium signal transducer 2	GO:0008283; P:cell proliferation; TAS:ProtInc
P09758	TACSTD2	Tumor-associated calcium signal transducer 2	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P09758	TACSTD2	Tumor-associated calcium signal transducer 2	GO:0090191; P:negative regulation of branching involved in ureteric bud morphogenesis; ISS:UniProtKB
P09758	TACSTD2	Tumor-associated calcium signal transducer 2	GO:2000146; P:negative regulation of cell motility; ISS:UniProtKB
P09758	TACSTD2	Tumor-associated calcium signal transducer 2	GO:0010633; P:negative regulation of epithelial cell migration; ISS:UniProtKB
P09758	TACSTD2	Tumor-associated calcium signal transducer 2	GO:1900028; P:negative regulation of ruffle assembly; ISS:UniProtKB
P09758	TACSTD2	Tumor-associated calcium signal transducer 2	GO:0051497; P:negative regulation of stress fiber assembly; ISS:UniProtKB
P09758	TACSTD2	Tumor-associated calcium signal transducer 2	GO:1900025; P:negative regulation of substrate adhesion-dependent cell spreading; ISS:UniProtKB
P09758	TACSTD2	Tumor-associated calcium signal transducer 2	GO:2000738; P:positive regulation of stem cell differentiation; IEA:Ensembl
P09758	TACSTD2	Tumor-associated calcium signal transducer 2	GO:0050678; P:regulation of epithelial cell proliferation; IEA:Ensembl
P09758	TACSTD2	Tumor-associated calcium signal transducer 2	GO:0060675; P:ureteric bud morphogenesis; IEA:Ensembl
P09758	TACSTD2	Tumor-associated calcium signal transducer 2	GO:0007601; P:visual perception; TAS:ProtInc
P40200	CD96	T-cell surface protein tactile	GO:0007155; P:cell adhesion; TAS:ProtInc
P40200	CD96	T-cell surface protein tactile	GO:0006955; P:immune response; TAS:ProtInc
P40200	CD96	T-cell surface protein tactile	GO:0050776; P:regulation of immune response; TAS:Reactome
O75478	TADA2A	Transcriptional adapter 2-alpha	GO:0003682; F:chromatin binding; IEA:InterPro
O75478	TADA2A	Transcriptional adapter 2-alpha	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O75478	TADA2A	Transcriptional adapter 2-alpha	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O75478	TADA2A	Transcriptional adapter 2-alpha	GO:0003712; F:transcription cofactor activity; TAS:ProtInc
O75478	TADA2A	Transcriptional adapter 2-alpha	GO:0008270; F:zinc ion binding; IEA:InterPro
O75478	TADA2A	Transcriptional adapter 2-alpha	GO:0006325; P:chromatin organization; TAS:Reactome
O75478	TADA2A	Transcriptional adapter 2-alpha	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
O75478	TADA2A	Transcriptional adapter 2-alpha	GO:0007067; P:mitosis; IEA:Ensembl
O75478	TADA2A	Transcriptional adapter 2-alpha	GO:0031063; P:regulation of histone deacetylation; IEA:Ensembl
O75478	TADA2A	Transcriptional adapter 2-alpha	GO:0001932; P:regulation of protein phosphorylation; IEA:Ensembl
O75478	TADA2A	Transcriptional adapter 2-alpha	GO:0031647; P:regulation of protein stability; IEA:Ensembl
O75478	TADA2A	Transcriptional adapter 2-alpha	GO:0090043; P:regulation of tubulin deacetylation; IEA:Ensembl
O75478	TADA2A	Transcriptional adapter 2-alpha	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q86TJ2	TADA2B	Transcriptional adapter 2-beta	GO:0003682; F:chromatin binding; IEA:InterPro
Q86TJ2	TADA2B	Transcriptional adapter 2-beta	GO:0003677; F:DNA binding; IEA:InterPro
Q86TJ2	TADA2B	Transcriptional adapter 2-beta	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86TJ2	TADA2B	Transcriptional adapter 2-beta	GO:0006325; P:chromatin organization; TAS:Reactome
Q86TJ2	TADA2B	Transcriptional adapter 2-beta	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q86TJ2	TADA2B	Transcriptional adapter 2-beta	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96BN2	TADA1	Transcriptional adapter 1	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q96BN2	TADA1	Transcriptional adapter 1	GO:0006325; P:chromatin organization; TAS:Reactome
Q96BN2	TADA1	Transcriptional adapter 1	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
Q96BN2	TADA1	Transcriptional adapter 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96BN2	TADA1	Transcriptional adapter 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75528	TADA3	Transcriptional adapter 3	GO:0016922; F:ligand-dependent nuclear receptor binding; IPI:UniProtKB
O75528	TADA3	Transcriptional adapter 3	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IEA:Ensembl
O75528	TADA3	Transcriptional adapter 3	GO:0005515; F:protein binding; IPI:IntAct
O75528	TADA3	Transcriptional adapter 3	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
O75528	TADA3	Transcriptional adapter 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O75528	TADA3	Transcriptional adapter 3	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
O75528	TADA3	Transcriptional adapter 3	GO:0006325; P:chromatin organization; TAS:Reactome
O75528	TADA3	Transcriptional adapter 3	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
O75528	TADA3	Transcriptional adapter 3	GO:0030520; P:intracellular estrogen receptor signaling pathway; TAS:UniProtKB
O75528	TADA3	Transcriptional adapter 3	GO:0007067; P:mitosis; IEA:Ensembl
O75528	TADA3	Transcriptional adapter 3	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
O75528	TADA3	Transcriptional adapter 3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O75528	TADA3	Transcriptional adapter 3	GO:0031063; P:regulation of histone deacetylation; IEA:Ensembl
O75528	TADA3	Transcriptional adapter 3	GO:0001932; P:regulation of protein phosphorylation; IEA:Ensembl
O75528	TADA3	Transcriptional adapter 3	GO:0031647; P:regulation of protein stability; IEA:Ensembl
O75528	TADA3	Transcriptional adapter 3	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O75528	TADA3	Transcriptional adapter 3	GO:0090043; P:regulation of tubulin deacetylation; IEA:Ensembl
O75528	TADA3	Transcriptional adapter 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13148	TARDBP	TAR DNA-binding protein 43	GO:0003690; F:double-stranded DNA binding; IDA:BHF-UCL
Q13148	TARDBP	TAR DNA-binding protein 43	GO:0042802; F:identical protein binding; IPI:IntAct
Q13148	TARDBP	TAR DNA-binding protein 43	GO:0003730; F:mRNA 3'-UTR binding; IDA:BHF-UCL
Q13148	TARDBP	TAR DNA-binding protein 43	GO:0000166; F:nucleotide binding; IEA:InterPro
Q13148	TARDBP	TAR DNA-binding protein 43	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13148	TARDBP	TAR DNA-binding protein 43	GO:0005515; F:protein binding; IPI:UniProtKB
Q13148	TARDBP	TAR DNA-binding protein 43	GO:0003723; F:RNA binding; IDA:BHF-UCL
Q13148	TARDBP	TAR DNA-binding protein 43	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q13148	TARDBP	TAR DNA-binding protein 43	GO:0070935; P:3'-UTR-mediated mRNA stabilization; IDA:BHF-UCL
Q13148	TARDBP	TAR DNA-binding protein 43	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q13148	TARDBP	TAR DNA-binding protein 43	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q13148	TARDBP	TAR DNA-binding protein 43	GO:0043922; P:negative regulation by host of viral transcription; IDA:BHF-UCL
Q13148	TARDBP	TAR DNA-binding protein 43	GO:0008380; P:RNA splicing; IDA:BHF-UCL
Q13148	TARDBP	TAR DNA-binding protein 43	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q12962	TAF10	Transcription initiation factor TFIID subunit 10	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q12962	TAF10	Transcription initiation factor TFIID subunit 10	GO:0030331; F:estrogen receptor binding; IDA:UniProtKB
Q12962	TAF10	Transcription initiation factor TFIID subunit 10	GO:0005515; F:protein binding; IPI:UniProtKB
Q12962	TAF10	Transcription initiation factor TFIID subunit 10	GO:0070063; F:RNA polymerase binding; IDA:UniProtKB
Q12962	TAF10	Transcription initiation factor TFIID subunit 10	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q12962	TAF10	Transcription initiation factor TFIID subunit 10	GO:0006325; P:chromatin organization; TAS:Reactome
Q12962	TAF10	Transcription initiation factor TFIID subunit 10	GO:0006352; P:DNA-templated transcription, initiation; IDA:UniProtKB
Q12962	TAF10	Transcription initiation factor TFIID subunit 10	GO:0010467; P:gene expression; TAS:Reactome
Q12962	TAF10	Transcription initiation factor TFIID subunit 10	GO:0016578; P:histone deubiquitination; IDA:UniProtKB
Q12962	TAF10	Transcription initiation factor TFIID subunit 10	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
Q12962	TAF10	Transcription initiation factor TFIID subunit 10	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
Q12962	TAF10	Transcription initiation factor TFIID subunit 10	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q12962	TAF10	Transcription initiation factor TFIID subunit 10	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q12962	TAF10	Transcription initiation factor TFIID subunit 10	GO:0006366; P:transcription from RNA polymerase II promoter; IC:UniProtKB
Q12962	TAF10	Transcription initiation factor TFIID subunit 10	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB
Q12962	TAF10	Transcription initiation factor TFIID subunit 10	GO:0016032; P:viral process; TAS:Reactome
Q15544	TAF11	Transcription initiation factor TFIID subunit 11	GO:0003677; F:DNA binding; IEA:Ensembl
Q15544	TAF11	Transcription initiation factor TFIID subunit 11	GO:0005515; F:protein binding; IPI:UniProtKB
Q15544	TAF11	Transcription initiation factor TFIID subunit 11	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q15544	TAF11	Transcription initiation factor TFIID subunit 11	GO:0046966; F:thyroid hormone receptor binding; IPI:UniProtKB
Q15544	TAF11	Transcription initiation factor TFIID subunit 11	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q15544	TAF11	Transcription initiation factor TFIID subunit 11	GO:0042809; F:vitamin D receptor binding; IPI:UniProtKB
Q15544	TAF11	Transcription initiation factor TFIID subunit 11	GO:0010467; P:gene expression; TAS:Reactome
Q15544	TAF11	Transcription initiation factor TFIID subunit 11	GO:0043923; P:positive regulation by host of viral transcription; IDA:UniProtKB
Q15544	TAF11	Transcription initiation factor TFIID subunit 11	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q15544	TAF11	Transcription initiation factor TFIID subunit 11	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q15544	TAF11	Transcription initiation factor TFIID subunit 11	GO:0006366; P:transcription from RNA polymerase II promoter; IC:UniProtKB
Q15544	TAF11	Transcription initiation factor TFIID subunit 11	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IC:UniProtKB
Q15544	TAF11	Transcription initiation factor TFIID subunit 11	GO:0016032; P:viral process; TAS:Reactome
Q16514	TAF12	Transcription initiation factor TFIID subunit 12	GO:0003677; F:DNA binding; IDA:UniProtKB
Q16514	TAF12	Transcription initiation factor TFIID subunit 12	GO:0005515; F:protein binding; IPI:UniProtKB
Q16514	TAF12	Transcription initiation factor TFIID subunit 12	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q16514	TAF12	Transcription initiation factor TFIID subunit 12	GO:0008134; F:transcription factor binding; IDA:UniProtKB
Q16514	TAF12	Transcription initiation factor TFIID subunit 12	GO:0006325; P:chromatin organization; TAS:Reactome
Q16514	TAF12	Transcription initiation factor TFIID subunit 12	GO:0006352; P:DNA-templated transcription, initiation; IDA:UniProtKB
Q16514	TAF12	Transcription initiation factor TFIID subunit 12	GO:0010467; P:gene expression; TAS:Reactome
Q16514	TAF12	Transcription initiation factor TFIID subunit 12	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
Q16514	TAF12	Transcription initiation factor TFIID subunit 12	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q16514	TAF12	Transcription initiation factor TFIID subunit 12	GO:2001141; P:regulation of RNA biosynthetic process; IDA:GOC
Q16514	TAF12	Transcription initiation factor TFIID subunit 12	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q16514	TAF12	Transcription initiation factor TFIID subunit 12	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q16514	TAF12	Transcription initiation factor TFIID subunit 12	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB
Q16514	TAF12	Transcription initiation factor TFIID subunit 12	GO:0016032; P:viral process; TAS:Reactome
Q15543	TAF13	Transcription initiation factor TFIID subunit 13	GO:0003677; F:DNA binding; IEA:Ensembl
Q15543	TAF13	Transcription initiation factor TFIID subunit 13	GO:0005515; F:protein binding; IPI:UniProtKB
Q15543	TAF13	Transcription initiation factor TFIID subunit 13	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q15543	TAF13	Transcription initiation factor TFIID subunit 13	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q15543	TAF13	Transcription initiation factor TFIID subunit 13	GO:0006352; P:DNA-templated transcription, initiation; NAS:UniProtKB
Q15543	TAF13	Transcription initiation factor TFIID subunit 13	GO:0010467; P:gene expression; TAS:Reactome
Q15543	TAF13	Transcription initiation factor TFIID subunit 13	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q15543	TAF13	Transcription initiation factor TFIID subunit 13	GO:0006366; P:transcription from RNA polymerase II promoter; IC:UniProtKB
Q15543	TAF13	Transcription initiation factor TFIID subunit 13	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IC:UniProtKB
Q15543	TAF13	Transcription initiation factor TFIID subunit 13	GO:0016032; P:viral process; TAS:Reactome
Q15573	TAF1A	TATA box-binding protein-associated factor RNA polymerase I subunit A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q15573	TAF1A	TATA box-binding protein-associated factor RNA polymerase I subunit A	GO:0005515; F:protein binding; IPI:IntAct
Q15573	TAF1A	TATA box-binding protein-associated factor RNA polymerase I subunit A	GO:0010467; P:gene expression; TAS:Reactome
Q15573	TAF1A	TATA box-binding protein-associated factor RNA polymerase I subunit A	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q15573	TAF1A	TATA box-binding protein-associated factor RNA polymerase I subunit A	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
Q15573	TAF1A	TATA box-binding protein-associated factor RNA polymerase I subunit A	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
Q15573	TAF1A	TATA box-binding protein-associated factor RNA polymerase I subunit A	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
Q15573	TAF1A	TATA box-binding protein-associated factor RNA polymerase I subunit A	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q15573	TAF1A	TATA box-binding protein-associated factor RNA polymerase I subunit A	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
Q53T94	TAF1B	TATA box-binding protein-associated factor RNA polymerase I subunit B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q53T94	TAF1B	TATA box-binding protein-associated factor RNA polymerase I subunit B	GO:0005515; F:protein binding; IPI:IntAct
Q53T94	TAF1B	TATA box-binding protein-associated factor RNA polymerase I subunit B	GO:0001164; F:RNA polymerase I CORE element sequence-specific DNA binding; IDA:UniProtKB
Q53T94	TAF1B	TATA box-binding protein-associated factor RNA polymerase I subunit B	GO:0001187; F:RNA polymerase I CORE element sequence-specific DNA binding transcription factor recruiting transcription factor activity; IDA:UniProtKB
Q53T94	TAF1B	TATA box-binding protein-associated factor RNA polymerase I subunit B	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q53T94	TAF1B	TATA box-binding protein-associated factor RNA polymerase I subunit B	GO:0017025; F:TBP-class protein binding; TAS:UniProtKB
Q53T94	TAF1B	TATA box-binding protein-associated factor RNA polymerase I subunit B	GO:0010467; P:gene expression; TAS:Reactome
Q53T94	TAF1B	TATA box-binding protein-associated factor RNA polymerase I subunit B	GO:0001189; P:RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript; IDA:UniProtKB
Q53T94	TAF1B	TATA box-binding protein-associated factor RNA polymerase I subunit B	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
Q53T94	TAF1B	TATA box-binding protein-associated factor RNA polymerase I subunit B	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
Q53T94	TAF1B	TATA box-binding protein-associated factor RNA polymerase I subunit B	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
Q53T94	TAF1B	TATA box-binding protein-associated factor RNA polymerase I subunit B	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
Q53T94	TAF1B	TATA box-binding protein-associated factor RNA polymerase I subunit B	GO:0006351; P:transcription, DNA-templated; NAS:UniProtKB
Q15572	TAF1C	TATA box-binding protein-associated factor RNA polymerase I subunit C	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q15572	TAF1C	TATA box-binding protein-associated factor RNA polymerase I subunit C	GO:0005515; F:protein binding; IPI:IntAct
Q15572	TAF1C	TATA box-binding protein-associated factor RNA polymerase I subunit C	GO:0010467; P:gene expression; TAS:Reactome
Q15572	TAF1C	TATA box-binding protein-associated factor RNA polymerase I subunit C	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q15572	TAF1C	TATA box-binding protein-associated factor RNA polymerase I subunit C	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
Q15572	TAF1C	TATA box-binding protein-associated factor RNA polymerase I subunit C	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
Q15572	TAF1C	TATA box-binding protein-associated factor RNA polymerase I subunit C	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
Q15572	TAF1C	TATA box-binding protein-associated factor RNA polymerase I subunit C	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q15572	TAF1C	TATA box-binding protein-associated factor RNA polymerase I subunit C	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
Q9H5J8	TAF1D	TATA box-binding protein-associated factor RNA polymerase I subunit D	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H5J8	TAF1D	TATA box-binding protein-associated factor RNA polymerase I subunit D	GO:0005515; F:protein binding; IPI:IntAct
Q9H5J8	TAF1D	TATA box-binding protein-associated factor RNA polymerase I subunit D	GO:0010467; P:gene expression; TAS:Reactome
Q9H5J8	TAF1D	TATA box-binding protein-associated factor RNA polymerase I subunit D	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H5J8	TAF1D	TATA box-binding protein-associated factor RNA polymerase I subunit D	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
Q9H5J8	TAF1D	TATA box-binding protein-associated factor RNA polymerase I subunit D	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
Q9H5J8	TAF1D	TATA box-binding protein-associated factor RNA polymerase I subunit D	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
Q9H5J8	TAF1D	TATA box-binding protein-associated factor RNA polymerase I subunit D	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
Q8IZX4	TAF1L	Transcription initiation factor TFIID subunit 1-like	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IZX4	TAF1L	Transcription initiation factor TFIID subunit 1-like	GO:0070577; F:lysine-acetylated histone binding; IDA:UniProtKB
Q8IZX4	TAF1L	Transcription initiation factor TFIID subunit 1-like	GO:0004402; F:histone acetyltransferase activity; ISS:UniProtKB
Q8IZX4	TAF1L	Transcription initiation factor TFIID subunit 1-like	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB
Q8IZX4	TAF1L	Transcription initiation factor TFIID subunit 1-like	GO:0017025; F:TBP-class protein binding; IPI:UniProtKB
Q8IZX4	TAF1L	Transcription initiation factor TFIID subunit 1-like	GO:0006352; P:DNA-templated transcription, initiation; IEA:InterPro
Q8IZX4	TAF1L	Transcription initiation factor TFIID subunit 1-like	GO:0016573; P:histone acetylation; ISS:GOC
Q8IZX4	TAF1L	Transcription initiation factor TFIID subunit 1-like	GO:0007140; P:male meiosis; IEP:UniProtKB
Q8IZX4	TAF1L	Transcription initiation factor TFIID subunit 1-like	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q8IZX4	TAF1L	Transcription initiation factor TFIID subunit 1-like	GO:0006468; P:protein phosphorylation; ISS:GOC
Q8IZX4	TAF1L	Transcription initiation factor TFIID subunit 1-like	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0070577; F:lysine-acetylated histone binding; IDA:BHF-UCL
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0004402; F:histone acetyltransferase activity; IDA:UniProtKB
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0002039; F:p53 binding; IPI:BHF-UCL
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0005515; F:protein binding; IPI:UniProtKB
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0043565; F:sequence-specific DNA binding; ISS:BHF-UCL
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0017025; F:TBP-class protein binding; IPI:BHF-UCL
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0003713; F:transcription coactivator activity; IDA:BHF-UCL
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0006974; P:cellular response to DNA damage stimulus; IC:BHF-UCL
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0006352; P:DNA-templated transcription, initiation; ISS:BHF-UCL
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0010467; P:gene expression; TAS:Reactome
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0016573; P:histone acetylation; IDA:GOC
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0018107; P:peptidyl-threonine phosphorylation; IDA:BHF-UCL
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:BHF-UCL
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0060261; P:positive regulation of transcription initiation from RNA polymerase II promoter; ISS:BHF-UCL
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0046777; P:protein autophosphorylation; TAS:UniProtKB
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0000117; P:regulation of transcription involved in G2/M transition of mitotic cell cycle; ISS:BHF-UCL
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0051123; P:RNA polymerase II transcriptional preinitiation complex assembly; ISS:BHF-UCL
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P21675	TAF1	Transcription initiation factor TFIID subunit 1	GO:0016032; P:viral process; TAS:Reactome
Q6P1X5	TAF2	Transcription initiation factor TFIID subunit 2	GO:0008237; F:metallopeptidase activity; IEA:InterPro
Q6P1X5	TAF2	Transcription initiation factor TFIID subunit 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q6P1X5	TAF2	Transcription initiation factor TFIID subunit 2	GO:0044212; F:transcription regulatory region DNA binding; IMP:UniProtKB
Q6P1X5	TAF2	Transcription initiation factor TFIID subunit 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6P1X5	TAF2	Transcription initiation factor TFIID subunit 2	GO:0000086; P:G2/M transition of mitotic cell cycle; IMP:UniProtKB
Q6P1X5	TAF2	Transcription initiation factor TFIID subunit 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q6P1X5	TAF2	Transcription initiation factor TFIID subunit 2	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
Q6P1X5	TAF2	Transcription initiation factor TFIID subunit 2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB
Q5VWG9	TAF3	Transcription initiation factor TFIID subunit 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q5VWG9	TAF3	Transcription initiation factor TFIID subunit 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5VWG9	TAF3	Transcription initiation factor TFIID subunit 3	GO:0051457; P:maintenance of protein location in nucleus; IDA:HGNC
Q5VWG9	TAF3	Transcription initiation factor TFIID subunit 3	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q5VWG9	TAF3	Transcription initiation factor TFIID subunit 3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q5VWG9	TAF3	Transcription initiation factor TFIID subunit 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75529	TAF5L	TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O75529	TAF5L	TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
O75529	TAF5L	TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L	GO:0006325; P:chromatin organization; TAS:Reactome
O75529	TAF5L	TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
O75529	TAF5L	TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q92750	TAF4B	Transcription initiation factor TFIID subunit 4B	GO:0003677; F:DNA binding; IDA:UniProtKB
Q92750	TAF4B	Transcription initiation factor TFIID subunit 4B	GO:0051059; F:NF-kappaB binding; IPI:UniProtKB
Q92750	TAF4B	Transcription initiation factor TFIID subunit 4B	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q92750	TAF4B	Transcription initiation factor TFIID subunit 4B	GO:0010467; P:gene expression; TAS:Reactome
Q92750	TAF4B	Transcription initiation factor TFIID subunit 4B	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q92750	TAF4B	Transcription initiation factor TFIID subunit 4B	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q92750	TAF4B	Transcription initiation factor TFIID subunit 4B	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q92750	TAF4B	Transcription initiation factor TFIID subunit 4B	GO:0016032; P:viral process; TAS:Reactome
O00268	TAF4	Transcription initiation factor TFIID subunit 4	GO:0003677; F:DNA binding; IDA:UniProtKB
O00268	TAF4	Transcription initiation factor TFIID subunit 4	GO:0005515; F:protein binding; IPI:UniProtKB
O00268	TAF4	Transcription initiation factor TFIID subunit 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O00268	TAF4	Transcription initiation factor TFIID subunit 4	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
O00268	TAF4	Transcription initiation factor TFIID subunit 4	GO:0006352; P:DNA-templated transcription, initiation; IDA:UniProtKB
O00268	TAF4	Transcription initiation factor TFIID subunit 4	GO:0010467; P:gene expression; TAS:Reactome
O00268	TAF4	Transcription initiation factor TFIID subunit 4	GO:0001541; P:ovarian follicle development; IEA:Ensembl
O00268	TAF4	Transcription initiation factor TFIID subunit 4	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O00268	TAF4	Transcription initiation factor TFIID subunit 4	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
O00268	TAF4	Transcription initiation factor TFIID subunit 4	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
O00268	TAF4	Transcription initiation factor TFIID subunit 4	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB
O00268	TAF4	Transcription initiation factor TFIID subunit 4	GO:0016032; P:viral process; TAS:Reactome
Q15542	TAF5	Transcription initiation factor TFIID subunit 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q15542	TAF5	Transcription initiation factor TFIID subunit 5	GO:0046983; F:protein dimerization activity; IDA:UniProtKB
Q15542	TAF5	Transcription initiation factor TFIID subunit 5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IMP:UniProtKB
Q15542	TAF5	Transcription initiation factor TFIID subunit 5	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q15542	TAF5	Transcription initiation factor TFIID subunit 5	GO:0016568; P:chromatin modification; IC:UniProtKB
Q15542	TAF5	Transcription initiation factor TFIID subunit 5	GO:0006352; P:DNA-templated transcription, initiation; IDA:UniProtKB
Q15542	TAF5	Transcription initiation factor TFIID subunit 5	GO:0010467; P:gene expression; TAS:Reactome
Q15542	TAF5	Transcription initiation factor TFIID subunit 5	GO:0016573; P:histone acetylation; IDA:GOC
Q15542	TAF5	Transcription initiation factor TFIID subunit 5	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q15542	TAF5	Transcription initiation factor TFIID subunit 5	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q15542	TAF5	Transcription initiation factor TFIID subunit 5	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB
Q15542	TAF5	Transcription initiation factor TFIID subunit 5	GO:0016032; P:viral process; TAS:Reactome
Q9Y6J9	TAF6L	TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L	GO:0003677; F:DNA binding; TAS:ProtInc
Q9Y6J9	TAF6L	TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L	GO:0005515; F:protein binding; IPI:IntAct
Q9Y6J9	TAF6L	TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q9Y6J9	TAF6L	TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L	GO:0006325; P:chromatin organization; TAS:Reactome
Q9Y6J9	TAF6L	TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L	GO:0006338; P:chromatin remodeling; TAS:ProtInc
Q9Y6J9	TAF6L	TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L	GO:0006352; P:DNA-templated transcription, initiation; IEA:InterPro
Q9Y6J9	TAF6L	TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
Q9Y6J9	TAF6L	TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9Y6J9	TAF6L	TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P49848	TAF6	Transcription initiation factor TFIID subunit 6	GO:0003677; F:DNA binding; IDA:UniProtKB
P49848	TAF6	Transcription initiation factor TFIID subunit 6	GO:0005515; F:protein binding; IPI:UniProtKB
P49848	TAF6	Transcription initiation factor TFIID subunit 6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P49848	TAF6	Transcription initiation factor TFIID subunit 6	GO:0006352; P:DNA-templated transcription, initiation; IDA:UniProtKB
P49848	TAF6	Transcription initiation factor TFIID subunit 6	GO:0010467; P:gene expression; TAS:Reactome
P49848	TAF6	Transcription initiation factor TFIID subunit 6	GO:0045786; P:negative regulation of cell cycle; IDA:UniProtKB
P49848	TAF6	Transcription initiation factor TFIID subunit 6	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
P49848	TAF6	Transcription initiation factor TFIID subunit 6	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IEA:InterPro
P49848	TAF6	Transcription initiation factor TFIID subunit 6	GO:0006355; P:regulation of transcription, DNA-templated; IDA:GOC
P49848	TAF6	Transcription initiation factor TFIID subunit 6	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P49848	TAF6	Transcription initiation factor TFIID subunit 6	GO:0006366; P:transcription from RNA polymerase II promoter; NAS:UniProtKB
P49848	TAF6	Transcription initiation factor TFIID subunit 6	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB
P49848	TAF6	Transcription initiation factor TFIID subunit 6	GO:0016032; P:viral process; TAS:Reactome
Q5H9L4	TAF7L	Transcription initiation factor TFIID subunit 7-like	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q5H9L4	TAF7L	Transcription initiation factor TFIID subunit 7-like	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q5H9L4	TAF7L	Transcription initiation factor TFIID subunit 7-like	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5H9L4	TAF7L	Transcription initiation factor TFIID subunit 7-like	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q5H9L4	TAF7L	Transcription initiation factor TFIID subunit 7-like	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IEA:InterPro
Q15545	TAF7	Transcription initiation factor TFIID subunit 7	GO:0035035; F:histone acetyltransferase binding; IPI:UniProtKB
Q15545	TAF7	Transcription initiation factor TFIID subunit 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q15545	TAF7	Transcription initiation factor TFIID subunit 7	GO:0046966; F:thyroid hormone receptor binding; IPI:UniProtKB
Q15545	TAF7	Transcription initiation factor TFIID subunit 7	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q15545	TAF7	Transcription initiation factor TFIID subunit 7	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q15545	TAF7	Transcription initiation factor TFIID subunit 7	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q15545	TAF7	Transcription initiation factor TFIID subunit 7	GO:0042809; F:vitamin D receptor binding; IPI:UniProtKB
Q15545	TAF7	Transcription initiation factor TFIID subunit 7	GO:0006352; P:DNA-templated transcription, initiation; IDA:UniProtKB
Q15545	TAF7	Transcription initiation factor TFIID subunit 7	GO:0030520; P:intracellular estrogen receptor signaling pathway; IEA:Ensembl
Q15545	TAF7	Transcription initiation factor TFIID subunit 7	GO:0035067; P:negative regulation of histone acetylation; IDA:UniProtKB
Q15545	TAF7	Transcription initiation factor TFIID subunit 7	GO:0006469; P:negative regulation of protein kinase activity; IDA:UniProtKB
Q15545	TAF7	Transcription initiation factor TFIID subunit 7	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q15545	TAF7	Transcription initiation factor TFIID subunit 7	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q15545	TAF7	Transcription initiation factor TFIID subunit 7	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q15545	TAF7	Transcription initiation factor TFIID subunit 7	GO:0000296; P:spermine transport; ISS:UniProtKB
Q15545	TAF7	Transcription initiation factor TFIID subunit 7	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
Q15545	TAF7	Transcription initiation factor TFIID subunit 7	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB
Q7Z7C8	TAF8	Transcription initiation factor TFIID subunit 8	GO:0005515; F:protein binding; IPI:HGNC
Q7Z7C8	TAF8	Transcription initiation factor TFIID subunit 8	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q7Z7C8	TAF8	Transcription initiation factor TFIID subunit 8	GO:0001833; P:inner cell mass cell proliferation; IEA:Ensembl
Q7Z7C8	TAF8	Transcription initiation factor TFIID subunit 8	GO:0051457; P:maintenance of protein location in nucleus; IDA:HGNC
Q7Z7C8	TAF8	Transcription initiation factor TFIID subunit 8	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:MGI
Q7Z7C8	TAF8	Transcription initiation factor TFIID subunit 8	GO:0045598; P:regulation of fat cell differentiation; IDA:MGI
Q7Z7C8	TAF8	Transcription initiation factor TFIID subunit 8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HBM6	TAF9B	Transcription initiation factor TFIID subunit 9B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HBM6	TAF9B	Transcription initiation factor TFIID subunit 9B	GO:0003714; F:transcription corepressor activity; IC:BHF-UCL
Q9HBM6	TAF9B	Transcription initiation factor TFIID subunit 9B	GO:0006352; P:DNA-templated transcription, initiation; IEA:InterPro
Q9HBM6	TAF9B	Transcription initiation factor TFIID subunit 9B	GO:0043066; P:negative regulation of apoptotic process; IMP:BHF-UCL
Q9HBM6	TAF9B	Transcription initiation factor TFIID subunit 9B	GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IC:BHF-UCL
Q9HBM6	TAF9B	Transcription initiation factor TFIID subunit 9B	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q9HBM6	TAF9B	Transcription initiation factor TFIID subunit 9B	GO:0030307; P:positive regulation of cell growth; IMP:UniProtKB
Q9HBM6	TAF9B	Transcription initiation factor TFIID subunit 9B	GO:0012501; P:programmed cell death; IEA:Ensembl
Q9HBM6	TAF9B	Transcription initiation factor TFIID subunit 9B	GO:0050821; P:protein stabilization; IDA:BHF-UCL
Q9HBM6	TAF9B	Transcription initiation factor TFIID subunit 9B	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0033613; F:activating transcription factor binding; IPI:BHF-UCL
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0070742; F:C2H2 zinc finger domain binding; IPI:BHF-UCL
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0003677; F:DNA binding; IDA:UniProtKB
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0002039; F:p53 binding; IPI:BHF-UCL
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0005515; F:protein binding; IPI:UniProtKB
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0006974; P:cellular response to DNA damage stimulus; IC:BHF-UCL
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0006325; P:chromatin organization; TAS:Reactome
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0010467; P:gene expression; TAS:Reactome
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0043066; P:negative regulation of apoptotic process; IMP:BHF-UCL
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IC:BHF-UCL
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:BHF-UCL
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0030307; P:positive regulation of cell growth; IMP:UniProtKB
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0060760; P:positive regulation of response to cytokine stimulus; IMP:BHF-UCL
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0050821; P:protein stabilization; IDA:BHF-UCL
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0070555; P:response to interleukin-1; IMP:BHF-UCL
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q16594	TAF9	Transcription initiation factor TFIID subunit 9	GO:0016032; P:viral process; TAS:Reactome
Q8N103	TAGAP	T-cell activation Rho GTPase-activating protein	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW
Q8N103	TAGAP	T-cell activation Rho GTPase-activating protein	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q8N103	TAGAP	T-cell activation Rho GTPase-activating protein	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P37802	TAGLN2	Transgelin-2	GO:0005515; F:protein binding; IPI:IntAct
P37802	TAGLN2	Transgelin-2	GO:0030855; P:epithelial cell differentiation; IDA:UniProt
Q9UI15	TAGLN3	Transgelin-3	GO:0007417; P:central nervous system development; TAS:ProtInc
Q9UI15	TAGLN3	Transgelin-3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q01995	TAGLN	Transgelin	GO:0005515; F:protein binding; IPI:IntAct
Q01995	TAGLN	Transgelin	GO:0030855; P:epithelial cell differentiation; IDA:UniProt
Q01995	TAGLN	Transgelin	GO:0007517; P:muscle organ development; TAS:ProtInc
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0003682; F:chromatin binding; IDA:MGI
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0070888; F:E-box binding; IDA:BHF-UCL
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; IEA:Ensembl
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0001085; F:RNA polymerase II transcription factor binding; IPI:BHF-UCL
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IEA:Ensembl
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0044212; F:transcription regulatory region DNA binding; ISS:BHF-UCL
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0001525; P:angiogenesis; IEA:Ensembl
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0060018; P:astrocyte fate commitment; IEA:Ensembl
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0030221; P:basophil differentiation; IEP:BHF-UCL
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0045165; P:cell fate commitment; ISS:BHF-UCL
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0060216; P:definitive hemopoiesis; IEA:Ensembl
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0035162; P:embryonic hemopoiesis; ISS:UniProtKB
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0030218; P:erythrocyte differentiation; IMP:BHF-UCL
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0043249; P:erythrocyte maturation; IEA:Ensembl
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0060217; P:hemangioblast cell differentiation; IEA:Ensembl
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0060218; P:hematopoietic stem cell differentiation; IEA:Ensembl
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0030097; P:hemopoiesis; ISS:BHF-UCL
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0007626; P:locomotory behavior; IEA:Ensembl
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0035855; P:megakaryocyte development; IEA:Ensembl
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0030219; P:megakaryocyte differentiation; IEP:BHF-UCL
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0030220; P:platelet formation; IEA:Ensembl
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0051781; P:positive regulation of cell division; IMP:BHF-UCL
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0045799; P:positive regulation of chromatin assembly or disassembly; IMP:BHF-UCL
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0045648; P:positive regulation of erythrocyte differentiation; IDA:UniProtKB
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0045931; P:positive regulation of mitotic cell cycle; IMP:BHF-UCL
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0031334; P:positive regulation of protein complex assembly; IDA:BHF-UCL
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0060375; P:regulation of mast cell differentiation; IEA:Ensembl
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:2000036; P:regulation of stem cell maintenance; IEA:Ensembl
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P17542	TAL1	T-cell acute lymphocytic leukemia protein 1	GO:0021527; P:spinal cord association neuron differentiation; IEA:Ensembl
Q16559	TAL2	T-cell acute lymphocytic leukemia protein 2	GO:0003677; F:DNA binding; TAS:ProtInc
Q16559	TAL2	T-cell acute lymphocytic leukemia protein 2	GO:0030901; P:midbrain development; IEA:Ensembl
Q16559	TAL2	T-cell acute lymphocytic leukemia protein 2	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q16559	TAL2	T-cell acute lymphocytic leukemia protein 2	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q16559	TAL2	T-cell acute lymphocytic leukemia protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q16559	TAL2	T-cell acute lymphocytic leukemia protein 2	GO:0021794; P:thalamus development; IEA:Ensembl
Q16559	TAL2	T-cell acute lymphocytic leukemia protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BVV6	KIAA0586	Protein TALPID3	GO:0060271; P:cilium morphogenesis; ISS:UniProtKB
Q9BVV6	KIAA0586	Protein TALPID3	GO:0007224; P:smoothened signaling pathway; ISS:UniProtKB
P37837	TALDO1	Transaldolase	GO:0048029; F:monosaccharide binding; IEA:Ensembl
P37837	TALDO1	Transaldolase	GO:0004801; F:sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity; TAS:ProtInc
P37837	TALDO1	Transaldolase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P37837	TALDO1	Transaldolase	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P37837	TALDO1	Transaldolase	GO:0006002; P:fructose 6-phosphate metabolic process; IEA:Ensembl
P37837	TALDO1	Transaldolase	GO:0019682; P:glyceraldehyde-3-phosphate metabolic process; IEA:Ensembl
P37837	TALDO1	Transaldolase	GO:0006098; P:pentose-phosphate shunt; TAS:Reactome
P37837	TALDO1	Transaldolase	GO:0009052; P:pentose-phosphate shunt, non-oxidative branch; IEA:Ensembl
P37837	TALDO1	Transaldolase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P37837	TALDO1	Transaldolase	GO:0005999; P:xylulose biosynthetic process; TAS:Reactome
Q96BW9	TAMM41	Mitochondrial translocator assembly and maintenance protein 41 homolog	GO:0030150; P:protein import into mitochondrial matrix; ISS:UniProtKB
Q9C0D5	TANC1	Protein TANC1	GO:0097062; P:dendritic spine maintenance; IEA:Ensembl
Q9C0D5	TANC1	Protein TANC1	GO:0007520; P:myoblast fusion; IEA:Ensembl
Q9C0D5	TANC1	Protein TANC1	GO:0008542; P:visual learning; IEA:Ensembl
Q9HCD6	TANC2	Protein TANC2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q92844	TANK	TRAF family member-associated NF-kappa-B activator	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q92844	TANK	TRAF family member-associated NF-kappa-B activator	GO:0005515; F:protein binding; IPI:UniProtKB
Q92844	TANK	TRAF family member-associated NF-kappa-B activator	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q92844	TANK	TRAF family member-associated NF-kappa-B activator	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
Q92844	TANK	TRAF family member-associated NF-kappa-B activator	GO:0045087; P:innate immune response; TAS:Reactome
Q92844	TANK	TRAF family member-associated NF-kappa-B activator	GO:0007165; P:signal transduction; TAS:ProtInc
Q7L7X3	TAOK1	Serine/threonine-protein kinase TAO1	GO:0005524; F:ATP binding; NAS:HGNC
Q7L7X3	TAOK1	Serine/threonine-protein kinase TAO1	GO:0016301; F:kinase activity; NAS:HGNC
Q7L7X3	TAOK1	Serine/threonine-protein kinase TAO1	GO:0004709; F:MAP kinase kinase kinase activity; IBA:RefGenome
Q7L7X3	TAOK1	Serine/threonine-protein kinase TAO1	GO:0005515; F:protein binding; IPI:WormBase
Q7L7X3	TAOK1	Serine/threonine-protein kinase TAO1	GO:0004672; F:protein kinase activity; NAS:HGNC
Q7L7X3	TAOK1	Serine/threonine-protein kinase TAO1	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB
Q7L7X3	TAOK1	Serine/threonine-protein kinase TAO1	GO:0016740; F:transferase activity; NAS:HGNC
Q7L7X3	TAOK1	Serine/threonine-protein kinase TAO1	GO:0000186; P:activation of MAPKK activity; IBA:GOC
Q7L7X3	TAOK1	Serine/threonine-protein kinase TAO1	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q7L7X3	TAOK1	Serine/threonine-protein kinase TAO1	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q7L7X3	TAOK1	Serine/threonine-protein kinase TAO1	GO:0097194; P:execution phase of apoptosis; IDA:UniProtKB
Q7L7X3	TAOK1	Serine/threonine-protein kinase TAO1	GO:0031572; P:G2 DNA damage checkpoint; IMP:UniProtKB
Q7L7X3	TAOK1	Serine/threonine-protein kinase TAO1	GO:0000165; P:MAPK cascade; IBA:GOC
Q7L7X3	TAOK1	Serine/threonine-protein kinase TAO1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q7L7X3	TAOK1	Serine/threonine-protein kinase TAO1	GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB
Q7L7X3	TAOK1	Serine/threonine-protein kinase TAO1	GO:0032874; P:positive regulation of stress-activated MAPK cascade; IMP:UniProtKB
Q7L7X3	TAOK1	Serine/threonine-protein kinase TAO1	GO:0006468; P:protein phosphorylation; NAS:HGNC
Q7L7X3	TAOK1	Serine/threonine-protein kinase TAO1	GO:0051493; P:regulation of cytoskeleton organization; ISS:UniProtKB
Q9UL54	TAOK2	Serine/threonine-protein kinase TAO2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UL54	TAOK2	Serine/threonine-protein kinase TAO2	GO:0004709; F:MAP kinase kinase kinase activity; IBA:RefGenome
Q9UL54	TAOK2	Serine/threonine-protein kinase TAO2	GO:0031434; F:mitogen-activated protein kinase kinase binding; IPI:UniProtKB
Q9UL54	TAOK2	Serine/threonine-protein kinase TAO2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9UL54	TAOK2	Serine/threonine-protein kinase TAO2	GO:0030036; P:actin cytoskeleton organization; IDA:UniProtKB
Q9UL54	TAOK2	Serine/threonine-protein kinase TAO2	GO:0000186; P:activation of MAPKK activity; IDA:UniProtKB
Q9UL54	TAOK2	Serine/threonine-protein kinase TAO2	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q9UL54	TAOK2	Serine/threonine-protein kinase TAO2	GO:0016477; P:cell migration; NAS:UniProtKB
Q9UL54	TAOK2	Serine/threonine-protein kinase TAO2	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q9UL54	TAOK2	Serine/threonine-protein kinase TAO2	GO:0048041; P:focal adhesion assembly; IDA:UniProtKB
Q9UL54	TAOK2	Serine/threonine-protein kinase TAO2	GO:0031572; P:G2 DNA damage checkpoint; IMP:UniProtKB
Q9UL54	TAOK2	Serine/threonine-protein kinase TAO2	GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB
Q9UL54	TAOK2	Serine/threonine-protein kinase TAO2	GO:0032874; P:positive regulation of stress-activated MAPK cascade; IMP:UniProtKB
Q9UL54	TAOK2	Serine/threonine-protein kinase TAO2	GO:0006612; P:protein targeting to membrane; NAS:UniProtKB
Q9UL54	TAOK2	Serine/threonine-protein kinase TAO2	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
Q9UL54	TAOK2	Serine/threonine-protein kinase TAO2	GO:0008360; P:regulation of cell shape; IDA:UniProtKB
Q9UL54	TAOK2	Serine/threonine-protein kinase TAO2	GO:0006950; P:response to stress; IDA:UniProtKB
Q9UL54	TAOK2	Serine/threonine-protein kinase TAO2	GO:0051403; P:stress-activated MAPK cascade; IDA:UniProtKB
Q9H2K8	TAOK3	Serine/threonine-protein kinase TAO3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H2K8	TAOK3	Serine/threonine-protein kinase TAO3	GO:0004709; F:MAP kinase kinase kinase activity; IBA:RefGenome
Q9H2K8	TAOK3	Serine/threonine-protein kinase TAO3	GO:0005515; F:protein binding; IPI:IntAct
Q9H2K8	TAOK3	Serine/threonine-protein kinase TAO3	GO:0004860; F:protein kinase inhibitor activity; TAS:ProtInc
Q9H2K8	TAOK3	Serine/threonine-protein kinase TAO3	GO:0004674; F:protein serine/threonine kinase activity; IDA:HGNC
Q9H2K8	TAOK3	Serine/threonine-protein kinase TAO3	GO:0016740; F:transferase activity; IDA:HGNC
Q9H2K8	TAOK3	Serine/threonine-protein kinase TAO3	GO:0000186; P:activation of MAPKK activity; IBA:GOC
Q9H2K8	TAOK3	Serine/threonine-protein kinase TAO3	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q9H2K8	TAOK3	Serine/threonine-protein kinase TAO3	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q9H2K8	TAOK3	Serine/threonine-protein kinase TAO3	GO:0031572; P:G2 DNA damage checkpoint; IMP:UniProtKB
Q9H2K8	TAOK3	Serine/threonine-protein kinase TAO3	GO:0000165; P:MAPK cascade; IMP:HGNC
Q9H2K8	TAOK3	Serine/threonine-protein kinase TAO3	GO:0046329; P:negative regulation of JNK cascade; IDA:HGNC
Q9H2K8	TAOK3	Serine/threonine-protein kinase TAO3	GO:0006469; P:negative regulation of protein kinase activity; TAS:GOC
Q9H2K8	TAOK3	Serine/threonine-protein kinase TAO3	GO:0046330; P:positive regulation of JNK cascade; IMP:HGNC
Q9H2K8	TAOK3	Serine/threonine-protein kinase TAO3	GO:0043507; P:positive regulation of JUN kinase activity; IMP:UniProtKB
Q9H2K8	TAOK3	Serine/threonine-protein kinase TAO3	GO:0032874; P:positive regulation of stress-activated MAPK cascade; IMP:UniProtKB
Q9H2K8	TAOK3	Serine/threonine-protein kinase TAO3	GO:0046777; P:protein autophosphorylation; IDA:HGNC
Q9H2K8	TAOK3	Serine/threonine-protein kinase TAO3	GO:0006468; P:protein phosphorylation; IMP:UniProtKB
Q03518	TAP1	Antigen peptide transporter 1	GO:0043531; F:ADP binding; IDA:UniProtKB
Q03518	TAP1	Antigen peptide transporter 1	GO:0005524; F:ATP binding; IDA:UniProtKB
Q03518	TAP1	Antigen peptide transporter 1	GO:0042288; F:MHC class I protein binding; IBA:RefGenome
Q03518	TAP1	Antigen peptide transporter 1	GO:0023029; F:MHC class Ib protein binding; IPI:UniProt
Q03518	TAP1	Antigen peptide transporter 1	GO:0015421; F:oligopeptide-transporting ATPase activity; IBA:RefGenome
Q03518	TAP1	Antigen peptide transporter 1	GO:0042605; F:peptide antigen binding; NAS:UniProtKB
Q03518	TAP1	Antigen peptide transporter 1	GO:0015197; F:peptide transporter activity; IMP:UniProtKB
Q03518	TAP1	Antigen peptide transporter 1	GO:0005515; F:protein binding; IPI:IntAct
Q03518	TAP1	Antigen peptide transporter 1	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q03518	TAP1	Antigen peptide transporter 1	GO:0046978; F:TAP1 binding; ISS:UniProtKB
Q03518	TAP1	Antigen peptide transporter 1	GO:0046979; F:TAP2 binding; IPI:UniProtKB
Q03518	TAP1	Antigen peptide transporter 1	GO:0046980; F:tapasin binding; IBA:RefGenome
Q03518	TAP1	Antigen peptide transporter 1	GO:0019885; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; IMP:UniProtKB
Q03518	TAP1	Antigen peptide transporter 1	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q03518	TAP1	Antigen peptide transporter 1	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q03518	TAP1	Antigen peptide transporter 1	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q03518	TAP1	Antigen peptide transporter 1	GO:0046967; P:cytosol to ER transport; IMP:UniProtKB
Q03518	TAP1	Antigen peptide transporter 1	GO:0006952; P:defense response; IEA:Ensembl
Q03518	TAP1	Antigen peptide transporter 1	GO:0019060; P:intracellular transport of viral protein in host cell; IMP:UniProtKB
Q03518	TAP1	Antigen peptide transporter 1	GO:0035672; P:oligopeptide transmembrane transport; IBA:GOC
Q03518	TAP1	Antigen peptide transporter 1	GO:0015833; P:peptide transport; IMP:UniProtKB
Q03518	TAP1	Antigen peptide transporter 1	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IBA:RefGenome
Q03518	TAP1	Antigen peptide transporter 1	GO:0055085; P:transmembrane transport; IBA:RefGenome
Q03519	TAP2	Antigen peptide transporter 2	GO:0005524; F:ATP binding; IDA:UniProtKB
Q03519	TAP2	Antigen peptide transporter 2	GO:0042288; F:MHC class I protein binding; IBA:RefGenome
Q03519	TAP2	Antigen peptide transporter 2	GO:0023029; F:MHC class Ib protein binding; IPI:UniProt
Q03519	TAP2	Antigen peptide transporter 2	GO:0015421; F:oligopeptide-transporting ATPase activity; IBA:RefGenome
Q03519	TAP2	Antigen peptide transporter 2	GO:0042605; F:peptide antigen binding; IBA:RefGenome
Q03519	TAP2	Antigen peptide transporter 2	GO:0015433; F:peptide antigen-transporting ATPase activity; IMP:UniProtKB
Q03519	TAP2	Antigen peptide transporter 2	GO:0005515; F:protein binding; IPI:IntAct
Q03519	TAP2	Antigen peptide transporter 2	GO:0046978; F:TAP1 binding; IPI:UniProtKB
Q03519	TAP2	Antigen peptide transporter 2	GO:0046979; F:TAP2 binding; IBA:RefGenome
Q03519	TAP2	Antigen peptide transporter 2	GO:0046980; F:tapasin binding; ISS:UniProtKB
Q03519	TAP2	Antigen peptide transporter 2	GO:0005215; F:transporter activity; IDA:MGI
Q03519	TAP2	Antigen peptide transporter 2	GO:0019885; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; IDA:UniProtKB
Q03519	TAP2	Antigen peptide transporter 2	GO:0002485; P:antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent; IBA:RefGenome
Q03519	TAP2	Antigen peptide transporter 2	GO:0002489; P:antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent; IMP:UniProtKB
Q03519	TAP2	Antigen peptide transporter 2	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
Q03519	TAP2	Antigen peptide transporter 2	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
Q03519	TAP2	Antigen peptide transporter 2	GO:0002481; P:antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent; IBA:RefGenome
Q03519	TAP2	Antigen peptide transporter 2	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
Q03519	TAP2	Antigen peptide transporter 2	GO:0046967; P:cytosol to ER transport; IMP:UniProtKB
Q03519	TAP2	Antigen peptide transporter 2	GO:0019060; P:intracellular transport of viral protein in host cell; IMP:UniProtKB
Q03519	TAP2	Antigen peptide transporter 2	GO:0035672; P:oligopeptide transmembrane transport; IBA:GOC
Q03519	TAP2	Antigen peptide transporter 2	GO:0046968; P:peptide antigen transport; IDA:UniProtKB
Q03519	TAP2	Antigen peptide transporter 2	GO:0015833; P:peptide transport; IBA:RefGenome
Q03519	TAP2	Antigen peptide transporter 2	GO:0002591; P:positive regulation of antigen processing and presentation of peptide antigen via MHC class I; IBA:RefGenome
Q03519	TAP2	Antigen peptide transporter 2	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IBA:RefGenome
Q03519	TAP2	Antigen peptide transporter 2	GO:0055085; P:transmembrane transport; IBA:RefGenome
Q9P031	CCDC59	Thyroid transcription factor 1-associated protein 26	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9P031	CCDC59	Thyroid transcription factor 1-associated protein 26	GO:0005515; F:protein binding; IPI:IntAct
Q9P031	CCDC59	Thyroid transcription factor 1-associated protein 26	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9P031	CCDC59	Thyroid transcription factor 1-associated protein 26	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6NXT6	TAPT1	Transmembrane anterior posterior transformation protein 1 homolog	GO:0016520; F:growth hormone-releasing hormone receptor activity; TAS:UniProtKB
Q6NXT6	TAPT1	Transmembrane anterior posterior transformation protein 1 homolog	GO:0048706; P:embryonic skeletal system development; IEA:Ensembl
Q6NXT6	TAPT1	Transmembrane anterior posterior transformation protein 1 homolog	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GOC
Q6NXT6	TAPT1	Transmembrane anterior posterior transformation protein 1 homolog	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q6NXT6	TAPT1	Transmembrane anterior posterior transformation protein 1 homolog	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q9H2D6	TRIOBP	TRIO and F-actin-binding protein	GO:0051015; F:actin filament binding; IDA:MGI
Q9H2D6	TRIOBP	TRIO and F-actin-binding protein	GO:0017049; F:GTP-Rho binding; NAS:UniProtKB
Q9H2D6	TRIOBP	TRIO and F-actin-binding protein	GO:0045159; F:myosin II binding; NAS:UniProtKB
Q9H2D6	TRIOBP	TRIO and F-actin-binding protein	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q9H2D6	TRIOBP	TRIO and F-actin-binding protein	GO:0030047; P:actin modification; NAS:UniProtKB
Q9H2D6	TRIOBP	TRIO and F-actin-binding protein	GO:0051016; P:barbed-end actin filament capping; NAS:UniProtKB
Q9H2D6	TRIOBP	TRIO and F-actin-binding protein	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9H2D6	TRIOBP	TRIO and F-actin-binding protein	GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IDA:MGI
Q13395	TARBP1	Probable methyltransferase TARBP1	GO:0003723; F:RNA binding; TAS:ProtInc
Q13395	TARBP1	Probable methyltransferase TARBP1	GO:0008173; F:RNA methyltransferase activity; IEA:InterPro
Q13395	TARBP1	Probable methyltransferase TARBP1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q13395	TARBP1	Probable methyltransferase TARBP1	GO:0006396; P:RNA processing; IEA:InterPro
Q7Z7G0	ABI3BP	Target of Nesh-SH3	GO:0008201; F:heparin binding; IEA:Ensembl
Q7Z7G0	ABI3BP	Target of Nesh-SH3	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q7Z7G0	ABI3BP	Target of Nesh-SH3	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
Q9H6P5	TASP1	Threonine aspartase 1	GO:0004298; F:threonine-type endopeptidase activity; IMP:UniProtKB
Q9H6P5	TASP1	Threonine aspartase 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q6P1N9	TATDN1	Putative deoxyribonuclease TATDN1	GO:0004536; F:deoxyribonuclease activity; IBA:RefGenome
Q6P1N9	TATDN1	Putative deoxyribonuclease TATDN1	GO:0016888; F:endodeoxyribonuclease activity, producing 5'-phosphomonoesters; IEA:InterPro
Q6P1N9	TATDN1	Putative deoxyribonuclease TATDN1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6P1N9	TATDN1	Putative deoxyribonuclease TATDN1	GO:0006309; P:apoptotic DNA fragmentation; IBA:RefGenome
Q93075	TATDN2	Putative deoxyribonuclease TATDN2	GO:0016888; F:endodeoxyribonuclease activity, producing 5'-phosphomonoesters; IEA:InterPro
Q93075	TATDN2	Putative deoxyribonuclease TATDN2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q93075	TATDN2	Putative deoxyribonuclease TATDN2	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q93075	TATDN2	Putative deoxyribonuclease TATDN2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q93075	TATDN2	Putative deoxyribonuclease TATDN2	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q17R31	TATDN3	Putative deoxyribonuclease TATDN3	GO:0016888; F:endodeoxyribonuclease activity, producing 5'-phosphomonoesters; IEA:InterPro
Q17R31	TATDN3	Putative deoxyribonuclease TATDN3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P10636	MAPT	Microtubule-associated protein tau	GO:0034185; F:apolipoprotein binding; IPI:BHF-UCL
P10636	MAPT	Microtubule-associated protein tau	GO:0019899; F:enzyme binding; IPI:UniProtKB
P10636	MAPT	Microtubule-associated protein tau	GO:0071813; F:lipoprotein particle binding; IPI:UniProtKB
P10636	MAPT	Microtubule-associated protein tau	GO:0008017; F:microtubule binding; IDA:UniProtKB
P10636	MAPT	Microtubule-associated protein tau	GO:0005515; F:protein binding; IPI:IntAct
P10636	MAPT	Microtubule-associated protein tau	GO:0017124; F:SH3 domain binding; IPI:UniProtKB
P10636	MAPT	Microtubule-associated protein tau	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P10636	MAPT	Microtubule-associated protein tau	GO:0007628; P:adult walking behavior; IEA:Ensembl
P10636	MAPT	Microtubule-associated protein tau	GO:0006915; P:apoptotic process; TAS:Reactome
P10636	MAPT	Microtubule-associated protein tau	GO:0008088; P:axon cargo transport; IEA:Ensembl
P10636	MAPT	Microtubule-associated protein tau	GO:0048675; P:axon extension; IEA:Ensembl
P10636	MAPT	Microtubule-associated protein tau	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
P10636	MAPT	Microtubule-associated protein tau	GO:0048699; P:generation of neurons; NAS:UniProtKB
P10636	MAPT	Microtubule-associated protein tau	GO:0000226; P:microtubule cytoskeleton organization; IDA:UniProtKB
P10636	MAPT	Microtubule-associated protein tau	GO:0047497; P:mitochondrion transport along microtubule; IEA:Ensembl
P10636	MAPT	Microtubule-associated protein tau	GO:0032387; P:negative regulation of intracellular transport; IEA:Ensembl
P10636	MAPT	Microtubule-associated protein tau	GO:0001764; P:neuron migration; IEA:Ensembl
P10636	MAPT	Microtubule-associated protein tau	GO:0045773; P:positive regulation of axon extension; IDA:UniProtKB
P10636	MAPT	Microtubule-associated protein tau	GO:0031116; P:positive regulation of microtubule polymerization; IDA:UniProtKB
P10636	MAPT	Microtubule-associated protein tau	GO:0010506; P:regulation of autophagy; IGI:MGI
P10636	MAPT	Microtubule-associated protein tau	GO:0031113; P:regulation of microtubule polymerization; NAS:UniProtKB
P10636	MAPT	Microtubule-associated protein tau	GO:0060632; P:regulation of microtubule-based movement; IEA:Ensembl
Q86VP1	TAX1BP1	Tax1-binding protein 1	GO:0019900; F:kinase binding; ISS:BHF-UCL
Q86VP1	TAX1BP1	Tax1-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q86VP1	TAX1BP1	Tax1-binding protein 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q86VP1	TAX1BP1	Tax1-binding protein 1	GO:0045087; P:innate immune response; TAS:Reactome
Q86VP1	TAX1BP1	Tax1-binding protein 1	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
Q86VP1	TAX1BP1	Tax1-binding protein 1	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; ISS:BHF-UCL
Q86VP1	TAX1BP1	Tax1-binding protein 1	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
Q16635	TAZ	Tafazzin	GO:0047184; F:1-acylglycerophosphocholine O-acyltransferase activity; IDA:BHF-UCL
Q16635	TAZ	Tafazzin	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
Q16635	TAZ	Tafazzin	GO:0048738; P:cardiac muscle tissue development; IMP:HGNC
Q16635	TAZ	Tafazzin	GO:0035965; P:cardiolipin acyl-chain remodeling; TAS:Reactome
Q16635	TAZ	Tafazzin	GO:0032049; P:cardiolipin biosynthetic process; IMP:UniProtKB
Q16635	TAZ	Tafazzin	GO:0042407; P:cristae formation; IMP:HGNC
Q16635	TAZ	Tafazzin	GO:0046474; P:glycerophospholipid biosynthetic process; TAS:Reactome
Q16635	TAZ	Tafazzin	GO:0007507; P:heart development; IMP:HGNC
Q16635	TAZ	Tafazzin	GO:0030097; P:hemopoiesis; IMP:HGNC
Q16635	TAZ	Tafazzin	GO:0042775; P:mitochondrial ATP synthesis coupled electron transport; IDA:BHF-UCL
Q16635	TAZ	Tafazzin	GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:HGNC
Q16635	TAZ	Tafazzin	GO:0006936; P:muscle contraction; IMP:HGNC
Q16635	TAZ	Tafazzin	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q16635	TAZ	Tafazzin	GO:0007519; P:skeletal muscle tissue development; IMP:HGNC
Q16635	TAZ	Tafazzin	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BXI6	TBC1D10A	TBC1 domain family member 10A	GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW
Q9BXI6	TBC1D10A	TBC1 domain family member 10A	GO:0030165; F:PDZ domain binding; IPI:UniProtKB
Q9BXI6	TBC1D10A	TBC1 domain family member 10A	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BXI6	TBC1D10A	TBC1 domain family member 10A	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q9BXI6	TBC1D10A	TBC1 domain family member 10A	GO:0097202; P:activation of cysteine-type endopeptidase activity; IDA:BHF-UCL
Q9BXI6	TBC1D10A	TBC1 domain family member 10A	GO:0045862; P:positive regulation of proteolysis; IDA:BHF-UCL
Q8IV04	TBC1D10C	Carabin	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q4KMP7	TBC1D10B	TBC1 domain family member 10B	GO:0005097; F:Rab GTPase activator activity; IDA:UniProtKB
Q4KMP7	TBC1D10B	TBC1 domain family member 10B	GO:0032851; P:positive regulation of Rab GTPase activity; IDA:GOC
Q4KMP7	TBC1D10B	TBC1 domain family member 10B	GO:0032313; P:regulation of Rab GTPase activity; IDA:UniProtKB
P0CG34	TMSB15A	Thymosin beta-15A	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
P0CG34	TMSB15A	Thymosin beta-15A	GO:0042989; P:sequestering of actin monomers; IEA:InterPro
Q9C0C2	TNKS1BP1	182 kDa tankyrase-1-binding protein	GO:0030506; F:ankyrin binding; NAS:UniProtKB
Q9C0C2	TNKS1BP1	182 kDa tankyrase-1-binding protein	GO:0019899; F:enzyme binding; NAS:UniProtKB
Q9C0C2	TNKS1BP1	182 kDa tankyrase-1-binding protein	GO:0010467; P:gene expression; TAS:Reactome
Q9C0C2	TNKS1BP1	182 kDa tankyrase-1-binding protein	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q9C0C2	TNKS1BP1	182 kDa tankyrase-1-binding protein	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q9C0C2	TNKS1BP1	182 kDa tankyrase-1-binding protein	GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome
Q9C0C2	TNKS1BP1	182 kDa tankyrase-1-binding protein	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9C0C2	TNKS1BP1	182 kDa tankyrase-1-binding protein	GO:0007004; P:telomere maintenance via telomerase; NAS:UniProtKB
P0CG35	TMSB15B	Thymosin beta-15B	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
P0CG35	TMSB15B	Thymosin beta-15B	GO:0042989; P:sequestering of actin monomers; IEA:InterPro
Q8WUA7	TBC1D22A	TBC1 domain family member 22A	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q8WUA7	TBC1D22A	TBC1 domain family member 22A	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q9NU19	TBC1D22B	TBC1 domain family member 22B	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q71U36	TUBA1A	Tubulin alpha-1A chain	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q71U36	TUBA1A	Tubulin alpha-1A chain	GO:0003924; F:GTPase activity; IEA:InterPro
Q71U36	TUBA1A	Tubulin alpha-1A chain	GO:0005515; F:protein binding; IPI:IntAct
Q71U36	TUBA1A	Tubulin alpha-1A chain	GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro
Q71U36	TUBA1A	Tubulin alpha-1A chain	GO:0005198; F:structural molecule activity; TAS:BHF-UCL
Q71U36	TUBA1A	Tubulin alpha-1A chain	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
Q71U36	TUBA1A	Tubulin alpha-1A chain	GO:0051301; P:cell division; TAS:BHF-UCL
Q71U36	TUBA1A	Tubulin alpha-1A chain	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q71U36	TUBA1A	Tubulin alpha-1A chain	GO:0030705; P:cytoskeleton-dependent intracellular transport; TAS:BHF-UCL
Q71U36	TUBA1A	Tubulin alpha-1A chain	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q71U36	TUBA1A	Tubulin alpha-1A chain	GO:0007017; P:microtubule-based process; TAS:BHF-UCL
Q71U36	TUBA1A	Tubulin alpha-1A chain	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q71U36	TUBA1A	Tubulin alpha-1A chain	GO:0006457; P:protein folding; TAS:Reactome
Q71U36	TUBA1A	Tubulin alpha-1A chain	GO:0051258; P:protein polymerization; IEA:InterPro
P68363	TUBA1B	Tubulin alpha-1B chain	GO:0003725; F:double-stranded RNA binding; IDA:MGI
P68363	TUBA1B	Tubulin alpha-1B chain	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P68363	TUBA1B	Tubulin alpha-1B chain	GO:0003924; F:GTPase activity; IEA:InterPro
P68363	TUBA1B	Tubulin alpha-1B chain	GO:0005515; F:protein binding; IPI:UniProtKB
P68363	TUBA1B	Tubulin alpha-1B chain	GO:0005200; F:structural constituent of cytoskeleton; IEA:Ensembl
P68363	TUBA1B	Tubulin alpha-1B chain	GO:0005198; F:structural molecule activity; TAS:BHF-UCL
P68363	TUBA1B	Tubulin alpha-1B chain	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
P68363	TUBA1B	Tubulin alpha-1B chain	GO:0051301; P:cell division; TAS:BHF-UCL
P68363	TUBA1B	Tubulin alpha-1B chain	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P68363	TUBA1B	Tubulin alpha-1B chain	GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl
P68363	TUBA1B	Tubulin alpha-1B chain	GO:0030705; P:cytoskeleton-dependent intracellular transport; TAS:BHF-UCL
P68363	TUBA1B	Tubulin alpha-1B chain	GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl
P68363	TUBA1B	Tubulin alpha-1B chain	GO:0007017; P:microtubule-based process; TAS:BHF-UCL
P68363	TUBA1B	Tubulin alpha-1B chain	GO:0006457; P:protein folding; TAS:Reactome
P68363	TUBA1B	Tubulin alpha-1B chain	GO:0051258; P:protein polymerization; IEA:InterPro
Q9BQE3	TUBA1C	Tubulin alpha-1C chain	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9BQE3	TUBA1C	Tubulin alpha-1C chain	GO:0003924; F:GTPase activity; IEA:InterPro
Q9BQE3	TUBA1C	Tubulin alpha-1C chain	GO:0005515; F:protein binding; IPI:UniProt
Q9BQE3	TUBA1C	Tubulin alpha-1C chain	GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro
Q9BQE3	TUBA1C	Tubulin alpha-1C chain	GO:0005198; F:structural molecule activity; TAS:BHF-UCL
Q9BQE3	TUBA1C	Tubulin alpha-1C chain	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
Q9BQE3	TUBA1C	Tubulin alpha-1C chain	GO:0051301; P:cell division; TAS:BHF-UCL
Q9BQE3	TUBA1C	Tubulin alpha-1C chain	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9BQE3	TUBA1C	Tubulin alpha-1C chain	GO:0030705; P:cytoskeleton-dependent intracellular transport; TAS:BHF-UCL
Q9BQE3	TUBA1C	Tubulin alpha-1C chain	GO:0007017; P:microtubule-based process; TAS:BHF-UCL
Q9BQE3	TUBA1C	Tubulin alpha-1C chain	GO:0006457; P:protein folding; TAS:Reactome
Q9BQE3	TUBA1C	Tubulin alpha-1C chain	GO:0051258; P:protein polymerization; IEA:InterPro
Q13748	TUBA3C	Tubulin alpha-3C/D chain	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q13748	TUBA3C	Tubulin alpha-3C/D chain	GO:0003924; F:GTPase activity; IEA:InterPro
Q13748	TUBA3C	Tubulin alpha-3C/D chain	GO:0005515; F:protein binding; IPI:IntAct
Q13748	TUBA3C	Tubulin alpha-3C/D chain	GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro
Q13748	TUBA3C	Tubulin alpha-3C/D chain	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
Q13748	TUBA3C	Tubulin alpha-3C/D chain	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q13748	TUBA3C	Tubulin alpha-3C/D chain	GO:0007017; P:microtubule-based process; IEA:InterPro
Q13748	TUBA3C	Tubulin alpha-3C/D chain	GO:0006457; P:protein folding; TAS:Reactome
Q13748	TUBA3C	Tubulin alpha-3C/D chain	GO:0051258; P:protein polymerization; IEA:InterPro
Q6PEY2	TUBA3E	Tubulin alpha-3E chain	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q6PEY2	TUBA3E	Tubulin alpha-3E chain	GO:0003924; F:GTPase activity; IEA:InterPro
Q6PEY2	TUBA3E	Tubulin alpha-3E chain	GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro
Q6PEY2	TUBA3E	Tubulin alpha-3E chain	GO:0007017; P:microtubule-based process; IEA:InterPro
Q6PEY2	TUBA3E	Tubulin alpha-3E chain	GO:0051258; P:protein polymerization; IEA:InterPro
P68366	TUBA4A	Tubulin alpha-4A chain	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P68366	TUBA4A	Tubulin alpha-4A chain	GO:0003924; F:GTPase activity; IEA:InterPro
P68366	TUBA4A	Tubulin alpha-4A chain	GO:0005515; F:protein binding; IPI:IntAct
P68366	TUBA4A	Tubulin alpha-4A chain	GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro
P68366	TUBA4A	Tubulin alpha-4A chain	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
P68366	TUBA4A	Tubulin alpha-4A chain	GO:0007596; P:blood coagulation; TAS:Reactome
P68366	TUBA4A	Tubulin alpha-4A chain	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P68366	TUBA4A	Tubulin alpha-4A chain	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P68366	TUBA4A	Tubulin alpha-4A chain	GO:0007017; P:microtubule-based process; IEA:InterPro
P68366	TUBA4A	Tubulin alpha-4A chain	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P68366	TUBA4A	Tubulin alpha-4A chain	GO:0030168; P:platelet activation; TAS:Reactome
P68366	TUBA4A	Tubulin alpha-4A chain	GO:0002576; P:platelet degranulation; TAS:Reactome
P68366	TUBA4A	Tubulin alpha-4A chain	GO:0006457; P:protein folding; TAS:Reactome
P68366	TUBA4A	Tubulin alpha-4A chain	GO:0051258; P:protein polymerization; IEA:InterPro
Q9H853	TUBA4B	Putative tubulin-like protein alpha-4B	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9H853	TUBA4B	Putative tubulin-like protein alpha-4B	GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro
Q9H853	TUBA4B	Putative tubulin-like protein alpha-4B	GO:0007017; P:microtubule-based process; IEA:InterPro
Q9NY65	TUBA8	Tubulin alpha-8 chain	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9NY65	TUBA8	Tubulin alpha-8 chain	GO:0003924; F:GTPase activity; IEA:InterPro
Q9NY65	TUBA8	Tubulin alpha-8 chain	GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro
Q9NY65	TUBA8	Tubulin alpha-8 chain	GO:0007017; P:microtubule-based process; IEA:InterPro
Q9NY65	TUBA8	Tubulin alpha-8 chain	GO:0051258; P:protein polymerization; IEA:InterPro
Q96M53	TBATA	Protein TBATA	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96M53	TBATA	Protein TBATA	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q96M53	TBATA	Protein TBATA	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
A6NHL2	TUBAL3	Tubulin alpha chain-like 3	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
A6NHL2	TUBAL3	Tubulin alpha chain-like 3	GO:0003924; F:GTPase activity; IEA:InterPro
A6NHL2	TUBAL3	Tubulin alpha chain-like 3	GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro
A6NHL2	TUBAL3	Tubulin alpha chain-like 3	GO:0007017; P:microtubule-based process; IEA:InterPro
A6NHL2	TUBAL3	Tubulin alpha chain-like 3	GO:0051258; P:protein polymerization; IEA:InterPro
Q9H4B7	TUBB1	Tubulin beta-1 chain	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9H4B7	TUBB1	Tubulin beta-1 chain	GO:0003924; F:GTPase activity; IEA:InterPro
Q9H4B7	TUBB1	Tubulin beta-1 chain	GO:0005200; F:structural constituent of cytoskeleton; IEA:Ensembl
Q9H4B7	TUBB1	Tubulin beta-1 chain	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
Q9H4B7	TUBB1	Tubulin beta-1 chain	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9H4B7	TUBB1	Tubulin beta-1 chain	GO:0006457; P:protein folding; TAS:Reactome
Q9H4B7	TUBB1	Tubulin beta-1 chain	GO:0051258; P:protein polymerization; IEA:InterPro
Q9H4B7	TUBB1	Tubulin beta-1 chain	GO:0051225; P:spindle assembly; IEA:Ensembl
Q13885	TUBB2A	Tubulin beta-2A chain	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q13885	TUBB2A	Tubulin beta-2A chain	GO:0003924; F:GTPase activity; IEA:InterPro
Q13885	TUBB2A	Tubulin beta-2A chain	GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro
Q13885	TUBB2A	Tubulin beta-2A chain	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
Q13885	TUBB2A	Tubulin beta-2A chain	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q13885	TUBB2A	Tubulin beta-2A chain	GO:0007017; P:microtubule-based process; IEA:InterPro
Q13885	TUBB2A	Tubulin beta-2A chain	GO:0006457; P:protein folding; TAS:Reactome
Q13885	TUBB2A	Tubulin beta-2A chain	GO:0051258; P:protein polymerization; IEA:InterPro
Q9BVA1	TUBB2B	Tubulin beta-2B chain	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9BVA1	TUBB2B	Tubulin beta-2B chain	GO:0003924; F:GTPase activity; IEA:InterPro
Q9BVA1	TUBB2B	Tubulin beta-2B chain	GO:0005515; F:protein binding; IPI:IntAct
Q9BVA1	TUBB2B	Tubulin beta-2B chain	GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro
Q9BVA1	TUBB2B	Tubulin beta-2B chain	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
Q9BVA1	TUBB2B	Tubulin beta-2B chain	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9BVA1	TUBB2B	Tubulin beta-2B chain	GO:0007017; P:microtubule-based process; IEA:InterPro
Q9BVA1	TUBB2B	Tubulin beta-2B chain	GO:0001764; P:neuron migration; IMP:UniProtKB
Q9BVA1	TUBB2B	Tubulin beta-2B chain	GO:0006457; P:protein folding; TAS:Reactome
Q9BVA1	TUBB2B	Tubulin beta-2B chain	GO:0051258; P:protein polymerization; IEA:InterPro
Q13509	TUBB3	Tubulin beta-3 chain	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q13509	TUBB3	Tubulin beta-3 chain	GO:0003924; F:GTPase activity; IEA:InterPro
Q13509	TUBB3	Tubulin beta-3 chain	GO:0005515; F:protein binding; IPI:IntAct
Q13509	TUBB3	Tubulin beta-3 chain	GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro
Q13509	TUBB3	Tubulin beta-3 chain	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
Q13509	TUBB3	Tubulin beta-3 chain	GO:0007411; P:axon guidance; IMP:UniProtKB
Q13509	TUBB3	Tubulin beta-3 chain	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q13509	TUBB3	Tubulin beta-3 chain	GO:0007017; P:microtubule-based process; IEA:InterPro
Q13509	TUBB3	Tubulin beta-3 chain	GO:0006457; P:protein folding; TAS:Reactome
Q13509	TUBB3	Tubulin beta-3 chain	GO:0051258; P:protein polymerization; IEA:InterPro
P04350	TUBB4A	Tubulin beta-4A chain	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P04350	TUBB4A	Tubulin beta-4A chain	GO:0003924; F:GTPase activity; IEA:InterPro
P04350	TUBB4A	Tubulin beta-4A chain	GO:0005515; F:protein binding; IPI:IntAct
P04350	TUBB4A	Tubulin beta-4A chain	GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro
P04350	TUBB4A	Tubulin beta-4A chain	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
P04350	TUBB4A	Tubulin beta-4A chain	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P04350	TUBB4A	Tubulin beta-4A chain	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P04350	TUBB4A	Tubulin beta-4A chain	GO:0007017; P:microtubule-based process; IEA:InterPro
P04350	TUBB4A	Tubulin beta-4A chain	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P04350	TUBB4A	Tubulin beta-4A chain	GO:0006457; P:protein folding; TAS:Reactome
P04350	TUBB4A	Tubulin beta-4A chain	GO:0051258; P:protein polymerization; IEA:InterPro
P68371	TUBB4B	Tubulin beta-4B chain	GO:0003725; F:double-stranded RNA binding; IDA:MGI
P68371	TUBB4B	Tubulin beta-4B chain	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P68371	TUBB4B	Tubulin beta-4B chain	GO:0003924; F:GTPase activity; IEA:InterPro
P68371	TUBB4B	Tubulin beta-4B chain	GO:0042288; F:MHC class I protein binding; TAS:UniProtKB
P68371	TUBB4B	Tubulin beta-4B chain	GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro
P68371	TUBB4B	Tubulin beta-4B chain	GO:0051082; F:unfolded protein binding; NAS:UniProtKB
P68371	TUBB4B	Tubulin beta-4B chain	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
P68371	TUBB4B	Tubulin beta-4B chain	GO:0006928; P:cellular component movement; TAS:ProtInc
P68371	TUBB4B	Tubulin beta-4B chain	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P68371	TUBB4B	Tubulin beta-4B chain	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P68371	TUBB4B	Tubulin beta-4B chain	GO:0007017; P:microtubule-based process; IEA:InterPro
P68371	TUBB4B	Tubulin beta-4B chain	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P68371	TUBB4B	Tubulin beta-4B chain	GO:0042267; P:natural killer cell mediated cytotoxicity; NAS:UniProtKB
P68371	TUBB4B	Tubulin beta-4B chain	GO:0006457; P:protein folding; TAS:Reactome
P68371	TUBB4B	Tubulin beta-4B chain	GO:0051258; P:protein polymerization; IEA:InterPro
P07437	TUBB	Tubulin beta chain	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P07437	TUBB	Tubulin beta chain	GO:0003924; F:GTPase activity; IEA:InterPro
P07437	TUBB	Tubulin beta chain	GO:0042288; F:MHC class I protein binding; IDA:UniProtKB
P07437	TUBB	Tubulin beta chain	GO:0005515; F:protein binding; IPI:IntAct
P07437	TUBB	Tubulin beta chain	GO:0005200; F:structural constituent of cytoskeleton; IEA:Ensembl
P07437	TUBB	Tubulin beta chain	GO:0005198; F:structural molecule activity; TAS:BHF-UCL
P07437	TUBB	Tubulin beta chain	GO:0051301; P:cell division; TAS:BHF-UCL
P07437	TUBB	Tubulin beta chain	GO:0006928; P:cellular component movement; TAS:UniProtKB
P07437	TUBB	Tubulin beta chain	GO:0009987; P:cellular process; IDA:DFLAT
P07437	TUBB	Tubulin beta chain	GO:0030705; P:cytoskeleton-dependent intracellular transport; TAS:BHF-UCL
P07437	TUBB	Tubulin beta chain	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P07437	TUBB	Tubulin beta chain	GO:0007017; P:microtubule-based process; TAS:BHF-UCL
P07437	TUBB	Tubulin beta chain	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P07437	TUBB	Tubulin beta chain	GO:0042267; P:natural killer cell mediated cytotoxicity; NAS:UniProtKB
P07437	TUBB	Tubulin beta chain	GO:0051258; P:protein polymerization; IEA:InterPro
P07437	TUBB	Tubulin beta chain	GO:0051225; P:spindle assembly; IEA:Ensembl
Q9BUF5	TUBB6	Tubulin beta-6 chain	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9BUF5	TUBB6	Tubulin beta-6 chain	GO:0003924; F:GTPase activity; IEA:InterPro
Q9BUF5	TUBB6	Tubulin beta-6 chain	GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro
Q9BUF5	TUBB6	Tubulin beta-6 chain	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
Q9BUF5	TUBB6	Tubulin beta-6 chain	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9BUF5	TUBB6	Tubulin beta-6 chain	GO:0007017; P:microtubule-based process; IEA:InterPro
Q9BUF5	TUBB6	Tubulin beta-6 chain	GO:0006457; P:protein folding; TAS:Reactome
Q9BUF5	TUBB6	Tubulin beta-6 chain	GO:0051258; P:protein polymerization; IEA:InterPro
DR   GO:0005525; F:GTP binding; IEA:UniProtKB-KW
DR   GO:0003924; F:GTPase activity; IEA:InterPro
DR   GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro
DR   GO:0007017; P:microtubule-based process; IEA:InterPro
DR   GO:0051258; P:protein polymerization; IEA:InterPro
Q3ZCM7	TUBB8	Tubulin beta-8 chain	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q3ZCM7	TUBB8	Tubulin beta-8 chain	GO:0003924; F:GTPase activity; IEA:InterPro
Q3ZCM7	TUBB8	Tubulin beta-8 chain	GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro
Q3ZCM7	TUBB8	Tubulin beta-8 chain	GO:0007017; P:microtubule-based process; IEA:InterPro
Q3ZCM7	TUBB8	Tubulin beta-8 chain	GO:0051258; P:protein polymerization; IEA:InterPro
O60347	TBC1D12	TBC1 domain family member 12	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q9NVG8	TBC1D13	TBC1 domain family member 13	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q9P2M4	TBC1D14	TBC1 domain family member 14	GO:0005515; F:protein binding; IPI:IntAct
Q9P2M4	TBC1D14	TBC1 domain family member 14	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
Q9P2M4	TBC1D14	TBC1 domain family member 14	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q9P2M4	TBC1D14	TBC1 domain family member 14	GO:0010507; P:negative regulation of autophagy; IMP:BHF-UCL
Q9P2M4	TBC1D14	TBC1 domain family member 14	GO:2000785; P:regulation of autophagic vacuole assembly; IMP:BHF-UCL
Q8TC07	TBC1D15	TBC1 domain family member 15	GO:0005515; F:protein binding; IPI:IntAct
Q8TC07	TBC1D15	TBC1 domain family member 15	GO:0005097; F:Rab GTPase activator activity; ISS:UniProtKB
Q8TC07	TBC1D15	TBC1 domain family member 15	GO:0032313; P:regulation of Rab GTPase activity; ISS:UniProtKB
Q9HA65	TBC1D17	TBC1 domain family member 17	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q8TBP0	TBC1D16	TBC1 domain family member 16	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q96BZ9	TBC1D20	TBC1 domain family member 20	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q96BZ9	TBC1D20	TBC1 domain family member 20	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q8N5T2	TBC1D19	TBC1 domain family member 19	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q8IYX1	TBC1D21	TBC1 domain family member 21	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q9NUY8	TBC1D23	TBC1 domain family member 23	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q9NUY8	TBC1D23	TBC1 domain family member 23	GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl
Q9NUY8	TBC1D23	TBC1 domain family member 23	GO:0050727; P:regulation of inflammatory response; IEA:Ensembl
Q9NUY8	TBC1D23	TBC1 domain family member 23	GO:0032680; P:regulation of tumor necrosis factor production; IEA:Ensembl
Q9ULP9	TBC1D24	TBC1 domain family member 24	GO:0005515; F:protein binding; IPI:UniProtKB
Q9ULP9	TBC1D24	TBC1 domain family member 24	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q9ULP9	TBC1D24	TBC1 domain family member 24	GO:0031175; P:neuron projection development; IMP:UniProtKB
Q3MII6	TBC1D25	TBC1 domain family member 25	GO:0005515; F:protein binding; IPI:UniProtKB
Q3MII6	TBC1D25	TBC1 domain family member 25	GO:0005097; F:Rab GTPase activator activity; IDA:UniProtKB
Q3MII6	TBC1D25	TBC1 domain family member 25	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q3MII6	TBC1D25	TBC1 domain family member 25	GO:0032851; P:positive regulation of Rab GTPase activity; IDA:GOC
Q3MII6	TBC1D25	TBC1 domain family member 25	GO:1901096; P:regulation of autophagic vacuole maturation; IMP:UniProtKB
Q86UD7	TBC1D26	TBC1 domain family member 26	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q2M2D7	TBC1D28	TBC1 domain family member 28	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q9UFV1	TBC1D29	Putative TBC1 domain family member 29	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q96DN5	TBC1D31	TBC1 domain family member 31	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q9Y2I9	TBC1D30	TBC1 domain family member 30	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q8IZP1	TBC1D3	TBC1 domain family member 3	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
A6NDS4	TBC1D3B	TBC1 domain family member 3B	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
A6NER0	TBC1D3F	TBC1 domain family member 3F	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q6IPX1	TBC1D3C	TBC1 domain family member 3C	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q6DHY5	TBC1D3G	TBC1 domain family member 3G	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
P0C7X1	TBC1D3H	TBC1 domain family member 3H	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q0IIM8	TBC1D8B	TBC1 domain family member 8B	GO:0005509; F:calcium ion binding; IEA:InterPro
Q0IIM8	TBC1D8B	TBC1 domain family member 8B	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q66K14	TBC1D9B	TBC1 domain family member 9B	GO:0005509; F:calcium ion binding; IEA:InterPro
Q66K14	TBC1D9B	TBC1 domain family member 9B	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
O75347	TBCA	Tubulin-specific chaperone A	GO:0051087; F:chaperone binding; TAS:ProtInc
O75347	TBCA	Tubulin-specific chaperone A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75347	TBCA	Tubulin-specific chaperone A	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
O75347	TBCA	Tubulin-specific chaperone A	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O75347	TBCA	Tubulin-specific chaperone A	GO:0007023; P:post-chaperonin tubulin folding pathway; TAS:ProtInc
O75347	TBCA	Tubulin-specific chaperone A	GO:0006457; P:protein folding; TAS:UniProtKB
O75347	TBCA	Tubulin-specific chaperone A	GO:0007021; P:tubulin complex assembly; IEA:InterPro
Q99426	TBCB	Tubulin-folding cofactor B	GO:0005515; F:protein binding; IPI:IntAct
Q99426	TBCB	Tubulin-folding cofactor B	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
Q99426	TBCB	Tubulin-folding cofactor B	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q99426	TBCB	Tubulin-folding cofactor B	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q99426	TBCB	Tubulin-folding cofactor B	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q9NVR7	TBCCD1	TBCC domain-containing protein 1	GO:0000902; P:cell morphogenesis; IEA:InterPro
Q9NVR7	TBCCD1	TBCC domain-containing protein 1	GO:0007010; P:cytoskeleton organization; IEA:InterPro
Q9NVR7	TBCCD1	TBCC domain-containing protein 1	GO:0051661; P:maintenance of centrosome location; IMP:UniProtKB
Q9NVR7	TBCCD1	TBCC domain-containing protein 1	GO:0051684; P:maintenance of Golgi location; IMP:UniProtKB
Q9NVR7	TBCCD1	TBCC domain-containing protein 1	GO:0030334; P:regulation of cell migration; IMP:UniProtKB
Q9NVR7	TBCCD1	TBCC domain-containing protein 1	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
Q15814	TBCC	Tubulin-specific chaperone C	GO:0051087; F:chaperone binding; TAS:ProtInc
Q15814	TBCC	Tubulin-specific chaperone C	GO:0003924; F:GTPase activity; IDA:UniProtKB
Q15814	TBCC	Tubulin-specific chaperone C	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
Q15814	TBCC	Tubulin-specific chaperone C	GO:0000902; P:cell morphogenesis; IEA:InterPro
Q15814	TBCC	Tubulin-specific chaperone C	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q15814	TBCC	Tubulin-specific chaperone C	GO:0006184; P:GTP catabolic process; IDA:GOC
Q15814	TBCC	Tubulin-specific chaperone C	GO:0007023; P:post-chaperonin tubulin folding pathway; IDA:UniProtKB
Q15814	TBCC	Tubulin-specific chaperone C	GO:0006457; P:protein folding; TAS:UniProtKB
Q86TI0	TBC1D1	TBC1 domain family member 1	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q86TI0	TBC1D1	TBC1 domain family member 1	GO:0061024; P:membrane organization; TAS:Reactome
Q86TI0	TBC1D1	TBC1 domain family member 1	GO:0032880; P:regulation of protein localization; IEA:Ensembl
O60343	TBC1D4	TBC1 domain family member 4	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
O60343	TBC1D4	TBC1 domain family member 4	GO:0032869; P:cellular response to insulin stimulus; IMP:UniProtKB
O60343	TBC1D4	TBC1 domain family member 4	GO:0061024; P:membrane organization; TAS:Reactome
O60343	TBC1D4	TBC1 domain family member 4	GO:0031339; P:negative regulation of vesicle fusion; IEA:Ensembl
O60343	TBC1D4	TBC1 domain family member 4	GO:0016192; P:vesicle-mediated transport; IMP:UniProtKB
Q92609	TBC1D5	TBC1 domain family member 5	GO:0005515; F:protein binding; IPI:IntAct
Q92609	TBC1D5	TBC1 domain family member 5	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q9P0N9	TBC1D7	TBC1 domain family member 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P0N9	TBC1D7	TBC1 domain family member 7	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q9P0N9	TBC1D7	TBC1 domain family member 7	GO:0032862; P:activation of Rho GTPase activity; IMP:UniProtKB
Q9P0N9	TBC1D7	TBC1 domain family member 7	GO:0032007; P:negative regulation of TOR signaling; IMP:UniProtKB
Q9P0N9	TBC1D7	TBC1 domain family member 7	GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB
Q9P0N9	TBC1D7	TBC1 domain family member 7	GO:0070848; P:response to growth factor; IMP:UniProtKB
O95759	TBC1D8	TBC1 domain family member 8	GO:0005509; F:calcium ion binding; IEA:InterPro
O95759	TBC1D8	TBC1 domain family member 8	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
O95759	TBC1D8	TBC1 domain family member 8	GO:0008015; P:blood circulation; TAS:ProtInc
O95759	TBC1D8	TBC1 domain family member 8	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q6ZT07	TBC1D9	TBC1 domain family member 9	GO:0005509; F:calcium ion binding; IEA:InterPro
Q6ZT07	TBC1D9	TBC1 domain family member 9	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q9BTW9	TBCD	Tubulin-specific chaperone D	GO:0048487; F:beta-tubulin binding; IDA:UniProtKB
Q9BTW9	TBCD	Tubulin-specific chaperone D	GO:0051087; F:chaperone binding; TAS:ProtInc
Q9BTW9	TBCD	Tubulin-specific chaperone D	GO:0005096; F:GTPase activator activity; IDA:UniProtKB
Q9BTW9	TBCD	Tubulin-specific chaperone D	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BTW9	TBCD	Tubulin-specific chaperone D	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
Q9BTW9	TBCD	Tubulin-specific chaperone D	GO:0034333; P:adherens junction assembly; ISS:UniProtKB
Q9BTW9	TBCD	Tubulin-specific chaperone D	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9BTW9	TBCD	Tubulin-specific chaperone D	GO:0010812; P:negative regulation of cell-substrate adhesion; ISS:UniProtKB
Q9BTW9	TBCD	Tubulin-specific chaperone D	GO:0031115; P:negative regulation of microtubule polymerization; IDA:UniProtKB
Q9BTW9	TBCD	Tubulin-specific chaperone D	GO:0043547; P:positive regulation of GTPase activity; IDA:GOC
Q9BTW9	TBCD	Tubulin-specific chaperone D	GO:0007023; P:post-chaperonin tubulin folding pathway; IDA:UniProtKB
Q9BTW9	TBCD	Tubulin-specific chaperone D	GO:0006457; P:protein folding; IDA:UniProtKB
Q9BTW9	TBCD	Tubulin-specific chaperone D	GO:0070830; P:tight junction assembly; ISS:UniProtKB
Q15813	TBCE	Tubulin-specific chaperone E	GO:0051087; F:chaperone binding; TAS:ProtInc
Q15813	TBCE	Tubulin-specific chaperone E	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
Q15813	TBCE	Tubulin-specific chaperone E	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
Q15813	TBCE	Tubulin-specific chaperone E	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q15813	TBCE	Tubulin-specific chaperone E	GO:0048589; P:developmental growth; IEA:Ensembl
Q15813	TBCE	Tubulin-specific chaperone E	GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl
Q15813	TBCE	Tubulin-specific chaperone E	GO:0014889; P:muscle atrophy; IEA:Ensembl
Q15813	TBCE	Tubulin-specific chaperone E	GO:0048936; P:peripheral nervous system neuron axonogenesis; IEA:Ensembl
Q15813	TBCE	Tubulin-specific chaperone E	GO:0007023; P:post-chaperonin tubulin folding pathway; IDA:UniProtKB
Q15813	TBCE	Tubulin-specific chaperone E	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q15813	TBCE	Tubulin-specific chaperone E	GO:0006457; P:protein folding; TAS:UniProtKB
Q8TEA7	TBCK	TBC domain-containing protein kinase-like protein	GO:0005524; F:ATP binding; IEA:InterPro
Q8TEA7	TBCK	TBC domain-containing protein kinase-like protein	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q8TEA7	TBCK	TBC domain-containing protein kinase-like protein	GO:0016772; F:transferase activity, transferring phosphorus-containing groups; IEA:InterPro
Q9BYX2	TBC1D2	TBC1 domain family member 2A	GO:0045296; F:cadherin binding; IPI:UniProtKB
Q9BYX2	TBC1D2	TBC1 domain family member 2A	GO:0005097; F:Rab GTPase activator activity; IDA:UniProtKB
Q9BYX2	TBC1D2	TBC1 domain family member 2A	GO:0032851; P:positive regulation of Rab GTPase activity; IDA:UniProtKB
Q9UPU7	TBC1D2B	TBC1 domain family member 2B	GO:0005515; F:protein binding; IPI:IntAct
Q9UPU7	TBC1D2B	TBC1 domain family member 2B	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
Q9UJT1	TUBD1	Tubulin delta chain	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9UJT1	TUBD1	Tubulin delta chain	GO:0003924; F:GTPase activity; IEA:InterPro
Q9UJT1	TUBD1	Tubulin delta chain	GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro
Q9UJT1	TUBD1	Tubulin delta chain	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9UJT1	TUBD1	Tubulin delta chain	GO:0007017; P:microtubule-based process; IEA:InterPro
Q9UJT1	TUBD1	Tubulin delta chain	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9UJT1	TUBD1	Tubulin delta chain	GO:0051258; P:protein polymerization; IEA:InterPro
Q9UJT1	TUBD1	Tubulin delta chain	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q9UJT0	TUBE1	Tubulin epsilon chain	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9UJT0	TUBE1	Tubulin epsilon chain	GO:0003924; F:GTPase activity; IEA:InterPro
Q9UJT0	TUBE1	Tubulin epsilon chain	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
Q9UJT0	TUBE1	Tubulin epsilon chain	GO:0007098; P:centrosome cycle; TAS:ProtInc
Q9UJT0	TUBE1	Tubulin epsilon chain	GO:0051258; P:protein polymerization; IEA:InterPro
P23258	TUBG1	Tubulin gamma-1 chain	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
P23258	TUBG1	Tubulin gamma-1 chain	GO:0003924; F:GTPase activity; IEA:InterPro
P23258	TUBG1	Tubulin gamma-1 chain	GO:0005515; F:protein binding; IPI:UniProtKB
P23258	TUBG1	Tubulin gamma-1 chain	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
P23258	TUBG1	Tubulin gamma-1 chain	GO:0031122; P:cytoplasmic microtubule organization; IEA:InterPro
P23258	TUBG1	Tubulin gamma-1 chain	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P23258	TUBG1	Tubulin gamma-1 chain	GO:0000212; P:meiotic spindle organization; ISS:UniProtKB
P23258	TUBG1	Tubulin gamma-1 chain	GO:0000226; P:microtubule cytoskeleton organization; TAS:ProtInc
P23258	TUBG1	Tubulin gamma-1 chain	GO:0007020; P:microtubule nucleation; IEA:InterPro
P23258	TUBG1	Tubulin gamma-1 chain	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P23258	TUBG1	Tubulin gamma-1 chain	GO:0051258; P:protein polymerization; IEA:InterPro
Q9NRH3	TUBG2	Tubulin gamma-2 chain	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q9NRH3	TUBG2	Tubulin gamma-2 chain	GO:0003924; F:GTPase activity; IEA:InterPro
Q9NRH3	TUBG2	Tubulin gamma-2 chain	GO:0005198; F:structural molecule activity; TAS:ProtInc
Q9NRH3	TUBG2	Tubulin gamma-2 chain	GO:0031122; P:cytoplasmic microtubule organization; IEA:InterPro
Q9NRH3	TUBG2	Tubulin gamma-2 chain	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
Q9NRH3	TUBG2	Tubulin gamma-2 chain	GO:0007020; P:microtubule nucleation; IEA:InterPro
Q9NRH3	TUBG2	Tubulin gamma-2 chain	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9NRH3	TUBG2	Tubulin gamma-2 chain	GO:0051258; P:protein polymerization; IEA:InterPro
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0003676; F:nucleic acid binding; IEA:Ensembl
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0051219; F:phosphoprotein binding; IPI:UniProtKB
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0004672; F:protein kinase activity; NAS:ProtInc
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0004674; F:protein serine/threonine kinase activity; TAS:UniProtKB
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0050830; P:defense response to Gram-positive bacterium; IEA:Ensembl
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:UniProtKB
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0006954; P:inflammatory response; TAS:UniProtKB
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0045087; P:innate immune response; TAS:UniProtKB
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0032727; P:positive regulation of interferon-alpha production; IDA:BHF-UCL
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0045359; P:positive regulation of interferon-beta biosynthetic process; IEA:Ensembl
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0032728; P:positive regulation of interferon-beta production; IDA:BHF-UCL
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; NAS:BHF-UCL
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0009615; P:response to virus; TAS:UniProtKB
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0032606; P:type I interferon production; TAS:UniProtKB
Q9UHD2	TBK1	Serine/threonine-protein kinase TBK1	GO:0016032; P:viral process; IEA:UniProtKB-KW
A7MCY6	TBKBP1	TANK-binding kinase 1-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
A7MCY6	TBKBP1	TANK-binding kinase 1-binding protein 1	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q9BZK7	TBL1XR1	F-box-like/WD repeat-containing protein TBL1XR1	GO:0008013; F:beta-catenin binding; IPI:UniProtKB
Q9BZK7	TBL1XR1	F-box-like/WD repeat-containing protein TBL1XR1	GO:0042393; F:histone binding; IDA:UniProtKB
Q9BZK7	TBL1XR1	F-box-like/WD repeat-containing protein TBL1XR1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BZK7	TBL1XR1	F-box-like/WD repeat-containing protein TBL1XR1	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q9BZK7	TBL1XR1	F-box-like/WD repeat-containing protein TBL1XR1	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q9BZK7	TBL1XR1	F-box-like/WD repeat-containing protein TBL1XR1	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q9BZK7	TBL1XR1	F-box-like/WD repeat-containing protein TBL1XR1	GO:0060070; P:canonical Wnt signaling pathway; IMP:UniProtKB
Q9BZK7	TBL1XR1	F-box-like/WD repeat-containing protein TBL1XR1	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9BZK7	TBL1XR1	F-box-like/WD repeat-containing protein TBL1XR1	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q9BZK7	TBL1XR1	F-box-like/WD repeat-containing protein TBL1XR1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9BZK7	TBL1XR1	F-box-like/WD repeat-containing protein TBL1XR1	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q9BZK7	TBL1XR1	F-box-like/WD repeat-containing protein TBL1XR1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9BZK7	TBL1XR1	F-box-like/WD repeat-containing protein TBL1XR1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9BZK7	TBL1XR1	F-box-like/WD repeat-containing protein TBL1XR1	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB
Q9BZK7	TBL1XR1	F-box-like/WD repeat-containing protein TBL1XR1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BZK7	TBL1XR1	F-box-like/WD repeat-containing protein TBL1XR1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60907	TBL1X	F-box-like/WD repeat-containing protein TBL1X	GO:0008013; F:beta-catenin binding; IPI:UniProtKB
O60907	TBL1X	F-box-like/WD repeat-containing protein TBL1X	GO:0042393; F:histone binding; IDA:UniProtKB
O60907	TBL1X	F-box-like/WD repeat-containing protein TBL1X	GO:0005515; F:protein binding; IPI:UniProtKB
O60907	TBL1X	F-box-like/WD repeat-containing protein TBL1X	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
O60907	TBL1X	F-box-like/WD repeat-containing protein TBL1X	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
O60907	TBL1X	F-box-like/WD repeat-containing protein TBL1X	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
O60907	TBL1X	F-box-like/WD repeat-containing protein TBL1X	GO:0008134; F:transcription factor binding; IPI:UniProtKB
O60907	TBL1X	F-box-like/WD repeat-containing protein TBL1X	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
O60907	TBL1X	F-box-like/WD repeat-containing protein TBL1X	GO:0060070; P:canonical Wnt signaling pathway; IMP:UniProtKB
O60907	TBL1X	F-box-like/WD repeat-containing protein TBL1X	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O60907	TBL1X	F-box-like/WD repeat-containing protein TBL1X	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O60907	TBL1X	F-box-like/WD repeat-containing protein TBL1X	GO:0007219; P:Notch signaling pathway; TAS:Reactome
O60907	TBL1X	F-box-like/WD repeat-containing protein TBL1X	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O60907	TBL1X	F-box-like/WD repeat-containing protein TBL1X	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O60907	TBL1X	F-box-like/WD repeat-containing protein TBL1X	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB
O60907	TBL1X	F-box-like/WD repeat-containing protein TBL1X	GO:0006508; P:proteolysis; IMP:UniProtKB
O60907	TBL1X	F-box-like/WD repeat-containing protein TBL1X	GO:0007605; P:sensory perception of sound; IMP:UniProtKB
O60907	TBL1X	F-box-like/WD repeat-containing protein TBL1X	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60907	TBL1X	F-box-like/WD repeat-containing protein TBL1X	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BQ87	TBL1Y	F-box-like/WD repeat-containing protein TBL1Y	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9BQ87	TBL1Y	F-box-like/WD repeat-containing protein TBL1Y	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
Q9BQ87	TBL1Y	F-box-like/WD repeat-containing protein TBL1Y	GO:0044212; F:transcription regulatory region DNA binding; IEA:Ensembl
Q9BQ87	TBL1Y	F-box-like/WD repeat-containing protein TBL1Y	GO:0045444; P:fat cell differentiation; IEA:Ensembl
Q9BQ87	TBL1Y	F-box-like/WD repeat-containing protein TBL1Y	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q9BQ87	TBL1Y	F-box-like/WD repeat-containing protein TBL1Y	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9BQ87	TBL1Y	F-box-like/WD repeat-containing protein TBL1Y	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q9BQ87	TBL1Y	F-box-like/WD repeat-containing protein TBL1Y	GO:0043627; P:response to estrogen; IEA:Ensembl
Q9BQ87	TBL1Y	F-box-like/WD repeat-containing protein TBL1Y	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y4P3	TBL2	Transducin beta-like protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q12788	TBL3	Transducin beta-like protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q12788	TBL3	Transducin beta-like protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q12788	TBL3	Transducin beta-like protein 3	GO:0005057; F:receptor signaling protein activity; TAS:ProtInc
Q12788	TBL3	Transducin beta-like protein 3	GO:0007199; P:G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger; TAS:ProtInc
Q12788	TBL3	Transducin beta-like protein 3	GO:0035556; P:intracellular signal transduction; TAS:GOC
Q12788	TBL3	Transducin beta-like protein 3	GO:0006364; P:rRNA processing; IEA:InterPro
P62380	TBPL1	TATA box-binding protein-like protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P62380	TBPL1	TATA box-binding protein-like protein 1	GO:0003713; F:transcription coactivator activity; TAS:UniProtKB
P62380	TBPL1	TATA box-binding protein-like protein 1	GO:0001675; P:acrosome assembly; IEA:Ensembl
P62380	TBPL1	TATA box-binding protein-like protein 1	GO:0006352; P:DNA-templated transcription, initiation; IEA:InterPro
P62380	TBPL1	TATA box-binding protein-like protein 1	GO:0006235; P:dTTP biosynthetic process; IEA:Ensembl
P62380	TBPL1	TATA box-binding protein-like protein 1	GO:2001141; P:regulation of RNA biosynthetic process; TAS:GOC
P62380	TBPL1	TATA box-binding protein-like protein 1	GO:0007289; P:spermatid nucleus differentiation; IEA:Ensembl
P62380	TBPL1	TATA box-binding protein-like protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:UniProtKB
Q6SJ96	TBPL2	TATA box-binding protein-like protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6SJ96	TBPL2	TATA box-binding protein-like protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q6SJ96	TBPL2	TATA box-binding protein-like protein 2	GO:0006352; P:DNA-templated transcription, initiation; IEA:InterPro
Q6SJ96	TBPL2	TATA box-binding protein-like protein 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q6SJ96	TBPL2	TATA box-binding protein-like protein 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
P20226	TBP	TATA-box-binding protein	GO:0005515; F:protein binding; IPI:UniProtKB
P20226	TBP	TATA-box-binding protein	GO:0070491; F:repressing transcription factor binding; IPI:BHF-UCL
P20226	TBP	TATA-box-binding protein	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P20226	TBP	TATA-box-binding protein	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P20226	TBP	TATA-box-binding protein	GO:0008219; P:cell death; IEA:UniProtKB-KW
P20226	TBP	TATA-box-binding protein	GO:0010467; P:gene expression; TAS:Reactome
P20226	TBP	TATA-box-binding protein	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
P20226	TBP	TATA-box-binding protein	GO:0007283; P:spermatogenesis; IEA:Ensembl
P20226	TBP	TATA-box-binding protein	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
P20226	TBP	TATA-box-binding protein	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
P20226	TBP	TATA-box-binding protein	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P20226	TBP	TATA-box-binding protein	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
P20226	TBP	TATA-box-binding protein	GO:0006366; P:transcription from RNA polymerase II promoter; IC:UniProtKB
P20226	TBP	TATA-box-binding protein	GO:0006383; P:transcription from RNA polymerase III promoter; IDA:MGI
P20226	TBP	TATA-box-binding protein	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
P20226	TBP	TATA-box-binding protein	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IC:UniProtKB
P20226	TBP	TATA-box-binding protein	GO:0016032; P:viral process; TAS:Reactome
Q16650	TBR1	T-box brain protein 1	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl
Q16650	TBR1	T-box brain protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q16650	TBR1	T-box brain protein 1	GO:0007411; P:axon guidance; IEA:Ensembl
Q16650	TBR1	T-box brain protein 1	GO:0007420; P:brain development; TAS:ProtInc
Q16650	TBR1	T-box brain protein 1	GO:0030902; P:hindbrain development; IEA:Ensembl
Q16650	TBR1	T-box brain protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q16650	TBR1	T-box brain protein 1	GO:0010975; P:regulation of neuron projection development; IEA:Ensembl
Q16650	TBR1	T-box brain protein 1	GO:0010092; P:specification of organ identity; IEA:Ensembl
Q16650	TBR1	T-box brain protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q3YBR2	TBRG1	Transforming growth factor beta regulator 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q3YBR2	TBRG1	Transforming growth factor beta regulator 1	GO:0007050; P:cell cycle arrest; IMP:HGNC
Q3YBR2	TBRG1	Transforming growth factor beta regulator 1	GO:0006260; P:DNA replication; IMP:HGNC
Q3YBR2	TBRG1	Transforming growth factor beta regulator 1	GO:0008285; P:negative regulation of cell proliferation; IMP:HGNC
Q3YBR2	TBRG1	Transforming growth factor beta regulator 1	GO:0032066; P:nucleolus to nucleoplasm transport; IDA:HGNC
Q3YBR2	TBRG1	Transforming growth factor beta regulator 1	GO:0050821; P:protein stabilization; IMP:HGNC
Q969Z0	TBRG4	Protein TBRG4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q969Z0	TBRG4	Protein TBRG4	GO:0004672; F:protein kinase activity; IEA:InterPro
Q969Z0	TBRG4	Protein TBRG4	GO:0007050; P:cell cycle arrest; TAS:UniProtKB
Q969Z0	TBRG4	Protein TBRG4	GO:0045333; P:cellular respiration; ISS:UniProtKB
Q969Z0	TBRG4	Protein TBRG4	GO:0000080; P:mitotic G1 phase; TAS:UniProtKB
Q969Z0	TBRG4	Protein TBRG4	GO:0008284; P:positive regulation of cell proliferation; TAS:UniProtKB
O75333	TBX10	T-box transcription factor TBX10	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O75333	TBX10	T-box transcription factor TBX10	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O75333	TBX10	T-box transcription factor TBX10	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
O75333	TBX10	T-box transcription factor TBX10	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O75333	TBX10	T-box transcription factor TBX10	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96SF7	TBX15	T-box transcription factor TBX15	GO:0001106; F:RNA polymerase II transcription corepressor activity; IEA:Ensembl
Q96SF7	TBX15	T-box transcription factor TBX15	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q96SF7	TBX15	T-box transcription factor TBX15	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:Ensembl
Q96SF7	TBX15	T-box transcription factor TBX15	GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl
O60806	TBX19	T-box transcription factor TBX19	GO:0001158; F:enhancer sequence-specific DNA binding; IEA:Ensembl
O60806	TBX19	T-box transcription factor TBX19	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
O60806	TBX19	T-box transcription factor TBX19	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
O60806	TBX19	T-box transcription factor TBX19	GO:0045165; P:cell fate commitment; IEA:Ensembl
O60806	TBX19	T-box transcription factor TBX19	GO:0021983; P:pituitary gland development; IEA:Ensembl
O60806	TBX19	T-box transcription factor TBX19	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O60806	TBX19	T-box transcription factor TBX19	GO:0045595; P:regulation of cell differentiation; IEA:Ensembl
O60806	TBX19	T-box transcription factor TBX19	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
O60806	TBX19	T-box transcription factor TBX19	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O60806	TBX19	T-box transcription factor TBX19	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95935	TBX18	T-box transcription factor TBX18	GO:0046982; F:protein heterodimerization activity; ISS:BHF-UCL
O95935	TBX18	T-box transcription factor TBX18	GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
O95935	TBX18	T-box transcription factor TBX18	GO:0001106; F:RNA polymerase II transcription corepressor activity; ISS:BHF-UCL
O95935	TBX18	T-box transcription factor TBX18	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O95935	TBX18	T-box transcription factor TBX18	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; ISS:BHF-UCL
O95935	TBX18	T-box transcription factor TBX18	GO:0009948; P:anterior/posterior axis specification; IEA:Ensembl
O95935	TBX18	T-box transcription factor TBX18	GO:0090103; P:cochlea morphogenesis; IEA:Ensembl
O95935	TBX18	T-box transcription factor TBX18	GO:0016331; P:morphogenesis of embryonic epithelium; IEA:Ensembl
O95935	TBX18	T-box transcription factor TBX18	GO:0060829; P:negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation; ISS:BHF-UCL
O95935	TBX18	T-box transcription factor TBX18	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:GOC
O95935	TBX18	T-box transcription factor TBX18	GO:0022409; P:positive regulation of cell-cell adhesion; IEA:Ensembl
O95935	TBX18	T-box transcription factor TBX18	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
O95935	TBX18	T-box transcription factor TBX18	GO:2000729; P:positive regulation of mesenchymal cell proliferation involved in ureter development; IEA:Ensembl
O95935	TBX18	T-box transcription factor TBX18	GO:0007605; P:sensory perception of sound; IEA:Ensembl
O95935	TBX18	T-box transcription factor TBX18	GO:0003163; P:sinoatrial node development; IEA:Ensembl
O95935	TBX18	T-box transcription factor TBX18	GO:0051145; P:smooth muscle cell differentiation; IEA:Ensembl
O95935	TBX18	T-box transcription factor TBX18	GO:0001756; P:somitogenesis; IEA:Ensembl
O43435	TBX1	T-box transcription factor TBX1	GO:0003677; F:DNA binding; IDA:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0046983; F:protein dimerization activity; TAS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0001525; P:angiogenesis; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0009952; P:anterior/posterior pattern specification; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0035909; P:aorta morphogenesis; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0048844; P:artery morphogenesis; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0001568; P:blood vessel development; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0048514; P:blood vessel morphogenesis; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
O43435	TBX1	T-box transcription factor TBX1	GO:0001708; P:cell fate specification; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0008283; P:cell proliferation; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0044344; P:cellular response to fibroblast growth factor stimulus; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0090103; P:cochlea morphogenesis; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0060982; P:coronary artery morphogenesis; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0007368; P:determination of left/right symmetry; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0042471; P:ear morphogenesis; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0048701; P:embryonic cranial skeleton morphogenesis; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0048703; P:embryonic viscerocranium morphogenesis; IMP:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0070166; P:enamel mineralization; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0030855; P:epithelial cell differentiation; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0060325; P:face morphogenesis; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0007507; P:heart development; IMP:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0003007; P:heart morphogenesis; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0042472; P:inner ear morphogenesis; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0001945; P:lymph vessel development; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0097152; P:mesenchymal cell apoptotic process; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0007498; P:mesoderm development; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0042474; P:middle ear morphogenesis; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0042693; P:muscle cell fate commitment; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0007517; P:muscle organ development; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0048644; P:muscle organ morphogenesis; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0060415; P:muscle tissue morphogenesis; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0045596; P:negative regulation of cell differentiation; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:2001054; P:negative regulation of mesenchymal cell apoptotic process; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0001755; P:neural crest cell migration; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0042475; P:odontogenesis of dentin-containing tooth; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0071600; P:otic vesicle morphogenesis; IEA:Ensembl
O43435	TBX1	T-box transcription factor TBX1	GO:0042473; P:outer ear morphogenesis; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0003151; P:outflow tract morphogenesis; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0003148; P:outflow tract septum morphogenesis; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0060017; P:parathyroid gland development; IMP:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0007389; P:pattern specification process; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0060037; P:pharyngeal system development; IMP:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0008284; P:positive regulation of cell proliferation; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0050679; P:positive regulation of epithelial cell proliferation; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0043410; P:positive regulation of MAPK cascade; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0002053; P:positive regulation of mesenchymal cell proliferation; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0072513; P:positive regulation of secondary heart field cardioblast proliferation; IEA:Ensembl
O43435	TBX1	T-box transcription factor TBX1	GO:2001037; P:positive regulation of tongue muscle cell differentiation; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:2000027; P:regulation of organ morphogenesis; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0048384; P:retinoic acid receptor signaling pathway; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0048752; P:semicircular canal morphogenesis; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0007605; P:sensory perception of sound; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0035176; P:social behavior; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0060023; P:soft palate development; IMP:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0048538; P:thymus development; IMP:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0030878; P:thyroid gland development; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0043587; P:tongue morphogenesis; ISS:UniProtKB
O43435	TBX1	T-box transcription factor TBX1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43435	TBX1	T-box transcription factor TBX1	GO:0021644; P:vagus nerve morphogenesis; ISS:UniProtKB
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0001102; F:RNA polymerase II activating transcription factor binding; ISS:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0001105; F:RNA polymerase II transcription coactivator activity; IDA:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0001085; F:RNA polymerase II transcription factor binding; ISS:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0003180; P:aortic valve morphogenesis; IMP:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0060413; P:atrial septum morphogenesis; IMP:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0008015; P:blood circulation; IEA:Ensembl
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0003207; P:cardiac chamber formation; ISS:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0055008; P:cardiac muscle tissue morphogenesis; ISS:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0003215; P:cardiac right ventricle morphogenesis; ISS:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0003279; P:cardiac septum development; ISS:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0008283; P:cell proliferation; IEA:Ensembl
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0009953; P:dorsal/ventral pattern formation; ISS:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0036306; P:embryonic heart tube elongation; IEA:Ensembl
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0003143; P:embryonic heart tube morphogenesis; ISS:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0003272; P:endocardial cushion formation; ISS:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0003203; P:endocardial cushion morphogenesis; ISS:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0001706; P:endoderm formation; ISS:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0035922; P:foramen ovale closure; IMP:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0001947; P:heart looping; ISS:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0048370; P:lateral mesoderm formation; ISS:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0006936; P:muscle contraction; IEA:Ensembl
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0010991; P:negative regulation of SMAD protein complex assembly; IEA:Ensembl
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0001764; P:neuron migration; IEA:Ensembl
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0003148; P:outflow tract septum morphogenesis; IMP:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0001569; P:patterning of blood vessels; IEA:Ensembl
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0003344; P:pericardium morphogenesis; ISS:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0060045; P:positive regulation of cardiac muscle cell proliferation; ISS:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:GOC
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0003193; P:pulmonary valve formation; ISS:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0060577; P:pulmonary vein morphogenesis; IMP:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0003175; P:tricuspid valve development; ISS:BHF-UCL
Q9UMR3	TBX20	T-box transcription factor TBX20	GO:0021524; P:visceral motor neuron differentiation; ISS:BHF-UCL
Q9UL17	TBX21	T-box transcription factor TBX21	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:UniProtKB
Q9UL17	TBX21	T-box transcription factor TBX21	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q9UL17	TBX21	T-box transcription factor TBX21	GO:0072676; P:lymphocyte migration; IDA:UniProtKB
Q9UL17	TBX21	T-box transcription factor TBX21	GO:0007275; P:multicellular organismal development; TAS:UniProtKB
Q9UL17	TBX21	T-box transcription factor TBX21	GO:0048304; P:positive regulation of isotype switching to IgG isotypes; IEA:Ensembl
Q9UL17	TBX21	T-box transcription factor TBX21	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UL17	TBX21	T-box transcription factor TBX21	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q9UL17	TBX21	T-box transcription factor TBX21	GO:0009615; P:response to virus; IEP:UniProtKB
Q9UL17	TBX21	T-box transcription factor TBX21	GO:0030217; P:T cell differentiation; IEA:Ensembl
Q9UL17	TBX21	T-box transcription factor TBX21	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y458	TBX22	T-box transcription factor TBX22	GO:0003677; F:DNA binding; IDA:BHF-UCL
Q9Y458	TBX22	T-box transcription factor TBX22	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:UniProtKB
Q9Y458	TBX22	T-box transcription factor TBX22	GO:0007275; P:multicellular organismal development; TAS:UniProtKB
Q9Y458	TBX22	T-box transcription factor TBX22	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9Y458	TBX22	T-box transcription factor TBX22	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
Q9Y458	TBX22	T-box transcription factor TBX22	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q9Y458	TBX22	T-box transcription factor TBX22	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13207	TBX2	T-box transcription factor TBX2	GO:0003677; F:DNA binding; TAS:ProtInc
Q13207	TBX2	T-box transcription factor TBX2	GO:0005515; F:protein binding; IPI:UniProtKB
Q13207	TBX2	T-box transcription factor TBX2	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q13207	TBX2	T-box transcription factor TBX2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q13207	TBX2	T-box transcription factor TBX2	GO:0035909; P:aorta morphogenesis; ISS:BHF-UCL
Q13207	TBX2	T-box transcription factor TBX2	GO:0036302; P:atrioventricular canal development; ISS:BHF-UCL
Q13207	TBX2	T-box transcription factor TBX2	GO:0048738; P:cardiac muscle tissue development; ISS:BHF-UCL
Q13207	TBX2	T-box transcription factor TBX2	GO:0007569; P:cell aging; IDA:UniProtKB
Q13207	TBX2	T-box transcription factor TBX2	GO:0090398; P:cellular senescence; IDA:UniProtKB
Q13207	TBX2	T-box transcription factor TBX2	GO:0060560; P:developmental growth involved in morphogenesis; IEA:Ensembl
Q13207	TBX2	T-box transcription factor TBX2	GO:0048596; P:embryonic camera-type eye morphogenesis; ISS:BHF-UCL
Q13207	TBX2	T-box transcription factor TBX2	GO:0042733; P:embryonic digit morphogenesis; ISS:BHF-UCL
Q13207	TBX2	T-box transcription factor TBX2	GO:0003203; P:endocardial cushion morphogenesis; ISS:BHF-UCL
Q13207	TBX2	T-box transcription factor TBX2	GO:0060596; P:mammary placode formation; IEA:Ensembl
Q13207	TBX2	T-box transcription factor TBX2	GO:0007521; P:muscle cell fate determination; ISS:BHF-UCL
Q13207	TBX2	T-box transcription factor TBX2	GO:1901211; P:negative regulation of cardiac chamber formation; ISS:BHF-UCL
Q13207	TBX2	T-box transcription factor TBX2	GO:1901208; P:negative regulation of heart looping; ISS:BHF-UCL
Q13207	TBX2	T-box transcription factor TBX2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q13207	TBX2	T-box transcription factor TBX2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q13207	TBX2	T-box transcription factor TBX2	GO:0003151; P:outflow tract morphogenesis; ISS:BHF-UCL
Q13207	TBX2	T-box transcription factor TBX2	GO:0003148; P:outflow tract septum morphogenesis; ISS:BHF-UCL
Q13207	TBX2	T-box transcription factor TBX2	GO:0060021; P:palate development; IEA:Ensembl
Q13207	TBX2	T-box transcription factor TBX2	GO:0060465; P:pharynx development; ISS:BHF-UCL
Q13207	TBX2	T-box transcription factor TBX2	GO:0060045; P:positive regulation of cardiac muscle cell proliferation; ISS:BHF-UCL
Q13207	TBX2	T-box transcription factor TBX2	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q13207	TBX2	T-box transcription factor TBX2	GO:0003256; P:regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; ISS:BHF-UCL
Q13207	TBX2	T-box transcription factor TBX2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15119	TBX3	T-box transcription factor TBX3	GO:0005515; F:protein binding; IPI:UniProtKB
O15119	TBX3	T-box transcription factor TBX3	GO:0001102; F:RNA polymerase II activating transcription factor binding; ISS:BHF-UCL
O15119	TBX3	T-box transcription factor TBX3	GO:0001085; F:RNA polymerase II transcription factor binding; ISS:BHF-UCL
O15119	TBX3	T-box transcription factor TBX3	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
O15119	TBX3	T-box transcription factor TBX3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
O15119	TBX3	T-box transcription factor TBX3	GO:0008595; P:anterior/posterior axis specification, embryo; IMP:UniProtKB
O15119	TBX3	T-box transcription factor TBX3	GO:0003167; P:atrioventricular bundle cell differentiation; IEA:Ensembl
O15119	TBX3	T-box transcription factor TBX3	GO:0001568; P:blood vessel development; IEA:Ensembl
O15119	TBX3	T-box transcription factor TBX3	GO:0060444; P:branching involved in mammary gland duct morphogenesis; IEA:Ensembl
O15119	TBX3	T-box transcription factor TBX3	GO:0060923; P:cardiac muscle cell fate commitment; IEA:Ensembl
O15119	TBX3	T-box transcription factor TBX3	GO:0007569; P:cell aging; IDA:UniProtKB
O15119	TBX3	T-box transcription factor TBX3	GO:0090398; P:cellular senescence; IDA:UniProtKB
O15119	TBX3	T-box transcription factor TBX3	GO:0042733; P:embryonic digit morphogenesis; IMP:UniProtKB
O15119	TBX3	T-box transcription factor TBX3	GO:0035115; P:embryonic forelimb morphogenesis; IMP:UniProtKB
O15119	TBX3	T-box transcription factor TBX3	GO:0030540; P:female genitalia development; IMP:UniProtKB
O15119	TBX3	T-box transcription factor TBX3	GO:0046884; P:follicle-stimulating hormone secretion; IMP:UniProtKB
O15119	TBX3	T-box transcription factor TBX3	GO:0035136; P:forelimb morphogenesis; IDA:MGI
O15119	TBX3	T-box transcription factor TBX3	GO:0001947; P:heart looping; IEA:Ensembl
O15119	TBX3	T-box transcription factor TBX3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O15119	TBX3	T-box transcription factor TBX3	GO:0021761; P:limbic system development; IEA:Ensembl
O15119	TBX3	T-box transcription factor TBX3	GO:0032275; P:luteinizing hormone secretion; IMP:UniProtKB
O15119	TBX3	T-box transcription factor TBX3	GO:0030539; P:male genitalia development; IMP:UniProtKB
O15119	TBX3	T-box transcription factor TBX3	GO:0030879; P:mammary gland development; IMP:UniProtKB
O15119	TBX3	T-box transcription factor TBX3	GO:0060596; P:mammary placode formation; IEA:Ensembl
O15119	TBX3	T-box transcription factor TBX3	GO:0048332; P:mesoderm morphogenesis; IMP:UniProtKB
O15119	TBX3	T-box transcription factor TBX3	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
O15119	TBX3	T-box transcription factor TBX3	GO:0030857; P:negative regulation of epithelial cell differentiation; IEA:Ensembl
O15119	TBX3	T-box transcription factor TBX3	GO:0045662; P:negative regulation of myoblast differentiation; IDA:UniProtKB
O15119	TBX3	T-box transcription factor TBX3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O15119	TBX3	T-box transcription factor TBX3	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
O15119	TBX3	T-box transcription factor TBX3	GO:0009887; P:organ morphogenesis; IDA:MGI
O15119	TBX3	T-box transcription factor TBX3	GO:0003151; P:outflow tract morphogenesis; IEA:Ensembl
O15119	TBX3	T-box transcription factor TBX3	GO:0060021; P:palate development; IEA:Ensembl
O15119	TBX3	T-box transcription factor TBX3	GO:0045787; P:positive regulation of cell cycle; IDA:UniProtKB
O15119	TBX3	T-box transcription factor TBX3	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
O15119	TBX3	T-box transcription factor TBX3	GO:2000648; P:positive regulation of stem cell proliferation; IEA:Ensembl
O15119	TBX3	T-box transcription factor TBX3	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
O15119	TBX3	T-box transcription factor TBX3	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:UniProtKB
O15119	TBX3	T-box transcription factor TBX3	GO:0060931; P:sinoatrial node cell development; IEA:Ensembl
O15119	TBX3	T-box transcription factor TBX3	GO:0001501; P:skeletal system development; IMP:UniProtKB
O15119	TBX3	T-box transcription factor TBX3	GO:0010159; P:specification of organ position; IEA:Ensembl
O15119	TBX3	T-box transcription factor TBX3	GO:0019827; P:stem cell maintenance; IEA:Ensembl
O15119	TBX3	T-box transcription factor TBX3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15119	TBX3	T-box transcription factor TBX3	GO:0060412; P:ventricular septum morphogenesis; IEA:Ensembl
P57082	TBX4	T-box transcription factor TBX4	GO:0003677; F:DNA binding; NAS:UniProtKB
P57082	TBX4	T-box transcription factor TBX4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:UniProtKB
P57082	TBX4	T-box transcription factor TBX4	GO:0001525; P:angiogenesis; IEA:Ensembl
P57082	TBX4	T-box transcription factor TBX4	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
P57082	TBX4	T-box transcription factor TBX4	GO:0035108; P:limb morphogenesis; IMP:UniProtKB
P57082	TBX4	T-box transcription factor TBX4	GO:0030324; P:lung development; IEA:Ensembl
P57082	TBX4	T-box transcription factor TBX4	GO:0002009; P:morphogenesis of an epithelium; IEA:Ensembl
P57082	TBX4	T-box transcription factor TBX4	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
P57082	TBX4	T-box transcription factor TBX4	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P57082	TBX4	T-box transcription factor TBX4	GO:0048705; P:skeletal system morphogenesis; IMP:UniProtKB
P57082	TBX4	T-box transcription factor TBX4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q99593	TBX5	T-box transcription factor TBX5	GO:0003677; F:DNA binding; IDA:UniProtKB
Q99593	TBX5	T-box transcription factor TBX5	GO:0005515; F:protein binding; IPI:IntAct
Q99593	TBX5	T-box transcription factor TBX5	GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl
Q99593	TBX5	T-box transcription factor TBX5	GO:0001228; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q99593	TBX5	T-box transcription factor TBX5	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q99593	TBX5	T-box transcription factor TBX5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q99593	TBX5	T-box transcription factor TBX5	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
Q99593	TBX5	T-box transcription factor TBX5	GO:0030262; P:apoptotic nuclear changes; IDA:UniProtKB
Q99593	TBX5	T-box transcription factor TBX5	GO:0060413; P:atrial septum morphogenesis; IEA:Ensembl
Q99593	TBX5	T-box transcription factor TBX5	GO:0003181; P:atrioventricular valve morphogenesis; IEA:Ensembl
Q99593	TBX5	T-box transcription factor TBX5	GO:0003166; P:bundle of His development; IEA:Ensembl
Q99593	TBX5	T-box transcription factor TBX5	GO:0003218; P:cardiac left ventricle formation; ISS:BHF-UCL
Q99593	TBX5	T-box transcription factor TBX5	GO:0055007; P:cardiac muscle cell differentiation; IEA:Ensembl
Q99593	TBX5	T-box transcription factor TBX5	GO:0060980; P:cell migration involved in coronary vasculogenesis; TAS:DFLAT
Q99593	TBX5	T-box transcription factor TBX5	GO:0007267; P:cell-cell signaling; IDA:UniProtKB
Q99593	TBX5	T-box transcription factor TBX5	GO:0035115; P:embryonic forelimb morphogenesis; IMP:UniProtKB
Q99593	TBX5	T-box transcription factor TBX5	GO:0030326; P:embryonic limb morphogenesis; IMP:UniProtKB
Q99593	TBX5	T-box transcription factor TBX5	GO:0003197; P:endocardial cushion development; IEA:Ensembl
Q99593	TBX5	T-box transcription factor TBX5	GO:0035136; P:forelimb morphogenesis; IMP:MGI
Q99593	TBX5	T-box transcription factor TBX5	GO:0010467; P:gene expression; TAS:Reactome
Q99593	TBX5	T-box transcription factor TBX5	GO:0007507; P:heart development; IDA:UniProtKB
Q99593	TBX5	T-box transcription factor TBX5	GO:0030324; P:lung development; IEA:Ensembl
Q99593	TBX5	T-box transcription factor TBX5	GO:0002009; P:morphogenesis of an epithelium; IEA:Ensembl
Q99593	TBX5	T-box transcription factor TBX5	GO:0060044; P:negative regulation of cardiac muscle cell proliferation; IDA:UniProtKB
Q99593	TBX5	T-box transcription factor TBX5	GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB
Q99593	TBX5	T-box transcription factor TBX5	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q99593	TBX5	T-box transcription factor TBX5	GO:0010719; P:negative regulation of epithelial to mesenchymal transition; TAS:DFLAT
Q99593	TBX5	T-box transcription factor TBX5	GO:0007389; P:pattern specification process; IEA:Ensembl
Q99593	TBX5	T-box transcription factor TBX5	GO:0060039; P:pericardium development; IDA:UniProtKB
Q99593	TBX5	T-box transcription factor TBX5	GO:0060045; P:positive regulation of cardiac muscle cell proliferation; IEA:Ensembl
Q99593	TBX5	T-box transcription factor TBX5	GO:0051891; P:positive regulation of cardioblast differentiation; IDA:UniProtKB
Q99593	TBX5	T-box transcription factor TBX5	GO:0072513; P:positive regulation of secondary heart field cardioblast proliferation; IEA:Ensembl
Q99593	TBX5	T-box transcription factor TBX5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q99593	TBX5	T-box transcription factor TBX5	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q99593	TBX5	T-box transcription factor TBX5	GO:1900117; P:regulation of execution phase of apoptosis; IC:UniProtKB
Q99593	TBX5	T-box transcription factor TBX5	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q99593	TBX5	T-box transcription factor TBX5	GO:0003229; P:ventricular cardiac muscle tissue development; IEA:Ensembl
Q99593	TBX5	T-box transcription factor TBX5	GO:0003281; P:ventricular septum development; ISS:BHF-UCL
O95947	TBX6	T-box transcription factor TBX6	GO:0003677; F:DNA binding; TAS:ProtInc
O95947	TBX6	T-box transcription factor TBX6	GO:0001102; F:RNA polymerase II activating transcription factor binding; ISS:BHF-UCL
O95947	TBX6	T-box transcription factor TBX6	GO:0001085; F:RNA polymerase II transcription factor binding; ISS:BHF-UCL
O95947	TBX6	T-box transcription factor TBX6	GO:0001191; F:RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription; ISS:BHF-UCL
O95947	TBX6	T-box transcription factor TBX6	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O95947	TBX6	T-box transcription factor TBX6	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
O95947	TBX6	T-box transcription factor TBX6	GO:0001708; P:cell fate specification; IEA:Ensembl
O95947	TBX6	T-box transcription factor TBX6	GO:0007498; P:mesoderm development; TAS:ProtInc
O95947	TBX6	T-box transcription factor TBX6	GO:0001707; P:mesoderm formation; IEA:Ensembl
O95947	TBX6	T-box transcription factor TBX6	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
O95947	TBX6	T-box transcription factor TBX6	GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl
Q8WW35	TCTEX1D2	Tctex1 domain-containing protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q8IZS6	TCTE3	Tctex1 domain-containing protein 3	GO:0003774; F:motor activity; IEA:UniProtKB-KW
Q8IZS6	TCTE3	Tctex1 domain-containing protein 3	GO:0006810; P:transport; IEA:UniProtKB-KW
Q5JR98	TCTEX1D4	Tctex1 domain-containing protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q15170	TCEAL1	Transcription elongation factor A protein-like 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
Q15170	TCEAL1	Transcription elongation factor A protein-like 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q15170	TCEAL1	Transcription elongation factor A protein-like 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H3H9	TCEAL2	Transcription elongation factor A protein-like 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H3H9	TCEAL2	Transcription elongation factor A protein-like 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q969E4	TCEAL3	Transcription elongation factor A protein-like 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q969E4	TCEAL3	Transcription elongation factor A protein-like 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5H9L2	TCEAL5	Transcription elongation factor A protein-like 5	GO:0005515; F:protein binding; IPI:IntAct
Q5H9L2	TCEAL5	Transcription elongation factor A protein-like 5	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5H9L2	TCEAL5	Transcription elongation factor A protein-like 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96EI5	TCEAL4	Transcription elongation factor A protein-like 4	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96EI5	TCEAL4	Transcription elongation factor A protein-like 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6IPX3	TCEAL6	Transcription elongation factor A protein-like 6	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6IPX3	TCEAL6	Transcription elongation factor A protein-like 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BRU2	TCEAL7	Transcription elongation factor A protein-like 7	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q9BRU2	TCEAL7	Transcription elongation factor A protein-like 7	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9BRU2	TCEAL7	Transcription elongation factor A protein-like 7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IYN2	TCEAL8	Transcription elongation factor A protein-like 8	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8IYN2	TCEAL8	Transcription elongation factor A protein-like 8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0097190; P:apoptotic signaling pathway; IEA:Ensembl
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0045087; P:innate immune response; TAS:Reactome
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IEA:Ensembl
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0002281; P:macrophage activation involved in immune response; IEA:Ensembl
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0030890; P:positive regulation of B cell proliferation; IEA:Ensembl
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0045080; P:positive regulation of chemokine biosynthetic process; IEA:Ensembl
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0045359; P:positive regulation of interferon-beta biosynthetic process; IEA:Ensembl
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:Ensembl
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IEA:Ensembl
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0032092; P:positive regulation of protein binding; IEA:Ensembl
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0031398; P:positive regulation of protein ubiquitination; IEA:Ensembl
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0032760; P:positive regulation of tumor necrosis factor production; IEA:Ensembl
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0032481; P:positive regulation of type I interferon production; IEA:Ensembl
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0043496; P:regulation of protein homodimerization activity; IEA:Ensembl
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0043330; P:response to exogenous dsRNA; IMP:MGI
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q8IUC6	TICAM1	TIR domain-containing adapter molecule 1	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q86XR7	TICAM2	TIR domain-containing adapter molecule 2	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q86XR7	TICAM2	TIR domain-containing adapter molecule 2	GO:0071222; P:cellular response to lipopolysaccharide; IDA:UniProtKB
Q86XR7	TICAM2	TIR domain-containing adapter molecule 2	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
Q86XR7	TICAM2	TIR domain-containing adapter molecule 2	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q86XR7	TICAM2	TIR domain-containing adapter molecule 2	GO:0045087; P:innate immune response; TAS:Reactome
Q86XR7	TICAM2	TIR domain-containing adapter molecule 2	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q86XR7	TICAM2	TIR domain-containing adapter molecule 2	GO:0071650; P:negative regulation of chemokine (C-C motif) ligand 5 production; IMP:UniProtKB
Q86XR7	TICAM2	TIR domain-containing adapter molecule 2	GO:0034144; P:negative regulation of toll-like receptor 4 signaling pathway; IDA:UniProtKB
Q86XR7	TICAM2	TIR domain-containing adapter molecule 2	GO:0071651; P:positive regulation of chemokine (C-C motif) ligand 5 production; IMP:UniProtKB
Q86XR7	TICAM2	TIR domain-containing adapter molecule 2	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q86XR7	TICAM2	TIR domain-containing adapter molecule 2	GO:2000494; P:positive regulation of interleukin-18-mediated signaling pathway; IMP:UniProtKB
Q86XR7	TICAM2	TIR domain-containing adapter molecule 2	GO:0034145; P:positive regulation of toll-like receptor 4 signaling pathway; IDA:UniProtKB
Q86XR7	TICAM2	TIR domain-containing adapter molecule 2	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q86XR7	TICAM2	TIR domain-containing adapter molecule 2	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q86XR7	TICAM2	TIR domain-containing adapter molecule 2	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q86XR7	TICAM2	TIR domain-containing adapter molecule 2	GO:0035669; P:TRAM-dependent toll-like receptor 4 signaling pathway; IDA:UniProtKB
Q86XR7	TICAM2	TIR domain-containing adapter molecule 2	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P01848	TRAC	T-cell receptor alpha chain C region	GO:0050776; P:regulation of immune response; TAS:Reactome
P01848	TRAC	T-cell receptor alpha chain C region	GO:0031295; P:T cell costimulation; TAS:Reactome
P01848	TRAC	T-cell receptor alpha chain C region	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P23193	TCEA1	Transcription elongation factor A protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P23193	TCEA1	Transcription elongation factor A protein 1	GO:0005515; F:protein binding; IPI:IntAct
P23193	TCEA1	Transcription elongation factor A protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
P23193	TCEA1	Transcription elongation factor A protein 1	GO:0006281; P:DNA repair; TAS:Reactome
P23193	TCEA1	Transcription elongation factor A protein 1	GO:0030218; P:erythrocyte differentiation; IEA:Ensembl
P23193	TCEA1	Transcription elongation factor A protein 1	GO:0010467; P:gene expression; TAS:Reactome
P23193	TCEA1	Transcription elongation factor A protein 1	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P23193	TCEA1	Transcription elongation factor A protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P23193	TCEA1	Transcription elongation factor A protein 1	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P23193	TCEA1	Transcription elongation factor A protein 1	GO:0032784; P:regulation of DNA-templated transcription, elongation; IEA:InterPro
P23193	TCEA1	Transcription elongation factor A protein 1	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P23193	TCEA1	Transcription elongation factor A protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
P23193	TCEA1	Transcription elongation factor A protein 1	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P23193	TCEA1	Transcription elongation factor A protein 1	GO:0016032; P:viral process; TAS:Reactome
Q15560	TCEA2	Transcription elongation factor A protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q15560	TCEA2	Transcription elongation factor A protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q15560	TCEA2	Transcription elongation factor A protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q15560	TCEA2	Transcription elongation factor A protein 2	GO:0006354; P:DNA-templated transcription, elongation; NAS:UniProtKB
Q15560	TCEA2	Transcription elongation factor A protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q15560	TCEA2	Transcription elongation factor A protein 2	GO:0032784; P:regulation of DNA-templated transcription, elongation; NAS:UniProtKB
O75764	TCEA3	Transcription elongation factor A protein 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O75764	TCEA3	Transcription elongation factor A protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
O75764	TCEA3	Transcription elongation factor A protein 3	GO:0032784; P:regulation of DNA-templated transcription, elongation; IEA:InterPro
O75764	TCEA3	Transcription elongation factor A protein 3	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:InterPro
O75764	TCEA3	Transcription elongation factor A protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q12870	TCF15	Transcription factor 15	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q12870	TCF15	Transcription factor 15	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q12870	TCF15	Transcription factor 15	GO:0016265; P:death; IEA:Ensembl
Q12870	TCF15	Transcription factor 15	GO:0043583; P:ear development; IEA:Ensembl
Q12870	TCF15	Transcription factor 15	GO:0042755; P:eating behavior; IEA:Ensembl
Q12870	TCF15	Transcription factor 15	GO:0007498; P:mesoderm development; TAS:ProtInc
Q12870	TCF15	Transcription factor 15	GO:0048644; P:muscle organ morphogenesis; IEA:Ensembl
Q12870	TCF15	Transcription factor 15	GO:0050884; P:neuromuscular process controlling posture; IEA:Ensembl
Q12870	TCF15	Transcription factor 15	GO:0048339; P:paraxial mesoderm development; IEA:Ensembl
Q12870	TCF15	Transcription factor 15	GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl
Q12870	TCF15	Transcription factor 15	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q12870	TCF15	Transcription factor 15	GO:0003016; P:respiratory system process; IEA:Ensembl
Q12870	TCF15	Transcription factor 15	GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl
Q12870	TCF15	Transcription factor 15	GO:0043588; P:skin development; IEA:Ensembl
Q12870	TCF15	Transcription factor 15	GO:0001756; P:somitogenesis; IEA:Ensembl
Q12870	TCF15	Transcription factor 15	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y242	TCF19	Transcription factor 19	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9Y242	TCF19	Transcription factor 19	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y242	TCF19	Transcription factor 19	GO:0008283; P:cell proliferation; TAS:ProtInc
Q9Y242	TCF19	Transcription factor 19	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9Y242	TCF19	Transcription factor 19	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UGU0	TCF20	Transcription factor 20	GO:0003677; F:DNA binding; NAS:UniProtKB
Q9UGU0	TCF20	Transcription factor 20	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UGU0	TCF20	Transcription factor 20	GO:0003713; F:transcription coactivator activity; NAS:UniProtKB
Q9UGU0	TCF20	Transcription factor 20	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UGU0	TCF20	Transcription factor 20	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9UGU0	TCF20	Transcription factor 20	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43680	TCF21	Transcription factor 21	GO:0050681; F:androgen receptor binding; ISS:BHF-UCL
O43680	TCF21	Transcription factor 21	GO:0043425; F:bHLH transcription factor binding; IPI:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0070888; F:E-box binding; ISS:BHF-UCL
O43680	TCF21	Transcription factor 21	GO:0046983; F:protein dimerization activity; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IDA:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0001658; P:branching involved in ureteric bud morphogenesis; ISS:BHF-UCL
O43680	TCF21	Transcription factor 21	GO:0014707; P:branchiomeric skeletal muscle development; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0060435; P:bronchiole development; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0060539; P:diaphragm development; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0048557; P:embryonic digestive tract morphogenesis; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0030855; P:epithelial cell differentiation; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0048732; P:gland development; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0032835; P:glomerulus development; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0001822; P:kidney development; ISS:BHF-UCL
O43680	TCF21	Transcription factor 21	GO:0048286; P:lung alveolus development; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0060425; P:lung morphogenesis; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0060426; P:lung vasculature development; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0072277; P:metanephric glomerular capillary formation; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0072162; P:metanephric mesenchymal cell differentiation; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0001763; P:morphogenesis of a branching structure; ISS:BHF-UCL
O43680	TCF21	Transcription factor 21	GO:0060766; P:negative regulation of androgen receptor signaling pathway; ISS:BHF-UCL
O43680	TCF21	Transcription factor 21	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0060021; P:palate development; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0048608; P:reproductive structure development; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0060541; P:respiratory system development; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0060008; P:Sertoli cell differentiation; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0007530; P:sex determination; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0048536; P:spleen development; ISS:UniProtKB
O43680	TCF21	Transcription factor 21	GO:0001657; P:ureteric bud development; ISS:BHF-UCL
O43680	TCF21	Transcription factor 21	GO:0001944; P:vasculature development; ISS:BHF-UCL
Q7RTU1	TCF23	Transcription factor 23	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q7RTU1	TCF23	Transcription factor 23	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
Q7RTU0	TCF24	Transcription factor 24	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7RTU0	TCF24	Transcription factor 24	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7RTU0	TCF24	Transcription factor 24	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BQ70	TCF25	Transcription factor 25	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BQ70	TCF25	Transcription factor 25	GO:0005515; F:protein binding; IPI:IntAct
Q9BQ70	TCF25	Transcription factor 25	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9BQ70	TCF25	Transcription factor 25	GO:0007507; P:heart development; NAS:UniProtKB
Q9BQ70	TCF25	Transcription factor 25	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9BQ70	TCF25	Transcription factor 25	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P36402	TCF7	Transcription factor 7	GO:0008013; F:beta-catenin binding; IDA:BHF-UCL
P36402	TCF7	Transcription factor 7	GO:0003682; F:chromatin binding; IBA:RefGenome
P36402	TCF7	Transcription factor 7	GO:0005515; F:protein binding; IPI:UniProtKB
P36402	TCF7	Transcription factor 7	GO:0043565; F:sequence-specific DNA binding; IBA:RefGenome
P36402	TCF7	Transcription factor 7	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P36402	TCF7	Transcription factor 7	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P36402	TCF7	Transcription factor 7	GO:0046632; P:alpha-beta T cell differentiation; IEA:Ensembl
P36402	TCF7	Transcription factor 7	GO:0007420; P:brain development; IBA:RefGenome
P36402	TCF7	Transcription factor 7	GO:0060070; P:canonical Wnt signaling pathway; IBA:RefGenome
P36402	TCF7	Transcription factor 7	GO:0044336; P:canonical Wnt signaling pathway involved in negative regulation of apoptotic process; IEA:Ensembl
P36402	TCF7	Transcription factor 7	GO:0071353; P:cellular response to interleukin-4; IDA:UniProtKB
P36402	TCF7	Transcription factor 7	GO:0048557; P:embryonic digestive tract morphogenesis; IEA:Ensembl
P36402	TCF7	Transcription factor 7	GO:0030538; P:embryonic genitalia morphogenesis; IEA:Ensembl
P36402	TCF7	Transcription factor 7	GO:0048619; P:embryonic hindgut morphogenesis; IEA:Ensembl
P36402	TCF7	Transcription factor 7	GO:0048699; P:generation of neurons; IBA:RefGenome
P36402	TCF7	Transcription factor 7	GO:0006955; P:immune response; TAS:ProtInc
P36402	TCF7	Transcription factor 7	GO:0021915; P:neural tube development; IEA:Ensembl
P36402	TCF7	Transcription factor 7	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P36402	TCF7	Transcription factor 7	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
P36402	TCF7	Transcription factor 7	GO:0033153; P:T cell receptor V(D)J recombination; IEA:Ensembl
P36402	TCF7	Transcription factor 7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UL49	TCFL5	Transcription factor-like 5 protein	GO:0003677; F:DNA binding; IDA:UniProtKB
Q9UL49	TCFL5	Transcription factor-like 5 protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9UL49	TCFL5	Transcription factor-like 5 protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9UL49	TCFL5	Transcription factor-like 5 protein	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9UL49	TCFL5	Transcription factor-like 5 protein	GO:0045595; P:regulation of cell differentiation; IEP:UniProtKB
Q9UL49	TCFL5	Transcription factor-like 5 protein	GO:0042127; P:regulation of cell proliferation; IEP:UniProtKB
Q9UL49	TCFL5	Transcription factor-like 5 protein	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UL49	TCFL5	Transcription factor-like 5 protein	GO:0007283; P:spermatogenesis; IEP:UniProtKB
Q9UL49	TCFL5	Transcription factor-like 5 protein	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q5QJ38	TCHHL1	Trichohyalin-like protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9BT92	TCHP	Trichoplein keratin filament-binding protein	GO:0005515; F:protein binding; IPI:HGNC
Q9BT92	TCHP	Trichoplein keratin filament-binding protein	GO:0006915; P:apoptotic process; IDA:UniProtKB
Q9BT92	TCHP	Trichoplein keratin filament-binding protein	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
P56279	TCL1A	T-cell leukemia/lymphoma protein 1A	GO:0005515; F:protein binding; IPI:UniProtKB
P56279	TCL1A	T-cell leukemia/lymphoma protein 1A	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P56279	TCL1A	T-cell leukemia/lymphoma protein 1A	GO:0019827; P:stem cell maintenance; IEA:Ensembl
P20061	TCN1	Transcobalamin-1	GO:0031419; F:cobalamin binding; IBA:RefGenome
P20061	TCN1	Transcobalamin-1	GO:0009235; P:cobalamin metabolic process; IBA:RefGenome
P20061	TCN1	Transcobalamin-1	GO:0015889; P:cobalamin transport; TAS:ProtInc
P20061	TCN1	Transcobalamin-1	GO:0006824; P:cobalt ion transport; IEA:UniProtKB-KW
P20061	TCN1	Transcobalamin-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P20061	TCN1	Transcobalamin-1	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P20061	TCN1	Transcobalamin-1	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
P20062	TCN2	Transcobalamin-2	GO:0031419; F:cobalamin binding; IDA:UniProtKB
P20062	TCN2	Transcobalamin-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P20062	TCN2	Transcobalamin-2	GO:0009235; P:cobalamin metabolic process; IBA:RefGenome
P20062	TCN2	Transcobalamin-2	GO:0015889; P:cobalamin transport; TAS:ProtInc
P20062	TCN2	Transcobalamin-2	GO:0006824; P:cobalt ion transport; IEA:UniProtKB-KW
P20062	TCN2	Transcobalamin-2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P20062	TCN2	Transcobalamin-2	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P20062	TCN2	Transcobalamin-2	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q13428	TCOF1	Treacle protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13428	TCOF1	Treacle protein	GO:0005515; F:protein binding; IPI:IntAct
Q13428	TCOF1	Treacle protein	GO:0005215; F:transporter activity; TAS:ProtInc
Q13428	TCOF1	Treacle protein	GO:0001501; P:skeletal system development; TAS:ProtInc
Q13428	TCOF1	Treacle protein	GO:0042790; P:transcription of nuclear large rRNA transcript from RNA polymerase I promoter; IEA:Ensembl
Q8WWU5	TCP11	T-complex protein 11 homolog	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8WWU5	TCP11	T-complex protein 11 homolog	GO:0007275; P:multicellular organismal development; TAS:UniProtKB
Q8WWU5	TCP11	T-complex protein 11 homolog	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
P53999	SUB1	Activated RNA polymerase II transcriptional coactivator p15	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P53999	SUB1	Activated RNA polymerase II transcriptional coactivator p15	GO:0005515; F:protein binding; IPI:IntAct
P53999	SUB1	Activated RNA polymerase II transcriptional coactivator p15	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
P53999	SUB1	Activated RNA polymerase II transcriptional coactivator p15	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
P53999	SUB1	Activated RNA polymerase II transcriptional coactivator p15	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P53999	SUB1	Activated RNA polymerase II transcriptional coactivator p15	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17987	TCP1	T-complex protein 1 subunit alpha	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P17987	TCP1	T-complex protein 1 subunit alpha	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P17987	TCP1	T-complex protein 1 subunit alpha	GO:0051082; F:unfolded protein binding; TAS:ProtInc
P17987	TCP1	T-complex protein 1 subunit alpha	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
P17987	TCP1	T-complex protein 1 subunit alpha	GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl
P17987	TCP1	T-complex protein 1 subunit alpha	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P17987	TCP1	T-complex protein 1 subunit alpha	GO:0006457; P:protein folding; TAS:Reactome
P17987	TCP1	T-complex protein 1 subunit alpha	GO:0007021; P:tubulin complex assembly; NAS:UniProtKB
P78371	CCT2	T-complex protein 1 subunit beta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P78371	CCT2	T-complex protein 1 subunit beta	GO:0005515; F:protein binding; IPI:IntAct
P78371	CCT2	T-complex protein 1 subunit beta	GO:0051082; F:unfolded protein binding; NAS:UniProtKB
P78371	CCT2	T-complex protein 1 subunit beta	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
P78371	CCT2	T-complex protein 1 subunit beta	GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl
P78371	CCT2	T-complex protein 1 subunit beta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P78371	CCT2	T-complex protein 1 subunit beta	GO:0051131; P:chaperone-mediated protein complex assembly; IMP:MGI
P78371	CCT2	T-complex protein 1 subunit beta	GO:0006457; P:protein folding; NAS:UniProtKB
P50991	CCT4	T-complex protein 1 subunit delta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P50991	CCT4	T-complex protein 1 subunit delta	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P50991	CCT4	T-complex protein 1 subunit delta	GO:0051082; F:unfolded protein binding; TAS:ProtInc
P50991	CCT4	T-complex protein 1 subunit delta	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
P50991	CCT4	T-complex protein 1 subunit delta	GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl
P50991	CCT4	T-complex protein 1 subunit delta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P50991	CCT4	T-complex protein 1 subunit delta	GO:0006457; P:protein folding; TAS:Reactome
P48643	CCT5	T-complex protein 1 subunit epsilon	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P48643	CCT5	T-complex protein 1 subunit epsilon	GO:0031681; F:G-protein beta-subunit binding; IPI:UniProt
P48643	CCT5	T-complex protein 1 subunit epsilon	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
P48643	CCT5	T-complex protein 1 subunit epsilon	GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl
P48643	CCT5	T-complex protein 1 subunit epsilon	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P48643	CCT5	T-complex protein 1 subunit epsilon	GO:0006457; P:protein folding; TAS:Reactome
P48643	CCT5	T-complex protein 1 subunit epsilon	GO:0009615; P:response to virus; IEP:UniProtKB
P49368	CCT3	T-complex protein 1 subunit gamma	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49368	CCT3	T-complex protein 1 subunit gamma	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P49368	CCT3	T-complex protein 1 subunit gamma	GO:0005515; F:protein binding; IPI:IntAct
P49368	CCT3	T-complex protein 1 subunit gamma	GO:0051082; F:unfolded protein binding; TAS:ProtInc
P49368	CCT3	T-complex protein 1 subunit gamma	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
P49368	CCT3	T-complex protein 1 subunit gamma	GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl
P49368	CCT3	T-complex protein 1 subunit gamma	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P49368	CCT3	T-complex protein 1 subunit gamma	GO:0006457; P:protein folding; TAS:Reactome
Q99832	CCT7	T-complex protein 1 subunit eta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q99832	CCT7	T-complex protein 1 subunit eta	GO:0051082; F:unfolded protein binding; TAS:ProtInc
Q99832	CCT7	T-complex protein 1 subunit eta	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
Q99832	CCT7	T-complex protein 1 subunit eta	GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl
Q99832	CCT7	T-complex protein 1 subunit eta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q99832	CCT7	T-complex protein 1 subunit eta	GO:0006457; P:protein folding; TAS:Reactome
A6NM43	CCT8L1P	Putative T-complex protein 1 subunit theta-like 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
A6NM43	CCT8L1P	Putative T-complex protein 1 subunit theta-like 1	GO:0044267; P:cellular protein metabolic process; IEA:InterPro
Q96SF2	CCT8L2	Putative T-complex protein 1 subunit theta-like 2	GO:0005253; F:anion channel activity; TAS:ProtInc
Q96SF2	CCT8L2	Putative T-complex protein 1 subunit theta-like 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96SF2	CCT8L2	Putative T-complex protein 1 subunit theta-like 2	GO:0015269; F:calcium-activated potassium channel activity; TAS:ProtInc
Q96SF2	CCT8L2	Putative T-complex protein 1 subunit theta-like 2	GO:0006820; P:anion transport; TAS:GOC
Q96SF2	CCT8L2	Putative T-complex protein 1 subunit theta-like 2	GO:0044267; P:cellular protein metabolic process; IEA:InterPro
Q96SF2	CCT8L2	Putative T-complex protein 1 subunit theta-like 2	GO:0071805; P:potassium ion transmembrane transport; TAS:GOC
Q96SF2	CCT8L2	Putative T-complex protein 1 subunit theta-like 2	GO:0006810; P:transport; TAS:ProtInc
P50990	CCT8	T-complex protein 1 subunit theta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P50990	CCT8	T-complex protein 1 subunit theta	GO:0042623; F:ATPase activity, coupled; TAS:ProtInc
P50990	CCT8	T-complex protein 1 subunit theta	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
P50990	CCT8	T-complex protein 1 subunit theta	GO:0006200; P:ATP catabolic process; TAS:GOC
P50990	CCT8	T-complex protein 1 subunit theta	GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl
P50990	CCT8	T-complex protein 1 subunit theta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P50990	CCT8	T-complex protein 1 subunit theta	GO:0006457; P:protein folding; IEA:InterPro
Q7Z6L1	TECPR1	Tectonin beta-propeller repeat-containing protein 1	GO:0032266; F:phosphatidylinositol-3-phosphate binding; IDA:UniProtKB
Q7Z6L1	TECPR1	Tectonin beta-propeller repeat-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z6L1	TECPR1	Tectonin beta-propeller repeat-containing protein 1	GO:0000046; P:autophagic vacuole fusion; IMP:UniProtKB
Q7Z6L1	TECPR1	Tectonin beta-propeller repeat-containing protein 1	GO:0006914; P:autophagy; IDA:UniProtKB
O15040	TECPR2	Tectonin beta-propeller repeat-containing protein 2	GO:0005515; F:protein binding; IPI:IntAct
O15040	TECPR2	Tectonin beta-propeller repeat-containing protein 2	GO:0006914; P:autophagy; IEA:UniProtKB-KW
O15040	TECPR2	Tectonin beta-propeller repeat-containing protein 2	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q92526	CCT6B	T-complex protein 1 subunit zeta-2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q92526	CCT6B	T-complex protein 1 subunit zeta-2	GO:0008565; F:protein transporter activity; TAS:ProtInc
Q92526	CCT6B	T-complex protein 1 subunit zeta-2	GO:0051082; F:unfolded protein binding; TAS:ProtInc
Q92526	CCT6B	T-complex protein 1 subunit zeta-2	GO:0051131; P:chaperone-mediated protein complex assembly; TAS:ProtInc
Q92526	CCT6B	T-complex protein 1 subunit zeta-2	GO:0006457; P:protein folding; TAS:ProtInc
Q92526	CCT6B	T-complex protein 1 subunit zeta-2	GO:0015031; P:protein transport; TAS:GOC
Q92526	CCT6B	T-complex protein 1 subunit zeta-2	GO:0007283; P:spermatogenesis; TAS:ProtInc
P40227	CCT6A	T-complex protein 1 subunit zeta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P40227	CCT6A	T-complex protein 1 subunit zeta	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P40227	CCT6A	T-complex protein 1 subunit zeta	GO:0051082; F:unfolded protein binding; TAS:ProtInc
P40227	CCT6A	T-complex protein 1 subunit zeta	GO:0051084; P:'de novo' posttranslational protein folding; TAS:Reactome
P40227	CCT6A	T-complex protein 1 subunit zeta	GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl
P40227	CCT6A	T-complex protein 1 subunit zeta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P40227	CCT6A	T-complex protein 1 subunit zeta	GO:0006457; P:protein folding; TAS:Reactome
O14776	TCERG1	Transcription elongation regulator 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O14776	TCERG1	Transcription elongation regulator 1	GO:0005515; F:protein binding; IPI:IntAct
O14776	TCERG1	Transcription elongation regulator 1	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:BHF-UCL
O14776	TCERG1	Transcription elongation regulator 1	GO:0001106; F:RNA polymerase II transcription corepressor activity; IDA:BHF-UCL
O14776	TCERG1	Transcription elongation regulator 1	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
O14776	TCERG1	Transcription elongation regulator 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
O14776	TCERG1	Transcription elongation regulator 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9HAU6	TPT1P8	Putative translationally-controlled tumor protein-like protein TPT1P8	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P13693	TPT1	Translationally-controlled tumor protein	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P13693	TPT1	Translationally-controlled tumor protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P13693	TPT1	Translationally-controlled tumor protein	GO:0005515; F:protein binding; IPI:IntAct
P13693	TPT1	Translationally-controlled tumor protein	GO:0006816; P:calcium ion transport; IC:UniProtKB
P13693	TPT1	Translationally-controlled tumor protein	GO:0006874; P:cellular calcium ion homeostasis; IC:UniProtKB
P13693	TPT1	Translationally-controlled tumor protein	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
P13693	TPT1	Translationally-controlled tumor protein	GO:2000384; P:negative regulation of ectoderm development; IEA:Ensembl
P13693	TPT1	Translationally-controlled tumor protein	GO:1902230; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; IMP:MGI
P13693	TPT1	Translationally-controlled tumor protein	GO:0042981; P:regulation of apoptotic process; NAS:UniProtKB
P13693	TPT1	Translationally-controlled tumor protein	GO:0009615; P:response to virus; IEP:UniProtKB
P13693	TPT1	Translationally-controlled tumor protein	GO:0019827; P:stem cell maintenance; IEA:Ensembl
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0008083; F:growth factor activity; IDA:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0005515; F:protein binding; IPI:HGNC
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0005102; F:receptor binding; IDA:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0000187; P:activation of MAPK activity; IDA:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0008595; P:anterior/posterior axis specification, embryo; ISS:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0030509; P:BMP signaling pathway; IEA:Ensembl
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0055007; P:cardiac muscle cell differentiation; IEA:Ensembl
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0030154; P:cell differentiation; TAS:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0002042; P:cell migration involved in sprouting angiogenesis; IMP:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0071364; P:cellular response to epidermal growth factor stimulus; IDA:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0044344; P:cellular response to fibroblast growth factor stimulus; IDA:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0035729; P:cellular response to hepatocyte growth factor stimulus; IDA:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0071346; P:cellular response to interferon-gamma; IDA:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0071354; P:cellular response to interleukin-6; IDA:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0071356; P:cellular response to tumor necrosis factor; IDA:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0009790; P:embryo development; TAS:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0007369; P:gastrulation; IEA:Ensembl
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0007507; P:heart development; IDA:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0030879; P:mammary gland development; TAS:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0001763; P:morphogenesis of a branching structure; TAS:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0008284; P:positive regulation of cell proliferation; TAS:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0001954; P:positive regulation of cell-matrix adhesion; IEA:Ensembl
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0010595; P:positive regulation of endothelial cell migration; IDA:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0009966; P:regulation of signal transduction; IDA:UniProtKB
P13385	TDGF1	Teratocarcinoma-derived growth factor 1	GO:0001570; P:vasculogenesis; IEA:Ensembl
P51864	TDGF1P3	Putative teratocarcinoma-derived growth factor 3	GO:0008083; F:growth factor activity; NAS:UniProtKB
P51864	TDGF1P3	Putative teratocarcinoma-derived growth factor 3	GO:0007165; P:signal transduction; IDA:UniProtKB
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0003684; F:damaged DNA binding; TAS:ProtInc
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0019104; F:DNA N-glycosylase activity; IDA:UniProtKB
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0030983; F:mismatched DNA binding; IDA:UniProtKB
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0005515; F:protein binding; IPI:IntAct
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0008263; F:pyrimidine-specific mismatch base pair DNA N-glycosylase activity; IDA:UniProtKB
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0001104; F:RNA polymerase II transcription cofactor activity; IEA:Ensembl
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0043566; F:structure-specific DNA binding; ISS:UniProtKB
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0006284; P:base-excision repair; IDA:UniProtKB
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0006285; P:base-excision repair, AP site formation; TAS:Reactome
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0045008; P:depyrimidination; TAS:Reactome
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0080111; P:DNA demethylation; ISS:UniProtKB
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0006281; P:DNA repair; TAS:Reactome
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0009790; P:embryo development; ISS:UniProtKB
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0006298; P:mismatch repair; IDA:UniProtKB
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0035562; P:negative regulation of chromatin binding; IEA:Ensembl
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0032091; P:negative regulation of protein binding; IEA:Ensembl
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q13569	TDG	G/T mismatch-specific thymine DNA glycosylase	GO:0040029; P:regulation of gene expression, epigenetic; ISS:UniProtKB
Q8IZJ6	TDH	Inactive L-threonine 3-dehydrogenase, mitochondrial	GO:0003824; F:catalytic activity; IEA:InterPro
Q8IZJ6	TDH	Inactive L-threonine 3-dehydrogenase, mitochondrial	GO:0050662; F:coenzyme binding; IEA:InterPro
Q8IZJ6	TDH	Inactive L-threonine 3-dehydrogenase, mitochondrial	GO:0044237; P:cellular metabolic process; IEA:InterPro
Q5QJE6	DNTTIP2	Deoxynucleotidyltransferase terminal-interacting protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q5QJE6	DNTTIP2	Deoxynucleotidyltransferase terminal-interacting protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5QJE6	DNTTIP2	Deoxynucleotidyltransferase terminal-interacting protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5VZ19	TDRD10	Tudor domain-containing protein 10	GO:0000166; F:nucleotide binding; IEA:InterPro
Q5VZ19	TDRD10	Tudor domain-containing protein 10	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
B5MCY1	TDRD15	Tudor domain-containing protein 15	GO:0016788; F:hydrolase activity, acting on ester bonds; IEA:InterPro
B5MCY1	TDRD15	Tudor domain-containing protein 15	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9BXT4	TDRD1	Tudor domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BXT4	TDRD1	Tudor domain-containing protein 1	GO:0043046; P:DNA methylation involved in gamete generation; ISS:UniProtKB
Q9BXT4	TDRD1	Tudor domain-containing protein 1	GO:0031047; P:gene silencing by RNA; ISS:UniProtKB
Q9BXT4	TDRD1	Tudor domain-containing protein 1	GO:0007281; P:germ cell development; ISS:UniProtKB
Q9BXT4	TDRD1	Tudor domain-containing protein 1	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q9BXT4	TDRD1	Tudor domain-containing protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9BXT4	TDRD1	Tudor domain-containing protein 1	GO:0034587; P:piRNA metabolic process; ISS:UniProtKB
Q9BXT4	TDRD1	Tudor domain-containing protein 1	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q587J7	TDRD12	Putative ATP-dependent RNA helicase TDRD12	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q587J7	TDRD12	Putative ATP-dependent RNA helicase TDRD12	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q587J7	TDRD12	Putative ATP-dependent RNA helicase TDRD12	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q587J7	TDRD12	Putative ATP-dependent RNA helicase TDRD12	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q587J7	TDRD12	Putative ATP-dependent RNA helicase TDRD12	GO:0043046; P:DNA methylation involved in gamete generation; ISS:UniProtKB
Q587J7	TDRD12	Putative ATP-dependent RNA helicase TDRD12	GO:0009566; P:fertilization; ISS:UniProtKB
Q587J7	TDRD12	Putative ATP-dependent RNA helicase TDRD12	GO:0031047; P:gene silencing by RNA; ISS:UniProtKB
Q587J7	TDRD12	Putative ATP-dependent RNA helicase TDRD12	GO:0007140; P:male meiosis; ISS:UniProtKB
Q587J7	TDRD12	Putative ATP-dependent RNA helicase TDRD12	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q587J7	TDRD12	Putative ATP-dependent RNA helicase TDRD12	GO:0034587; P:piRNA metabolic process; ISS:UniProtKB
Q587J7	TDRD12	Putative ATP-dependent RNA helicase TDRD12	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q9H7E2	TDRD3	Tudor domain-containing protein 3	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q9H7E2	TDRD3	Tudor domain-containing protein 3	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q9H7E2	TDRD3	Tudor domain-containing protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H7E2	TDRD3	Tudor domain-containing protein 3	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q9H7E2	TDRD3	Tudor domain-containing protein 3	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q9H7E2	TDRD3	Tudor domain-containing protein 3	GO:2001141; P:regulation of RNA biosynthetic process; IDA:GOC
Q8NAT2	TDRD5	Tudor domain-containing protein 5	GO:0043046; P:DNA methylation involved in gamete generation; ISS:UniProtKB
Q8NAT2	TDRD5	Tudor domain-containing protein 5	GO:0030719; P:P granule organization; ISS:UniProtKB
Q8NAT2	TDRD5	Tudor domain-containing protein 5	GO:0007286; P:spermatid development; ISS:UniProtKB
O60522	TDRD6	Tudor domain-containing protein 6	GO:0007281; P:germ cell development; IEA:Ensembl
O60522	TDRD6	Tudor domain-containing protein 6	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
O60522	TDRD6	Tudor domain-containing protein 6	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q8NHU6	TDRD7	Tudor domain-containing protein 7	GO:0003729; F:mRNA binding; IDA:UniProtKB
Q8NHU6	TDRD7	Tudor domain-containing protein 7	GO:0005515; F:protein binding; IPI:IntAct
Q8NHU6	TDRD7	Tudor domain-containing protein 7	GO:0007281; P:germ cell development; IEA:Ensembl
Q8NHU6	TDRD7	Tudor domain-containing protein 7	GO:0070306; P:lens fiber cell differentiation; IMP:UniProtKB
Q8NHU6	TDRD7	Tudor domain-containing protein 7	GO:0002089; P:lens morphogenesis in camera-type eye; IMP:UniProtKB
Q8NHU6	TDRD7	Tudor domain-containing protein 7	GO:0010608; P:posttranscriptional regulation of gene expression; IMP:UniProtKB
Q8NHU6	TDRD7	Tudor domain-containing protein 7	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q8NDG6	TDRD9	Putative ATP-dependent RNA helicase TDRD9	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NDG6	TDRD9	Putative ATP-dependent RNA helicase TDRD9	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q8NDG6	TDRD9	Putative ATP-dependent RNA helicase TDRD9	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8NDG6	TDRD9	Putative ATP-dependent RNA helicase TDRD9	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8NDG6	TDRD9	Putative ATP-dependent RNA helicase TDRD9	GO:0043046; P:DNA methylation involved in gamete generation; ISS:UniProtKB
Q8NDG6	TDRD9	Putative ATP-dependent RNA helicase TDRD9	GO:0009566; P:fertilization; ISS:UniProtKB
Q8NDG6	TDRD9	Putative ATP-dependent RNA helicase TDRD9	GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW
Q8NDG6	TDRD9	Putative ATP-dependent RNA helicase TDRD9	GO:0007140; P:male meiosis; ISS:UniProtKB
Q8NDG6	TDRD9	Putative ATP-dependent RNA helicase TDRD9	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8NDG6	TDRD9	Putative ATP-dependent RNA helicase TDRD9	GO:0034587; P:piRNA metabolic process; ISS:UniProtKB
Q8NDG6	TDRD9	Putative ATP-dependent RNA helicase TDRD9	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q3Y452	TDRG1	Testis development-related protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9Y2W6	TDRKH	Tudor and KH domain-containing protein	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9Y2W6	TDRKH	Tudor and KH domain-containing protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9Y2W6	TDRKH	Tudor and KH domain-containing protein	GO:0043046; P:DNA methylation involved in gamete generation; ISS:UniProtKB
Q9Y2W6	TDRKH	Tudor and KH domain-containing protein	GO:0009566; P:fertilization; ISS:UniProtKB
Q9Y2W6	TDRKH	Tudor and KH domain-containing protein	GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW
Q9Y2W6	TDRKH	Tudor and KH domain-containing protein	GO:0007140; P:male meiosis; ISS:UniProtKB
Q9Y2W6	TDRKH	Tudor and KH domain-containing protein	GO:0034587; P:piRNA metabolic process; ISS:UniProtKB
Q9Y2W6	TDRKH	Tudor and KH domain-containing protein	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q86YL5	TDRP	Testis development-related protein	GO:0007283; P:spermatogenesis; IDA:MGI
P04053	DNTT	DNA nucleotidylexotransferase	GO:0003677; F:DNA binding; IEA:InterPro
P04053	DNTT	DNA nucleotidylexotransferase	GO:0003912; F:DNA nucleotidylexotransferase activity; TAS:ProtInc
P04053	DNTT	DNA nucleotidylexotransferase	GO:0003887; F:DNA-directed DNA polymerase activity; IEA:InterPro
P04053	DNTT	DNA nucleotidylexotransferase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P04053	DNTT	DNA nucleotidylexotransferase	GO:0006304; P:DNA modification; IEA:UniProtKB-KW
Q9NYB0	TERF2IP	Telomeric repeat-binding factor 2-interacting protein 1	GO:0003677; F:DNA binding; IEA:InterPro
Q9NYB0	TERF2IP	Telomeric repeat-binding factor 2-interacting protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NYB0	TERF2IP	Telomeric repeat-binding factor 2-interacting protein 1	GO:0048239; P:negative regulation of DNA recombination at telomere; ISS:UniProtKB
Q9NYB0	TERF2IP	Telomeric repeat-binding factor 2-interacting protein 1	GO:0032205; P:negative regulation of telomere maintenance; IDA:UniProtKB
Q9NYB0	TERF2IP	Telomeric repeat-binding factor 2-interacting protein 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; ISS:UniProtKB
Q9NYB0	TERF2IP	Telomeric repeat-binding factor 2-interacting protein 1	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB
Q9NYB0	TERF2IP	Telomeric repeat-binding factor 2-interacting protein 1	GO:0031848; P:protection from non-homologous end joining at telomere; IMP:BHF-UCL
Q9NYB0	TERF2IP	Telomeric repeat-binding factor 2-interacting protein 1	GO:0070198; P:protein localization to chromosome, telomeric region; IMP:BHF-UCL
Q9NYB0	TERF2IP	Telomeric repeat-binding factor 2-interacting protein 1	GO:0010569; P:regulation of double-strand break repair via homologous recombination; ISS:UniProtKB
Q9NYB0	TERF2IP	Telomeric repeat-binding factor 2-interacting protein 1	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
Q9NYB0	TERF2IP	Telomeric repeat-binding factor 2-interacting protein 1	GO:0000723; P:telomere maintenance; IDA:BHF-UCL
Q9NYB0	TERF2IP	Telomeric repeat-binding factor 2-interacting protein 1	GO:0007004; P:telomere maintenance via telomerase; TAS:ProtInc
Q9NYB0	TERF2IP	Telomeric repeat-binding factor 2-interacting protein 1	GO:0010833; P:telomere maintenance via telomere lengthening; ISS:UniProtKB
Q9NYB0	TERF2IP	Telomeric repeat-binding factor 2-interacting protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P28347	TEAD1	Transcriptional enhancer factor TEF-1	GO:0003677; F:DNA binding; TAS:ProtInc
P28347	TEAD1	Transcriptional enhancer factor TEF-1	GO:0005515; F:protein binding; IPI:UniProtKB
P28347	TEAD1	Transcriptional enhancer factor TEF-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P28347	TEAD1	Transcriptional enhancer factor TEF-1	GO:0010467; P:gene expression; TAS:Reactome
P28347	TEAD1	Transcriptional enhancer factor TEF-1	GO:0035329; P:hippo signaling; IDA:UniProtKB
P28347	TEAD1	Transcriptional enhancer factor TEF-1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q15562	TEAD2	Transcriptional enhancer factor TEF-4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q15562	TEAD2	Transcriptional enhancer factor TEF-4	GO:0005515; F:protein binding; IPI:UniProtKB
Q15562	TEAD2	Transcriptional enhancer factor TEF-4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q15562	TEAD2	Transcriptional enhancer factor TEF-4	GO:0010467; P:gene expression; TAS:Reactome
Q15562	TEAD2	Transcriptional enhancer factor TEF-4	GO:0035329; P:hippo signaling; IDA:UniProtKB
Q15562	TEAD2	Transcriptional enhancer factor TEF-4	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q15562	TEAD2	Transcriptional enhancer factor TEF-4	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q15561	TEAD4	Transcriptional enhancer factor TEF-3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q15561	TEAD4	Transcriptional enhancer factor TEF-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q15561	TEAD4	Transcriptional enhancer factor TEF-3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q15561	TEAD4	Transcriptional enhancer factor TEF-3	GO:0010467; P:gene expression; TAS:Reactome
Q15561	TEAD4	Transcriptional enhancer factor TEF-3	GO:0035329; P:hippo signaling; IDA:UniProtKB
Q15561	TEAD4	Transcriptional enhancer factor TEF-3	GO:0007517; P:muscle organ development; TAS:ProtInc
Q15561	TEAD4	Transcriptional enhancer factor TEF-3	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q15561	TEAD4	Transcriptional enhancer factor TEF-3	GO:0001501; P:skeletal system development; TAS:ProtInc
Q15561	TEAD4	Transcriptional enhancer factor TEF-3	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q99594	TEAD3	Transcriptional enhancer factor TEF-5	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q99594	TEAD3	Transcriptional enhancer factor TEF-5	GO:0005515; F:protein binding; IPI:UniProtKB
Q99594	TEAD3	Transcriptional enhancer factor TEF-5	GO:0001085; F:RNA polymerase II transcription factor binding; IPI:WormBase
Q99594	TEAD3	Transcriptional enhancer factor TEF-5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q99594	TEAD3	Transcriptional enhancer factor TEF-5	GO:0007565; P:female pregnancy; TAS:ProtInc
Q99594	TEAD3	Transcriptional enhancer factor TEF-5	GO:0010467; P:gene expression; TAS:Reactome
Q99594	TEAD3	Transcriptional enhancer factor TEF-5	GO:0035329; P:hippo signaling; IDA:UniProtKB
Q99594	TEAD3	Transcriptional enhancer factor TEF-5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q99594	TEAD3	Transcriptional enhancer factor TEF-5	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q99594	TEAD3	Transcriptional enhancer factor TEF-5	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q96MN5	TCEANC2	Transcription elongation factor A N-terminal and central domain-containing protein 2	GO:0003677; F:DNA binding; IEA:InterPro
Q96MN5	TCEANC2	Transcription elongation factor A N-terminal and central domain-containing protein 2	GO:0006351; P:transcription, DNA-templated; IEA:InterPro
Q8N8B7	TCEANC	Transcription elongation factor A N-terminal and central domain-containing protein	GO:0003677; F:DNA binding; IEA:InterPro
Q8N8B7	TCEANC	Transcription elongation factor A N-terminal and central domain-containing protein	GO:0032784; P:regulation of DNA-templated transcription, elongation; IEA:InterPro
Q8N8B7	TCEANC	Transcription elongation factor A N-terminal and central domain-containing protein	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:InterPro
Q8N8B7	TCEANC	Transcription elongation factor A N-terminal and central domain-containing protein	GO:0006351; P:transcription, DNA-templated; IEA:InterPro
Q2MV58	TCTN1	Tectonic-1	GO:0021956; P:central nervous system interneuron axonogenesis; IEA:Ensembl
Q2MV58	TCTN1	Tectonic-1	GO:0060271; P:cilium morphogenesis; ISS:UniProtKB
Q2MV58	TCTN1	Tectonic-1	GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl
Q2MV58	TCTN1	Tectonic-1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q2MV58	TCTN1	Tectonic-1	GO:0001841; P:neural tube formation; IEA:Ensembl
Q2MV58	TCTN1	Tectonic-1	GO:0008589; P:regulation of smoothened signaling pathway; IEA:Ensembl
Q2MV58	TCTN1	Tectonic-1	GO:0021523; P:somatic motor neuron differentiation; IEA:Ensembl
Q2MV58	TCTN1	Tectonic-1	GO:0021537; P:telencephalon development; IEA:Ensembl
Q15185	PTGES3	Prostaglandin E synthase 3	GO:0050220; F:prostaglandin-E synthase activity; IDA:UniProtKB
Q15185	PTGES3	Prostaglandin E synthase 3	GO:0005515; F:protein binding; IPI:IntAct
Q15185	PTGES3	Prostaglandin E synthase 3	GO:0003720; F:telomerase activity; IDA:UniProtKB
Q15185	PTGES3	Prostaglandin E synthase 3	GO:0051082; F:unfolded protein binding; IDA:UniProtKB
Q15185	PTGES3	Prostaglandin E synthase 3	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
Q15185	PTGES3	Prostaglandin E synthase 3	GO:0070389; P:chaperone cofactor-dependent protein refolding; IDA:UniProtKB
Q15185	PTGES3	Prostaglandin E synthase 3	GO:0019371; P:cyclooxygenase pathway; TAS:Reactome
Q15185	PTGES3	Prostaglandin E synthase 3	GO:0001516; P:prostaglandin biosynthetic process; IDA:UniProtKB
Q15185	PTGES3	Prostaglandin E synthase 3	GO:0006278; P:RNA-dependent DNA replication; IDA:GOC
Q15185	PTGES3	Prostaglandin E synthase 3	GO:0007165; P:signal transduction; TAS:ProtInc
Q15185	PTGES3	Prostaglandin E synthase 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q15185	PTGES3	Prostaglandin E synthase 3	GO:0000723; P:telomere maintenance; TAS:UniProtKB
Q9NZ01	TECR	Very-long-chain enoyl-CoA reductase	GO:0016627; F:oxidoreductase activity, acting on the CH-CH group of donors; IEA:InterPro
Q9NZ01	TECR	Very-long-chain enoyl-CoA reductase	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q9NZ01	TECR	Very-long-chain enoyl-CoA reductase	GO:0030497; P:fatty acid elongation; IDA:UniProtKB
Q9NZ01	TECR	Very-long-chain enoyl-CoA reductase	GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome
Q9NZ01	TECR	Very-long-chain enoyl-CoA reductase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NZ01	TECR	Very-long-chain enoyl-CoA reductase	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
Q9NZ01	TECR	Very-long-chain enoyl-CoA reductase	GO:0042761; P:very long-chain fatty acid biosynthetic process; IDA:UniProtKB
Q6NUS6	TCTN3	Tectonic-3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q6NUS6	TCTN3	Tectonic-3	GO:0060271; P:cilium morphogenesis; ISS:UniProtKB
Q6NUS6	TCTN3	Tectonic-3	GO:0007224; P:smoothened signaling pathway; IMP:UniProtKB
Q96GX1	TCTN2	Tectonic-2	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q96GX1	TCTN2	Tectonic-2	GO:0060271; P:cilium morphogenesis; ISS:UniProtKB
Q96GX1	TCTN2	Tectonic-2	GO:0007224; P:smoothened signaling pathway; ISS:UniProtKB
Q5HYJ1	TECRL	Trans-2,3-enoyl-CoA reductase-like	GO:0016627; F:oxidoreductase activity, acting on the CH-CH group of donors; IEA:InterPro
Q5HYJ1	TECRL	Trans-2,3-enoyl-CoA reductase-like	GO:0006629; P:lipid metabolic process; IEA:InterPro
O75443	TECTA	Alpha-tectorin	GO:0007160; P:cell-matrix adhesion; IEA:InterPro
O75443	TECTA	Alpha-tectorin	GO:0007605; P:sensory perception of sound; TAS:ProtInc
P42680	TEC	Tyrosine-protein kinase Tec	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P42680	TEC	Tyrosine-protein kinase Tec	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
P42680	TEC	Tyrosine-protein kinase Tec	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P42680	TEC	Tyrosine-protein kinase Tec	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB
P42680	TEC	Tyrosine-protein kinase Tec	GO:0050853; P:B cell receptor signaling pathway; IDA:UniProtKB
P42680	TEC	Tyrosine-protein kinase Tec	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P42680	TEC	Tyrosine-protein kinase Tec	GO:0045087; P:innate immune response; TAS:Reactome
P42680	TEC	Tyrosine-protein kinase Tec	GO:0007229; P:integrin-mediated signaling pathway; IDA:UniProtKB
P42680	TEC	Tyrosine-protein kinase Tec	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
P42680	TEC	Tyrosine-protein kinase Tec	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:GOC
P42680	TEC	Tyrosine-protein kinase Tec	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P42680	TEC	Tyrosine-protein kinase Tec	GO:0010543; P:regulation of platelet activation; IDA:UniProtKB
P42680	TEC	Tyrosine-protein kinase Tec	GO:0042246; P:tissue regeneration; IEA:Ensembl
Q8IYR6	TMEFF1	Tomoregulin-1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q96QE5	TEFM	Transcription elongation factor, mitochondrial	GO:0030337; F:DNA polymerase processivity factor activity; IDA:UniProtKB
Q96QE5	TEFM	Transcription elongation factor, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96QE5	TEFM	Transcription elongation factor, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q96QE5	TEFM	Transcription elongation factor, mitochondrial	GO:0006259; P:DNA metabolic process; IDA:GOC
Q96QE5	TEFM	Transcription elongation factor, mitochondrial	GO:0006119; P:oxidative phosphorylation; IMP:UniProtKB
Q96QE5	TEFM	Transcription elongation factor, mitochondrial	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96QE5	TEFM	Transcription elongation factor, mitochondrial	GO:0006390; P:transcription from mitochondrial promoter; IMP:UniProtKB
Q10587	TEF	Thyrotroph embryonic factor	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
Q10587	TEF	Thyrotroph embryonic factor	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q10587	TEF	Thyrotroph embryonic factor	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q10587	TEF	Thyrotroph embryonic factor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q10587	TEF	Thyrotroph embryonic factor	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q10587	TEF	Thyrotroph embryonic factor	GO:0048511; P:rhythmic process; IEA:UniProtKB-KW
Q10587	TEF	Thyrotroph embryonic factor	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q969V4	TEKT1	Tektin-1	GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro
Q9UIF3	TEKT2	Tektin-2	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
Q9UIF3	TEKT2	Tektin-2	GO:0001539; P:cilium or flagellum-dependent cell motility; IEA:Ensembl
Q9UIF3	TEKT2	Tektin-2	GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro
Q9UIF3	TEKT2	Tektin-2	GO:0030317; P:sperm motility; IEA:Ensembl
Q8WW24	TEKT4	Tektin-4	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
Q8WW24	TEKT4	Tektin-4	GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro
Q9BXF9	TEKT3	Tektin-3	GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro
Q96M29	TEKT5	Tektin-5	GO:0000226; P:microtubule cytoskeleton organization; IEA:InterPro
Q9Y4R8	TELO2	Telomere length regulation protein TEL2 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y4R8	TELO2	Telomere length regulation protein TEL2 homolog	GO:0032403; F:protein complex binding; IDA:MGI
Q9Y4R8	TELO2	Telomere length regulation protein TEL2 homolog	GO:0032006; P:regulation of TOR signaling; IMP:UniProtKB
O15273	TCAP	Telethonin	GO:0051373; F:FATZ binding; IPI:BHF-UCL
O15273	TCAP	Telethonin	GO:0044325; F:ion channel binding; IPI:BHF-UCL
O15273	TCAP	Telethonin	GO:0005515; F:protein binding; IPI:UniProtKB
O15273	TCAP	Telethonin	GO:0030674; F:protein binding, bridging; IDA:BHF-UCL
O15273	TCAP	Telethonin	GO:0008307; F:structural constituent of muscle; IMP:BHF-UCL
O15273	TCAP	Telethonin	GO:0031432; F:titin binding; IPI:BHF-UCL
O15273	TCAP	Telethonin	GO:0070080; F:titin Z domain binding; IPI:BHF-UCL
O15273	TCAP	Telethonin	GO:0007512; P:adult heart development; IMP:BHF-UCL
O15273	TCAP	Telethonin	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
O15273	TCAP	Telethonin	GO:0048739; P:cardiac muscle fiber development; IMP:BHF-UCL
O15273	TCAP	Telethonin	GO:0003300; P:cardiac muscle hypertrophy; IMP:BHF-UCL
O15273	TCAP	Telethonin	GO:0014898; P:cardiac muscle hypertrophy in response to stress; IMP:BHF-UCL
O15273	TCAP	Telethonin	GO:0055008; P:cardiac muscle tissue morphogenesis; IMP:BHF-UCL
O15273	TCAP	Telethonin	GO:0055003; P:cardiac myofibril assembly; IMP:BHF-UCL
O15273	TCAP	Telethonin	GO:0050982; P:detection of mechanical stimulus; TAS:BHF-UCL
O15273	TCAP	Telethonin	GO:0035995; P:detection of muscle stretch; IMP:BHF-UCL
O15273	TCAP	Telethonin	GO:0030049; P:muscle filament sliding; TAS:Reactome
O15273	TCAP	Telethonin	GO:0030916; P:otic vesicle formation; IEA:Ensembl
O15273	TCAP	Telethonin	GO:0006461; P:protein complex assembly; TAS:ProtInc
O15273	TCAP	Telethonin	GO:0035994; P:response to muscle stretch; TAS:BHF-UCL
O15273	TCAP	Telethonin	GO:0045214; P:sarcomere organization; IMP:BHF-UCL
O15273	TCAP	Telethonin	GO:0048769; P:sarcomerogenesis; IMP:BHF-UCL
O15273	TCAP	Telethonin	GO:0003009; P:skeletal muscle contraction; IEP:BHF-UCL
O15273	TCAP	Telethonin	GO:0030241; P:skeletal muscle myosin thick filament assembly; IMP:BHF-UCL
O15273	TCAP	Telethonin	GO:0030240; P:skeletal muscle thin filament assembly; IMP:BHF-UCL
O15273	TCAP	Telethonin	GO:0001756; P:somitogenesis; IEA:Ensembl
Q86WV5	TEN1	CST complex subunit TEN1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86WV5	TEN1	CST complex subunit TEN1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKZ4	TENM1	Teneurin-1	GO:0008201; F:heparin binding; TAS:ProtInc
Q9UKZ4	TENM1	Teneurin-1	GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB
Q9UKZ4	TENM1	Teneurin-1	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q9UKZ4	TENM1	Teneurin-1	GO:0006955; P:immune response; TAS:ProtInc
Q9UKZ4	TENM1	Teneurin-1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q9UKZ4	TENM1	Teneurin-1	GO:0007399; P:nervous system development; TAS:ProtInc
Q9UKZ4	TENM1	Teneurin-1	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
Q9UKZ4	TENM1	Teneurin-1	GO:0030838; P:positive regulation of actin filament polymerization; ISS:UniProtKB
Q9UKZ4	TENM1	Teneurin-1	GO:0051491; P:positive regulation of filopodium assembly; ISS:UniProtKB
Q9UKZ4	TENM1	Teneurin-1	GO:0090316; P:positive regulation of intracellular protein transport; ISS:UniProtKB
Q9UKZ4	TENM1	Teneurin-1	GO:0043406; P:positive regulation of MAP kinase activity; ISS:UniProtKB
Q9UKZ4	TENM1	Teneurin-1	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISS:UniProtKB
Q9UKZ4	TENM1	Teneurin-1	GO:0006359; P:regulation of transcription from RNA polymerase III promoter; ISS:UniProtKB
Q9UKZ4	TENM1	Teneurin-1	GO:0006950; P:response to stress; IEA:UniProtKB-KW
Q9UKZ4	TENM1	Teneurin-1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NT68	TENM2	Teneurin-2	GO:0050839; F:cell adhesion molecule binding; IDA:UniProtKB
Q9NT68	TENM2	Teneurin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NT68	TENM2	Teneurin-2	GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB
Q9NT68	TENM2	Teneurin-2	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q9NT68	TENM2	Teneurin-2	GO:0005102; F:receptor binding; IDA:UniProtKB
Q9NT68	TENM2	Teneurin-2	GO:0007411; P:axon guidance; IDA:UniProtKB
Q9NT68	TENM2	Teneurin-2	GO:0035584; P:calcium-mediated signaling using intracellular calcium source; IDA:UniProtKB
Q9NT68	TENM2	Teneurin-2	GO:0016337; P:single organismal cell-cell adhesion; ISS:UniProtKB
Q9NT68	TENM2	Teneurin-2	GO:0007157; P:heterophilic cell-cell adhesion; IDA:UniProtKB
Q9NT68	TENM2	Teneurin-2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q9NT68	TENM2	Teneurin-2	GO:0051491; P:positive regulation of filopodium assembly; ISS:UniProtKB
Q9NT68	TENM2	Teneurin-2	GO:0007165; P:signal transduction; IEA:InterPro
Q9NT68	TENM2	Teneurin-2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9P273	TENM3	Teneurin-3	GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB
Q9P273	TENM3	Teneurin-3	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q9P273	TENM3	Teneurin-3	GO:0007156; P:homophilic cell adhesion; ISS:UniProtKB
Q9P273	TENM3	Teneurin-3	GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB
Q9P273	TENM3	Teneurin-3	GO:0007165; P:signal transduction; IEA:InterPro
Q6N022	TENM4	Teneurin-4	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
Q6N022	TENM4	Teneurin-4	GO:0060912; P:cardiac cell fate specification; IEA:Ensembl
Q6N022	TENM4	Teneurin-4	GO:0060038; P:cardiac muscle cell proliferation; IEA:Ensembl
Q6N022	TENM4	Teneurin-4	GO:0032289; P:central nervous system myelin formation; ISS:UniProtKB
Q6N022	TENM4	Teneurin-4	GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl
Q6N022	TENM4	Teneurin-4	GO:0048666; P:neuron development; IEA:InterPro
Q6N022	TENM4	Teneurin-4	GO:2000543; P:positive regulation of gastrulation; ISS:UniProtKB
Q6N022	TENM4	Teneurin-4	GO:0031643; P:positive regulation of myelination; ISS:UniProtKB
Q6N022	TENM4	Teneurin-4	GO:0048714; P:positive regulation of oligodendrocyte differentiation; ISS:UniProtKB
Q6N022	TENM4	Teneurin-4	GO:0007165; P:signal transduction; IEA:InterPro
P24821	TNC	Tenascin	GO:0045545; F:syndecan binding; IPI:MGI
P24821	TNC	Tenascin	GO:0060447; P:bud outgrowth involved in lung branching; IEA:Ensembl
P24821	TNC	Tenascin	GO:0007155; P:cell adhesion; TAS:ProtInc
P24821	TNC	Tenascin	GO:0071799; P:cellular response to prostaglandin D stimulus; IEA:Ensembl
P24821	TNC	Tenascin	GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl
P24821	TNC	Tenascin	GO:0071305; P:cellular response to vitamin D; IEA:Ensembl
P24821	TNC	Tenascin	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P24821	TNC	Tenascin	GO:0060739; P:mesenchymal-epithelial cell signaling involved in prostate gland development; IEA:Ensembl
P24821	TNC	Tenascin	GO:0007162; P:negative regulation of cell adhesion; IEA:Ensembl
P24821	TNC	Tenascin	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
P24821	TNC	Tenascin	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
P24821	TNC	Tenascin	GO:0014012; P:peripheral nervous system axon regeneration; IEA:Ensembl
P24821	TNC	Tenascin	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P24821	TNC	Tenascin	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P24821	TNC	Tenascin	GO:0060740; P:prostate gland epithelium morphogenesis; IEA:Ensembl
P24821	TNC	Tenascin	GO:0045471; P:response to ethanol; IEA:Ensembl
P24821	TNC	Tenascin	GO:0071774; P:response to fibroblast growth factor; IEA:Ensembl
P24821	TNC	Tenascin	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P24821	TNC	Tenascin	GO:0009611; P:response to wounding; IEP:BHF-UCL
P24821	TNC	Tenascin	GO:0042060; P:wound healing; IEA:Ensembl
Q63HR2	TENC1	Tensin-like C1 domain-containing phosphatase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q63HR2	TENC1	Tensin-like C1 domain-containing phosphatase	GO:0004721; F:phosphoprotein phosphatase activity; IEA:UniProtKB-KW
Q63HR2	TENC1	Tensin-like C1 domain-containing phosphatase	GO:0005515; F:protein binding; IPI:UniProtKB
Q63HR2	TENC1	Tensin-like C1 domain-containing phosphatase	GO:0019725; P:cellular homeostasis; IEA:Ensembl
Q63HR2	TENC1	Tensin-like C1 domain-containing phosphatase	GO:0032963; P:collagen metabolic process; IEA:Ensembl
Q63HR2	TENC1	Tensin-like C1 domain-containing phosphatase	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q63HR2	TENC1	Tensin-like C1 domain-containing phosphatase	GO:0001822; P:kidney development; IEA:Ensembl
Q63HR2	TENC1	Tensin-like C1 domain-containing phosphatase	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q63HR2	TENC1	Tensin-like C1 domain-containing phosphatase	GO:0048871; P:multicellular organismal homeostasis; IEA:Ensembl
Q63HR2	TENC1	Tensin-like C1 domain-containing phosphatase	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q63HR2	TENC1	Tensin-like C1 domain-containing phosphatase	GO:0014850; P:response to muscle activity; IEA:Ensembl
Q9UQP3	TNN	Tenascin-N	GO:0007409; P:axonogenesis; IEA:Ensembl
Q9UQP3	TNN	Tenascin-N	GO:0016049; P:cell growth; ISS:UniProtKB
Q9UQP3	TNN	Tenascin-N	GO:0016477; P:cell migration; ISS:UniProtKB
Q9UQP3	TNN	Tenascin-N	GO:0007160; P:cell-matrix adhesion; IEA:Ensembl
Q92752	TNR	Tenascin-R	GO:0008306; P:associative learning; IEA:Ensembl
Q92752	TNR	Tenascin-R	GO:0007411; P:axon guidance; NAS:ProtInc
Q92752	TNR	Tenascin-R	GO:0007155; P:cell adhesion; NAS:ProtInc
Q92752	TNR	Tenascin-R	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q92752	TNR	Tenascin-R	GO:0035641; P:locomotory exploration behavior; IEA:Ensembl
Q92752	TNR	Tenascin-R	GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl
Q92752	TNR	Tenascin-R	GO:0048692; P:negative regulation of axon extension involved in regeneration; IEA:Ensembl
Q92752	TNR	Tenascin-R	GO:0022408; P:negative regulation of cell-cell adhesion; IEA:Ensembl
Q92752	TNR	Tenascin-R	GO:0050805; P:negative regulation of synaptic transmission; IEA:Ensembl
Q92752	TNR	Tenascin-R	GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl
Q92752	TNR	Tenascin-R	GO:0007158; P:neuron cell-cell adhesion; IEA:Ensembl
Q92752	TNR	Tenascin-R	GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IEA:Ensembl
Q92752	TNR	Tenascin-R	GO:0051971; P:positive regulation of transmission of nerve impulse; IEA:Ensembl
Q92752	TNR	Tenascin-R	GO:0050808; P:synapse organization; IEA:Ensembl
Q92752	TNR	Tenascin-R	GO:0022029; P:telencephalon cell migration; IEA:Ensembl
Q9HBL0	TNS1	Tensin-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9HBL0	TNS1	Tensin-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HBL0	TNS1	Tensin-1	GO:0007044; P:cell-substrate junction assembly; IEA:Ensembl
Q9HBL0	TNS1	Tensin-1	GO:0010761; P:fibroblast migration; IEA:Ensembl
Q68CZ2	TNS3	Tensin-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q68CZ2	TNS3	Tensin-3	GO:0016477; P:cell migration; IEA:Ensembl
Q68CZ2	TNS3	Tensin-3	GO:0048286; P:lung alveolus development; IEA:Ensembl
Q68CZ2	TNS3	Tensin-3	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q8IZW8	TNS4	Tensin-4	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IZW8	TNS4	Tensin-4	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8IZW8	TNS4	Tensin-4	GO:0008104; P:protein localization; IDA:UniProtKB
P22105	TNXB	Tenascin-X	GO:0008201; F:heparin binding; ISS:UniProtKB
P22105	TNXB	Tenascin-X	GO:0005178; F:integrin binding; ISS:UniProtKB
P22105	TNXB	Tenascin-X	GO:0030036; P:actin cytoskeleton organization; ISS:UniProtKB
P22105	TNXB	Tenascin-X	GO:0007155; P:cell adhesion; ISS:UniProtKB
P22105	TNXB	Tenascin-X	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
P22105	TNXB	Tenascin-X	GO:0007160; P:cell-matrix adhesion; IEA:Ensembl
P22105	TNXB	Tenascin-X	GO:0030199; P:collagen fibril organization; IEA:Ensembl
P22105	TNXB	Tenascin-X	GO:0032963; P:collagen metabolic process; IMP:UniProtKB
P22105	TNXB	Tenascin-X	GO:0048251; P:elastic fiber assembly; IMP:UniProtKB
P22105	TNXB	Tenascin-X	GO:0043206; P:extracellular fibril organization; IEA:Ensembl
P22105	TNXB	Tenascin-X	GO:0006631; P:fatty acid metabolic process; IEA:Ensembl
P22105	TNXB	Tenascin-X	GO:0043506; P:regulation of JUN kinase activity; IEA:Ensembl
P22105	TNXB	Tenascin-X	GO:0006641; P:triglyceride metabolic process; IEA:Ensembl
Q99973	TEP1	Telomerase protein component 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q99973	TEP1	Telomerase protein component 1	GO:0003723; F:RNA binding; ISS:UniProtKB
Q99973	TEP1	Telomerase protein component 1	GO:0006278; P:RNA-dependent DNA replication; IDA:GOC
Q99973	TEP1	Telomerase protein component 1	GO:0000722; P:telomere maintenance via recombination; IDA:UniProtKB
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0043531; F:ADP binding; IEA:Ensembl
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0016887; F:ATPase activity; TAS:UniProtKB
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0008289; F:lipid binding; IEA:UniProtKB-KW
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0031593; F:polyubiquitin binding; IDA:BHF-UCL
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0005515; F:protein binding; IPI:UniProtKB
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0019903; F:protein phosphatase binding; IPI:BHF-UCL
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; ISS:UniProtKB
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0070842; P:aggresome assembly; IEA:Ensembl
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0006281; P:DNA repair; NAS:UniProtKB
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0006302; P:double-strand break repair; IDA:UniProtKB
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:UniProtKB
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0006888; P:ER to Golgi vesicle-mediated transport; IEA:Ensembl
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0045184; P:establishment of protein localization; TAS:UniProtKB
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:BHF-UCL
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0045732; P:positive regulation of protein catabolic process; IDA:BHF-UCL
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0031334; P:positive regulation of protein complex assembly; IDA:BHF-UCL
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; NAS:UniProtKB
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0051260; P:protein homooligomerization; IEA:Ensembl
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0018279; P:protein N-linked glycosylation via asparagine; IMP:UniProtKB
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0030970; P:retrograde protein transport, ER to cytosol; IDA:UniProtKB
P55072	VCP	Transitional endoplasmic reticulum ATPase	GO:0019985; P:translesion synthesis; IMP:UniProtKB
Q8NA31	CCDC79	Telomere repeats-binding bouquet formation protein 1	GO:0003682; F:chromatin binding; IEA:InterPro
Q8NA31	CCDC79	Telomere repeats-binding bouquet formation protein 1	GO:0003677; F:DNA binding; IEA:InterPro
Q8NA31	CCDC79	Telomere repeats-binding bouquet formation protein 1	GO:0045141; P:meiotic telomere clustering; ISS:UniProtKB
Q8NA31	CCDC79	Telomere repeats-binding bouquet formation protein 1	GO:0007129; P:synapsis; ISS:UniProtKB
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0003682; F:chromatin binding; IEA:InterPro
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0003677; F:DNA binding; NAS:UniProtKB
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0008301; F:DNA binding, bending; IDA:BHF-UCL
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0003691; F:double-stranded telomeric DNA binding; IDA:UniProtKB
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0008017; F:microtubule binding; IDA:UniProtKB
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0042162; F:telomeric DNA binding; IDA:UniProtKB
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0001309; P:age-dependent telomere shortening; IDA:UniProtKB
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0000086; P:G2/M transition of mitotic cell cycle; IEP:UniProtKB
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0007094; P:mitotic spindle assembly checkpoint; IMP:UniProtKB
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0008156; P:negative regulation of DNA replication; IDA:BHF-UCL
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0051974; P:negative regulation of telomerase activity; IGI:BHF-UCL
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0032214; P:negative regulation of telomere maintenance via semi-conservative replication; NAS:BHF-UCL
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0032211; P:negative regulation of telomere maintenance via telomerase; IGI:BHF-UCL
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0031116; P:positive regulation of microtubule polymerization; IDA:UniProtKB
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0045840; P:positive regulation of mitosis; IMP:UniProtKB
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0045931; P:positive regulation of mitotic cell cycle; IMP:UniProtKB
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0042493; P:response to drug; IEA:Ensembl
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0000723; P:telomere maintenance; TAS:Reactome
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0007004; P:telomere maintenance via telomerase; IMP:UniProtKB
P54274	TERF1	Telomeric repeat-binding factor 1	GO:0010834; P:telomere maintenance via telomere shortening; IMP:BHF-UCL
Q15554	TERF2	Telomeric repeat-binding factor 2	GO:0003682; F:chromatin binding; IEA:InterPro
Q15554	TERF2	Telomeric repeat-binding factor 2	GO:0003691; F:double-stranded telomeric DNA binding; ISS:BHF-UCL
Q15554	TERF2	Telomeric repeat-binding factor 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q15554	TERF2	Telomeric repeat-binding factor 2	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q15554	TERF2	Telomeric repeat-binding factor 2	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q15554	TERF2	Telomeric repeat-binding factor 2	GO:0042162; F:telomeric DNA binding; IDA:UniProtKB
Q15554	TERF2	Telomeric repeat-binding factor 2	GO:0001309; P:age-dependent telomere shortening; NAS:BHF-UCL
Q15554	TERF2	Telomeric repeat-binding factor 2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q15554	TERF2	Telomeric repeat-binding factor 2	GO:0090398; P:cellular senescence; NAS:BHF-UCL
Q15554	TERF2	Telomeric repeat-binding factor 2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q15554	TERF2	Telomeric repeat-binding factor 2	GO:0032205; P:negative regulation of telomere maintenance; IDA:UniProtKB
Q15554	TERF2	Telomeric repeat-binding factor 2	GO:0032214; P:negative regulation of telomere maintenance via semi-conservative replication; NAS:BHF-UCL
Q15554	TERF2	Telomeric repeat-binding factor 2	GO:0032206; P:positive regulation of telomere maintenance; IEA:Ensembl
Q15554	TERF2	Telomeric repeat-binding factor 2	GO:0031848; P:protection from non-homologous end joining at telomere; IMP:BHF-UCL
Q15554	TERF2	Telomeric repeat-binding factor 2	GO:0070198; P:protein localization to chromosome, telomeric region; IMP:BHF-UCL
Q15554	TERF2	Telomeric repeat-binding factor 2	GO:0016233; P:telomere capping; IMP:BHF-UCL
Q15554	TERF2	Telomeric repeat-binding factor 2	GO:0000723; P:telomere maintenance; IMP:UniProtKB
Q15554	TERF2	Telomeric repeat-binding factor 2	GO:0007004; P:telomere maintenance via telomerase; IC:BHF-UCL
Q15554	TERF2	Telomeric repeat-binding factor 2	GO:0010834; P:telomere maintenance via telomere shortening; IMP:BHF-UCL
Q15554	TERF2	Telomeric repeat-binding factor 2	GO:0031627; P:telomeric loop formation; IDA:BHF-UCL
O14746	TERT	Telomerase reverse transcriptase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14746	TERT	Telomerase reverse transcriptase	GO:0005515; F:protein binding; IPI:UniProtKB
O14746	TERT	Telomerase reverse transcriptase	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
O14746	TERT	Telomerase reverse transcriptase	GO:0003720; F:telomerase activity; IDA:UniProtKB
O14746	TERT	Telomerase reverse transcriptase	GO:0042162; F:telomeric DNA binding; TAS:ProtInc
O14746	TERT	Telomerase reverse transcriptase	GO:0070034; F:telomeric RNA binding; IDA:BHF-UCL
O14746	TERT	Telomerase reverse transcriptase	GO:0003721; F:telomeric template RNA reverse transcriptase activity; TAS:UniProtKB
O14746	TERT	Telomerase reverse transcriptase	GO:0022616; P:DNA strand elongation; IDA:BHF-UCL
O14746	TERT	Telomerase reverse transcriptase	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IMP:BHF-UCL
O14746	TERT	Telomerase reverse transcriptase	GO:0090399; P:replicative senescence; IMP:BHF-UCL
O14746	TERT	Telomerase reverse transcriptase	GO:0032203; P:telomere formation via telomerase; IDA:BHF-UCL
O14746	TERT	Telomerase reverse transcriptase	GO:0000723; P:telomere maintenance; TAS:UniProtKB
O14746	TERT	Telomerase reverse transcriptase	GO:0007004; P:telomere maintenance via telomerase; IMP:BHF-UCL
Q15569	TESK1	Dual specificity testis-specific protein kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q15569	TESK1	Dual specificity testis-specific protein kinase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15569	TESK1	Dual specificity testis-specific protein kinase 1	GO:0005515; F:protein binding; IPI:IntAct
Q15569	TESK1	Dual specificity testis-specific protein kinase 1	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
Q15569	TESK1	Dual specificity testis-specific protein kinase 1	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC
Q15569	TESK1	Dual specificity testis-specific protein kinase 1	GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW
Q15569	TESK1	Dual specificity testis-specific protein kinase 1	GO:0034329; P:cell junction assembly; TAS:Reactome
Q15569	TESK1	Dual specificity testis-specific protein kinase 1	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q96S53	TESK2	Dual specificity testis-specific protein kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96S53	TESK2	Dual specificity testis-specific protein kinase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96S53	TESK2	Dual specificity testis-specific protein kinase 2	GO:0005515; F:protein binding; IPI:IntAct
Q96S53	TESK2	Dual specificity testis-specific protein kinase 2	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q96S53	TESK2	Dual specificity testis-specific protein kinase 2	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB
Q96S53	TESK2	Dual specificity testis-specific protein kinase 2	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC
Q96S53	TESK2	Dual specificity testis-specific protein kinase 2	GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW
Q96S53	TESK2	Dual specificity testis-specific protein kinase 2	GO:0030036; P:actin cytoskeleton organization; ISS:UniProtKB
Q96S53	TESK2	Dual specificity testis-specific protein kinase 2	GO:0048041; P:focal adhesion assembly; ISS:UniProtKB
Q96S53	TESK2	Dual specificity testis-specific protein kinase 2	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
Q96S53	TESK2	Dual specificity testis-specific protein kinase 2	GO:0007283; P:spermatogenesis; ISS:UniProtKB
A2RU30	TESPA1	Protein TESPA1	GO:0010387; P:COP9 signalosome assembly; ISS:UniProtKB
A2RU30	TESPA1	Protein TESPA1	GO:0033089; P:positive regulation of T cell differentiation in thymus; ISS:UniProtKB
A2RU30	TESPA1	Protein TESPA1	GO:0050862; P:positive regulation of T cell receptor signaling pathway; ISS:UniProtKB
Q9Y6M0	PRSS21	Testisin	GO:0005515; F:protein binding; IPI:IntAct
Q9Y6M0	PRSS21	Testisin	GO:0004252; F:serine-type endopeptidase activity; IEA:Ensembl
Q9Y6M0	PRSS21	Testisin	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
Q9Y6M0	PRSS21	Testisin	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q9UGI8	TES	Testin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UGI8	TES	Testin	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q9UGI8	TES	Testin	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q8NFU7	TET1	Methylcytosine dioxygenase TET1	GO:0005506; F:iron ion binding; IDA:UniProtKB
Q8NFU7	TET1	Methylcytosine dioxygenase TET1	GO:0070579; F:methylcytosine dioxygenase activity; IDA:UniProtKB
Q8NFU7	TET1	Methylcytosine dioxygenase TET1	GO:0043566; F:structure-specific DNA binding; IDA:UniProtKB
Q8NFU7	TET1	Methylcytosine dioxygenase TET1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8NFU7	TET1	Methylcytosine dioxygenase TET1	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q8NFU7	TET1	Methylcytosine dioxygenase TET1	GO:0080111; P:DNA demethylation; IMP:UniProtKB
Q8NFU7	TET1	Methylcytosine dioxygenase TET1	GO:0001826; P:inner cell mass cell differentiation; ISS:UniProtKB
Q8NFU7	TET1	Methylcytosine dioxygenase TET1	GO:0090310; P:negative regulation of methylation-dependent chromatin silencing; IMP:UniProtKB
Q8NFU7	TET1	Methylcytosine dioxygenase TET1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q8NFU7	TET1	Methylcytosine dioxygenase TET1	GO:0006493; P:protein O-linked glycosylation; ISS:UniProtKB
Q8NFU7	TET1	Methylcytosine dioxygenase TET1	GO:0044030; P:regulation of DNA methylation; IEA:Ensembl
Q8NFU7	TET1	Methylcytosine dioxygenase TET1	GO:0019827; P:stem cell maintenance; ISS:UniProtKB
Q8NFU7	TET1	Methylcytosine dioxygenase TET1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6N021	TET2	Methylcytosine dioxygenase TET2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6N021	TET2	Methylcytosine dioxygenase TET2	GO:0008198; F:ferrous iron binding; IDA:UniProtKB
Q6N021	TET2	Methylcytosine dioxygenase TET2	GO:0070579; F:methylcytosine dioxygenase activity; IDA:UniProtKB
Q6N021	TET2	Methylcytosine dioxygenase TET2	GO:0005515; F:protein binding; IPI:UniProtKB
Q6N021	TET2	Methylcytosine dioxygenase TET2	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q6N021	TET2	Methylcytosine dioxygenase TET2	GO:0006211; P:5-methylcytosine catabolic process; IDA:UniProtKB
Q6N021	TET2	Methylcytosine dioxygenase TET2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q6N021	TET2	Methylcytosine dioxygenase TET2	GO:0080111; P:DNA demethylation; IDA:UniProtKB
Q6N021	TET2	Methylcytosine dioxygenase TET2	GO:0080182; P:histone H3-K4 trimethylation; IMP:UniProtKB
Q6N021	TET2	Methylcytosine dioxygenase TET2	GO:0001822; P:kidney development; IEA:Ensembl
Q6N021	TET2	Methylcytosine dioxygenase TET2	GO:0030099; P:myeloid cell differentiation; IMP:UniProtKB
Q6N021	TET2	Methylcytosine dioxygenase TET2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q6N021	TET2	Methylcytosine dioxygenase TET2	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q6N021	TET2	Methylcytosine dioxygenase TET2	GO:0006493; P:protein O-linked glycosylation; IDA:UniProtKB
O43151	TET3	Methylcytosine dioxygenase TET3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O43151	TET3	Methylcytosine dioxygenase TET3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43151	TET3	Methylcytosine dioxygenase TET3	GO:0070579; F:methylcytosine dioxygenase activity; ISS:UniProtKB
O43151	TET3	Methylcytosine dioxygenase TET3	GO:0005515; F:protein binding; IPI:UniProtKB
O43151	TET3	Methylcytosine dioxygenase TET3	GO:0080111; P:DNA demethylation; ISS:UniProtKB
O43151	TET3	Methylcytosine dioxygenase TET3	GO:0044727; P:DNA demethylation of male pronucleus; ISS:UniProtKB
O43151	TET3	Methylcytosine dioxygenase TET3	GO:0080182; P:histone H3-K4 trimethylation; IMP:UniProtKB
O43151	TET3	Methylcytosine dioxygenase TET3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
O43151	TET3	Methylcytosine dioxygenase TET3	GO:0006493; P:protein O-linked glycosylation; IMP:UniProtKB
P05452	CLEC3B	Tetranectin	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P05452	CLEC3B	Tetranectin	GO:0030246; F:carbohydrate binding; IEA:InterPro
P05452	CLEC3B	Tetranectin	GO:0008201; F:heparin binding; IDA:UniProtKB
P05452	CLEC3B	Tetranectin	GO:0036143; F:kringle domain binding; IPI:UniProtKB
P05452	CLEC3B	Tetranectin	GO:0030282; P:bone mineralization; IDA:UniProtKB
P05452	CLEC3B	Tetranectin	GO:0071310; P:cellular response to organic substance; IEP:UniProtKB
P05452	CLEC3B	Tetranectin	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:UniProtKB
P05452	CLEC3B	Tetranectin	GO:0001503; P:ossification; IEP:UniProtKB
P05452	CLEC3B	Tetranectin	GO:0010756; P:positive regulation of plasminogen activation; ISS:UniProtKB
P05452	CLEC3B	Tetranectin	GO:0001501; P:skeletal system development; IEA:Ensembl
Q9NXF1	TEX10	Testis-expressed sequence 10 protein	GO:0005515; F:protein binding; IPI:IntAct
Q8IYF3	TEX11	Testis-expressed sequence 11 protein	GO:0005515; F:protein binding; IPI:IntAct
Q8IYF3	TEX11	Testis-expressed sequence 11 protein	GO:0051026; P:chiasma assembly; IEA:Ensembl
Q8IYF3	TEX11	Testis-expressed sequence 11 protein	GO:0009566; P:fertilization; IEA:Ensembl
Q8IYF3	TEX11	Testis-expressed sequence 11 protein	GO:0008584; P:male gonad development; IEA:Ensembl
Q8IYF3	TEX11	Testis-expressed sequence 11 protein	GO:0007060; P:male meiosis chromosome segregation; IEA:Ensembl
Q8IYF3	TEX11	Testis-expressed sequence 11 protein	GO:0006311; P:meiotic gene conversion; ISS:UniProtKB
Q8IYF3	TEX11	Testis-expressed sequence 11 protein	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q8IYF3	TEX11	Testis-expressed sequence 11 protein	GO:0007131; P:reciprocal meiotic recombination; ISS:UniProtKB
Q8IYF3	TEX11	Testis-expressed sequence 11 protein	GO:0000712; P:resolution of meiotic recombination intermediates; IEA:Ensembl
Q8IYF3	TEX11	Testis-expressed sequence 11 protein	GO:0007130; P:synaptonemal complex assembly; IEA:Ensembl
Q8IWB6	TEX14	Inactive serine/threonine-protein kinase TEX14	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IWB6	TEX14	Inactive serine/threonine-protein kinase TEX14	GO:0005515; F:protein binding; IPI:IntAct
Q8IWB6	TEX14	Inactive serine/threonine-protein kinase TEX14	GO:0004672; F:protein kinase activity; IEA:InterPro
Q8IWB6	TEX14	Inactive serine/threonine-protein kinase TEX14	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q8IWB6	TEX14	Inactive serine/threonine-protein kinase TEX14	GO:0008608; P:attachment of spindle microtubules to kinetochore; ISS:UniProtKB
Q8IWB6	TEX14	Inactive serine/threonine-protein kinase TEX14	GO:0043063; P:intercellular bridge organization; ISS:UniProtKB
Q8IWB6	TEX14	Inactive serine/threonine-protein kinase TEX14	GO:0007140; P:male meiosis; ISS:UniProtKB
Q8IWB6	TEX14	Inactive serine/threonine-protein kinase TEX14	GO:0051306; P:mitotic sister chromatid separation; ISS:UniProtKB
Q8IWB6	TEX14	Inactive serine/threonine-protein kinase TEX14	GO:0007094; P:mitotic spindle assembly checkpoint; ISS:UniProtKB
Q8IWB6	TEX14	Inactive serine/threonine-protein kinase TEX14	GO:0032466; P:negative regulation of cytokinesis; IEA:Ensembl
Q8IWB6	TEX14	Inactive serine/threonine-protein kinase TEX14	GO:0032091; P:negative regulation of protein binding; IEA:Ensembl
Q9BXT5	TEX15	Testis-expressed sequence 15 protein	GO:0009566; P:fertilization; IEA:Ensembl
Q9BXT5	TEX15	Testis-expressed sequence 15 protein	GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl
Q9BXT5	TEX15	Testis-expressed sequence 15 protein	GO:0030539; P:male genitalia development; IEA:Ensembl
Q9BXT5	TEX15	Testis-expressed sequence 15 protein	GO:0007140; P:male meiosis; IEA:Ensembl
Q9BXT5	TEX15	Testis-expressed sequence 15 protein	GO:0034502; P:protein localization to chromosome; IEA:Ensembl
Q9BXT5	TEX15	Testis-expressed sequence 15 protein	GO:0010569; P:regulation of double-strand break repair via homologous recombination; IEA:Ensembl
Q9BXT5	TEX15	Testis-expressed sequence 15 protein	GO:0032880; P:regulation of protein localization; IEA:Ensembl
Q9BXT5	TEX15	Testis-expressed sequence 15 protein	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q9BXT5	TEX15	Testis-expressed sequence 15 protein	GO:0007130; P:synaptonemal complex assembly; IEA:Ensembl
Q8NA77	TEX19	Testis-expressed sequence 19 protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8NA77	TEX19	Testis-expressed sequence 19 protein	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q8NA77	TEX19	Testis-expressed sequence 19 protein	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q8IWB9	TEX2	Testis-expressed sequence 2 protein	GO:0007165; P:signal transduction; NAS:UniProtKB
Q8IWB9	TEX2	Testis-expressed sequence 2 protein	GO:0006665; P:sphingolipid metabolic process; NAS:UniProtKB
Q9NTU4	TEX40	Testis-expressed sequence 40 protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9NTU4	TEX40	Testis-expressed sequence 40 protein	GO:0007140; P:male meiosis; ISS:UniProtKB
Q9NTU4	TEX40	Testis-expressed sequence 40 protein	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
P52655	GTF2A1	Transcription initiation factor IIA subunit 1	GO:0003677; F:DNA binding; IDA:BHF-UCL
P52655	GTF2A1	Transcription initiation factor IIA subunit 1	GO:0005515; F:protein binding; IPI:UniProtKB
P52655	GTF2A1	Transcription initiation factor IIA subunit 1	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P52655	GTF2A1	Transcription initiation factor IIA subunit 1	GO:0017025; F:TBP-class protein binding; IPI:BHF-UCL
P52655	GTF2A1	Transcription initiation factor IIA subunit 1	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P52655	GTF2A1	Transcription initiation factor IIA subunit 1	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
P52655	GTF2A1	Transcription initiation factor IIA subunit 1	GO:0010467; P:gene expression; TAS:Reactome
P52655	GTF2A1	Transcription initiation factor IIA subunit 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P52655	GTF2A1	Transcription initiation factor IIA subunit 1	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P52655	GTF2A1	Transcription initiation factor IIA subunit 1	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:BHF-UCL
P52655	GTF2A1	Transcription initiation factor IIA subunit 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P52655	GTF2A1	Transcription initiation factor IIA subunit 1	GO:0016032; P:viral process; TAS:Reactome
Q9UNN4	GTF2A1L	TFIIA-alpha and beta-like factor	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UNN4	GTF2A1L	TFIIA-alpha and beta-like factor	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q9UNN4	GTF2A1L	TFIIA-alpha and beta-like factor	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UNN4	GTF2A1L	TFIIA-alpha and beta-like factor	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9UNN4	GTF2A1L	TFIIA-alpha and beta-like factor	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IEA:InterPro
Q00403	GTF2B	Transcription initiation factor IIB	GO:0001047; F:core promoter binding; IEA:Ensembl
Q00403	GTF2B	Transcription initiation factor IIB	GO:0005515; F:protein binding; IPI:UniProtKB
Q00403	GTF2B	Transcription initiation factor IIB	GO:0046966; F:thyroid hormone receptor binding; IPI:UniProtKB
Q00403	GTF2B	Transcription initiation factor IIB	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q00403	GTF2B	Transcription initiation factor IIB	GO:0008270; F:zinc ion binding; IEA:InterPro
Q00403	GTF2B	Transcription initiation factor IIB	GO:0010467; P:gene expression; TAS:Reactome
Q00403	GTF2B	Transcription initiation factor IIB	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q00403	GTF2B	Transcription initiation factor IIB	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q00403	GTF2B	Transcription initiation factor IIB	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q00403	GTF2B	Transcription initiation factor IIB	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q00403	GTF2B	Transcription initiation factor IIB	GO:0016032; P:viral process; TAS:Reactome
P32780	GTF2H1	General transcription factor IIH subunit 1	GO:0005515; F:protein binding; IPI:UniProtKB
P32780	GTF2H1	General transcription factor IIH subunit 1	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
P32780	GTF2H1	General transcription factor IIH subunit 1	GO:0006200; P:ATP catabolic process; IDA:GOC
P32780	GTF2H1	General transcription factor IIH subunit 1	GO:0006281; P:DNA repair; TAS:Reactome
P32780	GTF2H1	General transcription factor IIH subunit 1	GO:0010467; P:gene expression; TAS:Reactome
P32780	GTF2H1	General transcription factor IIH subunit 1	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P32780	GTF2H1	General transcription factor IIH subunit 1	GO:0000718; P:nucleotide-excision repair, DNA damage removal; TAS:Reactome
P32780	GTF2H1	General transcription factor IIH subunit 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P32780	GTF2H1	General transcription factor IIH subunit 1	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
P32780	GTF2H1	General transcription factor IIH subunit 1	GO:0006468; P:protein phosphorylation; IDA:GOC
P32780	GTF2H1	General transcription factor IIH subunit 1	GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc
P32780	GTF2H1	General transcription factor IIH subunit 1	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
P32780	GTF2H1	General transcription factor IIH subunit 1	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
P32780	GTF2H1	General transcription factor IIH subunit 1	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
P32780	GTF2H1	General transcription factor IIH subunit 1	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
P32780	GTF2H1	General transcription factor IIH subunit 1	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
P32780	GTF2H1	General transcription factor IIH subunit 1	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
P32780	GTF2H1	General transcription factor IIH subunit 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P32780	GTF2H1	General transcription factor IIH subunit 1	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
P32780	GTF2H1	General transcription factor IIH subunit 1	GO:0016032; P:viral process; TAS:Reactome
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0003676; F:nucleic acid binding; TAS:ProtInc
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0008135; F:translation factor activity, nucleic acid binding; TAS:ProtInc
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0006200; P:ATP catabolic process; IDA:GOC
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0006281; P:DNA repair; TAS:Reactome
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0002031; P:G-protein coupled receptor internalization; IMP:UniProtKB
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0010467; P:gene expression; TAS:Reactome
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0000718; P:nucleotide-excision repair, DNA damage removal; TAS:Reactome
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0006468; P:protein phosphorylation; IDA:GOC
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0009411; P:response to UV; TAS:ProtInc
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0006412; P:translation; TAS:GOC
Q13888	GTF2H2	General transcription factor IIH subunit 2	GO:0016032; P:viral process; TAS:Reactome
Q6ZYL4	GTF2H5	General transcription factor IIH subunit 5	GO:0006289; P:nucleotide-excision repair; IMP:MGI
Q6ZYL4	GTF2H5	General transcription factor IIH subunit 5	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZYL4	GTF2H5	General transcription factor IIH subunit 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IUE1	TGIF2LX	Homeobox protein TGIF2LX	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q8IUE1	TGIF2LX	Homeobox protein TGIF2LX	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8IUE1	TGIF2LX	Homeobox protein TGIF2LX	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NZI6	TFCP2L1	Transcription factor CP2-like protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NZI6	TFCP2L1	Transcription factor CP2-like protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9NZI6	TFCP2L1	Transcription factor CP2-like protein 1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q9NZI6	TFCP2L1	Transcription factor CP2-like protein 1	GO:0000902; P:cell morphogenesis; IEA:Ensembl
Q9NZI6	TFCP2L1	Transcription factor CP2-like protein 1	GO:0007028; P:cytoplasm organization; IEA:Ensembl
Q9NZI6	TFCP2L1	Transcription factor CP2-like protein 1	GO:0008340; P:determination of adult lifespan; IEA:Ensembl
Q9NZI6	TFCP2L1	Transcription factor CP2-like protein 1	GO:0002070; P:epithelial cell maturation; IEA:Ensembl
Q9NZI6	TFCP2L1	Transcription factor CP2-like protein 1	GO:0007565; P:female pregnancy; TAS:ProtInc
Q9NZI6	TFCP2L1	Transcription factor CP2-like protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9NZI6	TFCP2L1	Transcription factor CP2-like protein 1	GO:0045927; P:positive regulation of growth; IEA:Ensembl
Q9NZI6	TFCP2L1	Transcription factor CP2-like protein 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9NZI6	TFCP2L1	Transcription factor CP2-like protein 1	GO:0007431; P:salivary gland development; IEA:Ensembl
Q9NZI6	TFCP2L1	Transcription factor CP2-like protein 1	GO:0006694; P:steroid biosynthetic process; TAS:ProtInc
Q9NZI6	TFCP2L1	Transcription factor CP2-like protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0003684; F:damaged DNA binding; TAS:ProtInc
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0008135; F:translation factor activity, nucleic acid binding; TAS:ProtInc
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0006200; P:ATP catabolic process; IDA:GOC
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0006281; P:DNA repair; TAS:Reactome
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0010467; P:gene expression; TAS:Reactome
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0000718; P:nucleotide-excision repair, DNA damage removal; TAS:Reactome
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0006468; P:protein phosphorylation; IDA:GOC
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0006412; P:translation; TAS:GOC
Q13889	GTF2H3	General transcription factor IIH subunit 3	GO:0016032; P:viral process; TAS:Reactome
Q8IUE0	TGIF2LY	Homeobox protein TGIF2LY	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q8IUE0	TGIF2LY	Homeobox protein TGIF2LY	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8IUE0	TGIF2LY	Homeobox protein TGIF2LY	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q92759	GTF2H4	General transcription factor IIH subunit 4	GO:0004003; F:ATP-dependent DNA helicase activity; IEA:InterPro
Q92759	GTF2H4	General transcription factor IIH subunit 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q92759	GTF2H4	General transcription factor IIH subunit 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q92759	GTF2H4	General transcription factor IIH subunit 4	GO:0006370; P:7-methylguanosine mRNA capping; TAS:Reactome
Q92759	GTF2H4	General transcription factor IIH subunit 4	GO:0006200; P:ATP catabolic process; IDA:GOC
Q92759	GTF2H4	General transcription factor IIH subunit 4	GO:0006281; P:DNA repair; TAS:Reactome
Q92759	GTF2H4	General transcription factor IIH subunit 4	GO:0010467; P:gene expression; TAS:Reactome
Q92759	GTF2H4	General transcription factor IIH subunit 4	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
Q92759	GTF2H4	General transcription factor IIH subunit 4	GO:0000718; P:nucleotide-excision repair, DNA damage removal; TAS:Reactome
Q92759	GTF2H4	General transcription factor IIH subunit 4	GO:0050434; P:positive regulation of viral transcription; TAS:Reactome
Q92759	GTF2H4	General transcription factor IIH subunit 4	GO:0006468; P:protein phosphorylation; IDA:GOC
Q92759	GTF2H4	General transcription factor IIH subunit 4	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
Q92759	GTF2H4	General transcription factor IIH subunit 4	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
Q92759	GTF2H4	General transcription factor IIH subunit 4	GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome
Q92759	GTF2H4	General transcription factor IIH subunit 4	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
Q92759	GTF2H4	General transcription factor IIH subunit 4	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
Q92759	GTF2H4	General transcription factor IIH subunit 4	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
Q92759	GTF2H4	General transcription factor IIH subunit 4	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q92759	GTF2H4	General transcription factor IIH subunit 4	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
Q92759	GTF2H4	General transcription factor IIH subunit 4	GO:0016032; P:viral process; TAS:Reactome
Q92664	GTF3A	Transcription factor IIIA	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q92664	GTF3A	Transcription factor IIIA	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q92664	GTF3A	Transcription factor IIIA	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q92664	GTF3A	Transcription factor IIIA	GO:0010467; P:gene expression; TAS:Reactome
Q92664	GTF3A	Transcription factor IIIA	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q92664	GTF3A	Transcription factor IIIA	GO:0009303; P:rRNA transcription; TAS:ProtInc
Q92664	GTF3A	Transcription factor IIIA	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
Q92994	BRF1	Transcription factor IIIB 90 kDa subunit	GO:0008270; F:zinc ion binding; IEA:InterPro
Q92994	BRF1	Transcription factor IIIB 90 kDa subunit	GO:0010467; P:gene expression; TAS:Reactome
Q92994	BRF1	Transcription factor IIIB 90 kDa subunit	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:InterPro
Q92994	BRF1	Transcription factor IIIB 90 kDa subunit	GO:0043488; P:regulation of mRNA stability; IEA:Ensembl
Q92994	BRF1	Transcription factor IIIB 90 kDa subunit	GO:0009303; P:rRNA transcription; TAS:ProtInc
Q92994	BRF1	Transcription factor IIIB 90 kDa subunit	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
Q92994	BRF1	Transcription factor IIIB 90 kDa subunit	GO:0006384; P:transcription initiation from RNA polymerase III promoter; TAS:ProtInc
Q92994	BRF1	Transcription factor IIIB 90 kDa subunit	GO:0009304; P:tRNA transcription; TAS:ProtInc
Q12789	GTF3C1	General transcription factor 3C polypeptide 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q12789	GTF3C1	General transcription factor 3C polypeptide 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q12789	GTF3C1	General transcription factor 3C polypeptide 1	GO:0042791; P:5S class rRNA transcription from RNA polymerase III type 1 promoter; IC:HGNC
Q12789	GTF3C1	General transcription factor 3C polypeptide 1	GO:0010467; P:gene expression; TAS:Reactome
Q12789	GTF3C1	General transcription factor 3C polypeptide 1	GO:0009303; P:rRNA transcription; TAS:ProtInc
Q12789	GTF3C1	General transcription factor 3C polypeptide 1	GO:0006383; P:transcription from RNA polymerase III promoter; IC:HGNC
Q12789	GTF3C1	General transcription factor 3C polypeptide 1	GO:0006351; P:transcription, DNA-templated; IC:HGNC
Q12789	GTF3C1	General transcription factor 3C polypeptide 1	GO:0009304; P:tRNA transcription; TAS:ProtInc
Q12789	GTF3C1	General transcription factor 3C polypeptide 1	GO:0042797; P:tRNA transcription from RNA polymerase III promoter; IC:HGNC
Q8WUA4	GTF3C2	General transcription factor 3C polypeptide 2	GO:0042791; P:5S class rRNA transcription from RNA polymerase III type 1 promoter; IC:HGNC
Q8WUA4	GTF3C2	General transcription factor 3C polypeptide 2	GO:0010467; P:gene expression; TAS:Reactome
Q8WUA4	GTF3C2	General transcription factor 3C polypeptide 2	GO:0006383; P:transcription from RNA polymerase III promoter; IDA:HGNC
Q8WUA4	GTF3C2	General transcription factor 3C polypeptide 2	GO:0006351; P:transcription, DNA-templated; IDA:HGNC
Q8WUA4	GTF3C2	General transcription factor 3C polypeptide 2	GO:0042797; P:tRNA transcription from RNA polymerase III promoter; IC:HGNC
Q9Y5Q9	GTF3C3	General transcription factor 3C polypeptide 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y5Q9	GTF3C3	General transcription factor 3C polypeptide 3	GO:0005515; F:protein binding; IPI:IntAct
Q9Y5Q9	GTF3C3	General transcription factor 3C polypeptide 3	GO:0042791; P:5S class rRNA transcription from RNA polymerase III type 1 promoter; IC:HGNC
Q9Y5Q9	GTF3C3	General transcription factor 3C polypeptide 3	GO:0010467; P:gene expression; TAS:Reactome
Q9Y5Q9	GTF3C3	General transcription factor 3C polypeptide 3	GO:0006383; P:transcription from RNA polymerase III promoter; IC:HGNC
Q9Y5Q9	GTF3C3	General transcription factor 3C polypeptide 3	GO:0006351; P:transcription, DNA-templated; IC:HGNC
Q9Y5Q9	GTF3C3	General transcription factor 3C polypeptide 3	GO:0042797; P:tRNA transcription from RNA polymerase III promoter; IC:HGNC
Q9UKN8	GTF3C4	General transcription factor 3C polypeptide 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UKN8	GTF3C4	General transcription factor 3C polypeptide 4	GO:0008047; F:enzyme activator activity; TAS:ProtInc
Q9UKN8	GTF3C4	General transcription factor 3C polypeptide 4	GO:0004402; F:histone acetyltransferase activity; TAS:ProtInc
Q9UKN8	GTF3C4	General transcription factor 3C polypeptide 4	GO:0005515; F:protein binding; IPI:HGNC
Q9UKN8	GTF3C4	General transcription factor 3C polypeptide 4	GO:0042791; P:5S class rRNA transcription from RNA polymerase III type 1 promoter; IC:HGNC
Q9UKN8	GTF3C4	General transcription factor 3C polypeptide 4	GO:0010467; P:gene expression; TAS:Reactome
Q9UKN8	GTF3C4	General transcription factor 3C polypeptide 4	GO:0016573; P:histone acetylation; TAS:GOC
Q9UKN8	GTF3C4	General transcription factor 3C polypeptide 4	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
Q9UKN8	GTF3C4	General transcription factor 3C polypeptide 4	GO:0006383; P:transcription from RNA polymerase III promoter; IC:HGNC
Q9UKN8	GTF3C4	General transcription factor 3C polypeptide 4	GO:0006384; P:transcription initiation from RNA polymerase III promoter; TAS:ProtInc
Q9UKN8	GTF3C4	General transcription factor 3C polypeptide 4	GO:0006351; P:transcription, DNA-templated; IC:HGNC
Q9UKN8	GTF3C4	General transcription factor 3C polypeptide 4	GO:0042797; P:tRNA transcription from RNA polymerase III promoter; IC:HGNC
Q9Y5Q8	GTF3C5	General transcription factor 3C polypeptide 5	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y5Q8	GTF3C5	General transcription factor 3C polypeptide 5	GO:0005515; F:protein binding; IPI:HGNC
Q9Y5Q8	GTF3C5	General transcription factor 3C polypeptide 5	GO:0042791; P:5S class rRNA transcription from RNA polymerase III type 1 promoter; IC:HGNC
Q9Y5Q8	GTF3C5	General transcription factor 3C polypeptide 5	GO:0010467; P:gene expression; TAS:Reactome
Q9Y5Q8	GTF3C5	General transcription factor 3C polypeptide 5	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q9Y5Q8	GTF3C5	General transcription factor 3C polypeptide 5	GO:0006383; P:transcription from RNA polymerase III promoter; IC:HGNC
Q9Y5Q8	GTF3C5	General transcription factor 3C polypeptide 5	GO:0006351; P:transcription, DNA-templated; IC:HGNC
Q9Y5Q8	GTF3C5	General transcription factor 3C polypeptide 5	GO:0042797; P:tRNA transcription from RNA polymerase III promoter; IC:HGNC
Q969F1	GTF3C6	General transcription factor 3C polypeptide 6	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q969F1	GTF3C6	General transcription factor 3C polypeptide 6	GO:0005515; F:protein binding; IPI:HGNC
Q969F1	GTF3C6	General transcription factor 3C polypeptide 6	GO:0042791; P:5S class rRNA transcription from RNA polymerase III type 1 promoter; IC:HGNC
Q969F1	GTF3C6	General transcription factor 3C polypeptide 6	GO:0006383; P:transcription from RNA polymerase III promoter; IDA:HGNC
Q969F1	GTF3C6	General transcription factor 3C polypeptide 6	GO:0006351; P:transcription, DNA-templated; IDA:HGNC
Q969F1	GTF3C6	General transcription factor 3C polypeptide 6	GO:0042797; P:tRNA transcription from RNA polymerase III promoter; IC:HGNC
Q04206	RELA	Transcription factor p65	GO:0033613; F:activating transcription factor binding; IPI:BHF-UCL
Q04206	RELA	Transcription factor p65	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0003677; F:DNA binding; IDA:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0042802; F:identical protein binding; IDA:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0051059; F:NF-kappaB binding; IPI:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0042301; F:phosphate ion binding; IDA:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0005515; F:protein binding; IPI:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0070491; F:repressing transcription factor binding; IPI:BHF-UCL
Q04206	RELA	Transcription factor p65	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0006117; P:acetaldehyde metabolic process; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0007568; P:aging; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0006968; P:cellular defense response; NAS:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0070301; P:cellular response to hydrogen peroxide; IDA:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0071347; P:cellular response to interleukin-1; IDA:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0071356; P:cellular response to tumor necrosis factor; IDA:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0019221; P:cytokine-mediated signaling pathway; IDA:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0051607; P:defense response to virus; NAS:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q04206	RELA	Transcription factor p65	GO:0001942; P:hair follicle development; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0006954; P:inflammatory response; IDA:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0045087; P:innate immune response; TAS:Reactome
Q04206	RELA	Transcription factor p65	GO:0001889; P:liver development; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0031293; P:membrane protein intracellular domain proteolysis; TAS:Reactome
Q04206	RELA	Transcription factor p65	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q04206	RELA	Transcription factor p65	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q04206	RELA	Transcription factor p65	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q04206	RELA	Transcription factor p65	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:BHF-UCL
Q04206	RELA	Transcription factor p65	GO:0046627; P:negative regulation of insulin receptor signaling pathway; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0042177; P:negative regulation of protein catabolic process; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q04206	RELA	Transcription factor p65	GO:0070431; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; IDA:MGI
Q04206	RELA	Transcription factor p65	GO:0009887; P:organ morphogenesis; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0032332; P:positive regulation of chondrocyte differentiation; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0045084; P:positive regulation of interleukin-12 biosynthetic process; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:MGI
Q04206	RELA	Transcription factor p65	GO:0014040; P:positive regulation of Schwann cell differentiation; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q04206	RELA	Transcription factor p65	GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0043200; P:response to amino acid; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0051591; P:response to cAMP; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0033590; P:response to cobalamin; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0042493; P:response to drug; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0032868; P:response to insulin; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0070555; P:response to interleukin-1; IGI:BHF-UCL
Q04206	RELA	Transcription factor p65	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0043278; P:response to morphine; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0032495; P:response to muramyl dipeptide; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0010033; P:response to organic substance; IDA:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0032570; P:response to progesterone; IEA:Ensembl
Q04206	RELA	Transcription factor p65	GO:0010224; P:response to UV-B; IDA:UniProtKB
Q04206	RELA	Transcription factor p65	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q04206	RELA	Transcription factor p65	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q04206	RELA	Transcription factor p65	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q04206	RELA	Transcription factor p65	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q04206	RELA	Transcription factor p65	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q04206	RELA	Transcription factor p65	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q04206	RELA	Transcription factor p65	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q04206	RELA	Transcription factor p65	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q04206	RELA	Transcription factor p65	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q04206	RELA	Transcription factor p65	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q04206	RELA	Transcription factor p65	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:GOC
Q04206	RELA	Transcription factor p65	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q04206	RELA	Transcription factor p65	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:0008013; F:beta-catenin binding; IBA:RefGenome
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:0003682; F:chromatin binding; IBA:RefGenome
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:0003677; F:DNA binding; NAS:UniProtKB
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:0043565; F:sequence-specific DNA binding; IBA:RefGenome
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:0044212; F:transcription regulatory region DNA binding; IBA:RefGenome
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:0008595; P:anterior/posterior axis specification, embryo; IEA:Ensembl
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:0048319; P:axial mesoderm morphogenesis; IEA:Ensembl
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:0007420; P:brain development; IBA:RefGenome
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:0060070; P:canonical Wnt signaling pathway; IBA:RefGenome
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:0006325; P:chromatin organization; NAS:UniProtKB
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:0048699; P:generation of neurons; IBA:RefGenome
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:0046022; P:positive regulation of transcription from RNA polymerase II promoter during mitosis; IEA:Ensembl
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:2000036; P:regulation of stem cell maintenance; IEA:Ensembl
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:RefGenome
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:0030111; P:regulation of Wnt signaling pathway; NAS:UniProtKB
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:0043588; P:skin development; IEA:Ensembl
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
Q9HCS4	TCF7L1	Transcription factor 7-like 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0070016; F:armadillo repeat domain binding; IPI:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0008013; F:beta-catenin binding; IDA:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0003682; F:chromatin binding; IBA:RefGenome
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0045295; F:gamma-catenin binding; IPI:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0035257; F:nuclear hormone receptor binding; IPI:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0043565; F:sequence-specific DNA binding; IMP:UniProtKB
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0001568; P:blood vessel development; IMP:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0030282; P:bone mineralization; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0007420; P:brain development; IBA:RefGenome
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0060070; P:canonical Wnt signaling pathway; IC:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0044334; P:canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition; IMP:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0035411; P:catenin import into nucleus; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0007050; P:cell cycle arrest; IMP:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0008283; P:cell proliferation; IMP:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0048557; P:embryonic digestive tract morphogenesis; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0030538; P:embryonic genitalia morphogenesis; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0048619; P:embryonic hindgut morphogenesis; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0060325; P:face morphogenesis; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0045444; P:fat cell differentiation; IDA:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0048699; P:generation of neurons; IBA:RefGenome
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0042593; P:glucose homeostasis; IDA:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0043570; P:maintenance of DNA repeat elements; IMP:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0048625; P:myoblast fate commitment; IDA:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0030514; P:negative regulation of BMP signaling pathway; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:UniProtKB
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IDA:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0045599; P:negative regulation of fat cell differentiation; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0040037; P:negative regulation of fibroblast growth factor receptor signaling pathway; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0046621; P:negative regulation of organ growth; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:2000675; P:negative regulation of type B pancreatic cell apoptotic process; IDA:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0021915; P:neural tube development; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0014003; P:oligodendrocyte development; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0031016; P:pancreas development; TAS:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0021983; P:pituitary gland development; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0010909; P:positive regulation of heparan sulfate proteoglycan biosynthetic process; IMP:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0032024; P:positive regulation of insulin secretion; IDA:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0032092; P:positive regulation of protein binding; IDA:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0046827; P:positive regulation of protein export from nucleus; IMP:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0051897; P:positive regulation of protein kinase B signaling; IMP:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0032350; P:regulation of hormone metabolic process; IDA:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0031641; P:regulation of myelination; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0048713; P:regulation of oligodendrocyte differentiation; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0048641; P:regulation of skeletal muscle tissue development; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0048660; P:regulation of smooth muscle cell proliferation; IMP:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0009749; P:response to glucose; ISS:BHF-UCL
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0032252; P:secretory granule localization; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0043588; P:skin development; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
Q9NQB0	TCF7L2	Transcription factor 7-like 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q00059	TFAM	Transcription factor A, mitochondrial	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q00059	TFAM	Transcription factor A, mitochondrial	GO:0008301; F:DNA binding, bending; IDA:UniProtKB
Q00059	TFAM	Transcription factor A, mitochondrial	GO:0070363; F:mitochondrial light strand promoter sense binding; IDA:UniProtKB
Q00059	TFAM	Transcription factor A, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q00059	TFAM	Transcription factor A, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q00059	TFAM	Transcription factor A, mitochondrial	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IMP:UniProtKB
Q00059	TFAM	Transcription factor A, mitochondrial	GO:0006261; P:DNA-dependent DNA replication; TAS:ProtInc
Q00059	TFAM	Transcription factor A, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
Q00059	TFAM	Transcription factor A, mitochondrial	GO:0033108; P:mitochondrial respiratory chain complex assembly; IEA:Ensembl
Q00059	TFAM	Transcription factor A, mitochondrial	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q00059	TFAM	Transcription factor A, mitochondrial	GO:0006356; P:regulation of transcription from RNA polymerase I promoter; TAS:ProtInc
Q00059	TFAM	Transcription factor A, mitochondrial	GO:0006390; P:transcription from mitochondrial promoter; IMP:UniProtKB
Q00059	TFAM	Transcription factor A, mitochondrial	GO:0006391; P:transcription initiation from mitochondrial promoter; IDA:UniProtKB
Q01664	TFAP4	Transcription factor AP-4	GO:0003677; F:DNA binding; IDA:UniProtKB
Q01664	TFAP4	Transcription factor AP-4	GO:0070888; F:E-box binding; IDA:UniProtKB
Q01664	TFAP4	Transcription factor AP-4	GO:0042826; F:histone deacetylase binding; IPI:UniProtKB
Q01664	TFAP4	Transcription factor AP-4	GO:0005515; F:protein binding; IPI:UniProtKB
Q01664	TFAP4	Transcription factor AP-4	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q01664	TFAP4	Transcription factor AP-4	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl
Q01664	TFAP4	Transcription factor AP-4	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q01664	TFAP4	Transcription factor AP-4	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q01664	TFAP4	Transcription factor AP-4	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q01664	TFAP4	Transcription factor AP-4	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q01664	TFAP4	Transcription factor AP-4	GO:0071549; P:cellular response to dexamethasone stimulus; IEA:Ensembl
Q01664	TFAP4	Transcription factor AP-4	GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IDA:UniProtKB
Q01664	TFAP4	Transcription factor AP-4	GO:0043922; P:negative regulation by host of viral transcription; IDA:UniProtKB
Q01664	TFAP4	Transcription factor AP-4	GO:0071157; P:negative regulation of cell cycle arrest; IMP:UniProtKB
Q01664	TFAP4	Transcription factor AP-4	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q01664	TFAP4	Transcription factor AP-4	GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:UniProtKB
Q01664	TFAP4	Transcription factor AP-4	GO:0043392; P:negative regulation of DNA binding; IDA:UniProtKB
Q01664	TFAP4	Transcription factor AP-4	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q01664	TFAP4	Transcription factor AP-4	GO:0043923; P:positive regulation by host of viral transcription; IDA:UniProtKB
Q01664	TFAP4	Transcription factor AP-4	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q01664	TFAP4	Transcription factor AP-4	GO:2001269; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; IEA:Ensembl
Q01664	TFAP4	Transcription factor AP-4	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q01664	TFAP4	Transcription factor AP-4	GO:0006461; P:protein complex assembly; IDA:UniProtKB
Q01664	TFAP4	Transcription factor AP-4	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:GOC
Q8WVM0	TFB1M	Dimethyladenosine transferase 1, mitochondrial	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8WVM0	TFB1M	Dimethyladenosine transferase 1, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8WVM0	TFB1M	Dimethyladenosine transferase 1, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q8WVM0	TFB1M	Dimethyladenosine transferase 1, mitochondrial	GO:0000179; F:rRNA (adenine-N6,N6-)-dimethyltransferase activity; IEA:InterPro
Q8WVM0	TFB1M	Dimethyladenosine transferase 1, mitochondrial	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8WVM0	TFB1M	Dimethyladenosine transferase 1, mitochondrial	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H5Q4	TFB2M	Dimethyladenosine transferase 2, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H5Q4	TFB2M	Dimethyladenosine transferase 2, mitochondrial	GO:0000179; F:rRNA (adenine-N6,N6-)-dimethyltransferase activity; IEA:InterPro
Q9H5Q4	TFB2M	Dimethyladenosine transferase 2, mitochondrial	GO:0003712; F:transcription cofactor activity; IDA:UniProtKB
Q9H5Q4	TFB2M	Dimethyladenosine transferase 2, mitochondrial	GO:0010467; P:gene expression; TAS:Reactome
Q9H5Q4	TFB2M	Dimethyladenosine transferase 2, mitochondrial	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9H5Q4	TFB2M	Dimethyladenosine transferase 2, mitochondrial	GO:0006390; P:transcription from mitochondrial promoter; IDA:UniProtKB
Q9H5Q4	TFB2M	Dimethyladenosine transferase 2, mitochondrial	GO:0006391; P:transcription initiation from mitochondrial promoter; IDA:UniProtKB
Q12800	TFCP2	Alpha-globin transcription factor CP2	GO:0003677; F:DNA binding; TAS:ProtInc
Q12800	TFCP2	Alpha-globin transcription factor CP2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q12800	TFCP2	Alpha-globin transcription factor CP2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q12800	TFCP2	Alpha-globin transcription factor CP2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14188	TFDP2	Transcription factor Dp-2	GO:0003677; F:DNA binding; TAS:ProtInc
Q14188	TFDP2	Transcription factor Dp-2	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q14188	TFDP2	Transcription factor Dp-2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
Q14188	TFDP2	Transcription factor Dp-2	GO:0003712; F:transcription cofactor activity; TAS:ProtInc
Q14188	TFDP2	Transcription factor Dp-2	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q14188	TFDP2	Transcription factor Dp-2	GO:0010467; P:gene expression; TAS:Reactome
Q14188	TFDP2	Transcription factor Dp-2	GO:0007507; P:heart development; IEA:Ensembl
Q14188	TFDP2	Transcription factor Dp-2	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q14188	TFDP2	Transcription factor Dp-2	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q14188	TFDP2	Transcription factor Dp-2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
Q14188	TFDP2	Transcription factor Dp-2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q14188	TFDP2	Transcription factor Dp-2	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
Q14188	TFDP2	Transcription factor Dp-2	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q14186	TFDP1	Transcription factor Dp-1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q14186	TFDP1	Transcription factor Dp-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q14186	TFDP1	Transcription factor Dp-1	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q14186	TFDP1	Transcription factor Dp-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q14186	TFDP1	Transcription factor Dp-1	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q14186	TFDP1	Transcription factor Dp-1	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q14186	TFDP1	Transcription factor Dp-1	GO:0006915; P:apoptotic process; TAS:Reactome
Q14186	TFDP1	Transcription factor Dp-1	GO:0008283; P:cell proliferation; TAS:ProtInc
Q14186	TFDP1	Transcription factor Dp-1	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
Q14186	TFDP1	Transcription factor Dp-1	GO:0010467; P:gene expression; TAS:Reactome
Q14186	TFDP1	Transcription factor Dp-1	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
Q14186	TFDP1	Transcription factor Dp-1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q14186	TFDP1	Transcription factor Dp-1	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q14186	TFDP1	Transcription factor Dp-1	GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome
Q14186	TFDP1	Transcription factor Dp-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
Q14186	TFDP1	Transcription factor Dp-1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q14186	TFDP1	Transcription factor Dp-1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q14186	TFDP1	Transcription factor Dp-1	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
Q14186	TFDP1	Transcription factor Dp-1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P15923	TCF3	Transcription factor E2-alpha	GO:0043425; F:bHLH transcription factor binding; IPI:BHF-UCL
P15923	TCF3	Transcription factor E2-alpha	GO:0003682; F:chromatin binding; IEA:Ensembl
P15923	TCF3	Transcription factor E2-alpha	GO:0003677; F:DNA binding; IDA:UniProtKB
P15923	TCF3	Transcription factor E2-alpha	GO:0070888; F:E-box binding; IDA:UniProtKB
P15923	TCF3	Transcription factor E2-alpha	GO:0031435; F:mitogen-activated protein kinase kinase kinase binding; IPI:UniProtKB
P15923	TCF3	Transcription factor E2-alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P15923	TCF3	Transcription factor E2-alpha	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
P15923	TCF3	Transcription factor E2-alpha	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P15923	TCF3	Transcription factor E2-alpha	GO:0070491; F:repressing transcription factor binding; IPI:UniProtKB
P15923	TCF3	Transcription factor E2-alpha	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P15923	TCF3	Transcription factor E2-alpha	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P15923	TCF3	Transcription factor E2-alpha	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
P15923	TCF3	Transcription factor E2-alpha	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P15923	TCF3	Transcription factor E2-alpha	GO:0070644; F:vitamin D response element binding; IDA:BHF-UCL
P15923	TCF3	Transcription factor E2-alpha	GO:0030183; P:B cell differentiation; NAS:UniProtKB
P15923	TCF3	Transcription factor E2-alpha	GO:0002326; P:B cell lineage commitment; IDA:UniProtKB
P15923	TCF3	Transcription factor E2-alpha	GO:0048468; P:cell development; IEA:Ensembl
P15923	TCF3	Transcription factor E2-alpha	GO:0043966; P:histone H3 acetylation; IEA:Ensembl
P15923	TCF3	Transcription factor E2-alpha	GO:0043967; P:histone H4 acetylation; IEA:Ensembl
P15923	TCF3	Transcription factor E2-alpha	GO:0033152; P:immunoglobulin V(D)J recombination; IDA:MGI
P15923	TCF3	Transcription factor E2-alpha	GO:0042692; P:muscle cell differentiation; TAS:Reactome
P15923	TCF3	Transcription factor E2-alpha	GO:0001779; P:natural killer cell differentiation; IEA:Ensembl
P15923	TCF3	Transcription factor E2-alpha	GO:0048541; P:Peyer's patch development; IEA:Ensembl
P15923	TCF3	Transcription factor E2-alpha	GO:0030890; P:positive regulation of B cell proliferation; IMP:UniProtKB
P15923	TCF3	Transcription factor E2-alpha	GO:0045787; P:positive regulation of cell cycle; IDA:UniProtKB
P15923	TCF3	Transcription factor E2-alpha	GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome
P15923	TCF3	Transcription factor E2-alpha	GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB
P15923	TCF3	Transcription factor E2-alpha	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P15923	TCF3	Transcription factor E2-alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P15923	TCF3	Transcription factor E2-alpha	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
P15923	TCF3	Transcription factor E2-alpha	GO:0050821; P:protein stabilization; IEA:Ensembl
P15923	TCF3	Transcription factor E2-alpha	GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; IDA:UniProtKB
P15923	TCF3	Transcription factor E2-alpha	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P15923	TCF3	Transcription factor E2-alpha	GO:0042493; P:response to drug; IEA:Ensembl
P15923	TCF3	Transcription factor E2-alpha	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P15923	TCF3	Transcription factor E2-alpha	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
P15923	TCF3	Transcription factor E2-alpha	GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB
Q5H9I0	TFDP3	Transcription factor Dp family member 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5H9I0	TFDP3	Transcription factor Dp family member 3	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
Q5H9I0	TFDP3	Transcription factor Dp family member 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q5H9I0	TFDP3	Transcription factor Dp family member 3	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q5H9I0	TFDP3	Transcription factor Dp family member 3	GO:0000082; P:G1/S transition of mitotic cell cycle; IDA:UniProtKB
Q5H9I0	TFDP3	Transcription factor Dp family member 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P19532	TFE3	Transcription factor E3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
P19532	TFE3	Transcription factor E3	GO:0044212; F:transcription regulatory region DNA binding; ISS:UniProtKB
P19532	TFE3	Transcription factor E3	GO:0006959; P:humoral immune response; ISS:UniProtKB
P19532	TFE3	Transcription factor E3	GO:0045785; P:positive regulation of cell adhesion; IMP:UniProtKB
P19532	TFE3	Transcription factor E3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
P19532	TFE3	Transcription factor E3	GO:0045670; P:regulation of osteoclast differentiation; IEA:Ensembl
P19532	TFE3	Transcription factor E3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P19484	TFEB	Transcription factor EB	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P19484	TFEB	Transcription factor EB	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P19484	TFEB	Transcription factor EB	GO:0006914; P:autophagy; IEA:UniProtKB-KW
P19484	TFEB	Transcription factor EB	GO:0001892; P:embryonic placenta development; ISS:UniProtKB
P19484	TFEB	Transcription factor EB	GO:0006959; P:humoral immune response; ISS:UniProtKB
P19484	TFEB	Transcription factor EB	GO:0007040; P:lysosome organization; IMP:UniProtKB
P19484	TFEB	Transcription factor EB	GO:0010508; P:positive regulation of autophagy; IMP:UniProtKB
P19484	TFEB	Transcription factor EB	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P19484	TFEB	Transcription factor EB	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P19484	TFEB	Transcription factor EB	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O14948	TFEC	Transcription factor EC	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O14948	TFEC	Transcription factor EC	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O14948	TFEC	Transcription factor EC	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
O14948	TFEC	Transcription factor EC	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
O14948	TFEC	Transcription factor EC	GO:0034605; P:cellular response to heat; IEA:Ensembl
O14948	TFEC	Transcription factor EC	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P04155	TFF1	Trefoil factor 1	GO:0005515; F:protein binding; IPI:IntAct
P04155	TFF1	Trefoil factor 1	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
P04155	TFF1	Trefoil factor 1	GO:0030154; P:cell differentiation; IEA:Ensembl
P04155	TFF1	Trefoil factor 1	GO:0007586; P:digestion; NAS:ProtInc
P04155	TFF1	Trefoil factor 1	GO:0030277; P:maintenance of gastrointestinal epithelium; IEA:Ensembl
P04155	TFF1	Trefoil factor 1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P04155	TFF1	Trefoil factor 1	GO:0032355; P:response to estradiol; IDA:BHF-UCL
P04155	TFF1	Trefoil factor 1	GO:0010039; P:response to iron ion; IEA:Ensembl
P04155	TFF1	Trefoil factor 1	GO:0043434; P:response to peptide hormone; IEA:Ensembl
Q03403	TFF2	Trefoil factor 2	GO:0005515; F:protein binding; IPI:IntAct
Q03403	TFF2	Trefoil factor 2	GO:0019722; P:calcium-mediated signaling; IEA:Ensembl
Q03403	TFF2	Trefoil factor 2	GO:0070098; P:chemokine-mediated signaling pathway; IEA:Ensembl
Q03403	TFF2	Trefoil factor 2	GO:0007586; P:digestion; TAS:ProtInc
Q03403	TFF2	Trefoil factor 2	GO:0060455; P:negative regulation of gastric acid secretion; IEA:Ensembl
Q03403	TFF2	Trefoil factor 2	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
Q03403	TFF2	Trefoil factor 2	GO:0043031; P:negative regulation of macrophage activation; IEA:Ensembl
Q03403	TFF2	Trefoil factor 2	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q03403	TFF2	Trefoil factor 2	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl
Q03403	TFF2	Trefoil factor 2	GO:0030334; P:regulation of cell migration; IEA:Ensembl
Q07654	TFF3	Trefoil factor 3	GO:0006952; P:defense response; TAS:ProtInc
Q07654	TFF3	Trefoil factor 3	GO:0007586; P:digestion; TAS:ProtInc
Q07654	TFF3	Trefoil factor 3	GO:0043434; P:response to peptide hormone; IEA:Ensembl
Q92734	TFG	Protein TFG	GO:0005515; F:protein binding; IPI:IntAct
Q92734	TFG	Protein TFG	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q92734	TFG	Protein TFG	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q92734	TFG	Protein TFG	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q92734	TFG	Protein TFG	GO:0007165; P:signal transduction; IMP:GOC
O95379	TNFAIP8	Tumor necrosis factor alpha-induced protein 8	GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IMP:UniProtKB
O95379	TNFAIP8	Tumor necrosis factor alpha-induced protein 8	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
O95379	TNFAIP8	Tumor necrosis factor alpha-induced protein 8	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:GOC
Q9UBB9	TFIP11	Tuftelin-interacting protein 11	GO:0003677; F:DNA binding; IEA:InterPro
Q9UBB9	TFIP11	Tuftelin-interacting protein 11	GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW
Q9UBB9	TFIP11	Tuftelin-interacting protein 11	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q9UBB9	TFIP11	Tuftelin-interacting protein 11	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q9UBB9	TFIP11	Tuftelin-interacting protein 11	GO:0006396; P:RNA processing; IC:UniProtKB
Q9UBB9	TFIP11	Tuftelin-interacting protein 11	GO:0000390; P:spliceosomal complex disassembly; IMP:UniProtKB
P10646	TFPI	Tissue factor pathway inhibitor	GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc
P10646	TFPI	Tissue factor pathway inhibitor	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
P10646	TFPI	Tissue factor pathway inhibitor	GO:0007596; P:blood coagulation; TAS:Reactome
P10646	TFPI	Tissue factor pathway inhibitor	GO:0007598; P:blood coagulation, extrinsic pathway; TAS:Reactome
P10646	TFPI	Tissue factor pathway inhibitor	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
P48307	TFPI2	Tissue factor pathway inhibitor 2	GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc
P48307	TFPI2	Tissue factor pathway inhibitor 2	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
P48307	TFPI2	Tissue factor pathway inhibitor 2	GO:0007596; P:blood coagulation; IEA:UniProtKB-KW
P0C1Z6	TFPT	TCF3 fusion partner	GO:0003677; F:DNA binding; ISS:UniProtKB
P0C1Z6	TFPT	TCF3 fusion partner	GO:0005515; F:protein binding; IPI:IntAct
P0C1Z6	TFPT	TCF3 fusion partner	GO:0097190; P:apoptotic signaling pathway; IDA:UniProtKB
P0C1Z6	TFPT	TCF3 fusion partner	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
P0C1Z6	TFPT	TCF3 fusion partner	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
P0C1Z6	TFPT	TCF3 fusion partner	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P0C1Z6	TFPT	TCF3 fusion partner	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P0C1Z6	TFPT	TCF3 fusion partner	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P02786	TFRC	Transferrin receptor protein 1	GO:0003725; F:double-stranded RNA binding; IDA:MGI
P02786	TFRC	Transferrin receptor protein 1	GO:0042802; F:identical protein binding; IPI:IntAct
P02786	TFRC	Transferrin receptor protein 1	GO:0008233; F:peptidase activity; IEA:InterPro
P02786	TFRC	Transferrin receptor protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P02786	TFRC	Transferrin receptor protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P02786	TFRC	Transferrin receptor protein 1	GO:0004998; F:transferrin receptor activity; NAS:UniProtKB
P02786	TFRC	Transferrin receptor protein 1	GO:0006879; P:cellular iron ion homeostasis; NAS:UniProtKB
P02786	TFRC	Transferrin receptor protein 1	GO:0097286; P:iron ion import; IDA:UniProt
P02786	TFRC	Transferrin receptor protein 1	GO:0030316; P:osteoclast differentiation; IEA:Ensembl
P02786	TFRC	Transferrin receptor protein 1	GO:0045780; P:positive regulation of bone resorption; IEA:Ensembl
P02786	TFRC	Transferrin receptor protein 1	GO:0006898; P:receptor-mediated endocytosis; NAS:GOC
P02786	TFRC	Transferrin receptor protein 1	GO:0033572; P:transferrin transport; TAS:Reactome
P02786	TFRC	Transferrin receptor protein 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P02786	TFRC	Transferrin receptor protein 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9UP52	TFR2	Transferrin receptor protein 2	GO:0008233; F:peptidase activity; IEA:InterPro
Q9UP52	TFR2	Transferrin receptor protein 2	GO:0004998; F:transferrin receptor activity; NAS:UniProtKB
Q9UP52	TFR2	Transferrin receptor protein 2	GO:0006879; P:cellular iron ion homeostasis; TAS:UniProtKB
Q9UP52	TFR2	Transferrin receptor protein 2	GO:0006826; P:iron ion transport; NAS:UniProtKB
Q9UP52	TFR2	Transferrin receptor protein 2	GO:0006898; P:receptor-mediated endocytosis; NAS:GOC
P13726	F3	Tissue factor	GO:0005543; F:phospholipid binding; IDA:BHF-UCL
P13726	F3	Tissue factor	GO:0002020; F:protease binding; IPI:BHF-UCL
P13726	F3	Tissue factor	GO:0005515; F:protein binding; IPI:UniProtKB
P13726	F3	Tissue factor	GO:0002543; P:activation of blood coagulation via clotting cascade; IC:BHF-UCL
P13726	F3	Tissue factor	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:BHF-UCL
P13726	F3	Tissue factor	GO:0002541; P:activation of plasma proteins involved in acute inflammatory response; IDA:BHF-UCL
P13726	F3	Tissue factor	GO:0007596; P:blood coagulation; TAS:Reactome
P13726	F3	Tissue factor	GO:0007598; P:blood coagulation, extrinsic pathway; TAS:Reactome
P13726	F3	Tissue factor	GO:0045766; P:positive regulation of angiogenesis; IDA:BHF-UCL
P13726	F3	Tissue factor	GO:0030335; P:positive regulation of cell migration; TAS:BHF-UCL
P13726	F3	Tissue factor	GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:BHF-UCL
P13726	F3	Tissue factor	GO:0010641; P:positive regulation of platelet-derived growth factor receptor signaling pathway; IDA:BHF-UCL
P13726	F3	Tissue factor	GO:0050927; P:positive regulation of positive chemotaxis; IC:BHF-UCL
P13726	F3	Tissue factor	GO:0051897; P:positive regulation of protein kinase B signaling; IMP:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0015026; F:coreceptor activity; IDA:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0005539; F:glycosaminoglycan binding; ISS:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0008201; F:heparin binding; ISS:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0030165; F:PDZ domain binding; ISS:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0005515; F:protein binding; IPI:IntAct
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0046332; F:SMAD binding; IMP:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0050431; F:transforming growth factor beta binding; IDA:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0070123; F:transforming growth factor beta receptor activity, type III; IDA:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0005160; F:transforming growth factor beta receptor binding; ISS:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0005024; F:transforming growth factor beta-activated receptor activity; IDA:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0005114; F:type II transforming growth factor beta receptor binding; IDA:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0001824; P:blastocyst development; IEA:Ensembl
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0001568; P:blood vessel development; IEA:Ensembl
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0060317; P:cardiac epithelial to mesenchymal transition; IDA:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0060038; P:cardiac muscle cell proliferation; ISS:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0016049; P:cell growth; ISS:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0016477; P:cell migration; ISS:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0060318; P:definitive erythrocyte differentiation; ISS:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0060216; P:definitive hemopoiesis; ISS:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0001837; P:epithelial to mesenchymal transition; IDA:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0003007; P:heart morphogenesis; ISS:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0060347; P:heart trabecula formation; ISS:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0006955; P:immune response; IMP:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0035556; P:intracellular signal transduction; IMP:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0001889; P:liver development; ISS:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0051271; P:negative regulation of cellular component movement; IDA:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0010633; P:negative regulation of epithelial cell migration; IEA:Ensembl
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0050680; P:negative regulation of epithelial cell proliferation; ISS:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0010719; P:negative regulation of epithelial to mesenchymal transition; IEA:Ensembl
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0031100; P:organ regeneration; IEA:Ensembl
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0060021; P:palate development; ISS:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0060389; P:pathway-restricted SMAD protein phosphorylation; IMP:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:Ensembl
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0043393; P:regulation of protein binding; IEA:Ensembl
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0032354; P:response to follicle-stimulating hormone; IDA:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0034699; P:response to luteinizing hormone; IDA:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0034695; P:response to prostaglandin E; IDA:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0007181; P:transforming growth factor beta receptor complex assembly; IEA:Ensembl
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
Q03167	TGFBR3	Transforming growth factor beta receptor type 3	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; ISS:BHF-UCL
O95455	TGDS	dTDP-D-glucose 4,6-dehydratase	GO:0050662; F:coenzyme binding; IEA:InterPro
O95455	TGDS	dTDP-D-glucose 4,6-dehydratase	GO:0008460; F:dTDP-glucose 4,6-dehydratase activity; IEA:UniProtKB-EC
O95455	TGDS	dTDP-D-glucose 4,6-dehydratase	GO:0009225; P:nucleotide-sugar metabolic process; IEA:InterPro
Q8WUH2	TGFBRAP1	Transforming growth factor-beta receptor-associated protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WUH2	TGFBRAP1	Transforming growth factor-beta receptor-associated protein 1	GO:0046332; F:SMAD binding; IDA:UniProtKB
Q8WUH2	TGFBRAP1	Transforming growth factor-beta receptor-associated protein 1	GO:0005083; F:small GTPase regulator activity; IEA:InterPro
Q8WUH2	TGFBRAP1	Transforming growth factor-beta receptor-associated protein 1	GO:0005160; F:transforming growth factor beta receptor binding; IDA:UniProtKB
Q8WUH2	TGFBRAP1	Transforming growth factor-beta receptor-associated protein 1	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q8WUH2	TGFBRAP1	Transforming growth factor-beta receptor-associated protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q8WUH2	TGFBRAP1	Transforming growth factor-beta receptor-associated protein 1	GO:0007165; P:signal transduction; IDA:UniProtKB
Q8WUH2	TGFBRAP1	Transforming growth factor-beta receptor-associated protein 1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:UniProtKB
Q8WUH2	TGFBRAP1	Transforming growth factor-beta receptor-associated protein 1	GO:0016192; P:vesicle-mediated transport; IEA:InterPro
P01135	TGFA	Protransforming growth factor alpha	GO:0005154; F:epidermal growth factor receptor binding; IDA:UniProtKB
P01135	TGFA	Protransforming growth factor alpha	GO:0008083; F:growth factor activity; IDA:HGNC
P01135	TGFA	Protransforming growth factor alpha	GO:0004708; F:MAP kinase kinase activity; IDA:HGNC
P01135	TGFA	Protransforming growth factor alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P01135	TGFA	Protransforming growth factor alpha	GO:0000187; P:activation of MAPK activity; IDA:HGNC
P01135	TGFA	Protransforming growth factor alpha	GO:0001525; P:angiogenesis; IEA:Ensembl
P01135	TGFA	Protransforming growth factor alpha	GO:0008283; P:cell proliferation; TAS:ProtInc
P01135	TGFA	Protransforming growth factor alpha	GO:0007173; P:epidermal growth factor receptor signaling pathway; IEA:Ensembl
P01135	TGFA	Protransforming growth factor alpha	GO:0060749; P:mammary gland alveolus development; IEA:Ensembl
P01135	TGFA	Protransforming growth factor alpha	GO:0000165; P:MAPK cascade; IDA:GOC
P01135	TGFA	Protransforming growth factor alpha	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P01135	TGFA	Protransforming growth factor alpha	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P01135	TGFA	Protransforming growth factor alpha	GO:0045741; P:positive regulation of epidermal growth factor-activated receptor activity; IDA:HGNC
P01135	TGFA	Protransforming growth factor alpha	GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:HGNC
P01135	TGFA	Protransforming growth factor alpha	GO:0045840; P:positive regulation of mitosis; IDA:HGNC
P01135	TGFA	Protransforming growth factor alpha	GO:0042493; P:response to drug; IEA:Ensembl
P01135	TGFA	Protransforming growth factor alpha	GO:0042060; P:wound healing; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0003823; F:antigen binding; IPI:UniProt
P01137	TGFB1	Transforming growth factor beta-1	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0005515; F:protein binding; IPI:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0005114; F:type II transforming growth factor beta receptor binding; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0046732; P:active induction of host immune response by virus; TAS:Reactome
P01137	TGFB1	Transforming growth factor beta-1	GO:0002460; P:adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0007568; P:aging; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0006754; P:ATP biosynthetic process; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0007596; P:blood coagulation; TAS:Reactome
P01137	TGFB1	Transforming growth factor beta-1	GO:0060751; P:branch elongation involved in mammary gland duct branching; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0007050; P:cell cycle arrest; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0016049; P:cell growth; IEA:InterPro
P01137	TGFB1	Transforming growth factor beta-1	GO:0045216; P:cell-cell junction organization; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0071549; P:cellular response to dexamethasone stimulus; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0071407; P:cellular response to organic cyclic compound; IDA:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0002062; P:chondrocyte differentiation; IDA:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0007182; P:common-partner SMAD protein phosphorylation; IDA:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0002248; P:connective tissue replacement involved in inflammatory response wound healing; TAS:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0009817; P:defense response to fungus, incompatible interaction; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0048565; P:digestive tract development; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0009790; P:embryo development; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0007492; P:endoderm development; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0007173; P:epidermal growth factor receptor signaling pathway; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0001837; P:epithelial to mesenchymal transition; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0019049; P:evasion or tolerance of host defenses by virus; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0085029; P:extracellular matrix assembly; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P01137	TGFB1	Transforming growth factor beta-1	GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0060325; P:face morphogenesis; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0007565; P:female pregnancy; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0060364; P:frontal suture morphogenesis; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0008354; P:germ cell migration; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0002244; P:hematopoietic progenitor cell differentiation; IDA:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0030214; P:hyaluronan catabolic process; IDA:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0006954; P:inflammatory response; IDA:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0048839; P:inner ear development; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0070306; P:lens fiber cell differentiation; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IDA:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0048535; P:lymph node development; ISS:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0010742; P:macrophage derived foam cell differentiation; IC:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0060744; P:mammary gland branching involved in thelarche; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0000165; P:MAPK cascade; IMP:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0007093; P:mitotic cell cycle checkpoint; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0019048; P:modulation by virus of host morphology or physiology; TAS:Reactome
P01137	TGFB1	Transforming growth factor beta-1	GO:0032943; P:mononuclear cell proliferation; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0042552; P:myelination; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0043011; P:myeloid dendritic cell differentiation; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0043537; P:negative regulation of blood vessel endothelial cell migration; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0045786; P:negative regulation of cell cycle; IDA:HGNC
P01137	TGFB1	Transforming growth factor beta-1	GO:0030308; P:negative regulation of cell growth; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0022408; P:negative regulation of cell-cell adhesion; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0008156; P:negative regulation of DNA replication; IMP:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0050680; P:negative regulation of epithelial cell proliferation; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0045599; P:negative regulation of fat cell differentiation; IDA:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:1900126; P:negative regulation of hyaluronan biosynthetic process; IDA:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0050777; P:negative regulation of immune response; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0010936; P:negative regulation of macrophage cytokine production; IDA:DFLAT
P01137	TGFB1	Transforming growth factor beta-1	GO:0045930; P:negative regulation of mitotic cell cycle; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0045662; P:negative regulation of myoblast differentiation; IDA:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0007406; P:negative regulation of neuroblast proliferation; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0030279; P:negative regulation of ossification; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0050765; P:negative regulation of phagocytosis; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0001933; P:negative regulation of protein phosphorylation; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0051280; P:negative regulation of release of sequestered calcium ion into cytosol; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0048642; P:negative regulation of skeletal muscle tissue development; IDA:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
P01137	TGFB1	Transforming growth factor beta-1	GO:0031100; P:organ regeneration; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0043932; P:ossification involved in bone remodeling; IEP:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0060389; P:pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0006796; P:phosphate-containing compound metabolic process; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0030168; P:platelet activation; TAS:Reactome
P01137	TGFB1	Transforming growth factor beta-1	GO:0002576; P:platelet degranulation; TAS:Reactome
P01137	TGFB1	Transforming growth factor beta-1	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0030501; P:positive regulation of bone mineralization; IEP:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0071158; P:positive regulation of cell cycle arrest; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P01137	TGFB1	Transforming growth factor beta-1	GO:0030335; P:positive regulation of cell migration; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0032270; P:positive regulation of cellular protein metabolic process; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0050921; P:positive regulation of chemotaxis; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0032967; P:positive regulation of collagen biosynthetic process; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0031536; P:positive regulation of exit from mitosis; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0010763; P:positive regulation of fibroblast migration; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0035066; P:positive regulation of histone acetylation; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0031065; P:positive regulation of histone deacetylation; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0032740; P:positive regulation of interleukin-17 production; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0048298; P:positive regulation of isotype switching to IgA isotypes; IDA:MGI
P01137	TGFB1	Transforming growth factor beta-1	GO:0043406; P:positive regulation of MAP kinase activity; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:1901666; P:positive regulation of NAD+ ADP-ribosyltransferase activity; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0042482; P:positive regulation of odontogenesis; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0031334; P:positive regulation of protein complex assembly; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0035307; P:positive regulation of protein dephosphorylation; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0042307; P:positive regulation of protein import into nucleus; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0001934; P:positive regulation of protein phosphorylation; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0050714; P:positive regulation of protein secretion; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0060391; P:positive regulation of SMAD protein import into nucleus; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0051152; P:positive regulation of smooth muscle cell differentiation; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0032930; P:positive regulation of superoxide anion generation; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:2000679; P:positive regulation of transcription regulatory region DNA binding; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0010575; P:positive regulation vascular endothelial growth factor production; TAS:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0006611; P:protein export from nucleus; IDA:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0000060; P:protein import into nucleus, translocation; IDA:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0043491; P:protein kinase B signaling; IMP:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0032801; P:receptor catabolic process; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0051098; P:regulation of binding; ISS:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0060762; P:regulation of branching involved in mammary gland duct morphogenesis; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0061035; P:regulation of cartilage development; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0030334; P:regulation of cell migration; TAS:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0051101; P:regulation of DNA binding; ISS:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0042306; P:regulation of protein import into nucleus; ISS:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0002028; P:regulation of sodium ion transport; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0016202; P:regulation of striated muscle tissue development; ISS:UniProtKB
P01137	TGFB1	Transforming growth factor beta-1	GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0045066; P:regulatory T cell differentiation; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0070723; P:response to cholesterol; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0042493; P:response to drug; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0032355; P:response to estradiol; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0009749; P:response to glucose; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0001666; P:response to hypoxia; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0034616; P:response to laminar fluid shear stress; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0032570; P:response to progesterone; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0009314; P:response to radiation; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0033280; P:response to vitamin D; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0009611; P:response to wounding; IEP:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0007435; P:salivary gland morphogenesis; IEP:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0007183; P:SMAD protein complex assembly; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0007184; P:SMAD protein import into nucleus; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0043029; P:T cell homeostasis; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0002513; P:tolerance induction to self antigen; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
P01137	TGFB1	Transforming growth factor beta-1	GO:0001657; P:ureteric bud development; IEA:Ensembl
P01137	TGFB1	Transforming growth factor beta-1	GO:0019058; P:viral life cycle; TAS:Reactome
P61812	TGFB2	Transforming growth factor beta-2	GO:0001540; F:beta-amyloid binding; IDA:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0005125; F:cytokine activity; TAS:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0005515; F:protein binding; IPI:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0046982; F:protein heterodimerization activity; TAS:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0005102; F:receptor binding; IMP:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0005160; F:transforming growth factor beta receptor binding; IDA:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0005114; F:type II transforming growth factor beta receptor binding; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0032147; P:activation of protein kinase activity; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0001525; P:angiogenesis; TAS:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0007411; P:axon guidance; IEA:Ensembl
P61812	TGFB2	Transforming growth factor beta-2	GO:0007596; P:blood coagulation; TAS:Reactome
P61812	TGFB2	Transforming growth factor beta-2	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
P61812	TGFB2	Transforming growth factor beta-2	GO:0060317; P:cardiac epithelial to mesenchymal transition; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0060038; P:cardiac muscle cell proliferation; IDA:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0010002; P:cardioblast differentiation; IDA:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0001502; P:cartilage condensation; IEA:Ensembl
P61812	TGFB2	Transforming growth factor beta-2	GO:0042637; P:catagen; IDA:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0007050; P:cell cycle arrest; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0008219; P:cell death; IDA:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0016049; P:cell growth; IEA:InterPro
P61812	TGFB2	Transforming growth factor beta-2	GO:0016477; P:cell migration; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0000902; P:cell morphogenesis; IDA:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0008283; P:cell proliferation; TAS:ProtInc
P61812	TGFB2	Transforming growth factor beta-2	GO:0045216; P:cell-cell junction organization; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P61812	TGFB2	Transforming growth factor beta-2	GO:0030199; P:collagen fibril organization; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0042416; P:dopamine biosynthetic process; ISS:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0009790; P:embryo development; TAS:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0048566; P:embryonic digestive tract development; IEP:DFLAT
P61812	TGFB2	Transforming growth factor beta-2	GO:0001837; P:epithelial to mesenchymal transition; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P61812	TGFB2	Transforming growth factor beta-2	GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0001654; P:eye development; IDA:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0060325; P:face morphogenesis; IEA:Ensembl
P61812	TGFB2	Transforming growth factor beta-2	GO:0048699; P:generation of neurons; TAS:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0008347; P:glial cell migration; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0001942; P:hair follicle development; IDA:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0031069; P:hair follicle morphogenesis; ISS:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0007507; P:heart development; IDA:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0003007; P:heart morphogenesis; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0030097; P:hemopoiesis; ISS:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0022601; P:menstrual cycle phase; IEP:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0010693; P:negative regulation of alkaline phosphatase activity; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0030308; P:negative regulation of cell growth; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0050680; P:negative regulation of epithelial cell proliferation; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0050777; P:negative regulation of immune response; TAS:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0010936; P:negative regulation of macrophage cytokine production; IDA:DFLAT
P61812	TGFB2	Transforming growth factor beta-2	GO:0048666; P:neuron development; ISS:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0048663; P:neuron fate commitment; IEA:Ensembl
P61812	TGFB2	Transforming growth factor beta-2	GO:0030593; P:neutrophil chemotaxis; ISS:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0042476; P:odontogenesis; NAS:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0060389; P:pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0030168; P:platelet activation; TAS:Reactome
P61812	TGFB2	Transforming growth factor beta-2	GO:0002576; P:platelet degranulation; TAS:Reactome
P61812	TGFB2	Transforming growth factor beta-2	GO:0070237; P:positive regulation of activation-induced cell death of T cells; IEA:Ensembl
P61812	TGFB2	Transforming growth factor beta-2	GO:0051891; P:positive regulation of cardioblast differentiation; IDA:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0051795; P:positive regulation of catagen; IDA:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0033630; P:positive regulation of cell adhesion mediated by integrin; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0045787; P:positive regulation of cell cycle; ISS:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P61812	TGFB2	Transforming growth factor beta-2	GO:0030307; P:positive regulation of cell growth; IDA:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0010634; P:positive regulation of epithelial cell migration; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P61812	TGFB2	Transforming growth factor beta-2	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P61812	TGFB2	Transforming growth factor beta-2	GO:0045823; P:positive regulation of heart contraction; IDA:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0050778; P:positive regulation of immune response; ISS:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0045726; P:positive regulation of integrin biosynthetic process; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0043525; P:positive regulation of neuron apoptotic process; IDA:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0045778; P:positive regulation of ossification; IEP:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0050714; P:positive regulation of protein secretion; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0032874; P:positive regulation of stress-activated MAPK cascade; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0006468; P:protein phosphorylation; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0032909; P:regulation of transforming growth factor beta2 production; IMP:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0042493; P:response to drug; IDA:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0001666; P:response to hypoxia; IMP:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0032570; P:response to progesterone; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0009611; P:response to wounding; IEP:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0007435; P:salivary gland morphogenesis; IEP:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0023014; P:signal transduction by phosphorylation; IDA:GOC
P61812	TGFB2	Transforming growth factor beta-2	GO:0007184; P:SMAD protein import into nucleus; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0048103; P:somatic stem cell division; ISS:UniProtKB
P61812	TGFB2	Transforming growth factor beta-2	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
P61812	TGFB2	Transforming growth factor beta-2	GO:0042060; P:wound healing; ISS:UniProtKB
P10600	TGFB3	Transforming growth factor beta-3	GO:0042802; F:identical protein binding; IDA:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0005515; F:protein binding; IPI:UniProtKB
P10600	TGFB3	Transforming growth factor beta-3	GO:0050431; F:transforming growth factor beta binding; IDA:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0034713; F:type I transforming growth factor beta receptor binding; IDA:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0005114; F:type II transforming growth factor beta receptor binding; IDA:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0000187; P:activation of MAPK activity; IEA:Ensembl
P10600	TGFB3	Transforming growth factor beta-3	GO:0007568; P:aging; IEA:Ensembl
P10600	TGFB3	Transforming growth factor beta-3	GO:0007596; P:blood coagulation; TAS:Reactome
P10600	TGFB3	Transforming growth factor beta-3	GO:0016049; P:cell growth; IEA:InterPro
P10600	TGFB3	Transforming growth factor beta-3	GO:0045216; P:cell-cell junction organization; IDA:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0070483; P:detection of hypoxia; IDA:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0048565; P:digestive tract development; IEA:Ensembl
P10600	TGFB3	Transforming growth factor beta-3	GO:0048702; P:embryonic neurocranium morphogenesis; IEA:Ensembl
P10600	TGFB3	Transforming growth factor beta-3	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P10600	TGFB3	Transforming growth factor beta-3	GO:0060325; P:face morphogenesis; IMP:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0007565; P:female pregnancy; IEA:Ensembl
P10600	TGFB3	Transforming growth factor beta-3	GO:0060364; P:frontal suture morphogenesis; IEA:Ensembl
P10600	TGFB3	Transforming growth factor beta-3	GO:0001701; P:in utero embryonic development; ISS:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0048839; P:inner ear development; IEA:Ensembl
P10600	TGFB3	Transforming growth factor beta-3	GO:0048286; P:lung alveolus development; ISS:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0030879; P:mammary gland development; ISS:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0022601; P:menstrual cycle phase; IEP:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0008285; P:negative regulation of cell proliferation; ISS:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0008156; P:negative regulation of DNA replication; IMP:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0010936; P:negative regulation of macrophage cytokine production; IDA:DFLAT
P10600	TGFB3	Transforming growth factor beta-3	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl
P10600	TGFB3	Transforming growth factor beta-3	GO:0042476; P:odontogenesis; NAS:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0043932; P:ossification involved in bone remodeling; IEP:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0060021; P:palate development; ISS:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0030168; P:platelet activation; TAS:Reactome
P10600	TGFB3	Transforming growth factor beta-3	GO:0002576; P:platelet degranulation; TAS:Reactome
P10600	TGFB3	Transforming growth factor beta-3	GO:0043065; P:positive regulation of apoptotic process; ISS:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0030501; P:positive regulation of bone mineralization; IEP:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P10600	TGFB3	Transforming growth factor beta-3	GO:0032967; P:positive regulation of collagen biosynthetic process; IMP:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0045740; P:positive regulation of DNA replication; IMP:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IDA:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0051491; P:positive regulation of filopodium assembly; ISS:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; ISS:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0050714; P:positive regulation of protein secretion; IDA:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0060391; P:positive regulation of SMAD protein import into nucleus; ISS:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0043627; P:response to estrogen; IEA:Ensembl
P10600	TGFB3	Transforming growth factor beta-3	GO:0001666; P:response to hypoxia; IDA:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0034616; P:response to laminar fluid shear stress; IEA:Ensembl
P10600	TGFB3	Transforming growth factor beta-3	GO:0032570; P:response to progesterone; IDA:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0007435; P:salivary gland morphogenesis; IEP:BHF-UCL
P10600	TGFB3	Transforming growth factor beta-3	GO:0007184; P:SMAD protein import into nucleus; IEA:Ensembl
P10600	TGFB3	Transforming growth factor beta-3	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0050681; F:androgen receptor binding; IPI:UniProtKB
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0070411; F:I-SMAD binding; IPI:BHF-UCL
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0005515; F:protein binding; IPI:UniProtKB
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0048495; F:Roundabout binding; IPI:UniProtKB
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0008270; F:zinc ion binding; IEA:InterPro
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0007155; P:cell adhesion; TAS:ProtInc
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0045165; P:cell fate commitment; IEA:Ensembl
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0030855; P:epithelial cell differentiation; IEA:Ensembl
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0016331; P:morphogenesis of embryonic epithelium; IEA:Ensembl
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0045599; P:negative regulation of fat cell differentiation; IEA:Ensembl
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IDA:BHF-UCL
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0009408; P:response to heat; IEA:Ensembl
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0030579; P:ubiquitin-dependent SMAD protein catabolic process; IDA:BHF-UCL
O43294	TGFB1I1	Transforming growth factor beta-1-induced transcript 1 protein	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P36897	TGFBR1	TGF-beta receptor type-1	GO:0005524; F:ATP binding; IDA:HGNC
P36897	TGFBR1	TGF-beta receptor type-1	GO:0070411; F:I-SMAD binding; IPI:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P36897	TGFBR1	TGF-beta receptor type-1	GO:0005515; F:protein binding; IPI:UniProtKB
P36897	TGFBR1	TGF-beta receptor type-1	GO:0004672; F:protein kinase activity; IDA:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0004674; F:protein serine/threonine kinase activity; IDA:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0046332; F:SMAD binding; IDA:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0050431; F:transforming growth factor beta binding; IDA:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0005025; F:transforming growth factor beta receptor activity, type I; IDA:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0005024; F:transforming growth factor beta-activated receptor activity; IDA:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0005114; F:type II transforming growth factor beta receptor binding; IDA:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0000186; P:activation of MAPKK activity; IDA:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0001525; P:angiogenesis; IEA:Ensembl
P36897	TGFBR1	TGF-beta receptor type-1	GO:0009952; P:anterior/posterior pattern specification; ISS:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P36897	TGFBR1	TGF-beta receptor type-1	GO:0048844; P:artery morphogenesis; ISS:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0001824; P:blastocyst development; IEA:Ensembl
P36897	TGFBR1	TGF-beta receptor type-1	GO:0007050; P:cell cycle arrest; TAS:UniProtKB
P36897	TGFBR1	TGF-beta receptor type-1	GO:0048870; P:cell motility; IMP:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IDA:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0030199; P:collagen fibril organization; ISS:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0048701; P:embryonic cranial skeleton morphogenesis; ISS:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0043542; P:endothelial cell migration; IEA:Ensembl
P36897	TGFBR1	TGF-beta receptor type-1	GO:0001837; P:epithelial to mesenchymal transition; IDA:UniProtKB
P36897	TGFBR1	TGF-beta receptor type-1	GO:0043062; P:extracellular structure organization; TAS:UniProtKB
P36897	TGFBR1	TGF-beta receptor type-1	GO:0008354; P:germ cell migration; ISS:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0007507; P:heart development; ISS:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0001701; P:in utero embryonic development; ISS:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0001822; P:kidney development; ISS:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0002088; P:lens development in camera-type eye; IEA:Ensembl
P36897	TGFBR1	TGF-beta receptor type-1	GO:0048762; P:mesenchymal cell differentiation; TAS:UniProtKB
P36897	TGFBR1	TGF-beta receptor type-1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P36897	TGFBR1	TGF-beta receptor type-1	GO:0032331; P:negative regulation of chondrocyte differentiation; ISS:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0001937; P:negative regulation of endothelial cell proliferation; IEA:Ensembl
P36897	TGFBR1	TGF-beta receptor type-1	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
P36897	TGFBR1	TGF-beta receptor type-1	GO:0048663; P:neuron fate commitment; ISS:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0060021; P:palate development; ISS:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0060017; P:parathyroid gland development; ISS:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0060389; P:pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB
P36897	TGFBR1	TGF-beta receptor type-1	GO:0018107; P:peptidyl-threonine phosphorylation; IDA:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0060037; P:pharyngeal system development; ISS:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:2001235; P:positive regulation of apoptotic signaling pathway; IDA:UniProtKB
P36897	TGFBR1	TGF-beta receptor type-1	GO:0030307; P:positive regulation of cell growth; IDA:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0008284; P:positive regulation of cell proliferation; IMP:HGNC
P36897	TGFBR1	TGF-beta receptor type-1	GO:0051272; P:positive regulation of cellular component movement; IMP:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0051491; P:positive regulation of filopodium assembly; IEA:Ensembl
P36897	TGFBR1	TGF-beta receptor type-1	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0060391; P:positive regulation of SMAD protein import into nucleus; IDA:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0009791; P:post-embryonic development; IEA:Ensembl
P36897	TGFBR1	TGF-beta receptor type-1	GO:0006468; P:protein phosphorylation; IDA:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0043393; P:regulation of protein binding; IEA:Ensembl
P36897	TGFBR1	TGF-beta receptor type-1	GO:0031396; P:regulation of protein ubiquitination; IDA:UniProtKB
P36897	TGFBR1	TGF-beta receptor type-1	GO:0006355; P:regulation of transcription, DNA-templated; IDA:HGNC
P36897	TGFBR1	TGF-beta receptor type-1	GO:0070723; P:response to cholesterol; IDA:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0007165; P:signal transduction; IDA:HGNC
P36897	TGFBR1	TGF-beta receptor type-1	GO:0001501; P:skeletal system development; ISS:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0048705; P:skeletal system morphogenesis; ISS:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0048538; P:thymus development; ISS:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
P36897	TGFBR1	TGF-beta receptor type-1	GO:0042060; P:wound healing; TAS:UniProtKB
P37173	TGFBR2	TGF-beta receptor type-2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P37173	TGFBR2	TGF-beta receptor type-2	GO:0005539; F:glycosaminoglycan binding; IDA:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P37173	TGFBR2	TGF-beta receptor type-2	GO:0005515; F:protein binding; IPI:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IEA:InterPro
P37173	TGFBR2	TGF-beta receptor type-2	GO:0046332; F:SMAD binding; IDA:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0050431; F:transforming growth factor beta binding; IDA:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0005026; F:transforming growth factor beta receptor activity, type II; IEA:InterPro
P37173	TGFBR2	TGF-beta receptor type-2	GO:0005024; F:transforming growth factor beta-activated receptor activity; IDA:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0004675; F:transmembrane receptor protein serine/threonine kinase activity; IDA:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0034713; F:type I transforming growth factor beta receptor binding; IDA:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0034714; F:type III transforming growth factor beta receptor binding; IDA:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0032147; P:activation of protein kinase activity; ISS:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0007568; P:aging; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0006915; P:apoptotic process; IDA:UniProtKB
P37173	TGFBR2	TGF-beta receptor type-2	GO:0001568; P:blood vessel development; TAS:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0007420; P:brain development; ISS:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0060434; P:bronchus morphogenesis; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0051216; P:cartilage development; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0007182; P:common-partner SMAD protein phosphorylation; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0048565; P:digestive tract development; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0007566; P:embryo implantation; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0048701; P:embryonic cranial skeleton morphogenesis; ISS:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0035162; P:embryonic hemopoiesis; ISS:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0007369; P:gastrulation; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0007507; P:heart development; ISS:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0002088; P:lens development in camera-type eye; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:1990086; P:lens fiber cell apoptotic process; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0060463; P:lung lobe morphogenesis; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0060443; P:mammary gland morphogenesis; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0043011; P:myeloid dendritic cell differentiation; ISS:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0060044; P:negative regulation of cardiac muscle cell proliferation; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
P37173	TGFBR2	TGF-beta receptor type-2	GO:0031100; P:organ regeneration; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0060021; P:palate development; ISS:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0060389; P:pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0001569; P:patterning of blood vessels; ISS:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0018105; P:peptidyl-serine phosphorylation; IDA:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0018107; P:peptidyl-threonine phosphorylation; IDA:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0002663; P:positive regulation of B cell tolerance induction; ISS:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P37173	TGFBR2	TGF-beta receptor type-2	GO:0010634; P:positive regulation of epithelial cell migration; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0002053; P:positive regulation of mesenchymal cell proliferation; ISS:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0051138; P:positive regulation of NK T cell differentiation; ISS:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IMP:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0043415; P:positive regulation of skeletal muscle tissue regeneration; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0002666; P:positive regulation of T cell tolerance induction; ISS:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0002651; P:positive regulation of tolerance induction to self antigen; ISS:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0006468; P:protein phosphorylation; IDA:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0006898; P:receptor-mediated endocytosis; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0042127; P:regulation of cell proliferation; ISS:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0070723; P:response to cholesterol; IDA:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0042493; P:response to drug; IDA:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0043627; P:response to estrogen; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0009749; P:response to glucose; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0007584; P:response to nutrient; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0060440; P:trachea formation; IEA:Ensembl
P37173	TGFBR2	TGF-beta receptor type-2	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0001570; P:vasculogenesis; ISS:BHF-UCL
P37173	TGFBR2	TGF-beta receptor type-2	GO:0042060; P:wound healing; IEA:Ensembl
Q15583	TGIF1	Homeobox protein TGIF1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q15583	TGIF1	Homeobox protein TGIF1	GO:0005515; F:protein binding; IPI:IntAct
Q15583	TGIF1	Homeobox protein TGIF1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q15583	TGIF1	Homeobox protein TGIF1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q15583	TGIF1	Homeobox protein TGIF1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q15583	TGIF1	Homeobox protein TGIF1	GO:0007368; P:determination of left/right symmetry; IEA:Ensembl
Q15583	TGIF1	Homeobox protein TGIF1	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
Q15583	TGIF1	Homeobox protein TGIF1	GO:0010467; P:gene expression; TAS:Reactome
Q15583	TGIF1	Homeobox protein TGIF1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q15583	TGIF1	Homeobox protein TGIF1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q15583	TGIF1	Homeobox protein TGIF1	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:Ensembl
Q15583	TGIF1	Homeobox protein TGIF1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:Reactome
Q15583	TGIF1	Homeobox protein TGIF1	GO:0001843; P:neural tube closure; IEA:Ensembl
Q15583	TGIF1	Homeobox protein TGIF1	GO:0038092; P:nodal signaling pathway; IEA:Ensembl
Q15583	TGIF1	Homeobox protein TGIF1	GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl
Q15583	TGIF1	Homeobox protein TGIF1	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
Q15583	TGIF1	Homeobox protein TGIF1	GO:0010470; P:regulation of gastrulation; IEA:Ensembl
Q15583	TGIF1	Homeobox protein TGIF1	GO:0042493; P:response to drug; IEA:Ensembl
Q15583	TGIF1	Homeobox protein TGIF1	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
Q15583	TGIF1	Homeobox protein TGIF1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q15583	TGIF1	Homeobox protein TGIF1	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
Q15583	TGIF1	Homeobox protein TGIF1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q9GZN2	TGIF2	Homeobox protein TGIF2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9GZN2	TGIF2	Homeobox protein TGIF2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9GZN2	TGIF2	Homeobox protein TGIF2	GO:0010467; P:gene expression; TAS:Reactome
Q9GZN2	TGIF2	Homeobox protein TGIF2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q9GZN2	TGIF2	Homeobox protein TGIF2	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9GZN2	TGIF2	Homeobox protein TGIF2	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q9GZN2	TGIF2	Homeobox protein TGIF2	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
Q9GZN2	TGIF2	Homeobox protein TGIF2	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P22735	TGM1	Protein-glutamine gamma-glutamyltransferase K	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P22735	TGM1	Protein-glutamine gamma-glutamyltransferase K	GO:0005515; F:protein binding; IPI:UniProtKB
P22735	TGM1	Protein-glutamine gamma-glutamyltransferase K	GO:0003810; F:protein-glutamine gamma-glutamyltransferase activity; IDA:UniProtKB
P22735	TGM1	Protein-glutamine gamma-glutamyltransferase K	GO:0043163; P:cell envelope organization; TAS:UniProtKB
P22735	TGM1	Protein-glutamine gamma-glutamyltransferase K	GO:0006464; P:cellular protein modification process; NAS:UniProtKB
P22735	TGM1	Protein-glutamine gamma-glutamyltransferase K	GO:0031424; P:keratinization; IEA:UniProtKB-KW
P22735	TGM1	Protein-glutamine gamma-glutamyltransferase K	GO:0030216; P:keratinocyte differentiation; IDA:UniProtKB
P22735	TGM1	Protein-glutamine gamma-glutamyltransferase K	GO:0009887; P:organ morphogenesis; IEA:Ensembl
P22735	TGM1	Protein-glutamine gamma-glutamyltransferase K	GO:0018149; P:peptide cross-linking; IEA:InterPro
P21980	TGM2	Protein-glutamine gamma-glutamyltransferase 2	GO:0005525; F:GTP binding; IEA:Ensembl
P21980	TGM2	Protein-glutamine gamma-glutamyltransferase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P21980	TGM2	Protein-glutamine gamma-glutamyltransferase 2	GO:0005515; F:protein binding; IPI:UniProtKB
P21980	TGM2	Protein-glutamine gamma-glutamyltransferase 2	GO:0003810; F:protein-glutamine gamma-glutamyltransferase activity; ISS:UniProtKB
P21980	TGM2	Protein-glutamine gamma-glutamyltransferase 2	GO:0043277; P:apoptotic cell clearance; IDA:UniProtKB
P21980	TGM2	Protein-glutamine gamma-glutamyltransferase 2	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
P21980	TGM2	Protein-glutamine gamma-glutamyltransferase 2	GO:0060445; P:branching involved in salivary gland morphogenesis; IEA:Ensembl
P21980	TGM2	Protein-glutamine gamma-glutamyltransferase 2	GO:0018153; P:isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine; IEA:Ensembl
P21980	TGM2	Protein-glutamine gamma-glutamyltransferase 2	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P21980	TGM2	Protein-glutamine gamma-glutamyltransferase 2	GO:0045785; P:positive regulation of cell adhesion; ISS:UniProtKB
P21980	TGM2	Protein-glutamine gamma-glutamyltransferase 2	GO:0051482; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway; IEA:Ensembl
P21980	TGM2	Protein-glutamine gamma-glutamyltransferase 2	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
P21980	TGM2	Protein-glutamine gamma-glutamyltransferase 2	GO:0050729; P:positive regulation of inflammatory response; IEA:Ensembl
P21980	TGM2	Protein-glutamine gamma-glutamyltransferase 2	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
P21980	TGM2	Protein-glutamine gamma-glutamyltransferase 2	GO:0051260; P:protein homooligomerization; IEA:Ensembl
P21980	TGM2	Protein-glutamine gamma-glutamyltransferase 2	GO:0060662; P:salivary gland cavitation; IEA:Ensembl
O95932	TGM6	Protein-glutamine gamma-glutamyltransferase 6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95932	TGM6	Protein-glutamine gamma-glutamyltransferase 6	GO:0003810; F:protein-glutamine gamma-glutamyltransferase activity; IDA:MGI
O95932	TGM6	Protein-glutamine gamma-glutamyltransferase 6	GO:0008219; P:cell death; IEA:UniProtKB-KW
O95932	TGM6	Protein-glutamine gamma-glutamyltransferase 6	GO:0018149; P:peptide cross-linking; IEA:InterPro
Q08188	TGM3	Protein-glutamine gamma-glutamyltransferase E	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q08188	TGM3	Protein-glutamine gamma-glutamyltransferase E	GO:0003824; F:catalytic activity; IDA:UniProtKB
Q08188	TGM3	Protein-glutamine gamma-glutamyltransferase E	GO:0003810; F:protein-glutamine gamma-glutamyltransferase activity; IDA:UniProtKB
Q08188	TGM3	Protein-glutamine gamma-glutamyltransferase E	GO:0016746; F:transferase activity, transferring acyl groups; TAS:UniProtKB
Q08188	TGM3	Protein-glutamine gamma-glutamyltransferase E	GO:0043163; P:cell envelope organization; IDA:UniProtKB
Q08188	TGM3	Protein-glutamine gamma-glutamyltransferase E	GO:0006464; P:cellular protein modification process; NAS:UniProtKB
Q08188	TGM3	Protein-glutamine gamma-glutamyltransferase E	GO:0031069; P:hair follicle morphogenesis; TAS:UniProtKB
Q08188	TGM3	Protein-glutamine gamma-glutamyltransferase E	GO:0031424; P:keratinization; IEA:UniProtKB-KW
Q08188	TGM3	Protein-glutamine gamma-glutamyltransferase E	GO:0030216; P:keratinocyte differentiation; IEP:UniProtKB
Q08188	TGM3	Protein-glutamine gamma-glutamyltransferase E	GO:0018149; P:peptide cross-linking; IDA:UniProtKB
Q08188	TGM3	Protein-glutamine gamma-glutamyltransferase E	GO:0051262; P:protein tetramerization; IDA:UniProtKB
P49221	TGM4	Protein-glutamine gamma-glutamyltransferase 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P49221	TGM4	Protein-glutamine gamma-glutamyltransferase 4	GO:0003810; F:protein-glutamine gamma-glutamyltransferase activity; NAS:UniProtKB
P49221	TGM4	Protein-glutamine gamma-glutamyltransferase 4	GO:0042628; P:mating plug formation; IEA:Ensembl
P49221	TGM4	Protein-glutamine gamma-glutamyltransferase 4	GO:0018149; P:peptide cross-linking; IEA:InterPro
O43548	TGM5	Protein-glutamine gamma-glutamyltransferase 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43548	TGM5	Protein-glutamine gamma-glutamyltransferase 5	GO:0003810; F:protein-glutamine gamma-glutamyltransferase activity; TAS:ProtInc
O43548	TGM5	Protein-glutamine gamma-glutamyltransferase 5	GO:0006464; P:cellular protein modification process; TAS:ProtInc
O43548	TGM5	Protein-glutamine gamma-glutamyltransferase 5	GO:0008544; P:epidermis development; TAS:ProtInc
O43548	TGM5	Protein-glutamine gamma-glutamyltransferase 5	GO:0018149; P:peptide cross-linking; IEA:InterPro
Q96PF1	TGM7	Protein-glutamine gamma-glutamyltransferase Z	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96PF1	TGM7	Protein-glutamine gamma-glutamyltransferase Z	GO:0003810; F:protein-glutamine gamma-glutamyltransferase activity; IEA:UniProtKB-EC
Q96PF1	TGM7	Protein-glutamine gamma-glutamyltransferase Z	GO:0018149; P:peptide cross-linking; IEA:InterPro
O43493	TGOLN2	Trans-Golgi network integral membrane protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q96RS0	TGS1	Trimethylguanosine synthase	GO:0005515; F:protein binding; IPI:IntAct
Q96RS0	TGS1	Trimethylguanosine synthase	GO:0071164; F:RNA trimethylguanosine synthase activity; IDA:BHF-UCL
Q96RS0	TGS1	Trimethylguanosine synthase	GO:0036261; P:7-methylguanosine cap hypermethylation; IDA:BHF-UCL
Q96RS0	TGS1	Trimethylguanosine synthase	GO:0009452; P:7-methylguanosine RNA capping; IEA:InterPro
Q96RS0	TGS1	Trimethylguanosine synthase	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q96RS0	TGS1	Trimethylguanosine synthase	GO:0010467; P:gene expression; TAS:Reactome
Q96RS0	TGS1	Trimethylguanosine synthase	GO:0034660; P:ncRNA metabolic process; TAS:Reactome
Q96RS0	TGS1	Trimethylguanosine synthase	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96RS0	TGS1	Trimethylguanosine synthase	GO:0022613; P:ribonucleoprotein complex biogenesis; IC:BHF-UCL
Q96RS0	TGS1	Trimethylguanosine synthase	GO:0071167; P:ribonucleoprotein complex import into nucleus; IC:BHF-UCL
Q96RS0	TGS1	Trimethylguanosine synthase	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q96RS0	TGS1	Trimethylguanosine synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96RS0	TGS1	Trimethylguanosine synthase	GO:0000387; P:spliceosomal snRNP assembly; TAS:Reactome
Q96RS0	TGS1	Trimethylguanosine synthase	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BXR0	QTRT1	Queuine tRNA-ribosyltransferase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BXR0	QTRT1	Queuine tRNA-ribosyltransferase	GO:0008479; F:queuine tRNA-ribosyltransferase activity; TAS:UniProtKB
Q9BXR0	QTRT1	Queuine tRNA-ribosyltransferase	GO:0008616; P:queuosine biosynthetic process; ISS:UniProtKB
Q9BXR0	QTRT1	Queuine tRNA-ribosyltransferase	GO:0006400; P:tRNA modification; TAS:UniProtKB
Q9P2Z0	THAP10	THAP domain-containing protein 10	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9P2Z0	THAP10	THAP domain-containing protein 10	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96EK4	THAP11	THAP domain-containing protein 11	GO:0003677; F:DNA binding; IDA:UniProtKB
Q96EK4	THAP11	THAP domain-containing protein 11	GO:0005515; F:protein binding; IPI:IntAct
Q96EK4	THAP11	THAP domain-containing protein 11	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q96EK4	THAP11	THAP domain-containing protein 11	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96EK4	THAP11	THAP domain-containing protein 11	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NVV9	THAP1	THAP domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NVV9	THAP1	THAP domain-containing protein 1	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q9NVV9	THAP1	THAP domain-containing protein 1	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q9NVV9	THAP1	THAP domain-containing protein 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9NVV9	THAP1	THAP domain-containing protein 1	GO:0001935; P:endothelial cell proliferation; IMP:UniProtKB
Q9NVV9	THAP1	THAP domain-containing protein 1	GO:0007346; P:regulation of mitotic cell cycle; IMP:UniProtKB
Q9NVV9	THAP1	THAP domain-containing protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB
Q9NVV9	THAP1	THAP domain-containing protein 1	GO:0006351; P:transcription, DNA-templated; IMP:UniProtKB
Q9H0W7	THAP2	THAP domain-containing protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H0W7	THAP2	THAP domain-containing protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8WTV1	THAP3	THAP domain-containing protein 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8WTV1	THAP3	THAP domain-containing protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8WTV1	THAP3	THAP domain-containing protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WY91	THAP4	THAP domain-containing protein 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8WY91	THAP4	THAP domain-containing protein 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z6K1	THAP5	THAP domain-containing protein 5	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7Z6K1	THAP5	THAP domain-containing protein 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z6K1	THAP5	THAP domain-containing protein 5	GO:0002020; F:protease binding; IPI:UniProtKB
Q7Z6K1	THAP5	THAP domain-containing protein 5	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q7Z6K1	THAP5	THAP domain-containing protein 5	GO:0045786; P:negative regulation of cell cycle; IMP:UniProtKB
Q9BT49	THAP7	THAP domain-containing protein 7	GO:0070742; F:C2H2 zinc finger domain binding; IDA:UniProtKB
Q9BT49	THAP7	THAP domain-containing protein 7	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BT49	THAP7	THAP domain-containing protein 7	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BT49	THAP7	THAP domain-containing protein 7	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q9BT49	THAP7	THAP domain-containing protein 7	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9BT49	THAP7	THAP domain-containing protein 7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NA92	THAP8	THAP domain-containing protein 8	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NA92	THAP8	THAP domain-containing protein 8	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TBB0	THAP6	THAP domain-containing protein 6	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TBB0	THAP6	THAP domain-containing protein 6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TBB0	THAP6	THAP domain-containing protein 6	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9H5L6	THAP9	DNA transposase THAP9	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H5L6	THAP9	DNA transposase THAP9	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q9H5L6	THAP9	DNA transposase THAP9	GO:0016740; F:transferase activity; IEA:UniProtKB-KW
Q9H5L6	THAP9	DNA transposase THAP9	GO:0004803; F:transposase activity; IDA:UniProtKB
Q9H5L6	THAP9	DNA transposase THAP9	GO:0015074; P:DNA integration; IDA:UniProtKB
Q9H5L6	THAP9	DNA transposase THAP9	GO:0006310; P:DNA recombination; IDA:UniProtKB
Q9H5L6	THAP9	DNA transposase THAP9	GO:0006313; P:transposition, DNA-mediated; IDA:UniProtKB
P24557	TBXAS1	Thromboxane-A synthase	GO:0020037; F:heme binding; IEA:InterPro
P24557	TBXAS1	Thromboxane-A synthase	GO:0005506; F:iron ion binding; IEA:InterPro
P24557	TBXAS1	Thromboxane-A synthase	GO:0004497; F:monooxygenase activity; IEA:UniProtKB-KW
P24557	TBXAS1	Thromboxane-A synthase	GO:0016705; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; IEA:InterPro
P24557	TBXAS1	Thromboxane-A synthase	GO:0004796; F:thromboxane-A synthase activity; IEA:UniProtKB-EC
P24557	TBXAS1	Thromboxane-A synthase	GO:0019369; P:arachidonic acid metabolic process; TAS:Reactome
P24557	TBXAS1	Thromboxane-A synthase	GO:0019371; P:cyclooxygenase pathway; TAS:Reactome
P24557	TBXAS1	Thromboxane-A synthase	GO:0006690; P:icosanoid metabolic process; TAS:Reactome
P24557	TBXAS1	Thromboxane-A synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P24557	TBXAS1	Thromboxane-A synthase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P10827	THRA	Thyroid hormone receptor alpha	GO:0031490; F:chromatin DNA binding; IEA:Ensembl
P10827	THRA	Thyroid hormone receptor alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P10827	THRA	Thyroid hormone receptor alpha	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P10827	THRA	Thyroid hormone receptor alpha	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P10827	THRA	Thyroid hormone receptor alpha	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P10827	THRA	Thyroid hormone receptor alpha	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P10827	THRA	Thyroid hormone receptor alpha	GO:0002153; F:steroid receptor RNA activator RNA binding; IEA:Ensembl
P10827	THRA	Thyroid hormone receptor alpha	GO:0017025; F:TBP-class protein binding; IDA:UniProtKB
P10827	THRA	Thyroid hormone receptor alpha	GO:0070324; F:thyroid hormone binding; IDA:UniProtKB
P10827	THRA	Thyroid hormone receptor alpha	GO:0004887; F:thyroid hormone receptor activity; IDA:UniProtKB
P10827	THRA	Thyroid hormone receptor alpha	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P10827	THRA	Thyroid hormone receptor alpha	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
P10827	THRA	Thyroid hormone receptor alpha	GO:0008270; F:zinc ion binding; IEA:InterPro
P10827	THRA	Thyroid hormone receptor alpha	GO:0001502; P:cartilage condensation; IEA:Ensembl
P10827	THRA	Thyroid hormone receptor alpha	GO:0042994; P:cytoplasmic sequestering of transcription factor; IEA:Ensembl
P10827	THRA	Thyroid hormone receptor alpha	GO:0030218; P:erythrocyte differentiation; IEA:Ensembl
P10827	THRA	Thyroid hormone receptor alpha	GO:0008050; P:female courtship behavior; IEA:Ensembl
P10827	THRA	Thyroid hormone receptor alpha	GO:0010467; P:gene expression; TAS:Reactome
P10827	THRA	Thyroid hormone receptor alpha	GO:0009755; P:hormone-mediated signaling pathway; IDA:BHF-UCL
P10827	THRA	Thyroid hormone receptor alpha	GO:0007611; P:learning or memory; IEA:Ensembl
P10827	THRA	Thyroid hormone receptor alpha	GO:2000143; P:negative regulation of DNA-templated transcription, initiation; IDA:UniProtKB
P10827	THRA	Thyroid hormone receptor alpha	GO:0017055; P:negative regulation of RNA polymerase II transcriptional preinitiation complex assembly; IDA:UniProtKB
P10827	THRA	Thyroid hormone receptor alpha	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P10827	THRA	Thyroid hormone receptor alpha	GO:0001503; P:ossification; IEA:Ensembl
P10827	THRA	Thyroid hormone receptor alpha	GO:0045925; P:positive regulation of female receptivity; IEA:Ensembl
P10827	THRA	Thyroid hormone receptor alpha	GO:0010831; P:positive regulation of myotube differentiation; IEA:Ensembl
P10827	THRA	Thyroid hormone receptor alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P10827	THRA	Thyroid hormone receptor alpha	GO:0008016; P:regulation of heart contraction; IEA:Ensembl
P10827	THRA	Thyroid hormone receptor alpha	GO:0050994; P:regulation of lipid catabolic process; IEA:Ensembl
P10827	THRA	Thyroid hormone receptor alpha	GO:0033032; P:regulation of myeloid cell apoptotic process; IEA:Ensembl
P10827	THRA	Thyroid hormone receptor alpha	GO:0002155; P:regulation of thyroid hormone mediated signaling pathway; IEA:Ensembl
P10827	THRA	Thyroid hormone receptor alpha	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P10827	THRA	Thyroid hormone receptor alpha	GO:0009409; P:response to cold; IEA:Ensembl
P10827	THRA	Thyroid hormone receptor alpha	GO:0030878; P:thyroid gland development; IEA:Ensembl
P10827	THRA	Thyroid hormone receptor alpha	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:UniProtKB
P10827	THRA	Thyroid hormone receptor alpha	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P10827	THRA	Thyroid hormone receptor alpha	GO:0060509; P:Type I pneumocyte differentiation; IEA:Ensembl
P05543	SERPINA7	Thyroxine-binding globulin	GO:0042562; F:hormone binding; IEA:Ensembl
P05543	SERPINA7	Thyroxine-binding globulin	GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome
P05543	SERPINA7	Thyroxine-binding globulin	GO:0007568; P:aging; IEA:Ensembl
P05543	SERPINA7	Thyroxine-binding globulin	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
P05543	SERPINA7	Thyroxine-binding globulin	GO:0009791; P:post-embryonic development; IEA:Ensembl
P05543	SERPINA7	Thyroxine-binding globulin	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
P05543	SERPINA7	Thyroxine-binding globulin	GO:0051412; P:response to corticosterone; IEA:Ensembl
P05543	SERPINA7	Thyroxine-binding globulin	GO:0042493; P:response to drug; IEA:Ensembl
P05543	SERPINA7	Thyroxine-binding globulin	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P05543	SERPINA7	Thyroxine-binding globulin	GO:0034695; P:response to prostaglandin E; IEA:Ensembl
P05543	SERPINA7	Thyroxine-binding globulin	GO:0033189; P:response to vitamin A; IEA:Ensembl
P10828	THRB	Thyroid hormone receptor beta	GO:0031490; F:chromatin DNA binding; IEA:Ensembl
P10828	THRB	Thyroid hormone receptor beta	GO:0003677; F:DNA binding; TAS:ProtInc
P10828	THRB	Thyroid hormone receptor beta	GO:0019899; F:enzyme binding; IPI:UniProtKB
P10828	THRB	Thyroid hormone receptor beta	GO:0005515; F:protein binding; IPI:UniProtKB
P10828	THRB	Thyroid hormone receptor beta	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P10828	THRB	Thyroid hormone receptor beta	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
P10828	THRB	Thyroid hormone receptor beta	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P10828	THRB	Thyroid hormone receptor beta	GO:0070324; F:thyroid hormone binding; IDA:UniProtKB
P10828	THRB	Thyroid hormone receptor beta	GO:0004887; F:thyroid hormone receptor activity; IDA:UniProtKB
P10828	THRB	Thyroid hormone receptor beta	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
P10828	THRB	Thyroid hormone receptor beta	GO:0008270; F:zinc ion binding; IEA:InterPro
P10828	THRB	Thyroid hormone receptor beta	GO:0008050; P:female courtship behavior; IEA:Ensembl
P10828	THRB	Thyroid hormone receptor beta	GO:0010467; P:gene expression; TAS:Reactome
P10828	THRB	Thyroid hormone receptor beta	GO:0030522; P:intracellular receptor signaling pathway; IDA:GOC
P10828	THRB	Thyroid hormone receptor beta	GO:0007621; P:negative regulation of female receptivity; IEA:Ensembl
P10828	THRB	Thyroid hormone receptor beta	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P10828	THRB	Thyroid hormone receptor beta	GO:0009887; P:organ morphogenesis; IEA:Ensembl
P10828	THRB	Thyroid hormone receptor beta	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P10828	THRB	Thyroid hormone receptor beta	GO:0008016; P:regulation of heart contraction; IEA:Ensembl
P10828	THRB	Thyroid hormone receptor beta	GO:0007605; P:sensory perception of sound; IEA:Ensembl
P10828	THRB	Thyroid hormone receptor beta	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P10828	THRB	Thyroid hormone receptor beta	GO:0006351; P:transcription, DNA-templated; TAS:ProtInc
P10828	THRB	Thyroid hormone receptor beta	GO:0060509; P:Type I pneumocyte differentiation; IEA:Ensembl
Q9P2T0	THEG	Testicular haploid expressed gene protein	GO:0005515; F:protein binding; IPI:IntAct
Q9P2T0	THEG	Testicular haploid expressed gene protein	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9P2T0	THEG	Testicular haploid expressed gene protein	GO:0051131; P:chaperone-mediated protein complex assembly; TAS:ProtInc
Q9P2T0	THEG	Testicular haploid expressed gene protein	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9P2T0	THEG	Testicular haploid expressed gene protein	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q5T1C6	THEM4	Acyl-coenzyme A thioesterase THEM4	GO:0016290; F:palmitoyl-CoA hydrolase activity; IDA:UniProtKB
Q5T1C6	THEM4	Acyl-coenzyme A thioesterase THEM4	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q5T1C6	THEM4	Acyl-coenzyme A thioesterase THEM4	GO:0006631; P:fatty acid metabolic process; IDA:UniProtKB
Q5T1C6	THEM4	Acyl-coenzyme A thioesterase THEM4	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q5T1C6	THEM4	Acyl-coenzyme A thioesterase THEM4	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q5T1C6	THEM4	Acyl-coenzyme A thioesterase THEM4	GO:0045087; P:innate immune response; TAS:Reactome
Q5T1C6	THEM4	Acyl-coenzyme A thioesterase THEM4	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q5T1C6	THEM4	Acyl-coenzyme A thioesterase THEM4	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q5T1C6	THEM4	Acyl-coenzyme A thioesterase THEM4	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q5T1C6	THEM4	Acyl-coenzyme A thioesterase THEM4	GO:0043491; P:protein kinase B signaling; IMP:UniProtKB
Q5T1C6	THEM4	Acyl-coenzyme A thioesterase THEM4	GO:1902108; P:regulation of mitochondrial membrane permeability involved in apoptotic process; IMP:UniProtKB
Q9NWX6	THG1L	Probable tRNA(His) guanylyltransferase	GO:0005524; F:ATP binding; IDA:BHF-UCL
Q9NWX6	THG1L	Probable tRNA(His) guanylyltransferase	GO:0005525; F:GTP binding; IDA:BHF-UCL
Q9NWX6	THG1L	Probable tRNA(His) guanylyltransferase	GO:0042802; F:identical protein binding; IPI:BHF-UCL
Q9NWX6	THG1L	Probable tRNA(His) guanylyltransferase	GO:0000287; F:magnesium ion binding; IDA:BHF-UCL
Q9NWX6	THG1L	Probable tRNA(His) guanylyltransferase	GO:0000049; F:tRNA binding; TAS:BHF-UCL
Q9NWX6	THG1L	Probable tRNA(His) guanylyltransferase	GO:0008193; F:tRNA guanylyltransferase activity; IDA:UniProtKB
Q9NWX6	THG1L	Probable tRNA(His) guanylyltransferase	GO:0051289; P:protein homotetramerization; IPI:UniProtKB
Q9NWX6	THG1L	Probable tRNA(His) guanylyltransferase	GO:0006400; P:tRNA modification; ISS:UniProtKB
Q9NWX6	THG1L	Probable tRNA(His) guanylyltransferase	GO:0008033; P:tRNA processing; IDA:UniProtKB
Q9BWD1	ACAT2	Acetyl-CoA acetyltransferase, cytosolic	GO:0003985; F:acetyl-CoA C-acetyltransferase activity; IDA:BHF-UCL
Q9BWD1	ACAT2	Acetyl-CoA acetyltransferase, cytosolic	GO:0006629; P:lipid metabolic process; IC:BHF-UCL
P09110	ACAA1	3-ketoacyl-CoA thiolase, peroxisomal	GO:0003988; F:acetyl-CoA C-acyltransferase activity; IEA:UniProtKB-EC
P09110	ACAA1	3-ketoacyl-CoA thiolase, peroxisomal	GO:0016401; F:palmitoyl-CoA oxidase activity; IMP:UniProtKB
P09110	ACAA1	3-ketoacyl-CoA thiolase, peroxisomal	GO:0005515; F:protein binding; IPI:UniProtKB
P09110	ACAA1	3-ketoacyl-CoA thiolase, peroxisomal	GO:0036109; P:alpha-linolenic acid metabolic process; TAS:Reactome
P09110	ACAA1	3-ketoacyl-CoA thiolase, peroxisomal	GO:0008206; P:bile acid metabolic process; IMP:UniProtKB
P09110	ACAA1	3-ketoacyl-CoA thiolase, peroxisomal	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P09110	ACAA1	3-ketoacyl-CoA thiolase, peroxisomal	GO:0006635; P:fatty acid beta-oxidation; IMP:UniProtKB
P09110	ACAA1	3-ketoacyl-CoA thiolase, peroxisomal	GO:0033540; P:fatty acid beta-oxidation using acyl-CoA oxidase; TAS:Reactome
P09110	ACAA1	3-ketoacyl-CoA thiolase, peroxisomal	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P09110	ACAA1	3-ketoacyl-CoA thiolase, peroxisomal	GO:0033559; P:unsaturated fatty acid metabolic process; TAS:Reactome
P09110	ACAA1	3-ketoacyl-CoA thiolase, peroxisomal	GO:0000038; P:very long-chain fatty acid metabolic process; IMP:UniProtKB
P24752	ACAT1	Acetyl-CoA acetyltransferase, mitochondrial	GO:0003985; F:acetyl-CoA C-acetyltransferase activity; EXP:Reactome
P24752	ACAT1	Acetyl-CoA acetyltransferase, mitochondrial	GO:0050662; F:coenzyme binding; IEA:Ensembl
P24752	ACAT1	Acetyl-CoA acetyltransferase, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P24752	ACAT1	Acetyl-CoA acetyltransferase, mitochondrial	GO:0060612; P:adipose tissue development; IEA:Ensembl
P24752	ACAT1	Acetyl-CoA acetyltransferase, mitochondrial	GO:0007420; P:brain development; IEA:Ensembl
P24752	ACAT1	Acetyl-CoA acetyltransferase, mitochondrial	GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome
P24752	ACAT1	Acetyl-CoA acetyltransferase, mitochondrial	GO:0046950; P:cellular ketone body metabolic process; TAS:Reactome
P24752	ACAT1	Acetyl-CoA acetyltransferase, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P24752	ACAT1	Acetyl-CoA acetyltransferase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P24752	ACAT1	Acetyl-CoA acetyltransferase, mitochondrial	GO:0046951; P:ketone body biosynthetic process; TAS:Reactome
P24752	ACAT1	Acetyl-CoA acetyltransferase, mitochondrial	GO:0046952; P:ketone body catabolic process; TAS:Reactome
P24752	ACAT1	Acetyl-CoA acetyltransferase, mitochondrial	GO:0001889; P:liver development; IEA:Ensembl
P24752	ACAT1	Acetyl-CoA acetyltransferase, mitochondrial	GO:0072229; P:metanephric proximal convoluted tubule development; IEA:Ensembl
P24752	ACAT1	Acetyl-CoA acetyltransferase, mitochondrial	GO:0051260; P:protein homooligomerization; IEA:Ensembl
P24752	ACAT1	Acetyl-CoA acetyltransferase, mitochondrial	GO:0009725; P:response to hormone; IEA:Ensembl
P24752	ACAT1	Acetyl-CoA acetyltransferase, mitochondrial	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
P24752	ACAT1	Acetyl-CoA acetyltransferase, mitochondrial	GO:0042594; P:response to starvation; IEA:Ensembl
P24752	ACAT1	Acetyl-CoA acetyltransferase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P42765	ACAA2	3-ketoacyl-CoA thiolase, mitochondrial	GO:0003988; F:acetyl-CoA C-acyltransferase activity; NAS:UniProtKB
P42765	ACAA2	3-ketoacyl-CoA thiolase, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P42765	ACAA2	3-ketoacyl-CoA thiolase, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
P42765	ACAA2	3-ketoacyl-CoA thiolase, mitochondrial	GO:0006695; P:cholesterol biosynthetic process; NAS:UniProtKB
P42765	ACAA2	3-ketoacyl-CoA thiolase, mitochondrial	GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-UniPathway
P42765	ACAA2	3-ketoacyl-CoA thiolase, mitochondrial	GO:1901029; P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; IDA:UniProtKB
Q99757	TXN2	Thioredoxin, mitochondrial	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
Q99757	TXN2	Thioredoxin, mitochondrial	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q99757	TXN2	Thioredoxin, mitochondrial	GO:0031669; P:cellular response to nutrient levels; IEA:Ensembl
Q99757	TXN2	Thioredoxin, mitochondrial	GO:0006662; P:glycerol ether metabolic process; IEA:InterPro
Q99757	TXN2	Thioredoxin, mitochondrial	GO:0048678; P:response to axon injury; IEA:Ensembl
Q99757	TXN2	Thioredoxin, mitochondrial	GO:0042493; P:response to drug; IEA:Ensembl
Q99757	TXN2	Thioredoxin, mitochondrial	GO:0009749; P:response to glucose; IEA:Ensembl
Q99757	TXN2	Thioredoxin, mitochondrial	GO:0009725; P:response to hormone; IEA:Ensembl
Q99757	TXN2	Thioredoxin, mitochondrial	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q99757	TXN2	Thioredoxin, mitochondrial	GO:0007584; P:response to nutrient; IEA:Ensembl
Q99757	TXN2	Thioredoxin, mitochondrial	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
Q99757	TXN2	Thioredoxin, mitochondrial	GO:0006979; P:response to oxidative stress; IEA:Ensembl
P10599	TXN	Thioredoxin	GO:0015037; F:peptide disulfide oxidoreductase activity; IEA:Ensembl
P10599	TXN	Thioredoxin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P10599	TXN	Thioredoxin	GO:0005515; F:protein binding; IPI:UniProtKB
P10599	TXN	Thioredoxin	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
P10599	TXN	Thioredoxin	GO:0008283; P:cell proliferation; TAS:ProtInc
P10599	TXN	Thioredoxin	GO:0045454; P:cell redox homeostasis; IEA:Ensembl
P10599	TXN	Thioredoxin	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P10599	TXN	Thioredoxin	GO:0006928; P:cellular component movement; TAS:ProtInc
P10599	TXN	Thioredoxin	GO:0006662; P:glycerol ether metabolic process; IEA:InterPro
P10599	TXN	Thioredoxin	GO:0045087; P:innate immune response; TAS:Reactome
P10599	TXN	Thioredoxin	GO:0046826; P:negative regulation of protein export from nucleus; IEA:Ensembl
P10599	TXN	Thioredoxin	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P10599	TXN	Thioredoxin	GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome
P10599	TXN	Thioredoxin	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P10599	TXN	Thioredoxin	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
P10599	TXN	Thioredoxin	GO:0055114; P:oxidation-reduction process; IDA:UniProtKB
P10599	TXN	Thioredoxin	GO:0043388; P:positive regulation of DNA binding; IDA:UniProtKB
P10599	TXN	Thioredoxin	GO:0033158; P:regulation of protein import into nucleus, translocation; IDA:UniProtKB
P10599	TXN	Thioredoxin	GO:0009314; P:response to radiation; IDA:UniProtKB
P10599	TXN	Thioredoxin	GO:0007165; P:signal transduction; TAS:ProtInc
P10599	TXN	Thioredoxin	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P10599	TXN	Thioredoxin	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N1K5	THEMIS	Protein THEMIS	GO:0005515; F:protein binding; IPI:IntAct
Q8N1K5	THEMIS	Protein THEMIS	GO:0043383; P:negative T cell selection; ISS:UniProtKB
Q8N1K5	THEMIS	Protein THEMIS	GO:0043368; P:positive T cell selection; ISS:UniProtKB
Q8N1K5	THEMIS	Protein THEMIS	GO:0050852; P:T cell receptor signaling pathway; ISS:UniProtKB
Q5TEJ8	THEMIS2	Protein THEMIS2	GO:0007155; P:cell adhesion; TAS:ProtInc
Q5TEJ8	THEMIS2	Protein THEMIS2	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q5TEJ8	THEMIS2	Protein THEMIS2	GO:0050852; P:T cell receptor signaling pathway; IEA:Ensembl
Q86YJ6	THNSL2	Threonine synthase-like 2	GO:0016829; F:lyase activity; IEA:UniProtKB-KW
Q86YJ6	THNSL2	Threonine synthase-like 2	GO:0030170; F:pyridoxal phosphate binding; ISS:BHF-UCL
Q86YJ6	THNSL2	Threonine synthase-like 2	GO:0070905; F:serine binding; ISS:BHF-UCL
Q86YJ6	THNSL2	Threonine synthase-like 2	GO:0046360; P:2-oxobutyrate biosynthetic process; ISS:BHF-UCL
Q86YJ6	THNSL2	Threonine synthase-like 2	GO:0016311; P:dephosphorylation; ISS:BHF-UCL
Q86YJ6	THNSL2	Threonine synthase-like 2	GO:0009071; P:serine family amino acid catabolic process; ISS:BHF-UCL
Q96FV9	THOC1	THO complex subunit 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96FV9	THOC1	THO complex subunit 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96FV9	THOC1	THO complex subunit 1	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q96FV9	THOC1	THO complex subunit 1	GO:0006915; P:apoptotic process; IDA:UniProtKB
Q96FV9	THOC1	THO complex subunit 1	GO:0006406; P:mRNA export from nucleus; IDA:UniProtKB
Q96FV9	THOC1	THO complex subunit 1	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q96FV9	THOC1	THO complex subunit 1	GO:2000002; P:negative regulation of DNA damage checkpoint; IMP:UniProtKB
Q96FV9	THOC1	THO complex subunit 1	GO:0048297; P:negative regulation of isotype switching to IgA isotypes; ISS:UniProtKB
Q96FV9	THOC1	THO complex subunit 1	GO:0032786; P:positive regulation of DNA-templated transcription, elongation; IMP:UniProtKB
Q96FV9	THOC1	THO complex subunit 1	GO:0000018; P:regulation of DNA recombination; IMP:UniProtKB
Q96FV9	THOC1	THO complex subunit 1	GO:0032784; P:regulation of DNA-templated transcription, elongation; IDA:UniProtKB
Q96FV9	THOC1	THO complex subunit 1	GO:0031297; P:replication fork processing; IMP:UniProtKB
Q96FV9	THOC1	THO complex subunit 1	GO:0006396; P:RNA processing; TAS:ProtInc
Q96FV9	THOC1	THO complex subunit 1	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q96FV9	THOC1	THO complex subunit 1	GO:0007165; P:signal transduction; IEA:InterPro
Q96FV9	THOC1	THO complex subunit 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96FV9	THOC1	THO complex subunit 1	GO:0046784; P:viral mRNA export from host cell nucleus; IDA:UniProtKB
Q8NI27	THOC2	THO complex subunit 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NI27	THOC2	THO complex subunit 2	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q8NI27	THOC2	THO complex subunit 2	GO:0006406; P:mRNA export from nucleus; IDA:UniProtKB
Q8NI27	THOC2	THO complex subunit 2	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q8NI27	THOC2	THO complex subunit 2	GO:0016973; P:poly(A)+ mRNA export from nucleus; IDA:UniProtKB
Q8NI27	THOC2	THO complex subunit 2	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q8NI27	THOC2	THO complex subunit 2	GO:0046784; P:viral mRNA export from host cell nucleus; IDA:UniProtKB
Q96J01	THOC3	THO complex subunit 3	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q96J01	THOC3	THO complex subunit 3	GO:0006406; P:mRNA export from nucleus; IDA:UniProtKB
Q96J01	THOC3	THO complex subunit 3	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q96J01	THOC3	THO complex subunit 3	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q96J01	THOC3	THO complex subunit 3	GO:0046784; P:viral mRNA export from host cell nucleus; IDA:UniProtKB
Q86V81	ALYREF	THO complex subunit 4	GO:0000166; F:nucleotide binding; IEA:InterPro
Q86V81	ALYREF	THO complex subunit 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q86V81	ALYREF	THO complex subunit 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q86V81	ALYREF	THO complex subunit 4	GO:0010467; P:gene expression; TAS:Reactome
Q86V81	ALYREF	THO complex subunit 4	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q86V81	ALYREF	THO complex subunit 4	GO:0006406; P:mRNA export from nucleus; IMP:UniProtKB
Q86V81	ALYREF	THO complex subunit 4	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q86V81	ALYREF	THO complex subunit 4	GO:0032786; P:positive regulation of DNA-templated transcription, elongation; IMP:UniProtKB
Q86V81	ALYREF	THO complex subunit 4	GO:0000018; P:regulation of DNA recombination; IMP:UniProtKB
Q86V81	ALYREF	THO complex subunit 4	GO:0031297; P:replication fork processing; IMP:UniProtKB
Q86V81	ALYREF	THO complex subunit 4	GO:0008380; P:RNA splicing; TAS:Reactome
Q86V81	ALYREF	THO complex subunit 4	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q86V81	ALYREF	THO complex subunit 4	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q86V81	ALYREF	THO complex subunit 4	GO:0046784; P:viral mRNA export from host cell nucleus; IDA:UniProtKB
Q13769	THOC5	THO complex subunit 5 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q13769	THOC5	THO complex subunit 5 homolog	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q13769	THOC5	THO complex subunit 5 homolog	GO:0030224; P:monocyte differentiation; IDA:UniProtKB
Q13769	THOC5	THO complex subunit 5 homolog	GO:0006406; P:mRNA export from nucleus; IDA:UniProtKB
Q13769	THOC5	THO complex subunit 5 homolog	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q13769	THOC5	THO complex subunit 5 homolog	GO:2000002; P:negative regulation of DNA damage checkpoint; IMP:UniProtKB
Q13769	THOC5	THO complex subunit 5 homolog	GO:0045650; P:negative regulation of macrophage differentiation; IEA:Ensembl
Q13769	THOC5	THO complex subunit 5 homolog	GO:0032786; P:positive regulation of DNA-templated transcription, elongation; IMP:UniProtKB
Q13769	THOC5	THO complex subunit 5 homolog	GO:0060215; P:primitive hemopoiesis; ISS:UniProtKB
Q13769	THOC5	THO complex subunit 5 homolog	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q13769	THOC5	THO complex subunit 5 homolog	GO:0046784; P:viral mRNA export from host cell nucleus; IDA:UniProtKB
Q86W42	THOC6	THO complex subunit 6 homolog	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q86W42	THOC6	THO complex subunit 6 homolog	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q86W42	THOC6	THO complex subunit 6 homolog	GO:0007417; P:central nervous system development; IMP:UniProtKB
Q86W42	THOC6	THO complex subunit 6 homolog	GO:0006406; P:mRNA export from nucleus; IDA:UniProtKB
Q86W42	THOC6	THO complex subunit 6 homolog	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q86W42	THOC6	THO complex subunit 6 homolog	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q86W42	THOC6	THO complex subunit 6 homolog	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q86W42	THOC6	THO complex subunit 6 homolog	GO:0046784; P:viral mRNA export from host cell nucleus; IDA:UniProtKB
Q6I9Y2	THOC7	THO complex subunit 7 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q6I9Y2	THOC7	THO complex subunit 7 homolog	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q6I9Y2	THOC7	THO complex subunit 7 homolog	GO:0006406; P:mRNA export from nucleus; IDA:UniProtKB
Q6I9Y2	THOC7	THO complex subunit 7 homolog	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q6I9Y2	THOC7	THO complex subunit 7 homolog	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q6I9Y2	THOC7	THO complex subunit 7 homolog	GO:0046784; P:viral mRNA export from host cell nucleus; IDA:UniProtKB
P52888	THOP1	Thimet oligopeptidase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P52888	THOP1	Thimet oligopeptidase	GO:0004222; F:metalloendopeptidase activity; TAS:ProtInc
P52888	THOP1	Thimet oligopeptidase	GO:0042277; F:peptide binding; IEA:Ensembl
P52888	THOP1	Thimet oligopeptidase	GO:0005515; F:protein binding; IPI:IntAct
P52888	THOP1	Thimet oligopeptidase	GO:0006518; P:peptide metabolic process; IEA:Ensembl
P00734	F2	Prothrombin	GO:0005509; F:calcium ion binding; IEA:InterPro
P00734	F2	Prothrombin	GO:0008083; F:growth factor activity; TAS:BHF-UCL
P00734	F2	Prothrombin	GO:0005515; F:protein binding; IPI:UniProtKB
P00734	F2	Prothrombin	GO:0005102; F:receptor binding; IPI:UniProtKB
P00734	F2	Prothrombin	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
P00734	F2	Prothrombin	GO:0070053; F:thrombospondin receptor activity; IDA:BHF-UCL
P00734	F2	Prothrombin	GO:0006953; P:acute-phase response; IEA:UniProtKB-KW
P00734	F2	Prothrombin	GO:0007596; P:blood coagulation; TAS:Reactome
P00734	F2	Prothrombin	GO:0007597; P:blood coagulation, intrinsic pathway; TAS:Reactome
P00734	F2	Prothrombin	GO:0007166; P:cell surface receptor signaling pathway; IDA:BHF-UCL
P00734	F2	Prothrombin	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P00734	F2	Prothrombin	GO:0051480; P:cytosolic calcium ion homeostasis; IDA:BHF-UCL
P00734	F2	Prothrombin	GO:0042730; P:fibrinolysis; IDA:UniProtKB
P00734	F2	Prothrombin	GO:0050900; P:leukocyte migration; TAS:Reactome
P00734	F2	Prothrombin	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P00734	F2	Prothrombin	GO:0048712; P:negative regulation of astrocyte differentiation; IDA:BHF-UCL
P00734	F2	Prothrombin	GO:0051918; P:negative regulation of fibrinolysis; TAS:BHF-UCL
P00734	F2	Prothrombin	GO:0010544; P:negative regulation of platelet activation; TAS:BHF-UCL
P00734	F2	Prothrombin	GO:0045861; P:negative regulation of proteolysis; IDA:BHF-UCL
P00734	F2	Prothrombin	GO:0017187; P:peptidyl-glutamic acid carboxylation; TAS:Reactome
P00734	F2	Prothrombin	GO:0030168; P:platelet activation; IDA:BHF-UCL
P00734	F2	Prothrombin	GO:0030194; P:positive regulation of blood coagulation; IDA:BHF-UCL
P00734	F2	Prothrombin	GO:0030307; P:positive regulation of cell growth; IEA:Ensembl
P00734	F2	Prothrombin	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P00734	F2	Prothrombin	GO:0032967; P:positive regulation of collagen biosynthetic process; IDA:BHF-UCL
P00734	F2	Prothrombin	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl
P00734	F2	Prothrombin	GO:1900738; P:positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway; IDA:BHF-UCL
P00734	F2	Prothrombin	GO:0001934; P:positive regulation of protein phosphorylation; IDA:BHF-UCL
P00734	F2	Prothrombin	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IDA:UniProtKB
P00734	F2	Prothrombin	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IDA:BHF-UCL
P00734	F2	Prothrombin	GO:0043687; P:post-translational protein modification; TAS:Reactome
P00734	F2	Prothrombin	GO:0006508; P:proteolysis; TAS:Reactome
P00734	F2	Prothrombin	GO:0030193; P:regulation of blood coagulation; TAS:UniProtKB
P00734	F2	Prothrombin	GO:0008360; P:regulation of cell shape; IEA:Ensembl
P00734	F2	Prothrombin	GO:0009611; P:response to wounding; IDA:BHF-UCL
Q92748	THRSP	Thyroid hormone-inducible hepatic protein	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q92748	THRSP	Thyroid hormone-inducible hepatic protein	GO:0046890; P:regulation of lipid biosynthetic process; ISS:UniProtKB
Q92748	THRSP	Thyroid hormone-inducible hepatic protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q92748	THRSP	Thyroid hormone-inducible hepatic protein	GO:0010866; P:regulation of triglyceride biosynthetic process; IEA:Ensembl
Q92748	THRSP	Thyroid hormone-inducible hepatic protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UPZ6	THSD7A	Thrombospondin type-1 domain-containing protein 7A	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q9UPZ6	THSD7A	Thrombospondin type-1 domain-containing protein 7A	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9NS62	THSD1	Thrombospondin type-1 domain-containing protein 1	GO:0002244; P:hematopoietic progenitor cell differentiation; IEA:Ensembl
Q6ZMP0	THSD4	Thrombospondin type-1 domain-containing protein 4	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q6ZMP0	THSD4	Thrombospondin type-1 domain-containing protein 4	GO:0048251; P:elastic fiber assembly; IEA:Ensembl
P25325	MPST	3-mercaptopyruvate sulfurtransferase	GO:0016784; F:3-mercaptopyruvate sulfurtransferase activity; IEA:UniProtKB-EC
P25325	MPST	3-mercaptopyruvate sulfurtransferase	GO:0004792; F:thiosulfate sulfurtransferase activity; TAS:ProtInc
P25325	MPST	3-mercaptopyruvate sulfurtransferase	GO:0009440; P:cyanate catabolic process; TAS:ProtInc
P25325	MPST	3-mercaptopyruvate sulfurtransferase	GO:0070814; P:hydrogen sulfide biosynthetic process; ISS:UniProtKB
P25325	MPST	3-mercaptopyruvate sulfurtransferase	GO:0009636; P:response to toxic substance; TAS:ProtInc
Q9BU02	THTPA	Thiamine-triphosphatase	GO:0016787; F:hydrolase activity; TAS:UniProtKB
Q9BU02	THTPA	Thiamine-triphosphatase	GO:0000287; F:magnesium ion binding; ISS:UniProtKB
Q9BU02	THTPA	Thiamine-triphosphatase	GO:0050333; F:thiamin-triphosphatase activity; IDA:UniProtKB
Q9BU02	THTPA	Thiamine-triphosphatase	GO:0016311; P:dephosphorylation; IDA:UniProtKB
Q9BU02	THTPA	Thiamine-triphosphatase	GO:0006091; P:generation of precursor metabolites and energy; NAS:UniProtKB
Q9BU02	THTPA	Thiamine-triphosphatase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BU02	THTPA	Thiamine-triphosphatase	GO:0042357; P:thiamine diphosphate metabolic process; ISS:UniProtKB
Q9BU02	THTPA	Thiamine-triphosphatase	GO:0006772; P:thiamine metabolic process; TAS:UniProtKB
Q9BU02	THTPA	Thiamine-triphosphatase	GO:0042723; P:thiamine-containing compound metabolic process; TAS:Reactome
Q9BU02	THTPA	Thiamine-triphosphatase	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9BU02	THTPA	Thiamine-triphosphatase	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
Q16762	TST	Thiosulfate sulfurtransferase	GO:0008097; F:5S rRNA binding; IDA:UniProtKB
Q16762	TST	Thiosulfate sulfurtransferase	GO:0004792; F:thiosulfate sulfurtransferase activity; TAS:ProtInc
Q16762	TST	Thiosulfate sulfurtransferase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q16762	TST	Thiosulfate sulfurtransferase	GO:0009440; P:cyanate catabolic process; TAS:ProtInc
Q16762	TST	Thiosulfate sulfurtransferase	GO:0030855; P:epithelial cell differentiation; IDA:UniProt
Q16762	TST	Thiosulfate sulfurtransferase	GO:0035928; P:rRNA import into mitochondrion; IMP:UniProtKB
Q16762	TST	Thiosulfate sulfurtransferase	GO:0051029; P:rRNA transport; IDA:UniProtKB
Q16762	TST	Thiosulfate sulfurtransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16762	TST	Thiosulfate sulfurtransferase	GO:0070221; P:sulfide oxidation, using sulfide:quinone oxidoreductase; TAS:Reactome
Q16762	TST	Thiosulfate sulfurtransferase	GO:0000098; P:sulfur amino acid catabolic process; TAS:Reactome
Q16762	TST	Thiosulfate sulfurtransferase	GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome
Q9NXG2	THUMPD1	THUMP domain-containing protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BTF0	THUMPD2	THUMP domain-containing protein 2	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q9BTF0	THUMPD2	THUMP domain-containing protein 2	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9BV44	THUMPD3	THUMP domain-containing protein 3	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q9BV44	THUMPD3	THUMP domain-containing protein 3	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
P04216	THY1	Thy-1 membrane glycoprotein	GO:0034235; F:GPI anchor binding; ISS:UniProtKB
P04216	THY1	Thy-1 membrane glycoprotein	GO:0005178; F:integrin binding; IPI:UniProtKB
P04216	THY1	Thy-1 membrane glycoprotein	GO:0005515; F:protein binding; IPI:UniProtKB
P04216	THY1	Thy-1 membrane glycoprotein	GO:0005100; F:Rho GTPase activator activity; ISS:UniProtKB
P04216	THY1	Thy-1 membrane glycoprotein	GO:0001525; P:angiogenesis; ISS:UniProtKB
P04216	THY1	Thy-1 membrane glycoprotein	GO:0016337; P:single organismal cell-cell adhesion; ISS:UniProtKB
P04216	THY1	Thy-1 membrane glycoprotein	GO:0007010; P:cytoskeleton organization; ISS:UniProtKB
P04216	THY1	Thy-1 membrane glycoprotein	GO:0048041; P:focal adhesion assembly; ISS:UniProtKB
P04216	THY1	Thy-1 membrane glycoprotein	GO:0050771; P:negative regulation of axonogenesis; ISS:UniProtKB
P04216	THY1	Thy-1 membrane glycoprotein	GO:0030336; P:negative regulation of cell migration; ISS:UniProtKB
P04216	THY1	Thy-1 membrane glycoprotein	GO:0006469; P:negative regulation of protein kinase activity; ISS:UniProtKB
P04216	THY1	Thy-1 membrane glycoprotein	GO:0050860; P:negative regulation of T cell receptor signaling pathway; ISS:UniProtKB
P04216	THY1	Thy-1 membrane glycoprotein	GO:0043547; P:positive regulation of GTPase activity; ISS:UniProtKB
P04216	THY1	Thy-1 membrane glycoprotein	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; ISS:UniProtKB
P04216	THY1	Thy-1 membrane glycoprotein	GO:0050870; P:positive regulation of T cell activation; ISS:UniProtKB
P04216	THY1	Thy-1 membrane glycoprotein	GO:0046549; P:retinal cone cell development; ISS:UniProtKB
P04216	THY1	Thy-1 membrane glycoprotein	GO:0050852; P:T cell receptor signaling pathway; ISS:UniProtKB
P01266	TG	Thyroglobulin	GO:0042446; P:hormone biosynthetic process; IEA:UniProtKB-KW
P01266	TG	Thyroglobulin	GO:0015705; P:iodide transport; IEA:Ensembl
P01266	TG	Thyroglobulin	GO:0031641; P:regulation of myelination; IEA:Ensembl
P01266	TG	Thyroglobulin	GO:0007165; P:signal transduction; NAS:ProtInc
P01266	TG	Thyroglobulin	GO:0030878; P:thyroid gland development; IEP:UniProtKB
P01266	TG	Thyroglobulin	GO:0006590; P:thyroid hormone generation; IBA:RefGenome
Q99595	TIMM17A	Mitochondrial import inner membrane translocase subunit Tim17-A	GO:0015450; F:P-P-bond-hydrolysis-driven protein transmembrane transporter activity; IEA:InterPro
Q99595	TIMM17A	Mitochondrial import inner membrane translocase subunit Tim17-A	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q99595	TIMM17A	Mitochondrial import inner membrane translocase subunit Tim17-A	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
O60830	TIMM17B	Mitochondrial import inner membrane translocase subunit Tim17-B	GO:0015450; F:P-P-bond-hydrolysis-driven protein transmembrane transporter activity; IEA:InterPro
O60830	TIMM17B	Mitochondrial import inner membrane translocase subunit Tim17-B	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O60830	TIMM17B	Mitochondrial import inner membrane translocase subunit Tim17-B	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
Q5SRD1	TIMM23B	Putative mitochondrial import inner membrane translocase subunit Tim23B	GO:0015450; F:P-P-bond-hydrolysis-driven protein transmembrane transporter activity; IEA:InterPro
Q5SRD1	TIMM23B	Putative mitochondrial import inner membrane translocase subunit Tim23B	GO:0006886; P:intracellular protein transport; IEA:InterPro
P31483	TIA1	Nucleolysin TIA-1 isoform p40	GO:0017091; F:AU-rich element binding; IEA:Ensembl
P31483	TIA1	Nucleolysin TIA-1 isoform p40	GO:0000166; F:nucleotide binding; IEA:InterPro
P31483	TIA1	Nucleolysin TIA-1 isoform p40	GO:0008143; F:poly(A) binding; TAS:ProtInc
P31483	TIA1	Nucleolysin TIA-1 isoform p40	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P31483	TIA1	Nucleolysin TIA-1 isoform p40	GO:0005515; F:protein binding; IPI:UniProtKB
P31483	TIA1	Nucleolysin TIA-1 isoform p40	GO:0006915; P:apoptotic process; TAS:ProtInc
P31483	TIA1	Nucleolysin TIA-1 isoform p40	GO:0042036; P:negative regulation of cytokine biosynthetic process; IEA:Ensembl
P31483	TIA1	Nucleolysin TIA-1 isoform p40	GO:0017148; P:negative regulation of translation; IEA:Ensembl
P31483	TIA1	Nucleolysin TIA-1 isoform p40	GO:0048024; P:regulation of mRNA splicing, via spliceosome; IDA:UniProtKB
O95411	TIAF1	TGFB1-induced anti-apoptotic factor 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O95411	TIAF1	TGFB1-induced anti-apoptotic factor 1	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
O95411	TIAF1	TGFB1-induced anti-apoptotic factor 1	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
Q8IVF5	TIAM2	T-lymphoma invasion and metastasis-inducing protein 2	GO:0005096; F:GTPase activator activity; IEA:Ensembl
Q8IVF5	TIAM2	T-lymphoma invasion and metastasis-inducing protein 2	GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:ProtInc
Q8IVF5	TIAM2	T-lymphoma invasion and metastasis-inducing protein 2	GO:0005057; F:receptor signaling protein activity; IEA:InterPro
Q8IVF5	TIAM2	T-lymphoma invasion and metastasis-inducing protein 2	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
Q8IVF5	TIAM2	T-lymphoma invasion and metastasis-inducing protein 2	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q8IVF5	TIAM2	T-lymphoma invasion and metastasis-inducing protein 2	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q8IVF5	TIAM2	T-lymphoma invasion and metastasis-inducing protein 2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q8IVF5	TIAM2	T-lymphoma invasion and metastasis-inducing protein 2	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q8IVF5	TIAM2	T-lymphoma invasion and metastasis-inducing protein 2	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q8IVF5	TIAM2	T-lymphoma invasion and metastasis-inducing protein 2	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q8IVF5	TIAM2	T-lymphoma invasion and metastasis-inducing protein 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q13009	TIAM1	T-lymphoma invasion and metastasis-inducing protein 1	GO:0005543; F:phospholipid binding; IEA:Ensembl
Q13009	TIAM1	T-lymphoma invasion and metastasis-inducing protein 1	GO:0030676; F:Rac guanyl-nucleotide exchange factor activity; IMP:UniProtKB
Q13009	TIAM1	T-lymphoma invasion and metastasis-inducing protein 1	GO:0005057; F:receptor signaling protein activity; IEA:InterPro
Q13009	TIAM1	T-lymphoma invasion and metastasis-inducing protein 1	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; TAS:ProtInc
Q13009	TIAM1	T-lymphoma invasion and metastasis-inducing protein 1	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q13009	TIAM1	T-lymphoma invasion and metastasis-inducing protein 1	GO:0016477; P:cell migration; IMP:UniProtKB
Q13009	TIAM1	T-lymphoma invasion and metastasis-inducing protein 1	GO:0007160; P:cell-matrix adhesion; IMP:UniProtKB
Q13009	TIAM1	T-lymphoma invasion and metastasis-inducing protein 1	GO:0048013; P:ephrin receptor signaling pathway; IEA:Ensembl
Q13009	TIAM1	T-lymphoma invasion and metastasis-inducing protein 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q13009	TIAM1	T-lymphoma invasion and metastasis-inducing protein 1	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q13009	TIAM1	T-lymphoma invasion and metastasis-inducing protein 1	GO:0050772; P:positive regulation of axonogenesis; IEA:Ensembl
Q13009	TIAM1	T-lymphoma invasion and metastasis-inducing protein 1	GO:0016601; P:Rac protein signal transduction; IMP:UniProtKB
Q13009	TIAM1	T-lymphoma invasion and metastasis-inducing protein 1	GO:0032314; P:regulation of Rac GTPase activity; IMP:GOC
Q13009	TIAM1	T-lymphoma invasion and metastasis-inducing protein 1	GO:0032319; P:regulation of Rho GTPase activity; TAS:GOC
Q13009	TIAM1	T-lymphoma invasion and metastasis-inducing protein 1	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q13009	TIAM1	T-lymphoma invasion and metastasis-inducing protein 1	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q01085	TIAL1	Nucleolysin TIAR	GO:0017091; F:AU-rich element binding; IEA:Ensembl
Q01085	TIAL1	Nucleolysin TIAR	GO:0000166; F:nucleotide binding; IEA:InterPro
Q01085	TIAL1	Nucleolysin TIAR	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q01085	TIAL1	Nucleolysin TIAR	GO:0003723; F:RNA binding; TAS:ProtInc
Q01085	TIAL1	Nucleolysin TIAR	GO:0006915; P:apoptotic process; TAS:ProtInc
Q01085	TIAL1	Nucleolysin TIAR	GO:0006952; P:defense response; TAS:ProtInc
Q01085	TIAL1	Nucleolysin TIAR	GO:0007281; P:germ cell development; IEA:Ensembl
Q01085	TIAL1	Nucleolysin TIAR	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
Q01085	TIAL1	Nucleolysin TIAR	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q01085	TIAL1	Nucleolysin TIAR	GO:0017145; P:stem cell division; IEA:Ensembl
Q08629	SPOCK1	Testican-1	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q08629	SPOCK1	Testican-1	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IDA:UniProtKB
Q08629	SPOCK1	Testican-1	GO:0008191; F:metalloendopeptidase inhibitor activity; IDA:UniProtKB
Q08629	SPOCK1	Testican-1	GO:0004867; F:serine-type endopeptidase inhibitor activity; NAS:UniProtKB
Q08629	SPOCK1	Testican-1	GO:0007155; P:cell adhesion; NAS:UniProtKB
Q08629	SPOCK1	Testican-1	GO:0021953; P:central nervous system neuron differentiation; ISS:UniProtKB
Q08629	SPOCK1	Testican-1	GO:0010812; P:negative regulation of cell-substrate adhesion; IDA:UniProtKB
Q08629	SPOCK1	Testican-1	GO:0010951; P:negative regulation of endopeptidase activity; IDA:UniProtKB
Q08629	SPOCK1	Testican-1	GO:0010977; P:negative regulation of neuron projection development; IDA:UniProtKB
Q08629	SPOCK1	Testican-1	GO:0007399; P:nervous system development; NAS:UniProtKB
Q08629	SPOCK1	Testican-1	GO:0022008; P:neurogenesis; ISS:UniProtKB
Q08629	SPOCK1	Testican-1	GO:0001764; P:neuron migration; ISS:UniProtKB
Q08629	SPOCK1	Testican-1	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
Q08629	SPOCK1	Testican-1	GO:0007165; P:signal transduction; IEA:InterPro
Q92563	SPOCK2	Testican-2	GO:0005509; F:calcium ion binding; IDA:UniProtKB
Q92563	SPOCK2	Testican-2	GO:0050840; F:extracellular matrix binding; IEA:Ensembl
Q92563	SPOCK2	Testican-2	GO:0005539; F:glycosaminoglycan binding; IEA:Ensembl
Q92563	SPOCK2	Testican-2	GO:0030198; P:extracellular matrix organization; NAS:UniProtKB
Q92563	SPOCK2	Testican-2	GO:0019800; P:peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan; IEA:Ensembl
Q92563	SPOCK2	Testican-2	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
Q92563	SPOCK2	Testican-2	GO:0045595; P:regulation of cell differentiation; NAS:UniProtKB
Q92563	SPOCK2	Testican-2	GO:0007165; P:signal transduction; IEA:InterPro
Q92563	SPOCK2	Testican-2	GO:0007416; P:synapse assembly; NAS:UniProtKB
Q9BQ16	SPOCK3	Testican-3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9BQ16	SPOCK3	Testican-3	GO:0005539; F:glycosaminoglycan binding; IEA:Ensembl
Q9BQ16	SPOCK3	Testican-3	GO:0008191; F:metalloendopeptidase inhibitor activity; IDA:UniProtKB
Q9BQ16	SPOCK3	Testican-3	GO:0010951; P:negative regulation of endopeptidase activity; IDA:UniProtKB
Q9BQ16	SPOCK3	Testican-3	GO:0019800; P:peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan; IEA:Ensembl
Q9BQ16	SPOCK3	Testican-3	GO:0007165; P:signal transduction; IEA:InterPro
Q7Z2Z1	TICRR	Treslin	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q7Z2Z1	TICRR	Treslin	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z2Z1	TICRR	Treslin	GO:0000075; P:cell cycle checkpoint; ISS:UniProtKB
Q7Z2Z1	TICRR	Treslin	GO:0006281; P:DNA repair; ISS:UniProtKB
Q7Z2Z1	TICRR	Treslin	GO:0006260; P:DNA replication; ISS:UniProtKB
Q7Z2Z1	TICRR	Treslin	GO:0001731; P:formation of translation preinitiation complex; ISS:UniProtKB
Q7Z2Z1	TICRR	Treslin	GO:0033314; P:mitotic DNA replication checkpoint; ISS:UniProtKB
Q7Z2Z1	TICRR	Treslin	GO:0030174; P:regulation of DNA-dependent DNA replication initiation; IMP:UniProtKB
Q7Z2Z1	TICRR	Treslin	GO:0010212; P:response to ionizing radiation; ISS:UniProtKB
P35590	TIE1	Tyrosine-protein kinase receptor Tie-1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P35590	TIE1	Tyrosine-protein kinase receptor Tie-1	GO:0005515; F:protein binding; IPI:IntAct
P35590	TIE1	Tyrosine-protein kinase receptor Tie-1	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; TAS:ProtInc
P35590	TIE1	Tyrosine-protein kinase receptor Tie-1	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P35590	TIE1	Tyrosine-protein kinase receptor Tie-1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P35590	TIE1	Tyrosine-protein kinase receptor Tie-1	GO:0007498; P:mesoderm development; TAS:ProtInc
P35590	TIE1	Tyrosine-protein kinase receptor Tie-1	GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl
P35590	TIE1	Tyrosine-protein kinase receptor Tie-1	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
P35590	TIE1	Tyrosine-protein kinase receptor Tie-1	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:GOC
P35590	TIE1	Tyrosine-protein kinase receptor Tie-1	GO:0045026; P:plasma membrane fusion; IEA:Ensembl
P35590	TIE1	Tyrosine-protein kinase receptor Tie-1	GO:0032526; P:response to retinoic acid; IEA:Ensembl
P35590	TIE1	Tyrosine-protein kinase receptor Tie-1	GO:0007165; P:signal transduction; TAS:ProtInc
P35590	TIE1	Tyrosine-protein kinase receptor Tie-1	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q02763	TEK	Angiopoietin-1 receptor	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q02763	TEK	Angiopoietin-1 receptor	GO:0005515; F:protein binding; IPI:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0004672; F:protein kinase activity; TAS:ProtInc
Q02763	TEK	Angiopoietin-1 receptor	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0004872; F:receptor activity; TAS:ProtInc
Q02763	TEK	Angiopoietin-1 receptor	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; TAS:ProtInc
Q02763	TEK	Angiopoietin-1 receptor	GO:0001525; P:angiogenesis; ISS:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0007596; P:blood coagulation; TAS:Reactome
Q02763	TEK	Angiopoietin-1 receptor	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
Q02763	TEK	Angiopoietin-1 receptor	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q02763	TEK	Angiopoietin-1 receptor	GO:0007160; P:cell-matrix adhesion; IEA:Ensembl
Q02763	TEK	Angiopoietin-1 receptor	GO:0060216; P:definitive hemopoiesis; TAS:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0001958; P:endochondral ossification; IEA:Ensembl
Q02763	TEK	Angiopoietin-1 receptor	GO:0001935; P:endothelial cell proliferation; ISS:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0072012; P:glomerulus vasculature development; ISS:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0007507; P:heart development; ISS:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0060347; P:heart trabecula formation; ISS:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0035556; P:intracellular signal transduction; IEA:Ensembl
Q02763	TEK	Angiopoietin-1 receptor	GO:0050900; P:leukocyte migration; TAS:Reactome
Q02763	TEK	Angiopoietin-1 receptor	GO:0016525; P:negative regulation of angiogenesis; IMP:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:2000352; P:negative regulation of endothelial cell apoptotic process; ISS:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0050728; P:negative regulation of inflammatory response; TAS:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0031100; P:organ regeneration; IEA:Ensembl
Q02763	TEK	Angiopoietin-1 receptor	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:2000251; P:positive regulation of actin cytoskeleton reorganization; IMP:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0010595; P:positive regulation of endothelial cell migration; IDA:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0001938; P:positive regulation of endothelial cell proliferation; TAS:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0051894; P:positive regulation of focal adhesion assembly; IMP:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:1902533; P:positive regulation of intracellular signal transduction; IMP:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IEA:Ensembl
Q02763	TEK	Angiopoietin-1 receptor	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IMP:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IMP:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0051259; P:protein oligomerization; IDA:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:2000351; P:regulation of endothelial cell apoptotic process; TAS:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0032878; P:regulation of establishment or maintenance of cell polarity; IMP:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0043114; P:regulation of vascular permeability; TAS:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0051591; P:response to cAMP; IEA:Ensembl
Q02763	TEK	Angiopoietin-1 receptor	GO:0043627; P:response to estrogen; IEA:Ensembl
Q02763	TEK	Angiopoietin-1 receptor	GO:0001666; P:response to hypoxia; IEA:Ensembl
Q02763	TEK	Angiopoietin-1 receptor	GO:0043434; P:response to peptide hormone; IEA:Ensembl
Q02763	TEK	Angiopoietin-1 receptor	GO:0007165; P:signal transduction; TAS:ProtInc
Q02763	TEK	Angiopoietin-1 receptor	GO:0002040; P:sprouting angiogenesis; IMP:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0034446; P:substrate adhesion-dependent cell spreading; IMP:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0048014; P:Tie signaling pathway; IDA:UniProtKB
Q02763	TEK	Angiopoietin-1 receptor	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IDA:UniProtKB
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0003682; F:chromatin binding; IDA:UniProtKB
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0034056; F:estrogen response element binding; IDA:UniProtKB
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0070577; F:lysine-acetylated histone binding; IDA:UniProtKB
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0002039; F:p53 binding; IPI:UniProtKB
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0005515; F:protein binding; IPI:UniProtKB
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0004672; F:protein kinase activity; IEA:Ensembl
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0005102; F:receptor binding; TAS:ProtInc
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0008270; F:zinc ion binding; IDA:UniProtKB
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0055074; P:calcium ion homeostasis; IEA:Ensembl
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0071391; P:cellular response to estrogen stimulus; IDA:UniProtKB
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0030163; P:protein catabolic process; IMP:UniProtKB
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0042981; P:regulation of apoptotic process; IMP:UniProtKB
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0031647; P:regulation of protein stability; IMP:UniProtKB
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:1901796; P:regulation of signal transduction by p53 class mediator; IEA:Ensembl
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0070562; P:regulation of vitamin D receptor signaling pathway; IEA:Ensembl
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0043434; P:response to peptide hormone; IEA:Ensembl
O15164	TRIM24	Transcription intermediary factor 1-alpha	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0070087; F:chromo shadow domain binding; IPI:BHF-UCL
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0003677; F:DNA binding; IDA:UniProtKB
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0035851; F:Krueppel-associated box domain binding; IDA:UniProtKB
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0005515; F:protein binding; IPI:UniProtKB
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0004672; F:protein kinase activity; IEA:Ensembl
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0003713; F:transcription coactivator activity; IEA:Ensembl
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0031625; F:ubiquitin protein ligase binding; IDA:UniProtKB
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0060028; P:convergent extension involved in axis elongation; IEA:Ensembl
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0006281; P:DNA repair; IDA:UniProtKB
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0060669; P:embryonic placenta morphogenesis; IEA:Ensembl
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0001837; P:epithelial to mesenchymal transition; ISS:HGNC
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0010467; P:gene expression; TAS:Reactome
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0045087; P:innate immune response; IDA:UniProt
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:1902187; P:negative regulation of viral release from host cell; IDA:UniProt
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0045739; P:positive regulation of DNA repair; IDA:UniProtKB
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0042993; P:positive regulation of transcription factor import into nucleus; IDA:UniProtKB
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:HGNC
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0051259; P:protein oligomerization; IDA:UniProtKB
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0016925; P:protein sumoylation; IDA:UniProtKB
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0016567; P:protein ubiquitination; IDA:GOC
Q13263	TRIM28	Transcription intermediary factor 1-beta	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q96CG3	TIFA	TRAF-interacting protein with FHA domain-containing protein A	GO:0005515; F:protein binding; IPI:IntAct
Q96CG3	TIFA	TRAF-interacting protein with FHA domain-containing protein A	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
P49788	RARRES1	Retinoic acid receptor responder protein 1	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q9NQ88	TIGAR	Fructose-2,6-bisphosphatase TIGAR	GO:0004331; F:fructose-2,6-bisphosphate 2-phosphatase activity; IEA:UniProtKB-EC
Q9NQ88	TIGAR	Fructose-2,6-bisphosphatase TIGAR	GO:1901525; P:negative regulation of macromitophagy; IEA:Ensembl
Q9NQ88	TIGAR	Fructose-2,6-bisphosphatase TIGAR	GO:2000378; P:negative regulation of reactive oxygen species metabolic process; IEA:Ensembl
Q9NQ88	TIGAR	Fructose-2,6-bisphosphatase TIGAR	GO:0010666; P:positive regulation of cardiac muscle cell apoptotic process; IEA:Ensembl
Q96MW7	TIGD1	Tigger transposable element-derived protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6B0B8	TIGD3	Tigger transposable element-derived protein 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q4W5G0	TIGD2	Tigger transposable element-derived protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IY51	TIGD4	Tigger transposable element-derived protein 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q53EQ6	TIGD5	Tigger transposable element-derived protein 5	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q17RP2	TIGD6	Tigger transposable element-derived protein 6	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6NT04	TIGD7	Tigger transposable element-derived protein 7	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q495A1	TIGIT	T-cell immunoreceptor with Ig and ITIM domains	GO:0005515; F:protein binding; IPI:UniProtKB
Q495A1	TIGIT	T-cell immunoreceptor with Ig and ITIM domains	GO:0005102; F:receptor binding; IPI:MGI
Q495A1	TIGIT	T-cell immunoreceptor with Ig and ITIM domains	GO:0032695; P:negative regulation of interleukin-12 production; IMP:UniProtKB
Q495A1	TIGIT	T-cell immunoreceptor with Ig and ITIM domains	GO:0050868; P:negative regulation of T cell activation; IMP:UniProtKB
Q495A1	TIGIT	T-cell immunoreceptor with Ig and ITIM domains	GO:0032733; P:positive regulation of interleukin-10 production; IMP:UniProtKB
Q86V40	TRABD2A	Metalloprotease TIKI1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86V40	TRABD2A	Metalloprotease TIKI1	GO:0004222; F:metalloendopeptidase activity; IDA:UniProtKB
Q86V40	TRABD2A	Metalloprotease TIKI1	GO:0017147; F:Wnt-protein binding; IDA:UniProtKB
Q86V40	TRABD2A	Metalloprotease TIKI1	GO:0060322; P:head development; ISS:UniProtKB
Q86V40	TRABD2A	Metalloprotease TIKI1	GO:0008152; P:metabolic process; IDA:UniProtKB
Q86V40	TRABD2A	Metalloprotease TIKI1	GO:0030178; P:negative regulation of Wnt signaling pathway; IDA:UniProtKB
Q86V40	TRABD2A	Metalloprotease TIKI1	GO:0018158; P:protein oxidation; IDA:UniProtKB
Q86V40	TRABD2A	Metalloprotease TIKI1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
A6NFA1	TRABD2B	Metalloprotease TIKI2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A6NFA1	TRABD2B	Metalloprotease TIKI2	GO:0004222; F:metalloendopeptidase activity; IDA:UniProtKB
A6NFA1	TRABD2B	Metalloprotease TIKI2	GO:0005515; F:protein binding; IPI:IntAct
A6NFA1	TRABD2B	Metalloprotease TIKI2	GO:0017147; F:Wnt-protein binding; IDA:UniProtKB
A6NFA1	TRABD2B	Metalloprotease TIKI2	GO:0008152; P:metabolic process; IDA:UniProtKB
A6NFA1	TRABD2B	Metalloprotease TIKI2	GO:0030178; P:negative regulation of Wnt signaling pathway; IDA:UniProtKB
A6NFA1	TRABD2B	Metalloprotease TIKI2	GO:0018158; P:protein oxidation; IDA:UniProtKB
A6NFA1	TRABD2B	Metalloprotease TIKI2	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q86X45	LRRC6	Protein tilB homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q86X45	LRRC6	Protein tilB homolog	GO:0003341; P:cilium movement; IMP:BHF-UCL
Q86X45	LRRC6	Protein tilB homolog	GO:0060287; P:epithelial cilium movement involved in determination of left/right asymmetry; IMP:BHF-UCL
Q86X45	LRRC6	Protein tilB homolog	GO:0036159; P:inner dynein arm assembly; IMP:BHF-UCL
Q86X45	LRRC6	Protein tilB homolog	GO:0008584; P:male gonad development; ISS:BHF-UCL
Q86X45	LRRC6	Protein tilB homolog	GO:0044458; P:motile cilium assembly; IMP:BHF-UCL
Q86X45	LRRC6	Protein tilB homolog	GO:0036158; P:outer dynein arm assembly; IMP:BHF-UCL
Q86X45	LRRC6	Protein tilB homolog	GO:0061458; P:reproductive system development; IMP:BHF-UCL
Q86X45	LRRC6	Protein tilB homolog	GO:0030317; P:sperm motility; IMP:BHF-UCL
P62072	TIMM10	Mitochondrial import inner membrane translocase subunit Tim10	GO:0051087; F:chaperone binding; IPI:BHF-UCL
P62072	TIMM10	Mitochondrial import inner membrane translocase subunit Tim10	GO:0005515; F:protein binding; IPI:IntAct
P62072	TIMM10	Mitochondrial import inner membrane translocase subunit Tim10	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P62072	TIMM10	Mitochondrial import inner membrane translocase subunit Tim10	GO:0005215; F:transporter activity; IDA:BHF-UCL
P62072	TIMM10	Mitochondrial import inner membrane translocase subunit Tim10	GO:0008270; F:zinc ion binding; TAS:UniProtKB
P62072	TIMM10	Mitochondrial import inner membrane translocase subunit Tim10	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P62072	TIMM10	Mitochondrial import inner membrane translocase subunit Tim10	GO:0072321; P:chaperone-mediated protein transport; IDA:BHF-UCL
P62072	TIMM10	Mitochondrial import inner membrane translocase subunit Tim10	GO:0045039; P:protein import into mitochondrial inner membrane; IDA:BHF-UCL
P62072	TIMM10	Mitochondrial import inner membrane translocase subunit Tim10	GO:0006626; P:protein targeting to mitochondrion; TAS:UniProtKB
P62072	TIMM10	Mitochondrial import inner membrane translocase subunit Tim10	GO:0007605; P:sensory perception of sound; TAS:UniProtKB
Q9Y5L4	TIMM13	Mitochondrial import inner membrane translocase subunit Tim13	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q9Y5L4	TIMM13	Mitochondrial import inner membrane translocase subunit Tim13	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9Y5L4	TIMM13	Mitochondrial import inner membrane translocase subunit Tim13	GO:0072321; P:chaperone-mediated protein transport; TAS:BHF-UCL
Q9Y5L4	TIMM13	Mitochondrial import inner membrane translocase subunit Tim13	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
Q9Y5L4	TIMM13	Mitochondrial import inner membrane translocase subunit Tim13	GO:0007605; P:sensory perception of sound; TAS:ProtInc
Q96DA6	DNAJC19	Mitochondrial import inner membrane translocase subunit TIM14	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q96DA6	DNAJC19	Mitochondrial import inner membrane translocase subunit TIM14	GO:0048806; P:genitalia development; IMP:UniProtKB
Q96DA6	DNAJC19	Mitochondrial import inner membrane translocase subunit TIM14	GO:0006457; P:protein folding; NAS:UniProtKB
Q96DA6	DNAJC19	Mitochondrial import inner membrane translocase subunit TIM14	GO:0006626; P:protein targeting to mitochondrion; NAS:UniProtKB
Q96DA6	DNAJC19	Mitochondrial import inner membrane translocase subunit TIM14	GO:0007601; P:visual perception; IMP:UniProtKB
Q9Y3D7	PAM16	Mitochondrial import inner membrane translocase subunit TIM16	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9Y3D7	PAM16	Mitochondrial import inner membrane translocase subunit TIM16	GO:0030150; P:protein import into mitochondrial matrix; IEA:InterPro
Q9Y3D7	PAM16	Mitochondrial import inner membrane translocase subunit TIM16	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
Q9BVV7	TIMM21	Mitochondrial import inner membrane translocase subunit Tim21	GO:0005515; F:protein binding; IPI:IntAct
Q9BVV7	TIMM21	Mitochondrial import inner membrane translocase subunit Tim21	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9BVV7	TIMM21	Mitochondrial import inner membrane translocase subunit Tim21	GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:UniProtKB
Q9BVV7	TIMM21	Mitochondrial import inner membrane translocase subunit Tim21	GO:0033617; P:mitochondrial respiratory chain complex IV assembly; IMP:UniProtKB
Q9BVV7	TIMM21	Mitochondrial import inner membrane translocase subunit Tim21	GO:0030150; P:protein import into mitochondrial matrix; IMP:UniProtKB
Q9BVV7	TIMM21	Mitochondrial import inner membrane translocase subunit Tim21	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
Q9Y584	TIMM22	Mitochondrial import inner membrane translocase subunit Tim22	GO:0015266; F:protein channel activity; TAS:BHF-UCL
Q9Y584	TIMM22	Mitochondrial import inner membrane translocase subunit Tim22	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9Y584	TIMM22	Mitochondrial import inner membrane translocase subunit Tim22	GO:0045039; P:protein import into mitochondrial inner membrane; TAS:BHF-UCL
Q9Y584	TIMM22	Mitochondrial import inner membrane translocase subunit Tim22	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
O14925	TIMM23	Mitochondrial import inner membrane translocase subunit Tim23	GO:0015450; F:P-P-bond-hydrolysis-driven protein transmembrane transporter activity; IEA:InterPro
O14925	TIMM23	Mitochondrial import inner membrane translocase subunit Tim23	GO:0005515; F:protein binding; IPI:UniProtKB
O14925	TIMM23	Mitochondrial import inner membrane translocase subunit Tim23	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O14925	TIMM23	Mitochondrial import inner membrane translocase subunit Tim23	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
O43615	TIMM44	Mitochondrial import inner membrane translocase subunit TIM44	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43615	TIMM44	Mitochondrial import inner membrane translocase subunit TIM44	GO:0015450; F:P-P-bond-hydrolysis-driven protein transmembrane transporter activity; IEA:InterPro
O43615	TIMM44	Mitochondrial import inner membrane translocase subunit TIM44	GO:0005515; F:protein binding; IPI:IntAct
O43615	TIMM44	Mitochondrial import inner membrane translocase subunit TIM44	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O43615	TIMM44	Mitochondrial import inner membrane translocase subunit TIM44	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
Q3ZCQ8	TIMM50	Mitochondrial import inner membrane translocase subunit TIM50	GO:0005134; F:interleukin-2 receptor binding; IDA:MGI
Q3ZCQ8	TIMM50	Mitochondrial import inner membrane translocase subunit TIM50	GO:0004721; F:phosphoprotein phosphatase activity; IDA:MGI
Q3ZCQ8	TIMM50	Mitochondrial import inner membrane translocase subunit TIM50	GO:0005515; F:protein binding; IPI:UniProtKB
Q3ZCQ8	TIMM50	Mitochondrial import inner membrane translocase subunit TIM50	GO:0004722; F:protein serine/threonine phosphatase activity; IDA:UniProtKB
Q3ZCQ8	TIMM50	Mitochondrial import inner membrane translocase subunit TIM50	GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB
Q3ZCQ8	TIMM50	Mitochondrial import inner membrane translocase subunit TIM50	GO:0043021; F:ribonucleoprotein complex binding; IDA:UniProtKB
Q3ZCQ8	TIMM50	Mitochondrial import inner membrane translocase subunit TIM50	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q3ZCQ8	TIMM50	Mitochondrial import inner membrane translocase subunit TIM50	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q3ZCQ8	TIMM50	Mitochondrial import inner membrane translocase subunit TIM50	GO:0007006; P:mitochondrial membrane organization; IMP:UniProtKB
Q3ZCQ8	TIMM50	Mitochondrial import inner membrane translocase subunit TIM50	GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:GOC
Q3ZCQ8	TIMM50	Mitochondrial import inner membrane translocase subunit TIM50	GO:0006470; P:protein dephosphorylation; IDA:UniProtKB
Q3ZCQ8	TIMM50	Mitochondrial import inner membrane translocase subunit TIM50	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
Q3ZCQ8	TIMM50	Mitochondrial import inner membrane translocase subunit TIM50	GO:0001836; P:release of cytochrome c from mitochondria; IDA:MGI
O60220	TIMM8A	Mitochondrial import inner membrane translocase subunit Tim8 A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60220	TIMM8A	Mitochondrial import inner membrane translocase subunit Tim8 A	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O60220	TIMM8A	Mitochondrial import inner membrane translocase subunit Tim8 A	GO:0072321; P:chaperone-mediated protein transport; TAS:BHF-UCL
O60220	TIMM8A	Mitochondrial import inner membrane translocase subunit Tim8 A	GO:0007399; P:nervous system development; TAS:ProtInc
O60220	TIMM8A	Mitochondrial import inner membrane translocase subunit Tim8 A	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
Q9Y5J9	TIMM8B	Mitochondrial import inner membrane translocase subunit Tim8 B	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q9Y5J9	TIMM8B	Mitochondrial import inner membrane translocase subunit Tim8 B	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9Y5J9	TIMM8B	Mitochondrial import inner membrane translocase subunit Tim8 B	GO:0072321; P:chaperone-mediated protein transport; TAS:BHF-UCL
Q9Y5J9	TIMM8B	Mitochondrial import inner membrane translocase subunit Tim8 B	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
Q9Y5J9	TIMM8B	Mitochondrial import inner membrane translocase subunit Tim8 B	GO:0007605; P:sensory perception of sound; TAS:ProtInc
Q9Y5J7	TIMM9	Mitochondrial import inner membrane translocase subunit Tim9	GO:0051087; F:chaperone binding; IPI:BHF-UCL
Q9Y5J7	TIMM9	Mitochondrial import inner membrane translocase subunit Tim9	GO:0005515; F:protein binding; IPI:IntAct
Q9Y5J7	TIMM9	Mitochondrial import inner membrane translocase subunit Tim9	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q9Y5J7	TIMM9	Mitochondrial import inner membrane translocase subunit Tim9	GO:0005215; F:transporter activity; IDA:BHF-UCL
Q9Y5J7	TIMM9	Mitochondrial import inner membrane translocase subunit Tim9	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q9Y5J7	TIMM9	Mitochondrial import inner membrane translocase subunit Tim9	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9Y5J7	TIMM9	Mitochondrial import inner membrane translocase subunit Tim9	GO:0072321; P:chaperone-mediated protein transport; IDA:BHF-UCL
Q9Y5J7	TIMM9	Mitochondrial import inner membrane translocase subunit Tim9	GO:0045039; P:protein import into mitochondrial inner membrane; IDA:BHF-UCL
Q9Y5J7	TIMM9	Mitochondrial import inner membrane translocase subunit Tim9	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
Q9Y5J7	TIMM9	Mitochondrial import inner membrane translocase subunit Tim9	GO:0007605; P:sensory perception of sound; TAS:ProtInc
P01033	TIMP1	Metalloproteinase inhibitor 1	GO:0005125; F:cytokine activity; IDA:UniProtKB
P01033	TIMP1	Metalloproteinase inhibitor 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P01033	TIMP1	Metalloproteinase inhibitor 1	GO:0008191; F:metalloendopeptidase inhibitor activity; IDA:UniProtKB
P01033	TIMP1	Metalloproteinase inhibitor 1	GO:0005515; F:protein binding; IPI:UniProtKB
P01033	TIMP1	Metalloproteinase inhibitor 1	GO:0007568; P:aging; IEA:Ensembl
P01033	TIMP1	Metalloproteinase inhibitor 1	GO:0007596; P:blood coagulation; TAS:Reactome
P01033	TIMP1	Metalloproteinase inhibitor 1	GO:0043249; P:erythrocyte maturation; IEA:UniProtKB-KW
P01033	TIMP1	Metalloproteinase inhibitor 1	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P01033	TIMP1	Metalloproteinase inhibitor 1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P01033	TIMP1	Metalloproteinase inhibitor 1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P01033	TIMP1	Metalloproteinase inhibitor 1	GO:0010951; P:negative regulation of endopeptidase activity; IDA:UniProtKB
P01033	TIMP1	Metalloproteinase inhibitor 1	GO:0051045; P:negative regulation of membrane protein ectodomain proteolysis; IDA:UniProtKB
P01033	TIMP1	Metalloproteinase inhibitor 1	GO:0048553; P:negative regulation of metalloenzyme activity; IDA:UniProtKB
P01033	TIMP1	Metalloproteinase inhibitor 1	GO:1901164; P:negative regulation of trophoblast cell migration; IMP:BHF-UCL
P01033	TIMP1	Metalloproteinase inhibitor 1	GO:0030168; P:platelet activation; TAS:Reactome
P01033	TIMP1	Metalloproteinase inhibitor 1	GO:0002576; P:platelet degranulation; TAS:Reactome
P01033	TIMP1	Metalloproteinase inhibitor 1	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P01033	TIMP1	Metalloproteinase inhibitor 1	GO:2001044; P:regulation of integrin-mediated signaling pathway; IMP:UniProtKB
P01033	TIMP1	Metalloproteinase inhibitor 1	GO:0034097; P:response to cytokine; IEA:Ensembl
P01033	TIMP1	Metalloproteinase inhibitor 1	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P16035	TIMP2	Metalloproteinase inhibitor 2	GO:0008047; F:enzyme activator activity; IEA:Ensembl
P16035	TIMP2	Metalloproteinase inhibitor 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P16035	TIMP2	Metalloproteinase inhibitor 2	GO:0008191; F:metalloendopeptidase inhibitor activity; TAS:ProtInc
P16035	TIMP2	Metalloproteinase inhibitor 2	GO:0005515; F:protein binding; IPI:IntAct
P16035	TIMP2	Metalloproteinase inhibitor 2	GO:0007568; P:aging; IEA:Ensembl
P16035	TIMP2	Metalloproteinase inhibitor 2	GO:0071310; P:cellular response to organic substance; IEA:Ensembl
P16035	TIMP2	Metalloproteinase inhibitor 2	GO:0007417; P:central nervous system development; IEA:Ensembl
P16035	TIMP2	Metalloproteinase inhibitor 2	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P16035	TIMP2	Metalloproteinase inhibitor 2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P16035	TIMP2	Metalloproteinase inhibitor 2	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P16035	TIMP2	Metalloproteinase inhibitor 2	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
P16035	TIMP2	Metalloproteinase inhibitor 2	GO:0045930; P:negative regulation of mitotic cell cycle; IEA:Ensembl
P16035	TIMP2	Metalloproteinase inhibitor 2	GO:0045861; P:negative regulation of proteolysis; IEA:Ensembl
P16035	TIMP2	Metalloproteinase inhibitor 2	GO:0046580; P:negative regulation of Ras protein signal transduction; IEA:Ensembl
P16035	TIMP2	Metalloproteinase inhibitor 2	GO:0045762; P:positive regulation of adenylate cyclase activity; IEA:Ensembl
P16035	TIMP2	Metalloproteinase inhibitor 2	GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl
P16035	TIMP2	Metalloproteinase inhibitor 2	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
P16035	TIMP2	Metalloproteinase inhibitor 2	GO:0032487; P:regulation of Rap protein signal transduction; IEA:Ensembl
P16035	TIMP2	Metalloproteinase inhibitor 2	GO:0034097; P:response to cytokine; IEA:Ensembl
P16035	TIMP2	Metalloproteinase inhibitor 2	GO:0042493; P:response to drug; IEA:Ensembl
P35625	TIMP3	Metalloproteinase inhibitor 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P35625	TIMP3	Metalloproteinase inhibitor 3	GO:0008191; F:metalloendopeptidase inhibitor activity; TAS:BHF-UCL
P35625	TIMP3	Metalloproteinase inhibitor 3	GO:0005515; F:protein binding; IPI:IntAct
P35625	TIMP3	Metalloproteinase inhibitor 3	GO:0071310; P:cellular response to organic substance; IEA:Ensembl
P35625	TIMP3	Metalloproteinase inhibitor 3	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
P35625	TIMP3	Metalloproteinase inhibitor 3	GO:0051045; P:negative regulation of membrane protein ectodomain proteolysis; IMP:BHF-UCL
P35625	TIMP3	Metalloproteinase inhibitor 3	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q99727	TIMP4	Metalloproteinase inhibitor 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q99727	TIMP4	Metalloproteinase inhibitor 4	GO:0008191; F:metalloendopeptidase inhibitor activity; NAS:UniProtKB
Q99727	TIMP4	Metalloproteinase inhibitor 4	GO:0007417; P:central nervous system development; IEA:Ensembl
Q99727	TIMP4	Metalloproteinase inhibitor 4	GO:0010951; P:negative regulation of endopeptidase activity; NAS:GOC
Q99727	TIMP4	Metalloproteinase inhibitor 4	GO:0042698; P:ovulation cycle; IEA:Ensembl
Q99727	TIMP4	Metalloproteinase inhibitor 4	GO:0034097; P:response to cytokine; IEA:Ensembl
Q99727	TIMP4	Metalloproteinase inhibitor 4	GO:0042493; P:response to drug; IEA:Ensembl
Q99727	TIMP4	Metalloproteinase inhibitor 4	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
Q99727	TIMP4	Metalloproteinase inhibitor 4	GO:0043434; P:response to peptide hormone; IEA:Ensembl
Q9UNS1	TIMELESS	Protein timeless homolog	GO:0005515; F:protein binding; IPI:IntAct
Q9UNS1	TIMELESS	Protein timeless homolog	GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl
Q9UNS1	TIMELESS	Protein timeless homolog	GO:0044770; P:cell cycle phase transition; IMP:BHF-UCL
Q9UNS1	TIMELESS	Protein timeless homolog	GO:0006974; P:cellular response to DNA damage stimulus; IEA:UniProtKB-KW
Q9UNS1	TIMELESS	Protein timeless homolog	GO:0007623; P:circadian rhythm; ISS:UniProtKB
Q9UNS1	TIMELESS	Protein timeless homolog	GO:0009582; P:detection of abiotic stimulus; TAS:ProtInc
Q9UNS1	TIMELESS	Protein timeless homolog	GO:0009790; P:embryo development; IEA:Ensembl
Q9UNS1	TIMELESS	Protein timeless homolog	GO:0030324; P:lung development; IEA:Ensembl
Q9UNS1	TIMELESS	Protein timeless homolog	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9UNS1	TIMELESS	Protein timeless homolog	GO:0002009; P:morphogenesis of an epithelium; ISS:UniProtKB
Q9UNS1	TIMELESS	Protein timeless homolog	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UNS1	TIMELESS	Protein timeless homolog	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UNS1	TIMELESS	Protein timeless homolog	GO:0009628; P:response to abiotic stimulus; TAS:ProtInc
Q9UNS1	TIMELESS	Protein timeless homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UJW2	TINAG	Tubulointerstitial nephritis antigen	GO:0004197; F:cysteine-type endopeptidase activity; TAS:ProtInc
Q9UJW2	TINAG	Tubulointerstitial nephritis antigen	GO:0000166; F:nucleotide binding; TAS:ProtInc
Q9UJW2	TINAG	Tubulointerstitial nephritis antigen	GO:0030247; F:polysaccharide binding; IEA:InterPro
Q9UJW2	TINAG	Tubulointerstitial nephritis antigen	GO:0005044; F:scavenger receptor activity; IEA:InterPro
Q9UJW2	TINAG	Tubulointerstitial nephritis antigen	GO:0007155; P:cell adhesion; IDA:UniProtKB
Q9UJW2	TINAG	Tubulointerstitial nephritis antigen	GO:0006955; P:immune response; IEA:InterPro
Q9GZM7	TINAGL1	Tubulointerstitial nephritis antigen-like	GO:0008234; F:cysteine-type peptidase activity; IEA:InterPro
Q9GZM7	TINAGL1	Tubulointerstitial nephritis antigen-like	GO:0005201; F:extracellular matrix structural constituent; NAS:UniProtKB
Q9GZM7	TINAGL1	Tubulointerstitial nephritis antigen-like	GO:0030247; F:polysaccharide binding; IEA:InterPro
Q9GZM7	TINAGL1	Tubulointerstitial nephritis antigen-like	GO:0005044; F:scavenger receptor activity; IEA:InterPro
Q9GZM7	TINAGL1	Tubulointerstitial nephritis antigen-like	GO:0016197; P:endosomal transport; TAS:UniProtKB
Q9GZM7	TINAGL1	Tubulointerstitial nephritis antigen-like	GO:0006955; P:immune response; IEA:InterPro
Q9BSI4	TINF2	TERF1-interacting nuclear factor 2	GO:0005515; F:protein binding; IPI:IntAct
Q9BSI4	TINF2	TERF1-interacting nuclear factor 2	GO:0042162; F:telomeric DNA binding; IDA:UniProtKB
Q9BSI4	TINF2	TERF1-interacting nuclear factor 2	GO:0050680; P:negative regulation of epithelial cell proliferation; IMP:BHF-UCL
Q9BSI4	TINF2	TERF1-interacting nuclear factor 2	GO:0010836; P:negative regulation of protein ADP-ribosylation; IGI:BHF-UCL
Q9BSI4	TINF2	TERF1-interacting nuclear factor 2	GO:0032211; P:negative regulation of telomere maintenance via telomerase; IGI:BHF-UCL
Q9BSI4	TINF2	TERF1-interacting nuclear factor 2	GO:0032206; P:positive regulation of telomere maintenance; IMP:BHF-UCL
Q9BSI4	TINF2	TERF1-interacting nuclear factor 2	GO:0034502; P:protein localization to chromosome; IMP:BHF-UCL
Q9BSI4	TINF2	TERF1-interacting nuclear factor 2	GO:0070198; P:protein localization to chromosome, telomeric region; IMP:BHF-UCL
Q9BSI4	TINF2	TERF1-interacting nuclear factor 2	GO:0032202; P:telomere assembly; IMP:BHF-UCL
Q9BSI4	TINF2	TERF1-interacting nuclear factor 2	GO:0000723; P:telomere maintenance; TAS:Reactome
Q9BSI4	TINF2	TERF1-interacting nuclear factor 2	GO:0010833; P:telomere maintenance via telomere lengthening; IMP:BHF-UCL
Q96A98	PTH2	Tuberoinfundibular peptide of 39 residues	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
Q9BVW5	TIPIN	TIMELESS-interacting protein	GO:0005515; F:protein binding; IPI:HGNC
Q9BVW5	TIPIN	TIMELESS-interacting protein	GO:0044770; P:cell cycle phase transition; IMP:BHF-UCL
Q9BVW5	TIPIN	TIMELESS-interacting protein	GO:0000076; P:DNA replication checkpoint; IMP:HGNC
Q9BVW5	TIPIN	TIMELESS-interacting protein	GO:0031573; P:intra-S DNA damage checkpoint; IMP:HGNC
Q9BVW5	TIPIN	TIMELESS-interacting protein	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9BVW5	TIPIN	TIMELESS-interacting protein	GO:0008284; P:positive regulation of cell proliferation; IMP:HGNC
Q9BVW5	TIPIN	TIMELESS-interacting protein	GO:0033262; P:regulation of nuclear cell cycle DNA replication; TAS:HGNC
Q9BVW5	TIPIN	TIMELESS-interacting protein	GO:0048478; P:replication fork protection; IEA:InterPro
Q9BVW5	TIPIN	TIMELESS-interacting protein	GO:0009411; P:response to UV; IEA:Ensembl
O75663	TIPRL	TIP41-like protein	GO:0005515; F:protein binding; IPI:UniProtKB
O75663	TIPRL	TIP41-like protein	GO:0000077; P:DNA damage checkpoint; IMP:UniProtKB
O75663	TIPRL	TIP41-like protein	GO:0034048; P:negative regulation of protein phosphatase type 2A activity; IDA:UniProtKB
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISS:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0005515; F:protein binding; IPI:UniProtKB
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0030674; F:protein binding, bridging; NAS:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0046982; F:protein heterodimerization activity; IDA:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0005080; F:protein kinase C binding; IPI:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0035663; F:Toll-like receptor 2 binding; IPI:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0035662; F:Toll-like receptor 4 binding; IPI:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0070935; P:3'-UTR-mediated mRNA stabilization; IDA:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0007166; P:cell surface receptor signaling pathway; ISS:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0071221; P:cellular response to bacterial lipopeptide; ISS:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0071223; P:cellular response to lipoteichoic acid; ISS:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0050830; P:defense response to Gram-positive bacterium; ISS:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0045087; P:innate immune response; TAS:Reactome
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0030099; P:myeloid cell differentiation; ISS:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0044130; P:negative regulation of growth of symbiont in host; ISS:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0030890; P:positive regulation of B cell proliferation; ISS:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:2000340; P:positive regulation of chemokine (C-X-C motif) ligand 1 production; ISS:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:2000343; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; ISS:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0032735; P:positive regulation of interleukin-12 production; ISS:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0032738; P:positive regulation of interleukin-15 production; IDA:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0045410; P:positive regulation of interleukin-6 biosynthetic process; IMP:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0032757; P:positive regulation of interleukin-8 production; IMP:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0046330; P:positive regulation of JNK cascade; IMP:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0090023; P:positive regulation of neutrophil chemotaxis; ISS:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0090073; P:positive regulation of protein homodimerization activity; IDA:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0034137; P:positive regulation of toll-like receptor 2 signaling pathway; IMP:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0034141; P:positive regulation of toll-like receptor 3 signaling pathway; ISS:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0034145; P:positive regulation of toll-like receptor 4 signaling pathway; IMP:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0032760; P:positive regulation of tumor necrosis factor production; IMP:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0045088; P:regulation of innate immune response; IC:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0032648; P:regulation of interferon-beta production; ISS:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0032496; P:response to lipopolysaccharide; IDA:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0035665; P:TIRAP-dependent toll-like receptor 4 signaling pathway; IDA:BHF-UCL
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P58753	TIRAP	Toll/interleukin-1 receptor domain-containing adapter protein	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q07352	ZFP36L1	Zinc finger protein 36, C3H1 type-like 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q07352	ZFP36L1	Zinc finger protein 36, C3H1 type-like 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q07352	ZFP36L1	Zinc finger protein 36, C3H1 type-like 1	GO:0003729; F:mRNA binding; IDA:MGI
Q07352	ZFP36L1	Zinc finger protein 36, C3H1 type-like 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q07352	ZFP36L1	Zinc finger protein 36, C3H1 type-like 1	GO:0005515; F:protein binding; IPI:IntAct
Q07352	ZFP36L1	Zinc finger protein 36, C3H1 type-like 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
Q07352	ZFP36L1	Zinc finger protein 36, C3H1 type-like 1	GO:0010467; P:gene expression; TAS:Reactome
Q07352	ZFP36L1	Zinc finger protein 36, C3H1 type-like 1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q07352	ZFP36L1	Zinc finger protein 36, C3H1 type-like 1	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; IEA:Ensembl
Q07352	ZFP36L1	Zinc finger protein 36, C3H1 type-like 1	GO:0043488; P:regulation of mRNA stability; IDA:MGI
Q07352	ZFP36L1	Zinc finger protein 36, C3H1 type-like 1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:GOC
Q07352	ZFP36L1	Zinc finger protein 36, C3H1 type-like 1	GO:0006417; P:regulation of translation; IEA:Ensembl
Q07352	ZFP36L1	Zinc finger protein 36, C3H1 type-like 1	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q07352	ZFP36L1	Zinc finger protein 36, C3H1 type-like 1	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
Q07352	ZFP36L1	Zinc finger protein 36, C3H1 type-like 1	GO:0001570; P:vasculogenesis; IEA:Ensembl
P47974	ZFP36L2	Zinc finger protein 36, C3H1 type-like 2	GO:0017091; F:AU-rich element binding; IDA:UniProtKB
P47974	ZFP36L2	Zinc finger protein 36, C3H1 type-like 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P47974	ZFP36L2	Zinc finger protein 36, C3H1 type-like 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P47974	ZFP36L2	Zinc finger protein 36, C3H1 type-like 2	GO:0035925; F:mRNA 3'-UTR AU-rich region binding; IEA:Ensembl
P47974	ZFP36L2	Zinc finger protein 36, C3H1 type-like 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P47974	ZFP36L2	Zinc finger protein 36, C3H1 type-like 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P47974	ZFP36L2	Zinc finger protein 36, C3H1 type-like 2	GO:0008283; P:cell proliferation; TAS:ProtInc
P47974	ZFP36L2	Zinc finger protein 36, C3H1 type-like 2	GO:0060216; P:definitive hemopoiesis; ISS:UniProtKB
P47974	ZFP36L2	Zinc finger protein 36, C3H1 type-like 2	GO:0030097; P:hemopoiesis; ISS:UniProtKB
P47974	ZFP36L2	Zinc finger protein 36, C3H1 type-like 2	GO:0006402; P:mRNA catabolic process; ISS:UniProtKB
P47974	ZFP36L2	Zinc finger protein 36, C3H1 type-like 2	GO:2000737; P:negative regulation of stem cell differentiation; ISS:UniProtKB
P47974	ZFP36L2	Zinc finger protein 36, C3H1 type-like 2	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; IEA:Ensembl
P47974	ZFP36L2	Zinc finger protein 36, C3H1 type-like 2	GO:1900153; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; ISS:UniProtKB
P47974	ZFP36L2	Zinc finger protein 36, C3H1 type-like 2	GO:0043488; P:regulation of mRNA stability; IEA:Ensembl
P47974	ZFP36L2	Zinc finger protein 36, C3H1 type-like 2	GO:0006355; P:regulation of transcription, DNA-templated; TAS:GOC
P47974	ZFP36L2	Zinc finger protein 36, C3H1 type-like 2	GO:0048103; P:somatic stem cell division; ISS:UniProtKB
P47974	ZFP36L2	Zinc finger protein 36, C3H1 type-like 2	GO:0035019; P:somatic stem cell maintenance; ISS:UniProtKB
P47974	ZFP36L2	Zinc finger protein 36, C3H1 type-like 2	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
Q9Y5M6	OCLM	Oculomedin	GO:0007601; P:visual perception; TAS:ProtInc
Q8WZ42	TTN	Titin	GO:0051015; F:actin filament binding; IDA:BHF-UCL
Q8WZ42	TTN	Titin	GO:0042805; F:actinin binding; IDA:BHF-UCL
Q8WZ42	TTN	Titin	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8WZ42	TTN	Titin	GO:0005509; F:calcium ion binding; IDA:BHF-UCL
Q8WZ42	TTN	Titin	GO:0005516; F:calmodulin binding; TAS:UniProtKB
Q8WZ42	TTN	Titin	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q8WZ42	TTN	Titin	GO:0042802; F:identical protein binding; IPI:IntAct
Q8WZ42	TTN	Titin	GO:0051371; F:muscle alpha-actinin binding; IPI:BHF-UCL
Q8WZ42	TTN	Titin	GO:0002020; F:protease binding; IPI:UniProtKB
Q8WZ42	TTN	Titin	GO:0005515; F:protein binding; IPI:BHF-UCL
Q8WZ42	TTN	Titin	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
Q8WZ42	TTN	Titin	GO:0043621; F:protein self-association; IDA:BHF-UCL
Q8WZ42	TTN	Titin	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q8WZ42	TTN	Titin	GO:0004713; F:protein tyrosine kinase activity; IEA:InterPro
Q8WZ42	TTN	Titin	GO:0008307; F:structural constituent of muscle; TAS:UniProtKB
Q8WZ42	TTN	Titin	GO:0097493; F:structural molecule activity conferring elasticity; TAS:BHF-UCL
Q8WZ42	TTN	Titin	GO:0031433; F:telethonin binding; IPI:BHF-UCL
Q8WZ42	TTN	Titin	GO:0007512; P:adult heart development; IEA:Ensembl
Q8WZ42	TTN	Titin	GO:0007596; P:blood coagulation; TAS:Reactome
Q8WZ42	TTN	Titin	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
Q8WZ42	TTN	Titin	GO:0048739; P:cardiac muscle fiber development; IMP:BHF-UCL
Q8WZ42	TTN	Titin	GO:0003300; P:cardiac muscle hypertrophy; IMP:BHF-UCL
Q8WZ42	TTN	Titin	GO:0055008; P:cardiac muscle tissue morphogenesis; IMP:BHF-UCL
Q8WZ42	TTN	Titin	GO:0055003; P:cardiac myofibril assembly; IMP:BHF-UCL
Q8WZ42	TTN	Titin	GO:0035995; P:detection of muscle stretch; TAS:BHF-UCL
Q8WZ42	TTN	Titin	GO:0043056; P:forward locomotion; IEA:Ensembl
Q8WZ42	TTN	Titin	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q8WZ42	TTN	Titin	GO:0007076; P:mitotic chromosome condensation; IEP:BHF-UCL
Q8WZ42	TTN	Titin	GO:0006936; P:muscle contraction; NAS:UniProtKB
Q8WZ42	TTN	Titin	GO:0030049; P:muscle filament sliding; TAS:Reactome
Q8WZ42	TTN	Titin	GO:0030168; P:platelet activation; TAS:Reactome
Q8WZ42	TTN	Titin	GO:0002576; P:platelet degranulation; TAS:Reactome
Q8WZ42	TTN	Titin	GO:0050790; P:regulation of catalytic activity; IMP:BHF-UCL
Q8WZ42	TTN	Titin	GO:0045859; P:regulation of protein kinase activity; IMP:BHF-UCL
Q8WZ42	TTN	Titin	GO:0051592; P:response to calcium ion; IDA:BHF-UCL
Q8WZ42	TTN	Titin	GO:0045214; P:sarcomere organization; IMP:BHF-UCL
Q8WZ42	TTN	Titin	GO:0048769; P:sarcomerogenesis; IMP:BHF-UCL
Q8WZ42	TTN	Titin	GO:0030241; P:skeletal muscle myosin thick filament assembly; IMP:BHF-UCL
Q8WZ42	TTN	Titin	GO:0030240; P:skeletal muscle thin filament assembly; IMP:BHF-UCL
Q8WZ42	TTN	Titin	GO:0006941; P:striated muscle contraction; TAS:UniProtKB
Q5JTD0	TJAP1	Tight junction-associated protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P20366	TAC1	Protachykinin-1	GO:0005515; F:protein binding; IPI:IntAct
P20366	TAC1	Protachykinin-1	GO:0008306; P:associative learning; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P20366	TAC1	Protachykinin-1	GO:0009582; P:detection of abiotic stimulus; TAS:ProtInc
P20366	TAC1	Protachykinin-1	GO:0006954; P:inflammatory response; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:0007320; P:insemination; TAS:ProtInc
P20366	TAC1	Protachykinin-1	GO:0007616; P:long-term memory; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:0010459; P:negative regulation of heart rate; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
P20366	TAC1	Protachykinin-1	GO:0045760; P:positive regulation of action potential; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:0002675; P:positive regulation of acute inflammatory response; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:2000854; P:positive regulation of corticosterone secretion; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB
P20366	TAC1	Protachykinin-1	GO:0010634; P:positive regulation of epithelial cell migration; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:0050671; P:positive regulation of lymphocyte proliferation; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:0045778; P:positive regulation of ossification; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:0035815; P:positive regulation of renal sodium excretion; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:0046878; P:positive regulation of saliva secretion; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:0051496; P:positive regulation of stress fiber assembly; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:0032224; P:positive regulation of synaptic transmission, cholinergic; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:0032230; P:positive regulation of synaptic transmission, GABAergic; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:0008217; P:regulation of blood pressure; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:0009725; P:response to hormone; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:0043278; P:response to morphine; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:0048265; P:response to pain; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P20366	TAC1	Protachykinin-1	GO:0007268; P:synaptic transmission; IEA:UniProtKB-KW
P20366	TAC1	Protachykinin-1	GO:0007217; P:tachykinin receptor signaling pathway; IEA:InterPro
Q86UU9	TAC4	Tachykinin-4	GO:0046878; P:positive regulation of saliva secretion; IEA:Ensembl
Q86UU9	TAC4	Tachykinin-4	GO:0008217; P:regulation of blood pressure; IEA:UniProtKB-KW
Q86UU9	TAC4	Tachykinin-4	GO:0007217; P:tachykinin receptor signaling pathway; IEA:Ensembl
Q9UHF0	TAC3	Tachykinin-3	GO:0005515; F:protein binding; IPI:IntAct
Q9UHF0	TAC3	Tachykinin-3	GO:0005102; F:receptor binding; TAS:ProtInc
Q9UHF0	TAC3	Tachykinin-3	GO:0007565; P:female pregnancy; TAS:ProtInc
Q9UHF0	TAC3	Tachykinin-3	GO:0007218; P:neuropeptide signaling pathway; IEA:UniProtKB-KW
Q9UHF0	TAC3	Tachykinin-3	GO:0007217; P:tachykinin receptor signaling pathway; TAS:ProtInc
P51854	TKTL1	Transketolase-like protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P51854	TKTL1	Transketolase-like protein 1	GO:0004802; F:transketolase activity; TAS:ProtInc
P51854	TKTL1	Transketolase-like protein 1	GO:0006007; P:glucose catabolic process; TAS:ProtInc
P51854	TKTL1	Transketolase-like protein 1	GO:0006772; P:thiamine metabolic process; TAS:ProtInc
Q9H0I9	TKTL2	Transketolase-like protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H0I9	TKTL2	Transketolase-like protein 2	GO:0004802; F:transketolase activity; IEA:UniProtKB-EC
P29401	TKT	Transketolase	GO:0048037; F:cofactor binding; IDA:UniProtKB
P29401	TKT	Transketolase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P29401	TKT	Transketolase	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P29401	TKT	Transketolase	GO:0004802; F:transketolase activity; IDA:UniProtKB
P29401	TKT	Transketolase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P29401	TKT	Transketolase	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P29401	TKT	Transketolase	GO:0046166; P:glyceraldehyde-3-phosphate biosynthetic process; IDA:UniProtKB
P29401	TKT	Transketolase	GO:0006098; P:pentose-phosphate shunt; TAS:Reactome
P29401	TKT	Transketolase	GO:0009052; P:pentose-phosphate shunt, non-oxidative branch; NAS:UniProtKB
P29401	TKT	Transketolase	GO:0040008; P:regulation of growth; IEA:Ensembl
P29401	TKT	Transketolase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P29401	TKT	Transketolase	GO:0005999; P:xylulose biosynthetic process; TAS:Reactome
Q6P9B6	TLDC1	TLD domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q04724	TLE1	Transducin-like enhancer protein 1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q04724	TLE1	Transducin-like enhancer protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q04724	TLE1	Transducin-like enhancer protein 1	GO:0001106; F:RNA polymerase II transcription corepressor activity; IDA:BHF-UCL
Q04724	TLE1	Transducin-like enhancer protein 1	GO:0008134; F:transcription factor binding; IDA:UniProtKB
Q04724	TLE1	Transducin-like enhancer protein 1	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q04724	TLE1	Transducin-like enhancer protein 1	GO:2000811; P:negative regulation of anoikis; IMP:UniProtKB
Q04724	TLE1	Transducin-like enhancer protein 1	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q04724	TLE1	Transducin-like enhancer protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q04724	TLE1	Transducin-like enhancer protein 1	GO:0030178; P:negative regulation of Wnt signaling pathway; NAS:UniProtKB
Q04724	TLE1	Transducin-like enhancer protein 1	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q04724	TLE1	Transducin-like enhancer protein 1	GO:0009887; P:organ morphogenesis; TAS:ProtInc
Q04724	TLE1	Transducin-like enhancer protein 1	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
Q04724	TLE1	Transducin-like enhancer protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q04724	TLE1	Transducin-like enhancer protein 1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q04725	TLE2	Transducin-like enhancer protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q04725	TLE2	Transducin-like enhancer protein 2	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q04725	TLE2	Transducin-like enhancer protein 2	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:UniProtKB
Q04725	TLE2	Transducin-like enhancer protein 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q04725	TLE2	Transducin-like enhancer protein 2	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q04725	TLE2	Transducin-like enhancer protein 2	GO:0009887; P:organ morphogenesis; TAS:ProtInc
Q04725	TLE2	Transducin-like enhancer protein 2	GO:0007165; P:signal transduction; TAS:ProtInc
Q04725	TLE2	Transducin-like enhancer protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q04725	TLE2	Transducin-like enhancer protein 2	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q04726	TLE3	Transducin-like enhancer protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q04726	TLE3	Transducin-like enhancer protein 3	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q04726	TLE3	Transducin-like enhancer protein 3	GO:0009887; P:organ morphogenesis; TAS:ProtInc
Q04726	TLE3	Transducin-like enhancer protein 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q04726	TLE3	Transducin-like enhancer protein 3	GO:0007165; P:signal transduction; TAS:ProtInc
Q04726	TLE3	Transducin-like enhancer protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q04726	TLE3	Transducin-like enhancer protein 3	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q04727	TLE4	Transducin-like enhancer protein 4	GO:0003682; F:chromatin binding; IEA:Ensembl
Q04727	TLE4	Transducin-like enhancer protein 4	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q04727	TLE4	Transducin-like enhancer protein 4	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
Q04727	TLE4	Transducin-like enhancer protein 4	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q04727	TLE4	Transducin-like enhancer protein 4	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q04727	TLE4	Transducin-like enhancer protein 4	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9H808	TLE6	Transducin-like enhancer protein 6	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q9UKI8	TLK1	Serine/threonine-protein kinase tousled-like 1	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9UKI8	TLK1	Serine/threonine-protein kinase tousled-like 1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9UKI8	TLK1	Serine/threonine-protein kinase tousled-like 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9UKI8	TLK1	Serine/threonine-protein kinase tousled-like 1	GO:0006974; P:cellular response to DNA damage stimulus; IEA:UniProtKB-KW
Q9UKI8	TLK1	Serine/threonine-protein kinase tousled-like 1	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q9UKI8	TLK1	Serine/threonine-protein kinase tousled-like 1	GO:0006886; P:intracellular protein transport; IDA:UniProtKB
Q9UKI8	TLK1	Serine/threonine-protein kinase tousled-like 1	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q9UKI8	TLK1	Serine/threonine-protein kinase tousled-like 1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9UKI8	TLK1	Serine/threonine-protein kinase tousled-like 1	GO:0001672; P:regulation of chromatin assembly or disassembly; IDA:UniProtKB
Q86UE8	TLK2	Serine/threonine-protein kinase tousled-like 2	GO:0005524; F:ATP binding; IDA:UniProtKB
Q86UE8	TLK2	Serine/threonine-protein kinase tousled-like 2	GO:0005515; F:protein binding; IPI:IntAct
Q86UE8	TLK2	Serine/threonine-protein kinase tousled-like 2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q86UE8	TLK2	Serine/threonine-protein kinase tousled-like 2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q86UE8	TLK2	Serine/threonine-protein kinase tousled-like 2	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q86UE8	TLK2	Serine/threonine-protein kinase tousled-like 2	GO:0071480; P:cellular response to gamma radiation; IDA:UniProtKB
Q86UE8	TLK2	Serine/threonine-protein kinase tousled-like 2	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q86UE8	TLK2	Serine/threonine-protein kinase tousled-like 2	GO:0007059; P:chromosome segregation; IMP:UniProtKB
Q86UE8	TLK2	Serine/threonine-protein kinase tousled-like 2	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q86UE8	TLK2	Serine/threonine-protein kinase tousled-like 2	GO:0010507; P:negative regulation of autophagy; NAS:BHF-UCL
Q86UE8	TLK2	Serine/threonine-protein kinase tousled-like 2	GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q86UE8	TLK2	Serine/threonine-protein kinase tousled-like 2	GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB
Q86UE8	TLK2	Serine/threonine-protein kinase tousled-like 2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q86UE8	TLK2	Serine/threonine-protein kinase tousled-like 2	GO:0001672; P:regulation of chromatin assembly or disassembly; IDA:UniProtKB
O43897	TLL1	Tolloid-like protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
O43897	TLL1	Tolloid-like protein 1	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
O43897	TLL1	Tolloid-like protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
O43897	TLL1	Tolloid-like protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O43897	TLL1	Tolloid-like protein 1	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
O43897	TLL1	Tolloid-like protein 1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
O43897	TLL1	Tolloid-like protein 1	GO:0001501; P:skeletal system development; TAS:ProtInc
Q9Y6L7	TLL2	Tolloid-like protein 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9Y6L7	TLL2	Tolloid-like protein 2	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q9Y6L7	TLL2	Tolloid-like protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y6L7	TLL2	Tolloid-like protein 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9Y6L7	TLL2	Tolloid-like protein 2	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q9Y6L7	TLL2	Tolloid-like protein 2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q9Y6L7	TLL2	Tolloid-like protein 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9Y490	TLN1	Talin-1	GO:0005178; F:integrin binding; IPI:UniProtKB
Q9Y490	TLN1	Talin-1	GO:0030274; F:LIM domain binding; IPI:UniProtKB
Q9Y490	TLN1	Talin-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y490	TLN1	Talin-1	GO:0005200; F:structural constituent of cytoskeleton; NAS:UniProtKB
Q9Y490	TLN1	Talin-1	GO:0017166; F:vinculin binding; IPI:UniProtKB
Q9Y490	TLN1	Talin-1	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q9Y490	TLN1	Talin-1	GO:0007411; P:axon guidance; TAS:Reactome
Q9Y490	TLN1	Talin-1	GO:0007596; P:blood coagulation; TAS:Reactome
Q9Y490	TLN1	Talin-1	GO:0007155; P:cell adhesion; IEA:InterPro
Q9Y490	TLN1	Talin-1	GO:0007043; P:cell-cell junction assembly; TAS:UniProtKB
Q9Y490	TLN1	Talin-1	GO:0007044; P:cell-substrate junction assembly; IEA:Ensembl
Q9Y490	TLN1	Talin-1	GO:0006928; P:cellular component movement; NAS:UniProtKB
Q9Y490	TLN1	Talin-1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9Y490	TLN1	Talin-1	GO:0030866; P:cortical actin cytoskeleton organization; IEA:Ensembl
Q9Y490	TLN1	Talin-1	GO:0007016; P:cytoskeletal anchoring at plasma membrane; NAS:UniProtKB
Q9Y490	TLN1	Talin-1	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q9Y490	TLN1	Talin-1	GO:0006936; P:muscle contraction; TAS:Reactome
Q9Y490	TLN1	Talin-1	GO:0030168; P:platelet activation; TAS:Reactome
Q9Y490	TLN1	Talin-1	GO:0002576; P:platelet degranulation; TAS:Reactome
Q9Y4G6	TLN2	Talin-2	GO:0003779; F:actin binding; NAS:UniProtKB
Q9Y4G6	TLN2	Talin-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y4G6	TLN2	Talin-2	GO:0005200; F:structural constituent of cytoskeleton; IEA:InterPro
Q9Y4G6	TLN2	Talin-2	GO:0005198; F:structural molecule activity; NAS:UniProtKB
Q9Y4G6	TLN2	Talin-2	GO:0007155; P:cell adhesion; NAS:UniProtKB
Q9Y4G6	TLN2	Talin-2	GO:0007043; P:cell-cell junction assembly; TAS:UniProtKB
Q9Y4G6	TLN2	Talin-2	GO:0007016; P:cytoskeletal anchoring at plasma membrane; IEA:InterPro
Q9BXR5	TLR10	Toll-like receptor 10	GO:0004888; F:transmembrane signaling receptor activity; TAS:UniProtKB
Q9BXR5	TLR10	Toll-like receptor 10	GO:0006955; P:immune response; NAS:UniProtKB
Q9BXR5	TLR10	Toll-like receptor 10	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q9BXR5	TLR10	Toll-like receptor 10	GO:0045087; P:innate immune response; TAS:Reactome
Q9BXR5	TLR10	Toll-like receptor 10	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q9BXR5	TLR10	Toll-like receptor 10	GO:0050729; P:positive regulation of inflammatory response; IEA:InterPro
Q9BXR5	TLR10	Toll-like receptor 10	GO:0050707; P:regulation of cytokine secretion; IEA:InterPro
Q9BXR5	TLR10	Toll-like receptor 10	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q9BXR5	TLR10	Toll-like receptor 10	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q9BXR5	TLR10	Toll-like receptor 10	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q15399	TLR1	Toll-like receptor 1	GO:0046982; F:protein heterodimerization activity; IDA:MGI
Q15399	TLR1	Toll-like receptor 1	GO:0004872; F:receptor activity; TAS:ProtInc
Q15399	TLR1	Toll-like receptor 1	GO:0004888; F:transmembrane signaling receptor activity; NAS:UniProtKB
Q15399	TLR1	Toll-like receptor 1	GO:0071727; P:cellular response to triacyl bacterial lipopeptide; IDA:MGI
Q15399	TLR1	Toll-like receptor 1	GO:0042495; P:detection of triacyl bacterial lipopeptide; IDA:MGI
Q15399	TLR1	Toll-like receptor 1	GO:0006955; P:immune response; TAS:ProtInc
Q15399	TLR1	Toll-like receptor 1	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q15399	TLR1	Toll-like receptor 1	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q15399	TLR1	Toll-like receptor 1	GO:0042116; P:macrophage activation; NAS:UniProtKB
Q15399	TLR1	Toll-like receptor 1	GO:0045410; P:positive regulation of interleukin-6 biosynthetic process; ISS:UniProtKB
Q15399	TLR1	Toll-like receptor 1	GO:0042535; P:positive regulation of tumor necrosis factor biosynthetic process; ISS:UniProtKB
Q15399	TLR1	Toll-like receptor 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q15399	TLR1	Toll-like receptor 1	GO:0002224; P:toll-like receptor signaling pathway; IEA:InterPro
O60603	TLR2	Toll-like receptor 2	GO:0042498; F:diacyl lipopeptide binding; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0001875; F:lipopolysaccharide receptor activity; TAS:UniProtKB
O60603	TLR2	Toll-like receptor 2	GO:0070891; F:lipoteichoic acid binding; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0042834; F:peptidoglycan binding; IDA:UniProtKB
O60603	TLR2	Toll-like receptor 2	GO:0005515; F:protein binding; IPI:UniProtKB
O60603	TLR2	Toll-like receptor 2	GO:0046982; F:protein heterodimerization activity; IDA:MGI
O60603	TLR2	Toll-like receptor 2	GO:0004872; F:receptor activity; IDA:UniProtKB
O60603	TLR2	Toll-like receptor 2	GO:0008329; F:signaling pattern recognition receptor activity; IDA:UniProtKB
O60603	TLR2	Toll-like receptor 2	GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro
O60603	TLR2	Toll-like receptor 2	GO:0042497; F:triacyl lipopeptide binding; IDA:MGI
O60603	TLR2	Toll-like receptor 2	GO:0006915; P:apoptotic process; TAS:ProtInc
O60603	TLR2	Toll-like receptor 2	GO:0002752; P:cell surface pattern recognition receptor signaling pathway; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0071221; P:cellular response to bacterial lipopeptide; TAS:BHF-UCL
O60603	TLR2	Toll-like receptor 2	GO:0071726; P:cellular response to diacyl bacterial lipopeptide; IDA:MGI
O60603	TLR2	Toll-like receptor 2	GO:0071223; P:cellular response to lipoteichoic acid; IDA:MGI
O60603	TLR2	Toll-like receptor 2	GO:0071224; P:cellular response to peptidoglycan; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0071727; P:cellular response to triacyl bacterial lipopeptide; IDA:MGI
O60603	TLR2	Toll-like receptor 2	GO:0032289; P:central nervous system myelin formation; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0042892; P:chloramphenicol transport; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProtKB
O60603	TLR2	Toll-like receptor 2	GO:0042496; P:detection of diacyl bacterial lipopeptide; IDA:MGI
O60603	TLR2	Toll-like receptor 2	GO:0042495; P:detection of triacyl bacterial lipopeptide; IDA:MGI
O60603	TLR2	Toll-like receptor 2	GO:0007252; P:I-kappaB phosphorylation; IDA:BHF-UCL
O60603	TLR2	Toll-like receptor 2	GO:0006955; P:immune response; TAS:ProtInc
O60603	TLR2	Toll-like receptor 2	GO:0052063; P:induction by symbiont of defense-related host nitric oxide production; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
O60603	TLR2	Toll-like receptor 2	GO:0045087; P:innate immune response; TAS:BHF-UCL
O60603	TLR2	Toll-like receptor 2	GO:0006691; P:leukotriene metabolic process; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; TAS:GOC
O60603	TLR2	Toll-like receptor 2	GO:0002282; P:microglial cell activation involved in immune response; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
O60603	TLR2	Toll-like receptor 2	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0044130; P:negative regulation of growth of symbiont in host; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0032695; P:negative regulation of interleukin-12 production; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0032700; P:negative regulation of interleukin-17 production; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0046209; P:nitric oxide metabolic process; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0052033; P:pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0032722; P:positive regulation of chemokine production; IDA:BHF-UCL
O60603	TLR2	Toll-like receptor 2	GO:0050715; P:positive regulation of cytokine secretion; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0050729; P:positive regulation of inflammatory response; IC:BHF-UCL
O60603	TLR2	Toll-like receptor 2	GO:0032728; P:positive regulation of interferon-beta production; ISS:BHF-UCL
O60603	TLR2	Toll-like receptor 2	GO:0032733; P:positive regulation of interleukin-10 production; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0032735; P:positive regulation of interleukin-12 production; ISS:BHF-UCL
O60603	TLR2	Toll-like receptor 2	GO:0032741; P:positive regulation of interleukin-18 production; ISS:BHF-UCL
O60603	TLR2	Toll-like receptor 2	GO:0032755; P:positive regulation of interleukin-6 production; IDA:BHF-UCL
O60603	TLR2	Toll-like receptor 2	GO:0032757; P:positive regulation of interleukin-8 production; IDA:BHF-UCL
O60603	TLR2	Toll-like receptor 2	GO:0002687; P:positive regulation of leukocyte migration; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0060907; P:positive regulation of macrophage cytokine production; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0042346; P:positive regulation of NF-kappaB import into nucleus; IDA:BHF-UCL
O60603	TLR2	Toll-like receptor 2	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:MGI
O60603	TLR2	Toll-like receptor 2	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; ISS:BHF-UCL
O60603	TLR2	Toll-like receptor 2	GO:0048714; P:positive regulation of oligodendrocyte differentiation; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0034123; P:positive regulation of toll-like receptor signaling pathway; IDA:BHF-UCL
O60603	TLR2	Toll-like receptor 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
O60603	TLR2	Toll-like receptor 2	GO:0042535; P:positive regulation of tumor necrosis factor biosynthetic process; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0032760; P:positive regulation of tumor necrosis factor production; ISS:BHF-UCL
O60603	TLR2	Toll-like receptor 2	GO:0030177; P:positive regulation of Wnt signaling pathway; IMP:BHF-UCL
O60603	TLR2	Toll-like receptor 2	GO:0070542; P:response to fatty acid; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0001666; P:response to hypoxia; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0032868; P:response to insulin; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0002238; P:response to molecule of fungal origin; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0032570; P:response to progesterone; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0009636; P:response to toxic substance; IEA:Ensembl
O60603	TLR2	Toll-like receptor 2	GO:0007165; P:signal transduction; TAS:UniProtKB
O60603	TLR2	Toll-like receptor 2	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
O60603	TLR2	Toll-like receptor 2	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
O60603	TLR2	Toll-like receptor 2	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
O60603	TLR2	Toll-like receptor 2	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
O60603	TLR2	Toll-like receptor 2	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
O15455	TLR3	Toll-like receptor 3	GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB
O15455	TLR3	Toll-like receptor 3	GO:0005515; F:protein binding; IPI:IntAct
O15455	TLR3	Toll-like receptor 3	GO:0004872; F:receptor activity; TAS:ProtInc
O15455	TLR3	Toll-like receptor 3	GO:0004888; F:transmembrane signaling receptor activity; NAS:UniProtKB
O15455	TLR3	Toll-like receptor 3	GO:0007250; P:activation of NF-kappaB-inducing kinase activity; NAS:UniProtKB
O15455	TLR3	Toll-like receptor 3	GO:0035690; P:cellular response to drug; IEA:Ensembl
O15455	TLR3	Toll-like receptor 3	GO:0071360; P:cellular response to exogenous dsRNA; IEA:Ensembl
O15455	TLR3	Toll-like receptor 3	GO:0035458; P:cellular response to interferon-beta; IEA:Ensembl
O15455	TLR3	Toll-like receptor 3	GO:0071346; P:cellular response to interferon-gamma; IEA:Ensembl
O15455	TLR3	Toll-like receptor 3	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
O15455	TLR3	Toll-like receptor 3	GO:0042742; P:defense response to bacterium; TAS:ProtInc
O15455	TLR3	Toll-like receptor 3	GO:0051607; P:defense response to virus; TAS:BHF-UCL
O15455	TLR3	Toll-like receptor 3	GO:0009597; P:detection of virus; NAS:UniProtKB
O15455	TLR3	Toll-like receptor 3	GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:UniProtKB
O15455	TLR3	Toll-like receptor 3	GO:0006972; P:hyperosmotic response; NAS:UniProtKB
O15455	TLR3	Toll-like receptor 3	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
O15455	TLR3	Toll-like receptor 3	GO:0007252; P:I-kappaB phosphorylation; IDA:BHF-UCL
O15455	TLR3	Toll-like receptor 3	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
O15455	TLR3	Toll-like receptor 3	GO:0045087; P:innate immune response; TAS:BHF-UCL
O15455	TLR3	Toll-like receptor 3	GO:0008584; P:male gonad development; IEA:Ensembl
O15455	TLR3	Toll-like receptor 3	GO:0002282; P:microglial cell activation involved in immune response; IEA:Ensembl
O15455	TLR3	Toll-like receptor 3	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
O15455	TLR3	Toll-like receptor 3	GO:0097527; P:necroptotic signaling pathway; IDA:UniProtKB
O15455	TLR3	Toll-like receptor 3	GO:0045671; P:negative regulation of osteoclast differentiation; NAS:UniProtKB
O15455	TLR3	Toll-like receptor 3	GO:0052033; P:pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response; IEA:Ensembl
O15455	TLR3	Toll-like receptor 3	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
O15455	TLR3	Toll-like receptor 3	GO:0045080; P:positive regulation of chemokine biosynthetic process; IEA:Ensembl
O15455	TLR3	Toll-like receptor 3	GO:0032722; P:positive regulation of chemokine production; IDA:BHF-UCL
O15455	TLR3	Toll-like receptor 3	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
O15455	TLR3	Toll-like receptor 3	GO:0050729; P:positive regulation of inflammatory response; IC:BHF-UCL
O15455	TLR3	Toll-like receptor 3	GO:0045356; P:positive regulation of interferon-alpha biosynthetic process; IDA:UniProtKB
O15455	TLR3	Toll-like receptor 3	GO:0045359; P:positive regulation of interferon-beta biosynthetic process; IDA:UniProtKB
O15455	TLR3	Toll-like receptor 3	GO:0032728; P:positive regulation of interferon-beta production; ISS:BHF-UCL
O15455	TLR3	Toll-like receptor 3	GO:0045078; P:positive regulation of interferon-gamma biosynthetic process; IDA:UniProtKB
O15455	TLR3	Toll-like receptor 3	GO:0032735; P:positive regulation of interleukin-12 production; ISS:BHF-UCL
O15455	TLR3	Toll-like receptor 3	GO:0032755; P:positive regulation of interleukin-6 production; IDA:BHF-UCL
O15455	TLR3	Toll-like receptor 3	GO:0032757; P:positive regulation of interleukin-8 production; IDA:BHF-UCL
O15455	TLR3	Toll-like receptor 3	GO:0046330; P:positive regulation of JNK cascade; IEA:Ensembl
O15455	TLR3	Toll-like receptor 3	GO:0042346; P:positive regulation of NF-kappaB import into nucleus; IDA:BHF-UCL
O15455	TLR3	Toll-like receptor 3	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:Ensembl
O15455	TLR3	Toll-like receptor 3	GO:0034123; P:positive regulation of toll-like receptor signaling pathway; IDA:BHF-UCL
O15455	TLR3	Toll-like receptor 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
O15455	TLR3	Toll-like receptor 3	GO:0032760; P:positive regulation of tumor necrosis factor production; ISS:BHF-UCL
O15455	TLR3	Toll-like receptor 3	GO:0034346; P:positive regulation of type III interferon production; IEA:Ensembl
O15455	TLR3	Toll-like receptor 3	GO:0043330; P:response to exogenous dsRNA; IDA:MGI
O15455	TLR3	Toll-like receptor 3	GO:0007165; P:signal transduction; TAS:ProtInc
O15455	TLR3	Toll-like receptor 3	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
O15455	TLR3	Toll-like receptor 3	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
O15455	TLR3	Toll-like receptor 3	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
O15455	TLR3	Toll-like receptor 3	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
O00206	TLR4	Toll-like receptor 4	GO:0001530; F:lipopolysaccharide binding; NAS:UniProtKB
O00206	TLR4	Toll-like receptor 4	GO:0001875; F:lipopolysaccharide receptor activity; IDA:UniProtKB
O00206	TLR4	Toll-like receptor 4	GO:0005515; F:protein binding; IPI:UniProtKB
O00206	TLR4	Toll-like receptor 4	GO:0004872; F:receptor activity; TAS:ProtInc
O00206	TLR4	Toll-like receptor 4	GO:0004888; F:transmembrane signaling receptor activity; NAS:UniProtKB
O00206	TLR4	Toll-like receptor 4	GO:0000187; P:activation of MAPK activity; ISS:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0002322; P:B cell proliferation involved in immune response; IEA:Ensembl
O00206	TLR4	Toll-like receptor 4	GO:0071222; P:cellular response to lipopolysaccharide; ISS:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0071223; P:cellular response to lipoteichoic acid; IEA:Ensembl
O00206	TLR4	Toll-like receptor 4	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
O00206	TLR4	Toll-like receptor 4	GO:0042742; P:defense response to bacterium; TAS:UniProtKB
O00206	TLR4	Toll-like receptor 4	GO:0050829; P:defense response to Gram-negative bacterium; IC:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0016046; P:detection of fungus; NAS:UniProtKB
O00206	TLR4	Toll-like receptor 4	GO:0032497; P:detection of lipopolysaccharide; IDA:UniProtKB
O00206	TLR4	Toll-like receptor 4	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
O00206	TLR4	Toll-like receptor 4	GO:0007252; P:I-kappaB phosphorylation; IDA:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0006955; P:immune response; TAS:ProtInc
O00206	TLR4	Toll-like receptor 4	GO:0045087; P:innate immune response; TAS:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0032609; P:interferon-gamma production; IEA:Ensembl
O00206	TLR4	Toll-like receptor 4	GO:0060729; P:intestinal epithelial structure maintenance; ISS:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IGI:MGI
O00206	TLR4	Toll-like receptor 4	GO:0042116; P:macrophage activation; IMP:UniProtKB
O00206	TLR4	Toll-like receptor 4	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
O00206	TLR4	Toll-like receptor 4	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
O00206	TLR4	Toll-like receptor 4	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; ISS:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0032689; P:negative regulation of interferon-gamma production; ISS:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0032700; P:negative regulation of interleukin-17 production; ISS:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0032707; P:negative regulation of interleukin-23 production; ISS:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0032715; P:negative regulation of interleukin-6 production; ISS:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0045671; P:negative regulation of osteoclast differentiation; NAS:UniProtKB
O00206	TLR4	Toll-like receptor 4	GO:0032720; P:negative regulation of tumor necrosis factor production; ISS:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0002537; P:nitric oxide production involved in inflammatory response; IEA:Ensembl
O00206	TLR4	Toll-like receptor 4	GO:0030890; P:positive regulation of B cell proliferation; IEA:Ensembl
O00206	TLR4	Toll-like receptor 4	GO:0032722; P:positive regulation of chemokine production; IDA:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl
O00206	TLR4	Toll-like receptor 4	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
O00206	TLR4	Toll-like receptor 4	GO:0050729; P:positive regulation of inflammatory response; IC:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0032727; P:positive regulation of interferon-alpha production; ISS:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0045359; P:positive regulation of interferon-beta biosynthetic process; IEA:Ensembl
O00206	TLR4	Toll-like receptor 4	GO:0032728; P:positive regulation of interferon-beta production; ISS:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0032729; P:positive regulation of interferon-gamma production; ISS:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0032732; P:positive regulation of interleukin-1 production; ISS:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0032733; P:positive regulation of interleukin-10 production; ISS:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0045084; P:positive regulation of interleukin-12 biosynthetic process; IDA:UniProtKB
O00206	TLR4	Toll-like receptor 4	GO:0032735; P:positive regulation of interleukin-12 production; ISS:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0032755; P:positive regulation of interleukin-6 production; IDA:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0045416; P:positive regulation of interleukin-8 biosynthetic process; IDA:UniProtKB
O00206	TLR4	Toll-like receptor 4	GO:0032757; P:positive regulation of interleukin-8 production; IDA:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0046330; P:positive regulation of JNK cascade; IEA:Ensembl
O00206	TLR4	Toll-like receptor 4	GO:0060907; P:positive regulation of macrophage cytokine production; IEA:Ensembl
O00206	TLR4	Toll-like receptor 4	GO:0045348; P:positive regulation of MHC class II biosynthetic process; IEA:Ensembl
O00206	TLR4	Toll-like receptor 4	GO:0042346; P:positive regulation of NF-kappaB import into nucleus; IDA:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:MGI
O00206	TLR4	Toll-like receptor 4	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IEA:Ensembl
O00206	TLR4	Toll-like receptor 4	GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; ISS:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0070430; P:positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway; IEA:Ensembl
O00206	TLR4	Toll-like receptor 4	GO:0070434; P:positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway; IEA:Ensembl
O00206	TLR4	Toll-like receptor 4	GO:0010572; P:positive regulation of platelet activation; ISS:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0042535; P:positive regulation of tumor necrosis factor biosynthetic process; IDA:UniProtKB
O00206	TLR4	Toll-like receptor 4	GO:0032760; P:positive regulation of tumor necrosis factor production; ISS:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0032496; P:response to lipopolysaccharide; IC:BHF-UCL
O00206	TLR4	Toll-like receptor 4	GO:0042088; P:T-helper 1 type immune response; NAS:UniProtKB
O00206	TLR4	Toll-like receptor 4	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
O00206	TLR4	Toll-like receptor 4	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
O00206	TLR4	Toll-like receptor 4	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
O00206	TLR4	Toll-like receptor 4	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
O00206	TLR4	Toll-like receptor 4	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
O00206	TLR4	Toll-like receptor 4	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
O00206	TLR4	Toll-like receptor 4	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
O60602	TLR5	Toll-like receptor 5	GO:0005149; F:interleukin-1 receptor binding; IPI:UniProtKB
O60602	TLR5	Toll-like receptor 5	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
O60602	TLR5	Toll-like receptor 5	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
O60602	TLR5	Toll-like receptor 5	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
O60602	TLR5	Toll-like receptor 5	GO:0045087; P:innate immune response; TAS:Reactome
O60602	TLR5	Toll-like receptor 5	GO:0008584; P:male gonad development; IEA:Ensembl
O60602	TLR5	Toll-like receptor 5	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
O60602	TLR5	Toll-like receptor 5	GO:0032757; P:positive regulation of interleukin-8 production; IDA:BHF-UCL
O60602	TLR5	Toll-like receptor 5	GO:0034123; P:positive regulation of toll-like receptor signaling pathway; IDA:BHF-UCL
O60602	TLR5	Toll-like receptor 5	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
O60602	TLR5	Toll-like receptor 5	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
O60602	TLR5	Toll-like receptor 5	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0042498; F:diacyl lipopeptide binding; IEA:Ensembl
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0071723; F:lipopeptide binding; ISS:UniProtKB
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0004872; F:receptor activity; TAS:ProtInc
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0007250; P:activation of NF-kappaB-inducing kinase activity; NAS:UniProtKB
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0071726; P:cellular response to diacyl bacterial lipopeptide; IDA:MGI
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0042742; P:defense response to bacterium; TAS:ProtInc
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0042496; P:detection of diacyl bacterial lipopeptide; IDA:MGI
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0042495; P:detection of triacyl bacterial lipopeptide; IEA:InterPro
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0006955; P:immune response; TAS:ProtInc
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0045087; P:innate immune response; TAS:Reactome
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0002282; P:microglial cell activation involved in immune response; IEA:Ensembl
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0046209; P:nitric oxide metabolic process; IEA:Ensembl
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0052033; P:pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response; IEA:Ensembl
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:MGI
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0045410; P:positive regulation of interleukin-6 biosynthetic process; ISS:UniProtKB
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0043507; P:positive regulation of JUN kinase activity; IDA:MGI
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0050707; P:regulation of cytokine secretion; IEA:InterPro
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0042088; P:T-helper 1 type immune response; IC:UniProtKB
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0034130; P:toll-like receptor 1 signaling pathway; IEA:InterPro
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q9Y2C9	TLR6	Toll-like receptor 6	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q9NYK1	TLR7	Toll-like receptor 7	GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB
Q9NYK1	TLR7	Toll-like receptor 7	GO:0008144; F:drug binding; IEA:Ensembl
Q9NYK1	TLR7	Toll-like receptor 7	GO:0003727; F:single-stranded RNA binding; ISS:UniProtKB
Q9NYK1	TLR7	Toll-like receptor 7	GO:0035197; F:siRNA binding; ISS:UniProtKB
Q9NYK1	TLR7	Toll-like receptor 7	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
Q9NYK1	TLR7	Toll-like receptor 7	GO:0051607; P:defense response to virus; IMP:UniProtKB
Q9NYK1	TLR7	Toll-like receptor 7	GO:0007252; P:I-kappaB phosphorylation; IDA:BHF-UCL
Q9NYK1	TLR7	Toll-like receptor 7	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q9NYK1	TLR7	Toll-like receptor 7	GO:0045087; P:innate immune response; TAS:Reactome
Q9NYK1	TLR7	Toll-like receptor 7	GO:0002282; P:microglial cell activation involved in immune response; IEA:Ensembl
Q9NYK1	TLR7	Toll-like receptor 7	GO:0052033; P:pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response; IEA:Ensembl
Q9NYK1	TLR7	Toll-like receptor 7	GO:0032722; P:positive regulation of chemokine production; IDA:BHF-UCL
Q9NYK1	TLR7	Toll-like receptor 7	GO:0050729; P:positive regulation of inflammatory response; IC:BHF-UCL
Q9NYK1	TLR7	Toll-like receptor 7	GO:0045356; P:positive regulation of interferon-alpha biosynthetic process; IDA:UniProtKB
Q9NYK1	TLR7	Toll-like receptor 7	GO:0045359; P:positive regulation of interferon-beta biosynthetic process; IDA:UniProtKB
Q9NYK1	TLR7	Toll-like receptor 7	GO:0045078; P:positive regulation of interferon-gamma biosynthetic process; IDA:UniProtKB
Q9NYK1	TLR7	Toll-like receptor 7	GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl
Q9NYK1	TLR7	Toll-like receptor 7	GO:0045416; P:positive regulation of interleukin-8 biosynthetic process; IMP:UniProtKB
Q9NYK1	TLR7	Toll-like receptor 7	GO:0032757; P:positive regulation of interleukin-8 production; IDA:BHF-UCL
Q9NYK1	TLR7	Toll-like receptor 7	GO:0042346; P:positive regulation of NF-kappaB import into nucleus; IDA:BHF-UCL
Q9NYK1	TLR7	Toll-like receptor 7	GO:0034154; P:toll-like receptor 7 signaling pathway; IEA:Ensembl
Q9NYK1	TLR7	Toll-like receptor 7	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q9NYK1	TLR7	Toll-like receptor 7	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q9NR97	TLR8	Toll-like receptor 8	GO:0003677; F:DNA binding; IDA:UniProtKB
Q9NR97	TLR8	Toll-like receptor 8	GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB
Q9NR97	TLR8	Toll-like receptor 8	GO:0008144; F:drug binding; IEA:Ensembl
Q9NR97	TLR8	Toll-like receptor 8	GO:0004872; F:receptor activity; NAS:UniProtKB
Q9NR97	TLR8	Toll-like receptor 8	GO:0003723; F:RNA binding; TAS:UniProtKB
Q9NR97	TLR8	Toll-like receptor 8	GO:0003727; F:single-stranded RNA binding; IDA:UniProtKB
Q9NR97	TLR8	Toll-like receptor 8	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
Q9NR97	TLR8	Toll-like receptor 8	GO:0051607; P:defense response to virus; IMP:UniProtKB
Q9NR97	TLR8	Toll-like receptor 8	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q9NR97	TLR8	Toll-like receptor 8	GO:0016064; P:immunoglobulin mediated immune response; TAS:UniProtKB
Q9NR97	TLR8	Toll-like receptor 8	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q9NR97	TLR8	Toll-like receptor 8	GO:0045087; P:innate immune response; NAS:UniProtKB
Q9NR97	TLR8	Toll-like receptor 8	GO:0002282; P:microglial cell activation involved in immune response; IEA:Ensembl
Q9NR97	TLR8	Toll-like receptor 8	GO:0052033; P:pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response; IEA:Ensembl
Q9NR97	TLR8	Toll-like receptor 8	GO:0045089; P:positive regulation of innate immune response; IDA:UniProtKB
Q9NR97	TLR8	Toll-like receptor 8	GO:0045356; P:positive regulation of interferon-alpha biosynthetic process; IDA:UniProtKB
Q9NR97	TLR8	Toll-like receptor 8	GO:0045359; P:positive regulation of interferon-beta biosynthetic process; IDA:UniProtKB
Q9NR97	TLR8	Toll-like receptor 8	GO:0045078; P:positive regulation of interferon-gamma biosynthetic process; IDA:UniProtKB
Q9NR97	TLR8	Toll-like receptor 8	GO:0045416; P:positive regulation of interleukin-8 biosynthetic process; IMP:UniProtKB
Q9NR97	TLR8	Toll-like receptor 8	GO:0009615; P:response to virus; IDA:UniProtKB
Q9NR97	TLR8	Toll-like receptor 8	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q9NR97	TLR8	Toll-like receptor 8	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q9NR96	TLR9	Toll-like receptor 9	GO:0005149; F:interleukin-1 receptor binding; IPI:UniProtKB
Q9NR96	TLR9	Toll-like receptor 9	GO:0035197; F:siRNA binding; IMP:UniProtKB
Q9NR96	TLR9	Toll-like receptor 9	GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro
Q9NR96	TLR9	Toll-like receptor 9	GO:0042742; P:defense response to bacterium; NAS:UniProtKB
Q9NR96	TLR9	Toll-like receptor 9	GO:0050829; P:defense response to Gram-negative bacterium; IMP:UniProt
Q9NR96	TLR9	Toll-like receptor 9	GO:0007252; P:I-kappaB phosphorylation; IDA:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q9NR96	TLR9	Toll-like receptor 9	GO:0045087; P:innate immune response; TAS:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q9NR96	TLR9	Toll-like receptor 9	GO:0030277; P:maintenance of gastrointestinal epithelium; ISS:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; IEA:InterPro
Q9NR96	TLR9	Toll-like receptor 9	GO:0032715; P:negative regulation of interleukin-6 production; ISS:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0032717; P:negative regulation of interleukin-8 production; IDA:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0034122; P:negative regulation of toll-like receptor signaling pathway; IDA:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0032722; P:positive regulation of chemokine production; IDA:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0050729; P:positive regulation of inflammatory response; IC:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0045356; P:positive regulation of interferon-alpha biosynthetic process; IDA:UniProtKB
Q9NR96	TLR9	Toll-like receptor 9	GO:0045359; P:positive regulation of interferon-beta biosynthetic process; IDA:UniProtKB
Q9NR96	TLR9	Toll-like receptor 9	GO:0032728; P:positive regulation of interferon-beta production; ISS:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0045078; P:positive regulation of interferon-gamma biosynthetic process; IDA:UniProtKB
Q9NR96	TLR9	Toll-like receptor 9	GO:0032733; P:positive regulation of interleukin-10 production; ISS:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0032735; P:positive regulation of interleukin-12 production; ISS:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0032741; P:positive regulation of interleukin-18 production; ISS:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0032755; P:positive regulation of interleukin-6 production; IDA:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0032757; P:positive regulation of interleukin-8 production; IDA:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0046330; P:positive regulation of JNK cascade; IC:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0043507; P:positive regulation of JUN kinase activity; IDA:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0042346; P:positive regulation of NF-kappaB import into nucleus; IDA:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; ISS:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0034123; P:positive regulation of toll-like receptor signaling pathway; IDA:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0032760; P:positive regulation of tumor necrosis factor production; ISS:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0050707; P:regulation of cytokine secretion; IEA:InterPro
Q9NR96	TLR9	Toll-like receptor 9	GO:0002237; P:response to molecule of bacterial origin; TAS:BHF-UCL
Q9NR96	TLR9	Toll-like receptor 9	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q9NR96	TLR9	Toll-like receptor 9	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P31314	TLX1	T-cell leukemia homeobox protein 1	GO:0005515; F:protein binding; IPI:IntAct
P31314	TLX1	T-cell leukemia homeobox protein 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P31314	TLX1	T-cell leukemia homeobox protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P31314	TLX1	T-cell leukemia homeobox protein 1	GO:0045165; P:cell fate commitment; IEA:Ensembl
P31314	TLX1	T-cell leukemia homeobox protein 1	GO:0007417; P:central nervous system development; IEA:Ensembl
P31314	TLX1	T-cell leukemia homeobox protein 1	GO:0030182; P:neuron differentiation; IEA:Ensembl
P31314	TLX1	T-cell leukemia homeobox protein 1	GO:0048645; P:organ formation; IEA:Ensembl
P31314	TLX1	T-cell leukemia homeobox protein 1	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P31314	TLX1	T-cell leukemia homeobox protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P31314	TLX1	T-cell leukemia homeobox protein 1	GO:0048536; P:spleen development; IEA:Ensembl
O43711	TLX3	T-cell leukemia homeobox protein 3	GO:0005515; F:protein binding; IPI:IntAct
O43711	TLX3	T-cell leukemia homeobox protein 3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O43711	TLX3	T-cell leukemia homeobox protein 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O43711	TLX3	T-cell leukemia homeobox protein 3	GO:0007417; P:central nervous system development; IEA:Ensembl
O43711	TLX3	T-cell leukemia homeobox protein 3	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
O43711	TLX3	T-cell leukemia homeobox protein 3	GO:0048665; P:neuron fate specification; IEA:Ensembl
O43711	TLX3	T-cell leukemia homeobox protein 3	GO:0001764; P:neuron migration; IEA:Ensembl
O43711	TLX3	T-cell leukemia homeobox protein 3	GO:0002087; P:regulation of respiratory gaseous exchange by neurological system process; IEA:Ensembl
O43711	TLX3	T-cell leukemia homeobox protein 3	GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl
Q9NV29	TMEM100	Transmembrane protein 100	GO:0001525; P:angiogenesis; IEA:Ensembl
Q9NV29	TMEM100	Transmembrane protein 100	GO:0060842; P:arterial endothelial cell differentiation; IEA:Ensembl
Q9NV29	TMEM100	Transmembrane protein 100	GO:0030509; P:BMP signaling pathway; IDA:UniProtKB
Q9NV29	TMEM100	Transmembrane protein 100	GO:0071773; P:cellular response to BMP stimulus; IDA:UniProtKB
Q9NV29	TMEM100	Transmembrane protein 100	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9NV29	TMEM100	Transmembrane protein 100	GO:0007219; P:Notch signaling pathway; IEA:Ensembl
Q9NV29	TMEM100	Transmembrane protein 100	GO:0045603; P:positive regulation of endothelial cell differentiation; ISS:UniProtKB
Q9NV29	TMEM100	Transmembrane protein 100	GO:2001214; P:positive regulation of vasculogenesis; ISS:UniProtKB
Q9NV29	TMEM100	Transmembrane protein 100	GO:0043491; P:protein kinase B signaling; IEA:Ensembl
Q9NV29	TMEM100	Transmembrane protein 100	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q96IK0	TMEM101	Transmembrane protein 101	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q96IK0	TMEM101	Transmembrane protein 101	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q96IK0	TMEM101	Transmembrane protein 101	GO:0007165; P:signal transduction; IMP:GOC
O43763	TLX2	T-cell leukemia homeobox protein 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O43763	TLX2	T-cell leukemia homeobox protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O43763	TLX2	T-cell leukemia homeobox protein 2	GO:0048484; P:enteric nervous system development; IEA:Ensembl
O43763	TLX2	T-cell leukemia homeobox protein 2	GO:0001707; P:mesoderm formation; IEA:Ensembl
O43763	TLX2	T-cell leukemia homeobox protein 2	GO:0050774; P:negative regulation of dendrite morphogenesis; IEA:Ensembl
O43763	TLX2	T-cell leukemia homeobox protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N9M5	TMEM102	Transmembrane protein 102	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N9M5	TMEM102	Transmembrane protein 102	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8N9M5	TMEM102	Transmembrane protein 102	GO:1901028; P:regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; IDA:UniProtKB
Q8N9M5	TMEM102	Transmembrane protein 102	GO:0034097; P:response to cytokine; IDA:UniProtKB
Q8N9M5	TMEM102	Transmembrane protein 102	GO:0007165; P:signal transduction; IDA:UniProtKB
Q6UX40	TMEM107	Transmembrane protein 107	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q6UX40	TMEM107	Transmembrane protein 107	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
Q6UX40	TMEM107	Transmembrane protein 107	GO:0021532; P:neural tube patterning; IEA:Ensembl
Q9BVC6	TMEM109	Transmembrane protein 109	GO:0071480; P:cellular response to gamma radiation; IMP:MGI
Q9BVC6	TMEM109	Transmembrane protein 109	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IEA:Ensembl
Q9BVC6	TMEM109	Transmembrane protein 109	GO:0060548; P:negative regulation of cell death; IMP:MGI
Q8TBZ6	TRMT10A	tRNA methyltransferase 10 homolog A	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q8TBZ6	TRMT10A	tRNA methyltransferase 10 homolog A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6PF06	TRMT10B	tRNA methyltransferase 10 homolog B	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q12893	TMEM115	Transmembrane protein 115	GO:0008285; P:negative regulation of cell proliferation; NAS:UniProtKB
Q4V9L6	TMEM119	Transmembrane protein 119	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
Q86T26	TMPRSS11B	Transmembrane protease serine 11B	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q6ZMR5	TMPRSS11A	Transmembrane protease serine 11A	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q6ZMR5	TMPRSS11A	Transmembrane protease serine 11A	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
O60235	TMPRSS11D	Transmembrane protease serine 11D	GO:0008233; F:peptidase activity; TAS:ProtInc
O60235	TMPRSS11D	Transmembrane protease serine 11D	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
O60235	TMPRSS11D	Transmembrane protease serine 11D	GO:0006508; P:proteolysis; IDA:UniProtKB
O60235	TMPRSS11D	Transmembrane protease serine 11D	GO:0007585; P:respiratory gaseous exchange; TAS:ProtInc
Q6ZWK6	TMPRSS11F	Transmembrane protease serine 11F	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q9UL52	TMPRSS11E	Transmembrane protease serine 11E	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q9UL52	TMPRSS11E	Transmembrane protease serine 11E	GO:0008236; F:serine-type peptidase activity; ISS:UniProtKB
Q9UL52	TMPRSS11E	Transmembrane protease serine 11E	GO:0006508; P:proteolysis; ISS:UniProtKB
O75204	TMEM127	Transmembrane protein 127	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
O75204	TMEM127	Transmembrane protein 127	GO:0032007; P:negative regulation of TOR signaling; IMP:UniProtKB
Q86UB9	TMEM135	Transmembrane protein 135	GO:0007031; P:peroxisome organization; ISS:UniProtKB
Q9NPI0	TMEM138	Transmembrane protein 138	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q8NBT3	TMEM145	Transmembrane protein 145	GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:InterPro
Q8NBT3	TMEM145	Transmembrane protein 145	GO:0019236; P:response to pheromone; IEA:InterPro
Q9P0S9	TMEM14C	Transmembrane protein 14C	GO:0006783; P:heme biosynthetic process; IEA:UniProtKB-KW
Q8WZ71	TMEM158	Transmembrane protein 158	GO:0042277; F:peptide binding; IEA:Ensembl
Q8TC26	TMEM163	Transmembrane protein 163	GO:0008270; F:zinc ion binding; ISS:UniProtKB
Q9HC07	TMEM165	Transmembrane protein 165	GO:0006874; P:cellular calcium ion homeostasis; IGI:UniProtKB
Q9HC07	TMEM165	Transmembrane protein 165	GO:0032472; P:Golgi calcium ion transport; IDA:UniProtKB
Q9HC07	TMEM165	Transmembrane protein 165	GO:0006487; P:protein N-linked glycosylation; IMP:UniProtKB
Q9HC07	TMEM165	Transmembrane protein 165	GO:0035751; P:regulation of lysosomal lumen pH; IMP:UniProtKB
Q9P2C4	TMEM181	Transmembrane protein 181	GO:0015643; F:toxic substance binding; IDA:UniProtKB
Q9P2C4	TMEM181	Transmembrane protein 181	GO:0009405; P:pathogenesis; IMP:UniProtKB
Q8IY95	TMEM192	Transmembrane protein 192	GO:0042803; F:protein homodimerization activity; IDA:UniProt
Q66K66	TMEM198	Transmembrane protein 198	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q66K66	TMEM198	Transmembrane protein 198	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:UniProtKB
Q66K66	TMEM198	Transmembrane protein 198	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
O75674	TOM1L1	TOM1-like protein 1	GO:0030276; F:clathrin binding; IDA:UniProtKB
O75674	TOM1L1	TOM1-like protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
O75674	TOM1L1	TOM1-like protein 1	GO:0030295; F:protein kinase activator activity; IEA:Ensembl
O75674	TOM1L1	TOM1-like protein 1	GO:0019901; F:protein kinase binding; IPI:UniProtKB
O75674	TOM1L1	TOM1-like protein 1	GO:0043130; F:ubiquitin binding; TAS:HGNC
O75674	TOM1L1	TOM1-like protein 1	GO:0032147; P:activation of protein kinase activity; IDA:UniProtKB
O75674	TOM1L1	TOM1-like protein 1	GO:0006886; P:intracellular protein transport; IEA:InterPro
O75674	TOM1L1	TOM1-like protein 1	GO:0045839; P:negative regulation of mitosis; IDA:UniProtKB
O75674	TOM1L1	TOM1-like protein 1	GO:0031954; P:positive regulation of protein autophosphorylation; IDA:UniProtKB
O75674	TOM1L1	TOM1-like protein 1	GO:0007165; P:signal transduction; IDA:UniProtKB
O75674	TOM1L1	TOM1-like protein 1	GO:0043162; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; NAS:HGNC
Q6ZVM7	TOM1L2	TOM1-like protein 2	GO:0030276; F:clathrin binding; IDA:UniProt
Q6ZVM7	TOM1L2	TOM1-like protein 2	GO:0005515; F:protein binding; IPI:UniProt
Q6ZVM7	TOM1L2	TOM1-like protein 2	GO:0019901; F:protein kinase binding; IPI:UniProt
Q6ZVM7	TOM1L2	TOM1-like protein 2	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q6ZVM7	TOM1L2	TOM1-like protein 2	GO:0045839; P:negative regulation of mitosis; IDA:UniProt
Q6ZVM7	TOM1L2	TOM1-like protein 2	GO:0007165; P:signal transduction; IDA:UniProt
Q9BSN7	TMEM204	Transmembrane protein 204	GO:0001945; P:lymph vessel development; IEA:Ensembl
Q9BSN7	TMEM204	Transmembrane protein 204	GO:0030947; P:regulation of vascular endothelial growth factor receptor signaling pathway; IEA:Ensembl
Q9BSN7	TMEM204	Transmembrane protein 204	GO:0006950; P:response to stress; IEA:UniProtKB-KW
Q9BSN7	TMEM204	Transmembrane protein 204	GO:0051145; P:smooth muscle cell differentiation; IEA:Ensembl
Q9BTX3	TMEM208	Transmembrane protein 208	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q6NUQ4	TMEM214	Transmembrane protein 214	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9P0N5	TMEM216	Transmembrane protein 216	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q9P0N5	TMEM216	Transmembrane protein 216	GO:0060271; P:cilium morphogenesis; ISS:UniProtKB
Q86XT9	TMEM219	Insulin-like growth factor-binding protein 3 receptor	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q6GV28	TMEM225	Transmembrane protein 225	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q9H6L2	TMEM231	Transmembrane protein 231	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q9H6L2	TMEM231	Transmembrane protein 231	GO:0007224; P:smoothened signaling pathway; ISS:UniProtKB
B4DJY2	TMEM233	Transmembrane protein 233	GO:0009607; P:response to biotic stimulus; IEA:InterPro
A6NFC5	TMEM235	Transmembrane protein 235	GO:0005198; F:structural molecule activity; IEA:InterPro
Q96Q45	TMEM237	Transmembrane protein 237	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q96Q45	TMEM237	Transmembrane protein 237	GO:0030111; P:regulation of Wnt signaling pathway; IMP:UniProtKB
Q9BX74	TM2D1	TM2 domain-containing protein 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9H6F2	TMEM38A	Trimeric intracellular cation channel type A	GO:0005267; F:potassium channel activity; TAS:BHF-UCL
Q9NVV0	TMEM38B	Trimeric intracellular cation channel type B	GO:0005267; F:potassium channel activity; TAS:BHF-UCL
Q969M1	TOMM40L	Mitochondrial import receptor subunit TOM40B	GO:0015288; F:porin activity; IEA:UniProtKB-KW
Q969M1	TOMM40L	Mitochondrial import receptor subunit TOM40B	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q969M1	TOMM40L	Mitochondrial import receptor subunit TOM40B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q5BJD5	TMEM41B	Transmembrane protein 41B	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q8N4L2	TMEM55A	Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q86T03	TMEM55B	Type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
O94886	TMEM63A	Transmembrane protein 63A	GO:0000166; F:nucleotide binding; IEA:InterPro
Q5T3F8	TMEM63B	Transmembrane protein 63B	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8N661	TMEM86B	Lysoplasmalogenase	GO:0047408; F:alkenylglycerophosphocholine hydrolase activity; IDA:UniProtKB
Q8N661	TMEM86B	Lysoplasmalogenase	GO:0047409; F:alkenylglycerophosphoethanolamine hydrolase activity; IDA:UniProtKB
Q8N661	TMEM86B	Lysoplasmalogenase	GO:0046485; P:ether lipid metabolic process; IDA:UniProtKB
O15321	TM9SF1	Transmembrane 9 superfamily member 1	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q99805	TM9SF2	Transmembrane 9 superfamily member 2	GO:0006810; P:transport; TAS:ProtInc
Q8TDI8	TMC1	Transmembrane channel-like protein 1	GO:0060117; P:auditory receptor cell development; IEA:Ensembl
Q8TDI8	TMC1	Transmembrane channel-like protein 1	GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; IEA:Ensembl
Q8TDI8	TMC1	Transmembrane channel-like protein 1	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q8TDI8	TMC1	Transmembrane channel-like protein 1	GO:0060005; P:vestibular reflex; IEA:Ensembl
Q8TDI7	TMC2	Transmembrane channel-like protein 2	GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; IEA:Ensembl
Q8TDI7	TMC2	Transmembrane channel-like protein 2	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q8TDI7	TMC2	Transmembrane channel-like protein 2	GO:0060005; P:vestibular reflex; IEA:Ensembl
Q7Z5M5	TMC3	Transmembrane channel-like protein 3	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q7Z404	TMC4	Transmembrane channel-like protein 4	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q6UXY8	TMC5	Transmembrane channel-like protein 5	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q7Z403	TMC6	Transmembrane channel-like protein 6	GO:0005515; F:protein binding; IPI:UniProt
Q7Z403	TMC6	Transmembrane channel-like protein 6	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q7Z402	TMC7	Transmembrane channel-like protein 7	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q8IU68	TMC8	Transmembrane channel-like protein 8	GO:0005515; F:protein binding; IPI:UniProt
Q8IU68	TMC8	Transmembrane channel-like protein 8	GO:0005102; F:receptor binding; IPI:UniProt
Q8IU68	TMC8	Transmembrane channel-like protein 8	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q8IU68	TMC8	Transmembrane channel-like protein 8	GO:0032091; P:negative regulation of protein binding; IDA:UniProt
Q8IU68	TMC8	Transmembrane channel-like protein 8	GO:0032460; P:negative regulation of protein oligomerization; IDA:UniProt
Q8IU68	TMC8	Transmembrane channel-like protein 8	GO:0001558; P:regulation of cell growth; IDA:UniProt
Q8IU68	TMC8	Transmembrane channel-like protein 8	GO:1902041; P:regulation of extrinsic apoptotic signaling pathway via death domain receptors; IDA:UniProt
Q8IU68	TMC8	Transmembrane channel-like protein 8	GO:0055069; P:zinc ion homeostasis; IDA:UniProt
O75069	TMCC2	Transmembrane and coiled-coil domains protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q6UWJ1	TMCO3	Transmembrane and coiled-coil domain-containing protein 3	GO:0015299; F:solute:proton antiporter activity; IEA:InterPro
Q13445	TMED1	Transmembrane emp24 domain-containing protein 1	GO:0005515; F:protein binding; IPI:HGNC
Q13445	TMED1	Transmembrane emp24 domain-containing protein 1	GO:0005102; F:receptor binding; TAS:ProtInc
Q13445	TMED1	Transmembrane emp24 domain-containing protein 1	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q13445	TMED1	Transmembrane emp24 domain-containing protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q13445	TMED1	Transmembrane emp24 domain-containing protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q96DC7	TMCO6	Transmembrane and coiled-coil domain-containing protein 6	GO:0008565; F:protein transporter activity; IEA:InterPro
Q96DC7	TMCO6	Transmembrane and coiled-coil domain-containing protein 6	GO:0006606; P:protein import into nucleus; IEA:InterPro
Q9Y3Q3	TMED3	Transmembrane emp24 domain-containing protein 3	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q15363	TMED2	Transmembrane emp24 domain-containing protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q15363	TMED2	Transmembrane emp24 domain-containing protein 2	GO:0035459; P:cargo loading into vesicle; TAS:UniProtKB
Q15363	TMED2	Transmembrane emp24 domain-containing protein 2	GO:0048205; P:COPI coating of Golgi vesicle; TAS:UniProtKB
Q15363	TMED2	Transmembrane emp24 domain-containing protein 2	GO:0048208; P:COPII vesicle coating; TAS:UniProtKB
Q15363	TMED2	Transmembrane emp24 domain-containing protein 2	GO:0048598; P:embryonic morphogenesis; IEA:Ensembl
Q15363	TMED2	Transmembrane emp24 domain-containing protein 2	GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:UniProtKB
Q15363	TMED2	Transmembrane emp24 domain-containing protein 2	GO:0007030; P:Golgi organization; IMP:UniProtKB
Q15363	TMED2	Transmembrane emp24 domain-containing protein 2	GO:0006886; P:intracellular protein transport; IDA:UniProtKB
Q15363	TMED2	Transmembrane emp24 domain-containing protein 2	GO:0001893; P:maternal placenta development; IEA:Ensembl
Q15363	TMED2	Transmembrane emp24 domain-containing protein 2	GO:0034260; P:negative regulation of GTPase activity; IDA:UniProtKB
Q15363	TMED2	Transmembrane emp24 domain-containing protein 2	GO:0072661; P:protein targeting to plasma membrane; IDA:UniProtKB
Q9Y3A6	TMED5	Transmembrane emp24 domain-containing protein 5	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3A6	TMED5	Transmembrane emp24 domain-containing protein 5	GO:0090161; P:Golgi ribbon formation; IMP:UniProtKB
Q9Y3A6	TMED5	Transmembrane emp24 domain-containing protein 5	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q7Z7H5	TMED4	Transmembrane emp24 domain-containing protein 4	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q7Z7H5	TMED4	Transmembrane emp24 domain-containing protein 4	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q7Z7H5	TMED4	Transmembrane emp24 domain-containing protein 4	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q7Z7H5	TMED4	Transmembrane emp24 domain-containing protein 4	GO:0007165; P:signal transduction; IMP:GOC
Q8WW62	TMED6	Transmembrane emp24 domain-containing protein 6	GO:0006810; P:transport; IEA:InterPro
Q9Y3B3	TMED7	Transmembrane emp24 domain-containing protein 7	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q6PL24	TMED8	Protein TMED8	GO:0006810; P:transport; IEA:InterPro
Q9BVK6	TMED9	Transmembrane emp24 domain-containing protein 9	GO:0005515; F:protein binding; IPI:IntAct
Q9BVK6	TMED9	Transmembrane emp24 domain-containing protein 9	GO:0019905; F:syntaxin binding; IPI:UniProtKB
Q9BVK6	TMED9	Transmembrane emp24 domain-containing protein 9	GO:0048205; P:COPI coating of Golgi vesicle; IMP:UniProtKB
Q9BVK6	TMED9	Transmembrane emp24 domain-containing protein 9	GO:0007030; P:Golgi organization; IMP:UniProtKB
Q9BVK6	TMED9	Transmembrane emp24 domain-containing protein 9	GO:0010638; P:positive regulation of organelle organization; IMP:UniProtKB
Q9BVK6	TMED9	Transmembrane emp24 domain-containing protein 9	GO:0015031; P:protein transport; IEA:UniProtKB-KW
P49755	TMED10	Transmembrane emp24 domain-containing protein 10	GO:0005515; F:protein binding; IPI:IntAct
P49755	TMED10	Transmembrane emp24 domain-containing protein 10	GO:0019905; F:syntaxin binding; IPI:UniProtKB
P49755	TMED10	Transmembrane emp24 domain-containing protein 10	GO:0034205; P:beta-amyloid formation; IMP:UniProtKB
P49755	TMED10	Transmembrane emp24 domain-containing protein 10	GO:0035459; P:cargo loading into vesicle; TAS:UniProtKB
P49755	TMED10	Transmembrane emp24 domain-containing protein 10	GO:0048205; P:COPI coating of Golgi vesicle; TAS:UniProtKB
P49755	TMED10	Transmembrane emp24 domain-containing protein 10	GO:0035964; P:COPI-coated vesicle budding; IDA:UniProtKB
P49755	TMED10	Transmembrane emp24 domain-containing protein 10	GO:0048208; P:COPII vesicle coating; TAS:UniProtKB
P49755	TMED10	Transmembrane emp24 domain-containing protein 10	GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:UniProtKB
P49755	TMED10	Transmembrane emp24 domain-containing protein 10	GO:0007030; P:Golgi organization; IEA:Ensembl
P49755	TMED10	Transmembrane emp24 domain-containing protein 10	GO:0006886; P:intracellular protein transport; IDA:UniProtKB
P49755	TMED10	Transmembrane emp24 domain-containing protein 10	GO:0001822; P:kidney development; IEA:Ensembl
P49755	TMED10	Transmembrane emp24 domain-containing protein 10	GO:0051259; P:protein oligomerization; IEA:Ensembl
P49755	TMED10	Transmembrane emp24 domain-containing protein 10	GO:0045055; P:regulated secretory pathway; ISS:HGNC
P49755	TMED10	Transmembrane emp24 domain-containing protein 10	GO:0001101; P:response to acid; IEA:Ensembl
P49755	TMED10	Transmembrane emp24 domain-containing protein 10	GO:0043279; P:response to alkaloid; IEA:Ensembl
P49755	TMED10	Transmembrane emp24 domain-containing protein 10	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; ISS:UniProtKB
P49755	TMED10	Transmembrane emp24 domain-containing protein 10	GO:0048199; P:vesicle targeting, to, from or within Golgi; ISS:HGNC
Q9UHN6	TMEM2	Transmembrane protein 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9P0T7	TMEM9	Transmembrane protein 9	GO:0006810; P:transport; IEA:UniProtKB-KW
P82094	TMF1	TATA element modulatory factor	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P82094	TMF1	TATA element modulatory factor	GO:0005515; F:protein binding; IPI:IntAct
P82094	TMF1	TATA element modulatory factor	GO:0003712; F:transcription cofactor activity; TAS:ProtInc
P82094	TMF1	TATA element modulatory factor	GO:0001675; P:acrosome assembly; IEA:Ensembl
P82094	TMF1	TATA element modulatory factor	GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl
P82094	TMF1	TATA element modulatory factor	GO:0042742; P:defense response to bacterium; IEA:Ensembl
P82094	TMF1	TATA element modulatory factor	GO:0033327; P:Leydig cell differentiation; IEA:Ensembl
P82094	TMF1	TATA element modulatory factor	GO:0032275; P:luteinizing hormone secretion; IEA:Ensembl
P82094	TMF1	TATA element modulatory factor	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P82094	TMF1	TATA element modulatory factor	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
P82094	TMF1	TATA element modulatory factor	GO:0001819; P:positive regulation of cytokine production; IEA:Ensembl
P82094	TMF1	TATA element modulatory factor	GO:2000845; P:positive regulation of testosterone secretion; IEA:Ensembl
P82094	TMF1	TATA element modulatory factor	GO:0061136; P:regulation of proteasomal protein catabolic process; ISS:UniProtKB
P82094	TMF1	TATA element modulatory factor	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
P82094	TMF1	TATA element modulatory factor	GO:0030317; P:sperm motility; IEA:Ensembl
P82094	TMF1	TATA element modulatory factor	GO:0007289; P:spermatid nucleus differentiation; IEA:Ensembl
P82094	TMF1	TATA element modulatory factor	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q96BF3	TMIGD2	Transmembrane and immunoglobulin domain-containing protein 2	GO:0015026; F:coreceptor activity; IDA:UniProtKB
Q96BF3	TMIGD2	Transmembrane and immunoglobulin domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q96BF3	TMIGD2	Transmembrane and immunoglobulin domain-containing protein 2	GO:0042104; P:positive regulation of activated T cell proliferation; IDA:UniProtKB
Q96BF3	TMIGD2	Transmembrane and immunoglobulin domain-containing protein 2	GO:0001819; P:positive regulation of cytokine production; IDA:UniProtKB
Q96BF3	TMIGD2	Transmembrane and immunoglobulin domain-containing protein 2	GO:0007165; P:signal transduction; IDA:GOC
Q96BF3	TMIGD2	Transmembrane and immunoglobulin domain-containing protein 2	GO:0031295; P:T cell costimulation; IDA:UniProtKB
O14668	PRRG1	Transmembrane gamma-carboxyglutamic acid protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9BZD6	PRRG4	Transmembrane gamma-carboxyglutamic acid protein 4	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9BZD7	PRRG3	Transmembrane gamma-carboxyglutamic acid protein 3	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8NEW7	TMIE	Transmembrane inner ear expressed protein	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q8NEW7	TMIE	Transmembrane inner ear expressed protein	GO:0007605; P:sensory perception of sound; IEA:Ensembl
O14669	PRRG2	Transmembrane gamma-carboxyglutamic acid protein 2	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8TAF8	LHFPL5	Tetraspan membrane protein of hair cell stereocilia	GO:0060088; P:auditory receptor cell stereocilium organization; IEA:Ensembl
Q8TAF8	LHFPL5	Tetraspan membrane protein of hair cell stereocilia	GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; IEA:Ensembl
Q8TAF8	LHFPL5	Tetraspan membrane protein of hair cell stereocilia	GO:0006811; P:ion transport; IEA:UniProtKB-KW
Q9NVH6	TMLHE	Trimethyllysine dioxygenase, mitochondrial	GO:0005506; F:iron ion binding; IEA:InterPro
Q9NVH6	TMLHE	Trimethyllysine dioxygenase, mitochondrial	GO:0031418; F:L-ascorbic acid binding; IEA:InterPro
Q9NVH6	TMLHE	Trimethyllysine dioxygenase, mitochondrial	GO:0016702; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen; IEA:Ensembl
Q9NVH6	TMLHE	Trimethyllysine dioxygenase, mitochondrial	GO:0050353; F:trimethyllysine dioxygenase activity; IDA:BHF-UCL
Q9NVH6	TMLHE	Trimethyllysine dioxygenase, mitochondrial	GO:0045329; P:carnitine biosynthetic process; IDA:BHF-UCL
Q9NVH6	TMLHE	Trimethyllysine dioxygenase, mitochondrial	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q9NVH6	TMLHE	Trimethyllysine dioxygenase, mitochondrial	GO:0051354; P:negative regulation of oxidoreductase activity; IDA:BHF-UCL
Q9NVH6	TMLHE	Trimethyllysine dioxygenase, mitochondrial	GO:0055114; P:oxidation-reduction process; IDA:GOC
Q9NVH6	TMLHE	Trimethyllysine dioxygenase, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q86X19	TMEM17	Transmembrane protein 17	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q86X19	TMEM17	Transmembrane protein 17	GO:0007224; P:smoothened signaling pathway; ISS:UniProtKB
P17152	TMEM11	Transmembrane protein 11, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
P17152	TMEM11	Transmembrane protein 11, mitochondrial	GO:0007005; P:mitochondrion organization; IMP:UniProtKB
Q96B42	TMEM18	Transmembrane protein 18	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96B42	TMEM18	Transmembrane protein 18	GO:0016477; P:cell migration; IDA:UniProtKB
Q96B42	TMEM18	Transmembrane protein 18	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HBJ8	TMEM27	Collectrin	GO:0008237; F:metallopeptidase activity; IEA:InterPro
Q9HBJ8	TMEM27	Collectrin	GO:0008241; F:peptidyl-dipeptidase activity; IEA:InterPro
Q9HBJ8	TMEM27	Collectrin	GO:0005515; F:protein binding; IPI:UniProt
Q9HBJ8	TMEM27	Collectrin	GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; IDA:UniProt
Q9HBJ8	TMEM27	Collectrin	GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IDA:UniProt
Q9HBJ8	TMEM27	Collectrin	GO:0035543; P:positive regulation of SNARE complex assembly; IDA:UniProt
Q9BTV4	TMEM43	Transmembrane protein 43	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BXS4	TMEM59	Transmembrane protein 59	GO:0004175; F:endopeptidase activity; IEA:Ensembl
Q9BXS4	TMEM59	Transmembrane protein 59	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BXS4	TMEM59	Transmembrane protein 59	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q9BXS4	TMEM59	Transmembrane protein 59	GO:0090005; P:negative regulation of establishment of protein localization to plasma membrane; IDA:UniProt
Q9BXS4	TMEM59	Transmembrane protein 59	GO:0090285; P:negative regulation of protein glycosylation in Golgi; IDA:UniProt
Q9BXS4	TMEM59	Transmembrane protein 59	GO:0010955; P:negative regulation of protein processing; IDA:UniProt
Q9BXS4	TMEM59	Transmembrane protein 59	GO:0010508; P:positive regulation of autophagy; IMP:UniProtKB
Q6YI46	TMEM64	Transmembrane protein 64	GO:0051480; P:cytosolic calcium ion homeostasis; IEA:Ensembl
Q6YI46	TMEM64	Transmembrane protein 64	GO:0045780; P:positive regulation of bone resorption; IEA:Ensembl
Q6YI46	TMEM64	Transmembrane protein 64	GO:0045672; P:positive regulation of osteoclast differentiation; IEA:Ensembl
Q6YI46	TMEM64	Transmembrane protein 64	GO:0043462; P:regulation of ATPase activity; IEA:Ensembl
Q96MH6	TMEM68	Transmembrane protein 68	GO:0016746; F:transferase activity, transferring acyl groups; IEA:InterPro
Q9BUB7	TMEM70	Transmembrane protein 70, mitochondrial	GO:0033615; P:mitochondrial proton-transporting ATP synthase complex assembly; IMP:UniProtKB
Q96NL1	TMEM74	Transmembrane protein 74	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q9BSE2	TMEM79	Transmembrane protein 79	GO:0002070; P:epithelial cell maturation; ISS:UniProtKB
Q9BSE2	TMEM79	Transmembrane protein 79	GO:0061436; P:establishment of skin barrier; ISS:UniProtKB
Q9BSE2	TMEM79	Transmembrane protein 79	GO:0045684; P:positive regulation of epidermis development; ISS:UniProtKB
Q9BSE2	TMEM79	Transmembrane protein 79	GO:0045055; P:regulated secretory pathway; ISS:UniProtKB
Q6PEY1	TMEM88	Transmembrane protein 88	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q6PEY1	TMEM88	Transmembrane protein 88	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9HCN3	TMEM8A	Transmembrane protein 8A	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
A6NDV4	TMEM8B	Transmembrane protein 8B	GO:0005515; F:protein binding; IPI:HGNC
A6NDV4	TMEM8B	Transmembrane protein 8B	GO:0007160; P:cell-matrix adhesion; IMP:HGNC
A6NDV4	TMEM8B	Transmembrane protein 8B	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
A6NDV4	TMEM8B	Transmembrane protein 8B	GO:0007346; P:regulation of mitotic cell cycle; TAS:HGNC
A6NI61	TMEM8C	Protein myomaker	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
A6NI61	TMEM8C	Protein myomaker	GO:0007520; P:myoblast fusion; ISS:UniProtKB
A6NI61	TMEM8C	Protein myomaker	GO:0045026; P:plasma membrane fusion; ISS:UniProtKB
Q6ZNR0	TMEM91	Transmembrane protein 91	GO:0009607; P:response to biotic stimulus; IEA:InterPro
Q5BJF2	TMEM97	Transmembrane protein 97	GO:0005515; F:protein binding; IPI:UniProtKB
Q5BJF2	TMEM97	Transmembrane protein 97	GO:0042632; P:cholesterol homeostasis; IDA:UniProtKB
Q5BJF2	TMEM97	Transmembrane protein 97	GO:0001558; P:regulation of cell growth; NAS:UniProtKB
Q9NQ34	TMEM9B	Transmembrane protein 9B	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q9NQ34	TMEM9B	Transmembrane protein 9B	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q9NQ34	TMEM9B	Transmembrane protein 9B	GO:0007165; P:signal transduction; IMP:GOC
P28289	TMOD1	Tropomodulin-1	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P28289	TMOD1	Tropomodulin-1	GO:0030049; P:muscle filament sliding; TAS:Reactome
P28289	TMOD1	Tropomodulin-1	GO:0030239; P:myofibril assembly; IEA:Ensembl
Q9NZR1	TMOD2	Tropomodulin-2	GO:0005523; F:tropomyosin binding; TAS:ProtInc
Q9NZR1	TMOD2	Tropomodulin-2	GO:0007611; P:learning or memory; IEA:Ensembl
Q9NZR1	TMOD2	Tropomodulin-2	GO:0007399; P:nervous system development; TAS:ProtInc
Q9NZR1	TMOD2	Tropomodulin-2	GO:0007270; P:neuron-neuron synaptic transmission; IEA:Ensembl
Q9NZR1	TMOD2	Tropomodulin-2	GO:0045745; P:positive regulation of G-protein coupled receptor protein signaling pathway; IEA:Ensembl
Q9NYL9	TMOD3	Tropomodulin-3	GO:0005523; F:tropomyosin binding; TAS:ProtInc
Q9NZQ9	TMOD4	Tropomodulin-4	GO:0005523; F:tropomyosin binding; TAS:ProtInc
Q9NZQ9	TMOD4	Tropomodulin-4	GO:0006936; P:muscle contraction; TAS:ProtInc
Q6ZT21	TMPPE	Transmembrane protein with metallophosphoesterase domain	GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW
Q6ZT21	TMPPE	Transmembrane protein with metallophosphoesterase domain	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15393	TMPRSS2	Transmembrane protease serine 2	GO:0005515; F:protein binding; IPI:UniProtKB
O15393	TMPRSS2	Transmembrane protease serine 2	GO:0005044; F:scavenger receptor activity; IEA:InterPro
O15393	TMPRSS2	Transmembrane protease serine 2	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
O15393	TMPRSS2	Transmembrane protease serine 2	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
O15393	TMPRSS2	Transmembrane protease serine 2	GO:0046598; P:positive regulation of viral entry into host cell; IDA:UniProtKB
O15393	TMPRSS2	Transmembrane protease serine 2	GO:0016540; P:protein autoprocessing; IMP:UniProtKB
O15393	TMPRSS2	Transmembrane protease serine 2	GO:0006508; P:proteolysis; IDA:UniProtKB
P57727	TMPRSS3	Transmembrane protease serine 3	GO:0005044; F:scavenger receptor activity; IEA:InterPro
P57727	TMPRSS3	Transmembrane protease serine 3	GO:0004252; F:serine-type endopeptidase activity; NAS:UniProtKB
P57727	TMPRSS3	Transmembrane protease serine 3	GO:0017080; F:sodium channel regulator activity; IDA:MGI
P57727	TMPRSS3	Transmembrane protease serine 3	GO:0006883; P:cellular sodium ion homeostasis; IDA:MGI
P57727	TMPRSS3	Transmembrane protease serine 3	GO:0006508; P:proteolysis; NAS:UniProtKB
P57727	TMPRSS3	Transmembrane protease serine 3	GO:0007605; P:sensory perception of sound; IEA:Ensembl
Q9NRS4	TMPRSS4	Transmembrane protease serine 4	GO:0005044; F:scavenger receptor activity; IEA:InterPro
Q9NRS4	TMPRSS4	Transmembrane protease serine 4	GO:0004252; F:serine-type endopeptidase activity; NAS:UniProtKB
Q9NRS4	TMPRSS4	Transmembrane protease serine 4	GO:0006508; P:proteolysis; NAS:UniProtKB
Q9H3S3	TMPRSS5	Transmembrane protease serine 5	GO:0008233; F:peptidase activity; IMP:UniProtKB
Q9H3S3	TMPRSS5	Transmembrane protease serine 5	GO:0005044; F:scavenger receptor activity; IEA:InterPro
Q9H3S3	TMPRSS5	Transmembrane protease serine 5	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q9H3S3	TMPRSS5	Transmembrane protease serine 5	GO:0006508; P:proteolysis; IMP:UniProtKB
Q8IU80	TMPRSS6	Transmembrane protease serine 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IU80	TMPRSS6	Transmembrane protease serine 6	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
Q8IU80	TMPRSS6	Transmembrane protease serine 6	GO:0001525; P:angiogenesis; NAS:UniProtKB
Q8IU80	TMPRSS6	Transmembrane protease serine 6	GO:0030198; P:extracellular matrix organization; NAS:UniProtKB
Q8IU80	TMPRSS6	Transmembrane protease serine 6	GO:0042730; P:fibrinolysis; IDA:UniProtKB
Q8IU80	TMPRSS6	Transmembrane protease serine 6	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
Q8IU80	TMPRSS6	Transmembrane protease serine 6	GO:0055072; P:iron ion homeostasis; IMP:UniProtKB
Q8IU80	TMPRSS6	Transmembrane protease serine 6	GO:0006508; P:proteolysis; IDA:UniProtKB
Q7RTY8	TMPRSS7	Transmembrane protease serine 7	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q7RTY8	TMPRSS7	Transmembrane protease serine 7	GO:0008236; F:serine-type peptidase activity; ISS:UniProtKB
Q7RTY8	TMPRSS7	Transmembrane protease serine 7	GO:0006508; P:proteolysis; ISS:UniProtKB
Q7Z410	TMPRSS9	Transmembrane protease serine 9	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q86WS5	TMPRSS12	Transmembrane protease serine 12	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q9BYE2	TMPRSS13	Transmembrane protease serine 13	GO:0005044; F:scavenger receptor activity; IEA:InterPro
Q9BYE2	TMPRSS13	Transmembrane protease serine 13	GO:0004252; F:serine-type endopeptidase activity; NAS:UniProtKB
Q6ZXV5	TMTC3	Transmembrane and TPR repeat-containing protein 3	GO:0060447; P:bud outgrowth involved in lung branching; IEA:Ensembl
Q6ZXV5	TMTC3	Transmembrane and TPR repeat-containing protein 3	GO:0048286; P:lung alveolus development; IEA:Ensembl
Q6ZXV5	TMTC3	Transmembrane and TPR repeat-containing protein 3	GO:0048747; P:muscle fiber development; IEA:Ensembl
Q6ZXV5	TMTC3	Transmembrane and TPR repeat-containing protein 3	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q6ZXV5	TMTC3	Transmembrane and TPR repeat-containing protein 3	GO:0010468; P:regulation of gene expression; IEA:Ensembl
Q9H3N1	TMX1	Thioredoxin-related transmembrane protein 1	GO:0015036; F:disulfide oxidoreductase activity; IDA:UniProtKB
Q9H3N1	TMX1	Thioredoxin-related transmembrane protein 1	GO:0003756; F:protein disulfide isomerase activity; IBA:RefGenome
Q9H3N1	TMX1	Thioredoxin-related transmembrane protein 1	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q9H3N1	TMX1	Thioredoxin-related transmembrane protein 1	GO:0006457; P:protein folding; IBA:RefGenome
Q9H3N1	TMX1	Thioredoxin-related transmembrane protein 1	GO:0034976; P:response to endoplasmic reticulum stress; IMP:UniProtKB
Q9Y320	TMX2	Thioredoxin-related transmembrane protein 2	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q96JJ7	TMX3	Protein disulfide-isomerase TMX3	GO:0003756; F:protein disulfide isomerase activity; IBA:RefGenome
Q96JJ7	TMX3	Protein disulfide-isomerase TMX3	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
Q96JJ7	TMX3	Protein disulfide-isomerase TMX3	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q96JJ7	TMX3	Protein disulfide-isomerase TMX3	GO:0006662; P:glycerol ether metabolic process; IEA:InterPro
Q96JJ7	TMX3	Protein disulfide-isomerase TMX3	GO:0006457; P:protein folding; IBA:RefGenome
Q96JJ7	TMX3	Protein disulfide-isomerase TMX3	GO:0034976; P:response to endoplasmic reticulum stress; IBA:RefGenome
Q9H1E5	TMX4	Thioredoxin-related transmembrane protein 4	GO:0003756; F:protein disulfide isomerase activity; IBA:RefGenome
Q9H1E5	TMX4	Thioredoxin-related transmembrane protein 4	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q9H1E5	TMX4	Thioredoxin-related transmembrane protein 4	GO:0055114; P:oxidation-reduction process; IEA:UniProtKB-KW
Q9H1E5	TMX4	Thioredoxin-related transmembrane protein 4	GO:0006457; P:protein folding; IBA:RefGenome
Q9H1E5	TMX4	Thioredoxin-related transmembrane protein 4	GO:0034976; P:response to endoplasmic reticulum stress; IBA:RefGenome
Q9Y275	TNFSF13B	Tumor necrosis factor ligand superfamily member 13B	GO:0005515; F:protein binding; IPI:IntAct
Q9Y275	TNFSF13B	Tumor necrosis factor ligand superfamily member 13B	GO:0005102; F:receptor binding; TAS:ProtInc
Q9Y275	TNFSF13B	Tumor necrosis factor ligand superfamily member 13B	GO:0031296; P:B cell costimulation; IEA:Ensembl
Q9Y275	TNFSF13B	Tumor necrosis factor ligand superfamily member 13B	GO:0001782; P:B cell homeostasis; IEA:Ensembl
Q9Y275	TNFSF13B	Tumor necrosis factor ligand superfamily member 13B	GO:0008283; P:cell proliferation; TAS:ProtInc
Q9Y275	TNFSF13B	Tumor necrosis factor ligand superfamily member 13B	GO:0006955; P:immune response; IEA:InterPro
Q9Y275	TNFSF13B	Tumor necrosis factor ligand superfamily member 13B	GO:0048305; P:immunoglobulin secretion; IEA:Ensembl
Q9Y275	TNFSF13B	Tumor necrosis factor ligand superfamily member 13B	GO:0030890; P:positive regulation of B cell proliferation; IEA:Ensembl
Q9Y275	TNFSF13B	Tumor necrosis factor ligand superfamily member 13B	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q9Y275	TNFSF13B	Tumor necrosis factor ligand superfamily member 13B	GO:0002636; P:positive regulation of germinal center formation; IEA:Ensembl
Q9Y275	TNFSF13B	Tumor necrosis factor ligand superfamily member 13B	GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl
Q9Y275	TNFSF13B	Tumor necrosis factor ligand superfamily member 13B	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y275	TNFSF13B	Tumor necrosis factor ligand superfamily member 13B	GO:0031295; P:T cell costimulation; IEA:Ensembl
Q03169	TNFAIP2	Tumor necrosis factor alpha-induced protein 2	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q03169	TNFAIP2	Tumor necrosis factor alpha-induced protein 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q03169	TNFAIP2	Tumor necrosis factor alpha-induced protein 2	GO:0006887; P:exocytosis; IEA:InterPro
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0002020; F:protease binding; IPI:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0005515; F:protein binding; IPI:IntAct
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0043621; F:protein self-association; IDA:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0043130; F:ubiquitin binding; IPI:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0004221; F:ubiquitin thiolesterase activity; IMP:UniProtKB
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0001922; P:B-1 B cell homeostasis; ISS:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0070301; P:cellular response to hydrogen peroxide; ISS:UniProtKB
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0071222; P:cellular response to lipopolysaccharide; IDA:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0045087; P:innate immune response; TAS:Reactome
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0050869; P:negative regulation of B cell activation; ISS:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0045779; P:negative regulation of bone resorption; NAS:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:2000349; P:negative regulation of CD40 signaling pathway; IMP:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0002677; P:negative regulation of chronic inflammatory response; IEA:Ensembl
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:Ensembl
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:2000352; P:negative regulation of endothelial cell apoptotic process; IDA:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IDA:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0050728; P:negative regulation of inflammatory response; ISS:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0045824; P:negative regulation of innate immune response; ISS:UniProtKB
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0032691; P:negative regulation of interleukin-1 beta production; IEA:Ensembl
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0032703; P:negative regulation of interleukin-2 production; IMP:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0032715; P:negative regulation of interleukin-6 production; ISS:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0070429; P:negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway; IEA:Ensembl
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0070433; P:negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway; IEA:Ensembl
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0090291; P:negative regulation of osteoclast proliferation; NAS:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0031397; P:negative regulation of protein ubiquitination; IDA:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IDA:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0034136; P:negative regulation of toll-like receptor 2 signaling pathway; NAS:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0034140; P:negative regulation of toll-like receptor 3 signaling pathway; IDA:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0034144; P:negative regulation of toll-like receptor 4 signaling pathway; NAS:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0034148; P:negative regulation of toll-like receptor 5 signaling pathway; IEA:Ensembl
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0032720; P:negative regulation of tumor necrosis factor production; ISS:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:2000347; P:positive regulation of hepatocyte proliferation; IEA:Ensembl
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0045732; P:positive regulation of protein catabolic process; IDA:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0016579; P:protein deubiquitination; TAS:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0035871; P:protein K11-linked deubiquitination; IDA:UniProtKB
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0071108; P:protein K48-linked deubiquitination; IDA:UniProtKB
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0070536; P:protein K63-linked deubiquitination; IDA:UniProtKB
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0051259; P:protein oligomerization; NAS:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0050691; P:regulation of defense response to virus by host; NAS:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0002634; P:regulation of germinal center formation; ISS:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0061043; P:regulation of vascular wound healing; NAS:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0002237; P:response to molecule of bacterial origin; IDA:BHF-UCL
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0032495; P:response to muramyl dipeptide; IEA:Ensembl
P21580	TNFAIP3	Tumor necrosis factor alpha-induced protein 3	GO:0072573; P:tolerance induction to lipopolysaccharide; IMP:BHF-UCL
O15417	TNRC18	Trinucleotide repeat-containing gene 18 protein	GO:0003682; F:chromatin binding; IEA:InterPro
P50591	TNFSF10	Tumor necrosis factor ligand superfamily member 10	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P50591	TNFSF10	Tumor necrosis factor ligand superfamily member 10	GO:0005515; F:protein binding; IPI:IntAct
P50591	TNFSF10	Tumor necrosis factor ligand superfamily member 10	GO:0005102; F:receptor binding; TAS:ProtInc
P50591	TNFSF10	Tumor necrosis factor ligand superfamily member 10	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:Reactome
P50591	TNFSF10	Tumor necrosis factor ligand superfamily member 10	GO:0006915; P:apoptotic process; TAS:Reactome
P50591	TNFSF10	Tumor necrosis factor ligand superfamily member 10	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
P50591	TNFSF10	Tumor necrosis factor ligand superfamily member 10	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P50591	TNFSF10	Tumor necrosis factor ligand superfamily member 10	GO:0006955; P:immune response; IEA:InterPro
P50591	TNFSF10	Tumor necrosis factor ligand superfamily member 10	GO:0008584; P:male gonad development; IEA:Ensembl
P50591	TNFSF10	Tumor necrosis factor ligand superfamily member 10	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P50591	TNFSF10	Tumor necrosis factor ligand superfamily member 10	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P50591	TNFSF10	Tumor necrosis factor ligand superfamily member 10	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IDA:UniProtKB
P50591	TNFSF10	Tumor necrosis factor ligand superfamily member 10	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
P50591	TNFSF10	Tumor necrosis factor ligand superfamily member 10	GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; IDA:UniProtKB
P50591	TNFSF10	Tumor necrosis factor ligand superfamily member 10	GO:2001239; P:regulation of extrinsic apoptotic signaling pathway in absence of ligand; TAS:Reactome
P50591	TNFSF10	Tumor necrosis factor ligand superfamily member 10	GO:0032868; P:response to insulin; IEA:Ensembl
P50591	TNFSF10	Tumor necrosis factor ligand superfamily member 10	GO:0007165; P:signal transduction; TAS:ProtInc
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0005125; F:cytokine activity; NAS:UniProtKB
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0005164; F:tumor necrosis factor receptor binding; NAS:UniProtKB
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0032813; F:tumor necrosis factor receptor superfamily binding; IC:BHF-UCL
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0007257; P:activation of JUN kinase activity; IEA:Ensembl
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0045453; P:bone resorption; IEA:Ensembl
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0055074; P:calcium ion homeostasis; IEA:Ensembl
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0019221; P:cytokine-mediated signaling pathway; IDA:BHF-UCL
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0070371; P:ERK1 and ERK2 cascade; IEA:Ensembl
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0006955; P:immune response; NAS:UniProtKB
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0060749; P:mammary gland alveolus development; IEA:Ensembl
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0033598; P:mammary gland epithelial cell proliferation; IEA:Ensembl
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0002548; P:monocyte chemotaxis; IDA:BHF-UCL
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0009887; P:organ morphogenesis; IEA:Ensembl
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0001503; P:ossification; IEA:Ensembl
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0030316; P:osteoclast differentiation; NAS:UniProtKB
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0002158; P:osteoclast proliferation; IEA:Ensembl
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0045780; P:positive regulation of bone resorption; IDA:UniProtKB
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0051466; P:positive regulation of corticotropin-releasing hormone secretion; ISS:BHF-UCL
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0071848; P:positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling; IDA:BHF-UCL
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0071812; P:positive regulation of fever generation by positive regulation of prostaglandin secretion; ISS:BHF-UCL
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0034112; P:positive regulation of homotypic cell-cell adhesion; IDA:BHF-UCL
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:1902533; P:positive regulation of intracellular signal transduction; IDA:BHF-UCL
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0046330; P:positive regulation of JNK cascade; IEA:Ensembl
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0043406; P:positive regulation of MAP kinase activity; IDA:BHF-UCL
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:BHF-UCL
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0045672; P:positive regulation of osteoclast differentiation; IDA:UniProtKB
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0050870; P:positive regulation of T cell activation; IDA:BHF-UCL
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0051260; P:protein homooligomerization; IEA:Ensembl
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0071847; P:TNFSF11-mediated signaling pathway; IDA:BHF-UCL
O14788	TNFSF11	Tumor necrosis factor ligand superfamily member 11	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; ISS:BHF-UCL
O43508	TNFSF12	Tumor necrosis factor ligand superfamily member 12	GO:0005125; F:cytokine activity; TAS:UniProtKB
O43508	TNFSF12	Tumor necrosis factor ligand superfamily member 12	GO:0005515; F:protein binding; IPI:UniProtKB
O43508	TNFSF12	Tumor necrosis factor ligand superfamily member 12	GO:0005102; F:receptor binding; TAS:ProtInc
O43508	TNFSF12	Tumor necrosis factor ligand superfamily member 12	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
O43508	TNFSF12	Tumor necrosis factor ligand superfamily member 12	GO:0006915; P:apoptotic process; TAS:ProtInc
O43508	TNFSF12	Tumor necrosis factor ligand superfamily member 12	GO:0097190; P:apoptotic signaling pathway; TAS:UniProtKB
O43508	TNFSF12	Tumor necrosis factor ligand superfamily member 12	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O43508	TNFSF12	Tumor necrosis factor ligand superfamily member 12	GO:0043542; P:endothelial cell migration; TAS:UniProtKB
O43508	TNFSF12	Tumor necrosis factor ligand superfamily member 12	GO:0006955; P:immune response; IEA:InterPro
O43508	TNFSF12	Tumor necrosis factor ligand superfamily member 12	GO:0045766; P:positive regulation of angiogenesis; TAS:UniProtKB
O43508	TNFSF12	Tumor necrosis factor ligand superfamily member 12	GO:0001938; P:positive regulation of endothelial cell proliferation; TAS:UniProtKB
O43508	TNFSF12	Tumor necrosis factor ligand superfamily member 12	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IDA:UniProtKB
O43508	TNFSF12	Tumor necrosis factor ligand superfamily member 12	GO:0007165; P:signal transduction; TAS:ProtInc
O43557	TNFSF14	Tumor necrosis factor ligand superfamily member 14	GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IDA:UniProtKB
O43557	TNFSF14	Tumor necrosis factor ligand superfamily member 14	GO:0005515; F:protein binding; IPI:IntAct
O43557	TNFSF14	Tumor necrosis factor ligand superfamily member 14	GO:0005102; F:receptor binding; IPI:UniProtKB
O43557	TNFSF14	Tumor necrosis factor ligand superfamily member 14	GO:0006915; P:apoptotic process; TAS:ProtInc
O43557	TNFSF14	Tumor necrosis factor ligand superfamily member 14	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
O43557	TNFSF14	Tumor necrosis factor ligand superfamily member 14	GO:0006955; P:immune response; IEA:InterPro
O43557	TNFSF14	Tumor necrosis factor ligand superfamily member 14	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:GOC
O43557	TNFSF14	Tumor necrosis factor ligand superfamily member 14	GO:0010820; P:positive regulation of T cell chemotaxis; IEA:Ensembl
O43557	TNFSF14	Tumor necrosis factor ligand superfamily member 14	GO:0008588; P:release of cytoplasmic sequestered NF-kappaB; IDA:UniProtKB
O43557	TNFSF14	Tumor necrosis factor ligand superfamily member 14	GO:0007165; P:signal transduction; NAS:UniProtKB
O43557	TNFSF14	Tumor necrosis factor ligand superfamily member 14	GO:0042110; P:T cell activation; NAS:UniProtKB
O43557	TNFSF14	Tumor necrosis factor ligand superfamily member 14	GO:0031295; P:T cell costimulation; IEA:Ensembl
O43557	TNFSF14	Tumor necrosis factor ligand superfamily member 14	GO:0043029; P:T cell homeostasis; NAS:UniProtKB
O43557	TNFSF14	Tumor necrosis factor ligand superfamily member 14	GO:0042098; P:T cell proliferation; NAS:UniProtKB
O75888	TNFSF13	Tumor necrosis factor ligand superfamily member 13	GO:0005102; F:receptor binding; TAS:ProtInc
O75888	TNFSF13	Tumor necrosis factor ligand superfamily member 13	GO:0010467; P:gene expression; TAS:Reactome
O75888	TNFSF13	Tumor necrosis factor ligand superfamily member 13	GO:0002426; P:immunoglobulin production in mucosal tissue; IEA:Ensembl
O75888	TNFSF13	Tumor necrosis factor ligand superfamily member 13	GO:0016071; P:mRNA metabolic process; TAS:Reactome
O75888	TNFSF13	Tumor necrosis factor ligand superfamily member 13	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
O75888	TNFSF13	Tumor necrosis factor ligand superfamily member 13	GO:0002636; P:positive regulation of germinal center formation; IEA:Ensembl
O75888	TNFSF13	Tumor necrosis factor ligand superfamily member 13	GO:0048298; P:positive regulation of isotype switching to IgA isotypes; IDA:MGI
O75888	TNFSF13	Tumor necrosis factor ligand superfamily member 13	GO:0016070; P:RNA metabolic process; TAS:Reactome
O75888	TNFSF13	Tumor necrosis factor ligand superfamily member 13	GO:0007165; P:signal transduction; TAS:ProtInc
O95150	TNFSF15	Tumor necrosis factor ligand superfamily member 15	GO:0005102; F:receptor binding; TAS:ProtInc
O95150	TNFSF15	Tumor necrosis factor ligand superfamily member 15	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:MGI
O95150	TNFSF15	Tumor necrosis factor ligand superfamily member 15	GO:0007250; P:activation of NF-kappaB-inducing kinase activity; IDA:MGI
O95150	TNFSF15	Tumor necrosis factor ligand superfamily member 15	GO:0042107; P:cytokine metabolic process; IDA:MGI
O95150	TNFSF15	Tumor necrosis factor ligand superfamily member 15	GO:0006955; P:immune response; IEA:InterPro
O95150	TNFSF15	Tumor necrosis factor ligand superfamily member 15	GO:0050715; P:positive regulation of cytokine secretion; IEA:Ensembl
O95150	TNFSF15	Tumor necrosis factor ligand superfamily member 15	GO:0007165; P:signal transduction; NAS:ProtInc
Q9UNG2	TNFSF18	Tumor necrosis factor ligand superfamily member 18	GO:0005102; F:receptor binding; TAS:ProtInc
Q9UNG2	TNFSF18	Tumor necrosis factor ligand superfamily member 18	GO:0032813; F:tumor necrosis factor receptor superfamily binding; ISS:UniProtKB
Q9UNG2	TNFSF18	Tumor necrosis factor ligand superfamily member 18	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9UNG2	TNFSF18	Tumor necrosis factor ligand superfamily member 18	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
Q9UNG2	TNFSF18	Tumor necrosis factor ligand superfamily member 18	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB
Q9UNG2	TNFSF18	Tumor necrosis factor ligand superfamily member 18	GO:0042129; P:regulation of T cell proliferation; ISS:UniProtKB
Q9UNG2	TNFSF18	Tumor necrosis factor ligand superfamily member 18	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UNG2	TNFSF18	Tumor necrosis factor ligand superfamily member 18	GO:0002309; P:T cell proliferation involved in immune response; ISS:UniProtKB
Q9UNG2	TNFSF18	Tumor necrosis factor ligand superfamily member 18	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; ISS:UniProtKB
O95407	TNFRSF6B	Tumor necrosis factor receptor superfamily member 6B	GO:0005515; F:protein binding; IPI:IntAct
O95407	TNFRSF6B	Tumor necrosis factor receptor superfamily member 6B	GO:0004872; F:receptor activity; TAS:ProtInc
O95407	TNFRSF6B	Tumor necrosis factor receptor superfamily member 6B	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O95407	TNFRSF6B	Tumor necrosis factor receptor superfamily member 6B	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
P01375	TNF	Tumor necrosis factor	GO:0005125; F:cytokine activity; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0042802; F:identical protein binding; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0002020; F:protease binding; IPI:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0005515; F:protein binding; IPI:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0005164; F:tumor necrosis factor receptor binding; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0000187; P:activation of MAPK activity; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0000185; P:activation of MAPKKK activity; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0006915; P:apoptotic process; TAS:Reactome
P01375	TNF	Tumor necrosis factor	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
P01375	TNF	Tumor necrosis factor	GO:0019722; P:calcium-mediated signaling; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0001775; P:cell activation; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0008652; P:cellular amino acid biosynthetic process; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0071316; P:cellular response to nicotine; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0071407; P:cellular response to organic cyclic compound; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0002439; P:chronic inflammatory response to antigenic stimulus; IMP:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0050830; P:defense response to Gram-positive bacterium; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0048566; P:embryonic digestive tract development; IEP:DFLAT
P01375	TNF	Tumor necrosis factor	GO:0060664; P:epithelial cell proliferation involved in salivary gland morphogenesis; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0006006; P:glucose metabolic process; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0006959; P:humoral immune response; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0006954; P:inflammatory response; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0007254; P:JNK cascade; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0050901; P:leukocyte tethering or rolling; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0000165; P:MAPK cascade; IMP:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0097527; P:necroptotic signaling pathway; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0010693; P:negative regulation of alkaline phosphatase activity; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0061048; P:negative regulation of branching involved in lung morphogenesis; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0002740; P:negative regulation of cytokine secretion involved in immune response; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0045599; P:negative regulation of fat cell differentiation; NAS:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0046325; P:negative regulation of glucose import; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0044130; P:negative regulation of growth of symbiont in host; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0032715; P:negative regulation of interleukin-6 production; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0002037; P:negative regulation of L-glutamate transport; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0050995; P:negative regulation of lipid catabolic process; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0010888; P:negative regulation of lipid storage; NAS:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0043242; P:negative regulation of protein complex disassembly; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0045071; P:negative regulation of viral genome replication; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0009887; P:organ morphogenesis; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0030316; P:osteoclast differentiation; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0060559; P:positive regulation of calcidiol 1-monooxygenase activity; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:2000343; P:positive regulation of chemokine (C-X-C motif) ligand 2 production; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0045080; P:positive regulation of chemokine biosynthetic process; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0032722; P:positive regulation of chemokine production; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0002876; P:positive regulation of chronic inflammatory response to antigenic stimulus; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0001819; P:positive regulation of cytokine production; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0050715; P:positive regulation of cytokine secretion; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; NAS:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0031622; P:positive regulation of fever generation; ISS:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0051798; P:positive regulation of hair follicle development; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0034116; P:positive regulation of heterotypic cell-cell adhesion; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0002925; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0032729; P:positive regulation of interferon-gamma production; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0032741; P:positive regulation of interleukin-18 production; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0045416; P:positive regulation of interleukin-8 biosynthetic process; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0046330; P:positive regulation of JNK cascade; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0043507; P:positive regulation of JUN kinase activity; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0043406; P:positive regulation of MAP kinase activity; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0051044; P:positive regulation of membrane protein ectodomain proteolysis; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0045840; P:positive regulation of mitosis; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0071677; P:positive regulation of mononuclear cell migration; NAS:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0042346; P:positive regulation of NF-kappaB import into nucleus; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0051533; P:positive regulation of NFAT protein import into nucleus; IDA:MGI
P01375	TNF	Tumor necrosis factor	GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0045672; P:positive regulation of osteoclast differentiation; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0071803; P:positive regulation of podosome assembly; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0043068; P:positive regulation of programmed cell death; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0031334; P:positive regulation of protein complex assembly; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0043243; P:positive regulation of protein complex disassembly; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:2000010; P:positive regulation of protein localization to cell surface; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0051222; P:positive regulation of protein transport; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0050806; P:positive regulation of synaptic transmission; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0045994; P:positive regulation of translational initiation by iron; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0060557; P:positive regulation of vitamin D biosynthetic process; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0000060; P:protein import into nucleus, translocation; IDA:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0043491; P:protein kinase B signaling; IMP:UniProtKB
P01375	TNF	Tumor necrosis factor	GO:0032800; P:receptor biosynthetic process; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0060693; P:regulation of branching involved in salivary gland morphogenesis; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0043122; P:regulation of I-kappaB kinase/NF-kappaB signaling; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0051023; P:regulation of immunoglobulin secretion; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0050796; P:regulation of insulin secretion; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0014823; P:response to activity; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0042493; P:response to drug; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0051384; P:response to glucocorticoid; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0001666; P:response to hypoxia; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0009651; P:response to salt stress; TAS:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0009615; P:response to virus; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0030730; P:sequestering of triglyceride; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0003009; P:skeletal muscle contraction; IEA:Ensembl
P01375	TNF	Tumor necrosis factor	GO:0006927; P:transformed cell apoptotic process; IDA:BHF-UCL
P01375	TNF	Tumor necrosis factor	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IMP:BHF-UCL
P01374	LTA	Lymphotoxin-alpha	GO:0005102; F:receptor binding; TAS:ProtInc
P01374	LTA	Lymphotoxin-alpha	GO:0006915; P:apoptotic process; TAS:ProtInc
P01374	LTA	Lymphotoxin-alpha	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P01374	LTA	Lymphotoxin-alpha	GO:0050830; P:defense response to Gram-positive bacterium; IEA:Ensembl
P01374	LTA	Lymphotoxin-alpha	GO:0006959; P:humoral immune response; IEA:Ensembl
P01374	LTA	Lymphotoxin-alpha	GO:0048535; P:lymph node development; IEA:Ensembl
P01374	LTA	Lymphotoxin-alpha	GO:0048147; P:negative regulation of fibroblast proliferation; IEA:Ensembl
P01374	LTA	Lymphotoxin-alpha	GO:0044130; P:negative regulation of growth of symbiont in host; IEA:Ensembl
P01374	LTA	Lymphotoxin-alpha	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P01374	LTA	Lymphotoxin-alpha	GO:0002876; P:positive regulation of chronic inflammatory response to antigenic stimulus; IEA:Ensembl
P01374	LTA	Lymphotoxin-alpha	GO:0002925; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; IEA:Ensembl
P01374	LTA	Lymphotoxin-alpha	GO:0032729; P:positive regulation of interferon-gamma production; IEA:Ensembl
P01374	LTA	Lymphotoxin-alpha	GO:0042493; P:response to drug; IEA:Ensembl
P01374	LTA	Lymphotoxin-alpha	GO:0001666; P:response to hypoxia; IEA:Ensembl
P01374	LTA	Lymphotoxin-alpha	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P01374	LTA	Lymphotoxin-alpha	GO:0007584; P:response to nutrient; IEA:Ensembl
P01374	LTA	Lymphotoxin-alpha	GO:0007165; P:signal transduction; TAS:ProtInc
Q06643	LTB	Lymphotoxin-beta	GO:0005102; F:receptor binding; TAS:ProtInc
Q06643	LTB	Lymphotoxin-beta	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q06643	LTB	Lymphotoxin-beta	GO:0010467; P:gene expression; IEA:Ensembl
Q06643	LTB	Lymphotoxin-beta	GO:0006955; P:immune response; IEA:InterPro
Q06643	LTB	Lymphotoxin-beta	GO:0048535; P:lymph node development; IEA:Ensembl
Q06643	LTB	Lymphotoxin-beta	GO:0045084; P:positive regulation of interleukin-12 biosynthetic process; ISS:UniProtKB
Q06643	LTB	Lymphotoxin-beta	GO:0007165; P:signal transduction; TAS:ProtInc
Q06643	LTB	Lymphotoxin-beta	GO:0043588; P:skin development; IEA:Ensembl
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0005102; F:receptor binding; TAS:ProtInc
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0032813; F:tumor necrosis factor receptor superfamily binding; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0002526; P:acute inflammatory response; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0035783; P:CD4-positive, alpha-beta T cell costimulation; IEA:Ensembl
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0071222; P:cellular response to lipopolysaccharide; IDA:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0035714; P:cellular response to nitrogen dioxide; IEA:Ensembl
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0071380; P:cellular response to prostaglandin E stimulus; IDA:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0071954; P:chemokine (C-C motif) ligand 11 production; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0008203; P:cholesterol metabolic process; IEA:Ensembl
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0002215; P:defense response to nematode; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0006955; P:immune response; IEA:InterPro
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0035709; P:memory T cell activation; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0050710; P:negative regulation of cytokine secretion; IEA:Ensembl
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0032689; P:negative regulation of interferon-gamma production; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0032700; P:negative regulation of interleukin-17 production; IDA:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0045590; P:negative regulation of regulatory T cell differentiation; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0045626; P:negative regulation of T-helper 1 cell differentiation; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0042104; P:positive regulation of activated T cell proliferation; IEA:Ensembl
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0046641; P:positive regulation of alpha-beta T cell proliferation; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0050871; P:positive regulation of B cell activation; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:1900281; P:positive regulation of CD4-positive, alpha-beta T cell costimulation; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0043372; P:positive regulation of CD4-positive, alpha-beta T cell differentiation; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0002891; P:positive regulation of immunoglobulin mediated immune response; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0051024; P:positive regulation of immunoglobulin secretion; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0050729; P:positive regulation of inflammatory response; IDA:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0032729; P:positive regulation of interferon-gamma production; IDA:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0032733; P:positive regulation of interleukin-10 production; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0032735; P:positive regulation of interleukin-12 production; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0032736; P:positive regulation of interleukin-13 production; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0032743; P:positive regulation of interleukin-2 production; IEA:Ensembl
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0032753; P:positive regulation of interleukin-4 production; IDA:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:2000572; P:positive regulation of interleukin-4-dependent isotype switching to IgE isotypes; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0032755; P:positive regulation of interleukin-6 production; IDA:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:2000568; P:positive regulation of memory T cell activation; IEA:Ensembl
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0043382; P:positive regulation of memory T cell differentiation; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0002726; P:positive regulation of T cell cytokine production; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:2000570; P:positive regulation of T-helper 2 cell activation; IEA:Ensembl
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0045630; P:positive regulation of T-helper 2 cell differentiation; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0002830; P:positive regulation of type 2 immune response; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0002819; P:regulation of adaptive immune response; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0050727; P:regulation of inflammatory response; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0035713; P:response to nitrogen dioxide; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0009615; P:response to virus; ISS:BHF-UCL
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0007165; P:signal transduction; TAS:ProtInc
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0042098; P:T cell proliferation; IEA:Ensembl
P23510	TNFSF4	Tumor necrosis factor ligand superfamily member 4	GO:0035712; P:T-helper 2 cell activation; ISS:BHF-UCL
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0005515; F:protein binding; IPI:IntAct
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0005102; F:receptor binding; TAS:ProtInc
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:BHF-UCL
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0006915; P:apoptotic process; TAS:Reactome
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0097190; P:apoptotic signaling pathway; IDA:BHF-UCL
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0030644; P:cellular chloride ion homeostasis; IEA:Ensembl
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0048388; P:endosomal lumen acidification; IEA:Ensembl
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:UniProtKB
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IDA:BHF-UCL
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0006955; P:immune response; IEA:InterPro
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0006925; P:inflammatory cell apoptotic process; IEA:Ensembl
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0070266; P:necroptotic process; IDA:BHF-UCL
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0097527; P:necroptotic signaling pathway; IDA:BHF-UCL
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0016525; P:negative regulation of angiogenesis; IDA:BHF-UCL
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:2000353; P:positive regulation of endothelial cell apoptotic process; IDA:BHF-UCL
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0045742; P:positive regulation of epidermal growth factor receptor signaling pathway; IEA:Ensembl
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:2001239; P:regulation of extrinsic apoptotic signaling pathway in absence of ligand; TAS:Reactome
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0070848; P:response to growth factor; IEA:Ensembl
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0046666; P:retinal cell programmed cell death; IEA:Ensembl
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0007165; P:signal transduction; TAS:ProtInc
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0070231; P:T cell apoptotic process; IDA:UniProtKB
P48023	FASLG	Tumor necrosis factor ligand superfamily member 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P32971	TNFSF8	Tumor necrosis factor ligand superfamily member 8	GO:0005102; F:receptor binding; TAS:ProtInc
P32971	TNFSF8	Tumor necrosis factor ligand superfamily member 8	GO:0006915; P:apoptotic process; TAS:ProtInc
P32971	TNFSF8	Tumor necrosis factor ligand superfamily member 8	GO:0043374; P:CD8-positive, alpha-beta T cell differentiation; IEA:Ensembl
P32971	TNFSF8	Tumor necrosis factor ligand superfamily member 8	GO:0008283; P:cell proliferation; TAS:ProtInc
P32971	TNFSF8	Tumor necrosis factor ligand superfamily member 8	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P32971	TNFSF8	Tumor necrosis factor ligand superfamily member 8	GO:0050830; P:defense response to Gram-positive bacterium; IEA:Ensembl
P32971	TNFSF8	Tumor necrosis factor ligand superfamily member 8	GO:0006955; P:immune response; IEA:InterPro
P32971	TNFSF8	Tumor necrosis factor ligand superfamily member 8	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P32971	TNFSF8	Tumor necrosis factor ligand superfamily member 8	GO:0007165; P:signal transduction; TAS:ProtInc
P41273	TNFSF9	Tumor necrosis factor ligand superfamily member 9	GO:0005102; F:receptor binding; TAS:ProtInc
P41273	TNFSF9	Tumor necrosis factor ligand superfamily member 9	GO:0006915; P:apoptotic process; TAS:ProtInc
P41273	TNFSF9	Tumor necrosis factor ligand superfamily member 9	GO:0008283; P:cell proliferation; TAS:ProtInc
P41273	TNFSF9	Tumor necrosis factor ligand superfamily member 9	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P41273	TNFSF9	Tumor necrosis factor ligand superfamily member 9	GO:0006955; P:immune response; IEA:InterPro
P41273	TNFSF9	Tumor necrosis factor ligand superfamily member 9	GO:0043011; P:myeloid dendritic cell differentiation; IEA:Ensembl
P41273	TNFSF9	Tumor necrosis factor ligand superfamily member 9	GO:0042104; P:positive regulation of activated T cell proliferation; IEA:Ensembl
P41273	TNFSF9	Tumor necrosis factor ligand superfamily member 9	GO:0045585; P:positive regulation of cytotoxic T cell differentiation; IEA:Ensembl
P41273	TNFSF9	Tumor necrosis factor ligand superfamily member 9	GO:0032729; P:positive regulation of interferon-gamma production; IEA:Ensembl
P41273	TNFSF9	Tumor necrosis factor ligand superfamily member 9	GO:0032735; P:positive regulation of interleukin-12 production; IEA:Ensembl
P41273	TNFSF9	Tumor necrosis factor ligand superfamily member 9	GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl
P41273	TNFSF9	Tumor necrosis factor ligand superfamily member 9	GO:0007165; P:signal transduction; TAS:ProtInc
Q59H18	TNNI3K	Serine/threonine-protein kinase TNNI3K	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q59H18	TNNI3K	Serine/threonine-protein kinase TNNI3K	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q59H18	TNNI3K	Serine/threonine-protein kinase TNNI3K	GO:0005515; F:protein binding; IPI:IntAct
Q59H18	TNNI3K	Serine/threonine-protein kinase TNNI3K	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q59H18	TNNI3K	Serine/threonine-protein kinase TNNI3K	GO:0004672; F:protein kinase activity; IDA:UniProtKB
Q59H18	TNNI3K	Serine/threonine-protein kinase TNNI3K	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q59H18	TNNI3K	Serine/threonine-protein kinase TNNI3K	GO:0031013; F:troponin I binding; IPI:UniProtKB
Q59H18	TNNI3K	Serine/threonine-protein kinase TNNI3K	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9UKE5	TNIK	TRAF2 and NCK-interacting protein kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UKE5	TNIK	TRAF2 and NCK-interacting protein kinase	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKE5	TNIK	TRAF2 and NCK-interacting protein kinase	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9UKE5	TNIK	TRAF2 and NCK-interacting protein kinase	GO:0004702; F:receptor signaling protein serine/threonine kinase activity; IBA:RefGenome
Q9UKE5	TNIK	TRAF2 and NCK-interacting protein kinase	GO:0005083; F:small GTPase regulator activity; IEA:InterPro
Q9UKE5	TNIK	TRAF2 and NCK-interacting protein kinase	GO:0031532; P:actin cytoskeleton reorganization; IDA:UniProtKB
Q9UKE5	TNIK	TRAF2 and NCK-interacting protein kinase	GO:0007256; P:activation of JNKK activity; IDA:UniProtKB
Q9UKE5	TNIK	TRAF2 and NCK-interacting protein kinase	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q9UKE5	TNIK	TRAF2 and NCK-interacting protein kinase	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q9UKE5	TNIK	TRAF2 and NCK-interacting protein kinase	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q9UKE5	TNIK	TRAF2 and NCK-interacting protein kinase	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9UKE5	TNIK	TRAF2 and NCK-interacting protein kinase	GO:0048814; P:regulation of dendrite morphogenesis; IDA:UniProtKB
Q9UKE5	TNIK	TRAF2 and NCK-interacting protein kinase	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q15025	TNIP1	TNFAIP3-interacting protein 1	GO:0051019; F:mitogen-activated protein kinase binding; IDA:UniProtKB
Q15025	TNIP1	TNFAIP3-interacting protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q15025	TNIP1	TNFAIP3-interacting protein 1	GO:0006952; P:defense response; TAS:ProtInc
Q15025	TNIP1	TNFAIP3-interacting protein 1	GO:0009101; P:glycoprotein biosynthetic process; IDA:UniProtKB
Q15025	TNIP1	TNFAIP3-interacting protein 1	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q15025	TNIP1	TNFAIP3-interacting protein 1	GO:0007159; P:leukocyte cell-cell adhesion; IMP:UniProtKB
Q15025	TNIP1	TNFAIP3-interacting protein 1	GO:0085032; P:modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade; IDA:UniProtKB
Q15025	TNIP1	TNFAIP3-interacting protein 1	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; ISS:UniProtKB
Q15025	TNIP1	TNFAIP3-interacting protein 1	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
Q15025	TNIP1	TNFAIP3-interacting protein 1	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q15025	TNIP1	TNFAIP3-interacting protein 1	GO:0045071; P:negative regulation of viral genome replication; TAS:UniProtKB
Q15025	TNIP1	TNFAIP3-interacting protein 1	GO:0050729; P:positive regulation of inflammatory response; ISS:UniProtKB
Q15025	TNIP1	TNFAIP3-interacting protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q15025	TNIP1	TNFAIP3-interacting protein 1	GO:0006412; P:translation; TAS:ProtInc
Q8NFZ5	TNIP2	TNFAIP3-interacting protein 2	GO:0031593; F:polyubiquitin binding; IDA:UniProtKB
Q8NFZ5	TNIP2	TNFAIP3-interacting protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q8NFZ5	TNIP2	TNFAIP3-interacting protein 2	GO:0019901; F:protein kinase binding; IDA:UniProtKB
Q8NFZ5	TNIP2	TNFAIP3-interacting protein 2	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8NFZ5	TNIP2	TNFAIP3-interacting protein 2	GO:0023035; P:CD40 signaling pathway; ISS:UniProtKB
Q8NFZ5	TNIP2	TNFAIP3-interacting protein 2	GO:0071222; P:cellular response to lipopolysaccharide; ISS:UniProtKB
Q8NFZ5	TNIP2	TNFAIP3-interacting protein 2	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
Q8NFZ5	TNIP2	TNFAIP3-interacting protein 2	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q8NFZ5	TNIP2	TNFAIP3-interacting protein 2	GO:0070498; P:interleukin-1-mediated signaling pathway; ISS:UniProtKB
Q8NFZ5	TNIP2	TNFAIP3-interacting protein 2	GO:2000352; P:negative regulation of endothelial cell apoptotic process; IDA:UniProtKB
Q8NFZ5	TNIP2	TNFAIP3-interacting protein 2	GO:0050871; P:positive regulation of B cell activation; ISS:UniProtKB
Q8NFZ5	TNIP2	TNFAIP3-interacting protein 2	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q8NFZ5	TNIP2	TNFAIP3-interacting protein 2	GO:0043032; P:positive regulation of macrophage activation; ISS:UniProtKB
Q8NFZ5	TNIP2	TNFAIP3-interacting protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q8NFZ5	TNIP2	TNFAIP3-interacting protein 2	GO:0050821; P:protein stabilization; ISS:UniProtKB
Q8NFZ5	TNIP2	TNFAIP3-interacting protein 2	GO:0034134; P:toll-like receptor 2 signaling pathway; ISS:UniProtKB
Q8NFZ5	TNIP2	TNFAIP3-interacting protein 2	GO:0034138; P:toll-like receptor 3 signaling pathway; ISS:UniProtKB
Q8NFZ5	TNIP2	TNFAIP3-interacting protein 2	GO:0034162; P:toll-like receptor 9 signaling pathway; ISS:UniProtKB
Q8NFZ5	TNIP2	TNFAIP3-interacting protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96KP6	TNIP3	TNFAIP3-interacting protein 3	GO:0031593; F:polyubiquitin binding; IDA:UniProtKB
Q96KP6	TNIP3	TNFAIP3-interacting protein 3	GO:0071222; P:cellular response to lipopolysaccharide; IDA:UniProtKB
Q96KP6	TNIP3	TNFAIP3-interacting protein 3	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q96KP6	TNIP3	TNFAIP3-interacting protein 3	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; IDA:UniProtKB
Q96KP6	TNIP3	TNFAIP3-interacting protein 3	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q96KP6	TNIP3	TNFAIP3-interacting protein 3	GO:0034142; P:toll-like receptor 4 signaling pathway; IDA:UniProtKB
Q13470	TNK1	Non-receptor tyrosine-protein kinase TNK1	GO:0005524; F:ATP binding; IDA:UniProtKB
Q13470	TNK1	Non-receptor tyrosine-protein kinase TNK1	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; NAS:UniProtKB
Q13470	TNK1	Non-receptor tyrosine-protein kinase TNK1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13470	TNK1	Non-receptor tyrosine-protein kinase TNK1	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
Q13470	TNK1	Non-receptor tyrosine-protein kinase TNK1	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q13470	TNK1	Non-receptor tyrosine-protein kinase TNK1	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
Q13470	TNK1	Non-receptor tyrosine-protein kinase TNK1	GO:0046580; P:negative regulation of Ras protein signal transduction; IEA:Ensembl
Q13470	TNK1	Non-receptor tyrosine-protein kinase TNK1	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:GOC
Q13470	TNK1	Non-receptor tyrosine-protein kinase TNK1	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q13470	TNK1	Non-receptor tyrosine-protein kinase TNK1	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q13470	TNK1	Non-receptor tyrosine-protein kinase TNK1	GO:0007165; P:signal transduction; TAS:GOC
O95271	TNKS	Tankyrase-1	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IDA:UniProtKB
O95271	TNKS	Tankyrase-1	GO:0005515; F:protein binding; IPI:UniProtKB
O95271	TNKS	Tankyrase-1	GO:0008270; F:zinc ion binding; IDA:BHF-UCL
O95271	TNKS	Tankyrase-1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
O95271	TNKS	Tankyrase-1	GO:0007052; P:mitotic spindle organization; TAS:BHF-UCL
O95271	TNKS	Tankyrase-1	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
O95271	TNKS	Tankyrase-1	GO:0043392; P:negative regulation of DNA binding; IDA:BHF-UCL
O95271	TNKS	Tankyrase-1	GO:0018105; P:peptidyl-serine phosphorylation; IDA:MGI
O95271	TNKS	Tankyrase-1	GO:0018107; P:peptidyl-threonine phosphorylation; IDA:MGI
O95271	TNKS	Tankyrase-1	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:UniProtKB
O95271	TNKS	Tankyrase-1	GO:0032212; P:positive regulation of telomere maintenance via telomerase; IDA:BHF-UCL
O95271	TNKS	Tankyrase-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O95271	TNKS	Tankyrase-1	GO:0006471; P:protein ADP-ribosylation; IDA:BHF-UCL
O95271	TNKS	Tankyrase-1	GO:0070213; P:protein auto-ADP-ribosylation; IDA:UniProtKB
O95271	TNKS	Tankyrase-1	GO:0070198; P:protein localization to chromosome, telomeric region; IMP:BHF-UCL
O95271	TNKS	Tankyrase-1	GO:0070212; P:protein poly-ADP-ribosylation; IDA:BHF-UCL
O95271	TNKS	Tankyrase-1	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
O95271	TNKS	Tankyrase-1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O95271	TNKS	Tankyrase-1	GO:0032210; P:regulation of telomere maintenance via telomerase; IC:BHF-UCL
O95271	TNKS	Tankyrase-1	GO:0051225; P:spindle assembly; TAS:BHF-UCL
O95271	TNKS	Tankyrase-1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9H2K2	TNKS2	Tankyrase-2	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q9H2K2	TNKS2	Tankyrase-2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H2K2	TNKS2	Tankyrase-2	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IDA:UniProtKB
Q9H2K2	TNKS2	Tankyrase-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H2K2	TNKS2	Tankyrase-2	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q9H2K2	TNKS2	Tankyrase-2	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:UniProtKB
Q9H2K2	TNKS2	Tankyrase-2	GO:0032212; P:positive regulation of telomere maintenance via telomerase; IC:BHF-UCL
Q9H2K2	TNKS2	Tankyrase-2	GO:0006471; P:protein ADP-ribosylation; IDA:BHF-UCL
Q9H2K2	TNKS2	Tankyrase-2	GO:0070213; P:protein auto-ADP-ribosylation; IDA:UniProtKB
Q9H2K2	TNKS2	Tankyrase-2	GO:0070198; P:protein localization to chromosome, telomeric region; IMP:BHF-UCL
Q9H2K2	TNKS2	Tankyrase-2	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q9H2K2	TNKS2	Tankyrase-2	GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl
Q9H2K2	TNKS2	Tankyrase-2	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9H2S6	TNMD	Tenomodulin	GO:0071773; P:cellular response to BMP stimulus; IEA:Ensembl
Q9H2S6	TNMD	Tenomodulin	GO:0001886; P:endothelial cell morphogenesis; IEA:Ensembl
Q9H2S6	TNMD	Tenomodulin	GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl
Q9H2S6	TNMD	Tenomodulin	GO:0001937; P:negative regulation of endothelial cell proliferation; IEA:Ensembl
Q9H2S6	TNMD	Tenomodulin	GO:0035990; P:tendon cell differentiation; IEA:Ensembl
P63316	TNNC1	Troponin C, slow skeletal and cardiac muscles	GO:0051015; F:actin filament binding; ISS:BHF-UCL
P63316	TNNC1	Troponin C, slow skeletal and cardiac muscles	GO:0005509; F:calcium ion binding; IDA:BHF-UCL
P63316	TNNC1	Troponin C, slow skeletal and cardiac muscles	GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB
P63316	TNNC1	Troponin C, slow skeletal and cardiac muscles	GO:0005515; F:protein binding; IPI:UniProtKB
P63316	TNNC1	Troponin C, slow skeletal and cardiac muscles	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
P63316	TNNC1	Troponin C, slow skeletal and cardiac muscles	GO:0031013; F:troponin I binding; IPI:UniProtKB
P63316	TNNC1	Troponin C, slow skeletal and cardiac muscles	GO:0031014; F:troponin T binding; IPI:UniProtKB
P63316	TNNC1	Troponin C, slow skeletal and cardiac muscles	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
P63316	TNNC1	Troponin C, slow skeletal and cardiac muscles	GO:0002086; P:diaphragm contraction; IEA:Ensembl
P63316	TNNC1	Troponin C, slow skeletal and cardiac muscles	GO:0030049; P:muscle filament sliding; TAS:Reactome
P63316	TNNC1	Troponin C, slow skeletal and cardiac muscles	GO:0043462; P:regulation of ATPase activity; ISS:BHF-UCL
P63316	TNNC1	Troponin C, slow skeletal and cardiac muscles	GO:0006937; P:regulation of muscle contraction; TAS:UniProtKB
P63316	TNNC1	Troponin C, slow skeletal and cardiac muscles	GO:0032972; P:regulation of muscle filament sliding speed; ISS:BHF-UCL
P63316	TNNC1	Troponin C, slow skeletal and cardiac muscles	GO:0010038; P:response to metal ion; IEA:Ensembl
P63316	TNNC1	Troponin C, slow skeletal and cardiac muscles	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IMP:BHF-UCL
P02585	TNNC2	Troponin C, skeletal muscle	GO:0005509; F:calcium ion binding; IEA:InterPro
P02585	TNNC2	Troponin C, skeletal muscle	GO:0030049; P:muscle filament sliding; TAS:Reactome
P02585	TNNC2	Troponin C, skeletal muscle	GO:0006937; P:regulation of muscle contraction; TAS:ProtInc
P02585	TNNC2	Troponin C, skeletal muscle	GO:0003009; P:skeletal muscle contraction; IDA:UniProtKB
P19237	TNNI1	Troponin I, slow skeletal muscle	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P19237	TNNI1	Troponin I, slow skeletal muscle	GO:0030049; P:muscle filament sliding; TAS:Reactome
P19237	TNNI1	Troponin I, slow skeletal muscle	GO:0006942; P:regulation of striated muscle contraction; NAS:UniProtKB
P19237	TNNI1	Troponin I, slow skeletal muscle	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IEA:Ensembl
P48788	TNNI2	Troponin I, fast skeletal muscle	GO:0005515; F:protein binding; IPI:UniProtKB
P48788	TNNI2	Troponin I, fast skeletal muscle	GO:0031014; F:troponin T binding; IPI:UniProtKB
P48788	TNNI2	Troponin I, fast skeletal muscle	GO:0030049; P:muscle filament sliding; TAS:Reactome
P48788	TNNI2	Troponin I, fast skeletal muscle	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P48788	TNNI2	Troponin I, fast skeletal muscle	GO:0003009; P:skeletal muscle contraction; IDA:UniProtKB
P19429	TNNI3	Troponin I, cardiac muscle	GO:0003779; F:actin binding; IDA:UniProtKB
P19429	TNNI3	Troponin I, cardiac muscle	GO:0019855; F:calcium channel inhibitor activity; IPI:UniProtKB
P19429	TNNI3	Troponin I, cardiac muscle	GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB
P19429	TNNI3	Troponin I, cardiac muscle	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P19429	TNNI3	Troponin I, cardiac muscle	GO:0005515; F:protein binding; IPI:UniProtKB
P19429	TNNI3	Troponin I, cardiac muscle	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P19429	TNNI3	Troponin I, cardiac muscle	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P19429	TNNI3	Troponin I, cardiac muscle	GO:0030172; F:troponin C binding; IPI:UniProtKB
P19429	TNNI3	Troponin I, cardiac muscle	GO:0031014; F:troponin T binding; IPI:UniProtKB
P19429	TNNI3	Troponin I, cardiac muscle	GO:0060048; P:cardiac muscle contraction; IMP:UniProtKB
P19429	TNNI3	Troponin I, cardiac muscle	GO:0006874; P:cellular calcium ion homeostasis; ISS:UniProtKB
P19429	TNNI3	Troponin I, cardiac muscle	GO:0060047; P:heart contraction; IMP:UniProtKB
P19429	TNNI3	Troponin I, cardiac muscle	GO:0007507; P:heart development; ISS:UniProtKB
P19429	TNNI3	Troponin I, cardiac muscle	GO:0030049; P:muscle filament sliding; TAS:Reactome
P19429	TNNI3	Troponin I, cardiac muscle	GO:0032780; P:negative regulation of ATPase activity; IDA:UniProtKB
P19429	TNNI3	Troponin I, cardiac muscle	GO:0006940; P:regulation of smooth muscle contraction; IEA:Ensembl
P19429	TNNI3	Troponin I, cardiac muscle	GO:0001980; P:regulation of systemic arterial blood pressure by ischemic conditions; ISS:UniProtKB
P19429	TNNI3	Troponin I, cardiac muscle	GO:0001570; P:vasculogenesis; ISS:UniProtKB
P19429	TNNI3	Troponin I, cardiac muscle	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IMP:BHF-UCL
P13805	TNNT1	Troponin T, slow skeletal muscle	GO:0005523; F:tropomyosin binding; IMP:UniProtKB
P13805	TNNT1	Troponin T, slow skeletal muscle	GO:0030049; P:muscle filament sliding; TAS:Reactome
P13805	TNNT1	Troponin T, slow skeletal muscle	GO:0045932; P:negative regulation of muscle contraction; IDA:UniProtKB
P13805	TNNT1	Troponin T, slow skeletal muscle	GO:0003009; P:skeletal muscle contraction; IMP:UniProtKB
P13805	TNNT1	Troponin T, slow skeletal muscle	GO:0031444; P:slow-twitch skeletal muscle fiber contraction; IEA:Ensembl
P45379	TNNT2	Troponin T, cardiac muscle	GO:0003779; F:actin binding; IDA:UniProtKB
P45379	TNNT2	Troponin T, cardiac muscle	GO:0005200; F:structural constituent of cytoskeleton; IEA:Ensembl
P45379	TNNT2	Troponin T, cardiac muscle	GO:0005523; F:tropomyosin binding; IDA:UniProtKB
P45379	TNNT2	Troponin T, cardiac muscle	GO:0030172; F:troponin C binding; IPI:UniProtKB
P45379	TNNT2	Troponin T, cardiac muscle	GO:0031013; F:troponin I binding; IPI:UniProtKB
P45379	TNNT2	Troponin T, cardiac muscle	GO:0006200; P:ATP catabolic process; IDA:GOC
P45379	TNNT2	Troponin T, cardiac muscle	GO:0055009; P:atrial cardiac muscle tissue morphogenesis; IEA:Ensembl
P45379	TNNT2	Troponin T, cardiac muscle	GO:0030049; P:muscle filament sliding; IDA:UniProtKB
P45379	TNNT2	Troponin T, cardiac muscle	GO:0032780; P:negative regulation of ATPase activity; IDA:UniProtKB
P45379	TNNT2	Troponin T, cardiac muscle	GO:0032781; P:positive regulation of ATPase activity; IDA:UniProtKB
P45379	TNNT2	Troponin T, cardiac muscle	GO:0008016; P:regulation of heart contraction; IMP:UniProtKB
P45379	TNNT2	Troponin T, cardiac muscle	GO:0006937; P:regulation of muscle contraction; IEA:InterPro
P45379	TNNT2	Troponin T, cardiac muscle	GO:0051592; P:response to calcium ion; IDA:UniProtKB
P45379	TNNT2	Troponin T, cardiac muscle	GO:0045214; P:sarcomere organization; IEA:Ensembl
P45379	TNNT2	Troponin T, cardiac muscle	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IMP:BHF-UCL
P45378	TNNT3	Troponin T, fast skeletal muscle	GO:0048306; F:calcium-dependent protein binding; IDA:UniProtKB
P45378	TNNT3	Troponin T, fast skeletal muscle	GO:0005523; F:tropomyosin binding; IMP:UniProtKB
P45378	TNNT3	Troponin T, fast skeletal muscle	GO:0030172; F:troponin C binding; IPI:UniProtKB
P45378	TNNT3	Troponin T, fast skeletal muscle	GO:0031013; F:troponin I binding; IPI:UniProtKB
P45378	TNNT3	Troponin T, fast skeletal muscle	GO:0006200; P:ATP catabolic process; IDA:GOC
P45378	TNNT3	Troponin T, fast skeletal muscle	GO:0030049; P:muscle filament sliding; TAS:Reactome
P45378	TNNT3	Troponin T, fast skeletal muscle	GO:0043462; P:regulation of ATPase activity; IDA:UniProtKB
P45378	TNNT3	Troponin T, fast skeletal muscle	GO:0006942; P:regulation of striated muscle contraction; IDA:UniProtKB
P45378	TNNT3	Troponin T, fast skeletal muscle	GO:0003009; P:skeletal muscle contraction; IDA:UniProtKB
Q92973	TNPO1	Transportin-1	GO:0008139; F:nuclear localization sequence binding; TAS:ProtInc
Q92973	TNPO1	Transportin-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q92973	TNPO1	Transportin-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q92973	TNPO1	Transportin-1	GO:0010467; P:gene expression; TAS:Reactome
Q92973	TNPO1	Transportin-1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q92973	TNPO1	Transportin-1	GO:0000060; P:protein import into nucleus, translocation; TAS:ProtInc
Q92973	TNPO1	Transportin-1	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q92973	TNPO1	Transportin-1	GO:0016032; P:viral process; IEA:UniProtKB-KW
O14787	TNPO2	Transportin-2	GO:0008139; F:nuclear localization sequence binding; TAS:ProtInc
O14787	TNPO2	Transportin-2	GO:0005515; F:protein binding; IPI:UniProtKB
O14787	TNPO2	Transportin-2	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9Y5L0	TNPO3	Transportin-3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y5L0	TNPO3	Transportin-3	GO:0004872; F:receptor activity; TAS:ProtInc
Q9Y5L0	TNPO3	Transportin-3	GO:0035048; P:splicing factor protein import into nucleus; IDA:UniProtKB
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0019955; F:cytokine binding; IPI:BHF-UCL
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0004872; F:receptor activity; TAS:ProtInc
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0004888; F:transmembrane signaling receptor activity; IDA:BHF-UCL
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0005031; F:tumor necrosis factor-activated receptor activity; ISS:BHF-UCL
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0002250; P:adaptive immune response; IMP:BHF-UCL
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0060086; P:circadian temperature homeostasis; ISS:BHF-UCL
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0048535; P:lymph node development; IEA:Ensembl
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0060749; P:mammary gland alveolus development; IEA:Ensembl
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0002548; P:monocyte chemotaxis; NAS:BHF-UCL
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0001503; P:ossification; IEA:Ensembl
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0030316; P:osteoclast differentiation; IMP:BHF-UCL
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0071848; P:positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling; IMP:BHF-UCL
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0071812; P:positive regulation of fever generation by positive regulation of prostaglandin secretion; ISS:BHF-UCL
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0043507; P:positive regulation of JUN kinase activity; IMP:BHF-UCL
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:BHF-UCL
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0034097; P:response to cytokine; IMP:BHF-UCL
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0070555; P:response to interleukin-1; ISS:BHF-UCL
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0032496; P:response to lipopolysaccharide; ISS:BHF-UCL
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0009314; P:response to radiation; IEA:Ensembl
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0034612; P:response to tumor necrosis factor; ISS:BHF-UCL
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0071847; P:TNFSF11-mediated signaling pathway; IMP:BHF-UCL
Q9Y6Q6	TNFRSF11A	Tumor necrosis factor receptor superfamily member 11A	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; ISS:BHF-UCL
Q9NP84	TNFRSF12A	Tumor necrosis factor receptor superfamily member 12A	GO:0005515; F:protein binding; IPI:IntAct
Q9NP84	TNFRSF12A	Tumor necrosis factor receptor superfamily member 12A	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q9NP84	TNFRSF12A	Tumor necrosis factor receptor superfamily member 12A	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9NP84	TNFRSF12A	Tumor necrosis factor receptor superfamily member 12A	GO:0006928; P:cellular component movement; TAS:ProtInc
Q9NP84	TNFRSF12A	Tumor necrosis factor receptor superfamily member 12A	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q9NP84	TNFRSF12A	Tumor necrosis factor receptor superfamily member 12A	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProt
Q9NP84	TNFRSF12A	Tumor necrosis factor receptor superfamily member 12A	GO:0045773; P:positive regulation of axon extension; IEA:Ensembl
Q9NP84	TNFRSF12A	Tumor necrosis factor receptor superfamily member 12A	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB
Q9NP84	TNFRSF12A	Tumor necrosis factor receptor superfamily member 12A	GO:0006931; P:substrate-dependent cell migration, cell attachment to substrate; IEA:Ensembl
Q92956	TNFRSF14	Tumor necrosis factor receptor superfamily member 14	GO:0005515; F:protein binding; IPI:IntAct
Q92956	TNFRSF14	Tumor necrosis factor receptor superfamily member 14	GO:0005031; F:tumor necrosis factor-activated receptor activity; TAS:ProtInc
Q92956	TNFRSF14	Tumor necrosis factor receptor superfamily member 14	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q92956	TNFRSF14	Tumor necrosis factor receptor superfamily member 14	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
Q92956	TNFRSF14	Tumor necrosis factor receptor superfamily member 14	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q92956	TNFRSF14	Tumor necrosis factor receptor superfamily member 14	GO:0050829; P:defense response to Gram-negative bacterium; IEA:Ensembl
Q92956	TNFRSF14	Tumor necrosis factor receptor superfamily member 14	GO:0050830; P:defense response to Gram-positive bacterium; IEA:Ensembl
Q92956	TNFRSF14	Tumor necrosis factor receptor superfamily member 14	GO:0006955; P:immune response; TAS:ProtInc
Q92956	TNFRSF14	Tumor necrosis factor receptor superfamily member 14	GO:0046642; P:negative regulation of alpha-beta T cell proliferation; IEA:Ensembl
Q92956	TNFRSF14	Tumor necrosis factor receptor superfamily member 14	GO:0002741; P:positive regulation of cytokine secretion involved in immune response; IEA:Ensembl
Q92956	TNFRSF14	Tumor necrosis factor receptor superfamily member 14	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl
Q92956	TNFRSF14	Tumor necrosis factor receptor superfamily member 14	GO:2000406; P:positive regulation of T cell migration; IEA:Ensembl
Q92956	TNFRSF14	Tumor necrosis factor receptor superfamily member 14	GO:0031295; P:T cell costimulation; TAS:Reactome
Q92956	TNFRSF14	Tumor necrosis factor receptor superfamily member 14	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; TAS:GOC
Q92956	TNFRSF14	Tumor necrosis factor receptor superfamily member 14	GO:0016032; P:viral process; IEA:UniProtKB-KW
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0005035; F:death receptor activity; IEA:Ensembl
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0005515; F:protein binding; IPI:IntAct
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0017137; F:Rab GTPase binding; ISS:UniProtKB
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0004872; F:receptor activity; TAS:ProtInc
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0004871; F:signal transducer activity; TAS:ProtInc
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0007411; P:axon guidance; IEA:Ensembl
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0007417; P:central nervous system development; IEA:Ensembl
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0016048; P:detection of temperature stimulus; IEA:Ensembl
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0042593; P:glucose homeostasis; ISS:UniProtKB
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0006886; P:intracellular protein transport; ISS:UniProtKB
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0031293; P:membrane protein intracellular domain proteolysis; TAS:Reactome
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0050771; P:negative regulation of axonogenesis; TAS:Reactome
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0045786; P:negative regulation of cell cycle; TAS:Reactome
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0040037; P:negative regulation of fibroblast growth factor receptor signaling pathway; IEA:Ensembl
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0051799; P:negative regulation of hair follicle development; IEA:Ensembl
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0021675; P:nerve development; IEA:Ensembl
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0050772; P:positive regulation of axonogenesis; TAS:Reactome
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0042488; P:positive regulation of odontogenesis of dentin-containing tooth; IEA:Ensembl
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0050770; P:regulation of axonogenesis; TAS:Reactome
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0043281; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:Reactome
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:0010468; P:regulation of gene expression; IEA:Ensembl
P08138	NGFR	Tumor necrosis factor receptor superfamily member 16	GO:2001273; P:regulation of glucose import in response to insulin stimulus; ISS:UniProtKB
Q02223	TNFRSF17	Tumor necrosis factor receptor superfamily member 17	GO:0004872; F:receptor activity; TAS:ProtInc
Q02223	TNFRSF17	Tumor necrosis factor receptor superfamily member 17	GO:0008283; P:cell proliferation; TAS:ProtInc
Q02223	TNFRSF17	Tumor necrosis factor receptor superfamily member 17	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q02223	TNFRSF17	Tumor necrosis factor receptor superfamily member 17	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q02223	TNFRSF17	Tumor necrosis factor receptor superfamily member 17	GO:0007165; P:signal transduction; TAS:ProtInc
Q9NS68	TNFRSF19	Tumor necrosis factor receptor superfamily member 19	GO:0005031; F:tumor necrosis factor-activated receptor activity; NAS:UniProtKB
Q9NS68	TNFRSF19	Tumor necrosis factor receptor superfamily member 19	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q9NS68	TNFRSF19	Tumor necrosis factor receptor superfamily member 19	GO:0001942; P:hair follicle development; IEA:Ensembl
Q9NS68	TNFRSF19	Tumor necrosis factor receptor superfamily member 19	GO:0007254; P:JNK cascade; NAS:UniProtKB
Q9NS68	TNFRSF19	Tumor necrosis factor receptor superfamily member 19	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
Q9NS68	TNFRSF19	Tumor necrosis factor receptor superfamily member 19	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; NAS:GOC
Q9Y5U5	TNFRSF18	Tumor necrosis factor receptor superfamily member 18	GO:0005031; F:tumor necrosis factor-activated receptor activity; TAS:ProtInc
Q9Y5U5	TNFRSF18	Tumor necrosis factor receptor superfamily member 18	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9Y5U5	TNFRSF18	Tumor necrosis factor receptor superfamily member 18	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
Q9Y5U5	TNFRSF18	Tumor necrosis factor receptor superfamily member 18	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y5U5	TNFRSF18	Tumor necrosis factor receptor superfamily member 18	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; TAS:GOC
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0005515; F:protein binding; IPI:UniProtKB
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0005031; F:tumor necrosis factor-activated receptor activity; TAS:UniProtKB
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0006915; P:apoptotic process; TAS:Reactome
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0071392; P:cellular response to estradiol stimulus; IEA:Ensembl
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0019221; P:cytokine-mediated signaling pathway; ISS:UniProtKB
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0042742; P:defense response to bacterium; IEA:Ensembl
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; TAS:BHF-UCL
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0006954; P:inflammatory response; ISS:UniProtKB
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0050728; P:negative regulation of inflammatory response; IMP:BHF-UCL
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0032715; P:negative regulation of interleukin-6 production; IEA:Ensembl
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0050729; P:positive regulation of inflammatory response; ISS:UniProtKB
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0033160; P:positive regulation of protein import into nucleus, translocation; IEA:Ensembl
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0032760; P:positive regulation of tumor necrosis factor production; IEA:Ensembl
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0042511; P:positive regulation of tyrosine phosphorylation of Stat1 protein; IMP:BHF-UCL
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0006693; P:prostaglandin metabolic process; IEA:InterPro
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0043279; P:response to alkaloid; IEA:Ensembl
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0043200; P:response to amino acid; IEA:Ensembl
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0045471; P:response to ethanol; IEA:Ensembl
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0001666; P:response to hypoxia; IEA:Ensembl
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0033013; P:tetrapyrrole metabolic process; IEA:Ensembl
P19438	TNFRSF1A	Tumor necrosis factor receptor superfamily member 1A	GO:0016032; P:viral process; IEA:UniProtKB-KW
P20333	TNFRSF1B	Tumor necrosis factor receptor superfamily member 1B	GO:0005515; F:protein binding; IPI:UniProtKB
P20333	TNFRSF1B	Tumor necrosis factor receptor superfamily member 1B	GO:0005031; F:tumor necrosis factor-activated receptor activity; TAS:ProtInc
P20333	TNFRSF1B	Tumor necrosis factor receptor superfamily member 1B	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P20333	TNFRSF1B	Tumor necrosis factor receptor superfamily member 1B	GO:0007568; P:aging; IEA:Ensembl
P20333	TNFRSF1B	Tumor necrosis factor receptor superfamily member 1B	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P20333	TNFRSF1B	Tumor necrosis factor receptor superfamily member 1B	GO:0071222; P:cellular response to lipopolysaccharide; IMP:BHF-UCL
P20333	TNFRSF1B	Tumor necrosis factor receptor superfamily member 1B	GO:0006955; P:immune response; IEA:Ensembl
P20333	TNFRSF1B	Tumor necrosis factor receptor superfamily member 1B	GO:0006954; P:inflammatory response; IEA:Ensembl
P20333	TNFRSF1B	Tumor necrosis factor receptor superfamily member 1B	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
P20333	TNFRSF1B	Tumor necrosis factor receptor superfamily member 1B	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
P20333	TNFRSF1B	Tumor necrosis factor receptor superfamily member 1B	GO:0051044; P:positive regulation of membrane protein ectodomain proteolysis; IMP:BHF-UCL
P20333	TNFRSF1B	Tumor necrosis factor receptor superfamily member 1B	GO:0050779; P:RNA destabilization; IEA:Ensembl
O75509	TNFRSF21	Tumor necrosis factor receptor superfamily member 21	GO:0005515; F:protein binding; IPI:IntAct
O75509	TNFRSF21	Tumor necrosis factor receptor superfamily member 21	GO:0002250; P:adaptive immune response; ISS:UniProtKB
O75509	TNFRSF21	Tumor necrosis factor receptor superfamily member 21	GO:0006915; P:apoptotic process; IMP:UniProtKB
O75509	TNFRSF21	Tumor necrosis factor receptor superfamily member 21	GO:0001783; P:B cell apoptotic process; ISS:UniProtKB
O75509	TNFRSF21	Tumor necrosis factor receptor superfamily member 21	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O75509	TNFRSF21	Tumor necrosis factor receptor superfamily member 21	GO:0071356; P:cellular response to tumor necrosis factor; IDA:UniProtKB
O75509	TNFRSF21	Tumor necrosis factor receptor superfamily member 21	GO:0006959; P:humoral immune response; ISS:UniProtKB
O75509	TNFRSF21	Tumor necrosis factor receptor superfamily member 21	GO:0042552; P:myelination; ISS:UniProtKB
O75509	TNFRSF21	Tumor necrosis factor receptor superfamily member 21	GO:0030889; P:negative regulation of B cell proliferation; ISS:UniProtKB
O75509	TNFRSF21	Tumor necrosis factor receptor superfamily member 21	GO:2001180; P:negative regulation of interleukin-10 secretion; ISS:UniProtKB
O75509	TNFRSF21	Tumor necrosis factor receptor superfamily member 21	GO:2000666; P:negative regulation of interleukin-13 secretion; ISS:UniProtKB
O75509	TNFRSF21	Tumor necrosis factor receptor superfamily member 21	GO:2000663; P:negative regulation of interleukin-5 secretion; ISS:UniProtKB
O75509	TNFRSF21	Tumor necrosis factor receptor superfamily member 21	GO:0031642; P:negative regulation of myelination; IMP:UniProtKB
O75509	TNFRSF21	Tumor necrosis factor receptor superfamily member 21	GO:0042130; P:negative regulation of T cell proliferation; ISS:UniProtKB
O75509	TNFRSF21	Tumor necrosis factor receptor superfamily member 21	GO:0051402; P:neuron apoptotic process; ISS:UniProtKB
O75509	TNFRSF21	Tumor necrosis factor receptor superfamily member 21	GO:0097252; P:oligodendrocyte apoptotic process; ISS:UniProtKB
O75509	TNFRSF21	Tumor necrosis factor receptor superfamily member 21	GO:0048713; P:regulation of oligodendrocyte differentiation; ISS:UniProtKB
O75509	TNFRSF21	Tumor necrosis factor receptor superfamily member 21	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O75509	TNFRSF21	Tumor necrosis factor receptor superfamily member 21	GO:0050852; P:T cell receptor signaling pathway; ISS:UniProtKB
Q93038	TNFRSF25	Tumor necrosis factor receptor superfamily member 25	GO:0004872; F:receptor activity; NAS:UniProtKB
Q93038	TNFRSF25	Tumor necrosis factor receptor superfamily member 25	GO:0005031; F:tumor necrosis factor-activated receptor activity; TAS:ProtInc
Q93038	TNFRSF25	Tumor necrosis factor receptor superfamily member 25	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q93038	TNFRSF25	Tumor necrosis factor receptor superfamily member 25	GO:0097190; P:apoptotic signaling pathway; TAS:ProtInc
Q93038	TNFRSF25	Tumor necrosis factor receptor superfamily member 25	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q93038	TNFRSF25	Tumor necrosis factor receptor superfamily member 25	GO:0042981; P:regulation of apoptotic process; NAS:UniProtKB
Q93038	TNFRSF25	Tumor necrosis factor receptor superfamily member 25	GO:0007165; P:signal transduction; TAS:ProtInc
Q93038	TNFRSF25	Tumor necrosis factor receptor superfamily member 25	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; TAS:GOC
Q9HAV5	EDA2R	Tumor necrosis factor receptor superfamily member 27	GO:0005515; F:protein binding; IPI:HGNC
Q9HAV5	EDA2R	Tumor necrosis factor receptor superfamily member 27	GO:0004872; F:receptor activity; IDA:HGNC
Q9HAV5	EDA2R	Tumor necrosis factor receptor superfamily member 27	GO:0005031; F:tumor necrosis factor-activated receptor activity; NAS:UniProtKB
Q9HAV5	EDA2R	Tumor necrosis factor receptor superfamily member 27	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9HAV5	EDA2R	Tumor necrosis factor receptor superfamily member 27	GO:0009790; P:embryo development; NAS:HGNC
Q9HAV5	EDA2R	Tumor necrosis factor receptor superfamily member 27	GO:0008544; P:epidermis development; NAS:UniProtKB
Q9HAV5	EDA2R	Tumor necrosis factor receptor superfamily member 27	GO:0046330; P:positive regulation of JNK cascade; IDA:HGNC
Q9HAV5	EDA2R	Tumor necrosis factor receptor superfamily member 27	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:HGNC
Q9HAV5	EDA2R	Tumor necrosis factor receptor superfamily member 27	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; NAS:GOC
P36941	LTBR	Tumor necrosis factor receptor superfamily member 3	GO:0042802; F:identical protein binding; IPI:IntAct
P36941	LTBR	Tumor necrosis factor receptor superfamily member 3	GO:0005515; F:protein binding; IPI:UniProtKB
P36941	LTBR	Tumor necrosis factor receptor superfamily member 3	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P36941	LTBR	Tumor necrosis factor receptor superfamily member 3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P36941	LTBR	Tumor necrosis factor receptor superfamily member 3	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
P36941	LTBR	Tumor necrosis factor receptor superfamily member 3	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB
P36941	LTBR	Tumor necrosis factor receptor superfamily member 3	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
P36941	LTBR	Tumor necrosis factor receptor superfamily member 3	GO:0046330; P:positive regulation of JNK cascade; IMP:UniProtKB
P36941	LTBR	Tumor necrosis factor receptor superfamily member 3	GO:0007165; P:signal transduction; TAS:ProtInc
P36941	LTBR	Tumor necrosis factor receptor superfamily member 3	GO:0016032; P:viral process; IEA:UniProtKB-KW
P43489	TNFRSF4	Tumor necrosis factor receptor superfamily member 4	GO:0005031; F:tumor necrosis factor-activated receptor activity; TAS:ProtInc
P43489	TNFRSF4	Tumor necrosis factor receptor superfamily member 4	GO:0006968; P:cellular defense response; IEA:Ensembl
P43489	TNFRSF4	Tumor necrosis factor receptor superfamily member 4	GO:0006955; P:immune response; TAS:ProtInc
P43489	TNFRSF4	Tumor necrosis factor receptor superfamily member 4	GO:0006954; P:inflammatory response; IEA:Ensembl
P43489	TNFRSF4	Tumor necrosis factor receptor superfamily member 4	GO:0050710; P:negative regulation of cytokine secretion; IEA:Ensembl
P43489	TNFRSF4	Tumor necrosis factor receptor superfamily member 4	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
P43489	TNFRSF4	Tumor necrosis factor receptor superfamily member 4	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:BHF-UCL
P43489	TNFRSF4	Tumor necrosis factor receptor superfamily member 4	GO:0030890; P:positive regulation of B cell proliferation; ISS:BHF-UCL
P43489	TNFRSF4	Tumor necrosis factor receptor superfamily member 4	GO:0051024; P:positive regulation of immunoglobulin secretion; ISS:BHF-UCL
P43489	TNFRSF4	Tumor necrosis factor receptor superfamily member 4	GO:0042981; P:regulation of apoptotic process; IEA:Ensembl
P43489	TNFRSF4	Tumor necrosis factor receptor superfamily member 4	GO:0045859; P:regulation of protein kinase activity; IEA:Ensembl
P43489	TNFRSF4	Tumor necrosis factor receptor superfamily member 4	GO:0042098; P:T cell proliferation; ISS:BHF-UCL
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0003823; F:antigen binding; IEA:Ensembl
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0019899; F:enzyme binding; IPI:UniProtKB
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0005515; F:protein binding; IPI:UniProtKB
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0004872; F:receptor activity; TAS:ProtInc
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0004871; F:signal transducer activity; TAS:ProtInc
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0042100; P:B cell proliferation; NAS:UniProtKB
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0006874; P:cellular calcium ion homeostasis; IMP:BHF-UCL
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0051607; P:defense response to virus; IEA:Ensembl
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0002768; P:immune response-regulating cell surface receptor signaling pathway; IEA:Ensembl
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0006954; P:inflammatory response; TAS:ProtInc
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0030168; P:platelet activation; NAS:UniProtKB
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0030890; P:positive regulation of B cell proliferation; IEA:Ensembl
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0043089; P:positive regulation of Cdc42 GTPase activity; IMP:BHF-UCL
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:2000353; P:positive regulation of endothelial cell apoptotic process; IDA:BHF-UCL
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0032735; P:positive regulation of interleukin-12 production; IEA:Ensembl
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0048304; P:positive regulation of isotype switching to IgG isotypes; IEA:Ensembl
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0043406; P:positive regulation of MAP kinase activity; IMP:BHF-UCL
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:BHF-UCL
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0090037; P:positive regulation of protein kinase C signaling; IMP:BHF-UCL
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0001934; P:positive regulation of protein phosphorylation; IMP:BHF-UCL
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0032855; P:positive regulation of Rac GTPase activity; IMP:BHF-UCL
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0042511; P:positive regulation of tyrosine phosphorylation of Stat1 protein; IMP:BHF-UCL
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0006461; P:protein complex assembly; TAS:ProtInc
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0050776; P:regulation of immune response; TAS:Reactome
P25942	CD40	Tumor necrosis factor receptor superfamily member 5	GO:0051023; P:regulation of immunoglobulin secretion; IEA:Ensembl
Q8NDV7	TNRC6A	Trinucleotide repeat-containing gene 6A protein	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8NDV7	TNRC6A	Trinucleotide repeat-containing gene 6A protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8NDV7	TNRC6A	Trinucleotide repeat-containing gene 6A protein	GO:0005515; F:protein binding; IPI:IntAct
Q8NDV7	TNRC6A	Trinucleotide repeat-containing gene 6A protein	GO:0009267; P:cellular response to starvation; IEA:Ensembl
Q8NDV7	TNRC6A	Trinucleotide repeat-containing gene 6A protein	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q8NDV7	TNRC6A	Trinucleotide repeat-containing gene 6A protein	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q8NDV7	TNRC6A	Trinucleotide repeat-containing gene 6A protein	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q8NDV7	TNRC6A	Trinucleotide repeat-containing gene 6A protein	GO:0010467; P:gene expression; TAS:Reactome
Q8NDV7	TNRC6A	Trinucleotide repeat-containing gene 6A protein	GO:0045087; P:innate immune response; TAS:Reactome
Q8NDV7	TNRC6A	Trinucleotide repeat-containing gene 6A protein	GO:0035278; P:negative regulation of translation involved in gene silencing by miRNA; IDA:UniProtKB
Q8NDV7	TNRC6A	Trinucleotide repeat-containing gene 6A protein	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q8NDV7	TNRC6A	Trinucleotide repeat-containing gene 6A protein	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q8NDV7	TNRC6A	Trinucleotide repeat-containing gene 6A protein	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q9UPQ9	TNRC6B	Trinucleotide repeat-containing gene 6B protein	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9UPQ9	TNRC6B	Trinucleotide repeat-containing gene 6B protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UPQ9	TNRC6B	Trinucleotide repeat-containing gene 6B protein	GO:0005515; F:protein binding; IPI:IntAct
Q9UPQ9	TNRC6B	Trinucleotide repeat-containing gene 6B protein	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q9UPQ9	TNRC6B	Trinucleotide repeat-containing gene 6B protein	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9UPQ9	TNRC6B	Trinucleotide repeat-containing gene 6B protein	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q9UPQ9	TNRC6B	Trinucleotide repeat-containing gene 6B protein	GO:0010467; P:gene expression; TAS:Reactome
Q9UPQ9	TNRC6B	Trinucleotide repeat-containing gene 6B protein	GO:0031047; P:gene silencing by RNA; IMP:UniProtKB
Q9UPQ9	TNRC6B	Trinucleotide repeat-containing gene 6B protein	GO:0045087; P:innate immune response; TAS:Reactome
Q9UPQ9	TNRC6B	Trinucleotide repeat-containing gene 6B protein	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9UPQ9	TNRC6B	Trinucleotide repeat-containing gene 6B protein	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q9UPQ9	TNRC6B	Trinucleotide repeat-containing gene 6B protein	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q9UPQ9	TNRC6B	Trinucleotide repeat-containing gene 6B protein	GO:1900153; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; IMP:UniProtKB
Q9UPQ9	TNRC6B	Trinucleotide repeat-containing gene 6B protein	GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; IMP:UniProtKB
Q9UPQ9	TNRC6B	Trinucleotide repeat-containing gene 6B protein	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q9HCJ0	TNRC6C	Trinucleotide repeat-containing gene 6C protein	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9HCJ0	TNRC6C	Trinucleotide repeat-containing gene 6C protein	GO:0005515; F:protein binding; IPI:IntAct
Q9HCJ0	TNRC6C	Trinucleotide repeat-containing gene 6C protein	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q9HCJ0	TNRC6C	Trinucleotide repeat-containing gene 6C protein	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q9HCJ0	TNRC6C	Trinucleotide repeat-containing gene 6C protein	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9HCJ0	TNRC6C	Trinucleotide repeat-containing gene 6C protein	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q9HCJ0	TNRC6C	Trinucleotide repeat-containing gene 6C protein	GO:0010467; P:gene expression; TAS:Reactome
Q9HCJ0	TNRC6C	Trinucleotide repeat-containing gene 6C protein	GO:0045087; P:innate immune response; TAS:Reactome
Q9HCJ0	TNRC6C	Trinucleotide repeat-containing gene 6C protein	GO:0035278; P:negative regulation of translation involved in gene silencing by miRNA; TAS:UniProtKB
Q9HCJ0	TNRC6C	Trinucleotide repeat-containing gene 6C protein	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9HCJ0	TNRC6C	Trinucleotide repeat-containing gene 6C protein	GO:0007219; P:Notch signaling pathway; TAS:Reactome
Q9HCJ0	TNRC6C	Trinucleotide repeat-containing gene 6C protein	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q9HCJ0	TNRC6C	Trinucleotide repeat-containing gene 6C protein	GO:1900153; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; IDA:UniProtKB
Q9HCJ0	TNRC6C	Trinucleotide repeat-containing gene 6C protein	GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; IDA:UniProtKB
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0042802; F:identical protein binding; IPI:IntAct
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0019900; F:kinase binding; IPI:BHF-UCL
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0005515; F:protein binding; IPI:UniProtKB
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0004872; F:receptor activity; NAS:UniProtKB
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0004871; F:signal transducer activity; TAS:ProtInc
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:Reactome
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0006924; P:activation-induced cell death of T cells; IEA:Ensembl
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0006915; P:apoptotic process; IDA:MGI
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0019724; P:B cell mediated immunity; IEA:Ensembl
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0071455; P:cellular response to hyperoxia; IMP:UniProtKB
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0071285; P:cellular response to lithium ion; IEA:Ensembl
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0097191; P:extrinsic apoptotic signaling pathway; IMP:UniProtKB
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0002377; P:immunoglobulin production; IEA:Ensembl
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0006925; P:inflammatory cell apoptotic process; IEA:Ensembl
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0097049; P:motor neuron apoptotic process; IEA:Ensembl
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0097527; P:necroptotic signaling pathway; IMP:BHF-UCL
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0050869; P:negative regulation of B cell activation; IEA:Ensembl
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0045060; P:negative thymic T cell selection; IEA:Ensembl
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0032464; P:positive regulation of protein homooligomerization; IEA:Ensembl
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0006461; P:protein complex assembly; TAS:ProtInc
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0051260; P:protein homooligomerization; IEA:Ensembl
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0042981; P:regulation of apoptotic process; NAS:UniProtKB
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:2001239; P:regulation of extrinsic apoptotic signaling pathway in absence of ligand; TAS:Reactome
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0045619; P:regulation of lymphocyte differentiation; IEA:Ensembl
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0045637; P:regulation of myeloid cell differentiation; IEA:Ensembl
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0003014; P:renal system process; IEA:Ensembl
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0009636; P:response to toxic substance; IEA:Ensembl
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0007165; P:signal transduction; TAS:ProtInc
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0048536; P:spleen development; IEA:Ensembl
P25445	FAS	Tumor necrosis factor receptor superfamily member 6	GO:0006927; P:transformed cell apoptotic process; IEA:Ensembl
P28908	TNFRSF8	Tumor necrosis factor receptor superfamily member 8	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
P28908	TNFRSF8	Tumor necrosis factor receptor superfamily member 8	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
P28908	TNFRSF8	Tumor necrosis factor receptor superfamily member 8	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P28908	TNFRSF8	Tumor necrosis factor receptor superfamily member 8	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P28908	TNFRSF8	Tumor necrosis factor receptor superfamily member 8	GO:0045556; P:positive regulation of TRAIL biosynthetic process; IDA:UniProtKB
P28908	TNFRSF8	Tumor necrosis factor receptor superfamily member 8	GO:0042535; P:positive regulation of tumor necrosis factor biosynthetic process; IDA:UniProtKB
P28908	TNFRSF8	Tumor necrosis factor receptor superfamily member 8	GO:0007165; P:signal transduction; TAS:ProtInc
Q07011	TNFRSF9	Tumor necrosis factor receptor superfamily member 9	GO:0004872; F:receptor activity; TAS:ProtInc
Q07011	TNFRSF9	Tumor necrosis factor receptor superfamily member 9	GO:0006915; P:apoptotic process; TAS:ProtInc
Q07011	TNFRSF9	Tumor necrosis factor receptor superfamily member 9	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q07011	TNFRSF9	Tumor necrosis factor receptor superfamily member 9	GO:2001180; P:negative regulation of interleukin-10 secretion; IEA:Ensembl
Q07011	TNFRSF9	Tumor necrosis factor receptor superfamily member 9	GO:2001183; P:negative regulation of interleukin-12 secretion; IEA:Ensembl
Q07011	TNFRSF9	Tumor necrosis factor receptor superfamily member 9	GO:0070207; P:protein homotrimerization; IEA:Ensembl
Q6UXN7	TOMM20L	TOMM20-like protein 1	GO:0006605; P:protein targeting; IEA:InterPro
P50616	TOB1	Protein Tob1	GO:0005515; F:protein binding; IPI:IntAct
P50616	TOB1	Protein Tob1	GO:0030971; F:receptor tyrosine kinase binding; IDA:UniProtKB
P50616	TOB1	Protein Tob1	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
P50616	TOB1	Protein Tob1	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
P50616	TOB1	Protein Tob1	GO:0060212; P:negative regulation of nuclear-transcribed mRNA poly(A) tail shortening; IDA:UniProtKB
P50616	TOB1	Protein Tob1	GO:0017148; P:negative regulation of translation; IDA:UniProtKB
P50616	TOB1	Protein Tob1	GO:1900153; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; IDA:UniProtKB
P50616	TOB1	Protein Tob1	GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; IDA:UniProtKB
P50616	TOB1	Protein Tob1	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
Q14106	TOB2	Protein Tob2	GO:0005515; F:protein binding; IPI:IntAct
Q14106	TOB2	Protein Tob2	GO:0007292; P:female gamete generation; TAS:ProtInc
Q14106	TOB2	Protein Tob2	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
Q14106	TOB2	Protein Tob2	GO:0045671; P:negative regulation of osteoclast differentiation; IEA:Ensembl
Q14106	TOB2	Protein Tob2	GO:0045778; P:positive regulation of ossification; IEA:Ensembl
Q14106	TOB2	Protein Tob2	GO:0010468; P:regulation of gene expression; IEA:Ensembl
Q96GM8	TOE1	Target of EGR1 protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96GM8	TOE1	Target of EGR1 protein 1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q96GM8	TOE1	Target of EGR1 protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q5JTV8	TOR1AIP1	Torsin-1A-interacting protein 1	GO:0001671; F:ATPase activator activity; IDA:UniProtKB
Q5JTV8	TOR1AIP1	Torsin-1A-interacting protein 1	GO:0051117; F:ATPase binding; IPI:UniProtKB
Q5JTV8	TOR1AIP1	Torsin-1A-interacting protein 1	GO:0008092; F:cytoskeletal protein binding; IPI:UniProtKB
Q5JTV8	TOR1AIP1	Torsin-1A-interacting protein 1	GO:0032781; P:positive regulation of ATPase activity; IDA:UniProtKB
Q8NFQ8	TOR1AIP2	Torsin-1A-interacting protein 2	GO:0001671; F:ATPase activator activity; IDA:UniProtKB
Q8NFQ8	TOR1AIP2	Torsin-1A-interacting protein 2	GO:0051117; F:ATPase binding; IPI:UniProtKB
Q8NFQ8	TOR1AIP2	Torsin-1A-interacting protein 2	GO:0007029; P:endoplasmic reticulum organization; IMP:UniProtKB
Q8NFQ8	TOR1AIP2	Torsin-1A-interacting protein 2	GO:0032781; P:positive regulation of ATPase activity; IDA:UniProtKB
Q9H0E2	TOLLIP	Toll-interacting protein	GO:0019900; F:kinase binding; IPI:UniProtKB
Q9H0E2	TOLLIP	Toll-interacting protein	GO:0005515; F:protein binding; IPI:IntAct
Q9H0E2	TOLLIP	Toll-interacting protein	GO:0004871; F:signal transducer activity; NAS:UniProtKB
Q9H0E2	TOLLIP	Toll-interacting protein	GO:0035325; F:Toll-like receptor binding; IPI:UniProtKB
Q9H0E2	TOLLIP	Toll-interacting protein	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9H0E2	TOLLIP	Toll-interacting protein	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
Q9H0E2	TOLLIP	Toll-interacting protein	GO:0006954; P:inflammatory response; NAS:UniProtKB
Q9H0E2	TOLLIP	Toll-interacting protein	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q9H0E2	TOLLIP	Toll-interacting protein	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
Q9H0E2	TOLLIP	Toll-interacting protein	GO:0045321; P:leukocyte activation; NAS:UniProtKB
Q9H0E2	TOLLIP	Toll-interacting protein	GO:0016310; P:phosphorylation; IDA:UniProtKB
Q9H0E2	TOLLIP	Toll-interacting protein	GO:0033235; P:positive regulation of protein sumoylation; IEA:Ensembl
Q9H0E2	TOLLIP	Toll-interacting protein	GO:0036010; P:protein localization to endosome; IDA:UniProt
Q9H0E2	TOLLIP	Toll-interacting protein	GO:0007165; P:signal transduction; IPI:UniProtKB
O60784	TOM1	Target of Myb protein 1	GO:0030276; F:clathrin binding; IDA:UniProtKB
O60784	TOM1	Target of Myb protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
O60784	TOM1	Target of Myb protein 1	GO:0006897; P:endocytosis; NAS:UniProtKB
O60784	TOM1	Target of Myb protein 1	GO:0016197; P:endosomal transport; NAS:UniProtKB
O60784	TOM1	Target of Myb protein 1	GO:0006886; P:intracellular protein transport; IEA:InterPro
O60784	TOM1	Target of Myb protein 1	GO:0015031; P:protein transport; NAS:UniProtKB
Q15388	TOMM20	Mitochondrial import receptor subunit TOM20 homolog	GO:0015450; F:P-P-bond-hydrolysis-driven protein transmembrane transporter activity; IDA:HGNC
Q15388	TOMM20	Mitochondrial import receptor subunit TOM20 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q15388	TOMM20	Mitochondrial import receptor subunit TOM20 homolog	GO:0051082; F:unfolded protein binding; IDA:HGNC
Q15388	TOMM20	Mitochondrial import receptor subunit TOM20 homolog	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q15388	TOMM20	Mitochondrial import receptor subunit TOM20 homolog	GO:0006626; P:protein targeting to mitochondrion; IDA:HGNC
Q15388	TOMM20	Mitochondrial import receptor subunit TOM20 homolog	GO:0071806; P:protein transmembrane transport; IDA:GOC
Q9NS69	TOMM22	Mitochondrial import receptor subunit TOM22 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q9NS69	TOMM22	Mitochondrial import receptor subunit TOM22 homolog	GO:0008320; F:protein transmembrane transporter activity; ISS:BHF-UCL
Q9NS69	TOMM22	Mitochondrial import receptor subunit TOM22 homolog	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9NS69	TOMM22	Mitochondrial import receptor subunit TOM22 homolog	GO:0045040; P:protein import into mitochondrial outer membrane; IDA:BHF-UCL
Q9NS69	TOMM22	Mitochondrial import receptor subunit TOM22 homolog	GO:0006626; P:protein targeting to mitochondrion; TAS:HGNC
Q15785	TOMM34	Mitochondrial import receptor subunit TOM34	GO:0031072; F:heat shock protein binding; IPI:UniProtKB
Q15785	TOMM34	Mitochondrial import receptor subunit TOM34	GO:0006626; P:protein targeting to mitochondrion; IMP:UniProtKB
O96008	TOMM40	Mitochondrial import receptor subunit TOM40 homolog	GO:0015288; F:porin activity; IEA:UniProtKB-KW
O96008	TOMM40	Mitochondrial import receptor subunit TOM40 homolog	GO:0008320; F:protein transmembrane transporter activity; ISS:BHF-UCL
O96008	TOMM40	Mitochondrial import receptor subunit TOM40 homolog	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O96008	TOMM40	Mitochondrial import receptor subunit TOM40 homolog	GO:0006811; P:ion transport; IEA:UniProtKB-KW
O96008	TOMM40	Mitochondrial import receptor subunit TOM40 homolog	GO:0006626; P:protein targeting to mitochondrion; IMP:UniProtKB
O96008	TOMM40	Mitochondrial import receptor subunit TOM40 homolog	GO:0071806; P:protein transmembrane transport; ISS:GOC
Q8N4H5	TOMM5	Mitochondrial import receptor subunit TOM5 homolog	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8N4H5	TOMM5	Mitochondrial import receptor subunit TOM5 homolog	GO:0006626; P:protein targeting to mitochondrion; IC:UniProtKB
Q96B49	TOMM6	Mitochondrial import receptor subunit TOM6 homolog	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q96B49	TOMM6	Mitochondrial import receptor subunit TOM6 homolog	GO:0006626; P:protein targeting to mitochondrion; TAS:Reactome
O94826	TOMM70A	Mitochondrial import receptor subunit TOM70	GO:0005515; F:protein binding; IPI:UniProtKB
O94826	TOMM70A	Mitochondrial import receptor subunit TOM70	GO:0008320; F:protein transmembrane transporter activity; TAS:BHF-UCL
O94826	TOMM70A	Mitochondrial import receptor subunit TOM70	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O94826	TOMM70A	Mitochondrial import receptor subunit TOM70	GO:0006626; P:protein targeting to mitochondrion; TAS:BHF-UCL
O94826	TOMM70A	Mitochondrial import receptor subunit TOM70	GO:0071806; P:protein transmembrane transport; TAS:GOC
Q9P0U1	TOMM7	Mitochondrial import receptor subunit TOM7 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q9P0U1	TOMM7	Mitochondrial import receptor subunit TOM7 homolog	GO:0008320; F:protein transmembrane transporter activity; TAS:BHF-UCL
Q9P0U1	TOMM7	Mitochondrial import receptor subunit TOM7 homolog	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9P0U1	TOMM7	Mitochondrial import receptor subunit TOM7 homolog	GO:0030150; P:protein import into mitochondrial matrix; IEA:InterPro
Q9P0U1	TOMM7	Mitochondrial import receptor subunit TOM7 homolog	GO:0006626; P:protein targeting to mitochondrion; TAS:BHF-UCL
Q8WZ04	LRTOMT	Transmembrane O-methyltransferase	GO:0016206; F:catechol O-methyltransferase activity; ISS:UniProtKB
Q8WZ04	LRTOMT	Transmembrane O-methyltransferase	GO:0060117; P:auditory receptor cell development; ISS:UniProtKB
Q8WZ04	LRTOMT	Transmembrane O-methyltransferase	GO:0042424; P:catecholamine catabolic process; ISS:UniProtKB
Q8WZ04	LRTOMT	Transmembrane O-methyltransferase	GO:0042135; P:neurotransmitter catabolic process; IEA:UniProtKB-KW
Q8WZ04	LRTOMT	Transmembrane O-methyltransferase	GO:0007605; P:sensory perception of sound; ISS:UniProtKB
Q96HA7	TONSL	Tonsoku-like protein	GO:0042393; F:histone binding; IDA:UniProtKB
Q96HA7	TONSL	Tonsoku-like protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q96HA7	TONSL	Tonsoku-like protein	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q96HA7	TONSL	Tonsoku-like protein	GO:0042994; P:cytoplasmic sequestering of transcription factor; TAS:ProtInc
Q96HA7	TONSL	Tonsoku-like protein	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
Q96HA7	TONSL	Tonsoku-like protein	GO:2001141; P:regulation of RNA biosynthetic process; TAS:GOC
Q96HA7	TONSL	Tonsoku-like protein	GO:0031297; P:replication fork processing; IMP:UniProtKB
Q969P6	TOP1MT	DNA topoisomerase I, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q969P6	TOP1MT	DNA topoisomerase I, mitochondrial	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q969P6	TOP1MT	DNA topoisomerase I, mitochondrial	GO:0003917; F:DNA topoisomerase type I activity; IBA:RefGenome
Q969P6	TOP1MT	DNA topoisomerase I, mitochondrial	GO:0003918; F:DNA topoisomerase type II (ATP-hydrolyzing) activity; IEA:InterPro
Q969P6	TOP1MT	DNA topoisomerase I, mitochondrial	GO:0006260; P:DNA replication; IBA:RefGenome
Q969P6	TOP1MT	DNA topoisomerase I, mitochondrial	GO:0006265; P:DNA topological change; IBA:RefGenome
P11387	TOP1	DNA topoisomerase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P11387	TOP1	DNA topoisomerase 1	GO:0003682; F:chromatin binding; IDA:UniProtKB
P11387	TOP1	DNA topoisomerase 1	GO:0003677; F:DNA binding; IDA:UniProtKB
P11387	TOP1	DNA topoisomerase 1	GO:0003917; F:DNA topoisomerase type I activity; IDA:UniProtKB
P11387	TOP1	DNA topoisomerase 1	GO:0003918; F:DNA topoisomerase type II (ATP-hydrolyzing) activity; IEA:InterPro
P11387	TOP1	DNA topoisomerase 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P11387	TOP1	DNA topoisomerase 1	GO:0005515; F:protein binding; IPI:UniProtKB
P11387	TOP1	DNA topoisomerase 1	GO:0006338; P:chromatin remodeling; IBA:RefGenome
P11387	TOP1	DNA topoisomerase 1	GO:0007059; P:chromosome segregation; IBA:RefGenome
P11387	TOP1	DNA topoisomerase 1	GO:0006260; P:DNA replication; IBA:RefGenome
P11387	TOP1	DNA topoisomerase 1	GO:0006265; P:DNA topological change; IDA:UniProtKB
P11387	TOP1	DNA topoisomerase 1	GO:0040016; P:embryonic cleavage; IEA:Ensembl
P11387	TOP1	DNA topoisomerase 1	GO:0016310; P:phosphorylation; NAS:UniProtKB
P11387	TOP1	DNA topoisomerase 1	GO:0012501; P:programmed cell death; NAS:UniProtKB
P11387	TOP1	DNA topoisomerase 1	GO:0042493; P:response to drug; IEP:UniProtKB
P11387	TOP1	DNA topoisomerase 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0003682; F:chromatin binding; IDA:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0003677; F:DNA binding; IDA:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0008301; F:DNA binding, bending; IDA:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0003918; F:DNA topoisomerase type II (ATP-hydrolyzing) activity; IDA:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0008094; F:DNA-dependent ATPase activity; IDA:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0008144; F:drug binding; IDA:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0019899; F:enzyme binding; IPI:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0042826; F:histone deacetylase binding; IPI:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0005515; F:protein binding; IPI:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0005080; F:protein kinase C binding; IPI:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0043130; F:ubiquitin binding; IMP:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0030263; P:apoptotic chromosome condensation; IDA:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0006200; P:ATP catabolic process; IDA:GOC
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0007059; P:chromosome segregation; IMP:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0006266; P:DNA ligation; IDA:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0006281; P:DNA repair; NAS:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0006260; P:DNA replication; NAS:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0006265; P:DNA topological change; IDA:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0006261; P:DNA-dependent DNA replication; IBA:RefGenome
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0040016; P:embryonic cleavage; IEA:Ensembl
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0006312; P:mitotic recombination; IBA:RefGenome
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0048015; P:phosphatidylinositol-mediated signaling; NAS:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0045870; P:positive regulation of single stranded viral RNA replication via double stranded DNA intermediate; IMP:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0045070; P:positive regulation of viral genome replication; IMP:UniProtKB
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0000712; P:resolution of meiotic recombination intermediates; IBA:RefGenome
P11388	TOP2A	DNA topoisomerase 2-alpha	GO:0000819; P:sister chromatid segregation; IBA:RefGenome
Q02880	TOP2B	DNA topoisomerase 2-beta	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q02880	TOP2B	DNA topoisomerase 2-beta	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q02880	TOP2B	DNA topoisomerase 2-beta	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q02880	TOP2B	DNA topoisomerase 2-beta	GO:0003918; F:DNA topoisomerase type II (ATP-hydrolyzing) activity; IDA:UniProtKB
Q02880	TOP2B	DNA topoisomerase 2-beta	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q02880	TOP2B	DNA topoisomerase 2-beta	GO:0042826; F:histone deacetylase binding; IPI:UniProtKB
Q02880	TOP2B	DNA topoisomerase 2-beta	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q02880	TOP2B	DNA topoisomerase 2-beta	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q02880	TOP2B	DNA topoisomerase 2-beta	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q02880	TOP2B	DNA topoisomerase 2-beta	GO:0005080; F:protein kinase C binding; IPI:UniProtKB
Q02880	TOP2B	DNA topoisomerase 2-beta	GO:0006200; P:ATP catabolic process; IDA:GOC
Q02880	TOP2B	DNA topoisomerase 2-beta	GO:0007409; P:axonogenesis; IEA:Ensembl
Q02880	TOP2B	DNA topoisomerase 2-beta	GO:0007059; P:chromosome segregation; IBA:RefGenome
Q02880	TOP2B	DNA topoisomerase 2-beta	GO:0006265; P:DNA topological change; IDA:UniProtKB
Q02880	TOP2B	DNA topoisomerase 2-beta	GO:0006261; P:DNA-dependent DNA replication; IBA:RefGenome
Q02880	TOP2B	DNA topoisomerase 2-beta	GO:0030900; P:forebrain development; IEA:Ensembl
Q02880	TOP2B	DNA topoisomerase 2-beta	GO:0006312; P:mitotic recombination; IBA:RefGenome
Q02880	TOP2B	DNA topoisomerase 2-beta	GO:0001764; P:neuron migration; IEA:Ensembl
Q02880	TOP2B	DNA topoisomerase 2-beta	GO:0000712; P:resolution of meiotic recombination intermediates; IBA:RefGenome
Q02880	TOP2B	DNA topoisomerase 2-beta	GO:0000819; P:sister chromatid segregation; IBA:RefGenome
Q13472	TOP3A	DNA topoisomerase 3-alpha	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q13472	TOP3A	DNA topoisomerase 3-alpha	GO:0003677; F:DNA binding; TAS:ProtInc
Q13472	TOP3A	DNA topoisomerase 3-alpha	GO:0003917; F:DNA topoisomerase type I activity; IDA:UniProtKB
Q13472	TOP3A	DNA topoisomerase 3-alpha	GO:0005515; F:protein binding; IPI:UniProtKB
Q13472	TOP3A	DNA topoisomerase 3-alpha	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13472	TOP3A	DNA topoisomerase 3-alpha	GO:0006265; P:DNA topological change; IDA:UniProtKB
Q13472	TOP3A	DNA topoisomerase 3-alpha	GO:0007126; P:meiotic nuclear division; TAS:ProtInc
O95985	TOP3B	DNA topoisomerase 3-beta-1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O95985	TOP3B	DNA topoisomerase 3-beta-1	GO:0003677; F:DNA binding; TAS:ProtInc
O95985	TOP3B	DNA topoisomerase 3-beta-1	GO:0003916; F:DNA topoisomerase activity; TAS:ProtInc
O95985	TOP3B	DNA topoisomerase 3-beta-1	GO:0003917; F:DNA topoisomerase type I activity; IEA:UniProtKB-EC
O95985	TOP3B	DNA topoisomerase 3-beta-1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O95985	TOP3B	DNA topoisomerase 3-beta-1	GO:0007059; P:chromosome segregation; IEA:Ensembl
O95985	TOP3B	DNA topoisomerase 3-beta-1	GO:0006265; P:DNA topological change; IEA:InterPro
Q92547	TOPBP1	DNA topoisomerase 2-binding protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q92547	TOPBP1	DNA topoisomerase 2-binding protein 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q92547	TOPBP1	DNA topoisomerase 2-binding protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q92547	TOPBP1	DNA topoisomerase 2-binding protein 1	GO:0008022; F:protein C-terminus binding; TAS:ProtInc
Q92547	TOPBP1	DNA topoisomerase 2-binding protein 1	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q92547	TOPBP1	DNA topoisomerase 2-binding protein 1	GO:0006259; P:DNA metabolic process; TAS:ProtInc
Q92547	TOPBP1	DNA topoisomerase 2-binding protein 1	GO:0006281; P:DNA repair; NAS:UniProtKB
Q92547	TOPBP1	DNA topoisomerase 2-binding protein 1	GO:0010212; P:response to ionizing radiation; IDA:UniProtKB
Q96KB5	PBK	Lymphokine-activated killer T-cell-originated protein kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96KB5	PBK	Lymphokine-activated killer T-cell-originated protein kinase	GO:0005515; F:protein binding; IPI:UniProtKB
Q96KB5	PBK	Lymphokine-activated killer T-cell-originated protein kinase	GO:0004674; F:protein serine/threonine kinase activity; TAS:UniProtKB
Q96KB5	PBK	Lymphokine-activated killer T-cell-originated protein kinase	GO:0007067; P:mitosis; NAS:UniProtKB
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0003823; F:antigen binding; IPI:UniProtKB
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0003677; F:DNA binding; IDA:UniProtKB
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0044547; F:DNA topoisomerase binding; IPI:UniProtKB
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0019789; F:SUMO ligase activity; IDA:UniProtKB
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IDA:UniProtKB
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IEA:Ensembl
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0051457; P:maintenance of protein location in nucleus; IDA:UniProtKB
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0043066; P:negative regulation of apoptotic process; ISS:BHF-UCL
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0035845; P:photoreceptor cell outer segment organization; ISS:BHF-UCL
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0051443; P:positive regulation of ubiquitin-protein ligase activity; IDA:BHF-UCL
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0070936; P:protein K48-linked ubiquitination; IDA:BHF-UCL
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0034504; P:protein localization to nucleus; IMP:UniProtKB
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0006513; P:protein monoubiquitination; IDA:BHF-UCL
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0016925; P:protein sumoylation; IDA:UniProtKB
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0010842; P:retina layer formation; ISS:BHF-UCL
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0046549; P:retinal cone cell development; ISS:BHF-UCL
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0046548; P:retinal rod cell development; ISS:BHF-UCL
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0006351; P:transcription, DNA-templated; NAS:UniProtKB
Q9NS56	TOPORS	E3 ubiquitin-protein ligase Topors	GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q8N9V7	TOPAZ1	Testis- and ovary-specific PAZ domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14656	TOR1A	Torsin-1A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O14656	TOR1A	Torsin-1A	GO:0016887; F:ATPase activity; IDA:UniProtKB
O14656	TOR1A	Torsin-1A	GO:0008092; F:cytoskeletal protein binding; IPI:UniProtKB
O14656	TOR1A	Torsin-1A	GO:0019894; F:kinesin binding; IPI:UniProtKB
O14656	TOR1A	Torsin-1A	GO:0005515; F:protein binding; IPI:UniProtKB
O14656	TOR1A	Torsin-1A	GO:0051082; F:unfolded protein binding; TAS:ProtInc
O14656	TOR1A	Torsin-1A	GO:0006200; P:ATP catabolic process; IDA:UniProtKB
O14656	TOR1A	Torsin-1A	GO:0007155; P:cell adhesion; IMP:UniProtKB
O14656	TOR1A	Torsin-1A	GO:0051085; P:chaperone mediated protein folding requiring cofactor; IEA:InterPro
O14656	TOR1A	Torsin-1A	GO:0061077; P:chaperone-mediated protein folding; IDA:UniProtKB
O14656	TOR1A	Torsin-1A	GO:0072321; P:chaperone-mediated protein transport; IDA:UniProtKB
O14656	TOR1A	Torsin-1A	GO:0071712; P:ER-associated misfolded protein catabolic process; ISS:UniProtKB
O14656	TOR1A	Torsin-1A	GO:0045104; P:intermediate filament cytoskeleton organization; IMP:UniProtKB
O14656	TOR1A	Torsin-1A	GO:0031175; P:neuron projection development; IMP:UniProtKB
O14656	TOR1A	Torsin-1A	GO:0006998; P:nuclear envelope organization; ISS:UniProtKB
O14656	TOR1A	Torsin-1A	GO:0071763; P:nuclear membrane organization; ISS:UniProtKB
O14656	TOR1A	Torsin-1A	GO:0006996; P:organelle organization; ISS:UniProtKB
O14656	TOR1A	Torsin-1A	GO:1900244; P:positive regulation of synaptic vesicle endocytosis; IMP:UniProtKB
O14656	TOR1A	Torsin-1A	GO:0000338; P:protein deneddylation; IMP:UniProtKB
O14656	TOR1A	Torsin-1A	GO:0051260; P:protein homooligomerization; IDA:MGI
O14656	TOR1A	Torsin-1A	GO:0034504; P:protein localization to nucleus; IMP:UniProtKB
O14656	TOR1A	Torsin-1A	GO:0051584; P:regulation of dopamine uptake involved in synaptic transmission; IDA:UniProtKB
O14656	TOR1A	Torsin-1A	GO:2000008; P:regulation of protein localization to cell surface; IMP:UniProtKB
O14656	TOR1A	Torsin-1A	GO:0006979; P:response to oxidative stress; IEA:Ensembl
O14656	TOR1A	Torsin-1A	GO:0048489; P:synaptic vesicle transport; IMP:UniProtKB
O14656	TOR1A	Torsin-1A	GO:0044319; P:wound healing, spreading of cells; ISS:UniProtKB
O14657	TOR1B	Torsin-1B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O14657	TOR1B	Torsin-1B	GO:0016887; F:ATPase activity; IDA:UniProtKB
O14657	TOR1B	Torsin-1B	GO:0005515; F:protein binding; IPI:UniProtKB
O14657	TOR1B	Torsin-1B	GO:0006200; P:ATP catabolic process; IDA:UniProtKB
O14657	TOR1B	Torsin-1B	GO:0051085; P:chaperone mediated protein folding requiring cofactor; IEA:InterPro
O14657	TOR1B	Torsin-1B	GO:0007029; P:endoplasmic reticulum organization; IDA:UniProtKB
O14657	TOR1B	Torsin-1B	GO:0071763; P:nuclear membrane organization; IEA:Ensembl
O14657	TOR1B	Torsin-1B	GO:0051260; P:protein homooligomerization; IDA:MGI
O14657	TOR1B	Torsin-1B	GO:0006986; P:response to unfolded protein; TAS:ProtInc
Q5JU69	TOR2A	Torsin-2A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5JU69	TOR2A	Torsin-2A	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q5JU69	TOR2A	Torsin-2A	GO:0051085; P:chaperone mediated protein folding requiring cofactor; IEA:InterPro
Q5JU69	TOR2A	Torsin-2A	GO:0051260; P:protein homooligomerization; IDA:MGI
Q8N2E6	TOR2A	Prosalusin	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8N2E6	TOR2A	Prosalusin	GO:0051085; P:chaperone mediated protein folding requiring cofactor; IEA:InterPro
Q9NXH8	TOR4A	Torsin-4A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NXH8	TOR4A	Torsin-4A	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q9NXH8	TOR4A	Torsin-4A	GO:0051085; P:chaperone mediated protein folding requiring cofactor; IEA:InterPro
Q9H497	TOR3A	Torsin-3A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H497	TOR3A	Torsin-3A	GO:0016887; F:ATPase activity; IDA:UniProtKB
Q9H497	TOR3A	Torsin-3A	GO:0006200; P:ATP catabolic process; IDA:UniProtKB
Q9H497	TOR3A	Torsin-3A	GO:0051085; P:chaperone mediated protein folding requiring cofactor; IEA:InterPro
Q96NM4	TOX2	TOX high mobility group box family member 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96NM4	TOX2	TOX high mobility group box family member 2	GO:0008585; P:female gonad development; IEA:Ensembl
Q96NM4	TOX2	TOX high mobility group box family member 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q96NM4	TOX2	TOX high mobility group box family member 2	GO:0034698; P:response to gonadotropin; IEA:Ensembl
Q96NM4	TOX2	TOX high mobility group box family member 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15405	TOX3	TOX high mobility group box family member 3	GO:0003682; F:chromatin binding; IDA:UniProtKB
O15405	TOX3	TOX high mobility group box family member 3	GO:0034056; F:estrogen response element binding; IDA:UniProtKB
O15405	TOX3	TOX high mobility group box family member 3	GO:0051219; F:phosphoprotein binding; IPI:UniProtKB
O15405	TOX3	TOX high mobility group box family member 3	GO:0005515; F:protein binding; IPI:UniProtKB
O15405	TOX3	TOX high mobility group box family member 3	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O15405	TOX3	TOX high mobility group box family member 3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O15405	TOX3	TOX high mobility group box family member 3	GO:0043524; P:negative regulation of neuron apoptotic process; IDA:UniProtKB
O15405	TOX3	TOX high mobility group box family member 3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O15405	TOX3	TOX high mobility group box family member 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O94842	TOX4	TOX high mobility group box family member 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O94842	TOX4	TOX high mobility group box family member 4	GO:0005515; F:protein binding; IPI:UniProtKB
O94900	TOX	Thymocyte selection-associated high mobility group box protein TOX	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q93096	PTP4A1	Protein tyrosine phosphatase type IVA 1	GO:0004725; F:protein tyrosine phosphatase activity; NAS:UniProtKB
Q93096	PTP4A1	Protein tyrosine phosphatase type IVA 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q93096	PTP4A1	Protein tyrosine phosphatase type IVA 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q93096	PTP4A1	Protein tyrosine phosphatase type IVA 1	GO:0035335; P:peptidyl-tyrosine dephosphorylation; NAS:GOC
Q93096	PTP4A1	Protein tyrosine phosphatase type IVA 1	GO:0030335; P:positive regulation of cell migration; IEA:Ensembl
Q12974	PTP4A2	Protein tyrosine phosphatase type IVA 2	GO:0004727; F:prenylated protein tyrosine phosphatase activity; TAS:ProtInc
Q12974	PTP4A2	Protein tyrosine phosphatase type IVA 2	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
O75365	PTP4A3	Protein tyrosine phosphatase type IVA 3	GO:0004727; F:prenylated protein tyrosine phosphatase activity; TAS:ProtInc
O75365	PTP4A3	Protein tyrosine phosphatase type IVA 3	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
Q8TEL6	TRPC4AP	Short transient receptor potential channel 4-associated protein	GO:0019902; F:phosphatase binding; IDA:UniProtKB
Q8TEL6	TRPC4AP	Short transient receptor potential channel 4-associated protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TEL6	TRPC4AP	Short transient receptor potential channel 4-associated protein	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
Q8TEL6	TRPC4AP	Short transient receptor potential channel 4-associated protein	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q8TEL6	TRPC4AP	Short transient receptor potential channel 4-associated protein	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q8TEL6	TRPC4AP	Short transient receptor potential channel 4-associated protein	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8TEL6	TRPC4AP	Short transient receptor potential channel 4-associated protein	GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q12888	TP53BP1	Tumor suppressor p53-binding protein 1	GO:0003684; F:damaged DNA binding; IEA:Ensembl
Q12888	TP53BP1	Tumor suppressor p53-binding protein 1	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q12888	TP53BP1	Tumor suppressor p53-binding protein 1	GO:0002039; F:p53 binding; IPI:BHF-UCL
Q12888	TP53BP1	Tumor suppressor p53-binding protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q12888	TP53BP1	Tumor suppressor p53-binding protein 1	GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL
Q12888	TP53BP1	Tumor suppressor p53-binding protein 1	GO:0001104; F:RNA polymerase II transcription cofactor activity; IMP:BHF-UCL
Q12888	TP53BP1	Tumor suppressor p53-binding protein 1	GO:0042162; F:telomeric DNA binding; IEA:Ensembl
Q12888	TP53BP1	Tumor suppressor p53-binding protein 1	GO:0006974; P:cellular response to DNA damage stimulus; IDA:MGI
Q12888	TP53BP1	Tumor suppressor p53-binding protein 1	GO:0006281; P:DNA repair; TAS:Reactome
Q12888	TP53BP1	Tumor suppressor p53-binding protein 1	GO:0006302; P:double-strand break repair; TAS:Reactome
Q12888	TP53BP1	Tumor suppressor p53-binding protein 1	GO:0000724; P:double-strand break repair via homologous recombination; TAS:Reactome
Q12888	TP53BP1	Tumor suppressor p53-binding protein 1	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IC:BHF-UCL
Q12888	TP53BP1	Tumor suppressor p53-binding protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q12888	TP53BP1	Tumor suppressor p53-binding protein 1	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
Q12888	TP53BP1	Tumor suppressor p53-binding protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; IMP:GOC
Q6P589	TNFAIP8L2	Tumor necrosis factor alpha-induced protein 8-like protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q6P589	TNFAIP8L2	Tumor necrosis factor alpha-induced protein 8-like protein 2	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q6P589	TNFAIP8L2	Tumor necrosis factor alpha-induced protein 8-like protein 2	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
Q6P589	TNFAIP8L2	Tumor necrosis factor alpha-induced protein 8-like protein 2	GO:0050868; P:negative regulation of T cell activation; IEA:Ensembl
P00750	PLAT	Tissue-type plasminogen activator	GO:0005515; F:protein binding; IPI:UniProtKB
P00750	PLAT	Tissue-type plasminogen activator	GO:0004252; F:serine-type endopeptidase activity; IDA:BHF-UCL
P00750	PLAT	Tissue-type plasminogen activator	GO:0007596; P:blood coagulation; TAS:Reactome
P00750	PLAT	Tissue-type plasminogen activator	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P00750	PLAT	Tissue-type plasminogen activator	GO:0042730; P:fibrinolysis; TAS:Reactome
P00750	PLAT	Tissue-type plasminogen activator	GO:0045861; P:negative regulation of proteolysis; IDA:BHF-UCL
P00750	PLAT	Tissue-type plasminogen activator	GO:0031639; P:plasminogen activation; IDA:UniProtKB
P00750	PLAT	Tissue-type plasminogen activator	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IEA:Ensembl
P00750	PLAT	Tissue-type plasminogen activator	GO:0060279; P:positive regulation of ovulation; IEA:Ensembl
P00750	PLAT	Tissue-type plasminogen activator	GO:0006508; P:proteolysis; TAS:ProtInc
P00750	PLAT	Tissue-type plasminogen activator	GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl
P00750	PLAT	Tissue-type plasminogen activator	GO:0051591; P:response to cAMP; IEA:Ensembl
P00750	PLAT	Tissue-type plasminogen activator	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P00750	PLAT	Tissue-type plasminogen activator	GO:0001666; P:response to hypoxia; IEA:Ensembl
P00750	PLAT	Tissue-type plasminogen activator	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P00750	PLAT	Tissue-type plasminogen activator	GO:0014909; P:smooth muscle cell migration; IEA:Ensembl
P00750	PLAT	Tissue-type plasminogen activator	GO:0035249; P:synaptic transmission, glutamatergic; IEA:Ensembl
Q13641	TPBG	Trophoblast glycoprotein	GO:0007155; P:cell adhesion; NAS:ProtInc
P48553	TRAPPC10	Trafficking protein particle complex subunit 10	GO:0005515; F:protein binding; IPI:IntAct
P48553	TRAPPC10	Trafficking protein particle complex subunit 10	GO:0015081; F:sodium ion transmembrane transporter activity; TAS:ProtInc
P48553	TRAPPC10	Trafficking protein particle complex subunit 10	GO:0035725; P:sodium ion transmembrane transport; TAS:GOC
P48553	TRAPPC10	Trafficking protein particle complex subunit 10	GO:0006814; P:sodium ion transport; TAS:ProtInc
P48553	TRAPPC10	Trafficking protein particle complex subunit 10	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q7Z392	TRAPPC11	Trafficking protein particle complex subunit 11	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q8WVT3	TRAPPC12	Trafficking protein particle complex subunit 12	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
A5PLN9	TRAPPC13	Trafficking protein particle complex subunit 13	GO:0005515; F:protein binding; IPI:IntAct
Q9ULQ1	TPCN1	Two pore calcium channel protein 1	GO:0042802; F:identical protein binding; IPI:IntAct
Q9ULQ1	TPCN1	Two pore calcium channel protein 1	GO:0072345; F:NAADP-sensitive calcium-release channel activity; IDA:UniProtKB
Q9ULQ1	TPCN1	Two pore calcium channel protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9ULQ1	TPCN1	Two pore calcium channel protein 1	GO:0005245; F:voltage-gated calcium channel activity; IBA:RefGenome
Q9ULQ1	TPCN1	Two pore calcium channel protein 1	GO:0006816; P:calcium ion transport; IBA:RefGenome
Q9ULQ1	TPCN1	Two pore calcium channel protein 1	GO:0034220; P:ion transmembrane transport; IBA:RefGenome
Q9ULQ1	TPCN1	Two pore calcium channel protein 1	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q9ULQ1	TPCN1	Two pore calcium channel protein 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P0DI81	TRAPPC2	Trafficking protein particle complex subunit 2	GO:0044325; F:ion channel binding; IPI:BHF-UCL
P0DI81	TRAPPC2	Trafficking protein particle complex subunit 2	GO:0005515; F:protein binding; IPI:UniProtKB
P0DI81	TRAPPC2	Trafficking protein particle complex subunit 2	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P0DI81	TRAPPC2	Trafficking protein particle complex subunit 2	GO:0006888; P:ER to Golgi vesicle-mediated transport; NAS:UniProtKB
P0DI81	TRAPPC2	Trafficking protein particle complex subunit 2	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
P0DI81	TRAPPC2	Trafficking protein particle complex subunit 2	GO:0001501; P:skeletal system development; IMP:UniProtKB
P0DI81	TRAPPC2	Trafficking protein particle complex subunit 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P0DI82	TRAPPC2P1	Trafficking protein particle complex subunit 2 protein TRAPPC2P1	GO:0006888; P:ER to Golgi vesicle-mediated transport; IEA:InterPro
P0DI82	TRAPPC2P1	Trafficking protein particle complex subunit 2 protein TRAPPC2P1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UL33	TRAPPC2L	Trafficking protein particle complex subunit 2-like protein	GO:0005515; F:protein binding; IPI:IntAct
Q9UL33	TRAPPC2L	Trafficking protein particle complex subunit 2-like protein	GO:0006888; P:ER to Golgi vesicle-mediated transport; IEA:InterPro
Q8NHX9	TPCN2	Two pore calcium channel protein 2	GO:0042802; F:identical protein binding; IPI:IntAct
Q8NHX9	TPCN2	Two pore calcium channel protein 2	GO:0072345; F:NAADP-sensitive calcium-release channel activity; IDA:UniProtKB
Q8NHX9	TPCN2	Two pore calcium channel protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q8NHX9	TPCN2	Two pore calcium channel protein 2	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q8NHX9	TPCN2	Two pore calcium channel protein 2	GO:0005245; F:voltage-gated calcium channel activity; ISS:UniProtKB
Q8NHX9	TPCN2	Two pore calcium channel protein 2	GO:0006816; P:calcium ion transport; IBA:RefGenome
Q8NHX9	TPCN2	Two pore calcium channel protein 2	GO:0006874; P:cellular calcium ion homeostasis; IDA:UniProtKB
Q8NHX9	TPCN2	Two pore calcium channel protein 2	GO:0034220; P:ion transmembrane transport; IBA:RefGenome
Q8NHX9	TPCN2	Two pore calcium channel protein 2	GO:0086010; P:membrane depolarization during action potential; IBA:RefGenome
Q8NHX9	TPCN2	Two pore calcium channel protein 2	GO:0051209; P:release of sequestered calcium ion into cytosol; IEA:Ensembl
Q8NHX9	TPCN2	Two pore calcium channel protein 2	GO:0006939; P:smooth muscle contraction; ISS:UniProtKB
Q8NHX9	TPCN2	Two pore calcium channel protein 2	GO:0055085; P:transmembrane transport; TAS:Reactome
O75865	TRAPPC6A	Trafficking protein particle complex subunit 6A	GO:0005515; F:protein binding; IPI:IntAct
O75865	TRAPPC6A	Trafficking protein particle complex subunit 6A	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q5T215	TRAPPC3L	Trafficking protein particle complex subunit 3-like protein	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q86SZ2	TRAPPC6B	Trafficking protein particle complex subunit 6B	GO:0005515; F:protein binding; IPI:IntAct
Q86SZ2	TRAPPC6B	Trafficking protein particle complex subunit 6B	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q9HC21	SLC25A19	Mitochondrial thiamine pyrophosphate carrier	GO:0030233; F:deoxynucleotide transmembrane transporter activity; TAS:UniProtKB
Q9HC21	SLC25A19	Mitochondrial thiamine pyrophosphate carrier	GO:0030302; P:deoxynucleotide transport; NAS:UniProtKB
P55327	TPD52	Tumor protein D52	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P55327	TPD52	Tumor protein D52	GO:0005515; F:protein binding; IPI:UniProtKB
P55327	TPD52	Tumor protein D52	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
P55327	TPD52	Tumor protein D52	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P55327	TPD52	Tumor protein D52	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P55327	TPD52	Tumor protein D52	GO:0030183; P:B cell differentiation; IEP:UniProtKB
P55327	TPD52	Tumor protein D52	GO:0046903; P:secretion; TAS:UniProtKB
Q16890	TPD52L1	Tumor protein D53	GO:0042802; F:identical protein binding; IPI:IntAct
Q16890	TPD52L1	Tumor protein D53	GO:0005515; F:protein binding; IPI:UniProtKB
Q16890	TPD52L1	Tumor protein D53	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
Q16890	TPD52L1	Tumor protein D53	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q16890	TPD52L1	Tumor protein D53	GO:0000086; P:G2/M transition of mitotic cell cycle; IDA:UniProtKB
Q16890	TPD52L1	Tumor protein D53	GO:2001235; P:positive regulation of apoptotic signaling pathway; IDA:UniProtKB
Q16890	TPD52L1	Tumor protein D53	GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB
Q16890	TPD52L1	Tumor protein D53	GO:0043406; P:positive regulation of MAP kinase activity; IDA:UniProtKB
Q16890	TPD52L1	Tumor protein D53	GO:0043281; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
O43399	TPD52L2	Tumor protein D54	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O43399	TPD52L2	Tumor protein D54	GO:0005515; F:protein binding; IPI:UniProtKB
O43399	TPD52L2	Tumor protein D54	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
O43399	TPD52L2	Tumor protein D54	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O43399	TPD52L2	Tumor protein D54	GO:0042127; P:regulation of cell proliferation; TAS:UniProtKB
Q6ZTW0	TPGS1	Tubulin polyglutamylase complex subunit 1	GO:0070740; F:tubulin-glutamic acid ligase activity; IEA:Ensembl
Q6ZTW0	TPGS1	Tubulin polyglutamylase complex subunit 1	GO:0030534; P:adult behavior; IEA:Ensembl
Q6ZTW0	TPGS1	Tubulin polyglutamylase complex subunit 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q6ZTW0	TPGS1	Tubulin polyglutamylase complex subunit 1	GO:0018095; P:protein polyglutamylation; IEA:Ensembl
Q6ZTW0	TPGS1	Tubulin polyglutamylase complex subunit 1	GO:0007288; P:sperm axoneme assembly; IEA:Ensembl
Q6ZTW0	TPGS1	Tubulin polyglutamylase complex subunit 1	GO:0007268; P:synaptic transmission; IEA:Ensembl
Q6ZTW0	TPGS1	Tubulin polyglutamylase complex subunit 1	GO:0051648; P:vesicle localization; IEA:Ensembl
P17752	TPH1	Tryptophan 5-hydroxylase 1	GO:0016597; F:amino acid binding; IEA:InterPro
P17752	TPH1	Tryptophan 5-hydroxylase 1	GO:0005506; F:iron ion binding; IEA:InterPro
P17752	TPH1	Tryptophan 5-hydroxylase 1	GO:0004510; F:tryptophan 5-monooxygenase activity; IEA:UniProtKB-EC
P17752	TPH1	Tryptophan 5-hydroxylase 1	GO:0009072; P:aromatic amino acid family metabolic process; IEA:InterPro
P17752	TPH1	Tryptophan 5-hydroxylase 1	GO:0046849; P:bone remodeling; IEA:Ensembl
P17752	TPH1	Tryptophan 5-hydroxylase 1	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P17752	TPH1	Tryptophan 5-hydroxylase 1	GO:0007623; P:circadian rhythm; IEA:Ensembl
P17752	TPH1	Tryptophan 5-hydroxylase 1	GO:0046219; P:indolalkylamine biosynthetic process; TAS:Reactome
P17752	TPH1	Tryptophan 5-hydroxylase 1	GO:0060749; P:mammary gland alveolus development; IEA:Ensembl
P17752	TPH1	Tryptophan 5-hydroxylase 1	GO:0030279; P:negative regulation of ossification; IEA:Ensembl
P17752	TPH1	Tryptophan 5-hydroxylase 1	GO:0035902; P:response to immobilization stress; IEA:Ensembl
P17752	TPH1	Tryptophan 5-hydroxylase 1	GO:0042427; P:serotonin biosynthetic process; IEA:UniProtKB-UniPathway
P17752	TPH1	Tryptophan 5-hydroxylase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8IWU9	TPH2	Tryptophan 5-hydroxylase 2	GO:0016597; F:amino acid binding; IEA:InterPro
Q8IWU9	TPH2	Tryptophan 5-hydroxylase 2	GO:0005506; F:iron ion binding; IEA:InterPro
Q8IWU9	TPH2	Tryptophan 5-hydroxylase 2	GO:0004510; F:tryptophan 5-monooxygenase activity; IEA:UniProtKB-EC
Q8IWU9	TPH2	Tryptophan 5-hydroxylase 2	GO:0009072; P:aromatic amino acid family metabolic process; IEA:InterPro
Q8IWU9	TPH2	Tryptophan 5-hydroxylase 2	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
Q8IWU9	TPH2	Tryptophan 5-hydroxylase 2	GO:0071285; P:cellular response to lithium ion; IEA:Ensembl
Q8IWU9	TPH2	Tryptophan 5-hydroxylase 2	GO:0007623; P:circadian rhythm; IEA:Ensembl
Q8IWU9	TPH2	Tryptophan 5-hydroxylase 2	GO:0046219; P:indolalkylamine biosynthetic process; TAS:Reactome
Q8IWU9	TPH2	Tryptophan 5-hydroxylase 2	GO:0014823; P:response to activity; IEA:Ensembl
Q8IWU9	TPH2	Tryptophan 5-hydroxylase 2	GO:0051592; P:response to calcium ion; IEA:Ensembl
Q8IWU9	TPH2	Tryptophan 5-hydroxylase 2	GO:0043627; P:response to estrogen; IEA:Ensembl
Q8IWU9	TPH2	Tryptophan 5-hydroxylase 2	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
Q8IWU9	TPH2	Tryptophan 5-hydroxylase 2	GO:0031667; P:response to nutrient levels; IEA:Ensembl
Q8IWU9	TPH2	Tryptophan 5-hydroxylase 2	GO:0042427; P:serotonin biosynthetic process; IEA:UniProtKB-UniPathway
Q8IWU9	TPH2	Tryptophan 5-hydroxylase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9HCN2	TP53AIP1	p53-regulated apoptosis-inducing protein 1	GO:0006915; P:apoptotic process; TAS:UniProtKB
P60174	TPI1	Triosephosphate isomerase	GO:0005515; F:protein binding; IPI:IntAct
P60174	TPI1	Triosephosphate isomerase	GO:0004807; F:triose-phosphate isomerase activity; NAS:UniProtKB
P60174	TPI1	Triosephosphate isomerase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P60174	TPI1	Triosephosphate isomerase	GO:0009790; P:embryo development; IEA:Ensembl
P60174	TPI1	Triosephosphate isomerase	GO:0006094; P:gluconeogenesis; TAS:Reactome
P60174	TPI1	Triosephosphate isomerase	GO:0006006; P:glucose metabolic process; TAS:Reactome
P60174	TPI1	Triosephosphate isomerase	GO:0019682; P:glyceraldehyde-3-phosphate metabolic process; IEA:Ensembl
P60174	TPI1	Triosephosphate isomerase	GO:0006096; P:glycolytic process; TAS:Reactome
P60174	TPI1	Triosephosphate isomerase	GO:0006098; P:pentose-phosphate shunt; IEA:UniProtKB-KW
P60174	TPI1	Triosephosphate isomerase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H3S4	TPK1	Thiamin pyrophosphokinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H3S4	TPK1	Thiamin pyrophosphokinase 1	GO:0016301; F:kinase activity; IEA:UniProtKB-KW
Q9H3S4	TPK1	Thiamin pyrophosphokinase 1	GO:0004788; F:thiamine diphosphokinase activity; TAS:Reactome
Q9H3S4	TPK1	Thiamin pyrophosphokinase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9H3S4	TPK1	Thiamin pyrophosphokinase 1	GO:0009229; P:thiamine diphosphate biosynthetic process; IEA:UniProtKB-UniPathway
Q9H3S4	TPK1	Thiamin pyrophosphokinase 1	GO:0006772; P:thiamine metabolic process; IEA:Ensembl
Q9H3S4	TPK1	Thiamin pyrophosphokinase 1	GO:0042723; P:thiamine-containing compound metabolic process; TAS:Reactome
Q9H3S4	TPK1	Thiamin pyrophosphokinase 1	GO:0006766; P:vitamin metabolic process; TAS:Reactome
Q9H3S4	TPK1	Thiamin pyrophosphokinase 1	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0003779; F:actin binding; TAS:BHF-UCL
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0008092; F:cytoskeletal protein binding; IPI:UniProtKB
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0005200; F:structural constituent of cytoskeleton; TAS:BHF-UCL
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0008307; F:structural constituent of muscle; TAS:ProtInc
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0006928; P:cellular component movement; TAS:UniProtKB
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0034614; P:cellular response to reactive oxygen species; IEP:BHF-UCL
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0007010; P:cytoskeleton organization; TAS:BHF-UCL
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0006936; P:muscle contraction; TAS:Reactome
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0030049; P:muscle filament sliding; ISS:BHF-UCL
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0030336; P:negative regulation of cell migration; ISS:BHF-UCL
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0032781; P:positive regulation of ATPase activity; ISS:BHF-UCL
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0045785; P:positive regulation of cell adhesion; ISS:BHF-UCL
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0003065; P:positive regulation of heart rate by epinephrine; ISS:BHF-UCL
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0051496; P:positive regulation of stress fiber assembly; ISS:BHF-UCL
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0008016; P:regulation of heart contraction; TAS:ProtInc
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0006937; P:regulation of muscle contraction; TAS:ProtInc
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0031529; P:ruffle organization; ISS:BHF-UCL
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0045214; P:sarcomere organization; IMP:BHF-UCL
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IMP:BHF-UCL
P09493	TPM1	Tropomyosin alpha-1 chain	GO:0042060; P:wound healing; ISS:BHF-UCL
P07951	TPM2	Tropomyosin beta chain	GO:0003779; F:actin binding; IDA:UniProtKB
P07951	TPM2	Tropomyosin beta chain	GO:0008307; F:structural constituent of muscle; TAS:ProtInc
P07951	TPM2	Tropomyosin beta chain	GO:0006936; P:muscle contraction; TAS:Reactome
P07951	TPM2	Tropomyosin beta chain	GO:0030049; P:muscle filament sliding; TAS:Reactome
P07951	TPM2	Tropomyosin beta chain	GO:0043462; P:regulation of ATPase activity; IDA:UniProtKB
P06753	TPM3	Tropomyosin alpha-3 chain	GO:0007155; P:cell adhesion; IEA:InterPro
P06753	TPM3	Tropomyosin alpha-3 chain	GO:0006928; P:cellular component movement; TAS:UniProtKB
P06753	TPM3	Tropomyosin alpha-3 chain	GO:0006936; P:muscle contraction; TAS:Reactome
P06753	TPM3	Tropomyosin alpha-3 chain	GO:0030049; P:muscle filament sliding; TAS:Reactome
P67936	TPM4	Tropomyosin alpha-4 chain	GO:0005509; F:calcium ion binding; NAS:UniProtKB
P67936	TPM4	Tropomyosin alpha-4 chain	GO:0008307; F:structural constituent of muscle; TAS:ProtInc
P67936	TPM4	Tropomyosin alpha-4 chain	GO:0006928; P:cellular component movement; TAS:UniProtKB
P67936	TPM4	Tropomyosin alpha-4 chain	GO:0006936; P:muscle contraction; TAS:Reactome
P67936	TPM4	Tropomyosin alpha-4 chain	GO:0030049; P:muscle filament sliding; TAS:Reactome
P51580	TPMT	Thiopurine S-methyltransferase	GO:0008119; F:thiopurine S-methyltransferase activity; TAS:ProtInc
P51580	TPMT	Thiopurine S-methyltransferase	GO:0032259; P:methylation; TAS:Reactome
P51580	TPMT	Thiopurine S-methyltransferase	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
P51580	TPMT	Thiopurine S-methyltransferase	GO:0033574; P:response to testosterone; IEA:Ensembl
P51580	TPMT	Thiopurine S-methyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P51580	TPMT	Thiopurine S-methyltransferase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P40238	MPL	Thrombopoietin receptor	GO:0004896; F:cytokine receptor activity; IEA:InterPro
P40238	MPL	Thrombopoietin receptor	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
P40238	MPL	Thrombopoietin receptor	GO:0007596; P:blood coagulation; TAS:Reactome
P40238	MPL	Thrombopoietin receptor	GO:0008283; P:cell proliferation; TAS:ProtInc
P40238	MPL	Thrombopoietin receptor	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
P40238	MPL	Thrombopoietin receptor	GO:0048872; P:homeostasis of number of cells; IEA:Ensembl
P40238	MPL	Thrombopoietin receptor	GO:0030168; P:platelet activation; TAS:Reactome
P40238	MPL	Thrombopoietin receptor	GO:0032642; P:regulation of chemokine production; IEA:Ensembl
P40225	THPO	Thrombopoietin	GO:0008083; F:growth factor activity; TAS:ProtInc
P40225	THPO	Thrombopoietin	GO:0007596; P:blood coagulation; TAS:Reactome
P40225	THPO	Thrombopoietin	GO:0008283; P:cell proliferation; TAS:ProtInc
P40225	THPO	Thrombopoietin	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P40225	THPO	Thrombopoietin	GO:0030099; P:myeloid cell differentiation; IEA:Ensembl
P40225	THPO	Thrombopoietin	GO:0030168; P:platelet activation; TAS:Reactome
P40225	THPO	Thrombopoietin	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB
P40225	THPO	Thrombopoietin	GO:0045654; P:positive regulation of megakaryocyte differentiation; ISS:UniProtKB
P40225	THPO	Thrombopoietin	GO:0051897; P:positive regulation of protein kinase B signaling; ISS:UniProtKB
P40225	THPO	Thrombopoietin	GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB
P40225	THPO	Thrombopoietin	GO:0038163; P:thrombopoietin-mediated signaling pathway; ISS:UniProtKB
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0004175; F:endopeptidase activity; IDA:UniProtKB
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0008233; F:peptidase activity; IMP:UniProtKB
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0042277; F:peptide binding; ISS:UniProtKB
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0005515; F:protein binding; IPI:UniProtKB
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0008236; F:serine-type peptidase activity; IMP:UniProtKB
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0008240; F:tripeptidyl-peptidase activity; IDA:UniProtKB
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0045453; P:bone resorption; IMP:UniProtKB
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0008219; P:cell death; IEA:UniProtKB-KW
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0006629; P:lipid metabolic process; TAS:ProtInc
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0007040; P:lysosome organization; ISS:UniProtKB
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0007399; P:nervous system development; IMP:UniProtKB
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0050885; P:neuromuscular process controlling balance; ISS:UniProtKB
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0043171; P:peptide catabolic process; IMP:UniProtKB
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0030163; P:protein catabolic process; NAS:UniProtKB
O14773	TPP1	Tripeptidyl-peptidase 1	GO:0006508; P:proteolysis; IMP:UniProtKB
P29144	TPP2	Tripeptidyl-peptidase 2	GO:0004177; F:aminopeptidase activity; IEA:UniProtKB-KW
P29144	TPP2	Tripeptidyl-peptidase 2	GO:0004175; F:endopeptidase activity; TAS:ProtInc
P29144	TPP2	Tripeptidyl-peptidase 2	GO:0004252; F:serine-type endopeptidase activity; IBA:RefGenome
P29144	TPP2	Tripeptidyl-peptidase 2	GO:0008240; F:tripeptidyl-peptidase activity; TAS:ProtInc
P29144	TPP2	Tripeptidyl-peptidase 2	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P29144	TPP2	Tripeptidyl-peptidase 2	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P29144	TPP2	Tripeptidyl-peptidase 2	GO:0006508; P:proteolysis; IBA:RefGenome
Q9Y5R8	TRAPPC1	Trafficking protein particle complex subunit 1	GO:0006888; P:ER to Golgi vesicle-mediated transport; IEA:InterPro
O43617	TRAPPC3	Trafficking protein particle complex subunit 3	GO:0005515; F:protein binding; IPI:IntAct
O43617	TRAPPC3	Trafficking protein particle complex subunit 3	GO:0006888; P:ER to Golgi vesicle-mediated transport; IEA:Ensembl
Q9Y296	TRAPPC4	Trafficking protein particle complex subunit 4	GO:0005515; F:protein binding; IPI:IntAct
Q9Y296	TRAPPC4	Trafficking protein particle complex subunit 4	GO:0016358; P:dendrite development; ISS:UniProtKB
Q9Y296	TRAPPC4	Trafficking protein particle complex subunit 4	GO:0006888; P:ER to Golgi vesicle-mediated transport; IEA:InterPro
Q9Y296	TRAPPC4	Trafficking protein particle complex subunit 4	GO:0030198; P:extracellular matrix organization; TAS:Reactome
Q8IUR0	TRAPPC5	Trafficking protein particle complex subunit 5	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q9Y2L5	TRAPPC8	Trafficking protein particle complex subunit 8	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2L5	TRAPPC8	Trafficking protein particle complex subunit 8	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q96Q05	TRAPPC9	Trafficking protein particle complex subunit 9	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9BW30	TPPP3	Tubulin polymerization-promoting protein family member 3	GO:0015631; F:tubulin binding; IDA:UniProtKB
Q9BW30	TPPP3	Tubulin polymerization-promoting protein family member 3	GO:0001578; P:microtubule bundle formation; IDA:UniProtKB
O94811	TPPP	Tubulin polymerization-promoting protein	GO:0008017; F:microtubule binding; ISS:HGNC
O94811	TPPP	Tubulin polymerization-promoting protein	GO:0005515; F:protein binding; IPI:UniProtKB
O94811	TPPP	Tubulin polymerization-promoting protein	GO:0015631; F:tubulin binding; IDA:UniProtKB
O94811	TPPP	Tubulin polymerization-promoting protein	GO:0001578; P:microtubule bundle formation; IDA:UniProtKB
O94811	TPPP	Tubulin polymerization-promoting protein	GO:0046785; P:microtubule polymerization; IDA:UniProtKB
O94811	TPPP	Tubulin polymerization-promoting protein	GO:0031334; P:positive regulation of protein complex assembly; ISS:HGNC
O94811	TPPP	Tubulin polymerization-promoting protein	GO:0032273; P:positive regulation of protein polymerization; IDA:HGNC
Q86W33	TPRA1	Transmembrane protein adipocyte-associated 1	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q86W33	TPRA1	Transmembrane protein adipocyte-associated 1	GO:0007568; P:aging; TAS:ProtInc
Q86W33	TPRA1	Transmembrane protein adipocyte-associated 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:GOC
Q86W33	TPRA1	Transmembrane protein adipocyte-associated 1	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q9Y3C4	TPRKB	EKC/KEOPS complex subunit TPRKB	GO:0005515; F:protein binding; IPI:IntAct
Q9Y3C4	TPRKB	EKC/KEOPS complex subunit TPRKB	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q9Y3C4	TPRKB	EKC/KEOPS complex subunit TPRKB	GO:0030163; P:protein catabolic process; NAS:UniProtKB
Q9Y3C4	TPRKB	EKC/KEOPS complex subunit TPRKB	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q4KMQ1	TPRN	Taperin	GO:0007605; P:sensory perception of sound; IMP:UniProtKB
Q8N7U7	TPRX1	Tetra-peptide repeat homeobox protein 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q8N7U7	TPRX1	Tetra-peptide repeat homeobox protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P12270	TPR	Nucleoprotein TPR	GO:0005524; F:ATP binding; IEA:InterPro
P12270	TPR	Nucleoprotein TPR	GO:0003682; F:chromatin binding; IDA:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0070840; F:dynein complex binding; IDA:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0031072; F:heat shock protein binding; IDA:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0051019; F:mitogen-activated protein kinase binding; IDA:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0003729; F:mRNA binding; IDA:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0005487; F:nucleocytoplasmic transporter activity; IDA:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0005515; F:protein binding; IPI:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0004828; F:serine-tRNA ligase activity; IEA:InterPro
P12270	TPR	Nucleoprotein TPR	GO:0015631; F:tubulin binding; IDA:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P12270	TPR	Nucleoprotein TPR	GO:0034605; P:cellular response to heat; IDA:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0035457; P:cellular response to interferon-alpha; ISS:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P12270	TPR	Nucleoprotein TPR	GO:0015758; P:glucose transport; TAS:Reactome
P12270	TPR	Nucleoprotein TPR	GO:0008645; P:hexose transport; TAS:Reactome
P12270	TPR	Nucleoprotein TPR	GO:0000189; P:MAPK import into nucleus; IMP:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P12270	TPR	Nucleoprotein TPR	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P12270	TPR	Nucleoprotein TPR	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
P12270	TPR	Nucleoprotein TPR	GO:0007094; P:mitotic spindle assembly checkpoint; IMP:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0031990; P:mRNA export from nucleus in response to heat stress; IDA:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0046832; P:negative regulation of RNA export from nucleus; IDA:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0045947; P:negative regulation of translational initiation; IMP:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0006999; P:nuclear pore organization; IMP:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0031453; P:positive regulation of heterochromatin assembly; IMP:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0090316; P:positive regulation of intracellular protein transport; IMP:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0090267; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; IMP:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0046827; P:positive regulation of protein export from nucleus; ISS:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0042307; P:positive regulation of protein import into nucleus; IMP:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0006606; P:protein import into nucleus; TAS:ProtInc
P12270	TPR	Nucleoprotein TPR	GO:0010827; P:regulation of glucose transport; TAS:Reactome
P12270	TPR	Nucleoprotein TPR	GO:0010965; P:regulation of mitotic sister chromatid separation; IMP:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:1901673; P:regulation of spindle assembly involved in mitosis; IMP:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0070849; P:response to epidermal growth factor; IDA:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0006405; P:RNA export from nucleus; IMP:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0006404; P:RNA import into nucleus; IDA:UniProtKB
P12270	TPR	Nucleoprotein TPR	GO:0006434; P:seryl-tRNA aminoacylation; IEA:InterPro
P12270	TPR	Nucleoprotein TPR	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P12270	TPR	Nucleoprotein TPR	GO:0055085; P:transmembrane transport; TAS:Reactome
P12270	TPR	Nucleoprotein TPR	GO:0016032; P:viral process; TAS:Reactome
O15533	TAPBP	Tapasin	GO:0042288; F:MHC class I protein binding; TAS:UniProtKB
O15533	TAPBP	Tapasin	GO:0042605; F:peptide antigen binding; TAS:UniProtKB
O15533	TAPBP	Tapasin	GO:0015433; F:peptide antigen-transporting ATPase activity; TAS:ProtInc
O15533	TAPBP	Tapasin	GO:0005515; F:protein binding; IPI:IntAct
O15533	TAPBP	Tapasin	GO:0046978; F:TAP1 binding; IPI:UniProtKB
O15533	TAPBP	Tapasin	GO:0046979; F:TAP2 binding; IPI:UniProtKB
O15533	TAPBP	Tapasin	GO:0051082; F:unfolded protein binding; TAS:UniProtKB
O15533	TAPBP	Tapasin	GO:0042886; P:amide transport; TAS:GOC
O15533	TAPBP	Tapasin	GO:0019885; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; IEA:InterPro
O15533	TAPBP	Tapasin	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
O15533	TAPBP	Tapasin	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
O15533	TAPBP	Tapasin	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
O15533	TAPBP	Tapasin	GO:0006955; P:immune response; TAS:ProtInc
O15533	TAPBP	Tapasin	GO:0050823; P:peptide antigen stabilization; ISS:UniProtKB
O15533	TAPBP	Tapasin	GO:0015833; P:peptide transport; TAS:GOC
O15533	TAPBP	Tapasin	GO:0006461; P:protein complex assembly; TAS:ProtInc
O15533	TAPBP	Tapasin	GO:0006890; P:retrograde vesicle-mediated transport, Golgi to ER; NAS:UniProtKB
O60507	TPST1	Protein-tyrosine sulfotransferase 1	GO:0008476; F:protein-tyrosine sulfotransferase activity; TAS:ProtInc
O60507	TPST1	Protein-tyrosine sulfotransferase 1	GO:0006954; P:inflammatory response; TAS:ProtInc
O60507	TPST1	Protein-tyrosine sulfotransferase 1	GO:0006478; P:peptidyl-tyrosine sulfation; TAS:ProtInc
O60704	TPST2	Protein-tyrosine sulfotransferase 2	GO:0008476; F:protein-tyrosine sulfotransferase activity; TAS:ProtInc
O60704	TPST2	Protein-tyrosine sulfotransferase 2	GO:0007342; P:fusion of sperm to egg plasma membrane; IEA:Ensembl
O60704	TPST2	Protein-tyrosine sulfotransferase 2	GO:0006478; P:peptidyl-tyrosine sulfation; TAS:ProtInc
O60704	TPST2	Protein-tyrosine sulfotransferase 2	GO:0060468; P:prevention of polyspermy; IEA:Ensembl
Q6XPS3	TPTE2	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2	GO:0005216; F:ion channel activity; IEA:InterPro
Q6XPS3	TPTE2	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2	GO:0016314; F:phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; IEA:UniProtKB-EC
Q6XPS3	TPTE2	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2	GO:0004725; F:protein tyrosine phosphatase activity; IEA:InterPro
Q6XPS3	TPTE2	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro
Q6XPS3	TPTE2	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q6XPS3	TPTE2	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q6XPS3	TPTE2	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P56180	TPTE	Putative tyrosine-protein phosphatase TPTE	GO:0005216; F:ion channel activity; IEA:InterPro
P56180	TPTE	Putative tyrosine-protein phosphatase TPTE	GO:0004725; F:protein tyrosine phosphatase activity; TAS:ProtInc
P56180	TPTE	Putative tyrosine-protein phosphatase TPTE	GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro
P56180	TPTE	Putative tyrosine-protein phosphatase TPTE	GO:0035335; P:peptidyl-tyrosine dephosphorylation; TAS:GOC
P56180	TPTE	Putative tyrosine-protein phosphatase TPTE	GO:0006470; P:protein dephosphorylation; TAS:ProtInc
P56180	TPTE	Putative tyrosine-protein phosphatase TPTE	GO:0007165; P:signal transduction; TAS:ProtInc
Q9ULW0	TPX2	Targeting protein for Xklp2	GO:0005524; F:ATP binding; TAS:ProtInc
Q9ULW0	TPX2	Targeting protein for Xklp2	GO:0005525; F:GTP binding; TAS:ProtInc
Q9ULW0	TPX2	Targeting protein for Xklp2	GO:0005515; F:protein binding; IPI:IntAct
Q9ULW0	TPX2	Targeting protein for Xklp2	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q9ULW0	TPX2	Targeting protein for Xklp2	GO:0032147; P:activation of protein kinase activity; IDA:UniProtKB
Q9ULW0	TPX2	Targeting protein for Xklp2	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9ULW0	TPX2	Targeting protein for Xklp2	GO:0008283; P:cell proliferation; TAS:ProtInc
Q9ULW0	TPX2	Targeting protein for Xklp2	GO:0007067; P:mitosis; TAS:ProtInc
Q9ULW0	TPX2	Targeting protein for Xklp2	GO:0060236; P:regulation of mitotic spindle organization; ISS:UniProtKB
O00220	TNFRSF10A	Tumor necrosis factor receptor superfamily member 10A	GO:0005035; F:death receptor activity; TAS:ProtInc
O00220	TNFRSF10A	Tumor necrosis factor receptor superfamily member 10A	GO:0005515; F:protein binding; IPI:UniProtKB
O00220	TNFRSF10A	Tumor necrosis factor receptor superfamily member 10A	GO:0004872; F:receptor activity; NAS:UniProtKB
O00220	TNFRSF10A	Tumor necrosis factor receptor superfamily member 10A	GO:0045569; F:TRAIL binding; NAS:UniProtKB
O00220	TNFRSF10A	Tumor necrosis factor receptor superfamily member 10A	GO:0008134; F:transcription factor binding; IPI:UniProtKB
O00220	TNFRSF10A	Tumor necrosis factor receptor superfamily member 10A	GO:0007250; P:activation of NF-kappaB-inducing kinase activity; NAS:UniProtKB
O00220	TNFRSF10A	Tumor necrosis factor receptor superfamily member 10A	GO:0006915; P:apoptotic process; NAS:UniProtKB
O00220	TNFRSF10A	Tumor necrosis factor receptor superfamily member 10A	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
O00220	TNFRSF10A	Tumor necrosis factor receptor superfamily member 10A	GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:UniProtKB
O00220	TNFRSF10A	Tumor necrosis factor receptor superfamily member 10A	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; NAS:UniProtKB
O00220	TNFRSF10A	Tumor necrosis factor receptor superfamily member 10A	GO:0007165; P:signal transduction; TAS:ProtInc
O14763	TNFRSF10B	Tumor necrosis factor receptor superfamily member 10B	GO:0005515; F:protein binding; IPI:IntAct
O14763	TNFRSF10B	Tumor necrosis factor receptor superfamily member 10B	GO:0004872; F:receptor activity; NAS:UniProtKB
O14763	TNFRSF10B	Tumor necrosis factor receptor superfamily member 10B	GO:0045569; F:TRAIL binding; NAS:UniProtKB
O14763	TNFRSF10B	Tumor necrosis factor receptor superfamily member 10B	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:Reactome
O14763	TNFRSF10B	Tumor necrosis factor receptor superfamily member 10B	GO:0007250; P:activation of NF-kappaB-inducing kinase activity; NAS:UniProtKB
O14763	TNFRSF10B	Tumor necrosis factor receptor superfamily member 10B	GO:0006915; P:apoptotic process; NAS:UniProtKB
O14763	TNFRSF10B	Tumor necrosis factor receptor superfamily member 10B	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
O14763	TNFRSF10B	Tumor necrosis factor receptor superfamily member 10B	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
O14763	TNFRSF10B	Tumor necrosis factor receptor superfamily member 10B	GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB
O14763	TNFRSF10B	Tumor necrosis factor receptor superfamily member 10B	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; NAS:UniProtKB
O14763	TNFRSF10B	Tumor necrosis factor receptor superfamily member 10B	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IMP:UniProtKB
O14763	TNFRSF10B	Tumor necrosis factor receptor superfamily member 10B	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
O14763	TNFRSF10B	Tumor necrosis factor receptor superfamily member 10B	GO:0042981; P:regulation of apoptotic process; NAS:UniProtKB
O14763	TNFRSF10B	Tumor necrosis factor receptor superfamily member 10B	GO:2001239; P:regulation of extrinsic apoptotic signaling pathway in absence of ligand; TAS:Reactome
O14763	TNFRSF10B	Tumor necrosis factor receptor superfamily member 10B	GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB
O14798	TNFRSF10C	Tumor necrosis factor receptor superfamily member 10C	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
O14798	TNFRSF10C	Tumor necrosis factor receptor superfamily member 10C	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O14798	TNFRSF10C	Tumor necrosis factor receptor superfamily member 10C	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UBN6	TNFRSF10D	Tumor necrosis factor receptor superfamily member 10D	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q9UBN6	TNFRSF10D	Tumor necrosis factor receptor superfamily member 10D	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9UBN6	TNFRSF10D	Tumor necrosis factor receptor superfamily member 10D	GO:0043066; P:negative regulation of apoptotic process; TAS:ProtInc
Q9UBN6	TNFRSF10D	Tumor necrosis factor receptor superfamily member 10D	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UI30	TRMT112	tRNA methyltransferase 112 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UI30	TRMT112	tRNA methyltransferase 112 homolog	GO:0008276; F:protein methyltransferase activity; IDA:MGI
Q9UI30	TRMT112	tRNA methyltransferase 112 homolog	GO:0018364; P:peptidyl-glutamine methylation; IDA:UniProtKB
O00300	TNFRSF11B	Tumor necrosis factor receptor superfamily member 11B	GO:0005125; F:cytokine activity; TAS:ProtInc
O00300	TNFRSF11B	Tumor necrosis factor receptor superfamily member 11B	GO:0004872; F:receptor activity; TAS:ProtInc
O00300	TNFRSF11B	Tumor necrosis factor receptor superfamily member 11B	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O00300	TNFRSF11B	Tumor necrosis factor receptor superfamily member 11B	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
O00300	TNFRSF11B	Tumor necrosis factor receptor superfamily member 11B	GO:0045779; P:negative regulation of bone resorption; IEA:Ensembl
O00300	TNFRSF11B	Tumor necrosis factor receptor superfamily member 11B	GO:0042489; P:negative regulation of odontogenesis of dentin-containing tooth; IEA:Ensembl
O00300	TNFRSF11B	Tumor necrosis factor receptor superfamily member 11B	GO:0046685; P:response to arsenic-containing substance; IEA:Ensembl
O00300	TNFRSF11B	Tumor necrosis factor receptor superfamily member 11B	GO:0042493; P:response to drug; IEA:Ensembl
O00300	TNFRSF11B	Tumor necrosis factor receptor superfamily member 11B	GO:0043627; P:response to estrogen; IEA:Ensembl
O00300	TNFRSF11B	Tumor necrosis factor receptor superfamily member 11B	GO:0032026; P:response to magnesium ion; IEA:Ensembl
O00300	TNFRSF11B	Tumor necrosis factor receptor superfamily member 11B	GO:0007584; P:response to nutrient; IEA:Ensembl
O00300	TNFRSF11B	Tumor necrosis factor receptor superfamily member 11B	GO:0007165; P:signal transduction; TAS:ProtInc
O00300	TNFRSF11B	Tumor necrosis factor receptor superfamily member 11B	GO:0001501; P:skeletal system development; TAS:ProtInc
O14836	TNFRSF13B	Tumor necrosis factor receptor superfamily member 13B	GO:0005515; F:protein binding; IPI:IntAct
O14836	TNFRSF13B	Tumor necrosis factor receptor superfamily member 13B	GO:0004872; F:receptor activity; TAS:ProtInc
O14836	TNFRSF13B	Tumor necrosis factor receptor superfamily member 13B	GO:0001782; P:B cell homeostasis; IEA:Ensembl
O14836	TNFRSF13B	Tumor necrosis factor receptor superfamily member 13B	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
O14836	TNFRSF13B	Tumor necrosis factor receptor superfamily member 13B	GO:0030889; P:negative regulation of B cell proliferation; IEA:Ensembl
Q96RJ3	TNFRSF13C	Tumor necrosis factor receptor superfamily member 13C	GO:0031296; P:B cell costimulation; IEA:Ensembl
Q96RJ3	TNFRSF13C	Tumor necrosis factor receptor superfamily member 13C	GO:0001782; P:B cell homeostasis; IEA:Ensembl
Q96RJ3	TNFRSF13C	Tumor necrosis factor receptor superfamily member 13C	GO:0030890; P:positive regulation of B cell proliferation; IEA:Ensembl
Q96RJ3	TNFRSF13C	Tumor necrosis factor receptor superfamily member 13C	GO:0002636; P:positive regulation of germinal center formation; IEA:Ensembl
Q96RJ3	TNFRSF13C	Tumor necrosis factor receptor superfamily member 13C	GO:0045078; P:positive regulation of interferon-gamma biosynthetic process; IEA:Ensembl
Q96RJ3	TNFRSF13C	Tumor necrosis factor receptor superfamily member 13C	GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl
Q96RJ3	TNFRSF13C	Tumor necrosis factor receptor superfamily member 13C	GO:0031295; P:T cell costimulation; IEA:Ensembl
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; NAS:UniProtKB
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0051219; F:phosphoprotein binding; IDA:UniProtKB
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0004872; F:receptor activity; IDA:UniProtKB
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0001104; F:RNA polymerase II transcription cofactor activity; IDA:UniProtKB
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0046966; F:thyroid hormone receptor binding; IDA:UniProtKB
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0003713; F:transcription coactivator activity; IDA:MGI
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0003712; F:transcription cofactor activity; IDA:UniProtKB
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0042809; F:vitamin D receptor binding; NAS:UniProtKB
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0030521; P:androgen receptor signaling pathway; IDA:UniProtKB
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0030518; P:intracellular steroid hormone receptor signaling pathway; IDA:UniProtKB
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0048255; P:mRNA stabilization; IMP:UniProtKB
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0000956; P:nuclear-transcribed mRNA catabolic process; IDA:UniProtKB
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; IMP:UniProtKB
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IMP:UniProtKB
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q9Y2W1	THRAP3	Thyroid hormone receptor-associated protein 3	GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB
Q8N609	TRAM1L1	Translocating chain-associated membrane protein 1-like 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
A6NCK2	TRIM43B	Tripartite motif-containing protein 43B	GO:0008270; F:zinc ion binding; IEA:InterPro
A6NDI0	TRIM49B	Putative tripartite motif-containing protein 49B	GO:0008270; F:zinc ion binding; IEA:InterPro
P0CI26	TRIM49C	Tripartite motif-containing protein 49C	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BVS5	TRMT61B	tRNA (adenine(58)-N(1))-methyltransferase, mitochondrial	GO:0005515; F:protein binding; IPI:IntAct
Q9BVS5	TRMT61B	tRNA (adenine(58)-N(1))-methyltransferase, mitochondrial	GO:0016429; F:tRNA (adenine-N1-)-methyltransferase activity; IDA:UniProtKB
Q9BVS5	TRMT61B	tRNA (adenine(58)-N(1))-methyltransferase, mitochondrial	GO:0070901; P:mitochondrial tRNA methylation; IDA:UniProtKB
Q9BVS5	TRMT61B	tRNA (adenine(58)-N(1))-methyltransferase, mitochondrial	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
A6NI03	TRIM64B	Putative tripartite motif-containing protein 64B	GO:0008270; F:zinc ion binding; IEA:InterPro
A6NLI5	TRIM64C	Putative tripartite motif-containing protein 64C	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13595	TRA2A	Transformer-2 protein homolog alpha	GO:0000166; F:nucleotide binding; IEA:InterPro
Q13595	TRA2A	Transformer-2 protein homolog alpha	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q13595	TRA2A	Transformer-2 protein homolog alpha	GO:0000398; P:mRNA splicing, via spliceosome; IDA:UniProtKB
P62995	TRA2B	Transformer-2 protein homolog beta	GO:0003729; F:mRNA binding; IDA:UniProtKB
P62995	TRA2B	Transformer-2 protein homolog beta	GO:0000166; F:nucleotide binding; IEA:InterPro
P62995	TRA2B	Transformer-2 protein homolog beta	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62995	TRA2B	Transformer-2 protein homolog beta	GO:0005515; F:protein binding; IPI:UniProtKB
P62995	TRA2B	Transformer-2 protein homolog beta	GO:0000398; P:mRNA splicing, via spliceosome; IDA:UniProtKB
P62995	TRA2B	Transformer-2 protein homolog beta	GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; IDA:UniProtKB
P62995	TRA2B	Transformer-2 protein homolog beta	GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB
P62995	TRA2B	Transformer-2 protein homolog beta	GO:0000375; P:RNA splicing, via transesterification reactions; TAS:UniProtKB
O14545	TRAFD1	TRAF-type zinc finger domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14545	TRAFD1	TRAF-type zinc finger domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
O14545	TRAFD1	TRAF-type zinc finger domain-containing protein 1	GO:0045824; P:negative regulation of innate immune response; ISS:UniProtKB
O14545	TRAFD1	TRAF-type zinc finger domain-containing protein 1	GO:0034097; P:response to cytokine; IEA:Ensembl
Q15628	TRADD	Tumor necrosis factor receptor type 1-associated DEATH domain protein	GO:0060090; F:binding, bridging; IPI:BHF-UCL
Q15628	TRADD	Tumor necrosis factor receptor type 1-associated DEATH domain protein	GO:0070513; F:death domain binding; IPI:BHF-UCL
Q15628	TRADD	Tumor necrosis factor receptor type 1-associated DEATH domain protein	GO:0042802; F:identical protein binding; IPI:IntAct
Q15628	TRADD	Tumor necrosis factor receptor type 1-associated DEATH domain protein	GO:0019900; F:kinase binding; IPI:BHF-UCL
Q15628	TRADD	Tumor necrosis factor receptor type 1-associated DEATH domain protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q15628	TRADD	Tumor necrosis factor receptor type 1-associated DEATH domain protein	GO:0004871; F:signal transducer activity; IEA:InterPro
Q15628	TRADD	Tumor necrosis factor receptor type 1-associated DEATH domain protein	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:Reactome
Q15628	TRADD	Tumor necrosis factor receptor type 1-associated DEATH domain protein	GO:0006915; P:apoptotic process; TAS:Reactome
Q15628	TRADD	Tumor necrosis factor receptor type 1-associated DEATH domain protein	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q15628	TRADD	Tumor necrosis factor receptor type 1-associated DEATH domain protein	GO:0097191; P:extrinsic apoptotic signaling pathway; IMP:UniProtKB
Q15628	TRADD	Tumor necrosis factor receptor type 1-associated DEATH domain protein	GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; TAS:BHF-UCL
Q15628	TRADD	Tumor necrosis factor receptor type 1-associated DEATH domain protein	GO:0043065; P:positive regulation of apoptotic process; TAS:UniProtKB
Q15628	TRADD	Tumor necrosis factor receptor type 1-associated DEATH domain protein	GO:0051798; P:positive regulation of hair follicle development; IEA:Ensembl
Q15628	TRADD	Tumor necrosis factor receptor type 1-associated DEATH domain protein	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
Q15628	TRADD	Tumor necrosis factor receptor type 1-associated DEATH domain protein	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:UniProtKB
Q15628	TRADD	Tumor necrosis factor receptor type 1-associated DEATH domain protein	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q15628	TRADD	Tumor necrosis factor receptor type 1-associated DEATH domain protein	GO:2001239; P:regulation of extrinsic apoptotic signaling pathway in absence of ligand; TAS:Reactome
Q15628	TRADD	Tumor necrosis factor receptor type 1-associated DEATH domain protein	GO:0007165; P:signal transduction; TAS:ProtInc
Q15628	TRADD	Tumor necrosis factor receptor type 1-associated DEATH domain protein	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; TAS:BHF-UCL
Q13077	TRAF1	TNF receptor-associated factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q13077	TRAF1	TNF receptor-associated factor 1	GO:0031996; F:thioesterase binding; IPI:UniProtKB
Q13077	TRAF1	TNF receptor-associated factor 1	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q13077	TRAF1	TNF receptor-associated factor 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13077	TRAF1	TNF receptor-associated factor 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q13077	TRAF1	TNF receptor-associated factor 1	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q13077	TRAF1	TNF receptor-associated factor 1	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q13077	TRAF1	TNF receptor-associated factor 1	GO:2001236; P:regulation of extrinsic apoptotic signaling pathway; IDA:UniProtKB
Q13077	TRAF1	TNF receptor-associated factor 1	GO:0007165; P:signal transduction; IEA:InterPro
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0005174; F:CD40 receptor binding; ISS:BHF-UCL
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0019899; F:enzyme binding; IPI:BHF-UCL
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0042802; F:identical protein binding; IPI:IntAct
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0005515; F:protein binding; IPI:IntAct
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0004871; F:signal transducer activity; NAS:ProtInc
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0046625; F:sphingolipid binding; IDA:UniProtKB
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0031996; F:thioesterase binding; IPI:UniProtKB
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0005164; F:tumor necrosis factor receptor binding; IPI:UniProtKB
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:Reactome
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0007250; P:activation of NF-kappaB-inducing kinase activity; IMP:UniProtKB
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0006915; P:apoptotic process; TAS:Reactome
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0043623; P:cellular protein complex assembly; ISS:BHF-UCL
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0045087; P:innate immune response; TAS:Reactome
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0034351; P:negative regulation of glial cell apoptotic process; IEA:Ensembl
Q12933	TRAF2	TNF receptor-associated factor 2	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0032743; P:positive regulation of interleukin-2 production; IMP:UniProtKB
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0043507; P:positive regulation of JUN kinase activity; IDA:UniProtKB
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0090073; P:positive regulation of protein homodimerization activity; IMP:UniProtKB
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0050870; P:positive regulation of T cell activation; IC:UniProtKB
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0002726; P:positive regulation of T cell cytokine production; IMP:UniProtKB
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0030163; P:protein catabolic process; IEA:Ensembl
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0070207; P:protein homotrimerization; IPI:UniProtKB
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0042981; P:regulation of apoptotic process; IDA:UniProtKB
Q12933	TRAF2	TNF receptor-associated factor 2	GO:2001239; P:regulation of extrinsic apoptotic signaling pathway in absence of ligand; TAS:Reactome
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0051023; P:regulation of immunoglobulin secretion; IEA:Ensembl
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0007165; P:signal transduction; TAS:ProtInc
Q12933	TRAF2	TNF receptor-associated factor 2	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IDA:UniProtKB
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0004871; F:signal transducer activity; TAS:ProtInc
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0031996; F:thioesterase binding; IPI:UniProtKB
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0004842; F:ubiquitin-protein ligase activity; IEA:InterPro
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0006915; P:apoptotic process; TAS:ProtInc
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0045087; P:innate immune response; TAS:Reactome
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0042981; P:regulation of apoptotic process; IEA:InterPro
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0001817; P:regulation of cytokine production; ISS:UniProtKB
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0050688; P:regulation of defense response to virus; ISS:UniProtKB
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0032648; P:regulation of interferon-beta production; ISS:UniProtKB
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0030162; P:regulation of proteolysis; IMP:UniProtKB
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0007165; P:signal transduction; TAS:ProtInc
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0002224; P:toll-like receptor signaling pathway; ISS:UniProtKB
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q13114	TRAF3	TNF receptor-associated factor 3	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IMP:UniProtKB
Q9BUZ4	TRAF4	TNF receptor-associated factor 4	GO:0003677; F:DNA binding; TAS:ProtInc
Q9BUZ4	TRAF4	TNF receptor-associated factor 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BUZ4	TRAF4	TNF receptor-associated factor 4	GO:0031996; F:thioesterase binding; IPI:UniProtKB
Q9BUZ4	TRAF4	TNF receptor-associated factor 4	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q9BUZ4	TRAF4	TNF receptor-associated factor 4	GO:0004842; F:ubiquitin-protein ligase activity; IEA:InterPro
Q9BUZ4	TRAF4	TNF receptor-associated factor 4	GO:0050699; F:WW domain binding; IPI:UniProtKB
Q9BUZ4	TRAF4	TNF receptor-associated factor 4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BUZ4	TRAF4	TNF receptor-associated factor 4	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9BUZ4	TRAF4	TNF receptor-associated factor 4	GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB
Q9BUZ4	TRAF4	TNF receptor-associated factor 4	GO:0090073; P:positive regulation of protein homodimerization activity; IDA:UniProtKB
Q9BUZ4	TRAF4	TNF receptor-associated factor 4	GO:0045860; P:positive regulation of protein kinase activity; IDA:UniProtKB
Q9BUZ4	TRAF4	TNF receptor-associated factor 4	GO:0042981; P:regulation of apoptotic process; IEA:InterPro
Q9BUZ4	TRAF4	TNF receptor-associated factor 4	GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl
Q9BUZ4	TRAF4	TNF receptor-associated factor 4	GO:0030323; P:respiratory tube development; IEA:Ensembl
Q9BUZ4	TRAF4	TNF receptor-associated factor 4	GO:0007165; P:signal transduction; TAS:ProtInc
O00463	TRAF5	TNF receptor-associated factor 5	GO:0005515; F:protein binding; IPI:UniProtKB
O00463	TRAF5	TNF receptor-associated factor 5	GO:0004871; F:signal transducer activity; IEA:Ensembl
O00463	TRAF5	TNF receptor-associated factor 5	GO:0031996; F:thioesterase binding; IPI:UniProtKB
O00463	TRAF5	TNF receptor-associated factor 5	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
O00463	TRAF5	TNF receptor-associated factor 5	GO:0004842; F:ubiquitin-protein ligase activity; IEA:InterPro
O00463	TRAF5	TNF receptor-associated factor 5	GO:0008270; F:zinc ion binding; IEA:InterPro
O00463	TRAF5	TNF receptor-associated factor 5	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O00463	TRAF5	TNF receptor-associated factor 5	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
O00463	TRAF5	TNF receptor-associated factor 5	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB
O00463	TRAF5	TNF receptor-associated factor 5	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
O00463	TRAF5	TNF receptor-associated factor 5	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL
O00463	TRAF5	TNF receptor-associated factor 5	GO:0042981; P:regulation of apoptotic process; IEA:InterPro
O00463	TRAF5	TNF receptor-associated factor 5	GO:0007165; P:signal transduction; TAS:ProtInc
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0042826; F:histone deacetylase binding; IPI:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0031435; F:mitogen-activated protein kinase kinase kinase binding; IPI:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0043422; F:protein kinase B binding; IPI:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0031996; F:thioesterase binding; IPI:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0031624; F:ubiquitin conjugating enzyme binding; IDA:MGI
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0000187; P:activation of MAPK activity; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0007250; P:activation of NF-kappaB-inducing kinase activity; IMP:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0032147; P:activation of protein kinase activity; IDA:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; IEA:Ensembl
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0045453; P:bone resorption; IEA:Ensembl
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0048468; P:cell development; IEA:Ensembl
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0071222; P:cellular response to lipopolysaccharide; IDA:MGI
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0045087; P:innate immune response; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0070498; P:interleukin-1-mediated signaling pathway; IEA:Ensembl
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0007254; P:JNK cascade; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0031293; P:membrane protein intracellular domain proteolysis; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0043011; P:myeloid dendritic cell differentiation; IEA:Ensembl
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0001843; P:neural tube closure; IEA:Ensembl
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0001503; P:ossification; IEA:UniProtKB-KW
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0030316; P:osteoclast differentiation; IEA:Ensembl
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0045084; P:positive regulation of interleukin-12 biosynthetic process; IEA:Ensembl
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0032743; P:positive regulation of interleukin-2 production; IMP:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0045410; P:positive regulation of interleukin-6 biosynthetic process; IEA:Ensembl
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0043507; P:positive regulation of JUN kinase activity; NAS:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0031666; P:positive regulation of lipopolysaccharide-mediated signaling pathway; IEA:Ensembl
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0045672; P:positive regulation of osteoclast differentiation; IDA:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0031398; P:positive regulation of protein ubiquitination; NAS:BHF-UCL
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0050870; P:positive regulation of T cell activation; IC:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0002726; P:positive regulation of T cell cytokine production; IMP:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:2000679; P:positive regulation of transcription regulatory region DNA binding; IDA:BHF-UCL
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0006461; P:protein complex assembly; IEA:Ensembl
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0051023; P:regulation of immunoglobulin secretion; IEA:Ensembl
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0070555; P:response to interleukin-1; IDA:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0050852; P:T cell receptor signaling pathway; IMP:UniProtKB
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0042088; P:T-helper 1 type immune response; IEA:Ensembl
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q9Y4K3	TRAF6	TNF receptor-associated factor 6	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
Q6Q0C0	TRAF7	E3 ubiquitin-protein ligase TRAF7	GO:0005515; F:protein binding; IPI:IntAct
Q6Q0C0	TRAF7	E3 ubiquitin-protein ligase TRAF7	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q6Q0C0	TRAF7	E3 ubiquitin-protein ligase TRAF7	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q6Q0C0	TRAF7	E3 ubiquitin-protein ligase TRAF7	GO:0000185; P:activation of MAPKKK activity; IDA:UniProtKB
Q6Q0C0	TRAF7	E3 ubiquitin-protein ligase TRAF7	GO:0006915; P:apoptotic process; IDA:MGI
Q6Q0C0	TRAF7	E3 ubiquitin-protein ligase TRAF7	GO:2001235; P:positive regulation of apoptotic signaling pathway; IMP:UniProtKB
Q6Q0C0	TRAF7	E3 ubiquitin-protein ligase TRAF7	GO:0043410; P:positive regulation of MAPK cascade; IDA:MGI
Q6Q0C0	TRAF7	E3 ubiquitin-protein ligase TRAF7	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q6Q0C0	TRAF7	E3 ubiquitin-protein ligase TRAF7	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6Q0C0	TRAF7	E3 ubiquitin-protein ligase TRAF7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BWF2	TRAIP	E3 ubiquitin-protein ligase TRAIP	GO:0005515; F:protein binding; IPI:IntAct
Q9BWF2	TRAIP	E3 ubiquitin-protein ligase TRAIP	GO:0005057; F:receptor signaling protein activity; IEA:Ensembl
Q9BWF2	TRAIP	E3 ubiquitin-protein ligase TRAIP	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BWF2	TRAIP	E3 ubiquitin-protein ligase TRAIP	GO:0006915; P:apoptotic process; TAS:ProtInc
Q9BWF2	TRAIP	E3 ubiquitin-protein ligase TRAIP	GO:0008283; P:cell proliferation; TAS:ProtInc
Q9BWF2	TRAIP	E3 ubiquitin-protein ligase TRAIP	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UPV9	TRAK1	Trafficking kinesin-binding protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UPV9	TRAK1	Trafficking kinesin-binding protein 1	GO:0008333; P:endosome to lysosome transport; IDA:UniProtKB
Q9UPV9	TRAK1	Trafficking kinesin-binding protein 1	GO:0006493; P:protein O-linked glycosylation; ISS:UniProtKB
Q9UPV9	TRAK1	Trafficking kinesin-binding protein 1	GO:0006605; P:protein targeting; ISS:UniProtKB
Q9UPV9	TRAK1	Trafficking kinesin-binding protein 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
O60296	TRAK2	Trafficking kinesin-binding protein 2	GO:0050811; F:GABA receptor binding; NAS:HGNC
O60296	TRAK2	Trafficking kinesin-binding protein 2	GO:0005515; F:protein binding; IPI:HGNC
O60296	TRAK2	Trafficking kinesin-binding protein 2	GO:0005102; F:receptor binding; ISS:UniProtKB
O60296	TRAK2	Trafficking kinesin-binding protein 2	GO:0006493; P:protein O-linked glycosylation; IEA:Ensembl
O60296	TRAK2	Trafficking kinesin-binding protein 2	GO:0006605; P:protein targeting; IEA:Ensembl
O60296	TRAK2	Trafficking kinesin-binding protein 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q15629	TRAM1	Translocating chain-associated membrane protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q15629	TRAM1	Translocating chain-associated membrane protein 1	GO:0004872; F:receptor activity; TAS:ProtInc
Q15629	TRAM1	Translocating chain-associated membrane protein 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q15629	TRAM1	Translocating chain-associated membrane protein 1	GO:0006613; P:cotranslational protein targeting to membrane; TAS:ProtInc
Q15629	TRAM1	Translocating chain-associated membrane protein 1	GO:0010467; P:gene expression; TAS:Reactome
Q15629	TRAM1	Translocating chain-associated membrane protein 1	GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome
Q15629	TRAM1	Translocating chain-associated membrane protein 1	GO:0006412; P:translation; TAS:Reactome
Q15629	TRAM1	Translocating chain-associated membrane protein 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q15035	TRAM2	Translocating chain-associated membrane protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q15035	TRAM2	Translocating chain-associated membrane protein 2	GO:0032964; P:collagen biosynthetic process; IMP:UniProtKB
Q15035	TRAM2	Translocating chain-associated membrane protein 2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q12931	TRAP1	Heat shock protein 75 kDa, mitochondrial	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q12931	TRAP1	Heat shock protein 75 kDa, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q12931	TRAP1	Heat shock protein 75 kDa, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q12931	TRAP1	Heat shock protein 75 kDa, mitochondrial	GO:0005164; F:tumor necrosis factor receptor binding; NAS:UniProtKB
Q12931	TRAP1	Heat shock protein 75 kDa, mitochondrial	GO:1901856; P:negative regulation of cellular respiration; IMP:UniProtKB
Q12931	TRAP1	Heat shock protein 75 kDa, mitochondrial	GO:0006457; P:protein folding; IEA:InterPro
Q12931	TRAP1	Heat shock protein 75 kDa, mitochondrial	GO:0006950; P:response to stress; IEA:InterPro
Q6PIZ9	TRAT1	T-cell receptor-associated transmembrane adapter 1	GO:0005068; F:transmembrane receptor protein tyrosine kinase adaptor activity; TAS:ProtInc
Q6PIZ9	TRAT1	T-cell receptor-associated transmembrane adapter 1	GO:0006968; P:cellular defense response; TAS:ProtInc
Q6PIZ9	TRAT1	T-cell receptor-associated transmembrane adapter 1	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q6PIZ9	TRAT1	T-cell receptor-associated transmembrane adapter 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q6PIZ9	TRAT1	T-cell receptor-associated transmembrane adapter 1	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q6PIZ9	TRAT1	T-cell receptor-associated transmembrane adapter 1	GO:0045087; P:innate immune response; TAS:Reactome
Q6PIZ9	TRAT1	T-cell receptor-associated transmembrane adapter 1	GO:0001920; P:negative regulation of receptor recycling; IDA:MGI
Q6PIZ9	TRAT1	T-cell receptor-associated transmembrane adapter 1	GO:0051051; P:negative regulation of transport; IDA:MGI
Q6PIZ9	TRAT1	T-cell receptor-associated transmembrane adapter 1	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q6PIZ9	TRAT1	T-cell receptor-associated transmembrane adapter 1	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q6PIZ9	TRAT1	T-cell receptor-associated transmembrane adapter 1	GO:0050850; P:positive regulation of calcium-mediated signaling; IDA:MGI
Q6PIZ9	TRAT1	T-cell receptor-associated transmembrane adapter 1	GO:0050862; P:positive regulation of T cell receptor signaling pathway; IDA:MGI
Q6PIZ9	TRAT1	T-cell receptor-associated transmembrane adapter 1	GO:0007165; P:signal transduction; TAS:ProtInc
Q6PIZ9	TRAT1	T-cell receptor-associated transmembrane adapter 1	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P01850	TRBC1	T-cell receptor beta-1 chain C region	GO:0006955; P:immune response; NAS:UniProtKB
P01850	TRBC1	T-cell receptor beta-1 chain C region	GO:0050776; P:regulation of immune response; TAS:Reactome
P01850	TRBC1	T-cell receptor beta-1 chain C region	GO:0031295; P:T cell costimulation; TAS:Reactome
P01850	TRBC1	T-cell receptor beta-1 chain C region	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P07204	THBD	Thrombomodulin	GO:0005509; F:calcium ion binding; TAS:ProtInc
P07204	THBD	Thrombomodulin	GO:0030246; F:carbohydrate binding; IEA:InterPro
P07204	THBD	Thrombomodulin	GO:0005515; F:protein binding; IPI:IntAct
P07204	THBD	Thrombomodulin	GO:0004872; F:receptor activity; TAS:ProtInc
P07204	THBD	Thrombomodulin	GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro
P07204	THBD	Thrombomodulin	GO:0007596; P:blood coagulation; TAS:Reactome
P07204	THBD	Thrombomodulin	GO:0009790; P:embryo development; IEA:Ensembl
P07204	THBD	Thrombomodulin	GO:0007565; P:female pregnancy; IEA:Ensembl
P07204	THBD	Thrombomodulin	GO:0050900; P:leukocyte migration; TAS:Reactome
P07204	THBD	Thrombomodulin	GO:0030195; P:negative regulation of blood coagulation; TAS:BHF-UCL
P07204	THBD	Thrombomodulin	GO:0051918; P:negative regulation of fibrinolysis; TAS:BHF-UCL
P07204	THBD	Thrombomodulin	GO:0010544; P:negative regulation of platelet activation; TAS:BHF-UCL
P07204	THBD	Thrombomodulin	GO:0051591; P:response to cAMP; IEA:Ensembl
P07204	THBD	Thrombomodulin	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P07204	THBD	Thrombomodulin	GO:0010165; P:response to X-ray; IEA:Ensembl
Q15633	TARBP2	RISC-loading complex subunit TARBP2	GO:0003725; F:double-stranded RNA binding; IEA:InterPro
Q15633	TARBP2	RISC-loading complex subunit TARBP2	GO:0035198; F:miRNA binding; IEA:UniProtKB-HAMAP
Q15633	TARBP2	RISC-loading complex subunit TARBP2	GO:0005515; F:protein binding; IPI:UniProtKB
Q15633	TARBP2	RISC-loading complex subunit TARBP2	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q15633	TARBP2	RISC-loading complex subunit TARBP2	GO:0035197; F:siRNA binding; IDA:UniProtKB
Q15633	TARBP2	RISC-loading complex subunit TARBP2	GO:0010467; P:gene expression; TAS:Reactome
Q15633	TARBP2	RISC-loading complex subunit TARBP2	GO:0035280; P:miRNA loading onto RISC involved in gene silencing by miRNA; IDA:UniProtKB
Q15633	TARBP2	RISC-loading complex subunit TARBP2	GO:0050689; P:negative regulation of defense response to virus by host; IDA:UniProtKB
Q15633	TARBP2	RISC-loading complex subunit TARBP2	GO:0006469; P:negative regulation of protein kinase activity; TAS:UniProtKB
Q15633	TARBP2	RISC-loading complex subunit TARBP2	GO:0045070; P:positive regulation of viral genome replication; IDA:UniProtKB
Q15633	TARBP2	RISC-loading complex subunit TARBP2	GO:0031054; P:pre-miRNA processing; IDA:UniProtKB
Q15633	TARBP2	RISC-loading complex subunit TARBP2	GO:0030422; P:production of siRNA involved in RNA interference; IDA:UniProtKB
Q15633	TARBP2	RISC-loading complex subunit TARBP2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q15633	TARBP2	RISC-loading complex subunit TARBP2	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
Q15633	TARBP2	RISC-loading complex subunit TARBP2	GO:0006417; P:regulation of translation; IEA:UniProtKB-KW
Q15633	TARBP2	RISC-loading complex subunit TARBP2	GO:0046782; P:regulation of viral transcription; IDA:UniProtKB
Q15633	TARBP2	RISC-loading complex subunit TARBP2	GO:0030423; P:targeting of mRNA for destruction involved in RNA interference; IMP:UniProtKB
DR   GO:0003684; F:damaged DNA binding; IEA:InterPro
DR   GO:0000012; P:single strand break repair; IEA:InterPro
O14717	TRDMT1	tRNA (cytosine(38)-C(5))-methyltransferase	GO:0003886; F:DNA (cytosine-5-)-methyltransferase activity; TAS:ProtInc
O14717	TRDMT1	tRNA (cytosine(38)-C(5))-methyltransferase	GO:0003677; F:DNA binding; IEA:InterPro
O14717	TRDMT1	tRNA (cytosine(38)-C(5))-methyltransferase	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
O14717	TRDMT1	tRNA (cytosine(38)-C(5))-methyltransferase	GO:0008175; F:tRNA methyltransferase activity; IDA:MGI
O14717	TRDMT1	tRNA (cytosine(38)-C(5))-methyltransferase	GO:0090116; P:C-5 methylation of cytosine; TAS:GOC
O14717	TRDMT1	tRNA (cytosine(38)-C(5))-methyltransferase	GO:0001975; P:response to amphetamine; IEA:Ensembl
O14717	TRDMT1	tRNA (cytosine(38)-C(5))-methyltransferase	GO:0030488; P:tRNA methylation; IDA:MGI
Q13061	TRDN	Triadin	GO:0044325; F:ion channel binding; ISS:BHF-UCL
Q13061	TRDN	Triadin	GO:0005515; F:protein binding; IPI:BHF-UCL
Q13061	TRDN	Triadin	GO:0030674; F:protein binding, bridging; ISS:BHF-UCL
Q13061	TRDN	Triadin	GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
Q13061	TRDN	Triadin	GO:0006874; P:cellular calcium ion homeostasis; ISS:BHF-UCL
Q13061	TRDN	Triadin	GO:0031122; P:cytoplasmic microtubule organization; ISS:BHF-UCL
Q13061	TRDN	Triadin	GO:0090158; P:endoplasmic reticulum membrane organization; ISS:BHF-UCL
Q13061	TRDN	Triadin	GO:0060047; P:heart contraction; IMP:BHF-UCL
Q13061	TRDN	Triadin	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q13061	TRDN	Triadin	GO:0006936; P:muscle contraction; TAS:ProtInc
Q13061	TRDN	Triadin	GO:0014902; P:myotube differentiation; IEA:Ensembl
Q13061	TRDN	Triadin	GO:0060315; P:negative regulation of ryanodine-sensitive calcium-release channel activity; TAS:BHF-UCL
Q13061	TRDN	Triadin	GO:1901846; P:positive regulation of cell communication by electrical coupling involved in cardiac conduction; ISS:BHF-UCL
Q13061	TRDN	Triadin	GO:0060316; P:positive regulation of ryanodine-sensitive calcium-release channel activity; ISS:BHF-UCL
Q13061	TRDN	Triadin	GO:0086036; P:regulation of cardiac muscle cell membrane potential; ISS:BHF-UCL
Q13061	TRDN	Triadin	GO:0010649; P:regulation of cell communication by electrical coupling; TAS:BHF-UCL
Q13061	TRDN	Triadin	GO:0051279; P:regulation of release of sequestered calcium ion into cytosol; TAS:BHF-UCL
Q13061	TRDN	Triadin	GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; ISS:BHF-UCL
Q13061	TRDN	Triadin	GO:0014808; P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; ISS:BHF-UCL
Q13061	TRDN	Triadin	GO:0014070; P:response to organic cyclic compound; IEA:Ensembl
Q13061	TRDN	Triadin	GO:0055085; P:transmembrane transport; TAS:Reactome
O43280	TREH	Trehalase	GO:0004555; F:alpha,alpha-trehalase activity; IDA:UniProtKB
O43280	TREH	Trehalase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
O43280	TREH	Trehalase	GO:0009887; P:organ morphogenesis; IEA:Ensembl
O43280	TREH	Trehalase	GO:0044245; P:polysaccharide digestion; TAS:Reactome
O43280	TREH	Trehalase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43280	TREH	Trehalase	GO:0005993; P:trehalose catabolic process; TAS:ProtInc
O43280	TREH	Trehalase	GO:0005991; P:trehalose metabolic process; NAS:UniProtKB
Q96PN7	TRERF1	Transcriptional-regulating factor 1	GO:0003682; F:chromatin binding; IEA:InterPro
Q96PN7	TRERF1	Transcriptional-regulating factor 1	GO:0008301; F:DNA binding, bending; NAS:UniProtKB
Q96PN7	TRERF1	Transcriptional-regulating factor 1	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; NAS:UniProtKB
Q96PN7	TRERF1	Transcriptional-regulating factor 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96PN7	TRERF1	Transcriptional-regulating factor 1	GO:0001104; F:RNA polymerase II transcription cofactor activity; NAS:UniProtKB
Q96PN7	TRERF1	Transcriptional-regulating factor 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q96PN7	TRERF1	Transcriptional-regulating factor 1	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q96PN7	TRERF1	Transcriptional-regulating factor 1	GO:0006707; P:cholesterol catabolic process; NAS:UniProtKB
Q96PN7	TRERF1	Transcriptional-regulating factor 1	GO:0042592; P:homeostatic process; NAS:UniProtKB
Q96PN7	TRERF1	Transcriptional-regulating factor 1	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
Q96PN7	TRERF1	Transcriptional-regulating factor 1	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q96PN7	TRERF1	Transcriptional-regulating factor 1	GO:0046885; P:regulation of hormone biosynthetic process; NAS:UniProtKB
Q96PN7	TRERF1	Transcriptional-regulating factor 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; NAS:GOC
Q96PN7	TRERF1	Transcriptional-regulating factor 1	GO:0006694; P:steroid biosynthetic process; NAS:UniProtKB
Q96PN7	TRERF1	Transcriptional-regulating factor 1	GO:0006366; P:transcription from RNA polymerase II promoter; NAS:GOC
Q9NP99	TREM1	Triggering receptor expressed on myeloid cells 1	GO:0004872; F:receptor activity; TAS:ProtInc
Q9NP99	TREM1	Triggering receptor expressed on myeloid cells 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q9NP99	TREM1	Triggering receptor expressed on myeloid cells 1	GO:0006959; P:humoral immune response; TAS:ProtInc
Q9NP99	TREM1	Triggering receptor expressed on myeloid cells 1	GO:0045087; P:innate immune response; TAS:Reactome
Q9NP99	TREM1	Triggering receptor expressed on myeloid cells 1	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
Q9NP99	TREM1	Triggering receptor expressed on myeloid cells 1	GO:0050900; P:leukocyte migration; TAS:Reactome
Q9NZC2	TREM2	Triggering receptor expressed on myeloid cells 2	GO:0001530; F:lipopolysaccharide binding; IEA:Ensembl
Q9NZC2	TREM2	Triggering receptor expressed on myeloid cells 2	GO:0004872; F:receptor activity; TAS:ProtInc
Q9NZC2	TREM2	Triggering receptor expressed on myeloid cells 2	GO:0007411; P:axon guidance; TAS:Reactome
Q9NZC2	TREM2	Triggering receptor expressed on myeloid cells 2	GO:0006959; P:humoral immune response; TAS:ProtInc
Q9NZC2	TREM2	Triggering receptor expressed on myeloid cells 2	GO:0045087; P:innate immune response; TAS:Reactome
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0008408; F:3'-5' exonuclease activity; IDA:UniProtKB
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0008296; F:3'-5'-exodeoxyribonuclease activity; ISS:UniProtKB
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0032558; F:adenyl deoxyribonucleotide binding; IEA:Ensembl
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0008853; F:exodeoxyribonuclease III activity; IEA:UniProtKB-EC
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0046872; F:metal ion binding; NAS:UniProtKB
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0032405; F:MutLalpha complex binding; IDA:MGI
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0032407; F:MutSalpha complex binding; IDA:MGI
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0042803; F:protein homodimerization activity; NAS:UniProtKB
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0003697; F:single-stranded DNA binding; TAS:UniProtKB
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0035458; P:cellular response to interferon-beta; IEA:Ensembl
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0000738; P:DNA catabolic process, exonucleolytic; ISS:GOC
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0006259; P:DNA metabolic process; ISS:UniProtKB
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0006310; P:DNA recombination; NAS:UniProtKB
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0006281; P:DNA repair; TAS:ProtInc
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0006260; P:DNA replication; NAS:UniProtKB
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0045087; P:innate immune response; TAS:Reactome
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0006298; P:mismatch repair; NAS:UniProtKB
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:GOC
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q9NSU2	TREX1	Three-prime repair exonuclease 1	GO:0032479; P:regulation of type I interferon production; TAS:Reactome
Q9BQ50	TREX2	Three prime repair exonuclease 2	GO:0008296; F:3'-5'-exodeoxyribonuclease activity; IDA:UniProtKB
Q9BQ50	TREX2	Three prime repair exonuclease 2	GO:0008853; F:exodeoxyribonuclease III activity; IEA:UniProtKB-EC
Q9BQ50	TREX2	Three prime repair exonuclease 2	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q9BQ50	TREX2	Three prime repair exonuclease 2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9BQ50	TREX2	Three prime repair exonuclease 2	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q9BQ50	TREX2	Three prime repair exonuclease 2	GO:0000738; P:DNA catabolic process, exonucleolytic; IDA:GOC
Q9BQ50	TREX2	Three prime repair exonuclease 2	GO:0006259; P:DNA metabolic process; IDA:UniProtKB
Q9BQ50	TREX2	Three prime repair exonuclease 2	GO:0006281; P:DNA repair; TAS:ProtInc
P02787	TF	Serotransferrin	GO:0008199; F:ferric iron binding; IEA:InterPro
P02787	TF	Serotransferrin	GO:0005515; F:protein binding; IPI:UniProtKB
P02787	TF	Serotransferrin	GO:0007596; P:blood coagulation; TAS:Reactome
P02787	TF	Serotransferrin	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
P02787	TF	Serotransferrin	GO:0030168; P:platelet activation; TAS:Reactome
P02787	TF	Serotransferrin	GO:0002576; P:platelet degranulation; TAS:Reactome
P02787	TF	Serotransferrin	GO:0001895; P:retina homeostasis; IEP:UniProt
P02787	TF	Serotransferrin	GO:0033572; P:transferrin transport; TAS:Reactome
P02787	TF	Serotransferrin	GO:0055085; P:transmembrane transport; TAS:Reactome
P02788	LTF	Lactotransferrin	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P02788	LTF	Lactotransferrin	GO:0008199; F:ferric iron binding; IEA:InterPro
P02788	LTF	Lactotransferrin	GO:0008201; F:heparin binding; IDA:MGI
P02788	LTF	Lactotransferrin	GO:0005506; F:iron ion binding; IDA:UniProtKB
P02788	LTF	Lactotransferrin	GO:0008233; F:peptidase activity; IEA:Ensembl
P02788	LTF	Lactotransferrin	GO:0005515; F:protein binding; IPI:IntAct
P02788	LTF	Lactotransferrin	GO:0043539; F:protein serine/threonine kinase activator activity; IDA:UniProtKB
P02788	LTF	Lactotransferrin	GO:0004252; F:serine-type endopeptidase activity; TAS:ProtInc
P02788	LTF	Lactotransferrin	GO:0019731; P:antibacterial humoral response; IDA:UniProtKB
P02788	LTF	Lactotransferrin	GO:0019732; P:antifungal humoral response; IDA:UniProtKB
P02788	LTF	Lactotransferrin	GO:0060349; P:bone morphogenesis; IDA:UniProtKB
P02788	LTF	Lactotransferrin	GO:0006879; P:cellular iron ion homeostasis; IEA:InterPro
P02788	LTF	Lactotransferrin	GO:0006959; P:humoral immune response; TAS:ProtInc
P02788	LTF	Lactotransferrin	GO:0002227; P:innate immune response in mucosa; IDA:UniProtKB
P02788	LTF	Lactotransferrin	GO:0051701; P:interaction with host; TAS:Reactome
P02788	LTF	Lactotransferrin	GO:0033214; P:iron assimilation by chelation and transport; TAS:Reactome
P02788	LTF	Lactotransferrin	GO:0006826; P:iron ion transport; IEA:InterPro
P02788	LTF	Lactotransferrin	GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB
P02788	LTF	Lactotransferrin	GO:0031665; P:negative regulation of lipopolysaccharide-mediated signaling pathway; IDA:UniProtKB
P02788	LTF	Lactotransferrin	GO:2001205; P:negative regulation of osteoclast development; ISS:UniProtKB
P02788	LTF	Lactotransferrin	GO:1900229; P:negative regulation of single-species biofilm formation in or on host organism; IDA:UniProtKB
P02788	LTF	Lactotransferrin	GO:2000308; P:negative regulation of tumor necrosis factor (ligand) superfamily member 11 production; ISS:UniProtKB
P02788	LTF	Lactotransferrin	GO:0001503; P:ossification; IEA:UniProtKB-KW
P02788	LTF	Lactotransferrin	GO:0090382; P:phagosome maturation; TAS:Reactome
P02788	LTF	Lactotransferrin	GO:1900159; P:positive regulation of bone mineralization involved in bone maturation; ISS:UniProtKB
P02788	LTF	Lactotransferrin	GO:1902732; P:positive regulation of chondrocyte proliferation; IDA:UniProtKB
P02788	LTF	Lactotransferrin	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
P02788	LTF	Lactotransferrin	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
P02788	LTF	Lactotransferrin	GO:0045669; P:positive regulation of osteoblast differentiation; IDA:UniProtKB
P02788	LTF	Lactotransferrin	GO:0033690; P:positive regulation of osteoblast proliferation; IDA:UniProtKB
P02788	LTF	Lactotransferrin	GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IDA:UniProtKB
P02788	LTF	Lactotransferrin	GO:0034145; P:positive regulation of toll-like receptor 4 signaling pathway; IMP:UniProtKB
P02788	LTF	Lactotransferrin	GO:0001817; P:regulation of cytokine production; IDA:UniProtKB
P02788	LTF	Lactotransferrin	GO:0032680; P:regulation of tumor necrosis factor production; IDA:UniProtKB
P02788	LTF	Lactotransferrin	GO:0052572; P:response to host immune response; TAS:Reactome
P02788	LTF	Lactotransferrin	GO:0001895; P:retina homeostasis; IEP:UniProt
P02788	LTF	Lactotransferrin	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P08582	MFI2	Melanotransferrin	GO:0008199; F:ferric iron binding; IEA:InterPro
P08582	MFI2	Melanotransferrin	GO:0005506; F:iron ion binding; IMP:UniProt
P08582	MFI2	Melanotransferrin	GO:0005515; F:protein binding; IPI:UniProtKB
P08582	MFI2	Melanotransferrin	GO:0006879; P:cellular iron ion homeostasis; IEA:InterPro
P08582	MFI2	Melanotransferrin	GO:0097286; P:iron ion import; IMP:UniProt
P08582	MFI2	Melanotransferrin	GO:1900025; P:negative regulation of substrate adhesion-dependent cell spreading; IDA:UniProt
P08582	MFI2	Melanotransferrin	GO:0090091; P:positive regulation of extracellular matrix disassembly; IDA:UniProt
P08582	MFI2	Melanotransferrin	GO:0010756; P:positive regulation of plasminogen activation; IDA:UniProt
P34981	TRHR	Thyrotropin-releasing hormone receptor	GO:0004997; F:thyrotropin-releasing hormone receptor activity; TAS:ProtInc
P34981	TRHR	Thyrotropin-releasing hormone receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P03986	TRGC2	T-cell receptor gamma-2 chain C region	GO:0004888; F:transmembrane signaling receptor activity; NAS:UniProtKB
P03986	TRGC2	T-cell receptor gamma-2 chain C region	GO:0006955; P:immune response; NAS:UniProtKB
P03986	TRGC2	T-cell receptor gamma-2 chain C region	GO:0007165; P:signal transduction; NAS:GOC
Q9UKU6	TRHDE	Thyrotropin-releasing hormone-degrading ectoenzyme	GO:0004177; F:aminopeptidase activity; TAS:ProtInc
Q9UKU6	TRHDE	Thyrotropin-releasing hormone-degrading ectoenzyme	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
Q9UKU6	TRHDE	Thyrotropin-releasing hormone-degrading ectoenzyme	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UKU6	TRHDE	Thyrotropin-releasing hormone-degrading ectoenzyme	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q9UKU6	TRHDE	Thyrotropin-releasing hormone-degrading ectoenzyme	GO:0007165; P:signal transduction; TAS:ProtInc
Q07283	TCHH	Trichohyalin	GO:0005509; F:calcium ion binding; TAS:UniProtKB
Q07283	TCHH	Trichohyalin	GO:0031424; P:keratinization; IEA:UniProtKB-KW
P20396	TRH	Pro-thyrotropin-releasing hormone	GO:0008437; F:thyrotropin-releasing hormone activity; TAS:ProtInc
P20396	TRH	Pro-thyrotropin-releasing hormone	GO:0007628; P:adult walking behavior; IEA:Ensembl
P20396	TRH	Pro-thyrotropin-releasing hormone	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P20396	TRH	Pro-thyrotropin-releasing hormone	GO:0042755; P:eating behavior; IEA:Ensembl
P20396	TRH	Pro-thyrotropin-releasing hormone	GO:0001692; P:histamine metabolic process; IEA:Ensembl
P20396	TRH	Pro-thyrotropin-releasing hormone	GO:0009755; P:hormone-mediated signaling pathway; IEA:InterPro
P20396	TRH	Pro-thyrotropin-releasing hormone	GO:2000252; P:negative regulation of feeding behavior; IEA:Ensembl
P20396	TRH	Pro-thyrotropin-releasing hormone	GO:0014050; P:negative regulation of glutamate secretion; IEA:Ensembl
P20396	TRH	Pro-thyrotropin-releasing hormone	GO:0014054; P:positive regulation of gamma-aminobutyric acid secretion; IEA:Ensembl
P20396	TRH	Pro-thyrotropin-releasing hormone	GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl
P20396	TRH	Pro-thyrotropin-releasing hormone	GO:0009409; P:response to cold; IEA:Ensembl
P20396	TRH	Pro-thyrotropin-releasing hormone	GO:0051412; P:response to corticosterone; IEA:Ensembl
P20396	TRH	Pro-thyrotropin-releasing hormone	GO:0045471; P:response to ethanol; IEA:Ensembl
P20396	TRH	Pro-thyrotropin-releasing hormone	GO:0009749; P:response to glucose; IEA:Ensembl
P20396	TRH	Pro-thyrotropin-releasing hormone	GO:0001666; P:response to hypoxia; IEA:Ensembl
P20396	TRH	Pro-thyrotropin-releasing hormone	GO:0007165; P:signal transduction; TAS:ProtInc
Q9UDY6	TRIM10	Tripartite motif-containing protein 10	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UDY6	TRIM10	Tripartite motif-containing protein 10	GO:0030218; P:erythrocyte differentiation; IEA:Ensembl
Q96F44	TRIM11	E3 ubiquitin-protein ligase TRIM11	GO:0005515; F:protein binding; IPI:IntAct
Q96F44	TRIM11	E3 ubiquitin-protein ligase TRIM11	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q96F44	TRIM11	E3 ubiquitin-protein ligase TRIM11	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96F44	TRIM11	E3 ubiquitin-protein ligase TRIM11	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q96F44	TRIM11	E3 ubiquitin-protein ligase TRIM11	GO:0045087; P:innate immune response; IMP:UniProt
Q96F44	TRIM11	E3 ubiquitin-protein ligase TRIM11	GO:0050768; P:negative regulation of neurogenesis; IEA:Ensembl
Q96F44	TRIM11	E3 ubiquitin-protein ligase TRIM11	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q96F44	TRIM11	E3 ubiquitin-protein ligase TRIM11	GO:0046597; P:negative regulation of viral entry into host cell; IMP:UniProt
Q96F44	TRIM11	E3 ubiquitin-protein ligase TRIM11	GO:1902187; P:negative regulation of viral release from host cell; IDA:UniProt
Q96F44	TRIM11	E3 ubiquitin-protein ligase TRIM11	GO:0032897; P:negative regulation of viral transcription; IDA:UniProt
Q96F44	TRIM11	E3 ubiquitin-protein ligase TRIM11	GO:0046598; P:positive regulation of viral entry into host cell; IMP:UniProt
O60858	TRIM13	E3 ubiquitin-protein ligase TRIM13	GO:0005515; F:protein binding; IPI:UniProtKB
O60858	TRIM13	E3 ubiquitin-protein ligase TRIM13	GO:0004871; F:signal transducer activity; IMP:UniProtKB
O60858	TRIM13	E3 ubiquitin-protein ligase TRIM13	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
O60858	TRIM13	E3 ubiquitin-protein ligase TRIM13	GO:0008270; F:zinc ion binding; IEA:InterPro
O60858	TRIM13	E3 ubiquitin-protein ligase TRIM13	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
O60858	TRIM13	E3 ubiquitin-protein ligase TRIM13	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
O60858	TRIM13	E3 ubiquitin-protein ligase TRIM13	GO:0045087; P:innate immune response; IDA:UniProt
O60858	TRIM13	E3 ubiquitin-protein ligase TRIM13	GO:1902187; P:negative regulation of viral release from host cell; IDA:UniProt
O60858	TRIM13	E3 ubiquitin-protein ligase TRIM13	GO:0032897; P:negative regulation of viral transcription; IDA:UniProt
O60858	TRIM13	E3 ubiquitin-protein ligase TRIM13	GO:0010942; P:positive regulation of cell death; IDA:UniProtKB
O60858	TRIM13	E3 ubiquitin-protein ligase TRIM13	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
O60858	TRIM13	E3 ubiquitin-protein ligase TRIM13	GO:0016239; P:positive regulation of macroautophagy; IDA:UniProtKB
O60858	TRIM13	E3 ubiquitin-protein ligase TRIM13	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProt
O60858	TRIM13	E3 ubiquitin-protein ligase TRIM13	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
O60858	TRIM13	E3 ubiquitin-protein ligase TRIM13	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
O60858	TRIM13	E3 ubiquitin-protein ligase TRIM13	GO:0010332; P:response to gamma radiation; IEP:UniProtKB
O60858	TRIM13	E3 ubiquitin-protein ligase TRIM13	GO:0007165; P:signal transduction; IMP:GOC
Q14142	TRIM14	Tripartite motif-containing protein 14	GO:0008270; F:zinc ion binding; IEA:InterPro
Q14142	TRIM14	Tripartite motif-containing protein 14	GO:0045087; P:innate immune response; IDA:UniProt
Q14142	TRIM14	Tripartite motif-containing protein 14	GO:0032897; P:negative regulation of viral transcription; IDA:UniProt
Q14142	TRIM14	Tripartite motif-containing protein 14	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProt
Q14142	TRIM14	Tripartite motif-containing protein 14	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProt
Q9C019	TRIM15	Tripartite motif-containing protein 15	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9C019	TRIM15	Tripartite motif-containing protein 15	GO:0045087; P:innate immune response; IMP:UniProt
Q9C019	TRIM15	Tripartite motif-containing protein 15	GO:0007500; P:mesodermal cell fate determination; TAS:ProtInc
Q9C019	TRIM15	Tripartite motif-containing protein 15	GO:1901253; P:negative regulation of intracellular transport of viral material; IMP:UniProt
Q9C019	TRIM15	Tripartite motif-containing protein 15	GO:1902187; P:negative regulation of viral release from host cell; IDA:UniProt
Q9C019	TRIM15	Tripartite motif-containing protein 15	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProt
Q9C019	TRIM15	Tripartite motif-containing protein 15	GO:1900246; P:positive regulation of RIG-I signaling pathway; IMP:UniProt
Q9C019	TRIM15	Tripartite motif-containing protein 15	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:UniProt
Q9C019	TRIM15	Tripartite motif-containing protein 15	GO:0032481; P:positive regulation of type I interferon production; IMP:UniProt
O95361	TRIM16	Tripartite motif-containing protein 16	GO:0003677; F:DNA binding; IDA:UniProtKB
O95361	TRIM16	Tripartite motif-containing protein 16	GO:0019966; F:interleukin-1 binding; IPI:UniProtKB
O95361	TRIM16	Tripartite motif-containing protein 16	GO:0032089; F:NACHT domain binding; IPI:UniProtKB
O95361	TRIM16	Tripartite motif-containing protein 16	GO:0005515; F:protein binding; IPI:UniProtKB
O95361	TRIM16	Tripartite motif-containing protein 16	GO:0008270; F:zinc ion binding; IEA:InterPro
O95361	TRIM16	Tripartite motif-containing protein 16	GO:0043966; P:histone H3 acetylation; IDA:UniProtKB
O95361	TRIM16	Tripartite motif-containing protein 16	GO:0043967; P:histone H4 acetylation; IDA:UniProtKB
O95361	TRIM16	Tripartite motif-containing protein 16	GO:0050718; P:positive regulation of interleukin-1 beta secretion; IMP:UniProtKB
O95361	TRIM16	Tripartite motif-containing protein 16	GO:0045618; P:positive regulation of keratinocyte differentiation; IDA:UniProtKB
O95361	TRIM16	Tripartite motif-containing protein 16	GO:0048386; P:positive regulation of retinoic acid receptor signaling pathway; IDA:UniProtKB
O95361	TRIM16	Tripartite motif-containing protein 16	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
O95361	TRIM16	Tripartite motif-containing protein 16	GO:0060416; P:response to growth hormone; IDA:UniProtKB
O95361	TRIM16	Tripartite motif-containing protein 16	GO:0046683; P:response to organophosphorus; IEP:UniProtKB
O95361	TRIM16	Tripartite motif-containing protein 16	GO:0032526; P:response to retinoic acid; IEP:UniProtKB
Q9Y577	TRIM17	E3 ubiquitin-protein ligase TRIM17	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y577	TRIM17	E3 ubiquitin-protein ligase TRIM17	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9Y577	TRIM17	E3 ubiquitin-protein ligase TRIM17	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y577	TRIM17	E3 ubiquitin-protein ligase TRIM17	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
O15344	MID1	E3 ubiquitin-protein ligase Midline-1	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
O15344	MID1	E3 ubiquitin-protein ligase Midline-1	GO:0008017; F:microtubule binding; IMP:UniProt
O15344	MID1	E3 ubiquitin-protein ligase Midline-1	GO:0051219; F:phosphoprotein binding; IPI:UniProt
O15344	MID1	E3 ubiquitin-protein ligase Midline-1	GO:0046982; F:protein heterodimerization activity; IDA:UniProt
O15344	MID1	E3 ubiquitin-protein ligase Midline-1	GO:0042803; F:protein homodimerization activity; IDA:UniProt
O15344	MID1	E3 ubiquitin-protein ligase Midline-1	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
O15344	MID1	E3 ubiquitin-protein ligase Midline-1	GO:0008270; F:zinc ion binding; IEA:InterPro
O15344	MID1	E3 ubiquitin-protein ligase Midline-1	GO:0000226; P:microtubule cytoskeleton organization; TAS:ProtInc
O15344	MID1	E3 ubiquitin-protein ligase Midline-1	GO:0007389; P:pattern specification process; TAS:ProtInc
O15344	MID1	E3 ubiquitin-protein ligase Midline-1	GO:0032874; P:positive regulation of stress-activated MAPK cascade; IMP:UniProtKB
O15344	MID1	E3 ubiquitin-protein ligase Midline-1	GO:0035372; P:protein localization to microtubule; IMP:UniProt
Q8IYM9	TRIM22	E3 ubiquitin-protein ligase TRIM22	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q8IYM9	TRIM22	E3 ubiquitin-protein ligase TRIM22	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q8IYM9	TRIM22	E3 ubiquitin-protein ligase TRIM22	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q8IYM9	TRIM22	E3 ubiquitin-protein ligase TRIM22	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IYM9	TRIM22	E3 ubiquitin-protein ligase TRIM22	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q8IYM9	TRIM22	E3 ubiquitin-protein ligase TRIM22	GO:0006955; P:immune response; TAS:ProtInc
Q8IYM9	TRIM22	E3 ubiquitin-protein ligase TRIM22	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProt
Q8IYM9	TRIM22	E3 ubiquitin-protein ligase TRIM22	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProt
Q8IYM9	TRIM22	E3 ubiquitin-protein ligase TRIM22	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProt
Q8IYM9	TRIM22	E3 ubiquitin-protein ligase TRIM22	GO:0070206; P:protein trimerization; IDA:UniProtKB
Q8IYM9	TRIM22	E3 ubiquitin-protein ligase TRIM22	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8IYM9	TRIM22	E3 ubiquitin-protein ligase TRIM22	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
Q8IYM9	TRIM22	E3 ubiquitin-protein ligase TRIM22	GO:0009615; P:response to virus; TAS:ProtInc
Q8IYM9	TRIM22	E3 ubiquitin-protein ligase TRIM22	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IYM9	TRIM22	E3 ubiquitin-protein ligase TRIM22	GO:0016032; P:viral process; IEA:UniProtKB-KW
P36406	TRIM23	E3 ubiquitin-protein ligase TRIM23	GO:0008047; F:enzyme activator activity; TAS:ProtInc
P36406	TRIM23	E3 ubiquitin-protein ligase TRIM23	GO:0019003; F:GDP binding; IDA:HGNC
P36406	TRIM23	E3 ubiquitin-protein ligase TRIM23	GO:0005525; F:GTP binding; IDA:HGNC
P36406	TRIM23	E3 ubiquitin-protein ligase TRIM23	GO:0003924; F:GTPase activity; IDA:HGNC
P36406	TRIM23	E3 ubiquitin-protein ligase TRIM23	GO:0042802; F:identical protein binding; IPI:IntAct
P36406	TRIM23	E3 ubiquitin-protein ligase TRIM23	GO:0005515; F:protein binding; IPI:IntAct
P36406	TRIM23	E3 ubiquitin-protein ligase TRIM23	GO:0004842; F:ubiquitin-protein ligase activity; IDA:HGNC
P36406	TRIM23	E3 ubiquitin-protein ligase TRIM23	GO:0008270; F:zinc ion binding; IEA:InterPro
P36406	TRIM23	E3 ubiquitin-protein ligase TRIM23	GO:0006184; P:GTP catabolic process; IDA:GOC
P36406	TRIM23	E3 ubiquitin-protein ligase TRIM23	GO:0043085; P:positive regulation of catalytic activity; TAS:GOC
P36406	TRIM23	E3 ubiquitin-protein ligase TRIM23	GO:0016567; P:protein ubiquitination; IDA:HGNC
P36406	TRIM23	E3 ubiquitin-protein ligase TRIM23	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
P36406	TRIM23	E3 ubiquitin-protein ligase TRIM23	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q14258	TRIM25	E3 ubiquitin/ISG15 ligase TRIM25	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14258	TRIM25	E3 ubiquitin/ISG15 ligase TRIM25	GO:0005515; F:protein binding; IPI:IntAct
Q14258	TRIM25	E3 ubiquitin/ISG15 ligase TRIM25	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q14258	TRIM25	E3 ubiquitin/ISG15 ligase TRIM25	GO:0004842; F:ubiquitin-protein ligase activity; IEA:UniProtKB-EC
Q14258	TRIM25	E3 ubiquitin/ISG15 ligase TRIM25	GO:0008270; F:zinc ion binding; IEA:InterPro
Q14258	TRIM25	E3 ubiquitin/ISG15 ligase TRIM25	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q14258	TRIM25	E3 ubiquitin/ISG15 ligase TRIM25	GO:0045087; P:innate immune response; IDA:UniProt
Q14258	TRIM25	E3 ubiquitin/ISG15 ligase TRIM25	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
Q14258	TRIM25	E3 ubiquitin/ISG15 ligase TRIM25	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProt
Q14258	TRIM25	E3 ubiquitin/ISG15 ligase TRIM25	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProt
Q14258	TRIM25	E3 ubiquitin/ISG15 ligase TRIM25	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:UniProt
Q14258	TRIM25	E3 ubiquitin/ISG15 ligase TRIM25	GO:0046596; P:regulation of viral entry into host cell; IDA:UniProt
Q14258	TRIM25	E3 ubiquitin/ISG15 ligase TRIM25	GO:1902186; P:regulation of viral release from host cell; IMP:UniProt
Q14258	TRIM25	E3 ubiquitin/ISG15 ligase TRIM25	GO:0043627; P:response to estrogen; IEA:Ensembl
Q14258	TRIM25	E3 ubiquitin/ISG15 ligase TRIM25	GO:0033280; P:response to vitamin D; IEA:Ensembl
Q14258	TRIM25	E3 ubiquitin/ISG15 ligase TRIM25	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q12899	TRIM26	Tripartite motif-containing protein 26	GO:0003677; F:DNA binding; NAS:UniProtKB
Q12899	TRIM26	Tripartite motif-containing protein 26	GO:0046872; F:metal ion binding; NAS:UniProtKB
Q12899	TRIM26	Tripartite motif-containing protein 26	GO:0008270; F:zinc ion binding; IEA:InterPro
Q12899	TRIM26	Tripartite motif-containing protein 26	GO:0045087; P:innate immune response; IDA:UniProt
Q12899	TRIM26	Tripartite motif-containing protein 26	GO:0046597; P:negative regulation of viral entry into host cell; IDA:UniProt
Q12899	TRIM26	Tripartite motif-containing protein 26	GO:1902187; P:negative regulation of viral release from host cell; IDA:UniProt
Q12899	TRIM26	Tripartite motif-containing protein 26	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProt
P14373	TRIM27	Zinc finger protein RFP	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P14373	TRIM27	Zinc finger protein RFP	GO:0046872; F:metal ion binding; TAS:ProtInc
P14373	TRIM27	Zinc finger protein RFP	GO:0003676; F:nucleic acid binding; TAS:ProtInc
P14373	TRIM27	Zinc finger protein RFP	GO:0005515; F:protein binding; IPI:UniProtKB
P14373	TRIM27	Zinc finger protein RFP	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; TAS:ProtInc
P14373	TRIM27	Zinc finger protein RFP	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
P14373	TRIM27	Zinc finger protein RFP	GO:0008270; F:zinc ion binding; IEA:InterPro
P14373	TRIM27	Zinc finger protein RFP	GO:0008283; P:cell proliferation; TAS:ProtInc
P14373	TRIM27	Zinc finger protein RFP	GO:0045087; P:innate immune response; IDA:UniProt
P14373	TRIM27	Zinc finger protein RFP	GO:0072643; P:interferon-gamma secretion; IMP:UniProtKB
P14373	TRIM27	Zinc finger protein RFP	GO:0002820; P:negative regulation of adaptive immune response; IMP:UniProtKB
P14373	TRIM27	Zinc finger protein RFP	GO:0090281; P:negative regulation of calcium ion import; IMP:UniProtKB
P14373	TRIM27	Zinc finger protein RFP	GO:0045814; P:negative regulation of gene expression, epigenetic; IDA:MGI
P14373	TRIM27	Zinc finger protein RFP	GO:1900041; P:negative regulation of interleukin-2 secretion; IMP:UniProtKB
P14373	TRIM27	Zinc finger protein RFP	GO:0006469; P:negative regulation of protein kinase activity; IDA:UniProtKB
P14373	TRIM27	Zinc finger protein RFP	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:MGI
P14373	TRIM27	Zinc finger protein RFP	GO:0032720; P:negative regulation of tumor necrosis factor production; IMP:UniProtKB
P14373	TRIM27	Zinc finger protein RFP	GO:0032897; P:negative regulation of viral transcription; IDA:UniProt
P14373	TRIM27	Zinc finger protein RFP	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:GOC
P14373	TRIM27	Zinc finger protein RFP	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProt
P14373	TRIM27	Zinc finger protein RFP	GO:0070206; P:protein trimerization; IDA:UniProtKB
P14373	TRIM27	Zinc finger protein RFP	GO:0016567; P:protein ubiquitination; IDA:GOC
P14373	TRIM27	Zinc finger protein RFP	GO:0007283; P:spermatogenesis; TAS:ProtInc
P14373	TRIM27	Zinc finger protein RFP	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14134	TRIM29	Tripartite motif-containing protein 29	GO:0005515; F:protein binding; IPI:IntAct
Q14134	TRIM29	Tripartite motif-containing protein 29	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q14134	TRIM29	Tripartite motif-containing protein 29	GO:0008270; F:zinc ion binding; IEA:InterPro
Q14134	TRIM29	Tripartite motif-containing protein 29	GO:1900181; P:negative regulation of protein localization to nucleus; IEA:Ensembl
Q14134	TRIM29	Tripartite motif-containing protein 29	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q14134	TRIM29	Tripartite motif-containing protein 29	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9BZY9	TRIM31	E3 ubiquitin-protein ligase TRIM31	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9BZY9	TRIM31	E3 ubiquitin-protein ligase TRIM31	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BZY9	TRIM31	E3 ubiquitin-protein ligase TRIM31	GO:0045087; P:innate immune response; IMP:UniProt
Q9BZY9	TRIM31	E3 ubiquitin-protein ligase TRIM31	GO:0046597; P:negative regulation of viral entry into host cell; IMP:UniProt
Q9BZY9	TRIM31	E3 ubiquitin-protein ligase TRIM31	GO:0032897; P:negative regulation of viral transcription; IDA:UniProt
Q9BZY9	TRIM31	E3 ubiquitin-protein ligase TRIM31	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:UniProt
Q9BZY9	TRIM31	E3 ubiquitin-protein ligase TRIM31	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9BZY9	TRIM31	E3 ubiquitin-protein ligase TRIM31	GO:1902186; P:regulation of viral release from host cell; IMP:UniProt
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0017022; F:myosin binding; ISS:BHF-UCL
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0005515; F:protein binding; IPI:UniProtKB
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0043621; F:protein self-association; IDA:UniProtKB
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0003723; F:RNA binding; ISS:BHF-UCL
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0030957; F:Tat protein binding; TAS:BHF-UCL
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0031369; F:translation initiation factor binding; ISS:BHF-UCL
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0008270; F:zinc ion binding; IEA:InterPro
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0045444; P:fat cell differentiation; ISS:BHF-UCL
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0045087; P:innate immune response; IDA:UniProt
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0048147; P:negative regulation of fibroblast proliferation; ISS:BHF-UCL
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:1902230; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; IDA:BHF-UCL
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:1902187; P:negative regulation of viral release from host cell; IDA:UniProt
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0032897; P:negative regulation of viral transcription; IDA:UniProt
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0045787; P:positive regulation of cell cycle; IDA:BHF-UCL
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0030307; P:positive regulation of cell growth; IDA:BHF-UCL
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0030335; P:positive regulation of cell migration; IDA:BHF-UCL
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:2000147; P:positive regulation of cell motility; ISS:BHF-UCL
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProt
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0050769; P:positive regulation of neurogenesis; ISS:BHF-UCL
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0045666; P:positive regulation of neuron differentiation; ISS:BHF-UCL
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProt
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0045732; P:positive regulation of protein catabolic process; ISS:BHF-UCL
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0045862; P:positive regulation of proteolysis; IDA:BHF-UCL
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProt
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0000209; P:protein polyubiquitination; IDA:BHF-UCL
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0016567; P:protein ubiquitination; IDA:BHF-UCL
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0032479; P:regulation of type I interferon production; TAS:Reactome
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0034612; P:response to tumor necrosis factor; ISS:BHF-UCL
Q13049	TRIM32	E3 ubiquitin-protein ligase TRIM32	GO:0009411; P:response to UV; ISS:BHF-UCL
Q9UPN9	TRIM33	E3 ubiquitin-protein ligase TRIM33	GO:0070410; F:co-SMAD binding; IPI:BHF-UCL
Q9UPN9	TRIM33	E3 ubiquitin-protein ligase TRIM33	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UPN9	TRIM33	E3 ubiquitin-protein ligase TRIM33	GO:0005515; F:protein binding; IPI:IntAct
Q9UPN9	TRIM33	E3 ubiquitin-protein ligase TRIM33	GO:0070412; F:R-SMAD binding; IPI:BHF-UCL
Q9UPN9	TRIM33	E3 ubiquitin-protein ligase TRIM33	GO:0004842; F:ubiquitin-protein ligase activity; TAS:Reactome
Q9UPN9	TRIM33	E3 ubiquitin-protein ligase TRIM33	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UPN9	TRIM33	E3 ubiquitin-protein ligase TRIM33	GO:0010467; P:gene expression; TAS:Reactome
Q9UPN9	TRIM33	E3 ubiquitin-protein ligase TRIM33	GO:0030514; P:negative regulation of BMP signaling pathway; IDA:UniProtKB
Q9UPN9	TRIM33	E3 ubiquitin-protein ligase TRIM33	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:Reactome
Q9UPN9	TRIM33	E3 ubiquitin-protein ligase TRIM33	GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB
Q9UPN9	TRIM33	E3 ubiquitin-protein ligase TRIM33	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q9UPN9	TRIM33	E3 ubiquitin-protein ligase TRIM33	GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
Q9UPN9	TRIM33	E3 ubiquitin-protein ligase TRIM33	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q9UPN9	TRIM33	E3 ubiquitin-protein ligase TRIM33	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
Q9UPN9	TRIM33	E3 ubiquitin-protein ligase TRIM33	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q9UPQ4	TRIM35	Tripartite motif-containing protein 35	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UPQ4	TRIM35	Tripartite motif-containing protein 35	GO:0006915; P:apoptotic process; ISS:UniProtKB
Q9UPQ4	TRIM35	Tripartite motif-containing protein 35	GO:0045087; P:innate immune response; IDA:UniProt
Q9UPQ4	TRIM35	Tripartite motif-containing protein 35	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q9UPQ4	TRIM35	Tripartite motif-containing protein 35	GO:0045930; P:negative regulation of mitotic cell cycle; IDA:UniProtKB
Q9UPQ4	TRIM35	Tripartite motif-containing protein 35	GO:1902187; P:negative regulation of viral release from host cell; IDA:UniProt
Q9UPQ4	TRIM35	Tripartite motif-containing protein 35	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q9BYJ4	TRIM34	Tripartite motif-containing protein 34	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BYJ4	TRIM34	Tripartite motif-containing protein 34	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProt
Q9BYJ4	TRIM34	Tripartite motif-containing protein 34	GO:0070206; P:protein trimerization; IDA:UniProtKB
Q9NQ86	TRIM36	E3 ubiquitin-protein ligase TRIM36	GO:0004842; F:ubiquitin-protein ligase activity; IEA:InterPro
Q9NQ86	TRIM36	E3 ubiquitin-protein ligase TRIM36	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NQ86	TRIM36	E3 ubiquitin-protein ligase TRIM36	GO:0007340; P:acrosome reaction; IEA:Ensembl
Q9NQ86	TRIM36	E3 ubiquitin-protein ligase TRIM36	GO:0051726; P:regulation of cell cycle; IEA:InterPro
O00635	TRIM38	Tripartite motif-containing protein 38	GO:0004871; F:signal transducer activity; IMP:UniProtKB
O00635	TRIM38	Tripartite motif-containing protein 38	GO:0008270; F:zinc ion binding; IEA:InterPro
O00635	TRIM38	Tripartite motif-containing protein 38	GO:0050687; P:negative regulation of defense response to virus; IEA:Ensembl
O00635	TRIM38	Tripartite motif-containing protein 38	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
O00635	TRIM38	Tripartite motif-containing protein 38	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProt
O00635	TRIM38	Tripartite motif-containing protein 38	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProt
O00635	TRIM38	Tripartite motif-containing protein 38	GO:0046598; P:positive regulation of viral entry into host cell; IDA:UniProt
O00635	TRIM38	Tripartite motif-containing protein 38	GO:0045070; P:positive regulation of viral genome replication; IEA:Ensembl
O00635	TRIM38	Tripartite motif-containing protein 38	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:Ensembl
O00635	TRIM38	Tripartite motif-containing protein 38	GO:0070936; P:protein K48-linked ubiquitination; IEA:Ensembl
O00635	TRIM38	Tripartite motif-containing protein 38	GO:0032648; P:regulation of interferon-beta production; IEA:Ensembl
O00635	TRIM38	Tripartite motif-containing protein 38	GO:0007165; P:signal transduction; IMP:GOC
Q9HCM9	TRIM39	E3 ubiquitin-protein ligase TRIM39	GO:0042802; F:identical protein binding; IPI:IntAct
Q9HCM9	TRIM39	E3 ubiquitin-protein ligase TRIM39	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9HCM9	TRIM39	E3 ubiquitin-protein ligase TRIM39	GO:0005515; F:protein binding; IPI:IntAct
Q9HCM9	TRIM39	E3 ubiquitin-protein ligase TRIM39	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9HCM9	TRIM39	E3 ubiquitin-protein ligase TRIM39	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9HCM9	TRIM39	E3 ubiquitin-protein ligase TRIM39	GO:2000059; P:negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:BHF-UCL
Q9HCM9	TRIM39	E3 ubiquitin-protein ligase TRIM39	GO:2001235; P:positive regulation of apoptotic signaling pathway; IDA:BHF-UCL
Q9HCM9	TRIM39	E3 ubiquitin-protein ligase TRIM39	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
O94972	TRIM37	E3 ubiquitin-protein ligase TRIM37	GO:0005515; F:protein binding; IPI:UniProtKB
O94972	TRIM37	E3 ubiquitin-protein ligase TRIM37	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
O94972	TRIM37	E3 ubiquitin-protein ligase TRIM37	GO:0005164; F:tumor necrosis factor receptor binding; IPI:UniProtKB
O94972	TRIM37	E3 ubiquitin-protein ligase TRIM37	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
O94972	TRIM37	E3 ubiquitin-protein ligase TRIM37	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
O94972	TRIM37	E3 ubiquitin-protein ligase TRIM37	GO:0008270; F:zinc ion binding; IEA:InterPro
O94972	TRIM37	E3 ubiquitin-protein ligase TRIM37	GO:0070842; P:aggresome assembly; IDA:UniProtKB
O94972	TRIM37	E3 ubiquitin-protein ligase TRIM37	GO:0046600; P:negative regulation of centriole replication; IMP:UniProtKB
O94972	TRIM37	E3 ubiquitin-protein ligase TRIM37	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
O94972	TRIM37	E3 ubiquitin-protein ligase TRIM37	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProt
O94972	TRIM37	E3 ubiquitin-protein ligase TRIM37	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProt
O94972	TRIM37	E3 ubiquitin-protein ligase TRIM37	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
Q6P9F5	TRIM40	Tripartite motif-containing protein 40	GO:0005515; F:protein binding; IPI:UniProt
Q6P9F5	TRIM40	Tripartite motif-containing protein 40	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6P9F5	TRIM40	Tripartite motif-containing protein 40	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
Q6P9F5	TRIM40	Tripartite motif-containing protein 40	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProt
Q6P9F5	TRIM40	Tripartite motif-containing protein 40	GO:1901223; P:negative regulation of NIK/NF-kappaB signaling; NAS:UniProt
Q6P9F5	TRIM40	Tripartite motif-containing protein 40	GO:0042177; P:negative regulation of protein catabolic process; IDA:UniProt
Q6P9F5	TRIM40	Tripartite motif-containing protein 40	GO:1900181; P:negative regulation of protein localization to nucleus; IDA:UniProt
Q6P9F5	TRIM40	Tripartite motif-containing protein 40	GO:0045116; P:protein neddylation; IDA:UniProt
Q8IWZ5	TRIM42	Tripartite motif-containing protein 42	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WV44	TRIM41	E3 ubiquitin-protein ligase TRIM41	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q8WV44	TRIM41	E3 ubiquitin-protein ligase TRIM41	GO:0005515; F:protein binding; IPI:IntAct
Q8WV44	TRIM41	E3 ubiquitin-protein ligase TRIM41	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WV44	TRIM41	E3 ubiquitin-protein ligase TRIM41	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q96BQ3	TRIM43	Tripartite motif-containing protein 43	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96DX7	TRIM44	Tripartite motif-containing protein 44	GO:0005515; F:protein binding; IPI:UniProtKB
Q96DX7	TRIM44	Tripartite motif-containing protein 44	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H8W5	TRIM45	Tripartite motif-containing protein 45	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H8W5	TRIM45	Tripartite motif-containing protein 45	GO:0060348; P:bone development; IEA:Ensembl
Q96LD4	TRIM47	Tripartite motif-containing protein 47	GO:0008270; F:zinc ion binding; IEA:InterPro
Q7Z4K8	TRIM46	Tripartite motif-containing protein 46	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IWZ4	TRIM48	Tripartite motif-containing protein 48	GO:0008270; F:zinc ion binding; IEA:InterPro
P0CI25	TRIM49	Tripartite motif-containing protein 49	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86XT4	TRIM50	E3 ubiquitin-protein ligase TRIM50	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q86XT4	TRIM50	E3 ubiquitin-protein ligase TRIM50	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96A61	TRIM52	Tripartite motif-containing protein 52	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96A61	TRIM52	Tripartite motif-containing protein 52	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProt
Q9BYV2	TRIM54	Tripartite motif-containing protein 54	GO:0004871; F:signal transducer activity; NAS:UniProtKB
Q9BYV2	TRIM54	Tripartite motif-containing protein 54	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9BYV2	TRIM54	Tripartite motif-containing protein 54	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9BYV2	TRIM54	Tripartite motif-containing protein 54	GO:0007017; P:microtubule-based process; NAS:UniProtKB
Q9BYV2	TRIM54	Tripartite motif-containing protein 54	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9BYV2	TRIM54	Tripartite motif-containing protein 54	GO:0007026; P:negative regulation of microtubule depolymerization; NAS:UniProtKB
Q9BYV2	TRIM54	Tripartite motif-containing protein 54	GO:0007165; P:signal transduction; NAS:UniProtKB
Q9BSJ1	TRIM51	Tripartite motif-containing protein 51	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BYV6	TRIM55	Tripartite motif-containing protein 55	GO:0042802; F:identical protein binding; IPI:IntAct
Q9BYV6	TRIM55	Tripartite motif-containing protein 55	GO:0004871; F:signal transducer activity; NAS:UniProtKB
Q9BYV6	TRIM55	Tripartite motif-containing protein 55	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BYV6	TRIM55	Tripartite motif-containing protein 55	GO:0007165; P:signal transduction; NAS:UniProtKB
Q9BRZ2	TRIM56	E3 ubiquitin-protein ligase TRIM56	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BRZ2	TRIM56	E3 ubiquitin-protein ligase TRIM56	GO:0004842; F:ubiquitin-protein ligase activity; ISS:UniProtKB
Q9BRZ2	TRIM56	E3 ubiquitin-protein ligase TRIM56	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BRZ2	TRIM56	E3 ubiquitin-protein ligase TRIM56	GO:0051607; P:defense response to virus; ISS:UniProtKB
Q9BRZ2	TRIM56	E3 ubiquitin-protein ligase TRIM56	GO:0045087; P:innate immune response; TAS:Reactome
Q9BRZ2	TRIM56	E3 ubiquitin-protein ligase TRIM56	GO:0032608; P:interferon-beta production; ISS:UniProtKB
Q9BRZ2	TRIM56	E3 ubiquitin-protein ligase TRIM56	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q9BRZ2	TRIM56	E3 ubiquitin-protein ligase TRIM56	GO:0070534; P:protein K63-linked ubiquitination; ISS:UniProtKB
Q9BRZ2	TRIM56	E3 ubiquitin-protein ligase TRIM56	GO:0032479; P:regulation of type I interferon production; TAS:Reactome
Q9BRZ2	TRIM56	E3 ubiquitin-protein ligase TRIM56	GO:0034340; P:response to type I interferon; ISS:UniProtKB
Q8NG06	TRIM58	Tripartite motif-containing protein 58	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IWR1	TRIM59	Tripartite motif-containing protein 59	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q8IWR1	TRIM59	Tripartite motif-containing protein 59	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IWR1	TRIM59	Tripartite motif-containing protein 59	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IMP:MGI
Q495X7	TRIM60	Tripartite motif-containing protein 60	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BVG3	TRIM62	E3 ubiquitin-protein ligase TRIM62	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9BVG3	TRIM62	E3 ubiquitin-protein ligase TRIM62	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BVG3	TRIM62	E3 ubiquitin-protein ligase TRIM62	GO:0045087; P:innate immune response; IMP:UniProt
Q9BVG3	TRIM62	E3 ubiquitin-protein ligase TRIM62	GO:0032897; P:negative regulation of viral transcription; IDA:UniProt
Q9BVG3	TRIM62	E3 ubiquitin-protein ligase TRIM62	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProt
Q9BVG3	TRIM62	E3 ubiquitin-protein ligase TRIM62	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProt
Q9BVG3	TRIM62	E3 ubiquitin-protein ligase TRIM62	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:UniProt
Q9BVG3	TRIM62	E3 ubiquitin-protein ligase TRIM62	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9BVG3	TRIM62	E3 ubiquitin-protein ligase TRIM62	GO:0046596; P:regulation of viral entry into host cell; IDA:UniProt
Q9BVG3	TRIM62	E3 ubiquitin-protein ligase TRIM62	GO:1902186; P:regulation of viral release from host cell; IMP:UniProt
Q5EBN2	TRIM61	Putative tripartite motif-containing protein 61	GO:0008270; F:zinc ion binding; IEA:InterPro
Q969Q1	TRIM63	E3 ubiquitin-protein ligase TRIM63	GO:0005515; F:protein binding; IPI:IntAct
Q969Q1	TRIM63	E3 ubiquitin-protein ligase TRIM63	GO:0004871; F:signal transducer activity; NAS:UniProtKB
Q969Q1	TRIM63	E3 ubiquitin-protein ligase TRIM63	GO:0031432; F:titin binding; IDA:UniProtKB
Q969Q1	TRIM63	E3 ubiquitin-protein ligase TRIM63	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q969Q1	TRIM63	E3 ubiquitin-protein ligase TRIM63	GO:0008270; F:zinc ion binding; IEA:InterPro
Q969Q1	TRIM63	E3 ubiquitin-protein ligase TRIM63	GO:0006936; P:muscle contraction; IEA:Ensembl
Q969Q1	TRIM63	E3 ubiquitin-protein ligase TRIM63	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q969Q1	TRIM63	E3 ubiquitin-protein ligase TRIM63	GO:0010468; P:regulation of gene expression; IEA:Ensembl
Q969Q1	TRIM63	E3 ubiquitin-protein ligase TRIM63	GO:0014878; P:response to electrical stimulus involved in regulation of muscle adaptation; ISS:UniProtKB
Q969Q1	TRIM63	E3 ubiquitin-protein ligase TRIM63	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
Q969Q1	TRIM63	E3 ubiquitin-protein ligase TRIM63	GO:0070555; P:response to interleukin-1; IEA:Ensembl
Q969Q1	TRIM63	E3 ubiquitin-protein ligase TRIM63	GO:0007165; P:signal transduction; NAS:UniProtKB
Q969Q1	TRIM63	E3 ubiquitin-protein ligase TRIM63	GO:0014732; P:skeletal muscle atrophy; IEA:Ensembl
A6NGJ6	TRIM64	Tripartite motif-containing protein 64	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6PJ69	TRIM65	Tripartite motif-containing protein 65	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6ZTA4	TRIM67	Tripartite motif-containing protein 67	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6ZTA4	TRIM67	Tripartite motif-containing protein 67	GO:0046580; P:negative regulation of Ras protein signal transduction; IEA:Ensembl
Q6ZTA4	TRIM67	Tripartite motif-containing protein 67	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
Q6ZTA4	TRIM67	Tripartite motif-containing protein 67	GO:2000060; P:positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IEA:Ensembl
O15016	TRIM66	Tripartite motif-containing protein 66	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6AZZ1	TRIM68	E3 ubiquitin-protein ligase TRIM68	GO:0050681; F:androgen receptor binding; IPI:UniProtKB
Q6AZZ1	TRIM68	E3 ubiquitin-protein ligase TRIM68	GO:0035035; F:histone acetyltransferase binding; IPI:UniProtKB
Q6AZZ1	TRIM68	E3 ubiquitin-protein ligase TRIM68	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q6AZZ1	TRIM68	E3 ubiquitin-protein ligase TRIM68	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6AZZ1	TRIM68	E3 ubiquitin-protein ligase TRIM68	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
Q6AZZ1	TRIM68	E3 ubiquitin-protein ligase TRIM68	GO:0060765; P:regulation of androgen receptor signaling pathway; IDA:UniProtKB
Q86WT6	TRIM69	E3 ubiquitin-protein ligase TRIM69	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q86WT6	TRIM69	E3 ubiquitin-protein ligase TRIM69	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86WT6	TRIM69	E3 ubiquitin-protein ligase TRIM69	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q6ZMU5	TRIM72	Tripartite motif-containing protein 72	GO:0001786; F:phosphatidylserine binding; ISS:UniProtKB
Q6ZMU5	TRIM72	Tripartite motif-containing protein 72	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6ZMU5	TRIM72	Tripartite motif-containing protein 72	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q6ZMU5	TRIM72	Tripartite motif-containing protein 72	GO:0007517; P:muscle organ development; ISS:UniProtKB
Q6ZMU5	TRIM72	Tripartite motif-containing protein 72	GO:0003012; P:muscle system process; ISS:UniProtKB
Q6ZMU5	TRIM72	Tripartite motif-containing protein 72	GO:0001778; P:plasma membrane repair; ISS:UniProtKB
Q6ZMU5	TRIM72	Tripartite motif-containing protein 72	GO:0051260; P:protein homooligomerization; ISS:UniProtKB
Q86UV7	TRIM73	Tripartite motif-containing protein 73	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86UV6	TRIM74	Tripartite motif-containing protein 74	GO:0008270; F:zinc ion binding; IEA:InterPro
I1YAP6	TRIM77	Tripartite motif-containing protein 77	GO:0008270; F:zinc ion binding; IEA:InterPro
A6NK02	TRIM75	Putative tripartite motif-containing protein 75	GO:0008270; F:zinc ion binding; IEA:InterPro
O43715	TRIAP1	TP53-regulated inhibitor of apoptosis 1	GO:0002039; F:p53 binding; IPI:BHF-UCL
O43715	TRIAP1	TP53-regulated inhibitor of apoptosis 1	GO:0005515; F:protein binding; IPI:UniProtKB
O43715	TRIAP1	TP53-regulated inhibitor of apoptosis 1	GO:0034644; P:cellular response to UV; IDA:BHF-UCL
O43715	TRIAP1	TP53-regulated inhibitor of apoptosis 1	GO:0030330; P:DNA damage response, signal transduction by p53 class mediator; IDA:BHF-UCL
O43715	TRIAP1	TP53-regulated inhibitor of apoptosis 1	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:HGNC
O43715	TRIAP1	TP53-regulated inhibitor of apoptosis 1	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
O43715	TRIAP1	TP53-regulated inhibitor of apoptosis 1	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:BHF-UCL
O43715	TRIAP1	TP53-regulated inhibitor of apoptosis 1	GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IMP:BHF-UCL
O43715	TRIAP1	TP53-regulated inhibitor of apoptosis 1	GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; IMP:UniProtKB
O43715	TRIAP1	TP53-regulated inhibitor of apoptosis 1	GO:0015914; P:phospholipid transport; IDA:GOC
O43715	TRIAP1	TP53-regulated inhibitor of apoptosis 1	GO:2001140; P:positive regulation of phospholipid transport; IDA:UniProtKB
O43715	TRIAP1	TP53-regulated inhibitor of apoptosis 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
O43715	TRIAP1	TP53-regulated inhibitor of apoptosis 1	GO:0097035; P:regulation of membrane lipid distribution; IMP:UniProtKB
Q96RU8	TRIB1	Tribbles homolog 1	GO:0031434; F:mitogen-activated protein kinase kinase binding; IDA:BHF-UCL
Q96RU8	TRIB1	Tribbles homolog 1	GO:0004860; F:protein kinase inhibitor activity; IMP:BHF-UCL
Q96RU8	TRIB1	Tribbles homolog 1	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
Q96RU8	TRIB1	Tribbles homolog 1	GO:0016772; F:transferase activity, transferring phosphorus-containing groups; IEA:InterPro
Q96RU8	TRIB1	Tribbles homolog 1	GO:0031625; F:ubiquitin protein ligase binding; ISS:BHF-UCL
Q96RU8	TRIB1	Tribbles homolog 1	GO:0055106; F:ubiquitin-protein ligase regulator activity; ISS:BHF-UCL
Q96RU8	TRIB1	Tribbles homolog 1	GO:0007254; P:JNK cascade; IMP:BHF-UCL
Q96RU8	TRIB1	Tribbles homolog 1	GO:0031665; P:negative regulation of lipopolysaccharide-mediated signaling pathway; IMP:BHF-UCL
Q96RU8	TRIB1	Tribbles homolog 1	GO:0006469; P:negative regulation of protein kinase activity; IMP:BHF-UCL
Q96RU8	TRIB1	Tribbles homolog 1	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL
Q96RU8	TRIB1	Tribbles homolog 1	GO:0014912; P:negative regulation of smooth muscle cell migration; IMP:BHF-UCL
Q96RU8	TRIB1	Tribbles homolog 1	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IMP:BHF-UCL
Q96RU8	TRIB1	Tribbles homolog 1	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; ISS:BHF-UCL
Q96RU8	TRIB1	Tribbles homolog 1	GO:0043405; P:regulation of MAP kinase activity; IDA:UniProtKB
Q96RU8	TRIB1	Tribbles homolog 1	GO:0032496; P:response to lipopolysaccharide; IMP:BHF-UCL
Q92519	TRIB2	Tribbles homolog 2	GO:0004860; F:protein kinase inhibitor activity; IEA:UniProtKB-KW
Q92519	TRIB2	Tribbles homolog 2	GO:0008134; F:transcription factor binding; ISS:BHF-UCL
Q92519	TRIB2	Tribbles homolog 2	GO:0016772; F:transferase activity, transferring phosphorus-containing groups; IEA:InterPro
Q92519	TRIB2	Tribbles homolog 2	GO:0031625; F:ubiquitin protein ligase binding; ISS:BHF-UCL
Q92519	TRIB2	Tribbles homolog 2	GO:0055106; F:ubiquitin-protein ligase regulator activity; ISS:BHF-UCL
Q92519	TRIB2	Tribbles homolog 2	GO:0045599; P:negative regulation of fat cell differentiation; ISS:BHF-UCL
Q92519	TRIB2	Tribbles homolog 2	GO:0045081; P:negative regulation of interleukin-10 biosynthetic process; IMP:BHF-UCL
Q92519	TRIB2	Tribbles homolog 2	GO:0006469; P:negative regulation of protein kinase activity; NAS:BHF-UCL
Q92519	TRIB2	Tribbles homolog 2	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; ISS:BHF-UCL
Q92519	TRIB2	Tribbles homolog 2	GO:0043405; P:regulation of MAP kinase activity; ISS:UniProtKB
Q96RU7	TRIB3	Tribbles homolog 3	GO:0005524; F:ATP binding; IEA:InterPro
Q96RU7	TRIB3	Tribbles homolog 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q96RU7	TRIB3	Tribbles homolog 3	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q96RU7	TRIB3	Tribbles homolog 3	GO:0004860; F:protein kinase inhibitor activity; IEA:UniProtKB-KW
Q96RU7	TRIB3	Tribbles homolog 3	GO:0003714; F:transcription corepressor activity; ISS:UniProtKB
Q96RU7	TRIB3	Tribbles homolog 3	GO:0016772; F:transferase activity, transferring phosphorus-containing groups; IEA:InterPro
Q96RU7	TRIB3	Tribbles homolog 3	GO:0031625; F:ubiquitin protein ligase binding; ISS:BHF-UCL
Q96RU7	TRIB3	Tribbles homolog 3	GO:0055106; F:ubiquitin-protein ligase regulator activity; ISS:BHF-UCL
Q96RU7	TRIB3	Tribbles homolog 3	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q96RU7	TRIB3	Tribbles homolog 3	GO:0032869; P:cellular response to insulin stimulus; ISS:BHF-UCL
Q96RU7	TRIB3	Tribbles homolog 3	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
Q96RU7	TRIB3	Tribbles homolog 3	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q96RU7	TRIB3	Tribbles homolog 3	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
Q96RU7	TRIB3	Tribbles homolog 3	GO:0045087; P:innate immune response; TAS:Reactome
Q96RU7	TRIB3	Tribbles homolog 3	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q96RU7	TRIB3	Tribbles homolog 3	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IDA:UniProtKB
Q96RU7	TRIB3	Tribbles homolog 3	GO:0045599; P:negative regulation of fat cell differentiation; ISS:BHF-UCL
Q96RU7	TRIB3	Tribbles homolog 3	GO:0045717; P:negative regulation of fatty acid biosynthetic process; ISS:BHF-UCL
Q96RU7	TRIB3	Tribbles homolog 3	GO:0006469; P:negative regulation of protein kinase activity; IDA:BHF-UCL
Q96RU7	TRIB3	Tribbles homolog 3	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q96RU7	TRIB3	Tribbles homolog 3	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q96RU7	TRIB3	Tribbles homolog 3	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
Q96RU7	TRIB3	Tribbles homolog 3	GO:0032092; P:positive regulation of protein binding; ISS:BHF-UCL
Q96RU7	TRIB3	Tribbles homolog 3	GO:0051443; P:positive regulation of ubiquitin-protein ligase activity; ISS:BHF-UCL
Q96RU7	TRIB3	Tribbles homolog 3	GO:0006468; P:protein phosphorylation; IEA:InterPro
Q96RU7	TRIB3	Tribbles homolog 3	GO:0010827; P:regulation of glucose transport; ISS:BHF-UCL
Q96RU7	TRIB3	Tribbles homolog 3	GO:0043405; P:regulation of MAP kinase activity; IDA:UniProtKB
Q96RU7	TRIB3	Tribbles homolog 3	GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB
Q96RU7	TRIB3	Tribbles homolog 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q96RU7	TRIB3	Tribbles homolog 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7L0X0	TRIL	TLR4 interactor with leucine rich repeats	GO:0001530; F:lipopolysaccharide binding; IDA:UniProtKB
Q7L0X0	TRIL	TLR4 interactor with leucine rich repeats	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q7L0X0	TRIL	TLR4 interactor with leucine rich repeats	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q7L0X0	TRIL	TLR4 interactor with leucine rich repeats	GO:0002718; P:regulation of cytokine production involved in immune response; IDA:UniProtKB
Q7L0X0	TRIL	TLR4 interactor with leucine rich repeats	GO:0034142; P:toll-like receptor 4 signaling pathway; IDA:UniProtKB
Q9UJV3	MID2	Probable E3 ubiquitin-protein ligase MID2	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9UJV3	MID2	Probable E3 ubiquitin-protein ligase MID2	GO:0008017; F:microtubule binding; IMP:UniProt
Q9UJV3	MID2	Probable E3 ubiquitin-protein ligase MID2	GO:0051219; F:phosphoprotein binding; IPI:UniProt
Q9UJV3	MID2	Probable E3 ubiquitin-protein ligase MID2	GO:0046982; F:protein heterodimerization activity; IDA:UniProt
Q9UJV3	MID2	Probable E3 ubiquitin-protein ligase MID2	GO:0042803; F:protein homodimerization activity; IDA:UniProt
Q9UJV3	MID2	Probable E3 ubiquitin-protein ligase MID2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UJV3	MID2	Probable E3 ubiquitin-protein ligase MID2	GO:0045087; P:innate immune response; IDA:UniProt
Q9UJV3	MID2	Probable E3 ubiquitin-protein ligase MID2	GO:0046597; P:negative regulation of viral entry into host cell; IDA:UniProt
Q9UJV3	MID2	Probable E3 ubiquitin-protein ligase MID2	GO:1902187; P:negative regulation of viral release from host cell; IDA:UniProt
Q9UJV3	MID2	Probable E3 ubiquitin-protein ligase MID2	GO:0032897; P:negative regulation of viral transcription; IDA:UniProt
Q9UJV3	MID2	Probable E3 ubiquitin-protein ligase MID2	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProt
Q9UJV3	MID2	Probable E3 ubiquitin-protein ligase MID2	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProt
Q9UJV3	MID2	Probable E3 ubiquitin-protein ligase MID2	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:UniProt
Q9UJV3	MID2	Probable E3 ubiquitin-protein ligase MID2	GO:0035372; P:protein localization to microtubule; IMP:UniProt
Q9UJV3	MID2	Probable E3 ubiquitin-protein ligase MID2	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9C040	TRIM2	Tripartite motif-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9C040	TRIM2	Tripartite motif-containing protein 2	GO:0004842; F:ubiquitin-protein ligase activity; ISS:UniProtKB
Q9C040	TRIM2	Tripartite motif-containing protein 2	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9C040	TRIM2	Tripartite motif-containing protein 2	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9C040	TRIM2	Tripartite motif-containing protein 2	GO:0043523; P:regulation of neuron apoptotic process; ISS:UniProtKB
O75382	TRIM3	Tripartite motif-containing protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
O75382	TRIM3	Tripartite motif-containing protein 3	GO:0008022; F:protein C-terminus binding; TAS:ProtInc
O75382	TRIM3	Tripartite motif-containing protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
O75382	TRIM3	Tripartite motif-containing protein 3	GO:0007399; P:nervous system development; TAS:ProtInc
O75382	TRIM3	Tripartite motif-containing protein 3	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9C037	TRIM4	Tripartite motif-containing protein 4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9C037	TRIM4	Tripartite motif-containing protein 4	GO:0070206; P:protein trimerization; IDA:UniProtKB
Q9C035	TRIM5	Tripartite motif-containing protein 5	GO:0042802; F:identical protein binding; IPI:IntAct
Q9C035	TRIM5	Tripartite motif-containing protein 5	GO:0005515; F:protein binding; IPI:IntAct
Q9C035	TRIM5	Tripartite motif-containing protein 5	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q9C035	TRIM5	Tripartite motif-containing protein 5	GO:0008329; F:signaling pattern recognition receptor activity; IDA:UniProtKB
Q9C035	TRIM5	Tripartite motif-containing protein 5	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9C035	TRIM5	Tripartite motif-containing protein 5	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9C035	TRIM5	Tripartite motif-containing protein 5	GO:0002218; P:activation of innate immune response; IDA:UniProtKB
Q9C035	TRIM5	Tripartite motif-containing protein 5	GO:0051607; P:defense response to virus; TAS:UniProtKB
Q9C035	TRIM5	Tripartite motif-containing protein 5	GO:0045087; P:innate immune response; IDA:UniProt
Q9C035	TRIM5	Tripartite motif-containing protein 5	GO:0046597; P:negative regulation of viral entry into host cell; IDA:UniProt
Q9C035	TRIM5	Tripartite motif-containing protein 5	GO:1902187; P:negative regulation of viral release from host cell; IDA:UniProt
Q9C035	TRIM5	Tripartite motif-containing protein 5	GO:0002221; P:pattern recognition receptor signaling pathway; IDA:GOC
Q9C035	TRIM5	Tripartite motif-containing protein 5	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q9C035	TRIM5	Tripartite motif-containing protein 5	GO:0043410; P:positive regulation of MAPK cascade; IMP:UniProtKB
Q9C035	TRIM5	Tripartite motif-containing protein 5	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
Q9C035	TRIM5	Tripartite motif-containing protein 5	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IMP:UniProt
Q9C035	TRIM5	Tripartite motif-containing protein 5	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
Q9C035	TRIM5	Tripartite motif-containing protein 5	GO:0070206; P:protein trimerization; IDA:UniProtKB
Q9C035	TRIM5	Tripartite motif-containing protein 5	GO:0031664; P:regulation of lipopolysaccharide-mediated signaling pathway; IMP:UniProtKB
Q9C035	TRIM5	Tripartite motif-containing protein 5	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9C030	TRIM6	Tripartite motif-containing protein 6	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9C030	TRIM6	Tripartite motif-containing protein 6	GO:0070206; P:protein trimerization; IDA:UniProtKB
Q9C029	TRIM7	Tripartite motif-containing protein 7	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BZR9	TRIM8	Probable E3 ubiquitin-protein ligase TRIM8	GO:0042802; F:identical protein binding; IPI:IntAct
Q9BZR9	TRIM8	Probable E3 ubiquitin-protein ligase TRIM8	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9BZR9	TRIM8	Probable E3 ubiquitin-protein ligase TRIM8	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q9BZR9	TRIM8	Probable E3 ubiquitin-protein ligase TRIM8	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9BZR9	TRIM8	Probable E3 ubiquitin-protein ligase TRIM8	GO:0045087; P:innate immune response; IDA:UniProt
Q9BZR9	TRIM8	Probable E3 ubiquitin-protein ligase TRIM8	GO:1902187; P:negative regulation of viral release from host cell; IDA:UniProt
Q9BZR9	TRIM8	Probable E3 ubiquitin-protein ligase TRIM8	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProt
Q9BZR9	TRIM8	Probable E3 ubiquitin-protein ligase TRIM8	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProt
Q9BZR9	TRIM8	Probable E3 ubiquitin-protein ligase TRIM8	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProt
Q9BZR9	TRIM8	Probable E3 ubiquitin-protein ligase TRIM8	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9C026	TRIM9	E3 ubiquitin-protein ligase TRIM9	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q9C026	TRIM9	E3 ubiquitin-protein ligase TRIM9	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9C026	TRIM9	E3 ubiquitin-protein ligase TRIM9	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9C026	TRIM9	E3 ubiquitin-protein ligase TRIM9	GO:0045955; P:negative regulation of calcium ion-dependent exocytosis; IEA:Ensembl
Q9C026	TRIM9	E3 ubiquitin-protein ligase TRIM9	GO:0035544; P:negative regulation of SNARE complex assembly; IEA:Ensembl
Q9C026	TRIM9	E3 ubiquitin-protein ligase TRIM9	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q9C026	TRIM9	E3 ubiquitin-protein ligase TRIM9	GO:0016079; P:synaptic vesicle exocytosis; IEA:Ensembl
Q8N9V2	TRIML1	Probable E3 ubiquitin-protein ligase TRIML1	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q8N9V2	TRIML1	Probable E3 ubiquitin-protein ligase TRIML1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N9V2	TRIML1	Probable E3 ubiquitin-protein ligase TRIML1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8N9V2	TRIML1	Probable E3 ubiquitin-protein ligase TRIML1	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8N7C3	TRIML2	Probable E3 ubiquitin-protein ligase TRIML2	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q8N7C3	TRIML2	Probable E3 ubiquitin-protein ligase TRIML2	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8N7C3	TRIML2	Probable E3 ubiquitin-protein ligase TRIML2	GO:0032526; P:response to retinoic acid; IEA:Ensembl
O75962	TRIO	Triple functional domain protein	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75962	TRIO	Triple functional domain protein	GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:ProtInc
O75962	TRIO	Triple functional domain protein	GO:0005515; F:protein binding; IPI:IntAct
O75962	TRIO	Triple functional domain protein	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
O75962	TRIO	Triple functional domain protein	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
O75962	TRIO	Triple functional domain protein	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
O75962	TRIO	Triple functional domain protein	GO:0007411; P:axon guidance; TAS:Reactome
O75962	TRIO	Triple functional domain protein	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
O75962	TRIO	Triple functional domain protein	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
O75962	TRIO	Triple functional domain protein	GO:0043087; P:regulation of GTPase activity; TAS:GOC
O75962	TRIO	Triple functional domain protein	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
O75962	TRIO	Triple functional domain protein	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
O75962	TRIO	Triple functional domain protein	GO:0007185; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; TAS:ProtInc
Q15650	TRIP4	Activating signal cointegrator 1	GO:0016922; F:ligand-dependent nuclear receptor binding; IDA:UniProtKB
Q15650	TRIP4	Activating signal cointegrator 1	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q15650	TRIP4	Activating signal cointegrator 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q15650	TRIP4	Activating signal cointegrator 1	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
Q15650	TRIP4	Activating signal cointegrator 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q15654	TRIP6	Thyroid receptor-interacting protein 6	GO:0005149; F:interleukin-1 receptor binding; IDA:UniProtKB
Q15654	TRIP6	Thyroid receptor-interacting protein 6	GO:0019900; F:kinase binding; IPI:UniProtKB
Q15654	TRIP6	Thyroid receptor-interacting protein 6	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15654	TRIP6	Thyroid receptor-interacting protein 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q15654	TRIP6	Thyroid receptor-interacting protein 6	GO:0046966; F:thyroid hormone receptor binding; NAS:UniProtKB
Q15654	TRIP6	Thyroid receptor-interacting protein 6	GO:0008270; F:zinc ion binding; IEA:InterPro
Q15654	TRIP6	Thyroid receptor-interacting protein 6	GO:0048041; P:focal adhesion assembly; NAS:UniProtKB
Q15654	TRIP6	Thyroid receptor-interacting protein 6	GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB
Q15654	TRIP6	Thyroid receptor-interacting protein 6	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q15654	TRIP6	Thyroid receptor-interacting protein 6	GO:0008588; P:release of cytoplasmic sequestered NF-kappaB; IDA:UniProtKB
Q15654	TRIP6	Thyroid receptor-interacting protein 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15643	TRIP11	Thyroid receptor-interacting protein 11	GO:0005515; F:protein binding; IPI:UniProtKB
Q15643	TRIP11	Thyroid receptor-interacting protein 11	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
Q15643	TRIP11	Thyroid receptor-interacting protein 11	GO:0000042; P:protein targeting to Golgi; IEA:InterPro
Q15643	TRIP11	Thyroid receptor-interacting protein 11	GO:2001141; P:regulation of RNA biosynthetic process; TAS:GOC
Q15643	TRIP11	Thyroid receptor-interacting protein 11	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q15643	TRIP11	Thyroid receptor-interacting protein 11	GO:0003281; P:ventricular septum development; IEA:Ensembl
Q14669	TRIP12	E3 ubiquitin-protein ligase TRIP12	GO:0005515; F:protein binding; IPI:UniProtKB
Q14669	TRIP12	E3 ubiquitin-protein ligase TRIP12	GO:0046966; F:thyroid hormone receptor binding; IDA:UniProtKB
Q14669	TRIP12	E3 ubiquitin-protein ligase TRIP12	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q14669	TRIP12	E3 ubiquitin-protein ligase TRIP12	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
Q14669	TRIP12	E3 ubiquitin-protein ligase TRIP12	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q14669	TRIP12	E3 ubiquitin-protein ligase TRIP12	GO:0009790; P:embryo development; ISS:UniProtKB
Q14669	TRIP12	E3 ubiquitin-protein ligase TRIP12	GO:2000780; P:negative regulation of double-strand break repair; IMP:UniProtKB
Q14669	TRIP12	E3 ubiquitin-protein ligase TRIP12	GO:1901315; P:negative regulation of histone H2A K63-linked ubiquitination; IMP:UniProtKB
Q14669	TRIP12	E3 ubiquitin-protein ligase TRIP12	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q7Z4G4	TRMT11	tRNA (guanine(10)-N2)-methyltransferase homolog	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q7Z4G4	TRMT11	tRNA (guanine(10)-N2)-methyltransferase homolog	GO:0000049; F:tRNA binding; IEA:UniProtKB-KW
Q7Z4G4	TRMT11	tRNA (guanine(10)-N2)-methyltransferase homolog	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q9NUP7	TRMT13	tRNA:m(4)X modification enzyme TRM13 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NUP7	TRMT13	tRNA:m(4)X modification enzyme TRM13 homolog	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q9NUP7	TRMT13	tRNA:m(4)X modification enzyme TRM13 homolog	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q7Z2T5	TRMT1L	TRMT1-like protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z2T5	TRMT1L	TRMT1-like protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7Z2T5	TRMT1L	TRMT1-like protein	GO:0004809; F:tRNA (guanine-N2-)-methyltransferase activity; IEA:InterPro
Q7Z2T5	TRMT1L	TRMT1-like protein	GO:0000049; F:tRNA binding; IEA:UniProtKB-KW
Q7Z2T5	TRMT1L	TRMT1-like protein	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
Q9NXH9	TRMT1	tRNA (guanine(26)-N(2))-dimethyltransferase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NXH9	TRMT1	tRNA (guanine(26)-N(2))-dimethyltransferase	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NXH9	TRMT1	tRNA (guanine(26)-N(2))-dimethyltransferase	GO:0004809; F:tRNA (guanine-N2-)-methyltransferase activity; IEA:InterPro
Q9NXH9	TRMT1	tRNA (guanine(26)-N(2))-dimethyltransferase	GO:0000049; F:tRNA binding; IEA:UniProtKB-KW
Q8IZ69	TRMT2A	tRNA (uracil-5-)-methyltransferase homolog A	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8IZ69	TRMT2A	tRNA (uracil-5-)-methyltransferase homolog A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IZ69	TRMT2A	tRNA (uracil-5-)-methyltransferase homolog A	GO:0008173; F:RNA methyltransferase activity; IEA:InterPro
Q8IZ69	TRMT2A	tRNA (uracil-5-)-methyltransferase homolog A	GO:0006396; P:RNA processing; IEA:InterPro
Q96GJ1	TRMT2B	tRNA (uracil(54)-C(5))-methyltransferase homolog	GO:0030697; F:S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity; IEA:UniProtKB-EC
Q8IYL2	TRMT44	Probable tRNA (uracil-O(2)-)-methyltransferase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IYL2	TRMT44	Probable tRNA (uracil-O(2)-)-methyltransferase	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q8IYL2	TRMT44	Probable tRNA (uracil-O(2)-)-methyltransferase	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q32P41	TRMT5	tRNA (guanine(37)-N1)-methyltransferase	GO:0052906; F:tRNA (guanine(37)-N(1))-methyltransferase activity; IEA:UniProtKB-EC
Q96FX7	TRMT61A	tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A	GO:0016429; F:tRNA (adenine-N1-)-methyltransferase activity; IEA:InterPro
Q9UJA5	TRMT6	tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q9UJA5	TRMT6	tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UJA5	TRMT6	tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6	GO:0003743; F:translation initiation factor activity; IEA:InterPro
Q9UJA5	TRMT6	tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6	GO:0006446; P:regulation of translational initiation; IEA:InterPro
Q9UJA5	TRMT6	tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q9UET6	FTSJ1	Putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase	GO:0008175; F:tRNA methyltransferase activity; IEA:InterPro
Q9UBP6	METTL1	tRNA (guanine-N(7)-)-methyltransferase	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBP6	METTL1	tRNA (guanine-N(7)-)-methyltransferase	GO:0008176; F:tRNA (guanine-N7-)-methyltransferase activity; IDA:UniProtKB
Q9UBP6	METTL1	tRNA (guanine-N(7)-)-methyltransferase	GO:0000049; F:tRNA binding; IEA:UniProtKB-HAMAP
Q9UBP6	METTL1	tRNA (guanine-N(7)-)-methyltransferase	GO:0036265; P:RNA (guanine-N7)-methylation; IDA:GOC
Q9UBP6	METTL1	tRNA (guanine-N(7)-)-methyltransferase	GO:0006400; P:tRNA modification; IDA:UniProtKB
Q86YW5	TREML1	Trem-like transcript 1 protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q86YW5	TREML1	Trem-like transcript 1 protein	GO:0019722; P:calcium-mediated signaling; IDA:UniProtKB
Q86YW5	TREML1	Trem-like transcript 1 protein	GO:0045087; P:innate immune response; NAS:UniProtKB
Q86YW5	TREML1	Trem-like transcript 1 protein	GO:0030168; P:platelet activation; IEA:Ensembl
Q5T2D2	TREML2	Trem-like transcript 2 protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q5T2D2	TREML2	Trem-like transcript 2 protein	GO:0004872; F:receptor activity; IDA:UniProtKB
Q5T2D2	TREML2	Trem-like transcript 2 protein	GO:0042110; P:T cell activation; IDA:UniProtKB
O15050	TRANK1	TPR and ankyrin repeat-containing protein 1	GO:0005524; F:ATP binding; IEA:InterPro
O15050	TRANK1	TPR and ankyrin repeat-containing protein 1	GO:0016787; F:hydrolase activity; IEA:InterPro
Q96Q11	TRNT1	CCA tRNA nucleotidyltransferase 1, mitochondrial	GO:0005524; F:ATP binding; TAS:UniProtKB
Q96Q11	TRNT1	CCA tRNA nucleotidyltransferase 1, mitochondrial	GO:0052929; F:ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity; IEA:UniProtKB-EC
Q96Q11	TRNT1	CCA tRNA nucleotidyltransferase 1, mitochondrial	GO:0052928; F:CTP:3'-cytidine-tRNA cytidylyltransferase activity; IEA:UniProtKB-EC
Q96Q11	TRNT1	CCA tRNA nucleotidyltransferase 1, mitochondrial	GO:0052927; F:CTP:tRNA cytidylyltransferase activity; IEA:UniProtKB-EC
Q96Q11	TRNT1	CCA tRNA nucleotidyltransferase 1, mitochondrial	GO:0004810; F:tRNA adenylyltransferase activity; IDA:UniProtKB
Q96Q11	TRNT1	CCA tRNA nucleotidyltransferase 1, mitochondrial	GO:0000049; F:tRNA binding; IDA:UniProtKB
Q96Q11	TRNT1	CCA tRNA nucleotidyltransferase 1, mitochondrial	GO:0006626; P:protein targeting to mitochondrion; TAS:UniProtKB
Q96Q11	TRNT1	CCA tRNA nucleotidyltransferase 1, mitochondrial	GO:0042780; P:tRNA 3'-end processing; IDA:UniProtKB
Q96Q11	TRNT1	CCA tRNA nucleotidyltransferase 1, mitochondrial	GO:0001680; P:tRNA 3'-terminal CCA addition; IEA:UniProtKB-EC
Q6NT89	TRNP1	TMF-regulated nuclear protein 1	GO:0003677; F:DNA binding; ISS:UniProtKB
Q6NT89	TRNP1	TMF-regulated nuclear protein 1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q6NT89	TRNP1	TMF-regulated nuclear protein 1	GO:0021696; P:cerebellar cortex morphogenesis; ISS:UniProtKB
Q6NT89	TRNP1	TMF-regulated nuclear protein 1	GO:0061351; P:neural precursor cell proliferation; ISS:UniProtKB
Q6NT89	TRNP1	TMF-regulated nuclear protein 1	GO:0051726; P:regulation of cell cycle; ISS:UniProtKB
Q6NT89	TRNP1	TMF-regulated nuclear protein 1	GO:0042127; P:regulation of cell proliferation; ISS:UniProtKB
Q6NT89	TRNP1	TMF-regulated nuclear protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6NT89	TRNP1	TMF-regulated nuclear protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q12815	TROAP	Tastin	GO:0005515; F:protein binding; IPI:IntAct
Q12815	TROAP	Tastin	GO:0007155; P:cell adhesion; TAS:ProtInc
Q12816	TRO	Trophinin	GO:0005515; F:protein binding; IPI:IntAct
Q12816	TRO	Trophinin	GO:0007566; P:embryo implantation; TAS:ProtInc
Q12816	TRO	Trophinin	GO:0007156; P:homophilic cell adhesion; TAS:ProtInc
Q12816	TRO	Trophinin	GO:0030308; P:negative regulation of cell growth; IEA:Ensembl
O75762	TRPA1	Transient receptor potential cation channel subfamily A member 1	GO:0005262; F:calcium channel activity; IEA:Ensembl
O75762	TRPA1	Transient receptor potential cation channel subfamily A member 1	GO:0015267; F:channel activity; TAS:ProtInc
O75762	TRPA1	Transient receptor potential cation channel subfamily A member 1	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
O75762	TRPA1	Transient receptor potential cation channel subfamily A member 1	GO:0050968; P:detection of chemical stimulus involved in sensory perception of pain; IEA:Ensembl
O75762	TRPA1	Transient receptor potential cation channel subfamily A member 1	GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; IEA:Ensembl
O75762	TRPA1	Transient receptor potential cation channel subfamily A member 1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
O75762	TRPA1	Transient receptor potential cation channel subfamily A member 1	GO:0006811; P:ion transport; TAS:ProtInc
O75762	TRPA1	Transient receptor potential cation channel subfamily A member 1	GO:0009409; P:response to cold; IEA:Ensembl
O75762	TRPA1	Transient receptor potential cation channel subfamily A member 1	GO:0042493; P:response to drug; IEA:Ensembl
O75762	TRPA1	Transient receptor potential cation channel subfamily A member 1	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
O75762	TRPA1	Transient receptor potential cation channel subfamily A member 1	GO:0048265; P:response to pain; IEA:Ensembl
O75762	TRPA1	Transient receptor potential cation channel subfamily A member 1	GO:0050955; P:thermoception; IEA:Ensembl
O75762	TRPA1	Transient receptor potential cation channel subfamily A member 1	GO:0055085; P:transmembrane transport; TAS:Reactome
P48995	TRPC1	Short transient receptor potential channel 1	GO:0005262; F:calcium channel activity; TAS:ProtInc
P48995	TRPC1	Short transient receptor potential channel 1	GO:0005261; F:cation channel activity; EXP:Reactome
P48995	TRPC1	Short transient receptor potential channel 1	GO:0070679; F:inositol 1,4,5 trisphosphate binding; IDA:BHF-UCL
P48995	TRPC1	Short transient receptor potential channel 1	GO:0044325; F:ion channel binding; IPI:BHF-UCL
P48995	TRPC1	Short transient receptor potential channel 1	GO:0005515; F:protein binding; IPI:BHF-UCL
P48995	TRPC1	Short transient receptor potential channel 1	GO:0015279; F:store-operated calcium channel activity; TAS:ProtInc
P48995	TRPC1	Short transient receptor potential channel 1	GO:0007411; P:axon guidance; TAS:Reactome
P48995	TRPC1	Short transient receptor potential channel 1	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
P48995	TRPC1	Short transient receptor potential channel 1	GO:0006816; P:calcium ion transport; TAS:ProtInc
P48995	TRPC1	Short transient receptor potential channel 1	GO:0051480; P:cytosolic calcium ion homeostasis; IDA:BHF-UCL
P48995	TRPC1	Short transient receptor potential channel 1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P48995	TRPC1	Short transient receptor potential channel 1	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IDA:BHF-UCL
P48995	TRPC1	Short transient receptor potential channel 1	GO:0051592; P:response to calcium ion; IDA:BHF-UCL
P48995	TRPC1	Short transient receptor potential channel 1	GO:0046541; P:saliva secretion; IEA:Ensembl
P48995	TRPC1	Short transient receptor potential channel 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q13507	TRPC3	Short transient receptor potential channel 3	GO:0005262; F:calcium channel activity; TAS:ProtInc
Q13507	TRPC3	Short transient receptor potential channel 3	GO:0070679; F:inositol 1,4,5 trisphosphate binding; IDA:BHF-UCL
Q13507	TRPC3	Short transient receptor potential channel 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q13507	TRPC3	Short transient receptor potential channel 3	GO:0015279; F:store-operated calcium channel activity; TAS:ProtInc
Q13507	TRPC3	Short transient receptor potential channel 3	GO:0007411; P:axon guidance; TAS:Reactome
Q13507	TRPC3	Short transient receptor potential channel 3	GO:0007596; P:blood coagulation; TAS:Reactome
Q13507	TRPC3	Short transient receptor potential channel 3	GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB
Q13507	TRPC3	Short transient receptor potential channel 3	GO:0006816; P:calcium ion transport; TAS:ProtInc
Q13507	TRPC3	Short transient receptor potential channel 3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q13507	TRPC3	Short transient receptor potential channel 3	GO:0007602; P:phototransduction; TAS:ProtInc
Q13507	TRPC3	Short transient receptor potential channel 3	GO:0030168; P:platelet activation; TAS:Reactome
Q13507	TRPC3	Short transient receptor potential channel 3	GO:0010524; P:positive regulation of calcium ion transport into cytosol; IDA:UniProtKB
Q13507	TRPC3	Short transient receptor potential channel 3	GO:0033198; P:response to ATP; IDA:UniProtKB
Q13507	TRPC3	Short transient receptor potential channel 3	GO:0051592; P:response to calcium ion; IDA:UniProtKB
Q13507	TRPC3	Short transient receptor potential channel 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UBN4	TRPC4	Short transient receptor potential channel 4	GO:0008013; F:beta-catenin binding; IPI:BHF-UCL
Q9UBN4	TRPC4	Short transient receptor potential channel 4	GO:0045296; F:cadherin binding; IPI:BHF-UCL
Q9UBN4	TRPC4	Short transient receptor potential channel 4	GO:0070679; F:inositol 1,4,5 trisphosphate binding; IEA:Ensembl
Q9UBN4	TRPC4	Short transient receptor potential channel 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBN4	TRPC4	Short transient receptor potential channel 4	GO:0015279; F:store-operated calcium channel activity; IMP:UniProtKB
Q9UBN4	TRPC4	Short transient receptor potential channel 4	GO:0007411; P:axon guidance; TAS:Reactome
Q9UBN4	TRPC4	Short transient receptor potential channel 4	GO:0070509; P:calcium ion import; IDA:BHF-UCL
Q9UBN4	TRPC4	Short transient receptor potential channel 4	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
Q9UBN4	TRPC4	Short transient receptor potential channel 4	GO:0006816; P:calcium ion transport; TAS:ProtInc
Q9UBN4	TRPC4	Short transient receptor potential channel 4	GO:0014051; P:gamma-aminobutyric acid secretion; IEA:Ensembl
Q9UBN4	TRPC4	Short transient receptor potential channel 4	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9UBN4	TRPC4	Short transient receptor potential channel 4	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UL62	TRPC5	Short transient receptor potential channel 5	GO:0005262; F:calcium channel activity; IDA:UniProtKB
Q9UL62	TRPC5	Short transient receptor potential channel 5	GO:0070679; F:inositol 1,4,5 trisphosphate binding; IEA:Ensembl
Q9UL62	TRPC5	Short transient receptor potential channel 5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UL62	TRPC5	Short transient receptor potential channel 5	GO:0015279; F:store-operated calcium channel activity; TAS:ProtInc
Q9UL62	TRPC5	Short transient receptor potential channel 5	GO:0007411; P:axon guidance; TAS:Reactome
Q9UL62	TRPC5	Short transient receptor potential channel 5	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
Q9UL62	TRPC5	Short transient receptor potential channel 5	GO:0006816; P:calcium ion transport; TAS:ProtInc
Q9UL62	TRPC5	Short transient receptor potential channel 5	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9UL62	TRPC5	Short transient receptor potential channel 5	GO:0007399; P:nervous system development; TAS:ProtInc
Q9UL62	TRPC5	Short transient receptor potential channel 5	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9Y210	TRPC6	Short transient receptor potential channel 6	GO:0070679; F:inositol 1,4,5 trisphosphate binding; IDA:BHF-UCL
Q9Y210	TRPC6	Short transient receptor potential channel 6	GO:0005515; F:protein binding; IPI:IntAct
Q9Y210	TRPC6	Short transient receptor potential channel 6	GO:0015279; F:store-operated calcium channel activity; IEA:Ensembl
Q9Y210	TRPC6	Short transient receptor potential channel 6	GO:0007568; P:aging; IEA:Ensembl
Q9Y210	TRPC6	Short transient receptor potential channel 6	GO:0007411; P:axon guidance; TAS:Reactome
Q9Y210	TRPC6	Short transient receptor potential channel 6	GO:0007596; P:blood coagulation; TAS:Reactome
Q9Y210	TRPC6	Short transient receptor potential channel 6	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
Q9Y210	TRPC6	Short transient receptor potential channel 6	GO:0006812; P:cation transport; TAS:ProtInc
Q9Y210	TRPC6	Short transient receptor potential channel 6	GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl
Q9Y210	TRPC6	Short transient receptor potential channel 6	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
Q9Y210	TRPC6	Short transient receptor potential channel 6	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9Y210	TRPC6	Short transient receptor potential channel 6	GO:0030168; P:platelet activation; TAS:Reactome
Q9Y210	TRPC6	Short transient receptor potential channel 6	GO:0051928; P:positive regulation of calcium ion transport; IDA:MGI
Q9Y210	TRPC6	Short transient receptor potential channel 6	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
Q9Y210	TRPC6	Short transient receptor potential channel 6	GO:0032414; P:positive regulation of ion transmembrane transporter activity; IDA:MGI
Q9Y210	TRPC6	Short transient receptor potential channel 6	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9HCX4	TRPC7	Short transient receptor potential channel 7	GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW
Q9HCX4	TRPC7	Short transient receptor potential channel 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HCX4	TRPC7	Short transient receptor potential channel 7	GO:0007411; P:axon guidance; TAS:Reactome
Q9HCX4	TRPC7	Short transient receptor potential channel 7	GO:0007596; P:blood coagulation; TAS:Reactome
Q9HCX4	TRPC7	Short transient receptor potential channel 7	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
Q9HCX4	TRPC7	Short transient receptor potential channel 7	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9HCX4	TRPC7	Short transient receptor potential channel 7	GO:0006828; P:manganese ion transport; IEA:Ensembl
Q9HCX4	TRPC7	Short transient receptor potential channel 7	GO:0030168; P:platelet activation; TAS:Reactome
Q9HCX4	TRPC7	Short transient receptor potential channel 7	GO:0055085; P:transmembrane transport; TAS:Reactome
Q7Z4N2	TRPM1	Transient receptor potential cation channel subfamily M member 1	GO:0005262; F:calcium channel activity; IDA:UniProtKB
Q7Z4N2	TRPM1	Transient receptor potential cation channel subfamily M member 1	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
Q7Z4N2	TRPM1	Transient receptor potential cation channel subfamily M member 1	GO:0060402; P:calcium ion transport into cytosol; IDA:UniProtKB
Q7Z4N2	TRPM1	Transient receptor potential cation channel subfamily M member 1	GO:0071482; P:cellular response to light stimulus; IMP:UniProtKB
Q7Z4N2	TRPM1	Transient receptor potential cation channel subfamily M member 1	GO:0007216; P:G-protein coupled glutamate receptor signaling pathway; IMP:UniProtKB
Q7Z4N2	TRPM1	Transient receptor potential cation channel subfamily M member 1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q7Z4N2	TRPM1	Transient receptor potential cation channel subfamily M member 1	GO:0046548; P:retinal rod cell development; IEA:Ensembl
Q7Z4N2	TRPM1	Transient receptor potential cation channel subfamily M member 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q7Z4N2	TRPM1	Transient receptor potential cation channel subfamily M member 1	GO:0006810; P:transport; TAS:ProtInc
Q7Z4N2	TRPM1	Transient receptor potential cation channel subfamily M member 1	GO:0007601; P:visual perception; IMP:UniProtKB
O94759	TRPM2	Transient receptor potential cation channel subfamily M member 2	GO:0047631; F:ADP-ribose diphosphatase activity; IEA:UniProtKB-EC
O94759	TRPM2	Transient receptor potential cation channel subfamily M member 2	GO:0005262; F:calcium channel activity; TAS:ProtInc
O94759	TRPM2	Transient receptor potential cation channel subfamily M member 2	GO:0005384; F:manganese ion transmembrane transporter activity; IEA:Ensembl
O94759	TRPM2	Transient receptor potential cation channel subfamily M member 2	GO:0005272; F:sodium channel activity; IEA:UniProtKB-KW
O94759	TRPM2	Transient receptor potential cation channel subfamily M member 2	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
O94759	TRPM2	Transient receptor potential cation channel subfamily M member 2	GO:0006816; P:calcium ion transport; TAS:ProtInc
O94759	TRPM2	Transient receptor potential cation channel subfamily M member 2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
O94759	TRPM2	Transient receptor potential cation channel subfamily M member 2	GO:0033194; P:response to hydroperoxide; IEA:Ensembl
O94759	TRPM2	Transient receptor potential cation channel subfamily M member 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9HCF6	TRPM3	Transient receptor potential cation channel subfamily M member 3	GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW
Q9HCF6	TRPM3	Transient receptor potential cation channel subfamily M member 3	GO:0005261; F:cation channel activity; IDA:MGI
Q9HCF6	TRPM3	Transient receptor potential cation channel subfamily M member 3	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
Q9HCF6	TRPM3	Transient receptor potential cation channel subfamily M member 3	GO:0006812; P:cation transport; IDA:MGI
Q9HCF6	TRPM3	Transient receptor potential cation channel subfamily M member 3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9HCF6	TRPM3	Transient receptor potential cation channel subfamily M member 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8TD43	TRPM4	Transient receptor potential cation channel subfamily M member 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8TD43	TRPM4	Transient receptor potential cation channel subfamily M member 4	GO:0005227; F:calcium activated cation channel activity; ISS:UniProtKB
Q8TD43	TRPM4	Transient receptor potential cation channel subfamily M member 4	GO:0005262; F:calcium channel activity; IEA:Ensembl
Q8TD43	TRPM4	Transient receptor potential cation channel subfamily M member 4	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
Q8TD43	TRPM4	Transient receptor potential cation channel subfamily M member 4	GO:0002407; P:dendritic cell chemotaxis; ISS:UniProtKB
Q8TD43	TRPM4	Transient receptor potential cation channel subfamily M member 4	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q8TD43	TRPM4	Transient receptor potential cation channel subfamily M member 4	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:UniProtKB
Q8TD43	TRPM4	Transient receptor potential cation channel subfamily M member 4	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q8TD43	TRPM4	Transient receptor potential cation channel subfamily M member 4	GO:0016925; P:protein sumoylation; IDA:UniProtKB
Q8TD43	TRPM4	Transient receptor potential cation channel subfamily M member 4	GO:0002724; P:regulation of T cell cytokine production; IDA:UniProtKB
Q8TD43	TRPM4	Transient receptor potential cation channel subfamily M member 4	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9NZQ8	TRPM5	Transient receptor potential cation channel subfamily M member 5	GO:0005227; F:calcium activated cation channel activity; IEA:Ensembl
Q9NZQ8	TRPM5	Transient receptor potential cation channel subfamily M member 5	GO:0005216; F:ion channel activity; TAS:ProtInc
Q9NZQ8	TRPM5	Transient receptor potential cation channel subfamily M member 5	GO:0005267; F:potassium channel activity; IEA:Ensembl
Q9NZQ8	TRPM5	Transient receptor potential cation channel subfamily M member 5	GO:0005272; F:sodium channel activity; IEA:Ensembl
Q9NZQ8	TRPM5	Transient receptor potential cation channel subfamily M member 5	GO:0005244; F:voltage-gated ion channel activity; IEA:UniProtKB-KW
Q9NZQ8	TRPM5	Transient receptor potential cation channel subfamily M member 5	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
Q9NZQ8	TRPM5	Transient receptor potential cation channel subfamily M member 5	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9NZQ8	TRPM5	Transient receptor potential cation channel subfamily M member 5	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9BX84	TRPM6	Transient receptor potential cation channel subfamily M member 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BX84	TRPM6	Transient receptor potential cation channel subfamily M member 6	GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW
Q9BX84	TRPM6	Transient receptor potential cation channel subfamily M member 6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BX84	TRPM6	Transient receptor potential cation channel subfamily M member 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BX84	TRPM6	Transient receptor potential cation channel subfamily M member 6	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q9BX84	TRPM6	Transient receptor potential cation channel subfamily M member 6	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
Q9BX84	TRPM6	Transient receptor potential cation channel subfamily M member 6	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9BX84	TRPM6	Transient receptor potential cation channel subfamily M member 6	GO:0009636; P:response to toxic substance; IDA:UniProtKB
Q9BX84	TRPM6	Transient receptor potential cation channel subfamily M member 6	GO:0055085; P:transmembrane transport; TAS:Reactome
Q96QT4	TRPM7	Transient receptor potential cation channel subfamily M member 7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96QT4	TRPM7	Transient receptor potential cation channel subfamily M member 7	GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW
Q96QT4	TRPM7	Transient receptor potential cation channel subfamily M member 7	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96QT4	TRPM7	Transient receptor potential cation channel subfamily M member 7	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q96QT4	TRPM7	Transient receptor potential cation channel subfamily M member 7	GO:0031032; P:actomyosin structure organization; IEA:Ensembl
Q96QT4	TRPM7	Transient receptor potential cation channel subfamily M member 7	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
Q96QT4	TRPM7	Transient receptor potential cation channel subfamily M member 7	GO:0016340; P:calcium-dependent cell-matrix adhesion; IEA:Ensembl
Q96QT4	TRPM7	Transient receptor potential cation channel subfamily M member 7	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q96QT4	TRPM7	Transient receptor potential cation channel subfamily M member 7	GO:0070266; P:necroptotic process; IMP:UniProtKB
Q96QT4	TRPM7	Transient receptor potential cation channel subfamily M member 7	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
Q96QT4	TRPM7	Transient receptor potential cation channel subfamily M member 7	GO:0055085; P:transmembrane transport; TAS:Reactome
Q7Z2W7	TRPM8	Transient receptor potential cation channel subfamily M member 8	GO:0005262; F:calcium channel activity; IEA:Ensembl
Q7Z2W7	TRPM8	Transient receptor potential cation channel subfamily M member 8	GO:0005216; F:ion channel activity; IEA:InterPro
Q7Z2W7	TRPM8	Transient receptor potential cation channel subfamily M member 8	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
Q7Z2W7	TRPM8	Transient receptor potential cation channel subfamily M member 8	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
Q7Z2W7	TRPM8	Transient receptor potential cation channel subfamily M member 8	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q7Z2W7	TRPM8	Transient receptor potential cation channel subfamily M member 8	GO:0051289; P:protein homotetramerization; IEA:Ensembl
Q7Z2W7	TRPM8	Transient receptor potential cation channel subfamily M member 8	GO:0070207; P:protein homotrimerization; IEA:Ensembl
Q7Z2W7	TRPM8	Transient receptor potential cation channel subfamily M member 8	GO:0009409; P:response to cold; IEA:Ensembl
Q7Z2W7	TRPM8	Transient receptor potential cation channel subfamily M member 8	GO:0050955; P:thermoception; IEA:Ensembl
Q7Z2W7	TRPM8	Transient receptor potential cation channel subfamily M member 8	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UHF7	TRPS1	Zinc finger transcription factor Trps1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UHF7	TRPS1	Zinc finger transcription factor Trps1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9UHF7	TRPS1	Zinc finger transcription factor Trps1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9UHF7	TRPS1	Zinc finger transcription factor Trps1	GO:0008270; F:zinc ion binding; TAS:ProtInc
Q9UHF7	TRPS1	Zinc finger transcription factor Trps1	GO:0002062; P:chondrocyte differentiation; IEA:Ensembl
Q9UHF7	TRPS1	Zinc finger transcription factor Trps1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9UHF7	TRPS1	Zinc finger transcription factor Trps1	GO:0006607; P:NLS-bearing protein import into nucleus; TAS:ProtInc
Q9UHF7	TRPS1	Zinc finger transcription factor Trps1	GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
Q9UHF7	TRPS1	Zinc finger transcription factor Trps1	GO:0032330; P:regulation of chondrocyte differentiation; ISS:UniProtKB
Q9UHF7	TRPS1	Zinc finger transcription factor Trps1	GO:0031063; P:regulation of histone deacetylation; IEA:InterPro
Q9UHF7	TRPS1	Zinc finger transcription factor Trps1	GO:0001501; P:skeletal system development; TAS:ProtInc
Q9UHF7	TRPS1	Zinc finger transcription factor Trps1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9UHF7	TRPS1	Zinc finger transcription factor Trps1	GO:0007178; P:transmembrane receptor protein serine/threonine kinase signaling pathway; IEA:Ensembl
Q86TN4	TRPT1	tRNA 2'-phosphotransferase 1	GO:0000215; F:tRNA 2'-phosphotransferase activity; IEA:UniProtKB-EC
Q86TN4	TRPT1	tRNA 2'-phosphotransferase 1	GO:0045859; P:regulation of protein kinase activity; IEA:Ensembl
Q86TN4	TRPT1	tRNA 2'-phosphotransferase 1	GO:0006388; P:tRNA splicing, via endonucleolytic cleavage and ligation; IEA:Ensembl
Q8NER1	TRPV1	Transient receptor potential cation channel subfamily V member 1	GO:0005524; F:ATP binding; ISS:UniProtKB
Q8NER1	TRPV1	Transient receptor potential cation channel subfamily V member 1	GO:0005262; F:calcium channel activity; TAS:ProtInc
Q8NER1	TRPV1	Transient receptor potential cation channel subfamily V member 1	GO:0015278; F:calcium-release channel activity; ISS:UniProtKB
Q8NER1	TRPV1	Transient receptor potential cation channel subfamily V member 1	GO:0005231; F:excitatory extracellular ligand-gated ion channel activity; ISS:UniProtKB
Q8NER1	TRPV1	Transient receptor potential cation channel subfamily V member 1	GO:0051219; F:phosphoprotein binding; IPI:UniProt
Q8NER1	TRPV1	Transient receptor potential cation channel subfamily V member 1	GO:0004888; F:transmembrane signaling receptor activity; ISS:UniProtKB
Q8NER1	TRPV1	Transient receptor potential cation channel subfamily V member 1	GO:0070588; P:calcium ion transmembrane transport; ISS:UniProtKB
Q8NER1	TRPV1	Transient receptor potential cation channel subfamily V member 1	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
Q8NER1	TRPV1	Transient receptor potential cation channel subfamily V member 1	GO:0071312; P:cellular response to alkaloid; ISS:UniProtKB
Q8NER1	TRPV1	Transient receptor potential cation channel subfamily V member 1	GO:0071318; P:cellular response to ATP; ISS:UniProtKB
Q8NER1	TRPV1	Transient receptor potential cation channel subfamily V member 1	GO:0007635; P:chemosensory behavior; TAS:ProtInc
Q8NER1	TRPV1	Transient receptor potential cation channel subfamily V member 1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q8NER1	TRPV1	Transient receptor potential cation channel subfamily V member 1	GO:0050955; P:thermoception; IDA:MGI
Q8NER1	TRPV1	Transient receptor potential cation channel subfamily V member 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8NER1	TRPV1	Transient receptor potential cation channel subfamily V member 1	GO:0006810; P:transport; TAS:ProtInc
Q9Y5S1	TRPV2	Transient receptor potential cation channel subfamily V member 2	GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW
Q9Y5S1	TRPV2	Transient receptor potential cation channel subfamily V member 2	GO:0005261; F:cation channel activity; IDA:MGI
Q9Y5S1	TRPV2	Transient receptor potential cation channel subfamily V member 2	GO:0005216; F:ion channel activity; TAS:ProtInc
Q9Y5S1	TRPV2	Transient receptor potential cation channel subfamily V member 2	GO:0015075; F:ion transmembrane transporter activity; TAS:ProtInc
Q9Y5S1	TRPV2	Transient receptor potential cation channel subfamily V member 2	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
Q9Y5S1	TRPV2	Transient receptor potential cation channel subfamily V member 2	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9Y5S1	TRPV2	Transient receptor potential cation channel subfamily V member 2	GO:0045773; P:positive regulation of axon extension; IEA:Ensembl
Q9Y5S1	TRPV2	Transient receptor potential cation channel subfamily V member 2	GO:0090280; P:positive regulation of calcium ion import; IEA:Ensembl
Q9Y5S1	TRPV2	Transient receptor potential cation channel subfamily V member 2	GO:0009408; P:response to heat; IEA:Ensembl
Q9Y5S1	TRPV2	Transient receptor potential cation channel subfamily V member 2	GO:0009266; P:response to temperature stimulus; IDA:MGI
Q9Y5S1	TRPV2	Transient receptor potential cation channel subfamily V member 2	GO:0007600; P:sensory perception; TAS:ProtInc
Q9Y5S1	TRPV2	Transient receptor potential cation channel subfamily V member 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9Y5S1	TRPV2	Transient receptor potential cation channel subfamily V member 2	GO:0006810; P:transport; TAS:ProtInc
Q8NET8	TRPV3	Transient receptor potential cation channel subfamily V member 3	GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW
Q8NET8	TRPV3	Transient receptor potential cation channel subfamily V member 3	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
Q8NET8	TRPV3	Transient receptor potential cation channel subfamily V member 3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q8NET8	TRPV3	Transient receptor potential cation channel subfamily V member 3	GO:0042636; P:negative regulation of hair cycle; IMP:UniProtKB
Q8NET8	TRPV3	Transient receptor potential cation channel subfamily V member 3	GO:0090280; P:positive regulation of calcium ion import; IEA:Ensembl
Q8NET8	TRPV3	Transient receptor potential cation channel subfamily V member 3	GO:0009408; P:response to heat; IEA:Ensembl
Q8NET8	TRPV3	Transient receptor potential cation channel subfamily V member 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0003779; F:actin binding; ISS:BHF-UCL
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0051015; F:actin filament binding; ISS:BHF-UCL
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0043014; F:alpha-tubulin binding; ISS:BHF-UCL
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0048487; F:beta-tubulin binding; ISS:BHF-UCL
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0005262; F:calcium channel activity; IDA:UniProtKB
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0005516; F:calmodulin binding; IMP:UniProtKB
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0005261; F:cation channel activity; IDA:UniProtKB
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0008017; F:microtubule binding; ISS:BHF-UCL
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0005034; F:osmosensor activity; IEA:Ensembl
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0005080; F:protein kinase C binding; ISS:BHF-UCL
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0042169; F:SH2 domain binding; ISS:BHF-UCL
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0031532; P:actin cytoskeleton reorganization; ISS:BHF-UCL
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0007015; P:actin filament organization; ISS:BHF-UCL
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0070509; P:calcium ion import; ISS:BHF-UCL
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0006816; P:calcium ion transport; IDA:UniProtKB
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0006884; P:cell volume homeostasis; TAS:UniProtKB
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0007043; P:cell-cell junction assembly; ISS:UniProtKB
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0006874; P:cellular calcium ion homeostasis; IDA:UniProtKB
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0071476; P:cellular hypotonic response; ISS:BHF-UCL
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0034605; P:cellular response to heat; ISS:UniProtKB
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0071470; P:cellular response to osmotic stress; ISS:UniProtKB
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0043622; P:cortical microtubule organization; ISS:BHF-UCL
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0042538; P:hyperosmotic salinity response; IEA:Ensembl
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0046785; P:microtubule polymerization; ISS:BHF-UCL
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0010977; P:negative regulation of neuron projection development; ISS:BHF-UCL
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0007231; P:osmosensory signaling pathway; TAS:UniProtKB
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0031117; P:positive regulation of microtubule depolymerization; ISS:BHF-UCL
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0047484; P:regulation of response to osmotic stress; IEA:Ensembl
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0009612; P:response to mechanical stimulus; TAS:UniProtKB
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9HBA0	TRPV4	Transient receptor potential cation channel subfamily V member 4	GO:0030103; P:vasopressin secretion; IEA:Ensembl
Q9NQA5	TRPV5	Transient receptor potential cation channel subfamily V member 5	GO:0005262; F:calcium channel activity; ISS:UniProtKB
Q9NQA5	TRPV5	Transient receptor potential cation channel subfamily V member 5	GO:0005515; F:protein binding; IPI:IntAct
Q9NQA5	TRPV5	Transient receptor potential cation channel subfamily V member 5	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
Q9NQA5	TRPV5	Transient receptor potential cation channel subfamily V member 5	GO:0006816; P:calcium ion transport; ISS:UniProtKB
Q9NQA5	TRPV5	Transient receptor potential cation channel subfamily V member 5	GO:0060402; P:calcium ion transport into cytosol; IEA:Ensembl
Q9NQA5	TRPV5	Transient receptor potential cation channel subfamily V member 5	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9NQA5	TRPV5	Transient receptor potential cation channel subfamily V member 5	GO:0051262; P:protein tetramerization; ISS:UniProtKB
Q9NQA5	TRPV5	Transient receptor potential cation channel subfamily V member 5	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9H1D0	TRPV6	Transient receptor potential cation channel subfamily V member 6	GO:0005262; F:calcium channel activity; IDA:UniProtKB
Q9H1D0	TRPV6	Transient receptor potential cation channel subfamily V member 6	GO:0005516; F:calmodulin binding; IDA:UniProtKB
Q9H1D0	TRPV6	Transient receptor potential cation channel subfamily V member 6	GO:0005515; F:protein binding; IPI:IntAct
Q9H1D0	TRPV6	Transient receptor potential cation channel subfamily V member 6	GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome
Q9H1D0	TRPV6	Transient receptor potential cation channel subfamily V member 6	GO:0006816; P:calcium ion transport; NAS:UniProtKB
Q9H1D0	TRPV6	Transient receptor potential cation channel subfamily V member 6	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9H1D0	TRPV6	Transient receptor potential cation channel subfamily V member 6	GO:0017158; P:regulation of calcium ion-dependent exocytosis; NAS:UniProtKB
Q9H1D0	TRPV6	Transient receptor potential cation channel subfamily V member 6	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9Y4A5	TRRAP	Transformation/transcription domain-associated protein	GO:0016773; F:phosphotransferase activity, alcohol group as acceptor; IEA:InterPro
Q9Y4A5	TRRAP	Transformation/transcription domain-associated protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y4A5	TRRAP	Transformation/transcription domain-associated protein	GO:0003713; F:transcription coactivator activity; IEA:Ensembl
Q9Y4A5	TRRAP	Transformation/transcription domain-associated protein	GO:0003712; F:transcription cofactor activity; IDA:UniProtKB
Q9Y4A5	TRRAP	Transformation/transcription domain-associated protein	GO:0006325; P:chromatin organization; TAS:Reactome
Q9Y4A5	TRRAP	Transformation/transcription domain-associated protein	GO:0016573; P:histone acetylation; NAS:UniProtKB
Q9Y4A5	TRRAP	Transformation/transcription domain-associated protein	GO:0016578; P:histone deubiquitination; IDA:UniProtKB
Q9Y4A5	TRRAP	Transformation/transcription domain-associated protein	GO:0043968; P:histone H2A acetylation; IDA:UniProtKB
Q9Y4A5	TRRAP	Transformation/transcription domain-associated protein	GO:0043967; P:histone H4 acetylation; IDA:UniProtKB
Q9Y4A5	TRRAP	Transformation/transcription domain-associated protein	GO:0007093; P:mitotic cell cycle checkpoint; IEA:Ensembl
Q9Y4A5	TRRAP	Transformation/transcription domain-associated protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y4A5	TRRAP	Transformation/transcription domain-associated protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y606	PUS1	tRNA pseudouridine synthase A, mitochondrial	GO:0003677; F:DNA binding; IEA:Ensembl
Q9Y606	PUS1	tRNA pseudouridine synthase A, mitochondrial	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IEA:Ensembl
Q9Y606	PUS1	tRNA pseudouridine synthase A, mitochondrial	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y606	PUS1	tRNA pseudouridine synthase A, mitochondrial	GO:0009982; F:pseudouridine synthase activity; IEA:UniProtKB-EC
Q9Y606	PUS1	tRNA pseudouridine synthase A, mitochondrial	GO:0004730; F:pseudouridylate synthase activity; NAS:UniProtKB
Q9Y606	PUS1	tRNA pseudouridine synthase A, mitochondrial	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9Y606	PUS1	tRNA pseudouridine synthase A, mitochondrial	GO:0031119; P:tRNA pseudouridine synthesis; IEA:Ensembl
Q8WWH5	TRUB1	Probable tRNA pseudouridine synthase 1	GO:0009982; F:pseudouridine synthase activity; IEA:InterPro
Q8WWH5	TRUB1	Probable tRNA pseudouridine synthase 1	GO:0003723; F:RNA binding; IEA:InterPro
Q8WWH5	TRUB1	Probable tRNA pseudouridine synthase 1	GO:0001522; P:pseudouridine synthesis; IEA:InterPro
Q8WWH5	TRUB1	Probable tRNA pseudouridine synthase 1	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
O95900	TRUB2	Probable tRNA pseudouridine synthase 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O95900	TRUB2	Probable tRNA pseudouridine synthase 2	GO:0009982; F:pseudouridine synthase activity; IEA:InterPro
O95900	TRUB2	Probable tRNA pseudouridine synthase 2	GO:0001522; P:pseudouridine synthesis; IEA:InterPro
O95900	TRUB2	Probable tRNA pseudouridine synthase 2	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q16881	TXNRD1	Thioredoxin reductase 1, cytoplasmic	GO:0009055; F:electron carrier activity; IEA:InterPro
Q16881	TXNRD1	Thioredoxin reductase 1, cytoplasmic	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q16881	TXNRD1	Thioredoxin reductase 1, cytoplasmic	GO:0050661; F:NADP binding; IEA:InterPro
Q16881	TXNRD1	Thioredoxin reductase 1, cytoplasmic	GO:0005515; F:protein binding; IPI:IntAct
Q16881	TXNRD1	Thioredoxin reductase 1, cytoplasmic	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
Q16881	TXNRD1	Thioredoxin reductase 1, cytoplasmic	GO:0004791; F:thioredoxin-disulfide reductase activity; EXP:Reactome
Q16881	TXNRD1	Thioredoxin reductase 1, cytoplasmic	GO:0008283; P:cell proliferation; IEA:Ensembl
Q16881	TXNRD1	Thioredoxin reductase 1, cytoplasmic	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q16881	TXNRD1	Thioredoxin reductase 1, cytoplasmic	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
Q16881	TXNRD1	Thioredoxin reductase 1, cytoplasmic	GO:0001707; P:mesoderm formation; IEA:Ensembl
Q16881	TXNRD1	Thioredoxin reductase 1, cytoplasmic	GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome
Q16881	TXNRD1	Thioredoxin reductase 1, cytoplasmic	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q16881	TXNRD1	Thioredoxin reductase 1, cytoplasmic	GO:0007165; P:signal transduction; NAS:ProtInc
Q16881	TXNRD1	Thioredoxin reductase 1, cytoplasmic	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NNW7	TXNRD2	Thioredoxin reductase 2, mitochondrial	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q9NNW7	TXNRD2	Thioredoxin reductase 2, mitochondrial	GO:0050661; F:NADP binding; IEA:InterPro
Q9NNW7	TXNRD2	Thioredoxin reductase 2, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NNW7	TXNRD2	Thioredoxin reductase 2, mitochondrial	GO:0004791; F:thioredoxin-disulfide reductase activity; ISS:UniProtKB
Q9NNW7	TXNRD2	Thioredoxin reductase 2, mitochondrial	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q9NNW7	TXNRD2	Thioredoxin reductase 2, mitochondrial	GO:0007507; P:heart development; IEA:Ensembl
Q9NNW7	TXNRD2	Thioredoxin reductase 2, mitochondrial	GO:0030097; P:hemopoiesis; IEA:Ensembl
Q9NNW7	TXNRD2	Thioredoxin reductase 2, mitochondrial	GO:0000305; P:response to oxygen radical; TAS:UniProtKB
Q86VQ6	TXNRD3	Thioredoxin reductase 3	GO:0009055; F:electron carrier activity; IEA:InterPro
Q86VQ6	TXNRD3	Thioredoxin reductase 3	GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro
Q86VQ6	TXNRD3	Thioredoxin reductase 3	GO:0050661; F:NADP binding; IEA:InterPro
Q86VQ6	TXNRD3	Thioredoxin reductase 3	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
Q86VQ6	TXNRD3	Thioredoxin reductase 3	GO:0004791; F:thioredoxin-disulfide reductase activity; NAS:UniProtKB
Q86VQ6	TXNRD3	Thioredoxin reductase 3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q86VQ6	TXNRD3	Thioredoxin reductase 3	GO:0045454; P:cell redox homeostasis; NAS:UniProtKB
Q86VQ6	TXNRD3	Thioredoxin reductase 3	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q86VQ6	TXNRD3	Thioredoxin reductase 3	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
P07477	PRSS1	Trypsin-1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P07477	PRSS1	Trypsin-1	GO:0004252; F:serine-type endopeptidase activity; TAS:UniProtKB
P07477	PRSS1	Trypsin-1	GO:0009235; P:cobalamin metabolic process; TAS:Reactome
P07477	PRSS1	Trypsin-1	GO:0007586; P:digestion; IEA:UniProtKB-KW
P07477	PRSS1	Trypsin-1	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P07477	PRSS1	Trypsin-1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P07477	PRSS1	Trypsin-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P07477	PRSS1	Trypsin-1	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P07477	PRSS1	Trypsin-1	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
P07478	PRSS2	Trypsin-2	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P07478	PRSS2	Trypsin-2	GO:0005515; F:protein binding; IPI:UniProtKB
P07478	PRSS2	Trypsin-2	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
P07478	PRSS2	Trypsin-2	GO:0030574; P:collagen catabolic process; IDA:UniProtKB
P07478	PRSS2	Trypsin-2	GO:0007586; P:digestion; IEA:UniProtKB-KW
P07478	PRSS2	Trypsin-2	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
P07478	PRSS2	Trypsin-2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P07478	PRSS2	Trypsin-2	GO:0045087; P:innate immune response; TAS:Reactome
P07478	PRSS2	Trypsin-2	GO:0045785; P:positive regulation of cell adhesion; TAS:UniProtKB
P07478	PRSS2	Trypsin-2	GO:0030307; P:positive regulation of cell growth; TAS:UniProtKB
P07478	PRSS2	Trypsin-2	GO:0006508; P:proteolysis; IDA:UniProtKB
P35030	PRSS3	Trypsin-3	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P35030	PRSS3	Trypsin-3	GO:0005515; F:protein binding; IPI:UniProtKB
P35030	PRSS3	Trypsin-3	GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB
P35030	PRSS3	Trypsin-3	GO:0008236; F:serine-type peptidase activity; IDA:UniProtKB
P35030	PRSS3	Trypsin-3	GO:0009235; P:cobalamin metabolic process; TAS:Reactome
P35030	PRSS3	Trypsin-3	GO:0007586; P:digestion; TAS:UniProtKB
P35030	PRSS3	Trypsin-3	GO:0043542; P:endothelial cell migration; IMP:UniProtKB
P35030	PRSS3	Trypsin-3	GO:0045087; P:innate immune response; TAS:Reactome
P35030	PRSS3	Trypsin-3	GO:0006508; P:proteolysis; IDA:GOC
P35030	PRSS3	Trypsin-3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P35030	PRSS3	Trypsin-3	GO:0006766; P:vitamin metabolic process; TAS:Reactome
P35030	PRSS3	Trypsin-3	GO:0006767; P:water-soluble vitamin metabolic process; TAS:Reactome
P35030	PRSS3	Trypsin-3	GO:0031638; P:zymogen activation; IDA:UniProtKB
Q8NHM4	PRSS3P2	Putative trypsin-6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NHM4	PRSS3P2	Putative trypsin-6	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q8NHM4	PRSS3P2	Putative trypsin-6	GO:0043542; P:endothelial cell migration; IMP:UniProtKB
Q15661	TPSAB1	Tryptase alpha/beta-1	GO:0005515; F:protein binding; IPI:IntAct
Q15661	TPSAB1	Tryptase alpha/beta-1	GO:0004252; F:serine-type endopeptidase activity; NAS:UniProtKB
Q15661	TPSAB1	Tryptase alpha/beta-1	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
Q15661	TPSAB1	Tryptase alpha/beta-1	GO:0006952; P:defense response; TAS:ProtInc
Q15661	TPSAB1	Tryptase alpha/beta-1	GO:0022617; P:extracellular matrix disassembly; TAS:Reactome
Q15661	TPSAB1	Tryptase alpha/beta-1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P20231	TPSB2	Tryptase beta-2	GO:0004252; F:serine-type endopeptidase activity; NAS:UniProtKB
P20231	TPSB2	Tryptase beta-2	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
Q9BZJ3	TPSD1	Tryptase delta	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q9BZJ3	TPSD1	Tryptase delta	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
Q9NRR2	TPSG1	Tryptase gamma	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q9NRR2	TPSG1	Tryptase gamma	GO:0008236; F:serine-type peptidase activity; TAS:ProtInc
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0048306; F:calcium-dependent protein binding; IPI:UniProtKB
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0003677; F:DNA binding; TAS:ProtInc
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0043130; F:ubiquitin binding; IDA:UniProt
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0007050; P:cell cycle arrest; IEA:Ensembl
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0051301; P:cell division; IEA:UniProtKB-KW
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0006464; P:cellular protein modification process; IEA:InterPro
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0016197; P:endosomal transport; TAS:Reactome
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0075733; P:intracellular transport of virus; TAS:Reactome
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0061024; P:membrane organization; TAS:Reactome
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0001558; P:regulation of cell growth; IEA:Ensembl
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0043162; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; IMP:UniProtKB
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0046755; P:viral budding; ISS:UniProtKB
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0019058; P:viral life cycle; TAS:Reactome
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0016032; P:viral process; TAS:Reactome
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0019082; P:viral protein processing; TAS:Reactome
Q99816	TSG101	Tumor susceptibility gene 101 protein	GO:0019068; P:virion assembly; TAS:Reactome
Q7RTX1	TAS1R1	Taste receptor type 1 member 1	GO:0046982; F:protein heterodimerization activity; NAS:UniProtKB
Q7RTX1	TAS1R1	Taste receptor type 1 member 1	GO:0008527; F:taste receptor activity; IDA:UniProtKB
Q7RTX1	TAS1R1	Taste receptor type 1 member 1	GO:0050912; P:detection of chemical stimulus involved in sensory perception of taste; IDA:GOC
Q7RTX1	TAS1R1	Taste receptor type 1 member 1	GO:0050917; P:sensory perception of umami taste; IDA:UniProtKB
Q8TE23	TAS1R2	Taste receptor type 1 member 2	GO:0046982; F:protein heterodimerization activity; NAS:UniProtKB
Q8TE23	TAS1R2	Taste receptor type 1 member 2	GO:0008527; F:taste receptor activity; IDA:UniProtKB
Q8TE23	TAS1R2	Taste receptor type 1 member 2	GO:0001582; P:detection of chemical stimulus involved in sensory perception of sweet taste; IDA:HGNC
Q8TE23	TAS1R2	Taste receptor type 1 member 2	GO:0007186; P:G-protein coupled receptor signaling pathway; IC:HGNC
Q8TE23	TAS1R2	Taste receptor type 1 member 2	GO:0032467; P:positive regulation of cytokinesis; IMP:UniProt
Q8TE23	TAS1R2	Taste receptor type 1 member 2	GO:0050916; P:sensory perception of sweet taste; IDA:UniProtKB
Q7RTX0	TAS1R3	Taste receptor type 1 member 3	GO:0046982; F:protein heterodimerization activity; NAS:UniProtKB
Q7RTX0	TAS1R3	Taste receptor type 1 member 3	GO:0008527; F:taste receptor activity; IDA:UniProtKB
Q7RTX0	TAS1R3	Taste receptor type 1 member 3	GO:0001582; P:detection of chemical stimulus involved in sensory perception of sweet taste; IDA:HGNC
Q7RTX0	TAS1R3	Taste receptor type 1 member 3	GO:0007186; P:G-protein coupled receptor signaling pathway; IC:HGNC
Q7RTX0	TAS1R3	Taste receptor type 1 member 3	GO:0050916; P:sensory perception of sweet taste; IDA:UniProtKB
Q7RTX0	TAS1R3	Taste receptor type 1 member 3	GO:0050917; P:sensory perception of umami taste; IDA:UniProtKB
Q96A04	TSACC	TSSK6-activating co-chaperone protein	GO:0051087; F:chaperone binding; IPI:UniProtKB
Q9NX07	TRNAU1AP	tRNA selenocysteine 1-associated protein 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q9NX07	TRNAU1AP	tRNA selenocysteine 1-associated protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NX07	TRNAU1AP	tRNA selenocysteine 1-associated protein 1	GO:0001514; P:selenocysteine incorporation; ISS:HGNC
Q92574	TSC1	Hamartin	GO:0051087; F:chaperone binding; IPI:UniProtKB
Q92574	TSC1	Hamartin	GO:0030695; F:GTPase regulator activity; IEA:Ensembl
Q92574	TSC1	Hamartin	GO:0005515; F:protein binding; IPI:UniProtKB
Q92574	TSC1	Hamartin	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q92574	TSC1	Hamartin	GO:0032862; P:activation of Rho GTPase activity; IDA:UniProtKB
Q92574	TSC1	Hamartin	GO:0055007; P:cardiac muscle cell differentiation; IEA:Ensembl
Q92574	TSC1	Hamartin	GO:0007050; P:cell cycle arrest; TAS:Reactome
Q92574	TSC1	Hamartin	GO:0030030; P:cell projection organization; IEA:Ensembl
Q92574	TSC1	Hamartin	GO:0007160; P:cell-matrix adhesion; IMP:UniProtKB
Q92574	TSC1	Hamartin	GO:0021987; P:cerebral cortex development; IEA:Ensembl
Q92574	TSC1	Hamartin	GO:0021766; P:hippocampus development; IEA:Ensembl
Q92574	TSC1	Hamartin	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q92574	TSC1	Hamartin	GO:0001822; P:kidney development; IEA:Ensembl
Q92574	TSC1	Hamartin	GO:0042552; P:myelination; IEA:Ensembl
Q92574	TSC1	Hamartin	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q92574	TSC1	Hamartin	GO:0045792; P:negative regulation of cell size; IEA:Ensembl
Q92574	TSC1	Hamartin	GO:0032007; P:negative regulation of TOR signaling; IMP:UniProtKB
Q92574	TSC1	Hamartin	GO:0017148; P:negative regulation of translation; IMP:UniProtKB
Q92574	TSC1	Hamartin	GO:0001843; P:neural tube closure; IEA:Ensembl
Q92574	TSC1	Hamartin	GO:0051894; P:positive regulation of focal adhesion assembly; IDA:UniProtKB
Q92574	TSC1	Hamartin	GO:0006813; P:potassium ion transport; IEA:Ensembl
Q92574	TSC1	Hamartin	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
Q92574	TSC1	Hamartin	GO:0050821; P:protein stabilization; IDA:UniProtKB
Q92574	TSC1	Hamartin	GO:0001952; P:regulation of cell-matrix adhesion; IMP:UniProtKB
Q92574	TSC1	Hamartin	GO:0043666; P:regulation of phosphoprotein phosphatase activity; IMP:UniProtKB
Q92574	TSC1	Hamartin	GO:0045859; P:regulation of protein kinase activity; IEA:Ensembl
Q92574	TSC1	Hamartin	GO:0051492; P:regulation of stress fiber assembly; IDA:UniProtKB
Q92574	TSC1	Hamartin	GO:0006417; P:regulation of translation; IDA:UniProtKB
Q92574	TSC1	Hamartin	GO:0032868; P:response to insulin; IDA:UniProtKB
Q92574	TSC1	Hamartin	GO:0006407; P:rRNA export from nucleus; IMP:UniProtKB
Q92574	TSC1	Hamartin	GO:0050808; P:synapse organization; IEA:Ensembl
P49815	TSC2	Tuberin	GO:0005096; F:GTPase activator activity; IDA:UniProtKB
P49815	TSC2	Tuberin	GO:0019902; F:phosphatase binding; IDA:UniProtKB
P49815	TSC2	Tuberin	GO:0005515; F:protein binding; IPI:UniProtKB
P49815	TSC2	Tuberin	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P49815	TSC2	Tuberin	GO:0006953; P:acute-phase response; IEA:Ensembl
P49815	TSC2	Tuberin	GO:0007050; P:cell cycle arrest; TAS:Reactome
P49815	TSC2	Tuberin	GO:0030030; P:cell projection organization; IEA:Ensembl
P49815	TSC2	Tuberin	GO:0006897; P:endocytosis; TAS:ProtInc
P49815	TSC2	Tuberin	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P49815	TSC2	Tuberin	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P49815	TSC2	Tuberin	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P49815	TSC2	Tuberin	GO:0007507; P:heart development; ISS:UniProtKB
P49815	TSC2	Tuberin	GO:0045087; P:innate immune response; TAS:Reactome
P49815	TSC2	Tuberin	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P49815	TSC2	Tuberin	GO:0048009; P:insulin-like growth factor receptor signaling pathway; ISS:UniProtKB
P49815	TSC2	Tuberin	GO:0008285; P:negative regulation of cell proliferation; ISS:UniProtKB
P49815	TSC2	Tuberin	GO:0045792; P:negative regulation of cell size; IBA:RefGenome
P49815	TSC2	Tuberin	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
P49815	TSC2	Tuberin	GO:0043407; P:negative regulation of MAP kinase activity; IEA:Ensembl
P49815	TSC2	Tuberin	GO:0014067; P:negative regulation of phosphatidylinositol 3-kinase signaling; ISS:UniProtKB
P49815	TSC2	Tuberin	GO:0006469; P:negative regulation of protein kinase activity; ISS:UniProtKB
P49815	TSC2	Tuberin	GO:0051898; P:negative regulation of protein kinase B signaling; ISS:UniProtKB
P49815	TSC2	Tuberin	GO:0032007; P:negative regulation of TOR signaling; IBA:RefGenome
P49815	TSC2	Tuberin	GO:0030178; P:negative regulation of Wnt signaling pathway; IBA:RefGenome
P49815	TSC2	Tuberin	GO:0001843; P:neural tube closure; ISS:UniProtKB
P49815	TSC2	Tuberin	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P49815	TSC2	Tuberin	GO:0014065; P:phosphatidylinositol 3-kinase signaling; IEA:Ensembl
P49815	TSC2	Tuberin	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P49815	TSC2	Tuberin	GO:0050918; P:positive chemotaxis; ISS:UniProtKB
P49815	TSC2	Tuberin	GO:0051291; P:protein heterooligomerization; IEA:Ensembl
P49815	TSC2	Tuberin	GO:0051260; P:protein homooligomerization; IEA:Ensembl
P49815	TSC2	Tuberin	GO:0006606; P:protein import into nucleus; ISS:UniProtKB
P49815	TSC2	Tuberin	GO:0043491; P:protein kinase B signaling; ISS:UniProtKB
P49815	TSC2	Tuberin	GO:0008104; P:protein localization; ISS:UniProtKB
P49815	TSC2	Tuberin	GO:0051726; P:regulation of cell cycle; IBA:RefGenome
P49815	TSC2	Tuberin	GO:0030100; P:regulation of endocytosis; ISS:UniProtKB
P49815	TSC2	Tuberin	GO:0046626; P:regulation of insulin receptor signaling pathway; ISS:UniProtKB
P49815	TSC2	Tuberin	GO:0051056; P:regulation of small GTPase mediated signal transduction; IEA:InterPro
P49815	TSC2	Tuberin	GO:0001666; P:response to hypoxia; IEA:Ensembl
P49815	TSC2	Tuberin	GO:0016192; P:vesicle-mediated transport; TAS:ProtInc
Q9BY10	SLC46A2	Thymic stromal cotransporter homolog	GO:0015293; F:symporter activity; NAS:UniProtKB
Q9BY10	SLC46A2	Thymic stromal cotransporter homolog	GO:0070233; P:negative regulation of T cell apoptotic process; IEA:Ensembl
Q9BY10	SLC46A2	Thymic stromal cotransporter homolog	GO:0045580; P:regulation of T cell differentiation; IEA:Ensembl
Q9BY10	SLC46A2	Thymic stromal cotransporter homolog	GO:0043029; P:T cell homeostasis; IEA:Ensembl
Q9BY10	SLC46A2	Thymic stromal cotransporter homolog	GO:0048538; P:thymus development; IEA:Ensembl
Q8WU66	TSPEAR	Thrombospondin-type laminin G domain and EAR repeat-containing protein	GO:0007605; P:sensory perception of sound; IMP:UniProtKB
Q9BZW7	TSGA10	Testis-specific gene 10 protein	GO:0030031; P:cell projection assembly; IEA:Ensembl
Q9BZW7	TSGA10	Testis-specific gene 10 protein	GO:0007283; P:spermatogenesis; TAS:UniProtKB
P98066	TNFAIP6	Tumor necrosis factor-inducible gene 6 protein	GO:0005540; F:hyaluronic acid binding; TAS:ProtInc
P98066	TNFAIP6	Tumor necrosis factor-inducible gene 6 protein	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P98066	TNFAIP6	Tumor necrosis factor-inducible gene 6 protein	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P98066	TNFAIP6	Tumor necrosis factor-inducible gene 6 protein	GO:0006954; P:inflammatory response; TAS:ProtInc
P98066	TNFAIP6	Tumor necrosis factor-inducible gene 6 protein	GO:0007165; P:signal transduction; TAS:ProtInc
Q6ZSZ6	TSHZ1	Teashirt homolog 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZSZ6	TSHZ1	Teashirt homolog 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q6ZSZ6	TSHZ1	Teashirt homolog 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q6ZSZ6	TSHZ1	Teashirt homolog 1	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q6ZSZ6	TSHZ1	Teashirt homolog 1	GO:0042474; P:middle ear morphogenesis; IEA:Ensembl
Q6ZSZ6	TSHZ1	Teashirt homolog 1	GO:0060023; P:soft palate development; IEA:Ensembl
Q6ZSZ6	TSHZ1	Teashirt homolog 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NRE2	TSHZ2	Teashirt homolog 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NRE2	TSHZ2	Teashirt homolog 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9NRE2	TSHZ2	Teashirt homolog 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9NRE2	TSHZ2	Teashirt homolog 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9NRE2	TSHZ2	Teashirt homolog 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q63HK5	TSHZ3	Teashirt homolog 3	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q63HK5	TSHZ3	Teashirt homolog 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q63HK5	TSHZ3	Teashirt homolog 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q63HK5	TSHZ3	Teashirt homolog 3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q63HK5	TSHZ3	Teashirt homolog 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q63HK5	TSHZ3	Teashirt homolog 3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q63HK5	TSHZ3	Teashirt homolog 3	GO:0060993; P:kidney morphogenesis; IEA:Ensembl
Q63HK5	TSHZ3	Teashirt homolog 3	GO:0072195; P:kidney smooth muscle cell differentiation; IEA:Ensembl
Q63HK5	TSHZ3	Teashirt homolog 3	GO:0030324; P:lung development; IEA:Ensembl
Q63HK5	TSHZ3	Teashirt homolog 3	GO:0001656; P:metanephros development; IEA:Ensembl
Q63HK5	TSHZ3	Teashirt homolog 3	GO:0050881; P:musculoskeletal movement; IEA:Ensembl
Q63HK5	TSHZ3	Teashirt homolog 3	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q63HK5	TSHZ3	Teashirt homolog 3	GO:0051152; P:positive regulation of smooth muscle cell differentiation; IEA:Ensembl
Q63HK5	TSHZ3	Teashirt homolog 3	GO:0002087; P:regulation of respiratory gaseous exchange by neurological system process; ISS:UniProtKB
Q63HK5	TSHZ3	Teashirt homolog 3	GO:0050975; P:sensory perception of touch; IEA:Ensembl
Q63HK5	TSHZ3	Teashirt homolog 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q63HK5	TSHZ3	Teashirt homolog 3	GO:0072193; P:ureter smooth muscle cell differentiation; IEA:Ensembl
Q63HK5	TSHZ3	Teashirt homolog 3	GO:0001657; P:ureteric bud development; IEA:Ensembl
Q63HK5	TSHZ3	Teashirt homolog 3	GO:0072105; P:ureteric peristalsis; IEA:Ensembl
P01222	TSHB	Thyrotropin subunit beta	GO:0005179; F:hormone activity; TAS:ProtInc
P01222	TSHB	Thyrotropin subunit beta	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P01222	TSHB	Thyrotropin subunit beta	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P01222	TSHB	Thyrotropin subunit beta	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P01222	TSHB	Thyrotropin subunit beta	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P01222	TSHB	Thyrotropin subunit beta	GO:0016486; P:peptide hormone processing; TAS:Reactome
P01222	TSHB	Thyrotropin subunit beta	GO:0051592; P:response to calcium ion; IEA:Ensembl
P01222	TSHB	Thyrotropin subunit beta	GO:0043627; P:response to estrogen; IEA:Ensembl
P01222	TSHB	Thyrotropin subunit beta	GO:0033189; P:response to vitamin A; IEA:Ensembl
P16473	TSHR	Thyrotropin receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P16473	TSHR	Thyrotropin receptor	GO:0004996; F:thyroid-stimulating hormone receptor activity; IEA:Ensembl
P16473	TSHR	Thyrotropin receptor	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
P16473	TSHR	Thyrotropin receptor	GO:0008344; P:adult locomotory behavior; IEA:Ensembl
P16473	TSHR	Thyrotropin receptor	GO:0030183; P:B cell differentiation; IEA:Ensembl
P16473	TSHR	Thyrotropin receptor	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P16473	TSHR	Thyrotropin receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P16473	TSHR	Thyrotropin receptor	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P16473	TSHR	Thyrotropin receptor	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P16473	TSHR	Thyrotropin receptor	GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl
P16473	TSHR	Thyrotropin receptor	GO:0040012; P:regulation of locomotion; IEA:Ensembl
P16473	TSHR	Thyrotropin receptor	GO:0038194; P:thyroid-stimulating hormone signaling pathway; TAS:GOC
Q9UJT2	TSKS	Testis-specific serine kinase substrate	GO:0005515; F:protein binding; IPI:IntAct
Q9UJT2	TSKS	Testis-specific serine kinase substrate	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q9UJT2	TSKS	Testis-specific serine kinase substrate	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q8WUA8	TSKU	Tsukushin	GO:0021960; P:anterior commissure morphogenesis; IEA:Ensembl
Q8WUA8	TSKU	Tsukushin	GO:0061073; P:ciliary body morphogenesis; IEA:Ensembl
Q8WUA8	TSKU	Tsukushin	GO:0021540; P:corpus callosum morphogenesis; IEA:Ensembl
Q8WUA8	TSKU	Tsukushin	GO:0021670; P:lateral ventricle development; IEA:Ensembl
Q8WUA8	TSKU	Tsukushin	GO:0030178; P:negative regulation of Wnt signaling pathway; IEA:Ensembl
Q8WUA8	TSKU	Tsukushin	GO:0010468; P:regulation of gene expression; IEA:Ensembl
O95859	TSPAN12	Tetraspanin-12	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
O95859	TSPAN12	Tetraspanin-12	GO:0007166; P:cell surface receptor signaling pathway; ISS:UniProtKB
O95859	TSPAN12	Tetraspanin-12	GO:0045765; P:regulation of angiogenesis; ISS:UniProtKB
O95859	TSPAN12	Tetraspanin-12	GO:0010842; P:retina layer formation; ISS:UniProtKB
Q96FV3	TSPAN17	Tetraspanin-17	GO:0004842; F:ubiquitin-protein ligase activity; NAS:UniProtKB
Q96FV3	TSPAN17	Tetraspanin-17	GO:0016567; P:protein ubiquitination; NAS:UniProtKB
O60636	TSPAN2	Tetraspanin-2	GO:0007420; P:brain development; IEA:Ensembl
Q12999	TSPAN31	Tetraspanin-31	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q96QS1	TSPAN32	Tetraspanin-32	GO:0007267; P:cell-cell signaling; TAS:UniProtKB
Q96QS1	TSPAN32	Tetraspanin-32	GO:0007010; P:cytoskeleton organization; IEA:Ensembl
Q96QS1	TSPAN32	Tetraspanin-32	GO:0042832; P:defense response to protozoan; IEA:Ensembl
Q96QS1	TSPAN32	Tetraspanin-32	GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl
Q96QS1	TSPAN32	Tetraspanin-32	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q96QS1	TSPAN32	Tetraspanin-32	GO:0030886; P:negative regulation of myeloid dendritic cell activation; IEA:Ensembl
Q96QS1	TSPAN32	Tetraspanin-32	GO:0070527; P:platelet aggregation; IEA:Ensembl
Q96QS1	TSPAN32	Tetraspanin-32	GO:0050688; P:regulation of defense response to virus; IEA:Ensembl
O14817	TSPAN4	Tetraspanin-4	GO:0006461; P:protein complex assembly; TAS:ProtInc
O43657	TSPAN6	Tetraspanin-6	GO:0004871; F:signal transducer activity; IMP:UniProtKB
O43657	TSPAN6	Tetraspanin-6	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
O43657	TSPAN6	Tetraspanin-6	GO:0007165; P:signal transduction; IMP:GOC
P19075	TSPAN8	Tetraspanin-8	GO:0004871; F:signal transducer activity; TAS:ProtInc
P19075	TSPAN8	Tetraspanin-8	GO:0030195; P:negative regulation of blood coagulation; IEA:Ensembl
P19075	TSPAN8	Tetraspanin-8	GO:0006486; P:protein glycosylation; TAS:ProtInc
P19075	TSPAN8	Tetraspanin-8	GO:0007165; P:signal transduction; TAS:GOC
P41732	TSPAN7	Tetraspanin-7	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q99598	TSNAX	Translin-associated protein X	GO:0003677; F:DNA binding; TAS:ProtInc
Q99598	TSNAX	Translin-associated protein X	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q99598	TSNAX	Translin-associated protein X	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q99598	TSNAX	Translin-associated protein X	GO:0008565; F:protein transporter activity; TAS:ProtInc
Q99598	TSNAX	Translin-associated protein X	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q99598	TSNAX	Translin-associated protein X	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q99598	TSNAX	Translin-associated protein X	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q99598	TSNAX	Translin-associated protein X	GO:0015031; P:protein transport; TAS:GOC
Q99598	TSNAX	Translin-associated protein X	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q96NA8	TSNARE1	t-SNARE domain-containing protein 1	GO:0005484; F:SNAP receptor activity; IBA:RefGenome
Q96NA8	TSNARE1	t-SNARE domain-containing protein 1	GO:0000149; F:SNARE binding; IBA:RefGenome
Q96NA8	TSNARE1	t-SNARE domain-containing protein 1	GO:0006886; P:intracellular protein transport; IBA:RefGenome
Q96NA8	TSNARE1	t-SNARE domain-containing protein 1	GO:0016079; P:synaptic vesicle exocytosis; IBA:RefGenome
Q15631	TSN	Translin	GO:0003677; F:DNA binding; TAS:ProtInc
Q15631	TSN	Translin	GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW
Q15631	TSN	Translin	GO:0003729; F:mRNA binding; IEA:Ensembl
Q15631	TSN	Translin	GO:0005515; F:protein binding; IPI:IntAct
Q15631	TSN	Translin	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q15631	TSN	Translin	GO:0006310; P:DNA recombination; TAS:ProtInc
P07996	THBS1	Thrombospondin-1	GO:0005509; F:calcium ion binding; NAS:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0070052; F:collagen V binding; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0070051; F:fibrinogen binding; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0017134; F:fibroblast growth factor binding; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0001968; F:fibronectin binding; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0001948; F:glycoprotein binding; NAS:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0008201; F:heparin binding; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0042802; F:identical protein binding; NAS:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0005178; F:integrin binding; IMP:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0043236; F:laminin binding; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0030169; F:low-density lipoprotein particle binding; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0001786; F:phosphatidylserine binding; IDA:UniProtKB
P07996	THBS1	Thrombospondin-1	GO:0005515; F:protein binding; IPI:UniProtKB
P07996	THBS1	Thrombospondin-1	GO:0043394; F:proteoglycan binding; TAS:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0050431; F:transforming growth factor beta binding; ISS:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0000187; P:activation of MAPK activity; IMP:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0048266; P:behavioral response to pain; ISS:UniProtKB
P07996	THBS1	Thrombospondin-1	GO:0007596; P:blood coagulation; TAS:Reactome
P07996	THBS1	Thrombospondin-1	GO:0007155; P:cell adhesion; NAS:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0007050; P:cell cycle arrest; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0016477; P:cell migration; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P07996	THBS1	Thrombospondin-1	GO:0034605; P:cellular response to heat; NAS:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl
P07996	THBS1	Thrombospondin-1	GO:0002544; P:chronic inflammatory response; IEP:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0003197; P:endocardial cushion development; IEA:Ensembl
P07996	THBS1	Thrombospondin-1	GO:0043652; P:engulfment of apoptotic cell; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P07996	THBS1	Thrombospondin-1	GO:0003417; P:growth plate cartilage development; IEA:Ensembl
P07996	THBS1	Thrombospondin-1	GO:0006955; P:immune response; IEP:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0016525; P:negative regulation of angiogenesis; IDA:UniProtKB
P07996	THBS1	Thrombospondin-1	GO:0002581; P:negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P07996	THBS1	Thrombospondin-1	GO:0043537; P:negative regulation of blood vessel endothelial cell migration; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0001953; P:negative regulation of cell-matrix adhesion; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0010754; P:negative regulation of cGMP-mediated signaling; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P07996	THBS1	Thrombospondin-1	GO:0002605; P:negative regulation of dendritic cell antigen processing and presentation; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0010596; P:negative regulation of endothelial cell migration; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0001937; P:negative regulation of endothelial cell proliferation; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; TAS:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0051918; P:negative regulation of fibrinolysis; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0040037; P:negative regulation of fibroblast growth factor receptor signaling pathway; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0051895; P:negative regulation of focal adhesion assembly; TAS:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0032695; P:negative regulation of interleukin-12 production; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0010751; P:negative regulation of nitric oxide mediated signal transduction; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0010748; P:negative regulation of plasma membrane long-chain fatty acid transport; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0010757; P:negative regulation of plasminogen activation; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0003151; P:outflow tract morphogenesis; IEA:Ensembl
P07996	THBS1	Thrombospondin-1	GO:0018149; P:peptide cross-linking; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0030168; P:platelet activation; TAS:Reactome
P07996	THBS1	Thrombospondin-1	GO:0002576; P:platelet degranulation; TAS:Reactome
P07996	THBS1	Thrombospondin-1	GO:0045766; P:positive regulation of angiogenesis; IMP:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0030194; P:positive regulation of blood coagulation; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0030335; P:positive regulation of cell migration; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
P07996	THBS1	Thrombospondin-1	GO:0050921; P:positive regulation of chemotaxis; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:2000353; P:positive regulation of endothelial cell apoptotic process; IDA:UniProtKB
P07996	THBS1	Thrombospondin-1	GO:0010595; P:positive regulation of endothelial cell migration; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0010763; P:positive regulation of fibroblast migration; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0043032; P:positive regulation of macrophage activation; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0010759; P:positive regulation of macrophage chemotaxis; ISS:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0042327; P:positive regulation of phosphorylation; IMP:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:UniProtKB
P07996	THBS1	Thrombospondin-1	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0032914; P:positive regulation of transforming growth factor beta1 production; ISS:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0045727; P:positive regulation of translation; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0042535; P:positive regulation of tumor necrosis factor biosynthetic process; IDA:UniProtKB
P07996	THBS1	Thrombospondin-1	GO:0051592; P:response to calcium ion; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0042493; P:response to drug; IEP:UniProtKB
P07996	THBS1	Thrombospondin-1	GO:0034976; P:response to endoplasmic reticulum stress; ISS:UniProtKB
P07996	THBS1	Thrombospondin-1	GO:0009749; P:response to glucose; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0001666; P:response to hypoxia; NAS:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0032026; P:response to magnesium ion; IDA:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
P07996	THBS1	Thrombospondin-1	GO:0032570; P:response to progesterone; TAS:BHF-UCL
P07996	THBS1	Thrombospondin-1	GO:0033574; P:response to testosterone; IEA:Ensembl
P07996	THBS1	Thrombospondin-1	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
P07996	THBS1	Thrombospondin-1	GO:0002040; P:sprouting angiogenesis; IMP:BHF-UCL
P35442	THBS2	Thrombospondin-2	GO:0005509; F:calcium ion binding; IEA:InterPro
P35442	THBS2	Thrombospondin-2	GO:0008201; F:heparin binding; TAS:ProtInc
P35442	THBS2	Thrombospondin-2	GO:0005515; F:protein binding; IPI:IntAct
P35442	THBS2	Thrombospondin-2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P35442	THBS2	Thrombospondin-2	GO:0016525; P:negative regulation of angiogenesis; IDA:UniProtKB
P35442	THBS2	Thrombospondin-2	GO:0051965; P:positive regulation of synapse assembly; IEA:Ensembl
P49746	THBS3	Thrombospondin-3	GO:0005509; F:calcium ion binding; NAS:UniProtKB
P49746	THBS3	Thrombospondin-3	GO:0008201; F:heparin binding; IDA:MGI
P49746	THBS3	Thrombospondin-3	GO:0060346; P:bone trabecula formation; IEA:Ensembl
P49746	THBS3	Thrombospondin-3	GO:0007160; P:cell-matrix adhesion; NAS:UniProtKB
P49746	THBS3	Thrombospondin-3	GO:0003417; P:growth plate cartilage development; IEA:Ensembl
P49746	THBS3	Thrombospondin-3	GO:0043931; P:ossification involved in bone maturation; IEA:Ensembl
P35443	THBS4	Thrombospondin-4	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P35443	THBS4	Thrombospondin-4	GO:0008201; F:heparin binding; IDA:UniProtKB
P35443	THBS4	Thrombospondin-4	GO:0005178; F:integrin binding; IDA:UniProtKB
P35443	THBS4	Thrombospondin-4	GO:0005515; F:protein binding; IPI:UniProtKB
P35443	THBS4	Thrombospondin-4	GO:0048266; P:behavioral response to pain; ISS:UniProtKB
P35443	THBS4	Thrombospondin-4	GO:0071603; P:endothelial cell-cell adhesion; IDA:UniProtKB
P35443	THBS4	Thrombospondin-4	GO:0051451; P:myoblast migration; IDA:UniProtKB
P35443	THBS4	Thrombospondin-4	GO:0016525; P:negative regulation of angiogenesis; IEP:UniProtKB
P35443	THBS4	Thrombospondin-4	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P35443	THBS4	Thrombospondin-4	GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:UniProtKB
P35443	THBS4	Thrombospondin-4	GO:0090023; P:positive regulation of neutrophil chemotaxis; IDA:UniProtKB
P35443	THBS4	Thrombospondin-4	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P35443	THBS4	Thrombospondin-4	GO:0034103; P:regulation of tissue remodeling; ISS:UniProtKB
P35443	THBS4	Thrombospondin-4	GO:0034976; P:response to endoplasmic reticulum stress; ISS:UniProtKB
P35443	THBS4	Thrombospondin-4	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
P35443	THBS4	Thrombospondin-4	GO:0048771; P:tissue remodeling; IEA:UniProtKB-KW
Q9UI38	PRSS50	Probable threonine protease PRSS50	GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro
Q9UI38	PRSS50	Probable threonine protease PRSS50	GO:0004298; F:threonine-type endopeptidase activity; IMP:UniProtKB
Q9UI38	PRSS50	Probable threonine protease PRSS50	GO:0006508; P:proteolysis; IDA:UniProtKB
Q5TGU0	TSPO2	Translocator protein 2	GO:0015485; F:cholesterol binding; ISS:UniProtKB
Q5TGU0	TSPO2	Translocator protein 2	GO:0006810; P:transport; IEA:UniProtKB-KW
P30536	TSPO	Translocator protein	GO:0005497; F:androgen binding; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0008503; F:benzodiazepine receptor activity; TAS:ProtInc
P30536	TSPO	Translocator protein	GO:0015485; F:cholesterol binding; TAS:HGNC
P30536	TSPO	Translocator protein	GO:0030325; P:adrenal gland development; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0007568; P:aging; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0006820; P:anion transport; TAS:HGNC
P30536	TSPO	Translocator protein	GO:0006915; P:apoptotic process; TAS:HGNC
P30536	TSPO	Translocator protein	GO:0048266; P:behavioral response to pain; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0008283; P:cell proliferation; TAS:HGNC
P30536	TSPO	Translocator protein	GO:0071476; P:cellular hypotonic response; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0071294; P:cellular response to zinc ion; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0006821; P:chloride transport; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0060242; P:contact inhibition; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0008347; P:glial cell migration; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0006783; P:heme biosynthetic process; TAS:HGNC
P30536	TSPO	Translocator protein	GO:0060253; P:negative regulation of glial cell proliferation; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0045019; P:negative regulation of nitric oxide biosynthetic process; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0032720; P:negative regulation of tumor necrosis factor production; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0014012; P:peripheral nervous system axon regeneration; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0051928; P:positive regulation of calcium ion transport; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0060252; P:positive regulation of glial cell proliferation; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0051901; P:positive regulation of mitochondrial depolarization; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0010940; P:positive regulation of necrotic cell death; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0006626; P:protein targeting to mitochondrion; TAS:ProtInc
P30536	TSPO	Translocator protein	GO:0032374; P:regulation of cholesterol transport; TAS:HGNC
P30536	TSPO	Translocator protein	GO:0050810; P:regulation of steroid biosynthetic process; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0042493; P:response to drug; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0010042; P:response to manganese ion; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0032570; P:response to progesterone; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0033574; P:response to testosterone; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0010266; P:response to vitamin B1; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0006694; P:steroid biosynthetic process; IEA:Ensembl
P30536	TSPO	Translocator protein	GO:0008202; P:steroid metabolic process; TAS:HGNC
P30536	TSPO	Translocator protein	GO:0007268; P:synaptic transmission; TAS:GOC
Q01534	TSPY1	Testis-specific Y-encoded protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q01534	TSPY1	Testis-specific Y-encoded protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q01534	TSPY1	Testis-specific Y-encoded protein 1	GO:0008283; P:cell proliferation; TAS:ProtInc
Q01534	TSPY1	Testis-specific Y-encoded protein 1	GO:0007506; P:gonadal mesoderm development; IEA:UniProtKB-KW
Q01534	TSPY1	Testis-specific Y-encoded protein 1	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q01534	TSPY1	Testis-specific Y-encoded protein 1	GO:0007548; P:sex differentiation; TAS:ProtInc
Q01534	TSPY1	Testis-specific Y-encoded protein 1	GO:0007283; P:spermatogenesis; TAS:ProtInc
P0CV98	TSPY3	Testis-specific Y-encoded protein 3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P0CV98	TSPY3	Testis-specific Y-encoded protein 3	GO:0007506; P:gonadal mesoderm development; IEA:UniProtKB-KW
P0CV98	TSPY3	Testis-specific Y-encoded protein 3	GO:0006334; P:nucleosome assembly; IEA:InterPro
P0CV98	TSPY3	Testis-specific Y-encoded protein 3	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
A6NKD2	TSPY2	Testis-specific Y-encoded protein 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
A6NKD2	TSPY2	Testis-specific Y-encoded protein 2	GO:0007506; P:gonadal mesoderm development; IEA:UniProtKB-KW
A6NKD2	TSPY2	Testis-specific Y-encoded protein 2	GO:0006334; P:nucleosome assembly; IEA:InterPro
A6NKD2	TSPY2	Testis-specific Y-encoded protein 2	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
P0CW00	TSPY8	Testis-specific Y-encoded protein 8	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P0CW00	TSPY8	Testis-specific Y-encoded protein 8	GO:0007506; P:gonadal mesoderm development; IEA:UniProtKB-KW
P0CW00	TSPY8	Testis-specific Y-encoded protein 8	GO:0006334; P:nucleosome assembly; IEA:InterPro
P0CW00	TSPY8	Testis-specific Y-encoded protein 8	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
P0CV99	TSPY4	Testis-specific Y-encoded protein 4	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P0CV99	TSPY4	Testis-specific Y-encoded protein 4	GO:0007506; P:gonadal mesoderm development; IEA:UniProtKB-KW
P0CV99	TSPY4	Testis-specific Y-encoded protein 4	GO:0006334; P:nucleosome assembly; IEA:InterPro
P0CV99	TSPY4	Testis-specific Y-encoded protein 4	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
P0CW01	TSPY10	Testis-specific Y-encoded protein 10	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P0CW01	TSPY10	Testis-specific Y-encoded protein 10	GO:0007506; P:gonadal mesoderm development; IEA:UniProtKB-KW
P0CW01	TSPY10	Testis-specific Y-encoded protein 10	GO:0006334; P:nucleosome assembly; IEA:InterPro
P0CW01	TSPY10	Testis-specific Y-encoded protein 10	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q2NL82	TSR1	Pre-rRNA-processing protein TSR1 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q2NL82	TSR1	Pre-rRNA-processing protein TSR1 homolog	GO:0042255; P:ribosome assembly; ISS:UniProtKB
Q969E8	TSR2	Pre-rRNA-processing protein TSR2 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q969E8	TSR2	Pre-rRNA-processing protein TSR2 homolog	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q9UJK0	TSR3	Ribosome biogenesis protein TSR3 homolog	GO:0006364; P:rRNA processing; IEA:UniProtKB-HAMAP
Q96PF2	TSSK2	Testis-specific serine/threonine-protein kinase 2	GO:0005524; F:ATP binding; ISS:UniProtKB
Q96PF2	TSSK2	Testis-specific serine/threonine-protein kinase 2	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q96PF2	TSSK2	Testis-specific serine/threonine-protein kinase 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q96PF2	TSSK2	Testis-specific serine/threonine-protein kinase 2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q96PF2	TSSK2	Testis-specific serine/threonine-protein kinase 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q96PF2	TSSK2	Testis-specific serine/threonine-protein kinase 2	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q96PF2	TSSK2	Testis-specific serine/threonine-protein kinase 2	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
Q96PF2	TSSK2	Testis-specific serine/threonine-protein kinase 2	GO:0007286; P:spermatid development; ISS:UniProtKB
Q9BXA7	TSSK1B	Testis-specific serine/threonine-protein kinase 1	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9BXA7	TSSK1B	Testis-specific serine/threonine-protein kinase 1	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q9BXA7	TSSK1B	Testis-specific serine/threonine-protein kinase 1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9BXA7	TSSK1B	Testis-specific serine/threonine-protein kinase 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9BXA7	TSSK1B	Testis-specific serine/threonine-protein kinase 1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9BXA7	TSSK1B	Testis-specific serine/threonine-protein kinase 1	GO:0007286; P:spermatid development; ISS:UniProtKB
Q96PN8	TSSK3	Testis-specific serine/threonine-protein kinase 3	GO:0005524; F:ATP binding; ISS:UniProtKB
Q96PN8	TSSK3	Testis-specific serine/threonine-protein kinase 3	GO:0000287; F:magnesium ion binding; ISS:UniProtKB
Q96PN8	TSSK3	Testis-specific serine/threonine-protein kinase 3	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB
Q96PN8	TSSK3	Testis-specific serine/threonine-protein kinase 3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96PN8	TSSK3	Testis-specific serine/threonine-protein kinase 3	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q96PN8	TSSK3	Testis-specific serine/threonine-protein kinase 3	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
Q96PN8	TSSK3	Testis-specific serine/threonine-protein kinase 3	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q6SA08	TSSK4	Testis-specific serine/threonine-protein kinase 4	GO:0005524; F:ATP binding; IDA:UniProtKB
Q6SA08	TSSK4	Testis-specific serine/threonine-protein kinase 4	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q6SA08	TSSK4	Testis-specific serine/threonine-protein kinase 4	GO:0005515; F:protein binding; IPI:IntAct
Q6SA08	TSSK4	Testis-specific serine/threonine-protein kinase 4	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q6SA08	TSSK4	Testis-specific serine/threonine-protein kinase 4	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q6SA08	TSSK4	Testis-specific serine/threonine-protein kinase 4	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q6SA08	TSSK4	Testis-specific serine/threonine-protein kinase 4	GO:0032793; P:positive regulation of CREB transcription factor activity; IDA:UniProtKB
Q6SA08	TSSK4	Testis-specific serine/threonine-protein kinase 4	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q6SA08	TSSK4	Testis-specific serine/threonine-protein kinase 4	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q9BXA6	TSSK6	Testis-specific serine/threonine-protein kinase 6	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9BXA6	TSSK6	Testis-specific serine/threonine-protein kinase 6	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q9BXA6	TSSK6	Testis-specific serine/threonine-protein kinase 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BXA6	TSSK6	Testis-specific serine/threonine-protein kinase 6	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9BXA6	TSSK6	Testis-specific serine/threonine-protein kinase 6	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9BXA6	TSSK6	Testis-specific serine/threonine-protein kinase 6	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9BXA6	TSSK6	Testis-specific serine/threonine-protein kinase 6	GO:0035092; P:sperm chromatin condensation; ISS:UniProtKB
Q9NQE7	PRSS16	Thymus-specific serine protease	GO:0008236; F:serine-type peptidase activity; NAS:UniProtKB
Q9NQE7	PRSS16	Thymus-specific serine protease	GO:0030163; P:protein catabolic process; NAS:UniProtKB
Q9H489	TSPY26P	Putative testis-specific Y-encoded-like protein 3	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q9H0U9	TSPYL1	Testis-specific Y-encoded-like protein 1	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q9H2G4	TSPYL2	Testis-specific Y-encoded-like protein 2	GO:0000182; F:rDNA binding; NAS:UniProtKB
Q9H2G4	TSPYL2	Testis-specific Y-encoded-like protein 2	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q9H2G4	TSPYL2	Testis-specific Y-encoded-like protein 2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9H2G4	TSPYL2	Testis-specific Y-encoded-like protein 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9H2G4	TSPYL2	Testis-specific Y-encoded-like protein 2	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q9H2G4	TSPYL2	Testis-specific Y-encoded-like protein 2	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q9H2G4	TSPYL2	Testis-specific Y-encoded-like protein 2	GO:0045786; P:negative regulation of cell cycle; NAS:UniProtKB
Q9H2G4	TSPYL2	Testis-specific Y-encoded-like protein 2	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
Q9H2G4	TSPYL2	Testis-specific Y-encoded-like protein 2	GO:0008156; P:negative regulation of DNA replication; IDA:UniProtKB
Q9H2G4	TSPYL2	Testis-specific Y-encoded-like protein 2	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q9H2G4	TSPYL2	Testis-specific Y-encoded-like protein 2	GO:0045859; P:regulation of protein kinase activity; IDA:UniProtKB
Q9H2G4	TSPYL2	Testis-specific Y-encoded-like protein 2	GO:0009966; P:regulation of signal transduction; NAS:UniProtKB
Q9H2G4	TSPYL2	Testis-specific Y-encoded-like protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H2G4	TSPYL2	Testis-specific Y-encoded-like protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UJ04	TSPYL4	Testis-specific Y-encoded-like protein 4	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q86VY4	TSPYL5	Testis-specific Y-encoded-like protein 5	GO:0005515; F:protein binding; IPI:IntAct
Q86VY4	TSPYL5	Testis-specific Y-encoded-like protein 5	GO:0071480; P:cellular response to gamma radiation; IMP:UniProtKB
Q86VY4	TSPYL5	Testis-specific Y-encoded-like protein 5	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q86VY4	TSPYL5	Testis-specific Y-encoded-like protein 5	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q86VY4	TSPYL5	Testis-specific Y-encoded-like protein 5	GO:0051897; P:positive regulation of protein kinase B signaling; IMP:UniProtKB
Q86VY4	TSPYL5	Testis-specific Y-encoded-like protein 5	GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB
Q86VY4	TSPYL5	Testis-specific Y-encoded-like protein 5	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q8N831	TSPYL6	Testis-specific Y-encoded-like protein 6	GO:0006334; P:nucleosome assembly; IEA:InterPro
Q7Z4L5	TTC21B	Tetratricopeptide repeat protein 21B	GO:0060271; P:cilium morphogenesis; IEA:Ensembl
Q7Z4L5	TTC21B	Tetratricopeptide repeat protein 21B	GO:0042073; P:intraciliary transport; IEA:Ensembl
Q7Z4L5	TTC21B	Tetratricopeptide repeat protein 21B	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IMP:MGI
Q7Z4L5	TTC21B	Tetratricopeptide repeat protein 21B	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
Q86WT1	TTC30A	Tetratricopeptide repeat protein 30A	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
Q8N4P2	TTC30B	Tetratricopeptide repeat protein 30B	GO:0005515; F:protein binding; IPI:IntAct
Q8N4P2	TTC30B	Tetratricopeptide repeat protein 30B	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
Q5TCY1	TTBK1	Tau-tubulin kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5TCY1	TTBK1	Tau-tubulin kinase 1	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q5TCY1	TTBK1	Tau-tubulin kinase 1	GO:0021762; P:substantia nigra development; IEP:UniProt
Q6IQ55	TTBK2	Tau-tubulin kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6IQ55	TTBK2	Tau-tubulin kinase 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q6IQ55	TTBK2	Tau-tubulin kinase 2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q6IQ55	TTBK2	Tau-tubulin kinase 2	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q6IQ55	TTBK2	Tau-tubulin kinase 2	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q6IQ55	TTBK2	Tau-tubulin kinase 2	GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB
Q6IQ55	TTBK2	Tau-tubulin kinase 2	GO:0007224; P:smoothened signaling pathway; ISS:UniProtKB
Q96N46	TTC14	Tetratricopeptide repeat protein 14	GO:0003723; F:RNA binding; IEA:InterPro
Q96AE7	TTC17	Tetratricopeptide repeat protein 17	GO:0005515; F:protein binding; IPI:UniProtKB
Q96AE7	TTC17	Tetratricopeptide repeat protein 17	GO:0030041; P:actin filament polymerization; IMP:UniProtKB
Q96AE7	TTC17	Tetratricopeptide repeat protein 17	GO:0044782; P:cilium organization; IMP:UniProtKB
Q6DKK2	TTC19	Tetratricopeptide repeat protein 19, mitochondrial	GO:0005515; F:protein binding; IPI:UniProtKB
Q6DKK2	TTC19	Tetratricopeptide repeat protein 19, mitochondrial	GO:0000910; P:cytokinesis; TAS:UniProtKB
Q6DKK2	TTC19	Tetratricopeptide repeat protein 19, mitochondrial	GO:0034551; P:mitochondrial respiratory chain complex III assembly; IMP:UniProtKB
Q99614	TTC1	Tetratricopeptide repeat protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q99614	TTC1	Tetratricopeptide repeat protein 1	GO:0051082; F:unfolded protein binding; NAS:UniProtKB
Q99614	TTC1	Tetratricopeptide repeat protein 1	GO:0006457; P:protein folding; NAS:UniProtKB
A0AVF1	TTC26	Tetratricopeptide repeat protein 26	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q96AY4	TTC28	Tetratricopeptide repeat protein 28	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q6PGP7	TTC37	Tetratricopeptide repeat protein 37	GO:0005515; F:protein binding; IPI:IntAct
P53804	TTC3	E3 ubiquitin-protein ligase TTC3	GO:0005515; F:protein binding; IPI:UniProtKB
P53804	TTC3	E3 ubiquitin-protein ligase TTC3	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
P53804	TTC3	E3 ubiquitin-protein ligase TTC3	GO:0008270; F:zinc ion binding; IEA:InterPro
P53804	TTC3	E3 ubiquitin-protein ligase TTC3	GO:0010771; P:negative regulation of cell morphogenesis involved in differentiation; IEA:Ensembl
P53804	TTC3	E3 ubiquitin-protein ligase TTC3	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
P53804	TTC3	E3 ubiquitin-protein ligase TTC3	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
P53804	TTC3	E3 ubiquitin-protein ligase TTC3	GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q8N0Z6	TTC5	Tetratricopeptide repeat protein 5	GO:0003682; F:chromatin binding; IEA:Ensembl
Q8N0Z6	TTC5	Tetratricopeptide repeat protein 5	GO:0003677; F:DNA binding; IEA:Ensembl
Q8N0Z6	TTC5	Tetratricopeptide repeat protein 5	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q8N0Z6	TTC5	Tetratricopeptide repeat protein 5	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9ULT0	TTC7A	Tetratricopeptide repeat protein 7A	GO:0006879; P:cellular iron ion homeostasis; IEA:Ensembl
Q9ULT0	TTC7A	Tetratricopeptide repeat protein 7A	GO:0030097; P:hemopoiesis; IEA:Ensembl
Q8TAM2	TTC8	Tetratricopeptide repeat protein 8	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TAM2	TTC8	Tetratricopeptide repeat protein 8	GO:0001103; F:RNA polymerase II repressing transcription factor binding; IPI:MGI
Q8TAM2	TTC8	Tetratricopeptide repeat protein 8	GO:0007411; P:axon guidance; IEA:Ensembl
Q8TAM2	TTC8	Tetratricopeptide repeat protein 8	GO:0060219; P:camera-type eye photoreceptor cell differentiation; IEA:Ensembl
Q8TAM2	TTC8	Tetratricopeptide repeat protein 8	GO:0042384; P:cilium assembly; TAS:BHF-UCL
Q8TAM2	TTC8	Tetratricopeptide repeat protein 8	GO:0048560; P:establishment of anatomical structure orientation; IMP:BHF-UCL
Q8TAM2	TTC8	Tetratricopeptide repeat protein 8	GO:0045444; P:fat cell differentiation; IEA:Ensembl
Q8TAM2	TTC8	Tetratricopeptide repeat protein 8	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q8TAM2	TTC8	Tetratricopeptide repeat protein 8	GO:0021772; P:olfactory bulb development; IEA:Ensembl
Q8TAM2	TTC8	Tetratricopeptide repeat protein 8	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8TAM2	TTC8	Tetratricopeptide repeat protein 8	GO:0032880; P:regulation of protein localization; IEA:Ensembl
Q8TAM2	TTC8	Tetratricopeptide repeat protein 8	GO:0061326; P:renal tubule development; IEA:Ensembl
Q8TAM2	TTC8	Tetratricopeptide repeat protein 8	GO:0007608; P:sensory perception of smell; IEA:Ensembl
Q8TAM2	TTC8	Tetratricopeptide repeat protein 8	GO:0050893; P:sensory processing; TAS:BHF-UCL
Q15361	TTF1	Transcription termination factor 1	GO:0003682; F:chromatin binding; IEA:Ensembl
Q15361	TTF1	Transcription termination factor 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q15361	TTF1	Transcription termination factor 1	GO:0006338; P:chromatin remodeling; IEA:Ensembl
Q15361	TTF1	Transcription termination factor 1	GO:0006353; P:DNA-templated transcription, termination; NAS:UniProtKB
Q15361	TTF1	Transcription termination factor 1	GO:0010467; P:gene expression; TAS:Reactome
Q15361	TTF1	Transcription termination factor 1	GO:0008156; P:negative regulation of DNA replication; IEA:UniProtKB-KW
Q15361	TTF1	Transcription termination factor 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q15361	TTF1	Transcription termination factor 1	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
Q15361	TTF1	Transcription termination factor 1	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
Q15361	TTF1	Transcription termination factor 1	GO:0006361; P:transcription initiation from RNA polymerase I promoter; IEA:Ensembl
Q9UNY4	TTF2	Transcription termination factor 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UNY4	TTF2	Transcription termination factor 2	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q9UNY4	TTF2	Transcription termination factor 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UNY4	TTF2	Transcription termination factor 2	GO:0008094; F:DNA-dependent ATPase activity; TAS:ProtInc
Q9UNY4	TTF2	Transcription termination factor 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UNY4	TTF2	Transcription termination factor 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UNY4	TTF2	Transcription termination factor 2	GO:0006200; P:ATP catabolic process; TAS:GOC
Q9UNY4	TTF2	Transcription termination factor 2	GO:0006353; P:DNA-templated transcription, termination; TAS:ProtInc
Q9UNY4	TTF2	Transcription termination factor 2	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9UNY4	TTF2	Transcription termination factor 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UNY4	TTF2	Transcription termination factor 2	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q9UNY4	TTF2	Transcription termination factor 2	GO:0006369; P:termination of RNA polymerase II transcription; TAS:ProtInc
O43156	TTI1	TELO2-interacting protein 1 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
O43156	TTI1	TELO2-interacting protein 1 homolog	GO:0032006; P:regulation of TOR signaling; IMP:UniProtKB
P02766	TTR	Transthyretin	GO:0042562; F:hormone binding; IEA:Ensembl
P02766	TTR	Transthyretin	GO:0042802; F:identical protein binding; IPI:IntAct
P02766	TTR	Transthyretin	GO:0005515; F:protein binding; IPI:IntAct
P02766	TTR	Transthyretin	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P02766	TTR	Transthyretin	GO:0007603; P:phototransduction, visible light; TAS:Reactome
P02766	TTR	Transthyretin	GO:0001523; P:retinoid metabolic process; TAS:Reactome
P02766	TTR	Transthyretin	GO:0042572; P:retinol metabolic process; IEA:Ensembl
P02766	TTR	Transthyretin	GO:0006810; P:transport; NAS:ProtInc
P33981	TTK	Dual specificity protein kinase TTK	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P33981	TTK	Dual specificity protein kinase TTK	GO:0005515; F:protein binding; IPI:UniProtKB
P33981	TTK	Dual specificity protein kinase TTK	GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc
P33981	TTK	Dual specificity protein kinase TTK	GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC
P33981	TTK	Dual specificity protein kinase TTK	GO:0004713; F:protein tyrosine kinase activity; TAS:ProtInc
P33981	TTK	Dual specificity protein kinase TTK	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:ProtInc
P33981	TTK	Dual specificity protein kinase TTK	GO:0007052; P:mitotic spindle organization; TAS:ProtInc
P33981	TTK	Dual specificity protein kinase TTK	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:GOC
P33981	TTK	Dual specificity protein kinase TTK	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P33981	TTK	Dual specificity protein kinase TTK	GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; TAS:BHF-UCL
P33981	TTK	Dual specificity protein kinase TTK	GO:0007051; P:spindle organization; TAS:ProtInc
Q6ZVT0	TTLL10	Inactive polyglycylase TTLL10	GO:0005515; F:protein binding; IPI:IntAct
Q6ZVT0	TTLL10	Inactive polyglycylase TTLL10	GO:0006464; P:cellular protein modification process; IEA:InterPro
Q8NHH1	TTLL11	Tubulin polyglutamylase TTLL11	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q8NHH1	TTLL11	Tubulin polyglutamylase TTLL11	GO:0006464; P:cellular protein modification process; IEA:InterPro
Q14166	TTLL12	Tubulin--tyrosine ligase-like protein 12	GO:0006464; P:cellular protein modification process; IEA:InterPro
A6NNM8	TTLL13	Tubulin polyglutamylase TTLL13	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
A6NNM8	TTLL13	Tubulin polyglutamylase TTLL13	GO:0006464; P:cellular protein modification process; IEA:InterPro
O95922	TTLL1	Probable tubulin polyglutamylase TTLL1	GO:0070740; F:tubulin-glutamic acid ligase activity; TAS:UniProtKB
O95922	TTLL1	Probable tubulin polyglutamylase TTLL1	GO:0060271; P:cilium morphogenesis; IEA:Ensembl
O95922	TTLL1	Probable tubulin polyglutamylase TTLL1	GO:0044782; P:cilium organization; IEA:Ensembl
O95922	TTLL1	Probable tubulin polyglutamylase TTLL1	GO:0003351; P:epithelial cilium movement; IEA:Ensembl
O95922	TTLL1	Probable tubulin polyglutamylase TTLL1	GO:0018095; P:protein polyglutamylation; TAS:UniProtKB
Q9BWV7	TTLL2	Probable tubulin polyglutamylase TTLL2	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9BWV7	TTLL2	Probable tubulin polyglutamylase TTLL2	GO:0006464; P:cellular protein modification process; IEA:InterPro
Q9Y4R7	TTLL3	Tubulin monoglycylase TTLL3	GO:0070735; F:protein-glycine ligase activity; IDA:UniProtKB
Q9Y4R7	TTLL3	Tubulin monoglycylase TTLL3	GO:0070736; F:protein-glycine ligase activity, initiating; ISS:UniProtKB
Q9Y4R7	TTLL3	Tubulin monoglycylase TTLL3	GO:0035082; P:axoneme assembly; ISS:UniProtKB
Q9Y4R7	TTLL3	Tubulin monoglycylase TTLL3	GO:0042384; P:cilium assembly; ISS:UniProtKB
Q9Y4R7	TTLL3	Tubulin monoglycylase TTLL3	GO:0018094; P:protein polyglycylation; IDA:UniProtKB
Q14679	TTLL4	Tubulin polyglutamylase TTLL4	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q14679	TTLL4	Tubulin polyglutamylase TTLL4	GO:0015631; F:tubulin binding; ISS:UniProtKB
Q14679	TTLL4	Tubulin polyglutamylase TTLL4	GO:0018095; P:protein polyglutamylation; ISS:UniProtKB
Q6EMB2	TTLL5	Tubulin polyglutamylase TTLL5	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q6EMB2	TTLL5	Tubulin polyglutamylase TTLL5	GO:0006464; P:cellular protein modification process; IEA:InterPro
Q6EMB2	TTLL5	Tubulin polyglutamylase TTLL5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N841	TTLL6	Tubulin polyglutamylase TTLL6	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q8N841	TTLL6	Tubulin polyglutamylase TTLL6	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N841	TTLL6	Tubulin polyglutamylase TTLL6	GO:0015631; F:tubulin binding; ISS:UniProtKB
Q8N841	TTLL6	Tubulin polyglutamylase TTLL6	GO:0001578; P:microtubule bundle formation; IEA:Ensembl
Q8N841	TTLL6	Tubulin polyglutamylase TTLL6	GO:0051013; P:microtubule severing; IEA:Ensembl
Q8N841	TTLL6	Tubulin polyglutamylase TTLL6	GO:0018095; P:protein polyglutamylation; ISS:UniProtKB
Q6ZT98	TTLL7	Tubulin polyglutamylase TTLL7	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q6ZT98	TTLL7	Tubulin polyglutamylase TTLL7	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q6ZT98	TTLL7	Tubulin polyglutamylase TTLL7	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q6ZT98	TTLL7	Tubulin polyglutamylase TTLL7	GO:0018095; P:protein polyglutamylation; IEA:Ensembl
A6PVC2	TTLL8	Protein monoglycylase TTLL8	GO:0070735; F:protein-glycine ligase activity; ISS:UniProtKB
A6PVC2	TTLL8	Protein monoglycylase TTLL8	GO:0070736; F:protein-glycine ligase activity, initiating; ISS:UniProtKB
A6PVC2	TTLL8	Protein monoglycylase TTLL8	GO:0018094; P:protein polyglycylation; ISS:UniProtKB
Q3SXZ7	TTLL9	Probable tubulin polyglutamylase TTLL9	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q3SXZ7	TTLL9	Probable tubulin polyglutamylase TTLL9	GO:0006464; P:cellular protein modification process; IEA:InterPro
Q8NG68	TTL	Tubulin--tyrosine ligase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8NG68	TTL	Tubulin--tyrosine ligase	GO:0004835; F:tubulin-tyrosine ligase activity; IEA:UniProtKB-EC
Q8NG68	TTL	Tubulin--tyrosine ligase	GO:0006464; P:cellular protein modification process; IEA:InterPro
Q8NG68	TTL	Tubulin--tyrosine ligase	GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl
Q8NG68	TTL	Tubulin--tyrosine ligase	GO:0030516; P:regulation of axon extension; IEA:Ensembl
Q9BTX7	TTPAL	Alpha-tocopherol transfer protein-like	GO:0005215; F:transporter activity; IEA:InterPro
P49638	TTPA	Alpha-tocopherol transfer protein	GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; ISS:UniProtKB
P49638	TTPA	Alpha-tocopherol transfer protein	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISS:UniProtKB
P49638	TTPA	Alpha-tocopherol transfer protein	GO:0005215; F:transporter activity; IEA:InterPro
P49638	TTPA	Alpha-tocopherol transfer protein	GO:0008431; F:vitamin E binding; ISS:UniProtKB
P49638	TTPA	Alpha-tocopherol transfer protein	GO:0001892; P:embryonic placenta development; IEA:Ensembl
P49638	TTPA	Alpha-tocopherol transfer protein	GO:0046909; P:intermembrane transport; ISS:UniProtKB
P49638	TTPA	Alpha-tocopherol transfer protein	GO:0051452; P:intracellular pH reduction; IEA:Ensembl
P49638	TTPA	Alpha-tocopherol transfer protein	GO:0006629; P:lipid metabolic process; TAS:ProtInc
P49638	TTPA	Alpha-tocopherol transfer protein	GO:0060548; P:negative regulation of cell death; IEA:Ensembl
P49638	TTPA	Alpha-tocopherol transfer protein	GO:0090212; P:negative regulation of establishment of blood-brain barrier; IEA:Ensembl
P49638	TTPA	Alpha-tocopherol transfer protein	GO:0007584; P:response to nutrient; IEA:Ensembl
P49638	TTPA	Alpha-tocopherol transfer protein	GO:0009268; P:response to pH; IEA:Ensembl
P49638	TTPA	Alpha-tocopherol transfer protein	GO:0009636; P:response to toxic substance; IEA:Ensembl
P49638	TTPA	Alpha-tocopherol transfer protein	GO:0006810; P:transport; TAS:ProtInc
P49638	TTPA	Alpha-tocopherol transfer protein	GO:0042360; P:vitamin E metabolic process; IEA:Ensembl
P49638	TTPA	Alpha-tocopherol transfer protein	GO:0051180; P:vitamin transport; ISS:UniProtKB
P26651	ZFP36	Tristetraprolin	GO:0071889; F:14-3-3 protein binding; IDA:UniProtKB
P26651	ZFP36	Tristetraprolin	GO:0017091; F:AU-rich element binding; IDA:UniProtKB
P26651	ZFP36	Tristetraprolin	GO:0019957; F:C-C chemokine binding; IPI:UniProtKB
P26651	ZFP36	Tristetraprolin	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P26651	ZFP36	Tristetraprolin	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P26651	ZFP36	Tristetraprolin	GO:0003729; F:mRNA binding; IDA:MGI
P26651	ZFP36	Tristetraprolin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P26651	ZFP36	Tristetraprolin	GO:0005515; F:protein binding; IPI:UniProtKB
P26651	ZFP36	Tristetraprolin	GO:0019901; F:protein kinase binding; IPI:UniProtKB
P26651	ZFP36	Tristetraprolin	GO:0003727; F:single-stranded RNA binding; TAS:ProtInc
P26651	ZFP36	Tristetraprolin	GO:0070935; P:3'-UTR-mediated mRNA stabilization; IDA:UniProtKB
P26651	ZFP36	Tristetraprolin	GO:0010467; P:gene expression; TAS:Reactome
P26651	ZFP36	Tristetraprolin	GO:0006402; P:mRNA catabolic process; IDA:UniProtKB
P26651	ZFP36	Tristetraprolin	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P26651	ZFP36	Tristetraprolin	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
P26651	ZFP36	Tristetraprolin	GO:0035278; P:negative regulation of translation involved in gene silencing by miRNA; ISS:UniProtKB
P26651	ZFP36	Tristetraprolin	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; IDA:UniProtKB
P26651	ZFP36	Tristetraprolin	GO:1900153; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; ISS:UniProtKB
P26651	ZFP36	Tristetraprolin	GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; IDA:UniProtKB
P26651	ZFP36	Tristetraprolin	GO:0032680; P:regulation of tumor necrosis factor production; IDA:UniProtKB
P26651	ZFP36	Tristetraprolin	GO:0042594; P:response to starvation; IDA:UniProtKB
P26651	ZFP36	Tristetraprolin	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q9H313	TTYH1	Protein tweety homolog 1	GO:0005509; F:calcium ion binding; IEA:Ensembl
Q9H313	TTYH1	Protein tweety homolog 1	GO:0005381; F:iron ion transmembrane transporter activity; NAS:UniProtKB
Q9H313	TTYH1	Protein tweety homolog 1	GO:0072320; F:volume-sensitive chloride channel activity; IDA:FlyBase
Q9H313	TTYH1	Protein tweety homolog 1	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
Q9H313	TTYH1	Protein tweety homolog 1	GO:0031589; P:cell-substrate adhesion; IEA:Ensembl
Q9H313	TTYH1	Protein tweety homolog 1	GO:0006821; P:chloride transport; IDA:FlyBase
Q9H313	TTYH1	Protein tweety homolog 1	GO:0046847; P:filopodium assembly; IEA:Ensembl
Q9H313	TTYH1	Protein tweety homolog 1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9H313	TTYH1	Protein tweety homolog 1	GO:0034755; P:iron ion transmembrane transport; NAS:GOC
Q9H313	TTYH1	Protein tweety homolog 1	GO:0006826; P:iron ion transport; NAS:UniProtKB
Q9H313	TTYH1	Protein tweety homolog 1	GO:0007067; P:mitosis; IEA:Ensembl
Q9H313	TTYH1	Protein tweety homolog 1	GO:0044070; P:regulation of anion transport; IDA:GOC
Q9H313	TTYH1	Protein tweety homolog 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9BSA4	TTYH2	Protein tweety homolog 2	GO:0005254; F:chloride channel activity; IEA:UniProtKB-KW
Q9BSA4	TTYH2	Protein tweety homolog 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9C0H2	TTYH3	Protein tweety homolog 3	GO:0005254; F:chloride channel activity; IMP:UniProtKB
Q9C0H2	TTYH3	Protein tweety homolog 3	GO:0005229; F:intracellular calcium activated chloride channel activity; IDA:FlyBase
Q9C0H2	TTYH3	Protein tweety homolog 3	GO:1902476; P:chloride transmembrane transport; IDA:GOC
Q9C0H2	TTYH3	Protein tweety homolog 3	GO:0006821; P:chloride transport; IDA:FlyBase
Q9C0H2	TTYH3	Protein tweety homolog 3	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9C0H2	TTYH3	Protein tweety homolog 3	GO:0055085; P:transmembrane transport; TAS:Reactome
P50607	TUB	Tubby protein homolog	GO:0008020; F:G-protein coupled photoreceptor activity; IEA:Ensembl
P50607	TUB	Tubby protein homolog	GO:0044259; P:multicellular organismal macromolecule metabolic process; IEA:Ensembl
P50607	TUB	Tubby protein homolog	GO:0006909; P:phagocytosis; IEA:UniProtKB-KW
P50607	TUB	Tubby protein homolog	GO:0007602; P:phototransduction; IEA:Ensembl
P50607	TUB	Tubby protein homolog	GO:0050766; P:positive regulation of phagocytosis; IDA:UniProtKB
P50607	TUB	Tubby protein homolog	GO:0009725; P:response to hormone; IEA:Ensembl
P50607	TUB	Tubby protein homolog	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
P50607	TUB	Tubby protein homolog	GO:0007605; P:sensory perception of sound; IEA:Ensembl
Q9NNX1	TUFT1	Tuftelin	GO:0030345; F:structural constituent of tooth enamel; NAS:UniProtKB
Q9NNX1	TUFT1	Tuftelin	GO:0030282; P:bone mineralization; NAS:UniProtKB
Q9NNX1	TUFT1	Tuftelin	GO:0042476; P:odontogenesis; NAS:UniProtKB
O00295	TULP2	Tubby-related protein 2	GO:0007601; P:visual perception; TAS:ProtInc
O00294	TULP1	Tubby-related protein 1	GO:0051015; F:actin filament binding; IDA:UniProtKB
O00294	TULP1	Tubby-related protein 1	GO:0008020; F:G-protein coupled photoreceptor activity; IEA:Ensembl
O00294	TULP1	Tubby-related protein 1	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProtKB
O00294	TULP1	Tubby-related protein 1	GO:0005515; F:protein binding; IPI:IntAct
O00294	TULP1	Tubby-related protein 1	GO:0016358; P:dendrite development; ISS:UniProtKB
O00294	TULP1	Tubby-related protein 1	GO:0050908; P:detection of light stimulus involved in visual perception; IMP:UniProt
O00294	TULP1	Tubby-related protein 1	GO:0042462; P:eye photoreceptor cell development; ISS:UniProtKB
O00294	TULP1	Tubby-related protein 1	GO:0006909; P:phagocytosis; IEA:UniProtKB-KW
O00294	TULP1	Tubby-related protein 1	GO:0045494; P:photoreceptor cell maintenance; ISS:UniProtKB
O00294	TULP1	Tubby-related protein 1	GO:0007602; P:phototransduction; IEA:Ensembl
O00294	TULP1	Tubby-related protein 1	GO:0050766; P:positive regulation of phagocytosis; IDA:UniProtKB
O00294	TULP1	Tubby-related protein 1	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
O00294	TULP1	Tubby-related protein 1	GO:0001895; P:retina homeostasis; IMP:UniProt
O00294	TULP1	Tubby-related protein 1	GO:0007601; P:visual perception; TAS:ProtInc
O75386	TULP3	Tubby-related protein 3	GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB
O75386	TULP3	Tubby-related protein 3	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; NAS:UniProtKB
O75386	TULP3	Tubby-related protein 3	GO:0005515; F:protein binding; IPI:IntAct
O75386	TULP3	Tubby-related protein 3	GO:0007420; P:brain development; IEA:Ensembl
O75386	TULP3	Tubby-related protein 3	GO:0060434; P:bronchus morphogenesis; IEA:Ensembl
O75386	TULP3	Tubby-related protein 3	GO:0021953; P:central nervous system neuron differentiation; IEA:Ensembl
O75386	TULP3	Tubby-related protein 3	GO:0031076; P:embryonic camera-type eye development; IEA:Ensembl
O75386	TULP3	Tubby-related protein 3	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
O75386	TULP3	Tubby-related protein 3	GO:0048702; P:embryonic neurocranium morphogenesis; IEA:Ensembl
O75386	TULP3	Tubby-related protein 3	GO:0007186; P:G-protein coupled receptor signaling pathway; NAS:UniProtKB
O75386	TULP3	Tubby-related protein 3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O75386	TULP3	Tubby-related protein 3	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
O75386	TULP3	Tubby-related protein 3	GO:0045879; P:negative regulation of smoothened signaling pathway; IDA:UniProtKB
O75386	TULP3	Tubby-related protein 3	GO:0021914; P:negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning; IEA:Ensembl
O75386	TULP3	Tubby-related protein 3	GO:0001843; P:neural tube closure; IEA:Ensembl
O75386	TULP3	Tubby-related protein 3	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; IDA:UniProtKB
O75386	TULP3	Tubby-related protein 3	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
O75386	TULP3	Tubby-related protein 3	GO:0060831; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; IEA:Ensembl
Q9NRJ4	TULP4	Tubby-related protein 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9NRJ4	TULP4	Tubby-related protein 4	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9NRJ4	TULP4	Tubby-related protein 4	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9NRJ4	TULP4	Tubby-related protein 4	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9NRJ4	TULP4	Tubby-related protein 4	GO:0007584; P:response to nutrient; TAS:ProtInc
O75896	TUSC2	Tumor suppressor candidate 2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
O75896	TUSC2	Tumor suppressor candidate 2	GO:0048469; P:cell maturation; IEA:Ensembl
O75896	TUSC2	Tumor suppressor candidate 2	GO:0008283; P:cell proliferation; TAS:ProtInc
O75896	TUSC2	Tumor suppressor candidate 2	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O75896	TUSC2	Tumor suppressor candidate 2	GO:0071609; P:chemokine (C-C motif) ligand 5 production; IEA:Ensembl
O75896	TUSC2	Tumor suppressor candidate 2	GO:0006954; P:inflammatory response; IEA:Ensembl
O75896	TUSC2	Tumor suppressor candidate 2	GO:0032618; P:interleukin-15 production; IEA:Ensembl
O75896	TUSC2	Tumor suppressor candidate 2	GO:0001779; P:natural killer cell differentiation; IEA:Ensembl
O75896	TUSC2	Tumor suppressor candidate 2	GO:0051881; P:regulation of mitochondrial membrane potential; IEA:Ensembl
O75896	TUSC2	Tumor suppressor candidate 2	GO:2000377; P:regulation of reactive oxygen species metabolic process; IEA:Ensembl
Q13454	TUSC3	Tumor suppressor candidate 3	GO:0015095; F:magnesium ion transmembrane transporter activity; IMP:UniProtKB
Q13454	TUSC3	Tumor suppressor candidate 3	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q13454	TUSC3	Tumor suppressor candidate 3	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q13454	TUSC3	Tumor suppressor candidate 3	GO:0050890; P:cognition; IMP:UniProtKB
Q13454	TUSC3	Tumor suppressor candidate 3	GO:0015693; P:magnesium ion transport; IGI:UniProtKB
Q13454	TUSC3	Tumor suppressor candidate 3	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q13454	TUSC3	Tumor suppressor candidate 3	GO:0006487; P:protein N-linked glycosylation; NAS:UniProtKB
Q13454	TUSC3	Tumor suppressor candidate 3	GO:0018279; P:protein N-linked glycosylation via asparagine; ISS:UniProtKB
Q8IXB3	TUSC5	Tumor suppressor candidate 5	GO:0009607; P:response to biotic stimulus; IEA:InterPro
Q5TAX3	ZCCHC11	Terminal uridylyltransferase 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q5TAX3	ZCCHC11	Terminal uridylyltransferase 4	GO:0005515; F:protein binding; IPI:IntAct
Q5TAX3	ZCCHC11	Terminal uridylyltransferase 4	GO:0050265; F:RNA uridylyltransferase activity; IDA:UniProtKB
Q5TAX3	ZCCHC11	Terminal uridylyltransferase 4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5TAX3	ZCCHC11	Terminal uridylyltransferase 4	GO:0001816; P:cytokine production; IEA:Ensembl
Q5TAX3	ZCCHC11	Terminal uridylyltransferase 4	GO:0070102; P:interleukin-6-mediated signaling pathway; IEA:Ensembl
Q5TAX3	ZCCHC11	Terminal uridylyltransferase 4	GO:0010587; P:miRNA catabolic process; IMP:UniProtKB
Q5TAX3	ZCCHC11	Terminal uridylyltransferase 4	GO:0010586; P:miRNA metabolic process; ISS:UniProtKB
Q5TAX3	ZCCHC11	Terminal uridylyltransferase 4	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IEA:Ensembl
Q5TAX3	ZCCHC11	Terminal uridylyltransferase 4	GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl
Q5TAX3	ZCCHC11	Terminal uridylyltransferase 4	GO:0031054; P:pre-miRNA processing; IMP:UniProtKB
Q5TAX3	ZCCHC11	Terminal uridylyltransferase 4	GO:0031664; P:regulation of lipopolysaccharide-mediated signaling pathway; IEA:Ensembl
Q5TAX3	ZCCHC11	Terminal uridylyltransferase 4	GO:0031123; P:RNA 3'-end processing; IDA:UniProtKB
Q5TAX3	ZCCHC11	Terminal uridylyltransferase 4	GO:0019827; P:stem cell maintenance; IMP:UniProtKB
Q5VYS8	ZCCHC6	Terminal uridylyltransferase 7	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q5VYS8	ZCCHC6	Terminal uridylyltransferase 7	GO:0050265; F:RNA uridylyltransferase activity; IDA:UniProtKB
Q5VYS8	ZCCHC6	Terminal uridylyltransferase 7	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5VYS8	ZCCHC6	Terminal uridylyltransferase 7	GO:0031123; P:RNA 3'-end processing; IDA:UniProtKB
Q9P2J2	IGSF9	Protein turtle homolog A	GO:0016358; P:dendrite development; IEA:Ensembl
DR   GO:0042287; F:MHC protein binding; NAS:UniProtKB
DR   GO:0042605; F:peptide antigen binding; NAS:UniProtKB
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0031295; P:T cell costimulation; TAS:Reactome
DR   GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P04437	TCRA	T-cell receptor alpha chain V region CTL-L17	GO:0042287; F:MHC protein binding; NAS:UniProtKB
P04437	TCRA	T-cell receptor alpha chain V region CTL-L17	GO:0042605; F:peptide antigen binding; NAS:UniProtKB
P04437	TCRA	T-cell receptor alpha chain V region CTL-L17	GO:0006955; P:immune response; NAS:UniProtKB
P04437	TCRA	T-cell receptor alpha chain V region CTL-L17	GO:0050776; P:regulation of immune response; TAS:Reactome
P04437	TCRA	T-cell receptor alpha chain V region CTL-L17	GO:0031295; P:T cell costimulation; TAS:Reactome
P04437	TCRA	T-cell receptor alpha chain V region CTL-L17	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
DR   GO:0042287; F:MHC protein binding; NAS:UniProtKB
DR   GO:0042605; F:peptide antigen binding; NAS:UniProtKB
DR   GO:0006955; P:immune response; NAS:UniProtKB
DR   GO:0050776; P:regulation of immune response; TAS:Reactome
DR   GO:0031295; P:T cell costimulation; TAS:Reactome
DR   GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P04435	TCRB	T-cell receptor beta chain V region CTL-L17	GO:0042287; F:MHC protein binding; NAS:UniProtKB
P04435	TCRB	T-cell receptor beta chain V region CTL-L17	GO:0042605; F:peptide antigen binding; NAS:UniProtKB
P04435	TCRB	T-cell receptor beta chain V region CTL-L17	GO:0006955; P:immune response; NAS:UniProtKB
P04435	TCRB	T-cell receptor beta chain V region CTL-L17	GO:0050776; P:regulation of immune response; TAS:Reactome
P04435	TCRB	T-cell receptor beta chain V region CTL-L17	GO:0031295; P:T cell costimulation; TAS:Reactome
P04435	TCRB	T-cell receptor beta chain V region CTL-L17	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P01733	TRBV12-3	T-cell receptor beta chain V region YT35	GO:0042287; F:MHC protein binding; NAS:UniProtKB
P01733	TRBV12-3	T-cell receptor beta chain V region YT35	GO:0042605; F:peptide antigen binding; NAS:UniProtKB
P01733	TRBV12-3	T-cell receptor beta chain V region YT35	GO:0006955; P:immune response; NAS:UniProtKB
P01733	TRBV12-3	T-cell receptor beta chain V region YT35	GO:0050776; P:regulation of immune response; TAS:Reactome
P01733	TRBV12-3	T-cell receptor beta chain V region YT35	GO:0031295; P:T cell costimulation; TAS:Reactome
P01733	TRBV12-3	T-cell receptor beta chain V region YT35	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P03979	TRGV3	T-cell receptor gamma chain V region PT-gamma-1/2	GO:0042287; F:MHC protein binding; NAS:UniProtKB
P03979	TRGV3	T-cell receptor gamma chain V region PT-gamma-1/2	GO:0042605; F:peptide antigen binding; NAS:UniProtKB
P03979	TRGV3	T-cell receptor gamma chain V region PT-gamma-1/2	GO:0006955; P:immune response; NAS:UniProtKB
Q12792	TWF1	Twinfilin-1	GO:0003785; F:actin monomer binding; ISS:BHF-UCL
Q12792	TWF1	Twinfilin-1	GO:0005524; F:ATP binding; IDA:BHF-UCL
Q12792	TWF1	Twinfilin-1	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISS:BHF-UCL
Q12792	TWF1	Twinfilin-1	GO:0051016; P:barbed-end actin filament capping; IEA:Ensembl
Q12792	TWF1	Twinfilin-1	GO:0030837; P:negative regulation of actin filament polymerization; ISS:BHF-UCL
Q12792	TWF1	Twinfilin-1	GO:0043538; P:regulation of actin phosphorylation; IDA:BHF-UCL
Q12792	TWF1	Twinfilin-1	GO:0042989; P:sequestering of actin monomers; ISS:BHF-UCL
Q6IBS0	TWF2	Twinfilin-2	GO:0003785; F:actin monomer binding; ISS:BHF-UCL
Q6IBS0	TWF2	Twinfilin-2	GO:0005524; F:ATP binding; IDA:UniProtKB
Q6IBS0	TWF2	Twinfilin-2	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; ISS:BHF-UCL
Q6IBS0	TWF2	Twinfilin-2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6IBS0	TWF2	Twinfilin-2	GO:0005080; F:protein kinase C binding; IPI:BHF-UCL
Q6IBS0	TWF2	Twinfilin-2	GO:0051016; P:barbed-end actin filament capping; ISS:BHF-UCL
Q6IBS0	TWF2	Twinfilin-2	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
Q6IBS0	TWF2	Twinfilin-2	GO:0071363; P:cellular response to growth factor stimulus; IMP:BHF-UCL
Q6IBS0	TWF2	Twinfilin-2	GO:0071300; P:cellular response to retinoic acid; IMP:BHF-UCL
Q6IBS0	TWF2	Twinfilin-2	GO:0030837; P:negative regulation of actin filament polymerization; ISS:BHF-UCL
Q6IBS0	TWF2	Twinfilin-2	GO:0045773; P:positive regulation of axon extension; IMP:BHF-UCL
Q6IBS0	TWF2	Twinfilin-2	GO:0010592; P:positive regulation of lamellipodium assembly; IMP:BHF-UCL
Q6IBS0	TWF2	Twinfilin-2	GO:0010976; P:positive regulation of neuron projection development; IMP:BHF-UCL
Q6IBS0	TWF2	Twinfilin-2	GO:0032956; P:regulation of actin cytoskeleton organization; IMP:BHF-UCL
Q6IBS0	TWF2	Twinfilin-2	GO:0032532; P:regulation of microvillus length; IC:BHF-UCL
Q6IBS0	TWF2	Twinfilin-2	GO:0042989; P:sequestering of actin monomers; ISS:BHF-UCL
Q9GZX9	TWSG1	Twisted gastrulation protein homolog 1	GO:0030509; P:BMP signaling pathway; IEA:Ensembl
Q9GZX9	TWSG1	Twisted gastrulation protein homolog 1	GO:0043010; P:camera-type eye development; IEA:Ensembl
Q9GZX9	TWSG1	Twisted gastrulation protein homolog 1	GO:0030154; P:cell differentiation; IEA:Ensembl
Q9GZX9	TWSG1	Twisted gastrulation protein homolog 1	GO:0030900; P:forebrain development; IEA:Ensembl
Q9GZX9	TWSG1	Twisted gastrulation protein homolog 1	GO:0030097; P:hemopoiesis; IEA:Ensembl
Q9GZX9	TWSG1	Twisted gastrulation protein homolog 1	GO:0001707; P:mesoderm formation; IEA:Ensembl
Q9GZX9	TWSG1	Twisted gastrulation protein homolog 1	GO:0030514; P:negative regulation of BMP signaling pathway; IEA:Ensembl
Q9GZX9	TWSG1	Twisted gastrulation protein homolog 1	GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl
Q9GZX9	TWSG1	Twisted gastrulation protein homolog 1	GO:0001503; P:ossification; IEA:Ensembl
Q9GZX9	TWSG1	Twisted gastrulation protein homolog 1	GO:0030513; P:positive regulation of BMP signaling pathway; IEA:Ensembl
Q9GZX9	TWSG1	Twisted gastrulation protein homolog 1	GO:0007435; P:salivary gland morphogenesis; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:0043425; F:bHLH transcription factor binding; IPI:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0070888; F:E-box binding; IDA:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q15672	TWIST1	Twist-related protein 1	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IDA:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q15672	TWIST1	Twist-related protein 1	GO:0003180; P:aortic valve morphogenesis; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0003253; P:cardiac neural crest cell migration involved in outflow tract morphogenesis; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:2000793; P:cell proliferation involved in heart valve development; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:0071456; P:cellular response to hypoxia; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0060363; P:cranial suture morphogenesis; TAS:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0060900; P:embryonic camera-type eye formation; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0048701; P:embryonic cranial skeleton morphogenesis; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0042733; P:embryonic digit morphogenesis; TAS:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:0003203; P:endocardial cushion morphogenesis; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:0061029; P:eyelid development in camera-type eye; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:0003183; P:mitral valve morphogenesis; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
Q15672	TWIST1	Twist-related protein 1	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:2000773; P:negative regulation of cellular senescence; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0043518; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:2000780; P:negative regulation of double-strand break repair; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0035067; P:negative regulation of histone acetylation; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:0033128; P:negative regulation of histone phosphorylation; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0045668; P:negative regulation of osteoblast differentiation; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:2000276; P:negative regulation of oxidative phosphorylation uncoupler activity; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:0035359; P:negative regulation of peroxisome proliferator activated receptor signaling pathway; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:0014067; P:negative regulation of phosphatidylinositol 3-kinase signaling; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:0048642; P:negative regulation of skeletal muscle tissue development; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q15672	TWIST1	Twist-related protein 1	GO:0032720; P:negative regulation of tumor necrosis factor production; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:0001843; P:neural tube closure; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:0001764; P:neuron migration; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:0042476; P:odontogenesis; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:0001503; P:ossification; TAS:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:0042473; P:outer ear morphogenesis; TAS:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0060021; P:palate development; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:0045766; P:positive regulation of angiogenesis; NAS:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:2000147; P:positive regulation of cell motility; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:2000802; P:positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
Q15672	TWIST1	Twist-related protein 1	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0032000; P:positive regulation of fatty acid beta-oxidation; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:2000778; P:positive regulation of interleukin-6 secretion; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0071639; P:positive regulation of monocyte chemotactic protein-1 production; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:2000679; P:positive regulation of transcription regulatory region DNA binding; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0032760; P:positive regulation of tumor necrosis factor production; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0030500; P:regulation of bone mineralization; IMP:BHF-UCL
Q15672	TWIST1	Twist-related protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:GOC
Q8WVJ9	TWIST2	Twist-related protein 2	GO:0003682; F:chromatin binding; IEA:Ensembl
Q8WVJ9	TWIST2	Twist-related protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8WVJ9	TWIST2	Twist-related protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q8WVJ9	TWIST2	Twist-related protein 2	GO:0001076; F:RNA polymerase II transcription factor binding transcription factor activity; IEA:Ensembl
Q8WVJ9	TWIST2	Twist-related protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q8WVJ9	TWIST2	Twist-related protein 2	GO:0061303; P:cornea development in camera-type eye; IEA:Ensembl
Q8WVJ9	TWIST2	Twist-related protein 2	GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl
Q8WVJ9	TWIST2	Twist-related protein 2	GO:0060325; P:face morphogenesis; IEA:Ensembl
Q8WVJ9	TWIST2	Twist-related protein 2	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
Q8WVJ9	TWIST2	Twist-related protein 2	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q8WVJ9	TWIST2	Twist-related protein 2	GO:0043392; P:negative regulation of DNA binding; IEA:Ensembl
Q8WVJ9	TWIST2	Twist-related protein 2	GO:0045638; P:negative regulation of myeloid cell differentiation; IEA:Ensembl
Q8WVJ9	TWIST2	Twist-related protein 2	GO:0045668; P:negative regulation of osteoblast differentiation; IDA:UniProtKB
Q8WVJ9	TWIST2	Twist-related protein 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8WVJ9	TWIST2	Twist-related protein 2	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q8WVJ9	TWIST2	Twist-related protein 2	GO:0032720; P:negative regulation of tumor necrosis factor production; IEA:Ensembl
Q8WVJ9	TWIST2	Twist-related protein 2	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
Q8WVJ9	TWIST2	Twist-related protein 2	GO:0010838; P:positive regulation of keratinocyte proliferation; IEA:Ensembl
Q9BXU3	TEX13A	Testis-expressed sequence 13A protein	GO:0008270; F:zinc ion binding; IEA:InterPro
O14907	TAX1BP3	Tax1-binding protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
O14907	TAX1BP3	Tax1-binding protein 3	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
O14907	TAX1BP3	Tax1-binding protein 3	GO:0032864; P:activation of Cdc42 GTPase activity; IDA:BHF-UCL
O14907	TAX1BP3	Tax1-binding protein 3	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
O14907	TAX1BP3	Tax1-binding protein 3	GO:2000009; P:negative regulation of protein localization to cell surface; IDA:UniProtKB
O14907	TAX1BP3	Tax1-binding protein 3	GO:0030178; P:negative regulation of Wnt signaling pathway; ISS:UniProtKB
O14907	TAX1BP3	Tax1-binding protein 3	GO:0007266; P:Rho protein signal transduction; IDA:UniProtKB
O14907	TAX1BP3	Tax1-binding protein 3	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q6PKC3	TXNDC11	Thioredoxin domain-containing protein 11	GO:0005515; F:protein binding; IPI:IntAct
Q6PKC3	TXNDC11	Thioredoxin domain-containing protein 11	GO:0003756; F:protein disulfide isomerase activity; IBA:RefGenome
Q6PKC3	TXNDC11	Thioredoxin domain-containing protein 11	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q6PKC3	TXNDC11	Thioredoxin domain-containing protein 11	GO:0006457; P:protein folding; IBA:RefGenome
Q6PKC3	TXNDC11	Thioredoxin domain-containing protein 11	GO:0034976; P:response to endoplasmic reticulum stress; IBA:RefGenome
O95881	TXNDC12	Thioredoxin domain-containing protein 12	GO:0019153; F:protein-disulfide reductase (glutathione) activity; IEA:UniProtKB-EC
O95881	TXNDC12	Thioredoxin domain-containing protein 12	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q96J42	TXNDC15	Thioredoxin domain-containing protein 15	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q9P2K2	TXNDC16	Thioredoxin domain-containing protein 16	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q9BRA2	TXNDC17	Thioredoxin domain-containing protein 17	GO:0009055; F:electron carrier activity; IDA:UniProtKB
Q9BRA2	TXNDC17	Thioredoxin domain-containing protein 17	GO:0004601; F:peroxidase activity; IDA:UniProtKB
Q9BRA2	TXNDC17	Thioredoxin domain-containing protein 17	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BRA2	TXNDC17	Thioredoxin domain-containing protein 17	GO:0047134; F:protein-disulfide reductase activity; IDA:UniProtKB
Q9BRA2	TXNDC17	Thioredoxin domain-containing protein 17	GO:0055114; P:oxidation-reduction process; IDA:GOC
Q9BRA2	TXNDC17	Thioredoxin domain-containing protein 17	GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IMP:UniProtKB
Q2TAA8	TSNAXIP1	Translin-associated factor X-interacting protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q2TAA8	TSNAXIP1	Translin-associated factor X-interacting protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q2TAA8	TSNAXIP1	Translin-associated factor X-interacting protein 1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
P42681	TXK	Tyrosine-protein kinase TXK	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P42681	TXK	Tyrosine-protein kinase TXK	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; TAS:ProtInc
P42681	TXK	Tyrosine-protein kinase TXK	GO:0001012; F:RNA polymerase II regulatory region DNA binding; IDA:UniProtKB
P42681	TXK	Tyrosine-protein kinase TXK	GO:0007202; P:activation of phospholipase C activity; ISS:UniProtKB
P42681	TXK	Tyrosine-protein kinase TXK	GO:0002250; P:adaptive immune response; ISS:UniProtKB
P42681	TXK	Tyrosine-protein kinase TXK	GO:0001816; P:cytokine production; ISS:UniProtKB
P42681	TXK	Tyrosine-protein kinase TXK	GO:0032609; P:interferon-gamma production; IEA:Ensembl
P42681	TXK	Tyrosine-protein kinase TXK	GO:0032633; P:interleukin-4 production; IEA:Ensembl
P42681	TXK	Tyrosine-protein kinase TXK	GO:0001865; P:NK T cell differentiation; IEA:Ensembl
P42681	TXK	Tyrosine-protein kinase TXK	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:GOC
P42681	TXK	Tyrosine-protein kinase TXK	GO:0032729; P:positive regulation of interferon-gamma production; IDA:UniProtKB
P42681	TXK	Tyrosine-protein kinase TXK	GO:0060335; P:positive regulation of interferon-gamma-mediated signaling pathway; IDA:UniProtKB
P42681	TXK	Tyrosine-protein kinase TXK	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P42681	TXK	Tyrosine-protein kinase TXK	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P42681	TXK	Tyrosine-protein kinase TXK	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
P42681	TXK	Tyrosine-protein kinase TXK	GO:0050852; P:T cell receptor signaling pathway; ISS:UniProtKB
P42681	TXK	Tyrosine-protein kinase TXK	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P40222	TXLNA	Alpha-taxilin	GO:0005125; F:cytokine activity; NAS:UniProtKB
P40222	TXLNA	Alpha-taxilin	GO:0030372; F:high molecular weight B cell growth factor receptor binding; NAS:UniProtKB
P40222	TXLNA	Alpha-taxilin	GO:0005515; F:protein binding; IPI:IntAct
P40222	TXLNA	Alpha-taxilin	GO:0042113; P:B cell activation; IEA:Ensembl
P40222	TXLNA	Alpha-taxilin	GO:0008283; P:cell proliferation; NAS:UniProtKB
P40222	TXLNA	Alpha-taxilin	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q8N3L3	TXLNB	Beta-taxilin	GO:0005515; F:protein binding; IPI:IntAct
Q9NUQ3	TXLNG	Gamma-taxilin	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
Q9NUQ3	TXLNG	Gamma-taxilin	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9NUQ3	TXLNG	Gamma-taxilin	GO:0030500; P:regulation of bone mineralization; ISS:UniProtKB
Q9NUQ3	TXLNG	Gamma-taxilin	GO:0051726; P:regulation of cell cycle; ISS:UniProtKB
Q9NUQ3	TXLNG	Gamma-taxilin	GO:0010564; P:regulation of cell cycle process; IMP:UniProtKB
Q9NUQ3	TXLNG	Gamma-taxilin	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NUQ3	TXLNG	Gamma-taxilin	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P83876	TXNL4A	Thioredoxin-like protein 4A	GO:0005515; F:protein binding; IPI:UniProtKB
P83876	TXNL4A	Thioredoxin-like protein 4A	GO:0010467; P:gene expression; TAS:Reactome
P83876	TXNL4A	Thioredoxin-like protein 4A	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P83876	TXNL4A	Thioredoxin-like protein 4A	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P83876	TXNL4A	Thioredoxin-like protein 4A	GO:0008380; P:RNA splicing; TAS:Reactome
P83876	TXNL4A	Thioredoxin-like protein 4A	GO:0000375; P:RNA splicing, via transesterification reactions; TAS:UniProtKB
P83876	TXNL4A	Thioredoxin-like protein 4A	GO:0000245; P:spliceosomal complex assembly; TAS:UniProtKB
Q9NX01	TXNL4B	Thioredoxin-like protein 4B	GO:0007067; P:mitosis; IEA:InterPro
Q9NX01	TXNL4B	Thioredoxin-like protein 4B	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9NX01	TXNL4B	Thioredoxin-like protein 4B	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q86VQ3	TXNDC2	Thioredoxin domain-containing protein 2	GO:0045735; F:nutrient reservoir activity; IEA:InterPro
Q86VQ3	TXNDC2	Thioredoxin domain-containing protein 2	GO:0003756; F:protein disulfide isomerase activity; IEA:Ensembl
Q86VQ3	TXNDC2	Thioredoxin domain-containing protein 2	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
Q86VQ3	TXNDC2	Thioredoxin domain-containing protein 2	GO:0004791; F:thioredoxin-disulfide reductase activity; IDA:UniProtKB
Q86VQ3	TXNDC2	Thioredoxin domain-containing protein 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q86VQ3	TXNDC2	Thioredoxin domain-containing protein 2	GO:0045454; P:cell redox homeostasis; NAS:UniProtKB
Q86VQ3	TXNDC2	Thioredoxin domain-containing protein 2	GO:0006662; P:glycerol ether metabolic process; IEA:InterPro
Q86VQ3	TXNDC2	Thioredoxin domain-containing protein 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q86VQ3	TXNDC2	Thioredoxin domain-containing protein 2	GO:0055114; P:oxidation-reduction process; IDA:GOC
Q86VQ3	TXNDC2	Thioredoxin domain-containing protein 2	GO:0007283; P:spermatogenesis; NAS:UniProtKB
Q8N427	NME8	Thioredoxin domain-containing protein 3	GO:0005524; F:ATP binding; IEA:InterPro
Q8N427	NME8	Thioredoxin domain-containing protein 3	GO:0004550; F:nucleoside diphosphate kinase activity; IEA:InterPro
Q8N427	NME8	Thioredoxin domain-containing protein 3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8N427	NME8	Thioredoxin domain-containing protein 3	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q8N427	NME8	Thioredoxin domain-containing protein 3	GO:0006241; P:CTP biosynthetic process; IEA:InterPro
Q8N427	NME8	Thioredoxin domain-containing protein 3	GO:0006183; P:GTP biosynthetic process; IEA:InterPro
Q8N427	NME8	Thioredoxin domain-containing protein 3	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8N427	NME8	Thioredoxin domain-containing protein 3	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q8N427	NME8	Thioredoxin domain-containing protein 3	GO:0006228; P:UTP biosynthetic process; IEA:InterPro
Q8NBS9	TXNDC5	Thioredoxin domain-containing protein 5	GO:0005515; F:protein binding; IPI:IntAct
Q8NBS9	TXNDC5	Thioredoxin domain-containing protein 5	GO:0003756; F:protein disulfide isomerase activity; IBA:RefGenome
Q8NBS9	TXNDC5	Thioredoxin domain-containing protein 5	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
Q8NBS9	TXNDC5	Thioredoxin domain-containing protein 5	GO:0043277; P:apoptotic cell clearance; IBA:RefGenome
Q8NBS9	TXNDC5	Thioredoxin domain-containing protein 5	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q8NBS9	TXNDC5	Thioredoxin domain-containing protein 5	GO:0006662; P:glycerol ether metabolic process; IEA:InterPro
Q8NBS9	TXNDC5	Thioredoxin domain-containing protein 5	GO:0061024; P:membrane organization; TAS:Reactome
Q8NBS9	TXNDC5	Thioredoxin domain-containing protein 5	GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB
Q8NBS9	TXNDC5	Thioredoxin domain-containing protein 5	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
Q8NBS9	TXNDC5	Thioredoxin domain-containing protein 5	GO:0006457; P:protein folding; IBA:RefGenome
Q8NBS9	TXNDC5	Thioredoxin domain-containing protein 5	GO:0034976; P:response to endoplasmic reticulum stress; IBA:RefGenome
Q86XW9	NME9	Thioredoxin domain-containing protein 6	GO:0005524; F:ATP binding; IEA:InterPro
Q86XW9	NME9	Thioredoxin domain-containing protein 6	GO:0004550; F:nucleoside diphosphate kinase activity; IEA:InterPro
Q86XW9	NME9	Thioredoxin domain-containing protein 6	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q86XW9	NME9	Thioredoxin domain-containing protein 6	GO:0006241; P:CTP biosynthetic process; IEA:InterPro
Q86XW9	NME9	Thioredoxin domain-containing protein 6	GO:0006183; P:GTP biosynthetic process; IEA:InterPro
Q86XW9	NME9	Thioredoxin domain-containing protein 6	GO:0006228; P:UTP biosynthetic process; IEA:InterPro
Q6A555	TXNDC8	Thioredoxin domain-containing protein 8	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
Q6A555	TXNDC8	Thioredoxin domain-containing protein 8	GO:0001675; P:acrosome assembly; IEA:Ensembl
Q6A555	TXNDC8	Thioredoxin domain-containing protein 8	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q6A555	TXNDC8	Thioredoxin domain-containing protein 8	GO:0006662; P:glycerol ether metabolic process; IEA:InterPro
Q6A555	TXNDC8	Thioredoxin domain-containing protein 8	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
O14530	TXNDC9	Thioredoxin domain-containing protein 9	GO:0005515; F:protein binding; IPI:IntAct
O14530	TXNDC9	Thioredoxin domain-containing protein 9	GO:0045454; P:cell redox homeostasis; IEA:InterPro
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0004857; F:enzyme inhibitor activity; IEA:Ensembl
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0071228; P:cellular response to tumor cell; IDA:UniProtKB
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0045087; P:innate immune response; TAS:Reactome
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0030216; P:keratinocyte differentiation; IDA:UniProtKB
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0051782; P:negative regulation of cell division; IDA:UniProtKB
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IEA:Ensembl
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0006606; P:protein import into nucleus; IEA:Ensembl
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0051592; P:response to calcium ion; IEA:Ensembl
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0042493; P:response to drug; IEA:Ensembl
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0032355; P:response to estradiol; IEA:Ensembl
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0009749; P:response to glucose; IEA:Ensembl
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0009612; P:response to mechanical stimulus; IEA:Ensembl
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0032570; P:response to progesterone; IEA:Ensembl
Q9H3M7	TXNIP	Thioredoxin-interacting protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43396	TXNL1	Thioredoxin-like protein 1	GO:0015036; F:disulfide oxidoreductase activity; IDA:UniProtKB
O43396	TXNL1	Thioredoxin-like protein 1	GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro
O43396	TXNL1	Thioredoxin-like protein 1	GO:0045454; P:cell redox homeostasis; IEA:InterPro
O43396	TXNL1	Thioredoxin-like protein 1	GO:0006662; P:glycerol ether metabolic process; IEA:InterPro
P53007	SLC25A1	Tricarboxylate transport protein, mitochondrial	GO:0015137; F:citrate transmembrane transporter activity; TAS:UniProtKB
P53007	SLC25A1	Tricarboxylate transport protein, mitochondrial	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P53007	SLC25A1	Tricarboxylate transport protein, mitochondrial	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
P53007	SLC25A1	Tricarboxylate transport protein, mitochondrial	GO:0015746; P:citrate transport; TAS:GOC
P53007	SLC25A1	Tricarboxylate transport protein, mitochondrial	GO:0006094; P:gluconeogenesis; TAS:Reactome
P53007	SLC25A1	Tricarboxylate transport protein, mitochondrial	GO:0006006; P:glucose metabolic process; TAS:Reactome
P53007	SLC25A1	Tricarboxylate transport protein, mitochondrial	GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome
P53007	SLC25A1	Tricarboxylate transport protein, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P53007	SLC25A1	Tricarboxylate transport protein, mitochondrial	GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome
P07101	TH	Tyrosine 3-monooxygenase	GO:0016597; F:amino acid binding; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0035240; F:dopamine binding; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0008199; F:ferric iron binding; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0008198; F:ferrous iron binding; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0005506; F:iron ion binding; IEA:InterPro
P07101	TH	Tyrosine 3-monooxygenase	GO:0019825; F:oxygen binding; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0005515; F:protein binding; IPI:BHF-UCL
P07101	TH	Tyrosine 3-monooxygenase	GO:0034617; F:tetrahydrobiopterin binding; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0004511; F:tyrosine 3-monooxygenase activity; IEA:InterPro
P07101	TH	Tyrosine 3-monooxygenase	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
P07101	TH	Tyrosine 3-monooxygenase	GO:0009072; P:aromatic amino acid family metabolic process; IEA:InterPro
P07101	TH	Tyrosine 3-monooxygenase	GO:0042423; P:catecholamine biosynthetic process; TAS:Reactome
P07101	TH	Tyrosine 3-monooxygenase	GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome
P07101	TH	Tyrosine 3-monooxygenase	GO:0035690; P:cellular response to drug; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0071287; P:cellular response to manganese ion; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0071316; P:cellular response to nicotine; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0021987; P:cerebral cortex development; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0042745; P:circadian sleep/wake cycle; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0042416; P:dopamine biosynthetic process; IDA:BHF-UCL
P07101	TH	Tyrosine 3-monooxygenase	GO:0006585; P:dopamine biosynthetic process from tyrosine; NAS:BHF-UCL
P07101	TH	Tyrosine 3-monooxygenase	GO:0042755; P:eating behavior; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0048596; P:embryonic camera-type eye morphogenesis; ISS:BHF-UCL
P07101	TH	Tyrosine 3-monooxygenase	GO:0042418; P:epinephrine biosynthetic process; IDA:BHF-UCL
P07101	TH	Tyrosine 3-monooxygenase	GO:0042462; P:eye photoreceptor cell development; ISS:BHF-UCL
P07101	TH	Tyrosine 3-monooxygenase	GO:0006631; P:fatty acid metabolic process; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0016137; P:glycoside metabolic process; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0007507; P:heart development; ISS:BHF-UCL
P07101	TH	Tyrosine 3-monooxygenase	GO:0003007; P:heart morphogenesis; NAS:BHF-UCL
P07101	TH	Tyrosine 3-monooxygenase	GO:0033076; P:isoquinoline alkaloid metabolic process; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0007612; P:learning; ISS:BHF-UCL
P07101	TH	Tyrosine 3-monooxygenase	GO:0007626; P:locomotory behavior; ISS:BHF-UCL
P07101	TH	Tyrosine 3-monooxygenase	GO:0007617; P:mating behavior; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0007613; P:memory; ISS:BHF-UCL
P07101	TH	Tyrosine 3-monooxygenase	GO:0010259; P:multicellular organismal aging; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0042136; P:neurotransmitter biosynthetic process; IEA:UniProtKB-KW
P07101	TH	Tyrosine 3-monooxygenase	GO:0042421; P:norepinephrine biosynthetic process; IDA:BHF-UCL
P07101	TH	Tyrosine 3-monooxygenase	GO:0009887; P:organ morphogenesis; ISS:BHF-UCL
P07101	TH	Tyrosine 3-monooxygenase	GO:0018963; P:phthalate metabolic process; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0052314; P:phytoalexin metabolic process; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0043473; P:pigmentation; TAS:BHF-UCL
P07101	TH	Tyrosine 3-monooxygenase	GO:0008016; P:regulation of heart contraction; ISS:BHF-UCL
P07101	TH	Tyrosine 3-monooxygenase	GO:0014823; P:response to activity; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0001975; P:response to amphetamine; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0051412; P:response to corticosterone; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0051602; P:response to electrical stimulus; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0032355; P:response to estradiol; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0045471; P:response to ethanol; IDA:BHF-UCL
P07101	TH	Tyrosine 3-monooxygenase	GO:0045472; P:response to ether; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0009635; P:response to herbicide; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0001666; P:response to hypoxia; IDA:BHF-UCL
P07101	TH	Tyrosine 3-monooxygenase	GO:0009416; P:response to light stimulus; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0031667; P:response to nutrient levels; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0043434; P:response to peptide hormone; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0046684; P:response to pyrethroid; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0009651; P:response to salt stress; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0009414; P:response to water deprivation; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0010043; P:response to zinc ion; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0007605; P:sensory perception of sound; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P07101	TH	Tyrosine 3-monooxygenase	GO:0035176; P:social behavior; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0006665; P:sphingolipid metabolic process; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0001963; P:synaptic transmission, dopaminergic; ISS:BHF-UCL
P07101	TH	Tyrosine 3-monooxygenase	GO:0015842; P:synaptic vesicle amine transport; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0042214; P:terpene metabolic process; IEA:Ensembl
P07101	TH	Tyrosine 3-monooxygenase	GO:0007601; P:visual perception; ISS:BHF-UCL
P63313	TMSB10	Thymosin beta-10	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
P63313	TMSB10	Thymosin beta-10	GO:0042989; P:sequestering of actin monomers; IEA:InterPro
O14604	TMSB4Y	Thymosin beta-4, Y-chromosomal	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
O14604	TMSB4Y	Thymosin beta-4, Y-chromosomal	GO:0008064; P:regulation of actin polymerization or depolymerization; TAS:ProtInc
O14604	TMSB4Y	Thymosin beta-4, Y-chromosomal	GO:0030334; P:regulation of cell migration; IEA:Ensembl
O14604	TMSB4Y	Thymosin beta-4, Y-chromosomal	GO:0042989; P:sequestering of actin monomers; TAS:ProtInc
P62328	TMSB4X	Thymosin beta-4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P62328	TMSB4X	Thymosin beta-4	GO:0005515; F:protein binding; IPI:IntAct
P62328	TMSB4X	Thymosin beta-4	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
P62328	TMSB4X	Thymosin beta-4	GO:0007596; P:blood coagulation; TAS:Reactome
P62328	TMSB4X	Thymosin beta-4	GO:0030168; P:platelet activation; TAS:Reactome
P62328	TMSB4X	Thymosin beta-4	GO:0002576; P:platelet degranulation; TAS:Reactome
P62328	TMSB4X	Thymosin beta-4	GO:0042989; P:sequestering of actin monomers; IEA:InterPro
Q9NUW8	TDP1	Tyrosyl-DNA phosphodiesterase 1	GO:0017005; F:3'-tyrosyl-DNA phosphodiesterase activity; IDA:UniProtKB
Q9NUW8	TDP1	Tyrosyl-DNA phosphodiesterase 1	GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB
Q9NUW8	TDP1	Tyrosyl-DNA phosphodiesterase 1	GO:0004527; F:exonuclease activity; IEA:UniProtKB-KW
Q9NUW8	TDP1	Tyrosyl-DNA phosphodiesterase 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NUW8	TDP1	Tyrosyl-DNA phosphodiesterase 1	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
Q9NUW8	TDP1	Tyrosyl-DNA phosphodiesterase 1	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9NUW8	TDP1	Tyrosyl-DNA phosphodiesterase 1	GO:0006281; P:DNA repair; IDA:UniProtKB
Q9NUW8	TDP1	Tyrosyl-DNA phosphodiesterase 1	GO:0006302; P:double-strand break repair; IDA:UniProtKB
Q9NUW8	TDP1	Tyrosyl-DNA phosphodiesterase 1	GO:0000012; P:single strand break repair; IDA:UniProtKB
O95551	TDP2	Tyrosyl-DNA phosphodiesterase 2	GO:0070260; F:5'-tyrosyl-DNA phosphodiesterase activity; IDA:UniProtKB
O95551	TDP2	Tyrosyl-DNA phosphodiesterase 2	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
O95551	TDP2	Tyrosyl-DNA phosphodiesterase 2	GO:0030145; F:manganese ion binding; IDA:UniProtKB
O95551	TDP2	Tyrosyl-DNA phosphodiesterase 2	GO:0004518; F:nuclease activity; IEA:UniProtKB-KW
O95551	TDP2	Tyrosyl-DNA phosphodiesterase 2	GO:0005515; F:protein binding; IPI:UniProtKB
O95551	TDP2	Tyrosyl-DNA phosphodiesterase 2	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
O95551	TDP2	Tyrosyl-DNA phosphodiesterase 2	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
O95551	TDP2	Tyrosyl-DNA phosphodiesterase 2	GO:0036317; F:tyrosyl-RNA phosphodiesterase activity; IDA:UniProtKB
O95551	TDP2	Tyrosyl-DNA phosphodiesterase 2	GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc
O95551	TDP2	Tyrosyl-DNA phosphodiesterase 2	GO:0006302; P:double-strand break repair; IDA:UniProtKB
O95551	TDP2	Tyrosyl-DNA phosphodiesterase 2	GO:2001141; P:regulation of RNA biosynthetic process; TAS:GOC
P29597	TYK2	Non-receptor tyrosine-protein kinase TYK2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P29597	TYK2	Non-receptor tyrosine-protein kinase TYK2	GO:0005131; F:growth hormone receptor binding; IPI:BHF-UCL
P29597	TYK2	Non-receptor tyrosine-protein kinase TYK2	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; TAS:ProtInc
P29597	TYK2	Non-receptor tyrosine-protein kinase TYK2	GO:0005515; F:protein binding; IPI:IntAct
P29597	TYK2	Non-receptor tyrosine-protein kinase TYK2	GO:0004713; F:protein tyrosine kinase activity; TAS:Reactome
P29597	TYK2	Non-receptor tyrosine-protein kinase TYK2	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P29597	TYK2	Non-receptor tyrosine-protein kinase TYK2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
P29597	TYK2	Non-receptor tyrosine-protein kinase TYK2	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:GOC
P29597	TYK2	Non-receptor tyrosine-protein kinase TYK2	GO:0006468; P:protein phosphorylation; TAS:ProtInc
P29597	TYK2	Non-receptor tyrosine-protein kinase TYK2	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
P29597	TYK2	Non-receptor tyrosine-protein kinase TYK2	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
O43914	TYROBP	TYRO protein tyrosine kinase-binding protein	GO:0042802; F:identical protein binding; IPI:IntAct
O43914	TYROBP	TYRO protein tyrosine kinase-binding protein	GO:0005515; F:protein binding; IPI:IntAct
O43914	TYROBP	TYRO protein tyrosine kinase-binding protein	GO:0005102; F:receptor binding; IPI:UniProtKB
O43914	TYROBP	TYRO protein tyrosine kinase-binding protein	GO:0005057; F:receptor signaling protein activity; TAS:ProtInc
O43914	TYROBP	TYRO protein tyrosine kinase-binding protein	GO:0007411; P:axon guidance; TAS:Reactome
O43914	TYROBP	TYRO protein tyrosine kinase-binding protein	GO:0006968; P:cellular defense response; TAS:ProtInc
O43914	TYROBP	TYRO protein tyrosine kinase-binding protein	GO:0045087; P:innate immune response; TAS:Reactome
O43914	TYROBP	TYRO protein tyrosine kinase-binding protein	GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl
O43914	TYROBP	TYRO protein tyrosine kinase-binding protein	GO:0035556; P:intracellular signal transduction; TAS:ProtInc
O43914	TYROBP	TYRO protein tyrosine kinase-binding protein	GO:0002281; P:macrophage activation involved in immune response; IEA:Ensembl
O43914	TYROBP	TYRO protein tyrosine kinase-binding protein	GO:0002283; P:neutrophil activation involved in immune response; IEA:Ensembl
O43914	TYROBP	TYRO protein tyrosine kinase-binding protein	GO:0050776; P:regulation of immune response; TAS:Reactome
O43914	TYROBP	TYRO protein tyrosine kinase-binding protein	GO:2001204; P:regulation of osteoclast development; IEA:Ensembl
O43914	TYROBP	TYRO protein tyrosine kinase-binding protein	GO:0007165; P:signal transduction; TAS:ProtInc
P19971	TYMP	Thymidine phosphorylase	GO:0004645; F:phosphorylase activity; IEA:InterPro
P19971	TYMP	Thymidine phosphorylase	GO:0005161; F:platelet-derived growth factor receptor binding; TAS:ProtInc
P19971	TYMP	Thymidine phosphorylase	GO:0016154; F:pyrimidine-nucleoside phosphorylase activity; IEA:InterPro
P19971	TYMP	Thymidine phosphorylase	GO:0009032; F:thymidine phosphorylase activity; TAS:ProtInc
P19971	TYMP	Thymidine phosphorylase	GO:0016763; F:transferase activity, transferring pentosyl groups; EXP:Reactome
P19971	TYMP	Thymidine phosphorylase	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P19971	TYMP	Thymidine phosphorylase	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P19971	TYMP	Thymidine phosphorylase	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
P19971	TYMP	Thymidine phosphorylase	GO:0006260; P:DNA replication; TAS:ProtInc
P19971	TYMP	Thymidine phosphorylase	GO:0000002; P:mitochondrial genome maintenance; TAS:ProtInc
P19971	TYMP	Thymidine phosphorylase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P19971	TYMP	Thymidine phosphorylase	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
P19971	TYMP	Thymidine phosphorylase	GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome
P19971	TYMP	Thymidine phosphorylase	GO:0043097; P:pyrimidine nucleoside salvage; TAS:Reactome
P19971	TYMP	Thymidine phosphorylase	GO:0006220; P:pyrimidine nucleotide metabolic process; TAS:ProtInc
P19971	TYMP	Thymidine phosphorylase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0043548; F:phosphatidylinositol 3-kinase binding; IPI:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0005515; F:protein binding; IPI:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0004716; F:receptor signaling protein tyrosine kinase activity; NAS:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; NAS:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0043277; P:apoptotic cell clearance; ISS:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0007155; P:cell adhesion; NAS:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0021885; P:forebrain cell migration; ISS:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0001779; P:natural killer cell differentiation; IEA:Ensembl
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0050728; P:negative regulation of inflammatory response; ISS:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0045824; P:negative regulation of innate immune response; ISS:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0051250; P:negative regulation of lymphocyte activation; IEA:Ensembl
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0034122; P:negative regulation of toll-like receptor signaling pathway; ISS:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0070050; P:neuron cellular homeostasis; ISS:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0042698; P:ovulation cycle; ISS:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:GOC
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0014065; P:phosphatidylinositol 3-kinase signaling; NAS:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0030168; P:platelet activation; ISS:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0070527; P:platelet aggregation; ISS:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0043491; P:protein kinase B signaling; ISS:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0032940; P:secretion by cell; ISS:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0007165; P:signal transduction; NAS:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0023014; P:signal transduction by phosphorylation; NAS:GOC
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0034446; P:substrate adhesion-dependent cell spreading; ISS:UniProtKB
Q06418	TYRO3	Tyrosine-protein kinase receptor TYRO3	GO:0060068; P:vagina development; IEA:Ensembl
P14679	TYR	Tyrosinase	GO:0005507; F:copper ion binding; IMP:UniProtKB
P14679	TYR	Tyrosinase	GO:0004503; F:monophenol monooxygenase activity; IDA:UniProtKB
P14679	TYR	Tyrosinase	GO:0005515; F:protein binding; IPI:UniProtKB
P14679	TYR	Tyrosinase	GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB
P14679	TYR	Tyrosinase	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
P14679	TYR	Tyrosinase	GO:0008283; P:cell proliferation; IEA:Ensembl
P14679	TYR	Tyrosinase	GO:0006726; P:eye pigment biosynthetic process; TAS:ProtInc
P14679	TYR	Tyrosinase	GO:0006583; P:melanin biosynthetic process from tyrosine; TAS:ProtInc
P14679	TYR	Tyrosinase	GO:0048538; P:thymus development; IEA:Ensembl
P14679	TYR	Tyrosinase	GO:0007601; P:visual perception; TAS:ProtInc
P17643	TYRP1	5,6-dihydroxyindole-2-carboxylic acid oxidase	GO:0005507; F:copper ion binding; IEA:InterPro
P17643	TYRP1	5,6-dihydroxyindole-2-carboxylic acid oxidase	GO:0016716; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen; IEA:InterPro
P17643	TYRP1	5,6-dihydroxyindole-2-carboxylic acid oxidase	GO:0005515; F:protein binding; IPI:UniProtKB
P17643	TYRP1	5,6-dihydroxyindole-2-carboxylic acid oxidase	GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB
P17643	TYRP1	5,6-dihydroxyindole-2-carboxylic acid oxidase	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
P17643	TYRP1	5,6-dihydroxyindole-2-carboxylic acid oxidase	GO:0043438; P:acetoacetic acid metabolic process; IEA:Ensembl
P17643	TYRP1	5,6-dihydroxyindole-2-carboxylic acid oxidase	GO:0042438; P:melanin biosynthetic process; IEA:UniProtKB-UniPathway
P17643	TYRP1	5,6-dihydroxyindole-2-carboxylic acid oxidase	GO:0030318; P:melanocyte differentiation; IEA:Ensembl
P17643	TYRP1	5,6-dihydroxyindole-2-carboxylic acid oxidase	GO:0032438; P:melanosome organization; IEA:Ensembl
P40126	DCT	L-dopachrome tautomerase	GO:0005507; F:copper ion binding; TAS:ProtInc
P40126	DCT	L-dopachrome tautomerase	GO:0004167; F:dopachrome isomerase activity; ISS:UniProtKB
P40126	DCT	L-dopachrome tautomerase	GO:0016491; F:oxidoreductase activity; IEA:InterPro
P40126	DCT	L-dopachrome tautomerase	GO:0048468; P:cell development; IEA:Ensembl
P40126	DCT	L-dopachrome tautomerase	GO:0048066; P:developmental pigmentation; IEA:Ensembl
P40126	DCT	L-dopachrome tautomerase	GO:0008544; P:epidermis development; TAS:ProtInc
P40126	DCT	L-dopachrome tautomerase	GO:0006583; P:melanin biosynthetic process from tyrosine; ISS:UniProtKB
P40126	DCT	L-dopachrome tautomerase	GO:0002052; P:positive regulation of neuroblast proliferation; IEA:Ensembl
P40126	DCT	L-dopachrome tautomerase	GO:0021847; P:ventricular zone neuroblast division; IEA:Ensembl
Q2T9J0	TYSND1	Peroxisomal leader peptide-processing protease	GO:0042802; F:identical protein binding; IPI:IntAct
Q2T9J0	TYSND1	Peroxisomal leader peptide-processing protease	GO:0002020; F:protease binding; IPI:UniProtKB
Q2T9J0	TYSND1	Peroxisomal leader peptide-processing protease	GO:0004252; F:serine-type endopeptidase activity; IMP:UniProtKB
Q2T9J0	TYSND1	Peroxisomal leader peptide-processing protease	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
Q2T9J0	TYSND1	Peroxisomal leader peptide-processing protease	GO:0016485; P:protein processing; IMP:UniProtKB
Q2T9J0	TYSND1	Peroxisomal leader peptide-processing protease	GO:0006508; P:proteolysis; IMP:UniProtKB
Q2T9J0	TYSND1	Peroxisomal leader peptide-processing protease	GO:0031998; P:regulation of fatty acid beta-oxidation; IMP:UniProtKB
P04818	TYMS	Thymidylate synthase	GO:0048037; F:cofactor binding; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0008144; F:drug binding; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0005542; F:folic acid binding; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0003729; F:mRNA binding; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0000166; F:nucleotide binding; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0004799; F:thymidylate synthase activity; TAS:Reactome
P04818	TYMS	Thymidylate synthase	GO:0007568; P:aging; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0051216; P:cartilage development; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0007623; P:circadian rhythm; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0009157; P:deoxyribonucleoside monophosphate biosynthetic process; TAS:ProtInc
P04818	TYMS	Thymidylate synthase	GO:0048589; P:developmental growth; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0006281; P:DNA repair; NAS:UniProtKB
P04818	TYMS	Thymidylate synthase	GO:0006260; P:DNA replication; NAS:UniProtKB
P04818	TYMS	Thymidylate synthase	GO:0006231; P:dTMP biosynthetic process; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0006235; P:dTTP biosynthetic process; IEA:UniProtKB-UniPathway
P04818	TYMS	Thymidylate synthase	GO:0046078; P:dUMP metabolic process; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P04818	TYMS	Thymidylate synthase	GO:0019088; P:immortalization of host cell by virus; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0060574; P:intestinal epithelial cell maturation; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P04818	TYMS	Thymidylate synthase	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
P04818	TYMS	Thymidylate synthase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P04818	TYMS	Thymidylate synthase	GO:0031100; P:organ regeneration; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0048015; P:phosphatidylinositol-mediated signaling; NAS:UniProtKB
P04818	TYMS	Thymidylate synthase	GO:0005976; P:polysaccharide metabolic process; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
P04818	TYMS	Thymidylate synthase	GO:0046134; P:pyrimidine nucleoside biosynthetic process; TAS:Reactome
P04818	TYMS	Thymidylate synthase	GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; TAS:Reactome
P04818	TYMS	Thymidylate synthase	GO:0034097; P:response to cytokine; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0042493; P:response to drug; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0045471; P:response to ethanol; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0051593; P:response to folic acid; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0046683; P:response to organophosphorus; IEP:UniProtKB
P04818	TYMS	Thymidylate synthase	GO:0032570; P:response to progesterone; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0009636; P:response to toxic substance; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0033189; P:response to vitamin A; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P04818	TYMS	Thymidylate synthase	GO:0046653; P:tetrahydrofolate metabolic process; IEA:Ensembl
P04818	TYMS	Thymidylate synthase	GO:0019860; P:uracil metabolic process; IEA:Ensembl
Q6NUM6	TYW1B	S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
Q6NUM6	TYW1B	S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase	GO:0010181; F:FMN binding; IEA:InterPro
Q6NUM6	TYW1B	S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase	GO:0005506; F:iron ion binding; IEA:InterPro
Q6NUM6	TYW1B	S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase	GO:0016829; F:lyase activity; IEA:UniProtKB-KW
Q6NUM6	TYW1B	S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase	GO:0016491; F:oxidoreductase activity; IEA:InterPro
Q6NUM6	TYW1B	S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q9NV66	TYW1	S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase	GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW
Q9NV66	TYW1	S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase	GO:0010181; F:FMN binding; IEA:InterPro
Q9NV66	TYW1	S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase	GO:0005506; F:iron ion binding; IEA:InterPro
Q9NV66	TYW1	S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase	GO:0016829; F:lyase activity; IEA:UniProtKB-KW
Q9NV66	TYW1	S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase	GO:0016491; F:oxidoreductase activity; IEA:InterPro
Q9NV66	TYW1	S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q53H54	TRMT12	tRNA wybutosine-synthesizing protein 2 homolog	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q53H54	TRMT12	tRNA wybutosine-synthesizing protein 2 homolog	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
Q6IPR3	TYW3	tRNA wybutosine-synthesizing protein 3 homolog	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q6IPR3	TYW3	tRNA wybutosine-synthesizing protein 3 homolog	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
O60294	LCMT2	tRNA wybutosine-synthesizing protein 4	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
O60294	LCMT2	tRNA wybutosine-synthesizing protein 4	GO:0005515; F:protein binding; IPI:UniProtKB
O60294	LCMT2	tRNA wybutosine-synthesizing protein 4	GO:0008033; P:tRNA processing; IEA:UniProtKB-KW
A2RUC4	TYW5	tRNA wybutosine-synthesizing protein 5	GO:0005506; F:iron ion binding; IDA:UniProtKB
A2RUC4	TYW5	tRNA wybutosine-synthesizing protein 5	GO:0016706; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; IDA:UniProtKB
A2RUC4	TYW5	tRNA wybutosine-synthesizing protein 5	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
A2RUC4	TYW5	tRNA wybutosine-synthesizing protein 5	GO:0000049; F:tRNA binding; IDA:UniProtKB
A2RUC4	TYW5	tRNA wybutosine-synthesizing protein 5	GO:0031591; P:wybutosine biosynthetic process; IDA:UniProtKB
P25490	YY1	Transcriptional repressor protein YY1	GO:0003677; F:DNA binding; IDA:MGI
P25490	YY1	Transcriptional repressor protein YY1	GO:0000400; F:four-way junction DNA binding; IDA:UniProtKB
P25490	YY1	Transcriptional repressor protein YY1	GO:0005515; F:protein binding; IPI:UniProtKB
P25490	YY1	Transcriptional repressor protein YY1	GO:0003723; F:RNA binding; IDA:MGI
P25490	YY1	Transcriptional repressor protein YY1	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; ISS:BHF-UCL
P25490	YY1	Transcriptional repressor protein YY1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P25490	YY1	Transcriptional repressor protein YY1	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P25490	YY1	Transcriptional repressor protein YY1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
P25490	YY1	Transcriptional repressor protein YY1	GO:0044212; F:transcription regulatory region DNA binding; IDA:MGI
P25490	YY1	Transcriptional repressor protein YY1	GO:0008270; F:zinc ion binding; TAS:ProtInc
P25490	YY1	Transcriptional repressor protein YY1	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
P25490	YY1	Transcriptional repressor protein YY1	GO:0048593; P:camera-type eye morphogenesis; IEA:Ensembl
P25490	YY1	Transcriptional repressor protein YY1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P25490	YY1	Transcriptional repressor protein YY1	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
P25490	YY1	Transcriptional repressor protein YY1	GO:0034644; P:cellular response to UV; IMP:UniProtKB
P25490	YY1	Transcriptional repressor protein YY1	GO:0051276; P:chromosome organization; IEA:Ensembl
P25490	YY1	Transcriptional repressor protein YY1	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
P25490	YY1	Transcriptional repressor protein YY1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:MGI
P25490	YY1	Transcriptional repressor protein YY1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P25490	YY1	Transcriptional repressor protein YY1	GO:0034696; P:response to prostaglandin F; IEA:Ensembl
P25490	YY1	Transcriptional repressor protein YY1	GO:0010225; P:response to UV-C; IMP:UniProtKB
P25490	YY1	Transcriptional repressor protein YY1	GO:0006403; P:RNA localization; IEA:Ensembl
P25490	YY1	Transcriptional repressor protein YY1	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
O15391	YY2	Transcription factor YY2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O15391	YY2	Transcription factor YY2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15391	YY2	Transcription factor YY2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O15391	YY2	Transcription factor YY2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13432	UNC119	Protein unc-119 homolog A	GO:0008289; F:lipid binding; IDA:UniProtKB
Q13432	UNC119	Protein unc-119 homolog A	GO:0005515; F:protein binding; IPI:UniProtKB
Q13432	UNC119	Protein unc-119 homolog A	GO:0007109; P:cytokinesis, completion of separation; IMP:UniProtKB
Q13432	UNC119	Protein unc-119 homolog A	GO:0042953; P:lipoprotein transport; IDA:UniProtKB
Q13432	UNC119	Protein unc-119 homolog A	GO:2001287; P:negative regulation of caveolin-mediated endocytosis; ISS:UniProtKB
Q13432	UNC119	Protein unc-119 homolog A	GO:1900186; P:negative regulation of clathrin-mediated endocytosis; ISS:UniProtKB
Q13432	UNC119	Protein unc-119 homolog A	GO:0007602; P:phototransduction; TAS:ProtInc
Q13432	UNC119	Protein unc-119 homolog A	GO:0061098; P:positive regulation of protein tyrosine kinase activity; IMP:UniProtKB
Q13432	UNC119	Protein unc-119 homolog A	GO:0007268; P:synaptic transmission; TAS:ProtInc
Q13432	UNC119	Protein unc-119 homolog A	GO:0007601; P:visual perception; TAS:ProtInc
A6NIH7	UNC119B	Protein unc-119 homolog B	GO:0008289; F:lipid binding; IDA:UniProtKB
A6NIH7	UNC119B	Protein unc-119 homolog B	GO:0005515; F:protein binding; IPI:UniProtKB
A6NIH7	UNC119B	Protein unc-119 homolog B	GO:0060271; P:cilium morphogenesis; IMP:UniProtKB
A6NIH7	UNC119B	Protein unc-119 homolog B	GO:0042953; P:lipoprotein transport; IDA:UniProtKB
Q7RTZ2	USP17L1P	Putative ubiquitin carboxyl-terminal hydrolase 17-like protein 1	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
Q7RTZ2	USP17L1P	Putative ubiquitin carboxyl-terminal hydrolase 17-like protein 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q7RTZ2	USP17L1P	Putative ubiquitin carboxyl-terminal hydrolase 17-like protein 1	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:0005515; F:protein binding; IPI:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:0004221; F:ubiquitin thiolesterase activity; IMP:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:0071586; P:CAAX-box protein processing; IMP:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:0000075; P:cell cycle checkpoint; IMP:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:0007093; P:mitotic cell cycle checkpoint; IMP:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:0031064; P:negative regulation of histone deacetylation; IMP:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:0010955; P:negative regulation of protein processing; IMP:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:0090315; P:negative regulation of protein targeting to membrane; IMP:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:0034261; P:negative regulation of Ras GTPase activity; IDA:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:1900245; P:positive regulation of MDA-5 signaling pathway; IMP:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:0032321; P:positive regulation of Rho GTPase activity; IMP:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:1900246; P:positive regulation of RIG-I signaling pathway; IMP:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:0071108; P:protein K48-linked deubiquitination; IMP:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:0070536; P:protein K63-linked deubiquitination; IDA:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:0042981; P:regulation of apoptotic process; IMP:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:0030334; P:regulation of cell migration; IMP:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:0042127; P:regulation of cell proliferation; IMP:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:0050691; P:regulation of defense response to virus by host; IMP:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:1900027; P:regulation of ruffle assembly; IMP:UniProtKB
Q6R6M4	USP17L2	Ubiquitin carboxyl-terminal hydrolase 17	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
A6NCW0	USP17L3	Ubiquitin carboxyl-terminal hydrolase 17-like protein 3	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
A6NCW0	USP17L3	Ubiquitin carboxyl-terminal hydrolase 17-like protein 3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
A6NCW0	USP17L3	Ubiquitin carboxyl-terminal hydrolase 17-like protein 3	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
A8MUK1	USP17L5	Ubiquitin carboxyl-terminal hydrolase 17-like protein 5	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
A8MUK1	USP17L5	Ubiquitin carboxyl-terminal hydrolase 17-like protein 5	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
A8MUK1	USP17L5	Ubiquitin carboxyl-terminal hydrolase 17-like protein 5	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
A6NCW7	USP17L4	Inactive ubiquitin carboxyl-terminal hydrolase 17-like protein 4	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
P0C7H9	USP17L7	Inactive ubiquitin carboxyl-terminal hydrolase 17-like protein 7	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q6QN14	USP17L6P	Ubiquitin carboxyl-terminal hydrolase 17-like protein 6	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
Q6QN14	USP17L6P	Ubiquitin carboxyl-terminal hydrolase 17-like protein 6	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
P0C7I0	USP17L8	Inactive ubiquitin carboxyl-terminal hydrolase 17-like protein 8	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
C9JJH3	USP17L10	Ubiquitin carboxyl-terminal hydrolase 17-like protein 10	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
C9JJH3	USP17L10	Ubiquitin carboxyl-terminal hydrolase 17-like protein 10	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
C9JLJ4	USP17L13	Ubiquitin carboxyl-terminal hydrolase 17-like protein 13	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
C9JLJ4	USP17L13	Ubiquitin carboxyl-terminal hydrolase 17-like protein 13	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
C9JVI0	USP17L11	Ubiquitin carboxyl-terminal hydrolase 17-like protein 11	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
C9JVI0	USP17L11	Ubiquitin carboxyl-terminal hydrolase 17-like protein 11	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
D6RBQ6	USP17L17	Ubiquitin carboxyl-terminal hydrolase 17-like protein 17	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
D6RBQ6	USP17L17	Ubiquitin carboxyl-terminal hydrolase 17-like protein 17	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
D6R9N7	USP17L18	Ubiquitin carboxyl-terminal hydrolase 17-like protein 18	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
D6R9N7	USP17L18	Ubiquitin carboxyl-terminal hydrolase 17-like protein 18	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
C9J2P7	USP17L15	Ubiquitin carboxyl-terminal hydrolase 17-like protein 15	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
C9J2P7	USP17L15	Ubiquitin carboxyl-terminal hydrolase 17-like protein 15	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
D6RJB6	USP17L20	Ubiquitin carboxyl-terminal hydrolase 17-like protein 20	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
D6RJB6	USP17L20	Ubiquitin carboxyl-terminal hydrolase 17-like protein 20	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
D6RCP7	USP17L19	Ubiquitin carboxyl-terminal hydrolase 17-like protein 19	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
D6RCP7	USP17L19	Ubiquitin carboxyl-terminal hydrolase 17-like protein 19	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
D6RA61	USP17L22	Ubiquitin carboxyl-terminal hydrolase 17-like protein 22	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
D6RA61	USP17L22	Ubiquitin carboxyl-terminal hydrolase 17-like protein 22	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
D6R901	USP17L21	Ubiquitin carboxyl-terminal hydrolase 17-like protein 21	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
D6R901	USP17L21	Ubiquitin carboxyl-terminal hydrolase 17-like protein 21	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q0WX57	USP17L24	Ubiquitin carboxyl-terminal hydrolase 17-like protein 24	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
Q0WX57	USP17L24	Ubiquitin carboxyl-terminal hydrolase 17-like protein 24	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q0WX57	USP17L24	Ubiquitin carboxyl-terminal hydrolase 17-like protein 24	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
D6RBM5	USP17L23	Putative ubiquitin carboxyl-terminal hydrolase 17-like protein 23	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q16560	SNRNP35	U11/U12 small nuclear ribonucleoprotein 35 kDa protein	GO:0000166; F:nucleotide binding; IEA:InterPro
Q16560	SNRNP35	U11/U12 small nuclear ribonucleoprotein 35 kDa protein	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q16560	SNRNP35	U11/U12 small nuclear ribonucleoprotein 35 kDa protein	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q16560	SNRNP35	U11/U12 small nuclear ribonucleoprotein 35 kDa protein	GO:0008380; P:RNA splicing; IC:HGNC
Q01081	U2AF1	Splicing factor U2AF 35 kDa subunit	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q01081	U2AF1	Splicing factor U2AF 35 kDa subunit	GO:0000166; F:nucleotide binding; IEA:InterPro
Q01081	U2AF1	Splicing factor U2AF 35 kDa subunit	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q01081	U2AF1	Splicing factor U2AF 35 kDa subunit	GO:0005515; F:protein binding; IPI:UniProtKB
Q01081	U2AF1	Splicing factor U2AF 35 kDa subunit	GO:0010467; P:gene expression; TAS:Reactome
Q01081	U2AF1	Splicing factor U2AF 35 kDa subunit	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q01081	U2AF1	Splicing factor U2AF 35 kDa subunit	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
Q01081	U2AF1	Splicing factor U2AF 35 kDa subunit	GO:0006397; P:mRNA processing; TAS:ProtInc
Q01081	U2AF1	Splicing factor U2AF 35 kDa subunit	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q01081	U2AF1	Splicing factor U2AF 35 kDa subunit	GO:0008380; P:RNA splicing; TAS:Reactome
Q01081	U2AF1	Splicing factor U2AF 35 kDa subunit	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q01081	U2AF1	Splicing factor U2AF 35 kDa subunit	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
P26368	U2AF2	Splicing factor U2AF 65 kDa subunit	GO:0019899; F:enzyme binding; IPI:UniProtKB
P26368	U2AF2	Splicing factor U2AF 65 kDa subunit	GO:0000166; F:nucleotide binding; IEA:InterPro
P26368	U2AF2	Splicing factor U2AF 65 kDa subunit	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P26368	U2AF2	Splicing factor U2AF 65 kDa subunit	GO:0005515; F:protein binding; IPI:UniProtKB
P26368	U2AF2	Splicing factor U2AF 65 kDa subunit	GO:0010467; P:gene expression; TAS:Reactome
P26368	U2AF2	Splicing factor U2AF 65 kDa subunit	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
P26368	U2AF2	Splicing factor U2AF 65 kDa subunit	GO:0006406; P:mRNA export from nucleus; TAS:Reactome
P26368	U2AF2	Splicing factor U2AF 65 kDa subunit	GO:0006397; P:mRNA processing; TAS:ProtInc
P26368	U2AF2	Splicing factor U2AF 65 kDa subunit	GO:0000398; P:mRNA splicing, via spliceosome; IC:HGNC
P26368	U2AF2	Splicing factor U2AF 65 kDa subunit	GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; IDA:UniProtKB
P26368	U2AF2	Splicing factor U2AF 65 kDa subunit	GO:0008380; P:RNA splicing; TAS:Reactome
P26368	U2AF2	Splicing factor U2AF 65 kDa subunit	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
P26368	U2AF2	Splicing factor U2AF 65 kDa subunit	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q8WU68	U2AF1L4	Splicing factor U2AF 26 kDa subunit	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8WU68	U2AF1L4	Splicing factor U2AF 26 kDa subunit	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8WU68	U2AF1L4	Splicing factor U2AF 26 kDa subunit	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q8WU68	U2AF1L4	Splicing factor U2AF 26 kDa subunit	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q8WU68	U2AF1L4	Splicing factor U2AF 26 kDa subunit	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q15695	ZRSR1	U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15695	ZRSR1	U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q15695	ZRSR1	U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 1	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q15696	ZRSR2	U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15696	ZRSR2	U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2	GO:0000166; F:nucleotide binding; IEA:InterPro
Q15696	ZRSR2	U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2	GO:0030628; F:pre-mRNA 3'-splice site binding; IDA:UniProtKB
Q15696	ZRSR2	U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q15696	ZRSR2	U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2	GO:0000398; P:mRNA splicing, via spliceosome; IMP:UniProtKB
Q15696	ZRSR2	U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2	GO:0008380; P:RNA splicing; IC:HGNC
Q15696	ZRSR2	U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2	GO:0000245; P:spliceosomal complex assembly; IMP:UniProtKB
Q8IWF7	UBE2DNL	Putative ubiquitin-conjugating enzyme E2 D2-like protein	GO:0016881; F:acid-amino acid ligase activity; IEA:InterPro
A1L167	UBE2QL1	Ubiquitin-conjugating enzyme E2Q-like protein 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
A1L167	UBE2QL1	Ubiquitin-conjugating enzyme E2Q-like protein 1	GO:0004842; F:ubiquitin-protein ligase activity; IEA:UniProtKB-EC
O43818	RRP9	U3 small nucleolar RNA-interacting protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O43818	RRP9	U3 small nucleolar RNA-interacting protein 2	GO:0006364; P:rRNA processing; TAS:ProtInc
O75643	SNRNP200	U5 small nuclear ribonucleoprotein 200 kDa helicase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75643	SNRNP200	U5 small nuclear ribonucleoprotein 200 kDa helicase	GO:0008026; F:ATP-dependent helicase activity; IDA:HGNC
O75643	SNRNP200	U5 small nuclear ribonucleoprotein 200 kDa helicase	GO:0004004; F:ATP-dependent RNA helicase activity; IDA:UniProtKB
O75643	SNRNP200	U5 small nuclear ribonucleoprotein 200 kDa helicase	GO:0042802; F:identical protein binding; IPI:IntAct
O75643	SNRNP200	U5 small nuclear ribonucleoprotein 200 kDa helicase	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75643	SNRNP200	U5 small nuclear ribonucleoprotein 200 kDa helicase	GO:0005515; F:protein binding; IPI:UniProtKB
O75643	SNRNP200	U5 small nuclear ribonucleoprotein 200 kDa helicase	GO:0006200; P:ATP catabolic process; IDA:GOC
O75643	SNRNP200	U5 small nuclear ribonucleoprotein 200 kDa helicase	GO:0000354; P:cis assembly of pre-catalytic spliceosome; IC:HGNC
O75643	SNRNP200	U5 small nuclear ribonucleoprotein 200 kDa helicase	GO:0010467; P:gene expression; TAS:Reactome
O75643	SNRNP200	U5 small nuclear ribonucleoprotein 200 kDa helicase	GO:0000398; P:mRNA splicing, via spliceosome; IDA:UniProtKB
O75643	SNRNP200	U5 small nuclear ribonucleoprotein 200 kDa helicase	GO:0008380; P:RNA splicing; TAS:Reactome
Q15029	EFTUD2	116 kDa U5 small nuclear ribonucleoprotein component	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
Q15029	EFTUD2	116 kDa U5 small nuclear ribonucleoprotein component	GO:0003924; F:GTPase activity; TAS:ProtInc
Q15029	EFTUD2	116 kDa U5 small nuclear ribonucleoprotein component	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15029	EFTUD2	116 kDa U5 small nuclear ribonucleoprotein component	GO:0005515; F:protein binding; IPI:UniProtKB
Q15029	EFTUD2	116 kDa U5 small nuclear ribonucleoprotein component	GO:0010467; P:gene expression; TAS:Reactome
Q15029	EFTUD2	116 kDa U5 small nuclear ribonucleoprotein component	GO:0006184; P:GTP catabolic process; TAS:GOC
Q15029	EFTUD2	116 kDa U5 small nuclear ribonucleoprotein component	GO:0006397; P:mRNA processing; TAS:ProtInc
Q15029	EFTUD2	116 kDa U5 small nuclear ribonucleoprotein component	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q15029	EFTUD2	116 kDa U5 small nuclear ribonucleoprotein component	GO:0008380; P:RNA splicing; TAS:Reactome
Q9BZF9	UACA	Uveal autoantigen with coiled-coil domains and ankyrin repeats	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BZF9	UACA	Uveal autoantigen with coiled-coil domains and ankyrin repeats	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
Q9BZF9	UACA	Uveal autoantigen with coiled-coil domains and ankyrin repeats	GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IEA:Ensembl
Q9BZF9	UACA	Uveal autoantigen with coiled-coil domains and ankyrin repeats	GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl
Q9BZF9	UACA	Uveal autoantigen with coiled-coil domains and ankyrin repeats	GO:0042347; P:negative regulation of NF-kappaB import into nucleus; IEA:Ensembl
Q9BZF9	UACA	Uveal autoantigen with coiled-coil domains and ankyrin repeats	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q9BZF9	UACA	Uveal autoantigen with coiled-coil domains and ankyrin repeats	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
Q9BZF9	UACA	Uveal autoantigen with coiled-coil domains and ankyrin repeats	GO:0042307; P:positive regulation of protein import into nucleus; IEA:Ensembl
Q9BZF9	UACA	Uveal autoantigen with coiled-coil domains and ankyrin repeats	GO:0009411; P:response to UV; IEA:Ensembl
Q3KQV9	UAP1L1	UDP-N-acetylhexosamine pyrophosphorylase-like protein 1	GO:0016779; F:nucleotidyltransferase activity; IEA:UniProtKB-KW
Q16222	UAP1	UDP-N-acetylhexosamine pyrophosphorylase	GO:0030246; F:carbohydrate binding; IEA:Ensembl
Q16222	UAP1	UDP-N-acetylhexosamine pyrophosphorylase	GO:0003977; F:UDP-N-acetylglucosamine diphosphorylase activity; TAS:Reactome
Q16222	UAP1	UDP-N-acetylhexosamine pyrophosphorylase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q16222	UAP1	UDP-N-acetylhexosamine pyrophosphorylase	GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome
Q16222	UAP1	UDP-N-acetylhexosamine pyrophosphorylase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q16222	UAP1	UDP-N-acetylhexosamine pyrophosphorylase	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q16222	UAP1	UDP-N-acetylhexosamine pyrophosphorylase	GO:0006048; P:UDP-N-acetylglucosamine biosynthetic process; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0005515; F:protein binding; IPI:UniProtKB
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0030509; P:BMP signaling pathway; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0010467; P:gene expression; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0045087; P:innate immune response; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P51668	UBE2D1	Ubiquitin-conjugating enzyme E2 D1	GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB
P62837	UBE2D2	Ubiquitin-conjugating enzyme E2 D2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P62837	UBE2D2	Ubiquitin-conjugating enzyme E2 D2	GO:0005515; F:protein binding; IPI:UniProtKB
P62837	UBE2D2	Ubiquitin-conjugating enzyme E2 D2	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
P62837	UBE2D2	Ubiquitin-conjugating enzyme E2 D2	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P62837	UBE2D2	Ubiquitin-conjugating enzyme E2 D2	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
P62837	UBE2D2	Ubiquitin-conjugating enzyme E2 D2	GO:0045087; P:innate immune response; TAS:Reactome
P62837	UBE2D2	Ubiquitin-conjugating enzyme E2 D2	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P62837	UBE2D2	Ubiquitin-conjugating enzyme E2 D2	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
P62837	UBE2D2	Ubiquitin-conjugating enzyme E2 D2	GO:0000209; P:protein polyubiquitination; IDA:BHF-UCL
P62837	UBE2D2	Ubiquitin-conjugating enzyme E2 D2	GO:0016567; P:protein ubiquitination; IDA:BHF-UCL
P62837	UBE2D2	Ubiquitin-conjugating enzyme E2 D2	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
P62837	UBE2D2	Ubiquitin-conjugating enzyme E2 D2	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P62837	UBE2D2	Ubiquitin-conjugating enzyme E2 D2	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P62837	UBE2D2	Ubiquitin-conjugating enzyme E2 D2	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P62837	UBE2D2	Ubiquitin-conjugating enzyme E2 D2	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P62837	UBE2D2	Ubiquitin-conjugating enzyme E2 D2	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0005515; F:protein binding; IPI:IntAct
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0030509; P:BMP signaling pathway; TAS:Reactome
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0010467; P:gene expression; TAS:Reactome
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0045087; P:innate immune response; TAS:Reactome
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:Reactome
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0006513; P:protein monoubiquitination; IDA:UniProtKB
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P61077	UBE2D3	Ubiquitin-conjugating enzyme E2 D3	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
P51965	UBE2E1	Ubiquitin-conjugating enzyme E2 E1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P51965	UBE2E1	Ubiquitin-conjugating enzyme E2 E1	GO:0042296; F:ISG15 ligase activity; IDA:HGNC
P51965	UBE2E1	Ubiquitin-conjugating enzyme E2 E1	GO:0005515; F:protein binding; IPI:IntAct
P51965	UBE2E1	Ubiquitin-conjugating enzyme E2 E1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
P51965	UBE2E1	Ubiquitin-conjugating enzyme E2 E1	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P51965	UBE2E1	Ubiquitin-conjugating enzyme E2 E1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P51965	UBE2E1	Ubiquitin-conjugating enzyme E2 E1	GO:0033523; P:histone H2B ubiquitination; IDA:UniProtKB
P51965	UBE2E1	Ubiquitin-conjugating enzyme E2 E1	GO:0010390; P:histone monoubiquitination; IDA:UniProtKB
P51965	UBE2E1	Ubiquitin-conjugating enzyme E2 E1	GO:0032020; P:ISG15-protein conjugation; IDA:HGNC
P51965	UBE2E1	Ubiquitin-conjugating enzyme E2 E1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P51965	UBE2E1	Ubiquitin-conjugating enzyme E2 E1	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:Reactome
P51965	UBE2E1	Ubiquitin-conjugating enzyme E2 E1	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P51965	UBE2E1	Ubiquitin-conjugating enzyme E2 E1	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P51965	UBE2E1	Ubiquitin-conjugating enzyme E2 E1	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
P51965	UBE2E1	Ubiquitin-conjugating enzyme E2 E1	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
P51965	UBE2E1	Ubiquitin-conjugating enzyme E2 E1	GO:0016567; P:protein ubiquitination; IDA:BHF-UCL
P51965	UBE2E1	Ubiquitin-conjugating enzyme E2 E1	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P51965	UBE2E1	Ubiquitin-conjugating enzyme E2 E1	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
Q9Y2X8	UBE2D4	Ubiquitin-conjugating enzyme E2 D4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y2X8	UBE2D4	Ubiquitin-conjugating enzyme E2 D4	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2X8	UBE2D4	Ubiquitin-conjugating enzyme E2 D4	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9Y2X8	UBE2D4	Ubiquitin-conjugating enzyme E2 D4	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
Q9Y2X8	UBE2D4	Ubiquitin-conjugating enzyme E2 D4	GO:0044314; P:protein K27-linked ubiquitination; IDA:UniProtKB
Q9Y2X8	UBE2D4	Ubiquitin-conjugating enzyme E2 D4	GO:0035519; P:protein K29-linked ubiquitination; IDA:UniProtKB
Q9Y2X8	UBE2D4	Ubiquitin-conjugating enzyme E2 D4	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
Q9Y2X8	UBE2D4	Ubiquitin-conjugating enzyme E2 D4	GO:0085020; P:protein K6-linked ubiquitination; IDA:UniProtKB
Q9Y2X8	UBE2D4	Ubiquitin-conjugating enzyme E2 D4	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
Q96LR5	UBE2E2	Ubiquitin-conjugating enzyme E2 E2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96LR5	UBE2E2	Ubiquitin-conjugating enzyme E2 E2	GO:0042296; F:ISG15 ligase activity; IDA:HGNC
Q96LR5	UBE2E2	Ubiquitin-conjugating enzyme E2 E2	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q96LR5	UBE2E2	Ubiquitin-conjugating enzyme E2 E2	GO:0032020; P:ISG15-protein conjugation; IDA:HGNC
Q96LR5	UBE2E2	Ubiquitin-conjugating enzyme E2 E2	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
Q96LR5	UBE2E2	Ubiquitin-conjugating enzyme E2 E2	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
Q96LR5	UBE2E2	Ubiquitin-conjugating enzyme E2 E2	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
Q969T4	UBE2E3	Ubiquitin-conjugating enzyme E2 E3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q969T4	UBE2E3	Ubiquitin-conjugating enzyme E2 E3	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q969T4	UBE2E3	Ubiquitin-conjugating enzyme E2 E3	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
Q969T4	UBE2E3	Ubiquitin-conjugating enzyme E2 E3	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
Q969T4	UBE2E3	Ubiquitin-conjugating enzyme E2 E3	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
Q969T4	UBE2E3	Ubiquitin-conjugating enzyme E2 E3	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
P62253	UBE2G1	Ubiquitin-conjugating enzyme E2 G1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P62253	UBE2G1	Ubiquitin-conjugating enzyme E2 G1	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P62253	UBE2G1	Ubiquitin-conjugating enzyme E2 G1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
P62253	UBE2G1	Ubiquitin-conjugating enzyme E2 G1	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
P62253	UBE2G1	Ubiquitin-conjugating enzyme E2 G1	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
P62253	UBE2G1	Ubiquitin-conjugating enzyme E2 G1	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
P60604	UBE2G2	Ubiquitin-conjugating enzyme E2 G2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P60604	UBE2G2	Ubiquitin-conjugating enzyme E2 G2	GO:0005515; F:protein binding; IPI:UniProtKB
P60604	UBE2G2	Ubiquitin-conjugating enzyme E2 G2	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
P60604	UBE2G2	Ubiquitin-conjugating enzyme E2 G2	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
P60604	UBE2G2	Ubiquitin-conjugating enzyme E2 G2	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
P60604	UBE2G2	Ubiquitin-conjugating enzyme E2 G2	GO:0018279; P:protein N-linked glycosylation via asparagine; IMP:UniProtKB
P60604	UBE2G2	Ubiquitin-conjugating enzyme E2 G2	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
Q9Y385	UBE2J1	Ubiquitin-conjugating enzyme E2 J1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y385	UBE2J1	Ubiquitin-conjugating enzyme E2 J1	GO:0004842; F:ubiquitin-protein ligase activity; IEA:UniProtKB-EC
Q9Y385	UBE2J1	Ubiquitin-conjugating enzyme E2 J1	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q9Y385	UBE2J1	Ubiquitin-conjugating enzyme E2 J1	GO:0018279; P:protein N-linked glycosylation via asparagine; IMP:UniProtKB
Q8N2K1	UBE2J2	Ubiquitin-conjugating enzyme E2 J2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8N2K1	UBE2J2	Ubiquitin-conjugating enzyme E2 J2	GO:0004842; F:ubiquitin-protein ligase activity; IEA:UniProtKB-EC
Q8N2K1	UBE2J2	Ubiquitin-conjugating enzyme E2 J2	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
P68036	UBE2L3	Ubiquitin-conjugating enzyme E2 L3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P68036	UBE2L3	Ubiquitin-conjugating enzyme E2 L3	GO:0019899; F:enzyme binding; TAS:UniProtKB
P68036	UBE2L3	Ubiquitin-conjugating enzyme E2 L3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P68036	UBE2L3	Ubiquitin-conjugating enzyme E2 L3	GO:0005515; F:protein binding; IPI:UniProtKB
P68036	UBE2L3	Ubiquitin-conjugating enzyme E2 L3	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
P68036	UBE2L3	Ubiquitin-conjugating enzyme E2 L3	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P68036	UBE2L3	Ubiquitin-conjugating enzyme E2 L3	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
P68036	UBE2L3	Ubiquitin-conjugating enzyme E2 L3	GO:0008283; P:cell proliferation; IMP:UniProtKB
P68036	UBE2L3	Ubiquitin-conjugating enzyme E2 L3	GO:0006464; P:cellular protein modification process; TAS:UniProtKB
P68036	UBE2L3	Ubiquitin-conjugating enzyme E2 L3	GO:0071385; P:cellular response to glucocorticoid stimulus; IDA:UniProtKB
P68036	UBE2L3	Ubiquitin-conjugating enzyme E2 L3	GO:0071383; P:cellular response to steroid hormone stimulus; IMP:UniProtKB
P68036	UBE2L3	Ubiquitin-conjugating enzyme E2 L3	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
P68036	UBE2L3	Ubiquitin-conjugating enzyme E2 L3	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
P68036	UBE2L3	Ubiquitin-conjugating enzyme E2 L3	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
P68036	UBE2L3	Ubiquitin-conjugating enzyme E2 L3	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
P68036	UBE2L3	Ubiquitin-conjugating enzyme E2 L3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P68036	UBE2L3	Ubiquitin-conjugating enzyme E2 L3	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:UniProtKB
O14933	UBE2L6	Ubiquitin/ISG15-conjugating enzyme E2 L6	GO:0042296; F:ISG15 ligase activity; IEA:Ensembl
O14933	UBE2L6	Ubiquitin/ISG15-conjugating enzyme E2 L6	GO:0005515; F:protein binding; IPI:UniProtKB
O14933	UBE2L6	Ubiquitin/ISG15-conjugating enzyme E2 L6	GO:0004842; F:ubiquitin-protein ligase activity; TAS:ProtInc
O14933	UBE2L6	Ubiquitin/ISG15-conjugating enzyme E2 L6	GO:0006464; P:cellular protein modification process; TAS:ProtInc
O14933	UBE2L6	Ubiquitin/ISG15-conjugating enzyme E2 L6	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
O14933	UBE2L6	Ubiquitin/ISG15-conjugating enzyme E2 L6	GO:0045087; P:innate immune response; TAS:Reactome
O14933	UBE2L6	Ubiquitin/ISG15-conjugating enzyme E2 L6	GO:0032020; P:ISG15-protein conjugation; IEA:Ensembl
O14933	UBE2L6	Ubiquitin/ISG15-conjugating enzyme E2 L6	GO:0019941; P:modification-dependent protein catabolic process; IEA:Ensembl
O14933	UBE2L6	Ubiquitin/ISG15-conjugating enzyme E2 L6	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
Q7Z7E8	UBE2Q1	Ubiquitin-conjugating enzyme E2 Q1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q7Z7E8	UBE2Q1	Ubiquitin-conjugating enzyme E2 Q1	GO:0005515; F:protein binding; IPI:IntAct
Q7Z7E8	UBE2Q1	Ubiquitin-conjugating enzyme E2 Q1	GO:0004842; F:ubiquitin-protein ligase activity; IEA:UniProtKB-EC
Q8WVN8	UBE2Q2	Ubiquitin-conjugating enzyme E2 Q2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8WVN8	UBE2Q2	Ubiquitin-conjugating enzyme E2 Q2	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q8WVN8	UBE2Q2	Ubiquitin-conjugating enzyme E2 Q2	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
P49427	CDC34	Ubiquitin-conjugating enzyme E2 R1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49427	CDC34	Ubiquitin-conjugating enzyme E2 R1	GO:0005515; F:protein binding; IPI:UniProtKB
P49427	CDC34	Ubiquitin-conjugating enzyme E2 R1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
P49427	CDC34	Ubiquitin-conjugating enzyme E2 R1	GO:0006464; P:cellular protein modification process; NAS:UniProtKB
P49427	CDC34	Ubiquitin-conjugating enzyme E2 R1	GO:0006270; P:DNA replication initiation; NAS:UniProtKB
P49427	CDC34	Ubiquitin-conjugating enzyme E2 R1	GO:0000082; P:G1/S transition of mitotic cell cycle; NAS:UniProtKB
P49427	CDC34	Ubiquitin-conjugating enzyme E2 R1	GO:0043951; P:negative regulation of cAMP-mediated signaling; IDA:UniProtKB
P49427	CDC34	Ubiquitin-conjugating enzyme E2 R1	GO:0090261; P:positive regulation of inclusion body assembly; IEA:Ensembl
P49427	CDC34	Ubiquitin-conjugating enzyme E2 R1	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
P49427	CDC34	Ubiquitin-conjugating enzyme E2 R1	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
P49427	CDC34	Ubiquitin-conjugating enzyme E2 R1	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
P49427	CDC34	Ubiquitin-conjugating enzyme E2 R1	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
P49427	CDC34	Ubiquitin-conjugating enzyme E2 R1	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
P49427	CDC34	Ubiquitin-conjugating enzyme E2 R1	GO:0070848; P:response to growth factor; IEA:Ensembl
Q712K3	UBE2R2	Ubiquitin-conjugating enzyme E2 R2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q712K3	UBE2R2	Ubiquitin-conjugating enzyme E2 R2	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q712K3	UBE2R2	Ubiquitin-conjugating enzyme E2 R2	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
Q712K3	UBE2R2	Ubiquitin-conjugating enzyme E2 R2	GO:0006513; P:protein monoubiquitination; IDA:UniProtKB
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0016881; F:acid-amino acid ligase activity; IEA:InterPro
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0005515; F:protein binding; IPI:IntAct
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0030154; P:cell differentiation; NAS:UniProtKB
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0045087; P:innate immune response; TAS:Reactome
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:HGNC
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:HGNC
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0045893; P:positive regulation of transcription, DNA-templated; TAS:UniProtKB
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0000209; P:protein polyubiquitination; TAS:ProtInc
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0006282; P:regulation of DNA repair; TAS:ProtInc
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
Q13404	UBE2V1	Ubiquitin-conjugating enzyme E2 variant 1	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
Q15819	UBE2V2	Ubiquitin-conjugating enzyme E2 variant 2	GO:0016881; F:acid-amino acid ligase activity; IEA:InterPro
Q15819	UBE2V2	Ubiquitin-conjugating enzyme E2 variant 2	GO:0005515; F:protein binding; IPI:IntAct
Q15819	UBE2V2	Ubiquitin-conjugating enzyme E2 variant 2	GO:0008283; P:cell proliferation; TAS:ProtInc
Q15819	UBE2V2	Ubiquitin-conjugating enzyme E2 variant 2	GO:0000729; P:DNA double-strand break processing; IMP:HGNC
Q15819	UBE2V2	Ubiquitin-conjugating enzyme E2 variant 2	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q15819	UBE2V2	Ubiquitin-conjugating enzyme E2 variant 2	GO:0045739; P:positive regulation of DNA repair; IEA:Ensembl
Q15819	UBE2V2	Ubiquitin-conjugating enzyme E2 variant 2	GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl
Q15819	UBE2V2	Ubiquitin-conjugating enzyme E2 variant 2	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q15819	UBE2V2	Ubiquitin-conjugating enzyme E2 variant 2	GO:0051965; P:positive regulation of synapse assembly; IEA:Ensembl
Q15819	UBE2V2	Ubiquitin-conjugating enzyme E2 variant 2	GO:0000209; P:protein polyubiquitination; TAS:ProtInc
Q15819	UBE2V2	Ubiquitin-conjugating enzyme E2 variant 2	GO:0016567; P:protein ubiquitination; TAS:HGNC
Q15819	UBE2V2	Ubiquitin-conjugating enzyme E2 variant 2	GO:0006282; P:regulation of DNA repair; TAS:ProtInc
P22314	UBA1	Ubiquitin-like modifier-activating enzyme 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P22314	UBA1	Ubiquitin-like modifier-activating enzyme 1	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
P22314	UBA1	Ubiquitin-like modifier-activating enzyme 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P22314	UBA1	Ubiquitin-like modifier-activating enzyme 1	GO:0005515; F:protein binding; IPI:IntAct
P22314	UBA1	Ubiquitin-like modifier-activating enzyme 1	GO:0008641; F:small protein activating enzyme activity; IEA:InterPro
P22314	UBA1	Ubiquitin-like modifier-activating enzyme 1	GO:0008219; P:cell death; IEA:UniProtKB-KW
P22314	UBA1	Ubiquitin-like modifier-activating enzyme 1	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8TBC4	UBA3	NEDD8-activating enzyme E1 catalytic subunit	GO:0016881; F:acid-amino acid ligase activity; IEA:InterPro
Q8TBC4	UBA3	NEDD8-activating enzyme E1 catalytic subunit	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8TBC4	UBA3	NEDD8-activating enzyme E1 catalytic subunit	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TBC4	UBA3	NEDD8-activating enzyme E1 catalytic subunit	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q8TBC4	UBA3	NEDD8-activating enzyme E1 catalytic subunit	GO:0008641; F:small protein activating enzyme activity; IEA:InterPro
Q8TBC4	UBA3	NEDD8-activating enzyme E1 catalytic subunit	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q8TBC4	UBA3	NEDD8-activating enzyme E1 catalytic subunit	GO:0007113; P:endomitotic cell cycle; IEA:Ensembl
Q8TBC4	UBA3	NEDD8-activating enzyme E1 catalytic subunit	GO:0045116; P:protein neddylation; IEA:UniProtKB-UniPathway
Q8TBC4	UBA3	NEDD8-activating enzyme E1 catalytic subunit	GO:0006508; P:proteolysis; TAS:ProtInc
Q8TBC4	UBA3	NEDD8-activating enzyme E1 catalytic subunit	GO:0051726; P:regulation of cell cycle; IEA:Ensembl
Q9GZZ9	UBA5	Ubiquitin-like modifier-activating enzyme 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9GZZ9	UBA5	Ubiquitin-like modifier-activating enzyme 5	GO:0048037; F:cofactor binding; IEA:InterPro
Q9GZZ9	UBA5	Ubiquitin-like modifier-activating enzyme 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9GZZ9	UBA5	Ubiquitin-like modifier-activating enzyme 5	GO:0016616; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; IEA:InterPro
Q9GZZ9	UBA5	Ubiquitin-like modifier-activating enzyme 5	GO:0005515; F:protein binding; IPI:IntAct
Q9GZZ9	UBA5	Ubiquitin-like modifier-activating enzyme 5	GO:0071566; F:UFM1 activating enzyme activity; IDA:UniProtKB
Q9GZZ9	UBA5	Ubiquitin-like modifier-activating enzyme 5	GO:0071569; P:protein ufmylation; IDA:UniProtKB
Q9GZZ9	UBA5	Ubiquitin-like modifier-activating enzyme 5	GO:0034976; P:response to endoplasmic reticulum stress; IDA:MGI
A0AVT1	UBA6	Ubiquitin-like modifier-activating enzyme 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
A0AVT1	UBA6	Ubiquitin-like modifier-activating enzyme 6	GO:0019780; F:FAT10 activating enzyme activity; IMP:UniProtKB
A0AVT1	UBA6	Ubiquitin-like modifier-activating enzyme 6	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
A0AVT1	UBA6	Ubiquitin-like modifier-activating enzyme 6	GO:0005515; F:protein binding; IPI:UniProtKB
A0AVT1	UBA6	Ubiquitin-like modifier-activating enzyme 6	GO:0016567; P:protein ubiquitination; IMP:UniProtKB
A0AVT1	UBA6	Ubiquitin-like modifier-activating enzyme 6	GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB
P41226	UBA7	Ubiquitin-like modifier-activating enzyme 7	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P41226	UBA7	Ubiquitin-like modifier-activating enzyme 7	GO:0019782; F:ISG15 activating enzyme activity; IDA:HGNC
P41226	UBA7	Ubiquitin-like modifier-activating enzyme 7	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
P41226	UBA7	Ubiquitin-like modifier-activating enzyme 7	GO:0006464; P:cellular protein modification process; IDA:HGNC
P41226	UBA7	Ubiquitin-like modifier-activating enzyme 7	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P41226	UBA7	Ubiquitin-like modifier-activating enzyme 7	GO:0045087; P:innate immune response; TAS:Reactome
P41226	UBA7	Ubiquitin-like modifier-activating enzyme 7	GO:0032020; P:ISG15-protein conjugation; IDA:HGNC
P41226	UBA7	Ubiquitin-like modifier-activating enzyme 7	GO:0019941; P:modification-dependent protein catabolic process; IEA:Ensembl
P41226	UBA7	Ubiquitin-like modifier-activating enzyme 7	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
P41226	UBA7	Ubiquitin-like modifier-activating enzyme 7	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9BSL1	UBAC1	Ubiquitin-associated domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9BSL1	UBAC1	Ubiquitin-associated domain-containing protein 1	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8NBM4	UBAC2	Ubiquitin-associated domain-containing protein 2	GO:0070972; P:protein localization to endoplasmic reticulum; IDA:MGI
Q9NZ09	UBAP1	Ubiquitin-associated protein 1	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
Q9NZ09	UBAP1	Ubiquitin-associated protein 1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9NZ09	UBAP1	Ubiquitin-associated protein 1	GO:0043162; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; IMP:UniProtKB
Q5T6F2	UBAP2	Ubiquitin-associated protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P0CG47	UBB	Polyubiquitin-B	GO:0005515; F:protein binding; IPI:IntAct
P0CG47	UBB	Polyubiquitin-B	GO:0000187; P:activation of MAPK activity; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0006915; P:apoptotic process; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0006281; P:DNA repair; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0016197; P:endosomal transport; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0010467; P:gene expression; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0006006; P:glucose metabolic process; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0005978; P:glycogen biosynthetic process; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0045087; P:innate immune response; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0075733; P:intracellular transport of virus; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0007254; P:JNK cascade; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0061024; P:membrane organization; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0007220; P:Notch receptor processing; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0032479; P:regulation of type I interferon production; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0016070; P:RNA metabolic process; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0055085; P:transmembrane transport; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0019058; P:viral life cycle; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0016032; P:viral process; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0019082; P:viral protein processing; TAS:Reactome
P0CG47	UBB	Polyubiquitin-B	GO:0019068; P:virion assembly; TAS:Reactome
P61081	UBE2M	NEDD8-conjugating enzyme Ubc12	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P61081	UBE2M	NEDD8-conjugating enzyme Ubc12	GO:0019788; F:NEDD8 ligase activity; IDA:UniProtKB
P61081	UBE2M	NEDD8-conjugating enzyme Ubc12	GO:0005515; F:protein binding; IPI:UniProtKB
P61081	UBE2M	NEDD8-conjugating enzyme Ubc12	GO:0018169; F:ribosomal S6-glutamic acid ligase activity; IDA:UniProtKB
P61081	UBE2M	NEDD8-conjugating enzyme Ubc12	GO:0004842; F:ubiquitin-protein ligase activity; IMP:UniProtKB
P61081	UBE2M	NEDD8-conjugating enzyme Ubc12	GO:0006464; P:cellular protein modification process; IMP:UniProtKB
P61081	UBE2M	NEDD8-conjugating enzyme Ubc12	GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl
P61081	UBE2M	NEDD8-conjugating enzyme Ubc12	GO:0045116; P:protein neddylation; IDA:UniProtKB
P61081	UBE2M	NEDD8-conjugating enzyme Ubc12	GO:0016567; P:protein ubiquitination; IMP:GOC
P61081	UBE2M	NEDD8-conjugating enzyme Ubc12	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0019899; F:enzyme binding; IPI:UniProtKB
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0005515; F:protein binding; IPI:UniProtKB
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0071535; F:RING-like zinc finger domain binding; IPI:UniProtKB
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0019789; F:SUMO ligase activity; IEA:Ensembl
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0004842; F:ubiquitin-protein ligase activity; TAS:BHF-UCL
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0033145; P:positive regulation of intracellular steroid hormone receptor signaling pathway; IEA:Ensembl
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0043687; P:post-translational protein modification; TAS:Reactome
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:Ensembl
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0016925; P:protein sumoylation; IDA:BHF-UCL
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0010469; P:regulation of receptor activity; IEA:Ensembl
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
P63279	UBE2I	SUMO-conjugating enzyme UBC9	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q8WVY7	UBLCP1	Ubiquitin-like domain-containing CTD phosphatase 1	GO:0004721; F:phosphoprotein phosphatase activity; IEA:UniProtKB-KW
P0CG48	UBC	Polyubiquitin-C	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P0CG48	UBC	Polyubiquitin-C	GO:0002020; F:protease binding; IPI:UniProtKB
P0CG48	UBC	Polyubiquitin-C	GO:0005515; F:protein binding; IPI:UniProtKB
P0CG48	UBC	Polyubiquitin-C	GO:0000187; P:activation of MAPK activity; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0006915; P:apoptotic process; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0006281; P:DNA repair; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0016197; P:endosomal transport; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0010467; P:gene expression; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0006006; P:glucose metabolic process; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0005978; P:glycogen biosynthetic process; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0045087; P:innate immune response; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0075733; P:intracellular transport of virus; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0034220; P:ion transmembrane transport; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0007254; P:JNK cascade; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0061024; P:membrane organization; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0016071; P:mRNA metabolic process; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0002756; P:MyD88-independent toll-like receptor signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0007220; P:Notch receptor processing; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0007219; P:Notch signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0032479; P:regulation of type I interferon production; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0016070; P:RNA metabolic process; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0055085; P:transmembrane transport; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0019058; P:viral life cycle; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0016032; P:viral process; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0019082; P:viral protein processing; TAS:Reactome
P0CG48	UBC	Polyubiquitin-C	GO:0019068; P:virion assembly; TAS:Reactome
O15205	UBD	Ubiquitin D	GO:0070628; F:proteasome binding; IDA:UniProtKB
O15205	UBD	Ubiquitin D	GO:0005515; F:protein binding; IPI:UniProtKB
O15205	UBD	Ubiquitin D	GO:0070842; P:aggresome assembly; IDA:UniProtKB
O15205	UBD	Ubiquitin D	GO:0043011; P:myeloid dendritic cell differentiation; IMP:UniProtKB
O15205	UBD	Ubiquitin D	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
O15205	UBD	Ubiquitin D	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
O15205	UBD	Ubiquitin D	GO:0032446; P:protein modification by small protein conjugation; NAS:UniProtKB
O15205	UBD	Ubiquitin D	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
O15205	UBD	Ubiquitin D	GO:0006508; P:proteolysis; NAS:UniProtKB
O15205	UBD	Ubiquitin D	GO:0034341; P:response to interferon-gamma; IEP:UniProtKB
O15205	UBD	Ubiquitin D	GO:0010243; P:response to organonitrogen compound; IEA:Ensembl
O15205	UBD	Ubiquitin D	GO:0034612; P:response to tumor necrosis factor; IEP:UniProtKB
O15205	UBD	Ubiquitin D	GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB
P49459	UBE2A	Ubiquitin-conjugating enzyme E2 A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P49459	UBE2A	Ubiquitin-conjugating enzyme E2 A	GO:0005515; F:protein binding; IPI:UniProtKB
P49459	UBE2A	Ubiquitin-conjugating enzyme E2 A	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P49459	UBE2A	Ubiquitin-conjugating enzyme E2 A	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
P49459	UBE2A	Ubiquitin-conjugating enzyme E2 A	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome
P49459	UBE2A	Ubiquitin-conjugating enzyme E2 A	GO:0006281; P:DNA repair; IGI:UniProtKB
P49459	UBE2A	Ubiquitin-conjugating enzyme E2 A	GO:0033522; P:histone H2A ubiquitination; IDA:UniProtKB
P49459	UBE2A	Ubiquitin-conjugating enzyme E2 A	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P49459	UBE2A	Ubiquitin-conjugating enzyme E2 A	GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl
P49459	UBE2A	Ubiquitin-conjugating enzyme E2 A	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P49459	UBE2A	Ubiquitin-conjugating enzyme E2 A	GO:0006301; P:postreplication repair; NAS:UniProtKB
P49459	UBE2A	Ubiquitin-conjugating enzyme E2 A	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
P49459	UBE2A	Ubiquitin-conjugating enzyme E2 A	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
P49459	UBE2A	Ubiquitin-conjugating enzyme E2 A	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
P49459	UBE2A	Ubiquitin-conjugating enzyme E2 A	GO:0000209; P:protein polyubiquitination; TAS:Reactome
P49459	UBE2A	Ubiquitin-conjugating enzyme E2 A	GO:0009411; P:response to UV; IGI:UniProtKB
P49459	UBE2A	Ubiquitin-conjugating enzyme E2 A	GO:0006511; P:ubiquitin-dependent protein catabolic process; NAS:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0005515; F:protein binding; IPI:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0060070; P:canonical Wnt signaling pathway; ISS:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0051026; P:chiasma assembly; IEA:Ensembl
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0006281; P:DNA repair; IGI:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0033522; P:histone H2A ubiquitination; IMP:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0070076; P:histone lysine demethylation; IEA:Ensembl
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0006344; P:maintenance of chromatin silencing; IEA:Ensembl
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0043951; P:negative regulation of cAMP-mediated signaling; IDA:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0033128; P:negative regulation of histone phosphorylation; IEA:Ensembl
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0010845; P:positive regulation of reciprocal meiotic recombination; IEA:Ensembl
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0006301; P:postreplication repair; IDA:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0006513; P:protein monoubiquitination; IMP:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0000209; P:protein polyubiquitination; IMP:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0050821; P:protein stabilization; IMP:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0042493; P:response to drug; IDA:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0001666; P:response to hypoxia; IEA:Ensembl
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0009411; P:response to UV; IGI:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0007288; P:sperm axoneme assembly; IEA:Ensembl
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0007283; P:spermatogenesis; TAS:UniProtKB
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0070193; P:synaptonemal complex organization; IEA:Ensembl
P63146	UBE2B	Ubiquitin-conjugating enzyme E2 B	GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0005515; F:protein binding; IPI:UniProtKB
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0051488; P:activation of anaphase-promoting complex activity; TAS:UniProtKB
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0007049; P:cell cycle; NAS:UniProtKB
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0008054; P:cyclin catabolic process; IDA:UniProtKB
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0010458; P:exit from mitosis; IMP:UniProtKB
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0010994; P:free ubiquitin chain polymerization; IDA:UniProtKB
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0007094; P:mitotic spindle assembly checkpoint; TAS:Reactome
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0051436; P:negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0048015; P:phosphatidylinositol-mediated signaling; NAS:UniProtKB
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0031536; P:positive regulation of exit from mitosis; IMP:UniProtKB
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0051437; P:positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0051439; P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; TAS:Reactome
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0007051; P:spindle organization; NAS:UniProtKB
O00762	UBE2C	Ubiquitin-conjugating enzyme E2 C	GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q969M7	UBE2F	NEDD8-conjugating enzyme UBE2F	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q969M7	UBE2F	NEDD8-conjugating enzyme UBE2F	GO:0019788; F:NEDD8 ligase activity; IDA:UniProtKB
Q969M7	UBE2F	NEDD8-conjugating enzyme UBE2F	GO:0005515; F:protein binding; IPI:UniProtKB
Q969M7	UBE2F	NEDD8-conjugating enzyme UBE2F	GO:0045116; P:protein neddylation; IDA:UniProtKB
P62256	UBE2H	Ubiquitin-conjugating enzyme E2 H	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P62256	UBE2H	Ubiquitin-conjugating enzyme E2 H	GO:0005515; F:protein binding; IPI:UniProtKB
P62256	UBE2H	Ubiquitin-conjugating enzyme E2 H	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
P62256	UBE2H	Ubiquitin-conjugating enzyme E2 H	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
P62256	UBE2H	Ubiquitin-conjugating enzyme E2 H	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
P62256	UBE2H	Ubiquitin-conjugating enzyme E2 H	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
P61086	UBE2K	Ubiquitin-conjugating enzyme E2 K	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P61086	UBE2K	Ubiquitin-conjugating enzyme E2 K	GO:0005515; F:protein binding; IPI:IntAct
P61086	UBE2K	Ubiquitin-conjugating enzyme E2 K	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P61086	UBE2K	Ubiquitin-conjugating enzyme E2 K	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
P61086	UBE2K	Ubiquitin-conjugating enzyme E2 K	GO:0034450; F:ubiquitin-ubiquitin ligase activity; IDA:UniProtKB
P61086	UBE2K	Ubiquitin-conjugating enzyme E2 K	GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IEA:Ensembl
P61086	UBE2K	Ubiquitin-conjugating enzyme E2 K	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
P61086	UBE2K	Ubiquitin-conjugating enzyme E2 K	GO:0032434; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; IEA:Ensembl
P61086	UBE2K	Ubiquitin-conjugating enzyme E2 K	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0005515; F:protein binding; IPI:UniProtKB
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0043130; F:ubiquitin binding; IDA:HGNC
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0000729; P:DNA double-strand break processing; IMP:HGNC
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0000724; P:double-strand break repair via homologous recombination; IMP:HGNC
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0016574; P:histone ubiquitination; IMP:HGNC
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0045087; P:innate immune response; TAS:Reactome
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0045739; P:positive regulation of DNA repair; IMP:HGNC
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0031058; P:positive regulation of histone modification; IMP:HGNC
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:HGNC
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0051443; P:positive regulation of ubiquitin-protein ligase activity; IMP:HGNC
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0006301; P:postreplication repair; IMP:HGNC
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0016567; P:protein ubiquitination; IMP:HGNC
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0006508; P:proteolysis; TAS:ProtInc
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0006282; P:regulation of DNA repair; TAS:ProtInc
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0033182; P:regulation of histone ubiquitination; IMP:HGNC
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0050852; P:T cell receptor signaling pathway; IMP:UniProtKB
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome
P61088	UBE2N	Ubiquitin-conjugating enzyme E2 N	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q9C0C9	UBE2O	Ubiquitin-conjugating enzyme E2 O	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9C0C9	UBE2O	Ubiquitin-conjugating enzyme E2 O	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9C0C9	UBE2O	Ubiquitin-conjugating enzyme E2 O	GO:0005515; F:protein binding; IPI:IntAct
Q9C0C9	UBE2O	Ubiquitin-conjugating enzyme E2 O	GO:0004842; F:ubiquitin-protein ligase activity; IEA:UniProtKB-EC
Q16763	UBE2S	Ubiquitin-conjugating enzyme E2 S	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q16763	UBE2S	Ubiquitin-conjugating enzyme E2 S	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q16763	UBE2S	Ubiquitin-conjugating enzyme E2 S	GO:0051488; P:activation of anaphase-promoting complex activity; IDA:UniProtKB
Q16763	UBE2S	Ubiquitin-conjugating enzyme E2 S	GO:0031145; P:anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q16763	UBE2S	Ubiquitin-conjugating enzyme E2 S	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q16763	UBE2S	Ubiquitin-conjugating enzyme E2 S	GO:0010458; P:exit from mitosis; IDA:UniProtKB
Q16763	UBE2S	Ubiquitin-conjugating enzyme E2 S	GO:0010994; P:free ubiquitin chain polymerization; IDA:UniProtKB
Q16763	UBE2S	Ubiquitin-conjugating enzyme E2 S	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
Q16763	UBE2S	Ubiquitin-conjugating enzyme E2 S	GO:0044314; P:protein K27-linked ubiquitination; IDA:UniProtKB
Q16763	UBE2S	Ubiquitin-conjugating enzyme E2 S	GO:0035519; P:protein K29-linked ubiquitination; IDA:UniProtKB
Q16763	UBE2S	Ubiquitin-conjugating enzyme E2 S	GO:0085020; P:protein K6-linked ubiquitination; IDA:UniProtKB
Q16763	UBE2S	Ubiquitin-conjugating enzyme E2 S	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
Q9NPD8	UBE2T	Ubiquitin-conjugating enzyme E2 T	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NPD8	UBE2T	Ubiquitin-conjugating enzyme E2 T	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q9NPD8	UBE2T	Ubiquitin-conjugating enzyme E2 T	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q9NPD8	UBE2T	Ubiquitin-conjugating enzyme E2 T	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9NPD8	UBE2T	Ubiquitin-conjugating enzyme E2 T	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
Q9NPD8	UBE2T	Ubiquitin-conjugating enzyme E2 T	GO:0006281; P:DNA repair; IMP:UniProtKB
Q9NPD8	UBE2T	Ubiquitin-conjugating enzyme E2 T	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
Q9NPD8	UBE2T	Ubiquitin-conjugating enzyme E2 T	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
Q9NPD8	UBE2T	Ubiquitin-conjugating enzyme E2 T	GO:0044314; P:protein K27-linked ubiquitination; IDA:UniProtKB
Q9NPD8	UBE2T	Ubiquitin-conjugating enzyme E2 T	GO:0035519; P:protein K29-linked ubiquitination; IDA:UniProtKB
Q9NPD8	UBE2T	Ubiquitin-conjugating enzyme E2 T	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
Q9NPD8	UBE2T	Ubiquitin-conjugating enzyme E2 T	GO:0085020; P:protein K6-linked ubiquitination; IDA:UniProtKB
Q9NPD8	UBE2T	Ubiquitin-conjugating enzyme E2 T	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
Q9NPD8	UBE2T	Ubiquitin-conjugating enzyme E2 T	GO:0006513; P:protein monoubiquitination; IDA:UniProtKB
Q5VVX9	UBE2U	Ubiquitin-conjugating enzyme E2 U	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5VVX9	UBE2U	Ubiquitin-conjugating enzyme E2 U	GO:0004842; F:ubiquitin-protein ligase activity; IEA:UniProtKB-EC
Q96B02	UBE2W	Ubiquitin-conjugating enzyme E2 W	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96B02	UBE2W	Ubiquitin-conjugating enzyme E2 W	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q96B02	UBE2W	Ubiquitin-conjugating enzyme E2 W	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q96B02	UBE2W	Ubiquitin-conjugating enzyme E2 W	GO:0071218; P:cellular response to misfolded protein; ISS:UniProtKB
Q96B02	UBE2W	Ubiquitin-conjugating enzyme E2 W	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q96B02	UBE2W	Ubiquitin-conjugating enzyme E2 W	GO:0006515; P:misfolded or incompletely synthesized protein catabolic process; ISS:UniProtKB
Q96B02	UBE2W	Ubiquitin-conjugating enzyme E2 W	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB
Q96B02	UBE2W	Ubiquitin-conjugating enzyme E2 W	GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB
Q96B02	UBE2W	Ubiquitin-conjugating enzyme E2 W	GO:0006513; P:protein monoubiquitination; IDA:UniProtKB
Q9H832	UBE2Z	Ubiquitin-conjugating enzyme E2 Z	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H832	UBE2Z	Ubiquitin-conjugating enzyme E2 Z	GO:0005515; F:protein binding; IPI:IntAct
Q9H832	UBE2Z	Ubiquitin-conjugating enzyme E2 Z	GO:0004842; F:ubiquitin-protein ligase activity; IEA:UniProtKB-EC
Q9H832	UBE2Z	Ubiquitin-conjugating enzyme E2 Z	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q05086	UBE3A	Ubiquitin-protein ligase E3A	GO:0005515; F:protein binding; IPI:IntAct
Q05086	UBE3A	Ubiquitin-protein ligase E3A	GO:0003713; F:transcription coactivator activity; IEA:Ensembl
Q05086	UBE3A	Ubiquitin-protein ligase E3A	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q05086	UBE3A	Ubiquitin-protein ligase E3A	GO:0030521; P:androgen receptor signaling pathway; IBA:RefGenome
Q05086	UBE3A	Ubiquitin-protein ligase E3A	GO:0007420; P:brain development; TAS:ProtInc
Q05086	UBE3A	Ubiquitin-protein ligase E3A	GO:0001541; P:ovarian follicle development; IEA:Ensembl
Q05086	UBE3A	Ubiquitin-protein ligase E3A	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl
Q05086	UBE3A	Ubiquitin-protein ligase E3A	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q05086	UBE3A	Ubiquitin-protein ligase E3A	GO:0060736; P:prostate gland growth; IEA:Ensembl
Q05086	UBE3A	Ubiquitin-protein ligase E3A	GO:0051865; P:protein autoubiquitination; IDA:FlyBase
Q05086	UBE3A	Ubiquitin-protein ligase E3A	GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB
Q05086	UBE3A	Ubiquitin-protein ligase E3A	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:RefGenome
Q05086	UBE3A	Ubiquitin-protein ligase E3A	GO:0006508; P:proteolysis; TAS:ProtInc
Q05086	UBE3A	Ubiquitin-protein ligase E3A	GO:0035037; P:sperm entry; IEA:Ensembl
Q05086	UBE3A	Ubiquitin-protein ligase E3A	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
Q05086	UBE3A	Ubiquitin-protein ligase E3A	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q7Z3V4	UBE3B	Ubiquitin-protein ligase E3B	GO:0004842; F:ubiquitin-protein ligase activity; IBA:RefGenome
Q7Z3V4	UBE3B	Ubiquitin-protein ligase E3B	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:RefGenome
Q15386	UBE3C	Ubiquitin-protein ligase E3C	GO:0005515; F:protein binding; IPI:UniProtKB
Q15386	UBE3C	Ubiquitin-protein ligase E3C	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q15386	UBE3C	Ubiquitin-protein ligase E3C	GO:0000209; P:protein polyubiquitination; IDA:UniProtKB
Q15386	UBE3C	Ubiquitin-protein ligase E3C	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:RefGenome
Q7Z6J8	UBE3D	E3 ubiquitin-protein ligase E3D	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q7Z6J8	UBE3D	E3 ubiquitin-protein ligase E3D	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q14139	UBE4A	Ubiquitin conjugation factor E4 A	GO:0005515; F:protein binding; IPI:IntAct
Q14139	UBE4A	Ubiquitin conjugation factor E4 A	GO:0034450; F:ubiquitin-ubiquitin ligase activity; IEA:Ensembl
Q14139	UBE4A	Ubiquitin conjugation factor E4 A	GO:0000209; P:protein polyubiquitination; IEA:Ensembl
Q14139	UBE4A	Ubiquitin conjugation factor E4 A	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
O95155	UBE4B	Ubiquitin conjugation factor E4 B	GO:0019899; F:enzyme binding; ISS:UniProtKB
O95155	UBE4B	Ubiquitin conjugation factor E4 B	GO:0034450; F:ubiquitin-ubiquitin ligase activity; IEA:InterPro
O95155	UBE4B	Ubiquitin conjugation factor E4 B	GO:0008626; P:granzyme-mediated apoptotic signaling pathway; IDA:UniProtKB
O95155	UBE4B	Ubiquitin conjugation factor E4 B	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:MGI
O95155	UBE4B	Ubiquitin conjugation factor E4 B	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; TAS:UniProtKB
O95155	UBE4B	Ubiquitin conjugation factor E4 B	GO:0009411; P:response to UV; IDA:UniProtKB
P17480	UBTF	Nucleolar transcription factor 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P17480	UBTF	Nucleolar transcription factor 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P17480	UBTF	Nucleolar transcription factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
P17480	UBTF	Nucleolar transcription factor 1	GO:0000183; P:chromatin silencing at rDNA; IEA:Ensembl
P17480	UBTF	Nucleolar transcription factor 1	GO:0010467; P:gene expression; TAS:Reactome
P17480	UBTF	Nucleolar transcription factor 1	GO:0045943; P:positive regulation of transcription from RNA polymerase I promoter; ISS:UniProtKB
P17480	UBTF	Nucleolar transcription factor 1	GO:0006356; P:regulation of transcription from RNA polymerase I promoter; TAS:ProtInc
P17480	UBTF	Nucleolar transcription factor 1	GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome
P17480	UBTF	Nucleolar transcription factor 1	GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome
P17480	UBTF	Nucleolar transcription factor 1	GO:0006360; P:transcription from RNA polymerase I promoter; TAS:Reactome
P17480	UBTF	Nucleolar transcription factor 1	GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome
O14562	UBFD1	Ubiquitin domain-containing protein UBFD1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P0CB47	UBTFL1	Putative upstream-binding factor 1-like protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P0CB47	UBTFL1	Putative upstream-binding factor 1-like protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P0CB48	UBTFL6	Putative upstream-binding factor 1-like protein 6	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y5Z9	UBIAD1	UbiA prenyltransferase domain-containing protein 1	GO:0016209; F:antioxidant activity; IMP:UniProtKB
Q9Y5Z9	UBIAD1	UbiA prenyltransferase domain-containing protein 1	GO:0004659; F:prenyltransferase activity; IDA:UniProtKB
Q9Y5Z9	UBIAD1	UbiA prenyltransferase domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9Y5Z9	UBIAD1	UbiA prenyltransferase domain-containing protein 1	GO:0009234; P:menaquinone biosynthetic process; IMP:UniProtKB
Q9Y5Z9	UBIAD1	UbiA prenyltransferase domain-containing protein 1	GO:0006744; P:ubiquinone biosynthetic process; IMP:UniProtKB
Q9Y5Z9	UBIAD1	UbiA prenyltransferase domain-containing protein 1	GO:0042371; P:vitamin K biosynthetic process; IDA:UniProtKB
Q9NZI7	UBP1	Upstream-binding protein 1	GO:0003677; F:DNA binding; TAS:ProtInc
Q9NZI7	UBP1	Upstream-binding protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9NZI7	UBP1	Upstream-binding protein 1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q9NZI7	UBP1	Upstream-binding protein 1	GO:0001525; P:angiogenesis; IEA:Ensembl
Q9NZI7	UBP1	Upstream-binding protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; TAS:UniProtKB
Q9NZI7	UBP1	Upstream-binding protein 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9NZI7	UBP1	Upstream-binding protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NZI7	UBP1	Upstream-binding protein 1	GO:0019079; P:viral genome replication; TAS:ProtInc
P35544	FAU	Ubiquitin-like protein FUBI	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P11441	UBL4A	Ubiquitin-like protein 4A	GO:0005515; F:protein binding; IPI:IntAct
P11441	UBL4A	Ubiquitin-like protein 4A	GO:0019787; F:small conjugating protein ligase activity; TAS:ProtInc
P11441	UBL4A	Ubiquitin-like protein 4A	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P11441	UBL4A	Ubiquitin-like protein 4A	GO:0071816; P:tail-anchored membrane protein insertion into ER membrane; IMP:UniProtKB
P11441	UBL4A	Ubiquitin-like protein 4A	GO:0006810; P:transport; IEA:UniProtKB-KW
Q9BZL1	UBL5	Ubiquitin-like protein 5	GO:0005515; F:protein binding; IPI:IntAct
Q9NPG3	UBN1	Ubinuclein-1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NPG3	UBN1	Ubinuclein-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NPG3	UBN1	Ubinuclein-1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9NPG3	UBN1	Ubinuclein-1	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q9NPG3	UBN1	Ubinuclein-1	GO:0006336; P:DNA replication-independent nucleosome assembly; IDA:UniProt
Q9NPG3	UBN1	Ubinuclein-1	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q9NPG3	UBN1	Ubinuclein-1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9NPG3	UBN1	Ubinuclein-1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q14694	USP10	Ubiquitin carboxyl-terminal hydrolase 10	GO:0004197; F:cysteine-type endopeptidase activity; IMP:UniProtKB
Q14694	USP10	Ubiquitin carboxyl-terminal hydrolase 10	GO:0044325; F:ion channel binding; IDA:UniProtKB
Q14694	USP10	Ubiquitin carboxyl-terminal hydrolase 10	GO:0002039; F:p53 binding; IPI:UniProtKB
Q14694	USP10	Ubiquitin carboxyl-terminal hydrolase 10	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14694	USP10	Ubiquitin carboxyl-terminal hydrolase 10	GO:0005515; F:protein binding; IPI:UniProtKB
Q14694	USP10	Ubiquitin carboxyl-terminal hydrolase 10	GO:0004221; F:ubiquitin thiolesterase activity; IDA:UniProtKB
Q14694	USP10	Ubiquitin carboxyl-terminal hydrolase 10	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q14694	USP10	Ubiquitin carboxyl-terminal hydrolase 10	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q14694	USP10	Ubiquitin carboxyl-terminal hydrolase 10	GO:0030330; P:DNA damage response, signal transduction by p53 class mediator; IMP:UniProtKB
Q14694	USP10	Ubiquitin carboxyl-terminal hydrolase 10	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q14694	USP10	Ubiquitin carboxyl-terminal hydrolase 10	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
Q14694	USP10	Ubiquitin carboxyl-terminal hydrolase 10	GO:0010506; P:regulation of autophagy; IDA:UniProtKB
Q14694	USP10	Ubiquitin carboxyl-terminal hydrolase 10	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
P51784	USP11	Ubiquitin carboxyl-terminal hydrolase 11	GO:0004197; F:cysteine-type endopeptidase activity; TAS:ProtInc
P51784	USP11	Ubiquitin carboxyl-terminal hydrolase 11	GO:0005515; F:protein binding; IPI:UniProtKB
P51784	USP11	Ubiquitin carboxyl-terminal hydrolase 11	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
P51784	USP11	Ubiquitin carboxyl-terminal hydrolase 11	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
P51784	USP11	Ubiquitin carboxyl-terminal hydrolase 11	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
O75317	USP12	Ubiquitin carboxyl-terminal hydrolase 12	GO:0004197; F:cysteine-type endopeptidase activity; IMP:UniProtKB
O75317	USP12	Ubiquitin carboxyl-terminal hydrolase 12	GO:0005515; F:protein binding; IPI:UniProtKB
O75317	USP12	Ubiquitin carboxyl-terminal hydrolase 12	GO:0004221; F:ubiquitin thiolesterase activity; IDA:UniProtKB
O75317	USP12	Ubiquitin carboxyl-terminal hydrolase 12	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
O75317	USP12	Ubiquitin carboxyl-terminal hydrolase 12	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
O75317	USP12	Ubiquitin carboxyl-terminal hydrolase 12	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q92995	USP13	Ubiquitin carboxyl-terminal hydrolase 13	GO:0004197; F:cysteine-type endopeptidase activity; IMP:UniProtKB
Q92995	USP13	Ubiquitin carboxyl-terminal hydrolase 13	GO:0008242; F:omega peptidase activity; IEA:InterPro
Q92995	USP13	Ubiquitin carboxyl-terminal hydrolase 13	GO:0005515; F:protein binding; IPI:UniProtKB
Q92995	USP13	Ubiquitin carboxyl-terminal hydrolase 13	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
Q92995	USP13	Ubiquitin carboxyl-terminal hydrolase 13	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q92995	USP13	Ubiquitin carboxyl-terminal hydrolase 13	GO:0004221; F:ubiquitin thiolesterase activity; IDA:UniProtKB
Q92995	USP13	Ubiquitin carboxyl-terminal hydrolase 13	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q92995	USP13	Ubiquitin carboxyl-terminal hydrolase 13	GO:0008270; F:zinc ion binding; IEA:InterPro
Q92995	USP13	Ubiquitin carboxyl-terminal hydrolase 13	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q92995	USP13	Ubiquitin carboxyl-terminal hydrolase 13	GO:0008283; P:cell proliferation; IMP:UniProtKB
Q92995	USP13	Ubiquitin carboxyl-terminal hydrolase 13	GO:0030318; P:melanocyte differentiation; TAS:UniProtKB
Q92995	USP13	Ubiquitin carboxyl-terminal hydrolase 13	GO:0070536; P:protein K63-linked deubiquitination; IDA:UniProtKB
Q92995	USP13	Ubiquitin carboxyl-terminal hydrolase 13	GO:0050821; P:protein stabilization; IDA:UniProtKB
Q92995	USP13	Ubiquitin carboxyl-terminal hydrolase 13	GO:0010506; P:regulation of autophagy; IDA:UniProtKB
Q92995	USP13	Ubiquitin carboxyl-terminal hydrolase 13	GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB
Q92995	USP13	Ubiquitin carboxyl-terminal hydrolase 13	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
P54578	USP14	Ubiquitin carboxyl-terminal hydrolase 14	GO:0004197; F:cysteine-type endopeptidase activity; TAS:ProtInc
P54578	USP14	Ubiquitin carboxyl-terminal hydrolase 14	GO:0004866; F:endopeptidase inhibitor activity; IMP:UniProtKB
P54578	USP14	Ubiquitin carboxyl-terminal hydrolase 14	GO:0070628; F:proteasome binding; IDA:UniProtKB
P54578	USP14	Ubiquitin carboxyl-terminal hydrolase 14	GO:0005515; F:protein binding; IPI:UniProtKB
P54578	USP14	Ubiquitin carboxyl-terminal hydrolase 14	GO:0008193; F:tRNA guanylyltransferase activity; TAS:ProtInc
P54578	USP14	Ubiquitin carboxyl-terminal hydrolase 14	GO:0004221; F:ubiquitin thiolesterase activity; IDA:UniProtKB
P54578	USP14	Ubiquitin carboxyl-terminal hydrolase 14	GO:0004843; F:ubiquitin-specific protease activity; IDA:FlyBase
P54578	USP14	Ubiquitin carboxyl-terminal hydrolase 14	GO:0010951; P:negative regulation of endopeptidase activity; IMP:GOC
P54578	USP14	Ubiquitin carboxyl-terminal hydrolase 14	GO:0016579; P:protein deubiquitination; IDA:FlyBase
P54578	USP14	Ubiquitin carboxyl-terminal hydrolase 14	GO:0050920; P:regulation of chemotaxis; IMP:UniProtKB
P54578	USP14	Ubiquitin carboxyl-terminal hydrolase 14	GO:0061136; P:regulation of proteasomal protein catabolic process; IMP:UniProtKB
P54578	USP14	Ubiquitin carboxyl-terminal hydrolase 14	GO:0007268; P:synaptic transmission; IEA:Ensembl
P54578	USP14	Ubiquitin carboxyl-terminal hydrolase 14	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q9Y4E8	USP15	Ubiquitin carboxyl-terminal hydrolase 15	GO:0004197; F:cysteine-type endopeptidase activity; IMP:UniProtKB
Q9Y4E8	USP15	Ubiquitin carboxyl-terminal hydrolase 15	GO:0042802; F:identical protein binding; IPI:IntAct
Q9Y4E8	USP15	Ubiquitin carboxyl-terminal hydrolase 15	GO:0046332; F:SMAD binding; IPI:UniProtKB
Q9Y4E8	USP15	Ubiquitin carboxyl-terminal hydrolase 15	GO:0005160; F:transforming growth factor beta receptor binding; IPI:UniProtKB
Q9Y4E8	USP15	Ubiquitin carboxyl-terminal hydrolase 15	GO:0004221; F:ubiquitin thiolesterase activity; IDA:UniProtKB
Q9Y4E8	USP15	Ubiquitin carboxyl-terminal hydrolase 15	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q9Y4E8	USP15	Ubiquitin carboxyl-terminal hydrolase 15	GO:0030509; P:BMP signaling pathway; IDA:UniProtKB
Q9Y4E8	USP15	Ubiquitin carboxyl-terminal hydrolase 15	GO:0035520; P:monoubiquitinated protein deubiquitination; IDA:UniProtKB
Q9Y4E8	USP15	Ubiquitin carboxyl-terminal hydrolase 15	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q9Y4E8	USP15	Ubiquitin carboxyl-terminal hydrolase 15	GO:0060389; P:pathway-restricted SMAD protein phosphorylation; IMP:UniProtKB
Q9Y4E8	USP15	Ubiquitin carboxyl-terminal hydrolase 15	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
Q9Y4E8	USP15	Ubiquitin carboxyl-terminal hydrolase 15	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
Q9Y4E8	USP15	Ubiquitin carboxyl-terminal hydrolase 15	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q9Y5T5	USP16	Ubiquitin carboxyl-terminal hydrolase 16	GO:0004197; F:cysteine-type endopeptidase activity; IMP:UniProtKB
Q9Y5T5	USP16	Ubiquitin carboxyl-terminal hydrolase 16	GO:0042393; F:histone binding; IDA:UniProtKB
Q9Y5T5	USP16	Ubiquitin carboxyl-terminal hydrolase 16	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q9Y5T5	USP16	Ubiquitin carboxyl-terminal hydrolase 16	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
Q9Y5T5	USP16	Ubiquitin carboxyl-terminal hydrolase 16	GO:0004221; F:ubiquitin thiolesterase activity; IDA:UniProtKB
Q9Y5T5	USP16	Ubiquitin carboxyl-terminal hydrolase 16	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q9Y5T5	USP16	Ubiquitin carboxyl-terminal hydrolase 16	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q9Y5T5	USP16	Ubiquitin carboxyl-terminal hydrolase 16	GO:0007049; P:cell cycle; TAS:ProtInc
Q9Y5T5	USP16	Ubiquitin carboxyl-terminal hydrolase 16	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q9Y5T5	USP16	Ubiquitin carboxyl-terminal hydrolase 16	GO:0016578; P:histone deubiquitination; IDA:UniProtKB
Q9Y5T5	USP16	Ubiquitin carboxyl-terminal hydrolase 16	GO:0070537; P:histone H2A K63-linked deubiquitination; IMP:UniProtKB
Q9Y5T5	USP16	Ubiquitin carboxyl-terminal hydrolase 16	GO:0007067; P:mitosis; IDA:UniProtKB
Q9Y5T5	USP16	Ubiquitin carboxyl-terminal hydrolase 16	GO:0035522; P:monoubiquitinated histone H2A deubiquitination; ISS:UniProtKB
Q9Y5T5	USP16	Ubiquitin carboxyl-terminal hydrolase 16	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q9Y5T5	USP16	Ubiquitin carboxyl-terminal hydrolase 16	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q9Y5T5	USP16	Ubiquitin carboxyl-terminal hydrolase 16	GO:0045901; P:positive regulation of translational elongation; IMP:UniProtKB
Q9Y5T5	USP16	Ubiquitin carboxyl-terminal hydrolase 16	GO:0051289; P:protein homotetramerization; IPI:UniProtKB
Q9Y5T5	USP16	Ubiquitin carboxyl-terminal hydrolase 16	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q9Y5T5	USP16	Ubiquitin carboxyl-terminal hydrolase 16	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y5T5	USP16	Ubiquitin carboxyl-terminal hydrolase 16	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
O94966	USP19	Ubiquitin carboxyl-terminal hydrolase 19	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O94966	USP19	Ubiquitin carboxyl-terminal hydrolase 19	GO:0005515; F:protein binding; IPI:UniProtKB
O94966	USP19	Ubiquitin carboxyl-terminal hydrolase 19	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
O94966	USP19	Ubiquitin carboxyl-terminal hydrolase 19	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IDA:UniProtKB
O94966	USP19	Ubiquitin carboxyl-terminal hydrolase 19	GO:0048642; P:negative regulation of skeletal muscle tissue development; ISS:UniProtKB
O94966	USP19	Ubiquitin carboxyl-terminal hydrolase 19	GO:0090068; P:positive regulation of cell cycle process; ISS:UniProtKB
O94966	USP19	Ubiquitin carboxyl-terminal hydrolase 19	GO:0016579; P:protein deubiquitination; ISS:UniProtKB
O94966	USP19	Ubiquitin carboxyl-terminal hydrolase 19	GO:1900037; P:regulation of cellular response to hypoxia; IMP:UniProtKB
O94966	USP19	Ubiquitin carboxyl-terminal hydrolase 19	GO:0031647; P:regulation of protein stability; ISS:UniProtKB
O94966	USP19	Ubiquitin carboxyl-terminal hydrolase 19	GO:0034976; P:response to endoplasmic reticulum stress; IEP:UniProtKB
O94966	USP19	Ubiquitin carboxyl-terminal hydrolase 19	GO:0014732; P:skeletal muscle atrophy; ISS:UniProtKB
Q9UMW8	USP18	Ubl carboxyl-terminal hydrolase 18	GO:0005515; F:protein binding; IPI:IntAct
Q9UMW8	USP18	Ubl carboxyl-terminal hydrolase 18	GO:0004843; F:ubiquitin-specific protease activity; TAS:ProtInc
Q9UMW8	USP18	Ubl carboxyl-terminal hydrolase 18	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q9UMW8	USP18	Ubl carboxyl-terminal hydrolase 18	GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome
Q9UMW8	USP18	Ubl carboxyl-terminal hydrolase 18	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q9UMW8	USP18	Ubl carboxyl-terminal hydrolase 18	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
O94782	USP1	Ubiquitin carboxyl-terminal hydrolase 1	GO:0004197; F:cysteine-type endopeptidase activity; TAS:ProtInc
O94782	USP1	Ubiquitin carboxyl-terminal hydrolase 1	GO:0005515; F:protein binding; IPI:UniProtKB
O94782	USP1	Ubiquitin carboxyl-terminal hydrolase 1	GO:0004221; F:ubiquitin thiolesterase activity; IDA:UniProtKB
O94782	USP1	Ubiquitin carboxyl-terminal hydrolase 1	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
O94782	USP1	Ubiquitin carboxyl-terminal hydrolase 1	GO:0006281; P:DNA repair; TAS:Reactome
O94782	USP1	Ubiquitin carboxyl-terminal hydrolase 1	GO:0035520; P:monoubiquitinated protein deubiquitination; IMP:UniProtKB
O94782	USP1	Ubiquitin carboxyl-terminal hydrolase 1	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
O94782	USP1	Ubiquitin carboxyl-terminal hydrolase 1	GO:0006282; P:regulation of DNA repair; IDA:UniProtKB
O94782	USP1	Ubiquitin carboxyl-terminal hydrolase 1	GO:0009411; P:response to UV; IDA:UniProtKB
O94782	USP1	Ubiquitin carboxyl-terminal hydrolase 1	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q9Y2K6	USP20	Ubiquitin carboxyl-terminal hydrolase 20	GO:0004197; F:cysteine-type endopeptidase activity; IMP:UniProtKB
Q9Y2K6	USP20	Ubiquitin carboxyl-terminal hydrolase 20	GO:0001664; F:G-protein coupled receptor binding; IPI:UniProtKB
Q9Y2K6	USP20	Ubiquitin carboxyl-terminal hydrolase 20	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y2K6	USP20	Ubiquitin carboxyl-terminal hydrolase 20	GO:0004221; F:ubiquitin thiolesterase activity; IDA:UniProtKB
Q9Y2K6	USP20	Ubiquitin carboxyl-terminal hydrolase 20	GO:0004843; F:ubiquitin-specific protease activity; IEA:InterPro
Q9Y2K6	USP20	Ubiquitin carboxyl-terminal hydrolase 20	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y2K6	USP20	Ubiquitin carboxyl-terminal hydrolase 20	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q9Y2K6	USP20	Ubiquitin carboxyl-terminal hydrolase 20	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
Q9Y2K6	USP20	Ubiquitin carboxyl-terminal hydrolase 20	GO:0071108; P:protein K48-linked deubiquitination; IDA:UniProtKB
Q9Y2K6	USP20	Ubiquitin carboxyl-terminal hydrolase 20	GO:0070536; P:protein K63-linked deubiquitination; IDA:UniProtKB
Q9Y2K6	USP20	Ubiquitin carboxyl-terminal hydrolase 20	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; IMP:UniProtKB
Q9Y2K6	USP20	Ubiquitin carboxyl-terminal hydrolase 20	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q9UK80	USP21	Ubiquitin carboxyl-terminal hydrolase 21	GO:0008234; F:cysteine-type peptidase activity; IMP:UniProtKB
Q9UK80	USP21	Ubiquitin carboxyl-terminal hydrolase 21	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UK80	USP21	Ubiquitin carboxyl-terminal hydrolase 21	GO:0019784; F:NEDD8-specific protease activity; IDA:UniProtKB
Q9UK80	USP21	Ubiquitin carboxyl-terminal hydrolase 21	GO:0003713; F:transcription coactivator activity; ISS:UniProtKB
Q9UK80	USP21	Ubiquitin carboxyl-terminal hydrolase 21	GO:0004221; F:ubiquitin thiolesterase activity; IDA:UniProtKB
Q9UK80	USP21	Ubiquitin carboxyl-terminal hydrolase 21	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q9UK80	USP21	Ubiquitin carboxyl-terminal hydrolase 21	GO:0016578; P:histone deubiquitination; ISS:UniProtKB
Q9UK80	USP21	Ubiquitin carboxyl-terminal hydrolase 21	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q9UK80	USP21	Ubiquitin carboxyl-terminal hydrolase 21	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UK80	USP21	Ubiquitin carboxyl-terminal hydrolase 21	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q9UPT9	USP22	Ubiquitin carboxyl-terminal hydrolase 22	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IMP:UniProtKB
Q9UPT9	USP22	Ubiquitin carboxyl-terminal hydrolase 22	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UPT9	USP22	Ubiquitin carboxyl-terminal hydrolase 22	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q9UPT9	USP22	Ubiquitin carboxyl-terminal hydrolase 22	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q9UPT9	USP22	Ubiquitin carboxyl-terminal hydrolase 22	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UPT9	USP22	Ubiquitin carboxyl-terminal hydrolase 22	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9UPT9	USP22	Ubiquitin carboxyl-terminal hydrolase 22	GO:0006325; P:chromatin organization; TAS:Reactome
Q9UPT9	USP22	Ubiquitin carboxyl-terminal hydrolase 22	GO:0009790; P:embryo development; NAS:UniProtKB
Q9UPT9	USP22	Ubiquitin carboxyl-terminal hydrolase 22	GO:0016578; P:histone deubiquitination; IDA:UniProtKB
Q9UPT9	USP22	Ubiquitin carboxyl-terminal hydrolase 22	GO:0043967; P:histone H4 acetylation; IDA:GOC
Q9UPT9	USP22	Ubiquitin carboxyl-terminal hydrolase 22	GO:0016574; P:histone ubiquitination; IDA:UniProtKB
Q9UPT9	USP22	Ubiquitin carboxyl-terminal hydrolase 22	GO:0045931; P:positive regulation of mitotic cell cycle; IMP:UniProtKB
Q9UPT9	USP22	Ubiquitin carboxyl-terminal hydrolase 22	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q9UPT9	USP22	Ubiquitin carboxyl-terminal hydrolase 22	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
Q9UPT9	USP22	Ubiquitin carboxyl-terminal hydrolase 22	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UPT9	USP22	Ubiquitin carboxyl-terminal hydrolase 22	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q9UPU5	USP24	Ubiquitin carboxyl-terminal hydrolase 24	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
Q9UPU5	USP24	Ubiquitin carboxyl-terminal hydrolase 24	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q9BXU7	USP26	Ubiquitin carboxyl-terminal hydrolase 26	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
Q9BXU7	USP26	Ubiquitin carboxyl-terminal hydrolase 26	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BXU7	USP26	Ubiquitin carboxyl-terminal hydrolase 26	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
Q9BXU7	USP26	Ubiquitin carboxyl-terminal hydrolase 26	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q9UHP3	USP25	Ubiquitin carboxyl-terminal hydrolase 25	GO:0008233; F:peptidase activity; TAS:ProtInc
Q9UHP3	USP25	Ubiquitin carboxyl-terminal hydrolase 25	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UHP3	USP25	Ubiquitin carboxyl-terminal hydrolase 25	GO:0032183; F:SUMO binding; IDA:UniProtKB
Q9UHP3	USP25	Ubiquitin carboxyl-terminal hydrolase 25	GO:0004843; F:ubiquitin-specific protease activity; IMP:UniProtKB
Q9UHP3	USP25	Ubiquitin carboxyl-terminal hydrolase 25	GO:0006464; P:cellular protein modification process; TAS:ProtInc
Q9UHP3	USP25	Ubiquitin carboxyl-terminal hydrolase 25	GO:0071108; P:protein K48-linked deubiquitination; IMP:UniProtKB
Q9UHP3	USP25	Ubiquitin carboxyl-terminal hydrolase 25	GO:0070536; P:protein K63-linked deubiquitination; IMP:UniProtKB
Q9UHP3	USP25	Ubiquitin carboxyl-terminal hydrolase 25	GO:0006508; P:proteolysis; TAS:ProtInc
Q9UHP3	USP25	Ubiquitin carboxyl-terminal hydrolase 25	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
A6NNY8	USP27X	Ubiquitin carboxyl-terminal hydrolase 27	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
A6NNY8	USP27X	Ubiquitin carboxyl-terminal hydrolase 27	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q96RU2	USP28	Ubiquitin carboxyl-terminal hydrolase 28	GO:0005515; F:protein binding; IPI:UniProtKB
Q96RU2	USP28	Ubiquitin carboxyl-terminal hydrolase 28	GO:0004221; F:ubiquitin thiolesterase activity; IMP:UniProtKB
Q96RU2	USP28	Ubiquitin carboxyl-terminal hydrolase 28	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q96RU2	USP28	Ubiquitin carboxyl-terminal hydrolase 28	GO:0008283; P:cell proliferation; IMP:UniProtKB
Q96RU2	USP28	Ubiquitin carboxyl-terminal hydrolase 28	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q96RU2	USP28	Ubiquitin carboxyl-terminal hydrolase 28	GO:0034644; P:cellular response to UV; IDA:UniProtKB
Q96RU2	USP28	Ubiquitin carboxyl-terminal hydrolase 28	GO:0000077; P:DNA damage checkpoint; IMP:UniProtKB
Q96RU2	USP28	Ubiquitin carboxyl-terminal hydrolase 28	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q96RU2	USP28	Ubiquitin carboxyl-terminal hydrolase 28	GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IDA:UniProtKB
Q96RU2	USP28	Ubiquitin carboxyl-terminal hydrolase 28	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
Q96RU2	USP28	Ubiquitin carboxyl-terminal hydrolase 28	GO:0010212; P:response to ionizing radiation; IDA:UniProtKB
Q96RU2	USP28	Ubiquitin carboxyl-terminal hydrolase 28	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q14157	UBAP2L	Ubiquitin-associated protein 2-like	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14157	UBAP2L	Ubiquitin-associated protein 2-like	GO:0005515; F:protein binding; IPI:UniProtKB
Q14157	UBAP2L	Ubiquitin-associated protein 2-like	GO:0007339; P:binding of sperm to zona pellucida; IMP:UniProtKB
Q9HBJ7	USP29	Ubiquitin carboxyl-terminal hydrolase 29	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
Q9HBJ7	USP29	Ubiquitin carboxyl-terminal hydrolase 29	GO:0004221; F:ubiquitin thiolesterase activity; TAS:UniProtKB
Q9HBJ7	USP29	Ubiquitin carboxyl-terminal hydrolase 29	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
O75604	USP2	Ubiquitin carboxyl-terminal hydrolase 2	GO:0030332; F:cyclin binding; IPI:UniProtKB
O75604	USP2	Ubiquitin carboxyl-terminal hydrolase 2	GO:0004197; F:cysteine-type endopeptidase activity; TAS:ProtInc
O75604	USP2	Ubiquitin carboxyl-terminal hydrolase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75604	USP2	Ubiquitin carboxyl-terminal hydrolase 2	GO:0005515; F:protein binding; IPI:UniProtKB
O75604	USP2	Ubiquitin carboxyl-terminal hydrolase 2	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
O75604	USP2	Ubiquitin carboxyl-terminal hydrolase 2	GO:0004221; F:ubiquitin thiolesterase activity; IDA:UniProtKB
O75604	USP2	Ubiquitin carboxyl-terminal hydrolase 2	GO:0004843; F:ubiquitin-specific protease activity; IDA:FlyBase
O75604	USP2	Ubiquitin carboxyl-terminal hydrolase 2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
O75604	USP2	Ubiquitin carboxyl-terminal hydrolase 2	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
O75604	USP2	Ubiquitin carboxyl-terminal hydrolase 2	GO:0048642; P:negative regulation of skeletal muscle tissue development; IEA:Ensembl
O75604	USP2	Ubiquitin carboxyl-terminal hydrolase 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
O75604	USP2	Ubiquitin carboxyl-terminal hydrolase 2	GO:0045931; P:positive regulation of mitotic cell cycle; IMP:UniProtKB
O75604	USP2	Ubiquitin carboxyl-terminal hydrolase 2	GO:0048643; P:positive regulation of skeletal muscle tissue development; IEA:Ensembl
O75604	USP2	Ubiquitin carboxyl-terminal hydrolase 2	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
O75604	USP2	Ubiquitin carboxyl-terminal hydrolase 2	GO:0050821; P:protein stabilization; IDA:UniProtKB
O75604	USP2	Ubiquitin carboxyl-terminal hydrolase 2	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q70CQ3	USP30	Ubiquitin carboxyl-terminal hydrolase 30	GO:0004843; F:ubiquitin-specific protease activity; IDA:FlyBase
Q70CQ3	USP30	Ubiquitin carboxyl-terminal hydrolase 30	GO:0016579; P:protein deubiquitination; IDA:FlyBase
Q70CQ3	USP30	Ubiquitin carboxyl-terminal hydrolase 30	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q70CQ4	USP31	Ubiquitin carboxyl-terminal hydrolase 31	GO:0004843; F:ubiquitin-specific protease activity; IDA:FlyBase
Q70CQ4	USP31	Ubiquitin carboxyl-terminal hydrolase 31	GO:0016579; P:protein deubiquitination; IDA:FlyBase
Q70CQ4	USP31	Ubiquitin carboxyl-terminal hydrolase 31	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q8NFA0	USP32	Ubiquitin carboxyl-terminal hydrolase 32	GO:0005509; F:calcium ion binding; IEA:InterPro
Q8NFA0	USP32	Ubiquitin carboxyl-terminal hydrolase 32	GO:0004221; F:ubiquitin thiolesterase activity; IDA:UniProtKB
Q8NFA0	USP32	Ubiquitin carboxyl-terminal hydrolase 32	GO:0004843; F:ubiquitin-specific protease activity; IEA:InterPro
Q8NFA0	USP32	Ubiquitin carboxyl-terminal hydrolase 32	GO:0016579; P:protein deubiquitination; TAS:UniProtKB
Q8NFA0	USP32	Ubiquitin carboxyl-terminal hydrolase 32	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q8TEY7	USP33	Ubiquitin carboxyl-terminal hydrolase 33	GO:0004197; F:cysteine-type endopeptidase activity; IMP:UniProtKB
Q8TEY7	USP33	Ubiquitin carboxyl-terminal hydrolase 33	GO:0001664; F:G-protein coupled receptor binding; IPI:UniProtKB
Q8TEY7	USP33	Ubiquitin carboxyl-terminal hydrolase 33	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TEY7	USP33	Ubiquitin carboxyl-terminal hydrolase 33	GO:0004221; F:ubiquitin thiolesterase activity; IDA:UniProtKB
Q8TEY7	USP33	Ubiquitin carboxyl-terminal hydrolase 33	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q8TEY7	USP33	Ubiquitin carboxyl-terminal hydrolase 33	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q8TEY7	USP33	Ubiquitin carboxyl-terminal hydrolase 33	GO:0007411; P:axon guidance; ISS:UniProtKB
Q8TEY7	USP33	Ubiquitin carboxyl-terminal hydrolase 33	GO:0016477; P:cell migration; ISS:UniProtKB
Q8TEY7	USP33	Ubiquitin carboxyl-terminal hydrolase 33	GO:0051298; P:centrosome duplication; IMP:UniProtKB
Q8TEY7	USP33	Ubiquitin carboxyl-terminal hydrolase 33	GO:0006897; P:endocytosis; IEA:UniProtKB-KW
Q8TEY7	USP33	Ubiquitin carboxyl-terminal hydrolase 33	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
Q8TEY7	USP33	Ubiquitin carboxyl-terminal hydrolase 33	GO:0071108; P:protein K48-linked deubiquitination; IDA:UniProtKB
Q8TEY7	USP33	Ubiquitin carboxyl-terminal hydrolase 33	GO:0070536; P:protein K63-linked deubiquitination; IDA:UniProtKB
Q8TEY7	USP33	Ubiquitin carboxyl-terminal hydrolase 33	GO:0008277; P:regulation of G-protein coupled receptor protein signaling pathway; IMP:UniProtKB
Q8TEY7	USP33	Ubiquitin carboxyl-terminal hydrolase 33	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:UniProtKB
Q70CQ2	USP34	Ubiquitin carboxyl-terminal hydrolase 34	GO:0004197; F:cysteine-type endopeptidase activity; IMP:UniProtKB
Q70CQ2	USP34	Ubiquitin carboxyl-terminal hydrolase 34	GO:0005515; F:protein binding; IPI:UniProtKB
Q70CQ2	USP34	Ubiquitin carboxyl-terminal hydrolase 34	GO:0004221; F:ubiquitin thiolesterase activity; IDA:UniProtKB
Q70CQ2	USP34	Ubiquitin carboxyl-terminal hydrolase 34	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q70CQ2	USP34	Ubiquitin carboxyl-terminal hydrolase 34	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:UniProtKB
Q70CQ2	USP34	Ubiquitin carboxyl-terminal hydrolase 34	GO:0016579; P:protein deubiquitination; IDA:FlyBase
Q70CQ2	USP34	Ubiquitin carboxyl-terminal hydrolase 34	GO:0071108; P:protein K48-linked deubiquitination; IDA:UniProtKB
Q70CQ2	USP34	Ubiquitin carboxyl-terminal hydrolase 34	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q70CQ2	USP34	Ubiquitin carboxyl-terminal hydrolase 34	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9P2H5	USP35	Ubiquitin carboxyl-terminal hydrolase 35	GO:0004843; F:ubiquitin-specific protease activity; IDA:FlyBase
Q9P2H5	USP35	Ubiquitin carboxyl-terminal hydrolase 35	GO:0016579; P:protein deubiquitination; IDA:FlyBase
Q9P2H5	USP35	Ubiquitin carboxyl-terminal hydrolase 35	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q9P275	USP36	Ubiquitin carboxyl-terminal hydrolase 36	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9P275	USP36	Ubiquitin carboxyl-terminal hydrolase 36	GO:0004843; F:ubiquitin-specific protease activity; IDA:FlyBase
Q9P275	USP36	Ubiquitin carboxyl-terminal hydrolase 36	GO:0016579; P:protein deubiquitination; IDA:FlyBase
Q9P275	USP36	Ubiquitin carboxyl-terminal hydrolase 36	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q86T82	USP37	Ubiquitin carboxyl-terminal hydrolase 37	GO:0004197; F:cysteine-type endopeptidase activity; IDA:UniProtKB
Q86T82	USP37	Ubiquitin carboxyl-terminal hydrolase 37	GO:0005515; F:protein binding; IPI:UniProtKB
Q86T82	USP37	Ubiquitin carboxyl-terminal hydrolase 37	GO:0019901; F:protein kinase binding; IPI:UniProtKB
Q86T82	USP37	Ubiquitin carboxyl-terminal hydrolase 37	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q86T82	USP37	Ubiquitin carboxyl-terminal hydrolase 37	GO:0000082; P:G1/S transition of mitotic cell cycle; IDA:UniProtKB
Q86T82	USP37	Ubiquitin carboxyl-terminal hydrolase 37	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q86T82	USP37	Ubiquitin carboxyl-terminal hydrolase 37	GO:0016579; P:protein deubiquitination; IDA:FlyBase
Q86T82	USP37	Ubiquitin carboxyl-terminal hydrolase 37	GO:0035871; P:protein K11-linked deubiquitination; IDA:UniProtKB
Q86T82	USP37	Ubiquitin carboxyl-terminal hydrolase 37	GO:0071108; P:protein K48-linked deubiquitination; IDA:UniProtKB
Q86T82	USP37	Ubiquitin carboxyl-terminal hydrolase 37	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q9Y6I4	USP3	Ubiquitin carboxyl-terminal hydrolase 3	GO:0042393; F:histone binding; IPI:UniProtKB
Q9Y6I4	USP3	Ubiquitin carboxyl-terminal hydrolase 3	GO:0004221; F:ubiquitin thiolesterase activity; IMP:UniProtKB
Q9Y6I4	USP3	Ubiquitin carboxyl-terminal hydrolase 3	GO:0004843; F:ubiquitin-specific protease activity; TAS:ProtInc
Q9Y6I4	USP3	Ubiquitin carboxyl-terminal hydrolase 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y6I4	USP3	Ubiquitin carboxyl-terminal hydrolase 3	GO:0006281; P:DNA repair; IMP:UniProtKB
Q9Y6I4	USP3	Ubiquitin carboxyl-terminal hydrolase 3	GO:0016578; P:histone deubiquitination; IDA:UniProtKB
Q9Y6I4	USP3	Ubiquitin carboxyl-terminal hydrolase 3	GO:0000278; P:mitotic cell cycle; IMP:UniProtKB
Q9Y6I4	USP3	Ubiquitin carboxyl-terminal hydrolase 3	GO:0031647; P:regulation of protein stability; IDA:UniProtKB
Q9Y6I4	USP3	Ubiquitin carboxyl-terminal hydrolase 3	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q9NVE5	USP40	Ubiquitin carboxyl-terminal hydrolase 40	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
Q9NVE5	USP40	Ubiquitin carboxyl-terminal hydrolase 40	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q9H9J4	USP42	Ubiquitin carboxyl-terminal hydrolase 42	GO:0005515; F:protein binding; IPI:IntAct
Q9H9J4	USP42	Ubiquitin carboxyl-terminal hydrolase 42	GO:0004843; F:ubiquitin-specific protease activity; IDA:FlyBase
Q9H9J4	USP42	Ubiquitin carboxyl-terminal hydrolase 42	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9H9J4	USP42	Ubiquitin carboxyl-terminal hydrolase 42	GO:0016579; P:protein deubiquitination; ISS:UniProtKB
Q9H9J4	USP42	Ubiquitin carboxyl-terminal hydrolase 42	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q9H9J4	USP42	Ubiquitin carboxyl-terminal hydrolase 42	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q3LFD5	USP41	Putative ubiquitin carboxyl-terminal hydrolase 41	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
Q3LFD5	USP41	Putative ubiquitin carboxyl-terminal hydrolase 41	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q8NB14	USP38	Ubiquitin carboxyl-terminal hydrolase 38	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
Q8NB14	USP38	Ubiquitin carboxyl-terminal hydrolase 38	GO:0004843; F:ubiquitin-specific protease activity; IDA:FlyBase
Q8NB14	USP38	Ubiquitin carboxyl-terminal hydrolase 38	GO:0016579; P:protein deubiquitination; IDA:FlyBase
Q8NB14	USP38	Ubiquitin carboxyl-terminal hydrolase 38	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q70EL4	USP43	Ubiquitin carboxyl-terminal hydrolase 43	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
Q70EL4	USP43	Ubiquitin carboxyl-terminal hydrolase 43	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q9H0E7	USP44	Ubiquitin carboxyl-terminal hydrolase 44	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H0E7	USP44	Ubiquitin carboxyl-terminal hydrolase 44	GO:0004221; F:ubiquitin thiolesterase activity; IMP:UniProtKB
Q9H0E7	USP44	Ubiquitin carboxyl-terminal hydrolase 44	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q9H0E7	USP44	Ubiquitin carboxyl-terminal hydrolase 44	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H0E7	USP44	Ubiquitin carboxyl-terminal hydrolase 44	GO:0051322; P:anaphase; IMP:UniProtKB
Q9H0E7	USP44	Ubiquitin carboxyl-terminal hydrolase 44	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9H0E7	USP44	Ubiquitin carboxyl-terminal hydrolase 44	GO:0060564; P:negative regulation of mitotic anaphase-promoting complex activity; IMP:UniProtKB
Q9H0E7	USP44	Ubiquitin carboxyl-terminal hydrolase 44	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB
Q9H0E7	USP44	Ubiquitin carboxyl-terminal hydrolase 44	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
Q9H0E7	USP44	Ubiquitin carboxyl-terminal hydrolase 44	GO:0090266; P:regulation of mitotic cell cycle spindle assembly checkpoint; ISS:UniProtKB
Q9H0E7	USP44	Ubiquitin carboxyl-terminal hydrolase 44	GO:0090231; P:regulation of spindle checkpoint; IMP:UniProtKB
Q70EL2	USP45	Ubiquitin carboxyl-terminal hydrolase 45	GO:0004843; F:ubiquitin-specific protease activity; IDA:FlyBase
Q70EL2	USP45	Ubiquitin carboxyl-terminal hydrolase 45	GO:0008270; F:zinc ion binding; IEA:InterPro
Q70EL2	USP45	Ubiquitin carboxyl-terminal hydrolase 45	GO:0016579; P:protein deubiquitination; IDA:FlyBase
Q70EL2	USP45	Ubiquitin carboxyl-terminal hydrolase 45	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q96K76	USP47	Ubiquitin carboxyl-terminal hydrolase 47	GO:0005515; F:protein binding; IPI:UniProtKB
Q96K76	USP47	Ubiquitin carboxyl-terminal hydrolase 47	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q96K76	USP47	Ubiquitin carboxyl-terminal hydrolase 47	GO:0071987; F:WD40-repeat domain binding; IPI:UniProtKB
Q96K76	USP47	Ubiquitin carboxyl-terminal hydrolase 47	GO:0006284; P:base-excision repair; IMP:UniProtKB
Q96K76	USP47	Ubiquitin carboxyl-terminal hydrolase 47	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
Q96K76	USP47	Ubiquitin carboxyl-terminal hydrolase 47	GO:0034644; P:cellular response to UV; ISS:UniProtKB
Q96K76	USP47	Ubiquitin carboxyl-terminal hydrolase 47	GO:0035520; P:monoubiquitinated protein deubiquitination; IDA:UniProtKB
Q96K76	USP47	Ubiquitin carboxyl-terminal hydrolase 47	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q96K76	USP47	Ubiquitin carboxyl-terminal hydrolase 47	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB
Q96K76	USP47	Ubiquitin carboxyl-terminal hydrolase 47	GO:0010972; P:negative regulation of G2/M transition of mitotic cell cycle; IMP:UniProtKB
Q96K76	USP47	Ubiquitin carboxyl-terminal hydrolase 47	GO:1902230; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
Q96K76	USP47	Ubiquitin carboxyl-terminal hydrolase 47	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q96K76	USP47	Ubiquitin carboxyl-terminal hydrolase 47	GO:0030307; P:positive regulation of cell growth; IMP:UniProtKB
Q96K76	USP47	Ubiquitin carboxyl-terminal hydrolase 47	GO:0042493; P:response to drug; IMP:UniProtKB
Q96K76	USP47	Ubiquitin carboxyl-terminal hydrolase 47	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
P62068	USP46	Ubiquitin carboxyl-terminal hydrolase 46	GO:0005515; F:protein binding; IPI:UniProtKB
P62068	USP46	Ubiquitin carboxyl-terminal hydrolase 46	GO:0004221; F:ubiquitin thiolesterase activity; IDA:UniProtKB
P62068	USP46	Ubiquitin carboxyl-terminal hydrolase 46	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
P62068	USP46	Ubiquitin carboxyl-terminal hydrolase 46	GO:0001662; P:behavioral fear response; IEA:Ensembl
P62068	USP46	Ubiquitin carboxyl-terminal hydrolase 46	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
P62068	USP46	Ubiquitin carboxyl-terminal hydrolase 46	GO:0032228; P:regulation of synaptic transmission, GABAergic; ISS:UniProtKB
P62068	USP46	Ubiquitin carboxyl-terminal hydrolase 46	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q86UV5	USP48	Ubiquitin carboxyl-terminal hydrolase 48	GO:0004843; F:ubiquitin-specific protease activity; IEA:InterPro
Q86UV5	USP48	Ubiquitin carboxyl-terminal hydrolase 48	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q70CQ1	USP49	Ubiquitin carboxyl-terminal hydrolase 49	GO:0004197; F:cysteine-type endopeptidase activity; IMP:UniProtKB
Q70CQ1	USP49	Ubiquitin carboxyl-terminal hydrolase 49	GO:0042393; F:histone binding; IDA:UniProtKB
Q70CQ1	USP49	Ubiquitin carboxyl-terminal hydrolase 49	GO:0005515; F:protein binding; IPI:UniProtKB
Q70CQ1	USP49	Ubiquitin carboxyl-terminal hydrolase 49	GO:0004221; F:ubiquitin thiolesterase activity; IDA:UniProtKB
Q70CQ1	USP49	Ubiquitin carboxyl-terminal hydrolase 49	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q70CQ1	USP49	Ubiquitin carboxyl-terminal hydrolase 49	GO:0008270; F:zinc ion binding; IEA:InterPro
Q70CQ1	USP49	Ubiquitin carboxyl-terminal hydrolase 49	GO:0035616; P:histone H2B conserved C-terminal lysine deubiquitination; IDA:UniProtKB
Q70CQ1	USP49	Ubiquitin carboxyl-terminal hydrolase 49	GO:0000398; P:mRNA splicing, via spliceosome; IMP:UniProtKB
Q70CQ1	USP49	Ubiquitin carboxyl-terminal hydrolase 49	GO:0016579; P:protein deubiquitination; IDA:FlyBase
Q70CQ1	USP49	Ubiquitin carboxyl-terminal hydrolase 49	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q13107	USP4	Ubiquitin carboxyl-terminal hydrolase 4	GO:0031685; F:adenosine receptor binding; IPI:UniProtKB
Q13107	USP4	Ubiquitin carboxyl-terminal hydrolase 4	GO:0042802; F:identical protein binding; IPI:IntAct
Q13107	USP4	Ubiquitin carboxyl-terminal hydrolase 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13107	USP4	Ubiquitin carboxyl-terminal hydrolase 4	GO:0005515; F:protein binding; IPI:IntAct
Q13107	USP4	Ubiquitin carboxyl-terminal hydrolase 4	GO:0004221; F:ubiquitin thiolesterase activity; IMP:UniProtKB
Q13107	USP4	Ubiquitin carboxyl-terminal hydrolase 4	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q13107	USP4	Ubiquitin carboxyl-terminal hydrolase 4	GO:0031397; P:negative regulation of protein ubiquitination; IMP:UniProtKB
Q13107	USP4	Ubiquitin carboxyl-terminal hydrolase 4	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
Q13107	USP4	Ubiquitin carboxyl-terminal hydrolase 4	GO:0034394; P:protein localization to cell surface; IDA:UniProtKB
Q13107	USP4	Ubiquitin carboxyl-terminal hydrolase 4	GO:0031647; P:regulation of protein stability; IDA:UniProtKB
Q13107	USP4	Ubiquitin carboxyl-terminal hydrolase 4	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q70EL3	USP50	Inactive ubiquitin carboxyl-terminal hydrolase 50	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q70EK8	USP53	Inactive ubiquitin carboxyl-terminal hydrolase 53	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q70EL1	USP54	Inactive ubiquitin carboxyl-terminal hydrolase 54	GO:0005515; F:protein binding; IPI:IntAct
Q70EL1	USP54	Inactive ubiquitin carboxyl-terminal hydrolase 54	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q70EK9	USP51	Ubiquitin carboxyl-terminal hydrolase 51	GO:0004843; F:ubiquitin-specific protease activity; IDA:FlyBase
Q70EK9	USP51	Ubiquitin carboxyl-terminal hydrolase 51	GO:0008270; F:zinc ion binding; IEA:InterPro
Q70EK9	USP51	Ubiquitin carboxyl-terminal hydrolase 51	GO:0016579; P:protein deubiquitination; IDA:FlyBase
Q70EK9	USP51	Ubiquitin carboxyl-terminal hydrolase 51	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
P45974	USP5	Ubiquitin carboxyl-terminal hydrolase 5	GO:0004197; F:cysteine-type endopeptidase activity; TAS:ProtInc
P45974	USP5	Ubiquitin carboxyl-terminal hydrolase 5	GO:0008242; F:omega peptidase activity; IEA:InterPro
P45974	USP5	Ubiquitin carboxyl-terminal hydrolase 5	GO:0005515; F:protein binding; IPI:IntAct
P45974	USP5	Ubiquitin carboxyl-terminal hydrolase 5	GO:0004221; F:ubiquitin thiolesterase activity; TAS:ProtInc
P45974	USP5	Ubiquitin carboxyl-terminal hydrolase 5	GO:0008270; F:zinc ion binding; IEA:InterPro
P45974	USP5	Ubiquitin carboxyl-terminal hydrolase 5	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB
P45974	USP5	Ubiquitin carboxyl-terminal hydrolase 5	GO:0071108; P:protein K48-linked deubiquitination; IMP:UniProtKB
P45974	USP5	Ubiquitin carboxyl-terminal hydrolase 5	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
P35125	USP6	Ubiquitin carboxyl-terminal hydrolase 6	GO:0005516; F:calmodulin binding; IPI:UniProtKB
P35125	USP6	Ubiquitin carboxyl-terminal hydrolase 6	GO:0004197; F:cysteine-type endopeptidase activity; TAS:UniProtKB
P35125	USP6	Ubiquitin carboxyl-terminal hydrolase 6	GO:0003676; F:nucleic acid binding; TAS:ProtInc
P35125	USP6	Ubiquitin carboxyl-terminal hydrolase 6	GO:0005515; F:protein binding; IPI:UniProtKB
P35125	USP6	Ubiquitin carboxyl-terminal hydrolase 6	GO:0005097; F:Rab GTPase activator activity; IEA:InterPro
P35125	USP6	Ubiquitin carboxyl-terminal hydrolase 6	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
P35125	USP6	Ubiquitin carboxyl-terminal hydrolase 6	GO:0006464; P:cellular protein modification process; NAS:UniProtKB
P35125	USP6	Ubiquitin carboxyl-terminal hydrolase 6	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
P35125	USP6	Ubiquitin carboxyl-terminal hydrolase 6	GO:0060627; P:regulation of vesicle-mediated transport; IDA:UniProtKB
P35125	USP6	Ubiquitin carboxyl-terminal hydrolase 6	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q93009	USP7	Ubiquitin carboxyl-terminal hydrolase 7	GO:0004197; F:cysteine-type endopeptidase activity; IMP:UniProtKB
Q93009	USP7	Ubiquitin carboxyl-terminal hydrolase 7	GO:0002039; F:p53 binding; IDA:UniProtKB
Q93009	USP7	Ubiquitin carboxyl-terminal hydrolase 7	GO:0005515; F:protein binding; IPI:UniProtKB
Q93009	USP7	Ubiquitin carboxyl-terminal hydrolase 7	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q93009	USP7	Ubiquitin carboxyl-terminal hydrolase 7	GO:0008134; F:transcription factor binding; IPI:UniProtKB
Q93009	USP7	Ubiquitin carboxyl-terminal hydrolase 7	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q93009	USP7	Ubiquitin carboxyl-terminal hydrolase 7	GO:0004221; F:ubiquitin thiolesterase activity; IDA:UniProtKB
Q93009	USP7	Ubiquitin carboxyl-terminal hydrolase 7	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q93009	USP7	Ubiquitin carboxyl-terminal hydrolase 7	GO:0010216; P:maintenance of DNA methylation; IMP:UniProtKB
Q93009	USP7	Ubiquitin carboxyl-terminal hydrolase 7	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q93009	USP7	Ubiquitin carboxyl-terminal hydrolase 7	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
Q93009	USP7	Ubiquitin carboxyl-terminal hydrolase 7	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
Q93009	USP7	Ubiquitin carboxyl-terminal hydrolase 7	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q93009	USP7	Ubiquitin carboxyl-terminal hydrolase 7	GO:0006283; P:transcription-coupled nucleotide-excision repair; IMP:UniProtKB
Q93009	USP7	Ubiquitin carboxyl-terminal hydrolase 7	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q93009	USP7	Ubiquitin carboxyl-terminal hydrolase 7	GO:0016032; P:viral process; IEA:UniProtKB-KW
P40818	USP8	Ubiquitin carboxyl-terminal hydrolase 8	GO:0004197; F:cysteine-type endopeptidase activity; TAS:ProtInc
P40818	USP8	Ubiquitin carboxyl-terminal hydrolase 8	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
P40818	USP8	Ubiquitin carboxyl-terminal hydrolase 8	GO:0005515; F:protein binding; IPI:UniProtKB
P40818	USP8	Ubiquitin carboxyl-terminal hydrolase 8	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
P40818	USP8	Ubiquitin carboxyl-terminal hydrolase 8	GO:0008283; P:cell proliferation; TAS:ProtInc
P40818	USP8	Ubiquitin carboxyl-terminal hydrolase 8	GO:0007032; P:endosome organization; IMP:UniProtKB
P40818	USP8	Ubiquitin carboxyl-terminal hydrolase 8	GO:0000281; P:mitotic cytokinesis; IMP:MGI
P40818	USP8	Ubiquitin carboxyl-terminal hydrolase 8	GO:0016579; P:protein deubiquitination; IMP:MGI
P40818	USP8	Ubiquitin carboxyl-terminal hydrolase 8	GO:0071108; P:protein K48-linked deubiquitination; IDA:UniProtKB
P40818	USP8	Ubiquitin carboxyl-terminal hydrolase 8	GO:0070536; P:protein K63-linked deubiquitination; IDA:UniProtKB
P40818	USP8	Ubiquitin carboxyl-terminal hydrolase 8	GO:0007265; P:Ras protein signal transduction; IEA:Ensembl
P40818	USP8	Ubiquitin carboxyl-terminal hydrolase 8	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q9UMX0	UBQLN1	Ubiquilin-1	GO:0019900; F:kinase binding; IPI:UniProtKB
Q9UMX0	UBQLN1	Ubiquilin-1	GO:0005515; F:protein binding; IPI:IntAct
Q9UMX0	UBQLN1	Ubiquilin-1	GO:0071456; P:cellular response to hypoxia; IMP:BHF-UCL
Q9UMX0	UBQLN1	Ubiquilin-1	GO:1902175; P:regulation of intrinsic apoptotic signaling pathway in response to oxidative stress; IMP:BHF-UCL
Q9UMX0	UBQLN1	Ubiquilin-1	GO:0031396; P:regulation of protein ubiquitination; IDA:HGNC
Q9UMX0	UBQLN1	Ubiquilin-1	GO:0034976; P:response to endoplasmic reticulum stress; IMP:BHF-UCL
Q9UHD9	UBQLN2	Ubiquilin-2	GO:0005515; F:protein binding; IPI:IntAct
Q9UHD9	UBQLN2	Ubiquilin-2	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q9NRR5	UBQLN4	Ubiquilin-4	GO:0042802; F:identical protein binding; IPI:IntAct
Q9NRR5	UBQLN4	Ubiquilin-4	GO:0031593; F:polyubiquitin binding; IDA:UniProtKB
Q9NRR5	UBQLN4	Ubiquilin-4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NRR5	UBQLN4	Ubiquilin-4	GO:0032434; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q8IWV7	UBR1	E3 ubiquitin-protein ligase UBR1	GO:0070728; F:leucine binding; IDA:UniProtKB
Q8IWV7	UBR1	E3 ubiquitin-protein ligase UBR1	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q8IWV7	UBR1	E3 ubiquitin-protein ligase UBR1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IWV7	UBR1	E3 ubiquitin-protein ligase UBR1	GO:0071233; P:cellular response to leucine; IDA:UniProtKB
Q8IWV7	UBR1	E3 ubiquitin-protein ligase UBR1	GO:0032007; P:negative regulation of TOR signaling; IMP:UniProtKB
Q8IWV7	UBR1	E3 ubiquitin-protein ligase UBR1	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q8IWV8	UBR2	E3 ubiquitin-protein ligase UBR2	GO:0070728; F:leucine binding; IDA:UniProtKB
Q8IWV8	UBR2	E3 ubiquitin-protein ligase UBR2	GO:0005515; F:protein binding; IPI:IntAct
Q8IWV8	UBR2	E3 ubiquitin-protein ligase UBR2	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q8IWV8	UBR2	E3 ubiquitin-protein ligase UBR2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IWV8	UBR2	E3 ubiquitin-protein ligase UBR2	GO:0071233; P:cellular response to leucine; IDA:UniProtKB
Q8IWV8	UBR2	E3 ubiquitin-protein ligase UBR2	GO:0006342; P:chromatin silencing; ISS:UniProtKB
Q8IWV8	UBR2	E3 ubiquitin-protein ligase UBR2	GO:0033522; P:histone H2A ubiquitination; ISS:UniProtKB
Q8IWV8	UBR2	E3 ubiquitin-protein ligase UBR2	GO:0007141; P:male meiosis I; IEA:Ensembl
Q8IWV8	UBR2	E3 ubiquitin-protein ligase UBR2	GO:0032007; P:negative regulation of TOR signaling; IMP:UniProtKB
Q8IWV8	UBR2	E3 ubiquitin-protein ligase UBR2	GO:0007283; P:spermatogenesis; IEA:Ensembl
Q8IWV8	UBR2	E3 ubiquitin-protein ligase UBR2	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q6ZT12	UBR3	E3 ubiquitin-protein ligase UBR3	GO:0004842; F:ubiquitin-protein ligase activity; ISS:UniProtKB
Q6ZT12	UBR3	E3 ubiquitin-protein ligase UBR3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6ZT12	UBR3	E3 ubiquitin-protein ligase UBR3	GO:0009790; P:embryo development; ISS:UniProtKB
Q6ZT12	UBR3	E3 ubiquitin-protein ligase UBR3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q6ZT12	UBR3	E3 ubiquitin-protein ligase UBR3	GO:0042048; P:olfactory behavior; IEA:Ensembl
Q6ZT12	UBR3	E3 ubiquitin-protein ligase UBR3	GO:0007608; P:sensory perception of smell; ISS:UniProtKB
Q6ZT12	UBR3	E3 ubiquitin-protein ligase UBR3	GO:0001967; P:suckling behavior; ISS:UniProtKB
Q6ZT12	UBR3	E3 ubiquitin-protein ligase UBR3	GO:0006511; P:ubiquitin-dependent protein catabolic process; ISS:UniProtKB
Q5T4S7	UBR4	E3 ubiquitin-protein ligase UBR4	GO:0005515; F:protein binding; IPI:UniProtKB
Q5T4S7	UBR4	E3 ubiquitin-protein ligase UBR4	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q5T4S7	UBR4	E3 ubiquitin-protein ligase UBR4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5T4S7	UBR4	E3 ubiquitin-protein ligase UBR4	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q5T4S7	UBR4	E3 ubiquitin-protein ligase UBR4	GO:0016032; P:viral process; IEA:UniProtKB-KW
O95071	UBR5	E3 ubiquitin-protein ligase UBR5	GO:0005515; F:protein binding; IPI:IntAct
O95071	UBR5	E3 ubiquitin-protein ligase UBR5	GO:0003723; F:RNA binding; IEA:InterPro
O95071	UBR5	E3 ubiquitin-protein ligase UBR5	GO:0004842; F:ubiquitin-protein ligase activity; IEA:InterPro
O95071	UBR5	E3 ubiquitin-protein ligase UBR5	GO:0034450; F:ubiquitin-ubiquitin ligase activity; IDA:BHF-UCL
O95071	UBR5	E3 ubiquitin-protein ligase UBR5	GO:0008270; F:zinc ion binding; IEA:InterPro
O95071	UBR5	E3 ubiquitin-protein ligase UBR5	GO:0008283; P:cell proliferation; TAS:ProtInc
O95071	UBR5	E3 ubiquitin-protein ligase UBR5	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
O95071	UBR5	E3 ubiquitin-protein ligase UBR5	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
O95071	UBR5	E3 ubiquitin-protein ligase UBR5	GO:2000780; P:negative regulation of double-strand break repair; IMP:UniProtKB
O95071	UBR5	E3 ubiquitin-protein ligase UBR5	GO:1901315; P:negative regulation of histone H2A K63-linked ubiquitination; IMP:UniProtKB
O95071	UBR5	E3 ubiquitin-protein ligase UBR5	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
O95071	UBR5	E3 ubiquitin-protein ligase UBR5	GO:0035413; P:positive regulation of catenin import into nucleus; IMP:BHF-UCL
O95071	UBR5	E3 ubiquitin-protein ligase UBR5	GO:0033160; P:positive regulation of protein import into nucleus, translocation; IMP:BHF-UCL
O95071	UBR5	E3 ubiquitin-protein ligase UBR5	GO:0050847; P:progesterone receptor signaling pathway; IDA:HGNC
O95071	UBR5	E3 ubiquitin-protein ligase UBR5	GO:0000209; P:protein polyubiquitination; IDA:BHF-UCL
O95071	UBR5	E3 ubiquitin-protein ligase UBR5	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:RefGenome
O95071	UBR5	E3 ubiquitin-protein ligase UBR5	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
Q8N806	UBR7	Putative E3 ubiquitin-protein ligase UBR7	GO:0004842; F:ubiquitin-protein ligase activity; IEA:InterPro
Q8N806	UBR7	Putative E3 ubiquitin-protein ligase UBR7	GO:0008270; F:zinc ion binding; IEA:InterPro
P57075	UBASH3A	Ubiquitin-associated and SH3 domain-containing protein A	GO:0003824; F:catalytic activity; IEA:InterPro
P57075	UBASH3A	Ubiquitin-associated and SH3 domain-containing protein A	GO:0050860; P:negative regulation of T cell receptor signaling pathway; IEA:Ensembl
P57075	UBASH3A	Ubiquitin-associated and SH3 domain-containing protein A	GO:0001817; P:regulation of cytokine production; IEA:Ensembl
Q8TF42	UBASH3B	Ubiquitin-associated and SH3 domain-containing protein B	GO:0005515; F:protein binding; IPI:IntAct
Q8TF42	UBASH3B	Ubiquitin-associated and SH3 domain-containing protein B	GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC
Q8TF42	UBASH3B	Ubiquitin-associated and SH3 domain-containing protein B	GO:0090331; P:negative regulation of platelet aggregation; IEA:Ensembl
Q8TF42	UBASH3B	Ubiquitin-associated and SH3 domain-containing protein B	GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl
Q8TF42	UBASH3B	Ubiquitin-associated and SH3 domain-containing protein B	GO:0051279; P:regulation of release of sequestered calcium ion into cytosol; IEA:Ensembl
P68543	UBXN2A	UBX domain-containing protein 2A	GO:0010468; P:regulation of gene expression; IEA:Ensembl
P68543	UBXN2A	UBX domain-containing protein 2A	GO:0042176; P:regulation of protein catabolic process; IEA:Ensembl
P68543	UBXN2A	UBX domain-containing protein 2A	GO:0031396; P:regulation of protein ubiquitination; IEA:Ensembl
Q04323	UBXN1	UBX domain-containing protein 1	GO:0051117; F:ATPase binding; IPI:UniProtKB
Q04323	UBXN1	UBX domain-containing protein 1	GO:0071796; F:K6-linked polyubiquitin binding; IDA:UniProtKB
Q04323	UBXN1	UBX domain-containing protein 1	GO:0031593; F:polyubiquitin binding; IDA:UniProtKB
Q04323	UBXN1	UBX domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q04323	UBXN1	UBX domain-containing protein 1	GO:0043130; F:ubiquitin binding; IDA:BHF-UCL
Q04323	UBXN1	UBX domain-containing protein 1	GO:0031625; F:ubiquitin protein ligase binding; IDA:BHF-UCL
Q04323	UBXN1	UBX domain-containing protein 1	GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q04323	UBXN1	UBX domain-containing protein 1	GO:0031397; P:negative regulation of protein ubiquitination; IDA:UniProtKB
Q04323	UBXN1	UBX domain-containing protein 1	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; NAS:UniProtKB
Q92575	UBXN4	UBX domain-containing protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q92575	UBXN4	UBX domain-containing protein 4	GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW
Q9BZV1	UBXN6	UBX domain-containing protein 6	GO:0005515; F:protein binding; IPI:IntAct
O94888	UBXN7	UBX domain-containing protein 7	GO:0005515; F:protein binding; IPI:IntAct
O94888	UBXN7	UBX domain-containing protein 7	GO:0008134; F:transcription factor binding; IPI:BHF-UCL
O94888	UBXN7	UBX domain-containing protein 7	GO:0043130; F:ubiquitin binding; IDA:BHF-UCL
O94888	UBXN7	UBX domain-containing protein 7	GO:0031625; F:ubiquitin protein ligase binding; IDA:BHF-UCL
O00124	UBXN8	UBX domain-containing protein 8	GO:0005515; F:protein binding; IPI:UniProtKB
O00124	UBXN8	UBX domain-containing protein 8	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
O00124	UBXN8	UBX domain-containing protein 8	GO:0007338; P:single fertilization; TAS:ProtInc
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0031694; F:alpha-2A adrenergic receptor binding; IPI:BHF-UCL
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0004197; F:cysteine-type endopeptidase activity; IDA:UniProtKB
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0008242; F:omega peptidase activity; IDA:UniProtKB
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0005515; F:protein binding; IPI:IntAct
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0004221; F:ubiquitin thiolesterase activity; TAS:UniProtKB
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0004843; F:ubiquitin-specific protease activity; IEA:InterPro
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0007628; P:adult walking behavior; IEA:Ensembl
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0007412; P:axon target recognition; IEA:Ensembl
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0019896; P:axon transport of mitochondrion; IEA:Ensembl
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0008219; P:cell death; IEA:UniProtKB-KW
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0008283; P:cell proliferation; IEA:Ensembl
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0042755; P:eating behavior; IEA:Ensembl
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0048747; P:muscle fiber development; IEA:Ensembl
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0043407; P:negative regulation of MAP kinase activity; IDA:BHF-UCL
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0050905; P:neuromuscular process; IEA:Ensembl
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0002931; P:response to ischemia; IEA:Ensembl
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0019233; P:sensory perception of pain; IEA:Ensembl
P09936	UCHL1	Ubiquitin carboxyl-terminal hydrolase isozyme L1	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:Ensembl
P15374	UCHL3	Ubiquitin carboxyl-terminal hydrolase isozyme L3	GO:0008233; F:peptidase activity; IDA:UniProtKB
P15374	UCHL3	Ubiquitin carboxyl-terminal hydrolase isozyme L3	GO:0005515; F:protein binding; IPI:IntAct
P15374	UCHL3	Ubiquitin carboxyl-terminal hydrolase isozyme L3	GO:0043130; F:ubiquitin binding; IDA:UniProtKB
P15374	UCHL3	Ubiquitin carboxyl-terminal hydrolase isozyme L3	GO:0004221; F:ubiquitin thiolesterase activity; TAS:UniProtKB
P15374	UCHL3	Ubiquitin carboxyl-terminal hydrolase isozyme L3	GO:0004843; F:ubiquitin-specific protease activity; IEA:InterPro
P15374	UCHL3	Ubiquitin carboxyl-terminal hydrolase isozyme L3	GO:0030163; P:protein catabolic process; IDA:UniProtKB
P15374	UCHL3	Ubiquitin carboxyl-terminal hydrolase isozyme L3	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q9Y5K5	UCHL5	Ubiquitin carboxyl-terminal hydrolase isozyme L5	GO:0004866; F:endopeptidase inhibitor activity; IMP:UniProtKB
Q9Y5K5	UCHL5	Ubiquitin carboxyl-terminal hydrolase isozyme L5	GO:0008242; F:omega peptidase activity; IEA:InterPro
Q9Y5K5	UCHL5	Ubiquitin carboxyl-terminal hydrolase isozyme L5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y5K5	UCHL5	Ubiquitin carboxyl-terminal hydrolase isozyme L5	GO:0070628; F:proteasome binding; IDA:UniProtKB
Q9Y5K5	UCHL5	Ubiquitin carboxyl-terminal hydrolase isozyme L5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y5K5	UCHL5	Ubiquitin carboxyl-terminal hydrolase isozyme L5	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q9Y5K5	UCHL5	Ubiquitin carboxyl-terminal hydrolase isozyme L5	GO:0006310; P:DNA recombination; IEA:UniProtKB-KW
Q9Y5K5	UCHL5	Ubiquitin carboxyl-terminal hydrolase isozyme L5	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q9Y5K5	UCHL5	Ubiquitin carboxyl-terminal hydrolase isozyme L5	GO:0048853; P:forebrain morphogenesis; IEA:Ensembl
Q9Y5K5	UCHL5	Ubiquitin carboxyl-terminal hydrolase isozyme L5	GO:0021670; P:lateral ventricle development; IEA:Ensembl
Q9Y5K5	UCHL5	Ubiquitin carboxyl-terminal hydrolase isozyme L5	GO:0030901; P:midbrain development; IEA:Ensembl
Q9Y5K5	UCHL5	Ubiquitin carboxyl-terminal hydrolase isozyme L5	GO:0010951; P:negative regulation of endopeptidase activity; IMP:GOC
Q9Y5K5	UCHL5	Ubiquitin carboxyl-terminal hydrolase isozyme L5	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q9Y5K5	UCHL5	Ubiquitin carboxyl-terminal hydrolase isozyme L5	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
Q9Y5K5	UCHL5	Ubiquitin carboxyl-terminal hydrolase isozyme L5	GO:0061136; P:regulation of proteasomal protein catabolic process; IMP:UniProtKB
Q9Y5K5	UCHL5	Ubiquitin carboxyl-terminal hydrolase isozyme L5	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y5K5	UCHL5	Ubiquitin carboxyl-terminal hydrolase isozyme L5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y5K5	UCHL5	Ubiquitin carboxyl-terminal hydrolase isozyme L5	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
Q9Y5K5	UCHL5	Ubiquitin carboxyl-terminal hydrolase isozyme L5	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q9HA47	UCK1	Uridine-cytidine kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9HA47	UCK1	Uridine-cytidine kinase 1	GO:0019206; F:nucleoside kinase activity; EXP:Reactome
Q9HA47	UCK1	Uridine-cytidine kinase 1	GO:0016773; F:phosphotransferase activity, alcohol group as acceptor; IEA:InterPro
Q9HA47	UCK1	Uridine-cytidine kinase 1	GO:0004849; F:uridine kinase activity; IEA:UniProtKB-EC
Q9HA47	UCK1	Uridine-cytidine kinase 1	GO:0044211; P:CTP salvage; IEA:UniProtKB-UniPathway
Q9HA47	UCK1	Uridine-cytidine kinase 1	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q9HA47	UCK1	Uridine-cytidine kinase 1	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
Q9HA47	UCK1	Uridine-cytidine kinase 1	GO:0043097; P:pyrimidine nucleoside salvage; TAS:Reactome
Q9HA47	UCK1	Uridine-cytidine kinase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9HA47	UCK1	Uridine-cytidine kinase 1	GO:0044206; P:UMP salvage; IEA:UniProtKB-UniPathway
Q8WVF2	UCMA	Unique cartilage matrix-associated protein	GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl
Q96RP3	UCN2	Urocortin-2	GO:0042562; F:hormone binding; IPI:UniProtKB
Q96RP3	UCN2	Urocortin-2	GO:0005102; F:receptor binding; IPI:UniProtKB
Q96RP3	UCN2	Urocortin-2	GO:0006171; P:cAMP biosynthetic process; IEP:UniProtKB
Q96RP3	UCN2	Urocortin-2	GO:0008283; P:cell proliferation; IEA:Ensembl
Q96RP3	UCN2	Urocortin-2	GO:0071385; P:cellular response to glucocorticoid stimulus; IEA:Ensembl
Q96RP3	UCN2	Urocortin-2	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
Q96RP3	UCN2	Urocortin-2	GO:0007586; P:digestion; NAS:UniProtKB
Q96RP3	UCN2	Urocortin-2	GO:0046882; P:negative regulation of follicle-stimulating hormone secretion; IEA:Ensembl
Q96RP3	UCN2	Urocortin-2	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
Q96RP3	UCN2	Urocortin-2	GO:0033685; P:negative regulation of luteinizing hormone secretion; IEA:Ensembl
Q96RP3	UCN2	Urocortin-2	GO:0006950; P:response to stress; NAS:UniProtKB
Q969E3	UCN3	Urocortin-3	GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IEA:Ensembl
Q969E3	UCN3	Urocortin-3	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
Q969E3	UCN3	Urocortin-3	GO:0031669; P:cellular response to nutrient levels; IEA:Ensembl
Q969E3	UCN3	Urocortin-3	GO:0007586; P:digestion; IEA:InterPro
Q969E3	UCN3	Urocortin-3	GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl
Q969E3	UCN3	Urocortin-3	GO:0045838; P:positive regulation of membrane potential; IEA:Ensembl
Q969E3	UCN3	Urocortin-3	GO:0051412; P:response to corticosterone; IEA:Ensembl
Q969E3	UCN3	Urocortin-3	GO:0009749; P:response to glucose; IEA:Ensembl
Q969E3	UCN3	Urocortin-3	GO:0035902; P:response to immobilization stress; IEA:Ensembl
Q969E3	UCN3	Urocortin-3	GO:0042594; P:response to starvation; IEA:Ensembl
Q9BZX2	UCK2	Uridine-cytidine kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9BZX2	UCK2	Uridine-cytidine kinase 2	GO:0019206; F:nucleoside kinase activity; EXP:Reactome
Q9BZX2	UCK2	Uridine-cytidine kinase 2	GO:0016773; F:phosphotransferase activity, alcohol group as acceptor; IEA:InterPro
Q9BZX2	UCK2	Uridine-cytidine kinase 2	GO:0004849; F:uridine kinase activity; IEA:UniProtKB-EC
Q9BZX2	UCK2	Uridine-cytidine kinase 2	GO:0071453; P:cellular response to oxygen levels; IEA:Ensembl
Q9BZX2	UCK2	Uridine-cytidine kinase 2	GO:0044211; P:CTP salvage; IEA:UniProtKB-UniPathway
Q9BZX2	UCK2	Uridine-cytidine kinase 2	GO:0007631; P:feeding behavior; IEA:Ensembl
Q9BZX2	UCK2	Uridine-cytidine kinase 2	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q9BZX2	UCK2	Uridine-cytidine kinase 2	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
Q9BZX2	UCK2	Uridine-cytidine kinase 2	GO:0043097; P:pyrimidine nucleoside salvage; TAS:Reactome
Q9BZX2	UCK2	Uridine-cytidine kinase 2	GO:0048678; P:response to axon injury; IEA:Ensembl
Q9BZX2	UCK2	Uridine-cytidine kinase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BZX2	UCK2	Uridine-cytidine kinase 2	GO:0044206; P:UMP salvage; IEA:UniProtKB-UniPathway
P25874	UCP1	Mitochondrial brown fat uncoupling protein 1	GO:0017077; F:oxidative phosphorylation uncoupler activity; IEA:Ensembl
P25874	UCP1	Mitochondrial brown fat uncoupling protein 1	GO:0050873; P:brown fat cell differentiation; ISS:HGNC
P25874	UCP1	Mitochondrial brown fat uncoupling protein 1	GO:0044237; P:cellular metabolic process; TAS:Reactome
P25874	UCP1	Mitochondrial brown fat uncoupling protein 1	GO:0006839; P:mitochondrial transport; IEA:InterPro
P25874	UCP1	Mitochondrial brown fat uncoupling protein 1	GO:0015992; P:proton transport; TAS:Reactome
P25874	UCP1	Mitochondrial brown fat uncoupling protein 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P25874	UCP1	Mitochondrial brown fat uncoupling protein 1	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P25874	UCP1	Mitochondrial brown fat uncoupling protein 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9NWZ5	UCKL1	Uridine-cytidine kinase-like 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9NWZ5	UCKL1	Uridine-cytidine kinase-like 1	GO:0016773; F:phosphotransferase activity, alcohol group as acceptor; IEA:InterPro
Q9NWZ5	UCKL1	Uridine-cytidine kinase-like 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NWZ5	UCKL1	Uridine-cytidine kinase-like 1	GO:0004849; F:uridine kinase activity; IEA:UniProtKB-EC
Q9NWZ5	UCKL1	Uridine-cytidine kinase-like 1	GO:0044211; P:CTP salvage; IEA:UniProtKB-UniPathway
Q9NWZ5	UCKL1	Uridine-cytidine kinase-like 1	GO:0044206; P:UMP salvage; IEA:UniProtKB-UniPathway
Q9NWZ5	UCKL1	Uridine-cytidine kinase-like 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
P55089	UCN	Urocortin	GO:0046811; F:histone deacetylase inhibitor activity; IEA:Ensembl
P55089	UCN	Urocortin	GO:0005184; F:neuropeptide hormone activity; TAS:ProtInc
P55089	UCN	Urocortin	GO:0005515; F:protein binding; IPI:UniProtKB
P55089	UCN	Urocortin	GO:0034199; P:activation of protein kinase A activity; IEA:Ensembl
P55089	UCN	Urocortin	GO:0009060; P:aerobic respiration; IEA:Ensembl
P55089	UCN	Urocortin	GO:0008306; P:associative learning; IEA:Ensembl
P55089	UCN	Urocortin	GO:0042756; P:drinking behavior; IEA:Ensembl
P55089	UCN	Urocortin	GO:0007565; P:female pregnancy; IEA:Ensembl
P55089	UCN	Urocortin	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P55089	UCN	Urocortin	GO:0035483; P:gastric emptying; IEA:Ensembl
P55089	UCN	Urocortin	GO:0006954; P:inflammatory response; IEA:Ensembl
P55089	UCN	Urocortin	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P55089	UCN	Urocortin	GO:0032099; P:negative regulation of appetite; IEA:Ensembl
P55089	UCN	Urocortin	GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl
P55089	UCN	Urocortin	GO:0045792; P:negative regulation of cell size; IEA:Ensembl
P55089	UCN	Urocortin	GO:2000252; P:negative regulation of feeding behavior; IEA:Ensembl
P55089	UCN	Urocortin	GO:0060455; P:negative regulation of gastric acid secretion; IEA:Ensembl
P55089	UCN	Urocortin	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
P55089	UCN	Urocortin	GO:0046888; P:negative regulation of hormone secretion; IEA:Ensembl
P55089	UCN	Urocortin	GO:0060547; P:negative regulation of necrotic cell death; IEA:Ensembl
P55089	UCN	Urocortin	GO:1901215; P:negative regulation of neuron death; IEA:Ensembl
P55089	UCN	Urocortin	GO:0031175; P:neuron projection development; IEA:Ensembl
P55089	UCN	Urocortin	GO:0007218; P:neuropeptide signaling pathway; IEA:Ensembl
P55089	UCN	Urocortin	GO:0030157; P:pancreatic juice secretion; IEA:Ensembl
P55089	UCN	Urocortin	GO:2000987; P:positive regulation of behavioral fear response; IEA:Ensembl
P55089	UCN	Urocortin	GO:0090280; P:positive regulation of calcium ion import; IEA:Ensembl
P55089	UCN	Urocortin	GO:0030819; P:positive regulation of cAMP biosynthetic process; IEA:Ensembl
P55089	UCN	Urocortin	GO:0060452; P:positive regulation of cardiac muscle contraction; IEA:Ensembl
P55089	UCN	Urocortin	GO:0030307; P:positive regulation of cell growth; IEA:Ensembl
P55089	UCN	Urocortin	GO:0032967; P:positive regulation of collagen biosynthetic process; IEA:Ensembl
P55089	UCN	Urocortin	GO:0051461; P:positive regulation of corticotropin secretion; IEA:Ensembl
P55089	UCN	Urocortin	GO:0045740; P:positive regulation of DNA replication; IEA:Ensembl
P55089	UCN	Urocortin	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P55089	UCN	Urocortin	GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl
P55089	UCN	Urocortin	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IEA:Ensembl
P55089	UCN	Urocortin	GO:0045727; P:positive regulation of translation; IEA:Ensembl
P55089	UCN	Urocortin	GO:0043117; P:positive regulation of vascular permeability; IEA:Ensembl
P55089	UCN	Urocortin	GO:0045909; P:positive regulation of vasodilation; IEA:Ensembl
P55089	UCN	Urocortin	GO:0051966; P:regulation of synaptic transmission, glutamatergic; IEA:Ensembl
P55089	UCN	Urocortin	GO:0032355; P:response to estradiol; IEA:Ensembl
P55089	UCN	Urocortin	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P55089	UCN	Urocortin	GO:0006979; P:response to oxidative stress; IEA:Ensembl
P55089	UCN	Urocortin	GO:0048265; P:response to pain; IEA:Ensembl
P55851	UCP2	Mitochondrial uncoupling protein 2	GO:0007568; P:aging; IEA:Ensembl
P55851	UCP2	Mitochondrial uncoupling protein 2	GO:0044237; P:cellular metabolic process; TAS:Reactome
P55851	UCP2	Mitochondrial uncoupling protein 2	GO:0034198; P:cellular response to amino acid starvation; IEA:Ensembl
P55851	UCP2	Mitochondrial uncoupling protein 2	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
P55851	UCP2	Mitochondrial uncoupling protein 2	GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl
P55851	UCP2	Mitochondrial uncoupling protein 2	GO:0007565; P:female pregnancy; IEA:Ensembl
P55851	UCP2	Mitochondrial uncoupling protein 2	GO:0097421; P:liver regeneration; IEA:Ensembl
P55851	UCP2	Mitochondrial uncoupling protein 2	GO:0006839; P:mitochondrial transport; IEA:Ensembl
P55851	UCP2	Mitochondrial uncoupling protein 2	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P55851	UCP2	Mitochondrial uncoupling protein 2	GO:0061179; P:negative regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl
P55851	UCP2	Mitochondrial uncoupling protein 2	GO:0010942; P:positive regulation of cell death; IEA:Ensembl
P55851	UCP2	Mitochondrial uncoupling protein 2	GO:0015992; P:proton transport; TAS:Reactome
P55851	UCP2	Mitochondrial uncoupling protein 2	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P55851	UCP2	Mitochondrial uncoupling protein 2	GO:0070542; P:response to fatty acid; IEA:Ensembl
P55851	UCP2	Mitochondrial uncoupling protein 2	GO:0001666; P:response to hypoxia; IEA:Ensembl
P55851	UCP2	Mitochondrial uncoupling protein 2	GO:0000303; P:response to superoxide; IEA:Ensembl
P55851	UCP2	Mitochondrial uncoupling protein 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P55851	UCP2	Mitochondrial uncoupling protein 2	GO:0006810; P:transport; NAS:ProtInc
P55916	UCP3	Mitochondrial uncoupling protein 3	GO:0017077; F:oxidative phosphorylation uncoupler activity; IEA:Ensembl
P55916	UCP3	Mitochondrial uncoupling protein 3	GO:0005515; F:protein binding; IPI:IntAct
P55916	UCP3	Mitochondrial uncoupling protein 3	GO:0005215; F:transporter activity; TAS:ProtInc
P55916	UCP3	Mitochondrial uncoupling protein 3	GO:0007568; P:aging; IEA:Ensembl
P55916	UCP3	Mitochondrial uncoupling protein 3	GO:0044237; P:cellular metabolic process; TAS:Reactome
P55916	UCP3	Mitochondrial uncoupling protein 3	GO:0032870; P:cellular response to hormone stimulus; IEA:Ensembl
P55916	UCP3	Mitochondrial uncoupling protein 3	GO:0006631; P:fatty acid metabolic process; IEA:Ensembl
P55916	UCP3	Mitochondrial uncoupling protein 3	GO:0006629; P:lipid metabolic process; TAS:ProtInc
P55916	UCP3	Mitochondrial uncoupling protein 3	GO:0006839; P:mitochondrial transport; IEA:InterPro
P55916	UCP3	Mitochondrial uncoupling protein 3	GO:0015992; P:proton transport; TAS:Reactome
P55916	UCP3	Mitochondrial uncoupling protein 3	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P55916	UCP3	Mitochondrial uncoupling protein 3	GO:0007585; P:respiratory gaseous exchange; TAS:ProtInc
P55916	UCP3	Mitochondrial uncoupling protein 3	GO:0014823; P:response to activity; IEA:Ensembl
P55916	UCP3	Mitochondrial uncoupling protein 3	GO:0009409; P:response to cold; IEA:Ensembl
P55916	UCP3	Mitochondrial uncoupling protein 3	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P55916	UCP3	Mitochondrial uncoupling protein 3	GO:0001666; P:response to hypoxia; IEA:Ensembl
P55916	UCP3	Mitochondrial uncoupling protein 3	GO:0032868; P:response to insulin; IEA:Ensembl
P55916	UCP3	Mitochondrial uncoupling protein 3	GO:0007584; P:response to nutrient; IEA:Ensembl
P55916	UCP3	Mitochondrial uncoupling protein 3	GO:0000303; P:response to superoxide; IEA:Ensembl
P55916	UCP3	Mitochondrial uncoupling protein 3	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95847	SLC25A27	Mitochondrial uncoupling protein 4	GO:0035356; P:cellular triglyceride homeostasis; IEA:Ensembl
O95847	SLC25A27	Mitochondrial uncoupling protein 4	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
O95847	SLC25A27	Mitochondrial uncoupling protein 4	GO:0048839; P:inner ear development; IEA:Ensembl
O95847	SLC25A27	Mitochondrial uncoupling protein 4	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
O95847	SLC25A27	Mitochondrial uncoupling protein 4	GO:0051562; P:negative regulation of mitochondrial calcium ion concentration; IEA:Ensembl
O95847	SLC25A27	Mitochondrial uncoupling protein 4	GO:0010917; P:negative regulation of mitochondrial membrane potential; IEA:Ensembl
O95847	SLC25A27	Mitochondrial uncoupling protein 4	GO:0070997; P:neuron death; IEA:Ensembl
O95847	SLC25A27	Mitochondrial uncoupling protein 4	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
O95847	SLC25A27	Mitochondrial uncoupling protein 4	GO:0046324; P:regulation of glucose import; IEA:Ensembl
O95847	SLC25A27	Mitochondrial uncoupling protein 4	GO:0006810; P:transport; IEA:UniProtKB-KW
O95258	SLC25A14	Brain mitochondrial carrier protein 1	GO:0009060; P:aerobic respiration; TAS:ProtInc
O95258	SLC25A14	Brain mitochondrial carrier protein 1	GO:0006839; P:mitochondrial transport; IEA:InterPro
O95258	SLC25A14	Brain mitochondrial carrier protein 1	GO:0006810; P:transport; TAS:ProtInc
P0C7P4	UQCRFS1P1	Putative cytochrome b-c1 complex subunit Rieske-like protein 1	GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:UniProtKB-KW
P0C7P4	UQCRFS1P1	Putative cytochrome b-c1 complex subunit Rieske-like protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P0C7P4	UQCRFS1P1	Putative cytochrome b-c1 complex subunit Rieske-like protein 1	GO:0008121; F:ubiquinol-cytochrome-c reductase activity; IEA:InterPro
P47985	UQCRFS1	Cytochrome b-c1 complex subunit Rieske, mitochondrial	GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:UniProtKB-KW
P47985	UQCRFS1	Cytochrome b-c1 complex subunit Rieske, mitochondrial	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P47985	UQCRFS1	Cytochrome b-c1 complex subunit Rieske, mitochondrial	GO:0008121; F:ubiquinol-cytochrome-c reductase activity; IEA:UniProtKB-EC
P47985	UQCRFS1	Cytochrome b-c1 complex subunit Rieske, mitochondrial	GO:0044237; P:cellular metabolic process; TAS:Reactome
P47985	UQCRFS1	Cytochrome b-c1 complex subunit Rieske, mitochondrial	GO:0022904; P:respiratory electron transport chain; TAS:Reactome
P47985	UQCRFS1	Cytochrome b-c1 complex subunit Rieske, mitochondrial	GO:0046677; P:response to antibiotic; IEA:Ensembl
P47985	UQCRFS1	Cytochrome b-c1 complex subunit Rieske, mitochondrial	GO:0042493; P:response to drug; IEA:Ensembl
P47985	UQCRFS1	Cytochrome b-c1 complex subunit Rieske, mitochondrial	GO:0009725; P:response to hormone; IEA:Ensembl
P47985	UQCRFS1	Cytochrome b-c1 complex subunit Rieske, mitochondrial	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9HAW8	UGT1A10	UDP-glucuronosyltransferase 1-10	GO:0019899; F:enzyme binding; IDA:BHF-UCL
Q9HAW8	UGT1A10	UDP-glucuronosyltransferase 1-10	GO:0015020; F:glucuronosyltransferase activity; IDA:BHF-UCL
Q9HAW8	UGT1A10	UDP-glucuronosyltransferase 1-10	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
Q9HAW8	UGT1A10	UDP-glucuronosyltransferase 1-10	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q9HAW8	UGT1A10	UDP-glucuronosyltransferase 1-10	GO:0005080; F:protein kinase C binding; IPI:BHF-UCL
Q9HAW8	UGT1A10	UDP-glucuronosyltransferase 1-10	GO:0052695; P:cellular glucuronidation; IDA:BHF-UCL
Q9HAW8	UGT1A10	UDP-glucuronosyltransferase 1-10	GO:0051552; P:flavone metabolic process; IDA:BHF-UCL
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0019899; F:enzyme binding; IDA:BHF-UCL
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0004857; F:enzyme inhibitor activity; IDA:BHF-UCL
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0015020; F:glucuronosyltransferase activity; IDA:BHF-UCL
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0001972; F:retinoic acid binding; IDA:BHF-UCL
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0005496; F:steroid binding; IDA:BHF-UCL
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0006953; P:acute-phase response; IEA:Ensembl
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0006789; P:bilirubin conjugation; TAS:ProtInc
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0070980; P:biphenyl catabolic process; IEA:Ensembl
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0052695; P:cellular glucuronidation; TAS:Reactome
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0071361; P:cellular response to ethanol; IEA:Ensembl
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0071385; P:cellular response to glucocorticoid stimulus; IEA:Ensembl
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0007586; P:digestion; NAS:ProtInc
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0017144; P:drug metabolic process; IC:BHF-UCL
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0008210; P:estrogen metabolic process; TAS:ProtInc
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0051552; P:flavone metabolic process; IDA:BHF-UCL
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0052696; P:flavonoid glucuronidation; IDA:BHF-UCL
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0042167; P:heme catabolic process; TAS:Reactome
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0046483; P:heterocycle metabolic process; IC:BHF-UCL
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0001889; P:liver development; IEA:Ensembl
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0043086; P:negative regulation of catalytic activity; IDA:GOC
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:2001030; P:negative regulation of cellular glucuronidation; IDA:UniProtKB
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0045939; P:negative regulation of steroid metabolic process; IC:BHF-UCL
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0031100; P:organ regeneration; IEA:Ensembl
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0006778; P:porphyrin-containing compound metabolic process; TAS:Reactome
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0042493; P:response to drug; IEA:Ensembl
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0007584; P:response to nutrient; IEA:Ensembl
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0042594; P:response to starvation; IEA:Ensembl
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0042573; P:retinoic acid metabolic process; IC:BHF-UCL
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0008202; P:steroid metabolic process; IC:BHF-UCL
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0052697; P:xenobiotic glucuronidation; IDA:BHF-UCL
P22309	UGT1A1	UDP-glucuronosyltransferase 1-1	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P35503	UGT1A3	UDP-glucuronosyltransferase 1-3	GO:0019899; F:enzyme binding; IDA:BHF-UCL
P35503	UGT1A3	UDP-glucuronosyltransferase 1-3	GO:0015020; F:glucuronosyltransferase activity; IDA:BHF-UCL
P35503	UGT1A3	UDP-glucuronosyltransferase 1-3	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P35503	UGT1A3	UDP-glucuronosyltransferase 1-3	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P35503	UGT1A3	UDP-glucuronosyltransferase 1-3	GO:0001972; F:retinoic acid binding; IDA:BHF-UCL
P35503	UGT1A3	UDP-glucuronosyltransferase 1-3	GO:0008194; F:UDP-glycosyltransferase activity; TAS:ProtInc
P35503	UGT1A3	UDP-glucuronosyltransferase 1-3	GO:0052696; P:flavonoid glucuronidation; IDA:BHF-UCL
P35503	UGT1A3	UDP-glucuronosyltransferase 1-3	GO:0008152; P:metabolic process; TAS:ProtInc
P35503	UGT1A3	UDP-glucuronosyltransferase 1-3	GO:0042573; P:retinoic acid metabolic process; IC:BHF-UCL
P35503	UGT1A3	UDP-glucuronosyltransferase 1-3	GO:0052697; P:xenobiotic glucuronidation; IDA:BHF-UCL
P22310	UGT1A4	UDP-glucuronosyltransferase 1-4	GO:0019899; F:enzyme binding; IDA:BHF-UCL
P22310	UGT1A4	UDP-glucuronosyltransferase 1-4	GO:0015020; F:glucuronosyltransferase activity; IEA:UniProtKB-EC
P22310	UGT1A4	UDP-glucuronosyltransferase 1-4	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P22310	UGT1A4	UDP-glucuronosyltransferase 1-4	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P22310	UGT1A4	UDP-glucuronosyltransferase 1-4	GO:0052695; P:cellular glucuronidation; TAS:Reactome
P22310	UGT1A4	UDP-glucuronosyltransferase 1-4	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P22310	UGT1A4	UDP-glucuronosyltransferase 1-4	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
P19224	UGT1A6	UDP-glucuronosyltransferase 1-6	GO:0019899; F:enzyme binding; IDA:BHF-UCL
P19224	UGT1A6	UDP-glucuronosyltransferase 1-6	GO:0015020; F:glucuronosyltransferase activity; IEA:UniProtKB-EC
P19224	UGT1A6	UDP-glucuronosyltransferase 1-6	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P19224	UGT1A6	UDP-glucuronosyltransferase 1-6	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P19224	UGT1A6	UDP-glucuronosyltransferase 1-6	GO:0052695; P:cellular glucuronidation; TAS:Reactome
P19224	UGT1A6	UDP-glucuronosyltransferase 1-6	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P19224	UGT1A6	UDP-glucuronosyltransferase 1-6	GO:0006805; P:xenobiotic metabolic process; IDA:UniProtKB
Q9HAW7	UGT1A7	UDP-glucuronosyltransferase 1-7	GO:0008144; F:drug binding; IDA:BHF-UCL
Q9HAW7	UGT1A7	UDP-glucuronosyltransferase 1-7	GO:0019899; F:enzyme binding; IDA:BHF-UCL
Q9HAW7	UGT1A7	UDP-glucuronosyltransferase 1-7	GO:0004857; F:enzyme inhibitor activity; IDA:BHF-UCL
Q9HAW7	UGT1A7	UDP-glucuronosyltransferase 1-7	GO:0015020; F:glucuronosyltransferase activity; IDA:BHF-UCL
Q9HAW7	UGT1A7	UDP-glucuronosyltransferase 1-7	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
Q9HAW7	UGT1A7	UDP-glucuronosyltransferase 1-7	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q9HAW7	UGT1A7	UDP-glucuronosyltransferase 1-7	GO:0005080; F:protein kinase C binding; IPI:BHF-UCL
Q9HAW7	UGT1A7	UDP-glucuronosyltransferase 1-7	GO:0001972; F:retinoic acid binding; IDA:BHF-UCL
Q9HAW7	UGT1A7	UDP-glucuronosyltransferase 1-7	GO:0009804; P:coumarin metabolic process; IC:BHF-UCL
Q9HAW7	UGT1A7	UDP-glucuronosyltransferase 1-7	GO:0017144; P:drug metabolic process; IDA:BHF-UCL
Q9HAW7	UGT1A7	UDP-glucuronosyltransferase 1-7	GO:0007588; P:excretion; IC:BHF-UCL
Q9HAW7	UGT1A7	UDP-glucuronosyltransferase 1-7	GO:0051552; P:flavone metabolic process; IC:BHF-UCL
Q9HAW7	UGT1A7	UDP-glucuronosyltransferase 1-7	GO:0052696; P:flavonoid glucuronidation; IDA:BHF-UCL
Q9HAW7	UGT1A7	UDP-glucuronosyltransferase 1-7	GO:0043086; P:negative regulation of catalytic activity; IDA:GOC
Q9HAW7	UGT1A7	UDP-glucuronosyltransferase 1-7	GO:2001030; P:negative regulation of cellular glucuronidation; IDA:UniProtKB
Q9HAW7	UGT1A7	UDP-glucuronosyltransferase 1-7	GO:0045922; P:negative regulation of fatty acid metabolic process; IDA:BHF-UCL
Q9HAW7	UGT1A7	UDP-glucuronosyltransferase 1-7	GO:0042573; P:retinoic acid metabolic process; IC:BHF-UCL
Q9HAW7	UGT1A7	UDP-glucuronosyltransferase 1-7	GO:0052697; P:xenobiotic glucuronidation; IDA:BHF-UCL
P35504	UGT1A5	UDP-glucuronosyltransferase 1-5	GO:0015020; F:glucuronosyltransferase activity; IEA:UniProtKB-EC
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0008144; F:drug binding; IC:BHF-UCL
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0019899; F:enzyme binding; IC:BHF-UCL
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0004857; F:enzyme inhibitor activity; IDA:BHF-UCL
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0005504; F:fatty acid binding; IDA:BHF-UCL
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0015020; F:glucuronosyltransferase activity; IDA:BHF-UCL
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0001972; F:retinoic acid binding; IC:BHF-UCL
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0005496; F:steroid binding; IDA:BHF-UCL
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0009804; P:coumarin metabolic process; IC:BHF-UCL
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0017144; P:drug metabolic process; IDA:BHF-UCL
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0006631; P:fatty acid metabolic process; IDA:BHF-UCL
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0051552; P:flavone metabolic process; IDA:BHF-UCL
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0052696; P:flavonoid glucuronidation; IDA:BHF-UCL
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0043086; P:negative regulation of catalytic activity; IDA:GOC
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:2001030; P:negative regulation of cellular glucuronidation; IDA:UniProtKB
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0031324; P:negative regulation of cellular metabolic process; IDA:BHF-UCL
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0045922; P:negative regulation of fatty acid metabolic process; IC:BHF-UCL
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0045939; P:negative regulation of steroid metabolic process; IC:BHF-UCL
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0042573; P:retinoic acid metabolic process; IC:BHF-UCL
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0008202; P:steroid metabolic process; IC:BHF-UCL
Q9HAW9	UGT1A8	UDP-glucuronosyltransferase 1-8	GO:0052697; P:xenobiotic glucuronidation; IDA:BHF-UCL
O60656	UGT1A9	UDP-glucuronosyltransferase 1-9	GO:0019899; F:enzyme binding; IDA:BHF-UCL
O60656	UGT1A9	UDP-glucuronosyltransferase 1-9	GO:0004857; F:enzyme inhibitor activity; IDA:BHF-UCL
O60656	UGT1A9	UDP-glucuronosyltransferase 1-9	GO:0015020; F:glucuronosyltransferase activity; IDA:BHF-UCL
O60656	UGT1A9	UDP-glucuronosyltransferase 1-9	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
O60656	UGT1A9	UDP-glucuronosyltransferase 1-9	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
O60656	UGT1A9	UDP-glucuronosyltransferase 1-9	GO:0001972; F:retinoic acid binding; IDA:BHF-UCL
O60656	UGT1A9	UDP-glucuronosyltransferase 1-9	GO:0044255; P:cellular lipid metabolic process; TAS:Reactome
O60656	UGT1A9	UDP-glucuronosyltransferase 1-9	GO:0017144; P:drug metabolic process; IDA:BHF-UCL
O60656	UGT1A9	UDP-glucuronosyltransferase 1-9	GO:0051552; P:flavone metabolic process; IDA:BHF-UCL
O60656	UGT1A9	UDP-glucuronosyltransferase 1-9	GO:0052696; P:flavonoid glucuronidation; IDA:BHF-UCL
O60656	UGT1A9	UDP-glucuronosyltransferase 1-9	GO:0008152; P:metabolic process; TAS:ProtInc
O60656	UGT1A9	UDP-glucuronosyltransferase 1-9	GO:0043086; P:negative regulation of catalytic activity; IDA:GOC
O60656	UGT1A9	UDP-glucuronosyltransferase 1-9	GO:2001030; P:negative regulation of cellular glucuronidation; IDA:UniProtKB
O60656	UGT1A9	UDP-glucuronosyltransferase 1-9	GO:0045922; P:negative regulation of fatty acid metabolic process; IDA:BHF-UCL
O60656	UGT1A9	UDP-glucuronosyltransferase 1-9	GO:0042573; P:retinoic acid metabolic process; IC:BHF-UCL
O60656	UGT1A9	UDP-glucuronosyltransferase 1-9	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60656	UGT1A9	UDP-glucuronosyltransferase 1-9	GO:0052697; P:xenobiotic glucuronidation; IDA:BHF-UCL
O60656	UGT1A9	UDP-glucuronosyltransferase 1-9	GO:0006805; P:xenobiotic metabolic process; IDA:UniProtKB
Q9Y4X1	UGT2A1	UDP-glucuronosyltransferase 2A1	GO:0015020; F:glucuronosyltransferase activity; IDA:UniProtKB
Q9Y4X1	UGT2A1	UDP-glucuronosyltransferase 2A1	GO:0052695; P:cellular glucuronidation; IDA:BHF-UCL
Q9Y4X1	UGT2A1	UDP-glucuronosyltransferase 2A1	GO:0009593; P:detection of chemical stimulus; TAS:ProtInc
Q9Y4X1	UGT2A1	UDP-glucuronosyltransferase 2A1	GO:0008152; P:metabolic process; IDA:GOC
Q9Y4X1	UGT2A1	UDP-glucuronosyltransferase 2A1	GO:0007608; P:sensory perception of smell; IEA:UniProtKB-KW
Q6UWM9	UGT2A3	UDP-glucuronosyltransferase 2A3	GO:0015020; F:glucuronosyltransferase activity; IDA:UniProtKB
Q6UWM9	UGT2A3	UDP-glucuronosyltransferase 2A3	GO:0052695; P:cellular glucuronidation; IDA:BHF-UCL
P06133	UGT2B4	UDP-glucuronosyltransferase 2B4	GO:0015020; F:glucuronosyltransferase activity; IDA:BHF-UCL
P06133	UGT2B4	UDP-glucuronosyltransferase 2B4	GO:0052695; P:cellular glucuronidation; IDA:BHF-UCL
P06133	UGT2B4	UDP-glucuronosyltransferase 2B4	GO:0006711; P:estrogen catabolic process; IDA:UniProtKB
P06133	UGT2B4	UDP-glucuronosyltransferase 2B4	GO:0008152; P:metabolic process; IDA:UniProtKB
P06133	UGT2B4	UDP-glucuronosyltransferase 2B4	GO:0006805; P:xenobiotic metabolic process; IDA:UniProtKB
P16662	UGT2B7	UDP-glucuronosyltransferase 2B7	GO:0015020; F:glucuronosyltransferase activity; IDA:UniProtKB
P16662	UGT2B7	UDP-glucuronosyltransferase 2B7	GO:0008209; P:androgen metabolic process; IDA:UniProtKB
P16662	UGT2B7	UDP-glucuronosyltransferase 2B7	GO:0052695; P:cellular glucuronidation; IDA:UniProtKB
P16662	UGT2B7	UDP-glucuronosyltransferase 2B7	GO:0006629; P:lipid metabolic process; TAS:ProtInc
Q6NUS8	UGT3A1	UDP-glucuronosyltransferase 3A1	GO:0015020; F:glucuronosyltransferase activity; IDA:MGI
Q6NUS8	UGT3A1	UDP-glucuronosyltransferase 3A1	GO:0008194; F:UDP-glycosyltransferase activity; IDA:MGI
Q3SY77	UGT3A2	UDP-glucuronosyltransferase 3A2	GO:0015020; F:glucuronosyltransferase activity; IEA:UniProtKB-EC
Q3SY77	UGT3A2	UDP-glucuronosyltransferase 3A2	GO:0008194; F:UDP-glycosyltransferase activity; IDA:MGI
Q3SY77	UGT3A2	UDP-glucuronosyltransferase 3A2	GO:0071412; P:cellular response to genistein; IDA:MGI
P36537	UGT2B10	UDP-glucuronosyltransferase 2B10	GO:0015020; F:glucuronosyltransferase activity; IEA:UniProtKB-EC
P36537	UGT2B10	UDP-glucuronosyltransferase 2B10	GO:0016758; F:transferase activity, transferring hexosyl groups; IEA:InterPro
P36537	UGT2B10	UDP-glucuronosyltransferase 2B10	GO:0006629; P:lipid metabolic process; TAS:ProtInc
O75310	UGT2B11	UDP-glucuronosyltransferase 2B11	GO:0015020; F:glucuronosyltransferase activity; IEA:UniProtKB-EC
O75310	UGT2B11	UDP-glucuronosyltransferase 2B11	GO:0008210; P:estrogen metabolic process; TAS:ProtInc
O75310	UGT2B11	UDP-glucuronosyltransferase 2B11	GO:0006805; P:xenobiotic metabolic process; TAS:ProtInc
P54855	UGT2B15	UDP-glucuronosyltransferase 2B15	GO:0015020; F:glucuronosyltransferase activity; IDA:BHF-UCL
P54855	UGT2B15	UDP-glucuronosyltransferase 2B15	GO:0016758; F:transferase activity, transferring hexosyl groups; IEA:InterPro
P54855	UGT2B15	UDP-glucuronosyltransferase 2B15	GO:0052695; P:cellular glucuronidation; IDA:BHF-UCL
P54855	UGT2B15	UDP-glucuronosyltransferase 2B15	GO:0008202; P:steroid metabolic process; TAS:ProtInc
P54855	UGT2B15	UDP-glucuronosyltransferase 2B15	GO:0006805; P:xenobiotic metabolic process; TAS:ProtInc
O75795	UGT2B17	UDP-glucuronosyltransferase 2B17	GO:0015020; F:glucuronosyltransferase activity; IEA:UniProtKB-EC
O75795	UGT2B17	UDP-glucuronosyltransferase 2B17	GO:0008202; P:steroid metabolic process; TAS:ProtInc
Q9BY64	UGT2B28	UDP-glucuronosyltransferase 2B28	GO:0015020; F:glucuronosyltransferase activity; IEA:UniProtKB-EC
Q9BY64	UGT2B28	UDP-glucuronosyltransferase 2B28	GO:0008152; P:metabolic process; IDA:UniProtKB
Q9BY64	UGT2B28	UDP-glucuronosyltransferase 2B28	GO:0006805; P:xenobiotic metabolic process; IDA:UniProtKB
Q5JXB2	UBE2NL	Putative ubiquitin-conjugating enzyme E2 N-like	GO:0016881; F:acid-amino acid ligase activity; IEA:InterPro
Q8IX04	UEVLD	Ubiquitin-conjugating enzyme E2 variant 3	GO:0016616; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; IEA:InterPro
Q8IX04	UEVLD	Ubiquitin-conjugating enzyme E2 variant 3	GO:0044262; P:cellular carbohydrate metabolic process; IEA:InterPro
Q8IX04	UEVLD	Ubiquitin-conjugating enzyme E2 variant 3	GO:0006464; P:cellular protein modification process; IEA:InterPro
Q8IX04	UEVLD	Ubiquitin-conjugating enzyme E2 variant 3	GO:0015031; P:protein transport; IEA:InterPro
Q9Y3C8	UFC1	Ubiquitin-fold modifier-conjugating enzyme 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y3C8	UFC1	Ubiquitin-fold modifier-conjugating enzyme 1	GO:0071568; F:UFM1 conjugating enzyme activity; IDA:UniProtKB
Q9Y3C8	UFC1	Ubiquitin-fold modifier-conjugating enzyme 1	GO:0071569; P:protein ufmylation; IDA:UniProtKB
Q9Y3C8	UFC1	Ubiquitin-fold modifier-conjugating enzyme 1	GO:0034976; P:response to endoplasmic reticulum stress; IDA:MGI
Q92890	UFD1L	Ubiquitin fusion degradation protein 1 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q92890	UFD1L	Ubiquitin fusion degradation protein 1 homolog	GO:0004843; F:ubiquitin-specific protease activity; TAS:ProtInc
Q92890	UFD1L	Ubiquitin fusion degradation protein 1 homolog	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:UniProtKB-UniPathway
Q92890	UFD1L	Ubiquitin fusion degradation protein 1 homolog	GO:0001501; P:skeletal system development; TAS:ProtInc
Q92890	UFD1L	Ubiquitin fusion degradation protein 1 homolog	GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc
O94874	UFL1	E3 UFM1-protein ligase 1	GO:0005515; F:protein binding; IPI:UniProtKB
O94874	UFL1	E3 UFM1-protein ligase 1	GO:0071568; F:UFM1 conjugating enzyme activity; IDA:UniProtKB
O94874	UFL1	E3 UFM1-protein ligase 1	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IMP:UniProtKB
O94874	UFL1	E3 UFM1-protein ligase 1	GO:0031397; P:negative regulation of protein ubiquitination; IDA:UniProtKB
O94874	UFL1	E3 UFM1-protein ligase 1	GO:0071569; P:protein ufmylation; IDA:UniProtKB
O94874	UFL1	E3 UFM1-protein ligase 1	GO:0034976; P:response to endoplasmic reticulum stress; IDA:MGI
P61960	UFM1	Ubiquitin-fold modifier 1	GO:0071569; P:protein ufmylation; IDA:UniProtKB
P61960	UFM1	Ubiquitin-fold modifier 1	GO:0034976; P:response to endoplasmic reticulum stress; IDA:MGI
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0001786; F:phosphatidylserine binding; IDA:UniProtKB
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0005515; F:protein binding; IPI:UniProtKB
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; TAS:ProtInc
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0043277; P:apoptotic cell clearance; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0001974; P:blood vessel remodeling; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0048469; P:cell maturation; IEP:UniProtKB
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0031668; P:cellular response to extracellular stimulus; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0035457; P:cellular response to interferon-alpha; IDA:UniProtKB
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0071222; P:cellular response to lipopolysaccharide; IDA:UniProtKB
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0097028; P:dendritic cell differentiation; IEP:UniProtKB
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0007167; P:enzyme linked receptor protein signaling pathway; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0034101; P:erythrocyte homeostasis; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0021885; P:forebrain cell migration; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0006954; P:inflammatory response; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0001779; P:natural killer cell differentiation; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:2000669; P:negative regulation of dendritic cell apoptotic process; IDA:UniProtKB
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0032689; P:negative regulation of interferon-gamma production; IDA:UniProtKB
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0051250; P:negative regulation of lymphocyte activation; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0032720; P:negative regulation of tumor necrosis factor production; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0001764; P:neuron migration; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0031100; P:organ regeneration; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0042698; P:ovulation cycle; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0018108; P:peptidyl-tyrosine phosphorylation; TAS:GOC
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0006909; P:phagocytosis; IDA:UniProtKB
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0030168; P:platelet activation; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0001961; P:positive regulation of cytokine-mediated signaling pathway; IDA:UniProtKB
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0032825; P:positive regulation of natural killer cell differentiation; IDA:UniProtKB
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0043491; P:protein kinase B signaling; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0032940; P:secretion by cell; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0007165; P:signal transduction; TAS:ProtInc
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0007283; P:spermatogenesis; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0034446; P:substrate adhesion-dependent cell spreading; IEA:Ensembl
P30530	AXL	Tyrosine-protein kinase receptor UFO	GO:0060068; P:vagina development; IEA:Ensembl
Q6NVU6	UFSP1	Inactive Ufm1-specific protease 1	GO:0016790; F:thiolester hydrolase activity; IEA:Ensembl
Q6NVU6	UFSP1	Inactive Ufm1-specific protease 1	GO:0071567; F:UFM1 hydrolase activity; IEA:Ensembl
Q9NUQ7	UFSP2	Ufm1-specific protease 2	GO:0019783; F:small conjugating protein-specific protease activity; ISS:UniProtKB
Q9NUQ7	UFSP2	Ufm1-specific protease 2	GO:0016790; F:thiolester hydrolase activity; IEA:Ensembl
O60701	UGDH	UDP-glucose 6-dehydrogenase	GO:0009055; F:electron carrier activity; TAS:UniProtKB
O60701	UGDH	UDP-glucose 6-dehydrogenase	GO:0051287; F:NAD binding; IEA:InterPro
O60701	UGDH	UDP-glucose 6-dehydrogenase	GO:0003979; F:UDP-glucose 6-dehydrogenase activity; TAS:Reactome
O60701	UGDH	UDP-glucose 6-dehydrogenase	GO:0052695; P:cellular glucuronidation; TAS:Reactome
O60701	UGDH	UDP-glucose 6-dehydrogenase	GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl
O60701	UGDH	UDP-glucose 6-dehydrogenase	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:ProtInc
O60701	UGDH	UDP-glucose 6-dehydrogenase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O60701	UGDH	UDP-glucose 6-dehydrogenase	GO:0006011; P:UDP-glucose metabolic process; TAS:ProtInc
O60701	UGDH	UDP-glucose 6-dehydrogenase	GO:0006065; P:UDP-glucuronate biosynthetic process; TAS:Reactome
O60701	UGDH	UDP-glucose 6-dehydrogenase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q9NYU2	UGGT1	UDP-glucose:glycoprotein glucosyltransferase 1	GO:0003980; F:UDP-glucose:glycoprotein glucosyltransferase activity; IDA:UniProtKB
Q9NYU2	UGGT1	UDP-glucose:glycoprotein glucosyltransferase 1	GO:0051082; F:unfolded protein binding; IDA:UniProtKB
Q9NYU2	UGGT1	UDP-glucose:glycoprotein glucosyltransferase 1	GO:0051084; P:'de novo' posttranslational protein folding; TAS:UniProtKB
Q9NYU2	UGGT1	UDP-glucose:glycoprotein glucosyltransferase 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9NYU2	UGGT1	UDP-glucose:glycoprotein glucosyltransferase 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9NYU2	UGGT1	UDP-glucose:glycoprotein glucosyltransferase 1	GO:0006457; P:protein folding; TAS:Reactome
Q9NYU2	UGGT1	UDP-glucose:glycoprotein glucosyltransferase 1	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9NYU1	UGGT2	UDP-glucose:glycoprotein glucosyltransferase 2	GO:0003980; F:UDP-glucose:glycoprotein glucosyltransferase activity; ISS:UniProtKB
Q9NYU1	UGGT2	UDP-glucose:glycoprotein glucosyltransferase 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9NYU1	UGGT2	UDP-glucose:glycoprotein glucosyltransferase 2	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9NYU1	UGGT2	UDP-glucose:glycoprotein glucosyltransferase 2	GO:0006457; P:protein folding; TAS:Reactome
Q9NYU1	UGGT2	UDP-glucose:glycoprotein glucosyltransferase 2	GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome
Q9NYU1	UGGT2	UDP-glucose:glycoprotein glucosyltransferase 2	GO:0097359; P:UDP-glucosylation; ISS:GOC
Q16851	UGP2	UTP--glucose-1-phosphate uridylyltransferase	GO:0005536; F:glucose binding; IEA:Ensembl
Q16851	UGP2	UTP--glucose-1-phosphate uridylyltransferase	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q16851	UGP2	UTP--glucose-1-phosphate uridylyltransferase	GO:0005515; F:protein binding; IPI:IntAct
Q16851	UGP2	UTP--glucose-1-phosphate uridylyltransferase	GO:0032557; F:pyrimidine ribonucleotide binding; IEA:Ensembl
Q16851	UGP2	UTP--glucose-1-phosphate uridylyltransferase	GO:0003983; F:UTP:glucose-1-phosphate uridylyltransferase activity; TAS:UniProtKB
Q16851	UGP2	UTP--glucose-1-phosphate uridylyltransferase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q16851	UGP2	UTP--glucose-1-phosphate uridylyltransferase	GO:0052695; P:cellular glucuronidation; TAS:Reactome
Q16851	UGP2	UTP--glucose-1-phosphate uridylyltransferase	GO:0019255; P:glucose 1-phosphate metabolic process; IEA:Ensembl
Q16851	UGP2	UTP--glucose-1-phosphate uridylyltransferase	GO:0006006; P:glucose metabolic process; TAS:Reactome
Q16851	UGP2	UTP--glucose-1-phosphate uridylyltransferase	GO:0005978; P:glycogen biosynthetic process; TAS:Reactome
Q16851	UGP2	UTP--glucose-1-phosphate uridylyltransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16851	UGP2	UTP--glucose-1-phosphate uridylyltransferase	GO:0006011; P:UDP-glucose metabolic process; TAS:ProtInc
Q16851	UGP2	UTP--glucose-1-phosphate uridylyltransferase	GO:0006065; P:UDP-glucuronate biosynthetic process; TAS:Reactome
Q16851	UGP2	UTP--glucose-1-phosphate uridylyltransferase	GO:0006805; P:xenobiotic metabolic process; TAS:Reactome
Q8TAS1	UHMK1	Serine/threonine-protein kinase Kist	GO:0005524; F:ATP binding; IC:HGNC
Q8TAS1	UHMK1	Serine/threonine-protein kinase Kist	GO:0005515; F:protein binding; IPI:HGNC
Q8TAS1	UHMK1	Serine/threonine-protein kinase Kist	GO:0004674; F:protein serine/threonine kinase activity; IDA:HGNC
Q8TAS1	UHMK1	Serine/threonine-protein kinase Kist	GO:0043021; F:ribonucleoprotein complex binding; ISS:BHF-UCL
Q8TAS1	UHMK1	Serine/threonine-protein kinase Kist	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q8TAS1	UHMK1	Serine/threonine-protein kinase Kist	GO:0016740; F:transferase activity; IC:HGNC
Q8TAS1	UHMK1	Serine/threonine-protein kinase Kist	GO:0007050; P:cell cycle arrest; IMP:HGNC
Q8TAS1	UHMK1	Serine/threonine-protein kinase Kist	GO:0031175; P:neuron projection development; ISS:BHF-UCL
Q8TAS1	UHMK1	Serine/threonine-protein kinase Kist	GO:0018105; P:peptidyl-serine phosphorylation; ISS:UniProtKB
Q8TAS1	UHMK1	Serine/threonine-protein kinase Kist	GO:0045948; P:positive regulation of translational initiation; ISS:BHF-UCL
Q8TAS1	UHMK1	Serine/threonine-protein kinase Kist	GO:0046777; P:protein autophosphorylation; IDA:HGNC
Q8TAS1	UHMK1	Serine/threonine-protein kinase Kist	GO:0046825; P:regulation of protein export from nucleus; IDA:HGNC
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0000987; F:core promoter proximal region sequence-specific DNA binding; IDA:BHF-UCL
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0044729; F:hemi-methylated DNA-binding; IDA:UniProtKB
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0042393; F:histone binding; IDA:UniProtKB
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0042802; F:identical protein binding; ISS:BHF-UCL
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0008327; F:methyl-CpG binding; IDA:UniProtKB
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0031493; F:nucleosomal histone binding; ISS:BHF-UCL
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0008283; P:cell proliferation; IEP:BHF-UCL
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0006281; P:DNA repair; IEA:UniProtKB-KW
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0010390; P:histone monoubiquitination; ISS:BHF-UCL
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0016574; P:histone ubiquitination; IDA:UniProtKB
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0010216; P:maintenance of DNA methylation; IMP:UniProtKB
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0032270; P:positive regulation of cellular protein metabolic process; IDA:BHF-UCL
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:2000373; P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity; IC:BHF-UCL
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IC:BHF-UCL
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q96T88	UHRF1	E3 ubiquitin-protein ligase UHRF1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96PU4	UHRF2	E3 ubiquitin-protein ligase UHRF2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96PU4	UHRF2	E3 ubiquitin-protein ligase UHRF2	GO:0042393; F:histone binding; ISS:UniProtKB
Q96PU4	UHRF2	E3 ubiquitin-protein ligase UHRF2	GO:0005515; F:protein binding; IPI:UniProtKB
Q96PU4	UHRF2	E3 ubiquitin-protein ligase UHRF2	GO:0004842; F:ubiquitin-protein ligase activity; IDA:HGNC
Q96PU4	UHRF2	E3 ubiquitin-protein ligase UHRF2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96PU4	UHRF2	E3 ubiquitin-protein ligase UHRF2	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q96PU4	UHRF2	E3 ubiquitin-protein ligase UHRF2	GO:0030154; P:cell differentiation; IEP:HGNC
Q96PU4	UHRF2	E3 ubiquitin-protein ligase UHRF2	GO:0008283; P:cell proliferation; IEP:HGNC
Q96PU4	UHRF2	E3 ubiquitin-protein ligase UHRF2	GO:0071158; P:positive regulation of cell cycle arrest; IDA:UniProtKB
Q96PU4	UHRF2	E3 ubiquitin-protein ligase UHRF2	GO:0051865; P:protein autoubiquitination; IDA:HGNC
Q96PU4	UHRF2	E3 ubiquitin-protein ligase UHRF2	GO:0016567; P:protein ubiquitination; IDA:HGNC
Q96PU4	UHRF2	E3 ubiquitin-protein ligase UHRF2	GO:0051726; P:regulation of cell cycle; TAS:HGNC
Q96PU4	UHRF2	E3 ubiquitin-protein ligase UHRF2	GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:HGNC
Q96QD9	FYTTD1	UAP56-interacting factor	GO:0003729; F:mRNA binding; IDA:UniProtKB
Q96QD9	FYTTD1	UAP56-interacting factor	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96QD9	FYTTD1	UAP56-interacting factor	GO:0005515; F:protein binding; IPI:UniProtKB
Q96QD9	FYTTD1	UAP56-interacting factor	GO:0006406; P:mRNA export from nucleus; IMP:UniProtKB
Q96RL1	UIMC1	BRCA1-A complex subunit RAP80	GO:0042393; F:histone binding; IDA:UniProtKB
Q96RL1	UIMC1	BRCA1-A complex subunit RAP80	GO:0070530; F:K63-linked polyubiquitin binding; IDA:UniProtKB
Q96RL1	UIMC1	BRCA1-A complex subunit RAP80	GO:0005515; F:protein binding; IPI:UniProtKB
Q96RL1	UIMC1	BRCA1-A complex subunit RAP80	GO:0006302; P:double-strand break repair; IMP:UniProtKB
Q96RL1	UIMC1	BRCA1-A complex subunit RAP80	GO:0031572; P:G2 DNA damage checkpoint; IMP:UniProtKB
Q96RL1	UIMC1	BRCA1-A complex subunit RAP80	GO:0070537; P:histone H2A K63-linked deubiquitination; IMP:UniProtKB
Q96RL1	UIMC1	BRCA1-A complex subunit RAP80	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:HGNC
Q96RL1	UIMC1	BRCA1-A complex subunit RAP80	GO:0045739; P:positive regulation of DNA repair; IMP:UniProtKB
Q96RL1	UIMC1	BRCA1-A complex subunit RAP80	GO:0010212; P:response to ionizing radiation; IMP:UniProtKB
Q96RL1	UIMC1	BRCA1-A complex subunit RAP80	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P52758	HRSP12	Ribonuclease UK114	GO:0019239; F:deaminase activity; IEA:InterPro
P52758	HRSP12	Ribonuclease UK114	GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW
P52758	HRSP12	Ribonuclease UK114	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P52758	HRSP12	Ribonuclease UK114	GO:0006449; P:regulation of translational termination; TAS:ProtInc
C9JPN9	USP17L12	Ubiquitin carboxyl-terminal hydrolase 17-like protein 12	GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW
C9JPN9	USP17L12	Ubiquitin carboxyl-terminal hydrolase 17-like protein 12	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q13564	NAE1	NEDD8-activating enzyme E1 regulatory subunit	GO:0003824; F:catalytic activity; IEA:InterPro
Q13564	NAE1	NEDD8-activating enzyme E1 regulatory subunit	GO:0005515; F:protein binding; IPI:UniProtKB
Q13564	NAE1	NEDD8-activating enzyme E1 regulatory subunit	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q13564	NAE1	NEDD8-activating enzyme E1 regulatory subunit	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q13564	NAE1	NEDD8-activating enzyme E1 regulatory subunit	GO:0033314; P:mitotic DNA replication checkpoint; IDA:UniProtKB
Q13564	NAE1	NEDD8-activating enzyme E1 regulatory subunit	GO:0051402; P:neuron apoptotic process; IDA:UniProtKB
Q13564	NAE1	NEDD8-activating enzyme E1 regulatory subunit	GO:0045116; P:protein neddylation; IDA:UniProtKB
Q13564	NAE1	NEDD8-activating enzyme E1 regulatory subunit	GO:0042981; P:regulation of apoptotic process; IDA:UniProtKB
Q13564	NAE1	NEDD8-activating enzyme E1 regulatory subunit	GO:0043523; P:regulation of neuron apoptotic process; IDA:UniProtKB
Q13564	NAE1	NEDD8-activating enzyme E1 regulatory subunit	GO:0007165; P:signal transduction; TAS:ProtInc
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0005515; F:protein binding; IPI:UniProtKB
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0032403; F:protein complex binding; IPI:UniProtKB
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0017137; F:Rab GTPase binding; IPI:BHF-UCL
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0000045; P:autophagic vacuole assembly; IEA:Ensembl
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0048675; P:axon extension; IEA:Ensembl
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0031669; P:cellular response to nutrient levels; ISS:UniProtKB
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0021707; P:cerebellar granule cell differentiation; IEA:Ensembl
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0048671; P:negative regulation of collateral sprouting; IEA:Ensembl
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0031175; P:neuron projection development; IMP:UniProtKB
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0031102; P:neuron projection regeneration; IEA:Ensembl
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0010508; P:positive regulation of autophagy; ISS:UniProtKB
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0016239; P:positive regulation of macroautophagy; IMP:BHF-UCL
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0008104; P:protein localization; IMP:UniProtKB
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0006468; P:protein phosphorylation; NAS:UniProtKB
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0021933; P:radial glia guided migration of cerebellar granule cell; IEA:Ensembl
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0007265; P:Ras protein signal transduction; IEA:Ensembl
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0031623; P:receptor internalization; IEA:Ensembl
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0010506; P:regulation of autophagy; IDA:UniProtKB
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0051386; P:regulation of neurotrophin TRK receptor signaling pathway; IEA:Ensembl
O75385	ULK1	Serine/threonine-protein kinase ULK1	GO:0042594; P:response to starvation; ISS:UniProtKB
Q8IYT8	ULK2	Serine/threonine-protein kinase ULK2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q8IYT8	ULK2	Serine/threonine-protein kinase ULK2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IYT8	ULK2	Serine/threonine-protein kinase ULK2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q8IYT8	ULK2	Serine/threonine-protein kinase ULK2	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q8IYT8	ULK2	Serine/threonine-protein kinase ULK2	GO:0048675; P:axon extension; IEA:Ensembl
Q8IYT8	ULK2	Serine/threonine-protein kinase ULK2	GO:0048671; P:negative regulation of collateral sprouting; IEA:Ensembl
Q8IYT8	ULK2	Serine/threonine-protein kinase ULK2	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q8IYT8	ULK2	Serine/threonine-protein kinase ULK2	GO:0010506; P:regulation of autophagy; IDA:UniProtKB
Q8IYT8	ULK2	Serine/threonine-protein kinase ULK2	GO:0042594; P:response to starvation; ISS:UniProtKB
Q8IYT8	ULK2	Serine/threonine-protein kinase ULK2	GO:0007165; P:signal transduction; IEA:InterPro
Q96C45	ULK4	Serine/threonine-protein kinase ULK4	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96C45	ULK4	Serine/threonine-protein kinase ULK4	GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW
Q96C45	ULK4	Serine/threonine-protein kinase ULK4	GO:0060271; P:cilium morphogenesis; IEA:Ensembl
Q96C45	ULK4	Serine/threonine-protein kinase ULK4	GO:0003351; P:epithelial cilium movement; IEA:Ensembl
Q96C45	ULK4	Serine/threonine-protein kinase ULK4	GO:0021591; P:ventricular system development; IEA:Ensembl
Q6PHR2	ULK3	Serine/threonine-protein kinase ULK3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6PHR2	ULK3	Serine/threonine-protein kinase ULK3	GO:0005515; F:protein binding; IPI:UniProtKB
Q6PHR2	ULK3	Serine/threonine-protein kinase ULK3	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q6PHR2	ULK3	Serine/threonine-protein kinase ULK3	GO:0006914; P:autophagy; TAS:UniProtKB
Q6PHR2	ULK3	Serine/threonine-protein kinase ULK3	GO:0090398; P:cellular senescence; TAS:UniProtKB
Q6PHR2	ULK3	Serine/threonine-protein kinase ULK3	GO:0045879; P:negative regulation of smoothened signaling pathway; IDA:UniProtKB
Q6PHR2	ULK3	Serine/threonine-protein kinase ULK3	GO:0045880; P:positive regulation of smoothened signaling pathway; IDA:UniProtKB
Q6PHR2	ULK3	Serine/threonine-protein kinase ULK3	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P11172	UMPS	Uridine 5'-monophosphate synthase	GO:0004588; F:orotate phosphoribosyltransferase activity; IDA:UniProtKB
P11172	UMPS	Uridine 5'-monophosphate synthase	GO:0004590; F:orotidine-5'-phosphate decarboxylase activity; IDA:UniProtKB
P11172	UMPS	Uridine 5'-monophosphate synthase	GO:0006207; P:'de novo' pyrimidine nucleobase biosynthetic process; IEA:InterPro
P11172	UMPS	Uridine 5'-monophosphate synthase	GO:0044205; P:'de novo' UMP biosynthetic process; IEA:UniProtKB-UniPathway
P11172	UMPS	Uridine 5'-monophosphate synthase	GO:0035690; P:cellular response to drug; IEA:Ensembl
P11172	UMPS	Uridine 5'-monophosphate synthase	GO:0007565; P:female pregnancy; IEA:Ensembl
P11172	UMPS	Uridine 5'-monophosphate synthase	GO:0007595; P:lactation; IEA:Ensembl
P11172	UMPS	Uridine 5'-monophosphate synthase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P11172	UMPS	Uridine 5'-monophosphate synthase	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
P11172	UMPS	Uridine 5'-monophosphate synthase	GO:0046134; P:pyrimidine nucleoside biosynthetic process; TAS:Reactome
P11172	UMPS	Uridine 5'-monophosphate synthase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P11172	UMPS	Uridine 5'-monophosphate synthase	GO:0006222; P:UMP biosynthetic process; IDA:UniProtKB
Q9UPW8	UNC13A	Protein unc-13 homolog A	GO:0019992; F:diacylglycerol binding; IEA:Ensembl
Q9UPW8	UNC13A	Protein unc-13 homolog A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UPW8	UNC13A	Protein unc-13 homolog A	GO:0050435; P:beta-amyloid metabolic process; IEA:Ensembl
Q9UPW8	UNC13A	Protein unc-13 homolog A	GO:0060384; P:innervation; IEA:Ensembl
Q9UPW8	UNC13A	Protein unc-13 homolog A	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9UPW8	UNC13A	Protein unc-13 homolog A	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
Q9UPW8	UNC13A	Protein unc-13 homolog A	GO:0001956; P:positive regulation of neurotransmitter secretion; IEA:Ensembl
Q9UPW8	UNC13A	Protein unc-13 homolog A	GO:0048172; P:regulation of short-term neuronal synaptic plasticity; IEA:Ensembl
Q9UPW8	UNC13A	Protein unc-13 homolog A	GO:0035249; P:synaptic transmission, glutamatergic; IEA:Ensembl
Q9UPW8	UNC13A	Protein unc-13 homolog A	GO:0016081; P:synaptic vesicle docking involved in exocytosis; IEA:Ensembl
Q9UPW8	UNC13A	Protein unc-13 homolog A	GO:0016188; P:synaptic vesicle maturation; IEA:Ensembl
O14795	UNC13B	Protein unc-13 homolog B	GO:0019992; F:diacylglycerol binding; IEA:InterPro
O14795	UNC13B	Protein unc-13 homolog B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14795	UNC13B	Protein unc-13 homolog B	GO:0005515; F:protein binding; IPI:UniProt
O14795	UNC13B	Protein unc-13 homolog B	GO:0004872; F:receptor activity; TAS:ProtInc
O14795	UNC13B	Protein unc-13 homolog B	GO:0004871; F:signal transducer activity; TAS:ProtInc
O14795	UNC13B	Protein unc-13 homolog B	GO:0006915; P:apoptotic process; TAS:ProtInc
O14795	UNC13B	Protein unc-13 homolog B	GO:0007588; P:excretion; TAS:ProtInc
O14795	UNC13B	Protein unc-13 homolog B	GO:0060384; P:innervation; IEA:Ensembl
O14795	UNC13B	Protein unc-13 homolog B	GO:0035556; P:intracellular signal transduction; IEA:InterPro
O14795	UNC13B	Protein unc-13 homolog B	GO:0007528; P:neuromuscular junction development; IEA:Ensembl
O14795	UNC13B	Protein unc-13 homolog B	GO:0048172; P:regulation of short-term neuronal synaptic plasticity; IEA:Ensembl
O14795	UNC13B	Protein unc-13 homolog B	GO:0007165; P:signal transduction; TAS:ProtInc
O14795	UNC13B	Protein unc-13 homolog B	GO:0035249; P:synaptic transmission, glutamatergic; IEA:Ensembl
O14795	UNC13B	Protein unc-13 homolog B	GO:0016081; P:synaptic vesicle docking involved in exocytosis; IEA:Ensembl
O14795	UNC13B	Protein unc-13 homolog B	GO:0016082; P:synaptic vesicle priming; IEA:Ensembl
Q8NB66	UNC13C	Protein unc-13 homolog C	GO:0019992; F:diacylglycerol binding; IEA:InterPro
Q8NB66	UNC13C	Protein unc-13 homolog C	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NB66	UNC13C	Protein unc-13 homolog C	GO:0006887; P:exocytosis; IEA:UniProtKB-KW
Q8NB66	UNC13C	Protein unc-13 homolog C	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q8NB66	UNC13C	Protein unc-13 homolog C	GO:0007268; P:synaptic transmission; IEA:Ensembl
Q70J99	UNC13D	Protein unc-13 homolog D	GO:0005515; F:protein binding; IPI:UniProtKB
Q70J99	UNC13D	Protein unc-13 homolog D	GO:0051607; P:defense response to virus; IEA:Ensembl
Q70J99	UNC13D	Protein unc-13 homolog D	GO:0002467; P:germinal center formation; IEA:Ensembl
Q70J99	UNC13D	Protein unc-13 homolog D	GO:0002432; P:granuloma formation; IEA:Ensembl
Q70J99	UNC13D	Protein unc-13 homolog D	GO:0043320; P:natural killer cell degranulation; IEA:Ensembl
Q70J99	UNC13D	Protein unc-13 homolog D	GO:0006909; P:phagocytosis; IEA:Ensembl
Q70J99	UNC13D	Protein unc-13 homolog D	GO:0045921; P:positive regulation of exocytosis; IMP:UniProtKB
Q70J99	UNC13D	Protein unc-13 homolog D	GO:0043304; P:regulation of mast cell degranulation; IMP:UniProtKB
Q9H3U1	UNC45A	Protein unc-45 homolog A	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9H3U1	UNC45A	Protein unc-45 homolog A	GO:0061077; P:chaperone-mediated protein folding; IEA:Ensembl
Q9H3U1	UNC45A	Protein unc-45 homolog A	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
Q8IWX7	UNC45B	Protein unc-45 homolog B	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8IWX7	UNC45B	Protein unc-45 homolog B	GO:0061077; P:chaperone-mediated protein folding; IEA:Ensembl
Q8IWX7	UNC45B	Protein unc-45 homolog B	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
Q8IV45	UNC5CL	UNC5C-like protein	GO:0007165; P:signal transduction; IEA:InterPro
Q9H1C4	UNC93B1	Protein unc-93 homolog B1	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q9H1C4	UNC93B1	Protein unc-93 homolog B1	GO:0045087; P:innate immune response; TAS:Reactome
Q9H1C4	UNC93B1	Protein unc-93 homolog B1	GO:0006886; P:intracellular protein transport; ISS:UniProtKB
Q9H1C4	UNC93B1	Protein unc-93 homolog B1	GO:0034138; P:toll-like receptor 3 signaling pathway; IMP:UniProtKB
Q9H1C4	UNC93B1	Protein unc-93 homolog B1	GO:0034154; P:toll-like receptor 7 signaling pathway; IMP:UniProtKB
Q9H1C4	UNC93B1	Protein unc-93 homolog B1	GO:0034162; P:toll-like receptor 9 signaling pathway; IMP:UniProtKB
Q9H1C4	UNC93B1	Protein unc-93 homolog B1	GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome
A6NJT0	UNCX	Homeobox protein unc-4 homolog	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
A6NJT0	UNCX	Homeobox protein unc-4 homolog	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
A6NJT0	UNCX	Homeobox protein unc-4 homolog	GO:0001502; P:cartilage condensation; IEA:Ensembl
A6NJT0	UNCX	Homeobox protein unc-4 homolog	GO:0035726; P:common myeloid progenitor cell proliferation; IEA:Ensembl
A6NJT0	UNCX	Homeobox protein unc-4 homolog	GO:0021516; P:dorsal spinal cord development; IEA:Ensembl
A6NJT0	UNCX	Homeobox protein unc-4 homolog	GO:0021889; P:olfactory bulb interneuron differentiation; IEA:Ensembl
A6NJT0	UNCX	Homeobox protein unc-4 homolog	GO:0007389; P:pattern specification process; IEA:Ensembl
A6NJT0	UNCX	Homeobox protein unc-4 homolog	GO:0045595; P:regulation of cell differentiation; IEA:Ensembl
A6NJT0	UNCX	Homeobox protein unc-4 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q53HI1	UNC50	Protein unc-50 homolog	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q53HI1	UNC50	Protein unc-50 homolog	GO:0007166; P:cell surface receptor signaling pathway; IEA:Ensembl
Q53HI1	UNC50	Protein unc-50 homolog	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q6ZN44	UNC5A	Netrin receptor UNC5A	GO:0033564; P:anterior/posterior axon guidance; IEA:Ensembl
Q6ZN44	UNC5A	Netrin receptor UNC5A	GO:0006915; P:apoptotic process; TAS:Reactome
Q6ZN44	UNC5A	Netrin receptor UNC5A	GO:0007411; P:axon guidance; TAS:Reactome
Q6ZN44	UNC5A	Netrin receptor UNC5A	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q6ZN44	UNC5A	Netrin receptor UNC5A	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
Q6ZN44	UNC5A	Netrin receptor UNC5A	GO:0007165; P:signal transduction; IEA:InterPro
Q8IZJ1	UNC5B	Netrin receptor UNC5B	GO:0005515; F:protein binding; IPI:IntAct
Q8IZJ1	UNC5B	Netrin receptor UNC5B	GO:0033564; P:anterior/posterior axon guidance; IEA:Ensembl
Q8IZJ1	UNC5B	Netrin receptor UNC5B	GO:0006915; P:apoptotic process; TAS:Reactome
Q8IZJ1	UNC5B	Netrin receptor UNC5B	GO:0007411; P:axon guidance; TAS:Reactome
Q8IZJ1	UNC5B	Netrin receptor UNC5B	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IMP:UniProtKB
Q8IZJ1	UNC5B	Netrin receptor UNC5B	GO:0043524; P:negative regulation of neuron apoptotic process; IMP:UniProtKB
Q8IZJ1	UNC5B	Netrin receptor UNC5B	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q8IZJ1	UNC5B	Netrin receptor UNC5B	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IMP:UniProtKB
Q8IZJ1	UNC5B	Netrin receptor UNC5B	GO:0042981; P:regulation of apoptotic process; TAS:Reactome
Q8IZJ1	UNC5B	Netrin receptor UNC5B	GO:0007165; P:signal transduction; IEA:InterPro
O95185	UNC5C	Netrin receptor UNC5C	GO:0005042; F:netrin receptor activity; TAS:ProtInc
O95185	UNC5C	Netrin receptor UNC5C	GO:0033564; P:anterior/posterior axon guidance; IEA:Ensembl
O95185	UNC5C	Netrin receptor UNC5C	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
O95185	UNC5C	Netrin receptor UNC5C	GO:0007411; P:axon guidance; TAS:Reactome
O95185	UNC5C	Netrin receptor UNC5C	GO:0007420; P:brain development; TAS:ProtInc
O95185	UNC5C	Netrin receptor UNC5C	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
O95185	UNC5C	Netrin receptor UNC5C	GO:0030334; P:regulation of cell migration; IEA:Ensembl
Q6UXZ4	UNC5D	Netrin receptor UNC5D	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q6UXZ4	UNC5D	Netrin receptor UNC5D	GO:0007411; P:axon guidance; TAS:Reactome
Q6UXZ4	UNC5D	Netrin receptor UNC5D	GO:0021859; P:pyramidal neuron differentiation; IEA:Ensembl
Q6UXZ4	UNC5D	Netrin receptor UNC5D	GO:0007165; P:signal transduction; IEA:InterPro
Q9P2D8	UNC79	Protein unc-79 homolog	GO:0048149; P:behavioral response to ethanol; IEA:Ensembl
Q9P2D8	UNC79	Protein unc-79 homolog	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9P2D8	UNC79	Protein unc-79 homolog	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q9P2D8	UNC79	Protein unc-79 homolog	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8N2C7	UNC80	Protein unc-80 homolog	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q8N2C7	UNC80	Protein unc-80 homolog	GO:0055085; P:transmembrane transport; TAS:Reactome
P13051	UNG	Uracil-DNA glycosylase	GO:0004844; F:uracil DNA N-glycosylase activity; NAS:UniProtKB
P13051	UNG	Uracil-DNA glycosylase	GO:0006284; P:base-excision repair; TAS:ProtInc
P13051	UNG	Uracil-DNA glycosylase	GO:0006281; P:DNA repair; TAS:ProtInc
P13051	UNG	Uracil-DNA glycosylase	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P13051	UNG	Uracil-DNA glycosylase	GO:0016446; P:somatic hypermutation of immunoglobulin genes; IEA:Ensembl
P13051	UNG	Uracil-DNA glycosylase	GO:0016447; P:somatic recombination of immunoglobulin gene segments; IEA:Ensembl
P13051	UNG	Uracil-DNA glycosylase	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9H9P5	UNKL	Putative E3 ubiquitin-protein ligase UNKL	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q9H9P5	UNKL	Putative E3 ubiquitin-protein ligase UNKL	GO:0005515; F:protein binding; IPI:IntAct
Q9H9P5	UNKL	Putative E3 ubiquitin-protein ligase UNKL	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H9P5	UNKL	Putative E3 ubiquitin-protein ligase UNKL	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9C0B0	UNK	RING finger protein unkempt homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9C0B0	UNK	RING finger protein unkempt homolog	GO:0008270; F:zinc ion binding; IEA:InterPro
Q03405	PLAUR	Urokinase plasminogen activator surface receptor	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q03405	PLAUR	Urokinase plasminogen activator surface receptor	GO:0005515; F:protein binding; IPI:UniProtKB
Q03405	PLAUR	Urokinase plasminogen activator surface receptor	GO:0004872; F:receptor activity; NAS:UniProtKB
Q03405	PLAUR	Urokinase plasminogen activator surface receptor	GO:0030377; F:urokinase plasminogen activator receptor activity; NAS:UniProtKB
Q03405	PLAUR	Urokinase plasminogen activator surface receptor	GO:0016255; P:attachment of GPI anchor to protein; TAS:Reactome
Q03405	PLAUR	Urokinase plasminogen activator surface receptor	GO:0007596; P:blood coagulation; NAS:UniProtKB
Q03405	PLAUR	Urokinase plasminogen activator surface receptor	GO:0006501; P:C-terminal protein lipidation; TAS:Reactome
Q03405	PLAUR	Urokinase plasminogen activator surface receptor	GO:0006928; P:cellular component movement; NAS:UniProtKB
Q03405	PLAUR	Urokinase plasminogen activator surface receptor	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q03405	PLAUR	Urokinase plasminogen activator surface receptor	GO:0006935; P:chemotaxis; TAS:ProtInc
Q03405	PLAUR	Urokinase plasminogen activator surface receptor	GO:0042730; P:fibrinolysis; TAS:Reactome
Q03405	PLAUR	Urokinase plasminogen activator surface receptor	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q03405	PLAUR	Urokinase plasminogen activator surface receptor	GO:0030162; P:regulation of proteolysis; NAS:UniProtKB
Q03405	PLAUR	Urokinase plasminogen activator surface receptor	GO:0007165; P:signal transduction; TAS:ProtInc
Q03405	PLAUR	Urokinase plasminogen activator surface receptor	GO:0038195; P:urokinase plasminogen activator signaling pathway; NAS:GOC
O00322	UPK1A	Uroplakin-1a	GO:0048029; F:monosaccharide binding; ISS:UniProtKB
O00322	UPK1A	Uroplakin-1a	GO:0042803; F:protein homodimerization activity; ISS:UniProtKB
O00322	UPK1A	Uroplakin-1a	GO:0030855; P:epithelial cell differentiation; IDA:UniProtKB
O00322	UPK1A	Uroplakin-1a	GO:0051259; P:protein oligomerization; ISS:UniProtKB
O75841	UPK1B	Uroplakin-1b	GO:0005198; F:structural molecule activity; NAS:UniProtKB
O75841	UPK1B	Uroplakin-1b	GO:0030855; P:epithelial cell differentiation; IDA:UniProtKB
O00526	UPK2	Uroplakin-2	GO:0030855; P:epithelial cell differentiation; IDA:UniProtKB
O00526	UPK2	Uroplakin-2	GO:0061024; P:membrane organization; IEA:InterPro
O00526	UPK2	Uroplakin-2	GO:0007275; P:multicellular organismal development; TAS:ProtInc
O75631	UPK3A	Uroplakin-3a	GO:0000902; P:cell morphogenesis; IEA:Ensembl
O75631	UPK3A	Uroplakin-3a	GO:0030855; P:epithelial cell differentiation; IDA:UniProtKB
O75631	UPK3A	Uroplakin-3a	GO:0001822; P:kidney development; IEA:Ensembl
O75631	UPK3A	Uroplakin-3a	GO:0055075; P:potassium ion homeostasis; IEA:Ensembl
O75631	UPK3A	Uroplakin-3a	GO:0055078; P:sodium ion homeostasis; IEA:Ensembl
O75631	UPK3A	Uroplakin-3a	GO:0015840; P:urea transport; IEA:Ensembl
O75631	UPK3A	Uroplakin-3a	GO:0060157; P:urinary bladder development; IEA:Ensembl
O75631	UPK3A	Uroplakin-3a	GO:0006833; P:water transport; IEA:Ensembl
Q9BT76	UPK3B	Uroplakin-3b	GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB
Q16831	UPP1	Uridine phosphorylase 1	GO:0004850; F:uridine phosphorylase activity; TAS:ProtInc
Q16831	UPP1	Uridine phosphorylase 1	GO:0042149; P:cellular response to glucose starvation; IEA:Ensembl
Q16831	UPP1	Uridine phosphorylase 1	GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc
Q16831	UPP1	Uridine phosphorylase 1	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
Q16831	UPP1	Uridine phosphorylase 1	GO:0009166; P:nucleotide catabolic process; IEA:InterPro
Q16831	UPP1	Uridine phosphorylase 1	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
Q16831	UPP1	Uridine phosphorylase 1	GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome
Q16831	UPP1	Uridine phosphorylase 1	GO:0043097; P:pyrimidine nucleoside salvage; TAS:Reactome
Q16831	UPP1	Uridine phosphorylase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q16831	UPP1	Uridine phosphorylase 1	GO:0044206; P:UMP salvage; IEA:UniProtKB-UniPathway
Q16831	UPP1	Uridine phosphorylase 1	GO:0046108; P:uridine metabolic process; IEA:Ensembl
O95045	UPP2	Uridine phosphorylase 2	GO:0004850; F:uridine phosphorylase activity; IDA:UniProtKB
O95045	UPP2	Uridine phosphorylase 2	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
O95045	UPP2	Uridine phosphorylase 2	GO:0009116; P:nucleoside metabolic process; NAS:UniProtKB
O95045	UPP2	Uridine phosphorylase 2	GO:0009166; P:nucleotide catabolic process; IEA:InterPro
O95045	UPP2	Uridine phosphorylase 2	GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome
O95045	UPP2	Uridine phosphorylase 2	GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome
O95045	UPP2	Uridine phosphorylase 2	GO:0043097; P:pyrimidine nucleoside salvage; TAS:Reactome
O95045	UPP2	Uridine phosphorylase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95045	UPP2	Uridine phosphorylase 2	GO:0044206; P:UMP salvage; IEA:UniProtKB-UniPathway
O95045	UPP2	Uridine phosphorylase 2	GO:0046108; P:uridine metabolic process; NAS:UniProtKB
Q96BW1	UPRT	Uracil phosphoribosyltransferase homolog	GO:0007565; P:female pregnancy; IEA:Ensembl
Q96BW1	UPRT	Uracil phosphoribosyltransferase homolog	GO:0007595; P:lactation; IEA:Ensembl
Q96BW1	UPRT	Uracil phosphoribosyltransferase homolog	GO:0032868; P:response to insulin; IEA:Ensembl
Q96BW1	UPRT	Uracil phosphoribosyltransferase homolog	GO:0006222; P:UMP biosynthetic process; IEA:Ensembl
Q9BRT2	UQCC2	Ubiquinol-cytochrome-c reductase complex assembly factor 2	GO:0050796; P:regulation of insulin secretion; ISS:UniProtKB
Q9BRT2	UQCC2	Ubiquinol-cytochrome-c reductase complex assembly factor 2	GO:0002082; P:regulation of oxidative phosphorylation; IMP:UniProtKB
Q9BRT2	UQCC2	Ubiquinol-cytochrome-c reductase complex assembly factor 2	GO:2001014; P:regulation of skeletal muscle cell differentiation; ISS:UniProtKB
Q9UKP6	UTS2R	Urotensin-2 receptor	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q9UKP6	UTS2R	Urotensin-2 receptor	GO:0001604; F:urotensin II receptor activity; IEA:Ensembl
Q9UKP6	UTS2R	Urotensin-2 receptor	GO:0008015; P:blood circulation; TAS:ProtInc
Q9UKP6	UTS2R	Urotensin-2 receptor	GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl
Q9UKP6	UTS2R	Urotensin-2 receptor	GO:0003105; P:negative regulation of glomerular filtration; IEA:Ensembl
Q9UKP6	UTS2R	Urotensin-2 receptor	GO:0035814; P:negative regulation of renal sodium excretion; IEA:Ensembl
Q9UKP6	UTS2R	Urotensin-2 receptor	GO:0035811; P:negative regulation of urine volume; IEA:Ensembl
Q9UKP6	UTS2R	Urotensin-2 receptor	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
Q9UKP6	UTS2R	Urotensin-2 receptor	GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl
Q9UKP6	UTS2R	Urotensin-2 receptor	GO:0030307; P:positive regulation of cell growth; IEA:Ensembl
Q9UKP6	UTS2R	Urotensin-2 receptor	GO:0046005; P:positive regulation of circadian sleep/wake cycle, REM sleep; IEA:Ensembl
Q9UKP6	UTS2R	Urotensin-2 receptor	GO:0010841; P:positive regulation of circadian sleep/wake cycle, wakefulness; IEA:Ensembl
Q9UKP6	UTS2R	Urotensin-2 receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
Q9UKP6	UTS2R	Urotensin-2 receptor	GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl
Q9UKP6	UTS2R	Urotensin-2 receptor	GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl
Q9UKP6	UTS2R	Urotensin-2 receptor	GO:0042312; P:regulation of vasodilation; IEA:InterPro
Q9UKP6	UTS2R	Urotensin-2 receptor	GO:0042493; P:response to drug; IEA:Ensembl
Q9UKP6	UTS2R	Urotensin-2 receptor	GO:0007165; P:signal transduction; TAS:ProtInc
A6NGE7	URAD	Putative 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase	GO:0016831; F:carboxy-lyase activity; ISS:UniProtKB
A6NGE7	URAD	Putative 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase	GO:0019428; P:allantoin biosynthetic process; IEA:InterPro
A6NGE7	URAD	Putative 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase	GO:0006144; P:purine nucleobase metabolic process; IEA:UniProtKB-KW
A6NGE7	URAD	Putative 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase	GO:0019628; P:urate catabolic process; IEA:UniProtKB-UniPathway
Q6BDS2	UHRF1BP1	UHRF1-binding protein 1	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
Q6BDS2	UHRF1BP1	UHRF1-binding protein 1	GO:0042802; F:identical protein binding; IPI:BHF-UCL
Q6BDS2	UHRF1BP1	UHRF1-binding protein 1	GO:0005515; F:protein binding; IPI:BHF-UCL
Q8TCY9	URGCP	Up-regulator of cell proliferation	GO:0005525; F:GTP binding; IEA:InterPro
Q8TCY9	URGCP	Up-regulator of cell proliferation	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q9BTM9	URM1	Ubiquitin-related modifier 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BTM9	URM1	Ubiquitin-related modifier 1	GO:0032447; P:protein urmylation; IEA:UniProtKB-HAMAP
Q9BTM9	URM1	Ubiquitin-related modifier 1	GO:0034227; P:tRNA thio-modification; IMP:UniProtKB
Q9BTM9	URM1	Ubiquitin-related modifier 1	GO:0002098; P:tRNA wobble uridine modification; IMP:UniProtKB
P00749	PLAU	Urokinase-type plasminogen activator	GO:0005515; F:protein binding; IPI:UniProtKB
P00749	PLAU	Urokinase-type plasminogen activator	GO:0004252; F:serine-type endopeptidase activity; TAS:Reactome
P00749	PLAU	Urokinase-type plasminogen activator	GO:0007596; P:blood coagulation; TAS:Reactome
P00749	PLAU	Urokinase-type plasminogen activator	GO:0006935; P:chemotaxis; TAS:ProtInc
P00749	PLAU	Urokinase-type plasminogen activator	GO:0042730; P:fibrinolysis; TAS:Reactome
P00749	PLAU	Urokinase-type plasminogen activator	GO:0006508; P:proteolysis; TAS:ProtInc
P00749	PLAU	Urokinase-type plasminogen activator	GO:0033628; P:regulation of cell adhesion mediated by integrin; IDA:BHF-UCL
P00749	PLAU	Urokinase-type plasminogen activator	GO:0042127; P:regulation of cell proliferation; IEA:Ensembl
P00749	PLAU	Urokinase-type plasminogen activator	GO:0010469; P:regulation of receptor activity; IDA:BHF-UCL
P00749	PLAU	Urokinase-type plasminogen activator	GO:0014910; P:regulation of smooth muscle cell migration; IDA:BHF-UCL
P00749	PLAU	Urokinase-type plasminogen activator	GO:2000097; P:regulation of smooth muscle cell-matrix adhesion; IDA:BHF-UCL
P00749	PLAU	Urokinase-type plasminogen activator	GO:0061041; P:regulation of wound healing; IC:BHF-UCL
P00749	PLAU	Urokinase-type plasminogen activator	GO:0001666; P:response to hypoxia; IEA:Ensembl
P00749	PLAU	Urokinase-type plasminogen activator	GO:0007165; P:signal transduction; TAS:ProtInc
P00749	PLAU	Urokinase-type plasminogen activator	GO:0014909; P:smooth muscle cell migration; IEA:Ensembl
Q5DID0	UMODL1	Uromodulin-like 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q5DID0	UMODL1	Uromodulin-like 1	GO:0030414; F:peptidase inhibitor activity; IEA:InterPro
P07911	UMOD	Uromodulin	GO:0005509; F:calcium ion binding; IEA:InterPro
P07911	UMOD	Uromodulin	GO:0019864; F:IgG binding; IDA:BHF-UCL
P07911	UMOD	Uromodulin	GO:0006968; P:cellular defense response; TAS:ProtInc
P07911	UMOD	Uromodulin	GO:0048878; P:chemical homeostasis; IEA:Ensembl
P07911	UMOD	Uromodulin	GO:0007588; P:excretion; IEA:Ensembl
P07911	UMOD	Uromodulin	GO:0007157; P:heterophilic cell-cell adhesion; IDA:BHF-UCL
P07911	UMOD	Uromodulin	GO:0007159; P:leukocyte cell-cell adhesion; IDA:BHF-UCL
P07911	UMOD	Uromodulin	GO:0072218; P:metanephric ascending thin limb development; IEA:Ensembl
P07911	UMOD	Uromodulin	GO:0072221; P:metanephric distal convoluted tubule development; IEA:Ensembl
P07911	UMOD	Uromodulin	GO:0072233; P:metanephric thick ascending limb development; IEA:Ensembl
P07911	UMOD	Uromodulin	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P07911	UMOD	Uromodulin	GO:1990266; P:neutrophil migration; IDA:BHF-UCL
P07911	UMOD	Uromodulin	GO:2000021; P:regulation of ion homeostasis; IEA:Ensembl
P07911	UMOD	Uromodulin	GO:0010033; P:response to organic substance; IEA:Ensembl
Q86UX7	FERMT3	Fermitin family homolog 3	GO:0005178; F:integrin binding; ISS:UniProtKB
Q86UX7	FERMT3	Fermitin family homolog 3	GO:0033622; P:integrin activation; IMP:UniProtKB
Q86UX7	FERMT3	Fermitin family homolog 3	GO:0007159; P:leukocyte cell-cell adhesion; IMP:UniProtKB
Q86UX7	FERMT3	Fermitin family homolog 3	GO:0070527; P:platelet aggregation; ISS:UniProtKB
Q86UX7	FERMT3	Fermitin family homolog 3	GO:0033632; P:regulation of cell-cell adhesion mediated by integrin; IMP:UniProtKB
Q92738	USP6NL	USP6 N-terminal-like protein	GO:0005097; F:Rab GTPase activator activity; IDA:UniProtKB
Q92738	USP6NL	USP6 N-terminal-like protein	GO:0007030; P:Golgi organization; IMP:UniProtKB
Q92738	USP6NL	USP6 N-terminal-like protein	GO:0032851; P:positive regulation of Rab GTPase activity; IDA:GOC
Q92738	USP6NL	USP6 N-terminal-like protein	GO:0035526; P:retrograde transport, plasma membrane to Golgi; IMP:UniProtKB
Q9BQ65	USB1	U6 snRNA phosphodiesterase	GO:0000175; F:3'-5'-exoribonuclease activity; IDA:UniProtKB
Q9BQ65	USB1	U6 snRNA phosphodiesterase	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9BQ65	USB1	U6 snRNA phosphodiesterase	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; IDA:GOC
Q9BQ65	USB1	U6 snRNA phosphodiesterase	GO:0008380; P:RNA splicing; IMP:UniProtKB
Q9BQ65	USB1	U6 snRNA phosphodiesterase	GO:0034477; P:U6 snRNA 3'-end processing; IMP:UniProtKB
Q8N6Y0	USHBP1	Usher syndrome type-1C protein-binding protein 1	GO:0030165; F:PDZ domain binding; IPI:HGNC
Q8N6Y0	USHBP1	Usher syndrome type-1C protein-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9NZ43	USE1	Vesicle transport protein USE1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NZ43	USE1	Vesicle transport protein USE1	GO:0071786; P:endoplasmic reticulum tubular network organization; IEA:Ensembl
Q9NZ43	USE1	Vesicle transport protein USE1	GO:0007041; P:lysosomal transport; ISS:HGNC
Q9NZ43	USE1	Vesicle transport protein USE1	GO:0030163; P:protein catabolic process; ISS:HGNC
Q9NZ43	USE1	Vesicle transport protein USE1	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9NZ43	USE1	Vesicle transport protein USE1	GO:0060628; P:regulation of ER to Golgi vesicle-mediated transport; IEA:Ensembl
Q9NZ43	USE1	Vesicle transport protein USE1	GO:0032940; P:secretion by cell; ISS:HGNC
Q9NZ43	USE1	Vesicle transport protein USE1	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q15853	USF2	Upstream stimulatory factor 2	GO:0043425; F:bHLH transcription factor binding; IPI:BHF-UCL
Q15853	USF2	Upstream stimulatory factor 2	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
Q15853	USF2	Upstream stimulatory factor 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q15853	USF2	Upstream stimulatory factor 2	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
Q15853	USF2	Upstream stimulatory factor 2	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
Q15853	USF2	Upstream stimulatory factor 2	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl
Q15853	USF2	Upstream stimulatory factor 2	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IMP:BHF-UCL
Q15853	USF2	Upstream stimulatory factor 2	GO:0043565; F:sequence-specific DNA binding; IDA:BHF-UCL
Q15853	USF2	Upstream stimulatory factor 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q15853	USF2	Upstream stimulatory factor 2	GO:0007595; P:lactation; IEA:Ensembl
Q15853	USF2	Upstream stimulatory factor 2	GO:0019086; P:late viral transcription; IC:BHF-UCL
Q15853	USF2	Upstream stimulatory factor 2	GO:0055088; P:lipid homeostasis; ISS:BHF-UCL
Q15853	USF2	Upstream stimulatory factor 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
Q15853	USF2	Upstream stimulatory factor 2	GO:0000432; P:positive regulation of transcription from RNA polymerase II promoter by glucose; IMP:BHF-UCL
Q15853	USF2	Upstream stimulatory factor 2	GO:0000430; P:regulation of transcription from RNA polymerase II promoter by glucose; IC:BHF-UCL
Q15853	USF2	Upstream stimulatory factor 2	GO:0006366; P:transcription from RNA polymerase II promoter; IMP:GOC
Q15853	USF2	Upstream stimulatory factor 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P22415	USF1	Upstream stimulatory factor 1	GO:0043425; F:bHLH transcription factor binding; IPI:BHF-UCL
P22415	USF1	Upstream stimulatory factor 1	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
P22415	USF1	Upstream stimulatory factor 1	GO:0019899; F:enzyme binding; IPI:BHF-UCL
P22415	USF1	Upstream stimulatory factor 1	GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL
P22415	USF1	Upstream stimulatory factor 1	GO:0005515; F:protein binding; IPI:IntAct
P22415	USF1	Upstream stimulatory factor 1	GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL
P22415	USF1	Upstream stimulatory factor 1	GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL
P22415	USF1	Upstream stimulatory factor 1	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
P22415	USF1	Upstream stimulatory factor 1	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P22415	USF1	Upstream stimulatory factor 1	GO:0043565; F:sequence-specific DNA binding; IDA:BHF-UCL
P22415	USF1	Upstream stimulatory factor 1	GO:0045990; P:carbon catabolite regulation of transcription; TAS:BHF-UCL
P22415	USF1	Upstream stimulatory factor 1	GO:0032869; P:cellular response to insulin stimulus; IDA:BHF-UCL
P22415	USF1	Upstream stimulatory factor 1	GO:0042593; P:glucose homeostasis; TAS:BHF-UCL
P22415	USF1	Upstream stimulatory factor 1	GO:0006006; P:glucose metabolic process; IEA:Ensembl
P22415	USF1	Upstream stimulatory factor 1	GO:0019086; P:late viral transcription; IDA:BHF-UCL
P22415	USF1	Upstream stimulatory factor 1	GO:0055088; P:lipid homeostasis; ISS:BHF-UCL
P22415	USF1	Upstream stimulatory factor 1	GO:0051918; P:negative regulation of fibrinolysis; IC:BHF-UCL
P22415	USF1	Upstream stimulatory factor 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P22415	USF1	Upstream stimulatory factor 1	GO:0000432; P:positive regulation of transcription from RNA polymerase II promoter by glucose; IMP:BHF-UCL
P22415	USF1	Upstream stimulatory factor 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:BHF-UCL
P22415	USF1	Upstream stimulatory factor 1	GO:0000430; P:regulation of transcription from RNA polymerase II promoter by glucose; IC:BHF-UCL
P22415	USF1	Upstream stimulatory factor 1	GO:0001666; P:response to hypoxia; IMP:BHF-UCL
P22415	USF1	Upstream stimulatory factor 1	GO:0009411; P:response to UV; ISS:BHF-UCL
P22415	USF1	Upstream stimulatory factor 1	GO:0006366; P:transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9Y6N9	USH1C	Harmonin	GO:0005515; F:protein binding; IPI:HGNC
Q9Y6N9	USH1C	Harmonin	GO:0030507; F:spectrin binding; IDA:MGI
Q9Y6N9	USH1C	Harmonin	GO:0042491; P:auditory receptor cell differentiation; IEA:Ensembl
Q9Y6N9	USH1C	Harmonin	GO:0050957; P:equilibrioception; IMP:HGNC
Q9Y6N9	USH1C	Harmonin	GO:0000086; P:G2/M transition of mitotic cell cycle; IMP:HGNC
Q9Y6N9	USH1C	Harmonin	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q9Y6N9	USH1C	Harmonin	GO:0030046; P:parallel actin filament bundle assembly; IEA:Ensembl
Q9Y6N9	USH1C	Harmonin	GO:0045494; P:photoreceptor cell maintenance; IMP:HGNC
Q9Y6N9	USH1C	Harmonin	GO:0050953; P:sensory perception of light stimulus; IMP:HGNC
Q9Y6N9	USH1C	Harmonin	GO:0007605; P:sensory perception of sound; IMP:HGNC
Q495M9	USH1G	Usher syndrome type-1G protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q495M9	USH1G	Usher syndrome type-1G protein	GO:0030507; F:spectrin binding; IDA:MGI
Q495M9	USH1G	Usher syndrome type-1G protein	GO:0050957; P:equilibrioception; IMP:HGNC
Q495M9	USH1G	Usher syndrome type-1G protein	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
Q495M9	USH1G	Usher syndrome type-1G protein	GO:0060113; P:inner ear receptor cell differentiation; IEA:Ensembl
Q495M9	USH1G	Usher syndrome type-1G protein	GO:0045494; P:photoreceptor cell maintenance; IMP:HGNC
Q495M9	USH1G	Usher syndrome type-1G protein	GO:0050953; P:sensory perception of light stimulus; IMP:HGNC
Q495M9	USH1G	Usher syndrome type-1G protein	GO:0007605; P:sensory perception of sound; IMP:HGNC
O75445	USH2A	Usherin	GO:0005518; F:collagen binding; IDA:HGNC
O75445	USH2A	Usherin	GO:0017022; F:myosin binding; ISS:BHF-UCL
O75445	USH2A	Usherin	GO:0005515; F:protein binding; IPI:UniProtKB
O75445	USH2A	Usherin	GO:0035315; P:hair cell differentiation; ISS:BHF-UCL
O75445	USH2A	Usherin	GO:0060113; P:inner ear receptor cell differentiation; ISS:BHF-UCL
O75445	USH2A	Usherin	GO:0048496; P:maintenance of organ identity; IMP:HGNC
O75445	USH2A	Usherin	GO:0045494; P:photoreceptor cell maintenance; IMP:HGNC
O75445	USH2A	Usherin	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
O75445	USH2A	Usherin	GO:0050953; P:sensory perception of light stimulus; IMP:HGNC
O75445	USH2A	Usherin	GO:0007605; P:sensory perception of sound; IMP:HGNC
O75445	USH2A	Usherin	GO:0007601; P:visual perception; IEA:UniProtKB-KW
O60763	USO1	General vesicular transport factor p115	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O60763	USO1	General vesicular transport factor p115	GO:0008565; F:protein transporter activity; IBA:RefGenome
O60763	USO1	General vesicular transport factor p115	GO:0006888; P:ER to Golgi vesicle-mediated transport; IBA:RefGenome
O60763	USO1	General vesicular transport factor p115	GO:0048211; P:Golgi vesicle docking; IBA:RefGenome
O60763	USO1	General vesicular transport factor p115	GO:0006886; P:intracellular protein transport; IBA:RefGenome
O60763	USO1	General vesicular transport factor p115	GO:0061025; P:membrane fusion; IBA:RefGenome
O60763	USO1	General vesicular transport factor p115	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O60763	USO1	General vesicular transport factor p115	GO:0045056; P:transcytosis; IBA:RefGenome
O60763	USO1	General vesicular transport factor p115	GO:0048280; P:vesicle fusion with Golgi apparatus; IEA:InterPro
Q93008	USP9X	Probable ubiquitin carboxyl-terminal hydrolase FAF-X	GO:0070410; F:co-SMAD binding; IPI:BHF-UCL
Q93008	USP9X	Probable ubiquitin carboxyl-terminal hydrolase FAF-X	GO:0004197; F:cysteine-type endopeptidase activity; TAS:ProtInc
Q93008	USP9X	Probable ubiquitin carboxyl-terminal hydrolase FAF-X	GO:0008234; F:cysteine-type peptidase activity; TAS:ProtInc
Q93008	USP9X	Probable ubiquitin carboxyl-terminal hydrolase FAF-X	GO:0005515; F:protein binding; IPI:UniProtKB
Q93008	USP9X	Probable ubiquitin carboxyl-terminal hydrolase FAF-X	GO:0004221; F:ubiquitin thiolesterase activity; TAS:Reactome
Q93008	USP9X	Probable ubiquitin carboxyl-terminal hydrolase FAF-X	GO:0030509; P:BMP signaling pathway; IDA:UniProtKB
Q93008	USP9X	Probable ubiquitin carboxyl-terminal hydrolase FAF-X	GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW
Q93008	USP9X	Probable ubiquitin carboxyl-terminal hydrolase FAF-X	GO:0007292; P:female gamete generation; TAS:ProtInc
Q93008	USP9X	Probable ubiquitin carboxyl-terminal hydrolase FAF-X	GO:0010467; P:gene expression; TAS:Reactome
Q93008	USP9X	Probable ubiquitin carboxyl-terminal hydrolase FAF-X	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q93008	USP9X	Probable ubiquitin carboxyl-terminal hydrolase FAF-X	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:Reactome
Q93008	USP9X	Probable ubiquitin carboxyl-terminal hydrolase FAF-X	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
Q93008	USP9X	Probable ubiquitin carboxyl-terminal hydrolase FAF-X	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q93008	USP9X	Probable ubiquitin carboxyl-terminal hydrolase FAF-X	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
Q93008	USP9X	Probable ubiquitin carboxyl-terminal hydrolase FAF-X	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IMP:UniProtKB
Q93008	USP9X	Probable ubiquitin carboxyl-terminal hydrolase FAF-X	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
O00507	USP9Y	Probable ubiquitin carboxyl-terminal hydrolase FAF-Y	GO:0070410; F:co-SMAD binding; ISS:BHF-UCL
O00507	USP9Y	Probable ubiquitin carboxyl-terminal hydrolase FAF-Y	GO:0008234; F:cysteine-type peptidase activity; TAS:ProtInc
O00507	USP9Y	Probable ubiquitin carboxyl-terminal hydrolase FAF-Y	GO:0004843; F:ubiquitin-specific protease activity; TAS:ProtInc
O00507	USP9Y	Probable ubiquitin carboxyl-terminal hydrolase FAF-Y	GO:0030509; P:BMP signaling pathway; ISS:UniProtKB
O00507	USP9Y	Probable ubiquitin carboxyl-terminal hydrolase FAF-Y	GO:0016579; P:protein deubiquitination; ISS:UniProtKB
O00507	USP9Y	Probable ubiquitin carboxyl-terminal hydrolase FAF-Y	GO:0007283; P:spermatogenesis; TAS:ProtInc
O00507	USP9Y	Probable ubiquitin carboxyl-terminal hydrolase FAF-Y	GO:0007179; P:transforming growth factor beta receptor signaling pathway; ISS:UniProtKB
O00507	USP9Y	Probable ubiquitin carboxyl-terminal hydrolase FAF-Y	GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro
Q5W0Q7	USPL1	SUMO-specific isopeptidase USPL1	GO:0005515; F:protein binding; IPI:IntAct
Q5W0Q7	USPL1	SUMO-specific isopeptidase USPL1	GO:0032183; F:SUMO binding; IDA:UniProtKB
Q5W0Q7	USPL1	SUMO-specific isopeptidase USPL1	GO:0070140; F:SUMO-specific isopeptidase activity; IDA:UniProtKB
Q5W0Q7	USPL1	SUMO-specific isopeptidase USPL1	GO:0030576; P:Cajal body organization; IMP:UniProtKB
Q5W0Q7	USPL1	SUMO-specific isopeptidase USPL1	GO:0008283; P:cell proliferation; IMP:UniProtKB
Q5W0Q7	USPL1	SUMO-specific isopeptidase USPL1	GO:0016926; P:protein desumoylation; IDA:UniProtKB
Q9Y2C2	UST	Uronyl 2-sulfotransferase	GO:0008146; F:sulfotransferase activity; TAS:ProtInc
Q9Y2C2	UST	Uronyl 2-sulfotransferase	GO:0005975; P:carbohydrate metabolic process; TAS:Reactome
Q9Y2C2	UST	Uronyl 2-sulfotransferase	GO:0030204; P:chondroitin sulfate metabolic process; TAS:Reactome
Q9Y2C2	UST	Uronyl 2-sulfotransferase	GO:0030208; P:dermatan sulfate biosynthetic process; TAS:Reactome
Q9Y2C2	UST	Uronyl 2-sulfotransferase	GO:0030203; P:glycosaminoglycan metabolic process; TAS:Reactome
Q9Y2C2	UST	Uronyl 2-sulfotransferase	GO:0006477; P:protein sulfation; TAS:ProtInc
Q9Y2C2	UST	Uronyl 2-sulfotransferase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9BVJ6	UTP14A	U3 small nucleolar RNA-associated protein 14 homolog A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BVJ6	UTP14A	U3 small nucleolar RNA-associated protein 14 homolog A	GO:0005515; F:protein binding; IPI:IntAct
Q9BVJ6	UTP14A	U3 small nucleolar RNA-associated protein 14 homolog A	GO:0006364; P:rRNA processing; IEA:InterPro
Q13336	SLC14A1	Urea transporter 1	GO:0015204; F:urea transmembrane transporter activity; TAS:ProtInc
Q13336	SLC14A1	Urea transporter 1	GO:0005372; F:water transmembrane transporter activity; IEA:Ensembl
Q13336	SLC14A1	Urea transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q13336	SLC14A1	Urea transporter 1	GO:0015840; P:urea transport; TAS:ProtInc
Q5TAP6	UTP14C	U3 small nucleolar RNA-associated protein 14 homolog C	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q5TAP6	UTP14C	U3 small nucleolar RNA-associated protein 14 homolog C	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q5TAP6	UTP14C	U3 small nucleolar RNA-associated protein 14 homolog C	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q5TAP6	UTP14C	U3 small nucleolar RNA-associated protein 14 homolog C	GO:0006364; P:rRNA processing; IEA:InterPro
Q5TAP6	UTP14C	U3 small nucleolar RNA-associated protein 14 homolog C	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q15849	SLC14A2	Urea transporter 2	GO:0005515; F:protein binding; IPI:IntAct
Q15849	SLC14A2	Urea transporter 2	GO:0015204; F:urea transmembrane transporter activity; TAS:ProtInc
Q15849	SLC14A2	Urea transporter 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q15849	SLC14A2	Urea transporter 2	GO:0015840; P:urea transport; TAS:ProtInc
P11684	SCGB1A1	Uteroglobin	GO:0019834; F:phospholipase A2 inhibitor activity; IEA:UniProtKB-KW
P11684	SCGB1A1	Uteroglobin	GO:0005515; F:protein binding; IPI:IntAct
P11684	SCGB1A1	Uteroglobin	GO:0007566; P:embryo implantation; TAS:ProtInc
P11684	SCGB1A1	Uteroglobin	GO:0007565; P:female pregnancy; NAS:ProtInc
P11684	SCGB1A1	Uteroglobin	GO:0032689; P:negative regulation of interferon-gamma production; IEA:Ensembl
P11684	SCGB1A1	Uteroglobin	GO:0032696; P:negative regulation of interleukin-13 production; IEA:Ensembl
P11684	SCGB1A1	Uteroglobin	GO:0032713; P:negative regulation of interleukin-4 production; IEA:Ensembl
P11684	SCGB1A1	Uteroglobin	GO:0032714; P:negative regulation of interleukin-5 production; IEA:Ensembl
P11684	SCGB1A1	Uteroglobin	GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl
P11684	SCGB1A1	Uteroglobin	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P11684	SCGB1A1	Uteroglobin	GO:0050727; P:regulation of inflammatory response; IEA:Ensembl
P11684	SCGB1A1	Uteroglobin	GO:0043488; P:regulation of mRNA stability; IEA:Ensembl
P11684	SCGB1A1	Uteroglobin	GO:0034097; P:response to cytokine; IEA:Ensembl
P11684	SCGB1A1	Uteroglobin	GO:0042493; P:response to drug; IEA:Ensembl
P11684	SCGB1A1	Uteroglobin	GO:0071774; P:response to fibroblast growth factor; IEA:Ensembl
P11684	SCGB1A1	Uteroglobin	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P11684	SCGB1A1	Uteroglobin	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P11684	SCGB1A1	Uteroglobin	GO:0010193; P:response to ozone; IEA:Ensembl
P11684	SCGB1A1	Uteroglobin	GO:0034021; P:response to silicon dioxide; IEA:Ensembl
P11684	SCGB1A1	Uteroglobin	GO:0009410; P:response to xenobiotic stimulus; IEA:Ensembl
P11684	SCGB1A1	Uteroglobin	GO:0007165; P:signal transduction; NAS:ProtInc
Q5T230	UTF1	Undifferentiated embryonic cell transcription factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q5T230	UTF1	Undifferentiated embryonic cell transcription factor 1	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q5T230	UTF1	Undifferentiated embryonic cell transcription factor 1	GO:0008584; P:male gonad development; IEP:UniProtKB
Q5T230	UTF1	Undifferentiated embryonic cell transcription factor 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q5T230	UTF1	Undifferentiated embryonic cell transcription factor 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q5T230	UTF1	Undifferentiated embryonic cell transcription factor 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y3A2	UTP11L	Probable U3 small nucleolar RNA-associated protein 11	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y3A2	UTP11L	Probable U3 small nucleolar RNA-associated protein 11	GO:0005515; F:protein binding; IPI:HGNC
Q9Y3A2	UTP11L	Probable U3 small nucleolar RNA-associated protein 11	GO:0007399; P:nervous system development; IMP:HGNC
Q9Y3A2	UTP11L	Probable U3 small nucleolar RNA-associated protein 11	GO:0043065; P:positive regulation of apoptotic process; IMP:BHF-UCL
Q9Y3A2	UTP11L	Probable U3 small nucleolar RNA-associated protein 11	GO:0042274; P:ribosomal small subunit biogenesis; IBA:RefGenome
Q9Y3A2	UTP11L	Probable U3 small nucleolar RNA-associated protein 11	GO:0006364; P:rRNA processing; IBA:RefGenome
Q8TED0	UTP15	U3 small nucleolar RNA-associated protein 15 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8TED0	UTP15	U3 small nucleolar RNA-associated protein 15 homolog	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q9Y5J1	UTP18	U3 small nucleolar RNA-associated protein 18 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y5J1	UTP18	U3 small nucleolar RNA-associated protein 18 homolog	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
O75691	UTP20	Small subunit processome component 20 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75691	UTP20	Small subunit processome component 20 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
O75691	UTP20	Small subunit processome component 20 homolog	GO:0000480; P:endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); ISS:UniProtKB
O75691	UTP20	Small subunit processome component 20 homolog	GO:0000447; P:endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); ISS:UniProtKB
O75691	UTP20	Small subunit processome component 20 homolog	GO:0000472; P:endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA); ISS:UniProtKB
O75691	UTP20	Small subunit processome component 20 homolog	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
O75691	UTP20	Small subunit processome component 20 homolog	GO:0006364; P:rRNA processing; IMP:UniProtKB
Q9BRU9	UTP23	rRNA-processing protein UTP23 homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BRU9	UTP23	rRNA-processing protein UTP23 homolog	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q9NYH9	UTP6	U3 small nucleolar RNA-associated protein 6 homolog	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
P46939	UTRN	Utrophin	GO:0003779; F:actin binding; IDA:BHF-UCL
P46939	UTRN	Utrophin	GO:0005509; F:calcium ion binding; IEA:InterPro
P46939	UTRN	Utrophin	GO:0005178; F:integrin binding; IPI:BHF-UCL
P46939	UTRN	Utrophin	GO:0005515; F:protein binding; IPI:UniProtKB
P46939	UTRN	Utrophin	GO:0019901; F:protein kinase binding; IPI:BHF-UCL
P46939	UTRN	Utrophin	GO:0017166; F:vinculin binding; IPI:BHF-UCL
P46939	UTRN	Utrophin	GO:0008270; F:zinc ion binding; IEA:InterPro
P46939	UTRN	Utrophin	GO:0006936; P:muscle contraction; TAS:ProtInc
P46939	UTRN	Utrophin	GO:0007517; P:muscle organ development; TAS:ProtInc
P46939	UTRN	Utrophin	GO:0001954; P:positive regulation of cell-matrix adhesion; IMP:UniProtKB
P46939	UTRN	Utrophin	GO:2000649; P:regulation of sodium ion transmembrane transporter activity; ISS:BHF-UCL
Q765I0	UTS2B	Urotensin-2B	GO:0008217; P:regulation of blood pressure; IEA:Ensembl
Q765I0	UTS2B	Urotensin-2B	GO:0042312; P:regulation of vasodilation; IEA:InterPro
O95399	UTS2	Urotensin-2	GO:0005179; F:hormone activity; TAS:ProtInc
O95399	UTS2	Urotensin-2	GO:0005102; F:receptor binding; TAS:ProtInc
O95399	UTS2	Urotensin-2	GO:0006936; P:muscle contraction; TAS:ProtInc
O95399	UTS2	Urotensin-2	GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0003105; P:negative regulation of glomerular filtration; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0010459; P:negative regulation of heart rate; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0046676; P:negative regulation of insulin secretion; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0035814; P:negative regulation of renal sodium excretion; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0035811; P:negative regulation of urine volume; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0045597; P:positive regulation of cell differentiation; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0046005; P:positive regulation of circadian sleep/wake cycle, REM sleep; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0010841; P:positive regulation of circadian sleep/wake cycle, wakefulness; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0032967; P:positive regulation of collagen biosynthetic process; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0010763; P:positive regulation of fibroblast migration; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0010460; P:positive regulation of heart rate; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0032224; P:positive regulation of synaptic transmission, cholinergic; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0045909; P:positive regulation of vasodilation; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0008217; P:regulation of blood pressure; TAS:ProtInc
O95399	UTS2	Urotensin-2	GO:0042493; P:response to drug; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0001666; P:response to hypoxia; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0033574; P:response to testosterone; IEA:Ensembl
O95399	UTS2	Urotensin-2	GO:0007268; P:synaptic transmission; TAS:ProtInc
O14607	UTY	Histone demethylase UTY	GO:0051864; F:histone demethylase activity (H3-K36 specific); IEA:Ensembl
O14607	UTY	Histone demethylase UTY	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14607	UTY	Histone demethylase UTY	GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl
O14607	UTY	Histone demethylase UTY	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
O14607	UTY	Histone demethylase UTY	GO:0086003; P:cardiac muscle cell contraction; IEA:Ensembl
O14607	UTY	Histone demethylase UTY	GO:0045184; P:establishment of protein localization; IEA:Ensembl
O14607	UTY	Histone demethylase UTY	GO:0007507; P:heart development; IEA:Ensembl
O14607	UTY	Histone demethylase UTY	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O14607	UTY	Histone demethylase UTY	GO:0031935; P:regulation of chromatin silencing; IEA:Ensembl
Q9P2Y5	UVRAG	UV radiation resistance-associated gene protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P2Y5	UVRAG	UV radiation resistance-associated gene protein	GO:0006281; P:DNA repair; TAS:ProtInc
Q9P2Y5	UVRAG	UV radiation resistance-associated gene protein	GO:0010508; P:positive regulation of autophagy; IEA:InterPro
Q2YD98	UVSSA	UV-stimulated scaffold protein A	GO:0005515; F:protein binding; IPI:UniProtKB
Q2YD98	UVSSA	UV-stimulated scaffold protein A	GO:0000993; F:RNA polymerase II core binding; IDA:UniProtKB
Q2YD98	UVSSA	UV-stimulated scaffold protein A	GO:0016567; P:protein ubiquitination; IMP:UniProtKB
Q2YD98	UVSSA	UV-stimulated scaffold protein A	GO:0009411; P:response to UV; IMP:UniProtKB
Q2YD98	UVSSA	UV-stimulated scaffold protein A	GO:0006283; P:transcription-coupled nucleotide-excision repair; IMP:UniProtKB
Q8NBZ7	UXS1	UDP-glucuronic acid decarboxylase 1	GO:0070403; F:NAD+ binding; IDA:UniProt
Q8NBZ7	UXS1	UDP-glucuronic acid decarboxylase 1	GO:0042803; F:protein homodimerization activity; IDA:UniProt
Q8NBZ7	UXS1	UDP-glucuronic acid decarboxylase 1	GO:0048040; F:UDP-glucuronate decarboxylase activity; IDA:UniProt
Q8NBZ7	UXS1	UDP-glucuronic acid decarboxylase 1	GO:0051262; P:protein tetramerization; IDA:UniProt
Q8NBZ7	UXS1	UDP-glucuronic acid decarboxylase 1	GO:0033320; P:UDP-D-xylose biosynthetic process; IEA:UniProtKB-UniPathway
Q9UBK9	UXT	Protein UXT	GO:0048487; F:beta-tubulin binding; IDA:HGNC
Q9UBK9	UXT	Protein UXT	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q9UBK9	UXT	Protein UXT	GO:0008017; F:microtubule binding; TAS:HGNC
Q9UBK9	UXT	Protein UXT	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UBK9	UXT	Protein UXT	GO:0001106; F:RNA polymerase II transcription corepressor activity; IDA:UniProtKB
Q9UBK9	UXT	Protein UXT	GO:0051297; P:centrosome organization; IMP:HGNC
Q9UBK9	UXT	Protein UXT	GO:0000226; P:microtubule cytoskeleton organization; IMP:HGNC
Q9UBK9	UXT	Protein UXT	GO:0047497; P:mitochondrion transport along microtubule; TAS:HGNC
Q9UBK9	UXT	Protein UXT	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9UBK9	UXT	Protein UXT	GO:0006457; P:protein folding; IEA:InterPro
P37288	AVPR1A	Vasopressin V1a receptor	GO:0017046; F:peptide hormone binding; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P37288	AVPR1A	Vasopressin V1a receptor	GO:0005080; F:protein kinase C binding; TAS:ProtInc
P37288	AVPR1A	Vasopressin V1a receptor	GO:0005000; F:vasopressin receptor activity; TAS:ProtInc
P37288	AVPR1A	Vasopressin V1a receptor	GO:0007202; P:activation of phospholipase C activity; TAS:ProtInc
P37288	AVPR1A	Vasopressin V1a receptor	GO:0008015; P:blood circulation; TAS:ProtInc
P37288	AVPR1A	Vasopressin V1a receptor	GO:0019722; P:calcium-mediated signaling; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0042631; P:cellular response to water deprivation; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P37288	AVPR1A	Vasopressin V1a receptor	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
P37288	AVPR1A	Vasopressin V1a receptor	GO:0007625; P:grooming behavior; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0002125; P:maternal aggressive behavior; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0042711; P:maternal behavior; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0014902; P:myotube differentiation; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0007621; P:negative regulation of female receptivity; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0051970; P:negative regulation of transmission of nerve impulse; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0043084; P:penile erection; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0030307; P:positive regulation of cell growth; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0032849; P:positive regulation of cellular pH reduction; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
P37288	AVPR1A	Vasopressin V1a receptor	GO:0014049; P:positive regulation of glutamate secretion; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0010460; P:positive regulation of heart rate; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0031394; P:positive regulation of prostaglandin biosynthetic process; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0035815; P:positive regulation of renal sodium excretion; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0003084; P:positive regulation of systemic arterial blood pressure; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0001992; P:regulation of systemic arterial blood pressure by vasopressin; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0051412; P:response to corticosterone; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0035176; P:social behavior; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0042713; P:sperm ejaculation; IEA:Ensembl
P37288	AVPR1A	Vasopressin V1a receptor	GO:0021537; P:telencephalon development; IEA:Ensembl
P47901	AVPR1B	Vasopressin V1b receptor	GO:0005080; F:protein kinase C binding; TAS:ProtInc
P47901	AVPR1B	Vasopressin V1b receptor	GO:0005000; F:vasopressin receptor activity; TAS:ProtInc
P47901	AVPR1B	Vasopressin V1b receptor	GO:0007202; P:activation of phospholipase C activity; TAS:ProtInc
P47901	AVPR1B	Vasopressin V1b receptor	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P47901	AVPR1B	Vasopressin V1b receptor	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
P47901	AVPR1B	Vasopressin V1b receptor	GO:0001992; P:regulation of systemic arterial blood pressure by vasopressin; IEA:Ensembl
P30518	AVPR2	Vasopressin V2 receptor	GO:0005515; F:protein binding; IPI:UniProt
P30518	AVPR2	Vasopressin V2 receptor	GO:0005000; F:vasopressin receptor activity; TAS:UniProtKB
P30518	AVPR2	Vasopressin V2 receptor	GO:0007190; P:activation of adenylate cyclase activity; TAS:ProtInc
P30518	AVPR2	Vasopressin V2 receptor	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; TAS:ProtInc
P30518	AVPR2	Vasopressin V2 receptor	GO:0007588; P:excretion; TAS:ProtInc
P30518	AVPR2	Vasopressin V2 receptor	GO:0007599; P:hemostasis; TAS:ProtInc
P30518	AVPR2	Vasopressin V2 receptor	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl
P30518	AVPR2	Vasopressin V2 receptor	GO:0032609; P:interferon-gamma production; IEA:Ensembl
P30518	AVPR2	Vasopressin V2 receptor	GO:0035814; P:negative regulation of renal sodium excretion; IEA:Ensembl
P30518	AVPR2	Vasopressin V2 receptor	GO:0035811; P:negative regulation of urine volume; IEA:Ensembl
P30518	AVPR2	Vasopressin V2 receptor	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P30518	AVPR2	Vasopressin V2 receptor	GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB
P30518	AVPR2	Vasopressin V2 receptor	GO:0031398; P:positive regulation of protein ubiquitination; NAS:BHF-UCL
P30518	AVPR2	Vasopressin V2 receptor	GO:0003084; P:positive regulation of systemic arterial blood pressure; IEA:Ensembl
P30518	AVPR2	Vasopressin V2 receptor	GO:0034097; P:response to cytokine; IEA:Ensembl
P30518	AVPR2	Vasopressin V2 receptor	GO:0021537; P:telencephalon development; IEA:Ensembl
P30518	AVPR2	Vasopressin V2 receptor	GO:0055085; P:transmembrane transport; TAS:Reactome
P30518	AVPR2	Vasopressin V2 receptor	GO:0006833; P:water transport; TAS:Reactome
P61421	ATP6V0D1	V-type proton ATPase subunit d 1	GO:0008553; F:hydrogen-exporting ATPase activity, phosphorylative mechanism; IEA:Ensembl
P61421	ATP6V0D1	V-type proton ATPase subunit d 1	GO:0005515; F:protein binding; IPI:UniProtKB
P61421	ATP6V0D1	V-type proton ATPase subunit d 1	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P61421	ATP6V0D1	V-type proton ATPase subunit d 1	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
P61421	ATP6V0D1	V-type proton ATPase subunit d 1	GO:0007420; P:brain development; IEA:Ensembl
P61421	ATP6V0D1	V-type proton ATPase subunit d 1	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
P61421	ATP6V0D1	V-type proton ATPase subunit d 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P61421	ATP6V0D1	V-type proton ATPase subunit d 1	GO:0042384; P:cilium assembly; ISS:UniProtKB
P61421	ATP6V0D1	V-type proton ATPase subunit d 1	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P61421	ATP6V0D1	V-type proton ATPase subunit d 1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P61421	ATP6V0D1	V-type proton ATPase subunit d 1	GO:0051701; P:interaction with host; TAS:Reactome
P61421	ATP6V0D1	V-type proton ATPase subunit d 1	GO:0090382; P:phagosome maturation; TAS:Reactome
P61421	ATP6V0D1	V-type proton ATPase subunit d 1	GO:0015992; P:proton transport; NAS:UniProtKB
P61421	ATP6V0D1	V-type proton ATPase subunit d 1	GO:0033572; P:transferrin transport; TAS:Reactome
P61421	ATP6V0D1	V-type proton ATPase subunit d 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8N8Y2	ATP6V0D2	V-type proton ATPase subunit d 2	GO:0015078; F:hydrogen ion transmembrane transporter activity; IEA:InterPro
Q8N8Y2	ATP6V0D2	V-type proton ATPase subunit d 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N8Y2	ATP6V0D2	V-type proton ATPase subunit d 2	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
Q8N8Y2	ATP6V0D2	V-type proton ATPase subunit d 2	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
Q8N8Y2	ATP6V0D2	V-type proton ATPase subunit d 2	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q8N8Y2	ATP6V0D2	V-type proton ATPase subunit d 2	GO:0051701; P:interaction with host; TAS:Reactome
Q8N8Y2	ATP6V0D2	V-type proton ATPase subunit d 2	GO:0090382; P:phagosome maturation; TAS:Reactome
Q8N8Y2	ATP6V0D2	V-type proton ATPase subunit d 2	GO:0033572; P:transferrin transport; TAS:Reactome
Q8N8Y2	ATP6V0D2	V-type proton ATPase subunit d 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8NHE4	ATP6V0E2	V-type proton ATPase subunit e 2	GO:0042625; F:ATPase activity, coupled to transmembrane movement of ions; ISS:UniProtKB
Q8NHE4	ATP6V0E2	V-type proton ATPase subunit e 2	GO:0015078; F:hydrogen ion transmembrane transporter activity; IEA:InterPro
Q8NHE4	ATP6V0E2	V-type proton ATPase subunit e 2	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
Q8NHE4	ATP6V0E2	V-type proton ATPase subunit e 2	GO:0016049; P:cell growth; IGI:UniProtKB
Q8NHE4	ATP6V0E2	V-type proton ATPase subunit e 2	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
Q8NHE4	ATP6V0E2	V-type proton ATPase subunit e 2	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q8NHE4	ATP6V0E2	V-type proton ATPase subunit e 2	GO:0051701; P:interaction with host; TAS:Reactome
Q8NHE4	ATP6V0E2	V-type proton ATPase subunit e 2	GO:0090382; P:phagosome maturation; TAS:Reactome
Q8NHE4	ATP6V0E2	V-type proton ATPase subunit e 2	GO:0033572; P:transferrin transport; TAS:Reactome
Q8NHE4	ATP6V0E2	V-type proton ATPase subunit e 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8NHE4	ATP6V0E2	V-type proton ATPase subunit e 2	GO:0007035; P:vacuolar acidification; ISS:UniProtKB
O15342	ATP6V0E1	V-type proton ATPase subunit e 1	GO:0042625; F:ATPase activity, coupled to transmembrane movement of ions; ISS:UniProtKB
O15342	ATP6V0E1	V-type proton ATPase subunit e 1	GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; TAS:ProtInc
O15342	ATP6V0E1	V-type proton ATPase subunit e 1	GO:0005215; F:transporter activity; NAS:ProtInc
O15342	ATP6V0E1	V-type proton ATPase subunit e 1	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
O15342	ATP6V0E1	V-type proton ATPase subunit e 1	GO:0016049; P:cell growth; IGI:UniProtKB
O15342	ATP6V0E1	V-type proton ATPase subunit e 1	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
O15342	ATP6V0E1	V-type proton ATPase subunit e 1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
O15342	ATP6V0E1	V-type proton ATPase subunit e 1	GO:0051701; P:interaction with host; TAS:Reactome
O15342	ATP6V0E1	V-type proton ATPase subunit e 1	GO:0090382; P:phagosome maturation; TAS:Reactome
O15342	ATP6V0E1	V-type proton ATPase subunit e 1	GO:0015992; P:proton transport; TAS:ProtInc
O15342	ATP6V0E1	V-type proton ATPase subunit e 1	GO:0043200; P:response to amino acid; IEA:Ensembl
O15342	ATP6V0E1	V-type proton ATPase subunit e 1	GO:0033572; P:transferrin transport; TAS:Reactome
O15342	ATP6V0E1	V-type proton ATPase subunit e 1	GO:0055085; P:transmembrane transport; TAS:Reactome
O15342	ATP6V0E1	V-type proton ATPase subunit e 1	GO:0007035; P:vacuolar acidification; ISS:UniProtKB
Q08AM6	VAC14	Protein VAC14 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q08AM6	VAC14	Protein VAC14 homolog	GO:0004872; F:receptor activity; NAS:UniProtKB
Q08AM6	VAC14	Protein VAC14 homolog	GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome
Q08AM6	VAC14	Protein VAC14 homolog	GO:0006644; P:phospholipid metabolic process; TAS:Reactome
Q08AM6	VAC14	Protein VAC14 homolog	GO:0007165; P:signal transduction; NAS:UniProtKB
Q08AM6	VAC14	Protein VAC14 homolog	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q08AM6	VAC14	Protein VAC14 homolog	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q16572	SLC18A3	Vesicular acetylcholine transporter	GO:0005277; F:acetylcholine transmembrane transporter activity; TAS:ProtInc
Q16572	SLC18A3	Vesicular acetylcholine transporter	GO:0015870; P:acetylcholine transport; TAS:ProtInc
Q16572	SLC18A3	Vesicular acetylcholine transporter	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
Q16572	SLC18A3	Vesicular acetylcholine transporter	GO:0007268; P:synaptic transmission; TAS:Reactome
P23763	VAMP1	Vesicle-associated membrane protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P23763	VAMP1	Vesicle-associated membrane protein 1	GO:0005484; F:SNAP receptor activity; IBA:RefGenome
P23763	VAMP1	Vesicle-associated membrane protein 1	GO:0000149; F:SNARE binding; IBA:RefGenome
P23763	VAMP1	Vesicle-associated membrane protein 1	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
P23763	VAMP1	Vesicle-associated membrane protein 1	GO:0017157; P:regulation of exocytosis; IBA:RefGenome
P23763	VAMP1	Vesicle-associated membrane protein 1	GO:0007268; P:synaptic transmission; TAS:Reactome
P23763	VAMP1	Vesicle-associated membrane protein 1	GO:0006906; P:vesicle fusion; IBA:RefGenome
P63027	VAMP2	Vesicle-associated membrane protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
P63027	VAMP2	Vesicle-associated membrane protein 2	GO:0005484; F:SNAP receptor activity; IBA:RefGenome
P63027	VAMP2	Vesicle-associated membrane protein 2	GO:0019905; F:syntaxin binding; IBA:RefGenome
P63027	VAMP2	Vesicle-associated membrane protein 2	GO:0017156; P:calcium ion-dependent exocytosis; IEA:InterPro
P63027	VAMP2	Vesicle-associated membrane protein 2	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P63027	VAMP2	Vesicle-associated membrane protein 2	GO:0006112; P:energy reserve metabolic process; TAS:Reactome
P63027	VAMP2	Vesicle-associated membrane protein 2	GO:0014047; P:glutamate secretion; TAS:Reactome
P63027	VAMP2	Vesicle-associated membrane protein 2	GO:0061024; P:membrane organization; TAS:Reactome
P63027	VAMP2	Vesicle-associated membrane protein 2	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
P63027	VAMP2	Vesicle-associated membrane protein 2	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
P63027	VAMP2	Vesicle-associated membrane protein 2	GO:0017157; P:regulation of exocytosis; IBA:RefGenome
P63027	VAMP2	Vesicle-associated membrane protein 2	GO:0050796; P:regulation of insulin secretion; TAS:Reactome
P63027	VAMP2	Vesicle-associated membrane protein 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P63027	VAMP2	Vesicle-associated membrane protein 2	GO:0007268; P:synaptic transmission; TAS:Reactome
P63027	VAMP2	Vesicle-associated membrane protein 2	GO:0006906; P:vesicle fusion; IBA:RefGenome
Q15836	VAMP3	Vesicle-associated membrane protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q15836	VAMP3	Vesicle-associated membrane protein 3	GO:0005484; F:SNAP receptor activity; IBA:RefGenome
Q15836	VAMP3	Vesicle-associated membrane protein 3	GO:0000149; F:SNARE binding; IBA:RefGenome
Q15836	VAMP3	Vesicle-associated membrane protein 3	GO:0017156; P:calcium ion-dependent exocytosis; IEA:Ensembl
Q15836	VAMP3	Vesicle-associated membrane protein 3	GO:0006887; P:exocytosis; TAS:ProtInc
Q15836	VAMP3	Vesicle-associated membrane protein 3	GO:0043001; P:Golgi to plasma membrane protein transport; IEA:Ensembl
Q15836	VAMP3	Vesicle-associated membrane protein 3	GO:0061025; P:membrane fusion; TAS:ProtInc
Q15836	VAMP3	Vesicle-associated membrane protein 3	GO:0007269; P:neurotransmitter secretion; IBA:RefGenome
Q15836	VAMP3	Vesicle-associated membrane protein 3	GO:0001921; P:positive regulation of receptor recycling; ISS:UniProtKB
Q15836	VAMP3	Vesicle-associated membrane protein 3	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q15836	VAMP3	Vesicle-associated membrane protein 3	GO:0042147; P:retrograde transport, endosome to Golgi; IDA:UniProtKB
Q15836	VAMP3	Vesicle-associated membrane protein 3	GO:0034446; P:substrate adhesion-dependent cell spreading; ISS:UniProtKB
Q15836	VAMP3	Vesicle-associated membrane protein 3	GO:0006904; P:vesicle docking involved in exocytosis; TAS:ProtInc
Q15836	VAMP3	Vesicle-associated membrane protein 3	GO:0006906; P:vesicle fusion; IBA:RefGenome
Q15836	VAMP3	Vesicle-associated membrane protein 3	GO:0016192; P:vesicle-mediated transport; ISS:UniProtKB
O75379	VAMP4	Vesicle-associated membrane protein 4	GO:0005484; F:SNAP receptor activity; IBA:RefGenome
O75379	VAMP4	Vesicle-associated membrane protein 4	GO:0000149; F:SNARE binding; IBA:RefGenome
O75379	VAMP4	Vesicle-associated membrane protein 4	GO:0006897; P:endocytosis; IBA:RefGenome
O75379	VAMP4	Vesicle-associated membrane protein 4	GO:0006887; P:exocytosis; IBA:RefGenome
O75379	VAMP4	Vesicle-associated membrane protein 4	GO:0043001; P:Golgi to plasma membrane protein transport; IEA:Ensembl
O75379	VAMP4	Vesicle-associated membrane protein 4	GO:0042996; P:regulation of Golgi to plasma membrane protein transport; IEA:Ensembl
O75379	VAMP4	Vesicle-associated membrane protein 4	GO:0035493; P:SNARE complex assembly; IDA:BHF-UCL
O75379	VAMP4	Vesicle-associated membrane protein 4	GO:0006906; P:vesicle fusion; IBA:RefGenome
O95183	VAMP5	Vesicle-associated membrane protein 5	GO:0005484; F:SNAP receptor activity; IBA:RefGenome
O95183	VAMP5	Vesicle-associated membrane protein 5	GO:0000149; F:SNARE binding; IBA:RefGenome
O95183	VAMP5	Vesicle-associated membrane protein 5	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O95183	VAMP5	Vesicle-associated membrane protein 5	GO:0006887; P:exocytosis; IBA:RefGenome
O95183	VAMP5	Vesicle-associated membrane protein 5	GO:0043001; P:Golgi to plasma membrane protein transport; IEA:Ensembl
O95183	VAMP5	Vesicle-associated membrane protein 5	GO:0007517; P:muscle organ development; TAS:ProtInc
O95183	VAMP5	Vesicle-associated membrane protein 5	GO:0007269; P:neurotransmitter secretion; IBA:RefGenome
O95183	VAMP5	Vesicle-associated membrane protein 5	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
O95183	VAMP5	Vesicle-associated membrane protein 5	GO:0006906; P:vesicle fusion; IBA:RefGenome
P51809	VAMP7	Vesicle-associated membrane protein 7	GO:0005515; F:protein binding; IPI:UniProtKB
P51809	VAMP7	Vesicle-associated membrane protein 7	GO:0005484; F:SNAP receptor activity; IBA:RefGenome
P51809	VAMP7	Vesicle-associated membrane protein 7	GO:0000149; F:SNARE binding; IBA:RefGenome
P51809	VAMP7	Vesicle-associated membrane protein 7	GO:0017156; P:calcium ion-dependent exocytosis; ISS:UniProtKB
P51809	VAMP7	Vesicle-associated membrane protein 7	GO:0006897; P:endocytosis; IBA:RefGenome
P51809	VAMP7	Vesicle-associated membrane protein 7	GO:0008333; P:endosome to lysosome transport; IDA:UniProtKB
P51809	VAMP7	Vesicle-associated membrane protein 7	GO:0043308; P:eosinophil degranulation; ISS:UniProtKB
P51809	VAMP7	Vesicle-associated membrane protein 7	GO:0006888; P:ER to Golgi vesicle-mediated transport; ISS:UniProtKB
P51809	VAMP7	Vesicle-associated membrane protein 7	GO:0006887; P:exocytosis; IBA:RefGenome
P51809	VAMP7	Vesicle-associated membrane protein 7	GO:0043001; P:Golgi to plasma membrane protein transport; IEA:Ensembl
P51809	VAMP7	Vesicle-associated membrane protein 7	GO:0061024; P:membrane organization; TAS:Reactome
P51809	VAMP7	Vesicle-associated membrane protein 7	GO:0043312; P:neutrophil degranulation; ISS:UniProtKB
P51809	VAMP7	Vesicle-associated membrane protein 7	GO:0006911; P:phagocytosis, engulfment; ISS:UniProtKB
P51809	VAMP7	Vesicle-associated membrane protein 7	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
P51809	VAMP7	Vesicle-associated membrane protein 7	GO:1900483; P:regulation of protein targeting to vacuolar membrane; IEA:Ensembl
P51809	VAMP7	Vesicle-associated membrane protein 7	GO:0034197; P:triglyceride transport; IEA:Ensembl
P51809	VAMP7	Vesicle-associated membrane protein 7	GO:0006906; P:vesicle fusion; IDA:UniProtKB
P51809	VAMP7	Vesicle-associated membrane protein 7	GO:0048280; P:vesicle fusion with Golgi apparatus; IEA:Ensembl
P51809	VAMP7	Vesicle-associated membrane protein 7	GO:0016192; P:vesicle-mediated transport; IDA:UniProtKB
Q9BV40	VAMP8	Vesicle-associated membrane protein 8	GO:0005484; F:SNAP receptor activity; IBA:RefGenome
Q9BV40	VAMP8	Vesicle-associated membrane protein 8	GO:0000149; F:SNARE binding; IBA:RefGenome
Q9BV40	VAMP8	Vesicle-associated membrane protein 8	GO:0000046; P:autophagic vacuole fusion; IMP:UniProtKB
Q9BV40	VAMP8	Vesicle-associated membrane protein 8	GO:0006897; P:endocytosis; IBA:RefGenome
Q9BV40	VAMP8	Vesicle-associated membrane protein 8	GO:0006887; P:exocytosis; IBA:RefGenome
Q9BV40	VAMP8	Vesicle-associated membrane protein 8	GO:0061024; P:membrane organization; TAS:Reactome
Q9BV40	VAMP8	Vesicle-associated membrane protein 8	GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome
Q9BV40	VAMP8	Vesicle-associated membrane protein 8	GO:0006461; P:protein complex assembly; IEA:Ensembl
Q9BV40	VAMP8	Vesicle-associated membrane protein 8	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9BV40	VAMP8	Vesicle-associated membrane protein 8	GO:0030100; P:regulation of endocytosis; IEA:Ensembl
Q9BV40	VAMP8	Vesicle-associated membrane protein 8	GO:0006906; P:vesicle fusion; IBA:RefGenome
Q8TAA9	VANGL1	Vang-like protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q8TAA9	VANGL1	Vang-like protein 1	GO:0007275; P:multicellular organismal development; IEA:InterPro
Q9ULK5	VANGL2	Vang-like protein 2	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0045176; P:apical protein localization; ISS:UniProtKB
Q9ULK5	VANGL2	Vang-like protein 2	GO:0035787; P:cell migration involved in kidney development; ISS:UniProtKB
Q9ULK5	VANGL2	Vang-like protein 2	GO:0090103; P:cochlea morphogenesis; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0060028; P:convergent extension involved in axis elongation; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0022007; P:convergent extension involved in neural plate elongation; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0048546; P:digestive tract morphogenesis; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0048105; P:establishment of body hair planar orientation; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0001736; P:establishment of planar polarity; ISS:UniProtKB
Q9ULK5	VANGL2	Vang-like protein 2	GO:0090177; P:establishment of planar polarity involved in neural tube closure; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0032835; P:glomerulus development; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0001942; P:hair follicle development; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0001947; P:heart looping; ISS:UniProtKB
Q9ULK5	VANGL2	Vang-like protein 2	GO:0060122; P:inner ear receptor stereocilium organization; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0060993; P:kidney morphogenesis; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0060490; P:lateral sprouting involved in lung morphogenesis; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0003149; P:membranous septum morphogenesis; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0003150; P:muscular septum morphogenesis; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0001843; P:neural tube closure; ISS:UniProtKB
Q9ULK5	VANGL2	Vang-like protein 2	GO:0035058; P:nonmotile primary cilium assembly; ISS:UniProtKB
Q9ULK5	VANGL2	Vang-like protein 2	GO:0060488; P:orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0003402; P:planar cell polarity pathway involved in axis elongation; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0090179; P:planar cell polarity pathway involved in neural tube closure; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0060489; P:planar dichotomous subdivision of terminal units involved in lung branching morphogenesis; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0043507; P:positive regulation of JUN kinase activity; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0032956; P:regulation of actin cytoskeleton organization; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0007266; P:Rho protein signal transduction; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0048103; P:somatic stem cell division; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
Q9ULK5	VANGL2	Vang-like protein 2	GO:0042060; P:wound healing; IEA:Ensembl
Q9P0L0	VAPA	Vesicle-associated membrane protein-associated protein A	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P0L0	VAPA	Vesicle-associated membrane protein-associated protein A	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
Q9P0L0	VAPA	Vesicle-associated membrane protein-associated protein A	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q9P0L0	VAPA	Vesicle-associated membrane protein-associated protein A	GO:0005198; F:structural molecule activity; IEA:InterPro
Q9P0L0	VAPA	Vesicle-associated membrane protein-associated protein A	GO:0008219; P:cell death; IMP:UniProtKB
Q9P0L0	VAPA	Vesicle-associated membrane protein-associated protein A	GO:0061025; P:membrane fusion; TAS:ProtInc
Q9P0L0	VAPA	Vesicle-associated membrane protein-associated protein A	GO:0031175; P:neuron projection development; IMP:UniProtKB
Q9P0L0	VAPA	Vesicle-associated membrane protein-associated protein A	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q9P0L0	VAPA	Vesicle-associated membrane protein-associated protein A	GO:0070972; P:protein localization to endoplasmic reticulum; IMP:UniProtKB
Q9P0L0	VAPA	Vesicle-associated membrane protein-associated protein A	GO:0007165; P:signal transduction; IMP:GOC
Q9P0L0	VAPA	Vesicle-associated membrane protein-associated protein A	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q9P0L0	VAPA	Vesicle-associated membrane protein-associated protein A	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
Q9P0L0	VAPA	Vesicle-associated membrane protein-associated protein A	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
O95292	VAPB	Vesicle-associated membrane protein-associated protein B/C	GO:0048487; F:beta-tubulin binding; IDA:UniProtKB
O95292	VAPB	Vesicle-associated membrane protein-associated protein B/C	GO:0019899; F:enzyme binding; IPI:UniProtKB
O95292	VAPB	Vesicle-associated membrane protein-associated protein B/C	GO:0005515; F:protein binding; IPI:UniProtKB
O95292	VAPB	Vesicle-associated membrane protein-associated protein B/C	GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB
O95292	VAPB	Vesicle-associated membrane protein-associated protein B/C	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
O95292	VAPB	Vesicle-associated membrane protein-associated protein B/C	GO:0005198; F:structural molecule activity; IEA:InterPro
O95292	VAPB	Vesicle-associated membrane protein-associated protein B/C	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; IDA:UniProtKB
O95292	VAPB	Vesicle-associated membrane protein-associated protein B/C	GO:0008219; P:cell death; IEA:UniProtKB-KW
O95292	VAPB	Vesicle-associated membrane protein-associated protein B/C	GO:0006874; P:cellular calcium ion homeostasis; IMP:UniProtKB
O95292	VAPB	Vesicle-associated membrane protein-associated protein B/C	GO:0030968; P:endoplasmic reticulum unfolded protein response; IMP:UniProtKB
O95292	VAPB	Vesicle-associated membrane protein-associated protein B/C	GO:0019048; P:modulation by virus of host morphology or physiology; IDA:UniProtKB
O95292	VAPB	Vesicle-associated membrane protein-associated protein B/C	GO:0045070; P:positive regulation of viral genome replication; IMP:UniProtKB
O95292	VAPB	Vesicle-associated membrane protein-associated protein B/C	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O95292	VAPB	Vesicle-associated membrane protein-associated protein B/C	GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome
O95292	VAPB	Vesicle-associated membrane protein-associated protein B/C	GO:0006665; P:sphingolipid metabolic process; TAS:Reactome
Q52LC2	ATP6AP1L	V-type proton ATPase subunit S1-like protein	GO:0046933; F:proton-transporting ATP synthase activity, rotational mechanism; IEA:InterPro
Q52LC2	ATP6AP1L	V-type proton ATPase subunit S1-like protein	GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; IEA:InterPro
Q52LC2	ATP6AP1L	V-type proton ATPase subunit S1-like protein	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
Q7L8A9	VASH1	Vasohibin-1	GO:0001525; P:angiogenesis; IDA:MGI
Q7L8A9	VASH1	Vasohibin-1	GO:0007050; P:cell cycle arrest; IEA:UniProtKB-KW
Q7L8A9	VASH1	Vasohibin-1	GO:0016525; P:negative regulation of angiogenesis; IDA:UniProtKB
Q7L8A9	VASH1	Vasohibin-1	GO:0043537; P:negative regulation of blood vessel endothelial cell migration; IDA:UniProtKB
Q7L8A9	VASH1	Vasohibin-1	GO:0010596; P:negative regulation of endothelial cell migration; IGI:MGI
Q7L8A9	VASH1	Vasohibin-1	GO:0001937; P:negative regulation of endothelial cell proliferation; IDA:UniProtKB
Q7L8A9	VASH1	Vasohibin-1	GO:1901491; P:negative regulation of lymphangiogenesis; IGI:MGI
Q7L8A9	VASH1	Vasohibin-1	GO:2000772; P:regulation of cellular senescence; IMP:MGI
Q7L8A9	VASH1	Vasohibin-1	GO:0009611; P:response to wounding; IDA:MGI
Q15904	ATP6AP1	V-type proton ATPase subunit S1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q15904	ATP6AP1	V-type proton ATPase subunit S1	GO:0046933; F:proton-transporting ATP synthase activity, rotational mechanism; IEA:InterPro
Q15904	ATP6AP1	V-type proton ATPase subunit S1	GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; IEA:InterPro
Q15904	ATP6AP1	V-type proton ATPase subunit S1	GO:0005215; F:transporter activity; TAS:ProtInc
Q15904	ATP6AP1	V-type proton ATPase subunit S1	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
Q15904	ATP6AP1	V-type proton ATPase subunit S1	GO:0015992; P:proton transport; TAS:ProtInc
Q86V25	VASH2	Vasohibin-2	GO:0045766; P:positive regulation of angiogenesis; IDA:MGI
Q86V25	VASH2	Vasohibin-2	GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:MGI
Q6EMK4	VASN	Vasorin	GO:0071456; P:cellular response to hypoxia; IEA:Ensembl
Q6EMK4	VASN	Vasorin	GO:0071461; P:cellular response to redox state; IEA:Ensembl
P50552	VASP	Vasodilator-stimulated phosphoprotein	GO:0005522; F:profilin binding; IPI:UniProtKB
P50552	VASP	Vasodilator-stimulated phosphoprotein	GO:0005515; F:protein binding; IPI:UniProtKB
P50552	VASP	Vasodilator-stimulated phosphoprotein	GO:0008154; P:actin polymerization or depolymerization; IEA:InterPro
P50552	VASP	Vasodilator-stimulated phosphoprotein	GO:0007411; P:axon guidance; TAS:Reactome
P50552	VASP	Vasodilator-stimulated phosphoprotein	GO:0034329; P:cell junction assembly; TAS:Reactome
P50552	VASP	Vasodilator-stimulated phosphoprotein	GO:0001843; P:neural tube closure; IEA:Ensembl
P50552	VASP	Vasodilator-stimulated phosphoprotein	GO:0030838; P:positive regulation of actin filament polymerization; IDA:UniProt
P50552	VASP	Vasodilator-stimulated phosphoprotein	GO:0051289; P:protein homotetramerization; IEA:InterPro
P50552	VASP	Vasodilator-stimulated phosphoprotein	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q9HCJ6	VAT1L	Synaptic vesicle membrane protein VAT-1 homolog-like	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q9HCJ6	VAT1L	Synaptic vesicle membrane protein VAT-1 homolog-like	GO:0008270; F:zinc ion binding; IEA:InterPro
Q99536	VAT1	Synaptic vesicle membrane protein VAT-1 homolog	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q99536	VAT1	Synaptic vesicle membrane protein VAT-1 homolog	GO:0008270; F:zinc ion binding; IEA:InterPro
Q99536	VAT1	Synaptic vesicle membrane protein VAT-1 homolog	GO:0010637; P:negative regulation of mitochondrial fusion; IMP:UniProtKB
P38606	ATP6V1A	V-type proton ATPase catalytic subunit A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P38606	ATP6V1A	V-type proton ATPase catalytic subunit A	GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; IEA:InterPro
P38606	ATP6V1A	V-type proton ATPase catalytic subunit A	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
P38606	ATP6V1A	V-type proton ATPase catalytic subunit A	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
P38606	ATP6V1A	V-type proton ATPase catalytic subunit A	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P38606	ATP6V1A	V-type proton ATPase catalytic subunit A	GO:0051701; P:interaction with host; TAS:Reactome
P38606	ATP6V1A	V-type proton ATPase catalytic subunit A	GO:0090382; P:phagosome maturation; TAS:Reactome
P38606	ATP6V1A	V-type proton ATPase catalytic subunit A	GO:0033572; P:transferrin transport; TAS:Reactome
P38606	ATP6V1A	V-type proton ATPase catalytic subunit A	GO:0055085; P:transmembrane transport; TAS:Reactome
P38606	ATP6V1A	V-type proton ATPase catalytic subunit A	GO:0006810; P:transport; TAS:ProtInc
P15313	ATP6V1B1	V-type proton ATPase subunit B, kidney isoform	GO:0005524; F:ATP binding; IEA:InterPro
P15313	ATP6V1B1	V-type proton ATPase subunit B, kidney isoform	GO:0015078; F:hydrogen ion transmembrane transporter activity; ISS:UniProtKB
P15313	ATP6V1B1	V-type proton ATPase subunit B, kidney isoform	GO:0016820; F:hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; IEA:InterPro
P15313	ATP6V1B1	V-type proton ATPase subunit B, kidney isoform	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
P15313	ATP6V1B1	V-type proton ATPase subunit B, kidney isoform	GO:0046034; P:ATP metabolic process; IEA:InterPro
P15313	ATP6V1B1	V-type proton ATPase subunit B, kidney isoform	GO:0055074; P:calcium ion homeostasis; IMP:UniProtKB
P15313	ATP6V1B1	V-type proton ATPase subunit B, kidney isoform	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
P15313	ATP6V1B1	V-type proton ATPase subunit B, kidney isoform	GO:0007588; P:excretion; IMP:UniProtKB
P15313	ATP6V1B1	V-type proton ATPase subunit B, kidney isoform	GO:0042472; P:inner ear morphogenesis; IMP:UniProtKB
P15313	ATP6V1B1	V-type proton ATPase subunit B, kidney isoform	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P15313	ATP6V1B1	V-type proton ATPase subunit B, kidney isoform	GO:0051701; P:interaction with host; TAS:Reactome
P15313	ATP6V1B1	V-type proton ATPase subunit B, kidney isoform	GO:0001503; P:ossification; IMP:HGNC
P15313	ATP6V1B1	V-type proton ATPase subunit B, kidney isoform	GO:0045851; P:pH reduction; IMP:UniProtKB
P15313	ATP6V1B1	V-type proton ATPase subunit B, kidney isoform	GO:0090382; P:phagosome maturation; TAS:Reactome
P15313	ATP6V1B1	V-type proton ATPase subunit B, kidney isoform	GO:0015992; P:proton transport; IMP:HGNC
P15313	ATP6V1B1	V-type proton ATPase subunit B, kidney isoform	GO:0006885; P:regulation of pH; IMP:HGNC
P15313	ATP6V1B1	V-type proton ATPase subunit B, kidney isoform	GO:0007605; P:sensory perception of sound; IMP:UniProtKB
P15313	ATP6V1B1	V-type proton ATPase subunit B, kidney isoform	GO:0033572; P:transferrin transport; TAS:Reactome
P15313	ATP6V1B1	V-type proton ATPase subunit B, kidney isoform	GO:0055085; P:transmembrane transport; TAS:Reactome
P21281	ATP6V1B2	V-type proton ATPase subunit B, brain isoform	GO:0005524; F:ATP binding; IEA:InterPro
P21281	ATP6V1B2	V-type proton ATPase subunit B, brain isoform	GO:0015078; F:hydrogen ion transmembrane transporter activity; TAS:ProtInc
P21281	ATP6V1B2	V-type proton ATPase subunit B, brain isoform	GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; TAS:ProtInc
P21281	ATP6V1B2	V-type proton ATPase subunit B, brain isoform	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
P21281	ATP6V1B2	V-type proton ATPase subunit B, brain isoform	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
P21281	ATP6V1B2	V-type proton ATPase subunit B, brain isoform	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P21281	ATP6V1B2	V-type proton ATPase subunit B, brain isoform	GO:0051701; P:interaction with host; TAS:Reactome
P21281	ATP6V1B2	V-type proton ATPase subunit B, brain isoform	GO:0090382; P:phagosome maturation; TAS:Reactome
P21281	ATP6V1B2	V-type proton ATPase subunit B, brain isoform	GO:0015992; P:proton transport; TAS:ProtInc
P21281	ATP6V1B2	V-type proton ATPase subunit B, brain isoform	GO:0033572; P:transferrin transport; TAS:Reactome
P21281	ATP6V1B2	V-type proton ATPase subunit B, brain isoform	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8NEY4	ATP6V1C2	V-type proton ATPase subunit C 2	GO:0008553; F:hydrogen-exporting ATPase activity, phosphorylative mechanism; IEA:Ensembl
Q8NEY4	ATP6V1C2	V-type proton ATPase subunit C 2	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
Q8NEY4	ATP6V1C2	V-type proton ATPase subunit C 2	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
Q8NEY4	ATP6V1C2	V-type proton ATPase subunit C 2	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q8NEY4	ATP6V1C2	V-type proton ATPase subunit C 2	GO:0051701; P:interaction with host; TAS:Reactome
Q8NEY4	ATP6V1C2	V-type proton ATPase subunit C 2	GO:0090382; P:phagosome maturation; TAS:Reactome
Q8NEY4	ATP6V1C2	V-type proton ATPase subunit C 2	GO:0033572; P:transferrin transport; TAS:Reactome
Q8NEY4	ATP6V1C2	V-type proton ATPase subunit C 2	GO:0055085; P:transmembrane transport; TAS:Reactome
P21283	ATP6V1C1	V-type proton ATPase subunit C 1	GO:0008553; F:hydrogen-exporting ATPase activity, phosphorylative mechanism; IEA:Ensembl
P21283	ATP6V1C1	V-type proton ATPase subunit C 1	GO:0005515; F:protein binding; IPI:IntAct
P21283	ATP6V1C1	V-type proton ATPase subunit C 1	GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; TAS:ProtInc
P21283	ATP6V1C1	V-type proton ATPase subunit C 1	GO:0005215; F:transporter activity; NAS:ProtInc
P21283	ATP6V1C1	V-type proton ATPase subunit C 1	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
P21283	ATP6V1C1	V-type proton ATPase subunit C 1	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
P21283	ATP6V1C1	V-type proton ATPase subunit C 1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P21283	ATP6V1C1	V-type proton ATPase subunit C 1	GO:0051701; P:interaction with host; TAS:Reactome
P21283	ATP6V1C1	V-type proton ATPase subunit C 1	GO:0090382; P:phagosome maturation; TAS:Reactome
P21283	ATP6V1C1	V-type proton ATPase subunit C 1	GO:0015992; P:proton transport; TAS:ProtInc
P21283	ATP6V1C1	V-type proton ATPase subunit C 1	GO:0033572; P:transferrin transport; TAS:Reactome
P21283	ATP6V1C1	V-type proton ATPase subunit C 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9Y5K8	ATP6V1D	V-type proton ATPase subunit D	GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IEA:InterPro
Q9Y5K8	ATP6V1D	V-type proton ATPase subunit D	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y5K8	ATP6V1D	V-type proton ATPase subunit D	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
Q9Y5K8	ATP6V1D	V-type proton ATPase subunit D	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q9Y5K8	ATP6V1D	V-type proton ATPase subunit D	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q9Y5K8	ATP6V1D	V-type proton ATPase subunit D	GO:0051701; P:interaction with host; TAS:Reactome
Q9Y5K8	ATP6V1D	V-type proton ATPase subunit D	GO:0090382; P:phagosome maturation; TAS:Reactome
Q9Y5K8	ATP6V1D	V-type proton ATPase subunit D	GO:0061512; P:protein localization to cilium; IMP:UniProtKB
Q9Y5K8	ATP6V1D	V-type proton ATPase subunit D	GO:0015992; P:proton transport; IEA:UniProtKB-KW
Q9Y5K8	ATP6V1D	V-type proton ATPase subunit D	GO:0033572; P:transferrin transport; TAS:Reactome
Q9Y5K8	ATP6V1D	V-type proton ATPase subunit D	GO:0055085; P:transmembrane transport; TAS:Reactome
Q96A05	ATP6V1E2	V-type proton ATPase subunit E 2	GO:0008553; F:hydrogen-exporting ATPase activity, phosphorylative mechanism; IEA:Ensembl
Q96A05	ATP6V1E2	V-type proton ATPase subunit E 2	GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; IEA:InterPro
Q96A05	ATP6V1E2	V-type proton ATPase subunit E 2	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:Ensembl
Q96A05	ATP6V1E2	V-type proton ATPase subunit E 2	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
Q96A05	ATP6V1E2	V-type proton ATPase subunit E 2	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q96A05	ATP6V1E2	V-type proton ATPase subunit E 2	GO:0051701; P:interaction with host; TAS:Reactome
Q96A05	ATP6V1E2	V-type proton ATPase subunit E 2	GO:0090382; P:phagosome maturation; TAS:Reactome
Q96A05	ATP6V1E2	V-type proton ATPase subunit E 2	GO:0033572; P:transferrin transport; TAS:Reactome
Q96A05	ATP6V1E2	V-type proton ATPase subunit E 2	GO:0055085; P:transmembrane transport; TAS:Reactome
P36543	ATP6V1E1	V-type proton ATPase subunit E 1	GO:0051117; F:ATPase binding; IPI:UniProtKB
P36543	ATP6V1E1	V-type proton ATPase subunit E 1	GO:0008553; F:hydrogen-exporting ATPase activity, phosphorylative mechanism; IEA:Ensembl
P36543	ATP6V1E1	V-type proton ATPase subunit E 1	GO:0005515; F:protein binding; IPI:UniProtKB
P36543	ATP6V1E1	V-type proton ATPase subunit E 1	GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; IEA:InterPro
P36543	ATP6V1E1	V-type proton ATPase subunit E 1	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:Ensembl
P36543	ATP6V1E1	V-type proton ATPase subunit E 1	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
P36543	ATP6V1E1	V-type proton ATPase subunit E 1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P36543	ATP6V1E1	V-type proton ATPase subunit E 1	GO:0051701; P:interaction with host; TAS:Reactome
P36543	ATP6V1E1	V-type proton ATPase subunit E 1	GO:0090382; P:phagosome maturation; TAS:Reactome
P36543	ATP6V1E1	V-type proton ATPase subunit E 1	GO:0015992; P:proton transport; TAS:ProtInc
P36543	ATP6V1E1	V-type proton ATPase subunit E 1	GO:0033572; P:transferrin transport; TAS:Reactome
P36543	ATP6V1E1	V-type proton ATPase subunit E 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q16864	ATP6V1F	V-type proton ATPase subunit F	GO:0042624; F:ATPase activity, uncoupled; NAS:UniProtKB
Q16864	ATP6V1F	V-type proton ATPase subunit F	GO:0015078; F:hydrogen ion transmembrane transporter activity; NAS:UniProtKB
Q16864	ATP6V1F	V-type proton ATPase subunit F	GO:0005515; F:protein binding; IPI:UniProtKB
Q16864	ATP6V1F	V-type proton ATPase subunit F	GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; IEA:InterPro
Q16864	ATP6V1F	V-type proton ATPase subunit F	GO:0006200; P:ATP catabolic process; NAS:GOC
Q16864	ATP6V1F	V-type proton ATPase subunit F	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
Q16864	ATP6V1F	V-type proton ATPase subunit F	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
Q16864	ATP6V1F	V-type proton ATPase subunit F	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q16864	ATP6V1F	V-type proton ATPase subunit F	GO:0051701; P:interaction with host; TAS:Reactome
Q16864	ATP6V1F	V-type proton ATPase subunit F	GO:0090382; P:phagosome maturation; TAS:Reactome
Q16864	ATP6V1F	V-type proton ATPase subunit F	GO:0015992; P:proton transport; NAS:UniProtKB
Q16864	ATP6V1F	V-type proton ATPase subunit F	GO:0033572; P:transferrin transport; TAS:Reactome
Q16864	ATP6V1F	V-type proton ATPase subunit F	GO:0055085; P:transmembrane transport; TAS:Reactome
O75348	ATP6V1G1	V-type proton ATPase subunit G 1	GO:0051117; F:ATPase binding; IPI:UniProtKB
O75348	ATP6V1G1	V-type proton ATPase subunit G 1	GO:0016820; F:hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; IEA:InterPro
O75348	ATP6V1G1	V-type proton ATPase subunit G 1	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
O75348	ATP6V1G1	V-type proton ATPase subunit G 1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
O75348	ATP6V1G1	V-type proton ATPase subunit G 1	GO:0051701; P:interaction with host; TAS:Reactome
O75348	ATP6V1G1	V-type proton ATPase subunit G 1	GO:0090382; P:phagosome maturation; TAS:Reactome
O75348	ATP6V1G1	V-type proton ATPase subunit G 1	GO:0015992; P:proton transport; IEA:UniProtKB-KW
O75348	ATP6V1G1	V-type proton ATPase subunit G 1	GO:0033572; P:transferrin transport; TAS:Reactome
O75348	ATP6V1G1	V-type proton ATPase subunit G 1	GO:0055085; P:transmembrane transport; TAS:Reactome
O95670	ATP6V1G2	V-type proton ATPase subunit G 2	GO:0008553; F:hydrogen-exporting ATPase activity, phosphorylative mechanism; IEA:Ensembl
O95670	ATP6V1G2	V-type proton ATPase subunit G 2	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
O95670	ATP6V1G2	V-type proton ATPase subunit G 2	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
O95670	ATP6V1G2	V-type proton ATPase subunit G 2	GO:0051701; P:interaction with host; TAS:Reactome
O95670	ATP6V1G2	V-type proton ATPase subunit G 2	GO:0090382; P:phagosome maturation; TAS:Reactome
O95670	ATP6V1G2	V-type proton ATPase subunit G 2	GO:0033572; P:transferrin transport; TAS:Reactome
O95670	ATP6V1G2	V-type proton ATPase subunit G 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q96LB4	ATP6V1G3	V-type proton ATPase subunit G 3	GO:0051117; F:ATPase binding; IPI:UniProtKB
Q96LB4	ATP6V1G3	V-type proton ATPase subunit G 3	GO:0008553; F:hydrogen-exporting ATPase activity, phosphorylative mechanism; IEA:Ensembl
Q96LB4	ATP6V1G3	V-type proton ATPase subunit G 3	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
Q96LB4	ATP6V1G3	V-type proton ATPase subunit G 3	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q96LB4	ATP6V1G3	V-type proton ATPase subunit G 3	GO:0051701; P:interaction with host; TAS:Reactome
Q96LB4	ATP6V1G3	V-type proton ATPase subunit G 3	GO:0090382; P:phagosome maturation; TAS:Reactome
Q96LB4	ATP6V1G3	V-type proton ATPase subunit G 3	GO:0033572; P:transferrin transport; TAS:Reactome
Q96LB4	ATP6V1G3	V-type proton ATPase subunit G 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UI12	ATP6V1H	V-type proton ATPase subunit H	GO:0030234; F:enzyme regulator activity; NAS:UniProtKB
Q9UI12	ATP6V1H	V-type proton ATPase subunit H	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UI12	ATP6V1H	V-type proton ATPase subunit H	GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; IEA:InterPro
Q9UI12	ATP6V1H	V-type proton ATPase subunit H	GO:0006200; P:ATP catabolic process; NAS:GOC
Q9UI12	ATP6V1H	V-type proton ATPase subunit H	GO:0015991; P:ATP hydrolysis coupled proton transport; NAS:UniProtKB
Q9UI12	ATP6V1H	V-type proton ATPase subunit H	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
Q9UI12	ATP6V1H	V-type proton ATPase subunit H	GO:0006897; P:endocytosis; IDA:UniProtKB
Q9UI12	ATP6V1H	V-type proton ATPase subunit H	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q9UI12	ATP6V1H	V-type proton ATPase subunit H	GO:0051701; P:interaction with host; TAS:Reactome
Q9UI12	ATP6V1H	V-type proton ATPase subunit H	GO:0090382; P:phagosome maturation; TAS:Reactome
Q9UI12	ATP6V1H	V-type proton ATPase subunit H	GO:0050790; P:regulation of catalytic activity; NAS:GOC
Q9UI12	ATP6V1H	V-type proton ATPase subunit H	GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome
Q9UI12	ATP6V1H	V-type proton ATPase subunit H	GO:0033572; P:transferrin transport; TAS:Reactome
Q9UI12	ATP6V1H	V-type proton ATPase subunit H	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UI12	ATP6V1H	V-type proton ATPase subunit H	GO:0007035; P:vacuolar acidification; NAS:UniProtKB
Q9UI12	ATP6V1H	V-type proton ATPase subunit H	GO:0016032; P:viral process; TAS:Reactome
P27449	ATP6V0C	V-type proton ATPase 16 kDa proteolipid subunit	GO:0005515; F:protein binding; IPI:IntAct
P27449	ATP6V0C	V-type proton ATPase 16 kDa proteolipid subunit	GO:0046933; F:proton-transporting ATP synthase activity, rotational mechanism; TAS:UniProtKB
P27449	ATP6V0C	V-type proton ATPase 16 kDa proteolipid subunit	GO:0046961; F:proton-transporting ATPase activity, rotational mechanism; TAS:ProtInc
P27449	ATP6V0C	V-type proton ATPase 16 kDa proteolipid subunit	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P27449	ATP6V0C	V-type proton ATPase 16 kDa proteolipid subunit	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
P27449	ATP6V0C	V-type proton ATPase 16 kDa proteolipid subunit	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
P27449	ATP6V0C	V-type proton ATPase 16 kDa proteolipid subunit	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
P27449	ATP6V0C	V-type proton ATPase 16 kDa proteolipid subunit	GO:0051701; P:interaction with host; TAS:Reactome
P27449	ATP6V0C	V-type proton ATPase 16 kDa proteolipid subunit	GO:0090382; P:phagosome maturation; TAS:Reactome
P27449	ATP6V0C	V-type proton ATPase 16 kDa proteolipid subunit	GO:0015992; P:proton transport; TAS:ProtInc
P27449	ATP6V0C	V-type proton ATPase 16 kDa proteolipid subunit	GO:0033572; P:transferrin transport; TAS:Reactome
P27449	ATP6V0C	V-type proton ATPase 16 kDa proteolipid subunit	GO:0055085; P:transmembrane transport; TAS:Reactome
P27449	ATP6V0C	V-type proton ATPase 16 kDa proteolipid subunit	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q99437	ATP6V0B	V-type proton ATPase 21 kDa proteolipid subunit	GO:0015078; F:hydrogen ion transmembrane transporter activity; IEA:InterPro
Q99437	ATP6V0B	V-type proton ATPase 21 kDa proteolipid subunit	GO:0005215; F:transporter activity; TAS:ProtInc
Q99437	ATP6V0B	V-type proton ATPase 21 kDa proteolipid subunit	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
Q99437	ATP6V0B	V-type proton ATPase 21 kDa proteolipid subunit	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
Q99437	ATP6V0B	V-type proton ATPase 21 kDa proteolipid subunit	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q99437	ATP6V0B	V-type proton ATPase 21 kDa proteolipid subunit	GO:0051701; P:interaction with host; TAS:Reactome
Q99437	ATP6V0B	V-type proton ATPase 21 kDa proteolipid subunit	GO:0090382; P:phagosome maturation; TAS:Reactome
Q99437	ATP6V0B	V-type proton ATPase 21 kDa proteolipid subunit	GO:0015992; P:proton transport; TAS:ProtInc
Q99437	ATP6V0B	V-type proton ATPase 21 kDa proteolipid subunit	GO:0033572; P:transferrin transport; TAS:Reactome
Q99437	ATP6V0B	V-type proton ATPase 21 kDa proteolipid subunit	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0005096; F:GTPase activator activity; TAS:ProtInc
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0005085; F:guanyl-nucleotide exchange factor activity; EXP:Reactome
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0005515; F:protein binding; IPI:IntAct
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0030676; F:Rac guanyl-nucleotide exchange factor activity; IEA:Ensembl
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0005070; F:SH3/SH2 adaptor activity; TAS:ProtInc
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0050853; P:B cell receptor signaling pathway; IMP:UniProtKB
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0007596; P:blood coagulation; TAS:Reactome
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0016477; P:cell migration; IEA:Ensembl
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0045087; P:innate immune response; TAS:Reactome
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0030032; P:lamellipodium assembly; IEA:Ensembl
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0030168; P:platelet activation; TAS:Reactome
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0030890; P:positive regulation of B cell proliferation; IMP:UniProtKB
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0045785; P:positive regulation of cell adhesion; IEA:Ensembl
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0043547; P:positive regulation of GTPase activity; TAS:GOC
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IEA:Ensembl
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0009967; P:positive regulation of signal transduction; TAS:GOC
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0042493; P:response to drug; IMP:UniProtKB
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
Q9UKW4	VAV3	Guanine nucleotide exchange factor VAV3	GO:0006906; P:vesicle fusion; IEA:Ensembl
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0005085; F:guanyl-nucleotide exchange factor activity; EXP:Reactome
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0005515; F:protein binding; IPI:IntAct
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0007411; P:axon guidance; TAS:Reactome
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0007596; P:blood coagulation; TAS:Reactome
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0016477; P:cell migration; IEA:Ensembl
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0045087; P:innate immune response; TAS:Reactome
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0030032; P:lamellipodium assembly; IEA:Ensembl
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0030168; P:platelet activation; TAS:Reactome
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IEA:Ensembl
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0043087; P:regulation of GTPase activity; EXP:GOC
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0007165; P:signal transduction; TAS:ProtInc
P52735	VAV2	Guanine nucleotide exchange factor VAV2	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P15498	VAV1	Proto-oncogene vav	GO:0005085; F:guanyl-nucleotide exchange factor activity; EXP:Reactome
P15498	VAV1	Proto-oncogene vav	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P15498	VAV1	Proto-oncogene vav	GO:0005515; F:protein binding; IPI:UniProtKB
P15498	VAV1	Proto-oncogene vav	GO:0030676; F:Rac guanyl-nucleotide exchange factor activity; IEA:Ensembl
P15498	VAV1	Proto-oncogene vav	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P15498	VAV1	Proto-oncogene vav	GO:0097190; P:apoptotic signaling pathway; TAS:Reactome
P15498	VAV1	Proto-oncogene vav	GO:0007596; P:blood coagulation; TAS:Reactome
P15498	VAV1	Proto-oncogene vav	GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome
P15498	VAV1	Proto-oncogene vav	GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome
P15498	VAV1	Proto-oncogene vav	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P15498	VAV1	Proto-oncogene vav	GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome
P15498	VAV1	Proto-oncogene vav	GO:0045087; P:innate immune response; TAS:Reactome
P15498	VAV1	Proto-oncogene vav	GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl
P15498	VAV1	Proto-oncogene vav	GO:0048011; P:neurotrophin TRK receptor signaling pathway; TAS:Reactome
P15498	VAV1	Proto-oncogene vav	GO:0048015; P:phosphatidylinositol-mediated signaling; TAS:Reactome
P15498	VAV1	Proto-oncogene vav	GO:0030168; P:platelet activation; TAS:Reactome
P15498	VAV1	Proto-oncogene vav	GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome
P15498	VAV1	Proto-oncogene vav	GO:0045785; P:positive regulation of cell adhesion; IEA:Ensembl
P15498	VAV1	Proto-oncogene vav	GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome
P15498	VAV1	Proto-oncogene vav	GO:0006355; P:regulation of transcription, DNA-templated; TAS:GOC
P15498	VAV1	Proto-oncogene vav	GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome
P15498	VAV1	Proto-oncogene vav	GO:0042110; P:T cell activation; IEA:Ensembl
P15498	VAV1	Proto-oncogene vav	GO:0031295; P:T cell costimulation; TAS:Reactome
Q5SQQ9	VAX1	Ventral anterior homeobox 1	GO:0031490; F:chromatin DNA binding; IEA:Ensembl
Q5SQQ9	VAX1	Ventral anterior homeobox 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q5SQQ9	VAX1	Ventral anterior homeobox 1	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
Q5SQQ9	VAX1	Ventral anterior homeobox 1	GO:0007411; P:axon guidance; IEA:Ensembl
Q5SQQ9	VAX1	Ventral anterior homeobox 1	GO:0007420; P:brain development; IEA:Ensembl
Q5SQQ9	VAX1	Ventral anterior homeobox 1	GO:0043010; P:camera-type eye development; IEA:Ensembl
Q5SQQ9	VAX1	Ventral anterior homeobox 1	GO:0007406; P:negative regulation of neuroblast proliferation; IEA:Ensembl
Q5SQQ9	VAX1	Ventral anterior homeobox 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q5SQQ9	VAX1	Ventral anterior homeobox 1	GO:0001764; P:neuron migration; IEA:Ensembl
Q5SQQ9	VAX1	Ventral anterior homeobox 1	GO:0060021; P:palate development; IEA:Ensembl
Q5SQQ9	VAX1	Ventral anterior homeobox 1	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q5SQQ9	VAX1	Ventral anterior homeobox 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UIW0	VAX2	Ventral anterior homeobox 2	GO:0031490; F:chromatin DNA binding; IEA:Ensembl
Q9UIW0	VAX2	Ventral anterior homeobox 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
Q9UIW0	VAX2	Ventral anterior homeobox 2	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:InterPro
Q9UIW0	VAX2	Ventral anterior homeobox 2	GO:0007409; P:axonogenesis; IEA:Ensembl
Q9UIW0	VAX2	Ventral anterior homeobox 2	GO:0009950; P:dorsal/ventral axis specification; IEA:Ensembl
Q9UIW0	VAX2	Ventral anterior homeobox 2	GO:0007398; P:ectoderm development; TAS:ProtInc
Q9UIW0	VAX2	Ventral anterior homeobox 2	GO:0048048; P:embryonic eye morphogenesis; IEA:Ensembl
Q9UIW0	VAX2	Ventral anterior homeobox 2	GO:0030900; P:forebrain development; ISS:UniProtKB
Q9UIW0	VAX2	Ventral anterior homeobox 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UIW0	VAX2	Ventral anterior homeobox 2	GO:0060041; P:retina development in camera-type eye; IEA:Ensembl
Q9UIW0	VAX2	Ventral anterior homeobox 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UIW0	VAX2	Ventral anterior homeobox 2	GO:0007601; P:visual perception; TAS:ProtInc
Q9UIW0	VAX2	Ventral anterior homeobox 2	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0050839; F:cell adhesion molecule binding; IDA:BHF-UCL
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0005178; F:integrin binding; IDA:BHF-UCL
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0008131; F:primary amine oxidase activity; IDA:UniProtKB
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0002526; P:acute inflammatory response; IEA:Ensembl
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0007568; P:aging; IEA:Ensembl
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0009308; P:amine metabolic process; IDA:UniProtKB
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0030183; P:B cell differentiation; IC:BHF-UCL
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0007155; P:cell adhesion; IDA:BHF-UCL
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0060326; P:cell chemotaxis; IEA:Ensembl
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IEA:Ensembl
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0060710; P:chorio-allantoic fusion; IEA:Ensembl
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0002544; P:chronic inflammatory response; IEA:Ensembl
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0007507; P:heart development; IEA:Ensembl
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0007157; P:heterophilic cell-cell adhesion; IDA:BHF-UCL
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0007159; P:leukocyte cell-cell adhesion; IDA:BHF-UCL
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0050901; P:leukocyte tethering or rolling; IEP:BHF-UCL
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0022614; P:membrane to membrane docking; IEP:BHF-UCL
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0055114; P:oxidation-reduction process; IDA:GOC
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0042102; P:positive regulation of T cell proliferation; IDA:BHF-UCL
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0050776; P:regulation of immune response; TAS:Reactome
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0045471; P:response to ethanol; IEA:Ensembl
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0001666; P:response to hypoxia; IEA:Ensembl
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0010212; P:response to ionizing radiation; IEA:Ensembl
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0035094; P:response to nicotine; IEA:Ensembl
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0007584; P:response to nutrient; IEA:Ensembl
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0010043; P:response to zinc ion; IEA:Ensembl
P19320	VCAM1	Vascular cell adhesion protein 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q6UXB2	CXCL17	VEGF coregulated chemokine 1	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q6UXB2	CXCL17	VEGF coregulated chemokine 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q6UXB2	CXCL17	VEGF coregulated chemokine 1	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
Q96JH7	VCPIP1	Deubiquitinating protein VCIP135	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q96JH7	VCPIP1	Deubiquitinating protein VCIP135	GO:0016320; P:endoplasmic reticulum membrane fusion; IEA:Ensembl
Q96JH7	VCPIP1	Deubiquitinating protein VCIP135	GO:0090168; P:Golgi reassembly; IEA:Ensembl
Q96JH7	VCPIP1	Deubiquitinating protein VCIP135	GO:0007067; P:mitosis; IEA:Ensembl
Q96JH7	VCPIP1	Deubiquitinating protein VCIP135	GO:0035871; P:protein K11-linked deubiquitination; IDA:UniProtKB
Q96JH7	VCPIP1	Deubiquitinating protein VCIP135	GO:0071108; P:protein K48-linked deubiquitination; IDA:UniProtKB
Q96JH7	VCPIP1	Deubiquitinating protein VCIP135	GO:0016567; P:protein ubiquitination; ISS:UniProtKB
Q9H320	VCX	Variable charge X-linked protein 1	GO:0003682; F:chromatin binding; TAS:UniProtKB
Q9H320	VCX	Variable charge X-linked protein 1	GO:0006325; P:chromatin organization; TAS:UniProtKB
Q9H320	VCX	Variable charge X-linked protein 1	GO:0042255; P:ribosome assembly; NAS:UniProtKB
Q9H320	VCX	Variable charge X-linked protein 1	GO:0007283; P:spermatogenesis; TAS:ProtInc
O14599	BPY2	Testis-specific basic protein Y 2	GO:0032399; F:HECT domain binding; IPI:HGNC
O14599	BPY2	Testis-specific basic protein Y 2	GO:0005515; F:protein binding; IPI:IntAct
O14599	BPY2	Testis-specific basic protein Y 2	GO:0007338; P:single fertilization; TAS:ProtInc
O14599	BPY2	Testis-specific basic protein Y 2	GO:0007283; P:spermatogenesis; IMP:HGNC
Q9NNX9	VCX3A	Variable charge X-linked protein 3	GO:0007420; P:brain development; IMP:UniProtKB
P21796	VDAC1	Voltage-dependent anion-selective channel protein 1	GO:0015288; F:porin activity; IEA:UniProtKB-KW
P21796	VDAC1	Voltage-dependent anion-selective channel protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P21796	VDAC1	Voltage-dependent anion-selective channel protein 1	GO:0008308; F:voltage-gated anion channel activity; ISS:UniProtKB
P21796	VDAC1	Voltage-dependent anion-selective channel protein 1	GO:0006820; P:anion transport; TAS:ProtInc
P21796	VDAC1	Voltage-dependent anion-selective channel protein 1	GO:0006915; P:apoptotic process; TAS:UniProtKB
P21796	VDAC1	Voltage-dependent anion-selective channel protein 1	GO:0001662; P:behavioral fear response; IEA:Ensembl
P21796	VDAC1	Voltage-dependent anion-selective channel protein 1	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
P21796	VDAC1	Voltage-dependent anion-selective channel protein 1	GO:0007612; P:learning; IEA:Ensembl
P21796	VDAC1	Voltage-dependent anion-selective channel protein 1	GO:0007270; P:neuron-neuron synaptic transmission; IEA:Ensembl
P21796	VDAC1	Voltage-dependent anion-selective channel protein 1	GO:0016032; P:viral process; IEA:UniProtKB-KW
P45880	VDAC2	Voltage-dependent anion-selective channel protein 2	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
P45880	VDAC2	Voltage-dependent anion-selective channel protein 2	GO:0015288; F:porin activity; IEA:UniProtKB-KW
P45880	VDAC2	Voltage-dependent anion-selective channel protein 2	GO:0005515; F:protein binding; IPI:IntAct
P45880	VDAC2	Voltage-dependent anion-selective channel protein 2	GO:0008308; F:voltage-gated anion channel activity; TAS:UniProtKB
P45880	VDAC2	Voltage-dependent anion-selective channel protein 2	GO:0006820; P:anion transport; TAS:ProtInc
P45880	VDAC2	Voltage-dependent anion-selective channel protein 2	GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl
P45880	VDAC2	Voltage-dependent anion-selective channel protein 2	GO:0032272; P:negative regulation of protein polymerization; IEA:Ensembl
Q9Y277	VDAC3	Voltage-dependent anion-selective channel protein 3	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
Q9Y277	VDAC3	Voltage-dependent anion-selective channel protein 3	GO:0015288; F:porin activity; IEA:UniProtKB-KW
Q9Y277	VDAC3	Voltage-dependent anion-selective channel protein 3	GO:0008308; F:voltage-gated anion channel activity; TAS:UniProtKB
Q9Y277	VDAC3	Voltage-dependent anion-selective channel protein 3	GO:0015853; P:adenine transport; TAS:ProtInc
P11473	VDR	Vitamin D3 receptor	GO:1902098; F:calcitriol binding; IDA:UniProtKB
P11473	VDR	Vitamin D3 receptor	GO:0008434; F:calcitriol receptor activity; IDA:UniProtKB
P11473	VDR	Vitamin D3 receptor	GO:0003677; F:DNA binding; IDA:MGI
P11473	VDR	Vitamin D3 receptor	GO:1902121; F:lithocholic acid binding; IDA:UniProtKB
P11473	VDR	Vitamin D3 receptor	GO:0038186; F:lithocholic acid receptor activity; IDA:UniProtKB
P11473	VDR	Vitamin D3 receptor	GO:0005515; F:protein binding; IPI:UniProtKB
P11473	VDR	Vitamin D3 receptor	GO:0046965; F:retinoid X receptor binding; IPI:BHF-UCL
P11473	VDR	Vitamin D3 receptor	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P11473	VDR	Vitamin D3 receptor	GO:0003707; F:steroid hormone receptor activity; IEA:InterPro
P11473	VDR	Vitamin D3 receptor	GO:0008270; F:zinc ion binding; IEA:InterPro
P11473	VDR	Vitamin D3 receptor	GO:0038183; P:bile acid signaling pathway; IDA:UniProtKB
P11473	VDR	Vitamin D3 receptor	GO:0006816; P:calcium ion transport; IEA:Ensembl
P11473	VDR	Vitamin D3 receptor	GO:0000902; P:cell morphogenesis; IMP:UniProtKB
P11473	VDR	Vitamin D3 receptor	GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl
P11473	VDR	Vitamin D3 receptor	GO:0046697; P:decidualization; IEP:BHF-UCL
P11473	VDR	Vitamin D3 receptor	GO:0010467; P:gene expression; TAS:Reactome
P11473	VDR	Vitamin D3 receptor	GO:0050892; P:intestinal absorption; IEA:Ensembl
P11473	VDR	Vitamin D3 receptor	GO:0007595; P:lactation; IEA:Ensembl
P11473	VDR	Vitamin D3 receptor	GO:0060745; P:mammary gland branching involved in pregnancy; IEA:Ensembl
P11473	VDR	Vitamin D3 receptor	GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL
P11473	VDR	Vitamin D3 receptor	GO:0010839; P:negative regulation of keratinocyte proliferation; IMP:UniProtKB
P11473	VDR	Vitamin D3 receptor	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P11473	VDR	Vitamin D3 receptor	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:MGI
P11473	VDR	Vitamin D3 receptor	GO:0009887; P:organ morphogenesis; IEA:Ensembl
P11473	VDR	Vitamin D3 receptor	GO:0060058; P:positive regulation of apoptotic process involved in mammary gland involution; IEA:Ensembl
P11473	VDR	Vitamin D3 receptor	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
P11473	VDR	Vitamin D3 receptor	GO:0045618; P:positive regulation of keratinocyte differentiation; IMP:UniProtKB
P11473	VDR	Vitamin D3 receptor	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB
P11473	VDR	Vitamin D3 receptor	GO:0010980; P:positive regulation of vitamin D 24-hydroxylase activity; IDA:BHF-UCL
P11473	VDR	Vitamin D3 receptor	GO:0060558; P:regulation of calcidiol 1-monooxygenase activity; ISS:BHF-UCL
P11473	VDR	Vitamin D3 receptor	GO:0007165; P:signal transduction; TAS:ProtInc
P11473	VDR	Vitamin D3 receptor	GO:0001501; P:skeletal system development; IEA:Ensembl
P11473	VDR	Vitamin D3 receptor	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P11473	VDR	Vitamin D3 receptor	GO:0070561; P:vitamin D receptor signaling pathway; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0042056; F:chemoattractant activity; IDA:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0005125; F:cytokine activity; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0050840; F:extracellular matrix binding; IC:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0001968; F:fibronectin binding; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0008083; F:growth factor activity; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0008201; F:heparin binding; IDA:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0042802; F:identical protein binding; IPI:IntAct
P15692	VEGFA	Vascular endothelial growth factor A	GO:0005161; F:platelet-derived growth factor receptor binding; IPI:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0005515; F:protein binding; IPI:IntAct
P15692	VEGFA	Vascular endothelial growth factor A	GO:0046982; F:protein heterodimerization activity; IDA:MGI
P15692	VEGFA	Vascular endothelial growth factor A	GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0048018; F:receptor agonist activity; IPI:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0043183; F:vascular endothelial growth factor receptor 1 binding; IPI:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0043184; F:vascular endothelial growth factor receptor 2 binding; IPI:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0005172; F:vascular endothelial growth factor receptor binding; IPI:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0032147; P:activation of protein kinase activity; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0001525; P:angiogenesis; IDA:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0048844; P:artery morphogenesis; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0002575; P:basophil chemotaxis; IDA:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0007596; P:blood coagulation; TAS:Reactome
P15692	VEGFA	Vascular endothelial growth factor A	GO:0048754; P:branching morphogenesis of an epithelial tube; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0048593; P:camera-type eye morphogenesis; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0048739; P:cardiac muscle fiber development; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0060948; P:cardiac vascular smooth muscle cell development; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0048469; P:cell maturation; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0002042; P:cell migration involved in sprouting angiogenesis; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0071456; P:cellular response to hypoxia; IDA:MGI
P15692	VEGFA	Vascular endothelial growth factor A	GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0071679; P:commissural neuron axon guidance; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0060982; P:coronary artery morphogenesis; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0003169; P:coronary vein morphogenesis; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0071542; P:dopaminergic neuron differentiation; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0035767; P:endothelial cell chemotaxis; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0030855; P:epithelial cell differentiation; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0042462; P:eye photoreceptor cell development; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0040007; P:growth; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0003007; P:heart morphogenesis; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0001701; P:in utero embryonic development; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0050930; P:induction of positive chemotaxis; IDA:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0001822; P:kidney development; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0007595; P:lactation; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0030324; P:lung development; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0036303; P:lymph vessel morphogenesis; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0030225; P:macrophage differentiation; IDA:DFLAT
P15692	VEGFA	Vascular endothelial growth factor A	GO:0060749; P:mammary gland alveolus development; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0007498; P:mesoderm development; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0030224; P:monocyte differentiation; IDA:DFLAT
P15692	VEGFA	Vascular endothelial growth factor A	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0007399; P:nervous system development; TAS:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0003151; P:outflow tract morphogenesis; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0001541; P:ovarian follicle development; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0001569; P:patterning of blood vessels; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0030168; P:platelet activation; TAS:Reactome
P15692	VEGFA	Vascular endothelial growth factor A	GO:0002576; P:platelet degranulation; TAS:Reactome
P15692	VEGFA	Vascular endothelial growth factor A	GO:0050918; P:positive chemotaxis; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0048842; P:positive regulation of axon extension involved in axon guidance; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0045785; P:positive regulation of cell adhesion; IDA:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P15692	VEGFA	Vascular endothelial growth factor A	GO:0030335; P:positive regulation of cell migration; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0038091; P:positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0051272; P:positive regulation of cellular component movement; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0032793; P:positive regulation of CREB transcription factor activity; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0038033; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0010595; P:positive regulation of endothelial cell migration; IDA:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0050679; P:positive regulation of epithelial cell proliferation; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0051894; P:positive regulation of focal adhesion assembly; IDA:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:1901727; P:positive regulation of histone deacetylase activity; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:1902533; P:positive regulation of intracellular signal transduction; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0002687; P:positive regulation of leukocyte migration; TAS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0043406; P:positive regulation of MAP kinase activity; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0060754; P:positive regulation of mast cell chemotaxis; IDA:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0002053; P:positive regulation of mesenchymal cell proliferation; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0002052; P:positive regulation of neuroblast proliferation; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:1900745; P:positive regulation of p38MAPK cascade; IDA:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:1900086; P:positive regulation of peptidyl-tyrosine autophosphorylation; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0050927; P:positive regulation of positive chemotaxis; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0031954; P:positive regulation of protein autophosphorylation; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0031334; P:positive regulation of protein complex assembly; IDA:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0090037; P:positive regulation of protein kinase C signaling; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0002092; P:positive regulation of receptor internalization; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:1902336; P:positive regulation of retinal ganglion cell axon guidance; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0061419; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; IMP:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0043117; P:positive regulation of vascular permeability; IDA:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0031077; P:post-embryonic camera-type eye development; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0060319; P:primitive erythrocyte differentiation; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0008360; P:regulation of cell shape; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0090259; P:regulation of retinal ganglion cell axon guidance; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
P15692	VEGFA	Vascular endothelial growth factor A	GO:0001666; P:response to hypoxia; IDA:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0043129; P:surfactant homeostasis; ISS:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0035148; P:tube formation; IDA:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IDA:BHF-UCL
P15692	VEGFA	Vascular endothelial growth factor A	GO:0001570; P:vasculogenesis; TAS:UniProtKB
P15692	VEGFA	Vascular endothelial growth factor A	GO:0038190; P:VEGF-activated neuropilin signaling pathway; ISS:BHF-UCL
P49765	VEGFB	Vascular endothelial growth factor B	GO:0042056; F:chemoattractant activity; IDA:UniProtKB
P49765	VEGFB	Vascular endothelial growth factor B	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P49765	VEGFB	Vascular endothelial growth factor B	GO:0005515; F:protein binding; IPI:UniProtKB
P49765	VEGFB	Vascular endothelial growth factor B	GO:0043183; F:vascular endothelial growth factor receptor 1 binding; IPI:UniProtKB
P49765	VEGFB	Vascular endothelial growth factor B	GO:0001525; P:angiogenesis; IEA:Ensembl
P49765	VEGFB	Vascular endothelial growth factor B	GO:0007596; P:blood coagulation; TAS:Reactome
P49765	VEGFB	Vascular endothelial growth factor B	GO:0060048; P:cardiac muscle contraction; IEA:Ensembl
P49765	VEGFB	Vascular endothelial growth factor B	GO:0060976; P:coronary vasculature development; IEA:Ensembl
P49765	VEGFB	Vascular endothelial growth factor B	GO:0050930; P:induction of positive chemotaxis; IDA:UniProtKB
P49765	VEGFB	Vascular endothelial growth factor B	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P49765	VEGFB	Vascular endothelial growth factor B	GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB
P49765	VEGFB	Vascular endothelial growth factor B	GO:0043524; P:negative regulation of neuron apoptotic process; IDA:UniProtKB
P49765	VEGFB	Vascular endothelial growth factor B	GO:0030168; P:platelet activation; TAS:Reactome
P49765	VEGFB	Vascular endothelial growth factor B	GO:0002576; P:platelet degranulation; TAS:Reactome
P49765	VEGFB	Vascular endothelial growth factor B	GO:0050918; P:positive chemotaxis; IDA:GOC
P49765	VEGFB	Vascular endothelial growth factor B	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P49765	VEGFB	Vascular endothelial growth factor B	GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:UniProtKB
P49765	VEGFB	Vascular endothelial growth factor B	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB
P49765	VEGFB	Vascular endothelial growth factor B	GO:0060754; P:positive regulation of mast cell chemotaxis; IDA:UniProtKB
P49765	VEGFB	Vascular endothelial growth factor B	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P49765	VEGFB	Vascular endothelial growth factor B	GO:0051897; P:positive regulation of protein kinase B signaling; IDA:UniProtKB
P49765	VEGFB	Vascular endothelial growth factor B	GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; IDA:UniProtKB
P49765	VEGFB	Vascular endothelial growth factor B	GO:0035470; P:positive regulation of vascular wound healing; IDA:UniProtKB
P49765	VEGFB	Vascular endothelial growth factor B	GO:0006493; P:protein O-linked glycosylation; IEA:Ensembl
P49765	VEGFB	Vascular endothelial growth factor B	GO:0042493; P:response to drug; IEA:Ensembl
P49765	VEGFB	Vascular endothelial growth factor B	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; TAS:Reactome
P49767	VEGFC	Vascular endothelial growth factor C	GO:0042056; F:chemoattractant activity; IDA:UniProtKB
P49767	VEGFC	Vascular endothelial growth factor C	GO:0005515; F:protein binding; IPI:IntAct
P49767	VEGFC	Vascular endothelial growth factor C	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
P49767	VEGFC	Vascular endothelial growth factor C	GO:0007596; P:blood coagulation; TAS:Reactome
P49767	VEGFC	Vascular endothelial growth factor C	GO:0050930; P:induction of positive chemotaxis; IDA:UniProtKB
P49767	VEGFC	Vascular endothelial growth factor C	GO:0016331; P:morphogenesis of embryonic epithelium; IEA:Ensembl
P49767	VEGFC	Vascular endothelial growth factor C	GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl
P49767	VEGFC	Vascular endothelial growth factor C	GO:0009887; P:organ morphogenesis; IEA:Ensembl
P49767	VEGFC	Vascular endothelial growth factor C	GO:0030168; P:platelet activation; TAS:Reactome
P49767	VEGFC	Vascular endothelial growth factor C	GO:0002576; P:platelet degranulation; TAS:Reactome
P49767	VEGFC	Vascular endothelial growth factor C	GO:0050918; P:positive chemotaxis; IDA:GOC
P49767	VEGFC	Vascular endothelial growth factor C	GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IEA:Ensembl
P49767	VEGFC	Vascular endothelial growth factor C	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P49767	VEGFC	Vascular endothelial growth factor C	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P49767	VEGFC	Vascular endothelial growth factor C	GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl
P49767	VEGFC	Vascular endothelial growth factor C	GO:1901492; P:positive regulation of lymphangiogenesis; IEA:Ensembl
P49767	VEGFC	Vascular endothelial growth factor C	GO:0060754; P:positive regulation of mast cell chemotaxis; IDA:UniProtKB
P49767	VEGFC	Vascular endothelial growth factor C	GO:0002052; P:positive regulation of neuroblast proliferation; IEA:Ensembl
P49767	VEGFC	Vascular endothelial growth factor C	GO:0031954; P:positive regulation of protein autophosphorylation; IEA:Ensembl
P49767	VEGFC	Vascular endothelial growth factor C	GO:0050714; P:positive regulation of protein secretion; IEA:Ensembl
P49767	VEGFC	Vascular endothelial growth factor C	GO:0030947; P:regulation of vascular endothelial growth factor receptor signaling pathway; IEA:Ensembl
P49767	VEGFC	Vascular endothelial growth factor C	GO:0042493; P:response to drug; IEA:Ensembl
P49767	VEGFC	Vascular endothelial growth factor C	GO:0007165; P:signal transduction; TAS:ProtInc
P49767	VEGFC	Vascular endothelial growth factor C	GO:0006929; P:substrate-dependent cell migration; TAS:ProtInc
P49767	VEGFC	Vascular endothelial growth factor C	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; TAS:Reactome
O43915	FIGF	Vascular endothelial growth factor D	GO:0042056; F:chemoattractant activity; IDA:UniProtKB
O43915	FIGF	Vascular endothelial growth factor D	GO:0005161; F:platelet-derived growth factor receptor binding; TAS:ProtInc
O43915	FIGF	Vascular endothelial growth factor D	GO:0005172; F:vascular endothelial growth factor receptor binding; IPI:UniProtKB
O43915	FIGF	Vascular endothelial growth factor D	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
O43915	FIGF	Vascular endothelial growth factor D	GO:0007596; P:blood coagulation; TAS:Reactome
O43915	FIGF	Vascular endothelial growth factor D	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O43915	FIGF	Vascular endothelial growth factor D	GO:0008283; P:cell proliferation; IEA:Ensembl
O43915	FIGF	Vascular endothelial growth factor D	GO:0050930; P:induction of positive chemotaxis; IDA:UniProtKB
O43915	FIGF	Vascular endothelial growth factor D	GO:0030168; P:platelet activation; TAS:Reactome
O43915	FIGF	Vascular endothelial growth factor D	GO:0002576; P:platelet degranulation; TAS:Reactome
O43915	FIGF	Vascular endothelial growth factor D	GO:0050918; P:positive chemotaxis; IDA:GOC
O43915	FIGF	Vascular endothelial growth factor D	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
O43915	FIGF	Vascular endothelial growth factor D	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
O43915	FIGF	Vascular endothelial growth factor D	GO:0060754; P:positive regulation of mast cell chemotaxis; IDA:UniProtKB
O43915	FIGF	Vascular endothelial growth factor D	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; TAS:Reactome
O95231	VENTX	Homeobox protein VENTX	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O95231	VENTX	Homeobox protein VENTX	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O95231	VENTX	Homeobox protein VENTX	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9HBM0	VEZT	Vezatin	GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl
Q9HBM0	VEZT	Vezatin	GO:0043009; P:chordate embryonic development; IEA:Ensembl
Q14119	VEZF1	Vascular endothelial zinc finger 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q14119	VEZF1	Vascular endothelial zinc finger 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14119	VEZF1	Vascular endothelial zinc finger 1	GO:0001525; P:angiogenesis; IEA:Ensembl
Q14119	VEZF1	Vascular endothelial zinc finger 1	GO:0006968; P:cellular defense response; TAS:ProtInc
Q14119	VEZF1	Vascular endothelial zinc finger 1	GO:0001885; P:endothelial cell development; IEA:Ensembl
Q14119	VEZF1	Vascular endothelial zinc finger 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q14119	VEZF1	Vascular endothelial zinc finger 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0019838; F:growth factor binding; IPI:UniProtKB
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0036332; F:placental growth factor-activated receptor activity; IDA:UniProtKB
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0005515; F:protein binding; IPI:IntAct
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; TAS:ProtInc
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0005021; F:vascular endothelial growth factor-activated receptor activity; IDA:UniProtKB
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0036326; F:VEGF-A-activated receptor activity; IDA:UniProtKB
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0036327; F:VEGF-B-activated receptor activity; IDA:UniProtKB
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0048514; P:blood vessel morphogenesis; ISS:UniProtKB
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0016477; P:cell migration; IMP:UniProtKB
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IDA:UniProtKB
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0048598; P:embryonic morphogenesis; ISS:UniProtKB
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0002548; P:monocyte chemotaxis; IDA:UniProtKB
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0001569; P:patterning of blood vessels; IEA:Ensembl
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0043406; P:positive regulation of MAP kinase activity; IDA:UniProtKB
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0043410; P:positive regulation of MAPK cascade; IDA:UniProtKB
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IMP:UniProtKB
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IMP:UniProtKB
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0010863; P:positive regulation of phospholipase C activity; IMP:UniProtKB
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; IDA:BHF-UCL
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0002040; P:sprouting angiogenesis; IEA:Ensembl
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IDA:UniProtKB
P17948	FLT1	Vascular endothelial growth factor receptor 1	GO:0036323; P:vascular endothelial growth factor receptor-1 signaling pathway; IDA:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0019838; F:growth factor binding; IPI:BHF-UCL
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0051879; F:Hsp90 protein binding; TAS:BHF-UCL
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0005178; F:integrin binding; IPI:BHF-UCL
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0005515; F:protein binding; IPI:BHF-UCL
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0004716; F:receptor signaling protein tyrosine kinase activity; TAS:BHF-UCL
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; TAS:BHF-UCL
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0038085; F:vascular endothelial growth factor binding; IPI:BHF-UCL
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0005021; F:vascular endothelial growth factor-activated receptor activity; IDA:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0001525; P:angiogenesis; TAS:BHF-UCL
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0048754; P:branching morphogenesis of an epithelial tube; IEA:Ensembl
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0055074; P:calcium ion homeostasis; IEA:Ensembl
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0035584; P:calcium-mediated signaling using intracellular calcium source; IMP:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0045165; P:cell fate commitment; IEA:Ensembl
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0048469; P:cell maturation; IEA:Ensembl
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0002042; P:cell migration involved in sprouting angiogenesis; ISS:BHF-UCL
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IDA:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0035162; P:embryonic hemopoiesis; ISS:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0045446; P:endothelial cell differentiation; IEA:Ensembl
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0003158; P:endothelium development; ISS:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0048286; P:lung alveolus development; IEA:Ensembl
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0001945; P:lymph vessel development; IEA:Ensembl
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:2000352; P:negative regulation of endothelial cell apoptotic process; IDA:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0001541; P:ovarian follicle development; IEA:Ensembl
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0038083; P:peptidyl-tyrosine autophosphorylation; ISS:BHF-UCL
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0010595; P:positive regulation of endothelial cell migration; IMP:BHF-UCL
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0051894; P:positive regulation of focal adhesion assembly; IDA:BHF-UCL
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0043410; P:positive regulation of MAPK cascade; IDA:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; IDA:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IDA:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0050927; P:positive regulation of positive chemotaxis; IDA:BHF-UCL
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:2001214; P:positive regulation of vasculogenesis; ISS:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0008360; P:regulation of cell shape; IDA:BHF-UCL
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0023014; P:signal transduction by phosphorylation; TAS:GOC
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0043129; P:surfactant homeostasis; IEA:Ensembl
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IDA:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0038084; P:vascular endothelial growth factor signaling pathway; IDA:GOC
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0001570; P:vasculogenesis; ISS:UniProtKB
P35968	KDR	Vascular endothelial growth factor receptor 2	GO:0016032; P:viral process; IEA:UniProtKB-KW
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0019838; F:growth factor binding; IPI:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0005515; F:protein binding; IPI:IntAct
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0019903; F:protein phosphatase binding; IPI:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IMP:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0005021; F:vascular endothelial growth factor-activated receptor activity; IMP:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0048514; P:blood vessel morphogenesis; ISS:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IDA:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0001945; P:lymph vessel development; ISS:BHF-UCL
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0001946; P:lymphangiogenesis; IMP:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0010595; P:positive regulation of endothelial cell migration; IMP:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0046330; P:positive regulation of JNK cascade; IMP:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0043410; P:positive regulation of MAPK cascade; IMP:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0090037; P:positive regulation of protein kinase C signaling; IMP:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0001934; P:positive regulation of protein phosphorylation; IMP:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0010575; P:positive regulation vascular endothelial growth factor production; IMP:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0060312; P:regulation of blood vessel remodeling; ISS:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0002040; P:sprouting angiogenesis; ISS:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IMP:UniProtKB
P35916	FLT4	Vascular endothelial growth factor receptor 3	GO:0001944; P:vasculature development; ISS:UniProtKB
O15240	VGF	Neurosecretory protein VGF	GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW
O15240	VGF	Neurosecretory protein VGF	GO:0006091; P:generation of precursor metabolites and energy; IEA:Ensembl
O15240	VGF	Neurosecretory protein VGF	GO:0042593; P:glucose homeostasis; IEA:Ensembl
O15240	VGF	Neurosecretory protein VGF	GO:0030073; P:insulin secretion; IEA:Ensembl
O15240	VGF	Neurosecretory protein VGF	GO:0001541; P:ovarian follicle development; IEA:Ensembl
O15240	VGF	Neurosecretory protein VGF	GO:0051591; P:response to cAMP; IEP:UniProtKB
O15240	VGF	Neurosecretory protein VGF	GO:0009409; P:response to cold; IEA:Ensembl
O15240	VGF	Neurosecretory protein VGF	GO:0002021; P:response to dietary excess; IEA:Ensembl
O15240	VGF	Neurosecretory protein VGF	GO:0032868; P:response to insulin; IEA:Ensembl
O15240	VGF	Neurosecretory protein VGF	GO:0019953; P:sexual reproduction; IEA:Ensembl
Q8N8G2	VGLL2	Transcription cofactor vestigial-like protein 2	GO:0003713; F:transcription coactivator activity; IEA:Ensembl
Q8N8G2	VGLL2	Transcription cofactor vestigial-like protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8N8G2	VGLL2	Transcription cofactor vestigial-like protein 2	GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl
Q8N8G2	VGLL2	Transcription cofactor vestigial-like protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q99990	VGLL1	Transcription cofactor vestigial-like protein 1	GO:0003713; F:transcription coactivator activity; TAS:UniProtKB
Q99990	VGLL1	Transcription cofactor vestigial-like protein 1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q99990	VGLL1	Transcription cofactor vestigial-like protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A8MV65	VGLL3	Transcription cofactor vestigial-like protein 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A8MV65	VGLL3	Transcription cofactor vestigial-like protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14135	VGLL4	Transcription cofactor vestigial-like protein 4	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q14135	VGLL4	Transcription cofactor vestigial-like protein 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9P2U7	SLC17A7	Vesicular glutamate transporter 1	GO:0005315; F:inorganic phosphate transmembrane transporter activity; IEA:Ensembl
Q9P2U7	SLC17A7	Vesicular glutamate transporter 1	GO:0005313; F:L-glutamate transmembrane transporter activity; TAS:Reactome
Q9P2U7	SLC17A7	Vesicular glutamate transporter 1	GO:0015321; F:sodium-dependent phosphate transmembrane transporter activity; TAS:ProtInc
Q9P2U7	SLC17A7	Vesicular glutamate transporter 1	GO:0015319; F:sodium:inorganic phosphate symporter activity; IDA:MGI
Q9P2U7	SLC17A7	Vesicular glutamate transporter 1	GO:0014047; P:glutamate secretion; TAS:Reactome
Q9P2U7	SLC17A7	Vesicular glutamate transporter 1	GO:0006811; P:ion transport; TAS:Reactome
Q9P2U7	SLC17A7	Vesicular glutamate transporter 1	GO:0051938; P:L-glutamate import; IEA:Ensembl
Q9P2U7	SLC17A7	Vesicular glutamate transporter 1	GO:0007616; P:long-term memory; IEA:Ensembl
Q9P2U7	SLC17A7	Vesicular glutamate transporter 1	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
Q9P2U7	SLC17A7	Vesicular glutamate transporter 1	GO:0035435; P:phosphate ion transmembrane transport; IDA:GOC
Q9P2U7	SLC17A7	Vesicular glutamate transporter 1	GO:0006817; P:phosphate ion transport; TAS:ProtInc
Q9P2U7	SLC17A7	Vesicular glutamate transporter 1	GO:0060079; P:regulation of excitatory postsynaptic membrane potential; IEA:Ensembl
Q9P2U7	SLC17A7	Vesicular glutamate transporter 1	GO:0042137; P:sequestering of neurotransmitter; IEA:Ensembl
Q9P2U7	SLC17A7	Vesicular glutamate transporter 1	GO:0035725; P:sodium ion transmembrane transport; IDA:GOC
Q9P2U7	SLC17A7	Vesicular glutamate transporter 1	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9P2U7	SLC17A7	Vesicular glutamate transporter 1	GO:0035249; P:synaptic transmission, glutamatergic; IEA:Ensembl
Q9P2U7	SLC17A7	Vesicular glutamate transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9P2U8	SLC17A6	Vesicular glutamate transporter 2	GO:0005313; F:L-glutamate transmembrane transporter activity; IEA:Ensembl
Q9P2U8	SLC17A6	Vesicular glutamate transporter 2	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q9P2U8	SLC17A6	Vesicular glutamate transporter 2	GO:0006811; P:ion transport; TAS:Reactome
Q9P2U8	SLC17A6	Vesicular glutamate transporter 2	GO:0001504; P:neurotransmitter uptake; IEA:Ensembl
Q9P2U8	SLC17A6	Vesicular glutamate transporter 2	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q9P2U8	SLC17A6	Vesicular glutamate transporter 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8NDX2	SLC17A8	Vesicular glutamate transporter 3	GO:0005313; F:L-glutamate transmembrane transporter activity; IEA:Ensembl
Q8NDX2	SLC17A8	Vesicular glutamate transporter 3	GO:0015293; F:symporter activity; IEA:UniProtKB-KW
Q8NDX2	SLC17A8	Vesicular glutamate transporter 3	GO:0006811; P:ion transport; TAS:Reactome
Q8NDX2	SLC17A8	Vesicular glutamate transporter 3	GO:0006836; P:neurotransmitter transport; IEA:UniProtKB-KW
Q8NDX2	SLC17A8	Vesicular glutamate transporter 3	GO:0007605; P:sensory perception of sound; IEA:UniProtKB-KW
Q8NDX2	SLC17A8	Vesicular glutamate transporter 3	GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW
Q8NDX2	SLC17A8	Vesicular glutamate transporter 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q6RSH7	VHLL	Von Hippel-Lindau-like protein	GO:0016567; P:protein ubiquitination; IEA:InterPro
P40337	VHL	Von Hippel-Lindau disease tumor suppressor	GO:0019899; F:enzyme binding; IPI:UniProtKB
P40337	VHL	Von Hippel-Lindau disease tumor suppressor	GO:0005515; F:protein binding; IPI:IntAct
P40337	VHL	Von Hippel-Lindau disease tumor suppressor	GO:0008134; F:transcription factor binding; IPI:UniProtKB
P40337	VHL	Von Hippel-Lindau disease tumor suppressor	GO:0004842; F:ubiquitin-protein ligase activity; TAS:Reactome
P40337	VHL	Von Hippel-Lindau disease tumor suppressor	GO:0000902; P:cell morphogenesis; NAS:UniProtKB
P40337	VHL	Von Hippel-Lindau disease tumor suppressor	GO:0071456; P:cellular response to hypoxia; TAS:Reactome
P40337	VHL	Von Hippel-Lindau disease tumor suppressor	GO:0043066; P:negative regulation of apoptotic process; NAS:UniProtKB
P40337	VHL	Von Hippel-Lindau disease tumor suppressor	GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc
P40337	VHL	Von Hippel-Lindau disease tumor suppressor	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P40337	VHL	Von Hippel-Lindau disease tumor suppressor	GO:0061428; P:negative regulation of transcription from RNA polymerase II promoter in response to hypoxia; IDA:UniProtKB
P40337	VHL	Von Hippel-Lindau disease tumor suppressor	GO:0045597; P:positive regulation of cell differentiation; NAS:UniProtKB
P40337	VHL	Von Hippel-Lindau disease tumor suppressor	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
P40337	VHL	Von Hippel-Lindau disease tumor suppressor	GO:0050821; P:protein stabilization; NAS:UniProtKB
P40337	VHL	Von Hippel-Lindau disease tumor suppressor	GO:0016567; P:protein ubiquitination; IMP:UniProtKB
P40337	VHL	Von Hippel-Lindau disease tumor suppressor	GO:0006508; P:proteolysis; TAS:ProtInc
P40337	VHL	Von Hippel-Lindau disease tumor suppressor	GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome
P40337	VHL	Von Hippel-Lindau disease tumor suppressor	GO:0006355; P:regulation of transcription, DNA-templated; IMP:BHF-UCL
P40337	VHL	Von Hippel-Lindau disease tumor suppressor	GO:0006950; P:response to stress; NAS:UniProtKB
Q9H598	SLC32A1	Vesicular inhibitory amino acid transporter	GO:0015495; F:gamma-aminobutyric acid:proton symporter activity; IEA:Ensembl
Q9H598	SLC32A1	Vesicular inhibitory amino acid transporter	GO:0015187; F:glycine transmembrane transporter activity; IEA:Ensembl
Q9H598	SLC32A1	Vesicular inhibitory amino acid transporter	GO:0007568; P:aging; IEA:Ensembl
Q9H598	SLC32A1	Vesicular inhibitory amino acid transporter	GO:0006811; P:ion transport; TAS:Reactome
Q9H598	SLC32A1	Vesicular inhibitory amino acid transporter	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
Q9H598	SLC32A1	Vesicular inhibitory amino acid transporter	GO:0007268; P:synaptic transmission; TAS:Reactome
Q9H598	SLC32A1	Vesicular inhibitory amino acid transporter	GO:0055085; P:transmembrane transport; TAS:Reactome
Q00341	HDLBP	Vigilin	GO:0008289; F:lipid binding; TAS:ProtInc
Q00341	HDLBP	Vigilin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q00341	HDLBP	Vigilin	GO:0008203; P:cholesterol metabolic process; TAS:ProtInc
Q00341	HDLBP	Vigilin	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
P09327	VIL1	Villin-1	GO:0051015; F:actin filament binding; IDA:UniProtKB
P09327	VIL1	Villin-1	GO:0005509; F:calcium ion binding; IDA:UniProtKB
P09327	VIL1	Villin-1	GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IEA:Ensembl
P09327	VIL1	Villin-1	GO:0042802; F:identical protein binding; IPI:IntAct
P09327	VIL1	Villin-1	GO:0035727; F:lysophosphatidic acid binding; IDA:UniProtKB
P09327	VIL1	Villin-1	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProtKB
P09327	VIL1	Villin-1	GO:0005515; F:protein binding; IPI:UniProtKB
P09327	VIL1	Villin-1	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P09327	VIL1	Villin-1	GO:0051693; P:actin filament capping; IDA:UniProtKB
P09327	VIL1	Villin-1	GO:0030042; P:actin filament depolymerization; IDA:UniProtKB
P09327	VIL1	Villin-1	GO:0030041; P:actin filament polymerization; IDA:UniProtKB
P09327	VIL1	Villin-1	GO:0051014; P:actin filament severing; IDA:UniProtKB
P09327	VIL1	Villin-1	GO:0071364; P:cellular response to epidermal growth factor stimulus; IDA:UniProtKB
P09327	VIL1	Villin-1	GO:0035729; P:cellular response to hepatocyte growth factor stimulus; IEA:Ensembl
P09327	VIL1	Villin-1	GO:0060327; P:cytoplasmic actin-based contraction involved in cell motility; IDA:UniProtKB
P09327	VIL1	Villin-1	GO:0007010; P:cytoskeleton organization; IEA:InterPro
P09327	VIL1	Villin-1	GO:0007173; P:epidermal growth factor receptor signaling pathway; IDA:UniProtKB
P09327	VIL1	Villin-1	GO:0030855; P:epithelial cell differentiation; IEP:UniProt
P09327	VIL1	Villin-1	GO:0032233; P:positive regulation of actin filament bundle assembly; IDA:UniProtKB
P09327	VIL1	Villin-1	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
P09327	VIL1	Villin-1	GO:0010634; P:positive regulation of epithelial cell migration; IDA:UniProtKB
P09327	VIL1	Villin-1	GO:0006461; P:protein complex assembly; TAS:ProtInc
P09327	VIL1	Villin-1	GO:0051125; P:regulation of actin nucleation; IDA:UniProtKB
P09327	VIL1	Villin-1	GO:0008360; P:regulation of cell shape; IDA:UniProtKB
P09327	VIL1	Villin-1	GO:2000392; P:regulation of lamellipodium morphogenesis; IEA:Ensembl
P09327	VIL1	Villin-1	GO:0061041; P:regulation of wound healing; IEA:Ensembl
P09327	VIL1	Villin-1	GO:0009617; P:response to bacterium; IDA:UniProtKB
O15195	VILL	Villin-like protein	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
O15195	VILL	Villin-like protein	GO:0051693; P:actin filament capping; IEA:UniProtKB-KW
O15195	VILL	Villin-like protein	GO:0007010; P:cytoskeleton organization; IEA:InterPro
P08670	VIM	Vimentin	GO:0003725; F:double-stranded RNA binding; IDA:MGI
P08670	VIM	Vimentin	GO:0001948; F:glycoprotein binding; IPI:UniProt
P08670	VIM	Vimentin	GO:0042802; F:identical protein binding; IPI:IntAct
P08670	VIM	Vimentin	GO:0005515; F:protein binding; IPI:UniProtKB
P08670	VIM	Vimentin	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P08670	VIM	Vimentin	GO:0097110; F:scaffold protein binding; IPI:BHF-UCL
P08670	VIM	Vimentin	GO:0005200; F:structural constituent of cytoskeleton; IDA:UniProtKB
P08670	VIM	Vimentin	GO:0005212; F:structural constituent of eye lens; IEA:Ensembl
P08670	VIM	Vimentin	GO:0006915; P:apoptotic process; TAS:Reactome
P08670	VIM	Vimentin	GO:0014002; P:astrocyte development; IEA:Ensembl
P08670	VIM	Vimentin	GO:0060020; P:Bergmann glial cell differentiation; IEA:Ensembl
P08670	VIM	Vimentin	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
P08670	VIM	Vimentin	GO:0006928; P:cellular component movement; TAS:UniProtKB
P08670	VIM	Vimentin	GO:0045109; P:intermediate filament organization; IEA:Ensembl
P08670	VIM	Vimentin	GO:0070307; P:lens fiber cell development; IEA:Ensembl
P08670	VIM	Vimentin	GO:0030049; P:muscle filament sliding; TAS:Reactome
P08670	VIM	Vimentin	GO:0010977; P:negative regulation of neuron projection development; IEA:Ensembl
P08670	VIM	Vimentin	GO:0016032; P:viral process; IEA:UniProtKB-KW
P18206	VCL	Vinculin	GO:0003779; F:actin binding; IDA:BHF-UCL
P18206	VCL	Vinculin	GO:0045294; F:alpha-catenin binding; IPI:UniProtKB
P18206	VCL	Vinculin	GO:0008013; F:beta-catenin binding; ISS:BHF-UCL
P18206	VCL	Vinculin	GO:0045296; F:cadherin binding; ISS:BHF-UCL
P18206	VCL	Vinculin	GO:0002162; F:dystroglycan binding; IPI:UniProtKB
P18206	VCL	Vinculin	GO:0005515; F:protein binding; IPI:UniProtKB
P18206	VCL	Vinculin	GO:0005198; F:structural molecule activity; IEA:InterPro
P18206	VCL	Vinculin	GO:0034333; P:adherens junction assembly; IMP:BHF-UCL
P18206	VCL	Vinculin	GO:0043297; P:apical junction assembly; IMP:UniProtKB
P18206	VCL	Vinculin	GO:0007596; P:blood coagulation; TAS:Reactome
P18206	VCL	Vinculin	GO:0007155; P:cell adhesion; TAS:UniProtKB
P18206	VCL	Vinculin	GO:0007160; P:cell-matrix adhesion; TAS:BHF-UCL
P18206	VCL	Vinculin	GO:0006928; P:cellular component movement; TAS:UniProtKB
P18206	VCL	Vinculin	GO:0090136; P:epithelial cell-cell adhesion; IMP:BHF-UCL
P18206	VCL	Vinculin	GO:0030032; P:lamellipodium assembly; ISS:UniProtKB
P18206	VCL	Vinculin	GO:0002009; P:morphogenesis of an epithelium; IMP:BHF-UCL
P18206	VCL	Vinculin	GO:0006936; P:muscle contraction; TAS:Reactome
P18206	VCL	Vinculin	GO:0030336; P:negative regulation of cell migration; TAS:UniProtKB
P18206	VCL	Vinculin	GO:0030168; P:platelet activation; TAS:Reactome
P18206	VCL	Vinculin	GO:0002576; P:platelet degranulation; TAS:Reactome
P18206	VCL	Vinculin	GO:0034394; P:protein localization to cell surface; IMP:BHF-UCL
O60504	SORBS3	Vinexin	GO:0005515; F:protein binding; IPI:IntAct
O60504	SORBS3	Vinexin	GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc
O60504	SORBS3	Vinexin	GO:0017166; F:vinculin binding; IPI:UniProtKB
O60504	SORBS3	Vinexin	GO:0007155; P:cell adhesion; TAS:ProtInc
O60504	SORBS3	Vinexin	GO:0031589; P:cell-substrate adhesion; IEA:Ensembl
O60504	SORBS3	Vinexin	GO:0006936; P:muscle contraction; TAS:Reactome
O60504	SORBS3	Vinexin	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O60504	SORBS3	Vinexin	GO:0051495; P:positive regulation of cytoskeleton organization; NAS:UniProtKB
O60504	SORBS3	Vinexin	GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl
O60504	SORBS3	Vinexin	GO:0051496; P:positive regulation of stress fiber assembly; IDA:UniProtKB
Q6PFW1	PPIP5K1	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1	GO:0003993; F:acid phosphatase activity; IEA:InterPro
Q6PFW1	PPIP5K1	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q6PFW1	PPIP5K1	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1	GO:0033857; F:diphosphoinositol-pentakisphosphate kinase activity; IDA:UniProtKB
Q6PFW1	PPIP5K1	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1	GO:0052723; F:inositol hexakisphosphate 1-kinase activity; IEA:UniProtKB-EC
Q6PFW1	PPIP5K1	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1	GO:0052724; F:inositol hexakisphosphate 3-kinase activity; IEA:UniProtKB-EC
Q6PFW1	PPIP5K1	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1	GO:0000832; F:inositol hexakisphosphate 5-kinase activity; IDA:UniProtKB
Q6PFW1	PPIP5K1	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1	GO:0000827; F:inositol-1,3,4,5,6-pentakisphosphate kinase activity; IDA:UniProtKB
Q6PFW1	PPIP5K1	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1	GO:0006020; P:inositol metabolic process; IDA:UniProtKB
Q6PFW1	PPIP5K1	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
Q6PFW1	PPIP5K1	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O43314	PPIP5K2	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2	GO:0003993; F:acid phosphatase activity; IEA:InterPro
O43314	PPIP5K2	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43314	PPIP5K2	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2	GO:0033857; F:diphosphoinositol-pentakisphosphate kinase activity; ISS:UniProtKB
O43314	PPIP5K2	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2	GO:0052723; F:inositol hexakisphosphate 1-kinase activity; IEA:UniProtKB-EC
O43314	PPIP5K2	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2	GO:0052724; F:inositol hexakisphosphate 3-kinase activity; IEA:UniProtKB-EC
O43314	PPIP5K2	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2	GO:0000832; F:inositol hexakisphosphate 5-kinase activity; ISS:UniProtKB
O43314	PPIP5K2	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2	GO:0000827; F:inositol-1,3,4,5,6-pentakisphosphate kinase activity; ISS:UniProtKB
O43314	PPIP5K2	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2	GO:0006020; P:inositol metabolic process; ISS:UniProtKB
O43314	PPIP5K2	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2	GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome
O43314	PPIP5K2	Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P32241	VIPR1	Vasoactive intestinal polypeptide receptor 1	GO:0005515; F:protein binding; IPI:IntAct
P32241	VIPR1	Vasoactive intestinal polypeptide receptor 1	GO:0004999; F:vasoactive intestinal polypeptide receptor activity; TAS:ProtInc
P32241	VIPR1	Vasoactive intestinal polypeptide receptor 1	GO:0007586; P:digestion; TAS:ProtInc
P32241	VIPR1	Vasoactive intestinal polypeptide receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P32241	VIPR1	Vasoactive intestinal polypeptide receptor 1	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P32241	VIPR1	Vasoactive intestinal polypeptide receptor 1	GO:0006955; P:immune response; TAS:ProtInc
P32241	VIPR1	Vasoactive intestinal polypeptide receptor 1	GO:0006936; P:muscle contraction; TAS:ProtInc
P32241	VIPR1	Vasoactive intestinal polypeptide receptor 1	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P32241	VIPR1	Vasoactive intestinal polypeptide receptor 1	GO:0007268; P:synaptic transmission; TAS:ProtInc
P41587	VIPR2	Vasoactive intestinal polypeptide receptor 2	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
P41587	VIPR2	Vasoactive intestinal polypeptide receptor 2	GO:0004999; F:vasoactive intestinal polypeptide receptor activity; IEA:InterPro
P41587	VIPR2	Vasoactive intestinal polypeptide receptor 2	GO:0007190; P:activation of adenylate cyclase activity; IEA:Ensembl
P41587	VIPR2	Vasoactive intestinal polypeptide receptor 2	GO:0007267; P:cell-cell signaling; TAS:ProtInc
P41587	VIPR2	Vasoactive intestinal polypeptide receptor 2	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IEA:Ensembl
P41587	VIPR2	Vasoactive intestinal polypeptide receptor 2	GO:0007165; P:signal transduction; TAS:ProtInc
P01282	VIP	VIP peptides	GO:0005179; F:hormone activity; IDA:BHF-UCL
P01282	VIP	VIP peptides	GO:0005184; F:neuropeptide hormone activity; TAS:ProtInc
P01282	VIP	VIP peptides	GO:0005515; F:protein binding; IPI:IntAct
P01282	VIP	VIP peptides	GO:0007589; P:body fluid secretion; TAS:ProtInc
P01282	VIP	VIP peptides	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P01282	VIP	VIP peptides	GO:0007611; P:learning or memory; IEA:Ensembl
P01282	VIP	VIP peptides	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P01282	VIP	VIP peptides	GO:0043267; P:negative regulation of potassium ion transport; IEA:Ensembl
P01282	VIP	VIP peptides	GO:0048662; P:negative regulation of smooth muscle cell proliferation; IEA:Ensembl
P01282	VIP	VIP peptides	GO:0010579; P:positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway; IDA:BHF-UCL
P01282	VIP	VIP peptides	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
P01282	VIP	VIP peptides	GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl
P01282	VIP	VIP peptides	GO:0060406; P:positive regulation of penile erection; IEA:Ensembl
P01282	VIP	VIP peptides	GO:0045732; P:positive regulation of protein catabolic process; IDA:BHF-UCL
P01282	VIP	VIP peptides	GO:0045909; P:positive regulation of vasodilation; IEA:Ensembl
P01282	VIP	VIP peptides	GO:0032880; P:regulation of protein localization; IDA:BHF-UCL
P01282	VIP	VIP peptides	GO:0051930; P:regulation of sensory perception of pain; IEA:Ensembl
P01282	VIP	VIP peptides	GO:0009966; P:regulation of signal transduction; IEA:Ensembl
Q69YN4	KIAA1429	Protein virilizer homolog	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q69YN4	KIAA1429	Protein virilizer homolog	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q69YN4	KIAA1429	Protein virilizer homolog	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
P62760	VSNL1	Visinin-like protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
Q6UXI7	VIT	Vitrin	GO:0005539; F:glycosaminoglycan binding; IEA:Ensembl
Q6UXI7	VIT	Vitrin	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q6UXI7	VIT	Vitrin	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
P38435	GGCX	Vitamin K-dependent gamma-carboxylase	GO:0008488; F:gamma-glutamyl carboxylase activity; TAS:ProtInc
P38435	GGCX	Vitamin K-dependent gamma-carboxylase	GO:0007596; P:blood coagulation; TAS:ProtInc
P38435	GGCX	Vitamin K-dependent gamma-carboxylase	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P38435	GGCX	Vitamin K-dependent gamma-carboxylase	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P38435	GGCX	Vitamin K-dependent gamma-carboxylase	GO:0017187; P:peptidyl-glutamic acid carboxylation; TAS:Reactome
P38435	GGCX	Vitamin K-dependent gamma-carboxylase	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q76NI1	KNDC1	Protein very KIND	GO:0004674; F:protein serine/threonine kinase activity; IEA:Ensembl
Q76NI1	KNDC1	Protein very KIND	GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; IEA:Ensembl
Q76NI1	KNDC1	Protein very KIND	GO:0021707; P:cerebellar granule cell differentiation; IEA:Ensembl
Q76NI1	KNDC1	Protein very KIND	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
Q76NI1	KNDC1	Protein very KIND	GO:0048814; P:regulation of dendrite morphogenesis; IEA:Ensembl
Q76NI1	KNDC1	Protein very KIND	GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro
Q9BQB6	VKORC1	Vitamin K epoxide reductase complex subunit 1	GO:0047057; F:vitamin-K-epoxide reductase (warfarin-sensitive) activity; IDA:UniProtKB
Q9BQB6	VKORC1	Vitamin K epoxide reductase complex subunit 1	GO:0007596; P:blood coagulation; IMP:UniProtKB
Q9BQB6	VKORC1	Vitamin K epoxide reductase complex subunit 1	GO:0060348; P:bone development; ISS:UniProtKB
Q9BQB6	VKORC1	Vitamin K epoxide reductase complex subunit 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q9BQB6	VKORC1	Vitamin K epoxide reductase complex subunit 1	GO:0017144; P:drug metabolic process; IMP:UniProtKB
Q9BQB6	VKORC1	Vitamin K epoxide reductase complex subunit 1	GO:0017187; P:peptidyl-glutamic acid carboxylation; IMP:UniProtKB
Q9BQB6	VKORC1	Vitamin K epoxide reductase complex subunit 1	GO:0043687; P:post-translational protein modification; TAS:Reactome
Q9BQB6	VKORC1	Vitamin K epoxide reductase complex subunit 1	GO:0042373; P:vitamin K metabolic process; IDA:UniProtKB
Q8N0U8	VKORC1L1	Vitamin K epoxide reductase complex subunit 1-like protein 1	GO:0047057; F:vitamin-K-epoxide reductase (warfarin-sensitive) activity; IDA:UniProtKB
Q8N0U8	VKORC1L1	Vitamin K epoxide reductase complex subunit 1-like protein 1	GO:0034599; P:cellular response to oxidative stress; IMP:UniProtKB
Q8N0U8	VKORC1L1	Vitamin K epoxide reductase complex subunit 1-like protein 1	GO:0055114; P:oxidation-reduction process; IDA:GOC
Q8N0U8	VKORC1L1	Vitamin K epoxide reductase complex subunit 1-like protein 1	GO:0017187; P:peptidyl-glutamic acid carboxylation; IMP:UniProtKB
Q8N0U8	VKORC1L1	Vitamin K epoxide reductase complex subunit 1-like protein 1	GO:0042373; P:vitamin K metabolic process; IDA:UniProtKB
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0034185; F:apolipoprotein binding; IDA:BHF-UCL
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0005509; F:calcium ion binding; IEA:InterPro
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0048306; F:calcium-dependent protein binding; IPI:BHF-UCL
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0001948; F:glycoprotein binding; IPI:BHF-UCL
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0034437; F:glycoprotein transporter activity; IDA:BHF-UCL
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0005041; F:low-density lipoprotein receptor activity; TAS:ProtInc
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0005515; F:protein binding; IPI:IntAct
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0038025; F:reelin receptor activity; ISS:BHF-UCL
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0034189; F:very-low-density lipoprotein particle binding; IDA:BHF-UCL
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0030229; F:very-low-density lipoprotein particle receptor activity; IDA:BHF-UCL
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0008203; P:cholesterol metabolic process; IEA:UniProtKB-KW
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0034436; P:glycoprotein transport; IDA:BHF-UCL
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0007613; P:memory; TAS:ProtInc
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0007399; P:nervous system development; TAS:ProtInc
P98155	VLDLR	Very low-density lipoprotein receptor	GO:1900006; P:positive regulation of dendrite development; ISS:BHF-UCL
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0045860; P:positive regulation of protein kinase activity; IEA:Ensembl
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0006898; P:receptor-mediated endocytosis; IDA:BHF-UCL
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0038026; P:reelin-mediated signaling pathway; ISS:BHF-UCL
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0007165; P:signal transduction; TAS:ProtInc
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0021517; P:ventral spinal cord development; IEA:Ensembl
P98155	VLDLR	Very low-density lipoprotein receptor	GO:0034447; P:very-low-density lipoprotein particle clearance; IDA:BHF-UCL
Q3ZAQ7	VMA21	Vacuolar ATPase assembly integral membrane protein VMA21	GO:0070072; P:vacuolar proton-transporting V-type ATPase complex assembly; IDA:UniProtKB
P54219	SLC18A1	Chromaffin granule amine transporter	GO:0015238; F:drug transmembrane transporter activity; IEA:InterPro
P54219	SLC18A1	Chromaffin granule amine transporter	GO:0008504; F:monoamine transmembrane transporter activity; TAS:UniProtKB
P54219	SLC18A1	Chromaffin granule amine transporter	GO:0015844; P:monoamine transport; TAS:UniProtKB
P54219	SLC18A1	Chromaffin granule amine transporter	GO:0006836; P:neurotransmitter transport; IEA:UniProtKB-KW
P54219	SLC18A1	Chromaffin granule amine transporter	GO:0055085; P:transmembrane transport; TAS:Reactome
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0005275; F:amine transmembrane transporter activity; IEA:Ensembl
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0008144; F:drug binding; IEA:Ensembl
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0008504; F:monoamine transmembrane transporter activity; TAS:ProtInc
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0015222; F:serotonin transmembrane transporter activity; IEA:Ensembl
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0007568; P:aging; IEA:Ensembl
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0071242; P:cellular response to ammonium ion; IEA:Ensembl
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0035690; P:cellular response to drug; IEA:Ensembl
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0016265; P:death; IEA:Ensembl
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0032456; P:endocytic recycling; IEA:Ensembl
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0042593; P:glucose homeostasis; IEA:Ensembl
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0030073; P:insulin secretion; IEA:Ensembl
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0015844; P:monoamine transport; TAS:ProtInc
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0051589; P:negative regulation of neurotransmitter transport; IEA:Ensembl
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0007269; P:neurotransmitter secretion; TAS:Reactome
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0009791; P:post-embryonic development; IEA:Ensembl
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0001975; P:response to amphetamine; IEA:Ensembl
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0042220; P:response to cocaine; IEA:Ensembl
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0051412; P:response to corticosterone; IEA:Ensembl
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0009635; P:response to herbicide; IEA:Ensembl
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0042594; P:response to starvation; IEA:Ensembl
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0010043; P:response to zinc ion; IEA:Ensembl
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0007268; P:synaptic transmission; TAS:Reactome
Q05940	SLC18A2	Synaptic vesicular amine transporter	GO:0055085; P:transmembrane transport; TAS:Reactome
Q7Z5L0	VMO1	Vitelline membrane outer layer protein 1 homolog	GO:0030704; P:vitelline membrane formation; IEA:InterPro
Q96GC9	VMP1	Vacuole membrane protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96GC9	VMP1	Vacuole membrane protein 1	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q96GC9	VMP1	Vacuole membrane protein 1	GO:0034329; P:cell junction assembly; IMP:UniProtKB
Q96GC9	VMP1	Vacuole membrane protein 1	GO:0016337; P:single organismal cell-cell adhesion; IMP:UniProtKB
Q96GC9	VMP1	Vacuole membrane protein 1	GO:0007566; P:embryo implantation; IEA:Ensembl
Q96GC9	VMP1	Vacuole membrane protein 1	GO:0010506; P:regulation of autophagy; ISS:UniProtKB
Q9GZP7	VN1R1	Vomeronasal type-1 receptor 1	GO:0016503; F:pheromone receptor activity; IEA:InterPro
Q9GZP7	VN1R1	Vomeronasal type-1 receptor 1	GO:0019236; P:response to pheromone; IEA:UniProtKB-KW
Q9BXE9	VN1R3	Vomeronasal type-1 receptor 3	GO:0016503; F:pheromone receptor activity; IEA:InterPro
Q9BXE9	VN1R3	Vomeronasal type-1 receptor 3	GO:0019236; P:response to pheromone; IEA:UniProtKB-KW
Q8NFZ6	VN1R2	Vomeronasal type-1 receptor 2	GO:0016503; F:pheromone receptor activity; IEA:InterPro
Q8NFZ6	VN1R2	Vomeronasal type-1 receptor 2	GO:0019236; P:response to pheromone; IEA:UniProtKB-KW
Q7Z5H5	VN1R4	Vomeronasal type-1 receptor 4	GO:0016503; F:pheromone receptor activity; IEA:InterPro
Q7Z5H5	VN1R4	Vomeronasal type-1 receptor 4	GO:0019236; P:response to pheromone; IEA:UniProtKB-KW
Q7Z5H4	VN1R5	Vomeronasal type-1 receptor 5	GO:0016503; F:pheromone receptor activity; IEA:InterPro
Q7Z5H4	VN1R5	Vomeronasal type-1 receptor 5	GO:0019236; P:response to pheromone; IEA:UniProtKB-KW
O95497	VNN1	Pantetheinase	GO:0034235; F:GPI anchor binding; TAS:BHF-UCL
O95497	VNN1	Pantetheinase	GO:0017159; F:pantetheine hydrolase activity; IDA:BHF-UCL
O95497	VNN1	Pantetheinase	GO:0002526; P:acute inflammatory response; ISS:BHF-UCL
O95497	VNN1	Pantetheinase	GO:0016337; P:single organismal cell-cell adhesion; ISS:BHF-UCL
O95497	VNN1	Pantetheinase	GO:0006928; P:cellular component movement; TAS:ProtInc
O95497	VNN1	Pantetheinase	GO:0002544; P:chronic inflammatory response; ISS:BHF-UCL
O95497	VNN1	Pantetheinase	GO:0006954; P:inflammatory response; ISS:BHF-UCL
O95497	VNN1	Pantetheinase	GO:0045087; P:innate immune response; ISS:BHF-UCL
O95497	VNN1	Pantetheinase	GO:1902176; P:negative regulation of intrinsic apoptotic signaling pathway in response to oxidative stress; ISS:BHF-UCL
O95497	VNN1	Pantetheinase	GO:0015939; P:pantothenate metabolic process; IDA:BHF-UCL
O95497	VNN1	Pantetheinase	GO:0033089; P:positive regulation of T cell differentiation in thymus; ISS:BHF-UCL
O95497	VNN1	Pantetheinase	GO:0006979; P:response to oxidative stress; TAS:BHF-UCL
O95498	VNN2	Vascular non-inflammatory molecule 2	GO:0017159; F:pantetheine hydrolase activity; IDA:BHF-UCL
O95498	VNN2	Vascular non-inflammatory molecule 2	GO:0006928; P:cellular component movement; TAS:ProtInc
O95498	VNN2	Vascular non-inflammatory molecule 2	GO:0015939; P:pantothenate metabolic process; IDA:BHF-UCL
Q9NY84	VNN3	Vascular non-inflammatory molecule 3	GO:0017159; F:pantetheine hydrolase activity; NAS:UniProtKB
Q9NY84	VNN3	Vascular non-inflammatory molecule 3	GO:0015939; P:pantothenate metabolic process; IEA:Ensembl
Q8TDU5	VN1R17P	Putative vomeronasal receptor-like protein 4	GO:0016503; F:pheromone receptor activity; IEA:InterPro
Q8TDU5	VN1R17P	Putative vomeronasal receptor-like protein 4	GO:0019236; P:response to pheromone; IEA:UniProtKB-KW
Q96AW1	VOPP1	Vesicular, overexpressed in cancer, prosurvival protein 1	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q96AW1	VOPP1	Vesicular, overexpressed in cancer, prosurvival protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96AW1	VOPP1	Vesicular, overexpressed in cancer, prosurvival protein 1	GO:0007165; P:signal transduction; IMP:GOC
Q96AW1	VOPP1	Vesicular, overexpressed in cancer, prosurvival protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96RL7	VPS13A	Vacuolar protein sorting-associated protein 13A	GO:0005515; F:protein binding; IPI:IntAct
Q96RL7	VPS13A	Vacuolar protein sorting-associated protein 13A	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q96RL7	VPS13A	Vacuolar protein sorting-associated protein 13A	GO:0006895; P:Golgi to endosome transport; NAS:UniProtKB
Q96RL7	VPS13A	Vacuolar protein sorting-associated protein 13A	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q96RL7	VPS13A	Vacuolar protein sorting-associated protein 13A	GO:0007399; P:nervous system development; IEA:Ensembl
Q96RL7	VPS13A	Vacuolar protein sorting-associated protein 13A	GO:0008104; P:protein localization; NAS:UniProtKB
Q96RL7	VPS13A	Vacuolar protein sorting-associated protein 13A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96RL7	VPS13A	Vacuolar protein sorting-associated protein 13A	GO:0035176; P:social behavior; IEA:Ensembl
Q7Z7G8	VPS13B	Vacuolar protein sorting-associated protein 13B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O75436	VPS26A	Vacuolar protein sorting-associated protein 26A	GO:0005515; F:protein binding; IPI:UniProtKB
O75436	VPS26A	Vacuolar protein sorting-associated protein 26A	GO:0008565; F:protein transporter activity; NAS:UniProtKB
O75436	VPS26A	Vacuolar protein sorting-associated protein 26A	GO:0042147; P:retrograde transport, endosome to Golgi; NAS:UniProtKB
Q4G0F5	VPS26B	Vacuolar protein sorting-associated protein 26B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96AX1	VPS33A	Vacuolar protein sorting-associated protein 33A	GO:0005515; F:protein binding; IPI:UniProtKB
Q96AX1	VPS33A	Vacuolar protein sorting-associated protein 33A	GO:0032418; P:lysosome localization; IDA:UniProtKB
Q96AX1	VPS33A	Vacuolar protein sorting-associated protein 33A	GO:0032400; P:melanosome localization; IDA:UniProtKB
Q96AX1	VPS33A	Vacuolar protein sorting-associated protein 33A	GO:0030220; P:platelet formation; ISS:UniProtKB
Q96AX1	VPS33A	Vacuolar protein sorting-associated protein 33A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96AX1	VPS33A	Vacuolar protein sorting-associated protein 33A	GO:0048070; P:regulation of developmental pigmentation; ISS:UniProtKB
Q96AX1	VPS33A	Vacuolar protein sorting-associated protein 33A	GO:0006904; P:vesicle docking involved in exocytosis; IEA:InterPro
Q96AX1	VPS33A	Vacuolar protein sorting-associated protein 33A	GO:0016192; P:vesicle-mediated transport; IDA:MGI
Q9H267	VPS33B	Vacuolar protein sorting-associated protein 33B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H267	VPS33B	Vacuolar protein sorting-associated protein 33B	GO:0032418; P:lysosome localization; IDA:UniProtKB
Q9H267	VPS33B	Vacuolar protein sorting-associated protein 33B	GO:0032400; P:melanosome localization; IDA:UniProtKB
Q9H267	VPS33B	Vacuolar protein sorting-associated protein 33B	GO:0061025; P:membrane fusion; IMP:UniProtKB
Q9H267	VPS33B	Vacuolar protein sorting-associated protein 33B	GO:0070889; P:platelet alpha granule organization; IMP:UniProtKB
Q9H267	VPS33B	Vacuolar protein sorting-associated protein 33B	GO:0015031; P:protein transport; IMP:UniProtKB
Q9H267	VPS33B	Vacuolar protein sorting-associated protein 33B	GO:0006904; P:vesicle docking involved in exocytosis; IEA:InterPro
Q9H267	VPS33B	Vacuolar protein sorting-associated protein 33B	GO:0016192; P:vesicle-mediated transport; IDA:MGI
Q9H9H4	VPS37B	Vacuolar protein sorting-associated protein 37B	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H9H4	VPS37B	Vacuolar protein sorting-associated protein 37B	GO:0016197; P:endosomal transport; TAS:Reactome
Q9H9H4	VPS37B	Vacuolar protein sorting-associated protein 37B	GO:0075733; P:intracellular transport of virus; TAS:Reactome
Q9H9H4	VPS37B	Vacuolar protein sorting-associated protein 37B	GO:0061024; P:membrane organization; TAS:Reactome
Q9H9H4	VPS37B	Vacuolar protein sorting-associated protein 37B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9H9H4	VPS37B	Vacuolar protein sorting-associated protein 37B	GO:0019058; P:viral life cycle; TAS:Reactome
Q9H9H4	VPS37B	Vacuolar protein sorting-associated protein 37B	GO:0016032; P:viral process; TAS:Reactome
Q9H9H4	VPS37B	Vacuolar protein sorting-associated protein 37B	GO:0019082; P:viral protein processing; TAS:Reactome
Q9H9H4	VPS37B	Vacuolar protein sorting-associated protein 37B	GO:0019068; P:virion assembly; TAS:Reactome
A5D8V6	VPS37C	Vacuolar protein sorting-associated protein 37C	GO:0016197; P:endosomal transport; TAS:Reactome
A5D8V6	VPS37C	Vacuolar protein sorting-associated protein 37C	GO:0075733; P:intracellular transport of virus; TAS:Reactome
A5D8V6	VPS37C	Vacuolar protein sorting-associated protein 37C	GO:0061024; P:membrane organization; TAS:Reactome
A5D8V6	VPS37C	Vacuolar protein sorting-associated protein 37C	GO:0015031; P:protein transport; IEA:UniProtKB-KW
A5D8V6	VPS37C	Vacuolar protein sorting-associated protein 37C	GO:0019058; P:viral life cycle; TAS:Reactome
A5D8V6	VPS37C	Vacuolar protein sorting-associated protein 37C	GO:0016032; P:viral process; TAS:Reactome
A5D8V6	VPS37C	Vacuolar protein sorting-associated protein 37C	GO:0019082; P:viral protein processing; TAS:Reactome
A5D8V6	VPS37C	Vacuolar protein sorting-associated protein 37C	GO:0019068; P:virion assembly; TAS:Reactome
Q8NEZ2	VPS37A	Vacuolar protein sorting-associated protein 37A	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q8NEZ2	VPS37A	Vacuolar protein sorting-associated protein 37A	GO:0016197; P:endosomal transport; TAS:Reactome
Q8NEZ2	VPS37A	Vacuolar protein sorting-associated protein 37A	GO:0075733; P:intracellular transport of virus; TAS:Reactome
Q8NEZ2	VPS37A	Vacuolar protein sorting-associated protein 37A	GO:0061024; P:membrane organization; TAS:Reactome
Q8NEZ2	VPS37A	Vacuolar protein sorting-associated protein 37A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q8NEZ2	VPS37A	Vacuolar protein sorting-associated protein 37A	GO:0043162; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; IMP:UniProtKB
Q8NEZ2	VPS37A	Vacuolar protein sorting-associated protein 37A	GO:0019058; P:viral life cycle; TAS:Reactome
Q8NEZ2	VPS37A	Vacuolar protein sorting-associated protein 37A	GO:0016032; P:viral process; TAS:Reactome
Q8NEZ2	VPS37A	Vacuolar protein sorting-associated protein 37A	GO:0019082; P:viral protein processing; TAS:Reactome
Q8NEZ2	VPS37A	Vacuolar protein sorting-associated protein 37A	GO:0019068; P:virion assembly; TAS:Reactome
Q86XT2	VPS37D	Vacuolar protein sorting-associated protein 37D	GO:0016197; P:endosomal transport; TAS:Reactome
Q86XT2	VPS37D	Vacuolar protein sorting-associated protein 37D	GO:0075733; P:intracellular transport of virus; TAS:Reactome
Q86XT2	VPS37D	Vacuolar protein sorting-associated protein 37D	GO:0061024; P:membrane organization; TAS:Reactome
Q86XT2	VPS37D	Vacuolar protein sorting-associated protein 37D	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q86XT2	VPS37D	Vacuolar protein sorting-associated protein 37D	GO:0019058; P:viral life cycle; TAS:Reactome
Q86XT2	VPS37D	Vacuolar protein sorting-associated protein 37D	GO:0016032; P:viral process; TAS:Reactome
Q86XT2	VPS37D	Vacuolar protein sorting-associated protein 37D	GO:0019082; P:viral protein processing; TAS:Reactome
Q86XT2	VPS37D	Vacuolar protein sorting-associated protein 37D	GO:0019068; P:virion assembly; TAS:Reactome
Q9Y2B5	VPS9D1	VPS9 domain-containing protein 1	GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW
Q9Y2B5	VPS9D1	VPS9 domain-containing protein 1	GO:0005215; F:transporter activity; TAS:ProtInc
Q9Y2B5	VPS9D1	VPS9 domain-containing protein 1	GO:0015986; P:ATP synthesis coupled proton transport; TAS:ProtInc
DR   GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW
DR   GO:0003676; F:nucleic acid binding; IEA:InterPro
DR   GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW
DR   GO:0003676; F:nucleic acid binding; IEA:InterPro
DR   GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW
DR   GO:0003676; F:nucleic acid binding; IEA:InterPro
DR   GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW
DR   GO:0003676; F:nucleic acid binding; IEA:InterPro
DR   GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW
DR   GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9Y6I0	ERVK6	HERV-K_7p22.1 provirus ancestral Pro protein	GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW
Q9Y6I0	ERVK6	HERV-K_7p22.1 provirus ancestral Pro protein	GO:0003676; F:nucleic acid binding; IEA:InterPro
DR   GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW
DR   GO:0003676; F:nucleic acid binding; IEA:InterPro
DR   GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW
DR   GO:0003676; F:nucleic acid binding; IEA:InterPro
DR   GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW
DR   GO:0003676; F:nucleic acid binding; IEA:InterPro
DR   GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW
DR   GO:0003676; F:nucleic acid binding; IEA:InterPro
DR   GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW
DR   GO:0003676; F:nucleic acid binding; IEA:InterPro
DR   GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW
DR   GO:0003676; F:nucleic acid binding; IEA:InterPro
Q93050	ATP6V0A1	V-type proton ATPase 116 kDa subunit a isoform 1	GO:0051117; F:ATPase binding; IPI:UniProtKB
Q93050	ATP6V0A1	V-type proton ATPase 116 kDa subunit a isoform 1	GO:0015078; F:hydrogen ion transmembrane transporter activity; IEA:InterPro
Q93050	ATP6V0A1	V-type proton ATPase 116 kDa subunit a isoform 1	GO:0005515; F:protein binding; IPI:HGNC
Q93050	ATP6V0A1	V-type proton ATPase 116 kDa subunit a isoform 1	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
Q93050	ATP6V0A1	V-type proton ATPase 116 kDa subunit a isoform 1	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
Q93050	ATP6V0A1	V-type proton ATPase 116 kDa subunit a isoform 1	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q93050	ATP6V0A1	V-type proton ATPase 116 kDa subunit a isoform 1	GO:0051701; P:interaction with host; TAS:Reactome
Q93050	ATP6V0A1	V-type proton ATPase 116 kDa subunit a isoform 1	GO:0090382; P:phagosome maturation; TAS:Reactome
Q93050	ATP6V0A1	V-type proton ATPase 116 kDa subunit a isoform 1	GO:0033572; P:transferrin transport; TAS:Reactome
Q93050	ATP6V0A1	V-type proton ATPase 116 kDa subunit a isoform 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9Y487	ATP6V0A2	V-type proton ATPase 116 kDa subunit a isoform 2	GO:0015078; F:hydrogen ion transmembrane transporter activity; IEA:InterPro
Q9Y487	ATP6V0A2	V-type proton ATPase 116 kDa subunit a isoform 2	GO:0005515; F:protein binding; IPI:IntAct
Q9Y487	ATP6V0A2	V-type proton ATPase 116 kDa subunit a isoform 2	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
Q9Y487	ATP6V0A2	V-type proton ATPase 116 kDa subunit a isoform 2	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
Q9Y487	ATP6V0A2	V-type proton ATPase 116 kDa subunit a isoform 2	GO:0006955; P:immune response; TAS:ProtInc
Q9Y487	ATP6V0A2	V-type proton ATPase 116 kDa subunit a isoform 2	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q9Y487	ATP6V0A2	V-type proton ATPase 116 kDa subunit a isoform 2	GO:0051701; P:interaction with host; TAS:Reactome
Q9Y487	ATP6V0A2	V-type proton ATPase 116 kDa subunit a isoform 2	GO:0090382; P:phagosome maturation; TAS:Reactome
Q9Y487	ATP6V0A2	V-type proton ATPase 116 kDa subunit a isoform 2	GO:0033572; P:transferrin transport; TAS:Reactome
Q9Y487	ATP6V0A2	V-type proton ATPase 116 kDa subunit a isoform 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q13488	TCIRG1	V-type proton ATPase 116 kDa subunit a isoform 3	GO:0015078; F:hydrogen ion transmembrane transporter activity; IEA:InterPro
Q13488	TCIRG1	V-type proton ATPase 116 kDa subunit a isoform 3	GO:0005215; F:transporter activity; TAS:ProtInc
Q13488	TCIRG1	V-type proton ATPase 116 kDa subunit a isoform 3	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:InterPro
Q13488	TCIRG1	V-type proton ATPase 116 kDa subunit a isoform 3	GO:0006968; P:cellular defense response; TAS:ProtInc
Q13488	TCIRG1	V-type proton ATPase 116 kDa subunit a isoform 3	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
Q13488	TCIRG1	V-type proton ATPase 116 kDa subunit a isoform 3	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q13488	TCIRG1	V-type proton ATPase 116 kDa subunit a isoform 3	GO:0051701; P:interaction with host; TAS:Reactome
Q13488	TCIRG1	V-type proton ATPase 116 kDa subunit a isoform 3	GO:0090382; P:phagosome maturation; TAS:Reactome
Q13488	TCIRG1	V-type proton ATPase 116 kDa subunit a isoform 3	GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc
Q13488	TCIRG1	V-type proton ATPase 116 kDa subunit a isoform 3	GO:0015992; P:proton transport; TAS:ProtInc
Q13488	TCIRG1	V-type proton ATPase 116 kDa subunit a isoform 3	GO:0033572; P:transferrin transport; TAS:Reactome
Q13488	TCIRG1	V-type proton ATPase 116 kDa subunit a isoform 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9HBG4	ATP6V0A4	V-type proton ATPase 116 kDa subunit a isoform 4	GO:0051117; F:ATPase binding; IPI:UniProtKB
Q9HBG4	ATP6V0A4	V-type proton ATPase 116 kDa subunit a isoform 4	GO:0015078; F:hydrogen ion transmembrane transporter activity; IEA:InterPro
Q9HBG4	ATP6V0A4	V-type proton ATPase 116 kDa subunit a isoform 4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HBG4	ATP6V0A4	V-type proton ATPase 116 kDa subunit a isoform 4	GO:0015991; P:ATP hydrolysis coupled proton transport; IEA:Ensembl
Q9HBG4	ATP6V0A4	V-type proton ATPase 116 kDa subunit a isoform 4	GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome
Q9HBG4	ATP6V0A4	V-type proton ATPase 116 kDa subunit a isoform 4	GO:0007588; P:excretion; IMP:HGNC
Q9HBG4	ATP6V0A4	V-type proton ATPase 116 kDa subunit a isoform 4	GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome
Q9HBG4	ATP6V0A4	V-type proton ATPase 116 kDa subunit a isoform 4	GO:0051701; P:interaction with host; TAS:Reactome
Q9HBG4	ATP6V0A4	V-type proton ATPase 116 kDa subunit a isoform 4	GO:0001503; P:ossification; IMP:HGNC
Q9HBG4	ATP6V0A4	V-type proton ATPase 116 kDa subunit a isoform 4	GO:0090382; P:phagosome maturation; TAS:Reactome
Q9HBG4	ATP6V0A4	V-type proton ATPase 116 kDa subunit a isoform 4	GO:0015992; P:proton transport; IMP:HGNC
Q9HBG4	ATP6V0A4	V-type proton ATPase 116 kDa subunit a isoform 4	GO:0006885; P:regulation of pH; IMP:HGNC
Q9HBG4	ATP6V0A4	V-type proton ATPase 116 kDa subunit a isoform 4	GO:0007605; P:sensory perception of sound; IMP:HGNC
Q9HBG4	ATP6V0A4	V-type proton ATPase 116 kDa subunit a isoform 4	GO:0033572; P:transferrin transport; TAS:Reactome
Q9HBG4	ATP6V0A4	V-type proton ATPase 116 kDa subunit a isoform 4	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9Y4B6	VPRBP	Protein VPRBP	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9Y4B6	VPRBP	Protein VPRBP	GO:1990244; F:histone kinase activity (H2A-T120 specific); IDA:UniProtKB
Q9Y4B6	VPRBP	Protein VPRBP	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y4B6	VPRBP	Protein VPRBP	GO:0030183; P:B cell differentiation; ISS:UniProtKB
Q9Y4B6	VPRBP	Protein VPRBP	GO:0035212; P:cell competition in a multicellular organism; IMP:UniProtKB
Q9Y4B6	VPRBP	Protein VPRBP	GO:1990245; P:histone H2A-T120 phosphorylation; IDA:UniProtKB
Q9Y4B6	VPRBP	Protein VPRBP	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9Y4B6	VPRBP	Protein VPRBP	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9Y4B6	VPRBP	Protein VPRBP	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y4B6	VPRBP	Protein VPRBP	GO:0033151; P:V(D)J recombination; ISS:UniProtKB
Q9Y4B6	VPRBP	Protein VPRBP	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9H270	VPS11	Vacuolar protein sorting-associated protein 11 homolog	GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW
Q9H270	VPS11	Vacuolar protein sorting-associated protein 11 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q9H270	VPS11	Vacuolar protein sorting-associated protein 11 homolog	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H270	VPS11	Vacuolar protein sorting-associated protein 11 homolog	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9H270	VPS11	Vacuolar protein sorting-associated protein 11 homolog	GO:0016192; P:vesicle-mediated transport; IEA:InterPro
Q9H269	VPS16	Vacuolar protein sorting-associated protein 16 homolog	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9P253	VPS18	Vacuolar protein sorting-associated protein 18 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9P253	VPS18	Vacuolar protein sorting-associated protein 18 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q9P253	VPS18	Vacuolar protein sorting-associated protein 18 homolog	GO:0007032; P:endosome organization; IDA:UniProtKB
Q9P253	VPS18	Vacuolar protein sorting-associated protein 18 homolog	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9P253	VPS18	Vacuolar protein sorting-associated protein 18 homolog	GO:0007040; P:lysosome organization; IDA:UniProtKB
Q9P253	VPS18	Vacuolar protein sorting-associated protein 18 homolog	GO:0016192; P:vesicle-mediated transport; IEA:InterPro
Q9BRG1	VPS25	Vacuolar protein-sorting-associated protein 25	GO:0016197; P:endosomal transport; TAS:Reactome
Q9BRG1	VPS25	Vacuolar protein-sorting-associated protein 25	GO:0061024; P:membrane organization; TAS:Reactome
Q9BRG1	VPS25	Vacuolar protein-sorting-associated protein 25	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9BRG1	VPS25	Vacuolar protein-sorting-associated protein 25	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9BRG1	VPS25	Vacuolar protein-sorting-associated protein 25	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UK41	VPS28	Vacuolar protein sorting-associated protein 28 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q9UK41	VPS28	Vacuolar protein sorting-associated protein 28 homolog	GO:0016197; P:endosomal transport; TAS:Reactome
Q9UK41	VPS28	Vacuolar protein sorting-associated protein 28 homolog	GO:0075733; P:intracellular transport of virus; TAS:Reactome
Q9UK41	VPS28	Vacuolar protein sorting-associated protein 28 homolog	GO:0061024; P:membrane organization; TAS:Reactome
Q9UK41	VPS28	Vacuolar protein sorting-associated protein 28 homolog	GO:0031397; P:negative regulation of protein ubiquitination; IDA:UniProtKB
Q9UK41	VPS28	Vacuolar protein sorting-associated protein 28 homolog	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9UK41	VPS28	Vacuolar protein sorting-associated protein 28 homolog	GO:0043162; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway; IMP:UniProtKB
Q9UK41	VPS28	Vacuolar protein sorting-associated protein 28 homolog	GO:0019058; P:viral life cycle; TAS:Reactome
Q9UK41	VPS28	Vacuolar protein sorting-associated protein 28 homolog	GO:0016032; P:viral process; TAS:Reactome
Q9UK41	VPS28	Vacuolar protein sorting-associated protein 28 homolog	GO:0019082; P:viral protein processing; TAS:Reactome
Q9UK41	VPS28	Vacuolar protein sorting-associated protein 28 homolog	GO:0019068; P:virion assembly; TAS:Reactome
Q9UBQ0	VPS29	Vacuolar protein sorting-associated protein 29	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UBQ0	VPS29	Vacuolar protein sorting-associated protein 29	GO:0004647; F:phosphoserine phosphatase activity; IEA:UniProtKB-EC
Q9UBQ0	VPS29	Vacuolar protein sorting-associated protein 29	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96QK1	VPS35	Vacuolar protein sorting-associated protein 35	GO:0005515; F:protein binding; IPI:UniProtKB
Q96QK1	VPS35	Vacuolar protein sorting-associated protein 35	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q96QK1	VPS35	Vacuolar protein sorting-associated protein 35	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q96QK1	VPS35	Vacuolar protein sorting-associated protein 35	GO:0042147; P:retrograde transport, endosome to Golgi; NAS:UniProtKB
Q86VN1	VPS36	Vacuolar protein-sorting-associated protein 36	GO:0032266; F:phosphatidylinositol-3-phosphate binding; IEA:InterPro
Q86VN1	VPS36	Vacuolar protein-sorting-associated protein 36	GO:0016197; P:endosomal transport; TAS:Reactome
Q86VN1	VPS36	Vacuolar protein-sorting-associated protein 36	GO:0061024; P:membrane organization; TAS:Reactome
Q86VN1	VPS36	Vacuolar protein-sorting-associated protein 36	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q86VN1	VPS36	Vacuolar protein-sorting-associated protein 36	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q86VN1	VPS36	Vacuolar protein-sorting-associated protein 36	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96JC1	VPS39	Vam6/Vps39-like protein	GO:0005083; F:small GTPase regulator activity; IEA:InterPro
Q96JC1	VPS39	Vam6/Vps39-like protein	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q96JC1	VPS39	Vam6/Vps39-like protein	GO:0016192; P:vesicle-mediated transport; IEA:InterPro
P49754	VPS41	Vacuolar protein sorting-associated protein 41 homolog	GO:0005515; F:protein binding; IPI:IntAct
P49754	VPS41	Vacuolar protein sorting-associated protein 41 homolog	GO:0008270; F:zinc ion binding; IEA:InterPro
P49754	VPS41	Vacuolar protein sorting-associated protein 41 homolog	GO:0048193; P:Golgi vesicle transport; IMP:UniProtKB
P49754	VPS41	Vacuolar protein sorting-associated protein 41 homolog	GO:0006886; P:intracellular protein transport; IEA:InterPro
P49754	VPS41	Vacuolar protein sorting-associated protein 41 homolog	GO:0016192; P:vesicle-mediated transport; IEA:InterPro
Q9NRW7	VPS45	Vacuolar protein sorting-associated protein 45	GO:0007596; P:blood coagulation; TAS:Reactome
Q9NRW7	VPS45	Vacuolar protein sorting-associated protein 45	GO:0006886; P:intracellular protein transport; NAS:UniProtKB
Q9NRW7	VPS45	Vacuolar protein sorting-associated protein 45	GO:0006904; P:vesicle docking involved in exocytosis; IEA:InterPro
Q9UN37	VPS4A	Vacuolar protein sorting-associated protein 4A	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9UN37	VPS4A	Vacuolar protein sorting-associated protein 4A	GO:0042623; F:ATPase activity, coupled; NAS:UniProtKB
Q9UN37	VPS4A	Vacuolar protein sorting-associated protein 4A	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UN37	VPS4A	Vacuolar protein sorting-associated protein 4A	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q9UN37	VPS4A	Vacuolar protein sorting-associated protein 4A	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q9UN37	VPS4A	Vacuolar protein sorting-associated protein 4A	GO:0006200; P:ATP catabolic process; NAS:GOC
Q9UN37	VPS4A	Vacuolar protein sorting-associated protein 4A	GO:0000910; P:cytokinesis; IDA:UniProtKB
Q9UN37	VPS4A	Vacuolar protein sorting-associated protein 4A	GO:0016197; P:endosomal transport; IMP:UniProtKB
Q9UN37	VPS4A	Vacuolar protein sorting-associated protein 4A	GO:0061024; P:membrane organization; TAS:Reactome
Q9UN37	VPS4A	Vacuolar protein sorting-associated protein 4A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9UN37	VPS4A	Vacuolar protein sorting-associated protein 4A	GO:0016192; P:vesicle-mediated transport; IDA:UniProtKB
Q9UN37	VPS4A	Vacuolar protein sorting-associated protein 4A	GO:0019058; P:viral life cycle; TAS:Reactome
Q9UN37	VPS4A	Vacuolar protein sorting-associated protein 4A	GO:0016032; P:viral process; TAS:Reactome
O75351	VPS4B	Vacuolar protein sorting-associated protein 4B	GO:0005524; F:ATP binding; IMP:UniProtKB
O75351	VPS4B	Vacuolar protein sorting-associated protein 4B	GO:0016887; F:ATPase activity; IMP:UniProtKB
O75351	VPS4B	Vacuolar protein sorting-associated protein 4B	GO:0042623; F:ATPase activity, coupled; NAS:UniProtKB
O75351	VPS4B	Vacuolar protein sorting-associated protein 4B	GO:0005515; F:protein binding; IPI:UniProtKB
O75351	VPS4B	Vacuolar protein sorting-associated protein 4B	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
O75351	VPS4B	Vacuolar protein sorting-associated protein 4B	GO:0006200; P:ATP catabolic process; IMP:UniProtKB
O75351	VPS4B	Vacuolar protein sorting-associated protein 4B	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
O75351	VPS4B	Vacuolar protein sorting-associated protein 4B	GO:0051301; P:cell division; IEA:UniProtKB-KW
O75351	VPS4B	Vacuolar protein sorting-associated protein 4B	GO:0016197; P:endosomal transport; IMP:UniProtKB
O75351	VPS4B	Vacuolar protein sorting-associated protein 4B	GO:0007032; P:endosome organization; IEA:Ensembl
O75351	VPS4B	Vacuolar protein sorting-associated protein 4B	GO:0032510; P:endosome to lysosome transport via multivesicular body sorting pathway; IMP:UniProtKB
O75351	VPS4B	Vacuolar protein sorting-associated protein 4B	GO:0032367; P:intracellular cholesterol transport; IMP:UniProtKB
O75351	VPS4B	Vacuolar protein sorting-associated protein 4B	GO:0061024; P:membrane organization; TAS:Reactome
O75351	VPS4B	Vacuolar protein sorting-associated protein 4B	GO:0006813; P:potassium ion transport; IEA:Ensembl
O75351	VPS4B	Vacuolar protein sorting-associated protein 4B	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O75351	VPS4B	Vacuolar protein sorting-associated protein 4B	GO:0033993; P:response to lipid; IDA:UniProtKB
O75351	VPS4B	Vacuolar protein sorting-associated protein 4B	GO:0019058; P:viral life cycle; TAS:Reactome
O75351	VPS4B	Vacuolar protein sorting-associated protein 4B	GO:0016032; P:viral process; TAS:Reactome
Q9UID3	VPS51	Vacuolar protein sorting-associated protein 51 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UID3	VPS51	Vacuolar protein sorting-associated protein 51 homolog	GO:0006914; P:autophagy; IMP:UniProtKB
Q9UID3	VPS51	Vacuolar protein sorting-associated protein 51 homolog	GO:0006869; P:lipid transport; IEA:UniProtKB-KW
Q9UID3	VPS51	Vacuolar protein sorting-associated protein 51 homolog	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9UID3	VPS51	Vacuolar protein sorting-associated protein 51 homolog	GO:0042147; P:retrograde transport, endosome to Golgi; IDA:UniProtKB
Q8N1B4	VPS52	Vacuolar protein sorting-associated protein 52 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N1B4	VPS52	Vacuolar protein sorting-associated protein 52 homolog	GO:0010668; P:ectodermal cell differentiation; IEA:Ensembl
Q8N1B4	VPS52	Vacuolar protein sorting-associated protein 52 homolog	GO:0048611; P:embryonic ectodermal digestive tract development; IEA:Ensembl
Q8N1B4	VPS52	Vacuolar protein sorting-associated protein 52 homolog	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q5VIR6	VPS53	Vacuolar protein sorting-associated protein 53 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q5VIR6	VPS53	Vacuolar protein sorting-associated protein 53 homolog	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9P1Q0	VPS54	Vacuolar protein sorting-associated protein 54	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P1Q0	VPS54	Vacuolar protein sorting-associated protein 54	GO:0040007; P:growth; IEA:Ensembl
Q9P1Q0	VPS54	Vacuolar protein sorting-associated protein 54	GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl
Q9P1Q0	VPS54	Vacuolar protein sorting-associated protein 54	GO:0050881; P:musculoskeletal movement; IEA:Ensembl
Q9P1Q0	VPS54	Vacuolar protein sorting-associated protein 54	GO:0060052; P:neurofilament cytoskeleton organization; IEA:Ensembl
Q9P1Q0	VPS54	Vacuolar protein sorting-associated protein 54	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9P1Q0	VPS54	Vacuolar protein sorting-associated protein 54	GO:0042147; P:retrograde transport, endosome to Golgi; IEA:InterPro
Q15906	VPS72	Vacuolar protein sorting-associated protein 72 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q15906	VPS72	Vacuolar protein sorting-associated protein 72 homolog	GO:0005515; F:protein binding; IPI:IntAct
Q15906	VPS72	Vacuolar protein sorting-associated protein 72 homolog	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q15906	VPS72	Vacuolar protein sorting-associated protein 72 homolog	GO:0006325; P:chromatin organization; TAS:Reactome
Q15906	VPS72	Vacuolar protein sorting-associated protein 72 homolog	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q15906	VPS72	Vacuolar protein sorting-associated protein 72 homolog	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
Q15906	VPS72	Vacuolar protein sorting-associated protein 72 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N3P4	VPS8	Vacuolar protein sorting-associated protein 8 homolog	GO:0008270; F:zinc ion binding; IEA:InterPro
Q99986	VRK1	Serine/threonine-protein kinase VRK1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q99986	VRK1	Serine/threonine-protein kinase VRK1	GO:0035175; F:histone kinase activity (H3-S10 specific); IDA:UniProt
Q99986	VRK1	Serine/threonine-protein kinase VRK1	GO:0072354; F:histone kinase activity (H3-T3 specific); IDA:UniProt
Q99986	VRK1	Serine/threonine-protein kinase VRK1	GO:0031493; F:nucleosomal histone binding; IPI:UniProt
Q99986	VRK1	Serine/threonine-protein kinase VRK1	GO:0005515; F:protein binding; IPI:IntAct
Q99986	VRK1	Serine/threonine-protein kinase VRK1	GO:0004672; F:protein kinase activity; IDA:UniProt
Q99986	VRK1	Serine/threonine-protein kinase VRK1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q99986	VRK1	Serine/threonine-protein kinase VRK1	GO:0090166; P:Golgi disassembly; IDA:UniProtKB
Q99986	VRK1	Serine/threonine-protein kinase VRK1	GO:0043987; P:histone H3-S10 phosphorylation; IDA:UniProt
Q99986	VRK1	Serine/threonine-protein kinase VRK1	GO:0072355; P:histone H3-T3 phosphorylation; IDA:UniProt
Q99986	VRK1	Serine/threonine-protein kinase VRK1	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q99986	VRK1	Serine/threonine-protein kinase VRK1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q99986	VRK1	Serine/threonine-protein kinase VRK1	GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome
Q99986	VRK1	Serine/threonine-protein kinase VRK1	GO:0007084; P:mitotic nuclear envelope reassembly; TAS:Reactome
Q99986	VRK1	Serine/threonine-protein kinase VRK1	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q99986	VRK1	Serine/threonine-protein kinase VRK1	GO:0006468; P:protein phosphorylation; IDA:UniProt
Q86Y07	VRK2	Serine/threonine-protein kinase VRK2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q86Y07	VRK2	Serine/threonine-protein kinase VRK2	GO:0005515; F:protein binding; IPI:IntAct
Q86Y07	VRK2	Serine/threonine-protein kinase VRK2	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q86Y07	VRK2	Serine/threonine-protein kinase VRK2	GO:0034599; P:cellular response to oxidative stress; IMP:UniProtKB
Q86Y07	VRK2	Serine/threonine-protein kinase VRK2	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q86Y07	VRK2	Serine/threonine-protein kinase VRK2	GO:0006468; P:protein phosphorylation; TAS:ProtInc
Q86Y07	VRK2	Serine/threonine-protein kinase VRK2	GO:2000659; P:regulation of interleukin-1-mediated signaling pathway; IMP:UniProtKB
Q86Y07	VRK2	Serine/threonine-protein kinase VRK2	GO:0043408; P:regulation of MAPK cascade; IMP:UniProtKB
Q86Y07	VRK2	Serine/threonine-protein kinase VRK2	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q8IV63	VRK3	Inactive serine/threonine-protein kinase VRK3	GO:0005524; F:ATP binding; IEA:InterPro
Q8IV63	VRK3	Inactive serine/threonine-protein kinase VRK3	GO:0004672; F:protein kinase activity; IEA:InterPro
Q8IV63	VRK3	Inactive serine/threonine-protein kinase VRK3	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IEA:Ensembl
Q8IV63	VRK3	Inactive serine/threonine-protein kinase VRK3	GO:0032516; P:positive regulation of phosphoprotein phosphatase activity; IEA:Ensembl
Q9H8Y1	VRTN	Vertnin	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9H8Y1	VRTN	Vertnin	GO:0004803; F:transposase activity; IEA:InterPro
Q9H8Y1	VRTN	Vertnin	GO:0006313; P:transposition, DNA-mediated; IEA:InterPro
Q5VU13	VSIG8	V-set and immunoglobulin domain-containing protein 8	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y279	VSIG4	V-set and immunoglobulin domain-containing protein 4	GO:0005515; F:protein binding; IPI:IntAct
Q9Y279	VSIG4	V-set and immunoglobulin domain-containing protein 4	GO:0006957; P:complement activation, alternative pathway; IEA:UniProtKB-KW
Q9Y279	VSIG4	V-set and immunoglobulin domain-containing protein 4	GO:0032703; P:negative regulation of interleukin-2 production; IEA:Ensembl
Q9Y279	VSIG4	V-set and immunoglobulin domain-containing protein 4	GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl
Q6UX27	VSTM1	V-set and transmembrane domain-containing protein 1	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q9NZR4	VSX1	Visual system homeobox 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9NZR4	VSX1	Visual system homeobox 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
Q9NZR4	VSX1	Visual system homeobox 1	GO:0042551; P:neuron maturation; IEA:Ensembl
Q9NZR4	VSX1	Visual system homeobox 1	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q9NZR4	VSX1	Visual system homeobox 1	GO:0060040; P:retinal bipolar neuron differentiation; IEA:Ensembl
Q9NZR4	VSX1	Visual system homeobox 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NZR4	VSX1	Visual system homeobox 1	GO:0007601; P:visual perception; TAS:ProtInc
P58304	VSX2	Visual system homeobox 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P58304	VSX2	Visual system homeobox 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P58304	VSX2	Visual system homeobox 2	GO:0045165; P:cell fate commitment; IEA:Ensembl
P58304	VSX2	Visual system homeobox 2	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P58304	VSX2	Visual system homeobox 2	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P58304	VSX2	Visual system homeobox 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P58304	VSX2	Visual system homeobox 2	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
P58304	VSX2	Visual system homeobox 2	GO:0060040; P:retinal bipolar neuron differentiation; IEA:Ensembl
P58304	VSX2	Visual system homeobox 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P58304	VSX2	Visual system homeobox 2	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q9NP79	VTA1	Vacuolar protein sorting-associated protein VTA1 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NP79	VTA1	Vacuolar protein sorting-associated protein VTA1 homolog	GO:0016197; P:endosomal transport; TAS:Reactome
Q9NP79	VTA1	Vacuolar protein sorting-associated protein VTA1 homolog	GO:0061024; P:membrane organization; TAS:Reactome
Q9NP79	VTA1	Vacuolar protein sorting-associated protein VTA1 homolog	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9NP79	VTA1	Vacuolar protein sorting-associated protein VTA1 homolog	GO:0019058; P:viral life cycle; TAS:Reactome
Q9NP79	VTA1	Vacuolar protein sorting-associated protein VTA1 homolog	GO:0016032; P:viral process; TAS:Reactome
Q7Z7D3	VTCN1	V-set domain-containing T-cell activation inhibitor 1	GO:0002376; P:immune system process; IEA:UniProtKB-KW
Q7Z7D3	VTCN1	V-set domain-containing T-cell activation inhibitor 1	GO:0072643; P:interferon-gamma secretion; IEA:Ensembl
Q7Z7D3	VTCN1	V-set domain-containing T-cell activation inhibitor 1	GO:0072602; P:interleukin-4 secretion; IEA:Ensembl
Q7Z7D3	VTCN1	V-set domain-containing T-cell activation inhibitor 1	GO:0050868; P:negative regulation of T cell activation; IEA:Ensembl
Q7Z7D3	VTCN1	V-set domain-containing T-cell activation inhibitor 1	GO:0001562; P:response to protozoan; IEA:Ensembl
P02774	GC	Vitamin D-binding protein	GO:0003779; F:actin binding; IPI:UniProtKB
P02774	GC	Vitamin D-binding protein	GO:1902118; F:calcidiol binding; IDA:UniProtKB
P02774	GC	Vitamin D-binding protein	GO:0005499; F:vitamin D binding; TAS:ProtInc
P02774	GC	Vitamin D-binding protein	GO:0051183; F:vitamin transporter activity; IEA:InterPro
P02774	GC	Vitamin D-binding protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P02774	GC	Vitamin D-binding protein	GO:0008202; P:steroid metabolic process; TAS:Reactome
P02774	GC	Vitamin D-binding protein	GO:0042359; P:vitamin D metabolic process; TAS:Reactome
P02774	GC	Vitamin D-binding protein	GO:0051180; P:vitamin transport; TAS:ProtInc
Q96AJ9	VTI1A	Vesicle transport through interaction with t-SNAREs homolog 1A	GO:0005484; F:SNAP receptor activity; IDA:HGNC
Q96AJ9	VTI1A	Vesicle transport through interaction with t-SNAREs homolog 1A	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q96AJ9	VTI1A	Vesicle transport through interaction with t-SNAREs homolog 1A	GO:0042147; P:retrograde transport, endosome to Golgi; IDA:UniProtKB
Q9UEU0	VTI1B	Vesicle transport through interaction with t-SNAREs homolog 1B	GO:0008283; P:cell proliferation; TAS:ProtInc
Q9UEU0	VTI1B	Vesicle transport through interaction with t-SNAREs homolog 1B	GO:0006886; P:intracellular protein transport; IEA:InterPro
Q9UEU0	VTI1B	Vesicle transport through interaction with t-SNAREs homolog 1B	GO:0061025; P:membrane fusion; TAS:ProtInc
Q9UEU0	VTI1B	Vesicle transport through interaction with t-SNAREs homolog 1B	GO:0006904; P:vesicle docking involved in exocytosis; TAS:ProtInc
Q9UEU0	VTI1B	Vesicle transport through interaction with t-SNAREs homolog 1B	GO:0016192; P:vesicle-mediated transport; TAS:ProtInc
Q96N03	VSTM2L	V-set and transmembrane domain-containing protein 2-like protein	GO:0005515; F:protein binding; IPI:IntAct
P04004	VTN	Vitronectin	GO:0050840; F:extracellular matrix binding; IEA:Ensembl
P04004	VTN	Vitronectin	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
P04004	VTN	Vitronectin	GO:0005178; F:integrin binding; IPI:BHF-UCL
P04004	VTN	Vitronectin	GO:0030247; F:polysaccharide binding; IEA:InterPro
P04004	VTN	Vitronectin	GO:0005515; F:protein binding; IPI:IntAct
P04004	VTN	Vitronectin	GO:0005044; F:scavenger receptor activity; IEA:InterPro
P04004	VTN	Vitronectin	GO:0007155; P:cell adhesion; TAS:ProtInc
P04004	VTN	Vitronectin	GO:0033627; P:cell adhesion mediated by integrin; IDA:BHF-UCL
P04004	VTN	Vitronectin	GO:0007160; P:cell-matrix adhesion; IDA:BHF-UCL
P04004	VTN	Vitronectin	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P04004	VTN	Vitronectin	GO:0006955; P:immune response; TAS:ProtInc
P04004	VTN	Vitronectin	GO:0045087; P:innate immune response; TAS:Reactome
P04004	VTN	Vitronectin	GO:0030195; P:negative regulation of blood coagulation; IC:BHF-UCL
P04004	VTN	Vitronectin	GO:0010951; P:negative regulation of endopeptidase activity; IDA:BHF-UCL
P04004	VTN	Vitronectin	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
P04004	VTN	Vitronectin	GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL
P04004	VTN	Vitronectin	GO:0032092; P:positive regulation of protein binding; IDA:BHF-UCL
P04004	VTN	Vitronectin	GO:0048260; P:positive regulation of receptor-mediated endocytosis; IDA:BHF-UCL
P04004	VTN	Vitronectin	GO:0014911; P:positive regulation of smooth muscle cell migration; IDA:BHF-UCL
P04004	VTN	Vitronectin	GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; TAS:BHF-UCL
P04004	VTN	Vitronectin	GO:0090303; P:positive regulation of wound healing; IC:BHF-UCL
P04004	VTN	Vitronectin	GO:0030449; P:regulation of complement activation; TAS:Reactome
P04004	VTN	Vitronectin	GO:0061302; P:smooth muscle cell-matrix adhesion; IDA:BHF-UCL
Q6PCB0	VWA1	von Willebrand factor A domain-containing protein 1	GO:0048266; P:behavioral response to pain; IEA:Ensembl
Q6PCB0	VWA1	von Willebrand factor A domain-containing protein 1	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
Q5GFL6	VWA2	von Willebrand factor A domain-containing protein 2	GO:0007161; P:calcium-independent cell-matrix adhesion; IEA:Ensembl
A3KMH1	VWA8	von Willebrand factor A domain-containing protein 8	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
A3KMH1	VWA8	von Willebrand factor A domain-containing protein 8	GO:0016887; F:ATPase activity; IEA:InterPro
B2RUY7	VWC2L	von Willebrand factor C domain-containing protein 2-like	GO:0030514; P:negative regulation of BMP signaling pathway; IEA:Ensembl
B2RUY7	VWC2L	von Willebrand factor C domain-containing protein 2-like	GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl
Q2TAL6	VWC2	Brorin	GO:0030514; P:negative regulation of BMP signaling pathway; ISS:HGNC
Q2TAL6	VWC2	Brorin	GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl
Q2TAL6	VWC2	Brorin	GO:0045666; P:positive regulation of neuron differentiation; ISS:HGNC
Q96DN2	VWCE	von Willebrand factor C and EGF domain-containing protein	GO:0005509; F:calcium ion binding; IEA:InterPro
P04275	VWF	von Willebrand factor	GO:0051087; F:chaperone binding; IDA:UniProtKB
P04275	VWF	von Willebrand factor	GO:0005518; F:collagen binding; IDA:UniProtKB
P04275	VWF	von Willebrand factor	GO:0001948; F:glycoprotein binding; IDA:UniProtKB
P04275	VWF	von Willebrand factor	GO:0042802; F:identical protein binding; IPI:IntAct
P04275	VWF	von Willebrand factor	GO:0019865; F:immunoglobulin binding; IDA:UniProtKB
P04275	VWF	von Willebrand factor	GO:0005178; F:integrin binding; IPI:UniProtKB
P04275	VWF	von Willebrand factor	GO:0002020; F:protease binding; IPI:UniProtKB
P04275	VWF	von Willebrand factor	GO:0005515; F:protein binding; IPI:UniProtKB
P04275	VWF	von Willebrand factor	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
P04275	VWF	von Willebrand factor	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
P04275	VWF	von Willebrand factor	GO:0007596; P:blood coagulation; IMP:UniProtKB
P04275	VWF	von Willebrand factor	GO:0007597; P:blood coagulation, intrinsic pathway; TAS:Reactome
P04275	VWF	von Willebrand factor	GO:0007155; P:cell adhesion; IDA:UniProtKB
P04275	VWF	von Willebrand factor	GO:0031589; P:cell-substrate adhesion; IDA:UniProtKB
P04275	VWF	von Willebrand factor	GO:0030198; P:extracellular matrix organization; TAS:Reactome
P04275	VWF	von Willebrand factor	GO:0007599; P:hemostasis; IMP:UniProtKB
P04275	VWF	von Willebrand factor	GO:0001889; P:liver development; IEA:Ensembl
P04275	VWF	von Willebrand factor	GO:0001890; P:placenta development; IEA:Ensembl
P04275	VWF	von Willebrand factor	GO:0030168; P:platelet activation; IDA:UniProtKB
P04275	VWF	von Willebrand factor	GO:0002576; P:platelet degranulation; TAS:Reactome
P04275	VWF	von Willebrand factor	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
P04275	VWF	von Willebrand factor	GO:0009611; P:response to wounding; TAS:UniProtKB
Q9BTA9	WAC	WW domain-containing adapter protein with coiled-coil	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q9BTA9	WAC	WW domain-containing adapter protein with coiled-coil	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BTA9	WAC	WW domain-containing adapter protein with coiled-coil	GO:0000993; F:RNA polymerase II core binding; IDA:UniProtKB
Q9BTA9	WAC	WW domain-containing adapter protein with coiled-coil	GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB
Q9BTA9	WAC	WW domain-containing adapter protein with coiled-coil	GO:0044783; P:G1 DNA damage checkpoint; IMP:UniProtKB
Q9BTA9	WAC	WW domain-containing adapter protein with coiled-coil	GO:0071894; P:histone H2B conserved C-terminal lysine ubiquitination; IMP:UniProtKB
Q9BTA9	WAC	WW domain-containing adapter protein with coiled-coil	GO:0010390; P:histone monoubiquitination; IMP:UniProtKB
Q9BTA9	WAC	WW domain-containing adapter protein with coiled-coil	GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:BHF-UCL
Q9BTA9	WAC	WW domain-containing adapter protein with coiled-coil	GO:0016239; P:positive regulation of macroautophagy; IMP:BHF-UCL
Q9BTA9	WAC	WW domain-containing adapter protein with coiled-coil	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q9BTA9	WAC	WW domain-containing adapter protein with coiled-coil	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BUR4	WRAP53	Telomerase Cajal body protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BUR4	WRAP53	Telomerase Cajal body protein 1	GO:0003723; F:RNA binding; IDA:UniProtKB
Q9BUR4	WRAP53	Telomerase Cajal body protein 1	GO:0051973; P:positive regulation of telomerase activity; IDA:UniProtKB
Q9BUR4	WRAP53	Telomerase Cajal body protein 1	GO:0032203; P:telomere formation via telomerase; IMP:UniProtKB
Q7Z5K2	WAPAL	Wings apart-like protein homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z5K2	WAPAL	Wings apart-like protein homolog	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q7Z5K2	WAPAL	Wings apart-like protein homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q7Z5K2	WAPAL	Wings apart-like protein homolog	GO:0035562; P:negative regulation of chromatin binding; IMP:UniProtKB
Q7Z5K2	WAPAL	Wings apart-like protein homolog	GO:0008156; P:negative regulation of DNA replication; IMP:UniProtKB
Q7Z5K2	WAPAL	Wings apart-like protein homolog	GO:0045875; P:negative regulation of sister chromatid cohesion; IMP:UniProtKB
Q7Z5K2	WAPAL	Wings apart-like protein homolog	GO:0071168; P:protein localization to chromatin; IMP:UniProtKB
Q7Z5K2	WAPAL	Wings apart-like protein homolog	GO:0071922; P:regulation of cohesin localization to chromatin; IMP:UniProtKB
Q7Z5K2	WAPAL	Wings apart-like protein homolog	GO:0009636; P:response to toxic substance; IEA:Ensembl
Q7Z5K2	WAPAL	Wings apart-like protein homolog	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q92558	WASF1	Wiskott-Aldrich syndrome protein family member 1	GO:0005515; F:protein binding; IPI:IntAct
Q92558	WASF1	Wiskott-Aldrich syndrome protein family member 1	GO:0032403; F:protein complex binding; IMP:UniProt
Q92558	WASF1	Wiskott-Aldrich syndrome protein family member 1	GO:0030041; P:actin filament polymerization; TAS:ProtInc
Q92558	WASF1	Wiskott-Aldrich syndrome protein family member 1	GO:0006928; P:cellular component movement; TAS:ProtInc
Q92558	WASF1	Wiskott-Aldrich syndrome protein family member 1	GO:0072673; P:lamellipodium morphogenesis; IEA:Ensembl
Q92558	WASF1	Wiskott-Aldrich syndrome protein family member 1	GO:2000601; P:positive regulation of Arp2/3 complex-mediated actin nucleation; IMP:UniProt
Q92558	WASF1	Wiskott-Aldrich syndrome protein family member 1	GO:0006461; P:protein complex assembly; NAS:ProtInc
Q92558	WASF1	Wiskott-Aldrich syndrome protein family member 1	GO:0016601; P:Rac protein signal transduction; IMP:UniProt
Q9UPY6	WASF3	Wiskott-Aldrich syndrome protein family member 3	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
Q9UPY6	WASF3	Wiskott-Aldrich syndrome protein family member 3	GO:0030041; P:actin filament polymerization; TAS:ProtInc
Q9UPY6	WASF3	Wiskott-Aldrich syndrome protein family member 3	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q9UPY6	WASF3	Wiskott-Aldrich syndrome protein family member 3	GO:0030032; P:lamellipodium assembly; IEA:Ensembl
Q9UPY6	WASF3	Wiskott-Aldrich syndrome protein family member 3	GO:0014003; P:oligodendrocyte development; IEA:Ensembl
Q9UPY6	WASF3	Wiskott-Aldrich syndrome protein family member 3	GO:0031643; P:positive regulation of myelination; IEA:Ensembl
Q9UPY6	WASF3	Wiskott-Aldrich syndrome protein family member 3	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q9UPY6	WASF3	Wiskott-Aldrich syndrome protein family member 3	GO:0008360; P:regulation of cell shape; IMP:UniProtKB
Q9Y6W5	WASF2	Wiskott-Aldrich syndrome protein family member 2	GO:0003779; F:actin binding; TAS:ProtInc
Q9Y6W5	WASF2	Wiskott-Aldrich syndrome protein family member 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6W5	WASF2	Wiskott-Aldrich syndrome protein family member 2	GO:0032403; F:protein complex binding; IDA:UniProt
Q9Y6W5	WASF2	Wiskott-Aldrich syndrome protein family member 2	GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc
Q9Y6W5	WASF2	Wiskott-Aldrich syndrome protein family member 2	GO:0030048; P:actin filament-based movement; IEA:Ensembl
Q9Y6W5	WASF2	Wiskott-Aldrich syndrome protein family member 2	GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; TAS:ProtInc
Q9Y6W5	WASF2	Wiskott-Aldrich syndrome protein family member 2	GO:0001667; P:ameboidal cell migration; IEA:Ensembl
Q9Y6W5	WASF2	Wiskott-Aldrich syndrome protein family member 2	GO:0001525; P:angiogenesis; IEA:Ensembl
Q9Y6W5	WASF2	Wiskott-Aldrich syndrome protein family member 2	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q9Y6W5	WASF2	Wiskott-Aldrich syndrome protein family member 2	GO:0045087; P:innate immune response; TAS:Reactome
Q9Y6W5	WASF2	Wiskott-Aldrich syndrome protein family member 2	GO:0030032; P:lamellipodium assembly; IEA:Ensembl
Q9Y6W5	WASF2	Wiskott-Aldrich syndrome protein family member 2	GO:0072673; P:lamellipodium morphogenesis; IEA:Ensembl
Q9Y6W5	WASF2	Wiskott-Aldrich syndrome protein family member 2	GO:0035855; P:megakaryocyte development; IEA:Ensembl
Q9Y6W5	WASF2	Wiskott-Aldrich syndrome protein family member 2	GO:0051497; P:negative regulation of stress fiber assembly; IMP:UniProt
Q9Y6W5	WASF2	Wiskott-Aldrich syndrome protein family member 2	GO:0010592; P:positive regulation of lamellipodium assembly; IMP:UniProt
Q9Y6W5	WASF2	Wiskott-Aldrich syndrome protein family member 2	GO:0016601; P:Rac protein signal transduction; IEA:Ensembl
A8K0Z3	WASH1	WAS protein family homolog 1	GO:0043014; F:alpha-tubulin binding; IDA:UniProtKB
A8K0Z3	WASH1	WAS protein family homolog 1	GO:0005515; F:protein binding; IPI:UniProtKB
A8K0Z3	WASH1	WAS protein family homolog 1	GO:0034314; P:Arp2/3 complex-mediated actin nucleation; ISS:UniProtKB
A8K0Z3	WASH1	WAS protein family homolog 1	GO:0016197; P:endosomal transport; ISS:UniProtKB
A8K0Z3	WASH1	WAS protein family homolog 1	GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB
Q6VEQ5	WASH2P	WAS protein family homolog 2	GO:0043014; F:alpha-tubulin binding; ISS:UniProtKB
Q6VEQ5	WASH2P	WAS protein family homolog 2	GO:0034314; P:Arp2/3 complex-mediated actin nucleation; ISS:UniProtKB
Q6VEQ5	WASH2P	WAS protein family homolog 2	GO:0016197; P:endosomal transport; ISS:UniProtKB
Q6VEQ5	WASH2P	WAS protein family homolog 2	GO:0042147; P:retrograde transport, endosome to Golgi; ISS:UniProtKB
C4AMC7	WASH3P	Putative WAS protein family homolog 3	GO:0043014; F:alpha-tubulin binding; ISS:UniProtKB
C4AMC7	WASH3P	Putative WAS protein family homolog 3	GO:0034314; P:Arp2/3 complex-mediated actin nucleation; IDA:UniProtKB
C4AMC7	WASH3P	Putative WAS protein family homolog 3	GO:0016197; P:endosomal transport; ISS:UniProtKB
C4AMC7	WASH3P	Putative WAS protein family homolog 3	GO:0042147; P:retrograde transport, endosome to Golgi; ISS:UniProtKB
Q9NQA3	WASH6P	WAS protein family homolog 6	GO:0043014; F:alpha-tubulin binding; ISS:UniProtKB
Q9NQA3	WASH6P	WAS protein family homolog 6	GO:0034314; P:Arp2/3 complex-mediated actin nucleation; ISS:UniProtKB
Q9NQA3	WASH6P	WAS protein family homolog 6	GO:0016197; P:endosomal transport; ISS:UniProtKB
Q9NQA3	WASH6P	WAS protein family homolog 6	GO:0042147; P:retrograde transport, endosome to Golgi; ISS:UniProtKB
A8MWX3	WASH4P	Putative WAS protein family homolog 4	GO:0043014; F:alpha-tubulin binding; ISS:UniProtKB
A8MWX3	WASH4P	Putative WAS protein family homolog 4	GO:0034314; P:Arp2/3 complex-mediated actin nucleation; ISS:UniProtKB
A8MWX3	WASH4P	Putative WAS protein family homolog 4	GO:0016197; P:endosomal transport; ISS:UniProtKB
A8MWX3	WASH4P	Putative WAS protein family homolog 4	GO:0042147; P:retrograde transport, endosome to Golgi; ISS:UniProtKB
Q2M389	KIAA1033	WASH complex subunit 7	GO:0016197; P:endosomal transport; ISS:UniProtKB
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0005515; F:protein binding; IPI:IntAct
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0005083; F:small GTPase regulator activity; TAS:ProtInc
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0008154; P:actin polymerization or depolymerization; TAS:ProtInc
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0007411; P:axon guidance; TAS:Reactome
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0006928; P:cellular component movement; TAS:ProtInc
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0034629; P:cellular protein complex localization; IEA:Ensembl
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0045087; P:innate immune response; TAS:Reactome
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0006900; P:membrane budding; ISS:BHF-UCL
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0007067; P:mitosis; IEA:UniProtKB-KW
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0046209; P:nitric oxide metabolic process; TAS:Reactome
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:2000601; P:positive regulation of Arp2/3 complex-mediated actin nucleation; IEA:InterPro
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:2000370; P:positive regulation of clathrin-mediated endocytosis; ISS:BHF-UCL
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0051491; P:positive regulation of filopodium assembly; ISS:BHF-UCL
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0006461; P:protein complex assembly; TAS:ProtInc
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0032880; P:regulation of protein localization; IEA:Ensembl
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0009617; P:response to bacterium; IEA:Ensembl
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0044281; P:small molecule metabolic process; TAS:Reactome
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0051653; P:spindle localization; IEA:Ensembl
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0016050; P:vesicle organization; ISS:BHF-UCL
O00401	WASL	Neural Wiskott-Aldrich syndrome protein	GO:0030050; P:vesicle transport along actin filament; ISS:BHF-UCL
P42768	WAS	Wiskott-Aldrich syndrome protein	GO:0042802; F:identical protein binding; IPI:IntAct
P42768	WAS	Wiskott-Aldrich syndrome protein	GO:0005515; F:protein binding; IPI:IntAct
P42768	WAS	Wiskott-Aldrich syndrome protein	GO:0005083; F:small GTPase regulator activity; TAS:ProtInc
P42768	WAS	Wiskott-Aldrich syndrome protein	GO:0030041; P:actin filament polymerization; IEA:Ensembl
P42768	WAS	Wiskott-Aldrich syndrome protein	GO:0030048; P:actin filament-based movement; IEA:Ensembl
P42768	WAS	Wiskott-Aldrich syndrome protein	GO:0008154; P:actin polymerization or depolymerization; TAS:ProtInc
P42768	WAS	Wiskott-Aldrich syndrome protein	GO:0007596; P:blood coagulation; TAS:ProtInc
P42768	WAS	Wiskott-Aldrich syndrome protein	GO:0006952; P:defense response; TAS:ProtInc
P42768	WAS	Wiskott-Aldrich syndrome protein	GO:0016197; P:endosomal transport; IEA:Ensembl
P42768	WAS	Wiskott-Aldrich syndrome protein	GO:0008544; P:epidermis development; TAS:ProtInc
P42768	WAS	Wiskott-Aldrich syndrome protein	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P42768	WAS	Wiskott-Aldrich syndrome protein	GO:0006955; P:immune response; IMP:HGNC
P42768	WAS	Wiskott-Aldrich syndrome protein	GO:0045087; P:innate immune response; TAS:Reactome
P42768	WAS	Wiskott-Aldrich syndrome protein	GO:2000601; P:positive regulation of Arp2/3 complex-mediated actin nucleation; IEA:InterPro
P42768	WAS	Wiskott-Aldrich syndrome protein	GO:0006461; P:protein complex assembly; TAS:ProtInc
P42768	WAS	Wiskott-Aldrich syndrome protein	GO:0050790; P:regulation of catalytic activity; TAS:GOC
P42768	WAS	Wiskott-Aldrich syndrome protein	GO:0042110; P:T cell activation; IEA:Ensembl
P42768	WAS	Wiskott-Aldrich syndrome protein	GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome
Q9Y2W2	WBP11	WW domain-binding protein 11	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y2W2	WBP11	WW domain-binding protein 11	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2W2	WBP11	WW domain-binding protein 11	GO:0008599; F:protein phosphatase type 1 regulator activity; IEA:Ensembl
Q9Y2W2	WBP11	WW domain-binding protein 11	GO:0003697; F:single-stranded DNA binding; TAS:ProtInc
Q9Y2W2	WBP11	WW domain-binding protein 11	GO:0050699; F:WW domain binding; IPI:UniProtKB
Q9Y2W2	WBP11	WW domain-binding protein 11	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9Y2W2	WBP11	WW domain-binding protein 11	GO:0008380; P:RNA splicing; IEA:UniProtKB-KW
Q9Y2W2	WBP11	WW domain-binding protein 11	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q96G27	WBP1	WW domain-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q96G27	WBP1	WW domain-binding protein 1	GO:0050699; F:WW domain binding; IPI:UniProtKB
Q6ICG8	WBP2NL	Postacrosomal sheath WW domain-binding protein	GO:0050699; F:WW domain binding; ISS:HGNC
Q6ICG8	WBP2NL	Postacrosomal sheath WW domain-binding protein	GO:0007343; P:egg activation; ISS:HGNC
Q6ICG8	WBP2NL	Postacrosomal sheath WW domain-binding protein	GO:0035039; P:male pronucleus assembly; ISS:HGNC
Q6ICG8	WBP2NL	Postacrosomal sheath WW domain-binding protein	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q969T9	WBP2	WW domain-binding protein 2	GO:0005515; F:protein binding; IPI:IntAct
O75554	WBP4	WW domain-binding protein 4	GO:0003676; F:nucleic acid binding; IEA:InterPro
O75554	WBP4	WW domain-binding protein 4	GO:0070064; F:proline-rich region binding; IPI:UniProtKB
O75554	WBP4	WW domain-binding protein 4	GO:0005515; F:protein binding; IPI:IntAct
O75554	WBP4	WW domain-binding protein 4	GO:0008270; F:zinc ion binding; IEA:InterPro
O75554	WBP4	WW domain-binding protein 4	GO:0045292; P:mRNA cis splicing, via spliceosome; IDA:UniProtKB
Q96I51	WBSCR16	Williams-Beuren syndrome chromosomal region 16 protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O43709	WBSCR22	Ribosome biogenesis methyltransferase WBSCR22	GO:0008168; F:methyltransferase activity; IEA:InterPro
O43709	WBSCR22	Ribosome biogenesis methyltransferase WBSCR22	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O43709	WBSCR22	Ribosome biogenesis methyltransferase WBSCR22	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q8IWB7	WDFY1	WD repeat and FYVE domain-containing protein 1	GO:0005545; F:1-phosphatidylinositol binding; IDA:UniProtKB
Q8IWB7	WDFY1	WD repeat and FYVE domain-containing protein 1	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q96P53	WDFY2	WD repeat and FYVE domain-containing protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IZQ1	WDFY3	WD repeat and FYVE domain-containing protein 3	GO:0005545; F:1-phosphatidylinositol binding; IDA:MGI
Q8IZQ1	WDFY3	WD repeat and FYVE domain-containing protein 3	GO:0003831; F:beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; IEA:Ensembl
Q8IZQ1	WDFY3	WD repeat and FYVE domain-containing protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IZQ1	WDFY3	WD repeat and FYVE domain-containing protein 3	GO:0005515; F:protein binding; IPI:IntAct
O75717	WDHD1	WD repeat and HMG-box DNA-binding protein 1	GO:0003682; F:chromatin binding; IEA:Ensembl
O75717	WDHD1	WD repeat and HMG-box DNA-binding protein 1	GO:0003677; F:DNA binding; TAS:ProtInc
O75717	WDHD1	WD repeat and HMG-box DNA-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
O75717	WDHD1	WD repeat and HMG-box DNA-binding protein 1	GO:0003723; F:RNA binding; IEA:Ensembl
O75717	WDHD1	WD repeat and HMG-box DNA-binding protein 1	GO:0070829; P:heterochromatin maintenance; IEA:Ensembl
O75717	WDHD1	WD repeat and HMG-box DNA-binding protein 1	GO:0033044; P:regulation of chromosome organization; IEA:Ensembl
O75717	WDHD1	WD repeat and HMG-box DNA-binding protein 1	GO:0006396; P:RNA processing; IEA:Ensembl
Q9BZH6	WDR11	WD repeat-containing protein 11	GO:0005515; F:protein binding; IPI:UniProtKB
Q9GZL7	WDR12	Ribosome biogenesis protein WDR12	GO:0005515; F:protein binding; IPI:UniProtKB
Q9GZL7	WDR12	Ribosome biogenesis protein WDR12	GO:0043021; F:ribonucleoprotein complex binding; IEA:UniProtKB-HAMAP
Q9GZL7	WDR12	Ribosome biogenesis protein WDR12	GO:0008283; P:cell proliferation; IMP:UniProtKB
Q9GZL7	WDR12	Ribosome biogenesis protein WDR12	GO:0000466; P:maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IMP:UniProtKB
Q9GZL7	WDR12	Ribosome biogenesis protein WDR12	GO:0000463; P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IMP:UniProtKB
Q9GZL7	WDR12	Ribosome biogenesis protein WDR12	GO:0007219; P:Notch signaling pathway; IEA:Ensembl
Q9GZL7	WDR12	Ribosome biogenesis protein WDR12	GO:0042273; P:ribosomal large subunit biogenesis; IC:UniProtKB
Q8N1V2	WDR16	WD repeat-containing protein 16	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BV38	WDR18	WD repeat-containing protein 18	GO:0005515; F:protein binding; IPI:IntAct
Q9BV38	WDR18	WD repeat-containing protein 18	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8NEZ3	WDR19	WD repeat-containing protein 19	GO:0060830; P:ciliary receptor clustering involved in smoothened signaling pathway; IEA:Ensembl
Q8NEZ3	WDR19	WD repeat-containing protein 19	GO:0042384; P:cilium assembly; IEA:Ensembl
Q8NEZ3	WDR19	WD repeat-containing protein 19	GO:0055123; P:digestive system development; IEA:Ensembl
Q8NEZ3	WDR19	WD repeat-containing protein 19	GO:0042471; P:ear morphogenesis; IEA:Ensembl
Q8NEZ3	WDR19	WD repeat-containing protein 19	GO:0031076; P:embryonic camera-type eye development; IEA:Ensembl
Q8NEZ3	WDR19	WD repeat-containing protein 19	GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl
Q8NEZ3	WDR19	WD repeat-containing protein 19	GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl
Q8NEZ3	WDR19	WD repeat-containing protein 19	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q8NEZ3	WDR19	WD repeat-containing protein 19	GO:0061055; P:myotome development; IEA:Ensembl
Q8NEZ3	WDR19	WD repeat-containing protein 19	GO:0050877; P:neurological system process; IEA:Ensembl
Q8NEZ3	WDR19	WD repeat-containing protein 19	GO:0060831; P:smoothened signaling pathway involved in dorsal/ventral neural tube patterning; IEA:Ensembl
O75083	WDR1	WD repeat-containing protein 1	GO:0007596; P:blood coagulation; TAS:Reactome
O75083	WDR1	WD repeat-containing protein 1	GO:0030168; P:platelet activation; TAS:Reactome
O75083	WDR1	WD repeat-containing protein 1	GO:0002576; P:platelet degranulation; TAS:Reactome
O75083	WDR1	WD repeat-containing protein 1	GO:0007605; P:sensory perception of sound; TAS:ProtInc
Q9C0J8	WDR33	pre-mRNA 3' end processing protein WDR33	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9C0J8	WDR33	pre-mRNA 3' end processing protein WDR33	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9C0J8	WDR33	pre-mRNA 3' end processing protein WDR33	GO:0006301; P:postreplication repair; NAS:UniProtKB
Q9C0J8	WDR33	pre-mRNA 3' end processing protein WDR33	GO:0007283; P:spermatogenesis; NAS:UniProtKB
Q9P2L0	WDR35	WD repeat-containing protein 35	GO:0042384; P:cilium assembly; IMP:UniProtKB
Q8NI36	WDR36	WD repeat-containing protein 36	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8NI36	WDR36	WD repeat-containing protein 36	GO:0030516; P:regulation of axon extension; IEA:Ensembl
Q8NI36	WDR36	WD repeat-containing protein 36	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q8NI36	WDR36	WD repeat-containing protein 36	GO:0001895; P:retina homeostasis; IEA:Ensembl
Q8NI36	WDR36	WD repeat-containing protein 36	GO:0006364; P:rRNA processing; IEA:UniProtKB-KW
Q8NI36	WDR36	WD repeat-containing protein 36	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q9UNX4	WDR3	WD repeat-containing protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15061	WDR43	WD repeat-containing protein 43	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O15213	WDR46	WD repeat-containing protein 46	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O94967	WDR47	WD repeat-containing protein 47	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8TAF3	WDR48	WD repeat-containing protein 48	GO:0005515; F:protein binding; IPI:UniProtKB
Q8TAF3	WDR48	WD repeat-containing protein 48	GO:0016579; P:protein deubiquitination; IDA:UniProtKB
Q8TAF3	WDR48	WD repeat-containing protein 48	GO:0016032; P:viral process; IEA:UniProtKB-KW
P57081	WDR4	tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4	GO:0005515; F:protein binding; IPI:UniProtKB
P57081	WDR4	tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4	GO:0036265; P:RNA (guanine-N7)-methylation; IEA:InterPro
P57081	WDR4	tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4	GO:0030488; P:tRNA methylation; IEA:UniProtKB-HAMAP
P57081	WDR4	tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4	GO:0006400; P:tRNA modification; IDA:UniProtKB
Q9H6Y2	WDR55	WD repeat-containing protein 55	GO:0006364; P:rRNA processing; ISS:UniProtKB
P61964	WDR5	WD repeat-containing protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
P61964	WDR5	WD repeat-containing protein 5	GO:0006325; P:chromatin organization; TAS:Reactome
P61964	WDR5	WD repeat-containing protein 5	GO:0043966; P:histone H3 acetylation; IDA:BHF-UCL
P61964	WDR5	WD repeat-containing protein 5	GO:0051568; P:histone H3-K4 methylation; IDA:UniProtKB
P61964	WDR5	WD repeat-containing protein 5	GO:0043984; P:histone H4-K16 acetylation; IDA:UniProtKB
P61964	WDR5	WD repeat-containing protein 5	GO:0043981; P:histone H4-K5 acetylation; IDA:UniProtKB
P61964	WDR5	WD repeat-containing protein 5	GO:0043982; P:histone H4-K8 acetylation; IDA:UniProtKB
P61964	WDR5	WD repeat-containing protein 5	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P61964	WDR5	WD repeat-containing protein 5	GO:0001501; P:skeletal system development; IEA:Ensembl
P61964	WDR5	WD repeat-containing protein 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WVS4	WDR60	WD repeat-containing protein 60	GO:0030030; P:cell projection organization; IEA:UniProtKB-KW
Q9GZS3	WDR61	WD repeat-containing protein 61	GO:0005515; F:protein binding; IPI:IntAct
Q9GZS3	WDR61	WD repeat-containing protein 61	GO:0080182; P:histone H3-K4 trimethylation; IMP:UniProtKB
Q9GZS3	WDR61	WD repeat-containing protein 61	GO:0045638; P:negative regulation of myeloid cell differentiation; IDA:UniProtKB
Q9GZS3	WDR61	WD repeat-containing protein 61	GO:0051571; P:positive regulation of histone H3-K4 methylation; IMP:UniProtKB
Q9GZS3	WDR61	WD repeat-containing protein 61	GO:2001162; P:positive regulation of histone H3-K79 methylation; IMP:UniProtKB
Q9GZS3	WDR61	WD repeat-containing protein 61	GO:0032968; P:positive regulation of transcription elongation from RNA polymerase II promoter; IDA:UniProtKB
Q9GZS3	WDR61	WD repeat-containing protein 61	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9GZS3	WDR61	WD repeat-containing protein 61	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9GZS3	WDR61	WD repeat-containing protein 61	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
O43379	WDR62	WD repeat-containing protein 62	GO:0021987; P:cerebral cortex development; IMP:UniProtKB
O43379	WDR62	WD repeat-containing protein 62	GO:0022008; P:neurogenesis; IMP:UniProtKB
Q8TBY9	WDR66	WD repeat-containing protein 66	GO:0005509; F:calcium ion binding; IEA:InterPro
Q9NNW5	WDR6	WD repeat-containing protein 6	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NNW5	WDR6	WD repeat-containing protein 6	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NNW5	WDR6	WD repeat-containing protein 6	GO:0007050; P:cell cycle arrest; IDA:UniProtKB
Q9NNW5	WDR6	WD repeat-containing protein 6	GO:0010507; P:negative regulation of autophagy; IMP:BHF-UCL
Q9NNW5	WDR6	WD repeat-containing protein 6	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q6RFH5	WDR74	WD repeat-containing protein 74	GO:0001825; P:blastocyst formation; IEA:Ensembl
Q6RFH5	WDR74	WD repeat-containing protein 74	GO:0016070; P:RNA metabolic process; IEA:Ensembl
Q8IWA0	WDR75	WD repeat-containing protein 75	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q562E7	WDR81	WD repeat-containing protein 81	GO:0016772; F:transferase activity, transferring phosphorus-containing groups; IEA:InterPro
Q562E7	WDR81	WD repeat-containing protein 81	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q6UXN9	WDR82	WD repeat-containing protein 82	GO:0003682; F:chromatin binding; IEA:Ensembl
Q6UXN9	WDR82	WD repeat-containing protein 82	GO:0005515; F:protein binding; IPI:UniProtKB
Q6UXN9	WDR82	WD repeat-containing protein 82	GO:0051568; P:histone H3-K4 methylation; IDA:UniProtKB
Q9BRX9	WDR83	WD repeat domain-containing protein 83	GO:0005515; F:protein binding; IPI:IntAct
Q9BRX9	WDR83	WD repeat domain-containing protein 83	GO:0000398; P:mRNA splicing, via spliceosome; IDA:UniProtKB
Q9BRX9	WDR83	WD repeat domain-containing protein 83	GO:0000375; P:RNA splicing, via transesterification reactions; IDA:UniProtKB
Q96MX6	WDR92	WD repeat-containing protein 92	GO:0035064; F:methylated histone binding; IDA:UniProtKB
Q96MX6	WDR92	WD repeat-containing protein 92	GO:0005515; F:protein binding; IPI:IntAct
Q96MX6	WDR92	WD repeat-containing protein 92	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q96MX6	WDR92	WD repeat-containing protein 92	GO:0034968; P:histone lysine methylation; IDA:UniProtKB
Q6P2C0	WDR93	WD repeat-containing protein 93	GO:0016651; F:oxidoreductase activity, acting on NAD(P)H; IEA:InterPro
Q6P2C0	WDR93	WD repeat-containing protein 93	GO:0022900; P:electron transport chain; IEA:InterPro
Q8N5D0	WDTC1	WD and tetratricopeptide repeats protein 1	GO:0004857; F:enzyme inhibitor activity; IEA:Ensembl
Q8N5D0	WDTC1	WD and tetratricopeptide repeats protein 1	GO:0005515; F:protein binding; IPI:DFLAT
Q8N5D0	WDTC1	WD and tetratricopeptide repeats protein 1	GO:0055082; P:cellular chemical homeostasis; IEA:Ensembl
Q8N5D0	WDTC1	WD and tetratricopeptide repeats protein 1	GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl
Q8N5D0	WDTC1	WD and tetratricopeptide repeats protein 1	GO:0006006; P:glucose metabolic process; IEA:Ensembl
Q8N5D0	WDTC1	WD and tetratricopeptide repeats protein 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q8N5D0	WDTC1	WD and tetratricopeptide repeats protein 1	GO:0035264; P:multicellular organism growth; IEA:Ensembl
Q8N5D0	WDTC1	WD and tetratricopeptide repeats protein 1	GO:0045717; P:negative regulation of fatty acid biosynthetic process; IEA:Ensembl
Q8N5D0	WDTC1	WD and tetratricopeptide repeats protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8N5D0	WDTC1	WD and tetratricopeptide repeats protein 1	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q8N5D0	WDTC1	WD and tetratricopeptide repeats protein 1	GO:0008361; P:regulation of cell size; IEA:Ensembl
P30291	WEE1	Wee1-like protein kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P30291	WEE1	Wee1-like protein kinase	GO:0000287; F:magnesium ion binding; IEA:InterPro
P30291	WEE1	Wee1-like protein kinase	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC
P30291	WEE1	Wee1-like protein kinase	GO:0005515; F:protein binding; IPI:IntAct
P30291	WEE1	Wee1-like protein kinase	GO:0004674; F:protein serine/threonine kinase activity; IEA:InterPro
P30291	WEE1	Wee1-like protein kinase	GO:0004713; F:protein tyrosine kinase activity; TAS:ProtInc
P30291	WEE1	Wee1-like protein kinase	GO:0007596; P:blood coagulation; TAS:Reactome
P30291	WEE1	Wee1-like protein kinase	GO:0030010; P:establishment of cell polarity; IEA:Ensembl
P30291	WEE1	Wee1-like protein kinase	GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome
P30291	WEE1	Wee1-like protein kinase	GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome
P30291	WEE1	Wee1-like protein kinase	GO:0000226; P:microtubule cytoskeleton organization; IEA:Ensembl
P30291	WEE1	Wee1-like protein kinase	GO:0007067; P:mitosis; IEA:UniProtKB-KW
P30291	WEE1	Wee1-like protein kinase	GO:0000278; P:mitotic cell cycle; TAS:Reactome
P30291	WEE1	Wee1-like protein kinase	GO:0048812; P:neuron projection morphogenesis; IEA:Ensembl
P30291	WEE1	Wee1-like protein kinase	GO:0051726; P:regulation of cell cycle; TAS:Reactome
P0C1S8	WEE2	Wee1-like protein kinase 2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P0C1S8	WEE2	Wee1-like protein kinase 2	GO:0000287; F:magnesium ion binding; IEA:InterPro
P0C1S8	WEE2	Wee1-like protein kinase 2	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC
P0C1S8	WEE2	Wee1-like protein kinase 2	GO:0004674; F:protein serine/threonine kinase activity; IEA:InterPro
P0C1S8	WEE2	Wee1-like protein kinase 2	GO:0007143; P:female meiotic division; ISS:UniProtKB
P0C1S8	WEE2	Wee1-like protein kinase 2	GO:0035038; P:female pronucleus assembly; ISS:UniProtKB
P0C1S8	WEE2	Wee1-like protein kinase 2	GO:0007067; P:mitosis; IEA:InterPro
P0C1S8	WEE2	Wee1-like protein kinase 2	GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:Ensembl
P0C1S8	WEE2	Wee1-like protein kinase 2	GO:1900194; P:negative regulation of oocyte maturation; ISS:UniProtKB
P0C1S8	WEE2	Wee1-like protein kinase 2	GO:0060631; P:regulation of meiosis I; ISS:UniProtKB
Q9H1F0	WFDC10A	WAP four-disulfide core domain protein 10A	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q8IUB3	WFDC10B	Protein WFDC10B	GO:0030414; F:peptidase inhibitor activity; IEA:InterPro
Q8WWY7	WFDC12	WAP four-disulfide core domain protein 12	GO:0004867; F:serine-type endopeptidase inhibitor activity; NAS:UniProtKB
Q8WWY7	WFDC12	WAP four-disulfide core domain protein 12	GO:0042742; P:defense response to bacterium; ISS:UniProtKB
Q8WWY7	WFDC12	WAP four-disulfide core domain protein 12	GO:0010951; P:negative regulation of endopeptidase activity; NAS:GOC
Q8IUB5	WFDC13	WAP four-disulfide core domain protein 13	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q9HC57	WFDC1	WAP four-disulfide core domain protein 1	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q9HC57	WFDC1	WAP four-disulfide core domain protein 1	GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB
Q9HC57	WFDC1	WAP four-disulfide core domain protein 1	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
Q9HC57	WFDC1	WAP four-disulfide core domain protein 1	GO:0042493; P:response to drug; IEA:Ensembl
Q9HC57	WFDC1	WAP four-disulfide core domain protein 1	GO:0032355; P:response to estradiol; IEA:Ensembl
Q14508	WFDC2	WAP four-disulfide core domain protein 2	GO:0019828; F:aspartic-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q14508	WFDC2	WAP four-disulfide core domain protein 2	GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q14508	WFDC2	WAP four-disulfide core domain protein 2	GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc
Q14508	WFDC2	WAP four-disulfide core domain protein 2	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q14508	WFDC2	WAP four-disulfide core domain protein 2	GO:0010951; P:negative regulation of endopeptidase activity; TAS:GOC
Q14508	WFDC2	WAP four-disulfide core domain protein 2	GO:0006508; P:proteolysis; TAS:ProtInc
Q14508	WFDC2	WAP four-disulfide core domain protein 2	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q8IUB2	WFDC3	WAP four-disulfide core domain protein 3	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q8TCV5	WFDC5	WAP four-disulfide core domain protein 5	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q9BQY6	WFDC6	WAP four-disulfide core domain protein 6	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q8IUA0	WFDC8	WAP four-disulfide core domain protein 8	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q96NZ8	WFIKKN1	WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1	GO:0008191; F:metalloendopeptidase inhibitor activity; IEA:UniProtKB-KW
Q96NZ8	WFIKKN1	WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q96NZ8	WFIKKN1	WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q8TEU8	WFIKKN2	WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2	GO:0008191; F:metalloendopeptidase inhibitor activity; IEA:UniProtKB-KW
Q8TEU8	WFIKKN2	WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2	GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW
Q8TEU8	WFIKKN2	WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl
O76024	WFS1	Wolframin	GO:0033613; F:activating transcription factor binding; ISS:BHF-UCL
O76024	WFS1	Wolframin	GO:0051117; F:ATPase binding; IPI:BHF-UCL
O76024	WFS1	Wolframin	GO:0005215; F:transporter activity; ISS:BHF-UCL
O76024	WFS1	Wolframin	GO:0031625; F:ubiquitin protein ligase binding; ISS:BHF-UCL
O76024	WFS1	Wolframin	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
O76024	WFS1	Wolframin	GO:0055074; P:calcium ion homeostasis; IDA:BHF-UCL
O76024	WFS1	Wolframin	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O76024	WFS1	Wolframin	GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; IDA:BHF-UCL
O76024	WFS1	Wolframin	GO:0030968; P:endoplasmic reticulum unfolded protein response; ISS:BHF-UCL
O76024	WFS1	Wolframin	GO:0006983; P:ER overload response; TAS:BHF-UCL
O76024	WFS1	Wolframin	GO:0030433; P:ER-associated ubiquitin-dependent protein catabolic process; ISS:BHF-UCL
O76024	WFS1	Wolframin	GO:0042593; P:glucose homeostasis; IMP:BHF-UCL
O76024	WFS1	Wolframin	GO:0001822; P:kidney development; IMP:BHF-UCL
O76024	WFS1	Wolframin	GO:1902236; P:negative regulation of intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISS:BHF-UCL
O76024	WFS1	Wolframin	GO:0043524; P:negative regulation of neuron apoptotic process; IMP:BHF-UCL
O76024	WFS1	Wolframin	GO:0043069; P:negative regulation of programmed cell death; IMP:BHF-UCL
O76024	WFS1	Wolframin	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
O76024	WFS1	Wolframin	GO:2000675; P:negative regulation of type B pancreatic cell apoptotic process; IMP:BHF-UCL
O76024	WFS1	Wolframin	GO:0050877; P:neurological system process; IMP:BHF-UCL
O76024	WFS1	Wolframin	GO:0042048; P:olfactory behavior; IEA:Ensembl
O76024	WFS1	Wolframin	GO:0070845; P:polyubiquitinated misfolded protein transport; ISS:BHF-UCL
O76024	WFS1	Wolframin	GO:0051928; P:positive regulation of calcium ion transport; IDA:BHF-UCL
O76024	WFS1	Wolframin	GO:0045927; P:positive regulation of growth; ISS:BHF-UCL
O76024	WFS1	Wolframin	GO:0051247; P:positive regulation of protein metabolic process; IDA:BHF-UCL
O76024	WFS1	Wolframin	GO:0031398; P:positive regulation of protein ubiquitination; ISS:BHF-UCL
O76024	WFS1	Wolframin	GO:0045862; P:positive regulation of proteolysis; ISS:BHF-UCL
O76024	WFS1	Wolframin	GO:0022417; P:protein maturation by protein folding; IC:BHF-UCL
O76024	WFS1	Wolframin	GO:0050821; P:protein stabilization; ISS:BHF-UCL
O76024	WFS1	Wolframin	GO:0003091; P:renal water homeostasis; IMP:BHF-UCL
O76024	WFS1	Wolframin	GO:0034976; P:response to endoplasmic reticulum stress; IDA:BHF-UCL
O76024	WFS1	Wolframin	GO:0007605; P:sensory perception of sound; IMP:BHF-UCL
O76024	WFS1	Wolframin	GO:0007601; P:visual perception; IMP:BHF-UCL
Q9P202	DFNB31	Whirlin	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P202	DFNB31	Whirlin	GO:0060122; P:inner ear receptor stereocilium organization; ISS:UniProtKB
Q9P202	DFNB31	Whirlin	GO:0001895; P:retina homeostasis; IMP:HGNC
Q9P202	DFNB31	Whirlin	GO:0050953; P:sensory perception of light stimulus; IMP:HGNC
Q9P202	DFNB31	Whirlin	GO:0007605; P:sensory perception of sound; IMP:HGNC
Q9BRP8	WIBG	Partner of Y14 and mago	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9BRP8	WIBG	Partner of Y14 and mago	GO:0005515; F:protein binding; IPI:UniProtKB
Q9BRP8	WIBG	Partner of Y14 and mago	GO:0043022; F:ribosome binding; IDA:UniProtKB
Q9BRP8	WIBG	Partner of Y14 and mago	GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IDA:UniProtKB
Q9BRP8	WIBG	Partner of Y14 and mago	GO:0045727; P:positive regulation of translation; IDA:UniProtKB
Q9Y5W5	WIF1	Wnt inhibitory factor 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y5W5	WIF1	Wnt inhibitory factor 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9Y5W5	WIF1	Wnt inhibitory factor 1	GO:0045600; P:positive regulation of fat cell differentiation; IEA:Ensembl
Q9Y5W5	WIF1	Wnt inhibitory factor 1	GO:0007165; P:signal transduction; NAS:ProtInc
Q9Y5W5	WIF1	Wnt inhibitory factor 1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
O43516	WIPF1	WAS/WASL-interacting protein family member 1	GO:0003779; F:actin binding; TAS:ProtInc
O43516	WIPF1	WAS/WASL-interacting protein family member 1	GO:0005522; F:profilin binding; TAS:ProtInc
O43516	WIPF1	WAS/WASL-interacting protein family member 1	GO:0005515; F:protein binding; IPI:IntAct
O43516	WIPF1	WAS/WASL-interacting protein family member 1	GO:0030048; P:actin filament-based movement; IEA:Ensembl
O43516	WIPF1	WAS/WASL-interacting protein family member 1	GO:0008154; P:actin polymerization or depolymerization; TAS:ProtInc
O43516	WIPF1	WAS/WASL-interacting protein family member 1	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
O43516	WIPF1	WAS/WASL-interacting protein family member 1	GO:0045087; P:innate immune response; TAS:Reactome
O43516	WIPF1	WAS/WASL-interacting protein family member 1	GO:0006461; P:protein complex assembly; TAS:ProtInc
O43516	WIPF1	WAS/WASL-interacting protein family member 1	GO:0051707; P:response to other organism; IEA:Ensembl
Q8TF74	WIPF2	WAS/WASL-interacting protein family member 2	GO:0005515; F:protein binding; IPI:IntAct
Q8TF74	WIPF2	WAS/WASL-interacting protein family member 2	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
Q8TF74	WIPF2	WAS/WASL-interacting protein family member 2	GO:0045087; P:innate immune response; TAS:Reactome
A6NGB9	WIPF3	WAS/WASL-interacting protein family member 3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
A6NGB9	WIPF3	WAS/WASL-interacting protein family member 3	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
A6NGB9	WIPF3	WAS/WASL-interacting protein family member 3	GO:0045087; P:innate immune response; TAS:Reactome
A6NGB9	WIPF3	WAS/WASL-interacting protein family member 3	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
A6NGB9	WIPF3	WAS/WASL-interacting protein family member 3	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q5MNZ9	WIPI1	WD repeat domain phosphoinositide-interacting protein 1	GO:0050681; F:androgen receptor binding; IDA:UniProtKB
Q5MNZ9	WIPI1	WD repeat domain phosphoinositide-interacting protein 1	GO:0030331; F:estrogen receptor binding; IDA:UniProtKB
Q5MNZ9	WIPI1	WD repeat domain phosphoinositide-interacting protein 1	GO:0080025; F:phosphatidylinositol-3,5-bisphosphate binding; IDA:UniProtKB
Q5MNZ9	WIPI1	WD repeat domain phosphoinositide-interacting protein 1	GO:0032266; F:phosphatidylinositol-3-phosphate binding; IDA:UniProtKB
Q5MNZ9	WIPI1	WD repeat domain phosphoinositide-interacting protein 1	GO:0005102; F:receptor binding; IDA:MGI
Q5MNZ9	WIPI1	WD repeat domain phosphoinositide-interacting protein 1	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q5MNZ9	WIPI1	WD repeat domain phosphoinositide-interacting protein 1	GO:0000045; P:autophagic vacuole assembly; IBA:RefGenome
Q5MNZ9	WIPI1	WD repeat domain phosphoinositide-interacting protein 1	GO:0006914; P:autophagy; IEP:UniProtKB
Q5MNZ9	WIPI1	WD repeat domain phosphoinositide-interacting protein 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q5MNZ9	WIPI1	WD repeat domain phosphoinositide-interacting protein 1	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q5MNZ9	WIPI1	WD repeat domain phosphoinositide-interacting protein 1	GO:0048203; P:vesicle targeting, trans-Golgi to endosome; IDA:UniProtKB
Q9Y4P8	WIPI2	WD repeat domain phosphoinositide-interacting protein 2	GO:0080025; F:phosphatidylinositol-3,5-bisphosphate binding; IDA:UniProtKB
Q9Y4P8	WIPI2	WD repeat domain phosphoinositide-interacting protein 2	GO:0032266; F:phosphatidylinositol-3-phosphate binding; IDA:UniProtKB
Q9Y4P8	WIPI2	WD repeat domain phosphoinositide-interacting protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y4P8	WIPI2	WD repeat domain phosphoinositide-interacting protein 2	GO:0000045; P:autophagic vacuole assembly; IMP:UniProtKB
Q5MNZ6	WDR45B	WD repeat domain phosphoinositide-interacting protein 3	GO:0080025; F:phosphatidylinositol-3,5-bisphosphate binding; IBA:RefGenome
Q5MNZ6	WDR45B	WD repeat domain phosphoinositide-interacting protein 3	GO:0032266; F:phosphatidylinositol-3-phosphate binding; IBA:RefGenome
Q5MNZ6	WDR45B	WD repeat domain phosphoinositide-interacting protein 3	GO:0000045; P:autophagic vacuole assembly; IBA:RefGenome
Q9Y484	WDR45	WD repeat domain phosphoinositide-interacting protein 4	GO:0080025; F:phosphatidylinositol-3,5-bisphosphate binding; IBA:RefGenome
Q9Y484	WDR45	WD repeat domain phosphoinositide-interacting protein 4	GO:0032266; F:phosphatidylinositol-3-phosphate binding; IBA:RefGenome
Q9Y484	WDR45	WD repeat domain phosphoinositide-interacting protein 4	GO:0000045; P:autophagic vacuole assembly; IBA:RefGenome
Q9Y484	WDR45	WD repeat domain phosphoinositide-interacting protein 4	GO:0006914; P:autophagy; IMP:UniProtKB
Q9Y484	WDR45	WD repeat domain phosphoinositide-interacting protein 4	GO:0008219; P:cell death; IEA:UniProtKB-KW
O95388	WISP1	WNT1-inducible-signaling pathway protein 1	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
O95388	WISP1	WNT1-inducible-signaling pathway protein 1	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O95388	WISP1	WNT1-inducible-signaling pathway protein 1	GO:0001558; P:regulation of cell growth; IEA:InterPro
O95388	WISP1	WNT1-inducible-signaling pathway protein 1	GO:0007165; P:signal transduction; TAS:ProtInc
O95388	WISP1	WNT1-inducible-signaling pathway protein 1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
O76076	WISP2	WNT1-inducible-signaling pathway protein 2	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
O76076	WISP2	WNT1-inducible-signaling pathway protein 2	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O76076	WISP2	WNT1-inducible-signaling pathway protein 2	GO:0001558; P:regulation of cell growth; IEA:Ensembl
O76076	WISP2	WNT1-inducible-signaling pathway protein 2	GO:0007165; P:signal transduction; TAS:ProtInc
O95389	WISP3	WNT1-inducible-signaling pathway protein 3	GO:0007267; P:cell-cell signaling; TAS:ProtInc
O95389	WISP3	WNT1-inducible-signaling pathway protein 3	GO:0001558; P:regulation of cell growth; IEA:InterPro
O95389	WISP3	WNT1-inducible-signaling pathway protein 3	GO:0007165; P:signal transduction; TAS:ProtInc
O95785	WIZ	Protein Wiz	GO:0046872; F:metal ion binding; IEA:InterPro
O95785	WIZ	Protein Wiz	GO:0005515; F:protein binding; IPI:UniProt
O95785	WIZ	Protein Wiz	GO:0010571; P:positive regulation of nuclear cell cycle DNA replication; IMP:UniProt
O95785	WIZ	Protein Wiz	GO:0070208; P:protein heterotrimerization; IDA:UniProt
O95785	WIZ	Protein Wiz	GO:0050821; P:protein stabilization; IMP:UniProt
Q5T9L3	WLS	Protein wntless homolog	GO:0005515; F:protein binding; IPI:IntAct
Q5T9L3	WLS	Protein wntless homolog	GO:0004871; F:signal transducer activity; ISS:UniProtKB
Q5T9L3	WLS	Protein wntless homolog	GO:0009948; P:anterior/posterior axis specification; IEA:Ensembl
Q5T9L3	WLS	Protein wntless homolog	GO:0001707; P:mesoderm formation; IEA:Ensembl
Q5T9L3	WLS	Protein wntless homolog	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
Q5T9L3	WLS	Protein wntless homolog	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; ISS:UniProtKB
Q5T9L3	WLS	Protein wntless homolog	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9GZT5	WNT10A	Protein Wnt-10a	GO:0005109; F:frizzled binding; IBA:RefGenome
Q9GZT5	WNT10A	Protein Wnt-10a	GO:0045165; P:cell fate commitment; IBA:RefGenome
Q9GZT5	WNT10A	Protein Wnt-10a	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:UniProtKB
Q9GZT5	WNT10A	Protein Wnt-10a	GO:0048730; P:epidermis morphogenesis; IMP:BHF-UCL
Q9GZT5	WNT10A	Protein Wnt-10a	GO:0001942; P:hair follicle development; IMP:BHF-UCL
Q9GZT5	WNT10A	Protein Wnt-10a	GO:0031069; P:hair follicle morphogenesis; IMP:BHF-UCL
Q9GZT5	WNT10A	Protein Wnt-10a	GO:0014033; P:neural crest cell differentiation; IEA:Ensembl
Q9GZT5	WNT10A	Protein Wnt-10a	GO:0030182; P:neuron differentiation; IBA:RefGenome
Q9GZT5	WNT10A	Protein Wnt-10a	GO:0042476; P:odontogenesis; IMP:BHF-UCL
Q9GZT5	WNT10A	Protein Wnt-10a	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
Q9GZT5	WNT10A	Protein Wnt-10a	GO:0042487; P:regulation of odontogenesis of dentin-containing tooth; IEA:Ensembl
Q9GZT5	WNT10A	Protein Wnt-10a	GO:0048733; P:sebaceous gland development; IMP:BHF-UCL
Q9GZT5	WNT10A	Protein Wnt-10a	GO:0043588; P:skin development; IMP:BHF-UCL
Q9GZT5	WNT10A	Protein Wnt-10a	GO:0043586; P:tongue development; IMP:BHF-UCL
Q9GZT5	WNT10A	Protein Wnt-10a	GO:0016055; P:Wnt signaling pathway; IBA:RefGenome
O00744	WNT10B	Protein Wnt-10b	GO:0005109; F:frizzled binding; IBA:RefGenome
O00744	WNT10B	Protein Wnt-10b	GO:0048018; F:receptor agonist activity; IC:BHF-UCL
O00744	WNT10B	Protein Wnt-10b	GO:0060346; P:bone trabecula formation; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0060070; P:canonical Wnt signaling pathway; IDA:BHF-UCL
O00744	WNT10B	Protein Wnt-10b	GO:0007050; P:cell cycle arrest; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0045165; P:cell fate commitment; IBA:RefGenome
O00744	WNT10B	Protein Wnt-10b	GO:0071320; P:cellular response to cAMP; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0071464; P:cellular response to hydrostatic pressure; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0071374; P:cellular response to parathyroid hormone stimulus; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB
O00744	WNT10B	Protein Wnt-10b	GO:0002062; P:chondrocyte differentiation; IEP:UniProtKB
O00744	WNT10B	Protein Wnt-10b	GO:0061196; P:fungiform papilla development; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0000086; P:G2/M transition of mitotic cell cycle; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0071425; P:hematopoietic stem cell proliferation; IDA:BHF-UCL
O00744	WNT10B	Protein Wnt-10b	GO:0006629; P:lipid metabolic process; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0014835; P:myoblast differentiation involved in skeletal muscle regeneration; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0045599; P:negative regulation of fat cell differentiation; IDA:BHF-UCL
O00744	WNT10B	Protein Wnt-10b	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0030182; P:neuron differentiation; ISS:UniProtKB
O00744	WNT10B	Protein Wnt-10b	GO:0051885; P:positive regulation of anagen; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0043065; P:positive regulation of apoptotic process; IMP:BHF-UCL
O00744	WNT10B	Protein Wnt-10b	GO:0030501; P:positive regulation of bone mineralization; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0030858; P:positive regulation of epithelial cell differentiation; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0045899; P:positive regulation of RNA polymerase II transcriptional preinitiation complex assembly; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0050821; P:protein stabilization; IDA:BHF-UCL
O00744	WNT10B	Protein Wnt-10b	GO:0032434; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0048641; P:regulation of skeletal muscle tissue development; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0050909; P:sensory perception of taste; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0048741; P:skeletal muscle fiber development; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0007224; P:smoothened signaling pathway; IEA:Ensembl
O00744	WNT10B	Protein Wnt-10b	GO:0016055; P:Wnt signaling pathway; IMP:UniProtKB
Q9H4A3	WNK1	Serine/threonine-protein kinase WNK1	GO:0005524; F:ATP binding; IDA:UniProtKB
Q9H4A3	WNK1	Serine/threonine-protein kinase WNK1	GO:0019869; F:chloride channel inhibitor activity; IDA:UniProt
Q9H4A3	WNK1	Serine/threonine-protein kinase WNK1	GO:0019902; F:phosphatase binding; IDA:UniProtKB
Q9H4A3	WNK1	Serine/threonine-protein kinase WNK1	GO:0005515; F:protein binding; IPI:IntAct
Q9H4A3	WNK1	Serine/threonine-protein kinase WNK1	GO:0004860; F:protein kinase inhibitor activity; IEA:UniProtKB-KW
Q9H4A3	WNK1	Serine/threonine-protein kinase WNK1	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9H4A3	WNK1	Serine/threonine-protein kinase WNK1	GO:0035556; P:intracellular signal transduction; IDA:UniProtKB
Q9H4A3	WNK1	Serine/threonine-protein kinase WNK1	GO:0006811; P:ion transport; ISS:UniProtKB
Q9H4A3	WNK1	Serine/threonine-protein kinase WNK1	GO:0090188; P:negative regulation of pancreatic juice secretion; IEA:Ensembl
Q9H4A3	WNK1	Serine/threonine-protein kinase WNK1	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q9H4A3	WNK1	Serine/threonine-protein kinase WNK1	GO:0048666; P:neuron development; NAS:UniProtKB
Q9H4A3	WNK1	Serine/threonine-protein kinase WNK1	GO:0003084; P:positive regulation of systemic arterial blood pressure; IEA:Ensembl
Q9H4A3	WNK1	Serine/threonine-protein kinase WNK1	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9H4A3	WNK1	Serine/threonine-protein kinase WNK1	GO:0050794; P:regulation of cellular process; ISS:UniProtKB
Q9Y3S1	WNK2	Serine/threonine-protein kinase WNK2	GO:0005524; F:ATP binding; ISS:UniProtKB
Q9Y3S1	WNK2	Serine/threonine-protein kinase WNK2	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB
Q9Y3S1	WNK2	Serine/threonine-protein kinase WNK2	GO:0035556; P:intracellular signal transduction; ISS:UniProtKB
Q9Y3S1	WNK2	Serine/threonine-protein kinase WNK2	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q9Y3S1	WNK2	Serine/threonine-protein kinase WNK2	GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IMP:UniProtKB
Q9Y3S1	WNK2	Serine/threonine-protein kinase WNK2	GO:2000651; P:positive regulation of sodium ion transmembrane transporter activity; IMP:UniProtKB
Q9Y3S1	WNK2	Serine/threonine-protein kinase WNK2	GO:0046777; P:protein autophosphorylation; IDA:UniProtKB
Q9Y3S1	WNK2	Serine/threonine-protein kinase WNK2	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
Q9Y3S1	WNK2	Serine/threonine-protein kinase WNK2	GO:2000021; P:regulation of ion homeostasis; IMP:UniProtKB
Q9BYP7	WNK3	Serine/threonine-protein kinase WNK3	GO:0005524; F:ATP binding; ISS:UniProtKB
Q9BYP7	WNK3	Serine/threonine-protein kinase WNK3	GO:0019869; F:chloride channel inhibitor activity; IDA:UniProt
Q9BYP7	WNK3	Serine/threonine-protein kinase WNK3	GO:0005515; F:protein binding; IPI:IntAct
Q9BYP7	WNK3	Serine/threonine-protein kinase WNK3	GO:0004672; F:protein kinase activity; IDA:BHF-UCL
Q9BYP7	WNK3	Serine/threonine-protein kinase WNK3	GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB
Q9BYP7	WNK3	Serine/threonine-protein kinase WNK3	GO:0035556; P:intracellular signal transduction; ISS:UniProtKB
Q9BYP7	WNK3	Serine/threonine-protein kinase WNK3	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q9BYP7	WNK3	Serine/threonine-protein kinase WNK3	GO:0051928; P:positive regulation of calcium ion transport; IMP:UniProtKB
Q9BYP7	WNK3	Serine/threonine-protein kinase WNK3	GO:0090004; P:positive regulation of establishment of protein localization to plasma membrane; IDA:BHF-UCL
Q9BYP7	WNK3	Serine/threonine-protein kinase WNK3	GO:0032414; P:positive regulation of ion transmembrane transporter activity; IDA:BHF-UCL
Q9BYP7	WNK3	Serine/threonine-protein kinase WNK3	GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IDA:UniProtKB
Q9BYP7	WNK3	Serine/threonine-protein kinase WNK3	GO:2000688; P:positive regulation of rubidium ion transmembrane transporter activity; IDA:UniProtKB
Q9BYP7	WNK3	Serine/threonine-protein kinase WNK3	GO:2000682; P:positive regulation of rubidium ion transport; IDA:UniProtKB
Q9BYP7	WNK3	Serine/threonine-protein kinase WNK3	GO:2000651; P:positive regulation of sodium ion transmembrane transporter activity; IDA:UniProtKB
Q9BYP7	WNK3	Serine/threonine-protein kinase WNK3	GO:0010765; P:positive regulation of sodium ion transport; IDA:BHF-UCL
Q9BYP7	WNK3	Serine/threonine-protein kinase WNK3	GO:0046777; P:protein autophosphorylation; IDA:BHF-UCL
Q9BYP7	WNK3	Serine/threonine-protein kinase WNK3	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
Q9BYP7	WNK3	Serine/threonine-protein kinase WNK3	GO:2000021; P:regulation of ion homeostasis; IMP:UniProtKB
Q96J92	WNK4	Serine/threonine-protein kinase WNK4	GO:0005524; F:ATP binding; ISS:UniProtKB
Q96J92	WNK4	Serine/threonine-protein kinase WNK4	GO:0019869; F:chloride channel inhibitor activity; IDA:UniProt
Q96J92	WNK4	Serine/threonine-protein kinase WNK4	GO:0005515; F:protein binding; IPI:UniProtKB
Q96J92	WNK4	Serine/threonine-protein kinase WNK4	GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB
Q96J92	WNK4	Serine/threonine-protein kinase WNK4	GO:0006821; P:chloride transport; IEA:Ensembl
Q96J92	WNK4	Serine/threonine-protein kinase WNK4	GO:0072156; P:distal tubule morphogenesis; IMP:UniProtKB
Q96J92	WNK4	Serine/threonine-protein kinase WNK4	GO:0035556; P:intracellular signal transduction; ISS:UniProtKB
Q96J92	WNK4	Serine/threonine-protein kinase WNK4	GO:0050801; P:ion homeostasis; IMP:UniProtKB
Q96J92	WNK4	Serine/threonine-protein kinase WNK4	GO:0006811; P:ion transport; ISS:UniProtKB
Q96J92	WNK4	Serine/threonine-protein kinase WNK4	GO:0090188; P:negative regulation of pancreatic juice secretion; IEA:Ensembl
Q96J92	WNK4	Serine/threonine-protein kinase WNK4	GO:0008104; P:protein localization; IEA:Ensembl
Q96J92	WNK4	Serine/threonine-protein kinase WNK4	GO:0006468; P:protein phosphorylation; ISS:UniProtKB
Q96J92	WNK4	Serine/threonine-protein kinase WNK4	GO:0050794; P:regulation of cellular process; ISS:UniProtKB
Q96J92	WNK4	Serine/threonine-protein kinase WNK4	GO:0070294; P:renal sodium ion absorption; IMP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0005109; F:frizzled binding; IBA:RefGenome
O96014	WNT11	Protein Wnt-11	GO:0030295; F:protein kinase activator activity; IMP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0005099; F:Ras GTPase activator activity; IMP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0030325; P:adrenal gland development; IEP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0048844; P:artery morphogenesis; IEA:Ensembl
O96014	WNT11	Protein Wnt-11	GO:0030282; P:bone mineralization; IEA:Ensembl
O96014	WNT11	Protein Wnt-11	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
O96014	WNT11	Protein Wnt-11	GO:0045165; P:cell fate commitment; IBA:RefGenome
O96014	WNT11	Protein Wnt-11	GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0060197; P:cloacal septation; IEP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0048706; P:embryonic skeletal system development; IEP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0060484; P:lung-associated mesenchyme development; IEP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0072177; P:mesonephric duct development; IEP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0061037; P:negative regulation of cartilage development; NAS:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0060548; P:negative regulation of cell death; IMP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0030308; P:negative regulation of cell growth; IMP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0090272; P:negative regulation of fibroblast growth factor production; IEA:Ensembl
O96014	WNT11	Protein Wnt-11	GO:0072201; P:negative regulation of mesenchymal cell proliferation; IEA:Ensembl
O96014	WNT11	Protein Wnt-11	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0061101; P:neuroendocrine cell differentiation; IMP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0030182; P:neuron differentiation; ISS:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0035567; P:non-canonical Wnt signaling pathway; IEA:Ensembl
O96014	WNT11	Protein Wnt-11	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
O96014	WNT11	Protein Wnt-11	GO:0003151; P:outflow tract morphogenesis; IEA:Ensembl
O96014	WNT11	Protein Wnt-11	GO:0060021; P:palate development; IMP:BHF-UCL
O96014	WNT11	Protein Wnt-11	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
O96014	WNT11	Protein Wnt-11	GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0045860; P:positive regulation of protein kinase activity; IMP:GOC
O96014	WNT11	Protein Wnt-11	GO:0090037; P:positive regulation of protein kinase C signaling; IMP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0032320; P:positive regulation of Ras GTPase activity; IMP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0051496; P:positive regulation of stress fiber assembly; IMP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0032915; P:positive regulation of transforming growth factor beta2 production; IEA:Ensembl
O96014	WNT11	Protein Wnt-11	GO:0034394; P:protein localization to cell surface; IMP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0006468; P:protein phosphorylation; IMP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0031667; P:response to nutrient levels; IEA:Ensembl
O96014	WNT11	Protein Wnt-11	GO:0070830; P:tight junction assembly; IEA:Ensembl
O96014	WNT11	Protein Wnt-11	GO:0060675; P:ureteric bud morphogenesis; IEP:UniProtKB
O96014	WNT11	Protein Wnt-11	GO:0060412; P:ventricular septum morphogenesis; IEA:Ensembl
Q9UBV4	WNT16	Protein Wnt-16	GO:0005109; F:frizzled binding; IBA:RefGenome
Q9UBV4	WNT16	Protein Wnt-16	GO:0060317; P:cardiac epithelial to mesenchymal transition; IEA:Ensembl
Q9UBV4	WNT16	Protein Wnt-16	GO:0045165; P:cell fate commitment; IBA:RefGenome
Q9UBV4	WNT16	Protein Wnt-16	GO:0030216; P:keratinocyte differentiation; IMP:BHF-UCL
Q9UBV4	WNT16	Protein Wnt-16	GO:0043616; P:keratinocyte proliferation; IMP:BHF-UCL
Q9UBV4	WNT16	Protein Wnt-16	GO:0060548; P:negative regulation of cell death; IMP:BHF-UCL
Q9UBV4	WNT16	Protein Wnt-16	GO:0030182; P:neuron differentiation; IBA:RefGenome
Q9UBV4	WNT16	Protein Wnt-16	GO:0003408; P:optic cup formation involved in camera-type eye development; ISS:BHF-UCL
Q9UBV4	WNT16	Protein Wnt-16	GO:0090403; P:oxidative stress-induced premature senescence; IMP:BHF-UCL
Q9UBV4	WNT16	Protein Wnt-16	GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL
Q9UBV4	WNT16	Protein Wnt-16	GO:0046330; P:positive regulation of JNK cascade; IMP:BHF-UCL
Q9UBV4	WNT16	Protein Wnt-16	GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IMP:BHF-UCL
Q9UBV4	WNT16	Protein Wnt-16	GO:0090399; P:replicative senescence; IMP:BHF-UCL
Q9UBV4	WNT16	Protein Wnt-16	GO:0016055; P:Wnt signaling pathway; IBA:RefGenome
P04628	WNT1	Proto-oncogene Wnt-1	GO:0005125; F:cytokine activity; ISS:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0005109; F:frizzled binding; IC:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0048018; F:receptor agonist activity; IC:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P04628	WNT1	Proto-oncogene Wnt-1	GO:0060348; P:bone development; IMP:UniProtKB
P04628	WNT1	Proto-oncogene Wnt-1	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
P04628	WNT1	Proto-oncogene Wnt-1	GO:0060070; P:canonical Wnt signaling pathway; IMP:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0044336; P:canonical Wnt signaling pathway involved in negative regulation of apoptotic process; IMP:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0045165; P:cell fate commitment; IBA:RefGenome
P04628	WNT1	Proto-oncogene Wnt-1	GO:0007267; P:cell-cell signaling; ISS:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0071375; P:cellular response to peptide hormone stimulus; IEA:Ensembl
P04628	WNT1	Proto-oncogene Wnt-1	GO:0021551; P:central nervous system morphogenesis; ISS:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0021588; P:cerebellum formation; ISS:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0021536; P:diencephalon development; IEA:Ensembl
P04628	WNT1	Proto-oncogene Wnt-1	GO:0000578; P:embryonic axis specification; ISS:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0021797; P:forebrain anterior/posterior pattern specification; IEA:Ensembl
P04628	WNT1	Proto-oncogene Wnt-1	GO:0071425; P:hematopoietic stem cell proliferation; IEA:Ensembl
P04628	WNT1	Proto-oncogene Wnt-1	GO:0070365; P:hepatocyte differentiation; IEA:Ensembl
P04628	WNT1	Proto-oncogene Wnt-1	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
P04628	WNT1	Proto-oncogene Wnt-1	GO:0030901; P:midbrain development; ISS:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0022004; P:midbrain-hindbrain boundary maturation during brain development; IEA:Ensembl
P04628	WNT1	Proto-oncogene Wnt-1	GO:0007520; P:myoblast fusion; IEA:Ensembl
P04628	WNT1	Proto-oncogene Wnt-1	GO:0030514; P:negative regulation of BMP signaling pathway; IMP:AgBase
P04628	WNT1	Proto-oncogene Wnt-1	GO:0090344; P:negative regulation of cell aging; IDA:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0022408; P:negative regulation of cell-cell adhesion; IMP:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0010812; P:negative regulation of cell-substrate adhesion; IDA:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0045599; P:negative regulation of fat cell differentiation; ISS:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:2000059; P:negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IEA:Ensembl
P04628	WNT1	Proto-oncogene Wnt-1	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl
P04628	WNT1	Proto-oncogene Wnt-1	GO:0030182; P:neuron differentiation; IBA:RefGenome
P04628	WNT1	Proto-oncogene Wnt-1	GO:0048664; P:neuron fate determination; IEA:Ensembl
P04628	WNT1	Proto-oncogene Wnt-1	GO:0031100; P:organ regeneration; IEA:Ensembl
P04628	WNT1	Proto-oncogene Wnt-1	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0061184; P:positive regulation of dermatome development; IDA:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0048146; P:positive regulation of fibroblast proliferation; IMP:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0043568; P:positive regulation of insulin-like growth factor receptor signaling pathway; IDA:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0010592; P:positive regulation of lamellipodium assembly; IMP:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0045747; P:positive regulation of Notch signaling pathway; IDA:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl
P04628	WNT1	Proto-oncogene Wnt-1	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P04628	WNT1	Proto-oncogene Wnt-1	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
P04628	WNT1	Proto-oncogene Wnt-1	GO:0009611; P:response to wounding; IEP:UniProtKB
P04628	WNT1	Proto-oncogene Wnt-1	GO:0042770; P:signal transduction in response to DNA damage; IDA:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0060061; P:Spemann organizer formation; ISS:BHF-UCL
P04628	WNT1	Proto-oncogene Wnt-1	GO:0021527; P:spinal cord association neuron differentiation; IEA:Ensembl
P04628	WNT1	Proto-oncogene Wnt-1	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
P04628	WNT1	Proto-oncogene Wnt-1	GO:0030579; P:ubiquitin-dependent SMAD protein catabolic process; IEA:Ensembl
P04628	WNT1	Proto-oncogene Wnt-1	GO:0016055; P:Wnt signaling pathway; IDA:BHF-UCL
Q93097	WNT2B	Protein Wnt-2b	GO:0005109; F:frizzled binding; IBA:RefGenome
Q93097	WNT2B	Protein Wnt-2b	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
Q93097	WNT2B	Protein Wnt-2b	GO:0045165; P:cell fate commitment; IBA:RefGenome
Q93097	WNT2B	Protein Wnt-2b	GO:0002062; P:chondrocyte differentiation; IEP:UniProtKB
Q93097	WNT2B	Protein Wnt-2b	GO:0061303; P:cornea development in camera-type eye; ISS:BHF-UCL
Q93097	WNT2B	Protein Wnt-2b	GO:0021871; P:forebrain regionalization; IEP:UniProtKB
Q93097	WNT2B	Protein Wnt-2b	GO:0071425; P:hematopoietic stem cell proliferation; IDA:BHF-UCL
Q93097	WNT2B	Protein Wnt-2b	GO:0061072; P:iris morphogenesis; ISS:BHF-UCL
Q93097	WNT2B	Protein Wnt-2b	GO:0002088; P:lens development in camera-type eye; ISS:BHF-UCL
Q93097	WNT2B	Protein Wnt-2b	GO:0060492; P:lung induction; IEA:Ensembl
Q93097	WNT2B	Protein Wnt-2b	GO:0008584; P:male gonad development; IEP:UniProtKB
Q93097	WNT2B	Protein Wnt-2b	GO:0060638; P:mesenchymal-epithelial cell signaling; IEA:Ensembl
Q93097	WNT2B	Protein Wnt-2b	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q93097	WNT2B	Protein Wnt-2b	GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; IEA:Ensembl
Q93097	WNT2B	Protein Wnt-2b	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:UniProtKB
Q93097	WNT2B	Protein Wnt-2b	GO:0016055; P:Wnt signaling pathway; IMP:UniProtKB
P09544	WNT2	Protein Wnt-2	GO:0005125; F:cytokine activity; IDA:BHF-UCL
P09544	WNT2	Protein Wnt-2	GO:0005109; F:frizzled binding; IPI:UniProtKB
P09544	WNT2	Protein Wnt-2	GO:0005515; F:protein binding; IPI:BHF-UCL
P09544	WNT2	Protein Wnt-2	GO:0048018; F:receptor agonist activity; IC:BHF-UCL
P09544	WNT2	Protein Wnt-2	GO:0055009; P:atrial cardiac muscle tissue morphogenesis; IEA:Ensembl
P09544	WNT2	Protein Wnt-2	GO:0060070; P:canonical Wnt signaling pathway; IDA:BHF-UCL
P09544	WNT2	Protein Wnt-2	GO:0060317; P:cardiac epithelial to mesenchymal transition; IEA:Ensembl
P09544	WNT2	Protein Wnt-2	GO:0045165; P:cell fate commitment; IBA:RefGenome
P09544	WNT2	Protein Wnt-2	GO:0007267; P:cell-cell signaling; IDA:BHF-UCL
P09544	WNT2	Protein Wnt-2	GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB
P09544	WNT2	Protein Wnt-2	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:UniProtKB
P09544	WNT2	Protein Wnt-2	GO:0061072; P:iris morphogenesis; ISS:BHF-UCL
P09544	WNT2	Protein Wnt-2	GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl
P09544	WNT2	Protein Wnt-2	GO:0002088; P:lens development in camera-type eye; ISS:BHF-UCL
P09544	WNT2	Protein Wnt-2	GO:0030324; P:lung development; IEA:Ensembl
P09544	WNT2	Protein Wnt-2	GO:0060492; P:lung induction; IEA:Ensembl
P09544	WNT2	Protein Wnt-2	GO:0061180; P:mammary gland epithelium development; IEP:UniProtKB
P09544	WNT2	Protein Wnt-2	GO:0030182; P:neuron differentiation; ISS:UniProtKB
P09544	WNT2	Protein Wnt-2	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:UniProtKB
P09544	WNT2	Protein Wnt-2	GO:0060045; P:positive regulation of cardiac muscle cell proliferation; IEA:Ensembl
P09544	WNT2	Protein Wnt-2	GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL
P09544	WNT2	Protein Wnt-2	GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl
P09544	WNT2	Protein Wnt-2	GO:0060501; P:positive regulation of epithelial cell proliferation involved in lung morphogenesis; IEA:Ensembl
P09544	WNT2	Protein Wnt-2	GO:0048146; P:positive regulation of fibroblast proliferation; IMP:BHF-UCL
P09544	WNT2	Protein Wnt-2	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl
P09544	WNT2	Protein Wnt-2	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P09544	WNT2	Protein Wnt-2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P09544	WNT2	Protein Wnt-2	GO:0016055; P:Wnt signaling pathway; IDA:UniProtKB
P56704	WNT3A	Protein Wnt-3a	GO:0005109; F:frizzled binding; IBA:RefGenome
P56704	WNT3A	Protein Wnt-3a	GO:0005515; F:protein binding; IPI:UniProtKB
P56704	WNT3A	Protein Wnt-3a	GO:0048018; F:receptor agonist activity; IDA:BHF-UCL
P56704	WNT3A	Protein Wnt-3a	GO:0003713; F:transcription coactivator activity; ISS:BHF-UCL
P56704	WNT3A	Protein Wnt-3a	GO:0090245; P:axis elongation involved in somitogenesis; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0007411; P:axon guidance; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0060070; P:canonical Wnt signaling pathway; IDA:BHF-UCL
P56704	WNT3A	Protein Wnt-3a	GO:0061317; P:canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment; IDA:BHF-UCL
P56704	WNT3A	Protein Wnt-3a	GO:0021846; P:cell proliferation in forebrain; ISS:BHF-UCL
P56704	WNT3A	Protein Wnt-3a	GO:0034613; P:cellular protein localization; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB
P56704	WNT3A	Protein Wnt-3a	GO:0010387; P:COP9 signalosome assembly; ISS:BHF-UCL
P56704	WNT3A	Protein Wnt-3a	GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0030198; P:extracellular matrix organization; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0001947; P:heart looping; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0030097; P:hemopoiesis; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0021766; P:hippocampus development; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0042472; P:inner ear morphogenesis; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0030879; P:mammary gland development; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0048843; P:negative regulation of axon extension involved in axon guidance; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0045599; P:negative regulation of fat cell differentiation; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0003136; P:negative regulation of heart induction by canonical Wnt signaling pathway; IDA:BHF-UCL
P56704	WNT3A	Protein Wnt-3a	GO:0050768; P:negative regulation of neurogenesis; ISS:BHF-UCL
P56704	WNT3A	Protein Wnt-3a	GO:0010977; P:negative regulation of neuron projection development; ISS:UniProtKB
P56704	WNT3A	Protein Wnt-3a	GO:0030182; P:neuron differentiation; ISS:UniProtKB
P56704	WNT3A	Protein Wnt-3a	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0060021; P:palate development; IMP:BHF-UCL
P56704	WNT3A	Protein Wnt-3a	GO:0048343; P:paraxial mesodermal cell fate commitment; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0070527; P:platelet aggregation; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0030890; P:positive regulation of B cell proliferation; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:UniProtKB
P56704	WNT3A	Protein Wnt-3a	GO:2000081; P:positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:2000727; P:positive regulation of cardiac muscle cell differentiation; IDA:BHF-UCL
P56704	WNT3A	Protein Wnt-3a	GO:0035413; P:positive regulation of catenin import into nucleus; IDA:BHF-UCL
P56704	WNT3A	Protein Wnt-3a	GO:0008284; P:positive regulation of cell proliferation; ISS:BHF-UCL
P56704	WNT3A	Protein Wnt-3a	GO:2000049; P:positive regulation of cell-cell adhesion mediated by cadherin; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0048697; P:positive regulation of collateral sprouting in absence of injury; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0061184; P:positive regulation of dermatome development; IDA:BHF-UCL
P56704	WNT3A	Protein Wnt-3a	GO:0048337; P:positive regulation of mesodermal cell fate specification; IDA:BHF-UCL
P56704	WNT3A	Protein Wnt-3a	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:BHF-UCL
P56704	WNT3A	Protein Wnt-3a	GO:0032092; P:positive regulation of protein binding; IDA:BHF-UCL
P56704	WNT3A	Protein Wnt-3a	GO:0001934; P:positive regulation of protein phosphorylation; IDA:BHF-UCL
P56704	WNT3A	Protein Wnt-3a	GO:0061098; P:positive regulation of protein tyrosine kinase activity; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0002092; P:positive regulation of receptor internalization; IDA:BHF-UCL
P56704	WNT3A	Protein Wnt-3a	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
P56704	WNT3A	Protein Wnt-3a	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:BHF-UCL
P56704	WNT3A	Protein Wnt-3a	GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0070507; P:regulation of microtubule cytoskeleton organization; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0021527; P:spinal cord association neuron differentiation; IEA:Ensembl
P56704	WNT3A	Protein Wnt-3a	GO:0021874; P:Wnt signaling pathway involved in forebrain neuroblast division; IEA:Ensembl
P56703	WNT3	Proto-oncogene Wnt-3	GO:0005109; F:frizzled binding; IPI:UniProtKB
P56703	WNT3	Proto-oncogene Wnt-3	GO:0005515; F:protein binding; IPI:IntAct
P56703	WNT3	Proto-oncogene Wnt-3	GO:0048018; F:receptor agonist activity; IC:BHF-UCL
P56703	WNT3	Proto-oncogene Wnt-3	GO:0009948; P:anterior/posterior axis specification; IEA:Ensembl
P56703	WNT3	Proto-oncogene Wnt-3	GO:0007411; P:axon guidance; IEA:Ensembl
P56703	WNT3	Proto-oncogene Wnt-3	GO:0060070; P:canonical Wnt signaling pathway; IDA:UniProtKB
P56703	WNT3	Proto-oncogene Wnt-3	GO:0044338; P:canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation; IMP:BHF-UCL
P56703	WNT3	Proto-oncogene Wnt-3	GO:0044339; P:canonical Wnt signaling pathway involved in osteoblast differentiation; IMP:BHF-UCL
P56703	WNT3	Proto-oncogene Wnt-3	GO:0045165; P:cell fate commitment; IBA:RefGenome
P56703	WNT3	Proto-oncogene Wnt-3	GO:0000902; P:cell morphogenesis; IMP:BHF-UCL
P56703	WNT3	Proto-oncogene Wnt-3	GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB
P56703	WNT3	Proto-oncogene Wnt-3	GO:0009950; P:dorsal/ventral axis specification; IEA:Ensembl
P56703	WNT3	Proto-oncogene Wnt-3	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
P56703	WNT3	Proto-oncogene Wnt-3	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
P56703	WNT3	Proto-oncogene Wnt-3	GO:0060323; P:head morphogenesis; IEA:Ensembl
P56703	WNT3	Proto-oncogene Wnt-3	GO:0060174; P:limb bud formation; IMP:BHF-UCL
P56703	WNT3	Proto-oncogene Wnt-3	GO:0061180; P:mammary gland epithelium development; IEP:UniProtKB
P56703	WNT3	Proto-oncogene Wnt-3	GO:0001707; P:mesoderm formation; IEA:Ensembl
P56703	WNT3	Proto-oncogene Wnt-3	GO:0048843; P:negative regulation of axon extension involved in axon guidance; IEA:Ensembl
P56703	WNT3	Proto-oncogene Wnt-3	GO:0030182; P:neuron differentiation; ISS:UniProtKB
P56703	WNT3	Proto-oncogene Wnt-3	GO:0048697; P:positive regulation of collateral sprouting in absence of injury; IEA:Ensembl
P56703	WNT3	Proto-oncogene Wnt-3	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P56703	WNT3	Proto-oncogene Wnt-3	GO:0060064; P:Spemann organizer formation at the anterior end of the primitive streak; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0005109; F:frizzled binding; IBA:RefGenome
P56705	WNT4	Protein Wnt-4	GO:0048018; F:receptor agonist activity; IC:BHF-UCL
P56705	WNT4	Protein Wnt-4	GO:0003714; F:transcription corepressor activity; ISS:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0030325; P:adrenal gland development; IEP:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0006702; P:androgen biosynthetic process; IDA:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0060070; P:canonical Wnt signaling pathway; IDA:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0045165; P:cell fate commitment; IBA:RefGenome
P56705	WNT4	Protein Wnt-4	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0001838; P:embryonic epithelial tube formation; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0001837; P:epithelial to mesenchymal transition; IEP:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0090002; P:establishment of protein localization to plasma membrane; IDA:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0008585; P:female gonad development; ISS:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0030237; P:female sex determination; IMP:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0033080; P:immature T cell proliferation in thymus; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0001822; P:kidney development; IEP:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0001889; P:liver development; IEP:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0008584; P:male gonad development; IMP:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0061180; P:mammary gland epithelium development; IEP:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0060231; P:mesenchymal to epithelial transition; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0072164; P:mesonephric tubule development; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0072162; P:metanephric mesenchymal cell differentiation; NAS:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0072273; P:metanephric nephron morphogenesis; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0045596; P:negative regulation of cell differentiation; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0030336; P:negative regulation of cell migration; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0040037; P:negative regulation of fibroblast growth factor receptor signaling pathway; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:2000019; P:negative regulation of male gonad development; IMP:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0010894; P:negative regulation of steroid biosynthetic process; IDA:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0061369; P:negative regulation of testicular blood vessel morphogenesis; IMP:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:2000225; P:negative regulation of testosterone biosynthetic process; IMP:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0061045; P:negative regulation of wound healing; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0030182; P:neuron differentiation; IBA:RefGenome
P56705	WNT4	Protein Wnt-4	GO:0038030; P:non-canonical Wnt signaling pathway via MAPK cascade; IDA:BHF-UCL
P56705	WNT4	Protein Wnt-4	GO:0048599; P:oocyte development; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0061205; P:paramesonephric duct development; IMP:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0032349; P:positive regulation of aldosterone biosynthetic process; IDA:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0030501; P:positive regulation of bone mineralization; IDA:BHF-UCL
P56705	WNT4	Protein Wnt-4	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0032967; P:positive regulation of collagen biosynthetic process; IDA:BHF-UCL
P56705	WNT4	Protein Wnt-4	GO:2000066; P:positive regulation of cortisol biosynthetic process; IDA:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0061184; P:positive regulation of dermatome development; IDA:BHF-UCL
P56705	WNT4	Protein Wnt-4	GO:0051894; P:positive regulation of focal adhesion assembly; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0045836; P:positive regulation of meiosis; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0045669; P:positive regulation of osteoblast differentiation; IDA:BHF-UCL
P56705	WNT4	Protein Wnt-4	GO:0032321; P:positive regulation of Rho GTPase activity; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0051496; P:positive regulation of stress fiber assembly; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0018345; P:protein palmitoylation; IDA:UniProtKB
P56705	WNT4	Protein Wnt-4	GO:0022407; P:regulation of cell-cell adhesion; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0072033; P:renal vesicle formation; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0072034; P:renal vesicle induction; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0051145; P:smooth muscle cell differentiation; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0060126; P:somatotropin secreting cell differentiation; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0060748; P:tertiary branching involved in mammary gland duct morphogenesis; IEA:Ensembl
P56705	WNT4	Protein Wnt-4	GO:0060129; P:thyroid-stimulating hormone-secreting cell differentiation; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0005109; F:frizzled binding; IPI:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0048018; F:receptor agonist activity; IC:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0005115; F:receptor tyrosine kinase-like orphan receptor binding; IPI:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IMP:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0007257; P:activation of JUN kinase activity; IDA:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0000187; P:activation of MAPK activity; IDA:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0032148; P:activation of protein kinase B activity; IDA:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0001667; P:ameboidal cell migration; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0008595; P:anterior/posterior axis specification, embryo; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0007411; P:axon guidance; ISS:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0051216; P:cartilage development; IEA:UniProtKB-KW
P41221	WNT5A	Protein Wnt-5a	GO:0045165; P:cell fate commitment; IBA:RefGenome
P41221	WNT5A	Protein Wnt-5a	GO:0034613; P:cellular protein localization; IDA:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0071277; P:cellular response to calcium ion; IEP:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0071346; P:cellular response to interferon-gamma; IEP:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0071222; P:cellular response to lipopolysaccharide; IEP:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0060067; P:cervix development; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0090103; P:cochlea morphogenesis; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0060029; P:convergent extension involved in organogenesis; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0071542; P:dopaminergic neuron differentiation; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0048706; P:embryonic skeletal system development; IMP:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0060750; P:epithelial cell proliferation involved in mammary gland duct elongation; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0001837; P:epithelial to mesenchymal transition; IEP:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0001736; P:establishment of planar polarity; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0060324; P:face development; IMP:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0048806; P:genitalia development; IMP:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0001947; P:heart looping; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0071425; P:hematopoietic stem cell proliferation; IDA:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0007442; P:hindgut morphogenesis; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0048850; P:hypophysis morphogenesis; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0030216; P:keratinocyte differentiation; IEP:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0060599; P:lateral sprouting involved in mammary gland duct morphogenesis; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0002088; P:lens development in camera-type eye; ISS:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0030324; P:lung development; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0008584; P:male gonad development; IEP:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0060744; P:mammary gland branching involved in thelarche; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0060638; P:mesenchymal-epithelial cell signaling; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0007494; P:midgut development; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0050919; P:negative chemotaxis; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0048843; P:negative regulation of axon extension involved in axon guidance; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0030514; P:negative regulation of BMP signaling pathway; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0045599; P:negative regulation of fat cell differentiation; IMP:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0040037; P:negative regulation of fibroblast growth factor receptor signaling pathway; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0072201; P:negative regulation of mesenchymal cell proliferation; IDA:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0060686; P:negative regulation of prostatic bud formation; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0051964; P:negative regulation of synapse assembly; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0001843; P:neural tube closure; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0030182; P:neuron differentiation; ISS:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0038031; P:non-canonical Wnt signaling pathway via JNK cascade; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0021891; P:olfactory bulb interneuron development; ISS:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0003408; P:optic cup formation involved in camera-type eye development; ISS:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0060021; P:palate development; IMP:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0061350; P:planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0061349; P:planar cell polarity pathway involved in cardiac right atrium morphogenesis; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0090179; P:planar cell polarity pathway involved in neural tube closure; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0061347; P:planar cell polarity pathway involved in outflow tract morphogenesis; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0061354; P:planar cell polarity pathway involved in pericardium morphogenesis; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0061348; P:planar cell polarity pathway involved in ventricular septum morphogenesis; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0061036; P:positive regulation of cartilage development; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:2000049; P:positive regulation of cell-cell adhesion mediated by cadherin; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0030825; P:positive regulation of cGMP metabolic process; IDA:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0045080; P:positive regulation of chemokine biosynthetic process; IMP:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0002741; P:positive regulation of cytokine secretion involved in immune response; IMP:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0010595; P:positive regulation of endothelial cell migration; IMP:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0048146; P:positive regulation of fibroblast proliferation; IDA:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0050729; P:positive regulation of inflammatory response; IMP:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0032729; P:positive regulation of interferon-gamma production; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0050718; P:positive regulation of interleukin-1 beta secretion; IMP:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0032755; P:positive regulation of interleukin-6 production; IMP:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:2000484; P:positive regulation of interleukin-8 secretion; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0046330; P:positive regulation of JNK cascade; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0043032; P:positive regulation of macrophage activation; IMP:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0060907; P:positive regulation of macrophage cytokine production; IMP:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0045836; P:positive regulation of meiosis; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0045778; P:positive regulation of ossification; IMP:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0045732; P:positive regulation of protein catabolic process; IGI:MGI
P41221	WNT5A	Protein Wnt-5a	GO:0090037; P:positive regulation of protein kinase C signaling; IMP:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0060760; P:positive regulation of response to cytokine stimulus; IDA:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0010820; P:positive regulation of T cell chemotaxis; IMP:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0070245; P:positive regulation of thymocyte apoptotic process; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0060340; P:positive regulation of type I interferon-mediated signaling pathway; IDA:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0090009; P:primitive streak formation; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0006468; P:protein phosphorylation; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0060762; P:regulation of branching involved in mammary gland duct morphogenesis; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0010033; P:response to organic substance; IEP:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0001756; P:somitogenesis; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0003323; P:type B pancreatic cell development; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0060157; P:urinary bladder development; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0060065; P:uterus development; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0060068; P:vagina development; IEA:Ensembl
P41221	WNT5A	Protein Wnt-5a	GO:0016055; P:Wnt signaling pathway; IDA:BHF-UCL
P41221	WNT5A	Protein Wnt-5a	GO:0007223; P:Wnt signaling pathway, calcium modulating pathway; IMP:UniProtKB
P41221	WNT5A	Protein Wnt-5a	GO:0042060; P:wound healing; IDA:UniProtKB
Q9H1J7	WNT5B	Protein Wnt-5b	GO:0005109; F:frizzled binding; IBA:RefGenome
Q9H1J7	WNT5B	Protein Wnt-5b	GO:0005102; F:receptor binding; IPI:UniProtKB
Q9H1J7	WNT5B	Protein Wnt-5b	GO:0045165; P:cell fate commitment; IBA:RefGenome
Q9H1J7	WNT5B	Protein Wnt-5b	GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB
Q9H1J7	WNT5B	Protein Wnt-5b	GO:0002062; P:chondrocyte differentiation; IEP:UniProtKB
Q9H1J7	WNT5B	Protein Wnt-5b	GO:0045444; P:fat cell differentiation; NAS:UniProtKB
Q9H1J7	WNT5B	Protein Wnt-5b	GO:0070307; P:lens fiber cell development; ISS:BHF-UCL
Q9H1J7	WNT5B	Protein Wnt-5b	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IEA:Ensembl
Q9H1J7	WNT5B	Protein Wnt-5b	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q9H1J7	WNT5B	Protein Wnt-5b	GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB
Q9H1J7	WNT5B	Protein Wnt-5b	GO:0045600; P:positive regulation of fat cell differentiation; IEA:Ensembl
Q9H1J7	WNT5B	Protein Wnt-5b	GO:0016055; P:Wnt signaling pathway; IDA:UniProtKB
Q9H1J7	WNT5B	Protein Wnt-5b	GO:0042060; P:wound healing; IEA:Ensembl
Q9Y6F9	WNT6	Protein Wnt-6	GO:0005109; F:frizzled binding; IBA:RefGenome
Q9Y6F9	WNT6	Protein Wnt-6	GO:0009798; P:axis specification; IEA:Ensembl
Q9Y6F9	WNT6	Protein Wnt-6	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
Q9Y6F9	WNT6	Protein Wnt-6	GO:0045165; P:cell fate commitment; IBA:RefGenome
Q9Y6F9	WNT6	Protein Wnt-6	GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB
Q9Y6F9	WNT6	Protein Wnt-6	GO:0061303; P:cornea development in camera-type eye; ISS:BHF-UCL
Q9Y6F9	WNT6	Protein Wnt-6	GO:0060684; P:epithelial-mesenchymal cell signaling; IEA:Ensembl
Q9Y6F9	WNT6	Protein Wnt-6	GO:0072079; P:nephron tubule formation; IEA:Ensembl
Q9Y6F9	WNT6	Protein Wnt-6	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q9Y6F9	WNT6	Protein Wnt-6	GO:0042475; P:odontogenesis of dentin-containing tooth; IMP:BHF-UCL
Q9Y6F9	WNT6	Protein Wnt-6	GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL
Q9Y6F9	WNT6	Protein Wnt-6	GO:0070172; P:positive regulation of tooth mineralization; IMP:BHF-UCL
Q9Y6F9	WNT6	Protein Wnt-6	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q9Y6F9	WNT6	Protein Wnt-6	GO:0016055; P:Wnt signaling pathway; IBA:RefGenome
O00755	WNT7A	Protein Wnt-7a	GO:0005125; F:cytokine activity; IDA:BHF-UCL
O00755	WNT7A	Protein Wnt-7a	GO:0005109; F:frizzled binding; IBA:RefGenome
O00755	WNT7A	Protein Wnt-7a	GO:0048018; F:receptor agonist activity; IDA:BHF-UCL
O00755	WNT7A	Protein Wnt-7a	GO:0005102; F:receptor binding; IPI:BHF-UCL
O00755	WNT7A	Protein Wnt-7a	GO:0008105; P:asymmetric protein localization; IEA:Ensembl
O00755	WNT7A	Protein Wnt-7a	GO:0060070; P:canonical Wnt signaling pathway; IDA:BHF-UCL
O00755	WNT7A	Protein Wnt-7a	GO:0001502; P:cartilage condensation; IDA:AgBase
O00755	WNT7A	Protein Wnt-7a	GO:0045165; P:cell fate commitment; IBA:RefGenome
O00755	WNT7A	Protein Wnt-7a	GO:0021846; P:cell proliferation in forebrain; IDA:BHF-UCL
O00755	WNT7A	Protein Wnt-7a	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:UniProtKB
O00755	WNT7A	Protein Wnt-7a	GO:0022009; P:central nervous system vasculogenesis; IEA:Ensembl
O00755	WNT7A	Protein Wnt-7a	GO:0021707; P:cerebellar granule cell differentiation; IEA:Ensembl
O00755	WNT7A	Protein Wnt-7a	GO:0002062; P:chondrocyte differentiation; IDA:AgBase
O00755	WNT7A	Protein Wnt-7a	GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl
O00755	WNT7A	Protein Wnt-7a	GO:0000578; P:embryonic axis specification; IMP:BHF-UCL
O00755	WNT7A	Protein Wnt-7a	GO:0042733; P:embryonic digit morphogenesis; IMP:BHF-UCL
O00755	WNT7A	Protein Wnt-7a	GO:0035115; P:embryonic forelimb morphogenesis; IMP:BHF-UCL
O00755	WNT7A	Protein Wnt-7a	GO:0035116; P:embryonic hindlimb morphogenesis; IMP:BHF-UCL
O00755	WNT7A	Protein Wnt-7a	GO:0030010; P:establishment of cell polarity; IEA:Ensembl
O00755	WNT7A	Protein Wnt-7a	GO:0070307; P:lens fiber cell development; ISS:BHF-UCL
O00755	WNT7A	Protein Wnt-7a	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
O00755	WNT7A	Protein Wnt-7a	GO:0050768; P:negative regulation of neurogenesis; IDA:BHF-UCL
O00755	WNT7A	Protein Wnt-7a	GO:0030182; P:neuron differentiation; IBA:RefGenome
O00755	WNT7A	Protein Wnt-7a	GO:0007269; P:neurotransmitter secretion; IEA:Ensembl
O00755	WNT7A	Protein Wnt-7a	GO:0035567; P:non-canonical Wnt signaling pathway; IEA:Ensembl
O00755	WNT7A	Protein Wnt-7a	GO:0060066; P:oviduct development; IEA:Ensembl
O00755	WNT7A	Protein Wnt-7a	GO:0060021; P:palate development; IMP:BHF-UCL
O00755	WNT7A	Protein Wnt-7a	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl
O00755	WNT7A	Protein Wnt-7a	GO:0060054; P:positive regulation of epithelial cell proliferation involved in wound healing; IDA:BHF-UCL
O00755	WNT7A	Protein Wnt-7a	GO:0046330; P:positive regulation of JNK cascade; IBA:RefGenome
O00755	WNT7A	Protein Wnt-7a	GO:0051965; P:positive regulation of synapse assembly; IDA:BHF-UCL
O00755	WNT7A	Protein Wnt-7a	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
O00755	WNT7A	Protein Wnt-7a	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL
O00755	WNT7A	Protein Wnt-7a	GO:0031133; P:regulation of axon diameter; IEA:Ensembl
O00755	WNT7A	Protein Wnt-7a	GO:0032355; P:response to estradiol; IEA:Ensembl
O00755	WNT7A	Protein Wnt-7a	GO:0014719; P:satellite cell activation; IEA:Ensembl
O00755	WNT7A	Protein Wnt-7a	GO:0014834; P:satellite cell maintenance involved in skeletal muscle regeneration; IEA:Ensembl
O00755	WNT7A	Protein Wnt-7a	GO:0007548; P:sex differentiation; TAS:ProtInc
O00755	WNT7A	Protein Wnt-7a	GO:0048103; P:somatic stem cell division; IEA:Ensembl
O00755	WNT7A	Protein Wnt-7a	GO:0048864; P:stem cell development; IDA:BHF-UCL
O00755	WNT7A	Protein Wnt-7a	GO:0050808; P:synapse organization; IEA:Ensembl
O00755	WNT7A	Protein Wnt-7a	GO:0061038; P:uterus morphogenesis; IEA:Ensembl
O00755	WNT7A	Protein Wnt-7a	GO:0035659; P:Wnt signaling pathway involved in wound healing, spreading of epidermal cells; IDA:BHF-UCL
P56706	WNT7B	Protein Wnt-7b	GO:0005109; F:frizzled binding; IBA:RefGenome
P56706	WNT7B	Protein Wnt-7b	GO:0007257; P:activation of JUN kinase activity; IEA:Ensembl
P56706	WNT7B	Protein Wnt-7b	GO:0060033; P:anatomical structure regression; IEA:Ensembl
P56706	WNT7B	Protein Wnt-7b	GO:1902262; P:apoptotic process involved in patterning of blood vessels; IEA:Ensembl
P56706	WNT7B	Protein Wnt-7b	GO:0060070; P:canonical Wnt signaling pathway; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0045165; P:cell fate commitment; IBA:RefGenome
P56706	WNT7B	Protein Wnt-7b	GO:0044237; P:cellular metabolic process; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0071300; P:cellular response to retinoic acid; IEP:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0022009; P:central nervous system vasculogenesis; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0060710; P:chorio-allantoic fusion; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0060560; P:developmental growth involved in morphogenesis; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0048568; P:embryonic organ development; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0060669; P:embryonic placenta morphogenesis; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0016332; P:establishment or maintenance of polarity of embryonic epithelium; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0048144; P:fibroblast proliferation; IEP:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0021871; P:forebrain regionalization; IEP:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0042592; P:homeostatic process; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0001701; P:in utero embryonic development; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0072061; P:inner medullary collecting duct development; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0070307; P:lens fiber cell development; ISS:BHF-UCL
P56706	WNT7B	Protein Wnt-7b	GO:0060482; P:lobar bronchus development; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0030324; P:lung development; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0060428; P:lung epithelium development; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0060425; P:lung morphogenesis; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0060484; P:lung-associated mesenchyme development; IEA:Ensembl
P56706	WNT7B	Protein Wnt-7b	GO:0061180; P:mammary gland epithelium development; IEP:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0072205; P:metanephric collecting duct development; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0072207; P:metanephric epithelium development; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0072236; P:metanephric loop of Henle development; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0003338; P:metanephros morphogenesis; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0045879; P:negative regulation of smoothened signaling pathway; IEA:Ensembl
P56706	WNT7B	Protein Wnt-7b	GO:0030182; P:neuron differentiation; IEP:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0048812; P:neuron projection morphogenesis; IEA:Ensembl
P56706	WNT7B	Protein Wnt-7b	GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl
P56706	WNT7B	Protein Wnt-7b	GO:0072060; P:outer medullary collecting duct development; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0032364; P:oxygen homeostasis; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P56706	WNT7B	Protein Wnt-7b	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
P56706	WNT7B	Protein Wnt-7b	GO:0046330; P:positive regulation of JNK cascade; IBA:RefGenome
P56706	WNT7B	Protein Wnt-7b	GO:0045669; P:positive regulation of osteoblast differentiation; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0032536; P:regulation of cell projection size; IEA:Ensembl
P56706	WNT7B	Protein Wnt-7b	GO:0072053; P:renal inner medulla development; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0072054; P:renal outer medulla development; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0051384; P:response to glucocorticoid; IEA:Ensembl
P56706	WNT7B	Protein Wnt-7b	GO:0051145; P:smooth muscle cell differentiation; IEA:Ensembl
P56706	WNT7B	Protein Wnt-7b	GO:0072089; P:stem cell proliferation; IEP:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0050808; P:synapse organization; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0060535; P:trachea cartilage morphogenesis; ISS:UniProtKB
P56706	WNT7B	Protein Wnt-7b	GO:0016055; P:Wnt signaling pathway; ISS:UniProtKB
Q9H1J5	WNT8A	Protein Wnt-8a	GO:0005109; F:frizzled binding; NAS:BHF-UCL
Q9H1J5	WNT8A	Protein Wnt-8a	GO:0048018; F:receptor agonist activity; NAS:BHF-UCL
Q9H1J5	WNT8A	Protein Wnt-8a	GO:0060070; P:canonical Wnt signaling pathway; ISS:BHF-UCL
Q9H1J5	WNT8A	Protein Wnt-8a	GO:0061317; P:canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment; IEP:BHF-UCL
Q9H1J5	WNT8A	Protein Wnt-8a	GO:0044335; P:canonical Wnt signaling pathway involved in neural crest cell differentiation; ISS:BHF-UCL
Q9H1J5	WNT8A	Protein Wnt-8a	GO:0007492; P:endoderm development; IEA:Ensembl
Q9H1J5	WNT8A	Protein Wnt-8a	GO:0048561; P:establishment of organ orientation; IEA:Ensembl
Q9H1J5	WNT8A	Protein Wnt-8a	GO:0014034; P:neural crest cell fate commitment; ISS:BHF-UCL
Q9H1J5	WNT8A	Protein Wnt-8a	GO:0030182; P:neuron differentiation; IBA:RefGenome
Q9H1J5	WNT8A	Protein Wnt-8a	GO:0060021; P:palate development; IMP:BHF-UCL
Q9H1J5	WNT8A	Protein Wnt-8a	GO:0009949; P:polarity specification of anterior/posterior axis; IEA:Ensembl
Q9H1J5	WNT8A	Protein Wnt-8a	GO:0010085; P:polarity specification of proximal/distal axis; IEA:Ensembl
Q9H1J5	WNT8A	Protein Wnt-8a	GO:0032880; P:regulation of protein localization; IEA:Ensembl
Q9H1J5	WNT8A	Protein Wnt-8a	GO:0044324; P:regulation of transcription involved in anterior/posterior axis specification; ISS:BHF-UCL
Q9H1J5	WNT8A	Protein Wnt-8a	GO:0032526; P:response to retinoic acid; NAS:BHF-UCL
Q93098	WNT8B	Protein Wnt-8b	GO:0005109; F:frizzled binding; IBA:RefGenome
Q93098	WNT8B	Protein Wnt-8b	GO:0045165; P:cell fate commitment; IBA:RefGenome
Q93098	WNT8B	Protein Wnt-8b	GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB
Q93098	WNT8B	Protein Wnt-8b	GO:0048263; P:determination of dorsal identity; ISS:BHF-UCL
Q93098	WNT8B	Protein Wnt-8b	GO:0007369; P:gastrulation; ISS:BHF-UCL
Q93098	WNT8B	Protein Wnt-8b	GO:0010629; P:negative regulation of gene expression; IEA:Ensembl
Q93098	WNT8B	Protein Wnt-8b	GO:0007399; P:nervous system development; TAS:ProtInc
Q93098	WNT8B	Protein Wnt-8b	GO:0030182; P:neuron differentiation; ISS:UniProtKB
Q93098	WNT8B	Protein Wnt-8b	GO:0010628; P:positive regulation of gene expression; IEA:Ensembl
Q93098	WNT8B	Protein Wnt-8b	GO:0032355; P:response to estradiol; NAS:BHF-UCL
Q93098	WNT8B	Protein Wnt-8b	GO:0032526; P:response to retinoic acid; NAS:BHF-UCL
Q93098	WNT8B	Protein Wnt-8b	GO:0007165; P:signal transduction; TAS:ProtInc
Q93098	WNT8B	Protein Wnt-8b	GO:0016055; P:Wnt signaling pathway; IBA:RefGenome
O14904	WNT9A	Protein Wnt-9a	GO:0005109; F:frizzled binding; IBA:RefGenome
O14904	WNT9A	Protein Wnt-9a	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
O14904	WNT9A	Protein Wnt-9a	GO:0045165; P:cell fate commitment; IBA:RefGenome
O14904	WNT9A	Protein Wnt-9a	GO:0007267; P:cell-cell signaling; NAS:UniProtKB
O14904	WNT9A	Protein Wnt-9a	GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB
O14904	WNT9A	Protein Wnt-9a	GO:0061303; P:cornea development in camera-type eye; ISS:BHF-UCL
O14904	WNT9A	Protein Wnt-9a	GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl
O14904	WNT9A	Protein Wnt-9a	GO:0072498; P:embryonic skeletal joint development; ISS:BHF-UCL
O14904	WNT9A	Protein Wnt-9a	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
O14904	WNT9A	Protein Wnt-9a	GO:0061072; P:iris morphogenesis; ISS:BHF-UCL
O14904	WNT9A	Protein Wnt-9a	GO:0007093; P:mitotic cell cycle checkpoint; IMP:BHF-UCL
O14904	WNT9A	Protein Wnt-9a	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
O14904	WNT9A	Protein Wnt-9a	GO:0061037; P:negative regulation of cartilage development; IEA:Ensembl
O14904	WNT9A	Protein Wnt-9a	GO:0060548; P:negative regulation of cell death; IEA:Ensembl
O14904	WNT9A	Protein Wnt-9a	GO:0008285; P:negative regulation of cell proliferation; IMP:BHF-UCL
O14904	WNT9A	Protein Wnt-9a	GO:0032331; P:negative regulation of chondrocyte differentiation; ISS:BHF-UCL
O14904	WNT9A	Protein Wnt-9a	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl
O14904	WNT9A	Protein Wnt-9a	GO:0030182; P:neuron differentiation; ISS:UniProtKB
O14904	WNT9A	Protein Wnt-9a	GO:0045597; P:positive regulation of cell differentiation; IEA:Ensembl
O14904	WNT9A	Protein Wnt-9a	GO:0045880; P:positive regulation of smoothened signaling pathway; IEA:Ensembl
O14904	WNT9A	Protein Wnt-9a	GO:0016055; P:Wnt signaling pathway; IBA:RefGenome
O14905	WNT9B	Protein Wnt-9b	GO:0005109; F:frizzled binding; IBA:RefGenome
O14905	WNT9B	Protein Wnt-9b	GO:0001658; P:branching involved in ureteric bud morphogenesis; IEA:Ensembl
O14905	WNT9B	Protein Wnt-9b	GO:0045165; P:cell fate commitment; IBA:RefGenome
O14905	WNT9B	Protein Wnt-9b	GO:0007267; P:cell-cell signaling; NAS:UniProtKB
O14905	WNT9B	Protein Wnt-9b	GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB
O14905	WNT9B	Protein Wnt-9b	GO:0072044; P:collecting duct development; IEA:Ensembl
O14905	WNT9B	Protein Wnt-9b	GO:0061303; P:cornea development in camera-type eye; ISS:BHF-UCL
O14905	WNT9B	Protein Wnt-9b	GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl
O14905	WNT9B	Protein Wnt-9b	GO:0072046; P:establishment of planar polarity involved in nephron morphogenesis; IEA:Ensembl
O14905	WNT9B	Protein Wnt-9b	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O14905	WNT9B	Protein Wnt-9b	GO:0072003; P:kidney rudiment formation; IEA:Ensembl
O14905	WNT9B	Protein Wnt-9b	GO:0030539; P:male genitalia development; IEA:Ensembl
O14905	WNT9B	Protein Wnt-9b	GO:0072181; P:mesonephric duct formation; IEA:Ensembl
O14905	WNT9B	Protein Wnt-9b	GO:0072170; P:metanephric tubule development; IEA:Ensembl
O14905	WNT9B	Protein Wnt-9b	GO:0007275; P:multicellular organismal development; NAS:UniProtKB
O14905	WNT9B	Protein Wnt-9b	GO:0030182; P:neuron differentiation; ISS:UniProtKB
O14905	WNT9B	Protein Wnt-9b	GO:0060021; P:palate development; IEA:Ensembl
O14905	WNT9B	Protein Wnt-9b	GO:0043085; P:positive regulation of catalytic activity; IEA:Ensembl
O14905	WNT9B	Protein Wnt-9b	GO:0009786; P:regulation of asymmetric cell division; IEA:Ensembl
O14905	WNT9B	Protein Wnt-9b	GO:0003339; P:regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; IEA:Ensembl
O14905	WNT9B	Protein Wnt-9b	GO:0001932; P:regulation of protein phosphorylation; IEA:Ensembl
O14905	WNT9B	Protein Wnt-9b	GO:0035150; P:regulation of tube size; IEA:Ensembl
O14905	WNT9B	Protein Wnt-9b	GO:0032526; P:response to retinoic acid; NAS:BHF-UCL
O14905	WNT9B	Protein Wnt-9b	GO:0061038; P:uterus morphogenesis; IEA:Ensembl
O14905	WNT9B	Protein Wnt-9b	GO:0016055; P:Wnt signaling pathway; IBA:RefGenome
O14905	WNT9B	Protein Wnt-9b	GO:0060071; P:Wnt signaling pathway, planar cell polarity pathway; IEA:Ensembl
Q96S55	WRNIP1	ATPase WRNIP1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96S55	WRNIP1	ATPase WRNIP1	GO:0016887; F:ATPase activity; IMP:UniProtKB
Q96S55	WRNIP1	ATPase WRNIP1	GO:0003677; F:DNA binding; IEA:InterPro
Q96S55	WRNIP1	ATPase WRNIP1	GO:0042802; F:identical protein binding; IPI:IntAct
Q96S55	WRNIP1	ATPase WRNIP1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96S55	WRNIP1	ATPase WRNIP1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96S55	WRNIP1	ATPase WRNIP1	GO:0006200; P:ATP catabolic process; IMP:GOC
Q96S55	WRNIP1	ATPase WRNIP1	GO:0006260; P:DNA replication; IEA:UniProtKB-KW
Q96S55	WRNIP1	ATPase WRNIP1	GO:0000731; P:DNA synthesis involved in DNA repair; IDA:UniProtKB
Q96S55	WRNIP1	ATPase WRNIP1	GO:0030174; P:regulation of DNA-dependent DNA replication initiation; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0043138; F:3'-5' DNA helicase activity; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0008408; F:3'-5' exonuclease activity; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0043140; F:ATP-dependent 3'-5' DNA helicase activity; IEA:InterPro
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0004003; F:ATP-dependent DNA helicase activity; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0016887; F:ATPase activity; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0000405; F:bubble DNA binding; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0003677; F:DNA binding; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0003678; F:DNA helicase activity; IMP:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0004527; F:exonuclease activity; IDA:MGI
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0009378; F:four-way junction helicase activity; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0051880; F:G-quadruplex DNA binding; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0004386; F:helicase activity; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0000287; F:magnesium ion binding; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0030145; F:manganese ion binding; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0005515; F:protein binding; IPI:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0032403; F:protein complex binding; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0000403; F:Y-form DNA binding; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0007568; P:aging; NAS:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0006200; P:ATP catabolic process; IDA:GOC
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0006284; P:base-excision repair; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0007569; P:cell aging; IMP:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0071480; P:cellular response to gamma radiation; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0009267; P:cellular response to starvation; IDA:MGI
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0032508; P:DNA duplex unwinding; IDA:GOC
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0006259; P:DNA metabolic process; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0006310; P:DNA recombination; IEA:InterPro
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0006260; P:DNA replication; IMP:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0000731; P:DNA synthesis involved in DNA repair; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0006302; P:double-strand break repair; IMP:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0010259; P:multicellular organismal aging; IMP:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IDA:GOC
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0032066; P:nucleolus to nucleoplasm transport; IDA:MGI
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0051345; P:positive regulation of hydrolase activity; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0042981; P:regulation of apoptotic process; IGI:MGI
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0040009; P:regulation of growth rate; IEA:Ensembl
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0031297; P:replication fork processing; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0001302; P:replicative cell aging; IEA:Ensembl
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0006979; P:response to oxidative stress; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0010225; P:response to UV-C; IDA:UniProtKB
Q14191	WRN	Werner syndrome ATP-dependent helicase	GO:0000723; P:telomere maintenance; IMP:UniProtKB
Q9Y6I7	WSB1	WD repeat and SOCS box-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9Y6I7	WSB1	WD repeat and SOCS box-containing protein 1	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9Y6I7	WSB1	WD repeat and SOCS box-containing protein 1	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9NYS7	WSB2	WD repeat and SOCS box-containing protein 2	GO:0035556; P:intracellular signal transduction; IEA:InterPro
Q9NYS7	WSB2	WD repeat and SOCS box-containing protein 2	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q658N2	WSCD1	WSC domain-containing protein 1	GO:0008146; F:sulfotransferase activity; IEA:InterPro
Q8N9V3	WDSUB1	WD repeat, SAM and U-box domain-containing protein 1	GO:0004842; F:ubiquitin-protein ligase activity; IEA:InterPro
P19544	WT1	Wilms tumor protein	GO:0070742; F:C2H2 zinc finger domain binding; IPI:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0005515; F:protein binding; IPI:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
P19544	WT1	Wilms tumor protein	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0008270; F:zinc ion binding; IDA:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0035802; P:adrenal cortex formation; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0030325; P:adrenal gland development; IGI:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0006309; P:apoptotic DNA fragmentation; IDA:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0001658; P:branching involved in ureteric bud morphogenesis; IGI:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0043010; P:camera-type eye development; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0060923; P:cardiac muscle cell fate commitment; ISS:BHF-UCL
P19544	WT1	Wilms tumor protein	GO:0071320; P:cellular response to cAMP; IEP:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0071371; P:cellular response to gonadotropin stimulus; IDA:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0060539; P:diaphragm development; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0030855; P:epithelial cell differentiation; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0007281; P:germ cell development; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0032836; P:glomerular basement membrane development; IMP:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0072112; P:glomerular visceral epithelial cell differentiation; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0032835; P:glomerulus development; IGI:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0008406; P:gonad development; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0007507; P:heart development; IGI:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0001822; P:kidney development; IGI:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0030539; P:male genitalia development; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0008584; P:male gonad development; IEP:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0060231; P:mesenchymal to epithelial transition; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0072207; P:metanephric epithelium development; IEP:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0072075; P:metanephric mesenchyme development; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0072284; P:metanephric S-shaped body morphogenesis; IGI:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0043066; P:negative regulation of apoptotic process; IGI:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
P19544	WT1	Wilms tumor protein	GO:2000195; P:negative regulation of female gonad development; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0072302; P:negative regulation of metanephric glomerular mesangial cell proliferation; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:MGI
P19544	WT1	Wilms tumor protein	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0017148; P:negative regulation of translation; IDA:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0060421; P:positive regulation of heart growth; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:2000020; P:positive regulation of male gonad development; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:2001076; P:positive regulation of metanephric ureteric bud development; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:GOC
P19544	WT1	Wilms tumor protein	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0072166; P:posterior mesonephric tubule development; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0003156; P:regulation of organ formation; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0006355; P:regulation of transcription, DNA-templated; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0008380; P:RNA splicing; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0007530; P:sex determination; IDA:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0007356; P:thorax and anterior abdomen determination; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0009888; P:tissue development; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0001657; P:ureteric bud development; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0001570; P:vasculogenesis; ISS:UniProtKB
P19544	WT1	Wilms tumor protein	GO:0061032; P:visceral serous pericardium development; IGI:UniProtKB
A6NIX2	WTIP	Wilms tumor protein 1-interacting protein	GO:0005515; F:protein binding; IPI:UniProtKB
A6NIX2	WTIP	Wilms tumor protein 1-interacting protein	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
A6NIX2	WTIP	Wilms tumor protein 1-interacting protein	GO:0008270; F:zinc ion binding; IEA:InterPro
A6NIX2	WTIP	Wilms tumor protein 1-interacting protein	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
A6NIX2	WTIP	Wilms tumor protein 1-interacting protein	GO:0035195; P:gene silencing by miRNA; IMP:MGI
A6NIX2	WTIP	Wilms tumor protein 1-interacting protein	GO:0035331; P:negative regulation of hippo signaling; IDA:UniProtKB
A6NIX2	WTIP	Wilms tumor protein 1-interacting protein	GO:2000637; P:positive regulation of gene silencing by miRNA; IMP:UniProtKB
A6NIX2	WTIP	Wilms tumor protein 1-interacting protein	GO:0022604; P:regulation of cell morphogenesis; IMP:UniProtKB
A6NIX2	WTIP	Wilms tumor protein 1-interacting protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A6NIX2	WTIP	Wilms tumor protein 1-interacting protein	GO:0001666; P:response to hypoxia; IDA:UniProtKB
A6NIX2	WTIP	Wilms tumor protein 1-interacting protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NZC7	WWOX	WW domain-containing oxidoreductase	GO:0050662; F:coenzyme binding; TAS:UniProtKB
Q9NZC7	WWOX	WW domain-containing oxidoreductase	GO:0048037; F:cofactor binding; TAS:UniProtKB
Q9NZC7	WWOX	WW domain-containing oxidoreductase	GO:0019899; F:enzyme binding; IPI:BHF-UCL
Q9NZC7	WWOX	WW domain-containing oxidoreductase	GO:0016491; F:oxidoreductase activity; NAS:UniProtKB
Q9NZC7	WWOX	WW domain-containing oxidoreductase	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NZC7	WWOX	WW domain-containing oxidoreductase	GO:0046983; F:protein dimerization activity; TAS:UniProtKB
Q9NZC7	WWOX	WW domain-containing oxidoreductase	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IDA:BHF-UCL
Q9NZC7	WWOX	WW domain-containing oxidoreductase	GO:0097191; P:extrinsic apoptotic signaling pathway; IEA:Ensembl
Q9NZC7	WWOX	WW domain-containing oxidoreductase	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IEA:Ensembl
Q9NZC7	WWOX	WW domain-containing oxidoreductase	GO:0030178; P:negative regulation of Wnt signaling pathway; IDA:UniProtKB
Q9NZC7	WWOX	WW domain-containing oxidoreductase	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
Q9NZC7	WWOX	WW domain-containing oxidoreductase	GO:0055114; P:oxidation-reduction process; TAS:UniProtKB
Q9NZC7	WWOX	WW domain-containing oxidoreductase	GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; ISS:BHF-UCL
Q9NZC7	WWOX	WW domain-containing oxidoreductase	GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
Q9NZC7	WWOX	WW domain-containing oxidoreductase	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL
Q9NZC7	WWOX	WW domain-containing oxidoreductase	GO:0048705; P:skeletal system morphogenesis; ISS:BHF-UCL
Q9NZC7	WWOX	WW domain-containing oxidoreductase	GO:0008202; P:steroid metabolic process; TAS:UniProtKB
Q9NZC7	WWOX	WW domain-containing oxidoreductase	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9H0M0	WWP1	NEDD4-like E3 ubiquitin-protein ligase WWP1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H0M0	WWP1	NEDD4-like E3 ubiquitin-protein ligase WWP1	GO:0004842; F:ubiquitin-protein ligase activity; TAS:UniProtKB
Q9H0M0	WWP1	NEDD4-like E3 ubiquitin-protein ligase WWP1	GO:0007417; P:central nervous system development; NAS:UniProtKB
Q9H0M0	WWP1	NEDD4-like E3 ubiquitin-protein ligase WWP1	GO:0034220; P:ion transmembrane transport; TAS:Reactome
Q9H0M0	WWP1	NEDD4-like E3 ubiquitin-protein ligase WWP1	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q9H0M0	WWP1	NEDD4-like E3 ubiquitin-protein ligase WWP1	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:Ensembl
Q9H0M0	WWP1	NEDD4-like E3 ubiquitin-protein ligase WWP1	GO:0016567; P:protein ubiquitination; TAS:UniProtKB
Q9H0M0	WWP1	NEDD4-like E3 ubiquitin-protein ligase WWP1	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:RefGenome
Q9H0M0	WWP1	NEDD4-like E3 ubiquitin-protein ligase WWP1	GO:0007165; P:signal transduction; NAS:UniProtKB
Q9H0M0	WWP1	NEDD4-like E3 ubiquitin-protein ligase WWP1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9H0M0	WWP1	NEDD4-like E3 ubiquitin-protein ligase WWP1	GO:0046718; P:viral entry into host cell; TAS:UniProtKB
O00308	WWP2	NEDD4-like E3 ubiquitin-protein ligase WWP2	GO:0005515; F:protein binding; IPI:UniProtKB
O00308	WWP2	NEDD4-like E3 ubiquitin-protein ligase WWP2	GO:0001085; F:RNA polymerase II transcription factor binding; IPI:BHF-UCL
O00308	WWP2	NEDD4-like E3 ubiquitin-protein ligase WWP2	GO:0008134; F:transcription factor binding; IPI:UniProtKB
O00308	WWP2	NEDD4-like E3 ubiquitin-protein ligase WWP2	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
O00308	WWP2	NEDD4-like E3 ubiquitin-protein ligase WWP2	GO:0006464; P:cellular protein modification process; TAS:ProtInc
O00308	WWP2	NEDD4-like E3 ubiquitin-protein ligase WWP2	GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB
O00308	WWP2	NEDD4-like E3 ubiquitin-protein ligase WWP2	GO:0051224; P:negative regulation of protein transport; IMP:UniProtKB
O00308	WWP2	NEDD4-like E3 ubiquitin-protein ligase WWP2	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; ISS:BHF-UCL
O00308	WWP2	NEDD4-like E3 ubiquitin-protein ligase WWP2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
O00308	WWP2	NEDD4-like E3 ubiquitin-protein ligase WWP2	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:BHF-UCL
O00308	WWP2	NEDD4-like E3 ubiquitin-protein ligase WWP2	GO:0032410; P:negative regulation of transporter activity; IDA:UniProtKB
O00308	WWP2	NEDD4-like E3 ubiquitin-protein ligase WWP2	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB
O00308	WWP2	NEDD4-like E3 ubiquitin-protein ligase WWP2	GO:0051865; P:protein autoubiquitination; IDA:FlyBase
O00308	WWP2	NEDD4-like E3 ubiquitin-protein ligase WWP2	GO:0070534; P:protein K63-linked ubiquitination; ISS:UniProtKB
O00308	WWP2	NEDD4-like E3 ubiquitin-protein ligase WWP2	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
O00308	WWP2	NEDD4-like E3 ubiquitin-protein ligase WWP2	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IBA:RefGenome
O00308	WWP2	NEDD4-like E3 ubiquitin-protein ligase WWP2	GO:0034765; P:regulation of ion transmembrane transport; IDA:BHF-UCL
O00308	WWP2	NEDD4-like E3 ubiquitin-protein ligase WWP2	GO:0042391; P:regulation of membrane potential; IDA:BHF-UCL
O00308	WWP2	NEDD4-like E3 ubiquitin-protein ligase WWP2	GO:1901016; P:regulation of potassium ion transmembrane transporter activity; IDA:BHF-UCL
O00308	WWP2	NEDD4-like E3 ubiquitin-protein ligase WWP2	GO:0046718; P:viral entry into host cell; TAS:UniProtKB
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0060271; P:cilium morphogenesis; IEA:Ensembl
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0010467; P:gene expression; TAS:Reactome
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0032835; P:glomerulus development; IEA:Ensembl
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0035329; P:hippo signaling; IDA:UniProtKB
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:BHF-UCL
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0035414; P:negative regulation of catenin import into nucleus; IMP:BHF-UCL
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0045599; P:negative regulation of fat cell differentiation; IEA:Ensembl
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0006469; P:negative regulation of protein kinase activity; IMP:BHF-UCL
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0001933; P:negative regulation of protein phosphorylation; IMP:BHF-UCL
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0001649; P:osteoblast differentiation; IEA:Ensembl
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IDA:UniProtKB
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0060390; P:regulation of SMAD protein import into nucleus; IDA:UniProtKB
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0017145; P:stem cell division; IDA:UniProtKB
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0006351; P:transcription, DNA-templated; TAS:Reactome
Q9GZV5	WWTR1	WW domain-containing transcription regulator protein 1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
P78423	CX3CL1	Fractalkine	GO:0008009; F:chemokine activity; IDA:UniProtKB
P78423	CX3CL1	Fractalkine	GO:0005515; F:protein binding; IPI:UniProtKB
P78423	CX3CL1	Fractalkine	GO:0005102; F:receptor binding; TAS:UniProtKB
P78423	CX3CL1	Fractalkine	GO:0060055; P:angiogenesis involved in wound healing; IEA:Ensembl
P78423	CX3CL1	Fractalkine	GO:0007155; P:cell adhesion; IEA:UniProtKB-KW
P78423	CX3CL1	Fractalkine	GO:0006935; P:chemotaxis; IDA:UniProtKB
P78423	CX3CL1	Fractalkine	GO:0019221; P:cytokine-mediated signaling pathway; TAS:UniProtKB
P78423	CX3CL1	Fractalkine	GO:0006952; P:defense response; TAS:UniProtKB
P78423	CX3CL1	Fractalkine	GO:0006955; P:immune response; TAS:UniProtKB
P78423	CX3CL1	Fractalkine	GO:0050902; P:leukocyte adhesive activation; TAS:UniProtKB
P78423	CX3CL1	Fractalkine	GO:0030595; P:leukocyte chemotaxis; TAS:UniProtKB
P78423	CX3CL1	Fractalkine	GO:0048247; P:lymphocyte chemotaxis; IEA:Ensembl
P78423	CX3CL1	Fractalkine	GO:0048246; P:macrophage chemotaxis; IEA:Ensembl
P78423	CX3CL1	Fractalkine	GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl
P78423	CX3CL1	Fractalkine	GO:0030593; P:neutrophil chemotaxis; IEA:Ensembl
P78423	CX3CL1	Fractalkine	GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl
P78423	CX3CL1	Fractalkine	GO:0051041; P:positive regulation of calcium-independent cell-cell adhesion; IDA:UniProtKB
P78423	CX3CL1	Fractalkine	GO:0050729; P:positive regulation of inflammatory response; IEP:UniProtKB
P78423	CX3CL1	Fractalkine	GO:0032914; P:positive regulation of transforming growth factor beta1 production; IEA:Ensembl
Q6GPH4	XAF1	XIAP-associated factor 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6GPH4	XAF1	XIAP-associated factor 1	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q6GPH4	XAF1	XIAP-associated factor 1	GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome
Q6GPH4	XAF1	XIAP-associated factor 1	GO:0031333; P:negative regulation of protein complex assembly; IEA:Ensembl
Q6GPH4	XAF1	XIAP-associated factor 1	GO:0035456; P:response to interferon-beta; IDA:BHF-UCL
Q6GPH4	XAF1	XIAP-associated factor 1	GO:0060337; P:type I interferon signaling pathway; TAS:Reactome
Q8WTP9	XAGE3	X antigen family member 3	GO:0005515; F:protein binding; IPI:IntAct
P17861	XBP1	X-box-binding protein 1	GO:0003677; F:DNA binding; TAS:ProtInc
P17861	XBP1	X-box-binding protein 1	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
P17861	XBP1	X-box-binding protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P17861	XBP1	X-box-binding protein 1	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
P17861	XBP1	X-box-binding protein 1	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
P17861	XBP1	X-box-binding protein 1	GO:0071236; P:cellular response to antibiotic; IEA:Ensembl
P17861	XBP1	X-box-binding protein 1	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
P17861	XBP1	X-box-binding protein 1	GO:0060691; P:epithelial cell maturation involved in salivary gland development; IEA:Ensembl
P17861	XBP1	X-box-binding protein 1	GO:0031017; P:exocrine pancreas development; IEA:Ensembl
P17861	XBP1	X-box-binding protein 1	GO:0006955; P:immune response; TAS:ProtInc
P17861	XBP1	X-box-binding protein 1	GO:1900103; P:positive regulation of endoplasmic reticulum unfolded protein response; IMP:UniProtKB
P17861	XBP1	X-box-binding protein 1	GO:0042493; P:response to drug; IEA:Ensembl
P17861	XBP1	X-box-binding protein 1	GO:0051602; P:response to electrical stimulus; IEA:Ensembl
P17861	XBP1	X-box-binding protein 1	GO:0060096; P:serotonin secretion, neurotransmission; IEA:Ensembl
P17861	XBP1	X-box-binding protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; IEA:Ensembl
P47992	XCL1	Lymphotactin	GO:0008009; F:chemokine activity; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0042379; F:chemokine receptor binding; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0007267; P:cell-cell signaling; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0071353; P:cellular response to interleukin-4; ISS:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0071560; P:cellular response to transforming growth factor beta stimulus; ISS:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0006955; P:immune response; IEA:InterPro
P47992	XCL1	Lymphotactin	GO:0035782; P:mature natural killer cell chemotaxis; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:2000562; P:negative regulation of CD4-positive, alpha-beta T cell proliferation; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0032689; P:negative regulation of interferon-gamma production; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0032703; P:negative regulation of interleukin-2 production; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0002725; P:negative regulation of T cell cytokine production; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:2000518; P:negative regulation of T-helper 1 cell activation; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0002826; P:negative regulation of T-helper 1 type immune response; IC:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0030593; P:neutrophil chemotaxis; TAS:BHF-UCL
P47992	XCL1	Lymphotactin	GO:2000538; P:positive regulation of B cell chemotaxis; ISS:BHF-UCL
P47992	XCL1	Lymphotactin	GO:2000563; P:positive regulation of CD4-positive, alpha-beta T cell proliferation; ISS:BHF-UCL
P47992	XCL1	Lymphotactin	GO:2000566; P:positive regulation of CD8-positive, alpha-beta T cell proliferation; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:2000513; P:positive regulation of granzyme A production; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0071663; P:positive regulation of granzyme B production; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:2000558; P:positive regulation of immunoglobulin production in mucosal tissue; ISS:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0032733; P:positive regulation of interleukin-10 production; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0002690; P:positive regulation of leukocyte chemotaxis; ISS:BHF-UCL
P47992	XCL1	Lymphotactin	GO:2000503; P:positive regulation of natural killer cell chemotaxis; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0090023; P:positive regulation of neutrophil chemotaxis; ISS:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0010820; P:positive regulation of T cell chemotaxis; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0002726; P:positive regulation of T cell cytokine production; ISS:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:2000556; P:positive regulation of T-helper 1 cell cytokine production; ISS:BHF-UCL
P47992	XCL1	Lymphotactin	GO:2000553; P:positive regulation of T-helper 2 cell cytokine production; ISS:BHF-UCL
P47992	XCL1	Lymphotactin	GO:2000412; P:positive regulation of thymocyte migration; ISS:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0071636; P:positive regulation of transforming growth factor beta production; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0050727; P:regulation of inflammatory response; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0051209; P:release of sequestered calcium ion into cytosol; ISS:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0009615; P:response to virus; IDA:BHF-UCL
P47992	XCL1	Lymphotactin	GO:0007165; P:signal transduction; IC:BHF-UCL
Q9UBD3	XCL2	Cytokine SCM-1 beta	GO:0008009; F:chemokine activity; TAS:ProtInc
Q9UBD3	XCL2	Cytokine SCM-1 beta	GO:0008015; P:blood circulation; TAS:ProtInc
Q9UBD3	XCL2	Cytokine SCM-1 beta	GO:0060326; P:cell chemotaxis; TAS:GOC
Q9UBD3	XCL2	Cytokine SCM-1 beta	GO:0006955; P:immune response; IEA:InterPro
Q9UBD3	XCL2	Cytokine SCM-1 beta	GO:0007165; P:signal transduction; TAS:ProtInc
P46094	XCR1	Chemokine XC receptor 1	GO:0004950; F:chemokine receptor activity; TAS:ProtInc
P46094	XCR1	Chemokine XC receptor 1	GO:0070098; P:chemokine-mediated signaling pathway; TAS:GOC
P46094	XCR1	Chemokine XC receptor 1	GO:0006935; P:chemotaxis; TAS:ProtInc
P46094	XCR1	Chemokine XC receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P46094	XCR1	Chemokine XC receptor 1	GO:0007187; P:G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; TAS:ProtInc
P46094	XCR1	Chemokine XC receptor 1	GO:0006954; P:inflammatory response; TAS:ProtInc
P46094	XCR1	Chemokine XC receptor 1	GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc
P46094	XCR1	Chemokine XC receptor 1	GO:0051209; P:release of sequestered calcium ion into cytosol; IEA:Ensembl
Q9UPY5	SLC7A11	Cystine/glutamate transporter	GO:0015327; F:cystine:glutamate antiporter activity; TAS:ProtInc
Q9UPY5	SLC7A11	Cystine/glutamate transporter	GO:0005515; F:protein binding; IPI:IntAct
Q9UPY5	SLC7A11	Cystine/glutamate transporter	GO:0006865; P:amino acid transport; TAS:Reactome
Q9UPY5	SLC7A11	Cystine/glutamate transporter	GO:0007596; P:blood coagulation; TAS:Reactome
Q9UPY5	SLC7A11	Cystine/glutamate transporter	GO:0007420; P:brain development; IEA:Ensembl
Q9UPY5	SLC7A11	Cystine/glutamate transporter	GO:0006811; P:ion transport; TAS:Reactome
Q9UPY5	SLC7A11	Cystine/glutamate transporter	GO:0015813; P:L-glutamate transport; TAS:GOC
Q9UPY5	SLC7A11	Cystine/glutamate transporter	GO:0070306; P:lens fiber cell differentiation; IEA:Ensembl
Q9UPY5	SLC7A11	Cystine/glutamate transporter	GO:0050900; P:leukocyte migration; TAS:Reactome
Q9UPY5	SLC7A11	Cystine/glutamate transporter	GO:0070527; P:platelet aggregation; IEA:Ensembl
Q9UPY5	SLC7A11	Cystine/glutamate transporter	GO:0035094; P:response to nicotine; IEA:Ensembl
Q9UPY5	SLC7A11	Cystine/glutamate transporter	GO:0006979; P:response to oxidative stress; IEA:Ensembl
Q9UPY5	SLC7A11	Cystine/glutamate transporter	GO:0009636; P:response to toxic substance; IDA:UniProtKB
Q9UPY5	SLC7A11	Cystine/glutamate transporter	GO:0055085; P:transmembrane transport; TAS:Reactome
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0051537; F:2 iron, 2 sulfur cluster binding; IDA:UniProtKB
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0009055; F:electron carrier activity; IEA:InterPro
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0005506; F:iron ion binding; IEA:InterPro
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0043546; F:molybdopterin cofactor binding; IDA:UniProtKB
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0008762; F:UDP-N-acetylmuramate dehydrogenase activity; IEA:InterPro
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0004854; F:xanthine dehydrogenase activity; IDA:UniProtKB
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0004855; F:xanthine oxidase activity; IDA:UniProtKB
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0007595; P:lactation; IEA:Ensembl
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0045602; P:negative regulation of endothelial cell differentiation; IDA:UniProtKB
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0001937; P:negative regulation of endothelial cell proliferation; IDA:UniProtKB
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0051898; P:negative regulation of protein kinase B signaling; IDA:UniProtKB
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0001933; P:negative regulation of protein phosphorylation; IDA:UniProtKB
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:1900747; P:negative regulation of vascular endothelial growth factor signaling pathway; IDA:UniProtKB
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:2001213; P:negative regulation of vasculogenesis; IDA:UniProtKB
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:1900745; P:positive regulation of p38MAPK cascade; IDA:UniProtKB
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IDA:UniProtKB
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0006144; P:purine nucleobase metabolic process; TAS:Reactome
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0006195; P:purine nucleotide catabolic process; TAS:Reactome
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0044281; P:small molecule metabolic process; TAS:Reactome
P47989	XDH	Xanthine dehydrogenase/oxidase	GO:0009115; P:xanthine catabolic process; IDA:UniProtKB
P98170	XIAP	E3 ubiquitin-protein ligase XIAP	GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IDA:ProtInc
P98170	XIAP	E3 ubiquitin-protein ligase XIAP	GO:0005515; F:protein binding; IPI:UniProtKB
P98170	XIAP	E3 ubiquitin-protein ligase XIAP	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
P98170	XIAP	E3 ubiquitin-protein ligase XIAP	GO:0008270; F:zinc ion binding; IEA:InterPro
P98170	XIAP	E3 ubiquitin-protein ligase XIAP	GO:0006915; P:apoptotic process; TAS:Reactome
P98170	XIAP	E3 ubiquitin-protein ligase XIAP	GO:0006974; P:cellular response to DNA damage stimulus; IEP:UniProtKB
P98170	XIAP	E3 ubiquitin-protein ligase XIAP	GO:0055070; P:copper ion homeostasis; TAS:UniProtKB
P98170	XIAP	E3 ubiquitin-protein ligase XIAP	GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:Reactome
P98170	XIAP	E3 ubiquitin-protein ligase XIAP	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
P98170	XIAP	E3 ubiquitin-protein ligase XIAP	GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB
P98170	XIAP	E3 ubiquitin-protein ligase XIAP	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:UniProtKB
P98170	XIAP	E3 ubiquitin-protein ligase XIAP	GO:1902530; P:positive regulation of protein linear polyubiquitination; IDA:UniProtKB
P98170	XIAP	E3 ubiquitin-protein ligase XIAP	GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB
P98170	XIAP	E3 ubiquitin-protein ligase XIAP	GO:0016567; P:protein ubiquitination; IDA:GOC
P98170	XIAP	E3 ubiquitin-protein ligase XIAP	GO:0030510; P:regulation of BMP signaling pathway; TAS:UniProtKB
P98170	XIAP	E3 ubiquitin-protein ligase XIAP	GO:0042127; P:regulation of cell proliferation; TAS:UniProtKB
P98170	XIAP	E3 ubiquitin-protein ligase XIAP	GO:0050727; P:regulation of inflammatory response; TAS:UniProtKB
P98170	XIAP	E3 ubiquitin-protein ligase XIAP	GO:0045088; P:regulation of innate immune response; TAS:UniProtKB
P98170	XIAP	E3 ubiquitin-protein ligase XIAP	GO:0070424; P:regulation of nucleotide-binding oligomerization domain containing signaling pathway; TAS:UniProtKB
P98170	XIAP	E3 ubiquitin-protein ligase XIAP	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q702N8	XIRP1	Xin actin-binding repeat-containing protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q702N8	XIRP1	Xin actin-binding repeat-containing protein 1	GO:0055013; P:cardiac muscle cell development; IEA:Ensembl
Q702N8	XIRP1	Xin actin-binding repeat-containing protein 1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q702N8	XIRP1	Xin actin-binding repeat-containing protein 1	GO:0042391; P:regulation of membrane potential; IEA:Ensembl
Q702N8	XIRP1	Xin actin-binding repeat-containing protein 1	GO:0045214; P:sarcomere organization; IEA:Ensembl
A4UGR9	XIRP2	Xin actin-binding repeat-containing protein 2	GO:0030036; P:actin cytoskeleton organization; IEA:InterPro
A4UGR9	XIRP2	Xin actin-binding repeat-containing protein 2	GO:0055008; P:cardiac muscle tissue morphogenesis; IEA:Ensembl
A4UGR9	XIRP2	Xin actin-binding repeat-containing protein 2	GO:0045216; P:cell-cell junction organization; IEA:Ensembl
A4UGR9	XIRP2	Xin actin-binding repeat-containing protein 2	GO:0003281; P:ventricular septum development; IEA:Ensembl
Q9H6D3	XKR8	XK-related protein 8	GO:0043652; P:engulfment of apoptotic cell; IDA:UniProtKB
Q9H6D3	XKR8	XK-related protein 8	GO:0070782; P:phosphatidylserine exposure on apoptotic cell surface; IDA:UniProtKB
O14609	XKRY	Testis-specific XK-related protein, Y-linked	GO:0007338; P:single fertilization; TAS:ProtInc
P51811	XK	Membrane transport protein XK	GO:0005515; F:protein binding; IPI:HGNC
P51811	XK	Membrane transport protein XK	GO:0005215; F:transporter activity; TAS:ProtInc
P51811	XK	Membrane transport protein XK	GO:0006865; P:amino acid transport; IEA:UniProtKB-KW
P51811	XK	Membrane transport protein XK	GO:0006810; P:transport; TAS:ProtInc
O15537	RS1	Retinoschisin	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IEA:Ensembl
O15537	RS1	Retinoschisin	GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; IEA:Ensembl
O15537	RS1	Retinoschisin	GO:0080025; F:phosphatidylinositol-3,5-bisphosphate binding; IEA:Ensembl
O15537	RS1	Retinoschisin	GO:0032266; F:phosphatidylinositol-3-phosphate binding; IEA:Ensembl
O15537	RS1	Retinoschisin	GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IEA:Ensembl
O15537	RS1	Retinoschisin	GO:0070273; F:phosphatidylinositol-4-phosphate binding; IEA:Ensembl
O15537	RS1	Retinoschisin	GO:0010314; F:phosphatidylinositol-5-phosphate binding; IEA:Ensembl
O15537	RS1	Retinoschisin	GO:0001786; F:phosphatidylserine binding; IEA:Ensembl
O15537	RS1	Retinoschisin	GO:0016062; P:adaptation of rhodopsin mediated signaling; IEA:Ensembl
O15537	RS1	Retinoschisin	GO:0007155; P:cell adhesion; TAS:ProtInc
O15537	RS1	Retinoschisin	GO:0007275; P:multicellular organismal development; TAS:ProtInc
O15537	RS1	Retinoschisin	GO:0010842; P:retina layer formation; IEA:Ensembl
O15537	RS1	Retinoschisin	GO:0007601; P:visual perception; TAS:ProtInc
Q5T750	XP32	Skin-specific protein 32	GO:0008544; P:epidermis development; NAS:UniProtKB
P23025	XPA	DNA repair protein complementing XP-A cells	GO:0003684; F:damaged DNA binding; TAS:ProtInc
P23025	XPA	DNA repair protein complementing XP-A cells	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P23025	XPA	DNA repair protein complementing XP-A cells	GO:0005515; F:protein binding; IPI:UniProtKB
P23025	XPA	DNA repair protein complementing XP-A cells	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
P23025	XPA	DNA repair protein complementing XP-A cells	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
P23025	XPA	DNA repair protein complementing XP-A cells	GO:0006281; P:DNA repair; TAS:Reactome
P23025	XPA	DNA repair protein complementing XP-A cells	GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl
P23025	XPA	DNA repair protein complementing XP-A cells	GO:0035264; P:multicellular organism growth; IEA:Ensembl
P23025	XPA	DNA repair protein complementing XP-A cells	GO:0006289; P:nucleotide-excision repair; TAS:Reactome
P23025	XPA	DNA repair protein complementing XP-A cells	GO:0000718; P:nucleotide-excision repair, DNA damage removal; TAS:Reactome
P23025	XPA	DNA repair protein complementing XP-A cells	GO:0006979; P:response to oxidative stress; IEA:Ensembl
P23025	XPA	DNA repair protein complementing XP-A cells	GO:0009636; P:response to toxic substance; IEA:Ensembl
P23025	XPA	DNA repair protein complementing XP-A cells	GO:0009411; P:response to UV; IEA:Ensembl
Q01831	XPC	DNA repair protein complementing XP-C cells	GO:0000405; F:bubble DNA binding; TAS:UniProtKB
Q01831	XPC	DNA repair protein complementing XP-C cells	GO:0003684; F:damaged DNA binding; IDA:UniProtKB
Q01831	XPC	DNA repair protein complementing XP-C cells	GO:0000404; F:heteroduplex DNA loop binding; TAS:UniProtKB
Q01831	XPC	DNA repair protein complementing XP-C cells	GO:0005515; F:protein binding; IPI:IntAct
Q01831	XPC	DNA repair protein complementing XP-C cells	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
Q01831	XPC	DNA repair protein complementing XP-C cells	GO:0006281; P:DNA repair; TAS:Reactome
Q01831	XPC	DNA repair protein complementing XP-C cells	GO:0031573; P:intra-S DNA damage checkpoint; IEA:Ensembl
Q01831	XPC	DNA repair protein complementing XP-C cells	GO:0006289; P:nucleotide-excision repair; IDA:UniProtKB
Q01831	XPC	DNA repair protein complementing XP-C cells	GO:0000715; P:nucleotide-excision repair, DNA damage recognition; IDA:UniProtKB
Q01831	XPC	DNA repair protein complementing XP-C cells	GO:0000718; P:nucleotide-excision repair, DNA damage removal; TAS:Reactome
Q01831	XPC	DNA repair protein complementing XP-C cells	GO:1901990; P:regulation of mitotic cell cycle phase transition; IMP:UniProtKB
Q01831	XPC	DNA repair protein complementing XP-C cells	GO:0042493; P:response to drug; IEA:Ensembl
Q01831	XPC	DNA repair protein complementing XP-C cells	GO:0010224; P:response to UV-B; IEA:Ensembl
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0003684; F:damaged DNA binding; IMP:UniProtKB
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0004520; F:endodeoxyribonuclease activity; IDA:UniProtKB
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0005515; F:protein binding; IPI:UniProtKB
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0047485; F:protein N-terminus binding; IPI:UniProtKB
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0000014; F:single-stranded DNA endodeoxyribonuclease activity; IBA:RefGenome
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0006281; P:DNA repair; IMP:UniProtKB
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0000710; P:meiotic mismatch repair; IBA:RefGenome
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0032205; P:negative regulation of telomere maintenance; IMP:UniProtKB
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0006289; P:nucleotide-excision repair; IMP:UniProtKB
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0000718; P:nucleotide-excision repair, DNA damage removal; TAS:Reactome
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0033683; P:nucleotide-excision repair, DNA incision; IDA:UniProtKB
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0006295; P:nucleotide-excision repair, DNA incision, 3'-to lesion; IMP:UniProtKB
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0006296; P:nucleotide-excision repair, DNA incision, 5'-to lesion; IMP:UniProtKB
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0000712; P:resolution of meiotic recombination intermediates; IBA:RefGenome
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0009411; P:response to UV; IMP:UniProtKB
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0000723; P:telomere maintenance; IMP:BHF-UCL
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0010834; P:telomere maintenance via telomere shortening; IMP:BHF-UCL
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome
Q92889	ERCC4	DNA repair endonuclease XPF	GO:0009650; P:UV protection; IEA:Ensembl
O14980	XPO1	Exportin-1	GO:0005515; F:protein binding; IPI:UniProtKB
O14980	XPO1	Exportin-1	GO:0008565; F:protein transporter activity; IEA:Ensembl
O14980	XPO1	Exportin-1	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
O14980	XPO1	Exportin-1	GO:0005215; F:transporter activity; TAS:Reactome
O14980	XPO1	Exportin-1	GO:0010467; P:gene expression; TAS:Reactome
O14980	XPO1	Exportin-1	GO:0075733; P:intracellular transport of virus; TAS:Reactome
O14980	XPO1	Exportin-1	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O14980	XPO1	Exportin-1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
O14980	XPO1	Exportin-1	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
O14980	XPO1	Exportin-1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O14980	XPO1	Exportin-1	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
O14980	XPO1	Exportin-1	GO:0006611; P:protein export from nucleus; IEA:Ensembl
O14980	XPO1	Exportin-1	GO:0034504; P:protein localization to nucleus; IEA:Ensembl
O14980	XPO1	Exportin-1	GO:0010824; P:regulation of centrosome duplication; IEA:Ensembl
O14980	XPO1	Exportin-1	GO:0042176; P:regulation of protein catabolic process; IEA:Ensembl
O14980	XPO1	Exportin-1	GO:0046825; P:regulation of protein export from nucleus; IEA:Ensembl
O14980	XPO1	Exportin-1	GO:0042493; P:response to drug; IEA:Ensembl
O14980	XPO1	Exportin-1	GO:0016070; P:RNA metabolic process; TAS:Reactome
O14980	XPO1	Exportin-1	GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome
O14980	XPO1	Exportin-1	GO:0019058; P:viral life cycle; TAS:Reactome
O14980	XPO1	Exportin-1	GO:0016032; P:viral process; TAS:Reactome
P55060	CSE1L	Exportin-2	GO:0008262; F:importin-alpha export receptor activity; TAS:ProtInc
P55060	CSE1L	Exportin-2	GO:0005515; F:protein binding; IPI:IntAct
P55060	CSE1L	Exportin-2	GO:0006915; P:apoptotic process; TAS:ProtInc
P55060	CSE1L	Exportin-2	GO:0008283; P:cell proliferation; TAS:ProtInc
P55060	CSE1L	Exportin-2	GO:0006611; P:protein export from nucleus; TAS:GOC
Q9C0E2	XPO4	Exportin-4	GO:0005515; F:protein binding; IPI:UniProtKB
Q9C0E2	XPO4	Exportin-4	GO:0046827; P:positive regulation of protein export from nucleus; IMP:BHF-UCL
Q9C0E2	XPO4	Exportin-4	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9HAV4	XPO5	Exportin-5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9HAV4	XPO5	Exportin-5	GO:0005515; F:protein binding; IPI:UniProtKB
Q9HAV4	XPO5	Exportin-5	GO:0008565; F:protein transporter activity; IEA:Ensembl
Q9HAV4	XPO5	Exportin-5	GO:0003723; F:RNA binding; TAS:Reactome
Q9HAV4	XPO5	Exportin-5	GO:0000049; F:tRNA binding; IEA:UniProtKB-KW
Q9HAV4	XPO5	Exportin-5	GO:0010467; P:gene expression; TAS:Reactome
Q9HAV4	XPO5	Exportin-5	GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW
Q9HAV4	XPO5	Exportin-5	GO:0006611; P:protein export from nucleus; IEA:Ensembl
Q96QU8	XPO6	Exportin-6	GO:0005515; F:protein binding; IPI:UniProtKB
Q96QU8	XPO6	Exportin-6	GO:0008565; F:protein transporter activity; IDA:UniProtKB
Q96QU8	XPO6	Exportin-6	GO:0006611; P:protein export from nucleus; IDA:UniProtKB
Q9UIA9	XPO7	Exportin-7	GO:0005049; F:nuclear export signal receptor activity; IDA:UniProtKB
Q9UIA9	XPO7	Exportin-7	GO:0051028; P:mRNA transport; IEA:UniProtKB-KW
Q9UIA9	XPO7	Exportin-7	GO:0006611; P:protein export from nucleus; IDA:UniProtKB
O43592	XPOT	Exportin-T	GO:0000049; F:tRNA binding; IDA:UniProtKB
O43592	XPOT	Exportin-T	GO:0006886; P:intracellular protein transport; IEA:InterPro
O43592	XPOT	Exportin-T	GO:0006409; P:tRNA export from nucleus; IDA:UniProtKB
Q9NQW7	XPNPEP1	Xaa-Pro aminopeptidase 1	GO:0004177; F:aminopeptidase activity; IDA:UniProtKB
Q9NQW7	XPNPEP1	Xaa-Pro aminopeptidase 1	GO:0030145; F:manganese ion binding; IDA:UniProtKB
Q9NQW7	XPNPEP1	Xaa-Pro aminopeptidase 1	GO:0070006; F:metalloaminopeptidase activity; IDA:UniProtKB
Q9NQW7	XPNPEP1	Xaa-Pro aminopeptidase 1	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q9NQW7	XPNPEP1	Xaa-Pro aminopeptidase 1	GO:0010815; P:bradykinin catabolic process; IDA:UniProtKB
Q9NQW7	XPNPEP1	Xaa-Pro aminopeptidase 1	GO:0006508; P:proteolysis; IDA:UniProtKB
O43895	XPNPEP2	Xaa-Pro aminopeptidase 2	GO:0004177; F:aminopeptidase activity; TAS:ProtInc
O43895	XPNPEP2	Xaa-Pro aminopeptidase 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43895	XPNPEP2	Xaa-Pro aminopeptidase 2	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
Q9NQH7	XPNPEP3	Probable Xaa-Pro aminopeptidase 3	GO:0004177; F:aminopeptidase activity; IMP:MGI
Q9NQH7	XPNPEP3	Probable Xaa-Pro aminopeptidase 3	GO:0030145; F:manganese ion binding; IEA:InterPro
Q9NQH7	XPNPEP3	Probable Xaa-Pro aminopeptidase 3	GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW
Q9NQH7	XPNPEP3	Probable Xaa-Pro aminopeptidase 3	GO:0003094; P:glomerular filtration; IMP:MGI
Q9NQH7	XPNPEP3	Probable Xaa-Pro aminopeptidase 3	GO:0016485; P:protein processing; IMP:MGI
Q9UBH6	XPR1	Xenotropic and polytropic retrovirus receptor 1	GO:0004930; F:G-protein coupled receptor activity; TAS:ProtInc
Q9UBH6	XPR1	Xenotropic and polytropic retrovirus receptor 1	GO:0004872; F:receptor activity; TAS:ProtInc
Q9UBH6	XPR1	Xenotropic and polytropic retrovirus receptor 1	GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc
Q9UBH6	XPR1	Xenotropic and polytropic retrovirus receptor 1	GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW
Q9UBH6	XPR1	Xenotropic and polytropic retrovirus receptor 1	GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc
P18887	XRCC1	DNA repair protein XRCC1	GO:0003684; F:damaged DNA binding; IEA:InterPro
P18887	XRCC1	DNA repair protein XRCC1	GO:0005515; F:protein binding; IPI:UniProtKB
P18887	XRCC1	DNA repair protein XRCC1	GO:0006284; P:base-excision repair; TAS:Reactome
P18887	XRCC1	DNA repair protein XRCC1	GO:0006281; P:DNA repair; TAS:Reactome
P18887	XRCC1	DNA repair protein XRCC1	GO:0021766; P:hippocampus development; IEA:Ensembl
P18887	XRCC1	DNA repair protein XRCC1	GO:0042493; P:response to drug; IEA:Ensembl
P18887	XRCC1	DNA repair protein XRCC1	GO:0001666; P:response to hypoxia; IEA:Ensembl
P18887	XRCC1	DNA repair protein XRCC1	GO:0010033; P:response to organic substance; IEA:Ensembl
P18887	XRCC1	DNA repair protein XRCC1	GO:0000012; P:single strand break repair; IEA:InterPro
O43543	XRCC2	DNA repair protein XRCC2	GO:0005524; F:ATP binding; IEA:InterPro
O43543	XRCC2	DNA repair protein XRCC2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O43543	XRCC2	DNA repair protein XRCC2	GO:0008094; F:DNA-dependent ATPase activity; IEA:InterPro
O43543	XRCC2	DNA repair protein XRCC2	GO:0005515; F:protein binding; IPI:IntAct
O43543	XRCC2	DNA repair protein XRCC2	GO:0051297; P:centrosome organization; IMP:UniProtKB
O43543	XRCC2	DNA repair protein XRCC2	GO:0006281; P:DNA repair; IGI:BHF-UCL
O43543	XRCC2	DNA repair protein XRCC2	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
O43543	XRCC2	DNA repair protein XRCC2	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O43543	XRCC2	DNA repair protein XRCC2	GO:0007126; P:meiotic nuclear division; TAS:ProtInc
O43543	XRCC2	DNA repair protein XRCC2	GO:0000278; P:mitotic cell cycle; IMP:UniProtKB
O43543	XRCC2	DNA repair protein XRCC2	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
O43543	XRCC2	DNA repair protein XRCC2	GO:0050769; P:positive regulation of neurogenesis; IEA:Ensembl
O43543	XRCC2	DNA repair protein XRCC2	GO:0010332; P:response to gamma radiation; IEA:Ensembl
O43543	XRCC2	DNA repair protein XRCC2	GO:0010165; P:response to X-ray; IEA:Ensembl
O43543	XRCC2	DNA repair protein XRCC2	GO:0042148; P:strand invasion; IDA:UniProtKB
O43542	XRCC3	DNA repair protein XRCC3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O43542	XRCC3	DNA repair protein XRCC3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O43542	XRCC3	DNA repair protein XRCC3	GO:0008094; F:DNA-dependent ATPase activity; IEA:InterPro
O43542	XRCC3	DNA repair protein XRCC3	GO:0005515; F:protein binding; IPI:IntAct
O43542	XRCC3	DNA repair protein XRCC3	GO:0006974; P:cellular response to DNA damage stimulus; TAS:ProtInc
O43542	XRCC3	DNA repair protein XRCC3	GO:0000737; P:DNA catabolic process, endonucleolytic; IMP:GOC
O43542	XRCC3	DNA repair protein XRCC3	GO:0006310; P:DNA recombination; TAS:ProtInc
O43542	XRCC3	DNA repair protein XRCC3	GO:0006281; P:DNA repair; IGI:BHF-UCL
O43542	XRCC3	DNA repair protein XRCC3	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
O43542	XRCC3	DNA repair protein XRCC3	GO:0090267; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; IMP:UniProtKB
O43542	XRCC3	DNA repair protein XRCC3	GO:0010824; P:regulation of centrosome duplication; IMP:UniProtKB
O43542	XRCC3	DNA repair protein XRCC3	GO:0071140; P:resolution of mitotic recombination intermediates; IMP:UniProtKB
O43542	XRCC3	DNA repair protein XRCC3	GO:0010033; P:response to organic substance; IEA:Ensembl
Q13426	XRCC4	DNA repair protein XRCC4	GO:0005515; F:protein binding; IPI:UniProtKB
Q13426	XRCC4	DNA repair protein XRCC4	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
Q13426	XRCC4	DNA repair protein XRCC4	GO:0071285; P:cellular response to lithium ion; IEA:Ensembl
Q13426	XRCC4	DNA repair protein XRCC4	GO:0007417; P:central nervous system development; IEA:Ensembl
Q13426	XRCC4	DNA repair protein XRCC4	GO:0051103; P:DNA ligation involved in DNA repair; IDA:UniProtKB
Q13426	XRCC4	DNA repair protein XRCC4	GO:0006281; P:DNA repair; TAS:Reactome
Q13426	XRCC4	DNA repair protein XRCC4	GO:0006302; P:double-strand break repair; IDA:UniProtKB
Q13426	XRCC4	DNA repair protein XRCC4	GO:0006303; P:double-strand break repair via nonhomologous end joining; IDA:UniProtKB
Q13426	XRCC4	DNA repair protein XRCC4	GO:0075713; P:establishment of integrated proviral latency; TAS:Reactome
Q13426	XRCC4	DNA repair protein XRCC4	GO:0033152; P:immunoglobulin V(D)J recombination; IEA:Ensembl
Q13426	XRCC4	DNA repair protein XRCC4	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q13426	XRCC4	DNA repair protein XRCC4	GO:0045190; P:isotype switching; IEA:Ensembl
Q13426	XRCC4	DNA repair protein XRCC4	GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl
Q13426	XRCC4	DNA repair protein XRCC4	GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl
Q13426	XRCC4	DNA repair protein XRCC4	GO:0051351; P:positive regulation of ligase activity; IDA:UniProtKB
Q13426	XRCC4	DNA repair protein XRCC4	GO:0050769; P:positive regulation of neurogenesis; IEA:Ensembl
Q13426	XRCC4	DNA repair protein XRCC4	GO:0002328; P:pro-B cell differentiation; IEA:Ensembl
Q13426	XRCC4	DNA repair protein XRCC4	GO:0010332; P:response to gamma radiation; IEA:Ensembl
Q13426	XRCC4	DNA repair protein XRCC4	GO:0010165; P:response to X-ray; IDA:UniProtKB
Q13426	XRCC4	DNA repair protein XRCC4	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
Q13426	XRCC4	DNA repair protein XRCC4	GO:0016032; P:viral process; TAS:Reactome
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0004003; F:ATP-dependent DNA helicase activity; TAS:ProtInc
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0003684; F:damaged DNA binding; IEA:InterPro
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0003677; F:DNA binding; NAS:UniProtKB
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0003690; F:double-stranded DNA binding; TAS:ProtInc
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0005515; F:protein binding; IPI:UniProtKB
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0042162; F:telomeric DNA binding; IDA:BHF-UCL
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0007420; P:brain development; IEA:Ensembl
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0008283; P:cell proliferation; IEA:Ensembl
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0071475; P:cellular hyperosmotic salinity response; IEA:Ensembl
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0071398; P:cellular response to fatty acid; IEA:Ensembl
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0071481; P:cellular response to X-ray; IEA:Ensembl
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0032508; P:DNA duplex unwinding; TAS:GOC
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0006310; P:DNA recombination; TAS:ProtInc
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0006281; P:DNA repair; TAS:Reactome
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0006302; P:double-strand break repair; TAS:Reactome
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0006303; P:double-strand break repair via nonhomologous end joining; IMP:UniProtKB
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0075713; P:establishment of integrated proviral latency; TAS:Reactome
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0060218; P:hematopoietic stem cell differentiation; IEA:Ensembl
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0045087; P:innate immune response; TAS:Reactome
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0050769; P:positive regulation of neurogenesis; IEA:Ensembl
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0042493; P:response to drug; IEA:Ensembl
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0000723; P:telomere maintenance; TAS:BHF-UCL
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P13010	XRCC5	X-ray repair cross-complementing protein 5	GO:0016032; P:viral process; TAS:Reactome
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0051575; F:5'-deoxyribose-5-phosphate lyase activity; IMP:UniProtKB
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0004003; F:ATP-dependent DNA helicase activity; TAS:ProtInc
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0003684; F:damaged DNA binding; IEA:InterPro
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0003677; F:DNA binding; NAS:UniProtKB
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0003690; F:double-stranded DNA binding; TAS:ProtInc
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0005515; F:protein binding; IPI:UniProtKB
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0042162; F:telomeric DNA binding; IEA:InterPro
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0007420; P:brain development; IEA:Ensembl
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0071475; P:cellular hyperosmotic salinity response; IEA:Ensembl
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0071481; P:cellular response to X-ray; IEA:Ensembl
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0032508; P:DNA duplex unwinding; TAS:GOC
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0006266; P:DNA ligation; TAS:ProtInc
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0006281; P:DNA repair; TAS:Reactome
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0006302; P:double-strand break repair; TAS:Reactome
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0006303; P:double-strand break repair via nonhomologous end joining; IMP:UniProtKB
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0075713; P:establishment of integrated proviral latency; TAS:Reactome
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0045087; P:innate immune response; TAS:Reactome
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0050769; P:positive regulation of neurogenesis; IEA:Ensembl
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0000723; P:telomere maintenance; TAS:BHF-UCL
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0033151; P:V(D)J recombination; IEA:Ensembl
P12956	XRCC6	X-ray repair cross-complementing protein 6	GO:0016032; P:viral process; TAS:Reactome
Q8IZH2	XRN1	5'-3' exoribonuclease 1	GO:0008409; F:5'-3' exonuclease activity; IEA:InterPro
Q8IZH2	XRN1	5'-3' exoribonuclease 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IZH2	XRN1	5'-3' exoribonuclease 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IZH2	XRN1	5'-3' exoribonuclease 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IZH2	XRN1	5'-3' exoribonuclease 1	GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome
Q8IZH2	XRN1	5'-3' exoribonuclease 1	GO:0010467; P:gene expression; TAS:Reactome
Q8IZH2	XRN1	5'-3' exoribonuclease 1	GO:0071044; P:histone mRNA catabolic process; IMP:UniProtKB
Q8IZH2	XRN1	5'-3' exoribonuclease 1	GO:0016071; P:mRNA metabolic process; TAS:Reactome
Q8IZH2	XRN1	5'-3' exoribonuclease 1	GO:0071028; P:nuclear mRNA surveillance; IMP:UniProtKB
Q8IZH2	XRN1	5'-3' exoribonuclease 1	GO:0000956; P:nuclear-transcribed mRNA catabolic process; IMP:UniProtKB
Q8IZH2	XRN1	5'-3' exoribonuclease 1	GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome
Q8IZH2	XRN1	5'-3' exoribonuclease 1	GO:0016070; P:RNA metabolic process; TAS:Reactome
Q8IZH2	XRN1	5'-3' exoribonuclease 1	GO:0016075; P:rRNA catabolic process; IMP:UniProtKB
Q9H0D6	XRN2	5'-3' exoribonuclease 2	GO:0008409; F:5'-3' exonuclease activity; IDA:UniProtKB
Q9H0D6	XRN2	5'-3' exoribonuclease 2	GO:0004534; F:5'-3' exoribonuclease activity; TAS:UniProtKB
Q9H0D6	XRN2	5'-3' exoribonuclease 2	GO:0004518; F:nuclease activity; TAS:ProtInc
Q9H0D6	XRN2	5'-3' exoribonuclease 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H0D6	XRN2	5'-3' exoribonuclease 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H0D6	XRN2	5'-3' exoribonuclease 2	GO:0016049; P:cell growth; ISS:UniProtKB
Q9H0D6	XRN2	5'-3' exoribonuclease 2	GO:0000738; P:DNA catabolic process, exonucleolytic; IDA:UniProtKB
Q9H0D6	XRN2	5'-3' exoribonuclease 2	GO:0006353; P:DNA-templated transcription, termination; IEA:UniProtKB-KW
Q9H0D6	XRN2	5'-3' exoribonuclease 2	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9H0D6	XRN2	5'-3' exoribonuclease 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H0D6	XRN2	5'-3' exoribonuclease 2	GO:0006401; P:RNA catabolic process; TAS:ProtInc
Q9H0D6	XRN2	5'-3' exoribonuclease 2	GO:0016070; P:RNA metabolic process; ISS:UniProtKB
Q9H0D6	XRN2	5'-3' exoribonuclease 2	GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; TAS:GOC
Q9H0D6	XRN2	5'-3' exoribonuclease 2	GO:0006396; P:RNA processing; TAS:ProtInc
Q9H0D6	XRN2	5'-3' exoribonuclease 2	GO:0007283; P:spermatogenesis; IEP:UniProtKB
O75695	RP2	Protein XRP2	GO:0005524; F:ATP binding; IEA:InterPro
O75695	RP2	Protein XRP2	GO:0005525; F:GTP binding; IEA:UniProtKB-KW
O75695	RP2	Protein XRP2	GO:0005096; F:GTPase activator activity; IDA:UniProtKB
O75695	RP2	Protein XRP2	GO:0004550; F:nucleoside diphosphate kinase activity; IEA:InterPro
O75695	RP2	Protein XRP2	GO:0005515; F:protein binding; IPI:UniProtKB
O75695	RP2	Protein XRP2	GO:0051082; F:unfolded protein binding; TAS:ProtInc
O75695	RP2	Protein XRP2	GO:0000902; P:cell morphogenesis; IEA:InterPro
O75695	RP2	Protein XRP2	GO:0006241; P:CTP biosynthetic process; IEA:InterPro
O75695	RP2	Protein XRP2	GO:0007010; P:cytoskeleton organization; IEA:InterPro
O75695	RP2	Protein XRP2	GO:0006183; P:GTP biosynthetic process; IEA:InterPro
O75695	RP2	Protein XRP2	GO:0043547; P:positive regulation of GTPase activity; IDA:GOC
O75695	RP2	Protein XRP2	GO:0006892; P:post-Golgi vesicle-mediated transport; IMP:MGI
O75695	RP2	Protein XRP2	GO:0006457; P:protein folding; TAS:UniProtKB
O75695	RP2	Protein XRP2	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O75695	RP2	Protein XRP2	GO:0006228; P:UTP biosynthetic process; IEA:InterPro
O75695	RP2	Protein XRP2	GO:0007601; P:visual perception; TAS:ProtInc
Q6P2D8	XRRA1	X-ray radiation resistance-associated protein 1	GO:0010165; P:response to X-ray; IDA:UniProtKB
Q8NBI6	XXYLT1	Xyloside xylosyltransferase 1	GO:0016763; F:transferase activity, transferring pentosyl groups; IEA:UniProtKB-EC
O75191	XYLB	Xylulose kinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75191	XYLB	Xylulose kinase	GO:0004856; F:xylulokinase activity; IDA:UniProtKB
O75191	XYLB	Xylulose kinase	GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc
O75191	XYLB	Xylulose kinase	GO:0046835; P:carbohydrate phosphorylation; IDA:GOC
O75191	XYLB	Xylulose kinase	GO:0042732; P:D-xylose metabolic process; IEA:UniProtKB-KW
O75191	XYLB	Xylulose kinase	GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc
O75191	XYLB	Xylulose kinase	GO:0005998; P:xylulose catabolic process; TAS:BHF-UCL
O75191	XYLB	Xylulose kinase	GO:0005997; P:xylulose metabolic process; IDA:UniProtKB
O75063	FAM20B	Glycosaminoglycan xylosylkinase	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
O75063	FAM20B	Glycosaminoglycan xylosylkinase	GO:0016301; F:kinase activity; IEA:UniProtKB-KW
O75063	FAM20B	Glycosaminoglycan xylosylkinase	GO:0016773; F:phosphotransferase activity, alcohol group as acceptor; IDA:UniProtKB
Q86Y38	XYLT1	Xylosyltransferase 1	GO:0008375; F:acetylglucosaminyltransferase activity; IEA:InterPro
Q86Y38	XYLT1	Xylosyltransferase 1	GO:0030158; F:protein xylosyltransferase activity; TAS:UniProtKB
Q86Y38	XYLT1	Xylosyltransferase 1	GO:0034605; P:cellular response to heat; IEA:Ensembl
Q86Y38	XYLT1	Xylosyltransferase 1	GO:0030206; P:chondroitin sulfate biosynthetic process; IEA:UniProtKB-UniPathway
Q86Y38	XYLT1	Xylosyltransferase 1	GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:UniProtKB
Q86Y38	XYLT1	Xylosyltransferase 1	GO:0015012; P:heparan sulfate proteoglycan biosynthetic process; IEA:UniProtKB-UniPathway
Q9H1B5	XYLT2	Xylosyltransferase 2	GO:0008375; F:acetylglucosaminyltransferase activity; IEA:InterPro
Q9H1B5	XYLT2	Xylosyltransferase 2	GO:0030158; F:protein xylosyltransferase activity; NAS:UniProtKB
Q9H1B5	XYLT2	Xylosyltransferase 2	GO:0030206; P:chondroitin sulfate biosynthetic process; IEA:UniProtKB-UniPathway
Q9H1B5	XYLT2	Xylosyltransferase 2	GO:0006024; P:glycosaminoglycan biosynthetic process; NAS:UniProtKB
Q9H1B5	XYLT2	Xylosyltransferase 2	GO:0015012; P:heparan sulfate proteoglycan biosynthetic process; IEA:UniProtKB-UniPathway
Q6ZU45	LINC00083	Putative C-type lectin domain-containing protein LINC00083	GO:0030246; F:carbohydrate binding; IEA:InterPro
DR   GO:0001578; P:microtubule bundle formation; IEA:Ensembl
DR   GO:0001764; P:neuron migration; IEA:Ensembl
Q8IY57	YAF2	YY1-associated factor 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8IY57	YAF2	YY1-associated factor 2	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q8IY57	YAF2	YY1-associated factor 2	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q8IY57	YAF2	YY1-associated factor 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IY57	YAF2	YY1-associated factor 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q8IY57	YAF2	YY1-associated factor 2	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q8IY57	YAF2	YY1-associated factor 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P46937	YAP1	Yorkie homolog	GO:0003682; F:chromatin binding; IEA:Ensembl
P46937	YAP1	Yorkie homolog	GO:0005515; F:protein binding; IPI:IntAct
P46937	YAP1	Yorkie homolog	GO:0001076; F:RNA polymerase II transcription factor binding transcription factor activity; IEA:Ensembl
P46937	YAP1	Yorkie homolog	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
P46937	YAP1	Yorkie homolog	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
P46937	YAP1	Yorkie homolog	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
P46937	YAP1	Yorkie homolog	GO:0008283; P:cell proliferation; IDA:UniProtKB
P46937	YAP1	Yorkie homolog	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
P46937	YAP1	Yorkie homolog	GO:0071480; P:cellular response to gamma radiation; IDA:UniProtKB
P46937	YAP1	Yorkie homolog	GO:0060242; P:contact inhibition; IDA:UniProtKB
P46937	YAP1	Yorkie homolog	GO:0003143; P:embryonic heart tube morphogenesis; IEA:Ensembl
P46937	YAP1	Yorkie homolog	GO:0010467; P:gene expression; TAS:Reactome
P46937	YAP1	Yorkie homolog	GO:0035329; P:hippo signaling; TAS:UniProtKB
P46937	YAP1	Yorkie homolog	GO:0030216; P:keratinocyte differentiation; IEA:Ensembl
P46937	YAP1	Yorkie homolog	GO:0048368; P:lateral mesoderm development; IEA:Ensembl
P46937	YAP1	Yorkie homolog	GO:0030857; P:negative regulation of epithelial cell differentiation; IEA:Ensembl
P46937	YAP1	Yorkie homolog	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl
P46937	YAP1	Yorkie homolog	GO:0030903; P:notochord development; IEA:Ensembl
P46937	YAP1	Yorkie homolog	GO:0048339; P:paraxial mesoderm development; IEA:Ensembl
P46937	YAP1	Yorkie homolog	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl
P46937	YAP1	Yorkie homolog	GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl
P46937	YAP1	Yorkie homolog	GO:0046622; P:positive regulation of organ growth; IEA:Ensembl
P46937	YAP1	Yorkie homolog	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P46937	YAP1	Yorkie homolog	GO:0010837; P:regulation of keratinocyte proliferation; IEA:Ensembl
P46937	YAP1	Yorkie homolog	GO:0072091; P:regulation of stem cell proliferation; IEA:Ensembl
P46937	YAP1	Yorkie homolog	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
P46937	YAP1	Yorkie homolog	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
P46937	YAP1	Yorkie homolog	GO:0001570; P:vasculogenesis; IEA:Ensembl
DR   GO:0080019; F:fatty-acyl-CoA reductase (alcohol-forming) activity; IEA:InterPro
P58557	YBEY	Putative ribonuclease	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P58557	YBEY	Putative ribonuclease	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
P58557	YBEY	Putative ribonuclease	GO:0006364; P:rRNA processing; IEA:InterPro
P67809	YBX1	Nuclease-sensitive element-binding protein 1	GO:0003677; F:DNA binding; IDA:UniProtKB
P67809	YBX1	Nuclease-sensitive element-binding protein 1	GO:0003690; F:double-stranded DNA binding; TAS:ProtInc
P67809	YBX1	Nuclease-sensitive element-binding protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P67809	YBX1	Nuclease-sensitive element-binding protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
P67809	YBX1	Nuclease-sensitive element-binding protein 1	GO:0003723; F:RNA binding; IDA:UniProtKB
P67809	YBX1	Nuclease-sensitive element-binding protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P67809	YBX1	Nuclease-sensitive element-binding protein 1	GO:0003697; F:single-stranded DNA binding; TAS:ProtInc
P67809	YBX1	Nuclease-sensitive element-binding protein 1	GO:0070934; P:CRD-mediated mRNA stabilization; IMP:UniProtKB
P67809	YBX1	Nuclease-sensitive element-binding protein 1	GO:0010467; P:gene expression; TAS:Reactome
P67809	YBX1	Nuclease-sensitive element-binding protein 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P67809	YBX1	Nuclease-sensitive element-binding protein 1	GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome
P67809	YBX1	Nuclease-sensitive element-binding protein 1	GO:0051154; P:negative regulation of striated muscle cell differentiation; IEA:Ensembl
P67809	YBX1	Nuclease-sensitive element-binding protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P67809	YBX1	Nuclease-sensitive element-binding protein 1	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P67809	YBX1	Nuclease-sensitive element-binding protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
P67809	YBX1	Nuclease-sensitive element-binding protein 1	GO:0008380; P:RNA splicing; TAS:Reactome
P67809	YBX1	Nuclease-sensitive element-binding protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9Y2T7	YBX2	Y-box-binding protein 2	GO:0003682; F:chromatin binding; IEA:Ensembl
Q9Y2T7	YBX2	Y-box-binding protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y2T7	YBX2	Y-box-binding protein 2	GO:0008289; F:lipid binding; IEA:Ensembl
Q9Y2T7	YBX2	Y-box-binding protein 2	GO:0003730; F:mRNA 3'-UTR binding; IEA:Ensembl
Q9Y2T7	YBX2	Y-box-binding protein 2	GO:0043021; F:ribonucleoprotein complex binding; IEA:Ensembl
Q9Y2T7	YBX2	Y-box-binding protein 2	GO:0045182; F:translation regulator activity; IEA:Ensembl
Q9Y2T7	YBX2	Y-box-binding protein 2	GO:0048255; P:mRNA stabilization; IEA:Ensembl
Q9Y2T7	YBX2	Y-box-binding protein 2	GO:0051100; P:negative regulation of binding; IEA:Ensembl
Q9Y2T7	YBX2	Y-box-binding protein 2	GO:0017148; P:negative regulation of translation; IEA:Ensembl
Q9Y2T7	YBX2	Y-box-binding protein 2	GO:0048599; P:oocyte development; IEA:Ensembl
Q9Y2T7	YBX2	Y-box-binding protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q9Y2T7	YBX2	Y-box-binding protein 2	GO:0007286; P:spermatid development; IEA:Ensembl
Q9Y2T7	YBX2	Y-box-binding protein 2	GO:0007283; P:spermatogenesis; TAS:ProtInc
Q9Y2T7	YBX2	Y-box-binding protein 2	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q9Y2T7	YBX2	Y-box-binding protein 2	GO:0009386; P:translational attenuation; TAS:ProtInc
P16989	YBX3	Y-box-binding protein 3	GO:0003690; F:double-stranded DNA binding; TAS:ProtInc
P16989	YBX3	Y-box-binding protein 3	GO:0003730; F:mRNA 3'-UTR binding; ISS:BHF-UCL
P16989	YBX3	Y-box-binding protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P16989	YBX3	Y-box-binding protein 3	GO:0017048; F:Rho GTPase binding; ISS:BHF-UCL
P16989	YBX3	Y-box-binding protein 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:ProtInc
P16989	YBX3	Y-box-binding protein 3	GO:0003697; F:single-stranded DNA binding; IEA:Ensembl
P16989	YBX3	Y-box-binding protein 3	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
P16989	YBX3	Y-box-binding protein 3	GO:0070935; P:3'-UTR-mediated mRNA stabilization; IC:BHF-UCL
P16989	YBX3	Y-box-binding protein 3	GO:0071474; P:cellular hyperosmotic response; IMP:BHF-UCL
P16989	YBX3	Y-box-binding protein 3	GO:0071356; P:cellular response to tumor necrosis factor; IMP:BHF-UCL
P16989	YBX3	Y-box-binding protein 3	GO:0009566; P:fertilization; IEA:Ensembl
P16989	YBX3	Y-box-binding protein 3	GO:0001701; P:in utero embryonic development; IEA:Ensembl
P16989	YBX3	Y-box-binding protein 3	GO:0008584; P:male gonad development; IEA:Ensembl
P16989	YBX3	Y-box-binding protein 3	GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
P16989	YBX3	Y-box-binding protein 3	GO:1902219; P:negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress; IMP:BHF-UCL
P16989	YBX3	Y-box-binding protein 3	GO:0060546; P:negative regulation of necroptotic process; IMP:BHF-UCL
P16989	YBX3	Y-box-binding protein 3	GO:0048642; P:negative regulation of skeletal muscle tissue development; IEA:Ensembl
P16989	YBX3	Y-box-binding protein 3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P16989	YBX3	Y-box-binding protein 3	GO:2000767; P:positive regulation of cytoplasmic translation; ISS:BHF-UCL
P16989	YBX3	Y-box-binding protein 3	GO:0046622; P:positive regulation of organ growth; IEA:Ensembl
P16989	YBX3	Y-box-binding protein 3	GO:0009409; P:response to cold; TAS:ProtInc
P16989	YBX3	Y-box-binding protein 3	GO:0007283; P:spermatogenesis; IEA:Ensembl
P16989	YBX3	Y-box-binding protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A6NC05	C5orf63	Glutaredoxin-like protein C5orf63	GO:0055114; P:oxidation-reduction process; IEA:UniProtKB-KW
A8MPS7	YDJC	UPF0249 protein ydjC homolog	GO:0016810; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; IEA:InterPro
A8MPS7	YDJC	UPF0249 protein ydjC homolog	GO:0005975; P:carbohydrate metabolic process; IEA:InterPro
DR   GO:0006367; P:transcription initiation from RNA polymerase II promoter; IEA:InterPro
P07947	YES1	Tyrosine-protein kinase Yes	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
P07947	YES1	Tyrosine-protein kinase Yes	GO:0019899; F:enzyme binding; IPI:UniProtKB
P07947	YES1	Tyrosine-protein kinase Yes	GO:0044325; F:ion channel binding; IPI:BHF-UCL
P07947	YES1	Tyrosine-protein kinase Yes	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; TAS:BHF-UCL
P07947	YES1	Tyrosine-protein kinase Yes	GO:0005515; F:protein binding; IPI:IntAct
P07947	YES1	Tyrosine-protein kinase Yes	GO:0004713; F:protein tyrosine kinase activity; EXP:Reactome
P07947	YES1	Tyrosine-protein kinase Yes	GO:0007596; P:blood coagulation; TAS:Reactome
P07947	YES1	Tyrosine-protein kinase Yes	GO:0006464; P:cellular protein modification process; TAS:ProtInc
P07947	YES1	Tyrosine-protein kinase Yes	GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome
P07947	YES1	Tyrosine-protein kinase Yes	GO:0015758; P:glucose transport; IEA:Ensembl
P07947	YES1	Tyrosine-protein kinase Yes	GO:0045087; P:innate immune response; TAS:Reactome
P07947	YES1	Tyrosine-protein kinase Yes	GO:0050900; P:leukocyte migration; TAS:Reactome
P07947	YES1	Tyrosine-protein kinase Yes	GO:0018108; P:peptidyl-tyrosine phosphorylation; EXP:GOC
P07947	YES1	Tyrosine-protein kinase Yes	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
P07947	YES1	Tyrosine-protein kinase Yes	GO:0043114; P:regulation of vascular permeability; TAS:BHF-UCL
P07947	YES1	Tyrosine-protein kinase Yes	GO:0031295; P:T cell costimulation; TAS:Reactome
Q9ULM3	YEATS2	YEATS domain-containing protein 2	GO:0005515; F:protein binding; IPI:BHF-UCL
Q9ULM3	YEATS2	YEATS domain-containing protein 2	GO:0017025; F:TBP-class protein binding; IPI:BHF-UCL
Q9ULM3	YEATS2	YEATS domain-containing protein 2	GO:0006325; P:chromatin organization; TAS:Reactome
Q9ULM3	YEATS2	YEATS domain-containing protein 2	GO:0043966; P:histone H3 acetylation; IDA:BHF-UCL
Q9ULM3	YEATS2	YEATS domain-containing protein 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q9ULM3	YEATS2	YEATS domain-containing protein 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL
O95619	YEATS4	YEATS domain-containing protein 4	GO:0003677; F:DNA binding; TAS:ProtInc
O95619	YEATS4	YEATS domain-containing protein 4	GO:0005515; F:protein binding; IPI:IntAct
O95619	YEATS4	YEATS domain-containing protein 4	GO:0008022; F:protein C-terminus binding; IPI:UniProtKB
O95619	YEATS4	YEATS domain-containing protein 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O95619	YEATS4	YEATS domain-containing protein 4	GO:0005200; F:structural constituent of cytoskeleton; NAS:UniProtKB
O95619	YEATS4	YEATS domain-containing protein 4	GO:0006325; P:chromatin organization; TAS:Reactome
O95619	YEATS4	YEATS domain-containing protein 4	GO:0043968; P:histone H2A acetylation; IDA:UniProtKB
O95619	YEATS4	YEATS domain-containing protein 4	GO:0043967; P:histone H4 acetylation; IDA:UniProtKB
O95619	YEATS4	YEATS domain-containing protein 4	GO:0007067; P:mitosis; NAS:UniProtKB
O95619	YEATS4	YEATS domain-containing protein 4	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
O95619	YEATS4	YEATS domain-containing protein 4	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
O95619	YEATS4	YEATS domain-containing protein 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
DR   GO:0004930; F:G-protein coupled receptor activity; IEA:UniProtKB-KW
DR   GO:0004984; F:olfactory receptor activity; IEA:InterPro
DR   GO:0008378; F:galactosyltransferase activity; IEA:InterPro
DR   GO:0006486; P:protein glycosylation; IEA:InterPro
O95070	YIF1A	Protein YIF1A	GO:0005515; F:protein binding; IPI:IntAct
O95070	YIF1A	Protein YIF1A	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
O95070	YIF1A	Protein YIF1A	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
O95070	YIF1A	Protein YIF1A	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
O95070	YIF1A	Protein YIF1A	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O95070	YIF1A	Protein YIF1A	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q9GZM5	YIPF3	Protein YIPF3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q969M3	YIPF5	Protein YIPF5	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q969M3	YIPF5	Protein YIPF5	GO:0060628; P:regulation of ER to Golgi vesicle-mediated transport; IEA:Ensembl
Q969M3	YIPF5	Protein YIPF5	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q96EC8	YIPF6	Protein YIPF6	GO:0060576; P:intestinal epithelial cell development; IEA:Ensembl
DR   GO:0006810; P:transport; IEA:UniProtKB-KW
DR   GO:0008270; F:zinc ion binding; IEA:InterPro
O15498	YKT6	Synaptobrevin homolog YKT6	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IDA:HGNC
O15498	YKT6	Synaptobrevin homolog YKT6	GO:0005484; F:SNAP receptor activity; IDA:HGNC
O15498	YKT6	Synaptobrevin homolog YKT6	GO:0000149; F:SNARE binding; IBA:RefGenome
O15498	YKT6	Synaptobrevin homolog YKT6	GO:0006888; P:ER to Golgi vesicle-mediated transport; IDA:HGNC
O15498	YKT6	Synaptobrevin homolog YKT6	GO:0008152; P:metabolic process; IDA:GOC
O15498	YKT6	Synaptobrevin homolog YKT6	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O15498	YKT6	Synaptobrevin homolog YKT6	GO:0042147; P:retrograde transport, endosome to Golgi; IDA:HGNC
O15498	YKT6	Synaptobrevin homolog YKT6	GO:0006904; P:vesicle docking involved in exocytosis; IDA:HGNC
O15498	YKT6	Synaptobrevin homolog YKT6	GO:0006906; P:vesicle fusion; IBA:RefGenome
O15498	YKT6	Synaptobrevin homolog YKT6	GO:0006903; P:vesicle targeting; IDA:HGNC
Q9UM01	SLC7A7	Y+L amino acid transporter 1	GO:0015171; F:amino acid transmembrane transporter activity; IEA:InterPro
Q9UM01	SLC7A7	Y+L amino acid transporter 1	GO:0006865; P:amino acid transport; TAS:Reactome
Q9UM01	SLC7A7	Y+L amino acid transporter 1	GO:0007596; P:blood coagulation; TAS:Reactome
Q9UM01	SLC7A7	Y+L amino acid transporter 1	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
Q9UM01	SLC7A7	Y+L amino acid transporter 1	GO:0006811; P:ion transport; TAS:Reactome
Q9UM01	SLC7A7	Y+L amino acid transporter 1	GO:0050900; P:leukocyte migration; TAS:Reactome
Q9UM01	SLC7A7	Y+L amino acid transporter 1	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q9UM01	SLC7A7	Y+L amino acid transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9UM01	SLC7A7	Y+L amino acid transporter 1	GO:0006810; P:transport; TAS:ProtInc
Q92536	SLC7A6	Y+L amino acid transporter 2	GO:0015171; F:amino acid transmembrane transporter activity; TAS:ProtInc
Q92536	SLC7A6	Y+L amino acid transporter 2	GO:0015297; F:antiporter activity; IEA:UniProtKB-KW
Q92536	SLC7A6	Y+L amino acid transporter 2	GO:0006865; P:amino acid transport; TAS:Reactome
Q92536	SLC7A6	Y+L amino acid transporter 2	GO:0007596; P:blood coagulation; TAS:Reactome
Q92536	SLC7A6	Y+L amino acid transporter 2	GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc
Q92536	SLC7A6	Y+L amino acid transporter 2	GO:0006811; P:ion transport; TAS:Reactome
Q92536	SLC7A6	Y+L amino acid transporter 2	GO:0050900; P:leukocyte migration; TAS:Reactome
Q92536	SLC7A6	Y+L amino acid transporter 2	GO:0006461; P:protein complex assembly; TAS:ProtInc
Q92536	SLC7A6	Y+L amino acid transporter 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q92536	SLC7A6	Y+L amino acid transporter 2	GO:0006810; P:transport; TAS:ProtInc
P49750	YLPM1	YLP motif-containing protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
P49750	YLPM1	YLP motif-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
P49750	YLPM1	YLP motif-containing protein 1	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IEA:Ensembl
P49750	YLPM1	YLP motif-containing protein 1	GO:0032204; P:regulation of telomere maintenance; IEA:Ensembl
Q96TA2	YME1L1	ATP-dependent zinc metalloprotease YME1L1	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q96TA2	YME1L1	ATP-dependent zinc metalloprotease YME1L1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96TA2	YME1L1	ATP-dependent zinc metalloprotease YME1L1	GO:0004222; F:metalloendopeptidase activity; IEA:InterPro
Q96TA2	YME1L1	ATP-dependent zinc metalloprotease YME1L1	GO:0017111; F:nucleoside-triphosphatase activity; IEA:InterPro
Q96TA2	YME1L1	ATP-dependent zinc metalloprotease YME1L1	GO:0008283; P:cell proliferation; IMP:UniProtKB
Q96TA2	YME1L1	ATP-dependent zinc metalloprotease YME1L1	GO:0006515; P:misfolded or incompletely synthesized protein catabolic process; IMP:UniProtKB
Q96TA2	YME1L1	ATP-dependent zinc metalloprotease YME1L1	GO:0007005; P:mitochondrion organization; IMP:UniProtKB
DR   GO:0007218; P:neuropeptide signaling pathway; IEA:InterPro
O60688	YPEL1	Protein yippee-like 1	GO:0051898; P:negative regulation of protein kinase B signaling; IEA:Ensembl
O60688	YPEL1	Protein yippee-like 1	GO:0031641; P:regulation of myelination; IEA:Ensembl
Q86U90	YRDC	YrdC domain-containing protein, mitochondrial	GO:0003725; F:double-stranded RNA binding; IEA:InterPro
Q86U90	YRDC	YrdC domain-containing protein, mitochondrial	GO:0051051; P:negative regulation of transport; IDA:MGI
DR   GO:0003677; F:DNA binding; IEA:UniProtKB-KW
DR   GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
DR   GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
DR   GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96MU7	YTHDC1	YTH domain-containing protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96MU7	YTHDC1	YTH domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96MU7	YTHDC1	YTH domain-containing protein 1	GO:0003723; F:RNA binding; IDA:UniProtKB
Q96MU7	YTHDC1	YTH domain-containing protein 1	GO:0006376; P:mRNA splice site selection; IDA:UniProtKB
Q9H6S0	YTHDC2	Probable ATP-dependent RNA helicase YTHDC2	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q9H6S0	YTHDC2	Probable ATP-dependent RNA helicase YTHDC2	GO:0008026; F:ATP-dependent helicase activity; IEA:InterPro
Q9H6S0	YTHDC2	Probable ATP-dependent RNA helicase YTHDC2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H6S0	YTHDC2	Probable ATP-dependent RNA helicase YTHDC2	GO:0005515; F:protein binding; IPI:IntAct
Q7Z739	YTHDF3	YTH domain-containing family protein 3	GO:1990247; F:N6-methyladenosine-containing RNA binding; IDA:UniProtKB
Q7Z739	YTHDF3	YTH domain-containing family protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7Z739	YTHDF3	YTH domain-containing family protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q9Y5A9	YTHDF2	YTH domain-containing family protein 2	GO:1990247; F:N6-methyladenosine-containing RNA binding; IDA:UniProtKB
Q9Y5A9	YTHDF2	YTH domain-containing family protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9Y5A9	YTHDF2	YTH domain-containing family protein 2	GO:0006959; P:humoral immune response; TAS:ProtInc
Q9Y5A9	YTHDF2	YTH domain-containing family protein 2	GO:0043488; P:regulation of mRNA stability; IMP:UniProtKB
Q9BYJ9	YTHDF1	YTH domain-containing family protein 1	GO:1990247; F:N6-methyladenosine-containing RNA binding; IDA:UniProtKB
Q9BYJ9	YTHDF1	YTH domain-containing family protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H869	YY1AP1	YY1-associated protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H869	YY1AP1	YY1-associated protein 1	GO:0051726; P:regulation of cell cycle; IDA:UniProtKB
Q9H869	YY1AP1	YY1-associated protein 1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H869	YY1AP1	YY1-associated protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UI56	MEG3	Very putative protein from MEG3 locus	GO:0003713; F:transcription coactivator activity; IDA:UniProtKB
Q9UI56	MEG3	Very putative protein from MEG3 locus	GO:0007411; P:axon guidance; ISS:UniProtKB
Q9UI56	MEG3	Very putative protein from MEG3 locus	GO:0030154; P:cell differentiation; ISS:UniProtKB
Q9UI56	MEG3	Very putative protein from MEG3 locus	GO:0032274; P:gonadotropin secretion; IMP:UniProtKB
Q9UI56	MEG3	Very putative protein from MEG3 locus	GO:0044029; P:hypomethylation of CpG island; ISS:UniProtKB
Q9UI56	MEG3	Very putative protein from MEG3 locus	GO:0016525; P:negative regulation of angiogenesis; ISS:UniProtKB
Q9UI56	MEG3	Very putative protein from MEG3 locus	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB
Q9UI56	MEG3	Very putative protein from MEG3 locus	GO:2000279; P:negative regulation of DNA biosynthetic process; IDA:UniProtKB
Q9UI56	MEG3	Very putative protein from MEG3 locus	GO:0045746; P:negative regulation of Notch signaling pathway; ISS:UniProtKB
Q9UI56	MEG3	Very putative protein from MEG3 locus	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UI56	MEG3	Very putative protein from MEG3 locus	GO:0030948; P:negative regulation of vascular endothelial growth factor receptor signaling pathway; ISS:UniProtKB
Q9UI56	MEG3	Very putative protein from MEG3 locus	GO:0040019; P:positive regulation of embryonic development; ISS:UniProtKB
Q9UI56	MEG3	Very putative protein from MEG3 locus	GO:0048743; P:positive regulation of skeletal muscle fiber development; ISS:UniProtKB
Q9UI56	MEG3	Very putative protein from MEG3 locus	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UI56	MEG3	Very putative protein from MEG3 locus	GO:0034337; P:RNA folding; IDA:UniProtKB
P59817	ZNF280A	Zinc finger protein 280A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P59817	ZNF280A	Zinc finger protein 280A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P59817	ZNF280A	Zinc finger protein 280A	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P59817	ZNF280A	Zinc finger protein 280A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6N043	ZNF280D	Zinc finger protein 280D	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6N043	ZNF280D	Zinc finger protein 280D	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6N043	ZNF280D	Zinc finger protein 280D	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6N043	ZNF280D	Zinc finger protein 280D	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86YH2	ZNF280B	Zinc finger protein 280B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86YH2	ZNF280B	Zinc finger protein 280B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86YH2	ZNF280B	Zinc finger protein 280B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q86YH2	ZNF280B	Zinc finger protein 280B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8ND82	ZNF280C	Zinc finger protein 280C	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8ND82	ZNF280C	Zinc finger protein 280C	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8ND82	ZNF280C	Zinc finger protein 280C	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8ND82	ZNF280C	Zinc finger protein 280C	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HBT8	ZNF286A	Zinc finger protein 286A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9HBT8	ZNF286A	Zinc finger protein 286A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HBT8	ZNF286A	Zinc finger protein 286A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9HBT8	ZNF286A	Zinc finger protein 286A	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9HBT8	ZNF286A	Zinc finger protein 286A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P0CG31	ZNF286B	Putative zinc finger protein 286B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P0CG31	ZNF286B	Putative zinc finger protein 286B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P0CG31	ZNF286B	Putative zinc finger protein 286B	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P0CG31	ZNF286B	Putative zinc finger protein 286B	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P0CG31	ZNF286B	Putative zinc finger protein 286B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75467	ZNF324	Zinc finger protein 324A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O75467	ZNF324	Zinc finger protein 324A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75467	ZNF324	Zinc finger protein 324A	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O75467	ZNF324	Zinc finger protein 324A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6AW86	ZNF324B	Zinc finger protein 324B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6AW86	ZNF324B	Zinc finger protein 324B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6AW86	ZNF324B	Zinc finger protein 324B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6AW86	ZNF324B	Zinc finger protein 324B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60765	ZNF354A	Zinc finger protein 354A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O60765	ZNF354A	Zinc finger protein 354A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60765	ZNF354A	Zinc finger protein 354A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
O60765	ZNF354A	Zinc finger protein 354A	GO:0001822; P:kidney development; IEA:Ensembl
O60765	ZNF354A	Zinc finger protein 354A	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O60765	ZNF354A	Zinc finger protein 354A	GO:0007576; P:nucleolar fragmentation; IEA:Ensembl
O60765	ZNF354A	Zinc finger protein 354A	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O60765	ZNF354A	Zinc finger protein 354A	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
O60765	ZNF354A	Zinc finger protein 354A	GO:0051593; P:response to folic acid; IEA:Ensembl
O60765	ZNF354A	Zinc finger protein 354A	GO:0001666; P:response to hypoxia; IEA:Ensembl
O60765	ZNF354A	Zinc finger protein 354A	GO:0007605; P:sensory perception of sound; TAS:ProtInc
O60765	ZNF354A	Zinc finger protein 354A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96LW1	ZNF354B	Zinc finger protein 354B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96LW1	ZNF354B	Zinc finger protein 354B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96LW1	ZNF354B	Zinc finger protein 354B	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q96LW1	ZNF354B	Zinc finger protein 354B	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q96LW1	ZNF354B	Zinc finger protein 354B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86Y25	ZNF354C	Zinc finger protein 354C	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86Y25	ZNF354C	Zinc finger protein 354C	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86Y25	ZNF354C	Zinc finger protein 354C	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q86Y25	ZNF354C	Zinc finger protein 354C	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q86Y25	ZNF354C	Zinc finger protein 354C	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NSJ1	ZNF355P	Putative zinc finger protein 355P	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NSJ1	ZNF355P	Putative zinc finger protein 355P	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NSJ1	ZNF355P	Putative zinc finger protein 355P	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NSJ1	ZNF355P	Putative zinc finger protein 355P	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96PM9	ZNF385A	Zinc finger protein 385A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96PM9	ZNF385A	Zinc finger protein 385A	GO:0003730; F:mRNA 3'-UTR binding; ISS:UniProtKB
Q96PM9	ZNF385A	Zinc finger protein 385A	GO:0002039; F:p53 binding; IPI:UniProtKB
Q96PM9	ZNF385A	Zinc finger protein 385A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96PM9	ZNF385A	Zinc finger protein 385A	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96PM9	ZNF385A	Zinc finger protein 385A	GO:0006915; P:apoptotic process; ISS:UniProtKB
Q96PM9	ZNF385A	Zinc finger protein 385A	GO:0006974; P:cellular response to DNA damage stimulus; ISS:UniProtKB
Q96PM9	ZNF385A	Zinc finger protein 385A	GO:0007599; P:hemostasis; IEA:Ensembl
Q96PM9	ZNF385A	Zinc finger protein 385A	GO:0007611; P:learning or memory; IEA:Ensembl
Q96PM9	ZNF385A	Zinc finger protein 385A	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q96PM9	ZNF385A	Zinc finger protein 385A	GO:0035855; P:megakaryocyte development; ISS:UniProtKB
Q96PM9	ZNF385A	Zinc finger protein 385A	GO:0010609; P:mRNA localization resulting in posttranscriptional regulation of gene expression; ISS:UniProtKB
Q96PM9	ZNF385A	Zinc finger protein 385A	GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IMP:UniProtKB
Q96PM9	ZNF385A	Zinc finger protein 385A	GO:0070889; P:platelet alpha granule organization; IEA:Ensembl
Q96PM9	ZNF385A	Zinc finger protein 385A	GO:0030220; P:platelet formation; IEA:Ensembl
Q96PM9	ZNF385A	Zinc finger protein 385A	GO:1902164; P:positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IMP:UniProtKB
Q96PM9	ZNF385A	Zinc finger protein 385A	GO:0045600; P:positive regulation of fat cell differentiation; ISS:UniProtKB
Q96PM9	ZNF385A	Zinc finger protein 385A	GO:2000765; P:regulation of cytoplasmic translation; ISS:UniProtKB
Q96PM9	ZNF385A	Zinc finger protein 385A	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96PM9	ZNF385A	Zinc finger protein 385A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q569K4	ZNF385B	Zinc finger protein 385B	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q569K4	ZNF385B	Zinc finger protein 385B	GO:0002039; F:p53 binding; IPI:UniProtKB
Q569K4	ZNF385B	Zinc finger protein 385B	GO:0008270; F:zinc ion binding; IEA:InterPro
Q569K4	ZNF385B	Zinc finger protein 385B	GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IDA:UniProtKB
Q66K41	ZNF385C	Zinc finger protein 385C	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q66K41	ZNF385C	Zinc finger protein 385C	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H6B1	ZNF385D	Zinc finger protein 385D	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9H6B1	ZNF385D	Zinc finger protein 385D	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IWR0	ZC3H7A	Zinc finger CCCH domain-containing protein 7A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IWR0	ZC3H7A	Zinc finger CCCH domain-containing protein 7A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UGR2	ZC3H7B	Zinc finger CCCH domain-containing protein 7B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UGR2	ZC3H7B	Zinc finger CCCH domain-containing protein 7B	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UGR2	ZC3H7B	Zinc finger CCCH domain-containing protein 7B	GO:0005515; F:protein binding; IPI:IntAct
Q9UGR2	ZC3H7B	Zinc finger CCCH domain-containing protein 7B	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q96KM6	ZNF512B	Zinc finger protein 512B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96KM6	ZNF512B	Zinc finger protein 512B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96KM6	ZNF512B	Zinc finger protein 512B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96KM6	ZNF512B	Zinc finger protein 512B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6AHZ1	ZNF518A	Zinc finger protein 518A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6AHZ1	ZNF518A	Zinc finger protein 518A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6AHZ1	ZNF518A	Zinc finger protein 518A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q6AHZ1	ZNF518A	Zinc finger protein 518A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9C0D4	ZNF518B	Zinc finger protein 518B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9C0D4	ZNF518B	Zinc finger protein 518B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9C0D4	ZNF518B	Zinc finger protein 518B	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q9C0D4	ZNF518B	Zinc finger protein 518B	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
Q9C0D4	ZNF518B	Zinc finger protein 518B	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q6P3V2	ZNF585A	Zinc finger protein 585A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6P3V2	ZNF585A	Zinc finger protein 585A	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q6P3V2	ZNF585A	Zinc finger protein 585A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6P3V2	ZNF585A	Zinc finger protein 585A	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q6P3V2	ZNF585A	Zinc finger protein 585A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q52M93	ZNF585B	Zinc finger protein 585B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q52M93	ZNF585B	Zinc finger protein 585B	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q52M93	ZNF585B	Zinc finger protein 585B	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q52M93	ZNF585B	Zinc finger protein 585B	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q52M93	ZNF585B	Zinc finger protein 585B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
E7ETH6	ZNF587B	Zinc finger protein 587B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
E7ETH6	ZNF587B	Zinc finger protein 587B	GO:0003676; F:nucleic acid binding; IEA:InterPro
E7ETH6	ZNF587B	Zinc finger protein 587B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q4V348	ZNF658B	Zinc finger protein 658B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q4V348	ZNF658B	Zinc finger protein 658B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q4V348	ZNF658B	Zinc finger protein 658B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q4V348	ZNF658B	Zinc finger protein 658B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZN79	ZNF705A	Zinc finger protein 705A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZN79	ZNF705A	Zinc finger protein 705A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZN79	ZNF705A	Zinc finger protein 705A	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZN79	ZNF705A	Zinc finger protein 705A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P0CI00	ZNF705B	Putative zinc finger protein 705B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P0CI00	ZNF705B	Putative zinc finger protein 705B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P0CI00	ZNF705B	Putative zinc finger protein 705B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P0CI00	ZNF705B	Putative zinc finger protein 705B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P0CH99	ZNF705D	Zinc finger protein 705D	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P0CH99	ZNF705D	Zinc finger protein 705D	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P0CH99	ZNF705D	Zinc finger protein 705D	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P0CH99	ZNF705D	Zinc finger protein 705D	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A8MWA4	ZNF705E	Putative zinc finger protein 705E	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A8MWA4	ZNF705E	Putative zinc finger protein 705E	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A8MWA4	ZNF705E	Putative zinc finger protein 705E	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A8MWA4	ZNF705E	Putative zinc finger protein 705E	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A8MVS1	ZNF705F	Zinc finger protein 705F	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A8MVS1	ZNF705F	Zinc finger protein 705F	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A8MVS1	ZNF705F	Zinc finger protein 705F	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A8MVS1	ZNF705F	Zinc finger protein 705F	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y6R6	ZNF780B	Zinc finger protein 780B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y6R6	ZNF780B	Zinc finger protein 780B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y6R6	ZNF780B	Zinc finger protein 780B	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9Y6R6	ZNF780B	Zinc finger protein 780B	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9Y6R6	ZNF780B	Zinc finger protein 780B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75290	ZNF780A	Zinc finger protein 780A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O75290	ZNF780A	Zinc finger protein 780A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75290	ZNF780A	Zinc finger protein 780A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
O75290	ZNF780A	Zinc finger protein 780A	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
O75290	ZNF780A	Zinc finger protein 780A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A8MUZ8	ZNF705G	Putative zinc finger protein 705G	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A8MUZ8	ZNF705G	Putative zinc finger protein 705G	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A8MUZ8	ZNF705G	Putative zinc finger protein 705G	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A8MUZ8	ZNF705G	Putative zinc finger protein 705G	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z570	ZNF804A	Zinc finger protein 804A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A4D1E1	ZNF804B	Zinc finger protein 804B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q49A33	ZNF876P	Putative zinc finger protein 876	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q49A33	ZNF876P	Putative zinc finger protein 876	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q49A33	ZNF876P	Putative zinc finger protein 876	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q49A33	ZNF876P	Putative zinc finger protein 876	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P25311	AZGP1	Zinc-alpha-2-glycoprotein	GO:0003823; F:antigen binding; IBA:RefGenome
P25311	AZGP1	Zinc-alpha-2-glycoprotein	GO:0001948; F:glycoprotein binding; IPI:UniProt
P25311	AZGP1	Zinc-alpha-2-glycoprotein	GO:0042605; F:peptide antigen binding; IEA:InterPro
P25311	AZGP1	Zinc-alpha-2-glycoprotein	GO:0008320; F:protein transmembrane transporter activity; NAS:UniProtKB
P25311	AZGP1	Zinc-alpha-2-glycoprotein	GO:0004540; F:ribonuclease activity; NAS:UniProtKB
P25311	AZGP1	Zinc-alpha-2-glycoprotein	GO:0019882; P:antigen processing and presentation; IBA:RefGenome
P25311	AZGP1	Zinc-alpha-2-glycoprotein	GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:InterPro
P25311	AZGP1	Zinc-alpha-2-glycoprotein	GO:0007155; P:cell adhesion; IDA:UniProtKB
P25311	AZGP1	Zinc-alpha-2-glycoprotein	GO:0001580; P:detection of chemical stimulus involved in sensory perception of bitter taste; IDA:UniProt
P25311	AZGP1	Zinc-alpha-2-glycoprotein	GO:0006955; P:immune response; IEA:InterPro
P25311	AZGP1	Zinc-alpha-2-glycoprotein	GO:0008285; P:negative regulation of cell proliferation; NAS:UniProtKB
P25311	AZGP1	Zinc-alpha-2-glycoprotein	GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IEA:InterPro
P25311	AZGP1	Zinc-alpha-2-glycoprotein	GO:0071806; P:protein transmembrane transport; NAS:GOC
P25311	AZGP1	Zinc-alpha-2-glycoprotein	GO:0001895; P:retina homeostasis; IEP:UniProt
P25311	AZGP1	Zinc-alpha-2-glycoprotein	GO:0090501; P:RNA phosphodiester bond hydrolysis; NAS:GOC
Q401N2	ZACN	Zinc-activated ligand-gated ion channel	GO:0005230; F:extracellular ligand-gated ion channel activity; IEA:InterPro
Q401N2	ZACN	Zinc-activated ligand-gated ion channel	GO:0008270; F:zinc ion binding; IC:HGNC
Q401N2	ZACN	Zinc-activated ligand-gated ion channel	GO:0010043; P:response to zinc ion; IDA:HGNC
Q8N4Q0	ZADH2	Zinc-binding alcohol dehydrogenase domain-containing protein 2	GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW
Q8N4Q0	ZADH2	Zinc-binding alcohol dehydrogenase domain-containing protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y493	ZAN	Zonadhesin	GO:0007339; P:binding of sperm to zona pellucida; NAS:UniProtKB
Q9Y493	ZAN	Zonadhesin	GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0005524; F:ATP binding; NAS:UniProtKB
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; TAS:UniProtKB
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0005515; F:protein binding; IPI:UniProtKB
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0002250; P:adaptive immune response; TAS:UniProtKB
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0042113; P:B cell activation; TAS:UniProtKB
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0043366; P:beta selection; IEA:Ensembl
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0006955; P:immune response; IDA:UniProtKB
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0035556; P:intracellular signal transduction; NAS:UniProtKB
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0045060; P:negative thymic T cell selection; IEA:Ensembl
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:MGI
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0046638; P:positive regulation of alpha-beta T cell differentiation; IEA:Ensembl
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0046641; P:positive regulation of alpha-beta T cell proliferation; IEA:Ensembl
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0050850; P:positive regulation of calcium-mediated signaling; IEA:Ensembl
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0045582; P:positive regulation of T cell differentiation; IDA:MGI
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0045059; P:positive thymic T cell selection; IDA:MGI
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0046777; P:protein autophosphorylation; IEA:Ensembl
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0006468; P:protein phosphorylation; IDA:UniProtKB
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0042110; P:T cell activation; TAS:UniProtKB
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0070489; P:T cell aggregation; TAS:UniProtKB
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0030217; P:T cell differentiation; NAS:UniProtKB
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0072678; P:T cell migration; TAS:UniProtKB
P43403	ZAP70	Tyrosine-protein kinase ZAP-70	GO:0050852; P:T cell receptor signaling pathway; TAS:UniProtKB
Q86SH2	ZAR1	Zygote arrest protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
A8MT70	ZBBX	Zinc finger B-box domain-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
O96006	ZBED1	Zinc finger BED domain-containing protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O96006	ZBED1	Zinc finger BED domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O96006	ZBED1	Zinc finger BED domain-containing protein 1	GO:0004803; F:transposase activity; TAS:ProtInc
O96006	ZBED1	Zinc finger BED domain-containing protein 1	GO:0008152; P:metabolic process; TAS:GOC
Q9BTP6	ZBED2	Zinc finger BED domain-containing protein 2	GO:0003677; F:DNA binding; IEA:InterPro
Q9BTP6	ZBED2	Zinc finger BED domain-containing protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96IU2	ZBED3	Zinc finger BED domain-containing protein 3	GO:0003677; F:DNA binding; IEA:InterPro
Q96IU2	ZBED3	Zinc finger BED domain-containing protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96IU2	ZBED3	Zinc finger BED domain-containing protein 3	GO:0001933; P:negative regulation of protein phosphorylation; ISS:UniProtKB
Q96IU2	ZBED3	Zinc finger BED domain-containing protein 3	GO:0090263; P:positive regulation of canonical Wnt signaling pathway; ISS:UniProtKB
Q96IU2	ZBED3	Zinc finger BED domain-containing protein 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q96IU2	ZBED3	Zinc finger BED domain-containing protein 3	GO:0050821; P:protein stabilization; ISS:UniProtKB
Q96IU2	ZBED3	Zinc finger BED domain-containing protein 3	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
O75132	ZBED4	Zinc finger BED domain-containing protein 4	GO:0003677; F:DNA binding; IEA:InterPro
O75132	ZBED4	Zinc finger BED domain-containing protein 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q49AG3	ZBED5	Zinc finger BED domain-containing protein 5	GO:0003677; F:DNA binding; IEA:InterPro
Q49AG3	ZBED5	Zinc finger BED domain-containing protein 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P86452	ZBED6	Zinc finger BED domain-containing protein 6	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P86452	ZBED6	Zinc finger BED domain-containing protein 6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P86452	ZBED6	Zinc finger BED domain-containing protein 6	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P86452	ZBED6	Zinc finger BED domain-containing protein 6	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
P86452	ZBED6	Zinc finger BED domain-containing protein 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IZ13	ZBED8	Protein ZBED8	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9H171	ZBP1	Z-DNA-binding protein 1	GO:0003677; F:DNA binding; IDA:MGI
Q9H171	ZBP1	Z-DNA-binding protein 1	GO:0003726; F:double-stranded RNA adenosine deaminase activity; IEA:InterPro
Q9H171	ZBP1	Z-DNA-binding protein 1	GO:0003692; F:left-handed Z-DNA binding; NAS:UniProtKB
Q9H171	ZBP1	Z-DNA-binding protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9H171	ZBP1	Z-DNA-binding protein 1	GO:0003723; F:RNA binding; IEA:InterPro
Q9H171	ZBP1	Z-DNA-binding protein 1	GO:0045087; P:innate immune response; TAS:Reactome
Q9H171	ZBP1	Z-DNA-binding protein 1	GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome
Q9H171	ZBP1	Z-DNA-binding protein 1	GO:0060340; P:positive regulation of type I interferon-mediated signaling pathway; IEA:Ensembl
Q96DT7	ZBTB10	Zinc finger and BTB domain-containing protein 10	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96DT7	ZBTB10	Zinc finger and BTB domain-containing protein 10	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96DT7	ZBTB10	Zinc finger and BTB domain-containing protein 10	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96DT7	ZBTB10	Zinc finger and BTB domain-containing protein 10	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95625	ZBTB11	Zinc finger and BTB domain-containing protein 11	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O95625	ZBTB11	Zinc finger and BTB domain-containing protein 11	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95625	ZBTB11	Zinc finger and BTB domain-containing protein 11	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O95625	ZBTB11	Zinc finger and BTB domain-containing protein 11	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y330	ZBTB12	Zinc finger and BTB domain-containing protein 12	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y330	ZBTB12	Zinc finger and BTB domain-containing protein 12	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y330	ZBTB12	Zinc finger and BTB domain-containing protein 12	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y330	ZBTB12	Zinc finger and BTB domain-containing protein 12	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43829	ZBTB14	Zinc finger and BTB domain-containing protein 14	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43829	ZBTB14	Zinc finger and BTB domain-containing protein 14	GO:0005515; F:protein binding; IPI:UniProtKB
O43829	ZBTB14	Zinc finger and BTB domain-containing protein 14	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
O43829	ZBTB14	Zinc finger and BTB domain-containing protein 14	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
O43829	ZBTB14	Zinc finger and BTB domain-containing protein 14	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
O43829	ZBTB14	Zinc finger and BTB domain-containing protein 14	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O43829	ZBTB14	Zinc finger and BTB domain-containing protein 14	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
O43829	ZBTB14	Zinc finger and BTB domain-containing protein 14	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0003677; F:DNA binding; NAS:UniProtKB
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0042802; F:identical protein binding; IPI:IntAct
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0005515; F:protein binding; IPI:UniProtKB
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0006915; P:apoptotic process; NAS:UniProtKB
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0051216; P:cartilage development; IDA:UniProtKB
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0007417; P:central nervous system development; ISS:UniProtKB
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0009880; P:embryonic pattern specification; IEA:Ensembl
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0035136; P:forelimb morphogenesis; IEA:Ensembl
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0030097; P:hemopoiesis; IDA:UniProtKB
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0048133; P:male germ-line stem cell division; IEA:Ensembl
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0001823; P:mesonephros development; ISS:UniProtKB
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0030099; P:myeloid cell differentiation; TAS:UniProtKB
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0045638; P:negative regulation of myeloid cell differentiation; ISS:UniProtKB
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0061036; P:positive regulation of cartilage development; IDA:UniProtKB
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0032332; P:positive regulation of chondrocyte differentiation; IMP:UniProtKB
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0045600; P:positive regulation of fat cell differentiation; IMP:UniProtKB
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0045778; P:positive regulation of ossification; IDA:UniProtKB
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0034504; P:protein localization to nucleus; IEA:Ensembl
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q05516	ZBTB16	Zinc finger and BTB domain-containing protein 16	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13105	ZBTB17	Zinc finger and BTB domain-containing protein 17	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q13105	ZBTB17	Zinc finger and BTB domain-containing protein 17	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13105	ZBTB17	Zinc finger and BTB domain-containing protein 17	GO:0005515; F:protein binding; IPI:UniProtKB
Q13105	ZBTB17	Zinc finger and BTB domain-containing protein 17	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q13105	ZBTB17	Zinc finger and BTB domain-containing protein 17	GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; TAS:Reactome
Q13105	ZBTB17	Zinc finger and BTB domain-containing protein 17	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q13105	ZBTB17	Zinc finger and BTB domain-containing protein 17	GO:0007398; P:ectoderm development; IEA:Ensembl
Q13105	ZBTB17	Zinc finger and BTB domain-containing protein 17	GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:Reactome
Q13105	ZBTB17	Zinc finger and BTB domain-containing protein 17	GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl
Q13105	ZBTB17	Zinc finger and BTB domain-containing protein 17	GO:0045786; P:negative regulation of cell cycle; TAS:UniProtKB
Q13105	ZBTB17	Zinc finger and BTB domain-containing protein 17	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q13105	ZBTB17	Zinc finger and BTB domain-containing protein 17	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q99592	ZBTB18	Zinc finger and BTB domain-containing protein 18	GO:0003677; F:DNA binding; TAS:UniProtKB
Q99592	ZBTB18	Zinc finger and BTB domain-containing protein 18	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q99592	ZBTB18	Zinc finger and BTB domain-containing protein 18	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q99592	ZBTB18	Zinc finger and BTB domain-containing protein 18	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q99592	ZBTB18	Zinc finger and BTB domain-containing protein 18	GO:0021549; P:cerebellum development; IEA:Ensembl
Q99592	ZBTB18	Zinc finger and BTB domain-containing protein 18	GO:0021987; P:cerebral cortex development; IEA:Ensembl
Q99592	ZBTB18	Zinc finger and BTB domain-containing protein 18	GO:0021766; P:hippocampus development; IEA:Ensembl
Q99592	ZBTB18	Zinc finger and BTB domain-containing protein 18	GO:0048872; P:homeostasis of number of cells; IEA:Ensembl
Q99592	ZBTB18	Zinc finger and BTB domain-containing protein 18	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q99592	ZBTB18	Zinc finger and BTB domain-containing protein 18	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q99592	ZBTB18	Zinc finger and BTB domain-containing protein 18	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q99592	ZBTB18	Zinc finger and BTB domain-containing protein 18	GO:0048666; P:neuron development; IEA:Ensembl
Q99592	ZBTB18	Zinc finger and BTB domain-containing protein 18	GO:0051302; P:regulation of cell division; IEA:Ensembl
Q99592	ZBTB18	Zinc finger and BTB domain-containing protein 18	GO:0007519; P:skeletal muscle tissue development; ISS:UniProtKB
Q99592	ZBTB18	Zinc finger and BTB domain-containing protein 18	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HC78	ZBTB20	Zinc finger and BTB domain-containing protein 20	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9HC78	ZBTB20	Zinc finger and BTB domain-containing protein 20	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HC78	ZBTB20	Zinc finger and BTB domain-containing protein 20	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IEA:Ensembl
Q9ULJ3	ZBTB21	Zinc finger and BTB domain-containing protein 21	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9ULJ3	ZBTB21	Zinc finger and BTB domain-containing protein 21	GO:0008327; F:methyl-CpG binding; IDA:UniProtKB
Q9ULJ3	ZBTB21	Zinc finger and BTB domain-containing protein 21	GO:0005515; F:protein binding; IPI:UniProtKB
Q9ULJ3	ZBTB21	Zinc finger and BTB domain-containing protein 21	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9ULJ3	ZBTB21	Zinc finger and BTB domain-containing protein 21	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9ULJ3	ZBTB21	Zinc finger and BTB domain-containing protein 21	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43167	ZBTB24	Zinc finger and BTB domain-containing protein 24	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O43167	ZBTB24	Zinc finger and BTB domain-containing protein 24	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43167	ZBTB24	Zinc finger and BTB domain-containing protein 24	GO:0005515; F:protein binding; IPI:IntAct
O43167	ZBTB24	Zinc finger and BTB domain-containing protein 24	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O43167	ZBTB24	Zinc finger and BTB domain-containing protein 24	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15209	ZBTB22	Zinc finger and BTB domain-containing protein 22	GO:0003677; F:DNA binding; TAS:ProtInc
O15209	ZBTB22	Zinc finger and BTB domain-containing protein 22	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15209	ZBTB22	Zinc finger and BTB domain-containing protein 22	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O15209	ZBTB22	Zinc finger and BTB domain-containing protein 22	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P24278	ZBTB25	Zinc finger and BTB domain-containing protein 25	GO:0003677; F:DNA binding; IDA:UniProtKB
P24278	ZBTB25	Zinc finger and BTB domain-containing protein 25	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P24278	ZBTB25	Zinc finger and BTB domain-containing protein 25	GO:0005515; F:protein binding; IPI:IntAct
P24278	ZBTB25	Zinc finger and BTB domain-containing protein 25	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P24278	ZBTB25	Zinc finger and BTB domain-containing protein 25	GO:0010467; P:gene expression; IEP:UniProtKB
P24278	ZBTB25	Zinc finger and BTB domain-containing protein 25	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HCK0	ZBTB26	Zinc finger and BTB domain-containing protein 26	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9HCK0	ZBTB26	Zinc finger and BTB domain-containing protein 26	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HCK0	ZBTB26	Zinc finger and BTB domain-containing protein 26	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9HCK0	ZBTB26	Zinc finger and BTB domain-containing protein 26	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2Y4	ZBTB32	Zinc finger and BTB domain-containing protein 32	GO:0003677; F:DNA binding; ISS:UniProtKB
Q9Y2Y4	ZBTB32	Zinc finger and BTB domain-containing protein 32	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2Y4	ZBTB32	Zinc finger and BTB domain-containing protein 32	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q9Y2Y4	ZBTB32	Zinc finger and BTB domain-containing protein 32	GO:0008270; F:zinc ion binding; ISS:UniProtKB
Q9Y2Y4	ZBTB32	Zinc finger and BTB domain-containing protein 32	GO:0006281; P:DNA repair; TAS:Reactome
Q9Y2Y4	ZBTB32	Zinc finger and BTB domain-containing protein 32	GO:0030097; P:hemopoiesis; IEA:Ensembl
Q9Y2Y4	ZBTB32	Zinc finger and BTB domain-containing protein 32	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9Y2Y4	ZBTB32	Zinc finger and BTB domain-containing protein 32	GO:0001817; P:regulation of cytokine production; IEA:Ensembl
Q9Y2Y4	ZBTB32	Zinc finger and BTB domain-containing protein 32	GO:0042098; P:T cell proliferation; IEA:Ensembl
Q9Y2Y4	ZBTB32	Zinc finger and BTB domain-containing protein 32	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q8NCN2	ZBTB34	Zinc finger and BTB domain-containing protein 34	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NCN2	ZBTB34	Zinc finger and BTB domain-containing protein 34	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NCN2	ZBTB34	Zinc finger and BTB domain-containing protein 34	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NCN2	ZBTB34	Zinc finger and BTB domain-containing protein 34	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5TC79	ZBTB37	Zinc finger and BTB domain-containing protein 37	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5TC79	ZBTB37	Zinc finger and BTB domain-containing protein 37	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5TC79	ZBTB37	Zinc finger and BTB domain-containing protein 37	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5TC79	ZBTB37	Zinc finger and BTB domain-containing protein 37	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NAP3	ZBTB38	Zinc finger and BTB domain-containing protein 38	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NAP3	ZBTB38	Zinc finger and BTB domain-containing protein 38	GO:0008327; F:methyl-CpG binding; IDA:UniProt
Q8NAP3	ZBTB38	Zinc finger and BTB domain-containing protein 38	GO:0005515; F:protein binding; IPI:UniProt
Q8NAP3	ZBTB38	Zinc finger and BTB domain-containing protein 38	GO:0042803; F:protein homodimerization activity; IDA:UniProt
Q8NAP3	ZBTB38	Zinc finger and BTB domain-containing protein 38	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q8NAP3	ZBTB38	Zinc finger and BTB domain-containing protein 38	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProt
Q8NAP3	ZBTB38	Zinc finger and BTB domain-containing protein 38	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q8NAP3	ZBTB38	Zinc finger and BTB domain-containing protein 38	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NUA8	ZBTB40	Zinc finger and BTB domain-containing protein 40	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NUA8	ZBTB40	Zinc finger and BTB domain-containing protein 40	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NUA8	ZBTB40	Zinc finger and BTB domain-containing protein 40	GO:0030282; P:bone mineralization; NAS:UniProtKB
Q9NUA8	ZBTB40	Zinc finger and BTB domain-containing protein 40	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q9NUA8	ZBTB40	Zinc finger and BTB domain-containing protein 40	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NUA8	ZBTB40	Zinc finger and BTB domain-containing protein 40	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15060	ZBTB39	Zinc finger and BTB domain-containing protein 39	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O15060	ZBTB39	Zinc finger and BTB domain-containing protein 39	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15060	ZBTB39	Zinc finger and BTB domain-containing protein 39	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O15060	ZBTB39	Zinc finger and BTB domain-containing protein 39	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5SVQ8	ZBTB41	Zinc finger and BTB domain-containing protein 41	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5SVQ8	ZBTB41	Zinc finger and BTB domain-containing protein 41	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5SVQ8	ZBTB41	Zinc finger and BTB domain-containing protein 41	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5SVQ8	ZBTB41	Zinc finger and BTB domain-containing protein 41	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
B2RXF5	ZBTB42	Zinc finger and BTB domain-containing protein 42	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
B2RXF5	ZBTB42	Zinc finger and BTB domain-containing protein 42	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
B2RXF5	ZBTB42	Zinc finger and BTB domain-containing protein 42	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
B2RXF5	ZBTB42	Zinc finger and BTB domain-containing protein 42	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43298	ZBTB43	Zinc finger and BTB domain-containing protein 43	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O43298	ZBTB43	Zinc finger and BTB domain-containing protein 43	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43298	ZBTB43	Zinc finger and BTB domain-containing protein 43	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O43298	ZBTB43	Zinc finger and BTB domain-containing protein 43	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NCP5	ZBTB44	Zinc finger and BTB domain-containing protein 44	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NCP5	ZBTB44	Zinc finger and BTB domain-containing protein 44	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NCP5	ZBTB44	Zinc finger and BTB domain-containing protein 44	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NCP5	ZBTB44	Zinc finger and BTB domain-containing protein 44	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86UZ6	ZBTB46	Zinc finger and BTB domain-containing protein 46	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86UZ6	ZBTB46	Zinc finger and BTB domain-containing protein 46	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q86UZ6	ZBTB46	Zinc finger and BTB domain-containing protein 46	GO:2001199; P:negative regulation of dendritic cell differentiation; IEA:Ensembl
Q86UZ6	ZBTB46	Zinc finger and BTB domain-containing protein 46	GO:0030853; P:negative regulation of granulocyte differentiation; IEA:Ensembl
Q86UZ6	ZBTB46	Zinc finger and BTB domain-containing protein 46	GO:0045650; P:negative regulation of macrophage differentiation; IEA:Ensembl
Q86UZ6	ZBTB46	Zinc finger and BTB domain-containing protein 46	GO:0045656; P:negative regulation of monocyte differentiation; IEA:Ensembl
Q86UZ6	ZBTB46	Zinc finger and BTB domain-containing protein 46	GO:2001200; P:positive regulation of dendritic cell differentiation; IEA:Ensembl
Q86UZ6	ZBTB46	Zinc finger and BTB domain-containing protein 46	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q86UZ6	ZBTB46	Zinc finger and BTB domain-containing protein 46	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96K62	ZBTB45	Zinc finger and BTB domain-containing protein 45	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96K62	ZBTB45	Zinc finger and BTB domain-containing protein 45	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96K62	ZBTB45	Zinc finger and BTB domain-containing protein 45	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96K62	ZBTB45	Zinc finger and BTB domain-containing protein 45	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UFB7	ZBTB47	Zinc finger and BTB domain-containing protein 47	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UFB7	ZBTB47	Zinc finger and BTB domain-containing protein 47	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UFB7	ZBTB47	Zinc finger and BTB domain-containing protein 47	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UFB7	ZBTB47	Zinc finger and BTB domain-containing protein 47	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P10074	ZBTB48	Zinc finger and BTB domain-containing protein 48	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P10074	ZBTB48	Zinc finger and BTB domain-containing protein 48	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P10074	ZBTB48	Zinc finger and BTB domain-containing protein 48	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P10074	ZBTB48	Zinc finger and BTB domain-containing protein 48	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZSB9	ZBTB49	Zinc finger and BTB domain-containing protein 49	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZSB9	ZBTB49	Zinc finger and BTB domain-containing protein 49	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZSB9	ZBTB49	Zinc finger and BTB domain-containing protein 49	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZSB9	ZBTB49	Zinc finger and BTB domain-containing protein 49	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95365	ZBTB7A	Zinc finger and BTB domain-containing protein 7A	GO:0003677; F:DNA binding; ISS:UniProtKB
O95365	ZBTB7A	Zinc finger and BTB domain-containing protein 7A	GO:0035035; F:histone acetyltransferase binding; ISS:UniProtKB
O95365	ZBTB7A	Zinc finger and BTB domain-containing protein 7A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95365	ZBTB7A	Zinc finger and BTB domain-containing protein 7A	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O95365	ZBTB7A	Zinc finger and BTB domain-containing protein 7A	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
O95365	ZBTB7A	Zinc finger and BTB domain-containing protein 7A	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O95365	ZBTB7A	Zinc finger and BTB domain-containing protein 7A	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
O95365	ZBTB7A	Zinc finger and BTB domain-containing protein 7A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15156	ZBTB7B	Zinc finger and BTB domain-containing protein 7B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O15156	ZBTB7B	Zinc finger and BTB domain-containing protein 7B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15156	ZBTB7B	Zinc finger and BTB domain-containing protein 7B	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O15156	ZBTB7B	Zinc finger and BTB domain-containing protein 7B	GO:0007398; P:ectoderm development; TAS:ProtInc
O15156	ZBTB7B	Zinc finger and BTB domain-containing protein 7B	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
O15156	ZBTB7B	Zinc finger and BTB domain-containing protein 7B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O15156	ZBTB7B	Zinc finger and BTB domain-containing protein 7B	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
A1YPR0	ZBTB7C	Zinc finger and BTB domain-containing protein 7C	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A1YPR0	ZBTB7C	Zinc finger and BTB domain-containing protein 7C	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q96BR9	ZBTB8A	Zinc finger and BTB domain-containing protein 8A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96BR9	ZBTB8A	Zinc finger and BTB domain-containing protein 8A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96BR9	ZBTB8A	Zinc finger and BTB domain-containing protein 8A	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96BR9	ZBTB8A	Zinc finger and BTB domain-containing protein 8A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NAP8	ZBTB8B	Zinc finger and BTB domain-containing protein 8B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NAP8	ZBTB8B	Zinc finger and BTB domain-containing protein 8B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NAP8	ZBTB8B	Zinc finger and BTB domain-containing protein 8B	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NAP8	ZBTB8B	Zinc finger and BTB domain-containing protein 8B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2K1	ZBTB1	Zinc finger and BTB domain-containing protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y2K1	ZBTB1	Zinc finger and BTB domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y2K1	ZBTB1	Zinc finger and BTB domain-containing protein 1	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
Q9Y2K1	ZBTB1	Zinc finger and BTB domain-containing protein 1	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q9Y2K1	ZBTB1	Zinc finger and BTB domain-containing protein 1	GO:0030183; P:B cell differentiation; IEA:Ensembl
Q9Y2K1	ZBTB1	Zinc finger and BTB domain-containing protein 1	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q9Y2K1	ZBTB1	Zinc finger and BTB domain-containing protein 1	GO:0042789; P:mRNA transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9Y2K1	ZBTB1	Zinc finger and BTB domain-containing protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9Y2K1	ZBTB1	Zinc finger and BTB domain-containing protein 1	GO:0032825; P:positive regulation of natural killer cell differentiation; ISS:UniProtKB
Q9Y2K1	ZBTB1	Zinc finger and BTB domain-containing protein 1	GO:2000176; P:positive regulation of pro-T cell differentiation; ISS:UniProtKB
Q9Y2K1	ZBTB1	Zinc finger and BTB domain-containing protein 1	GO:0045582; P:positive regulation of T cell differentiation; ISS:UniProtKB
Q9Y2K1	ZBTB1	Zinc finger and BTB domain-containing protein 1	GO:0002711; P:positive regulation of T cell mediated immunity; ISS:UniProtKB
Q9Y2K1	ZBTB1	Zinc finger and BTB domain-containing protein 1	GO:0051260; P:protein homooligomerization; IDA:UniProtKB
Q9Y2K1	ZBTB1	Zinc finger and BTB domain-containing protein 1	GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl
Q9Y2K1	ZBTB1	Zinc finger and BTB domain-containing protein 1	GO:0048538; P:thymus development; ISS:UniProtKB
Q8N680	ZBTB2	Zinc finger and BTB domain-containing protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N680	ZBTB2	Zinc finger and BTB domain-containing protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N680	ZBTB2	Zinc finger and BTB domain-containing protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N680	ZBTB2	Zinc finger and BTB domain-containing protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H5J0	ZBTB3	Zinc finger and BTB domain-containing protein 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H5J0	ZBTB3	Zinc finger and BTB domain-containing protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H5J0	ZBTB3	Zinc finger and BTB domain-containing protein 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H5J0	ZBTB3	Zinc finger and BTB domain-containing protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9P1Z0	ZBTB4	Zinc finger and BTB domain-containing protein 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9P1Z0	ZBTB4	Zinc finger and BTB domain-containing protein 4	GO:0008327; F:methyl-CpG binding; IDA:UniProt
Q9P1Z0	ZBTB4	Zinc finger and BTB domain-containing protein 4	GO:0010428; F:methyl-CpNpG binding; IDA:UniProt
Q9P1Z0	ZBTB4	Zinc finger and BTB domain-containing protein 4	GO:0005515; F:protein binding; IPI:UniProt
Q9P1Z0	ZBTB4	Zinc finger and BTB domain-containing protein 4	GO:0042803; F:protein homodimerization activity; IDA:UniProt
Q9P1Z0	ZBTB4	Zinc finger and BTB domain-containing protein 4	GO:0019901; F:protein kinase binding; IPI:UniProt
Q9P1Z0	ZBTB4	Zinc finger and BTB domain-containing protein 4	GO:0043565; F:sequence-specific DNA binding; IDA:UniProt
Q9P1Z0	ZBTB4	Zinc finger and BTB domain-containing protein 4	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProt
Q9P1Z0	ZBTB4	Zinc finger and BTB domain-containing protein 4	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProt
Q9P1Z0	ZBTB4	Zinc finger and BTB domain-containing protein 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15062	ZBTB5	Zinc finger and BTB domain-containing protein 5	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O15062	ZBTB5	Zinc finger and BTB domain-containing protein 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15062	ZBTB5	Zinc finger and BTB domain-containing protein 5	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O15062	ZBTB5	Zinc finger and BTB domain-containing protein 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15916	ZBTB6	Zinc finger and BTB domain-containing protein 6	GO:0003677; F:DNA binding; TAS:ProtInc
Q15916	ZBTB6	Zinc finger and BTB domain-containing protein 6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15916	ZBTB6	Zinc finger and BTB domain-containing protein 6	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q15916	ZBTB6	Zinc finger and BTB domain-containing protein 6	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96C00	ZBTB9	Zinc finger and BTB domain-containing protein 9	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96C00	ZBTB9	Zinc finger and BTB domain-containing protein 9	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96C00	ZBTB9	Zinc finger and BTB domain-containing protein 9	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96C00	ZBTB9	Zinc finger and BTB domain-containing protein 9	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75152	ZC3H11A	Zinc finger CCCH domain-containing protein 11A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75152	ZC3H11A	Zinc finger CCCH domain-containing protein 11A	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O75152	ZC3H11A	Zinc finger CCCH domain-containing protein 11A	GO:0005515; F:protein binding; IPI:UniProtKB
O75152	ZC3H11A	Zinc finger CCCH domain-containing protein 11A	GO:0016973; P:poly(A)+ mRNA export from nucleus; IMP:UniProtKB
Q5HYM0	ZC3H12B	Probable ribonuclease ZC3H12B	GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW
Q5HYM0	ZC3H12B	Probable ribonuclease ZC3H12B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9C0D7	ZC3H12C	Probable ribonuclease ZC3H12C	GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW
Q9C0D7	ZC3H12C	Probable ribonuclease ZC3H12C	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5D1E8	ZC3H12A	Ribonuclease ZC3H12A	GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW
Q5D1E8	ZC3H12A	Ribonuclease ZC3H12A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5D1E8	ZC3H12A	Ribonuclease ZC3H12A	GO:0005515; F:protein binding; IPI:IntAct
Q5D1E8	ZC3H12A	Ribonuclease ZC3H12A	GO:0001525; P:angiogenesis; IEA:UniProtKB-KW
Q5D1E8	ZC3H12A	Ribonuclease ZC3H12A	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q5D1E8	ZC3H12A	Ribonuclease ZC3H12A	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q5D1E8	ZC3H12A	Ribonuclease ZC3H12A	GO:0071222; P:cellular response to lipopolysaccharide; IDA:BHF-UCL
Q5D1E8	ZC3H12A	Ribonuclease ZC3H12A	GO:0010629; P:negative regulation of gene expression; IDA:BHF-UCL
Q5D1E8	ZC3H12A	Ribonuclease ZC3H12A	GO:0032715; P:negative regulation of interleukin-6 production; IDA:BHF-UCL
Q5D1E8	ZC3H12A	Ribonuclease ZC3H12A	GO:0043031; P:negative regulation of macrophage activation; IC:BHF-UCL
Q5D1E8	ZC3H12A	Ribonuclease ZC3H12A	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:BHF-UCL
Q5D1E8	ZC3H12A	Ribonuclease ZC3H12A	GO:0045019; P:negative regulation of nitric oxide biosynthetic process; IDA:BHF-UCL
Q5D1E8	ZC3H12A	Ribonuclease ZC3H12A	GO:0032720; P:negative regulation of tumor necrosis factor production; IDA:BHF-UCL
Q5D1E8	ZC3H12A	Ribonuclease ZC3H12A	GO:0010508; P:positive regulation of autophagy; IDA:BHF-UCL
Q5D1E8	ZC3H12A	Ribonuclease ZC3H12A	GO:0045600; P:positive regulation of fat cell differentiation; IDA:BHF-UCL
Q5D1E8	ZC3H12A	Ribonuclease ZC3H12A	GO:0010628; P:positive regulation of gene expression; IDA:BHF-UCL
Q5D1E8	ZC3H12A	Ribonuclease ZC3H12A	GO:0010884; P:positive regulation of lipid storage; IDA:BHF-UCL
Q5D1E8	ZC3H12A	Ribonuclease ZC3H12A	GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IDA:BHF-UCL
A2A288	ZC3H12D	Probable ribonuclease ZC3H12D	GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW
A2A288	ZC3H12D	Probable ribonuclease ZC3H12D	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A2A288	ZC3H12D	Probable ribonuclease ZC3H12D	GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB
A2A288	ZC3H12D	Probable ribonuclease ZC3H12D	GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IDA:UniProtKB
Q96GY0	ZC2HC1A	Zinc finger C2HC domain-containing protein 1A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5TFG8	ZC2HC1B	Zinc finger C2HC domain-containing protein 1B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q53FD0	ZC2HC1C	Zinc finger C2HC domain-containing protein 1C	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60293	ZFC3H1	Zinc finger C3H1 domain-containing protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60293	ZFC3H1	Zinc finger C3H1 domain-containing protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O60293	ZFC3H1	Zinc finger C3H1 domain-containing protein	GO:0005515; F:protein binding; IPI:IntAct
O60293	ZFC3H1	Zinc finger C3H1 domain-containing protein	GO:0006396; P:RNA processing; IEA:InterPro
Q9UPT8	ZC3H4	Zinc finger CCCH domain-containing protein 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UPT8	ZC3H4	Zinc finger CCCH domain-containing protein 4	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8IXZ2	ZC3H3	Zinc finger CCCH domain-containing protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IXZ2	ZC3H3	Zinc finger CCCH domain-containing protein 3	GO:0006378; P:mRNA polyadenylation; IMP:UniProtKB
Q8IXZ2	ZC3H3	Zinc finger CCCH domain-containing protein 3	GO:0016973; P:poly(A)+ mRNA export from nucleus; IMP:UniProtKB
Q8IXZ2	ZC3H3	Zinc finger CCCH domain-containing protein 3	GO:0010793; P:regulation of mRNA export from nucleus; IMP:UniProtKB
P61129	ZC3H6	Zinc finger CCCH domain-containing protein 6	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N5P1	ZC3H8	Zinc finger CCCH domain-containing protein 8	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N5P1	ZC3H8	Zinc finger CCCH domain-containing protein 8	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8N5P1	ZC3H8	Zinc finger CCCH domain-containing protein 8	GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB
Q8N5P1	ZC3H8	Zinc finger CCCH domain-containing protein 8	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IMP:UniProtKB
Q8N5P1	ZC3H8	Zinc finger CCCH domain-containing protein 8	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8N5P1	ZC3H8	Zinc finger CCCH domain-containing protein 8	GO:0033085; P:negative regulation of T cell differentiation in thymus; IMP:UniProtKB
Q8N5P1	ZC3H8	Zinc finger CCCH domain-containing protein 8	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q8N5P1	ZC3H8	Zinc finger CCCH domain-containing protein 8	GO:0070245; P:positive regulation of thymocyte apoptotic process; IMP:UniProtKB
Q8N5P1	ZC3H8	Zinc finger CCCH domain-containing protein 8	GO:0046677; P:response to antibiotic; IDA:UniProtKB
Q8N5P1	ZC3H8	Zinc finger CCCH domain-containing protein 8	GO:0043029; P:T cell homeostasis; IMP:UniProtKB
Q8N5P1	ZC3H8	Zinc finger CCCH domain-containing protein 8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5T200	ZC3H13	Zinc finger CCCH domain-containing protein 13	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5T200	ZC3H13	Zinc finger CCCH domain-containing protein 13	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q5T200	ZC3H13	Zinc finger CCCH domain-containing protein 13	GO:0005515; F:protein binding; IPI:IntAct
Q96K80	ZC3H10	Zinc finger CCCH domain-containing protein 10	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96K80	ZC3H10	Zinc finger CCCH domain-containing protein 10	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96K80	ZC3H10	Zinc finger CCCH domain-containing protein 10	GO:0005515; F:protein binding; IPI:IntAct
Q6PJT7	ZC3H14	Zinc finger CCCH domain-containing protein 14	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6PJT7	ZC3H14	Zinc finger CCCH domain-containing protein 14	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6PJT7	ZC3H14	Zinc finger CCCH domain-containing protein 14	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WU90	ZC3H15	Zinc finger CCCH domain-containing protein 15	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8WU90	ZC3H15	Zinc finger CCCH domain-containing protein 15	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8WU90	ZC3H15	Zinc finger CCCH domain-containing protein 15	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WU90	ZC3H15	Zinc finger CCCH domain-containing protein 15	GO:0019221; P:cytokine-mediated signaling pathway; IEA:Ensembl
Q9NQZ6	ZC4H2	Zinc finger C4H2 domain-containing protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NQZ6	ZC4H2	Zinc finger C4H2 domain-containing protein	GO:0007399; P:nervous system development; IDA:UniProtKB
Q9NQZ6	ZC4H2	Zinc finger C4H2 domain-containing protein	GO:0007528; P:neuromuscular junction development; ISS:UniProtKB
Q9NQZ6	ZC4H2	Zinc finger C4H2 domain-containing protein	GO:0021522; P:spinal cord motor neuron differentiation; ISS:UniProtKB
P0CG32	ZCCHC18	Putative zinc finger CCHC domain-containing protein 18	GO:0003676; F:nucleic acid binding; IEA:InterPro
P0CG32	ZCCHC18	Putative zinc finger CCHC domain-containing protein 18	GO:0008270; F:zinc ion binding; IEA:InterPro
Q7Z2W4	ZC3HAV1	Zinc finger CCCH-type antiviral protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z2W4	ZC3HAV1	Zinc finger CCCH-type antiviral protein 1	GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IEA:InterPro
Q7Z2W4	ZC3HAV1	Zinc finger CCCH-type antiviral protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q7Z2W4	ZC3HAV1	Zinc finger CCCH-type antiviral protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q7Z2W4	ZC3HAV1	Zinc finger CCCH-type antiviral protein 1	GO:0071360; P:cellular response to exogenous dsRNA; IEA:Ensembl
Q7Z2W4	ZC3HAV1	Zinc finger CCCH-type antiviral protein 1	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q7Z2W4	ZC3HAV1	Zinc finger CCCH-type antiviral protein 1	GO:0045087; P:innate immune response; IEA:UniProtKB-KW
Q7Z2W4	ZC3HAV1	Zinc finger CCCH-type antiviral protein 1	GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB
Q7Z2W4	ZC3HAV1	Zinc finger CCCH-type antiviral protein 1	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q7Z2W4	ZC3HAV1	Zinc finger CCCH-type antiviral protein 1	GO:0032727; P:positive regulation of interferon-alpha production; IDA:UniProtKB
Q7Z2W4	ZC3HAV1	Zinc finger CCCH-type antiviral protein 1	GO:0032728; P:positive regulation of interferon-beta production; IDA:UniProtKB
Q7Z2W4	ZC3HAV1	Zinc finger CCCH-type antiviral protein 1	GO:0061014; P:positive regulation of mRNA catabolic process; IDA:UniProtKB
Q7Z2W4	ZC3HAV1	Zinc finger CCCH-type antiviral protein 1	GO:1900246; P:positive regulation of RIG-I signaling pathway; IMP:UniProtKB
Q7Z2W4	ZC3HAV1	Zinc finger CCCH-type antiviral protein 1	GO:0032481; P:positive regulation of type I interferon production; IEA:Ensembl
Q7Z2W4	ZC3HAV1	Zinc finger CCCH-type antiviral protein 1	GO:0009615; P:response to virus; IDA:UniProtKB
Q8TBK6	ZCCHC10	Zinc finger CCHC domain-containing protein 10	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8TBK6	ZCCHC10	Zinc finger CCHC domain-containing protein 10	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6PEW1	ZCCHC12	Zinc finger CCHC domain-containing protein 12	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IBA:RefGenome
Q6PEW1	ZCCHC12	Zinc finger CCHC domain-containing protein 12	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q6PEW1	ZCCHC12	Zinc finger CCHC domain-containing protein 12	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6PEW1	ZCCHC12	Zinc finger CCHC domain-containing protein 12	GO:0030509; P:BMP signaling pathway; IBA:RefGenome
Q6PEW1	ZCCHC12	Zinc finger CCHC domain-containing protein 12	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WW36	ZCCHC13	Zinc finger CCHC domain-containing protein 13	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8WW36	ZCCHC13	Zinc finger CCHC domain-containing protein 13	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WYQ9	ZCCHC14	Zinc finger CCHC domain-containing protein 14	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8WYQ9	ZCCHC14	Zinc finger CCHC domain-containing protein 14	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
Q8WYQ9	ZCCHC14	Zinc finger CCHC domain-containing protein 14	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6ZR62	ZCCHC16	Zinc finger CCHC domain-containing protein 16	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q6ZR62	ZCCHC16	Zinc finger CCHC domain-containing protein 16	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86VM9	ZC3H18	Zinc finger CCCH domain-containing protein 18	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86VM9	ZC3H18	Zinc finger CCCH domain-containing protein 18	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8N2G6	ZCCHC24	Zinc finger CCHC domain-containing protein 24	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8N2G6	ZCCHC24	Zinc finger CCHC domain-containing protein 24	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6ZST2	ZCCHC23	Zinc finger CCHC domain-containing protein 23	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q6ZST2	ZCCHC23	Zinc finger CCHC domain-containing protein 23	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9C0B9	ZCCHC2	Zinc finger CCHC domain-containing protein 2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9C0B9	ZCCHC2	Zinc finger CCHC domain-containing protein 2	GO:0035091; F:phosphatidylinositol binding; IEA:InterPro
Q9C0B9	ZCCHC2	Zinc finger CCHC domain-containing protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NUD5	ZCCHC3	Zinc finger CCHC domain-containing protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9NUD5	ZCCHC3	Zinc finger CCHC domain-containing protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H5U6	ZCCHC4	Zinc finger CCHC domain-containing protein 4	GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW
Q9H5U6	ZCCHC4	Zinc finger CCHC domain-containing protein 4	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9H5U6	ZCCHC4	Zinc finger CCHC domain-containing protein 4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N8U3	ZCCHC5	Zinc finger CCHC domain-containing protein 5	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8N8U3	ZCCHC5	Zinc finger CCHC domain-containing protein 5	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N3Z6	ZCCHC7	Zinc finger CCHC domain-containing protein 7	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8N3Z6	ZCCHC7	Zinc finger CCHC domain-containing protein 7	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6NZY4	ZCCHC8	Zinc finger CCHC domain-containing protein 8	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q6NZY4	ZCCHC8	Zinc finger CCHC domain-containing protein 8	GO:0005515; F:protein binding; IPI:IntAct
Q6NZY4	ZCCHC8	Zinc finger CCHC domain-containing protein 8	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6NZY4	ZCCHC8	Zinc finger CCHC domain-containing protein 8	GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB
Q8N567	ZCCHC9	Zinc finger CCHC domain-containing protein 9	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8N567	ZCCHC9	Zinc finger CCHC domain-containing protein 9	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N567	ZCCHC9	Zinc finger CCHC domain-containing protein 9	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
Q9H0M4	ZCWPW1	Zinc finger CW-type PWWP domain protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q504Y3	ZCWPW2	Zinc finger CW-type PWWP domain protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TBF4	ZCRB1	Zinc finger CCHC-type and RNA-binding motif-containing protein 1	GO:0000166; F:nucleotide binding; IEA:InterPro
Q8TBF4	ZCRB1	Zinc finger CCHC-type and RNA-binding motif-containing protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8TBF4	ZCRB1	Zinc finger CCHC-type and RNA-binding motif-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8TBF4	ZCRB1	Zinc finger CCHC-type and RNA-binding motif-containing protein 1	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q8TBF4	ZCRB1	Zinc finger CCHC-type and RNA-binding motif-containing protein 1	GO:0008380; P:RNA splicing; IC:HGNC
Q9HCK1	ZDBF2	DBF4-type zinc finger-containing protein 2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9HCK1	ZDBF2	DBF4-type zinc finger-containing protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H8X9	ZDHHC11	Probable palmitoyltransferase ZDHHC11	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q9H8X9	ZDHHC11	Probable palmitoyltransferase ZDHHC11	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96GR4	ZDHHC12	Probable palmitoyltransferase ZDHHC12	GO:0016409; F:palmitoyltransferase activity; IDA:UniProt
Q96GR4	ZDHHC12	Probable palmitoyltransferase ZDHHC12	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q96GR4	ZDHHC12	Probable palmitoyltransferase ZDHHC12	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96GR4	ZDHHC12	Probable palmitoyltransferase ZDHHC12	GO:0018345; P:protein palmitoylation; IDA:UniProt
Q8IUH4	ZDHHC13	Palmitoyltransferase ZDHHC13	GO:0015095; F:magnesium ion transmembrane transporter activity; ISS:UniProtKB
Q8IUH4	ZDHHC13	Palmitoyltransferase ZDHHC13	GO:0016409; F:palmitoyltransferase activity; ISS:UniProtKB
Q8IUH4	ZDHHC13	Palmitoyltransferase ZDHHC13	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q8IUH4	ZDHHC13	Palmitoyltransferase ZDHHC13	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q8IUH4	ZDHHC13	Palmitoyltransferase ZDHHC13	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IUH4	ZDHHC13	Palmitoyltransferase ZDHHC13	GO:0008152; P:metabolic process; ISS:GOC
Q8IUH4	ZDHHC13	Palmitoyltransferase ZDHHC13	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q8IUH4	ZDHHC13	Palmitoyltransferase ZDHHC13	GO:0007165; P:signal transduction; IMP:GOC
Q8IZN3	ZDHHC14	Probable palmitoyltransferase ZDHHC14	GO:0016409; F:palmitoyltransferase activity; IDA:UniProt
Q8IZN3	ZDHHC14	Probable palmitoyltransferase ZDHHC14	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q8IZN3	ZDHHC14	Probable palmitoyltransferase ZDHHC14	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IZN3	ZDHHC14	Probable palmitoyltransferase ZDHHC14	GO:0018345; P:protein palmitoylation; IDA:UniProt
Q96MV8	ZDHHC15	Palmitoyltransferase ZDHHC15	GO:0016409; F:palmitoyltransferase activity; IDA:UniProt
Q96MV8	ZDHHC15	Palmitoyltransferase ZDHHC15	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q96MV8	ZDHHC15	Palmitoyltransferase ZDHHC15	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96MV8	ZDHHC15	Palmitoyltransferase ZDHHC15	GO:0045184; P:establishment of protein localization; IEA:Ensembl
Q96MV8	ZDHHC15	Palmitoyltransferase ZDHHC15	GO:0018345; P:protein palmitoylation; IDA:UniProt
Q96MV8	ZDHHC15	Palmitoyltransferase ZDHHC15	GO:0016188; P:synaptic vesicle maturation; IEA:Ensembl
Q969W1	ZDHHC16	Probable palmitoyltransferase ZDHHC16	GO:0016409; F:palmitoyltransferase activity; IDA:UniProt
Q969W1	ZDHHC16	Probable palmitoyltransferase ZDHHC16	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q969W1	ZDHHC16	Probable palmitoyltransferase ZDHHC16	GO:0008270; F:zinc ion binding; IEA:InterPro
Q969W1	ZDHHC16	Probable palmitoyltransferase ZDHHC16	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q969W1	ZDHHC16	Probable palmitoyltransferase ZDHHC16	GO:0018345; P:protein palmitoylation; IDA:UniProt
Q8IUH5	ZDHHC17	Palmitoyltransferase ZDHHC17	GO:0015095; F:magnesium ion transmembrane transporter activity; IDA:UniProtKB
Q8IUH5	ZDHHC17	Palmitoyltransferase ZDHHC17	GO:0016409; F:palmitoyltransferase activity; IDA:UniProt
Q8IUH5	ZDHHC17	Palmitoyltransferase ZDHHC17	GO:0005515; F:protein binding; IPI:IntAct
Q8IUH5	ZDHHC17	Palmitoyltransferase ZDHHC17	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IDA:UniProtKB
Q8IUH5	ZDHHC17	Palmitoyltransferase ZDHHC17	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q8IUH5	ZDHHC17	Palmitoyltransferase ZDHHC17	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IUH5	ZDHHC17	Palmitoyltransferase ZDHHC17	GO:0042953; P:lipoprotein transport; IDA:UniProtKB
Q8IUH5	ZDHHC17	Palmitoyltransferase ZDHHC17	GO:0015693; P:magnesium ion transport; IDA:GOC
Q8IUH5	ZDHHC17	Palmitoyltransferase ZDHHC17	GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q8IUH5	ZDHHC17	Palmitoyltransferase ZDHHC17	GO:0018345; P:protein palmitoylation; IDA:UniProt
Q8IUH5	ZDHHC17	Palmitoyltransferase ZDHHC17	GO:0007165; P:signal transduction; IMP:GOC
Q9NUE0	ZDHHC18	Palmitoyltransferase ZDHHC18	GO:0016409; F:palmitoyltransferase activity; IDA:UniProt
Q9NUE0	ZDHHC18	Palmitoyltransferase ZDHHC18	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q9NUE0	ZDHHC18	Palmitoyltransferase ZDHHC18	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NUE0	ZDHHC18	Palmitoyltransferase ZDHHC18	GO:0034613; P:cellular protein localization; IEA:Ensembl
Q9NUE0	ZDHHC18	Palmitoyltransferase ZDHHC18	GO:0018345; P:protein palmitoylation; IDA:UniProt
Q8WVZ1	ZDHHC19	Probable palmitoyltransferase ZDHHC19	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q8WVZ1	ZDHHC19	Probable palmitoyltransferase ZDHHC19	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5W0Z9	ZDHHC20	Probable palmitoyltransferase ZDHHC20	GO:0016409; F:palmitoyltransferase activity; IDA:UniProt
Q5W0Z9	ZDHHC20	Probable palmitoyltransferase ZDHHC20	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q5W0Z9	ZDHHC20	Probable palmitoyltransferase ZDHHC20	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5W0Z9	ZDHHC20	Probable palmitoyltransferase ZDHHC20	GO:0018345; P:protein palmitoylation; IDA:UniProt
Q8IVQ6	ZDHHC21	Palmitoyltransferase ZDHHC21	GO:0016409; F:palmitoyltransferase activity; IDA:UniProt
Q8IVQ6	ZDHHC21	Palmitoyltransferase ZDHHC21	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q8IVQ6	ZDHHC21	Palmitoyltransferase ZDHHC21	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IVQ6	ZDHHC21	Palmitoyltransferase ZDHHC21	GO:0001942; P:hair follicle development; IEA:Ensembl
Q8IVQ6	ZDHHC21	Palmitoyltransferase ZDHHC21	GO:0046209; P:nitric oxide metabolic process; TAS:Reactome
Q8IVQ6	ZDHHC21	Palmitoyltransferase ZDHHC21	GO:0018230; P:peptidyl-L-cysteine S-palmitoylation; IMP:UniProtKB
Q8IVQ6	ZDHHC21	Palmitoyltransferase ZDHHC21	GO:0018345; P:protein palmitoylation; IDA:UniProt
Q8IVQ6	ZDHHC21	Palmitoyltransferase ZDHHC21	GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome
Q8IVQ6	ZDHHC21	Palmitoyltransferase ZDHHC21	GO:0048733; P:sebaceous gland development; IEA:Ensembl
Q8IVQ6	ZDHHC21	Palmitoyltransferase ZDHHC21	GO:0044281; P:small molecule metabolic process; TAS:Reactome
Q8N966	ZDHHC22	Palmitoyltransferase ZDHHC22	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q8N966	ZDHHC22	Palmitoyltransferase ZDHHC22	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N966	ZDHHC22	Palmitoyltransferase ZDHHC22	GO:0072659; P:protein localization to plasma membrane; IEA:Ensembl
Q8N966	ZDHHC22	Palmitoyltransferase ZDHHC22	GO:0018345; P:protein palmitoylation; IEA:Ensembl
Q8IYP9	ZDHHC23	Palmitoyltransferase ZDHHC23	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q8IYP9	ZDHHC23	Palmitoyltransferase ZDHHC23	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IYP9	ZDHHC23	Palmitoyltransferase ZDHHC23	GO:0072659; P:protein localization to plasma membrane; IEA:Ensembl
Q8IYP9	ZDHHC23	Palmitoyltransferase ZDHHC23	GO:0018345; P:protein palmitoylation; IEA:Ensembl
Q6UX98	ZDHHC24	Probable palmitoyltransferase ZDHHC24	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q6UX98	ZDHHC24	Probable palmitoyltransferase ZDHHC24	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WTX9	ZDHHC1	Probable palmitoyltransferase ZDHHC1	GO:0003677; F:DNA binding; NAS:UniProtKB
Q8WTX9	ZDHHC1	Probable palmitoyltransferase ZDHHC1	GO:0016409; F:palmitoyltransferase activity; IDA:UniProt
Q8WTX9	ZDHHC1	Probable palmitoyltransferase ZDHHC1	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q8WTX9	ZDHHC1	Probable palmitoyltransferase ZDHHC1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WTX9	ZDHHC1	Probable palmitoyltransferase ZDHHC1	GO:0018345; P:protein palmitoylation; IDA:UniProt
Q9UIJ5	ZDHHC2	Palmitoyltransferase ZDHHC2	GO:0016409; F:palmitoyltransferase activity; IDA:UniProt
Q9UIJ5	ZDHHC2	Palmitoyltransferase ZDHHC2	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q9UIJ5	ZDHHC2	Palmitoyltransferase ZDHHC2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UIJ5	ZDHHC2	Palmitoyltransferase ZDHHC2	GO:0018345; P:protein palmitoylation; IDA:UniProt
Q9NYG2	ZDHHC3	Palmitoyltransferase ZDHHC3	GO:0016409; F:palmitoyltransferase activity; IDA:UniProt
Q9NYG2	ZDHHC3	Palmitoyltransferase ZDHHC3	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q9NYG2	ZDHHC3	Palmitoyltransferase ZDHHC3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NYG2	ZDHHC3	Palmitoyltransferase ZDHHC3	GO:0018345; P:protein palmitoylation; IDA:UniProt
Q9NYG2	ZDHHC3	Palmitoyltransferase ZDHHC3	GO:0006605; P:protein targeting; IEA:Ensembl
Q9NPG8	ZDHHC4	Probable palmitoyltransferase ZDHHC4	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q9NPG8	ZDHHC4	Probable palmitoyltransferase ZDHHC4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9C0B5	ZDHHC5	Palmitoyltransferase ZDHHC5	GO:0016409; F:palmitoyltransferase activity; IDA:UniProt
Q9C0B5	ZDHHC5	Palmitoyltransferase ZDHHC5	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q9C0B5	ZDHHC5	Palmitoyltransferase ZDHHC5	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9C0B5	ZDHHC5	Palmitoyltransferase ZDHHC5	GO:0018345; P:protein palmitoylation; IDA:UniProt
Q9H6R6	ZDHHC6	Palmitoyltransferase ZDHHC6	GO:0016409; F:palmitoyltransferase activity; IDA:UniProt
Q9H6R6	ZDHHC6	Palmitoyltransferase ZDHHC6	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q9H6R6	ZDHHC6	Palmitoyltransferase ZDHHC6	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H6R6	ZDHHC6	Palmitoyltransferase ZDHHC6	GO:0018345; P:protein palmitoylation; IDA:UniProt
Q9NXF8	ZDHHC7	Palmitoyltransferase ZDHHC7	GO:0016409; F:palmitoyltransferase activity; IDA:UniProt
Q9NXF8	ZDHHC7	Palmitoyltransferase ZDHHC7	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q9NXF8	ZDHHC7	Palmitoyltransferase ZDHHC7	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NXF8	ZDHHC7	Palmitoyltransferase ZDHHC7	GO:0018230; P:peptidyl-L-cysteine S-palmitoylation; IMP:UniProtKB
Q9NXF8	ZDHHC7	Palmitoyltransferase ZDHHC7	GO:0018345; P:protein palmitoylation; IDA:UniProt
Q9ULC8	ZDHHC8	Probable palmitoyltransferase ZDHHC8	GO:0016409; F:palmitoyltransferase activity; IDA:UniProt
Q9ULC8	ZDHHC8	Probable palmitoyltransferase ZDHHC8	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q9ULC8	ZDHHC8	Probable palmitoyltransferase ZDHHC8	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9ULC8	ZDHHC8	Probable palmitoyltransferase ZDHHC8	GO:0007626; P:locomotory behavior; IEA:Ensembl
Q9ULC8	ZDHHC8	Probable palmitoyltransferase ZDHHC8	GO:0018345; P:protein palmitoylation; IDA:UniProt
Q9Y397	ZDHHC9	Palmitoyltransferase ZDHHC9	GO:0016409; F:palmitoyltransferase activity; IDA:UniProt
Q9Y397	ZDHHC9	Palmitoyltransferase ZDHHC9	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
Q9Y397	ZDHHC9	Palmitoyltransferase ZDHHC9	GO:0043849; F:Ras palmitoyltransferase activity; IDA:UniProt
Q9Y397	ZDHHC9	Palmitoyltransferase ZDHHC9	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9Y397	ZDHHC9	Palmitoyltransferase ZDHHC9	GO:0018230; P:peptidyl-L-cysteine S-palmitoylation; IDA:UniProt
Q9Y397	ZDHHC9	Palmitoyltransferase ZDHHC9	GO:0018345; P:protein palmitoylation; IDA:UniProt
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0003682; F:chromatin binding; IEA:Ensembl
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0070888; F:E-box binding; ISS:UniProtKB
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0005515; F:protein binding; IPI:UniProtKB
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0008270; F:zinc ion binding; TAS:ProtInc
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0051216; P:cartilage development; IEA:Ensembl
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0008283; P:cell proliferation; TAS:ProtInc
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEA:Ensembl
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0090103; P:cochlea morphogenesis; IEA:Ensembl
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0048596; P:embryonic camera-type eye morphogenesis; IEA:Ensembl
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0030900; P:forebrain development; IEA:Ensembl
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0006955; P:immune response; TAS:ProtInc
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0030857; P:negative regulation of epithelial cell differentiation; IEA:Ensembl
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0007389; P:pattern specification process; IEA:Ensembl
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0010464; P:regulation of mesenchymal cell proliferation; IEA:Ensembl
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0051150; P:regulation of smooth muscle cell differentiation; IEA:Ensembl
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0033081; P:regulation of T cell differentiation in thymus; IEA:Ensembl
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0014823; P:response to activity; IEA:Ensembl
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0031667; P:response to nutrient levels; IEA:Ensembl
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0048752; P:semicircular canal morphogenesis; IEA:Ensembl
P37275	ZEB1	Zinc finger E-box-binding homeobox 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60315	ZEB2	Zinc finger E-box-binding homeobox 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60315	ZEB2	Zinc finger E-box-binding homeobox 2	GO:0019208; F:phosphatase regulator activity; NAS:UniProtKB
O60315	ZEB2	Zinc finger E-box-binding homeobox 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
O60315	ZEB2	Zinc finger E-box-binding homeobox 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O60315	ZEB2	Zinc finger E-box-binding homeobox 2	GO:0021846; P:cell proliferation in forebrain; IEA:Ensembl
O60315	ZEB2	Zinc finger E-box-binding homeobox 2	GO:0021766; P:hippocampus development; IEA:Ensembl
O60315	ZEB2	Zinc finger E-box-binding homeobox 2	GO:0007399; P:nervous system development; NAS:UniProtKB
O60315	ZEB2	Zinc finger E-box-binding homeobox 2	GO:0001755; P:neural crest cell migration; IEA:Ensembl
O60315	ZEB2	Zinc finger E-box-binding homeobox 2	GO:0001843; P:neural tube closure; IEA:Ensembl
O60315	ZEB2	Zinc finger E-box-binding homeobox 2	GO:0043507; P:positive regulation of JUN kinase activity; IEA:Ensembl
O60315	ZEB2	Zinc finger E-box-binding homeobox 2	GO:0030177; P:positive regulation of Wnt signaling pathway; IEA:Ensembl
O60315	ZEB2	Zinc finger E-box-binding homeobox 2	GO:0001756; P:somitogenesis; IEA:Ensembl
O60315	ZEB2	Zinc finger E-box-binding homeobox 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P31629	HIVEP2	Transcription factor HIVEP2	GO:0003677; F:DNA binding; TAS:UniProtKB
P31629	HIVEP2	Transcription factor HIVEP2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P31629	HIVEP2	Transcription factor HIVEP2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P31629	HIVEP2	Transcription factor HIVEP2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P15822	HIVEP1	Zinc finger protein 40	GO:0003677; F:DNA binding; TAS:ProtInc
P15822	HIVEP1	Zinc finger protein 40	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P15822	HIVEP1	Zinc finger protein 40	GO:0005515; F:protein binding; IPI:UniProtKB
P15822	HIVEP1	Zinc finger protein 40	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P15822	HIVEP1	Zinc finger protein 40	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5T1R4	HIVEP3	Transcription factor HIVEP3	GO:0003677; F:DNA binding; IEA:Ensembl
Q5T1R4	HIVEP3	Transcription factor HIVEP3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5T1R4	HIVEP3	Transcription factor HIVEP3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:MGI
Q5T1R4	HIVEP3	Transcription factor HIVEP3	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q5T1R4	HIVEP3	Transcription factor HIVEP3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z7L7	ZER1	Protein zer-1 homolog	GO:0004842; F:ubiquitin-protein ligase activity; IMP:UniProtKB
Q7Z7L7	ZER1	Protein zer-1 homolog	GO:0016567; P:protein ubiquitination; IMP:GOC
Q7Z7L7	ZER1	Protein zer-1 homolog	GO:0051438; P:regulation of ubiquitin-protein ligase activity; IMP:UniProtKB
Q9NPA5	ZFP64	Zinc finger protein 64 homolog, isoforms 1 and 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NPA5	ZFP64	Zinc finger protein 64 homolog, isoforms 1 and 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NPA5	ZFP64	Zinc finger protein 64 homolog, isoforms 1 and 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NPA5	ZFP64	Zinc finger protein 64 homolog, isoforms 1 and 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NTW7	ZFP64	Zinc finger protein 64 homolog, isoforms 3 and 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NTW7	ZFP64	Zinc finger protein 64 homolog, isoforms 3 and 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NTW7	ZFP64	Zinc finger protein 64 homolog, isoforms 3 and 4	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NTW7	ZFP64	Zinc finger protein 64 homolog, isoforms 3 and 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UJL9	ZFP69B	Zinc finger protein ZFP69B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UJL9	ZFP69B	Zinc finger protein ZFP69B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UJL9	ZFP69B	Zinc finger protein ZFP69B	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9UJL9	ZFP69B	Zinc finger protein ZFP69B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TCF1	ZFAND1	AN1-type zinc finger protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H8U3	ZFAND3	AN1-type zinc finger protein 3	GO:0003677; F:DNA binding; IEA:InterPro
Q9H8U3	ZFAND3	AN1-type zinc finger protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86XD8	ZFAND4	AN1-type zinc finger protein 4	GO:0008270; F:zinc ion binding; IEA:InterPro
O76080	ZFAND5	AN1-type zinc finger protein 5	GO:0003677; F:DNA binding; IEA:InterPro
O76080	ZFAND5	AN1-type zinc finger protein 5	GO:0005515; F:protein binding; IPI:IntAct
O76080	ZFAND5	AN1-type zinc finger protein 5	GO:0008270; F:zinc ion binding; IEA:InterPro
O76080	ZFAND5	AN1-type zinc finger protein 5	GO:0060324; P:face development; IEA:Ensembl
O76080	ZFAND5	AN1-type zinc finger protein 5	GO:0010761; P:fibroblast migration; IEA:Ensembl
O76080	ZFAND5	AN1-type zinc finger protein 5	GO:0001701; P:in utero embryonic development; IEA:Ensembl
O76080	ZFAND5	AN1-type zinc finger protein 5	GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IEA:Ensembl
O76080	ZFAND5	AN1-type zinc finger protein 5	GO:0003016; P:respiratory system process; IEA:Ensembl
O76080	ZFAND5	AN1-type zinc finger protein 5	GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl
O76080	ZFAND5	AN1-type zinc finger protein 5	GO:0048745; P:smooth muscle tissue development; IEA:Ensembl
O76080	ZFAND5	AN1-type zinc finger protein 5	GO:0001944; P:vasculature development; IEA:Ensembl
Q6FIF0	ZFAND6	AN1-type zinc finger protein 6	GO:0003677; F:DNA binding; IEA:InterPro
Q6FIF0	ZFAND6	AN1-type zinc finger protein 6	GO:0031593; F:polyubiquitin binding; ISS:UniProtKB
Q6FIF0	ZFAND6	AN1-type zinc finger protein 6	GO:0005515; F:protein binding; IPI:IntAct
Q6FIF0	ZFAND6	AN1-type zinc finger protein 6	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6FIF0	ZFAND6	AN1-type zinc finger protein 6	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q6FIF0	ZFAND6	AN1-type zinc finger protein 6	GO:0071356; P:cellular response to tumor necrosis factor; IMP:UniProtKB
Q6FIF0	ZFAND6	AN1-type zinc finger protein 6	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q6FIF0	ZFAND6	AN1-type zinc finger protein 6	GO:0006625; P:protein targeting to peroxisome; ISS:UniProtKB
Q6FIF0	ZFAND6	AN1-type zinc finger protein 6	GO:0043122; P:regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q9P243	ZFAT	Zinc finger protein ZFAT	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9P243	ZFAT	Zinc finger protein ZFAT	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9P243	ZFAT	Zinc finger protein ZFAT	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q9P243	ZFAT	Zinc finger protein ZFAT	GO:0002244; P:hematopoietic progenitor cell differentiation; IEA:Ensembl
Q9P243	ZFAT	Zinc finger protein ZFAT	GO:0060712; P:spongiotrophoblast layer development; IEA:Ensembl
Q9C0A1	ZFHX2	Zinc finger homeobox protein 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9C0A1	ZFHX2	Zinc finger homeobox protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9C0A1	ZFHX2	Zinc finger homeobox protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9C0A1	ZFHX2	Zinc finger homeobox protein 2	GO:0030534; P:adult behavior; IEA:Ensembl
Q9C0A1	ZFHX2	Zinc finger homeobox protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15911	ZFHX3	Zinc finger homeobox protein 3	GO:0019899; F:enzyme binding; IPI:UniProtKB
Q15911	ZFHX3	Zinc finger homeobox protein 3	GO:0003705; F:RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity; TAS:UniProtKB
Q15911	ZFHX3	Zinc finger homeobox protein 3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q15911	ZFHX3	Zinc finger homeobox protein 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q15911	ZFHX3	Zinc finger homeobox protein 3	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q15911	ZFHX3	Zinc finger homeobox protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q15911	ZFHX3	Zinc finger homeobox protein 3	GO:0007420; P:brain development; IEA:Ensembl
Q15911	ZFHX3	Zinc finger homeobox protein 3	GO:0007050; P:cell cycle arrest; IEA:Ensembl
Q15911	ZFHX3	Zinc finger homeobox protein 3	GO:0007517; P:muscle organ development; IEA:UniProtKB-KW
Q15911	ZFHX3	Zinc finger homeobox protein 3	GO:0045662; P:negative regulation of myoblast differentiation; IDA:UniProtKB
Q15911	ZFHX3	Zinc finger homeobox protein 3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IGI:MGI
Q15911	ZFHX3	Zinc finger homeobox protein 3	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q15911	ZFHX3	Zinc finger homeobox protein 3	GO:0045663; P:positive regulation of myoblast differentiation; IDA:UniProtKB
Q15911	ZFHX3	Zinc finger homeobox protein 3	GO:0045664; P:regulation of neuron differentiation; IEA:Ensembl
Q15911	ZFHX3	Zinc finger homeobox protein 3	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q15911	ZFHX3	Zinc finger homeobox protein 3	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q86UP3	ZFHX4	Zinc finger homeobox protein 4	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q86UP3	ZFHX4	Zinc finger homeobox protein 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q86UP3	ZFHX4	Zinc finger homeobox protein 4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q86UP3	ZFHX4	Zinc finger homeobox protein 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N6M9	ZFAND2A	AN1-type zinc finger protein 2A	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8WV99	ZFAND2B	AN1-type zinc finger protein 2B	GO:0005515; F:protein binding; IPI:IntAct
Q8WV99	ZFAND2B	AN1-type zinc finger protein 2B	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9HCL3	ZFP14	Zinc finger protein 14 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9HCL3	ZFP14	Zinc finger protein 14 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HCL3	ZFP14	Zinc finger protein 14 homolog	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9HCL3	ZFP14	Zinc finger protein 14 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9HCL3	ZFP14	Zinc finger protein 14 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6P2D0	ZFP1	Zinc finger protein 1 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6P2D0	ZFP1	Zinc finger protein 1 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6P2D0	ZFP1	Zinc finger protein 1 homolog	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6P2D0	ZFP1	Zinc finger protein 1 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q6P2D0	ZFP1	Zinc finger protein 1 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NHY6	ZFP28	Zinc finger protein 28 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NHY6	ZFP28	Zinc finger protein 28 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NHY6	ZFP28	Zinc finger protein 28 homolog	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q8NHY6	ZFP28	Zinc finger protein 28 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q8NHY6	ZFP28	Zinc finger protein 28 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZN57	ZFP2	Zinc finger protein 2 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZN57	ZFP2	Zinc finger protein 2 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZN57	ZFP2	Zinc finger protein 2 homolog	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6ZN57	ZFP2	Zinc finger protein 2 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q6ZN57	ZFP2	Zinc finger protein 2 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2G7	ZFP30	Zinc finger protein 30 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y2G7	ZFP30	Zinc finger protein 30 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y2G7	ZFP30	Zinc finger protein 30 homolog	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9Y2G7	ZFP30	Zinc finger protein 30 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9Y2G7	ZFP30	Zinc finger protein 30 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y6Q3	ZFP37	Zinc finger protein 37 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y6Q3	ZFP37	Zinc finger protein 37 homolog	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9Y6Q3	ZFP37	Zinc finger protein 37 homolog	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9Y6Q3	ZFP37	Zinc finger protein 37 homolog	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9Y6Q3	ZFP37	Zinc finger protein 37 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96NJ6	ZFP3	Zinc finger protein 3 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96NJ6	ZFP3	Zinc finger protein 3 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96NJ6	ZFP3	Zinc finger protein 3 homolog	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q96NJ6	ZFP3	Zinc finger protein 3 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q96NJ6	ZFP3	Zinc finger protein 3 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N8Y5	ZFP41	Zinc finger protein 41 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N8Y5	ZFP41	Zinc finger protein 41 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N8Y5	ZFP41	Zinc finger protein 41 homolog	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8N8Y5	ZFP41	Zinc finger protein 41 homolog	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q8N8Y5	ZFP41	Zinc finger protein 41 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N8Y5	ZFP41	Zinc finger protein 41 homolog	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q8N8Y5	ZFP41	Zinc finger protein 41 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96MM3	ZFP42	Zinc finger protein 42 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96MM3	ZFP42	Zinc finger protein 42 homolog	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q96MM3	ZFP42	Zinc finger protein 42 homolog	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q96MM3	ZFP42	Zinc finger protein 42 homolog	GO:0008585; P:female gonad development; IEP:UniProtKB
Q96MM3	ZFP42	Zinc finger protein 42 homolog	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q96MM3	ZFP42	Zinc finger protein 42 homolog	GO:0008584; P:male gonad development; IEP:UniProtKB
Q96MM3	ZFP42	Zinc finger protein 42 homolog	GO:0007126; P:meiotic nuclear division; NAS:UniProtKB
Q96MM3	ZFP42	Zinc finger protein 42 homolog	GO:2000653; P:regulation of genetic imprinting; IEA:Ensembl
Q96MM3	ZFP42	Zinc finger protein 42 homolog	GO:0007286; P:spermatid development; IEA:Ensembl
Q96MM3	ZFP42	Zinc finger protein 42 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NU63	ZFP57	Zinc finger protein 57 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NU63	ZFP57	Zinc finger protein 57 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NU63	ZFP57	Zinc finger protein 57 homolog	GO:0043045; P:DNA methylation involved in embryo development; IMP:UniProtKB
Q9NU63	ZFP57	Zinc finger protein 57 homolog	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9NU63	ZFP57	Zinc finger protein 57 homolog	GO:0007422; P:peripheral nervous system development; IEA:Ensembl
Q9NU63	ZFP57	Zinc finger protein 57 homolog	GO:0006349; P:regulation of gene expression by genetic imprinting; IMP:UniProtKB
Q9NU63	ZFP57	Zinc finger protein 57 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NB50	ZFP62	Zinc finger protein 62 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NB50	ZFP62	Zinc finger protein 62 homolog	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8NB50	ZFP62	Zinc finger protein 62 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NB50	ZFP62	Zinc finger protein 62 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q49AA0	ZFP69	Zinc finger protein ZFP69	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q49AA0	ZFP69	Zinc finger protein ZFP69	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q49AA0	ZFP69	Zinc finger protein ZFP69	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q49AA0	ZFP69	Zinc finger protein ZFP69	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N141	ZFP82	Zinc finger protein 82 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N141	ZFP82	Zinc finger protein 82 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N141	ZFP82	Zinc finger protein 82 homolog	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q8N141	ZFP82	Zinc finger protein 82 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q8N141	ZFP82	Zinc finger protein 82 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TF47	ZFP90	Zinc finger protein 90 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TF47	ZFP90	Zinc finger protein 90 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TF47	ZFP90	Zinc finger protein 90 homolog	GO:0001078; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; IEA:Ensembl
Q8TF47	ZFP90	Zinc finger protein 90 homolog	GO:0043392; P:negative regulation of DNA binding; IEA:Ensembl
Q8TF47	ZFP90	Zinc finger protein 90 homolog	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
A6NM28	ZFP92	Zinc finger protein 92 homolog	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A6NM28	ZFP92	Zinc finger protein 92 homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A6NM28	ZFP92	Zinc finger protein 92 homolog	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A6NM28	ZFP92	Zinc finger protein 92 homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96JP5	ZFP91	E3 ubiquitin-protein ligase ZFP91	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96JP5	ZFP91	E3 ubiquitin-protein ligase ZFP91	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q96JP5	ZFP91	E3 ubiquitin-protein ligase ZFP91	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q96JP5	ZFP91	E3 ubiquitin-protein ligase ZFP91	GO:0007250; P:activation of NF-kappaB-inducing kinase activity; IDA:UniProtKB
Q96JP5	ZFP91	E3 ubiquitin-protein ligase ZFP91	GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB
O95159	ZFPL1	Zinc finger protein-like 1	GO:0003677; F:DNA binding; NAS:UniProtKB
O95159	ZFPL1	Zinc finger protein-like 1	GO:0008270; F:zinc ion binding; NAS:UniProtKB
O95159	ZFPL1	Zinc finger protein-like 1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
O95159	ZFPL1	Zinc finger protein-like 1	GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW
Q96KR1	ZFR	Zinc finger RNA-binding protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96KR1	ZFR	Zinc finger RNA-binding protein	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q96KR1	ZFR	Zinc finger RNA-binding protein	GO:0005515; F:protein binding; IPI:IntAct
Q96KR1	ZFR	Zinc finger RNA-binding protein	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96KR1	ZFR	Zinc finger RNA-binding protein	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9UPR6	ZFR2	Zinc finger RNA-binding protein 2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9UPR6	ZFR2	Zinc finger RNA-binding protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
P17010	ZFX	Zinc finger X-chromosomal protein	GO:0003677; F:DNA binding; IEA:InterPro
P17010	ZFX	Zinc finger X-chromosomal protein	GO:0046872; F:metal ion binding; IEA:InterPro
P17010	ZFX	Zinc finger X-chromosomal protein	GO:0003713; F:transcription coactivator activity; TAS:ProtInc
P17010	ZFX	Zinc finger X-chromosomal protein	GO:0016265; P:death; IEA:Ensembl
P17010	ZFX	Zinc finger X-chromosomal protein	GO:0009790; P:embryo development; IEA:Ensembl
P17010	ZFX	Zinc finger X-chromosomal protein	GO:0009566; P:fertilization; IEA:Ensembl
P17010	ZFX	Zinc finger X-chromosomal protein	GO:0048872; P:homeostasis of number of cells; IEA:Ensembl
P17010	ZFX	Zinc finger X-chromosomal protein	GO:0035264; P:multicellular organism growth; IEA:Ensembl
P17010	ZFX	Zinc finger X-chromosomal protein	GO:0048599; P:oocyte development; IEA:Ensembl
P17010	ZFX	Zinc finger X-chromosomal protein	GO:0001541; P:ovarian follicle development; IEA:Ensembl
P17010	ZFX	Zinc finger X-chromosomal protein	GO:0060746; P:parental behavior; IEA:Ensembl
P17010	ZFX	Zinc finger X-chromosomal protein	GO:0009791; P:post-embryonic development; IEA:Ensembl
P17010	ZFX	Zinc finger X-chromosomal protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
P17010	ZFX	Zinc finger X-chromosomal protein	GO:0007283; P:spermatogenesis; IEA:Ensembl
P17010	ZFX	Zinc finger X-chromosomal protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z3T8	ZFYVE16	Zinc finger FYVE domain-containing protein 16	GO:0005545; F:1-phosphatidylinositol binding; IDA:UniProtKB
Q7Z3T8	ZFYVE16	Zinc finger FYVE domain-containing protein 16	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z3T8	ZFYVE16	Zinc finger FYVE domain-containing protein 16	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB
Q7Z3T8	ZFYVE16	Zinc finger FYVE domain-containing protein 16	GO:0005515; F:protein binding; IPI:UniProtKB
Q7Z3T8	ZFYVE16	Zinc finger FYVE domain-containing protein 16	GO:0008565; F:protein transporter activity; IMP:UniProtKB
Q7Z3T8	ZFYVE16	Zinc finger FYVE domain-containing protein 16	GO:0030509; P:BMP signaling pathway; TAS:Reactome
Q7Z3T8	ZFYVE16	Zinc finger FYVE domain-containing protein 16	GO:0016197; P:endosomal transport; IMP:UniProtKB
Q7Z3T8	ZFYVE16	Zinc finger FYVE domain-containing protein 16	GO:0006622; P:protein targeting to lysosome; IMP:UniProtKB
Q7Z3T8	ZFYVE16	Zinc finger FYVE domain-containing protein 16	GO:0030100; P:regulation of endocytosis; TAS:UniProtKB
Q7Z3T8	ZFYVE16	Zinc finger FYVE domain-containing protein 16	GO:0007165; P:signal transduction; NAS:UniProtKB
Q7Z3T8	ZFYVE16	Zinc finger FYVE domain-containing protein 16	GO:0016050; P:vesicle organization; NAS:UniProtKB
Q96K21	ZFYVE19	Zinc finger FYVE domain-containing protein 19	GO:0005515; F:protein binding; IPI:IntAct
Q96K21	ZFYVE19	Zinc finger FYVE domain-containing protein 19	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9BQ24	ZFYVE21	Zinc finger FYVE domain-containing protein 21	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q68DK2	ZFYVE26	Zinc finger FYVE domain-containing protein 26	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q68DK2	ZFYVE26	Zinc finger FYVE domain-containing protein 26	GO:0032266; F:phosphatidylinositol-3-phosphate binding; IDA:UniProtKB
Q68DK2	ZFYVE26	Zinc finger FYVE domain-containing protein 26	GO:0005515; F:protein binding; IPI:UniProtKB
Q68DK2	ZFYVE26	Zinc finger FYVE domain-containing protein 26	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q68DK2	ZFYVE26	Zinc finger FYVE domain-containing protein 26	GO:0000910; P:cytokinesis; IMP:UniProtKB
Q68DK2	ZFYVE26	Zinc finger FYVE domain-containing protein 26	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
Q5T4F4	ZFYVE27	Protrudin	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5T4F4	ZFYVE27	Protrudin	GO:0005515; F:protein binding; IPI:IntAct
Q5T4F4	ZFYVE27	Protrudin	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q5T4F4	ZFYVE27	Protrudin	GO:0031175; P:neuron projection development; IDA:UniProtKB
Q5T4F4	ZFYVE27	Protrudin	GO:0048011; P:neurotrophin TRK receptor signaling pathway; ISS:UniProtKB
Q5T4F4	ZFYVE27	Protrudin	GO:0072659; P:protein localization to plasma membrane; ISS:UniProtKB
Q9HBF4	ZFYVE1	Zinc finger FYVE domain-containing protein 1	GO:0005545; F:1-phosphatidylinositol binding; IDA:UniProtKB
Q9HBF4	ZFYVE1	Zinc finger FYVE domain-containing protein 1	GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB
Q9HBF4	ZFYVE1	Zinc finger FYVE domain-containing protein 1	GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; IDA:UniProtKB
Q9HBF4	ZFYVE1	Zinc finger FYVE domain-containing protein 1	GO:0005515; F:protein binding; IPI:IntAct
Q9HBF4	ZFYVE1	Zinc finger FYVE domain-containing protein 1	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9HBF4	ZFYVE1	Zinc finger FYVE domain-containing protein 1	GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB
O95405	ZFYVE9	Zinc finger FYVE domain-containing protein 9	GO:0005545; F:1-phosphatidylinositol binding; IDA:UniProtKB
O95405	ZFYVE9	Zinc finger FYVE domain-containing protein 9	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95405	ZFYVE9	Zinc finger FYVE domain-containing protein 9	GO:0005515; F:protein binding; IPI:UniProtKB
O95405	ZFYVE9	Zinc finger FYVE domain-containing protein 9	GO:0008236; F:serine-type peptidase activity; NAS:UniProtKB
O95405	ZFYVE9	Zinc finger FYVE domain-containing protein 9	GO:0006897; P:endocytosis; NAS:UniProtKB
O95405	ZFYVE9	Zinc finger FYVE domain-containing protein 9	GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome
O95405	ZFYVE9	Zinc finger FYVE domain-containing protein 9	GO:0006508; P:proteolysis; NAS:GOC
O95405	ZFYVE9	Zinc finger FYVE domain-containing protein 9	GO:0007183; P:SMAD protein complex assembly; IDA:UniProtKB
O95405	ZFYVE9	Zinc finger FYVE domain-containing protein 9	GO:0007184; P:SMAD protein import into nucleus; IMP:UniProtKB
O95405	ZFYVE9	Zinc finger FYVE domain-containing protein 9	GO:0007179; P:transforming growth factor beta receptor signaling pathway; IMP:UniProtKB
P08048	ZFY	Zinc finger Y-chromosomal protein	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P08048	ZFY	Zinc finger Y-chromosomal protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P08048	ZFY	Zinc finger Y-chromosomal protein	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P08048	ZFY	Zinc finger Y-chromosomal protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96DA0	ZG16B	Zymogen granule protein 16 homolog B	GO:0001895; P:retina homeostasis; IEP:UniProt
O60844	ZG16	Zymogen granule membrane protein 16	GO:0015031; P:protein transport; TAS:UniProtKB
P0C6A0	ZGLP1	GATA-type zinc finger protein 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
P0C6A0	ZGLP1	GATA-type zinc finger protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P0C6A0	ZGLP1	GATA-type zinc finger protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
P0C6A0	ZGLP1	GATA-type zinc finger protein 1	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P0C6A0	ZGLP1	GATA-type zinc finger protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
P0C6A0	ZGLP1	GATA-type zinc finger protein 1	GO:0048599; P:oocyte development; IEA:Ensembl
P0C6A0	ZGLP1	GATA-type zinc finger protein 1	GO:0007283; P:spermatogenesis; IEA:Ensembl
P0C6A0	ZGLP1	GATA-type zinc finger protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N5A5	ZGPAT	Zinc finger CCCH-type with G patch domain-containing protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N5A5	ZGPAT	Zinc finger CCCH-type with G patch domain-containing protein	GO:0005515; F:protein binding; IPI:UniProtKB
Q8N5A5	ZGPAT	Zinc finger CCCH-type with G patch domain-containing protein	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q8N5A5	ZGPAT	Zinc finger CCCH-type with G patch domain-containing protein	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q8N5A5	ZGPAT	Zinc finger CCCH-type with G patch domain-containing protein	GO:0007175; P:negative regulation of epidermal growth factor-activated receptor activity; IDA:UniProtKB
Q8N5A5	ZGPAT	Zinc finger CCCH-type with G patch domain-containing protein	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q8N5A5	ZGPAT	Zinc finger CCCH-type with G patch domain-containing protein	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86YA3	ZGRF1	Protein ZGRF1	GO:0008270; F:zinc ion binding; IEA:InterPro
P0C7U3	ZDHHC11B	Probable palmitoyltransferase ZDHHC11B	GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IEA:UniProtKB-EC
P0C7U3	ZDHHC11B	Probable palmitoyltransferase ZDHHC11B	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NS37	CREBZF	CREB/ATF bZIP transcription factor	GO:0003677; F:DNA binding; NAS:UniProtKB
Q9NS37	CREBZF	CREB/ATF bZIP transcription factor	GO:0042802; F:identical protein binding; IPI:IntAct
Q9NS37	CREBZF	CREB/ATF bZIP transcription factor	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NS37	CREBZF	CREB/ATF bZIP transcription factor	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9NS37	CREBZF	CREB/ATF bZIP transcription factor	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9NS37	CREBZF	CREB/ATF bZIP transcription factor	GO:0045814; P:negative regulation of gene expression, epigenetic; IEP:UniProtKB
Q9NS37	CREBZF	CREB/ATF bZIP transcription factor	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q9NS37	CREBZF	CREB/ATF bZIP transcription factor	GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9NS37	CREBZF	CREB/ATF bZIP transcription factor	GO:0009615; P:response to virus; IDA:UniProtKB
Q9NS37	CREBZF	CREB/ATF bZIP transcription factor	GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB
Q9UKY1	ZHX1	Zinc fingers and homeoboxes protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UKY1	ZHX1	Zinc fingers and homeoboxes protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UKY1	ZHX1	Zinc fingers and homeoboxes protein 1	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
Q9UKY1	ZHX1	Zinc fingers and homeoboxes protein 1	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9UKY1	ZHX1	Zinc fingers and homeoboxes protein 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9UKY1	ZHX1	Zinc fingers and homeoboxes protein 1	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q9UKY1	ZHX1	Zinc fingers and homeoboxes protein 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9UKY1	ZHX1	Zinc fingers and homeoboxes protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9UKY1	ZHX1	Zinc fingers and homeoboxes protein 1	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UKY1	ZHX1	Zinc fingers and homeoboxes protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y6X8	ZHX2	Zinc fingers and homeoboxes protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y6X8	ZHX2	Zinc fingers and homeoboxes protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y6X8	ZHX2	Zinc fingers and homeoboxes protein 2	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
Q9Y6X8	ZHX2	Zinc fingers and homeoboxes protein 2	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q9Y6X8	ZHX2	Zinc fingers and homeoboxes protein 2	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9Y6X8	ZHX2	Zinc fingers and homeoboxes protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9Y6X8	ZHX2	Zinc fingers and homeoboxes protein 2	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q9Y6X8	ZHX2	Zinc fingers and homeoboxes protein 2	GO:0006402; P:mRNA catabolic process; IEA:Ensembl
Q9Y6X8	ZHX2	Zinc fingers and homeoboxes protein 2	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
Q9Y6X8	ZHX2	Zinc fingers and homeoboxes protein 2	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q9Y6X8	ZHX2	Zinc fingers and homeoboxes protein 2	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9Y6X8	ZHX2	Zinc fingers and homeoboxes protein 2	GO:0035019; P:somatic stem cell maintenance; IEA:Ensembl
Q9Y6X8	ZHX2	Zinc fingers and homeoboxes protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H4I2	ZHX3	Zinc fingers and homeoboxes protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H4I2	ZHX3	Zinc fingers and homeoboxes protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H4I2	ZHX3	Zinc fingers and homeoboxes protein 3	GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB
Q9H4I2	ZHX3	Zinc fingers and homeoboxes protein 3	GO:0042803; F:protein homodimerization activity; IDA:UniProtKB
Q9H4I2	ZHX3	Zinc fingers and homeoboxes protein 3	GO:0043565; F:sequence-specific DNA binding; IEA:InterPro
Q9H4I2	ZHX3	Zinc fingers and homeoboxes protein 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9H4I2	ZHX3	Zinc fingers and homeoboxes protein 3	GO:0003714; F:transcription corepressor activity; IEA:Ensembl
Q9H4I2	ZHX3	Zinc fingers and homeoboxes protein 3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9H4I2	ZHX3	Zinc fingers and homeoboxes protein 3	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9H4I2	ZHX3	Zinc fingers and homeoboxes protein 3	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9H4I2	ZHX3	Zinc fingers and homeoboxes protein 3	GO:0045669; P:positive regulation of osteoblast differentiation; IMP:UniProtKB
Q9H4I2	ZHX3	Zinc fingers and homeoboxes protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15915	ZIC1	Zinc finger protein ZIC 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q15915	ZIC1	Zinc finger protein ZIC 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15915	ZIC1	Zinc finger protein ZIC 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q15915	ZIC1	Zinc finger protein ZIC 1	GO:0007628; P:adult walking behavior; IEA:Ensembl
Q15915	ZIC1	Zinc finger protein ZIC 1	GO:0007420; P:brain development; IDA:UniProtKB
Q15915	ZIC1	Zinc finger protein ZIC 1	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q15915	ZIC1	Zinc finger protein ZIC 1	GO:0042472; P:inner ear morphogenesis; ISS:UniProtKB
Q15915	ZIC1	Zinc finger protein ZIC 1	GO:0007389; P:pattern specification process; ISS:UniProtKB
Q15915	ZIC1	Zinc finger protein ZIC 1	GO:0042307; P:positive regulation of protein import into nucleus; ISS:UniProtKB
Q15915	ZIC1	Zinc finger protein ZIC 1	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q15915	ZIC1	Zinc finger protein ZIC 1	GO:0008589; P:regulation of smoothened signaling pathway; ISS:UniProtKB
Q15915	ZIC1	Zinc finger protein ZIC 1	GO:0021510; P:spinal cord development; IEA:Ensembl
Q15915	ZIC1	Zinc finger protein ZIC 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95409	ZIC2	Zinc finger protein ZIC 2	GO:0031490; F:chromatin DNA binding; ISS:UniProtKB
O95409	ZIC2	Zinc finger protein ZIC 2	GO:0003677; F:DNA binding; ISS:UniProtKB
O95409	ZIC2	Zinc finger protein ZIC 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95409	ZIC2	Zinc finger protein ZIC 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
O95409	ZIC2	Zinc finger protein ZIC 2	GO:0007420; P:brain development; TAS:ProtInc
O95409	ZIC2	Zinc finger protein ZIC 2	GO:0048066; P:developmental pigmentation; IEA:Ensembl
O95409	ZIC2	Zinc finger protein ZIC 2	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
O95409	ZIC2	Zinc finger protein ZIC 2	GO:0001843; P:neural tube closure; IEA:Ensembl
O95409	ZIC2	Zinc finger protein ZIC 2	GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
O95409	ZIC2	Zinc finger protein ZIC 2	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
O95409	ZIC2	Zinc finger protein ZIC 2	GO:0031290; P:retinal ganglion cell axon guidance; IEA:Ensembl
O95409	ZIC2	Zinc finger protein ZIC 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95409	ZIC2	Zinc finger protein ZIC 2	GO:0007601; P:visual perception; ISS:UniProtKB
O60481	ZIC3	Zinc finger protein ZIC 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60481	ZIC3	Zinc finger protein ZIC 3	GO:0005515; F:protein binding; IPI:UniProtKB
O60481	ZIC3	Zinc finger protein ZIC 3	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
O60481	ZIC3	Zinc finger protein ZIC 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
O60481	ZIC3	Zinc finger protein ZIC 3	GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl
O60481	ZIC3	Zinc finger protein ZIC 3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
O60481	ZIC3	Zinc finger protein ZIC 3	GO:0071907; P:determination of digestive tract left/right asymmetry; IMP:BHF-UCL
O60481	ZIC3	Zinc finger protein ZIC 3	GO:0035545; P:determination of left/right asymmetry in nervous system; IEA:Ensembl
O60481	ZIC3	Zinc finger protein ZIC 3	GO:0007368; P:determination of left/right symmetry; IMP:BHF-UCL
O60481	ZIC3	Zinc finger protein ZIC 3	GO:0071910; P:determination of liver left/right asymmetry; IMP:BHF-UCL
O60481	ZIC3	Zinc finger protein ZIC 3	GO:0035469; P:determination of pancreatic left/right asymmetry; IMP:BHF-UCL
O60481	ZIC3	Zinc finger protein ZIC 3	GO:0001947; P:heart looping; IMP:BHF-UCL
O60481	ZIC3	Zinc finger protein ZIC 3	GO:0030324; P:lung development; IMP:BHF-UCL
O60481	ZIC3	Zinc finger protein ZIC 3	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
O60481	ZIC3	Zinc finger protein ZIC 3	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
O60481	ZIC3	Zinc finger protein ZIC 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96T25	ZIC5	Zinc finger protein ZIC 5	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96T25	ZIC5	Zinc finger protein ZIC 5	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96T25	ZIC5	Zinc finger protein ZIC 5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q96T25	ZIC5	Zinc finger protein ZIC 5	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96T25	ZIC5	Zinc finger protein ZIC 5	GO:0030900; P:forebrain development; IEA:Ensembl
Q96T25	ZIC5	Zinc finger protein ZIC 5	GO:0001843; P:neural tube closure; IEA:Ensembl
Q8N9L1	ZIC4	Zinc finger protein ZIC 4	GO:0003677; F:DNA binding; ISS:UniProtKB
Q8N9L1	ZIC4	Zinc finger protein ZIC 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q3SY52	ZIK1	Zinc finger protein interacting with ribonucleoprotein K	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q3SY52	ZIK1	Zinc finger protein interacting with ribonucleoprotein K	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q3SY52	ZIK1	Zinc finger protein interacting with ribonucleoprotein K	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q3SY52	ZIK1	Zinc finger protein interacting with ribonucleoprotein K	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NZV7	ZIM2	Zinc finger imprinted 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NZV7	ZIM2	Zinc finger imprinted 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9NZV7	ZIM2	Zinc finger imprinted 2	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9NZV7	ZIM2	Zinc finger imprinted 2	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9NZV7	ZIM2	Zinc finger imprinted 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96PE6	ZIM3	Zinc finger imprinted 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96PE6	ZIM3	Zinc finger imprinted 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96PE6	ZIM3	Zinc finger imprinted 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q96PE6	ZIM3	Zinc finger imprinted 3	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q96PE6	ZIM3	Zinc finger imprinted 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17029	ZKSCAN1	Zinc finger protein with KRAB and SCAN domains 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P17029	ZKSCAN1	Zinc finger protein with KRAB and SCAN domains 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17029	ZKSCAN1	Zinc finger protein with KRAB and SCAN domains 1	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
P17029	ZKSCAN1	Zinc finger protein with KRAB and SCAN domains 1	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P17029	ZKSCAN1	Zinc finger protein with KRAB and SCAN domains 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q63HK3	ZKSCAN2	Zinc finger protein with KRAB and SCAN domains 2	GO:0003682; F:chromatin binding; IEA:InterPro
Q63HK3	ZKSCAN2	Zinc finger protein with KRAB and SCAN domains 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q63HK3	ZKSCAN2	Zinc finger protein with KRAB and SCAN domains 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q63HK3	ZKSCAN2	Zinc finger protein with KRAB and SCAN domains 2	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q63HK3	ZKSCAN2	Zinc finger protein with KRAB and SCAN domains 2	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
Q63HK3	ZKSCAN2	Zinc finger protein with KRAB and SCAN domains 2	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q9BRR0	ZKSCAN3	Zinc finger protein with KRAB and SCAN domains 3	GO:0003682; F:chromatin binding; IDA:UniProtKB
Q9BRR0	ZKSCAN3	Zinc finger protein with KRAB and SCAN domains 3	GO:0003677; F:DNA binding; IDA:UniProtKB
Q9BRR0	ZKSCAN3	Zinc finger protein with KRAB and SCAN domains 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BRR0	ZKSCAN3	Zinc finger protein with KRAB and SCAN domains 3	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q9BRR0	ZKSCAN3	Zinc finger protein with KRAB and SCAN domains 3	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9BRR0	ZKSCAN3	Zinc finger protein with KRAB and SCAN domains 3	GO:0006914; P:autophagy; IEA:UniProtKB-KW
Q9BRR0	ZKSCAN3	Zinc finger protein with KRAB and SCAN domains 3	GO:0007040; P:lysosome organization; IMP:UniProtKB
Q9BRR0	ZKSCAN3	Zinc finger protein with KRAB and SCAN domains 3	GO:0010507; P:negative regulation of autophagy; IMP:UniProtKB
Q9BRR0	ZKSCAN3	Zinc finger protein with KRAB and SCAN domains 3	GO:2000773; P:negative regulation of cellular senescence; IMP:UniProtKB
Q9BRR0	ZKSCAN3	Zinc finger protein with KRAB and SCAN domains 3	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9BRR0	ZKSCAN3	Zinc finger protein with KRAB and SCAN domains 3	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9BRR0	ZKSCAN3	Zinc finger protein with KRAB and SCAN domains 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2L8	ZKSCAN5	Zinc finger protein with KRAB and SCAN domains 5	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y2L8	ZKSCAN5	Zinc finger protein with KRAB and SCAN domains 5	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2L8	ZKSCAN5	Zinc finger protein with KRAB and SCAN domains 5	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9Y2L8	ZKSCAN5	Zinc finger protein with KRAB and SCAN domains 5	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9Y2L8	ZKSCAN5	Zinc finger protein with KRAB and SCAN domains 5	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9Y2L8	ZKSCAN5	Zinc finger protein with KRAB and SCAN domains 5	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q969J2	ZKSCAN4	Zinc finger protein with KRAB and SCAN domains 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q969J2	ZKSCAN4	Zinc finger protein with KRAB and SCAN domains 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q969J2	ZKSCAN4	Zinc finger protein with KRAB and SCAN domains 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q969J2	ZKSCAN4	Zinc finger protein with KRAB and SCAN domains 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9P0L1	ZKSCAN7	Zinc finger protein with KRAB and SCAN domains 7	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9P0L1	ZKSCAN7	Zinc finger protein with KRAB and SCAN domains 7	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9P0L1	ZKSCAN7	Zinc finger protein with KRAB and SCAN domains 7	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9P0L1	ZKSCAN7	Zinc finger protein with KRAB and SCAN domains 7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15776	ZKSCAN8	Zinc finger protein with KRAB and SCAN domains 8	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q15776	ZKSCAN8	Zinc finger protein with KRAB and SCAN domains 8	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15776	ZKSCAN8	Zinc finger protein with KRAB and SCAN domains 8	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q15776	ZKSCAN8	Zinc finger protein with KRAB and SCAN domains 8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5H9K5	ZMAT1	Zinc finger matrin-type protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5H9K5	ZMAT1	Zinc finger matrin-type protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9HA38	ZMAT3	Zinc finger matrin-type protein 3	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9HA38	ZMAT3	Zinc finger matrin-type protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q9HA38	ZMAT3	Zinc finger matrin-type protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9HA38	ZMAT3	Zinc finger matrin-type protein 3	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q9HA38	ZMAT3	Zinc finger matrin-type protein 3	GO:0006974; P:cellular response to DNA damage stimulus; IEA:UniProtKB-KW
Q9HA38	ZMAT3	Zinc finger matrin-type protein 3	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q9HA38	ZMAT3	Zinc finger matrin-type protein 3	GO:0015031; P:protein transport; IEA:UniProtKB-KW
Q9HA38	ZMAT3	Zinc finger matrin-type protein 3	GO:0040008; P:regulation of growth; IEA:UniProtKB-KW
Q96NC0	ZMAT2	Zinc finger matrin-type protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96NC0	ZMAT2	Zinc finger matrin-type protein 2	GO:0005515; F:protein binding; IPI:IntAct
Q96NC0	ZMAT2	Zinc finger matrin-type protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H898	ZMAT4	Zinc finger matrin-type protein 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H898	ZMAT4	Zinc finger matrin-type protein 4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UDW3	ZMAT5	Zinc finger matrin-type protein 5	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UDW3	ZMAT5	Zinc finger matrin-type protein 5	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q9UDW3	ZMAT5	Zinc finger matrin-type protein 5	GO:0008380; P:RNA splicing; IC:HGNC
Q9ULJ6	ZMIZ1	Zinc finger MIZ domain-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9ULJ6	ZMIZ1	Zinc finger MIZ domain-containing protein 1	GO:0048844; P:artery morphogenesis; IEA:Ensembl
Q9ULJ6	ZMIZ1	Zinc finger MIZ domain-containing protein 1	GO:0007569; P:cell aging; IEA:Ensembl
Q9ULJ6	ZMIZ1	Zinc finger MIZ domain-containing protein 1	GO:0048589; P:developmental growth; IEA:Ensembl
Q9ULJ6	ZMIZ1	Zinc finger MIZ domain-containing protein 1	GO:0003007; P:heart morphogenesis; IEA:Ensembl
Q9ULJ6	ZMIZ1	Zinc finger MIZ domain-containing protein 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9ULJ6	ZMIZ1	Zinc finger MIZ domain-containing protein 1	GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl
Q9ULJ6	ZMIZ1	Zinc finger MIZ domain-containing protein 1	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9ULJ6	ZMIZ1	Zinc finger MIZ domain-containing protein 1	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9ULJ6	ZMIZ1	Zinc finger MIZ domain-containing protein 1	GO:0001570; P:vasculogenesis; IEA:Ensembl
Q9ULJ6	ZMIZ1	Zinc finger MIZ domain-containing protein 1	GO:0007296; P:vitellogenesis; IEA:Ensembl
Q8NF64	ZMIZ2	Zinc finger MIZ domain-containing protein 2	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IDA:UniProtKB
Q8NF64	ZMIZ2	Zinc finger MIZ domain-containing protein 2	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NF64	ZMIZ2	Zinc finger MIZ domain-containing protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8NF64	ZMIZ2	Zinc finger MIZ domain-containing protein 2	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q8NF64	ZMIZ2	Zinc finger MIZ domain-containing protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75800	ZMYND10	Zinc finger MYND domain-containing protein 10	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75800	ZMYND10	Zinc finger MYND domain-containing protein 10	GO:0005515; F:protein binding; IPI:UniProtKB
O75800	ZMYND10	Zinc finger MYND domain-containing protein 10	GO:0036159; P:inner dynein arm assembly; IMP:UniProtKB
O75800	ZMYND10	Zinc finger MYND domain-containing protein 10	GO:0044458; P:motile cilium assembly; IMP:UniProtKB
O75800	ZMYND10	Zinc finger MYND domain-containing protein 10	GO:0036158; P:outer dynein arm assembly; IMP:UniProtKB
Q15326	ZMYND11	Zinc finger MYND domain-containing protein 11	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q15326	ZMYND11	Zinc finger MYND domain-containing protein 11	GO:0035064; F:methylated histone binding; ISS:UniProtKB
Q15326	ZMYND11	Zinc finger MYND domain-containing protein 11	GO:0005515; F:protein binding; IPI:IntAct
Q15326	ZMYND11	Zinc finger MYND domain-containing protein 11	GO:0003714; F:transcription corepressor activity; ISS:UniProtKB
Q15326	ZMYND11	Zinc finger MYND domain-containing protein 11	GO:0008270; F:zinc ion binding; ISS:UniProtKB
Q15326	ZMYND11	Zinc finger MYND domain-containing protein 11	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
Q15326	ZMYND11	Zinc finger MYND domain-containing protein 11	GO:0008283; P:cell proliferation; TAS:ProtInc
Q15326	ZMYND11	Zinc finger MYND domain-containing protein 11	GO:0016568; P:chromatin modification; IEA:UniProtKB-KW
Q15326	ZMYND11	Zinc finger MYND domain-containing protein 11	GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB
Q15326	ZMYND11	Zinc finger MYND domain-containing protein 11	GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB
Q15326	ZMYND11	Zinc finger MYND domain-containing protein 11	GO:0046329; P:negative regulation of JNK cascade; IMP:UniProtKB
Q15326	ZMYND11	Zinc finger MYND domain-containing protein 11	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q15326	ZMYND11	Zinc finger MYND domain-containing protein 11	GO:0034243; P:regulation of transcription elongation from RNA polymerase II promoter; ISS:UniProtKB
Q15326	ZMYND11	Zinc finger MYND domain-containing protein 11	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15326	ZMYND11	Zinc finger MYND domain-containing protein 11	GO:0016032; P:viral process; IEA:UniProtKB-KW
Q9H091	ZMYND15	Zinc finger MYND domain-containing protein 15	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H091	ZMYND15	Zinc finger MYND domain-containing protein 15	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q9H091	ZMYND15	Zinc finger MYND domain-containing protein 15	GO:0007286; P:spermatid development; IEA:Ensembl
Q9H091	ZMYND15	Zinc finger MYND domain-containing protein 15	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96E35	ZMYND19	Zinc finger MYND domain-containing protein 19	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H0C1	ZMYND12	Zinc finger MYND domain-containing protein 12	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5SVZ6	ZMYM1	Zinc finger MYM-type protein 1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q5SVZ6	ZMYM1	Zinc finger MYM-type protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UBW7	ZMYM2	Zinc finger MYM-type protein 2	GO:0031624; F:ubiquitin conjugating enzyme binding; IPI:UniProtKB
Q9UBW7	ZMYM2	Zinc finger MYM-type protein 2	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9UBW7	ZMYM2	Zinc finger MYM-type protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UBW7	ZMYM2	Zinc finger MYM-type protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5VZL5	ZMYM4	Zinc finger MYM-type protein 4	GO:0003677; F:DNA binding; TAS:ProtInc
Q5VZL5	ZMYM4	Zinc finger MYM-type protein 4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5VZL5	ZMYM4	Zinc finger MYM-type protein 4	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q5VZL5	ZMYM4	Zinc finger MYM-type protein 4	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q5VZL5	ZMYM4	Zinc finger MYM-type protein 4	GO:0022604; P:regulation of cell morphogenesis; IMP:UniProtKB
Q9UJ78	ZMYM5	Zinc finger MYM-type protein 5	GO:0008270; F:zinc ion binding; IEA:InterPro
Q14202	ZMYM3	Zinc finger MYM-type protein 3	GO:0003677; F:DNA binding; TAS:ProtInc
Q14202	ZMYM3	Zinc finger MYM-type protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q14202	ZMYM3	Zinc finger MYM-type protein 3	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q14202	ZMYM3	Zinc finger MYM-type protein 3	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q14202	ZMYM3	Zinc finger MYM-type protein 3	GO:0022604; P:regulation of cell morphogenesis; IMP:UniProtKB
O95789	ZMYM6	Zinc finger MYM-type protein 6	GO:0003677; F:DNA binding; TAS:ProtInc
O95789	ZMYM6	Zinc finger MYM-type protein 6	GO:0008270; F:zinc ion binding; IEA:InterPro
O95789	ZMYM6	Zinc finger MYM-type protein 6	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
O95789	ZMYM6	Zinc finger MYM-type protein 6	GO:0007275; P:multicellular organismal development; TAS:ProtInc
O95789	ZMYM6	Zinc finger MYM-type protein 6	GO:0022604; P:regulation of cell morphogenesis; IMP:UniProtKB
Q8IYN0	ZNF100	Zinc finger protein 100	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IYN0	ZNF100	Zinc finger protein 100	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IYN0	ZNF100	Zinc finger protein 100	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8IYN0	ZNF100	Zinc finger protein 100	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IZC7	ZNF101	Zinc finger protein 101	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IZC7	ZNF101	Zinc finger protein 101	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IZC7	ZNF101	Zinc finger protein 101	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8IZC7	ZNF101	Zinc finger protein 101	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H2Y7	ZNF106	Zinc finger protein 106	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H2Y7	ZNF106	Zinc finger protein 106	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H2Y7	ZNF106	Zinc finger protein 106	GO:0008286; P:insulin receptor signaling pathway; IEA:Ensembl
Q9UII5	ZNF107	Zinc finger protein 107	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UII5	ZNF107	Zinc finger protein 107	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UII5	ZNF107	Zinc finger protein 107	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UII5	ZNF107	Zinc finger protein 107	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UJU3	ZNF112	Zinc finger protein 112	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UJU3	ZNF112	Zinc finger protein 112	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UJU3	ZNF112	Zinc finger protein 112	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UJU3	ZNF112	Zinc finger protein 112	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NC26	ZNF114	Zinc finger protein 114	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NC26	ZNF114	Zinc finger protein 114	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NC26	ZNF114	Zinc finger protein 114	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NC26	ZNF114	Zinc finger protein 114	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q03924	ZNF117	Zinc finger protein 117	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q03924	ZNF117	Zinc finger protein 117	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q03924	ZNF117	Zinc finger protein 117	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q03924	ZNF117	Zinc finger protein 117	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15973	ZNF124	Zinc finger protein 124	GO:0003677; F:DNA binding; TAS:ProtInc
Q15973	ZNF124	Zinc finger protein 124	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15973	ZNF124	Zinc finger protein 124	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q15973	ZNF124	Zinc finger protein 124	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P58317	ZNF121	Zinc finger protein 121	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P58317	ZNF121	Zinc finger protein 121	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P58317	ZNF121	Zinc finger protein 121	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P58317	ZNF121	Zinc finger protein 121	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P58317	ZNF121	Zinc finger protein 121	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P52739	ZNF131	Zinc finger protein 131	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P52739	ZNF131	Zinc finger protein 131	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P52739	ZNF131	Zinc finger protein 131	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
P52739	ZNF131	Zinc finger protein 131	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
P52739	ZNF131	Zinc finger protein 131	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P52739	ZNF131	Zinc finger protein 131	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
P52740	ZNF132	Zinc finger protein 132	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P52740	ZNF132	Zinc finger protein 132	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P52740	ZNF132	Zinc finger protein 132	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P52740	ZNF132	Zinc finger protein 132	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P52740	ZNF132	Zinc finger protein 132	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P52736	ZNF133	Zinc finger protein 133	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P52736	ZNF133	Zinc finger protein 133	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P52736	ZNF133	Zinc finger protein 133	GO:0005515; F:protein binding; IPI:IntAct
P52736	ZNF133	Zinc finger protein 133	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P52736	ZNF133	Zinc finger protein 133	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P52741	ZNF134	Zinc finger protein 134	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P52741	ZNF134	Zinc finger protein 134	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P52741	ZNF134	Zinc finger protein 134	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
P52741	ZNF134	Zinc finger protein 134	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P52741	ZNF134	Zinc finger protein 134	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P52742	ZNF135	Zinc finger protein 135	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P52742	ZNF135	Zinc finger protein 135	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P52742	ZNF135	Zinc finger protein 135	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
P52742	ZNF135	Zinc finger protein 135	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
P52742	ZNF135	Zinc finger protein 135	GO:0022604; P:regulation of cell morphogenesis; IMP:UniProtKB
P52742	ZNF135	Zinc finger protein 135	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P52742	ZNF135	Zinc finger protein 135	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P52737	ZNF136	Zinc finger protein 136	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P52737	ZNF136	Zinc finger protein 136	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P52737	ZNF136	Zinc finger protein 136	GO:0005515; F:protein binding; IPI:IntAct
P52737	ZNF136	Zinc finger protein 136	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
P52737	ZNF136	Zinc finger protein 136	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P52737	ZNF136	Zinc finger protein 136	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P52743	ZNF137P	Putative zinc finger protein 137	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P52743	ZNF137P	Putative zinc finger protein 137	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P52743	ZNF137P	Putative zinc finger protein 137	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
P52743	ZNF137P	Putative zinc finger protein 137	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P52744	ZNF138	Zinc finger protein 138	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P52744	ZNF138	Zinc finger protein 138	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P52744	ZNF138	Zinc finger protein 138	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
P52744	ZNF138	Zinc finger protein 138	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P52744	ZNF138	Zinc finger protein 138	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P52738	ZNF140	Zinc finger protein 140	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P52738	ZNF140	Zinc finger protein 140	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P52738	ZNF140	Zinc finger protein 140	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P52738	ZNF140	Zinc finger protein 140	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P52738	ZNF140	Zinc finger protein 140	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15928	ZNF141	Zinc finger protein 141	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q15928	ZNF141	Zinc finger protein 141	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15928	ZNF141	Zinc finger protein 141	GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc
Q15928	ZNF141	Zinc finger protein 141	GO:0035108; P:limb morphogenesis; IMP:UniProtKB
Q15928	ZNF141	Zinc finger protein 141	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q15928	ZNF141	Zinc finger protein 141	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P52746	ZNF142	Zinc finger protein 142	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P52746	ZNF142	Zinc finger protein 142	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P52746	ZNF142	Zinc finger protein 142	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P52746	ZNF142	Zinc finger protein 142	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P52747	ZNF143	Zinc finger protein 143	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P52747	ZNF143	Zinc finger protein 143	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P52747	ZNF143	Zinc finger protein 143	GO:0005515; F:protein binding; IPI:UniProtKB
P52747	ZNF143	Zinc finger protein 143	GO:0010467; P:gene expression; TAS:Reactome
P52747	ZNF143	Zinc finger protein 143	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P52747	ZNF143	Zinc finger protein 143	GO:0006359; P:regulation of transcription from RNA polymerase III promoter; TAS:ProtInc
P52747	ZNF143	Zinc finger protein 143	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
P52747	ZNF143	Zinc finger protein 143	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:Reactome
Q9UQR1	ZNF148	Zinc finger protein 148	GO:0003690; F:double-stranded DNA binding; IEA:Ensembl
Q9UQR1	ZNF148	Zinc finger protein 148	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UQR1	ZNF148	Zinc finger protein 148	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UQR1	ZNF148	Zinc finger protein 148	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q9UQR1	ZNF148	Zinc finger protein 148	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q9UQR1	ZNF148	Zinc finger protein 148	GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IEA:Ensembl
Q9UQR1	ZNF148	Zinc finger protein 148	GO:0006968; P:cellular defense response; TAS:ProtInc
Q9UQR1	ZNF148	Zinc finger protein 148	GO:0007276; P:gamete generation; IEA:Ensembl
Q9UQR1	ZNF148	Zinc finger protein 148	GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB
Q9UQR1	ZNF148	Zinc finger protein 148	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q9UQR1	ZNF148	Zinc finger protein 148	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UQR1	ZNF148	Zinc finger protein 148	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q9UQR1	ZNF148	Zinc finger protein 148	GO:0006461; P:protein complex assembly; IEA:Ensembl
Q9UQR1	ZNF148	Zinc finger protein 148	GO:0021762; P:substantia nigra development; IEP:UniProt
Q9UQR1	ZNF148	Zinc finger protein 148	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q13106	ZNF154	Zinc finger protein 154	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q13106	ZNF154	Zinc finger protein 154	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13106	ZNF154	Zinc finger protein 154	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q13106	ZNF154	Zinc finger protein 154	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q13106	ZNF154	Zinc finger protein 154	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P51786	ZNF157	Zinc finger protein 157	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P51786	ZNF157	Zinc finger protein 157	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P51786	ZNF157	Zinc finger protein 157	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P51786	ZNF157	Zinc finger protein 157	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P51786	ZNF157	Zinc finger protein 157	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P51786	ZNF157	Zinc finger protein 157	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q12901	ZNF155	Zinc finger protein 155	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q12901	ZNF155	Zinc finger protein 155	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q12901	ZNF155	Zinc finger protein 155	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q12901	ZNF155	Zinc finger protein 155	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HCG1	ZNF160	Zinc finger protein 160	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9HCG1	ZNF160	Zinc finger protein 160	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HCG1	ZNF160	Zinc finger protein 160	GO:0030097; P:hemopoiesis; NAS:UniProtKB
Q9HCG1	ZNF160	Zinc finger protein 160	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9HCG1	ZNF160	Zinc finger protein 160	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14929	ZNF169	Zinc finger protein 169	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q14929	ZNF169	Zinc finger protein 169	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14929	ZNF169	Zinc finger protein 169	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q14929	ZNF169	Zinc finger protein 169	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15697	ZNF174	Zinc finger protein 174	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15697	ZNF174	Zinc finger protein 174	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q15697	ZNF174	Zinc finger protein 174	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q15697	ZNF174	Zinc finger protein 174	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q15697	ZNF174	Zinc finger protein 174	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q15697	ZNF174	Zinc finger protein 174	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q15697	ZNF174	Zinc finger protein 174	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q15697	ZNF174	Zinc finger protein 174	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q9Y473	ZNF175	Zinc finger protein 175	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y473	ZNF175	Zinc finger protein 175	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y473	ZNF175	Zinc finger protein 175	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9Y473	ZNF175	Zinc finger protein 175	GO:0051607; P:defense response to virus; IEA:UniProtKB-KW
Q9Y473	ZNF175	Zinc finger protein 175	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9Y473	ZNF175	Zinc finger protein 175	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P49910	ZNF165	Zinc finger protein 165	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P49910	ZNF165	Zinc finger protein 165	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P49910	ZNF165	Zinc finger protein 165	GO:0005515; F:protein binding; IPI:IntAct
P49910	ZNF165	Zinc finger protein 165	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P49910	ZNF165	Zinc finger protein 165	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13360	ZNF177	Zinc finger protein 177	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q13360	ZNF177	Zinc finger protein 177	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13360	ZNF177	Zinc finger protein 177	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q13360	ZNF177	Zinc finger protein 177	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UJW8	ZNF180	Zinc finger protein 180	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UJW8	ZNF180	Zinc finger protein 180	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UJW8	ZNF180	Zinc finger protein 180	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UJW8	ZNF180	Zinc finger protein 180	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q2M3W8	ZNF181	Zinc finger protein 181	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q2M3W8	ZNF181	Zinc finger protein 181	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q2M3W8	ZNF181	Zinc finger protein 181	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q2M3W8	ZNF181	Zinc finger protein 181	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17025	ZNF182	Zinc finger protein 182	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P17025	ZNF182	Zinc finger protein 182	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17025	ZNF182	Zinc finger protein 182	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P17025	ZNF182	Zinc finger protein 182	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P17025	ZNF182	Zinc finger protein 182	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q99676	ZNF184	Zinc finger protein 184	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q99676	ZNF184	Zinc finger protein 184	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q99676	ZNF184	Zinc finger protein 184	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q99676	ZNF184	Zinc finger protein 184	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75820	ZNF189	Zinc finger protein 189	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O75820	ZNF189	Zinc finger protein 189	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75820	ZNF189	Zinc finger protein 189	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
O75820	ZNF189	Zinc finger protein 189	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O75820	ZNF189	Zinc finger protein 189	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
O75820	ZNF189	Zinc finger protein 189	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15231	ZNF185	Zinc finger protein 185	GO:0008270; F:zinc ion binding; IEA:InterPro
O14628	ZNF195	Zinc finger protein 195	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O14628	ZNF195	Zinc finger protein 195	GO:0008270; F:zinc ion binding; NAS:UniProtKB
O14628	ZNF195	Zinc finger protein 195	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O14628	ZNF195	Zinc finger protein 195	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95125	ZNF202	Zinc finger protein 202	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O95125	ZNF202	Zinc finger protein 202	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95125	ZNF202	Zinc finger protein 202	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
O95125	ZNF202	Zinc finger protein 202	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O95125	ZNF202	Zinc finger protein 202	GO:0006629; P:lipid metabolic process; TAS:ProtInc
O95125	ZNF202	Zinc finger protein 202	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O95125	ZNF202	Zinc finger protein 202	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
O14709	ZNF197	Zinc finger protein 197	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O14709	ZNF197	Zinc finger protein 197	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14709	ZNF197	Zinc finger protein 197	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
O14709	ZNF197	Zinc finger protein 197	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
O14709	ZNF197	Zinc finger protein 197	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95201	ZNF205	Zinc finger protein 205	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O95201	ZNF205	Zinc finger protein 205	GO:0005515; F:protein binding; IPI:IntAct
O95201	ZNF205	Zinc finger protein 205	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
O95201	ZNF205	Zinc finger protein 205	GO:0008270; F:zinc ion binding; NAS:UniProtKB
O95201	ZNF205	Zinc finger protein 205	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL
O95201	ZNF205	Zinc finger protein 205	GO:0010729; P:positive regulation of hydrogen peroxide biosynthetic process; IMP:BHF-UCL
O95201	ZNF205	Zinc finger protein 205	GO:1901030; P:positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; IMP:BHF-UCL
O95201	ZNF205	Zinc finger protein 205	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
O95201	ZNF205	Zinc finger protein 205	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P98182	ZNF200	Zinc finger protein 200	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P98182	ZNF200	Zinc finger protein 200	GO:0003676; F:nucleic acid binding; IEA:InterPro
P98182	ZNF200	Zinc finger protein 200	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P98182	ZNF200	Zinc finger protein 200	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43670	ZNF207	BUB3-interacting and GLEBS motif-containing protein ZNF207	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O43670	ZNF207	BUB3-interacting and GLEBS motif-containing protein ZNF207	GO:0008201; F:heparin binding; IEA:Ensembl
O43670	ZNF207	BUB3-interacting and GLEBS motif-containing protein ZNF207	GO:0008017; F:microtubule binding; IDA:UniProtKB
O43670	ZNF207	BUB3-interacting and GLEBS motif-containing protein ZNF207	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O43670	ZNF207	BUB3-interacting and GLEBS motif-containing protein ZNF207	GO:0005515; F:protein binding; IPI:UniProtKB
O43670	ZNF207	BUB3-interacting and GLEBS motif-containing protein ZNF207	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
O43670	ZNF207	BUB3-interacting and GLEBS motif-containing protein ZNF207	GO:0008270; F:zinc ion binding; NAS:UniProtKB
O43670	ZNF207	BUB3-interacting and GLEBS motif-containing protein ZNF207	GO:0008608; P:attachment of spindle microtubules to kinetochore; IMP:UniProtKB
O43670	ZNF207	BUB3-interacting and GLEBS motif-containing protein ZNF207	GO:0000070; P:mitotic sister chromatid segregation; IMP:UniProtKB
O43670	ZNF207	BUB3-interacting and GLEBS motif-containing protein ZNF207	GO:0007094; P:mitotic spindle assembly checkpoint; IMP:UniProtKB
O43670	ZNF207	BUB3-interacting and GLEBS motif-containing protein ZNF207	GO:0050821; P:protein stabilization; IMP:UniProtKB
O43670	ZNF207	BUB3-interacting and GLEBS motif-containing protein ZNF207	GO:0051983; P:regulation of chromosome segregation; IMP:UniProtKB
O43670	ZNF207	BUB3-interacting and GLEBS motif-containing protein ZNF207	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
O43345	ZNF208	Zinc finger protein 208	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O43345	ZNF208	Zinc finger protein 208	GO:0008270; F:zinc ion binding; NAS:UniProtKB
O43345	ZNF208	Zinc finger protein 208	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O43345	ZNF208	Zinc finger protein 208	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q13398	ZNF211	Zinc finger protein 211	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q13398	ZNF211	Zinc finger protein 211	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q13398	ZNF211	Zinc finger protein 211	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q13398	ZNF211	Zinc finger protein 211	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UDV6	ZNF212	Zinc finger protein 212	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UDV6	ZNF212	Zinc finger protein 212	GO:0042802; F:identical protein binding; IPI:IntAct
Q9UDV6	ZNF212	Zinc finger protein 212	GO:0005515; F:protein binding; IPI:IntAct
Q9UDV6	ZNF212	Zinc finger protein 212	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9UDV6	ZNF212	Zinc finger protein 212	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9UDV6	ZNF212	Zinc finger protein 212	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O14771	ZNF213	Zinc finger protein 213	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O14771	ZNF213	Zinc finger protein 213	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14771	ZNF213	Zinc finger protein 213	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O14771	ZNF213	Zinc finger protein 213	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UL59	ZNF214	Zinc finger protein 214	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UL59	ZNF214	Zinc finger protein 214	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9UL59	ZNF214	Zinc finger protein 214	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UL59	ZNF214	Zinc finger protein 214	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UL58	ZNF215	Zinc finger protein 215	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UL58	ZNF215	Zinc finger protein 215	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UL58	ZNF215	Zinc finger protein 215	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q9UL58	ZNF215	Zinc finger protein 215	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q9UL58	ZNF215	Zinc finger protein 215	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
Q9UL58	ZNF215	Zinc finger protein 215	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
O75362	ZNF217	Zinc finger protein 217	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75362	ZNF217	Zinc finger protein 217	GO:0005515; F:protein binding; IPI:UniProtKB
O75362	ZNF217	Zinc finger protein 217	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O75362	ZNF217	Zinc finger protein 217	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
O75362	ZNF217	Zinc finger protein 217	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
O75362	ZNF217	Zinc finger protein 217	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
O75362	ZNF217	Zinc finger protein 217	GO:0006351; P:transcription, DNA-templated; TAS:ProtInc
Q9P2Y4	ZNF219	Zinc finger protein 219	GO:0003677; F:DNA binding; IDA:UniProtKB
Q9P2Y4	ZNF219	Zinc finger protein 219	GO:0004969; F:histamine receptor activity; IEA:InterPro
Q9P2Y4	ZNF219	Zinc finger protein 219	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9P2Y4	ZNF219	Zinc finger protein 219	GO:0005515; F:protein binding; IPI:UniProtKB
Q9P2Y4	ZNF219	Zinc finger protein 219	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9P2Y4	ZNF219	Zinc finger protein 219	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9P2Y4	ZNF219	Zinc finger protein 219	GO:0001505; P:regulation of neurotransmitter levels; IEA:InterPro
Q9P2Y4	ZNF219	Zinc finger protein 219	GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB
Q9P2Y4	ZNF219	Zinc finger protein 219	GO:0006351; P:transcription, DNA-templated; IDA:UniProtKB
Q9UK13	ZNF221	Zinc finger protein 221	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UK13	ZNF221	Zinc finger protein 221	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UK13	ZNF221	Zinc finger protein 221	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UK13	ZNF221	Zinc finger protein 221	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UK12	ZNF222	Zinc finger protein 222	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UK12	ZNF222	Zinc finger protein 222	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UK12	ZNF222	Zinc finger protein 222	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UK12	ZNF222	Zinc finger protein 222	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UK11	ZNF223	Zinc finger protein 223	GO:0003677; F:DNA binding; NAS:UniProtKB
Q9UK11	ZNF223	Zinc finger protein 223	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UK11	ZNF223	Zinc finger protein 223	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UK11	ZNF223	Zinc finger protein 223	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NZL3	ZNF224	Zinc finger protein 224	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NZL3	ZNF224	Zinc finger protein 224	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NZL3	ZNF224	Zinc finger protein 224	GO:0005515; F:protein binding; IPI:UniProtKB
Q9NZL3	ZNF224	Zinc finger protein 224	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9NZL3	ZNF224	Zinc finger protein 224	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9NZL3	ZNF224	Zinc finger protein 224	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UK10	ZNF225	Zinc finger protein 225	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UK10	ZNF225	Zinc finger protein 225	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UK10	ZNF225	Zinc finger protein 225	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UK10	ZNF225	Zinc finger protein 225	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NYT6	ZNF226	Zinc finger protein 226	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NYT6	ZNF226	Zinc finger protein 226	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NYT6	ZNF226	Zinc finger protein 226	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9NYT6	ZNF226	Zinc finger protein 226	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9NYT6	ZNF226	Zinc finger protein 226	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86WZ6	ZNF227	Zinc finger protein 227	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86WZ6	ZNF227	Zinc finger protein 227	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86WZ6	ZNF227	Zinc finger protein 227	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q86WZ6	ZNF227	Zinc finger protein 227	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q86WZ6	ZNF227	Zinc finger protein 227	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UJW7	ZNF229	Zinc finger protein 229	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UJW7	ZNF229	Zinc finger protein 229	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UJW7	ZNF229	Zinc finger protein 229	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9UJW7	ZNF229	Zinc finger protein 229	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9UJW7	ZNF229	Zinc finger protein 229	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UIE0	ZNF230	Zinc finger protein 230	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UIE0	ZNF230	Zinc finger protein 230	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UIE0	ZNF230	Zinc finger protein 230	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UIE0	ZNF230	Zinc finger protein 230	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UNY5	ZNF232	Zinc finger protein 232	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UNY5	ZNF232	Zinc finger protein 232	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UNY5	ZNF232	Zinc finger protein 232	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9UNY5	ZNF232	Zinc finger protein 232	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14588	ZNF234	Zinc finger protein 234	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q14588	ZNF234	Zinc finger protein 234	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14588	ZNF234	Zinc finger protein 234	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q14588	ZNF234	Zinc finger protein 234	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q14588	ZNF234	Zinc finger protein 234	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A6NK53	ZNF233	Zinc finger protein 233	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A6NK53	ZNF233	Zinc finger protein 233	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A6NK53	ZNF233	Zinc finger protein 233	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A6NK53	ZNF233	Zinc finger protein 233	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14590	ZNF235	Zinc finger protein 235	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q14590	ZNF235	Zinc finger protein 235	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14590	ZNF235	Zinc finger protein 235	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q14590	ZNF235	Zinc finger protein 235	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q14590	ZNF235	Zinc finger protein 235	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UL36	ZNF236	Zinc finger protein 236	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UL36	ZNF236	Zinc finger protein 236	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UL36	ZNF236	Zinc finger protein 236	GO:0071333; P:cellular response to glucose stimulus; IEP:UniProtKB
Q9UL36	ZNF236	Zinc finger protein 236	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UL36	ZNF236	Zinc finger protein 236	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q16600	ZNF239	Zinc finger protein 239	GO:0003677; F:DNA binding; TAS:ProtInc
Q16600	ZNF239	Zinc finger protein 239	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q16600	ZNF239	Zinc finger protein 239	GO:0003723; F:RNA binding; TAS:ProtInc
Q16600	ZNF239	Zinc finger protein 239	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q16600	ZNF239	Zinc finger protein 239	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q16600	ZNF239	Zinc finger protein 239	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NDW4	ZNF248	Zinc finger protein 248	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NDW4	ZNF248	Zinc finger protein 248	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NDW4	ZNF248	Zinc finger protein 248	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NDW4	ZNF248	Zinc finger protein 248	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P15622	ZNF250	Zinc finger protein 250	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P15622	ZNF250	Zinc finger protein 250	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P15622	ZNF250	Zinc finger protein 250	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P15622	ZNF250	Zinc finger protein 250	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P15622	ZNF250	Zinc finger protein 250	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BRH9	ZNF251	Zinc finger protein 251	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BRH9	ZNF251	Zinc finger protein 251	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BRH9	ZNF251	Zinc finger protein 251	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9BRH9	ZNF251	Zinc finger protein 251	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9BRH9	ZNF251	Zinc finger protein 251	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75346	ZNF253	Zinc finger protein 253	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O75346	ZNF253	Zinc finger protein 253	GO:0008270; F:zinc ion binding; NAS:UniProtKB
O75346	ZNF253	Zinc finger protein 253	GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB
O75346	ZNF253	Zinc finger protein 253	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
O75346	ZNF253	Zinc finger protein 253	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75437	ZNF254	Zinc finger protein 254	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O75437	ZNF254	Zinc finger protein 254	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75437	ZNF254	Zinc finger protein 254	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O75437	ZNF254	Zinc finger protein 254	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2P7	ZNF256	Zinc finger protein 256	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y2P7	ZNF256	Zinc finger protein 256	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y2P7	ZNF256	Zinc finger protein 256	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y2P7	ZNF256	Zinc finger protein 256	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q9Y2P7	ZNF256	Zinc finger protein 256	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q9Y2P7	ZNF256	Zinc finger protein 256	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9Y2P7	ZNF256	Zinc finger protein 256	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2Q1	ZNF257	Zinc finger protein 257	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y2Q1	ZNF257	Zinc finger protein 257	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9Y2Q1	ZNF257	Zinc finger protein 257	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q9Y2Q1	ZNF257	Zinc finger protein 257	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q3ZCT1	ZNF260	Zinc finger protein 260	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q3ZCT1	ZNF260	Zinc finger protein 260	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q3ZCT1	ZNF260	Zinc finger protein 260	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q3ZCT1	ZNF260	Zinc finger protein 260	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q3ZCT1	ZNF260	Zinc finger protein 260	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q3ZCT1	ZNF260	Zinc finger protein 260	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O14978	ZNF263	Zinc finger protein 263	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O14978	ZNF263	Zinc finger protein 263	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O14978	ZNF263	Zinc finger protein 263	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O14978	ZNF263	Zinc finger protein 263	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
O14978	ZNF263	Zinc finger protein 263	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
O14978	ZNF263	Zinc finger protein 263	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43296	ZNF264	Zinc finger protein 264	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O43296	ZNF264	Zinc finger protein 264	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43296	ZNF264	Zinc finger protein 264	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O43296	ZNF264	Zinc finger protein 264	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14584	ZNF266	Zinc finger protein 266	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q14584	ZNF266	Zinc finger protein 266	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14584	ZNF266	Zinc finger protein 266	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q14584	ZNF266	Zinc finger protein 266	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14586	ZNF267	Zinc finger protein 267	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q14586	ZNF267	Zinc finger protein 267	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14586	ZNF267	Zinc finger protein 267	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q14586	ZNF267	Zinc finger protein 267	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q14586	ZNF267	Zinc finger protein 267	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q14586	ZNF267	Zinc finger protein 267	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14587	ZNF268	Zinc finger protein 268	GO:0003677; F:DNA binding; NAS:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14587	ZNF268	Zinc finger protein 268	GO:0005515; F:protein binding; IPI:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q14587	ZNF268	Zinc finger protein 268	GO:0071356; P:cellular response to tumor necrosis factor; IDA:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0071157; P:negative regulation of cell cycle arrest; IMP:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0045597; P:positive regulation of cell differentiation; IMP:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0045732; P:positive regulation of protein catabolic process; IDA:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0090073; P:positive regulation of protein homodimerization activity; IDA:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0046022; P:positive regulation of transcription from RNA polymerase II promoter during mitosis; IMP:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0007346; P:regulation of mitotic cell cycle; IMP:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0043497; P:regulation of protein heterodimerization activity; IDA:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0008588; P:release of cytoplasmic sequestered NF-kappaB; IDA:UniProtKB
Q14587	ZNF268	Zinc finger protein 268	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14591	ZNF271	Zinc finger protein 271	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q14591	ZNF271	Zinc finger protein 271	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14591	ZNF271	Zinc finger protein 271	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q14591	ZNF271	Zinc finger protein 271	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14593	ZNF273	Zinc finger protein 273	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q14593	ZNF273	Zinc finger protein 273	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14593	ZNF273	Zinc finger protein 273	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q14593	ZNF273	Zinc finger protein 273	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96GC6	ZNF274	Neurotrophin receptor-interacting factor homolog	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96GC6	ZNF274	Neurotrophin receptor-interacting factor homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q96GC6	ZNF274	Neurotrophin receptor-interacting factor homolog	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q96GC6	ZNF274	Neurotrophin receptor-interacting factor homolog	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q96GC6	ZNF274	Neurotrophin receptor-interacting factor homolog	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q96GC6	ZNF274	Neurotrophin receptor-interacting factor homolog	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
Q96GC6	ZNF274	Neurotrophin receptor-interacting factor homolog	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NSD4	ZNF275	Zinc finger protein 275	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NSD4	ZNF275	Zinc finger protein 275	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NSD4	ZNF275	Zinc finger protein 275	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NSD4	ZNF275	Zinc finger protein 275	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NRM2	ZNF277	Zinc finger protein 277	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NRM2	ZNF277	Zinc finger protein 277	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NRM2	ZNF277	Zinc finger protein 277	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NRM2	ZNF277	Zinc finger protein 277	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2X9	ZNF281	Zinc finger protein 281	GO:0001047; F:core promoter binding; ISS:UniProtKB
Q9Y2X9	ZNF281	Zinc finger protein 281	GO:0046872; F:metal ion binding; IEA:InterPro
Q9Y2X9	ZNF281	Zinc finger protein 281	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9Y2X9	ZNF281	Zinc finger protein 281	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y2X9	ZNF281	Zinc finger protein 281	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q9Y2X9	ZNF281	Zinc finger protein 281	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9Y2X9	ZNF281	Zinc finger protein 281	GO:0003714; F:transcription corepressor activity; ISS:UniProtKB
Q9Y2X9	ZNF281	Zinc finger protein 281	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q9Y2X9	ZNF281	Zinc finger protein 281	GO:0010172; P:embryonic body morphogenesis; ISS:UniProtKB
Q9Y2X9	ZNF281	Zinc finger protein 281	GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB
Q9Y2X9	ZNF281	Zinc finger protein 281	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9Y2X9	ZNF281	Zinc finger protein 281	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q9Y2X9	ZNF281	Zinc finger protein 281	GO:0048863; P:stem cell differentiation; ISS:UniProtKB
Q9Y2X9	ZNF281	Zinc finger protein 281	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UDV7	ZNF282	Zinc finger protein 282	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UDV7	ZNF282	Zinc finger protein 282	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9UDV7	ZNF282	Zinc finger protein 282	GO:0045892; P:negative regulation of transcription, DNA-templated; TAS:UniProtKB
Q9UDV7	ZNF282	Zinc finger protein 282	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q9UDV7	ZNF282	Zinc finger protein 282	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N554	ZNF276	Zinc finger protein 276	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N554	ZNF276	Zinc finger protein 276	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N554	ZNF276	Zinc finger protein 276	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N554	ZNF276	Zinc finger protein 276	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N7M2	ZNF283	Zinc finger protein 283	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N7M2	ZNF283	Zinc finger protein 283	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N7M2	ZNF283	Zinc finger protein 283	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q8N7M2	ZNF283	Zinc finger protein 283	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q8N7M2	ZNF283	Zinc finger protein 283	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HBT7	ZNF287	Zinc finger protein 287	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9HBT7	ZNF287	Zinc finger protein 287	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HBT7	ZNF287	Zinc finger protein 287	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9HBT7	ZNF287	Zinc finger protein 287	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q9HBT7	ZNF287	Zinc finger protein 287	GO:0042035; P:regulation of cytokine biosynthetic process; IEA:Ensembl
Q9HBT7	ZNF287	Zinc finger protein 287	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96NJ3	ZNF285	Zinc finger protein 285	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96NJ3	ZNF285	Zinc finger protein 285	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96NJ3	ZNF285	Zinc finger protein 285	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96NJ3	ZNF285	Zinc finger protein 285	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q2VY69	ZNF284	Zinc finger protein 284	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q2VY69	ZNF284	Zinc finger protein 284	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q2VY69	ZNF284	Zinc finger protein 284	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q2VY69	ZNF284	Zinc finger protein 284	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60281	ZNF292	Zinc finger protein 292	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O60281	ZNF292	Zinc finger protein 292	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60281	ZNF292	Zinc finger protein 292	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IEA:Ensembl
Q96RE9	ZNF300	Zinc finger protein 300	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96RE9	ZNF300	Zinc finger protein 300	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96RE9	ZNF300	Zinc finger protein 300	GO:0005515; F:protein binding; IPI:UniProtKB
Q96RE9	ZNF300	Zinc finger protein 300	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q96RE9	ZNF300	Zinc finger protein 300	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q96RE9	ZNF300	Zinc finger protein 300	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WUU4	ZNF296	Zinc finger protein 296	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8WUU4	ZNF296	Zinc finger protein 296	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8WUU4	ZNF296	Zinc finger protein 296	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8WUU4	ZNF296	Zinc finger protein 296	GO:0007283; P:spermatogenesis; ISS:UniProtKB
Q8WUU4	ZNF296	Zinc finger protein 296	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NR11	ZNF302	Zinc finger protein 302	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NR11	ZNF302	Zinc finger protein 302	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NR11	ZNF302	Zinc finger protein 302	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9NR11	ZNF302	Zinc finger protein 302	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9NR11	ZNF302	Zinc finger protein 302	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HCX3	ZNF304	Zinc finger protein 304	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9HCX3	ZNF304	Zinc finger protein 304	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HCX3	ZNF304	Zinc finger protein 304	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9HCX3	ZNF304	Zinc finger protein 304	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5JNZ3	ZNF311	Zinc finger protein 311	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5JNZ3	ZNF311	Zinc finger protein 311	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5JNZ3	ZNF311	Zinc finger protein 311	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q5JNZ3	ZNF311	Zinc finger protein 311	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q5JNZ3	ZNF311	Zinc finger protein 311	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A6NFI3	ZNF316	Zinc finger protein 316	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A6NFI3	ZNF316	Zinc finger protein 316	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A6NFI3	ZNF316	Zinc finger protein 316	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A6NFI3	ZNF316	Zinc finger protein 316	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96PQ6	ZNF317	Zinc finger protein 317	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96PQ6	ZNF317	Zinc finger protein 317	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96PQ6	ZNF317	Zinc finger protein 317	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q96PQ6	ZNF317	Zinc finger protein 317	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q96PQ6	ZNF317	Zinc finger protein 317	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5VUA4	ZNF318	Zinc finger protein 318	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q5VUA4	ZNF318	Zinc finger protein 318	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5VUA4	ZNF318	Zinc finger protein 318	GO:0007126; P:meiotic nuclear division; IEA:UniProtKB-KW
Q5VUA4	ZNF318	Zinc finger protein 318	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5VUA4	ZNF318	Zinc finger protein 318	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9P2F9	ZNF319	Zinc finger protein 319	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9P2F9	ZNF319	Zinc finger protein 319	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9P2F9	ZNF319	Zinc finger protein 319	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9P2F9	ZNF319	Zinc finger protein 319	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A2RRD8	ZNF320	Zinc finger protein 320	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A2RRD8	ZNF320	Zinc finger protein 320	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A2RRD8	ZNF320	Zinc finger protein 320	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
A2RRD8	ZNF320	Zinc finger protein 320	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
A2RRD8	ZNF320	Zinc finger protein 320	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6U7Q0	ZNF322	Zinc finger protein 322	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6U7Q0	ZNF322	Zinc finger protein 322	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6U7Q0	ZNF322	Zinc finger protein 322	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6U7Q0	ZNF322	Zinc finger protein 322	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q6U7Q0	ZNF322	Zinc finger protein 322	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5BKZ1	ZNF326	DBIRD complex subunit ZNF326	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5BKZ1	ZNF326	DBIRD complex subunit ZNF326	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q5BKZ1	ZNF326	DBIRD complex subunit ZNF326	GO:0005515; F:protein binding; IPI:UniProtKB
Q5BKZ1	ZNF326	DBIRD complex subunit ZNF326	GO:0000993; F:RNA polymerase II core binding; IDA:UniProtKB
Q5BKZ1	ZNF326	DBIRD complex subunit ZNF326	GO:0008270; F:zinc ion binding; IEA:Ensembl
Q5BKZ1	ZNF326	DBIRD complex subunit ZNF326	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
Q5BKZ1	ZNF326	DBIRD complex subunit ZNF326	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q5BKZ1	ZNF326	DBIRD complex subunit ZNF326	GO:0032784; P:regulation of DNA-templated transcription, elongation; IMP:UniProtKB
Q5BKZ1	ZNF326	DBIRD complex subunit ZNF326	GO:0008380; P:RNA splicing; IMP:UniProtKB
Q5BKZ1	ZNF326	DBIRD complex subunit ZNF326	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86UD4	ZNF329	Zinc finger protein 329	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86UD4	ZNF329	Zinc finger protein 329	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86UD4	ZNF329	Zinc finger protein 329	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q86UD4	ZNF329	Zinc finger protein 329	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y3S2	ZNF330	Zinc finger protein 330	GO:0046872; F:metal ion binding; NAS:UniProtKB
Q9Y3S2	ZNF330	Zinc finger protein 330	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9NQX6	ZNF331	Zinc finger protein 331	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NQX6	ZNF331	Zinc finger protein 331	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9NQX6	ZNF331	Zinc finger protein 331	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NQX6	ZNF331	Zinc finger protein 331	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HCZ1	ZNF334	Zinc finger protein 334	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9HCZ1	ZNF334	Zinc finger protein 334	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HCZ1	ZNF334	Zinc finger protein 334	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9HCZ1	ZNF334	Zinc finger protein 334	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9HCZ1	ZNF334	Zinc finger protein 334	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96JL9	ZNF333	Zinc finger protein 333	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96JL9	ZNF333	Zinc finger protein 333	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96JL9	ZNF333	Zinc finger protein 333	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96JL9	ZNF333	Zinc finger protein 333	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H4Z2	ZNF335	Zinc finger protein 335	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H4Z2	ZNF335	Zinc finger protein 335	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H4Z2	ZNF335	Zinc finger protein 335	GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl
Q9H4Z2	ZNF335	Zinc finger protein 335	GO:0044212; F:transcription regulatory region DNA binding; ISS:UniProtKB
Q9H4Z2	ZNF335	Zinc finger protein 335	GO:0007420; P:brain development; IMP:UniProtKB
Q9H4Z2	ZNF335	Zinc finger protein 335	GO:0048854; P:brain morphogenesis; IEA:Ensembl
Q9H4Z2	ZNF335	Zinc finger protein 335	GO:0021895; P:cerebral cortex neuron differentiation; IEA:Ensembl
Q9H4Z2	ZNF335	Zinc finger protein 335	GO:0080182; P:histone H3-K4 trimethylation; IMP:UniProtKB
Q9H4Z2	ZNF335	Zinc finger protein 335	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9H4Z2	ZNF335	Zinc finger protein 335	GO:0048812; P:neuron projection morphogenesis; ISS:UniProtKB
Q9H4Z2	ZNF335	Zinc finger protein 335	GO:0050671; P:positive regulation of lymphocyte proliferation; IMP:UniProtKB
Q9H4Z2	ZNF335	Zinc finger protein 335	GO:0002052; P:positive regulation of neuroblast proliferation; ISS:UniProtKB
Q9H4Z2	ZNF335	Zinc finger protein 335	GO:0050769; P:positive regulation of neurogenesis; IMP:UniProtKB
Q9H4Z2	ZNF335	Zinc finger protein 335	GO:0040029; P:regulation of gene expression, epigenetic; IMP:UniProtKB
Q9H4Z2	ZNF335	Zinc finger protein 335	GO:0051569; P:regulation of histone H3-K4 methylation; IEA:Ensembl
Q9H4Z2	ZNF335	Zinc finger protein 335	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H4Z2	ZNF335	Zinc finger protein 335	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q06730	ZNF33A	Zinc finger protein 33A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q06730	ZNF33A	Zinc finger protein 33A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q06730	ZNF33A	Zinc finger protein 33A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q06730	ZNF33A	Zinc finger protein 33A	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q06730	ZNF33A	Zinc finger protein 33A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y3M9	ZNF337	Zinc finger protein 337	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y3M9	ZNF337	Zinc finger protein 337	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y3M9	ZNF337	Zinc finger protein 337	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y3M9	ZNF337	Zinc finger protein 337	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q06732	ZNF33B	Zinc finger protein 33B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q06732	ZNF33B	Zinc finger protein 33B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q06732	ZNF33B	Zinc finger protein 33B	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q06732	ZNF33B	Zinc finger protein 33B	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q06732	ZNF33B	Zinc finger protein 33B	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6P1L6	ZNF343	Zinc finger protein 343	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6P1L6	ZNF343	Zinc finger protein 343	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6P1L6	ZNF343	Zinc finger protein 343	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6P1L6	ZNF343	Zinc finger protein 343	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BYN7	ZNF341	Zinc finger protein 341	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BYN7	ZNF341	Zinc finger protein 341	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BYN7	ZNF341	Zinc finger protein 341	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9BYN7	ZNF341	Zinc finger protein 341	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UL40	ZNF346	Zinc finger protein 346	GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB
Q9UL40	ZNF346	Zinc finger protein 346	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UL40	ZNF346	Zinc finger protein 346	GO:0005515; F:protein binding; IPI:IntAct
Q9UL40	ZNF346	Zinc finger protein 346	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UL40	ZNF346	Zinc finger protein 346	GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl
Q14585	ZNF345	Zinc finger protein 345	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q14585	ZNF345	Zinc finger protein 345	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14585	ZNF345	Zinc finger protein 345	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q14585	ZNF345	Zinc finger protein 345	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
Q14585	ZNF345	Zinc finger protein 345	GO:0006359; P:regulation of transcription from RNA polymerase III promoter; TAS:ProtInc
Q14585	ZNF345	Zinc finger protein 345	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q14585	ZNF345	Zinc finger protein 345	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc
Q14585	ZNF345	Zinc finger protein 345	GO:0006383; P:transcription from RNA polymerase III promoter; TAS:ProtInc
Q96SE7	ZNF347	Zinc finger protein 347	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96SE7	ZNF347	Zinc finger protein 347	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96SE7	ZNF347	Zinc finger protein 347	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96SE7	ZNF347	Zinc finger protein 347	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5T0B9	ZNF362	Zinc finger protein 362	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5T0B9	ZNF362	Zinc finger protein 362	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5T0B9	ZNF362	Zinc finger protein 362	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5T0B9	ZNF362	Zinc finger protein 362	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9GZX5	ZNF350	Zinc finger protein 350	GO:0003677; F:DNA binding; IDA:UniProtKB
Q9GZX5	ZNF350	Zinc finger protein 350	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9GZX5	ZNF350	Zinc finger protein 350	GO:0005515; F:protein binding; IPI:IntAct
Q9GZX5	ZNF350	Zinc finger protein 350	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9GZX5	ZNF350	Zinc finger protein 350	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q9GZX5	ZNF350	Zinc finger protein 350	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NW07	ZNF358	Zinc finger protein 358	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NW07	ZNF358	Zinc finger protein 358	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NW07	ZNF358	Zinc finger protein 358	GO:0035115; P:embryonic forelimb morphogenesis; ISS:UniProtKB
Q9NW07	ZNF358	Zinc finger protein 358	GO:0021915; P:neural tube development; ISS:UniProtKB
Q9NW07	ZNF358	Zinc finger protein 358	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NW07	ZNF358	Zinc finger protein 358	GO:0019827; P:stem cell maintenance; ISS:UniProtKB
Q9NW07	ZNF358	Zinc finger protein 358	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96PM5	RCHY1	RING finger and CHY zinc finger domain-containing protein 1	GO:0002039; F:p53 binding; IPI:UniProtKB
Q96PM5	RCHY1	RING finger and CHY zinc finger domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
Q96PM5	RCHY1	RING finger and CHY zinc finger domain-containing protein 1	GO:0042803; F:protein homodimerization activity; IPI:UniProtKB
Q96PM5	RCHY1	RING finger and CHY zinc finger domain-containing protein 1	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q96PM5	RCHY1	RING finger and CHY zinc finger domain-containing protein 1	GO:0008270; F:zinc ion binding; IDA:UniProtKB
Q96PM5	RCHY1	RING finger and CHY zinc finger domain-containing protein 1	GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q96PM5	RCHY1	RING finger and CHY zinc finger domain-containing protein 1	GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB
Q96PM5	RCHY1	RING finger and CHY zinc finger domain-containing protein 1	GO:0051865; P:protein autoubiquitination; IDA:UniProtKB
Q96PM5	RCHY1	RING finger and CHY zinc finger domain-containing protein 1	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q96PM5	RCHY1	RING finger and CHY zinc finger domain-containing protein 1	GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB
Q70YC5	ZNF365	Protein ZNF365	GO:0005515; F:protein binding; IPI:IntAct
Q8N895	ZNF366	Zinc finger protein 366	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N895	ZNF366	Zinc finger protein 366	GO:0030331; F:estrogen receptor binding; IDA:UniProtKB
Q8N895	ZNF366	Zinc finger protein 366	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N895	ZNF366	Zinc finger protein 366	GO:0005515; F:protein binding; IPI:IntAct
Q8N895	ZNF366	Zinc finger protein 366	GO:0003714; F:transcription corepressor activity; IDA:UniProtKB
Q8N895	ZNF366	Zinc finger protein 366	GO:0033147; P:negative regulation of intracellular estrogen receptor signaling pathway; IDA:UniProtKB
Q8N895	ZNF366	Zinc finger protein 366	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q8N895	ZNF366	Zinc finger protein 366	GO:0043627; P:response to estrogen; IDA:UniProtKB
Q8N895	ZNF366	Zinc finger protein 366	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7RTV3	ZNF367	Zinc finger protein 367	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7RTV3	ZNF367	Zinc finger protein 367	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7RTV3	ZNF367	Zinc finger protein 367	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:MGI
Q7RTV3	ZNF367	Zinc finger protein 367	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:MGI
Q7RTV3	ZNF367	Zinc finger protein 367	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96SR6	ZNF382	Zinc finger protein 382	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96SR6	ZNF382	Zinc finger protein 382	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96SR6	ZNF382	Zinc finger protein 382	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q96SR6	ZNF382	Zinc finger protein 382	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17032	ZNF37A	Zinc finger protein 37A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P17032	ZNF37A	Zinc finger protein 37A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17032	ZNF37A	Zinc finger protein 37A	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
P17032	ZNF37A	Zinc finger protein 37A	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P17032	ZNF37A	Zinc finger protein 37A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NA42	ZNF383	Zinc finger protein 383	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NA42	ZNF383	Zinc finger protein 383	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NA42	ZNF383	Zinc finger protein 383	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q8NA42	ZNF383	Zinc finger protein 383	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q8NA42	ZNF383	Zinc finger protein 383	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TF68	ZNF384	Zinc finger protein 384	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TF68	ZNF384	Zinc finger protein 384	GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl
Q8TF68	ZNF384	Zinc finger protein 384	GO:0006913; P:nucleocytoplasmic transport; IEA:Ensembl
Q8TF68	ZNF384	Zinc finger protein 384	GO:0050714; P:positive regulation of protein secretion; IEA:Ensembl
Q8TF68	ZNF384	Zinc finger protein 384	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q8TF68	ZNF384	Zinc finger protein 384	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UJN7	ZNF391	Zinc finger protein 391	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UJN7	ZNF391	Zinc finger protein 391	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UJN7	ZNF391	Zinc finger protein 391	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9UJN7	ZNF391	Zinc finger protein 391	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9UJN7	ZNF391	Zinc finger protein 391	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q53GI3	ZNF394	Zinc finger protein 394	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q53GI3	ZNF394	Zinc finger protein 394	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q53GI3	ZNF394	Zinc finger protein 394	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q53GI3	ZNF394	Zinc finger protein 394	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H8N7	ZNF395	Zinc finger protein 395	GO:0003677; F:DNA binding; IDA:UniProtKB
Q9H8N7	ZNF395	Zinc finger protein 395	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H8N7	ZNF395	Zinc finger protein 395	GO:0006355; P:regulation of transcription, DNA-templated; IC:UniProtKB
Q9H8N7	ZNF395	Zinc finger protein 395	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96N95	ZNF396	Zinc finger protein 396	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96N95	ZNF396	Zinc finger protein 396	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96N95	ZNF396	Zinc finger protein 396	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q96N95	ZNF396	Zinc finger protein 396	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NF99	ZNF397	Zinc finger protein 397	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NF99	ZNF397	Zinc finger protein 397	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NF99	ZNF397	Zinc finger protein 397	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8NF99	ZNF397	Zinc finger protein 397	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TD17	ZNF398	Zinc finger protein 398	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TD17	ZNF398	Zinc finger protein 398	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TD17	ZNF398	Zinc finger protein 398	GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB
Q8TD17	ZNF398	Zinc finger protein 398	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q8TD17	ZNF398	Zinc finger protein 398	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q17R26	ZNF300P1	Putative protein ZNF300P1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q17R26	ZNF300P1	Putative protein ZNF300P1	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q494X3	ZNF404	Zinc finger protein 404	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q494X3	ZNF404	Zinc finger protein 404	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q494X3	ZNF404	Zinc finger protein 404	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q494X3	ZNF404	Zinc finger protein 404	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9C0G0	ZNF407	Zinc finger protein 407	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9C0G0	ZNF407	Zinc finger protein 407	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9C0G0	ZNF407	Zinc finger protein 407	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9C0G0	ZNF407	Zinc finger protein 407	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H9D4	ZNF408	Zinc finger protein 408	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H9D4	ZNF408	Zinc finger protein 408	GO:0042802; F:identical protein binding; IPI:IntAct
Q9H9D4	ZNF408	Zinc finger protein 408	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H9D4	ZNF408	Zinc finger protein 408	GO:0005515; F:protein binding; IPI:IntAct
Q9H9D4	ZNF408	Zinc finger protein 408	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H9D4	ZNF408	Zinc finger protein 408	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86VK4	ZNF410	Zinc finger protein 410	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86VK4	ZNF410	Zinc finger protein 410	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86VK4	ZNF410	Zinc finger protein 410	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q86VK4	ZNF410	Zinc finger protein 410	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96IQ9	ZNF414	Zinc finger protein 414	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96IQ9	ZNF414	Zinc finger protein 414	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96IQ9	ZNF414	Zinc finger protein 414	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96IQ9	ZNF414	Zinc finger protein 414	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BWM5	ZNF416	Zinc finger protein 416	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BWM5	ZNF416	Zinc finger protein 416	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BWM5	ZNF416	Zinc finger protein 416	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9BWM5	ZNF416	Zinc finger protein 416	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q09FC8	ZNF415	Zinc finger protein 415	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q09FC8	ZNF415	Zinc finger protein 415	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q09FC8	ZNF415	Zinc finger protein 415	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q09FC8	ZNF415	Zinc finger protein 415	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q09FC8	ZNF415	Zinc finger protein 415	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TAU3	ZNF417	Zinc finger protein 417	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TAU3	ZNF417	Zinc finger protein 417	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TAU3	ZNF417	Zinc finger protein 417	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8TAU3	ZNF417	Zinc finger protein 417	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TF45	ZNF418	Zinc finger protein 418	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TF45	ZNF418	Zinc finger protein 418	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TF45	ZNF418	Zinc finger protein 418	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8TF45	ZNF418	Zinc finger protein 418	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96HQ0	ZNF419	Zinc finger protein 419	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96HQ0	ZNF419	Zinc finger protein 419	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96HQ0	ZNF419	Zinc finger protein 419	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96HQ0	ZNF419	Zinc finger protein 419	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TAQ5	ZNF420	Zinc finger protein 420	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TAQ5	ZNF420	Zinc finger protein 420	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TAQ5	ZNF420	Zinc finger protein 420	GO:0005515; F:protein binding; IPI:IntAct
Q8TAQ5	ZNF420	Zinc finger protein 420	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q8TAQ5	ZNF420	Zinc finger protein 420	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q8TAQ5	ZNF420	Zinc finger protein 420	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q2M1K9	ZNF423	Zinc finger protein 423	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q2M1K9	ZNF423	Zinc finger protein 423	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q2M1K9	ZNF423	Zinc finger protein 423	GO:0005515; F:protein binding; IPI:UniProtKB
Q2M1K9	ZNF423	Zinc finger protein 423	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q2M1K9	ZNF423	Zinc finger protein 423	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q2M1K9	ZNF423	Zinc finger protein 423	GO:0007399; P:nervous system development; IEA:UniProtKB-KW
Q2M1K9	ZNF423	Zinc finger protein 423	GO:0007219; P:Notch signaling pathway; ISS:UniProtKB
Q2M1K9	ZNF423	Zinc finger protein 423	GO:0030513; P:positive regulation of BMP signaling pathway; ISS:UniProtKB
Q2M1K9	ZNF423	Zinc finger protein 423	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q2M1K9	ZNF423	Zinc finger protein 423	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6IV72	ZNF425	Zinc finger protein 425	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6IV72	ZNF425	Zinc finger protein 425	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6IV72	ZNF425	Zinc finger protein 425	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q6IV72	ZNF425	Zinc finger protein 425	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BUY5	ZNF426	Zinc finger protein 426	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BUY5	ZNF426	Zinc finger protein 426	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BUY5	ZNF426	Zinc finger protein 426	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9BUY5	ZNF426	Zinc finger protein 426	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96B54	ZNF428	Zinc finger protein 428	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86V71	ZNF429	Zinc finger protein 429	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86V71	ZNF429	Zinc finger protein 429	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86V71	ZNF429	Zinc finger protein 429	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q86V71	ZNF429	Zinc finger protein 429	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q86V71	ZNF429	Zinc finger protein 429	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H8G1	ZNF430	Zinc finger protein 430	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H8G1	ZNF430	Zinc finger protein 430	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H8G1	ZNF430	Zinc finger protein 430	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H8G1	ZNF430	Zinc finger protein 430	GO:0021762; P:substantia nigra development; IEP:UniProt
Q9H8G1	ZNF430	Zinc finger protein 430	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TF32	ZNF431	Zinc finger protein 431	GO:0003682; F:chromatin binding; ISS:UniProtKB
Q8TF32	ZNF431	Zinc finger protein 431	GO:0001046; F:core promoter sequence-specific DNA binding; ISS:UniProtKB
Q8TF32	ZNF431	Zinc finger protein 431	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TF32	ZNF431	Zinc finger protein 431	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q8TF32	ZNF431	Zinc finger protein 431	GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q8TF32	ZNF431	Zinc finger protein 431	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB
Q8TF32	ZNF431	Zinc finger protein 431	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O94892	ZNF432	Zinc finger protein 432	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O94892	ZNF432	Zinc finger protein 432	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O94892	ZNF432	Zinc finger protein 432	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
O94892	ZNF432	Zinc finger protein 432	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
O94892	ZNF432	Zinc finger protein 432	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N7K0	ZNF433	Zinc finger protein 433	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N7K0	ZNF433	Zinc finger protein 433	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N7K0	ZNF433	Zinc finger protein 433	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N7K0	ZNF433	Zinc finger protein 433	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9C0F3	ZNF436	Zinc finger protein 436	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9C0F3	ZNF436	Zinc finger protein 436	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9C0F3	ZNF436	Zinc finger protein 436	GO:0005515; F:protein binding; IPI:IntAct
Q9C0F3	ZNF436	Zinc finger protein 436	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9C0F3	ZNF436	Zinc finger protein 436	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9C0F3	ZNF436	Zinc finger protein 436	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z4V0	ZNF438	Zinc finger protein 438	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7Z4V0	ZNF438	Zinc finger protein 438	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z4V0	ZNF438	Zinc finger protein 438	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q7Z4V0	ZNF438	Zinc finger protein 438	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q7Z4V0	ZNF438	Zinc finger protein 438	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z4V0	ZNF438	Zinc finger protein 438	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NDP4	ZNF439	Zinc finger protein 439	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NDP4	ZNF439	Zinc finger protein 439	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NDP4	ZNF439	Zinc finger protein 439	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NDP4	ZNF439	Zinc finger protein 439	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IYI8	ZNF440	Zinc finger protein 440	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IYI8	ZNF440	Zinc finger protein 440	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IYI8	ZNF440	Zinc finger protein 440	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8IYI8	ZNF440	Zinc finger protein 440	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H7R0	ZNF442	Zinc finger protein 442	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H7R0	ZNF442	Zinc finger protein 442	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H7R0	ZNF442	Zinc finger protein 442	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H7R0	ZNF442	Zinc finger protein 442	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N8Z8	ZNF441	Zinc finger protein 441	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N8Z8	ZNF441	Zinc finger protein 441	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N8Z8	ZNF441	Zinc finger protein 441	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N8Z8	ZNF441	Zinc finger protein 441	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2A4	ZNF443	Zinc finger protein 443	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y2A4	ZNF443	Zinc finger protein 443	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y2A4	ZNF443	Zinc finger protein 443	GO:0006915; P:apoptotic process; TAS:ProtInc
Q9Y2A4	ZNF443	Zinc finger protein 443	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2A4	ZNF443	Zinc finger protein 443	GO:0006950; P:response to stress; TAS:ProtInc
Q9Y2A4	ZNF443	Zinc finger protein 443	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P59923	ZNF445	Zinc finger protein 445	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P59923	ZNF445	Zinc finger protein 445	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P59923	ZNF445	Zinc finger protein 445	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P59923	ZNF445	Zinc finger protein 445	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N0Y2	ZNF444	Zinc finger protein 444	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N0Y2	ZNF444	Zinc finger protein 444	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N0Y2	ZNF444	Zinc finger protein 444	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q8N0Y2	ZNF444	Zinc finger protein 444	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
Q8N0Y2	ZNF444	Zinc finger protein 444	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q9NWS9	ZNF446	Zinc finger protein 446	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NWS9	ZNF446	Zinc finger protein 446	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NWS9	ZNF446	Zinc finger protein 446	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q9NWS9	ZNF446	Zinc finger protein 446	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
Q9NWS9	ZNF446	Zinc finger protein 446	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q6P9G9	ZNF449	Zinc finger protein 449	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6P9G9	ZNF449	Zinc finger protein 449	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6P9G9	ZNF449	Zinc finger protein 449	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q6P9G9	ZNF449	Zinc finger protein 449	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y4E5	ZNF451	Zinc finger protein 451	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y4E5	ZNF451	Zinc finger protein 451	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y4E5	ZNF451	Zinc finger protein 451	GO:0005515; F:protein binding; IPI:IntAct
Q9Y4E5	ZNF451	Zinc finger protein 451	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y4E5	ZNF451	Zinc finger protein 451	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N9F8	ZNF454	Zinc finger protein 454	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N9F8	ZNF454	Zinc finger protein 454	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N9F8	ZNF454	Zinc finger protein 454	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q8N9F8	ZNF454	Zinc finger protein 454	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q8N9F8	ZNF454	Zinc finger protein 454	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14592	ZNF460	Zinc finger protein 460	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q14592	ZNF460	Zinc finger protein 460	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q14592	ZNF460	Zinc finger protein 460	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q14592	ZNF460	Zinc finger protein 460	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TAF7	ZNF461	Zinc finger protein 461	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TAF7	ZNF461	Zinc finger protein 461	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TAF7	ZNF461	Zinc finger protein 461	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q8TAF7	ZNF461	Zinc finger protein 461	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q8TAF7	ZNF461	Zinc finger protein 461	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96JM2	ZNF462	Zinc finger protein 462	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96JM2	ZNF462	Zinc finger protein 462	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96JM2	ZNF462	Zinc finger protein 462	GO:0006325; P:chromatin organization; IEA:Ensembl
Q96JM2	ZNF462	Zinc finger protein 462	GO:0043392; P:negative regulation of DNA binding; IEA:Ensembl
Q96JM2	ZNF462	Zinc finger protein 462	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q96JM2	ZNF462	Zinc finger protein 462	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z7K2	ZNF467	Zinc finger protein 467	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7Z7K2	ZNF467	Zinc finger protein 467	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z7K2	ZNF467	Zinc finger protein 467	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z7K2	ZNF467	Zinc finger protein 467	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96JG9	ZNF469	Zinc finger protein 469	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96JG9	ZNF469	Zinc finger protein 469	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96JG9	ZNF469	Zinc finger protein 469	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96JG9	ZNF469	Zinc finger protein 469	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5VIY5	ZNF468	Zinc finger protein 468	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5VIY5	ZNF468	Zinc finger protein 468	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5VIY5	ZNF468	Zinc finger protein 468	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5VIY5	ZNF468	Zinc finger protein 468	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ECI4	ZNF470	Zinc finger protein 470	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ECI4	ZNF470	Zinc finger protein 470	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ECI4	ZNF470	Zinc finger protein 470	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6ECI4	ZNF470	Zinc finger protein 470	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q6ECI4	ZNF470	Zinc finger protein 470	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WTR7	ZNF473	Zinc finger protein 473	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8WTR7	ZNF473	Zinc finger protein 473	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8WTR7	ZNF473	Zinc finger protein 473	GO:0005515; F:protein binding; IPI:UniProtKB
Q8WTR7	ZNF473	Zinc finger protein 473	GO:0010467; P:gene expression; TAS:Reactome
Q8WTR7	ZNF473	Zinc finger protein 473	GO:0006398; P:histone mRNA 3'-end processing; IDA:UniProtKB
Q8WTR7	ZNF473	Zinc finger protein 473	GO:0008334; P:histone mRNA metabolic process; TAS:Reactome
Q8WTR7	ZNF473	Zinc finger protein 473	GO:0031124; P:mRNA 3'-end processing; TAS:Reactome
Q8WTR7	ZNF473	Zinc finger protein 473	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q8WTR7	ZNF473	Zinc finger protein 473	GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome
Q8WTR7	ZNF473	Zinc finger protein 473	GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome
Q9BX82	ZNF471	Zinc finger protein 471	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BX82	ZNF471	Zinc finger protein 471	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BX82	ZNF471	Zinc finger protein 471	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9BX82	ZNF471	Zinc finger protein 471	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9BX82	ZNF471	Zinc finger protein 471	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6S9Z5	ZNF474	Zinc finger protein 474	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96JC4	ZNF479	Zinc finger protein 479	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96JC4	ZNF479	Zinc finger protein 479	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96JC4	ZNF479	Zinc finger protein 479	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96JC4	ZNF479	Zinc finger protein 479	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WV37	ZNF480	Zinc finger protein 480	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8WV37	ZNF480	Zinc finger protein 480	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8WV37	ZNF480	Zinc finger protein 480	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8WV37	ZNF480	Zinc finger protein 480	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TF39	ZNF483	Zinc finger protein 483	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TF39	ZNF483	Zinc finger protein 483	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TF39	ZNF483	Zinc finger protein 483	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q8TF39	ZNF483	Zinc finger protein 483	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q8TF39	ZNF483	Zinc finger protein 483	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5JVG2	ZNF484	Zinc finger protein 484	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5JVG2	ZNF484	Zinc finger protein 484	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5JVG2	ZNF484	Zinc finger protein 484	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q5JVG2	ZNF484	Zinc finger protein 484	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q5JVG2	ZNF484	Zinc finger protein 484	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NCK3	ZNF485	Zinc finger protein 485	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NCK3	ZNF485	Zinc finger protein 485	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NCK3	ZNF485	Zinc finger protein 485	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NCK3	ZNF485	Zinc finger protein 485	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
B1APH4	ZNF487	Putative zinc finger protein 487	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
B1APH4	ZNF487	Putative zinc finger protein 487	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
B1APH4	ZNF487	Putative zinc finger protein 487	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
B1APH4	ZNF487	Putative zinc finger protein 487	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96H40	ZNF486	Zinc finger protein 486	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96H40	ZNF486	Zinc finger protein 486	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96H40	ZNF486	Zinc finger protein 486	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96H40	ZNF486	Zinc finger protein 486	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96MN9	ZNF488	Zinc finger protein 488	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96MN9	ZNF488	Zinc finger protein 488	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96MN9	ZNF488	Zinc finger protein 488	GO:0005515; F:protein binding; IPI:IntAct
Q96MN9	ZNF488	Zinc finger protein 488	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q96MN9	ZNF488	Zinc finger protein 488	GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl
Q96MN9	ZNF488	Zinc finger protein 488	GO:0014003; P:oligodendrocyte development; IBA:RefGenome
Q96MN9	ZNF488	Zinc finger protein 488	GO:0048714; P:positive regulation of oligodendrocyte differentiation; IEA:Ensembl
Q96MN9	ZNF488	Zinc finger protein 488	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
Q96MN9	ZNF488	Zinc finger protein 488	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q9P255	ZNF492	Zinc finger protein 492	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9P255	ZNF492	Zinc finger protein 492	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9P255	ZNF492	Zinc finger protein 492	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9P255	ZNF492	Zinc finger protein 492	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9ULM2	ZNF490	Zinc finger protein 490	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9ULM2	ZNF490	Zinc finger protein 490	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9ULM2	ZNF490	Zinc finger protein 490	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9ULM2	ZNF490	Zinc finger protein 490	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9ULM2	ZNF490	Zinc finger protein 490	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N8L2	ZNF491	Zinc finger protein 491	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N8L2	ZNF491	Zinc finger protein 491	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N8L2	ZNF491	Zinc finger protein 491	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N8L2	ZNF491	Zinc finger protein 491	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZR52	ZNF493	Zinc finger protein 493	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZR52	ZNF493	Zinc finger protein 493	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZR52	ZNF493	Zinc finger protein 493	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6ZR52	ZNF493	Zinc finger protein 493	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q6ZR52	ZNF493	Zinc finger protein 493	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96IT1	ZNF496	Zinc finger protein 496	GO:0003677; F:DNA binding; ISS:UniProtKB
Q96IT1	ZNF496	Zinc finger protein 496	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96IT1	ZNF496	Zinc finger protein 496	GO:0005515; F:protein binding; IPI:IntAct
Q96IT1	ZNF496	Zinc finger protein 496	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q96IT1	ZNF496	Zinc finger protein 496	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q96IT1	ZNF496	Zinc finger protein 496	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
Q96IT1	ZNF496	Zinc finger protein 496	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q6ZNH5	ZNF497	Zinc finger protein 497	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZNH5	ZNF497	Zinc finger protein 497	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZNH5	ZNF497	Zinc finger protein 497	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZNH5	ZNF497	Zinc finger protein 497	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O60304	ZNF500	Zinc finger protein 500	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O60304	ZNF500	Zinc finger protein 500	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60304	ZNF500	Zinc finger protein 500	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O60304	ZNF500	Zinc finger protein 500	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96CX3	ZNF501	Zinc finger protein 501	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96CX3	ZNF501	Zinc finger protein 501	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96CX3	ZNF501	Zinc finger protein 501	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q96CX3	ZNF501	Zinc finger protein 501	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q96CX3	ZNF501	Zinc finger protein 501	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TBZ5	ZNF502	Zinc finger protein 502	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TBZ5	ZNF502	Zinc finger protein 502	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TBZ5	ZNF502	Zinc finger protein 502	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8TBZ5	ZNF502	Zinc finger protein 502	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96F45	ZNF503	Zinc finger protein 503	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96F45	ZNF503	Zinc finger protein 503	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q96F45	ZNF503	Zinc finger protein 503	GO:0070315; P:G1 to G0 transition involved in cell differentiation; IDA:UniProt
Q96F45	ZNF503	Zinc finger protein 503	GO:0008285; P:negative regulation of cell proliferation; IDA:UniProt
Q96F45	ZNF503	Zinc finger protein 503	GO:0010629; P:negative regulation of gene expression; IDA:UniProt
Q96F45	ZNF503	Zinc finger protein 503	GO:0061351; P:neural precursor cell proliferation; IEA:Ensembl
Q96F45	ZNF503	Zinc finger protein 503	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96F45	ZNF503	Zinc finger protein 503	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5JVG8	ZNF506	Zinc finger protein 506	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5JVG8	ZNF506	Zinc finger protein 506	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5JVG8	ZNF506	Zinc finger protein 506	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5JVG8	ZNF506	Zinc finger protein 506	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TCN5	ZNF507	Zinc finger protein 507	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TCN5	ZNF507	Zinc finger protein 507	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TCN5	ZNF507	Zinc finger protein 507	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8TCN5	ZNF507	Zinc finger protein 507	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NB15	ZNF511	Zinc finger protein 511	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NB15	ZNF511	Zinc finger protein 511	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NB15	ZNF511	Zinc finger protein 511	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NB15	ZNF511	Zinc finger protein 511	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96ME7	ZNF512	Zinc finger protein 512	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96ME7	ZNF512	Zinc finger protein 512	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96ME7	ZNF512	Zinc finger protein 512	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96ME7	ZNF512	Zinc finger protein 512	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2H8	ZNF510	Zinc finger protein 510	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y2H8	ZNF510	Zinc finger protein 510	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y2H8	ZNF510	Zinc finger protein 510	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2H8	ZNF510	Zinc finger protein 510	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N8E2	ZNF513	Zinc finger protein 513	GO:0003677; F:DNA binding; IDA:UniProtKB
Q8N8E2	ZNF513	Zinc finger protein 513	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N8E2	ZNF513	Zinc finger protein 513	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q8N8E2	ZNF513	Zinc finger protein 513	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N8E2	ZNF513	Zinc finger protein 513	GO:0050896; P:response to stimulus; IEA:UniProtKB-KW
Q8N8E2	ZNF513	Zinc finger protein 513	GO:0060041; P:retina development in camera-type eye; IMP:UniProtKB
Q8N8E2	ZNF513	Zinc finger protein 513	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N8E2	ZNF513	Zinc finger protein 513	GO:0007601; P:visual perception; IEA:UniProtKB-KW
Q96K75	ZNF514	Zinc finger protein 514	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96K75	ZNF514	Zinc finger protein 514	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96K75	ZNF514	Zinc finger protein 514	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q96K75	ZNF514	Zinc finger protein 514	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q96K75	ZNF514	Zinc finger protein 514	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q92618	ZNF516	Zinc finger protein 516	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q92618	ZNF516	Zinc finger protein 516	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q92618	ZNF516	Zinc finger protein 516	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q92618	ZNF516	Zinc finger protein 516	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZMY9	ZNF517	Zinc finger protein 517	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZMY9	ZNF517	Zinc finger protein 517	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZMY9	ZNF517	Zinc finger protein 517	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZMY9	ZNF517	Zinc finger protein 517	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TB69	ZNF519	Zinc finger protein 519	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TB69	ZNF519	Zinc finger protein 519	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TB69	ZNF519	Zinc finger protein 519	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8TB69	ZNF519	Zinc finger protein 519	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96K83	ZNF521	Zinc finger protein 521	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96K83	ZNF521	Zinc finger protein 521	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96K83	ZNF521	Zinc finger protein 521	GO:0019904; F:protein domain specific binding; IPI:UniProtKB
Q96K83	ZNF521	Zinc finger protein 521	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q96K83	ZNF521	Zinc finger protein 521	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q96K83	ZNF521	Zinc finger protein 521	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96K83	ZNF521	Zinc finger protein 521	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96C55	ZNF524	Zinc finger protein 524	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96C55	ZNF524	Zinc finger protein 524	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96C55	ZNF524	Zinc finger protein 524	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96C55	ZNF524	Zinc finger protein 524	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TF50	ZNF526	Zinc finger protein 526	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TF50	ZNF526	Zinc finger protein 526	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TF50	ZNF526	Zinc finger protein 526	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8TF50	ZNF526	Zinc finger protein 526	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N782	ZNF525	Zinc finger protein 525	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N782	ZNF525	Zinc finger protein 525	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N782	ZNF525	Zinc finger protein 525	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q8N782	ZNF525	Zinc finger protein 525	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q8N782	ZNF525	Zinc finger protein 525	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NB42	ZNF527	Zinc finger protein 527	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NB42	ZNF527	Zinc finger protein 527	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NB42	ZNF527	Zinc finger protein 527	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NB42	ZNF527	Zinc finger protein 527	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6P280	ZNF529	Zinc finger protein 529	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6P280	ZNF529	Zinc finger protein 529	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6P280	ZNF529	Zinc finger protein 529	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6P280	ZNF529	Zinc finger protein 529	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6P9A1	ZNF530	Zinc finger protein 530	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6P9A1	ZNF530	Zinc finger protein 530	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6P9A1	ZNF530	Zinc finger protein 530	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6P9A1	ZNF530	Zinc finger protein 530	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q3MIS6	ZNF528	Zinc finger protein 528	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q3MIS6	ZNF528	Zinc finger protein 528	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q3MIS6	ZNF528	Zinc finger protein 528	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q3MIS6	ZNF528	Zinc finger protein 528	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q3MIS6	ZNF528	Zinc finger protein 528	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q76KX8	ZNF534	Zinc finger protein 534	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q76KX8	ZNF534	Zinc finger protein 534	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q76KX8	ZNF534	Zinc finger protein 534	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q76KX8	ZNF534	Zinc finger protein 534	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q76KX8	ZNF534	Zinc finger protein 534	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HCE3	ZNF532	Zinc finger protein 532	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9HCE3	ZNF532	Zinc finger protein 532	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HCE3	ZNF532	Zinc finger protein 532	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9HCE3	ZNF532	Zinc finger protein 532	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15090	ZNF536	Zinc finger protein 536	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15090	ZNF536	Zinc finger protein 536	GO:0044323; F:retinoic acid-responsive element binding; IEA:Ensembl
O15090	ZNF536	Zinc finger protein 536	GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl
O15090	ZNF536	Zinc finger protein 536	GO:0048387; P:negative regulation of retinoic acid receptor signaling pathway; IEA:Ensembl
O15090	ZNF536	Zinc finger protein 536	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O15090	ZNF536	Zinc finger protein 536	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NDQ6	ZNF540	Zinc finger protein 540	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NDQ6	ZNF540	Zinc finger protein 540	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NDQ6	ZNF540	Zinc finger protein 540	GO:0005515; F:protein binding; IPI:UniProtKB
Q8NDQ6	ZNF540	Zinc finger protein 540	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q8NDQ6	ZNF540	Zinc finger protein 540	GO:0000900; F:translation repressor activity, nucleic acid binding; IMP:UniProtKB
Q8NDQ6	ZNF540	Zinc finger protein 540	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q8NDQ6	ZNF540	Zinc finger protein 540	GO:0017148; P:negative regulation of translation; IMP:UniProtKB
Q8NDQ6	ZNF540	Zinc finger protein 540	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H0D2	ZNF541	Zinc finger protein 541	GO:0003682; F:chromatin binding; IEA:InterPro
Q9H0D2	ZNF541	Zinc finger protein 541	GO:0003677; F:DNA binding; IEA:InterPro
Q9H0D2	ZNF541	Zinc finger protein 541	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H0D2	ZNF541	Zinc finger protein 541	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q9H0D2	ZNF541	Zinc finger protein 541	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q9H0D2	ZNF541	Zinc finger protein 541	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H0D2	ZNF541	Zinc finger protein 541	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q9H0D2	ZNF541	Zinc finger protein 541	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5EBM4	ZNF542	Putative zinc finger protein 542	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5EBM4	ZNF542	Putative zinc finger protein 542	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5EBM4	ZNF542	Putative zinc finger protein 542	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5EBM4	ZNF542	Putative zinc finger protein 542	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q08ER8	ZNF543	Zinc finger protein 543	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q08ER8	ZNF543	Zinc finger protein 543	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q08ER8	ZNF543	Zinc finger protein 543	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q08ER8	ZNF543	Zinc finger protein 543	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6NX49	ZNF544	Zinc finger protein 544	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6NX49	ZNF544	Zinc finger protein 544	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6NX49	ZNF544	Zinc finger protein 544	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6NX49	ZNF544	Zinc finger protein 544	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q6NX49	ZNF544	Zinc finger protein 544	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IVP9	ZNF547	Zinc finger protein 547	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IVP9	ZNF547	Zinc finger protein 547	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IVP9	ZNF547	Zinc finger protein 547	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8IVP9	ZNF547	Zinc finger protein 547	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86UE3	ZNF546	Zinc finger protein 546	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86UE3	ZNF546	Zinc finger protein 546	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86UE3	ZNF546	Zinc finger protein 546	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q86UE3	ZNF546	Zinc finger protein 546	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q86UE3	ZNF546	Zinc finger protein 546	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6P9A3	ZNF549	Zinc finger protein 549	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6P9A3	ZNF549	Zinc finger protein 549	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6P9A3	ZNF549	Zinc finger protein 549	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6P9A3	ZNF549	Zinc finger protein 549	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NEK5	ZNF548	Zinc finger protein 548	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NEK5	ZNF548	Zinc finger protein 548	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NEK5	ZNF548	Zinc finger protein 548	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NEK5	ZNF548	Zinc finger protein 548	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z398	ZNF550	Zinc finger protein 550	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7Z398	ZNF550	Zinc finger protein 550	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z398	ZNF550	Zinc finger protein 550	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z398	ZNF550	Zinc finger protein 550	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z340	ZNF551	Zinc finger protein 551	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7Z340	ZNF551	Zinc finger protein 551	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z340	ZNF551	Zinc finger protein 551	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z340	ZNF551	Zinc finger protein 551	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86TJ5	ZNF554	Zinc finger protein 554	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86TJ5	ZNF554	Zinc finger protein 554	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86TJ5	ZNF554	Zinc finger protein 554	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q86TJ5	ZNF554	Zinc finger protein 554	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NEP9	ZNF555	Zinc finger protein 555	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NEP9	ZNF555	Zinc finger protein 555	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NEP9	ZNF555	Zinc finger protein 555	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NEP9	ZNF555	Zinc finger protein 555	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9HAH1	ZNF556	Zinc finger protein 556	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9HAH1	ZNF556	Zinc finger protein 556	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9HAH1	ZNF556	Zinc finger protein 556	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9HAH1	ZNF556	Zinc finger protein 556	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N988	ZNF557	Zinc finger protein 557	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N988	ZNF557	Zinc finger protein 557	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N988	ZNF557	Zinc finger protein 557	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N988	ZNF557	Zinc finger protein 557	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96NG5	ZNF558	Zinc finger protein 558	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96NG5	ZNF558	Zinc finger protein 558	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96NG5	ZNF558	Zinc finger protein 558	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96NG5	ZNF558	Zinc finger protein 558	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H707	ZNF552	Zinc finger protein 552	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H707	ZNF552	Zinc finger protein 552	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H707	ZNF552	Zinc finger protein 552	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H707	ZNF552	Zinc finger protein 552	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BR84	ZNF559	Zinc finger protein 559	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BR84	ZNF559	Zinc finger protein 559	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BR84	ZNF559	Zinc finger protein 559	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9BR84	ZNF559	Zinc finger protein 559	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96MR9	ZNF560	Zinc finger protein 560	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96MR9	ZNF560	Zinc finger protein 560	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96MR9	ZNF560	Zinc finger protein 560	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96MR9	ZNF560	Zinc finger protein 560	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N587	ZNF561	Zinc finger protein 561	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N587	ZNF561	Zinc finger protein 561	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N587	ZNF561	Zinc finger protein 561	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N587	ZNF561	Zinc finger protein 561	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TA94	ZNF563	Zinc finger protein 563	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TA94	ZNF563	Zinc finger protein 563	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TA94	ZNF563	Zinc finger protein 563	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8TA94	ZNF563	Zinc finger protein 563	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6V9R5	ZNF562	Zinc finger protein 562	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6V9R5	ZNF562	Zinc finger protein 562	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6V9R5	ZNF562	Zinc finger protein 562	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6V9R5	ZNF562	Zinc finger protein 562	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TBZ8	ZNF564	Zinc finger protein 564	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TBZ8	ZNF564	Zinc finger protein 564	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TBZ8	ZNF564	Zinc finger protein 564	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8TBZ8	ZNF564	Zinc finger protein 564	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N9K5	ZNF565	Zinc finger protein 565	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N9K5	ZNF565	Zinc finger protein 565	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N9K5	ZNF565	Zinc finger protein 565	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q8N9K5	ZNF565	Zinc finger protein 565	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q8N9K5	ZNF565	Zinc finger protein 565	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q969W8	ZNF566	Zinc finger protein 566	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q969W8	ZNF566	Zinc finger protein 566	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q969W8	ZNF566	Zinc finger protein 566	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q969W8	ZNF566	Zinc finger protein 566	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N184	ZNF567	Zinc finger protein 567	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N184	ZNF567	Zinc finger protein 567	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N184	ZNF567	Zinc finger protein 567	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N184	ZNF567	Zinc finger protein 567	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q3ZCX4	ZNF568	Zinc finger protein 568	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q3ZCX4	ZNF568	Zinc finger protein 568	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q3ZCX4	ZNF568	Zinc finger protein 568	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q3ZCX4	ZNF568	Zinc finger protein 568	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q3ZCX4	ZNF568	Zinc finger protein 568	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5MCW4	ZNF569	Zinc finger protein 569	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5MCW4	ZNF569	Zinc finger protein 569	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5MCW4	ZNF569	Zinc finger protein 569	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5MCW4	ZNF569	Zinc finger protein 569	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96NI8	ZNF570	Zinc finger protein 570	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96NI8	ZNF570	Zinc finger protein 570	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96NI8	ZNF570	Zinc finger protein 570	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96NI8	ZNF570	Zinc finger protein 570	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z3V5	ZNF571	Zinc finger protein 571	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7Z3V5	ZNF571	Zinc finger protein 571	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z3V5	ZNF571	Zinc finger protein 571	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q7Z3V5	ZNF571	Zinc finger protein 571	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q7Z3V5	ZNF571	Zinc finger protein 571	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z3I7	ZNF572	Zinc finger protein 572	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7Z3I7	ZNF572	Zinc finger protein 572	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z3I7	ZNF572	Zinc finger protein 572	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z3I7	ZNF572	Zinc finger protein 572	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86YE8	ZNF573	Zinc finger protein 573	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86YE8	ZNF573	Zinc finger protein 573	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86YE8	ZNF573	Zinc finger protein 573	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q86YE8	ZNF573	Zinc finger protein 573	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q86YE8	ZNF573	Zinc finger protein 573	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZN55	ZNF574	Zinc finger protein 574	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZN55	ZNF574	Zinc finger protein 574	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZN55	ZNF574	Zinc finger protein 574	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZN55	ZNF574	Zinc finger protein 574	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86XF7	ZNF575	Zinc finger protein 575	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86XF7	ZNF575	Zinc finger protein 575	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86XF7	ZNF575	Zinc finger protein 575	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q86XF7	ZNF575	Zinc finger protein 575	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H609	ZNF576	Zinc finger protein 576	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H609	ZNF576	Zinc finger protein 576	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H609	ZNF576	Zinc finger protein 576	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q9H609	ZNF576	Zinc finger protein 576	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
Q9H609	ZNF576	Zinc finger protein 576	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q9BSK1	ZNF577	Zinc finger protein 577	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BSK1	ZNF577	Zinc finger protein 577	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BSK1	ZNF577	Zinc finger protein 577	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9BSK1	ZNF577	Zinc finger protein 577	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9BSK1	ZNF577	Zinc finger protein 577	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96N58	ZNF578	Zinc finger protein 578	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96N58	ZNF578	Zinc finger protein 578	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96N58	ZNF578	Zinc finger protein 578	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96N58	ZNF578	Zinc finger protein 578	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NAF0	ZNF579	Zinc finger protein 579	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NAF0	ZNF579	Zinc finger protein 579	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NAF0	ZNF579	Zinc finger protein 579	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q8NAF0	ZNF579	Zinc finger protein 579	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NAF0	ZNF579	Zinc finger protein 579	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UK33	ZNF580	Zinc finger protein 580	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UK33	ZNF580	Zinc finger protein 580	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UK33	ZNF580	Zinc finger protein 580	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UK33	ZNF580	Zinc finger protein 580	GO:0070301; P:cellular response to hydrogen peroxide; IDA:UniProtKB
Q9UK33	ZNF580	Zinc finger protein 580	GO:0006935; P:chemotaxis; IEA:UniProtKB-KW
Q9UK33	ZNF580	Zinc finger protein 580	GO:0006954; P:inflammatory response; IEA:UniProtKB-KW
Q9UK33	ZNF580	Zinc finger protein 580	GO:0010595; P:positive regulation of endothelial cell migration; IDA:UniProtKB
Q9UK33	ZNF580	Zinc finger protein 580	GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:UniProtKB
Q9UK33	ZNF580	Zinc finger protein 580	GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB
Q9UK33	ZNF580	Zinc finger protein 580	GO:0032757; P:positive regulation of interleukin-8 production; IDA:UniProtKB
Q9UK33	ZNF580	Zinc finger protein 580	GO:0002690; P:positive regulation of leukocyte chemotaxis; IDA:UniProtKB
Q9UK33	ZNF580	Zinc finger protein 580	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UK33	ZNF580	Zinc finger protein 580	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9P0T4	ZNF581	Zinc finger protein 581	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9P0T4	ZNF581	Zinc finger protein 581	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9P0T4	ZNF581	Zinc finger protein 581	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9P0T4	ZNF581	Zinc finger protein 581	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96NG8	ZNF582	Zinc finger protein 582	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96NG8	ZNF582	Zinc finger protein 582	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96NG8	ZNF582	Zinc finger protein 582	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96NG8	ZNF582	Zinc finger protein 582	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96ND8	ZNF583	Zinc finger protein 583	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96ND8	ZNF583	Zinc finger protein 583	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96ND8	ZNF583	Zinc finger protein 583	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96ND8	ZNF583	Zinc finger protein 583	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NXT0	ZNF586	Zinc finger protein 586	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NXT0	ZNF586	Zinc finger protein 586	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NXT0	ZNF586	Zinc finger protein 586	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NXT0	ZNF586	Zinc finger protein 586	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96SQ5	ZNF587	Zinc finger protein 587	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96SQ5	ZNF587	Zinc finger protein 587	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96SQ5	ZNF587	Zinc finger protein 587	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96SQ5	ZNF587	Zinc finger protein 587	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IVC4	ZNF584	Zinc finger protein 584	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IVC4	ZNF584	Zinc finger protein 584	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IVC4	ZNF584	Zinc finger protein 584	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8IVC4	ZNF584	Zinc finger protein 584	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86UQ0	ZNF589	Zinc finger protein 589	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86UQ0	ZNF589	Zinc finger protein 589	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86UQ0	ZNF589	Zinc finger protein 589	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q92610	ZNF592	Zinc finger protein 592	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q92610	ZNF592	Zinc finger protein 592	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q92610	ZNF592	Zinc finger protein 592	GO:0008219; P:cell death; IEA:UniProtKB-KW
Q92610	ZNF592	Zinc finger protein 592	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q92610	ZNF592	Zinc finger protein 592	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O00488	ZNF593	Zinc finger protein 593	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O00488	ZNF593	Zinc finger protein 593	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O00488	ZNF593	Zinc finger protein 593	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
O00488	ZNF593	Zinc finger protein 593	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
O00488	ZNF593	Zinc finger protein 593	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96JF6	ZNF594	Zinc finger protein 594	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96JF6	ZNF594	Zinc finger protein 594	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96JF6	ZNF594	Zinc finger protein 594	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96JF6	ZNF594	Zinc finger protein 594	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IYB9	ZNF595	Zinc finger protein 595	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IYB9	ZNF595	Zinc finger protein 595	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IYB9	ZNF595	Zinc finger protein 595	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8IYB9	ZNF595	Zinc finger protein 595	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TC21	ZNF596	Zinc finger protein 596	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TC21	ZNF596	Zinc finger protein 596	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TC21	ZNF596	Zinc finger protein 596	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8TC21	ZNF596	Zinc finger protein 596	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96LX8	ZNF597	Zinc finger protein 597	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96LX8	ZNF597	Zinc finger protein 597	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96LX8	ZNF597	Zinc finger protein 597	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96LX8	ZNF597	Zinc finger protein 597	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86UK7	ZNF598	Zinc finger protein 598	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q86UK7	ZNF598	Zinc finger protein 598	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96NL3	ZNF599	Zinc finger protein 599	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96NL3	ZNF599	Zinc finger protein 599	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96NL3	ZNF599	Zinc finger protein 599	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96NL3	ZNF599	Zinc finger protein 599	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZNG1	ZNF600	Zinc finger protein 600	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZNG1	ZNF600	Zinc finger protein 600	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZNG1	ZNF600	Zinc finger protein 600	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6ZNG1	ZNF600	Zinc finger protein 600	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q6ZNG1	ZNF600	Zinc finger protein 600	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86T29	ZNF605	Zinc finger protein 605	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86T29	ZNF605	Zinc finger protein 605	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86T29	ZNF605	Zinc finger protein 605	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q86T29	ZNF605	Zinc finger protein 605	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q86T29	ZNF605	Zinc finger protein 605	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8WXB4	ZNF606	Zinc finger protein 606	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8WXB4	ZNF606	Zinc finger protein 606	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8WXB4	ZNF606	Zinc finger protein 606	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q8WXB4	ZNF606	Zinc finger protein 606	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q8WXB4	ZNF606	Zinc finger protein 606	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96SK3	ZNF607	Zinc finger protein 607	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96SK3	ZNF607	Zinc finger protein 607	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96SK3	ZNF607	Zinc finger protein 607	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q96SK3	ZNF607	Zinc finger protein 607	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q96SK3	ZNF607	Zinc finger protein 607	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9ULD9	ZNF608	Zinc finger protein 608	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15014	ZNF609	Zinc finger protein 609	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N823	ZNF611	Zinc finger protein 611	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N823	ZNF611	Zinc finger protein 611	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N823	ZNF611	Zinc finger protein 611	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q8N823	ZNF611	Zinc finger protein 611	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q8N823	ZNF611	Zinc finger protein 611	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6PF04	ZNF613	Zinc finger protein 613	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6PF04	ZNF613	Zinc finger protein 613	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6PF04	ZNF613	Zinc finger protein 613	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6PF04	ZNF613	Zinc finger protein 613	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N9Z0	ZNF610	Zinc finger protein 610	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N9Z0	ZNF610	Zinc finger protein 610	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N9Z0	ZNF610	Zinc finger protein 610	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N9Z0	ZNF610	Zinc finger protein 610	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N883	ZNF614	Zinc finger protein 614	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N883	ZNF614	Zinc finger protein 614	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N883	ZNF614	Zinc finger protein 614	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N883	ZNF614	Zinc finger protein 614	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N8J6	ZNF615	Zinc finger protein 615	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N8J6	ZNF615	Zinc finger protein 615	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N8J6	ZNF615	Zinc finger protein 615	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q8N8J6	ZNF615	Zinc finger protein 615	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q8N8J6	ZNF615	Zinc finger protein 615	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q08AN1	ZNF616	Zinc finger protein 616	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q08AN1	ZNF616	Zinc finger protein 616	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q08AN1	ZNF616	Zinc finger protein 616	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q08AN1	ZNF616	Zinc finger protein 616	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q08AN1	ZNF616	Zinc finger protein 616	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5T7W0	ZNF618	Zinc finger protein 618	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5T7W0	ZNF618	Zinc finger protein 618	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5T7W0	ZNF618	Zinc finger protein 618	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5T7W0	ZNF618	Zinc finger protein 618	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N2I2	ZNF619	Zinc finger protein 619	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N2I2	ZNF619	Zinc finger protein 619	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N2I2	ZNF619	Zinc finger protein 619	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N2I2	ZNF619	Zinc finger protein 619	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZNG0	ZNF620	Zinc finger protein 620	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZNG0	ZNF620	Zinc finger protein 620	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZNG0	ZNF620	Zinc finger protein 620	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZNG0	ZNF620	Zinc finger protein 620	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZSS3	ZNF621	Zinc finger protein 621	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZSS3	ZNF621	Zinc finger protein 621	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZSS3	ZNF621	Zinc finger protein 621	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6ZSS3	ZNF621	Zinc finger protein 621	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q6ZSS3	ZNF621	Zinc finger protein 621	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75123	ZNF623	Zinc finger protein 623	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O75123	ZNF623	Zinc finger protein 623	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75123	ZNF623	Zinc finger protein 623	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
O75123	ZNF623	Zinc finger protein 623	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
O75123	ZNF623	Zinc finger protein 623	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9P2J8	ZNF624	Zinc finger protein 624	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9P2J8	ZNF624	Zinc finger protein 624	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9P2J8	ZNF624	Zinc finger protein 624	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9P2J8	ZNF624	Zinc finger protein 624	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9P2J8	ZNF624	Zinc finger protein 624	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q969S3	ZNF622	Zinc finger protein 622	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q969S3	ZNF622	Zinc finger protein 622	GO:0005515; F:protein binding; IPI:IntAct
Q969S3	ZNF622	Zinc finger protein 622	GO:0008270; F:zinc ion binding; IEA:InterPro
Q969S3	ZNF622	Zinc finger protein 622	GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IDA:UniProtKB
Q969S3	ZNF622	Zinc finger protein 622	GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB
Q969S3	ZNF622	Zinc finger protein 622	GO:0046330; P:positive regulation of JNK cascade; IMP:UniProtKB
Q969S3	ZNF622	Zinc finger protein 622	GO:0033674; P:positive regulation of kinase activity; IDA:UniProtKB
Q969S3	ZNF622	Zinc finger protein 622	GO:0043410; P:positive regulation of MAPK cascade; IDA:UniProtKB
Q96I27	ZNF625	Zinc finger protein 625	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96I27	ZNF625	Zinc finger protein 625	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96I27	ZNF625	Zinc finger protein 625	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96I27	ZNF625	Zinc finger protein 625	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q68DY1	ZNF626	Zinc finger protein 626	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q68DY1	ZNF626	Zinc finger protein 626	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q68DY1	ZNF626	Zinc finger protein 626	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q68DY1	ZNF626	Zinc finger protein 626	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7L945	ZNF627	Zinc finger protein 627	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7L945	ZNF627	Zinc finger protein 627	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7L945	ZNF627	Zinc finger protein 627	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7L945	ZNF627	Zinc finger protein 627	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5EBL2	ZNF628	Zinc finger protein 628	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5EBL2	ZNF628	Zinc finger protein 628	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5EBL2	ZNF628	Zinc finger protein 628	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:Ensembl
Q5EBL2	ZNF628	Zinc finger protein 628	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UEG4	ZNF629	Zinc finger protein 629	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UEG4	ZNF629	Zinc finger protein 629	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UEG4	ZNF629	Zinc finger protein 629	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9UEG4	ZNF629	Zinc finger protein 629	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9UEG4	ZNF629	Zinc finger protein 629	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q2M218	ZNF630	Zinc finger protein 630	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q2M218	ZNF630	Zinc finger protein 630	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q2M218	ZNF630	Zinc finger protein 630	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q2M218	ZNF630	Zinc finger protein 630	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q2M218	ZNF630	Zinc finger protein 630	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q14966	ZNF638	Zinc finger protein 638	GO:0003690; F:double-stranded DNA binding; TAS:ProtInc
Q14966	ZNF638	Zinc finger protein 638	GO:0000166; F:nucleotide binding; IEA:InterPro
Q14966	ZNF638	Zinc finger protein 638	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q14966	ZNF638	Zinc finger protein 638	GO:0003723; F:RNA binding; TAS:ProtInc
Q14966	ZNF638	Zinc finger protein 638	GO:0008270; F:zinc ion binding; IEA:InterPro
Q14966	ZNF638	Zinc finger protein 638	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q14966	ZNF638	Zinc finger protein 638	GO:0008380; P:RNA splicing; TAS:ProtInc
Q14966	ZNF638	Zinc finger protein 638	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UID6	ZNF639	Zinc finger protein 639	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UID6	ZNF639	Zinc finger protein 639	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UID6	ZNF639	Zinc finger protein 639	GO:0043621; F:protein self-association; IPI:UniProtKB
Q9UID6	ZNF639	Zinc finger protein 639	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
Q9UID6	ZNF639	Zinc finger protein 639	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q9UID6	ZNF639	Zinc finger protein 639	GO:0043922; P:negative regulation by host of viral transcription; IMP:UniProtKB
Q9UID6	ZNF639	Zinc finger protein 639	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q9UID6	ZNF639	Zinc finger protein 639	GO:0043923; P:positive regulation by host of viral transcription; IMP:UniProtKB
Q9UID6	ZNF639	Zinc finger protein 639	GO:0030307; P:positive regulation of cell growth; IMP:UniProtKB
Q9UID6	ZNF639	Zinc finger protein 639	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UID6	ZNF639	Zinc finger protein 639	GO:0046718; P:viral entry into host cell; IDA:UniProtKB
Q96N77	ZNF641	Zinc finger protein 641	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96N77	ZNF641	Zinc finger protein 641	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96N77	ZNF641	Zinc finger protein 641	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q96N77	ZNF641	Zinc finger protein 641	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
Q96N77	ZNF641	Zinc finger protein 641	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q9H582	ZNF644	Zinc finger protein 644	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H582	ZNF644	Zinc finger protein 644	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H582	ZNF644	Zinc finger protein 644	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H582	ZNF644	Zinc finger protein 644	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15015	ZNF646	Zinc finger protein 646	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O15015	ZNF646	Zinc finger protein 646	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15015	ZNF646	Zinc finger protein 646	GO:0005515; F:protein binding; IPI:IntAct
O15015	ZNF646	Zinc finger protein 646	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O15015	ZNF646	Zinc finger protein 646	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N7E2	ZNF645	E3 ubiquitin-protein ligase ZNF645	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q8N7E2	ZNF645	E3 ubiquitin-protein ligase ZNF645	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8N7E2	ZNF645	E3 ubiquitin-protein ligase ZNF645	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9BS31	ZNF649	Zinc finger protein 649	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BS31	ZNF649	Zinc finger protein 649	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BS31	ZNF649	Zinc finger protein 649	GO:0005515; F:protein binding; IPI:IntAct
Q9BS31	ZNF649	Zinc finger protein 649	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9BS31	ZNF649	Zinc finger protein 649	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2D9	ZNF652	Zinc finger protein 652	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y2D9	ZNF652	Zinc finger protein 652	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y2D9	ZNF652	Zinc finger protein 652	GO:0005515; F:protein binding; IPI:IntAct
Q9Y2D9	ZNF652	Zinc finger protein 652	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y2D9	ZNF652	Zinc finger protein 652	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5T619	ZNF648	Zinc finger protein 648	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5T619	ZNF648	Zinc finger protein 648	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5T619	ZNF648	Zinc finger protein 648	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5T619	ZNF648	Zinc finger protein 648	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96CK0	ZNF653	Zinc finger protein 653	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96CK0	ZNF653	Zinc finger protein 653	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96CK0	ZNF653	Zinc finger protein 653	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96CK0	ZNF653	Zinc finger protein 653	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IZM8	ZNF654	Zinc finger protein 654	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IZM8	ZNF654	Zinc finger protein 654	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IZM8	ZNF654	Zinc finger protein 654	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8IZM8	ZNF654	Zinc finger protein 654	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N720	ZNF655	Zinc finger protein 655	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N720	ZNF655	Zinc finger protein 655	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N720	ZNF655	Zinc finger protein 655	GO:0005515; F:protein binding; IPI:IntAct
Q8N720	ZNF655	Zinc finger protein 655	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q8N720	ZNF655	Zinc finger protein 655	GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IDA:UniProtKB
Q8N720	ZNF655	Zinc finger protein 655	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q8N720	ZNF655	Zinc finger protein 655	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5TYW1	ZNF658	Zinc finger protein 658	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5TYW1	ZNF658	Zinc finger protein 658	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5TYW1	ZNF658	Zinc finger protein 658	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q5TYW1	ZNF658	Zinc finger protein 658	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q5TYW1	ZNF658	Zinc finger protein 658	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6AZW8	ZNF660	Zinc finger protein 660	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6AZW8	ZNF660	Zinc finger protein 660	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6AZW8	ZNF660	Zinc finger protein 660	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6AZW8	ZNF660	Zinc finger protein 660	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N3J9	ZNF664	Zinc finger protein 664	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N3J9	ZNF664	Zinc finger protein 664	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N3J9	ZNF664	Zinc finger protein 664	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N3J9	ZNF664	Zinc finger protein 664	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZS27	ZNF662	Zinc finger protein 662	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZS27	ZNF662	Zinc finger protein 662	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZS27	ZNF662	Zinc finger protein 662	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZS27	ZNF662	Zinc finger protein 662	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H7R5	ZNF665	Zinc finger protein 665	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H7R5	ZNF665	Zinc finger protein 665	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H7R5	ZNF665	Zinc finger protein 665	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9H7R5	ZNF665	Zinc finger protein 665	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9H7R5	ZNF665	Zinc finger protein 665	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5HYK9	ZNF667	Zinc finger protein 667	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5HYK9	ZNF667	Zinc finger protein 667	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5HYK9	ZNF667	Zinc finger protein 667	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5HYK9	ZNF667	Zinc finger protein 667	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96K58	ZNF668	Zinc finger protein 668	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96K58	ZNF668	Zinc finger protein 668	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96K58	ZNF668	Zinc finger protein 668	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q96K58	ZNF668	Zinc finger protein 668	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q96K58	ZNF668	Zinc finger protein 668	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BS34	ZNF670	Zinc finger protein 670	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BS34	ZNF670	Zinc finger protein 670	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BS34	ZNF670	Zinc finger protein 670	GO:0005515; F:protein binding; IPI:IntAct
Q9BS34	ZNF670	Zinc finger protein 670	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9BS34	ZNF670	Zinc finger protein 670	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TAW3	ZNF671	Zinc finger protein 671	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TAW3	ZNF671	Zinc finger protein 671	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TAW3	ZNF671	Zinc finger protein 671	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8TAW3	ZNF671	Zinc finger protein 671	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q499Z4	ZNF672	Zinc finger protein 672	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q499Z4	ZNF672	Zinc finger protein 672	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q499Z4	ZNF672	Zinc finger protein 672	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q499Z4	ZNF672	Zinc finger protein 672	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96BR6	ZNF669	Zinc finger protein 669	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96BR6	ZNF669	Zinc finger protein 669	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96BR6	ZNF669	Zinc finger protein 669	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96BR6	ZNF669	Zinc finger protein 669	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q2M3X9	ZNF674	Zinc finger protein 674	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q2M3X9	ZNF674	Zinc finger protein 674	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q2M3X9	ZNF674	Zinc finger protein 674	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q2M3X9	ZNF674	Zinc finger protein 674	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TD23	ZNF675	Zinc finger protein 675	GO:0003677; F:DNA binding; NAS:UniProtKB
Q8TD23	ZNF675	Zinc finger protein 675	GO:0005515; F:protein binding; IPI:IntAct
Q8TD23	ZNF675	Zinc finger protein 675	GO:0031625; F:ubiquitin protein ligase binding; IPI:BHF-UCL
Q8TD23	ZNF675	Zinc finger protein 675	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q8TD23	ZNF675	Zinc finger protein 675	GO:0045453; P:bone resorption; TAS:UniProtKB
Q8TD23	ZNF675	Zinc finger protein 675	GO:0019221; P:cytokine-mediated signaling pathway; IDA:UniProtKB
Q8TD23	ZNF675	Zinc finger protein 675	GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB
Q8TD23	ZNF675	Zinc finger protein 675	GO:2000660; P:negative regulation of interleukin-1-mediated signaling pathway; IDA:BHF-UCL
Q8TD23	ZNF675	Zinc finger protein 675	GO:0046329; P:negative regulation of JNK cascade; IDA:UniProtKB
Q8TD23	ZNF675	Zinc finger protein 675	GO:0043508; P:negative regulation of JUN kinase activity; IDA:BHF-UCL
Q8TD23	ZNF675	Zinc finger protein 675	GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:BHF-UCL
Q8TD23	ZNF675	Zinc finger protein 675	GO:0045671; P:negative regulation of osteoclast differentiation; IDA:UniProtKB
Q8TD23	ZNF675	Zinc finger protein 675	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL
Q8TD23	ZNF675	Zinc finger protein 675	GO:2000678; P:negative regulation of transcription regulatory region DNA binding; IDA:BHF-UCL
Q8TD23	ZNF675	Zinc finger protein 675	GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; IDA:BHF-UCL
Q8TD23	ZNF675	Zinc finger protein 675	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N7Q3	ZNF676	Zinc finger protein 676	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N7Q3	ZNF676	Zinc finger protein 676	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N7Q3	ZNF676	Zinc finger protein 676	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N7Q3	ZNF676	Zinc finger protein 676	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86XU0	ZNF677	Zinc finger protein 677	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86XU0	ZNF677	Zinc finger protein 677	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86XU0	ZNF677	Zinc finger protein 677	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q86XU0	ZNF677	Zinc finger protein 677	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q86XU0	ZNF677	Zinc finger protein 677	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5SXM1	ZNF678	Zinc finger protein 678	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5SXM1	ZNF678	Zinc finger protein 678	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5SXM1	ZNF678	Zinc finger protein 678	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5SXM1	ZNF678	Zinc finger protein 678	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IYX0	ZNF679	Zinc finger protein 679	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IYX0	ZNF679	Zinc finger protein 679	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IYX0	ZNF679	Zinc finger protein 679	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8IYX0	ZNF679	Zinc finger protein 679	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NEM1	ZNF680	Zinc finger protein 680	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NEM1	ZNF680	Zinc finger protein 680	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NEM1	ZNF680	Zinc finger protein 680	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NEM1	ZNF680	Zinc finger protein 680	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O95780	ZNF682	Zinc finger protein 682	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O95780	ZNF682	Zinc finger protein 682	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O95780	ZNF682	Zinc finger protein 682	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O95780	ZNF682	Zinc finger protein 682	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IZ20	ZNF683	Zinc finger protein 683	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IZ20	ZNF683	Zinc finger protein 683	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IZ20	ZNF683	Zinc finger protein 683	GO:0001779; P:natural killer cell differentiation; IEA:Ensembl
Q8IZ20	ZNF683	Zinc finger protein 683	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8IZ20	ZNF683	Zinc finger protein 683	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N1G0	ZNF687	Zinc finger protein 687	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N1G0	ZNF687	Zinc finger protein 687	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N1G0	ZNF687	Zinc finger protein 687	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N1G0	ZNF687	Zinc finger protein 687	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5T5D7	ZNF684	Zinc finger protein 684	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5T5D7	ZNF684	Zinc finger protein 684	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5T5D7	ZNF684	Zinc finger protein 684	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5T5D7	ZNF684	Zinc finger protein 684	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96N22	ZNF681	Zinc finger protein 681	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96N22	ZNF681	Zinc finger protein 681	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96N22	ZNF681	Zinc finger protein 681	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q96N22	ZNF681	Zinc finger protein 681	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q96N22	ZNF681	Zinc finger protein 681	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P0C7X2	ZNF688	Zinc finger protein 688	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P0C7X2	ZNF688	Zinc finger protein 688	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P0C7X2	ZNF688	Zinc finger protein 688	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P0C7X2	ZNF688	Zinc finger protein 688	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96CS4	ZNF689	Zinc finger protein 689	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96CS4	ZNF689	Zinc finger protein 689	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96CS4	ZNF689	Zinc finger protein 689	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96CS4	ZNF689	Zinc finger protein 689	GO:0035914; P:skeletal muscle cell differentiation; IEA:Ensembl
Q96CS4	ZNF689	Zinc finger protein 689	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5VV52	ZNF691	Zinc finger protein 691	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5VV52	ZNF691	Zinc finger protein 691	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BU19	ZNF692	Zinc finger protein 692	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BU19	ZNF692	Zinc finger protein 692	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BU19	ZNF692	Zinc finger protein 692	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9BU19	ZNF692	Zinc finger protein 692	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H7X3	ZNF696	Zinc finger protein 696	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H7X3	ZNF696	Zinc finger protein 696	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H7X3	ZNF696	Zinc finger protein 696	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9H7X3	ZNF696	Zinc finger protein 696	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9H7X3	ZNF696	Zinc finger protein 696	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5TEC3	ZNF697	Zinc finger protein 697	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5TEC3	ZNF697	Zinc finger protein 697	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5TEC3	ZNF697	Zinc finger protein 697	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5TEC3	ZNF697	Zinc finger protein 697	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IW36	ZNF695	Zinc finger protein 695	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IW36	ZNF695	Zinc finger protein 695	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8IW36	ZNF695	Zinc finger protein 695	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q32M78	ZNF699	Zinc finger protein 699	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q32M78	ZNF699	Zinc finger protein 699	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q32M78	ZNF699	Zinc finger protein 699	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q32M78	ZNF699	Zinc finger protein 699	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q32M78	ZNF699	Zinc finger protein 699	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H0M5	ZNF700	Zinc finger protein 700	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H0M5	ZNF700	Zinc finger protein 700	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H0M5	ZNF700	Zinc finger protein 700	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H0M5	ZNF700	Zinc finger protein 700	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NV72	ZNF701	Zinc finger protein 701	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NV72	ZNF701	Zinc finger protein 701	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NV72	ZNF701	Zinc finger protein 701	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9NV72	ZNF701	Zinc finger protein 701	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H963	ZNF702P	Putative zinc finger protein 702	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H963	ZNF702P	Putative zinc finger protein 702	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H963	ZNF702P	Putative zinc finger protein 702	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H963	ZNF702P	Putative zinc finger protein 702	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H7S9	ZNF703	Zinc finger protein 703	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H7S9	ZNF703	Zinc finger protein 703	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9H7S9	ZNF703	Zinc finger protein 703	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H7S9	ZNF703	Zinc finger protein 703	GO:0034333; P:adherens junction assembly; ISS:UniProtKB
Q9H7S9	ZNF703	Zinc finger protein 703	GO:0071392; P:cellular response to estradiol stimulus; IDA:UniProtKB
Q9H7S9	ZNF703	Zinc finger protein 703	GO:0060644; P:mammary gland epithelial cell differentiation; IDA:UniProtKB
Q9H7S9	ZNF703	Zinc finger protein 703	GO:0034111; P:negative regulation of homotypic cell-cell adhesion; ISS:UniProtKB
Q9H7S9	ZNF703	Zinc finger protein 703	GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB
Q9H7S9	ZNF703	Zinc finger protein 703	GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB
Q9H7S9	ZNF703	Zinc finger protein 703	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
Q9H7S9	ZNF703	Zinc finger protein 703	GO:0010718; P:positive regulation of epithelial to mesenchymal transition; ISS:UniProtKB
Q9H7S9	ZNF703	Zinc finger protein 703	GO:0033601; P:positive regulation of mammary gland epithelial cell proliferation; IDA:UniProtKB
Q9H7S9	ZNF703	Zinc finger protein 703	GO:0060828; P:regulation of canonical Wnt signaling pathway; ISS:UniProtKB
Q9H7S9	ZNF703	Zinc finger protein 703	GO:0051726; P:regulation of cell cycle; IDA:UniProtKB
Q9H7S9	ZNF703	Zinc finger protein 703	GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB
Q9H7S9	ZNF703	Zinc finger protein 703	GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB
Q9H7S9	ZNF703	Zinc finger protein 703	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZNC4	ZNF704	Zinc finger protein 704	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y5V0	ZNF706	Zinc finger protein 706	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96C28	ZNF707	Zinc finger protein 707	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96C28	ZNF707	Zinc finger protein 707	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96C28	ZNF707	Zinc finger protein 707	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96C28	ZNF707	Zinc finger protein 707	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17019	ZNF708	Zinc finger protein 708	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P17019	ZNF708	Zinc finger protein 708	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17019	ZNF708	Zinc finger protein 708	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P17019	ZNF708	Zinc finger protein 708	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N972	ZNF709	Zinc finger protein 709	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N972	ZNF709	Zinc finger protein 709	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N972	ZNF709	Zinc finger protein 709	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N972	ZNF709	Zinc finger protein 709	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N1W2	ZNF710	Zinc finger protein 710	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N1W2	ZNF710	Zinc finger protein 710	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N1W2	ZNF710	Zinc finger protein 710	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N1W2	ZNF710	Zinc finger protein 710	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9Y462	ZNF711	Zinc finger protein 711	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y462	ZNF711	Zinc finger protein 711	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y462	ZNF711	Zinc finger protein 711	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
Q9Y462	ZNF711	Zinc finger protein 711	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
Q9Y462	ZNF711	Zinc finger protein 711	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N859	ZNF713	Zinc finger protein 713	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N859	ZNF713	Zinc finger protein 713	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N859	ZNF713	Zinc finger protein 713	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N859	ZNF713	Zinc finger protein 713	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96N38	ZNF714	Zinc finger protein 714	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96N38	ZNF714	Zinc finger protein 714	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96N38	ZNF714	Zinc finger protein 714	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96N38	ZNF714	Zinc finger protein 714	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BY31	ZNF717	Zinc finger protein 717	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BY31	ZNF717	Zinc finger protein 717	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BY31	ZNF717	Zinc finger protein 717	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9BY31	ZNF717	Zinc finger protein 717	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9BY31	ZNF717	Zinc finger protein 717	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q3SXZ3	ZNF718	Zinc finger protein 718	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q3SXZ3	ZNF718	Zinc finger protein 718	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q3SXZ3	ZNF718	Zinc finger protein 718	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q3SXZ3	ZNF718	Zinc finger protein 718	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7Z2F6	ZNF720	Putative protein ZNF720	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q7Z2F6	ZNF720	Putative protein ZNF720	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
A6NP11	ZNF716	Zinc finger protein 716	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A6NP11	ZNF716	Zinc finger protein 716	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A6NP11	ZNF716	Zinc finger protein 716	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A6NP11	ZNF716	Zinc finger protein 716	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TF20	ZNF721	Zinc finger protein 721	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TF20	ZNF721	Zinc finger protein 721	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TF20	ZNF721	Zinc finger protein 721	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8TF20	ZNF721	Zinc finger protein 721	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A8MTY0	ZNF724P	Putative zinc finger protein 724	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A8MTY0	ZNF724P	Putative zinc finger protein 724	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A8MTY0	ZNF724P	Putative zinc finger protein 724	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A8MTY0	ZNF724P	Putative zinc finger protein 724	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A6NNF4	ZNF726	Zinc finger protein 726	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A6NNF4	ZNF726	Zinc finger protein 726	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A6NNF4	ZNF726	Zinc finger protein 726	GO:0003676; F:nucleic acid binding; IEA:InterPro
A6NNF4	ZNF726	Zinc finger protein 726	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
A6NNF4	ZNF726	Zinc finger protein 726	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
A6NNF4	ZNF726	Zinc finger protein 726	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P0DKX0	ZNF728	Zinc finger protein 728	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P0DKX0	ZNF728	Zinc finger protein 728	GO:0003676; F:nucleic acid binding; IEA:InterPro
P0DKX0	ZNF728	Zinc finger protein 728	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
A8MUV8	ZNF727	Putative zinc finger protein 727	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A8MUV8	ZNF727	Putative zinc finger protein 727	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A8MUV8	ZNF727	Putative zinc finger protein 727	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A8MUV8	ZNF727	Putative zinc finger protein 727	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A6NN14	ZNF729	Zinc finger protein 729	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A6NN14	ZNF729	Zinc finger protein 729	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A6NN14	ZNF729	Zinc finger protein 729	GO:0003676; F:nucleic acid binding; IEA:InterPro
A6NN14	ZNF729	Zinc finger protein 729	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
A6NN14	ZNF729	Zinc finger protein 729	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P0CB33	ZNF735	Putative zinc finger protein 735	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P0CB33	ZNF735	Putative zinc finger protein 735	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P0CB33	ZNF735	Putative zinc finger protein 735	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P0CB33	ZNF735	Putative zinc finger protein 735	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NDX6	ZNF740	Zinc finger protein 740	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NDX6	ZNF740	Zinc finger protein 740	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q8NDX6	ZNF740	Zinc finger protein 740	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NDX6	ZNF740	Zinc finger protein 740	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
B4DXR9	ZNF732	Zinc finger protein 732	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
B4DXR9	ZNF732	Zinc finger protein 732	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
B4DXR9	ZNF732	Zinc finger protein 732	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
B4DXR9	ZNF732	Zinc finger protein 732	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZMV8	ZNF730	Putative zinc finger protein 730	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZMV8	ZNF730	Putative zinc finger protein 730	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZMV8	ZNF730	Putative zinc finger protein 730	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZMV8	ZNF730	Putative zinc finger protein 730	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75373	ZNF737	Zinc finger protein 737	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O75373	ZNF737	Zinc finger protein 737	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75373	ZNF737	Zinc finger protein 737	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O75373	ZNF737	Zinc finger protein 737	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
B4DX44	ZNF736	Zinc finger protein 736	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
B4DX44	ZNF736	Zinc finger protein 736	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
B4DX44	ZNF736	Zinc finger protein 736	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
B4DX44	ZNF736	Zinc finger protein 736	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NE65	ZNF738	Protein ZNF738	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NE65	ZNF738	Protein ZNF738	GO:0004842; F:ubiquitin-protein ligase activity; ISS:UniProtKB
Q8NE65	ZNF738	Protein ZNF738	GO:0000209; P:protein polyubiquitination; ISS:UniProtKB
Q8NE65	ZNF738	Protein ZNF738	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NE65	ZNF738	Protein ZNF738	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6NUN9	ZNF746	Zinc finger protein 746	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6NUN9	ZNF746	Zinc finger protein 746	GO:0005515; F:protein binding; IPI:IntAct
Q6NUN9	ZNF746	Zinc finger protein 746	GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB
Q6NUN9	ZNF746	Zinc finger protein 746	GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB
Q6NUN9	ZNF746	Zinc finger protein 746	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
Q6NUN9	ZNF746	Zinc finger protein 746	GO:0070997; P:neuron death; IDA:UniProtKB
Q6NUN9	ZNF746	Zinc finger protein 746	GO:0010941; P:regulation of cell death; IDA:UniProtKB
Q6NUN9	ZNF746	Zinc finger protein 746	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BV97	ZNF747	KRAB domain-containing protein ZNF747	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9BV97	ZNF747	KRAB domain-containing protein ZNF747	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
O43361	ZNF749	Zinc finger protein 749	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O43361	ZNF749	Zinc finger protein 749	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43361	ZNF749	Zinc finger protein 749	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O43361	ZNF749	Zinc finger protein 749	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q32MQ0	ZNF750	Zinc finger protein 750	GO:0001046; F:core promoter sequence-specific DNA binding; IDA:UniProtKB
Q32MQ0	ZNF750	Zinc finger protein 750	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q32MQ0	ZNF750	Zinc finger protein 750	GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IDA:UniProtKB
Q32MQ0	ZNF750	Zinc finger protein 750	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q32MQ0	ZNF750	Zinc finger protein 750	GO:0008544; P:epidermis development; IMP:UniProtKB
Q32MQ0	ZNF750	Zinc finger protein 750	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB
Q96N20	ZNF75A	Zinc finger protein 75A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96N20	ZNF75A	Zinc finger protein 75A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96N20	ZNF75A	Zinc finger protein 75A	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96N20	ZNF75A	Zinc finger protein 75A	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q92670	ZNF75CP	Putative zinc finger protein 75C	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q92670	ZNF75CP	Putative zinc finger protein 75C	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q92670	ZNF75CP	Putative zinc finger protein 75C	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q92670	ZNF75CP	Putative zinc finger protein 75C	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q86XN6	ZNF761	Zinc finger protein 761	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86XN6	ZNF761	Zinc finger protein 761	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86XN6	ZNF761	Zinc finger protein 761	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q86XN6	ZNF761	Zinc finger protein 761	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96H86	ZNF764	Zinc finger protein 764	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96H86	ZNF764	Zinc finger protein 764	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96H86	ZNF764	Zinc finger protein 764	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96H86	ZNF764	Zinc finger protein 764	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q7L2R6	ZNF765	Zinc finger protein 765	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7L2R6	ZNF765	Zinc finger protein 765	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7L2R6	ZNF765	Zinc finger protein 765	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7L2R6	ZNF765	Zinc finger protein 765	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P51815	ZNF75D	Zinc finger protein 75D	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P51815	ZNF75D	Zinc finger protein 75D	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P51815	ZNF75D	Zinc finger protein 75D	GO:0008270; F:zinc ion binding; NAS:UniProtKB
P51815	ZNF75D	Zinc finger protein 75D	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q0D2J5	ZNF763	Zinc finger protein 763	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q0D2J5	ZNF763	Zinc finger protein 763	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q0D2J5	ZNF763	Zinc finger protein 763	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q0D2J5	ZNF763	Zinc finger protein 763	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5HY98	ZNF766	Zinc finger protein 766	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5HY98	ZNF766	Zinc finger protein 766	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5HY98	ZNF766	Zinc finger protein 766	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5HY98	ZNF766	Zinc finger protein 766	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6IQ21	ZNF770	Zinc finger protein 770	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6IQ21	ZNF770	Zinc finger protein 770	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6IQ21	ZNF770	Zinc finger protein 770	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q6IQ21	ZNF770	Zinc finger protein 770	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
Q6IQ21	ZNF770	Zinc finger protein 770	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q9H5H4	ZNF768	Zinc finger protein 768	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H5H4	ZNF768	Zinc finger protein 768	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H5H4	ZNF768	Zinc finger protein 768	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9H5H4	ZNF768	Zinc finger protein 768	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9H5H4	ZNF768	Zinc finger protein 768	GO:0006366; P:transcription from RNA polymerase II promoter; IEA:InterPro
Q7L3S4	ZNF771	Zinc finger protein 771	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7L3S4	ZNF771	Zinc finger protein 771	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7L3S4	ZNF771	Zinc finger protein 771	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q7L3S4	ZNF771	Zinc finger protein 771	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q68DY9	ZNF772	Zinc finger protein 772	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q68DY9	ZNF772	Zinc finger protein 772	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q68DY9	ZNF772	Zinc finger protein 772	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q68DY9	ZNF772	Zinc finger protein 772	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6PK81	ZNF773	Zinc finger protein 773	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6PK81	ZNF773	Zinc finger protein 773	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6PK81	ZNF773	Zinc finger protein 773	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6PK81	ZNF773	Zinc finger protein 773	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6NX45	ZNF774	Zinc finger protein 774	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6NX45	ZNF774	Zinc finger protein 774	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6NX45	ZNF774	Zinc finger protein 774	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6NX45	ZNF774	Zinc finger protein 774	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96BV0	ZNF775	Zinc finger protein 775	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96BV0	ZNF775	Zinc finger protein 775	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96BV0	ZNF775	Zinc finger protein 775	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96BV0	ZNF775	Zinc finger protein 775	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q68DI1	ZNF776	Zinc finger protein 776	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q68DI1	ZNF776	Zinc finger protein 776	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q68DI1	ZNF776	Zinc finger protein 776	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q68DI1	ZNF776	Zinc finger protein 776	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9ULD5	ZNF777	Zinc finger protein 777	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9ULD5	ZNF777	Zinc finger protein 777	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9ULD5	ZNF777	Zinc finger protein 777	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9ULD5	ZNF777	Zinc finger protein 777	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96MU6	ZNF778	Zinc finger protein 778	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96MU6	ZNF778	Zinc finger protein 778	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96MU6	ZNF778	Zinc finger protein 778	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96MU6	ZNF778	Zinc finger protein 778	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N8C0	ZNF781	Zinc finger protein 781	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N8C0	ZNF781	Zinc finger protein 781	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N8C0	ZNF781	Zinc finger protein 781	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N8C0	ZNF781	Zinc finger protein 781	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZMW2	ZNF782	Zinc finger protein 782	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZMW2	ZNF782	Zinc finger protein 782	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZMW2	ZNF782	Zinc finger protein 782	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6ZMW2	ZNF782	Zinc finger protein 782	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q6ZMW2	ZNF782	Zinc finger protein 782	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZMS7	ZNF783	Protein ZNF783	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZMS7	ZNF783	Protein ZNF783	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZMS7	ZNF783	Protein ZNF783	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NCA9	ZNF784	Zinc finger protein 784	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NCA9	ZNF784	Zinc finger protein 784	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NCA9	ZNF784	Zinc finger protein 784	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8NCA9	ZNF784	Zinc finger protein 784	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A8K8V0	ZNF785	Zinc finger protein 785	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A8K8V0	ZNF785	Zinc finger protein 785	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A8K8V0	ZNF785	Zinc finger protein 785	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A8K8V0	ZNF785	Zinc finger protein 785	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N393	ZNF786	Zinc finger protein 786	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N393	ZNF786	Zinc finger protein 786	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N393	ZNF786	Zinc finger protein 786	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8N393	ZNF786	Zinc finger protein 786	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6DD87	ZNF787	Zinc finger protein 787	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6DD87	ZNF787	Zinc finger protein 787	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6DD87	ZNF787	Zinc finger protein 787	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6DD87	ZNF787	Zinc finger protein 787	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5FWF6	ZNF789	Zinc finger protein 789	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5FWF6	ZNF789	Zinc finger protein 789	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5FWF6	ZNF789	Zinc finger protein 789	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q5FWF6	ZNF789	Zinc finger protein 789	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q5FWF6	ZNF789	Zinc finger protein 789	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZQV5	ZNF788	Zinc finger protein 788	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZQV5	ZNF788	Zinc finger protein 788	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZQV5	ZNF788	Zinc finger protein 788	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZQV5	ZNF788	Zinc finger protein 788	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6PG37	ZNF790	Zinc finger protein 790	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6PG37	ZNF790	Zinc finger protein 790	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6PG37	ZNF790	Zinc finger protein 790	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6PG37	ZNF790	Zinc finger protein 790	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q6PG37	ZNF790	Zinc finger protein 790	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q3KP31	ZNF791	Zinc finger protein 791	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q3KP31	ZNF791	Zinc finger protein 791	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q3KP31	ZNF791	Zinc finger protein 791	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q3KP31	ZNF791	Zinc finger protein 791	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q3KQV3	ZNF792	Zinc finger protein 792	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q3KQV3	ZNF792	Zinc finger protein 792	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q3KQV3	ZNF792	Zinc finger protein 792	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q3KQV3	ZNF792	Zinc finger protein 792	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZN11	ZNF793	Zinc finger protein 793	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZN11	ZNF793	Zinc finger protein 793	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZN11	ZNF793	Zinc finger protein 793	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZN11	ZNF793	Zinc finger protein 793	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q2TB10	ZNF800	Zinc finger protein 800	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q2TB10	ZNF800	Zinc finger protein 800	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q2TB10	ZNF800	Zinc finger protein 800	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q2TB10	ZNF800	Zinc finger protein 800	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96GE5	ZNF799	Zinc finger protein 799	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96GE5	ZNF799	Zinc finger protein 799	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96GE5	ZNF799	Zinc finger protein 799	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96GE5	ZNF799	Zinc finger protein 799	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5CZA5	ZNF805	Zinc finger protein 805	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q5CZA5	ZNF805	Zinc finger protein 805	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5CZA5	ZNF805	Zinc finger protein 805	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q5CZA5	ZNF805	Zinc finger protein 805	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P0C7X5	ZNF806	Zinc finger protein 806	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P0C7X5	ZNF806	Zinc finger protein 806	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P0C7X5	ZNF806	Zinc finger protein 806	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P0C7X5	ZNF806	Zinc finger protein 806	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N4W9	ZNF808	Zinc finger protein 808	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8N4W9	ZNF808	Zinc finger protein 808	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N4W9	ZNF808	Zinc finger protein 808	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q8N4W9	ZNF808	Zinc finger protein 808	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q8N4W9	ZNF808	Zinc finger protein 808	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P0C7V5	ZNF812	Putative zinc finger protein 812	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P0C7V5	ZNF812	Putative zinc finger protein 812	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P0C7V5	ZNF812	Putative zinc finger protein 812	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P0C7V5	ZNF812	Putative zinc finger protein 812	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZN06	ZNF813	Zinc finger protein 813	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZN06	ZNF813	Zinc finger protein 813	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZN06	ZNF813	Zinc finger protein 813	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZN06	ZNF813	Zinc finger protein 813	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
B7Z6K7	ZNF814	Putative uncharacterized zinc finger protein 814	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
B7Z6K7	ZNF814	Putative uncharacterized zinc finger protein 814	GO:0003676; F:nucleic acid binding; IEA:InterPro
B7Z6K7	ZNF814	Putative uncharacterized zinc finger protein 814	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
B7Z6K7	ZNF814	Putative uncharacterized zinc finger protein 814	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q0VGE8	ZNF816	Zinc finger protein 816	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q0VGE8	ZNF816	Zinc finger protein 816	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q0VGE8	ZNF816	Zinc finger protein 816	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q0VGE8	ZNF816	Zinc finger protein 816	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q0VGE8	ZNF816	Zinc finger protein 816	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O75541	ZNF821	Zinc finger protein 821	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O75541	ZNF821	Zinc finger protein 821	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O75541	ZNF821	Zinc finger protein 821	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O75541	ZNF821	Zinc finger protein 821	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZRF7	ZNF818P	Putative zinc finger protein 818	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZRF7	ZNF818P	Putative zinc finger protein 818	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZRF7	ZNF818P	Putative zinc finger protein 818	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZRF7	ZNF818P	Putative zinc finger protein 818	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q17R98	ZNF827	Zinc finger protein 827	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q17R98	ZNF827	Zinc finger protein 827	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q17R98	ZNF827	Zinc finger protein 827	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q17R98	ZNF827	Zinc finger protein 827	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P16415	ZNF823	Zinc finger protein 823	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P16415	ZNF823	Zinc finger protein 823	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P16415	ZNF823	Zinc finger protein 823	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P16415	ZNF823	Zinc finger protein 823	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZT77	ZNF826P	Putative zinc finger protein 826	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZT77	ZNF826P	Putative zinc finger protein 826	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZT77	ZNF826P	Putative zinc finger protein 826	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZT77	ZNF826P	Putative zinc finger protein 826	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q3KNS6	ZNF829	Zinc finger protein 829	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q3KNS6	ZNF829	Zinc finger protein 829	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q3KNS6	ZNF829	Zinc finger protein 829	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q3KNS6	ZNF829	Zinc finger protein 829	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96NB3	ZNF830	Zinc finger protein 830	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96NB3	ZNF830	Zinc finger protein 830	GO:0005515; F:protein binding; IPI:IntAct
Q96NB3	ZNF830	Zinc finger protein 830	GO:0001832; P:blastocyst growth; IEA:Ensembl
Q96NB3	ZNF830	Zinc finger protein 830	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q96NB3	ZNF830	Zinc finger protein 830	GO:0033260; P:nuclear cell cycle DNA replication; IEA:Ensembl
Q9Y2P0	ZNF835	Zinc finger protein 835	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y2P0	ZNF835	Zinc finger protein 835	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y2P0	ZNF835	Zinc finger protein 835	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9Y2P0	ZNF835	Zinc finger protein 835	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9Y2P0	ZNF835	Zinc finger protein 835	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q5JPB2	ZNF831	Zinc finger protein 831	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q5JPB2	ZNF831	Zinc finger protein 831	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q6ZNA1	ZNF836	Zinc finger protein 836	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZNA1	ZNF836	Zinc finger protein 836	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZNA1	ZNF836	Zinc finger protein 836	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6ZNA1	ZNF836	Zinc finger protein 836	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q6ZNA1	ZNF836	Zinc finger protein 836	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZTB9	ZNF833P	Putative zinc finger protein 833	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZTB9	ZNF833P	Putative zinc finger protein 833	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q96EG3	ZNF837	Zinc finger protein 837	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96EG3	ZNF837	Zinc finger protein 837	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96EG3	ZNF837	Zinc finger protein 837	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96EG3	ZNF837	Zinc finger protein 837	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A8K0R7	ZNF839	Zinc finger protein 839	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZN19	ZNF841	Zinc finger protein 841	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZN19	ZNF841	Zinc finger protein 841	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZN19	ZNF841	Zinc finger protein 841	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6ZN19	ZNF841	Zinc finger protein 841	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q6ZN19	ZNF841	Zinc finger protein 841	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8N446	ZNF843	Zinc finger protein 843	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8N446	ZNF843	Zinc finger protein 843	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q08AG5	ZNF844	Zinc finger protein 844	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q08AG5	ZNF844	Zinc finger protein 844	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q08AG5	ZNF844	Zinc finger protein 844	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q08AG5	ZNF844	Zinc finger protein 844	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96IR2	ZNF845	Zinc finger protein 845	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96IR2	ZNF845	Zinc finger protein 845	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96IR2	ZNF845	Zinc finger protein 845	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96IR2	ZNF845	Zinc finger protein 845	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A6NDX5	ZNF840	Putative zinc finger protein 840	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A6NDX5	ZNF840	Putative zinc finger protein 840	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A6NDX5	ZNF840	Putative zinc finger protein 840	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A6NDX5	ZNF840	Putative zinc finger protein 840	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A8MQ14	ZNF850	Zinc finger protein 850	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A8MQ14	ZNF850	Zinc finger protein 850	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A8MQ14	ZNF850	Zinc finger protein 850	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A8MQ14	ZNF850	Zinc finger protein 850	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q147U1	ZNF846	Zinc finger protein 846	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q147U1	ZNF846	Zinc finger protein 846	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q147U1	ZNF846	Zinc finger protein 846	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q147U1	ZNF846	Zinc finger protein 846	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZMS4	ZNF852	Putative zinc finger protein 852	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZMS4	ZNF852	Putative zinc finger protein 852	GO:0003676; F:nucleic acid binding; IEA:InterPro
A6NHJ4	ZNF860	Zinc finger protein 860	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A6NHJ4	ZNF860	Zinc finger protein 860	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A6NHJ4	ZNF860	Zinc finger protein 860	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A6NHJ4	ZNF860	Zinc finger protein 860	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P0CG23	ZNF853	Zinc finger protein 853	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P0CG23	ZNF853	Zinc finger protein 853	GO:0003676; F:nucleic acid binding; IEA:InterPro
O60384	ZNF861P	Putative zinc finger protein 861	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60384	ZNF861P	Putative zinc finger protein 861	GO:0003676; F:nucleic acid binding; IEA:InterPro
O60290	ZNF862	Zinc finger protein 862	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O60290	ZNF862	Zinc finger protein 862	GO:0003676; F:nucleic acid binding; IEA:InterPro
O60290	ZNF862	Zinc finger protein 862	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O60290	ZNF862	Zinc finger protein 862	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
C9JN71	ZNF878	Zinc finger protein 878	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
C9JN71	ZNF878	Zinc finger protein 878	GO:0003676; F:nucleic acid binding; IEA:InterPro
C9JN71	ZNF878	Zinc finger protein 878	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
C9JN71	ZNF878	Zinc finger protein 878	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
B4DU55	ZNF879	Zinc finger protein 879	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
B4DU55	ZNF879	Zinc finger protein 879	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
B4DU55	ZNF879	Zinc finger protein 879	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
B4DU55	ZNF879	Zinc finger protein 879	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
B4DU55	ZNF879	Zinc finger protein 879	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P0CJ78	ZNF865	Zinc finger protein 865	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P0CJ78	ZNF865	Zinc finger protein 865	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P0CJ78	ZNF865	Zinc finger protein 865	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P0CJ78	ZNF865	Zinc finger protein 865	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P0CJ79	ZNF888	Zinc finger protein 888	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P0CJ79	ZNF888	Zinc finger protein 888	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P0CJ79	ZNF888	Zinc finger protein 888	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P0CJ79	ZNF888	Zinc finger protein 888	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6PDB4	ZNF880	Zinc finger protein 880	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6PDB4	ZNF880	Zinc finger protein 880	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q6PDB4	ZNF880	Zinc finger protein 880	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q6PDB4	ZNF880	Zinc finger protein 880	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P0CG24	ZNF883	Zinc finger protein 883	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P0CG24	ZNF883	Zinc finger protein 883	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P0CG24	ZNF883	Zinc finger protein 883	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P0CG24	ZNF883	Zinc finger protein 883	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A8MT65	ZNF891	Zinc finger protein 891	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A8MT65	ZNF891	Zinc finger protein 891	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A8MT65	ZNF891	Zinc finger protein 891	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A8MT65	ZNF891	Zinc finger protein 891	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P21506	ZNF10	Zinc finger protein 10	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P21506	ZNF10	Zinc finger protein 10	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P21506	ZNF10	Zinc finger protein 10	GO:0005515; F:protein binding; IPI:UniProtKB
P21506	ZNF10	Zinc finger protein 10	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P21506	ZNF10	Zinc finger protein 10	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17014	ZNF12	Zinc finger protein 12	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P17014	ZNF12	Zinc finger protein 12	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17014	ZNF12	Zinc finger protein 12	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P17014	ZNF12	Zinc finger protein 12	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P17014	ZNF12	Zinc finger protein 12	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17017	ZNF14	Zinc finger protein 14	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P17017	ZNF14	Zinc finger protein 14	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17017	ZNF14	Zinc finger protein 14	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P17017	ZNF14	Zinc finger protein 14	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P17017	ZNF14	Zinc finger protein 14	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17020	ZNF16	Zinc finger protein 16	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P17020	ZNF16	Zinc finger protein 16	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17020	ZNF16	Zinc finger protein 16	GO:0005515; F:protein binding; IPI:IntAct
P17020	ZNF16	Zinc finger protein 16	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P17020	ZNF16	Zinc finger protein 16	GO:0007049; P:cell cycle; IEA:UniProtKB-KW
P17020	ZNF16	Zinc finger protein 16	GO:0051301; P:cell division; IEA:UniProtKB-KW
P17020	ZNF16	Zinc finger protein 16	GO:0072707; P:cellular response to sodium dodecyl sulfate; IDA:UniProtKB
P17020	ZNF16	Zinc finger protein 16	GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB
P17020	ZNF16	Zinc finger protein 16	GO:1901989; P:positive regulation of cell cycle phase transition; IDA:UniProtKB
P17020	ZNF16	Zinc finger protein 16	GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
P17020	ZNF16	Zinc finger protein 16	GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB
P17020	ZNF16	Zinc finger protein 16	GO:0045648; P:positive regulation of erythrocyte differentiation; IMP:UniProtKB
P17020	ZNF16	Zinc finger protein 16	GO:0033674; P:positive regulation of kinase activity; IDA:UniProtKB
P17020	ZNF16	Zinc finger protein 16	GO:0045654; P:positive regulation of megakaryocyte differentiation; IMP:UniProtKB
P17020	ZNF16	Zinc finger protein 16	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P17020	ZNF16	Zinc finger protein 16	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17021	ZNF17	Zinc finger protein 17	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P17021	ZNF17	Zinc finger protein 17	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17021	ZNF17	Zinc finger protein 17	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P17021	ZNF17	Zinc finger protein 17	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17022	ZNF18	Zinc finger protein 18	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P17022	ZNF18	Zinc finger protein 18	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17022	ZNF18	Zinc finger protein 18	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
P17022	ZNF18	Zinc finger protein 18	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
P17022	ZNF18	Zinc finger protein 18	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
P17023	ZNF19	Zinc finger protein 19	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P17023	ZNF19	Zinc finger protein 19	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17023	ZNF19	Zinc finger protein 19	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
P17023	ZNF19	Zinc finger protein 19	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P17023	ZNF19	Zinc finger protein 19	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17024	ZNF20	Zinc finger protein 20	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P17024	ZNF20	Zinc finger protein 20	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17024	ZNF20	Zinc finger protein 20	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P17024	ZNF20	Zinc finger protein 20	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17026	ZNF22	Zinc finger protein 22	GO:0003677; F:DNA binding; ISS:UniProtKB
P17026	ZNF22	Zinc finger protein 22	GO:0008270; F:zinc ion binding; TAS:ProtInc
P17026	ZNF22	Zinc finger protein 22	GO:0042476; P:odontogenesis; NAS:UniProtKB
P17026	ZNF22	Zinc finger protein 22	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
P17026	ZNF22	Zinc finger protein 22	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17027	ZNF23	Zinc finger protein 23	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P17027	ZNF23	Zinc finger protein 23	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17027	ZNF23	Zinc finger protein 23	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P17027	ZNF23	Zinc finger protein 23	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P17027	ZNF23	Zinc finger protein 23	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17028	ZNF24	Zinc finger protein 24	GO:0003677; F:DNA binding; TAS:ProtInc
P17028	ZNF24	Zinc finger protein 24	GO:0005515; F:protein binding; IPI:IntAct
P17028	ZNF24	Zinc finger protein 24	GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB
P17028	ZNF24	Zinc finger protein 24	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P17028	ZNF24	Zinc finger protein 24	GO:0008270; F:zinc ion binding; NAS:UniProtKB
P17028	ZNF24	Zinc finger protein 24	GO:0042552; P:myelination; ISS:UniProtKB
P17028	ZNF24	Zinc finger protein 24	GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB
P17028	ZNF24	Zinc finger protein 24	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17030	ZNF25	Zinc finger protein 25	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P17030	ZNF25	Zinc finger protein 25	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17030	ZNF25	Zinc finger protein 25	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P17030	ZNF25	Zinc finger protein 25	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17035	ZNF28	Zinc finger protein 28	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P17035	ZNF28	Zinc finger protein 28	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17035	ZNF28	Zinc finger protein 28	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P17035	ZNF28	Zinc finger protein 28	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P17035	ZNF28	Zinc finger protein 28	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17031	ZNF26	Zinc finger protein 26	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P17031	ZNF26	Zinc finger protein 26	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17031	ZNF26	Zinc finger protein 26	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P17031	ZNF26	Zinc finger protein 26	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P17031	ZNF26	Zinc finger protein 26	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9BSG1	ZNF2	Zinc finger protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BSG1	ZNF2	Zinc finger protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BSG1	ZNF2	Zinc finger protein 2	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q9BSG1	ZNF2	Zinc finger protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9BSG1	ZNF2	Zinc finger protein 2	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q9BSG1	ZNF2	Zinc finger protein 2	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
Q9BSG1	ZNF2	Zinc finger protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17039	ZNF30	Zinc finger protein 30	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P17039	ZNF30	Zinc finger protein 30	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17039	ZNF30	Zinc finger protein 30	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P17039	ZNF30	Zinc finger protein 30	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P17039	ZNF30	Zinc finger protein 30	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17041	ZNF32	Zinc finger protein 32	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P17041	ZNF32	Zinc finger protein 32	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17041	ZNF32	Zinc finger protein 32	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P17041	ZNF32	Zinc finger protein 32	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IZ26	ZNF34	Zinc finger protein 34	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IZ26	ZNF34	Zinc finger protein 34	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IZ26	ZNF34	Zinc finger protein 34	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8IZ26	ZNF34	Zinc finger protein 34	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P13682	ZNF35	Zinc finger protein 35	GO:0003677; F:DNA binding; TAS:ProtInc
P13682	ZNF35	Zinc finger protein 35	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P13682	ZNF35	Zinc finger protein 35	GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB
P13682	ZNF35	Zinc finger protein 35	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IDA:UniProtKB
P13682	ZNF35	Zinc finger protein 35	GO:0071300; P:cellular response to retinoic acid; ISS:UniProtKB
P13682	ZNF35	Zinc finger protein 35	GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc
P13682	ZNF35	Zinc finger protein 35	GO:0007283; P:spermatogenesis; ISS:UniProtKB
P13682	ZNF35	Zinc finger protein 35	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17036	ZNF3	Zinc finger protein 3	GO:0003677; F:DNA binding; NAS:UniProtKB
P17036	ZNF3	Zinc finger protein 3	GO:0042802; F:identical protein binding; IPI:IntAct
P17036	ZNF3	Zinc finger protein 3	GO:0005515; F:protein binding; IPI:IntAct
P17036	ZNF3	Zinc finger protein 3	GO:0008270; F:zinc ion binding; NAS:UniProtKB
P17036	ZNF3	Zinc finger protein 3	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
P17036	ZNF3	Zinc finger protein 3	GO:0045321; P:leukocyte activation; NAS:UniProtKB
P17036	ZNF3	Zinc finger protein 3	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
P17036	ZNF3	Zinc finger protein 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P17036	ZNF3	Zinc finger protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P51814	ZNF41	Zinc finger protein 41	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P51814	ZNF41	Zinc finger protein 41	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P51814	ZNF41	Zinc finger protein 41	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P51814	ZNF41	Zinc finger protein 41	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P51814	ZNF41	Zinc finger protein 41	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17038	ZNF43	Zinc finger protein 43	GO:0003677; F:DNA binding; TAS:ProtInc
P17038	ZNF43	Zinc finger protein 43	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17038	ZNF43	Zinc finger protein 43	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P17038	ZNF43	Zinc finger protein 43	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P17038	ZNF43	Zinc finger protein 43	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P15621	ZNF44	Zinc finger protein 44	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P15621	ZNF44	Zinc finger protein 44	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P15621	ZNF44	Zinc finger protein 44	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P15621	ZNF44	Zinc finger protein 44	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q02386	ZNF45	Zinc finger protein 45	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q02386	ZNF45	Zinc finger protein 45	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q02386	ZNF45	Zinc finger protein 45	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q02386	ZNF45	Zinc finger protein 45	GO:0010467; P:gene expression; TAS:Reactome
Q02386	ZNF45	Zinc finger protein 45	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q02386	ZNF45	Zinc finger protein 45	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q02386	ZNF45	Zinc finger protein 45	GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome
Q96MX3	ZNF48	Zinc finger protein 48	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96MX3	ZNF48	Zinc finger protein 48	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96MX3	ZNF48	Zinc finger protein 48	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q96MX3	ZNF48	Zinc finger protein 48	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15929	ZNF56	Putative zinc finger protein 56	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q15929	ZNF56	Putative zinc finger protein 56	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15929	ZNF56	Putative zinc finger protein 56	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q15929	ZNF56	Putative zinc finger protein 56	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q68EA5	ZNF57	Zinc finger protein 57	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q68EA5	ZNF57	Zinc finger protein 57	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q68EA5	ZNF57	Zinc finger protein 57	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q68EA5	ZNF57	Zinc finger protein 57	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15940	ZNF726P1	Putative zinc finger protein 726P1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15940	ZNF726P1	Putative zinc finger protein 726P1	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q6ZN08	ZNF66	Putative zinc finger protein 66	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6ZN08	ZNF66	Putative zinc finger protein 66	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6ZN08	ZNF66	Putative zinc finger protein 66	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q6ZN08	ZNF66	Putative zinc finger protein 66	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UC07	ZNF69	Zinc finger protein 69	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UC07	ZNF69	Zinc finger protein 69	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UC07	ZNF69	Zinc finger protein 69	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UC07	ZNF69	Zinc finger protein 69	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9UC06	ZNF70	Zinc finger protein 70	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9UC06	ZNF70	Zinc finger protein 70	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9UC06	ZNF70	Zinc finger protein 70	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q9UC06	ZNF70	Zinc finger protein 70	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NQZ8	ZNF71	Endothelial zinc finger protein induced by tumor necrosis factor alpha	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NQZ8	ZNF71	Endothelial zinc finger protein induced by tumor necrosis factor alpha	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NQZ8	ZNF71	Endothelial zinc finger protein induced by tumor necrosis factor alpha	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q9NQZ8	ZNF71	Endothelial zinc finger protein induced by tumor necrosis factor alpha	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q9NQZ8	ZNF71	Endothelial zinc finger protein induced by tumor necrosis factor alpha	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O43830	ZNF73	Zinc finger protein 73	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O43830	ZNF73	Zinc finger protein 73	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43830	ZNF73	Zinc finger protein 73	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
O43830	ZNF73	Zinc finger protein 73	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q16587	ZNF74	Zinc finger protein 74	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q16587	ZNF74	Zinc finger protein 74	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q16587	ZNF74	Zinc finger protein 74	GO:0003723; F:RNA binding; IEA:UniProtKB-KW
Q16587	ZNF74	Zinc finger protein 74	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
Q16587	ZNF74	Zinc finger protein 74	GO:0007275; P:multicellular organismal development; TAS:ProtInc
Q16587	ZNF74	Zinc finger protein 74	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q16587	ZNF74	Zinc finger protein 74	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P36508	ZNF76	Zinc finger protein 76	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P36508	ZNF76	Zinc finger protein 76	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P36508	ZNF76	Zinc finger protein 76	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; TAS:ProtInc
P36508	ZNF76	Zinc finger protein 76	GO:0006359; P:regulation of transcription from RNA polymerase III promoter; TAS:ProtInc
P36508	ZNF76	Zinc finger protein 76	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15937	ZNF79	Zinc finger protein 79	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q15937	ZNF79	Zinc finger protein 79	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15937	ZNF79	Zinc finger protein 79	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q15937	ZNF79	Zinc finger protein 79	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15935	ZNF77	Zinc finger protein 77	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q15935	ZNF77	Zinc finger protein 77	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15935	ZNF77	Zinc finger protein 77	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q15935	ZNF77	Zinc finger protein 77	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17097	ZNF7	Zinc finger protein 7	GO:0003677; F:DNA binding; TAS:ProtInc
P17097	ZNF7	Zinc finger protein 7	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17097	ZNF7	Zinc finger protein 7	GO:0003676; F:nucleic acid binding; IEA:InterPro
P17097	ZNF7	Zinc finger protein 7	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P17097	ZNF7	Zinc finger protein 7	GO:0007275; P:multicellular organismal development; TAS:ProtInc
P17097	ZNF7	Zinc finger protein 7	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
P17097	ZNF7	Zinc finger protein 7	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P51504	ZNF80	Zinc finger protein 80	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P51504	ZNF80	Zinc finger protein 80	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P51504	ZNF80	Zinc finger protein 80	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P51504	ZNF80	Zinc finger protein 80	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P51508	ZNF81	Zinc finger protein 81	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P51508	ZNF81	Zinc finger protein 81	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P51508	ZNF81	Zinc finger protein 81	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P51508	ZNF81	Zinc finger protein 81	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P51508	ZNF81	Zinc finger protein 81	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P51523	ZNF84	Zinc finger protein 84	GO:0003677; F:DNA binding; NAS:UniProtKB
P51523	ZNF84	Zinc finger protein 84	GO:0008270; F:zinc ion binding; NAS:UniProtKB
P51523	ZNF84	Zinc finger protein 84	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P51523	ZNF84	Zinc finger protein 84	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P51522	ZNF83	Zinc finger protein 83	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P51522	ZNF83	Zinc finger protein 83	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P51522	ZNF83	Zinc finger protein 83	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IBA:RefGenome
P51522	ZNF83	Zinc finger protein 83	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P51522	ZNF83	Zinc finger protein 83	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17098	ZNF8	Zinc finger protein 8	GO:0003677; F:DNA binding; NAS:UniProtKB
P17098	ZNF8	Zinc finger protein 8	GO:0008270; F:zinc ion binding; NAS:UniProtKB
P17098	ZNF8	Zinc finger protein 8	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P17098	ZNF8	Zinc finger protein 8	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q03923	ZNF85	Zinc finger protein 85	GO:0003677; F:DNA binding; TAS:ProtInc
Q03923	ZNF85	Zinc finger protein 85	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q03923	ZNF85	Zinc finger protein 85	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
Q03923	ZNF85	Zinc finger protein 85	GO:0003714; F:transcription corepressor activity; TAS:ProtInc
Q03923	ZNF85	Zinc finger protein 85	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q03938	ZNF90	Zinc finger protein 90	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q03938	ZNF90	Zinc finger protein 90	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q03938	ZNF90	Zinc finger protein 90	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q03938	ZNF90	Zinc finger protein 90	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q05481	ZNF91	Zinc finger protein 91	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q05481	ZNF91	Zinc finger protein 91	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q05481	ZNF91	Zinc finger protein 91	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q05481	ZNF91	Zinc finger protein 91	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q03936	ZNF92	Zinc finger protein 92	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q03936	ZNF92	Zinc finger protein 92	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q03936	ZNF92	Zinc finger protein 92	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q03936	ZNF92	Zinc finger protein 92	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P35789	ZNF93	Zinc finger protein 93	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P35789	ZNF93	Zinc finger protein 93	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
P35789	ZNF93	Zinc finger protein 93	GO:0008270; F:zinc ion binding; NAS:UniProtKB
P35789	ZNF93	Zinc finger protein 93	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
P35789	ZNF93	Zinc finger protein 93	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A6NK75	ZNF98	Zinc finger protein 98	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A6NK75	ZNF98	Zinc finger protein 98	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A6NK75	ZNF98	Zinc finger protein 98	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
A6NK75	ZNF98	Zinc finger protein 98	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A8MXY4	ZNF99	Zinc finger protein 99	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A8MXY4	ZNF99	Zinc finger protein 99	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A8MXY4	ZNF99	Zinc finger protein 99	GO:0003676; F:nucleic acid binding; IEA:InterPro
A8MXY4	ZNF99	Zinc finger protein 99	GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro
A8MXY4	ZNF99	Zinc finger protein 99	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9P2E3	ZNFX1	NFX1-type zinc finger-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9P2E3	ZNFX1	NFX1-type zinc finger-containing protein 1	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q9UHR6	ZNHIT2	Zinc finger HIT domain-containing protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43257	ZNHIT1	Zinc finger HIT domain-containing protein 1	GO:0003682; F:chromatin binding; IEA:Ensembl
O43257	ZNHIT1	Zinc finger HIT domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43257	ZNHIT1	Zinc finger HIT domain-containing protein 1	GO:0005515; F:protein binding; IPI:UniProtKB
O43257	ZNHIT1	Zinc finger HIT domain-containing protein 1	GO:0070317; P:negative regulation of G0 to G1 transition; IEA:Ensembl
O43257	ZNHIT1	Zinc finger HIT domain-containing protein 1	GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
O43257	ZNHIT1	Zinc finger HIT domain-containing protein 1	GO:0031063; P:regulation of histone deacetylation; IEA:Ensembl
O43257	ZNHIT1	Zinc finger HIT domain-containing protein 1	GO:0042129; P:regulation of T cell proliferation; IEA:Ensembl
Q15649	ZNHIT3	Zinc finger HIT domain-containing protein 3	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q15649	ZNHIT3	Zinc finger HIT domain-containing protein 3	GO:0046966; F:thyroid hormone receptor binding; TAS:UniProtKB
Q15649	ZNHIT3	Zinc finger HIT domain-containing protein 3	GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB
Q8ND25	ZNRF1	E3 ubiquitin-protein ligase ZNRF1	GO:0005515; F:protein binding; IPI:IntAct
Q8ND25	ZNRF1	E3 ubiquitin-protein ligase ZNRF1	GO:0004842; F:ubiquitin-protein ligase activity; ISS:UniProtKB
Q8ND25	ZNRF1	E3 ubiquitin-protein ligase ZNRF1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8ND25	ZNRF1	E3 ubiquitin-protein ligase ZNRF1	GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB
Q8ND25	ZNRF1	E3 ubiquitin-protein ligase ZNRF1	GO:0070936; P:protein K48-linked ubiquitination; ISS:UniProtKB
Q8NHG8	ZNRF2	E3 ubiquitin-protein ligase ZNRF2	GO:0016874; F:ligase activity; IEA:UniProtKB-KW
Q8NHG8	ZNRF2	E3 ubiquitin-protein ligase ZNRF2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8NHG8	ZNRF2	E3 ubiquitin-protein ligase ZNRF2	GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway
Q9ULT6	ZNRF3	E3 ubiquitin-protein ligase ZNRF3	GO:0005109; F:frizzled binding; IPI:UniProtKB
Q9ULT6	ZNRF3	E3 ubiquitin-protein ligase ZNRF3	GO:0005515; F:protein binding; IPI:UniProtKB
Q9ULT6	ZNRF3	E3 ubiquitin-protein ligase ZNRF3	GO:0004842; F:ubiquitin-protein ligase activity; IDA:UniProtKB
Q9ULT6	ZNRF3	E3 ubiquitin-protein ligase ZNRF3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9ULT6	ZNRF3	E3 ubiquitin-protein ligase ZNRF3	GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl
Q9ULT6	ZNRF3	E3 ubiquitin-protein ligase ZNRF3	GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:UniProtKB
Q9ULT6	ZNRF3	E3 ubiquitin-protein ligase ZNRF3	GO:2000051; P:negative regulation of non-canonical Wnt signaling pathway; IMP:UniProtKB
Q9ULT6	ZNRF3	E3 ubiquitin-protein ligase ZNRF3	GO:0016567; P:protein ubiquitination; IDA:UniProtKB
Q9ULT6	ZNRF3	E3 ubiquitin-protein ligase ZNRF3	GO:0072089; P:stem cell proliferation; ISS:UniProtKB
Q9ULT6	ZNRF3	E3 ubiquitin-protein ligase ZNRF3	GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB
Q9ULT6	ZNRF3	E3 ubiquitin-protein ligase ZNRF3	GO:0038018; P:Wnt receptor catabolic process; IMP:UniProtKB
Q9ULT6	ZNRF3	E3 ubiquitin-protein ligase ZNRF3	GO:0060071; P:Wnt signaling pathway, planar cell polarity pathway; IEA:Ensembl
Q8WWF5	ZNRF4	Zinc/RING finger protein 4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q6XR72	SLC30A10	Zinc transporter 10	GO:0008324; F:cation transmembrane transporter activity; IEA:InterPro
Q6XR72	SLC30A10	Zinc transporter 10	GO:0006829; P:zinc ion transport; IEA:UniProtKB-KW
Q9Y6M5	SLC30A1	Zinc transporter 1	GO:0019855; F:calcium channel inhibitor activity; ISS:BHF-UCL
Q9Y6M5	SLC30A1	Zinc transporter 1	GO:0005515; F:protein binding; IPI:UniProt
Q9Y6M5	SLC30A1	Zinc transporter 1	GO:0005385; F:zinc ion transmembrane transporter activity; IEA:Ensembl
Q9Y6M5	SLC30A1	Zinc transporter 1	GO:0070574; P:cadmium ion transmembrane transport; ISS:BHF-UCL
Q9Y6M5	SLC30A1	Zinc transporter 1	GO:0070509; P:calcium ion import; IEA:Ensembl
Q9Y6M5	SLC30A1	Zinc transporter 1	GO:0006874; P:cellular calcium ion homeostasis; ISS:BHF-UCL
Q9Y6M5	SLC30A1	Zinc transporter 1	GO:0006882; P:cellular zinc ion homeostasis; ISS:BHF-UCL
Q9Y6M5	SLC30A1	Zinc transporter 1	GO:0071585; P:detoxification of cadmium ion; IEA:Ensembl
Q9Y6M5	SLC30A1	Zinc transporter 1	GO:0001701; P:in utero embryonic development; IEA:Ensembl
Q9Y6M5	SLC30A1	Zinc transporter 1	GO:0090281; P:negative regulation of calcium ion import; ISS:BHF-UCL
Q9Y6M5	SLC30A1	Zinc transporter 1	GO:0046929; P:negative regulation of neurotransmitter secretion; ISS:BHF-UCL
Q9Y6M5	SLC30A1	Zinc transporter 1	GO:0071584; P:negative regulation of zinc ion transmembrane import; ISS:BHF-UCL
Q9Y6M5	SLC30A1	Zinc transporter 1	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9Y6M5	SLC30A1	Zinc transporter 1	GO:0006829; P:zinc ion transport; ISS:BHF-UCL
Q9BRI3	SLC30A2	Zinc transporter 2	GO:0008324; F:cation transmembrane transporter activity; IEA:InterPro
Q9BRI3	SLC30A2	Zinc transporter 2	GO:0061090; P:positive regulation of sequestering of zinc ion; IDA:BHF-UCL
Q9BRI3	SLC30A2	Zinc transporter 2	GO:0055085; P:transmembrane transport; TAS:Reactome
Q9BRI3	SLC30A2	Zinc transporter 2	GO:0006829; P:zinc ion transport; IEA:UniProtKB-KW
Q99726	SLC30A3	Zinc transporter 3	GO:0015633; F:zinc transporting ATPase activity; TAS:ProtInc
Q99726	SLC30A3	Zinc transporter 3	GO:0051050; P:positive regulation of transport; IEA:Ensembl
Q99726	SLC30A3	Zinc transporter 3	GO:0061088; P:regulation of sequestering of zinc ion; IDA:BHF-UCL
Q99726	SLC30A3	Zinc transporter 3	GO:0055085; P:transmembrane transport; TAS:Reactome
Q99726	SLC30A3	Zinc transporter 3	GO:0006810; P:transport; TAS:ProtInc
Q99726	SLC30A3	Zinc transporter 3	GO:0071577; P:zinc ion transmembrane transport; TAS:GOC
O14863	SLC30A4	Zinc transporter 4	GO:0005385; F:zinc ion transmembrane transporter activity; TAS:ProtInc
O14863	SLC30A4	Zinc transporter 4	GO:0061088; P:regulation of sequestering of zinc ion; IDA:BHF-UCL
O14863	SLC30A4	Zinc transporter 4	GO:0009636; P:response to toxic substance; IDA:UniProtKB
O14863	SLC30A4	Zinc transporter 4	GO:0055069; P:zinc ion homeostasis; IEA:Ensembl
O14863	SLC30A4	Zinc transporter 4	GO:0071577; P:zinc ion transmembrane transport; TAS:GOC
Q8TAD4	SLC30A5	Zinc transporter 5	GO:0008270; F:zinc ion binding; NAS:UniProtKB
Q8TAD4	SLC30A5	Zinc transporter 5	GO:0005385; F:zinc ion transmembrane transporter activity; IDA:UniProtKB
Q8TAD4	SLC30A5	Zinc transporter 5	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8TAD4	SLC30A5	Zinc transporter 5	GO:0006882; P:cellular zinc ion homeostasis; IDA:UniProtKB
Q8TAD4	SLC30A5	Zinc transporter 5	GO:0006824; P:cobalt ion transport; IDA:MGI
Q8TAD4	SLC30A5	Zinc transporter 5	GO:0010155; P:regulation of proton transport; NAS:UniProtKB
Q8TAD4	SLC30A5	Zinc transporter 5	GO:0010043; P:response to zinc ion; IDA:UniProtKB
Q8TAD4	SLC30A5	Zinc transporter 5	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8TAD4	SLC30A5	Zinc transporter 5	GO:0071577; P:zinc ion transmembrane transport; IDA:GOC
Q8TAD4	SLC30A5	Zinc transporter 5	GO:0006829; P:zinc ion transport; IDA:UniProtKB
Q6NXT4	SLC30A6	Zinc transporter 6	GO:0005385; F:zinc ion transmembrane transporter activity; IEA:Ensembl
Q6NXT4	SLC30A6	Zinc transporter 6	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q6NXT4	SLC30A6	Zinc transporter 6	GO:0006895; P:Golgi to endosome transport; IEA:Ensembl
Q6NXT4	SLC30A6	Zinc transporter 6	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8NEW0	SLC30A7	Zinc transporter 7	GO:0008324; F:cation transmembrane transporter activity; IEA:InterPro
Q8NEW0	SLC30A7	Zinc transporter 7	GO:0044267; P:cellular protein metabolic process; TAS:Reactome
Q8NEW0	SLC30A7	Zinc transporter 7	GO:0032119; P:sequestering of zinc ion; IEA:Ensembl
Q8NEW0	SLC30A7	Zinc transporter 7	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8NEW0	SLC30A7	Zinc transporter 7	GO:0006829; P:zinc ion transport; IEA:UniProtKB-KW
Q8IWU4	SLC30A8	Zinc transporter 8	GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL
Q8IWU4	SLC30A8	Zinc transporter 8	GO:0008270; F:zinc ion binding; IC:BHF-UCL
Q8IWU4	SLC30A8	Zinc transporter 8	GO:0005385; F:zinc ion transmembrane transporter activity; IDA:BHF-UCL
Q8IWU4	SLC30A8	Zinc transporter 8	GO:0006882; P:cellular zinc ion homeostasis; ISS:BHF-UCL
Q8IWU4	SLC30A8	Zinc transporter 8	GO:0030073; P:insulin secretion; IMP:BHF-UCL
Q8IWU4	SLC30A8	Zinc transporter 8	GO:0032024; P:positive regulation of insulin secretion; ISS:BHF-UCL
Q8IWU4	SLC30A8	Zinc transporter 8	GO:0061088; P:regulation of sequestering of zinc ion; ISS:BHF-UCL
Q8IWU4	SLC30A8	Zinc transporter 8	GO:0060627; P:regulation of vesicle-mediated transport; ISS:BHF-UCL
Q8IWU4	SLC30A8	Zinc transporter 8	GO:0009749; P:response to glucose; IMP:BHF-UCL
Q8IWU4	SLC30A8	Zinc transporter 8	GO:0034341; P:response to interferon-gamma; IEA:Ensembl
Q8IWU4	SLC30A8	Zinc transporter 8	GO:0070555; P:response to interleukin-1; IEA:Ensembl
Q8IWU4	SLC30A8	Zinc transporter 8	GO:0032119; P:sequestering of zinc ion; IDA:BHF-UCL
Q8IWU4	SLC30A8	Zinc transporter 8	GO:0055085; P:transmembrane transport; TAS:Reactome
Q8IWU4	SLC30A8	Zinc transporter 8	GO:0071577; P:zinc ion transmembrane transport; IDA:GOC
Q8IWU4	SLC30A8	Zinc transporter 8	GO:0006829; P:zinc ion transport; IDA:BHF-UCL
Q6PML9	SLC30A9	Zinc transporter 9	GO:0008324; F:cation transmembrane transporter activity; IEA:InterPro
Q6PML9	SLC30A9	Zinc transporter 9	GO:0003682; F:chromatin binding; IEA:Ensembl
Q6PML9	SLC30A9	Zinc transporter 9	GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IEA:Ensembl
Q6PML9	SLC30A9	Zinc transporter 9	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q6PML9	SLC30A9	Zinc transporter 9	GO:0006289; P:nucleotide-excision repair; TAS:BHF-UCL
Q6PML9	SLC30A9	Zinc transporter 9	GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl
Q6PML9	SLC30A9	Zinc transporter 9	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6PML9	SLC30A9	Zinc transporter 9	GO:0006829; P:zinc ion transport; IEA:UniProtKB-KW
Q07157	TJP1	Tight junction protein ZO-1	GO:0005515; F:protein binding; IPI:UniProtKB
Q07157	TJP1	Tight junction protein ZO-1	GO:0006915; P:apoptotic process; TAS:Reactome
Q07157	TJP1	Tight junction protein ZO-1	GO:0001825; P:blastocyst formation; IEA:Ensembl
Q07157	TJP1	Tight junction protein ZO-1	GO:0007043; P:cell-cell junction assembly; TAS:ProtInc
Q07157	TJP1	Tight junction protein ZO-1	GO:1901350; P:cell-cell signaling involved in cell-cell junction organization; NAS:UniProtKB
Q07157	TJP1	Tight junction protein ZO-1	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q07157	TJP1	Tight junction protein ZO-1	GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl
Q07157	TJP1	Tight junction protein ZO-1	GO:0035329; P:hippo signaling; TAS:Reactome
Q07157	TJP1	Tight junction protein ZO-1	GO:0061024; P:membrane organization; TAS:Reactome
Q07157	TJP1	Tight junction protein ZO-1	GO:0043116; P:negative regulation of vascular permeability; IEA:Ensembl
Q07157	TJP1	Tight junction protein ZO-1	GO:0042493; P:response to drug; IEA:Ensembl
Q07157	TJP1	Tight junction protein ZO-1	GO:0045471; P:response to ethanol; IEA:Ensembl
Q07157	TJP1	Tight junction protein ZO-1	GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl
Q07157	TJP1	Tight junction protein ZO-1	GO:0071000; P:response to magnetism; IEA:Ensembl
Q9UDY2	TJP2	Tight junction protein ZO-2	GO:0004385; F:guanylate kinase activity; TAS:ProtInc
Q9UDY2	TJP2	Tight junction protein ZO-2	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UDY2	TJP2	Tight junction protein ZO-2	GO:0006915; P:apoptotic process; TAS:Reactome
Q9UDY2	TJP2	Tight junction protein ZO-2	GO:0006921; P:cellular component disassembly involved in execution phase of apoptosis; TAS:Reactome
Q9UDY2	TJP2	Tight junction protein ZO-2	GO:0035329; P:hippo signaling; TAS:Reactome
Q9UDY2	TJP2	Tight junction protein ZO-2	GO:0046939; P:nucleotide phosphorylation; TAS:GOC
Q9UDY2	TJP2	Tight junction protein ZO-2	GO:0010033; P:response to organic substance; IEA:Ensembl
O95049	TJP3	Tight junction protein ZO-3	GO:0005515; F:protein binding; IPI:UniProtKB
O95049	TJP3	Tight junction protein ZO-3	GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl
P60852	ZP1	Zona pellucida sperm-binding protein 1	GO:0007339; P:binding of sperm to zona pellucida; TAS:Reactome
P60852	ZP1	Zona pellucida sperm-binding protein 1	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
P60852	ZP1	Zona pellucida sperm-binding protein 1	GO:0007338; P:single fertilization; TAS:Reactome
Q05996	ZP2	Zona pellucida sperm-binding protein 2	GO:0032190; F:acrosin binding; IPI:UniProtKB
Q05996	ZP2	Zona pellucida sperm-binding protein 2	GO:0015026; F:coreceptor activity; TAS:ProtInc
Q05996	ZP2	Zona pellucida sperm-binding protein 2	GO:0007339; P:binding of sperm to zona pellucida; ISS:UniProtKB
Q05996	ZP2	Zona pellucida sperm-binding protein 2	GO:0006886; P:intracellular protein transport; ISS:UniProtKB
Q05996	ZP2	Zona pellucida sperm-binding protein 2	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
Q05996	ZP2	Zona pellucida sperm-binding protein 2	GO:0060468; P:prevention of polyspermy; ISS:UniProtKB
Q05996	ZP2	Zona pellucida sperm-binding protein 2	GO:0007165; P:signal transduction; TAS:GOC
Q05996	ZP2	Zona pellucida sperm-binding protein 2	GO:0007338; P:single fertilization; TAS:Reactome
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0032190; F:acrosin binding; IPI:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0030246; F:carbohydrate binding; IDA:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0005384; F:manganese ion transmembrane transporter activity; ISS:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0005515; F:protein binding; IPI:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0004871; F:signal transducer activity; IMP:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0015279; F:store-operated calcium channel activity; IDA:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0007339; P:binding of sperm to zona pellucida; IDA:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0001825; P:blastocyst formation; ISS:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0070588; P:calcium ion transmembrane transport; IDA:GOC
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0035803; P:egg coat formation; ISS:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0002455; P:humoral immune response mediated by circulating immunoglobulin; ISS:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0006886; P:intracellular protein transport; ISS:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0035556; P:intracellular signal transduction; IMP:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0071421; P:manganese ion transmembrane transport; ISS:GOC
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0006828; P:manganese ion transport; ISS:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:2000360; P:negative regulation of binding of sperm to zona pellucida; IDA:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0048599; P:oocyte development; ISS:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0048015; P:phosphatidylinositol-mediated signaling; ISS:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:2000368; P:positive regulation of acrosomal vesicle exocytosis; IDA:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:2000344; P:positive regulation of acrosome reaction; IDA:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:2000388; P:positive regulation of antral ovarian follicle growth; ISS:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0090280; P:positive regulation of calcium ion import; IDA:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0002922; P:positive regulation of humoral immune response; IDA:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0050729; P:positive regulation of inflammatory response; ISS:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0032729; P:positive regulation of interferon-gamma production; ISS:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0032753; P:positive regulation of interleukin-4 production; ISS:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0002687; P:positive regulation of leukocyte migration; ISS:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:2000386; P:positive regulation of ovarian follicle development; ISS:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0010513; P:positive regulation of phosphatidylinositol biosynthetic process; ISS:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0045860; P:positive regulation of protein kinase activity; IDA:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0051897; P:positive regulation of protein kinase B signaling; ISS:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0042102; P:positive regulation of T cell proliferation; ISS:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0001809; P:positive regulation of type IV hypersensitivity; ISS:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0070528; P:protein kinase C signaling; IMP:UniProtKB
P21754	ZP3	Zona pellucida sperm-binding protein 3	GO:0007338; P:single fertilization; TAS:Reactome
Q12836	ZP4	Zona pellucida sperm-binding protein 4	GO:0032190; F:acrosin binding; IPI:UniProtKB
Q12836	ZP4	Zona pellucida sperm-binding protein 4	GO:0004871; F:signal transducer activity; IMP:UniProtKB
Q12836	ZP4	Zona pellucida sperm-binding protein 4	GO:0060478; P:acrosomal vesicle exocytosis; IMP:UniProtKB
Q12836	ZP4	Zona pellucida sperm-binding protein 4	GO:0007339; P:binding of sperm to zona pellucida; TAS:Reactome
Q12836	ZP4	Zona pellucida sperm-binding protein 4	GO:0035556; P:intracellular signal transduction; IMP:UniProtKB
Q12836	ZP4	Zona pellucida sperm-binding protein 4	GO:0032504; P:multicellular organism reproduction; TAS:Reactome
Q12836	ZP4	Zona pellucida sperm-binding protein 4	GO:2000360; P:negative regulation of binding of sperm to zona pellucida; IDA:UniProtKB
Q12836	ZP4	Zona pellucida sperm-binding protein 4	GO:2000344; P:positive regulation of acrosome reaction; IDA:UniProtKB
Q12836	ZP4	Zona pellucida sperm-binding protein 4	GO:0002922; P:positive regulation of humoral immune response; IDA:UniProtKB
Q12836	ZP4	Zona pellucida sperm-binding protein 4	GO:0045860; P:positive regulation of protein kinase activity; IDA:UniProtKB
Q12836	ZP4	Zona pellucida sperm-binding protein 4	GO:0042102; P:positive regulation of T cell proliferation; IDA:UniProtKB
Q12836	ZP4	Zona pellucida sperm-binding protein 4	GO:0010737; P:protein kinase A signaling; IDA:UniProtKB
Q12836	ZP4	Zona pellucida sperm-binding protein 4	GO:0070528; P:protein kinase C signaling; IMP:UniProtKB
Q12836	ZP4	Zona pellucida sperm-binding protein 4	GO:0007338; P:single fertilization; TAS:Reactome
Q9BS86	ZPBP	Zona pellucida-binding protein 1	GO:0001675; P:acrosome assembly; IEA:Ensembl
Q9BS86	ZPBP	Zona pellucida-binding protein 1	GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl
Q6X784	ZPBP2	Zona pellucida-binding protein 2	GO:0001675; P:acrosome assembly; IEA:Ensembl
Q6X784	ZPBP2	Zona pellucida-binding protein 2	GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl
Q9UK55	SERPINA10	Protein Z-dependent protease inhibitor	GO:0008201; F:heparin binding; IEA:UniProtKB-KW
Q9UK55	SERPINA10	Protein Z-dependent protease inhibitor	GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:RefGenome
Q9UK55	SERPINA10	Protein Z-dependent protease inhibitor	GO:0007596; P:blood coagulation; IEA:UniProtKB-KW
Q9UK55	SERPINA10	Protein Z-dependent protease inhibitor	GO:0010951; P:negative regulation of endopeptidase activity; IBA:RefGenome
Q9UK55	SERPINA10	Protein Z-dependent protease inhibitor	GO:0030162; P:regulation of proteolysis; IBA:RefGenome
O75312	ZPR1	Zinc finger protein ZPR1	GO:0005515; F:protein binding; IPI:UniProtKB
O75312	ZPR1	Zinc finger protein ZPR1	GO:0031369; F:translation initiation factor binding; IPI:UniProtKB
O75312	ZPR1	Zinc finger protein ZPR1	GO:0008270; F:zinc ion binding; IEA:Ensembl
O75312	ZPR1	Zinc finger protein ZPR1	GO:1902742; P:apoptotic process involved in development; ISS:UniProtKB
O75312	ZPR1	Zinc finger protein ZPR1	GO:0061564; P:axon development; IMP:UniProtKB
O75312	ZPR1	Zinc finger protein ZPR1	GO:0030576; P:Cajal body organization; IMP:UniProtKB
O75312	ZPR1	Zinc finger protein ZPR1	GO:0008283; P:cell proliferation; TAS:ProtInc
O75312	ZPR1	Zinc finger protein ZPR1	GO:0071364; P:cellular response to epidermal growth factor stimulus; IDA:UniProtKB
O75312	ZPR1	Zinc finger protein ZPR1	GO:0042023; P:DNA endoreduplication; ISS:UniProtKB
O75312	ZPR1	Zinc finger protein ZPR1	GO:0000226; P:microtubule cytoskeleton organization; ISS:UniProtKB
O75312	ZPR1	Zinc finger protein ZPR1	GO:2000672; P:negative regulation of motor neuron apoptotic process; ISS:UniProtKB
O75312	ZPR1	Zinc finger protein ZPR1	GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB
O75312	ZPR1	Zinc finger protein ZPR1	GO:0045927; P:positive regulation of growth; ISS:UniProtKB
O75312	ZPR1	Zinc finger protein ZPR1	GO:0042307; P:positive regulation of protein import into nucleus; IDA:UniProtKB
O75312	ZPR1	Zinc finger protein ZPR1	GO:0033120; P:positive regulation of RNA splicing; IMP:UniProtKB
O75312	ZPR1	Zinc finger protein ZPR1	GO:0071931; P:positive regulation of transcription involved in G1/S transition of mitotic cell cycle; IMP:UniProtKB
O75312	ZPR1	Zinc finger protein ZPR1	GO:1990261; P:pre-mRNA catabolic process; IMP:UniProtKB
O75312	ZPR1	Zinc finger protein ZPR1	GO:0031641; P:regulation of myelination; ISS:UniProtKB
O75312	ZPR1	Zinc finger protein ZPR1	GO:0007165; P:signal transduction; TAS:ProtInc
O75312	ZPR1	Zinc finger protein ZPR1	GO:0021510; P:spinal cord development; ISS:UniProtKB
O75312	ZPR1	Zinc finger protein ZPR1	GO:0001834; P:trophectodermal cell proliferation; ISS:UniProtKB
O95218	ZRANB2	Zinc finger Ran-binding domain-containing protein 2	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
O95218	ZRANB2	Zinc finger Ran-binding domain-containing protein 2	GO:0005515; F:protein binding; IPI:IntAct
O95218	ZRANB2	Zinc finger Ran-binding domain-containing protein 2	GO:0003723; F:RNA binding; TAS:ProtInc
O95218	ZRANB2	Zinc finger Ran-binding domain-containing protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc
O95218	ZRANB2	Zinc finger Ran-binding domain-containing protein 2	GO:0008270; F:zinc ion binding; IEA:InterPro
O95218	ZRANB2	Zinc finger Ran-binding domain-containing protein 2	GO:0006397; P:mRNA processing; IEA:UniProtKB-KW
O95218	ZRANB2	Zinc finger Ran-binding domain-containing protein 2	GO:0006355; P:regulation of transcription, DNA-templated; TAS:GOC
O95218	ZRANB2	Zinc finger Ran-binding domain-containing protein 2	GO:0008380; P:RNA splicing; TAS:ProtInc
Q5FWF4	ZRANB3	DNA annealing helicase and endonuclease ZRANB3	GO:0036310; F:annealing helicase activity; IDA:UniProtKB
Q5FWF4	ZRANB3	DNA annealing helicase and endonuclease ZRANB3	GO:0005524; F:ATP binding; IEA:UniProtKB-KW
Q5FWF4	ZRANB3	DNA annealing helicase and endonuclease ZRANB3	GO:0003677; F:DNA binding; IEA:InterPro
Q5FWF4	ZRANB3	DNA annealing helicase and endonuclease ZRANB3	GO:0004520; F:endodeoxyribonuclease activity; IDA:UniProtKB
Q5FWF4	ZRANB3	DNA annealing helicase and endonuclease ZRANB3	GO:0004386; F:helicase activity; IEA:UniProtKB-KW
Q5FWF4	ZRANB3	DNA annealing helicase and endonuclease ZRANB3	GO:0070530; F:K63-linked polyubiquitin binding; IDA:UniProtKB
Q5FWF4	ZRANB3	DNA annealing helicase and endonuclease ZRANB3	GO:0005515; F:protein binding; IPI:UniProtKB
Q5FWF4	ZRANB3	DNA annealing helicase and endonuclease ZRANB3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q5FWF4	ZRANB3	DNA annealing helicase and endonuclease ZRANB3	GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB
Q5FWF4	ZRANB3	DNA annealing helicase and endonuclease ZRANB3	GO:0000737; P:DNA catabolic process, endonucleolytic; IDA:GOC
Q5FWF4	ZRANB3	DNA annealing helicase and endonuclease ZRANB3	GO:0006281; P:DNA repair; IDA:UniProtKB
Q5FWF4	ZRANB3	DNA annealing helicase and endonuclease ZRANB3	GO:0036292; P:DNA rewinding; IDA:UniProtKB
Q5FWF4	ZRANB3	DNA annealing helicase and endonuclease ZRANB3	GO:0000733; P:DNA strand renaturation; IDA:GOC
Q5FWF4	ZRANB3	DNA annealing helicase and endonuclease ZRANB3	GO:0045910; P:negative regulation of DNA recombination; IDA:UniProtKB
Q5FWF4	ZRANB3	DNA annealing helicase and endonuclease ZRANB3	GO:0031297; P:replication fork processing; IDA:UniProtKB
Q5FWF4	ZRANB3	DNA annealing helicase and endonuclease ZRANB3	GO:0048478; P:replication fork protection; IDA:UniProtKB
Q5FWF4	ZRANB3	DNA annealing helicase and endonuclease ZRANB3	GO:0009411; P:response to UV; IDA:UniProtKB
Q9UGI0	ZRANB1	Ubiquitin thioesterase ZRANB1	GO:0070530; F:K63-linked polyubiquitin binding; IDA:BHF-UCL
Q9UGI0	ZRANB1	Ubiquitin thioesterase ZRANB1	GO:0005515; F:protein binding; IPI:UniProtKB
Q9UGI0	ZRANB1	Ubiquitin thioesterase ZRANB1	GO:0004221; F:ubiquitin thiolesterase activity; IMP:UniProtKB
Q9UGI0	ZRANB1	Ubiquitin thioesterase ZRANB1	GO:0004843; F:ubiquitin-specific protease activity; IDA:UniProtKB
Q9UGI0	ZRANB1	Ubiquitin thioesterase ZRANB1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9UGI0	ZRANB1	Ubiquitin thioesterase ZRANB1	GO:0016477; P:cell migration; IMP:UniProtKB
Q9UGI0	ZRANB1	Ubiquitin thioesterase ZRANB1	GO:0007010; P:cytoskeleton organization; IMP:UniProtKB
Q9UGI0	ZRANB1	Ubiquitin thioesterase ZRANB1	GO:0030177; P:positive regulation of Wnt signaling pathway; IMP:UniProtKB
Q9UGI0	ZRANB1	Ubiquitin thioesterase ZRANB1	GO:0071947; P:protein deubiquitination involved in ubiquitin-dependent protein catabolic process; IMP:BHF-UCL
Q9UGI0	ZRANB1	Ubiquitin thioesterase ZRANB1	GO:0035523; P:protein K29-linked deubiquitination; IDA:UniProtKB
Q9UGI0	ZRANB1	Ubiquitin thioesterase ZRANB1	GO:1990168; P:protein K33-linked deubiquitination; IDA:UniProtKB
Q9UGI0	ZRANB1	Ubiquitin thioesterase ZRANB1	GO:0070536; P:protein K63-linked deubiquitination; IDA:UniProtKB
Q9UGI0	ZRANB1	Ubiquitin thioesterase ZRANB1	GO:0022604; P:regulation of cell morphogenesis; IMP:UniProtKB
Q9UGI0	ZRANB1	Ubiquitin thioesterase ZRANB1	GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW
Q9BUG6	ZSCAN5A	Zinc finger and SCAN domain-containing protein 5A	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9BUG6	ZSCAN5A	Zinc finger and SCAN domain-containing protein 5A	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9BUG6	ZSCAN5A	Zinc finger and SCAN domain-containing protein 5A	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q9BUG6	ZSCAN5A	Zinc finger and SCAN domain-containing protein 5A	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
Q9BUG6	ZSCAN5A	Zinc finger and SCAN domain-containing protein 5A	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
A6NJL1	ZSCAN5B	Zinc finger and SCAN domain-containing protein 5B	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
A6NJL1	ZSCAN5B	Zinc finger and SCAN domain-containing protein 5B	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A6NJL1	ZSCAN5B	Zinc finger and SCAN domain-containing protein 5B	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
A6NJL1	ZSCAN5B	Zinc finger and SCAN domain-containing protein 5B	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
A6NJL1	ZSCAN5B	Zinc finger and SCAN domain-containing protein 5B	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
P0CG00	ZSCAN5D	Putative zinc finger and SCAN domain-containing protein 5D	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P0CG00	ZSCAN5D	Putative zinc finger and SCAN domain-containing protein 5D	GO:0003676; F:nucleic acid binding; IEA:InterPro
P0CG00	ZSCAN5D	Putative zinc finger and SCAN domain-containing protein 5D	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P0CG00	ZSCAN5D	Putative zinc finger and SCAN domain-containing protein 5D	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96SZ4	ZSCAN10	Zinc finger and SCAN domain-containing protein 10	GO:0046872; F:metal ion binding; IEA:InterPro
Q96SZ4	ZSCAN10	Zinc finger and SCAN domain-containing protein 10	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q96SZ4	ZSCAN10	Zinc finger and SCAN domain-containing protein 10	GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB
Q96SZ4	ZSCAN10	Zinc finger and SCAN domain-containing protein 10	GO:0003700; F:sequence-specific DNA binding transcription factor activity; ISS:UniProtKB
Q96SZ4	ZSCAN10	Zinc finger and SCAN domain-containing protein 10	GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB
Q96SZ4	ZSCAN10	Zinc finger and SCAN domain-containing protein 10	GO:0006355; P:regulation of transcription, DNA-templated; IBA:RefGenome
Q96SZ4	ZSCAN10	Zinc finger and SCAN domain-containing protein 10	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
A6NGD5	ZSCAN5C	Zinc finger and SCAN domain-containing protein 5C	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
A6NGD5	ZSCAN5C	Zinc finger and SCAN domain-containing protein 5C	GO:0003676; F:nucleic acid binding; IEA:InterPro
A6NGD5	ZSCAN5C	Zinc finger and SCAN domain-containing protein 5C	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
A6NGD5	ZSCAN5C	Zinc finger and SCAN domain-containing protein 5C	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
A6NGD5	ZSCAN5C	Zinc finger and SCAN domain-containing protein 5C	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
O43309	ZSCAN12	Zinc finger and SCAN domain-containing protein 12	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O43309	ZSCAN12	Zinc finger and SCAN domain-containing protein 12	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O43309	ZSCAN12	Zinc finger and SCAN domain-containing protein 12	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O43309	ZSCAN12	Zinc finger and SCAN domain-containing protein 12	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9H4T2	ZSCAN16	Zinc finger and SCAN domain-containing protein 16	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9H4T2	ZSCAN16	Zinc finger and SCAN domain-containing protein 16	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H4T2	ZSCAN16	Zinc finger and SCAN domain-containing protein 16	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9H4T2	ZSCAN16	Zinc finger and SCAN domain-containing protein 16	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P17040	ZSCAN20	Zinc finger and SCAN domain-containing protein 20	GO:0003682; F:chromatin binding; IEA:InterPro
P17040	ZSCAN20	Zinc finger and SCAN domain-containing protein 20	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P17040	ZSCAN20	Zinc finger and SCAN domain-containing protein 20	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P17040	ZSCAN20	Zinc finger and SCAN domain-containing protein 20	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P17040	ZSCAN20	Zinc finger and SCAN domain-containing protein 20	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8TBC5	ZSCAN18	Zinc finger and SCAN domain-containing protein 18	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8TBC5	ZSCAN18	Zinc finger and SCAN domain-containing protein 18	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8TBC5	ZSCAN18	Zinc finger and SCAN domain-containing protein 18	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q8TBC5	ZSCAN18	Zinc finger and SCAN domain-containing protein 18	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
Q8TBC5	ZSCAN18	Zinc finger and SCAN domain-containing protein 18	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q9Y5A6	ZSCAN21	Zinc finger and SCAN domain-containing protein 21	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9Y5A6	ZSCAN21	Zinc finger and SCAN domain-containing protein 21	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9Y5A6	ZSCAN21	Zinc finger and SCAN domain-containing protein 21	GO:0005515; F:protein binding; IPI:UniProtKB
Q9Y5A6	ZSCAN21	Zinc finger and SCAN domain-containing protein 21	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q9Y5A6	ZSCAN21	Zinc finger and SCAN domain-containing protein 21	GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl
Q9Y5A6	ZSCAN21	Zinc finger and SCAN domain-containing protein 21	GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB
Q9Y5A6	ZSCAN21	Zinc finger and SCAN domain-containing protein 21	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q3MJ62	ZSCAN23	Zinc finger and SCAN domain-containing protein 23	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q3MJ62	ZSCAN23	Zinc finger and SCAN domain-containing protein 23	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q3MJ62	ZSCAN23	Zinc finger and SCAN domain-containing protein 23	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q3MJ62	ZSCAN23	Zinc finger and SCAN domain-containing protein 23	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P10073	ZSCAN22	Zinc finger and SCAN domain-containing protein 22	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
P10073	ZSCAN22	Zinc finger and SCAN domain-containing protein 22	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P10073	ZSCAN22	Zinc finger and SCAN domain-containing protein 22	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
P10073	ZSCAN22	Zinc finger and SCAN domain-containing protein 22	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q6NSZ9	ZSCAN25	Zinc finger and SCAN domain-containing protein 25	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q6NSZ9	ZSCAN25	Zinc finger and SCAN domain-containing protein 25	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q6NSZ9	ZSCAN25	Zinc finger and SCAN domain-containing protein 25	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q6NSZ9	ZSCAN25	Zinc finger and SCAN domain-containing protein 25	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q16670	ZSCAN26	Zinc finger and SCAN domain-containing protein 26	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q16670	ZSCAN26	Zinc finger and SCAN domain-containing protein 26	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q16670	ZSCAN26	Zinc finger and SCAN domain-containing protein 26	GO:0003700; F:sequence-specific DNA binding transcription factor activity; NAS:UniProtKB
Q16670	ZSCAN26	Zinc finger and SCAN domain-containing protein 26	GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB
Q16670	ZSCAN26	Zinc finger and SCAN domain-containing protein 26	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8IWY8	ZSCAN29	Zinc finger and SCAN domain-containing protein 29	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IWY8	ZSCAN29	Zinc finger and SCAN domain-containing protein 29	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8IWY8	ZSCAN29	Zinc finger and SCAN domain-containing protein 29	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q8IWY8	ZSCAN29	Zinc finger and SCAN domain-containing protein 29	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
Q8IWY8	ZSCAN29	Zinc finger and SCAN domain-containing protein 29	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q86W11	ZSCAN30	Zinc finger and SCAN domain-containing protein 30	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q86W11	ZSCAN30	Zinc finger and SCAN domain-containing protein 30	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q86W11	ZSCAN30	Zinc finger and SCAN domain-containing protein 30	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q86W11	ZSCAN30	Zinc finger and SCAN domain-containing protein 30	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q96LW9	ZSCAN31	Zinc finger and SCAN domain-containing protein 31	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q96LW9	ZSCAN31	Zinc finger and SCAN domain-containing protein 31	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q96LW9	ZSCAN31	Zinc finger and SCAN domain-containing protein 31	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q96LW9	ZSCAN31	Zinc finger and SCAN domain-containing protein 31	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q9NX65	ZSCAN32	Zinc finger and SCAN domain-containing protein 32	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q9NX65	ZSCAN32	Zinc finger and SCAN domain-containing protein 32	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9NX65	ZSCAN32	Zinc finger and SCAN domain-containing protein 32	GO:0005515; F:protein binding; IPI:IntAct
Q9NX65	ZSCAN32	Zinc finger and SCAN domain-containing protein 32	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q9NX65	ZSCAN32	Zinc finger and SCAN domain-containing protein 32	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
Q9NX65	ZSCAN32	Zinc finger and SCAN domain-containing protein 32	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q7Z7L9	ZSCAN2	Zinc finger and SCAN domain-containing protein 2	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q7Z7L9	ZSCAN2	Zinc finger and SCAN domain-containing protein 2	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q7Z7L9	ZSCAN2	Zinc finger and SCAN domain-containing protein 2	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q7Z7L9	ZSCAN2	Zinc finger and SCAN domain-containing protein 2	GO:0030154; P:cell differentiation; IEA:UniProtKB-KW
Q7Z7L9	ZSCAN2	Zinc finger and SCAN domain-containing protein 2	GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW
Q7Z7L9	ZSCAN2	Zinc finger and SCAN domain-containing protein 2	GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW
Q7Z7L9	ZSCAN2	Zinc finger and SCAN domain-containing protein 2	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
O15535	ZSCAN9	Zinc finger and SCAN domain-containing protein 9	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
O15535	ZSCAN9	Zinc finger and SCAN domain-containing protein 9	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
O15535	ZSCAN9	Zinc finger and SCAN domain-containing protein 9	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
O15535	ZSCAN9	Zinc finger and SCAN domain-containing protein 9	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NAM6	ZSCAN4	Zinc finger and SCAN domain-containing protein 4	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NAM6	ZSCAN4	Zinc finger and SCAN domain-containing protein 4	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NAM6	ZSCAN4	Zinc finger and SCAN domain-containing protein 4	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro
Q8NAM6	ZSCAN4	Zinc finger and SCAN domain-containing protein 4	GO:0010833; P:telomere maintenance via telomere lengthening; ISS:UniProtKB
Q8NAM6	ZSCAN4	Zinc finger and SCAN domain-containing protein 4	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q8NBB4	ZSCAN1	Zinc finger and SCAN domain-containing protein 1	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8NBB4	ZSCAN1	Zinc finger and SCAN domain-containing protein 1	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q8NBB4	ZSCAN1	Zinc finger and SCAN domain-containing protein 1	GO:0000981; F:sequence-specific DNA binding RNA polymerase II transcription factor activity; IBA:RefGenome
Q8NBB4	ZSCAN1	Zinc finger and SCAN domain-containing protein 1	GO:0003713; F:transcription coactivator activity; IBA:RefGenome
Q8NBB4	ZSCAN1	Zinc finger and SCAN domain-containing protein 1	GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IBA:GOC
Q8NBB4	ZSCAN1	Zinc finger and SCAN domain-containing protein 1	GO:0006366; P:transcription from RNA polymerase II promoter; IBA:GOC
Q8NEG5	ZSWIM2	E3 ubiquitin-protein ligase ZSWIM2	GO:0004842; F:ubiquitin-protein ligase activity; IEA:Ensembl
Q8NEG5	ZSWIM2	E3 ubiquitin-protein ligase ZSWIM2	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8NEG5	ZSWIM2	E3 ubiquitin-protein ligase ZSWIM2	GO:0006915; P:apoptotic process; IEA:UniProtKB-KW
Q8NEG5	ZSWIM2	E3 ubiquitin-protein ligase ZSWIM2	GO:1902043; P:positive regulation of extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl
Q8NEG5	ZSWIM2	E3 ubiquitin-protein ligase ZSWIM2	GO:0000209; P:protein polyubiquitination; IEA:Ensembl
Q9BR11	ZSWIM1	Zinc finger SWIM domain-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96MP5	ZSWIM3	Zinc finger SWIM domain-containing protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9H7M6	ZSWIM4	Zinc finger SWIM domain-containing protein 4	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9HCJ5	ZSWIM6	Zinc finger SWIM domain-containing protein 6	GO:0008270; F:zinc ion binding; IEA:InterPro
Q9HCJ5	ZSWIM6	Zinc finger SWIM domain-containing protein 6	GO:0048812; P:neuron projection morphogenesis; IEA:Ensembl
Q9HCJ5	ZSWIM6	Zinc finger SWIM domain-containing protein 6	GO:2001222; P:regulation of neuron migration; IEA:Ensembl
Q9P217	ZSWIM5	Zinc finger SWIM domain-containing protein 5	GO:0008270; F:zinc ion binding; IEA:InterPro
Q19AV6	ZSWIM7	Zinc finger SWIM domain-containing protein 7	GO:0005515; F:protein binding; IPI:IntAct
Q19AV6	ZSWIM7	Zinc finger SWIM domain-containing protein 7	GO:0008270; F:zinc ion binding; IEA:InterPro
Q19AV6	ZSWIM7	Zinc finger SWIM domain-containing protein 7	GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB
Q19AV6	ZSWIM7	Zinc finger SWIM domain-containing protein 7	GO:0050821; P:protein stabilization; IMP:UniProtKB
A7E2V4	ZSWIM8	Zinc finger SWIM domain-containing protein 8	GO:0008270; F:zinc ion binding; IEA:InterPro
Q96AP4	ZUFSP	Zinc finger with UFM1-specific peptidase domain protein	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q9H900	ZWILCH	Protein zwilch homolog	GO:0005515; F:protein binding; IPI:UniProtKB
Q9H900	ZWILCH	Protein zwilch homolog	GO:0007067; P:mitosis; IEA:UniProtKB-KW
Q9H900	ZWILCH	Protein zwilch homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
Q9H900	ZWILCH	Protein zwilch homolog	GO:0007093; P:mitotic cell cycle checkpoint; IMP:UniProtKB
O43264	ZW10	Centromere/kinetochore protein zw10 homolog	GO:0019237; F:centromeric DNA binding; TAS:ProtInc
O43264	ZW10	Centromere/kinetochore protein zw10 homolog	GO:0005515; F:protein binding; IPI:UniProtKB
O43264	ZW10	Centromere/kinetochore protein zw10 homolog	GO:0006888; P:ER to Golgi vesicle-mediated transport; IMP:HGNC
O43264	ZW10	Centromere/kinetochore protein zw10 homolog	GO:0000132; P:establishment of mitotic spindle orientation; IMP:UniProtKB
O43264	ZW10	Centromere/kinetochore protein zw10 homolog	GO:0007126; P:meiotic nuclear division; TAS:ProtInc
O43264	ZW10	Centromere/kinetochore protein zw10 homolog	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O43264	ZW10	Centromere/kinetochore protein zw10 homolog	GO:0007093; P:mitotic cell cycle checkpoint; IDA:UniProtKB
O43264	ZW10	Centromere/kinetochore protein zw10 homolog	GO:0007080; P:mitotic metaphase plate congression; IMP:UniProtKB
O43264	ZW10	Centromere/kinetochore protein zw10 homolog	GO:0000070; P:mitotic sister chromatid segregation; IDA:HGNC
O43264	ZW10	Centromere/kinetochore protein zw10 homolog	GO:0006461; P:protein complex assembly; IDA:HGNC
O43264	ZW10	Centromere/kinetochore protein zw10 homolog	GO:0034501; P:protein localization to kinetochore; IMP:UniProtKB
O43264	ZW10	Centromere/kinetochore protein zw10 homolog	GO:0015031; P:protein transport; IEA:UniProtKB-KW
O43264	ZW10	Centromere/kinetochore protein zw10 homolog	GO:0007096; P:regulation of exit from mitosis; IDA:HGNC
O95229	ZWINT	ZW10 interactor	GO:0005515; F:protein binding; IPI:UniProtKB
O95229	ZWINT	ZW10 interactor	GO:0047485; F:protein N-terminus binding; IPI:HGNC
O95229	ZWINT	ZW10 interactor	GO:0007049; P:cell cycle; NAS:UniProtKB
O95229	ZWINT	ZW10 interactor	GO:0051649; P:establishment of localization in cell; IDA:HGNC
O95229	ZWINT	ZW10 interactor	GO:0000278; P:mitotic cell cycle; TAS:Reactome
O95229	ZWINT	ZW10 interactor	GO:0007093; P:mitotic cell cycle checkpoint; IDA:HGNC
O95229	ZWINT	ZW10 interactor	GO:0000070; P:mitotic sister chromatid segregation; IDA:HGNC
O95229	ZWINT	ZW10 interactor	GO:0048015; P:phosphatidylinositol-mediated signaling; NAS:UniProtKB
O95229	ZWINT	ZW10 interactor	GO:0007051; P:spindle organization; NAS:UniProtKB
P98168	ZXDA	Zinc finger X-linked protein ZXDA	GO:0070742; F:C2H2 zinc finger domain binding; IPI:UniProtKB
P98168	ZXDA	Zinc finger X-linked protein ZXDA	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P98168	ZXDA	Zinc finger X-linked protein ZXDA	GO:0003676; F:nucleic acid binding; IEA:InterPro
P98168	ZXDA	Zinc finger X-linked protein ZXDA	GO:0005515; F:protein binding; IPI:UniProtKB
P98168	ZXDA	Zinc finger X-linked protein ZXDA	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IMP:UniProtKB
P98168	ZXDA	Zinc finger X-linked protein ZXDA	GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB
P98168	ZXDA	Zinc finger X-linked protein ZXDA	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
P98169	ZXDB	Zinc finger X-linked protein ZXDB	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
P98169	ZXDB	Zinc finger X-linked protein ZXDB	GO:0003676; F:nucleic acid binding; IEA:InterPro
P98169	ZXDB	Zinc finger X-linked protein ZXDB	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
P98169	ZXDB	Zinc finger X-linked protein ZXDB	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q2QGD7	ZXDC	Zinc finger protein ZXDC	GO:0070742; F:C2H2 zinc finger domain binding; IPI:UniProtKB
Q2QGD7	ZXDC	Zinc finger protein ZXDC	GO:0030275; F:LRR domain binding; IPI:UniProtKB
Q2QGD7	ZXDC	Zinc finger protein ZXDC	GO:0046872; F:metal ion binding; IEA:UniProtKB-KW
Q2QGD7	ZXDC	Zinc finger protein ZXDC	GO:0003676; F:nucleic acid binding; IEA:InterPro
Q2QGD7	ZXDC	Zinc finger protein ZXDC	GO:0005515; F:protein binding; IPI:UniProtKB
Q2QGD7	ZXDC	Zinc finger protein ZXDC	GO:0003700; F:sequence-specific DNA binding transcription factor activity; IMP:UniProtKB
Q2QGD7	ZXDC	Zinc finger protein ZXDC	GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB
Q2QGD7	ZXDC	Zinc finger protein ZXDC	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW
Q15942	ZYX	Zyxin	GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB
Q15942	ZYX	Zyxin	GO:0005515; F:protein binding; IPI:IntAct
Q15942	ZYX	Zyxin	GO:0008270; F:zinc ion binding; IEA:InterPro
Q15942	ZYX	Zyxin	GO:0007155; P:cell adhesion; TAS:ProtInc
Q15942	ZYX	Zyxin	GO:0007267; P:cell-cell signaling; TAS:ProtInc
Q15942	ZYX	Zyxin	GO:0050727; P:regulation of inflammatory response; IEA:Ensembl
Q15942	ZYX	Zyxin	GO:0007165; P:signal transduction; TAS:ProtInc
Q15942	ZYX	Zyxin	GO:0016032; P:viral process; IEA:UniProtKB-KW
O43149	ZZEF1	Zinc finger ZZ-type and EF-hand domain-containing protein 1	GO:0005509; F:calcium ion binding; IEA:InterPro
O43149	ZZEF1	Zinc finger ZZ-type and EF-hand domain-containing protein 1	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IYH5	ZZZ3	ZZ-type zinc finger-containing protein 3	GO:0003682; F:chromatin binding; IEA:InterPro
Q8IYH5	ZZZ3	ZZ-type zinc finger-containing protein 3	GO:0003677; F:DNA binding; IEA:UniProtKB-KW
Q8IYH5	ZZZ3	ZZ-type zinc finger-containing protein 3	GO:0005515; F:protein binding; IPI:IntAct
Q8IYH5	ZZZ3	ZZ-type zinc finger-containing protein 3	GO:0008270; F:zinc ion binding; IEA:InterPro
Q8IYH5	ZZZ3	ZZ-type zinc finger-containing protein 3	GO:0006325; P:chromatin organization; TAS:Reactome
Q8IYH5	ZZZ3	ZZ-type zinc finger-containing protein 3	GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW
Q8IYH5	ZZZ3	ZZ-type zinc finger-containing protein 3	GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW